PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Oza, J; Ganguly, B; Kulkarni, A; Ginjala, V; Yao, M; Ganesan, S				Oza, Jay; Ganguly, Bratati; Kulkarni, Atul; Ginjala, Vasudeva; Yao, Ming; Ganesan, Shridar			A Novel Role of Chromodomain Protein CBX8 in DNA Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; CHROMATIN DYNAMICS; STEM-CELLS; POLYCOMB; REPAIR; COMPLEXES; CANCER; POLY(ADP-RIBOSYL)ATION; RECRUITMENT; FAMILY	Induction of DNA damage induces a dynamic repair process involving DNA repair factors and epigenetic regulators. Chromatin alterations must occur for DNA repair factors to gain access to DNA lesions and restore original chromatin configuration to preserve the gene expression profile. We characterize the novel role of CBX8, a chromodomain-containing protein with established roles in epigenetic regulation in DNA damage response. CBX8 protein rapidly accumulates at the sites of DNA damage within 30 s and progresses to accumulate until 4 min before gradually dispersing back to its predamage distribution by 15 min. CBX8 recruitment to the sites of DNA damage is dependent upon PARP1 activation and not dependent on ATM activation. CBX8 biochemically interacts with TRIM33, and its recruitment to DNA damage is also dependent on the presence of TRIM33. Knockdown of CBX8 using siRNA significantly reduces the efficiency of both homologous and the other non-homologous recombination, as well as increases sensitivity of cells to ionizing radiation. These findings demonstrate that CBX8 functions in the PARP-dependent DNA damage response partly through interaction with TRIM33 and is required for efficient DNA repair.	[Oza, Jay] Rutgers Robert Wood Johnson Med Sch, MD PhD Program, New Brunswick, NJ 08903 USA; [Oza, Jay; Ganesan, Shridar] Rutgers Grad Sch Biomed Sci, Dept Cellular & Mol Pharmacol, Piscataway, NJ 08854 USA; [Oza, Jay; Ganguly, Bratati; Kulkarni, Atul; Ginjala, Vasudeva; Yao, Ming; Ganesan, Shridar] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Oza, Jay] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Dartmouth College	Ganesan, S (corresponding author), Rutgers Grad Sch Biomed Sci, Dept Cellular & Mol Pharmacol, Piscataway, NJ 08854 USA.; Ganesan, S (corresponding author), Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA.	ganesash@cinj.rutgers.edu	Oza, Jay/ABG-8272-2021; Ginjala, Vasudeva/E-5869-2019	Oza, Jay/0000-0001-6050-1913	New Jersey State Commission on Cancer Research [808057]; Department of Defense Breast Cancer Research Program Award [W81XWH-10-BCRP-PREDOC]; NCI; National Institutes of Health; Val Skinner Foundation; Hugs for Brady Foundation; Triple Negative Breast Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA169182, P30CA072720] Funding Source: NIH RePORTER	New Jersey State Commission on Cancer Research; Department of Defense Breast Cancer Research Program Award(United States Department of Defense); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Val Skinner Foundation; Hugs for Brady Foundation; Triple Negative Breast Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Fellowship 808057 from the New Jersey State Commission on Cancer Research (to J. O.), Department of Defense Breast Cancer Research Program Award W81XWH-10-BCRP-PREDOC (to J. O.), and funding from the NCI, National Institutes of Health, the Val Skinner Foundation, Hugs for Brady Foundation and the Triple Negative Breast Cancer Foundation (to S. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; Bardos JI, 2000, J BIOL CHEM, V275, P28785, DOI 10.1074/jbc.M001835200; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Camahort R, 2012, CELL STEM CELL, V10, P4, DOI 10.1016/j.stem.2011.12.011; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dedes KJ, 2011, CELL CYCLE, V10, P1192, DOI 10.4161/cc.10.8.15273; Dungrawala H, 2015, MOL CELL, V59, P998, DOI 10.1016/j.molcel.2015.07.030; Eustermann S, 2010, NAT STRUCT MOL BIOL, V17, P241, DOI 10.1038/nsmb.1747; Facchino S, 2010, J NEUROSCI, V30, P10096, DOI 10.1523/JNEUROSCI.1634-10.2010; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Ganguly Bratati, 2016, Biomark Cancer, V8, P15, DOI 10.4137/BIC.S36679; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Ginjala V, 2011, MOL CELL BIOL, V31, P1972, DOI 10.1128/MCB.00981-10; Haince JF, 2008, J BIOL CHEM, V283, P1197, DOI 10.1074/jbc.M706734200; Hemenway CS, 2001, ONCOGENE, V20, P3798, DOI 10.1038/sj.onc.1204478; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; House NCM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00296; Huertas D, 2009, EPIGENETICS-US, V4, P31, DOI 10.4161/epi.4.1.7733; Ismail IH, 2010, J CELL BIOL, V191, P45, DOI 10.1083/jcb.201003034; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jasin M, 1996, TRENDS GENET, V12, P224, DOI 10.1016/0168-9525(96)10019-6; JONES GDD, 1995, INT J RADIAT BIOL, V67, P647, DOI 10.1080/09553009514550761; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Kaustov L, 2011, J BIOL CHEM, V286, P521, DOI 10.1074/jbc.M110.191411; Kohler C, 2008, TRENDS CELL BIOL, V18, P236, DOI 10.1016/j.tcb.2008.02.005; Kulkarni A, 2013, J BIOL CHEM, V288, P32357, DOI 10.1074/jbc.M113.459164; Lafon-Hughes L, 2008, MUTAT RES-REV MUTAT, V658, P191, DOI 10.1016/j.mrrev.2008.01.008; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Moding EJ, 2013, NAT REV DRUG DISCOV, V12, P526, DOI 10.1038/nrd4003; Morey L, 2012, CELL STEM CELL, V10, P47, DOI 10.1016/j.stem.2011.12.006; Mortusewicz O, 2007, NUCLEIC ACIDS RES, V35, P7665, DOI 10.1093/nar/gkm933; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Nakayama T, 2009, SEMIN IMMUNOL, V21, P78, DOI 10.1016/j.smim.2009.02.001; O'Loghlen A, 2012, CELL STEM CELL, V10, P33, DOI 10.1016/j.stem.2011.12.004; PARO R, 1991, P NATL ACAD SCI USA, V88, P263, DOI 10.1073/pnas.88.1.263; Quenet D, 2009, INT J BIOCHEM CELL B, V41, P60, DOI 10.1016/j.biocel.2008.07.023; Reliene R, 2007, ADV GENET, V58, P67, DOI 10.1016/S0065-2660(06)58003-4; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Sauvageau M, 2008, PLOS BIOL, V6, P678, DOI 10.1371/journal.pbio.0060113; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Senthilkumar R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-549; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Sinha M, 2009, EPIGENOMICS-UK, V1, P371, DOI 10.2217/epi.09.22; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Vincenz C, 2008, P NATL ACAD SCI USA, V105, P16572, DOI 10.1073/pnas.0805317105; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Xiao WF, 2014, INT J CLIN EXP PATHO, V7, P4817; Xu Bo, 2004, Methods Mol Biol, V281, P283; Xu Y, 2011, CELL CYCLE, V10, P261, DOI 10.4161/cc.10.2.14543; Yan KP, 2004, GENE, V334, P3, DOI 10.1016/j.gene.2004.02.056	62	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					22881	22893		10.1074/jbc.M116.725879	http://dx.doi.org/10.1074/jbc.M116.725879			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27555324	hybrid, Green Published			2022-12-26	WOS:000387224800003
J	Liu, LK; Abdelwahab, H; Del Campo, JSM; Mehra-Chaudhary, R; Sobrado, P; Tanner, JJ				Liu, Li-Kai; Abdelwahab, Heba; Campo, Julia S. Martin Del; Mehra-Chaudhary, Ritcha; Sobrado, Pablo; Tanner, John J.			The Structure of the Antibiotic Deactivating, N-hydroxylating Rifampicin Monooxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; enzyme structure; flavoprotein; small-angle X-ray scattering (SAXS); x-ray crystallography	SMALL-ANGLE SCATTERING; FLAVOPROTEIN MONOOXYGENASES; SUBSTRATE RECOGNITION; STRUCTURE REFINEMENT; CRYSTAL-STRUCTURE; RNA-POLYMERASE; BETA-SUBUNIT; RESISTANCE; BIOSYNTHESIS; GENE	Rifampicin monooxygenase (RIFMO) catalyzes the N-hydroxylation of the natural product antibiotic rifampicin (RIF) to 2-N-hydroxy-4-oxo-rifampicin, a metabolite with much lower antimicrobial activity. RIFMO shares moderate sequence similarity with well characterized flavoprotein monooxygenases, but the protein has not been isolated and characterized at the molecular level. Herein, we report crystal structures of RIFMO from Nocardia farcinica, the determination of the oligomeric state in solution with small angle x-ray scattering, and the spectrophotometric characterization of substrate binding. The structure identifies RIFMO as a class A flavoprotein monooxygenase and is similar in fold and quaternary structure to MtmOIV and OxyS, which are enzymes in the mithramycin and oxytetracycline biosynthetic pathways, respectively. RIFMO is distinguished from other class A flavoprotein monooxygenases by its unique middle domain, which is involved in binding RIF. Small angle x-ray scattering analysis shows that RIFMO dimerizes via the FAD-binding domain to form a bell-shaped homodimer in solution with a maximal dimension of 110 . RIF binding was monitored using absorbance at 525 nm to determine a dissociation constant of 13 m. Steady-state oxygen consumption assays show that NADPH efficiently reduces the FAD only when RIF is present, implying that RIF binds before NADPH in the catalytic scheme. The 1.8 resolution structure of RIFMO complexed with RIF represents the precatalytic conformation that occurs before formation of the ternary E-RIF-NADPH complex. The RIF naphthoquinone blocks access to the FAD N5 atom, implying that large conformational changes are required for NADPH to reduce the FAD. A model for these conformational changes is proposed.	[Liu, Li-Kai; Tanner, John J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Tanner, John J.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Mehra-Chaudhary, Ritcha] Univ Missouri, Struct Biol Core, Columbia, MO 65211 USA; [Abdelwahab, Heba; Campo, Julia S. Martin Del; Sobrado, Pablo] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Abdelwahab, Heba] Damietta Univ, Dept Chem, Fac Sci, Dumyat 34517, Egypt	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Virginia Polytechnic Institute & State University; Egyptian Knowledge Bank (EKB); Damietta University	Tanner, JJ (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.; Sobrado, P (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.	psobrado@vt.edu; tannerjj@missouri.edu		S. Martin del Campo, Julia/0000-0001-8914-2504; abdelwahab, heba/0000-0002-4005-464X; Tanner, John/0000-0001-8314-113X	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; National Institute of Health project MINOS [R01GM105404]; Direct For Biological Sciences [1021384] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); National Institute of Health project MINOS; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Jay Nix for help with x-ray diffraction data collection and Kathryn Burnett for collecting the SAXS data through the SIBYLS mail-in program at the Advanced Light Source. We thank Dr. Nicholas Noinaj for providing the model of MtmOIV complexed with NADPH. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231. Additional support for the SYBILS beamline comes from the National Institute of Health project MINOS (R01GM105404).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andersen SJ, 1997, ANTIMICROB AGENTS CH, V41, P218, DOI 10.1128/AAC.41.1.218; Aristoff PA, 2010, TUBERCULOSIS, V90, P94, DOI 10.1016/j.tube.2010.02.001; Baysarowich J, 2008, P NATL ACAD SCI USA, V105, P4886, DOI 10.1073/pnas.0711939105; Bosserman MA, 2013, ACS CHEM BIOL, V8, P2466, DOI 10.1021/cb400399b; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crozier-Reabe K, 2012, INT J MOL SCI, V13, P15601, DOI 10.3390/ijms131215601; Dyer KN, 2014, METHODS MOL BIOL, V1091, P245, DOI 10.1007/978-1-62703-691-7_18; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enroth C, 1998, STRUCTURE, V6, P605, DOI 10.1016/S0969-2126(98)00062-8; Entsch B, 2005, ARCH BIOCHEM BIOPHYS, V433, P297, DOI 10.1016/j.abb.2004.09.029; Floss HG, 2005, CHEM REV, V105, P621, DOI 10.1021/cr030112j; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Goldstein BP, 2014, J ANTIBIOT, V67, P625, DOI 10.1038/ja.2014.107; Hiromoto T, 2006, J MOL BIOL, V364, P878, DOI 10.1016/j.jmb.2006.09.031; Hoshino Y, 2010, J ANTIBIOT, V63, P23, DOI 10.1038/ja.2009.116; Ishikawa J, 2006, ANTIMICROB AGENTS CH, V50, P1342, DOI 10.1128/AAC.50.4.1342-1346.2006; Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lindqvist Y, 2009, J MOL BIOL, V393, P966, DOI 10.1016/j.jmb.2009.09.003; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Qi XF, 2016, P NATL ACAD SCI USA, V113, P3803, DOI 10.1073/pnas.1523614113; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; SEVERINOV K, 1993, J BIOL CHEM, V268, P14820; Spanogiannopoulos P, 2014, P NATL ACAD SCI USA, V111, P7102, DOI 10.1073/pnas.1402358111; Spanogiannopoulos P, 2012, ANTIMICROB AGENTS CH, V56, P5061, DOI 10.1128/AAC.01166-12; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Stogios PJ, 2016, NAT COMMUN, V7, P1, DOI 10.1038/ncomms11343; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tupin A, 2010, INT J ANTIMICROB AG, V35, P519, DOI 10.1016/j.ijantimicag.2009.12.017; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang P, 2013, J AM CHEM SOC, V135, P7138, DOI 10.1021/ja403516u; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; YAZAWA K, 1993, ANTIMICROB AGENTS CH, V37, P1313, DOI 10.1128/AAC.37.6.1313	44	30	31	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21553	21562		10.1074/jbc.M116.745315	http://dx.doi.org/10.1074/jbc.M116.745315			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27557658	Green Published, hybrid			2022-12-26	WOS:000385999200022
J	Nawaz, MS; Vik, ES; Berges, N; Fladeby, C; Bjoras, M; Dalhus, B; Alseth, I				Nawaz, Meh Sameen; Vik, Erik Sebastian; Berges, Natalia; Fladeby, Cathrine; Bjoras, Magnar; Dalhus, Bjorn; Alseth, Ingrun			Regulation of Human Endonuclease V Activity and Relocalization to Cytoplasmic Stress Granules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; nitrosative stress; ribonuclease; RNA; RNA processing; stress granule; endonuclease V; PABPC1; deamination; inosine	ESCHERICHIA-COLI; ENDORIBONUCLEASE G3BP; ADENOSINE-DEAMINASE; MESSENGER-RNA; ATP DEPLETION; TUDOR-SN; DNA; PROTEINS; CELLS; PHOSPHORYLATION	Endonuclease V (EndoV) is an enzyme with specificity for inosines in nucleic acids. Whereas the bacterial homologs are active on both DNA and RNA, the mammalian variants only cleave RNA, at least when assayed with recombinant proteins. Here we show that ectopically expressed, as well as endogenously expressed human (h)EndoV, share the same enzymatic properties as the recombinant protein and cleaves RNA with inosine but not DNA. In search for proteins interacting with hEndoV, polyadenylate-binding protein C1 (PABPC1) was identified. The association between PABPC1 and hEndoV is RNA dependent and furthermore, PABPC1 stimulates hEndoV activity and affinity for inosine-containing RNA. Upon cellular stress, PABPC1 relocates to cytoplasmic stress granules that are multimolecular aggregates of stalled translation initiation complexes formed to aid cell recovery. Arsenite, as well as other agents, triggered relocalization also of hEndoV to cytoplasmic stress granules. As inosines in RNA are highly abundant, hEndoV activity is likely regulated in cells to avoid aberrant cleavage of inosine-containing transcripts. Indeed, we find that hEndoV cleavage is inhibited by normal intracellular ATP concentrations. The ATP stores inside a cell do not overlay stress granules and we suggest that hEndoV is redistributed to stress granules as a strategy to create a local environment low in ATP to permit hEndoV activity.	[Nawaz, Meh Sameen; Vik, Erik Sebastian; Berges, Natalia; Fladeby, Cathrine; Bjoras, Magnar; Dalhus, Bjorn; Alseth, Ingrun] Natl Hosp Norway, Dept Microbiol, Oslo Univ Hosp HF, NO-0424 Oslo, Norway; [Nawaz, Meh Sameen; Vik, Erik Sebastian; Berges, Natalia; Fladeby, Cathrine; Bjoras, Magnar; Dalhus, Bjorn; Alseth, Ingrun] Univ Oslo, NO-0424 Oslo, Norway; [Bjoras, Magnar] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, NO-7491 Trondheim, Norway; [Dalhus, Bjorn] Univ Oslo, Inst Clin Med, Dept Med Biochem, NO-0424 Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; Norwegian University of Science & Technology (NTNU); University of Oslo	Alseth, I (corresponding author), Natl Hosp Norway, Dept Microbiol, Oslo Univ Hosp HF, NO-0424 Oslo, Norway.; Alseth, I (corresponding author), Univ Oslo, NO-0424 Oslo, Norway.	ingrun.alseth@rr-research.no	Dalhus, Bjørn/AAK-2895-2020; Bjørås, Magnar/N-9286-2017		Norwegian Cancer Society [5739724]; Research Council of Norway [250474]; South-Eastern Norway Regional Health Authorities [2014034, 2015095]; Erasmus+ program/EU; Molecular Life Science program at UiO	Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); South-Eastern Norway Regional Health Authorities; Erasmus+ program/EU; Molecular Life Science program at UiO	This work was supported by Norwegian Cancer Society Grant 5739724 (to E. S. V.), The Research Council of Norway Grant 250474 (to N. B.), South-Eastern Norway Regional Health Authorities Grants 2014034 and 2015095 (to B. D.), grants from the Erasmus+ program/EU (to N. B.) and the Molecular Life Science program at UiO (to M. S. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Alemu EA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378109; Allemand E, 2005, P NATL ACAD SCI USA, V102, P3605, DOI 10.1073/pnas.0409889102; Alseth I, 2014, CURR OPIN GENET DEV, V26, P116, DOI 10.1016/j.gde.2014.07.008; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Arimoto-Matsuzaki K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10252; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; FIELD AK, 1972, MEDICINE, V51, P169, DOI 10.1097/00005792-197205000-00002; Fladeby C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047466; George CX, 1999, GENE, V229, P203, DOI 10.1016/S0378-1119(99)00017-7; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; GORLACH M, 1994, EXP CELL RES, V211, P400, DOI 10.1006/excr.1994.1104; GRESSER MJ, 1981, J BIOL CHEM, V256, P5981; Guo GM, 1997, J BACTERIOL, V179, P310, DOI 10.1128/jb.179.2.310-316.1997; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Kawahara Y, 2003, J NEUROCHEM, V85, P680, DOI 10.1046/j.1471-4159.2003.01703.x; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Mannion N, 2015, BIOMOLECULES, V5, P2338, DOI 10.3390/biom5042338; Mayeda A, 1999, METH MOL B, V118, P309; Mi RJ, 2012, MUTAT RES-FUND MOL M, V735, P12, DOI 10.1016/j.mrfmmm.2012.05.003; Morita Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3273; Osenbroch PO, 2009, FEBS J, V276, P2811, DOI 10.1111/j.1742-4658.2009.07004.x; Pang B, 2012, P NATL ACAD SCI USA, V109, P2319, DOI 10.1073/pnas.1118455109; Prestwich EG, 2013, CHEM RES TOXICOL, V26, P538, DOI 10.1021/tx300473n; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Scadden ADJ, 2005, NAT STRUCT MOL BIOL, V12, P489, DOI 10.1038/nsmb936; Scadden ADJ, 2001, EMBO J, V20, P4243, DOI 10.1093/emboj/20.15.4243; Takahara T, 2012, MOL CELL, V47, P242, DOI 10.1016/j.molcel.2012.05.019; Toth AM, 2009, J BIOL CHEM, V284, P29350, DOI 10.1074/jbc.M109.045146; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tourriere H, 2001, MOL CELL BIOL, V21, P7747, DOI 10.1128/MCB.21.22.7747-7760.2001; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vik ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3271; Weissbach R, 2012, RNA, V18, P462, DOI 10.1261/rna.027656.111; Wolf J, 2002, EMBO J, V21, P3841, DOI 10.1093/emboj/cdf362; Xie JW, 2014, BBA-GENE REGUL MECH, V1839, P1062, DOI 10.1016/j.bbagrm.2014.08.001; YAO M, 1994, J BIOL CHEM, V269, P16260; Yasui M, 2008, J MOL BIOL, V377, P1015, DOI 10.1016/j.jmb.2008.01.033; YIH LH, 1991, CELL BIOL INT REP, V15, P253, DOI 10.1016/0309-1651(91)90157-E	46	7	7	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21786	21801		10.1074/jbc.M116.730911	http://dx.doi.org/10.1074/jbc.M116.730911			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27573237	Green Published, hybrid			2022-12-26	WOS:000385999200042
J	Gaston, AF; Durand, F; Roca, E; Doucende, G; Hapkova, I; Subirats, E				Gaston, Anne-Fleur; Durand, Fabienne; Roca, Emma; Doucende, Gregory; Hapkova, Ilona; Subirats, Enric			Exercise-Induced Hypoxaemia Developed at Sea-Level Influences Responses to Exercise at Moderate Altitude	PLOS ONE			English	Article							INDUCED ARTERIAL HYPOXEMIA; MAXIMAL OXYGEN-UPTAKE; PEAK HEART-RATE; ACUTE-HYPOXIA; INTERMITTENT HYPOXIA; ISOMETRIC CONTRACTION; VENTILATORY RESPONSE; RAT-HEART; VO2 MAX; DECREASE	Purpose The aim of this study was to investigate the impact of exercise-induced hypoxaemia (EIH) developed at sea-level on exercise responses at moderate acute altitude. Methods Twenty three subjects divided in three groups of individuals: highly trained with EIH (n = 7); highly trained without EIH (n = 8) and untrained participants (n = 8) performed two maximal incremental tests at sea-level and at 2,150 m. Haemoglobin O-2 saturation (SpO(2)), heart rate, oxygen uptake (VO2) and several ventilatory parameters were measured continuously during the tests. Results EIH athletes had a drop in SpO(2) from 99 +/- 0.8% to 91 +/- 1.2% from rest to maximal exercise at sea-level, while the other groups did not exhibit a similar decrease. EIH athletes had a greater decrease in VO2max at altitude compared to non-EIH and untrained groups (-22 +/- 7.9%, -16 +/- 5.3% and -13 +/- 9.4%, respectively). At altitude, non-EIH athletes had a similar drop in SpO(2) as EIH athletes (13 +/- 0.8%) but greater than untrained participants (6 +/- 1.0%). EIH athletes showed greater decrease in maximal heart rate than non-EIH athletes at altitude (8 +/- 3.3 bpm and 5 +/- 2.9 bpm, respectively). Conclusion EIH athletes demonstrated specific cardiorespiratory response to exercise at moderate altitude compared to non-EIH athletes with a higher decrease in VO2max certainly due to the lower ventilator and HRmax responses. Thus EIH phenomenon developed at sea-level negatively impact performance and cardiorespiratory responses at acute moderate altitude despite no potentiated O-2 desaturation.	[Gaston, Anne-Fleur; Durand, Fabienne; Roca, Emma; Doucende, Gregory; Hapkova, Ilona; Subirats, Enric] Univ Perpignan Via Domitia, EA4604, Lab Europeen Performance Sante Altitude, Font Romeu, France; [Roca, Emma; Subirats, Enric] Univ Girona, Fac Med, Girona, Spain	Universitat de Girona	Gaston, AF (corresponding author), Univ Perpignan Via Domitia, EA4604, Lab Europeen Performance Sante Altitude, Font Romeu, France.	anne-fleur.gaston@univ-perp.fr						BADIER M, 1994, MUSCLE NERVE, V17, P500, DOI 10.1002/mus.880170506; Bendahan D, 1998, CLIN SCI, V94, P279, DOI 10.1042/cs0940279; Benoit H, 2003, EUR J APPL PHYSIOL, V90, P514, DOI 10.1007/s00421-003-0899-y; Caquelard F, 2000, CLIN SCI, V98, P329, DOI 10.1042/CS19990263; Chapman RF, 1999, MED SCI SPORT EXER, V31, P658, DOI 10.1097/00005768-199905000-00006; Chapman Robert F, 2013, Br J Sports Med, V47 Suppl 1, pi40, DOI 10.1136/bjsports-2013-092837; Dempsey JA, 1999, J APPL PHYSIOL, V87, P1997, DOI 10.1152/jappl.1999.87.6.1997; Derchak PA, 2000, MED SCI SPORT EXER, V32, P1873, DOI 10.1097/00005768-200011000-00009; Dousset E, 2001, MUSCLE NERVE, V24, P364, DOI 10.1002/1097-4598(200103)24:3<364::AID-MUS1007>3.3.CO;2-2; Durand F, 2000, MED SCI SPORT EXER, V32, P926; Dwinell MR, 1997, J APPL PHYSIOL, V82, P118, DOI 10.1152/jappl.1997.82.1.118; Faulhaber M, 2010, J SPORT SCI, V28, P513, DOI 10.1080/02640410903581588; Foster GE, 2005, J PHYSIOL-LONDON, V567, P689, DOI 10.1113/jphysiol.2005.091462; Gavin TP, 1998, MED SCI SPORT EXER, V30, P195, DOI 10.1097/00005768-199802000-00004; Gore CJ, 1996, J APPL PHYSIOL, V80, P2204, DOI 10.1152/jappl.1996.80.6.2204; Grataloup O, 2007, INT J SPORTS MED, V28, P181, DOI 10.1055/s-2006-924216; Grataloup O, 2005, EUR J APPL PHYSIOL, V94, P641, DOI 10.1007/s00421-005-1361-0; HARMS CA, 1995, J APPL PHYSIOL, V79, P575, DOI 10.1152/jappl.1995.79.2.575; Hopkins SR, 2006, ADV EXP MED BIOL, V588, P17; KACIMI R, 1992, J APPL PHYSIOL, V73, P1377, DOI 10.1152/jappl.1992.73.4.1377; KACIMI R, 1993, J APPL PHYSIOL, V75, P1123, DOI 10.1152/jappl.1993.75.3.1123; Katayama B, 1998, EUR J APPL PHYSIOL, V78, P189, DOI 10.1007/s004210050406; Katayama K, 2007, INT J SPORTS MED, V28, P480, DOI 10.1055/s-2006-955895; Katayama K, 2001, J APPL PHYSIOL, V90, P1431, DOI 10.1152/jappl.2001.90.4.1431; Koehle MS, 2007, J APPL PHYSIOL, V103, P1973, DOI 10.1152/japplphysiol.00545.2007; LAWLER J, 1988, J APPL PHYSIOL, V64, P1486, DOI 10.1152/jappl.1988.64.4.1486; Lusina SJC, 2006, J PHYSIOL-LONDON, V575, P961, DOI 10.1113/jphysiol.2006.114660; MARTIN D, 1992, J APPL PHYSIOL, V72, P455, DOI 10.1152/jappl.1992.72.2.455; Martin D, 1993, J SPORT SCI, V11, P37, DOI 10.1080/02640419308729961; MIYAMURA M, 1990, EUR J APPL PHYSIOL O, V60, P353, DOI 10.1007/BF00713498; Mollard P, 2007, EUR J APPL PHYSIOL, V100, P663, DOI 10.1007/s00421-007-0457-0; Mollard P, 2010, RESP PHYSIOL NEUROBI, V172, P179, DOI 10.1016/j.resp.2010.05.017; Peltonen JE, 2001, EUR J APPL PHYSIOL, V85, P82, DOI 10.1007/s004210100411; Prefaut C, 2000, SPORTS MED, V30, P47, DOI 10.2165/00007256-200030010-00005; SCOGGIN CH, 1978, J APPL PHYSIOL, V44, P464, DOI 10.1152/jappl.1978.44.3.464; TERRADOS N, 1985, CLIN PHYSIOL, V5, P75, DOI 10.1111/j.1475-097X.1985.tb00605.x; Wehrlin JP, 2006, EUR J APPL PHYSIOL, V96, P404, DOI 10.1007/s00421-005-0081-9; WERLE EO, 1990, LIFE SCI, V46, P9, DOI 10.1016/0024-3205(90)90051-R	38	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161819	10.1371/journal.pone.0161819	http://dx.doi.org/10.1371/journal.pone.0161819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583364	Green Submitted, gold, Green Published			2022-12-26	WOS:000382855600064
J	Ringling, RE; Gastecki, ML; Woodford, ML; Lum-Naihe, KJ; Grant, RW; Pulakat, L; Vieira-Potter, VJ; Padilla, J				Ringling, Rebecca E.; Gastecki, Michelle L.; Woodford, Makenzie L.; Lum-Naihe, Kelly J.; Grant, Ryan W.; Pulakat, Lakshmi; Vieira-Potter, Victoria J.; Padilla, Jaume			Loss of Nlrp3 Does Not Protect Mice from Western Diet-Induced Adipose Tissue Inflammation and Glucose Intolerance	PLOS ONE			English	Article							INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; ARTERIAL STIFFNESS; URIC-ACID; OBESITY; DYSFUNCTION; INFLAMMASOMES; ACTIVATION; INJURY; FAT	We tested the hypothesis that loss of Nlrp3 would protect mice from Western diet-induced adipose tissue (AT) inflammation and associated glucose intolerance and cardiovascular complications. Five-week old C57BL6J wild-type (WT) and Nlrp3 knockout (Nlrp3(-/-)) mice were randomized to either a control diet (10% kcal from fat) or Western diet (45% kcal from fat and 1% cholesterol) for 24 weeks (n = 8/group). Contrary to our hypothesis that obesity-mediated white AT inflammation is Nlrp3-dependent, we found that Western diet-induced expression of AT inflammatory markers (i.e., Cd68, Cd11c, Emr1, Itgam, Lgals, Il18, Mcp1, Tnf, Ccr2, Ccl5 mRNAs, and Mac-2 protein) were not accompanied by increased caspase-1 cleavage, a hallmark feature of NLRP3 inflammasome activation. Furthermore, Nlrp3 null mice were not protected from Western diet-induced white or brown AT inflammation. Although Western diet promoted glucose intolerance in both WT and Nlrp3(-/-) mice, Nlrp3(-/-) mice were protected from Western diet-induced aortic stiffening. Additionally, Nlrp3-/- mice exhibited smaller cardiomyocytes and reduced cardiac fibrosis, independent of diet. Collectively, these findings suggest that presence of the Nlrp3 gene is not required for Western diet-induced AT inflammation and/or glucose intolerance; yet Nlrp3 appears to play a role in potentiating arterial stiffening, cardiac hypertrophy and fibrosis.	[Ringling, Rebecca E.; Gastecki, Michelle L.; Woodford, Makenzie L.; Pulakat, Lakshmi; Vieira-Potter, Victoria J.; Padilla, Jaume] Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO USA; [Lum-Naihe, Kelly J.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO USA; [Grant, Ryan W.] Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA; [Pulakat, Lakshmi] Univ Missouri, Dept Med, Columbia, MO USA; [Pulakat, Lakshmi] Harry S Truman Mem Vet Affairs Hosp, Res Serv, Columbia, MO USA; [Padilla, Jaume] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO USA; [Padilla, Jaume] Univ Missouri, Dept Child Hlth, Columbia, MO 65201 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Missouri System; University of Missouri Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Padilla, J (corresponding author), Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO USA.; Padilla, J (corresponding author), Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO USA.; Padilla, J (corresponding author), Univ Missouri, Dept Child Hlth, Columbia, MO 65201 USA.	padillaja@missouri.edu		Grant, Ryan/0000-0002-8940-4196	National Institutes of Health [K01 HL-125503, R21 DK-105368, 1R01 HL-118376-01]; Diversity Supplement award [5R01 HL-118376-02S]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL125503, R01HL118376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diversity Supplement award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants K01 HL-125503 and R21 DK-105368 (JP), 1R01 HL-118376-01 (LP), and Diversity Supplement award 5R01 HL-118376-02S (KJLN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bando S, 2015, ATHEROSCLEROSIS, V242, P407, DOI 10.1016/j.atherosclerosis.2015.07.043; Bigford GE, 2013, ASN NEURO, V5, P243, DOI 10.1042/AN20130021; Bracey NA, 2014, J BIOL CHEM, V289, P19571, DOI 10.1074/jbc.M114.550624; Bracey NA, 2013, EXP PHYSIOL, V98, P462, DOI 10.1113/expphysiol.2012.068338; Coelho OR, 2013, CIRCULATION, V128, P1225, DOI 10.1161/CIRCULATIONAHA.112.000438; Coll RC, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.19; De Nardo D, 2011, TRENDS IMMUNOL, V32, P373, DOI 10.1016/j.it.2011.05.004; DeMarco VG, 2015, HYPERTENSION, V66, P99, DOI 10.1161/HYPERTENSIONAHA.115.05674; Dixit VD, 2013, DIABETES, V62, P22, DOI 10.2337/db12-1115; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Farb MG, 2015, HORM MOL BIOL CLIN I, V21, P125, DOI 10.1515/hmbci-2014-0047; Ginsberg Henry N, 2009, J Cardiometab Syndr, V4, P113, DOI 10.1111/j.1559-4572.2008.00044.x; Gong W, 2016, AM J PHYSIOL-RENAL, DOI [10.1152/ajprenal.00534, DOI 10.1152/AJPRENAL.00534]; Grant RW, 2015, AM J PHYSIOL-ENDOC M, V309, pE205, DOI 10.1152/ajpendo.00053.2015; Grant RW, 2015, OBESITY, V23, P512, DOI 10.1002/oby.21003; Grant RW, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00050; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Inoue Y, 2014, J IMMUNOL, V192, P4342, DOI 10.4049/jimmunol.1302039; Jacobi D, 2012, ADIPOCYTE, V1, P4, DOI 10.4161/adip.19036; Jia GH, 2016, NAT REV ENDOCRINOL, V12, P144, DOI 10.1038/nrendo.2015.216; Jia GH, 2015, HYPERTENSION, V65, P531, DOI 10.1161/HYPERTENSIONAHA.114.04737; Kaiyala KJ, 2010, DIABETES, V59, P1657, DOI 10.2337/db09-1582; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kayama Y, 2015, INT J MOL SCI, V16, P25234, DOI 10.3390/ijms161025234; Kotas ME, 2013, P NATL ACAD SCI USA, V110, P4810, DOI 10.1073/pnas.1301996110; Luo BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104771; Marchetti C, 2015, J CARDIOVASC PHARM, V66, P1, DOI 10.1097/FJC.0000000000000247; Matyas C, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0309-x; Mehta T, 2015, AM J HYPERTENS, V28, P877, DOI 10.1093/ajh/hpu253; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Mori MA, 2011, CIRC RES, V108, P1160, DOI 10.1161/RES.0b013e318220b57b; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Pannier B, 2005, HYPERTENSION, V45, P592, DOI 10.1161/01.HYP.0000159190.71253.c3; Patel MN, 2015, P NATL ACAD SCI USA, V112, P506, DOI 10.1073/pnas.1414536112; Pettersson US, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046057; Potter VJV, 2012, ENDOCRINOLOGY, V153, P4266, DOI 10.1210/en.2011-2006; Reaven GM, 2011, MED CLIN N AM, V95, P875, DOI 10.1016/j.mcna.2011.06.002; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vieira-Potter VJ, 2015, EXERC SPORT SCI REV, V43, P172, DOI 10.1249/JES.0000000000000046; Vieira-Potter VJ, 2015, AM J PHYSIOL-REG I, V308, pR530, DOI 10.1152/ajpregu.00401.2014; Vieira-Potter VJ, 2014, CELL MICROBIOL, V16, P1484, DOI 10.1111/cmi.12336; Vlachopoulos C, 2010, AM J HYPERTENS, V23, P1183, DOI 10.1038/ajh.2010.144; Wainright KS, 2015, AM J PHYSIOL-REG I, V309, pR594, DOI 10.1152/ajpregu.00042.2015; Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010	44	16	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161939	10.1371/journal.pone.0161939	http://dx.doi.org/10.1371/journal.pone.0161939			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583382	Green Submitted, Green Published, gold			2022-12-26	WOS:000382855600075
J	Varas, C; Ravit, M; Mimoun, C; Panel, P; Huchon, C; Fauconnier, A				Varas, Catalina; Ravit, Marion; Mimoun, Camille; Panel, Pierre; Huchon, Cyrille; Fauconnier, Arnaud			Optimal Combination of Non-Invasive Tools for the Early Detection of Potentially Life-Threatening Emergencies in Gynecology	PLOS ONE			English	Article							SUSPECTED ECTOPIC PREGNANCY; PELVIC-INFLAMMATORY-DISEASE; CLINICAL-PREDICTION MODEL; PHYSICAL-EXAMINATION; TRANSVAGINAL ULTRASONOGRAPHY; ADNEXAL TORSION; TUBAL RUPTURE; SHOCK INDEX; OF-CARE; DIAGNOSIS	Objectives Potentially life-threatening gynecological emergencies (G-PLEs) are acute pelvic conditions that may spontaneously evolve into a life-threatening situation, or those for which there is a risk of sequelae or death in the absence of prompt diagnosis and treatment. The objective of this study was to identify the best combination of non-invasive diagnostic tools to ensure an accurate diagnosis and timely response when faced with G-PLEs for patients arriving with acute pelvic pain at the Gynecological Emergency Department (ED). Methods The data on non-invasive diagnostic tools were sourced from the records of patients presenting at the ED of two hospitals in the Parisian suburbs (France) with acute pelvic pain between September 2006 and April 2008. The medical history of the patients was obtained through a standardized questionnaire completed for a prospective observational study, and missing information was completed with data sourced from the medical forms. Diagnostic tool categories were predefined as a collection of signs or symptoms. We analyzed the association of each sign/symptom with G-PLEs using Pearson's Chi-Square or Fischer's exact tests. Symptoms and signs associated with G-PLEs (p-value < 0.20) were subjected to logistic regression to evaluate the diagnostic value of each of the predefined diagnostic tools and in various combinations. Results The data of 365 patients with acute pelvic pain were analyzed, of whom 103 were confirmed to have a PLE. We analyzed five diagnostic tools by logistic regression: Triage Process, History-Taking, Physical Examination, Ultrasonography, and Biological Exams. The combination of History-Taking and Ultrasonography had a C-index of 0.83, the highest for a model combining two tools. Conclusions The use of a standardized self-assessment questionnaire for history-taking and focal ultrasound examination were found to be the most successful tool combination for the diagnosis of gynecological emergencies in a Gynecological ED. Additional tools, such as physical examination, do not add substantial diagnostic value.	[Varas, Catalina; Ravit, Marion; Mimoun, Camille; Huchon, Cyrille; Fauconnier, Arnaud] Versailles St Quentin Univ UVSQ, EA Res Unit Risk & Safety Clin Med Women & Perina, Montigny Le Bretonneux, France; [Varas, Catalina; Mimoun, Camille; Huchon, Cyrille; Fauconnier, Arnaud] Intercommunal Hosp Ctr Poissy St Germain En Laye, Dept Gynecol & Obstet, Poissy, France; [Panel, Pierre] Mignot Hosp, Dept Gynecol & Obstet, Le Chesnay, France	UDICE-French Research Universities; Universite Paris Saclay; Centre Hospitalier de Versailles	Fauconnier, A (corresponding author), Versailles St Quentin Univ UVSQ, EA Res Unit Risk & Safety Clin Med Women & Perina, Montigny Le Bretonneux, France.; Fauconnier, A (corresponding author), Intercommunal Hosp Ctr Poissy St Germain En Laye, Dept Gynecol & Obstet, Poissy, France.	afauconnier@chi-poissy-st-germain.fr			Woman's Health Research Institute (France)	Woman's Health Research Institute (France)	CV received a research grant from the Woman's Health Research Institute (France). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT J, 1990, AM J EMERG MED, V8, P515, DOI 10.1016/0735-6757(90)90154-R; Adhikari S, 2007, AM J EMERG MED, V25, P591, DOI 10.1016/j.ajem.2006.11.020; Adhikari S, 2013, J EMERG MED, V44, P194, DOI 10.1016/j.jemermed.2012.05.008; ANKUM WM, 1993, HUM REPROD, V8, P1307, DOI 10.1093/oxfordjournals.humrep.a138247; Barnhart KT, 2009, NEW ENGL J MED, V361, P379, DOI 10.1056/NEJMcp0810384; Bignardi T, 2010, ULTRASOUND OBST GYN, V35, P344, DOI 10.1002/uog.7523; Birkhahn RH, 2005, AM J EMERG MED, V23, P323, DOI 10.1016/j.ajem.2005.02.029; Birkhahn RH, 2002, ACAD EMERG MED, V9, P115, DOI 10.1197/aemj.9.2.115; Bouquier J, 2014, SEX TRANSM DIS, V41, P525, DOI 10.1097/OLQ.0000000000000169; Buckley RG, 1998, ACAD EMERG MED, V5, P951, DOI 10.1111/j.1553-2712.1998.tb02770.x; Buckley RG, 1999, ANN EMERG MED, V34, P589, DOI 10.1016/S0196-0644(99)70160-5; Cohen J., 2003, APPL MULTIPLE REGRES; Condous G, 2005, HUM REPROD, V20, P1404, DOI 10.1093/humrep/deh770; Dart RG, 1999, ANN EMERG MED, V33, P283, DOI 10.1016/S0196-0644(99)70364-1; Eschenbach DA, 1997, OBSTET GYNECOL, V89, P184, DOI 10.1016/S0029-7844(96)00429-2; Eskelinen M, 1998, EUR UROL, V34, P467, DOI 10.1159/000019785; Fauconnier Arnaud, 2007, World J Emerg Surg, V2, P23; Haider Z, 2006, ULTRASOUND OBST GYN, V28, P207, DOI 10.1002/uog.2801; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HIRATA AJ, 1991, SOUTHERN MED J, V84, P1467, DOI 10.1097/00007611-199112000-00014; Huchon C, 2012, ACAD EMERG MED; Huchon C, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-46; Huchon C, 2012, HUM REPROD, V27, P2359, DOI 10.1093/humrep/des186; Huchon C, 2010, HUM REPROD, V25, P2276, DOI 10.1093/humrep/deq173; KAHN JG, 1991, JAMA-J AM MED ASSOC, V266, P2594, DOI 10.1001/jama.266.18.2594; Kontoravdis A, 1996, INT J GYNECOL OBSTET, V52, P243, DOI 10.1016/0020-7292(95)02611-8; McWilliams GDE, 2008, SURG CLIN N AM, V88, P265, DOI 10.1016/j.suc.2007.12.007; Mignini L, 2007, INTERVENTIONS TUBAL; Miller TD, 2002, AM J MED, V112, P290, DOI 10.1016/S0002-9343(01)01111-1; Mol BWJ, 1999, FERTIL STERIL, V71, P167, DOI 10.1016/S0015-0282(98)00418-X; Moore C, 2007, ACAD EMERG MED, V14, P755, DOI 10.1197/j.aem.2007.04.010; Polena V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114189; Popowski T, 2015, J ULTRAS MED, V34, P829, DOI 10.7863/ultra.34.5.829; Popowski T, 2012, INT J GYNECOL OBSTET, V116, P97, DOI 10.1016/j.ijgo.2011.09.019; Razzak JA, 2002, B WORLD HEALTH ORGAN, V80, P900; SACKETT DL, 1992, JAMA-J AM MED ASSOC, V267, P2638, DOI 10.1001/jama.267.19.2638; STOVALL TG, 1990, ANN EMERG MED, V19, P1098, DOI 10.1016/S0196-0644(05)81511-2; van Mello NM, 2012, FERTIL STERIL, V97, P623, DOI 10.1016/j.fertnstert.2011.12.021; Walker J W, 1987, Emerg Med Clin North Am, V5, P425; Workowski KA., 2010, SEXUALLY TRANSMITTED	40	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162301	10.1371/journal.pone.0162301	http://dx.doi.org/10.1371/journal.pone.0162301			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583697	gold, Green Published, Green Submitted			2022-12-26	WOS:000382855600127
J	Rogerson, T; Jayaprakash, B; Cai, DJ; Sano, Y; Lee, YS; Zhou, Y; Bekal, P; Deisseroth, K; Silva, AJ				Rogerson, Thomas; Jayaprakash, Balaji; Cai, Denise J.; Sano, Yoshitake; Lee, Yong-Seok; Zhou, Yu; Bekal, Pallavi; Deisseroth, Karl; Silva, Alcino J.			Molecular and Cellular Mechanisms for Trapping and Activating Emotional Memories	PLOS ONE			English	Article							FEAR MEMORY; LATERAL AMYGDALA; NEURAL CIRCUITS; NEURONS; ALLOCATION; ENGRAM; EXCITABILITY; EXPRESSION; CONTRIBUTE; BEHAVIOR	Recent findings suggest that memory allocation to specific neurons (i.e., neuronal allocation) in the amygdala is not random, but rather the transcription factor cAMP-response element binding protein (CREB) modulates this process, perhaps by regulating the transcription of channels that control neuronal excitability. Here, optogenetic studies in the mouse lateral amygdala (LA) were used to demonstrate that CREB and neuronal excitability regulate which neurons encode an emotional memory. To test the role of CREB in memory allocation, we overexpressed CREB in the lateral amygdala to recruit the encoding of an auditory-fear conditioning (AFC) memory to a subset of neurons. Then, post-training activation of these neurons with Channelrhodopsin-2 was sufficient to trigger recall of the memory for AFC, suggesting that CREB regulates memory allocation. To test the role of neuronal excitability in memory allocation, we used a step function opsin (SFO) to transiently increase neuronal excitability in a subset of LA neurons during AFC. Post-training activation of these neurons with Volvox Channelrhodopsin-1 was able to trigger recall of that memory. Importantly, our studies show that activation of the SFO did not affect AFC by either increasing anxiety or by strengthening the unconditioned stimulus. Our findings strongly support the hypothesis that CREB regulates memory allocation by modulating neuronal excitability.	[Rogerson, Thomas; Jayaprakash, Balaji; Cai, Denise J.; Sano, Yoshitake; Lee, Yong-Seok; Zhou, Yu; Bekal, Pallavi; Silva, Alcino J.] Integrat Ctr Learning & Memory, Dept Neurobiol, Los Angeles, CA USA; [Rogerson, Thomas; Jayaprakash, Balaji; Cai, Denise J.; Sano, Yoshitake; Lee, Yong-Seok; Zhou, Yu; Bekal, Pallavi; Silva, Alcino J.] Integrat Ctr Learning & Memory, Dept Psychol, Los Angeles, CA USA; [Rogerson, Thomas; Jayaprakash, Balaji; Cai, Denise J.; Sano, Yoshitake; Lee, Yong-Seok; Zhou, Yu; Bekal, Pallavi; Silva, Alcino J.] Integrat Ctr Learning & Memory, Dept Psychiat & Biobehav Sci, Los Angeles, CA USA; [Rogerson, Thomas; Jayaprakash, Balaji; Cai, Denise J.; Sano, Yoshitake; Lee, Yong-Seok; Zhou, Yu; Bekal, Pallavi; Silva, Alcino J.] Brain Res Inst, Los Angeles, CA USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, CNC Program, Neurosci Program,Dept Bioengn Psychiat & Behav Sc, Stanford, CA 94305 USA; [Rogerson, Thomas] Stanford Univ, Dept Biol, CNC Program, Stanford, CA 94305 USA; [Jayaprakash, Balaji] Indian Inst Sci, Ctr Neurosci, Bangalore, Karnataka, India; [Sano, Yoshitake] Toyama Univ, Grad Sch Med, Toyama, Japan; [Lee, Yong-Seok] Seoul Natl Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Zhou, Yu] Qingdao Univ, Coll Med, Dept Physiol, Qingdao, Shandong, Peoples R China	Howard Hughes Medical Institute; Stanford University; Stanford University; Indian Institute of Science (IISC) - Bangalore; University of Toyama; Seoul National University (SNU); Qingdao University	Silva, AJ (corresponding author), Integrat Ctr Learning & Memory, Dept Neurobiol, Los Angeles, CA USA.	silvaa@mednet.ucla.edu	Cai, Denise J/N-7229-2017; Silva, Alcino/ABD-7684-2021	Cai, Denise J/0000-0002-7729-0523; Silva, Alcino/0000-0002-1587-4558; Sano, Yoshitake/0000-0001-5188-3104	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation [1T32NS058280, 1F31MH092057-01]; Graduate Division Dissertation Year Fellowship; NIH-NCRR shared resources grant [CJX1-443835-WS-29646]; NSF Major Research Instrumentation grant [CHE-0722519];  [P50 MH077972];  [R37 AG013622];  [JCCC/P30CA016042];  [CURE/P30 DK041301]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084315] Funding Source: NIH RePORTER	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Graduate Division Dissertation Year Fellowship; NIH-NCRR shared resources grant; NSF Major Research Instrumentation grant; ; ; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This was supported by grants P50 MH077972, R37 AG013622, and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation to AJS and grants 1T32NS058280, 1F31MH092057-01 and the 2012-13 Graduate Division Dissertation Year Fellowship to TR. Confocal laser scanning microscopy was performed at the CNSI Advanced Light Microscopy/Spectroscopy Shared Resource Facility at UCLA, supported with funding from NIH-NCRR shared resources grant (CJX1-443835-WS-29646) and NSF Major Research Instrumentation grant (CHE-0722519). Viral packaging was performed by the UCLA Vectorcore, supported with funding from JCCC/P30CA016042 and CURE/P30 DK041301. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cai DJ, 2016, NATURE IN PRESS; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; Choi GB, 2011, CELL, V146, P1003, DOI 10.1016/j.cell.2011.07.041; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Garner AR, 2012, SCIENCE, V335, P1513, DOI 10.1126/science.1214985; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Johansen JP, 2010, NAT NEUROSCI, V13, P979, DOI 10.1038/nn.2594; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Kim J, 2014, NAT NEUROSCI, V17, P65, DOI 10.1038/nn.3592; Kwon JT, 2014, LEARN MEMORY, V21, P627, DOI 10.1101/lm.035816.114; LeDoux J, 2007, CURR BIOL, V17, pR868, DOI 10.1016/j.cub.2007.08.005; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Maren S, 1996, NEURON, V16, P237, DOI 10.1016/S0896-6273(00)80041-0; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Pavlov I.P., 1927, CONDITIONED REFLEXES; Paxinos G, 2004, THE MOUSE BRAIN IN S; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Ramirez S, 2015, NATURE, V522, P335, DOI 10.1038/nature14514; Ramirez S, 2013, SCIENCE, V341, P387, DOI 10.1126/science.1239073; Redondo RL, 2014, NATURE, V513, P426, DOI 10.1038/nature13725; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Rogerson T, 2014, NAT REV NEUROSCI, V15, P157, DOI 10.1038/nrn3667; Roy DS, 2016, NATURE, V531, P508, DOI 10.1038/nature17172; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Silva AJ, 2009, SCIENCE, V326, P391, DOI 10.1126/science.1174519; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Viosca J, 2009, LEARN MEMORY, V16, P193, DOI 10.1101/lm.1254209; Won J, 2008, NEUROBIOL LEARN MEM, V89, P285, DOI 10.1016/j.nlm.2007.08.017; Yaguchi M, 2013, HUM GENE THER METHOD, V24, P333, DOI 10.1089/hgtb.2012.238; Yiu AP, 2014, NEURON, V83, P722, DOI 10.1016/j.neuron.2014.07.017; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhou Y, 2009, NAT NEUROSCI	40	23	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161655	10.1371/journal.pone.0161655	http://dx.doi.org/10.1371/journal.pone.0161655			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579481	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877400034
J	Vonberg, I; Ehlen, F; Fromm, O; Kuhn, AA; Klostermann, F				Vonberg, Isabelle; Ehlen, Felicitas; Fromm, Ortwin; Kuehn, Andrea A.; Klostermann, Fabian			Deep Brain Stimulation of the Subthalamic Nucleus Improves Lexical Switching in Parkinsons Disease Patients	PLOS ONE			English	Article							SPREADING-ACTIVATION THEORY; VERBAL FLUENCY; FREE-RECALL; COGNITION; METAANALYSIS; STN; PERFORMANCE; IMPAIRMENT; MEDICATION; ABILITIES	Objective Reduced verbal fluency (VF) has been reported in patients with Parkinson's disease (PD), especially those treated by Deep Brain Stimulation of the subthalamic nucleus (STN DBS). To delineate the nature of this dysfunction we aimed at identifying the particular VF-related operations modified by STN DBS. Method Eleven PD patients performed VF tasks in their STN DBS ON and OFF condition. To differentiate VF-components modulated by the stimulation, a temporal cluster analysis was performed, separating production spurts (i.e., 'clusters' as correlates of automatic activation spread within lexical fields) from slower cluster transitions (i.e., 'switches' reflecting set-shifting towards new lexical fields). The results were compared to those of eleven healthy control subjects. Results PD patients produced significantly more switches accompanied by shorter switch times in the STN DBS ON compared to the STN DBS OFF condition. The number of clusters and time intervals between words within clusters were not affected by the treatment state. Although switch behavior in patients with DBS ON improved, their task performance was still lower compared to that of healthy controls. Discussion Beyond impacting on motor symptoms, STN DBS seems to influence the dynamics of cognitive procedures. Specifically, the results are in line with basal ganglia roles for cognitive switching, in the particular case of VF, from prevailing lexical concepts to new ones.	[Vonberg, Isabelle; Ehlen, Felicitas; Fromm, Ortwin; Klostermann, Fabian] Charite, Dept Neurol, Motor & Cognit Grp, Berlin, Germany; [Kuehn, Andrea A.] Charite, Dept Neurol, Motor Neurosci Grp, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Klostermann, F (corresponding author), Charite, Dept Neurol, Motor & Cognit Grp, Berlin, Germany.	fabian.klostermann@charite.de		Kuhn, Andrea A./0000-0002-4134-9060; Ehlen, Felicitas/0000-0003-4595-1822	German Research Foundation (DFG) [Kl 1276/4-2, Kl 1276/5-2, KFO 247]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG, projects Kl 1276/4-2 and Kl 1276/5-2 in KFO 247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the German Research Foundation (DFG, projects Kl 1276/4-2 and Kl 1276/5-2 in KFO 247).	AMDP, 2007, AMDP SYST MAN DOK PS; Anzak A, 2011, EXP NEUROL, V232, P136, DOI 10.1016/j.expneurol.2011.07.010; Aschenbrenner S., 2000, REGENSBURGER WORTFLU; Auriacombe S., 1993, NEUROPSYCHOLOGY, V7, P182, DOI DOI 10.1037/0894-4105.7.2.182; Ballanger B, 2009, ANN NEUROL, V66, P817, DOI 10.1002/ana.21795; Bousfield WA, 1944, J GEN PSYCHOL, V30, P149, DOI 10.1080/00221309.1944.10544467; Breit S, 2004, CELL TISSUE RES, V318, P275, DOI 10.1007/s00441-004-0936-0; Caligiore D, 2013, NEUROSCI BIOBEHAV R, V37, P2504, DOI 10.1016/j.neubiorev.2013.07.016; Chen CC, 2010, EXP NEUROL, V224, P234, DOI 10.1016/j.expneurol.2010.03.015; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Combs HL, 2015, NEUROPSYCHOL REV, V25, P439, DOI 10.1007/s11065-015-9302-0; Cools R, 2001, CEREB CORTEX, V11, P1136, DOI 10.1093/cercor/11.12.1136; Cools R, 2003, NEUROPSYCHOLOGIA, V41, P1431, DOI 10.1016/S0028-3932(03)00117-9; Dadgar Hooshang, 2013, Iran J Psychiatry, V8, P55; De Gaspari D, 2006, PARKINSONISM RELAT D, V12, P289, DOI 10.1016/j.parkreldis.2006.01.001; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; Dorval AD, 2014, J NEUROPHYSIOL, V111, P1949, DOI 10.1152/jn.00713.2013; Ehlen F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079247; Eusebio A, 2011, J NEUROL NEUROSUR PS, V82, P569, DOI 10.1136/jnnp.2010.217489; Fine EM, 2011, J CLIN EXP NEUROPSYC, V33, P226, DOI 10.1080/13803395.2010.507185; Frank MJ, 2006, NEURAL NETWORKS, V19, P1120, DOI 10.1016/j.neunet.2006.03.006; Graybiel AM, 2015, COLD SPRING HARB PER, V7; GRUENEWALD PJ, 1980, J EXP PSYCHOL-HUM L, V6, P225, DOI 10.1037/0278-7393.6.3.225; Halpern CH, 2009, INT J GERIATR PSYCH, V24, P443, DOI 10.1002/gps.2149; Harati Ali, 2013, Surg Neurol Int, V4, pS443, DOI 10.4103/2152-7806.121637; Henry JD, 2004, J INT NEUROPSYCH SOC, V10, P608, DOI 10.1017/S1355617704104141; Hilker R, 2004, J CEREBR BLOOD F MET, V24, P7, DOI 10.1097/01.WCB.0000092831.44769.09; Jahanshahi M, 2000, BRAIN, V123, P1142, DOI 10.1093/brain/123.6.1142; Koss AM, 2005, ANN NEUROL, V58, P168, DOI 10.1002/ana.20525; Kuhn AA, 2008, J NEUROSCI, V28, P6165, DOI 10.1523/JNEUROSCI.0282-08.2008; Le Goff F, 2015, J PARKINSON DIS, V5, P95, DOI 10.3233/JPD-140443; Lefaucheur R, 2012, J NEUROL SCI, V321, P96, DOI 10.1016/j.jns.2012.07.033; Little S, 2012, EXP NEUROL, V236, P383, DOI 10.1016/j.expneurol.2012.04.024; Little Simon, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS44, DOI 10.1016/S1353-8020(13)70013-0; Martinez-Fernandez R, 2014, MOVEMENT DISORD, V29, P305, DOI 10.1002/mds.25760; Morrison CE, 2004, ARCH CLIN NEUROPSYCH, V19, P165, DOI 10.1016/S0887-6177(03)00004-0; Nambu A, 2004, PROG BRAIN RES, V143, P461, DOI 10.1016/S0079-6123(03)43043-4; Nambu A, 1996, J NEUROSCI, V16, P2671; Obeso I, 2012, BEHAV NEUROL, V25, P111, DOI 10.1155/2012/673610; Obeso JA, 1997, ADV NEUROL, V74, P3; Okun MS, 2009, ANN NEUROL, V65, P586, DOI 10.1002/ana.21596; Page D, 2007, IEEE T NEUR SYS REH, V15, P198, DOI 10.1109/TNSRE.2007.897074; Parsons TD, 2006, LANCET NEUROL, V5, P578, DOI 10.1016/S1474-4422(06)70475-6; Pillon B, 2000, NEUROLOGY, V55, P411, DOI 10.1212/WNL.55.3.411; Plessow F, 2014, BRAIN COGNITION, V87, P16, DOI 10.1016/j.bandc.2014.02.009; POLLIO HR, 1969, J VERB LEARN VERB BE, V8, P529, DOI 10.1016/S0022-5371(69)80099-X; Rektor I, 2015, CLIN NEUROPHYSIOL, V126, P653, DOI 10.1016/j.clinph.2014.10.156; Riedel O, 2008, J NEUROL, V255, P255, DOI 10.1007/s00415-008-0720-2; ROELOFS A, 1992, J EXPT PSYCHOL LEARN, V42, P107, DOI DOI 10.1016/0010-0277(92)90041-F; Rubchinsky LL, 2003, P NATL ACAD SCI USA, V100, P14427, DOI 10.1073/pnas.2036283100; Saint-Cyr JA, 2000, BRAIN, V123, P2091, DOI 10.1093/brain/123.10.2091; Schonecker T, 2009, AM J NEURORADIOL, V30, P1914, DOI 10.3174/ajnr.A1741; Shook SK, 2005, NEUROPSYCHOLOGIA, V43, P1990, DOI 10.1016/j.neuropsychologia.2005.03.024; Suhr JA, 1998, ARCH CLIN NEUROPSYCH, V13, P447, DOI 10.1016/S0887-6177(97)00040-1; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Tremblay C, 2015, BRAIN LANG, V141, P103, DOI 10.1016/j.bandl.2014.12.004; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Vonberg I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115846; Witt K, 2013, BRAIN, V136, P2109, DOI 10.1093/brain/awt151; WIXTED JT, 1994, PSYCHON B REV, V1, P89, DOI 10.3758/BF03200763; Wyman-Chick KA, 2016, J INT NEUROPSYCH SOC, P1; Yilmaz R, 2015, STEREOT FUNCT NEUROS, V93, P326, DOI 10.1159/000438996; Zangaglia R, 2009, MOVEMENT DISORD, V24, P1621, DOI 10.1002/mds.22603	63	13	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161404	10.1371/journal.pone.0161404	http://dx.doi.org/10.1371/journal.pone.0161404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EE	27575379	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877200026
J	Xie, LH; Ai, ZY; Zhang, M; Sun, RZ; Zhao, WR				Xie, Lihong; Ai, Zhuyu; Zhang, Meng; Sun, Runze; Zhao, Weirong			Enhanced Hydrogen Evolution in the Presence of Plasmonic Au-Photo-Sensitized g-C3N4 with an Extended Absorption Spectrum from 460 to 640 nm	PLOS ONE			English	Article							LIGHT PHOTOCATALYTIC ACTIVITIES; GRAPHITIC CARBON NITRIDE; NANOPARTICLES; GOLD; H-2; PHOTODEGRADATION; PERFORMANCE; GENERATION; CATALYSTS; ETHANOL	Extensively spectral-responsive photocatalytic hydrogen production was achieved over g-C3N4 photo-sensitized by Au nanoparticles. The photo-sensitization, which was achieved by a facile photo-assisted reduction route, resulted in an extended spectral range of absorption from 460 to 640 nm. The photo-sensitized g-C3N4 (Au/g-C3N4) photocatalysts exhibit significantly enhanced photocatalytic hydrogen evolution with a TOF value of 223 mu mol g(-1) h(-1), which is a 130-fold improvement over g-C3N4. The hydrogen production result confirms that Au nanoparticles are effective photo-sensitizers for the visible light-responsive substrate g-C3N4. UV-vis diffuse reflection spectra (DRS), photoluminescence spectra (PL), electron spin resonance (ESR), and electrochemical measurements were used to investigate the transfer process of photogenerated electrons. The optimal Au/g-C3N4 photocatalyst displays the lowest charge transfer resistance of 18.45 Omega cm(-2) and a high electron transfer efficiency, as determined by electrochemical impedance spectroscopy (EIS). The photo-sensitized g-C3N4 shows a broad range of response to visible light (400-640 nm), with significantly high incident photon-to-current efficiency (IPCE) values of 14.52%, 2.9%, and 0.74% under monochromatic light irradiation of 400, 550, and 640 nm, respectively. ESR characterization suggests that Au nanoparticles are able to absorb visible light of wavelengths higher than 460 nm and to generate hot electrons due to the SPR effect.	[Xie, Lihong; Ai, Zhuyu; Zhang, Meng; Sun, Runze; Zhao, Weirong] Zhejiang Univ, Dept Environm Engn, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Zhao, WR (corresponding author), Zhejiang Univ, Dept Environm Engn, Hangzhou 310058, Zhejiang, Peoples R China.	weirong@mail.hz.zj.cn		zhao, weirong/0000-0002-8597-2292	National Nature Science Foundation of China [51278456, 51178412]; National Key Technologies RD Program [2013BAC16B01]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies RD Program(National Key Technology R&D Program)	This work has been partially supported by the National Nature Science Foundation of China (grant nos. 51278456 and 51178412, http://www.nsfc.gov.cn) and the National Key Technologies R&D Program (grant no. 2013BAC16B01, http://www.most.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is supported by the National Nature Science Foundation of China (Grants 51278456 and 51178412) and the National key Technologies R & D Program (Grant 2013BAC16B01).	Bhirud AP, 2015, NANOSCALE, V7, P5023, DOI 10.1039/c4nr06435f; Bian SW, 2009, J PHYS CHEM C, V113, P8668, DOI 10.1021/jp810630k; Bu YY, 2014, APPL CATAL B-ENVIRON, V144, P622, DOI 10.1016/j.apcatb.2013.07.066; Cao SW, 2015, ADV MATER, V27, P2150, DOI 10.1002/adma.201500033; Chang C, 2013, APPL CATAL B-ENVIRON, V142, P553, DOI 10.1016/j.apcatb.2013.05.044; Chen J, 2014, J MATER RES, V29, P64, DOI 10.1557/jmr.2013.200; Chen WC, 2014, ACS NANO, V8, P1254, DOI 10.1021/nn404346v; Chen YF, 2014, ACS APPL MATER INTER, V6, P14405, DOI 10.1021/am503674e; Choi H, 2008, ANGEW CHEM INT EDIT, V47, P8259, DOI 10.1002/anie.200802852; Cui WQ, 2012, APPL CATAL A-GEN, V417, P111, DOI 10.1016/j.apcata.2011.12.027; Cui YJ, 2011, J MATER CHEM, V21, P13032, DOI 10.1039/c1jm11961c; Dong GH, 2015, J MATER CHEM A, V3, P23435, DOI 10.1039/c5ta06540b; Dong GH, 2012, CHEM COMMUN, V48, P6178, DOI 10.1039/c2cc32181e; Dong GH, 2012, J MATER CHEM, V22, P1160, DOI 10.1039/c1jm14312c; Ge L, 2013, MATER RES BULL, V48, P3919, DOI 10.1016/j.materresbull.2013.06.002; Ge L, 2012, J PHYS CHEM C, V116, P13708, DOI 10.1021/jp3041692; Ge L, 2012, J MATER CHEM, V22, P11843, DOI 10.1039/c2jm16241e; Ge L, 2011, APPL CATAL A-GEN, V409, P215, DOI 10.1016/j.apcata.2011.10.006; Silva CG, 2011, J AM CHEM SOC, V133, P595, DOI 10.1021/ja1086358; Hollmann D, 2014, CHEM MATER, V26, P1727, DOI 10.1021/cm500034p; Li JT, 2014, J AM CHEM SOC, V136, P8438, DOI 10.1021/ja503508g; Li XF, 2009, APPL PHYS A-MATER, V94, P387, DOI 10.1007/s00339-008-4816-4; Mishra YK, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2838302; Mishra YK, 2012, J APPL PHYS, V112, DOI 10.1063/1.4752469; Mukherji A, 2011, ACS NANO, V5, P3483, DOI 10.1021/nn102469e; Murdoch M, 2011, NAT CHEM, V3, P489, DOI [10.1038/NCHEM.1048, 10.1038/nchem.1048]; Najafpour MM, 2012, INT J HYDROGEN ENERG, V37, P8753, DOI 10.1016/j.ijhydene.2012.02.075; Navarro RM, 2009, ENERG ENVIRON SCI, V2, P35, DOI 10.1039/b808138g; Ndong LBB, 2014, IND ENG CHEM RES, V53, P1368, DOI 10.1021/ie403405z; Niishiro R, 2014, APPL CATAL B-ENVIRON, V150, P187, DOI 10.1016/j.apcatb.2013.12.015; Onsuratoom S, 2011, INT J HYDROGEN ENERG, V36, P5246, DOI 10.1016/j.ijhydene.2011.01.176; Pawar RC, 2015, APPL CATAL B-ENVIRON, V176, P654, DOI 10.1016/j.apcatb.2015.04.045; Pawar RC, 2015, RSC ADV, V5, P24281, DOI 10.1039/c4ra15560b; Pawar RC, 2014, DALTON T, V43, P12514, DOI 10.1039/c4dt01278j; Priebe JB, 2015, ACS CATAL, V5, P2137, DOI 10.1021/cs5018375; Priebe JB, 2013, ANGEW CHEM INT EDIT, V52, P11420, DOI 10.1002/anie.201306504; Sarina S, 2013, GREEN CHEM, V15, P1814, DOI 10.1039/c3gc40450a; Wang HB, 2011, J MATER CHEM, V21, P5430, DOI 10.1039/c1jm00049g; Wang Q, 2014, CHEM MATER, V26, P4144, DOI 10.1021/cm5011983; Wu M, 2015, J MATER CHEM A, V3, P15710, DOI 10.1039/c5ta03358f; Wu YM, 2009, J PHYS CHEM C, V113, P14689, DOI 10.1021/jp904465d; Xu M, 2013, ACS APPL MATER INTER, V5, P12533, DOI 10.1021/am4038307; Xu YG, 2013, COLLOID SURFACE A, V436, P474, DOI 10.1016/j.colsurfa.2013.06.005; Xu ZH, 2011, ELECTROCHEM COMMUN, V13, P1260, DOI 10.1016/j.elecom.2011.08.029; Yang GR, 2013, NANOSCALE, V5, P12432, DOI 10.1039/c3nr03462c; Yang YX, 2013, APPL CATAL B-ENVIRON, V142, P828, DOI 10.1016/j.apcatb.2013.06.026; Yu JC, 2002, CHEM MATER, V14, P3808, DOI 10.1021/cm020027c; Zhang M, 2014, APPL CATAL B-ENVIRON, V147, P229, DOI 10.1016/j.apcatb.2013.09.002; Zhang XH, 2014, ACS CATAL, V4, P162, DOI 10.1021/cs400863c; Zhao WR, 2014, INT J HYDROGEN ENERG, V39, P7705, DOI 10.1016/j.ijhydene.2014.03.102; Zhao WR, 2016, INT J HYDROG ENERGY, V41	51	34	34	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161397	10.1371/journal.pone.0161397	http://dx.doi.org/10.1371/journal.pone.0161397			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575246	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877200025
J	Scialo, F; Sriram, A; Stefanatos, R; Sanz, A				Scialo, Filippo; Sriram, Ashwin; Stefanatos, Rhoda; Sanz, Alberto			Practical Recommendations for the Use of the GeneSwitch Gal4 System to Knock-Down Genes in Drosophila melanogaster	PLOS ONE			English	Article							LIFE-SPAN; TRANSGENE EXPRESSION; ALTERNATIVE OXIDASE; OXIDATIVE STRESS; RNAI; PHENOTYPES; INTERACTS; SUBUNIT	Drosophila melanogaster is a popular research model organism thanks to its' powerful genetic tools that allow spatial and temporal control of gene expression. The inducible GeneSwitch Gal4 system (GS) system is a modified version of the classic UAS/GAL4 system which allows inducible regulation of gene expression and eliminates background effects. It is widely acknowledged that the GS system is leaky, with low level expression of UAS transgenes in absence of the inducer RU-486 (the progesterone analog that activates the modified GAL4 protein). However, in the course of our experiments, we have observed that the extent of this leak depends on the nature of the transgene being expressed. In the absence of RU-486, when strong drivers are used to express protein coding transgenes, leaky expression is low or negligible, however expression of RNA interference (RNAi) transgenes results in complete depletion of protein levels. The majority of published studies, using the GS system and RNAi transgenes validate knock-down efficiency by comparing target gene mRNA levels between induced and non-induced groups. Here, we demonstrate that this approach is lacking and that both additional control groups and further validation is required at the protein level. Unfortunately, this experimental limitation of the GS system eliminates "the background advantage", but does offer the possibility of performing more complex experiments (e.g. studying depletion and overexpression of different proteins in the same genetic background). The limitations and new possible applications of the GS system are discussed in detail.	[Scialo, Filippo; Sriram, Ashwin; Stefanatos, Rhoda; Sanz, Alberto] Univ Newcastle, Inst Cell & Mol Biosci, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England	Newcastle University - UK	Sanz, A (corresponding author), Univ Newcastle, Inst Cell & Mol Biosci, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.	Alberto.Sanz@ncl.ac.uk	Sanz, Alberto/O-2329-2015; Scialò, Filippo/GQQ-0164-2022	Sanz, Alberto/0000-0003-2149-1753; Stefanatos, Rhoda/0000-0002-9072-7224; Scialo', Filippo/0000-0001-6648-1503	European Research Council [260632]; BBSRC (Biotechnology and Biological Sciences Research Council) [BB/M023311/1]; BBSRC [BB/M023311/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M023311/1] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study is supported by the European Research Council (260632 - ComplexI&Aging) and the BBSRC (Biotechnology and Biological Sciences Research Council) (BB/M023311/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAND AH, 1993, DEVELOPMENT, V118, P401; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Copeland JM, 2009, CURR BIOL, V19, P1591, DOI 10.1016/j.cub.2009.08.016; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004; Ford D, 2007, EXP GERONTOL, V42, P483, DOI 10.1016/j.exger.2007.01.004; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Karlikow M, 2014, DEV COMP IMMUNOL, V42, P85, DOI 10.1016/j.dci.2013.05.004; Kemppainen KK, 2014, HUM MOL GENET, V23, P2078, DOI 10.1093/hmg/ddt601; Matthews KA, 2005, NAT REV GENET, V6, P179, DOI 10.1038/nrg1554; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Pak J, 2012, CELL, V151, P885, DOI 10.1016/j.cell.2012.10.022; Park J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013151; Poirier L, 2008, AGING CELL, V7, P758, DOI 10.1111/j.1474-9726.2008.00421.x; Rovenko BM, 2015, J INSECT PHYSIOL, V79, P42, DOI 10.1016/j.jinsphys.2015.05.007; Sanz A, 2010, AGING-US, V2, P200, DOI 10.18632/aging.100137; Sanz A, 2010, P NATL ACAD SCI USA, V107, P9105, DOI 10.1073/pnas.0911539107; Scialo F, 2015, CELL CYCLE, V14, P2949, DOI 10.1080/15384101.2015.1071745; Stefanatos R, 2012, CELL CYCLE, V11, P3876, DOI 10.4161/cc.22073; Sun XP, 2014, CELL REP, V8, P1781, DOI 10.1016/j.celrep.2014.08.022; Suster ML, 2004, GENESIS, V39, P240, DOI 10.1002/gene.20051; Tsakiri EN, 2013, AGING CELL, V12, P802, DOI 10.1111/acel.12111; Venken KJT, 2005, NAT REV GENET, V6, P167, DOI 10.1038/nrg1553; Zhang K, 2013, J CELL BIOL, V200, P807, DOI 10.1083/jcb.201208033	24	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161817	10.1371/journal.pone.0161817	http://dx.doi.org/10.1371/journal.pone.0161817			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27570965	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000382876700033
J	Lu, KH; Hung, SC; Wen, HG; Marussich, L; Liu, ZM				Lu, Kun-Han; Hung, Shao-Chin; Wen, Haiguang; Marussich, Lauren; Liu, Zhongming			Influences of High-Level Features, Gaze, and Scene Transitions on the Reliability of BOLD Responses to Natural Movie Stimuli	PLOS ONE			English	Article							EYE-MOVEMENTS; BRAIN ACTIVITY; VISUAL-CORTEX; ATTENTION; SOFTWARE; NEURONS; OBJECT; INFORMATION; MODULATORS; DRIVERS	Complex, sustained, dynamic, and naturalistic visual stimulation can evoke distributed brain activities that are highly reproducible within and across individuals. However, the precise origins of such reproducible responses remain incompletely understood. Here, we employed concurrent functional magnetic resonance imaging (fMRI) and eye tracking to investigate the experimental and behavioral factors that influence fMRI activity and its intra- and inter-subject reproducibility during repeated movie stimuli. We found that widely distributed and highly reproducible fMRI responses were attributed primarily to the high-level natural content in the movie. In the absence of such natural content, low-level visual features alone in a spatiotemporally scrambled control stimulus evoked significantly reduced degree and extent of reproducible responses, which were mostly confined to the primary visual cortex (V1). We also found that the varying gaze behavior affected the cortical response at the peripheral part of V1 and in the oculomotor network, with minor effects on the response reproducibility over the extrastriate visual areas. Lastly, scene transitions in the movie stimulus due to film editing partly caused the reproducible fMRI responses at widespread cortical areas, especially along the ventral visual pathway. Therefore, the naturalistic nature of a movie stimulus is necessary for driving highly reliable visual activations. In a movie-stimulation paradigm, scene transitions and individuals' gaze behavior should be taken as potential confounding factors in order to properly interpret cortical activity that supports natural vision.	[Hung, Shao-Chin; Marussich, Lauren; Liu, Zhongming] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Lu, Kun-Han; Wen, Haiguang; Liu, Zhongming] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Lu, Kun-Han; Wen, Haiguang; Marussich, Lauren; Liu, Zhongming] Purdue Univ, Purdue Inst Integrat Neurosci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Liu, ZM (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.; Liu, ZM (corresponding author), Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA.; Liu, ZM (corresponding author), Purdue Univ, Purdue Inst Integrat Neurosci, W Lafayette, IN 47907 USA.	zmliu@purdue.edu			NIH, National Institute of Mental Health [R01MH104402]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH104402] Funding Source: NIH RePORTER	NIH, National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH R01MH104402, National Institute of Mental Health, to ZL.	Abbott LF, 2005, PROG BRAIN RES, V149, P147, DOI 10.1016/S0079-6123(05)49011-1; Bartels A, 2004, HUM BRAIN MAPP, V21, P75, DOI 10.1002/hbm.10153; Belitski A, 2008, J NEUROSCI, V28, P5696, DOI 10.1523/JNEUROSCI.0009-08.2008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chang WT, 2015, NEUROIMAGE, V114, P49, DOI 10.1016/j.neuroimage.2015.03.066; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Grosbras MN, 2005, HUM BRAIN MAPP, V25, P140, DOI 10.1002/hbm.20145; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Hasson U, 2008, J NEUROSCI, V28, P2539, DOI 10.1523/JNEUROSCI.5487-07.2008; Hasson U, 2008, PROJECTIONS, V2, P1, DOI 10.3167/proj.2008.020102; Hasson U, 2010, TRENDS COGN SCI, V14, P40, DOI 10.1016/j.tics.2009.10.011; Honey CJ, 2012, NEURON, V76, P423, DOI 10.1016/j.neuron.2012.08.011; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Huth AG, 2012, NEURON, V76, P1210, DOI 10.1016/j.neuron.2012.10.014; Jaaskelainen Iiro P, 2008, Open Neuroimag J, V2, P14, DOI 10.2174/1874440000802010014; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Kauppi JP, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00002; Klier EM, 2001, SUPERIOR COLLICULUS, P627; Lankinen K, 2014, NEUROIMAGE, V92, P217, DOI 10.1016/j.neuroimage.2014.02.004; LEE CK, 1988, NATURE, V332, P357, DOI 10.1038/332357a0; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; Lu JH, 1997, IEEE T CIRC SYST VID, V7, P429, DOI 10.1109/76.564122; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Marcus Daniel S, 2011, Front Neuroinform, V5, P4, DOI 10.3389/fninf.2011.00004; MAUNSELL JHR, 1987, ANNU REV NEUROSCI, V10, P363, DOI 10.1146/annurev.ne.10.030187.002051; Mechler F, 1998, J NEUROSCI, V18, P6583; Meshulam M, 2013, J NEUROPHYSIOL, V109, P2272, DOI 10.1152/jn.00474.2012; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pierrot-Deseilligny C, 2003, BRAIN, V126, P1460, DOI 10.1093/brain/awg148; Russ BE, 2015, NEUROIMAGE, V109, P84, DOI 10.1016/j.neuroimage.2015.01.012; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; VOGELS R, 1996, PROG BRAIN RES, P195; Zacks JM, 2001, NAT NEUROSCI, V4, P651, DOI 10.1038/88486	38	13	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161797	10.1371/journal.pone.0161797	http://dx.doi.org/10.1371/journal.pone.0161797			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564573	Green Submitted, Green Published, gold			2022-12-26	WOS:000382496300020
J	Yang, TQ; Fang, GY; He, H; Chen, JH				Yang, Tianquan; Fang, Genwang Yue; He, Hua; Chen, Jianghua			Genome-Wide Identification, Evolutionary Analysis and Expression Profiles of LATERAL ORGAN BOUNDARIES DOMAIN Gene Family in Lotus japonicus and Medicago truncatula	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; ROOT-FORMATION; TRANSCRIPTION FACTORS; PROTEIN; ARF7; ESTABLISHMENT; DEFINES; MEMBERS	The LATERAL ORGAN BOUNDARIES DOMAIN (LBD) gene family has been well-studied in Arabidopsis and play crucial roles in the diverse growth and development processes including establishment and maintenance of boundary of developmental lateral organs. In this study we identified and characterized 38 LBD genes in Lotus japonicus (LjLBD) and 57 LBD genes in Medicago truncatula (MtLBD), both of which are model legume plants that have some specific development features absent in Arabidopsis. The phylogenetic relationships, their locations in the genome, genes structure and conserved motifs were examined. The results revealed that all LjLBD and MtLBD genes could be distinctly divided into two classes: Class I and II. The evolutionary analysis showed that Type I functional divergence with some significantly site-specific shifts may be the main force for the divergence between Class I and Class II. In addition, the expression patterns of LjLBD genes uncovered the diverse functions in plant development. Interestingly, we found that two LjLBD proteins that were highly expressed during compound leaf and pulvinus development, can interact via yeast two-hybrid assays. Taken together, our findings provide an evolutionary and genetic foundation in further understanding the molecular basis of LBD gene family in general, specifically in L. japonicus and M. truncatula.	[Yang, Tianquan; Fang, Genwang Yue; He, Hua; Chen, Jianghua] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Plant Resources & Sustainable Use, Kunming 650204, Yunnan Province, Peoples R China; [Yang, Tianquan; Fang, Genwang Yue] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, JH (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Plant Resources & Sustainable Use, Kunming 650204, Yunnan Province, Peoples R China.	jhchen2016@163.com			National Natural Science Foundation of China [31500989]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (31500989). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (31500989).	Borghi L, 2007, PLANT CELL, V19, P1795, DOI 10.1105/tpc.106.047159; Bortiri E, 2006, PLANT CELL, V18, P574, DOI 10.1105/tpc.105.039032; Chen JH, 2012, P NATL ACAD SCI USA, V109, P11723, DOI 10.1073/pnas.1204566109; Gu X, 2013, MOL BIOL EVOL, V30, P1713, DOI 10.1093/molbev/mst069; Husbands A, 2007, NUCLEIC ACIDS RES, V35, P6663, DOI 10.1093/nar/gkm775; Lee HW, 2009, PLANT PHYSIOL, V151, P1377, DOI 10.1104/pp.109.143685; Liu HJ, 2005, PLANT J, V43, P47, DOI 10.1111/j.1365-313X.2005.02434.x; Luo Jiang-Hong, 2006, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V32, P202; Majer C, 2011, TRENDS PLANT SCI, V16, P47, DOI 10.1016/j.tplants.2010.09.009; Matsumura Y, 2009, PLANT J, V58, P525, DOI 10.1111/j.1365-313X.2009.03797.x; Naito T, 2007, BIOSCI BIOTECH BIOCH, V71, P1269, DOI 10.1271/bbb.60681; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Rubin G, 2009, PLANT CELL, V21, P3567, DOI 10.1105/tpc.109.067041; Semiarti E, 2001, DEVELOPMENT, V128, P1771; Shuai B, 2002, PLANT PHYSIOL, V129, P747, DOI 10.1104/pp.010926; Soyano T, 2008, PLANT CELL, V20, P3359, DOI 10.1105/tpc.108.061796; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Verdier J, 2013, PLANT J, V74, P351, DOI 10.1111/tpj.12119; Wang XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057044; Xu CZ, 2015, NEW PHYTOL, V207, P1123, DOI 10.1111/nph.13420; Yang Y, 2006, MOL PHYLOGENET EVOL, V39, P248, DOI 10.1016/j.ympev.2005.09.016; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zentella R, 2007, PLANT CELL, V19, P3037, DOI 10.1105/tpc.107.054999; Zhang YM, 2014, J GENET, V93, P79, DOI 10.1007/s12041-014-0342-7	25	11	13	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161901	10.1371/journal.pone.0161901	http://dx.doi.org/10.1371/journal.pone.0161901			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560982	gold, Green Published, Green Submitted			2022-12-26	WOS:000382258600115
J	Alday, EAP; Ni, HB; Zhang, C; Colman, MA; Gan, ZZ; Zhang, HG				Alday, Erick A. Perez; Ni, Haibo; Zhang, Chen; Colman, Michael A.; Gan, Zizhao; Zhang, Henggui			Comparison of Electric- and Magnetic-Cardiograms Produced by Myocardial Ischemia in Models of the Human Ventricle and Torso	PLOS ONE			English	Article							T-WAVE; MAGNETOCARDIOGRAPHY; TOMOGRAPHY; DISEASE; ECG; REPOLARIZATION; ARRHYTHMIAS; INFARCTION	Myocardial ventricular ischemia arises from a lack of blood supply to the heart, which may cause abnormal repolarization and excitation wave conduction patterns in the tissue, leading to cardiac arrhythmias and even sudden death. Current diagnosis of cardiac ischemia by the 12-lead electrocardiogram (ECG) has limitations as they are insensitive in many cases and may show unnoticeable differences to normal patterns. As the magnetic field provides extra information on cardiac excitation and is more sensitive to tangential currents to the surface of the chest, whereas the electric field is more sensitive to flux currents, it has been hypothesized that the magnetocardiogram (MCG) may provide a complementary method to the ECG in ischemic diagnosis. However, it is unclear yet about the differences in sensitivity regions of body surface ECG and MCG signals to ischemic conditions. The aim of this study was to investigate such differences by using 12-, 36-ECG and 36-MCG computed from multi-scale biophysically detailed computational models of the human ventricles and torso in both control and ischemic conditions. It was shown that ischemia produced changes in the ECG and MCG signals in the QRS complex, T-wave and ST-segment, with greater relative differences seen in the 36-lead ECG and MCG as compared to the 12-leads ECG (34% and 37% vs 26%, respectively). The 36-lead ECG showed more averaged sensitivity than the MCG in the change of T-wave due to ischemia (37% vs 32%, respectively), whereas the MCG showed greater sensitivity than the ECG in the change of the ST-segment (50% vs 40%, respectively). In addition, both MCG and ECG showed regional-dependent changes to ischemia, but with MCG showing a stronger correlation between ischemic region in the heart. In conclusion, MCG shows more sensitivity than ECG in response to ischemia, which may provide an alternative method for the diagnosis of ischemia.	[Alday, Erick A. Perez; Ni, Haibo; Zhang, Henggui] Univ Manchester, Sch Phys & Astron, Biol Phys Grp, Manchester, Lancs, England; [Zhang, Chen; Gan, Zizhao] Peking Univ, Sch Phys, Appl Superconduct Res Ctr, Beijing, Peoples R China; [Colman, Michael A.] Univ Manchester, Sch Phys & Astron, Theoret Phys Grp, Manchester, Lancs, England	University of Manchester; Peking University; University of Manchester	Zhang, HG (corresponding author), Univ Manchester, Sch Phys & Astron, Biol Phys Grp, Manchester, Lancs, England.	henggui.zhang@manchester.ac.uk	Ni, Haibo/G-1288-2011; Zhang, Henggui/D-6712-2011; Zhang, Henggui/AAM-1043-2020	Ni, Haibo/0000-0003-0083-4286; Colman, Michael/0000-0003-2817-8508; Perez Alday, Erick Andres/0000-0002-4269-0965	CONACyT; EPSRC; Engineering and Physical Sciences Research Council [EP/J00958X/1] Funding Source: researchfish; EPSRC [EP/J00958X/1] Funding Source: UKRI	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by CONACyT and EPSRC project grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar B, 1999, MED BIOL ENG COMPUT, V37, P574, DOI 10.1007/BF02513351; Adeniran I, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002313; Alday EAP, 2013, COMPUT CARDIOL CONF, V40, P1075; Alday EAP, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004026; COHEN JL, 1995, J AM COLL CARDIOL, V26, P1168, DOI 10.1016/0735-1097(95)00296-0; Ferrero JM, 2014, EUROPACE, V16, P405, DOI 10.1093/europace/eut405; GESELOWITZ DB, 1973, ANNU REV BIOPHYS BIO, V2, P37, DOI 10.1146/annurev.bb.02.060173.000345; GESELOWT.DB, 1970, IEEE T MAGN, VMAG6, P346, DOI 10.1109/TMAG.1970.1066765; Ghuran AV, 2001, BRIT MED BULL, V59, P193, DOI 10.1093/bmb/59.1.193; Glukhov AV, 2010, CIRC RES, V106, P981, DOI 10.1161/CIRCRESAHA.109.204891; Hailer B, 2005, PACE, V28, P8, DOI 10.1111/j.1540-8159.2005.09318.x; Hamilton-Craig C, 2012, INT J CARDIOVAS IMAG, V28, P1111, DOI 10.1007/s10554-011-9926-y; Hampton JR., 2013, THE ECG MADE EASY; Hanninen H, 2001, BASIC RES CARDIOL, V96, P405, DOI 10.1007/s003950170049; Helle-Valle TM, 2010, AM J CARDIOL, V106, P483, DOI 10.1016/j.amjcard.2010.03.063; Jie X, 2008, HEART RHYTHM, V5, P1036, DOI 10.1016/j.hrthm.2008.03.025; Jie X, 2010, HEART RHYTHM, V7, P379, DOI 10.1016/j.hrthm.2009.11.014; Jie X, 2010, CIRC RES, V106, P185, DOI 10.1161/CIRCRESAHA.109.210864; Kandori A, 2008, ANN NONINVAS ELECTRO, V13, P391, DOI 10.1111/j.1542-474X.2008.00246.x; Kandori A, 2008, PACE, V31, P422, DOI 10.1111/j.1540-8159.2008.01011.x; Kandori A, 2010, ANN NONINVAS ELECTRO, V15, P360, DOI 10.1111/j.1542-474X.2010.00392.x; Kapetanopoulos A, 2007, J NUCL CARDIOL, V14, P810, DOI 10.1016/j.nuclcard.2007.07.014; KAPLINSKY E, 1979, CIRCULATION, V60, P397, DOI 10.1161/01.CIR.60.2.397; Katz AM., 2010, PHYSL HEART; Kazbanov IV, 2014, EFFECT GLOBAL CARDIA; Keller DUJ, 2010, IFMBE PROC, V25, P145; Keller DUJ, 2012, IEEE T BIO-MED ENG, V59, P311, DOI 10.1109/TBME.2011.2168397; Keller DUJ, 2011, IEEE T BIO-MED ENG, V58, P2109, DOI 10.1109/TBME.2011.2147785; Keller DUJ, 2010, IEEE T BIO-MED ENG, V57, P1568, DOI 10.1109/TBME.2010.2046485; KITTNAR O, 1993, PHYSIOL RES, V42, P123; Klootwijk P, 1997, EUR HEART J, V18, P931; KORNREICH F, 1993, CIRCULATION, V87, P773, DOI 10.1161/01.CIR.87.3.773; Kwong JSW, 2013, INT J CARDIOL, V167, P1835, DOI 10.1016/j.ijcard.2012.12.056; LANT J, 1990, J ELECTROCARDIOL, V23, P315, DOI 10.1016/0022-0736(90)90121-H; Mantynen V, 2014, PHYS MED BIOL, V59, P7141, DOI 10.1088/0031-9155/59/23/7141; Members AF, 2015, EUR HEART J; NENONEN J, 1991, IEEE T BIO-MED ENG, V38, P658, DOI 10.1109/10.83565; O'Hara T, 2011, SIMULATION UNDISEASE; Pagidipati NJ, 2013, CIRCULATION, V127, P749, DOI 10.1161/CIRCULATIONAHA.112.128413; Perazzolo Marra M, 2012, CIRCULATION S, V126; Potyagaylo D, 2015, COMPUT CARDIOL CONF, V42, P1145, DOI 10.1109/CIC.2015.7411118; Robbes D, 2006, SENSOR ACTUAT A-PHYS, V129, P86, DOI 10.1016/j.sna.2005.11.023; Siontis KC, 2015, IJC HEART VASC, V6, P54, DOI 10.1016/j.ijcha.2015.01.005; Stilli D, 1986, CAN J CARDIOL SA, p107A; Taggart P, 2000, J MOL CELL CARDIOL, V32, P621, DOI 10.1006/jmcc.2000.1105; Taggart P, 1996, CIRCULATION, V94, P2526, DOI 10.1161/01.CIR.94.10.2526; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Tolstrup K, 2006, CARDIOLOGY, V106, P270, DOI 10.1159/000093490; Zhang C, 2014, AIP ADV, V4, DOI 10.1063/1.4904429	49	14	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0160999	10.1371/journal.pone.0160999	http://dx.doi.org/10.1371/journal.pone.0160999			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556808	Green Published, gold			2022-12-26	WOS:000382258100024
J	Emmanuel, A; Kumar, G; Christensen, P; Mealing, S; Storling, ZM; Andersen, F; Kirshblum, S				Emmanuel, Anton; Kumar, Gayathri; Christensen, Peter; Mealing, Stuart; Storling, Zenia M.; Andersen, Frederikke; Kirshblum, Steven			Long-Term Cost-Effectiveness of Transanal Irrigation in Patients with Neurogenic Bowel Dysfunction	PLOS ONE			English	Article							SPINAL-CORD-INJURY; FECAL INCONTINENCE; MANAGEMENT; CONSTIPATION; STIMULATION; PREVALENCE; SAFETY; ADULTS	Background People suffering from neurogenic bowel dysfunction (NBD) and an ineffective bowel regimen often suffer from fecal incontinence (FI) and related symptoms, which have a huge impact on their quality of life. In these situations, transanal irrigation (TAI) has been shown to reduce these symptoms and improve quality of life. Aim To investigate the long-term cost-effectiveness of initiating TAI in patients with NBD who have failed standard bowel care (SBC). Methods A deterministic Markov decision model was developed to project the lifetime health economic outcomes, including quality-adjusted life years (QALYs), episodes of FI, urinary tract infections (UTIs), and stoma surgery when initiating TAI relative to continuing SBC. A data set consisting of 227 patients with NBD due to spinal cord injury (SCI), multiple sclerosis, spina bifida and cauda equina syndrome was used in the analysis. In the model a 30-year old individual with SCI was used as a base-case. A probabilistic sensitivity analysis was applied to evaluate the robustness of the model. Results The model predicts that a 30-year old SCI patient with a life expectancy of 37 years initiating TAI will experience a 36% reduction in FI episodes, a 29% reduction in UTIs, a 35% reduction in likelihood of stoma surgery and a 0.4 improvement in QALYs, compared with patients continuing SBC. A lifetime cost-saving of 21,768 pound per patient was estimated for TAI versus continuing SBC alone. Conclusion TAI is a cost-saving treatment strategy reducing risk of stoma surgery, UTIs, episodes of FI and improving QALYs for NBD patients who have failed SBC.	[Emmanuel, Anton] Univ Coll London Hosp, GI Physiol Unit, London, England; [Kumar, Gayathri; Mealing, Stuart] ICON Hlth Econ, Oxford, England; [Christensen, Peter] Aarhus Univ Hosp, Pelv Floor Unit, Aarhus, Denmark; [Storling, Zenia M.; Andersen, Frederikke] Coloplast AS, Humlebaek, Denmark; [Kirshblum, Steven] Rutgers New Jersey Med Sch, Kessler Inst Rehabil, Newark, NJ USA	University College London Hospitals NHS Foundation Trust; University of London; University College London; ICON plc; Aarhus University; Kessler Institute for Rehabilitation; Rutgers State University New Brunswick; Rutgers State University Medical Center	Emmanuel, A (corresponding author), Univ Coll London Hosp, GI Physiol Unit, London, England.	a.emmanuel@ucl.ac.uk		Mealing, Stuart/0000-0002-2564-1440	Biomedical Research Centre at University College Hospital	Biomedical Research Centre at University College Hospital	The Biomedical Research Centre at University College Hospital supported the work by Anton Emmanuel. We confirm that the funder provided support in the form of salaries for author AE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of AE are articulated in the 'author contributions' section.	Bermingham SL, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8639; Briggs A, 2006, DECISION MODELLING H; British National Formulary British Medical Association British Royal Pharmaceutical Society of Great Britain, 2015, BRIT NATL FORMULARY; Christensen P, 2009, SPINAL CORD, V47, P138, DOI 10.1038/sc.2008.98; Christensen P, 2006, GASTROENTEROLOGY, V131, P738, DOI 10.1053/j.gastro.2006.06.004; Christensen P, 2009, DIS COLON RECTUM, V52, P286, DOI 10.1007/DCR.0b013e3181979341; Coggrave M., 2012, GUIDELINES MANAGEMEN; Correa GI, 2000, SPINAL CORD, V38, P301, DOI 10.1038/sj.sc.3100851; Dagenais S, 2013, NEUROSURGERY, V73, pE911, DOI 10.1227/NEU.0000000000000203; Del Popolo G, 2008, SPINAL CORD, V46, P517, DOI 10.1038/sj.sc.3102167; DeLisa J A, 1997, J Spinal Cord Med, V20, P384; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Dudding TC, 2008, BRIT J SURG, V95, P1155, DOI 10.1002/bjs.6237; Emmanuel A, 2015, FACTS MYTHS BOWEL MA; Emmanuel AV, 2013, SPINAL CORD, V51, P732, DOI 10.1038/sc.2013.86; Emmanuel A, 2010, CLIN REHABIL, V24, P483, DOI 10.1177/0269215509353253; Faaborg PM, 2009, SPINAL CORD, V47, P545, DOI 10.1038/sc.2008.159; Frankel HL, 1998, SPINAL CORD, V36, P266, DOI 10.1038/sj.sc.3100638; Furlan JC, 2007, BRIT J SURG, V94, P1139, DOI 10.1002/bjs.5781; Harari D, 1997, SPINAL CORD, V35, P394, DOI 10.1038/sj.sc.3100417; HINDS JP, 1990, GASTROENTEROLOGY, V98, P1538, DOI 10.1016/0016-5085(90)91087-M; Krogh K, 1997, DIS COLON RECTUM, V40, P1233, DOI 10.1007/BF02055170; Krogh K, 2006, SPINAL CORD, V44, P625, DOI 10.1038/sj.sc.3101887; Liu CW, 2009, J REHABIL MED, V41, P35, DOI 10.2340/16501977-0277; Lynch AC, 2001, SPINAL CORD, V39, P193, DOI 10.1038/sj.sc.3101119; Meisner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037813; National Health Service England and Wales, 2015, NHS EL DRUG TAR; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; NICE, 2012, INF PREV CONTR HEALT; SCNs High Impact Action Steering Group 2010, 2010, HIGH IMP ACT STOM CA; Verhoef M, 2005, SPINAL CORD, V43, P331, DOI 10.1038/sj.sc.3101705; Watt M, 2012, HEART, V98, P370, DOI 10.1136/heartjnl-2011-300444	32	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0159394	10.1371/journal.pone.0159394	http://dx.doi.org/10.1371/journal.pone.0159394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27557052	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258100007
J	Shamoun-Baranes, J; Farnsworth, A; Aelterman, B; Alves, JA; Azijn, K; Bernstein, G; Branco, S; Desmet, P; Dokter, AM; Horton, K; Kelling, S; Kelly, JF; Leijnse, H; Rong, JJ; Sheldon, D; Van den Broeck, W; Van den Meersche, JK; Van Doren, BM; Gasteren, H				Shamoun-Baranes, Judy; Farnsworth, Andrew; Aelterman, Bart; Alves, Jose A.; Azijn, Kevin; Bernstein, Garrett; Branco, Sergio; Desmet, Peter; Dokter, Adriaan M.; Horton, Kyle; Kelling, Steve; Kelly, Jeffrey F.; Leijnse, Hidde; Rong, Jingjing; Sheldon, Daniel; Van den Broeck, Wouter; Van den Meersche, Jan Klaas; Van Doren, Benjamin Mark; van Gasteren, Hans			Innovative Visualizations Shed Light on Avian Nocturnal Migration	PLOS ONE			English	Article							WESTERN NORTH-ATLANTIC; BIRD MIGRATION; RADAR OBSERVATIONS; WEATHER RADARS; FLIGHT; INFORMATION; WIND; AEROECOLOGY; ECOLOGY; NETWORK	Globally, billions of flying animals undergo seasonal migrations, many of which occur at night. The temporal and spatial scales at which migrations occur and our inability to directly observe these nocturnal movements makes monitoring and characterizing this critical period in migratory animals' life cycles difficult. Remote sensing, therefore, has played an important role in our understanding of large-scale nocturnal bird migrations. Weather surveillance radar networks in Europe and North America have great potential for long-term low-cost monitoring of bird migration at scales that have previously been impossible to achieve. Such long-term monitoring, however, poses a number of challenges for the ornithological and ecological communities: how does one take advantage of this vast data resource, integrate information across multiple sensors and large spatial and temporal scales, and visually represent the data for interpretation and dissemination, considering the dynamic nature of migration? We assembled an interdisciplinary team of ecologists, meteorologists, computer scientists, and graphic designers to develop two different flow visualizations, which are interactive and open source, in order to create novel representations of broad-front nocturnal bird migration to address a primary impediment to long-term, large-scale nocturnal migration monitoring. We have applied these visualization techniques to mass bird migration events recorded by two different weather surveillance radar networks covering regions in Europe and North America. These applications show the flexibility and portability of such an approach. The visualizations provide an intuitive representation of the scale and dynamics of these complex systems, are easily accessible for a broad interest group, and are biologically insightful. Additionally, they facilitate fundamental ecological research, conservation, mitigation of human-wildlife conflicts, improvement of meteorological products, and public outreach, education, and engagement.	[Shamoun-Baranes, Judy; Dokter, Adriaan M.; van Gasteren, Hans] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Computat Geoecol, Amsterdam, Netherlands; [Farnsworth, Andrew; Kelling, Steve; Van Doren, Benjamin Mark] Cornell Lab Ornithol, Informat Sci, Ithaca, NY USA; [Aelterman, Bart; Azijn, Kevin; Desmet, Peter] Res Inst Nat & Forest, Informat & Data Ctr, Brussels, Belgium; [Alves, Jose A.] Univ Aveiro, CESAM, Aveiro, Portugal; [Alves, Jose A.] Univ Iceland, South Iceland Res Ctr, Selfoss, Iceland; [Bernstein, Garrett; Sheldon, Daniel] Univ Massachusetts, Coll Informat & Comp Sci, Amherst, MA 01003 USA; [Branco, Sergio] Univ Minho, Dept Elect Engn, Guimaraes, Portugal; [Horton, Kyle; Kelly, Jeffrey F.] Univ Oklahoma, Oklahoma Biol Survey, Norman, OK 73019 USA; [Leijnse, Hidde] Royal Netherlands Meteorol Inst, De Bilt, Netherlands; [Rong, Jingjing; Sheldon, Daniel] Mt Holyoke Coll, S Hadley, MA 01075 USA; [Van den Broeck, Wouter] iMinds, Ghent, Belgium; [Van Doren, Benjamin Mark] Wildly Mild, Ninove, Belgium	University of Amsterdam; Cornell University; Research Institute for Nature & Forest; Universidade de Aveiro; University of Iceland; University of Massachusetts System; University of Massachusetts Amherst; Universidade do Minho; University of Oklahoma System; University of Oklahoma - Norman; Royal Netherlands Meteorological Institute; Mount Holyoke College; IMEC	Shamoun-Baranes, J (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Computat Geoecol, Amsterdam, Netherlands.	shamoun@uva.nl	van Gasteren, Hans/AAE-7105-2020; Alves, José A./U-4674-2018; Van Doren, Benjamin M./R-7761-2018; Shamoun-Baranes, Judy/Q-1311-2019; Desmet, Peter/AAT-3999-2020; Dokter, Adriaan/AAA-9244-2021	van Gasteren, Hans/0000-0002-4810-3899; Alves, José A./0000-0001-7182-0936; Van Doren, Benjamin M./0000-0002-7355-6005; Shamoun-Baranes, Judy/0000-0002-1652-7646; Desmet, Peter/0000-0002-8442-8025; Farnsworth, Andrew/0000-0002-9854-4449; Branco, Sergio/0000-0001-5372-1088; Leijnse, Hidde/0000-0001-7835-4480	National Science Foundation [IIS-1125098]; COST - European Cooperation in Science and Technology through the Action 'European Network for the Radar Surveillance of Animal Movement' (ENRAM) [ES1305]; iMinds and Wildly Mild; Direct For Computer & Info Scie & Enginr [1522054] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); COST - European Cooperation in Science and Technology through the Action 'European Network for the Radar Surveillance of Animal Movement' (ENRAM); iMinds and Wildly Mild; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	National Science Foundation Award IIS-1125098 supported research in the US. Additional funding for US research came from Leon Levy Foundation (leonlevyfoundation.org). The funders provided support in the form of salaries for authors AF, SK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Costs for travel, accommodation and local organization of workshops and short research visits were funded in part by COST - European Cooperation in Science and Technology through the Action ES1305 'European Network for the Radar Surveillance of Animal Movement' (ENRAM). The commercial entities iMinds and Wildly Mild funded the salaries of WVdB and JKVDM, respectively, during part of this study; however, these organizations did not play a role in study design, data collection, analysis, publication decision, of manuscript preparation. The specific roles of these authors are articulated in the 'author contributions' section.	Alerstam T, 2011, P ROY SOC B-BIOL SCI, V278, P3074, DOI 10.1098/rspb.2011.0058; Bauer S, 2014, SCIENCE, V344, P54, DOI 10.1126/science.1242552; Bruderer B, 1998, J AVIAN BIOL, V29, P499, DOI 10.2307/3677169; Bruderer B, 1997, NATURWISSENSCHAFTEN, V84, P1, DOI 10.1007/s001140050338; Buler JJ, 2014, CONDOR, V116, P357, DOI 10.1650/CONDOR-13-162.1; Buyya R, 2009, FUTURE GENER COMP SY, V25, P599, DOI 10.1016/j.future.2008.12.001; Chapman JW, 2016, J ANIM ECOL, V85, P115, DOI 10.1111/1365-2656.12420; Chapman JW, 2011, ANNU REV ENTOMOL, V56, P337, DOI 10.1146/annurev-ento-120709-144820; Chilson PB, 2012, B AM METEOROL SOC, V93, P669, DOI 10.1175/BAMS-D-11-00099.1; Darmofal D, 1996, FLUID DYN C FLUID DY; Desholm M, 2014, CURR ZOOL, V60, P680, DOI 10.1093/czoolo/60.5.680; Diehl RH, 2003, AUK, V120, P278, DOI 10.1642/0004-8038(2003)120[0278:ROOBMO]2.0.CO;2; Dokter AM, 2011, J R SOC INTERFACE, V8, P30, DOI 10.1098/rsif.2010.0116; Dokter AM, 2013, PLOS ONE, V8, DOI [10.13718ournaLpona0052300, DOI 10.1371/JOURNALPONA0052300]; Donald S., 1968, P 1968 23 ACM NAT C; Farnsworth A, 2016, ECOL APPL; Fox AD, 2006, IBIS, V148, P129, DOI 10.1111/j.1474-919X.2006.00510.x; Frick WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042737; GAUTHREA.SA, 1971, AUK, V88, P343, DOI 10.2307/4083884; Gauthreaux SA, 2003, AVIAN MIGRATION, P335; Gauthreaux SA, 2003, AUK, V120, P266, DOI 10.1642/0004-8038(2003)120[0266:ROABC]2.0.CO;2; Goring SJ, 2014, FRONT ECOL ENVIRON, V12, P39, DOI 10.1890/120370; Gurbuz SZ, 2015, RAD C RADARCON 2015; Hampton SE, 2013, FRONT ECOL ENVIRON, V11, P156, DOI 10.1890/120103; Horton KG, 2015, ECOL APPL, V25, P390, DOI 10.1890/14-0279.1; Huuskonen A, 2014, B AM METEOROL SOC, V95, P897, DOI 10.1175/BAMS-D-12-00216.1; Kemp MU, 2013, IBIS, V155, P734, DOI 10.1111/ibi.12064; Kemp MU, 2010, J AVIAN BIOL, V41, P672, DOI 10.1111/j.1600-048X.2010.05053.x; Kunz TH, 2008, INTEGR COMP BIOL, V48, P1, DOI [10.1093/icb/icn030, 10.1093/icb/icn037]; La Sorte FA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2588; LACK D, 1945, NATURE, V156, P446, DOI 10.1038/156446a0; LARKIN RP, 1979, BEHAV ECOL SOCIOBIOL, V4, P225, DOI 10.1007/BF00297646; LARKIN RP, 1980, BEHAV ECOL SOCIOBIOL, V7, P301, DOI 10.1007/BF00300671; Leskinen M, 2011, J APPL ENTOMOL, V135, P55, DOI 10.1111/j.1439-0418.2009.01480.x; Liechti F, 2006, J ORNITHOL, V147, P202, DOI 10.1007/s10336-006-0061-9; LIECHTI F, 1993, J ORNITHOL, V134, P373, DOI 10.1007/BF01639830; Loss SR, 2015, ANNU REV ECOL EVOL S, V46, P99, DOI 10.1146/annurev-ecolsys-112414-054133; Marra PP, 2009, FRONT ECOL ENVIRON, V7, P297, DOI 10.1890/090066; MAYNARD RH, 1945, J METEOROL, V2, P214, DOI 10.1175/1520-0469(1945)002<0214:RAW>2.0.CO;2; O'Neal BJ, 2015, IBIS, V157, P154, DOI 10.1111/ibi.12193; Popa-Lisseanu AG, 2009, J MAMMAL, V90, P1283, DOI 10.1644/09-MAMM-S-130R2.1; Richardson W.J., 1990, P78; Schoenberg I. J., 1973, CARDINAL SPLINE INTE; Shamoun-Baranes J, 2014, MOV ECOL, V2, DOI 10.1186/2051-3933-2-9; Shamoun-Baranes J, 2011, ANIM BEHAV, V81, P691, DOI 10.1016/j.anbehav.2011.01.003; Shamoun-Baranes J, 2010, INTEGR COMP BIOL, V50, P280, DOI 10.1093/icb/icq011; Shamoun-Baranes J, 2008, ECOL SOC, V13; Steele J., 2010, BEAUTIFUL VISUALIZAT, V1; STODDARD PK, 1983, ANIM BEHAV, V31, P173, DOI 10.1016/S0003-3472(83)80186-9; Van Gasteren H, 2008, IBIS, V150, P674; Weiskopf D, 2005, VISUALIZATION HDB, P261; Westbrook JK, 2014, INT J BIOMETEOROL, V58, P931, DOI 10.1007/s00484-013-0676-5; Zastrow M, 2015, NATURE, V519, P119, DOI 10.1038/519119a	53	14	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0160106	10.1371/journal.pone.0160106	http://dx.doi.org/10.1371/journal.pone.0160106			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27557096	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258100008
J	Lundqvist, A; Sandstedt, M; Sandstedt, J; Wickelgren, R; Hansson, GI; Jeppsson, A; Hulten, LM				Lundqvist, Annika; Sandstedt, Mikael; Sandstedt, Joakim; Wickelgren, Ruth; Hansson, Goran I.; Jeppsson, Anders; Hulten, Lillemor Mattsson			The Arachidonate 15-Lipoxygenase Enzyme Product 15-HETE Is Present in Heart Tissue from Patients with Ischemic Heart Disease and Enhances Clot Formation	PLOS ONE			English	Article							ROTATION THROMBELASTOGRAPHY; CARDIOMYOCYTE CLUSTERS; EXPRESSION; HYPERCOAGULABILITY; MACROPHAGES; SAMPLES	Ischemic heart disease is a major cause of death and morbidity and the search for novel therapeutic targets is still required. We have previously shown that the enzyme arachidonate 15 lipoxygenase (ALOX15), which catalyzes the conversion of arachidonic acid to 15-hydroxy eicosatetraenoic acid (15-HETE), is highly expressed in ischemic heart tissue, but its role in the pathogenesis of ischemic heart disease is unclear. Here we showed that expression of ALOX15, but not ALOX12 or ALOX15B, was increased in ischemic versus non-ischemic human heart biopsy samples. A similar ALOX expression pattern was found in hypoxic human cardiomyocytes and cardiac endothelial cells. We also showed that levels of 15-HETE were significantly higher in ischemic versus non-ischemic human heart biopsy samples and showed a tendency to increase in serum from the patients with ischemic heart disease. Moreover, hypoxia increased the production of 15-HETE levels from human cardiomyocytes and cardiac endothelial cells. The hypoxia-induced increase in 15-HETE levels from human cardiomyocytes was inhibited by the ALOX15 inhibitor baicalein. Finally, by using intrinsic rotational thromboelastometry, we showed that human whole blood clotted faster in the presence of 15-HETE. In summary, we propose that increased ALOX15 expression in heart tissue under ischemic conditions may lead to increased production of 15-HETE, potentially contributing to thrombosis.	[Lundqvist, Annika; Sandstedt, Mikael; Sandstedt, Joakim; Wickelgren, Ruth; Hulten, Lillemor Mattsson] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Clin Chem & Transfus Med, Gothenburg, Sweden; [Lundqvist, Annika; Sandstedt, Mikael; Sandstedt, Joakim; Wickelgren, Ruth; Hulten, Lillemor Mattsson] Sahlgrens Univ Hosp, Dept Clin Chem, Gothenburg, Sweden; [Hansson, Goran I.] AstraZeneca R&D, Translat Sci, Molndal, Sweden; [Jeppsson, Anders] Sahlgrenska Univ Hosp Gothenburg, Dept Cardiothorac Surg, Gothenburg, Sweden; [Jeppsson, Anders] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Hulten, Lillemor Mattsson] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Wallenberg Lab,Dept Mol & Clin Med, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital; AstraZeneca; Sahlgrenska University Hospital; University of Gothenburg; University of Gothenburg	Hulten, LM (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Clin Chem & Transfus Med, Gothenburg, Sweden.; Hulten, LM (corresponding author), Sahlgrens Univ Hosp, Dept Clin Chem, Gothenburg, Sweden.; Hulten, LM (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Wallenberg Lab,Dept Mol & Clin Med, Gothenburg, Sweden.	Lillemor.Mattsson@wlab.gu.se	Sandstedt, Mikael/GRO-7230-2022	Sandstedt, Mikael/0000-0002-3124-6359	Swedish Research Council; Swedish Heart-Lung Foundation; Swedish Federal Government under the LUA/ALF agreement; Emelle Foundation; Laboratory Medicine at Sahlgrenska University Hospital Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Federal Government under the LUA/ALF agreement; Emelle Foundation; Laboratory Medicine at Sahlgrenska University Hospital Sweden	This work was supported by the Swedish Research Council, the Swedish Heart-Lung Foundation, the Swedish Federal Government under the LUA/ALF agreement, the Emelle Foundation and the Laboratory Medicine at Sahlgrenska University Hospital Sweden.	Akay OM, 2009, MED ONCOL, V26, P358, DOI 10.1007/s12032-008-9129-0; Artang R, 2000, THROMB RES, V97, P499, DOI 10.1016/S0049-3848(99)00210-8; Asp J, 2012, PHYSIOL GENOMICS, V44, P89, DOI 10.1152/physiolgenomics.00137.2011; Gertow K, 2011, ATHEROSCLEROSIS, V215, P411, DOI 10.1016/j.atherosclerosis.2011.01.015; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Hakimi CS, 2014, THROMB RES, V134, P895, DOI 10.1016/j.thromres.2014.05.023; Hulten LM, 2010, EUR J CLIN INVEST, V40, P11, DOI 10.1111/j.1365-2362.2009.02223.x; Kashuk JL, 2009, SURGERY, V146, P764, DOI 10.1016/j.surg.2009.06.054; Krasopoulos G, 2008, BMJ-BRIT MED J, V336, P195, DOI 10.1136/bmj.39430.529549.BE; Kuhn H, 2015, BBA-MOL CELL BIOL L, V1851, P308, DOI 10.1016/j.bbalip.2014.10.002; Magnusson LU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043142; Magnusson LU, 2012, BIOCHEM BIOPH RES CO, V424, P327, DOI 10.1016/j.bbrc.2012.06.117; OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; Rydberg EK, 2004, ARTERIOSCL THROM VAS, V24, P2040, DOI 10.1161/01.ATV.0000144951.08072.0b; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seet RCS, 2011, STROKE, V42, P2326, DOI 10.1161/STROKEAHA.111.618835; SETTY BNY, 1992, BLOOD, V80, P2765; Shen TT, 2015, AM J PHYSIOL-LUNG C, V309, pL449, DOI 10.1152/ajplung.00004.2015; Silvain J, 2011, J AM COLL CARDIOL, V57, P1359, DOI 10.1016/j.jacc.2010.09.077; Solomon C, 2011, TRANSFUSION, V51, P1695, DOI 10.1111/j.1537-2995.2011.03066.x; Spiel AO, 2006, J THROMB HAEMOST, V4, P411, DOI 10.1111/j.1538-7836.2006.01715.x; Synnergren J, 2012, PHYSIOL GENOMICS, V44, P245, DOI 10.1152/physiolgenomics.00118.2011; Vijil C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088546; Yamazaki K, 2012, TOXICOL IN VITRO, V26, P335, DOI 10.1016/j.tiv.2011.12.005	25	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161629	10.1371/journal.pone.0161629	http://dx.doi.org/10.1371/journal.pone.0161629			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27552229	Green Submitted, gold, Green Published			2022-12-26	WOS:000381768800059
J	Jeffery, JM; Kalimutho, M; Johansson, P; Cardenas, DG; Kumar, R; Khanna, KK				Jeffery, J. M.; Kalimutho, M.; Johansson, P.; Cardenas, D. G.; Kumar, R.; Khanna, K. K.			FBXO31 protects against genomic instability by capping FOXM1 levels at the G2/M transition	ONCOGENE			English	Article							E3 UBIQUITIN LIGASES; F-BOX; TRANSCRIPTION FACTOR; CELL-CYCLE; MITOTIC PROGRESSION; TUMOR-SUPPRESSOR; POOR-PROGNOSIS; DEGRADATION; PROTEOLYSIS; CDT1	F-box proteins in conjunction with Skp1, Cul1 and Rbx1 generate SCF complexes that are responsible for the ubiquitination of proteins, leading to their activation or degradation. Here we show that the F-box protein FBXO31 is required for normal mitotic progression and genome stability due to its role in regulating FOXM1 levels during the G2/M transition. FBXO31-depleted cells undergo a transient delay in mitosis due to an activated spindle checkpoint concomitant with an increase in lagging chromosomes and anaphase bridges. FBXO31 regulates mitosis in part by controlling the levels of FOXM1, a transcription factor and master regulator of mitosis. FBXO31 specifically interacts with FOXM1 during the G2/M transition, resulting in FOXM1 ubiquitination and degradation. FBXO31 depletion results in increased expression of FOXM1 transcriptional targets and mimics the FOXM1 overexpression. In contrast, co-depletion of FBXO31 and FOXM1 restores the genomic instability phenotype but not the delay in mitosis, indicating that FBXO31 probably has additional mitotic substrates. Thus, FBXO31 is the first described negative regulator of FOXM1 during the G2/M transition.	[Jeffery, J. M.; Kalimutho, M.; Cardenas, D. G.; Khanna, K. K.] QIMR Berghofer Med Res Inst, Signal Transduct Lab, Dept Cell & Mol Biol, Brisbane, Qld, Australia; [Johansson, P.] Univ Gothenburg, Dept Clin Chem & Transfus Med, Sahlgrenska Acad, Gothenburg, Sweden; [Kumar, R.] Univ Adelaide, Dept Paediat, Sch Med, Adelaide, SA, Australia; [Kumar, R.] Univ Adelaide, Robinson Res Inst, Adelaide, SA 5000, Australia	QIMR Berghofer Medical Research Institute; University of Gothenburg; University of Adelaide; Robinson Research Institute; University of Adelaide	Kumar, R (corresponding author), Univ Adelaide, Robinson Res Inst, Adelaide, SA 5000, Australia.; Kumar, R (corresponding author), Univ Adelaide, Sch Med, Adelaide, SA 5000, Australia.; Khanna, KK (corresponding author), Queensland Inst Med Res, Dept Cell & Mol Biol, 300 Herston Rd, Herston, Qld 4006, Australia.	raman.sharma@adelaide.edu.au; kumkum.khanna@qimrberghofer.edu.au	Kumar, Raman/AHE-0538-2022; Kalimutho, Murugan/AAD-1441-2019	Kumar, Raman/0000-0001-7976-8386; Khanna, Kum Kum/0000-0001-8650-5381; Kalimutho, Murugan/0000-0002-0772-8673	NHMRC; Cancer Council of Queensland; Cancer Council of South Australia; Cancer Council Queensland	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Queensland(Cancer Council Queensland); Cancer Council of South Australia(Cancer Council South Australia); Cancer Council Queensland(Cancer Council Queensland)	This work is funded by the NHMRC (Program Grant), the Cancer Council of Queensland and the Cancer Council of South Australia. Murugan Kalimutho is supported by project grant from the Cancer Council Queensland. Pegah Johansson is a Swedish Research Council (Vetenskapsradet) post-doctoral fellow. We thank Professor Michele Pagano for the Skp1, Cul1 and Rbx1 antibodies, and the FLAG-Skp2, FLAG-FBW9, FLAG-HAFBXO10, FLAG-HA-FBXO24 and FLAG-beta-Trcp1 constructs; Dr Sabine Elowe for BUBR1 pS676 antibody; and Stephen Miles for tissue culture assistance.	Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Carter SL, 2009, Patent No. [US20090215054 A1, 20090215054]; Chen C, 2006, MOL CANCER RES, V4, P695, DOI 10.1158/1541-7786.MCR-06-0182; Chen DT, 2010, BREAST CANCER RES TR, V119, P335, DOI 10.1007/s10549-009-0344-y; Cheng WY, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002920; D'Angiolella V, 2012, CELL, V149, P1023, DOI 10.1016/j.cell.2012.03.043; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Fujita M, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-22; Gemenetzidis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004849; Halasi M, 2009, CELL CYCLE, V8, P1966, DOI 10.4161/cc.8.12.8708; Heix J, 1998, EMBO J, V17, P7373, DOI 10.1093/emboj/17.24.7373; Huang HL, 2010, ONCOL REP, V24, P715, DOI 10.3892/or_00000912; Jeffery JM, 2010, ONCOGENE, V29, P2649, DOI 10.1038/onc.2010.37; Johansson P, 2014, J BIOL CHEM, V289, P18514, DOI 10.1074/jbc.M114.559930; Klein J, 1999, P NATL ACAD SCI USA, V96, P6096, DOI 10.1073/pnas.96.11.6096; Kogo R, 2011, INT J ONCOL, V39, P155, DOI 10.3892/ijo.2011.1018; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Kumar R, 2005, CANCER RES, V65, P11304, DOI 10.1158/0008-5472.CAN-05-0936; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laoukili J, 2008, CELL CYCLE, V7, P2720, DOI 10.4161/cc.7.17.6580; Lee EK, 2014, ONCOGENE, V33, P2011, DOI 10.1038/onc.2013.144; Leung TWC, 2001, FEBS LETT, V507, P59, DOI 10.1016/S0014-5793(01)02915-5; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Liu J, 2014, J BIOL CHEM, V289, P21508, DOI 10.1074/jbc.M114.560342; Malonia SK, 2015, P NATL ACAD SCI USA, V112, P8632, DOI 10.1073/pnas.1510929112; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Montero-Conde C, 2008, ONCOGENE, V27, P1554, DOI 10.1038/sj.onc.1210792; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Park HJ, 2008, MOL CELL BIOL, V28, P5162, DOI 10.1128/MCB.00387-08; Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201; Santra MK, 2009, NATURE, V459, P722, DOI 10.1038/nature08011; Seki A, 2008, J CELL BIOL, V181, P65, DOI 10.1083/jcb.200712027; Sivan G, 2008, CELL CYCLE, V7, P741, DOI 10.4161/cc.7.6.5596; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Teh MT, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-45; Vadhvani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057530; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; Zhang XC, 2014, ONCOTARGET, V5, P6178, DOI 10.18632/oncotarget.2183; Zhou W, 2013, CANCER CELL, V23, P48, DOI 10.1016/j.ccr.2012.12.001	39	20	20	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 16	2017	36	7					1012	1022		10.1038/onc.2016.268	http://dx.doi.org/10.1038/onc.2016.268			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8JG	27568981				2022-12-26	WOS:000394169100013
J	Banuelos, CA; Tavakoli, I; Tien, AH; Caley, DP; Mawji, NR; Li, ZZ; Wang, J; Yang, YC; Imamura, Y; Yan, LP; Wen, JG; Andersen, RJ; Sadar, MD				Banuelos, Carmen A.; Tavakoli, Iran; Tien, Amy H.; Caley, Daniel P.; Mawji, Nasrin R.; Li, Zhenzhen; Wang, Jun; Yang, Yu Chi; Imamura, Yusuke; Yan, Luping; Wen, Jian Guo; Andersen, Raymond J.; Sadar, Marianne D.			Sintokamide A Is a Novel Antagonist of Androgen Receptor That Uniquely Binds Activation Function-1 in Its Amino-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						androgen receptor; drug development; intrinsically disordered protein; prostate cancer; steroid hormone receptor; transcription factor	RESISTANT PROSTATE-CANCER; SIGNAL-TRANSDUCTION PATHWAYS; SPLICE VARIANTS; TRANSCRIPTIONAL ACTIVATION; ENZALUTAMIDE; ABIRATERONE; ANTIANDROGEN; PROGRESSION; INDUCTION; MDV3100	Androgen receptor (AR) is a validated drug target for all stages of prostate cancer including metastatic castration-resistant prostate cancer (CRPC). All current hormone therapies for CRPC target the C-terminal ligand-binding domain of AR and ultimately all fail with resumed AR transcriptional activity. Within the AR N-terminal domain (NTD) is activation function-1 (AF-1) that is essential for AR transcriptional activity. Inhibitors of AR AF-1 would potentially block most AR mechanisms of resistance including constitutively active AR splice variants that lack the ligand-binding domain. Here we provide evidence that sintokamide A (SINT1) binds AR AF-1 region to specifically inhibit transactivation of AR NTD. Consistent with SINT1 targeting AR AF-1, it attenuated transcriptional activities of both full-length AR and constitutively active AR splice variants, which correlated with inhibition of growth of enzalutamide-resistant prostate cancer cells expressing AR splice variants. In vivo, SINT1 caused regression of CRPC xenografts and reduced expression of prostate-specific antigen, a gene transcriptionally regulated by AR. Inhibition of AR activity by SINT1 was additive to EPI-002, a known AR AF-1 inhibitor that is in clinical trials (NCT02606123). This implies that SINT1 binds to a site on AF-1 that is unique from EPI. Consistent with this suggestion, these two compounds showed differences in blocking AR interaction with STAT3. This work provides evidence that the intrinsically disordered NTD of AR is druggable and that SINT1 analogs may provide a novel scaffold for drug development for the treatment of prostate cancer or other diseases of the AR axis.	[Banuelos, Carmen A.; Tavakoli, Iran; Tien, Amy H.; Caley, Daniel P.; Mawji, Nasrin R.; Li, Zhenzhen; Wang, Jun; Yang, Yu Chi; Imamura, Yusuke; Sadar, Marianne D.] British Columbia Canc Agcy, Dept Genome Sci Ctr, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada; [Li, Zhenzhen] Zhengzhou Univ, Inst Clin Med, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China; [Yan, Luping; Andersen, Raymond J.] Univ British Columbia, Chem & Earth & Ocean Sci, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada; [Wen, Jian Guo] Zhengzhou Univ Hosp, Affiliated Hosp Zhengzhou 1, Urodynam Ctr, Zhengzhou 450052, Henan, Peoples R China	British Columbia Cancer Agency; Zhengzhou University; University of British Columbia; Zhengzhou University	Sadar, MD (corresponding author), British Columbia Canc Agcy, Dept Genome Sci Ctr, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada.	msadar@bcgsc.ca	Sadar, Marianne/E-9136-2012	Sadar, Marianne/0000-0003-0599-9215; Yang, Yu Chi/0000-0001-8318-1174	NCI, National Institutes of Health [2R01CA105304]; Canadian Institutes of Health Research Grant [MOP79308]; Country Meadows Senior Men's Golf Charity Classic; NATIONAL CANCER INSTITUTE [R01CA105304] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Country Meadows Senior Men's Golf Charity Classic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI, National Institutes of Health Grant 2R01CA105304 (to M. D. S.), Canadian Institutes of Health Research Grant MOP79308 (to M. D. S.), and Country Meadows Senior Men's Golf Charity Classic. C. A. B., N. R. M., J. W., R. J. A., and M. D. S. are shareholders of ESSA Pharma Inc. M. D. S. and R. J. A. receive compensation as consultants. M. D. S. and R. J. A. are Directors and Officers of ESSA Pharma Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Cao B, 2014, ONCOTARGET, V5, P1646, DOI 10.18632/oncotarget.1802; Clegg NJ, 2012, CANCER RES, V72, P1494, DOI 10.1158/0008-5472.CAN-11-3948; De Mol E, 2016, ACS CHEM BIOL, V11, P2499, DOI 10.1021/acschembio.6b00182; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Hammoudeh DI, 2009, J AM CHEM SOC, V131, P7390, DOI 10.1021/ja900616b; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Imamura Y, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87850; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; Kato M, 2016, CLIN CANCER RES, V22, P2744, DOI 10.1158/1078-0432.CCR-15-2119; Korpal M, 2013, CANCER DISCOV, V3, P1030, DOI 10.1158/2159-8290.CD-13-0142; Loriot Y, 2013, ANN ONCOL, V24, P1807, DOI 10.1093/annonc/mdt136; Malik Z, 2013, ADV THER, V30, P1041, DOI 10.1007/s12325-013-0070-z; Masiello D, 2002, J BIOL CHEM, V277, P26321, DOI 10.1074/jbc.M203310200; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Myung JK, 2013, J CLIN INVEST, V123, P2948, DOI 10.1172/JCI66398; Payne H, 2012, BJU INT, V110, P658, DOI 10.1111/j.1464-410X.2011.10886.x; Poujol N, 2000, J BIOL CHEM, V275, P24022, DOI 10.1074/jbc.M001999200; Rathkopf DE, 2014, EUR UROL, V66, P815, DOI 10.1016/j.eururo.2014.02.056; Sadar MD, 2008, ORG LETT, V10, P4947, DOI 10.1021/ol802021w; Sadar MD, 2011, CANCER RES, V71, P1208, DOI 10.1158/0008-5472.CAN_10-3398; Sadar MD, 1999, ENDOCR-RELAT CANCER, V6, P487, DOI 10.1677/erc.0.0060487; Sadar MD, 1999, J BIOL CHEM, V274, P7777, DOI 10.1074/jbc.274.12.7777; Scher HI, 2016, JAMA ONCOL, V2, P1441, DOI 10.1001/jamaoncol.2016.1828; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Ueda T, 2002, J BIOL CHEM, V277, P7076, DOI 10.1074/jbc.M108255200; Yang YC, 2016, CLIN CANCER RES, V22, P4466, DOI 10.1158/1078-0432.CCR-15-2901; Zhang XT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027970	37	35	40	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22231	22243		10.1074/jbc.M116.734475	http://dx.doi.org/10.1074/jbc.M116.734475			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27576691	Green Published, hybrid			2022-12-26	WOS:000386332600034
J	Beraldo, FH; Ostapchenko, VG; Caetano, FA; Guimaraes, ALS; Ferretti, GDS; Daude, N; Bertram, L; Nogueira, KOPC; Silva, JL; Westaway, D; Cashman, NR; Martins, VR; Prado, VF; Prado, MAM				Beraldo, Flavio H.; Ostapchenko, Valeriy G.; Caetano, Fabiana A.; Guimaraes, Andre L. S.; Ferretti, Giulia D. S.; Daude, Nathalie; Bertram, Lisa; Nogueira, Katiane O. P. C.; Silva, Jerson L.; Westaway, David; Cashman, Neil R.; Martins, Vilma R.; Prado, Vania F.; Prado, Marco A. M.			Regulation of Amyloid Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; calcium; laminin; metabotropic glutamate receptor (mGluR); prion; Protein trafficking; metabotropic glutamate receptor 5	STRESS-INDUCIBLE PROTEIN-1; GLUTAMATE-RECEPTOR 5; NICOTINIC ACETYLCHOLINE-RECEPTOR; CLATHRIN-COATED PITS; CELLULAR PRION; ALZHEIMERS-DISEASE; A-BETA; IN-VIVO; SIGNALING PATHWAYS; NEURITE OUTGROWTH	The prion protein (PrPC) has been suggested to operate as a scaffold/receptor protein in neurons, participating in both physiological and pathological associated events. PrPC, laminin, and metabotropic glutamate receptor 5 (mGluR5) form a protein complex on the plasma membrane that can trigger signaling pathways involved in neuronal differentiation. PrPC and mGluR5 are co-receptors also for -amyloid oligomers (AOs) and have been shown to modulate toxicity and neuronal death in Alzheimer's disease. In the present work, we addressed the potential crosstalk between these two signaling pathways, laminin-PrPC-mGluR5 or AO-PrPC-mGluR5, as well as their interplay. Herein, we demonstrated that an existing complex containing PrPC-mGluR5 has an important role in AO binding and activity in neurons. A peptide mimicking the binding site of laminin onto PrPC (Ln-1) binds to PrPC and induces intracellular Ca2+ increase in neurons via the complex PrPC-mGluR5. Ln-1 promotes internalization of PrPC and mGluR5 and transiently decreases AO biding to neurons; however, the peptide does not impact AO toxicity. Given that mGluR5 is critical for toxic signaling by AOs and in prion diseases, we tested whether mGlur5 knock-out mice would be susceptible to prion infection. Our results show mild, but significant, effects on disease progression, without affecting survival of mice after infection. These results suggest that PrPC-mGluR5 form a functional response unit by which multiple ligands can trigger signaling. We propose that trafficking of PrPC-mGluR5 may modulate signaling intensity by different PrPC ligands.	[Beraldo, Flavio H.; Ostapchenko, Valeriy G.; Caetano, Fabiana A.; Guimaraes, Andre L. S.; Ferretti, Giulia D. S.; Nogueira, Katiane O. P. C.; Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Robarts Res Inst, London, ON N6A 5B7, Canada; [Caetano, Fabiana A.; Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5B7, Canada; [Guimaraes, Andre L. S.] Univ Estadual Montes Claros, BR-39401089 Montes Claros, MG, Brazil; [Ferretti, Giulia D. S.; Silva, Jerson L.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Inst Nacl Biol Estrutural & Bioimagem, Ctr Nacl Ressonacia Magnet Nucl Jiri Jonas,Progra, BR-21941901 Rio De Janeiro, Brazil; [Nogueira, Katiane O. P. C.] Univ Fed Ouro Preto, Dept Ciencias Biol, Inst Ciencias Exatas & Biol, Campus Morro Cruzeiro S-N, BR-35400000 Ouro Preto, MG, Brazil; [Daude, Nathalie; Westaway, David] Univ Alberta, Ctr Pr & Prot Folding Dis, Edmonton, AB T6G 2M8, Canada; [Bertram, Lisa; Cashman, Neil R.] Univ British Columbia, Ctr Brain Hlth, Vancouver, BC V6T 1Z3, Canada; [Martins, Vilma R.] AC Camargo Canc Ctr, Int Ctr Res & Educ, BR-01509010 Sao Paulo, SP, Brazil; [Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 3K7, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Universidade Estadual de Montes Claros; Universidade Federal do Rio de Janeiro; Universidade Federal de Ouro Preto; University of Alberta; University of British Columbia; A.C.Camargo Cancer Center; Western University (University of Western Ontario)	Prado, MAM (corresponding author), 1151 Richmond St N, London, ON N6A 5B7, Canada.	mprado@robarts.ca	Martins, Vilma/N-5446-2019; Prado, Marco Antonio Maximo/K-7638-2013; Silva, Jerson/J-8984-2014; Guimarães, André Luiz Sena/D-8122-2011; Prado, Vania Ferreira/K-7630-2013; SILVA, JERSON Lima/GRF-1442-2022	Prado, Marco Antonio Maximo/0000-0002-3028-5778; Silva, Jerson/0000-0001-9523-9441; Guimarães, André Luiz Sena/0000-0002-3162-3206; Prado, Vania Ferreira/0000-0003-4994-6393; SILVA, JERSON Lima/0000-0001-9523-9441; Ostapchenko, Valeriy/0000-0002-3629-7702; Diniz da Silva Ferretti, Giulia/0000-0002-1205-6090	PrioNet-Canada; Canadian Institutes of Health Research [MOP 93651, MOP 136930, MOP 126000, MOP 89919]; Alzheimer's Association; Canadian Foundation for Innovation; Ontario Research Fund; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP	PrioNet-Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer's Association(Alzheimer's Association); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Research Fund; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by PrioNet-Canada, Canadian Institutes of Health Research (Grants MOP 93651, MOP 136930, MOP 126000, and MOP 89919), The Alzheimer's Association, the Canadian Foundation for Innovation, and the Ontario Research Fund (to M. A. M. P. and V. F. P.). This work was also supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (to V. R. M) The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar-Valles A, 2015, J NEUROSCI, V35, P11125, DOI 10.1523/JNEUROSCI.4615-14.2015; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Bate C, 2011, J BIOL CHEM, V286, P37955, DOI 10.1074/jbc.M111.248724; Beland M, 2014, NEUROBIOL AGING, V35, P1537, DOI 10.1016/j.neurobiolaging.2014.02.001; Beraldo FH, 2011, FASEB J, V25, P265, DOI 10.1096/fj.10-161653; Beraldo FH, 2010, J BIOL CHEM, V285, P36542, DOI 10.1074/jbc.M110.157263; Caetano FA, 2008, J NEUROSCI, V28, P6691, DOI 10.1523/JNEUROSCI.1701-08.2008; Caetano FA, 2011, J NEUROCHEM, V117, P538, DOI 10.1111/j.1471-4159.2011.07225.x; Calkins MJ, 2011, BBA-MOL BASIS DIS, V1812, P507, DOI 10.1016/j.bbadis.2011.01.007; Carneiro MV, 2016, BIOCHEM BIOPH RES CO, V472, P293, DOI 10.1016/j.bbrc.2016.02.122; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; D'Antoni S, 2014, NEUROSCI BIOBEHAV R, V46, P228, DOI 10.1016/j.neubiorev.2014.02.003; de Esch CEF, 2015, NEUROBIOL DIS, V75, P31, DOI 10.1016/j.nbd.2014.12.021; Fatemi SH, 2015, SCHIZOPHR RES, V167, P42, DOI 10.1016/j.schres.2014.10.010; Fourgeaud L, 2003, J BIOL CHEM, V278, P12222, DOI 10.1074/jbc.M205663200; Francesconi A, 2009, J NEUROSCI, V29, P3590, DOI 10.1523/JNEUROSCI.5824-08.2009; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Guillot-Sestier MV, 2012, J BIOL CHEM, V287, P5021, DOI 10.1074/jbc.M111.323626; Guo WR, 2016, J NEUROSCI, V36, P2131, DOI 10.1523/JNEUROSCI.2921-15.2016; Haas LT, 2016, BRAIN, V139, P526, DOI 10.1093/brain/awv356; Haas LT, 2014, J BIOL CHEM, V289, P28460, DOI 10.1074/jbc.M114.584342; Hamilton A, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-40; Hirsch TZ, 2014, BIOCHIMIE, V104, P2, DOI 10.1016/j.biochi.2014.06.009; Hu NW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4374; Hunt DL, 2013, NAT NEUROSCI, V16, P1049, DOI 10.1038/nn.3461; Jeong JK, 2015, ONCOTARGET, V6, P24660, DOI 10.18632/oncotarget.4953; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P2333, DOI 10.1073/pnas.94.6.2333; Kang YS, 2009, J CELL SCI, V122, P4062, DOI 10.1242/jcs.046292; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee KS, 2003, REV MED VIROL, V13, P399, DOI 10.1002/rmv.408; Lee KS, 2001, J NEUROCHEM, V79, P79, DOI 10.1046/j.1471-4159.2001.00529.x; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Loubet D, 2012, FASEB J, V26, P678, DOI 10.1096/fj.11-185579; Lourenco MV, 2015, PROG NEUROBIOL, V129, P37, DOI 10.1016/j.pneurobio.2015.03.003; Lu YM, 1997, J NEUROSCI, V17, P5196; Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486; Magalhaes AC, 2002, J BIOL CHEM, V277, P33311, DOI 10.1074/jbc.M203661200; Martins VR, 2016, J NEUROCHEM, V137, P9, DOI 10.1111/jnc.13541; Martins VR, 2010, CURR ISSUES MOL BIOL, V12, P63; Matosin N, 2015, SCHIZOPHR RES, V166, P212, DOI 10.1016/j.schres.2015.05.001; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Morris RJ, 2006, FEBS LETT, V580, P5565, DOI 10.1016/j.febslet.2006.07.053; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Mouillet-Richard S, 2005, J BIOL CHEM, V280, P4592, DOI 10.1074/jbc.M406199200; Mouillet-Richard S, 2007, ANN NY ACAD SCI, V1096, P106, DOI 10.1196/annals.1397.076; Ostapchenko VG, 2013, J NEUROCHEM, V127, P415, DOI 10.1111/jnc.12296; Ostapchenko VG, 2013, J NEUROSCI, V33, P16552, DOI 10.1523/JNEUROSCI.3214-13.2013; Petratos S, 2008, BRAIN, V131, P90, DOI 10.1093/brain/awm260; Pietri M, 2006, J BIOL CHEM, V281, P28470, DOI 10.1074/jbc.M602774200; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Rammes G, 2011, NEUROPHARMACOLOGY, V60, P982, DOI 10.1016/j.neuropharm.2011.01.051; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Ribeiro FM, 2009, J BIOL CHEM, V284, P23444, DOI 10.1074/jbc.M109.000778; Ribeiro FM, 2005, J NEUROCHEM, V94, P86, DOI 10.1111/j.1471-4159.2005.03171.x; Roche KW, 1999, J BIOL CHEM, V274, P25953, DOI 10.1074/jbc.274.36.25953; Roffe M, 2010, P NATL ACAD SCI USA, V107, P13147, DOI 10.1073/pnas.1000784107; Santos TG, 2013, J NEUROCHEM, V124, P210, DOI 10.1111/jnc.12091; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Sarnataro D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005829; SHYNG SL, 1994, J CELL BIOL, V125, P1239, DOI 10.1083/jcb.125.6.1239; SHYNG SL, 1995, J BIOL CHEM, V270, P14793, DOI 10.1074/jbc.270.24.14793; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Sonati T, 2013, NATURE, V501, P102, DOI 10.1038/nature12402; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Taylor DR, 2007, BIOCHEM J, V402, P17, DOI 10.1042/BJ20061736; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Tsutsui S, 2008, AM J PATHOL, V173, P1029, DOI 10.2353/ajpath.2008.071062; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Watt NT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2135; Yim YI, 2015, J CELL SCI, V128, P1434, DOI 10.1242/jcs.165472; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325	81	40	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21945	21955		10.1074/jbc.M116.738286	http://dx.doi.org/10.1074/jbc.M116.738286			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27563063	hybrid, Green Published			2022-12-26	WOS:000386332600010
J	Kluge, S; Bekeschus, S; Bender, C; Benkhai, H; Sckell, A; Below, H; Stope, MB; Kramer, A				Kluge, Susanne; Bekeschus, Sander; Bender, Claudia; Benkhai, Hicham; Sckell, Axel; Below, Harald; Stope, Matthias B.; Kramer, Axel			Investigating the Mutagenicity of a Cold Argon-Plasma Jet in an HET-MN Model	PLOS ONE			English	Article							ATMOSPHERIC-PRESSURE PLASMA; TISSUE-TOLERABLE PLASMA; HENS EGG TEST; ANTIOXIDANT DEFENSE; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; RISK-ASSESSMENT; DNA-DAMAGE; YOLK-SAC; EMBRYO	Objective So-called cold physical plasmas for biomedical applications generate reactive oxygen and nitrogen species and the latter can trigger DNA damage at high concentrations. Therefore, the mutagenic risks of a certified atmospheric pressure argon plasma jet (kINPen MED) and its predecessor model (kINPen 09) were assessed. Methods Inner egg membranes of fertilized chicken eggs received a single treatment with either the kINPen 09 (1.5, 2.0, or 2.5 min) or the kINPen MED (3, 4, 5, or 10 min). After three days of incubation, blood smears (panoptic May-Grunwald-Giemsa stain) were performed, and 1000 erythrocytes per egg were evaluated for the presence of polychromatic and normochromic nuclear staining as well as nuclear aberrations and binucleated cells (hen's egg test for micronuclei induction, HET-MN). At the same time, the embryo mortality was documented. For each experiment, positive controls (cyclophosphamide and methotrexate) and negative controls (NaCl-solution, argon gas) were included. Additionally, the antioxidant potential of the blood plasma was assessed by ascorbic acid oxidation assay after treatment. Results For both plasma sources, there was no evidence of genotoxicity, although at the longest plasma exposure time of 10 min the mortality of the embryos exceeded 40%. The antioxidant potential in the egg's blood plasma was not significantly reduced immediately (p = 0.32) or 1 h (p = 0.19) post exposure to cold plasma. Conclusion The longest plasma treatment time with the kINPen MED was 5-10 fold above the recommended limit for treatment of chronic wounds in clinics. We did not find mutagenic effects for any plasma treatment time using the either kINPen 09 or kINPen MED. The data provided with the current study seem to confirm the lack of a genotoxic potential suggesting that a veterinary or clinical application of these argon plasma jets does not pose mutagenic risks.	[Kluge, Susanne; Bender, Claudia; Benkhai, Hicham; Below, Harald; Kramer, Axel] Univ Med Greifswald, Inst Hyg & Environm Med, Walther Rathenau Str 49a, D-17485 Greifswald, Germany; [Bekeschus, Sander] ZIK Plasmatis, Leibniz Inst Plasma Sci & Technol, Felix Hausdorff Str 2, D-17489 Greifswald, Germany; [Sckell, Axel] Univ Med Greifswald, Dept Trauma & Reconstruct Surg, Sauerbruchstr, D-17475 Greifswald, Germany; [Stope, Matthias B.] Univ Med Greifswald, Dept Urol, Sauerbruchstr, D-17475 Greifswald, Germany	Greifswald Medical School; Leibniz Institut fur Plasmaforschung und Technologie; Greifswald Medical School; Greifswald Medical School	Bekeschus, S (corresponding author), ZIK Plasmatis, Leibniz Inst Plasma Sci & Technol, Felix Hausdorff Str 2, D-17489 Greifswald, Germany.	sander.bekeschus@inp-greifswald.de		Bekeschus, Sander/0000-0002-8773-8862	German Federal Ministry of Education and Research (BMBF) [13N9779, 03Z22DN11]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The authors acknowledge that this work was supported by grants funded by the German Federal Ministry of Education and Research (BMBF): grant numbers 13N9779 (SK, CB, HiB, AS, HaB, AK) and 03Z22DN11 (SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028154; ALLS AA, 1964, AVIAN DIS, V8, P245, DOI 10.2307/1588067; Barbabosa-Pliego, 2013, APPL PHYS RES, V5, P21, DOI [10.5539/apr.v5n5p21, DOI 10.5539/APR.V5N5P21]; Bekeschus S, 2014, FREE RADICAL RES, V48, P542, DOI 10.3109/10715762.2014.892937; Bekeschus S., 2013, PLASMA MED, V3, P267, DOI DOI 10.1615/PLASMAMED.2014011972; Bekeschus S, 2016, CLIN PLASMA MED, V4, P19, DOI 10.1016/j.cpme.2016.01.001; Bekeschus S, 2015, IEEE T PLASMA SCI, V43, P776, DOI 10.1109/TPS.2015.2393379; Bekeschus S, 2013, PLASMA PROCESS POLYM, V10, P706, DOI 10.1002/ppap.201300008; Bender C, 2011, TOXICOL IN VITRO, V25, P530, DOI 10.1016/j.tiv.2010.11.012; Bender C, 2010, PLASMA PROCESS POLYM, V7, P318, DOI 10.1002/ppap.200900119; Benkhai H, 2010, GMS HYG INFECT CONTR, V5, DOI 10.3205/dgkh000146; Blackert S, 2013, J DERMATOL SCI, V70, P173, DOI 10.1016/j.jdermsci.2013.01.012; Boxhammer V, 2013, MUTAT RES-GEN TOX EN, V753, P23, DOI 10.1016/j.mrgentox.2012.12.015; BRUNS GAP, 1973, PHILOS T ROY SOC B, V266, P225, DOI 10.1098/rstb.1973.0050; Bundscherer L., 2013, PLASMA MED, V3, P71, DOI DOI 10.1615/PLASMAMED.2013008538; BUSING WR, 1965, J CHEM PHYS, V42, P3054, DOI 10.1063/1.1696379; Bussiahn R., 2013, HYGMED, V38, P212; Chang TK, 1993, CANC RES, V53; Choucroun P, 2001, MUTAT RES-FUND MOL M, V478, P89, DOI 10.1016/S0027-5107(01)00123-3; DARZYNKIEWICZ Z, 1971, EXP CELL RES, V69, P477; de Haan JB, 2003, REDOX REP, V8, P69, DOI 10.1179/135100003125001378; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Dunnbier M, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/43/435203; Gaal T, 1995, COMP BIOCHEM PHYS B, V112, P711, DOI 10.1016/0305-0491(95)00125-5; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Graves DB, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/26/263001; Greywe D, 2012, MUTAT RES-GEN TOX EN, V747, P118, DOI 10.1016/j.mrgentox.2012.04.012; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; HAMILTON JW, 1983, P NATL ACAD SCI-BIOL, V80, P3372, DOI 10.1073/pnas.80.11.3372; Hammann A, 2010, SKIN PHARMACOL PHYS, V23, P328, DOI 10.1159/000314724; HEINRICHHIRSCH B, 1990, ARCH TOXICOL, V64, P128, DOI 10.1007/BF01974398; Isbary G, 2013, CLIN PLASMA MED, V1, P25, DOI 10.1016/j.cpme.2013.06.001; Iseni S, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/12/123011; Jablonowski H, 2015, CLIN PLASMA MED, V3, P42, DOI 10.1016/j.cpme.2015.11.003; Kalghatgi S., 2011, PLASMA MED J, V1, P167, DOI [10.1615/PlasmaMed.2011003798, DOI 10.1615/PLASMAMED.2011003798]; Kim GJ, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3292206; Kramer A, 2013, CLIN PLASMA MED, V1, P11, DOI 10.1016/j.cpme.2013.03.002; KUTCHAI H, 1971, RESP PHYSIOL, V11, P265, DOI 10.1016/0034-5687(71)90001-6; Lademann J, 2013, CLIN PLASMA MED, V1, P5, DOI 10.1016/j.cpme.2013.01.001; LASSILA O, 1982, BLOOD, V59, P377; LEVIMONTALCINI R, 1951, J EXP ZOOL, V116, P321, DOI 10.1002/jez.1401160206; Lucas AM, 1961, ATLAS OF AVIAN HEMAT; Morales-Ramirez P, 2013, RADIAT RES, V179, P669, DOI 10.1667/RR3223.1; MULLER WU, 1994, ADV MUTAGENESIS RES, V5, P1; Nouspikel T, 2002, DNA REPAIR, V1, P59, DOI 10.1016/S1568-7864(01)00005-2; Nowicka AM, 2010, ANGEW CHEM INT EDIT, V49, P3006, DOI 10.1002/anie.201000485; Nowicka AM, 2010, ANGEW CHEM INT EDIT, V49, P1061, DOI 10.1002/anie.200906358; Partecke LI, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-473; Piaton E, 2015, ANN PATHOL; Ptasinska S, 2010, PHYS CHEM CHEM PHYS, V12, P7779, DOI [10.1039/c001188f, 10.1039/e001188f]; REID WM, 1961, POULTRY SCI, V40, P1497, DOI 10.3382/ps.0401497; Schmidt A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9816072; Schmidt-Bleker A, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/14/145201; Sheng GJ, 2010, INT J DEV BIOL, V54, P1033, DOI 10.1387/ijdb.103105gs; SOMASHEKARAIAH BV, 1992, FREE RADICAL BIO MED, V13, P107, DOI 10.1016/0891-5849(92)90071-N; SORRELL JM, 1982, J MORPHOL, V171, P183, DOI 10.1002/jmor.1051710206; Surai PF, 1999, BRIT POULTRY SCI, V40, P397, DOI 10.1080/00071669987511; Surai PF, 1996, BBA-LIPID LIPID MET, V1304, P1, DOI 10.1016/S0005-2760(96)00099-9; Tarricone E, 2012, ITAL J ANAT EMBRYOL, V117, P186; Tresp H, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/43/435401; Ulrich C, 2015, J WOUND CARE, V24, P196, DOI 10.12968/jowc.2015.24.5.196; Weiss M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130350; Weltmann KD, 2009, CONTRIB PLASM PHYS, V49, P631, DOI 10.1002/ctpp.200910067; Welz C, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/4/045401; Wende K, 2016, MUTAT RES-GEN TOX EN, V798, P48, DOI 10.1016/j.mrgentox.2016.02.003; Wende K., 2013, PLASMA MED, V3, P81, DOI DOI 10.1615/PLASMAMED.2014009690; WILSON JX, 1992, NEUROCHEM RES, V17, P571, DOI 10.1007/BF00968785; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Wolf T, 2002, MUTAT RES-GEN TOX EN, V514, P59, DOI 10.1016/S1383-5718(01)00317-5; Wolf T, 1997, MUTAT RES-GEN TOX EN, V394, P163, DOI 10.1016/S1383-5718(97)00136-8; Wolf T, 2008, MUTAT RES-GEN TOX EN, V650, P150, DOI 10.1016/j.mrgentox.2007.11.009; Wu AS, 2013, J SURG RES, V179, pE1, DOI 10.1016/j.jss.2012.02.039; YASSINE F, 1989, CELL DIFFER DEV, V27, P29, DOI 10.1016/0922-3371(89)90042-7	73	78	79	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0160667	10.1371/journal.pone.0160667	http://dx.doi.org/10.1371/journal.pone.0160667			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584003	gold, Green Submitted, Green Published			2022-12-26	WOS:000382855600009
J	Sugi, H; Yamaguchi, M; Ohno, T; Kobayashi, T; Chaen, S; Okuyama, H				Sugi, Haruo; Yamaguchi, Maki; Ohno, Tetsuo; Kobayashi, Takakazu; Chaen, Shigeru; Okuyama, Hiroshi			Tension Recovery following Ramp-Shaped Release in High-Ca and Low-Ca Rigor Muscle Fibers: Evidence for the Dynamic State of AMADP Myosin Heads in the Absence of ATP	PLOS ONE			English	Article							SKELETAL-MUSCLE; DONNAN POTENTIALS; MECHANISM; BINDING; LOAD	During muscle contraction, myosin heads (M) bound to actin (A) perform power stroke associated with reaction, AMADPPi -> AM + ADP + Pi. In this scheme, A . M is believed to be a high-affinity complex after removal of ATP. Biochemical studies on extracted protein samples show that, in the AM complex, actin-binding sites are located at both sides of junctional peptide between 50K and 20K segments of myosin heavy chain. Recently, we found that a monoclonal antibody (IgG) to the junctional peptide had no effect on both in vitro actin-myosin sliding and skinned muscle fiber contraction, though it covers the actin-binding sites on myosin. It follows from this that, during muscle contraction, myosin heads do not pass through the static rigor AM configuration, determined biochemically and electron microscopically using extracted protein samples. To study the nature of AM and AMADP myosin heads, actually existing in muscle, we examined mechanical responses to ramp-shaped releases (0.5% of Lo, complete in 5ms) in single skinned rabbit psoas muscle fibers in high-Ca (pCa, 4) and low-Ca (pCa, >9) rigor states. The fibers exhibited initial elastic tension drop and subsequent small but definite tension recovery to a steady level. The tension recovery was present over many minutes in high-pCa rigor fibers, while it tended to decrease quickly in low-Ca rigor fibers. EDTA (10mM, with MgCl2 removed) had no appreciable effect on the tension recovery in high-Ca rigor fibers, while it completely eliminated the tension recovery in low-Ca rigor fibers. These results suggest that the AMADP myosin heads in rigor muscle have long lifetimes and dynamic properties, which show up as the tension recovery following applied release. Possible AM linkage structure in muscle is discussed in connection with the X-ray diffraction pattern from contracting muscle, which is intermediate between resting and rigor muscles.	[Sugi, Haruo] Teikyo Univ, Dept Physiol, Sch Med, Tokyo, Japan; [Yamaguchi, Maki; Ohno, Tetsuo; Okuyama, Hiroshi] Jikei Univ, Sch Med, Dept Physiol, Tokyo, Japan; [Kobayashi, Takakazu] Shibaura Inst Technol, Dept Elect Engn, Tokyo, Japan; [Chaen, Shigeru] Nihon Univ, Dept Integrated Sci Phys & Biol, Coll Humanities & Sci, Tokyo, Japan	Teikyo University; Jikei University; Shibaura Institute of Technology; Nihon University	Sugi, H (corresponding author), Teikyo Univ, Dept Physiol, Sch Med, Tokyo, Japan.	sugi@kyf.biglobe.ne.jp						Bagshaw CR, 1993, MUSCLE CONTRACTION, P93; BARTELS EM, 1985, BIOPHYS J, V48, P61, DOI 10.1016/S0006-3495(85)83760-7; BARTELS EM, 1993, BIOCHIM BIOPHYS ACTA, V1157, P63, DOI 10.1016/0304-4165(93)90079-N; HUXLEY AF, 1954, NATURE, V173, P971, DOI 10.1038/173971a0; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; HUXLEY H, 1954, NATURE, V173, P973, DOI 10.1038/173973a0; IWAMOTO H, 1990, J PHYSIOL-LONDON, V422, P185, DOI 10.1113/jphysiol.1990.sp017979; KUSHMERICK MJ, 1969, SCIENCE, V166, P1297, DOI 10.1126/science.166.3910.1297; Levine B.A., 1990, MOL MECHANISMS MUSCL, P171; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; MILLIGAN RA, 1990, NATURE, V348, P217, DOI 10.1038/348217a0; NAYLOR GRS, 1985, BIOPHYS J, V48, P47, DOI 10.1016/S0006-3495(85)83759-0; Radocaj A, 2009, BIOPHYS J, V96, P1430, DOI 10.1016/j.bpj.2008.11.023; Squire JM, 1981, STRUCTURAL BASIS MUS, P534; SUGI H, 1992, P NATL ACAD SCI USA, V89, P6134, DOI 10.1073/pnas.89.13.6134; Sugi H, 1998, P NATL ACAD SCI USA, V95, P2273, DOI 10.1073/pnas.95.5.2273; Sugi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093272; Sugi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063658; SUZUKI S, 1983, J GEN PHYSIOL, V81, P531, DOI 10.1085/jgp.81.4.531	19	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162003	10.1371/journal.pone.0162003	http://dx.doi.org/10.1371/journal.pone.0162003			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583360	Green Submitted, gold, Green Published			2022-12-26	WOS:000382855600084
J	Zimmer, C				Zimmer, Christoph			Experimental Design for Stochastic Models of Nonlinear Signaling Pathways Using an Interval-Wise Linear Noise Approximation and State Estimation	PLOS ONE			English	Article							BAYESIAN-INFERENCE; NUMERICAL-METHODS; GENE; FLUCTUATIONS; NETWORKS; CALCIUM	Background Computational modeling is a key technique for analyzing models in systems biology. There are well established methods for the estimation of the kinetic parameters in models of ordinary differential equations (ODE). Experimental design techniques aim at devising experiments that maximize the information encoded in the data. For ODE models there are well established approaches for experimental design and even software tools. However, data from single cell experiments on signaling pathways in systems biology often shows intrinsic stochastic effects prompting the development of specialized methods. While simulation methods have been developed for decades and parameter estimation has been targeted for the last years, only very few articles focus on experimental design for stochastic models. Methods The Fisher information matrix is the central measure for experimental design as it evaluates the information an experiment provides for parameter estimation. This article suggest an approach to calculate a Fisher information matrix for models containing intrinsic stochasticity and high nonlinearity. The approach makes use of a recently suggested multiple shooting for stochastic systems (MSS) objective function. The Fisher information matrix is calculated by evaluating pseudo data with the MSS technique. Results The performance of the approach is evaluated with simulation studies on an Immigration-Death, a Lotka-Volterra, and a Calcium oscillation model. The Calcium oscillation model is a particularly appropriate case study as it contains the challenges inherent to signaling pathways: high nonlinearity, intrinsic stochasticity, a qualitatively different behavior from an ODE solution, and partial observability. The computational speed of the MSS approach for the Fisher information matrix allows for an application in realistic size models.	[Zimmer, Christoph] Heidelberg Univ, BIOMS, Neuenheimer Feld 267, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Zimmer, C (corresponding author), Heidelberg Univ, BIOMS, Neuenheimer Feld 267, D-69120 Heidelberg, Germany.	christoph.zimmer@bioquant.uni-heidelberg.de			Bioms	Bioms	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CZ was supported by Bioms.	Andreychenko A, 2012, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2012-9; Bauer I, 2000, J COMPUT APPL MATH, V120, P1, DOI 10.1016/S0377-0427(00)00300-9; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bock H.G., 2007, REACTIVE FLOWS DIFFU, P117, DOI DOI 10.1007/978-3-540-28396-6_6; Boys RJ, 2008, STAT COMPUT, V18, P125, DOI 10.1007/s11222-007-9043-x; Chaloner K, 1995, STAT SCI, V10, P273, DOI 10.1214/ss/1177009939; Elf J, 2003, GENOME RES, V13, P2475, DOI 10.1101/gr.1196503; Faller D, 2003, SIMUL-T SOC MOD SIM, V79, P717, DOI 10.1177/0037549703040937; Fearnhead P, 2014, BIOMETRICS, V70, P457, DOI 10.1111/biom.12152; Fedorov V.V, 1997, MODEL ORIENTED DESIG; Finkenstadt B, 2013, ANN APPL STAT, V7, P1960, DOI 10.1214/13-AOAS669; Frohlich F, COMPUTATIONAL METHOD; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gillespie CS, 2009, IET SYST BIOL, V3, P52, DOI 10.1049/iet-syb:20070031; Gillespie CS, 2010, J R STAT SOC C-APPL, V59, P341, DOI 10.1111/j.1467-9876.2009.00696.x; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Grima R, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3454685; Grima R, 2015, J CHEM PHYS, P136; Hasenauer J, 2013, J MATH BIOL; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Komorowski M, 2011, P NATL ACAD SCI USA, V108, P8645, DOI 10.1073/pnas.1015814108; Korkel S, 2005, MODELLING, SIMULATION AND OPTIMIZATION OF COMPLEX PROCESSES, P255, DOI 10.1007/3-540-27170-8_20; Korkel S, 2004, OPTIM METHOD SOFTW, V19, P327, DOI 10.1080/10556780410001683078; Kreutz C, 2009, FEBS J, V276, P923, DOI 10.1111/j.1742-4658.2008.06843.x; Kummer U, 2005, BIOPHYS J, V89, P1603, DOI 10.1529/biophysj.104.057216; KURTZ TG, 1972, J CHEM PHYS, V57, P2976, DOI 10.1063/1.1678692; Lehmann EL, 1998, THEORY OF POINT ESTI; Mikeev L., 2012, HSCC 12; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Munsky B, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.75; Nandy P, 2012, OPTIMAL PERTURBATION, P686; Pagendam DE, 2010, THESIS; Pahle J, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-86; Pahle J, 2009, BRIEF BIOINFORM, V10, P53, DOI 10.1093/bib/bbn050; Piaggio HTH, 1982, AN ELEMENTARY TREATI; PORAT B, 1986, IEEE T ACOUST SPEECH, V34, P118, DOI 10.1109/TASSP.1986.1164786; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Raue A, BIOINFORMATICS, V25; Ruess J, 2015, P NATL ACAD SCI USA, V112, P8148, DOI 10.1073/pnas.1423947112; Ruess J, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0588; Steiert B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040052; Thomas P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S4-S5; Wang YF, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-99; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Wilkinson DJ, 2006, MATHEMATICAL AND COM; Wu S, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3576123; Zimmer C., 2012, J COMPUT SCI SYST BI, V6, P11, DOI DOI 10.4172/JCSB.1000095); Zimmer C, 2015, MATH BIOSCI, V269, P117, DOI 10.1016/j.mbs.2015.08.015; Zimmer C, 2015, IET SYST BIOL, V9, P181, DOI 10.1049/iet-syb.2014.0020; Zimmer C, 2015, IET SYST BIOL, V9, P64, DOI 10.1049/iet-syb.2014.0010	50	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0159902	10.1371/journal.pone.0159902	http://dx.doi.org/10.1371/journal.pone.0159902			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583802	Green Submitted, Green Published, gold			2022-12-26	WOS:000382855600002
J	Birkenmeier, G; Hemdan, NYA; Kurz, S; Bigl, M; Pieroh, P; Debebe, T; Buchold, M; Thieme, R; Wichmann, G; Dehghani, F				Birkenmeier, Gerd; Hemdan, Nasr Y. A.; Kurz, Susanne; Bigl, Marina; Pieroh, Philipp; Debebe, Tewodros; Buchold, Martin; Thieme, Rene; Wichmann, Gunnar; Dehghani, Faramarz			Ethyl Pyruvate Combats Human Leukemia Cells but Spares Normal Blood Cells	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; WIDE THERAPEUTIC WINDOW; OXIDATIVE STRESS; CANCER CELLS; ISCHEMIC-INJURY; IN-VIVO; GROWTH; INHIBITION; APOPTOSIS; DISEASE	Ethyl pyruvate, a known ROS scavenger and anti-inflammatory drug was found to combat leukemia cells. Tumor cell killing was achieved by concerted action of necrosis/apoptosis induction, ATP depletion, and inhibition of glycolytic and para-glycolytic enzymes. Ethyl lactate was less harmful to leukemia cells but was found to arrest cell cycle in the G0/G1 phase. Both, ethyl pyruvate and ethyl lactate were identified as new inhibitors of GSK-3 beta. Despite the strong effect of ethyl pyruvate on leukemia cells, human cognate blood cells were only marginally affected. The data were compiled by immune blotting, flow cytometry, enzyme activity assay and gene array analysis. Our results inform new mechanisms of ethyl pyruvate-induced cell death, offering thereby a new treatment regime with a high therapeutic window for leukemic tumors.	[Birkenmeier, Gerd; Hemdan, Nasr Y. A.; Kurz, Susanne; Bigl, Marina; Buchold, Martin] Univ Leipzig, Inst Biochem, Fac Med, Johannisallee 30, D-04103 Leipzig, Germany; [Pieroh, Philipp] Univ Leipzig, Dept Orthoped Trauma & Plast Surg, Liebigstr 20, D-04103 Leipzig, Germany; [Debebe, Tewodros] Univ Leipzig, Inst Med Microbiol, Fac Med, Liebigstr 21, D-04103 Leipzig, Germany; [Debebe, Tewodros] Bahir Dar Univ, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Thieme, Rene] Univ Leipzig, Univ Med Ctr, Dept Visceral Transplantat Thorac & Vasc Surg, Liebigstr 19, D-04103 Leipzig, Germany; [Wichmann, Gunnar] Univ Leipzig, Fac Med, Univ Hosp Leipzig, Dept Otolaryngol Head & Neck Surg,ENT Res Lab, Liebigstr 21, D-04103 Leipzig, Germany; [Pieroh, Philipp; Dehghani, Faramarz] Univ Halle Wittenberg, Dept Anat & Cell Biol, Grosse Steinstr 52, D-06097 Halle, Saale, Germany	Leipzig University; Leipzig University; Leipzig University; Bahir Dar University; Leipzig University; Leipzig University; Martin Luther University Halle Wittenberg	Birkenmeier, G (corresponding author), Univ Leipzig, Inst Biochem, Fac Med, Johannisallee 30, D-04103 Leipzig, Germany.	gerd.birkenmeier@medizin.uni-leipzig.de	Hemdan, Nasr Y. A./H-5430-2019; Wichmann, Gunnar/AGW-9592-2022	Hemdan, Nasr Y. A./0000-0002-6748-0649; Wichmann, Gunnar/0000-0001-6191-2095; Pieroh, Philipp/0000-0003-0906-5479; Aklilu, Tewodros Debebe/0000-0002-8421-1651				Aneja R, 2007, TRENDS MICROBIOL, V15, P31, DOI 10.1016/j.tim.2006.11.005; Baki L, 2004, EMBO J, V23, P2586, DOI 10.1038/sj.emboj.7600251; Bigl M, 1999, J NEURAL TRANSM, V106, P499, DOI 10.1007/s007020050174; Birkenmeier G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010399; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clary JJ, 1998, REGUL TOXICOL PHARM, V27, P88, DOI 10.1006/rtph.1997.1175; DELARUE JC, 1988, BREAST CANCER RES TR, V11, P273, DOI 10.1007/BF01807287; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Eguchi Y, 1997, CANCER RES, V57, P1835; Fink M P, 2001, Minerva Anestesiol, V67, P190; Ford CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054362; Gao C, 2012, REV NEUROSCIENCE, V23, P1, DOI [10.1515/RNS.2011.061, 10.1515/rns.2011.061]; Gozzini A, 2005, ANN HEMATOL, V84, P54, DOI 10.1007/s00277-005-0006-z; Hicsonmez G, 2006, LEUKEMIA RES, V30, P60, DOI 10.1016/j.leukres.2005.05.015; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hollenbach M, 2008, BIOCHEM PHARMACOL, V76, P631, DOI 10.1016/j.bcp.2008.06.006; Holmes T, 2008, STEM CELLS, V26, P1288, DOI 10.1634/stemcells.2007-0600; Hu XR, 2012, MOL BIOL REP, V39, P227, DOI 10.1007/s11033-011-0730-5; Huh SH, 2011, J IMMUNOL, V187, P960, DOI 10.4049/jimmunol.1100009; Jacobs Keith M, 2012, Int J Cell Biol, V2012, P930710, DOI 10.1155/2012/930710; Jaworski T, 2011, NATURE, V480, pE4, DOI 10.1038/nature10615; Jope RS, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00016; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; Kao KK, 2010, BIOCHEM PHARMACOL, V80, P151, DOI 10.1016/j.bcp.2010.03.007; Liang XY, 2009, J LEUKOCYTE BIOL, V86, P599, DOI 10.1189/jlb.0908578; Lindner I, 2010, CANCER RES, V70, P277, DOI 10.1158/0008-5472.CAN-09-1462; Mishra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-144; Miyazawa N, 2010, FREE RADICAL RES, V44, P101, DOI 10.3109/10715760903321788; Niehrs C, 2010, CELL, V143, P1044, DOI 10.1016/j.cell.2010.12.003; Obajimi O, 2008, CANCER CHEMOTH PHARM, V62, P215, DOI 10.1007/s00280-007-0593-6; Pardee TS, 2012, BLOOD, V119, P3561, DOI 10.1182/blood-2011-06-362442; Rabbani N, 2008, BIOCHEM SOC T, V36, P1045, DOI 10.1042/BST0361045; Shangari N, 2004, BIOCHEM PHARMACOL, V68, P1433, DOI 10.1016/j.bcp.2004.06.013; Shiohara M, 1996, J CELL PHYSIOL, V166, P568, DOI 10.1002/(SICI)1097-4652(199603)166:3<568::AID-JCP11>3.0.CO;2-3; Song EY, 2010, EXP HEMATOL, V38, P908, DOI 10.1016/j.exphem.2010.06.001; Su JW, 2008, CRIT CARE MED, V36, P1059, DOI 10.1097/CCM.0B013E318164403B; Su ZY, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0321-5; Thangaraju M, 2009, BIOCHEM J, V417, P379, DOI 10.1042/BJ20081132; Thieme R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130470; THORNALLEY PJ, 1993, MOL ASPECTS MED, V14, P287, DOI 10.1016/0098-2997(93)90002-U; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Verma D, 2009, CANCER-AM CANCER SOC, V115, P101, DOI 10.1002/cncr.24005; Wang Q, 2009, ANESTHESIOLOGY, V110, P1279, DOI 10.1097/ALN.0b013e3181a160d6; WARBURG O, 1956, SCIENCE, V124, P269; Worku N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137353; Yu YM, 2005, STROKE, V36, P2238, DOI 10.1161/01.STR.0000181779.83472.35; Zhang J, 2012, ONCOL REP, V27, P1511, DOI 10.3892/or.2012.1623; Zhou FF, 2011, MOL BIOL CELL, V22, P3533, DOI 10.1091/mbc.E11-06-0483	48	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161571	10.1371/journal.pone.0161571	http://dx.doi.org/10.1371/journal.pone.0161571			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579985	gold, Green Submitted, Green Published			2022-12-26	WOS:000382877400029
J	Diaz-Perez, L; Rodriguez-Zaragoza, FA; Ortiz, M; Cupul-Magana, AL; Carriquiry, JD; Rios-Jara, E; Rodriguez-Troncoso, AP; Garcia-Rivas, MD				Diaz-Perez, Leopoldo; Alejandro Rodriguez-Zaragoza, Fabian; Ortiz, Marco; Levi Cupul-Magana, Amilcar; Carriquiry, Jose D.; Rios-Jara, Eduardo; Paola Rodriguez-Troncoso, Alma; del Carmen Garcia-Rivas, Maria			Coral Reef Health Indices versus the Biological, Ecological and Functional Diversity of Fish and Coral Assemblages in the Caribbean Sea	PLOS ONE			English	Article							TAXONOMIC DISTINCTNESS; COMMUNITY STRUCTURE; BUILDING CORALS; CLIMATE-CHANGE; BIODIVERSITY; CONSERVATION; HABITAT; DECLINE; EXTINCTION; MANAGEMENT	This study evaluated the relationship between the indices known as the Reef Health Index (RHI) and two-dimensional Coral Health Index (2D-CHI) and different representative metrics of biological, ecological and functional diversity of fish and corals in 101 reef sites located across seven zones in the western Caribbean Sea. Species richness and average taxonomic distinctness were used to asses biological estimation; while ecological diversity was evaluated with the indices of Shannon diversity and Pielou's evenness, as well as by taxonomic diversity and distinctness. Functional diversity considered the number of functional groups, the Shannon diversity and the functional Pielou's evenness. According to the RHI, 57.15% of the zones were classified as presenting a "poor" health grade, while 42.85% were in "critical" grade. Based on the 2D-CHI, 28.5% of the zones were in "degraded" condition and 71.5% were "very degraded". Differences in fish and coral diversity among sites and zones were demonstrated using permutational ANOVAs. Differences between the two health indices (RHI and 2D-CHI) and some indices of biological, ecological and functional diversity of fish and corals were observed; however, only the RHI showed a correlation between the health grades and the species and functional group richness of fish at the scale of sites, and with the species and functional group richness and Shannon diversity of the fish assemblages at the scale of zones. None of the health indices were related to the metrics analyzed for the coral diversity. In general, our study suggests that the estimation of health indices should be complemented with classic community indices, or should at least include diversity indices of fish and corals, in order to improve the accuracy of the estimated health status of coral reefs in the western Caribbean Sea.	[Diaz-Perez, Leopoldo; Alejandro Rodriguez-Zaragoza, Fabian; Rios-Jara, Eduardo] Univ Guadalajara, Ctr Univ Ciencias Biol & Agr, Dept Ecol, Lab Ecosistemas Marinos & Acuicultura, Zapopan Jalisco, Mexico; [Ortiz, Marco] Univ Antofagasta, Fac Recursos Mar, Fac Ciencias Mar & Recursos Biol Invest Oceanol, Inst Ciencias Nat AvH,LAMSEC, Antofagasta, Chile; [Levi Cupul-Magana, Amilcar; Paola Rodriguez-Troncoso, Alma] Univ Guadalajara, Ctr Univ La Costa, Ctr Invest Costeras, Dept Ciencias Biol, Puerto Vallarta, Jalisco, Mexico; [Carriquiry, Jose D.] Univ Autonoma Baja California, Inst Invest Oceanol, Ensenada, Baja California, Mexico; [del Carmen Garcia-Rivas, Maria] Reserva Biosfera Banco Chinchorro CONANP, Chetmal, Quintana Roo, Mexico	Universidad de Guadalajara; Universidad de Antofagasta; Universidad de Guadalajara; Universidad Autonoma de Baja California	Rodriguez-Zaragoza, FA (corresponding author), Univ Guadalajara, Ctr Univ Ciencias Biol & Agr, Dept Ecol, Lab Ecosistemas Marinos & Acuicultura, Zapopan Jalisco, Mexico.	fabianrz@cucba.udg.mx	CARRIQUIRY, JOSE D/R-9190-2017; Rodríguez-Troncoso, Alma P/B-2495-2014; Zaragoza, Fabian Alejandro Rodriguez/B-3477-2015	Zaragoza, Fabian Alejandro Rodriguez/0000-0002-0066-4275	National Commission of Natural Protected Areas (PROCODES); Universidad de GUadalajara [P3E2009-2011]; University of Baja California - National Biodiversity Commission [GM006]; World Wildlife Fund-CA [KL82]; PROMEP-SEP [PROMEP / 103.5 / 12/9144]	National Commission of Natural Protected Areas (PROCODES); Universidad de GUadalajara; University of Baja California - National Biodiversity Commission; World Wildlife Fund-CA; PROMEP-SEP	This work was supported by the National Commission of Natural Protected Areas (PROCODES 2007, 2008, 2009, 2011), Universidad de GUadalajara (project P3E2009-2011), University of Baja California - National Biodiversity Commission (project GM006), and World Wildlife Fund-CA (Agreement KL82). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the National Commission of Natural Protected Areas (CONANP by its Spanish acronym), the University of Guadalajara, University of Baja California-National Biodiversity Commission (CONABIO, by its Spanish acronym), as well as the Nicaraguan Institute of Fishery (INPESCA, by its Spanish acronym), World Wildlife Fund (WWF - CA), Cayo Cochinos Foundation and Mario Dary Foundation for your cooperation for this research. We also thank to PROMEP-SEP for the postdoctoral fellowship No. PROMEP / 103.5 / 12/9144 assigned to Dr. Leopoldo Diaz Perez of faculty of Aquatic Ecosystems and Fisheries of the University of Guadalajara. The authors thank all the people involved in the field work of the government and nongovernmental institutions of the different countries involved in this project, particularly Felipe Fonseca (CONANP), Alicia Medina and Pablo Rico (WWF-CA), Renaldy Barnutti and Oscar Gonzaga (INPESCA), Rosario Priego, Brenda Hermosillo and Irving Chavez (U. de G.) and Julio Villaescusa (UABC). Finally, we want to thank Melanie McField (Director of Healthy Reefs Initiative), and one anonymous reviewer, as well as PLOS ONE editors for providing comments that improved the manuscript.	Acosta-Gonzalez G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065665; Alvarez-Filip L, 2006, MAR ECOL-EVOL PERSP, V27, P253, DOI 10.1111/j.1439-0485.2006.00108.x; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Arias-Gonzalez JE, 2011, CIENC MAR, V37, P87, DOI 10.7773/cm.v37i1.1746; Bak RP, 2005, CORAL REEFS, V24, P475, DOI 10.1007/s00338-005-0009-1; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Barber RT, 2001, HUM ECOL RISK ASSESS, V7, P1255, DOI 10.1080/20018091094989; BELL JD, 1984, MAR ECOL PROG SER, V15, P265, DOI 10.3354/meps015265; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Ben-Tzvi O, 2004, MAR POLLUT BULL, V48, P954, DOI 10.1016/j.marpolbul.2003.11.022; Booth DJ, 2002, MAR ECOL PROG SER, V245, P205, DOI 10.3354/meps245205; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Carriquiry JD, 2013, CONSERVATION SUSTAIN, DOI [10.5772/54339, DOI 10.5772/54339]; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Clarke KR, 1999, MAR ECOL PROG SER, V184, P21, DOI 10.3354/meps184021; Clarke KR, 1998, OECOLOGIA, V113, P278, DOI 10.1007/s004420050379; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; DeVantier LM, 2006, CORAL REEFS, V25, P329, DOI 10.1007/s00338-006-0115-8; Done Terence J., 1996, SCOPE, V55, P393; Edinger EN, 2000, BIOL CONSERV, V92, P1, DOI 10.1016/S0006-3207(99)00067-1; Arias-Gonzalez JE, 2012, BIODIVERS CONSERV, V21, P115, DOI 10.1007/s10531-011-0169-y; Arias-Gonzalez JE, 2008, J EXP MAR BIOL ECOL, V366, P28, DOI 10.1016/j.jembe.2008.07.035; Froese R., 2014, FISHBASE; Galvan-Villa CM, 2010, REV BIOL MAR OCEANOG, V45, P311; Garcia-Salgado M, 2008, STATUS CORAL REEFS W, P253; GOMEZ ED, 1994, MAR POLLUT BULL, V29, P62, DOI 10.1016/0025-326X(94)90427-8; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Heino J, 2008, LANDSCAPE ECOL, V23, P417, DOI 10.1007/s10980-008-9199-6; HIRATA H, 1986, ECOL MODEL, V31, P79, DOI 10.1016/0304-3800(86)90057-8; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P391, DOI 10.1007/978-94-007-0114-4_22; HRI, 2010, 2010 REP CARD MES RE; HRI, 2008, 2008 REP CARD MES RE; HRI, 2015, 2015 REP CARD MES RE; HRI, 2012, 2012 REP CARD MES RE; Humann P, 2006, REEF FISH IDENTIFICA; Jameson SC, 2001, B MAR SCI, V69, P701; Jameson SC, 1999, CORAL REEFS, V18, P333, DOI 10.1007/s003380050208; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Jorgensen S.E., 2005, HDB ECOLOGICAL INDIC; Kaufman L, 2011, CORAL HLTH INDEX CHI; Kuhlmann KJ, 2002, AQUACULT INT, V10, P527, DOI 10.1023/A:1023955626357; Lasagna R, 2014, ECOL INDIC, V40, P1, DOI 10.1016/j.ecolind.2013.12.020; Levins R., 1998, ECOSYSTEM HLTH EDITE, P178; LOYA Y, 1976, ECOLOGY, V57, P278, DOI 10.2307/1934816; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; McField M., 2007, HLTH REEFS HLTH PEOP; Mcfield MD, 2005, P 10 INT COR REEF S, P1118; McField Melanie, 2011, University of British Columbia Fisheries Centre Research Reports, V19, P129; Monaco ME, 1997, MAR ECOL PROG SER, V161, P239, DOI 10.3354/meps161239; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Munday PL, 2004, GLOBAL CHANGE BIOL, V10, P1642, DOI 10.1111/j.1365-2486.2004.00839.x; Nunez-Lara Enrique, 2003, Atoll Research Bulletin, V496, P338; Opitz S, 43 ICLARM, V43, P341; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Rodriguez-Zaragoza FA, 2008, CARIBB J SCI, V44, P90; Rodriguez-Zaragoza FA, 2012, LAT AM J AQUAT RES, V40, P992, DOI 10.3856/vol40-issue4-fulltext-15; Rodriguez-Zaragoza FA, 2011, BIODIVERS CONSERV, V20, P1655, DOI 10.1007/s10531-011-0053-9; Selig ER, 2010, GLOBAL ECOL BIOGEOGR, V19, P397, DOI 10.1111/j.1466-8238.2009.00522.x; Smith M.J., 2001, DESIGN IMPLEMENTATIO; Smith TB, 2008, MAR POLLUT BULL, V56, P1983, DOI 10.1016/j.marpolbul.2008.08.015; Sweatman H, 2007, CORAL REEF HLT UNPUB; Underwood A.J, 1997, EXPT ECOLOGY THEIR L; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Warwick RM, 1995, MAR ECOL PROG SER, V129, P301, DOI 10.3354/meps129301; Wilkinson C, 2008, STATUS CARIBBEAN COR; ZAHL S, 1977, ECOLOGY, V58, P907, DOI 10.2307/1936227	71	25	25	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161812	10.1371/journal.pone.0161812	http://dx.doi.org/10.1371/journal.pone.0161812			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579575	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877400042
J	Elf, M; Eriksson, G; Johansson, S; von Koch, L; Ytterberg, C				Elf, Marie; Eriksson, Gunilla; Johansson, Sverker; von Koch, Lena; Ytterberg, Charlotte			Self-Reported Fatigue and Associated Factors Six Years after Stroke	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; SCALE-RASCH ANALYSES; POSTSTROKE FATIGUE; PSYCHOMETRIC PROPERTIES; SEVERITY SCALE; FOLLOW-UP; IMPACT SCALE; LIFE; INTERVENTION; RELIABILITY	Several studies have found that fatigue is one of the most commonly reported symptoms after stroke and the most difficult to cope with. The present study aimed to investigate the presence and severity of self-reported fatigue six years after stroke onset and associated factors. The cohort "Life After Stroke Phase I" (n = 349 persons) was invited at six years to report fatigue (Fatigue Severity Scale 7-item version), perceived impact of stroke and global recovery after stroke (Stroke Impact Scale), anxiety and depression (Hospital Anxiety and Depression Scale), life satisfaction (Life Satisfaction Checklist) and participation in everyday social activities (Frenchay Activities Index). At six years 37% of the 102 participants in this cross-sectional study reported fatigue. The results showed that in nearly all SIS domains the odds for post-stroke fatigue were higher in persons with a higher perceived impact. Furthermore, the odds for post-stroke fatigue were higher in those who had experienced a moderate/severe stroke and had signs of depression and anxiety. Fatigue is still present in one-third of persons as long as six years after stroke onset and is perceived to hinder many aspects of functioning in everyday life. There is an urgent need to develop and evaluate interventions to reduce fatigue.	[Elf, Marie] Dalarna Univ, Sch Educ Hlth & Social Studies, Dept Nursing, Falun, Sweden; [Elf, Marie; Eriksson, Gunilla; Johansson, Sverker; von Koch, Lena; Ytterberg, Charlotte] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Johansson, Sverker; Ytterberg, Charlotte] Karolinska Univ Hosp, Funct Area Occupat Therapy & Physiotherapy, Stockholm, Sweden; [von Koch, Lena] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden	Dalarna University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Elf, M (corresponding author), Dalarna Univ, Sch Educ Hlth & Social Studies, Dept Nursing, Falun, Sweden.; Elf, M (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.	mel@du.se	von Koch, Lena/P-2310-2018	von Koch, Lena/0000-0002-8560-3016; Elf, Marie/0000-0001-7044-8896; Ytterberg, Charlotte/0000-0003-3704-8887	Stockholm County Council; Karolinska Institutet (ALF); Hjarnfonden (Swedish Brain Foundation); Swedish Research Council; Swedish Stroke Association	Stockholm County Council(Stockholm County Council); Karolinska Institutet (ALF)(Karolinska Institutet); Hjarnfonden (Swedish Brain Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Stroke Association	Financial support was provided through the regional agreement on medical training and clinical research between Stockholm County Council and the Karolinska Institutet (ALF), Hjarnfonden (Swedish Brain Foundation), the Swedish Research Council and the Swedish Stroke Association.; Financial support was provided through the regional agreement on medical training and clinical research between Stockholm County Council and the Karolinska Institutet (ALF), the Swedish Research Council and the Swedish Stroke Association.	Appelros P, 2006, INT J REHABIL RES, V29, P329, DOI 10.1097/MRR.0b013e328010c7b8; Armes J, 2007, CANCER-AM CANCER SOC, V110, P1385, DOI 10.1002/cncr.22923; Barker-Collo S, 2007, NEW ZEAL MED J, V120; Bertilsson AS, 2014, SCAND J OCCUP THER, V21, P377, DOI 10.3109/11038128.2014.880126; BOND MJ, 1995, DISABIL REHABIL, V17, P63, DOI 10.3109/09638289509166629; Braley TJ, 2014, NEUROLOGY, V81, P1581; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Choi-Kwon S, 2005, CEREBROVASC DIS, V19, P84, DOI 10.1159/000082784; Choi-Kwon S, 2011, INT J STROKE, V6, P328, DOI 10.1111/j.1747-4949.2011.00624.x; Christensen D, 2008, CEREBROVASC DIS, V26, P134, DOI 10.1159/000139660; de Groot MH, 2003, ARCH PHYS MED REHAB, V84, P1714, DOI 10.1053/S0003-9993(03)00346-0; Duncan F, 2012, J PSYCHOSOM RES, V73, P18, DOI 10.1016/j.jpsychores.2012.04.001; Duncan PW, 1999, STROKE, V30, P2131, DOI 10.1161/01.STR.30.10.2131; Egerton T, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0438-6; Fugl-Meyer AR, 2002, J REHABIL MED, V34, P239, DOI 10.1080/165019702760279242; Glader EL, 2002, STROKE, V33, P1327, DOI 10.1161/01.STR.0000014248.28711.D6; Govan L, 2009, STROKE, V40, P3396, DOI 10.1161/STROKEAHA.109.557645; Ingles JL, 1999, ARCH PHYS MED REHAB, V80, P173, DOI 10.1016/S0003-9993(99)90116-8; Kirkevold M, 2012, DISABIL REHABIL, V34, P665, DOI 10.3109/09638288.2011.615373; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lai SM, 2003, STROKE, V34, P488, DOI 10.1161/01.STR.0000054162.94998.C0; Lerdal A, 2005, SCAND J PUBLIC HEALT, V33, P123, DOI 10.1080/14034940410028406; Lerdal A, 2010, MULT SCLER J, V16, P733, DOI 10.1177/1352458510370792; Lerdal A, 2011, INT J NURS STUD, V48, P1258, DOI 10.1016/j.ijnurstu.2011.02.019; Lerdal A, 2009, J PAIN SYMPTOM MANAG, V38, P928, DOI 10.1016/j.jpainsymman.2009.04.028; Lynch J, 2007, J PSYCHOSOM RES, V63, P539, DOI 10.1016/j.jpsychores.2007.08.004; MAHONEY F I, 1965, Md State Med J, V14, P61; McGeough E, 2009, COCHRANE DATABASE SY, V8; Michael Kathleen, 2002, Rehabil Nurs, V27, P89; Naess H, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002404; Naess H, 2012, J NEUROL SCI, V312, P138, DOI 10.1016/j.jns.2011.08.002; Park JY, 2009, AM J PHYS MED REHAB, V88, P554, DOI 10.1097/PHM.0b013e3181a0dae0; Passier PE, 2001, J NEUROL, V258, P1091; Pollock A, 2014, INT J STROKE, V9, P313, DOI 10.1111/j.1747-4949.2012.00942.x; Post MWM, 2003, CLIN REHABIL, V17, P548, DOI 10.1191/0269215503cr648oa; Sagen U, 2009, J PSYCHOSOM RES, V67, P325, DOI 10.1016/j.jpsychores.2009.03.007; Smith ORF, 2008, J AM GERIATR SOC, V56, P1915, DOI 10.1111/j.1532-5415.2008.01925.x; Snaphaan L, 2011, EUR J NEUROL, V18, P611, DOI 10.1111/j.1468-1331.2010.03217.x; Staub F, 2001, CEREBROVASC DIS, V12, P75, DOI 10.1159/000047685; Thomas S, 2013, J NEUROL NEUROSUR PS, V84, P1092, DOI 10.1136/jnnp-2012-303816; Tistad M, 2012, J NEUROL SCI, V313, P160, DOI 10.1016/j.jns.2011.08.038; van de Port IGL, 2007, CEREBROVASC DIS, V23, P40, DOI 10.1159/000095757; van der Werf SP, 2001, EUR NEUROL, V45, P28, DOI 10.1159/000052085; van Eijsden HM, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/863978; White JH, 2012, DISABIL REHABIL, V34, P1376, DOI 10.3109/09638288.2011.645111; White PD, 2011, LANCET, V377, P823, DOI 10.1016/S0140-6736(11)60096-2; Winward C, 2009, STROKE, V40, P757, DOI 10.1161/STROKEAHA.108.527101; Wolfe CDA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001033; Wu SM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007030.pub3; Wu SM, 2015, STROKE, V46, P893, DOI 10.1161/STROKEAHA.114.006647; Wu SM, 2014, STROKE, V45, P1778, DOI 10.1161/STROKEAHA.113.004584; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	52	31	34	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161942	10.1371/journal.pone.0161942	http://dx.doi.org/10.1371/journal.pone.0161942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EE	27575043	gold, Green Published, Green Submitted			2022-12-26	WOS:000382877200046
J	Korshed, P; Li, L; Liu, Z; Wang, T				Korshed, Peri; Li, Lin; Liu, Zhu; Wang, Tao			The Molecular Mechanisms of the Antibacterial Effect of Picosecond Laser Generated Silver Nanoparticles and Their Toxicity to Human Cells	PLOS ONE			English	Article							IN-VITRO; ANTIMICROBIAL ACTIVITY; STAPHYLOCOCCUS-AUREUS; MAMMALIAN-CELLS; ROS GENERATION; CYTOTOXICITY; ABLATION; AG; AGGLOMERATION; RESPONSES	Silver nanoparticles (Ag NPs) are known to have antibacterial properties. They are commonly produced by chemical synthesis which involves the use of harmful reducing agents. Contras, the laser technique is able to generate high-purity Ag NPs in water with specified surface charge characteristics. In the past, the molecular mechanisms contributing to the bactericidal effects of Ag NPs have been investigated extensively, but little is known of the antibacterial and toxic effects and mechanisms involved in laser-generated Ag NPs. In the current study Ag NPs were generated by picosecond laser ablation. Their antibacterial activity was determined on the gram-negative bacteria E. coli and Pseudomonas aeruginosa, and the gram positive bacteria Staphylococcus aureus including the methicillin resistant strain MRSA. Results showed that the laser generated Ag NPs exhibited strong dose-dependent antibacterial activity against all the three bacterial strains tested. Using E. coli as a model system, the laser Ag NPs treatment induced significantly high levels of reactive oxygen species (ROS). These ROS did not include detectable hydroxyl radicals, suggesting for the first time the selective ROS induction in bacterial cells by laser generated Ag NPs. The increased ROS was accompanied by significantly reduced cellular glutathione, and increased lipid peroxidation and permeability, suggesting ROS related bacterial cell damage. The laser generated Ag NPs exhibited low toxicity (within 72 hours) to five types of human cells although a weak significant decrease in cell survival was observed for endothelial cells and the lung cells. We conclude that picosecond laser generated Ag NPs have a broad spectrum of antibacterial effects against microbes including MRSA with minimal human cell toxicity. The oxidative stress is likely the key mechanism underlying the bactericidal effect, which leads to lipid peroxidation, depletion of glutathione, DNA damages and eventual disintegration of the cell membrane.	[Korshed, Peri; Wang, Tao] Univ Manchester, Fac Med & Human Sci, Manchester M13 9PL, Lancs, England; [Li, Lin] Univ Manchester, Sch Mech Aerosp & Civil Engn, Laser Proc Res Ctr, Manchester M60 1QD, Lancs, England; [Liu, Zhu] Univ Manchester, Sch Mat, Ctr Corros & Protect, Mill, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Wang, T (corresponding author), Univ Manchester, Fac Med & Human Sci, Manchester M13 9PL, Lancs, England.; Li, L (corresponding author), Univ Manchester, Sch Mech Aerosp & Civil Engn, Laser Proc Res Ctr, Manchester M60 1QD, Lancs, England.	lin.li@manchester.ac.uk; tao.wang@manchester.ac.uk	khorshed, peri/ACL-8458-2022	khorshed, peri/0000-0002-3138-7442	Kurdistan regional government; Wellcome Trust	Kurdistan regional government; Wellcome Trust(Wellcome TrustEuropean Commission)	This work is funded by Kurdistan regional government as a PhD studentship.; We would like to thank Mr. Abubaker Hamad from the School of Mechanical, Aerospace and Civil Engineering, the University of Manchester for his assistance in the generation of Ag NPs using laser ablation technology. The authors wish to thank the staff, especially Dr Aleksandr Mironov, in the Faculty of Life Sciences EM Facility for their assistance and the Wellcome Trust for equipment grant support to the EM Facility.	Ahmad Zahoor, 2006, Indian J Chest Dis Allied Sci, V48, P171; Arora S, 2008, TOXICOL LETT, V179, P93, DOI 10.1016/j.toxlet.2008.04.009; Asharani PV, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/25/255102; Avalos A, 2014, J APPL TOXICOL, V34, P413, DOI 10.1002/jat.2957; Bondarenko O, 2013, ARCH TOXICOL, V87, P1181, DOI 10.1007/s00204-013-1079-4; Castiglioni Sara, 2014, World J Biol Chem, V5, P457, DOI 10.4331/wjbc.v5.i4.457; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Chhibber S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056022; Chudasama B, 2010, J NANOPART RES, V12, P1677, DOI 10.1007/s11051-009-9845-1; Davda J, 2002, INT J PHARM, V233, P51, DOI 10.1016/S0378-5173(01)00923-1; Dibrov P, 2002, ANTIMICROB AGENTS CH, V46, P2668, DOI 10.1128/AAC.46.8.2668-2670.2002; Dror-Ehre A, 2009, J COLLOID INTERF SCI, V339, P521, DOI 10.1016/j.jcis.2009.07.052; Elliott GC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107175; Feinendegen LE, 2002, HUM EXP TOXICOL, V21, P85, DOI 10.1191/0960327102ht216oa; Gliga AR, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-11; Goel A, 2007, FEBS LETT, V581, P2447, DOI 10.1016/j.febslet.2007.04.052; Grade S, 2012, ADV ENG MATER, V14, pB231, DOI 10.1002/adem.201180016; Gu HW, 2003, NANO LETT, V3, P1261, DOI 10.1021/nl034396z; Hamad A, 2015, RSC ADV, V5, P72981, DOI 10.1039/c5ra16466d; He D, 2011, J PHYS CHEM C, V115, P5461, DOI 10.1021/jp111275a; Hussain SM, 2005, TOXICOL IN VITRO, V19, P975, DOI 10.1016/j.tiv.2005.06.034; Hwang IS, 2012, FEBS J, V279, P1327, DOI 10.1111/j.1742-4658.2012.08527.x; Jennifer M, 2013, NANOPARTICLE TECHNOL; Kaur J, 2013, FOOD CHEM TOXICOL, V51, P1, DOI 10.1016/j.fct.2012.08.044; Kavita K, 2014, MICROBIOL RES, V169, P301, DOI 10.1016/j.micres.2013.07.002; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Kim Soo-Hwan, 2011, Korean Journal of Microbiology and Biotechnology, V39, P77; Lankoff A, 2012, TOXICOL LETT, V208, P197, DOI 10.1016/j.toxlet.2011.11.006; Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5; Menendez-Manjon A, 2009, J LASER MICRO NANOEN, V4, P95, DOI 10.2961/jlmn.2009.02.0004; Mollick MMR, 2014, MICROFLUID NANOFLUID, V16, P541, DOI 10.1007/s10404-013-1252-3; Narayanan KB, 2010, ADV COLLOID INTERFAC, V156, P1, DOI 10.1016/j.cis.2010.02.001; Paddle-Ledinek JE, 2006, PLAST RECONSTR SURG, V117, p110S, DOI 10.1097/01.prs.0000225439.39352.ce; Park HJ, 2012, ENVIRON SCI TECHNOL, V46, P11299, DOI 10.1021/es302379q; Prabhu S, 2012, INT NANO LETT, V2, DOI 10.1186/2228-5326-2-32; Ramachandran S, 2010, ARCH DERMATOL RES, V302, P733, DOI 10.1007/s00403-010-1072-1; Ruparelia JP, 2008, ACTA BIOMATER, V4, P707, DOI 10.1016/j.actbio.2007.11.006; Seil JT, 2012, INT J NANOMED, V7, P2767, DOI 10.2147/IJN.S24805; Shahverdi AR, 2007, NANOMED-NANOTECHNOL, V3, P168, DOI 10.1016/j.nano.2007.02.001; Shameli K, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-73; Siddiqui MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069534; Su HL, 2009, BIOMATERIALS, V30, P5979, DOI 10.1016/j.biomaterials.2009.07.030; Svetlichnyi VA, 2013, RUSS PHYS J+, V56, P581, DOI 10.1007/s11182-013-0071-z; Swathy JR, 2014, SCI REP-UK, V4, DOI 10.1038/srep07161; Thomas V, 2007, J COLLOID INTERF SCI, V315, P389, DOI 10.1016/j.jcis.2007.06.068; Vanwinkle BA, 2009, NANOTOXICOLOGY, V3, P307, DOI 10.3109/17435390903121949; Wang T, 2007, CELL SIGNAL, V19, P2458, DOI 10.1016/j.cellsig.2007.07.019; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; Xu HY, 2012, BIOMETALS, V25, P45, DOI 10.1007/s10534-011-9482-x; Xu PS, 2007, ANGEW CHEM INT EDIT, V46, P4999, DOI 10.1002/anie.200605254; You CG, 2012, MOL BIOL REP, V39, P9193, DOI 10.1007/s11033-012-1792-8	51	50	50	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0160078	10.1371/journal.pone.0160078	http://dx.doi.org/10.1371/journal.pone.0160078			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575485	gold, Green Published			2022-12-26	WOS:000382877200005
J	Wang, JK; Fan, YL; Dong, Y; Ma, MY; Ma, Y; Dong, YR; Niu, YJ; Jiang, Y; Wang, H; Wang, ZY; Wu, LZ; Sun, HQ; Cui, CL				Wang, Junkai; Fan, Yunli; Dong, Yue; Ma, Mengying; Ma, Yi; Dong, Yuru; Niu, Yajuan; Jiang, Yin; Wang, Hong; Wang, Zhiyan; Wu, Liuzhen; Sun, Hongqiang; Cui, Cailian			Alterations in Brain Structure and Functional Connectivity in Alcohol Dependent Patients and Possible Association with Impulsivity	PLOS ONE			English	Article							WHITE-MATTER INTEGRITY; DECISION-MAKING; DRUG-USE; COGNITIVE CONTROL; NEURAL SYSTEMS; FAMILY-HISTORY; USE DISORDERS; ADDICTION; DIFFUSION; CORTEX	Background Previous studies have documented that heightened impulsivity likely contributes to the development and maintenance of alcohol use disorders. However, there is still a lack of studies that comprehensively detected the brain changes associated with abnormal impulsivity in alcohol addicts. This study was designed to investigate the alterations in brain structure and functional connectivity associated with abnormal impulsivity in alcohol dependent patients. Methods Brain structural and functional magnetic resonance imaging data as well as impulsive behavior data were collected from 20 alcohol dependent patients and 20 age- and sex-matched healthy controls respectively. Voxel-based morphometry was used to investigate the differences of grey matter volume, and tract-based spatial statistics was used to detect abnormal white matter regions between alcohol dependent patients and healthy controls. The alterations in resting-state functional connectivity in alcohol dependent patients were examined using selected brain areas with gray matter deficits as seed regions. Results Compared with healthy controls, alcohol dependent patients had significantly reduced gray matter volume in the mesocorticolimbic system including the dorsal posterior cingulate cortex, the dorsal anterior cingulate cortex, the medial prefrontal cortex, the orbitofrontal cortex and the putamen, decreased fractional anisotropy in the regions connecting the damagedgrey matter areas driven by higher radial diffusivity value in the same areas and decreased resting-state functional connectivity within the reward network. Moreover, the gray matter volume of the left medial prefrontal cortex exhibited negative correlations with various impulse indices. Conclusions These findings suggest that chronic alcohol dependence could cause a complex neural changes linked to abnormal impulsivity.	[Wang, Junkai; Wang, Zhiyan; Wu, Liuzhen; Cui, Cailian] Peking Univ, Neurosci Res Inst, Beijing, Peoples R China; [Wang, Junkai; Wang, Zhiyan; Wu, Liuzhen; Cui, Cailian] Peking Univ, Sch Basic Med Sci, Dept Neurobiol, Beijing, Peoples R China; [Wang, Junkai; Wang, Zhiyan; Wu, Liuzhen; Cui, Cailian] Minist Educ, Key Lab Neurosci, Beijing, Peoples R China; [Wang, Junkai; Wang, Zhiyan; Wu, Liuzhen; Cui, Cailian] Minist Publ Hlth, Beijing, Peoples R China; [Fan, Yunli; Ma, Mengying; Niu, Yajuan] Peking Univ, Beijing Hui Long Guan Hosp, Beijing, Peoples R China; [Sun, Hongqiang] Peking Univ, Hosp 6, Inst Mental Hlth, Beijing, Peoples R China; [Sun, Hongqiang] Peking Univ, Key Lab Mental Hlth, Minist Hlth, Beijing, Peoples R China; [Dong, Yue; Ma, Yi; Dong, Yuru; Wang, Hong] Gen Hosp Armed Police Forces, Dept Magnet Resonance, Beijing, Peoples R China; [Jiang, Yin] Capital Med Univ, Beijing Neurosurg Inst, Stereotact & Funct Neurosurg Lab, Beijing 100050, Peoples R China	Peking University; Peking University; Peking University; Peking University; Peking University; Beijing Neurosurgical Institute; Capital Medical University	Wu, LZ; Cui, CL (corresponding author), Peking Univ, Neurosci Res Inst, Beijing, Peoples R China.; Wu, LZ; Cui, CL (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Neurobiol, Beijing, Peoples R China.; Wu, LZ; Cui, CL (corresponding author), Minist Educ, Key Lab Neurosci, Beijing, Peoples R China.; Wu, LZ; Cui, CL (corresponding author), Minist Publ Hlth, Beijing, Peoples R China.; Sun, HQ (corresponding author), Peking Univ, Hosp 6, Inst Mental Hlth, Beijing, Peoples R China.; Sun, HQ (corresponding author), Peking Univ, Key Lab Mental Hlth, Minist Hlth, Beijing, Peoples R China.	liuzw@bjmu.edu.cn; sunhq@bjmu.edu.cn; clcui@bjmu.edu.cn		Wang, Zhiyan/0000-0001-7910-3245	National Natural Science Foundation of China [81371462]; Science Fund for Creative Research Groups from the National Natural Science Foundation [81221002]; National Basic Research Program of China [2015CB553500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Fund for Creative Research Groups from the National Natural Science Foundation; National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (grant number 81371462) to LZ Wu, the Science Fund for Creative Research Groups from the National Natural Science Foundation (grant number 81221002), and the National Basic Research Program (grant number 2015CB553500) of China to CL Cui. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Asensio S, 2016, ADDICT BIOL, V21, P962, DOI 10.1111/adb.12257; Brown MRG, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00024; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Claus ED, 2012, ALCOHOL CLIN EXP RES, V36, P408, DOI 10.1111/j.1530-0277.2011.01694.x; Clewett D, 2014, HUM BRAIN MAPP, V35, P3774, DOI 10.1002/hbm.22436; Cui ZX, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00042; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; de Wit H, 2009, ADDICT BIOL, V14, P22, DOI 10.1111/j.1369-1600.2008.00129.x; Demirakca T, 2011, ALCOHOL CLIN EXP RES, V35, P1678, DOI 10.1111/j.1530-0277.2011.01514.x; Dick DM, 2010, ADDICT BIOL, V15, P217, DOI 10.1111/j.1369-1600.2009.00190.x; Ersche KD, 2011, BRAIN, V134, P2013, DOI 10.1093/brain/awr138; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; EYSENCK SBG, 1977, BRIT J SOC CLIN PSYC, V16, P57, DOI 10.1111/j.2044-8260.1977.tb01003.x; Fein G, 2008, DRUG ALCOHOL DEPEN, V92, P141, DOI 10.1016/j.drugalcdep.2007.07.017; Filbey FM, 2014, P NATL ACAD SCI USA, V111, P16913, DOI 10.1073/pnas.1415297111; Forbes EE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094640; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Gilman JM, 2012, ADDICT BIOL, V17, P465, DOI 10.1111/j.1369-1600.2011.00383.x; Heitzeg MM, 2010, BIOL PSYCHIAT, V68, P287, DOI 10.1016/j.biopsych.2010.02.020; Herting MM, 2010, ALCOHOL CLIN EXP RES, V34, P1590, DOI 10.1111/j.1530-0277.2010.01244.x; Hu YZ, 2015, JAMA PSYCHIAT, V72, P584, DOI 10.1001/jamapsychiatry.2015.1; JONES B, 1971, ARCH GEN PSYCHIAT, V24, P71; Kamarajan C, 2005, BIOL PSYCHOL, V69, P353, DOI 10.1016/j.biopsycho.2004.08.004; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Lee B, 2009, J NEUROSCI, V29, P14734, DOI 10.1523/JNEUROSCI.3765-09.2009; Lejuez CW, 2010, ALCOHOL CLIN EXP RES, V34, P1334, DOI 10.1111/j.1530-0277.2010.01217.x; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Liu IC, 2010, PSYCHIAT RES-NEUROIM, V184, P128, DOI 10.1016/j.pscychresns.2010.07.002; MacKillop J, 2010, J ABNORM PSYCHOL, V119, P106, DOI 10.1037/a0017513; Marczinski CA, 2003, EXP CLIN PSYCHOPHARM, V11, P110, DOI 10.1037/1064-1297.11.1.110; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Mitchell JM, 2005, ALCOHOL CLIN EXP RES, V29, P2158, DOI 10.1097/01.alc.0000191755.63639.4a; Mitchell SH, 1999, PSYCHOPHARMACOLOGY, V146, P455, DOI 10.1007/PL00005491; Moeller FG, 2001, AM J PSYCHIAT, V158, P1783, DOI 10.1176/appi.ajp.158.11.1783; Muller-Oehring EM, 2015, CEREB CORTEX, V25, P4155, DOI 10.1093/cercor/bhu134; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Oscar-Berman M, 2007, NEUROPSYCHOL REV, V17, P239, DOI 10.1007/s11065-007-9038-6; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rogers RD, 2010, ALCOHOL CLIN EXP RES, V34, P1319, DOI 10.1111/j.1530-0277.2010.01216.x; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sorg SF, 2012, BIOL PSYCHIAT, V71, P262, DOI 10.1016/j.biopsych.2011.09.022; Sutherland MT, 2012, NEUROIMAGE, V62, P2281, DOI 10.1016/j.neuroimage.2012.01.117; Swann AC, 2002, BIOL PSYCHIAT, V51, P988, DOI 10.1016/S0006-3223(01)01357-9; Wang LB, 2016, ADDICT BIOL, V21, P646, DOI 10.1111/adb.12228; Zhu X, 2017, ADDICT BIOL, V22, P206, DOI 10.1111/adb.12272; Zorlu N, 2013, PSYCHIAT RES-NEUROIM, V214, P382, DOI 10.1016/j.pscychresns.2013.06.014	54	48	49	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161956	10.1371/journal.pone.0161956	http://dx.doi.org/10.1371/journal.pone.0161956			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EE	27575491	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877200048
J	Pardo, JD; Anderson, JS				Pardo, Jason D.; Anderson, Jason S.			Cranial Morphology of the Carboniferous-Permian Tetrapod Brachydectes newberryi (Lepospondyli, Lysorophia): New Data from mu CT	PLOS ONE			English	Article							PALEOZOIC ANCESTRY; EXTANT AMPHIBIANS; ACROPLOUS-VORAX; EARLY EVOLUTION; SPEISER SHALE; TEMNOSPONDYLI; ORIGIN; KANSAS; SALAMANDERS; PHYLOGENY	Lysorophians are a group of early tetrapods with extremely elongate trunks, reduced limbs, and highly reduced skulls. Since the first discovery of this group, general similarities in outward appearance between lysorophians and some modern lissamphibian orders (specifically Urodela and Gymnophiona) have been recognized, and sometimes been the basis for hypotheses of lissamphibian origins. We studied the morphology of the skull, with particular emphasis on the neurocranium, of a partial growth series of the lysorophian Brachydectes newberryi using x-ray micro-computed tomography (mu CT). Our study reveals similarities between the braincase of Brachydectes and brachystelechid recumbirostrans, corroborating prior work suggesting a close relationship between these taxa. We also describe the morphology of the epipterygoid, stapes, and quadrate in this taxon for the first time. Contra the proposals of some workers, we find no evidence of expected lissamphibian synapomorphies in the skull morphology in Brachydectes newberryi, and instead recognize a number of derived amniote characteristics within the braincase and suspensorium. Morphology previously considered indicative of taxonomic diversity within Lysorophia may reflect ontogenetic rather than taxonomic variation. The highly divergent morphology of lysorophians represents a refinement of morphological and functional trends within recumbirostrans, and is analogous to morphology observed in many modern fossorial reptiles.	[Pardo, Jason D.; Anderson, Jason S.] Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB, Canada	University of Calgary	Pardo, JD (corresponding author), Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB, Canada.	jdpardo@ucalgary.ca			National Science and Engineering Council of Canada [327756-2011]	National Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by National Science and Engineering Council of Canada Discovery Grant 327756-2011 awarded to JSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2008, NATURE, V453, P515, DOI 10.1038/nature06865; Anderson Jason S., 2007, P182; Anderson JS, 2009, J VERTEBR PALEONTOL, V29, P379, DOI 10.1671/039.029.0222; Anderson JS, 2002, J PALEONTOL, V76, P1029, DOI 10.1666/0022-3360(2002)076<1029:ROTAGP>2.0.CO;2; Anderson JS, 2001, SYST BIOL, V50, P170; [Anonymous], 2004, RECENT ADV ORIGIN EA; Barros FC, 2011, J EVOLUTION BIOL, V24, P2423, DOI 10.1111/j.1420-9101.2011.02372.x; BEERBOWER JAMES R., 1963, BULL MUS COMP ZOOL [HARVARD UNIV], V130, P31; Berman DS, 2000, J PALEONTOL, V74, P938, DOI 10.1666/0022-3360(2000)074<0938:OAEEOT>2.0.CO;2; Boardman D.R., 2009, KANS GEOL SURV BULL, V255, P1; BOLT J R, 1975, Paleobiology, V1, P320; Bolt JR, 2009, J PALEONTOL, V83, P471, DOI 10.1666/08-076.1; BOLT JR, 1969, SCIENCE, V166, P888, DOI 10.1126/science.166.3907.888; Broili F., 1908, Anatomischer Anzeiger, V33; Carroll R.L., 1978, Memoirs of the American Philosophical Society, V126, P1; CARROLL RL, 1975, ZOOL J LINN SOC-LOND, V57, P229, DOI 10.1111/j.1096-3642.1975.tb00817.x; Carroll RL, 2007, ZOOL J LINN SOC-LOND, V150, P1, DOI 10.1111/j.1096-3642.2007.00246.x; Case EC, 1908, B AM MUS NAT HIST, V24, P531; CLACK JA, 1994, NATURE, V369, P392, DOI 10.1038/369392a0; CLACK JA, 1988, PALAEONTOLOGY, V31, P85; Coldiron R.W., 1978, AM MUS NOVIT, V2662, P1; Cope ED, 1875, OHIO GEOL SURV, V2, P349; Cope ED, 1868, P ACAD NAT SCI PHILA, V1868, P208, DOI [10.5962/bhl.title.60482, DOI 10.5962/BHL.TITLE.60482]; DALY E, 1973, J PALEONTOL, V47, P562; de Beer S.G.R., 1937, DEV VERTEBRATE SKULL; Dempster WT, 1935, J COMP NEUROL, V62, P171, DOI 10.1002/cne.900620108; Englehorn J, 2008, J VERTEBR PALEONTOL, V28, P291, DOI 10.1671/0272-4634(2008)28[291:AROAVT]2.0.CO;2; Foreman B.C., 1990, Journal of Vertebrate Paleontology, V10, P390; Foreman BC, 1981, OCC PAPERS MUS NAT H, V91, P1; Foreman BC, 1988, KANSAS GEOLOGICAL SU, V6, P133; FOX H., 1954, TRANS ZOOL SOC LONDON, V28, P241; Francis ETB, 1934, ANATOMY SALAMANDER; Friedman M, 2007, ZOOL J LINN SOC-LOND, V151, P115, DOI 10.1111/j.1096-3642.2007.00320.x; Frobisch NB, 2007, EVOL DEV, V9, P69; GANS C, 1968, AM NAT, V102, P345, DOI 10.1086/282548; Gardner NM, 2010, PALAEONTOL ELECTRON, V13, P1; Germain D, 2010, HIST BIOL, V22, P4, DOI 10.1080/08912961003779678; Gold MEL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105793; Gubin YM, 1999, PALEONTOL J, V33, P630; Heaton M.J., 1979, OKLAHOMA GEOL SURV B, V127, P1; Hembree DI, 2005, J PALEONTOL, V79, P583, DOI 10.1666/0022-3360(2005)079<0583:TENIAI>2.0.CO;2; Hembree DI, 2004, PALAEOGEOGR PALAEOCL, V203, P127, DOI 10.1016/S0031-0182(03)00664-3; Henrici AC, 2011, J VERTEBR PALEONTOL, V31, P997, DOI 10.1080/02724634.2011.596601; Hook R.W., 1986, Journal of Vertebrate Paleontology, V6, P174; HOTTON N, 1959, J PALEONTOL, V33, P161; Huttenlocker AK, 2007, J VERTEBR PALEONTOL, V27, P316, DOI 10.1671/0272-4634(2007)27[316:PSGESN]2.0.CO;2; Huttenlocker AK, 2013, J VERTEBR PALEONTOL, V33, P540, DOI 10.1080/02724634.2013.728998; Huttenlocker AK, 2005, NEW MEXICO MUSEUM NA, V30, P133; Jamniczky HA, 2011, EVOL DEV, V13, P28, DOI 10.1111/j.1525-142X.2010.00453.x; Jenkins Farish A. Jr., 2007, Bulletin of the Museum of Comparative Zoology, V158, P285, DOI 10.3099/0027-4100(2007)158[285:AOEMAL]2.0.CO;2; Joeckel RM, 1991, J SEDIMENT PETR, V59, P469; Kearney M, 2004, P ROY SOC B-BIOL SCI, V271, P1677, DOI 10.1098/rspb.2004.2771; Kearney M, 2003, HERPETOL MONOGR, V17, P1, DOI 10.1655/0733-1347(2003)017[0001:SOTALB]2.0.CO;2; Kleinteich T, 2012, J EXP BIOL, V215, P833, DOI 10.1242/jeb.065979; LAURIN M, 1995, ZOOL J LINN SOC-LOND, V113, P165, DOI 10.1111/j.1096-3642.1995.tb00932.x; Maddin Hillary C., 2012, Fieldiana-Life and Earth Sciences, V5, P59; Maddin HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050743; Maddin HC, 2012, ZOOL J LINN SOC-LOND, V166, P160, DOI 10.1111/j.1096-3642.2012.00838.x; Maddin HC, 2011, J MORPHOL, V272, P850, DOI 10.1002/jmor.10953; Maddin HC, 2011, J MORPHOL, V272, P722, DOI 10.1002/jmor.10946; Maddin HC, 2010, EVOL DEV, V12, P393, DOI 10.1111/j.1525-142X.2010.00426.x; Marjanovic D, 2013, GEODIVERSITAS, V35, P207, DOI 10.5252/g2013n1a8; Marjanovic D, 2008, CONTRIB ZOOL, V77, P149, DOI 10.1163/18759866-07703002; McAllister J.A., 1992, FOSSIL FISHES LIVING, P91; McCahon TJ, 2015, PALAEOGEOGR PALAEOCL, V435, P1, DOI 10.1016/j.palaeo.2015.05.032; McGinnis H. J., 1967, University of California Publications in Geological Sciences, V71, P1; Moodie RL, 1909, AM NAT, V43, P186, DOI 10.1086/279044; Muller J, 2011, NEUES JAHRB GEOL P-A, V261, P289, DOI 10.1127/0077-7749/2011/0157; Navas CA, 2004, J EXP BIOL, V207, P2433, DOI 10.1242/jeb.01041; NUSSBAUM RA, 1983, J ZOOL, V199, P545; Olori JC, 2013, PALEOBIOLOGY, V39, P400, DOI 10.1666/12031; Olson E.C., 1975, Fieldiana Geology, V33, P271; OLSON E C, 1971, Journal of Paleontology, V45, P443; Olson EC, 1936, J MORPHOL, V59, P265, DOI 10.1002/jmor.1050590204; OLSON EC, 1956, FIELDIANA GEOLOGY, V10, P313; Pardo JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130359; Pardo JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108542; Paterson NF, 1939, Q J MICROSC SCI, V81, P161; RAGE J-C, 1989, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V206, P1; REISZ RR, 1981, SPEC PUBL MUS NAT HI, V7, P1; Rieppel O, 2000, ZOOL SCR, V29, P199, DOI 10.1046/j.1463-6409.2000.00039.x; Romer A. S., 1969, Breviora, VNo. 314, P1; Ruta M, 2003, P ROY SOC B-BIOL SCI, V270, P2507, DOI 10.1098/rspb.2003.2524; Ruta M, 2007, J SYST PALAEONTOL, V5, P69, DOI 10.1017/S1477201906002008; Sawin RS, 2006, CURRENT RES EARTH SC, V252, P1; Schoch RR, 2003, EVOL DEV, V5, P314, DOI 10.1046/j.1525-142X.2003.03038.x; SHISHKIN M A, 1968, Acta Zoologica (Stockholm), V49, P1; SHUBIN NH, 1995, NATURE, V377, P49, DOI 10.1038/377049a0; Sigurdsen T, 2011, ZOOL J LINN SOC-LOND, V162, P457, DOI 10.1111/j.1096-3642.2010.00683.x; Sigurdsen T, 2008, ZOOL J LINN SOC-LOND, V154, P738, DOI 10.1111/j.1096-3642.2008.00459.x; Skutschas P, 2011, ZOOL J LINN SOC-LOND, V161, P816, DOI 10.1111/j.1096-3642.2010.00663.x; Sollas WJ, 1920, PHILOS T R SOC LON B, V209, P481, DOI 10.1098/rstb.1920.0011; Szostakiwskyj M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127307; Vallin G, 2004, J VERTEBR PALEONTOL, V24, P56, DOI 10.1671/5.1; Vaughn PP, 1955, B MUS COMP ZOOL HARV, V114, P36; WELLSTEAD CF, 1991, B AM MUS NAT HIST, V209, P1; Williston SW, 1908, BIOL BULL-US, V15, P229, DOI 10.2307/1536077; Yates AM, 2000, ZOOL J LINN SOC-LOND, V128, P77, DOI 10.1111/j.1096-3642.2000.tb00650.x	98	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161823	10.1371/journal.pone.0161823	http://dx.doi.org/10.1371/journal.pone.0161823			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27563722	Green Published, Green Submitted, gold			2022-12-26	WOS:000382496300022
J	Ram, MS; Kittur, SM; Biswas, J; Nag, S; Shil, J; Umapathy, G				Ram, Muthuvarmadam S.; Kittur, Sagar M.; Biswas, Jihosuo; Nag, Sudipta; Shil, Joydeep; Umapathy, Govindhaswamy			Genetic Diversity and Structure among Isolated Populations of the Endangered Gees Golden Langur in Assam, India	PLOS ONE			English	Article							HABITAT FRAGMENTATION; TRACHYPITHECUS-GEEI; RHINOPITHECUS-BIETI; MACACA-FASCICULARIS; MITOCHONDRIAL; PHYLOGENY; PHYLOGEOGRAPHY; EXTINCTION; ROXELLANA; SEQUENCES	Gee's golden langur (Trachypithecus geei) is an endangered colobine primate, endemic to the semi-evergreen and mixed-deciduous forests of Indo-Bhutan border. During the last few decades, extensive fragmentation has caused severe population decline and local extinction of golden langur from several fragments. However, no studies are available on the impact of habitat fragmentation and the genetic diversity of golden langur in the fragmented habitats. The present study aimed to estimate the genetic diversity in the Indian population of golden langur. We sequenced and analyzed around 500 bases of the mitochondrial DNA (mtDNA) hypervariable region-I from 59 fecal samples of wild langur collected from nine forest fragments. Overall, genetic diversity was high (h = 0.934, pi = 0.0244) and comparable with other colobines. Populations in smaller fragments showed lower nucleotide diversity compared to the larger forest fragments. The median-joining network of haplotypes revealed a genetic structure that corresponded with the geographical distribution. The Aie and Champabati Rivers were found to be a barrier to gene flow between golden langur populations. In addition, it also established that T. geei is monophyletic but revealed possible hybridization with capped langur, T. pileatus, in the wild. It is hoped that these findings would result in a more scientific approach towards managing the fragmented populations of this enigmatic species.	[Ram, Muthuvarmadam S.; Kittur, Sagar M.; Umapathy, Govindhaswamy] Ctr Cellular & Mol Biol, CSIR, Lab Conservat Endangered Species, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India; [Biswas, Jihosuo; Nag, Sudipta; Shil, Joydeep] Primate Res Ctr NE India, H-N 4,Byelane 3, Pandu 781012, Guwahati, India; [Shil, Joydeep] Salim Ali Ctr Ornithol & Nat Hist, Coimbatore 641108, Tamil Nadu, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Salim Ali Center for Ornithology & Natural History (SACON)	Umapathy, G (corresponding author), Ctr Cellular & Mol Biol, CSIR, Lab Conservat Endangered Species, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.	guma@ccmb.res.in	Shil, Joydeep/AAH-5757-2021	Shil, Joydeep/0000-0001-5475-0681; Umapathy, Govindhaswamy/0000-0003-4086-7445	Department of Science and Technology, Government of India, Science and Engineering Research Board [SR/SO/ AS - 17/2012]; DST (SERB project) [SR/SO/ AS-17/2012]	Department of Science and Technology, Government of India, Science and Engineering Research Board; DST (SERB project)	This work was supported by the Department of Science and Technology, Government of India, Science and Engineering Research Board, grant # SR/SO/ AS - 17/2012 to JB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful to the Department of Environment and Forest, Govt of Assam particularly PCCF, Wildlife Mr. S. Chand, Council Head of the Department, Forest etc., BTC Mr. G.C. Basumatary, Director, Manas TR Mr. A. Sargiary and others for providing necessary permission and other logistic support. We specially thank Prof. S.M. Mohnot, Dr. Nabajit Das, Mr. Pankaj Milli, Mr. Dharmeswar Rabha, Mr. Sunil Basumatary and Mr. Ratneswar Mushahary for their constant encouragement and support in the field. We also indebted to all members of Primate Research Centre, NE India for their constant support and kind help during the survey and sample collection. This study was supported by DST (SERB project # SR/SO/ AS-17/2012) to Dr. Jihosuo Biswas	ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Badhan A, 2015, J MED PRIMATOL, V44, P125, DOI 10.1111/jmp.12163; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; Biswas J, 1956, THESIS; Biswas J, 2010, PRCNETECR14 CEPFATRE; Blancher A, 2008, J HERED, V99, P254, DOI 10.1093/jhered/esn003; Chaves PB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020722; Choudhury Anwaruddin, 2002, Zoos' Print Journal, V17, P699; Choudhury Anwaruddin, 2008, Primate Conservation, V23, P65, DOI 10.1896/052.023.0107; Chu JH, 2005, CONSERV GENET, V6, P101, DOI 10.1007/s10592-004-7749-2; Dixon JD, 2007, CONSERV GENET, V8, P455, DOI 10.1007/s10592-006-9184-z; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 1999, J WILDLIFE MANAGE, V61, P603; FRANKHAM R, 1995, CONSERV BIOL, V9, P792, DOI 10.1046/j.1523-1739.1995.09040792.x; Frantzen MAJ, 1998, MOL ECOL, V7, P1423, DOI 10.1046/j.1365-294x.1998.00449.x; Gee E. P., 1961, Journal of the Bombay Natural History Society, V58, P1; Ghosh S., 2009, REPORT DISTRIBUTION; Ghosh S, 2011, MANAGEMENT PLAN CH 1; Gibbs JP, 2001, ECOL APPL, V11, P79, DOI 10.1890/1051-0761(2001)011[0079:HFAACC]2.0.CO;2; Hagell S, 2013, ECOL EVOL, V3, P1388, DOI 10.1002/ece3.547; Horwich R.H., 2013, Primate Conservation, V27, P77, DOI 10.1896/052.027.0104; Karanth P., 2000, THESIS; Khajuria H., 1956, ANN MAGAZINE NATURAL, V9, P86, DOI DOI 10.1080/00222935608655728; Li M, 2007, AM J PRIMATOL, V69, P1195, DOI 10.1002/ajp.20425; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu Z, 2007, MOL ECOL, V16, P3334, DOI 10.1111/j.1365-294X.2007.03383.x; Liu ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061659; Medhi R, 2004, INT J PRIMATOL, V25, P1331, DOI 10.1023/B:IJOP.0000043965.38722.63; Menon Vivek, 1996, Journal of the Bombay Natural History Society, V93, P284; Meyer D, 2011, MOL PHYLOGENET EVOL, V59, P311, DOI 10.1016/j.ympev.2011.02.015; Modolo L, 2005, P NATL ACAD SCI USA, V102, P7392, DOI 10.1073/pnas.0502186102; Monda K, 2007, AM J PRIMATOL, V69, P1285, DOI 10.1002/ajp.20439; Mukherjee RP, 1980, P WILDL WORKSH, P129; Munshi-South J, 2011, J HERED, V102, P342, DOI 10.1093/jhered/esr013; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ram MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142597; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Shi FL, 2015, MITOCHONDR DNA, V26, P809, DOI 10.3109/19401736.2013.855904; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Smith DG, 2005, AM J PRIMATOL, V65, P1, DOI 10.1002/ajp.20094; Srivastava A, 2001, AM J PRIMATOL, V55, P15, DOI 10.1002/ajp.1035; Subba P.B., 1989, Tigerpaper (Bangkok), V16, P16; Verma SK, 2003, MOL ECOL NOTES, V3, P28, DOI 10.1046/j.1471-8286.2003.00340.x; Wang WR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129782; Wangchuk T., 2001, American Journal of Primatology, V54, P40; Wangchuk T, 1995, CENSUS BIOGEOGRAPHY; Wangchuk T, 2003, REPORT STATUS UNPUB; Wangchuk T, 2008, INT J PRIMATOL, V29, P565, DOI 10.1007/s10764-008-9258-5; Westemeier RL, 1998, SCIENCE, V282, P1695, DOI 10.1126/science.282.5394.1695; Xiao W, 2003, INT J PRIMATOL, V24, P389, DOI 10.1023/A:1023009518806; Yang MY, 2012, AM J PHYS ANTHROPOL, V147, P1, DOI 10.1002/ajpa.21618	55	9	10	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161866	10.1371/journal.pone.0161866	http://dx.doi.org/10.1371/journal.pone.0161866			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564405	gold, Green Submitted, Green Published			2022-12-26	WOS:000382496300026
J	Sun, XJ; Liu, ZH; Zhou, LQ; Wu, B; Dong, YH; Yang, AG				Sun, Xiujun; Liu, Zhihong; Zhou, Liqing; Wu, Biao; Dong, Yinghui; Yang, Aiguo			Integration of Next Generation Sequencing and EPR Analysis to Uncover Molecular Mechanism Underlying Shell Color Variation in Scallops	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; CHLAMYS-NOBILIS; MELANIN PIGMENT; TYROSINASE GENE; HAIR MELANINS; NOBLE SCALLOP; NITRIC-OXIDE; SKIN; MELANOGENESIS; LOCALIZATION	The Yesso scallop Patinopecten yessoensis displays polymorphism in shell colors, which is of great interest for the scallop industry. To identify genes involved in the shell coloration, in the present study, we investigate the transcriptome differences by Illumina digital gene expression (DGE) analysis in two extreme color phenotypes, Red and White. Illumina sequencing yields a total of 62,715,364 clean sequence reads, and more than 85% reads are mapped into our previously sequenced transcriptome. There are 25 significantly differentially expressed genes between Red and White scallops. EPR (Electron paramagnetic resonance) analysis has identified EPR spectra of pheomelanin and eumelanin in the red shells, but not in the white shells. Compared to the Red scallops, the White scallops have relatively higher mRNA expression in tyrosinase genes, but lower expression in other mela-nogensis-associated genes. Meantime, the relatively lower tyrosinase protein and decreased tyrosinase activity in White scallops are suggested to be associated with the lack of melanin in the white shells. Our findings highlight the functional roles of mela-nogensis-associated genes in the melanization process of scallop shells, and shed new lights on the transcriptional and post-transcriptional mechanisms in the regulation of tyrosinase activity during the process of melanin synthesis. The present results will assist our molecular understanding of melanin synthesis underlying shell color polymorphism in scallops, as well as other bivalves, and also help the color-based breeding in shellfish aquaculture.	[Sun, Xiujun; Liu, Zhihong; Zhou, Liqing; Wu, Biao; Yang, Aiguo] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China; [Dong, Yinghui] Zhejiang Wanli Univ, Zhejiang Prov Top Key Discipline Biol Engn, Ningbo 315100, Zhejiang, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Zhejiang Wanli University	Yang, AG (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China.	yangag@ysfri.ac.cn			Basic Scientific Research Fund of YSFRI [2060302201516054]; Zhejiang Provincial Top Key Discipline of Biological Engineering [KF2015005]	Basic Scientific Research Fund of YSFRI; Zhejiang Provincial Top Key Discipline of Biological Engineering	This work was supported by the grants from the Basic Scientific Research Fund of YSFRI (No. 2060302201516054), Zhejiang Provincial Top Key Discipline of Biological Engineering (KF2015005).; We would like to thank the two anonymous reviewers for their extensive and constructive comments on the manuscript. This work was supported by the grants from the Basic Scientific Research Fund of YSFRI (No. 2060302201516054), Zhejiang Provincial Top Key Discipline of Biological Engineering (KF2015005).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bai ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053617; Bergamonti L, 2013, EUR J MINERAL, V25, P845, DOI 10.1127/0935-1221/2013/0025-2318; Colihueque N, 2010, REV FISH BIOL FISHER, V20, P71, DOI 10.1007/s11160-009-9121-6; COMFORT A., 1950, PROC MALACOL SOC LONDON, V28, P79; COMFORT A, 1951, BIOL REV, V26, P285, DOI 10.1111/j.1469-185X.1951.tb01358.x; d'Ischia M, 2013, PIGM CELL MELANOMA R, V26, P616, DOI 10.1111/pcmr.12121; Decker H, 2007, GENE, V398, P183, DOI 10.1016/j.gene.2007.02.051; Del Bino S, 2015, PIGM CELL MELANOMA R, V28, P707, DOI 10.1111/pcmr.12410; ENOCHS WS, 1993, PIGM CELL RES, V6, P91, DOI 10.1111/j.1600-0749.1993.tb00587.x; Fox DL, 1942, BIOL BULL-US, V82, P284, DOI 10.2307/1538078; Ge JL, 2015, AQUACULTURE, V441, P21, DOI 10.1016/j.aquaculture.2015.01.031; Goncalves RCR, 2012, WORLD J MICROB BIOT, V28, P1467, DOI 10.1007/s11274-011-0948-3; GORDON J, 1980, MAR BIOL, V57, P251, DOI 10.1007/BF00387568; Hao SX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142439; Hedegaard C, 2006, J MOLLUS STUD, V72, P157, DOI 10.1093/mollus/eyi062; Hoogduijn MJ, 2006, PIGM CELL RES, V19, P58, DOI 10.1111/j.1600-0749.2005.00284.x; ITO S, 1989, PIGM CELL RES, V2, P53, DOI 10.1111/j.1600-0749.1989.tb00158.x; Ito S, 2011, PIGM CELL MELANOMA R, V24, P63, DOI 10.1111/j.1755-148X.2010.00755.x; Jiggins CD, 2001, NATURE, V411, P302, DOI 10.1038/35077075; Joubert C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-613; Kaelin CB, 2013, ANNU REV ANIM BIOSCI, V1, P125, DOI 10.1146/annurev-animal-031412-103659; KING RA, 1988, DERMATOL CLIN, V6, P217, DOI 10.1016/S0733-8635(18)30668-5; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Lemer S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1776-x; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Liu HL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1241-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maan ME, 2013, SEMIN CELL DEV BIOL, V24, P516, DOI 10.1016/j.semcdb.2013.05.003; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; McKinnon JS, 2010, MOL ECOL, V19, P5101, DOI 10.1111/j.1365-294X.2010.04846.x; Messenger JB, 2001, BIOL REV, V76, P473, DOI 10.1017/S1464793101005772; Miyashita T, 2011, J MOLLUS STUD, V77, P312, DOI 10.1093/mollus/eyr013; MULLER G, 1988, EMBO J, V7, P2723, DOI 10.1002/j.1460-2075.1988.tb03126.x; Nagai K, 2007, COMP BIOCHEM PHYS B, V146, P207, DOI 10.1016/j.cbpb.2006.10.105; Oetting WS, 2003, PIGM CELL RES, V16, P307, DOI 10.1034/j.1600-0749.2003.00045.x; Palumbo A, 1999, J NEUROCHEM, V73, P1254, DOI 10.1046/j.1471-4159.1999.0731254.x; Palumbo A, 2003, PIGM CELL RES, V16, P517, DOI 10.1034/j.1600-0749.2003.00080.x; Plonka PM, 2006, ACTA BIOCHIM POL, V53, P429, DOI 10.18388/abp.2006_3314; Prota G, 1995, Fortschr Chem Org Naturst, V64, P93; PROTA G, 1981, COMP BIOCHEM PHYS B, V68, P415, DOI 10.1016/0305-0491(81)90149-8; RomeroGraillet C, 1996, J BIOL CHEM, V271, P28052, DOI 10.1074/jbc.271.45.28052; Roulin A, 2013, SEMIN CELL DEV BIOL, V24, P594, DOI 10.1016/j.semcdb.2013.05.005; RUPPERT S, 1988, EMBO J, V7, P2715, DOI 10.1002/j.1460-2075.1988.tb03125.x; Selvakumar P, 2008, WORLD J MICROB BIOT, V24, P2125, DOI 10.1007/s11274-008-9718-2; Shibahara S, 2001, J INVEST DERM SYMP P, V6, P99, DOI 10.1046/j.0022-202x.2001.00010.x; Slominski A, 2005, ENDOCRINOLOGY, V146, P1245, DOI 10.1210/en.2004-0733; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2005, J INVEST DERMATOL, V124, P13, DOI 10.1111/j.0022-202X.2004.23528.x; Stemmer K, 2014, J MOLLUS STUD, V80, P365, DOI 10.1093/mollus/eyu033; Sun XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122967; Takahashi T, 2013, MOL ECOL, V22, P3049, DOI 10.1111/mec.12120; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; VSEVOLODOV EB, 1991, PIGM CELL RES, V4, P30, DOI 10.1111/j.1600-0749.1991.tb00310.x; Widlund HR, 2003, ONCOGENE, V22, P3035, DOI 10.1038/sj.onc.1206443; Wolnicka-Glubisz A, 2012, EXP DERMATOL, V21, P537, DOI 10.1111/j.1600-0625.2012.01511.x; Xu KF, 2008, AQUAC RES, V40, P35, DOI 10.1111/j.1365-2109.2008.02058.x; Yue X, 2015, MAR BIOTECHNOL, V17, P364, DOI 10.1007/s10126-015-9625-0; Zhang C, 2006, BIOCHEM BIOPH RES CO, V342, P632, DOI 10.1016/j.bbrc.2006.01.182; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zheng HP, 2013, AQUAC RES, V44, P1229, DOI 10.1111/j.1365-2109.2012.03124.x	62	15	16	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161876	10.1371/journal.pone.0161876	http://dx.doi.org/10.1371/journal.pone.0161876			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27563719	gold, Green Published, Green Submitted			2022-12-26	WOS:000382496300030
J	Batson, S; Sutton, A; Abrams, K				Batson, Sarah; Sutton, Alex; Abrams, Keith			Exploratory Network Meta Regression Analysis of Stroke Prevention in Atrial Fibrillation Fails to Identify Any Interactions with Treatment Effect	PLOS ONE			English	Article							FIXED MINIDOSE WARFARIN; K ORAL ANTICOAGULANTS; RELATIVE EFFICACY; VASCULAR EVENTS; METAANALYSIS; ASPIRIN; SAFETY; DABIGATRAN; THERAPY; TRIAL	Background Patients with atrial fibrillation are at a greater risk of stroke and therefore the main goal for treatment of patients with atrial fibrillation is to prevent stroke from occurring. There are a number of different stroke prevention treatments available to include warfarin and novel oral anticoagulants. Previous network meta-analyses of novel oral anticoagulants for stroke prevention in atrial fibrillation acknowledge the limitation of heterogeneity across the included trials but have not explored the impact of potentially important treatment modifying covariates. Objectives To explore potentially important treatment modifying covariates using network meta-regression analyses for stroke prevention in atrial fibrillation. Methods We performed a network meta-analysis for the outcome of ischaemic stroke and conducted an exploratory regression analysis considering potentially important treatment modifying covariates. These covariates included the proportion of patients with a previous stroke, proportion of males, mean age, the duration of study follow-up and the patients underlying risk of ischaemic stroke. Results None of the covariates explored impacted relative treatment effects relative to placebo. Notably, the exploration of 'study follow-up' as a covariate supported the assumption that difference in trial durations is unimportant in this indication despite the variation across trials in the network. Conclusion This study is limited by the quantity of data available. Further investigation is warranted, and, as justifying further trials may be difficult, it would be desirable to obtain individual patient level data (IPD) to facilitate an effort to relate treatment effects to IPD covariates in order to investigate heterogeneity. Observational data could also be examined to establish if there are potential trends elsewhere. The approach and methods presented have potentially wide applications within any indication as to highlight the potential benefit of extending decision problems to include additional comparators outside of those of primary interest to allow for the exploration of heterogeneity.	[Batson, Sarah] DRG Abacus, Talisman Business Ctr 6, Talisman Rd, Bicester OX26 6HR, Oxon, England; [Sutton, Alex; Abrams, Keith] Univ Leicester, Dept Hlth Sci, Ctr Med, Univ Rd, Leicester LE1 7RH, Leics, England	University of Leicester	Batson, S (corresponding author), DRG Abacus, Talisman Business Ctr 6, Talisman Rd, Bicester OX26 6HR, Oxon, England.	S.Batson@TeamDRG.com	Abrams, Keith/AAA-2557-2020	Sutton, Alexander/0000-0002-8934-9940	DRG Abacus	DRG Abacus	This study was funded by DRG Abacus. DRG Abacus provided support in the form of salary for author SB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690; Albers GW, 2003, LANCET, V362, P1691; Blackshear JL, 1996, LANCET, V348, P633; Bousser MG, 2008, LANCET, V371, P315, DOI 10.1016/S0140-6736(08)60168-3; Cameron C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004301; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; CONNOLLY SJ, 1991, J AM COLL CARDIOL, V18, P349, DOI 10.1016/0735-1097(91)90585-W; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cooper NJ, 2006, ARCH INTERN MED, V166, P1269, DOI 10.1001/archinte.166.12.1269; Cope S, 2015, VALUE HEALTH, V18, P234, DOI 10.1016/j.jval.2014.10.012; Dequen P, 2014, VALUE HEALTH, V17, P416, DOI 10.1016/j.jval.2014.02.013; Dias S, 2011, 2 NICE DSU; Dias S, 2011, 3 NICE DSU; EZEKOWITZ MD, 1992, NEW ENGL J MED, V327, P1406, DOI 10.1056/NEJM199211123272002; Fu WB, 2014, J CARDIOVASC MED, V15, P873, DOI 10.2459/JCM.0000000000000206; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Gullov AL, 1998, ARCH INTERN MED, V158, P1513, DOI 10.1001/archinte.158.14.1513; Gullov AL, 1999, ARCH INTERN MED, V159, P1322, DOI 10.1001/archinte.159.12.1322; Hellemons BSP, 1999, BMJ-BRIT MED J, V319, P958, DOI 10.1136/bmj.319.7215.958; Hylek EM, 2007, CIRCULATION, V115, P2689, DOI 10.1161/CIRCULATIONAHA.106.653048; Hylek Elaine M, 2003, Semin Vasc Med, V3, P271; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; KISTLER JP, 1990, NEW ENGL J MED, V323, P1505; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; Lip GYH, 2016, INT J CARDIOL, V204, P88, DOI 10.1016/j.ijcard.2015.11.084; Lunn D, 2013, BUGS BOOK PRACRICAL; Manning WJ, 2015, ATRIAL FIBRILLATION; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; MCBRIDE R, 1994, LANCET, V343, P687; MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527; Messori A, 2015, INT J CLIN PHARM TH, V53, P211, DOI 10.5414/CP202183; Morocutti C, 1997, STROKE, V28, P1015, DOI 10.1161/01.STR.28.5.1015; Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pengo V, 1998, AM J CARDIOL, V82, P433, DOI 10.1016/S0002-9149(98)00357-9; Perez-Gomez F, 2004, J AM COLL CARDIOL, V44, P1557, DOI 10.1016/j.jacc.2004.05.084; PETERSEN P, 1989, LANCET, V1, P175; Rash A, 2007, AGE AGEING, V36, P151, DOI 10.1093/ageing/afl129; Roskell NS, 2010, THROMB HAEMOSTASIS, V104, P1106, DOI 10.1160/TH10-10-0642; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Thompson SG, 1997, STAT MED, V16, P2741, DOI 10.1002/(SICI)1097-0258(19971215)16:23<2741::AID-SIM703>3.0.CO;2-0; Verdecchia P, 2015, EXPERT OPIN DRUG SAF, V14, P7, DOI 10.1517/14740338.2014.971009; Welton NJ., 2012, EVIDENCE SYNTHESIS D; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	47	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161864	10.1371/journal.pone.0161864	http://dx.doi.org/10.1371/journal.pone.0161864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560191	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258600109
J	Goyal, A; Murray, JM				Goyal, Ashish; Murray, John M.			Modelling the Impact of Cell-To-Cell Transmission in Hepatitis B Virus	PLOS ONE			English	Article							HEPATOCYTE TURNOVER; VIRAL CONTROL; HALF-LIFE; INFECTION; DYNAMICS; SPREAD; TRANSIENT; DNA; PATHOGENESIS; REPLICATION	Cell-free virus is a well-recognized and efficient mechanism for the spread of hepatitis B virus (HBV) infection in the liver. Cell-to-cell transmission (CCT) can be a more efficient means of virus propagation. Despite experimental evidence implying CCT occurs in HBV, its relative impact is uncertain. We develop a 3-D agent-based model where each hepatocyte changes its viral state according to a dynamical process driven by cell-free virus infection, CCT and intracellular replication. We determine the relative importance of CCT in the development and resolution of acute HBV infection in the presence of cytolytic (CTL) and non-CTL mechanisms. T cell clearance number is defined as the minimum number of infected cells needed to be killed by each T cell at peak infection that results in infection clearance within 12 weeks with hepatocyte turnover (HT, number of equivalent livers) <= 3. We find that CCT has very little impact on the establishment of infection as the mean cccDNA copies/cell remains between 15 to 20 at the peak of the infection regardless of CCT strength. In contrast, CCT inhibit immune-mediated clearance of acute HBV infection as higher CCT strength requires higher T cell clearance number and increases the probability of T cell exhaustion. An effective non-CTL inhibition can counter these negative effects of higher strengths of CCT by supporting rapid, efficient viral clearance and with little liver destruction. This is evident as the T cell clearance number drops by approximately 50% when non-CTL inhibition is increased from 10% to 80%. Higher CCT strength also increases the probability of the incidence of fulminant hepatitis with this phenomenon being unlikely to arise for no CCT. In conclusion, we report the possibility of CCT impacting HBV clearance and its contribution to fulminant hepatitis.	[Goyal, Ashish; Murray, John M.] UNSW, Sch Math & Stat, Sydney, NSW, Australia	University of New South Wales Sydney	Goyal, A (corresponding author), UNSW, Sch Math & Stat, Sydney, NSW, Australia.	ashish.goyal@student.unsw.edu.au	Goyal, Ashish/AAE-9948-2022; Murray, John/B-5481-2009; Goyal, Ashish/H-3586-2019; Goyal, Ashish/AFF-7955-2022	Murray, John/0000-0001-9314-2283; Goyal, Ashish/0000-0003-1582-3379; 				Asabe S, 2009, J VIROL, V83, P9652, DOI 10.1128/JVI.00867-09; Bertoletti A, 2006, J GEN VIROL, V87, P1439, DOI 10.1099/vir.0.81920-0; Bertoletti A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003784; Bhat P, 2011, J VIROL, V85, P12474, DOI 10.1128/JVI.05344-11; Bukong TN, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004424; Chisari FV, 2000, AM J PATHOL, V156, P1117, DOI 10.1016/S0002-9440(10)64980-2; Chong CL, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-96; Ciupe SM, 2007, J THEOR BIOL, V247, P23, DOI 10.1016/j.jtbi.2007.02.017; Ciupe SM, 2007, P NATL ACAD SCI USA, V104, P5050, DOI 10.1073/pnas.0603626104; Ciupe SM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003730; Ciupe SM, 2011, MATH POPUL STUD, V18, P87, DOI 10.1080/08898480.2011.564563; Dandri M, 2008, HEPATOLOGY, V48, P1079, DOI 10.1002/hep.22469; Elaiw AM, 2013, DISCRETE DYN NAT SOC, V2013, DOI 10.1155/2013/712829; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Funk A, 2004, J VIROL, V78, P8289, DOI 10.1128/jvi.78.15.8289-8300.2004; Funk A, 2004, J VIROL, V78, P3977, DOI 10.1128/JVI.78.8.3977-3983.2004; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Graw F, 2015, J VIROL, V89, P6551, DOI 10.1128/JVI.00016-15; Graw F, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003934; Graw F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002436; Guidotti LG, 2015, CURR OPIN IMMUNOL, V36, P61, DOI 10.1016/j.coi.2015.06.016; Horras CJ, 2011, CYTOKINE GROWTH F R, V22, P35, DOI 10.1016/j.cytogfr.2011.01.001; Li JH, 2013, NAT IMMUNOL, V14, P793, DOI 10.1038/ni.2647; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Mason WS, 2007, J VIRAL HEPATITIS, V14, P22, DOI 10.1111/j.1365-2893.2007.00911.x; Mason WS, 2009, J VIROL, V83, P1778, DOI 10.1128/JVI.01587-08; Meckes DG, 2011, J VIROL, V85, P12844, DOI 10.1128/JVI.05853-11; Mothes W, 2010, J VIROL, V84, P8360, DOI 10.1128/JVI.00443-10; Murray JM, 2005, P NATL ACAD SCI USA, V102, P17780, DOI 10.1073/pnas.0508913102; Murray JM, 2006, HEPATOLOGY, V44, P1117, DOI 10.1002/hep.21364; Murray JM, 2015, J THEOR BIOL, V366, P91, DOI 10.1016/j.jtbi.2014.11.020; Nuti S, 1998, EUR J IMMUNOL, V28, P3448, DOI 10.1002/(SICI)1521-4141(199811)28:11<3448::AID-IMMU3448>3.0.CO;2-5; Phillips S, 2010, J IMMUNOL, V184, P287, DOI 10.4049/jimmunol.0902761; Rehermann B, 2000, J EXP MED, V191, P1263, DOI 10.1084/jem.191.8.1263; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; SUMMERS J, 1990, J VIROL, V64, P2819, DOI 10.1128/JVI.64.6.2819-2824.1990; Summers J, 2003, P NATL ACAD SCI USA, V100, P11652, DOI 10.1073/pnas.1635109100; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; TUTTLEMAN JS, 1986, J VIROL, V58, P17, DOI 10.1128/JVI.58.1.17-25.1986; Webster GJM, 2002, IMMUNOL CELL BIOL, V80, P101, DOI 10.1046/j.1440-1711.2002.01060.x; Whalley SA, 2001, J EXP MED, V193, P847, DOI 10.1084/jem.193.7.847; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Wolint P, 2004, J EXP MED, V199, P925, DOI 10.1084/jem.20031799; Xiao F, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004128; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Ye B, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.42; Yousfi N, 2011, J MATH BIOL, V63, P933, DOI 10.1007/s00285-010-0397-x; Zhang YZ, 2003, P NATL ACAD SCI USA, V100, P12372, DOI 10.1073/pnas.2033898100; Zhong P, 2013, CURR OPIN VIROL, V3, P44, DOI 10.1016/j.coviro.2012.11.004	51	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161978	10.1371/journal.pone.0161978	http://dx.doi.org/10.1371/journal.pone.0161978			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560827	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258600123
J	Anderson, EC; Barrett, LF				Anderson, Eric C.; Barrett, Lisa Feldman			Affective Beliefs Influence the Experience of Eating Meat	PLOS ONE			English	Article							VEGETABLE CONSUMPTION; METAANALYSIS; PREFERENCES; VEGETARIAN; FRUIT; TASTE; DIET; RISK; FOOD; MIND	People believe they experience the world objectively, but research continually demonstrates that beliefs influence perception. Emerging research indicates that beliefs influence the experience of eating. In three studies, we test whether beliefs about how animals are raised can influence the experience of eating meat. Samples of meat were paired with descriptions of animals raised on factory farms or raised on humane farms. Importantly, the meat samples in both conditions were identical. However, participants experienced the samples differently: meat paired with factory farm descriptions looked, smelled, and tasted less pleasant. Even basic properties of flavor were influenced: factory farmed samples tasted more salty and greasy. Finally, actual behavior was influenced: participants consumed less when samples were paired with factory farm descriptions. These findings demonstrate that the experience of eating is not determined solely by physical properties of stimuli-beliefs also shape experience.	[Anderson, Eric C.] Tufts Univ, Ctr Appl Brain & Cognit Sci, Medford, MA 02155 USA; [Barrett, Lisa Feldman] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA; [Barrett, Lisa Feldman] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Barrett, Lisa Feldman] Harvard Med Sch, Boston, MA USA	Tufts University; Northeastern University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Anderson, EC (corresponding author), Tufts Univ, Ctr Appl Brain & Cognit Sci, Medford, MA 02155 USA.	ericmranderson@gmail.com	Barrett, Lisa Feldman/ABC-8157-2020	Barrett, Lisa/0000-0003-4478-2051				Anderson E, 2012, EMOTION, V12, P1210, DOI 10.1037/a0027514; Anderson E, 2011, SCIENCE, V332, P1446, DOI 10.1126/science.1201574; BARNARD ND, 1995, PREV MED, V24, P646, DOI 10.1006/pmed.1995.1100; Barrett LF, 2009, ADV EXP SOC PSYCHOL, V41, P167, DOI 10.1016/S0065-2601(08)00404-8; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Bastian B, 2012, PERS SOC PSYCHOL B, V38, P247, DOI 10.1177/0146167211424291; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Bratanova B, 2015, APPETITE, V91, P137, DOI 10.1016/j.appet.2015.04.006; Cardello AV, 2007, WOODHEAD PUBL FOOD S, P223, DOI 10.1533/9781845693381.2.223; Dauchet L, 2006, J NUTR, V136, P2588, DOI 10.1093/jn/136.10.2588; Enax L, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00247; Grabenhorst F, 2008, CEREB CORTEX, V18, P1549, DOI 10.1093/cercor/bhm185; Graham J, 2011, J PERS SOC PSYCHOL, V101, P366, DOI 10.1037/a0021847; He FJ, 2006, LANCET, V367, P320, DOI 10.1016/S0140-6736(06)68069-0; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; HIRSCHMAN EC, 1982, J MARKETING, V46, P92, DOI 10.2307/1251707; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kalva JJ, 2014, J FOOD SCI, V79, pS238, DOI [10.1111/1750-3841.1, 10.1111/1750-3841.12342]; Lang PJ, 2008, A6 IAPS; Lea E, 2003, PUBLIC HEALTH NUTR, V6, P505, DOI 10.1079/PHN2002452; Lee L, 2006, PSYCHOL SCI, V17, P1054, DOI 10.1111/j.1467-9280.2006.01829.x; Lee WCJ, 2013, FOOD QUAL PREFER, V29, P33, DOI 10.1016/j.foodqual.2013.01.010; Loughnan S., 2016, PERSONAL SOC PSYCHOL; Loughnan S, 2010, APPETITE, V55, P156, DOI 10.1016/j.appet.2010.05.043; Lowe MR, 2007, PHYSIOL BEHAV, V91, P432, DOI 10.1016/j.physbeh.2007.04.006; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287; Piqueras-Fiszman B, 2015, FOOD QUAL PREFER, V40, P165, DOI 10.1016/j.foodqual.2014.09.013; Plassmann H, 2008, P NATL ACAD SCI USA, V105, P1050, DOI 10.1073/pnas.0706929105; Pollan Michael, 2006, OMNIVORES DILEMMA; Robinson J., 2004, PASTURE PERFECT FAR; Rozin P, 1997, PSYCHOL SCI, V8, P67, DOI 10.1111/j.1467-9280.1997.tb00685.x; Ruby MB, 2012, APPETITE, V58, P141, DOI 10.1016/j.appet.2011.09.019; SINGER P, 1975, ANIMAL LIBERATION NE; Sorqvist P, 2015, FOOD QUAL PREFER; Sorqvist P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080719; Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585; Van Dam YK, 2015, J CONSUM POLICY, V38, P19, DOI 10.1007/s10603-014-9274-0; Wundt W., 1998, OUTLINE PSYCHOL; Yeomans MR, 2008, FOOD QUAL PREFER, V19, P565, DOI 10.1016/j.foodqual.2008.02.009; Zaki J, 2012, NAT NEUROSCI, V15, P675, DOI 10.1038/nn.3085	41	38	39	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0160424	10.1371/journal.pone.0160424	http://dx.doi.org/10.1371/journal.pone.0160424			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU5NI	27556643	gold, Green Published, Green Submitted			2022-12-26	WOS:000382258100014
J	Schacht, R; Kramer, KL				Schacht, Ryan; Kramer, Karen L.			Patterns of Family Formation in Response to Sex Ratio Variation	PLOS ONE			English	Article							CHINA; RATES; EVOLUTION; BEHAVIOR; GENDER; CRIME; WOMEN; MEN; POPULATIONS; INFECTION	The impact that unbalanced sex ratios have on health and societal outcomes is of mounting contemporary concern. However, it is increasingly unclear whether it is male-or femalebiased sex ratios that are associated with family and social instability. From a socio-demographic perspective, male-biased sex ratios leave many men unable to find a mate, elevating competition among males, disrupting family formation and negatively affecting social stability. In contrast, from a mating-market perspective, males are expected to be less willing to marry and commit to a family when the sex ratio is female-biased and males are rare. Here we use U.S. data to evaluate predictions from these competing frameworks by testing the relationship between the adult sex ratio and measures of family formation. We find that when women are rare men are more likely to marry, be part of a family and be sexually committed to a single partner. Our results do not support claims that male-biased sex ratios lead to negative family outcomes due to a surplus of unmarried men. Rather, our results highlight the need to pay increased attention to female-biased sex ratios.	[Schacht, Ryan; Kramer, Karen L.] Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Schacht, R (corresponding author), Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA.	r.schacht@utah.edu	Schacht, Ryan/S-5311-2019; Kramer, Karen L/AAM-3022-2020	Schacht, Ryan/0000-0002-4606-7345				ACOCK AC, 1989, SOC FORCES, V68, P553, DOI 10.2307/2579260; Adimora AA, 2013, ANN EPIDEMIOL, V23, P716, DOI 10.1016/j.annepidem.2013.08.002; Angrist J, 2002, Q J ECON, V117, P997, DOI 10.1162/003355302760193940; Bates D, 2012, LME4 LINEAR MIXED EF; Becker Gary Stanley, 1991, TREATISE FAMILY; Beltran S, 2010, TRENDS PARASITOL, V26, P63, DOI 10.1016/j.pt.2009.11.003; Brooks R, 2012, EVOL PSYCHOL-US, V10, P910, DOI 10.1177/147470491201000512; Burnham K. P., 2002, MODEL SELECTION AND; BYRNE RW, 1987, INT J PRIMATOL, V8, P615, DOI 10.1007/BF02735780; CARROLL SP, 1990, J INSECT BEHAV, V3, P33, DOI 10.1007/BF01049193; CARROLL SP, 1995, BEHAV ECOL, V6, P46, DOI 10.1093/beheco/6.1.46; Cox OC, 1940, AM SOCIOL REV, V5, P937, DOI 10.2307/2084528; D'Alessio SJ, 2010, J CRIM JUST, V38, P555, DOI 10.1016/j.jcrimjus.2010.04.026; Daly M., 1988, HOMICIDE; Das Gupta M, 2009, POPUL DEV REV, V35, P401; Dreze J, 2000, POPUL DEV REV, V26, P335, DOI 10.1111/j.1728-4457.2000.00335.x; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Greenhalgh S, 2013, POPUL DEV REV, V38, P130, DOI 10.1111/j.1728-4457.2013.00556.x; Guo Z., 2011, CHINESE J POPULATION, V25, P2; Guttentag M., 1983, TOO MANY WOMEN; Hesketh T, 2005, AIDS CARE, V17, P958, DOI 10.1080/09540120500100676; Hesketh T, 2006, P NATL ACAD SCI USA, V103, P13271, DOI 10.1073/pnas.0602203103; Hesketh T, 2012, EMBO REP, V13, P487, DOI 10.1038/embor.2012.62; Hudson Valerie M., 2004, BARE BRANCHES SECURI; Hudson VM, 2002, INT SECURITY, V26, P5, DOI 10.1162/016228802753696753; JAMES WH, 1987, HUM BIOL, V59, P721; Johnson RC, 2009, J LAW ECON, V52, P251, DOI 10.1086/597102; Jones J, 2013, MARITAL STATUS DESIR; Kokko H, 2008, J EVOLUTION BIOL, V21, P919, DOI 10.1111/j.1420-9101.2008.01540.x; Liker A, 2014, CURR BIOL, V24, P880, DOI 10.1016/j.cub.2014.02.059; Liker A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2600; Mathews LM, 2002, BEHAV ECOL SOCIOBIOL, V51, P426, DOI 10.1007/s00265-002-0465-3; Mayer P, 2008, IS N INDIA VIOLENT I; Mayr E, 1939, AM NAT, V73, P156, DOI 10.1086/280824; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; MESSNER SF, 1991, SOC FORCES, V69, P693, DOI 10.2307/2579470; Miller SL, 2012, EVOL HUM BEHAV, V33, P57, DOI 10.1016/j.evolhumbehav.2011.05.006; OLDENBURG P, 1992, ECON POLIT WEEKLY, V27, P2657; OTTERBEIN KF, 1965, AM ANTHROPOL, V67, P66, DOI 10.1525/aa.1965.67.1.02a00050; Pedersen F A, 1991, Hum Nat, V2, P271, DOI 10.1007/BF02692189; Pollet TV, 2014, HUM NATURE-INT BIOS, V25, P410, DOI 10.1007/s12110-014-9206-3; Poston DL, 2011, VULNERABLE CHILD YOU, V6, P314, DOI 10.1080/17450128.2011.630428; Pouget ER, 2010, PUBLIC HEALTH REP, V125, P70, DOI 10.1177/00333549101250S411; R Development Core Team, 2008, LANG ENV STAT COMP; Sampson RJ, 2006, CRIMINOLOGY, V44, P465, DOI 10.1111/j.1745-9125.2006.00055.x; Schacht R, HUMAN NATUR IN PRESS; Schacht R, NATURE SCI IN PRESS; Schacht R, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140402; Schacht R, 2014, TRENDS ECOL EVOL, V29, P214, DOI 10.1016/j.tree.2014.02.001; Schwartz SK, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0113; Shi R, 2002, POPULATION RES, V26, P57; SMUTS B, 1995, HUM NATURE-INT BIOS, V6, P1, DOI 10.1007/BF02734133; South SJ, 2014, DEMOGRAPHY, V51, P1019, DOI 10.1007/s13524-014-0289-6; South SJ, 2010, J HEALTH SOC BEHAV, V51, P376, DOI 10.1177/0022146510386789; Symons D, 1979, EVOLUTION HUMAN SEXU; Thomson RL, 2014, BEHAV ECOL SOCIOBIOL, V68, P1261, DOI 10.1007/s00265-014-1737-4; Titterington VB, 2006, SOCIOL SPECTRUM, V26, P205, DOI 10.1080/02732170500463429; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; U.S. Census Bureau, 2013, POV 2009 2010; Uggla C, 2016, BEHAV ECOL, V27, P158, DOI 10.1093/beheco/arv133; Uggla Caroline, 2015, Evolution Medicine and Public Health, P266, DOI 10.1093/emph/eov020; United Nations, 2013, TRENDS INT MIGR STOC; Wei SJ, 2011, J POLIT ECON, V119, P511, DOI 10.1086/660887; Zhou XD, 2011, SOC SCI MED, V73, P1422, DOI 10.1016/j.socscimed.2011.07.033	64	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0160320	10.1371/journal.pone.0160320	http://dx.doi.org/10.1371/journal.pone.0160320			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU5NI	27556401	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258100012
J	Dysthe, JC; Carim, KJ; Paroz, YM; McKelvey, KS; Young, MK; Schwartz, MK				Dysthe, Joseph C.; Carim, Kellie J.; Paroz, Yvette M.; McKelvey, Kevin S.; Young, Michael K.; Schwartz, Michael K.			Quantitative PCR Assays for Detecting Loach Minnow (Rhinichthys cobitis) and Spikedace (Meda fulgida) in the Southwestern United States	PLOS ONE			English	Article							ENVIRONMENTAL DNA; TIAROGA-COBITIS	Loach minnow (Rhinichthys cobitis) and spikedace (Meda fulgida) are legally protected with the status of Endangered under the U.S. Endangered Species Act and are endemic to the Gila River basin of Arizona and New Mexico. Efficient and sensitive methods for monitoring these species' distributions are critical for prioritizing conservation efforts. We developed quantitative PCR assays for detecting loach minnow and spikedace DNA in environmental samples. Each assay reliably detected low concentrations of target DNA without detection of non-target species, including other cyprinid fishes with which they co-occur.	[Dysthe, Joseph C.; Carim, Kellie J.; McKelvey, Kevin S.; Young, Michael K.; Schwartz, Michael K.] Forest Serv, USDA, Natl Genom Ctr Wildlife & Fish Conservat, Rocky Mt Res Stn, Missoula, MT 59807 USA; [Paroz, Yvette M.] Forest Serv, USDA, Albuquerque, NM USA	United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Dysthe, JC (corresponding author), Forest Serv, USDA, Natl Genom Ctr Wildlife & Fish Conservat, Rocky Mt Res Stn, Missoula, MT 59807 USA.	jdysthe@fs.fed.us		Dysthe, Joseph/0000-0002-6790-7841	USDA Forest Service Southwestern Region; USDA Forest Service Region 1	USDA Forest Service Southwestern Region; USDA Forest Service Region 1	This work was completed through funding issued to Yvette M Paroz by the USDA Forest Service Southwestern Region with in-kind support from the USDA Forest Service Region 1. As the authors of this study, the funders did have a role in all aspects of the study and manuscript preparation.	BARBER WE, 1970, COPEIA, P9; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carim KJ, 2016, CONSERV GENET RESOUR; Carim KJ, 2015, PROTOCOL COLLECTING; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Marsh PC, 2003, SOUTHWEST NAT, V48, P666, DOI 10.1894/0038-4909(2003)048<0666:NARPOL>2.0.CO;2; McKelvey KS, 2016, J FISH BIOL, V88, P1215, DOI 10.1111/jfb.12863; Paroz YM, 2007, DISTRIBUTION SPIKEDA; PROPST DL, 1991, COPEIA, P29; Propst DL, 1988, 17 US FISH WILDL SER; R Core Development Team, 2013, R LANG ENV STAT COMP; Sigsgaard EE, 2015, BIOL CONSERV, V183, P46, DOI 10.1016/j.biocon.2014.11.023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; USFWS, 1986, FED REGISTER, V51, P39468; USFWS, 2012, FED REGISTER, V77, P10810; USFWS, 1986, FED REGISTER, V51, P23769; USFWS, 1990, SPIK REC PLAN; USFWS (United States Fish and Wildlife Service), 1990, LOACH MINN REC PLAN; Wilcox TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142008; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Wright ES, 2014, ENVIRON MICROBIOL, V16, P1354, DOI 10.1111/1462-2920.12259	21	2	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162200	10.1371/journal.pone.0162200	http://dx.doi.org/10.1371/journal.pone.0162200			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583576	Green Submitted, Green Published, gold			2022-12-26	WOS:000382855600119
J	Oldham, M; Yoon, P; Fathi, Z; Beyer, WF; Adamson, J; Liu, LH; Alcorta, D; Xia, WL; Osada, T; Liu, CX; Yang, XY; Dodd, RD; Herndon, JE; Meng, BY; Kirsch, DG; Lyerly, HK; Dewhirst, MW; Fecci, P; Walder, H; Spector, NL				Oldham, Mark; Yoon, Paul; Fathi, Zak; Beyer, Wayne F.; Adamson, Justus; Liu, Leihua; Alcorta, David; Xia, Wenle; Osada, Takuya; Liu, Congxiao; Yang, Xiao Y.; Dodd, Rebecca D.; Herndon, James E., II; Meng, Boyu; Kirsch, David G.; Lyerly, H. Kim; Dewhirst, Mark W.; Fecci, Peter; Walder, Harold; Spector, Neil L.			X-Ray Psoralen Activated Cancer Therapy (X-PACT)	PLOS ONE			English	Article							T-CELL LYMPHOMA; TERM-FOLLOW-UP; EXTRACORPOREAL PHOTOCHEMOTHERAPY; PUVA; TRANSIMMUNIZATION; APOPTOSIS; PSORIASIS; PHOTOBIOLOGY; MONOCYTE	This work investigates X-PACT (X-ray Psoralen Activated Cancer Therapy): a new approach for the treatment of solid cancer. X-PACT utilizes psoralen, a potent anti-cancer therapeutic with current application to proliferative disease and extracorporeal photopheresis (ECP) of cutaneous T Cell Lymphoma. An immunogenic role for light-activated psoralen has been reported, contributing to long-term clinical responses. Psoralen therapies have to-date been limited to superficial or extracorporeal scenarios due to the requirement for psoralen activation by UVA light, which has limited penetration in tissue. X-PACT solves this challenge by activating psoralen with UV light emitted from novel non-tethered phosphors (co-incubated with psoralen) that absorb x-rays and re-radiate (phosphoresce) at UV wavelengths. The efficacy of X-PACT was evaluated in both in-vitro and in-vivo settings. In-vitro studies utilized breast (4T1), glioma (CT2A) and sarcoma (KP-B) cell lines. Cells were exposed to X-PACT treatments where the concentrations of drug (psoralen and phosphor) and radiation parameters (energy, dose, and dose rate) were varied. Efficacy was evaluated primarily using flow cell cytometry in combination with complimentary assays, and the in-vivo mouse study. In an in-vitro study, we show that X-PACT induces significant tumor cell apoptosis and cytotoxicity, unlike psoralen or phosphor alone (p<0.0001). We also show that apoptosis increases as doses of phosphor, psoralen, or radiation increase. Finally, in an in-vivo pilot study of BALBc mice with syngeneic 4T1 tumors, we show that the rate of tumor growth is slower with X-PACT than with saline or AMT + X-ray (p<0.0001). Overall these studies demonstrate a potential therapeutic effect for X-PACT, and provide a foundation and rationale for future studies. In summary, X-PACT represents a novel treatment approach in which well-tolerated low doses of x-ray radiation are delivered to a specific tumor site to generate UVA light which in-turn unleashes both short- and potentially long-term antitumor activity of photo-active therapeutics like psoralen.	[Oldham, Mark; Yoon, Paul; Adamson, Justus; Dodd, Rebecca D.; Meng, Boyu; Kirsch, David G.; Dewhirst, Mark W.; Walder, Harold] Duke Univ, Dept Radiat Oncol, Med Ctr, Durham, NC USA; [Fathi, Zak] Immunolight LLC, Detroit, MI USA; [Beyer, Wayne F.] QNS Grp LLC, Bahama, NC USA; [Liu, Leihua; Alcorta, David; Xia, Wenle; Spector, Neil L.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Osada, Takuya; Liu, Congxiao; Yang, Xiao Y.; Lyerly, H. Kim] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Herndon, James E., II] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC USA; [Fecci, Peter] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University	Oldham, M (corresponding author), Duke Univ, Dept Radiat Oncol, Med Ctr, Durham, NC USA.	Mark.Oldham@Duke.edu	Lyerly, Herbert Kim/AAX-4925-2020; Lyerly, Herbert K/B-6528-2014; Adamson, Justus/AAM-5335-2021; Dewhirst, Mark/Q-1302-2019	Lyerly, Herbert Kim/0000-0002-0063-4770; Lyerly, Herbert K/0000-0002-0063-4770; Dewhirst, Mark/0000-0003-3459-6546; Fecci, Peter/0000-0002-2912-8695; Yoon, Suk Whan "Paul"/0000-0002-0313-8131; Adamson, Justus/0000-0002-7868-5631; Dodd, Rebecca/0000-0001-7295-1882	Duke University, Immunolight LLC [P50 CA190991]; Duke SPORE in Brain Cancer [P50 CA190991]; NATIONAL CANCER INSTITUTE [P50CA190991] Funding Source: NIH RePORTER	Duke University, Immunolight LLC; Duke SPORE in Brain Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	MO received Brainspore funding from Duke University P50 CA190991, Immunolight LLC funding was provided to MO MD NS and KL. Immunolight personnel (HW ZF WB) provided the energy converters and psoralen.; Funding support was received from P50 CA190991-Duke SPORE in Brain Cancer. We are very grateful to Dr Kathleen Ashcraft and Dr Kelly Lee for discussions and technical assistance arising from related work to that presented here.	Berger CL, 2002, TRANSFUS APHER SCI, V26, P205, DOI 10.1016/S1473-0502(02)00014-9; Bethea D, 1999, J DERMATOL SCI, V19, P78, DOI 10.1016/S0923-1811(98)00064-4; Bourke FA, 2014, US Patent Number, Patent No. [US20140323946 A1, 20140323946]; Bourke FA, 2014, US Patent Number, Patent No. [US20140272030 A1, 20140272030]; EDELSON R, 1987, NEW ENGL J MED, V316, P297, DOI 10.1056/NEJM198702053160603; Edelson RL, 2014, TRANSFUS APHER SCI, V50, P322, DOI 10.1016/j.transci.2013.07.031; El-Domyati M, 2013, PHOTODERMATOL PHOTO, V29, P18, DOI 10.1111/phpp.12012; Gasparro F P, 1997, Recent Results Cancer Res, V143, P101; Girardi M, 2003, HEMATOL ONCOL CLIN N, V17, P1391, DOI 10.1016/S0889-8588(03)00106-0; Girardi M, 2002, TRANSFUS APHER SCI, V26, P181, DOI 10.1016/S1473-0502(02)00011-3; Girardi M, 2006, LEUKEMIA LYMPHOMA, V47, P1495, DOI 10.1080/10428190600581419; Gonzalez AL, 2014, CLIN EXP IMMUNOL, V175, P449, DOI 10.1111/cei.12231; HERRMANN JJ, 1995, J AM ACAD DERMATOL, V33, P234, DOI 10.1016/0190-9622(95)90241-4; Holtick U, 2012, TRANSPLANTATION, V94, pE31, DOI 10.1097/TP.0b013e31825f4454; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Knobler R, 2012, PHOTODERMATOL PHOTO, V28, P250, DOI 10.1111/j.1600-0781.2012.00689.x; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Maves RC, 2011, VACCINE, V29, P2691, DOI 10.1016/j.vaccine.2011.01.077; Morse MA, 2010, INT J CANCER, V126, P2893, DOI 10.1002/ijc.24995; Panno ML, 2014, WORLD J CLIN ONCOL, V5, P348, DOI 10.5306/wjco.v5.i3.348; Sachdeva M, 2014, J CLIN INVEST, V124, P4305, DOI 10.1172/JCI77116; Scaffidi JP, 2011, ACS NANO, V5, P4679, DOI 10.1021/nn200511m; SCHMITT IM, 1995, J PHOTOCH PHOTOBIO B, V27, P101, DOI 10.1016/1011-1344(94)07101-S; Shenoi SD, 2014, INDIAN J DERMATOL VE, V80, P497, DOI 10.4103/0378-6323.144143; Steinmetz KA, 1996, J AM DIET ASSOC, V96, P1027, DOI 10.1016/S0002-8223(96)00273-8; THORNES RD, 1994, J CANCER RES CLIN, V120, pS32, DOI 10.1007/BF01377122; Valbuena MC, 2007, PHOTODERMATOL PHOTO, V23, P126, DOI 10.1111/j.1600-0781.2007.00294.x; Wang Y, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nen087; Xia WL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088983	29	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162078	10.1371/journal.pone.0162078	http://dx.doi.org/10.1371/journal.pone.0162078			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583569	Green Published, gold			2022-12-26	WOS:000382855600099
J	Tilgner, J; von Trotha, KT; Gombert, A; Jacobs, MJ; Drechsler, M; Doring, Y; Soehnlein, O; Grommes, J				Tilgner, Jessica; von Trotha, Klaus Thilo; Gombert, Alexander; Jacobs, Michael J.; Drechsler, Maik; Doering, Yvonne; Soehnlein, Oliver; Grommes, Jochen			Aspirin, but Not Tirofiban Displays Protective Effects in Endotoxin Induced Lung Injury	PLOS ONE			English	Article							NEUTROPHILS	Background Treatment of acute lung injury (ALI) remains an unsolved problem in intensive care medicine. Recruitment of neutrophils into the lungs, regarded as a key mechanism in progression of ALI, depends on signaling between neutrophils and platelets. Consequently we explored the effect of platelet-targeted aspirin and tirofiban treatment in endotoxin induced acute lung injury Methods C57Bl/6 mice were exposed to aerosolized LPS (500 mu g/ml) for 30min and treated with Aspirin (100 mu g/g bodyweight via intraperitoneal injection, 30 min before or 1 hour after LPS inhalation) or Tirofiban (0.5 mu g/g bodyweight via tail vein injection 30 min before or 1 hour after LPS inhalation). The count of alveolar, interstitial, and intravascular neutrophils was assessed 4h later by flow cytometry. Lung permeability changes were assessed by FITC-dextran clearance and protein content in the BAL fluid. Results Aspirin both before and after LPS inhalation reduced neutrophil influx into the lung and lung permeability indicating the protective role of Aspirin in ALI. Tirofiban, however, did not alter neutrophil recruitment after LPS inhalation. Release of platelet-derived chemokines CCL5 and PF4 and neutrophil extracellular traps was reduced by Aspirin but not by Tirofiban. Conclusion Aspirin, but not Tirofiban reduces neutrophil recruitment and displays protective effects during endotoxin induced lung injury.	[Tilgner, Jessica; von Trotha, Klaus Thilo; Gombert, Alexander; Jacobs, Michael J.; Grommes, Jochen] Rhenish Westphalian Tech Univ Aachen, European Vasc Ctr Aachen Maastricht, Aachen, Germany; [Jacobs, Michael J.] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Drechsler, Maik; Doering, Yvonne; Soehnlein, Oliver; Grommes, Jochen] Univ Munich, Inst Cardiovasc Prevent, Munich, Germany; [Soehnlein, Oliver] Univ Amsterdam, Dept Pathol, Amsterdam, Netherlands; [Drechsler, Maik; Doering, Yvonne; Soehnlein, Oliver] German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany	Maastricht University; RWTH Aachen University; Maastricht University; University of Munich; University of Amsterdam; German Centre for Cardiovascular Research; Munich Heart Alliance	Grommes, J (corresponding author), Rhenish Westphalian Tech Univ Aachen, European Vasc Ctr Aachen Maastricht, Aachen, Germany.; Grommes, J (corresponding author), Univ Munich, Inst Cardiovasc Prevent, Munich, Germany.	jgrommes@ukaachen.de	Doring, Yvonne/E-1796-2013; Drechsler, Maik/C-3829-2008; Döring, Yvonne/E-9414-2017; Döring, Yvonne/AAA-3018-2022	Döring, Yvonne/0000-0001-9307-3396; Grommes, Jochen/0000-0002-6419-6802	Else-Kroner-Fresenius Stiftung; B. Braun Foundation	Else-Kroner-Fresenius Stiftung; B. Braun Foundation	This study was supported by the Else-Kroner-Fresenius Stiftung and the B. Braun Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to acknowledge Patricia Lemnitzer, Carmen Schaller and Zohreh Packsereshtmogharab for excellent technical assistance. This study was supported by the Else-Kroner-Fresenius Stiftung and the B. Braun Foundation.	Bdeir K, 2010, AM J RESP CRIT CARE, V181, P935, DOI 10.1164/rccm.200907-1128OC; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; DOERSCHUK CM, 1987, J APPL PHYSIOL, V63, P1806, DOI 10.1152/jappl.1987.63.5.1806; Doerschuk CM, 2001, MICROCIRCULATION, V8, P71, DOI 10.1038/sj.mn.7300151; Doerschuk CM, 2000, AM J RESP CELL MOL, V23, P133, DOI 10.1165/ajrcmb.23.2.f193; Folkesson HG, 1997, J APPL PHYSIOL, V82, P1743, DOI 10.1152/jappl.1997.82.6.1743; Gautam N, 2001, NAT MED, V7, P1123, DOI 10.1038/nm1001-1123; Grommes J, 2014, J INNATE IMMUN, V6, P111, DOI 10.1159/000353229; Grommes J, 2012, EUR RESPIR J, V40, P416, DOI 10.1183/09031936.00091011; Grommes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038917; Grommes J, 2012, AM J RESP CRIT CARE, V185, P628, DOI 10.1164/rccm.201108-1533OC; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Looney MR, 2006, J CLIN INVEST, V116, P1615, DOI 10.1172/JCI27238; Looney MR, 2009, J CLIN INVEST, V119, P3450, DOI 10.1172/JCI38432; Massberg S, 2010, NAT MED; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Ortiz-Munoz G, 2014, BLOOD, V124, P2625, DOI 10.1182/blood-2014-03-562876; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rossaint J, 2015, CARDIOVASC RES; Rossaint J, 2014, BLOOD, V123, P2573, DOI 10.1182/blood-2013-07-516484; Soehnlein O, 2008, EUR RESPIR J, V32, P405, DOI 10.1183/09031936.00173207; von Hundelshausen P, 2007, THROMB HAEMOSTASIS, V97, P704, DOI 10.1160/TH07-01-0066; Von Hundelshausen P, 2009, MICROCIRCULATION, V16, P84, DOI 10.1080/10739680802564787; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wildhagen KCAA, 2014, BLOOD, V123, P1098, DOI 10.1182/blood-2013-07-514984; Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499	30	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161218	10.1371/journal.pone.0161218	http://dx.doi.org/10.1371/journal.pone.0161218			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583400	Green Submitted, Green Published, gold			2022-12-26	WOS:000382855600015
J	Gao, YS; Wang, B; Gao, SG				Gao, Yushun; Wang, Bing; Gao, Shugeng			BRD7 Acts as a Tumor Suppressor Gene in Lung Adenocarcinoma	PLOS ONE			English	Article							PROGNOSTIC CLASSIFIER; EXPRESSION; BROMODOMAIN; COMBINATION; RELEVANCE; CARCINOMA; MICRORNA; TARGET	Lung cancer is one of the most malignant tumors and the leading cause of cancer-related deaths worldwide. Among lung cancers, 40% are diagnosed as adenocarcinoma. Bromodomain containing 7 (BRD7) is a member of bromodomain-containing protein family. It was proved to be downregulated in various cancers. However, the role of BRD7 in lung adenocarcinoma is still unknown. Western blot and qRT-PCR was performed to measure the BRD7 expression in lung adenocarcinoma tissues and cells. CCK8 and migration assay was done to detect the functional role of BRD7 in lung adenocarcinoma. In this study, we showed that the expression of BRD7 was downregulated in lung adenocarcinoma tissues and cells. The lower of BRD7 levels in patients with lung adenocarcinoma was associated with shortened disease-free survival. Furthermore, overexpression of BRD7 inhibited lung adenocarcinoma cell proliferation and migration. Inhibition of BRD7 expression promoted cell proliferation and migration by activating ERK phosphorylation. Overexpression of BRD7 inhibited cyclin D and myc expression. Our findings are consistent with a tumor suppressor role for BRD7 in lung adenocarcinoma tumorigenesis.	[Gao, Yushun; Wang, Bing; Gao, Shugeng] Chinese Acad Med Sci, Peking Union Med Coll, Canc Inst Hosp, Dept Thorac Surg Oncol, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College	Gao, SG (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Canc Inst Hosp, Dept Thorac Surg Oncol, Beijing 100021, Peoples R China.	yushun1gao@163.com						Akagi I, 2013, CANCER RES, V73, P3821, DOI 10.1158/0008-5472.CAN-13-0031; Chiu YH, 2014, MOL CELL, V54, P193, DOI 10.1016/j.molcel.2014.02.016; Drost J, 2010, NAT CELL BIOL, V12, P380, DOI 10.1038/ncb2038; Feng J, 2014, ONCOTARGET, V5, P9689, DOI 10.18632/oncotarget.2103; Ge XJ, 2015, MOL MED REP, V11, P333, DOI 10.3892/mmr.2014.2757; Ho CS, 2014, LUNG CANCER, V83, P154, DOI 10.1016/j.lungcan.2013.11.024; Hu KS, 2014, ONCOTARGET, V5, P3088, DOI 10.18632/oncotarget.1816; Kaeser MD, 2008, J BIOL CHEM, V283, P32254, DOI 10.1074/jbc.M806061200; Kikuchi M, 2009, BBA-MOL CELL RES, V1793, P1828, DOI 10.1016/j.bbamcr.2009.11.001; Li D, 2015, INT J CLIN EXP PATHO, V8, P14693; Liu HY, 2008, J HISTOCHEM CYTOCHEM, V56, P531, DOI 10.1369/jhc.7A7340.2007; Liu HY, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-111; Liu HY, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-253; Maquilan G, 2018, AM J CLIN ONCOL-CANC, V41, P391, DOI 10.1097/COC.0000000000000288; Pal S, 2016, CANCER MICROENVIRON, V9, P77, DOI 10.1007/s12307-016-0184-3; Park SW, 2014, CELL METAB, V20, P73, DOI 10.1016/j.cmet.2014.04.006; Park YA, 2014, CLIN CANCER RES, V20, P565, DOI 10.1158/1078-0432.CCR-13-1271; Park YA, 2012, GYNECOL ONCOL, V124, P125, DOI 10.1016/j.ygyno.2011.09.026; Pern F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047993; Robles AI, 2015, J THORAC ONCOL, V10, P1037, DOI 10.1097/JTO.0000000000000560; Schliekelman MJ, 2015, CANCER RES, V75, P1789, DOI 10.1158/0008-5472.CAN-14-2535; Song XY, 2016, DRUG DES DEV THER, V10, P1345, DOI 10.2147/DDDT.S96766; Sun HB, 2007, BIOCHEM BIOPH RES CO, V358, P435, DOI 10.1016/j.bbrc.2007.04.139; Sun Y, 2015, ONCOTARGET; Tejero R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101899; Van de Vijver P, 2012, CHEM COMMUN, V48, P9403, DOI 10.1039/c2cc34956f; Wu WJ, 2013, EUR J CLIN INVEST, V43, P131, DOI 10.1111/eci.12024; Xu P, 2015, INT J CLIN EXP PATHO, V8, P15887; Yan GZ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0203-5; Yang WB, 2014, ONCOTARGET, V5, P740, DOI 10.18632/oncotarget.1608; Yarchoan M, 2015, CUREUS, V7, DOI 10.7759/cureus.409; Zhang ZY, 2015, ONCOTARGET, V6, P1462, DOI 10.18632/oncotarget.2808; Zhou J, 2004, J CELL PHYSIOL, V200, P89, DOI 10.1002/jcp.20013	33	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0156701	10.1371/journal.pone.0156701	http://dx.doi.org/10.1371/journal.pone.0156701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580131	Green Submitted, gold, Green Published			2022-12-26	WOS:000382877400001
J	Kuehne, A; Tiffany, A; Lasry, E; Janssens, M; Besse, C; Okonta, C; Larbi, K; Pah, AC; Danis, K; Porten, K				Kuehne, Anna; Tiffany, Amanda; Lasry, Estrella; Janssens, Michel; Besse, Clement; Okonta, Chibuzo; Larbi, Kwabena; Pah, Alfred C.; Danis, Kostas; Porten, Klaudia			Impact and Lessons Learned from Mass Drug Administrations of Malaria Chemoprevention during the Ebola Outbreak in Monrovia, Liberia, 2014	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; FIXED-DOSE COMBINATIONS; ARTESUNATE-AMODIAQUINE; NIMBA COUNTY; OPEN-LABEL; TRIAL	Background In October 2014, during the Ebola outbreak in Liberia healthcare services were limited while malaria transmission continued. Medecins Sans Frontieres (MSF) implemented a mass drug administration (MDA) of malaria chemoprevention (CP) in Monrovia to reduce malaria-associated morbidity. In order to inform future interventions, we described the scale of the MDA, evaluated its acceptance and estimated the effectiveness. Methods MSF carried out two rounds of MDA with artesunate/amodiaquine (ASAQ) targeting four neighbourhoods of Monrovia (October to December 2014). We systematically selected households in the distribution area and administered standardized questionnaires. We calculated incidence ratios (IR) of side effects using poisson regression and compared self-reported fever risk differences (RD) pre- and post-MDA using a z-test. Findings In total, 1,259,699 courses of ASAQ-CP were distributed. All households surveyed (n = 222; 1233 household members) attended the MDA in round 1 (r1) and 96% in round 2 (r2) (212/222 households; 1,154 household members). 52% (643/1233) initiated ASAQ-CP in r1 and 22% (256/1154) in r2. Of those not initiating ASAQ-CP, 29% (172/590) saved it for later in r1, 47% (423/898) in r2. Experiencing side effects in r1 was not associated with ASAQ-CP initiation in r2 (IR 1.0, 95% CI 0.49-2.1). The incidence of self-reported fever decreased from 4.2% (52/1229) in the month prior to r1 to 1.5% (18/1229) after r1 (p<0.001) and decrease was larger among household members completing ASAQ-CP (RD = 4.9%) compared to those not initiating ASAQ-CP (RD = 0.6%) in r1 (p<0.001). Conclusions The reduction in self-reported fever cases following the intervention suggests that MDAs may be effective in reducing cases of fever during Ebola outbreaks. Despite high coverage, initiation of ASAQ-CP was low. Combining MDAs with longer term interventions to prevent malaria and to improve access to healthcare may reduce both the incidence of malaria and the proportion of respondents saving their treatment for future malaria episodes.	[Kuehne, Anna] Robert Koch Inst, Postgrad Training Appl Epidemiol, Berlin, Germany; [Kuehne, Anna; Danis, Kostas] ECDC, European Programme Intervent Epidemiol Training E, Stockholm, Sweden; [Kuehne, Anna; Porten, Klaudia] Epictr, Paris, France; [Tiffany, Amanda] Epictr, Geneva, Switzerland; [Lasry, Estrella] Med Sans Frontieres, Operat Ctr Paris, Trop Med, New York, NY USA; [Janssens, Michel; Besse, Clement] Med Sans Frontieres, Operat Ctr Paris, Monrovia Project, Monrovia, Liberia; [Okonta, Chibuzo] Med Sans Frontieres, Operat Ctr Paris, Desk Urgence, Paris, France; [Larbi, Kwabena; Pah, Alfred C.] Minist Hlth, Liberian Natl Malaria Control Programme, Monrovia, Liberia; [Danis, Kostas] Inst Veille Sanitaire, Paris, France	Robert Koch Institute; European Centre for Disease Prevention & Control; Doctors Without Borders; Institute of Public Health Surveillance	Kuehne, A (corresponding author), Robert Koch Inst, Postgrad Training Appl Epidemiol, Berlin, Germany.; Kuehne, A (corresponding author), ECDC, European Programme Intervent Epidemiol Training E, Stockholm, Sweden.; Kuehne, A (corresponding author), Epictr, Paris, France.; Tiffany, A (corresponding author), Epictr, Geneva, Switzerland.	KuehneAn@rki.de; Amanda.Tiffany@geneva.msf.org	Danis, Kostas/ABD-7357-2020; Kuehne, Anna/AAD-7816-2022	Kuehne, Anna/0000-0002-8578-0362	Medecins sans Frontieres	Medecins sans Frontieres	Epicentre (AT, KP) received core funding from Medecins sans Frontieres to conduct this research.	Alba S, 2011, INT J EPIDEMIOL, V40, P405, DOI 10.1093/ije/dyq240; [Anonymous], 2015, 2014 ANN REP; [Anonymous], 2010, NAT MAL STRAT PLAN 2; Kuehne A, 2015, TROP MED INT HEALTH, V20, P43; Ministry of Health and Social Welfare (MOHSW) [Liberia], 2014, LIB EB DAIL SITR 202; National Malaria Control Program (NMCP) [Liberia] Ministry of Health and Social Welfare (MOHSW) Liberia Institute of Statistics and Geo-information Services (LISGIS) and ICF International, 2012, LIB MAL IND SURV 201; Newby G, 2015, AM J TROP MED HYG, V93, P125, DOI 10.4269/ajtmh.14-0254; Poirot E, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008846.pub2; Schramm B, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-250; Schramm B, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-251; Song JP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-57; von Seidlein L, 2003, T ROY SOC TROP MED H, V97, P217, DOI 10.1016/S0035-9203(03)90125-8; von Seidlein L, 2003, TRENDS PARASITOL, V19, P452, DOI 10.1016/j.pt.2003.08.003; von Seidlein L, 2015, EXPERT REV ANTI-INFE, V13, P715, DOI 10.1586/14787210.2015.1031744; Walker PGT, 2015, LANCET INFECT DIS, V15, P825, DOI 10.1016/S1473-3099(15)70124-6; WHO, 2015, EB SIT REP; World Health Organisation (WHO), 2015, GUID TEMP MAL CONTR	17	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161311	10.1371/journal.pone.0161311	http://dx.doi.org/10.1371/journal.pone.0161311			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580098	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877400023
J	Farnworth, MJ; Chen, RN; Packer, RMA; Caney, SMA; Gunn-Moore, DA				Farnworth, Mark J.; Chen, Ruoning; Packer, Rowena M. A.; Caney, Sarah M. A.; Gunn-Moore, Danielle A.			Flat Feline Faces: Is Brachycephaly Associated with Respiratory Abnormalities in the Domestic Cat (Felis catus)?	PLOS ONE			English	Article							AIRWAY SYNDROME; DISORDERS; BREED; DOGS	There has been little research into brachycephalism and associated disorders in cats. A questionnaire aimed at cat owners was used to determine the relationship between feline facial conformation and owner-reported cat management requirements and respiratory abnormalities. Owner-submitted photographs of cats were used to develop novel measures of skull conformation. One thousand valid questionnaires were received. Within these there were 373 valid photographs that allowed measurement of muzzle ratio (M%) and 494 that allowed nose position ratio (NP%). The data included 239 cats for which both measurements were available. Owners reported lifestyle factors (e.g. feeding type, grooming routine, activity level), physical characteristics (e.g. hair length) and other health characteristics of their cat (e.g. tear staining, body condition score). A composite respiratory score (RS) was calculated for each cat using their owner's assessment of respiratory noise whilst their cat was asleep and then breathing difficulty following activity. Multivariate analyses were carried out using linear models to explore the relationship between RS and facial conformation, and lifestyle risk factors. The results showed that reductions in NP% and M% were significantly associated with RS (P < 0.001 and P = 0.026, respectively) and that the relationship was significantly negatively correlated (r = -0.56, P < 0.001 for both). Respiratory score was also significantly associated with increased presence of tear staining (P < 0.001) and a sedentary lifestyle (P = 0.01). This study improves current knowledge concerning cats with breeding-related alterations in skull confirmation and indicates that brachycephalism may have negative respiratory implications for cat health and welfare, as has been previously shown in dogs.	[Farnworth, Mark J.] Univ Plymouth, Sch Biol Sci, Plymouth PL4 8AA, Devon, England; [Chen, Ruoning; Gunn-Moore, Danielle A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Chen, Ruoning; Gunn-Moore, Danielle A.] Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland; [Packer, Rowena M. A.] Royal Vet Coll, Dept Clin Sci & Serv, Hatfield, Herts, England; [Caney, Sarah M. A.] Vet Profess Ltd, Midlothian Innovat Ctr, Roslin, Midlothian, Scotland	University of Plymouth; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of London; University of London Royal Veterinary College	Gunn-Moore, DA (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland.; Gunn-Moore, DA (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland.	Danielle.Gunn-Moore@ed.ac.uk		Gunn-Moore, Danielle/0000-0003-2088-503X; Packer, Rowena/0000-0002-9988-9828; Farnworth, Mark/0000-0001-6226-0818	Vet Professionals Limited	Vet Professionals Limited	This research received funding in kind from Vet Professionals Limited. The funder provided support in the form of a salary for author SMAC and assisted with data collection via the funder website. The funder did not have any additional role in the study design, analyses, decision to publish, or preparation of the manuscript. Author DAG also provides ad hoc consultancy services via the funder. The specific roles of these authors are articulated in the 'author contributions' section. Other than above, no additional conflicts of interest arise from this work.	Bateson P., 2010, INDEPENDENT INQUIRY; Blocker T, 2001, VET OPHTHALMOL, V4, P127, DOI 10.1046/j.1463-5224.2001.00189.x; Breit S, 2003, ANAT HISTOL EMBRYOL, V32, P224, DOI 10.1046/j.1439-0264.2003.00464.x; Corgozinho KB, 2012, J FELINE MED SURG, V14, P417, DOI 10.1177/1098612X12442024; Emmerson T, 2014, J SMALL ANIM PRACT, V55, P543, DOI 10.1111/jsap.12286; Ginn JA, 2008, J AM ANIM HOSP ASSOC, V44, P243, DOI 10.5326/0440243; Gunn-Moore D, 2008, J SMALL ANIM PRACT, V49, P167, DOI 10.1111/j.1748-5827.2008.00572.x; Hale F, 2013, CAN VET J, V54, P185; Hammond G, 2011, J FELINE MED SURG, V13, P881, DOI 10.1016/j.jfms.2011.05.015; LEONARD H C, 1957, J Am Vet Med Assoc, V131, P83; Liu NC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130741; Malik R, 2009, J FELINE MED SURG, V11, P889, DOI 10.1016/j.jfms.2009.09.009; Meola SD, 2013, TOP COMPANION ANIM M, V28, P91, DOI 10.1053/j.tcam.2013.06.004; O'Neill Dan G, 2015, Canine Genet Epidemiol, V2, P10, DOI 10.1186/s40575-015-0023-8; Packer RMA, 2012, ANIM WELFARE, V21, P81, DOI 10.7120/096272812X13345905673809; Packer RMA, 2015, VET MED-RES REP, V6, P219, DOI 10.2147/VMRR.S60475; Packer RMA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137496; Packer RMA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123827; Pratschke K., 2014, Companion Animal, V19, P70, DOI 10.12968/coan.2014.19.2.70; PURINA, 1997, BOD COND TOOL; Ribas GC, 2001, J NEUROSURG, V95, P1057, DOI 10.3171/jns.2001.95.6.1057; Roedler FS, 2013, VET J, V198, P606, DOI 10.1016/j.tvjl.2013.09.009; Rooney N., 2009, PEDIGREE DOG BREEDIN; Schlueter C, 2009, J FELINE MED SURG, V11, P891, DOI 10.1016/j.jfms.2009.09.010; Schuenemann R, 2014, J AM ANIM HOSP ASSOC, V50, P149, DOI 10.5326/JAAHA-MS-5991; Scott DW, 1995, MULLER KIRKS SMALL A, P679; Wilkerson R., 2014, 5 MOST DEMAND CAT BR	27	28	28	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161777	10.1371/journal.pone.0161777	http://dx.doi.org/10.1371/journal.pone.0161777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27574987	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000382877200035
J	Xu, C; Fan, YN; Kan, HD; Chen, RJ; Liu, JH; Li, YF; Zhang, Y; Ji, AL; Cai, TJ				Xu, Chen; Fan, Yan-Ni; Kan, Hai-Dong; Chen, Ren-Jie; Liu, Jiang Hong; Li, Ya-Fei; Zhang, Yao; Ji, Ai-Ling; Cai, Tong-Jian			The Novel Relationship between Urban Air Pollution and Epilepsy: A Time Series Study	PLOS ONE			English	Article							SO2 INHALATION; OXIDATIVE STRESS; OZONE EXPOSURE; HOSPITALIZATION; HIPPOCAMPUS; ISCHEMIA; THERAPY; SYSTEM; HEALTH; IMPACT	Background and purpose The data concerning the association between environmental pollution and epilepsy attacks are limited. The aim of this study was to explore the association between acute air pollution exposure and epilepsy attack. Methods A hospital record-based study was carried out in Xi'an, a heavily-polluted metropolis in China. Daily baseline data were obtained. Time-series Poisson regression models were applied to analyze the association between air pollution and epilepsy. Results A 10 mu g/m(3) increase of NO2, SO2, and O-3 concentrations corresponded to 3.17% (95%Cl: 1.41%, 4.93%), 3.55% (95% Cl: 1.93%, 5.18%), and -0.84% (95% Cl: -1.58%, 0.09%) increase in outpatient-visits for epilepsy on the concurrent days, which were significantly influenced by sex and age. The effects of NO2 and SO2 would be stronger when adjusted for PM2.5. As for O-3, a -1.14% (95%Cl: -1.90%, -0.39%) decrease was evidenced when adjusted for NO2. The lag models showed that the most significant effects were evidenced on concurrent days. Conclusions We discovered previously undocumented relationships between short-term air pollution exposure and epilepsy: while NO2 and SO2 were positively associated with outpatient-visits of epilepsy, O-3 might be associated with reduced risk.	[Xu, Chen; Li, Ya-Fei; Cai, Tong-Jian] Third Mil Med Univ, Coll Prevent Med, Dept Epidemiol, Chongqing, Peoples R China; [Fan, Yan-Ni] Fourth Mil Med Univ, Affiliated Hosp 2, Informat Dept Med Record Room, Xian, Peoples R China; [Kan, Hai-Dong; Chen, Ren-Jie] Fudan Univ, Sch Publ Hlth, Dept Environm Hlth, Shanghai, Peoples R China; [Liu, Jiang Hong] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [Ji, Ai-Ling] Fourth Mil Med Univ, Sch Publ Hlth, Xian, Peoples R China	Army Medical University; Air Force Military Medical University; Fudan University; University of Pennsylvania; Air Force Military Medical University	Cai, TJ (corresponding author), Third Mil Med Univ, Coll Prevent Med, Dept Epidemiol, Chongqing, Peoples R China.; Ji, AL (corresponding author), Fourth Mil Med Univ, Sch Publ Hlth, Xian, Peoples R China.	jailing2008@hotmail.com; ctjcsl@netease.com	Kan, Haidong/AGU-0328-2022; Cai, Tong-Jian/AAX-6338-2021	Cai, Tong-Jian/0000-0003-3188-6265				Ajamieh H, 2002, PHARMACOL RES, V45, P333, DOI 10.1006/phrs.2002.0952; Berg Anne T., 2003, Epilepsy Curr, V3, P129, DOI 10.1046/j.1535-7597.2003.03408.x; Bocci VA, 2006, ARCH MED RES, V37, P425, DOI 10.1016/j.arcmed.2005.08.006; Cai J, 2014, ENVIRON POLLUT, V191, P139, DOI 10.1016/j.envpol.2014.04.028; Cakmak S, 2010, ENVIRON INT, V36, P501, DOI 10.1016/j.envint.2010.03.008; Calderon-Garciduenas L, 2015, ENVIRON RES, V137, P157, DOI 10.1016/j.envres.2014.12.012; Cao JJ, 2012, ENVIRON HEALTH PERSP, V120, P373, DOI 10.1289/ehp.1103671; Martinez-Lazcano JC, 2013, REV NEUROSCIENCE, V24, P337, DOI 10.1515/revneuro-2012-0084; Chen BH, 2011, J AIR WASTE MANAGE, V61, P1292, DOI 10.1080/10473289.2011.604288; Clavo B, 2011, FORSCH KOMPLEMENTMED, V18, P283, DOI 10.1159/000333795; Clavo B, 2004, EVID-BASED COMPL ALT, V1, P315, DOI 10.1093/ecam/neh039; Coppola L, 2010, INT J GERIATR PSYCH, V25, P206, DOI 10.1002/gps.2322; Diffey B, 2004, PHYS MED BIOL, V49, pR1, DOI 10.1088/0031-9155/49/1/R01; FARAHANI H, 1990, PHARMACOL TOXICOL, V66, P146, DOI 10.1111/j.1600-0773.1990.tb00722.x; FARAHANI H, 1992, J ENVIRON SCI HEAL B, V27, P53, DOI 10.1080/03601239209372767; Freire C, 2010, J EPIDEMIOL COMMUN H, V64, P223, DOI 10.1136/jech.2008.084574; Goodarzi Parisa, 2014, Acta Med Iran, V52, P651; Kan HD, 2009, ENVIRON HEALTH PERSP, V117, pA187, DOI 10.1289/ehp.12737; Leon OS, 1998, MEDIAT INFLAMM, V7, P289, DOI 10.1080/09629359890983; Lu F, 2015, SCI TOTAL ENVIRON, V536, P123, DOI 10.1016/j.scitotenv.2015.07.048; Mallok A, 2015, NEUROL RES, V37, P204, DOI 10.1179/1743132814Y.0000000445; Migliore L, 2009, MUTAT RES-GEN TOX EN, V674, P73, DOI 10.1016/j.mrgentox.2008.09.013; MORGENSTERN H, 1995, ANNU REV PUBL HEALTH, V16, P61, DOI 10.1146/annurev.pu.16.050195.000425; Ngugi AK, 2010, EPILEPSIA, V51, P883, DOI 10.1111/j.1528-1167.2009.02481.x; Rivas-Arancibia S, 2010, TOXICOL SCI, V113, P187, DOI 10.1093/toxsci/kfp252; Sancak EB, 2016, INFLAMMATION, V39, P209, DOI 10.1007/s10753-015-0240-z; Sang N, 2009, ECOTOX ENVIRON SAFE, V72, P879, DOI 10.1016/j.ecoenv.2008.07.007; Shah ASV, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/bmj.i4851, 10.1136/bmj.h1295]; Swiader MJ, 2014, PHARMACOL REP, V66, P335, DOI 10.1016/j.pharep.2013.10.005; Szyszkowicz M, 2009, INT J OCCUP MED ENV, V22, P7, DOI 10.2478/v10001-009-0006-7; Xu Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153099; Yao GY, 2015, ENVIRON RES, V137, P85, DOI 10.1016/j.envres.2014.11.012; Ye XF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151119; Yu L, 2014, AM J EMERG MED, V32, DOI 10.1016/j.ajem.2014.01.039; Yun Y, 2013, CHEMOSPHERE, V93, P2426, DOI 10.1016/j.chemosphere.2013.08.063	35	24	24	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161992	10.1371/journal.pone.0161992	http://dx.doi.org/10.1371/journal.pone.0161992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571507	gold, Green Submitted, Green Published			2022-12-26	WOS:000382876700049
J	Zhao, WT; Pang, Q; Xu, RX; Liu, JW; Liu, SF; Li, J; Su, XZ				Zhao, Wenting; Pang, Qin; Xu, Ruixue; Liu, Jianwen; Liu, Shengfa; Li, Jian; Su, Xin-zhuan			Monitoring the Prevalence of Leucocytozoon sabrazesi in Southern China and Testing Tricyclic Compounds against Gametocytes	PLOS ONE			English	Article							AVIAN BLOOD PARASITES; PCR-BASED DETECTION; PLASMODIUM; SIMONDI; OWLS; HAEMOPROTEUS; PRIMAQUINE; HEMATOZOA; INFECTION; THERAPY	Leucocytozoon parasites infect many species of avian hosts, including domestic chicken, and can inflict heavy economic loss on the poultry industry. Two major species of Leucocytozoon parasites have been reported in China, L. sabrazesi and L. caulleryi, although L. sabrazesi appears to be more widespread than L. caulleryi in southern China. The traditional method for detecting Leucocytozoon infection is microscopic examination of blood smears for the presence of mature gametocytes in circulation, which may miss infections with low parasitemia (gametocytemia) or immature gametocytes. Here we developed a PCR-based method to monitor L. sabrazesi infections at seven sites in four provinces of China after testing two PCR primer pairs based on parasite mitochondrial cytochrome b (cytb) and cytochrome c oxidase III (coxIII) genes. We compared the results of PCR detection with those of microscopic observation. As expected, the PCR assays were more sensitive than microscope examination in detecting L. sabrazesi infection and were able to detect parasite DNA after gametocytes disappeared in the blood stream. Using these methods, we investigated monthly dynamics of L. sabrazesi in chickens from a free-range farm in Xiamen, Fujian province of China, over one year. Our results showed that chickens were infected with L. sabrazesi year-round in southern China. Finally, we tested several compounds for potential treatment of Leucocytozoon infections, including primaquine, ketotifen, clomipramine hydrochloride, desipramine hydrochloride, sulfaquinoxaline, and pyrimethamine. Only primaquine had activity against L. sabrazesi gametocytes. Our results provide important information for controlling parasite transmission in southern China and disease management.	[Zhao, Wenting; Pang, Qin; Xu, Ruixue; Liu, Jianwen; Liu, Shengfa; Li, Jian; Su, Xin-zhuan] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen 361005, Fujian, Peoples R China; [Su, Xin-zhuan] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA	Xiamen University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Li, J; Su, XZ (corresponding author), Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen 361005, Fujian, Peoples R China.; Su, XZ (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA.	jianli_204@xmu.edu.cn; xsu@niaid.nih.gov		Su, Xinzhuan/0000-0003-3246-3248	National Natural Science Foundation of China [81220108019, 81271858, 81572017]; Fundamental Research Funds for the Central Universities [20720160057]; Project 111 of the State Bureau of Foreign Experts and Ministry of Education of China [B06016]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000892] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Project 111 of the State Bureau of Foreign Experts and Ministry of Education of China; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Natural Science Foundation of China #81220108019, #81271858, and #81572017, by Fundamental Research Funds for the Central Universities (20720160057), by Project 111 of the State Bureau of Foreign Experts and Ministry of Education of China (B06016), and by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argilla LS, 2013, PARASITOLOGY, V140, P672, DOI 10.1017/S0031182012002089; Ashley EA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-418; ATKINSON CT, 1988, J PARASITOL, V74, P228, DOI 10.2307/3282448; Baird JK, 2005, NEW ENGL J MED, V352, P1565, DOI 10.1056/NEJMra043207; Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663; Bunbury N, 2007, PARASITOLOGY, V134, P797, DOI 10.1017/S0031182006002149; Chen X, 1995, CHINA ANI HLTH INSPE, V12, P8; Dezfoulian O, 2013, IRAN J PARASITOL, V8, P171; Eastman RT, 2013, ANTIMICROB AGENTS CH, V57, P425, DOI 10.1128/AAC.00920-12; FALLIS A. MURRAY, 1948, CANADIAN JOUR RES SECT D ZOOL SCI, V26, P73; Ferraguti M, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-208; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; HERMAN C M, 1975, Journal of Wildlife Diseases, V11, P404; HONG L, 1990, Acta Zoologica Sinica, V36, P123; Huff CG, 1942, J INFECT DIS, V71, P18, DOI 10.1093/infdis/71.1.18; Hunter DB, 1997, J WILDLIFE DIS, V33, P486, DOI 10.7589/0090-3558-33.3.486; Imura T, 2012, VET PARASITOL, V183, P244, DOI 10.1016/j.vetpar.2011.07.027; Ishak HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002304; KOHNE HJ, 1975, POULTRY SCI, V54, P472, DOI 10.3382/ps.0540472; Kumnuan R, 2013, VET PARASITOL, V197, P447, DOI 10.1016/j.vetpar.2013.07.024; [李国清 Li Guoqing], 2003, [中国预防兽医学报, Chinase Journal of Preventive Veterinary Medicine], V25, P148; Liu W, 1995, CHIN J VET SCI TECHN, V25, P40; MALEY GJM, 1977, CAN J ZOOL, V55, P355, DOI 10.1139/z77-048; Merino S, 2000, P ROY SOC B-BIOL SCI, V267, P2507, DOI 10.1098/rspb.2000.1312; MORII T, 1992, J PROTOZOOL RES, V2, P128; Ortego J, 2009, PARASITOL RES, V104, P467, DOI 10.1007/s00436-008-1207-x; Peirce MA, 2005, VET REC, V157, DOI 10.1136/vr.157.25.819-a; Ramey AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045789; Sato Y, 2009, PARASITOL RES, V104, P251, DOI 10.1007/s00436-008-1183-1; Shutler D, 1999, CAN J ZOOL, V77, P1573, DOI 10.1139/cjz-77-10-1573; STEELE EJ, 1993, J EUKARYOT MICROBIOL, V40, P384, DOI 10.1111/j.1550-7408.1993.tb04932.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TANABE A, 1985, FOLIA PHARMACOL JPN, V86, P175, DOI 10.1254/fpj.86.175; TANABE A, 1986, FOLIA PHARMACOL JPN, V87, P273, DOI 10.1254/fpj.87.273; Valki<umacron>nas G, 2005, AVIAN MALARIA PARASI; Valkiunas G, 2005, AVIN MALARIA PARASIT; Valkiunas G, 2008, J PARASITOL, V94, P1395, DOI 10.1645/GE-1570.1; Weng Z, 1998, FUJIAN J ANIMAL HUSB, V2; Wingstrand KG, 1947, SOME HAEMATOZOA SWED; Zhao WT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133478; Zhao WT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094877; Garamszegi LZ, 2010, J PARASITOL, V96, P1197, DOI 10.1645/GE-2531.1	42	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161869	10.1371/journal.pone.0161869	http://dx.doi.org/10.1371/journal.pone.0161869			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571513	Green Published, gold, Green Submitted			2022-12-26	WOS:000382876700038
J	Yu, BH; Shui, RH; Sheng, WQ; Wang, CF; Lu, HF; Zhou, XY; Zhu, XZ; Li, XQ				Yu, Bao-Hua; Shui, Ruo-Hong; Sheng, Wei-Qi; Wang, Chao-Fu; Lu, Hong-Fen; Zhou, Xiao-Yan; Zhu, Xiong-Zeng; Li, Xiao-Qiu			Primary Intestinal Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Comprehensive Clinicopathological Analysis of 55 Cases	PLOS ONE			English	Article							T-CELL; NK-CELL; GASTROINTESTINAL-TRACT; CLINICAL-FEATURES; POOR SURVIVAL; LINEAGE	Purpose To investigate the clinicopathological features, survival and prognostic factors of primary intestinal extranodal natural killer/T-cell lymphoma, nasal type (PI-ENKTCL). Methods Clinical and histological characteristics of PI-ENKTCL cases were retrospectively evaluated. Immunohistochemical phenotype and status of Epstein-Barr virus (EBV) and T-cell receptor (TCR) gene rearrangement were examined. The overall survival and prognostic parameters were also analyzed. Results Fifty-five (2.7%) cases with PI-ENKTCL were identified out of 2017 archived ENKTCL cases, with a median age of 39 years and a male to female ratio of 2.1:1. The most common symptom was abdominal pain (90.9%), accompanied frequently with fever and less commonly with intestinal perforation or B symptoms. Small intestine (50.9%) was the most common site to be involved. 47.3% and 36.4% cases presented with stage I and II diseases, respectively. Histologically, most cases displayed characteristic morphologic changes of ENKTCL. Cytoplasmic CD3, TIA-1 and CD56 expression was found in 100%, 94.5% and 89.1% of cases, respectively. In situ hybridization detection for EBV demonstrated positive results in all cases. Monoclonal TCR gene rearrangement was found in 52.9% of tested cases. Chemotherapy with a DICE or L-asparaginase/peg-asparginase-containing regimen was most often employed. Both advanced tumor stage and B symptoms were independent inferior prognostic factors (p = 0.001 and p = 0.010). Noticeably, 6 cases demonstrated a CD4-positive phenotype. These cases featured a relatively older median age (58 years), predominance of small/medium-sized neoplastic cells, a higher rate of TCR rearrangement and slightly favorable outcome. Conclusion We reported by far the largest series of PI-ENKTCL, and demonstrated its heterogeneity, aggressive clinical behavior and unsatisfying response to the current therapeutic strategies. Those CD4-positive cases might represent a unique subtype of PI-ENKTCL or distinct entity. Further investigations are required for the better understanding and management of this unusual disease.	[Yu, Bao-Hua; Shui, Ruo-Hong; Sheng, Wei-Qi; Wang, Chao-Fu; Lu, Hong-Fen; Zhou, Xiao-Yan; Zhu, Xiong-Zeng; Li, Xiao-Qiu] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R China; [Yu, Bao-Hua; Shui, Ruo-Hong; Sheng, Wei-Qi; Wang, Chao-Fu; Lu, Hong-Fen; Zhou, Xiao-Yan; Zhu, Xiong-Zeng; Li, Xiao-Qiu] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China	Fudan University; Fudan University	Li, XQ (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R China.; Li, XQ (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China.	leexiaoqiu@hotmail.com	Wang, Chao/GXF-8353-2022					Aozasa K, 2011, SCI WORLD J, V14, P422; Au WY, 2009, BLOOD, V113, P3931, DOI 10.1182/blood-2008-10-185256; Bautista-Quach MA, 2012, J GASTROINTEST ONCOL, V3, P209, DOI 10.3978/j.issn.2078-6891.2012.024; Chan JC, 2008, WHO CLASSIFICATION T, P285; Chuang SS, 2009, AM J SURG PATHOL, V33, P1230, DOI 10.1097/PAS.0b013e3181a95c63; Fang JC, 2015, INT J SURG PATHOL, V23, P609, DOI 10.1177/1066896915595863; Gou HF, 2012, MED ONCOL, V29, P227, DOI 10.1007/s12032-010-9783-x; Gualco G, 2011, AM J SURG PATHOL, V35, P1195, DOI 10.1097/PAS.0b013e31821ec4b5; Hawkes EA, 2012, LEUKEMIA LYMPHOMA, V53, P2341, DOI 10.3109/10428194.2012.695780; Jhuang JY, 2015, HUM PATHOL, V46, P313, DOI 10.1016/j.humpath.2014.11.008; Jiang M, 2013, J CLIN GASTROENTEROL, V47, pE74, DOI 10.1097/MCG.0b013e31829e444f; Jo JC, 2012, EUR J HAEMATOL, V89, P103, DOI 10.1111/j.1600-0609.2012.01796.x; Kim SJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-321; Kim SJ, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-86; Ko YH, 2004, HISTOPATHOLOGY, V44, P480, DOI 10.1111/j.1365-2559.2004.01867.x; Li SY, 2013, AM J SURG PATHOL, V37, P14, DOI 10.1097/PAS.0b013e31826731b5; Li YX, 2011, LEUKEMIA LYMPHOMA, V52, P417, DOI 10.3109/10428194.2010.543718; Medeiros LJ, 2011, DIAGNOSTIC PATHOLOGY; Ng SB, 2004, MODERN PATHOL, V17, P1097, DOI 10.1038/modpathol.3800157; Perry AM, 2013, BLOOD, V122, P3599, DOI 10.1182/blood-2013-07-512830; Pongpruttipan T, 2012, AM J SURG PATHOL, V36, P481, DOI 10.1097/PAS.0b013e31824433d8; Pongpruttipan T, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-79; Richendollar BG, 2009, AM J CLIN PATHOL, V132, P581, DOI 10.1309/AJCPX70TIHETNBRL; Sun J, 2011, MODERN PATHOL, V24, P983, DOI 10.1038/modpathol.2011.45; Suzuki R, 2010, ANN ONCOL, V21, P1032, DOI 10.1093/annonc/mdp418; Takata K, 2015, AM J SURG PATHOL, V39, P1, DOI 10.1097/PAS.0000000000000312; Takeuchi K, 2010, BLOOD, V116, P5631, DOI 10.1182/blood-2010-06-290650; Tse E, 2013, BLOOD, V121, P4997, DOI 10.1182/blood-2013-01-453233; Wang L, 2015, TUMOR BIOL, V36, P7717, DOI 10.1007/s13277-015-3485-0; Yong WB, 2016, HEMATOL ONCOL, V34, P61, DOI 10.1002/hon.2207; Zheng SM, 2012, ARCH IRAN MED, V15, P36, DOI 012151/AIM.0011	31	20	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161831	10.1371/journal.pone.0161831	http://dx.doi.org/10.1371/journal.pone.0161831			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564014	Green Submitted, Green Published, gold			2022-12-26	WOS:000382496300023
J	Chae, EY; Shin, HJ; Kim, S; Baek, HM; Yoon, D; Kim, S; Shim, YE; Kim, HH; Cha, JH; Choi, WJ; Lee, JH; Shin, JH; Lee, HJ; Gong, G				Chae, Eun Young; Shin, Hee Jung; Kim, Suhkmann; Baek, Hyeon-Man; Yoon, Dahye; Kim, Siwon; Shim, Ye Eun; Kim, Hak Hee; Cha, Joo Hee; Choi, Woo Jung; Lee, Jeong Hyun; Shin, Ji Hoon; Lee, Hee Jin; Gong, Gyungyub			The Role of High-Resolution Magic Angle Spinning 1H Nuclear Magnetic Resonance Spectroscopy for Predicting the Invasive Component in Patients with Ductal Carcinoma In Situ Diagnosed on Preoperative Biopsy	PLOS ONE			English	Article							BREAST-CANCER; METABOLOMICS; MYOINOSITOL; METABOLISM; PROFILES; NOMOGRAM; CELLS; RISK	The purpose of this study was to evaluate the role of high-resolution magic angle spinning (HR-MAS) 1H nuclear magnetic resonance (NMR) spectroscopy in patients with ductal carcinoma in situ (DCIS) diagnosed on preoperative biopsy. We investigated whether the metabolic profiling of tissue samples using HR-MAS 1H NMR spectroscopy could be used to distinguish between DCIS lesions with or without an invasive component. Our institutional review board approved this combined retrospective and prospective study. Tissue samples were collected from 30 patients with pure DCIS and from 30 with DCIS accompanying invasive carcinoma. All patients were diagnosed with DCIS by preoperative core-needle biopsy and underwent surgical resection. The metabolic profiling of tissue samples was performed by HR-MAS 1H NMR spectroscopy. All observable metabolite signals were identified and quantified in all tissue samples. Metabolite intensity normalized by total spectral intensities was compared according to the tumor type using the Mann-Whitney test. Multivariate analysis was performed with orthogonal projections to latent structure-discriminant analysis (OPLS-DA). By univariate analysis, the metabolite concentrations of choline-containing compounds obtained with HR-MAS 1H NMR spectroscopy did not differ significantly between the pure DCIS and DCIS accompanying invasive carcinoma groups. However, the GPC/PC ratio was higher in the pure DCIS group than in the DCIS accompanying invasive carcinoma group (p = 0.004, Bonferroni-corrected p = 0.064), as well as the concentration of myo-inositol and succinate. By multivariate analysis, the OPLS-DA models built with HRMAS MR metabolic profiles could clearly discriminate between pure DCIS and DCIS accompanying invasive carcinoma. Our preliminary results suggest that HR-MAS MR metabolomics on breast tissue may be able to distinguish between DCIS lesions with or without an invasive component.	[Chae, Eun Young; Shin, Hee Jung; Kim, Hak Hee; Cha, Joo Hee; Choi, Woo Jung; Lee, Jeong Hyun; Shin, Ji Hoon] Univ Ulsan, Coll Med, Dept Radiol, Asan Med Ctr, Seoul, South Korea; [Chae, Eun Young; Shin, Hee Jung; Kim, Hak Hee; Cha, Joo Hee; Choi, Woo Jung; Lee, Jeong Hyun; Shin, Ji Hoon] Univ Ulsan, Coll Med, Res Inst Radiol, Asan Med Ctr, Seoul, South Korea; [Kim, Suhkmann; Yoon, Dahye; Kim, Siwon] Pusan Natl Univ, Dept Chem, Busan, South Korea; [Kim, Suhkmann; Yoon, Dahye; Kim, Siwon] Pusan Natl Univ, Chem Inst Funct Mat, Busan, South Korea; [Baek, Hyeon-Man] Korea Basic Sci Inst, Ctr Magnet Resonance Res, Chungbuk, South Korea; [Baek, Hyeon-Man] Korea Univ Sci & Technol, Dept Bioanalyt Sci, Daejeon, South Korea; [Shim, Ye Eun] Univ Ulsan, Coll Med, Seoul, South Korea; [Lee, Hee Jin; Gong, Gyungyub] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea	University of Ulsan; University of Ulsan; Pusan National University; Pusan National University; Korea Basic Science Institute (KBSI); University of Science & Technology (UST); University of Ulsan; University of Ulsan; Asan Medical Center	Shin, HJ (corresponding author), Univ Ulsan, Coll Med, Dept Radiol, Asan Med Ctr, Seoul, South Korea.; Shin, HJ (corresponding author), Univ Ulsan, Coll Med, Res Inst Radiol, Asan Med Ctr, Seoul, South Korea.	docshin@amc.seoul.kr	Yoon, Dahye/AAQ-4618-2020; Yoon, Dahye/AFW-1896-2022	Yoon, Dahye/0000-0002-0286-8896; Yoon, Dahye/0000-0002-0286-8896				Ackerstaff E, 2003, J CELL BIOCHEM, V90, P525, DOI 10.1002/jcb.10659; Brennan ME, 2011, RADIOLOGY, V260, P119, DOI 10.1148/radiol.11102368; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Burstein HJ, 2004, NEW ENGL J MED, V350, P1430, DOI 10.1056/NEJMra031301; Choi JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083866; Choi JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051712; Erbas B, 2006, BREAST CANCER RES TR, V97, P135, DOI 10.1007/s10549-005-9101-z; Giskeodegard GF, 2010, J PROTEOME RES, V9, P972, DOI 10.1021/pr9008783; Glunde K, 2006, EXPERT REV MOL DIAGN, V6, P821, DOI 10.1586/14737159.6.6.821; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Kaur H, 2013, EXPERT REV MOL DIAGN, V13, P151, DOI [10.1586/ERM.13.4, 10.1586/erm.13.4]; Kuerer HM, 2009, J CLIN ONCOL, V27, P279, DOI 10.1200/JCO.2008.18.3103; Lam S, 2006, CANCER EPIDEM BIOMAR, V15, P1526, DOI 10.1158/1055-9965.EPI-06-0128; Opstad KS, 2008, NMR BIOMED, V21, P1138, DOI 10.1002/nbm.1296; Rudloff U, 2010, J CLIN ONCOL, V28, P3762, DOI 10.1200/JCO.2009.26.8847; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sitter B, 2006, NMR BIOMED, V19, P30, DOI 10.1002/nbm.992; Wattenberg LW, 1996, CANCER RES, V56, P5132; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Worley B, 2013, CURR METABOL, V1, P92, DOI 10.2174/2213235X11301010092; Yi M, 2012, J CLIN ONCOL, V30, P600, DOI 10.1200/JCO.2011.36.4976	22	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161038	10.1371/journal.pone.0161038	http://dx.doi.org/10.1371/journal.pone.0161038			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560937	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258600024
J	Huang, CC; Hsu, TW; Wang, HV; Liu, ZH; Chen, YY; Chiu, CT; Huang, CL; Hung, KH; Chiang, TY				Huang, Chi-Chun; Hsu, Tsai-Wen; Wang, Hao-Ven; Liu, Zin-Huang; Chen, Yi-Yen; Chiu, Chi-Te; Huang, Chao-Li; Hung, Kuo-Hsiang; Chiang, Tzen-Yuh			Multilocus Analyses Reveal Postglacial Demographic Shrinkage of Juniperus morrisonicola (Cupressaceae), a Dominant Alpine Species in Taiwan	PLOS ONE			English	Article							CONTRASTING PHYLOGEOGRAPHICAL PATTERNS; QINGHAI-TIBETAN PLATEAU; GENETIC DIVERSITY; CLIMATE-CHANGE; POPULATION-STRUCTURE; MOUNTAIN PLANTS; VASCULAR PLANTS; DNA; CHLOROPLAST; EVOLUTION	Postglacial climate changes alter geographical distributions and diversity of species. Such ongoing changes often force species to migrate along the latitude/altitude. Altitudinal gradients represent assemblage of environmental, especially climatic, variable factors that influence the plant distributions. Global warming that triggered upward migrations has therefore impacted the alpine plants on an island. In this study, we examined the genetic structure of Juniperus morrisonicola, a dominant alpine species in Taiwan, and inferred historical, demographic dynamics based on multilocus analyses. Lower levels of genetic diversity in north indicated that populations at higher latitudes were vulnerable to climate change, possibly related to historical alpine glaciers. Neither organellar DNA nor nuclear genes displayed geographical subdivisions, indicating that populations were likely interconnected before migrating upward to isolated mountain peaks, providing low possibilities of seed/pollen dispersal across mountain ranges. Bayesian skyline plots suggested steady population growth of J. morrisonicola followed by recent demographic contraction. In contrast, most lower-elevation plants experienced recent demographic expansion as a result of global warming. The endemic alpine conifer may have experienced dramatic climate changes over the alternation of glacial and interglacial periods, as indicated by a trend showing decreasing genetic diversity with the altitudinal gradient, plus a fact of upward migration.	[Huang, Chi-Chun] Kinmen Natl Pk, Kinmen, Taiwan; [Hsu, Tsai-Wen] Endem Species Res Inst, Nantou, Taiwan; [Wang, Hao-Ven; Chen, Yi-Yen; Chiu, Chi-Te; Huang, Chao-Li; Chiang, Tzen-Yuh] Natl Cheng Kung Univ, Dept Life Sci, Tainan, Taiwan; [Liu, Zin-Huang] Natl Cheng Kung Univ, Inst Trop Plant Sci, Tainan, Taiwan; [Hung, Kuo-Hsiang] Natl Pingtung Univ Sci & Technol, Grad Inst Bioresources, Pingtung, Taiwan; [Chiang, Tzen-Yuh] Natl Cheng Kung Univ, Univ Ctr Biosci & Biotechnol, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University; National Pingtung University Science & Technology; National Cheng Kung University	Huang, CL; Chiang, TY (corresponding author), Natl Cheng Kung Univ, Dept Life Sci, Tainan, Taiwan.; Hung, KH (corresponding author), Natl Pingtung Univ Sci & Technol, Grad Inst Bioresources, Pingtung, Taiwan.; Chiang, TY (corresponding author), Natl Cheng Kung Univ, Univ Ctr Biosci & Biotechnol, Tainan, Taiwan.	clhuang65535@gmail.com; khhung424@npust.edu.tw; tychiang@mail.ncku.edu.tw		Wang, Hao-Ven/0000-0001-7523-087X	Ministry of Science and Technology [104-2621-B-006-002]; National Cheng Kung University [D103-38A03]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Cheng Kung University	This work was supported by the Ministry of Science and Technology: 104-2621-B-006-002, https://www.most.gov.tw/en/public; National Cheng Kung University: D103-38A03, http://web.ncku.edu.tw/bin/home.php?Lang=en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2003, MOL ECOL, V12, P299, DOI 10.1046/j.1365-294X.2003.01731.x; Adams R.P., 2014, JUNIPERS WORLD GENUS; Alsos IG, 2012, P ROY SOC B-BIOL SCI, V279, P2042, DOI 10.1098/rspb.2011.2363; BENNETT KD, 1990, PALEOBIOLOGY, V16, P11, DOI 10.1017/S0094837300009684; Breshears DD, 2008, P NATL ACAD SCI USA, V105, P11591, DOI 10.1073/pnas.0806579105; Chen CY, 2014, TREE GENET GENOMES, V10, P111, DOI 10.1007/s11295-013-0669-x; Chen SH, 2007, THESIS; Cheng YP, 2005, MOL ECOL, V14, P2075, DOI 10.1111/j.1365-294X.2005.02567.x; Chiang TY, 2006, TAXON, V55, P31, DOI 10.2307/25065526; Chiang TY, 2004, ANN MO BOT GARD, V91, P207; Chiang YC, 2006, MOL ECOL, V15, P765, DOI 10.1111/j.1365-294X.2005.02833.x; Chiu C-W, 2010, THESIS; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Cui ZJ, 2002, QUATERN INT, V97-8, P147, DOI 10.1016/S1040-6182(02)00060-5; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Douaihy B, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr003; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dullinger S, 2004, J ECOL, V92, P241, DOI 10.1111/j.0022-0477.2004.00872.x; Dullinger S, 2012, NAT CLIM CHANGE, V2, P619, DOI 10.1038/NCLIMATE1514; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1994, GENETICS, V136, P343; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feeley K.J., 2012, FRONTIERS BIOGEOGRAP, V4, P69, DOI [10.21425/F5FBG12621, DOI 10.21425/F5FBG12621, 10.21425/f5fbg12621., DOI 10.21425/F54212621]; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hebenstreit R, 2006, QUATERN INT, V147, P70, DOI 10.1016/j.quaint.2005.09.008; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hsieh Chang-Fu, 2002, Taiwania, V47, P298; Huang CC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-108; Huang S, 2001, MOL ECOL, V10, P2669, DOI 10.1046/j.0962-1083.2001.01395.x; Huang SF, 2004, J BIOGEOGR, V31, P1251, DOI 10.1111/j.1365-2699.2004.01082.x; Huang SSF, 2002, MOL ECOL, V11, P2349, DOI 10.1046/j.1365-294X.2002.01624.x; Hwang SY, 2003, MOL ECOL, V12, P2689, DOI 10.1046/j.1365-294X.2003.01935.x; Ikeda H, 2006, J PLANT RES, V119, P489, DOI 10.1007/s10265-006-0012-9; Jump AS, 2012, ECOGRAPHY, V35, P204, DOI 10.1111/j.1600-0587.2011.06984.x; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Kusumi J, 2002, MOL BIOL EVOL, V19, P736, DOI 10.1093/oxfordjournals.molbev.a004132; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Li ZH, 2012, EVOLUTION, V66, P831, DOI 10.1111/j.1558-5646.2011.01466.x; Li ZH, 2011, J BIOGEOGR, V38, P31, DOI 10.1111/j.1365-2699.2010.02400.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin CC, 2012, Q J FOR RES, V34, P53; Lu SY, 2002, J PLANT RES, V115, P203, DOI 10.1007/s102650200026; Mao KS, 2010, NEW PHYTOL, V188, P254, DOI 10.1111/j.1469-8137.2010.03351.x; Michalczyk IM, 2006, MOL ECOL NOTES, V6, P346, DOI 10.1111/j.1471-8286.2005.01227.x; Moreno-Letelier A, 2014, NEW PHYTOL, V203, P335, DOI 10.1111/nph.12761; Mosca E, 2012, MOL ECOL, V21, P5530, DOI 10.1111/mec.12043; Mudelsee M, 1997, EARTH PLANET SC LETT, V151, P117, DOI 10.1016/S0012-821X(97)00114-3; NEALE DB, 1989, P NATL ACAD SCI USA, V86, P9347, DOI 10.1073/pnas.86.23.9347; Ono YG, 2005, QUATERN INT, V138, P79, DOI 10.1016/j.quaint.2005.02.007; Oostermeijer JGB, 2004, PLANT SPEC BIOL, V19, P175, DOI 10.1111/j.1442-1984.2004.00113.x; Parolo G, 2008, BASIC APPL ECOL, V9, P100, DOI 10.1016/j.baae.2007.01.005; Pauli H, 2007, GLOBAL CHANGE BIOL, V13, P147, DOI 10.1111/j.1365-2486.2006.01282.x; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; Pielou EC, 1991, AFTER THE ICE AGE; Pritchard J, 2003, DOCUMENTATION STRUCT; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2013, TRACER V1 5; Shang HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10216; Shih FL, 2007, AM J BOT, V94, P194, DOI 10.3732/ajb.94.2.194; Sibuet JC, 2004, TECTONOPHYSICS, V379, P159, DOI 10.1016/j.tecto.2003.10.022; Sork VL, 2010, MOL ECOL, V19, P3806, DOI 10.1111/j.1365-294X.2010.04726.x; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teixeira H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088996; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Till-Bottraud I, 2002, MOUNTAIN BIODIVERSITY: A GLOBAL ASSESSMENT, P23; Vazquez-Lobo A, 2007, EVOL DEV, V9, P446, DOI 10.1111/j.1525-142X.2007.00182.x; Vittoz P, 2008, ARCT ANTARCT ALP RES, V40, P225, DOI 10.1657/1523-0430(06-010)[VITTOZ]2.0.CO;2; Vranckx G, 2012, CONSERV BIOL, V26, P228, DOI 10.1111/j.1523-1739.2011.01778.x; Walther GR, 2004, PERSPECT PLANT ECOL, V6, P169, DOI 10.1078/1433-8319-00076; Wu MJ, 2005, J BIOGEOGR, V32, P1921, DOI 10.1111/j.1365-2699.2005.01327.x; Wu SH, 2006, J BIOGEOGR, V33, P936, DOI 10.1111/j.1365-2699.2006.01431.x; Zhang Q, 2008, CONSERV GENET, V9, P767, DOI 10.1007/s10592-007-9387-y; Zheng BX, 2002, QUATERN INT, V97-8, P93, DOI 10.1016/S1040-6182(02)00054-X	80	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161713	10.1371/journal.pone.0161713	http://dx.doi.org/10.1371/journal.pone.0161713			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27561108	Green Submitted, Green Published, gold			2022-12-26	WOS:000382258600086
J	Khaitan, A; Kilberg, M; Kravietz, A; Ilmet, T; Tastan, C; Mwamzuka, M; Marshed, F; Liu, ML; Ahmed, A; Borkowsky, W; Unutmaz, D				Khaitan, Alka; Kilberg, Max; Kravietz, Adam; Ilmet, Tiina; Tastan, Cihan; Mwamzuka, Mussa; Marshed, Fatma; Liu, Mengling; Ahmed, Aabid; Borkowsky, William; Unutmaz, Derya			HIV-Infected Children Have Lower Frequencies of CD8+Mucosal-Associated Invariant T (MAIT) Cells that Correlate with Innate, Th17 and Th22 Cell Subsets	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MR1; MORTALITY; DIFFERENTIATION; EXPRESSION; RESPONSES; DECREASE; BACTERIA; NUMBERS; DISEASE	Mucosal-associated invariant T cells (MAIT) are innate T cells restricted by major histocompatibility related molecule 1 (MR1) presenting riboflavin metabolite ligands derived from microbes. Specificity to riboflavin metabolites confers MAIT cells a broad array of host-protective activity against gram-negative and -positive bacteria, mycobacteria, and fungal pathogens. MAIT cells are present at low levels in the peripheral blood of neonates and gradually expand to relatively abundant levels during childhood. Despite no anti-viral activity, MAIT cells are depleted early and irreversibly in HIV infected adults. Such loss or impaired expansion of MAIT cells in HIV-positive children may render them more susceptible to common childhood illnesses and opportunistic infections. In this study we evaluated the frequency of MAIT cells in perinatally HIV-infected children, their response to antiretroviral treatment and their associations with HIV clinical status and related innate and adaptive immune cell subsets with potent antibacterial effector functions. We found HIV+ children between ages 3 to 18 years have significantly decreased CD8+ MAIT cell frequencies compared to uninfected healthy children. Remarkably, CD8 MAIT levels gradually increased with antiretroviral therapy, with greater recovery when treatment is initiated at a young age. Moreover, diminished CD8+ MAIT cell frequencies are associated with low CD4: CD8 ratios and elevated sCD14, suggesting a link with HIV disease progression. Last, CD8+ MAIT cell levels tightly correlate with other antibacterial and mucosa-protective immune subsets, namely, neutrophils, innate-like T cells, and Th17 and Th22 cells. Together these findings suggest that low frequencies of MAIT cells in HIV positive children are part of a concerted disruption to the innate and adaptive immune compartments specialized in sensing and responding to pathogenic or commensal bacteria.	[Khaitan, Alka; Kilberg, Max; Ilmet, Tiina; Borkowsky, William] NYU, Dept Pediat, Sch Med, Div Infect Dis & Immunol, New York, NY 10016 USA; [Kravietz, Adam; Tastan, Cihan; Unutmaz, Derya] NYU, Dept Microbiol, New York, NY 10016 USA; [Mwamzuka, Mussa; Marshed, Fatma; Ahmed, Aabid] Bomu Hosp, Mombasa, Kenya; [Liu, Mengling] NYU, Dept Environm Med, Dept Populat Hlth, Div Biostat, 550 1St Ave, New York, NY 10016 USA; [Unutmaz, Derya] Jackson Lab Genom Med, Farmington, CT USA	New York University; New York University; New York University; Jackson Laboratory	Khaitan, A (corresponding author), NYU, Dept Pediat, Sch Med, Div Infect Dis & Immunol, New York, NY 10016 USA.	alka.khaitan@nyumc.org	Tastan, Cihan/AAF-8070-2019	Tastan, Cihan/0000-0002-4173-6634; Kravietz, Adam/0000-0002-7445-6532; Liu, Mengling/0000-0001-9758-8522	NIH [5K08AI093235-02, R01AI065303]; NYU CTSA grant from the NIH National Center for Advancing Translational Sciences [1UL1TR001445, 1KL2 TR001446, 1TL1 TR001447]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001447, KL2TR001446, UL1TR001445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI093235, R01AI065303] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYU CTSA grant from the NIH National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by NIH grant 5K08AI093235-02 to AK and R01AI065303 to DU, and supported in part by the NYU CTSA grant 1UL1TR001445, 1KL2 TR001446, and 1TL1 TR001447 from the NIH National Center for Advancing Translational Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all of the children and families who participated in this study. We thank Dave Mellert for critical reading and valuable suggestions and Lina Kozhaya for help with designing MAIT cell staining panels. This study was funded by NIH grant 5K08AI093235-02 to AK and R01AI065303 to DU, and supported in part by the NYU CTSA grant 1UL1TR001445, 1KL2 TR001446, and 1TL1 TR001447 from the NIH National Center for Advancing Translational Sciences.	Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Carolan E, 2015, J IMMUNOL, V194, P5775, DOI 10.4049/jimmunol.1402945; Chiappini E, 2010, INT J IMMUNOPATH PH, V23, P665, DOI 10.1177/039463201002300232; Cho YN, 2014, J IMMUNOL, V193, P3891, DOI 10.4049/jimmunol.1302701; Cosgrove C, 2013, BLOOD, V121, P951, DOI 10.1182/blood-2012-06-436436; Davey MS, 2014, J IMMUNOL, V193, P3704, DOI 10.4049/jimmunol.1401018; Dunne MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076008; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Eberhard JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111323; El Hed A, 2010, J INFECT DIS, V201, P843, DOI 10.1086/651021; Fernandez CS, 2015, IMMUNOL CELL BIOL, V93, P177, DOI 10.1038/icb.2014.91; Gaardbo J. C., 2015, J ACQUIR IMMUNE DEFI; Georgel P, 2011, MOL IMMUNOL, V48, P769, DOI 10.1016/j.molimm.2010.12.002; Gibbs A, 2017, MUCOSAL IMMUNOL, V10, P35, DOI 10.1038/mi.2016.30; Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298; Gold MC, 2013, MUCOSAL IMMUNOL, V6, P35, DOI 10.1038/mi.2012.45; Gold MC, 2014, J EXP MED, V211, P1601, DOI 10.1084/jem.20140507; Gold MC, 2013, NAT REV MICROBIOL, V11, P14, DOI 10.1038/nrmicro2918; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Gold MC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040039; Greathead L, 2014, AIDS, V28, P1690, DOI 10.1097/QAD.0000000000000351; Harms RZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117335; Hiejima E, 2015, INFLAMM BOWEL DIS, V21, P1529, DOI 10.1097/MIB.0000000000000397; Hinks TSC, 2016, IMMUNOLOGY, V148, P1, DOI 10.1111/imm.12582; Huang SX, 2009, P NATL ACAD SCI USA, V106, P8290, DOI 10.1073/pnas.0903196106; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; KOZBOR D, 1993, J CLIN IMMUNOL, V13, P193, DOI 10.1007/BF00919972; Kurioka A, 2015, MUCOSAL IMMUNOL, V8, P429, DOI 10.1038/mi.2014.81; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Leeansyah E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005072; Leeansyah E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4143; Leeansyah E, 2013, BLOOD, V121, P1124, DOI 10.1182/blood-2012-07-445429; Leung DT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003076; Magalhaes I, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00341; Magalhaes I, 2015, J CLIN INVEST, V125, P1752, DOI 10.1172/JCI78941; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Modi S, 2013, AIDS, V27, pS159, DOI 10.1097/QAD.0000000000000080; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Novak J, 2014, SCAND J IMMUNOL, V80, P271, DOI 10.1111/sji.12193; Peters A, 2011, CURR OPIN IMMUNOL, V23, P702, DOI 10.1016/j.coi.2011.08.007; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Riegert P, 1998, J IMMUNOL, V161, P4066; Saeidi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124659; Salerno-Goncalves R, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00511; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Treiner E, 2005, MICROBES INFECT, V7, P552, DOI 10.1016/j.micinf.2004.12.013; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Ussher JE, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001134; Ussher JE, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00450; Vinton C, 2016, J VIROL, V90, P4520, DOI 10.1128/JVI.02876-15; Wan Q, 2011, J EXP MED, V208, P1875, DOI 10.1084/jem.20102516; Wilson RP, 2015, J EXP MED, V212, P855, DOI 10.1084/jem.20141992; Witte E, 2010, CYTOKINE GROWTH F R, V21, P365, DOI 10.1016/j.cytogfr.2010.08.002; Wong EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083474; World Health Organization, 2016, CONS GUID US ANT DRU; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	60	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161786	10.1371/journal.pone.0161786	http://dx.doi.org/10.1371/journal.pone.0161786			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560150	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258600098
J	Adekeye, OA; Abara, WE; Xu, JJ; Lee, JM; Rust, G; Satcher, D				Adekeye, Oluwatoyosi A.; Abara, Winston E.; Xu, Junjun; Lee, Joel M.; Rust, George; Satcher, David			HIV Screening Rates among Medicaid Enrollees Diagnosed with Other Sexually Transmitted Infections	PLOS ONE			English	Article							HEALTH-CARE SETTINGS; UNITED-STATES; DISEASES; VIRUS; EMERGENCY; TRANSMISSION; PREVENTION; SYPHILIS; WOMEN; RACE	Introduction Approximately 20 million new sexually transmitted infections (STIs) are diagnosed yearly in the United States costing the healthcare system an estimated $16 billion in direct medical expenses. The presence of other STIs increases the risk of HIV transmission. The Centers for Disease Control and Prevention (CDC) has long recommended routine HIV screening for individuals with a diagnosed STI. Unfortunately, HIV screening prevalence among STI diagnosed patients are still sub-optimal in many healthcare settings. Objective To determine the proportion of STI-diagnosed persons in the Medicaid population who are screened for HIV, examine correlates of HIV screening, and to suggest critical intervention points to increase HIV screening in this population. Methods A retrospective database analysis was conducted to examine the prevalence and correlates of HIV screening among participants. Participant eligibility was restricted to Medicaid enrollees in 29 states with a primary STI diagnosis (chlamydia, gonorrhea, and syphilis) or pelvic inflammatory disease claim in 2009. HIV-positive persons were excluded from the study. Frequencies and descriptive statistics were conducted to characterize the sample in general and by STI diagnosis. Univariate and multivariate logistic regression were performed to estimate unadjusted odds ratios and adjusted odds ratio respectively and the 95% confidence intervals. Multivariate logistic regression models that included the independent variables (race, STI diagnosis, and healthcare setting) and covariates (gender, residential status, age, and state) were analyzed to examine independent associations with HIV screening. Results About 43% of all STI-diagnosed study participants were screened for HIV. STI-diagnosed persons that were between 20-24 years, female, residing in a large metropolitan area and with a syphilis diagnosis were more likely to be screened for HIV. Participants who received their STI diagnosis in the emergency department were less likely to be screened for HIV than those diagnosed in a physician's office. Conclusion This study showed that HIV screening prevalence among persons diagnosed with an STI are lower than expected based on the CDC's recommendations. These suboptimal HIV screening prevalence present "missed opportunities" for HIV screening in at-risk populations. Measures and incentives to increase HIV screening among all STI-diagnosed persons are vital to the timely identification of HIV infection, linkage to HIV care, and mitigating further HIV transmission.	[Adekeye, Oluwatoyosi A.; Abara, Winston E.; Satcher, David] Morehouse Sch Med, Satcher Hlth Leadership Inst, Dept Community Hlth & Prevent Med, Atlanta, GA 30310 USA; [Xu, Junjun; Rust, George] Morehouse Sch Med, Natl Ctr Primary Care, Atlanta, GA 30310 USA; [Lee, Joel M.] Univ Georgia, Dept Hlth Policy & Management, Athens, GA 30602 USA; [Rust, George] Florida State Univ, Coll Med, Dept Behav Sci & Social Med, Tallahassee, FL 32306 USA	Morehouse School of Medicine; Morehouse School of Medicine; University System of Georgia; University of Georgia; State University System of Florida; Florida State University	Adekeye, OA (corresponding author), Morehouse Sch Med, Satcher Hlth Leadership Inst, Dept Community Hlth & Prevent Med, Atlanta, GA 30310 USA.	oadekeye@msm.edu		Rust, George/0000-0002-9040-9744	Agency for Healthcare Research and Quality (AHRQ) [1K18HS022444]; DHHS Office of Minority Health [MPCMP121069]; National Institute of Health/National Institute on Minority Health and Health Disparities [U54MD008173, 3U54MD007588]; Marguerite Casey Foundation; National Institute on Minority Health and Health Disparities [U54MD008173] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); DHHS Office of Minority Health; National Institute of Health/National Institute on Minority Health and Health Disparities; Marguerite Casey Foundation; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was produced with support from Agency for Healthcare Research and Quality (AHRQ) grant number 1K18HS022444, DHHS Office of Minority Health grant number MPCMP121069, National Institute of Health/National Institute on Minority Health and Health Disparities grant numbers U54MD008173 and 3U54MD007588, and the Marguerite Casey Foundation.	Abara W, 2014, J ASSOC NURSE AIDS C, V25, P476, DOI 10.1016/j.jana.2014.05.002; Abara WE, 2014, AM J PUBLIC HEALTH, V104, pE135, DOI 10.2105/AJPH.2014.302227; Adekeye OA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043618; Bradley H, 2013, AIDS BEHAV, V17, P1205, DOI 10.1007/s10461-012-0304-0; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Centers for Disease Control and Prevention, 2013, HIV TEST TRENDS US 2; Chen JY, 2011, SEX TRANSM DIS, V38, P522, DOI 10.1097/OLQ.0b013e318206ffc4; Chen Z, 1998, SEX TRANSM DIS, V25, P539, DOI 10.1097/00007435-199811000-00008; Cohen MS, 2005, J INFECT DIS, V191, P1391, DOI 10.1086/429414; Durall PS, 2014, ATTITUDE RAPID HIV T, DOI [10.1111/scd.12096, DOI 10.1111/SCD.12096]; Fincher-Mergi M, 2002, AIDS PATIENT CARE ST, V16, P549, DOI 10.1089/108729102761041100; Gift TL, 2006, ACAD EMERG MED, V13, P993, DOI [10.1197/j.aem.2006.04.017, 10.1111/j.1553-2712.2006.tb00353.x]; Goulet JL, 2014, MED CARE; Hayes R, 2010, AIDS, V24, pS15, DOI 10.1097/01.aids.0000390704.35642.47; Health Resources and Services Administration, 2009, AR RES FIL; Kersten M, 2016, ACCEPTANCE HIV TESTI; Lanier Y, 2014, AIDS PATIENT CARE ST, V28, P113, DOI 10.1089/apc.2013.0328; Lin X, 2014, MMWR-MORBID MORTAL W, V63, P537; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Meditz AL, 2011, J INFECT DIS, V203, P442, DOI 10.1093/infdis/jiq085; Montoy JCC, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6895; Owusu-Edusei K, 2013, SEX TRANSM DIS, V40, P197, DOI 10.1097/OLQ.0b013e318285c6d2; Patton ME, 2014, MMWR-MORBID MORTAL W, V63, P402; Peterman TA, 1996, J ACQ IMMUN DEF SYND, V12, P69, DOI 10.1097/00042560-199605010-00010; Rust G, 2003, SEX TRANSM DIS, V30, P723, DOI 10.1097/01.OLQ.0000078652.66397.4C; SAS Institute Inc, 2011, BAS SAS 9 3 PROC GUI; Satterwhite CL, 2013, SEX TRANSM DIS, V40, P187, DOI 10.1097/OLQ.0b013e318286bb53; STLOUIS ME, 1998, MMWR-MORBID MORTAL W, V47, P1; Tai M, 2014, AIDS CARE, V26, P1105, DOI 10.1080/09540121.2013.871220; Tao G, 2008, SEX TRANSM DIS, V35, P43, DOI 10.1097/OLQ.0b013e318148c35a; WASSERHEIT JN, 1992, SEX TRANSM DIS, V19, P61, DOI 10.1097/00007435-199219020-00001; Wimberly YH, 2004, SOUTH MED J, V97, P624, DOI 10.1097/00007611-200407000-00003; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; Zhang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096148	34	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161560	10.1371/journal.pone.0161560	http://dx.doi.org/10.1371/journal.pone.0161560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU5NI	27556925	gold, Green Submitted, Green Published			2022-12-26	WOS:000382258100052
J	Zhao, YJ; McAnulty, MJ; Wood, TK				Zhao, Yueju; McAnulty, Michael J.; Wood, Thomas K.			Toxin YafQ Reduces Escherichia coli Growth at Low Temperatures	PLOS ONE			English	Article							PERSISTER CELL-FORMATION; GLYCINE CLEAVAGE SYSTEM; ANTITOXIN SYSTEMS; MESSENGER-RNA; TRANSCRIPTIONAL REPRESSION; MULTIDRUG TOLERANCE; REACTION-MECHANISM; PROTEIN; INDOLE; RIBOSOME	Toxin/antitoxin (TA) systems reduce metabolism under stress; for example, toxin YafQ of the YafQ/DinJ Escherichia coli TA system reduces growth by cleaving transcripts with inframe 5' -AAA-G/A-3' sites, and antitoxin DinJ is a global regulator that represses its locus as well as controls levels of the stationary sigma factor RpoS. Here we investigated the influence on cell growth at various temperatures and found that deletion of the antitoxin gene, dinJ, resulted in both reduced metabolism and slower growth at 18 degrees C but not at 37 degrees C. The reduction in growth could be complemented by producing DinJ from a plasmid. Using a transposon screen to reverse the effect of the absence of DinJ, two mutations were found that inactivated the toxin YafQ; hence, the toxin caused the slower growth only at low temperatures rather than DinJ acting as a global regulator. Corroborating this result, a clean deletion of yafQ in the.dinJ.KmR strain restored both metabolism and growth at 18 degrees C. In addition, production of YafQ was more toxic at 18 degrees C compared to 37 degrees C. Furthermore, by overproducing all the E. coli proteins, the global transcription repressor Mlc was found that counteracts YafQ toxicity only at 18 degrees C. Therefore, YafQ is more effective at reducing metabolism at low temperatures, and Mlc is its putative target.	[Zhao, Yueju] Chinese Acad Agr Sci, Inst Food Sci & Technol, Beijing 100193, Peoples R China; [Zhao, Yueju] Minist Agr, Key Lab Agroprod Proc, Beijing 100193, Peoples R China; [Zhao, Yueju; McAnulty, Michael J.; Wood, Thomas K.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA; [Wood, Thomas K.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Chinese Academy of Agricultural Sciences; Institute of Food Science & Technology, CAAS; Ministry of Agriculture & Rural Affairs; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wood, TK (corresponding author), Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA.; Wood, TK (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	twood@engr.psu.edu	Wood, Thomas/GWZ-2481-2022	Wood, Thomas/0000-0001-8962-8571; McAnulty, Michael/0000-0002-1926-196X; Wood, Thomas/0000-0002-6258-529X	ARO [W911NF-14-1-0279]; National Natural Science Foundation of China [31401600]; China Scholarship Council [201403250037]	ARO; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This work was supported by the ARO (W911NF-14-1-0279) and National Natural Science Foundation of China (31401600). YZ was supported by the China Scholarship Council for study at the Pennsylvania State University, and TKW is the Biotechnology Endowed Chair at Pennsylvania State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the ARO (W911NF-14-1-0279) and National Natural Science Foundation of China (31401600). Y. Z. was supported by the China Scholarship Council forstudy at the Pennsylvania State University (201403250037), and T.K.W. is the Biotechnology Endowed Chair at Pennsylvania State University. We are grateful for the Keio and ASKA strains provided by the National Institute of Genetics of Japan.	Ainelo A, 2016, MOL MICROBIOL, V100, P719, DOI 10.1111/mmi.13344; Amitai S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000390; Armalyte J, 2012, J BACTERIOL, V194, P1523, DOI 10.1128/JB.06104-11; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Balandina A, 2001, MOL MICROBIOL, V39, P1069, DOI 10.1046/j.1365-2958.2001.02305.x; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Blower TR, 2012, NUCLEIC ACIDS RES, V40, P6158, DOI 10.1093/nar/gks231; Brechemier-Baey D, 2012, MOL MICROBIOL, V85, P1007, DOI 10.1111/j.1365-2958.2012.08158.x; Brown BL, 2013, J BIOL CHEM, V288, P1286, DOI 10.1074/jbc.M112.421008; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Claret L, 1997, J MOL BIOL, V273, P93, DOI 10.1006/jmbi.1997.1310; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; Fineran PC, 2009, P NATL ACAD SCI USA, V106, P894, DOI 10.1073/pnas.0808832106; Fozo EM, 2010, NUCLEIC ACIDS RES, V38, P3743, DOI 10.1093/nar/gkq054; Guo YX, 2014, NUCLEIC ACIDS RES, V42, P6448, DOI 10.1093/nar/gku279; Harrison JJ, 2009, ANTIMICROB AGENTS CH, V53, P2253, DOI 10.1128/AAC.00043-09; Hazan R, 2004, MOL GENET GENOMICS, V272, P227, DOI 10.1007/s00438-004-1048-y; Hu Y, 2015, ENVIRON MICROBIOL, V17, P1275, DOI 10.1111/1462-2920.12567; Hu Y, 2012, ENVIRON MICROBIOL, V14, P669, DOI 10.1111/j.1462-2920.2011.02618.x; Jahn N, 2012, MOL MICROBIOL, V83, P579, DOI 10.1111/j.1365-2958.2011.07952.x; Jain C, 2012, J BACTERIOL, V194, P3883, DOI 10.1128/JB.06554-11; Janssen BD, 2015, MICROBIOLOGYOPEN, V4, P682, DOI 10.1002/mbo3.272; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; KIKUCHI G, 1973, MOL CELL BIOCHEM, V1, P169, DOI 10.1007/BF01659328; Kikuchi G, 2008, P JPN ACAD B-PHYS, V84, P246, DOI [10.2183/pjab.84.246, 10.2183/pjab/84.246]; Kim Y, 2010, ENVIRON MICROBIOL, V12, P1105, DOI 10.1111/j.1462-2920.2009.02147.x; Kim YH, 2009, J BACTERIOL, V191, P1258, DOI 10.1128/JB.01465-08; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kwan BW, 2015, ENVIRON MICROBIOL, V17, P4406, DOI 10.1111/1462-2920.12873; Kwan BW, 2015, BIOTECHNOL BIOENG, V112, P588, DOI 10.1002/bit.25456; Kwan BW, 2013, ANTIMICROB AGENTS CH, V57, P1468, DOI 10.1128/AAC.02135-12; Lee J, 2008, ISME J, V2, P1007, DOI 10.1038/ismej.2008.54; Lee JT, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-42; Lee J, 2009, MICROB BIOTECHNOL, V2, P75, DOI 10.1111/j.1751-7915.2008.00061.x; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Liang YJ, 2014, J BIOL CHEM, V289, P21191, DOI 10.1074/jbc.M114.559773; Loris R, 2014, CHEM REV, V114, P6933, DOI 10.1021/cr400656f; Maehigashi T, 2015, NUCLEIC ACIDS RES, V43, P8002, DOI 10.1093/nar/gkv791; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; MEEDEL TH, 1974, J BACTERIOL, V118, P905, DOI 10.1128/JB.118.3.905-910.1974; Motiejunaite R, 2005, BIOLOGIJA, V4, P9; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Pecota DC, 1996, J BACTERIOL, V178, P2044, DOI 10.1128/jb.178.7.2044-2050.1996; Phadtare S, 2004, J BACTERIOL, V186, P7007, DOI 10.1128/JB.186.20.7007-7014.2004; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Ren D, 2004, APPL MICROBIOL BIOT, V64, P515, DOI 10.1007/s00253-003-1517-y; Rocker A, 2015, MOL MICROBIOL, V97, P589, DOI 10.1111/mmi.13051; ROUVIEREYANIV J, 1979, FEBS LETT, V106, P297, DOI 10.1016/0014-5793(79)80518-9; ROUVIEREYANIV J, 1975, P NATL ACAD SCI USA, V72, P3428, DOI 10.1073/pnas.72.9.3428; Ruangprasert A, 2014, J BIOL CHEM, V289, P20559, DOI 10.1074/jbc.M114.573006; SAGERS RD, 1961, J BACTERIOL, V81, P541, DOI 10.1128/JB.81.4.541-549.1961; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schuster CF, 2013, FEMS MICROBIOL LETT, V340, P73, DOI 10.1111/1574-6968.12074; Soo VWC, 2013, SCI REP-UK, V3, DOI 10.1038/srep03186; Sukhodolets MV, 2001, GENE DEV, V15, P3330, DOI 10.1101/gad.936701; Tamman H, 2014, J BACTERIOL, V196, P157, DOI 10.1128/JB.00851-13; Tan QA, 2011, MOL MICROBIOL, V79, P109, DOI 10.1111/j.1365-2958.2010.07433.x; Wang XX, 2012, NAT CHEM BIOL, V8, P855, DOI 10.1038/NCHEMBIO.1062; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Wang XX, 2011, NAT CHEM BIOL, V7, P359, DOI [10.1038/NCHEMBIO.560, 10.1038/nchembio.560]; Wood TK, 2013, APPL ENVIRON MICROB, V79, P7116, DOI 10.1128/AEM.02636-13	64	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161577	10.1371/journal.pone.0161577	http://dx.doi.org/10.1371/journal.pone.0161577			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27557125	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258100055
J	Al-Allawi, N; Mohammad, AM; Jamal, S				Al-Allawi, Nasir; Mohammad, Ameen M.; Jamal, Shakir			Doppler-Defined Pulmonary Hypertension in Sickle Cell Anemia in Kurdistan, Iraq	PLOS ONE			English	Article							EUROPEAN-ASSOCIATION; AMERICAN-SOCIETY; DISEASE PATIENTS; RISK-FACTORS; RIGHT HEART; CHILDREN; ECHOCARDIOGRAPHY; ADULTS; PREVALENCE; DEATH	To determine the frequency, clinical and laboratory associations of pulmonary hypertension in Iraqi Kurds with sickle cell anemia, a total of ninety four such patients attending a major hemoglobinopathy center in Iraqi Kurdistan were enrolled. All patients were re-evaluated clinically and had their blood counts, HbF, serum ferritin, LDH, renal and liver function assessed. Transthoracic Doppler echocardiography with measurement of tricuspid valve regurgitant jet velocity (TRV) was performed. A TRV in excess of 2.8 m/s was considered for the purposes of this study as indicative of pulmonary hypertension (PH). The prevalence of TRV in excess of 2.8m/s was 10.6%. By univariate analysis: significantly higher reticulocyte count, more frequent blood transfusions and pain episodes were encountered in the PH group as compared to the non-PH group (p = 0.001, 0.045 and 0.02 respectively). Moreover, PH patients had significantly higher mean right atrial area, left atrial size, E wave/A wave ratio and ejection fraction by echocardiography (p = 0.027, 0.037, <0.001 and 0.008 respectively). Except for reticulocyte count none of the other parameters remained significant by multivariate analysis (p = 0.024). In conclusion the current study revealed that pulmonary hypertension is rather frequent among Iraqi Kurds with sickle cell anemia, and identified reticulocyte count as an independently associated parameter with PH in this population. Future prospective studies including right heart catheterization and appropriate medical intervention are warranted.	[Al-Allawi, Nasir] Univ Duhok, Dept Pathol, Coll Med, Duhok, Kurdistan, Iraq; [Mohammad, Ameen M.] Univ Duhok, Dept Med, Coll Med, Duhok, Kurdistan, Iraq; [Jamal, Shakir] Azadi Teaching Hosp, Dept Hematol, Duhok, Kurdistan, Iraq	University of Duhok; University of Duhok	Mohammad, AM (corresponding author), Univ Duhok, Dept Med, Coll Med, Duhok, Kurdistan, Iraq.	doctoramb@yahoo.com						Al-Allawi NAS, 2012, HEMOGLOBIN, V36, P333, DOI 10.3109/03630269.2012.692344; Aliyu ZY, 2008, AM J HEMATOL, V83, P485, DOI 10.1002/ajh.21162; Ataga KI, 2004, AM J MED, V117, P665, DOI 10.1016/j.amjmed.2004.03.034; Ballas SK, 2011, HEMOGLOBIN, V35, P511, DOI 10.3109/03630269.2011.610477; Caughey MC, 2015, BRIT J HAEMATOL, V170, P416, DOI 10.1111/bjh.13447; Colombatti R, 2010, BRIT J HAEMATOL, V150, P601, DOI 10.1111/j.1365-2141.2010.08269.x; De Castro LM, 2008, AM J HEMATOL, V83, P19, DOI 10.1002/ajh.21058; Fonseca GHH, 2012, EUR RESPIR J, V39, P112, DOI 10.1183/09031936.00134410; Gladwin MT, 2008, NEW ENGL J MED, V359, P2254, DOI 10.1056/NEJMra0804411; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Hagar RW, 2008, BRIT J HAEMATOL, V140, P104, DOI 10.1111/j.1365-2141.2007.06822.x; Hamamy HA, 2013, J COMMUN GENET, V4, P147, DOI 10.1007/s12687-012-0127-8; Kato GJ, 2006, BLOOD, V107, P2279, DOI 10.1182/blood-2005-06-2373; Kato GJ, 2007, PEDIATR HEMAT ONCOL, V24, P159, DOI 10.1080/08880010601185892; Klings ES, 2014, AM J RESP CRIT CARE, V189, P727, DOI 10.1164/rccm.201401-0065ST; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lee MT, 2009, BRIT J HAEMATOL, V146, P437, DOI 10.1111/j.1365-2141.2009.07779.x; Machado RF, 2007, BRIT J HAEMATOL, V136, P319, DOI 10.1111/j.1365-2141.2006.06417.x; Marouf R, 2014, MED PRIN PRACT, V23, P212, DOI 10.1159/000362126; Mehari A, 2013, AM J RESP CRIT CARE, V187, P840, DOI 10.1164/rccm.201207-1222OC; Mehari A, 2012, JAMA-J AM MED ASSOC, V307, P1254, DOI 10.1001/jama.2012.358; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nef HM, 2010, HEART, V96, P552, DOI 10.1136/hrt.2008.156299; Nelson SC, 2007, J PEDIAT HEMATOL ONC, V29, P334, DOI 10.1097/MPH.0b013e31805d8f32; Parent F, 2011, NEW ENGL J MED, V365, P44, DOI 10.1056/NEJMoa1005565; Pashankar FD, 2008, PEDIATRICS, V121, P777, DOI 10.1542/peds.2007-0730; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Stuart MJ, 2004, LANCET, V364, P1343, DOI 10.1016/S0140-6736(04)17192-4; SUTTON LL, 1994, AM J CARDIOL, V74, P626, DOI 10.1016/0002-9149(94)90760-9	29	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162036	10.1371/journal.pone.0162036	http://dx.doi.org/10.1371/journal.pone.0162036			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583566	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600090
J	Borghi, SM; Pinho-Ribeiro, FA; Fattori, V; Bussmann, AJC; Vignoli, JA; Camilios-Neto, D; Casagrande, R; Verri, WA				Borghi, Sergio M.; Pinho-Ribeiro, Felipe A.; Fattori, Victor; Bussmann, Allan J. C.; Vignoli, Josiane A.; Camilios-Neto, Doumit; Casagrande, Rubia; Verri, Waldiceu A., Jr.			Quercetin Inhibits Peripheral and Spinal Cord Nociceptive Mechanisms to Reduce Intense Acute Swimming-Induced Muscle Pain in Mice	PLOS ONE			English	Article							NF-KAPPA-B; INDUCED OXIDATIVE STRESS; INDUCED INFLAMMATION; NRF2 EXPRESSION; TNF-ALPHA; HYPERALGESIA; EXERCISE; SUPEROXIDE; SUPPLEMENTATION; ACTIVATION	The present study aimed to evaluate the effects of the flavonoid quercetin (3,3', 4', 5,7-pen-tahydroxyflavone) in a mice model of intense acute swimming-induced muscle pain, which resembles delayed onset muscle soreness. Quercetin intraperitoneal (i.p.) treatment dose-dependently reduced muscle mechanical hyperalgesia. Quercetin inhibited myelo-peroxidase (MPO) and N-acetyl-beta-D-glucosaminidase (NAG) activities, cytokine production, oxidative stress, cyclooxygenase-2 (COX-2) and gp91(phox) mRNA expression and muscle injury (creatinine kinase [CK] blood levels and myoblast determination protein [MyoD] mRNA expression) as well as inhibited NF kappa B activation and induced Nrf2 and HO-1 mRNA expression in the soleus muscle. Beyond inhibiting those peripheral effects, quercetin also inhibited spinal cord cytokine production, oxidative stress and glial cells activation (glial fibrillary acidic protein [GFAP] and ionized calcium-binding adapter molecule 1 [Iba-1] mRNA expression). Concluding, the present data demonstrate that quercetin is a potential molecule for the treatment of muscle pain conditions related to unaccustomed exercise.	[Borghi, Sergio M.; Pinho-Ribeiro, Felipe A.; Fattori, Victor; Verri, Waldiceu A., Jr.] Univ Estadual Londrina, Dept Ciencias Patol, Ctr Ciencias Biol, Rodovia Celso Garcia Cid,Km 380,PR445, BR-86057970 Londrina, Parana, Brazil; [Bussmann, Allan J. C.] Univ Estadual Londrina, Lab Anat Patol, Ctr Ciencias Saude, Univ Hosp, Ave Robert Koch 60, BR-86039440 Londrina, Parana, Brazil; [Vignoli, Josiane A.; Camilios-Neto, Doumit] Univ Estadual Londrina, Dept Bioquim & Biotecnol, Ctr Ciencias Exatas, Rodovia Celso Garcia Cid,Km 380,PR445, BR-86057970 Londrina, Parana, Brazil; [Casagrande, Rubia] Univ Estadual Londrina, Dept Ciencias Farmaceut, Ctr Ciencias Exatas, Univ Hosp, Ave Robert Koch 60, BR-86039440 Londrina, Parana, Brazil	Universidade Estadual de Londrina; Universidade Estadual de Londrina; Universidade Estadual de Londrina; Universidade Estadual de Londrina	Verri, WA (corresponding author), Univ Estadual Londrina, Dept Ciencias Patol, Ctr Ciencias Biol, Rodovia Celso Garcia Cid,Km 380,PR445, BR-86057970 Londrina, Parana, Brazil.	waverri@uel.br	Fattori, Victor/C-2745-2016; Borghi, Sergio M/H-7137-2017; WA, Verri/I-1330-2013; Vignoli, Josiane/AFQ-1790-2022; de Pinho Ribeiro, Felipe Almeida/AAI-8107-2020; Casagrande, Rubia/I-1377-2013; Neto, Doumit Camilios/H-3688-2013; Casagrande, Rubia/U-6019-2019	Fattori, Victor/0000-0002-4565-7706; Borghi, Sergio M/0000-0002-6978-7505; WA, Verri/0000-0003-2756-9283; Vignoli, Josiane/0000-0002-8615-8161; de Pinho Ribeiro, Felipe Almeida/0000-0003-4264-9839; Neto, Doumit Camilios/0000-0002-1986-658X; Casagrande, Rubia/0000-0002-2296-1668	Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Araucaria; Parana State Government; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Parana State Government; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Brazilian grants from Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao Araucaria, Parana State Government and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work received financial support from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao Araucaria, Parana State Government and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). It is noteworthy to mention that this manuscript has been read and approved by all the authors, which contributed substantially to the work. The authors declare no conflict of interest.	Akram M, 2015, J ETHNOPHARMACOL, V174, P322, DOI 10.1016/j.jep.2015.08.028; Anjaneyulu M, 2003, PROG NEURO-PSYCHOPH, V27, P1001, DOI 10.1016/S0278-5846(03)00160-X; Askari G, 2012, J RES MED SCI, V17, P637; Azevedo MI, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-53; Bagul PK, 2015, J NUTR BIOCHEM, V26, P1298, DOI 10.1016/j.jnutbio.2015.06.006; Borghi SM, 2015, EXP PHYSIOL, V100, P531, DOI 10.1113/EP085026; Borghi SM, 2014, J PHARM PHARMACOL, V66, P1009, DOI 10.1111/jphp.12226; Borghi SM, 2014, PHYSIOL BEHAV, V128, P277, DOI 10.1016/j.physbeh.2014.01.023; Calixto-Campos C, 2015, ANAL CELL PATHOL, V2015, DOI 10.1155/2015/285708; Carvalho TT, 2015, EUR J PHARMACOL, V749, P62, DOI 10.1016/j.ejphar.2014.12.023; Chacur M, 2009, EUR J PAIN, V13, P915, DOI 10.1016/j.ejpain.2008.11.008; Chen XL, 2004, AM J PHYSIOL-HEART C, V286, pH1001, DOI 10.1152/ajpheart.00716.2003; Cheung K, 2003, SPORTS MED, V33, P145, DOI 10.2165/00007256-200333020-00005; Cleto LS, 2011, BRAZ J MED BIOL RES, V44, P546, DOI 10.1590/S0100-879X2011007500050; Cunha TM, 2004, BRAZ J MED BIOL RES, V37, P401, DOI 10.1590/S0100-879X2004000300018; Diaz-Ruiz A, 2009, NEUROSCI LETT, V452, P56, DOI 10.1016/j.neulet.2009.01.020; Ding Y, 2014, CHINESE MED J-PEKING, V127, P3265, DOI 10.3760/cma.j.issn.0366-6999.20141191; FACCIOLI LH, 1990, AGENTS ACTIONS, V30, P344, DOI 10.1007/BF01966298; Faria A, 2014, FOOD CHEM, V149, P190, DOI 10.1016/j.foodchem.2013.10.095; Fattori V, 2015, INFLAMM RES, V64, P993, DOI 10.1007/s00011-015-0885-y; Gao C, 2014, EUR J APPL PHYSIOL, V114, P695, DOI 10.1007/s00421-013-2802-9; Gao YJ, 2010, PHARMACOL THERAPEUT, V126, P56, DOI 10.1016/j.pharmthera.2010.01.002; Gao Z, 2014, BIOCHEM PHARMACOL, V91, P474, DOI 10.1016/j.bcp.2014.08.009; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Grau JW, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00100; Graven-Nielsen Thomas, 2003, Curr Pain Headache Rep, V7, P443, DOI 10.1007/s11916-003-0060-y; Guazelli CFS, 2013, J NAT PROD, V76, P200, DOI 10.1021/np300670w; Guedes RP, 2009, BRAIN RES BULL, V80, P422, DOI 10.1016/j.brainresbull.2009.08.007; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hohmann MSN, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/627046; Hsu CC, 2013, BIOCHEM PHARMACOL, V85, P385, DOI 10.1016/j.bcp.2012.11.002; Huang JQ, 2012, J PHARM PHARMACOL, V64, P1119, DOI 10.1111/j.2042-7158.2012.01504.x; Jang M, 2016, J PAIN, V17, P282, DOI 10.1016/j.jpain.2015.10.007; Kang JS, 2010, CURR OPIN CLIN NUTR, V13, P243, DOI 10.1097/MCO.0b013e328336ea98; Kiyomoto M, 2013, J NEUROSCI, V33, P7667, DOI 10.1523/JNEUROSCI.4968-12.2013; Konrad M, 2011, INT J SPORT NUTR EXE, V21, P338, DOI 10.1123/ijsnem.21.4.338; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Liu XD, 2009, ARCH ORAL BIOL, V54, P1143, DOI 10.1016/j.archoralbio.2009.09.006; Maioli NA, 2015, BRAZ J MED BIOL RES, V48, P321, DOI [10.1590/1414-431X20144187, 10.1590/1414-431x20144187]; Marina R, 2015, MOL MED REP, V11, P539, DOI 10.3892/mmr.2014.2741; McAnulty SR, 2008, APPL PHYSIOL NUTR ME, V33, P254, DOI 10.1139/H07-177; Murase S, 2013, J PHYSIOL-LONDON, V591, P3035, DOI 10.1113/jphysiol.2012.249235; Nakao S, 2002, MOL CELL BIOCHEM, V238, P11, DOI 10.1023/A:1019927616000; Nieman DC, 2007, J APPL PHYSIOL, V103, P1728, DOI 10.1152/japplphysiol.00707.2007; Nieman DC, 2009, MED SCI SPORT EXER, V41, P1467, DOI 10.1249/MSS.0b013e318199491f; O'Fallon KS, 2012, INT J SPORT NUTR EXE, V22, P430, DOI 10.1123/ijsnem.22.6.430; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Pinho-Ribeiro FA, 2016, NEUROPHARMACOLOGY, V105, P508, DOI 10.1016/j.neuropharm.2016.02.019; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Ramyaa P, 2014, BBA-GEN SUBJECTS, V1840, P681, DOI 10.1016/j.bbagen.2013.10.024; Ruiz-Miyazawa KW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118942; Schiavuzzo JG, 2015, NEUROSCIENCE, V285, P24, DOI 10.1016/j.neuroscience.2014.11.020; Seo MJ, 2015, J NUTR BIOCHEM, V26, P1308, DOI 10.1016/j.jnutbio.2015.06.005; Souza GR, 2013, P NATL ACAD SCI USA, V110, P11193, DOI 10.1073/pnas.1307445110; Tenschert S, 2004, NEUROSCI LETT, V361, P196, DOI 10.1016/j.neulet.2003.12.003; Testa G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096795; Valerio DA, 2009, J NAT PROD, V72, P1975, DOI 10.1021/np900259y; Verri WA, 2006, PHARMACOL THERAPEUT, V112, P116, DOI 10.1016/j.pharmthera.2006.04.001; Verri WA, 2012, STUD NAT PROD CHEM, V36, P297, DOI 10.1016/B978-0-444-53836-9.00026-8; Vicentini FTMC, 2011, J DERMATOL SCI, V61, P162, DOI 10.1016/j.jdermsci.2011.01.002; Wang DM, 2014, EUR J PHARMACOL, V728, P59, DOI 10.1016/j.ejphar.2014.01.057; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Wang ZQ, 2004, J PHARMACOL EXP THER, V309, P869, DOI 10.1124/jpet.103.064154; Wiczkowski W, 2015, MOL NUTR FOOD RES, V59, P1088, DOI 10.1002/mnfr.201400567; Willain A, 2008, ARCH PHARM RES, V31, P713, DOI 10.1007/s12272-001-1217-2; Xu X, 2015, MEDIAT INFLAMM, V2015, DOI [10.1155/2015/810798, 10.1155/2015/380218]; Yang T, 2014, CELL MOL NEUROBIOL, V34, P797, DOI 10.1007/s10571-014-0070-9; Zarpelon AC, 2016, FASEB J, V30, P54, DOI 10.1096/fj.14-267146; Zhao YJ, 2015, PHYSIOL BEHAV, V142, P57, DOI 10.1016/j.physbeh.2015.02.005	70	31	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162267	10.1371/journal.pone.0162267	http://dx.doi.org/10.1371/journal.pone.0162267			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583449	Green Published, gold, Green Submitted			2022-12-26	WOS:000382855600126
J	Park, SM; Shin, SY; Cho, KH				Park, Sang-Min; Shin, Sung-Young; Cho, Kwang-Hyun			A Regulated Double-Negative Feedback Decodes the Temporal Gradient of Input Stimulation in a Cell Signaling Network	PLOS ONE			English	Article							SYSTEMS BIOLOGY; DYNAMICS; FATE; TRANSDUCTION; INFORMATION; BISTABILITY; SENSITIVITY; COORDINATE; MOTIFS; KINASE	Revealing the hidden mechanism of how cells sense and react to environmental signals has been a central question in cell biology. We focused on the rate of increase of stimulation, or temporal gradient, known to cause different responses of cells. We have investigated all possible three-node enzymatic networks and identified a network motif that robustly generates a transient or sustained response by acute or gradual stimulation, respectively. We also found that a regulated double-negative feedback within the motif is essential for the temporal gradient-sensitive switching. Our analysis highlights the essential structure and mechanism enabling cells to properly respond to dynamic environmental changes.	[Park, Sang-Min; Shin, Sung-Young; Cho, Kwang-Hyun] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, 291 Daehak Ro, Daejeon 34141, South Korea; [Shin, Sung-Young] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Shin, Sung-Young] Monash Univ, Biomed Discovery Inst, Clayton, Vic 3800, Australia	Korea Advanced Institute of Science & Technology (KAIST); Monash University; Monash University	Cho, KH (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, 291 Daehak Ro, Daejeon 34141, South Korea.	ckh@kaist.ac.kr	Cho, Kwang-Hyun/C-1684-2011; Shin, Sungyoung/B-7336-2018	Shin, Sungyoung/0000-0002-1447-9687	National Research Foundation of Korea (NRF) - Korea Government, Ministry of Science, ICT & Future Planning [2015M3A9A7067220, 2014R1A2A1A10052404, 2013M3A9A7046303]; KUSTAR-KAIST Institute, Korea under the RD program; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C2162]; KAIST Future Systems Healthcare Project from the Ministry of Science, ICT and Future Planning	National Research Foundation of Korea (NRF) - Korea Government, Ministry of Science, ICT & Future Planning; KUSTAR-KAIST Institute, Korea under the RD program; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; KAIST Future Systems Healthcare Project from the Ministry of Science, ICT and Future Planning	This work was supported by the National Research Foundation of Korea (NRF) grants funded by the Korea Government, the Ministry of Science, ICT & Future Planning (2015M3A9A7067220, 2014R1A2A1A10052404 and 2013M3A9A7046303). This work was also supported by the KUSTAR-KAIST Institute, Korea, under the R&D program supervised by the KAIST, the grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C2162), and the KAIST Future Systems Healthcare Project from the Ministry of Science, ICT and Future Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagha A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00426; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Ashwin P, 2012, PHILOS T R SOC A, V370, P1166, DOI 10.1098/rsta.2011.0306; Behar M, 2010, CURR OPIN GENET DEV, V20, P684, DOI 10.1016/j.gde.2010.09.007; Bergmann S, 2007, PLOS BIOL, V5, P232, DOI 10.1371/journal.pbio.0050046; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Chakrabarty A, 2012, P NATL ACAD SCI USA, V109, P2718, DOI 10.1073/pnas.1018001108; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Cullen PJ, 2003, CURR BIOL, V13, pR699, DOI 10.1016/j.cub.2003.08.041; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Dovzhenok A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042811; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Hoare A, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-4; IZHIKEVICH EM, 2007, DYNAMICAL SYSTEMS IN; Ji YY, 2010, NAT NEUROSCI, V13, P302, DOI 10.1038/nn.2505; Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004; Ma WZ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100111; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Meng XY, 2012, DISCRETE CONT DYN-A, V32, P2729, DOI 10.3934/dcds.2012.32.2729; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nene NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040085; Nene NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032779; Nguyen LK, 2015, CELL CYCLE, V14, P189, DOI 10.4161/15384101.2014.973743; Perryman C, 2014, P ROY SOC A-MATH PHY, V470, DOI 10.1098/rspa.2014.0226; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Ratte S, 2013, NEURON, V78, P758, DOI 10.1016/j.neuron.2013.05.030; Saka Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-47; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Sauro HM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.3; Schneider A, 2012, BIOESSAYS, V34, P542, DOI 10.1002/bies.201100172; Selimkhanov J, 2014, SCIENCE, V346, P1370, DOI 10.1126/science.1254933; Shin SY, 2010, CANCER RES, V70, P6715, DOI 10.1158/0008-5472.CAN-10-1377; Shin SY, 2009, J CELL SCI, V122, P425, DOI 10.1242/jcs.036319; Smedler E, 2014, BBA-GEN SUBJECTS, V1840, P964, DOI 10.1016/j.bbagen.2013.11.015; Sokolowski TR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002654; Stocker TF, 1997, NATURE, V388, P862, DOI 10.1038/42224; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457; Wolkenhauer O, 2005, MOL BIOSYST, V1, P14, DOI 10.1039/b502088n; Yao G, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.19; Young JW, 2013, P NATL ACAD SCI USA, V110, P4140, DOI 10.1073/pnas.1213060110	47	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162153	10.1371/journal.pone.0162153	http://dx.doi.org/10.1371/journal.pone.0162153			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584002	gold, Green Submitted, Green Published			2022-12-26	WOS:000382855600113
J	Patel, P; Kato, T; Ujiie, H; Wada, H; Lee, D; Hu, HP; Hirohashi, K; Ahn, JY; Zheng, JZ; Yasufuku, K				Patel, Priya; Kato, Tatsuya; Ujiie, Hideki; Wada, Hironobu; Lee, Daiyoon; Hu, Hsin-pei; Hirohashi, Kentaro; Ahn, Jin Young; Zheng, Jinzi; Yasufuku, Kazuhiro			Multi-Modal Imaging in a Mouse Model of Orthotopic Lung Cancer	PLOS ONE			English	Article							CONTRAST AGENT; CT; LOCALIZATION; TELOMERASE; GFP	Background Investigation of CF800, a novel PEGylated nano-liposomal imaging agent containing indocyanine green (ICG) and iohexol, for real-time near infrared (NIR) fluorescence and computed tomography (CT) image-guided surgery in an orthotopic lung cancer model in nude mice. Methods CF800 was intravenously administered into 13 mice bearing the H460 orthotopic human lung cancer. At 48 h post-injection (peak imaging agent accumulation time point), ex vivo NIR and CT imaging was performed. A clinical NIR imaging system (SPY (R), Novadaq) was used to measure fluorescence intensity of tumor and lung. Tumor-to-background-ratios (TBR) were calculated in inflated and deflated states. The mean Hounsfield unit (HU) of lung tumor was quantified using the CT data set and a semi-automated threshold-based method. Histological evaluation using H&E, the macrophage marker F4/80 and the endothelial cell marker CD31, was performed, and compared to the liposomal fluorescence signal obtained from adjacent tissue sections Results The fluorescence TBR measured when the lung is in the inflated state (2.0 +/- 0.58) was significantly greater than in the deflated state (1.42 +/- 0.380 (n = 7, p<0.003). Mean fluorescent signal in tumor was highly variable across samples, (49.0 +/- 18.8 AU). CT image analysis revealed greater contrast enhancement in lung tumors (a mean increase of 110 +/- 57 HU) when CF800 is administered compared to the no contrast enhanced tumors (p = 0.0002). Conclusion Preliminary data suggests that the high fluorescence TBR and CT tumor contrast enhancement provided by CF800 may have clinical utility in localization of lung cancer during CT and NIR image-guided surgery.	[Patel, Priya; Kato, Tatsuya; Ujiie, Hideki; Wada, Hironobu; Lee, Daiyoon; Hu, Hsin-pei; Hirohashi, Kentaro; Ahn, Jin Young; Yasufuku, Kazuhiro] Univ Hlth Network, Toronto Gen Hosp, Div Thorac Surg, Toronto, ON, Canada; [Zheng, Jinzi; Yasufuku, Kazuhiro] Univ Hlth Network, TECHNA Inst, Toronto, ON, Canada; [Zheng, Jinzi; Yasufuku, Kazuhiro] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Yasufuku, K (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Div Thorac Surg, Toronto, ON, Canada.; Zheng, JZ; Yasufuku, K (corresponding author), Univ Hlth Network, TECHNA Inst, Toronto, ON, Canada.; Zheng, JZ; Yasufuku, K (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 1A1, Canada.	jinzi.zheng@rmp.uhn.on.ca; kazuhiro.yasufuku@uhn.ca	Ujiie, Hideki/I-1939-2019	Ujiie, Hideki/0000-0001-6119-8776; Zheng, Jinzi/0000-0002-7650-3910; Patel, Priya/0000-0002-5886-8481	Canadian Cancer Society Research Institute (CCSRI) Innovation Grant; Princess Margaret Cancer Foundation; Spatio-Temporal Targeting and Amplification of Radiation Response (STTARR) program	Canadian Cancer Society Research Institute (CCSRI) Innovation Grant; Princess Margaret Cancer Foundation(University of Toronto); Spatio-Temporal Targeting and Amplification of Radiation Response (STTARR) program	The authors would like to thank Novadaq Inc. for providing the PINPOINT (R) system for our studies. We are grateful to the funding agencies and following grants for supporting the work and staff involved in this research: Canadian Cancer Society Research Institute (CCSRI) Innovation Grant, Princess Margaret Cancer Foundation, Spatio-Temporal Targeting and Amplification of Radiation Response (STTARR) program and its affiliated funding agencies. We would also like to acknowledge Dr. Trevor McKee for histology image analysis, Ms. Linyu Fan for liposome preparation, and Ms. Maria Bisa for animal technical services.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Buseman CM, 2012, MUTAT RES-FUND MOL M, V730, P90, DOI 10.1016/j.mrfmmm.2011.07.006; Dunne M, 2011, J CONTROL RELEASE, V154, P298, DOI 10.1016/j.jconrel.2011.05.022; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Howington JA, 2013, CHEST, V143, pE278, DOI 10.1378/chest.12-2359; Ichinose J, 2013, ANN THORAC SURG, V96, P1203, DOI 10.1016/j.athoracsur.2013.05.026; Kirpotin DB, 2006, CANCER RES, V66, P6732, DOI 10.1158/0008-5472.CAN-05-4199; Kishimoto H, 2011, CELL CYCLE, V10, P2737, DOI 10.4161/cc.10.16.16756; Kishimoto H, 2009, P NATL ACAD SCI USA, V106, P14514, DOI 10.1073/pnas.0906388106; Kunhachan S, 2014, NANO LETT, V14, P972, DOI [10.1021/nl404391r, DOI 10.1021/NL404391R]; Mayo JR, 2009, RADIOLOGY, V250, P576, DOI 10.1148/radiol.2502080442; Nakajima T, 2014, ANN THORAC SURG, V97, P1771, DOI 10.1016/j.athoracsur.2014.01.048; O'Shannessy DJ, 2012, ONCOTARGET, V3, P414; Silverman JD, 2009, MED PHYS, V36, P1700, DOI 10.1118/1.3112363; Takizawa H, 2014, J THORAC CARDIOV SUR, V147, pE50, DOI 10.1016/j.jtcvs.2013.12.058; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; Yano S, 2015, CANCER GENE THER, V22, P344, DOI 10.1038/cgt.2015.26; Yano S, 2016, PLOS ONE, V11; Yano S, 2015, ONCOTARGET, V6, P13133, DOI 10.18632/oncotarget.3811; Zheng JZ, 2007, PHARM RES-DORDR, V24, P1193, DOI 10.1007/s11095-006-9220-1; Zheng JZ, 2015, BIOMATERIALS, V67, P160, DOI 10.1016/j.biomaterials.2015.07.010; Zheng JZ, 2010, CONTRAST MEDIA MOL I, V5, P147, DOI 10.1002/cmmi.378; Zheng J, 2009, MOL PHARMACEUT, V6, P571, DOI 10.1021/mp800234r	23	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161991	10.1371/journal.pone.0161991	http://dx.doi.org/10.1371/journal.pone.0161991			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584018	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600082
J	Sengupta, T; Manoj, N				Sengupta, Tanusree; Manoj, Narayanan			Phosphatidylserine and Phosphatidylethanolamine Bind to Protein Z Cooperatively and with Equal Affinity	PLOS ONE			English	Article							FACTOR X-A; KINETIC CHARACTERIZATION; MOLECULAR DETERMINANTS; PROTHROMBINASE COMPLEX; FACTOR-VIII; INHIBITOR; COAGULATION; ACTIVATION; DOMAIN; MEMBRANES	Protein Z (PZ) is an anticoagulant that binds with high affinity to Protein Z-dependent protease inhibitor (ZPI) and accelerates the rate of ZPI-mediated inhibition of factor Xa (fXa) by more than 1000-fold in the presence of Ca2+ and phospholipids. PZ promotion of the ZPI-fXa interaction results from the anchoring of the Gla domain of PZ onto phospholipid surfaces and positioning the bound ZPI in close proximity to the Gla-anchored fXa, forming a ternary complex of PZ/ZPI/fXa. Although interaction of PZ with phospholipid membrane appears to be absolutely crucial for its cofactor activity, little is known about the binding of different phospholipids to PZ. The present study was conceived to understand the interaction of different phospholipids with PZ. Experiments with both soluble lipids and model membranes revealed that PZ binds to phosphatidylserine (PS) and phosphatidylethanolamine (PE) with equal affinity (K-d similar to 48 mu M); further, PS and PE bound to PZ synergistically. Equilibrium dialysis experiments revealed two lipid-binding sites for both PS and PE. PZ binds with weaker affinity to other phospholipids, e.g., phosphatidic acid, phosphatidylglycerol, phosphatidylcholine and binding of these lipids is not synergistic with respect to PS. Both PS and PE -containing membranes supported the formation of a fXa-PZ complex. PZ protection of fXa from antithrombin inhibition were also shown to be comparable in presence of both PS: PC and PE: PC membranes. These findings are particularly important and intriguing since they suggest a special affinity of PZ, in vivo, towards activated platelets, the primary membrane involved in blood coagulation process.	[Sengupta, Tanusree; Manoj, Narayanan] Indian Inst Technol, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Sengupta, T (corresponding author), Indian Inst Technol, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	tanusree@imail.iitm.ac.in	S, Tanusree/AAI-8680-2021; Manoj, Narayanan/W-2301-2019	S, Tanusree/0000-0002-6828-667X; Manoj, Narayanan/0000-0002-8144-1566	Department of Biotechnology (DBT); Ministry of Science and Technology, Government of India (GoI) [BT/BIO-CARE/01/88/2011-12]; Bio-CARe scheme of the DBT, GoI	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Ministry of Science and Technology, Government of India (GoI); Bio-CARe scheme of the DBT, GoI	This work received funding from the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India (GoI) and was supported by grant number BT/BIO-CARE/01/88/2011-12. TS is supported by funding from the Bio-CARe scheme of the DBT, GoI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandari S, 2014, CHEM PHYS LIPIDS, V184, P25, DOI 10.1016/j.chemphyslip.2014.09.001; Banerjee M, 2002, SPECIFICITY SOLUBLE, P7751; BROZE GJ, 1984, J CLIN INVEST, V73, P933, DOI 10.1172/JCI111317; Chattopadhyay R, 2012, ARTERIOSCL THROM VAS, V32, P2387, DOI 10.1161/ATVBAHA.112.250928; Clark SR, 2013, P NATL ACAD SCI USA, V110, P5875, DOI 10.1073/pnas.1222419110; Dayer Mohammad Reza, 2012, ISRN Hematol, V2012, P762728, DOI 10.5402/2012/762728; GILBERT GE, 1990, J BIOL CHEM, V265, P815; Han X, 1998, P NATL ACAD SCI USA, V95, P9250, DOI 10.1073/pnas.95.16.9250; Huang X, 2008, J BIOL CHEM, V283, P29770, DOI 10.1074/jbc.M805214200; Huang X, 2015, J BIOL CHEM, V290, P9906, DOI 10.1074/jbc.M114.633479; Huang X, 2010, J BIOL CHEM, V285, P20399, DOI 10.1074/jbc.M110.112748; ICHINOSE A, 1990, BIOCHEM BIOPH RES CO, V172, P1139, DOI 10.1016/0006-291X(90)91566-B; JONES ME, 1985, THROMB RES, V39, P711, DOI 10.1016/0049-3848(85)90255-5; KALYANASUNDARAM K, 1977, J AM CHEM SOC, V99, P2039, DOI 10.1021/ja00449a004; Karimi Z, 2012, BIOINFORMATION, V8, P407, DOI 10.6026/97320630008407; Majumder R, 2005, BIOCHEMISTRY-US, V44, P16998, DOI 10.1021/bi051469f; Majumder R, 2003, BIOPHYS J, V84, P1238, DOI 10.1016/S0006-3495(03)74939-X; Majumder R, 2008, BLOOD, V112, P2795, DOI 10.1182/blood-2008-02-138941; Majumder R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100006; Majumder R, 2011, J BIOL CHEM, V286, P35535, DOI 10.1074/jbc.M111.260141; McDonald JF, 1997, BIOCHEMISTRY-US, V36, P5120, DOI 10.1021/bi9626160; Morrissey JH, 2008, THROMB RES, V122, pS23, DOI 10.1016/S0049-3848(08)70014-8; NEUENSCHWANDER PF, 1995, BIOCHEMISTRY-US, V34, P13988, DOI 10.1021/bi00043a004; Okajima K, 2001, IMMUNOL REV, V184, P258, DOI 10.1034/j.1600-065x.2001.1840123.x; Peng WM, 2004, BIOCHEMISTRY-US, V43, P4385, DOI 10.1021/bi035763o; Qureshi SH, 2014, BBA-PROTEINS PROTEOM, V1844, P1631, DOI 10.1016/j.bbapap.2014.06.011; RAWALASHEIKH R, 1992, BLOOD, V79, P398; Rezaie AR, 2008, J BIOL CHEM, V283, P19922, DOI 10.1074/jbc.M802639200; Saenko EL, 1999, TRENDS CARDIOVAS MED, V9, P185, DOI 10.1016/S1050-1738(00)00019-0; SHAW MC, 1971, ANAL BIOCHEM, V44, P288, DOI 10.1016/0003-2697(71)90371-X; SMIRNOV MD, 1994, J BIOL CHEM, V269, P816; Srivastava A, 2002, J BIOL CHEM, V277, P1855, DOI 10.1074/jbc.M105697200; Tavoosi N, 2013, BIOCHEMISTRY-US, V52, P5545, DOI 10.1021/bi4006368; Tavoosi N, 2011, J BIOL CHEM, V286, P23247, DOI 10.1074/jbc.M111.251769; Vasse M, 2011, HAMOSTASEOLOGIE, V31, P155, DOI 10.5482/ha-1161; Wei ZQ, 2009, BLOOD, V114, P3662, DOI 10.1182/blood-2009-04-210021; Yegneswaran S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135025; Yin ZF, 2000, P NATL ACAD SCI USA, V97, P6734, DOI 10.1073/pnas.120081897; Zhai X, 2002, BIOCHEMISTRY-US, V41, P5675, DOI 10.1021/bi011844d	39	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161896	10.1371/journal.pone.0161896	http://dx.doi.org/10.1371/journal.pone.0161896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584039	gold, Green Submitted, Green Published			2022-12-26	WOS:000382855600072
J	Brooks, AT; Krumlauf, M; Fryer, CS; Beck, KH; Yang, L; Ramchandani, VA; Wallen, GR				Brooks, Alyssa Todaro; Krumlauf, Michael; Fryer, Craig S.; Beck, Kenneth H.; Yang, Li; Ramchandani, Vijay A.; Wallen, Gwenyth R.			Critical Transitions: A Mixed Methods Examination of Sleep from Inpatient Alcohol Rehabilitation Treatment to the Community	PLOS ONE			English	Article							QUALITY INDEX; DAYTIME SLEEPINESS; DEPENDENT PATIENTS; INSOMNIA; SCALE; ABSTINENCE; DRINKING; DURATION; RELAPSE; DEPRESSION	Aims This prospective, repeated measures study utilized a convergent parallel mixed methods approach to assess sleep experiences among individuals who were alcohol-dependent undergoing inpatient detoxification and treatment at a clinical research facility across the transition periods associated with the rehabilitation process: the initial adjustment to becoming an inpatient and the transition from inpatient to outpatient status. Methods This study included individual semi-structured interviews and quantitative measures relating to psychological distress, sleep quality, daytime sleepiness, and sleep-related beliefs and behavior (n = 33; 66.7% male). Interviews were conducted and questionnaires were administered within one week of participants' scheduled discharge date and again four to six weeks post-discharge when they returned for a follow-up visit (or via phone). Results Participants self-reported significant sleep disturbances at both study time points. Of those participants with valid data at both time points (n = 28), there were no significant changes in mean scores from pre- to post-discharge with the exception of self-efficacy for sleep (SE-S) being significantly higher post-discharge. Preliminary qualitative findings suggested differences between those with ongoing sleep disturbances, those whose sleep disturbances had resolved, and those with no sleep disturbances at either time point. Conclusions This analysis highlights individual variation in sleep throughout the process of inpatient treatment and transition to outpatient aftercare in individuals with alcohol dependence. Collecting quantitative and qualitative data concurrently and combining emerging themes from qualitative data with quantitative analyses allowed for a more thorough examination of this relatively novel area of research and provided information that can be utilized to inform future behavioral sleep interventions.	[Brooks, Alyssa Todaro; Krumlauf, Michael; Yang, Li; Wallen, Gwenyth R.] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Brooks, Alyssa Todaro; Ramchandani, Vijay A.] NIAAA, Bethesda, MD 20892 USA; [Fryer, Craig S.; Beck, Kenneth H.] Univ Maryland, Sch Publ Hlth, Dept Behav & Community Hlth, College Pk, MD 20742 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University System of Maryland; University of Maryland College Park	Brooks, AT (corresponding author), NIH, Ctr Clin, Bethesda, MD 20892 USA.; Brooks, AT (corresponding author), NIAAA, Bethesda, MD 20892 USA.	todaroad@mail.nih.gov; gwallen@cc.nih.gov	Fryer, Craig/N-1744-2014; Ramchandani, Vijay A./N-5081-2018	Ramchandani, Vijay A./0000-0003-2474-2183; Krumlauf, Michael/0000-0002-2955-2998	National Institutes of Health, Clinical Center intramural research program; NATIONAL CANCER INSTITUTE [K01CA148789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000466] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006737] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL002000] Funding Source: NIH RePORTER	National Institutes of Health, Clinical Center intramural research program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); CLINICAL CENTER	This project has been funded in whole or in part with federal funds from the National Institutes of Health, Clinical Center intramural research program. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government.	ALLING C, 1982, ACTA PSYCHIAT SCAND, V66, P384, DOI 10.1111/j.1600-0447.1982.tb06720.x; ASBERG M, 1978, ACTA PSYCHIAT SCAND, P5; Ayas NT, 2003, DIABETES CARE, V26, P380, DOI 10.2337/diacare.26.2.380; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Barroso J., 2010, NURSING RES METHODS; Benca RM, 1996, NEUROL CLIN, V14, P739, DOI 10.1016/S0733-8619(05)70283-8; Bishop FL, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/187365; Brooks AT, 2014, SUBST ABUS-RES TREAT, V8, P55, DOI 10.4137/SART.S18446; Brower KJ, 2011, AM J ADDICTION, V20, P435, DOI 10.1111/j.1521-0391.2011.00152.x; Brower KJ, 2001, AM J PSYCHIAT, V158, P399, DOI 10.1176/appi.ajp.158.3.399; Brower KJ, 2001, ALCOHOL RES HEALTH, V25, P110; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chaudhary NS, 2015, ADDICT BEHAV, V50, P165, DOI 10.1016/j.addbeh.2015.06.021; Conroy DA, 2006, ALCOHOL CLIN EXP RES, V30, P1992, DOI 10.1111/j.1530-0277.2006.00245.x; Creswell W. C., 2011, DESIGNING CONDUCTING; Doi Y, 2000, PSYCHIAT RES, V97, P165, DOI 10.1016/S0165-1781(00)00232-8; Dominguez D, 2012, CONTEMP CLIN TRIALS, V33, P860, DOI 10.1016/j.cct.2012.05.001; Drummond SPA, 1998, ALCOHOL CLIN EXP RES, V22, P1796, DOI 10.1097/00000374-199811000-00026; Edinger JD, 2007, SLEEP, V30, P203, DOI 10.1093/sleep/30.2.203; First M. B., 2002, USERS GUIDE SCID 1 S; Flannery BA, 1999, ALCOHOL CLIN EXP RES, V23, P1289, DOI 10.1097/00000374-199908000-00001; Foster JH, 1999, ALCOHOL CLIN EXP RES, V23, P1044, DOI 10.1111/j.1530-0277.1999.tb04223.x; GILLIN JC, 1990, BIOL PSYCHIAT, V27, P477, DOI 10.1016/0006-3223(90)90439-9; Gillin JC, 2000, PRINCIPLES PRACTICE; HANSON M, 1994, HEALTH SOC WORK, V19, P23, DOI 10.1093/hsw/19.1.23; JOHNS MW, 1993, CHEST, V103, P30, DOI 10.1378/chest.103.1.30; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kolla BP, 2015, AM J ADDICTION, V24, P362, DOI 10.1111/ajad.12199; Landolt HP, 2001, CNS DRUGS, V15, P413, DOI 10.2165/00023210-200115050-00006; Levola J, 2014, NORD J PSYCHIAT, V68, P369, DOI 10.3109/08039488.2013.852242; McKay James R, 2006, Curr Psychiatry Rep, V8, P355; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Morin CM, 2007, SLEEP, V30, P1547, DOI 10.1093/sleep/30.11.1547; MOSSBERG D, 1985, ALCOHOL, V2, P551, DOI 10.1016/0741-8329(85)90133-8; National Heart Lunch and Blood Institute (NHLBI), 2011, WHAT IS INS; Newman I, 2003, HDB MIXED METHODS SO; Ree MJ, 2004, BEHAV CHANGE, V21, P26, DOI 10.1375/bech.21.1.26.35971; Schaefer JA, 2008, J STUD ALCOHOL DRUGS, V69, P747, DOI 10.15288/jsad.2008.69.747; Sobell LC, 1992, MEASURING ALCOHOL CO, P42; Strine TW, 2005, SLEEP MED, V6, P23, DOI 10.1016/j.sleep.2004.06.003; SULLIVAN JT, 1989, BRIT J ADDICT, V84, P1353; Teplin D, 2006, AM J DRUG ALCOHOL AB, V32, P111, DOI 10.1080/00952990500328695; TYRER P, 1984, J NEUROL NEUROSUR PS, V47, P970, DOI 10.1136/jnnp.47.9.970; Vgontzas AN, 2009, DIABETES CARE, V32, P1980, DOI 10.2337/dc09-0284; Vgontzas AN, 2009, SLEEP, V32, P491, DOI 10.1093/sleep/32.4.491; Vitiello MV, 1997, ADDICT BIOL, V2, P151, DOI 10.1080/13556219772697; Wallen GR, 2014, FAM COMMUNITY HEALTH, V37, P288, DOI 10.1097/FCH.0000000000000040; WHO, 2013, PUBL HLTH PROBL CAUS; World Health Organization, 2013, ALCOHOL	49	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161725	10.1371/journal.pone.0161725	http://dx.doi.org/10.1371/journal.pone.0161725			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4DZ	27571353	Green Submitted, Green Published, gold			2022-12-26	WOS:000382876700030
J	Amadou, A; Biessy, C; Rinaldi, S; Fedirko, V; Assi, N; Lajous, M; Ortiz-Panozo, E; Yunes, E; Lopez-Ridaura, R; Torres-Mejia, G; Romieu, I				Amadou, Amina; Biessy, Carine; Rinaldi, Sabina; Fedirko, Veronika; Assi, Nada; Lajous, Martin; Ortiz-Panozo, Eduardo; Yunes, Elsa; Lopez-Ridaura, Ruy; Torres-Mejia, Gabriela; Romieu, Isabelle			Serum 25-Hydroxyvitamin D-3 and Mammography Density among Mexican Women	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-3; VITAMIN-D DEFICIENCY; BREAST-CANCER RISK; GROWTH-FACTOR-I; POSTMENOPAUSAL WOMEN; CLINICAL-PRACTICE; ASSOCIATION; MECHANISMS; PREMENOPAUSAL; POLYMORPHISMS	Low circulating levels of vitamin D and high mammographic density (MD) have been associated with higher risk of breast cancer. Although some evidence suggested an inverse association between circulating vitamin D and MD, no studies have investigated this association among Mexican women. We examined whether serum 25 -hydroxyvitamin D3 [25 (OH) D3] levels were associated with MD in a cross-sectional study nested within the large Mexican Teacher's Cohort. This study included 491 premenopausal women with a mean age of 42.9 years. Serum 25(OH) D3 levels were measured by liquid chromatography/tandem mass spectrometry. Linear regression and non-linear adjusted models were used to estimate the association of MD with serum 25(OH) D3. Median serum 25(OH) D3 level was 27.3 (23.3-32.8) (ng/ml). Forty one (8%) women had 25(OH) D3 levels in the deficient range (< 20 ng/ml). Body mass index (BMI) and total physical activity were significantly correlated with 25(OH) D3 (r = -0.109, P = 0.019 and r = 0.095, P = 0.003, respectively). In the multivariable linear regression, no significant association was observed between 25(OH) D3 levels and MD overall. However, in stratified analyses, higher serum 25(OH) D3 levels (>= 27.3 ng/ml) were significantly inversely associated with percent MD among women with BMI below the median (beta = -0.52, P = 0.047). Although no significant association was observed between serum 25(OH) D3 and percent MD in the overall population, specific subgroups of women may benefit from higher serum 25(OH) D3 levels.	[Amadou, Amina; Biessy, Carine; Rinaldi, Sabina; Assi, Nada; Romieu, Isabelle] Int Agcy Res Canc, Nutr & Metab Sect, Lyon, France; [Fedirko, Veronika] Emory Univ, Winship Canc Inst, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Lajous, Martin; Ortiz-Panozo, Eduardo; Yunes, Elsa; Lopez-Ridaura, Ruy; Torres-Mejia, Gabriela; Romieu, Isabelle] Natl Inst Publ Hlth, Ctr Res Populat Hlth, Cuernavaca, Morelos, Mexico; [Lajous, Martin] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	World Health Organization; International Agency for Research on Cancer (IARC); Emory University; Rollins School Public Health; Instituto Nacional de Salud Publica; Harvard University; Harvard T.H. Chan School of Public Health	Romieu, I (corresponding author), Int Agcy Res Canc, Nutr & Metab Sect, Lyon, France.; Romieu, I (corresponding author), Natl Inst Publ Hlth, Ctr Res Populat Hlth, Cuernavaca, Morelos, Mexico.	romieui@iarc.fr	Ortiz-Panozo, Eduardo/AAY-7743-2020	Ortiz-Panozo, Eduardo/0000-0002-3141-210X	American Institute for Cancer Research (AICR) [10A035]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [115312]; Ministry of Health of Mexico, AVON, Banorte	American Institute for Cancer Research (AICR); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ministry of Health of Mexico, AVON, Banorte	This work was supported by the American Institute for Cancer Research (AICR), grant number 10A035; Consejo Nacional de Ciencia y Tecnologia (CONACYT), grant number 115312; and Ministry of Health of Mexico, AVON, Banorte.	Ameri P, 2013, CLIN ENDOCRINOL, V79, P457, DOI 10.1111/cen.12268; Angeles-Llerenas A, 2010, CANCER CAUSE CONTROL, V21, P577, DOI 10.1007/s10552-009-9487-8; Assi V, 2012, NAT REV CLIN ONCOL, V9, P33, DOI 10.1038/nrclinonc.2011.173; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bertone-Johnson ER, 2010, MENOPAUSE, V17, P1152, DOI 10.1097/gme.0b013e3181e102d9; Berube S, 2005, CANCER EPIDEM BIOMAR, V14, P1653, DOI 10.1158/1055-9965.EPI-05-0068; Berube S, 2004, CANCER EPIDEM BIOMAR, V13, P1466; Boyd NF, 2005, LANCET ONCOL, V6, P798, DOI 10.1016/S1470-2045(05)70390-9; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Boyd NF, 2011, J CLIN ONCOL, V29, P2985, DOI 10.1200/JCO.2010.33.7964; Boyd Norman F., 2009, V472, P343, DOI 10.1007/978-1-60327-492-0_15; Brisson J, 2007, CANCER EPIDEM BIOMAR, V16, P929, DOI 10.1158/1055-9965.EPI-06-0746; BYNG JW, 1994, PHYS MED BIOL, V39, P1629, DOI 10.1088/0031-9155/39/10/008; Chai W, 2010, EUR J CLIN NUTR, V64, P652, DOI 10.1038/ejcn.2010.36; Chen PZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049312; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Colston KW, 1998, J MOL ENDOCRINOL, V20, P157, DOI 10.1677/jme.0.0200157; Colston KW, 2002, ENDOCR-RELAT CANCER, V9, P45, DOI 10.1677/erc.0.0090045; Crew KD, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-18; De Neve JE, 2012, P NATL ACAD SCI USA, V109, P19953, DOI 10.1073/pnas.1211437109; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Diorio C, 2006, CANCER RES, V66, P588, DOI 10.1158/0008-5472.CAN-05-1959; Diorio C, 2005, CANCER EPIDEM BIOMAR, V14, P1065, DOI 10.1158/1055-9965.EPI-04-0706; Diorio C, 2008, CANCER EPIDEM BIOMAR, V17, P2505, DOI 10.1158/1055-9965.EPI-08-0493; Fedirko V, 2012, CANCER CAUSE CONTROL, V23, P1149, DOI 10.1007/s10552-012-9984-z; Feldman D, 2014, NAT REV CANCER, V14, P342, DOI 10.1038/nrc3691; Haukoos JS, 2005, ACAD EMERG MED, V12, P360, DOI 10.1197/j.aem.2004.11.018; Heo DS, 2014, NUTR CANCER, V66, P97, DOI 10.1080/01635581.2014.851715; Hofmann JN, 2010, CANCER EPIDEM BIOMAR, V19, P927, DOI 10.1158/1055-9965.EPI-09-1121; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Huo CW, 2014, BREAST CANCER RES TR, V144, P479, DOI 10.1007/s10549-014-2901-2; Jones G, 2014, J LIPID RES, V55, P13, DOI 10.1194/jlr.R031534; Khan QJ, 2010, CURR ONCOL REP, V12, P136, DOI 10.1007/s11912-010-0081-8; Knight JA, 2006, CANCER EPIDEM BIOMAR, V15, P1988, DOI 10.1158/1055-9965.EPI-06-0241; Krishnan AV, 2011, ANNU REV PHARMACOL, V51, P311, DOI 10.1146/annurev-pharmtox-010510-100611; Kuhn T, 2013, INT J CANCER, V133, P1689, DOI 10.1002/ijc.28172; Lowe L, 2003, RECENT RESULTS CANC, V164, P99; Martin LJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1831; Matthews D, 2010, J STEROID BIOCHEM, V121, P362, DOI 10.1016/j.jsbmb.2010.03.061; Peng LH, 2004, MOL ENDOCRINOL, V18, P1109, DOI 10.1210/me.2003-0344; Prentice A, 2008, AM J CLIN NUTR, V88, p500S, DOI 10.1093/ajcn/88.2.500S; Rice MS, 2013, CANCER PREV RES, V6, P701, DOI 10.1158/1940-6207.CAPR-12-0475; Rinaldi S, 2014, INT J CANCER, V134, P1436, DOI 10.1002/ijc.28469; Romieu I, 2012, PUBLIC HEALTH NUTR, V15, P116, DOI 10.1017/S1368980011001182; ROSENSTREICH SJ, 1971, J CLIN INVEST, V50, P679, DOI 10.1172/JCI106538; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Saenger AK, 2006, AM J CLIN PATHOL, V125, P914, DOI 10.1309/J32UF7GTQPWN25AP; Shanmugalingam T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-712; Thacher TD, 2011, MAYO CLIN PROC, V86, P50, DOI 10.4065/mcp.2010.0567; Thomson CA, 2007, MENOPAUSE, V14, P243, DOI 10.1097/01.gme.0000235362.72899.7b; Torres-Mejia G, 2005, CANCER EPIDEM BIOMAR, V14, P1052, DOI 10.1158/1055-9965.EPI-04-0717; Tseng M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1781; White J, 2000, J NATL CANCER I, V92, P443, DOI 10.1093/jnci/92.6.443; Wolpowitz D, 2006, J AM ACAD DERMATOL, V54, P301, DOI 10.1016/j.jaad.2005.11.1057; Yaghjyan L, 2012, CANCER CAUSE CONTROL, V23, P1, DOI 10.1007/s10552-011-9851-3	55	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161686	10.1371/journal.pone.0161686	http://dx.doi.org/10.1371/journal.pone.0161686			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564705	Green Submitted, Green Published, gold			2022-12-26	WOS:000382496300011
J	Hanabayashi, M; Takahashi, N; Sobue, Y; Hirabara, S; Ishiguro, N; Kojima, T				Hanabayashi, Masahiro; Takahashi, Nobunori; Sobue, Yasumori; Hirabara, Shinya; Ishiguro, Naoki; Kojima, Toshihisa			Hyaluronan Oligosaccharides Induce MMP-1 and-3 via Transcriptional Activation of NF-kappa B and p38 MAPK in Rheumatoid Synovial Fibroblasts	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; ARTICULAR CHONDROCYTES; MOLECULAR-WEIGHT; PERICELLULAR MATRIX; ARTHRITIS; CELLS; CD44; DEGRADATION; RECEPTOR; ACID	Objective To explore the effect of hyaluronan oligosaccharides (HAoligos) on interactions between HA and its principal receptor, CD44, in rheumatoid synovial fibroblasts (RSFs) and matrix metalloproteinase (MMP) production. Methods RSFs were isolated from rheumatoid synovial tissue. HA distribution was visualized by immunocytochemistry. MMP-1 and MMP-3 induction was analyzed by real-time RT-PCR and immunoblotting. The interaction between HAoligos and their MMP-producing receptors was tested by blocking with anti-CD44 and anti-Toll-like receptor 4 (TLR-4). Phosphorylation of nuclear factor kappa B (NF-kappa B) and mitogen-activated protein kinase (MAPK) was analyzed by immunoblotting. Results Endogenous HA decreased after treatment with HAoligos, while MMP-1 and MMP-3 expression increased in a dose-dependent manner. Pretreatment with anti-CD44 or anti-TLR-4 antibody significantly reduced the effect of HAoligos on MMP-1 and MMP-3 mRNA expression. NF-kappa B and p38 MAPK phosphorylation was enhanced by HAoligos pretreated with anti-TLR-4, and HAoligo-induced MMP production was blocked with an inhibitor of NF-kappa B and p38 MAPK pathways. Conclusions Disruptive changes in CD44-HA interactions by HAoligos enhanced MMP-1 and MMP-3 production via activation of NF-kappa B and p38 MAPK signaling pathways in RSFs.	[Hanabayashi, Masahiro; Takahashi, Nobunori; Sobue, Yasumori; Hirabara, Shinya; Ishiguro, Naoki; Kojima, Toshihisa] Nagoya Univ, Grad Sch Med, Dept Orthoped Surg & Rheumatol, Nagoya, Aichi, Japan	Nagoya University	Takahashi, N (corresponding author), Nagoya Univ, Grad Sch Med, Dept Orthoped Surg & Rheumatol, Nagoya, Aichi, Japan.	nobunori@med.nagoya-u.ac.jp			Japan Society for the Promotion of Science (KAKENHI) [25462366]	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Japan Society for the Promotion of Science (KAKENHI, #25462366). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren UM, 1997, FREE RADICAL BIO MED, V23, P996, DOI 10.1016/S0891-5849(97)00098-1; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Campo GM, 2010, BIOCHEM PHARMACOL, V80, P480, DOI 10.1016/j.bcp.2010.04.024; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; DAHL LB, 1985, ANN RHEUM DIS, V44, P817, DOI 10.1136/ard.44.12.817; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Fieber C, 2004, J CELL SCI, V117, P359, DOI 10.1242/jcs.00831; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; Girish KS, 2009, CURR MED CHEM, V16, P2261, DOI 10.2174/092986709788453078; Hiramitsu T, 2006, RHEUMATOLOGY, V45, P824, DOI 10.1093/rheumatology/kel026; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Knudson CB, 2004, CLIN ORTHOP RELAT R, pS152, DOI 10.1097/01.blo.0000143804.26638.82; KNUDSON CB, 1993, J CELL BIOL, V120, P825, DOI 10.1083/jcb.120.3.825; Knudson W, 2000, ARTHRITIS RHEUM-US, V43, P1165, DOI 10.1002/1529-0131(200005)43:5<1165::AID-ANR27>3.0.CO;2-H; Knudson W, 1996, EXP CELL RES, V228, P216, DOI 10.1006/excr.1996.0320; Konttinen YT, 1999, ANN RHEUM DIS, V58, P691, DOI 10.1136/ard.58.11.691; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Lesley J, 2000, J BIOL CHEM, V275, P26967; Matsuno H, 1999, INFLAMM RES, V48, P154, DOI 10.1007/s000110050439; Mengshol JA, 2002, ARTHRITIS RHEUM, V46, P13, DOI 10.1002/1529-0131(200201)46:1<13::AID-ART497>3.0.CO;2-S; Monaco C, 2011, ARTHRIT CARE RES, V63, P500, DOI 10.1002/acr.20382; Moseley R, 1997, BBA-MOL BASIS DIS, V1362, P221, DOI 10.1016/S0925-4439(97)00083-5; Nakatani Y, 2009, ARCH ORAL BIOL, V54, P757, DOI 10.1016/j.archoralbio.2009.05.005; Ohno S, 2006, J BIOL CHEM, V281, P17952, DOI 10.1074/jbc.M602750200; Ohno S, 2005, ARTHRITIS RHEUM-US, V52, P800, DOI 10.1002/art.20937; Pap T, 2000, ARTHRITIS RHEUM, V43, P2531, DOI 10.1002/1529-0131(200011)43:11<2531::AID-ANR21>3.0.CO;2-V; PITSILLIDES AA, 1994, BRIT J RHEUMATOL, V33, P5; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Saito S, 2009, MOD RHEUMATOL, V19, P643, DOI 10.1007/s10165-009-0207-8; SAMPSON PM, 1992, J CLIN INVEST, V90, P1492, DOI 10.1172/JCI116017; Schmitz I, 2010, OSTEOARTHR CARTILAGE, V18, P447, DOI 10.1016/j.joca.2009.10.007; Shimizu M, 2003, J RHEUMATOL, V30, P1164; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Uzuki M, 1999, ANAL QUANT CYTOL, V21, P75; Voelcker V, 2008, EXP DERMATOL, V17, P100, DOI 10.1111/j.1600-0625.2007.00638.x; Wang CT, 2006, OSTEOARTHR CARTILAGE, V14, P1237, DOI 10.1016/j.joca.2006.05.009; Ward JA, 2003, AM J PATHOL, V162, P1403, DOI 10.1016/S0002-9440(10)64273-3; WEIGEL PH, 1986, J THEOR BIOL, V119, P219, DOI 10.1016/S0022-5193(86)80076-5; Yoshihara Y, 2000, ANN RHEUM DIS, V59, P455, DOI 10.1136/ard.59.6.455; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	46	13	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161875	10.1371/journal.pone.0161875	http://dx.doi.org/10.1371/journal.pone.0161875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564851	Green Published, gold, Green Submitted			2022-12-26	WOS:000382496300029
J	Tefera, TW; Wong, YD; Barkl-Luke, ME; Ngo, ST; Thomas, NK; McDonald, TS; Borges, K				Tefera, Tesfaye W.; Wong, Yide; Barkl-Luke, Mallory E.; Ngo, Shyuan T.; Thomas, Nicola K.; McDonald, Tanya S.; Borges, Karin			Triheptanoin Protects Motor Neurons and Delays the Onset of Motor Symptoms in a Mouse Model of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							ANAPLEROTIC DIET THERAPY; ALPHA-KETOGLUTARATE DEHYDROGENASE; MEDIUM-CHAIN TRIGLYCERIDES; ALS-LINKED SOD1; SKELETAL-MUSCLE; MITOCHONDRIAL-FUNCTION; ENERGY-METABOLISM; TRANSGENIC MOUSE; OXIDATIVE STRESS; KETOGENIC DIET	There is increasing evidence that energy metabolism is disturbed in Amyotrophic Lateral Sclerosis (ALS) patients and animal models. Treatment with triheptanoin, the triglyceride of heptanoate, is a promising approach to provide alternative fuel to improve oxidative phosphorylation and aid ATP generation. Heptanoate can be metabolized to propionyl-CoA, which after carboxylation can produce succinyl-CoA and thereby re-fill the tricarboxylic acid (TCA) cycle (anaplerosis). Here we tested the hypothesis that treatment with triheptanoin prevents motor neuron loss and delays the onset of disease symptoms in female mice over-expressing the mutant human SOD1(G93A) (hSOD1(G93A)) gene. When oral triheptanoin (35% of caloric content) was initiated at P35, motor neuron loss at 70 days of age was attenuated by 33%. In untreated hSOD1(G93A) mice, the loss of hind limb grip strength began at 16.7 weeks. Triheptanoin maintained hind limb grip strength for 2.8 weeks longer (p<0.01). Loss of balance on the rotarod and reduction of body weight were delayed by 13 and 11 days respectively (both p<0.01). Improved motor function occurred in parallel with alterations in the expression of genes associated with muscle metabolism. In gastrocnemius muscles, the mRNA levels of pyruvate, 2-oxoglutarate and succinate dehydrogenases and methylmalonyl mutase were reduced by 24-33% in 10 week old hSOD1(G93A) mice when compared to wild-type mice, suggesting that TCA cycling in skeletal muscle may be slowed in this ALS mouse model at a stage when muscle strength is still normal. At 25 weeks of age, mRNA levels of succinate dehydrogenases, glutamic pyruvic transaminase 2 and the propionyl carboxylase beta subunit were reduced by 69-84% in control, but not in triheptanoin treated hSOD1(G93A) animals. Taken together, our results suggest that triheptanoin slows motor neuron loss and the onset of motor symptoms in ALS mice by improving TCA cycling.	[Tefera, Tesfaye W.; Wong, Yide; Barkl-Luke, Mallory E.; Ngo, Shyuan T.; Thomas, Nicola K.; McDonald, Tanya S.; Borges, Karin] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Ngo, Shyuan T.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Wong, Yide] Queensland Inst Med Res, Brisbane, Qld, Australia; [Ngo, Shyuan T.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland; University of Queensland; QIMR Berghofer Medical Research Institute; University of Queensland	Borges, K (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	k.borges@uq.edu.au	Ngo, Shyuan/O-3908-2016; Borges, Karin/B-4276-2011	Ngo, Shyuan/0000-0002-1388-2108; Borges, Karin/0000-0001-7448-0770; Tefera, Tesfaye Wolde/0000-0001-5203-2299; Wong, Yide/0000-0001-6049-0177; McDonald, Tanya/0000-0003-4325-3537	MND and Me Foundation; Queensland Brain Institute; Royal Brisbane and Women's Hospital Foundation; Australian National Health and Medical Research Council [1044407]; UQI; APA scholarship	MND and Me Foundation; Queensland Brain Institute; Royal Brisbane and Women's Hospital Foundation; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); UQI; APA scholarship	STN is currently a Scott Sullivan Research Fellow funded by the MND and Me Foundation, The Queensland Brain Institute and The Royal Brisbane and Women's Hospital Foundation. KB is funded by the Australian National Health and Medical Research Council (Grant 1044407). TWT and TSM receive UQI and APA scholarship support, respectively. Sasol and Ultragenyx Pharmaceuticals Inc. donated triheptanoin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adanyeguh IM, 2015, NEUROLOGY, V84, P490, DOI 10.1212/WNL.0000000000001214; Andersson U, 1998, BIOCHEM BIOPH RES CO, V249, P512, DOI 10.1006/bbrc.1998.9171; Ari C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103526; Aso E, 2013, CURR ALZHEIMER RES, V10, P290, DOI 10.2174/15672050112099990128; BACH AC, 1982, AM J CLIN NUTR, V36, P950, DOI 10.1093/ajcn/36.5.950; Baumer D, 2014, J ROY SOC MED, V107, P14, DOI 10.1177/0141076813511451; Barber SC, 2006, BBA-MOL BASIS DIS, V1762, P1051, DOI 10.1016/j.bbadis.2006.03.008; Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018; Borges K, 2012, EPILEPSY RES, V100, P239, DOI 10.1016/j.eplepsyres.2011.05.023; Bough KJ, 2007, EPILEPSIA, V48, P43, DOI 10.1111/j.1528-1167.2007.00915.x; Browne SE, 1998, J NEUROCHEM, V71, P281; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Brunengraber H, 2006, J INHERIT METAB DIS, V29, P327, DOI 10.1007/s10545-006-0320-1; Camilleri M, 1993, Clin Auton Res, V3, P95, DOI 10.1007/BF01818993; Chen S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-28; Choi JK, 2009, EUR J NEUROSCI, V30, P2143, DOI 10.1111/j.1460-9568.2009.07015.x; Cistaro A, 2012, EUR J NUCL MED MOL I, V39, P251, DOI 10.1007/s00259-011-1979-6; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Corbett AJ, 2015, ANN NEUROL, V78, pS102; Cozzolino M, 2012, PROG NEUROBIOL, V97, P54, DOI 10.1016/j.pneurobio.2011.06.003; Crugnola V, 2010, ARCH NEUROL-CHICAGO, V67, P849, DOI 10.1001/archneurol.2010.128; D'Alessandro G, 2011, NEUROBIOL DIS, V43, P346, DOI 10.1016/j.nbd.2011.04.003; DALAKAS MC, 1987, ANN NEUROL, V22, P580, DOI 10.1002/ana.410220504; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Derave W, 2003, NEUROBIOL DIS, V13, P264, DOI 10.1016/S0969-9961(03)00041-X; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Dupuis L, 2003, FASEB J, V17, P2091, DOI 10.1096/fj.02-1182fje; Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6; Echaniz-Laguna A, 2006, EXP NEUROL, V198, P25, DOI 10.1016/j.expneurol.2005.07.020; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Fournier C, 2013, AMYOTROPH LAT SCL FR, V14, P319, DOI 10.3109/21678421.2013.788405; Francis JS, 2014, J INHERIT METAB DIS, V37, P369, DOI 10.1007/s10545-013-9663-6; Gill A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006489; Gu L, 2010, AM J PHYSIOL-ENDOC M, V298, pE362, DOI 10.1152/ajpendo.00384.2009; Hadera MG, 2014, J NEUROCHEM, V129, P107, DOI 10.1111/jnc.12610; HATAZAWA J, 1988, J COMPUT ASSIST TOMO, V12, P630, DOI 10.1097/00004728-198807000-00019; Julien JP, 2000, J NEUROL SCI, V180, P7, DOI 10.1016/S0022-510X(00)00422-6; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kong JM, 1998, J NEUROSCI, V18, P3241; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; LAI JCK, 1986, J NEUROCHEM, V47, P1376, DOI 10.1111/j.1471-4159.1986.tb00768.x; Lederer CW, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-26; Lee JD, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-119; LUDOLPH AC, 1992, ACTA NEUROL SCAND, V85, P81, DOI 10.1111/j.1600-0404.1992.tb04003.x; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Luo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082112; Marin-Valencia I, 2013, J CEREBR BLOOD F MET, V33, P175, DOI 10.1038/jcbfm.2012.151; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; McDonald TS, 2014, J CEREBR BLOOD F MET, V34, P153, DOI 10.1038/jcbfm.2013.184; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Meethal SV, 2012, NEUROBIOL AGING, V33, P569, DOI 10.1016/j.neurobiolaging.2010.04.012; Milani P, 2011, NEUROL RES INT, V2011, DOI [10.1155/2011/458427, DOI 10.1155/2011/458427]; Miquel E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034776; Miyazaki K, 2012, J CEREBR BLOOD F MET, V32, P456, DOI 10.1038/jcbfm.2011.155; Mochel F, 2010, EUR J HUM GENET, V18, P1057, DOI 10.1038/ejhg.2010.72; Ngo S T, 2015, Cell Regen, V4, P5, DOI 10.1186/s13619-015-0019-6; Ngo ST, 2012, CLIN NEUROPHYSIOL, V123, P2080, DOI 10.1016/j.clinph.2012.01.028; Niessen HG, 2007, EUR J NEUROSCI, V25, P1669, DOI 10.1111/j.1460-9568.2007.05415.x; Pagani M, 2014, NEUROLOGY, V83, P1067, DOI 10.1212/WNL.0000000000000792; Palamiuc L, 2015, EMBO MOL MED, V7, P526, DOI 10.15252/emmm.201404433; Pascual JM, 2014, JAMA NEUROL, V71, P1255, DOI 10.1001/jamaneurol.2014.1584; Raman R, 2015, NEUROPATH APPL NEURO, V41, P201, DOI 10.1111/nan.12147; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Roe CR, 2008, NEUROLOGY, V71, P260, DOI 10.1212/01.wnl.0000318283.42961.e9; Roe CR, 2006, J INHERIT METAB DIS, V29, P332, DOI 10.1007/s10545-006-0290-3; Roe CR, 2010, MOL GENET METAB, V101, P246, DOI 10.1016/j.ymgme.2010.06.017; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18, DOI 10.1002/ana.410280106; Russell AP, 2013, NEUROBIOL DIS, V49, P107, DOI 10.1016/j.nbd.2012.08.015; Saris CGJ, 2013, AMYOTROPH LAT SCL FR, V14, P190, DOI 10.3109/21678421.2012.749914; Sasaki S, 1996, NEUROSCI LETT, V204, P53, DOI 10.1016/0304-3940(96)12314-4; Schwarzkopf TM, 2015, NEUROSCIENCE, V300, P201, DOI 10.1016/j.neuroscience.2015.05.014; Shi P, 2010, J ALZHEIMERS DIS, V20, pS311, DOI 10.3233/JAD-2010-100366; Smittkamp SE, 2014, NEURODEGENER DIS, V13, P29, DOI 10.1159/000351606; Steyn FJ, 2012, ENDOCRINOLOGY, V153, P3735, DOI 10.1210/en.2011-2171; Thomas NK, 2012, EPILEPSY RES, V99, P312, DOI 10.1016/j.eplepsyres.2011.12.013; Toepfer M, 1999, AMYOTROPH LATERAL SC, V1, P15; Tretter L, 2000, J NEUROSCI, V20, P8972; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vielhaber S, 1999, J NEUROL SCI, V169, P133, DOI 10.1016/S0022-510X(99)00236-1; Vielhaber S, 2000, BRAIN, V123, P1339, DOI 10.1093/brain/123.7.1339; Vucic S, 2009, CURR MOL MED, V9, P255, DOI 10.2174/156652409787847173; Wang XS, 2006, AMYOTROPH LATERAL SC, V7, P201, DOI 10.1080/17482960600947689; Wiedemann FR, 1998, J NEUROL SCI, V156, P65, DOI 10.1016/S0022-510X(98)00008-2; Willis S, 2010, NEUROBIOL DIS, V40, P565, DOI 10.1016/j.nbd.2010.07.017; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Zhao W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049191; Zhao Z, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-29	92	38	39	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161816	10.1371/journal.pone.0161816	http://dx.doi.org/10.1371/journal.pone.0161816			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564703	Green Published, gold, Green Accepted			2022-12-26	WOS:000382496300021
J	Burke, T; Pinto-Grau, M; Lonergan, K; Elamin, M; Bede, P; Costello, E; Hardiman, O; Pender, N				Burke, Tom; Pinto-Grau, Marta; Lonergan, Katie; Elamin, Marwa; Bede, Peter; Costello, Emmet; Hardiman, Orla; Pender, Niall			Measurement of Social Cognition in Amyotrophic Lateral Sclerosis: A Population Based Study	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; EYES TEST; MIND; DIAGNOSIS; DEMENTIA; DEFICITS; CRITERIA; DISEASE; VERSION; BIASES	Background: Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disease. Executive dysfunction is common in patients with ALS, with up to 50% of patients performing within an impaired range. There is evidence that social cognitive deficits associated with ALS are a function of deficits in executive function. The 'Reading the Mind in the Eyes' Test is a recognized test of social cognitive function, although the reliability of this instrument remains to be established. Methodology: Patients with ALS (n = 106), and age and IQ matched controls (n = 50) were recruited and asked to perform the Reading the Mind in the Eyes Test as part of an on-going population-based study of cognitive function. ALS patients were sub-stratified based on the presence, and/or extent of executive dysfunction. Results: Cronbach's Alpha of .73 was observed, indicating good reliability on this measure. Split-half reliability analysis further confirms these findings (p = 0.826). The Reading the Mind in the Eyes test had excellent psychometric properties when discriminating between ALS patients who are cognitively intact, and those who have executive impairment, with an overall medium difficulty. There was a large magnitude significant difference between patients and controls (p<0.001; eta(2) = .19). Post-hoc analysis revealed that controls performed significantly higher than patients with executive impairment (p<0.001), and patients with single executive deficits (p = 0.002). Conclusion: Executive dysfunction impacts on social cognitive performance. This study contributes not only to the psychometric knowledge of this measure, but also to the usability, efficacy, and reliability of social cognitive assessment in ALS. Using population-specific normative data, we confirm the Reading the Mind in the Eyes Test is a reliable measure of social cognitive processes in ALS.	[Burke, Tom; Pinto-Grau, Marta; Lonergan, Katie; Costello, Emmet; Pender, Niall] Beaumont Hosp, Dept Psychol, Dublin 9, Ireland; [Burke, Tom; Pinto-Grau, Marta; Lonergan, Katie; Elamin, Marwa; Bede, Peter; Hardiman, Orla; Pender, Niall] Trinity Biomed Sci Inst, Acad Unit Neurol, Dublin 2, Ireland; [Hardiman, Orla] Beaumont Hosp, Dept Neurol, Dublin 9, Ireland; [Pender, Niall] Royal Coll Surgeons Ireland, Dublin 2, Ireland	University College Dublin; Royal College of Surgeons - Ireland	Burke, T (corresponding author), Beaumont Hosp, Dept Psychol, Dublin 9, Ireland.; Burke, T (corresponding author), Trinity Biomed Sci Inst, Acad Unit Neurol, Dublin 2, Ireland.	burket2@tcd.ie	Burke, Tom/AAH-8963-2020; Hardiman, Orla/Y-3441-2019	Burke, Tom/0000-0002-6563-1597; Hardiman, Orla/0000-0003-2610-1291; Pender, Niall/0000-0002-4172-0704; Bede, Peter/0000-0003-0492-4772	European Community [259867]; JPND SOPHIA project; Irish Health Research Board [CSA2012/11]; Irish Institute of Clinical Neuroscience [12549. 201616]; charity Research Motor Neurone	European Community(European Commission); JPND SOPHIA project; Irish Health Research Board; Irish Institute of Clinical Neuroscience; charity Research Motor Neurone	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no (259867); the JPND SOPHIA project; Irish Health Research Board (CSA2012/11); the Irish Institute of Clinical Neuroscience (12549. 201616); and the charity Research Motor Neurone.	Abu-Akel A, 2011, NEUROPSYCHOLOGIA, V49, P2971, DOI 10.1016/j.neuropsychologia.2011.07.012; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Ahmed FS, 2011, J AUTISM DEV DISORD, V41, P667, DOI 10.1007/s10803-010-1087-7; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Bertoux M, 2016, J ALZHEIMERS DIS, V49, P1065, DOI 10.3233/JAD-150686; Boucher O, 2015, NEUROPSYCHOLOGIA, V71, P1, DOI 10.1016/j.neuropsychologia.2015.03.008; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Burke T, 2015, J NEUROL; Burrell J.R, 2016, LANCET; Byrne S, 2012, LANCET NEUROL, V11, P232, DOI 10.1016/S1474-4422(12)70014-5; Cassels TG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093653; Cavallo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025948; De Ferrari AR, 2015, PARKINSONISM RELAT D, V21, P509, DOI 10.1016/j.parkreldis.2015.02.023; Di Rosa E, 2015, J NEUROL, V262, P394, DOI 10.1007/s00415-014-7567-5; El Haj M, 2016, MEMORY, V24, P526, DOI 10.1080/09658211.2015.1021257; Elamin M, 2011, NEUROLOGY, V76, P1263, DOI 10.1212/WNL.0b013e318214359f; Elamin M, 2012, J NEUROL NEUROSUR PS, V83, P1071, DOI 10.1136/jnnp-2012-302817; Fernandez-Abascal EG, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-33; Gaweda L, 2015, J BEHAV THER EXP PSY, V48, P98, DOI 10.1016/j.jbtep.2015.02.002; Girardi A, 2011, NEUROPSYCHOLOGY, V25, P53, DOI 10.1037/a0020357; Heitz C, 2015, REV NEUROL-FRANCE, V171, P373, DOI 10.1016/j.neurol.2015.02.010; Holdnack H. A., 2001, WECHSLER TEST ADULT; Jelsone-Swain L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119862; Kelley TL, 1939, J EDUC PSYCHOL, V30, P17, DOI 10.1037/h0057123; Khorashad BS, 2015, J AUTISM DEV DISORD, V45, P2651, DOI 10.1007/s10803-015-2427-4; Levy NK, 2016, CHILD NEUROPSYCHOL, V22, P177, DOI 10.1080/09297049.2014.985642; Linda C., 2006, INTRO CLASSICAL MODE; Lodder GMA, 2015, JOURNAL, DOI [10.1111/bjop.12131, DOI 10.1111/BJOP.12131]; Mason SL, 2015, NEUROPSYCHOLOGIA, V70, P80, DOI 10.1016/j.neuropsychologia.2015.02.017; Nentjes L, 2015, INT J LAW PSYCHIAT, V38, P92, DOI 10.1016/j.ijlp.2015.01.012; O'Toole O, 2008, J NEUROL NEUROSUR PS, V79, P30, DOI 10.1136/jnnp.2007.117788; Phukan J, 2012, J NEUROL NEUROSUR PS, V83, P102, DOI 10.1136/jnnp-2011-300188; Raven J.C., 1998, ADV PROGR MATRICES; Segura M, 2015, NEUROGENETICS, V16, P123, DOI 10.1007/s10048-014-0434-9; Strong MJ, 2009, AMYOTROPH LATERAL SC, V10, P131, DOI 10.1080/17482960802654364; Watermeyer TJ, 2015, J NEUROL, V262, P1681, DOI 10.1007/s00415-015-7761-0	36	53	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0160850	10.1371/journal.pone.0160850	http://dx.doi.org/10.1371/journal.pone.0160850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU5NI	27556398	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258100021
J	Raval, MH; Quintero, OA; Weck, ML; Unrath, WC; Gallagher, JW; Cui, RJ; Kachar, B; Tyska, MJ; Yengo, CM				Raval, Manmeet H.; Quintero, Omar A.; Weck, Meredith L.; Unrath, William C.; Gallagher, James W.; Cui, Runjia; Kachar, Bechara; Tyska, Matthew J.; Yengo, Christopher M.			Impact of the Motor and Tail Domains of Class III Myosins on Regulating the Formation and Elongation of Actin Protrusions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; cytoskeleton; hair cell; molecular motor; myosin	DROSOPHILA-NINAC KINASE; HAIR-CELL STEREOCILIA; MOLECULAR TREADMILL; FILOPODIA FORMATION; DENDRITIC NETWORK; HEARING-LOSS; BUNDLES; LOCALIZATION; PROTEINS; BINDING	Class III myosins (MYO3A and MYO3B) are proposed to function as transporters as well as length and ultrastructure regulators within stable actin-based protrusions such as stereocilia and calycal processes. MYO3A differs from MYO3B in that it contains an extended tail domain with an additional actin-binding motif. We examined how the properties of the motor and tail domains of human class III myosins impact their ability to enhance the formation and elongation of actin protrusions. Direct examination of the motor and enzymatic properties of human MYO3A and MYO3B revealed that MYO3A is a 2-fold faster motor with enhanced ATPase activity and actin affinity. A chimera in which the MYO3A tail was fused to the MYO3B motor demonstrated that motor activity correlates with formation and elongation of actin protrusions. We demonstrate that removal of individual exons (30-34) in the MYO3A tail does not prevent filopodia tip localization but abolishes the ability to enhance actin protrusion formation and elongation in COS7 cells. Interestingly, our results demonstrate that MYO3A slows filopodia dynamics and enhances filopodia lifetime in COS7 cells. We also demonstrate that MYO3A is more efficient than MYO3B at increasing formation and elongation of stable microvilli on the surface of cultured epithelial cells. We propose that the unique features of MYO3A, enhanced motor activity, and an extended tail with tail actin-binding motif, allow it to play an important role in stable actin protrusion length and ultrastructure maintenance.	[Raval, Manmeet H.; Unrath, William C.; Yengo, Christopher M.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Quintero, Omar A.] Univ Richmond, Dept Biol, Richmond, VA 23173 USA; [Weck, Meredith L.; Tyska, Matthew J.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Gallagher, James W.] Lincoln Univ, Dept Biol, Philadelphia, PA 19104 USA; [Cui, Runjia; Kachar, Bechara] NIDCD, Lab Cell Struct & Dynam, NIH, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Richmond; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Lincoln University - Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Yengo, CM (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA.	cmy11@psu.edu	Raval, Manmeet H./J-5093-2019	Quintero-Carmona, Omar/0000-0002-9314-1704; Raval, Manmeet/0000-0002-7792-2375	National Institutes of Health [EYE018141, DK075555, R01-DK095811, CA160667, DK095811]; Pennsylvania Lions Hearing Research Foundation; National Institutes of Health Vanderbilt University Medical Center Developmental Biology Training Grant [T32-HD007502]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK108528, R01DK095811, P30DK058404, R01DK075555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000002] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Lions Hearing Research Foundation; National Institutes of Health Vanderbilt University Medical Center Developmental Biology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grant EYE018141, Pennsylvania Lions Hearing Research Foundation (to C. M. Y.), and National Institutes of Health Grants DK075555 and R01-DK095811 (to M. J. T.). This work was authored, in whole or in part, by National Institutes of Health staff. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by National Institutes of Health Grant CA160667.r Supported by National Institutes of Health Vanderbilt University Medical Center Developmental Biology Training Grant T32-HD007502.r Supported by National Institutes of Health Grants DK075555 and DK095811.r Supported by National Institutes of Health Grant EYE018141 and the Pennsylvania Lions Hearing Research Foundation.	Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Batters C, 2004, EMBO J, V23, P1433, DOI 10.1038/sj.emboj.7600169; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; BRETSCHER A, 1980, CELL, V20, P839, DOI 10.1016/0092-8674(80)90330-X; Courson DS, 2015, EXP CELL RES, V334, P10, DOI 10.1016/j.yexcr.2015.03.014; Dose AC, 2003, MOL BIOL CELL, V14, P1058, DOI 10.1091/mbc.E02-06-0317; Dose AC, 2000, GENOMICS, V67, P333, DOI 10.1006/geno.2000.6256; Dose AC, 2007, J BIOL CHEM, V282, P216, DOI 10.1074/jbc.M605964200; Dose AC, 2008, BIOCHEMISTRY-US, V47, P2485, DOI 10.1021/bi7021574; Ebrahim S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10833; Erickson FL, 2003, MOL BIOL CELL, V14, P4173, DOI 10.1091/mbc.e02-10-0656; Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002; Gillespie PG, 2004, ANNU REV PHYSIOL, V66, P521, DOI 10.1146/annurev.physiol.66.032102.112842; Grati M, 2016, HUM MUTAT, V37, P481, DOI 10.1002/humu.22961; Grati M, 2011, P NATL ACAD SCI USA, V108, P11476, DOI 10.1073/pnas.1104161108; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Grega-Larson NE, 2015, MOL BIOL CELL, V26, P3803, DOI 10.1091/mbc.E15-06-0443; Gupton Stephanie L, 2007, Sci STKE, V2007, pre5, DOI 10.1126/stke.4002007re5; KRON SJ, 1991, METHOD ENZYMOL, V196, P399; Lee SJ, 2004, NEURON, V43, P95, DOI 10.1016/j.neuron.2004.06.014; Lelli A, 2016, J CELL BIOL, V212, P231, DOI 10.1083/jcb.201509017; Lin HW, 2005, CURR OPIN CELL BIOL, V17, P55, DOI 10.1016/j.ceb.2004.12.005; Lin-Jones J, 2004, J CELL SCI, V117, P5825, DOI 10.1242/jcs.01512; Liu HY, 2016, ELIFE, V5, DOI 10.7554/eLife.12856; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Manor Uri, 2012, Bioarchitecture, V2, P171, DOI 10.4161/bioa.21733; Mecklenburg KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122502; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Merritt RC, 2012, CURR BIOL, V22, P320, DOI 10.1016/j.cub.2011.12.053; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Nal N, 2007, HUM MUTAT, V28, P1014, DOI 10.1002/humu.20556; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; PORTER JA, 1992, J CELL BIOL, V116, P683, DOI 10.1083/jcb.116.3.683; PORTER JA, 1993, J CELL BIOL, V122, P601, DOI 10.1083/jcb.122.3.601; Quintero OA, 2013, J BIOL CHEM, V288, P37126, DOI 10.1074/jbc.M113.511014; Quintero OA, 2010, J BIOL CHEM, V285, P35770, DOI 10.1074/jbc.M110.144360; Revenu C, 2012, MOL BIOL CELL, V23, P324, DOI 10.1091/mbc.E11-09-0765; ROSE GG, 1958, J BIOPHYS BIOCHEM CY, V4, P761, DOI 10.1083/jcb.4.6.761; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; Sahly I, 2012, J CELL BIOL, V199, P381, DOI 10.1083/jcb.201202012; Sakaguchi H, 2008, CELL MOTIL CYTOSKEL, V65, P528, DOI 10.1002/cm.20275; Salles FT, 2009, NAT CELL BIOL, V11, P443, DOI 10.1038/ncb1851; Sasaki N, 1998, J BIOL CHEM, V273, P20334, DOI 10.1074/jbc.273.32.20334; Schneider ME, 2006, J NEUROSCI, V26, P10243, DOI 10.1523/JNEUROSCI.2812-06.2006; Schneider ME, 2002, NATURE, V418, P837, DOI 10.1038/418837a; Seiler C, 2004, DEV BIOL, V272, P328, DOI 10.1016/j.ydbio.2004.05.004; Sekerkova G, 2006, CELL MOL LIFE SCI, V63, P2329, DOI 10.1007/s00018-006-6148-x; Sekerkova G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002032; Shifrin DA, 2014, GUT MICROBES, V5, P504, DOI 10.4161/gmic.32084; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Tilney LG, 2004, J CELL SCI, V117, P3531, DOI 10.1242/jcs.01215; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Tokuo H, 2007, J CELL BIOL, V179, P229, DOI 10.1083/jcb.200703178; Trivedi DV, 2013, BIOCHEMISTRY-US, V52, P4710, DOI 10.1021/bi4004364; Trivedi DV, 2012, BIOPHYS J, V102, P2545, DOI 10.1016/j.bpj.2012.04.025; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Walsh T, 2002, P NATL ACAD SCI USA, V99, P7518, DOI 10.1073/pnas.102091699; Walsh VL, 2011, MAMM GENOME, V22, P170, DOI 10.1007/s00335-010-9310-6; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; Wes PD, 1999, NAT NEUROSCI, V2, P447, DOI 10.1038/8116; Yengo CM, 2012, J MUSCLE RES CELL M, V33, P385, DOI 10.1007/s10974-012-9316-7; Yengo CM, 2002, BIOCHEMISTRY-US, V41, P8508, DOI 10.1021/bi015969u	66	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22781	22792		10.1074/jbc.M116.733741	http://dx.doi.org/10.1074/jbc.M116.733741			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27582493	Green Published, hybrid			2022-12-26	WOS:000386760600035
J	Paschkowsky, S; Hamze, M; Oestereich, F; Munter, LM				Paschkowsky, Sandra; Hamze, Mehdi; Oestereich, Felix; Munter, Lisa Marie			Alternative Processing of the Amyloid Precursor Protein Family by Rhomboid Protease RHBDL4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid precursor protein (APP); amyloid (A); endoplasmic reticulum (ER); lysosome; rhomboid protease; APLP1; APLP2; APP fragments	INTRAMEMBRANE PROTEASE; ALZHEIMERS-DISEASE; TERMINAL FRAGMENTS; NEURONAL-ACTIVITY; EGF RECEPTOR; ALPHA; APP; TRAFFICKING; SECRETION; CLEAVAGE	The amyloid precursor protein (APP) is an ubiquitously expressed cell surface protein and a key molecule in the etiology of Alzheimer disease. Amyloidogenic processing of APP through secretases leads to the generation of toxic amyloid (A) peptides, which are regarded as the molecular cause of the disease. We report here an alternative processing pathway of APP through the mammalian intramembrane rhomboid protease RHBDL4. RHBDL4 efficiently cleaves APP inside the cell, thus bypassing APP from amyloidogenic processing, leading to reduced A levels. RHBDL4 cleaves APP multiple times in the ectodomain, resulting in several N- and C-terminal fragments that are not further degraded by classical APP secretases. Knockdown of endogenous RHBDL4 results in decreased levels of C-terminal fragments derived from endogenous APP. Similarly, we found the APP family members APLP1 and APLP2 to be substrates of RHBDL4. We conclude that RHBDL4-mediated APP processing provides insight into APP and rhomboid physiology and qualifies for further investigations to elaborate its impact on Alzheimer disease pathology.	[Paschkowsky, Sandra; Hamze, Mehdi; Oestereich, Felix; Munter, Lisa Marie] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 0B1, Canada; [Oestereich, Felix] McGill Univ, Integrated Program Neurosci, Montreal, PQ H3G 0B1, Canada	McGill University; McGill University	Munter, LM (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 0B1, Canada.	lisa.munter@mcgill.ca		Munter, Lisa/0000-0001-5736-1462	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2015-04645]; Canada Foundation of Innovation Leaders Opportunity Fund Grant [32565]; Alzheimer Society of Canada Young Investigator Award [PT-58872]; Fonds d'innovation Pfizer-Fonds de recherche Sante Quebec (FRQS) sur la maladie d'Alzheimer et les maladies apparentees [31288]; McGill University; McGill Faculty of Medicine	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation of Innovation Leaders Opportunity Fund Grant(Canada Foundation for Innovation); Alzheimer Society of Canada Young Investigator Award; Fonds d'innovation Pfizer-Fonds de recherche Sante Quebec (FRQS) sur la maladie d'Alzheimer et les maladies apparentees; McGill University; McGill Faculty of Medicine	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant RGPIN-2015-04645, the Canada Foundation of Innovation Leaders Opportunity Fund Grant 32565, Alzheimer Society of Canada Young Investigator Award PT-58872, Fonds d'innovation Pfizer-Fonds de recherche Sante Quebec (FRQS) sur la maladie d'Alzheimer et les maladies apparentees 31288, McGill University Startup funding, and McGill Faculty of Medicine Incentive funding. The authors declare that they have no conflicts of interest with the contents of this article.	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Adrain C, 2011, EMBO REP, V12, P421, DOI 10.1038/embor.2011.50; Bergbold N, 2013, BBA-BIOMEMBRANES, V1828, P2840, DOI 10.1016/j.bbamem.2013.03.025; Blaydon DC, 2012, AM J HUM GENET, V90, P340, DOI 10.1016/j.ajhg.2011.12.008; Christova Y, 2013, EMBO REP, V14, P884, DOI 10.1038/embor.2013.128; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Eggert S, 2004, J BIOL CHEM, V279, P18146, DOI 10.1074/jbc.M311601200; Fleck D, 2016, J BIOL CHEM, V291, P318, DOI 10.1074/jbc.M115.697995; Fleig L, 2012, MOL CELL, V47, P558, DOI 10.1016/j.molcel.2012.06.008; Freeman M, 2014, ANNU REV CELL DEV BI, V30, P235, DOI 10.1146/annurev-cellbio-100913-012944; Halliday M, 2014, NEUROPHARMACOLOGY, V76, P169, DOI 10.1016/j.neuropharm.2013.08.034; Heber S, 2000, J NEUROSCI, V20, P7951; Hosur V, 2014, P NATL ACAD SCI USA, V111, pE2200, DOI 10.1073/pnas.1323908111; Issuree PDA, 2013, J CLIN INVEST, V123, P928, DOI 10.1172/JCI66168; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kinch LN, 2013, BBA-BIOMEMBRANES, V1828, P2937, DOI 10.1016/j.bbamem.2013.06.031; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lazareno-Saez C, 2013, J MOL BIOL, V425, P1127, DOI 10.1016/j.jmb.2013.01.019; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Liao HJ, 2012, TRAFFIC, V13, P1106, DOI 10.1111/j.1600-0854.2012.01371.x; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Maegawa S, 2007, MOL MICROBIOL, V64, P435, DOI 10.1111/j.1365-2958.2007.05679.x; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Mitani Y, 2012, J NEUROSCI, V32, P2037, DOI 10.1523/JNEUROSCI.4264-11.2012; Multhaup G, 1996, SCIENCE, V271, P1406, DOI 10.1126/science.271.5254.1406; Pierrot N, 2013, EMBO MOL MED, V5, P608, DOI 10.1002/emmm.201202215; Placido AI, 2014, BBA-MOL BASIS DIS, V1842, P1444, DOI 10.1016/j.bbadis.2014.05.003; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; Puig KL, 2013, EXP GERONTOL, V48, P608, DOI 10.1016/j.exger.2012.07.009; Shi G, 2011, HUM MOL GENET, V20, P1966, DOI 10.1093/hmg/ddr077; Siggs OM, 2012, BLOOD, V119, P5769, DOI 10.1182/blood-2012-03-417949; Song W, 2015, ADV METEOROL, V2015, DOI 10.1155/2015/213534; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; van der Kant R, 2015, DEV CELL, V32, P502, DOI 10.1016/j.devcel.2015.01.022; Vella LJ, 2012, FASEB J, V26, P2930, DOI 10.1096/fj.11-200295; Viola KL, 2015, ACTA NEUROPATHOL, V129, P183, DOI 10.1007/s00401-015-1386-3; Wang HZ, 2015, BIOCHEMISTRY-US, V54, P2806, DOI 10.1021/acs.biochem.5b00329; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Willem M, 2015, NATURE, V526, P443, DOI 10.1038/nature14864; Wunderle L, 2016, SCI REP-UK, V6, DOI 10.1038/srep27342; Xue Y, 2012, J BIOL CHEM, V287, P3099, DOI 10.1074/jbc.M111.310482; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047	46	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21903	21912		10.1074/jbc.M116.753582	http://dx.doi.org/10.1074/jbc.M116.753582			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27563067	Green Published, hybrid			2022-12-26	WOS:000386332600007
J	Yao, WL; Oh, YT; Deng, JS; Yue, P; Deng, L; Huang, H; Zhou, W; Sun, SY				Yao, Weilong; Oh, You-Take; Deng, Jiusheng; Yue, Ping; Deng, Liang; Huang, Henry; Zhou, Wei; Sun, Shi-Yong			Expression of Death Receptor 4 Is Positively Regulated by MEK/ERK/AP-1 Signaling and Suppressed upon MEK Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AP1 transcription factor (AP-1); apoptosis; cancer biology; gene expression; Trail; DR4; MEK	TRAIL-INDUCED APOPTOSIS; LUNG-CANCER CELLS; NF-KAPPA-B; C-JUN; DR4; ACTIVATION; INDUCTION; JNK; ERK; DIFFERENTIATION	Death receptor 4 (DR4) is a cell surface receptor for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and triggers apoptosis upon ligation with TRAIL or aggregation. MEK/ERK signaling is a well known and the best-studied effector pathway downstream of Ras and Raf. This study focuses on determining the impact of pharmacological MEK inhibition on DR4 expression and elucidating the underlying mechanism. We found that several MEK inhibitors including MEK162, AZD6244, and PD0325901 effectively decreased DR4 protein levels including cell surface DR4 in different cancer cell lines. Accordingly, pre-treatment of TRAIL-sensitive cancer cell lines with a MEK inhibitor desensitized them to TRAIL-induced apoptosis. These results indicate that MEK inhibition negatively regulates DR4 expression and cell response to TRAIL-induced apoptosis. MEK inhibitors did not alter DR4 protein stability, rather decreased its mRNA levels, suggesting a transcriptional regulation. In contrast, enforced activation of MEK/ERK signaling by expressing ectopic B-Raf (V600E) or constitutively activated MEK1 (MEK1-CA) or MEK2 (MEK2-CA) activated ERK and increased DR4 expression; these effects were inhibited when a MEK inhibitor was present. Promoter analysis through deletion and mutation identified the AP-1 binding site as an essential response element for enhancing DR4 transactivation by MEK1-CA. Furthermore, inhibition of AP-1 by c-Jun knockdown abrogated the ability of MEK1-CA to increase DR4 promoter activity and DR4 expression. These results suggest an essential role of AP-1 in mediating MEK/ERK activation-induced DR4 expression. Our findings together highlight a previously undiscovered mechanism that positively regulates DR4 expression through activation of the MEK/ERK/AP-1 signaling pathway.	[Yao, Weilong; Deng, Liang] Cent S Univ, Xiangya Sch Med, Changsha 410008, Hunan, Peoples R China; [Yao, Weilong; Oh, You-Take; Deng, Jiusheng; Yue, Ping; Deng, Liang; Huang, Henry; Zhou, Wei; Sun, Shi-Yong] Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Central South University; Emory University	Sun, SY (corresponding author), 1365-C Clifton Rd NE,Suite C3088, Atlanta, GA 30322 USA.	ssun@emory.edu			National Institutes of Health NCI [CA140571, CA160522, CA118450]; Emory Winship Cancer Institute Robbins Scholar awards; Halpern Research Scholar award; Anise McDaniel Brock Scholar award; NATIONAL CANCER INSTITUTE [R01CA160522, R01CA140571, R01CA118450] Funding Source: NIH RePORTER	National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Emory Winship Cancer Institute Robbins Scholar awards; Halpern Research Scholar award; Anise McDaniel Brock Scholar award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health NCI Grants R01s CA140571 (to W. Z.), CA160522 (to S. Y. S.), and CA118450 (to S. Y. S.) and Emory Winship Cancer Institute Robbins Scholar awards (to Y. T. O. and J. D.), Halpern Research Scholar award (to S. Y. S.), and Anise McDaniel Brock Scholar award (to W. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akinleye A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-27; Buchsbaum Donald J, 2007, Future Oncol, V3, P405, DOI 10.2217/14796694.3.4.405; Chen SZ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-23; den Hollander MW, 2013, CANCER LETT, V332, P194, DOI 10.1016/j.canlet.2012.04.007; Deng ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036739; Dhandapani L, 2011, CANCER RES, V71, P5245, DOI 10.1158/0008-5472.CAN-10-4180; Elrod HA, 2008, CANCER BIOL THER, V7, P163, DOI 10.4161/cbt.7.2.5335; Eriksson M, 2007, J CELL PHYSIOL, V210, P538, DOI 10.1002/jcp.20907; Falschlehner C, 2009, ADV EXP MED BIOL, V647, P195, DOI 10.1007/978-0-387-89520-8_14; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; Fu L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-315; Guan BX, 2002, ONCOGENE, V21, P3121, DOI 10.1038/sj.onc.1205430; Guan BX, 2001, J CELL PHYSIOL, V188, P98, DOI 10.1002/jcp.1101; Hersey P, 2009, CANCER IMMUNOL IMMUN, V58, P1751, DOI 10.1007/s00262-009-0732-5; Holland PM, 2014, CYTOKINE GROWTH F R, V25, P185, DOI 10.1016/j.cytogfr.2013.12.009; Huang TG, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-30; Jin FS, 2005, CANCER RES, V65, P6354, DOI 10.1158/0008-5472.CAN-04-4061; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Lemke J, 2010, J MOL MED, V88, P729, DOI 10.1007/s00109-010-0619-0; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; Liu XG, 2004, JNCI-J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322; Liu XG, 2004, CANCER RES, V64, P5078, DOI 10.1158/0008-5472.CAN-04-1195; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Martinez-Lostao L, 2015, IMMUNOTHERAPY-UK, V7, P883, DOI 10.2217/imt.15.56; Mendoza FJ, 2008, APOPTOSIS, V13, P756, DOI 10.1007/s10495-008-0210-0; Oh YT, 2016, ONCOGENE, V35, P459, DOI 10.1038/onc.2015.97; Oh YT, 2015, ONCOTARGET, V6, P41324, DOI 10.18632/oncotarget.5847; Oh YT, 2012, J BIOL CHEM, V287, P257, DOI 10.1074/jbc.M111.304006; Oh YT, 2010, J BIOL CHEM, V285, P41310, DOI 10.1074/jbc.M110.153775; Ravi R, 2001, NAT CELL BIOL, V3, P409, DOI 10.1038/35070096; Sun SY, 2005, APOPTOSIS, V10, P1203, DOI 10.1007/s10495-005-2274-4; Sun SY, 1997, CANCER RES, V57, P4931; Sussman RT, 2007, CANCER BIOL THER, V6, P1490, DOI 10.4161/cbt.6.9.4905; van Roosmalen IAM, 2014, BIOCHEM PHARMACOL, V91, P447, DOI 10.1016/j.bcp.2014.08.010; Yang A, 2010, CURR OPIN CELL BIOL, V22, P837, DOI 10.1016/j.ceb.2010.08.001; Yao WL, 2015, ONCOTARGET, V6, P34669, DOI 10.18632/oncotarget.5785; Yao WL, 2015, CANCER LETT, V364, P70, DOI 10.1016/j.canlet.2015.04.028; Zhao YJ, 2014, NAT REV CLIN ONCOL, V11, P385, DOI 10.1038/nrclinonc.2014.83	40	21	22	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21694	21702		10.1074/jbc.M116.738302	http://dx.doi.org/10.1074/jbc.M116.738302			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27576686	Green Published, hybrid			2022-12-26	WOS:000385999200034
J	Chung, S; Shah, B; Storey, P; Iqbal, S; Slater, J; Axel, L				Chung, Sohae; Shah, Binita; Storey, Pippa; Iqbal, Sohah; Slater, James; Axel, Leon			Quantitative Perfusion Analysis of First-Pass Contrast Enhancement Kinetics: Application to MRI of Myocardial Perfusion in Coronary Artery Disease	PLOS ONE			English	Article							TISSUE HOMOGENEITY MODEL; BLOOD-FLOW; ADIABATIC APPROXIMATION; COMPUTED-TOMOGRAPHY; WATER EXCHANGE; GD-DTPA; QUANTIFICATION; DECONVOLUTION; RESOLUTION; VOLUMES	Purpose Perfusion analysis from first-pass contrast enhancement kinetics requires modeling tissue contrast exchange. This study presents a new approach for numerical implementation of the tissue homogeneity model, incorporating flexible distance steps along the capillary (NTHf). Methods The proposed NTHf model considers contrast exchange in fluid packets flowing along the capillary, incorporating flexible distance steps, thus allowing more efficient and stable calculations of the transit of tracer through the tissue. We prospectively studied 8 patients (62 +/- 13 years old) with suspected CAD, who underwent first-pass perfusion CMR imaging at rest and stress prior to angiography. Myocardial blood flow (MBF) and myocardial perfusion reserve index (MPRI) were estimated using both the NTHf and the conventional adiabatic approximation of the TH models. Coronary artery lesions detected at angiography were clinically assigned to one of three categories of stenosis severity ('insignificant', 'mild to moderate' and 'severe') and related to corresponding myocardial territories. Results The mean MBF (ml/g/min) at rest/stress and MPRI were 0.80 +/- 0.33/1.25 +/- 0.45 and 1.68 +/- 0.54 in the insignificant regions, 0.74 +/- 0.21/1.09 +/- 0.28 and 1.54 +/- 0.46 in the mild to moderate regions, and 0.79 +/- 0.28/0.63 +/- 0.34 and 0.85 +/- 0.48 in the severe regions, respectively. The correlation coefficients of MBFs at rest/stress and MPRI between the NTHf and AATH models were r = 0.97/0.93 and r = 0.91, respectively. Conclusions The proposed NTHf model allows efficient quantitative analysis of the transit of tracer through tissue, particularly at higher flow. Results of initial application to MRI of myocardial perfusion in CAD are encouraging.	[Chung, Sohae; Storey, Pippa; Axel, Leon] NYU, Sch Med, CAI2R, New York, NY 10016 USA; [Chung, Sohae; Storey, Pippa; Axel, Leon] NYU, Sch Med, Dept Radiol, Bernard & Irene Schwartz Ctr Biomed Imaging, New York, NY 10016 USA; [Shah, Binita; Iqbal, Sohah; Slater, James] NYU, Sch Med, Dept Med, Div Cardiol, New York, NY 10016 USA	New York University; New York University; New York University	Chung, S (corresponding author), NYU, Sch Med, CAI2R, New York, NY 10016 USA.; Chung, S (corresponding author), NYU, Sch Med, Dept Radiol, Bernard & Irene Schwartz Ctr Biomed Imaging, New York, NY 10016 USA.	sohae.chung@nyumc.org	Chung, Sohae/S-9249-2019	Slater, James/0000-0003-3888-0317; Storey, Pippa/0000-0003-1915-7860; Chung, Sohae/0000-0002-1132-900X; Shah, Binita/0000-0001-8872-8001; Axel, Leon/0000-0003-0608-4690	NIH [R01 HL083309]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000053, UL1TR001445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG008051] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX001074] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was funded by NIH Grant R01 HL083309.	AXEL L, 1983, INVEST RADIOL, V18, P94, DOI 10.1097/00004424-198301000-00018; AXEL L, 1980, RADIOLOGY, V137, P679, DOI 10.1148/radiology.137.3.7003648; BASSINGT.JB, 1966, CIRC RES, V18, P398, DOI 10.1161/01.RES.18.4.398; Bhave NM, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-89; Breton E, 2011, J MAGN RESON IMAGING, V34, P676, DOI 10.1002/jmri.22647; Cernicanu A, 2006, ACAD RADIOL, V13, P686, DOI 10.1016/j.acra.2006.02.040; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; CZERNIN J, 1993, CIRCULATION, V88, P62, DOI 10.1161/01.CIR.88.1.62; DIESBOURG LD, 1992, MAGNET RESON MED, V23, P239, DOI 10.1002/mrm.1910230205; Fahraeus R, 1929, PHYSIOL REV, V9, P241, DOI 10.1152/physrev.1929.9.2.241; GONZALEZ F, 1990, AM J PHYSIOL, V258, pH1012, DOI 10.1152/ajpheart.1990.258.4.H1012; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; HAASE A, 1990, MAGN RESON MED, V13, P77, DOI 10.1002/mrm.1910130109; Jerosch-Herold M, 1998, MED PHYS, V25, P73, DOI 10.1118/1.598163; JOHNSON JA, 1966, AM J PHYSIOL, V210, P1299, DOI 10.1152/ajplegacy.1966.210.6.1299; Kershaw LE, 2010, MAGN RESON MED, V64, P1772, DOI 10.1002/mrm.22573; Larsson HBW, 1996, MAGN RESON MED, V35, P716, DOI 10.1002/mrm.1910350513; MANNING WJ, 1991, J AM COLL CARDIOL, V18, P959, DOI 10.1016/0735-1097(91)90754-W; Nagel E, 2003, CIRCULATION, V108, P432, DOI 10.1161/01.CIR.0000080915.35024.A9; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Pack NA, 2010, MAGN RESON MED, V64, P125, DOI 10.1002/mrm.22282; St Lawrence KS, 1998, J CEREBR BLOOD F MET, V18, P1365, DOI 10.1097/00004647-199812000-00011; St Lawrence KS, 1998, J CEREBR BLOOD F MET, V18, P1378; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113	24	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162067	10.1371/journal.pone.0162067	http://dx.doi.org/10.1371/journal.pone.0162067			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583385	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600095
J	Stillman, CM; Watt, JC; Grove, GA; Wollam, ME; Uyar, F; Mataro, M; Cohen, NJ; Howard, DV; Howard, JH; Erickson, KI				Stillman, Chelsea M.; Watt, Jennifer C.; Grove, George A., Jr.; Wollam, Mariegold E.; Uyar, Fatma; Mataro, Maria; Cohen, Neal J.; Howard, Darlene V.; Howard, James H., Jr.; Erickson, Kirk I.			Physical Activity Is Associated with Reduced Implicit Learning but Enhanced Relational Memory and Executive Functioning in Young Adults	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; MILD COGNITIVE IMPAIRMENT; AEROBIC EXERCISE; DRUG-ADDICTION; OLDER-ADULTS; AGE-DIFFERENCES; FITNESS; BRAIN; MOTOR; NEUROGENESIS	Accumulating evidence suggests that physical activity improves explicit memory and executive cognitive functioning at the extreme ends of the lifespan (i.e., in older adults and children). However, it is unknown whether these associations hold for younger adults who are considered to be in their cognitive prime, or for implicit cognitive functions that do not depend on motor sequencing. Here we report the results of a study in which we examine the relationship between objectively measured physical activity and (1) explicit relational memory, (2) executive control, and (3) implicit probabilistic sequence learning in a sample of healthy, college-aged adults. The main finding was that physical activity was positively associated with explicit relational memory and executive control (replicating previous research), but negatively associated with implicit learning, particularly in females. These results raise the intriguing possibility that physical activity upregulates some cognitive processes, but downregulates others. Possible implications of this pattern of results for physical health and health habits are discussed.	[Stillman, Chelsea M.; Erickson, Kirk I.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15260 USA; [Watt, Jennifer C.; Grove, George A., Jr.; Wollam, Mariegold E.; Uyar, Fatma; Erickson, Kirk I.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Mataro, Maria] Univ Barcelona, Dept Psychiat & Clin Psychobiol, Barcelona, Spain; [Cohen, Neal J.] Univ Illinois, Beckman Inst, Urbana, IL USA; [Howard, Darlene V.] Georgetown Univ, Dept Psychol, Washington, DC 20057 USA; [Howard, James H., Jr.] Catholic Univ Amer, Dept Psychol, Washington, DC 20064 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Barcelona; University of Illinois System; University of Illinois Urbana-Champaign; Georgetown University; Catholic University of America	Stillman, CM (corresponding author), Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15260 USA.	cms289@pitt.edu	Mataro, Maria/B-4524-2011; Stillman, Chelsea/ABF-2587-2020	Mataro, Maria/0000-0002-9946-2656; Stillman, Chelsea/0000-0003-2672-7374	National Institute of Diabetes and Digestive and Kidney Diseases [RO1DK095172]; National Institute of Mental Health [T32 MH109986]; NATIONAL INSTITUTE ON AGING [P30AG024827] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by funding from National Institute of Diabetes and Digestive and Kidney Diseases (http://www.niddk.nih.gov/Pages/default.aspx) grant number RO1DK095172 to KIE. CMS was supported by National Institute of Mental Health (https://www.nimh.nih.gov/index.shtml) grant T32 MH109986. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Bennett Ilana J, 2011, Neurobiol Aging, V32, DOI 10.1016/j.neurobiolaging.2010.03.017; Berchtold NC, 2001, EUR J NEUROSCI, V14, P1992, DOI 10.1046/j.0953-816x.2001.01825.x; Bergstrom JCR, 2012, APPL COGNITIVE PSYCH, V26, P91, DOI 10.1002/acp.1800; Boyer M, 2005, PSYCHOL RES-PSYCH FO, V69, P383, DOI 10.1007/s00426-004-0207-4; Burdette JH, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00023; CLEEREMANS A, 1991, J EXP PSYCHOL GEN, V120, P235, DOI 10.1037/0096-3445.120.3.235; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Drollette ES, 2016, DEVELOPMENTAL SCI, V19, P90, DOI 10.1111/desc.12291; Duchesne C, 2015, BRAIN COGNITION, V99, P68, DOI 10.1016/j.bandc.2015.07.005; DUSTMAN RE, 1984, NEUROBIOL AGING, V5, P35, DOI 10.1016/0197-4580(84)90083-6; Erickson KI, 2007, NEUROBIOL AGING, V28, P179, DOI 10.1016/j.neurobiolaging.2005.11.016; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Gamble KR, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00563; Gheysen F, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00137; Gillan CM, 2011, AM J PSYCHIAT, V168, P718, DOI 10.1176/appi.ajp.2011.10071062; Gujral S, 2014, PSYCHIAT RES, V218, P93, DOI 10.1016/j.psychres.2014.03.028; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Howard DV, 2001, PSYCHON B REV, V8, P798, DOI 10.3758/BF03196220; Howard JH, 2008, J EXP PSYCHOL LEARN, V34, P1139, DOI 10.1037/a0012797; Janacsek K, 2012, DEVELOPMENTAL SCI, V15, P496, DOI 10.1111/j.1467-7687.2012.01150.x; Janacsek K, 2012, INT J PSYCHOPHYSIOL, V83, P213, DOI 10.1016/j.ijpsycho.2011.11.012; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Korol DL, 2004, NEUROBIOL LEARN MEM, V82, P309, DOI 10.1016/j.nlm.2004.07.006; Korol DL, 2013, HIPPOCAMPUS, V23, P1125, DOI 10.1002/hipo.22197; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; LEWICKI P, 1987, J EXP PSYCHOL LEARN, V13, P523, DOI 10.1037/0278-7393.13.4.523; Lungu OV, 2004, EXP BRAIN RES, V159, P135, DOI 10.1007/s00221-004-1945-7; Lynch WJ, 2013, NEUROSCI BIOBEHAV R, V37, P1622, DOI 10.1016/j.neubiorev.2013.06.011; MacLeod CM, 2000, TRENDS COGN SCI, V4, P383, DOI 10.1016/S1364-6613(00)01530-8; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mang CS, 2014, J APPL PHYSIOL, V117, P1325, DOI 10.1152/japplphysiol.00498.2014; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Middleton L, 2008, J NEUROL SCI, V269, P80, DOI 10.1016/j.jns.2007.04.054; Monti JM, 2015, J COGNITIVE NEUROSCI, V27, P234, DOI 10.1162/jocn_a_00717; Monti JM, 2012, HIPPOCAMPUS, V22, P1876, DOI 10.1002/hipo.22023; Nemeth D, 2013, CEREB CORTEX, V23, P801, DOI 10.1093/cercor/bhs068; Niemann C, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00170; Poldrack RA, 2003, NEURON, V37, P891, DOI 10.1016/S0896-6273(03)00159-4; Rieckmann A, 2010, NEUROIMAGE, V50, P1303, DOI 10.1016/j.neuroimage.2010.01.015; Roig M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044594; Rose M, 2002, NEURON, V36, P1221, DOI 10.1016/S0896-6273(02)01105-4; Schendan HE, 2013, BEHAV NEUROSCI, V127, P204, DOI 10.1037/a0032012; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; Simon JR, 2012, J COGNITIVE NEUROSCI, V24, P451, DOI 10.1162/jocn_a_00116; Simon JR, 2011, J GERONTOL B-PSYCHOL, V66, P32, DOI 10.1093/geronb/gbq066; Simon JR, 2011, BEHAV BRAIN RES, V216, P452, DOI 10.1016/j.bbr.2010.08.043; Smith JC, 2013, J ALZHEIMERS DIS, V37, P197, DOI 10.3233/JAD-130467; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Sofi F, 2011, J INTERN MED, V269, P107, DOI 10.1111/j.1365-2796.2010.02281.x; SPIRDUSO WW, 1978, J GERONTOL, V33, P26, DOI 10.1093/geronj/33.1.26; Statton MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141393; Stillman CM, 2016, J GERONTOL B-PSYCHOL, V71, P212, DOI 10.1093/geronb/gbu135; Stillman CM, 2014, CONSCIOUS COGN, V28, P141, DOI 10.1016/j.concog.2014.07.002; Stillman CM, 2013, BRAIN CONNECT, V3, P601, DOI 10.1089/brain.2013.0169; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061483; ten Brinke LF, 2015, BRIT J SPORT MED, V49, P248, DOI 10.1136/bjsports-2013-093184; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; Volkow ND, 2002, NEUROBIOL LEARN MEM, V78, P610, DOI 10.1006/nlme.2002.4099; Voss MW, 2013, TRENDS COGN SCI, V17, P525, DOI 10.1016/j.tics.2013.08.001; Voss MW, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00032; Watson PD, 2013, HIPPOCAMPUS, V23, P570, DOI 10.1002/hipo.22115; Winker R, 2010, WIEN KLIN WOCHENSCHR, V122, P704, DOI 10.1007/s00508-010-1485-z; Wood W, 2007, PSYCHOL REV, V114, P843, DOI 10.1037/0033-295X.114.4.843; Young J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005381.pub4; Zhou YH, 2016, FRONT NEUROENDOCRIN, V40, P24, DOI 10.1016/j.yfrne.2015.07.001; Zhou YH, 2014, J SPORT HEALTH SCI, V3, P163, DOI 10.1016/j.jshs.2014.04.005	72	13	14	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162100	10.1371/journal.pone.0162100	http://dx.doi.org/10.1371/journal.pone.0162100			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV3WN	27584059	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600102
J	Riccadonna, C; Maroun, CY; de Silly, RV; Boehler, M; Tardon, MC; Jueliger, S; Taverna, P; Barba, L; Marinari, E; Pellegatta, S; Bassoy, EY; Martinvalet, D; Dietrich, PY; Walker, PR				Riccadonna, Cristina; Maroun, Celine Yacoub; de Silly, Romain Vuillefroy; Boehler, Margaux; Tardon, Marta Calvo; Jueliger, Simone; Taverna, Pietro; Barba, Leticia; Marinari, Eliana; Pellegatta, Serena; Bassoy, Esen Yonca; Martinvalet, Denis; Dietrich, Pierre-Yves; Walker, Paul R.			Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing	PLOS ONE			English	Article							HUMAN-LEUKOCYTE ANTIGEN; CANCER-TESTIS ANTIGENS; CLASS-I ANTIGENS; STEM-LIKE CELLS; CD8(+) T-CELLS; DNA METHYLATION; HUMAN GLIOBLASTOMA; IMMUNOTHERAPEUTIC IMPLICATIONS; MALIGNANT GLIOMAS; UP-REGULATION	Malignant gliomas are aggressive brain tumours with very poor prognosis. The majority of glioma cells are differentiated (glioma-differentiated cells: GDCs), whereas the smaller population (glioma-initiating cells, GICs) is undifferentiated and resistant to conventional therapies. Therefore, to better target this pool of heterogeneous cells, a combination of diverse therapeutic approaches is envisaged. Here we investigated whether the immunosensitising properties of the hypomethylating agent decitabine can be extended to GICs. Using the murine GL261 cell line, we demonstrate that decitabine augments the expression of the death receptor FAS both on GDCs and GICs. Interestingly, it had a higher impact on GICs and correlated with an enhanced sensitivity to FASL-mediated cell death. Moreover, the expression of other critical molecules involved in cognate recognition by cytotoxic T lymphocytes, MHCI and ICAM-1, was upregulated by decitabine treatment. Consequently, T-cell mediated killing of both GDCs and GICs was enhanced, as was T cell proliferation after reactivation. Overall, although GICs are described to resist classical therapies, our study shows that hypomethylating agents have the potential to enhance glioma cell recognition and subsequent destruction by immune cells, regardless of their differentiation status. These results support the development of combinatorial treatment modalities including epigenetic modulation together with immunotherapy in order to treat heterogenous malignancies such as glioblastoma.	[Riccadonna, Cristina; Maroun, Celine Yacoub; de Silly, Romain Vuillefroy; Boehler, Margaux; Tardon, Marta Calvo; Barba, Leticia; Marinari, Eliana; Dietrich, Pierre-Yves; Walker, Paul R.] Univ Hosp Geneva, Ctr Oncol, Geneva, Switzerland; [Riccadonna, Cristina; Maroun, Celine Yacoub; de Silly, Romain Vuillefroy; Boehler, Margaux; Tardon, Marta Calvo; Barba, Leticia; Marinari, Eliana; Dietrich, Pierre-Yves; Walker, Paul R.] Univ Geneva, Geneva, Switzerland; [Jueliger, Simone] Astex Pharmaceut, Cambridge Sci Pk, Cambridge, England; [Taverna, Pietro] Astex Pharmaceut, Pleasanton, CA USA; [Pellegatta, Serena] Fdn IRCCS Ist Neurol C Besta, Unit Mol Neurooncol, Milan, Italy; [Bassoy, Esen Yonca; Martinvalet, Denis] Univ Geneva, Dept Cell Physiol & Metab, Geneva, Switzerland	University of Geneva; University of Geneva; Astex Pharmaceuticals; IRCCS Istituto Neurologico Besta; University of Geneva	Walker, PR (corresponding author), Univ Hosp Geneva, Ctr Oncol, Geneva, Switzerland.; Walker, PR (corresponding author), Univ Geneva, Geneva, Switzerland.	Paul.Walker@hcuge.ch	Pellegatta, Serena/AAL-3693-2021; de Silly, Romain Vuillefroy/N-7978-2013	Pellegatta, Serena/0000-0001-7804-9486; de Silly, Romain Vuillefroy/0000-0001-6573-9752; Bassoy, Esen Yonca/0000-0001-8870-7040	Geneva Cancer League; Ernst and Lucie Schmidheiny Foundation	Geneva Cancer League; Ernst and Lucie Schmidheiny Foundation	This investigation was supported by a grant from the Geneva Cancer League (http://www.lgc.ch/) to PRW and by the Ernst and Lucie Schmidheiny Foundation (http://www.fondation-schmidheiny.ch/) to CR. SJ and PT are employees of Astex Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair SJ, 2009, CANCER IMMUNOL IMMUN, V58, P589, DOI 10.1007/s00262-008-0582-6; Alizadeh D, 2014, CANCER RES, V74, P2663, DOI 10.1158/0008-5472.CAN-14-0301; Almstedt M, 2010, LEUKEMIA RES, V34, P899, DOI 10.1016/j.leukres.2010.02.004; Auffinger B, 2015, EXPERT REV NEUROTHER, V15, P741, DOI 10.1586/14737175.2015.1051968; Avril T, 2012, BRAIN PATHOL, V22, P159, DOI 10.1111/j.1750-3639.2011.00515.x; Bao L, 2011, CANCER IMMUNOL IMMUN, V60, P1299, DOI 10.1007/s00262-011-1037-z; Bassoy EY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153433; Berghoff AS, 2015, NEURO-ONCOLOGY, V17, P1064, DOI 10.1093/neuonc/nou307; Brown CE, 2009, CANCER RES, V69, P8886, DOI 10.1158/0008-5472.CAN-09-2687; Cashen AF, 2008, CANCER CHEMOTH PHARM, V61, P759, DOI 10.1007/s00280-007-0531-7; CHABOT GG, 1983, CANCER RES, V43, P592; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Chu SH, 2012, MOL MED REP, V5, P138, DOI 10.3892/mmr.2011.620; Coral S, 2002, CLIN CANCER RES, V8, P2690; De Rosa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052113; de Silly RV, 2015, EUR J IMMUNOL, V45, P2263, DOI 10.1002/eji.201445284; Drachsler M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.102; Eisele G, 2013, ANTICANCER RES, V33, P3563; Eisele G, 2011, NEURO-ONCOLOGY, V13, P155, DOI 10.1093/neuonc/noq176; Eramo A, 2005, CANCER RES, V65, P11469, DOI 10.1158/0008-5472.CAN-05-1724; Everson RG, 2016, NEURO-ONCOLOGY, V18, P368, DOI 10.1093/neuonc/nov153; Facoetti A, 2005, CLIN CANCER RES, V11, P8304, DOI 10.1158/1078-0432.CCR-04-2588; Fonsatti E, 2007, CLIN CANCER RES, V13, P3333, DOI 10.1158/1078-0432.CCR-06-3091; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Guo ZS, 2006, CANCER RES, V66, P1105, DOI 10.1158/0008-5472.CAN-05-3020; He JS, 2010, J IMMUNOL, V184, P555, DOI 10.4049/jimmunol.0902465; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Joo KM, 2012, CANCER RES, V72, P3828, DOI 10.1158/0008-5472.CAN-11-3760; Kataoka T, 1996, J IMMUNOL, V156, P3678; Kim TY, 2006, CANCER RES, V66, P7490, DOI 10.1158/0008-5472.CAN-05-4552; Konkankit VV, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-192; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Licht JD, 2015, CELL, V162, P938, DOI 10.1016/j.cell.2015.08.005; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Masson F, 2007, J IMMUNOL, V179, P845, DOI 10.4049/jimmunol.179.2.845; Moen EL, 2014, MOL CANCER THER, V13, P1334, DOI 10.1158/1535-7163.MCT-13-0924; Natsume A, 2008, INT J CANCER, V122, P2542, DOI 10.1002/ijc.23407; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P896, DOI 10.1093/neuonc/nou087; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Pellegatta S, 2006, CANCER RES, V66, P10247, DOI 10.1158/0008-5472.CAN-06-2048; Poon C, 2016, NEUROPHARMACOLOGY; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Seki N, 2002, J IMMUNOL, V168, P3484, DOI 10.4049/jimmunol.168.7.3484; Serrano A, 2001, INT J CANCER, V94, P243, DOI 10.1002/ijc.1452; Shin DY, 2013, BIOMED PHARMACOTHER, V67, P305, DOI 10.1016/j.biopha.2013.01.004; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; VANGROENINGEN CJ, 1986, CANCER RES, V46, P4831; Walker PR, 2002, IMMUNOLOGY, V107, P28, DOI 10.1046/j.1365-2567.2002.01507.x; WEBER J, 1994, CANCER RES, V54, P1766; Weintraub K, 2016, NAT MED, V22, P8, DOI 10.1038/nm0116-8; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Zhang QM, 2014, ASIAN PAC J CANCER P, V15, P3495, DOI 10.7314/APJCP.2014.15.8.3495; Zitvogel L, 2013, IMMUNITY, V39, P74, DOI 10.1016/j.immuni.2013.06.014; Zitvogel L, 2011, NAT REV CLIN ONCOL, V8, P151, DOI 10.1038/nrclinonc.2010.223	59	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0162105	10.1371/journal.pone.0162105	http://dx.doi.org/10.1371/journal.pone.0162105			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579489	gold, Green Published, Green Submitted			2022-12-26	WOS:000382877400058
J	Kong, HL; Lv, M; Mao, N; Wang, C; Cheng, YX; Zhang, L; Jiang, XF; Luo, LZ				Kong, Hailong; Lv, Min; Mao, Nian; Wang, Cheng; Cheng, Yunxia; Zhang, Lei; Jiang, Xingfu; Luo, Lizhi			Molecular Characterization of a Lysozyme Gene and Its Altered Expression Profile in Crowded Beet Webworm (Loxostege sticticalis)	PLOS ONE			English	Article							DENSITY-DEPENDENT PROPHYLAXIS; GENOME-WIDE ANALYSIS; C-TYPE LYSOZYME; DESERT LOCUST; DROSOPHILA	There is growing evidence that insects living in high-density populations exhibit an increase in immune function to counter a higher risk of disease. This phenomenon, known as density-dependent prophylaxis, has been experimentally tested in a number of insect species. Although density-dependent prophylaxis is especially prevalent in insects exhibiting density-dependent phase polyphenism, the molecular mechanism remains unclear. Our previous study demonstrated that the antibacterial activity of lysozyme is important for this process in the beet webworm Loxostege sticticalis. In this study, a lysozyme cDNA from L. sticticalis was cloned and characterized. The full-length cDNA is 1078 bp long and contains an open reading frame of 426 bp that encodes 142 amino acids. The deduced protein possesses structural characteristics of a typical c-type lysozyme and clusters with c-type lysozymes from other Lepidoptera. LsLysozyme was found to be expressed throughout all developmental stages, showing the highest level in pupae. LsLysozyme was also highly expressed in the midgut and fat body. Elevated LsLysozyme expression was observed in L. sticticalis larvae infected by Beauveria bassiana and in larvae reared under crowding conditions. In addition, the expression level of LsLysozyme in infected larvae reared at a density of 10 larvae per jar was significantly higher compared to those reared at a density of 1 or 30 larvae per jar. These results suggest that larval crowding affects the gene expression profile of this lysozyme. This study provides additional insight into the expression of an immune-associated lysozyme gene and helps us to better understand the immune response of L. sticticalis under crowding conditions.	[Kong, Hailong; Mao, Nian; Wang, Cheng] Yangzhou Univ, Coll Hort & Plant Protect, Wenhui East Rd 48, Yangzhou 225009, Jiangsu, Peoples R China; [Lv, Min] Inst Agr Sci Lixiahe Dist Jiangsu Prov, Yangzijiang Rd 568, Yangzhou 225007, Jiangsu, Peoples R China; [Cheng, Yunxia; Zhang, Lei; Jiang, Xingfu; Luo, Lizhi] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Yuanmingyuan West Rd 2, Beijing 100193, Peoples R China	Yangzhou University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Jiang, XF (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Yuanmingyuan West Rd 2, Beijing 100193, Peoples R China.	khl2504@126.com			National Natural Science Foundation of China [31201503, 31373947, 31301656, 31672018]; State Key Laboratory for Biology of Plant Diseases and Insect Pests [SKLOF201512]; National Department of Public Benefit Research Foundation [201403031]; International Science and Technology Cooperation Program of China [2014DFR31250]; Beijing Natural Science Foundation [6142017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory for Biology of Plant Diseases and Insect Pests; National Department of Public Benefit Research Foundation; International Science and Technology Cooperation Program of China; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (31201503, 31373947, 31301656, 31672018), State Key Laboratory for Biology of Plant Diseases and Insect Pests (SKLOF201512), the National Department of Public Benefit Research Foundation (201403031), International Science and Technology Cooperation Program of China (2014DFR31250), and Beijing Natural Science Foundation (6142017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Natural Science Foundation of China (31201503, 31373947, 31301656), State Key Laboratory for Biology of Plant Diseases and Insect Pests (SKLOF201512), the National Department of Public Benefit Research Foundation (201403031), International Science and Technology Cooperation Program of China (2014DFR31250), and Beijing Natural Science Foundation (6142017).	De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Frolov A.N., 2008, ENTOMOL REV, V88, P666; Imler Jean-Luc, 2005, V86, P1, DOI 10.1159/000086648; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; Khajuria C, 2011, J INSECT PHYSIOL, V57, P345, DOI 10.1016/j.jinsphys.2010.12.005; Knor I.B., 1993, Entomologicheskoe Obozrenie, V72, P268; Kong HL, 2013, INT J PEST MANAGE, V59, P174, DOI 10.1080/09670874.2013.807957; KUMAGAI I, 1992, J BIOL CHEM, V267, P4608; Kwon H, 2014, MOL BIOL REP, V41, P5745, DOI 10.1007/s11033-014-3446-5; Lapcharoen P, 2012, DEV COMP IMMUNOL, V36, P104, DOI 10.1016/j.dci.2011.06.010; Li B, 2005, GENE, V360, P131, DOI 10.1016/j.gene.2005.07.001; Luo L.Z., 2009, PLANT PROT BEIJING, V35, P27; Luo Li-Zhi, 1993, Acta Entomologica Sinica, V36, P332; [罗礼智 Luo Lizhi], 2005, [植物保护, Plant Protection], V31, P69; MAENAKA K, 1995, J MOL BIOL, V247, P281, DOI 10.1006/jmbi.1994.0139; Mohamed AA, 2016, DEV COMP IMMUNOL, V61, P60, DOI 10.1016/j.dci.2016.03.018; Mohamed AA, 2013, EUR J ENTOMOL, V110, P559, DOI 10.14411/eje.2013.076; Pepper JH, 1938, ECOLOGY, V19, P565, DOI 10.2307/1930934; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POWNING RF, 1976, COMP BIOCHEM PHYS B, V55, P221, DOI 10.1016/0305-0491(76)90234-0; Prager E.M., 1996, Experientia Supplementum (Basel), V75, P9; Qu Xi-Feng, 1999, Entomological Knowledge, V36, P11; Regel R, 1998, INSECT BIOCHEM MOLEC, V28, P309, DOI 10.1016/S0965-1748(97)00108-2; Ren Q, 2009, J GENET GENOMICS, V36, P7, DOI 10.1016/S1673-8527(09)60002-3; Silva FWS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061582; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Wang WX, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.1701; Wang YD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003102; White KAJ, 1999, THEOR POPUL BIOL, V56, P163, DOI 10.1006/tpbi.1999.1425; Wilson K, 2002, P NATL ACAD SCI USA, V99, P5471, DOI 10.1073/pnas.082461999; Wilson K, 1998, ECOL ENTOMOL, V23, P100, DOI 10.1046/j.1365-2311.1998.00107.x; Yue ZD, 1983, JILIN AGR SCI, V8, P64; Zhang Y, 2009, ARCH INSECT BIOCHEM, V70, P18, DOI 10.1002/arch.20258; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177; 罗礼智, 2004, [植物保护, Plant Protection], V30, P86	36	7	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161384	10.1371/journal.pone.0161384	http://dx.doi.org/10.1371/journal.pone.0161384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575006	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877200024
J	Lei, W; Browning, JD; Eichen, PA; Folk, WR; Sun, GY; Lubahn, DB; Fritsche, KL				Lei, Wei; Browning, Jimmy D., Jr.; Eichen, Peggy A.; Folk, William R.; Sun, Grace Y.; Lubahn, Dennis B.; Fritsche, Kevin L.			An Investigation into the Immunomodulatory Activities of Sutherlandia frutescens in Healthy Mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE; INFLAMMATION; INNATE; POLYSACCHARIDES; INTERLEUKIN-6; TUBERCULOSIS; LISTERIOSIS; INFECTION; RESPONSES	Sutherlandia frutescens is a medicinal plant that has been traditionally used in southern Africa for cancers, infections, and inflammatory conditions. We recently published experiments demonstrating that an aqueous extract of S. frutescens possessed potent immune-stimulatory activity. This work was carried out with murine macrophages, an immune cell type that plays a pivotal role in host defense from infection and in shaping host inflammatory and immune responses. Here, we conducted a series of follow-up experiments to explore the impact of consuming S. frutescens on host response to bacterial challenge using healthy mice. We found that feeding mice a diet containing S. frutescens failed to significantly alter host response to systemic infection by either a gram-positive or gram-negative bacterium (i.e., L. monocytogenes and E.coli, respectively). In contrast to the in vitro observations, we found no evidence that S. frutescens consumption stimulated in vivo inflammatory responses; instead, consumption of S. frutescens tended to diminish in vivo inflammatory responses. Several possible reasons for this are discussed.	[Lei, Wei; Browning, Jimmy D., Jr.; Eichen, Peggy A.; Fritsche, Kevin L.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Folk, William R.; Sun, Grace Y.; Lubahn, Dennis B.] Univ Missouri, Dept Biochem, Columbia, MO 65201 USA; [Fritsche, Kevin L.] Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO 65203 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Fritsche, KL (corresponding author), Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.; Fritsche, KL (corresponding author), Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO 65203 USA.	fritschek@missouri.edu		Lei, Wei/0000-0002-0374-8642; Fritsche, Kevin/0000-0002-0740-3801; Folk, William/0000-0003-2216-3233	National Center for Complementary & Alternative Medicine (NCCAM) [P50AT006273]; Office of Dietary Supplements (ODS); National Cancer Institute (NCI); University of Missouri's College of Agriculture, Food, and Natural Resources; Food-for-the-21st Century Program	National Center for Complementary & Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Office of Dietary Supplements (ODS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Missouri's College of Agriculture, Food, and Natural Resources; Food-for-the-21st Century Program	This publication or project was made possible by Grant Number P50AT006273 from the National Center for Complementary & Alternative Medicine (NCCAM), the Office of Dietary Supplements (ODS), and the National Cancer Institute (NCI) and the support of the University of Missouri's College of Agriculture, Food, and Natural Resources, and the Food-for-the-21st Century Program. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NCCAM, ODS, NCI, or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Africa LD, 2015, J NEGAT RESULTS BIOM, V14, DOI 10.1186/s12952-015-0031-y; [Anonymous], 2013, Ann Emerg Med, V62, P536; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; BUCHMEIER NA, 1985, P NATL ACAD SCI USA, V82, P7404, DOI 10.1073/pnas.82.21.7404; Campbell P A, 1994, Immunol Ser, V60, P313; CHEERS C, 1978, INFECT IMMUN, V19, P763, DOI 10.1128/IAI.19.3.763-770.1978; Coleman JW, 2001, INT IMMUNOPHARMACOL, V1, P1397, DOI 10.1016/S1567-5769(01)00086-8; Couzin-Frankel J, 2010, SCIENCE, V330, P1621, DOI 10.1126/science.330.6011.1621; Di Paolo NC, 2015, IMMUNITY, V43, P1125, DOI 10.1016/j.immuni.2015.11.016; Eitel J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2010.00149; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Feng C, 1999, J INTERF CYTOK RES, V19, P41, DOI 10.1089/107999099314405; Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846; Johnson RW, 2002, VET IMMUNOL IMMUNOP, V87, P443, DOI 10.1016/S0165-2427(02)00069-7; Kohchi C, 2009, ANTICANCER RES, V29, P817; Lam GY, 2010, SEMIN IMMUNOPATHOL, V32, P415, DOI 10.1007/s00281-010-0221-0; Laroux FS, 2004, FRONT BIOSCI-LANDMRK, V9, P3156, DOI 10.2741/1468; Lei W, 2015, INT IMMUNOPHARMACOL, V29, P254, DOI 10.1016/j.intimp.2015.11.012; Lei W, 2015, J ETHNOPHARMACOL, V172, P247, DOI 10.1016/j.jep.2015.06.013; LIU Z, 1995, IMMUNOLOGY, V85, P562; Mills E, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-19; Montero D, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00384; NAKANE A, 1992, INFECT IMMUN, V60, P523, DOI 10.1128/IAI.60.2.523-528.1992; Poulsen KP, 2013, MICROB PATHOGENESIS, V56, P47, DOI 10.1016/j.micpath.2012.11.003; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rigato O, 1996, INFECTION, V24, P314, DOI 10.1007/BF01743367; Rucker RB, 2007, J ANIM PHYSIOL AN N, V91, P148, DOI 10.1111/j.1439-0396.2007.00681.x; Salgadon E, 2011, EXPERT REV CLIN IMMU, V7, P329, DOI [10.1586/ECI.11.6, 10.1586/eci.11.6]; Schepetkin IA, 2006, INT IMMUNOPHARMACOL, V6, P317, DOI 10.1016/j.intimp.2005.10.005; Sharma V, 2009, BRIT J PHARMACOL, V157, P907, DOI 10.1111/j.1476-5381.2009.00267.x; Shiloh MU, 1997, INFECT IMMUN, V65, P3193, DOI 10.1128/IAI.65.8.3193-3198.1997; Spiers DE, 2005, J ANIM SCI, V83, P1423; Tripp CS, 1995, RES IMMUNOL, V146, P515, DOI 10.1016/0923-2494(96)83025-2; Vujanovic NL, 2011, IMMUNOL RES, V50, P159, DOI 10.1007/s12026-011-8228-8; Wilson D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128522; Zhang BZ, 2014, J ETHNOPHARMACOL, V152, P340, DOI 10.1016/j.jep.2014.01.017	36	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0160994	10.1371/journal.pone.0160994	http://dx.doi.org/10.1371/journal.pone.0160994			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575007	Green Submitted, gold, Green Published			2022-12-26	WOS:000382877200013
J	Nicolaou, M; Gademan, MGJ; Snijder, MB; Engelbert, RHH; Dijkshoorn, H; Terwee, CB; Stronks, K				Nicolaou, M.; Gademan, M. G. J.; Snijder, M. B.; Engelbert, R. H. H.; Dijkshoorn, H.; Terwee, C. B.; Stronks, K.			Validation of the SQUASH Physical Activity Questionnaire in a Multi-Ethnic Population: The HELIUS Study	PLOS ONE			English	Article							CRITERION-RELATED VALIDITY; HEART-RATE; HEALTH; ADULTS; ACCELEROMETRY; RELIABILITY; AGREEMENT; IPAQ	Purpose To investigate the reliability and validity of the SQUASH physical activity (PA) questionnaire in a multi-ethnic population living in the Netherlands. Methods We included participants from the HELIUS study, a population-based cohort study. In this study we included Dutch (n = 114), Turkish (n = 88), Moroccan (n = 74), South-Asian Surinamese (n = 98) and African Surinamese (n = 91) adults, aged 18-70 years. The SQUASH was self-administered twice to assess test-re-test reliability (mean interval 6-7 weeks) and participants wore an accelerometer and heart rate monitor (Actiheart) to enable assessment of construct validity. Results We observed low test-re-test reliability; Intra class correlation coefficients ranged from low (0.05 for moderate/high intensity PA in African Surinamese women) to acceptable (0.78 for light intensity PA in Moroccan women). The discrepancy between self-reported and measured PA differed on the basis of the intensity of activity: self-reported light intensity PA was lower than measured but self-reported moderate/high intensity PA was higher than measured, with wide limits of agreement. The discrepancy between questionnaire and Actiheart measures of moderate intensity PA did not differ between ethnic minority and Dutch participants with correction for relevant confounders. Additionally, the SQUASH overestimated the number of participants meeting the Dutch PA norm; Cohen's kappas for the agreement were poor, the highest being 0.30 in Dutch women. Conclusion We found considerable variation in the test-re-test reliability and validity of self-reported PA with no consistency based on ethnic origin. Our findings imply that the SQUASH does not provide a valid basis for comparison of PA between ethnic groups.	[Nicolaou, M.; Gademan, M. G. J.; Snijder, M. B.; Stronks, K.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands; [Engelbert, R. H. H.] Univ Appl Sci, ASHP, Educ Phys Therapy, Amsterdam, Netherlands; [Engelbert, R. H. H.] Acad Med Ctr, Dept Rehabil, Amsterdam, Netherlands; [Dijkshoorn, H.] Publ Hlth Serv Amsterdam, Dept Epidemiol & Hlth Promot, Amsterdam, Netherlands; [Terwee, C. B.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Terwee, C. B.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Nicolaou, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands.	m.nicolaou@amc.uva.nl		Nicolaou, Mary/0000-0002-0419-5816; Terwee, Caroline/0000-0003-4570-2826; Stronks, Karien/0000-0002-0921-2232	Netherlands Organisation for Health Research and Development [200400012]	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	Funding for this study was provided by The Netherlands Organisation for Health Research and Development, grant number 200400012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107039; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; [Anonymous], [No title captured]; [Anonymous], 2010, TRENDRAPPORT BEWEGEN; Arvidson D, 2014, SCAND J PUBLIC HEALT, V42, P255, DOI 10.1177/1403494813514143; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Brage S, 2004, J APPL PHYSIOL, V96, P343, DOI 10.1152/japplphysiol.00703.2003; Buchowski MS, 2009, J PHYS ACT HEALTH, V6, P252, DOI 10.1123/jpah.6.2.252; Crouter SE, 2008, EUR J CLIN NUTR, V62, P704, DOI 10.1038/sj.ejcn.1602766; de Hollander EL, 2012, J CLIN EPIDEMIOL, V65, P73, DOI 10.1016/j.jclinepi.2011.05.005; de Munter JSL, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-85; Dijkshoorn H, 2014, PUBLIC HEALTH NUTR, V17, P2037, DOI 10.1017/S1368980013002322; Ekelund U, 2006, PUBLIC HEALTH NUTR, V9, P258, DOI 10.1079/PHN2005840; Espana-Romero V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087085; Gauthier AP, 2009, J PHYS ACT HEALTH, V6, pS54, DOI 10.1123/jpah.6.s1.s54; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; HAYS RD, 1989, EDUC PSYCHOL MEAS, V49, P629, DOI 10.1177/001316448904900315; Helmerhorst HJF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-103; Koshoedo SA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1893-0; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Nang EEK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-141; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Snijder MB, 2015, INT J CARDIOL, V191, P28, DOI 10.1016/j.ijcard.2015.04.234; Strath SJ, 2013, CIRCULATION, V128, P2259, DOI 10.1161/01.cir.0000435708.67487.da; Stronks K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-402; Stronks K, 2009, ETHNIC HEALTH, V14, P255, DOI 10.1080/13557850802509206; Thompson D, 2006, J NUTR, V136, P1037, DOI 10.1093/jn/136.4.1037; van Poppel MNM, 2010, SPORTS MED, V40, P565, DOI 10.2165/11531930-000000000-00000; Warnecke RB, 1997, ANN EPIDEMIOL, V7, P334, DOI 10.1016/S1047-2797(97)00030-6; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8	32	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161066	10.1371/journal.pone.0161066	http://dx.doi.org/10.1371/journal.pone.0161066			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575490	gold, Green Published, Green Submitted			2022-12-26	WOS:000382877200016
J	Kang, HG; Dingwell, JB				Kang, Hyun Gu; Dingwell, Jonathan B.			Differential Changes with Age in Multiscale Entropy of Electromyography Signals from Leg Muscles during Treadmill Walking	PLOS ONE			English	Article							APPROXIMATE ENTROPY; SAMPLE ENTROPY; GAIT; COMPLEXITY; TIME; DYNAMICS; SPEED	Age-related gait changes may be due to the loss of complexity in the neuromuscular system. This theory is disputed due to inconsistent results from single-scale analyses. Also, behavioral adaptations may confound these changes. We examined whether EMG dynamics during gait is less complex in older adults over a range of timescales using the multiscale entropy method, and whether slower walking attenuates this effect. Surface EMG was measured from the left vastus lateralis (VL), biceps femoris (BF), gastrocnemius (GA), and tibialis anterior (TA) in 17 young and 18 older adults as they walked on a treadmill for 5 minutes at 0.8x-1.2x of preferred speed. Sample entropy (SE) and the complexity index (C-I) of the EMG signals were calculated after successive coarse-graining to extract dynamics at timescales of 27 to 270 Hz, with m = 2 and r = 0.15 SD. SE and C-I were lower across the timescales in older adults in VL and BF, but higher in GA (all p<0.001); these results held for VL and GA even after accounting for longer EMG burst durations in older adults. CI was higher during slower walking speed in VL and BF (p<0.001). Results were mostly similar for m = 3 and r = 0.01-0.35. Smaller r was more sensitive to age-related differences. The decrease in complexity with aging in the timescales studied was limited to proximal muscles, particularly VL. The increase in GA may be driven by other factors. Walking slower may reflect a behavioral adaptation that allows the nervous system to function with greater complexity.	[Kang, Hyun Gu] Calif State Univ San Marcos, Kinesiol, San Marcos, CA 92096 USA; [Dingwell, Jonathan B.] Univ Texas Austin, Kinesiol & Hlth Educ, Austin, TX 78712 USA; [Dingwell, Jonathan B.] Univ Texas Austin, Biomed Engn, Austin, TX 78712 USA	California State University System; California State University San Marcos; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Kang, HG (corresponding author), Calif State Univ San Marcos, Kinesiol, San Marcos, CA 92096 USA.	hkang@csusm.edu		Dingwell, Jonathan/0000-0001-6990-4153	Whitaker Foundation Biomedical Engineering Research Grant [RG-02-0354]; American Society of Biomechanics; University of Texas A. D. Hutchinson Fellowship	Whitaker Foundation Biomedical Engineering Research Grant; American Society of Biomechanics; University of Texas A. D. Hutchinson Fellowship	This work was supported by Whitaker Foundation Biomedical Engineering Research Grant RG-02-0354 to JBD, and American Society of Biomechanics Grant-in-Aid and University of Texas A. D. Hutchinson Fellowship to HGK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NB, 1996, J AM GERIATR SOC, V44, P434, DOI 10.1111/j.1532-5415.1996.tb06417.x; Andersen JL, 2003, SCAND J MED SCI SPOR, V13, P40, DOI 10.1034/j.1600-0838.2003.00299.x; Brown LA, 2002, EXP BRAIN RES, V145, P286, DOI 10.1007/s00221-002-1082-0; Cashaback JGA, 2013, J ELECTROMYOGR KINES, V23, P78, DOI 10.1016/j.jelekin.2012.08.004; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2003, PHYSICA A, V330, P53, DOI 10.1016/j.physa.2003.08.022; Costa M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.020901; Costa MD, 2008, CARDIOVASC ENG, V8, P88, DOI 10.1007/s10558-007-9049-1; DeVita P, 2000, J APPL PHYSIOL, V88, P1804, DOI 10.1152/jappl.2000.88.5.1804; Evans JD., 1996, STRAIGHTFORWARD STAT; Franz JR, 2013, GAIT POSTURE, V37, P378, DOI 10.1016/j.gaitpost.2012.08.004; Franz JR, 2013, GAIT POSTURE, V11; Ghassemi M, 2014, COMPUT CARDIOL CONF, V41, P993; Heffernan KS, 1985, J APPL PHYSIOL, V106, P1227; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Kang HG, 2008, J BIOMECH, V41, P2899, DOI 10.1016/j.jbiomech.2008.08.002; Kang HG, 2008, GAIT POSTURE, V27, P572, DOI 10.1016/j.gaitpost.2007.07.009; Kang HG, 2009, J GERONTOL A-BIOL, V64, P1304, DOI 10.1093/gerona/glp113; Kang HG, 2009, J BIOMECH, V42, P2231, DOI 10.1016/j.jbiomech.2009.06.038; Kurz MJ, 2003, NEUROSCI LETT, V348, P155, DOI 10.1016/S0304-3940(03)00736-5; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Rowan SL, 2011, EXP GERONTOL, V46, P660, DOI 10.1016/j.exger.2011.03.005; Schmitz A, 2009, J ELECTROMYOGR KINES, V19, P1085, DOI 10.1016/j.jelekin.2008.10.008; Sosnoff JJ, 2009, J MOTOR BEHAV, V41, P137, DOI 10.3200/JMBR.41.2.137-146; Sung PS, 2007, J REHABIL RES DEV, V44, P599, DOI 10.1682/JRRD.2006.10.0132; Vaillancourt DE, 2003, J APPL PHYSIOL, V94, P903, DOI 10.1152/japplphysiol.00166.2002; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; Watanabe K, 2012, J ELECTROMYOGR KINES, V22, P74, DOI 10.1016/j.jelekin.2011.09.010; Yentes JM, 2013, ANN BIOMED ENG, V41, P349, DOI 10.1007/s10439-012-0668-3	31	22	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0162034	10.1371/journal.pone.0162034	http://dx.doi.org/10.1371/journal.pone.0162034			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27570974	Green Published, Green Submitted, gold			2022-12-26	WOS:000382876700051
J	Bailleul, G; Kravtzoff, A; Joulin-Giet, A; Lecaille, F; Labas, V; Meudal, H; Loth, K; Teixeira-Gomes, AP; Gilbert, FB; Coquet, L; Jouenne, T; Brmme, D; Schouler, C; Landon, C; Lalmanach, G; Lalmanach, AC				Bailleul, Geoffrey; Kravtzoff, Amanda; Joulin-Giet, Alix; Lecaille, Fabien; Labas, Valerie; Meudal, Herve; Loth, Karine; Teixeira-Gomes, Ana-Paula; Gilbert, Florence B.; Coquet, Laurent; Jouenne, Thierry; Brmme, Dieter; Schouler, Catherine; Landon, Celine; Lalmanach, Gilles; Lalmanach, Anne-Christine			The Unusual Resistance of Avian Defensin AvBD7 to Proteolytic Enzymes Preserves Its Antibacterial Activity	PLOS ONE			English	Article							CATHEPSIN-K; ANTIMICROBIAL PEPTIDES; CYSTEINE CATHEPSINS; SUBSTRATE; PROTEINS; CRYSTALLOGRAPHY; SPECIFICITY; EXPRESSION; INHIBITOR; INFECTION	Defensins are frontline peptides of mucosal immunity in the animal kingdom, including birds. Their resistance to proteolysis and their ensuing ability to maintain antimicrobial potential remains questionable and was therefore investigated. We have shown by bottom-up mass spectrometry analysis of protein extracts that both avian beta-defensins AvBD2 and AvBD7 were ubiquitously distributed along the chicken gut. Cathepsin B was found by immunoblotting in jejunum, ileum, caecum, and caecal tonsils, while cathepsins K, L, and S were merely identified in caecal tonsils. Hydrolysis product of AvBD2 and AvBD7 incubated with a panel of proteases was analysed by RP-HPLC, mass spectrometry and antimicrobial assays. AvBD2 and AvBD7 were resistant to serine proteases and to cathepsins D and H. Conversely cysteine cathepsins B, K, L, and S degraded AvBD2 and abolished its antibacterial activity. Only cathepsin K cleaved AvBD7 and released Ile4-AvBD7, a N-terminal truncated natural peptidoform of AvBD7 that displayed antibacterial activity. Besides the 3-stranded antiparallel beta-sheet typical of beta-defensins, structural analysis of AvBD7 by two-dimensional NMR spectroscopy highlighted the restricted accessibility of the C-terminus embedded by the N-terminal region and gave a formal evidence of a salt bridge (Asp9-Arg12) that could account for proteolysis resistance. The differential susceptibility of avian defensins to proteolysis opens intriguing questions about a distinctive role in the mucosal immunity against pathogen invasion.	[Bailleul, Geoffrey; Joulin-Giet, Alix; Teixeira-Gomes, Ana-Paula; Gilbert, Florence B.; Schouler, Catherine; Lalmanach, Anne-Christine] Univ Tours, INRA, ISP, UMR 1282, Nouzilly, France; [Kravtzoff, Amanda; Lecaille, Fabien; Lalmanach, Gilles] Univ Tours, CEPR, INSERM, UMR 1100, Tours, France; [Labas, Valerie; Teixeira-Gomes, Ana-Paula] Univ Tours, PRC, Plate Forme Anal Integrat Biomol, INRA,Lab Spectrometrie Masse,CNRS,UMR 7247,UMR 85, Nouzilly, France; [Meudal, Herve; Loth, Karine; Landon, Celine] CNRS, CBM, UPR 4301, Orleans, France; [Loth, Karine] Univ Orleans, Coll Sci & Tech, Orleans, France; [Coquet, Laurent; Jouenne, Thierry] Univ Rouen, Plate Forme Proteom PISSARO IRIB, CNRS, UMR 6270, Mont St Aignan, France; [Brmme, Dieter] Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC, Canada	INRAE; Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Universite de Tours; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Orleans; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Rouen Normandie; University of British Columbia	Lalmanach, AC (corresponding author), Univ Tours, INRA, ISP, UMR 1282, Nouzilly, France.	anne-christine.lalmanach@tours.inra.fr	Meudal, Hervé/B-5851-2016; Schouler, Catherine/AAE-2207-2022; Lecaille, Fabien/GRY-5313-2022	Meudal, Hervé/0000-0002-9642-3643; Schouler, Catherine/0000-0002-3480-6278; Lalmanach, Anne-Christine/0000-0002-2666-4839; Lecaille, Fabien/0000-0003-1060-4222; jouenne, thierry/0000-0003-0994-9944; Lalmanach, Gilles/0000-0001-8562-4821; COQUET, Laurent/0000-0001-7778-7321	Institut National de la Recherche Agronomique [00086685]; Region Centre Val de Loire; Centre National de la Recherche Scientifique; Institut National de la Recherche Agronomique; TGIR-RMN-THC of the Centre National de la Recherche Scientifique [Fr3050]; Canadian Institutes of Health Research [MOP89974, MOP201209]; EMIDA ERA-NET program of the European Union [ANR-10-EMID-001]	Institut National de la Recherche Agronomique; Region Centre Val de Loire(Region Centre-Val de Loire); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Recherche Agronomique; TGIR-RMN-THC of the Centre National de la Recherche Scientifique; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EMIDA ERA-NET program of the European Union	GB was supported by a doctoral fellowship (number 00086685) from the Institut National de la Recherche Agronomique (http://www.inra.fr/) and the Region Centre Val de Loire (http://www.regioncentre-valdeloire.fr/accueil.html). The Plate-forme d'Analyse Integrative des Biomolecules (VL APTG) was financially supported by the Region Centre Val de Loire (http://www.regioncentre-valdeloire.fr/accueil.html), the Centre National de la Recherche Scientifique (http://www.cnrs.fr/) and the Institut National de la Recherche Agronomique (http://www.inra.fr/). The NMR studies (HM CL) were financially supported by the TGIR-RMN-THC Fr3050 of the Centre National de la Recherche Scientifique (http://www.cnrs.fr/). DB was financially supported by grants (number MOP89974 and MOP201209) from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html). The work was supported by a grant (number ANR-10-EMID-001 "HealthyGut") from the EMIDA ERA-NET program of the European Union (https://ec.europa.eu/research/fp7/index_en. cfm?pg=eranet-projects-home).	Andersson HS, 2012, AMINO ACIDS, V43, P1471, DOI 10.1007/s00726-012-1220-3; Andrault PM, 2015, BIOCHEMISTRY-US, V54, P2785, DOI 10.1021/acs.biochem.5b00231; Arampatzidou M, 2011, BIOL CHEM, V392, P983, DOI 10.1515/BC.2011.096; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARROW PA, 1987, RES VET SCI, V42, P194, DOI 10.1016/S0034-5288(18)30685-4; Berndt A, 2007, INFECT IMMUN, V75, P5993, DOI 10.1128/IAI.00695-07; Biancheri P, 2013, CELL TISSUE RES, V351, P269, DOI 10.1007/s00441-012-1390-z; Bourin M, 2011, J AGR FOOD CHEM, V59, P12368, DOI 10.1021/jf203339t; Brix K, 2008, BIOCHIMIE, V90, P194, DOI 10.1016/j.biochi.2007.07.024; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cattaruzza F, 2011, GASTROENTEROLOGY, V141, P1864, DOI 10.1053/j.gastro.2011.07.035; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Derache C, 2012, J BIOL CHEM, V287, P7746, DOI 10.1074/jbc.M111.312108; Derache C, 2009, ANTIMICROB AGENTS CH, V53, P4647, DOI 10.1128/AAC.00301-09; Derache C, 2009, DEV COMP IMMUNOL, V33, P959, DOI 10.1016/j.dci.2009.03.005; EVANS EW, 1994, J LEUKOCYTE BIOL, V56, P661, DOI 10.1002/jlb.56.5.661; Garenne T, 2015, BIOCHEM BIOPH RES CO, V460, P250, DOI 10.1016/j.bbrc.2015.03.020; HARWIG SSL, 1994, FEBS LETT, V342, P281, DOI 10.1016/0014-5793(94)80517-2; Hubbard S. J., 1993, NACCESS; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Jamdar SN, 2005, BIORESOURCE TECHNOL, V96, P1276, DOI 10.1016/j.biortech.2004.10.014; Kulig P, 2011, J IMMUNOL, V187, P1403, DOI 10.4049/jimmunol.1002352; Labas V, 2015, J PROTEOMICS, V112, P313, DOI 10.1016/j.jprot.2014.07.024; Labas V, 2015, J PROTEOMICS, V113, P226, DOI 10.1016/j.jprot.2014.09.031; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landon C, 2004, J BIOL CHEM, V279, P30433, DOI 10.1074/jbc.M401338200; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lecaille F, 2003, BIOCHEM J, V375, P307, DOI 10.1042/BJ20030468; Lecaille F, 2008, BIOCHIMIE, V90, P208, DOI 10.1016/j.biochi.2007.08.011; Lecaille F, 2007, PROTEIN SCI, V16, P662, DOI 10.1110/ps.062666607; Lecaille F, 2016, BIOCHIMIE, V122, P151, DOI 10.1016/j.biochi.2015.08.014; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Lynn DJ, 2004, IMMUNOGENETICS, V56, P170, DOI 10.1007/s00251-004-0675-0; Menzel K, 2006, CLIN EXP IMMUNOL, V146, P169, DOI 10.1111/j.1365-2249.2006.03188.x; Pyrkov TV, 2009, BIOINFORMATICS, V25, P1201, DOI 10.1093/bioinformatics/btp111; Rawlings ND, 2016, BIOCHIMIE, V122, P5, DOI 10.1016/j.biochi.2015.10.003; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Riese RJ, 2000, CURR OPIN IMMUNOL, V12, P107, DOI 10.1016/S0952-7915(99)00058-8; Sadeyen JR, 2006, MICROBES INFECT, V8, P1308, DOI 10.1016/j.micinf.2005.12.014; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200; Semple F, 2012, J INNATE IMMUN, V4, P337, DOI 10.1159/000336619; Sina C, 2013, GUT, V62, P520, DOI 10.1136/gutjnl-2011-300076; Taggart CC, 2003, J IMMUNOL, V171, P931, DOI 10.4049/jimmunol.171.2.931; van Dijk A, 2008, VET IMMUNOL IMMUNOP, V124, P1, DOI 10.1016/j.vetimm.2007.12.006; Van Immerseel F, 2002, DEV COMP IMMUNOL, V26, P355, DOI 10.1016/S0145-305X(01)00084-2; Vizovisek M, 2015, PROTEOMICS, V15, P2479, DOI 10.1002/pmic.201400460; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WELKOS SL, 1984, J MED MICROBIOL, V18, P233, DOI 10.1099/00222615-18-2-233; Wiederanders B, 2003, CURR PROTEIN PEPT SC, V4, P309, DOI 10.2174/1389203033487081	53	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161573	10.1371/journal.pone.0161573	http://dx.doi.org/10.1371/journal.pone.0161573			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27561012	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258600056
J	Ma, XF; Tian, JZ; Wu, ZH; Zong, XP; Dong, JW; Zhan, WF; Xu, YK; Li, ZB; Jiang, GH				Ma, Xiaofen; Tian, Junzhang; Wu, Zhanhong; Zong, Xiaopeng; Dong, Jianwei; Zhan, Wenfeng; Xu, Yikai; Li, Zibo; Jiang, Guihua			Spatial Disassociation of Disrupted Functional Connectivity for the Default Mode Network in Patients with End-Stage Renal Disease	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; NEUROLOGICALLY ASYMPTOMATIC PATIENTS; COGNITIVE IMPAIRMENT; PARAVENTRICULAR NUCLEUS; HUMAN BRAIN; HEMODIALYSIS; CORTEX; COMPLICATIONS; DEPRESSION; VELOCITY	Purpose To investigate the aberrant functional connectivity of the default mode network (DMN) in patients with end-stage renal disease (ESRD) and their clinical relevance. Materials and Methods Resting-state functional MRI data were collected from 31 patients with ESRD (24 men, 2461 years) and 31 age-and gender-matched healthy controls (HCs, 21 men, 26-61years). A whole-brain seed-based functional connectivity analysis of these collected R-fMRI data was performed by locating the seeds in the posterior cingulate cortex (PCC) and ventromedial prefrontal cortex (vmPFC) to investigate the functional connectivity of the posterior and anterior DMN over the whole brain, respectively. Results Compared to the HCs, the patients exhibited significantly decreased functional connectivity with the PCC in the left middle temporal gyrus, the right anterior cingulate gyrus, and the bilateral medial superior frontal gyrus. For the vmPFC seed, only the right thalamus showed significantly decreased functional connectivity in the patients with ESRD compared to HCs. Interestingly, functional connectivity between the PCC and right medial superior frontal gyrus exhibited a significantly positive correlation with the hemoglobin level in the patients. Conclusion Our findings suggest a spatially specific disruption of functional connectivity in the DMN in patients with ESRD, thereby providing novel insights into our understanding of the neurophysiology mechanism that underlies the disease.	[Ma, Xiaofen; Tian, Junzhang; Zhan, Wenfeng; Jiang, Guihua] Guangdong Prov 2 Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China; [Wu, Zhanhong; Zong, Xiaopeng; Li, Zibo] Univ N Carolina, Biomed Res Imaging Ctr, Chapel Hill, NC USA; [Wu, Zhanhong; Zong, Xiaopeng; Li, Zibo] Univ N Carolina, Dept Radiol, Chapel Hill, NC USA; [Dong, Jianwei] Guangdong Pharmaceut Univ, Dept Math, Guangzhou, Guangdong, Peoples R China; [Xu, Yikai] Southern Med Univ, Nanfang Hosp, Dept Med, Imaging Ctr, Guangzhou, Guangdong, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Guangdong Pharmaceutical University; Southern Medical University - China	Jiang, GH (corresponding author), Guangdong Prov 2 Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China.; Li, ZB (corresponding author), Univ N Carolina, Biomed Res Imaging Ctr, Chapel Hill, NC USA.; Li, ZB (corresponding author), Univ N Carolina, Dept Radiol, Chapel Hill, NC USA.	zibo_li@med.unc.edu; jiangguihua177@163.com	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146; li, zibo/0000-0002-1063-0298; Tian, Junzhang/0000-0002-6212-1882; Wu, Zhanhong/0000-0002-3528-5603	National Natural Science Foundation of China [81471639]; Science and Technology Planning Project of Guangdong Province, China [2015A030313723]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, China	This work was supported by grants from National Natural Science Foundation of China (No. 81471639); The Science and Technology Planning Project of Guangdong Province, China (No. 2015A030313723).	Agildere AM, 2001, EUR RADIOL, V11, P1063; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bornivelli C, 2012, J REN CARE, V38, P93, DOI 10.1111/j.1755-6686.2012.00259.x; Brouns R, 2004, CLIN NEUROL NEUROSUR, V107, P1, DOI 10.1016/j.clineuro.2004.07.012; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; CHASTRETTE N, 1991, BRAIN RES, V563, P339, DOI 10.1016/0006-8993(91)91559-J; Chiu ML, 2010, EUR RADIOL, V20, P1502, DOI 10.1007/s00330-009-1673-2; Chou MC, 2013, AM J NEURORADIOL, V34, P1945, DOI 10.3174/ajnr.A3511; DEDEYN PP, 1992, ACTA NEUROL BELG, V92, P191; Fair DA, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00080; FAZEKAS G, 1995, J NEUROL SCI, V134, P83, DOI 10.1016/0022-510X(95)00226-7; Foley RN, 2007, J AM SOC NEPHROL, V18, P2644, DOI 10.1681/ASN.2007020220; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; GOTTLIEB D, 1987, J CEREBR BLOOD F MET, V7, P659, DOI 10.1038/jcbfm.1987.119; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; HATA R, 1994, STROKE, V25, P408, DOI 10.1161/01.STR.25.2.408; HOLZER H, 1981, P EUR DIAL TRANS, V18, P126; Hsieh TJ, 2009, RADIOLOGY, V252, P518, DOI 10.1148/radiol.2523080484; Jassal SV, 2008, INT UROL NEPHROL, V40, P849, DOI 10.1007/s11255-008-9375-2; Kalender B, 2006, NEPHRON CLIN PRACT, V102, pC115, DOI 10.1159/000089669; Kim HS, 2011, NEUROREHABILITATION, V29, P111, DOI 10.3233/NRE-2011-0684; Kimmel PL, 2007, ADV CHRONIC KIDNEY D, V14, P328, DOI 10.1053/j.ackd.2007.07.007; Korgaonkar MS, 2014, BIOL PSYCHIAT, V76, P567, DOI 10.1016/j.biopsych.2014.02.018; Kurella M, 2004, J AM GERIATR SOC, V52, P1863, DOI 10.1111/j.1532-5415.2004.52508.x; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Li SM, 2016, CLIN NEUROPHYSIOL, V127, P602, DOI 10.1016/j.clinph.2015.06.022; Li X, 2015, J NEUROSCI, V35, P10015, DOI 10.1523/JNEUROSCI.5113-14.2015; Liang X, 2013, P NATL ACAD SCI USA, V110, P1929, DOI 10.1073/pnas.1214900110; Liang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071507; LINDEGAARD KF, 1987, STROKE, V18, P1025, DOI 10.1161/01.STR.18.6.1025; Ma XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121085; Martinez-Vea A, 2006, AM J KIDNEY DIS, V47, P241, DOI 10.1053/j.ajkd.2005.10.029; Mitchell JP, 2002, P NATL ACAD SCI USA, V99, P15238, DOI 10.1073/pnas.232395699; Motzkin JC, 2015, CORTEX, V64, P281, DOI 10.1016/j.cortex.2014.11.013; Murray AM, 2006, NEUROLOGY, V67, P216, DOI 10.1212/01.wnl.0000225182.15532.40; Muschelli J, 2014, NEUROIMAGE, V96, P22, DOI 10.1016/j.neuroimage.2014.03.028; Myers-Schulz B, 2012, MOL PSYCHIATR, V17, P132, DOI 10.1038/mp.2011.88; Ni L, 2014, RADIOLOGY, V271, P543, DOI 10.1148/radiol.13130816; Patel AX, 2014, NEUROIMAGE, V95, P287, DOI 10.1016/j.neuroimage.2014.03.012; PAYNE RB, 1973, BMJ-BRIT MED J, V4, P643, DOI 10.1136/bmj.4.5893.643; Penzo MA, 2015, NATURE; POSTIGLIONE A, 1991, STROKE, V22, P1508, DOI 10.1161/01.STR.22.12.1508; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Prohovnik I, 2007, J CEREBR BLOOD F MET, V27, P1861, DOI 10.1038/sj.jcbfm.9600478; Qiu YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098346; Regolisti G, 2013, NEPHROL DIAL TRANSPL, V28, P79, DOI 10.1093/ndt/gfs182; Schultz-Larsen K, 2007, J CLIN EPIDEMIOL, V60, P260, DOI 10.1016/j.jclinepi.2006.06.008; Son SJ, 2015, ARCH GERONTOL GERIAT, V60, P210, DOI 10.1016/j.archger.2014.09.012; Spencer SJ, 2004, BRAIN RES, V997, P234, DOI 10.1016/j.brainres.2003.10.054; Stefanidis I, 2005, CLIN NEPHROL, V64, P129; Tamura MK, 2011, KIDNEY INT, V79, P14, DOI 10.1038/ki.2010.336; Tomasi D, 2013, P NATL ACAD SCI USA, V110, P13642, DOI 10.1073/pnas.1303346110; Tryc AB, 2011, NEPHROL DIAL TRANSPL, V26, P2635, DOI 10.1093/ndt/gfq729; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Wang JH, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/fnhum.2015.00386, 10.3389/fnhum.2015.00458]; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Williams MA, 2004, AM J KIDNEY DIS, V43, P705, DOI 10.1053/j.ajkd.2003.12.031; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yan CG, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00910	64	12	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161392	10.1371/journal.pone.0161392	http://dx.doi.org/10.1371/journal.pone.0161392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560146	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258600038
J	Olafsdottir, AS; Torfadottir, JE; Arngrimsson, SA				Olafsdottir, Anna S.; Torfadottir, Johanna E.; Arngrimsson, Sigurbjorn A.			Health Behavior and Metabolic Risk Factors Associated with Normal Weight Obesity in Adolescents	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; NATIONAL-HEALTH; CHILDREN; AGE; POPULATION; OVERWEIGHT; ADULTHOOD; WOMEN; LIVER	Objective To explore health behaviors and metabolic risk factors in normal weight obese (NWO) adolescents compared with normal weight lean (NWL) peers. Design and Methods A cross-sectional study of 18-year-old students (n = 182, 47% female) in the capital area of Iceland, with body mass index within normal range (BMI, 18.5-24.9 kg/m(2)). Body composition was estimated via dual energy X-ray absorptiometry, fitness was assessed with maximal oxygen uptake (VO(2)max) during treadmill test, dietary intake through 24-hour recall, questionnaires explained health behavior and fasting blood samples were taken. NWO was defined as normal BMI and body fat > 17.6% in males and > 31.6% in females. Results Among normal weight adolescents, 42% (n = 76) were defined as NWO, thereof 61% (n = 46) male participants. Fewer participants with NWO were physically active, ate breakfast on a regular basis, and consumed vegetables frequently compared with NWL. No difference was detected between the two groups in energy-and nutrient intake. The mean difference in aerobic fitness was 5.1 ml/kg/min between the groups in favor of the NWL group (p<0.001). NWO was positively associated with having one or more risk factors for metabolic syndrome (Odds Ratio OR = 2.2; 95% confidence interval CI: 1.2, 3.9) when adjusted for sex. High waist circumference was more prevalent among NWO than NWL, but only among girls (13% vs 4%, p = 0.019). Conclusions High prevalence of NWO was observed in the study group. Promoting healthy lifestyle with regard to nutrition and physical activity in early life should be emphasized regardless of BMI.	[Olafsdottir, Anna S.; Arngrimsson, Sigurbjorn A.] Univ Iceland, Sch Educ, Res Ctr Sport & Hlth Sci, Reykjavik, Iceland; [Torfadottir, Johanna E.] Univ Iceland, Educ Res Inst, Reykjavik, Iceland; [Torfadottir, Johanna E.] Univ Iceland, Fac Food Sci & Nutr, Unit Nutr Res, Reykjavik, Iceland	University of Iceland; University of Iceland; University of Iceland	Olafsdottir, AS (corresponding author), Univ Iceland, Sch Educ, Res Ctr Sport & Hlth Sci, Reykjavik, Iceland.	annaso@hi.is	Olafsdottir, Anna S/A-8804-2013	Olafsdottir, Anna S/0000-0002-7258-1727	Ministry of Education, Sport and Culture; University of Iceland Research Fund	Ministry of Education, Sport and Culture; University of Iceland Research Fund	This work was supported by the Sports Fund of the Ministry of Education, Sport and Culture (no grant number) to ASO and SAA (http://en.rannis.is/funding/youth-sport/the-icelandic-sport-fund/) and the University of Iceland Research Fund (no grant number) to ASO, SAA (http://sjodir.hi.is/node/16131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo OY, 2014, EUR J CLIN NUTR, DOI [10.1038/ejen.2014.14, DOI 10.1038/EJEN.2014.14]; Alberga AS, 2012, PEDIATR OBES, V7, P261, DOI 10.1111/j.2047-6310.2011.00046.x; Anderssen SA, 2007, EUR J CARDIOV PREV R, V14, P526, DOI 10.1097/HJR.0b013e328011efc1; Arngrimsson SA, 2004, EUR J APPL PHYSIOL, V92, P524, DOI 10.1007/s00421-004-1053-1; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Cerhan JR, 2014, MAYO CLIN PROC, V89, P335, DOI 10.1016/j.mayocp.2013.11.011; Choi J, 2012, NUTR METAB CARDIOVAS, V22, P567, DOI 10.1016/j.numecd.2010.09.001; Conus F, 2004, J CLIN ENDOCR METAB, V89, P5013, DOI 10.1210/jc.2004-0265; Conus F, 2007, APPL PHYSIOL NUTR ME, V32, P4, DOI [10.1139/H06-092, 10.1139/h06-092]; Lorenzo A, 2006, NUTR METAB CARDIOVAS, V16, P513, DOI 10.1016/j.numecd.2005.10.010; Deshmukh-Taskar PR, 2010, J AM DIET ASSOC, V110, P869, DOI 10.1016/j.jada.2010.03.023; Evans EM, 2006, INT J OBESITY, V30, P837, DOI 10.1038/sj.ijo.0803208; Friedrich N, 2012, DIABETES CARE, V35, P768, DOI 10.2337/dc11-1833; Hill JO, 2012, CIRCULATION, V126, P126, DOI 10.1161/CIRCULATIONAHA.111.087213; Hinriksdottir G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130597; Jean N, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0464-7; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; LOHMAN TG, 1997, ACSMS HEALTH FIT J, V1, P30; Madeira FB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060673; Magnussen CG, 2013, CURR OPIN CARDIOL, V28, P561, DOI 10.1097/HCO.0b013e32836428f4; Mannisto S, 2014, BRIT J NUTR, V111, P887, DOI 10.1017/S0007114513002742; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Marques-Vidal P, 2010, NUTR METAB CARDIOVAS, V20, P669, DOI 10.1016/j.numecd.2009.06.001; Marques-Vidal P, 2008, E SPEN, V3, pe159, DOI [10.1016/j.eclnm.2008.05.003, DOI 10.1016/J.ECLNM.2008.05.003]; Miech RA, 2006, JAMA-J AM MED ASSOC, V295, P2385, DOI 10.1001/jama.295.20.2385; Morrison JA, 2012, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2012-6; Moy FM, 2015, MATURITAS, V81, P389, DOI 10.1016/j.maturitas.2015.04.011; Nelson MC, 2008, OBESITY, V16, P2205, DOI 10.1038/oby.2008.365; Olafsdottir AS, 2006, ANN NUTR METAB, V50, P450, DOI 10.1159/000094781; Olafsdottir E, 2012, LAEKNABLADID, V98, P639, DOI 10.17992/lbl.2012.12.466; Oliveros E, 2014, PROG CARDIOVASC DIS, V56, P426, DOI 10.1016/j.pcad.2013.10.003; Pedersen SD, 2011, CLIN OBES, V1, P69, DOI 10.1111/j.1758-8111.2011.00016.x; Pineau JC, 2015, J SPORTS MED PHYS FI; Puavilai Wilai, 2009, Journal of the Medical Association of Thailand, V92, P182; Romero-Corral A, 2010, EUR HEART J, V31, P737, DOI 10.1093/eurheartj/ehp487; Shea JL, 2012, NUTR METAB CARDIOVAS, V22, P741, DOI 10.1016/j.numecd.2010.11.009; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Stallmann-Jorgensen IS, 2007, INT J OBESITY, V31, P622, DOI 10.1038/sj.ijo.0803587; Strom M, 2012, HYPERTENSION, V59, P36, DOI 10.1161/HYPERTENSIONAHA.111.179382; Zhu SK, 2003, AM J CLIN NUTR, V78, P228, DOI 10.1093/ajcn/78.2.228	42	34	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161451	10.1371/journal.pone.0161451	http://dx.doi.org/10.1371/journal.pone.0161451			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560824	Green Submitted, Green Published, gold			2022-12-26	WOS:000382258600043
J	Wu, HM; Padhi, A; Xu, JQ; Gong, XY; Tien, P				Wu, Haoming; Padhi, Abinash; Xu, Junqiang; Gong, Xiaoyan; Tien, Po			Evidence for Within-Host Genetic Recombination among the Human Pegiviral Strains in HIV Infected Subjects	PLOS ONE			English	Article							GB-VIRUS-C; HIGH PREVALENCE; HEPATITIS-C; DIVERSITY; SEX; TRANSMISSION; COINFECTION; PROGRESSION; SURVIVAL; GENOMES	The non-pathogenic Human Pegivirus ( HPgV, formerly GBV-C/HGV), the most prevalent RNA virus worldwide, is known to be associated with reduced morbidity and mortality in HIV-infected individuals. Although previous studies documented its ubiquity and important role in HIV-infected individuals, little is known about the underlying genetic mechanisms that maintain high genetic diversity of HPgV within the HIV-infected individuals. To assess the within-host genetic diversity of HPgV and forces that maintain such diversity within the co-infected hosts, we performed phylogenetic analyses taking into account 229 HPgV partial E1-E2 clonal sequences representing 15 male and 8 female co-infected HIV patients from Hubei province of central China. Our results revealed the presence of eleven strongly supported clades. While nine clades belonged to genotype 3, two clades belonged to genotype 2. Additionally, four clades that belonged to genotype 3 exhibited inter-clade recombination events. The presence of clonal sequences representing multiple clades within the HIV-infected individual provided the evidence of co-circulation of HPgV strains across the region. Of the 23 patients, six patients (i.e., five males and one female) were detected to have HPgV recombinant sequences. Our results also revealed that while male patients shared the viral strains with other patients, viral strains from the female patients had restricted dispersal. Taken together, the present study revealed that multiple infections with divergent HPgV viral strains may have caused within-host genetic recombination, predominantly in male patients, and therefore, could be the major driver in shaping genetic diversity of HPgV.	[Gong, Xiaoyan] Wuhan Univ, Coll Chem & Mol Sci, Wuhan 430072, Hubei, Peoples R China; [Wu, Haoming; Tien, Po] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Padhi, Abinash] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Tien, Po] Chinese Acad Sci, Inst Microbiol, Beijing 100101, Peoples R China; [Xu, Junqiang] Hubei Prov Ctr Dis Control & Prevent, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Wuhan University; University System of Maryland; University of Maryland College Park; Chinese Academy of Sciences; Institute of Microbiology, CAS	Gong, XY (corresponding author), Wuhan Univ, Coll Chem & Mol Sci, Wuhan 430072, Hubei, Peoples R China.; Tien, P (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.; Tien, P (corresponding author), Chinese Acad Sci, Inst Microbiol, Beijing 100101, Peoples R China.	xygong@whu.edu.cn; tienpo@sun.im.ac.cn		Wu, Haoming/0000-0001-8117-654X	National Basic Research Program of China (973 Program) [2010CB530102, 2011CB504703]; National Natural Science Foundation of China (NSFC) [81321063, 31370201, 81071341]; Natural Science Foundation of Hubei Province [2013CFB259]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This work is supported by the grants from the National Basic Research Program of China (973 Program) (Nos. 2010CB530102 and 2011CB504703), by the National Natural Science Foundation of China (NSFC, Grant Nos. 81321063, 31370201, and 81071341), and by the Natural Science Foundation of Hubei Province (2013CFB259). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berzsenyi MD, 2005, J CLIN VIROL, V33, P243, DOI 10.1016/j.jcv.2005.01.002; Bhattarai N, 2012, TRENDS MICROBIOL, V20, P124, DOI 10.1016/j.tim.2012.01.004; Blackard JT, 2016, J GEN VIROL, V97, P1537, DOI 10.1099/jgv.0.000477; Blackard JT, 2002, CLIN INFECT DIS, V34, P1108, DOI 10.1086/339547; Feng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021151; Garcia J.R., 2015, HDB SOCIOLOGY SEXUAL, P203; Geurs TL, 2012, J AUTOIMMUN, V38, pJ245, DOI 10.1016/j.jaut.2011.12.003; Ghai RR, 2013, J GEN VIROL, V94, P2670, DOI 10.1099/vir.0.055509-0; Hofer H, 2011, J VIRAL HEPATITIS, V18, P513, DOI 10.1111/j.1365-2893.2010.01340.x; Holmes E., 2009, EVOLUTION EMERGENCE; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kiwelu IE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071131; Klein SL, 2010, SEX HORMONES AND IMMUNITY TO INFECTION, P93, DOI 10.1007/978-3-642-02155-8_4; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lamers SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005065; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Liu HJ, 1998, J ACQ IMMUN DEF SYND, V19, P80, DOI 10.1097/00042560-199809010-00013; Liu W, 2011, INFECT GENET EVOL, V11, P1906, DOI 10.1016/j.meegid.2011.08.031; Liu Z, 2012, EPIDEMIOL INFECT, V140, P2199, DOI 10.1017/S0950268812000027; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Long EM, 2000, NAT MED, V6, P71; Lu L, 2001, VIRUS RES, V73, P131, DOI 10.1016/S0168-1702(00)00231-8; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; McClelland EE, 2011, ARCH IMMUNOL THER EX, V59, P203, DOI 10.1007/s00005-011-0124-3; Mohr EL, 2009, J VIRAL HEPATITIS, V16, P757, DOI 10.1111/j.1365-2893.2009.01194.x; Neibecker M, 2011, J MED VIROL, V83, P685, DOI 10.1002/jmv.22029; Nerurkar VR, 1998, J MED VIROL, V56, P123, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;123::AID-JMV4&gt;3.0.CO;2-A; Norberg P, 2015, J VIROL, V89, P7133, DOI 10.1128/JVI.00437-15; Norberg P, 2013, VIROLOGY, V440, P105, DOI 10.1016/j.virol.2013.02.017; Oertelt-Prigione S, 2012, AUTOIMMUN REV, V11, pA479, DOI 10.1016/j.autrev.2011.11.022; Parish W, 2006, SEXUAL PARTNERS CHIN; Parreira R, 2012, INFECT GENET EVOL, V12, P86, DOI 10.1016/j.meegid.2011.10.011; RCore Team, 2020, R LANG ENV STAT COMP; Scallan MF, 1998, J MED VIROL, V55, P203, DOI 10.1002/(SICI)1096-9071(199807)55:3&lt;203::AID-JMV4&gt;3.0.CO;2-5; Schwarze-Zander C, 2012, EXPERT REV ANTI-INFE, V10, P563, DOI [10.1586/eri.12.37, 10.1586/ERI.12.37]; Seifried C, 2004, TRANSFUSION, V44, P268, DOI 10.1111/j.1537-2995.2004.00665.x; Sentandreu V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003239; Simmonds P, 1999, J VIROL, V73, P5787, DOI 10.1128/JVI.73.7.5787-5794.1999; Smith DB, 2000, J GEN VIROL, V81, P769, DOI 10.1099/0022-1317-81-3-769; Stapleton JT, 2011, J GEN VIROL, V92, P233, DOI 10.1099/vir.0.027490-0; Thurner C, 2004, J GEN VIROL, V85, P1113, DOI 10.1099/vir.0.19462-0; Tillmann HL, 2001, NEW ENGL J MED, V345, P715, DOI 10.1056/NEJMoa010398; Preciado MV, 2014, WORLD J GASTROENTERO, V20, P15992, DOI 10.3748/wjg.v20.i43.15992; Williams CF, 2004, NEW ENGL J MED, V350, P981, DOI 10.1056/NEJMoa030107; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535; Worobey M, 2001, MOL BIOL EVOL, V18, P254, DOI 10.1093/oxfordjournals.molbev.a003799; Wu HM, 2013, VIRUS RES, V178, P502, DOI 10.1016/j.virusres.2013.10.011; Wu HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048417; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364; Yeo AET, 2000, ANN INTERN MED, V132, P959, DOI 10.7326/0003-4819-132-12-200006200-00006	51	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161880	10.1371/journal.pone.0161880	http://dx.doi.org/10.1371/journal.pone.0161880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560699	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258600112
J	da Silva, R; Sampaio, I; Schneider, H; Gomes, G				da Silva, Raimundo; Sampaio, Iracilda; Schneider, Horacio; Gomes, Grazielle			Lack of Spatial Subdivision for the Snapper Lutjanus purpureus (Lutjanidae - Perciformes) from Southwest Atlantic Based on Multi-Locus Analyses	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; GULF-OF-MEXICO; RED SNAPPER; HISTORICAL DEMOGRAPHY; DNA; DIVERSITY; MARINE; DIVERGENCE; INFERENCE; FISH	The Caribbean snapper Lutjanus purpureus is a marine species fish commonly found associated with rocky seabeds and is widely distributed along of Western Atlantic. Data on stock delineation and stock recognition are essential for establishing conservation measures for commercially fished species. However, few studies have investigated the population genetic structure of this economically valuable species, and previous studies (based on only a portion of the mitochondrial DNA) provide an incomplete picture. The present study used a multilocus approach (12 segments of mitochondrial and nuclear DNA) to elucidate the levels of genetic diversity and genetic connectivity of L. purpureus populations and their demographic history. L. purpureus has high levels of genetic diversity, which probably implies in high effective population sizes values for the species. The data show that this species is genetically homogeneous throughout the geographic region analyzed, most likely as a result of dispersal during larval phase. Regarding demographic history, a historical population growth event occurred, likely due to sea level changes during the Pleistocene.	[da Silva, Raimundo; Gomes, Grazielle] Univ Fed Para, Lab Genet Aplicada, Campus Braganca, Braganca, Para, Brazil; [Sampaio, Iracilda; Schneider, Horacio] Univ Fed Para, Lab Genet & Biol Mol, Campus Braganca, Braganca, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para	Gomes, G (corresponding author), Univ Fed Para, Lab Genet Aplicada, Campus Braganca, Braganca, Para, Brazil.	graziellefeg@gmail.com	SAMPAIO, IRACILDA/J-6514-2012; Gomes, Grazielle/G-9326-2019; Schneider, Horacio/J-7131-2012; da Silva, Raimundo/J-8177-2017	SAMPAIO, IRACILDA/0000-0002-2137-4656; Gomes, Grazielle/0000-0001-8898-0311; Schneider, Horacio/0000-0002-5987-6395; da Silva, Raimundo/0000-0002-3003-7272	CNPq [306233/2009-6]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding for this research was provided by CNPq (grants 306233/2009-6 to IS, 306233/2009-6 to HS and an MSc scholarship to RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allcock AL, 2012, TRENDS ECOL EVOL, V27, P520, DOI 10.1016/j.tree.2012.05.009; ALLEN G.R., 1985, FAO SPECIES CATALOGU, V6; Allendorf FW, 2014, MOL ECOL, V23, P23, DOI 10.1111/mec.12574; Alter SE, 2007, P NATL ACAD SCI USA, V104, P15162, DOI 10.1073/pnas.0706056104; AREVALO E, 1994, SYST BIOL, V43, P387, DOI 10.2307/2413675; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Barreto AMF, 2002, PALAEOGEOGR PALAEOCL, V179, P57, DOI 10.1016/S0031-0182(01)00408-4; Benevides EA, 2014, BIOCHEM SYST ECOL, V56, P255, DOI 10.1016/j.bse.2014.06.004; Benjamini Y, 2001, ANN STAT, V29, P1165; Bielawski JP, 2002, GENETICS, V161, P1589; Blel H, 2010, J EXP MAR BIOL ECOL, V387, P60, DOI 10.1016/j.jembe.2010.02.018; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Carvalho GR, 1998, ITAL J ZOOL, V65, P21, DOI 10.1080/11250009809386791; Chang CT, 2012, SCI WORLD J, DOI 10.1100/2012/365104; Chow S, 1998, MOL ECOL, V7, P1255; Da Silva R, AN ACAD BRA IN PRESS; da Silva R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122173; Dawson MN, 2014, J BIOGEOGR, V41, P52, DOI 10.1111/jbi.12190; Dawson MN, 2011, J BIOGEOGR, V38, P1600, DOI 10.1111/j.1365-2699.2011.02499.x; De Souza AS, 2015, AN ACAD BRAS CIENC, V87, P121, DOI 10.1590/0001-3765201520130411; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Eytan RI, 2010, EVOLUTION, V64, P3380, DOI 10.1111/j.1558-5646.2010.01071.x; Fahey AL, 2014, BIOL J LINN SOC, V112, P367, DOI 10.1111/bij.12259; Iriarte PJF, 2011, SCI MAR, V75, P701, DOI 10.3989/scimar.2011.75n4701; Flot JF, 2010, MOL ECOL RESOUR, V10, P162, DOI 10.1111/j.1755-0998.2009.02732.x; Fonteles-Filho A.A, 1972, ARQ CIENC MAR, V12, P21; Fu YX, 1997, GENETICS, V147, P915; Funk WC, 2012, TRENDS ECOL EVOL, V27, P489, DOI 10.1016/j.tree.2012.05.012; Furtado-Junior I, 2002, B TEC CIENT CEPNOR, V2, P173; Garber AF, 2004, MAR BIOTECHNOL, V6, P175, DOI 10.1007/s10126-003-0023-7; Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265; Gomes G, 2008, GENET MOL BIOL, V31, P372, DOI 10.1590/S1415-47572008000200035; Gomes G, 2012, AN ACAD BRAS CIENC, V84, P979, DOI 10.1590/S0001-37652012000400013; Grant WS, 2015, J HERED, V106, P333, DOI 10.1093/jhered/esv020; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hare MP, 2011, CONSERV BIOL, V25, P438, DOI 10.1111/j.1523-1739.2010.01637.x; Hassan M, 2002, MOL ECOL NOTES, V2, P334, DOI 10.1046/j.1471-8286.2002.00236.x; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; HELED J, 2010, EXTENDED BAYESIAN SK; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Horne JB, 2013, J EVOLUTION BIOL, V26, P783, DOI 10.1111/jeb.12092; Huelsenbeck JP, 2011, EVOL BIOINFORM, V7, P55, DOI 10.4137/EBO.S6761; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jarman SN, 2002, MAR BIOTECHNOL, V4, P347, DOI 10.1007/s10126-002-0029-6; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; LEE WJ, 1995, J MOL EVOL, V41, P54; Lindeman Kenneth C., 2001, Proceedings of the Gulf and Caribbean Fisheries Institute, V52, P732; McCusker MR, 2010, MOL ECOL, V19, P4852, DOI 10.1111/j.1365-294X.2010.04822.x; Miller M.A., 2010, P GAT COMP ENV WORKS; Moura RL, 2007, ZOOTAXA, P31; Nei M., 1987, MOL EVOLUTIONARY GEN; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Nielsen R, 2009, MOL ECOL, V18, P1034, DOI 10.1111/j.1365-294X.2008.04059.x; O'Brien SM, 2013, CONSERV GENET, V14, P125, DOI 10.1007/s10592-012-0437-8; Ovenden J. R., 2013, FISH FISHER, V16, P1; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; PETERSON RG, 1991, PROG OCEANOGR, V26, P1, DOI 10.1016/0079-6611(91)90006-8; Pinho C, 2010, CONSERV GENET RESOUR, V2, P181, DOI 10.1007/s12686-009-9126-4; Pinsky ML, 2014, MOL ECOL, V23, P29, DOI 10.1111/mec.12509; Planes Serge, 2002, P201, DOI 10.1016/B978-012615185-5/50012-8; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK., 2010, DOCUMENTATION STRUCT; Pruett C, 2005, MAR BIOL, V147, P593, DOI 10.1007/s00227-005-1615-8; Ptak SE, 2002, TRENDS GENET, V18, P559, DOI 10.1016/S0168-9525(02)02781-6; Ramirez-Soriano A, 2008, GENETICS, V179, P555, DOI 10.1534/genetics.107.083006; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Rezende S.M., 2003, B TECNICO CIENTIFICO, V11, P257; RODRIGUES L. M. A. M., 2011, THESIS; Rodriguez-Rey GT, 2014, MAR FRESHWATER RES, V65, P59, DOI 10.1071/MF12359; Salzburger W, 2011, MOL ECOL, V20, P1952, DOI 10.1111/j.1365-294X.2011.05066.x; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Santos S, 2003, GENET MOL BIOL, V26, P151, DOI 10.1590/S1415-47572003000200008; Santos S, 2006, MOL ECOL, V15, P4361, DOI 10.1111/j.1365-294X.2006.03108.x; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Selkoe KA, 2014, MOL ECOL, V23, P3064, DOI 10.1111/mec.12804; Sevilla RG, 2007, MOL ECOL NOTES, V7, P730, DOI 10.1111/j.1471-8286.2007.01863.x; SHULMAN MJ, 1995, EVOLUTION, V49, P897, DOI 10.1111/j.1558-5646.1995.tb02325.x; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vasconcellos AV, 2008, GENET MOL BIOL, V31, P308, DOI 10.1590/S1415-47572008000200026; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wessel Paul, 2013, Eos, Transactions American Geophysical Union, V94, P409, DOI 10.1002/2013EO450001; Wieman AC, 2014, MAR BIOL, V161, P173, DOI 10.1007/s00227-013-2327-0; Zhang JB, 2006, MOL ECOL NOTES, V6, P408, DOI 10.1111/j.1471-8286.2006.01251.x; Zhang JB, 2006, ICES J MAR SCI, V63, P693, DOI 10.1016/j.icesjms.2006.01.004	93	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161617	10.1371/journal.pone.0161617	http://dx.doi.org/10.1371/journal.pone.0161617			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556738	Green Submitted, Green Published, gold			2022-12-26	WOS:000382258100059
J	Vergnolle, O; Xu, H; Tufariello, JM; Favrot, L; Malek, AA; Jacobs, WR; Blanchard, JS				Vergnolle, Olivia; Xu, Hua; Tufariello, JoAnn M.; Favrot, Lorenza; Malek, Adel A.; Jacobs, William R., Jr.; Blanchard, John S.			Post-translational Acetylation of MbtA Modulates Mycobacterial Siderophore Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; enzyme structure; iron; Mycobacterium tuberculosis; post-translational modification (PTM); MbtA; mycobactin	CRYSTAL-STRUCTURE; IRON ACQUISITION; COA SYNTHETASE; TUBERCULOSIS; GENE; BINDING; IDER; METABOLISM; EXPRESSION; INHIBITORS	Iron is an essential element for life, but its soluble form is scarce in the environment and is rarer in the human body. Mtb (Mycobacterium tuberculosis) produces two aryl-capped siderophores, mycobactin (MBT) and carboxymycobactin (cMBT), to chelate intracellular iron. The adenylating enzyme MbtA catalyzes the first step of mycobactin biosynthesis in two half-reactions: activation of the salicylic acid as an acyl-adenylate and ligation onto the acyl carrier protein (ACP) domain of MbtB to form covalently salicylated MbtB-ACP. We report the first apo-MbtA structure from Mycobacterium smegmatis at 2.3 . We demonstrate here that MbtA activity can be reversibly, post-translationally regulated by acetylation. Indeed the mycobacterial Pat (protein lysine acetyltransferase), Rv0998, specifically acetylates MbtA on lysine 546, in a cAMP-dependent manner, leading to enzyme inhibition. MbtA acetylation can be reversed by the NAD(+)-dependent DAc (deacetyltransferase), Rv1151c. Deletion of Pat and DAc genes in Mtb revealed distinct phenotypes for strains lacking one or the other gene at low pH and limiting iron conditions. This study establishes a direct connection between the reversible acetylation system Pat/DAc and the ability of Mtb to adapt in limited iron conditions, which is critical for mycobacterial infection.	[Vergnolle, Olivia; Xu, Hua; Favrot, Lorenza; Blanchard, John S.] Albert Einstein Coll Med, Howard Hughes Med Inst, Dept Biochem, Bronx, NY 10461 USA; [Tufariello, JoAnn M.; Malek, Adel A.; Jacobs, William R., Jr.] Albert Einstein Coll Med, Howard Hughes Med Inst, Dept Microbiol & Immunol, Bronx, NY 10461 USA	Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine	Blanchard, JS (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	john.blanchard@einstein.yu.edu	Malek, Adel/ABF-9944-2021	Jacobs, William/0000-0003-3321-3080	National Institutes of Health [AI60899, AI26170, AI098925, P01AI63537]; Department of Energy Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI026170, R01AI026170, R01AI098925, P01AI063537, R01AI060899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI60899 (to J. S. B.) and AI26170, AI098925, and P01AI63537 (to W. R. J.). This research used resources of the Advanced Photon Source, a U.S. Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. Use of the Lilly Research Laboratories Collaborative Access Team Beamline at Sector 31 of the Advanced Photon Source was provided by Eli Lilly Company, which operates the facility. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; BYRD TF, 1993, J CLIN INVEST, V91, P969, DOI 10.1172/JCI116318; Chavadi SS, 2011, J BACTERIOL, V193, P5905, DOI 10.1128/JB.05811-11; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; Drake EJ, 2010, BIOCHEMISTRY-US, V49, P9292, DOI 10.1021/bi101226n; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Favrot L, 2016, BIOCHEMISTRY-US, V55, P989, DOI 10.1021/acs.biochem.5b01269; Ferreras JA, 2005, NAT CHEM BIOL, V1, P29, DOI 10.1038/nchembio706; Gobin J, 1996, J EXP MED, V183, P1527, DOI 10.1084/jem.183.4.1527; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Jain P, 2014, MBIO, V5, DOI 10.1128/mBio.01245-14; Jones CM, 2011, J BACTERIOL, V193, P1767, DOI 10.1128/JB.01312-10; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krithika R, 2006, P NATL ACAD SCI USA, V103, P2069, DOI 10.1073/pnas.0507924103; Lee HJ, 2012, NAT STRUCT MOL BIOL, V19, P811, DOI 10.1038/nsmb.2318; Lun S, 2013, ANTIMICROB AGENTS CH, V57, P5138, DOI 10.1128/AAC.00918-13; Luo MK, 2005, NAT CHEM BIOL, V1, P149, DOI 10.1038/nchembio717; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Nelson KM, 2015, J MED CHEM, V58, P5459, DOI 10.1021/acs.jmedchem.5b00391; Pandey R, 2014, MOL MICROBIOL, V91, P98, DOI 10.1111/mmi.12441; Pandey SD, 2014, J BACTERIOL, V196, P1853, DOI 10.1128/JB.01483-13; PFLEIDERER G, 1960, BIOCHEM Z, V333, P308; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Quadri LEN, 1998, CHEM BIOL, V5, P631, DOI 10.1016/S1074-5521(98)90291-5; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; RAYMOND KN, 1979, ACCOUNTS CHEM RES, V12, P183, DOI 10.1021/ar50137a004; Reger AS, 2007, BIOCHEMISTRY-US, V46, P6536, DOI 10.1021/bi6026506; Rodriguez GM, 2006, TRENDS MICROBIOL, V14, P320, DOI 10.1016/j.tim.2006.05.006; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; Ryndak MB, 2010, J BACTERIOL, V192, P861, DOI 10.1128/JB.00223-09; SCHMITT MP, 1995, INFECT IMMUN, V63, P4284, DOI 10.1128/IAI.63.11.4284-4289.1995; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tufariello JM, 2014, MBIO, V5, DOI 10.1128/mBio.01179-14; Tullius MV, 2011, P NATL ACAD SCI USA, V108, P5051, DOI 10.1073/pnas.1009516108; Vergnolle O, 2013, J BIOL CHEM, V288, P28116, DOI 10.1074/jbc.M113.495549; Vilcheze C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2898; Xu H, 2011, BIOCHEMISTRY-US, V50, P5883, DOI 10.1021/bi200156t; Zheng RJ, 2001, BIOCHEMISTRY-US, V40, P12904, DOI 10.1021/bi011522+	47	19	20	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22315	22326		10.1074/jbc.M116.744532	http://dx.doi.org/10.1074/jbc.M116.744532			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27566542	Green Published, hybrid			2022-12-26	WOS:000386332600041
J	Liu, YF; Wei, JY; Shi, MH; Jiang, H; Zhou, J				Liu, Yu-Feng; Wei, Jian-Yang; Shi, Mao-Hua; Jiang, Hua; Zhou, Jie			Glucocorticoid Induces Hepatic Steatosis by Inhibiting Activating Transcription Factor 3 (ATF3)/S100A9 Protein Signaling in Granulocytic Myeloid-derived Suppressor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cAMP response element-binding protein; glucocorticoid; immunosuppression; liver metabolism; S100 proteins	IMMUNE SUPPRESSION; LIVER-DISEASE; FATTY LIVER; ATF3; INFLAMMATION; DIFFERENTIATION; ACCUMULATION; REGULATOR; EXPANSION; MICE	Glucocorticoids (GCs) used as inflammation suppressors have harmful side effects, including induction of hepatic steatosis. The underlying mechanisms of GC-promoted dysregulation of lipid metabolism, however, are not fully understood. GCs could facilitate the accumulation of myeloid-derived suppressor cells (MDSC) in the liver of animals, and the potential role of MDSCs in GC-induced hepatic steatosis was therefore investigated in this study. We demonstrated that granulocytic (G)-MDSC accumulation mediated the effects of GCs on the fatty liver, in which activating transcription factor 3 (ATF3)/S100A9 signaling plays an important role. ATF3-deficient mice developed hepatic steatosis and displayed expansion of G-MDSCs in the liver and multiple immune organs, which shared high similarity with the phenotype observed in GC-treated wild-type littermates. Adoptive transfer of GC-induced or ATF3-deficient G-MDSCs promoted lipid accumulation in the liver, whereas depletion of G-MDSCs alleviated these effects. Mechanistic studies showed that in MDSCs, ATF3 was transrepressed by the GC receptor GR through direct binding to the negative GR-response element. S100A9 is the major transcriptional target of ATF3 in G-MDSCs. Silencing S100A9 clearly alleviated G-MDSCs expansion and hepatic steatosis caused by ATF3 deficiency or GC treatment. Our study uncovers an important role of G-MDSCs in GC-induced hepatic steatosis, in which ATF3 may have potential therapeutic implications.	[Liu, Yu-Feng; Jiang, Hua; Zhou, Jie] Zhongshan Sch Med, Affiliated Guangzhou Women & Childrens Med Ctr, Program Immunol, 9th Jin Sui Rd, Guangzhou 510623, Guangdong, Peoples R China; [Liu, Yu-Feng; Wei, Jian-Yang; Shi, Mao-Hua; Zhou, Jie] Sun Yat Sen Univ, Inst Human Virol, 74 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China; [Zhou, Jie] Sun Yat Sen Univ, Chinese Minist Educ, Key Lab Trop Dis Control, 74 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China; [Liu, Yu-Feng; Jiang, Hua] Guangzhou Med Univ, Dept Hematol Oncol, Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University	Zhou, J (corresponding author), 74 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.	zhouj72@mail.sysu.edu.cn			National Key Basic Research Program of China [2012CB524900]; Guangdong Innovative Research Team Program Grant [2009010058]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS); Programme for the 12th Five-year Plan [2012ZX10001003]; National Natural Science Foundation of China [91542112, 81571520, 31270921]; Fundamental Research Funds for the Central Universities; Provincial Talents Cultivated by "Thousand-Hundred-Ten" Programme of Guangdong Province; 111 Project [B12003]; China Postdoctoral Science Foundation [2015M582365]; Natural Science Foundation of Guangdong Province [2016A030310252]	National Key Basic Research Program of China(National Basic Research Program of China); Guangdong Innovative Research Team Program Grant; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS); Programme for the 12th Five-year Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Provincial Talents Cultivated by "Thousand-Hundred-Ten" Programme of Guangdong Province; 111 Project(Ministry of Education, China - 111 Project); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by National Key Basic Research Program of China Grant 2012CB524900; Guangdong Innovative Research Team Program Grant 2009010058; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS, 2014); Programme for the 12th Five-year Plan 2012ZX10001003; National Natural Science Foundation of China Grants 91542112, 81571520, 31270921; Fundamental Research Funds for the Central Universities; the Provincial Talents Cultivated by "Thousand-Hundred-Ten" Programme of Guangdong Province; 111 Project B12003; China Postdoctoral Science Foundation Grant 2015M582365, and Natural Science Foundation of Guangdong Province Grant 2016A030310252. The authors declare that they have no conflicts of interest with the contents of this article.	Boespflug ND, 2014, BLOOD, V123, P2084, DOI 10.1182/blood-2013-06-510909; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Chou HS, 2011, HEPATOLOGY, V53, P1007, DOI 10.1002/hep.24162; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; De Nardo D, 2014, NAT IMMUNOL, V15, P152, DOI 10.1038/ni.2784; Deng ZB, 2009, HEPATOLOGY, V50, P1412, DOI 10.1002/hep.23148; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gold ES, 2012, J EXP MED, V209, P807, DOI 10.1084/jem.20111202; Gustot T, 2006, HEPATOLOGY, V43, P989, DOI 10.1002/hep.21138; Hai T, 1999, GENE EXPRESSION, V7, P321; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Hritz I, 2008, HEPATOLOGY, V48, P1224, DOI 10.1002/hep.22470; Hu CE, 2011, SCAND J GASTROENTERO, V46, P156, DOI 10.3109/00365521.2010.516450; Huang A, 2014, J IMMUNOL, V193, P5461, DOI 10.4049/jimmunol.1400849; Ilkovitch D, 2009, CANCER RES, V69, P5514, DOI 10.1158/0008-5472.CAN-08-4625; Kim JY, 2014, J BIOL CHEM, V289, P27065, DOI 10.1074/jbc.M114.585653; Liao JB, 2014, J LEUKOCYTE BIOL, V96, P675, DOI 10.1189/jlb.2HI1113-611RR; Liu GW, 2014, J IMMUNOL, V192, P3068, DOI 10.4049/jimmunol.1301193; Maruyama K, 2012, IMMUNITY, V37, P1024, DOI 10.1016/j.immuni.2012.08.022; Miura K, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/362847; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nagaraj S, 2008, CANCER RES, V68, P2561, DOI 10.1158/0008-5472.CAN-07-6229; Oakley RH, 2012, P NATL ACAD SCI USA, V109, P17591, DOI 10.1073/pnas.1209411109; Ostrand-Rosenberg S, 2012, SEMIN CANCER BIOL, V22, P275, DOI 10.1016/j.semcancer.2012.01.011; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Patel R, 2011, J CLIN INVEST, V121, P431, DOI 10.1172/JCI41681; Qin AP, 2013, J VIROL, V87, P1477, DOI 10.1128/JVI.01759-12; Sade H, 2003, EUR J IMMUNOL, V33, P913, DOI 10.1002/eji.200323782; Sade-Feldman M, 2013, IMMUNITY, V38, P541, DOI 10.1016/j.immuni.2013.02.007; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Shi MH, 2014, J ALLERGY CLIN IMMUN, V134, P1163, DOI 10.1016/j.jaci.2014.04.035; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; van der Goes MC, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4686; Varga G, 2008, J LEUKOCYTE BIOL, V84, P644, DOI 10.1189/jlb.1107768; Varga G, 2014, J IMMUNOL, V193, P1090, DOI 10.4049/jimmunol.1300891; Vegiopoulos A, 2007, MOL CELL ENDOCRINOL, V275, P43, DOI 10.1016/j.mce.2007.05.015; Waight JD, 2013, J CLIN INVEST, V123, P4464, DOI 10.1172/JCI68189; Yan DH, 2013, EUR J IMMUNOL, V43, P2943, DOI 10.1002/eji.201343472; Yang Q, 2014, BLOOD, V124, P1610, DOI 10.1182/blood-2014-03-559658; Zhang K, 2012, INT J MOL MED, V30, P277, DOI 10.3892/ijmm.2012.1014	44	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21771	21785		10.1074/jbc.M116.726364	http://dx.doi.org/10.1074/jbc.M116.726364			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27573240	Green Published, hybrid			2022-12-26	WOS:000385999200041
J	Roberto, G; Leal, I; Sattar, N; Loomis, AK; Avillach, P; Egger, P; van Wijngaarden, R; Ansell, D; Reisberg, S; Tammesoo, ML; Alavere, H; Pasqua, A; Pedersen, L; Cunningham, J; Tramontan, L; Mayer, MA; Herings, R; Coloma, P; Lapi, F; Sturkenboom, M; van der Lei, J; Schuemie, MJ; Rijnbeek, P; Gini, R				Roberto, Giuseppe; Leal, Ingrid; Sattar, Naveed; Loomis, A. Katrina; Avillach, Paul; Egger, Peter; van Wijngaarden, Rients; Ansell, David; Reisberg, Sulev; Tammesoo, Mari-Liis; Alavere, Helene; Pasqua, Alessandro; Pedersen, Lars; Cunningham, James; Tramontan, Lara; Mayer, Miguel A.; Herings, Ron; Coloma, Preciosa; Lapi, Francesco; Sturkenboom, Miriam; van der Lei, Johan; Schuemie, Martijn J.; Rijnbeek, Peter; Gini, Rosa			Identifying Cases of Type 2 Diabetes in Heterogeneous Data Sources: Strategy from the EMIF Project	PLOS ONE			English	Article							HEALTH-CARE DATABASES; DRUG; PREVALENCE; VALIDATION; EXPERIENCE; RECORDS; RISK	Due to the heterogeneity of existing European sources of observational healthcare data, data source-tailored choices are needed to execute multi-data source, multi-national epidemiological studies. This makes transparent documentation paramount. In this proof-of-concept study, a novel standard data derivation procedure was tested in a set of heterogeneous data sources. Identification of subjects with type 2 diabetes (T2DM) was the test case. We included three primary care data sources (PCDs), three record linkage of administrative and/or registry data sources (RLDs), one hospital and one biobank. Overall, data from 12 million subjects from six European countries were extracted. Based on a shared event definition, sixteeen standard algorithms (components) useful to identify T2DM cases were generated through a top-down/bottom-up iterative approach. Each component was based on one single data domain among diagnoses, drugs, diagnostic test utilization and laboratory results. Diagnoses-based components were subclassified considering the healthcare setting (primary, secondary, inpatient care). The Unified Medical Language System was used for semantic harmonization within data domains. Individual components were extracted and proportion of population identified was compared across data sources. Drug-based components performed similarly in RLDs and PCDs, unlike diagnoses-based components. Using components as building blocks, logical combinations with AND, OR, AND NOT were tested and local experts recommended their preferred data source-tailored combination. The population identified per data sources by resulting algorithms varied from 3.5% to 15.7%, however, age-specific results were fairly comparable. The impact of individual components was assessed: diagnoses-based components identified the majority of cases in PCDs (93-100%), while drug-based components were the main contributors in RLDs (81-100%). The proposed data derivation procedure allowed the generation of data source-tailored case-finding algorithms in a standardized fashion, facilitated transparent documentation of the process and benchmarking of data sources, and provided bases for interpretation of possible inter-data source inconsistency of findings in future studies.	[Roberto, Giuseppe; Lapi, Francesco; Gini, Rosa] Reg Agcy Healthcare Serv Tuscany, Epidemiol Unit, Florence, Italy; [Leal, Ingrid; Avillach, Paul; Coloma, Preciosa; Sturkenboom, Miriam; van der Lei, Johan; Rijnbeek, Peter] Erasmus Univ, Med Ctr, Dept Med Informat, Rotterdam, Netherlands; [Sattar, Naveed] Univ Glasgow, British Heart Fdn Glasgow, Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Loomis, A. Katrina] Pfizer Worldwide Res & Dev, Groton, CT USA; [Avillach, Paul] Harvard Med Sch, Dept Biomed Informat, Boston, MA USA; [Avillach, Paul] Boston Childrens Hosp, Childrens Hosp Informat Program, Boston, MA USA; [Egger, Peter] GlaxoSmithKline, Worldwide Epidemiol GSK, Stockley Pk West, Uxbridge, Middx, England; [van Wijngaarden, Rients; Herings, Ron] PHARMO Inst Drug Outcomes Res, Utrecht, Netherlands; [Ansell, David] Cegedim Strateg Data Med Res Ltd, Hlth Improvement Network, London, England; [Reisberg, Sulev] Univ Tartu, Software Technol & Applicat Competence Ctr, Quretec, Tartu, Estonia; [Tammesoo, Mari-Liis; Alavere, Helene] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; [Tammesoo, Mari-Liis; Alavere, Helene] Tartu Univ Hosp, Tartu, Estonia; [Pasqua, Alessandro] Italian Coll Gen Practitioners & Primary Care, Hlth Search, Florence, Italy; [Pedersen, Lars] Aarhus Univ Hosptial, Dept Clin Epidemiol, Aarhus, Denmark; [Cunningham, James] Univ Manchester, Manchester, Lancs, England; [Tramontan, Lara] Arsenal IT Consortium, Venetos Res Ctr eHlth Innovat, Treviso, Italy; [Mayer, Miguel A.] Hosp del Mar Med Res Inst IMIM, Barcelona, Spain; [Mayer, Miguel A.] Univ Pompeu Fabra, Barcelona, Spain; [Schuemie, Martijn J.] Janssen Res & Dev, Epidemiol, Titusville, NJ USA; [Schuemie, Martijn J.] Observat Hlth Data Sci & Informat, New York, NY USA	Erasmus University Rotterdam; Erasmus MC; University of Glasgow; Pfizer; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; GlaxoSmithKline; University of Tartu; University of Tartu; Aarhus University; University of Manchester; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Johnson & Johnson; Janssen Pharmaceuticals	Roberto, G (corresponding author), Reg Agcy Healthcare Serv Tuscany, Epidemiol Unit, Florence, Italy.	giuseppe.roberto@ars.toscana.it	Roberto, Giuseppe/AAR-4498-2020; Mayer, Miguel Angel/AAL-2810-2021; Mayer, Miguel Angel/K-5255-2014; Herings, Ron/AAE-4096-2021	Roberto, Giuseppe/0000-0001-6478-6442; Mayer, Miguel Angel/0000-0003-0362-6298; Mayer, Miguel Angel/0000-0003-0362-6298; Herings, Ron/0000-0002-2561-8734; Gini, Rosa/0000-0002-6250-877X; Reisberg, Sulev/0000-0001-6835-9632; Schuemie, Martijn/0000-0002-0817-5361; Ansell, David/0000-0001-9575-1509; Sturkenboom, Miriam/0000-0003-1360-2388	Innovative Medicines Initiative Joint Undertaking under European Medical Information Framework grant [115372]; European Union's Seventh Framework Programme (FP7); European Federation of Pharmaceutical Industries and Association companies'; Pfizer Worldwide Research and Development; GlaxoSmithKline; Cegedim Strategic Data Medical Research Ltd; Janssen	Innovative Medicines Initiative Joint Undertaking under European Medical Information Framework grant; European Union's Seventh Framework Programme (FP7); European Federation of Pharmaceutical Industries and Association companies'; Pfizer Worldwide Research and Development; GlaxoSmithKline(GlaxoSmithKline); Cegedim Strategic Data Medical Research Ltd; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking (http://www.imi.europa.eu/) under European Medical Information Framework grant agreement no. 115372, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and European Federation of Pharmaceutical Industries and Association companies' in kind contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Pfizer Worldwide Research and Development, GlaxoSmithKline, Cegedim Strategic Data Medical Research Ltd and Janssen provided support in the form of salaries for AKL, PE, DA and MJS, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2011, PREV EST DIAB AD AG; Avillach P, 2013, J AM MED INFORM ASSN, V20, P184, DOI 10.1136/amiajnl-2012-000933; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Blak Betina T, 2011, Inform Prim Care, V19, P251; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Coloma PM, 2011, PHARMACOEPIDEM DR S, V20, P1, DOI 10.1002/pds.2053; Conway Mike, 2011, AMIA Annu Symp Proc, V2011, P274; Gini R, 2015, PHARMACOEPIDEM DR S, V24, P1; Gini Rosa, 2016, EGEMS (Wash DC), V4, P1189, DOI 10.13063/2327-9214.1189; Gini R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-15; Hernan MA, 2011, EPIDEMIOLOGY, V22, P290, DOI 10.1097/EDE.0b013e3182114039; Hripcsak G, 2013, J AM MED INFORM ASSN, V20, P117, DOI 10.1136/amiajnl-2012-001145; Johannesdottir Sigrun Alba, 2012, Clin Epidemiol, V4, P303, DOI 10.2147/CLEP.S37587; Kho AN, 2012, J AM MED INFORM ASSN, V19, P212, DOI 10.1136/amiajnl-2011-000439; Leitsalu L, 2015, INT J EPIDEMIOL, V44, P1137, DOI 10.1093/ije/dyt268; Mayer MA, 2015, STUD HEALTH TECHNOL, V210, P224, DOI 10.3233/978-1-61499-512-8-224; Morley KI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110900; Nexo BA, 2013, EPIDEMIOLOGY, V24, P331, DOI 10.1097/EDE.0b013e318281e48a; Overby CL, 2013, J AM MED INFORM ASSN, V20, pE243, DOI 10.1136/amiajnl-2013-001930; Pathak J, 2013, J AM MED INFORM ASSN, V20, pE206, DOI 10.1136/amiajnl-2013-002428; Richesson R L, 2014, Yearb Med Inform, V9, P215, DOI 10.15265/IY-2014-0009; Richesson RL, 2013, J AM MED INFORM ASSN, V20, pE319, DOI 10.1136/amiajnl-2013-001952; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Sancho JJ, 1998, ST HEAL T, V56, P35; Trifiro G, 2014, J INTERN MED, V275, P551, DOI 10.1111/joim.12159; Valkhoff VE, 2014, J CLIN EPIDEMIOL, V67, P921, DOI 10.1016/j.jclinepi.2014.02.020; van Herk-Sukel MPP, 2012, PHARMACOEPIDEM DR S, V21, P94, DOI 10.1002/pds.2205; Vlug AE, 1999, METHOD INFORM MED, V38, P339; World Health Organization, 1999, WHONCDNCS992	29	19	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0160648	10.1371/journal.pone.0160648	http://dx.doi.org/10.1371/journal.pone.0160648			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EG	27580049	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000382877400008
J	Skov, V; Burton, M; Thomassen, M; Larsen, TS; Riley, CH; Madelung, AB; Kjaer, L; Bondo, H; Stamp, I; Ehinger, M; Dahl-Sorensen, R; Brochmann, N; Nielsen, K; Thiele, J; Jensen, MK; Bjerrum, OW; Kruse, TA; Hasselbalch, HC				Skov, Vibe; Burton, Mark; Thomassen, Mads; Larsen, Thomas Stauffer; Riley, Caroline H.; Madelung, Ann Brinch; Kjaer, Lasse; Bondo, Henrik; Stamp, Inger; Ehinger, Mats; Dahl-Sorensen, Rasmus; Brochmann, Nana; Nielsen, Karsten; Thiele, Juergen; Jensen, Morten K.; Bjerrum, Ole Weis; Kruse, Torben A.; Hasselbalch, Hans Carl			A 7-Gene Signature Depicts the Biochemical Profile of Early Prefibrotic Myelofibrosis	PLOS ONE			English	Article							ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA; IDIOPATHIC MYELOFIBROSIS; GENE-EXPRESSION; CD34(+) CELLS; PANCREATIC ADENOCARCINOMA; CARCINOEMBRYONIC ANTIGEN; CHRONIC INFLAMMATION; DIAGNOSIS; DISEASE	Recent studies have shown that a large proportion of patients classified as essential thrombocythemia (ET) actually have early primary prefibrotic myelofibrosis (prePMF), which implies an inferior prognosis as compared to patients being diagnosed with so-called genuine or true ET. According to the World Health Organization (WHO) 2008 classification, bone marrow histology is a major component in the distinction between these disease entities. However, the differential diagnosis between them may be challenging and several studies have not been able to distinguish between them. Most lately, it has been argued that simple blood tests, including the leukocyte count and plasma lactate dehydrogenase (LDH) may be useful tools to separate genuine ET from prePMF, the latter disease entity more often being featured by anemia, leukocytosis and elevated LDH. Whole blood gene expression profiling was performed in 17 and 9 patients diagnosed with ET and PMF, respectively. Using elevated LDH obtained at the time of diagnosis as a marker of prePMF, a 7-gene signature was identified which correctly predicted the prePMF group with a sensitivity of 100% and a specificity of 89%. The 7 genes included MPO, CEACAM8, CRISP3, MS4A3, CEACAM6, HEMGN, and MMP8, which are genes known to be involved in inflammation, cell adhesion, differentiation and proliferation. Evaluation of bone marrow biopsies and the 7-gene signature showed a concordance rate of 71%, 79%, 62%, and 38%. Our 7-gene signature may be a useful tool to differentiate between genuine ET and prePMF but needs to be validated in a larger cohort of "ET" patients.	[Skov, Vibe; Riley, Caroline H.; Kjaer, Lasse; Dahl-Sorensen, Rasmus; Brochmann, Nana; Jensen, Morten K.; Hasselbalch, Hans Carl] Zealand Univ Hosp, Dept Hematol, Roskilde, Denmark; [Burton, Mark; Thomassen, Mads; Kruse, Torben A.] Odense Univ Hosp, Dept Clin Genet, Odense, Denmark; [Larsen, Thomas Stauffer] Odense Univ Hosp, Dept Hematol 10, Odense, Denmark; [Madelung, Ann Brinch; Bondo, Henrik; Stamp, Inger] Naestved Hosp, Dept Pathol, Naestved, Denmark; [Ehinger, Mats] Univ Lund Hosp, Dept Pathol, Lund, Sweden; [Nielsen, Karsten] Univ Aarhus, Dept Pathol, Aarhus, Denmark; [Thiele, Juergen] Univ Cologne, Inst Pathol, Cologne, Germany; [Bjerrum, Ole Weis] Univ Copenhagen, Dept Hematol L, Rigshosp, Copenhagen, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; Naestved Hospital; Lund University; Skane University Hospital; Aarhus University; University of Cologne; Rigshospitalet; University of Copenhagen	Hasselbalch, HC (corresponding author), Zealand Univ Hosp, Dept Hematol, Roskilde, Denmark.	hans.hasselbalch@gmail.com	Bjerrum, Ole Weis/AAF-9999-2019; Hasselbalch, Hans/H-2217-2017	Hasselbalch, Hans/0000-0003-3936-8032; Larsen, Thomas Stauffer/0000-0002-8418-6708	Danish Council for independent Research Medical Sciences	Danish Council for independent Research Medical Sciences(Det Frie Forskningsrad (DFF))	The study has received grants from The Danish Council for independent Research Medical Sciences (http://ufm.dk/forskning-og-innovation/rad-og-udvalg/det-frie-forskningsrad/radet/dff-sundhed-og-sygdom).	Aumann K, 2013, BLOOD, V122, P93, DOI 10.1182/blood-2012-11-463257; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barbui T, 2013, LEUKEMIA, V27, P1953, DOI 10.1038/leu.2013.74; Barbui T, 2012, BLOOD, V120, P569, DOI 10.1182/blood-2012-01-407981; Barbui T, 2011, J CLIN ONCOL, V29, P3179, DOI 10.1200/JCO.2010.34.5298; Barcellini W, 2013, LEUKEMIA RES, V37, P1509, DOI 10.1016/j.leukres.2013.09.001; Barosi G, 2001, BLOOD, V98, P3249, DOI 10.1182/blood.V98.12.3249; Barosi G, 2014, CURR HEMATOL MALIG R, V9, P331, DOI 10.1007/s11899-014-0227-0; Barosi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035631; Barosi G, 2010, LEUKEMIA RES, V34, P1119, DOI 10.1016/j.leukres.2010.05.010; Beer PA, 2010, HAEMATOL-HEMATOL J, V95, P1960, DOI 10.3324/haematol.2010.026708; BENCHIMOL S, 1989, CELL, V57, P327, DOI 10.1016/0092-8674(89)90970-7; Berkofsky-Fessler W, 2010, CLIN CANCER RES, V16, P4339, DOI 10.1158/1078-0432.CCR-10-1092; Borregaard N, 2001, CURR OPIN HEMATOL, V8, P23, DOI 10.1097/00062752-200101000-00005; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Brousseau M, 2010, HISTOPATHOLOGY, V56, P758, DOI 10.1111/j.1365-2559.2010.03545.x; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Carobbio A, 2012, AM J HEMATOL, V87, P203, DOI 10.1002/ajh.22241; Donato JL, 2002, J CLIN INVEST, V109, P51, DOI 10.1172/JCI14025; Duxbury MS, 2005, ANN SURG, V241, P491, DOI 10.1097/01.sla.0000154455.86404.e9; Duxbury MS, 2004, BRIT J CANCER, V91, P1384, DOI 10.1038/sj.bjc.6602113; Ester A, 1981, Sangre (Barc), V26, P567; Finazzi G, 2012, LEUKEMIA, V26, P716, DOI 10.1038/leu.2011.258; Gnatenko DV, 2010, BLOOD, V115, P7, DOI 10.1182/blood-2009-05-224477; GORDON BR, 1981, BLOOD, V58, P904; Guglielmelli P, 2007, STEM CELLS, V25, P165, DOI 10.1634/stemcells.2006-0351; Hager M, 2010, J INTERN MED, V268, P25, DOI 10.1111/j.1365-2796.2010.02237.x; HASSELBALCH H, 1985, SCAND J HAEMATOL, V34, P177; HASSELBALCH H, 1984, SCAND J HAEMATOL, V32, P179; HASSELBALCH H, 1990, AM J HEMATOL, V34, P291, DOI 10.1002/ajh.2830340411; Hasselbalch HC, 2014, LEUKEMIA RES, V38, P263, DOI 10.1016/j.leukres.2013.07.002; Hasselbalch HC, 2013, CYTOKINE GROWTH F R, V24, P133, DOI 10.1016/j.cytogfr.2013.01.004; Hasselbalch HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112786; Hasselbalch HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085567; Hasselbalch HC, 2013, LEUKEMIA RES, V37, P214, DOI 10.1016/j.leukres.2012.10.020; Hasselbalch HC, 2012, BLOOD, V119, P3219, DOI 10.1182/blood-2011-11-394775; Hasselbalch HC, 2011, LEUKEMIA RES, V35, P1330, DOI 10.1016/j.leukres.2011.03.013; Hasselbalch HC, 2009, LEUKEMIA RES, V33, P11, DOI 10.1016/j.leukres.2008.06.002; Hermouet S, 2011, HAEMATOL-HEMATOL J, V96, P1575, DOI 10.3324/haematol.2011.055392; Hussein K, 2009, EXP HEMATOL, V37, P1186, DOI 10.1016/j.exphem.2009.07.005; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang J, 2010, BLOOD, V116, P711, DOI 10.1182/blood-2009-07-235341; Koschmieder S, 2016, LEUKEMIA, V30, P1018, DOI 10.1038/leu.2016.12; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Kvasnicka HM, 2006, SEMIN THROMB HEMOST, V32, P362, DOI 10.1055/s-2006-942757; Lataillade JJ, 2008, BLOOD, V112, P3026, DOI 10.1182/blood-2008-06-158386; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Maraqa L, 2008, CLIN CANCER RES, V14, P405, DOI 10.1158/1078-0432.CCR-07-1363; Passamonti F, 2006, BLOOD, V107, P3676, DOI 10.1182/blood-2005-09-3826; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Rotunno G, 2014, BLOOD, V123, P1552, DOI 10.1182/blood-2013-11-538983; Rupoli S, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0269-1; Skov V, 2013, LEUKEMIA LYMPHOMA, V54, P2269, DOI 10.3109/10428194.2013.764417; Skov V, 2012, EXP HEMATOL, V40, P771, DOI 10.1016/j.exphem.2012.05.011; Skov V, 2012, LEUKEMIA LYMPHOMA, V53, P123, DOI 10.3109/10428194.2011.597905; Skov V, 2011, EUR J HAEMATOL, V87, P54, DOI 10.1111/j.1600-0609.2011.01618.x; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tefferi A, 2000, NEW ENGL J MED, V342, P1255, DOI 10.1056/NEJM200004273421706; Theilgaard-Monch K, 2005, BLOOD, V105, P1785, DOI 10.1182/blood-2004-08-3346; Thiele J, 2002, LEUKEMIA LYMPHOMA, V43, P1035, DOI 10.1080/10428190290021542; Thiele J, 2001, ANN HEMATOL, V80, P160, DOI 10.1007/s002770000278; Thiele J, 2000, HAEMATOLOGICA, V85, P1126; Thiele J, 2011, BLOOD, V117, P5710, DOI 10.1182/blood-2010-07-293761; Thiele Juergen, 2009, Curr Hematol Malig Rep, V4, P33, DOI 10.1007/s11899-009-0005-6; VELLENGA E, 1982, CLIN LAB HAEMATOL, V4, P239; Visekruna A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/239368; Wilkins BS, 2008, BLOOD, V111, P60, DOI 10.1182/blood-2007-05-091850; Xu M, 2005, BLOOD, V105, P4805; Yang LV, 2001, MECH DEVELOP, V104, P105, DOI 10.1016/S0925-4773(01)00376-8	70	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161570	10.1371/journal.pone.0161570	http://dx.doi.org/10.1371/journal.pone.0161570			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579896	Green Submitted, Green Published, gold			2022-12-26	WOS:000382877400028
J	Carrasco-Zevallos, OM; Nankivil, D; Viehland, C; Keller, B; Izatt, JA				Carrasco-Zevallos, Oscar M.; Nankivil, Derek; Viehland, Christian; Keller, Brenton; Izatt, Joseph A.			Pupil Tracking for Real-Time Motion Corrected Anterior Segment Optical Coherence Tomography	PLOS ONE			English	Article								Volumetric acquisition with anterior segment optical coherence tomography (ASOCT) is necessary to obtain accurate representations of the tissue structure and to account for asymmetries of the anterior eye anatomy. Additionally, recent interest in imaging of anterior segment vasculature and aqueous humor flow resulted in application of OCT angiography techniques to generate en face and 3D micro-vasculature maps of the anterior segment. Unfortunately, ASOCT structural and vasculature imaging systems do not capture volumes instantaneously and are subject to motion artifacts due to involuntary eye motion that may hinder their accuracy and repeatability. Several groups have demonstrated real-time tracking for motion-compensated in vivo OCT retinal imaging, but these techniques are not applicable in the anterior segment. In this work, we demonstrate a simple and low-cost pupil tracking system integrated into a custom swept-source OCT system for real-time motion-compensated anterior segment volumetric imaging. Pupil oculography hardware coaxial with the swept-source OCT system enabled fast detection and tracking of the pupil centroid. The pupil tracking ASOCT system with a field of view of 15 x 15 mm achieved diffraction-limited imaging over a lateral tracking range of +/-2.5 mm and was able to correct eye motion at up to 22 Hz. Pupil tracking ASOCT offers a novel real-time motion compensation approach that may facilitate accurate and reproducible anterior segment imaging.	[Carrasco-Zevallos, Oscar M.; Nankivil, Derek; Viehland, Christian; Keller, Brenton; Izatt, Joseph A.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Izatt, Joseph A.] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA; [Nankivil, Derek] Johnson & Johnson Vis Care Inc, Jacksonville, FL USA	Duke University; Duke University; Johnson & Johnson	Carrasco-Zevallos, OM (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	omc3@duke.edu	Izatt, Joseph/C-9067-2014	Izatt, Joseph/0000-0003-1993-2249; Nankivil, Derek/0000-0001-8588-923X	National Institutes of Health/National Eye Institute Biomedical Research Partnership grant [R01-EY023039]; Fitzpatrick Foundation Scholar; National Science Foundation Graduate Research Fellowship; Ford Foundation Predoctoral Fellowship; NIH T-32 Training Grant; NATIONAL EYE INSTITUTE [R01EY023039] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute Biomedical Research Partnership grant; Fitzpatrick Foundation Scholar; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Ford Foundation Predoctoral Fellowship; NIH T-32 Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health/National Eye Institute Biomedical Research Partnership grant #R01-EY023039 (www.nih.gov), the Fitzpatrick Foundation Scholar (www.pratt.duke.edu/about/fitzpatrick-center) awarded to DN, and a National Science Foundation Graduate Research Fellowship (https://www.nsfgrfp.org/), Ford Foundation Predoctoral Fellowship (http://sites.nationalacademies.org/pga/fordfellowships/index.htm), and NIH T-32 Training Grant (www.nih.gov) awarded to OMCZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERN M, 1958, ARCH OPHTHALMOL-CHIC, V60, P355, DOI 10.1001/archopht.1958.00940080371001; Barbosa M, 2014, BIOMED OPT EXPRESS, V5, P2458, DOI 10.1364/BOE.5.002458; Bharadwaj SR, 2009, INVEST OPHTH VIS SCI, V50, P3520, DOI 10.1167/iovs.08-2577; Braaf B, 2013, BIOMED OPT EXPRESS, V4, P51, DOI 10.1364/BOE.4.000051; Carrasco-Zevallos O, 2015, BIOMED OPT EXPRESS, V6, P3405, DOI 10.1364/BOE.6.003405; Carrasco-Zevallos OM, 2016, INVEST OPHTH VIS SCI, V57, pOCT37, DOI 10.1167/iovs.16-19277; EIZENMAN M, 1985, VISION RES, V25, P1635, DOI 10.1016/0042-6989(85)90134-8; Ferguson RD, 2004, OPT LETT, V29, P2139, DOI 10.1364/OL.29.002139; FINDLAY JM, 1971, KYBERNETIK, V8, P207, DOI 10.1007/BF00288749; Gabbur P, 2010, MACH VISION APPL, V21, P779, DOI 10.1007/s00138-009-0183-1; Goncharov AV, 2007, J OPT SOC AM A, V24, P2157, DOI 10.1364/JOSAA.24.002157; Hendargo HC, 2013, BIOMED OPT EXPRESS, V4, P803, DOI 10.1364/BOE.4.000803; Hiro-Oka H., 2012, BIOMED OPT EXPRESS, V3, P3067, DOI DOI 10.1364/B0E.3.003067; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Klein T, 2011, OPT EXPRESS, V19, P3044, DOI 10.1364/OE.19.003044; Kocaoglu OP, 2014, BIOMED OPT EXPRESS, V5, P2262, DOI 10.1364/BOE.5.002262; Kraus MF, 2012, BIOMED OPT EXPRESS, V3, P1182, DOI 10.1364/BOE.3.001182; LaRocca F, 2013, BIOMED OPT EXPRESS, V4, P2307, DOI 10.1364/BOE.4.002307; Li P, 2011, BIOMED OPT EXPRESS, V2, P492; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; McNabb RP, 2015, OPHTHALMOLOGY, V122, P677, DOI 10.1016/j.ophtha.2014.10.003; McNabb RP, 2013, OPT LETT, V38, P1212, DOI 10.1364/OL.38.001212; McNabb RP, 2012, BIOMED OPT EXPRESS, V3, P2050, DOI 10.1364/BOE.3.002050; Morimoto CH, 2000, IMAGE VISION COMPUT, V18, P331, DOI 10.1016/S0262-8856(99)00053-0; Otero-Millan J, 2008, J VISION, V8, DOI 10.1167/8.14.21; Poddar R, 2015, J OPTICS-UK, V17, DOI 10.1088/2040-8978/17/6/065301; Roig AB, 2012, OPTIK, V123, P11, DOI 10.1016/j.ijleo.2010.10.049; Schor CM, 2004, P ANN INT IEEE EMBS, V26, P766; Schuman J. S., 2013, OPTICAL COHERENCE TO, V3; Sheehy CK, 2012, BIOMED OPT EXPRESS, V3, P2611, DOI 10.1364/BOE.3.002611; Stevenson S. B., 2010, P 2010 S EYE TRACKIN, P195, DOI [DOI 10.1145/1743666.1743714, 10.1145/1743666.1743714]; Swirski L, 2012, P S EYE TRACK RES AP, P173, DOI DOI 10.1145/2168556.2168585; Todorich B, 2016, INVEST OPHTH VIS SCI, V57, DOI [10.1167/iovs.15-18818, DOI 10.1167/IOVS.15-18818]; Vienola KV, 2012, BIOMED OPT EXPRESS, V3, P2950, DOI 10.1364/BOE.3.002950	34	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0162015	10.1371/journal.pone.0162015	http://dx.doi.org/10.1371/journal.pone.0162015			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27574800	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877200055
J	Kativhu, CL; Libraty, DH				Kativhu, Chido Loveness; Libraty, Daniel H.			A Model to Explain How the Bacille Calmette Guerin (BCG) Vaccine Drives Interleukin-12 Production in Neonates	PLOS ONE			English	Article							IFN-GAMMA PRODUCTION; TOLL-LIKE RECEPTOR-2; MYCOBACTERIUM-TUBERCULOSIS; DENDRITIC CELLS; INNATE IMMUNITY; NATURAL-KILLER; CORD BLOOD; NK CELLS; RESPONSES; RECOGNITION	The Bacille Calmette Guerin (BCG) vaccine is the only routine vaccination at birth that effectively induces neonatal T-helper 1 (Th1)-polarized immune responses. The primary cytokine that drives CD4+ T-cell Th1 differentiation is interleukin (IL)-12 p70, a heterodimeric cytokine composed of the IL-12 p35 and IL-12 p40 subunits. We therefore examined the mechanisms involved in BCG vaccine stimulation of IL-12 p35 and p40 production from human umbilical cord (neonatal) cells. We found that BCG bacilli did not upregulate IL-12 p35 mRNA production, but upregulated IL-12 p40 mRNA production in a Toll-like receptor (TLR)2-dependent manner, in human neonatal monocyte-derived dendritic cells (mdDCs). The combination of TLR2 signaling, Type I interferon (IFN), and Type II IFN induced maximal levels of IL-12 p35 and p40 mRNA production in human neonatal mdDCs. The cell-free supernatants of reconstituted BCG vaccine vials contained extracellular mycobacterial (BCG) DNA which could induce IFN-alpha (Type I IFN) production in human neonatal plasmacytoid dendritic cells (pDCs). BCG bacilli also stimulated human neonatal CD16(lo) natural killer (NK) cells to produce IFN-gamma (Type II IFN) in a TLR2-dependent manner. We have therefore proposed a model where BCG vaccine could stimulate the combination of neonatal conventional DCs (cDCs), pDCs, and CD16(lo) NK cells to produce optimal neonatal IL-12 p35 and p40 (IL-12 p70) production and subsequent CD4+ T-cell Th1 polarization. An adjuvant that emulates the mechanism by which the BCG vaccine stimulates neonatal IL-12 p35 and p40 production could improve vaccine strategies at birth for protection against intracellular pathogens and toxins.	[Kativhu, Chido Loveness; Libraty, Daniel H.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Libraty, DH (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01655 USA.	daniel.libraty@umassmed.edu			U.S. National Institutes of Health [R01AI091820]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091820] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the U.S. National Institutes of Health R01AI091820. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaby P, 2011, J INFECT DIS, V204, P245, DOI 10.1093/infdis/jir240; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akkoc T, 2010, PEDIAT ALLERG IMM-UK, V21, P1059, DOI 10.1111/j.1399-3038.2010.01051.x; Barrios C, 1996, EUR J IMMUNOL, V26, P1489, DOI 10.1002/eji.1830260713; Basha S, 2014, EXPERT REV CLIN IMMU, V10, P1171, DOI 10.1586/1744666X.2014.942288; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Debock I, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00393; Eljaafari FM, 2011, J CLIN IMMUNOL, V31, P728, DOI 10.1007/s10875-011-9528-4; Esin S, 2013, SCAND J IMMUNOL, V77, P460, DOI 10.1111/sji.12052; Gehring AJ, 2004, J IMMUNOL, V173, P2660, DOI 10.4049/jimmunol.173.4.2660; Gilleron M, 2003, J BIOL CHEM, V278, P29880, DOI 10.1074/jbc.M303446200; Goodridge HS, 2016, NAT REV IMMUNOL, V16, P392, DOI 10.1038/nri.2016.43; Goriely S, 2001, J IMMUNOL, V166, P2141, DOI 10.4049/jimmunol.166.3.2141; Goriely S, 2004, J EXP MED, V199, P1011, DOI 10.1084/jem.20031272; Hussey GD, 2002, IMMUNOLOGY, V105, P314, DOI 10.1046/j.1365-2567.2002.01366.x; Jensen KJ, 2015, J INFECT DIS, V211, P956, DOI 10.1093/infdis/jiu508; de Castro MJ, 2015, CLIN INFECT DIS, V60, P1611, DOI 10.1093/cid/civ144; JPT Higgins KS-W. A Reingold, 2014, SYSTEMATIC REV NONSP; Kim Y, 2013, YONSEI MED J, V54, P1220, DOI 10.3349/ymj.2013.54.5.1220; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Lauzon NM, 2006, CELL IMMUNOL, V241, P102, DOI 10.1016/j.cellimm.2006.08.004; Lee SM, 1996, BLOOD, V88, P945; Libraty Daniel H, 2014, Trials Vaccinol, V3, P1, DOI 10.1016/j.trivac.2013.11.004; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Marchant A, 1999, J IMMUNOL, V163, P2249; MILSTIEN JB, 1990, B WORLD HEALTH ORGAN, V68, P93; Morris MC, 2016, NEONATOLOGY, V109, P161, DOI 10.1159/000442460; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; OSUGI Y, 1995, CLIN EXP IMMUNOL, V100, P543; Pecora ND, 2006, J IMMUNOL, V177, P422, DOI 10.4049/jimmunol.177.1.422; Quesniaux VJ, 2004, J IMMUNOL, V172, P4425, DOI 10.4049/jimmunol.172.7.4425; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Ritz N, 2013, VACCINE, V31, P3098, DOI 10.1016/j.vaccine.2013.03.059; Shann F, 2012, PEDIATR INFECT DIS J, V31, P308, DOI 10.1097/INF.0b013e3182465be8; Souza-Fonseca-Guimaraes F, 2012, MOL MED, V18, P270, DOI 10.2119/molmed.2011.00201; TRINCHIERI G, 1993, IMMUNOL TODAY, V14, P335, DOI 10.1016/0167-5699(93)90230-I; Uehori J, 2003, INFECT IMMUN, V71, P4238, DOI 10.1128/IAI.71.8.4238-4249.2003; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; Vekemans J, 2001, EUR J IMMUNOL, V31, P1531, DOI 10.1002/1521-4141(200105)31:5<1531::AID-IMMU1531>3.0.CO;2-1; von Meyenn F, 2006, IMMUNOBIOLOGY, V211, P557, DOI 10.1016/j.imbio.2006.05.004; Watkins MLV, 2008, CLIN VACCINE IMMUNOL, V15, P1666, DOI 10.1128/CVI.00202-08; World Health Organization Strategic Advisory Group of Experts, 2014, SYSTEMATIC REV NONSP; WU CY, 1993, J IMMUNOL, V151, P1938; Zhang XM, 2014, J INFECT DIS, V210, P424, DOI 10.1093/infdis/jiu103	44	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0162148	10.1371/journal.pone.0162148	http://dx.doi.org/10.1371/journal.pone.0162148			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571272	gold, Green Submitted, Green Published			2022-12-26	WOS:000382876700059
J	Amoshahy, MJ; Shamsi, M; Sedaaghi, MH				Amoshahy, Mohammad Javad; Shamsi, Mousa; Sedaaghi, Mohammad Hossein			A Novel Flexible Inertia Weight Particle Swarm Optimization Algorithm	PLOS ONE			English	Article							EVOLUTIONARY; TESTS	Particle swarm optimization (PSO) is an evolutionary computing method based on intelligent collective behavior of some animals. It is easy to implement and there are few parameters to adjust. The performance of PSO algorithm depends greatly on the appropriate parameter selection strategies for fine tuning its parameters. Inertia weight (IW) is one of PSO's parameters used to bring about a balance between the exploration and exploitation characteristics of PSO. This paper proposes a new nonlinear strategy for selecting inertia weight which is named Flexible Exponential Inertia Weight (FEIW) strategy because according to each problem we can construct an increasing or decreasing inertia weight strategy with suitable parameters selection. The efficacy and efficiency of PSO algorithm with FEIW strategy (FEPSO) is validated on a suite of benchmark problems with different dimensions. Also FEIW is compared with best time-varying, adaptive, constant and random inertia weights. Experimental results and statistical analysis prove that FEIW improves the search performance in terms of solution quality as well as convergence rate.	[Amoshahy, Mohammad Javad; Shamsi, Mousa; Sedaaghi, Mohammad Hossein] Sahand Univ Technol, Dept Elect Engn, Tabriz, Iran	Sahand University of Technology	Amoshahy, MJ (corresponding author), Sahand Univ Technol, Dept Elect Engn, Tabriz, Iran.	ajam@math.iut.ac.ir		Amoshahy, Mohammad Javad/0000-0002-2257-7607				Ab Wahab MN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122827; Alireza Alfi, 2011, Acta Automatica Sinica, V37, P541, DOI 10.3724/SP.J.1004.2011.00541; [Anonymous], 2007, COMPUTATIONAL INTELL, DOI DOI 10.1002/9780470512517; Arasomwan MA, 2013, SCI WORLD J, DOI 10.1155/2013/860289; Arumugam MS, 2008, APPL SOFT COMPUT, V8, P324, DOI 10.1016/j.asoc.2007.01.010; Bansal J.C., 2011, P 3 WORLD C NAT BIOL; Chatterjee A, 2006, COMPUT OPER RES, V33, P859, DOI 10.1016/j.cor.2004.08.012; Chen G, 2006, INT CONTR AUT 2006 W; Ciuprina G, 2002, IEEE T MAGN, V38, P1037, DOI 10.1109/20.996266; Demsar J, 2006, J MACH LEARN RES, V7, P1; Derrac J, 2011, SWARM EVOL COMPUT, V1, P3, DOI 10.1016/j.swevo.2011.02.002; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Eberhart R., 1995, MHS95 6 INT S MICR H, P39; Eberhart RC, 2000, EV COMP 2000 P 2000; Eberhart RC, 2001, EV COMP 2001 P 2001; Feng Y, 2007, INN COMP INF CONTR 2; Feng Y, 2007, MACH LEARN CYB 2007; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Friedman M, 1940, ANN MATH STAT, V11, P86, DOI 10.1214/aoms/1177731944; Jamil Momin, 2013, International Journal of Mathematical Modelling and Numerical Optimisation, V4, P150; Jiao B, 2008, CHAOS SOLITON FRACT, V37, P698, DOI 10.1016/j.chaos.2006.09.063; Kenndy J, 2002, P IEEE C EV COMP HON; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kumar Mukesh, 2015, COMP COMM AUT ICCCA; Kumar P, 2012, IEEE C EVOL COMPUTAT; Li H- R, 2009, INF COMP SCI 2009 IC; Liang J, 2014, 201411A ZHENGZH U CO, V29, P25640; Liang JJ, 2006, IEEE T EVOLUT COMPUT, V10, P281, DOI 10.1109/TEVC.2005.857610; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097822; Molga M., TEST FUNCTIONS OPTIM; Nickabadi A, 2011, APPL SOFT COMPUT, V11, P3658, DOI 10.1016/j.asoc.2011.01.037; Ratnaweera A, 2002, PARTICLE SWARM OPTIM; Shi Y., 1998, EVOLUTIONARY PROGRAM; Shi Y, 2001, EV COMP 2001 P 2001; Shi Y., 1998, EV COMP P 1998 IEEE; Suganthan PN, 2005, 2005005 KANGAL, V2005005, P2005; Trelea IC, 2003, INFORM PROCESS LETT, V85, P317, DOI 10.1016/S0020-0190(02)00447-7; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Xun Z, 2015, CONTR DEC C CCDC 201; Yao X, 1999, IEEE T EVOLUT COMPUT, V3, P82, DOI 10.1109/4235.771163	40	16	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161558	10.1371/journal.pone.0161558	http://dx.doi.org/10.1371/journal.pone.0161558			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560945	gold, Green Published, Green Submitted			2022-12-26	WOS:000382258600054
J	Chen, X; Liu, WY; Song, L; Li, S; Wu, Y; Shi, XM; Huang, JB; Wu, CS				Chen, Xi; Liu, Wen-yao; Song, Liang; Li, Su; Wu, Yi; Shi, Xian-meng; Huang, Jun-biao; Wu, Chuan-sheng			Physiological Responses of Two Epiphytic Bryophytes to Nitrogen, Phosphorus and Sulfur Addition in a Subtropical Montane Cloud Forest	PLOS ONE			English	Article							SPECIES COMPOSITION; OMBROTROPHIC BOG; RACOMITRIUM-LANUGINOSUM; NUTRIENT STOICHIOMETRY; TERRESTRIAL ECOSYSTEMS; SPHAGNUM-MAGELLANICUM; VASCULAR PLANTS; BOREAL FORESTS; LEAF NITROGEN; DEPOSITION	Atmospheric depositions pose significant threats to biodiversity and ecosystem function. However, the underlying physiological mechanisms are not well understood, and few studies have considered the combined effects and interactions of multiple pollutants. This in situ study explored the physiological responses of two epiphytic bryophytes to combined addition of nitrogen, phosphorus and sulfur. We investigated the electrical conductivity (EC), total chlorophyll concentration (Chl), nutrient stoichiometry and chlorophyll fluorescence signals in a subtropical montane cloud forest in south-west China. The results showed that enhanced fertilizer additions imposed detrimental effects on bryophytes, and the combined enrichment of simulated fertilization exerted limited synergistic effects in their natural environments. On the whole, EC, Chl, the effective quantum yield of photosystem II (FPSII) and photochemical quenching (qP) were the more reliable indicators of increased artificial fertilization. However, conclusions on nutrient stoichiometry should be drawn cautiously concerning the saturation uptake and nutrient interactions in bryophytes. Finally, we discuss the limitations of prevailing fertilization experiments and emphasize the importance of long-term data available for future investigations.	[Chen, Xi; Liu, Wen-yao; Song, Liang; Li, Su; Wu, Yi; Shi, Xian-meng; Huang, Jun-biao; Wu, Chuan-sheng] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Kunming, Peoples R China; [Chen, Xi; Wu, Yi; Shi, Xian-meng; Huang, Jun-biao; Wu, Chuan-sheng] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, WY (corresponding author), Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Kunming, Peoples R China.	liuwy@xtbg.ac.cn	Wu, CS/GXA-0960-2022	song, liang/0000-0002-1452-9939; Li, Su/0000-0001-5295-6846	National Natural Science Foundation of China [41471050, U1133605, 31300382, 31400384]; CAS "Light of West China" Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS "Light of West China" Program	This study was funded by the National Natural Science Foundation of China (No. 41471050, U1133605, 31300382, 31400384) and CAS "Light of West China" Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTS R, 1992, J ECOL, V80, P131, DOI 10.2307/2261070; Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Arroniz-Crespo M, 2008, NEW PHYTOL, V180, P864, DOI 10.1111/j.1469-8137.2008.02617.x; BADDELEY JA, 1994, ENVIRON POLLUT, V84, P189, DOI 10.1016/0269-7491(94)90102-3; Berendse F, 2001, GLOBAL CHANGE BIOL, V7, P591, DOI 10.1046/j.1365-2486.2001.00433.x; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; Bragazza L, 2004, NEW PHYTOL, V163, P609, DOI 10.1111/j.1469-8137.2004.01154.x; Bubier JL, 2007, GLOBAL CHANGE BIOL, V13, P1168, DOI 10.1111/j.1365-2486.2007.01346.x; Carfrae JA, 2007, APPL GEOCHEM, V22, P1111, DOI 10.1016/j.apgeochem.2007.03.002; CHAPIN FS, 1987, OECOLOGIA, V74, P310, DOI 10.1007/BF00379375; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Davidson EA, 2007, NATURE, V449, P1000, DOI 10.1038/4491000a; Drenovsky RE, 2004, PLANT SOIL, V259, P59, DOI 10.1023/B:PLSO.0000020945.09809.3d; Dupre C, 2010, GLOBAL CHANGE BIOL, V16, P344, DOI 10.1111/j.1365-2486.2009.01982.x; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; FERGUSON P, 1979, NEW PHYTOL, V82, P703, DOI 10.1111/j.1469-8137.1979.tb01665.x; Fritz C, 2012, PLANT BIOLOGY, V14, P491, DOI 10.1111/j.1438-8677.2011.00527.x; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gonzalez AL, 2011, OECOLOGIA, V167, P835, DOI 10.1007/s00442-011-2032-y; Gordon C, 2001, NEW PHYTOL, V149, P461, DOI 10.1046/j.1469-8137.2001.00053.x; Granath G, 2009, OECOLOGIA, V161, P481, DOI 10.1007/s00442-009-1406-x; Granberg G, 2001, ECOLOGY, V82, P1982, DOI 10.1890/0012-9658(2001)082[1982:EOTANA]2.0.CO;2; Gunnarsson U, 2000, NEW PHYTOL, V147, P527, DOI 10.1046/j.1469-8137.2000.00717.x; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Gusewell S, 2002, J VEG SCI, V13, P705, DOI 10.1111/j.1654-1103.2002.tb02098.x; HALLINGBACK T, 1992, BIOL CONSERV, V59, P163, DOI 10.1016/0006-3207(92)90577-A; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; Harmens H, 2011, ENVIRON POLLUT, V159, P2852, DOI 10.1016/j.envpol.2011.04.041; Hicks WK, 2000, ENVIRON POLLUT, V107, P367, DOI 10.1016/S0269-7491(99)00166-9; Jirousek M, 2011, ENVIRON POLLUT, V159, P585, DOI 10.1016/j.envpol.2010.10.004; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; [孔燕 Kong Yan], 2012, [环境科学学报, Acta Scientiae Circumstantiae], V32, P2160; Lamers LPM, 2000, GLOB CHANGE BIOL, V6, P583, DOI 10.1046/j.1365-2486.2000.00342.x; Larssen T., 1999, ENVIRON SCI POLICY, V2, P9, DOI DOI 10.1016/S1462-9011(98)00043-4; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Limpens J, 2004, ECOSYSTEMS, V7, P793, DOI 10.1007/s10021-004-0274-9; Limpens J, 2011, NEW PHYTOL, V191, P496, DOI 10.1111/j.1469-8137.2011.03680.x; Limpens J, 2003, OECOLOGIA, V135, P339, DOI 10.1007/s00442-003-1224-5; Liu WY, 2002, J TROP ECOL, V18, P527, DOI 10.1017/S0266467402002353; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Mahowald N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2008GB003240; Makipaa R, 1995, WATER AIR SOIL POLL, V85, P1239, DOI 10.1007/BF00477151; Mendez M, 2005, ECOLOGY, V86, P982, DOI 10.1890/04-0354; Nordin A, 2005, AMBIO, V34, P20, DOI 10.1639/0044-7447(2005)034[0020:NDATBO]2.0.CO;2; Okin GS, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002145; Payne RJ, 2011, ENVIRON POLLUT, V159, P2602, DOI 10.1016/j.envpol.2011.06.009; Pearce ISK, 2008, ENVIRON POLLUT, V152, P253, DOI 10.1016/j.envpol.2007.04.024; Pearce ISK, 2003, NEW PHYTOL, V160, P145, DOI 10.1046/j.1469-8137.2003.00875.x; Phoenix GK, 2012, GLOBAL CHANGE BIOL, V18, P1197, DOI 10.1111/j.1365-2486.2011.02590.x; Phuyal M, 2008, PLANT ECOL, V196, P111, DOI 10.1007/s11258-007-9338-1; Pitcairn C, 2006, ENVIRON POLLUT, V144, P941, DOI 10.1016/j.envpol.2006.01.049; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Reich PB, 2010, P ROY SOC B-BIOL SCI, V277, P877, DOI 10.1098/rspb.2009.1818; Roth T, 2013, AGR ECOSYST ENVIRON, V178, P121, DOI 10.1016/j.agee.2013.07.002; RUDOLPH H, 1986, PHYSIOL PLANTARUM, V66, P339, DOI 10.1111/j.1399-3054.1986.tb02429.x; Sheppard LJ, 2013, BIOGEOCHEMISTRY, V116, P39, DOI 10.1007/s10533-013-9880-y; Solga A, 2006, J BRYOL, V28, P46, DOI 10.1179/174328206X104552; Song L, 2012, BIOL CONSERV, V152, P127, DOI 10.1016/j.biocon.2012.04.002; Standish RJ, 2007, ENVIRON EXP BOT, V61, P58, DOI 10.1016/j.envexpbot.2007.03.004; Stevens CJ, 2011, ENVIRON POLLUT, V159, P2243, DOI 10.1016/j.envpol.2010.11.026; Strengbom J, 2001, FUNCT ECOL, V15, P451, DOI 10.1046/j.0269-8463.2001.00538.x; Tessier L., 1999, TOXICOL ENVIRON CHEM, V68, DOI [10.1080/02772249909358655, DOI 10.1080/02772249909358655]; Tsukuda S, 2006, BIOGEOCHEMISTRY, V77, P117, DOI 10.1007/s10533-005-1943-2; Venterink HO, 2003, ECOLOGY, V84, P2191, DOI 10.1890/01-0639; Wang TJ, 2000, ATMOS ENVIRON, V34, P4467, DOI 10.1016/S1352-2310(00)00101-1; Wassen MJ, 2005, NATURE, V437, P547, DOI 10.1038/nature03950; Wiedermann MM, 2009, NEW PHYTOL, V181, P208, DOI 10.1111/j.1469-8137.2008.02628.x	68	0	1	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161492	10.1371/journal.pone.0161492	http://dx.doi.org/10.1371/journal.pone.0161492			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560190	Green Submitted, gold, Green Published			2022-12-26	WOS:000382258600049
J	Eyer, M; Neumann, P; Dietemann, V				Eyer, Michael; Neumann, Peter; Dietemann, Vincent			A Look into the Cell: Honey Storage in Honey Bees, Apis mellifera	PLOS ONE			English	Article							NECTAR; COLONIES; NEST; EVAPORATION; FORAGERS; HUMIDITY; BROOD	Honey bees, Apis species, obtain carbohydrates from nectar and honeydew. These resources are ripened into honey in wax cells that are capped for long-term storage. These stores are used to overcome dearth periods when foraging is not possible. Despite the economic and ecological importance of honey, little is known about the processes of its production by workers. Here, we monitored the usage of storage cells and the ripening process of honey in free-flying A. mellifera colonies. We provided the colonies with solutions of different sugar concentrations to reflect the natural influx of nectar with varying quality. Since the amount of carbohydrates in a solution affects its density, we used computer tomography to measure the sugar concentration of cell content over time. The data show the occurrence of two cohorts of cells with different provisioning and ripening dynamics. The relocation of the content of many cells before final storage was part of the ripening process, because sugar concentration of the content removed was lower than that of content deposited. The results confirm the mixing of solutions of different concentrations in cells and show that honey is an inhomogeneous matrix. The last stage of ripening occurred when cell capping had already started, indicating a race against water absorption. The storage and ripening processes as well as resource use were context dependent because their dynamics changed with sugar concentration of the food. Our results support hypotheses regarding honey production proposed in earlier studies and provide new insights into the mechanisms involved.	[Eyer, Michael; Neumann, Peter; Dietemann, Vincent] Swiss Bee Res Ctr, Agroscope, Bern, Switzerland; [Eyer, Michael; Neumann, Peter] Univ Bern, Inst Bee Hlth, Vetsuisse Fac, Bern, Switzerland; [Neumann, Peter] Chiang Mai Univ, Dept Biol, Fac Sci, Bee Protect Lab, Chiang Mai, Thailand; [Dietemann, Vincent] Univ Pretoria, Social Insect Res Grp, Dept Zool & Entomol, Pretoria, South Africa	Swiss Federal Research Station Agroscope; University of Bern; Chiang Mai University; University of Pretoria	Eyer, M (corresponding author), Swiss Bee Res Ctr, Agroscope, Bern, Switzerland.; Eyer, M (corresponding author), Univ Bern, Inst Bee Hlth, Vetsuisse Fac, Bern, Switzerland.	michael-eyer@bluewin.ch	Neumann, Peter/C-9964-2015	Neumann, Peter/0000-0001-5163-5215	Vinetum foundation; Sur-La-Croix foundation	Vinetum foundation; Sur-La-Croix foundation	Financial support was granted to ME and PN by the Vinetum foundation. The Sur-La-Croix foundation is also thanked for financially supporting this study via a grant to ME.	[Anonymous], 2021, LANG ENV STAT COMP; Brunner E, 2002, NONPARAMETRIC ANAL L; CAMAZINE S, 1990, J THEOR BIOL, V147, P553, DOI 10.1016/S0022-5193(05)80264-4; Corbet SA, 2003, APIDOLOGIE, V34, P1, DOI 10.1051/apido:2002049; EICKWORT GC, 1980, ANNU REV ENTOMOL, V25, P421, DOI 10.1146/annurev.en.25.010180.002225; Ellis MB, 2010, NATURWISSENSCHAFTEN, V97, P429, DOI 10.1007/s00114-010-0655-1; Eyer M, 2016, INSECT SOC, V63, P51, DOI 10.1007/s00040-015-0432-4; Fabian F., 1928, TECH B AGR EXP STN M, V92, P1; Gallup E, 1868, AM BEE J, V3, P172; Greco M, 2005, J APICULT RES, V44, P97, DOI 10.1080/00218839.2005.11101156; Greco M. K., 2013, Open Journal of Animal Sciences, V3, P210, DOI 10.4236/ojas.2013.33031; Greco MK, 2010, NATURWISSENSCHAFTEN, V97, P319, DOI 10.1007/s00114-009-0631-9; Greenleaf WC, 1933, AM BEE J, V73, P436; Hambleton JI., 1925, USDA DEPT B, V1339, P1; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Hemmerle J, 2011, ABEILLE FRANCE APICU, P27; Human H, 2006, NATURWISSENSCHAFTEN, V93, P397, DOI 10.1007/s00114-006-0117-y; Kleinhenz M, 2003, J EXP BIOL, V206, P4217, DOI 10.1242/jeb.00680; Martin EC, 1939, J ECON ENTOMOL, V32, P660, DOI 10.1093/jee/32.5.660; Maurizio A., 1975, HONEY COMPREHENSIVE, P77; Nicolson SW, 2008, BIOL LETTERS, V4, P299, DOI 10.1098/rsbl.2008.0034; Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12; Park OW, 1933, J ECON ENTOMOL, V26, P188, DOI 10.1093/jee/26.1.188; Park OW, 1928, J ECON ENTOMOL, V21, P882, DOI 10.1093/jee/21.6.882; Park OW, 1927, J ECON ENTOMOL, V20, P510, DOI 10.1093/jee/20.3.510; Park OW, 1949, HIVE HONEY BEE, VIII, P125; Park W, 1925, J ECON ENTOMOL, V18, P405, DOI 10.1093/jee/18.2.405; PERCIVAL MARY S., 1961, NEW PHYTOL, V60, P235, DOI 10.1111/j.1469-8137.1961.tb06255.x; Reinhardt JF, 1939, J ECON ENTOMOL, V32, P654, DOI 10.1093/jee/32.5.654; ROBINSON GE, 1989, BEHAV ECOL SOCIOBIOL, V24, P317, DOI 10.1007/BF00290908; Seeley T., 1995, WISDOM HIVE SOCIAL P; SEELEY TD, 1989, BEHAV ECOL SOCIOBIOL, V24, P181, DOI 10.1007/BF00292101; SEELEY TD, 1986, BEHAV ECOL SOCIOBIOL, V19, P343, DOI 10.1007/BF00295707; Seeley TD, 1985, HONEYBEE ECOLOGY STU; Venables WN., 2002, MODERN APPL STAT S 4; Winston M.L., 1991, BIOL HONEY BEE; Wood W, 1807, ZOOGRAPHY BEAUTIES D	37	18	19	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161059	10.1371/journal.pone.0161059	http://dx.doi.org/10.1371/journal.pone.0161059			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560969	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258600025
J	Park, K; Cho, S; Bower, JK				Park, Kyong; Cho, Sukyung; Bower, Julie K.			Changes in Adherence to Non-Pharmacological Guidelines for Hypertension	PLOS ONE			English	Article							BLOOD-PRESSURE; GLOBAL BURDEN; DISEASE; RISK; AGE; SENSITIVITY; MANAGEMENT; NUTRITION; AWARENESS; MORTALITY	This study aimed to compare levels of adherence to non-pharmacological guidelines between patients with and without hypertension diagnoses, and examined temporal changes in adherence during recent decades. We used data from the Korean National Health and Nutrition Examination Survey (1998-2012), including 13,768 Korean hypertensive patients aged >= 30 years who were categorized according to the presence or absence of a hypertension diagnosis, based on blood pressure and self-reported information. Adherence to the guidelines was calculated for 6 components, including dietary and lifestyle habits. A multivariable generalized linear regression model was used. The proportion of hypertensive patients aware of their condition increased from 33.4% in 1998 to 74.8% in 2012 (p < 0.001), although these increments plateaued during recent survey years. Patients with hypertension diagnoses were older, and more likely to be female, and have lower education levels than those without hypertension diagnoses, for most survey years. Overall adherence levels were poor (mean score 2 of 6), and levels of adherence to non-pharmacological habits did not significantly differ between patients with and without hypertension diagnoses. However, overall adherence levels improved significantly among patients with hypertension diagnoses: from 2.09 in 1998 to 2.27 in 2012 (p = 0.007), particularly regarding sufficient vegetable/seaweed consumption (p = 0.03), maintaining a normal weight (p = 0.03), and avoidance of smoking (p < 0.001). Awareness of hypertension is increasing, but hypertensive Korean patients demonstrate poor overall adherence to non-pharmacological hypertension management guidelines. These findings suggest that well-planned education programs should be continued after hypertension is diagnosed.	[Park, Kyong; Cho, Sukyung] Yeungnam Univ, Dept Food & Nutr, Gyongsan, Gyeongbuk, South Korea; [Bower, Julie K.] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA	Yeungnam University; University System of Ohio; Ohio State University	Park, K (corresponding author), Yeungnam Univ, Dept Food & Nutr, Gyongsan, Gyeongbuk, South Korea.	kypark@ynu.ac.kr	Park, Kyong/AFJ-9812-2022; Park, Kyong/AAF-6888-2022	Park, Kyong/0000-0002-4681-1584; Park, Kyong/0000-0002-4681-1584; cho, sukyung/0000-0003-1401-3067	Basic Science Research Program through the National Research Foundation of Korea (NRF) - the Ministry of Science, ICT & Future Planning [NRF-2014R1A1A3049866]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - the Ministry of Science, ICT & Future Planning	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2014R1A1A3049866). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Ando K, 2012, ANN MED, V44, pS119, DOI 10.3109/07853890.2012.671538; Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083; Bertoia ML, 2014, AM J CLIN NUTR, V99, P344, DOI 10.3945/ajcn.112.056135; Cappuccio FP, 1997, LANCET, V350, P850, DOI 10.1016/S0140-6736(97)02264-2; Cho ES, QUALITY CONTROL ASSU; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Choi YH, 2003, KOREAN J PREV MED, V36, P263; Elliott P., 1991, HYPERTENSION S, V17, pI3; Fung TT, 2008, ARCH INTERN MED, V168, P713, DOI 10.1001/archinte.168.7.713; Gaddam KK, 2009, MED CLIN N AM, V93, P665, DOI 10.1016/j.mcna.2009.02.005; Gardner AW, 2008, J CARDIOPULM REHABIL, V28, P349, DOI 10.1097/HCR.0b013e31818c3b96; Huggins CE, 2011, BRIT J NUTR, V105, P248, DOI 10.1017/S0007114510003223; Jaddou HY, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/828797; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kalyani RR, 2014, LANCET DIABETES ENDO, V2, P819, DOI 10.1016/S2213-8587(14)70034-8; 장동민, 2008, [Health and Social Science, 보건과 사회과학], V24, P43; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; KEYS A, 1973, METABOLISM, V22, P579, DOI 10.1016/0026-0495(73)90071-1; Koo JO, 2012, DIET THERAPY PRINCIP; Korean Nutrition Society, 2011, DIET REF INT KOR 201; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Ministry of Health and Welfare, 2010, DIET GUID DIS MAN, P92; Ministry of Heath and Welfare Korea Centers for Disease Control and Prevention, 2012, KOR HLTH STAT 2012 K; Morimoto A, 1997, LANCET, V350, P1734, DOI 10.1016/S0140-6736(97)05189-1; Oh SW, 2013, J KOREAN MED SCI, V28, P1034, DOI 10.3346/jkms.2013.28.7.1034; Roberts SB, 1998, AM J CLIN NUTR, V68, p975S, DOI 10.1093/ajcn/68.4.975S; ROBERTS SB, 1993, J NUTR, V123, P474, DOI 10.1093/jn/123.suppl_2.474; Rural Development Administration of Korea National Academy of Agricultural Science, 2011, KOR STAND FOOD COMP, P1; Saneei P, 2014, NUTR METAB CARDIOVAS, V24, P1253, DOI 10.1016/j.numecd.2014.06.008; Scheltens T, 2010, J HUM HYPERTENS, V24, P561, DOI 10.1038/jhh.2010.26; So AY, 2008, J KOREAN ACAD NURS, V38, P822, DOI 10.4040/jkan.2008.38.6.822; Wang JG, 2015, PULSE, V3, P14, DOI 10.1159/000382025; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organization, 2000, 200005123054 WHO; World Health Organization, GLOB BRIEF HYP SIL K; World Health Organization, GUID SOD INT AD CHIL; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Yon Miyong, 2011, [Korean Journal of community Nutrition, 대한지역사회영양학회지], V16, P473; Yu DX, 2014, AM J CLIN NUTR, V100, P693, DOI 10.3945/ajcn.113.079194; 정정순, 2014, [The Journal of Korean Academic Society of Nursing Education, 한국간호교육학회지], V20, P321, DOI 10.5977/jkasne.2014.20.2.321	42	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161712	10.1371/journal.pone.0161712	http://dx.doi.org/10.1371/journal.pone.0161712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27561006	gold, Green Published, Green Submitted			2022-12-26	WOS:000382258600085
J	Johnsen, M; Spath, MR; Denzel, MS; Gobel, H; Kubacki, T; Hoyer, KJR; Hinze, Y; Benzing, T; Schermer, B; Antebi, A; Burst, V; Muller, RU				Johnsen, Marc; Spaeth, Martin Richard; Denzel, Martin S.; Goebel, Heike; Kubacki, Torsten; Hoyer, Karla Johanna Ruth; Hinze, Yvonne; Benzing, Thomas; Schermer, Bernhard; Antebi, Adam; Burst, Volker; Mueller, Roman-Ulrich			Oral Supplementation of Glucosamine Fails to Alleviate Acute Kidney Injury in Renal Ischemia-Reperfusion Damage	PLOS ONE			English	Article							TERM DIETARY RESTRICTION; BETA-N-ACETYLGLUCOSAMINE; O-GLCNAC; OXIDATIVE-STRESS; GLCNACYLATION; PATHWAY	Acute kidney injury is a leading contributor to morbidity and mortality in the ageing population. Proteotoxic stress response pathways have been suggested to contribute to the development of acute renal injury. Recent evidence suggests that increased synthesis of N-glycan precursors in the hexosamine pathway as well as feeding of animals with aminosugars produced in the hexosamine pathway may increase stress resistance through reducing proteotoxic stress and alleviate pathology in model organisms. As feeding of the hexosamine pathway metabolite glucosamine to aged mice increased their life expectancy we tested whether supplementation of this aminosugar may also protect mice from acute kidney injury after renal ischemia and reperfusion. Animals were fed for 4 weeks ad libitum with standard chow or standard chow supplemented with 0.5% N-acetylglucosamine. Preconditioning with caloric restriction for four weeks prior to surgery served as a positive control for protective dietary effects. Whereas caloric restriction demonstrated the known protective effect both on renal function as well as survival in the treated animals, glucosamine supplementation failed to promote any protection from ischemia-reperfusion injury. These data show that although hexosamine pathway metabolites have a proven role in enhancing protein quality control and survival in model organisms oral glucosamine supplementation at moderate doses that would be amenable to humans does not promote protection from ischemia-reperfusion injury of the kidney.	[Johnsen, Marc; Spaeth, Martin Richard; Kubacki, Torsten; Hoyer, Karla Johanna Ruth; Benzing, Thomas; Schermer, Bernhard; Burst, Volker; Mueller, Roman-Ulrich] Univ Cologne, Dept Internal Med 2, Kerpener Str 62, D-50937 Cologne, Germany; [Johnsen, Marc; Spaeth, Martin Richard; Kubacki, Torsten; Hoyer, Karla Johanna Ruth; Benzing, Thomas; Schermer, Bernhard; Burst, Volker; Mueller, Roman-Ulrich] Univ Cologne, Ctr Mol Med, Kerpener Str 62, D-50937 Cologne, Germany; [Denzel, Martin S.; Hinze, Yvonne; Antebi, Adam] Max Planck Inst Biol Ageing, Joseph Stelzmann Str 9b, D-50931 Cologne, Germany; [Denzel, Martin S.; Benzing, Thomas; Schermer, Bernhard; Mueller, Roman-Ulrich] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Benzing, Thomas; Schermer, Bernhard; Mueller, Roman-Ulrich] Univ Cologne, Syst Biol Ageing Cologne, Cologne, Germany; [Goebel, Heike] Univ Cologne, Inst Pathol, Diagnost & Expt Nephropathol Unit, Cologne, Germany	University of Cologne; University of Cologne; Max Planck Society; University of Cologne; University of Cologne; University of Cologne	Burst, V; Muller, RU (corresponding author), Univ Cologne, Dept Internal Med 2, Kerpener Str 62, D-50937 Cologne, Germany.; Burst, V; Muller, RU (corresponding author), Univ Cologne, Ctr Mol Med, Kerpener Str 62, D-50937 Cologne, Germany.; Muller, RU (corresponding author), Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.; Muller, RU (corresponding author), Univ Cologne, Syst Biol Ageing Cologne, Cologne, Germany.	volker.burst@uk-koeln.de; roman-ulrich.mueller@uk-koeln.de	Schermer, Bernhard/E-9972-2014; Benzing, Thomas/X-5476-2019; Müller, Roman-Ulrich/AAK-3493-2021; Denzel, Martin/C-9047-2014	Schermer, Bernhard/0000-0002-5194-9000; Müller, Roman-Ulrich/0000-0001-6910-0745; Denzel, Martin/0000-0002-5691-3349; Goebel, Heike/0000-0002-0171-7025	BMBF SyBACol; MIWF Nachwuchsgruppen.NRW; Deutsche Nierenstiftung	BMBF SyBACol; MIWF Nachwuchsgruppen.NRW; Deutsche Nierenstiftung	This work was supported by BMBF SyBACol, https://www.bmbf.de/; MIWF Nachwuchsgruppen.NRW, http://www.wissenschaft.nrw.de/; Deutsche Nierenstiftung, http://nierenstiftung.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma K, 2012, INFLAMMATION, V35, P1462, DOI 10.1007/s10753-012-9459-0; Banerjee PS, 2015, P NATL ACAD SCI USA, V112, P6050, DOI 10.1073/pnas.1424017112; Bernhardt WM, 2006, J AM SOC NEPHROL, V17, P1970, DOI 10.1681/ASN.2005121302; Chen YJ, 2015, INVEST OPHTH VIS SCI, V56, P1506, DOI 10.1167/iovs.14-15726; Denzel MS, 2014, CELL, V156, P1167, DOI 10.1016/j.cell.2014.01.061; Ferrer CM, 2014, MOL CELL, V54, P820, DOI 10.1016/j.molcel.2014.04.026; Fouque A, 2014, BBA-REV CANCER, V1846, P130, DOI 10.1016/j.bbcan.2014.04.007; Goujon JM, 1999, J SURG RES, V82, P228, DOI 10.1006/jsre.1998.5526; Grigorian A, 2011, J BIOL CHEM, V286, P40133, DOI 10.1074/jbc.M111.277814; Hwang SY, 2010, GLIA, V58, P1881, DOI 10.1002/glia.21058; Jensen RV, 2013, SCAND CARDIOVASC J, V47, P168, DOI 10.3109/14017431.2012.756984; Jones SP, 2008, CIRCULATION, V117, P1172, DOI 10.1161/CIRCULATIONAHA.107.730515; Khan NA, 2009, NEPHROL DIAL TRANSPL, V24, P2701, DOI 10.1093/ndt/gfp369; Lempiainen J, 2013, ACTA PHYSIOL, V208, P410, DOI 10.1111/apha.12120; Lima VV, 2008, J AM SOC HYPERTENS, V2, P410, DOI 10.1016/j.jash.2008.06.001; Liu J, 2007, J MOL CELL CARDIOL, V42, P177, DOI 10.1016/j.yjmcc.2006.09.015; Medford HM, 2012, LIFE SCI, V90, P883, DOI 10.1016/j.lfs.2012.04.030; Mehta R, 2009, SCIENCE, V324, P1196, DOI 10.1126/science.1173507; Mitchell JR, 2010, AGING CELL, V9, P40, DOI 10.1111/j.1474-9726.2009.00532.x; Muller RU, 2009, J AM SOC NEPHROL, V20, P2513, DOI 10.1681/ASN.2009050497; Ngoh GA, 2011, AMINO ACIDS, V40, P895, DOI 10.1007/s00726-010-0728-7; Parodi AJ, 2000, BIOCHEM J, V348, P1, DOI 10.1042/0264-6021:3480001; Rewa O, 2014, NAT REV NEPHROL, V10, P193, DOI 10.1038/nrneph.2013.282; Robertson LT, 2013, EXP GERONTOL, V48, P1043, DOI 10.1016/j.exger.2013.01.009; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Shatnyeva OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019927; Takahashi M, 2009, FOOD CHEM TOXICOL, V47, P462, DOI 10.1016/j.fct.2008.12.002; Tirapelli LF, 2009, TRANSPL P, V41, P4083, DOI 10.1016/j.transproceed.2009.09.061; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wang ZV, 2014, CELL, V156, P1179, DOI 10.1016/j.cell.2014.01.014; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Weimer S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4563; Zachara NE, 2012, AM J PHYSIOL-HEART C, V302, pH1905, DOI 10.1152/ajpheart.00445.2011; Zhang GX, 2005, J IMMUNOL, V175, P7202, DOI 10.4049/jimmunol.175.11.7202; Zhu YP, 2014, J BIOL CHEM, V289, P34472, DOI 10.1074/jbc.R114.601351; Zou LY, 2009, AM J PHYSIOL-HEART C, V296, pH515, DOI 10.1152/ajpheart.01025.2008	36	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161315	10.1371/journal.pone.0161315	http://dx.doi.org/10.1371/journal.pone.0161315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27557097	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258100035
J	Palacio, L; Krishnan, V; Le, NLO; Sharpless, NE; Beausejour, CM				Palacio, L.; Krishnan, V.; Le, N. L. O.; Sharpless, N. E.; Beausejour, C. M.			Sustained p16(INK4a) expression is required to prevent IR-induced tumorigenesis in mice	ONCOGENE			English	Article							HEMATOPOIETIC STEM-CELLS; SENESCENT CELLS; CELLULAR SENESCENCE; TUMOR SUPPRESSION; DNA-DAMAGE; LIFE-SPAN; IN-VIVO; P53; FIBROBLASTS; PROGRESSION	Exposure of murine and human tissues to ionizing radiation (IR) induces the expression of p16(INK4a), a tumor suppressor gene and senescence/aging biomarker. Increased p16(INK4a) expression is often delayed several weeks post exposure to IR. In this context, it remains unclear if it occurs to suppress aberrant cellular growth of potentially transformed cells or is simply a result of IR-induced loss of tissue homeostasis. To address this question, we used a conditional p16(INK4a) null mouse model and determined the impact of p16(INK4a) inactivation long-term post exposure to IR. We found that, in vitro, bone marrow stromal cells exposed to IR enter DNA replication following p16(INK4a) inactivation. However, these cells did not resume growth; instead, they mostly underwent cell cycle arrest in G2. Similarly, delayed inactivation of p16(INK4a) in mice several weeks post exposure to IR resulted in increased BrdU incorporation and cancer incidence. In fact, we found that the onset of tumorigenesis was similar whether p16(INK4a) was inactivated before or after exposure to IR. Overall, our results suggest that IR-induced p16(INK4a) dependent growth arrest is reversible in mice and that sustained p16(INK4a) expression is necessary to protect against tumorigenesis.	[Palacio, L.; Krishnan, V.; Le, N. L. O.; Beausejour, C. M.] Ctr Hosp Univ Ste Justine, Ctr Rech, Montreal, PQ, Canada; [Palacio, L.; Krishnan, V.; Beausejour, C. M.] Univ Montreal, Dept Pharmacol, Montreal, PQ, Canada; [Sharpless, N. E.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA; [Sharpless, N. E.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC USA	Universite de Montreal; Universite de Montreal; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Beausejour, CM (corresponding author), Ctr Hosp Univ Ste Justine, 3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	christian.beausejour@recherche-ste-justine.qc.ca	Krishnan, Vimal/AAP-1616-2020		Canadian Institute of Health Research [MOP-341566]; Fondation des Etoiles; Fonds de recherche du Quebec - Sante; NATIONAL INSTITUTE ON AGING [R01AG024379] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Fondation des Etoiles; Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to the members of Dr Elie Haddad's laboratory, flow cytometry and animal facility for providing technical support. We also would like to thank Dr Francis Rodier and Mohamad El-Ariss for the critical reading of the manuscript. This work was supported by a grant from the Canadian Institute of Health Research #MOP-341566 to CMB LP has been supported by a student fellowship from the Fondation des Etoiles. CMB is supported by a scientist award from the Fonds de recherche du Quebec - Sante.	Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Burd CE, 2013, CELL, V152, P340, DOI 10.1016/j.cell.2012.12.010; Carbonneau CL, 2012, BLOOD, V119, P717, DOI 10.1182/blood-2011-06-361626; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Hinkal G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006654; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Johmura Y, 2014, MOL CELL, V55, P73, DOI 10.1016/j.molcel.2014.05.003; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Le ONL, 2010, AGING CELL, V9, P398, DOI 10.1111/j.1474-9726.2010.00567.x; Marcoux S, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-252; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113; Sanoff HK, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju057; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sorrentino JA, 2014, J CLIN INVEST, V124, P169, DOI 10.1172/JCI70960; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Stein GH, 1999, MOL CELL BIOL, V19, P2109; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Yamakoshi K, 2009, J CELL BIOL, V186, P393, DOI 10.1083/jcb.200904105; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	33	6	6	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	9					1309	1314		10.1038/onc.2016.298	http://dx.doi.org/10.1038/onc.2016.298			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EN2SV	27568978	Green Accepted, Green Submitted			2022-12-26	WOS:000395861300014
J	Gong, JJ; Belinsky, G; Sagheer, U; Zhang, XC; Grippo, PJ; Chung, CH				Gong, Jingjing; Belinsky, Glenn; Sagheer, Usman; Zhang, Xuchen; Grippo, Paul J.; Chung, Chuhan			Pigment Epithelium-derived Factor (PEDF) Blocks Wnt3a Protein-induced Autophagy in Pancreatic Intraepithelial Neoplasms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; catalase; NFB (NFB); pancreas; superoxide dismutase (SOD); PEDF	NF-KAPPA-B; CANCER-CELLS; OXIDATIVE STRESS; TARGET GENES; EXPRESSION; MICE; ADENOCARCINOMA; DEATH; KRAS; CARCINOGENESIS	An increase in autophagy characterizes pancreatic carcinogenesis, but the signals that regulate this process are incompletely understood. Because canonical Wnt/-catenin signaling is necessary for the transition from early to advanced pancreatic intraepithelial neoplasia (PanIN) lesions, we assessed whether Wnt ligands and endogenous inhibitors of Wnt signaling modulate autophagy. In this study, canonical Wnt3a ligand induced autophagy markers and vacuoles in murine PanIN cells. Furthermore, pigment epithelium-derived factor (PEDF), a secreted glycoprotein known for its anti-tumor properties, blocked Wnt3a-directed induction of autophagy proteins. Autophagy inhibition was complemented by reciprocal regulation of the oxidative stress enzymes, superoxide dismutase 2 (SOD2) and catalase. Transcriptional control of Sod2 expression was mediated by PEDF-induced NFB nuclear translocation. PEDF-dependent SOD2 expression in PanIN lesions was recapitulated in a murine model of PanIN formation where PEDF was deleted. In human PanIN lesions, co-expression of PEDF and SOD2 was observed in the majority of early PanIN lesions (47/50, 94%), whereas PEDF and SOD2 immunolocalization in high-grade human PanIN-2/3 was uncommon (7/50, 14%). These results indicate that PEDF regulates autophagy through coordinate Wnt signaling blockade and NFB activation.	[Gong, Jingjing; Belinsky, Glenn; Chung, Chuhan] Yale Univ, Sch Med, Dept Med, 333 Cedar St, New Haven, CT 06520 USA; [Zhang, Xuchen] Yale Univ, Sch Med, Dept Pathol, 333 Cedar St, New Haven, CT 06520 USA; [Grippo, Paul J.] Univ Illinois, Dept Med, Sch Med, Chicago, IL 60612 USA; [Sagheer, Usman; Zhang, Xuchen; Chung, Chuhan] Vet Affairs Connecticut Healthcare Syst, West Haven, CT 06516 USA	Yale University; Yale University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Chung, CH (corresponding author), Yale Univ, Dept Med, Sch Med, Sect Digest Dis, New Haven, CT 06520 USA.	chuhan.chung@yale.edu	zhang, xu/GYE-3558-2022	Zhang, Xuchen/0000-0002-1484-4672; Chung, Chuhan/0000-0003-2803-6745	National Institutes of Health [R21AA023607]; National Institutes of Health Liver Center Core Grant [DK34989]; Veterans Affairs Merit Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA023607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Liver Center Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Grant(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health Grant R21AA023607, National Institutes of Health Liver Center Core Grant DK34989, and a Veterans Affairs Merit Grant (to C. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al Saati T, 2013, AM J PATHOL, V182, P1996, DOI 10.1016/j.ajpath.2013.02.034; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Becerra SP, 2013, NAT REV CANCER, V13, P258, DOI 10.1038/nrc3484; Becker J, 2011, AM J HUM GENET, V88, P362, DOI 10.1016/j.ajhg.2011.01.015; Chung CH, 2009, GASTROENTEROLOGY, V136, P331, DOI 10.1053/j.gastro.2008.09.065; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Du Q, 2009, CANCER RES, V69, P3764, DOI 10.1158/0008-5472.CAN-09-0014; Fujii S, 2008, CANCER SCI, V99, P1813, DOI 10.1111/j.1349-7006.2008.00893.x; Garg AD, 2013, AUTOPHAGY, V9, P1292, DOI 10.4161/auto.25399; Gattu AK, 2013, FASEB J, V27, P4384, DOI 10.1096/fj.13-232900; Gibson SB, 2010, AUTOPHAGY, V6, P835, DOI 10.4161/auto.6.7.13335; Gong JJ, 2014, ONCOTARGET, V5, P2529, DOI 10.18632/oncotarget.1810; Grippo PJ, 2012, GUT, V61, P1454, DOI 10.1136/gutjnl-2011-300821; Gukovsky I, 2013, GASTROENTEROLOGY, V144, P1199, DOI 10.1053/j.gastro.2013.02.007; Hase R, 2005, CLIN CANCER RES, V11, P8737, DOI 10.1158/1078-0432.CCR-05-1323; Ho TC, 2007, CARDIOVASC RES, V76, P213, DOI 10.1016/j.cardiores.2007.06.032; Ho TC, 2011, J BIOL CHEM, V286, P35943, DOI 10.1074/jbc.M111.266064; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Li F, 2015, J CELL PHYSIOL, V230, P1243, DOI 10.1002/jcp.24859; Libby RT, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-108; Liou GY, 2016, CELL REP, V14, P2325, DOI 10.1016/j.celrep.2016.02.029; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Ma B, 2015, J CELL SCI, V128, P2430, DOI 10.1242/jcs.168542; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Park K, 2011, MOL CELL BIOL, V31, P3038, DOI 10.1128/MCB.01211-10; Philip B, 2013, GASTROENTEROLOGY, V145, P1449, DOI 10.1053/j.gastro.2013.08.018; Principe DR, 2016, ONCOTARGET, V7, P28218, DOI 10.18632/oncotarget.8587; Protiva P, 2015, CELL MOL GASTROENTER, V1, P535, DOI 10.1016/j.jcmgh.2015.06.006; Qi WW, 2015, DIABETES, V64, P1407, DOI 10.2337/db14-1111; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Rao CV, 2012, NEOPLASIA, V14, P778, DOI 10.1593/neo.121026; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Sreekumar BK, 2014, PANCREAS, V43, P1256, DOI 10.1097/MPA.0000000000000201; Takada Y, 2003, J BIOL CHEM, V278, P24233, DOI 10.1074/jbc.M212389200; Uehara H, 2004, CANCER RES, V64, P3533, DOI 10.1158/0008-5472.CAN-03-3725; WANG ZW, 2011, NAT REV GASTRO HEPAT, V8, P27, DOI [DOI 10.1038/nrgastro.2010.188, DOI 10.1038/NRGASTRO.2010.188]; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wheatley-Price P, 2008, CANCER-AM CANCER SOC, V112, P1037, DOI 10.1002/cncr.23267; White E, 2015, J CLIN INVEST, V125, P42, DOI 10.1172/JCI73941; Williams JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043961; Yabe T, 2001, J BIOL CHEM, V276, P43313, DOI 10.1074/jbc.M107831200; Yang SH, 2011, AUTOPHAGY, V7, P912, DOI 10.4161/auto.7.8.15762; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yoon JC, 2010, GENE DEV, V24, P1507, DOI 10.1101/gad.1924910; Zhang YQ, 2013, CANCER RES, V73, P4909, DOI 10.1158/0008-5472.CAN-12-4384	47	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22074	22085		10.1074/jbc.M116.729962	http://dx.doi.org/10.1074/jbc.M116.729962			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27557659	Green Published, hybrid			2022-12-26	WOS:000386332600022
J	Pei, SS; Minhajuddin, M; D'Alessandro, A; Nemkov, T; Stevens, BM; Adane, B; Khan, N; Hagen, FK; Yadav, VK; De, S; Ashton, JM; Hansen, KC; Gutman, JA; Pollyea, DA; Crooks, PA; Smith, C; Jordan, CT				Pei, Shanshan; Minhajuddin, Mohammad; D'Alessandro, Angelo; Nemkov, Travis; Stevens, Brett M.; Adane, Biniam; Khan, Nabilah; Hagen, Fred K.; Yadav, Vinod K.; De, Subhajyoti; Ashton, John M.; Hansen, Kirk C.; Gutman, Jonathan A.; Pollyea, Daniel A.; Crooks, Peter A.; Smith, Clayton; Jordan, Craig T.			Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anticancer drug; drug development; drug resistance; endoplasmic reticulum stress (ER stress); leukemia; oxidative stress; 2-deoxyglucose; drug combination; parthenolide; temsirolimus	ACUTE MYELOID-LEUKEMIA; NF-KAPPA-B; SESQUITERPENE LACTONES; PROGENITOR CELLS; HUMAN CANCERS; EXPRESSION; INHIBITION; STRESS; HETEROGENEITY; PROTEOSTASIS	Although multidrug approaches to cancer therapy are common, few strategies are based on rigorous scientific principles. Rather, drug combinations are largely dictated by empirical or clinical parameters. In the present study we developed a strategy for rational design of a regimen that selectively targets human acute myelogenous leukemia (AML) stem cells. As a starting point, we used parthenolide, an agent shown to target critical mechanisms of redox balance in primary AML cells. Next, using proteomic, genomic, and metabolomic methods, we determined that treatment with parthenolide leads to induction of compensatory mechanisms that include up-regulated NADPH production via the pentose phosphate pathway as well as activation of the Nrf2-mediated oxidative stress response pathway. Using this knowledge we identified 2-deoxyglucose and temsirolimus as agents that can be added to a parthenolide regimen as a means to inhibit such compensatory events and thereby further enhance eradication of AML cells. We demonstrate that the parthenolide, 2-deoxyglucose, temsirolimus (termed PDT) regimen is a potent means of targeting AML stem cells but has little to no effect on normal stem cells. Taken together our findings illustrate a comprehensive approach to designing combination anticancer drug regimens.	[Pei, Shanshan; Minhajuddin, Mohammad; Stevens, Brett M.; Adane, Biniam; Khan, Nabilah; Gutman, Jonathan A.; Pollyea, Daniel A.; Smith, Clayton; Jordan, Craig T.] Univ Colorado Denver, Div Hematol, Aurora, CO 80045 USA; [D'Alessandro, Angelo; Nemkov, Travis; Hansen, Kirk C.] Univ Colorado Denver, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Hagen, Fred K.] Univ Rochester, Dept Biochem & Biophys, 601 Elmwood Ave, Rochester, NY 14642 USA; [Ashton, John M.] Univ Rochester, Dept Microbiol & Immunol, 601 Elmwood Ave, Rochester, NY 14642 USA; [Yadav, Vinod K.; De, Subhajyoti] Univ Colorado, Dept Med, Sch Med, Aurora, CO 80045 USA; [Crooks, Peter A.] Univ Arkansas, Dept Pharmaceut Sci, Little Rock, AR 72205 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Rochester; University of Rochester; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock	Jordan, CT (corresponding author), Univ Colorado, Anschutz Med Campus,12700 E 19th Ave,Rm 10016, Aurora, CO 80045 USA.	craig.jordan@ucdenver.edu	PEI, SHANSHAN/D-8200-2016; Stevens, Brett/AAL-1800-2021; Minhajuddin, Mohammad/AAC-9227-2022; D'Alessandro, Angelo/AAA-4695-2019; jordan, craig/D-7666-2014	PEI, SHANSHAN/0000-0001-9619-2614; D'Alessandro, Angelo/0000-0002-2258-6490; jordan, craig/0000-0003-0869-3465; Ashton, John/0000-0001-9875-5994	National Institutes of Health [R01 CA158275, R33 CA183685]; Leukemia and Lymphoma Society [TRP 6230-11, 6133-12]; NATIONAL CANCER INSTITUTE [R01CA158275, R33CA183685, T32CA082086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA158275 (to P. A. C.) and R33 CA183685 (to K. C. H.). This work was also supported by Leukemia and Lymphoma Society Grants TRP 6230-11 and 6133-12 (to C. T. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aiken CT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006924; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bork PM, 1997, FEBS LETT, V402, P85, DOI 10.1016/S0014-5793(96)01502-5; Buescher JM, 2015, CURR OPIN BIOTECH, V34, P189, DOI 10.1016/j.copbio.2015.02.003; Catenacci DVT, 2015, MOL ONCOL, V9, P967, DOI 10.1016/j.molonc.2014.09.011; D'Alessandro A, 2015, TRANSFUSION, V55, P1155, DOI 10.1111/trf.12975; D'Alessandro A, 2014, ONCOTARGET, V5, P7722, DOI 10.18632/oncotarget.2300; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Engreitz JM, 2010, J BIOMED INFORM, V43, P932, DOI 10.1016/j.jbi.2010.07.001; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Er TK, 2007, CLIN BIOCHEM, V40, P1015, DOI 10.1016/j.clinbiochem.2007.05.013; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Ghantous A, 2013, DRUG DISCOV TODAY, V18, P894, DOI 10.1016/j.drudis.2013.05.005; Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Guzman ML, 2007, BLOOD, V110, P4427, DOI 10.1182/blood-2007-05-090621; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hassane DC, 2008, BLOOD, V111, P5654, DOI 10.1182/blood-2007-11-126003; Hassane DC, 2010, BLOOD, V116, P5983, DOI 10.1182/blood-2010-04-278044; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Hoey T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001056; Jhaveri K, 2012, BBA-MOL CELL RES, V1823, P742, DOI 10.1016/j.bbamcr.2011.10.008; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Jin LQ, 2009, CELL STEM CELL, V5, P31, DOI 10.1016/j.stem.2009.04.018; Jordan CT, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000914; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kikushige Y, 2010, CELL STEM CELL, V7, P708, DOI 10.1016/j.stem.2010.11.014; Krause DS, 1996, BLOOD, V87, P1; Kwok BHB, 2001, CHEM BIOL, V8, P759, DOI 10.1016/S1074-5521(01)00049-7; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Marcucci G, 2011, J CLIN ONCOL, V29, P475, DOI 10.1200/JCO.2010.30.2554; Mathema VB, 2012, INFLAMMATION, V35, P560, DOI 10.1007/s10753-011-9346-0; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Minhajuddin M, 2005, J IMMUNOL, V174, P5823, DOI 10.4049/jimmunol.174.9.5823; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Nasim S, 2011, BIOORGAN MED CHEM, V19, P1515, DOI 10.1016/j.bmc.2010.12.045; Nemkov T, 2015, AMINO ACIDS, V47, P2345, DOI 10.1007/s00726-015-2019-9; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Pei SS, 2013, J BIOL CHEM, V288, P33542, DOI 10.1074/jbc.M113.511170; Ralser M, 2008, P NATL ACAD SCI USA, V105, P17807, DOI 10.1073/pnas.0803090105; Sahasrabuddhe AA, 2015, IMMUNOL REV, V263, P224, DOI 10.1111/imr.12236; Salk JJ, 2010, ANNU REV PATHOL-MECH, V5, P51, DOI 10.1146/annurev-pathol-121808-102113; Sallmyr A, 2008, CANCER LETT, V270, P1, DOI 10.1016/j.canlet.2008.03.036; Sallmyr A, 2008, BLOOD, V111, P3173, DOI 10.1182/blood-2007-05-092510; Samudio I, 2010, J CLIN INVEST, V120, P142, DOI 10.1172/JCI38942; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Spaans SK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00742; Stincone A, 2015, BIOL REV, V90, P927, DOI 10.1111/brv.12140; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan BT, 2006, LAB INVEST, V86, P1203, DOI 10.1038/labinvest.3700488; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Zhang Q, 2012, J MED CHEM, V55, P8757, DOI 10.1021/jm301064b; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	60	26	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21984	22000		10.1074/jbc.M116.750653	http://dx.doi.org/10.1074/jbc.M116.750653			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27573247	hybrid, Green Published			2022-12-26	WOS:000386332600014
J	Qin, XK; Wang, YL; Paudel, HK				Qin, Xike; Wang, Yunling; Paudel, Hemant K.			Early Growth Response 1 (Egr-1) Is a Transcriptional Activator of beta-Secretase 1 (BACE-1) in the Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid-beta (A); early growth response protein 1 (EGR1); gene regulation; neuroscience; promoter; transcription factor	ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; A-BETA; SYNAPTIC PLASTICITY; PRESENILIN-2 GENE; PROMOTER ACTIVITY; PEPTIDE LEVELS; EXPRESSION; PROTEIN; STRESS	Accumulation of amyloid- peptide (A) in the brain is regarded as central to Alzheimer's disease (AD) pathogenesis. A is generated by a sequential cleavage of amyloid precursor protein (APP) by -secretase 1 (BACE-1) followed by -secretase. BACE-1 cleavage of APP is the committed step in A synthesis. Understanding the mechanism by which BACE-1 is activated leading to A synthesis in the brain can provide better understanding of AD pathology and help to develop novel therapies. In this study, we found that the levels of A and BACE-1 are significantly reduced in the brains of mice lacking transcription factor early growth response 1 (Egr-1) when compared with the WT. We demonstrate that in COS-7 cells, Egr-1 binds to the BACE-1 promoter and activates BACE-1 transcription. In rat hippocampal primary neurons, overexpression of Egr-1 induces BACE-1 expression, activates BACE-1, promotes amyloidogenic APP processing, and enhances A synthesis. In mouse hippocampal primary neurons, knockdown of BACE-1 almost completely blocks Egr-1-induced amyloidogenic APP processing and A synthesis. Our data indicate that Egr-1 promotes A synthesis via transcriptional activation of BACE-1 and suggest that Egr-1 plays role in activation of BACE-1 and acceleration of A synthesis in AD brain. Egr-1 is a potential therapeutic target for AD.	[Qin, Xike; Wang, Yunling; Paudel, Hemant K.] Jewish Gen Hosp, Lady Davis Inst Med Res, 3755 Cote Ste Catherine, Montreal, PQ H3T 1E2, Canada; [Paudel, Hemant K.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H4H 1R3, Canada	Lady Davis Institute; McGill University; McGill University	Paudel, HK (corresponding author), Jewish Gen Hosp, Lady Davis Inst Med Res, 3755 Cote Ste Catherine, Montreal, PQ H3T 1E2, Canada.	hemant.paudel@mcgill.ca			Canadian Institute for Health Research; Alzheimer's Society of Canada	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer's Society of Canada	This work was supported by grants from Canadian Institute for Health Research and Alzheimer's Society of Canada. The authors declare that they have no conflicts of interest with the contents of this article.	Bakalash S, 2011, INVEST OPHTH VIS SCI, V52, P9033, DOI 10.1167/iovs.11-7498; Beckmann AM, 1997, NEUROCHEM INT, V31, P477, DOI 10.1016/S0197-0186(96)00136-2; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Bourne KZ, 2007, J NEUROSCI RES, V85, P1194, DOI 10.1002/jnr.21252; Chami L, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-52; Christensen MA, 2004, MOL CELL BIOL, V24, P865, DOI 10.1128/MCB.24.2.865-874.2004; Chu J, 2012, ANN NEUROL, V71, P57, DOI 10.1002/ana.22625; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Cole SL, 2009, NEUROBIOL AGING, V30, P1535, DOI 10.1016/j.neurobiolaging.2007.12.012; Coma M, 2008, NEUROBIOL AGING, V29, P969, DOI 10.1016/j.neurobiolaging.2007.01.009; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Fukumoto H, 2004, AM J PATHOL, V164, P719, DOI 10.1016/S0002-9440(10)63159-8; Gatta V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.11; Ravetti MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010153; Hardy J, 2014, J INTERN MED, V275, P296, DOI 10.1111/joim.12192; Harja E, 2004, CIRC RES, V94, P333, DOI 10.1161/01.RES.0000112405.61577.95; Hendrickx A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074305; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; James AB, 2006, J NEUROSCI, V26, P1624, DOI 10.1523/JNEUROSCI.4199-05.2006; Kam TI, 2013, J CLIN INVEST, V123, P2791, DOI 10.1172/JCI66827; Khachigian LM, 2006, CIRC RES, V98, P186, DOI 10.1161/01.RES.0000200177.53882.c3; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; Killick R, 2014, MOL PSYCHIATR, V19, P88, DOI 10.1038/mp.2012.163; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Knapska E, 2004, PROG NEUROBIOL, V74, P183, DOI 10.1016/j.pneurobio.2004.05.007; Kubosaki A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r41; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Lu YF, 2011, J BIOL CHEM, V286, P20569, DOI 10.1074/jbc.M111.220962; MacGibbon GA, 1997, EXP NEUROL, V147, P316, DOI 10.1006/exnr.1997.6600; Marwarha G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070773; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Mokin M, 2006, J NEUROPHYSIOL, V95, P215, DOI 10.1152/jn.00737.2005; Mukherjee A, 2002, J ALZHEIMERS DIS, V4, P341, DOI 10.3233/JAD-2002-4501; Nowak K, 2006, J NEUROCHEM, V96, P1696, DOI 10.1111/j.1471-4159.2006.03692.x; Ounallah-Saad H, 2009, GENE, V446, P81, DOI 10.1016/j.gene.2009.06.015; Piccini A, 2012, J NEUROCHEM, V122, P1023, DOI 10.1111/j.1471-4159.2012.07834.x; Qin XK, 2015, J BIOL CHEM, V290, P29603, DOI 10.1074/jbc.M115.668889; Renbaum P, 2003, GENE, V318, P113, DOI 10.1016/S0378-1119(03)00766-2; Rossner S, 2006, PROG NEUROBIOL, V79, P95, DOI 10.1016/j.pneurobio.2006.06.001; Salon ML, 2003, EXP NEUROL, V180, P131, DOI 10.1016/S0014-4886(02)00060-2; Sastre M, 2006, P NATL ACAD SCI USA, V103, P443, DOI 10.1073/pnas.0503839103; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Stanzione R, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.370; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Tong Y, 2005, J NEURAL TRANSM, V112, P455, DOI 10.1007/s00702-004-0255-3; Tyler SJ, 2002, BIOCHEM BIOPH RES CO, V299, P373, DOI 10.1016/S0006-291X(02)02635-9; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Wen Y, 2004, BRAIN RES, V1009, P1, DOI 10.1016/j.brainres.2003.09.086; Woodard-Grice AV, 2008, J BIOL CHEM, V283, P26364, DOI 10.1074/jbc.M800836200; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007; Zimmerman SM, 2014, AGING CELL, V13, P329, DOI 10.1111/acel.12179	61	22	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22276	22287		10.1074/jbc.M116.738849	http://dx.doi.org/10.1074/jbc.M116.738849			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27576688	hybrid, Green Published			2022-12-26	WOS:000386332600038
J	Sun, M; Cai, JY; Anderson, RA; Sun, Y				Sun, Ming; Cai, Jinyang; Anderson, Richard A.; Sun, Yue			Type I Phosphatidylinositol Phosphate 5-Kinase i5 Controls the Ubiquitination and Degradation of the Tumor Suppressor Mitogen-inducible Gene 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; E3 ubiquitin ligase; epidermal growth factor receptor (EGFR); phosphatidylinositol phosphatase; ubiquitylation (ubiquitination); Mig6; NEDD4-1; PIPKIi5; tumor suppressor	GROWTH-FACTOR RECEPTOR; EGF RECEPTOR; LUNG-CANCER; CELL-MIGRATION; KINASE DOMAIN; ENDOGENOUS INHIBITOR; NEGATIVE REGULATOR; DOWN-REGULATION; C2 DOMAIN; GAMMA	Mitogen-inducible gene 6 (Mig6) is a tumor suppressor, and the disruption of Mig6 expression is associated with cancer development. Mig6 directly interacts with epidermal growth factor receptor (EGFR) to suppress the activation and downstream signaling of EGFR. Therefore, loss of Mig6 enhances EGFR-mediated signaling and promotes EGFR-dependent carcinogenesis. The molecular mechanism modulating Mig6 expression in cancer remains unclear. Here we demonstrate that type I phosphatidylinositol phosphate 5-kinase i5 (PIPKIi5), an enzyme producing phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2), stabilizes Mig6 expression. Knockdown of PIPKIi5 leads to the loss of Mig6 expression, which dramatically enhances and prolongs EGFR-mediated cell signaling. Loss of PIPKIi5 significantly promotes Mig6 protein degradation via proteasomes, but it does not affect the Mig6 mRNA level. PIPKIi5 directly interacts with the E3 ubiquitin ligase neuronal precursor cell-expressed developmentally down-regulated 4-1 (NEDD4-1). The C-terminal domain of PIPKIi5 and the WW1 and WW2 domains of NEDD4-1 are required for their interaction. The C2 domain of NEDD4-1 is required for its interaction with PtdIns(4,5)P-2. By binding with NEDD4-1 and producing PtdIns(4,5)P-2, PIPKIi5 perturbs NEDD4-1-mediated Mig6 ubiquitination and the subsequent proteasomal degradation. Thus, loss of NEDD4-1 can rescue Mig6 expression in PIPKIi5 knockdown cells. In this way, PIPKIi5, NEDD4-1, and Mig6 form a novel molecular nexus that controls EGFR activation and downstream signaling.	[Sun, Ming; Cai, Jinyang; Sun, Yue] Virginia Commonwealth Univ, Philips Inst Oral Hlth Res, Sch Dent, 4154 Perkinson Bldg,1101 E Leigh St,POB 980566, Richmond, VA 23298 USA; [Sun, Ming; Cai, Jinyang; Sun, Yue] Virginia Commonwealth Univ, Philips Inst Oral Hlth Res, Massey Canc Ctr, 4154 Perkinson Bldg,1101 E Leigh St,POB 980566, Richmond, VA 23298 USA; [Anderson, Richard A.] Univ Wisconsin, Sch Med & Publ Hlth, Mol & Cellular Pharmacol Program, Madison, WI 53706 USA	Virginia Commonwealth University; Virginia Commonwealth University; University of Wisconsin System; University of Wisconsin Madison	Sun, Y (corresponding author), Virginia Commonwealth Univ, Philips Inst Oral Hlth Res, Sch Dent, 4154 Perkinson Bldg,1101 E Leigh St,POB 980566, Richmond, VA 23298 USA.; Sun, Y (corresponding author), Virginia Commonwealth Univ, Philips Inst Oral Hlth Res, Massey Canc Ctr, 4154 Perkinson Bldg,1101 E Leigh St,POB 980566, Richmond, VA 23298 USA.	ysun4@vcu.edu	Cai, Jinyang/HCH-0290-2022	Anderson, Richard/0000-0001-6265-8359; Cai, Jinyang/0000-0002-7385-8281	Scientist Development Grant from the American Heart Association [12SDG11950022]; Institutional Research Grant from the American Cancer Society [IRG-14-192-40]	Scientist Development Grant from the American Heart Association(American Heart Association); Institutional Research Grant from the American Cancer Society	This work was supported by Scientist Development Grant 12SDG11950022 from the American Heart Association and Institutional Research Grant IRG-14-192-40 from the American Cancer Society. The authors declare that they have no conflicts of interest with the contents of this article.	Amodio N, 2010, AM J PATHOL, V177, P2622, DOI 10.2353/ajpath.2010.091075; Anastasi S, 2005, ONCOGENE, V24, P4540, DOI 10.1038/sj.onc.1208658; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Carpenter G, 2009, EXP CELL RES, V315, P1556, DOI 10.1016/j.yexcr.2008.09.027; Casalini P, 2004, J CELL PHYSIOL, V200, P343, DOI 10.1002/jcp.20007; Chen C, 2015, ONCOGENE, V34, P4635, DOI 10.1038/onc.2014.393; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Eden ER, 2009, BIOCHEM SOC T, V37, P173, DOI 10.1042/BST0370173; Elkin SK, 2005, J BIOL CHEM, V280, P28701, DOI 10.1074/jbc.M504731200; Emerling BM, 2013, CELL, V155, P844, DOI 10.1016/j.cell.2013.09.057; Ferby I, 2006, NAT MED, V12, P568, DOI 10.1038/nm1401; Fiorentino L, 2000, MOL CELL BIOL, V20, P7735, DOI 10.1128/MCB.20.20.7735-7750.2000; Fiorini M, 2002, ONCOGENE, V21, P6530, DOI 10.1038/sj.onc.1205823; Frosi Y, 2010, J CELL BIOL, V189, P557, DOI 10.1083/jcb.201002032; Grandal MV, 2007, CARCINOGENESIS, V28, P1408, DOI 10.1093/carcin/bgm058; Heck JN, 2007, CRIT REV BIOCHEM MOL, V42, P15, DOI 10.1080/10409230601162752; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jung S, 2013, INT J ONCOL, V43, P1587, DOI 10.3892/ijo.2013.2064; Kittler R, 2005, P NATL ACAD SCI USA, V102, P2396, DOI 10.1073/pnas.0409861102; Li X, 2013, J CELL SCI, V126, P2617, DOI 10.1242/jcs.117044; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Maity TK, 2015, CANCER DISCOV, V5, P534, DOI 10.1158/2159-8290.CD-14-0750; Makkinje A, 2000, J BIOL CHEM, V275, P17838, DOI 10.1074/jbc.M909735199; Mendelsohn J, 2006, SEMIN ONCOL, V33, P369, DOI 10.1053/j.seminoncol.2006.04.003; Naslavsky N, 2007, J BIOL CHEM, V282, P16612, DOI 10.1074/jbc.M609493200; Nie J, 2010, FEBS LETT, V584, P3021, DOI 10.1016/j.febslet.2010.05.034; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Pante G, 2005, J CELL BIOL, V171, P337, DOI 10.1083/jcb.200502013; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sakurada A, 2006, CLIN LUNG CANCER, V7, pS138, DOI 10.3816/CLC.2006.s.005; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schill NJ, 2009, BIOCHEM J, V422, P473, DOI 10.1042/BJ20090638; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Segatto O, 2011, J CELL SCI, V124, P1785, DOI 10.1242/jcs.083303; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/nmeth.2857, 10.1038/NMETH.2857]; Shtiegman K, 2007, ONCOGENE, V26, P6968, DOI 10.1038/sj.onc.1210503; Siegelin MD, 2014, LAB INVEST, V94, P129, DOI 10.1038/labinvest.2013.147; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Sun AQ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-248; Sun Y, 2007, J CELL BIOL, V178, P297, DOI 10.1083/jcb.200701078; Sun Y, 2013, BIOESSAYS, V35, P513, DOI 10.1002/bies.201200171; Sun Y, 2013, DEV CELL, V25, P144, DOI 10.1016/j.devcel.2013.03.010; Sun Y, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2471; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Thapa N, 2015, J BIOL CHEM, V290, P18843, DOI 10.1074/jbc.M114.596742; Thapa N, 2013, J BIOL CHEM, V288, P34707, DOI 10.1074/jbc.M113.512848; Tsunoda T, 2002, CANCER RES, V62, P5668; Wang J, 2010, J BIOL CHEM, V285, P12279, DOI 10.1074/jbc.M109.086405; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; WICK M, 1995, EXP CELL RES, V219, P527, DOI 10.1006/excr.1995.1261; Xia Y, 2011, BIOCHEM BIOPH RES CO, V411, P416, DOI 10.1016/j.bbrc.2011.06.168; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xu DZ, 2005, J BIOL CHEM, V280, P2924, DOI 10.1074/jbc.M408907200; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Yang YL, 2009, ENDOCRINOLOGY, V150, P727, DOI 10.1210/en.2008-0090; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Ying HQ, 2010, P NATL ACAD SCI USA, V107, P6912, DOI 10.1073/pnas.0914930107; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; Zou X, 2015, BBA-REV CANCER, V1856, P91, DOI 10.1016/j.bbcan.2015.06.005	67	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21461	21473		10.1074/jbc.M116.736041	http://dx.doi.org/10.1074/jbc.M116.736041			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27557663	Green Published, hybrid			2022-12-26	WOS:000385999200014
J	Ellen, Y; Flecknell, P; Leach, M				Ellen, Yvette; Flecknell, Paul; Leach, Matt			Evaluation of Using Behavioural Changes to Assess Post-Operative Pain in the Guinea Pig (Cavia porcellus)	PLOS ONE			English	Article							FACIAL EXPRESSIONS; LABORATORY MOUSE; RAT; BUPRENORPHINE; RABBITS; LAPAROTOMY; NOCICEPTION; MODULATION; MANAGEMENT; MELOXICAM	To manage pain effectively in people and animals, it is essential to recognise when pain is present and to assess its intensity. Currently there is very little information regarding the signs of post-surgical pain or its management in guinea pigs. Studies from other rodent species indicate that behaviour-based scoring systems can be used successfully to detect pain and evaluate analgesic efficacy. This preliminary study aimed to establish whether behaviour-based scoring systems could be developed to assess post-surgical pain in guinea pigs. This prospective, randomised, placebo-controlled study used 16 guinea pigs, and evaluated changes in behaviour following either anaesthesia alone or anaesthesia and orchiectomy. Behaviour was assessed using a combination of manual and automated scoring of remotely obtained video footage. A small number of behaviours were identified that appeared to have high specificity for pain caused by orchiectomy. However, the behaviours were displayed infrequently. The most common was a change in posture from standing to recumbency, sometimes with one hind leg extended either to the side or behind the body. A composite behaviour score incorporating these abnormal behaviours differentiated between the effects of surgery and anaesthesia alone (p<0.0001), and between animals that received analgesia post-operatively compared to an untreated group (p<0.0001). Although behavioural changes occurred in these guinea pigs after orchiectomy, the changes were relatively subtle and the individual specific pain-related behaviours occurred infrequently. However, it may prove possible to develop a behaviour-based scoring system for routine use in this species using a combination of pain-related behaviours.	[Ellen, Yvette] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Flecknell, Paul] Newcastle Univ, Inst Neurosci, Newcastle, NSW, Australia; [Leach, Matt] Newcastle Univ, Sch Agr Food & Rural Dev, Newcastle, NSW, Australia	QIMR Berghofer Medical Research Institute; University of Newcastle; University of Newcastle	Flecknell, P (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle, NSW, Australia.	paul.flecknell@ncl.ac.uk		Flecknell, Paul/0000-0002-1075-1129	Wellcome Trust; Newcastle University	Wellcome Trust(Wellcome TrustEuropean Commission); Newcastle University	Yvette Ellen was supported by the Wellcome Trust. The cost of the project was funded by Newcastle University.	Arras Margarete, 2007, BMC Vet Res, V3, P16, DOI 10.1186/1746-6148-3-16; Aung HH, 2004, LIFE SCI, V74, P2685, DOI 10.1016/j.lfs.2003.08.047; Clark JA, 1997, LAB ANIM SCI, V47, P300; COLLIER HO, 1961, BRIT J PHARM CHEMOTH, V17, P28, DOI 10.1111/j.1476-5381.1961.tb01101.x; COLLIER HOJ, 1963, BRIT J PHARM CHEMOTH, V21, P155, DOI 10.1111/j.1476-5381.1963.tb01511.x; da Silva LFS, 2006, PHYSIOL BEHAV, V87, P821, DOI 10.1016/j.physbeh.2006.01.019; Dunbar ML, 2016, J AM ASSOC LAB ANIM, V55, P29; Farnworth MJ, 2011, ANIM WELFARE, V20, P225; Mendes LAF, 2008, LIFE SCI, V83, P644, DOI 10.1016/j.lfs.2008.09.006; Flecknell P, 2015, LAB ANIMAL ANAESTHES; Gebhart GF, 2009, REC ALL PAIN LAB AN; Glass G.V., 1972, REV ED RES, V42, P288; HARWELL MR, 1992, J EDUC STAT, V17, P315, DOI 10.2307/1165127; Hawkins MG, 2006, J EXOT PET MED, V15, P177, DOI 10.1053/j.jepm.2006.06.004; Home Office, 2014, GREAT BRIT 2014; Jirkof P, 2012, LAB ANIM-UK, V46, P325, DOI 10.1258/la.2012.012027; Kaiser S., 2010, The UFAW handbook on the care and management of laboratory and other research animals, P380, DOI 10.1002/9781444318777.ch27; Keating SCJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044437; Keown AJ, 2011, NEW ZEAL VET J, V59, P305, DOI 10.1080/00480169.2011.609477; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Leach MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035656; Leach MC, 2009, RES VET SCI, V87, P336, DOI 10.1016/j.rvsc.2009.02.001; LILES JH, 1992, LAB ANIM, V26, P241, DOI 10.1258/002367792780745706; Liles JH, 1998, LAB ANIM, V32, P149, DOI 10.1258/002367798780600025; Lix LM, 1996, REV EDUC RES, V66, P579, DOI 10.3102/00346543066004579; Miller AL, 2011, APPL ANIM BEHAV SCI, V131, P138, DOI 10.1016/j.applanim.2011.02.007; MITCHELL D, 1977, PHYSIOL BEHAV, V18, P125, DOI 10.1016/0031-9384(77)90103-2; MORRISEY J, 2012, FERRETS RABBITS RODE; MORTON DB, 1985, VET REC, V116, P431, DOI 10.1136/vr.116.16.431; Pet Food Manufacturer's Association, 2015, PET POP 2015; Rehbinder C, 1996, LAB ANIM, V30, P193, DOI 10.1258/002367796780684881; Reinert J., 2012, ASSESSMENT PAIN BEHA; Roughan JV, 2004, BEHAV PHARMACOL, V15, P461, DOI 10.1097/00008877-200411000-00002; Roughan JV, 2003, EUR J PAIN, V7, P397, DOI 10.1016/S1090-3801(02)00140-4; Roughan JV, 2002, LAB ANIM-UK, V36, P322, DOI 10.1258/002367702320162423; Roughan JV, 2001, PAIN, V90, P65, DOI 10.1016/S0304-3959(00)00387-0; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Thompson AC, 2004, COMPARATIVE MED, V54, P293; Turner PV, 2006, COMPARATIVE MED, V56, P63; Whittaker A. L., 2013, APPL ANIMAL BEHAV SC; Wright-Williams SL, 2007, PAIN, V130, P108, DOI 10.1016/j.pain.2006.11.003	41	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161941	10.1371/journal.pone.0161941	http://dx.doi.org/10.1371/journal.pone.0161941			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583446	gold, Green Published, Green Submitted			2022-12-26	WOS:000382855600076
J	Restagno, D; Venet, F; Paquet, C; Freyburger, L; Allaouchiche, B; Monneret, G; Bonnet, JM; Louzier, V				Restagno, Damien; Venet, Fabienne; Paquet, Christian; Freyburger, Ludovic; Allaouchiche, Bernard; Monneret, Guillaume; Bonnet, Jeanne-Marie; Louzier, Vanessa			Mice Survival and Plasmatic Cytokine Secretion in a "Two Hit" Model of Sepsis Depend on Intratracheal Pseudomonas Aeruginosa Bacterial Load	PLOS ONE			English	Article							CECAL LIGATION; NOSOCOMIAL PNEUMONIA; MORTALITY; IMMUNOSUPPRESSION; PUNCTURE; DEFECTS; SHOCK	Sepsis is characterized by pro-and anti-inflammatory responses following infection. While inflammation is responsible for widespread organ damage, anti-inflammatory mediators lead to immunoparalysis increasing susceptibility to secondary infections (nosocomial pneumonia). We aimed to investigate the impact of bacterial load on survival and cytokine release in a two-hit murine (C57BL/6J) model of CLP followed by P. aeruginosa pneumonia. Plasmatic TNF alpha, IL-6, IL-10, sTNFr I and II were quantified until 13 days. At D5, splenocytes were processed for immunological assays or mice were intratracheally instilled with Pseudomonas aeruginosa (5.10(6), 2.10(7) and 10(8) CFU) to evaluate survival and cytokines production. TNF alpha, sTNFrs, IL-6 and IL-10 increased 2h post CLP. TNF alpha and sTNFrs declined respectively one and two days later. In CLP mice, IL-6 and IL-10 remained high for the whole experiment, as compared to Sham. At D5, for CLP mice, whereas total T cells population (CD3+) decreased, Treg fraction (CD4+/CD25+) increased. In parallel, T cells proliferation and LPS-stimulated splenocytes ability to release TNF alpha decreased. At D13, survival was 100% after 5.10(6) CFU, 50% for CLP mice after 2.10(7) CFU and 0% for CLP and Sham after 10(8) CFU. After instillation, IL-10 and IL-6 increased and appeared to be dose and time dependent. Pseudomonas was detected in all CLP and Sham's lungs; in spleen and liver only in CLP at 2.10(7) CFU, and in CLP and Sham at 10(8) CFU. We demonstrated that post-CLP immunosuppression followed by Pseudomonas aeruginosa lung instillation increases mortality reactivates cytokines secretion and is associated with systemic dissemination in septic mice depending on bacterial load.	[Restagno, Damien; Paquet, Christian; Freyburger, Ludovic; Allaouchiche, Bernard; Bonnet, Jeanne-Marie; Louzier, Vanessa] Univ Lyon, APCSe, Pulm & Cardiovasc Agress Sepsis, VetAgro Sup Campus Vet Lyon, Marcy Letoile, France; [Venet, Fabienne; Monneret, Guillaume] Hosp Civils Lyon, Hop Edouard Herriot, Immunol Lab, Lyon, France; [Allaouchiche, Bernard] Hosp Civils Lyon, Hop Edouard Herriot, Serv Anesthesie Reanimat, Lyon, France	VetAgro Sup; CHU Lyon; CHU Lyon	Louzier, V (corresponding author), Univ Lyon, APCSe, Pulm & Cardiovasc Agress Sepsis, VetAgro Sup Campus Vet Lyon, Marcy Letoile, France.	vanessa.louzier@vetagro-sup.fr	FREYBURGER, Ludovic/AAH-7524-2019	Venet, Fabienne/0000-0003-0462-4235; FREYBURGER, Ludovic/0000-0002-9114-4055; Restagno, Damien/0000-0002-5120-7787; Louzier, Vanessa/0000-0003-1889-7189; Bonnet Garin, Jeanne-Marie/0000-0001-5350-338X	PREMAG project; FUI (Fond Unique Interministeriel) - "Region Rhone Alpes" of France; " Fonds Europeen de Developpement Regional" (FEDER)	PREMAG project; FUI (Fond Unique Interministeriel) - "Region Rhone Alpes" of France; " Fonds Europeen de Developpement Regional" (FEDER)(European Commission)	This work was supported by a grant from PREMAG project, a FUI (Fond Unique Interministeriel) co-financed by "Region Rhone Alpes" of France and the " Fonds Europeen de Developpement Regional" (FEDER). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Institut Claude Bourgelat-Biovivo of VetAgro Sup for animal facilities and Angeli Kodjo (VetAgro Sup, Laboratoire des Leptospires) for bacteriology facilities and equipment. We also thank Damien Guyomar and Claire Plantarose (VetAgro Sup-Institut Claude Bourgelat-BioVetim) for technical assistance for cytokines assessment. Karine Chalvet Monfray and Alice de Boyer des Roches helped us with our statistical analysis; we therefore would like to thank them. Finally we thank Thomas Douellou (UMR 5557, Research Group on Bacterial Opportunistic Pathogens and Environment) for his help during bacterial dissemination assessment. This work was supported by a grant from PREMAG project, a FUI (Fond Unique Interministeriel) co-financed by "Region Rhone Alpes" of France and the " Fonds Europeen de Developpement Regional " (FEDER).	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bone R, 1992, CHEST; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Brewer Susan Crouch, 1996, Chest, V109, P1019, DOI 10.1378/chest.109.4.1019; Cavassani KA, 2010, BLOOD, V115, P4403, DOI 10.1182/blood-2009-09-241083; Cotroneo TM, 2012, J AM ASSOC LAB ANIM, V51, P357; Delano MJ, 2011, J IMMUNOL, V186, P195, DOI 10.4049/jimmunol.1002104; FAGON JY, 1993, AM J MED, V94, P281, DOI 10.1016/0002-9343(93)90060-3; Felmet KA, 2005, J IMMUNOL, V174, P3765, DOI 10.4049/jimmunol.174.6.3765; Fitting C, 2004, J INFECT DIS, V189, P1295, DOI 10.1086/382657; Gomez HG, 2014, CRIT CARE MED, V42, P771, DOI 10.1097/CCM.0000000000000100; Grimaldi D, 2011, INTENS CARE MED, V37, P1438, DOI 10.1007/s00134-011-2306-1; Heidecke CD, 1999, AM J SURG, V178, P288, DOI 10.1016/S0002-9610(99)00183-X; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Iskander KN, 2013, PHYSIOL REV, V93, P1247, DOI 10.1152/physrev.00037.2012; Landelle C, 2010, INTENS CARE MED, V36, P1859, DOI 10.1007/s00134-010-1962-x; Monneret G, 2008, MOL MED, V14, P64, DOI 10.2119/2007-00102.Monneret; Monneret G, 2006, INTENS CARE MED, V32, P1175, DOI 10.1007/s00134-006-0204-8; Muenzer JT, 2006, SHOCK, V26, P565, DOI 10.1097/01.shk.0000235130.82363.ed; Nemzek JA, 2004, SHOCK, V21, P17, DOI 10.1097/01.shk.0000101667.49265.fd; Nemzek JA, 2008, COMPARATIVE MED, V58, P120; Osuchowski MF, 2006, J IMMUNOL, V177, P1967, DOI 10.4049/jimmunol.177.3.1967; Pelekanou A, 2009, CRIT CARE, V13, DOI 10.1186/cc8148; Pene F, 2012, J INFECT DIS, V206, P932, DOI 10.1093/infdis/jis438; Pene F, 2008, J IMMUNOL, V181, P8513, DOI 10.4049/jimmunol.181.12.8513; Rello J, 1996, CLIN INFECT DIS, V23, P973, DOI 10.1093/clinids/23.5.973; Saadia R, 1999, J ACCID EMERG MED, V16, P163; Skrupky LP, 2011, ANESTHESIOLOGY, V115, P1349, DOI 10.1097/ALN.0b013e31823422e8; Steinhauser ME, 1999, J IMMUNOL, V162, P392; Sutton S., 2011, J VALID TECHNOL, V17, P42; TAYLOR GD, 1995, CHEST, V108, P786, DOI 10.1378/chest.108.3.786; Torgersen C, 2009, ANESTH ANALG, V108, P1841, DOI 10.1213/ane.0b013e318195e11d; Turnbull IR, 2004, SHOCK, V21, P121, DOI 10.1097/01.shk.0000108399.56565.e7; Turnbull IR, 2003, SHOCK, V19, P310, DOI 10.1097/00024382-200304000-00003; van der Poll T, 2010, J INNATE IMMUN, V2, P379, DOI 10.1159/000318190; Van Hooser DT, 2002, VENTILATOR ASS PNEUM; Venet F, 2008, J LEUKOCYTE BIOL, V83, P523, DOI 10.1189/jlb.0607371; Weighardt H, 2000, SURGERY, V127, P309, DOI 10.1067/msy.2000.104118; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2	39	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0162109	10.1371/journal.pone.0162109	http://dx.doi.org/10.1371/journal.pone.0162109			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27574993	Green Submitted, gold, Green Published			2022-12-26	WOS:000382877200057
J	Zboromyrska, Y; De la Calle, C; Soto, M; Sampietro-Colom, L; Soriano, A; Alvarez-Martinez, MJ; Almela, M; Marco, F; Arjona, R; Cobos-Trigueros, N; Morata, L; Mensa, J; Martinez, JA; Mira, A; Vila, J				Zboromyrska, Yuliya; De la Calle, Cristina; Soto, Marcelo; Sampietro-Colom, Laura; Soriano, Alex; Jose Alvarez-Martinez, Mriam; Almela, Manel; Marco, Francesc; Arjona, Ruth; Cobos-Trigueros, Nazaret; Morata, Laura; Mensa, Jose; Antonio Martinez, Jose; Mira, Aurea; Vila, Jordi			Rapid Diagnosis of Staphylococcal Catheter-Related Bacteraemia in Direct Blood Samples by Real-Time PCR	PLOS ONE			English	Article							AUREUS BACTEREMIA; METHICILLIN-RESISTANCE; COST-EFFECTIVENESS; STREAM INFECTIONS; RISK-FACTORS; CULTURES; MORTALITY; SEPSIS; IMPACT; POSITIVITY	Catheter-related bacteremia (CRB) is an important cause of morbidity and mortality among hospitalized patients, being staphylococci the main etiologic agents. The objective of this study was to assess the use of a PCR-based assay for detection of staphylococci directly from blood obtained through the catheter to diagnose CRB caused by these microorganisms and to perform a cost-effectiveness analysis. A total of 92 patients with suspected CRB were included in the study. Samples were obtained through the catheter. Paired blood cultures were processed by standard culture methods and 4 ml blood samples were processed by GeneXpert-MRSA assay for the detection of methicillin-susceptible (MSSA) or methicillin-resistant (MRSA) Staphylococcus aureus, and methicillin-resistant coagulase-negative staphylococci (MR-CoNS). Sixteen CRB caused by staphylococci were diagnosed among 92 suspected patients. GeneXpert detected 14 out of 16 cases (87.5%), including 4 MSSA and 10 MR-CoNS in approximately 1 hour after specimen receipt. The sensitivity and specificity of GeneXpert were 87.5%(CI 95%: 60.4-97.8) and 92.1%(CI 95%: 83-96.7), respectively, compared with standard culture methods. The sensitivity of GeneXpert for S. aureus was 100%. Regarding a cost-effectiveness analysis, the incremental cost of using GeneXpert was of 31.1(sic) per patient while the incremental cost-effectiveness ratio of GeneXpert compared with blood culture alones was about 180(sic) per life year gained. In conclusion, GeneXpert can be used directly with blood samples obtained through infected catheters to detect S. aureus and MR-CoNS in approximately 1h after sampling. In addition, it is cost-effective especially in areas with high prevalence of staphylococcal CRB.	[Zboromyrska, Yuliya; Jose Alvarez-Martinez, Mriam; Almela, Manel; Marco, Francesc; Arjona, Ruth; Vila, Jordi] Univ Barcelona, Sch Med, Hosp Clin, Dept Clin Microbiol,Biomed Diagnost Ctr CDB, Barcelona, Spain; [De la Calle, Cristina; Soriano, Alex; Cobos-Trigueros, Nazaret; Morata, Laura; Mensa, Jose; Antonio Martinez, Jose] Univ Barcelona, Hosp Clin, Dept Infect Dis, Barcelona, Spain; [Soto, Marcelo; Sampietro-Colom, Laura] Univ Barcelona, Hosp Clin, Hlth Technol Assessment Unit, Barcelona, Spain; [Marco, Francesc; Vila, Jordi] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Mira, Aurea] Univ Barcelona, Sch Med, Hosp Clin, CDB, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Vila, J (corresponding author), Univ Barcelona, Sch Med, Hosp Clin, Dept Clin Microbiol,Biomed Diagnost Ctr CDB, Barcelona, Spain.; Vila, J (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.	jvila@clinic.ub.es	Marco, Francesc D/K-2900-2017; Soriano, Alex/I-1210-2017; Morata, Laura/B-1817-2019; Vila, Jordi/P-3613-2016	Marco, Francesc D/0000-0002-1863-6379; Soriano, Alex/0000-0002-9374-0811; Morata, Laura/0000-0001-5795-0814; Vila, Jordi/0000-0002-8025-3926; Poliakova Mazneva, Yuliya/0000-0003-2716-4729; Soto, Marcelo/0000-0002-2455-5700; Sampietro-Colom, Laura/0000-0001-7182-0231; Alvarez-Martinez, Miriam Jose/0000-0003-4157-0117	Cepheid (Sunnyvale, CA; USA); Departament de Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya [2014SGR0653]; Ministerio de Economia y Competitividad, Instituto de Salud Carlos III; European Regional Development Fund (ERDF) "A Way to Achieve Europe"; Spanish Network for Research in Infectious Diseases [REIPI RD12/0015]; Cepheid	Cepheid (Sunnyvale, CA; USA); Departament de Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya(Generalitat de Catalunya); Ministerio de Economia y Competitividad, Instituto de Salud Carlos III; European Regional Development Fund (ERDF) "A Way to Achieve Europe"; Spanish Network for Research in Infectious Diseases; Cepheid	This study was funded by Cepheid (Sunnyvale, CA; USA). This study was supported by grant 2014SGR0653 from the Departament de Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya, by the Ministerio de Economia y Competitividad, Instituto de Salud Carlos III, co-financed by European Regional Development Fund (ERDF) "A Way to Achieve Europe," the Spanish Network for Research in Infectious Diseases (REIPI RD12/0015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We received fundings from Cepheid, however, this does not alter our adherence to PLOS ONE policies on sharing data and materials.	ANDREMONT A, 1988, J CLIN MICROBIOL, V26, P2297, DOI 10.1128/JCM.26.11.2297-2299.1988; Bauer KA, 2010, CLIN INFECT DIS, V51, P1074, DOI 10.1086/656623; Bell CM, 2006, BMJ-BRIT MED J, V332, P699, DOI 10.1136/bmj.38737.607558.80; Blot F, 1999, LANCET, V354, P1071, DOI 10.1016/S0140-6736(98)11134-0; Brown J, 2010, PHARMACOECONOMICS, V28, P567, DOI 10.2165/11533020-000000000-00000; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; Dark P, 2015, INTENS CARE MED, V41, P21, DOI 10.1007/s00134-014-3553-8; Fowler VG, 2005, CLIN INFECT DIS, V40, P695, DOI 10.1086/427806; Kassis C, 2009, J CLIN MICROBIOL, V47, P3255, DOI 10.1128/JCM.01045-09; Kim SH, 2008, ANTIMICROB AGENTS CH, V52, P192, DOI 10.1128/AAC.00700-07; Laupland KB, 2008, J INFECT DIS, V198, P336, DOI 10.1086/589717; Liesenfeld O, 2014, EUR J MICROBIOL IMMU, V4, P1, DOI 10.1556/EuJMI.4.2014.1.1; Lorente L, 2005, CRIT CARE, V9, pR631, DOI 10.1186/cc3824; Marcos M, 2011, J ANTIMICROB CHEMOTH, V66, P2119, DOI 10.1093/jac/dkr231; Martinez JA, 2007, CLIN MICROBIOL INFEC, V13, P709, DOI 10.1111/j.1469-0691.2007.01736.x; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Molina J, 2013, J INFECTION, V66, P155, DOI 10.1016/j.jinf.2012.10.021; Quilici N, 1997, CLIN INFECT DIS, V25, P1066, DOI 10.1086/516090; Soriano A, 2000, CLIN INFECT DIS, V30, P368, DOI 10.1086/313650; WING EJ, 1979, ARCH INTERN MED, V139, P482, DOI 10.1001/archinte.139.4.482; Wolk DM, 2009, J CLIN MICROBIOL, V47, P823, DOI 10.1128/JCM.01884-08; YAGUPSKY P, 1990, CLIN MICROBIOL REV, V3, P269, DOI 10.1128/CMR.3.3.269-279.1990	22	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161684	10.1371/journal.pone.0161684	http://dx.doi.org/10.1371/journal.pone.0161684			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571200	Green Published, gold			2022-12-26	WOS:000382876700028
J	Atichartpongkul, S; Vattanaviboon, P; Wisitkamol, R; Jaroensuk, J; Mongkolsuk, S; Fuangthong, M				Atichartpongkul, Sopapan; Vattanaviboon, Paiboon; Wisitkamol, Ratiphorn; Jaroensuk, Juthamas; Mongkolsuk, Skorn; Fuangthong, Mayuree			Regulation of Organic Hydroperoxide Stress Response by Two OhrR Homologs in Pseudomonas aeruginosa	PLOS ONE			English	Article							CAMPESTRIS PV. PHASEOLI; BACILLUS-SUBTILIS; OXIDATIVE STRESS; TRANSCRIPTION REGULATOR; STAPHYLOCOCCUS-AUREUS; HYDROGEN-PEROXIDE; RESISTANCE; REPRESSOR; BACTERIA; SENSOR	Pseudomonas aeruginosa ohrR and ospR are gene homologs encoding oxidant sensing transcription regulators. OspR is known to regulate gpx, encoding a glutathione peroxidase, while OhrR regulates the expression of ohr that encodes an organic peroxide specific peroxiredoxin. Here, we show that ospR mediated gpx expression, like ohrR and ohr, specifically responds to organic hydroperoxides as compared to hydrogen peroxide and superoxide anion. Furthermore, the regulation of these two systems is interconnected. OspR is able to functionally complement an ohrR mutant, i.e. it regulates ohr in an oxidant dependent manner. In an ohrR mutant, in which ohr is derepressed, the induction of gpx expression by organic hydroperoxide is reduced. Likewise, in an ospR mutant, where gpx expression is constitutively high, oxidant dependent induction of ohr expression is reduced. Moreover, in vitro binding assays show that OspR binds the ohr promoter, while OhrR binds the gpx promoter, albeit with lower affinity. The binding of OhrR to the gpx promoter may not be physiologically relevant; however, OspR is shown to mediate oxidant-inducible expression at both promoters. Interestingly, the mechanism of OspR-mediated, oxidant-dependent induction at the two promoters appears to be distinct. OspR required two conserved cysteines (C24 and C134) for oxidant-dependent induction of the gpx promoter, while only C24 is essential at the ohr promoter. Overall, this study illustrates possible connection between two regulatory switches in response to oxidative stress.	[Atichartpongkul, Sopapan; Vattanaviboon, Paiboon; Mongkolsuk, Skorn; Fuangthong, Mayuree] Chulabhorn Res Inst, Biotechnol Lab, Bangkok, Thailand; [Vattanaviboon, Paiboon; Jaroensuk, Juthamas; Fuangthong, Mayuree] Chulabhorn Grad Inst, Appl Biol Sci Program, Bangkok, Thailand; [Vattanaviboon, Paiboon; Mongkolsuk, Skorn; Fuangthong, Mayuree] Ctr Excellence Environm Hlth & Toxicol EHT, Bangkok, Thailand; [Wisitkamol, Ratiphorn; Mongkolsuk, Skorn] Mahidol Univ, Dept Biotechnol, Fac Sci, Bangkok, Thailand; [Mongkolsuk, Skorn] Mahidol Univ, Ctr Excellence Emerging Bacterial Dis, Fac Sci, Bangkok, Thailand	Chulabhorn Research Institute; Chulabhorn Graduate Institute; Mahidol University; Mahidol University	Mongkolsuk, S; Fuangthong, M (corresponding author), Chulabhorn Res Inst, Biotechnol Lab, Bangkok, Thailand.; Fuangthong, M (corresponding author), Chulabhorn Grad Inst, Appl Biol Sci Program, Bangkok, Thailand.; Mongkolsuk, S; Fuangthong, M (corresponding author), Ctr Excellence Environm Hlth & Toxicol EHT, Bangkok, Thailand.; Mongkolsuk, S (corresponding author), Mahidol Univ, Dept Biotechnol, Fac Sci, Bangkok, Thailand.; Mongkolsuk, S (corresponding author), Mahidol Univ, Ctr Excellence Emerging Bacterial Dis, Fac Sci, Bangkok, Thailand.	skorn@cri.or.th; mayuree@cri.or.th	Vattanaviboon, Paiboon/V-1380-2019		Center of Excellence on Environmental Health and Toxicology, and Mahidol University; Chulabhorn Graduate Institute; Chulabhorn Research Institute	Center of Excellence on Environmental Health and Toxicology, and Mahidol University; Chulabhorn Graduate Institute; Chulabhorn Research Institute	This work was supported by Chulabhorn Research Institute, Chulabhorn Graduate Institute, Center of Excellence on Environmental Health and Toxicology, and Mahidol University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DI, 2009, ANNU REV GENET, V43, P167, DOI 10.1146/annurev-genet-102108-134805; Arenas FA, 2010, BIOCHEM BIOPH RES CO, V398, P690, DOI 10.1016/j.bbrc.2010.07.002; Atichartpongkul S, 2010, J BACTERIOL, V192, P2093, DOI 10.1128/JB.01510-09; Chen PR, 2006, NAT CHEM BIOL, V2, P591, DOI 10.1038/nchembio820; Chen PR, 2009, MOL MICROBIOL, V71, P198, DOI 10.1111/j.1365-2958.2008.06518.x; Chuchue T, 2006, J BACTERIOL, V188, P842, DOI 10.1128/JB.188.3.842-851.2006; Cussiol JRR, 2010, J BIOL CHEM, V285, P21943, DOI 10.1074/jbc.M110.117283; CUSSIOL JRR, 2008, J BIOL CHEM, V28, P11570; Neto JFD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047090; Dubbs JM, 2012, J BACTERIOL, V194, P5495, DOI 10.1128/JB.00304-12; Elkins JG, 1999, APPL ENVIRON MICROB, V65, P4594; Fuangthong M, 2002, P NATL ACAD SCI USA, V99, P6690, DOI 10.1073/pnas.102483199; Fuangthong M, 2001, J BACTERIOL, V183, P4134, DOI 10.1128/JB.183.14.4134-4141.2001; Heo YJ, 2010, J BACTERIOL, V192, P381, DOI 10.1128/JB.00980-09; Hillion M, 2015, BIOL CHEM, V396, P415, DOI 10.1515/hsz-2015-0102; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Lan LF, 2010, MOL MICROBIOL, V75, P76, DOI 10.1111/j.1365-2958.2009.06955.x; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Lesniak J, 2002, EMBO J, V21, P6649, DOI 10.1093/emboj/cdf670; Maerk M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-192; Marx CJ, 2002, BIOTECHNIQUES, V33, P1062, DOI 10.2144/02335rr01; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; Mongkolsuk S, 1997, J BACTERIOL, V179, P3950, DOI 10.1128/jb.179.12.3950-3955.1997; Mongkolsuk S, 1998, J BACTERIOL, V180, P2636, DOI 10.1128/JB.180.10.2636-2643.1998; Newberry KJ, 2007, MOL CELL, V28, P652, DOI 10.1016/j.molcel.2007.09.016; Ochsner UA, 2001, J BACTERIOL, V183, P773, DOI 10.1128/JB.183.2.773-778.2001; Ochsner UA, 2000, J BACTERIOL, V182, P4533, DOI 10.1128/JB.182.16.4533-4544.2000; Oh SY, 2007, J BACTERIOL, V189, P6284, DOI 10.1128/JB.00632-07; Panmanee W, 2006, J BACTERIOL, V188, P1389, DOI 10.1128/JB.188.4.1389-1395.2006; Panmanee W, 2002, MOL MICROBIOL, V45, P1647, DOI 10.1046/j.1365-2958.2002.03116.x; Saikolappan S, 2015, J BACTERIOL, V197, P51, DOI 10.1128/JB.02252-14; Soonsanga S, 2008, J BACTERIOL, V190, P5738, DOI 10.1128/JB.00576-08; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340	34	15	15	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161982	10.1371/journal.pone.0161982	http://dx.doi.org/10.1371/journal.pone.0161982			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560944	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258600124
J	Cattepoel, S; Gaida, A; Kropf, A; Nolte, MW; Bolli, R; Miescher, SM				Cattepoel, Susann; Gaida, Annette; Kropf, Alain; Nolte, Marc W.; Bolli, Reinhard; Miescher, Sylvia M.			Effect of IVIG Formulation on IgG Binding to Self- and Exo- Antigens In Vitro and In Vivo	PLOS ONE			English	Article							AMYLOID-BETA-PEPTIDE; INTRAVENOUS IMMUNOGLOBULIN; L-PROLINE; NATURAL ANTIBODIES; ALZHEIMERS-DISEASE; 10-PERCENT; AUTOIMMUNE; PROTEIN; SAFETY	In relation to the recent trials of Intravenous Immunoglobulin (IVIG) in Alzheimer's Disease (AD) it was demonstrated that different IgG preparations contain varying amounts of natural anti-amyloid beta (A beta) antibodies as measured by ELISA. We therefore investigated the relevance of ELISA data for measuring low-affinity antibodies, such as anti-A beta. We analysed the binding of different commercial Immunoglobulin G (IgG) preparations to A beta, actin and tetanus toxoid in different binding assays to further investigate the possible cause for observed differences in binding to A beta and actin between different IgG preparations. We show that the differences of commercial IgG preparations in binding to A beta and actin in ELISA assays are artefactual and only evident in in vitro binding assays. In functional assays and in vivo animal studies the different IVIG preparations exhibited very similar potency. ELISA data alone are not appropriate to analyse and rank the binding capacity of low-affinity antibodies to A beta or other endogenous self-antigens contained in IgG preparations. Additional analytical methods should be adopted to complement ELISA data.	[Cattepoel, Susann; Gaida, Annette; Kropf, Alain; Bolli, Reinhard; Miescher, Sylvia M.] CSL Behring AG, Bern, Switzerland; [Nolte, Marc W.] CSL Behring GmbH, Marburg, Germany	CSL; CSL	Cattepoel, S (corresponding author), CSL Behring AG, Bern, Switzerland.	susann.cattepoel@cslbehring.com			CSL Behring AG	CSL Behring AG	The study was funded entirely by CSL Behring AG. The funder provided support in the form of salaries for the authors [SC, AG, AK, RB, SMM, MWN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Arnson Y, 2009, AUTOIMMUNITY, V42, P553, DOI 10.1080/08916930902785363; Balakrishnan K, 2010, J ALZHEIMERS DIS, V20, P135, DOI 10.3233/JAD-2010-1353; Berger M, 2011, IMMUNOTHERAPY-UK, V3, P163, DOI 10.2217/IMT.10.108; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Bolli R, 2010, BIOLOGICALS, V38, P150, DOI 10.1016/j.biologicals.2009.09.002; Cattepoel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063162; Dimitrov JD, 2011, ANAL BIOCHEM, V418, P149, DOI 10.1016/j.ab.2011.07.007; Dimitrov JD, 2010, BIOCHEM BIOPH RES CO, V398, P266, DOI 10.1016/j.bbrc.2010.06.073; Djoumerska-Alexieva IK, 2010, FEBS J, V277, P3039, DOI 10.1111/j.1742-4658.2010.07714.x; Dodel R, 2002, ANN NEUROL, V52, P253, DOI 10.1002/ana.10253; Eibl MM, 2008, IMMUNOL ALLERGY CLIN, V28, P737, DOI 10.1016/j.iac.2008.06.004; Fillit H, 2009, NEUROLOGY, V73, P180, DOI 10.1212/WNL.0b013e3181ae7aaf; Hagan JB, 2012, EXPERT REV CLIN IMMU, V8, P169, DOI [10.1586/ECI.11.97, 10.1586/eci.11.97]; Kaveri SV, 2008, NEW ENGL J MED, V359, P307, DOI 10.1056/NEJMcibr0803649; Kaveri SV, 2012, AUTOIMMUN REV, V11, P792, DOI 10.1016/j.autrev.2012.02.006; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; Klaver AC, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-93; Klaver AC, 2010, J NEUROSCI METH, V187, P263, DOI 10.1016/j.jneumeth.2010.01.018; Klaver AC, 2010, INT IMMUNOPHARMACOL, V10, P115, DOI 10.1016/j.intimp.2009.10.005; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Nimmerjahn F, 2008, ANNU REV IMMUNOL, V26, P513, DOI 10.1146/annurev.immunol.26.021607.090232; O'Nuallain B, 2010, J CLIN IMMUNOL, V30, pS37, DOI 10.1007/s10875-010-9413-6; Reynolds MR, 2005, BIOCHEMISTRY-US, V44, P1690, DOI 10.1021/bi047982v; Schaub A, 2007, ANN NY ACAD SCI, V1110, P681, DOI 10.1196/annals.1423.071; Schwartz-Albiez R, 2009, CLIN EXP IMMUNOL, V158, P43, DOI [10.1111/j.1365-2249.2009.04026.X, 10.1111/j.1365-2249.2009.04026.x]; Stein MR, 2009, J CLIN IMMUNOL, V29, P137, DOI 10.1007/s10875-008-9231-2; Szabo P, 2010, J NEUROIMMUNOL, V227, P167, DOI 10.1016/j.jneuroim.2010.06.010; Webster SD, 2001, J IMMUNOL, V166, P7496, DOI 10.4049/jimmunol.166.12.7496; Weksler ME, 2009, TRENDS IMMUNOL, V30, P344, DOI 10.1016/j.it.2009.03.011	30	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161826	10.1371/journal.pone.0161826	http://dx.doi.org/10.1371/journal.pone.0161826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27561008	gold, Green Published, Green Submitted			2022-12-26	WOS:000382258600105
J	Ecker, BL; Taylor, L; Zhang, PJ; Furth, EE; Ginsberg, GG; McMillan, MT; Datta, J; Czerniecki, BJ; Roses, RE				Ecker, Brett L.; Taylor, Laura; Zhang, Paul J.; Furth, Emma E.; Ginsberg, Gregory G.; McMillan, Matthew T.; Datta, Jashodeep; Czerniecki, Brian J.; Roses, Robert E.			HER3 Expression Is a Marker of Tumor Progression in Premalignant Lesions of the Gastroesophageal Junction	PLOS ONE			English	Article							BARRETTS-ESOPHAGUS; GRADE DYSPLASIA; GASTRIC-CANCER; BREAST-CANCER; IN-SITU; ADENOCARCINOMA; OVEREXPRESSION; AMPLIFICATION; TRANSITION; PROGNOSIS	Overexpression of receptor tyrosine kinases (RTK), including members of the HER family, has prognostic and therapeutic significance in invasive esophagogastric carcinoma. RTK expression in premalignant gastroesophageal lesions has not been extensively explored. Formalin-fixed paraffin-embedded tissue samples of esophageal biopsy specimens from 73 patients with Barrett's esophagus with either low-grade dysplasia (LGD) (n = 32) or high-grade dysplasia (HGD) (n = 59) were analyzed for HER1, HER2, HER3 and CMET expression by immunohistochemistry (IHC). Immunophenotype was correlated with histologic and clinical features. High-grade dysplasia (HGD) was associated with overexpression of HER1 (20.7% vs. 3.1%, p = 0.023), HER2 (5.3% vs. 0.0%, p = 0.187) and HER3 (47.4% vs. 9.4%, p< 0.001) compared to low-grade dysplasia (LGD). There was a significant association of HER2 (20.0% vs. 2.1%, p = 0.022) and HER3 (80.0% vs. 40.4%, p = 0.023) overexpression in HGD lesions associated with foci of invasive carcinoma compared to those without invasive foci. Overexpression of CMET was observed in 42.9% of specimens, was increasingly observed with HGD compared to LGD (58.3% vs. 36.7%, p = 0.200), and was most often co-expressed with HER3 (62.5% of HER3-positive specimens vs. 38.2% of HER3-negative specimens, p = 0.212). In summary, HER3 is frequently overexpressed in high-grade dysplastic lesions of the gastroesophageal junction and may be a marker of invasive progression. These data provide rationale for targeting HER2 and HER3 pathways in an early disease setting to prevent disease progression.	[Ecker, Brett L.; McMillan, Matthew T.; Datta, Jashodeep; Czerniecki, Brian J.; Roses, Robert E.] Univ Penn, Dept Surg, Philadelphia, PA 19104 USA; [Taylor, Laura; Zhang, Paul J.; Furth, Emma E.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA; [Ginsberg, Gregory G.] Univ Penn, Dept Gastroenterol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Roses, RE (corresponding author), Univ Penn, Dept Surg, Philadelphia, PA 19104 USA.	Robert.Roses@uphs.upenn.edu	McMillan, Matthew/ABF-1374-2020	McMillan, Matthew/0000-0002-1172-9273	Thomas B. McCabe and Jeannette E. Laws McCabe Fund; Pennies in Action	Thomas B. McCabe and Jeannette E. Laws McCabe Fund; Pennies in Action	This work was supported by Thomas B. McCabe and Jeannette E. Laws McCabe Fund (http://www.med.upenn.edu/evdresearch/mccabefundawardprogram.html), received by RR; and Pennies in Action, received by RR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almhanna K, 2015, APPL IMMUNOHISTOCHEM; Bang YJ, 2010, LANCET, V376, P1302; CAMERON AJ, 1995, GASTROENTEROLOGY, V109, P1541, DOI 10.1016/0016-5085(95)90642-8; Edge S, 2010, AJCC CANC STAGING MA, V7th; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fassan M, 2012, HISTOPATHOLOGY, V61, P769, DOI 10.1111/j.1365-2559.2012.04272.x; Fichter CD, 2014, INT J CANCER, V135, P1517, DOI 10.1002/ijc.28771; Guarner-Argente C, 2013, GASTROINTEST ENDOSC, V77, P190, DOI 10.1016/j.gie.2012.10.013; Hayashi M, 2008, CLIN CANCER RES, V14, P7843, DOI 10.1158/1078-0432.CCR-08-1064; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; Kandel C, 2014, J CLIN PATHOL, V67, P307, DOI 10.1136/jclinpath-2013-201726; Koski GK, 2012, J IMMUNOTHER, V35, P54, DOI 10.1097/CJI.0b013e318235f512; Liu XD, 2011, CLIN CANCER RES, V17, P7127, DOI 10.1158/1078-0432.CCR-11-1157; Mesteri I, 2014, EUR J CANCER, V50, P1354, DOI 10.1016/j.ejca.2014.01.022; Montgomery E, 2001, HUM PATHOL, V32, P368, DOI 10.1053/hupa.2001.23510; National Institute on Alcohol Abuse and Alcoholism, 2005, NIH PUBLICATION; Phoa KN, 2014, JAMA-J AM MED ASSOC, V311, P1209, DOI 10.1001/jama.2014.2511; Roses RE, 2009, CANCER EPIDEM BIOMAR, V18, P1386, DOI 10.1158/1055-9965.EPI-08-1101; Rossi E, 2009, J CELL MOL MED, V13, P3826, DOI 10.1111/j.1582-4934.2008.00517.x; Sharma A, 2012, CANCER-AM CANCER SOC, V118, P4354, DOI 10.1002/cncr.26734; Streppel MM, 2014, ONCOGENE, V33, P347, DOI 10.1038/onc.2012.586; Yang RL, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0698-3	22	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161781	10.1371/journal.pone.0161781	http://dx.doi.org/10.1371/journal.pone.0161781			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27559738	gold, Green Published, Green Submitted			2022-12-26	WOS:000382258600097
J	Cao, JM; Zhang, XL; Zhang, YF; Zhou, J; Chen, YU; Liu, XW				Cao, Jiamu; Zhang, Xuelin; Zhang, Yufeng; Zhou, Jing; Chen, Yinuo; Liu, Xiaowei			Free MoS2 Nanoflowers Grown on Graphene by Microwave-Assisted Synthesis as Highly Efficient Non-Noble-Metal Electrocatalysts for the Hydrogen Evolution Reaction	PLOS ONE			English	Article							HYDROTHERMAL SYNTHESIS; REDUCTION; CATALYST; OXIDE; MICROSPHERES	Advanced approaches to preparing non-noble-metal electrocatalysts for the hydrogen evolution reaction (HER) are considered to be a significant breakthrough in promoting the exploration of renewable resources. In this work, a hybrid material of MoS2 nanoflowers (NFs) on reduced graphene oxide (rGO) was synthesized as a HER catalyst via an environmentally friendly, efficient approach that is also suitable for mass production. Small-sized MoS2 NFs with a diameter of ca. 190 nm and an abundance of exposed edges were prepared by a hydrothermal method and were subsequently supported on rGO by microwave-assisted synthesis. The results show that MoS2 NFs were distributed uniformly on the remarkably reduced GO and preserved the outstanding original structural features perfectly. Electrochemical tests show that the as-prepared hybrid material exhibited excellent HER activity, with a small Tafel slope of 80 mV/decade and a low overpotential of 170 mV.	[Cao, Jiamu; Zhang, Xuelin; Zhang, Yufeng; Chen, Yinuo; Liu, Xiaowei] Harbin Inst Technol, Sch Astronaut, MEMS Ctr, Harbin 150001, Peoples R China; [Zhou, Jing] Harbin Inst Technol, Sch Elect & Informat Engn, Harbin 150001, Peoples R China	Harbin Institute of Technology; Harbin Institute of Technology	Zhang, YF (corresponding author), Harbin Inst Technol, Sch Astronaut, MEMS Ctr, Harbin 150001, Peoples R China.	yufeng_zhang@hit.edu.cn	Zhang, Yufeng/GZL-1973-2022		National Natural Science Foundation of China [61404037, 61376113]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by National Natural Science Foundation of China - No.61404037 and National Natural Science Foundation of China - No. 61376113. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen WF, 2010, CARBON, V48, P1146, DOI 10.1016/j.carbon.2009.11.037; Dou S, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/4/045402; Hinnemann B, 2005, J AM CHEM SOC, V127, P5308, DOI 10.1021/ja0504690; Hu WH, 2015, MATER LETT, V161, P120, DOI 10.1016/j.matlet.2015.08.081; Jaramillo TF, 2007, SCIENCE, V317, P100, DOI 10.1126/science.1141483; Jiao TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101620; Li F, 2015, J POWER SOURCES, V292, P15, DOI 10.1016/j.jpowsour.2015.04.173; Li J, 2013, J MATER CHEM A, V1, P11451, DOI 10.1039/c3ta12228j; Li YG, 2011, J AM CHEM SOC, V133, P7296, DOI 10.1021/ja201269b; Liu QH, 2015, ELECTROCHIM ACTA, V177, P298, DOI 10.1016/j.electacta.2015.01.193; Liu S, 2011, J NANOPART RES, V13, P4731, DOI 10.1007/s11051-011-0440-x; Ma CB, 2014, NANOSCALE, V6, P5624, DOI 10.1039/c3nr04975b; Qiao XQ, 2016, MATER LETT, V169, P241, DOI 10.1016/j.matlet.2016.01.093; Suresh C, 2016, MATER LETT, V164, P417, DOI 10.1016/j.matlet.2015.11.052; Tao L, 2015, CHEM COMMUN, V51, P7470, DOI 10.1039/c5cc01981h; Wang DZ, 2014, J POWER SOURCES, V264, P229, DOI 10.1016/j.jpowsour.2014.04.066; Xiong FY, 2015, ACS APPL MATER INTER, V7, P12625, DOI 10.1021/acsami.5b02978; Xu CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144842; Ye GL, 2016, NANO LETT, V16, P1097, DOI 10.1021/acs.nanolett.5b04331; Zhang XH, 2015, MATER LETT, V148, P67, DOI 10.1016/j.matlet.2015.02.027	20	11	11	6	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161374	10.1371/journal.pone.0161374	http://dx.doi.org/10.1371/journal.pone.0161374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556402	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258100039
J	Dierck, R; De Keyser, E; De Riek, J; Dhooghe, E; Van Huylenbroeck, J; Prinsen, E; Van Der Straeten, D				Dierck, Robrecht; De Keyser, Ellen; De Riek, Jan; Dhooghe, Emmy; Van Huylenbroeck, Johan; Prinsen, Els; Van Der Straeten, Dominique			Change in Auxin and Cytokinin Levels Coincides with Altered Expression of Branching Genes during Axillary Bud Outgrowth in Chrysanthemum	PLOS ONE			English	Article							ACTS DOWNSTREAM; STRIGOLACTONE; ARABIDOPSIS; BIOSYNTHESIS; GROWTH; RESPONSES; FAMILY; MAX1; PEA; IDENTIFICATION	In the production and breeding of Chrysanthemum sp., shoot branching is an important quality aspect as the outgrowth of axillary buds determines the final plant shape. Bud outgrowth is mainly controlled by apical dominance and the crosstalk between the plant hormones auxin, cytokinin and strigolactone. In this work the hormonal and genetic regulation of axillary bud outgrowth was studied in two differently branching cut flower Chrysanthemum morifolium (Ramat) genotypes. C17 is a split-type which forms an inflorescence meristem after a certain vegetative period, while C18 remains vegetative under long day conditions. Plant growth of both genotypes was monitored during 5 subsequent weeks starting one week before flower initiation occurred in C17. Axillary bud outgrowth was measured weekly and samples of shoot apex, stem and axillary buds were taken during the first two weeks. We combined auxin and cytokinin measurements by UPLC-MS/MS with RT-qPCR expression analysis of genes involved in shoot branching regulation pathways in chrysanthemum. These included bud development genes (CmBRC1, CmDRM1, CmSTM, CmLsL), auxin pathway genes (CmPIN1, CmTIR3, CmTIR1, CmAXR1, CmAXR6, CmAXR2, CmIAA16, CmIAA12), cytokinin pathway genes (CmIPT3, CmHK3, CmRR1) and strigolactone genes (CmMAX1 and CmMAX2). Genotype C17 showed a release from apical dominance after floral transition coinciding with decreased auxin and increased cytokinin levels in the subapical axillary buds. As opposed to C17, C18 maintained strong apical dominance with vegetative growth throughout the experiment. Here high auxin levels and decreasing cytokinin levels in axillary buds and stem were measured. A differential expression of several branching genes accompanied the different hormonal change and bud outgrowth in C17 and C18. This was clear for the strigolactone biosynthesis gene CmMAX1, the transcription factor CmBRC1 and the dormancy associated gene CmDRM1, that all showed a decreased expression in C17 at floral transition and an increased expression in C18 with continuous vegetative growth. These results offer a case study for Chrysanthemum, showing an altered cytokinin to auxin balance and differential gene expression between vegetative growth with apical dominance and transition to generative growth with loss of apical dominance and axillary bud outgrowth. This suggests a conservation of several aspects of the hormonal and genetical regulation of bud outgrowth in Chrysanthemum. Furthermore, 15 previously uncharacterised genes in chrysanthemum, were described in this study. Of those genes involved in axillary bud outgrowth we identified CmDRM1, CmBRC1 and CmMAX1 as having an altered expression preceding axillary bud outgrowth, which could be useful as markers for bud activity.	[Dierck, Robrecht; De Keyser, Ellen; De Riek, Jan; Dhooghe, Emmy; Van Huylenbroeck, Johan] Inst Agr & Fisheries Res ILVO, Caritasstr 39, Melle, Belgium; [Prinsen, Els] Univ Antwerp, Groenenborgerlaan 171, Antwerp, Belgium; [Dierck, Robrecht; Van Der Straeten, Dominique] Univ Ghent, Dept Physiol, Lab Funct Plant Biol, KL Ledeganckstr 35, Ghent, Belgium	Institute For Agricultural & Fisheries Research; University of Antwerp; Ghent University	Dierck, R (corresponding author), Inst Agr & Fisheries Res ILVO, Caritasstr 39, Melle, Belgium.; Dierck, R (corresponding author), Univ Ghent, Dept Physiol, Lab Funct Plant Biol, KL Ledeganckstr 35, Ghent, Belgium.	Robrecht.dierck@ilvo.vlaanderen.be	Prinsen, Els/M-8973-2016; Van Der Straeten, Dominique/E-7385-2016	Prinsen, Els/0000-0003-4320-1585; Van Der Straeten, Dominique/0000-0002-7755-1420	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) [110771]	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This research was funded by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen Grant No. 110771).	Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; Aguilar-Martinez JA, 2007, PLANT CELL, V19, P458, DOI 10.1105/tpc.106.048934; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arite T, 2007, PLANT J, V51, P1019, DOI 10.1111/j.1365-313X.2007.03210.x; Bennett T, 2006, PLANT MOL BIOL, V60, P843, DOI 10.1007/s11103-005-2763-4; Beveridge CA, 2006, CURR OPIN PLANT BIOL, V9, P35, DOI 10.1016/j.pbi.2005.11.006; Booker J, 2005, DEV CELL, V8, P443, DOI 10.1016/j.devcel.2005.01.009; Braun N, 2012, PLANT PHYSIOL, V158, P225, DOI 10.1104/pp.111.182725; Brenner WG, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00008; Brewer PB, 2009, PLANT PHYSIOL, V150, P482, DOI 10.1104/pp.108.134783; Chatfield SP, 2000, PLANT J, V24, P159, DOI 10.1046/j.1365-313x.2000.00862.x; Chen XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061717; CLINE MG, 1991, BOT REV, V57, P318, DOI 10.1007/BF02858771; Crawford S, 2010, DEVELOPMENT, V137, P2905, DOI 10.1242/dev.051987; De Keyser E, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-13; del Pozo JC, 1998, SCIENCE, V280, P1760, DOI 10.1126/science.280.5370.1760; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Domagalska MA, 2011, NAT REV MOL CELL BIO, V12, P211, DOI 10.1038/nrm3088; Dong LL, 2013, J INTEGR PLANT BIOL, V55, P434, DOI 10.1111/jipb.12028; Dun EA, 2012, PLANT PHYSIOL, V158, P487, DOI 10.1104/pp.111.186783; Emery RJN, 1998, J EXP BOT, V49, P555, DOI 10.1093/jexbot/49.320.555; Foo E, 2005, PLANT CELL, V17, P464, DOI 10.1105/tpc.104.026716; Geuns JMC, 2001, PHYTOCHEMISTRY, V58, P911, DOI 10.1016/S0031-9422(01)00338-7; Gil P, 2001, GENE DEV, V15, P1985, DOI 10.1101/gad.905201; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Grbic V, 2000, PLANT J, V21, P215, DOI 10.1046/j.1365-313x.2000.00670.x; Greb T, 2003, GENE DEV, V17, P1175, DOI 10.1101/gad.260703; Guan JC, 2012, PLANT PHYSIOL, V160, P1303, DOI 10.1104/pp.112.204503; Guo XL, 2013, PLANTA, V237, P1135, DOI 10.1007/s00425-012-1834-4; Hayward A, 2009, PLANT PHYSIOL, V151, P400, DOI 10.1104/pp.109.137646; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hellmann H, 2003, EMBO J, V22, P3314, DOI 10.1093/emboj/cdg335; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; Ishida K, 2009, DNA RES, V16, P237, DOI 10.1093/dnares/dsp012; Ito S, 2013, J PESTIC SCI, V38, P147, DOI 10.1584/jpestics.D13-011; Jiang B, 2012, RUSS J PLANT PHYSL+, V59, P356, DOI 10.1134/S1021443712020045; Jiang BB, 2010, PLANT MOL BIOL REP, V28, P144, DOI 10.1007/s11105-009-0130-3; Kebrom TH, 2012, PLANT PHYSIOL, V160, P308, DOI 10.1104/pp.112.197954; Kebrom TH, 2006, PLANT PHYSIOL, V140, P1109, DOI 10.1104/pp.105.074856; Khodakovskaya M, 2009, PLANT CELL REP, V28, P1351, DOI 10.1007/s00299-009-0735-x; Leyser O, 2009, PLANT CELL ENVIRON, V32, P694, DOI 10.1111/j.1365-3040.2009.01930.x; Liang JL, 2010, J EXP BOT, V61, P3069, DOI 10.1093/jxb/erq133; Long J, 2000, DEV BIOL, V218, P341, DOI 10.1006/dbio.1999.9572; McSteen P, 2005, ANNU REV PLANT BIOL, V56, P353, DOI 10.1146/annurev.arplant.56.032604.144122; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Miyawaki K, 2004, PLANT J, V37, P128, DOI 10.1046/j.1365-313X.2003.01945.x; Mockaitis K, 2008, ANNU REV CELL DEV BI, V24, P55, DOI 10.1146/annurev.cellbio.23.090506.123214; Muller D, 2015, PLANT J, V82, P874, DOI 10.1111/tpj.12862; Muniz LM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-84; Nelson DC, 2011, P NATL ACAD SCI USA, V108, P8897, DOI 10.1073/pnas.1100987108; Nordstrom A, 2004, P NATL ACAD SCI USA, V101, P8039, DOI 10.1073/pnas.0402504101; Paponov IA, 2008, MOL PLANT, V1, P321, DOI 10.1093/mp/ssm021; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; Pozo JC, 2002, AXR1 ECR1 DEPENDENT, V14, P421; PRINSEN E, 1995, RAPID COMMUN MASS SP, V9, P948, DOI 10.1002/rcm.1290091016; Prinsen E, 2000, METH MOL B, V141, P49; Prusinkiewicz P, 2009, P NATL ACAD SCI USA, V106, P17431, DOI 10.1073/pnas.0906696106; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rameau C, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00741; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Rinaldi MA, 2012, PLANT MOL BIOL, V79, P359, DOI 10.1007/s11103-012-9917-y; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; SACHS T, 1967, AM J BOT, V54, P136, DOI 10.2307/2440896; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Shimizu-sato S, 2001, CONTROL OUTGROWTH DO, V1; Shimizu-Sato S, 2009, PLANT MOL BIOL, V69, P429, DOI 10.1007/s11103-008-9416-3; Shinohara N, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001474; Soundappan I, 2015, PLANT CELL, V27, P3143, DOI 10.1105/tpc.15.00562; Stafstrom JP, 1998, PLANTA, V205, P547, DOI 10.1007/s004250050354; Stirnberg P, 1999, PLANT PHYSIOL, V121, P839, DOI 10.1104/pp.121.3.839; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Takei K, 2004, PLANT CELL PHYSIOL, V45, P1053, DOI 10.1093/pcp/pch119; Tanaka M, 2006, PLANT J, V45, P1028, DOI 10.1111/j.1365-313X.2006.02656.x; Tatematsu K, 2005, PLANT PHYSIOL, V138, P757, DOI 10.1104/pp.104.057984; Van Minnebruggen A, 2014, MORPHOLOGICAL AND GE; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varanasi VK, 2012, AGROTECHNOLOGY, V1, P1; Vernoux T, 2010, COLD SPRING HARBOR P, V2, P1; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Wang YH, 2008, ANNU REV PLANT BIOL, V59, P253, DOI 10.1146/annurev.arplant.59.032607.092902; Xi L, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00694; Xu YJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-662; Yang DH, 2005, PLANT PHYSIOL BIOCH, V43, P1044, DOI 10.1016/j.plaphy.2005.10.005; Young NF, 2014, PLANT PHYSIOL, V165, P1723, DOI 10.1104/pp.114.239996; Zhang YX, 2014, NAT CHEM BIOL, V10, P1028, DOI 10.1038/nchembio.1660; Zhao Yunde, 2014, Arabidopsis Book, V12, pe0173, DOI 10.1199/tab.0173	87	31	37	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161732	10.1371/journal.pone.0161732	http://dx.doi.org/10.1371/journal.pone.0161732			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27557329	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258100064
J	Rowe, EC; Ford, AES; Smart, SM; Henrys, PA; Ashmore, MR				Rowe, Edwin C.; Ford, Adriana E. S.; Smart, Simon M.; Henrys, Peter A.; Ashmore, Mike R.			Using Qualitative and Quantitative Methods to Choose a Habitat Quality Metric for Air Pollution Policy Evaluation	PLOS ONE			English	Article							PLANT-SPECIES DIVERSITY; NITROGEN DEPOSITION; BIODIVERSITY INDICATORS; FLORISTIC QUALITY; NICHE MODELS; CONSERVATION; REPRESENTATION; COMMUNITIES; PREDICTION; MANAGEMENT	Atmospheric nitrogen (N) deposition has had detrimental effects on species composition in a range of sensitive habitats, although N deposition can also increase agricultural productivity and carbon storage, and favours a few species considered of importance for conservation. Conservation targets are multiple, and increasingly incorporate services derived from nature as well as concepts of intrinsic value. Priorities vary. How then should changes in a set of species caused by drivers such as N deposition be assessed? We used a novel combination of qualitative semi-structured interviews and quantitative ranking to elucidate the views of conservation professionals specialising in grasslands, heathlands and mires. Although conservation management goals are varied, terrestrial habitat quality is mainly assessed by these specialists on the basis of plant species, since these are readily observed. The presence and abundance of plant species that are scarce, or have important functional roles, emerged as important criteria for judging overall habitat quality. However, species defined as 'positive indicator-species' (not particularly scarce, but distinctive for the habitat) were considered particularly important. Scarce species are by definition not always found, and the presence of functionally important species is not a sufficient indicator of site quality. Habitat quality as assessed by the key informants was rank-correlated with the number of positive indicator-species present at a site for seven of the nine habitat classes assessed. Other metrics such as species-richness or a metric of scarcity were inconsistently or not correlated with the specialists' assessments. We recommend that metrics of habitat quality used to assess N pollution impacts are based on the occurrence of, or habitat-suitability for, distinctive species. Metrics of this type are likely to be widely applicable for assessing habitat change in response to different drivers. The novel combined qualitative and quantitative approach taken to elucidate the priorities of conservation professionals could be usefully applied in other contexts.	[Rowe, Edwin C.] Ctr Ecol & Hydrol, Bangor, Gwynedd, Wales; [Ford, Adriana E. S.] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England; [Ford, Adriana E. S.] Univ Greenwich, Fac Architecture Comp & Humanities, London, England; [Smart, Simon M.; Henrys, Peter A.] Ctr Ecol & Hydrol, Lancaster, Lancs, England; [Ashmore, Mike R.] Univ York, Stockholm Environm Inst, York, N Yorkshire, England	UK Centre for Ecology & Hydrology (UKCEH); University of York - UK; University of Greenwich; UK Centre for Ecology & Hydrology (UKCEH); University of York - UK	Rowe, EC (corresponding author), Ctr Ecol & Hydrol, Bangor, Gwynedd, Wales.	ecro@ceh.ac.uk	smart, simon M/I-6089-2012; Henrys, Peter/K-3321-2012; Rowe, Edwin C/A-7641-2011	Henrys, Peter/0000-0003-4758-1482; Rowe, Edwin C/0000-0003-4784-7236; smart, simon/0000-0003-2750-7832	UK Department for the Environment, Food and Rural Affairs (DEFRA) [AQ0828]; NERC [ceh020001] Funding Source: UKRI; Natural Environment Research Council [ceh020001] Funding Source: researchfish	UK Department for the Environment, Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was funded by the UK Department for the Environment, Food and Rural Affairs (DEFRA), https://www.gov.uk/government/organisations/department-for-environment-food-rural-affairs, under grant AQ0828 to ECR. The project steering committee (Clare Whitfield, Zoe Russell and Lynette Clapp) helped considerably with defining the study, but had no role in detailed study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Amann M, 2011, ENVIRON MODELL SOFTW, V26, P1489, DOI 10.1016/j.envsoft.2011.07.012; Arponen A, 2005, CONSERV BIOL, V19, P2009, DOI 10.1111/j.1523-1739.2005.00218.x; Belyazid S, 2011, ENVIRON POLLUT, V159, P789, DOI 10.1016/j.envpol.2010.11.005; Bleeker A, 2011, ENVIRON POLLUT, V159, P2280, DOI 10.1016/j.envpol.2010.10.036; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; Bowers K, 2008, ECOL INDIC, V8, P466, DOI 10.1016/j.ecolind.2007.05.001; Brock K, 1995, MEM SEG C INT SIST A; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Carignan V, 2002, ENVIRON MONIT ASSESS, V78, P45, DOI 10.1023/A:1016136723584; Czekanowski J., 1909, KORRESPOND DEUTSCH G, V40, P44; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; De Vries W, 2010, ECOL APPL, V20, P60, DOI 10.1890/08-1019.1; EEA, 2014, EUR NAT INF SYST; EEA, 2007, 112007 EEA; Ellenberg H., 1992, SCRIPTA GEOBOTANICA, V18, P1, DOI DOI 10.15468/TPNGMA; Emmett BA, 2011, 449 JNCC; Erisman JW, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0116; Failing L, 2003, J ENVIRON MANAGE, V68, P121, DOI 10.1016/S0301-4797(03)00014-8; Feest A, 2014, ECOL INDIC, V39, P115, DOI 10.1016/j.ecolind.2013.12.008; Feest A, 2013, ECOL INDIC, V28, P16, DOI 10.1016/j.ecolind.2012.10.015; Field CD, 2014, ECOSYSTEMS, V17, P864, DOI 10.1007/s10021-014-9765-5; Fischer A, 2007, BIOL CONSERV, V136, P271, DOI 10.1016/j.biocon.2006.11.024; Fleishman E, 2006, ECOL INDIC, V6, P543, DOI 10.1016/j.ecolind.2005.07.005; Ford-Thompson AES, 2015, WILDLIFE RES, V42, P60, DOI 10.1071/WR14122; Goldsmith FB, 1991, MONITORING CONSERVAT; Goncalves B, 2015, CURR OPIN ENV SUST, V14, P61, DOI 10.1016/j.cosust.2015.03.008; Hayes M, 2015, BIODIVERS CONSERV, V24, P2535, DOI 10.1007/s10531-015-0942-4; Heckenberger MJ, 2007, PHILOS T R SOC B, V362, P197, DOI 10.1098/rstb.2006.1979; Henrys P. A., 2015, New Journal of Botany, V5, P89, DOI 10.1179/2042349715Y.0000000010; Henrys PA, 2011, BIOGEOSCIENCES, V8, P3501, DOI 10.5194/bg-8-3501-2011; Hill M.O., 2004, PLANTATT ATTRIBUTES; Hill MO, 1997, J VEG SCI, V8, P579, DOI 10.2307/3237210; Hill MO., 2007, BRYOATT ATTRIBUTES B; Hodgson JG, 2014, FUNCT ECOL, V28, P1284, DOI 10.1111/1365-2435.12253; Hull RB, 2003, ENVIRON MANAGE, V31, P1, DOI 10.1007/s00267-002-2812-6; ICPMM, 2014, 24 CCE WORKSH 30 M P; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; IUCN, 2014, IUCN RED LIST THREAT; JNCC, 2006, COMM STAND MON GUID; JNCC, 2009, COMM STAND MON GUID, P47; JNCC, 2004, COMM STAND MON INTR; Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012; Landi S, 2010, SYST BIODIVERS, V8, P269, DOI 10.1080/14772001003770307; Leroy B, 2014, ECOL INDIC, V46, P351, DOI 10.1016/j.ecolind.2014.06.037; Lewandowski AS, 2010, CONSERV BIOL, V24, P1367, DOI 10.1111/j.1523-1739.2010.01513.x; Mace GM, 1994, SPECIES, P21; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; MARGULES C, 1981, BIOL CONSERV, V21, P79, DOI 10.1016/0006-3207(81)90073-2; Marshall MN, 1996, FAM PRACT, V13, P522, DOI 10.1093/fampra/13.6.522; Mascia MB, 2003, CONSERV BIOL, V17, P649, DOI 10.1046/j.1523-1739.2003.01738.x; Maskell LC, 2010, GLOBAL CHANGE BIOL, V16, P671, DOI 10.1111/j.1365-2486.2009.02022.x; Medeiros HR, 2015, J NAT CONSERV, V25, P1, DOI 10.1016/j.jnc.2015.01.008; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Mooney HA, 2013, P NATL ACAD SCI USA, V110, P3665, DOI 10.1073/pnas.1107484110; Munoz JM, 2013, PLANT BIOSYST, V147, P418, DOI 10.1080/11263504.2012.751062; NBN, 2013, NAT BIOD NETW HAB DI; Nicholson E, 2009, CONSERV BIOL, V23, P259, DOI 10.1111/j.1523-1739.2008.01158.x; Nilsson J, 1988, 18815 UNECE NORD COU; Pearsall J., 1998, NEW OXFORD DICT ENGL; Pierik M, 2011, ECOLOGY, V92, P1393, DOI 10.1890/10-0210.1; Preston C, 2002, NEW ATLAS BRIT IRISH; Reinds GJ, 2012, CCE STATUS REPORT 20, P49; Ridder B, 2007, J AGR ENVIRON ETHIC, V20, P195, DOI 10.1007/s10806-006-9025-6; Rodwell J.S., 1991, WOODLANDS SCRUB, VI; Rowe EC, 2013, AQ0828 ECW CTR EC HY, P90; Rowe EC, 2015, ENVIRON POLLUT SER, V25, P297, DOI 10.1007/978-94-017-9508-1_11; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schlutow A, 2015, ENVIRON POLLUT SER, V25, P381, DOI 10.1007/978-94-017-9508-1_14; Scientific Software Development, 2013, ATLAS TI VERS 6 2; Siddig AAH, 2016, ECOL INDIC, V60, P223, DOI 10.1016/j.ecolind.2015.06.036; Simberloff D, 2011, NATURE, V475, P36, DOI 10.1038/475036a; Smart SM, 2010, J VEG SCI, V21, P643, DOI 10.1111/j.1654-1103.2010.01173.x; Smart SM, 2000, MAVIS MODULAR ANAL V; Stanton JC, 2016, ECOL INDIC, V61, P683, DOI 10.1016/j.ecolind.2015.10.020; Stevens C.J., 2011, 447 JNCC; Stevens CJ, 2006, GLOBAL CHANGE BIOL, V12, P1823, DOI 10.1111/j.1365-2486.2006.01217.x; Strauss A., 1998, BASICS QUALITATIVE R; Suckall N, 2009, DRIVERS ENV CHANGE U, P393; SUTER GW, 1993, ENVIRON TOXICOL CHEM, V12, P1533, DOI 10.1002/etc.5620120903; Tipping E, 2013, ENVIRON POLLUT, V179, P218, DOI 10.1016/j.envpol.2013.04.008; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Trindade J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019746; Tucker CM, 2012, CONSERV BIOL, V26, P593, DOI 10.1111/j.1523-1739.2012.01845.x; UNEP, 2014, DEV IND NAT TARG PAR; van den Berg LJL, ENV POLLUTI IN PRESS; Van Der Wal R, 2015, ENVIRON CONSERV, V42, P349, DOI 10.1017/S0376892915000053; van Strien AJ, 2012, ECOL INDIC, V14, P202, DOI 10.1016/j.ecolind.2011.07.007; Verheyen K, 2012, J ECOL, V100, P352, DOI 10.1111/j.1365-2745.2011.01928.x; Wagner M, 2007, APPL VEG SCI, V10, P15, DOI 10.1111/j.1654-109X.2007.tb00499.x; Wallisdevries MF, 2006, GLOBAL CHANGE BIOL, V12, P1620, DOI 10.1111/j.1365-2486.2006.01202.x; Yoshioka PM, 2008, MAR ECOL PROG SER, V368, P309, DOI 10.3354/meps07728	92	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161085	10.1371/journal.pone.0161085	http://dx.doi.org/10.1371/journal.pone.0161085			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27557277	Green Published, Green Accepted, gold			2022-12-26	WOS:000382258100028
J	Sarmah, S; Muralidharan, P; Marrs, JA				Sarmah, Swapnalee; Muralidharan, Pooja; Marrs, James A.			Embryonic Ethanol Exposure Dysregulates BMP and Notch Signaling, Leading to Persistent Atrio-Ventricular Valve Defects in Zebrafish	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CONGENITAL HEART-DEFECTS; CARDIAC DEVELOPMENT; OUTFLOW TRACT; FOLIC-ACID; ALCOHOL; CUSHION; DIFFERENTIATION; MORPHOGENESIS; PREVALENCE	Fetal alcohol spectrum disorder (FASD), birth defects associated with ethanol exposure in utero, includes a wide spectrum of congenital heart defects (CHDs), the most prevalent of which are septal and conotruncal defects. Zebrafish FASD model was used to dissect the mechanisms underlying FASD-associated CHDs. Embryonic ethanol exposure (3-24 hours post fertilization) led to defects in atrio-ventricular (AV) valvulogenesis beginning around 37 hpf, a morphogenetic event that arises long after ethanol withdrawal. Valve leaflets of the control embryos comprised two layers of cells confined at the compact atrio-ventricular canal (AVC). Ethanol treated embryos had extended AVC and valve forming cells were found either as rows of cells spanning the AVC or as unorganized clusters near the AV boundary. Ethanol exposure reduced valve precursors at the AVC, but some ventricular cells in ethanol treated embryos exhibited few characteristics of valve precursors. Late staged larvae and juvenile fish exposed to ethanol during embryonic development had faulty AV valves. Examination of AVC morphogenesis regulatory networks revealed that early ethanol exposure disrupted the Bmp signaling gradient in the heart during valve formation. Bmp signaling was prominent at the AVC in controls, but ethanol-exposed embryos displayed active Bmp signaling throughout the ventricle. Ethanol exposure also led to mislocalization of Notch signaling cells in endocardium during AV valve formation. Normally, highly active Notch signaling cells were organized at the AVC. In ethanol-exposed embryos, highly active Notch signaling cells were dispersed throughout the ventricle. At later stages, ethanol-exposed embryos exhibited reduced Wnt/beta-catenin activity at the AVC. We conclude that early embryonic ethanol exposure alters Bmp, Notch and other signaling activities during AVC differentiation leading to faulty valve morphogenesis and valve defects persist in juvenile fish.	[Sarmah, Swapnalee; Muralidharan, Pooja; Marrs, James A.] Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Sarmah, S; Marrs, JA (corresponding author), Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46202 USA.	ssarmah@iupui.edu; jmarrs@iupui.edu			National Institute on Alcohol Abuse and Alcoholism [1 R21 AA0022396]; NIH/NIAAA [1 R21 AA0022396]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA022396] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIH/NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by 1 R21 AA0022396, National Institute on Alcohol Abuse and Alcoholism (JAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Kenneth Dunn, Ph.D. and Seth Winfree, Indiana Center for Biological Microscopy, for the SPIM imaging. We thank Keith W. Condon, Ph.D., Indiana University Histology core and Caroline Miller, Indiana University Electron Microscopy Center, for histology sections and scanning electron micrographs respectively. Plasmid probes to detect bmp4 and her2 were generously provided by Ela W. Knapik, Ph.D and Pamela Raymond, Ph.D. This work was supported by NIH/NIAAA 1 R21 AA0022396.	Alfieri CM, 2010, DEV BIOL, V338, P127, DOI 10.1016/j.ydbio.2009.11.030; Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Bartman T, 2004, PLOS BIOL, V2, P673, DOI 10.1371/journal.pbio.0020129; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bosada FM, 2016, DEVELOPMENT, V143, P1041, DOI 10.1242/dev.130575; Bruneau BG, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008292; BRUYERE HJ, 1993, TERATOLOGY, V48, P299, DOI 10.1002/tera.1420480403; Burd Larry, 2007, Congenit Heart Dis, V2, P250, DOI 10.1111/j.1747-0803.2007.00105.x; Cavieres MF, 2000, ALCOHOL CLIN EXP RES, V24, P102; Combs MD, 2009, CIRC RES, V105, P408, DOI 10.1161/CIRCRESAHA.109.201566; Cudd TA, 2005, EXP BIOL MED, V230, P389, DOI 10.1177/15353702-0323006-06; DAFT PA, 1986, TERATOLOGY, V33, P93, DOI 10.1002/tera.1420330112; Delot EC, 2003, DEVELOPMENT, V130, P209, DOI 10.1242/dev.00181; Dietrich AC, 2014, DEV CELL, V30, P367, DOI 10.1016/j.devcel.2014.06.020; FANG TT, 1987, TERATOLOGY, V35, P95, DOI 10.1002/tera.1420350113; Garside VC, 2013, CELL MOL LIFE SCI, V70, P2899, DOI 10.1007/s00018-012-1197-9; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; Haycock PC, 2009, BIOL REPROD, V81, P607, DOI 10.1095/biolreprod.108.074690; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Hu N, 2001, ANAT REC, V264, P1, DOI 10.1002/ar.1111; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Karunamuni G, 2014, AM J PHYSIOL-HEART C, V306, pH414, DOI 10.1152/ajpheart.00600.2013; Kokubo H, 2007, DEVELOPMENT, V134, P747, DOI 10.1242/dev.02777; Laux DW, 2011, DEV DYNAM, V240, P682, DOI 10.1002/dvdy.22558; Lazic S, 2011, DEV BIOL, V354, P123, DOI 10.1016/j.ydbio.2011.03.028; Lin CJ, 2012, DEVELOPMENT, V139, P3277, DOI 10.1242/dev.063495; Liu JD, 2012, CIRC RES, V110, P870, DOI 10.1161/CIRCRESAHA.111.246504; Luna-Zurita L, 2010, J CLIN INVEST, V120, P3493, DOI 10.1172/JCI42666; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; MacGrogan D, 2011, BIRTH DEFECTS RES A, V91, P449, DOI 10.1002/bdra.20815; Marrs JA, 2010, ALCOHOL, V44, P707, DOI 10.1016/j.alcohol.2009.03.004; Martin RT, 2009, DEV DYNAM, V238, P1796, DOI 10.1002/dvdy.21976; May PA, 2014, PEDIATRICS, V134, P855, DOI 10.1542/peds.2013-3319; May PA, 2009, DEV DISABIL RES REV, V15, P176, DOI 10.1002/ddrr.68; McCulley DJ, 2008, DEV DYNAM, V237, P3200, DOI 10.1002/dvdy.21743; Milan DJ, 2006, DEVELOPMENT, V133, P1125, DOI 10.1242/dev.02279; Misfeldt AM, 2009, DEV BIOL, V333, P78, DOI 10.1016/j.ydbio.2009.06.033; Muralidharan P, 2015, ALCOHOL, V49, P149, DOI 10.1016/j.alcohol.2014.11.001; Muralidharan P, 2013, BRAIN SCI, V3, P964, DOI 10.3390/brainsci3020964; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Palencia-Desai S, 2015, DEVELOPMENT, V142, P2304, DOI 10.1242/dev.118687; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Patra C, 2011, DEVELOPMENT, V138, P4499, DOI 10.1242/dev.067454; Rutenberg JB, 2006, DEVELOPMENT, V133, P4381, DOI 10.1242/dev.02607; Sampson PD, 1997, TERATOLOGY, V56, P317, DOI 10.1002/(SICI)1096-9926(199711)56:5<317::AID-TERA5>3.0.CO;2-U; Sarmah S, 2013, BIOL OPEN, V2, P1013, DOI 10.1242/bio.20135546; Sarmah S, 2013, DEV DYNAM, V242, P1184, DOI 10.1002/dvdy.24015; Sarmah S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010367; Scherz PJ, 2008, DEVELOPMENT, V135, P1179, DOI 10.1242/dev.010694; Serrano M, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.017; Shimizu N, 2012, DEV BIOL, V370, P71, DOI 10.1016/j.ydbio.2012.07.016; Shirai M, 2009, P NATL ACAD SCI USA, V106, P18604, DOI 10.1073/pnas.0900635106; Smith KA, 2011, DEVELOPMENT, V138, P4193, DOI 10.1242/dev.065375; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Staudt D, 2012, ANNU REV GENET, V46, P397, DOI 10.1146/annurev-genet-110711-155646; Sugi Y, 2004, DEV BIOL, V269, P505, DOI 10.1016/j.ydbio.2004.01.045; Sulik KK, 2005, EXP BIOL MED, V230, P366, DOI 10.1177/15353702-0323006-04; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Vermot J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000246; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; WEBSTER WS, 1984, CARDIOVASC RES, V18, P335, DOI 10.1093/cvr/18.6.335; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; WILLIAMS R, 1995, MECH DEVELOP, V53, P357, DOI 10.1016/0925-4773(95)00451-3; Yamada M, 2000, DEV BIOL, V228, P95, DOI 10.1006/dbio.2000.9927	65	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161205	10.1371/journal.pone.0161205	http://dx.doi.org/10.1371/journal.pone.0161205			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556898	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258100033
J	Wildgruber, M; Muller-Wille, R; Goessmann, H; Uller, W; Wohlgemuth, WA				Wildgruber, Moritz; Mueller-Wille, Rene; Goessmann, Holger; Uller, Wibke; Wohlgemuth, Walter A.			Direct Effective Dose Calculations in Pediatric Fluoroscopy-Guided Abdominal Interventions with Rando-Alderson Phantoms - Optimization of Preset Parameter Settings	PLOS ONE			English	Article							CARDIAC-CATHETERIZATION; RADIATION-EXPOSURE; COMPUTED-TOMOGRAPHY; PATIENT; RISK; NEURORADIOLOGY; DOSIMETERS; RADIOLOGY; DETECTOR; PRODUCT	Objective The aim of the study was to calculate the effective dose during fluoroscopy-guided pediatric interventional procedures of the liver in a phantom model before and after adjustment of preset parameters. Methods Organ doses were measured in three anthropomorphic Rando-Alderson phantoms representing children at various age and body weight (newborn 3.5kg, toddler 10kg, child 19kg). Collimation was performed focusing on the upper abdomen representing mock interventional radiology procedures such as percutaneous transhepatic cholangiography and drainage placement (PTCD). Fluoroscopy and digital subtraction angiography (DSA) acquisitions were performed in a posterior-anterior geometry using a state of the art flat-panel detector. Effective dose was directly measured from multiple incorporated thermoluminescent dosimeters (TLDs) using two different parameter settings. Results Effective dose values for each pediatric phantom were below 0.1mSv per minute fluoroscopy, and below 1mSv for a 1 minute DSA acquisition with a frame rate of 2 f/s. Lowering the values for the detector entrance dose enabled a reduction of the applied effective dose from 12 to 27% for fluoroscopy and 22 to 63% for DSA acquisitions. Similarly, organ doses of radiosensitive organs could be reduced by over 50%, especially when close to the primary x-ray beam. Conclusion Modification of preset parameter settings enabled to decrease the effective dose for pediatric interventional procedures, as determined by effective dose calculations using dedicated pediatric Rando-Alderson phantoms.	[Wildgruber, Moritz; Mueller-Wille, Rene; Goessmann, Holger; Uller, Wibke; Wohlgemuth, Walter A.] Univ Klinikum Regensburg, Inst Rontgendiagnost, Regensburg, Germany; [Wildgruber, Moritz] Univ Munster, Univ Klinikum Munster, Inst Klin Radiol, Munster, Germany	University of Regensburg; University of Munster	Wildgruber, M (corresponding author), Univ Klinikum Regensburg, Inst Rontgendiagnost, Regensburg, Germany.; Wildgruber, M (corresponding author), Univ Munster, Univ Klinikum Munster, Inst Klin Radiol, Munster, Germany.	moritz.wildgruber@ukmuenster.de						[Anonymous], 2007, ANN ICRP, V37, P1, DOI DOI 10.1016/J.ICRP.2007.10.003; Bacher K, 2005, CIRCULATION, V111, P83, DOI 10.1161/01.CIR.0000151098.52656.3A; Barnaoui S, 2014, PEDIATR CARDIOL, V35, P1037, DOI 10.1007/s00246-014-0895-5; Chida K, 2010, AM J ROENTGENOL, V195, P1175, DOI 10.2214/AJR.10.4466; Cortis K, 2014, CARDIOVASC INTER RAD, V37, P1078, DOI 10.1007/s00270-013-0814-9; Justino H, 2006, PEDIATR RADIOL, V36, P146, DOI 10.1007/s00247-006-0194-2; Mahnken AH, 2012, CARDIOVASC INTER RAD, V35, P1475, DOI 10.1007/s00270-011-0338-0; Miksys N, 2010, AM J ROENTGENOL, V194, P1315, DOI 10.2214/AJR.09.3634; Miraglia R, 2013, CARDIOVASC INTER RAD, V36, P1670, DOI 10.1007/s00270-013-0660-9; Otte JB, 2002, PEDIATR TRANSPLANT, V6, P378, DOI 10.1034/j.1399-3046.2002.01082.x; Paul J, 2012, EUR J RADIOL, V81, pE507, DOI 10.1016/j.ejrad.2011.06.006; Paul J, 2012, EUR J RADIOL, V81, pE699, DOI 10.1016/j.ejrad.2011.01.078; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Peters M, 2015, EUROPACE, V17, P611, DOI 10.1093/europace/euu207; Racadio JM, 2009, PEDIATR RADIOL, V39, pS71, DOI 10.1007/s00247-008-1004-9; Rassow J, 2000, BRIT J RADIOL, V73, P172, DOI 10.1259/bjr.73.866.10884731; SERVOMAA A, 1984, EUR J RADIOL, V4, P232; Servomaa A, 2001, RADIAT PROT DOSIM, V96, P235, DOI 10.1093/oxfordjournals.rpd.a006590; Struffert T, 2014, EUR RADIOL, V24, P1257, DOI 10.1007/s00330-014-3136-7; Thierry-Chef I, 2006, PEDIATR RADIOL, V36, P159, DOI 10.1007/s00247-006-0206-2; Tsapaki V, 2009, AM J ROENTGENOL, V193, P559, DOI 10.2214/AJR.08.2115; Varchena V, 2002, PEDIATR RADIOL, V32, P280, DOI 10.1007/s00247-002-0681-z	22	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161806	10.1371/journal.pone.0161806	http://dx.doi.org/10.1371/journal.pone.0161806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556584	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258100067
J	Peng, ZM; Liao, ZP; Matsumoto, Y; Yang, A; Tomkinson, AE				Peng, Zhimin; Liao, Zhongping; Matsumoto, Yoshihiro; Yang, Austin; Tomkinson, Alan E.			Human DNA Ligase I Interacts with and Is Targeted for Degradation by the DCAF7 Specificity Factor of the Cul4-DDB1 Ubiquitin Ligase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; DNA replication; proliferating cell nuclear antigen (PCNA); proteasome; protein turnover; proteolysis; ubiquitin; ubiquitin ligase; DNA ligase I; ubiquitylation	CELL NUCLEAR ANTIGEN; MOLECULAR-CLONING; REPLICATION FORK; GENE-EXPRESSION; AMINO-ACIDS; PHOSPHORYLATION; MUTATIONS; PROTEIN; INSTABILITY; CYCLE	The synthesis, processing, and joining of Okazaki fragments during DNA replication is complex, requiring the sequential action of a large number of proteins. Proliferating cell nuclear antigen, a DNA sliding clamp, interacts with and coordinates the activity of several DNA replication proteins, including the enzymes flap endonuclease 1 (FEN-1) and DNA ligase I that complete the processing and joining of Okazaki fragments, respectively. Although it is evident that maintaining the appropriate relative stoichiometry of FEN-1 and DNA ligase I, which compete for binding to proliferating cell nuclear antigen, is critical to prevent genomic instability, little is known about how the steady state levels of DNA replication proteins are regulated, in particular the proteolytic mechanisms involved in their turnover. Because DNA ligase I has been reported to be ubiquitylated, we used a proteomic approach to map ubiquitylation sites and screen for DNA ligase I-associated E3 ubiquitin ligases. We identified three ubiquitylated lysine residues and showed that DNA ligase I interacts with and is targeted for ubiquitylation by DCAF7, a specificity factor for the Cul4-DDB1 complex. Notably, knockdown of DCAF7 reduced the degradation of DNA ligase I in response to inhibition of proliferation and replacement of ubiquitylated lysine residues reduced the in vitro ubiquitylation of DNA ligase I by Cul4-DDB1 and DCAF7. In contrast, a different E3 ubiquitin ligase regulates FEN-1 turnover. Thus, although the expression of many of the genes encoding DNA replication proteins is coordinately regulated, our studies reveal that different mechanisms are involved in the turnover of these proteins.	[Peng, Zhimin; Matsumoto, Yoshihiro; Tomkinson, Alan E.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Peng, Zhimin; Matsumoto, Yoshihiro; Tomkinson, Alan E.] Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Peng, Zhimin; Matsumoto, Yoshihiro; Tomkinson, Alan E.] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA; [Liao, Zhongping; Yang, Austin] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Liao, Zhongping; Yang, Austin] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Liao, Zhongping] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Yang, Austin] NIA, NIH, Bethesda, MD 20892 USA	University of New Mexico; University of New Mexico; University of New Mexico; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Eli Lilly; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Tomkinson, AE (corresponding author), Canc Res Facil, 915 Camino Salud,1 Univ New Mexico, Albuquerque, NM 87131 USA.	atomkinson@salud.unm.edu		Matsumoto, Yoshihiro/0000-0001-6580-7188	University of New Mexico Comprehensive Cancer Center [P30 CA118100]; National Institute of Health [R01 GM057479]; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057479] Funding Source: NIH RePORTER	University of New Mexico Comprehensive Cancer Center; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of New Mexico Comprehensive Cancer Center (Grant P30 CA118100) and National Institute of Health Grant R01 GM057479 (to A. E. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; BARNES DE, 1990, P NATL ACAD SCI USA, V87, P6679, DOI 10.1073/pnas.87.17.6679; BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; Boisvert FM, 2010, MOL CELL PROTEOMICS, V9, P457, DOI 10.1074/mcp.M900429-MCP200; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castel AL, 2009, J BIOL CHEM, V284, P26631, DOI 10.1074/jbc.M109.034405; CHEN JW, 1995, MOL CELL BIOL, V15, P5412; Chen X, 2008, CANCER RES, V68, P3169, DOI 10.1158/0008-5472.CAN-07-6636; Ferrari G, 2003, J BIOL CHEM, V278, P37761, DOI 10.1074/jbc.M304462200; Gajewski E, 2007, BIOCHEM PHARMACOL, V73, P1947, DOI 10.1016/j.bcp.2007.03.022; Goetz JDM, 2005, DNA REPAIR, V4, P649, DOI 10.1016/j.dnarep.2005.02.004; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; Guo ZG, 2012, MOL CELL, V47, P444, DOI 10.1016/j.molcel.2012.05.042; Han JH, 2013, CELL, V155, P817, DOI 10.1016/j.cell.2013.10.014; Harrison C, 2002, CANCER RES, V62, P4065; Howes Timothy R L, 2012, Subcell Biochem, V62, P327, DOI 10.1007/978-94-007-4572-8_17; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Katiyar S, 2009, EMBO REP, V10, P866, DOI 10.1038/embor.2009.93; Kerzendorfer C, 2010, HUM MOL GENET, V19, P1324, DOI 10.1093/hmg/ddq008; Kim IS, 2000, BBA-MOL CELL RES, V1496, P333, DOI 10.1016/S0167-4889(00)00029-X; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Levin DS, 2000, CURR BIOL, V10, P919, DOI 10.1016/S0960-9822(00)00619-9; Levin DS, 2004, J BIOL CHEM, V279, P55196, DOI 10.1074/jbc.M409250200; Levin DS, 1997, P NATL ACAD SCI USA, V94, P12863, DOI 10.1073/pnas.94.24.12863; Liang L, 2008, NUCLEIC ACIDS RES, V36, P3297, DOI 10.1093/nar/gkn184; Liao Z, 2013, INT J PROTEOMICS, V2013, DOI DOI 10.1155/2013/291415; Liao ZP, 2012, ANAL CHEM, V84, P4535, DOI 10.1021/ac300510t; Montecucco A, 1998, EMBO J, V17, P3786, DOI 10.1093/emboj/17.13.3786; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; PETRINI JHJ, 1991, P NATL ACAD SCI USA, V88, P7615, DOI 10.1073/pnas.88.17.7615; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pirzio LM, 2004, CYTOGENET GENOME RES, V104, P87, DOI 10.1159/000077470; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Ritterhoff S, 2010, EMBO J, V29, P3750, DOI 10.1038/emboj.2010.251; Rossi R, 1999, EMBO J, V18, P5745, DOI 10.1093/emboj/18.20.5745; Singh P, 2008, MOL CANCER RES, V6, P1710, DOI 10.1158/1541-7786.MCR-08-0269; Skurat AV, 2004, J BIOL CHEM, V279, P2490, DOI 10.1074/jbc.M301769200; Subramanian J, 2005, GENETICS, V171, P427, DOI 10.1534/genetics.105.042861; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Sun DY, 2001, CLIN CANCER RES, V7, P4143; Tan FW, 2008, PROTEOMICS, V8, P2885, DOI 10.1002/pmic.200700887; Terai K, 2013, J BIOL CHEM, V288, P30509, DOI 10.1074/jbc.C113.505586; Vijayakumar S, 2009, MOL CELL BIOL, V29, P2042, DOI 10.1128/MCB.01732-08; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; WEBSTER ADB, 1992, LANCET, V339, P1508, DOI 10.1016/0140-6736(92)91266-B; WEI YF, 1995, MOL CELL BIOL, V15, P3206; WHITE JHM, 1986, EMBO J, V5, P1705, DOI 10.1002/j.1460-2075.1986.tb04414.x; Wisniewski JR, 2009, J PROTEOME RES, V8, P5674, DOI 10.1021/pr900748n; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Zhang SF, 2013, J BIOL CHEM, V288, P29550, DOI 10.1074/jbc.M113.490466; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599	58	12	12	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21893	21902		10.1074/jbc.M116.746198	http://dx.doi.org/10.1074/jbc.M116.746198			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27573245	Green Published, hybrid			2022-12-26	WOS:000386332600006
J	Racca, JD; Chen, YS; Yang, YW; Phillips, NB; Weiss, MA				Racca, Joseph D.; Chen, Yen-Shan; Yang, Yanwu; Phillips, Nelson B.; Weiss, Michael A.			Human Sex Determination at the Edge of Ambiguity INHERITED XY SEX REVERSAL DUE TO ENHANCED UBIQUITINATION AND PROTEASOMAL DEGRADATION OF A MASTER TRANSCRIPTION FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						developmental factor; proteasome; protein degradation; reproduction; transcription; DNA-binding domain; Sywer syndrome; disorders of sexual development; intersex	TESTIS-DETERMINING GENE; DETERMINING FACTOR SRY; DNA-BINDING ACTIVITY; HMG BOX REGION; GONADAL-DYSGENESIS; CAMPOMELIC DYSPLASIA; NUCLEAR-LOCALIZATION; TRANSCRIPTIONAL ACTIVATOR; HISTONE MODIFICATIONS; REGULATORY NETWORKS	A general problem is posed by analysis of transcriptional thresholds governing cell fate decisions in metazoan development. A model is provided by testis determination in therian mammals. Its key step, Sertoli cell differentiation in the embryonic gonadal ridge, is initiated by SRY, a Y-encoded architectural transcription factor. Mutations in human SRY cause gonadal dysgenesis leading to XY female development (Swyer syndrome). Here, we have characterized an inherited mutation compatible with either male or female somatic phenotypes as observed in an XY father and XY daughter, respectively. The mutation (a crevice-forming substitution at a conserved back surface of the SRY high mobility group box) markedly destabilizes the domain but preserves specific DNA affinity and induced DNA bend angle. On transient transfection of diverse human and rodent cell lines, the variant SRY exhibited accelerated proteasomal degradation (relative to wild type) associated with increased ubiquitination; in vitro susceptibility to ubiquitin-independent (default) cleavage by the 20S core proteasome was unchanged. The variant's gene regulatory activity (as assessed in a cellular model of the rat embryonic XY gonadal ridge) was reduced by 2-fold relative to wild-type SRY at similar levels of mRNA expression. Chemical proteasome inhibition restored native-like SRY expression and transcriptional activity in association with restored occupancy of a sex-specific enhancer element in principal downstream gene Sox9, demonstrating that the variant SRY exhibits essentially native activity on a per molecule basis. Our findings define a novel mechanism of impaired organogenesis, accelerated ubiquitin-directed proteasomal degradation of a master transcription factor leading to a developmental decision poised at the edge of ambiguity.	[Racca, Joseph D.; Chen, Yen-Shan; Yang, Yanwu; Phillips, Nelson B.; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, 10900 Euclid Ave, Cleveland, OH 44106 USA	Case Western Reserve University	Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem, 10900 Euclid Ave, Cleveland, OH 44106 USA.	maw21@case.edu			National Institutes of Health [GM080505]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work, a contribution from the Cleveland Center for Membrane and Structural Biology, was supported in part by National Institutes of Health Grant GM080505 (to M. A. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albrecht KH, 2003, GENETICS, V164, P277; Arkin A, 1998, GENETICS, V149, P1633; Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; Assumpcao JG, 2002, J MOL MED, V80, P782, DOI 10.1007/s00109-002-0376-9; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Ben-Nissan G, 2014, BIOMOLECULES, V4, P862, DOI 10.3390/biom4030862; Bowles J, 1999, NAT GENET, V22, P405, DOI 10.1038/11981; Chen Y., 2015, RARE DISORDERS DIAG, V1, P1; Chen YS, 2013, P NATL ACAD SCI USA, V110, pE3567, DOI 10.1073/pnas.1300828110; Chen YS, 2013, P NATL ACAD SCI USA, V110, pE3061, DOI 10.1073/pnas.1300860110; Correa SM, 2012, PLOS GENET, V8, P11, DOI 10.1371/journal.pgen.1002569; Czaja W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6434; Dahlmann B, 2016, ARCH BIOCHEM BIOPHYS, V591, P132, DOI 10.1016/j.abb.2015.12.012; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Desclozeaux M, 1998, J BIOL CHEM, V273, P7988, DOI 10.1074/jbc.273.14.7988; DICE JF, 1987, FASEB J, V1, P349, DOI 10.1096/fasebj.1.5.2824267; Domenice S, 1998, HUM GENET, V102, P213, DOI 10.1007/s004390050680; Dork T, 1998, HUM MUTAT, V11, P90; Draghi JA, 2010, NATURE, V463, P353, DOI 10.1038/nature08694; DUBIN RA, 1994, MOL ENDOCRINOL, V8, P1182, DOI 10.1210/me.8.9.1182; EICHER EM, 1983, J EXP ZOOL, V228, P297, DOI 10.1002/jez.1402280213; Eicher EM, 1996, NAT GENET, V14, P206, DOI 10.1038/ng1096-206; EICHER EM, 1982, SCIENCE, V217, P535, DOI 10.1126/science.7089579; Eicher EM, 2001, J EXP ZOOL, V290, P322, DOI 10.1002/jez.1072; ENNIS HL, 1964, SCIENCE, V146, P1474, DOI 10.1126/science.146.3650.1474; Forwood JK, 2001, J BIOL CHEM, V276, P46575, DOI 10.1074/jbc.M101668200; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Gianni S, 2014, BIOPHYS CHEM, V189, P33, DOI 10.1016/j.bpc.2014.03.003; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Graves JAM, 2002, NOVART FDN SYMP, V244, P86; Graves JAM, 2015, NATURE, V528, P343, DOI 10.1038/528343a; Graves JAM, 2013, DEV DYNAM, V242, P354, DOI 10.1002/dvdy.23887; Haqq CM, 1998, PHYSIOL REV, V78, P1; HAQQ CM, 1994, SCIENCE, V266, P1494, DOI 10.1126/science.7985018; Harley VR, 2003, P NATL ACAD SCI USA, V100, P7045, DOI 10.1073/pnas.1137864100; HARLEY VR, 1992, SCIENCE, V255, P453, DOI 10.1126/science.1734522; Hersmus R, 2009, EUR J HUM GENET, V17, P1642, DOI 10.1038/ejhg.2009.96; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; IKEGUCHI M, 1986, J BIOCHEM-TOKYO, V99, P1191, DOI 10.1093/oxfordjournals.jbchem.a135582; Imai A, 1999, ENDOCR J, V46, P735, DOI 10.1507/endocrj.46.735; IVANOV VI, 1973, BIOPOLYMERS, V12, P89, DOI 10.1002/bip.1973.360120109; JAGER RJ, 1992, HUM GENET, V90, P350; Jiang T., 2012, MOL BIOL REP, V316, P359; JOHNSON AD, 1981, NATURE, V294, P217, DOI 10.1038/294217a0; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Jordan BK, 2002, J CLIN ENDOCR METAB, V87, P3428, DOI 10.1210/jc.87.7.3428; KAPP OH, 1995, PROTEIN SCI, V4, P2179, DOI 10.1002/pro.5560041024; KEYES LN, 1992, CELL, V68, P933, DOI 10.1016/0092-8674(92)90036-C; KING CY, 1993, P NATL ACAD SCI USA, V90, P11990, DOI 10.1073/pnas.90.24.11990; Kirschner M, 1999, TRENDS CELL BIOL, V9, pM42, DOI 10.1016/S0962-8924(99)01666-9; Knower KC, 2003, CYTOGENET GENOME RES, V101, P185, DOI 10.1159/000074336; Knower KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017751; Kobayashi A, 2005, ANN NY ACAD SCI, V1061, P9, DOI 10.1196/annals.1336.003; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KURNIT DM, 1987, AM J HUM GENET, V41, P979; LAUDET V, 1993, NUCLEIC ACIDS RES, V21, P2493, DOI 10.1093/nar/21.10.2493; LEE CH, 1994, DEV BIOL, V165, P442, DOI 10.1006/dbio.1994.1266; Li B, 2006, J MOL BIOL, V360, P310, DOI 10.1016/j.jmb.2006.04.048; Li BR, 2001, J BIOL CHEM, V276, P46480, DOI 10.1074/jbc.C100388200; Liu ZR, 2014, PROTEIN SCI, V23, P539, DOI 10.1002/pro.2443; Livneh I, 2016, CELL RES, V26, P869, DOI 10.1038/cr.2016.86; Lodish H., 2000, MOL CELL BIOL, P129; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Matthews BW, 1996, FASEB J, V10, P35, DOI 10.1096/fasebj.10.1.8566545; MEYER BJ, 1980, J MOL BIOL, V139, P163, DOI 10.1016/0022-2836(80)90303-4; Meyer J, 1997, HUM MOL GENET, V6, P91, DOI 10.1093/hmg/6.1.91; Murphy EC, 2001, J MOL BIOL, V312, P481, DOI 10.1006/jmbi.2001.4977; Murphy FV, 1999, EMBO J, V18, P6610, DOI 10.1093/emboj/18.23.6610; NER S S, 1992, Current Biology, V2, P208, DOI 10.1016/0960-9822(92)90541-H; Paoletti M, 2007, CURR BIOL, V17, P1384, DOI 10.1016/j.cub.2007.07.012; Park SY, 2005, ENDOCRINOLOGY, V146, P1035, DOI 10.1210/en.2004-1454; Payne JL, 2014, ARTIF LIFE, V20, P111, DOI 10.1162/ARTL_a_00099; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Phillips NB, 2006, J MOL BIOL, V358, P172, DOI 10.1016/j.jmb.2006.01.060; Phillips NB, 2004, BIOCHEMISTRY-US, V43, P7066, DOI 10.1021/bi049920a; Phillips NB, 2011, J BIOL CHEM, V286, P36787, DOI 10.1074/jbc.M111.260091; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pingault V, 2013, AM J HUM GENET, V92, P707, DOI 10.1016/j.ajhg.2013.03.024; POULAT F, 1995, J CELL BIOL, V128, P737, DOI 10.1083/jcb.128.5.737; Privalov PL, 1999, J MOL BIOL, V294, P997, DOI 10.1006/jmbi.1999.3285; PTASHNE M, 1984, TRENDS BIOCHEM SCI, V9, P142, DOI 10.1016/0968-0004(84)90121-X; Ptashne M, 2004, GENETIC SWITCH PHAGE; Racca JD, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.597526; Rosenfeld JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-143; SAINI KS, 1990, MOL CELL BIOCHEM, V96, P15; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Sekido R, 2010, INT J BIOCHEM CELL B, V42, P417, DOI 10.1016/j.biocel.2009.12.005; Sequeira P., 2015, EVOLUTIONARY BIOL BI, P141; Sim H, 2008, TRENDS ENDOCRIN MET, V19, P213, DOI 10.1016/j.tem.2008.04.002; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Smith JM, 2004, TRENDS GENET, V20, P4, DOI 10.1016/j.tig.2003.11.007; Stent G. S., 1978, MOL GENETICS INTRO N, P204; TAJIMA T, 1994, HUM MOL GENET, V3, P1187, DOI 10.1093/hmg/3.7.1187; Tian TH, 2006, P NATL ACAD SCI USA, V103, P8372, DOI 10.1073/pnas.0507818103; Volker C., 2012, PROTEASOME UBIQUITIN, P1; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Warr N, 2012, WIRES DEV BIOL, V1, P559, DOI 10.1002/wdev.42; Weiss MA, 1997, J BIOMOL STRUCT DYN, V15, P177, DOI 10.1080/07391102.1997.10508185; WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4; WERNER MH, 1995, BIOCHEMISTRY-US, V34, P11998, DOI 10.1021/bi00037a042; Wilhelm D, 2009, MECH DEVELOP, V126, P324, DOI 10.1016/j.mod.2009.02.006; Wuensche A., 2004, MODULARITY DEV EVOLU, P600; YAMADA S, 1995, J BIOCHEM, V117, P1162, DOI 10.1093/oxfordjournals.jbchem.a124839; Zhang LY, 2015, MOL MED REP, V11, P4365, DOI 10.3892/mmr.2015.3273; Zhao L, 2014, P NATL ACAD SCI USA, V111, P11768, DOI 10.1073/pnas.1400666111	111	6	7	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22173	22195		10.1074/jbc.M116.741959	http://dx.doi.org/10.1074/jbc.M116.741959			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27576690	Green Published, hybrid			2022-12-26	WOS:000386332600030
J	Siegmund, K; Klepsch, V; Hermann-Kleiter, N; Baier, G				Siegmund, Kerstin; Klepsch, Victoria; Hermann-Kleiter, Natascha; Baier, Gottfried			Proof of Principle for a T Lymphocyte Intrinsic Function of Coronin 1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						animal model; autoimmunity; cell signaling; immunodeficiency; lymphocyte	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SEVERE COMBINED IMMUNODEFICIENCY; IMMUNE-RESPONSES; CELLS; SURVIVAL; DEFICIENCY; PROTEINS; MUTATION; CD4(+); MYCOBACTERIA	Coronins are evolutionarily conserved proteins that were originally identified as modulators of actin-dependent processes. Studies analyzing complete Coronin 1a knock-out mice have shown that this molecule is an important regulator of naive T cell homeostasis and it has been linked to immune deficiencies as well as autoimmune disorders. Nevertheless, because Coronin 1A is strongly expressed in all leukocyte subsets, it is not conclusive whether or not this phenotype is attributed to a T cell-intrinsic function of Coronin 1A. To address this research question, we have generated a T cell-specific Coronin 1a knock-out mouse (Coro1a(fl/fl) x Cd4[Cre]). Deletion of Coronin 1A specifically in T cells led to a strong reduction in T cell number and a shift toward the effector/memory phenotype in peripheral lymphoid organs when compared with Cd4[Cre] mice expressing wild-type Coronin 1A. In contrast to peripheral lymphoid tissue, thymocyte number and subsets were not affected by the deletion of Coronin 1a. Furthermore, T cell-specific Coronin 1a knock-out mice were largely resistant to the induction of autoimmunity when tested in the myelin oligoglycoprotein-induced EAE mouse model of multiple sclerosis. Thus, the phenotype of T cell-specific Coronin 1a deletion resembles the phenotype observed with conventional (whole body) Coronin 1a knock-out mice. In summary, our findings provide formal proof of the predominant T cell-intrinsic role of Coronin 1A.	[Siegmund, Kerstin; Klepsch, Victoria; Hermann-Kleiter, Natascha; Baier, Gottfried] Med Univ Innsbruck, Dept Pharmacol & Genet, Peter Mayr Str 1a, AT-6020 Innsbruck, Austria		Siegmund, K; Baier, G (corresponding author), Med Univ Innsbruck, Dept Pharmacol & Genet, Peter Mayr Str 1a, AT-6020 Innsbruck, Austria.	kerstin.siegmund@i-med.ac.at; Gottfried.Baier@i-med.ac.at	Klepsch, Victoria/ABB-9476-2021; Bellaire-Siegmund, Kerstin/D-4774-2018; Kleiter, Natascha/I-5101-2018; Bellaire-Siegmund, Kerstin/AAA-9702-2021	Bellaire-Siegmund, Kerstin/0000-0002-3654-1170; Kleiter, Natascha/0000-0003-4389-9813; Bellaire-Siegmund, Kerstin/0000-0002-3654-1170; Baier, Gottfried/0000-0002-2085-8325; Klepsch, Victoria/0000-0003-4146-4664	FWF Austrian Science Fund "Lise-Meitner" [M1636-B23, 25044-B21]; Medical University Innsbruck for young scientists MUI-START project [2013042002]; Austrian Science Fund (FWF) [M 1636, P 25044] Funding Source: researchfish	FWF Austrian Science Fund "Lise-Meitner"; Medical University Innsbruck for young scientists MUI-START project; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from the FWF Austrian Science Fund "Lise-Meitner" M1636-B23 (to K. S.) and 25044-B21 (to G. B.) and intramural funding program of the Medical University Innsbruck for young scientists MUI-START project 2013042002 (to K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Arandjelovic S, 2010, J LEUKOCYTE BIOL, V88, P737, DOI 10.1189/jlb.0310131; Batoulis H, 2010, ANN ANAT, V192, P179, DOI 10.1016/j.aanat.2010.06.006; Combaluzier B, 2009, J IMMUNOL, V182, P1954, DOI 10.4049/jimmunol.0801811; Combaluzier B, 2009, J IMMUNOL, V182, P2745, DOI 10.4049/jimmunol.0801812; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Foger N, 2011, J EXP MED, V208, P1777, DOI 10.1084/jem.20101757; Haraldsson MK, 2008, IMMUNITY, V28, P40, DOI 10.1016/j.immuni.2007.11.023; Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640; Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043; Jayachandran R, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001820; Kaminski S, 2011, J AUTOIMMUN, V37, P198, DOI 10.1016/j.jaut.2011.05.018; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Mace EM, 2014, P NATL ACAD SCI USA, V111, P6708, DOI 10.1073/pnas.1314975111; Moriceau S, 2009, J IMMUNOL, V182, P7254, DOI 10.4049/jimmunol.0803312; Moshous D, 2013, J ALLERGY CLIN IMMUN, V131, P1594, DOI 10.1016/j.jaci.2013.01.042; Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570; Mugnier B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003467; Pieters J, 2013, NAT REV IMMUNOL, V13, P510, DOI 10.1038/nri3465; Punwani D, 2015, J CLIN IMMUNOL, V35, P100, DOI 10.1007/s10875-015-0130-z; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Reddy J, 2004, P NATL ACAD SCI USA, V101, P15434, DOI 10.1073/pnas.0404444101; Seamons A, 2003, IMMUNOL RES, V28, P201, DOI 10.1385/IR:28:3:201; Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662; Shiow LR, 2009, CLIN IMMUNOL, V131, P24, DOI 10.1016/j.clim.2008.11.002; Siegmund K, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0100-3; Siegmund K, 2013, IMMUNOL LETT, V153, P62, DOI 10.1016/j.imlet.2013.06.005; Siegmund K, 2011, J IMMUNOL, V186, P3452, DOI 10.4049/jimmunol.1003491; Stephens LA, 2009, EUR J IMMUNOL, V39, P1108, DOI 10.1002/eji.200839073; Stray-Pedersen A, 2014, J CLIN IMMUNOL, V34, P871, DOI 10.1007/s10875-014-0074-8; Suo D, 2014, NAT NEUROSCI, V17, P36, DOI 10.1038/nn.3593; Tchang VSY, 2013, MOL IMMUNOL, V56, P683, DOI 10.1016/j.molimm.2013.05.003; Wachowicz K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096401; Westritschnig K, 2013, MOL IMMUNOL, V53, P379, DOI 10.1016/j.molimm.2012.09.002; Yee CS, 2016, J ALLERGY CLIN IMMUN, V137, P879, DOI 10.1016/j.jaci.2015.08.020	35	9	10	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22086	22092		10.1074/jbc.M116.748012	http://dx.doi.org/10.1074/jbc.M116.748012			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27566541	hybrid, Green Published			2022-12-26	WOS:000386332600023
J	Silverman, JM; Imperiali, B				Silverman, Julie Michelle; Imperiali, Barbara			Bacterial N-Glycosylation Efficiency Is Dependent on the Structural Context of Target Sequons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						N-linked glycosylation; oligosaccharyltransferase; protein folding; protein translocation; substrate specificity	LINKED PROTEIN GLYCOSYLATION; CAMPYLOBACTER-JEJUNI; OLIGOSACCHARYL TRANSFERASE; ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY; ENDOPLASMIC-RETICULUM; COMPLEX; STT3; IDENTIFICATION; CHAPERONES	Site selectivity of protein N-linked glycosylation is dependent on many factors, including accessibility of the modification site, amino acid composition of the glycosylation consensus sequence, and cellular localization of target proteins. Previous studies have shown that the bacterial oligosaccharyltransferase, PglB, of Campylobacter jejuni favors acceptor proteins with consensus sequences ((D/E)X1NX2(S/T), where X-1,X-2 proline) in flexible, solvent-exposed motifs; however, several native glycoproteins are known to harbor consensus sequences within structured regions of the acceptor protein, suggesting that unfolding or partial unfolding is required for efficient N-linked glycosylation in the native environment. To derive insight into these observations, we generated structural homology models of the N-linked glycoproteome of C. jejuni. This evaluation highlights the potential diversity of secondary structural conformations of previously identified N-linked glycosylation sequons. Detailed assessment of PglB activity with a structurally characterized acceptor protein, PEB3, demonstrated that this natively folded substrate protein is not efficiently glycosylated in vitro, whereas structural destabilization increases glycosylation efficiency. Furthermore, in vivo glycosylation studies in both glyco-competent Escherichia coli and the native system, C. jejuni, revealed that efficient glycosylation of glycoproteins, AcrA and PEB3, depends on translocation to the periplasmic space via the general secretory pathway. Our studies provide quantitative evidence that many acceptor proteins are likely to be N-linked-glycosylated before complete folding and suggest that PglB activity is coupled to general secretion-mediated translocation to the periplasm. This work extends our understanding of the molecular mechanisms underlying N-linked glycosylation in bacteria.	[Silverman, Julie Michelle; Imperiali, Barbara] MIT, Dept Biol, 77 Massachusetts Ave,68-380, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Imperiali, B (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave,68-380, Cambridge, MA 02139 USA.	imper@mit.edu		Imperiali, Barbara/0000-0002-5749-7869	National Institutes of Health [GM-039334, AI109857]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI109857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM-039334 (to B. I.) and AI109857 (to J. M. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Antonoaea R, 2008, BIOCHEMISTRY-US, V47, P5649, DOI 10.1021/bi800233w; Bagos PG, 2010, BIOINFORMATICS, V26, P2811, DOI 10.1093/bioinformatics/btq530; Beckwith J, 2013, RES MICROBIOL, V164, P497, DOI 10.1016/j.resmic.2013.03.007; Berks BC, 2015, ANNU REV BIOCHEM, V84, P843, DOI 10.1146/annurev-biochem-060614-034251; Chavan M, 2005, J BIOL CHEM, V280, P22917, DOI 10.1074/jbc.M502858200; Chen MM, 2007, BIOCHEMISTRY-US, V46, P5579, DOI 10.1021/bi602633n; Chen W, 2000, MOL BIOL CELL, V11, P765, DOI 10.1091/mbc.11.2.765; Cherepanova NA, 2014, J CELL BIOL, V206, P525, DOI 10.1083/jcb.201404083; Culyba EK, 2011, SCIENCE, V331, P571, DOI 10.1126/science.1198461; Davis Lindsay, 2008, Curr Protoc Microbiol, VChapter 8, DOI [10.1002/9780471729259.mc08a01s10, 10.1002/9780471729259.mc08a02s10]; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Fisher AC, 2011, APPL ENVIRON MICROB, V77, P871, DOI 10.1128/AEM.01901-10; Glover KJ, 2005, CHEM BIOL, V12, P1311, DOI 10.1016/j.chembiol.2005.10.004; Glover KJ, 2005, P NATL ACAD SCI USA, V102, P14255, DOI 10.1073/pnas.0507311102; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hendrixson DR, 2004, MOL MICROBIOL, V52, P471, DOI 10.1111/j.1365-2958.2004.03988.x; Hese K, 2009, GLYCOBIOLOGY, V19, P160, DOI 10.1093/glycob/cwn118; Hitchcock A, 2010, MICROBIOL-SGM, V156, P2994, DOI 10.1099/mic.0.042788-0; Jaffe SRP, 2014, CURR OPIN BIOTECH, V30, P205, DOI 10.1016/j.copbio.2014.07.006; Jaffee MB, 2013, PROTEIN EXPRES PURIF, V89, P241, DOI 10.1016/j.pep.2013.04.001; Johnson DE, 2009, J BIOL CHEM, V284, P20499, DOI 10.1074/jbc.M109.019042; Kale A, 2011, J BIOL CHEM, V286, P21254, DOI 10.1074/jbc.M111.220442; Kawai F, 2012, J STRUCT BIOL, V177, P583, DOI 10.1016/j.jsb.2012.01.001; Kelleher DJ, 2007, J CELL BIOL, V177, P29, DOI 10.1083/jcb.200611079; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Larsen JC, 2004, J BACTERIOL, V186, P6508, DOI 10.1128/JB.186.19.6508-6514.2004; LEI SP, 1987, J BACTERIOL, V169, P4379, DOI 10.1128/jb.169.9.4379-4383.1987; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Linton D, 2005, MOL MICROBIOL, V55, P1695, DOI 10.1111/j.1365-2958.2005.04519.x; Linton D, 2002, MOL MICROBIOL, V43, P497, DOI 10.1046/j.1365-2958.2002.02762.x; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Matern Y, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-251; Min T, 2009, BIOCHEMISTRY-US, V48, P3057, DOI 10.1021/bi802195d; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Mohorko E, 2014, STRUCTURE, V22, P590, DOI 10.1016/j.str.2014.02.013; Mohorko E, 2011, J INHERIT METAB DIS, V34, P869, DOI 10.1007/s10545-011-9337-1; Muller A, 2005, MOL MICROBIOL, V57, P143, DOI 10.1111/j.1365-2958.2005.04691.x; Nasab FP, 2008, MOL BIOL CELL, V19, P3758, DOI 10.1091/mbc.E08-05-0467; Nilsson I, 2003, J CELL BIOL, V161, P715, DOI 10.1083/jcb.200301043; Nothaft H, 2012, MOL CELL PROTEOMICS, V11, P1203, DOI 10.1074/mcp.M112.021519; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Pandhal J, 2013, BIOTECHNOL BIOENG, V110, P2482, DOI 10.1002/bit.24920; Pandhal J, 2012, BIOCHEM BIOPH RES CO, V419, P472, DOI 10.1016/j.bbrc.2012.02.020; Pandhal J, 2010, BIOTECHNOL LETT, V32, P1189, DOI 10.1007/s10529-010-0289-6; PEI ZH, 1991, J BIOL CHEM, V266, P16363; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Pfeffer S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4072; Rangarajan ES, 2007, PROTEIN SCI, V16, P990, DOI 10.1110/ps.062737507; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Schwarz F, 2010, NAT CHEM BIOL, V6, P264, DOI [10.1038/NCHEMBIO.314, 10.1038/nchembio.314]; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; Shibatani T, 2005, BIOCHEMISTRY-US, V44, P5982, DOI 10.1021/bi047328f; Shrimal S, 2013, J CELL BIOL, V201, P81, DOI 10.1083/jcb.201301031; Slynko V, 2009, J AM CHEM SOC, V131, P1274, DOI 10.1021/ja808682v; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; Szymanski CM, 2002, INFECT IMMUN, V70, P2242, DOI 10.1128/IAI.70.4.2242-2244.2002; Tullman-Ercek D, 2007, J BIOL CHEM, V282, P8309, DOI 10.1074/jbc.M610507200; Valderrama-Rincon JD, 2012, NAT CHEM BIOL, V8, P434, DOI [10.1038/NCHEMBIO.921, 10.1038/nchembio.921]; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Whitley P, 1996, J BIOL CHEM, V271, P6241, DOI 10.1074/jbc.271.11.6241; Yan G, 2002, J BIOL CHEM, V277, P47692, DOI 10.1074/jbc.M208136200; YAO RJ, 1993, GENE, V130, P127, DOI 10.1016/0378-1119(93)90355-7; Yusuf SNHM, 2013, BIOCHEM BIOPH RES CO, V432, P438, DOI 10.1016/j.bbrc.2013.01.128	72	25	27	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22001	22010		10.1074/jbc.M116.747121	http://dx.doi.org/10.1074/jbc.M116.747121			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27573243	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000386332600015
J	Abdi, S; Bahloul, A; Behlouli, A; Hardelin, JP; Makrelouf, M; Boudjelida, K; Louha, M; Cheknene, A; Belouni, R; Rous, Y; Merad, Z; Selmane, D; Hasbelaoui, M; Bonnet, C; Zenati, A; Petit, C				Abdi, Samia; Bahloul, Amel; Behlouli, Asma; Hardelin, Jean-Pierre; Makrelouf, Mohamed; Boudjelida, Kamel; Louha, Malek; Cheknene, Ahmed; Belouni, Rachid; Rous, Yahia; Merad, Zahida; Selmane, Djamel; Hasbelaoui, Mokhtar; Bonnet, Crystel; Zenati, Akila; Petit, Christine			Diversity of the Genes Implicated in Algerian Patients Affected by Usher Syndrome	PLOS ONE			English	Article							RETINITIS-PIGMENTOSA; MOLECULAR DIAGNOSIS; LONG ISOFORM; HAIR-CELLS; MUTATIONS; PROTEIN; DEAFNESS; PREVALENCE; PATHOGENESIS; FREQUENCY	Usher syndrome (USH) is an autosomal recessive disorder characterized by a dual sensory impairment affecting hearing and vision. USH is clinically and genetically heterogeneous. Ten different causal genes have been reported. We studied the molecular bases of the disease in 18 unrelated Algerian patients by targeted-exome sequencing, and identified the causal biallelic mutations in all of them: 16 patients carried the mutations at the homozygous state and 2 at the compound heterozygous state. Nine of the 17 different mutations detected in MYO7A (1 of 5 mutations), CDH23 (4 of 7 mutations), PCDH15 (1 mutation), USH1C (1 mutation), USH1G (1 mutation), and USH2A (1 of 2 mutations), had not been previously reported. The deleterious consequences of a missense mutation of CDH23 (p. Asp1501Asn) and the in-frame single codon deletion in USH1G (p. Ala397del) on the corresponding proteins were predicted from the solved 3D-structures of extracellular cadherin (EC) domains of cadherin-23 and the sterile alpha motif (SAM) domain of USH1G/sans, respectively. In addition, we were able to show that the USH1G mutation is likely to affect the binding interface between the SAM domain and USH1C/harmonin. This should spur the use of 3D-structures, not only of isolated protein domains, but also of protein-protein interaction interfaces, to predict the functional impact of mutations detected in the USH genes.	[Abdi, Samia; Behlouli, Asma; Makrelouf, Mohamed; Zenati, Akila] Univ Alger 1, Lab Biochim Genet, Serv Biol CHU Bab El Oued, Algiers 16, Algeria; [Abdi, Samia; Belouni, Rachid] CHU Frantz Fanon, Lab Cent Biol, Blida 09, Algeria; [Abdi, Samia; Boudjelida, Kamel; Cheknene, Ahmed; Belouni, Rachid; Rous, Yahia; Merad, Zahida] Univ Saad Dahleb, Fac Med, Blida 09, Algeria; [Bahloul, Amel; Hardelin, Jean-Pierre; Petit, Christine] Inst Pasteur, INSERM, UMRS1120, Unite Genet & Physiol Audit, F-75015 Paris, France; [Behlouli, Asma] Univ Sci & Technol Houari Boumediene, Fac Sci Biol, Algiers 16, Algeria; [Boudjelida, Kamel; Merad, Zahida] CHU Frantz Fanon, Serv Ophtalmol, Blida 09, Algeria; [Louha, Malek] Hop Armand Trousseau, AP HP, Serv Biochim & Biol Mol, F-75012 Paris, France; [Cheknene, Ahmed; Rous, Yahia] CHU Frantz Fanon, Serv ORL, Blida 09, Algeria; [Selmane, Djamel] CHU Bab El Oued, Serv ORL, Algiers 16, Algeria; [Hasbelaoui, Mokhtar] CHU Tizi Ouzou, Serv ORL, Tizi Ouzou 15, Algeria; [Bonnet, Crystel; Petit, Christine] Univ Paris 06, Inst Vis, INSERM, UMRS 1120, F-75005 Paris, France; [Petit, Christine] Coll France, F-75005 Paris, France	Universite Saad Dahlab de Blida; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University Science & Technology Houari Boumediene; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Bordeaux; UDICE-French Research Universities; PSL Research University Paris; College de France	Petit, C (corresponding author), Univ Paris 06, Inst Vis, INSERM, UMRS 1120, F-75005 Paris, France.; Petit, C (corresponding author), Coll France, F-75005 Paris, France.	christine.petit@pasteur.fr	Bonnet, Crystel/AAN-5950-2021	Bonnet, Crystel/0000-0002-1916-9119; Petit, Christine/0000-0002-9069-002X; BAHLOUL, Amel/0000-0001-7042-4616	Tassili Project; Algerian government; BNP Paribas Foundation; ERC grant "Hair bundle" [ERC-2011-AdG 294570]; French LABEX LIFESENSES grant [ANR-10-LABX-65]; ERC grant "Hair bundle" (LIGHT4DEAF) [ANR-15-RHUS-001]	Tassili Project; Algerian government; BNP Paribas Foundation; ERC grant "Hair bundle"; French LABEX LIFESENSES grant; ERC grant "Hair bundle" (LIGHT4DEAF)	This work was supported by grants from the Tassili Project, the Algerian government, the BNP Paribas Foundation, the ERC grant "Hair bundle" (ERC-2011-AdG 294570), ANR-15-RHUS-001 (LIGHT4DEAF), and the French LABEX LIFESENSES grant [reference ANR-10-LABX-65].; We thank all the family members for their participation in the study. We also thank Luce Smagghe for technical assistance. This work was supported by grants from the Tassili Project, the Algerian government, the BNP Paribas Foundation, the ERC grant "Hair bundle" (ERC-2011-AdG 294570), ANR-15-RHUS-001 (LIGHT4DEAF), and the French LABEX LIFE-SENSES grant [reference ANR-10-LABX-65].	Adato A, 1997, AM J HUM GENET, V61, P813, DOI 10.1086/514899; Adato A, 2005, HUM MOL GENET, V14, P347, DOI 10.1093/hmg/ddi031; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Aller E, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041764; Aller E, 2010, EUR J HUM GENET, V18, P788, DOI 10.1038/ejhg.2010.14; Ammar-Khodja F, 2015, MOL GENET GENOM MED, V3, P189, DOI 10.1002/mgg3.131; Ammar-Khodja F, 2009, EUR J MED GENET, V52, P174, DOI 10.1016/j.ejmg.2009.03.018; Aparisi MJ, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0168-7; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Besnard T, 2014, MOL GENET GENOM MED, V2, P30, DOI 10.1002/mgg3.25; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bonnet C, 2016, EUR J HUM GENET, V24, P1730, DOI 10.1038/ejhg.2016.99; Bonnet C, 2012, CURR OPIN NEUROL, V25, P42, DOI 10.1097/WCO.0b013e32834ef8b2; Bonnet C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-21; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; BOUGHMAN JA, 1983, J CHRON DIS, V36, P595, DOI 10.1016/0021-9681(83)90147-9; Ebermann I, 2007, HUM GENET, V121, P203, DOI 10.1007/s00439-006-0304-0; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Glockle N, 2014, EUR J HUM GENET, V22, P99, DOI 10.1038/ejhg.2013.72; Hope CI, 1997, BRIT J OPHTHALMOL, V81, P46, DOI 10.1136/bjo.81.1.46; Joensuu T, 2001, AM J HUM GENET, V69, P673, DOI 10.1086/323610; Kimberling WJ, 2010, GENET MED, V12, P512, DOI 10.1097/GIM.0b013e3181e5afb8; Lenarduzzi S, 2015, HEARING RES, V320, P18, DOI 10.1016/j.heares.2014.12.006; Michalski N, 2007, J NEUROSCI, V27, P6478, DOI 10.1523/JNEUROSCI.0342-07.2007; MOLLER CG, 1989, LARYNGOSCOPE, V99, P73; Oshima A, 2008, Hum Mutat, V29, pE37, DOI 10.1002/humu.20761; Reiners J, 2006, EXP EYE RES, V83, P97, DOI 10.1016/j.exer.2005.11.010; Riahi Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120584; Riazuddin S, 2012, NAT GENET, V44, P1265, DOI 10.1038/ng.2426; Roux AF, 2006, J MED GENET, V43, P763, DOI 10.1136/jmg.2006.041954; SMITH RJH, 1994, AM J MED GENET, V50, P32, DOI 10.1002/ajmg.1320500107; Sotomayor M, 2012, NATURE, V492, P128, DOI 10.1038/nature11590; Spandau UHM, 2002, GRAEF ARCH CLIN EXP, V240, P495, DOI 10.1007/s00417-002-0485-8; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Weil D, 2003, HUM MOL GENET, V12, P463, DOI 10.1093/hmg/ddg051; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; Weston MD, 1996, AM J HUM GENET, V59, P1074; Yan J, 2010, P NATL ACAD SCI USA, V107, P4040, DOI 10.1073/pnas.0911385107	40	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161893	10.1371/journal.pone.0161893	http://dx.doi.org/10.1371/journal.pone.0161893			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583663	Green Published, gold, Green Submitted			2022-12-26	WOS:000382855600070
J	Cagney, KA; Sterrett, D; Benz, J; Tompson, T				Cagney, Kathleen A.; Sterrett, David; Benz, Jennifer; Tompson, Trevor			Social Resources and Community Resilience in the Wake of Superstorm Sandy	PLOS ONE			English	Article							COLLECTIVE EFFICACY; VIOLENT CRIME; DISASTER; RECOVERY; PREPAREDNESS; PARADOX	Recovery efforts after natural disasters typically focus on physical infrastructure. In general less attention is paid to the social infrastructure that might impact the capacity of the community to rebuild. We examine perceptions of preparedness and recovery (markers of resilience at the community level) in the wake of Superstorm Sandy with a novel data set that includes a multi-mode survey of twelve neighborhoods severely affected by the storm. With these data, we suggest that social resources are associated with beliefs about neighborhood resilience. People who live in communities with higher social cohesion (coefficient = .73, p < .001), informal social control (coefficient = .53, p < .001), and social exchange (coefficient = .69, p < .001) are more likely to believe their neighborhoods are well prepared for a disaster. Likewise, people living in communities with higher social cohesion (coefficient = .35, p < .01), informal social control (coefficient = .27, p < .05), and social exchange (coefficient = .42, p < .001) are more likely to be confident their neighborhoods will recover quickly from a disaster. However, the effects of social resources on beliefs about resilience vary based on neighborhood socioeconomic status (SES) and the impact of the storm. Informal social control and social exchange lead to a greater increase in confidence in recovery in low, as compared to high, SES neighborhoods. Social resources tend to have more impact on perceptions of recovery in communities less affected by the storm. In sum, these findings suggest the potential value of various forms of social intervention to better equip communities to respond when disaster strikes.	[Cagney, Kathleen A.] Univ Chicago, Dept Sociol, Chicago, IL 60637 USA; [Sterrett, David; Benz, Jennifer; Tompson, Trevor] Univ Chicago, NORC, Associated Press NORC Ctr Publ Affairs Res, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Cagney, KA (corresponding author), Univ Chicago, Dept Sociol, Chicago, IL 60637 USA.	kacagney@uchicago.edu			Rockefeller Foundation	Rockefeller Foundation	This study was funded by the Rockefeller Foundation (rockefellerfoundation.org) and awarded to TT and KC. The funder commented on the study design. The funder had no role in data collection, data analysis, decision to publish or preparation of the manuscript.; We would like to thank the many researchers and journalists from across NORC, the University of Chicago, and the Associated Press who provided critical support to this project. From NORC, we thank Dan Malato, Rebecca Reimer, Matthew Courser (now at PIRE), Emily Dooley (now at Newsday), and Emily Alvarez for extensive support of the data collection and analysis, as well Mike Meit for his early contributions to the study design. We also thank NORC statisticians Ned English, Becki Curtis, Wei Zeng, and Jie Zhao for informing the neighborhood selection and leading the survey sampling and weighting. We especially thank the staff of NORC's Telephone Survey and Support Operations and Field Operations who collected the data for their invaluable contribution to the study. From AP, we thank Karen Testa, Evan Berland, James Martinez, and Amanda Barrett for their insights into the affected region, as well as Jennifer Agiesta (now at CNN) for her contributions to the analysis and report. We thank The Rockefeller Foundation for supporting our work and for contributing their expertise. In particular we acknowledge Nancy Kete, Neill Coleman, Sundaa Bridgett-Jones, and Sam Carter. We also thank the other Rockefeller grantees for input throughout the project period, including the participants of the workshop on Measuring, Assessing and Profiling Human Resilience at the Bellagio Center. We note that University of Chicago colleagues shared advice on the research design and subsequent analysis. We thank Christopher Browning from The Ohio State University for his help constructing the neighborhood-level measures and Wendy Fleischer from the NYC Housing and Neighborhood Recovery Donor Collaborative for her insights during the neighborhood selection process.	Abramson DM, 2015, J BEHAV HEALTH SER R, V42, P42, DOI 10.1007/s11414-014-9410-2; Aldrich DP, 2014, AM BEHAV SCI; Aldrich DP, 2012, BUILDING RESILIENCE, DOI 10.7208/chicago/9780226012896.001.0001; AP-NORC Center for Public Affairs Research, 2013, 2 YEARS SUP SAND EXP; Bandura A., 1986, SOCIAL FDN THOUGHT A; Berkes F, 2013, SOC NATUR RESOUR, V26, P5, DOI 10.1080/08941920.2012.736605; Bhandari RB, 2014, DISASTER PREV MANAG, V23, P314, DOI 10.1108/DPM-06-2013-0105; Bihari M, 2012, LANDSCAPE URBAN PLAN, V106, P253, DOI 10.1016/j.landurbplan.2012.03.011; Browning CR, 2006, AM SOCIOL REV, V71, P661, DOI 10.1177/000312240607100407; Browning CR, 2004, SOC FORCES, V83, P503, DOI 10.1353/sof.2005.0006; Browning CR, 2002, J HEALTH SOC BEHAV, V43, P383, DOI 10.2307/3090233; Browning CR, 2002, J MARRIAGE FAM, V64, P833, DOI 10.1111/j.1741-3737.2002.00833.x; Burayidi M., 2013, RESILIENT DOWNTOWNS; Burton I, 2015, INT J DISAST RISK RE, V12, P1, DOI 10.1016/j.ijdrr.2014.08.006; Cagney KA, 2007, AM J PUBLIC HEALTH, V97, P919, DOI 10.2105/AJPH.2005.071472; Chamlee-Wright E, 2011, SOCIOL REV, V59, P266, DOI 10.1111/j.1467-954X.2011.02008.x; Cox RS, 2011, AM J COMMUN PSYCHOL, V48, P395, DOI 10.1007/s10464-011-9427-0; House J.S., 1988, SCIENCE, V29, P241; Jacobs J, 1961, LIFE DEATH GREAT AM; Madsen W, 2016, J COMMUNITY PSYCHOL, V44, P277, DOI 10.1002/jcop.21764; McCreight R, 2010, J HOMEL SECUR EMERG, V7; Mukherji A, 2014, J CIV SOC, V10, P119, DOI 10.1080/17448689.2014.885787; Norris FH, 2008, AM J COMMUN PSYCHOL, V41, P127, DOI 10.1007/s10464-007-9156-6; Park Robert E., 1925, CITY; PORTES A., 1998, ANN REV SOCIOLOGY; Rae Douglas W., 2003, CITY URBANISM ITS EN; Rahill GJ, 2014, DISASTERS, V38, pS73, DOI 10.1111/disa.12051; Reininger BM, 2013, SOC SCI MED, V83, P50, DOI 10.1016/j.socscimed.2013.01.037; Rich MA, 2013, J URBAN AFF, V35, P365, DOI 10.1111/j.1467-9906.2012.00639.x; Sampson R. J., 2012, GREAT AMERICAN CITY; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Shaw C. R., 1969, CLASSICS ENV CRIMINO; Silver E, 2004, CRIMINOLOGY, V42, P551, DOI 10.1111/j.1745-9125.2004.tb00529.x; Subaiya S, 2014, AM J PUBLIC HEALTH, V104, P632, DOI 10.2105/AJPH.2013.301668; United Nations International Strategy for Disaster Reduction, 2005, HYOG FRAM ACT 2005 2; Walker B., 2012, RESILIENCE PRACTICE; Wirth L, 1938, AM J SOCIOL, V44, P1, DOI 10.1086/217913	37	42	43	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0160824	10.1371/journal.pone.0160824	http://dx.doi.org/10.1371/journal.pone.0160824			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EG	27579482	gold, Green Published, Green Submitted			2022-12-26	WOS:000382877400010
J	Chiu, WC; Chiou, TJ; Chung, MJ; Chiang, AN				Chiu, Wen-Chin; Chiou, Tzeon-Jye; Chung, Meng-Ju; Chiang, An-Na			beta(2)-Glycoprotein I Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Suppressing the Phosphorylation of Extracellular Signal-Regulated Kinase 1/2, Akt, and Endothelial Nitric Oxide Synthase	PLOS ONE			English	Article							CELL MIGRATION; STIMULATES ANGIOGENESIS; GLYCOPROTEIN-I; VEGF; BETA-2-GLYCOPROTEIN-I; NEOVASCULARIZATION; PROLIFERATION; PROGRESSION; EXPRESSION; CARCINOMA	Angiogenesis is the process of new blood vessel formation, and it plays a key role in various physiological and pathological conditions. The beta(2)-glycoprotein I (beta(2)-GPI) is a plasma glycoprotein with multiple biological functions, some of which remain to be elucidated. This study aimed to identify the contribution of beta(2)-GPI on the angiogenesis induced by vascular endothelial growth factor (VEGF), a pro-angiogenic factor that may regulate endothelial remodeling, and its underlying mechanism. Our results revealed that beta(2)-GPI dose-dependently decreased the VEGF-induced increase in endothelial cell proliferation, using the 3-(4,5-dimethylthiazol- 2-yl)-2,5-diphenyltetrazolium bromide (MTT) and the bromodeoxyuridine (BrdU) incorporation assays. Furthermore, incubation with both beta(2)-GPI and deglycosylated beta(2)-GPI inhibited the VEGF-induced tube formation. Our results suggest that the carbohydrate residues of beta(2)-GPI do not participate in the function of anti-angiogenesis. Using in vivo Matrigel plug and angioreactor assays, we show that beta(2)-GPI remarkably inhibited the VEGF-induced angiogenesis at a physiological concentration. Moreover, beta(2)-GPI inhibited the VEGF-induced phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2), Akt, and endothelial nitric oxide synthase (eNOS). In summary, our in vitro and in vivo data reveal for the first time that beta(2)-GPI inhibits the VEGF-induced angiogenesis and highlights the potential for beta(2)-GPI in anti-angiogenic therapy.	[Chiu, Wen-Chin; Chung, Meng-Ju; Chiang, An-Na] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei, Taiwan; [Chiu, Wen-Chin] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Thorac Surg, Kaohsiung, Taiwan; [Chiou, Tzeon-Jye] Taipei Vet Gen Hosp, Dept Med, Div Transfus Med, Taipei, Taiwan; [Chiou, Tzeon-Jye] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan	National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chiang, AN (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei, Taiwan.	anchia@ym.edu.tw			Ministry of Education, Aiming for the Top University Plan; National Science Council [NSC 102-2320-B-010-025]; Ministry of Science and Technology, Taiwan, ROC [MOST 103-2320-B-010-024-MY3]	Ministry of Education, Aiming for the Top University Plan; National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was supported by the grants from a grant from Ministry of Education, Aiming for the Top University Plan; the National Science Council (grant number NSC 102-2320-B-010-025); and the Ministry of Science and Technology (grant number MOST 103-2320-B-010-024-MY3), Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alard JE, 2010, J IMMUNOL, V185, P1550, DOI 10.4049/jimmunol.1000526; Beecken WDC, 2006, ANN SURG ONCOL, V13, P1241, DOI 10.1245/s10434-006-9009-9; Beecken WDC, 2010, CANCER LETT, V296, P160, DOI 10.1016/j.canlet.2010.04.010; Bekhite MM, 2011, J CELL SCI, V124, P1819, DOI 10.1242/jcs.077594; Belotti D, 2011, INT J BIOCHEM CELL B, V43, P1674, DOI 10.1016/j.biocel.2011.08.012; Bir SC, 2012, CARDIOVASC RES, V95, P7, DOI 10.1093/cvr/cvs143; Bouma B, 1999, EMBO J, V18, P5166, DOI 10.1093/emboj/18.19.5166; Bronneke S, 2015, ANGIOGENESIS, V18, P361, DOI 10.1007/s10456-015-9472-7; CAI G, 1995, BBA-MOL CELL RES, V1269, P13, DOI 10.1016/0167-4889(95)00091-6; Cao ZF, 2013, BBA-REV CANCER, V1836, P273, DOI 10.1016/j.bbcan.2013.08.001; Carpini JD, 2010, ANGIOGENESIS, V13, P43, DOI 10.1007/s10456-010-9163-3; Chistiakov DA, 2015, ACTA PHYSIOL, V213, P539, DOI 10.1111/apha.12438; Chiu WC, 2013, MOL CELL BIOCHEM, V372, P9, DOI 10.1007/s11010-012-1440-6; Chiu WC, 2012, BIOCHEM J, V445, P125, DOI 10.1042/BJ20111383; Chung BH, 2008, BIOCHEM BIOPH RES CO, V376, P404, DOI 10.1016/j.bbrc.2008.09.001; Ding Q, 2015, WORLD J GASTROENTERO, V21, P9566, DOI 10.3748/wjg.v21.i32.9566; Elshabrawy HA, 2015, ANGIOGENESIS, V18, P433, DOI 10.1007/s10456-015-9477-2; Esposito E, 2015, STROKE, V46, P2691, DOI 10.1161/STROKEAHA.115.009070; Eswarappa SM, 2015, CANCER RES, V75, P2765, DOI 10.1158/0008-5472.CAN-14-3805; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Gately S, 1997, P NATL ACAD SCI USA, V94, P10868, DOI 10.1073/pnas.94.20.10868; Huang D, 2008, CANCER RES, V68, P81, DOI 10.1158/0008-5472.CAN-07-5311; HUNT JE, 1993, P NATL ACAD SCI USA, V90, P2141, DOI 10.1073/pnas.90.6.2141; Ioannou Y, 2010, BLOOD, V116, P1961, DOI 10.1182/blood-2009-04-215335; Itoh Y, 2000, J BIOCHEM-TOKYO, V128, P1017, DOI 10.1093/oxfordjournals.jbchem.a022829; Iyer AKV, 2015, J CELL BIOCHEM, V116, P2484, DOI 10.1002/jcb.25192; Jeong DE, 2015, ONCOTARGET, V6, P33046, DOI 10.18632/oncotarget.5422; Kassaar O, 2014, BLOOD, V123, P1948, DOI 10.1182/blood-2013-11-535963; KATO H, 1991, BIOCHEMISTRY-US, V30, P11687, DOI 10.1021/bi00114a012; Kim BR, 2015, ONCOTARGET, V6, P31830, DOI 10.18632/oncotarget.5570; Kondo J, 2011, J BONE MINER METAB, V29, P23, DOI 10.1007/s00774-010-0193-0; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lee SJ, 2006, AM J PHYSIOL-HEART C, V291, pH2836, DOI 10.1152/ajpheart.00113.2006; Lin KY, 2005, J CELL BIOCHEM, V94, P485, DOI 10.1002/jcb.20314; Ma KY, 2000, J BIOL CHEM, V275, P15541, DOI 10.1074/jbc.275.20.15541; Mai JT, 2014, INFLAMMATION, V37, P858, DOI 10.1007/s10753-013-9806-9; Miyakis S, 2004, THROMB RES, V114, P335, DOI 10.1016/j.thromres.2004.07.017; Morbidelli L, 1996, AM J PHYSIOL-HEART C, V270, pH411, DOI 10.1152/ajpheart.1996.270.1.H411; Murohara T, 1998, CIRCULATION, V97, P99, DOI 10.1161/01.CIR.97.1.99; Nakagawa H, 2009, BLOOD, V114, P2553, DOI 10.1182/blood-2008-12-190629; Noiri E, 1998, AM J PHYSIOL-CELL PH, V274, pC236, DOI 10.1152/ajpcell.1998.274.1.C236; Passam FH, 2010, J AUTOIMMUN, V35, P232, DOI 10.1016/j.jaut.2010.06.013; POLZ E, 1979, FEBS LETT, V102, P183, DOI 10.1016/0014-5793(79)80955-2; Radziwon-Balicka A, 2012, CAN J PHYSIOL PHARM, V90, P679, DOI [10.1139/Y2012-036, 10.1139/y2012-036]; Rivera JC, 2015, INVEST OPHTH VIS SCI, V56, P7897, DOI 10.1167/iovs.15-17146; Ruan GX, 2012, CELL CYCLE, V11, P2047, DOI 10.4161/cc.20535; Sakai T, 2007, AM J PATHOL, V171, P1659, DOI 10.2353/ajpath.2007.070146; Santos IC, 2010, CANCER SCI, V101, P453, DOI 10.1111/j.1349-7006.2009.01403.x; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Schuermann A, 2015, ANGIOGENESIS, V18, P463, DOI 10.1007/s10456-015-9473-6; Somanath PR, 2006, CELL CYCLE, V5, P512, DOI 10.4161/cc.5.5.2538; Takeuchi R, 2000, BLOOD, V96, P1594, DOI 10.1182/blood.V96.4.1594.h8001594_1594_1595; Tian RH, 2015, CELLS TISSUES ORGANS, V201, P1, DOI 10.1159/000440949; Tong QY, 2014, TOXICOL APPL PHARM, V281, P166, DOI 10.1016/j.taap.2014.07.026; Wang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031195; Wang SX, 1998, BIOCHEM J, V335, P225, DOI 10.1042/bj3350225; Xu J, 2015, MOL MED REP, V12, P4708, DOI 10.3892/mmr.2015.3975; Yasuda S, 2000, ATHEROSCLEROSIS, V152, P337, DOI 10.1016/S0021-9150(99)00496-7; Yu P, 2008, J THROMB HAEMOST, V6, P1215, DOI 10.1111/j.1538-7836.2008.03000.x; ZABRENETZKY V, 1994, INT J CANCER, V59, P191, DOI 10.1002/ijc.2910590209; Zhang Y, 2015, DRUG DES DEV THER, V9, P3413, DOI 10.2147/DDDT.S87920	61	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161950	10.1371/journal.pone.0161950	http://dx.doi.org/10.1371/journal.pone.0161950			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579889	gold, Green Published, Green Submitted			2022-12-26	WOS:000382877400047
J	Kerkhofs, J; Leijten, J; Bolander, J; Luyten, FP; Post, JN; Geris, L				Kerkhofs, Johan; Leijten, Jeroen; Bolander, Johanna; Luyten, Frank P.; Post, Janine N.; Geris, Liesbet			A Qualitative Model of the Differentiation Network in Chondrocyte Maturation: A Holistic View of Chondrocyte Hypertrophy	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; MESENCHYMAL STEM-CELLS; BONE MORPHOGENETIC PROTEIN; SIGNAL-TRANSDUCTION NETWORKS; CARTILAGE IN-VIVO; GROWTH-FACTOR-I; ENDOCHONDRAL OSSIFICATION; TRANSCRIPTION FACTOR; OSTEOARTHRITIC CARTILAGE; GENE-EXPRESSION	Differentiation of chondrocytes towards hypertrophy is a natural process whose control is essential in endochondral bone formation. It is additionally thought to play a role in several pathophysiological processes, with osteoarthritis being a prominent example. We perform a dynamic analysis of a qualitative mathematical model of the regulatory network that directs this phenotypic switch to investigate the influence of the individual factors holistically. To estimate the stability of a SOX9 positive state (associated with resting/proliferation chondrocytes) versus a RUNX2 positive one (associated with hypertrophy) we employ two measures. The robustness of the state in canalisation (size of the attractor basin) is assessed by a Monte Carlo analysis and the sensitivity to perturbations is assessed by a perturbational analysis of the attractor. Through qualitative predictions, these measures allow for an in silico screening of the effect of the modelled factors on chondrocyte maintenance and hypertrophy. We show how discrepancies between experimental data and the model's results can be resolved by evaluating the dynamic plausibility of alternative network topologies. The findings are further supported by a literature study of proposed therapeutic targets in the case of osteoarthritis.	[Kerkhofs, Johan; Geris, Liesbet] Univ Liege, Biomech Res Unit, Liege, Belgium; [Kerkhofs, Johan; Geris, Liesbet] Katholieke Univ Leuven, Biomech Sect, Leuven, Belgium; [Kerkhofs, Johan; Leijten, Jeroen; Bolander, Johanna; Luyten, Frank P.; Geris, Liesbet] Katholieke Univ Leuven, Prometheus, Leuven, Belgium; [Leijten, Jeroen; Bolander, Johanna; Luyten, Frank P.] Katholieke Univ Leuven, Skeletal Biol & Engn Res Ctr, Leuven, Belgium; [Post, Janine N.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dev BioEngn, Enschede, Netherlands	University of Liege; KU Leuven; KU Leuven; KU Leuven; University of Twente	Geris, L (corresponding author), Univ Liege, Biomech Res Unit, Liege, Belgium.; Geris, L (corresponding author), Katholieke Univ Leuven, Biomech Sect, Leuven, Belgium.; Geris, L (corresponding author), Katholieke Univ Leuven, Prometheus, Leuven, Belgium.	liesbet.geris@ulg.ac.be	Luyten, Frank/GPS-7793-2022; Post, Janine N./E-9983-2011; Leijten, Jeroen/G-5311-2011; Bolander, Johanna/AAB-3461-2021; geris, liesbet/D-2343-2016	Post, Janine N./0000-0002-6645-6583; Leijten, Jeroen/0000-0002-8063-207X; geris, liesbet/0000-0002-8180-1445; Bolander, Johanna/0000-0002-6915-9509	Research Foundation Flanders (FWO-Vlaanderen); European Research Council under the European Union's Seventh Framework Programme/ERC [279100, 294191]; Special Research Council (KU Leuven) [GOA/13/016]	Research Foundation Flanders (FWO-Vlaanderen)(FWO); European Research Council under the European Union's Seventh Framework Programme/ERC(European Research Council (ERC)); Special Research Council (KU Leuven)	JK acknowledges scholarship funding from the Research Foundation Flanders (FWO-Vlaanderen). JL is a postdoctoral fellow of the Research Foundation Flanders (FWO-Vlaanderen) and received a F+ fellowship (GOA/13/016). The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC (Grant Agreement n. 279100 and 294191) and from the Special Research Council (KU Leuven-GOA/13/016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work is part of Prometheus, the KU Leuven R&D division for skeletal tissue engineering (http://www.kuleuven.be/prometheus).	Albeck JG, 2006, NAT REV MOL CELL BIO, V7, P803, DOI 10.1038/nrm2042; Andrade AC, 2011, ENDOCR DEV, V21, P52, DOI 10.1159/000328127; [Anonymous], 2014, R LANG ENV STAT COMP; Araldi E, 2011, NAT MED, V17, P25, DOI 10.1038/nm0111-25; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Augello A, 2010, HUM GENE THER, V21, P1226, DOI 10.1089/hum.2010.173; Bauge C, 2008, ARTHRITIS RHEUM, V58, P221, DOI 10.1002/art.23154; Bellon E, 2009, J CELL BIOL, V187, P685, DOI 10.1083/jcb.200904034; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Brown KK, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-22; Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Chen JZ, 2013, J CELL BIOCHEM, V114, P245, DOI 10.1002/jcb.24362; Chia SL, 2009, ARTHRITIS RHEUM-US, V60, P2019, DOI 10.1002/art.24654; Christensen C, 2007, IET SYST BIOL, V1, P61, DOI 10.1049/iet-syb:20060071; Daoud G, 2014, DEVELOPMENT, V141, P3978, DOI 10.1242/dev.111906; Daouti S, 2005, OSTEOARTHR CARTILAGE, V13, P508, DOI 10.1016/j.joca.2005.02.003; Davies OG, 2015, CALCIFIED TISSUE INT, V97, P432, DOI 10.1007/s00223-015-0034-1; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; De Bari C, 2006, ARTHRITIS RHEUM, V54, P1209, DOI 10.1002/art.21753; Dell'Accio F, 2001, ARTHRITIS RHEUM-US, V44, P1608, DOI 10.1002/1529-0131(200107)44:7<1608::AID-ART284>3.0.CO;2-T; Delorme B, 2009, STEM CELLS, V27, P1142, DOI 10.1002/stem.34; Ding M, 2012, J CELL PHYSIOL, V227, P3446, DOI 10.1002/jcp.24045; Dodig M, 1999, DEV BIOL, V209, P298, DOI 10.1006/dbio.1999.9258; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Dreier R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3117; Dy P, 2012, DEV CELL, V22, P597, DOI 10.1016/j.devcel.2011.12.024; Eberhard Voit, 2012, 1 COURSE SYSTEMS BIO; Edda Klipp, 2009, SYSTEMS BIOL; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Fosang AJ, 2011, BEST PRACT RES CL RH, V25, P751, DOI 10.1016/j.berh.2011.11.010; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Fukai A, 2010, ARTHRITIS RHEUM-US, V62, P826, DOI 10.1002/art.27296; Funck-Brentano T, 2014, ARTHRITIS RHEUMATOL, V66, P3028, DOI 10.1002/art.38799; Furumatsu T, 2005, J BIOL CHEM, V280, P8343, DOI 10.1074/jbc.M413913200; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; HARRISON ET, 1991, EXP CELL RES, V192, P340, DOI 10.1016/0014-4827(91)90050-5; Hecht J, 2007, GENE EXPR PATTERNS, V7, P102, DOI 10.1016/j.modgep.2006.05.014; Helikar T, 2008, P NATL ACAD SCI USA, V105, P1913, DOI 10.1073/pnas.0705088105; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang WD, 2000, MOL CELL BIOL, V20, P4149, DOI 10.1128/MCB.20.11.4149-4158.2000; Jeffries MA, 2014, ARTHRITIS RHEUMATOL, V66, P2804, DOI 10.1002/art.38762; Johnson ME, 2014, CALCIFIED TISSUE INT, V94, P396, DOI 10.1007/s00223-013-9824-5; Kaiser M, 2004, ARTHRITIS RHEUM-US, V50, P3535, DOI 10.1002/art.20750; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kerkhofs J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130033; Kerkhofs J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034729; Khan FM, 2014, BBA-PROTEINS PROTEOM, V1844, P289, DOI 10.1016/j.bbapap.2013.05.007; Kim DW, 2003, MOL CELL BIOL, V23, P8704, DOI 10.1128/MCB.23.23.8704-8717.2003; Kitagaki J, 2003, OSTEOARTHR CARTILAGE, V11, P36, DOI 10.1053/joca.2002.0863; Kobayashi H, 2013, OARSI 2013; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Krumsiek J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022649; Kumar D, 2009, MOL CELL BIOL, V29, P4262, DOI 10.1128/MCB.01779-08; Lammens J, 2012, ACTA ORTHOP BELG, V78, P569; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; Leijten JCH, 2012, ARTHRITIS RHEUM-US, V64, P3302, DOI 10.1002/art.34535; Leijten J, 2014, P NATL ACAD SCI USA, V111, P13954, DOI 10.1073/pnas.1410977111; Leijten JCH, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4306; Leijten JCH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049896; Lenas P, 2009, TISSUE ENG PART B-RE, V15, P381, DOI 10.1089/ten.TEB.2008.0575; Li DL, 2012, RHEUMATOL INT, V32, P2017, DOI 10.1007/s00296-011-1929-4; Li WJ, 2014, STEROIDS, V89, P20, DOI 10.1016/j.steroids.2014.07.011; Luo JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036010; Ma B, 2013, OSTEOARTHR CARTILAGE, V21, P599, DOI 10.1016/j.joca.2013.01.014; Ma B, 2013, J BIOL CHEM, V288, P17552, DOI 10.1074/jbc.M113.453985; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Melas IN, 2014, OSTEOARTHR CARTILAGE, V22, P509, DOI 10.1016/j.joca.2014.01.001; Miclea RL, 2011, OSTEOARTHR CARTILAGE, V19, P1363, DOI 10.1016/j.joca.2011.07.014; Mori Y, 2014, J BIOL CHEM, V289, P10192, DOI 10.1074/jbc.M113.524090; Oh JH, 2012, BIOCHEM BIOPH RES CO, V418, P634, DOI 10.1016/j.bbrc.2012.01.064; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Pan QH, 2008, J CELL PHYSIOL, V217, P228, DOI 10.1002/jcp.21496; Pap T, 2015, NAT REV RHEUMATOL, V11, P606, DOI 10.1038/nrrheum.2015.95; Peterson H, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00303; Piera-Velazquez S, 2007, EXP CELL RES, V313, P1069, DOI 10.1016/j.yexcr.2007.01.001; Qiao M, 2004, J BIOL CHEM, V279, P42709, DOI 10.1074/jbc.M404480200; Reynard LN, 2013, NAT REV RHEUMATOL, V9, P573, DOI 10.1038/nrrheum.2013.121; Roberts SJ, 2015, BONE, V70, P10, DOI 10.1016/j.bone.2014.08.007; Rue P, 2010, CHAOS, V20, DOI 10.1063/1.3524908; Saadatpour A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002267; Saadatpour A, 2010, J THEOR BIOL, V266, P641, DOI 10.1016/j.jtbi.2010.07.022; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Scharstuhl A, 2003, ARTHRITIS RHEUM-US, V48, P3442, DOI 10.1002/art.11328; Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107; Selvamurugan N, 2009, FEBS LETT, V583, P1141, DOI 10.1016/j.febslet.2009.02.040; Shirakabe K, 2001, GENES CELLS, V6, P851, DOI 10.1046/j.1365-2443.2001.00466.x; Singhania R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001077; Smeets B, 2013, COMPUT METHOD BIOMEC, V16, P1071, DOI 10.1080/10255842.2013.829461; Solomon Lauren A., 2008, Birth Defects Research, V84, P123, DOI 10.1002/bdrc.20124; Staines KA, 2013, J ENDOCRINOL, V219, pR1, DOI 10.1530/JOE-13-0276; Studer D, 2012, EUR CELLS MATER, V24, P118, DOI 10.22203/eCM.v024a09; Sun MMG, 2014, BIRTH DEFECTS RES C, V102, P74, DOI 10.1002/bdrc.21062; Sun YB, 2002, J BIOL CHEM, V277, P1544, DOI 10.1074/jbc.M100567200; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tamiya H, 2008, GENE, V416, P53, DOI 10.1016/j.gene.2008.03.003; Tate MLK, 2008, INT J BIOCHEM CELL B, V40, P2720, DOI 10.1016/j.biocel.2008.05.011; Thomas R, 2001, CHAOS, V11, P170, DOI 10.1063/1.1350439; Thompson EM, 2015, J TISSUE ENG REGEN M, V9, P889, DOI 10.1002/term.1918; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Ullah M, 2010, WIRES SYST BIOL MED, V2, P385, DOI 10.1002/wsbm.78; Veliz-Cuba A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-221; Verdicchio MP, 2011, BIOCOMPUT-PAC SYM, P350; Vortkamp A, 1998, MECH DEVELOP, V71, P65, DOI 10.1016/S0925-4773(97)00203-7; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wang BL, 2014, ARTHRITIS RHEUMATOL, V66, P107, DOI 10.1002/art.38195; Wang WG, 2009, DEVELOPMENT, V136, P4143, DOI 10.1242/dev.043281; Wang XB, 2004, OSTEOARTHR CARTILAGE, V12, P963, DOI 10.1016/j.joca.2004.08.008; Weng TJ, 2012, ARTHRITIS RHEUM-US, V64, P3982, DOI 10.1002/art.34645; Wu L, 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/752150; Wu QQ, 2010, ANN NY ACAD SCI, V1192, P344, DOI 10.1111/j.1749-6632.2009.05212.x; Wu SF, 2008, J BIOL CHEM, V283, P34037, DOI 10.1074/jbc.M803754200; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Xing WR, 2014, J BONE MINER RES, V29, P2262, DOI 10.1002/jbmr.2256; Yamashita S, 2009, EXP CELL RES, V315, P2231, DOI 10.1016/j.yexcr.2009.03.008; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153; Zeng L, 2002, GENE DEV, V16, P1990, DOI 10.1101/gad.1008002; Zhang M, 2009, J CELL SCI, V122, P1382, DOI 10.1242/jcs.040709; Zhong LL, 2015, INT J MOL SCI, V16, P19225, DOI 10.3390/ijms160819225; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103; Zhou JX, 2016, BIOSYSTEMS, V142, P15, DOI 10.1016/j.biosystems.2016.03.002; Zhou X, 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/809579; Zhu M, 2009, J BONE MINER RES, V24, P12, DOI 10.1359/JBMR.080901	128	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0162052	10.1371/journal.pone.0162052	http://dx.doi.org/10.1371/journal.pone.0162052			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579819	gold, Green Published, Green Submitted			2022-12-26	WOS:000382877400054
J	Liu, Y; Jiang, L; Yang, DP; Liu, H				Liu, Yuan; Jiang, Li; Yang, Dapeng; Liu, Hong			Analysis of Hand and Wrist Postural Synergies in Tolerance Grasping of Various Objects	PLOS ONE			English	Article							DIFFERENT FINGER MUSCLES; MECHANICAL IMPLEMENTATION; MYOELECTRIC CONTROL; JUNCTURAE-TENDINUM; DESIGN; CONSTRAINTS; MOVEMENTS; REACH; TOOL	Human can successfully grasp various objects in different acceptable relative positions between human hand and objects. This grasp functionality can be described as the grasp tolerance of human hand, which is a significant functionality of human grasp. To understand the motor control of human hand completely, an analysis of hand and wrist postural synergies in tolerance grasping of various objects is needed. Ten healthy right-handed subjects were asked to perform the tolerance grasping with right hand using 6 objects of different shapes, sizes and relative positions between human hand and objects. Subjects were wearing CyberGlove attaching motion tracker on right hand, allowing a measurement of the hand and wrist postures. Correlation analysis of joints and inter-joint/inter-finger modules were carried on to explore the coordination between joints or modules. As the correlation between hand and wrist module is not obvious in tolerance grasping, individual analysis of wrist synergies would be more practical. In this case, postural synergies of hand and wrist were then presented separately through principal component analysis (PCA), expressed through the principal component (PC) information transmitted ratio, PC elements distribution and reconstructed angle error of joints. Results on correlation comparison of different module movements can be well explained by the influence factors of the joint movement correlation. Moreover, correlation analysis of joints and modules showed the wrist module had the lowest correlation among all inter-finger and inter-joint modules. Hand and wrist postures were both sufficient to be described by a few principal components. In terms of the PC elements distribution of hand postures, compared with previous investigations, there was a greater proportion of movement in the thumb joints especially the interphalangeal (IP) and opposition rotation (ROT) joint. The research could serve to a complete understanding of hand grasp, and the design, control of the anthropomorphic hand and wrist.	[Liu, Yuan; Jiang, Li; Yang, Dapeng; Liu, Hong] Harbin Inst Technol, State Key Lab Robot & Syst, Harbin, Heilongjiang, Peoples R China	Harbin Institute of Technology	Yang, DP (corresponding author), Harbin Inst Technol, State Key Lab Robot & Syst, Harbin, Heilongjiang, Peoples R China.	yangdapeng@hit.edu.cn	Yang, Dapeng/S-5454-2017; Yang, Dapeng/AGE-4955-2022	Yang, Dapeng/0000-0003-2884-3854; Yang, Dapeng/0000-0003-2884-3854; Liu, Yuan/0000-0002-9703-7357	National Basic Research Program (973 Program) of China [2011CB013306]; National Natural Science Foundation of China [51205080]	National Basic Research Program (973 Program) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported in part by the National Basic Research Program (973 Program) of China (Grant No. 2011CB013306) and National Natural Science Foundation of China (51205080).	[Anonymous], 2012, P IEEE EMBS; Bandara DSV, 2014, P IEEE RAS-EMBS INT, P1039, DOI 10.1109/BIOROB.2014.6913917; BREMNER FD, 1991, J PHYSIOL-LONDON, V432, P355, DOI 10.1113/jphysiol.1991.sp018389; BREMNER FD, 1991, J PHYSIOL-LONDON, V432, P381, DOI 10.1113/jphysiol.1991.sp018390; Brown CY, 2007, 2007 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-9, P2883; Bullock IM, 2013, IEEE INT CONF ROBOT, P1068, DOI 10.1109/ICRA.2013.6630705; Bullock IM, 2013, IEEE T HAPTICS, V6, P296, DOI 10.1109/TOH.2013.6; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Chalon M, 2014, INT J HUM ROBOT, V11, DOI 10.1142/S0219843614500194; Chalon M, 2010, IEEE INT C INT ROBOT, P5886, DOI 10.1109/IROS.2010.5650454; Chen WR, 2014, IEEE INT CONF ROBOT, P403, DOI 10.1109/ICRA.2014.6906888; Controzzi M, 2010, IEEE ENG MED BIO, P499, DOI 10.1109/IEMBS.2010.5627148; CUTKOSKY MR, 1989, IEEE T ROBOTIC AUTOM, V5, P269, DOI 10.1109/70.34763; Eckart C, 1936, PSYCHOMETRIKA, V1, P211, DOI 10.1007/BF02288367; Fahrer M, 1981, INTERDEPENDENT INDEP, P399; Feix T., 2009, P ROB SCI SYST C WOR; Feix T, 2014, IEEE T HAPTICS, V7, P430, DOI 10.1109/TOH.2014.2326867; Feix T, 2014, IEEE T HAPTICS, V7, P311, DOI 10.1109/TOH.2014.2326871; Grinyagin IV, 2005, J NEUROPHYSIOL, V94, P2284, DOI 10.1152/jn.01310.2004; Hager-Ross C, 2000, J NEUROSCI, V20, P8542, DOI 10.1523/JNEUROSCI.20-22-08542.2000; Hairong Wang, 2012, 2012 IEEE International Conference on Mechatronics and Automation (ICMA), P777, DOI 10.1109/ICMA.2012.6283241; Huenerfauth M., 2009, CITY U NEW YORK, V4, P22; Jarrasse N, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-113; Jeannerod M., 1981, ATTENTION PERFORM, P153; Jiang L, 2015, LECT NOTES ARTIF INT, V9244, P269, DOI 10.1007/978-3-319-22879-2_25; KAMAKURA N, 1980, AM J OCCUP THER, V34, P437, DOI 10.5014/ajot.34.7.437; Keen D, 1999, SOC NEUR ABSTR; Keen DA, 2003, MUSCLE NERVE, V28, P614, DOI 10.1002/mus.10481; KILBREATH SL, 1994, J PHYSIOL-LONDON, V479, P487, DOI 10.1113/jphysiol.1994.sp020312; Kochan A, 2005, IND ROBOT, V32, P15, DOI 10.1108/01439910510573237; Li SC, 2014, IND ROBOT, V41, P447, DOI 10.1108/IR-03-2014-0312; Light CM, 2002, ARCH PHYS MED REHAB, V83, P776, DOI 10.1053/apmr.2002.32737; Liu Y, 2015, IEEE ASME INT C ADV, P877, DOI 10.1109/AIM.2015.7222649; Lovchik CS, 1999, ICRA '99: IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-4, PROCEEDINGS, P907, DOI 10.1109/ROBOT.1999.772420; Ma JX, 2015, IEEE T HUM-MACH SYST, V45, P74, DOI 10.1109/THMS.2014.2358634; Martin J, 2014, INT J ROBOT RES, V33, P783, DOI 10.1177/0278364913511677; Mason CR, 2001, J NEUROPHYSIOL, V86, P2896, DOI 10.1152/jn.2001.86.6.2896; Mouri T., 2002, P INT C CONTR AUT SY, P1288; NAPIER JR, 1956, J BONE JOINT SURG BR, V38, P902, DOI 10.1302/0301-620X.38B4.902; Pan LZ, 2015, IEEE T BIO-MED ENG, V62, P1927, DOI 10.1109/TBME.2015.2407491; Reilly KT, 2003, J NEUROPHYSIOL, V90, P2560, DOI 10.1152/jn.00287.2003; Rosmarin JB, 2008, IEEE INT CONF ROBOT, P773, DOI 10.1109/ROBOT.2008.4543299; Saliba MA, 2013, INT J HUM ROBOT, V10, DOI 10.1142/S0219843613500011; Santello M, 1998, J NEUROSCI, V18, P10105; Santello M, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00023; Schieber MH, 2004, J APPL PHYSIOL, V96, P2293, DOI 10.1152/japplphysiol.01063.2003; Schlesinger IG., 1919, MECH AUFBAU KUNSTLIC, P321; Smeets JBJ, 1999, MOTOR CONTROL, V3, P237, DOI 10.1123/mcj.3.3.237; Sun BY, 2014, IEEE ENG MED BIO, P6215, DOI 10.1109/EMBC.2014.6945049; Takeda H, 2009, IEEE ENG MED BIO, P5048, DOI 10.1109/IEMBS.2009.5333668; Touvet F, 2014, EXP BRAIN RES, V232, P3055, DOI 10.1007/s00221-014-3990-1; Vinjamuri R, 2007, P ANN INT IEEE EMBS, P4846, DOI 10.1109/IEMBS.2007.4353425; Vinjamuri R, 2010, IEEE T INF TECHNOL B, V14, P986, DOI 10.1109/TITB.2009.2038907; Vinjamuri R, 2010, IEEE T BIO-MED ENG, V57, P284, DOI 10.1109/TBME.2009.2032532; VONSCHROEDER HP, 1990, J HAND SURG-AM, V15A, P595, DOI 10.1016/S0363-5023(09)90021-1; VONSCHROEDER HP, 1993, J HAND SURG-AM, V18A, P641, DOI 10.1016/0363-5023(93)90309-Q; Xu K, 2014, IEEE INT CONF ROBOT, P1348, DOI 10.1109/ICRA.2014.6907027; Xu K, 2014, ADV ROBOTICS, V28, P1459, DOI 10.1080/01691864.2014.958534; Yang DP, 2014, ADV ROBOTICS, V28, P1533, DOI 10.1080/01691864.2014.957723; Zheng Joshua Z., 2011, IEEE International Conference on Robotics and Automation, P4169; Zinck A, 2012, APPL BIONICS BIOMECH, V9, P117, DOI 10.1155/2012/463245	62	10	10	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161772	10.1371/journal.pone.0161772	http://dx.doi.org/10.1371/journal.pone.0161772			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580298	gold, Green Published, Green Submitted			2022-12-26	WOS:000382877400041
J	Ross, RE; Nimmo-Smith, WAM; Howell, KL				Ross, Rebecca E.; Nimmo-Smith, W. Alex M.; Howell, Kerry L.			Increasing the Depth of Current Understanding: Sensitivity Testing of Deep-Sea Larval Dispersal Models for Ecologists	PLOS ONE			English	Article							ROCKALL TROUGH; OCEAN MODEL; WATER; CONNECTIVITY; TRAJECTORIES; SIMULATIONS; CIRCULATION; POPULATIONS; TRANSPORT; PATTERNS	Larval dispersal is an important ecological process of great interest to conservation and the establishment of marine protected areas. Increasing numbers of studies are turning to biophysical models to simulate dispersal patterns, including in the deep-sea, but for many ecologists unassisted by a physical oceanographer, a model can present as a black box. Sensitivity testing offers a means to test the models' abilities and limitations and is a starting point for all modelling efforts. The aim of this study is to illustrate a sensitivity testing process for the unassisted ecologist, through a deep-sea case study example, and demonstrate how sensitivity testing can be used to determine optimal model settings, assess model adequacy, and inform ecological interpretation of model outputs. Five input parameters are tested (timestep of particle simulator (TS), horizontal (HS) and vertical separation (VS) of release points, release frequency (RF), and temporal range (TR) of simulations) using a commonly employed pairing of models. The procedures used are relevant to all marine larval dispersal models. It is shown how the results of these tests can inform the future set up and interpretation of ecological studies in this area. For example, an optimal arrangement of release locations spanning a release area could be deduced; the increased depth range spanned in deep-sea studies may necessitate the stratification of dispersal simulations with different numbers of release locations at different depths; no fewer than 52 releases per year should be used unless biologically informed; three years of simulations chosen based on climatic extremes may provide results with 90% similarity to five years of simulation; and this model setup is not appropriate for simulating rare dispersal events. A step-by-step process, summarising advice on the sensitivity testing procedure, is provided to inform all future unassisted ecologists looking to run a larval dispersal simulation.	[Ross, Rebecca E.; Nimmo-Smith, W. Alex M.; Howell, Kerry L.] Univ Plymouth, Sch Marine Sci & Engn, Plymouth, Devon, England	University of Plymouth	Ross, RE (corresponding author), Univ Plymouth, Sch Marine Sci & Engn, Plymouth, Devon, England.	Rebecca.Ross@plymouth.ac.uk	Ross, Rebecca E./AAQ-6980-2020; Smith, William AM Nimmo/D-3344-2009	Ross, Rebecca E./0000-0002-5395-1219; Howell, Kerry/0000-0003-3359-1778	Natural Environment Research Council [NE/K501104/1]; Natural Environment Research Council [1220472] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Natural Environment Research Council as a PhD grant (NE/K501104/1) awarded to RER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailly-Bechet M, 2008, J THEOR BIOL, V255, P320, DOI 10.1016/j.jtbi.2008.08.016; Blanke B, 2012, DYNAM ATMOS OCEANS, V55-56, P22, DOI 10.1016/j.dynatmoce.2012.04.003; Bonhommeau S, 2009, FISH OCEANOGR, V18, P371, DOI 10.1111/j.1365-2419.2009.00517.x; Booth DA, 1987, J CONS INT EXPLORATI, V39, P175; Bradbury IR, 2008, P ROY SOC B-BIOL SCI, V275, P1803, DOI 10.1098/rspb.2008.0216; Brickman D, 2002, J ATMOS OCEAN TECH, V19, P83, DOI 10.1175/1520-0426(2002)019<0083:LSMICO>2.0.CO;2; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Carson HS, 2010, CURR BIOL, V20, P1926, DOI 10.1016/j.cub.2010.09.057; Chassignet EP, 2007, J MARINE SYST, V65, P60, DOI 10.1016/j.jmarsys.2005.09.016; COURANT R, 1967, IBM J RES DEV, V11, P215, DOI 10.1147/rd.112.0215; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Dawson MN, 2005, P NATL ACAD SCI USA, V102, P11968, DOI 10.1073/pnas.0503811102; ELLETT DJ, 1986, P ROY SOC EDINB B, V88, P61, DOI 10.1017/S0269727000004474; Etter RJ, 2015, DEEP-SEA RES, VI, DOI [10.1016/j.dsr.2015.6.009, DOI 10.1016/J.DSR.2015.6.009]; Etter RJ, 2011, MOL ECOL, V20, P829, DOI 10.1111/j.1365-294X.2010.04978.x; Fossette S, 2012, MAR ECOL PROG SER, V457, P285, DOI 10.3354/meps09581; Foster NL, 2012, MOL ECOL, V21, P1143, DOI 10.1111/j.1365-294X.2012.05455.x; Hardy SM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0193; Harris PT, 2014, MAR GEOL, V353, P169, DOI 10.1016/j.margeo.2014.03.023; Hilario A, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00006; Holliday NP, 2000, DEEP-SEA RES PT I, V47, P1303, DOI 10.1016/S0967-0637(99)00109-0; Holstein DM, 2014, MAR ECOL PROG SER, V499, P1, DOI 10.3354/meps10647; Kough AS, 2015, CORAL REEFS, V34, P753, DOI 10.1007/s00338-015-1311-1; Kough AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064970; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Marsh AG, 2001, NATURE, V411, P77, DOI 10.1038/35075063; Matthysen E, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P3; McClain CR, 2010, P ROY SOC B-BIOL SCI, V277, P3533, DOI 10.1098/rspb.2010.1057; McGrath T, 2012, DEEP-SEA RES PT I, V61, P57, DOI 10.1016/j.dsr.2011.11.007; Mercier A, 2011, J BIOL RHYTHM, V26, P82, DOI 10.1177/0748730410391948; Mercier A, 2008, MAR BIOL, V156, P205, DOI 10.1007/s00227-008-1077-x; Metaxas A, 2009, BIOL BULL-US, V216, P257, DOI 10.1086/BBLv216n3p257; Mullineaux Lauren S., 1994, P201; Mullineaux LS, 2002, CAH BIOL MAR, V43, P281; New AL, 2001, CONT SHELF RES, V21, P777, DOI 10.1016/S0278-4343(00)00113-8; North E.W., 2009, 295 ICES COOP RES; Paris CB, 2007, MAR ECOL PROG SER, V347, P285, DOI 10.3354/meps06985; Peck MA, 2012, J MARINE SYST, V93, P77, DOI 10.1016/j.jmarsys.2011.08.005; Putman NF, 2014, J EXP MAR BIOL ECOL, V450, P98, DOI 10.1016/j.jembe.2013.10.026; Putman NF, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0979; Sandwell DT, 2014, SCIENCE, V346, P65, DOI 10.1126/science.1258213; Sherwin TJ, 2015, OCEAN SCI, V11, P343, DOI 10.5194/os-11-343-2015; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Simons RD, 2013, J MARINE SYST, V119, P19, DOI 10.1016/j.jmarsys.2013.03.004; Stow CA, 2009, J MARINE SYST, V76, P4, DOI 10.1016/j.jmarsys.2008.03.011; Tian RC, 2009, FISH OCEANOGR, V18, P173, DOI 10.1111/j.1365-2419.2009.00506.x; Ullgren JE, 2010, DEEP-SEA RES PT I, V57, P248, DOI 10.1016/j.dsr.2009.11.005; von Storch JS, 2010, OCEAN DYNAM, V60, P759, DOI 10.1007/s10236-010-0303-5; Waller RG, 2005, CORAL REEFS, V24, P514, DOI 10.1007/s00338-005-0501-7; Werner FE, 2007, OCEANOGRAPHY, V20, P54, DOI 10.5670/oceanog.2007.29; Wood S, 2014, GLOBAL ECOL BIOGEOGR, V23, P1, DOI 10.1111/geb.12101; Yearsley JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023063; Young CM, 2012, INTEGR COMP BIOL, V52, P483, DOI 10.1093/icb/ics090	53	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161220	10.1371/journal.pone.0161220	http://dx.doi.org/10.1371/journal.pone.0161220			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575625	gold, Green Published, Green Submitted			2022-12-26	WOS:000382877200018
J	Yu, YH; Liao, PR; Guo, CJ; Chen, CH; Mochly-Rosen, D; Chuang, LM				Yu, Yu-Hsiang; Liao, Pei-Ru; Guo, Chien-Jung; Chen, Che-Hong; Mochly-Rosen, Daria; Chuang, Lee-Ming			PKC-ALDH2 Pathway Plays a Novel Role in Adipocyte Differentiation	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE 2; CARDIAC PROTECTION; METABOLIC SYNDROME; OXIDATIVE STRESS; PPAR-GAMMA; PROTEIN; OBESITY; CARBONYLATION; ACTIVATION; EXPRESSION	The ALDH2 gene encodes the mitochondrial aldehyde dehydrogenase 2 (ALDH2), a critical enzyme involved in ethanol clearance through acetaldehyde metabolism. ALDH2 also catalyzes the metabolism of other bioreactive aldehydes, including propionaldehyde, butyraldehyde, and 4-hydroxykenals (4-HNE). Increased levels of 4-HNE in adipose tissue positively correlate with obesity and insulin resistance. However, it remains unclear whether ALDH2 is involved in regulation of adipocyte differentiation. Here, we found that ALDH2 protein levels were lower in white adipose tissue of high-fat diet-fed mice and ob/ob mice relative to lean mice. Knockdown of ALDH2 expression in 3T3-L1 preadipocytes caused an increase in intracellular 4-HNE, thereby attenuated adipocyte differentiation. By contrast, an ALDH2 activator, Alda-1, significantly accelerated adipogenesis, which was accompanied by an increase in adipogenic gene expression. Consistently, adipogenesis was reduced when protein kinase C epsilon (PKC epsilon), an ALDH2 phosphorylating activator, was silenced in 3T3-L1 preadipocytes, whereas treatment with a PKCe agonist in 3T3-L1 preadipocytes enhanced adipogenesis. Whole-genome microarray profiling of Alda-1-treated cells demonstrated several upregulated transcripts encoding proteins involved in metabolism and the majority of these transcripts are for proteins involved in PPAR signaling pathways. Furthermore, PKC epsilon-ALDH2 interaction alleviates 4-HNE induced aberrant PPAR. regulation on adipogenesis. Taken together, these results demonstrate that ALDH2 activation enhances adipogenesis and signaling pathways involving PPAR gamma. Thus, activation of PKC epsilon-ALDH2 regulatory axis may be a therapeutic target for treating obesity and type 2 diabetes.	[Yu, Yu-Hsiang] Natl Ilan Univ, Dept Biotechnol & Anim Sci, Ilan, Taiwan; [Liao, Pei-Ru; Chuang, Lee-Ming] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Guo, Chien-Jung; Chuang, Lee-Ming] Natl Taiwan Univ, Inst Mol Med, Coll Med, Taipei, Taiwan; [Chen, Che-Hong; Mochly-Rosen, Daria] Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA; [Chuang, Lee-Ming] Natl Taiwan Univ, Dept Internal Med, Coll Med, Taipei, Taiwan	National Ilan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Stanford University; National Taiwan University	Chuang, LM (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.; Chuang, LM (corresponding author), Natl Taiwan Univ, Inst Mol Med, Coll Med, Taipei, Taiwan.; Chuang, LM (corresponding author), Natl Taiwan Univ, Dept Internal Med, Coll Med, Taipei, Taiwan.	leeming@ntu.edu.tw	Chuang, Lee-Ming/AAF-3324-2019; Yu, Yu-Hsiang/J-4424-2019	Yu, Yu-Hsiang/0000-0001-9629-8478; Mochly-Rosen, Daria/0000-0002-6691-8733; CHUANG, LEE-MING/0000-0003-0978-2662	Ministry of Science and Technology in Taiwan [MOST 101-2314-B-002-158-MY3]; Ministry of Science and Technology in the US [NIAAA11147]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA011147] Funding Source: NIH RePORTER	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology in the US; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by Ministry of Science and Technology MOST 101-2314-B-002-158-MY3 to LMC in Taiwan and NIAAA11147 to DMR in the US. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Budas GR, 2009, TRENDS CARDIOVAS MED, V19, P158, DOI 10.1016/j.tcm.2009.09.003; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Churchill EN, 2009, J MOL CELL CARDIOL, V46, P278, DOI 10.1016/j.yjmcc.2008.09.713; Crabb DW, 2001, ALCOHOL CLIN EXP RES, V25, P945, DOI 10.1097/00000374-200107000-00001; Dasuri K, 2013, FREE RADICAL RES, V47, P8, DOI 10.3109/10715762.2012.733003; Frohnert BI, 2011, OBESITY, V19, P1735, DOI 10.1038/oby.2011.115; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Grimsrud PA, 2007, MOL CELL PROTEOMICS, V6, P624, DOI 10.1074/mcp.M600120-MCP200; Guo JM, 2013, CELL RES, V23, P915, DOI 10.1038/cr.2013.69; Mattson MP, 2009, EXP GERONTOL, V44, P625, DOI 10.1016/j.exger.2009.07.003; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; Perez-Miller S, 2010, NAT STRUCT MOL BIOL, V17, P159, DOI 10.1038/nsmb.1737; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Soares AF, 2005, FREE RADICAL BIO MED, V38, P882, DOI 10.1016/j.freeradbiomed.2004.12.010; Wang JT, 2013, OCEAN ENG, V63, P8, DOI 10.1016/j.oceaneng.2013.01.028; Wang ZG, 2012, MOL CELL ENDOCRINOL, V349, P222, DOI 10.1016/j.mce.2011.10.027; Webb PR, 2003, CELL MOL LIFE SCI, V60, P1504, DOI 10.1007/s00018-003-2337-z; Weber D, 2013, REDOX BIOL, V1, P226, DOI 10.1016/j.redox.2013.01.012; Zambelli VO, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009539	22	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161993	10.1371/journal.pone.0161993	http://dx.doi.org/10.1371/journal.pone.0161993			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575855	Green Submitted, Green Published, gold			2022-12-26	WOS:000382877200052
J	Vickers, TA; Crooke, ST				Vickers, Timothy A.; Crooke, Stanley T.			Development of a Quantitative BRET Affinity Assay for Nucleic Acid-Protein Interactions	PLOS ONE			English	Article							ROUGH ENDOPLASMIC-RETICULUM; HUMAN RNASE H1; BINDING PROTEIN; AMINO-ACID; LA-MOTIF; STAUFEN; JUN; OLIGONUCLEOTIDES; RECOGNITION; DEGRADATION	Protein-nucleic acid interactions play a crucial role in the regulation of diverse biological processes. Elucidating the roles that protein-nucleic acid complexes play in the regulation of transcription, translation, DNA replication, repair and recombination, and RNA processing continues to be a crucial aspect of understanding of cell biology and the mechanisms of disease. In addition, proteins have been demonstrated to interact with antisense oligonucleotide therapeutics in a sequence and chemistry dependent manner, influencing ASO potency and distribution in cells and in vivo. While many assays have been developed to measure protein-nucleic acid interactions, many suffer from lack of throughput and sensitivity, or challenges with protein purification and scalability. In this report we present a new BRET assay for the analysis of DNA-protein interactions which makes use of an extremely bright luciferase as a tag for the binding protein, along with a long-wavelength fluorophore conjugated to the nucleic acid. The resulting assay is high throughput, sensitive, does not require protein purification, and even allows for quantitative characterization of these interactions within the biologically relevant context of whole cells.	[Vickers, Timothy A.; Crooke, Stanley T.] Ionis Pharmaceut Inc, Dept Core Antisense Res, 2855 Gazelle Court, Carlsbad, CA 92010 USA	Ionis Pharmaceuticals, Inc.	Vickers, TA (corresponding author), Ionis Pharmaceut Inc, Dept Core Antisense Res, 2855 Gazelle Court, Carlsbad, CA 92010 USA.	tvickers@ionisph.com			Ionis Pharmaceuticals, Inc.	Ionis Pharmaceuticals, Inc.	This work was supported by Ionis Pharmaceuticals, Inc. The funder provided support in the form of salaries for authors TAV and STC but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano C, 2004, NAT STRUCT MOL BIOL, V11, P323, DOI 10.1038/nsmb747; Bousquet-Antonelli C, 2009, RNA, V15, P750, DOI 10.1261/rna.1478709; Chen H, 2006, BIOPHYS J, V91, pL39, DOI 10.1529/biophysj.106.088773; DENG TL, 1993, GENE DEV, V7, P479, DOI 10.1101/gad.7.3.479; Dey B, 2012, MOL CELL BIOCHEM, V365, P279, DOI 10.1007/s11010-012-1269-z; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Jayaram B, 2004, ANNU REV BIOPH BIOM, V33, P343, DOI 10.1146/annurev.biophys.33.110502.140414; Koh YY, 2011, RNA, V17, P718, DOI 10.1261/rna.2540311; Liang XH, 2015, NUCLEIC ACIDS RES, V43, P2927, DOI 10.1093/nar/gkv143; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Machleidt T, 2015, ACS CHEM BIOL, V10, P1797, DOI 10.1021/acschembio.5b00143; Marion RM, 1999, MOL CELL BIOL, V19, P2212; Masuho I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab4068; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; Park E, 2013, WIRES RNA, V4, P423, DOI 10.1002/wrna.1168; Park H, 2015, AMINO ACIDS, V47, P729, DOI 10.1007/s00726-014-1900-2; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; Rhodes D, 2000, CURR OPIN STRUC BIOL, V10, P75, DOI 10.1016/S0959-440X(99)00052-4; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Shen W, 2015, NUCLEIC ACIDS RES, V43, P4569, DOI 10.1093/nar/gkv298; Shen W, 2014, NUCLEIC ACIDS RES, V42, P8648, DOI 10.1093/nar/gku579; Tolstorukov MY, 2004, J MOL BIOL, V337, P65, DOI 10.1016/j.jmb.2004.01.011; Vickers TA, 2007, NUCLEIC ACIDS RES, V35, P6598, DOI 10.1093/nar/gkm663; Vickers TA, 2015, NUCLEIC ACIDS RES, V43, P8955, DOI 10.1093/nar/gkv920; Vickers TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108625; Wang JF, 2015, P NATL ACAD SCI USA, V112, P148, DOI 10.1073/pnas.1412089112; Wickham L, 1999, MOL CELL BIOL, V19, P2220; Wu HJ, 1999, J BIOL CHEM, V274, P28270, DOI 10.1074/jbc.274.40.28270; Wu HJ, 2001, J BIOL CHEM, V276, P23547, DOI 10.1074/jbc.M009676200	30	46	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161930	10.1371/journal.pone.0161930	http://dx.doi.org/10.1371/journal.pone.0161930			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571227	Green Published, Green Submitted, gold			2022-12-26	WOS:000382876700046
J	Diaz, LA; Quaglia, AI; Konigheim, BS; Boris, AS; Aguilar, JJ; Komar, N; Contigiani, MS				Adrian Diaz, Luis; Ignacio Quaglia, Agustin; Salome Konigheim, Brenda; Silvana Boris, Analia; Javier Aguilar, Juan; Komar, Nicholas; Silvia Contigiani, Marta			Activity Patterns of St. Louis Encephalitis and West Nile Viruses in Free Ranging Birds during a Human Encephalitis Outbreak in Argentina	PLOS ONE			English	Article							CALIFORNIA BIRDS; TRANSMISSION; HOST; EPIDEMIOLOGY; FLAVIVIRIDAE; PERSISTENCE; INFECTIONS; DYNAMICS; AMERICA; STRAINS	St. Louis encephalitis virus (SLEV) (Flavivirus) is a reemerging arbovirus in the southern cone of South America. In 2005, an outbreak of SLEV in central Argentina resulted in 47 human cases with 9 deaths. In Argentina, the ecology of SLEV is poorly understood. Because certain birds are the primary amplifiers in North America, we hypothesized that birds amplify SLEV in Argentina as well. We compared avian SLEV seroprevalence in a variety of ecosystems in and around Cordoba city from 2004 (before the epidemic) and 2005 (during the epidemic). We also explored spatial patterns to better understand the local ecology of SLEV transmission. Because West Nile virus (WNV) was also detected in Argentina in 2005, all analyses were also conducted for WNV. A total of 980 birds were sampled for detection of SLEV and WNV neutralizing antibodies. SLEV seroprevalence in birds increased 11-fold from 2004 to 2005. Our study demonstrated that a high proportion (99.3%) of local birds were susceptible to SLEV infection immediately prior to the 2005 outbreak, indicating that the vertebrate host population was primed to amplify SLEV. SLEV was found distributed in a variety of environments throughout the city of Cordoba. However, the force of viral transmission varied among sites. Fine scale differences in populations of vectors and vertebrate hosts would explain this variation. In summary, we showed that in 2005, both SLEV and to a lesser extent WNV circulated in the avian population. Eared Dove, Picui Ground-Dove and Great Kiskadee are strong candidates to amplify SLEV because of their exposure to the pathogen at the population level, and their widespread abundance. For the same reasons, Rufous Hornero may be an important maintenance host for WNV in central Argentina. Competence studies and vector feeding studies are needed to confirm these relationships.	[Adrian Diaz, Luis; Ignacio Quaglia, Agustin; Salome Konigheim, Brenda; Silvana Boris, Analia; Javier Aguilar, Juan; Silvia Contigiani, Marta] Univ Nacl Cordoba, Fac Ciencias Med, Inst Virol Dr JM Vanella, Lab Arbovirus, Cordoba, Argentina; [Adrian Diaz, Luis] Univ Nacl Cordoba, CONICET, Inst Invest Biol & Tecnol, Cordoba, Argentina; [Komar, Nicholas] Ctr Dis Control & Prevent, Ft Collins, CO USA	National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Centers for Disease Control & Prevention - USA	Diaz, LA (corresponding author), Univ Nacl Cordoba, Fac Ciencias Med, Inst Virol Dr JM Vanella, Lab Arbovirus, Cordoba, Argentina.; Diaz, LA (corresponding author), Univ Nacl Cordoba, CONICET, Inst Invest Biol & Tecnol, Cordoba, Argentina.	adrian.diaz@conicet.gov.ar	Konigheim, Brenda/AHB-4508-2022	Konigheim, Brenda/0000-0003-1724-2156; Diaz, Adrian/0000-0001-5953-2907	Ministerio de Ciencia y Tecnologia de la Nacion Argentina (MINCYT) [PICT 2013/1779]; Consejo Nacional de Ciencia y Tecnologia [CONICET PIP 11220120100544]; Secretaria de Ciencia y Tecnologia Universidad Nacional de Cordoba [SECYT 203/14]; Fundacion Bunge y Born; Council for Scientific and Technical Research (CONICET); International Union of Microbiological Societies; International Society of Infectious Diseases	Ministerio de Ciencia y Tecnologia de la Nacion Argentina (MINCYT); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Secretaria de Ciencia y Tecnologia Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT)); Fundacion Bunge y Born; Council for Scientific and Technical Research (CONICET); International Union of Microbiological Societies; International Society of Infectious Diseases	This work was funded by grants from Ministerio de Ciencia y Tecnologia de la Nacion Argentina (MINCYT, PICT 2013/1779, MSC), Consejo Nacional de Ciencia y Tecnologia (CONICET PIP 11220120100544), Secretaria de Ciencia y Tecnologia Universidad Nacional de Cordoba (SECYT 203/14, LAD) and Fundacion Bunge y Born. AIQ is a recipient of a doctorate scholarship from Council for Scientific and Technical Research (CONICET). LAD's internship at the CDC Ft. Collins was supported by the International Union of Microbiological Societies (http://www.iums.org/) and International Society of Infectious Diseases (http://www.isid.org/).; Authors want thanks to Eric Edwards for his invaluable support in serological determinations at CDC (Ft. Collins). AIQ is a recipient of a doctorate scholarship from Council for Scientific and Technical Research (CONICET). LAD's internship at the CDC Ft. Collins was supported by the International Union of Microbiological Societies (http://www.iums.org/) and International Society of Infectious Diseases (http://www.isid.org/).	Diaz LA, 2008, EMERG INFECT DIS, V14, P689, DOI 10.3201/eid1404.071257; Diaz LA, 2006, EMERG INFECT DIS, V12, P1752, DOI 10.3201/eid1211.060486; Diaz LA, 2013, T ROY SOC TROP MED H, V107, P332, DOI 10.1093/trstmh/trt023; Diaz LA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001177; Diaz LA, 2011, J ORNITHOL, V152, P21, DOI 10.1007/s10336-010-0538-4; Barker CM, 2010, AM J TROP MED HYG, V82, P1185, DOI 10.4269/ajtmh.2010.09-0324; Batallan GP, 2015, ACTA TROP, V146, P53, DOI 10.1016/j.actatropica.2015.03.009; BOWEN GS, 1980, AM J TROP MED HYG, V29, P1411, DOI 10.4269/ajtmh.1980.29.1411; Cabrera AL., 1971, BOLET N SOC ARGENTIN, V14, P1; Diaz LA, 2003, ENTOMOLVECT, V10, P551; Diaz LA, 2008, VECTOR-BORNE ZOONOT, V8, P277, DOI 10.1089/vbz.2007.0168; Díaz Luis A., 2011, Hornero, V26, P5; Fabbri CM, 2011, REVARGMICROBIOL, V43, P90; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Jarsun B, 2003, RECURSOS NATURALES P, P23; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; Komar N, 2006, REV PANAM SALUD PUBL, V19, P112, DOI 10.1590/S1020-49892006000200006; Ledermann JP, 2011, CLIN VACCINE IMMUNOL, V18, P580, DOI 10.1128/CVI.00201-10; MONATH TP, 1985, AM J TROP MED HYG, V34, P966, DOI 10.4269/ajtmh.1985.34.966; Morales MA, 2006, EMERG INFECT DIS, V12, P1559, DOI 10.3201/eid1210.060852; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Patiris PJ, 2008, AM J TROP MED HYG, V78, P434, DOI 10.4269/ajtmh.2008.78.434; R Core Team, 2021, R LANGUAGE ENV STAT; Reisen William K, 2003, Adv Virus Res, V61, P139, DOI 10.1016/S0065-3527(03)61004-3; Reisen WK, 2010, ANNU REV ENTOMOL, V55, P461, DOI 10.1146/annurev-ento-112408-085419; Reisen WK, 2005, J MED ENTOMOL, V42, P367, DOI 10.1603/0022-2585(2005)042[0367:AHAMDC]2.0.CO;2; Reisen WK, 2001, J MED ENTOMOL, V38, P393, DOI 10.1603/0022-2585-38.3.393; Reisen WK, 2004, J MED ENTOMOL, V41, P462, DOI 10.1603/0022-2585-41.3.462; Rocco Iray M., 2005, Rev. Inst. Med. trop. S. Paulo, V47, P281, DOI 10.1590/S0036-46652005000500008; Sabattini MS, 1998, OVERVIEW ARBOVIROLOG, P113; Spinsanti LI, 2008, J CLIN VIROL, V42, P27, DOI 10.1016/j.jcv.2007.11.022; Stevens MHH, 2009, PRIMER ECOLOGY R; Cid CV, 2013, ACTA TROP, V125, P303, DOI 10.1016/j.actatropica.2012.12.005	34	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161871	10.1371/journal.pone.0161871	http://dx.doi.org/10.1371/journal.pone.0161871			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564679	Green Submitted, Green Published, gold			2022-12-26	WOS:000382496300028
J	Jeng, CJ; Hsieh, YT; Yang, CM; Yang, CH; Lin, CL; Wang, IJ				Jeng, Chi-Juei; Hsieh, Yi-Ting; Yang, Chung-May; Yang, Chang-Hao; Lin, Cheng-Li; Wang, I-Jong			Diabetic Retinopathy in Patients with Diabetic Nephropathy: Development and Progression	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INDEPENDENT RISK-FACTOR; CORONARY-HEART-DISEASE; MACULAR EDEMA; CARDIOVASCULAR-DISEASE; MICROVASCULAR COMPLICATIONS; BLOOD-PRESSURE; PATHOGENESIS; HYPERTENSION; PREVALENCE	The purpose of current study aims to investigate the development and progression of diabetic retinopathy (DR) in patients with diabetic nephropathy (DN) in a nationwide population-based cohort in Taiwan. Newly diagnosed DN patients and age-and sex-matched controls were identified from the Taiwanese Longitudinal Health Insurance Database from 2000 to 2010. We studied the effects of age, sex, hypertension, dyslipidemia, diabetic polyneuropathy (DPN), and medications on the development of nonproliferative DR (NPDR), proliferative DR (PDR), and diabetic macular edema (DME) in patients with DN. Cox proportional hazard regression analyses were used to estimate the adjusted hazard ratios (HRs) of the development of DR. Our results show that the adjusted HRs of NPDR and PDR were 5.01 (95% confidence interval (CI) = 4.68-5.37) and 9.7 (95% CI = 8.15-11.5), respectively, in patients with DN as compared with patients in the non-DN cohort. At 5-year follow-up, patients with DN showed an increased HR of NPDR progression to PDR (HR = 2.26, 95% CI = 1.68-3.03), and the major comorbidities were hypertension (HR = 1.23, 95% CI = 1.10-1.38 with NPDR; HR = 1.33, 95% CI = 1.02-1.72 with PDR) and DPN (HR = 2.03, 95% CI = 1.72-2.41 in NPDR; HR = 2.95, 95% CI = 2.16-4.03 in PDR). Dyslipidemia increased the HR of developing NPDR but not PDR or DME. Moreover, DN did not significantly affect DME development (HR = 1.47, 95% CI = 0.87-2.48) or progression (HR = 0.37, 95% CI = 0.11-1.20). We concluded that DN was an independent risk factor for DR development and progression; however, DN did not markedly affect DME development in this study, and the potential association between these disorders requires further investigation.	[Jeng, Chi-Juei] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Ophthalmol, Hsinchu, Taiwan; [Jeng, Chi-Juei] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Jeng, Chi-Juei; Hsieh, Yi-Ting; Yang, Chung-May; Yang, Chang-Hao; Wang, I-Jong] Natl Taiwan Univ Hosp, Sch Med, Dept Ophthalmol, Taipei, Taiwan; [Lin, Cheng-Li] China Med Univ, Management Off Hlth Data, Taichung, Taiwan; [Wang, I-Jong] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; China Medical University Taiwan	Wang, IJ (corresponding author), Natl Taiwan Univ Hosp, Sch Med, Dept Ophthalmol, Taipei, Taiwan.; Lin, CL (corresponding author), China Med Univ, Management Off Hlth Data, Taichung, Taiwan.; Wang, IJ (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan.	a21467@mail.cmuh.org.tw; ijong@ms8.hinet.net	Yang, Chung-May/AAV-3737-2020; Yang, Chang-Hao/AAR-3759-2021	Wang, I-Jong/0000-0002-3045-0614; JENG, CHI-JUEI/0000-0002-3579-2082; YANG, CHUNG-MAY/0000-0003-4082-420X; YANG, CHANG-HAO/0000-0002-4328-8716				Advani A, 2012, SEMIN NEPHROL, V32, P199, DOI 10.1016/j.semnephrol.2012.02.006; AGARDH E, 1994, DIABETIC MED, V11, P273, DOI 10.1111/j.1464-5491.1994.tb00271.x; Aiello LP, 1998, DIABETES CARE, V21, P143, DOI 10.2337/diacare.21.1.143; Arboleda-Velasquez JF, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-014-0573-2; Asensio-Sánchez V.M., 2008, Arch Soc Esp Oftalmol, V83, P173; BALLARD DJ, 1986, DIABETES CARE, V9, P334, DOI 10.2337/diacare.9.4.334; Bandello F, 2013, ACTA DIABETOL, V50, P1, DOI 10.1007/s00592-012-0449-3; Barr ELM, 2006, DIABETES CARE, V29, P1114, DOI 10.2337/dc05-2464; Bhagat N, 2009, SURV OPHTHALMOL, V54, P1, DOI 10.1016/j.survophthal.2008.10.001; Boelter MC, 2006, BRAZ J MED BIOL RES, V39, P1033, DOI 10.1590/S0100-879X2006000800006; Boeri D, 2001, DIABETES, V50, P1432, DOI 10.2337/diabetes.50.6.1432; Boulton M, 1998, BRIT J OPHTHALMOL, V82, P561, DOI 10.1136/bjo.82.5.561; Cai J, 2002, EYE, V16, P242, DOI 10.1038/sj.eye.6700133; Chang CJ, 2000, DIABETES RES CLIN PR, V50, pS49, DOI 10.1016/S0168-8227(00)00179-0; Chaturvedi N, 1998, LANCET, V351, P28, DOI 10.1016/S0140-6736(97)06209-0; Chen S, 2008, CURR DIABETES REP, V8, P470, DOI 10.1007/s11892-008-0081-3; Cheung N, 2008, PROG RETIN EYE RES, V27, P161, DOI 10.1016/j.preteyeres.2007.12.001; Cheung N, 2007, DIABETES CARE, V30, P1742, DOI 10.2337/dc07-0264; Cheung N, 2007, STROKE, V38, P398, DOI 10.1161/01.STR.0000254547.91276.50; Chew E Y, 1997, Curr Opin Ophthalmol, V8, P59, DOI 10.1097/00055735-199706000-00011; Chew EY, 2014, OPHTHALMOLOGY, V121, P2443, DOI 10.1016/j.ophtha.2014.07.019; Cohen O, 1998, ARCH INTERN MED, V158, P641, DOI 10.1001/archinte.158.6.641; COWIE CC, 1993, TRANSPL P, V25, P2426; Das R, 2015, OPHTHALMOLOGY, V122, P1820, DOI 10.1016/j.ophtha.2015.05.011; DCCT Res Grp, 1986, DIABETES, V35, P530; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Do DV, 2015, SAO PAULO MED J, V133, P278, DOI 10.1590/1516-3180.20151333T1; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Girach A, 2007, INT J CLIN PRACT, V61, P88, DOI 10.1111/j.1742-1241.2006.01211.x; Girach A, 2006, INT J CLIN PRACT, V60, P1471, DOI 10.1111/j.1742-1241.2006.01175.x; Girach A, 2006, J DIABETES COMPLICAT, V20, P228, DOI 10.1016/j.jdiacomp.2006.03.001; Golubovic-Arsovska M, 2007, Prilozi, V28, P149; Gruden G, 2005, CURR DIABETES REV, V1, P27, DOI 10.2174/1573399052952622; HAFFNER SM, 1988, DIABETES, V37, P878, DOI 10.2337/diabetes.37.7.878; HAMMAN RF, 1989, DIABETES, V38, P1231, DOI 10.2337/diabetes.38.10.1231; Hammes HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132492; Han HJ, 2006, CLIN EXP PHARMACOL P, V33, P1172, DOI 10.1111/j.1440-1681.2006.04495.x; Heng LZ, 2013, DIABETIC MED, V30, P640, DOI 10.1111/dme.12089; HirataDulas CAI, 1996, CLIN NEPHROL, V46, P92; Keech AC, 2007, LANCET, V370, P1687, DOI 10.1016/S0140-6736(07)61607-9; KLEIN R, 1989, DIABETES METAB REV, V5, P559, DOI 10.1002/dmr.5610050703; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; KLEIN R, 1984, OPHTHALMOLOGY, V91, P1464; KLEIN R, 1989, OPHTHALMOLOGY, V96, P1501; Kohner EM, 1999, DIABETOLOGIA, V42, P1107, DOI 10.1007/s001250051278; KOHNER EM, 1995, DIABETES, V44, P603, DOI 10.2337/diabetes.44.6.603; Lang GE, 2012, OPHTHALMOLOGICA, V227, P21, DOI 10.1159/000337156; Leske MC, 2005, OPHTHALMOLOGY, V112, P799, DOI 10.1016/j.ophtha.2004.11.054; Lewis Gareth, 2014, Practitioner, V258, P13; Lin IC, 2015, ACTA OPHTHALMOL, V93, P713, DOI 10.1111/aos.12746; Lupia E, 1999, DIABETES, V48, P1638, DOI 10.2337/diabetes.48.8.1638; Man REK, 2015, INVEST OPHTH VIS SCI, V56, P4810, DOI 10.1167/iovs.15-16987; Miettinen H, 1996, DIABETES CARE, V19, P1445, DOI 10.2337/diacare.19.12.1445; Najafian B, 2011, CONTRIB NEPHROL, V170, P36, DOI 10.1159/000324942; Nguyen-Khoa BA, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-11; NORGAARD K, 1991, DIABETIC MED, V8, P334, DOI 10.1111/j.1464-5491.1991.tb01606.x; Ochodnicky P, 2006, J CARDIOVASC PHARM, V47, pS151, DOI 10.1097/00005344-200606001-00009; OSTERBY R, 1990, DIABETES, V39, P1057, DOI 10.2337/diabetes.39.9.1057; Panagiotoglou TD, 2010, OPHTHAL SURG LAS IM, V41, P316, DOI 10.3928/15428877-20100430-04; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Pelzek Christopher, 2002, Ophthalmol Clin North Am, V15, P555, DOI 10.1016/S0896-1549(02)00043-3; REICHARD P, 1993, NEW ENGL J MED, V329, P304, DOI 10.1056/NEJM199307293290502; Ritz E, 1999, AM J KIDNEY DIS, V34, P795, DOI 10.1016/S0272-6386(99)70035-1; RITZ E, 1993, AM HEART J, V125, P1514, DOI 10.1016/0002-8703(93)90448-I; Samuels IS, 2015, J NEUROPHYSIOL, V113, P1085, DOI 10.1152/jn.00761.2014; Schmittdiel JA, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2014-000043; Sivaprasad S, 2012, SURV OPHTHALMOL, V57, P347, DOI 10.1016/j.survophthal.2012.01.004; Smith LEH, 1999, NAT MED, V5, P1390, DOI 10.1038/70963; Srivastava B K, 2005, J Assoc Physicians India, V53, P803; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; TEUSCHER A, 1988, DIABETES CARE, V11, P246, DOI 10.2337/diacare.11.3.246; Tufro A, 2012, SEMIN NEPHROL, V32, P385, DOI 10.1016/j.semnephrol.2012.06.010; van Hecke MV, 2005, DIABETES CARE, V28, P1383, DOI 10.2337/diacare.28.6.1383; Vasylyeva TL, 2007, DIABETES RES CLIN PR, V76, P177, DOI 10.1016/j.diabres.2006.09.012; Volpe M, 2015, CARDIOVASC DIAGN THE, V5, P353, DOI 10.3978/j.issn.2223-3652.2015.06.02; Ways D K, 2000, Vitam Horm, V60, P149, DOI 10.1016/S0083-6729(00)60019-5; Williams R, 2004, EYE, V18, P963, DOI 10.1038/sj.eye.6701476; Wright AD, 2011, EYE, V25, P842, DOI 10.1038/eye.2011.62; Young BA, 2003, DIABETES CARE, V26, P2392, DOI 10.2337/diacare.26.8.2392; Zheng YF, 2012, INDIAN J OPHTHALMOL, V60, P428, DOI 10.4103/0301-4738.100542	81	46	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161897	10.1371/journal.pone.0161897	http://dx.doi.org/10.1371/journal.pone.0161897			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564383	Green Published, Green Submitted, gold			2022-12-26	WOS:000382496300033
J	Kasai, A; Bai, SL; Hojo, H; Harada, T				Kasai, Atsushi; Bai, Songling; Hojo, Hatsune; Harada, Takeo			Epigenome Editing of Potato by Grafting Using Transgenic Tobacco as siRNA Donor	PLOS ONE			English	Article							DIRECTED DNA METHYLATION; EPIGENETIC INHERITANCE; GENE-EXPRESSION; PLANT; RNA; MOBILE; AMYLOSE; SIZE	In plants, it is possible to induce heritable transcriptional gene silencing (TGS) via RNA-directed DNA methylation (RdDM) using artificially synthesized small RNA (siRNA) homologous to the 5'-flanking region of the target gene. As the siRNA signal with a specific RNA determinant moves through plasmodesmata and sieve elements, we attempted to induce TGS of a transgene and an endogenous gene of potato (Solanum tuberosum) rootstock by grafting using siRNA produced in a tobacco (Nicotiana benthamiana) scion. Our results provide evidence that this system can induce TGS of target genes in tubers formed on potato rootstock. The TGS is maintained in the progeny tubers lacking the transported siRNAs. Our findings reveal that epigenome editing using mobile RNA has the potential to allow breeding of artificial sport cultivars in vegetative propagation crops.	[Kasai, Atsushi; Hojo, Hatsune; Harada, Takeo] Hirosaki Univ, Dept Agr & Life Sci, Hirosaki, Aomori, Japan; [Bai, Songling] Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou, Zhejiang, Peoples R China	Hirosaki University; Zhejiang University	Kasai, A (corresponding author), Hirosaki Univ, Dept Agr & Life Sci, Hirosaki, Aomori, Japan.	kasaia@hirosaki-u.ac.jp	Bai, Songling/X-9850-2019	Bai, Songling/0000-0002-8103-3095	Japan Society for the Promotion of Science [22380003, 24880007, 15K18624]; Ministry of Health, Labor and Welfare [H24-shokuhin-ippan-007, H27-shokuhin-ippan-007]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (KAKENHI) Grant Numbers 22380003, 24880007 and 15K18624 and by Ministry of Health, Labor and Welfare Grants (H24-shokuhin-ippan-007 and H27-shokuhin-ippan-007); Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (KAKENHI), http://www.jsps.go.jp/english/e-grants/index.html, Ministry of Health, Labor and Welfare Grants, http://mhlw-grants.niph.go.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aufsatz W, 2002, P NATL ACAD SCI USA, V99, P16499, DOI 10.1073/pnas.162371499; Bai SL, 2011, J EXP BOT, V62, P4561, DOI 10.1093/jxb/err163; Beaujean A, 1998, J EXP BOT, V49, P1589, DOI 10.1093/jexbot/49.326.1589; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Calarco JP, 2012, CELL, V151, P194, DOI 10.1016/j.cell.2012.09.001; Crevillen P, 2014, NATURE, V515, P587, DOI 10.1038/nature13722; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Goh T, 2012, DEVELOPMENT, V139, P883, DOI 10.1242/dev.071928; Gohlke J, 2015, AM J BOT, V102, P1399, DOI 10.3732/ajb.1500173; Han X, 2014, J EXP BOT, V65, P1737, DOI 10.1093/jxb/ert422; Hannapel DJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00257; Hartung F, 2014, PLANT J, V78, P742, DOI 10.1111/tpj.12413; Heap B, 2013, NATURE, V498, P409, DOI 10.1038/498409a; Heilersig BHJB, 2006, MOL GENET GENOMICS, V275, P437, DOI 10.1007/s00438-006-0101-4; Heilersig HJB, 2006, PLANT MOL BIOL, V60, P647, DOI 10.1007/s11103-005-5280-6; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; HENDRIKS T, 1991, PLANT MOL BIOL, V17, P385, DOI 10.1007/BF00040633; HOVENKAMPHERMELINK JHM, 1987, THEOR APPL GENET, V75, P217, DOI 10.1007/BF00249167; Kasai A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016895; Kawashima T, 2014, NAT REV GENET, V15, P613, DOI 10.1038/nrg3685; KUIPERS AGJ, 1994, PLANT CELL, V6, P43, DOI 10.1105/tpc.6.1.43; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lusser M, 2012, NAT BIOTECHNOL, V30, P231, DOI 10.1038/nbt.2142; Matsuda Y, 2002, PROTOPLASMA, V220, P51, DOI 10.1007/s00709-002-0027-6; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; Mudge K., 2009, Horticultural Reviews, V35, P437; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Otagaki S, 2011, EPIGENETICS-US, V6, P681, DOI 10.4161/epi.6.6.16214; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Smet I. D., 2011, NEW PHYTOL, V193, P867; Springer NM, 2013, TRENDS GENET, V29, P241, DOI 10.1016/j.tig.2012.10.009; TANAKA A, 1990, NUCLEIC ACIDS RES, V18, P6767, DOI 10.1093/nar/18.23.6767; Zhang ChangQing, 2013, Plant Breeding and Biotechnology, V1, P307, DOI 10.9787/PBB.2013.1.4.307; Zhang WN, 2014, PLANT J, V80, P106, DOI 10.1111/tpj.12622; Zhao DY, 2014, PLANT BIOTECHNOL J, V12, P1319, DOI 10.1111/pbi.12243	36	22	23	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161729	10.1371/journal.pone.0161729	http://dx.doi.org/10.1371/journal.pone.0161729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564864	Green Published, Green Submitted, gold			2022-12-26	WOS:000382496300012
J	Patra, N; Ioannidis, EI; Kulik, HJ				Patra, Niladri; Ioannidis, Efthymios I.; Kulik, Heather J.			Computational Investigation of the Interplay of Substrate Positioning and Reactivity in Catechol O-Methyltransferase	PLOS ONE			English	Article							FREE-ENERGY CALCULATIONS; HISTOGRAM ANALYSIS METHOD; METHYL-TRANSFER; TRANSITION-STATE; ACTIVE-SITE; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; CATALYTIC EFFICIENCY; BACKBONE PARAMETERS; AQUEOUS-SOLUTION	Catechol O-methyltransferase (COMT) is a SAM- and Mg2+-dependent methyltransferase that regulates neurotransmitters through methylation. Simulations and experiments have identified divergent catecholamine substrate orientations in the COMT active site: molecular dynamics simulations have favored a monodentate coordination of catecholate substrates to the active site Mg2+, and crystal structures instead preserve bidentate coordination along with short (2.65 angstrom) methyl donor-acceptor distances. We carry out longer dynamics (up to 350 ns) to quantify interconversion between bidentate and monodentate binding poses. We provide a systematic determination of the relative free energy of the monodentate and bidentate structures in order to identify whether structural differences alter the nature of the methyl transfer mechanism and source of enzymatic rate enhancement. We demonstrate that the bidentate and monodentate binding modes are close in energy but separated by a 7 kcal/mol free energy barrier. Analysis of interactions in the two binding modes reveals that the driving force for monodentate catecholate orientations in classical molecular dynamics simulations is derived from stronger electrostatic stabilization afforded by alternate Mg2+ coordination with strongly charged active site carboxylates. Mixed semi-empirical-classical (SQM/MM) substrate C-O distances (2.7 angstrom) for the bidentate case are in excellent agreement with COMT X-ray crystal structures, as long as charge transfer between the substrates, Mg2+, and surrounding ligands is permitted. SQM/MM free energy barriers for methyl transfer from bidentate and monodentate catecholate configurations are comparable at around 21-22 kcal/mol, in good agreement with experiment (18-19 kcal/mol). Overall, the work suggests that both binding poses are viable for methyl transfer, and accurate descriptions of charge transfer and electrostatics are needed to provide balanced relative barriers when multiple binding poses are accessible, for example in other transferases.	[Patra, Niladri; Ioannidis, Efthymios I.; Kulik, Heather J.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Kulik, HJ (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	hjkulik@mit.edu			Burroughs Wellcome Fund; National Science Foundation [ACI-1053575]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	H.J.K. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund, which supported both H.J.K. and N.P. This work was carried out in part using computational resources from the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number ACI-1053575. This work was also carried out in part using the computational resources of the Center for Nanoscale Materials (Carbon cluster), an Office of Science user facility, which was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357.; The authors acknowledge helpful conversations with Michael Funk and Adam H. Steeves. This work was carried out in part using computational resources from the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number ACI-1053575. This work was also carried out in part using the computational resources of the Center for Nanoscale Materials (Carbon cluster), an Office of Science user facility, was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357.	Allner O, 2012, J CHEM THEORY COMPUT, V8, P1493, DOI 10.1021/ct3000734; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; AXELROD J, 1958, J BIOL CHEM, V233, P702; AXELROD J, 1966, PHARMACOL REV, V18, P95; Bai HW, 2007, CHEM RES TOXICOL, V20, P1409, DOI 10.1021/tx700174w; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bleuzen A, 1997, MAGN RESON CHEM, V35, P765, DOI 10.1002/(SICI)1097-458X(199711)35:11<765::AID-OMR169>3.0.CO;2-F; Bonifacio MJ, 2002, MOL PHARMACOL, V62, P795, DOI 10.1124/mol.62.4.795; Cao Y, 2014, J PHYS CHEM B, V118, P470, DOI 10.1021/jp410296s; Carvalho ATP, 2014, J MOL GRAPH MODEL, V54, P62, DOI 10.1016/j.jmgm.2014.09.003; Case D., 2015, AMBER, V14; CHENG XD, 1993, CELL, V74, P299, DOI 10.1016/0092-8674(93)90421-L; COWARD JK, 1973, BIOCHEMISTRY-US, V12, P2291, DOI 10.1021/bi00736a017; CREVELING CR, 1970, MOL PHARMACOL, V6, P691; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Du X, 2008, P NATL ACAD SCI USA, V105, P14609, DOI 10.1073/pnas.0807219105; Dudev T, 2003, CHEM REV, V103, P773, DOI 10.1021/cr020467n; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; Ehler A, 2014, ACTA CRYSTALLOGR D, V70, P2163, DOI 10.1107/S1399004714012917; Ellermann M, 2012, ACTA CRYSTALLOGR D, V68, P253, DOI 10.1107/S0907444912001138; FURUKI T, 1995, J COMPUT CHEM, V16, P378, DOI 10.1002/jcc.540160311; Gao JL, 2002, ANNU REV PHYS CHEM, V53, P467, DOI 10.1146/annurev.physchem.53.091301.150114; Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172; Gerhards M, 1996, J CHEM PHYS, V104, P9362, DOI 10.1063/1.471682; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Gordon MS, 2005, THEORY AND APPLICATIONS OF COMPUTATIONAL CHEMISTRY: THE FIRST FORTY YEARS, P1167, DOI 10.1016/B978-044451719-7/50084-6; Grossfield A., 2015, WHAM WEIGHTED HISTOG; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; Harrison ST, 2015, ACS MED CHEM LETT, V6, P318, DOI 10.1021/ml500502d; HEGAZI MF, 1979, J AM CHEM SOC, V101, P4359, DOI 10.1021/ja00509a052; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Hu H, 2008, ANNU REV PHYS CHEM, V59, P573, DOI 10.1146/annurev.physchem.59.032607.093618; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kanaan N, 2008, CHEM COMMUN, P6114, DOI 10.1039/b814212b; Kuhn B, 2000, J AM CHEM SOC, V122, P2586, DOI 10.1021/ja992218v; Kulik HJ, 2013, J BIOL CHEM, V288, P11233, DOI 10.1074/jbc.M112.415570; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; LABAHN J, 1994, P NATL ACAD SCI USA, V91, P10957, DOI 10.1073/pnas.91.23.10957; Lameira J, 2015, PROTEINS, V83, P318, DOI 10.1002/prot.24717; Lau EY, 1998, J AM CHEM SOC, V120, P12387, DOI 10.1021/ja9827447; Lau EY, 2000, J AM CHEM SOC, V122, P7165, DOI 10.1021/ja000265d; Lautala P, 2001, MOL PHARMACOL, V59, P393, DOI 10.1124/mol.59.2.393; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Marti S, 2004, CHEM SOC REV, V33, P98, DOI 10.1039/b301875j; Martinie RJ, 2015, J AM CHEM SOC; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; MIHEL I, 1979, J AM CHEM SOC, V101, P4349, DOI 10.1021/ja00509a050; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Myers J, 2006, PROTEINS, V63, P928, DOI 10.1002/prot.20922; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Palma PN, 2006, MOL PHARMACOL, V70, P143, DOI 10.1124/mol.106.023119; Roca M, 2005, J AM CHEM SOC, V127, P10648, DOI 10.1021/ja051503d; Roca M, 2003, J AM CHEM SOC, V125, P7726, DOI 10.1021/ja0299497; Roca M, 2006, J AM CHEM SOC, V128, P6186, DOI 10.1021/ja058826u; Rod TH, 2005, J CHEM THEORY COMPUT, V1, P1240, DOI 10.1021/ct0501102; Rod TH, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.138302; Ruggiero GD, 2004, J AM CHEM SOC, V126, P8634, DOI 10.1021/ja048055e; Rutherford K, 2008, J MOL BIOL, V380, P120, DOI 10.1016/j.jmb.2008.04.040; Rutherford K, 2008, BBA-PROTEINS PROTEOM, V1784, P1098, DOI 10.1016/j.bbapap.2008.04.006; Rutherford K, 2006, BIOCHEMISTRY-US, V45, P2178, DOI 10.1021/bi051988i; Rutherford K, 2009, BIOCHEMISTRY-US, V48, P6450, DOI 10.1021/bi900174v; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; SCHULTZ E, 1989, BIOCHEM PHARMACOL, V38, P3953, DOI 10.1016/0006-2952(89)90673-4; Senn HM, 2009, ANGEW CHEM INT EDIT, V48, P1198, DOI 10.1002/anie.200802019; SHARP KA, 1990, J PHYS CHEM-US, V94, P7684, DOI 10.1021/j100382a068; Souaille M, 2001, COMPUT PHYS COMMUN, V135, P40, DOI 10.1016/S0010-4655(00)00215-0; Sparta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047172; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Tsao D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024287; Tsao D, 2011, CHEM PHYS LETT, V506, P135, DOI 10.1016/j.cplett.2011.03.048; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Tsuji E, 2009, J STRUCT BIOL, V165, P133, DOI 10.1016/j.jsb.2008.11.012; Tsuji E, 2009, BIOCHEM BIOPH RES CO, V378, P494, DOI 10.1016/j.bbrc.2008.11.085; van der Kamp MW, 2013, BIOCHEMISTRY-US, V52, P2708, DOI 10.1021/bi400215w; Vanquelef E, 2011, NUCLEIC ACIDS RES, V39, pW511, DOI 10.1093/nar/gkr288; VIDGREN J, 1994, NATURE, V368, P354, DOI 10.1038/368354a0; Wang F., 2013, PYTHON OBJECT ORIENT; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; WOODARD RW, 1980, J BIOL CHEM, V255, P9124; Xu DG, 2014, INT REV PHYS CHEM, V33, P1, DOI 10.1080/0144235X.2014.889378; Zhang JY, 2015, P NATL ACAD SCI USA, V112, P7954, DOI 10.1073/pnas.1506792112; Zhang JY, 2011, J AM CHEM SOC, V133, P17134, DOI 10.1021/ja207467d; Zheng YJ, 1997, J AM CHEM SOC, V119, P8137, DOI 10.1021/ja971019d	91	25	25	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161868	10.1371/journal.pone.0161868	http://dx.doi.org/10.1371/journal.pone.0161868			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564542	Green Submitted, Green Published, gold			2022-12-26	WOS:000382496300027
J	Gromnicova, R; Kaya, M; Romero, IA; Williams, P; Satchell, S; Sharrack, B; Male, D				Gromnicova, Radka; Kaya, Mehmet; Romero, Ignacio A.; Williams, Phil; Satchell, Simon; Sharrack, Basil; Male, David			Transport of Gold Nanoparticles by Vascular Endothelium from Different Human Tissues	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CELLULAR UPTAKE; LIPID-BILAYERS; IN-VITRO; SURFACE-CHARGE; GLYCOCALYX; SIZE; CELLS; PENETRATION; LECTIN	The selective entry of nanoparticles into target tissues is the key factor which determines their tissue distribution. Entry is primarily controlled by microvascular endothelial cells, which have tissue-specific properties. This study investigated the cellular properties involved in selective transport of gold nanoparticles (<5 nm) coated with PEG-amine/galactose in two different human vascular endothelia. Kidney endothelium (ciGENC) showed higher uptake of these nanoparticles than brain endothelium (hCMEC/D3), reflecting their biodistribution in vivo. Nanoparticle uptake and subcellular localisation was quantified by transmission electron microscopy. The rate of internalisation was approximately 4x higher in kidney endothelium than brain endothelium. Vesicular endocytosis was approximately 4x greater than cytosolic uptake in both cell types, and endocytosis was blocked by metabolic inhibition, whereas cytosolic uptake was energy-independent. The cellular basis for the different rates of internalisation was investigated. Morphologically, both endothelia had similar profiles of vesicles and cell volumes. However, the rate of endocytosis was higher in kidney endothelium. Moreover, the glycocalyces of the endothelia differed, as determined by lectin-binding, and partial removal of the glycocalyx reduced nanoparticle uptake by kidney endothelium, but not brain endothelium. This study identifies tissue-specific properties of vascular endothelium that affects their interaction with nanoparticles and rate of transport.	[Gromnicova, Radka; Romero, Ignacio A.; Male, David] Open Univ, Dept Life Hlth & Chem Sci, Milton Keynes, Bucks, England; [Kaya, Mehmet] Koc Univ, Sch Med, Dept Physiol, Istanbul, Turkey; [Williams, Phil] Midatech Pharma Plc, Abingdon, Oxon, England; [Satchell, Simon] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Sharrack, Basil] Univ Sheffield, Dept Neurol, Sheffield, S Yorkshire, England	Open University - UK; Koc University; University of Bristol; University of Sheffield	Male, D (corresponding author), Open Univ, Dept Life Hlth & Chem Sci, Milton Keynes, Bucks, England.	D.K.Male@Open.ac.uk		Romero, Ignacio/0000-0002-0322-9180; Male, David/0000-0002-1242-3137	Sheffield Teaching Hospitals Trust; Biotechnology and Biological Sciences Research Council [BB/K009184/1]; BBSRC [BB/K009184/1] Funding Source: UKRI	Sheffield Teaching Hospitals Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Sheffield Teaching Hospitals Trust and the Biotechnology and Biological Sciences Research Council (BB/K009184/1). The funders provided support in the form of salaries for authors (RG, IAR) and consumables, but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Midatech Pharma plc provided nanoparticles and facilities for ICP mass spectrometry. The specific roles of the authors are articulated in the 'author contributions' section.	Albanese A, 2011, ACS NANO, V5, P5478, DOI 10.1021/nn2007496; Arvizo RR, 2011, NANOMED-NANOTECHNOL, V7, P580, DOI 10.1016/j.nano.2011.01.011; Arvizo RR, 2010, NANO LETT, V10, P2543, DOI 10.1021/nl101140t; Atukorale PU, 2015, NANOSCALE, V7, P11420, DOI 10.1039/c5nr01355k; Chiodo F, 2014, BEILSTEIN J ORG CHEM, V10, P1339, DOI 10.3762/bjoc.10.136; Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Cho EC, 2009, NANO LETT, V9, P1080, DOI 10.1021/nl803487r; DOSSANTOS WLC, 1995, ACTA NEUROPATHOL, V90, P305; Ebong EE, 2011, ARTERIOSCL THROM VAS, V31, P1908, DOI 10.1161/ATVBAHA.111.225268; Freese C, 2013, BIOMATER SCI-UK, V1, P824, DOI 10.1039/c3bm60050e; Freese C, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-23; Garcia I, 2010, NANOMEDICINE-UK, V5, P777, DOI [10.2217/nnm.10.48, 10.2217/NNM.10.48]; Gromnicova R, 2016, NANOMEDICIN IN PRESS; Gromnicova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081043; Han HS, 2013, ANGEW CHEM INT EDIT, V52, P1414, DOI 10.1002/anie.201208331; Herrman G, 1996, HISTOCHEM CELL BIOL, V105, P129, DOI 10.1007/BF01696152; HOLTHOFER H, 1982, LAB INVEST, V47, P60; Huo SD, 2013, CANCER RES, V73, P319, DOI 10.1158/0008-5472.CAN-12-2071; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Jiang Y, 2015, ACS NANO, V9, P9986, DOI 10.1021/acsnano.5b03521; Lin JQ, 2010, ACS NANO, V4, P5421, DOI 10.1021/nn1010792; Lund T, 2011, BIOMATERIALS, V32, P9776, DOI 10.1016/j.biomaterials.2011.09.018; Ma XW, 2011, ACS NANO, V5, P8629, DOI 10.1021/nn202155y; Osaki F, 2004, J AM CHEM SOC, V126, P6520, DOI 10.1021/ja048792a; Potter DR, 2008, CIRC RES, V102, P770, DOI 10.1161/CIRCRESAHA.107.160226; Reichardt NC, 2013, CHEM SOC REV, V42, P4358, DOI 10.1039/c2cs35427f; Romero IA, 2003, NEUROSCI LETT, V344, P112, DOI 10.1016/S0304-3940(03)00348-3; Satchell SC, 2006, KIDNEY INT, V69, P1633, DOI 10.1038/sj.ki.5000277; SIMIONESCU M, 1982, J CELL BIOL, V94, P406, DOI 10.1083/jcb.94.2.406; Squire JM, 2001, J STRUCT BIOL, V136, P239, DOI 10.1006/jsbi.2002.4441; Sreekanthreddy P, 2015, F1000RESEARCH, P4, DOI 10.12688/f1000research.7142.1; Tatur S, 2013, LANGMUIR, V29, P6606, DOI 10.1021/la401074y; van den Berg BM, 2003, CIRC RES, V92, P592, DOI 10.1161/01.RES.0000065917.53950.75; van Haaren PMA, 2003, AM J PHYSIOL-HEART C, V285, pH2848, DOI 10.1152/ajpheart.00117.2003; Van Lehn RC, 2014, J PHYS CHEM A, V118, P5848, DOI 10.1021/jp411662c; Van Lehn RC, 2013, NANO LETT, V13, P4060, DOI 10.1021/nl401365n; Verma A, 2008, NAT MATER, V7, P588, DOI 10.1038/nmat2202; Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158; Walkey CD, 2012, CHEM SOC REV, V41, P2780, DOI 10.1039/c1cs15233e; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Yang K, 2010, NAT NANOTECHNOL, V5, P579, DOI [10.1038/NNANO.2010.141, 10.1038/nnano.2010.141]; Yuan S Y, 2010, STRUCTURE FUNCTION E; Zensi A, 2010, J DRUG TARGET, V18, P842, DOI 10.3109/1061186X.2010.513712; Zhang SL, 2009, ADV MATER, V21, P419, DOI 10.1002/adma.200801393	47	33	33	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161610	10.1371/journal.pone.0161610	http://dx.doi.org/10.1371/journal.pone.0161610			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560685	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000382258600062
J	Subramanian, S; Ricci, E; Souleimanov, A; Smith, DL				Subramanian, Sowmyalakshmi; Ricci, Emily; Souleimanov, Alfred; Smith, Donald L.			A Proteomic Approach to Lipo-Chitooligosaccharide and Thuricin 17 Effects on Soybean GerminationUnstressed and Salt Stress	PLOS ONE			English	Article							MAJOR NOD FACTOR; BACILLUS-THURINGIENSIS; STATISTICAL-MODEL; MOLECULAR-BASIS; EARLY GROWTH; PLANT; RHIZOBIUM; BACTERIOCIN; TOLERANCE; SALINITY	Salt stress is an important abiotic stressor affecting crop growth and productivity. Of the 20 percent of the terrestrial earth's surface available as agricultural land, 50 percent is estimated by the United Nations Environment Program to be salinized to the level that crops growing on it will be salt-stressed. Increased soil salinity has profound effects on seed germination and germinating seedlings as they are frequently confronted with much higher salinities than vigorously growing plants, because germination usually occurs in surface soils, the site of greatest soluble salt accumulation. The growth of soybean exposed to 40 mM NaCl is negatively affected, while an exposure to 80 mM NaCl is often lethal. When treated with the bacterial signal compounds lipo-chitooligosaccharide (LCO) and thuricin 17 (Th17), soybean seeds (variety Absolute RR) responded positively at salt stress of up to 150 mM NaCl. Shotgun proteomics of unstressed and 100 mM NaCl stressed seeds (48 h) in combination with the LCO and Th17 revealed many known, predicted, hypothetical and unknown proteins. In all, carbon, nitrogen and energy metabolic pathways were affected under both unstressed and salt stressed conditions when treated with signals. PEP carboxylase, Rubisco oxygenase large subunit, pyruvate kinase, and isocitrate lyase were some of the noteworthy proteins enhanced by the signals, along with antioxidant glutathione-Stransferase and other stress related proteins. These findings suggest that the germinating seeds alter their proteome based on bacterial signals and on stress, the specificity of this response plays a crucial role in organ maturation and transition from one stage to another in the plants' life cycle; understanding this response is of fundamental importance in agriculture and, as a result, global food security. The mass spectrometry proteomics data have been deposited to the ProteomeXchange with identifier PXD004106.	[Subramanian, Sowmyalakshmi; Ricci, Emily; Souleimanov, Alfred; Smith, Donald L.] McGill Univ, Dept Plant Sci, Macdonald Campus,21111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X3V9, Canada	McGill University	Smith, DL (corresponding author), McGill Univ, Dept Plant Sci, Macdonald Campus,21111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X3V9, Canada.	donald.smith@mcgill.ca		ricci, emily/0000-0002-5156-6579	NSERC Discovery Grant; NSERC Strategic Network Grant (Green Crop Network) [G228175 NSERC RGPIN-2015-06328]; Networks of Centres of Excellence (BioFuelNet Canada) [G234970]	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Strategic Network Grant (Green Crop Network); Networks of Centres of Excellence (BioFuelNet Canada)	This work was supported by an NSERC Discovery Grant, by an NSERC Strategic Network Grant (Green Crop Network) [G228175 NSERC RGPIN-2015-06328; http://www.nserc-crsng.gc.ca/index_eng.asp] and by a grant from the Networks of Centres of Excellence (BioFuelNet Canada) [G234970; http://www.nce-rce.gc.ca/index_eng.asp]. These funders did not have any role in the study design, data collection/analysis, decision to publish, or preparation of the manuscript.; This work was supported by an NSERC Discovery Grant, by an NSERC Strategic Network Grant (Green Crop Network) and by a grant from the Networks of Centres of Excellence (BioFuelNet Canada). The authors wish to thank Institut de recherches cliniques de Montreal (IRCM), Montreal, Quebec, Canada, for the LC-MS services provided. The authors also wish to thank Mr. Uttam Bhandari for the elemental analysis data collection.	Acton D., 1995, HLTH OUR SOILS SUSTA; Aghaei K, 2009, AMINO ACIDS, V36, P91, DOI 10.1007/s00726-008-0036-7; Allen DK, 2013, PLANT PHYSIOL, V161, P1458, DOI 10.1104/pp.112.203299; Almansouri M, 2001, PLANT SOIL, V231, P243, DOI 10.1023/A:1010378409663; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Bai YM, 2003, CROP SCI, V43, P1774, DOI 10.2135/cropsci2003.1774; Bai YM, 2002, CAN J MICROBIOL, V48, P230, DOI 10.1139/W02-014; Baier R, 1999, PLANTA, V210, P157, DOI 10.1007/s004250050665; BAKER J, 1988, PLANT MOL BIOL, V11, P277, DOI 10.1007/BF00027385; Barbosa HS, 2012, ANAL BIOANAL CHEM, V402, P299, DOI 10.1007/s00216-011-5409-1; Bloemberg GV, 2001, CURR OPIN PLANT BIOL, V4, P343, DOI 10.1016/S1369-5266(00)00183-7; Brandao AR, 2010, J PROTEOMICS, V73, P1433, DOI 10.1016/j.jprot.2010.01.009; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; CURRIER WW, 1976, PLANT PHYSIOL, V57, P820, DOI 10.1104/pp.57.5.820; D'Haeze W, 2002, GLYCOBIOLOGY, V12, P79; DEJONG AJ, 1993, PLANT CELL, V5, P615, DOI 10.2307/3869804; Du H, 2010, BIOCHEM BIOPH RES CO, V397, P22, DOI 10.1016/j.bbrc.2010.05.040; Essa TA, 2002, J AGRON CROP SCI, V188, P86, DOI 10.1046/j.1439-037X.2002.00537.x; FIRMIN JL, 1986, NATURE, V324, P90, DOI 10.1038/324090a0; FRAVEL DR, 1988, ANNU REV PHYTOPATHOL, V26, P75, DOI 10.1146/annurev.py.26.090188.000451; Gabaldon T, 2010, PHILOS T R SOC B, V365, P765, DOI 10.1098/rstb.2009.0240; Gotz S, 2011, BIOINFORMATICS, V27, P919, DOI 10.1093/bioinformatics/btr059; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gray EJ, 2006, FEMS MICROBIOL LETT, V255, P27, DOI 10.1111/j.1574-6968.2005.00054.x; Gray EJ, 2006, J APPL MICROBIOL, V100, P545, DOI 10.1111/j.1365-2672.2006.02822.x; GREENWAY H, 1980, ANNU REV PLANT PHYS, V31, P149, DOI 10.1146/annurev.pp.31.060180.001053; Hamayun M, 2010, PAK J BOT, V42, P3103; Hayati R, 1996, J EXP BOT, V47, P33, DOI 10.1093/jxb/47.1.33; JACK RW, 1995, MICROBIOL REV, V59, P171, DOI 10.1128/MMBR.59.2.171-200.1995; Jung WJ, 2008, J MICROBIOL BIOTECHN, V18, P1836, DOI 10.4014/jmb.0800.120; Kao WY, 2003, PHOTOSYNTHETICA, V41, P415, DOI 10.1023/B:PHOT.0000015466.22288.23; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim ST, 2008, PROTEOMICS, V8, P3577, DOI 10.1002/pmic.200800183; Kim YC, 2011, APPL ENVIRON MICROB, V77, P1548, DOI 10.1128/AEM.01867-10; KING EO, 1954, J LAB CLIN MED, V44, P301; Kirkup BC, 2004, NATURE, V428, P412, DOI 10.1038/nature02429; KIRST GO, 1990, ANNU REV PLANT PHYS, V41, P21, DOI 10.1146/annurev.pp.41.060190.000321; Komatsu S, 2009, J PROTEOME RES, V8, P4487, DOI 10.1021/pr9002883; Kosova K, 2013, INT J MOL SCI, V14, P6757, DOI 10.3390/ijms14046757; Lauchli A., 1984, Salinity tolerance in plants - strategies for crop improvement, P171; Lee KD, 2009, PLANTA, V229, P747, DOI 10.1007/s00425-008-0870-6; Lee MY, 2005, PLANT PHYSIOL, V139, P1881, DOI 10.1104/pp.105.067884; Leszczyszyn OI, 2013, METALLOMICS, V5, P1146, DOI 10.1039/c3mt00072a; Levitt J, 1980, CHILLING FREEZING HI; Li Yan, 2008, Pak J Biol Sci, V11, P1268, DOI 10.3923/pjbs.2008.1268.1272; Lindsay JK, 2007, THESIS; Maj D, 2009, J CHEM ECOL, V35, P479, DOI 10.1007/s10886-009-9620-x; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Meyer Y, 2005, PHOTOSYNTH RES, V86, P419, DOI 10.1007/s11120-005-5220-y; Montrichard F, 2009, J PROTEOMICS, V72, P452, DOI 10.1016/j.jprot.2008.12.002; Mooney BP, 2004, PHYTOCHEMISTRY, V65, P1733, DOI 10.1016/j.phytochem.2004.04.011; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Natarajan S, 2005, ANAL BIOCHEM, V342, P214, DOI 10.1016/j.ab.2005.04.046; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nylander M, 2001, PLANT MOL BIOL, V45, P263, DOI 10.1023/A:1006469128280; Oresnik IJ, 1999, APPL ENVIRON MICROB, V65, P2833; Pagani MA, 2012, J INORG BIOCHEM, V117, P306, DOI 10.1016/j.jinorgbio.2012.08.020; Parida AK, 2003, PHOTOSYNTHETICA, V41, P191, DOI 10.1023/B:PHOT.0000011951.37231.69; PELLA E, 1973, MIKROCHIM ACTA, P697; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; Pipolo AE, 2004, ANN APPL BIOL, V144, P223, DOI 10.1111/j.1744-7348.2004.tb00337.x; Plaxton WC, 2006, CRIT REV PLANT SCI, V25, P159, DOI 10.1080/07352680600563876; Prithiviraj B, 2003, PLANTA, V216, P437, DOI 10.1007/s00425-002-0928-9; Prithiviraj B, 2000, J EXP BOT, V51, P2045, DOI 10.1093/jexbot/51.353.2045; Qiu LJ, 2010, SOYBEAN: BOTANY, PRODUCTION AND USES, P1, DOI 10.1079/9781845936440.0001; Truong Q, 2013, J EXP BOT, V64, P2985, DOI 10.1093/jxb/ert138; Rengasamy P, 2008, GEOTIMES, V53, P34; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Rolletschek H, 2003, PLANT PHYSIOL, V132, P1196, DOI 10.1104/pp.102.017376; Ruddle P, 2013, THEOR APPL GENET, V126, P241, DOI 10.1007/s00122-012-1977-5; Ruuska SA, 2002, PLANT CELL, V14, P1191, DOI 10.1105/tpc.000877; SARAVITZ CH, 1995, PHYSIOL PLANTARUM, V93, P799, DOI 10.1111/j.1399-3054.1995.tb05134.x; Schwender J, 2004, CURR OPIN PLANT BIOL, V7, P309, DOI 10.1016/j.pbi.2004.03.016; Schwinghamer T, 2014, J PLANT GROWTH REG; Shoshan-Barmatz V, 2003, CELL BIOCHEM BIOPHYS, V39, P279, DOI 10.1385/CBB:39:3:279; SIEDOW JN, 1991, ANNU REV PLANT PHYS, V42, P145, DOI 10.1146/annurev.pp.42.060191.001045; Sobhanian H, 2011, J PROTEOMICS, V74, P1323, DOI 10.1016/j.jprot.2011.03.018; Sobhanian H, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-19; Soulages JL, 2002, PLANT PHYSIOL, V128, P822, DOI 10.1104/pp.010521; Souleimanov A, 2002, J EXP BOT, V53, P1929, DOI 10.1093/jxb/erf034; Soulemanov A, 2002, MICROBIOL RES, V157, P25, DOI 10.1078/0944-5013-00128; STAEHELIN C, 1994, P NATL ACAD SCI USA, V91, P2196, DOI 10.1073/pnas.91.6.2196; Supanjani S, 2006, PLANT PHYSIOL BIOCH, V44, P866, DOI 10.1016/j.plaphy.2006.10.001; TU JC, 1981, CAN J PLANT SCI, V61, P231, DOI 10.4141/cjps81-035; Turner WL, 2005, PLANTA, V222, P1051, DOI 10.1007/s00425-005-0044-8; VERNOOYGERRITSEN M, 1983, PLANT PHYSIOL, V73, P262, DOI 10.1104/pp.73.2.262; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031571; Wiebe BH, 2007, CAN J SOIL SCI, V87, P213, DOI 10.4141/S06-068; Wilson RA, 1998, SOIL BIOL BIOCHEM, V30, P413, DOI 10.1016/S0038-0717(97)00123-5; WONG JH, 1995, METHOD ENZYMOL, V252, P228; Xu XY, 2011, J ZHEJIANG UNIV-SC B, V12, P507, DOI 10.1631/jzus.B1100061; Zhang F, 2002, ADV AGRON, V76, P125, DOI 10.1016/S0065-2113(02)76004-5	95	27	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0160660	10.1371/journal.pone.0160660	http://dx.doi.org/10.1371/journal.pone.0160660			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560934	gold, Green Published, Green Submitted			2022-12-26	WOS:000382258600014
J	Bekker, EI; Karabanov, DP; Galimov, YR; Kotov, AA				Bekker, Eugeniya I.; Karabanov, Dmitry P.; Galimov, Yan R.; Kotov, Alexey A.			DNA Barcoding Reveals High Cryptic Diversity in the North Eurasian Moina Species (Crustacea: Cladocera)	PLOS ONE			English	Article							LONGISPINA COMPLEX CRUSTACEA; MACROCOPA STRAUS; WEISMANNI ISHIKAWA; ANOMOPODA; DAPHNIA; BRANCHIOPODA; CHYDORIDAE; MOINIDAE; HYBRIDIZATION; BIOGEOGRAPHY	Species of the genus Moina Baird (Cladocera: Moinidae) often dominate freshwater crustacean communities in temporary water bodies. Several species of Moina are used as food for fish larvae in aquaculture, as bioindicators in toxicological studies, and as common subjects for physiological studies. The aim of this paper is to estimate biodiversity of Moina in northern Eurasia using the standard DNA barcoding approach based on the cytochrome c oxidase subunit I (COI) gene. We analysed 160 newly obtained and 157 existing COI sequences, and found evidence for 21 phylogroups of Moina, some of which were detected here for the first time. Our study confirmed the opinion that the actual species diversity of cladocerans is several times higher than is presently accepted. Our results also indicated that Moina has the second richest species diversity among the cladoceran genera (with only Daphnia O.F. Mueller having a greater diversity of species). Our study strongly supports division of Moina into two faunistic groups: European-Western Siberian and Eastern Siberian-Far Eastern, with a transitional zone at the Yenisey River basin (Eastern Siberia). Here, we refrain from taxonomic descriptions of new species, as this requires a thorough morphological and taxonomic study for each putative taxon.	[Bekker, Eugeniya I.; Karabanov, Dmitry P.; Galimov, Yan R.; Kotov, Alexey A.] Russian Acad Sci, AN Severtsov Inst Ecol & Evolut, Lab Aquat Ecol & Invas, Moscow, Russia; [Karabanov, Dmitry P.] Russian Acad Sci, ID Papanin Inst Biol Inland Waters, Lab Fish Ecol, Borok, Yaroslavl Area, Russia; [Galimov, Yan R.] Russian Acad Sci, Koltzov Inst Dev Biol, Lab Expt Embryol, Moscow, Russia	Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution; Papanin Institute for Biology of Inland Waters; Russian Academy of Sciences; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences	Kotov, AA (corresponding author), Russian Acad Sci, AN Severtsov Inst Ecol & Evolut, Lab Aquat Ecol & Invas, Moscow, Russia.	alexey-a-kotov@yandex.ru	Bekker, Eugeniya/M-6955-2016; Galimov, Yan R/S-6242-2018; Kotov, Alexey A./B-1549-2010; Karabanov, Dmitry/F-3779-2011	Bekker, Eugeniya/0000-0001-6425-7727; Galimov, Yan R/0000-0002-8589-0166; Kotov, Alexey A./0000-0002-8863-6438; Karabanov, Dmitry/0000-0001-6008-7441	Russian Science Foundation [14-14-00778]	Russian Science Foundation(Russian Science Foundation (RSF))	The study is supported exclusively by the Russian Science Foundation (grant 14-14-00778) (http://www.rscf.ru/en/).	Adamowicz SJ, 2009, MOL PHYLOGENET EVOL, V50, P423, DOI 10.1016/j.ympev.2008.11.026; Adamowicz SJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P455, DOI 10.1111/j.1466-822x.2005.00164.x; Adamowicz SJ, 2004, ZOOL J LINN SOC-LOND, V140, P171, DOI 10.1111/j.1096-3642.2003.00089.x; Alonso M., 1996, CRUSTACEA BRANCHIOPO, V7; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Behning AL, 1928, BINNENGEWASSER, V5, P1; Bekker EI, 2012, ZOOTAXA, P1; Belyaeva M, 2009, MOL PHYLOGENET EVOL, V50, P534, DOI 10.1016/j.ympev.2008.11.007; Benider A, 2002, HYDROBIOLOGIA, V468, P1, DOI 10.1023/A:1015214530485; Billiones R, 2004, HYDROBIOLOGIA, V526, P43, DOI 10.1023/B:HYDR.0000041615.65087.06; Brehm V., 1950, Publicaciones del Instituto de Biologia Aplicada Barcelona, V7, P83; Brehm V., 1951, PUBLICATIONES I BIOL, V5, P83; BREHM VINZENZ, 1955, OESTERREICH ZOOL ZEITSCHR, V6, P250; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Burak ES, 1997, HYDROBIOLOGIA, V360, P101, DOI 10.1023/A:1003161201737; Chatterjee T, 2013, ZOOTAXA, V3667, P1; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Crease TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046620; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darwin C., 1882, NATURE, V25, P529, DOI 10.1038/025529f0; Darwin C.R., 1859, ORIGIN SPECIES MEANS; deWaard JR, 2006, MOL PHYLOGENET EVOL, V39, P491, DOI 10.1016/j.ympev.2005.11.003; Dlouha S, 2010, HYDROBIOLOGIA, V643, P107, DOI 10.1007/s10750-010-0128-8; DUDOV KP, 1984, CELL, V37, P457, DOI 10.1016/0092-8674(84)90376-3; Dumont H. J., 2002, INTRO CLASBRANCHIO, P398; Dumont HJ, 2013, ZOOTAXA, V3652, P533, DOI 10.11646/zootaxa.3652.5.3; Dumont HJ, 2000, HYDROBIOLOGIA, V435, P61, DOI 10.1023/A:1004006521874; Eitam A, 2004, HYDROBIOLOGIA, V525, P125, DOI 10.1023/B:HYDR.0000038859.51416.7d; Elias-Gutierrez M, 2008, ZOOTAXA, P1; Elias-Gutierrez M, 2008, HIDROBIOLOGICA, V18, P63; ELIASGUTIERREZ M, 1994, REV BIOL TROP, V42, P385; Elmoor-Loureiro LMA, 2010, BRAZ J BIOL, V70, P225, DOI 10.1590/S1519-69842010000100031; Faustova M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011623; Flossner D., 1972, Tierwelt Deutschlands, V60, P1; Flossner D, 2000, HAPLOPODA CLADOCERA; Forro L, 2008, HYDROBIOLOGIA, V595, P177, DOI 10.1007/s10750-007-9013-5; FORRO L, 1985, ACTA ZOOL HUNG, V31, P111; FORRO L, 1988, ACTA ZOOL HUNG, V34, P203; Forro L, 1997, HYDROBIOLOGIA, V360, P153, DOI 10.1023/A:1003105016758; Forro L., 1990, ACTA ZOOL BULGAR, V39, P78; FREY DG, 1988, LIMNOL OCEANOGR, V33, P1386, DOI 10.4319/lo.1988.33.6.1386; FREY DG, 1987, HYDROBIOLOGIA, V145, P5, DOI 10.1007/BF02530260; FREY DG, 1982, ARCH HYDROBIOL, V93, P484; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; GOULDEN C E, 1968, Transactions of the American Philosophical Society, V58, P1, DOI 10.2307/1006102; Haney RA, 2003, J EVOLUTION BIOL, V16, P871, DOI 10.1046/j.1420-9101.2003.00594.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huang XN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112808; Hudec I, 1997, HYDROBIOLOGIA, V360, P55, DOI 10.1023/A:1003192400074; HUDEC I, 1988, BIOLOGIA, V43, P871; HUDEC I, 1990, HYDROBIOLOGIA, V190, P33, DOI 10.1007/BF00020685; Hudec I., 2010, FAUNA SLOVENSKA; Incagnone G, 2015, HYDROBIOLOGIA, V750, P103, DOI 10.1007/s10750-014-2110-3; International Commission on Zoological Nomenclature, 1999, INT CODE ZOOLOGICAL, V4th; Ishida S, 2007, MOL ECOL, V16, P569, DOI 10.1111/j.1365-294X.2006.03160.x; Ishida S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-209; Jeffery NW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018364; Kotov AA, 2005, CRUSTACEANA, V78, P41, DOI 10.1163/1568540054024565; Kotov AA., 2013, MORPHOLOGY PHYLOGENY; Kotov AA, 2015, ZOOTAXA, V3911, P184, DOI 10.11646/zootaxa.3911.2.2; Kotov AA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-129; Kotov AA, 2010, J PLANKTON RES, V32, P937, DOI 10.1093/plankt/fbq018; Kotov AA, 2009, ZOOL J LINN SOC-LOND, V156, P1, DOI 10.1111/j.1096-3642.2008.00475.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linhart C, 2005, J COMPUT BIOL, V12, P431, DOI 10.1089/cmb.2005.12.431; Mangas-Ramirez E, 2002, ECOTOX ENVIRON SAFE, V51, P216, DOI 10.1006/eesa.2001.2128; MARGARITORA FG, 1987, HYDROBIOLOGIA, V145, P93, DOI 10.1007/BF02530269; Vignatti AM, 2013, BIOTA NEOTROP, V13, P86, DOI 10.1590/S1676-06032013000300011; Martinez-Jeronimo F, 2004, J CRUSTACEAN BIOL, V24, P232, DOI 10.1651/C-2450; Mergeay J, 2008, MOL ECOL, V17, P1789, DOI 10.1111/j.1365-294X.2007.03679.x; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MIRABDULLAEV IM, 1993, CRUSTACEANA, V64, P192, DOI 10.1163/156854093X00234; MIRABDULLAEV IM, 1992, ZOOL ZH, V71, P136; Mirabdullayev IM, 1998, HYDROBIOLOGIA, V385, P11, DOI 10.1023/A:1003436930510; Nedli J, 2014, FUND APPL LIMNOL, V184, P69, DOI 10.1127/1863-9135/2014/0462; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Padhye SM, 2014, ZOOTAXA, V3860, P561, DOI 10.11646/zootaxa.3860.6.4; Paggi JC, 1997, CRUSTACEANA, V70, P886, DOI 10.1163/156854097X00500; Petrusek A, 2004, HYDROBIOLOGIA, V526, P73, DOI 10.1023/B:HYDR.0000041612.08425.f0; Petrusek A., 2013, WORLD WIDE WEB ELECT; Petrusek A, 2008, ZOOL SCR, V37, P507, DOI 10.1111/j.1463-6409.2008.00336.x; Petrusek A, 2012, LIMNOL OCEANOGR, V57, P1838, DOI 10.4319/lo.2012.57.6.1838; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; PROCTOR VW, 1964, ECOLOGY, V45, P656, DOI 10.2307/1936124; Prosser S, 2013, MOL ECOL RESOUR, V13, P1151, DOI 10.1111/1755-0998.12132; Quicke Donald L.J., 1993, PRINCIPLES TECHNIQUE; Quiroz-Vazquez P, 2009, ZOOTAXA, P50, DOI 10.11646/zootaxa.2236.1.4; Regier JC, 2005, BIOTECHNIQUES, V38, P34, DOI 10.2144/05381BM02; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; SCHWENK K, 1993, MOL BIOL EVOL, V10, P1289; Schwenk K, 2000, P ROY SOC B-BIOL SCI, V267, P1833, DOI 10.1098/rspb.2000.1218; SMIRNOV N N, 1983, Records of the Australian Museum, P1; SMIRNOV N. N, 1976, FAUNA SSSR RAKOOBRAZ, V1; Smirnov NN, 1998, HYDROBIOLOGIA, V386, P63, DOI 10.1023/A:1003524414799; SMIRNOV NN, 1992, ZOOL J LINN SOC-LOND, V104, P97, DOI 10.1111/j.1096-3642.1992.tb00918.x; Smirnov NN, 1995, KEY FRESHWATER INVER, p[2, 64]; Smirnov NN., 2014, PHYSL CLADOCERA; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatsuta H, 2009, MOL ECOL RESOUR, V9, P904, DOI 10.1111/j.1755-0998.2008.02410.x; TAYLOR DJ, 1994, ZOOL J LINN SOC-LOND, V110, P27; Taylor DJ, 1998, EVOLUTION, V52, P1648, DOI 10.1111/j.1558-5646.1998.tb02245.x; Van Damme K, 2010, ZOOTAXA, P1; van Damme Kay, 2011, Zootaxa, V2875, P1; Van Damme Kay, 2008, Zootaxa, V1721, P24; VANIN EF, 1985, ANNU REV GENET, V19, P253, DOI 10.1146/annurev.genet.19.1.253; Wang WP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152436; WONG CK, 1995, WATER AIR SOIL POLL, V84, P399, DOI 10.1007/BF00475351; Xu L, 2011, J BIOGEOGR, V38, P359, DOI 10.1111/j.1365-2699.2010.02409.x; Xu S, 2009, MOL ECOL, V18, P5161, DOI 10.1111/j.1365-294X.2009.04422.x; Yevdokimov N.A., 2009, Biologiya Vnutrennikh Vod, V1, P62	113	56	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161737	10.1371/journal.pone.0161737	http://dx.doi.org/10.1371/journal.pone.0161737			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556403	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258100066
J	Frelinger, AL; Gerrits, AJ; Garner, AL; Torres, AS; Caiafa, A; Morton, CA; Berny-Lang, MA; Carmichael, SL; Neculaes, VB; Michelson, AD				Frelinger, Andrew L., III; Gerrits, Anja J.; Garner, Allen L.; Torres, Andrew S.; Caiafa, Antonio; Morton, Christine A.; Berny-Lang, Michelle A.; Carmichael, Sabrina L.; Neculaes, V. Bogdan; Michelson, Alan D.			Modification of Pulsed Electric Field Conditions Results in Distinct Activation Profiles of Platelet-Rich Plasma	PLOS ONE			English	Article							IRREVERSIBLE ELECTROPORATION; MEMBRANE PERMEABILIZATION; NANOSECOND PULSES; EPITHELIAL-CELLS; BOVINE THROMBIN; ELECTROPERMEABILIZATION; DURATION; IMPACT; GROWTH; GEL	Background Activated autologous platelet-rich plasma (PRP) used in therapeutic wound healing applications is poorly characterized and standardized. Using pulsed electric fields (PEF) to activate platelets may reduce variability and eliminate complications associated with the use of bovine thrombin. We previously reported that exposing PRP to sub-microsecond duration, high electric field (SMHEF) pulses generates a greater number of platelet-derived microparticles, increased expression of prothrombotic platelet surfaces, and differential release of growth factors compared to thrombin. Moreover, the platelet releasate produced by SMHEF pulses induced greater cell proliferation than plasma. Aims To determine whether sub-microsecond duration, low electric field (SMLEF) bipolar pulses results in differential activation of PRP compared to SMHEF, with respect to profiles of activation markers, growth factor release, and cell proliferation capacity. Methods PRP activation by SMLEF bipolar pulses was compared to SMHEF pulses and bovine thrombin. PRP was prepared using the Harvest SmartPreP2 System from acid citrate dextrose anticoagulated healthy donor blood. PEF activation by either SMHEF or SMLEF pulses was performed using a standard electroporation cuvette preloaded with CaCl2 and a prototype instrument designed to take into account the electrical properties of PRP. Flow cytometry was used to assess platelet surface P-selectin expression, and annexin V binding. Platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), endothelial growth factor (EGF) and platelet factor 4 (PF4), and were measured by ELISA. The ability of supernatants to stimulate proliferation of human epithelial cells in culture was also evaluated. Controls included vehicle-treated, unactivated PRP and PRP with 10 mM CaCl2 activated with 1 U/mL bovine thrombin. Results PRP activated with SMLEF bipolar pulses or thrombin had similar light scatter profiles, consistent with the presence of platelet-derived microparticles, platelets, and platelet aggregates whereas SMHEF pulses primarily resulted in platelet-derived microparticles. Microparticles and platelets in PRP activated with SMLEF bipolar pulses had significantly lower annexin V-positivity than those following SMHEF activation. In contrast, the% P-selectin positivity and surface P-selectin expression (MFI) for platelets and microparticles in SMLEF bipolar pulse activated PRP was significantly higher than that in SMHEF-activated PRP, but not significantly different from that produced by thrombin activation. Higher levels of EGF were observed following either SMLEF bipolar pulses or SMHEF pulses of PRP than after bovine thrombin activation while VEGF, PDGF, and PF4 levels were similar with all three activating conditions. Cell proliferation was significantly increased by releasates of both SMLEF bipolar pulse and SMHEF pulse activated PRP compared to plasma alone. Conclusions PEF activation of PRP at bipolar low vs. monopolar high field strength results in differential platelet-derived microparticle production and activation of platelet surface procoagulant markers while inducing similar release of growth factors and similar capacity to induce cell proliferation. Stimulation of PRP with SMLEF bipolar pulses is gentler than SMHEF pulses, resulting in less platelet microparticle generation but with overall activation levels similar to that obtained with thrombin. These results suggest that PEF provides the means to alter, in a controlled fashion, PRP properties thereby enabling evaluation of their effects on wound healing and clinical outcomes.	[Frelinger, Andrew L., III; Gerrits, Anja J.; Berny-Lang, Michelle A.; Carmichael, Sabrina L.; Michelson, Alan D.] Harvard Med Sch, Boston Childrens Hosp, Dana Farber Canc Inst, Ctr Platelet Res Studies,Div Hematol Oncol, Boston, MA 02115 USA; [Garner, Allen L.] Purdue Univ, Sch Nucl Engn, W Lafayette, IN 47907 USA; [Torres, Andrew S.; Caiafa, Antonio; Morton, Christine A.; Neculaes, V. Bogdan] GE Global Res Ctr, Niskayuna, NY 12309 USA; [Torres, Andrew S.] Regeneron Pharmaceut Inc, Rensselaer, NY USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Purdue University System; Purdue University; Purdue University West Lafayette Campus; General Electric; Regeneron	Frelinger, AL (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Dana Farber Canc Inst, Ctr Platelet Res Studies,Div Hematol Oncol, Boston, MA 02115 USA.; Neculaes, VB (corresponding author), GE Global Res Ctr, Niskayuna, NY 12309 USA.	Andrew.Frelinger@childrens.harvard.edu; Neculaes@research.ge.com	Michelson, Alan/ABE-8487-2021; Caiafa, Antonio/AAI-7593-2020	Michelson, Alan/0000-0002-1746-4819; Berny-Lang, Michelle/0000-0001-5889-4295; Frelinger, Andrew/0000-0002-6871-7441	GE Healthcare	GE Healthcare(General ElectricGE Healthcare)	This work was funded by a research grant from GE Healthcare to Boston Children's Hospital, Principal Investigator, ALF. The funders participated in study design, data collection, and preparation of the manuscript, but had no role in data analysis or the decision to publish.	Alexander W, 2009, P T, V34, P688; [Anonymous], 2014, THROMBIN JMI THROMB; Barnes R, 2015, FINITE ELEMENT METHO; Beebe SJ, 2015, BIOELECTROCHEMISTRY, V103, P52, DOI 10.1016/j.bioelechem.2014.08.014; Beebe Stephen J, 2013, Cells, V2, P136, DOI 10.3390/cells2010136; Beier HT, 2012, BIOCHEM BIOPH RES CO, V423, P863, DOI 10.1016/j.bbrc.2012.06.055; Berney-Lang MA, 2013, PLATELETS, P581; Berny-Lang MA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000026; Bielecki TM, 2007, J BONE JOINT SURG BR, V89B, P417, DOI 10.1302/0301-620X.89B3.18491; Breton M, 2012, J AM CHEM SOC, V134, P13938, DOI 10.1021/ja3052365; Breton M, 2012, BIOELECTROMAGNETICS, V33, P106, DOI 10.1002/bem.20692; Bundy L, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-43; CADA DJ, 2008, HOSP PHARM, V43, P43; Caiafa A, 2014, IEEE INT POWER MODUL, P35, DOI 10.1109/IPMHVC.2014.7287201; Chapman WC, 2007, J AM COLL SURGEONS, V205, P252, DOI 10.1016/j.jamcollsurg.2007.03.020; Diesen DL, 2008, VASCULAR, V16, pS29, DOI 10.2310/6670.2008.00031; Driver VR, 2006, OSTOMY WOUND MANAG, V52, P68; Frelinger AL, 2008, J THROMB HAEMOST, V6, P359; Frelinger AL, 2006, CIRCULATION, V113, P2888, DOI 10.1161/CIRCULATIONAHA.105.596627; Frelinger III AL, 2015, PLATELETS, P1; Garner AL, 2007, BIOCHEM BIOPH RES CO, V362, P139, DOI 10.1016/j.bbrc.2007.07.159; Garner AL, 2015, C ELECT INSUL DIEL P, P632, DOI 10.1109/CEIDP.2015.7352148; Gunaydin S, 2008, PERFUSION-UK, V23, P179, DOI 10.1177/0267659108097783; Haase I, 2003, J CELL SCI, V116, P3227, DOI 10.1242/jcs.00610; Ibey BL, 2014, BIOCHEM BIOPH RES CO, V443, P568, DOI 10.1016/j.bbrc.2013.12.004; Jiang CL, 2015, IEEE T BIO-MED ENG, V62, P4, DOI 10.1109/TBME.2014.2367543; Joshi R. P., 2010, Critical Reviews in Biomedical Engineering, V38, P255, DOI 10.1615/CritRevBiomedEng.v38.i3.20; Kotnik T, 2001, BIOELECTROCHEMISTRY, V54, P83, DOI 10.1016/S1567-5394(01)00114-1; Lacci Kathleen M., 2010, Yale Journal of Biology and Medicine, V83, P1; Lakka Klement G, 2013, PLATELETS, P487; Lambricht L, 2016, EXPERT OPIN DRUG DEL, V13, P295, DOI 10.1517/17425247.2016.1121990; LaPlante N, 2013, EX VIVO PLATELET ACT, P202; Lawson JH, 2006, SEMIN THROMB HEMOST, V32, P98, DOI 10.1055/s-2006-939559; Mahnic-Kalamiza S, 2014, J MEMBRANE BIOL, V247, P1279, DOI 10.1007/s00232-014-9737-x; Miklavcic D, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-29; Napotnik TB, 2012, BIOELECTROMAGNETICS, V33, P257, DOI 10.1002/bem.20707; Nuccitelli R, 2006, BIOCHEM BIOPH RES CO, V343, P351, DOI 10.1016/j.bbrc.2006.02.181; Ofosu FA, 2009, CLIN THER, V31, P679, DOI 10.1016/j.clinthera.2009.04.021; Pakhomov AG, 2007, ARCH BIOCHEM BIOPHYS, V465, P109, DOI 10.1016/j.abb.2007.05.003; Pakhomov AG, 2015, BBA-BIOMEMBRANES, V1848, P958, DOI 10.1016/j.bbamem.2014.12.026; Pakhomov AG, 2014, CELL MOL LIFE SCI, V71, P4431, DOI 10.1007/s00018-014-1626-z; Rogers WR, 2004, IEEE T PLASMA SCI, V32, P1587, DOI 10.1109/TPS.2004.831758; ROSA JP, 1987, J CLIN INVEST, V80, P1138, DOI 10.1172/JCI113171; Roth CC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15063; Scheffer HJ, 2014, J VASC INTERV RADIOL, V25, P997, DOI 10.1016/j.jvir.2014.01.028; Schoenbach KH, 2007, IEEE T DIELECT EL IN, V14, P1088, DOI 10.1109/TDEI.2007.4339468; Schoenbach KH, 2015, BIOELECTROCHEMISTRY, V103, P44, DOI 10.1016/j.bioelechem.2014.08.015; Schoenbach KH, 2004, P IEEE, V92, P1122, DOI 10.1109/JPROC.2004.829009; Semenov I, 2013, CELL CALCIUM, V54, P145, DOI 10.1016/j.ceca.2013.05.008; Shin I, 2005, J BIOL CHEM, V280, P14675, DOI 10.1074/jbc.M411625200; Stadelmann WK, 1998, AM J SURG, V176, p26S, DOI 10.1016/S0002-9610(98)00183-4; TEKLE E, 1991, P NATL ACAD SCI USA, V88, P4230, DOI 10.1073/pnas.88.10.4230; Torres AS, 2014, J TRAUMA ACUTE CARE, V77, pS94, DOI 10.1097/TA.0000000000000322; Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531; Vernier PT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-37; Vernier PT, 2006, J AM CHEM SOC, V128, P6288, DOI 10.1021/ja0588306; Vernier PT, 2003, BIOCHEM BIOPH RES CO, V310, P286, DOI 10.1016/j.bbrc.2003.08.140; Wasungu L, 2014, BIOELECTROCHEMISTRY, V100, P36, DOI 10.1016/j.bioelechem.2014.06.011; Weaver JC, 2012, BIOELECTROCHEMISTRY, V87, P236, DOI 10.1016/j.bioelechem.2012.02.007; Weaver JC, 1996, BIOELECTROCH BIOENER, V41, P135, DOI 10.1016/S0302-4598(96)05062-3; White JA, 2004, J BIOL CHEM, V279, P22964, DOI 10.1074/jbc.M311135200; Yarmush ML, 2014, ANNU REV BIOMED ENG, V16, P295, DOI 10.1146/annurev-bioeng-071813-104622; Zhang J, 2008, ARCH BIOCHEM BIOPHYS, V471, P240, DOI 10.1016/j.abb.2007.12.009	63	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0160933	10.1371/journal.pone.0160933	http://dx.doi.org/10.1371/journal.pone.0160933			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556645	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258100023
J	Horne, HN; Chung, CC; Zhang, H; Yu, K; Prokunina-Olsson, L; Michailidou, K; Bolla, MK; Wang, Q; Dennis, J; Hopper, JL; Southey, MC; Schmidt, MK; Broeks, A; Muir, K; Lophatananon, A; Fasching, PA; Beckmann, MW; Fletcher, O; Johnson, N; Sawyer, EJ; Tomlinson, I; Burwinkel, B; Marme, F; Guenel, P; Truong, T; Bojesen, SE; Flyger, H; Benitez, J; Gonzalez-Neira, A; Anton-Culver, H; Neuhausen, SL; Brenner, H; Arndt, V; Meindl, A; Schmutzler, RK; Brauch, H; Hamann, U; Nevanlinna, H; Khan, S; Matsuo, K; Iwata, H; Dork, T; Bogdanova, NV; Lindblom, A; Margolin, S; Mannermaa, A; Kosma, VM; Chenevix-Trench, G; Wu, AH; den Berg, DV; Smeets, A; Zhao, H; Chang-Claude, J; Rudolph, A; Radice, P; Barile, M; Couch, FJ; Vachon, C; Giles, GG; Milne, RL; Haiman, CA; Le Marchand, L; Goldberg, MS; Teo, SH; Taib, NAM; Kristensen, V; Borresen-Dale, AL; Zheng, W; Shrubsole, M; Winqvist, R; Jukkola-Vuorinen, A; Andrulis, IL; Knight, JA; Devilee, P; Seynaeve, C; Garcia-Closas, M; Czene, K; Darabi, H; Hollestelle, A; Martens, JWM; Li, JM; Lu, W; Shu, XO; Cox, A; Cross, SS; Blot, W; Cai, QY; Shah, M; Luccarini, C; Baynes, C; Harrington, P; Kang, D; Choi, JY; Hartman, M; Chia, KS; Kabisch, M; Torres, D; Jakubowska, A; Lubinski, J; Sangrajrang, S; Brennan, P; Slager, S; Yannoukakos, D; Shen, CY; Hou, MF; Swerdlow, A; Orr, N; Simard, J; Hall, P; Pharoah, PDP; Easton, DF; Chanock, SJ; Dunning, AM; Figueroa, JD				Horne, Hisani N.; Chung, Charles C.; Zhang, Han; Yu, Kai; Prokunina-Olsson, Ludmila; Michailidou, Kyriaki; Bolla, Manjeet K.; Wang, Qin; Dennis, Joe; Hopper, John L.; Southey, Melissa C.; Schmidt, Marjanka K.; Broeks, Annegien; Muir, Kenneth; Lophatananon, Artitaya; Fasching, Peter A.; Beckmann, Matthias W.; Fletcher, Olivia; Johnson, Nichola; Sawyer, Elinor J.; Tomlinson, Ian; Burwinkel, Barbara; Marme, Frederik; Guenel, Pascal; Truong, Therese; Bojesen, Stig E.; Flyger, Henrik; Benitez, Javier; Gonzalez-Neira, Anna; Anton-Culver, Hoda; Neuhausen, Susan L.; Brenner, Hermann; Arndt, Volker; Meindl, Alfons; Schmutzler, Rita K.; Brauch, Hiltrud; Hamann, Ute; Nevanlinna, Heli; Khan, Sofia; Matsuo, Keitaro; Iwata, Hiroji; Dork, Thilo; Bogdanova, Natalia V.; Lindblom, Annika; Margolin, Sara; Mannermaa, Arto; Kosma, Veli-Matti; Chenevix-Trench, Georgia; Wu, Anna H.; den Berg, David Ven; Smeets, Ann; Zhao, Hui; Chang-Claude, Jenny; Rudolph, Anja; Radice, Paolo; Barile, Monica; Couch, Fergus J.; Vachon, Celine; Giles, Graham G.; Milne, Roger L.; Haiman, Christopher A.; Le Marchand, Loic; Goldberg, Mark S.; Teo, Soo H.; Taib, Nur A. M.; Kristensen, Vessela; Borresen-Dale, Anne-Lise; Zheng, Wei; Shrubsole, Martha; Winqvist, Robert; Jukkola-Vuorinen, Arja; Andrulis, Irene L.; Knight, Julia A.; Devilee, Peter; Seynaeve, Caroline; Garcia-Closas, Montserrat; Czene, Kamila; Darabi, Hatef; Hollestelle, Antoinette; Martens, John W. M.; Li, Jingmei; Lu, Wei; Shu, Xiao-Ou; Cox, Angela; Cross, Simon S.; Blot, William; Cai, Qiuyin; Shah, Mitul; Luccarini, Craig; Baynes, Caroline; Harrington, Patricia; Kang, Daehee; Choi, Ji-Yeob; Hartman, Mikael; Chia, Kee Seng; Kabisch, Maria; Torres, Diana; Jakubowska, Anna; Lubinski, Jan; Sangrajrang, Suleeporn; Brennan, Paul; Slager, Susan; Yannoukakos, Drakoulis; Shen, Chen-Yang; Hou, Ming-Feng; Swerdlow, Anthony; Orr, Nick; Simard, Jacques; Hall, Per; Pharoah, Paul D. P.; Easton, Douglas F.; Chanock, Stephen J.; Dunning, Alison M.; Figueroa, Jonine D.		kConFab AOCS Investigators	Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; CONFER SUSCEPTIBILITY; GENETIC-VARIATION; 14Q24.1 RAD51L1; RISK; HETEROGENEITY; ALLELES; DISEASE	The Cancer Genetic Markers of Susceptibility genome-wide association study (GWAS) originally identified a single nucleotide polymorphism (SNP) rs11249433 at 1p11.2 associated with breast cancer risk. To fine-map this locus, we genotyped 92 SNPs in a 900kb region (120,505,799-121,481,132) flanking rs11249433 in 45,276 breast cancer cases and 48,998 controls of European, Asian and African ancestry from 50 studies in the Breast Cancer Association Consortium. Genotyping was done using iCOGS, a custom-built array. Due to the complicated nature of the region on chr1p11.2: 120,300,000-120,505,798, that lies near the centromere and contains seven duplicated genomic segments, we restricted analyses to 429 SNPs excluding the duplicated regions (42 genotyped and 387 imputed). Perallelic associations with breast cancer risk were estimated using logistic regression models adjusting for study and ancestry-specific principal components. The strongest association observed was with the original identified index SNP rs11249433 (minor allele frequency (MAF) 0.402; per-allele odds ratio (OR) = 1.10, 95% confidence interval (CI) 1.08-1.13, P = 1.49 x 10(-21)). The association for rs11249433 was limited to ER-positive breast cancers (test for heterogeneity P <= 8.41 x 10(-5)). Additional analyses by other tumor characteristics showed stronger associations with moderately/well differentiated tumors and tumors of lobular histology. Although no significant eQTL associations were observed, in silico analyses showed that rs11249433 was located in a region that is likely a weak enhancer/promoter. Fine-mapping analysis of the 1p11.2 breast cancer susceptibility locus confirms this region to be limited to risk to cancers that are ER-positive.	[Horne, Hisani N.; Chung, Charles C.; Zhang, Han; Yu, Kai; Prokunina-Olsson, Ludmila; Garcia-Closas, Montserrat; Chanock, Stephen J.; Figueroa, Jonine D.] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Horne, Hisani N.] US FDA, Silver Spring, MD USA; [Michailidou, Kyriaki; Bolla, Manjeet K.; Wang, Qin; Dennis, Joe; Pharoah, Paul D. P.; Easton, Douglas F.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge, England; [Hopper, John L.; Giles, Graham G.; Milne, Roger L.] Univ Melbourne, Ctr Epidemiol & Biostat, Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Southey, Melissa C.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Schmidt, Marjanka K.; Broeks, Annegien] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands; [Muir, Kenneth; Lophatananon, Artitaya] Univ Warwick, Div Hlth Sci, Warwick Med Sch, Coventry, W Midlands, England; [Muir, Kenneth] Univ Manchester, Inst Populat Hlth, Manchester, Lancs, England; [Fasching, Peter A.; Beckmann, Matthias W.] Univ Erlangen Nurnberg, Dept Obstet & Gynaecol, Univ Hosp Erlangen, Comprehens Canc Ctr Erlangen EMN, Erlangen, Germany; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Fletcher, Olivia; Johnson, Nichola; Orr, Nick] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London, England; [Fletcher, Olivia; Johnson, Nichola; Swerdlow, Anthony] Inst Canc Res, Div Breast Canc Res, London, England; [Sawyer, Elinor J.] Kings Coll London, Res Oncol, Guys Hosp, London, England; [Tomlinson, Ian] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Tomlinson, Ian] Univ Oxford, Oxford Biomed Res Ctr, Oxford, England; [Burwinkel, Barbara; Marme, Frederik] Heidelberg Univ, Dept Obstet & Gynecol, Heidelberg, Germany; [Burwinkel, Barbara] German Canc Res Ctr, Mol Epidemiol Grp, Heidelberg, Germany; [Marme, Frederik] Heidelberg Univ, Natl Ctr Tumor Dis, Heidelberg, Germany; [Guenel, Pascal; Truong, Therese] INSERM, Environm Epidemiol Canc, Ctr Res Epidemiol & Populat Hlth, Villejuif, France; [Guenel, Pascal; Truong, Therese] Univ Paris 11, Villejuif, France; [Bojesen, Stig E.] Copenhagen Univ Hosp, Copenhagen Gen Populat Study, Herlev Hosp, Herlev, Denmark; [Bojesen, Stig E.] Copenhagen Univ Hosp, Dept Clin Biochem, Herlev Hosp, Herlev, Denmark; [Bojesen, Stig E.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Flyger, Henrik] Copenhagen Univ Hosp, Dept Breast Surg, Herlev Hosp, Herlev, Denmark; [Benitez, Javier; Gonzalez-Neira, Anna] Spanish Natl Canc Res Ctr, Human Canc Genet Program, Madrid, Spain; [Benitez, Javier] Ctr Invest Red Enfermedades Raras, Valencia, Spain; [Anton-Culver, Hoda] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Neuhausen, Susan L.] Beckman Res Inst City Hope, Duarte, CA USA; [Brenner, Hermann; Arndt, Volker] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, Div Prevent Oncol, Heidelberg, Germany; [Brenner, Hermann; Brauch, Hiltrud] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany; [Meindl, Alfons] Tech Univ Munich, Div Gynaecol & Obstet, Munich, Germany; [Schmutzler, Rita K.] Univ Hosp Cologne, Dept Obstet & Gynaecol, Div Mol Gynecooncol, Cologne, Germany; [Schmutzler, Rita K.] Univ Hosp Cologne, Ctr Familial Breast & Ovarian Canc, Cologne, Germany; [Schmutzler, Rita K.] Univ Hosp Cologne, Ctr Integrated Oncol, Cologne, Germany; [Schmutzler, Rita K.] Univ Hosp Cologne, Ctr Mol Med, Cologne, Germany; [Brauch, Hiltrud] Dr Margarete Fischer Bosch Institute Clin Pharmac, Stuttgart, Germany; [Brauch, Hiltrud] Univ Tubingen, Tubingen, Germany; [Hamann, Ute; Kabisch, Maria; Torres, Diana] German Canc Res Ctr, Mol Genet Breast Canc, Heidelberg, Germany; [Nevanlinna, Heli; Khan, Sofia] Univ Helsinki, Helsinki Univ Hosp, Dept Obstet & Gynecol, Helsinki, Finland; [Matsuo, Keitaro] Kyushu Univ, Dept Prevent Med, Fac Med Sci, Fukuoka, Japan; [Iwata, Hiroji] Aichi Canc Ctr Hosp, Dept Breast Oncol, Nagoya, Aichi, Japan; [Dork, Thilo] Hannover Med Sch, Gynaecol Res Unit, Hannover, Germany; [Bogdanova, Natalia V.] Hannover Med Sch, Dept Radiat Oncol, Hannover, Germany; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Margolin, Sara] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Mannermaa, Arto; Kosma, Veli-Matti] Kuopio Univ Hosp, Ctr Canc, Kuopio, Finland; [Mannermaa, Arto; Kosma, Veli-Matti] Univ Eastern Finland, Inst Clin Med Pathol & Forens Med, Kuopio, Finland; [Mannermaa, Arto; Kosma, Veli-Matti] Kuopio Univ Hosp, Imaging Ctr, Dept Clin Pathol, Kuopio, Finland; [Chenevix-Trench, Georgia] QIMR Berghofer Med Res Inst, Dept Genet, Brisbane, Qld, Australia; [kConFab AOCS Investigators] Univ Melbourne, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Wu, Anna H.; den Berg, David Ven; Haiman, Christopher A.] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA; [Smeets, Ann] Univ Hosp Gashuisberg, Leuven, Belgium; [Zhao, Hui] Vesalius Res Ctr, Leuven, Belgium; [Zhao, Hui] Univ Leuven, Lab Translat Genet, Dept Oncol, Leuven, Belgium; [Chang-Claude, Jenny; Rudolph, Anja] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Chang-Claude, Jenny] Univ Med Ctr Hamburg Eppendorf, UCCH, Hamburg, Germany; [Radice, Paolo] Ist Nazl Tumori, Unit Mol Bases Genet Risk & Genet Testing, Dept Prevent & Predict Med, Fdn IRCCS Ist Ricovero & Cura Carattere Sci, Milan, Italy; [Barile, Monica] Ist Europeo Oncol, Div Canc Prevent & Genet, Milan, Italy; [Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Vachon, Celine; Slager, Susan] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Giles, Graham G.; Milne, Roger L.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [Goldberg, Mark S.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Goldberg, Mark S.] McGill Univ, Div Clin Epidemiol, Royal Victoria Hosp, Montreal, PQ, Canada; [Teo, Soo H.] Canc Res Initiat Fdn, Subang Jaya, Selangor, Malaysia; [Teo, Soo H.; Taib, Nur A. M.] Univ Malaya, Med Ctr, Breast Canc Res Unit, Canc Res Inst, Kuala Lumpur, Malaysia; [Kristensen, Vessela; Borresen-Dale, Anne-Lise] Oslo Univ Hosp, Dept Genet, Inst Canc Res, Radiumhosp, Oslo, Norway; [Kristensen, Vessela; Borresen-Dale, Anne-Lise] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Kristensen, Vessela] Univ Oslo, Oslo Univ Hosp, Dept Clin Mol Biol, Oslo, Norway; [Zheng, Wei; Shrubsole, Martha; Shu, Xiao-Ou; Blot, William; Cai, Qiuyin] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Div Epidemiol,Dept Med, Nashville, TN 37212 USA; [Winqvist, Robert] Univ Oulu, Lab Canc Genet & Tumor Biol, Dept Clin Chem, Oulu, Finland; [Winqvist, Robert] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Winqvist, Robert] Northern Finland Lab Ctr NordLab, Lab Canc Genet & Tumor Biol, Oulu, Finland; [Jukkola-Vuorinen, Arja] Univ Oulu, Dept Oncol, Oulu Univ Hosp, Oulu, Finland; [Andrulis, Irene L.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Knight, Julia A.] Mt Sinai Hosp, Prosserman Ctr Hlth Res, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Knight, Julia A.] Univ Toronto, Div Epidemiol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Seynaeve, Caroline; Hollestelle, Antoinette; Martens, John W. M.] Erasmus MC Canc Inst, Dept Med Oncol, Family Canc Clin, Rotterdam, Netherlands; [Garcia-Closas, Montserrat; Swerdlow, Anthony] Inst Canc Res, Div Genet & Epidemiol, London, England; [Czene, Kamila; Darabi, Hatef; Li, Jingmei; Hall, Per] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Lu, Wei] Shanghai Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Cox, Angela] Univ Sheffield, Sheffield Canc Res, Dept Oncol, Sheffield, S Yorkshire, England; [Cross, Simon S.] Univ Sheffield, Acad Unit Pathol, Dept Neurosci, Sheffield, S Yorkshire, England; [Blot, William] Int Epidemiol Inst, Rockville, MD USA; [Shah, Mitul; Luccarini, Craig; Baynes, Caroline; Harrington, Patricia; Pharoah, Paul D. P.; Easton, Douglas F.; Dunning, Alison M.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge, England; [Kang, Daehee] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Kang, Daehee; Choi, Ji-Yeob] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Kang, Daehee; Choi, Ji-Yeob] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Hartman, Mikael; Chia, Kee Seng] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Hartman, Mikael] Natl Univ Hlth Syst, Dept Surg, Singapore, Singapore; [Torres, Diana] Pontificia Univ Javeriana, Inst Human Genet, Bogota, Colombia; [Jakubowska, Anna; Lubinski, Jan] Pomeranian Med Univ, Dept Genet & Pathol, Szczecin, Poland; [Sangrajrang, Suleeporn] Natl Canc Inst, Bangkok, Thailand; [Brennan, Paul] Int Agcy Res Canc, Lyon, France; [Yannoukakos, Drakoulis] Natl Ctr Sci Res Demokritos, Mol Diagnost Lab, IRRP, Athens, Greece; [Shen, Chen-Yang] China Med Univ, Sch Publ Hlth, Taichung, Taiwan; [Shen, Chen-Yang] Acad Sinica, Taiwan Biobank, Inst Biomed Sci, Taipei, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Ctr Canc, Chung Ho Mem Hosp, Kaohsiung, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Dept Surg, Chung Ho Mem Hosp, Kaohsiung, Taiwan; [Simard, Jacques] Univ Laval, Ctr Hosp Univ Quebec, Res Ctr, Quebec City, PQ, Canada; [Figueroa, Jonine D.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Figueroa, Jonine D.] Univ Edinburgh, Edinburgh Canc Res UK Ctr, Edinburgh, Midlothian, Scotland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Food & Drug Administration (FDA); University of Cambridge; University of Melbourne; University of Melbourne; Netherlands Cancer Institute; University of Warwick; University of Manchester; University of Erlangen Nuremberg; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of California System; University of California Irvine; City of Hope; Beckman Research Institute of City of Hope; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Technical University of Munich; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); University of Helsinki; Helsinki University Central Hospital; Kyushu University; Aichi Cancer Center; Hannover Medical School; Hannover Medical School; Karolinska Institutet; Karolinska Institutet; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; QIMR Berghofer Medical Research Institute; Peter Maccallum Cancer Center; University of Melbourne; University of Southern California; KU Leuven; Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS European Institute of Oncology (IEO); Mayo Clinic; Mayo Clinic; Cancer Council Victoria; Cancer Research Center of Hawaii; University of Hawaii System; McGill University; McGill University; Royal Victoria Hospital; Universiti Malaya; University of Oslo; University of Oslo; University of Oslo; Vanderbilt University; University of Oulu; University of Oulu; University of Oulu; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Karolinska Institutet; Shanghai Center for Disease Control & Prevention; University of Sheffield; University of Sheffield; University of Cambridge; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); National University of Singapore; National University of Singapore; Pontificia Universidad Javeriana; Pomeranian Medical University; National Cancer Institute - Thailand; World Health Organization; International Agency for Research on Cancer (IARC); National Centre of Scientific Research "Demokritos"; China Medical University Taiwan; Academia Sinica - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Laval University; University of Edinburgh; University of Edinburgh	Figueroa, JD (corresponding author), NCI, Div Canc Epidemiol & Genet, Rockville, MD USA.; Figueroa, JD (corresponding author), Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland.; Figueroa, JD (corresponding author), Univ Edinburgh, Edinburgh Canc Res UK Ctr, Edinburgh, Midlothian, Scotland.	jonine.figueroa@ed.ac.uk	Zhang, Han/K-2118-2016; Zheng, Wei/GQQ-8951-2022; Brenner, Hermann/ABE-6383-2020; Knight, Julia/A-6843-2012; Fasching, Peter A/ABH-9912-2020; smeets, ann/AAP-9191-2020; Garcia-Closas, Montserrat/AAZ-6930-2021; Prokunina-Olsson, Ludmila/A-8240-2019; /AAM-5330-2020; Flyger, Henrik/AAM-6494-2021; Guenel, Pascal/AAS-7688-2021; Prokunina-Olsson, Ludmila/V-7960-2019; Bogdanova, Natalia V./Y-2205-2019; Andrulis, Irene L./E-7267-2013; Figueroa, Jonine/AAG-1065-2022; Li, Jingmei/I-2904-2012; Knight, Julia/R-5617-2019; Arndt, Volker/B-4999-2014; Pharoah, Paul/V-6658-2019; Matsuo, Keitaro/H-6758-2019; Devilee, Peter/GXV-8005-2022; Radice, Paolo/O-3119-2013; Taib, Nur Aishah Mohd/B-2370-2010; Dörk, Thilo/J-8620-2012; Gonzalez-Neira, Anna/C-5791-2015; Zheng, Wei/O-3351-2013; Chenevix-Trench, Georgia/AAV-2014-2020; Jakubowska, Anna/O-8050-2014; Margolin, Sara/AAX-9034-2020; Figueroa, Jonine/GWD-1322-2022; Brenner, Hermann/B-4627-2017; Michailidou, Kyriaki/ABD-5122-2020; Schmidt, Marjanka K/G-9058-2011; Arndt, Volker/AAI-7282-2020; DEVILEE, PETER/ABR-2140-2022; zhang, weihua/GXV-1334-2022; truong, therese/A-2837-2013; Teo, Soo-hwang/H-2353-2014; Figueroa, Jonine/AFK-2752-2022; Guenel, Pascal/H-3728-2018; Lu, Wei/AAE-2921-2022; benitez, javier/H-5232-2015; Hartman, Mikael/B-4324-2011	Zhang, Han/0000-0001-7977-9616; Brenner, Hermann/0000-0002-6129-1572; Fasching, Peter A/0000-0003-4885-8471; Garcia-Closas, Montserrat/0000-0003-1033-2650; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Guenel, Pascal/0000-0002-8359-518X; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Figueroa, Jonine/0000-0002-5100-623X; Li, Jingmei/0000-0001-8587-7511; Knight, Julia/0000-0002-7610-7635; Arndt, Volker/0000-0001-9320-8684; Pharoah, Paul/0000-0001-8494-732X; Matsuo, Keitaro/0000-0003-1761-6314; Radice, Paolo/0000-0001-6298-4111; Taib, Nur Aishah Mohd/0000-0001-8419-0478; Dörk, Thilo/0000-0002-9458-0282; Gonzalez-Neira, Anna/0000-0002-5421-2020; Zheng, Wei/0000-0003-1226-070X; Chenevix-Trench, Georgia/0000-0002-1878-2587; Jakubowska, Anna/0000-0002-5650-0501; Figueroa, Jonine/0000-0002-5100-623X; Brenner, Hermann/0000-0002-6129-1572; Michailidou, Kyriaki/0000-0001-7065-1237; Schmidt, Marjanka K/0000-0002-2228-429X; Arndt, Volker/0000-0001-9320-8684; truong, therese/0000-0002-2943-6786; Figueroa, Jonine/0000-0002-5100-623X; Guenel, Pascal/0000-0002-8359-518X; Lu, Wei/0000-0002-4150-8674; Devilee, Peter/0000-0002-8023-2009; Yannoukakos, Drakoulis/0000-0001-7509-3510; Kang, Daehee/0000-0003-4031-5878; benitez, javier/0000-0002-0923-7202; Southey, Melissa/0000-0002-6313-9005; Swerdlow, Anthony/0000-0001-5550-4159; Margolin, Sara/0000-0002-5526-5570; Thorne, Heather/0000-0003-3610-2511; Khan, Sofia/0000-0003-4185-8882; Lubinski, Jan/0000-0003-2931-3003; Simard, Jacques/0000-0001-6906-3390; Cox, Angela/0000-0002-5138-1099; Hartman, Mikael/0000-0001-5726-9965; Fletcher, Olivia/0000-0001-9387-7116; Hou, Ming-Feng/0000-0001-6030-9702; Torres-Lopez, Diana Maria/0000-0002-9879-9775; Winqvist, Robert/0000-0003-0932-9104; Bojesen, Stig/0000-0002-4061-4133; Dunning, Alison Margaret/0000-0001-6651-7166; Brauch, Hiltrud/0000-0001-7531-2736; Durocher, Francine/0000-0001-8012-4641	Cancer Research UK [10124] Funding Source: Medline; NCI NIH HHS [R01 CA148667, P50 CA116201, R01 CA176785, R01 CA092447, U01 CA116167] Funding Source: Medline; Cancer Research UK [16561, 16565, 16459] Funding Source: researchfish; National Breast Cancer Foundation [IF-12-06] Funding Source: researchfish; Cancer Foundation Finland sr [110135, 150147] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA092447, U01CA116167, R01CA176785, P50CA116201, R01CA148667] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); National Breast Cancer Foundation; Cancer Foundation Finland sr; The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Cai QY, 2014, NAT GENET, V46, P886, DOI 10.1038/ng.3041; Chen Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072487; Corradin O, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0085-3; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Figueroa JD, 2011, HUM MOL GENET, V20, P4693, DOI 10.1093/hmg/ddr368; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Fu YP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-113; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Hirose H, 2010, ONCOL REP, V23, P35, DOI 10.3892/or_00000603; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Horne HN, 2014, BREAST CANCER RES TR, V143, P181, DOI 10.1007/s10549-013-2771-z; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jiang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021563; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095912; Long JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058350; Long JR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002532; Luna A, 2007, BIOINFORMATICS, V23, P774, DOI 10.1093/bioinformatics/btl657; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Musumeci L, 2010, HUM MUTAT, V31, P67, DOI 10.1002/humu.21137; Parr C, 2004, INT J MOL MED, V14, P779; Purrington KS, 2014, CARCINOGENESIS, V35, P1012, DOI 10.1093/carcin/bgt404; Sawyer E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004285; Siddiq A, 2012, HUM MOL GENET, DOI [10.1093/hmgidds381, DOI 10.1093/HMGIDDS381]; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Suman S, 2013, BRIT J CANCER, V109, P2587, DOI 10.1038/bjc.2013.642; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Wu FT, 2007, FRONT BIOSCI-LANDMRK, V12, P4370, DOI 10.2741/2394; Wu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072526; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	43	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0160316	10.1371/journal.pone.0160316	http://dx.doi.org/10.1371/journal.pone.0160316			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556229	Green Published, gold, Green Accepted			2022-12-26	WOS:000382258100011
J	Yee, J; Kim, Y; Park, T; Park, M				Yee, Jaeyong; Kim, Yongkang; Park, Taesung; Park, Mira			Using the Generalized Index of Dissimilarity to Detect Gene-Gene Interactions in Multi-Class Phenotypes	PLOS ONE			English	Article							MULTIFACTOR-DIMENSIONALITY REDUCTION	To find genetic association between complex diseases and phenotypic traits, one important procedure is conducting a joint analysis. Multifactor dimensionality reduction (MDR) is an efficient method of examining the interactions between genes in genetic association studies. It commonly assumes a dichotomous classification of the binary phenotypes. Its usual approach to determining the genomic association is to construct a confusion matrix to estimate a classification error, where a binary risk status is determined and assigned to each genotypic multifactor class. While multi-class phenotypes are commonly observed, the current MDR approach does not handle these phenotypes appropriately because the thresholds for the risk statuses may not be clear. In this study, we suggest a new method for estimating gene-gene interactions for multi-class phenotypes. Our approach adopts the index of dissimilarity (IDS) as an evaluation measure. This is analytically equivalent to the common association measure of balanced accuracy (BA) for the binary traits, while it is not required to determine the risk status for the estimation. Moreover, it is easily expandable to the generalized index of dissimilarity (GIDS), which has an explicit form that can handle any number of categories. The performance of the proposed method was compared with those of other approaches via simulation studies in which fifteen genetic models were generated with three class outcomes. A consistently better performance was observed using the proposed method. The effect of a varying number of categories was examined. The proposed method was also illustrated using real genome-wide association studies (GWAS) data from the Korean Association Resource (KARE) project.	[Yee, Jaeyong] Eulji Univ, Dept Physiol & Biophys, Daejeon, South Korea; [Kim, Yongkang; Park, Taesung] Seoul Natl Univ, Dept Stat, Seoul, South Korea; [Park, Mira] Eulji Univ, Dept Prevent Med, Daejeon, South Korea	Eulji University; Seoul National University (SNU); Eulji University	Park, M (corresponding author), Eulji Univ, Dept Prevent Med, Daejeon, South Korea.	mira@eulji.ac.kr	Kim, Yongkang/AAC-7436-2020	Kim, Yongkang/0000-0002-8837-2620	Basic Science Research Program through the National Research Foundation of Korea (NRF) - the Ministry of Education, Science and Technology [NRF-2013R1A1A2062848]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - the Ministry of Education, Science and Technology	MP was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A2062848). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000564; Bush WS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-238; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Choi J, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S6-S15; Chung YJ, 2007, BIOINFORMATICS, V23, P71, DOI 10.1093/bioinformatics/btl557; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Evans DM, 2006, PLOS GENET, V2, P1424, DOI 10.1371/journal.pgen.0020157; Gui J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066545; Jensen DD, 2000, MACH LEARN, V38, P309, DOI 10.1023/A:1007631014630; Jung SH, 2005, BIOSTATISTICS, V6, P157, DOI 10.1093/biostatistics/kxh026; Jung SH, 2006, BIOINFORMATICS, V22, P1730, DOI 10.1093/bioinformatics/btl161; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Kim K, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S2-S9; Lee S, 2012, BIOINFORMATICS, V28, pI582, DOI 10.1093/bioinformatics/bts415; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Moore JH, 2004, EXPERT REV MOL DIAGN, V4, P795, DOI 10.1586/14737159.4.6.795; Motsinger Alison A., 2006, Human Genomics, V2, P318; Namkung J, 2009, BIOINFORMATICS, V25, P338, DOI 10.1093/bioinformatics/btn629; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; SAKODA JM, 1981, DEMOGRAPHY, V18, P245, DOI 10.2307/2061096; Schillaci G, 2009, CIRCULATION, V119, P210, DOI 10.1161/CIRCULATIONAHA.108.827931; Velez DR, 2007, GENET EPIDEMIOL, V31, P306, DOI 10.1002/gepi.20211; Xu HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108103; Yee J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/523641; Yu WB, 2015, HUM HERED, V79, P168, DOI 10.1159/000377723	28	2	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0158668	10.1371/journal.pone.0158668	http://dx.doi.org/10.1371/journal.pone.0158668			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556585	Green Submitted, gold, Green Published			2022-12-26	WOS:000382258100004
B	Nielsen, RO; Kluver, L		Kluver, L; Nielsen, RO; Jorgensen, ML		Nielsen, Rasmus Ojvind; Kluver, Lars			Introduction: On the Concept of Cross-European Technology Assessment	POLICY-ORIENTED TECHNOLOGY ASSESSMENT ACROSS EUROPE: EXPANDING CAPACITIES	Palgrave Pivot		English	Editorial Material; Book Chapter								Nielsen and Kluver introduce the concept of cross-European technology assessment developed in the PACITA project, the layers of which are unfolded in the remaining chapters of this book. As a supplement to existing European institutions, cross-European technology assessment is a vision of a networked support system for national parliaments supplying process-support for knowledge-based and participatory policy making. As well as discussing the possible role of such a support system within existing European frameworks of policy formation, Nielsen and Kluver propose the necessity of capacity building modelled on the concept of cross-European technology assessment as a means to counterbalance trends towards European centralization in the face of grand societal challenges.	[Nielsen, Rasmus Ojvind; Kluver, Lars] Danish Board Technol Fdn DBT, Hvidovre, Denmark; [Kluver, Lars] PACITA Project, Hvidovre, Denmark		Nielsen, RO (corresponding author), Danish Board Technol Fdn DBT, Hvidovre, Denmark.			Millsap, Brian/0000-0003-3969-249X					0	14	14	0	2	PALGRAVE MACMILLAN	LONDON	4 CRINAN ST, LONDON, LONDON, ENGLAND			978-1-137-56172-5; 978-1-137-56171-8	PALGRAVE PIVOT			2016							1	12		10.1057/9781137561725.0007	http://dx.doi.org/10.1057/9781137561725.0007	10.1057/9781137561725		12	Management; Political Science; Public Administration; Social Issues	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Business & Economics; Government & Law; Public Administration; Social Issues	BP8KI	27556735				2022-12-26	WOS:000565862900002
J	Selagea, L; Mishra, A; Anand, M; Ross, J; Tucker-Burden, C; Kong, J; Brat, DJ				Selagea, Ligia; Mishra, Alok; Anand, Monika; Ross, James; Tucker-Burden, Carol; Kong, Jun; Brat, Daniel J.			EGFR and C/EBP-beta oncogenic signaling is bidirectional in human glioma and varies with the C/EBP-beta isoform	FASEB JOURNAL			English	Article						glioblastoma; cell signaling; LIP; LAP	EPIDERMAL-GROWTH-FACTOR; BINDING-PROTEIN-BETA; TRANSCRIPTIONAL INHIBITORY PROTEIN; NF-KAPPA-B; FACTOR RECEPTOR; GENE-EXPRESSION; MESSENGER-RNA; LIP; ACTIVATION; LAP	We investigated the intersection of epidermal growth factor receptor (EGFR) and CCAAT enhancer binding protein (C/EBP)-beta signaling in glioblastoma (GBM), given that both gene products strongly influence neoplastic behavior. C/EBP-beta is known to drive themesenchymal transcriptional signature in GBM, likely through strong microenvironmental influences, whereas the genetic contributions to its up-regulation in this disease are not well described. We demonstrated that stable overexpression and activation of WT EGFR (U87MG-WT) led to elevated C/EBP-beta expression, as well as enhanced nuclear translocation and DNA-beta inding activity, leading to upregulation of C/EBP-beta transcription and translation. Deeper investigation identified bidirectional regulation, with C/EBP-beta also causing up-regulation of EGFR that was at least partially dependent on the STAT3. Based on ChIP-based studies, we also found that that the translational isoforms of C/EBP-beta [liver-enriched transcription-activating protein (LAP)-1/2 and liver inhibitory protein (LIP)] have differential occupancy on STAT3 promoter and opposing roles in transcriptional regulation of STAT3 and EGFR. We further demonstrated that the shorter C/EBP-beta isoform, LIP, promoted proliferation and migration of U87MG glioma cells, potentially via induction of cytokine IL-6. Our molecular dissection of EGFR and C/EBP-beta pathway interactions uncovered a complex signaling network in which increased activity of either EGFRorC/EBP-beta leads to the up-regulation of the other, enhancing oncogenic signaling. Disrupting the EGFR-C/EBP-beta signaling axis could attenuate malignant behavior of glioblastoma.	[Selagea, Ligia; Mishra, Alok; Anand, Monika; Ross, James; Tucker-Burden, Carol; Brat, Daniel J.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Kong, Jun; Brat, Daniel J.] Emory Univ, Dept Biomed Informat, Winship Canc Inst, Atlanta, GA 30322 USA; [Ross, James] Emory Univ, Grad Div Biol & Biomed Sci, Atlanta, GA 30322 USA; [Selagea, Ligia] Agnes Scott Coll, Dept Biol, Decatur, GA 30030 USA	Emory University; Emory University; Emory University	Brat, DJ (corresponding author), Emory Univ Hosp, Dept Pathol & Lab Med, H-195,1364 Clifton Rd NE, Atlanta, GA 30322 USA.	dbrat@emory.edu			U.S. Public Health Service through U.S. National Institutes of Health, National Cancer Institute (NCI) [R01CA176659, K25CA181503]; Winship Cancer Institute NCI Cancer Center Support Grant [P30CA138292]; NATIONAL CANCER INSTITUTE [P30CA138292, K25CA181503, R01CA176659] Funding Source: NIH RePORTER	U.S. Public Health Service through U.S. National Institutes of Health, National Cancer Institute (NCI); Winship Cancer Institute NCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank the Tissue Procurement Service and the Research Pathology Laboratory of the Cancer Tissue and Pathology Shared Resource at the Winship Cancer Institute. The U.S. Public Health Service supported this work through U.S. National Institutes of Health, National Cancer Institute (NCI) Grants R01CA176659 (to D.J.B.), K25CA181503 (to J.K.), and the Winship Cancer Institute NCI Cancer Center Support Grant P30CA138292. The authors declare no conflicts of interest.	Arcidiacono MV, 2008, J AM SOC NEPHROL, V19, P310, DOI 10.1681/ASN.2007040406; Baldwin BR, 2004, MOL CELL BIOL, V24, P3682, DOI 10.1128/MCB.24.9.3682-3691.2004; Begay V, 2015, J MOL MED, V93, P39, DOI 10.1007/s00109-014-1215-5; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Calkhoven CF, 2000, GENE DEV, V14, P1920; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Cooper LAD, 2012, AM J PATHOL, V180, P2108, DOI 10.1016/j.ajpath.2012.01.040; Dearth LR, 2001, J CELL BIOCHEM, V82, P357, DOI 10.1002/jcb.1167; Derer S, 2012, NEOPLASIA, V14, P190, DOI 10.1593/neo.111636; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; EKSTRAND AJ, 1991, CANCER RES, V51, P2164; EKSTRAND AJ, 1992, P NATL ACAD SCI USA, V89, P4309, DOI 10.1073/pnas.89.10.4309; Furnari FB, 2015, NAT REV CANCER, V15, P302, DOI 10.1038/nrc3918; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; He DH, 2008, BIOCHEM J, V412, P153, DOI 10.1042/BJ20071649; Jundt F, 2005, BLOOD, V106, P1801, DOI 10.1182/blood-2004-11-4513; Kagan BL, 2003, CANCER RES, V63, P1696; Laag E, 2006, INT J CANCER, V119, P1547, DOI 10.1002/ijc.21987; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; Li HL, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-100; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Luedde T, 2004, HEPATOLOGY, V40, P356, DOI 10.1002/hep.20333; Oh HS, 1998, J INVEST DERMATOL, V110, P939, DOI 10.1046/j.1523-1747.1998.00199.x; Ondrey FG, 1999, MOL CARCINOGEN, V26, P119, DOI 10.1002/(SICI)1098-2744(199910)26:2<119::AID-MC6>3.0.CO;2-N; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; Oya M, 2003, CLIN CANCER RES, V9, P1021; Perry C, 2004, NEOPLASIA, V6, P279, DOI 10.1593/neo.03424; Quesnelle KM, 2007, J CELL BIOCHEM, V102, P311, DOI 10.1002/jcb.21475; Rask K, 2000, INT J CANCER, V86, P337, DOI 10.1002/(SICI)1097-0215(20000501)86:3<337::AID-IJC6>3.3.CO;2-V; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Sebastian T, 2006, CELL CYCLE, V5, P953, DOI 10.4161/cc.5.9.2733; Smink JJ, 2009, EMBO J, V28, P1769, DOI 10.1038/emboj.2009.127; Sundfeldt K, 1999, BRIT J CANCER, V79, P1240, DOI 10.1038/sj.bjc.6690199; Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P4517, DOI 10.1093/nar/27.22.4517; Tyagi A, 2003, ONCOGENE, V22, P1302, DOI 10.1038/sj.onc.1206265; Zahnow CA, 2002, BREAST CANCER RES, V4, P109, DOI 10.1186/bcr428; Zahnow CA, 1997, J NATL CANCER I, V89, P1887, DOI 10.1093/jnci/89.24.1887	37	6	7	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4098	4108		10.1096/fj.201600550R	http://dx.doi.org/10.1096/fj.201600550R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27572958	Green Published			2022-12-26	WOS:000388201500016
J	Medeiros, RCA; Girardi, KDD; Cardoso, FKL; Mietto, BD; Pinto, TGD; Gomez, LS; Rodrigues, LS; Gandini, M; Amaral, JJ; Antunes, SLG; Corte-Real, S; Rosa, PS; Pessolani, MCV; Nery, JAD; Sarno, EN; Batista-Silva, LR; Sola-Penna, M; Oliveira, MF; Moraes, MO; Lara, FA				Affonso Medeiros, Rychelle Clayde; de Vasconcelos Girardi, Karina do Carmo; Luz Cardoso, Fernanda Karlla; Mietto, Bruno de Siqueira; de Toledo Pinto, Thiago Gomes; Gomez, Lilian Sales; Rodrigues, Luciana Silva; Gandini, Mariana; Amaral, Julio Jablonski; Gomes Antunes, Sergio Luiz; Corte-Real, Suzana; Rosa, Patricia Sammarco; Vidal Pessolani, Maria Cristina; da Costa Nery, Jose Augusto; Sarno, Euzenir Nunes; Batista-Silva, Leonardo Ribeiro; Sola-Penna, Mauro; Oliveira, Marcus Fernandes; Moraes, Milton Ozorio; Lara, Flavio Alves			Subversion of Schwann Cell Glucose Metabolism by Mycobacterium leprae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell metabolism; glucose-6-phosphate dehydrogenase (G6PD or G6PDH); mitochondria; mycobacteria; neuron; oxidative stress; pentose phosphate pathway (PPP); Leprosy; glutathione; host-target therapy	LIPID DROPLETS; MONOCARBOXYLATE TRANSPORTERS; MITOCHONDRIAL METABOLISM; LEPROSY; LACTATE; INFECTION; MYELINATION; GLUTATHIONE; ACTIVATION; SURVIVAL	Mycobacterium leprae, the intracellular etiological agent of leprosy, infects Schwann promoting irreversible physical disabilities and deformities. These cells are responsible for myelination and maintenance of axonal energy metabolism through export of metabolites, such as lactate and pyruvate. In the present work, we observed that infected Schwann cells increase glucose uptake with a concomitant increase in glucose-6-phosphate dehydrogenase (G6PDH) activity, the key enzyme of the oxidative pentose pathway. We also observed a mitochondria shutdown in infected cells and mitochondrial swelling in pure neural leprosy nerves. The classic Warburg effect described in macrophages infected by Mycobacterium avium was not observed in our model, which presented a drastic reduction in lactate generation and release by infected Schwann cells. This effect was followed by a decrease in lactate dehydrogenase isoform M (LDH-M) activity and an increase in cellular protection against hydrogen peroxide insult in a pentose phosphate pathway and GSH-dependent manner. M. leprae infection success was also dependent of the glutathione antioxidant system and its main reducing power source, the pentose pathway, as demonstrated by a 50 and 70% drop in intracellular viability after treatment with the GSH synthesis inhibitor buthionine sulfoximine, and aminonicotinamide (6-ANAM), an inhibitor of G6PDH 6-ANAM, respectively. We concluded that M. leprae could modulate host cell glucose metabolism to increase the cellular reducing power generation, facilitating glutathione regeneration and consequently free-radical control. The impact of this regulation in leprosy neuropathy is discussed.	[Affonso Medeiros, Rychelle Clayde; de Vasconcelos Girardi, Karina do Carmo; Luz Cardoso, Fernanda Karlla; Gandini, Mariana; Vidal Pessolani, Maria Cristina; Lara, Flavio Alves] Fiocruz MS, Lab Microbiol Celular, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil; [Corte-Real, Suzana] Fiocruz MS, Lab Biol Estrut, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil; [Mietto, Bruno de Siqueira; de Toledo Pinto, Thiago Gomes; Gomes Antunes, Sergio Luiz; da Costa Nery, Jose Augusto; Sarno, Euzenir Nunes; Batista-Silva, Leonardo Ribeiro; Moraes, Milton Ozorio] Fiocruz MS, Lab Hanseniase, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil; [Gomez, Lilian Sales; Sola-Penna, Mauro] Univ Estado Rio De Janeiro, Lab Enzimol & Controle Metabol, Rio De Janeiro, RJ, Brazil; [Rodrigues, Luciana Silva] Univ Estado Rio De Janeiro, Immunol Lab, Fac Med Sci, Rio De Janeiro, RJ, Brazil; [Amaral, Julio Jablonski] INMETRO, Natl Inst Metrol Qual & Technol, Rio De Janeiro, RJ, Brazil; [Rosa, Patricia Sammarco] Lauro de Souza Lima Inst, Dept Biol, Bauru, SP, Brazil; [Oliveira, Marcus Fernandes] Univ Fed Rio de Janeiro, Lab Bioquim Resposta Estresse, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Universidade Federal do Rio de Janeiro	Lara, FA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Ave Brasil,4365,Sala 27, BR-21040360 Rio De Janeiro, RJ, Brazil.	flavioalveslara2000@gmail.com	Moraes, Milton/AFF-1842-2022; Mietto, Bruno/J-1261-2016; Gandini, Mariana/AAZ-6964-2021; Oliveira, Marcus/G-3158-2011; Moraes, Milton Ozório/G-9753-2011; Sola-Penna, Mauro/E-8221-2011; Lara, Flavio Alves/L-1861-2013	Mietto, Bruno/0000-0002-4172-2670; Oliveira, Marcus/0000-0002-9890-8425; Moraes, Milton Ozório/0000-0003-2653-0037; Sola-Penna, Mauro/0000-0001-9796-6829; Nunes Sarno, Euzenir/0000-0003-0129-2159; Gandini, Mariana/0000-0003-3603-6921; Sales Gomez, Lilian/0000-0002-5309-7438				Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Guerreiro LTA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064748; Appelberg R, 2015, IMMUNOLOGY, V145, P498, DOI 10.1111/imm.12464; Beirowski B, 2014, NAT NEUROSCI, V17, P1351, DOI 10.1038/nn.3809; Beutler E, 1996, BLOOD REV, V10, P45, DOI 10.1016/S0268-960X(96)90019-3; Bohl LP, 2012, CANCER INVEST, V30, P560, DOI 10.3109/07357907.2012.700985; Brown AM, 2012, ANN NEUROL, V72, P406, DOI 10.1002/ana.23607; Chiu SY, 2011, NEUROSCIENTIST, V17, P343, DOI 10.1177/1073858410393740; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; de Mattos KA, 2012, MEM I OSWALDO CRUZ, V107, P156, DOI 10.1590/S0074-02762012000900023; Diaz-Vivancos P, 2015, FREE RADICAL BIO MED, V89, P1154, DOI 10.1016/j.freeradbiomed.2015.09.023; Domenech-Estevez E, 2015, J NEUROSCI, V35, P4151, DOI 10.1523/JNEUROSCI.3534-14.2015; Douki T, 1996, FREE RADICAL RES, V24, P369, DOI 10.3109/10715769609088035; HALESTRAP AP, 1989, BIOCHIM BIOPHYS ACTA, V973, P355, DOI 10.1016/S0005-2728(89)80378-0; Hsieh YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079566; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Lobato LS, 2014, ANTIMICROB AGENTS CH, V58, P5766, DOI 10.1128/AAC.01826-13; Lockwood DNJ, 2005, B WORLD HEALTH ORGAN, V83, P230; LUZZATTO L, 1969, SCIENCE, V164, P839, DOI 10.1126/science.164.3881.839; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Martinez-Gutierrez M, 2011, INTERVIROLOGY, V54, P202, DOI 10.1159/000321892; Masaki T, 2013, CELL, V152, P51, DOI 10.1016/j.cell.2012.12.014; Matthews GM, 2005, HELICOBACTER, V10, P298, DOI 10.1111/j.1523-5378.2005.00327.x; Mattos KA, 2011, J IMMUNOL, V187, P2548, DOI 10.4049/jimmunol.1101344; Mattos KA, 2011, CELL MICROBIOL, V13, P259, DOI 10.1111/j.1462-5822.2010.01533.x; Nagy C, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00164; Palsson-McDermott EM, 2013, BIOESSAYS, V35, P965, DOI 10.1002/bies.201300084; Pellerin L, 2003, NEUROCHEM INT, V43, P331, DOI 10.1016/S0197-0186(03)00020-2; Pooya S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5993; Rodrigues LS, 2010, CELL MICROBIOL, V12, P42, DOI 10.1111/j.1462-5822.2009.01377.x; Save MP, 2009, LEPROSY REV, V80, P388; Scollard DM, 2015, CLIN DERMATOL, V33, P46, DOI 10.1016/j.clindermatol.2014.07.008; Siegl C, 2014, CELL REP, V9, P918, DOI 10.1016/j.celrep.2014.10.004; Solenski NJ, 2002, STROKE, V33, P816, DOI 10.1161/hs0302.104541; STOCKS J, 1971, BRIT J HAEMATOL, V20, P95, DOI 10.1111/j.1365-2141.1971.tb00790.x; Tang F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4284; Tekkok SB, 2005, J NEUROSCI RES, V81, P644, DOI 10.1002/jnr.20573; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; WISNIEWSKI HM, 1975, J EXP MED, V141, P346, DOI 10.1084/jem.141.2.346; World Health Organization, 2015, WKLY EPIDEMIOL REC, V90, P461; Zoratti M, 2005, BBA-BIOENERGETICS, V1706, P40, DOI 10.1016/j.bbabio.2004.10.006	42	26	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21375	21387		10.1074/jbc.M116.725283	http://dx.doi.org/10.1074/jbc.M116.725283			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27555322	hybrid, Green Published			2022-12-26	WOS:000385999200004
J	Burley, SD; Whittingham-Dowd, J; Allen, J; Grosset, JF; Onambele-Pearson, GL				Burley, Simon D.; Whittingham-Dowd, Jayde; Allen, Jeremy; Grosset, Jean-Francois; Onambele-Pearson, Gladys L.			The Differential Hormonal Milieu of Morning versus Evening May Have an Impact on Muscle Hypertrophic Potential	PLOS ONE			English	Article							HEAVY-RESISTANCE EXERCISE; FACTOR BINDING PROTEIN-3; CIRCADIAN-RHYTHMS; SKELETAL-MUSCLE; NUTRITIONAL SUPPLEMENTATION; MUSCULAR PERFORMANCE; BODY-TEMPERATURE; IGF-I; RESPONSES; GROWTH	Substantial gains in muscle strength and hypertrophy are clearly associated with the routine performance of resistance training. What is less evident is the optimal timing of the resistance training stimulus to elicit these significant functional and structural skeletal muscle changes. Therefore, this investigation determined the impact of a single bout of resistance training performed either in the morning or evening upon acute anabolic signalling (insulinlike growth factor-binding protein-3 (IGFBP-3), myogenic index and differentiation) and catabolic processes (cortisol). Twenty-four male participants (age 21.4 +/- 1.9yrs, mass 83.7 +/- 13.7kg) with no sustained resistance training experience were allocated to a resistance exercise group (REP). Sixteen of the 24 participants were randomly selected to perform an additional non-exercising control group (CP) protocol. REP performed two bouts of resistance exercise (80% 1RM) in the morning (AM: 0800 hrs) and evening (PM: 1800 hrs), with the sessions separated by a minimum of 72 hours. Venous blood was collected immediately prior to, and 5 min after, each resistance exercise and control sessions. Serum cortisol and IGFBP-3 levels, myogenic index, myotube width, were determined at each sampling period. All data are reported as mean +/- SEM, statistical significance was set at P <= 0.05. As expected a significant reduction in evening cortisol concentration was observed at pre (AM: 98.4 +/- 10.5, PM: 49.8 +/- 4.4 ng/ml, P<0.001) and post (AM: 98.0 +/- 9.0, PM: 52.7 +/- 6.0 ng/ml, P<0.001) exercise. Interestingly, individual cortisol differences pre vs post exercise indicate a time-of-day effect (AM difference:-2 +/- 2.6%, PM difference: 14.0 +/- 6.7%, P = 0.03). A time-of-day related elevation in serum IGFBP-3 (AM: 3274.9 +/- 345.2, PM: 3605.1 +/- 367.5, p = 0.032) was also evident. Pre exercise myogenic index (AM: 8.0 +/- 0.6%, PM: 16.8 +/- 1.1%) and myotube width (AM: 48.0 +/- 3.0, PM: 71.6 +/- 1.9 mu m) were significantly elevated (P<0.001) in the evening. Post exercise myogenic index was greater AM (11.5 +/- 1.6%) compared with PM (4.6 +/- 0.9%). No difference was observed in myotube width (AM: 48.5 +/- 1.5, PM: 47.8 +/- 1.8 mu m) (P> 0.05). Timing of resistance training regimen in the evening appears to augment some markers of hypertrophic potential, with elevated IGFBP-3, suppressed cortisol and a superior cellular environment. Further investigation, to further elucidate the time course of peak anabolic signalling in morning vs evening training conditions, are timely.	[Burley, Simon D.; Grosset, Jean-Francois; Onambele-Pearson, Gladys L.] Manchester Metropolitan Univ, HEAL Res Ctr, Exercise & Sport Sci, Crewe Green Rd, Crewe CW1 5DU, England; [Whittingham-Dowd, Jayde] Univ Manchester, Fac Life Sci, AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England; [Allen, Jeremy] Univ Salford, Sch Hlth Sport & Rehabil Sci, Salford M5 4WT, Greater Manches, England; [Grosset, Jean-Francois] Univ Technol Compiegne, Biomecan & Bioingn, CNRS, UMR 7338, F-60205 Compiegne, France	Manchester Metropolitan University; University of Manchester; University of Salford; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Picardie Universites; Universite de Technologie de Compiegne	Onambele-Pearson, GL (corresponding author), Manchester Metropolitan Univ, HEAL Res Ctr, Exercise & Sport Sci, Crewe Green Rd, Crewe CW1 5DU, England.	g.pearson@mmu.ac.uk	Onambélé-Pearson, Gladys Leopoldine/F-1679-2013; Grosset, Jean-Francois/AFY-2470-2022	Onambélé-Pearson, Gladys Leopoldine/0000-0002-1466-3265; Whittingham-Dowd, Jayde/0000-0002-7939-6081; Grosset, Jean-Francois/0000-0003-4509-0778				Ahtiainen JP, 2003, EUR J APPL PHYSIOL, V89, P555, DOI 10.1007/s00421-003-0833-3; ATKINSON G, 1993, ERGONOMICS, V36, P273, DOI 10.1080/00140139308967882; Bermon S, 1999, ACTA PHYSIOL SCAND, V165, P51; Bird SP, 2004, CHRONOBIOL INT, V21, P131, DOI 10.1081/CBI-120027987; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bolster DR, 2003, J PHYSIOL-LONDON, V553, P213, DOI 10.1113/jphysiol.2003.047019; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Brzycki M., 1993, J PHYS ED REC DANCE, V64, P88, DOI [10.1080/07303084.1993.10606684, DOI 10.1080/07303084.1993.10606684]; Callard D, 2000, CHRONOBIOL INT, V17, P693, DOI 10.1081/CBI-100101075; Carrier J, 2000, CHRONOBIOL INT, V17, P719, DOI 10.1081/CBI-100102108; DINNEEN S, 1993, J CLIN INVEST, V92, P2283, DOI 10.1172/JCI116832; Dreyer HC, 2006, J PHYSIOL-LONDON, V576, P613, DOI 10.1113/jphysiol.2006.113175; Drust B, 2005, CHRONOBIOL INT, V22, P21, DOI 10.1081/CBI-200041039; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Forsling ML, 1998, EXP PHYSIOL, V83, P409, DOI 10.1113/expphysiol.1998.sp004124; Foulstone EJ, 2003, J CELL PHYSIOL, V195, P70, DOI 10.1002/jcp.10227; Gauthier A, 1996, CHRONOBIOL INT, V13, P135, DOI 10.3109/07420529609037077; HACK CE, 1989, BLOOD, V74, P1704; Hawley JA, 2004, EXERC SPORT SCI REV, V32, P4, DOI 10.1097/00003677-200401000-00002; Hayes LD, 2010, CHRONOBIOL INT, V27, P675, DOI 10.3109/07420521003778773; Juul A, 1998, J CLIN ENDOCR METAB, V83, P4408, DOI 10.1210/jc.83.12.4408; Kahn SM, 2002, J ENDOCRINOL, V175, P113, DOI 10.1677/joe.0.1750113; Komi PV, 2000, J BIOMECH, V33, P1197, DOI 10.1016/S0021-9290(00)00064-6; Koziris LP, 1999, J APPL PHYSIOL, V86, P1436, DOI 10.1152/jappl.1999.86.4.1436; KRAEMER RR, 1993, J SPORT MED PHYS FIT, V33, P246; Kraemer WJ, 2004, MED SCI SPORT EXER, V36, P674, DOI 10.1249/01.MSS.0000121945.36635.61; Kraemer WJ, 2003, J STRENGTH COND RES, V17, P455; KRAEMER WJ, 1993, J APPL PHYSIOL, V75, P594, DOI 10.1152/jappl.1993.75.2.594; KRAEMER WJ, 1990, J APPL PHYSIOL, V69, P1442, DOI 10.1152/jappl.1990.69.4.1442; Kraemer WJ, 1998, J APPL PHYSIOL, V85, P1544, DOI 10.1152/jappl.1998.85.4.1544; KRIEGER DT, 1971, J CLIN ENDOCR METAB, V32, P266, DOI 10.1210/jcem-32-2-266; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; MELHIM AF, 1993, INT J SPORTS MED, V14, P303, DOI 10.1055/s-2007-1021182; Nindl BC, 2001, J APPL PHYSIOL, V90, P1319, DOI 10.1152/jappl.2001.90.4.1319; Pearson SJ, 2005, CHRONOBIOL INT, V22, P1013, DOI 10.1080/07420520500397900; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; Pledge D, 2011, CYTOKINE, V55, P318, DOI 10.1016/j.cyto.2011.05.005; REFINETTI R, 1992, PHYSIOL BEHAV, V51, P613, DOI 10.1016/0031-9384(92)90188-8; Reilly T, 1983, Br J Sports Med, V17, P128; REILLY T, 1990, CHRONOBIOL INT, V7, P59, DOI 10.3109/07420529009056955; Reilly T, 1982, BRIT J SPORTS MED, V16, P115; Reilly T, 2009, EUR J APPL PHYSIOL, V106, P321, DOI 10.1007/s00421-009-1066-x; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; RUDOLF MCJ, 1991, AM J DIS CHILD, V145, P769; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Sedliak M, 2008, J SPORT SCI, V26, P1005, DOI 10.1080/02640410801930150; Sedliak M, 2009, J STRENGTH COND RES, V23, P2451, DOI 10.1519/JSC.0b013e3181bb7388; Smilios I, 2003, MED SCI SPORT EXER, V35, P644, DOI 10.1249/01.MSS.0000058366.04460.5F; Souissi N, 2002, J SPORT SCI, V20, P929, DOI 10.1080/026404102320761813; STEPHENSON LA, 1989, EUR J APPL PHYSIOL O, V58, P756, DOI 10.1007/BF00637388; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; Uchida MC, 2009, J STRENGTH COND RES, V23, P2003, DOI 10.1519/JSC.0b013e3181b73bf7; West DWD, 2010, INT J BIOCHEM CELL B, V42, P1371, DOI 10.1016/j.biocel.2010.05.012; West DWD, 2013, MED SCI SPORTS EXERC, P2044; Williams AG, 2002, EUR J APPL PHYSIOL, V86, P315, DOI 10.1007/s00421-001-0536-6; WYSE JP, 1994, BRIT J SPORT MED, V28, P167, DOI 10.1136/bjsm.28.3.167; Zafeiridis A, 2003, J APPL PHYSIOL, V94, P591, DOI 10.1152/japplphysiol.00330.2002	58	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161500	10.1371/journal.pone.0161500	http://dx.doi.org/10.1371/journal.pone.0161500			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583459	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000382855600035
J	Chen, GM; Lix, L; Tu, K; Hemmelgarn, BR; Campbell, NRC; McAlister, FA; Quan, H				Chen, Guanmin; Lix, Lisa; Tu, Karen; Hemmelgarn, Brenda R.; Campbell, Norm R. C.; McAlister, Finlay A.; Quan, Hude		Hypertension Outcome Surveillance	Influence of Using Different Databases and 'Look Back' Intervals to Define Comorbidity Profiles for Patients with Newly Diagnosed Hypertension: Implications for Health Services Researchers	PLOS ONE			English	Article							ICD-10 ADMINISTRATIVE DATA; CHRONIC DISEASE SCORE; MEDICARE CLAIMS; RISK; PERFORMANCE; ADJUSTMENT; CHARLSON; ELIXHAUSER; MORTALITY; VALIDITY	Objective To determine the data sources and 'look back' intervals to define comorbidities. Data Sources Hospital discharge abstracts database (DAD), physician claims, population registry and death registry from April 1, 1994 to March 31, 2010 in Alberta, Canada. Study Design Newly-diagnosed hypertension cases from 1997 to 2008 fiscal years were identified and followed up to 12 years. We defined comorbidities using data sources and duration of retrospective observation (6 months, 1 year, 2 years, and 3 years). The C-statistics for logistic regression and concordance index (CI) for Cox model of mortality and cardiovascular disease hospitalization were used to evaluate discrimination performance for each approach of defining comorbidities. Principal Findings The comorbidities prevalence became higher with a longer duration. Using DAD alone underestimated the prevalence by about 75%, compared to using both DAD and physicianclaims. The C-statistic and CI were highest when both DAD and physician claims were used, and model performance improved when observation duration increased from 6 months to one year or longer. Conclusion The comorbidities prevalence is greatly impacted by the data source and duration of retrospective observation. A combination of DAD and physicians claims with at least one year observation duration improves predictions for cardiovascular disease and one-year mortality outcome model performance.	[Chen, Guanmin; Hemmelgarn, Brenda R.; Campbell, Norm R. C.; Quan, Hude] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Chen, Guanmin; Hemmelgarn, Brenda R.; Quan, Hude] Univ Calgary, Inst Publ Hlth, Calgary, AB, Canada; [Lix, Lisa] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [Tu, Karen] Univ Toronto, Dept Family & Community Med, ICES, Toronto, ON, Canada; [Hemmelgarn, Brenda R.; Campbell, Norm R. C.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Campbell, Norm R. C.] Univ Calgary, Dept Pharmacol & Therapeut, Calgary, AB, Canada; [McAlister, Finlay A.] Univ Alberta, Div Gen Internal Med, Edmonton, ON, Canada; [Chen, Guanmin] Alberta Hlth Serv, Res Facilitat, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Manitoba; University of Toronto; University of Calgary; University of Calgary; University of Alberta; Alberta Health Services (AHS); University of Calgary	Chen, GM (corresponding author), Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada.; Chen, GM (corresponding author), Univ Calgary, Inst Publ Hlth, Calgary, AB, Canada.; Chen, GM (corresponding author), Alberta Hlth Serv, Res Facilitat, Calgary, AB, Canada.	guchen@ucalgary.ca	Chen, Guanmin/AAN-4510-2020; McAlister, Finlay/C-4151-2013	Quan, Hude/0000-0002-7848-7256; McAlister, Finlay/0000-0001-7435-3341; Tu, Karen/0000-0003-0883-4934	Canadian Institutes of Health Research (CIHR) [MOP-125977]; Alberta Innovates - Health Solutions; Canadian Institute for Health Research; Roy and Vi Baay Chair in Kidney Research	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates - Health Solutions; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Roy and Vi Baay Chair in Kidney Research	This project was funded by Canadian Institutes of Health Research (CIHR, funding reference number: MOP-125977). H.Q. and F.M. salary support is from Alberta Innovates - Health Solutions. F.M. holds the University of Alberta Chair in Cardiac Outcomes Research. K.T. is supported by a Fellowship in Primary Care Research by the Canadian Institute for Health Research. N.C. holds the Heart and Stroke Foundation of Canada CIHR Chair in Hypertension Prevention and Control. B.H. is supported by the Roy and Vi Baay Chair in Kidney Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; H.Q. and F.M. salary support is from Alberta Innovates-Health Solutions, FM holds the University of Alberta Chair in Cardiac Outcomes Research, K.T. is supported from a Fellowship in Primary Care Research by the Canadian Institute for Health Research, N.C. holds the Heart and Stroke Foundation of Canada CIHR Chair in Hypertension Prevention and Control. B.H is supported by the Roy and Vi Baay Chair in Kidney Research.	Austin PC, 2012, ANN EPIDEMIOL, V22, P881, DOI 10.1016/j.annepidem.2012.09.011; CLARK DO, 1995, MED CARE, V33, P783, DOI 10.1097/00005650-199508000-00004; Gonen M, 2005, BIOMETRIKA, V92, P965, DOI 10.1093/biomet/92.4.965; Howell S, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-96; JOHNSON RE, 1994, J CLIN EPIDEMIOL, V47, P1191, DOI 10.1016/0895-4356(94)90106-6; Klabunde CN, 2006, MED CARE, V44, P921, DOI 10.1097/01.mlr.0000223480.52713.b9; Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1; Leal JR, 2010, CLIN MICROBIOL INFEC, V16, P715, DOI 10.1111/j.1469-0691.2009.02867.x; Lee DS, 2005, MED CARE, V43, P182, DOI 10.1097/00005650-200502000-00012; Li B, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-12; Li PX, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-245; Lix LM, 2011, OSTEOPOROSIS INT, V22, P2633, DOI 10.1007/s00198-010-1516-7; Perkins AJ, 2004, J CLIN EPIDEMIOL, V57, P1040, DOI 10.1016/j.jclinepi.2004.03.002; Preen DB, 2006, J CLIN EPIDEMIOL, V59, P940, DOI 10.1016/j.jclinepi.2005.12.013; Quach S, 2010, CAN J CARDIOL, V26, pE306, DOI 10.1016/S0828-282X(10)70438-4; Quan HD, 2002, MED CARE, V40, P675, DOI 10.1097/00005650-200208000-00007; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; Quan HD, 2013, CAN J CARDIOL, V29, P592, DOI 10.1016/j.cjca.2012.12.016; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Quan HD, 2009, HYPERTENSION, V54, P1423, DOI 10.1161/HYPERTENSIONAHA.109.139279; Radley DC, 2008, J CLIN EPIDEMIOL, V61, P580, DOI 10.1016/j.jclinepi.2007.08.001; Schneeweiss S, 2004, J GEN INTERN MED, V19, P444, DOI 10.1111/j.1525-1497.2004.30109.x; Sharabiani MTA, 2012, MED CARE, V50, P1109, DOI 10.1097/MLR.0b013e31825f64d0; Southern DA, 2004, MED CARE, V42, P355, DOI 10.1097/01.mlr.0000118861.56848.ee; Wang PS, 2000, J CLIN EPIDEMIOL, V53, P571, DOI 10.1016/S0895-4356(00)00222-5; Yan Y, 2005, MED CARE, V43, P1073, DOI 10.1097/01.mlr.0000182477.29129.86; Zhang JX, 1999, MED CARE, V37, P1128, DOI 10.1097/00005650-199911000-00005	28	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162074	10.1371/journal.pone.0162074	http://dx.doi.org/10.1371/journal.pone.0162074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583532	gold, Green Submitted, Green Published			2022-12-26	WOS:000382855600098
J	Mantwill, S; Schulz, PJ				Mantwill, Sarah; Schulz, Peter J.			Causal Attribution and Coping Maxims Differences between Immigrants and Non-Immigrants Suffering from Back Pain in Switzerland	PLOS ONE			English	Article							COMMON-SENSE MODEL; PERCEPTION QUESTIONNAIRE; RHEUMATOID-ARTHRITIS; AFRICAN-AMERICAN; BREAST-CANCER; HEALTH; ILLNESS; WOMEN; REPRESENTATION; ADJUSTMENT	Objectives This study aimed at investigating the relationship between causal attributions and coping maxims in people suffering from back pain. Further, it aimed at identifying in how far causal attributions and related coping maxims would defer between immigrants and non-immigrants in Switzerland. Methods Data for this study came from a larger survey study that was conducted among immigrant populations in the German-and Italian-speaking part of Switzerland. Included in the analyses were native Swiss participants, as well as Albanian-and Serbian-speaking immigrants, who had indicated to have suffered from back pain within the last 12 months prior to the study. Data was analyzed for overall 495 participants. Items for causal attributions and coping maxims were subject to factor analyses. Cultural differences were assessed with ANOVA and regression analyses. Interaction terms were included to investigate whether the relationship between causal attributions and coping maxims would differ with cultural affiliation. Results For both immigrant groups the physician's influence on the course of their back pain was more important than for Swiss participants (p < .05). With regard to coping, both immigrant groups were more likely to agree with maxims that were related to the improvement of the back pain, as well as the acceptance of the current situation (p < .05). The only consistent interaction effect that was found indicated that being Albanian-speaking negatively moderated the relationship between physical activity as an attributed cause of back pain and all three identified coping maxims. Conclusion The study shows that differences in causal attribution and coping maxims between immigrants and non-immigrants exist. Further, the results support the assumption of an association between causal attribution and coping maxims. However cultural affiliation did not considerably moderate this relationship.	[Mantwill, Sarah; Schulz, Peter J.] Univ Lugano, Inst Commun & Hlth, Lugano, Switzerland	Universita della Svizzera Italiana	Mantwill, S (corresponding author), Univ Lugano, Inst Commun & Hlth, Lugano, Switzerland.	Sarah.Mantwill@usi.ch	Schulz, Peter/AAM-9816-2020; Schulz, Peter/GQQ-1290-2022	Schulz, Peter/0000-0003-4281-489X; Schulz, Peter/0000-0003-4281-489X	Swiss public sector insurer (SUVA)	Swiss public sector insurer (SUVA)	The authors received funding from a Swiss public sector insurer (SUVA). Funding was provided for (1.) one research assistant, (2.) assistants who recruited participants for the study and the (3.) prize draw that participants were eligible to participate in. The funders had no role in the study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	AFFLECK G, 1987, J CONSULT CLIN PSYCH, V55, P29, DOI 10.1037/0022-006X.55.1.29; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Bischoff A., 2009, DIVERSITY HLTH CARE, V6, P159; Bischoff A, 2008, J IMMIGR MINOR HEALT, V10, P325, DOI 10.1007/s10903-007-9089-z; Bischoff A, 2009, EUR J PUBLIC HEALTH, V19, P59, DOI 10.1093/eurpub/ckn113; Bundesamt fur Gesundheit (BAG) (Swiss Federal Office of Public Health (SFOPH)), 2010, GES MIGR MIGR SCHWEI; Bundesamt fur Gesundheit (BAG) (Swiss Federal Office of Public Health (SFOPH)), 2007, WIE GES SIND MIGR MI; Bundesamt fur Statistik (BFS) (Swiss Federal Statistical Office (SFSO)), 2015, MIGR INT IND BEV MIG; Bundesamt fur Statistik (BFS) (Swiss Federal Statistical Office (SFSO)), 2014, GESUNDHEITSSTATISTIK; Bundesamt fur Statistik (BFS) (Swiss Federal Statistical Office (SFSO)), 2014, MIGR INT IND AUSL BE; Burri Sharani B., 2010, KOSOVARISCHE BEVOLKE; Camerini AL, 2016, PATIENT EDUC COUNS, V99, P462, DOI 10.1016/j.pec.2015.10.018; Campbell CM, 2012, PAIN MANAG, V2, P219, DOI 10.2217/PMT.12.7; Cano A, 2006, J PAIN, V7, P459, DOI 10.1016/j.jpain.2006.01.445; Currie SR, 2004, PAIN, V107, P54, DOI 10.1016/j.pain.2003.09.015; EDWARDS LC, 1992, PAIN, V51, P267, DOI 10.1016/0304-3959(92)90209-T; Edwards RR, 2005, PAIN MED, V6, P88, DOI 10.1111/j.1526-4637.2005.05007.x; Fontana M, 2008, SWISS MED WKLY, V138, P752, DOI 2008/49/smw-12328; Geiger-Brown J. M., 2012, HDB OCCUPATIONAL HLT, P297; Graham-Engeland JE, 2016, ANN BEHAV MED, V50, P12, DOI 10.1007/s12160-015-9723-2; Grossmann FF, 2011, PUBLIC HEALTH NURS, V28, P129, DOI 10.1111/j.1525-1446.2010.00896.x; Grzywacz JG, 2007, J OCCUP ENVIRON MED, V49, P1302, DOI 10.1097/JOM.0b013e31815ae9bc; Guggisberg J, 2011, GESUNDHEITSMONITORIN; Hagger MS, 2003, PSYCHOL HEALTH, V18, P141, DOI 10.1080/088704403100081321; Hoffmann TC, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-7; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jordan MS, 1998, ARTHRIT CARE RES, V11, P80, DOI 10.1002/art.1790110203; Kellner U, 2013, CLIN RHEUMATOL, V32, P189, DOI 10.1007/s10067-012-2099-9; Kivimaki M, 2001, WORK STRESS, V15, P3, DOI 10.1080/02678370118685; Kneckt MC, 2000, J CLIN PERIODONTOL, V27, P205, DOI 10.1034/j.1600-051x.2000.027003205.x; KRAAIMAAT FW, 1988, J BEHAV MED, V11, P293, DOI 10.1007/BF00844434; Lavery JF, 1996, CANCER NURS, V19, P20, DOI 10.1097/00002820-199602000-00003; Leventhal H, 1998, PSYCHOL HEALTH, V13, P717, DOI 10.1080/08870449808407425; Leventhal H, 2003, SELF REGULATION HLTH, P77; Leventhal H, 1980, CONTRIBUTIONS MED PS, V2, P7; Leventhal H., 1997, PERCEPTIONS HLTH ILL, V2, P19; Leventhal H, 2011, ANN BEHAV MED, V41, P152, DOI 10.1007/s12160-010-9246-9; Linton SJ, 2011, SCAND J PAIN, V2, P47, DOI 10.1016/j.sjpain.2011.01.005; Macfarlane GJ, 1997, SPINE, V22, P1143, DOI 10.1097/00007632-199705150-00015; Marques-Vidal P, 2011, PUBLIC HEALTH NUTR, V14, P1148, DOI 10.1017/S1368980011000103; McAndrew LM, 2008, BRIT J HEALTH PSYCH, V13, P195, DOI 10.1348/135910708X295604; Meints SM, 2016, J PAIN, V17, P642, DOI 10.1016/j.jpain.2015.12.017; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Murgic L, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0059-z; Osborne J. W, 2015, PRACTICAL ASSESSMENT, V20, P2, DOI [DOI 10.7275/HB2G-M060, 10.7275/hb2g-m060]; Reid GJ, 1998, PAIN, V76, P83, DOI 10.1016/S0304-3959(98)00029-3; Roesch SC, 2001, J PSYCHOSOM RES, V50, P205, DOI 10.1016/S0022-3999(01)00188-X; Rutter CL, 2002, BRIT J HEALTH PSYCH, V7, P377, DOI 10.1348/135910702320645372; SCHIAFFINO KM, 1992, PERS SOC PSYCHOL B, V18, P709, DOI 10.1177/0146167292186007; Schulz PJ, 2006, PATIENT EDUC COUNS, V64, P294, DOI 10.1016/j.pec.2006.03.009; Schulz PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078029; SnowTurek AL, 1996, PAIN, V64, P455, DOI 10.1016/0304-3959(95)00190-5; Soares JJF, 1999, SCAND J CARING SCI, V13, P254, DOI 10.1080/02839319950162453; SWANSON GM, 1995, J NATL CANCER I, V87, P1747, DOI 10.1093/jnci/87.23.1747; TENNEN H, 1984, BASIC APPL SOC PSYCH, V5, P131, DOI 10.1207/s15324834basp0502_6; Vyshka G, 2011, BMC MED ETHICS, V12, DOI 10.1186/1472-6939-12-12; WEINER B, 1985, PSYCHOL REV, V92, P548, DOI 10.1037/0033-295X.92.4.548; Weinman J, 2000, BRIT J HEALTH PSYCH, V5, P263, DOI 10.1348/135910700168900; Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270; Wieser S, 2011, EUR J HEALTH ECON, V12, P455, DOI 10.1007/s10198-010-0258-y; Wimmer A, 2004, ETHNIC RACIAL STUD, V27, P1, DOI 10.1080/0141987032000147922; Yancey AK, 2006, ANNU REV PUBL HEALTH, V27, P1, DOI 10.1146/annurev.publhealth.27.021405.102113	62	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161758	10.1371/journal.pone.0161758	http://dx.doi.org/10.1371/journal.pone.0161758			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV3WN	27583445	gold, Green Submitted, Green Published			2022-12-26	WOS:000382855600056
J	Nair, D; Rajshekhar, N; Klinton, JS; Watson, B; Velayutham, B; Tripathy, JP; Jawahar, MS; Swaminathan, S				Nair, Dina; Rajshekhar, Nandita; Klinton, Joel Shyam; Watson, Basilea; Velayutham, Banurekha; Tripathy, Jaya Prasad; Jawahar, Mohideen Shaheed; Swaminathan, Soumya			Household Contact Screening and Yield of Tuberculosis Cases-A Clinic Based Study in Chennai, South India	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; RISK-FACTORS; SUSCEPTIBILITY; INFECTION; DISEASE	Background Contact investigation is an active case finding strategy to increase detection of Tuberculosis (TB) and a key component of TB control programs. The household contacts are at a higher risk of exposure than members of the general population. The information on the value and yield of household contact screening and the approaches used in high incidence settings like India is limited. Objective To evaluate the yield of active case finding in household contacts of newly diagnosed smear positive TB patients and the factors associated with increased yield. Method Retrospective record review of the household contacts of newly diagnosed sputum smear positive patients (index case) enrolled in a clinical trial at National Institute of Research in Tuberculosis, Chennai during the period 2007-2014. A sequential screening algorithm with chest x-ray followed by symptom screen was employed to identify presumptive TB patients. Results 643 household contacts of 280 index TB patients were identified out of which 544 (85%) consented for screening. 71/544 (13%) patients had an abnormal chest radiograph and out of them 70% were symptomatic. A total of 29/544 (5.3%) contacts were found to have TB among whom 23/29 (79%) were sputum smear positive. The number needed to screen (NNS) to identify a new TB case among all household contacts was 19 and among those with an abnormal CXR was 02. Age group > 44 years, male gender and siblings of the index case was associated with abnormal chest radiograph whereas age group between 15-44 was significantly associated with developing TB disease among household contacts. Conclusion Active screening among household contacts is an effective way to improve TB case detection. The yield for new TB cases among contacts with abnormal x-ray was high in this study and the use of Chest X-rays in combination with symptom screen is recommended.	[Nair, Dina; Klinton, Joel Shyam; Watson, Basilea; Velayutham, Banurekha; Jawahar, Mohideen Shaheed] Natl Inst Res TB, Madras, Tamil Nadu, India; [Rajshekhar, Nandita] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Tripathy, Jaya Prasad] Union South East Asia Off, Int Union TB & Lung Dis, New Delhi, India; [Swaminathan, Soumya] Indian Council Med Res, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Columbia University; Indian Council of Medical Research (ICMR)	Nair, D (corresponding author), Natl Inst Res TB, Madras, Tamil Nadu, India.	dinanair73@yahoo.co.in	Watson, Basilea/AGH-6965-2022					Bustamante J, 2014, SEMIN IMMUNOL, V26, P454, DOI 10.1016/j.smim.2014.09.008; Central TB Division, 2005, TECHN OP GUID TUB CO; Duarte R, 2011, REV PORT PNEUMOL, V17, P15; Fok A, 2008, INT J TUBERC LUNG D, V12, P480; Gonzalez-Ochoa E, 2009, TROP MED INT HEALTH, V14, P131, DOI 10.1111/j.1365-3156.2008.02201.x; Greenaway C, 2003, INT J TUBERC LUNG D, V7, pS479; Harries AD, 1997, T ROY SOC TROP MED H, V91, P416, DOI 10.1016/S0035-9203(97)90262-5; Hsu YH, 2006, J FORMOS MED ASSOC, V105, P363, DOI 10.1016/S0929-6646(09)60131-5; Jia ZW, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-64; Kenyon TA, 1996, NEW ENGL J MED, V334, P933, DOI 10.1056/NEJM199604113341501; Khaparde Kshitij, 2015, Tuberc Res Treat, V2015, P670167, DOI 10.1155/2015/670167; Kuaban C, 1996, Med Trop (Mars), V56, P156; Lee KW, 2000, RADIOLOGY, V214, P831, DOI 10.1148/radiology.214.3.r00mr05831; Lienhardt C, 2003, PEDIATRICS, V111, pE608, DOI 10.1542/peds.111.5.e608; Lienhardt C, 2001, EPIDEMIOL REV, V23, P288, DOI 10.1093/oxfordjournals.epirev.a000807; Liu EY, 2010, J PUBLIC HEALTH-UK, V32, P461, DOI 10.1093/pubmed/fdq032; Rieder HL, 2003, INT J TUBERC LUNG D, V7, pS333; Suggaravetsiri P, 2003, INT J TUBERC LUNG D, V7, pS424; van't Hoog AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038691; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120; WHO, 2015, ANTIMICROBIAL RESIST; WHO/APOC/MG/12.2, 2012, WHOAPOCMG122 AOPC, P28; World Health Organisation, END TB STRAT GLOB ST; World Health Organization, 2013, SYST SCREEN ACT TUB; Yim JJ, 2010, RESPIROLOGY, V15, P241, DOI 10.1111/j.1440-1843.2009.01690.x; Zachariah R, 2003, INT J TUBERC LUNG D, V7, P1033	26	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162090	10.1371/journal.pone.0162090	http://dx.doi.org/10.1371/journal.pone.0162090			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583974	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000382855600101
J	Sujon, MK; Alam, MK; Rahman, SA				Sujon, Mamun Khan; Alam, Mohammad Khursheed; Rahman, Shaifulizan Abdul			Prevalence of Third Molar Agenesis: Associated Dental Anomalies in Non-Syndromic 5923 Patients	PLOS ONE			English	Article							3RD-MOLAR AGENESIS; HYPODONTIA; TEETH; REDUCTION; DENTITION; ABSENCE; PATTERN; GROWTH; PEOPLE; SIZE	The aim of this study was to investigate the prevalence of third molar agenesis and other associated dental anomalies in Bangladeshi population and to investigate the relationship of other dental anomalies with the third molar presence/agenesis. A retrospective study was performed using panoramic radiographs of 5923 patients, who ranged in age from 10 to 50 years. All radiographs were analyzed by Planmeca Romexis (R) 3.0 software (Planmeca Oy, Helsinki, Finland). Pearson chi-square and one way ANOVA (Post Hoc) test were conducted. The prevalence of third molar agenesis was 38.4%. The frequency of third molar agenesis was significantly higher in females than males (p < 0.025). Third molar agenesis was significantly more prevalent in maxilla as compared to mandible (p < 0.007). The prevalence of other dental anomalies was 6.5%, among them hypodontia was 3.1%. Prevalence of third molar agenesis varies in different geographic region. Among the other dental anomalies hypodontia was more prevalent.	[Sujon, Mamun Khan; Alam, Mohammad Khursheed] Univ Sains Malaysia, Orthodont Unit, Sch Dent Sci, Kota Baharu 16150, Kelantan, Malaysia; [Rahman, Shaifulizan Abdul] Univ Sains Malaysia, Oral & Maxillofacial Surg, Sch Dent Sci, Kota Baharu 16150, Kelantan, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia	Alam, MK (corresponding author), Univ Sains Malaysia, Orthodont Unit, Sch Dent Sci, Kota Baharu 16150, Kelantan, Malaysia.	dralam@gmail.com	SUJON, MAMUN KHAN/AAD-8637-2019; alam, mohammed/GXH-3645-2022; Alam, Mohammad Khursheed/D-3062-2012; Alam, Mohammad/GQR-2648-2022	Alam, Mohammad Khursheed/0000-0001-7131-1752; Sujon, Mamun Khan/0000-0002-4159-9692	USM Grant (RU-Grant) by Universiti Sains Malaysia [1001/PPSG/812154]	USM Grant (RU-Grant) by Universiti Sains Malaysia	Sujon Mamun Khan has been awarded USM fellowship and is thankful for the financial support provided throughout his studies and we also grateful to USM Grant (RU-Grant 1001/PPSG/812154) by Universiti Sains Malaysia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed GS, 2007, ARCH ORAL BIOL, V52, P1018, DOI 10.1016/j.archoralbio.2007.05.008; Alam MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101157; Baba-Kawano S, 2002, ANGLE ORTHOD, V72, P112; Bianchi FJ, 2007, J APPL ORAL SCI, V15, P382, DOI 10.1590/S1678-77572007000500002; BISHARA SE, 1983, AM J ORTHOD DENTOFAC, V83, P131, DOI 10.1016/S0002-9416(83)90298-1; Cameron J, 1996, AUST DENT J, V41, P1, DOI 10.1111/j.1834-7819.1996.tb05645.x; Carter K, 2015, J DENT RES, V94, P886, DOI 10.1177/0022034515581644; Celikoglu M, 2011, AM J ORTHOD DENTOFAC, V140, P856, DOI 10.1016/j.ajodo.2011.05.021; Celikoglu M, 2010, J ORAL MAXIL SURG, V68, P990, DOI 10.1016/j.joms.2009.07.063; ENDO Y, 1994, PHYSIOL BEHAV, V56, P629, DOI 10.1016/0031-9384(94)90217-8; Garcia-Hernandez F, 2008, INT J MORPHOL, V26, P825, DOI 10.4067/S0717-95022008000400008; Garib DG, 2009, ANGLE ORTHOD, V79, P436, DOI 10.2319/021308-87.1; GARN SM, 1962, J DENT RES, V41, P717, DOI 10.1177/00220345620410033001; GARN SM, 1970, ANGLE ORTHOD, V40, P51; Gravely J F, 1965, Br Dent J, V119, P397; Hamasha AA, 2002, INT ENDOD J, V35, P910, DOI 10.1046/j.1365-2591.2002.00593.x; Harris EF, 2008, AM J ORTHOD DENTOFAC, V134, P761, DOI 10.1016/j.ajodo.2006.12.019; John J, 2012, J DENT SCI, V7, P211, DOI 10.1016/j.jds.2012.05.002; KEENE HJ, 1964, AM J ORTHOD DENTOFAC, V50, P445, DOI 10.1016/0002-9416(64)90207-6; Kiliaridis S, 2006, SEMIN ORTHOD, V12, P110, DOI DOI 10.1053/J.SODO.2006.01.004; Leco Berrocal MI, 2007, MED ORAL PATOL ORAL, V12, P134; Lee SH, 2009, FORENSIC SCI INT, V188, P107, DOI 10.1016/j.forsciint.2009.03.033; Massier M, 1941, AM J DIS CHILD, V62, P33; Mok Y. Y., 1996, Annals Academy of Medicine Singapore, V25, P828; Mostowska A, 2003, EUR J ORAL SCI, V111, P365, DOI 10.1034/j.1600-0722.2003.00069.x; NANDA RS, 1954, AM J ORTHOD DENTOFAC, V40, P698, DOI 10.1016/0002-9416(54)90058-5; Nomura R, 2003, J DENT RES, V82, P786, DOI 10.1177/154405910308201005; Ochoa BK, 2004, AM J ORTHOD DENTOFAC, V125, P148, DOI 10.1016/j.ajodo.2003.03.008; Poulsen S, 2013, PEDIAT DENT CLIN APP, P191; Rozkovcova E, 2004, Prague Med Rep, V105, P35; Sandhu S, 2005, J ORAL MAXIL SURG, V63, P640, DOI 10.1016/j.joms.2004.12.014; SHAH RM, 1979, J DENT RES, V58, P544, DOI 10.1177/00220345790580012201; Shinn D L, 1976, J Dent, V4, P42, DOI 10.1016/0300-5712(76)90069-5; Silvestri AR, 2004, J AM DENT ASSOC, V135, P1397, DOI 10.14219/jada.archive.2004.0049; YAMADA K, 1991, ARCH ORAL BIOL, V36, P129, DOI 10.1016/0003-9969(91)90075-6	35	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0162070	10.1371/journal.pone.0162070	http://dx.doi.org/10.1371/journal.pone.0162070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580050	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877400056
J	Humanes, A; Noonan, SHC; Willis, BL; Fabricius, KE; Negri, AP				Humanes, Adriana; Noonan, Sam H. C.; Willis, Bette L.; Fabricius, Katharina E.; Negri, Andrew P.			Cumulative Effects of Nutrient Enrichment and Elevated Temperature Compromise the Early Life History Stages of the Coral Acropora tenuis	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SCLERACTINIAN CORAL; SUSPENDED SEDIMENTS; WATER-QUALITY; FERTILIZATION SUCCESS; REDUCES SURVIVORSHIP; MILLEPORA EHRENBERG; LARVAL DEVELOPMENT; CLIMATE-CHANGE; HEAT-STRESS	Inshore coral reefs are experiencing the combined pressures of excess nutrient availability associated with coastal activities and warming seawater temperatures. Both pressures are known to have detrimental effects on the early life history stages of hard corals, but studies of their combined effects on early demographic stages are lacking. We conducted a series of experiments to test the combined effects of nutrient enrichment (three levels) and elevated seawater temperature (up to five levels) on early life history stages of the inshore coral Acropora tenuis, a common species in the Indo-Pacific and Red Sea. Gamete fertilization, larval survivorship and larval settlement were all significantly reduced as temperature increased, but only fertilization was further affected by simultaneous nutrient enrichment. Combined high temperatures and nutrient enrichment affected fertilization in an additive manner, whereas embryo abnormalities increased synergistically. Higher than normal temperatures (32 degrees C) increased coral juvenile growth rates 1.6-fold, but mortality also increased by 50%. The co-occurrence of nutrient enrichment with high temperatures reduced juvenile mortality to 36%, ameliorating temperature stress (antagonistic interaction). Overall, the types of effect (additive vs synergistic or antagonistic) and their magnitude varied among life stages. Gamete and embryo stages were more affected by temperature stress and, in some cases, also by nutrient enrichment than juveniles. The data suggest that coastal runoff events might exacerbate the impacts of warming temperatures on fertilization if these events co-occur during corals spawning. The cumulative impacts of simultaneous exposure to nutrient enrichment and elevated temperatures over all early life history stages increases the likelihood for failure of larval supply and recruitment for this coral species. Our results suggest that improving the water quality of river discharges into coastal areas might help to enhance the thermal tolerances of early life history stages in this common coral species.	[Humanes, Adriana; Willis, Bette L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Humanes, Adriana; Willis, Bette L.] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld, Australia; [Humanes, Adriana; Noonan, Sam H. C.; Fabricius, Katharina E.; Negri, Andrew P.] Australian Inst Marine Sci, Townsville, Qld, Australia	James Cook University; James Cook University; Australian Institute of Marine Science	Humanes, A (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia.; Humanes, A (corresponding author), James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld, Australia.; Humanes, A (corresponding author), Australian Inst Marine Sci, Townsville, Qld, Australia.	adrihumanes@gmail.com	Negri, Andrew P/G-9909-2017; Fabricius, Katharina/F-1759-2010	Negri, Andrew P/0000-0003-1388-7395; Noonan, Sam/0000-0002-0392-6197; Fabricius, Katharina/0000-0001-7671-4358	Australian Institute of Marine Science the Australian Government's National Environmental Research Program; Australian Government's National Environmental Science Programme; AIMS@JCU; Australian Research Council through AusAID	Australian Institute of Marine Science the Australian Government's National Environmental Research Program; Australian Government's National Environmental Science Programme(Australian Government); AIMS@JCU; Australian Research Council through AusAID(Australian Research Council)	This study was funded by the Australian Institute of Marine Science the Australian Government's National Environmental Research Program and the Australian Government's National Environmental Science Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Adriana Humanes also expresses gratitude for financial support from AIMS@JCU and to the Australian Research Council for support through AusAID.; We would like to thank Paul O'Brien, Manuela Giammusso and Cesar Herrera for assistance with experimental work. This study was funded by the Australian Institute of Marine Science the Australian Government's National Environmental Research Program and the Australian Government's National Environmental Science Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Adriana Humanes also expresses gratitude for financial support from AIMS@JCU and to the Australian Research Council for support through AusAID. The authors also acknowledge the contribution by C. Orejas and three anonymous referee, whose helpful reviews improved the manuscript.	Angly FE, 2016, PEERJ, V4, DOI 10.7717/peerj.1511; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Arrigo KR, 2005, NATURE, V5, P437; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Ball EE, 2002, INT J DEV BIOL, V46, P671; Ban SS, 2014, EVIDENCE MULTIPLE ST; Bartolini F, 2013, GLOBAL CHANGE BIOL, V19, P373, DOI 10.1111/gcb.12050; Bassim KM, 2003, MAR BIOL, V142, P241, DOI 10.1007/S00227-002-0953-z; Bassim KM, 2002, MAR BIOL, V140, P479, DOI 10.1007/s00227-001-0722-4; Berkelmans R, 1999, SEASONAL LOCAL SPATI; Bongiorni L, 2003, MAR ECOL PROG SER, V253, P137, DOI 10.3354/meps253137; Brodie J, 2010, MAR FRESHWATER RES, V61, P651, DOI 10.1071/MF08030; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Bryson S, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00027-15; Burke J, 2011, GUARDIAN 0228; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Caldwell GS, 2005, MAR ENVIRON RES, V59, P405, DOI 10.1016/j.marenvres.2004.06.005; Chua CM, 2013, MAR ECOL PROG SER, V475, P85, DOI 10.3354/meps10077; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Cunning R, 2015, CORAL REEFS, V34, P155, DOI 10.1007/s00338-014-1216-4; Cunning R, 2013, NAT CLIM CHANGE, V3, P259, DOI [10.1038/NCLIMATE1711, 10.1038/nclimate1711]; De'ath G, 2010, ECOL APPL, V20, P840, DOI 10.1890/08-2023.1; Devlin M, 2001, GBRMPA RES PUBLICATI, V68; Devlin MJ, 2005, MAR POLLUT BULL, V51, P9, DOI 10.1016/j.marpolbul.2004.10.037; Edmunds PJ, 2011, J EXP BIOL, V214, P2783, DOI 10.1242/jeb.055343; Edmunds PJ, 2005, OECOLOGIA, V146, P350, DOI 10.1007/s00442-005-0210-5; Edmunds PJ, 2004, MAR ECOL PROG SER, V269, P111, DOI 10.3354/meps269111; Edmunds PJ, 2001, MAR BIOL, V139, P981; Fabricius K, 2005, MAR POLLUT BULL, V51, P384, DOI 10.1016/j.marpolbul.2004.10.041; Fabricius KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054399; Fabricius KE, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P493, DOI 10.1007/978-94-007-0114-4_28; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fabricius KE, 2003, ESTUAR COAST SHELF S, V57, P613, DOI 10.1016/S0272-7714(02)00400-6; Fabricius KE, 2014, EFFECTS RIVER RUN OF; Ferrier-Pages C, 2000, CORAL REEFS, V19, P103, DOI 10.1007/s003380000078; Figueiredo J, 2014, NAT CLIM CHANGE, V4, P498, DOI 10.1038/NCLIMATE2210; Folt CL, 1999, LIMNOL OCEANOGR, V44, P864, DOI 10.4319/lo.1999.44.3_part_2.0864; Furnas M., 2003, CATCHMENTS CORALS TE; GESAMP, 2001, PROT OC LAND BAS ACT; Grossart HP, 2001, LIMNOL OCEANOGR, V46, P267, DOI 10.4319/lo.2001.46.2.0267; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Harrison P.L., 2000, 9 INT COR REEF S, V1, P409; Harrison PL, 2001, MAR BIOL, V139, P1057; Heyward AJ, 2010, CORAL REEFS, V29, P631, DOI 10.1007/s00338-009-0578-5; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hoegh-Guldberg O, 2011, REG ENVIRON CHANGE, V11, pS215, DOI 10.1007/s10113-010-0189-2; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Houlbreque F, 2003, J EXP MAR BIOL ECOL, V296, P145, DOI 10.1016/S0022-0981(03)00259-4; Howells EJ, 2012, NAT CLIM CHANGE, V2, P116, DOI 10.1038/NCLIMATE1330; Humphrey C, 2008, CORAL REEFS, V27, P837, DOI 10.1007/s00338-008-0408-1; Jones A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010437; Jones Alison M., 2011, Journal of Marine Biology, V2011, P1; Jones RJ, 1999, MAR POLLUT BULL, V38, P864, DOI 10.1016/S0025-326X(98)90160-6; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Keith SA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0011; Kroon FJ, 2012, MAR POLLUT BULL, V65, P167, DOI 10.1016/j.marpolbul.2011.10.018; Lam EKY, 2015, CORAL REEFS, V34, P837, DOI 10.1007/s00338-015-1317-8; Lincoln R.J., 1998, DICT ECOLOGY EVOLUTI, V2nd ed; Marshall DJ, 2006, MAR POLLUT BULL, V52, P734, DOI 10.1016/j.marpolbul.2006.05.005; Marubini F, 1996, MAR BIOL, V127, P319, DOI 10.1007/BF00942117; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; Meissner KJ, 2012, CORAL REEFS, V31, P309, DOI 10.1007/s00338-011-0866-8; Michalek-Wagner K, 2001, CORAL REEFS, V19, P231, DOI 10.1007/s003380170003; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Negri AP, 2007, CORAL REEFS, V26, P759, DOI 10.1007/s00338-007-0258-2; Negri AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019703; Negri AP, 2000, MAR POLLUT BULL, V41, P420, DOI 10.1016/S0025-326X(00)00139-9; Nogales B, 2011, FEMS MICROBIOL REV, V35, P275, DOI 10.1111/j.1574-6976.2010.00248.x; Nozawa Y, 2007, MAR BIOL, V152, P1181, DOI 10.1007/s00227-007-0765-2; Omori M, 2001, LIMNOL OCEANOGR, V46, P704, DOI 10.4319/lo.2001.46.3.0704; Portune KJ, 2010, MAR GENOM, V3, P51, DOI 10.1016/j.margen.2010.03.002; Ralph P. J., 2007, Toxicological and Environmental Chemistry, V89, P589, DOI 10.1080/02772240701561593; Randall CJ, 2009, CORAL REEFS, V28, P537, DOI 10.1007/s00338-009-0482-z; Ricardo GF, 2015, SCI REP-UK, V5, DOI 10.1038/srep18084; Ritson-Williams Raphael, 2009, Smithsonian Contributions to the Marine Sciences, P437; Sawall Y, 2011, CORAL REEFS, V30, P841, DOI 10.1007/s00338-011-0764-0; Sawall Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039951; Schaffelke B, 2012, MAR POLLUT BULL, V65, P249, DOI 10.1016/j.marpolbul.2011.10.031; Schnitzler CE, 2012, MAR BIOL, V159, P633, DOI 10.1007/s00227-011-1842-0; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Takahashi S, 2004, PLANT CELL PHYSIOL, V45, P251, DOI 10.1093/pcp/pch028; Thiyagarajan V, 2003, J EXP MAR BIOL ECOL, V287, P223, DOI 10.1016/S0022-0981(02)00570-1; Thurber RLV, 2014, GLOBAL CHANGE BIOL, V20, P544, DOI 10.1111/gcb.12450; Voolstra CR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-627; Waters D.K., 2014, TECHNICAL REPORT; Weber M, 2012, P NATL ACAD SCI USA, V109, pE1558, DOI 10.1073/pnas.1100715109; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; Wieczorek SK, 1998, BIOFOULING, V12, P81, DOI 10.1080/08927019809378348; Wiedenmann J, 2013, NAT CLIM CHANGE, V3, P160, DOI 10.1038/NCLIMATE1661; Willis BL, 1997, CORAL REEFS, V16, pS53, DOI 10.1007/s003380050242; Woolsey ES, 2015, CORAL REEFS, V34, P471, DOI 10.1007/s00338-014-1253-z	95	36	37	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161616	10.1371/journal.pone.0161616	http://dx.doi.org/10.1371/journal.pone.0161616			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575699	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000382877200030
J	Shlyueva, D; Meireles, ACA; Pagani, M; Stark, A				Shlyueva, Daria; Meireles-Filho, Antonio C. A.; Pagani, Michaela; Stark, Alexander			Genome-Wide Ultrabithorax Binding Analysis Reveals Highly Targeted Genomic Loci at Developmental Regulators and a Potential Connection to Polycomb-Mediated Regulation	PLOS ONE			English	Article							HOMEOTIC GENE-CONTROL; CELL-CYCLE; TRANSCRIPTION FACTORS; RESPONSE ELEMENTS; GROUP PROTEINS; ENDS-OUT; DROSOPHILA; HOX; EXPRESSION; COMPLEX	Hox homeodomain transcription factors are key regulators of animal development. They specify the identity of segments along the anterior-posterior body axis in metazoans by controlling the expression of diverse downstream targets, including transcription factors and signaling pathway components. The Drosophila melanogaster Hox factor Ultrabithorax (Ubx) directs the development of thoracic and abdominal segments and appendages, and loss of Ubx function can lead for example to the transformation of third thoracic segment appendages (e.g. halters) into second thoracic segment appendages (e.g. wings), resulting in a characteristic four-wing phenotype. Here we present a Drosophila melanogaster strain with a V5-epitope tagged Ubx allele, which we employed to obtain a high quality genome-wide map of Ubx binding sites using ChIP-seq. We confirm the sensitivity of the V5 ChIP-seq by recovering 7/8 of well-studied Ubx-dependent cis-regulatory regions. Moreover, we show that Ubx binding is predictive of enhancer activity as suggested by comparison with a genome-scale resource of in vivo tested enhancer candidates. We observed densely clustered Ubx binding sites at 12 extended genomic loci that included ANTP-C, BX-C, Polycomb complex genes, and other regulators and the clustered binding sites were frequently active enhancers. Furthermore, Ubx binding was detected at known Polycomb response elements (PREs) and was associated with significant enrichments of Pc and Pho ChIP signals in contrast to binding sites of other developmental TFs. Together, our results show that Ubx targets developmental regulators via strongly clustered binding sites and allow us to hypothesize that regulation by Ubx might involve Polycomb group proteins to maintain specific regulatory states in cooperative or mutually exclusive fashion, an attractive model that combines two groups of proteins with prominent gene regulatory roles during animal development.	[Shlyueva, Daria; Meireles-Filho, Antonio C. A.; Pagani, Michaela; Stark, Alexander] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Vienna, Austria; [Shlyueva, Daria] Univ Copenhagen, Biotech Res & Innovat Ctr, Fac Hlth & Med Sci, Copenhagen, Denmark; [Meireles-Filho, Antonio C. A.] Ecole Polytech Fed Lausanne, Lab Syst Biol & Genet, Lausanne, Switzerland	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Copenhagen; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Stark, A (corresponding author), Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Vienna, Austria.	stark@starklab.org	Stark, Alexander/D-1473-2012; Meireles-Filho, Antonio/E-5550-2014	Stark, Alexander/0000-0003-2611-0841; Meireles-Filho, Antonio/0000-0001-5853-9197; Shlyueva, Daria/0000-0002-8990-0843	Boehringer Ingelheim; Austrian Research Promotion Agency (FFG); Austrian Science Fund (FWF) [F4303-B09]; European Research Council (ERC) [242922]	Boehringer Ingelheim(Boehringer Ingelheim); Austrian Research Promotion Agency (FFG); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council (ERC)(European Research Council (ERC))	Research in the laboratory of AS is supported by Boehringer Ingelheim (www.boehringer-ingelheim.com), the Austrian Research Promotion Agency (FFG, www.ffg.at) and the Austrian Science Fund (FWF, F4303-B09, www.fwf.ac.at). DS was supported by a European Research Council starting grant (ERC, no. 242922, www.erc.europa.eu) awarded to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold CD, 2013, GENOME WIDE QUANTITA; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Bardet AF, 2013, BIOINFORMATICS, V29, P2705, DOI 10.1093/bioinformatics/btt470; Beck S, 2010, ADV EXP MED BIOL, V689, P41; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; BIENZ M, 1988, CELL, V53, P567, DOI 10.1016/0092-8674(88)90573-9; Biggin MD, 1997, DEVELOPMENT, V124, P4425; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bonn S, 2012, NAT PROTOC, V7, P978, DOI 10.1038/nprot.2012.049; BOULET AM, 1988, GENE DEV, V2, P1600, DOI 10.1101/gad.2.12a.1600; Calgaro S, 2002, GENETICS, V160, P547; CAPOVILLA M, 1994, CELL, V76, P461, DOI 10.1016/0092-8674(94)90111-2; Choo SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014778; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Down TA, 2007, PLOS COMPUT BIOL, V3, P95, DOI 10.1371/journal.pcbi.0030007; Galant R, 2002, DEVELOPMENT, V129, P3115; Garaulet DL, 2008, DEVELOPMENT, V135, P3219, DOI 10.1242/dev.025809; Gebelein B, 2004, NATURE, V431, P653, DOI 10.1038/nature02946; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; GOULD AP, 1990, NATURE, V348, P308, DOI 10.1038/348308a0; GOULD AP, 1992, DEVELOPMENT, V116, P1163; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Gutierrez L, 2003, DEVELOPMENT, V130, P343, DOI 10.1242/dev.00222; HAFEN E, 1984, NATURE, V307, P287, DOI 10.1038/307287a0; HINZ U, 1992, DEVELOPMENT, V116, P543; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Huang J, 2008, GENETICS, V180, P703, DOI 10.1534/genetics.108.090563; Hueber SD, 2008, BIOESSAYS, V30, P965, DOI 10.1002/bies.20823; Hueber SD, 2007, DEVELOPMENT, V134, P381, DOI 10.1242/dev.02746; KAUFMAN TC, 1980, GENETICS, V94, P115; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kuhnlein RP, 1997, MECH DEVELOP, V66, P107, DOI 10.1016/S0925-4773(97)00103-2; Kurant E, 1998, DEVELOPMENT, V125, P1037; Kvon EZ, 2014, NATURE, V512, P91, DOI 10.1038/nature13395; Kvon EZ, 2012, GENE DEV, V26, P908, DOI 10.1101/gad.188052.112; Kwong C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000178; Langmead B., 2009, GENOME BIOL; Leonid TB, 2013, P NATL ACAD SCI USA, V110, P18602, DOI 10.1073/pnas.1316064110; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Lohmann I, 2002, CELL, V110, P457, DOI 10.1016/S0092-8674(02)00871-1; Lopez A, 2001, MOL GENET GENOMICS, V266, P572, DOI 10.1007/s004380100572; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; MCCORMICK AM, 1995, DEVELOPMENT, V121, P2799; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Meireles ACA, 2014, CURR BIOL, V24, P1, DOI 10.1016/j.cub.2013.11.017; Mohit P, 2006, DEV BIOL, V291, P356, DOI 10.1016/j.ydbio.2005.12.022; MULLER J, 1989, EMBO J, V8, P4143, DOI 10.1002/j.1460-2075.1989.tb08599.x; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Park D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083506; Pavlopoulos A, 2011, P NATL ACAD SCI USA, V108, P2855, DOI 10.1073/pnas.1015077108; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Poorey K, 2013, SCIENCE, V342, P369, DOI 10.1126/science.1242369; Ringrose L, 2003, DEV CELL, V5, P759, DOI 10.1016/S1534-5807(03)00337-X; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Salvaing J, 2003, NUCLEIC ACIDS RES, V31, P2873, DOI 10.1093/nar/gkg381; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Scuderi A, 2006, DEV BIOL, V291, P110, DOI 10.1016/j.ydbio.2005.12.014; Slattery M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014686; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Sorge S, 2012, EMBO J; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Steffen PA, 2014, NAT REV MOL CELL BIO, V15, P340, DOI 10.1038/nrm3789; Strubbe G, 2011, P NATL ACAD SCI USA, V108, P5572, DOI 10.1073/pnas.1007916108; STRUHL G, 1982, P NATL ACAD SCI-BIOL, V79, P7380, DOI 10.1073/pnas.79.23.7380; Struhl G., 1981, HOMOEOTIC MUTATION T; STRUTT DI, 1994, MECH DEVELOP, V46, P27, DOI 10.1016/0925-4773(94)90035-3; Tomancak P, 2002, GENOME BIOL, V3, P88, DOI 10.1186/gb-2002-3-12-research0088; Tseng ASK, 2002, GENETICS, V162, P229; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474; Weihe U, 2004, DEVELOPMENT, V131, P767, DOI 10.1242/dev.00979; Yanez-Cuna JO, 2014, GENOME RES, V24, P1147, DOI 10.1101/gr.169243.113; Yanez-Cuna JO, 2012, GENOME RES, V22, P2018, DOI 10.1101/gr.132811.111; Zabidi MA, 2015, NATURE, V518, P556, DOI 10.1038/nature13994; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	84	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161997	10.1371/journal.pone.0161997	http://dx.doi.org/10.1371/journal.pone.0161997			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575958	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877200053
J	Koenig, S; Wolf, R; Heisenberg, M				Koenig, Sebastian; Wolf, Reinhard; Heisenberg, Martin			Visual Attention in Flies-Dopamine in the Mushroom Bodies Mediates the After-Effect of Cueing	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; LOCOMOTOR-ACTIVITY; FLIGHT ORIENTATION; FINE-STRUCTURE; YAW TORQUE; LONG-TERM; RECEPTOR; BODY; CATECHOLAMINES; HYPERACTIVITY	Visual environments may simultaneously comprise stimuli of different significance. Often such stimuli require incompatible responses. Selective visual attention allows an animal to respond exclusively to the stimuli at a certain location in the visual field. In the process of establishing its focus of attention the animal can be influenced by external cues. Here we characterize the behavioral properties and neural mechanism of cueing in the fly Drosophila melanogaster. A cue can be attractive, repulsive or ineffective depending upon (e.g.) its visual properties and location in the visual field. Dopamine signaling in the brain is required to maintain the effect of cueing once the cue has disappeared. Raising or lowering dopamine at the synapse abolishes this after-effect. Specifically, dopamine is necessary and sufficient in the alpha beta-lobes of the mushroom bodies. Evidence is provided for an involvement of the alpha beta(posterior) Kenyon cells.	[Koenig, Sebastian; Wolf, Reinhard; Heisenberg, Martin] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Joseph Schneider Str 2, D-97080 Wurzburg, Germany	University of Wurzburg	Heisenberg, M (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Joseph Schneider Str 2, D-97080 Wurzburg, Germany.	heisenberg@biozentrum.uni-wuerzburg.de			Rudolf-Virchow-Center; German Science Foundation; Rudolf Virchow Center;  [HE 986/20-1]	Rudolf-Virchow-Center; German Science Foundation(German Research Foundation (DFG)); Rudolf Virchow Center; 	This work was supported by the Rudolf-Virchow-Center and German Science Foundation, Reinhart Koselleck HE 986/20-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Rudolf Virchow Center and German Science Foundation, Reinhart Koselleck HE 986/20-1. We thank A. Haberberger (Rudolf-Virchow-Center) and S. Clemens-Richter (Department of Neurobiology and Genetics) for help with fly maintenance and experiments, K. Oechsner and H. Kaderschabek (Biocenter, University of Wurzburg) for technical support, M. Krischke (University of Wurzburg)for the HPLC measurements and J. Dubnau (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY), B. Gerber (Leibniz Institute for Neurobiology, Magdeburg, Germany), K. Kume (Nagoya University, Nagoya, Japan) and Scott Waddell (Oxford University, UK) for fly stocks. We thank the two reviewers for their constructive criticism.	AMALRIC M, 1995, EUR J NEUROSCI, V7, P972, DOI 10.1111/j.1460-9568.1995.tb01085.x; Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04577; Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Calipari ES, 2013, EUR J NEUROSCI, V38, P3749, DOI 10.1111/ejn.12381; Cools R, 2004, PHILOS T R SOC A, V362, P2871, DOI 10.1098/rsta.2004.1468; Cragg SJ, 2004, TRENDS NEUROSCI, V27, P270, DOI 10.1016/j.tins.2004.03.011; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Draper I, 2007, DEV NEUROBIOL, V67, P378, DOI 10.1002/dneu.20355; Elia J, 1999, NEW ENGL J MED, V340, P780, DOI 10.1056/NEJM199903113401007; Feng GP, 1996, J NEUROSCI, V16, P3925; HEISENBERG M, 1979, J COMP PHYSIOL, V130, P113, DOI 10.1007/BF00611046; Heisenberg M., 1984, VISION DROSOPHILA GE; Heisenberg M, 2015, LEARN MEMORY, V22, DOI 10.1101/lm.037481.114; Iversen SD, 2007, TRENDS NEUROSCI, V30, P188, DOI 10.1016/j.tins.2007.03.002; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Karpova E K, 2012, Genetika, V48, P999; Kim YC, 2003, GENE EXPR PATTERNS, V3, P237, DOI 10.1016/S1567-133X(02)00098-4; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; Koenig S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148208; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; Martin JR, 1998, LEARN MEMORY, V5, P179; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Perisse E, 2013, NEURON, V79, P945, DOI 10.1016/j.neuron.2013.07.045; Porzgen P, 2001, MOL PHARMACOL, V59, P83; Sareen P, 2011, P NATL ACAD SCI USA, V108, P7230, DOI 10.1073/pnas.1102522108; Seugnet L, 2008, CURR BIOL, V18, P1110, DOI 10.1016/j.cub.2008.07.028; Solanki N, 2015, J NEUROGENET, V29, P30, DOI 10.3109/01677063.2014.1002661; Srivastava DP, 2005, J NEUROSCI, V25, P6145, DOI 10.1523/JNEUROSCI.1005-05.2005; SUGAMORI KS, 1995, FEBS LETT, V362, P131, DOI 10.1016/0014-5793(95)00224-W; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; Tang SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014455; Tang SM, 2004, SCIENCE, V305, P1020, DOI 10.1126/science.1099839; Ueno T, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00303; van Swinderen B, 2011, INT REV NEUROBIOL, V99, P51, DOI 10.1016/B978-0-12-387003-2.00003-3; Van Swinderen B, 2011, P ROY SOC B-BIOL SCI, V278, P906, DOI 10.1098/rspb.2010.2564; van Swinderen B, 2010, J NEUROSCI, V30, P1003, DOI 10.1523/JNEUROSCI.4516-09.2010; Vogt K, 2016, ELIFE, V5, DOI 10.7554/eLife.14009; Volkow ND, 2009, JAMA-J AM MED ASSOC, V302, P1084, DOI 10.1001/jama.2009.1308; Warren R. M., 1968, HELMHOLTZ PERCEPTION; WOLF R, 1980, J COMP PHYSIOL, V140, P69, DOI 10.1007/BF00613749; Xi W, 2008, EUR J NEUROSCI, V27, P1441, DOI 10.1111/j.1460-9568.2008.06114.x; Ye YZ, 2004, EUR J NEUROSCI, V20, P1001, DOI 10.1111/j.1460-9568.2004.03575.x	45	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161412	10.1371/journal.pone.0161412	http://dx.doi.org/10.1371/journal.pone.0161412			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571359	gold, Green Published, Green Submitted			2022-12-26	WOS:000382876700018
J	Williams, JAE; Stampoulis, D; Gunter, CE; Greenwood, J; Adamson, P; Moss, SE				Williams, Jennifer A. E.; Stampoulis, Dimitris; Gunter, Chloe E.; Greenwood, John; Adamson, Peter; Moss, Stephen E.			Regulation of C3 Activation by the Alternative Complement Pathway in the Mouse Retina	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; AGED MICE; FACTOR-B; DEFICIENCY; EXPRESSION; DRUSEN; COMMON	The purpose of this study was to examine the retinas of mice carrying hemizygous and null double deletions of Cfb(-/-) and Cfh(-/-), and to compare these with the single knockouts of Cfb, Cfh and Cfd. Retinas were isolated from wild type (WT), Cfb(-/-)/Cfh(-/-), Cfb(-/-)/Cfh(+/-), Cfh(-/-)/Cfb(+/-), Cfb(-/-), Cfh(-/-) Cfd(-/-), and Cfd(+/-) mice. Complement proteins were evaluated by western blotting, ELISA and immunocytochemistry, and retinal morphology was assessed using toluidine blue stained semi-thin sections. WT mice showed staining for C3 and its breakdown products in the retinal vasculature and the basal surface of the retinal pigment epithelium (RPE). Cfb(-/-) mice exhibited a similar C3 staining pattern to WT in the retinal vessels but a decrease in C3 and its breakdown products at the basal surface of the RPE. Deletion of both Cfb and Cfh restored C3 to levels similar to those observed in WT mice, however this reversal of phenotype was not observed in Cfh(-/-)/Cfb(+/-) or Cfb(-/-)/Cfh(+/-) mice. Loss of CFD caused an increase in C3 and a decrease in C3 breakdown products along the basal surface of the RPE. Overall the retinal morphology and retinal vasculature did not appear different across the various genotypes. We observed that C3 accumulates at the basal RPE in Cfb(-/-), Cfb(-/-)/Cfh(-/-), Cfb(-/-)/Cfh(+/-), Cfd(-/-) and WT mice, but is absent in Cfh(-/-) and Cfh(-/-)/Cfb(+/-) mice, consistent with its consumption in the serum of mice lacking CFH when CFB is present. C3 breakdown products along the surface of the RPE were either decreased or absent when CFB, CFH or CFD was deleted or partially deleted.	[Williams, Jennifer A. E.; Stampoulis, Dimitris; Gunter, Chloe E.; Greenwood, John; Moss, Stephen E.] UCL Inst Ophthalmol, Dept Cell Biol, 11-43 Bath St, London EC1V 9EL, England; [Adamson, Peter] GlaxoSmithKline, Med Res Ctr, Ophthiris Discovery Performance Unit, Gunnelswood Rd, Stevenage SG1 2NY, Herts, England; [Adamson, Peter] GlaxoSmithKline, Med Res Ctr, Dept Lab Anim Sci, Gunnelswood Rd, Stevenage SG1 2NY, Herts, England; [Adamson, Peter] ProQR Therapeut, Darwinweg 24, NL-2333 CR Leiden, Netherlands	University of London; University College London; GlaxoSmithKline; GlaxoSmithKline	Moss, SE (corresponding author), UCL Inst Ophthalmol, Dept Cell Biol, 11-43 Bath St, London EC1V 9EL, England.	s.moss@ucl.ac.uk		Moss, Stephen/0000-0002-7304-8879; Greenwood, John/0000-0003-4496-2984	GSK; Wellcome Trust [090669]	GSK(GlaxoSmithKline); Wellcome Trust(Wellcome TrustEuropean Commission)	The work was funded by an Educational Grant from GSK, and a project grant from the Wellcome Trust (090669).; We are grateful to Marieta Ruseva and Matthew Pickering from Imperial College London for help with the C3 ELISAs, Shannon Conder at UCL for help with cardiac puncture, and Matt Hayes and Peter Munro at the UCL IoO imaging facility, and we acknowledge GSK for an educational grant and the Wellcome Trust for financial support.	Agarwal A, 2015, CLIN OPHTHALMOL, V9, P1001, DOI [10.2147/OPTH.S59725, 10.2147/OPTH.S74959]; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Chen M, 2008, EXP EYE RES, V87, P543, DOI 10.1016/j.exer.2008.09.005; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Faber C, 2012, INVEST OPHTH VIS SCI, V53, P6324, DOI 10.1167/iovs.12-10385; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Jack LS, 2016, DEV OPHTHALMOL, V55, P302, DOI 10.1159/000438954; Kam JH, 2013, AM J PATHOL, V183, P480, DOI 10.1016/j.ajpath.2013.04.008; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Law AL, 2009, MOL BIOL CELL, V20, P3896, DOI 10.1091/mbc.E08-12-1204; Luo C, 2013, EXP EYE RES, V112, P93, DOI 10.1016/j.exer.2013.04.016; Lyzogubov VV, 2010, AM J PATHOL, V177, P1870, DOI 10.2353/ajpath.2010.091168; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Pickering MC, 2002, NAT GENET, V31, P424, DOI 10.1038/ng912; Ristau T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093459; Rohrer B, 2007, INVEST OPHTH VIS SCI, V48, P5282, DOI 10.1167/iovs.07-0282; Rohrer Barbel, 2011, Mol Immunol, V48, pe1, DOI 10.1016/j.molimm.2010.12.016; Schnabolk G, 2015, INVEST OPHTH VIS SCI, V56, P1850, DOI 10.1167/iovs.14-15910; Spencer KL, 2007, HUM MOL GENET, V16, P1986, DOI 10.1093/hmg/ddm146; von Leithner PL, 2009, AM J PATHOL, V175, P412, DOI 10.2353/ajpath.2009.080927; Warwick A, 2014, J CLIN MED, V3, P1234, DOI 10.3390/jcm3041234; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; Williams JAE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068616	25	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161898	10.1371/journal.pone.0161898	http://dx.doi.org/10.1371/journal.pone.0161898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564415	Green Published, gold, Green Submitted			2022-12-26	WOS:000382496300034
J	Abbasi, S; Afsharzadeh, S; Saeidi, H; Triest, L				Abbasi, Shabnam; Afsharzadeh, Saeed; Saeidi, Hojjatollah; Triest, Ludwig			Strong Genetic Differentiation of Submerged Plant Populations across Mountain Ranges: Evidence from Potamogeton pectinatus in Iran	PLOS ONE			English	Article							AQUATIC PLANT; SPECIES-DIVERSITY; CLONAL DIVERSITY; F-STATISTICS; L.; MACROPHYTE; SOFTWARE; CONSERVATION; DIVERGENCE; WATERFOWL	Biogeographic barriers for freshwater biota can be effective at various spatial scales. At the largest spatial scale, freshwater organisms can become genetically isolated by their high mountain ranges, vast deserts, and inability to cross oceans. Isolation by distance of aquatic plants is expected to be stronger across than alongside mountain ridges whereas the heterogeneity of habitats among populations and temporary droughts may influence connectivity and hamper dispersal. Suitable aquatic plant habitats became reduced, even for the widespread submerged Potamogeton pectinatus L. (also named Stuckenia pectinata) giving structure to various aquatic habitats. We compared the level of genetic diversity in a heterogeneous series of aquatic habitats across Iran and tested their differentiation over distances and across mountain ranges (Alborz and Zagros) and desert zones (Kavir), with values obtained from temperate region populations. The diversity of aquatic ecosystems across and along large geographic barriers provided a unique ecological situation within Iran. P. pectinatus were considered from thirty-six sites across Iran at direct flight distances ranging from 20 to 1,200 km. Nine microsatellite loci revealed a very high number of alleles over all sites. A PCoA, NJT clustering and STRUCTURE analysis revealed a separate grouping of individuals of southeastern Iranian sites and was confirmed by their different nuclear ITS and cpDNA haplotypes thereby indicating an evolutionary significant unit (ESU). At the level of populations, a positive correlation between allelic differentiation D-est with geographic distance was found. Individual-based STRUCTURE analysis over 36 sites showed 7 genetic clusters. F-ST and R-ST values for ten populations reached 0.343 and 0.521, respectively thereby indicating that allele length differences are more important and contain evolutionary information. Overall, higher levels of diversity and a stronger differentiation was revealed among Iranian P. pectinatus than previously observed for temperate European regions, due to regional differences across mountain ranges over long distances.	[Abbasi, Shabnam; Afsharzadeh, Saeed; Saeidi, Hojjatollah] Univ Isfahan, Fac Sci, Dept Biol, Esfahan 8174673441, Iran; [Triest, Ludwig] VUB, Dept Biol, Lab Plant Biol & Nat Management APNA, Pl Laan 2, B-1050 Brussels, Belgium	University of Isfahan; Vrije Universiteit Brussel	Afsharzadeh, S (corresponding author), Univ Isfahan, Fac Sci, Dept Biol, Esfahan 8174673441, Iran.	afshar144@yahoo.com		Triest, Ludwig/0000-0002-4946-9614	Department of Biology, University of Isfahan; VUB (Vrije Universiteit Brussel) in Belgium's research group APNA laboratory [BAS42]; Iran's Ministry of Science	Department of Biology, University of Isfahan; VUB (Vrije Universiteit Brussel) in Belgium's research group APNA laboratory; Iran's Ministry of Science	This work was supported by the Department of Biology, University of Isfahan as part of PhD thesis and the VUB (Vrije Universiteit Brussel) in Belgium's research group APNA laboratory for support in experimental work on microsatellites (BAS42). ShA was supported by a scholarship from Iran's Ministry of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Department of Biology, University of Isfahan for supporting this work and VUB (Vrije Universiteit Brussel) in Belgium, research group APNA laboratory for supports in experimental work on microsatellites (BAS42). The first author was supported by a scholarship from Iran's Ministry of Science.	Angelibert S, 2004, AQUAT CONSERV, V14, P439, DOI 10.1002/aqc.616; BarratSegretain MH, 1996, VEGETATIO, V123, P13, DOI 10.1007/BF00044885; BARRETT SCH, 1993, AQUAT BOT, V44, P105, DOI 10.1016/0304-3770(93)90068-8; Biggs J, 2005, AQUAT CONSERV, V15, P693, DOI 10.1002/aqc.745; Cox CB, 1980, BIOGEOGRAPHY ECOLOGI; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Daryadel E., 2014, WORLD ACAD SCI ENG T, V8, P2091, DOI DOI 10.1016/J.AQUABOT.2016.10.003; Demirezen D, 2004, CHEMOSPHERE, V56, P685, DOI 10.1016/j.chemosphere.2004.04.011; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Firouz E, 2000, WILDLIFE IRAN VERTEB; Fordyce JA, 2006, J EXP BIOL, V209, P2377, DOI 10.1242/jeb.02271; Gawel N.J., 1991, PLANT MOL BIOL REP, V9, P262, DOI [10.1007/BF02672076, DOI 10.1007/BF02672076]; Gilbert S., 2012, IMPACT DROUGHT COAST; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gratani L., 2014, ADV IN BOT, V2014, DOI [10.1155/2014/208747, DOI 10.1155/2014/208747]; Hahn TC, 2012, PLOS ONE, V7, P1; Hamrick J. L., 1989, PLANT POPULATION GEN, P43; Han QX, 2014, BIOCHEM SYST ECOL, V57, P60, DOI 10.1016/j.bse.2014.07.003; Hangelbroek HH, 2003, J ECOL, V91, P1081, DOI 10.1046/j.1365-2745.2003.00835.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hettiarachchi P., 1991, OPERA BOT BELG, V4, P87; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hollingsworth PM, 1996, PLANT SYST EVOL, V202, P233, DOI 10.1007/BF00983385; Jackrel SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142362; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kaplan Z, 2010, PRESLIA, V82, P261; KAUTSKY L, 1990, HOLARCTIC ECOL, V13, P143; King RA, 2002, MOL ECOL, V11, P1947, DOI 10.1046/j.1365-294X.2002.01600.x; Klaassen M, 2007, HYDROBIOLOGIA, V584, P205, DOI 10.1007/s10750-007-0598-5; Kropf M, 2006, NEW PHYTOL, V172, P169, DOI 10.1111/j.1469-8137.2006.01795.x; Lindqvist C, 2006, CLADISTICS, V22, P568, DOI 10.1111/j.1096-0031.2006.00124.x; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Lone P., 2013, INT J SCI RES PUBL, V3, P1; Lyu N, 2016, AQUAT BOT, V128, P41, DOI 10.1016/j.aquabot.2015.09.007; Mader E, 1998, AQUAT BOT, V62, P147, DOI 10.1016/S0304-3770(98)00096-5; MANTEL N, 1967, CANCER RES, V27, P209; Michalakis Y, 1996, GENETICS, V142, P1061; Miyan MA, 2015, WEATHER CLIM EXTREME, V7, P8, DOI 10.1016/j.wace.2014.06.003; Moyle P.B., 2004, INTRO ICHTHYOLOGY, V5th; Nies G, 2005, J EVOLUTION BIOL, V18, P19, DOI 10.1111/j.1420-9101.2004.00818.x; Nies G, 2004, MOL ECOL NOTES, V4, P563, DOI 10.1111/j.1471-8286.2004.00734.x; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Odat N, 2004, MOL ECOL, V13, P1251, DOI 10.1111/j.1365-294X.2004.02115.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pollux BJA, 2009, FRESHWATER BIOL, V54, P64, DOI 10.1111/j.1365-2427.2008.02100.x; Pritchard JK, 2000, GENETICS, V155, P945; Rahel FJ, 2007, FRESHWATER BIOL, V52, P696, DOI 10.1111/j.1365-2427.2006.01708.x; Ramsar, 2014, LIST WETL INT IMP; Ren DD, 2006, TOXICOL IN VITRO, V20, P1411, DOI 10.1016/j.tiv.2006.06.011; Ricklefs Robert E., 1993, P350; Rodriguez-Bonilla L, 2014, PLOS ONE, V9, P1; Rousset F, 1997, GENETICS, V145, P1219; Sandsten H, 2005, HYDROBIOLOGIA, V537, P239, DOI 10.1007/s10750-004-3077-2; Sehhatisabet Mohammad E., 2013, Podoces, V8, P22; Stoelting RE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116005; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Thiel-Egenter C, 2009, GLOBAL ECOL BIOGEOGR, V18, P78, DOI 10.1111/j.1466-8238.2008.00421.x; Thompson JD, 1999, HEREDITY, V82, P229, DOI 10.1038/sj.hdy.6885040; Tian YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017017; Triest L, 2014, HYDROBIOLOGIA, V737, P145, DOI 10.1007/s10750-013-1583-9; Triest L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104264; Triest L, 2010, HYDROBIOLOGIA, V656, P15, DOI 10.1007/s10750-010-0434-1; VANWIJK RJ, 1989, AQUAT BOT, V33, P271, DOI 10.1016/0304-3770(89)90042-9; Wang IJ, 2014, MOL ECOL, V23, P5649, DOI 10.1111/mec.12938; Wang IJ, 2010, MOL ECOL, V19, P447, DOI 10.1111/j.1365-294X.2009.04465.x; Wei XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054169; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Werth S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099400; Wiegleb G, 1998, FOLIA GEOBOT, V33, P241, DOI 10.1007/BF03216205; Williams P, 2004, BIOL CONSERV, V115, P329, DOI 10.1016/S0006-3207(03)00153-8; Wright S, 1943, GENETICS, V28, P114; Wu ZG, 2016, ECOL EVOL, V6, P460, DOI 10.1002/ece3.1882; Yakimowski SB, 2014, MOL ECOL, V23, P2914, DOI 10.1111/mec.12791; Zacharias I, 2007, J ENVIRON BIOL, V28, P1	75	12	12	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161889	10.1371/journal.pone.0161889	http://dx.doi.org/10.1371/journal.pone.0161889			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560947	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258600114
J	Bolcaen, J; Lybaert, K; Moerman, L; Descamps, B; Deblaere, K; Boterberg, T; Kalala, JP; Van den Broecke, C; De Vos, F; Vanhove, C; Goethals, I				Bolcaen, Julie; Lybaert, Kelly; Moerman, Lieselotte; Descamps, Benedicte; Deblaere, Karel; Boterberg, Tom; Kalala, Jean-Pierre; Van den Broecke, Caroline; De Vos, Filip; Vanhove, Christian; Goethals, Ingeborg			Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; RECURRENT BRAIN-TUMOR; C-11-METHIONINE PET; PROSTATE-CANCER; QUANTIFICATION; METABOLISM; F-18-FDG; MRI; F-18-FLUOROCHOLINE; DIFFERENTIATION	Background Discrimination between glioblastoma (GB) and radiation necrosis (RN) post-irradiation remains challenging but has a large impact on further treatment and prognosis. In this study, the uptake mechanisms of 18F-fluorodeoxyglucose (18F-FDG), 18F-fluoroethyltyrosine (18F-FET) and 18F-fluoromethylcholine (18F-FCho) positron emission tomography (PET) tracers were investigated in a F98 GB and RN rat model applying kinetic modeling (KM) and graphical analysis (GA) to clarify our previous results. Methods Dynamic 18F-FDG (GB n = 6 and RN n = 5), 18F-FET (GB n = 5 and RN n = 5) and 18F-FCho PET (GB n = 5 and RN n = 5) were acquired with continuous arterial blood sampling. Arterial input function (AIF) corrections, KM and GA were performed. Results The influx rate (Ki) of 18F-FDG uptake described by a 2-compartmental model (CM) or using Patlak GA, showed more trapping (k(3)) in GB (0.07 min(-1)) compared to RN (0.04 min(-1)) (p = 0.017). K-1 of 18F-FET was significantly higher in GB (0.06 ml/ccm/min) compared to RN (0.02 ml/ccm/min), quantified using a 1-CM and Logan GA (p = 0.036). 18F-FCho was rapidly oxidized complicating data interpretation. Using a 1-CM and Logan GA no clear differences were found to discriminate GB from RN. Conclusions Based on our results we concluded that using KM and GA both 18F-FDG and 18F-FET were able to discriminate GB from RN. Using a 2-CM model more trapping of 18F-FDG was found in GB compared to RN. Secondly, the influx of 18F-FET was higher in GB compared to RN using a 1-CM model. Important correlations were found between SUV and kinetic or graphical measures for 18F-FDG and 18F-FET. 18F-FCho PET did not allow discrimination between GB and RN.	[Bolcaen, Julie; Lybaert, Kelly; Moerman, Lieselotte; Goethals, Ingeborg] Ghent Univ Hosp, Dept Nucl Med, Ghent, Belgium; [Descamps, Benedicte; Vanhove, Christian] Univ Ghent, Dept Elect & Informat Syst, iMinds IBiTech MEDISIP, Ghent, Belgium; [Deblaere, Karel] Ghent Univ Hosp, Dept Radiol, Ghent, Belgium; [Boterberg, Tom] Ghent Univ Hosp, Dept Radiat Oncol, Ghent, Belgium; [Kalala, Jean-Pierre] Ghent Univ Hosp, Dept Neurosurg, Ghent, Belgium; [Van den Broecke, Caroline] Ghent Univ Hosp, Dept Pathol, Ghent, Belgium; [De Vos, Filip] Univ Ghent, Dept Radiopharm, Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University; IMEC; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University	Bolcaen, J (corresponding author), Ghent Univ Hosp, Dept Nucl Med, Ghent, Belgium.	julie.bolcaen@ugent.be	Vanhove, Christian/I-2095-2019; Bolcaen, Julie/W-4953-2019	Vanhove, Christian/0000-0002-3988-5980; Bolcaen, Julie/0000-0001-8554-280X	GROUP-ID consortium	GROUP-ID consortium	Stichting Luka Hemelaere supported this work. Christian Vanhove is supported by the GROUP-ID consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atukeren E, 2010, ECON BULL, V30, P494; Bansal A, 2008, EUR J NUCL MED MOL I, V35, P1192, DOI 10.1007/s00259-008-0736-y; Bolcaen J, 2015, NUCL MED BIOL, V42, P38, DOI 10.1016/j.nucmedbio.2014.07.006; Bolcaen J, 2014, J NEURO-ONCOL, V120, P257, DOI 10.1007/s11060-014-1552-9; Brandes AA, 2008, NEURO-ONCOLOGY, V10, P361, DOI 10.1215/15228517-2008-008; Challapalli A, 2014, J NUCL MED, V55, P256, DOI 10.2967/jnumed.113.129577; Chao ST, 2001, INT J CANCER, V96, P191, DOI 10.1002/ijc.1016.abs; Convert L, 2007, J NUCL MED, V48, P1197, DOI 10.2967/jnumed.107.042606; DeGrado TR, 2001, CANCER RES, V61, P110; Dimitrakopoulou-Strauss A, 2012, CANCER IMAGING, V12, P283, DOI 10.1102/1470-7330.2012.0033; Galldiks N, 2012, J NUCL MED, V53, P1367, DOI 10.2967/jnumed.112.103325; Glatting G, 2007, MED PHYS, V34, P4285, DOI 10.1118/1.2794176; Habermeier A, 2015, AMINO ACIDS, V47, P335, DOI 10.1007/s00726-014-1863-3; Kim YH, 2010, CLIN NEUROL NEUROSUR, V112, P758, DOI 10.1016/j.clineuro.2010.06.005; Kimura N, 2009, NUCL MED COMMUN, V30, P602, DOI 10.1097/MNM.0b013e32832e1c7d; Kwee SA, 2007, RADIOLOGY, V244, P557, DOI 10.1148/radiol.2442060898; Langen KJ, 2006, NUCL MED BIOL, V33, P287, DOI 10.1016/j.nucmedbio.2006.01.002; Langleben DD, 2000, J NUCL MED, V41, P1861; Michel V, 2006, EXP BIOL MED, V231, P490; Moerman L, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-12; Muzi M, 2001, NUCL MED BIOL, V28, P107, DOI 10.1016/S0969-8051(00)00201-8; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; PMOD technologies, 2012, US GUID PMOD KIN MOD, V3, P55; Popperl G, 2006, EUR J NUCL MED MOL I, V33, P792, DOI 10.1007/s00259-005-0053-7; Rahmathulla G, 2013, J CLIN NEUROSCI, V20, P485, DOI 10.1016/j.jocn.2012.09.011; Ricci PE, 1998, AM J NEURORADIOL, V19, P407; Roivainen A, 2000, EUR J NUCL MED, V27, P25, DOI 10.1007/PL00006658; Slaets D, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-66; Spaeth N, 2006, EUR J NUCL MED MOL I, V33, P673, DOI 10.1007/s00259-005-0045-7; Takesh Mustafa, 2013, World J Nucl Med, V12, P101, DOI 10.4103/1450-1147.136734; Tan H, 2011, CLIN NUCL MED, V36, P978; Tan HB, 2011, CLIN NUCL MED, V36, P978, DOI 10.1097/RLU.0b013e31822f68a6; Thiele F, 2009, PHYS MED BIOL, V54, P5525, DOI 10.1088/0031-9155/54/18/012; Tomasi G, 2012, MOL IMAGING BIOL, V14, P131, DOI 10.1007/s11307-011-0514-2; Van Laere K, 2005, EUR J NUCL MED MOL I, V32, P39, DOI 10.1007/s00259-004-1564-3; Verwer EE, 2015, J NUCL MED, V56, P365, DOI 10.2967/jnumed.114.148007; Weber B, 2002, EUR J NUCL MED MOL I, V29, P319, DOI 10.1007/s00259-001-0712-2; Weber WA, 2000, NUCL MED BIOL, V27, P683, DOI 10.1016/S0969-8051(00)00141-4; Young H, 1999, EUR J CANCER, V35, P1773, DOI 10.1016/S0959-8049(99)00229-4	39	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161845	10.1371/journal.pone.0161845	http://dx.doi.org/10.1371/journal.pone.0161845			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27559736	Green Submitted, Green Published, gold			2022-12-26	WOS:000382258600107
J	Cho, CC; Chou, RH; Yu, C				Cho, Ching Chang; Chou, Ruey-Hwang; Yu, Chin			Amlexanox Blocks the Interaction between S100A4 and Epidermal Growth Factor and Inhibits Cell Proliferation	PLOS ONE			English	Article							PROTEIN S100A4; IN-VITRO; METASTASIS; RECEPTOR; EXPRESSION; TARGET; CANCER; MTS1; PROGRESSION; CARCINOMA	The human S100A4 protein binds calcium, resulting in a change in its conformation to promote the interaction with its target protein. Human epidermal growth factor (EGF) is the target protein of S100A4 and a critical ligand of the receptor EGFR. The EGF/EGFR system promotes cell survival, differentiation, and growth by activating several signaling pathways. Amlexanox is an anti-inflammatory and anti-allergic drug that is used to treat recurrent aphthous ulcers. In the present study, we determined that amlexanox interacts with S100A4 using heteronuclear single quantum correlation titration. We elucidated the interactions of S100A4 with EGF and amlexanox using fluorescence and nuclear magnetic resonance spectroscopy. We generated two binary models (for the S100A4-EGF and S100A4-amlexanox complexes) and observed that amlexanox and EGF share a similar binding region in mS100A4. We also used a WST-1 assay to investigate the bioactivity of S100A4, EGF, and amlexanox, and found that amlexanox blocks the binding between S100A4 and EGF, and is therefore useful for the development of new anti-proliferation drugs.	[Cho, Ching Chang; Yu, Chin] Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan; [Chou, Ruey-Hwang] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Chou, Ruey-Hwang] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Chou, Ruey-Hwang] Asia Univ, Dept Biotechnol, Taichung, Taiwan	National Tsing Hua University; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Yu, C (corresponding author), Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan.; Chou, RH (corresponding author), China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan.; Chou, RH (corresponding author), China Med Univ, Ctr Mol Med, Taichung, Taiwan.; Chou, RH (corresponding author), Asia Univ, Dept Biotechnol, Taichung, Taiwan.	rhchou@mail.cmu.edu.tw; cyu.nthu@gmail.com	Chou, Ruey-Hwang/K-8541-2013	Chou, Ruey-Hwang/0000-0002-2297-2180	Ministry of Science and Technology (MOST) Taiwan [MOST 103-2113-M-007 -017-MY3, MOST 104-2320-B-039-031]; China Medical University, Taiwan [CMU104-S-02]	Ministry of Science and Technology (MOST) Taiwan(Ministry of Science and Technology, Taiwan); China Medical University, Taiwan(China Medical University)	We acknowledge the financial support from the Ministry of Science and Technology (MOST) Taiwan (Grant number MOST 103-2113-M-007 -017-MY3); Ministry of Science and Technology (MOST) Taiwan (Grant number MOST 104-2320-B-039-031), and China Medical University (Grant number CMU104-S-02), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambartsumian N, 2001, ONCOGENE, V20, P4685, DOI 10.1038/sj.onc.1204636; Carreira CM, 1998, J BIOL CHEM, V273, P22224, DOI 10.1074/jbc.273.35.22224; Cho CC, 2015, J BIOMOL NMR, V62, P233, DOI 10.1007/s10858-015-9927-6; COHEN S, 1962, J BIOL CHEM, V237, P1555; COHEN S, 1975, P NATL ACAD SCI USA, V72, P1317, DOI 10.1073/pnas.72.4.1317; Davies BR, 2002, J PATHOL, V196, P292, DOI 10.1002/path.1051; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; Goddard T., 2001, SPARKY 3 NMR SOFTWAR; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; Grigorian M, 2008, CURR MOL MED, V8, P492, DOI 10.2174/156652408785747942; Gupta S, 2003, J CLIN ONCOL, V21, P106, DOI 10.1200/JCO.2003.03.024; Helfman DM, 2005, BRIT J CANCER, V92, P1955, DOI 10.1038/sj.bjc.6602613; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Herwig N, 2016, J CELL MOL MED, V20, P825, DOI 10.1111/jcmm.12808; Huang HW, 2010, BIOCHEM BIOPH RES CO, V402, P705, DOI 10.1016/j.bbrc.2010.10.089; Huang S, 2012, ONCOGENE, V31, P4164, DOI 10.1038/onc.2011.590; Huang YK, 2016, J BIOL CHEM, V291, P14300, DOI 10.1074/jbc.M116.722215; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; KAWAMOTO T, 1983, P NATL ACAD SCI-BIOL, V80, P1337, DOI 10.1073/pnas.80.5.1337; Klingelhofer J, 2009, FEBS J, V276, P5936, DOI 10.1111/j.1742-4658.2009.07274.x; Kozlova EN, 1999, GLIA, V27, P249, DOI 10.1002/(SICI)1098-1136(199909)27:3<249::AID-GLIA6>3.3.CO;2-5; Kriajevska M, 2002, J BIOL CHEM, V277, P5229, DOI 10.1074/jbc.M110976200; KRIAJEVSKA MV, 1994, J BIOL CHEM, V269, P19679; Landriscina M, 2000, J BIOL CHEM, V275, P32753, DOI 10.1074/jbc.M002336200; LANE AN, 1994, METHOD ENZYMOL, V239, P596; Lin HQ, 2010, ANTICANCER RES, V30, P4899; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; McInnes C, 2000, PROTEIN ENG, V13, P143, DOI 10.1093/protein/13.3.143; Merklinger SL, 2005, CIRC RES, V97, P596, DOI 10.1161/01.RES.0000182425.49768.8a; Murakami Y, 2006, BIOINFORMATICS, V22, P1794, DOI 10.1093/bioinformatics/btl171; Ninomiya I, 2001, INT J ONCOL, V18, P715; Novitskaya V, 2000, J BIOL CHEM, V275, P41278, DOI 10.1074/jbc.M007058200; Plestilova L, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0468-2; Schneider M, 2007, CARDIOVASC RES, V75, P40, DOI 10.1016/j.cardiores.2007.03.027; Shishibori T, 1999, BIOCHEM J, V338, P583, DOI 10.1042/0264-6021:3380583; TAKENAGA K, 1994, J CELL BIOL, V124, P757, DOI 10.1083/jcb.124.5.757; Venturi Sebastiano, 2009, Nutrition and Health (Bicester), V20, P119; Walters KJ, 1999, P NATL ACAD SCI USA, V96, P7877, DOI 10.1073/pnas.96.14.7877; Wang JR, 2013, EUR REV MED PHARMACO, V17, P427; Wu HY, 2011, PLANT PHYSIOL, V157, P1015, DOI 10.1104/pp.111.184739	42	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161663	10.1371/journal.pone.0161663	http://dx.doi.org/10.1371/journal.pone.0161663			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27559743	gold, Green Published, Green Submitted			2022-12-26	WOS:000382258600077
J	Homma, A; Hatakeyama, H; Mizumachi, T; Kano, S; Sakashita, T; Kuramoto, R; Nakamaru, Y; Onimaru, R; Tsuchiya, K; Yoshida, D; Yasuda, K; Shirato, H; Fukuda, S				Homma, Akihiro; Hatakeyama, Hiromitsu; Mizumachi, Takatsugu; Kano, Satoshi; Sakashita, Tomohiro; Kuramoto, Rinnosuke; Nakamaru, Yuji; Onimaru, Rikiya; Tsuchiya, Kazuhiko; Yoshida, Daisuke; Yasuda, Koichi; Shirato, Hiroki; Fukuda, Satoshi			A Retrospective Study of G-Tube Use in Japanese Patients Treated with Concurrent Chemoradiotherapy for Hypopharyngeal Cancer	PLOS ONE			English	Article							LOCALLY ADVANCED HEAD; SQUAMOUS-CELL CARCINOMA; INTENSITY-MODULATED RADIOTHERAPY; CONCOMITANT BOOST RADIATION; FACTORS AFFECTING PLACEMENT; LONG-TERM DYSPHAGIA; PHASE-III TRIAL; NECK-CANCER; DEFINITIVE RADIOTHERAPY; CISPLATIN INFUSION	Objective Late toxicity after concurrent chemoradiotherapy (CCRT), such as dysphagia, in patients with squamous cell carcinoma of the head and neck has received a good deal of attention recently. The gastrostomy tube (G-tube) dependence rate 1 year after CCRT was reported to be 16.7-42.9% in Western countries. We evaluated swallowing outcomes after CCRT in patients with hypopharyngeal cancer (HPC) treated in our hospital and compared them with previous reports. Methods We reviewed 96 consecutive patients with a HPC treated by radiotherapy with intravenous or intra-arterial chemotherapy between 2006 and 2013 at Hokkaido University Hospital, Sapporo, Japan. Results At 1 month after CCRT, 13 patients (13.7%) used a G-tube, whereas 5/91 (5.5%) and 4/81 (4.9%) used a G-tube at 3 and 6 months, respectively. Two patients used a G-tube at 12 and 24 months after CCRT (G-tube use rate: 2.8% at 12 months, and 3.2% at 24 months). The variables female, posterior wall primary, stage IV, ECOG performance status of 2, and smoking status were significantly associated with G-tube use at 12 months after CCRT, whereas the route of cisplatin administration was not related to G-tube use (p = 0.303). Conclusions The G-tube use rate up to 1year could be lower in Japanese patients than in Western patients according to previous reports. In particular, Japanese patients resume oral intake sooner than Western patients. Further study of the incidence of dysphagia after CCRT by ethnicity is required to clarify the differences in dysphagia after CCRT.	[Homma, Akihiro; Hatakeyama, Hiromitsu; Mizumachi, Takatsugu; Kano, Satoshi; Sakashita, Tomohiro; Kuramoto, Rinnosuke; Nakamaru, Yuji; Fukuda, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sapporo, Hokkaido, Japan; [Onimaru, Rikiya; Tsuchiya, Kazuhiko; Yoshida, Daisuke; Yasuda, Koichi; Shirato, Hiroki] Hokkaido Univ, Grad Sch Med, Dept Radiat Med, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Homma, A (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sapporo, Hokkaido, Japan.	ak-homma@med.hokudai.ac.jp	Onimaru, Rikiya/C-9805-2012; Yasuda, Koichi/ABE-6380-2021	Onimaru, Rikiya/0000-0002-4768-2358; 	Health and Labour Sciences Research Grants for Clinical Cancer Research from the Ministry of Health, and Labour and Welfare of Japan [H22-017, H26-141]; National Cancer Center Research and Development Fund of Japan [23-A-21, 26-A-4]	Health and Labour Sciences Research Grants for Clinical Cancer Research from the Ministry of Health, and Labour and Welfare of Japan; National Cancer Center Research and Development Fund of Japan	This study was supported in part by Health and Labour Sciences Research Grants for Clinical Cancer Research (H22-017 and H26-141) from the Ministry of Health, and Labour and Welfare of Japan, the National Cancer Center Research and Development Fund (23-A-21 and 26-A-4) of Japan.	Ackerstaff AH, 2012, HEAD NECK-J SCI SPEC, V34, P974, DOI 10.1002/hed.21851; Ackerstaff AH, 2009, HEAD NECK-J SCI SPEC, V31, P77, DOI 10.1002/hed.20937; Bhayani MK, 2013, HEAD NECK-J SCI SPEC, V35, P1641, DOI 10.1002/hed.23199; Bhayani MK, 2013, HEAD NECK-J SCI SPEC, V35, P1634, DOI 10.1002/hed.23200; Caglar HB, 2008, INT J RADIAT ONCOL, V72, P1110, DOI 10.1016/j.ijrobp.2008.02.048; Caudell JJ, 2010, INT J RADIAT ONCOL, V76, P403, DOI 10.1016/j.ijrobp.2009.02.017; Caudell JJ, 2009, INT J RADIAT ONCOL, V73, P410, DOI 10.1016/j.ijrobp.2008.04.048; COOK IJ, 1992, J GASTROEN HEPATOL, V7, P556, DOI 10.1111/j.1440-1746.1992.tb01485.x; Ferreira LEVVC, 2008, DIS ESOPHAGUS, V21, P1, DOI 10.1111/j.1442-2050.2007.00795.x; Furusawa J, 2015, AURIS NASUS LARYNX, V42, P443, DOI 10.1016/j.anl.2015.04.003; Garden AS, 2008, INT J RADIAT ONCOL, V71, P1351, DOI 10.1016/j.ijrobp.2008.04.006; Homma A, 2005, HEAD NECK-J SCI SPEC, V27, P65, DOI 10.1002/hed.20116; Homma A, 2011, JPN J CLIN ONCOL, V41, P980, DOI 10.1093/jjco/hyr086; Inohara H, 2015, INT J RADIAT ONCOL, V91, P934, DOI 10.1016/j.ijrobp.2014.12.032; Jang JY, ANN SURG ONCOL IN PR; Lee NY, 2007, INT J RADIAT ONCOL, V69, P459, DOI 10.1016/j.ijrobp.2007.03.013; Lee WT, 2006, HEAD NECK-J SCI SPEC, V28, P808, DOI 10.1002/hed.20427; Lefebvre JL, 1996, J NATL CANCER I, V88, P890, DOI 10.1093/jnci/88.13.890; Machtay M, 2008, J CLIN ONCOL, V26, P3582, DOI 10.1200/JCO.2007.14.8841; Mizumachi T, 2015, INT J CLIN ONCOL, V20, P431, DOI 10.1007/s10147-014-0726-y; Murono S, 2015, SUPPORT CARE CANCER, V23, P457, DOI 10.1007/s00520-014-2388-8; Paximadis P, 2012, INT J RADIAT ONCOL, V82, P1515, DOI 10.1016/j.ijrobp.2011.04.064; Shiley SG, 2006, OTOLARYNG HEAD NECK, V134, P455, DOI 10.1016/j.otohns.2005.10.054; Tsao AS, 2006, J CLIN ONCOL, V24, P4163, DOI 10.1200/JCO.2006.05.7851; van Overbeek J., 1994, CURR OPIN OTOLARYNGO, V2, P55; Yoon MS, 2008, ACTA OTO-LARYNGOL, V128, P590, DOI 10.1080/00016480701596021; Zenda S, 2011, RADIOTHER ONCOL, V101, P410, DOI 10.1016/j.radonc.2011.09.016	27	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161734	10.1371/journal.pone.0161734	http://dx.doi.org/10.1371/journal.pone.0161734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556279	Green Submitted, gold, Green Published			2022-12-26	WOS:000382258100065
J	Murungi, LK; Kirwa, H; Salifu, D; Torto, B				Murungi, Lucy Kananu; Kirwa, Hillary; Salifu, Daisy; Torto, Baldwyn			Opposing Roles of Foliar and Glandular Trichome Volatile Components in Cultivated Nightshade Interaction with a Specialist Herbivore	PLOS ONE			English	Article							EVANSI ACARI TETRANYCHIDAE; PLANT VOLATILES; INSECT HERBIVORES; PAPILIO-XUTHUS; WILD TOMATO; HOST-PLANT; NATURAL ENEMIES; DATURA-WRIGHTII; MITE-RESISTANT; URTICAE KOCH	Plant chemistry is an important contributor to the interaction with herbivores. Here, we report on a previously unknown role for foliar and glandular trichome volatiles in their interaction with the specialist herbivore of solanaceous plants, the tomato red spider mite Tetranychus evansi. We used various bioassays and chemical analyses including coupled gas chromatography-mass spectrometry (GC/MS) and liquid chromatography coupled to quadrupole time of flight mass spectrometry (LC-QToF-MS) to investigate this interaction between cultivated African nightshades and T. evansi. We show that, whereas morphologically different cultivated African nightshade species released similar foliar volatile organic compounds (VOCs) that attracted T. evansi, VOCs released from exudates of ruptured glandular trichomes of one nightshade species influenced local defense on the leaf surface. VOCs from ruptured glandular trichomes comprising mainly saturated and unsaturated fatty acids deterred T. evansi oviposition. Of the fatty acids, the unsaturated fatty acids accounted for > 40% of the oviposition deterrent activity. Our findings point to a defense strategy in a plant, based on opposing roles for volatiles released by foliar and glandular trichomes in response to attack by a specialist herbivore.	[Murungi, Lucy Kananu; Kirwa, Hillary; Salifu, Daisy; Torto, Baldwyn] Int Ctr Insect Physiol & Ecol, Behav & Chem Ecol Unit, Nairobi, Kenya; [Murungi, Lucy Kananu] Jomo Kenyatta Univ Agr & Technol, Dept Hort, Nairobi, Kenya	International Centre of Insect Physiology & Ecology (ICIPE); Jomo Kenyatta University of Agriculture & Technology	Torto, B (corresponding author), Int Ctr Insect Physiol & Ecol, Behav & Chem Ecol Unit, Nairobi, Kenya.	btorto@icipe.org		Kirwa, Hillary/0000-0003-2912-0762	International Foundation for Science [F/5201-1]	International Foundation for Science(International Foundation for Science)	The study was partially funded by the International Foundation for Science (www.ifs.se) through a grant to LKM (grant no. F/5201-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agut B, 2015, NEW PHYTOL, V207, P790, DOI 10.1111/nph.13357; Alba JM, 2011, J PLANT INTERACT, V6, P221, DOI 10.1080/17429145.2010.551670; Antonious GF, 2015, J ENVIRON SCI HEAL B, V50, P667, DOI 10.1080/03601234.2015.1038960; Bleeker PM, 2009, PLANT PHYSIOL, V151, P925, DOI 10.1104/pp.109.142661; Carlsson MA, 1999, J CHEM ECOL, V25, P2445, DOI 10.1023/A:1020865922827; Chatzivasileiadis EA, 1997, EXP APPL ACAROL, V21, P473, DOI 10.1023/A:1018436113892; Chu CC, 2003, SOUTHWEST ENTOMOL, V28, P235; Clauss MJ, 2006, J CHEM ECOL, V32, P2351, DOI 10.1007/s10886-006-9150-8; Edmonds JM, 1997, BLACK NIGHTSHADES SO, P9; Eigenbrode SD, 1996, ENTOMOL EXP APPL, V81, P335, DOI 10.1007/BF00187043; Gassmann AJ, 2005, OECOLOGIA, V144, P62, DOI 10.1007/s00442-005-0038-z; GERHOLD DL, 1984, J CHEM ECOL, V10, P713, DOI 10.1007/BF00988538; Glas JJ, 2012, INT J MOL SCI, V13, P17077, DOI 10.3390/ijms131217077; GOFFREDA JC, 1989, J CHEM ECOL, V15, P2135, DOI 10.1007/BF01207444; Grazzini RA, 1999, J CHEM ECOL, V25, P955, DOI 10.1023/A:1020865322035; Guo L, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.6701; Hare JD, 2011, ANNU REV ENTOMOL, V56, P161, DOI 10.1146/annurev-ento-120709-144753; Hare JD, 2002, ECOLOGY, V83, P2711, DOI 10.1890/0012-9658(2002)083[2711:VIODIH]2.0.CO;2; HELLE W, 1985, SPIDER MITES THEIR A, V1, P391, DOI DOI 10.1111/J.1570-7458.1987.TB03606; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Iwashina Tsukasa, 2003, Biol Sci Space, V17, P24; Jared JJ, 2015, PEST MANAG SCI; Kennedy GG, 2003, ANNU REV ENTOMOL, V48, P51, DOI 10.1146/annurev.ento.48.091801.112733; Kollner TG, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-15; Li GQ, 2001, J INSECT PHYSIOL, V47, P951, DOI 10.1016/S0022-1910(01)00051-8; Malakar R, 2000, ENTOMOL EXP APPL, V94, P249, DOI 10.1023/A:1003935206765; Marinosci C, 2015, ECOL EVOL, V5, P3151, DOI 10.1002/ece3.1554; Migeon A, 2009, EXP APPL ACAROL, V48, P199, DOI 10.1007/s10493-008-9229-8; Mithofer A, 2012, ANNU REV PLANT BIOL, V63, P431, DOI 10.1146/annurev-arplant-042110-103854; Mortensen B., 2013, NAT ED KNOWL, V4; Murungi L. K., 2011, International Journal of Tropical Insect Science, V31, P269, DOI 10.1017/S1742758411000403; Murungi LK, 2013, IND CROP PROD, V46, P73, DOI 10.1016/j.indcrop.2013.01.022; Murungi LK, 2010, EXP APPL ACAROL, V52, P19, DOI 10.1007/s10493-010-9350-3; Navajas M, 2013, EXP APPL ACAROL, V59, P43, DOI 10.1007/s10493-012-9590-5; Ning J, 2015, PLANT PHYSIOL, V169, P1821, DOI 10.1104/pp.15.00474; NISHIDA R, 1987, EXPERIENTIA, V43, P342, DOI 10.1007/BF01945578; NISHIDA R, 1990, AGR BIOL CHEM TOKYO, V54, P1265, DOI 10.1080/00021369.1990.10870089; Njihia TN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111316; Nyasembe VO, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-234; OHSUGI T, 1985, AGR BIOL CHEM TOKYO, V49, P1897, DOI 10.1080/00021369.1985.10867003; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Pavela R, 2009, IND CROP PROD, V30, P311, DOI 10.1016/j.indcrop.2009.06.005; Peiffer M, 2009, NEW PHYTOL, V184, P644, DOI 10.1111/j.1469-8137.2009.03002.x; Pichersky E, 2002, CURR OPIN PLANT BIOL, V5, P237, DOI 10.1016/S1369-5266(02)00251-0; Quiroz A, 1997, J CHEM ECOL, V23, P2599, DOI 10.1023/B:JOEC.0000006669.34845.0d; R Development Core Team, 2014, R LANG ENV STAT COMP; Resende Juliano T. V., 2002, Genetics and Molecular Research, V1, P106; Roda AL, 2003, PHYTOCHEMISTRY, V62, P527, DOI 10.1016/S0031-9422(02)00608-8; Romeis J, 1999, CROP SCI, V39, P564, DOI 10.2135/cropsci1999.0011183X003900020043x; Sarmento RA, 2011, ECOL LETT, V14, P229, DOI 10.1111/j.1461-0248.2010.01575.x; Schippers R. R., 2000, African indigenous vegetables: an overview of the cultivated species; Simmons AT, 2005, AGR FOREST ENTOMOL, V7, P265, DOI 10.1111/j.1461-9555.2005.00271.x; Unsicker SB, 2009, CURR OPIN PLANT BIOL, V12, P479, DOI 10.1016/j.pbi.2009.04.001; Verhage A, 2010, PLANT PHYSIOL, V154, P536, DOI 10.1104/pp.110.161570; Walling LL, 2008, PLANT PHYSIOL, V146, P859, DOI 10.1104/pp.107.113142; WALTERS DS, 1989, ENTOMOL EXP APPL, V53, P105, DOI 10.1007/BF00187990; Wang EM, 2004, MOL BREEDING, V13, P49, DOI 10.1023/B:MOLB.0000012328.04974.fb; Weinhold A, 2011, P NATL ACAD SCI USA, V108, P7855, DOI 10.1073/pnas.1101306108; Zhao YX, 2002, PHYSIOL ENTOMOL, V27, P103, DOI 10.1046/j.1365-3032.2002.00275.x	59	11	11	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0160383	10.1371/journal.pone.0160383	http://dx.doi.org/10.1371/journal.pone.0160383			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556560	Green Submitted, gold, Green Published			2022-12-26	WOS:000382258100013
J	Alicea-Velazquez, NL; Shinsky, SA; Loh, DM; Lee, JH; Skalnik, DG; Cosgrove, MS				Alicea-Velazquez, Nilda L.; Shinsky, Stephen A.; Loh, Daniel M.; Lee, Jeong-Heon; Skalnik, David G.; Cosgrove, Michael S.			Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme; epigenetics; histone methylation; protein structure; protein-protein interaction; MLL1; SETd1A; WDR5; Win motif	HISTONE H3 LYSINE-4; STRUCTURAL BASIS; MOLECULAR REGULATION; SET1 FAMILY; SACCHAROMYCES-CEREVISIAE; BINDING PROTEIN; FUSION PROTEIN; GENE; METHYLATION; RECOGNITION	MLL1 belongs to the SET1 family of histone H3 lysine 4 (H3K4) methyltransferases, composed of MLL1-4 and SETd1A/B. MLL1 translocations are present in acute leukemias, and mutations in several family members are associated with cancer and developmental disorders. MLL1 associates with a subcomplex containing WDR5, RbBP5, ASH2L, and DPY-30 (WRAD), forming the MLL1 core complex required for H3K4 mono- and dimethylation and transcriptional activation. Core complex assembly requires interaction of WDR5 with the MLL1 Win (WDR5 interaction) motif, which is conserved across the SET1 family. Agents that mimic the SET1 family Win motif inhibit the MLL1 core complex and have become an attractive approach for targeting MLL1 in cancers. Like MLL1, other SET1 family members interact with WRAD, but the roles of the Win motif in complex assembly and enzymatic activity remain unexplored. Here, we show that the Win motif is necessary for interaction of WDR5 with all members of the human SET1 family. Mutation of the Win motif-WDR5 interface severely disrupts assembly and activity of MLL1 and SETd1A complexes but only modestly disrupts MLL2/4 and SETd1B complexes without significantly altering enzymatic activity in vitro. Notably, in the absence of WDR5, MLL3 interacts with RAD and shows enhanced activity. To further probe the role of the Win motif-WDR5 interaction, we designed a peptidomimetic that binds WDR5 (K-d approximate to 3 nm) and selectively inhibits activity of MLL1 and SETd1A core complexes within the SET1 family. Our results reveal that SET1 family complexes with the weakest Win motif-WDR5 interaction are more susceptible to Win motif-based inhibitors.	[Alicea-Velazquez, Nilda L.; Shinsky, Stephen A.; Loh, Daniel M.; Cosgrove, Michael S.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA; [Lee, Jeong-Heon; Skalnik, David G.] Indiana Univ Purdue Univ, Sch Sci, Dept Biol, Indianapolis, IN 46202 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis	Cosgrove, MS (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	cosgrovm@upstate.edu		Loh, Daniel/0000-0003-4706-3829; Shinsky, Stephen/0000-0001-5437-1729	National Institutes of Health [R01CA140522]; NATIONAL CANCER INSTITUTE [R01CA140522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Grant R01CA140522 (to M. S. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Artinger EL, 2013, P NATL ACAD SCI USA, V110, P12000, DOI 10.1073/pnas.1301278110; Benedikt A, 2011, LEUKEMIA, V25, P135, DOI 10.1038/leu.2010.249; Bledau AS, 2014, DEVELOPMENT, V141, P1022, DOI 10.1242/dev.098152; Brautigam CA, 2016, NAT PROTOC, V11, P882, DOI 10.1038/nprot.2016.044; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Bursen A, 2010, BLOOD, V115, P3570, DOI 10.1182/blood-2009-06-229542; Cao F, 2014, MOL CELL, V53, P247, DOI 10.1016/j.molcel.2013.12.001; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cosgrove MS, 2010, FEBS J, V277, P1832, DOI 10.1111/j.1742-4658.2010.07609.x; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Dharmarajan V, 2012, J BIOL CHEM, V287, P27275, DOI 10.1074/jbc.M112.364125; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Dobson CL, 1999, EMBO J, V18, P3564, DOI 10.1093/emboj/18.13.3564; Dorrance AM, 2008, BLOOD, V112, P2508, DOI 10.1182/blood-2008-01-134338; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Emerenciano M, 2013, CANCER LETT, V332, P30, DOI 10.1016/j.canlet.2012.12.023; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Getlik M, 2016, J MED CHEM, V59, P2478, DOI 10.1021/acs.jmedchem.5b01630; Gori F, 2001, J BIOL CHEM, V276, P46515, DOI 10.1074/jbc.M105757200; Grebien F, 2015, NAT CHEM BIOL, V11, P571, DOI [10.1038/nchembio.1859, 10.1038/NCHEMBIO.1859]; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; He XX, 2015, NUCLEIC ACIDS RES, V43, P3712, DOI 10.1093/nar/gkv214; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Huntsman DG, 1999, ONCOGENE, V18, P7975, DOI 10.1038/sj.onc.1203291; Jude CD, 2007, CELL STEM CELL, V1, P324, DOI 10.1016/j.stem.2007.05.019; Karatas H, 2013, J AM CHEM SOC, V135, P669, DOI 10.1021/ja306028q; Karatas H, 2010, J MED CHEM, V53, P5179, DOI 10.1021/jm100139b; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Lee JH, 2008, MOL CELL BIOL, V28, P609, DOI 10.1128/MCB.01356-07; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Li YJ, 2016, NATURE, V530, P447, DOI 10.1038/nature16952; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMahon KA, 2007, CELL STEM CELL, V1, P338, DOI 10.1016/j.stem.2007.07.002; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mersman DP, 2012, J BIOL CHEM, V287, P2652, DOI 10.1074/jbc.M111.280867; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Muntean AG, 2012, ANNU REV PATHOL-MECH, V7, P283, DOI 10.1146/annurev-pathol-011811-132434; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pless B, 2011, LEUKEMIA, V25, P663, DOI 10.1038/leu.2010.308; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Prasad R, 1997, ONCOGENE, V15, P549, DOI 10.1038/sj.onc.1201211; Roguev A, 2003, J BIOL CHEM, V278, P8487, DOI 10.1074/jbc.M209562200; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Rozovskaia T, 2001, ONCOGENE, V20, P874, DOI 10.1038/sj.onc.1204174; Ruault M, 2002, GENE, V284, P73, DOI 10.1016/S0378-1119(02)00392-X; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Scheuermann TH, 2015, METHODS, V76, P87, DOI 10.1016/j.ymeth.2014.11.024; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Senisterra G, 2013, BIOCHEM J, V449, P151, DOI 10.1042/BJ20121280; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shinsky SA, 2015, J BIOL CHEM, V290, P25819, DOI 10.1074/jbc.M115.684142; Shinsky SA, 2015, J BIOL CHEM, V290, P6361, DOI 10.1074/jbc.M114.627646; Shinsky SA, 2014, J MOL BIOL, V426, P2283, DOI 10.1016/j.jmb.2014.03.011; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Thiel AT, 2010, CANCER CELL, V17, P148, DOI 10.1016/j.ccr.2009.12.034; Thomas LR, 2015, MOL CELL, V58, P440, DOI 10.1016/j.molcel.2015.02.028; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wilkinson AC, 2013, CELL REP, V3, P116, DOI 10.1016/j.celrep.2012.12.016; Wu M, 2008, MOL CELL BIOL, V28, P7337, DOI 10.1128/MCB.00976-08; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zeisig BB, 2004, MOL CELL BIOL, V24, P617, DOI 10.1128/MCB.24.2.617-628.2004; Zhang P, 2012, NUCLEIC ACIDS RES, V40, P4237, DOI 10.1093/nar/gkr1235; Zhao HY, 2015, METHODS, V76, P137, DOI 10.1016/j.ymeth.2014.11.012; Zhu JJ, 2015, NATURE, V525, P206, DOI 10.1038/nature15251	90	35	37	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22357	22372		10.1074/jbc.M116.752626	http://dx.doi.org/10.1074/jbc.M116.752626			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27563068	Green Published, hybrid			2022-12-26	WOS:000386760600002
J	Flood, D; Mux, S; Martinez, B; Garcia, P; Douglas, K; Goldberg, V; Lopez, W; Rohloff, P				Flood, David; Mux, Sandy; Martinez, Boris; Garcia, Pablo; Douglas, Kate; Goldberg, Vera; Lopez, Waleska; Rohloff, Peter			Implementation and Outcomes of a Comprehensive Type 2 Diabetes Program in Rural Guatemala	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; CHRONIC DISEASE; CENTRAL-AMERICA; HEALTH; CARE; MANAGEMENT; PREVALENCE; PREVENTION; GLUCOSE; HYPERTENSION	Background The burden of chronic, non-communicable diseases such as diabetes is growing rapidly in low-and middle-income countries. Implementing management programs for diabetes and other chronic diseases for underserved populations is thus a critical global health priority. However, there is a notable dearth of shared programmatic and outcomes data from diabetes treatment programs in these settings. Program Description We describe our experiences as a non-governmental organization designing and implementing a type 2 diabetes program serving Maya indigenous people in rural Guatemala. We detail the practical challenges and solutions we have developed to build and sustain diabetes programming in this setting. Methods We conduct a retrospective chart review from our electronic medical record to evaluate our program's performance. We generate a cohort profile, assess cross-sectional indicators using a framework adapted from the literature, and report on clinical longitudinal outcomes. Results A total of 142 patients were identified for the chart review. The cohort showed a decrease in hemoglobin A1C from a mean of 9.2% to 8.1% over an average of 2.1 years of follow-up (p < 0.001). The proportions of patients meeting glycemic targets were 53% for hemoglobin A1C < 8% and 32% for the stricter target of hemoglobin A1C < 7%. Conclusion We first offer programmatic experiences to address a gap in resources relating to the practical issues of designing and implementing global diabetes management interventions. We then present clinical data suggesting that favorable diabetes outcomes can be attained in poor areas of rural Guatemala.	[Flood, David; Mux, Sandy; Martinez, Boris; Garcia, Pablo; Douglas, Kate; Goldberg, Vera; Lopez, Waleska; Rohloff, Peter] Wuqu Kawoq, Maya Hlth Alliance, Santiago Sacatepequez, Sacatepequez, Guatemala; [Flood, David] Univ Minnesota, Med Pediat Residency Program, Minneapolis, MN USA; [Garcia, Pablo] St Peters Univ Hosp, Internal Med Residency Program, New Brunswick, NJ USA; [Goldberg, Vera] Harvard Med Sch, Boston, MA USA; [Rohloff, Peter] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA	University of Minnesota System; University of Minnesota Twin Cities; Saint Peter's University Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Rohloff, P (corresponding author), Wuqu Kawoq, Maya Hlth Alliance, Santiago Sacatepequez, Sacatepequez, Guatemala.; Rohloff, P (corresponding author), Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.	peter@wuqukawoq.org	Rohloff, Peter/P-8722-2017; Garcia, Pablo/AAU-7506-2020	Rohloff, Peter/0000-0001-7274-8315; Douglas, Katherine/0000-0002-7331-3716; Flood, David/0000-0002-4372-7387				[Anonymous], 2015, DIABETES CARE, V38, pS4, DOI 10.2337/dc15-S003; [Anonymous], 2013, IDF DIABETES ATLAS; Aschner P, 2014, DIABETES RES CLIN PR, V103, P238, DOI 10.1016/j.diabres.2013.11.010; Balcazar H, 2011, J AMBUL CARE MANAG, V34, P362, DOI 10.1097/JAC.0b013e31822cbd0b; Barcelo A, 2010, CENTRAL AMERICA DIAB; Barcelo A, 2012, DIABETES CARE, V35, P738, DOI 10.2337/dc11-1614; Barcelo A, 2010, PRIM CARE DIABETES, V4, P145, DOI 10.1016/j.pcd.2010.04.005; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Beran D, 2016, LANCET DIABETES ENDO, V4, P275, DOI 10.1016/S2213-8587(15)00521-5; Bukhman G, 2011, THE PIH GUIDE TO CHR; Chary A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-476; Clinical Guidelines Task Force, 2012, GLOBAL GUIDELINE FOR; Coleman R, 1998, B WORLD HEALTH ORGAN, V76, P633; Dagaenis GR, 2016, DIABETES CARE; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Dube L, 2015, DIABETES EDUCATOR, V41, P69, DOI 10.1177/0145721714558305; Esterson YB, 2014, J HEALTH CARE POOR U, V25, P72, DOI 10.1353/hpu.2014.0037; Flood D, 2015, PRIVATIZATION AND TH; Flores W, 2008, ANALYSIS OF POLITICS; Garcia Caal ER, 2015, NATIONAL HEALTH CALC; Gaziano T, 2015, HEALTH AFFAIR, V34, P1538, DOI 10.1377/hlthaff.2015.0349; Gaziano TA, 2015, LANCET GLOB HEALTH, V3, pE556, DOI 10.1016/S2214-109X(15)00143-6; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gherman A, 2011, PRACT DIABETES INT, V28, P125, DOI DOI 10.1002/PDI.1574; Gill GV, 2008, DIABETIC MED, V25, P606, DOI 10.1111/j.1464-5491.2008.02421.x; Gong Q, 2011, DIABETOLOGIA, V54, P300, DOI 10.1007/s00125-010-1948-9; Greiner M, 2012, HEART HEALTH RAXNAQI; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Instituto Nacional de Estadistica, 2011, MAPS OF RURAL POVERT; Joshi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103754; Katz I, 2009, PRIM CARE DIABETES, V3, P157, DOI 10.1016/j.pcd.2009.06.007; Kengne AP, 2009, PRIM CARE DIABETES, V3, P181, DOI 10.1016/j.pcd.2009.08.005; Kronick R, 2015, 2014 NATIONAL HEALTH; Labhardt ND, 2011, TROP MED INT HEALTH, V16, P1276, DOI 10.1111/j.1365-3156.2011.02827.x; Labhardt ND, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-339; Lekoubou A, 2010, INT J ENV RES PUB HE, V7, P353, DOI 10.3390/ijerph7020353; Liu SS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1043; Mamo Y, 2007, CLIN MED, V7, P228, DOI 10.7861/clinmedicine.7-3-228; Maronsky HS, 2012, HEALTH IN THE AMERIC; Moreira Diaz JP, 2014, REV GUATEM CARDIOL, V24, pS34; MSPAS, 2011, GUIDES FOR THE PREVE; Pastakia SD, 2011, ANN PHARMACOTHER, V45, P721, DOI 10.1345/aph.1P779; Perez-Cuevas R, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-50; Price C, 2011, QJM-INT J MED, V104, P571, DOI 10.1093/qjmed/hcr005; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Rawal LB, 2012, INT J BEHAV MED, V19, P121, DOI 10.1007/s12529-011-9162-9; Roglic G, 2010, DIABETES RES CLIN PR, V87, P15, DOI 10.1016/j.diabres.2009.10.006; Guzman JR, 2010, REV PANAM SALUD PUBL, V28, P463, DOI 10.1590/S1020-49892010001200008; Samb B, 2010, LANCET, V376, P1785, DOI 10.1016/S0140-6736(10)61353-0; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Universidad Rafael Landivar, 2009, STUDY INFORMATION AB; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; World Health Organization, 2012, PREVENTION CONTROL N; Zabetian A, 2014, DIABETES RES CLIN PR, V104, P206, DOI 10.1016/j.diabres.2014.01.005	54	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161152	10.1371/journal.pone.0161152	http://dx.doi.org/10.1371/journal.pone.0161152			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV3WN	27583362	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600014
J	McFarlane, SE; Sirkia, PM; Alund, M; Qvarnstrom, A				McFarlane, S. Eryn; Sirkia, Paivi M.; Alund, Murielle; Qvarnstrom, Anna			Hybrid Dysfunction Expressed as Elevated Metabolic Rate in Male Ficedula Flycatchers	PLOS ONE			English	Article							CLIMATE-CHANGE; DARWINS COROLLARY; MITOCHONDRIAL; EVOLUTION; HYBRIDIZATION; PERFORMANCE; SPECIATION; STERILITY; SURVIVAL; GENES	Studies of ecological speciation are often biased towards extrinsic sources of selection against hybrids, resulting from intermediate hybrid morphology, but the knowledge of how genetic incompatibilities accumulate over time under natural conditions is limited. Here we focus on a physiological trait, metabolic rate, which is central to life history strategies and thermoregulation but is also likely to be sensitive to mismatched mitonuclear interactions. We measured the resting metabolic rate of male collared, and pied flycatchers as well as of naturally occurring F1 hybrid males, in a recent hybrid zone. We found that hybrid males had a higher rather than intermediate metabolic rate, which is indicative of hybrid physiological dysfunction. Fitness costs associated with elevated metabolic rate are typically environmentally dependent and exaggerated under harsh conditions. By focusing on male hybrid dysfunction in an eco-physiological trait, our results contribute to the general understanding of how combined extrinsic and intrinsic sources of hybrid dysfunction build up under natural conditions.	[McFarlane, S. Eryn; Alund, Murielle; Qvarnstrom, Anna] Dept Ecol & Genet, Anim Ecol, Norbyvagen 18D, SE-75236 Uppsala, Sweden; [Sirkia, Paivi M.] Univ Helsinki, Finnish Museum Nat Hist, Zool Unit, Helsinki, Finland; [Sirkia, Paivi M.] Univ Turku, Sect Ecol, Dept Biol, Turku, Finland	University of Helsinki; University of Turku	McFarlane, SE (corresponding author), Dept Ecol & Genet, Anim Ecol, Norbyvagen 18D, SE-75236 Uppsala, Sweden.	eryn.mcfarlane@ebc.uu.se	Ålund, Murielle/Q-2996-2019	Ålund, Murielle/0000-0003-2861-9721; Sirkia, Paivi Maria/0000-0003-0346-6298	Swedish Research Council [621-2012-3722]; Natural Sciences and Engineering Research Council; Stiftelsen for Zoologisk Forskning; Academy of Finland [267430]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Stiftelsen for Zoologisk Forskning; Academy of Finland(Academy of Finland)	This work was supported by funding from the Swedish Research Council (AQ 621-2012-3722), the Natural Sciences and Engineering Research Council (SEM PGS-D), Stiftelsen for Zoologisk Forskning (SEM and MA) and the Academy of Finland (PMS 267430). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alund M, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0169; Arnqvist G, 2010, EVOLUTION, V64, P3354, DOI 10.1111/j.1558-5646.2010.01135.x; Bates D, LME4 LINEAR MIXED EF; Becker M, 2013, NAT CLIM CHANGE, V3, P1039, DOI 10.1038/NCLIMATE2027; BENNETT AF, 1979, SCIENCE, V206, P649, DOI 10.1126/science.493968; Blackmer AL, 2005, BEHAV ECOL, V16, P906, DOI 10.1093/beheco/ari069; Bolnick DI, 2008, GENETICS, V178, P1037, DOI 10.1534/genetics.107.081364; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Burton RS, 2012, MOL ECOL, V21, P4942, DOI 10.1111/mec.12006; Burton T, 2011, P ROY SOC B-BIOL SCI, V278, P3465, DOI 10.1098/rspb.2011.1778; Deerenberg C, 1998, J COMP PHYSIOL B, V168, P507, DOI 10.1007/s003600050171; Dieckmann U., 2004, ADAPTIVE SPECIATION; Dobzhansky T, 1936, GENETICS, V21, P113; Ellison CK, 2008, J EVOLUTION BIOL, V21, P1844, DOI 10.1111/j.1420-9101.2008.01608.x; Fishman L, 2001, EVOLUTION, V55, P1932, DOI 10.1111/j.0014-3820.2001.tb01311.x; FORD WCL, 1981, J REPROD FERTIL, V63, P271; Garroway CJ, 2010, GLOBAL CHANGE BIOL, V16, P113, DOI 10.1111/j.1365-2486.2009.01948.x; Gershoni M, 2009, BIOESSAYS, V31, P642, DOI 10.1002/bies.200800139; Gomendio M, 2011, P ROY SOC LOND B BIO; HALANGK W, 1985, BIOCHIM BIOPHYS ACTA, V808, P316, DOI 10.1016/0005-2728(85)90014-3; HEWITT GM, 1988, TRENDS ECOL EVOL, V3, P158, DOI 10.1016/0169-5347(88)90033-X; Hoekstra LA, 2013, GENETICS, V195, P1129, DOI 10.1534/genetics.113.154914; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hothorn T, 2008, BIOMETRICAL J, V50, P346; Huntley B., 2007, CLIMATIC ATLAS EUROP; Huxley J, 1940, NEW SYSTEMATICS, P185; Johnson NA, 2010, TRENDS GENET, V26, P317, DOI 10.1016/j.tig.2010.04.005; Kawakami T, 2014, MOL ECOLOGY RESOURCE; Klaassen M, 2004, COMP BIOCHEM PHYS A, V137, P639, DOI 10.1016/j.cbpb.2003.12.004; Krol E, 2003, J EXP BIOL, V206, P4283, DOI 10.1242/jeb.00676; Kuznetsova A, 2014, LMERTEST TESTS RANDO; Larivee ML, 2010, FUNCT ECOL, V24, P597, DOI 10.1111/j.1365-2435.2009.01680.x; LASIEWSKI R. C., 1964, CONDOR, V66, P212, DOI 10.2307/1365646; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; Lundberg A, 1992, PIED FLYCATCHER; Maheshwari S, 2011, ANNU REV GENET, V45, P331, DOI 10.1146/annurev-genet-110410-132514; MANI GS, 1990, PROC R SOC SER B-BIO, V240, P29, DOI 10.1098/rspb.1990.0025; Muhlfeld CC, 2014, NATURE CLIMATE CHANG; Nadachowska-Brzyska K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003942; Nilsson JA, 2002, P ROY SOC B-BIOL SCI, V269, P1735, DOI 10.1098/rspb.2002.2071; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Olson JR, 2010, PHYSIOL BIOCHEM ZOOL, V83, P263, DOI 10.1086/648395; Osada N, 2012, MOL BIOL EVOL, V29, P337, DOI 10.1093/molbev/msr211; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Qvarnstrom A, 2005, BIOL LETTERS, V1, P68, DOI 10.1098/rsbl.2004.0265; Qvarnstrom A, 2015, EVOLUTIONARY APPL; Qvarnstrom A, 2010, PHILOS T R SOC B, V365, P1841, DOI 10.1098/rstb.2009.0306; Qvarnstrom A, 2009, ECOLOGY, V90, P1948, DOI 10.1890/08-0494.1; R Core Team, 2021, R LANGUAGE ENV STAT; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Saetre GP, 1997, NATURE, V387, P589; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Skibiel AL, 2013, FUNCT ECOL, V27, P1382, DOI 10.1111/1365-2435.12130; Svedin N, 2008, P ROY SOC B-BIOL SCI, V275, P735, DOI 10.1098/rspb.2007.0967; Tieleman BI, 2009, P ROY SOC B-BIOL SCI, V276, P1685, DOI 10.1098/rspb.2008.1946; Tourmente M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021244; Trier CN, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004075; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; Turelli M, 2007, GENETICS, V176, P1059, DOI 10.1534/genetics.106.065979	60	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161547	10.1371/journal.pone.0161547	http://dx.doi.org/10.1371/journal.pone.0161547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583553	gold, Green Published, Green Submitted			2022-12-26	WOS:000382855600038
J	Wolkewitz, M; Schumacher, M				Wolkewitz, Martin; Schumacher, Martin			Neuraminidase Inhibitors and Hospital Mortality in British Patients with H1N1 Influenza A: A Re-Analysis of Observational Data	PLOS ONE			English	Article							CLINICAL-STUDY REPORTS; REAL-WORLD DATA; VIRUS-INFECTION; COMPETING RISK; IMMORTAL TIME; ADULTS; BIAS; METAANALYSIS; OSELTAMIVIR; CHILDREN	Background Observational studies claimed reducing effects of neuraminidase inhibitors (NI) on hospital mortality in patients with H1N1 influenza A. It has been criticized that such findings are prone to common and serious survival biases. Methods With observational data from the FLU-CIN study group, multi-state and dynamic prediction models have been used to avoid such biases. The data included 1391 patients with confirmed pandemic influenza A/H1N1 infection collected during 2009-2010 in the UK. Due to their close relationship, the main outcome measures were hospital death and length of hospital stay. Findings There is no direct effect of NI on the hospital death rate; the hazard ratio (HR) of NI was 1.03 (95%-CI: 0.64-1.66). The discharge rate is increased for NI patients (HR = 1.89 (95%-CI: 1.65-2.16)) indicating that NI-treated patients stay shorter in hospital than NI-untreated patients, on average 3.10 days (95%-CI: 2.07-4.14). We also showed that the initiation timing of NI treatment (<= 2 days versus > 2 days after onset) made no difference on the effects on the hospital death and discharge hazards. The hazard ratios remain stable after adjusting for potential confounders measured at admission (such as comorbidities and influenza-related clinical symptoms). Conclusions The potential beneficial effect of NI on hospitalized patients in the UK is rather a reduction of the length of hospital stay than a reduction of the mortality rate. There seems to be no confounding by indication and no differences if NI is given early or late. Different effects could be present in other populations (such as non-hospitalized individuals) or countries. Careful interpretation of the effect on length of hospital stay is needed due to potentially different discharge policies of NI-treated and NI-untreated patients.	[Wolkewitz, Martin; Schumacher, Martin] Univ Freiburg, Inst Med Biometry & Stat, Ctr Med Biometry & Med Informat, Med Ctr, Freiburg, Germany	University of Freiburg	Wolkewitz, M (corresponding author), Univ Freiburg, Inst Med Biometry & Stat, Ctr Med Biometry & Med Informat, Med Ctr, Freiburg, Germany.	wolke@imbi.uni-freiburg.de		Wolkewitz, Martin/0000-0002-1268-5057	German Research Foundation (Deutsche Forschungsgemeinschaft) [WO 1746/1-2]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	MW received funding from the German Research Foundation (Deutsche Forschungsgemeinschaft) (grant No WO 1746/1-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adisasmito W, 2010, J INFECT DIS, V202, P1154, DOI 10.1086/656316; [Anonymous], 2015, LANCET, V386, P1510, DOI [10.1016/S0140-6736(15)00523-1, DOI 10.1016/S0140-6736(15)00523-1]; Austin PC, 2013, STAT MED, V32, P2837, DOI 10.1002/sim.5705; Beyersmann J, 2006, INFECT CONT HOSP EP, V27, P493, DOI 10.1086/503375; Beyersmann J, 2011, COMPETING RISKS MULT; Cortese G, 2010, BIOMETRICAL J, V52, P138, DOI 10.1002/bimj.200900076; Dobson J, 2015, LANCET, V385, P1729, DOI 10.1016/S0140-6736(14)62449-1; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Freemantle N, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2371; Freemantle N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6409; Hanley JA, 2014, INT J EPIDEMIOL, V43, P949, DOI 10.1093/ije/dyu105; Heneghan CJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2547; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545; JONES M, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G3001; Jones Mark, 2014, Lancet Respir Med, V2, pe9, DOI 10.1016/S2213-2600(14)70126-2; Lange T, 2014, INT J EPIDEMIOL, V43, P971, DOI 10.1093/ije/dyu100; Leibovici L, 2014, CLIN MICROBIOL INFEC, V20, pO979, DOI 10.1111/1469-0691.12708; Antes Gerd, 2014, Lancet Respir Med, V2, pe10, DOI [10.1016/S2213-2600(14)70137-7, 10.1016/S2213-2600(14)70127-4]; Levesque LE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5087; Louie JK, 2012, CLIN INFECT DIS, V55, P1198, DOI 10.1093/cid/cis636; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Michiels B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060348; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; Myles PR, 2012, THORAX, V67, P709, DOI 10.1136/thoraxjnl-2011-200266; Nguyen TL, 2009, CLIN INFECT DIS, V48, P1639, DOI 10.1086/599031; Schumacher M, 2013, INT J EPIDEMIOL, V42, P1502, DOI 10.1093/ije/dyt111; van Houwelingen H., 2011, DYNAMIC PREDICTION C; van Walraven C, 2016, J CLIN EPIDEMIOL, V69, P170, DOI 10.1016/j.jclinepi.2015.07.006; Wiysonge CS, 2014, INT J EPIDEMIOL, V43, P1691, DOI 10.1093/ije/dyu219; Wolkewitz M, 2014, LANCET RESP MED, V2, P8, DOI [10.1016/S2213-, DOI 10.1016/S2213-]; Wolkewitz M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5060; Wolkewitz M, 2012, J CLIN EPIDEMIOL, V65, P1171, DOI 10.1016/j.jclinepi.2012.04.008; Wolkewitz M, 2011, J ANTIMICROB CHEMOTH, V66, P381, DOI 10.1093/jac/dkq424; Wong JY, 2015, AM J EPIDEMIOL, V182, P294, DOI 10.1093/aje/kwv054; Yu HJ, 2011, CLIN INFECT DIS, V52, P457, DOI 10.1093/cid/ciq144	35	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0160430	10.1371/journal.pone.0160430	http://dx.doi.org/10.1371/journal.pone.0160430			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583403	gold, Green Published, Green Submitted			2022-12-26	WOS:000382855600005
J	Rangel, LI; Henkels, MD; Shaffer, BT; Walker, FL; Davis, EW; Stockwell, VO; Bruck, D; Taylor, BJ; Loper, JE				Rangel, Lorena I.; Henkels, Marcella D.; Shaffer, Brenda T.; Walker, Francesca L.; Davis, Edward W., II; Stockwell, Virginia O.; Bruck, Denny; Taylor, Barbara J.; Loper, Joyce E.			Characterization of Toxin Complex Gene Clusters and Insect Toxicity of Bacteria Representing Four Subgroups of Pseudomonas fluorescens	PLOS ONE			English	Article							CATERPILLARS-FLOPPY MCF; BIOLOGICAL-CONTROL; PHOTORHABDUS; COLONIZATION; SPP.; IDENTIFICATION; PHENOLOXIDASE; RHIZOSPHERE; SEQUENCE; DISEASE	Ten strains representing four lineages of the Pseudomonas fluorescens group (P. chlororaphis, P. corrugata, P. koreensis, and P. fluorescens subgroups) were evaluated for toxicity to the tobacco hornworm Manduca sexta and the common fruit fly Drosophila melanogaster. The three strains within the P. chlororaphis subgroup exhibited both oral and injectable toxicity to the lepidopteran M. sexta. All three strains have the gene cluster encoding the FitD insect toxin and a Delta fitD mutant of P. protegens strain Pf-5 exhibited diminished oral toxicity compared to the wildtype strain. Only one of the three strains, P. protegens Pf-5, exhibited substantial levels of oral toxicity against the dipteran D. melanogaster. Three strains in the P. fluorescens subgroup, which lack fitD, consistently showed significant levels of injectable toxicity against M. sexta. In contrast, the oral toxicity of these strains against D. melanogaster was variable between experiments, with only one strain, Pseudomonas sp. BG33R, causing significant levels of mortality in repeated experiments. Toxin complex (Tc) gene clusters, which encode insecticidal properties in Photorhabdus luminescens, were identified in the genomes of seven of the ten strains evaluated in this study. Within those seven genomes, six types of Tc gene clusters were identified, distinguished by gene content, organization and genomic location, but no correlation was observed between the presence of Tc genes and insect toxicity of the evaluated strains. Our results demonstrate that members of the P. fluorescens group have the capacity to kill insects by both FitD-dependent and independent mechanisms.	[Rangel, Lorena I.; Henkels, Marcella D.; Stockwell, Virginia O.; Loper, Joyce E.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Henkels, Marcella D.; Shaffer, Brenda T.; Davis, Edward W., II; Stockwell, Virginia O.; Bruck, Denny; Loper, Joyce E.] ARS, USDA, Hort Crops Res Lab, Corvallis, OR 97333 USA; [Walker, Francesca L.; Taylor, Barbara J.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Rangel, Lorena I.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Bruck, Denny] DuPont Pioneer, Johnston, IA USA	Oregon State University; United States Department of Agriculture (USDA); Oregon State University; University of California System; University of California Davis; DuPont; Pioneer Hi-Bred International, Inc.	Loper, JE (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.; Loper, JE (corresponding author), ARS, USDA, Hort Crops Res Lab, Corvallis, OR 97333 USA.	loperj@science.oregonstate.edu		Rangel, Lorena/0000-0002-9081-5275; Davis, Edward/0000-0003-1229-4272; Loper, Joyce/0000-0003-3501-5969	Oregon State University; United States Department of Agriculture National Institute of Food and Agriculture [2008-35600-18770, 2011-67019-30192]	Oregon State University; United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	LIR was supported by a Provost's Distinguished Graduate Fellowship from Oregon State University. This work was supported by Agriculture and Food Research Initiative Competitive Grant 2008-35600-18770 and 2011-67019-30192 from the United States Department of Agriculture National Institute of Food and Agriculture.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bidla G, 2009, J INNATE IMMUN, V1, P301, DOI 10.1159/000168009; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen WJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004288; Commare RR, 2002, CROP PROT, V21, P671, DOI 10.1016/S0261-2194(02)00020-0; Daborn PJ, 2002, P NATL ACAD SCI USA, V99, P10742, DOI 10.1073/pnas.102068099; Defago G., 1990, SOIL BIOCH, P249; Dowling AJ, 2004, CELL MICROBIOL, V6, P345, DOI 10.1046/j.1462-5822.2003.00357.x; Ffrench-Constant R, 2006, ADV APPL MICROBIOL, V58, P169, DOI 10.1016/S0065-2164(06)58005-5; ffrench-Constant RH, 2000, CELL MOL LIFE SCI, V57, P828, DOI 10.1007/s000180050044; ffrench-Constant RH, 2007, TOXICON, V49, P436, DOI 10.1016/j.toxicon.2006.11.019; Flury P, 2016, ISME J, V10, P2527, DOI 10.1038/ismej.2016.5; Fuchs TM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-214; Garrido-Sanz D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150183; Gomila M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00214; Gross H, 2007, CHEM BIOL, V14, P53, DOI 10.1016/j.chembiol.2006.11.007; Guiney DG, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00129; Gupta S, 2003, MOL CELL BIOCHEM, V253, P41, DOI 10.1023/A:1026045100219; Henkels MD, 2014, MOL PLANT MICROBE IN, V27, P733, DOI 10.1094/MPMI-10-13-0311-R; Hinchliffe SJ, 2010, OPEN TOXINOL J, V3, P17, DOI [10.2174/1875414701003010083, DOI 10.2174/1875414701003010101]; Hofte M, 2010, RES MICROBIOL, V161, P464, DOI 10.1016/j.resmic.2010.04.007; HOWELL CR, 1979, PHYTOPATHOLOGY, V69, P480, DOI 10.1094/Phyto-69-480; Hurst MRH, 2011, J BACTERIOL, V193, P1966, DOI 10.1128/JB.01044-10; Jang JY, 2013, J AGR FOOD CHEM, V61, P6786, DOI 10.1021/jf401218w; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kim MS, 2004, PLANT BIOLOGY, V6, P105, DOI 10.1055/s-2004-817803; KING EO, 1954, J LAB CLIN MED, V44, P301; KLUEPFEL DA, 1993, PHYTOPATHOLOGY, V83, P1240, DOI 10.1094/Phyto-83-1240; Kupferschmied P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00287; Lee PJ, 2004, BIOCHEM BIOPH RES CO, V319, P1110, DOI 10.1016/j.bbrc.2004.04.203; Lehane MJ, 1997, ANNU REV ENTOMOL, V42, P525, DOI 10.1146/annurev.ento.42.1.525; Liu JR, 2010, J AGR FOOD CHEM, V58, P12343, DOI 10.1021/jf103604r; Loper JE, 2016, ENVIRON MICROBIOL, V18, P3509, DOI 10.1111/1462-2920.13369; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Ma ZW, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00382; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; MAZZOLA M, 2007, PHYTOPATHOLOGY S, V97, pS72; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Olcott MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012504; Olorunleke FE, 2015, ENV MICROBIOL REP, V7, P774, DOI 10.1111/1758-2229.12310; Otsu Y, 2004, BIOCONTROL SCI TECHN, V14, P427, DOI 10.1080/09583150410001683538; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Pechy-Tarr M, 2008, ENVIRON MICROBIOL, V10, P2368, DOI 10.1111/j.1462-2920.2008.01662.x; Puntener W, 1981, MANUAL FIELD TRIALS, P68; Raaijmakers JM, 1998, MOL PLANT MICROBE IN, V11, P144, DOI 10.1094/MPMI.1998.11.2.144; Ruffner B, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1763-2; Ruffner B, 2013, ENVIRON MICROBIOL, V15, P751, DOI 10.1111/j.1462-2920.2012.02884.x; Seaton SC, 2013, APPL ENVIRON MICROB, V79, P5405, DOI 10.1128/AEM.00819-13; Shrestha YK, 2011, J ASIA-PAC ENTOMOL, V14, P127, DOI 10.1016/j.aspen.2010.10.007; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stockwell VO, 2007, PHYTOPATHOLOGY, V97, P244, DOI 10.1094/PHYTO-97-2-0244; Tang HP, 2009, FLY, V3, P105, DOI 10.4161/fly.3.1.7747; THOMASHOW LS, 1990, APPL ENVIRON MICROB, V56, P908, DOI 10.1128/AEM.56.4.908-912.1990; Tran H, 2007, NEW PHYTOL, V175, P731, DOI 10.1111/j.1469-8137.2007.02138.x; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; VINCENT MN, 1991, APPL ENVIRON MICROB, V57, P2928, DOI 10.1128/AEM.57.10.2928-2934.1991; Waterfield N, 2005, CELL MICROBIOL, V7, P373, DOI 10.1111/j.1462-5822.2004.00467.x; Waterfield NR, 2003, FEMS MICROBIOL LETT, V229, P265, DOI 10.1016/S0378-1097(03)00846-2; Waterfield NR, 2001, TRENDS MICROBIOL, V9, P185, DOI 10.1016/S0966-842X(01)01978-3; Weller DM, 2002, ANNU REV PHYTOPATHOL, V40, P309, DOI 10.1146/annurev.phyto.40.030402.110010; WILSON M, 1993, PHYTOPATHOLOGY, V83, P117, DOI 10.1094/Phyto-83-117; Yang G, 2006, J BACTERIOL, V188, P2254, DOI 10.1128/JB.188.6.2254-2261.2006	64	27	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161120	10.1371/journal.pone.0161120	http://dx.doi.org/10.1371/journal.pone.0161120			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580176	gold, Green Submitted, Green Published			2022-12-26	WOS:000382877400017
J	Wang, WQ; Hao, QQ; Tian, FX; Li, QX; Wang, W				Wang, Wenqiang; Hao, Qunqun; Tian, Fengxia; Li, Qinxue; Wang, Wei			Cytokinin-Regulated Sucrose Metabolism in Stay-Green Wheat Phenotype	PLOS ONE			English	Article							EXTRACELLULAR INVERTASE; PHOSPHATE SYNTHASE; CHENOPODIUM-RUBRUM; MUTANT TASG1; INDUCTION; SINK; EXPRESSION; GLUCOSE; PROTEIN; SHOOTS	A wheat stay-green mutant, tasg1, was observed to exhibit significantly delayed senescence in the late developmental stage. The photosynthetic capacity of the flag leaf was greater in tasg1 than in wild type (WT) plants. In addition, the grain volume of tasg1 was significantly higher than that of WT at the early filling stage. The content of various cytokinins (CKs) in the grain was significantly higher in tasg1 than in WT and was accompanied by an upregulated expression of some cell cycle-related genes. Examination of the metabolism of soluble sugars in tasg1 and WT revealed that the concentrations of glucose (Glu), fructose (Fru), and sucrose (Suc) were higher in the flag leaves and grains of tasg1 than in WT plants. The activities of sucrose-phosphate synthase (SPS), sucrose synthase (SuSy), and cell wall invertase (CW-invertase) were higher in tasg1, suggesting an altered metabolism and transport of soluble sugars. Furthermore, when tasg1 was treated with the CK inhibitor lovastatin, the activity of invertase was inhibited and was associated with premature senescence phenotype. However, the activity of invertase was partially recovered in tasg1 when treated with 6-benzylaminopurine (BAP). The trend of change in the concentrations of Glu, Fru, and Suc was similar to that of invertase. Our results suggest that CKs might regulate the stay-green phenotype of tasg1 by regulating the invertase activity involved in Suc remobilization.	[Wang, Wenqiang; Hao, Qunqun; Li, Qinxue; Wang, Wei] Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Shandong Key Lab Crop Biol, Tai An 271018, Shandong, Peoples R China; [Tian, Fengxia] Nanyang Normal Univ, Coll Life Sci & Technol, Nanyang 473061, Henan, Peoples R China	Shandong Agricultural University; Nanyang Normal College	Wang, W (corresponding author), Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Shandong Key Lab Crop Biol, Tai An 271018, Shandong, Peoples R China.	wangw@sdau.edu.cn			National Natural Science Foundation of China [31370304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (no. 31370304).	Brenner Mark L., 1995, P649; Degenhardt B, 2000, PLANT SOIL, V225, P83, DOI 10.1023/A:1026539311358; Dekkers JCM, 2002, NAT REV GENET, V3, P22, DOI 10.1038/nrg701; Dewitte W, 2003, ANNU REV PLANT BIOL, V54, P235, DOI 10.1146/annurev.arplant.54.031902.134836; Ehness R, 1997, PLANT J, V11, P539, DOI 10.1046/j.1365-313X.1997.11030539.x; FLORES S, 1988, PLANT MOL BIOL, V11, P409, DOI 10.1007/BF00039021; Goetz M, 2001, P NATL ACAD SCI USA, V98, P6522, DOI 10.1073/pnas.091097998; Hauch S, 1998, PLANTA, V207, P266, DOI 10.1007/s004250050482; HUBER SC, 1989, PLANT CELL PHYSIOL, V30, P277, DOI 10.1093/oxfordjournals.pcp.a077740; HUBER SC, 1982, PLANT PHYSIOL, V69, P691, DOI 10.1104/pp.69.3.691; Hui Z, 2012, PLANT CELL REP, V31, P1073, DOI 10.1007/s00299-012-1226-z; JACQMARD A, 1994, CYTOKININS CHEM ACTI, P197; Joran V, 2013, PLANT CELL PHYSL, V2, P1; Kebrom TH, 2012, PLANT PHYSIOL, V160, P308, DOI 10.1104/pp.112.197954; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; Koonjul PK, 2005, J EXP BOT, V56, P179, DOI 10.1093/jxb/eri018; KUIPER D, 1993, PLANT CELL ENVIRON, V16, P1025, DOI 10.1111/j.1365-3040.1996.tb02052.x; Lara MEB, 2004, PLANT CELL, V16, P1276, DOI 10.1105/tpc.018929; LEFEBVRE R, 1992, CAN J BOT, V70, P1897, DOI 10.1139/b92-235; LERBS S, 1984, PLANTA, V162, P289, DOI 10.1007/BF00396739; Mok MC., 1994, CYTOKININS CHEM ACTI, P155, DOI DOI 10.1201/9781351071284; Mustroph A, 2006, PLANTA, V225, P103, DOI 10.1007/s00425-006-0333-x; POZUETAROMERO J, 1991, FEBS LETT, V291, P233, DOI 10.1016/0014-5793(91)81292-G; Roitsch T, 2003, J EXP BOT, V54, P513, DOI 10.1093/jxb/erg050; Roitsch T, 2004, TRENDS PLANT SCI, V9, P606, DOI 10.1016/j.tplants.2004.10.009; ROITSCH T, 1995, PLANT PHYSIOL, V108, P285, DOI 10.1104/pp.108.1.285; Roitsch T, 2000, PLANT GROWTH REGUL, V32, P359, DOI 10.1023/A:1010781500705; Spano G, 2003, J EXP BOT, V54, P1415, DOI 10.1093/jxb/erg150; Stitt M, 1988, PLANTA, V177, P116; Tang GQ, 1999, PLANT CELL, V11, P177, DOI 10.1105/tpc.11.2.177; Tian FX, 2013, J EXP BOT, V64, P1509, DOI 10.1093/jxb/ert004; Wang WQ, 2016, PLANT CELL REP, V35, P585, DOI 10.1007/s00299-015-1905-7; Werner T, 2008, J EXP BOT, V59, P2659, DOI 10.1093/jxb/ern134; Zheng HJ, 2009, PLANT BREEDING, V128, P54, DOI 10.1111/j.1439-0523.2008.01529.x	34	20	21	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161351	10.1371/journal.pone.0161351	http://dx.doi.org/10.1371/journal.pone.0161351			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580166	Green Submitted, Green Published, gold			2022-12-26	WOS:000382877400024
J	Farris, AB; Ellis, CL; Rogers, TE; Lawson, D; Cohen, C; Rosen, S				Farris, Alton B.; Ellis, Carla L.; Rogers, Thomas E.; Lawson, Diane; Cohen, Cynthia; Rosen, Seymour			Renal Medullary and Cortical Correlates in Fibrosis, Epithelial Mass, Microvascularity, and Microanatomy Using Whole Slide Image Analysis Morphometry	PLOS ONE			English	Article							INTERSTITIAL FIBROSIS; BIOPSY; COMPLICATIONS; ARCHITECTURE; FIBROBLASTS; TRANSITION; INSIGHTS; DISEASE; EMERGE	Renal tubulointerstitial injury often leads to interstitial fibrosis and tubular atrophy (IF/TA). IF/TA is typically assessed in the renal cortex and can be objectively quantitated with computerized image analysis (IA). However, the human medulla accounts for a substantial proportion of the nephron; therefore, medullary scarring will have important cortical consequences and may parallel overall chronic renal injury. Trichrome, periodic acid-Schiff (PAS), and collagen III immunohistochemistry (IHC) were visually examined and quantitated on scanned whole slide images (WSIs) (N = 67 cases). When tuned to measure fibrosis, IA of trichrome and Trichrome-PAS (T-P) WSIs correlated for all anatomic compartments (among cortex, medulla, and entire tissue, r = 0.84 to 0.89, P all < 0.0001); and collagen III deposition correlated between compartments (r = 0.69 to 0.89, P < 0.0001 to 0.0002); however, trichrome and T-P measures did not correlate with collagen deposition, suggesting heterogeneous contributions to extracellular matrix deposition. Epithelial cell mass (EPCM) correlated between cortex and medulla when measured with cytokeratin IHC and with the trichrome red portion (r = 0.85 and 0.66, respectively, all P < 0.0001). Visual assessment also correlated between compartments for fibrosis and EPCM. Correlations were found between increasing medullary inner stripe (IS) width and fibrosis in all of the tissue and the medulla by trichrome morphometry (r = 0.56, P < 0.0001, and r = 0.48, P = 0.00008, respectively). Weak correlations were found between increasing IS width and decreasing visual assessment of all tissue EPCM. Microvessel density (MVD) and microvessel area (MVA) measured using a MVD algorithm applied to CD34 IHC correlated significantly between all compartments (r = 0.76 to 0.87 for MVD and 0.71 to 0.87 for MVA, P all < 0.0001). Overall, these findings demonstrate the interrelatedness of the cortex and medulla and the importance of considering the renal parenchyma as a whole.	[Farris, Alton B.; Ellis, Carla L.; Rogers, Thomas E.; Lawson, Diane; Cohen, Cynthia] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA; [Rosen, Seymour] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA	Emory University; Harvard University; Beth Israel Deaconess Medical Center	Farris, AB (corresponding author), Emory Univ, Dept Pathol, Atlanta, GA 30322 USA.	abfarri@emory.edu	Farris, Alton Brad/S-6041-2017	Farris, Alton Brad/0000-0001-5534-7763				Aperio Technologies, 2009, AP SUPP DOC; Aperio Technologies, 2008, MICR AN ALG US GUID; Aperio Technologies, 2009, IM AN AP; Bankir L, 1987, Adv Nephrol Necker Hosp, V16, P69; BANKIR L, 1987, KIDNEY INT, V31, pS25; BANKIR L, 1985, AM J PHYSIOL, V249, pR643, DOI 10.1152/ajpregu.1985.249.6.R643; BURSTEIN DM, 1993, AM J KIDNEY DIS, V22, P545, DOI 10.1016/S0272-6386(12)80927-9; Christensen EI, 2008, KIDNEY INT, V74, P1233, DOI 10.1038/ki.2008.421; Corapi KM, 2012, AM J KIDNEY DIS, V60, P62, DOI 10.1053/j.ajkd.2012.02.330; de Rouffignac C., 1990, Comparative Physiology, V2, P31; EVERETT MM, 1974, HISTOCHEM J, V6, P25, DOI 10.1007/BF01011535; Farris AB, 2014, AM J TRANSPLANT, V14, P897, DOI 10.1111/ajt.12641; Farris AB, 2014, KIDNEY INT SUPPL, V4, P9, DOI 10.1038/kisup.2014.3; Farris AB, 2012, CURR OPIN NEPHROL HY, V21, P289, DOI 10.1097/MNH.0b013e3283521cfa; Farris AB, 2011, J AM SOC NEPHROL, V22, P176, DOI 10.1681/ASN.2009091005; Feldman DL, 2000, J CARDIOVASC PHARM, V36, pS255, DOI 10.1097/00005344-200036051-00075; Fry BC, 2014, AM J PHYSIOL-RENAL, V307, pF263, DOI 10.1152/ajprenal.00149.2014; Furness PN, 2001, KIDNEY INT, V60, P1998, DOI 10.1046/j.1523-1755.2001.00030.x; Hinkle DEJS, 2002, APPL STAT BEHAV SCI; Kaissling B, 2008, HISTOCHEM CELL BIOL, V130, P247, DOI 10.1007/s00418-008-0452-5; KRIZ W, 1981, AM J PHYSIOL, V241, pR3, DOI 10.1152/ajpregu.1981.241.1.R3; Lemley KV, 1994, RENAL PATHOLOGY CLIN, P981; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Lones ML, 2008, THEORY PRACTICE HIST; Lopez JI, 2015, PATHOL RES PRACT, V211, P271, DOI 10.1016/j.prp.2014.12.009; MARCUSSEN N, 1995, TRANSPLANTATION, V60, P1083, DOI 10.1097/00007890-199511270-00004; Masson P., 1929, J TECH METHODS, V12, P75; Mohamed A, 2013, J ANAL ONCOLOGY, V2, P135; Moreso F, 2001, AM J TRANSPLANT, V1, P82, DOI 10.1034/j.1600-6143.2001.010115.x; Mukaka MM, 2012, MALAWI MED J, V24, P69; Nicholson ML, 1999, TRANSPLANTATION, V68, P236, DOI 10.1097/00007890-199907270-00013; Okon K, 2003, AM J NEPHROL, V23, P409, DOI 10.1159/000074298; PARRISH AE, 1992, CLIN NEPHROL, V38, P135; Peter K., 1927, UNTERSUCHUNGEN BAU E; Qi GS, 2012, J CELL MOL MED, V16, P3116, DOI 10.1111/j.1582-4934.2012.01582.x; Racusen Lorraine C, 2002, Am J Transplant, V2, P203, DOI 10.1034/j.1600-6143.2002.20303.x; Satoh M, 2001, J AM SOC NEPHROL, V12, P317, DOI 10.1681/ASN.V122317; Tomioka M, 2010, NEPHROLOGY, V15, P568, DOI 10.1111/j.1440-1797.2010.01342.x; Venkatachalam MA, 2015, J AM SOC NEPHROL, V26, P1765, DOI 10.1681/ASN.2015010006; Wang X, 1998, AM J PHYSIOL-RENAL, V274, pF413, DOI 10.1152/ajprenal.1998.274.2.F413; Wang XL, 2014, KIDNEY INT, V85, P677, DOI 10.1038/ki.2013.359; Wei GJ, 2015, AM J PHYSIOL-RENAL, V309, pF627, DOI 10.1152/ajprenal.00236.2015; Whittier WL, 2012, ADV CHRONIC KIDNEY D, V19, P179, DOI 10.1053/j.ackd.2012.04.003; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeisberg M, 2008, FRONT BIOSCI, V13, P6991	46	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161019	10.1371/journal.pone.0161019	http://dx.doi.org/10.1371/journal.pone.0161019			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575381	gold, Green Published, Green Submitted			2022-12-26	WOS:000382877200015
J	Schlacher, TA; Carracher, LK; Porch, N; Connolly, RM; Olds, AD; Gilby, BL; Ekanayake, KB; Maslo, B; Weston, MA				Schlacher, Thomas A.; Carracher, Lucy K.; Porch, Nicholas; Connolly, Rod M.; Olds, Andrew D.; Gilby, Ben L.; Ekanayake, Kasun B.; Maslo, Brooke; Weston, Michael A.			The Early Shorebird Will Catch Fewer Invertebrates on Trampled Sandy Beaches	PLOS ONE			English	Article							PLOVER THINORNIS-RUBRICOLLIS; OFF-ROAD VEHICLES; HABITAT SELECTION; CONSERVATION; DISTURBANCE; MACROFAUNA; POPULATION; IMPACTS; BIRDS	Many species of birds breeding on ocean beaches and in coastal dunes are of global conservation concern. Most of these species rely on invertebrates (e.g. insects, small crustaceans) as an irreplaceable food source, foraging primarily around the strandline on the upper beach near the dunes. Sandy beaches are also prime sites for human recreation, which impacts these food resources via negative trampling effects. We quantified acute trampling impacts on assemblages of upper shore invertebrates in a controlled experiment over a range of foot traffic intensities (up to 56 steps per square metre) on a temperate beach in Victoria, Australia. Trampling significantly altered assemblage structure (species composition and density) and was correlated with significant declines in invertebrate abundance and species richness. Trampling effects were strongest for rare species. In heavily trafficked plots the abundance of sand hoppers (Amphipoda), a principal prey item of threatened Hooded Plovers breeding on this beach, was halved. In contrast to the consistently strong effects of trampling, natural habitat attributes (e.g. sediment grain size, compactness) were much less influential predictors. If acute suppression of invertebrates caused by trampling, as demonstrated here, is more widespread on beaches it may constitute a significant threat to endangered vertebrates reliant on these invertebrates. This calls for a re-thinking of conservation actions by considering active management of food resources, possibly through enhancement of wrack or direct augmentation of prey items to breeding territories.	[Schlacher, Thomas A.; Olds, Andrew D.; Gilby, Ben L.; Ekanayake, Kasun B.] Univ Sunshine Coast, Sch Sci & Engn, Q-4558, Maroochydore, Australia; [Carracher, Lucy K.; Porch, Nicholas; Ekanayake, Kasun B.; Weston, Michael A.] Deakin Univ, Sch Life & Environm, Ctr Integrat Ecol, Geelong, Vic, Australia; [Connolly, Rod M.] Griffith Univ, Australian Rivers Inst Coast & Estuaries, Gold Coast Campus, Southport, Qld, Australia; [Connolly, Rod M.] Griffith Univ, Sch Environm, Gold Coast Campus, Southport, Qld, Australia; [Maslo, Brooke] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, 55 Commercial Ave, New Brunswick, NJ 08901 USA	University of the Sunshine Coast; Deakin University; Griffith University; Griffith University; Rutgers State University New Brunswick	Schlacher, TA (corresponding author), Univ Sunshine Coast, Sch Sci & Engn, Q-4558, Maroochydore, Australia.	tschlach@usc.edu.au	Connolly, Rod M/C-4094-2008; Schlacher, Thomas/J-4614-2016	Connolly, Rod M/0000-0001-6223-1291; Olds, Andrew/0000-0002-8027-3599; Weston, Michael/0000-0002-8717-0410; Schlacher, Thomas/0000-0003-2184-9217				Anderson D. R., 2008, MODEL BASED INFERENC; Brindock KM, 2011, J WILDLIFE MANAGE, V75, P786, DOI 10.1002/jwmg.106; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; CAIRNS W E, 1982, Wilson Bulletin, V94, P531; Cuttriss A, 2015, MAR FRESHWATER RES, V66, P841, DOI 10.1071/MF14213; Dowling B, 1999, BIRD CONSERV INT, V9, P255, DOI 10.1017/S0959270900003440; Dugan JE, 2003, ESTUAR COAST SHELF S, V58, P25, DOI 10.1016/S0272-7714(03)00045-3; Eberhart-Phillips LJ, 2014, BIRD CONSERV INT, V24, P327, DOI 10.1017/S0959270913000506; Gorley C.K., 2006, GETTING STARTED PRIM; Huijbers CM, 2016, FUNCT ECOL, V30, P998, DOI 10.1111/1365-2435.12577; Jaramillo E, 1996, REV CHIL HIST NAT, V69, P655; Lastra M, 2010, MAR BIOL, V157, P613, DOI 10.1007/s00227-009-1346-3; Le Fer D, 2008, J WILDLIFE MANAGE, V72, P682, DOI 10.2193/2007-097; Lucrezi S, 2010, MAR FRESHWATER RES, V61, P951, DOI 10.1071/MF09259; Lucrezi S, 2009, ECOL INDIC, V9, P913, DOI 10.1016/j.ecolind.2008.10.013; Lucrezi S, 2009, ENVIRON MONIT ASSESS, V152, P413, DOI 10.1007/s10661-008-0326-2; Maguire GS, 2011, BIRD CONSERV INT, V21, P172, DOI 10.1017/S0959270910000420; Majka Christopher G., 2008, Wader Study Group Bulletin, V115, P77; Maslo B, 2012, J WILDLIFE MANAGE, V76, P181, DOI 10.1002/jwmg.210; Maslo B, 2011, RESTOR ECOL, V19, P194, DOI 10.1111/j.1526-100X.2010.00709.x; Maslo B, 2009, BIOL CONSERV, V142, P3213, DOI 10.1016/j.biocon.2009.07.034; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Meager JJ, 2012, DIVERS DISTRIB, V18, P294, DOI 10.1111/j.1472-4642.2011.00873.x; Moffett M. D., 1998, Journal of Coastal Conservation, V4, P87, DOI 10.1007/BF02806494; Barboza FR, 2015, SCI REP-UK, V5, DOI 10.1038/srep14515; Reyes-Martinez MJ, 2015, MAR ENVIRON RES, V103, P36, DOI 10.1016/j.marenvres.2014.11.005; Schlacher TA, 2008, ENVIRON MANAGE, V41, P878, DOI 10.1007/s00267-008-9071-0; Schlacher TA, 2007, MAR ECOL-EVOL PERSP, V28, P354, DOI 10.1111/j.1439-0485.2007.00156.x; Schlacher TA, 2007, DIVERS DISTRIB, V13, P556, DOI 10.1111/j.1472-4642.2007.00363.x; Schlacher TA, 2016, ESTUAR COAST SHELF S, V169, P56, DOI 10.1016/j.ecss.2015.11.025; Schlacher TA, 2015, ESTUAR COAST SHELF S, V157, P1, DOI 10.1016/j.ecss.2015.02.002; Schlacher TA, 2015, BIODIVERS CONSERV, V24, P493, DOI 10.1007/s10531-014-0830-3; Schlacher TA, 2014, J ENVIRON MANAGE, V144, P322, DOI 10.1016/j.jenvman.2014.05.036; Schlacher TA, 2014, MAR ECOL-EVOL PERSP, V35, P67, DOI 10.1111/maec.12055; Schlacher TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071200; Schlacher TA, 2013, ESTUAR COAST SHELF S, V118, P31, DOI 10.1016/j.ecss.2012.12.016; Schlacher TA, 2012, BIOL CONSERV, V147, P123, DOI 10.1016/j.biocon.2011.12.022; SHAFFER F, 1994, WILSON BULL, V106, P531; Stillman RA, 2002, J AVIAN BIOL, V33, P358, DOI 10.1034/j.1600-048X.2002.02925.x; Stillman RA, 2007, IBIS, V149, P73, DOI 10.1111/j.1474-919X.2007.00649.x; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Tulp I, 2009, AUK, V126, P155, DOI 10.1525/auk.2009.07181; VANDERMERWE D, 1992, OSTRICH, V63, P49, DOI 10.1080/00306525.1992.9633948; Veloso VG, 2008, MAR ECOL-EVOL PERSP, V29, P126, DOI 10.1111/j.1439-0485.2008.00222.x; Weston M. A., 2007, Journal of the Royal Society of Western Australia, V90, P89; Weston MA, 2005, EMU, V105, P283, DOI 10.1071/MU04004; Weston MA, 2014, FREE-RANGING DOGS AND WILDLIFE CONSERVATION, P94; Weston MA, 2014, ENVIRON MANAGE, V53, P999, DOI 10.1007/s00267-014-0256-4; Weston MA, 2009, WILDLIFE RES, V36, P289, DOI 10.1071/WR08084	50	31	32	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161905	10.1371/journal.pone.0161905	http://dx.doi.org/10.1371/journal.pone.0161905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564550	Green Published, gold, Green Submitted			2022-12-26	WOS:000382496300035
J	Mariano, AD; Kowaleski, MP; Boudrieau, RJ				Mariano, Abigail D.; Kowaleski, Michael P.; Boudrieau, Randy J.			Novel TPLO Alignment Jig/Saw Guide Reproduces Freehand and Ideal Osteotomy Positions	PLOS ONE			English	Article							PLATEAU-LEVELING OSTEOTOMY; IN-VITRO; ACCURACY; LIGAMENT; ANGLE	Objectives To evaluate the ability of an alignment jig/saw guide to reproduce appropriate osteotomy positions in the tibial plateau leveling osteotomy (TPLO) in the dog. Methods Lateral radiographs of 65 clinical TPLO procedures using an alignment jig and freehand osteotomy performed by experienced TPLO surgeons using a 24 mm radial saw blade between Dec 2005-Dec 2007 and Nov 2013-Nov 2015 were reviewed. The freehand osteotomy position was compared to potential osteotomy positions using the alignment jig/saw guide. The proximal and distal jig pin holes on postoperative radiographs were used to align the jig to the bone; saw guide position was selected to most closely match the osteotomy performed. The guide-to-osteotomy fit was categorized by the distance between the actual osteotomy and proposed saw guide osteotomy at its greatest offset (<= 1 mm = excellent; <= 2 mm = good; <= 3 mm = satisfactory; >3 mm = poor). Results Sixty-four of 65 TPLO osteotomies could be matched satisfactorily by the saw guide. Proximal jig pin placement 3-4 mm from the joint surface and pin location in a craniocaudal plane on the proximal tibia were significantly associated with the guide-to-osteotomy fit (P = 0.021 and P = 0.047, respectively). Clinical Significance The alignment jig/saw guide can be used to reproduce appropriate freehand osteotomy position for TPLO. Furthermore, an ideal osteotomy position centered on the tibial intercondylar tubercles also is possible. Accurate placement of the proximal jig pin is a crucial step for correct positioning of the saw guide in either instance.	[Mariano, Abigail D.; Kowaleski, Michael P.; Boudrieau, Randy J.] Tufts Univ, Cummings Sch Vet Med, Dept Clin Sci, North Grafton, MA 01536 USA	Tufts University	Boudrieau, RJ (corresponding author), Tufts Univ, Cummings Sch Vet Med, Dept Clin Sci, North Grafton, MA 01536 USA.	Randy.Boudrieau@tufts.edu						Bergh MS, 2008, VET SURG, V37, P374, DOI 10.1111/j.1532-950X.2008.00391.x; Burton NJ, 2013, VET SURG, V42, P28, DOI 10.1111/j.1532-950X.2012.01031.x; Collins JE, 2014, VET SURG, V43, P142, DOI 10.1111/j.1532-950X.2013.12093.x; Fischer C, 2015, ARCH MED VET, V47, P259, DOI 10.4067/S0301-732X2015000200021; Grierson J, 2005, VET COMP ORTHOPAED, V18, P215; Kowaleski MP, 2005, VET SURG, V34, P332, DOI 10.1111/j.1532-950X.2005.00051.x; Kowaleski MP, 2004, VET COMP ORTHOPAED, V17, P30; Kowaleski MP, 2012, VET SURG SMALL ANIMA, V1, P906; SLOCUM B, 1993, VET CLIN N AM-SMALL, V23, P777, DOI 10.1016/S0195-5616(93)50082-7; Tan CJ, 2014, VET SURG, V43, P525, DOI 10.1111/j.1532-950X.2014.12173.x; VASSEUR PB, 1981, AM J VET RES, V42, P1133; Wheeler JL, 2003, VET SURG, V32, P371, DOI 10.1053/jvet.2003.50038	12	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161110	10.1371/journal.pone.0161110	http://dx.doi.org/10.1371/journal.pone.0161110			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556230	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258100029
J	Basir, A; Grundeman, P; Moll, F; van Herwaarden, J; Pasterkamp, G; Nijland, R				Basir, Amir; Grundeman, Paul; Moll, Frans; van Herwaarden, Joost; Pasterkamp, Gerard; Nijland, Reindert			Adherence of Staphylococcus aureus to Dyneema Purity (R) Patches and to Clinically Used Cardiovascular Prostheses	PLOS ONE			English	Article							BACTERIAL BIOFILMS; VALVE ENDOCARDITIS	Various materials that are used for vascular and heart valve prostheses carry drawbacks: some require anticoagulant drugs or have moderate durability; others are not suitable for endovascular treatment. These prostheses are associated with bacterial infections. A material potentially suitable for prostheses is Dyneema Purity (R), made of ultra-high-molecular-weight polyethylene. Dyneema Purity (R) fibers are very thin, flexible, resistant to fatigue and abrasion, and have high strength. S. aureus adherence to Dyneema Purity (R) was tested and compared with currently used cardiovascular prostheses. We compared adhesion of S. aureus to Dyneema Purity (R) (1 membrane-based and 1 yarn-composed patch) with 5 clinically used yarn-composed polyester and membrane-based expanded polytetrafluoroethylene patches. Patches were contaminated with S. aureus bacteria and bacterial adherence was quantified. S. aureus adherence was also visualized in flow conditions. Overall, bacterial adherence was higher on yarn-composed prosthesis materials, with a rough surface, than on the membrane-based materials, with a smooth surface. Adherence to Dyneema Purity (R) materials was non-inferior to the currently used materials. Therefore, patches of Dyneema Purity (R) might be attractive for use in cardiovascular applications such as catheter-based heart valves and endovascular prostheses by their good mechanical properties combined with their noninferiority regarding bacterial adhesion.	[Basir, Amir; Grundeman, Paul; Pasterkamp, Gerard] UMC Utrecht, Dept Expt Cardiol, Utrecht, Netherlands; [Moll, Frans; van Herwaarden, Joost] UMC Utrecht, Dept Vasc Surg, Utrecht, Netherlands; [Nijland, Reindert] UMC Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Nijland, Reindert] Wageningen Univ, Lab Phytopathol, Wageningen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wageningen University & Research	Basir, A (corresponding author), UMC Utrecht, Dept Expt Cardiol, Utrecht, Netherlands.; Nijland, R (corresponding author), UMC Utrecht, Dept Med Microbiol, Utrecht, Netherlands.; Nijland, R (corresponding author), Wageningen Univ, Lab Phytopathol, Wageningen, Netherlands.	amirbasir@hotmail.com; reindert.nijland@wur.nl	Nijland, Reindert/B-8206-2008	Nijland, Reindert/0000-0003-0049-3768; van Herwaarden, Joost/0000-0003-1165-5179	University Medical Center Utrecht; DSM	University Medical Center Utrecht; DSM	University Medical Center Utrecht has a collaboration agreement with DSM, whereby DSM contributes its Dyneema Purity (R) fiber technology to enable UMC Utrecht to develop and evaluate a prototype of a non-biological supportive scaffold for the minimally invasive treatment of valvular and vascular diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas J, 2013, MOL MICROBIOL, V87, P254, DOI 10.1111/mmi.12097; Aydinuraz K, 2009, J SURG RES, V157, pE79, DOI 10.1016/j.jss.2009.04.008; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Basir Amir, 2015, Innovations (Phila), V10, P195, DOI 10.1097/IMI.0000000000000163; Begun J, 2007, PLOS PATHOG, V3, P526, DOI 10.1371/journal.ppat.0030057; Cornwett JL., RUTHERFORDS VASCULAR; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dingenen JLJv, 2001, HIGH PERFORMANCE FIB, P329; Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hasse B, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13754; Hurwit D, 2014, ARTHROSCOPY, V30, P1406, DOI 10.1016/j.arthro.2014.05.030; Joseph R, 2009, J MATER SCI-MATER M, V20, P153, DOI 10.1007/s10856-008-3502-6; Kim J, 2012, MOLECULES, V17, P9818, DOI 10.3390/molecules17089818; Kurtz SM, 2011, CLIN ORTHOP RELAT R, V469, P2262, DOI 10.1007/s11999-011-1872-4; Leroy O, 2012, CURR OPIN INFECT DIS, V25, P154, DOI 10.1097/QCO.0b013e3283501853; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; Naylor AR, 2001, EUR J VASC ENDOVASC, V21, P289, DOI 10.1053/ejvs.2001.1311; Peck M, 2012, CELLS TISSUES ORGANS, V195, P144, DOI 10.1159/000331406; Ricco JB, 2011, SEMIN VASC SURG, V24, P234, DOI 10.1053/j.semvascsurg.2011.10.006; Starakis Ioannis, 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P249; Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x; TORNOS P, 1992, CHEST, V101, P37, DOI 10.1378/chest.101.1.37; Wang A, 2007, JAMA-J AM MED ASSOC, V297, P1354, DOI 10.1001/jama.297.12.1354; Wust DM, 2006, ARTHROSCOPY, V22, P1146, DOI 10.1016/j.arthro.2006.06.013	26	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162216	10.1371/journal.pone.0162216	http://dx.doi.org/10.1371/journal.pone.0162216			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583703	Green Published, gold, Green Submitted			2022-12-26	WOS:000382855600120
J	Pramono, RXA; Imtiaz, SA; Rodriguez-Villegas, E				Pramono, Renard Xaviero Adhi; Imtiaz, Syed Anas; Rodriguez-Villegas, Esther			A Cough-Based Algorithm for Automatic Diagnosis of Pertussis	PLOS ONE			English	Article							SOUND; RECORDINGS	Pertussis is a contagious respiratory disease which mainly affects young children and can be fatal if left untreated. The World Health Organization estimates 16 million pertussis cases annually worldwide resulting in over 200,000 deaths. It is prevalent mainly in developing countries where it is difficult to diagnose due to the lack of healthcare facilities and medical professionals. Hence, a low-cost, quick and easily accessible solution is needed to provide pertussis diagnosis in such areas to contain an outbreak. In this paper we present an algorithm for automated diagnosis of pertussis using audio signals by analyzing cough and whoop sounds. The algorithm consists of three main blocks to perform automatic cough detection, cough classification and whooping sound detection. Each of these extract relevant features from the audio signal and subsequently classify them using a logistic regression model. The output from these blocks is collated to provide a pertussis likelihood diagnosis. The performance of the proposed algorithm is evaluated using audio recordings from 38 patients. The algorithm is able to diagnose all pertussis successfully from all audio recordings without any false diagnosis. It can also automatically detect individual cough sounds with 92% accuracy and PPV of 97%. The low complexity of the proposed algorithm coupled with its high accuracy demonstrates that it can be readily deployed using smartphones and can be extremely useful for quick identification or early screening of pertussis and for infection outbreaks control.	[Pramono, Renard Xaviero Adhi; Imtiaz, Syed Anas; Rodriguez-Villegas, Esther] Imperial Coll London, Dept Elect & Elect Engn, London, England	Imperial College London	Pramono, RXA (corresponding author), Imperial Coll London, Dept Elect & Elect Engn, London, England.	renard.pramono14@imperial.ac.uk		Pramono, Renard Xaviero Adhi/0000-0002-4731-2752; Imtiaz, Syed Anas/0000-0001-9017-8977				Abeyratne UR, 2013, IEEE ENG MED BIO, P5216, DOI 10.1109/EMBC.2013.6610724; Al-khassaweneh Mahmood, 2013, Journal of Medical Engineering & Technology, V37, P165, DOI 10.3109/03091902.2012.758322; Amrulloh YA, 2015, BIOMED SIGNAL PROCES, V21, P126, DOI 10.1016/j.bspc.2015.05.001; Barry Samantha J, 2006, Cough, V2, P8, DOI 10.1186/1745-9974-2-8; Brookes M., 2014, VOICEBOX SPEECH PROC; Chatrzarrin H., 2011, PROC IEEE 719 INT S, P162, DOI [10.1109/MeMeA.2011.5966670, DOI 10.1109/MEMEA.2011.5966670]; Chung KF, 2009, PULM PHARMACOL THER, V22, P139, DOI 10.1016/j.pupt.2008.12.008; Doherty MJ, 1997, EUR RESPIR J, V10, P202, DOI 10.1183/09031936.97.10010202; Gillet O, 2004, 2004 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH, AND SIGNAL PROCESSING, VOL IV, PROCEEDINGS, P269; Hankins RQ, 2014, INT CONF ELECTRO INF, P567, DOI 10.1109/EIT.2014.6871826; Jia-Ming Liu, 2013, 2013 IEEE China Summit and International Conference on Signal and Information Processing (ChinaSIP), P160, DOI 10.1109/ChinaSIP.2013.6625319; Korpas J, 1996, PULM PHARMACOL THER, V9, P261, DOI 10.1006/pulp.1996.0034; Kosasih K, 2012, IEEE ENG MED BIO, P5654, DOI 10.1109/EMBC.2012.6347277; Kosasih K, 2015, IEEE T BIO-MED ENG, V62, P1185, DOI 10.1109/TBME.2014.2381214; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Larson EC, 2011, UBICOMP'11: PROCEEDINGS OF THE 2011 ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P375, DOI 10.1145/2030112.2030163; Lucio C, 2014, 2014 7TH INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING AND INFORMATICS (BMEI 2014), P405, DOI 10.1109/BMEI.2014.7002808; Martinek J, 2008, J PHYSIOL PHARMACOL, V59, P433; MathWorks, 2016, MATLAB SIM TECHN COM; Matos S, 2006, IEEE T BIO-MED ENG, V53, P1078, DOI 10.1109/TBME.2006.873548; Morice AH, 2007, EUR RESPIR J, V29, P1256, DOI 10.1183/09031936.00101006; NHS, 2014, WHOOP COUGH SYMPT; Parker D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082971; Peeters G., 2004, LARGE AUDIO FEATURES; Pew Research Center, 2016, SMARTPH OWN INT US C; Public Health Agency of Canada, 2016, PERT WHOOP COUGH; Rabiner L., 1993, FUNDAMENTALS OF SPEE; Scheirer E, 1997, INT CONF ACOUST SPEE, P1331, DOI 10.1109/ICASSP.1997.596192; Swarnkar V, 2013, IEEE ENG MED BIO, P1764, DOI 10.1109/EMBC.2013.6609862; Swarnkar V, 2012, IEEE ENG MED BIO, P3147, DOI 10.1109/EMBC.2012.6346632; Swarnkar V, 2013, ANN BIOMED ENG, V41, P1016, DOI 10.1007/s10439-013-0741-6; Thorpe W, 2001, ANZIIS 2001: PROCEEDINGS OF THE SEVENTH AUSTRALIAN AND NEW ZEALAND INTELLIGENT INFORMATION SYSTEMS CONFERENCE, P391; Tracey BH, 2011, IEEE ENG MED BIO, P6017, DOI 10.1109/IEMBS.2011.6091487; World Health Organization, 2016, PERT	34	64	69	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162128	10.1371/journal.pone.0162128	http://dx.doi.org/10.1371/journal.pone.0162128			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583523	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600109
J	Di Carlo, S; Rossi, E; Politano, G; Inghilleri, S; Morbini, P; Calabrese, F; Benso, A; Savino, A; Cova, E; Zampieri, D; Meloni, F				Di Carlo, Stefano; Rossi, Elena; Politano, Gianfranco; Inghilleri, Simona; Morbini, Patrizia; Calabrese, Fiorella; Benso, Alfredo; Savino, Alessandro; Cova, Emanuela; Zampieri, Davide; Meloni, Federica			Identification of miRNAs Potentially Involved in Bronchiolitis Obliterans Syndrome: A Computational Study	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; MICRORNA EXPRESSION; FIBROSIS; GENES; TARGET; CANCER; ENRICHMENT; MIR-21; CELLS; MODEL	The pathogenesis of Bronchiolitis Obliterans Syndrome (BOS), the main clinical phenotype of chronic lung allograft dysfunction, is poorly understood. Recent studies suggest that epigenetic regulation of microRNAs might play a role in its development. In this paper we present the application of a complex computational pipeline to perform enrichment analysis of miRNAs in pathways applied to the study of BOS. The analysis considered the full set of miRNAs annotated in miRBase (version 21), and applied a sequence of filtering approaches and statistical analyses to reduce this set and to score the candidate miRNAs according to their potential involvement in BOS development. Dysregulation of two of the selected candidate miRNAs-miR-34a and miR-21 - was clearly shown in in-situ hybridization (ISH) on five explanted human BOS lungs and on a rat model of acute and chronic lung rejection, thus definitely identifying miR-34a and miR-21 as pathogenic factors in BOS and confirming the effectiveness of the computational pipeline.	[Di Carlo, Stefano; Politano, Gianfranco; Benso, Alfredo; Savino, Alessandro] Politecn Torino, Control & Comp Engn Dept, Turin, Italy; [Rossi, Elena; Morbini, Patrizia] Univ Pavia, Dept Mol Med, Pavia, Italy; [Meloni, Federica] Univ Pavia, Dept Internal Med, Pavia, Italy; [Inghilleri, Simona; Cova, Emanuela; Meloni, Federica] IRCCS Policlin S Matteo, Dept Resp Dis, Pavia, Italy; [Calabrese, Fiorella] Univ Padua, Dept Cardiovasc & Thorac Sci, Padua, Italy; [Zampieri, Davide] Univ Padua, Sch Med, Dept Cardiothorac & Vasc Sci, Thorac Surg Unit, Padua, Italy	Polytechnic University of Turin; University of Pavia; University of Pavia; IRCCS Fondazione San Matteo; University of Padua; University of Padua	Di Carlo, S (corresponding author), Politecn Torino, Control & Comp Engn Dept, Turin, Italy.	stefano.dicarlo@polito.it	morbini, patrizia/AAC-2658-2019; Benso, Alfredo/ABC-5311-2020; Savino, Alessandro/I-6132-2016; Benso, Alfredo/GRO-2198-2022; Di Carlo, Stefano/I-8872-2012; Rossi, Elena/O-1664-2016; MELONI, FEDERICA/K-5828-2016	morbini, patrizia/0000-0001-5012-5790; Benso, Alfredo/0000-0003-3433-7739; Savino, Alessandro/0000-0003-0529-7950; Di Carlo, Stefano/0000-0002-7512-5356; Rossi, Elena/0000-0001-9152-435X; MELONI, FEDERICA/0000-0003-4014-0617	 [Progetto Cariplo RIF. 2013-0943-BANDO 2013-Ricerca Medica]		This work was supported by Progetto Cariplo RIF. 2013-0943-BANDO 2013-Ricerca Medica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cavarretta E, 2015, EUR HEART J; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Chou C-H, 2015, NUCL ACIDS RES; Chung ACK, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00050; Cova E, 2015, NANOMEDICINE-UK, V10, P9, DOI 10.2217/nnm.13.208; Dai HY, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00032; Dai R, 2011, TRANSL RES, V157, P163, DOI 10.1016/j.trsl.2011.01.007; Dantas AT, 2015, PPAR RES, V2015, DOI 10.1155/2015/124624; Devulapally R, 2015, ACS NANO, V9, P2290, DOI 10.1021/nn507465d; Di Carlo Stefano, 2013, J Clin Bioinforma, V3, P20, DOI 10.1186/2043-9113-3-20; Dong M, 2015, INT J CLIN EXP PATHO, V8, P7050; Estenne M, 2002, AM J RESP CRIT CARE, V166, P440, DOI 10.1164/rccm.200201-003PP; Farooqi AA, 2014, ASIAN PAC J CANC PRE, V15; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Hammell M, 2010, SEMIN CELL DEV BIOL, V21, P738, DOI 10.1016/j.semcdb.2010.01.004; Heneghan HM, 2010, CURR OPIN PHARMACOL, V10, P543, DOI 10.1016/j.coph.2010.05.010; Hinske LC, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau099; Honeyman L, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-16; Hsieh WT, 2015, BMC SYST BIOL, V9, DOI 10.1186/1752-0509-9-S1-S5; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang Y, 2014, EXPERT OPIN THER TAR, V18, P1355, DOI 10.1517/14728222.2014.961424; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Jorgensen S, 2010, METHODS, V52, P375, DOI 10.1016/j.ymeth.2010.07.002; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li XJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.270; Li XF, 2015, MOL MED REP, V11, P1017, DOI 10.3892/mmr.2014.2846; Li YZ, 2011, ONCOL LETT, V2, P991, DOI 10.3892/ol.2011.351; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Lino Cardenas Christian L, 2013, Drug Discov Today Dis Models, V10, pe145; LITTELL RC, 1971, J AM STAT ASSOC, V66, P802, DOI 10.2307/2284230; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Manyam G, 2013, BIOINFORMATICS, V29, P2657, DOI 10.1093/bioinformatics/btt439; Montgomery SB, 2006, BIOINFORMATICS, V22, P637, DOI 10.1093/bioinformatics/btk027; Nagasaki M, 2009, FDN SYSTEMS BIOL USI, V13; O'Reilly S, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0929-x; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Orenstein Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046145; Pandit KV, 2011, TRANSL RES, V157, P191, DOI 10.1016/j.trsl.2011.01.012; Pena JTG, 2009, NAT METHODS, V6, P139, DOI [10.1038/NMETH.1294, 10.1038/nmeth.1294]; Politano G, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0964-2; Politano G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115585; Qiao PF, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1359-x; Riba A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003490; Ritchie W, 2010, BIOINFORMATICS, V26, P223, DOI 10.1093/bioinformatics/btp649; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Sayers E., 2010, GEN INTRO E UTILITIE; Seca H, 2013, CURR DRUG TARGETS, V14, P1135, DOI 10.2174/13894501113149990185; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Steinfeld I, 2012, NUCL ACIDS RES; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Todd JL, 2011, CHEST, V140, P502, DOI 10.1378/chest.10-2838; Tong BD, 2015, MOL VIS, V21, P324; Wang J, 2015, GENET MOL RES, V14, P19309, DOI 10.4238/2015.December.29.40; Wilflingseder J, 2015, NEPHROL DIAL TRANSPL, V30, P910, DOI 10.1093/ndt/gfu280; Xie Y, 2010, LUNG CANCER, V67, P170, DOI 10.1016/j.lungcan.2009.04.004; Xu XL, 2012, KIDNEY INT, V82, P1167, DOI 10.1038/ki.2012.241; Xu Z, 2015, AM J TRANSPLANT, V15, P1933, DOI 10.1111/ajt.13185; Zampetaki A, 2012, CIRC RES, V110, P508, DOI 10.1161/CIRCRESAHA.111.247445; Zanotti S, 2015, BBA-MOL BASIS DIS, V1852, P1451, DOI 10.1016/j.bbadis.2015.04.013; Zhao F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114549	69	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161771	10.1371/journal.pone.0161771	http://dx.doi.org/10.1371/journal.pone.0161771			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564214	Green Published, gold, Green Submitted			2022-12-26	WOS:000382496300016
J	Korjus, K; Hebart, MN; Vicente, R				Korjus, Kristjan; Hebart, Martin N.; Vicente, Raul			An Efficient Data Partitioning to Improve Classification Performance While Keeping Parameters Interpretable	PLOS ONE			English	Article							ERROR ESTIMATION	Supervised machine learning methods typically require splitting data into multiple chunks for training, validating, and finally testing classifiers. For finding the best parameters of a classifier, training and validation are usually carried out with cross-validation. This is followed by application of the classifier with optimized parameters to a separate test set for estimating the classifier's generalization performance. With limited data, this separation of test data creates a difficult trade-off between having more statistical power in estimating generalization performance versus choosing better parameters and fitting a better model. We propose a novel approach that we term "Cross-validation and cross-testing" improving this trade-off by re-using test data without biasing classifier performance. The novel approach is validated using simulated data and electrophysiological recordings in humans and rodents. The results demonstrate that the approach has a higher probability of discovering significant results than the standard approach of cross-validation and testing, while maintaining the nominal alpha level. In contrast to nested cross-validation, which is maximally efficient in re-using data, the proposed approach additionally maintains the interpretability of individual parameters. Taken together, we suggest an addition to currently used machine learning approaches which may be particularly useful in cases where model weights do not require interpretation, but parameters	[Korjus, Kristjan; Vicente, Raul] Univ Tartu, Inst Comp Sci, Computat Neurosci Lab, Tartu, Estonia; [Hebart, Martin N.] Univ Klinikum Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany	University of Tartu; University of Hamburg; University Medical Center Hamburg-Eppendorf	Korjus, K (corresponding author), Univ Tartu, Inst Comp Sci, Computat Neurosci Lab, Tartu, Estonia.	korjus@gmail.com		Hebart, Martin/0000-0001-7257-428X	Estonian Research Council [PUT438]	Estonian Research Council(Estonian Research Council)	RV thanks the financial support from the Estonian Research Council through the personal research grants program (PUT438 grant). Website of the funder: http://www.etag.ee/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Andero Uusberg and Kairi Kreegipuu for sharing the EEG data set. We would also like to thank George Prichard, Ardi Tampuu, Jaan Aru, and Ilya Kuzovkin for reading and commenting the manuscript. RV also thanks the financial support from the Estonian Research Council through the personal research grants program (PUT438 grant).	Allefeld C, 2016, NEUROIMAGE, V141, P378, DOI 10.1016/j.neuroimage.2016.07.040; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Efron B, 1994, INTRO BOOTSTRAP; Ernst MD, 2004, STAT SCI, V19, P676, DOI 10.1214/088342304000000396; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Kohavi R., 1995, P INT JOINT C ARTIFI, P1137, DOI DOI 10.1067/MOD.2000.109031; Korjus K, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00063; Larranaga P, 2006, BRIEF BIOINFORM, V7, P86, DOI 10.1093/bib/bbk007; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Pereira Francisco, 2009, Neuroimage, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Teeters JL, 2008, NEUROINFORMATICS, V6, P47, DOI 10.1007/s12021-008-9009-y; Varma S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-91; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9	16	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161788	10.1371/journal.pone.0161788	http://dx.doi.org/10.1371/journal.pone.0161788			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564393	Green Published, gold, Green Submitted			2022-12-26	WOS:000382496300018
J	Wang, MC; Dai, GM; Choo, KKR; Jayaraman, PP; Ranjan, R				Wang, Maocai; Dai, Guangming; Choo, Kim-Kwang Raymond; Jayaraman, Prem Prakash; Ranjan, Rajiv			Constructing Pairing-Friendly Elliptic Curves under Embedding Degree 1 for Securing Critical Infrastructures	PLOS ONE			English	Article							G-HADOOP; CYBERINFRASTRUCTURE	Information confidentiality is an essential requirement for cyber security in critical infrastructure. Identity-based cryptography, an increasingly popular branch of cryptography, is widely used to protect the information confidentiality in the critical infrastructure sector due to the ability to directly compute the user's public key based on the user's identity. However, computational requirements complicate the practical application of Identity-based cryptography. In order to improve the efficiency of identity-based cryptography, this paper presents an effective method to construct pairing-friendly elliptic curves with low hamming weight 4 under embedding degree 1. Based on the analysis of the Complex Multiplication(CM) method, the soundness of our method to calculate the characteristic of the finite field is proved. And then, three relative algorithms to construct pairing-friendly elliptic curve are put forward. 10 elliptic curves with low hamming weight 4 under 160 bits are presented to demonstrate the utility of our approach. Finally, the evaluation also indicates that it is more efficient to compute Tate pairing with our curves, than that of Bertoni et al.	[Wang, Maocai; Dai, Guangming; Choo, Kim-Kwang Raymond] China Univ Geosci, Sch Comp, Wuhan, Hubei, Peoples R China; [Wang, Maocai; Dai, Guangming; Choo, Kim-Kwang Raymond] China Univ Geosci, Hubei Key Lab Intelligent Geoinformat Proc, Wuhan, Hubei, Peoples R China; [Choo, Kim-Kwang Raymond] Univ Texas San Antonio, Dept Informat Syst & Cyber Secur, San Antonio, TX USA; [Jayaraman, Prem Prakash] RMIT Univ, Melbourne, Vic, Australia; [Ranjan, Rajiv] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England	China University of Geosciences; China University of Geosciences; University of Texas System; University of Texas at San Antonio (UTSA); Royal Melbourne Institute of Technology (RMIT); Newcastle University - UK	Dai, GM (corresponding author), China Univ Geosci, Sch Comp, Wuhan, Hubei, Peoples R China.; Dai, GM (corresponding author), China Univ Geosci, Hubei Key Lab Intelligent Geoinformat Proc, Wuhan, Hubei, Peoples R China.	cugdgm@126.com	Ranjan, Rajiv/F-4700-2011; Choo, Kim-Kwang Raymond/A-3634-2009	Ranjan, Rajiv/0000-0002-6610-1328; Choo, Kim-Kwang Raymond/0000-0001-9208-5336; Jayaraman, Prem Prakash/0000-0003-4500-3443; Wang, Maocai/0000-0002-5495-6417	National Natural Science Foundation of China [41571403, 61472375]; China Postdoctoral Science Foundation [2012T50681, 2011M501260]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Natural Science Foundation of China (Grant No. 41571403 and 61472375, http://www.nsfc.gov.cn/) and China Postdoctoral Science Foundation (Grant No. 2012T50681 and 2011M501260, www.chinapostdoctor.org.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreto PSLM, 2007, DESIGN CODE CRYPTOGR, V42, P239, DOI 10.1007/s10623-006-9033-6; Barreto PSLM, 2006, LECT NOTES COMPUT SC, V3897, P319; Bertoni G, 2005, P P WORKSH CRYPT HAR; Brezing F, 2005, DESIGN CODE CRYPTOGR, V37, P133, DOI 10.1007/s10623-004-3808-4; Chen D, 2013, MOBILE NETW APPL, V18, P651, DOI 10.1007/s11036-013-0456-9; Choo Kim-Kwang Raymond, 2010, Information Security Technical Report, V15, P104, DOI 10.1016/j.istr.2009.09.001; Choo KKR, 2011, COMPUT SECUR, V30, P719, DOI 10.1016/j.cose.2011.08.004; Cocks C, 2001, IDENTITY BASED CRYPT; Cornish P, 2011, CYBER SECURITY UKS C; Dai GM, 2011, INTELL AUTOM SOFT CO, V17, P607, DOI 10.1080/10798587.2011.10643174; Dong MX, 2016, IEEE T COMPUT AID D, V35, P712, DOI 10.1109/TCAD.2016.2539327; Dong MX, 2015, IEEE NETWORK, V29, P40, DOI 10.1109/MNET.2015.7166189; Duursma I, 2003, LECT NOTES COMPUT SC, V2894, P111; Eisentrager K, 2003, LECT NOTES COMPUT SC, V2612, P343; Fotiadis G, 2014, LECT NOTES COMPUT SC, V8813, P384, DOI 10.1007/978-3-319-12280-9_25; Freeman D, 2006, LECT NOTES COMPUT SC, V4076, P452; FREY G, 1994, MATH COMPUT, V62, P865, DOI 10.2307/2153546; IEEE-SA Standards Board, 2000, IEEE STAND SPEC PUBL; Izuta T, 2010, TENCON IEEE REGION, P769, DOI 10.1109/TENCON.2010.5686593; Jie W, 2007, PARALLEL COMPUT, V33, P572, DOI 10.1016/j.parco.2007.05.001; Joye M., 2008, IDENTITY BASED CRYPT; Kepler D, 2013, IMPLEMENTATION EO 13; Kolodziej J, 2014, FUTURE GENER COMP SY, V31, P77, DOI 10.1016/j.future.2012.09.009; Lee HS, 2009, LECT NOTES COMPUT SC, V5671, P66; Mao W., 2003, MODERN CRYPTOGRAPHY; MENEZES AJ, 1993, IEEE T INFORM THEORY, V39, P1639, DOI 10.1109/18.259647; Miller VS, 2004, J CRYPTOL, V17, P235, DOI 10.1007/s00145-004-0315-8; Miyaji A, 2001, IEICE T FUND ELECTR, VE84A, P1234; Moody D, 2015, J RES NATL INST STAN, V120, P11, DOI 10.6028/jres.120.002; Perera C, 2015, IT PROF, V17, P32, DOI 10.1109/MITP.2015.34; Pollard J. M., 1975, BIT (Nordisk Tidskrift for Informationsbehandling), V15, P331, DOI 10.1007/BF01933667; Rahuman AK, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/675161; Raymond CA, 2014, ICTS MILLENNIUM DEV, P81; Wang CJ, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/810969; Wang LZ, 2013, J SUPERCOMPUT, V66, P1178, DOI 10.1007/s11227-011-0666-5; Wang LZ, 2013, COMPUT ELECTR ENG, V39, P3, DOI 10.1016/j.compeleceng.2012.05.001; Wang LZ, 2013, FUTURE GENER COMP SY, V29, P739, DOI 10.1016/j.future.2012.09.001; Wang LZ, 2010, NEW GENERAT COMPUT, V28, P111, DOI 10.1007/s00354-009-0077-9; Yang Y, 2015, P INT WORKSH LIGHTW; Zhang FG, 2004, LECT NOTES COMPUT SC, V2947, P277; Zhang WF, 2013, CONCURR COMP-PRACT E, V25, P1798, DOI 10.1002/cpe.2966; Zhao JQ, 2014, J COMPUT SYST SCI, V80, P994, DOI 10.1016/j.jcss.2014.02.006	42	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161857	10.1371/journal.pone.0161857	http://dx.doi.org/10.1371/journal.pone.0161857			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564373	Green Published, gold, Green Submitted			2022-12-26	WOS:000382496300025
J	Hird, TR; Pirie, FJ; Esterhuizen, TM; O'Leary, B; McCarthy, MI; Young, EH; Sandhu, MS; Motala, AA				Hird, Thomas R.; Pirie, Fraser J.; Esterhuizen, Tonya M.; O'Leary, Brian; McCarthy, Mark I.; Young, Elizabeth H.; Sandhu, Manjinder S.; Motala, Ayesha A.			Burden of Diabetes and First Evidence for the Utility of HbA1c for Diagnosis and Detection of Diabetes in Urban Black South Africans: The Durban Diabetes Study	PLOS ONE			English	Article							PREVALENCE; GLYCEMIA; HBA(1C)	Objective Glycated haemoglobin (HbA(1c)) is recommended as an additional tool to glucose-based measures (fasting plasma glucose [FPG] and 2-hour plasma glucose [2PG] during oral glucose tolerance test [OGTT]) for the diagnosis of diabetes; however, its use in sub-Saharan African populations is not established. We assessed prevalence estimates and the diagnosis and detection of diabetes based on OGTT, FPG, and HbA(1c) in an urban black South African population. Research Design and Methods We conducted a population-based cross-sectional survey using multistage cluster sampling of adults aged >= 18 years in Durban (eThekwini municipality), KwaZulu-Natal. All participants had a 75-g OGTT and HbA(1c) measurements. Receiver operating characteristic (ROC) analysis was used to assess the overall diagnostic accuracy of HbA(1c), using OGTT as the reference, and to determine optimal HbA(1c) cut-offs. Results Among 1190 participants (851 women, 92.6% response rate), the age-standardised prevalence of diabetes was 12.9% based on OGTT, 11.9% based on FPG, and 13.1% based on HbA(1c). In participants without a previous history of diabetes (n = 1077), using OGTT as the reference, an HbA(1c) >= 48 mmol/mol (6.5%) detected diabetes with 70.3% sensitivity (95% CI 52.7-87.8) and 98.7% specificity (95% CI 97.9-99.4) (AUC 0.94 [95% CI 0.89-1.00]). Additional analyses suggested the optimal HbA(1c) cut-off for detection of diabetes in this population was 42 mmol/mol (6.0%) (sensitivity 89.2%[95% CI 78.6-99.8], specificity 92.0% [95% CI: 90.3-93.7]). Conclusions In an urban black South African population, we found a high prevalence of diabetes and provide the first evidence for the utility of HbA(1c) for the diagnosis and detection of diabetes in black Africans in sub-Saharan Africa.	[Hird, Thomas R.; Young, Elizabeth H.; Sandhu, Manjinder S.] Univ Cambridge, Dept Med, Cambridge, England; [Hird, Thomas R.; Young, Elizabeth H.; Sandhu, Manjinder S.] Wellcome Trust Sanger Inst, Hinxton, England; [Pirie, Fraser J.; Motala, Ayesha A.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Endocrinol & Diabet, Durban, South Africa; [Esterhuizen, Tonya M.] Univ Stellenbosch, Fac Med & Hlth Sci, Ctr Evidence Based Hlth Care, Stellenbosch, South Africa; [O'Leary, Brian] eThekwini Municipal, Off Strategy Management, Res & Policy Dept, Durban, South Africa; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX1 2JD, England	University of Cambridge; Wellcome Trust Sanger Institute; University of Kwazulu Natal; Stellenbosch University; University of Oxford	Sandhu, MS (corresponding author), Univ Cambridge, Dept Med, Cambridge, England.; Sandhu, MS (corresponding author), Wellcome Trust Sanger Inst, Hinxton, England.; Motala, AA (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Endocrinol & Diabet, Durban, South Africa.	ms23@sanger.ac.uk; motala@ukzn.ac.za	; McCarthy, Mark/M-3763-2015	Motala, Ayesha/0000-0003-0517-1784; Hird, Thomas Robert/0000-0003-3423-4617; McCarthy, Mark/0000-0002-4393-0510	Wellcome Trust [098051]; African Partnership for Chronic Disease Research (Medical Research Council UK partnership) [MR/K013491/1]; National Institute for Health Research, Cambridge Biomedical Research Centre (UK); Novo-Nordisk (South Africa); Sanofi Aventis (South Africa); MSD Pharmaceuticals (Pty) Ltd (Southern Africa); Medical Research Council [MR/K013491/1] Funding Source: researchfish; MRC [MR/K013491/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); African Partnership for Chronic Disease Research (Medical Research Council UK partnership)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research, Cambridge Biomedical Research Centre (UK)(National Institute for Health Research (NIHR)); Novo-Nordisk (South Africa)(Novo Nordisk); Sanofi Aventis (South Africa); MSD Pharmaceuticals (Pty) Ltd (Southern Africa); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was partly supported by the Wellcome Trust (grant number 098051), the African Partnership for Chronic Disease Research (Medical Research Council UK partnership grant number MR/K013491/1), the National Institute for Health Research, Cambridge Biomedical Research Centre (UK). The study was also partly supported by the following commercial funders; Novo-Nordisk (South Africa), Sanofi Aventis (South Africa), and MSD Pharmaceuticals (Pty) Ltd (Southern Africa). These funders played no role in the study design, conduct or analysis, or in the decision to submit the manuscript for publication.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Atun R, 2015, LANCET DIABETES ENDO, V3, P675, DOI 10.1016/S2213-8587(15)00236-3; Beran D, 2015, CURR DIABETES REP, V15, P591, DOI DOI 10.1007/S11892-015-0591-8.(HTTPS://WWW.RESEARCHGATE.NET/PUBLICATI0N/272835492_THE_IMPACT_0F_HEALTH_SYS-TEMS_0N_DIABETES_CARE_IN_L0W_AND_L0WER_MIDDLE_INC0ME_C0UNTRIES/CITATI0N/D0WNL0AD); Bonora E, 2011, DIABETES CARE, V34, pS184, DOI 10.2337/dc11-s216; Camara A, 2015, DIABETES RES CLIN PR, V108, P187, DOI 10.1016/j.diabres.2014.08.025; Christensen DL, 2010, DIABETES CARE, V33, P580, DOI 10.2337/dc09-1843; Danaei G, 2015, LANCET DIABETES ENDO, V3, P624, DOI 10.1016/S2213-8587(15)00129-1; Echouffo-Tcheugui JB, 2012, DIABETES RES CLIN PR, V98, P199, DOI 10.1016/j.diabres.2012.08.003; English E, 2015, DIABETOLOGIA, V58, P1409, DOI 10.1007/s00125-015-3599-3; Han TS, 2006, BMJ-BRIT MED J, V333, P695, DOI 10.1136/bmj.333.7570.695; Hare MJL, 2016, CURR DIABETES REV, V12, P51, DOI 10.2174/1573399811666150211112455; Herman WH, 2012, J CLIN ENDOCR METAB, V97, P1067, DOI 10.1210/jc.2011-1894; Hird TR, 2016, STUDY PROFILE DURBAN, P1; International Diabetes Federation, 2015, IDF DIABETES ATLAS; International Diabetes Federation (IDF), 2006, IDF CONS WORLDW DEF; Kim PS, 2009, DIABETES CARE, V32, P1591, DOI 10.2337/dc09-0177; Klug EQ, 2012, SAMJ S AFR MED J, V102, P178, DOI 10.7196/SAMJ.5502; Krause A, 2013, SAMJ S AFR MED J, V103, P989, DOI [10.7196/samj.7255, 10.7196/SAMJ.7255]; Lin CN, 2012, CLIN CHIM ACTA, V413, P819, DOI 10.1016/j.cca.2011.12.019; Maharaj R, 2013, SAMJ S AFR MED J, V103, P779, DOI [10.7196/samj.7441, 10.7196/SAMJ.7441]; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Motala AA, 2008, DIABETES CARE, V31, P1783, DOI 10.2337/dc08-0212; OMAR MAK, 1993, S AFR MED J, V83, P641; Peer N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043336; Preiss D, 2011, DIABETIC MED, V28, P19, DOI 10.1111/j.1464-5491.2010.03157.x; Rogan N, 2009, INTERNAL MIGRATION P; Rutjes A W S, 2007, Health Technol Assess, V11, pix; Sobngwi E, 2011, DIABETES VOICE, V56, P36; W.H. Organization, 1999, DEFINITION DIAGNOSIS; WHO, 2000, OB PREV MAN GLOB EP; Wonkam A, 2012, SAMJ S AFR MED J, V102, P752, DOI [10.7196/SAMJ.5886, 10.7196/samj.5886]; World Health Organization, WHO STEPWISE APPR NO; World Health Organization, 2011, US GLYC HAEM HBA1C D; World Health Organization (WHO), 2008, FRAM MON EV IMPL GLO; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	35	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161966	10.1371/journal.pone.0161966	http://dx.doi.org/10.1371/journal.pone.0161966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560687	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258600122
J	Shi, ZZ; Chapes, SK; Ben-Arieh, D; Wu, CH				Shi, Zhenzhen; Chapes, Stephen K.; Ben-Arieh, David; Wu, Chih-Hang			An Agent-Based Model of a Hepatic Inflammatory Response to Salmonella: A Computational Study under a Large Set of Experimental Data	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MOBILITY GROUP BOX-1; C-REACTIVE PROTEIN; NEUTROPHIL EXTRACELLULAR TRAPS; INTRAHEPATIC MAST-CELLS; KUPFFER CELLS; FACTOR-ALPHA; MONOCLONAL-ANTIBODY; BACTERIAL CLEARANCE; CLINICAL-TRIALS	We present an agent-based model (ABM) to simulate a hepatic inflammatory response (HIR) in a mouse infected by Salmonella that sometimes progressed to problematic proportions, known as "sepsis". Based on over 200 published studies, this ABM describes interactions among 21 cells or cytokines and incorporates 226 experimental data sets and/or data estimates from those reports to simulate a mouse HIR in silico. Our simulated results reproduced dynamic patterns of HIR reported in the literature. As shown in vivo, our model also demonstrated that sepsis was highly related to the initial Salmonella dose and the presence of components of the adaptive immune system. We determined that high mobility group box-1, C-reactive protein, and the interleukin-10: tumor necrosis factor-a ratio, and CD4+ T cell: CD8+ T cell ratio, all recognized as biomarkers during HIR, significantly correlated with outcomes of HIR. During therapy-directed silico simulations, our results demonstrated that anti-agent intervention impacted the survival rates of septic individuals in a time-dependent manner. By specifying the infected species, source of infection, and site of infection, this ABM enabled us to reproduce the kinetics of several essential indicators during a HIR, observe distinct dynamic patterns that are manifested during HIR, and allowed us to test proposed therapy-directed treatments. Although limitation still exists, this ABM is a step forward because it links underlying biological processes to computational simulation and was validated through a series of comparisons between the simulated results and experimental studies.	[Shi, Zhenzhen; Ben-Arieh, David; Wu, Chih-Hang] Kansas State Univ, Dept Ind & Mfg Syst Engn, Hlth Care Operat Resource Ctr, Manhattan, KS 66506 USA; [Chapes, Stephen K.] Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA; [Shi, Zhenzhen] Kansas State Univ, Inst Computat Comparat Med, Manhattan, KS 66506 USA	Kansas State University; Kansas State University; Kansas State University	Wu, CH (corresponding author), Kansas State Univ, Dept Ind & Mfg Syst Engn, Hlth Care Operat Resource Ctr, Manhattan, KS 66506 USA.	chw@ksu.edu	Wu, Chih-Hang/C-2518-2015	Wu, Chih-Hang/0000-0001-9929-4421; Shi, Zhenzhen/0000-0001-9922-3957	China Scholarship Council; National Institutes of Health (NIH) [GM103418]; National Aeronautics and Space Administration (NASA) [NNX13AN34G, NNX15AB45G]; Healthcare Operations Resource Center at Kansas State University; Kansas State University Open Access Publishing Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103418] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); Healthcare Operations Resource Center at Kansas State University; Kansas State University Open Access Publishing Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ZZS was supported by China Scholarship Council. SKC has been supported by National Institutes of Health (NIH) grant GM103418 and National Aeronautics and Space Administration (NASA) grants NNX13AN34G and NNX15AB45G. DBA and CW have been supported by the Healthcare Operations Resource Center at Kansas State University. Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2004, HEPATOLOGY, V40, P414, DOI 10.1002/hep.20301; ABRAHAM E, 1995, JAMA-J AM MED ASSOC, V273, P934, DOI 10.1001/jama.273.12.934; Abraham E, 1998, LANCET, V351, P929; Abraham SN, 1997, INFECT IMMUN, V65, P3501, DOI 10.1128/IAI.65.9.3501-3508.1997; Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; An G, 2004, CRIT CARE MED, V32, P2050, DOI 10.1097/01.CCM.0000139707.13729.7D; An G, 2001, SHOCK, V16, P266, DOI 10.1097/00024382-200116040-00006; An G, 2009, WIRES SYST BIOL MED, V1, P159, DOI 10.1002/wsbm.45; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2007, CRIT CARE MED, V35, P1061, DOI 10.1097/01.CCM.0000259534.68873.2A; Araujo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072206; Axelrod R., 1997, COMPLEXITY COOPERATI, DOI [10.1515/9781400822300, DOI 10.1515/9781400822300]; Aziz M, 2013, J LEUKOCYTE BIOL, V93, P329, DOI 10.1189/jlb.0912437; BARDADIN KA, 1986, J PATHOL, V149, P315, DOI 10.1002/path.1711490408; Bauer AL, 2009, INFORM SCIENCES, V179, P1379, DOI 10.1016/j.ins.2008.11.012; Bellingan GJ, 1996, J IMMUNOL, V157, P2577; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Beuzon CR, 2002, MICROBIOL-SGM, V148, P2705, DOI 10.1099/00221287-148-9-2705; Bharadwaj D, 1999, J EXP MED, V190, P585, DOI 10.1084/jem.190.4.585; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Chapes SK, 1998, J LEUKOCYTE BIOL, V63, P297, DOI 10.1002/jlb.63.3.297; Chen GQ, 2004, J LEUKOCYTE BIOL, V76, P994, DOI 10.1189/jlb.0404242; Chung KH, 2010, J IND ENG CHEM, V16, P115, DOI 10.1016/j.jiec.2010.01.009; Clair JMS, 2004, J CLIN INVEST, V113, P628, DOI 10.1172/JCI200419062; Cohen J, 1996, CRIT CARE MED, V24, P1431, DOI 10.1097/00003246-199609000-00002; CONLAN JW, 1992, INFECT IMMUN, V60, P5164, DOI 10.1128/IAI.60.12.5164-5171.1992; Conlan JW, 1996, INFECT IMMUN, V64, P1043, DOI 10.1128/IAI.64.3.1043-1047.1996; Cross AS, 2003, ANN INTERN MED, V138, P502, DOI 10.7326/0003-4819-138-6-200303180-00016; Czura CJ, 2003, J INFECT DIS, V187, pS391, DOI 10.1086/374753; Daniels R, 2011, J ANTIMICROB CHEMOTH, V66, pII11, DOI 10.1093/jac/dkq515; de Jong HK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002933; DIESSELHOFFDENDULK MMC, 1979, IMMUNOLOGY, V37, P7; Dietrich N, 2010, P NATL ACAD SCI USA, V107, P8748, DOI 10.1073/pnas.0912551107; Dimopoulou I, 2007, CYTOKINE, V37, P55, DOI 10.1016/j.cyto.2007.02.023; Dong X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009249; dos Santos SA, 2011, REV INST MED TROP SP, V53, P107, DOI 10.1590/S0036-46652011000200009; Du Clos TW, 2000, ANN MED, V32, P274, DOI 10.3109/07853890009011772; Dutta-Moscato Joyeeta, 2014, Front Bioeng Biotechnol, V2, P18, DOI 10.3389/fbioe.2014.00018; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Epstein J.M., 1996, GROWING ARTIFICIAL S; FARRELL DJ, 1995, HEPATOLOGY, V22, P1175, DOI 10.1016/0270-9139(95)90627-4; Ferrer R, 2014, CRIT CARE MED, V42, P1749, DOI 10.1097/CCM.0000000000000330; Folcik VA, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-39; FRIEDMAN RL, 1977, INFECT IMMUN, V16, P1005, DOI 10.1128/IAI.16.3.1005-1012.1977; Gallin JI., 1992, INFLAMMATION BASIC P; Ganta RR, 2007, INFECT IMMUN, V75, P135, DOI 10.1128/IAI.01127-06; Gao B, 2012, J GASTROEN HEPATOL, V27, P89, DOI 10.1111/j.1440-1746.2011.07003.x; GENG Y, 1994, P NATL ACAD SCI USA, V91, P8602, DOI 10.1073/pnas.91.18.8602; Gibot S, 2007, INTENS CARE MED, V33, P1347, DOI 10.1007/s00134-007-0691-2; Glauser MP, 2000, CRIT CARE MED, V28, pS4, DOI 10.1097/00003246-200009001-00002; Gog JR, 2012, J R SOC INTERFACE, V9, P2696, DOI 10.1098/rsif.2012.0163; Goswami B, 2009, CLIN CHIM ACTA, V408, P14, DOI 10.1016/j.cca.2009.06.029; Graham SM, 2002, CURR OPIN INFECT DIS, V15, P507, DOI 10.1097/00001432-200210000-00009; Gregory SH, 1996, J IMMUNOL, V157, P2514; Gregory SH, 2002, J LEUKOCYTE BIOL, V72, P239; Hart ML, 2003, INFECT IMMUN, V71, P663, DOI 10.1128/IAI.71.2.663-670.2003; Haveman JW, 1999, NETH J MED, V55, P132, DOI 10.1016/S0300-2977(98)00156-9; Helaine S, 2010, P NATL ACAD SCI USA, V107, P3746, DOI 10.1073/pnas.1000041107; Hess J, 1996, J IMMUNOL, V156, P3321; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huang H, 2014, HEPATOLOGY, V59, P1984, DOI 10.1002/hep.26976; Inatsu A, 2009, HEPATOLOGY, V49, P2044, DOI 10.1002/hep.22888; Ishibashi H, 2009, SEMIN IMMUNOPATHOL, V31, P399, DOI 10.1007/s00281-009-0155-6; Jaeschke H, 2006, TOXICOL SCI, V89, P31, DOI 10.1093/toxsci/kfi336; Jaeschke H, 1997, J LEUKOCYTE BIOL, V61, P647, DOI 10.1002/jlb.61.6.647; Janeway C., 2005, IMMUNOBIOLOGY IMMUNE; JOTWANI R, 1995, J MED MICROBIOL, V42, P348, DOI 10.1099/00222615-42-5-348; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kasten KR, 2010, SHOCK, V34, P327, DOI 10.1097/SHK.0b013e3181e14c2e; Kasten KR, 2010, BIOCHEM BIOPH RES CO, V393, P28, DOI 10.1016/j.bbrc.2010.01.066; Keir I, 2015, J VET EMERG CRIT CAR, V25, P55, DOI 10.1111/vec.12272; Khan SA, 2001, MICROB PATHOGENESIS, V30, P29, DOI 10.1006/mpat.2000.0405; Kindt TJ, 2006, KUBY IMMUNOLOGY; Kumar R, 2004, J THEOR BIOL, V230, P145, DOI 10.1016/j.jtbi.2004.04.044; Kumar V, 2010, INT IMMUNOPHARMACOL, V10, P1325, DOI 10.1016/j.intimp.2010.08.012; Lacy P, 2011, BLOOD, V118, P9, DOI 10.1182/blood-2010-08-265892; Lalor PF, 2002, IMMUNOL CELL BIOL, V80, P52, DOI 10.1046/j.1440-1711.2002.01062.x; Lau DCW, 2005, AM J PHYSIOL-HEART C, V288, pH2031, DOI 10.1152/ajpheart.01058.2004; LEIST M, 1995, J IMMUNOL, V154, P1307; Liaskou E, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/949157; Lindgren SW, 1996, P NATL ACAD SCI USA, V93, P4197, DOI 10.1073/pnas.93.9.4197; Liu XD, 2011, J IMMUNOL, V186, P4674, DOI 10.4049/jimmunol.1003584; Malarkey DE, 2005, TOXICOL PATHOL, V33, P27, DOI 10.1080/01926230590881826; Malhi H, 2010, PHYSIOL REV, V90, P1165, DOI 10.1152/physrev.00061.2009; Maurer M, 2004, NATURE, V432, P512, DOI 10.1038/nature03085; Melamed A, 2009, CRIT CARE, V13, DOI 10.1186/cc7733; Morris C, 2002, ANAESTHESIA, V57, P502, DOI 10.1046/j.1365-2044.2002.26264.x; Mosser DM, 2011, CURRENT PROTOCOLS IM, DOI 10.1002/0471142735.im1427s95; Nagl M, 2002, CLIN DIAGN LAB IMMUN, V9, P1165, DOI 10.1128/CDLI.9.6.1165-1168.2002; NAUCIEL C, 1988, INFECT IMMUN, V56, P2407, DOI 10.1128/IAI.56.9.2407-2411.1988; Nelson D.L., 2008, LEHNINGER PRINCIPLES; NNALUE NA, 1992, INFECT IMMUN, V60, P2758, DOI 10.1128/IAI.60.7.2758-2768.1992; OBRIEN AD, 1982, J IMMUNOL, V129, P1349; OBRIEN AD, 1980, J IMMUNOL, V124, P20; Otto SP, 2007, BIOL GUIDE MATH MODE; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; PARRILLO JE, 1990, ANN INTERN MED, V113, P227, DOI 10.7326/0003-4819-113-3-227; Parunak HV, 1998, LECT NOTES ARTIF INT, V1534, P10; PERL TM, 1995, JAMA-J AM MED ASSOC, V274, P338, DOI 10.1001/jama.274.4.338; Pollmacher J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111630; Povoa P, 2002, INTENS CARE MED, V28, P235, DOI 10.1007/s00134-002-1209-6; Ramaiah SK, 2007, TOXICOL PATHOL, V35, P757, DOI 10.1080/01926230701584163; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Reinhart K, 2001, CRIT CARE MED, V29, pS121, DOI 10.1097/00003246-200107001-00037; Reynolds A, 2006, J THEOR BIOL, V242, P220, DOI 10.1016/j.jtbi.2006.02.016; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; Schlatter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018646; Schottelius AJG, 1999, J BIOL CHEM, V274, P31868, DOI 10.1074/jbc.274.45.31868; Sharma S, 2003, CURR OPIN PULM MED, V9, P199, DOI 10.1097/00063198-200305000-00008; Shashkova T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148386; Sheppard M, 2003, CELL MICROBIOL, V5, P593, DOI 10.1046/j.1462-5822.2003.00296.x; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shi C, 2010, J IMMUNOL, V184, P6266, DOI 10.4049/jimmunol.0904160; Shi ZZ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/504259; Shi ZZ, 2014, OPEN J MODELLING SIM, V2, P12, DOI DOI 10.4236/ojmsi.2014.21004; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Slauch JM, 2011, MOL MICROBIOL, V80, P580, DOI 10.1111/j.1365-2958.2011.07612.x; Souwer Y, 2009, J IMMUNOL, V182, P7473, DOI 10.4049/jimmunol.0802831; Stanley AC, 2010, PHYSIOLOGY, V25, P218, DOI 10.1152/physiol.00017.2010; Steinfeld J.I., 1998, CHEM KINETICS DYNAMI; Sunden-Cullberg J, 2005, CRIT CARE MED, V33, P564, DOI [10.1097/01.CCM.0000155991.88802.4D, 10.1097/01.ccm.0000155991.88802.4D]; SYRJALA H, 1991, CLIN EXP IMMUNOL, V83, P326; Tacke F, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S27; Takeishi T, 1999, ARCH HISTOL CYTOL, V62, P413, DOI 10.1679/aohc.62.413; TAN JC, 1993, J BIOL CHEM, V268, P21053; Nguyen TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076547; Theodorakopoulou M, 2005, CRITICAL CARE S1, V9, pP174, DOI [10.1186/cc3237, DOI 10.1186/CC3237]; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Ulloa L, 2009, CURR PHARM DESIGN, V15, P1918, DOI 10.2174/138161209788453248; van Schaik SM, 2007, EUR J IMMUNOL, V37, P3101, DOI 10.1002/eji.200737295; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; Vincent JL, 2002, CLIN INFECT DIS, V34, P1084, DOI 10.1086/339549; Walley ER, 1996, INFECT IMMUN, V64, P4733, DOI 10.1128/IAI.64.11.4733-4738.1996; Wang H, 2004, J INTERN MED, V255, P320, DOI 10.1111/j.1365-2796.2003.01302.x; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang L, 2008, CURR PHARM DESIGN, V14, P1860, DOI 10.2174/138161208784980581; WANG P, 1994, J IMMUNOL, V153, P811; WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558; Waterer G, 2011, CURR OPIN INFECT DIS, V24, P137, DOI 10.1097/QCO.0b013e328343b70d; Weinrauch Y, 2002, NATURE, V417, P91, DOI 10.1038/417091a; WITTHAUT R, 1994, J LEUKOCYTE BIOL, V55, P105, DOI 10.1002/jlb.55.1.105; Wu John, 2011, International Journal of Artificial Life Research, V2, P105, DOI 10.4018/jalr.2011040106; Xia XJ, 2012, J SURG RES, V174, pE25, DOI 10.1016/j.jss.2011.10.006; Xu CS, 2012, J CELL BIOCHEM, V113, P229, DOI 10.1002/jcb.23348; Yamashiro M, 1998, VIRCHOWS ARCH, V433, P471, DOI 10.1007/s004280050276; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yang KK, 2002, J IMMUNOL, V169, P4475, DOI 10.4049/jimmunol.169.8.4475; Zimmermann HW, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00056	158	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161131	10.1371/journal.pone.0161131	http://dx.doi.org/10.1371/journal.pone.0161131			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556404	gold, Green Published, Green Submitted			2022-12-26	WOS:000382258100030
J	Sukumaran, S; Vijapure, T; Kubal, P; Mulik, J; Rokade, MA; Salvi, S; Thomas, J; Naidu, VS				Sukumaran, Soniya; Vijapure, Tejal; Kubal, Priti; Mulik, Jyoti; Rokade, M. A.; Salvi, Shailesh; Thomas, Jubin; Naidu, V. S.			Polychaete Community of a Marine Protected Area along the West Coast of India-Prior and Post the Tropical Cyclone, Phyan	PLOS ONE			English	Article							FEEDING GUILDS; ARABIAN SEA; DISTURBANCE; RECOVERY; ASSEMBLAGES; BAY; SEDIMENTS; HABITATS; BIOTA; GULF	Tropical cyclones are extreme random meteorological events that can have profound implications to coastal biodiversities. Given that the frequency, intensity and duration of these events are poised to increase due to the global climate change, understanding the ecological impacts of such erratic occurrences becomes imperative to devise better management strategies. The eventful passage of the tropical cyclone, Phyan, along the northwestern coast of India in November 2009, coupled with the availability of historical data presented a rare opportunity to elucidate the consequences on the polychaete assemblages of the Malvan Marine Sanctuary and their subsequent recovery. This was achieved by comparison of the pre- and post-Phyan seasonal data from four different sites in and around the Sanctuary. MDS analyses and polychaete community parameters suggested conspicuous cyclone related effects on the polychaete community characteristics in the three outer stations off Malvan, whereas the relatively protected bay station remained more or less unscathed. Impacts, attributable to the cyclone apart from seasonal variations, included changes in polychaete composition, reductions in total polychaete density, species diversity, evenness and functional groups. Dominance of the opportunistic polychaete, Paraprionospiopatiens was all pervasive just after Phyan, resulting in poor diversity and evenness values. In the outer stations, diverse feeding modes present prior to the cyclone were replaced by microphagous feeders post the disturbance. However, the study also observed complete recovery as substantiated by the improvement inpolychaete density, diversity indices and reinstatement of multiple feeding guilds in affected areas. This resilience of the coastal waters off Malvan is attributed to its marine protected status, implying that reduced human interference aided rapid revival of damaged ecosystems.	[Sukumaran, Soniya; Vijapure, Tejal; Kubal, Priti; Mulik, Jyoti; Rokade, M. A.; Salvi, Shailesh; Thomas, Jubin; Naidu, V. S.] CSIR Natl Inst Oceanog, Reg Ctr, Bombay, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO)	Sukumaran, S (corresponding author), CSIR Natl Inst Oceanog, Reg Ctr, Bombay, Maharashtra, India.	soniya@nio.org		Thomas, Jubin/0000-0003-0444-4605	Ministry of Earth Sciences, Government of India [GAP2740]; CSIR	Ministry of Earth Sciences, Government of India(Ministry of Earth Science (MoES), Government of India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	The Field study was funded by Ministry of Earth Sciences, Government of India under the project code GAP2740. TV was supported by a Senior Research Fellowship from CSIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2015, MAR ENVIRON RES, V112, P86, DOI 10.1016/j.marenvres.2015.09.011; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 1988, ADV ECOL RES; Balthis WL, 2006, ENVIRON MONIT ASSESS, V119, P367, DOI 10.1007/s10661-005-9031-6; Bevilacqua S, 2006, J ANIM ECOL, V75, P908, DOI 10.1111/j.1365-2656.2006.01108.x; Buchanan J. B, 1984, METHODS STUDY MARINE, P1; Byju P, 2011, MAR ENVIRON RES, V71, P325, DOI 10.1016/j.marenvres.2011.02.008; Carrasco FD, 1998, INT REV HYDROBIOL, V83, P233, DOI 10.1002/iroh.19980830306; Cheung SG, 2008, MAR POLLUT BULL, V56, P297, DOI 10.1016/j.marpolbul.2007.10.019; Chollett I, 2007, J EXP MAR BIOL ECOL, V340, P113, DOI 10.1016/j.jembe.2006.07.009; Dean H.K., 2008, REV BIOL TROP, V56, P11, DOI [10.15517/rbt.v56i4.27162, DOI 10.15517/RBT.V56I4.27162]; Del-Pilar-Ruso Y, 2009, MAR POLL B, V58, P765, DOI DOI 10.1016/j.marpolbul.2009.03.005; Dellapenna TM, 2003, ESTUAR COAST SHELF S, V58, P621, DOI 10.1016/S0272-7714(03)00174-4; Dogan Alper, 2005, Senckenbergiana Maritima, V35, P133; Elsner JB, 2008, NATURE, V455, P92, DOI 10.1038/nature07234; Engle VD, 2009, ENVIRON MONIT ASSESS, V150, P193, DOI 10.1007/s10661-008-0677-8; Flood PG, 1977, P 3 INT COR REEF S M, V2, P120; Game ET, RISK RESILIENCE SELE, V22, P1619, DOI [10.1111/j.1523-1739.2008.01037.x, DOI 10.1111/J.1523-1739.2008.01037.X]; Gamito S, 2012, ECOL INDIC, V19, P73, DOI 10.1016/j.ecolind.2011.08.003; Gamito S, 2009, ECOL INDIC, V9, P1009, DOI 10.1016/j.ecolind.2008.11.012; Goldenberg SB, 2001, SCIENCE, V293, P474, DOI 10.1126/science.1060040; Grasshoff K., 1999, METHODS SEAWATER ANA, V3, P1, DOI [10.1002/9783527613984, DOI 10.1002/9783527613984]; GRASSLE JF, 1974, J MAR RES, V32, P253; Harnstrom K, 2009, INDIAN J MAR SCI, V38, P224; Herkul K, 2011, BOREAL ENVIRON RES, V16, P209; HILL MO, 1980, VEGETATIO, V42, P47, DOI 10.1007/BF00048870; Hughes C, 2009, ESTUAR COAST SHELF S, V85, P377, DOI 10.1016/j.ecss.2009.08.023; Joseph A, 2011, NAT HAZARDS, V57, P293, DOI 10.1007/s11069-010-9613-7; Jumars PA, 2015, ANNU REV MAR SCI, V7, P497, DOI 10.1146/annurev-marine-010814-020007; Kendall MA, 2009, POL J ENVIRON STUD, V18, P69; Kumar KV, 2012, NAT HAZARDS, V64, P259, DOI 10.1007/s11069-012-0228-z; Labrune C, 2007, ESTUAR COAST SHELF S, V71, P133, DOI 10.1016/j.ecss.2006.07.007; Lomovasky BJ, 2011, J SEA RES, V65, P205, DOI 10.1016/j.seares.2010.10.002; Lucrezi S, 2010, MAR FRESHWATER RES, V61, P951, DOI 10.1071/MF09259; Martins R, 2013, J MARINE SYST, V123, P41, DOI 10.1016/j.jmarsys.2013.04.008; Mukherjee N, 2010, ENVIRON MANAGE, V46, P329, DOI 10.1007/s00267-010-9523-1; Muniz P, 1999, MAR BIOL, V134, P517, DOI 10.1007/s002270050567; Musco L, 2011, MAR ENVIRON RES, V71, P131, DOI 10.1016/j.marenvres.2010.12.004; PARULEKAR A H, 1971, Journal of the Bombay Natural History Society, V68, P726; Peng ST, 2013, MAR POLLUT BULL, V74, P302, DOI 10.1016/j.marpolbul.2013.06.037; Posey M, 1996, B MAR SCI, V59, P523; Rijn LC, 2007, J HYDRAULIC ENG, V133, P649; SAVIDGE WB, 1988, J EXP MAR BIOL ECOL, V115, P137, DOI 10.1016/0022-0981(88)90099-8; SHILEDAR BAA, 2013, INDIAN CONC AGRIC R, V215, P15; Simboura N, 2000, MAR ECOL-P S Z N I, V21, P129, DOI 10.1046/j.1439-0485.2000.00684.x; Teixido N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053742; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Urabe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062779; Wafar M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014613; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Witmer AD, 2014, OCEAN COAST MANAGE, V87, P52, DOI 10.1016/j.ocecoaman.2013.11.005; Won EJ, 2008, MAR POLLUT BULL, V57, P544, DOI 10.1016/j.marpolbul.2008.02.025	52	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0159368	10.1371/journal.pone.0159368	http://dx.doi.org/10.1371/journal.pone.0159368			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556895	Green Submitted, gold, Green Published			2022-12-26	WOS:000382258100006
J	Hanif, A; Edin, ML; Zeldin, DC; Morisseau, C; Nayeem, MA				Hanif, Ahmad; Edin, Matthew L.; Zeldin, Darryl C.; Morisseau, Christophe; Nayeem, Mohammed A.			Effect of Soluble Epoxide Hydrolase on the Modulation of Coronary Reactive Hyperemia: Role of Oxylipins and PPAR gamma	PLOS ONE			English	Article							LOWERS BLOOD-PRESSURE; EPOXYEICOSATRIENOIC ACIDS; ARACHIDONIC-ACID; ENDOTHELIAL-CELLS; LINOLEIC-ACID; LIPOXYGENASE PRODUCTS; POTENTIAL ROLE; METABOLISM; INHIBITION; EXPRESSION	Coronary reactive hyperemia (CRH) is a physiological response to ischemic insult that prevents the potential harm associated with an interruption of blood supply. The relationship between the pharmacologic inhibition of soluble epoxide hydrolase (sEH) and CRH response to a brief ischemia is not known. sEH is involved in the main catabolic pathway of epoxyeicosatrienoic acids (EETs), which are converted into dihydroxyeicosatrienoic acids (DHETs). EETs protect against ischemia/reperfusion injury and have numerous beneficial physiological effects. We hypothesized that inhibition of sEH by t-AUCB enhances CRH in isolated mouse hearts through changing the oxylipin profiles, including an increase in EETs/DHETs ratio. Compared to controls, t-AUCB-treated mice had increased CRH, including repayment volume (RV), repayment duration, and repayment/debt ratio (p < 0.05). Treatment with t-AUCB significantly changed oxylipin profiles, including an increase in EET/DHET ratio, increase in EpOME/DiHOME ratio, increase in the levels of HODEs, decrease in the levels of mid-chain HETEs, and decrease in prostanoids (p < 0.05). Treatment with MS-PPOH (CYP epoxygenase inhibitor) reduced CRH, including RV (p < 0.05). Involvement of PPAR gamma in the modulation of CRH was demonstrated using a PPAR gamma-antagonist (T0070907) and a PPAR gamma-agonist (rosiglitazone). T0070907 reduced CRH (p < 0.05), whereas rosiglitazone enhanced CRH (p < 0.05) in isolated mouse hearts compared to the non-treated. These data demonstrate that sEH inhibition enhances, whereas CYP epoxy-genases- inhibition attenuates CRH, PPAR gamma mediate CRH downstream of the CYP epoxy-genases-EET pathway, and the changes in oxylipin profiles associated with sEH-inhibition collectively contributed to the enhanced CRH.	[Hanif, Ahmad; Nayeem, Mohammed A.] West Virginia Univ, Ctr Basic & Translat Stroke Res, Sch Pharm, Basic Pharmaceut Sci, Morgantown, WV 26506 USA; [Edin, Matthew L.; Zeldin, Darryl C.] NIEHS, Div Intramural Res, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Morisseau, Christophe] Univ Calif Davis, One Shields Ave, Davis, CA 95616 USA	West Virginia University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of California System; University of California Davis	Nayeem, MA (corresponding author), West Virginia Univ, Ctr Basic & Translat Stroke Res, Sch Pharm, Basic Pharmaceut Sci, Morgantown, WV 26506 USA.	mnayeem@hsc.wvu.edu	Nayeem, Mohammed A/A-3949-2017; Zeldin, Darryl C/Y-7091-2018; Edin, Matthew/AAI-1934-2019	Nayeem, Mohammed A/0000-0002-7827-4760; Zeldin, Darryl C/0000-0002-2087-7307; Edin, Matthew/0000-0002-7042-500X	National Institutes of Health / National Heart, Lung, and Blood Institute [HL-114559]; Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences [Z01 ES025034]; NIGMS of the National Institutes of Health [U54GM104942]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES025034, ZIAES025034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER	National Institutes of Health / National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institutes of Health / National Heart, Lung, and Blood Institute grant (HL-114559) to M. A. Nayeem (http://www.nhlbi.nih.gov) and the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences (Z01 ES025034 to D. C. Zeldin) (http://www.niehs.nih.gov).; This work was supported by National Institutes of Health Grant (HL-114559) to M. A. Nayeem and the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (Z01 ES025034 to D. C. Zeldin). We thank Brandi Talkington, PhD, and the West Virginia Clinical and Translational Science Institute (WVCTSI) for editorial support. The WVCTSI is supported by the NIGMS of the National Institutes of Health under award number U54GM104942. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altmann R, 2007, BIOCHEM PHARMACOL, V74, P612, DOI 10.1016/j.bcp.2007.05.027; Belvisi MG, 2009, BRIT J PHARMACOL, V158, P994, DOI 10.1111/j.1476-5381.2009.00373.x; Berwick ZC, 2010, MICROCIRCULATION, V17, P600, DOI 10.1111/j.1549-8719.2010.00054.x; Borbouse L, 2010, AM J PHYSIOL-HEART C, V298, P29; BRINKMAN HJM, 1990, THROMB HAEMOSTASIS, V63, P291; BURHOP KE, 1988, CIRC RES, V62, P687, DOI 10.1161/01.RES.62.4.687; Cai ZJ, 2013, J LIPID RES, V54, P1448, DOI 10.1194/jlr.M036533; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; COFFMAN JD, 1960, AM J PHYSIOL, V199, P1143, DOI 10.1152/ajplegacy.1960.199.6.1143; CONRAD DJ, 1992, P NATL ACAD SCI USA, V89, P217, DOI 10.1073/pnas.89.1.217; Cowart LA, 2002, J BIOL CHEM, V277, P35105, DOI 10.1074/jbc.M201575200; DEMEYER GRY, 1992, BRIT J PHARMACOL, V107, P597; Dolegowska B, 2009, PLATELETS, V20, P242, DOI 10.1080/09537100902849836; Edin ML, 2011, FASEB J, V25, P3436, DOI 10.1096/fj.11-188300; Emerson MR, 2004, BRAIN RES, V1021, P140, DOI 10.1016/j.brainres.2004.06.045; Fang X, 2001, J BIOL CHEM, V276, P14867, DOI 10.1074/jbc.M011761200; Fleming I, 2014, PHARMACOL REV, V66, P1106, DOI 10.1124/pr.113.007781; Fritsche KL, 2008, PROSTAG LEUKOTR ESS, V79, P173, DOI 10.1016/j.plefa.2008.09.019; GEBREMEDHIN D, 1992, AM J PHYSIOL, V263, pH519, DOI 10.1152/ajpheart.1992.263.2.H519; Gilroy DW, 2016, P NATL ACAD SCI USA, V25; Hattori T, 2008, J INVEST DERMATOL, V128, P1123, DOI 10.1038/sj.jid.5701172; Honda HM, 1999, ARTERIOSCL THROM VAS, V19, P680, DOI 10.1161/01.ATV.19.3.680; Huang AL, 2007, ARTERIOSCL THROM VAS, V27, P2113, DOI 10.1161/ATVBAHA.107.147322; Imig JD, 2005, HYPERTENSION, V46, P975, DOI 10.1161/01.HYP.0000176237.74820.75; Imig JD, 1996, J AM SOC NEPHROL, V7, P2364; Imig JD, 2002, HYPERTENSION, V39, P690, DOI 10.1161/hy0202.103788; Imig JD, 2012, PHYSIOL REV, V92, P101, DOI 10.1152/physrev.00021.2011; Kingsbury MP, 2000, J MOL CELL CARDIOL, V32, P527, DOI 10.1006/jmcc.1999.1097; KITAKAZE M, 1992, CIRC RES, V71, P558, DOI 10.1161/01.RES.71.3.558; Konkel A, 2011, BBA-PROTEINS PROTEOM, V1814, P210, DOI 10.1016/j.bbapap.2010.09.009; Lee CR, 2010, FASEB J, V24, P3770, DOI 10.1096/fj.10-160119; Lee JW, 2012, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2012-7; Li LM, 2014, PLOS ONE, V9, pe8433; Liu Y, 2005, P NATL ACAD SCI USA, V102, P16747, DOI 10.1073/pnas.0508081102; Luria A, 2007, J BIOL CHEM, V282, P2891, DOI 10.1074/jbc.M608057200; MA YH, 1991, AM J PHYSIOL, V261, pH451, DOI 10.1152/ajpheart.1991.261.2.H451; Maayah ZH, 2016, ARCH TOXICOL, V90, P359, DOI 10.1007/s00204-014-1419-z; Mitchell Lex A, 2002, Cardiovasc Toxicol, V2, P219; Moghaddam MF, 1997, NAT MED, V3, P562, DOI 10.1038/nm0597-562; Moran JH, 1997, TOXICOL APPL PHARM, V146, P53, DOI 10.1006/taap.1997.8197; NAKAO J, 1982, ATHEROSCLEROSIS, V44, P339, DOI 10.1016/0021-9150(82)90008-9; Nayeem MA, 2013, AM J PHYSIOL-REG I, V304, P14; Nayeem MA, 2010, AM J PHYSIOL-REG I, V299, P28; Nayeem MA, 2011, MOL CELL BIOCHEM, V350, P101, DOI 10.1007/s11010-010-0686-0; Nowak G, 2004, TOXICOL LETT, V147, P161, DOI 10.1016/j.toxlet.2003.11.002; Obinata H, 2009, PROSTAG OTH LIPID M, V89, P66, DOI 10.1016/j.prostaglandins.2008.11.002; Park S, 2008, YONSEI MED J, V49, P592, DOI 10.3349/ymj.2008.49.4.592; Patricia MK, 1999, ARTERIOSCL THROM VAS, V19, P2615, DOI 10.1161/01.ATV.19.11.2615; Ponnoth DS, 2012, AM J PHYSIOL-REG I, V303, P26; Pradhan I, 2015, MOL CELL BIOCHEM, V5, P5; PROCTOR KG, 1987, CIRC RES, V60, P50, DOI 10.1161/01.RES.60.1.50; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Schmelzer KR, 2006, P NATL ACAD SCI USA, V103, P13646, DOI 10.1073/pnas.0605908103; Schmelzer KR, 2005, P NATL ACAD SCI USA, V102, P9772, DOI 10.1073/pnas.0503279102; Seubert J, 2004, CIRC RES, V95, P506, DOI 10.1161/01.RES.0000139436.89654.c8; Sha WX, 2012, IMMUNOBIOLOGY, V217, P1225, DOI 10.1016/j.imbio.2012.05.001; Sharifi-Sanjani M, 2013, AM J PHYSIOL-HEART C, V304, P22; Shim CY, 2014, AM J PHYSIOL-ENDOC M, V307, P21; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; Skrzypiec-Spring Monika, 2007, Journal of Pharmacological and Toxicological Methods, V55, P113, DOI 10.1016/j.vascn.2006.05.006; Spector AA, 2004, PROG LIPID RES, V43, P55, DOI 10.1016/S0163-7827(03)00049-3; STERN N, 1993, ENDOCRINOLOGY, V133, P843, DOI 10.1210/en.133.2.843; STERN N, 1989, ENDOCRINOLOGY, V125, P3090, DOI 10.1210/endo-125-6-3090; STOLL LL, 1994, AM J PHYSIOL, V266, pC990, DOI 10.1152/ajpcell.1994.266.4.C990; SUGIYAMA S, 1987, LIFE SCI, V40, P225, DOI 10.1016/0024-3205(87)90336-5; Tam VC, 2013, SEMIN IMMUNOL, V25, P240, DOI 10.1016/j.smim.2013.08.006; TANG DG, 1995, BIOCHEM BIOPH RES CO, V211, P462, DOI 10.1006/bbrc.1995.1836; Viswanathan S, 2003, J AM COLL NUTR, V22, P502, DOI 10.1080/07315724.2003.10719328; Wen YS, 1996, AM J PHYSIOL-CELL PH, V271, pC1212, DOI 10.1152/ajpcell.1996.271.4.C1212; Yu ZG, 2000, CIRC RES, V87, P992, DOI 10.1161/01.RES.87.11.992; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200; Zhao X, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-3; Zhou X, 2013, AM J PHYSIOL-HEART C, V305, P16	73	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162147	10.1371/journal.pone.0162147	http://dx.doi.org/10.1371/journal.pone.0162147			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583776	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600112
J	Won, EY; Lee, SO; Lee, DH; Lee, D; Bae, KH; Lee, SC; Kim, SJ; Chi, SW				Won, Eun-Young; Lee, Sang-Ok; Lee, Dong-Hwa; Lee, Daeyoup; Bae, Kwang-Hee; Lee, Sang Chul; Kim, Seung Jun; Chi, Seung-Wook			Structural Insight into the Critical Role of the N-Terminal Region in the Catalytic Activity of Dual-Specificity Phosphatase 26	PLOS ONE			English	Article							CHROMOSOME ARM 8P; CRYSTAL-STRUCTURE; PROTEIN PHOSPHATASE; P53 RESTORATION; DUSP26; SUPPRESSION; ACTIVATION; PATHWAY; GROWTH	Human dual-specificity phosphatase 26 (DUSP26) is a novel target for anticancer therapy because its dephosphorylation of the p53 tumor suppressor regulates the apoptosis of cancer cells. DUSP26 inhibition results in neuroblastoma cell cytotoxicity through p53-mediated apoptosis. Despite the previous structural studies of DUSP26 catalytic domain (residues 61-211, DUSP26-C), the high-resolution structure of its catalytically active form has not been resolved. In this study, we determined the crystal structure of a catalytically active form of DUSP26 (residues 39-211, DUSP26-N) with an additional N-terminal region at 2.0 angstrom resolution. Unlike the C-terminal domain-swapped dimeric structure of DUSP26-C, the DUSP26-N (C152S) monomer adopts a fold-back conformation of the C-terminal alpha 8-helix and has an additional alpha 1-helix in the N-terminal region. Consistent with the canonically active conformation of its protein tyrosine phosphate-binding loop (PTP loop) observed in the structure, the phosphatase assay results demonstrated that DUSP26-N has significantly higher catalytic activity than DUSP26-C. Furthermore, size exclusion chromatography-multiangle laser scattering (SEC-MALS) measurements showed that DUSP26-N (C152S) exists as a monomer in solution. Notably, the crystal structure of DUSP26-N (C152S) revealed that the N-terminal region of DUSP26-N (C152S) serves a scaffolding role by positioning the surrounding alpha 7-alpha 8 loop for interaction with the PTP-loop through formation of an extensive hydrogen bond network, which seems to be critical in making the PTP-loop conformation competent for phosphatase activity. Our study provides the first high-resolution structure of a catalytically active form of DUSP26, which will contribute to the structure-based rational design of novel DUSP26-targeting anticancer therapeutics.	[Won, Eun-Young; Lee, Sang-Ok; Lee, Dong-Hwa; Kim, Seung Jun; Chi, Seung-Wook] Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, Daejeon, South Korea; [Bae, Kwang-Hee; Lee, Sang Chul] Korea Res Inst Biosci & Biotechnol, Metab Regulat Res Ctr, Daejeon, South Korea; [Won, Eun-Young; Lee, Daeyoup] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Advanced Institute of Science & Technology (KAIST)	Kim, SJ; Chi, SW (corresponding author), Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, Daejeon, South Korea.	ksj@kribb.re.kr; swchi@kribb.re.kr	Lee, Daeyoup/C-1653-2011; Kim, Seung Jun/N-5248-2019	Lee, Daeyoup/0000-0003-2006-1823; Kim, Seung Jun/0000-0002-6913-6358; Bae, Kwang-Hee/0000-0002-5868-2556	National Research Foundation of Korea(NRF) grants - Korea government(MEST) [2011-0030027, NRF-2012M3C1A3671508, NRF-2014R1A2A2A05002961]; Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the National Research Foundation [NRF-2015M3A9C4076320]; KRIBB Research Initiative Program	National Research Foundation of Korea(NRF) grants - Korea government(MEST); Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the National Research Foundation; KRIBB Research Initiative Program	This work was supported by the National Research Foundation of Korea(NRF) grants funded by the Korea government(MEST) (2011-0030027; to SJK, NRF-2012M3C1A3671508 and NRF-2014R1A2A2A05002961; to SWC) and by the Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the National Research Foundation (NRF-2015M3A9C4076320; to SWC). This work was also supported by the KRIBB Research Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Armes JE, 2004, ONCOGENE, V23, P5697, DOI 10.1038/sj.onc.1207740; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chi SW, 2014, BMB REP, V47, P167, DOI 10.5483/BMBRep.2014.47.3.261; EMMERTBUCK MR, 1995, CANCER RES, V55, DOI DOI 10.1038/35042675; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jeong DG, 2014, ACTA CRYSTALLOGR D, V70, P421, DOI 10.1107/S1399004713029866; Jeong MS, 2012, CHEM COMMUN, V48, P6553, DOI 10.1039/c2cc31377d; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4351; Kim SJ, 2007, PROTEINS, V66, P239, DOI 10.1002/prot.21197; Koksal AC, 2009, J BIOL CHEM, V284, P10129, DOI 10.1074/jbc.M808362200; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lokareddy RK, 2013, BIOCHEMISTRY-US, V52, P938, DOI 10.1021/bi301476m; Lountos GT, 2011, ACTA CRYSTALLOGR D, V67, P471, DOI 10.1107/S090744491100970X; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Minton AP, 2016, ANAL BIOCHEM, V501, P4, DOI 10.1016/j.ab.2016.02.007; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Peisley A, 2014, NATURE, V509, P110, DOI 10.1038/nature13140; Pribill I, 2001, CANCER GENET CYTOGEN, V129, P23, DOI 10.1016/S0165-4608(01)00419-8; Shang X, 2010, ONCOGENE, V29, P4938, DOI 10.1038/onc.2010.244; Shi Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.207; Simon AC, 2014, NATURE, V510, P293, DOI 10.1038/nature13234; Tanuma N, 2009, ONCOGENE, V28, P752, DOI 10.1038/onc.2008.431; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang JY, 2006, J NEUROCHEM, V98, P89, DOI 10.1111/j.1471-4159.2006.03852.x; Wang JY, 2008, J NEUROCHEM, V107, P1544, DOI 10.1111/j.1471-4159.2008.05714.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Won EY, 2013, ACTA CRYSTALLOGR D, V69, P1160, DOI 10.1107/S0907444913004770; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yu W, 2007, ONCOGENE, V26, P1178, DOI 10.1038/sj.onc.1209899; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328	44	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162115	10.1371/journal.pone.0162115	http://dx.doi.org/10.1371/journal.pone.0162115			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583453	Green Published, gold, Green Submitted			2022-12-26	WOS:000382855600107
J	Wu, XL; Xu, JQ; Feng, GF; Wiggans, GR; Taylor, JF; He, J; Qian, CS; Qiu, JS; Simpson, B; Walker, J; Bauck, S				Wu, Xiao-Lin; Xu, Jiaqi; Feng, Guofei; Wiggans, George R.; Taylor, Jeremy F.; He, Jun; Qian, Changsong; Qiu, Jiansheng; Simpson, Barry; Walker, Jeremy; Bauck, Stewart			Optimal Design of Low-Density SNP Arrays for Genomic Prediction: Algorithm and Applications	PLOS ONE			English	Article							GENOTYPING ARRAY; MARKER PANELS; IMPUTATION; VALUES; CATTLE; ACCURACY; SUBSETS; CHIPS	Low-density (LD) single nucleotide polymorphism (SNP) arrays provide a cost-effective solution for genomic prediction and selection, but algorithms and computational tools are needed for the optimal design of LD SNP chips. A multiple-objective, local optimization (MOLO) algorithm was developed for design of optimal LD SNP chips that can be imputed accurately to medium-density (MD) or high-density (HD) SNP genotypes for genomic prediction. The objective function facilitates maximization of non-gap map length and system information for the SNP chip, and the latter is computed either as locus-averaged (LASE) or haplotype-averaged Shannon entropy (HASE) and adjusted for uniformity of the SNP distribution. HASE performed better than LASE with <= 1,000 SNPs, but required considerably more computing time. Nevertheless, the differences diminished when >5,000 SNPs were selected. Optimization was accomplished conditionally on the presence of SNPs that were obligated to each chromosome. The frame location of SNPs on a chip can be either uniform (evenly spaced) or non-uniform. For the latter design, a tunable empirical Beta distribution was used to guide location distribution of frame SNPs such that both ends of each chromosome were enriched with SNPs. The SNP distribution on each chromosome was finalized through the objective function that was locally and empirically maximized. This MOLO algorithm was capable of selecting a set of approximately evenly-spaced and highly-informative SNPs, which in turn led to increased imputation accuracy compared with selection solely of evenly-spaced SNPs. Imputation accuracy increased with LD chip size, and imputation error rate was extremely low for chips with >= 3,000 SNPs. Assuming that genotyping or imputation error occurs at random, imputation error rate can be viewed as the upper limit for genomic prediction error. Our results show that about 25% of imputation error rate was propagated to genomic prediction in an Angus population. The utility of this MOLO algorithm was also demonstrated in a real application, in which a 6K SNP panel was optimized	[Wu, Xiao-Lin; Xu, Jiaqi; Feng, Guofei; Qiu, Jiansheng; Simpson, Barry; Walker, Jeremy; Bauck, Stewart] GeneSeek, Bioinformat & Biostat, Lincoln, NE USA; [Xu, Jiaqi; Feng, Guofei] Univ Nebraska, Dept Stat, Lincoln, NE USA; [Wiggans, George R.] USDA ARS, Anim Genom & Improvement Lab, Beltsville, MD USA; [Taylor, Jeremy F.] Univ Missouri, Div Anim Sci, Columbia, MO USA; [He, Jun] Hunan Agr Univ, Coll Anim Sci & Technol, Changsha, Hunan, Peoples R China; [Qian, Changsong] Neogen Biosci Technol Shanghai Co Ltd, Mkt & Business Dev, Shanghai, Peoples R China	University of Nebraska System; University of Nebraska Lincoln; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia; Hunan Agricultural University	Wu, XL (corresponding author), GeneSeek, Bioinformat & Biostat, Lincoln, NE USA.	NWu@neogen.com	Wu, Xiaolin/GPX-5124-2022	Wu, Xiaolin/0000-0002-5604-9220	GeneSeek (a Neogen Company); Neogen Bio-Scientific Technology (Shanghai) Company Ltd.; visiting scholar program of University of Nebraska-Lincoln; Hundred-Talents Program of Hunan Province, China; "Improving Genetic Predictions in Dairy Animals Using Phenotypic and Genomic Information" of the Agricultural Research Service of the United States Department of Agriculture [8042-31000-101-00]; Neogen RD fund; GeneSeek; Neogen company	GeneSeek (a Neogen Company); Neogen Bio-Scientific Technology (Shanghai) Company Ltd.; visiting scholar program of University of Nebraska-Lincoln; Hundred-Talents Program of Hunan Province, China; "Improving Genetic Predictions in Dairy Animals Using Phenotypic and Genomic Information" of the Agricultural Research Service of the United States Department of Agriculture; Neogen RD fund; GeneSeek; Neogen company	GeneSeek (a Neogen Company) and Neogen Bio-Scientific Technology (Shanghai) Company Ltd. provided support in the form of salaries for XW, CQ, BS, JW and SB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funding by Neogen to this research does not alter our adherence to PLOS ONE policies on sharing data and materials. JH was supported partially by the visiting scholar program of University of Nebraska-Lincoln and by the Hundred-Talents Program of Hunan Province, China. GRW was supported by appropriated project 8042-31000-101-00, "Improving Genetic Predictions in Dairy Animals Using Phenotypic and Genomic Information" of the Agricultural Research Service of the United States Department of Agriculture. Mention of trade names or commercial products in this article is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the United States Department of Agriculture. USDA is an equal opportunity provider and employer.; This research was financially supported by Neogen R&D fund. JX and GF acknowledge the internship financial support by GeneSeek, an Neogen company. Adam McQuistan and Anna Fuller at GeneSeek are thanked for help in preparing and cleaning the data. Thanks also goes to Suzanne Hubbard at USDA (Beltsville, MD) for her technical assistance in preparing this manuscript.	[Anonymous], 2010, BOV GEN BEADCH; Boichard D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034130; Bolormaa S, 2015, ANIM GENET, V46, P544, DOI 10.1111/age.12340; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Corbin LJ, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-9; Dassonneville R, 2011, J DAIRY SCI, V94, P3679, DOI 10.3168/jds.2011-4299; Habier D, 2009, GENETICS, V182, P343, DOI 10.1534/genetics.108.100289; Harris BL, 2009, INTERBULL B, V44, P3; Houston RD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-90; Kranis A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-59; LaFramboise T, 2009, NUCLEIC ACIDS RES, V37, P4181, DOI 10.1093/nar/gkp552; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Moser G, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-37; Neogen, 2016, GENESEEK LAUNCH IMPR; Ha NT, 2014, EUR J HUM GENET, V22, P1124, DOI 10.1038/ejhg.2013.304; Okut H, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-34; Qanbari S, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-103; Rincon G, 2011, J DAIRY SCI, V94, P6116, DOI 10.3168/jds.2011-4764; Unterseer S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-823; Weigel KA, 2009, J DAIRY SCI, V92, P5248, DOI 10.3168/jds.2009-2092; Wiggans GR, 2013, J DAIRY SCI, V96, P1258, DOI 10.3168/jds.2012-6192; Wiggans GR, 2012, J DAIRY SCI, V95, P1552, DOI 10.3168/jds.2011-4985; Zhang Z, 2010, J DAIRY SCI, V93, P5487, DOI 10.3168/jds.2010-3501	23	19	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161719	10.1371/journal.pone.0161719	http://dx.doi.org/10.1371/journal.pone.0161719			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583971	Green Published, gold			2022-12-26	WOS:000382855600052
J	Torrado, B; Grana, M; Badano, JL; Irigoin, F				Torrado, Belen; Grana, Martin; Badano, Jose L.; Irigoin, Florencia			Ciliary Entry of the Hedgehog Transcriptional Activator Gli2 Is Mediated by the Nuclear Import Machinery but Differs from Nuclear Transport in Being Imp-alpha/beta 1-Independent	PLOS ONE			English	Article							RAN-DEPENDENT NUCLEAR; PRIMARY CILIUM; PROTEIN FUNCTION; SIGNALING CENTER; PORE COMPLEX; IN-VITRO; LOCALIZATION; MECHANISMS; SUPPRESSOR; EXPORT	Gli2 is the primary transcriptional activator of Hedgehog signalling in mammals. Upon stimulation of the pathway, Gli2 moves into the cilium before reaching the nucleus. However, the mechanisms underlying its entry into the cilium are not completely understood. Since several similarities have been reported between nuclear and ciliary import, we investigated if the nuclear import machinery participates in Gli2 ciliary entry. Here we show that while two conserved classical nuclear localization signals mediate Gli2 nuclear localization via importin (Imp)-alpha/beta 1, these sequences are not required for Gli2 ciliary import. However, blocking Imp-mediated transport through overexpression of GTP-locked Ran reduced the percentage of Gli2 positive cilia, an effect that was not explained by increased CRM1-dependent export of Gli2 from the cilium. We explored the participation of Imp-beta 2 in Gli2 ciliary traffic and observed that this transporter is involved in moving Gli2 into the cilium, as has been described for other ciliary proteins. In addition, our data indicate that Imp-beta 2 might also collaborate in Gli2 nuclear entry. How does Imp-beta 2 determine the final destination of a protein that can localize to two distinct subcellular compartments remains an open question. Therefore, our data shows that the nuclear-cytoplasmic shuttling machinery plays a critical role mediating the subcellular distribution of Gli2 and the activation of the pathway, but distinct importins likely play a differential role mediating its ciliary and nuclear translocation.	[Torrado, Belen; Badano, Jose L.; Irigoin, Florencia] Inst Pasteur Montevideo, Human Mol Genet Lab, Mataojo 2020, Montevideo 11400, Uruguay; [Grana, Martin] Inst Pasteur Montevideo, Bioinformat Unit, Mataojo 2020, Montevideo 11400, Uruguay; [Irigoin, Florencia] Univ Republica, Fac Med, Dept Histol & Embriol, Gral Flores 2125, Montevideo 11800, Uruguay	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Universidad de la Republica, Uruguay	Irigoin, F (corresponding author), Inst Pasteur Montevideo, Human Mol Genet Lab, Mataojo 2020, Montevideo 11400, Uruguay.; Irigoin, F (corresponding author), Univ Republica, Fac Med, Dept Histol & Embriol, Gral Flores 2125, Montevideo 11800, Uruguay.	firigoin@gmail.com	Irigoin, Florencia/HCH-3798-2022	Grana, Martin/0000-0003-1182-8236; Torrado, Belen/0000-0002-0679-3422; Badano, Jose/0000-0002-0706-8652	Interdisciplinary Grant from the Institut Pasteur de Montevideo; Agencia Nacional de Investigacion e Innovacion (ANII)-Programa Innova; MERCOSUR Structural Convergence Fund (FOCEM) [COF 03/11]; Agencia Nacional de Investigacion e Innovacion; Comision Academica de Posgrado, Universidad de la Republica (CAP); Programa para el Desarrollo de las Ciencias Basicas (PEDECIBA)	Interdisciplinary Grant from the Institut Pasteur de Montevideo; Agencia Nacional de Investigacion e Innovacion (ANII)-Programa Innova; MERCOSUR Structural Convergence Fund (FOCEM); Agencia Nacional de Investigacion e Innovacion; Comision Academica de Posgrado, Universidad de la Republica (CAP); Programa para el Desarrollo de las Ciencias Basicas (PEDECIBA)	This work was supported by an Interdisciplinary Grant from the Institut Pasteur de Montevideo (www.pasteur.edu.uy) to FI, Agencia Nacional de Investigacion e Innovacion (ANII, www.anii.org.uy)-Programa Innova to JLB and partially funded by MERCOSUR Structural Convergence Fund (FOCEM, COF 03/11). BT was supported with scholarships from the Agencia Nacional de Investigacion e Innovacion and the Comision Academica de Posgrado, Universidad de la Republica (CAP, www.posgrados.udelar.edu.uy). MG, JLB and FI are supported by the Agencia Nacional de Investigacion e Innovacion and the Programa para el Desarrollo de las Ciencias Basicas (PEDECIBA, www.pedeciba.edu.uy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnfield PC, 2005, DIFFERENTIATION, V73, P397, DOI 10.1111/j.1432-0436.2005.00042.x; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Breslow DK, 2013, J CELL BIOL, V203, P129, DOI 10.1083/jcb.201212024; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229; Cardenas-Rodriguez M, 2009, AM J MED GENET C, V151C, P263, DOI 10.1002/ajmg.c.30227; Carpenter BS, 2015, J CELL SCI, V128, P1034, DOI 10.1242/jcs.162552; Cautain B, 2015, FEBS J, V282, P445, DOI 10.1111/febs.13163; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Endoh-Yamagami S, 2009, CURR BIOL, V19, P1320, DOI 10.1016/j.cub.2009.06.046; Fan SL, 2011, ORGANOGENESIS, V7, P147, DOI 10.4161/org.7.3.17084; Ferreon ACM, 2013, NATURE, V498, P390, DOI 10.1038/nature12294; Garcia-Gonzalo FR, 2012, J CELL BIOL, V197, P697, DOI 10.1083/jcb.201111146; Gascue C, 2012, J CELL SCI, V125, P362, DOI 10.1242/jcs.089375; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guttler T, 2011, EMBO J, V30, P3457, DOI 10.1038/emboj.2011.287; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; He M, 2014, NAT CELL BIOL, V16, P663, DOI 10.1038/ncb2988; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Hurd TW, 2011, J CELL SCI, V124, P718, DOI 10.1242/jcs.070839; Insinna C, 2008, DEV BIOL, V316, P160, DOI 10.1016/j.ydbio.2008.01.025; Ishiguro K, 2007, EUR J IMMUNOL, V37, P2309, DOI 10.1002/eji.200737180; Ishikawa H, 2012, CURR BIOL, V22, P414, DOI 10.1016/j.cub.2012.01.031; Jenkins PM, 2006, CURR BIOL, V16, P1211, DOI 10.1016/j.cub.2006.04.034; Jia JP, 2009, DEV BIOL, V330, P452, DOI 10.1016/j.ydbio.2009.04.009; Kee H Lynn, 2013, Cilia, V2, P11, DOI 10.1186/2046-2530-2-11; Kee HL, 2012, NAT CELL BIOL, V14, P431, DOI 10.1038/ncb2450; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Liu JL, 2015, DEVELOPMENT, V142, P1651, DOI 10.1242/dev.119669; Lounsbury KM, 1996, J BIOL CHEM, V271, P32834, DOI 10.1074/jbc.271.51.32834; Maia TM, 2014, BIOL OPEN, V3, P138, DOI 10.1242/bio.20146577; Maiuri T, 2013, HUM MOL GENET, V22, P1383, DOI 10.1093/hmg/dds554; Mick DU, 2015, DEV CELL, V35, P497, DOI 10.1016/j.devcel.2015.10.015; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Niewiadomski P, 2014, CELL REP, V6, P168, DOI 10.1016/j.celrep.2013.12.003; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nozawa YI, 2013, CURR OPIN GENET DEV, V23, P429, DOI 10.1016/j.gde.2013.04.008; Pagano M., 2018, PRINCIPLES BIOSTATIS; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Reiter JF, 2012, EMBO REP, V13, P608, DOI 10.1038/embor.2012.73; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Santos N, 2014, J CELL SCI, V127, P1500, DOI 10.1242/jcs.139253; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Sheng T, 2006, J BIOL CHEM, V281, P9, DOI 10.1074/jbc.C500300200; Shi Q, 2014, J CELL SCI, V127, P1092, DOI 10.1242/jcs.142828; Soderholm JF, 2011, ACS CHEM BIOL, V6, P700, DOI 10.1021/cb2000296; Suel KE, 2008, PLOS BIOL, V6, P1253, DOI 10.1371/journal.pbio.0060137; Szczepny A, 2014, BIOCHEM J, V461, P469, DOI 10.1042/BJ20130709; Takao D, 2014, CURR BIOL, V24, P2288, DOI 10.1016/j.cub.2014.08.012; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Tuson M, 2011, DEVELOPMENT, V138, P4921, DOI 10.1242/dev.070805; Zalli D, 2012, HUM MOL GENET, V21, P1155, DOI 10.1093/hmg/ddr544; Zeng HQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015900; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648	70	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0162033	10.1371/journal.pone.0162033	http://dx.doi.org/10.1371/journal.pone.0162033			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579771	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877400053
J	Weber, EM; Hultgren, J; Algers, B; Olsson, IAS				Weber, Elin M.; Hultgren, Jan; Algers, Bo; Olsson, I. Anna S.			Do Laboratory Mouse Females that Lose Their Litters Behave Differently around Parturition?	PLOS ONE			English	Article							REPRODUCTIVE-PERFORMANCE; MATERNAL-BEHAVIOR; BREEDING PERFORMANCE; PERINATAL-MORTALITY; NESTING MATERIAL; MUS-MUSCULUS; HOUSE MICE; CAGE SIZE; C57BL/6J; SYSTEMS	Efficiency in laboratory mouse breeding is hampered by poor reproductive performance, including the loss of entire litters shortly after birth. However, the underlying mechanisms are not yet fully understood and establishing the cause of death in laboratory mouse pups can be complicated. Newborn mouse pups are generally hidden in nests, dead pups are often eaten by the female, and the widespread practice of leaving periparturient females undisturbed complicates inspection, which may delay the discovery of pup loss. In order to efficiently prevent problems with litter loss, it is important to find key factors for survival. We investigated differences in periparturient behavior between female laboratory mice whose pups survived until weaning and females whose entire litters were lost. Video recordings of 82 primiparous females of the C57BL/6 strain or knockouts with C57BL/6 background were used. The mice were observed from 24 h before until 24 h after parturition and female behaviors coded using a pre-established ethogram. The relationship between behavior and survival was analyzed using logistic models, where litter survival was regressed on the proportion of 30-s observations with at least one occurrence of the behavior. We found that females with surviving litters performed more nest building behavior during the last 24 h before parturition (p = 0.004) and spent less time outside the nest during the entire observation period (p = 0.001). Increased litter survival was also associated with more passive maternal behaviors and the female ignoring still pups less. Females that lost their litters performed more parturition-related behaviors, suggesting prolonged labor. The results indicate that maternal behavior plays a significant role in laboratory mouse pup survival. Complications at parturition also contribute to litter mortality.	[Weber, Elin M.; Hultgren, Jan; Algers, Bo] Swedish Univ Agr Sci, Dept Anim Environm & Hlth, Skara, Sweden; [Weber, Elin M.] Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA; [Olsson, I. Anna S.] Univ Porto, I3S Inst Invest & Inovacao Saude, Oporto, Portugal; [Weber, Elin M.; Olsson, I. Anna S.] Univ Porto, IBMC Inst Biol Mol & Celular, Lab Anim Sci, Oporto, Portugal	Swedish University of Agricultural Sciences; Stanford University; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto	Weber, EM (corresponding author), Swedish Univ Agr Sci, Dept Anim Environm & Hlth, Skara, Sweden.; Weber, EM (corresponding author), Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA.; Weber, EM (corresponding author), Univ Porto, IBMC Inst Biol Mol & Celular, Lab Anim Sci, Oporto, Portugal.	elin.weber@slu.se	Olsson, Anna/C-1792-2008	Olsson, Anna/0000-0002-4369-8723; Hultgren, Jan/0000-0001-9164-2321	Swedish Board of Agriculture [Dnr 31-4343/09]; Swedish Research Council [K2010-79X-21370-01-3]; Fundacao para a Ciencia e a Tecnologia (FCT), Ministerio da Ciencia, Tecnologia e Ensino Superior, Portugal [POCTI/NSE/45352/2002]	Swedish Board of Agriculture; Swedish Research Council(Swedish Research CouncilEuropean Commission); Fundacao para a Ciencia e a Tecnologia (FCT), Ministerio da Ciencia, Tecnologia e Ensino Superior, Portugal(Portuguese Foundation for Science and Technology)	This project was funded by Swedish Board of Agriculture, Dnr 31-4343/09, http://www.jordbruksverket.se/. IASO received this funding. It was also funded by Swedish Research Council, K2010-79X-21370-01-3, http://www.vr.se/. BA received this funding. The experimental study in which video recordings were made was funded by research grant POCTI/NSE/45352/2002 from the Fundacao para a Ciencia e a Tecnologia (FCT), Ministerio da Ciencia, Tecnologia e Ensino Superior, Portugal, http://www.fct.pt/. IASO and EMW received this funding.	Bond TLY, 2002, PHYSIOL BEHAV, V75, P551, DOI 10.1016/S0031-9384(02)00659-5; Borges VF, 2005, PREV VET MED, V70, P165, DOI 10.1016/j.prevetmed.2005.03.003; Brown JR, 1996, CELL, V86, P297, DOI 10.1016/S0092-8674(00)80101-4; Brown RE, 1999, PHYSIOL BEHAV, V67, P599, DOI 10.1016/S0031-9384(99)00109-2; BROWN RZ, 1953, ECOL MONOGR, V23, P217, DOI 10.2307/1943592; Carvalho AFU, 2009, BRAZ J BIOL, V69, P153, DOI 10.1590/S1519-69842009000100020; Cooper JC, 2007, BIOL REPROD, V77, P274, DOI 10.1095/biolreprod.106.057125; Edwards SA, 2002, LIVEST PROD SCI, V78, P3, DOI 10.1016/S0301-6226(02)00180-X; EHRET G, 1984, Z TIERPSYCHOL, V65, P25; Eskola S, 1999, LAB ANIM-UK, V33, P122, DOI 10.1258/002367799780578354; European Commission, 2013, COM2013859FINAL EUR; Ewer RF., 1968, ETHOLOGY MAMMALS, P234; Gaskill BN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074153; Gaskill BN, 2013, APPL ANIM BEHAV SCI, V143, P110, DOI 10.1016/j.applanim.2012.10.009; GUASTAVINO JM, 1984, PHYSIOL BEHAV, V32, P225, DOI 10.1016/0031-9384(84)90134-3; HAUSCHKA TS, 1952, J HERED, V43, P117, DOI 10.1093/oxfordjournals.jhered.a106283; ITURRIAN WB, 1968, LAB ANIM CARE, V18, P160; KONIG B, 1987, BEHAV ECOL SOCIOBIOL, V20, P1, DOI 10.1007/BF00292161; Kuroda KO, 2011, PROG NEURO-PSYCHOPH, V35, P1205, DOI 10.1016/j.pnpbp.2011.02.008; Malmkvist J, 2007, APPL ANIM BEHAV SCI, V107, P120, DOI 10.1016/j.applanim.2006.09.018; MARTINO PE, 1990, VET RES COMMUN, V14, P199, DOI 10.1007/BF00347738; Mellor DJ, 2004, VET J, V168, P118, DOI 10.1016/j.tvjl.2003.08.004; Offenbacher S, 2005, J PERIODONTOL, V76, P2133, DOI 10.1902/jop.2005.76.11-S.2133; Porto G, 2007, IRON OVERLOAD IMMUNI; Potgieter FJ, 1997, J S AFR VET ASSOC, V68, P8; Rasmussen S, 2009, J AM ASSOC LAB ANIM, V48, P363; Reeb-Whitaker CK, 2001, LAB ANIM-UK, V35, P58, DOI 10.1258/0023677011911381; Rodrigues P, 2006, INT J EXP PATHOL, V87, P317, DOI 10.1111/j.1365-2613.2006.00491.x; Shoji H, 2006, PHYSIOL BEHAV, V89, P320, DOI 10.1016/j.physbeh.2006.06.012; Singh J, 2006, BIRTH DEFECTS RES B, V77, P216, DOI 10.1002/bdrb.20077; Spangenberg EMF, 2014, LAB ANIM-UK, V48, P193, DOI 10.1177/0023677214531569; Tsai PP, 2003, LAB ANIM-UK, V37, P44, DOI 10.1258/002367703762226683; Turgeon B, 2009, PHYSIOL REV, V89, P1, DOI 10.1152/physrev.00040.2007; Weaver SR, 2015, USE RATLOFT DECREASE; Weber EM, 2013, REPROD DOMEST ANIM, V48, P292, DOI 10.1111/j.1439-0531.2012.02147.x; Weber EM, 2008, APPL ANIM BEHAV SCI, V114, P1, DOI 10.1016/j.applanim.2008.06.006; Weber EM, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-83; Wettschureck N, 2004, MOL CELL BIOL, V24, P8048, DOI 10.1128/MCB.24.18.8048-8054.2004; Whitaker J, 2007, LAB ANIMAL, V36, P32, DOI 10.1038/laban1107-32; Whitaker J, 2009, LAB ANIMAL, V38, P24, DOI 10.1038/laban0109-24	40	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161238	10.1371/journal.pone.0161238	http://dx.doi.org/10.1371/journal.pone.0161238			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575720	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877200019
J	Jujo, T; Tanabe, N; Sakao, S; Ishibashi-Ueda, H; Ishida, K; Naito, A; Kato, F; Takeuchi, T; Sekine, A; Nishimura, R; Sugiura, T; Shigeta, A; Masuda, M; Tatsumi, K				Jujo, Takayuki; Tanabe, Nobuhiro; Sakao, Seiichiro; Ishibashi-Ueda, Hatsue; Ishida, Keiichi; Naito, Akira; Kato, Fumiaki; Takeuchi, Takao; Sekine, Ayumi; Nishimura, Rintaro; Sugiura, Toshihiko; Shigeta, Ayako; Masuda, Masahisa; Tatsumi, Koichiro			Severe Pulmonary Arteriopathy Is Associated with Persistent Hypoxemia after Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension	PLOS ONE			English	Article							CONTROLLED-TRIAL; GAS-EXCHANGE; THROMBOENDARTERECTOMY; VASCULATURE; DIFFUSION; BOSENTAN; DISEASE; LESIONS; CT	Background Chronic thromboembolic pulmonary hypertension (CTEPH) is characterized by occlusion of pulmonary arteries by organized chronic thrombi. Persistent hypoxemia and residual pulmonary hypertension (PH) following successful pulmonary endarterectomy (PEA) are clinically important problems; however, the underlying mechanisms remain unclear. We have previously reported that residual PH is closely related to severe pulmonary vascular remodeling and hypothesize that this arteriopathy might also be involved in impaired gas exchange. The purpose of this study was to evaluate the association between hypoxemia and pulmonary arteriopathy after PEA. Methods and Results Between December 2011 and November 2014, 23 CTEPH patients underwent PEA and lung biopsy. The extent of pulmonary arteriopathy was quantified pathologically in lung biopsy specimens. We then analyzed the relationship between the severity of pulmonary arteriopathy and gas exchange after PEA. We observed that the severity of pulmonary arteriopathy was negatively correlated with postoperative and follow-up PaO2 (postoperative PaO2: r = -0.73, p = 0.0004; follow-up PaO2: r = -0.66, p = 0.001), but not with preoperative PaO2 (r = -0.373, p = 0.08). Multivariate analysis revealed that the obstruction ratio and patient age were determinants of PaO2 one month after PEA (R-2 = 0.651, p = 0.00009). Furthermore, the obstruction ratio and improvement of pulmonary vascular resistance were determinants of PaO2 at follow-up (R-2 = 0.545, p = 0.0002). Severe pulmonary arteriopathy might increase the alveolar-arterial oxygen difference and impair diffusion capacity, resulting in hypoxemia following PEA. Conclusion The severity of pulmonary arteriopathy was closely associated with postoperative and follow-up hypoxemia.	[Jujo, Takayuki; Tanabe, Nobuhiro; Sakao, Seiichiro; Naito, Akira; Kato, Fumiaki; Takeuchi, Takao; Sekine, Ayumi; Nishimura, Rintaro; Sugiura, Toshihiko; Shigeta, Ayako; Tatsumi, Koichiro] Chiba Univ, Grad Sch Med, Dept Respirol B2, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan; [Jujo, Takayuki; Tanabe, Nobuhiro; Sekine, Ayumi; Nishimura, Rintaro] Chiba Univ, Grad Sch Med, Dept Adv Med Pulm Hypertens, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan; [Ishibashi-Ueda, Hatsue] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan; [Ishida, Keiichi] Chiba Univ, Grad Sch Med, Dept Cardiovasc Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan; [Masuda, Masahisa] Natl Hosp Org, Chiba Med Ctr, Dept Cardiovasc Surg, Chuo Ku, 4-1-2 Tsubakimori, Chiba 2608606, Japan	Chiba University; Chiba University; National Cerebral & Cardiovascular Center - Japan; Chiba University	Jujo, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Respirol B2, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.; Jujo, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Adv Med Pulm Hypertens, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	naikamo_resp19184@chiba-u.jp	Jujo, Takayuki/Q-7627-2018	Jujo, Takayuki/0000-0001-5725-1810	Cardiovascular Research Fund; Ministry of Education, Culture, Sports, Science and Technology of Japan [25461148]; Ministry of Health, Labour and Welfare specifically designated for the Respiratory Failure Research Group and Cardiovascular Diseases; Respiratory Failure Research Group from the Ministry of Health, Labour and Welfare, Japan; Japan Agency for Medical Research and Development, AMED [27280401]; Japanese Ministry of Education and Science [15K09210]; Japan Society for the Promotion of Science; Japanese Ministry of Health, Labour and Welfare research	Cardiovascular Research Fund; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare specifically designated for the Respiratory Failure Research Group and Cardiovascular Diseases; Respiratory Failure Research Group from the Ministry of Health, Labour and Welfare, Japan; Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Japanese Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Health, Labour and Welfare research	T.J was supported by The Cardiovascular Research Fund. N.T was supported by a research grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (25461148), and a grant from the Ministry of Health, Labour and Welfare specifically designated for the Respiratory Failure Research Group and Cardiovascular Diseases. S.S was supported by research grants from the Respiratory Failure Research Group from the Ministry of Health, Labour and Welfare, Japan, a grant to the Pulmonary Hypertension Research Group (No. 27280401) from the Japan Agency for Medical Research and Development, AMED, and a Grant-in-Aid for Scientific Research (JSPS KAKENHI Grant Number 15K09210) from the Japanese Ministry of Education and Science; K.I was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science; K.T was supported by Japanese Ministry of Health, Labour and Welfare research grants specifically designated for the Respiratory Failure Research Group and Cardiovascular Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI J, 1974, AM J SURG, V128, P376, DOI 10.1016/0002-9610(74)90176-7; Bernstein RJ, 1996, CHEST, V110, P1430, DOI 10.1378/chest.110.6.1430; Boyden EA, 1955, SEMENTAL ANATOMY LUN; Corsico AG, 2008, AM J RESP CRIT CARE, V178, P419, DOI 10.1164/rccm.200801-101OC; Dorfmuller P, 2014, EUR RESPIR J, V44, P1275, DOI 10.1183/09031936.00169113; Gan HL, 2014, J THORAC CARDIOV SUR, V148, P3014, DOI 10.1016/j.jtcvs.2014.05.024; Ghofrani HA, 2002, LANCET, V360, P895, DOI 10.1016/S0140-6736(02)11024-5; Ghofrani HA, 2013, NEW ENGL J MED, V369, P319, DOI 10.1056/NEJMoa1209657; Ishida K, 2012, J THORAC CARDIOV SUR, V144, P321, DOI 10.1016/j.jtcvs.2011.09.004; Jais X, 2008, J AM COLL CARDIOL, V52, P2127, DOI 10.1016/j.jacc.2008.08.059; Jamieson SW, 2003, ANN THORAC SURG, V76, P1457, DOI 10.1016/S0003-4975(03)00828-2; Jenkins DP, 2013, EUR RESPIR J, V41, P735, DOI 10.1183/09031936.00058112; Jujo T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133167; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; KAPITAN KS, 1990, CHEST, V98, P14, DOI 10.1378/chest.98.1.14; KAPITAN KS, 1989, AM REV RESPIR DIS, V139, P1149, DOI 10.1164/ajrccm/139.5.1149; Kim NHS, 2004, CIRCULATION, V109, P18, DOI 10.1161/01.CIR.0000111841.28126.D4; Kim NH, 2013, J AM COLL CARDIOL, V62, pD92, DOI 10.1016/j.jacc.2013.10.024; Ley S, 2002, AM J ROENTGENOL, V179, P1209, DOI 10.2214/ajr.179.5.1791209; MOSER KM, 1993, CHEST, V103, P685, DOI 10.1378/chest.103.3.685; MOSER KM, 1993, CHEST, V104, P1441, DOI 10.1378/chest.104.5.1441; Ogawa A, 2014, INTERNAL MED, V53, P729, DOI 10.2169/internalmedicine.53.1343; Qanadli SD, 2001, AM J ROENTGENOL, V176, P1415, DOI 10.2214/ajr.176.6.1761415; Rich S, 2010, CHEST, V138, P1234, DOI 10.1378/chest.09-2815; Sacks RS, 2006, SEMIN THORAC CARDIOV, V18, P265, DOI 10.1053/j.semtcvs.2006.09.004; Shimizu H, 2008, CIRC J, V72, P1136, DOI 10.1253/circj.72.1136; Steenhuis LH, 2000, EUR RESPIR J, V16, P276, DOI 10.1034/j.1399-3003.2000.16b15.x; Stolz D, 2008, EUR RESPIR J, V32, P619, DOI 10.1183/09031936.00011308; Tanabe N, 1997, EUR RESPIR J, V10, P2066, DOI 10.1183/09031936.97.10092066; Tanabe N, 2013, RESPIR INVESTIG, V51, P134, DOI 10.1016/j.resinv.2013.02.005; van der Plas MN, 2011, ANN THORAC SURG, V91, P1094, DOI 10.1016/j.athoracsur.2010.11.061; Wagner P, 2012, CLIN RESP MED, P37; West JB, 1995, RESP PHYSL ESSENTIAL; Yamaki S, 2014, CIRC J, V78, P476, DOI 10.1253/circj.CJ-13-1016; Yi ES, 2000, AM J RESP CRIT CARE, V162, P1577, DOI 10.1164/ajrccm.162.4.9912131; Zoia MC, 2002, THORAX, V57, P608, DOI 10.1136/thorax.57.7.608	36	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161827	10.1371/journal.pone.0161827	http://dx.doi.org/10.1371/journal.pone.0161827			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571267	Green Published, gold, Green Submitted			2022-12-26	WOS:000382876700035
J	Liang, FW; Chan, WY; Chen, PJ; Zimmerman, C; Waring, S; Doody, R				Liang, Fu-Wen; Chan, Wenyaw; Chen, Ping-Jen; Zimmerman, Carissa; Waring, Stephen; Doody, Rachelle			Cognitively-Related Basic Activities of Daily Living Impairment Greatly Increases the Risk of Death in Alzheimers Disease	PLOS ONE			English	Article							SURVIVAL; PREDICTORS; MORTALITY; INSTITUTIONALIZATION; PROBABILITIES; DURATION; DEMENTIA; ONSET	Introduction Some Alzheimer's disease (AD) patients die without ever developing cognitively impaired basic activities of daily living (basic ADL), which may reflect slower disease progression or better compensatory mechanisms. Although impaired basic ADL is related to disease severity, it may exert an independent risk for death. This study examined the association between impaired basic ADL and survival of AD patients, and proposed a multistate approach for modeling the time to death for patients who demonstrate different patterns of progression of AD that do or do not include basic ADL impairment. Methods 1029 patients with probable AD at the Baylor College of Medicine Alzheimer's Disease and Memory Disorders Center met the criteria for this study. Two complementary definitions were used to define development of basic ADL impairment using the Physical Self-Maintenance Scale score. A weighted Cox regression model, including a time-dependent covariate (development of basic ADL impairment), and a multistate survival model were applied to examine the effect of basic ADL impairment on survival. Results As expected decreased ability to perform basic ADL at baseline, age at initial visit, years of education, and sex were all associated with significantly higher mortality risk. In those unimpaired at baseline, the development of basic ADL impairment was also associated with a much greater risk of death (hazard ratios 1.77-4.06) over and above the risk conferred by loss of MMSE points. A multi-state Cox model, controlling for those other variables quantified the substantive increase in hazard ratios for death conferred by the development of basic ADL impairment by two definitions and can be applied to calculate the short term risk of mortality in individual patients. Conclusions The current study demonstrates that the presence of basic ADL impairment or the development of such impairments are important predictors of death in AD patients, regardless of severity.	[Liang, Fu-Wen] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Publ Hlth, 1 Univ Rd, Tainan 701, Taiwan; [Chan, Wenyaw] Univ Texas Hlth Sci Ctr Houston, Dept Biostat, 1200 Pressler St,E827, Houston, TX 77030 USA; [Chen, Ping-Jen] Chi Mei Med Ctr, Dept Geriatr & Gerontol, 901 Zhong Hua Rd, Tainan 710, Taiwan; [Zimmerman, Carissa] Rice Univ, Dept Psychol, 6100 Main MS-27, Houston, TX 77005 USA; [Waring, Stephen] Essentia Inst Rural Hlth, 502 East Second St, Duluth, MN 55805 USA; [Doody, Rachelle] Baylor Coll Med, Alzheimers Dis & Memory Disorders Ctr, 7200 Cambridge St,A9-210, Houston, TX 77030 USA	National Cheng Kung University; National Cheng Kung University Hospital; University of Texas System; University of Texas Health Science Center Houston; Chi Mei Hospital; Rice University; Baylor College of Medicine	Chan, WY (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Biostat, 1200 Pressler St,E827, Houston, TX 77030 USA.	wenyaw.chan@uth.tmc.edu	Chen, Ping-Jen/AAG-8548-2021; Waring, Stephen/AAR-6870-2021	Chen, Ping-Jen/0000-0001-7636-0801; Waring, Stephen/0000-0002-9674-0083	Cynthia and George Mitchell Foundation; Cain Foundation in the Baylor Alzheimer's Disease and Memory Disorder Center; Cynthia and George Mitchell Fund	Cynthia and George Mitchell Foundation(General Electric); Cain Foundation in the Baylor Alzheimer's Disease and Memory Disorder Center; Cynthia and George Mitchell Fund	The authors would like to thank the Cynthia and George Mitchell Foundation (http://cgmf.org/p/home.html) and the Cain Foundation (http://www.thecainfoundation.com/bor/site/) in the Baylor Alzheimer's Disease and Memory Disorder Center for providing funds that contributed towards this analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Cynthia and George Mitchell Fund and the Cain Foundation in the Baylor Alzheimer's Disease and Memory Disorder Center for providing funds that contributed towards this analysis.	Aguero-Torres H, 1998, INT J GERIATR PSYCH, V13, P755, DOI 10.1002/(SICI)1099-1166(1998110)13:11<755::AID-GPS862>3.0.CO;2-Y; Aguero-Torres H, 1998, J AM GERIATR SOC, V46, P444, DOI 10.1111/j.1532-5415.1998.tb02464.x; ANDERSEN PK, 1991, SCAND J STAT, V18, P153; BELLONISONZOGNI A, 1989, ARCH GERONTOL GERIAT, V9, P193, DOI 10.1016/0167-4943(89)90039-3; BIANCHETTI A, 1995, DEMENTIA, V6, P108, DOI 10.1159/000106930; Bowen JD, 1996, NEUROLOGY, V47, P433, DOI 10.1212/WNL.47.2.433; Claus JJ, 1998, DEMENT GERIATR COGN, V9, P284, DOI 10.1159/000017073; Doody R, 2005, DEMENT GERIATR COGN, V20, P198, DOI 10.1159/000087300; Doody Rachelle S, 2015, Alzheimers Dement (Amst), V1, P464, DOI 10.1016/j.dadm.2015.08.001; Doody RS, 2010, ALZHEIMERS RES THER, V2, DOI [10.1186/alzrt25, 10.1186/alzrt38]; Doody RS, 2004, DEMENT GERIATR COGN, V17, P1, DOI 10.1159/000074078; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Heyman A, 1996, NEUROLOGY, V46, P656, DOI 10.1212/WNL.46.3.656; HIER DB, 1989, ARCH NEUROL-CHICAGO, V46, P1213, DOI 10.1001/archneur.1989.00520470073030; Klein J. P., 2003, SURVIVAL ANAL TECHNI; KLEIN JP, 1993, STAT MED, V12, P2315, DOI 10.1002/sim.4780122408; KNOPMAN DS, 1988, J AM GERIATR SOC, V36, P108, DOI 10.1111/j.1532-5415.1988.tb01778.x; Lapane KL, 2001, NEUROLOGY, V56, P650, DOI 10.1212/WNL.56.5.650; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MOLSA PK, 1995, ACTA NEUROL SCAND, V91, P159; MOLSA PK, 1986, ACTA NEUROL SCAND, V74, P103; MORITZ DJ, 1993, AM J EPIDEMIOL, V137, P456; Reisberg B, 1996, Int Psychogeriatr, V8, P291, DOI 10.1017/S1041610296002657; Rountree SD, 2009, ALZHEIMERS RES THER, V1, DOI 10.1186/alzrt7; Santerre R, 1996, HELTH EC THEORY INSI; Spiegel R, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt183; Stern Y, 1997, JAMA-J AM MED ASSOC, V277, P806, DOI 10.1001/jama.277.10.806; VANDIJK PTM, 1992, J GERONTOL, V47, pM28; Waring SC, 2005, ALZ DIS ASSOC DIS, V19, P178, DOI 10.1097/01.wad.0000189033.35579.2d; Weuve J., 2012, EPIDEMIOLOGY CAMBRID, V23; Wolfson C, 2001, NEW ENGL J MED, V344, P1111, DOI 10.1056/NEJM200104123441501	32	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0160671	10.1371/journal.pone.0160671	http://dx.doi.org/10.1371/journal.pone.0160671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571265	Green Published, gold, Green Submitted			2022-12-26	WOS:000382876700005
J	Lutz, NW; Banerjee, P; Wilson, BJ; Ma, J; Cozzone, PJ; Frank, MH				Lutz, Norbert W.; Banerjee, Pallavi; Wilson, Brian J.; Ma, Jie; Cozzone, Patrick J.; Frank, Markus H.			Expression of Cell-Surface Marker ABCB5 Causes Characteristic Modifications of Glucose, Amino Acid and Phospholipid Metabolism in the G3361 Melanoma-Initiating Cell Line	PLOS ONE			English	Article							NMR SPECTROSCOPIC ANALYSIS; MULTIDRUG-RESISTANCE; STEM-CELLS; MULTIPARAMETRIC OPTIMIZATION; ENERGY-METABOLISM; CANCER; HYPOXIA; P-31; OVEREXPRESSION; ACTIVATION	We present a pilot study aimed at determining the effects of expression of ATP-binding cassette member B5 (ABCB5), a previously described marker for melanoma-initiating cells, on cellular metabolism. Metabolic profiles for two groups of human G3361 melanoma cells were compared, i.e. wildtype melanoma cells with intact ABCB5 expression (ABCB5-WT) and corresponding melanoma cell variants with inhibited ABCB5 expression, through shRNA-mediated gene knockdown (ABCB5-KD). A comprehensive metabolomic analysis was performed by using proton and phosphorus NMR spectroscopy of cell extracts to examine water-soluble metabolites and lipids. Parametric and non-parametric statistical analysis of absolute and relative metabolite levels yielded significant differences for compounds involved in glucose, amino acid and phospholipid (PL) metabolism. By contrast, energy metabolism was virtually unaffected by ABCB5 expression. The sum of water-soluble metabolites per total protein was 17% higher in ABCB5-WT vs. ABCB5-KD G3361 variants, but no difference was found for the sum of PLs. Enhanced abundance was particularly pronounced for lactate (+23%) and alanine (+26%), suggesting an increase in glycolysis and potentially glutaminolysis. Increases in PL degradation products, glycerophosphocholine and glycerophosphoethanolamine (+85 and 123%, respectively), and redistributions within the PL pool suggested enhanced membrane PL turnover as a consequence of ABCB5 expression. The possibility of glycolysis modulation by an ABCB5-dependent IL1 beta-mediated mechanism was supported by functional studies employing monoclonal antibody (mAb)-dependent ABCB5 protein inhibition in wildtype G3361 melanoma cells. Our metabolomic results suggest that the underlying biochemical pathways may offer targets for melanoma therapy, potentially in combination with other treatment forms.	[Lutz, Norbert W.; Cozzone, Patrick J.] Aix Marseille Univ, Fac Med Timone, CNRS, UMR 7339,Ctr Resonance Magnet Biol & Med, Marseille, France; [Banerjee, Pallavi; Wilson, Brian J.; Ma, Jie; Frank, Markus H.] Harvard Med Sch, Boston Childrens Hosp, Transplant Res Program, Boston, MA USA; [Wilson, Brian J.; Frank, Markus H.] Harvard Med Sch, Brigham & Womens Hosp, Dept Dermatol, Harvard Skin Dis Res Ctr, Boston, MA USA; [Cozzone, Patrick J.] Agcy Sci Technol & Res, Singapore Imaging Consortium, Singapore, Singapore; [Frank, Markus H.] Edith Cowan Univ, Sch Med Sci, Joondalup, WA, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); Edith Cowan University	Lutz, NW (corresponding author), Aix Marseille Univ, Fac Med Timone, CNRS, UMR 7339,Ctr Resonance Magnet Biol & Med, Marseille, France.	Norbert.Lutz@univ-amu.fr	Frank, Markus/O-1625-2014	Frank, Markus/0000-0002-1312-0488	Centre National de la Recherche Scientifique [UMR 7339]; National Institutes of Health/National Cancer Institute [R01CA113796, R01CA158467, R01CA138231]; NATIONAL CANCER INSTITUTE [R01CA158467, R01CA138231, R01CA113796] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY025794] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Centre National de la Recherche Scientifique UMR 7339 (www.cnrs.fr): PJC, and the National Institutes of Health/National Cancer Institute R01CA113796, R01CA158467 and R01CA138231 (https://www.nih.gov): MHF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Ciavardelli D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.285; COHEN JS, 1986, CANCER RES, V46, P4087; Glunde K, 2008, CANCER RES, V68, P172, DOI 10.1158/0008-5472.CAN-07-2678; Haddad JJ, 2002, EUR CYTOKINE NETW, V13, P250; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; KAPLAN O, 1991, CANCER RES, V51, P1638; Kathagen A, 2013, ACTA NEUROPATHOL, V126, P763, DOI 10.1007/s00401-013-1173-y; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Liu PP, 2014, CELL DEATH DIFFER, V21, P124, DOI 10.1038/cdd.2013.131; Lutz NW, 2014, JOVE-J VIS EXP, DOI 10.3791/51829; Lutz NW, 2010, ANAL CHEM, V82, P5433, DOI 10.1021/ac100514n; Lutz NW, 2010, ANAL CHEM, V82, P5441, DOI 10.1021/ac100515y; Lutz NW, 2005, MAGN RESON MATER PHY, V18, P144, DOI 10.1007/s10334-005-0107-7; Marin-Hernandez A, 2009, MINI-REV MED CHEM, V9, P1084, DOI 10.2174/138955709788922610; Milane L, 2011, J CONTROL RELEASE, V155, P237, DOI 10.1016/j.jconrel.2011.03.032; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Sokal RR, 1995, BIOMETRY; Tome ME, 2012, EXP THER MED, V3, P845, DOI 10.3892/etm.2012.487; Tome ME, 2005, INT J MOL MED, V15, P497; Tome ME, 2004, BBA-MOL CELL RES, V1693, P57, DOI 10.1016/j.bbamcr.2004.05.004; Tome ME, 2003, BBA-MOL CELL RES, V1642, P149, DOI 10.1016/j.bbamcr.2003.08.002; Tonigold M, 2014, J CANCER RES CLIN, V140, P1689, DOI 10.1007/s00432-014-1727-y; Venkatesan PV, 1998, ANTI-CANCER DRUG, V9, P449, DOI 10.1097/00001813-199806000-00012; Viola A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000157; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Wilson BJ, 2014, CANCER RES, V74, P4196, DOI 10.1158/0008-5472.CAN-14-0582; Xie H, 2014, CELL METAB, V19, P795, DOI 10.1016/j.cmet.2014.03.003; Xie JS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04927; Yuan SQ, 2013, STEM CELLS, V31, P23, DOI 10.1002/stem.1273; Zangiacomi V, 2014, GENES CANC, V5, P250; Zhang XH, 2006, J CELL SCI, V119, P1005, DOI 10.1242/jcs.02821	35	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161803	10.1371/journal.pone.0161803	http://dx.doi.org/10.1371/journal.pone.0161803			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560924	Green Submitted, Green Published, gold			2022-12-26	WOS:000382258600103
J	Miethe, S; Mazuet, C; Liu, Y; Tierney, R; Rasetti-Escargueil, C; Avril, A; Frenzel, A; Thullier, P; Pelat, T; Urbain, R; Fontayne, A; Sesardic, D; Hust, M; Popoff, MR				Miethe, Sebastian; Mazuet, Christelle; Liu, Yvonne; Tierney, Robert; Rasetti-Escargueil, Christine; Avril, Arnaud; Frenzel, Andre; Thullier, Philippe; Pelat, Thibaut; Urbain, Remi; Fontayne, Alexandre; Sesardic, Dorothea; Hust, Michael; Popoff, Michel Robert			Development of Germline-Humanized Antibodies Neutralizing Botulinum Neurotoxin A and B	PLOS ONE			English	Article							IMMUNE GLOBULIN; INFANT BOTULISM; LIGHT-CHAIN; SCFV-FC; TOXIN; ELECTROPHORESIS; IMMUNOGLOBULIN; ANTITOXIN; SEROTYPE; OUTBREAK	Botulinum neurotoxins (BoNTs) are counted among the most toxic substances known and are responsible for human botulism, a life-threatening disease characterized by flaccid muscle paralysis that occurs naturally by food poisoning or colonization of the gastrointestinal tract by BoNT-producing clostridia. To date, 7 serologically distinct serotypes of BoNT (serotype A-G) are known. Due to the high toxicity of BoNTs the Centers for Disease Control and Prevention (CDC) have classified BoNTs as category A agent, including the six biological agents with the highest potential risk of use as bioweapons. Well tolerated antibodies neutralizing BoNTs are required to deal with the potential risk. In a previous work, we described the development of scFv and scFv-Fc (Yumab) from macaque origin (Macaca fascicularis) neutralizing BoNT/A and B by targeting the heavy and light chain of each serotype. In the present study, we humanized the macaque antibodies SEM120-IIIC1 (anti-BoNT/A light chain), A1HC38 (anti-BoNT/A heavy chain), BLC3 (anti-BoNT/B light chain) and B2-7 (anti-BoNT/B heavy chain) by germline-humanization to obtain a better potential immunotolerance in humans. We increased the Germinality Index (GI) of SEM120-IIIC1 to 94.5%, for A1HC38, to 95% for BLC3 and to 94.4% for B2-7. Furthermore, the neutralization efficacies of the germline-humanized antibodies were analyzed in lethal and non-lethal in vivo mouse assays as full IgG. The germline-humanized IgGs hu8SEM120-IIIC1, hu8A1HC38, hu8BLC3 and hu8B2-7 were protective in vivo, when anti-heavy and anti-light chain antibodies were combined. The synergistic effect and high humanness of the selected IgGs makes them promising lead candidates for further clinical development.	[Miethe, Sebastian; Frenzel, Andre; Hust, Michael] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, Abt Biotechnol, Braunschweig, Germany; [Mazuet, Christelle; Popoff, Michel Robert] Inst Pasteur, Unite Bacteries Anaerobies & Toxines, Paris, France; [Liu, Yvonne; Tierney, Robert; Rasetti-Escargueil, Christine; Sesardic, Dorothea] NIBSC, Div Bacteriol, Potters Bar, Herts, England; [Avril, Arnaud; Thullier, Philippe; Pelat, Thibaut] IRBA, Dept Malad Infect, Unite Interact Hote Pathogene, Bretigny Sur Orge, France; [Urbain, Remi; Fontayne, Alexandre] LFB Biotechnol, Therapeut Innovat Dept, Lille, France; [Pelat, Thibaut] BIOTEM, Apprieu, France; [Urbain, Remi] Ecdysis Pharma, Loos, France	Braunschweig University of Technology; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Institute for Biological Standards & Control	Hust, M (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, Abt Biotechnol, Braunschweig, Germany.; Popoff, MR (corresponding author), Inst Pasteur, Unite Bacteries Anaerobies & Toxines, Paris, France.	m.hust@tu-bs.de; mpopoff@pasteur.fr	Mazuet, Christelle/O-7731-2016; Popoff, Michel/O-7719-2016	Mazuet, Christelle/0000-0001-7619-9050; Popoff, Michel/0000-0001-9305-8989; FONTAYNE, Alexandre/0000-0002-0097-2294; AVRIL, Arnaud/0000-0003-1759-7256; Rasetti-Escargueil, Christine/0000-0003-0661-695X; Hust, Michael/0000-0003-3418-6045	European Community [241832]; LFB Biotechnologies	European Community(European Commission); LFB Biotechnologies	We acknowledge funding from the European Community's Seventh Framework Program (FP7/2007-2013) under agreement no. 241832 granted to the AntiBotABE project. LFB Biotechnologies provided support in the form of salaries for authors RU and A. Fontayne, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adekar SP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003023; Ahmadzadeh Vahideh, 2014, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V33, P67, DOI 10.1089/mab.2013.0080; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P299; Arnon SS, 2006, NEW ENGL J MED, V354, P462, DOI 10.1056/NEJMoa051926; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Avril A, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0206-0; Barash JR, 2014, J INFECT DIS, V209, P183, DOI 10.1093/infdis/jit449; BLACK RE, 1980, AM J MED, V69, P567, DOI 10.1016/0002-9343(80)90469-6; Bozheyeva G, 1999, 1 MONTR I INT STUD; Broad WJ, 1998, NY TIMES; Byrd JC, 2007, CLIN CANCER RES, V13, P4448, DOI 10.1158/1078-0432.CCR-06-1463; Cheng LW, 2009, INFECT IMMUN, V77, P4305, DOI 10.1128/IAI.00405-09; Dover N, 2014, J INFECT DIS, V209, P192, DOI 10.1093/infdis/jit450; Froude JW, 2011, MABS-AUSTIN, V3, P517, DOI 10.4161/mabs.3.6.17621; Fujinaga Y, 2013, CURR TOP MICROBIOL, V364, P45, DOI 10.1007/978-3-642-33570-9_3; Gupta A, 2005, NEUROLOGY, V65, P1694, DOI 10.1212/01.wnl.0000187127.92446.4c; GUTTMAN A, 1995, ELECTROPHORESIS, V16, P611, DOI 10.1002/elps.1150160198; Hibbs RG, 1996, CLIN INFECT DIS, V23, P337, DOI 10.1093/clinids/23.2.337; Hust M, 2011, J BIOTECHNOL, V152, P159, DOI 10.1016/j.jbiotec.2010.09.945; Jager V, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-52; Jalava K, 2011, EUROSURVEILLANCE, V16, P8; Jones RGA, 2006, TOXICON, V48, P246, DOI 10.1016/j.toxicon.2006.05.007; Long SS, 2007, PEDIATR INFECT DIS J, V26, P261, DOI 10.1097/01.inf.0000256442.06231.17; Maslanka SE, 2016, J INFECT DIS, V213, P379, DOI 10.1093/infdis/jiv327; Mazuet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012416; Miethe S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139905; Miethe S, 2014, MABS-AUSTIN, V6, P446, DOI 10.4161/mabs.27773; Morineaux V, 2015, ANAL BIOANAL CHEM, V407, P5559, DOI 10.1007/s00216-015-8707-1; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; Pelat T, 2009, MABS-AUSTIN, V1, P377, DOI 10.4161/mabs.1.4.8635; Pelat T, 2008, J MOL BIOL, V384, P1400, DOI 10.1016/j.jmb.2008.10.033; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pingeon JM, 2011, EUROSURVEILLANCE, V16, P5; Pommie C, 2004, J MOL RECOGNIT, V17, P17, DOI 10.1002/jmr.647; Prigent J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013245; Raphael BH, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-192; Rasetti-Escargueil C, 2015, MABS-AUSTIN, V7, P1161, DOI 10.1080/19420862.2015.1082016; Razai A, 2005, J MOL BIOL, V351, P158, DOI 10.1016/j.jmb.2005.06.003; Robert R, 2010, PROTEIN SCI, V19, P299, DOI 10.1002/pro.312; Rosenwasser LJ, 2003, J ALLERGY CLIN IMMUN, V112, P563, DOI 10.1067/mai.2003.1709; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Schuck P, 1996, TRENDS BIOCHEM SCI, V21, P458, DOI 10.1016/S0968-0004(96)20025-8; Sesardic D, 2004, MOVEMENT DISORD, V19, pS85, DOI 10.1002/mds.20021; Siberil S, 2006, IMMUNOL LETT, V106, P111, DOI 10.1016/j.imlet.2006.05.009; Sobel J, 2005, CLIN INFECT DIS, V41, P1167, DOI 10.1086/444507; Szabo Z, 2011, ANAL CHEM, V83, P5329, DOI 10.1021/ac2007587; Tan P, 2002, J IMMUNOL, V169, P1119, DOI 10.4049/jimmunol.169.2.1119; TSUJI K, 1980, APPL ENVIRON MICROB, V40, P533, DOI 10.1128/AEM.40.3.533-538.1980; WEBER JT, 1993, J INFECT DIS, V167, P451, DOI 10.1093/infdis/167.2.451; Wein LM, 2005, P NATL ACAD SCI USA, V102, P9984, DOI 10.1073/pnas.0408526102; Wheeler A, 2013, TOXICOLOGY, V306, P124, DOI 10.1016/j.tox.2013.02.006; Whitelegg NRJ, 2000, PROTEIN ENG, V13, P819, DOI 10.1093/protein/13.12.819; Williams GT, 2000, IMMUNITY, V13, P409, DOI 10.1016/S1074-7613(00)00040-6	53	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161446	10.1371/journal.pone.0161446	http://dx.doi.org/10.1371/journal.pone.0161446			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560688	gold, Green Submitted, Green Published			2022-12-26	WOS:000382258600042
J	Xue, WX; Fan, J; Zhang, Y; Xu, QX; Han, ZL; Sun, JR; Chen, JL				Xue, Wenxin; Fan, Jia; Zhang, Yong; Xu, Qingxuan; Han, Zongli; Sun, Jingrui; Chen, Julian			Identification and Expression Analysis of Candidate Odorant-Binding Protein and Chemosensory Protein Genes by Antennal Transcriptome of Sitobion avenae	PLOS ONE			English	Article							GENOME ANNOTATION; SOLUBLE-PROTEINS; APHIDS; PERCEPTION; PHEROMONE; HEMIPTERA; PATTERNS; CLONING; WHEAT; HAIRS	Odorant-binding proteins (OBPs) and chemosensory proteins (CSPs) of aphids are thought to be responsible for the initial molecular interactions during olfaction that mediate detection of chemical signals. Analysis of the diversity of proteins involved comprises critical basic research work that will facilitate the development of sustainable pest control strategies. To help us better understand differences in the olfactory system between winged and wingless grain aphids, we constructed an antennal transcriptome from winged and wingless Sitobion avenae (Fabricius), one of the most serious pests of cereal fields worldwide. Among the 133,331 unigenes in the antennal assembly, 13 OBP and 5 CSP putative transcripts were identified with 6 OBP and 3 CSP sequences representing new S. avenae annotations. We used qPCR to examine the expression profile of these genes sets across S. avenae development and in various tissues. We found 7 SaveOBPs and 1 SaveCSP were specifically or significantly elevated in antennae compared with other tissues, and that some transcripts (SaveOBP8, SaveCSP2 and SaveCSP5) were abundantly expressed in the legs of winged or wingless aphids. The expression levels of the SaveOBPs and SaveCSPs varied depending on the developmental stage. Possible physiological functions of these genes are discussed. Further molecular and functional studies of these olfactory related genes will explore their potential as novel targets for controlling S. avenae.	[Xue, Wenxin; Fan, Jia; Zhang, Yong; Xu, Qingxuan; Han, Zongli; Sun, Jingrui; Chen, Julian] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Chen, JL (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	jlchen1965@126.com	Chen, Julian/AAB-1846-2022		National Natural Science Foundation of China [31371946, 31401740]; The Agricultural Science and Technology Innovation Program (ASTIP); National Science and Technology Major Project [2014ZX0800201B]; Cooperation Project between China and Belgium from Ministry of Science and Technology (MOST) [2014DFG32270]; The National ST Major Project [2014ZX0800201B]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); The Agricultural Science and Technology Innovation Program (ASTIP); National Science and Technology Major Project; Cooperation Project between China and Belgium from Ministry of Science and Technology (MOST); The National ST Major Project	This work was supported by: 1. National Natural Science Foundation of China (http://www.nsfc.gov.cn/) 31371946. JLCH conceived and designed the experiments and made decision to publish, 2. National Natural Science Foundation of China (http://www.nsfc.gov.cn/) 31401740. JF conceived and designed the experiments and contributed to the writing of the manuscript, 3. The Agricultural Science and Technology Innovation Program (ASTIP). JLCH conceived and designed the experiments and made decision to publish, 4. The National Science and Technology Major Project (http://www.nmp.gov.cn/) 2014ZX0800201B. JF conceived and designed the experiments and contributed to the writing of the manuscript, and 5. Cooperation Project between China and Belgium from Ministry of Science and Technology (MOST) (http://www.istcp.org.cn/) 2014DFG32270. JLCH conceived and designed the experiments and decision to publish.; Our study was financially supported by the National Natural Science Foundation of China (31371946, 31401740), The Agricultural Science and Technology Innovation Program (ASTIP), The National S&T Major Project (2014ZX0800201B), and the Cooperation Project between China and Belgium from Ministry of Science and Technology (MOST) (2014DFG32270).	Blackman RL, 2006, APHIDS WORLD HERBACE; Calvello M, 2003, CELL MOL LIFE SCI, V60, P1933, DOI 10.1007/s00018-003-3186-5; Chen JL, 2013, WHEAT APHIDS CONTROL; Chi Bao-Jie, 2014, Chinese Journal of Applied Entomology, V51, P1496, DOI 10.7679/j.issn.2095-1353.2014.174; Dahanukar A, 2005, CURR OPIN NEUROBIOL, V15, P423, DOI 10.1016/j.conb.2005.06.001; Dani FR, 2011, CHEM SENSES, V36, P335, DOI 10.1093/chemse/bjq137; De Biasio F, 2015, INSECT SCI, V22, P220, DOI 10.1111/1744-7917.12118; de Bruyne M, 2008, J CHEM ECOL, V34, P882, DOI 10.1007/s10886-008-9485-4; Fan Jia, 2014, Chinese Journal of Applied Entomology, V51, P1413, DOI 10.7679/j.issn.2095-1353.2014.166; Gonzalez D, 2009, INSECT MOL BIOL, V18, P395, DOI 10.1111/j.1365-2583.2009.00883.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073524; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P254, DOI 10.1016/j.ibmb.2011.01.002; Harada E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029710; He M, 2014, COMP BIOCHEM PHYS B, V174, P1, DOI 10.1016/j.cbpb.2014.04.008; He P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028921; Honson NS, 2005, RECENT ADV PHYTOCHEM, V39, P227; Hull JJ, 2014, INSECT MOL BIOL, V23, P78, DOI 10.1111/imb.12064; Iovinella I, 2011, J PROTEOME RES, V10, P3439, DOI 10.1021/pr2000754; Jacobs SP, 2005, INSECT MOL BIOL, V14, P423, DOI 10.1111/j.1365-2583.2005.00573.x; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jeong YT, 2013, NEURON, V79, P725, DOI 10.1016/j.neuron.2013.06.025; Kitabayashi AN, 1998, INSECT BIOCHEM MOLEC, V28, P785, DOI 10.1016/S0965-1748(98)00058-7; KLEIN U, 1987, INSECT BIOCHEM, V17, P1193, DOI 10.1016/0020-1790(87)90093-X; Li S, 2008, BIOCHEM BIOPH RES CO, V372, P464, DOI 10.1016/j.bbrc.2008.05.064; Liu R, 2012, INSECT MOL BIOL, V21, P41, DOI 10.1111/j.1365-2583.2011.01114.x; Liu YL, 2014, J EXP BIOL, V217, P1821, DOI 10.1242/jeb.102020; Maleszka J, 2007, DEV GENES EVOL, V217, P189, DOI 10.1007/s00427-006-0127-y; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pan HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117153; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; PICKETT JA, 1992, ANNU REV ENTOMOL, V37, P67, DOI 10.1146/annurev.en.37.010192.000435; Pickett JA, 2014, CURR OPIN BIOTECH, V26, P125, DOI 10.1016/j.copbio.2013.12.006; Qiao HL, 2009, INSECT BIOCHEM MOLEC, V39, P414, DOI 10.1016/j.ibmb.2009.03.004; Sachse S., 2011, E NEUROFORUM, V2, P49, DOI [10.1007/s13295-011-0020-7, DOI 10.1007/S13295-011-0020-7]; Shanbhag SR, 2001, CELL TISSUE RES, V304, P423, DOI 10.1007/s004410100388; Sun YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030040; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; Vandermoten S, 2012, INSECT BIOCHEM MOLEC, V42, P155, DOI 10.1016/j.ibmb.2011.11.008; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verheggen FJ, 2010, VITAM HORM, V83, P215, DOI 10.1016/S0083-6729(10)83009-2; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P121, DOI 10.1146/annurev.en.31.010186.001005; Visser JH, 1996, ENTOMOL EXP APPL, V80, P35, DOI 10.1007/BF00194719; Vogel H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-29; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vogt RG, 1999, CHEM SENSES, V24, P481, DOI 10.1093/chemse/24.5.481; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Wu J.X., 2002, AGR ENTOMOLOGY; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Yan FM, 2013, REPORT ADV PLANT PRO; Yang CX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110454; Yang K, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu132; Yasukawa J, 2010, GENE, V467, P25, DOI 10.1016/j.gene.2010.07.006; Yuan HB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140562; Zhong T, 2012, J INSECT PHYSIOL, V58, P771, DOI 10.1016/j.jinsphys.2012.01.011; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zhou JJ, 2006, CHEM SENSES, V31, P453, DOI 10.1093/chemse/bjj050; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9; Zhou JJ, 2004, GENE, V327, P117, DOI 10.1016/j.gene.2003.11.007; Zhou SH, 2008, J APPL ENTOMOL, V132, P439, DOI 10.1111/j.1439-0418.2007.01255.x; Zhou SS, 2014, COMP BIOCHEM PHYS D, V9, P31, DOI 10.1016/j.cbd.2013.12.002	63	56	63	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161839	10.1371/journal.pone.0161839	http://dx.doi.org/10.1371/journal.pone.0161839			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27561107	gold, Green Published, Green Submitted			2022-12-26	WOS:000382258600106
J	Lee, J; Moraes-Vieira, PM; Castoldi, A; Aryal, P; Yee, EU; Vickers, C; Parnas, O; Donaldson, CJ; Saghatelian, A; Kahn, BB				Lee, Jennifer; Moraes-Vieira, Pedro M.; Castoldi, Angela; Aryal, Pratik; Yee, Eric U.; Vickers, Christopher; Parnas, Oren; Donaldson, Cynthia J.; Saghatelian, Alan; Kahn, Barbara B.			Branched Fatty Acid Esters of Hydroxy Fatty Acids (FAHFAs) Protect against Colitis by Regulating Gut Innate and Adaptive Immune Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						colitis; defensin; innate immunity; lipid; T helper cells; anti-inflammatory lipids; branched fatty acid esters of hydroxy fatty acids; immune regulation; Paneth cell; ulcerative colitis	INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SULFATE SODIUM; ULCERATIVE-COLITIS; MOUSE MODEL; EPITHELIAL BARRIER; TH17 CELLS; PROSTAGLANDINS; PREVALENCE; INDUCTION; REMISSION	We recently discovered a structurally novel class of endogenous lipids, branched palmitic acid esters of hydroxy stearic acids (PAHSAs), with beneficial metabolic and anti-inflammatory effects. We tested whether PAHSAs protect against colitis, which is a chronic inflammatory disease driven predominantly by defects in the innate mucosal barrier and adaptive immune system. There is an unmet clinical need for safe and well tolerated oral therapeutics with direct anti-inflammatory effects. Wild-type mice were pretreated orally with vehicle or 5-PAHSA (10 mg/kg) and 9-PAHSA (5 mg/kg) once daily for 3 days, followed by 10 days of either 0% or 2% dextran sulfate sodium water with continued vehicle or PAHSA treatment. The colon was collected for histopathology, gene expression, and flow cytometry. Intestinal crypt fractions were prepared for ex vivo bactericidal assays. Bone marrow-derived dendritic cells pretreated with vehicle or PAHSA and splenic CD4(+) T cells from syngeneic mice were co-cultured to assess antigen presentation and T cell activation in response to LPS. PAHSA treatment prevented weight loss, improved colitis scores (stool consistency, hematochezia, and mouse appearance), and augmented intestinal crypt Paneth cell bactericidal potency via a mechanism that may involve GPR120. In vitro, PAHSAs attenuated dendritic cell activation and subsequent T cell proliferation and Th1 polarization. The anti-inflammatory effects of PAHSAs in vivo resulted in reduced colonic T cell activation and pro-inflammatory cytokine and chemokine expression. These anti-inflammatory effects appear to be partially GPR120-dependent. We conclude that PAHSA treatment regulates innate and adaptive immune responses to prevent mucosal damage and protect against colitis. Thus, PAHSAs may be a novel treatment for colitis and related inflammation-driven diseases.	[Lee, Jennifer; Moraes-Vieira, Pedro M.; Castoldi, Angela; Aryal, Pratik; Kahn, Barbara B.] Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Yee, Eric U.; Kahn, Barbara B.] Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA; Harvard Med Sch, Boston, MA 02215 USA; [Vickers, Christopher; Donaldson, Cynthia J.; Saghatelian, Alan] Salk Inst Biol Studies, Helmsley Ctr Genom Med, Clayton Fdn, Labs Peptide Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Parnas, Oren] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02142 USA; [Moraes-Vieira, Pedro M.] Univ Estadual Campinas, Dept Genet Evolut & Bioagents, Inst Biol, BR-13083970 Sao Paulo, SP, Brazil; [Castoldi, Angela] Univ Sao Paulo, Dept Immunol, Inst Biomed Sci, Ave Prof Lineu Prestes 1730 Cidade Univ, BR-05508900 Sao Paulo, SP, Brazil; [Parnas, Oren] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Sch Med, Lautenberg Ctr Immunol & Canc Res, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Salk Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Universidade Estadual de Campinas; Universidade de Sao Paulo; Hebrew University of Jerusalem; Hadassah University Medical Center	Kahn, BB (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.; Kahn, BB (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.	bkahn@bidmc.harvard.edu	Moraes-Vieira, Pedro/C-8701-2014; Castoldi, Angela/K-1889-2015	Moraes-Vieira, Pedro/0000-0002-8263-786X; Castoldi, Angela/0000-0002-8434-7989; Aryal, Pratik/0000-0001-6443-8974	NIDDK, National Institutes of Health [RO1 DK043051, P30DK57521, RO1 DK106210]; JPB Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2014/02218-6, 2011/15682-4, 5T32DK007516-31]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, R01DK098002, T32DK007516, R01DK043051, R01DK106210] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); JPB Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health Grants RO1 DK043051 and P30DK57521 (to B. B. K.) and RO1 DK106210 (to B. B. K. and A. S.), a grant from the JPB Foundation (to B. B. K.), Leona M. and Harry B. Helmsley Charitable Trust Grant 2012-PG-MED002 (to A. S.), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo 2014/02218-6 and 2011/15682-4 (to A. C.), and 5T32DK007516-31 (to B. B. K. and J. L.). B. B. K., A. S., and P. V. are inventors on a patent and patent applications related to the fatty acid hydroxy fatty acids. J. L. is an inventor on a patent application related to the lipids. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Almallah YZ, 1998, AM J GASTROENTEROL, V93, P804, DOI 10.1111/j.1572-0241.1998.229_a.x; Bewtra M, 2014, INFLAMM BOWEL DIS, V20, P103, DOI 10.1097/01.MIB.0000437498.14804.50; Bosco N, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-81; Bressenot A, 2015, GUT, V64, P1412, DOI 10.1136/gutjnl-2014-307477; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Castoldi A, 2015, CURR PROTEIN PEPT SC, V16, P655, DOI 10.2174/1389203716666150630133141; Chen C, 2008, CELL METAB, V7, P135, DOI 10.1016/j.cmet.2007.12.003; Cho JY, 2011, MOL NUTR FOOD RES, V55, P239, DOI 10.1002/mnfr.201000070; Clardy J, 2004, NATURE, V432, P829, DOI 10.1038/nature03194; COREY EJ, 1970, J AM CHEM SOC, V92, P397, DOI 10.1021/ja00705a609; Curdia, 2015, REV ESP ENFERM DIG, V107, P614; Damas OM, 2015, J CROHNS COLITIS, V9, P928, DOI 10.1093/ecco-jcc/jjv118; Danese S, 2004, AUTOIMMUN REV, V3, P394, DOI 10.1016/j.autrev.2004.03.002; Dignass AU, 2004, ALIMENT PHARM THER, V20, P9, DOI 10.1111/j.1365-2036.2004.02047.x; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Feng T, 2011, J IMMUNOL, V186, P6313, DOI 10.4049/jimmunol.1001454; Feuerstein JD, 2014, MAYO CLIN PROC, V89, P1553, DOI 10.1016/j.mayocp.2014.07.002; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Geremia A, 2012, EXPERT REV GASTROENT, V6, P223, DOI [10.1586/EGH.11.107, 10.1586/egh.11.107]; Gersemann M, 2012, J INTERN MED, V271, P421, DOI 10.1111/j.1365-2796.2012.02515.x; Gonzalez-Cabrera PJ, 2012, MOL PHARMACOL, V81, P166, DOI 10.1124/mol.111.076109; Higenbottam T, 1998, HEART, V80, P151, DOI 10.1136/hrt.80.2.151; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Horst S, 2014, GASTROENTEROL CLIN N, V43, P495, DOI 10.1016/j.gtc.2014.05.005; Ishida T, 2010, INFLAMM BOWEL DIS, V16, P87, DOI 10.1002/ibd.21029; Julia A, 2014, HUM MOL GENET, V23, P6927, DOI 10.1093/hmg/ddu398; KITAHORA T, 1995, J GASTROENTEROL, V30, P5; Lakatos L, 2004, WORLD J GASTROENTERO, V10, P404; Linden C, 1999, DRUG AGING, V14, P387, DOI 10.2165/00002512-199914050-00006; Loeschke K, 1996, DIGEST DIS SCI, V41, P2087, DOI 10.1007/BF02093614; Maxwell Joseph R, 2009, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0558s47; Middleton SJ, 2002, ALIMENT PHARM THER, V16, P1131, DOI 10.1046/j.1365-2036.2002.01286.x; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; MONCADA S, 1978, PHARMACOL REV, V30, P293; Moraes-Vieira PM, 2014, CELL METAB, V19, P512, DOI 10.1016/j.cmet.2014.01.018; Moraes-Vieira PMM, 2014, EUR J IMMUNOL, V44, P794, DOI 10.1002/eji.201343592; Muller CA, 2005, CELL MOL LIFE SCI, V62, P1297, DOI 10.1007/s00018-005-5034-2; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ouellette AJ, 2011, CELL MOL LIFE SCI, V68, P2215, DOI 10.1007/s00018-011-0714-6; Pastorelli L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00280; PATERSON JC, 1961, AM J PATHOL, V38, P243; Rovedatti L, 2009, GUT, V58, P1629, DOI 10.1136/gut.2009.182170; Sikiric P, 2014, CURR PHARM DESIGN, V20, P1039, DOI 10.2174/138161282007140221100428; Simpson SJ, 1997, EUR J IMMUNOL, V27, P17, DOI 10.1002/eji.1830270104; Takedatsu H, 2008, GASTROENTEROLOGY, V135, P552, DOI 10.1053/j.gastro.2008.04.037; Turner D, 2007, CLIN GASTROENTEROL H, V5, P103, DOI 10.1016/j.cgh.2006.09.033; Wallace KL, 2014, WORLD J GASTROENTERO, V20, P6, DOI 10.3748/wjg.v20.i1.6; Woodworth HL, 2010, CANCER RES, V70, P7960, DOI 10.1158/0008-5472.CAN-10-1396; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035	50	81	81	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22207	22217		10.1074/jbc.M115.703835	http://dx.doi.org/10.1074/jbc.M115.703835			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27573241	hybrid, Green Published			2022-12-26	WOS:000386332600032
J	Wang, ZH; Bhattacharya, A; Villacorta, J; Diaz-Griffero, F; Ivanov, DN				Wang, Zhonghua; Bhattacharya, Akash; Villacorta, Jessica; Diaz-Griffero, Felipe; Ivanov, Dmitri N.			Allosteric Activation of SAMHD1 Protein by Deoxynucleotide Triphosphate (dNTP)-dependent Tetramerization Requires dNTP Concentrations That Are Similar to dNTP Concentrations Observed in Cycling T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autoimmune disease; human immunodeficiency virus (HIV); innate immunity; nucleoside; nucleotide metabolism; retrovirus	IMMUNODEFICIENCY-VIRUS TYPE-1; MONOCYTE-DERIVED MACROPHAGES; RESTRICTION FACTOR SAMHD1; DEOXYGUANOSINE TRIPHOSPHATE; ESCHERICHIA-COLI; STRUCTURAL BASIS; HIV-1 INFECTION; TRIPHOSPHOHYDROLASE; PHOSPHORYLATION; INHIBITION	SAMHD1 is a dNTP hydrolase, whose activity is required for maintaining low dNTP concentrations in non-cycling T cells, dendritic cells, and macrophages. SAMHD1-dependent dNTP depletion is thought to impair retroviral replication in these cells, but the relationship between the dNTPase activity and retroviral restriction is not fully understood. In this study, we investigate allosteric activation of SAMHD1 by deoxynucleotide-dependent tetramerization and measure how the lifetime of the enzymatically active tetramer is affected by different dNTP ligands bound in the allosteric site. The EC50dNTP values for SAMHD1 activation by dNTPs are in the 2-20 m range, and the half-life of the assembled tetramer after deoxynucleotide depletion varies from minutes to hours depending on what dNTP is bound in the A2 allosteric site. Comparison of the wild-type SAMHD1 and the T592D mutant reveals that the phosphomimetic mutation affects the rates of tetramer dissociation, but has no effect on the equilibrium of allosteric activation by deoxynucleotides. Collectively, our data suggest that deoxynucleotide-dependent tetramerization contributes to regulation of deoxynucleotide levels in cycling cells, whereas in non-cycling cells restrictive to retroviral replication, SAMHD1 activation is likely to be achieved through a distinct mechanism.	[Wang, Zhonghua; Bhattacharya, Akash; Villacorta, Jessica; Ivanov, Dmitri N.] Univ Texas San Antonio, Dept Biochem, Hlth Sci Ctr, San Antonio, TX 78229 USA; [Diaz-Griffero, Felipe] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas Health San Antonio; Yeshiva University; Albert Einstein College of Medicine	Ivanov, DN (corresponding author), Univ Texas San Antonio, Dept Biochem, Hlth Sci Ctr, San Antonio, TX 78229 USA.	ivanov@uthscsa.edu	Bhattacharya, Akash/G-9154-2016; Ivanov, Dmitri/B-4600-2011	Bhattacharya, Akash/0000-0001-8748-9969; 	National Institutes of Health [R01 AI104476, R01 AI087390]; Voelcker Fund Young Investigator Award; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087390, R01AI104476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Voelcker Fund Young Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants R01 AI104476 (to D. N. I.) and R01 AI087390 to (F. D.-G.) and a Voelcker Fund Young Investigator Award (to D. N. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnold LH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005194; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; BEAUCHAMP BB, 1988, P NATL ACAD SCI USA, V85, P2563, DOI 10.1073/pnas.85.8.2563; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Bhattacharya A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31353; Brandariz-Nunez A, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-131; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Hansen EC, 2014, P NATL ACAD SCI USA, V111, pE1843, DOI 10.1073/pnas.1401706111; Hollenbaugh JA, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0063-2; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Ji XY, 2014, P NATL ACAD SCI USA, V111, pE4305, DOI 10.1073/pnas.1412289111; Ji XY, 2013, NAT STRUCT MOL BIOL, V20, P1304, DOI 10.1038/nsmb.2692; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Koharudin LMI, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.591958; KORNBERG SR, 1958, J BIOL CHEM, V233, P159; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Schlosshauer M, 2004, PROTEIN SCI, V13, P1660, DOI 10.1110/ps.03517304; SETO D, 1988, J BIOL CHEM, V263, P1494; Welbourn S, 2016, VIROLOGY, V488, P271, DOI 10.1016/j.virol.2015.11.022; Welbourn S, 2013, J VIROL, V87, P11516, DOI 10.1128/JVI.01642-13; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796; Zhu CF, 2015, ACTA CRYSTALLOGR D, V71, P516, DOI 10.1107/S1399004714027527; Zhu CF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3722	28	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21407	21413		10.1074/jbc.C116.751446	http://dx.doi.org/10.1074/jbc.C116.751446			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27566548	Green Published, hybrid			2022-12-26	WOS:000385999200006
J	Nemes, A; Fortmann, T; Poeschke, S; Greve, B; Prevedello, D; Santacroce, A; Stummer, W; Senner, V; Ewelt, C				Nemes, Andrei; Fortmann, Thomas; Poeschke, Stephan; Greve, Burkhard; Prevedello, Daniel; Santacroce, Antonio; Stummer, Walter; Senner, Volker; Ewelt, Christian			5-ALA Fluorescence in Native Pituitary Adenoma Cell Lines: Resection Control and Basis for Photodynamic Therapy (PDT)?	PLOS ONE			English	Article							INDUCED PROTOPORPHYRIN-IX; TRANS-SPHENOIDAL MICROSURGERY; FOLLOW-UP; MITOCHONDRIAL; GLIOMA; LIGHT; EXCISION; SURGERY	Objective: Pituitary adenomas (PA), especially invasive ones, are often not completely resectable. Usage of 5-aminolevulinic acid (5-ALA) for fluorescence guided surgery could improve the rate of total resection and, additionally, open the doors for photodynamic therapy (PDT) in case of unresectable or partially resected PAs. The aim of this study was to investigate the uptake of 5-ALA and the effect of 5-ALA based PDT in cell lines. Methods: GH3 and AtT-20 cell lines were incubated with different concentrations of 5-ALA, protoporphyrin IX (PPIX) fluorescence was measured by flow cytometry and fluorescencespectrometry. WST-1 assays were performed to determine the surviving fraction of cells after PDT. PPIX fluorescence intensities and PDT effect of the pituitary adenoma cells were compared to U373MG, a well-known glioblastoma cell line. Results: Both cell lines showed a 5-ALA dependent intracellular PPIX fluorescence. Significant differences after 24hrs of incubation were observed in AtT-20 cells in comparison to GH3. Regardless of the incubation or metabolism time, there was a proliferation inhibiting effect after PDT, with no statistical significance. Conclusion: Since GH3 cells showed a heterogenous uptake of 5-ALA in the flow cytometry profile, but not constantly high concentrations they might have a 5-ALA efflux mechanism, which still needs to be determined. In the case of AtT-20, the cells might need a longer time for the uptake due to their size or slow metabolism. We showed that the different cell lines have different uptake and metabolism mechanisms, which needs to be further investigated. The general uptake of 5-ALA allows the possibility of resection control and PDT for pituitary adenomas. But, the role of PDT for unresectable pituitary adenomas deserves further investigations.	[Nemes, Andrei; Poeschke, Stephan; Senner, Volker] Univ Hosp Muenster, Inst Neuropathol, Munster, Germany; [Fortmann, Thomas; Stummer, Walter; Ewelt, Christian] Univ Hosp Muenster, Dept Neurosurg, Munster, Germany; [Greve, Burkhard] Univ Hosp Muenster, Dept Radiotherapy Radiooncol, Munster, Germany; [Prevedello, Daniel] Ohio State Univ, Dept Neurol Surg, Columbus, OH 43210 USA; [Santacroce, Antonio] Univ Hosp Tuebingen, Dept Neurosurg, Tubingen, Germany	University of Munster; University of Munster; University of Munster; University System of Ohio; Ohio State University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Ewelt, C (corresponding author), Univ Hosp Muenster, Dept Neurosurg, Munster, Germany.	christian.ewelt@ukmuenster.de	Stummer, Walter/AAF-9043-2019; Stummer, Walter/AAA-3319-2020					Buchfelder M, 1991, Acta Neurochir Suppl (Wien), V53, P72; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Choi MC, 2013, INT J GYNECOL CANCER, V23, P698, DOI 10.1097/IGC.0b013e31828b5ba2; CIRIC I, 1983, J NEUROSURG, V59, P395, DOI 10.3171/jns.1983.59.3.0395; de Vijlder HC, 2012, ACTA DERM-VENEREOL, V92, P641, DOI 10.2340/00015555-1448; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Eljamel MS, 2009, J NEURO-ONCOL, V92, P417, DOI 10.1007/s11060-009-9820-9; Etminan N, 2011, J NEUROSURG, V115, P281, DOI 10.3171/2011.3.JNS10434; Farrell WE, 2000, FRONT NEUROENDOCRIN, V21, P174, DOI 10.1006/frne.1999.0195; Fernandez-Miranda JC, 2010, ACTA NEUROCHIR, V152, P1281, DOI 10.1007/s00701-009-0487-y; Gopalan R, 2011, NEUROSURGERY, V69, P284, DOI 10.1227/NEU.0b013e31821bc44e; Grebenova D, 2003, J PHOTOCH PHOTOBIO B, V69, P71, DOI 10.1016/S1011-1344(02)00410-4; HARDY J, 1979, HOSP PRACT, V14, P81, DOI 10.1080/21548331.1979.11707562; Higgins TS, 2008, AM J RHINOL, V22, P649, DOI 10.2500/ajr.2008.22.3246; Jain AK, 2007, BRIT J NEUROSURG, V21, P328, DOI 10.1080/02688690701395447; Kawamata T, 2002, NEUROL RES, V24, P259, DOI 10.1179/016164102101199882; Kriska T, 2005, ARCH BIOCHEM BIOPHYS, V433, P435, DOI 10.1016/j.abb.2004.09.025; Li F, 2011, J CELL BIOCHEM, V112, P3035, DOI 10.1002/jcb.23228; Melmed S, 2011, J CLIN ENDOCR METAB, V96, P273, DOI 10.1210/jc.2010-1692; Nadeau V, 2004, PHOTODERMATOL PHOTO, V20, P170, DOI 10.1111/j.1600-0781.2004.00100.x; Onuki J, 2004, ARCH BIOCHEM BIOPHYS, V432, P178, DOI 10.1016/j.abb.2004.09.030; Oruckaptan HH, 2000, SURG NEUROL, V53, P211, DOI 10.1016/S0090-3019(00)00171-3; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; REGULA J, 1995, GUT, V36, P67, DOI 10.1136/gut.36.1.67; Robinson DJ, 1998, PHOTOCHEM PHOTOBIOL, V67, P140, DOI 10.1562/0031-8655(1998)067<0140:FPOAIP>2.3.CO;2; Rotenberg B, 2010, LARYNGOSCOPE, V120, P1292, DOI 10.1002/lary.20949; Saeger Wolfgang, 2005, Endocrine, V28, P57, DOI 10.1385/ENDO:28:1:057; Sailer R, 2007, PHOTOCH PHOTOBIO SCI, V6, P145, DOI 10.1039/b611715e; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sharwani A, 2014, Gulf J Oncolog, V1, P79; Sherlock M, 2011, NAT REV ENDOCRINOL, V7, P291, DOI 10.1038/nrendo.2011.42; Stummer W, 2000, J NEUROSURG, V93, P1003, DOI 10.3171/jns.2000.93.6.1003; Stummer W, 1998, NEUROSURGERY, V42, P518, DOI 10.1097/00006123-199803000-00017; Stummer W, 1998, ACTA NEUROCHIR, V140, P995, DOI 10.1007/s007010050206; Stylli SS, 2005, J CLIN NEUROSCI, V12, P389, DOI 10.1016/j.jocn.2005.01.006; Wild PJ, 2005, MOL CANCER THER, V4, P516, DOI 10.1158/1535-7163.MCT-04-0141	36	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161364	10.1371/journal.pone.0161364	http://dx.doi.org/10.1371/journal.pone.0161364			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583461	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600025
J	Chooi, WH; Chan, SCW; Gantenbein, B; Chan, BP				Chooi, Wai Hon; Chan, Samantha Chun Wai; Gantenbein, Benjamin; Chan, Barbara Pui			Loading-Induced Heat-Shock Response in Bovine Intervertebral Disc Organ Culture	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; SMOOTH-MUSCLE-CELLS; HYDROSTATIC-PRESSURE; IN-VITRO; ARTICULAR CHONDROCYTES; MECHANICAL-STRESS; DEGENERATION; HEAT-SHOCK-PROTEIN-70; COMPRESSION; VIVO	Mechanical loading has been shown to affect cell viability and matrix maintenance in the intervertebral disc (IVD) but there is no investigation on how cells survive mechanical stress and whether the IVD cells perceive mechanical loading as stress and respond by expression of heat shock proteins. This study investigates the stress response in the IVD in response to compressive loading. Bovine caudal disc organ culture was used to study the effect of physiological range static loading and dynamic loading. Cell activity, gene expression and immunofluorescence staining were used to analyze the cell response. Cell activity and cytoskeleton of the cells did not change significantly after loading. In gene expression analysis, significant up-regulation of heat shock protein-70 (HSP70) was observed in nucleus pulposus after two hours of loading. However, the expression of the matrix remodeling genes did not change significantly after loading. Similarly, expressions of stress response and matrix remodeling genes changed with application and removal of the dynamic loading. The results suggest that stress response was induced by physiological range loading without significantly changing cell activity and upregulating matrix remodeling. This study provides direct evidence on loading induced stress response in IVD cells and contributes to our understanding in the mechanoregulation of intervertebral disc cells.	[Chooi, Wai Hon; Chan, Barbara Pui] Univ Hong Kong, Dept Mech Engn, Tissue Engn Lab, Hong Kong, Hong Kong, Peoples R China; [Chan, Samantha Chun Wai; Gantenbein, Benjamin] Univ Bern, Inst Surg Technol & Biomech, Tissue & Organ Mechanobiol, Bern, Switzerland; [Chan, Samantha Chun Wai] Empa, Biointerfaces, Swiss Fed Labs Mat Sci & Technol, St Gallen, Switzerland	University of Hong Kong; University of Bern; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Chan, BP (corresponding author), Univ Hong Kong, Dept Mech Engn, Tissue Engn Lab, Hong Kong, Hong Kong, Peoples R China.	bpchan@hku.hk	Chan, Barbara Pui/AAM-7767-2020; Gantenbein, Benjamin/H-9302-2019	Gantenbein, Benjamin/0000-0002-9005-0655; Chan, BP/0000-0001-5419-2472; Chooi, Wai Hon/0000-0003-0268-0938	AOSpine award [SRN_2011_14]; Theme-Based Research Scheme [T12-708/12-N]; AOSpine Spine Research Network Grant; Swiss National Science Foundation Project [310030_153411]	AOSpine award; Theme-Based Research Scheme; AOSpine Spine Research Network Grant; Swiss National Science Foundation Project(Swiss National Science Foundation (SNSF))	This study was partially supported by an AOSpine award (SRN_2011_14) (https://aospine.aofoundation.org/Structure/Pages/default.aspx) and a Theme-Based Research Scheme (T12-708/12-N) (http://www.ugc.edu.hk/eng/rgc/theme/theme.htm) to BP, an AOSpine Spine Research Network Grant to WH (https://aospine.aofoundation.org/Structure/Pages/default.aspx), and a Swiss National Science Foundation Project (#310030_153411) (http://www.snf.ch/en/funding/projects/Pages/default.aspx) to BG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Y, 1997, J RHEUMATOL, V24, P1787; Battie MC, 2006, J BONE JOINT SURG AM, V88A, P3, DOI 10.2106/JBJS.E.01313; BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022; Chan D, 2006, EUR SPINE J, V15, pS317, DOI 10.1007/s00586-006-0171-3; Chan SCW, 2012, JOVE-J VIS EXP, DOI 10.3791/3490; Chan SCW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072489; Chan SCW, 2011, EUR SPINE J, V20, P1796, DOI 10.1007/s00586-011-1827-1; Chan SCW, 2011, SPINE, V36, P2021, DOI 10.1097/BRS.0b013e318203aea5; Chang J, 2001, CIRCULATION, V104, P209, DOI 10.1161/01.CIR.104.2.209; Enokiya Yasunobu, 2010, Bull Tokyo Dent Coll, V51, P129; Fitzgerald JB, 2004, J BIOL CHEM, V279, P19502, DOI 10.1074/jbc.M400437200; Fujita S, 2012, J ORTHOP RES, V30, P401, DOI 10.1002/jor.21535; Galvin DJ, 2002, AM J PHYSIOL-RENAL, V283, pF1192, DOI 10.1152/ajprenal.00168.2002; Gantenbein B, 2015, CURR STEM CELL RES T, V10, P339, DOI 10.2174/1574888X10666150312102948; Gruber HE, 1998, SPINE, V23, P751, DOI 10.1097/00007632-199804010-00001; HASKIN CL, 1993, BIOCHEM CELL BIOL, V71, P361, DOI 10.1139/o93-054; Iatridis JC, 2006, J BONE JOINT SURG AM, V88A, P41, DOI 10.2106/JBJS.E.01407; Illien-Junger S, 2010, SPINE, V35, P1744, DOI 10.1097/BRS.0b013e3181c48019; Jagodzinski M, 2006, EUR J APPL PHYSIOL, V96, P249, DOI 10.1007/s00421-005-0071-y; Kaarniranta K, 1998, P NATL ACAD SCI USA, V95, P2319, DOI 10.1073/pnas.95.5.2319; Kaarniranta K, 2001, OSTEOARTHR CARTILAGE, V9, P7, DOI 10.1053/joca.2000.0354; Kepler CK, 2013, SPINE J, V13, P318, DOI 10.1016/j.spinee.2012.12.003; Kippenberger S, 1999, PIGM CELL RES, V12, P246, DOI 10.1111/j.1600-0749.1999.tb00757.x; Korecki CL, 2008, SPINE, V33, P1403, DOI 10.1097/BRS.0b013e318175cae7; Kuperman DI, 1997, BRAIN RES, V771, P221, DOI 10.1016/S0006-8993(97)00710-5; Lee CR, 2006, SPINE, V31, P515, DOI 10.1097/01.brs.0000201302.59050.72; LIPSON SJ, 1981, ARTHRITIS RHEUM-US, V24, P12; Lomas C, 2011, EUR CELLS MATER, V22, P178, DOI 10.22203/eCM.v022a14; Lotz JC, 1998, SPINE, V23, P2493, DOI 10.1097/00007632-199812010-00004; Luna C, 2009, MOL VIS, V15, P534; Luo SS, 2007, ACTA HISTOCHEM CYTOC, V40, P9, DOI 10.1267/ahc.06011; Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016; MacLean JJ, 2008, J ORTHOP RES, V26, P579, DOI 10.1002/jor.20560; McCann MR, 2013, ARTHRITIS RHEUM-US, V65, P1853, DOI 10.1002/art.37979; Morimoto R, 2002, ENCY MOL BIOL; Nakamura S, 2006, J ORTHOP RES, V24, P733, DOI 10.1002/jor.20077; Paul CPL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033147; Schmocker A, 2016, BIOMATERIALS, V88, P110, DOI 10.1016/j.biomaterials.2016.02.015; Setton LA, 2006, J BONE JOINT SURG AM, V88A, P52, DOI 10.2106/JBJS.F.00001; Sharp CA, 2009, EUR SPINE J, V18, P1587, DOI 10.1007/s00586-009-1053-2; Smith LJ, 2011, DIS MODEL MECH, V4, P31, DOI 10.1242/dmm.006403; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Takahashi K, 1997, J ORTHOPAED RES, V15, P150, DOI 10.1002/jor.1100150122; Takao T, 2002, SPINE, V27, P361, DOI 10.1097/00007632-200202150-00007; Tsuchida S, 2014, J ORTHOP RES, V32, P975, DOI 10.1002/jor.22623; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629; Walser J, 2012, REPLACING ANIMAL MOD, V89; Xiao J, 2010, APPL BIOCHEM BIOTECH, V162, P1996, DOI 10.1007/s12010-010-8975-3; Xu QB, 2000, CIRC RES, V86, P1122	49	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161615	10.1371/journal.pone.0161615	http://dx.doi.org/10.1371/journal.pone.0161615			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580124	Green Published, gold			2022-12-26	WOS:000382877400031
J	Yonezawa, T; Uchida, M; Tomioka, M; Matsuki, N				Yonezawa, Tomohiro; Uchida, Mona; Tomioka, Michiko; Matsuki, Naoaki			Lunar Cycle Influences Spontaneous Delivery in Cows	PLOS ONE			English	Article							ATMOSPHERIC CONDITIONS; BAROMETRIC-PRESSURE; BIRTH-RATE; PHASE; PARTURITION; MELATONIN; LABOR; MOON	There is a popular belief that the lunar cycle influences spontaneous delivery in both humans and cattle. To assess this relationship, we investigated the synodic distribution of spontaneous deliveries in domestic Holstein cows. We used retrospective data from 428 spontaneous, full-term deliveries within a three-year period derived from the calving records of a private farm in Hokkaido, Japan. Spontaneous birth frequency increased uniformly from the new moon to the full moon phase and decreased until the waning crescent phase. There was a statistically significant peak between the waxing gibbous and full moon phases compared with those between the last quarter and the waning crescent. These changes were clearly observed in deliveries among multiparous cows, whereas they were not evident in deliveries among nulliparous cows. These data suggest the utility of dairy cows as models for bio-meteorological studies, and indicate that monitoring lunar phases may facilitate comprehensive understanding of parturition.	[Yonezawa, Tomohiro; Uchida, Mona; Matsuki, Naoaki] Univ Tokyo, Dept Vet Med Sci, Tokyo, Japan; [Tomioka, Michiko] Kitasato Univ, Sch Vet Med, Aomori, Japan	University of Tokyo; Kitasato University	Yonezawa, T (corresponding author), Univ Tokyo, Dept Vet Med Sci, Tokyo, Japan.	ayone@mail.ecc.u-tokyo.ac.jp	Uchida, Mona/AAK-1828-2021		Grants-in-Aid for Scientific Research [16K15045] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Arliss JM, 2005, AM J OBSTET GYNECOL, V192, P1462, DOI 10.1016/j.ajog.2004.12.034; Cajochen C, 2013, CURR BIOL, V23, P1485, DOI 10.1016/j.cub.2013.06.029; Carlhall S, 2013, EUR J OBSTET GYN R B, V171, P49, DOI 10.1016/j.ejogrb.2013.08.021; CUTLER WB, 1980, AM J OBSTET GYNECOL, V137, P834, DOI 10.1016/0002-9378(80)90895-9; Ghiandoni G, 1998, EUR J OBSTET GYN R B, V77, P47, DOI 10.1016/S0301-2115(97)00226-1; Hirsch E, 2011, INT J BIOMETEOROL, V55, P265, DOI 10.1007/s00484-010-0332-2; KELLY IW, 1994, PSYCHOL REP, V75, P507, DOI 10.2466/pr0.1994.75.1.507; King EA, 1997, J NURSE-MIDWIFERY, V42, P32, DOI 10.1016/S0091-2182(96)00101-2; Kuss O, 2008, ACTA OBSTET GYN SCAN, V87, P1378, DOI 10.1080/00016340802478174; Leonard P, 1987, D DUNLAP DOINGS, V20, P7; MARTENS R, 1988, PSYCHOL REP, V63, P923, DOI 10.2466/pr0.1988.63.3.923; Maudet C, 2002, J ANIM SCI, V80, P942; MIYAOKA E, 1989, CAN J STAT, V17, P123, DOI 10.2307/3314843; Morton-Pradhan S, 2005, AM J OBSTET GYNECOL, V192, P1970, DOI 10.1016/j.ajog.2005.02.066; Nakamura Y, 2001, J PINEAL RES, V30, P29, DOI 10.1034/j.1600-079X.2001.300104.x; Ochiai AM, 2012, INT J BIOMETEOROL, V56, P661, DOI 10.1007/s00484-011-0465-y; Olcese J, 2013, REPROD SCI, V20, P168, DOI 10.1177/1933719112442244; RIPPMANN ET, 1957, AM J OBSTET GYNECOL, V74, P148, DOI 10.1016/S0002-9378(16)37014-4; SIEBER M, 1989, J DAIRY SCI, V72, P2402, DOI 10.3168/jds.S0022-0302(89)79373-5; Stocker SD, 2004, AM J PHYSIOL-REG I, V287, pR127, DOI 10.1152/ajpregu.00526.2003; TRAP R, 1989, GYNECOL OBSTET INVES, V28, P14, DOI 10.1159/000293490; Troxel TR, 2012, J ANIM SCI, V90, P1583, DOI 10.2527/jas.2011-4088; Widjaja D, 2015, EUR J APPL PHYSIOL, V115, P1205, DOI 10.1007/s00421-015-3118-8; WITTER FR, 1983, AM J OBSTET GYNECOL, V145, P637, DOI 10.1016/0002-9378(83)91212-7	24	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161735	10.1371/journal.pone.0161735	http://dx.doi.org/10.1371/journal.pone.0161735			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580019	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877400038
J	Bianchette, TA; McCloskey, TA; Liu, KB				Bianchette, Thomas A.; McCloskey, Terrence A.; Liu, Kam-biu			Re-Evaluating the Geological Evidence for Late Holocene Marine Incursion Events along the Guerrero Seismic Gap on the Pacific Coast of Mexico	PLOS ONE			English	Article							SUBDUCTION ZONE; NEW-ZEALAND; SEA-LEVEL; TSUNAMI; DEPOSITS; STORM; JAPAN; LAGOON; RECONSTRUCTION; SEDIMENTATION	Despite the large number of tsunamis that impact Mexico's Pacific coast, stratigraphic studies focusing on geological impacts are scanty, making it difficult to assess the long-term risks for this vulnerable region. Surface samples and six cores were taken from Laguna Mitla near Acapulco to examine sedimentological and geochemical evidence for marine incursion events. Sediment cores collected from behind the beach barrier are dominated by intercalated layers of peat and inorganic sediments, mostly silt and clay, with little or no sand. Sand-and shell-rich clastic layers with high levels of sulfur, calcium, and strontium only occur adjacent to the relict beach ridge remnants near the center of the lagoon. With the exception of one thin fine sand layer, the absence of sand in the near-shore cores and the predominance of the terrigenous element titanium in the inorganic layers, evidently eroded from the surrounding hillslopes, suggests that these large-grained intervals do not represent episodic marine incursions, but rather were likely formed by the erosion and redeposition of older marine deposits derived from the beach ridge remnants when water levels were high. These results do not support the occurrence of a large tsunami event at Laguna Mitla during the Late Holocene.	[Bianchette, Thomas A.; McCloskey, Terrence A.; Liu, Kam-biu] Louisiana State Univ, Coll Coast & Environm, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Bianchette, TA (corresponding author), Louisiana State Univ, Coll Coast & Environm, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA.	tbianc1@lsu.edu	Lu, houyuan/AAD-3100-2019; Liu, Kam-Biu/B-4966-2012	Lu, houyuan/0000-0001-5721-6679; Liu, Kam-Biu/0000-0002-0038-2198	Inter-American Institute for Global Change Research (IAI) [IAI-CRN2050]; National Science Foundation (NSF) [BCS-1003654]; Geological Society of America; Association of American Geographers	Inter-American Institute for Global Change Research (IAI); National Science Foundation (NSF)(National Science Foundation (NSF)); Geological Society of America; Association of American Geographers	This work was supported by the Inter-American Institute for Global Change Research (IAI) Grant number: IAI-CRN2050 (URL:http://www.iai.int/) to KBL, the National Science Foundation (NSF) - Grant number: BCS-1003654 (URL: www.nsf.gov) to KBL and TAB, the Geological Society of America (URL: www.geosociety.org) to TAB, and the Association of American Geographers (URL: www.aag.org) to TAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alva VA, 2007, GEOS, V27, P119; ANDERSON JG, 1989, PHYS EARTH PLANET IN, V58, P307, DOI 10.1016/0031-9201(89)90102-7; Bianchette TA, HOLOCENE IN PRESS; Bussert R, 2004, J AFR EARTH SCI, V39, P549, DOI 10.1016/j.jafrearsci.2004.07.008; Cavalie O, 2013, EARTH PLANET SC LETT, V367, P52, DOI 10.1016/j.epsl.2013.02.020; Chague-Goff C, 2002, SEDIMENT GEOL, V150, P89, DOI 10.1016/S0037-0738(01)00269-X; Chen ZY, 1997, QUATERNARY RES, V47, P181, DOI 10.1006/qres.1996.1878; Contreras-Espinosa F, 2004, HYDROBIOLOGIA, V511, P233, DOI 10.1023/B:HYDR.0000014097.74263.54; Corona N, 2012, NAT HAZARD EARTH SYS, V12, P1337, DOI 10.5194/nhess-12-1337-2012; CRUZ G, 1983, B SEISMOL SOC AM, V73, P553; Curray F, 1969, COASTAL LAGOONS S, P63; FOSTER IDL, 1991, EARTH SURF PROCESSES, V16, P341, DOI 10.1002/esp.3290160407; Fujiwara O, 2000, SEDIMENT GEOL, V135, P219, DOI 10.1016/S0037-0738(00)00073-7; Goff J, 2004, MAR GEOL, V204, P235, DOI 10.1016/S0025-3227(03)00352-9; Gonzalez-Quintero L, 1980, MEMORIAS, V86, P133; Goto K, 2011, MAR GEOL, V290, P46, DOI 10.1016/j.margeo.2011.10.004; Habib D, 1970, MEM GEOL SOC AM, V126, P233; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Jauregui E, 2003, ATMOSFERA, V16, P193; Lankford RR., 1977, ESTUARINE PROCESSES, P182, DOI DOI 10.1016/B978-0-12-751802-2.50022-9; Liu KB, 2014, J COASTAL RES, P266, DOI 10.2112/SI70-045.1; Liu KB, 2000, QUATERNARY RES, V54, P238, DOI 10.1006/qres.2000.2166; McSaveney MJ, 2000, MAR GEOL, V170, P81, DOI 10.1016/S0025-3227(00)00067-0; MEADOWS PS, 1968, J MAR BIOL ASSOC UK, V48, P161, DOI 10.1017/S0025315400032501; Minoura K, 1996, SEDIMENT GEOL, V106, P145, DOI 10.1016/0037-0738(95)00148-4; MINOURA K, 1991, J GEOL, V99, P265, DOI 10.1086/629488; Morton RA, 2007, SEDIMENT GEOL, V200, P184, DOI 10.1016/j.sedgeo.2007.01.003; National Geophysical Data Center/World Data Service (NGDC/WDS), 2011, GLOB HIST TSUN DAT; National Meteorological Service of Mexico, 2012, NORM CLIM 1951 2010; Nichol SL, 2007, SEDIMENT GEOL, V200, P248, DOI 10.1016/j.sedgeo.2007.01.019; Ortiz M., 2000, GEOFIS INT, V39, P337; PAEZOSUNA F, 1985, ESTUAR COAST SHELF S, V20, P367, DOI 10.1016/0272-7714(85)90048-4; Ramirez-Herrera MT, 2009, GEOFIS INT, V48, P195; Ramirez-Herrera MT, 2007, HOLOCENE, V17, P1211, DOI 10.1177/0959683607085127; Ramirez-Herrera MT, 2012, GEOMORPHOLOGY, V139, P360, DOI 10.1016/j.geomorph.2011.11.002; Ramirez-Herrera MT, 1999, GEOMORPHOLOGY, V28, P237, DOI 10.1016/S0169-555X(99)00016-1; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Sawai Y, 2002, J ASIAN EARTH SCI, V20, P903, DOI 10.1016/S1367-9120(01)00077-3; Scasso RA, 2005, CRETACEOUS RES, V26, P283, DOI 10.1016/j.cretres.2004.12.003; Stuiver M., 2014, CALIB 7 0 PROGRAM DO; Switzer AD, 2005, J COASTAL RES, V21, P655, DOI 10.2112/04-0177.1; Ramirez-Herrera MT, 2011, PURE APPL GEOPHYS, V168, P1415, DOI 10.1007/s00024-010-0205-y; Ramirez-Herrera MT, 2016, GEOMORPHOLOGY, V259, P90, DOI 10.1016/j.geomorph.2016.02.011; Tuttle MP, 2004, SEISMOL RES LETT, V75, P117, DOI 10.1785/gssrl.75.1.117; Woodruff JD, 2008, GEOLOGY, V36, P391, DOI 10.1130/G24731A.1; Woodruff JD, 2009, QUATERNARY SCI REV, V28, P1774, DOI 10.1016/j.quascirev.2009.02.005; Yanez-Arancibia A, 1977, ANN M AM SOC LIMN OC	47	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161568	10.1371/journal.pone.0161568	http://dx.doi.org/10.1371/journal.pone.0161568			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571270	Green Published, gold, Green Submitted			2022-12-26	WOS:000382876700023
J	Martinelli, E; Mencattini, A; Daprati, E; Di Natale, C				Martinelli, Eugenio; Mencattini, Arianna; Daprati, Elena; Di Natale, Corrado			Strength Is in Numbers: Can Concordant Artificial Listeners Improve Prediction of Emotion from Speech?	PLOS ONE			English	Article							CIRCUMPLEX MODEL; LAST DANCE; RECOGNITION; AUDIO; SAVE	Humans can communicate their emotions by modulating facial expressions or the tone of their voice. Albeit numerous applications exist that enable machines to read facial emotions and recognize the content of verbal messages, methods for speech emotion recognition are still in their infancy. Yet, fast and reliable applications for emotion recognition are the obvious advancement of present 'intelligent personal assistants', and may have countless applications in diagnostics, rehabilitation and research. Taking inspiration from the dynamics of human group decision-making, we devised a novel speech emotion recognition system that applies, for the first time, a semi-supervised prediction model based on consensus. Three tests were carried out to compare this algorithm with traditional approaches. Labeling performances relative to a public database of spontaneous speeches are reported. The novel system appears to be fast, robust and less computationally demanding than traditional methods, allowing for easier implementation in portable voice-analyzers (as used in rehabilitation, research, industry, etc.) and for applications in the research domain (such as realtime pairing of stimuli to participants' emotional state, selective/differential data collection based on emotional content, etc.).	[Martinelli, Eugenio; Mencattini, Arianna; Di Natale, Corrado] Univ Roma Tor Vergata, Dept Elect Engn, Rome, Italy; [Daprati, Elena] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Daprati, Elena] Univ Roma Tor Vergata, CBMS, Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata	Daprati, E (corresponding author), Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy.; Daprati, E (corresponding author), Univ Roma Tor Vergata, CBMS, Rome, Italy.	elena.daprati@uniroma2.it	Di Natale, Corrado/M-8701-2014; Mencattini, Arianna/K-7910-2015; Martinelli, Eugenio/AAA-9105-2019; daprati, elena/AAA-2224-2019	Di Natale, Corrado/0000-0002-0543-4348; Mencattini, Arianna/0000-0002-3753-0457; Martinelli, Eugenio/0000-0002-6673-2066; 	PainTCare project (University of Rome Tor Vergara, Uncovering Excellence program)	PainTCare project (University of Rome Tor Vergara, Uncovering Excellence program)	Research supported by PainTCare project (University of Rome Tor Vergara, Uncovering Excellence program) (AM EM ED).	Alghowinem S., 2012, P 25 INT FLORIDA ART, P141; Ariatti A, 2008, NEUROL SCI, V29, P219, DOI 10.1007/s10072-008-0971-9; Bernstein J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027620; Chapelle O., 2006, IEEE T NEURAL NETWOR, V20, P542; Colibazzi T, 2010, EMOTION, V10, P377, DOI 10.1037/a0018484; Cowie R, 2003, SPEECH COMMUN, V40, P5, DOI 10.1016/S0167-6393(02)00071-7; Dara C, 2008, BRAIN RES, V1188, P100, DOI 10.1016/j.brainres.2007.10.034; DAVIS JH, 1973, PSYCHOL REV, V80, P97, DOI 10.1037/h0033951; de Bruin WB, 2006, ACTA PSYCHOL, V123, P299, DOI 10.1016/j.actpsy.2006.01.009; de Bruin WB, 2005, ACTA PSYCHOL, V118, P245, DOI 10.1016/j.actpsy.2004.08.005; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; El Ayadi M, 2011, PATTERN RECOGN, V44, P572, DOI 10.1016/j.patcog.2010.09.020; Eldar E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7149; Eyben F, 2013, P ACM MULT MM BARC; Eyben F., 2014, THESIS; Galton F, 1907, NATURE, V75, P450, DOI 10.1038/075450a0; Janis I.L., 1972, VICTIMS GROUPTHINK P; Janis IL, 1982, GROUPTHINK PSYCHOL S; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Magna G, 2016, KNOWL-BASED SYST, V101, P60, DOI 10.1016/j.knosys.2016.02.019; Marchi E, 2014, SPEECH AUTOMATA HEAL; Martinelli E, 2014, SENSOR ACTUAT B-CHEM, V199, P83, DOI 10.1016/j.snb.2014.03.070; Mencattini A, 2017, IEEE T AFFECT COMPUT, V8, P314, DOI 10.1109/TAFFC.2016.2531664; Mencattini A, 2014, KNOWL-BASED SYST, V63, P68, DOI 10.1016/j.knosys.2014.03.019; Ooi KEB, 2014, BIOMED SIGNAL PROCES, V14, P228, DOI 10.1016/j.bspc.2014.08.006; Posner J, 2005, DEV PSYCHOPATHOL, V17, P715, DOI 10.1017/S0954579405050340; Ringeval F., 2013, P FAC GEST 2013 2 IE; Ringeval F, 2015, PATTERN RECOGN LETT, V66, P22, DOI 10.1016/j.patrec.2014.11.007; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Schuller B., 2014, P INTERSPEECH 2014 1; Schuller B, 2011, SPEECH COMMUN, V53, P1062, DOI 10.1016/j.specom.2011.01.011; Schuller Bjorn, 2013, P INTERSPEECH 2013 1; Settles B., 2009, TECH REP; Stewart ME, 2013, AUTISM, V17, P6, DOI 10.1177/1362361311424572; Surowiecki J., 2005, WISDOM CROWDS; Tur G, 2005, SPEECH COMMUN, V45, P171, DOI 10.1016/j.specom.2004.08.002; Ventura MI, 2012, NEUROPSYCHOLOGIA, V50, P1936, DOI 10.1016/j.neuropsychologia.2012.04.018; Vogt T, 2008, LECT NOTES COMPUT SC, V4868, P75, DOI 10.1007/978-3-540-85099-1_7; Weninger F, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00292; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147; Zeng ZH, 2009, IEEE T PATTERN ANAL, V31, P39, DOI 10.1109/TPAMI.2008.52; Zhang ZX, 2015, IEEE-ACM T AUDIO SPE, V23, P115, DOI 10.1109/TASLP.2014.2375558; Zhu LL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085880, 10.1371/journal.pone.0102471, 10.1371/journal.pone.0097178]	43	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161752	10.1371/journal.pone.0161752	http://dx.doi.org/10.1371/journal.pone.0161752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27563724	Green Submitted, Green Published, gold			2022-12-26	WOS:000382496300014
J	Matsumoto, T; Mochizuki, W; Nibe, Y; Akiyama, S; Matsumoto, Y; Nozaki, K; Fukuda, M; Hayashi, A; Mizutani, T; Oshima, S; Watanabe, M; Nakamura, T				Matsumoto, Taichi; Mochizuki, Wakana; Nibe, Yoichi; Akiyama, Shintaro; Matsumoto, Yuka; Nozaki, Kengo; Fukuda, Masayoshi; Hayashi, Ayumi; Mizutani, Tomohiro; Oshima, Shigeru; Watanabe, Mamoru; Nakamura, Tetsuya			Retinol Promotes In Vitro Growth of Proximal Colon Organoids through a Retinoic Acid-Independent Mechanism	PLOS ONE			English	Article							INTESTINAL STEM-CELL; NULL MUTANT MICE; VITAMIN-A; RECEPTOR-BETA; SELF-RENEWAL; CANCER CELLS; MOUSE; DIFFERENTIATION; EPITHELIUM; ALCOHOL	Retinol (ROL), the alcohol form of vitamin A, is known to control cell fate decision of various types of stem cells in the form of its active metabolite, retinoic acid (RA). However, little is known about whether ROL has regulatory effects on colonic stem cells. We examined in this study the effect of ROL on the growth of murine normal colonic cells cultured as organoids. As genes involved in RA synthesis from ROL were differentially expressed along the length of the colon, we tested the effect of ROL on proximal and distal colon organoids separately. We found that organoid forming efficiency and the expression level of Lgr5, a marker gene for colonic stem cells were significantly enhanced by ROL in the proximal colon organoids, but not in the distal ones. Interestingly, neither retinaldehyde (RAL), an intermediate product of the ROL-RA pathway, nor RA exhibited growth promoting effects on the proximal colon organoids, suggesting that ROL-dependent growth enhancement in organoids involves an RA-independent mechanism. This was confirmed by the observation that an inhibitor for RA-mediated gene transcription did not abrogate the effect of ROL on organoids. This novel role of ROL in stem cell maintenance in the proximal colon provides insights into the mechanism of region-specific regulation for colonic stem cell maintenance.	[Matsumoto, Taichi; Mochizuki, Wakana; Nibe, Yoichi; Akiyama, Shintaro; Matsumoto, Yuka; Nozaki, Kengo; Fukuda, Masayoshi; Hayashi, Ayumi; Oshima, Shigeru; Watanabe, Mamoru] Tokyo Med & Dent Univ, Grad Sch, Dept Gastroenterol & Hepatol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan; [Mizutani, Tomohiro; Nakamura, Tetsuya] Tokyo Med & Dent Univ, Grad Sch, Dept Adv Therapeut GI Dis, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Nakamura, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Adv Therapeut GI Dis, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	nakamura.gast@tmd.ac.jp	Watanabe, Mamoru/AHE-0489-2022; Oshima, Shigeru/C-9865-2015; Mizutani, Tomohiro/AAX-5650-2021; Akiyama, Shintaro/CAH-6079-2022	Oshima, Shigeru/0000-0003-1186-9177; Mizutani, Tomohiro/0000-0002-8373-7969; Akiyama, Shintaro/0000-0003-0727-7638	MEXT KAKENHI [26112705]; JSPS KAKENHI [24390186, 26221307]; Regenerative Medicine Realization Base Network Program from the Japan Science and Technology Agency; Health and Labour Sciences Research Grants for research on Intractable Diseases from Ministry of Health, Labor and Welfare of Japan	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Regenerative Medicine Realization Base Network Program from the Japan Science and Technology Agency; Health and Labour Sciences Research Grants for research on Intractable Diseases from Ministry of Health, Labor and Welfare of Japan	MEXT KAKENHI (https://www.jsps.go.jp/english/e-grants/) Grant number 26112705 to TN; JSPS KAKENHI (https://www.jsps.go.jp/english/egrants/) Grant number 24390186 to TN, Grant number 26221307 to MW; the Regenerative Medicine Realization Base Network Program from the Japan Science and Technology Agency (http://www.jst.go.jp/saisei-nw/kadai_05.html) No Number, TN WM and T. Mizutani are receiving this funding; and Health and Labour Sciences Research Grants for research on Intractable Diseases from Ministry of Health, Labor and Welfare of Japan (http://www.mhlw.go.jp/seisakunitsuite/bunya/hokabunya/kenkyujigyou/hojokin-koubo-h26/gaiyo2/11.html) No Number, MW is receiving this grant.; We thank Lauren Unik for manuscript editing. This study was supported by MEXT KAKENHI (Grant number 26112705), JSPS KAKENHI (24390186 and 26221307), the Regenerative Medicine Realization Base Network Program from the Japan Science and Technology Agency, and Health and Labour Sciences Research Grants for research on Intractable Diseases from Ministry of Health, Labor and Welfare of Japan. The authors have no conflicting financial interests.	Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Bengtsson AM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-336; Beyaz S, 2016, NATURE, V531, P53, DOI 10.1038/nature17173; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chen L, 2008, STEM CELLS, V26, P1858, DOI 10.1634/stemcells.2008-0050; Chen LG, 2010, STEM CELLS, V28, P57, DOI 10.1002/stem.251; Chen YQ, 1997, P NATL ACAD SCI USA, V94, P10205, DOI 10.1073/pnas.94.19.10205; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Date S, 2015, ANNU REV CELL DEV BI, V31, P269, DOI 10.1146/annurev-cellbio-100814-125218; Davies JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138531; Dillard AC, 2007, MOL CARCINOGEN, V46, P315, DOI 10.1002/mc.20280; Dupe V, 2003, P NATL ACAD SCI USA, V100, P14036, DOI 10.1073/pnas.2336223100; Fan XH, 2003, MOL CELL BIOL, V23, P4637, DOI 10.1128/MCB.23.13.4637-4648.2003; Fukuda M, 2014, GENE DEV, V28, P1752, DOI 10.1101/gad.245233.114; Gudas LJ, 2011, J CELL PHYSIOL, V226, P322, DOI 10.1002/jcp.22417; Hirokawa Y, 2014, AM J PHYSIOL-GASTR L, V306, pG547, DOI 10.1152/ajpgi.00267.2013; Imam A, 2001, FASEB J, V15, P28; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Khillan JS, 2014, NUTRIENTS, V6, P1209, DOI 10.3390/nu6031209; Klein ES, 1996, J BIOL CHEM, V271, P22692, DOI 10.1074/jbc.271.37.22692; Kumar S, 2012, BBA-MOL CELL BIOL L, V1821, P198, DOI 10.1016/j.bbalip.2011.04.004; Lee MO, 2000, BIOCHEM PHARMACOL, V59, P485, DOI 10.1016/S0006-2952(99)00355-X; Mic FA, 2002, DEVELOPMENT, V129, P2271; Molotkov A, 2002, J BIOL CHEM, V277, P13804, DOI 10.1074/jbc.M112039200; Molotkov A, 2002, P NATL ACAD SCI USA, V99, P5337, DOI 10.1073/pnas.082093299; Nicke B, 1999, GUT, V45, P51, DOI 10.1136/gut.45.1.51; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 2002, MECH DEVELOP, V110, P165, DOI 10.1016/S0925-4773(01)00561-5; Onuma K, 2013, P NATL ACAD SCI USA, V110, P11127, DOI 10.1073/pnas.1221926110; Ordonez-Moran P, 2015, CANCER CELL, V28, P815, DOI 10.1016/j.ccell.2015.11.001; Park EY, 2005, CANCER RES, V65, P9923, DOI 10.1158/0008-5472.CAN-05-1604; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; SMITH FR, 1971, J CLIN INVEST, V50, P2426, DOI 10.1172/JCI106741; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Yum MK, 2016, CANCER RES, V76, P4559, DOI 10.1158/0008-5472.CAN-15-3357; Zasadil LM, 2016, MOL BIOL CELL, V27, P1981, DOI 10.1091/mbc.E15-10-0747; Zhang M, 2007, FASEB J, V21, P2886, DOI 10.1096/fj.06-7964com; Zhang SS, 2011, J CELL BIOCHEM, V112, P1009, DOI 10.1002/jcb.23029	42	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0162049	10.1371/journal.pone.0162049	http://dx.doi.org/10.1371/journal.pone.0162049			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564706	Green Published, Green Submitted, gold			2022-12-26	WOS:000382496300044
J	Tung, ILY; Machalek, DA; Garland, SM				Tung, Iris L. Y.; Machalek, Dorothy A.; Garland, Suzanne M.			Attitudes, Knowledge and Factors Associated with Human Papillomavirus (HPV) Vaccine Uptake in Adolescent Girls and Young Women in Victoria, Australia	PLOS ONE			English	Article							PARENTS; PROGRAM; IMMUNIZATION; COVERAGE; MOTHERS; CANCER; PREDICTORS; INFECTION; HISTORY; PHASE	Background Human papillomavirus (HPV) vaccination targets high-risk HPV16/18 that cause 70% of all cancers of the cervix. In Australia there is a fully-funded, school-based National HPV Vaccination Program which has achieved vaccine initiation rate of 82% among age-eligible females. Improving HPV vaccination rates is important in the prevention of morbidity and mortality associated with HPV-related disease. This study aimed to identify factors and barriers associated with uptake of the HPV vaccine in the Australian Program. Methods Between 2011 and 2014, females aged 18-25 years, living in Victoria, Australia who were offered HPV vaccination between 2007 and 2009 as part of the National HPV Vaccination Program, living in Victoria, Australia were recruited into a a young women's study examining effectiveness of the Australian National HPV Vaccination Program. Overall, 668 participants completed the recruitment survey, which collected data of participants' demographics and HPV knowledge. In 2015 these participants were invited to complete an additional supplementary survey on parental demographics and attitudes towards vaccinations. Results In 2015, 417 participants completed the supplementary survey (62% response rate). Overall, 19% of participants were unvaccinated. In multivariate analyses, HPV vaccination was significantly associated with their being born in Australia (p<0.001), having completed childhood vaccinations (p<0.001) and their parents being main decision-makers for participants' HPV vaccination (p<0.001). The main reason reported for HPV non-vaccination was parental concern about vaccine safety (43%). Compared with HPV-vaccinated participants, those unvaccinated were significantly more likely to be opposed to all vaccines, including HPV vaccines (p<0.001) and were less likely to consider vaccinating their own children with all vaccines (p = 0.033), including HPV vaccines (p<0.001). Overall, 61% of unvaccinated participants reported that a recommendation from GPs would increase HPV vaccine acceptance. Conclusions Attitudes towards general health, vaccinations in general, as well as HPV vaccines are important in HPV vaccine uptake. Long-term monitoring of the knowledge, attitude and beliefs towards HPV vaccination in the community is critical to ensure a continued high uptake of the vaccine and success of the program.	[Tung, Iris L. Y.; Machalek, Dorothy A.; Garland, Suzanne M.] Royal Womens Hosp, Dept Microbiol & Infect Dis, Parkville, Vic, Australia; [Machalek, Dorothy A.; Garland, Suzanne M.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Garland, Suzanne M.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic 3010, Australia	Murdoch Children's Research Institute; University of Melbourne	Garland, SM (corresponding author), Royal Womens Hosp, Dept Microbiol & Infect Dis, Parkville, Vic, Australia.; Garland, SM (corresponding author), Murdoch Childrens Res Inst, Parkville, Vic, Australia.; Garland, SM (corresponding author), Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic 3010, Australia.	suzanne.garland@thewomens.org.au			Victorian Cancer Agency [TS10_04]	Victorian Cancer Agency	SMG received funding from the Victorian Cancer Agency TS10_04. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the Victorian Cancer Agency for their TS10_04 grant-2011-2013, Monitoring the effectiveness of the Australian cervical cancer vaccine programme: translation to reduction in vaccine-related HPV infection and precancerous cervical lesions. We thank members of the VACCINE study group for project management and coordination, participants of the VACCINE study for their contribution to data of this study and Athena Costa for assisting with the manuscript submission. We thank the NHVPR staff who assisted with the study. The NHVPR is owned by the Australian Government Department of Health and operated by the Victorian Cytology Service.	Australian Bureau of Statistics, 2012, REFL NAT STOR 2011 C; Australian Bureau of Statistics, 2018, CENSUS POPULATION HO; Australian Bureau of Statistics, 2018, AUSTR STAT GEOGR STA; Australian Government DoH, 2015, HUM PAP IMM AUSTR PR; Balakrishnan VS, 2015, LANCET ONCOL, V16, pE592, DOI 10.1016/S1470-2045(15)00459-3; Barbaro B, 2014, AUST NZ J PUBL HEAL, V38, P419, DOI 10.1111/1753-6405.12218; Benin AL, 2006, PEDIATRICS, V117, P1532, DOI 10.1542/peds.2005-1728; Brewer NT, 2007, PREV MED, V45, P107, DOI 10.1016/j.ypmed.2007.05.013; Brotherton JML, 2016, SEX HEALTH, V13, P190, DOI 10.1071/SH15131; Bzhalava D, 2013, VIROLOGY, V445, P224, DOI 10.1016/j.virol.2013.07.015; Canfell K, 2015, VACCINE, V33, P2387, DOI 10.1016/j.vaccine.2015.01.024; Centers for Disease Control and Prevention, HUM PAP VACC COV AD; Chao C, 2009, AM J PUBLIC HEALTH, V99, P1137, DOI 10.2105/AJPH.2008.147876; Fenner Y, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1978; Fisher WA, 2012, VACCINE, V30, pF149, DOI 10.1016/j.vaccine.2012.04.107; Forbes TA, 2015, HUM VACC IMMUNOTHER, V11, P2895, DOI 10.1080/21645515.2015.1070997; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Garland SM, 2009, J INFECT DIS, V199, P805, DOI 10.1086/597071; Gertig DM, 2011, MEASURING HUMAN PAPI, V8; Gertig DM, 2011, SEX HEALTH, V8, P171, DOI 10.1071/SH10001; Giles M, 2006, AUST NZ J OBSTET GYN, V46, P311, DOI 10.1111/j.1479-828X.2006.00598.x; House Simon H., 2013, Nutrition and Health (Bicester), V22, P9, DOI 10.1177/0260106013506666; Jeudin P, 2014, CLIN THER, V36, P24, DOI 10.1016/j.clinthera.2013.11.001; Kahn JA, 2003, INT J STD AIDS, V14, P300, DOI 10.1258/095646203321605486; Kessels SJM, 2012, VACCINE, V30, P3546, DOI 10.1016/j.vaccine.2012.03.063; Koutsky Laura, 1997, American Journal of Medicine, V102, P3; Leask JA, 2000, BRIT MED J, V321, P109; Leask J, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-154; LOWY DR, 1994, P NATL ACAD SCI USA, V91, P2436, DOI 10.1073/pnas.91.7.2436; MECHANIC D, 1964, PEDIATRICS, V33, P444; Murray Sally B, 2005, Aust Health Rev, V29, P25; National HPV Vaccination Program Register, HPV VACC COV DOS 201; Osborne SL, 2015, VACCINE, V33, P201, DOI 10.1016/j.vaccine.2014.10.045; Public Health England, ANN HPV VACC COV 201; Rambout L, 2014, PREV MED, V58, P22, DOI 10.1016/j.ypmed.2013.10.009; Robbins SCC, 2010, VACCINE, V28, P3398, DOI 10.1016/j.vaccine.2010.02.078; Roberts ME, 2010, PEDIATRICS, V125, P982, DOI 10.1542/peds.2009-2888; Rosenthal SL, 2008, J ADOLESCENT HEALTH, V43, P239, DOI 10.1016/j.jadohealth.2008.06.009; Schreiber SMS, 2015, J ADOLESCENT HEALTH, V56, P402, DOI 10.1016/j.jadohealth.2014.12.008; Statens Serum Institut, EPI NEWS HPV VACC CO; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Walhart T, 2012, INT NURS REV, V59, P305, DOI 10.1111/j.1466-7657.2012.00991.x; Ward K, 2013, COMMUN DIS INTELL, V37, pE156; ZURHAUSEN H, 1976, CANCER RES, V36, P794	44	35	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161846	10.1371/journal.pone.0161846	http://dx.doi.org/10.1371/journal.pone.0161846			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU8WL	27564213	Green Published, gold			2022-12-26	WOS:000382496300024
J	Boraldi, F; Bartolomeo, A; De Biasi, S; Orlando, S; Costa, S; Cossarizza, A; Quaglino, D				Boraldi, Federica; Bartolomeo, Angelica; De Biasi, Sara; Orlando, Stefania; Costa, Sonia; Cossarizza, Andrea; Quaglino, Daniela			Innovative Flow Cytometry Allows Accurate Identification of Rare Circulating Cells Involved in Endothelial Dysfunction	PLOS ONE			English	Article							VASCULAR CALCIFICATION; PROGENITOR CELLS	Introduction Although rare, circulating endothelial and progenitor cells could be considered as markers of endothelial damage and repair potential, possibly predicting the severity of cardiovascular manifestations. A number of studies highlighted the role of these cells in age-related diseases, including those characterized by ectopic calcification. Nevertheless, their use in clinical practice is still controversial, mainly due to difficulties in finding reproducible and accurate methods for their determination. Methods Circulating mature cells (CMC, CD45(-), CD34(+), CD133(-)) and circulating progenitor cells (CPC, CD45(dim), CD34(bright), CD133(+)) were investigated by polychromatic high-speed flow cytometry to detect the expression of endothelial (CD309(+)) or osteogenic (BAP(+)) differentiation markers in healthy subjects and in patients affected by peripheral vascular manifestations associated with ectopic calcification. Results This study shows that: 1) polychromatic flow cytometry represents a valuable tool to accurately identify rare cells; 2) the balance of CD309(+) on CMC/CD309(+) on CPC is altered in patients affected by peripheral vascular manifestations, suggesting the occurrence of vascular damage and low repair potential; 3) the increase of circulating cells exhibiting a shift towards an osteoblast-like phenotype (BAP(+)) is observed in the presence of ectopic calcification. Conclusion Differences between healthy subjects and patients with ectopic calcification indicate that this approach may be useful to better evaluate endothelial dysfunction in a clinical context.	[Boraldi, Federica; Bartolomeo, Angelica; Orlando, Stefania; Costa, Sonia; Quaglino, Daniela] Univ Modena & Reggio Emilia, Dept Life Sci, Via Campi 287, Modena, Italy; [De Biasi, Sara; Cossarizza, Andrea] Univ Modena & Reggio Emilia, Dept Surg Med Dent & Morphol Sci, Via Campi 287, Modena, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia	Quaglino, D (corresponding author), Univ Modena & Reggio Emilia, Dept Life Sci, Via Campi 287, Modena, Italy.	daniela.quaglino@unimore.it	Boraldi, Federica/D-1263-2015; De Biasi, Sara/AAB-7520-2019	Boraldi, Federica/0000-0002-0277-9017; De Biasi, Sara/0000-0002-3217-9821; Orlando, Stefania/0000-0003-2403-9228; Cossarizza, Andrea/0000-0002-5381-1558	PXE Italia Onlus [E92I15000710007]	PXE Italia Onlus	The work was supported by a grant from PXE Italia Onlus (E92I15000710007) to DQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, SCIENCE, DOI DOI 10.1126/SCIENCE.347.6220.443-C; Bobryshev YV, 2005, J PATHOL, V205, P641, DOI 10.1002/path.1743; Bonello L, 2006, ARCH MAL COEUR VAISS, V99, P607; Boos CJ, 2006, J AM COLL CARDIOL, V48, P1538, DOI 10.1016/j.jacc.2006.02.078; Cossarizza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050728; Fadini GP, 2012, CIRCULATION, V125, P2772, DOI 10.1161/CIRCULATIONAHA.112.090860; Fadini GP, 2012, EXP DIABETES RES, DOI 10.1155/2012/921685; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Goon P, 2009, NEOPLASIA, V11, P771, DOI 10.1593/neo.09490; Goon PKY, 2005, CLIN LAB, V51, P531; Guaraldi G, 2013, HIV CLIN TRIALS, V14, P140, DOI 10.1310/hct1404-140; Hutcheson JD, 2015, SEMIN CELL DEV BIOL, V46, P68, DOI 10.1016/j.semcdb.2015.09.004; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Kachamakova-Trojanowska N, 2015, PHARMACOL REP, V67, P793, DOI 10.1016/j.pharep.2015.05.017; Lataillade JJ, 2000, BLOOD, V95, P756, DOI 10.1182/blood.V95.3.756; Leftheriotis Georges, 2013, Frontiers in Genetics, V4, P4, DOI 10.3389/fgene.2013.00004; Mody N, 2001, FREE RADICAL BIO MED, V31, P509, DOI 10.1016/S0891-5849(01)00610-4; Moroni G, 2005, KIDNEY INT, V68, P562, DOI 10.1111/j.1523-1755.2005.00434.x; Mutin M, 1999, BLOOD, V93, P2951; Prater DN, 2007, LEUKEMIA, V21, P1141, DOI 10.1038/sj.leu.2404676; Quaglino D., 2011, ADV STUDY GENET DISO, DOI [10.5772/22161, DOI 10.5772/22161]; Real Carla, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P185, DOI 10.2174/187152908785849071; Shao JS, 2010, HYPERTENSION, V55, P579, DOI 10.1161/HYPERTENSIONAHA.109.134205; Smadja DM, 2013, ANGIOGENESIS, V16, P147, DOI 10.1007/s10456-012-9306-9; Soriano S, 2014, AM J PHYSIOL-RENAL, V307, pF1302, DOI 10.1152/ajprenal.00114.2014; Steurer Michael, 2008, BMC Res Notes, V1, P71, DOI 10.1186/1756-0500-1-71; Yin TT, 2000, CIRCULATION, V102, P2636, DOI 10.1161/01.cir.102.21.2636	27	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0160153	10.1371/journal.pone.0160153	http://dx.doi.org/10.1371/journal.pone.0160153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560136	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258600008
J	Pallisgaard, JL; Gislason, GH; Torp-Pedersen, C; Lee, CJY; Sindet-Pedersen, C; Staerk, L; Olesen, JB; Lindhardt, TB				Pallisgaard, Jannik Langtved; Gislason, Gunnar Hilmar; Torp-Pedersen, Christian; Lee, Christina Ji-Young; Sindet-Pedersen, Caroline; Staerk, Laila; Olesen, Jonas Bjerring; Lindhardt, Tommi Bo			Risk of Ischemic Stroke, Hemorrhagic Stroke, Bleeding, and Death in Patients Switching from Vitamin K Antagonist to Dabigatran after an Ablation	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; WARFARIN	Background Safety regarding switching from vitamin K antagonist (VKA) to dabigatran therapy in postablation patients has never been investigated and safety data for this is urgently needed. The objective of this study was to examine if switch from VKA to dabigatran increased the risk of stroke, bleeding, and death in patients after ablation for atrial fibrillation. Methods Through the Danish nationwide registries, patients with non-valvular atrial fibrillation undergoing ablation were identified, in the period between August 22nd 2011 and December 31st 2015. The risk of ischemic stroke, hemorrhagic stroke, bleeding, and death, related to switching from VKA to dabigatran was examined using a multivariable Poisson regression model, where Incidence rate ratios (IRR) were estimated using VKA as reference. Results In total, 4,236 patients were included in the study cohort. The minority (n = 470, 11%) switched to dabigatran in the follow up period leaving the majority (n = 3,766, 89%) in VKA treatment. The patients in the dabigatran group were older, were more often males, and had higher CHA2DS2-VASc, and HAS-BLED scores. The incident rates of bleeding and death were almost twice as high in the dabigatran group compared with the VKA group. When adjusting for the individual components included in the CHA2DS2-VASc and HAS-BLED scores, the multivariable Poisson analyses yielded a non-significant IRR (95% CI) of 1.64 (0.72-3.75) for bleeding and of 1.41 (0.66-3.00) for death associated with the dabigatran group, compared to the VKA group. A significant increased risk of bleeding was found in the 110mg bid group with an IRR (95% CI) of 4.49(1.40-14.5). Conclusion Shifting from VKA to dabigatran after ablation was associated with twice as high incidence of bleeding compared to the incidence in patients staying in VKA treatment. The only significant increased risk found in the adjusted analyses was for bleeding with 110mg bid dabigatran and not for 150mg bid. Since there was no dose-response for bleeding, the switch from VKA to dabigatran in itself was not a risk factor for bleeding.	[Pallisgaard, Jannik Langtved; Gislason, Gunnar Hilmar; Lee, Christina Ji-Young; Sindet-Pedersen, Caroline; Staerk, Laila; Olesen, Jonas Bjerring; Lindhardt, Tommi Bo] Copenhagen Univ Hosp Herlev & Gentofte, Dept Cardiol, Copenhagen, Denmark; [Pallisgaard, Jannik Langtved; Gislason, Gunnar Hilmar; Sindet-Pedersen, Caroline; Staerk, Laila] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Gislason, Gunnar Hilmar] Danish Heart Fdn, Copenhagen, Denmark; [Gislason, Gunnar Hilmar] Univ Southern Denmark, Natl Inst Publ Hlth, Odense, Denmark; [Gislason, Gunnar Hilmar] Univ Southern Denmark, Natl Inst Publ Hlth, Odense, Denmark; [Torp-Pedersen, Christian] Aalborg Univ, Inst Hlth Sci & Technol, Aalborg, Denmark	University of Copenhagen; University of Southern Denmark; University of Southern Denmark; Aalborg University	Pallisgaard, JL (corresponding author), Copenhagen Univ Hosp Herlev & Gentofte, Dept Cardiol, Copenhagen, Denmark.; Pallisgaard, JL (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark.	jannikjannik@gmail.com	Pallisgaard, Jannik Langtved/S-9546-2019; Gislason, Gunnar/B-7561-2009	Pallisgaard, Jannik Langtved/0000-0002-8072-3318; Gislason, Gunnar/0000-0002-0548-402X	Boehringer Ingelheim; Novo Nordisk Fonden [NNF12OC1015957] Funding Source: researchfish	Boehringer Ingelheim(Boehringer Ingelheim); Novo Nordisk Fonden(Novo Nordisk Foundation)	Boehringer Ingelheim funded the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson C, 2010, EUR J HEART FAIL, V12, P1333, DOI 10.1093/eurjhf/hfq160; Beyer-Westendorf J, 2014, BRIT J CLIN PHARMACO, V78, P908, DOI 10.1111/bcp.12391; Bouillon K, 2015, LANCET HAEMATOL, V2, pE150, DOI 10.1016/S2352-3026(15)00027-7; Calkins H, 2012, EUROPACE, V14, P528, DOI 10.1093/europace/eus027; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Heidbuchel H, 2015, EUROPACE, V17, P1467, DOI 10.1093/europace/euv309; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Larsen TB, 2014, AM J MED, V127, P650, DOI 10.1016/j.amjmed.2014.01.031; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Olesen JB, 2011, THROMB HAEMOSTASIS, V106, P739, DOI 10.1160/TH11-05-0364; Olesen JB, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d124; Reilly PA, 2014, J AM COLL CARDIOL, V63, P321, DOI 10.1016/j.jacc.2013.07.104; Sorensen R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002758; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956; Weitz JI, 2012, CHEST, V141, pE120S, DOI 10.1378/chest.11-2294	16	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161768	10.1371/journal.pone.0161768	http://dx.doi.org/10.1371/journal.pone.0161768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560967	Green Submitted, Green Published, gold			2022-12-26	WOS:000382258600095
J	Seiler, A; Deichmann, R; Pfeilschifter, W; Hattingen, E; Singer, OC; Wagner, M				Seiler, Alexander; Deichmann, Ralf; Pfeilschifter, Waltraud; Hattingen, Elke; Singer, Oliver C.; Wagner, Marlies			T2-Imaging to Assess Cerebral Oxygen Extraction Fraction in Carotid Occlusive Disease: Influence of Cerebral Autoregulation and Cerebral Blood Volume	PLOS ONE			English	Article							SUSCEPTIBILITY CONTRAST MRI; HIGH-RESOLUTION MEASUREMENT; TRACER BOLUS PASSAGES; ACUTE ISCHEMIC-STROKE; CLINICAL-USE; NORMAL BRAIN; PERFUSION; FLOW; ARTERIAL; T2'	Purpose Quantitative T2'-mapping detects regional changes of the relation of oxygenated and deoxygenated hemoglobin (Hb) by using their different magnetic properties in gradient echo imaging and might therefore be a surrogate marker of increased oxygen extraction fraction (OEF) in cerebral hypoperfusion. Since elevations of cerebral blood volume (CBV) with consecutive accumulation of Hb might also increase the fraction of deoxygenated Hb and, through this, decrease the T2'-values in these patients we evaluated the relationship between T2'-values and CBV in patients with unilateral high-grade large-artery stenosis. Materials and Methods Data from 16 patients (13 male, 3 female; mean age 53 years) with unilateral symptomatic or asymptomatic high-grade internal carotid artery (ICA) or middle cerebral artery (MCA) stenosis/occlusion were analyzed. MRI included perfusion-weighted imaging and high-resolution T2'-mapping. Representative relative (r) CBV-values were analyzed in areas of decreased T2' with different degrees of perfusion delay and compared to corresponding contralateral areas. Results No significant elevations in cerebral rCBV were detected within areas with significantly decreased T2'-values. In contrast, rCBV was significantly decreased (p<0.05) in regions with severe perfusion delay and decreased T2'. Furthermore, no significant correlation between T2'- and rCBV-values was found. Conclusions rCBV is not significantly increased in areas of decreased T2' and in areas of restricted perfusion in patients with unilateral high-grade stenosis. Therefore, T2' should only be influenced by changes of oxygen metabolism, regarding our patient collective especially by an increase of the OEF. T2'-mapping is suitable to detect altered oxygen consumption in chronic cerebrovascular disease.	[Seiler, Alexander; Pfeilschifter, Waltraud; Singer, Oliver C.] Goethe Univ Frankfurt, Dept Neurol, Frankfurt, Germany; [Deichmann, Ralf] Goethe Univ Frankfurt, Brain Imaging Ctr, Frankfurt, Germany; [Hattingen, Elke] Univ Bonn, Dept Neuroradiol, Bonn, Germany; [Singer, Oliver C.] Helios HSK Hosp, Dept Neurol, Wiesbaden, Germany; [Wagner, Marlies] Goethe Univ Frankfurt, Inst Neuroradiol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; University of Bonn; Goethe University Frankfurt	Seiler, A (corresponding author), Goethe Univ Frankfurt, Dept Neurol, Frankfurt, Germany.	Alexander.Seiler@kgu.de	Wagner, Marlies/GQA-9181-2022; Wagner, Marlies/AAZ-5487-2021; Wagner, Marlies/AAL-3357-2020	Hattingen, Elke/0000-0002-8392-9004	Wellcome Trust Centre for Neuroimaging, UCL, London, UK	Wellcome Trust Centre for Neuroimaging, UCL, London, UK	Dr. R. Deichmann received compensation as a Consultant for MR scanner procurement by the Wellcome Trust Centre for Neuroimaging, UCL, London, UK. The other authors have declared that no competing interests exist. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	An HY, 2002, MAGNET RESON MED, V48, P583, DOI 10.1002/mrm.10257; Bauer S, 2014, STROKE, V45, P3280, DOI 10.1161/STROKEAHA.114.006530; BREGER RK, 1991, RADIOLOGY, V181, P545, DOI 10.1148/radiology.181.2.1924802; Calamante F, 2002, STROKE, V33, P1146, DOI 10.1161/01.STR.0000014208.05597.33; Calamante F, 2000, MAGN RESON MED, V44, P466, DOI 10.1002/1522-2594(200009)44:3<466::AID-MRM18>3.0.CO;2-M; Caplan LR, ARCH NEUROL; Chaves CJ, 2003, ARCH NEUROL-CHICAGO, V60, P237, DOI 10.1001/archneur.60.2.237; Chaves C, 2006, CEREBROVASC DIS, V22, P396, DOI 10.1159/000094858; Derdeyn CP, 2002, BRAIN, V125, P595, DOI 10.1093/brain/awf047; Ding XQ, 2004, INVEST RADIOL, V39, P740, DOI 10.1097/00004424-200412000-00005; Ebinger M, 2010, STROKE, V41, P95, DOI 10.1161/STROKEAHA.109.559807; Geisler BS, 2006, STROKE, V37, P1778, DOI 10.1161/01.STR.0000226738.97426.6f; Helenius J, 2003, ACTA RADIOL, V44, P538, DOI 10.1034/j.1600-0455.2003.00104.x; Hirsch NM, 2014, NMR BIOMED, V27, P853, DOI 10.1002/nbm.3131; Lee SP, 2001, MAGNET RESON MED, V45, P791, DOI 10.1002/mrm.1107; Magerkurth J, 2011, MAGN RESON MED, V66, P989, DOI 10.1002/mrm.22878; Mandeville JB, 1998, MAGNET RESON MED, V39, P615, DOI 10.1002/mrm.1910390415; Ostergaard L, 1996, MAGNET RESON MED, V36, P726, DOI 10.1002/mrm.1910360511; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Pollard V, 1996, ANESTH ANALG, V82, P278, DOI 10.1097/00000539-199602000-00011; Pollard V, 1996, ANESTH ANALG, V82, P269, DOI 10.1097/00000539-199602000-00010; Schreiber WG, 1998, J CEREBR BLOOD F MET, V18, P1143, DOI 10.1097/00004647-199810000-00011; Seiler A, 2012, STROKE, V43, P1831, DOI 10.1161/STROKEAHA.111.646109; SETTE G, 1989, BRAIN, V112, P931, DOI 10.1093/brain/112.4.931; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Singer OC, 2003, J CEREBR BLOOD F MET, V23, P605, DOI 10.1097/01.WCB.0000062342.57257.28; VILLRINGER A, 1988, MAGNET RESON MED, V6, P164, DOI 10.1002/mrm.1910060205; Vonken EJPA, 1999, JMRI-J MAGN RESON IM, V10, P109, DOI 10.1002/(SICI)1522-2586(199908)10:2<109::AID-JMRI1>3.0.CO;2-#; Wagner M, AJNR AM J NEURORADIO; Wagner M, 2015, NEURORADIOLOGY, V57, P1023, DOI 10.1007/s00234-015-1565-x; Wagner M, 2012, J MAGN RESON IMAGING, V36, P1347, DOI 10.1002/jmri.23777; Yamauchi H, 1999, J NUCL MED, V40, P1992	32	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161408	10.1371/journal.pone.0161408	http://dx.doi.org/10.1371/journal.pone.0161408			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560515	Green Submitted, Green Published, gold			2022-12-26	WOS:000382258600041
J	Yang, CH; Bian, GH; Yang, H; Zhang, XM; Chen, LM; Wang, JX				Yang, Chunhui; Bian, Guohui; Yang, Hong; Zhang, Xinmin; Chen, Limin; Wang, Jingxing			Development of High Hydrostatic Pressure Applied in Pathogen Inactivation for Plasma	PLOS ONE			English	Article							REDUCTION TECHNOLOGY; NOROVIRUS SURROGATE; FELINE CALICIVIRUS; BLOOD SAFETY; TRANSFUSION; HEAT	High hydrostatic pressure has been used to inactivate pathogens in foods for decades. There is a great potential to adapt this technology to inactivate pathogens in plasma and derivatives. To better evaluate the potential of this method, pathogen inoculated plasma samples were pressurized under different pressure application modes and temperatures. The inactivation efficacy of pathogens and activities of plasma proteins were monitored after treatment. The CFUs of E. coli was examined as the indicator of the inactivation efficiency. The factor V and VIII were chosen as the indicator of the plasma function. Preliminary experiments identified optimized treatment conditions: 200-250MPa, with 5x1 minute multi-pulsed high pressure at near 0 degrees C ( ice-water bath). Under this conditions, the inactivation efficacy of EMCV was > 8.5log. The CFUs of E. coli were reduced by 7.5log, B. cereus were 8log. However, PPV and S. aureus cannot be inactivated efficiently. The activities of factor II, VII, IX, X, XI, XII, fibrinogen, IgG, IgM stayed over 95% compared to untreated. Factor V and VIII activity was maintained at 46-63% and 77-82%, respectively.	[Yang, Chunhui; Bian, Guohui; Yang, Hong; Chen, Limin; Wang, Jingxing] Chinese Acad Med Sci, Inst Blood Transfus, Chengdu, Sichuan, Peoples R China; [Yang, Chunhui; Bian, Guohui; Yang, Hong; Chen, Limin; Wang, Jingxing] Peking Union Med Coll, Chengdu, Sichuan, Peoples R China; [Zhang, Xinmin] Zhengzhou Feilong Med Devices Co Ltd, Zhengzhou, Henan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Blood Transfusion - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, JX (corresponding author), Chinese Acad Med Sci, Inst Blood Transfus, Chengdu, Sichuan, Peoples R China.; Wang, JX (corresponding author), Peking Union Med Coll, Chengdu, Sichuan, Peoples R China.	jingxing_wang@vip.163.com	Chen, Limin/A-8813-2012		Sichuan province science and technology support project [2014SZ0025]; Zhengzhou Feilong medic devices Co,. Ltd	Sichuan province science and technology support project; Zhengzhou Feilong medic devices Co,. Ltd	This study was supported by Sichuan province science and technology support project (grant no: 2014SZ0025) (http://www.scst.gov.cn/). For the research, Zhengzhou Feilong medic devices Co,. Ltd provided support in the form of salaries for author ZX and the HHP device, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aertsen A, 2009, TRENDS BIOTECHNOL, V27, P434, DOI 10.1016/j.tibtech.2009.04.001; [Anonymous], 2012, 1846920111 GB, P11; Barshtein G, 1997, AM J PHYSIOL-HEART C, V272, pH538, DOI 10.1152/ajpheart.1997.272.1.H538; Benito A, 1999, APPL ENVIRON MICROB, V65, P1564; Bermudez-Aguirre D, 2011, FOOD ENG REV, V3, P44, DOI 10.1007/s12393-010-9030-4; Bradley DW, 2000, TRANSFUSION, V40, P193, DOI 10.1046/j.1537-2995.2000.40020193.x; Buckow R, 2008, APPL ENVIRON MICROB, V74, P1030, DOI 10.1128/AEM.01784-07; Buzrul S, 2014, INNOV FOOD SCI EMERG, V26, P1, DOI 10.1016/j.ifset.2014.07.004; CFDA, 2002, GUID PRINC BLOOD PRO; Chen HQ, 2005, J FOOD PROTECT, V68, P2389, DOI 10.4315/0362-028X-68.11.2389; Dodd RY, 2010, CLIN LAB MED, V30, P499, DOI 10.1016/j.cll.2010.02.007; Donsi G, 2007, J FOOD ENG, V78, P984, DOI 10.1016/j.jfoodeng.2005.12.042; Donsi G, 2010, J FOOD SCI, V75, pE169, DOI 10.1111/j.1750-3841.2010.01535.x; Epstein JS, 2010, BIOLOGICALS, V38, P31, DOI 10.1016/j.biologicals.2009.10.009; Goodrich RP, 2011, TRANSFUS APHER SCI, V45, P229, DOI 10.1016/j.transci.2011.10.001; Huang E, 2006, BIOSYST ENG, V94, P403, DOI 10.1016/j.biosystemseng.2006.03.008; Koseki S, 2007, INT J FOOD MICROBIOL, V116, P275, DOI 10.1016/j.ijfoodmicro.2007.01.008; Marietou A, 2014, APPL ENVIRON MICROB, V80, P5992, DOI 10.1128/AEM.02109-14; Meersman F, 2006, CHEM SOC REV, V35, P908, DOI 10.1039/b517761h; Palou E, 1998, LETT APPL MICROBIOL, V27, P375, DOI 10.1046/j.1472-765X.1998.00444.x; Pandey S, 2012, TRANSFUSION, V52, p65S, DOI 10.1111/j.1537-2995.2012.03663.x; Patterson MF, 2005, J APPL MICROBIOL, V98, P1400, DOI 10.1111/j.1365-2672.2005.02564.x; Pelletier JPR, 2006, BEST PRACT RES CL HA, V19, P205, DOI 10.1016/j.beha.2005.04.001; Politis C, 2014, TRANSFUSION MED, V24, P316, DOI 10.1111/tme.12144; Prowse CV, 2013, VOX SANG, V104, P183, DOI 10.1111/j.1423-0410.2012.01662.x; Rivalain N, 2012, NEW BIOTECHNOL, V29, P409, DOI 10.1016/j.nbt.2011.10.003; Salunkhe V, 2015, TRANSFUS APHER SCI, V52, P19, DOI 10.1016/j.transci.2014.12.016; Solheim BG, 2006, TRANSFUS APHER SCI, V35, P83, DOI 10.1016/j.transci.2006.02.004; Solheim BG, 2000, TRANSFUSION, V40, P84, DOI 10.1046/j.1537-2995.2000.40010084.x	30	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161775	10.1371/journal.pone.0161775	http://dx.doi.org/10.1371/journal.pone.0161775			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27561010	gold, Green Submitted, Green Published			2022-12-26	WOS:000382258600096
J	Munyua, P; Bitek, A; Osoro, E; Pieracci, EG; Muema, J; Mwatondo, A; Kungu, M; Nanyingi, M; Gharpure, R; Njenga, K; Thumbi, SM				Munyua, Peninah; Bitek, Austine; Osoro, Eric; Pieracci, Emily G.; Muema, Josephat; Mwatondo, Athman; Kungu, Mathew; Nanyingi, Mark; Gharpure, Radhika; Njenga, Kariuki; Thumbi, Samuel M.			Prioritization of Zoonotic Diseases in Kenya, 2015	PLOS ONE			English	Article							NEGLECTED ZOONOSES; AFRICA	Introduction Zoonotic diseases have varying public health burden and socio-economic impact across time and geographical settings making their prioritization for prevention and control important at the national level. We conducted systematic prioritization of zoonotic diseases and developed a ranked list of these diseases that would guide allocation of resources to enhance their surveillance, prevention, and control. Methods A group of 36 medical, veterinary, and wildlife experts in zoonoses from government, research institutions and universities in Kenya prioritized 36 diseases using a semi-quantitative One Health Zoonotic Disease Prioritization tool developed by Centers for Disease Control and Prevention with slight adaptations. The tool comprises five steps: listing of zoonotic diseases to be prioritized, development of ranking criteria, weighting criteria by pairwise comparison through analytical hierarchical process, scoring each zoonotic disease based on the criteria, and aggregation of scores. Results In order of importance, the participants identified severity of illness in humans, epidemic/pandemic potential in humans, socio-economic burden, prevalence/incidence and availability of interventions (weighted scores assigned to each criteria were 0.23, 0.22, 0.21, 0.17 and 0.17 respectively), as the criteria to define the relative importance of the diseases. The top five priority diseases in descending order of ranking were anthrax, trypanosomiasis, rabies, brucellosis and Rift Valley fever. Conclusion Although less prominently mentioned, neglected zoonotic diseases ranked highly compared to those with epidemic potential suggesting these endemic diseases cause substantial public health burden. The list of priority zoonotic disease is crucial for the targeted allocation of resources and informing disease prevention and control programs for zoonoses in Kenya.	[Munyua, Peninah] US Ctr Dis Control & Prevent, Div Global Hlth Protect, Global Dis Detect Program, Nairobi, Kenya; [Bitek, Austine; Muema, Josephat; Kungu, Mathew] Minist Agr Livestock & Fisheries, Zoonot Dis Unit, State Dept Vet Serv, Nairobi, Kenya; [Osoro, Eric; Mwatondo, Athman] Minist Hlth, Dept Prevent & Promot Hlth, Zoonot Dis Unit, Nairobi, Kenya; [Pieracci, Emily G.; Gharpure, Radhika] US Ctr Dis Control & Prevent, Div Vector Borne Dis, Atlanta, GA USA; [Pieracci, Emily G.] US Ctr Dis Control & Prevent, Epidem Intelligence Serv, Ctr Surveillance Epidemiol & Lab Serv, Atlanta, GA USA; [Muema, Josephat] Minist Hlth, Field Epidemiol & Lab Training Program, Nairobi, Kenya; [Nanyingi, Mark] Univ Nairobi, Dept Publ Hlth Pharmacol & Toxicol, Nairobi, Kenya; [Nanyingi, Mark] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Njenga, Kariuki; Thumbi, Samuel M.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Nairobi, Kenya; [Njenga, Kariuki; Thumbi, Samuel M.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of Nairobi; Colorado State University; Kenya Medical Research Institute; Washington State University	Munyua, P (corresponding author), US Ctr Dis Control & Prevent, Div Global Hlth Protect, Global Dis Detect Program, Nairobi, Kenya.	Pmunyua@cdc.gov	Mwangi, Thumbi/L-2216-2019; Munyua, Peninah/AAA-5922-2021; Muema, J/AAO-1598-2020	Mwangi, Thumbi/0000-0002-5754-0556; Nanyingi, Mark/0000-0001-7485-6416; Gharpure, Radhika/0000-0002-0702-5628; Osoro, Eric/0000-0001-5133-4279	US Centers for Disease Control and Prevention through Global Disease detection Division [GH000069]; Wellcome Trust [110330/Z/15/Z]	US Centers for Disease Control and Prevention through Global Disease detection Division; Wellcome Trust(Wellcome TrustEuropean Commission)	This work partially funded by US Centers for Disease Control and Prevention through cooperative agreements # GH000069, from the Global Disease detection Division. Participation of SM Thumbi was supported by Wellcome Trust # 110330/Z/15/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brookes VJ, 2015, EPIDEMIOL INFECT, V143, P2911, DOI [10.1017/S0950268815000801, 10.1017/S0950268]; Havelaar AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013965; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kadohira M, 2015, EPIDEMIOL INFECT, V143, P1477, DOI 10.1017/S0950268814002246; King CH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000209; Maudlin I, 2009, PHILOS T R SOC B, V364, P2777, DOI 10.1098/rstb.2009.0067; Mbabu M, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.106.4588; McMahon Barry J, 2015, Infect Ecol Epidemiol, V5, P27708, DOI 10.3402/iee.v5.27708; Ng V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048519; Ng V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029752; OiE, 2015, OIE LIST DIS INF INF; Okello A, 2015, HEALTH POLICY PLANN, V30, P804, DOI 10.1093/heapol/czu059; Omulo S, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-014-0041-4; Rich KM, 2010, AM J TROP MED HYG, V83, P52, DOI 10.4269/ajtmh.2010.09-0291; Rist CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109986; Saaty TL, 2008, INT J SERVICES SCI, V1, P16; Stebler N, 2015, PREV VET MED, V121, P165, DOI 10.1016/j.prevetmed.2015.05.006; Welburn SC, 2015, CLIN MICROBIOL INFEC, V21, P433, DOI 10.1016/j.cmi.2015.04.011; WHO, 2012, ACC WORK OV GLOB IMP, P13; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; World Health Organisation, 2004, HLTH STAT INF SYST	21	60	62	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161576	10.1371/journal.pone.0161576	http://dx.doi.org/10.1371/journal.pone.0161576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27557120	Green Submitted, Green Published, gold			2022-12-26	WOS:000382258100054
J	Przybysz Buzala, K; Przybysz, P; Kalinowska, H; Derkowska, M				Przybysz Buzala, Kamila; Przybysz, Piotr; Kalinowska, Halina; Derkowska, Malgorzata			Effect of Cellulases and Xylanases on Refining Process and Kraft Pulp Properties	PLOS ONE			English	Article							PAPER-INDUSTRY; FIBER	Samples of bleached kraft pine cellulosic pulp, either treated with an enzyme preparation (a Thermomyces lanuginosus xylanase, an Aspergillus sp. cellulase, and a multienzyme preparation NS-22086 containing both these activities) or untreated, were refined in a laboratory PFI mill. The treatment with cellulases contained in the last two preparations significantly improved the pulp's susceptibility to refining (the target freeness value of 30 degrees SR was achieved in a significantly shorter time), increased water retention value (WRV) and fines contents while the weighted average fiber length was significantly reduced. These changes of pulp parameters caused deterioration of paper strength properties. The treatment with the xylanase, which partially hydrolyzed xylan, small amounts of which are associated with cellulose fibers, only slightly loosened the structure of fibers. These subtle changes positively affected the susceptibility of the pulp to refining (refining energy was significantly reduced) and improved the static strength properties of paper. Thus, the treatment of kraft pulps with xylanases may lead to substantial savings of refining energy without negative effects on paper characteristics.	[Przybysz Buzala, Kamila; Przybysz, Piotr; Derkowska, Malgorzata] Lodz Univ Technol, Inst Papermaking & Printing Technol, Wolczanska Str 223, PL-90924 Lodz, Poland; [Kalinowska, Halina] Lodz Univ Technol, Inst Tech Biochem, Stefanowskiego Str 4-10, PL-90924 Lodz, Poland	Lodz University of Technology; Lodz University of Technology	Przybysz, P (corresponding author), Lodz Univ Technol, Inst Papermaking & Printing Technol, Wolczanska Str 223, PL-90924 Lodz, Poland.	piotrprzybysz@interia.pl		Kalinowska, Halina/0000-0001-8902-0005; Przybysz, Piotr/0000-0003-2044-6790	National Centre for Research and Development (NCBiR, Poland) [LIDER/042/407/L-4/12/NCBR/2013]	National Centre for Research and Development (NCBiR, Poland)	The work was financially supported by project LIDER/042/407/L-4/12/NCBR/2013 funded by National Centre for Research and Development (NCBiR, Poland). Funder URL: www.ncbr.gov.pl. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adney B., 2008, NRELTP51042628; ATALLA RH, 1980, TAPPI, V63, P121; Bajpai P, 1999, BIOTECHNOL PROGR, V15, P147, DOI 10.1021/bp990013k; Baker C.F, 2000, REFINING TECHNOLOGY; Batalha L. R., 2011, NATURAL RESOURCES, V2, P125; Buzala K, 2015, CELLULOSE, V22, P2737, DOI 10.1007/s10570-015-0644-9; Buzala K, 2015, CELLULOSE, V22, P663, DOI 10.1007/s10570-014-0522-x; Cui L, 2015, CARBOHYD POLYM, V115, P193, DOI 10.1016/j.carbpol.2014.08.076; Dickson AR, 2000, TAPPI J, V83, P64; Fornalski Z., 2014, POLISH PAPER REV; Garcia O, 2002, CELLULOSE, V9, P115, DOI 10.1023/A:1020191622764; Garcia-Ubasart J, 2013, IND CROP PROD, V44, P71, DOI 10.1016/j.indcrop.2012.10.019; Gil N, 2009, BIOCHEM ENG J, V46, P89, DOI 10.1016/j.bej.2009.04.011; Jacobs & IPST, 2006, PULP PAP IND EN BAND; Kim HJ, 2006, J IND ENG CHEM, V12, P578; Ko CH, 2010, BIORESOURCE TECHNOL, V101, P7882, DOI 10.1016/j.biortech.2010.05.043; Lecourt M, 2010, PROCESS BIOCHEM, V45, P1274, DOI 10.1016/j.procbio.2010.04.019; Liu N, 2012, BIORESOURCES, V7, P3367; Lumiainen J., 2000, PAPERMAK PART, V1, P86; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Oksanen T, 1997, CELLULOSE, V4, P329, DOI 10.1023/A:1018456411031; Siewert W. H., 1974, WOCHENBL PAPIERFABR, V102, P401; Torres CE, 2012, APPL MICROBIOL BIOT, V96, P327, DOI 10.1007/s00253-012-4345-0; Zhang JH, 2011, BIORESOURCE TECHNOL, V102, P9090, DOI 10.1016/j.biortech.2011.06.085; Znidarsic-Plazl P, 2009, CHEM BIOCHEM ENG Q, V23, P497	25	22	22	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161575	10.1371/journal.pone.0161575	http://dx.doi.org/10.1371/journal.pone.0161575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27557079	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258100053
J	Resende, LA; Aguiar-Soares, RDD; Gama-Ker, H; Roatt, BM; de Mendonca, LZ; Alves, MLR; da Silveira-Lemos, D; Correa-Oliveira, R; Martins, OA; Araujo, MSS; Fujiwara, RT; Gontijo, NF; Reis, AB; Giunchetti, RC				Resende, Lucilene Aparecida; de Oliveira Aguiar-Soares, Rodrigo Dian; Gama-Ker, Henrique; Roatt, Bruno Mendes; de Mendonca, Ludmila Zanandreis; Rodrigues Alves, Marina Luiza; da Silveira-Lemos, Denise; Correa-Oliveira, Rodrigo; Martins-Filho, Olindo Assis; Silva Araujo, Marcio Sobreira; Fujiwara, Ricardo Toshio; Gontijo, Nelder Figueiredo; Reis, Alexandre Barbosa; Giunchetti, Rodolfo Cordeiro			Impact of LbSapSal Vaccine in Canine Immunological and Parasitological Features before and after Leishmania chagasi-Challenge	PLOS ONE			English	Article							EXPERIMENTAL VISCERAL LEISHMANIASIS; LONG-LASTING PROTECTION; NITRIC-OXIDE PRODUCTION; PARASITE DENSITY; IMMUNE-RESPONSE; IFN-GAMMA; T-CELL; CUTANEOUS LEISHMANIASIS; CYTOKINE EXPRESSION; INTERFERON-GAMMA	Dogs represent the most important domestic reservoir of L. chagasi (syn. L. infantum). A vaccine against canine visceral leishmaniasis (CVL) would be an important tool for decreasing the anxiety related to possible L. chagasi infection and for controlling human visceral leishmaniasis (VL). Because the sand fly salivary proteins are potent immunogens obligatorily co-deposited during transmission of Leishmania parasites, their inclusion in an anti-Leishmania vaccine has been investigated in past decades. We investigated the immunogenicity of the "LbSapSal" vaccine (L. braziliensis antigens, saponin as adjuvant, and Lutzomyia longipalpis salivary gland extract) in dogs at baseline (T-0), during the post-vaccination protocol (T-3rd) and after early (T-90) and late (T-885) times following L. chagasi-challenge. Our major data indicated that immunization with "LbSapSal" is able to induce biomarkers characterized by enhanced amounts of type I (tumor necrosis factor [TNF]-alpha, interleukin [IL]-12, interferon [IFN]-gamma) cytokines and reduction in type II cytokines (IL-4 and TGF-beta), even after experimental challenge. The establishment of a prominent pro-inflammatory immune response after "LbSapSal" immunization supported the increased levels of nitric oxide production, favoring a reduction in spleen parasitism (78.9%) and indicating long-lasting protection against L. chagasi infection. In conclusion, these results confirmed the hypothesis that the "LbSapSal" vaccination is a potential tool to control the Leishmania chagasi infection.	[Resende, Lucilene Aparecida; de Mendonca, Ludmila Zanandreis; Rodrigues Alves, Marina Luiza; Giunchetti, Rodolfo Cordeiro] Univ Fed Minas Gerais, Dept Morfol, Lab Biol Interacoes Celulares, Belo Horizonte, MG, Brazil; [Resende, Lucilene Aparecida; de Oliveira Aguiar-Soares, Rodrigo Dian; Gama-Ker, Henrique; Roatt, Bruno Mendes; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Inst Ciencias Exatas & Biol, Lab Imunopatol, Nucleo Pesquisas Ciencias Biol NUPEB, Ouro Preto, MG, Brazil; [Fujiwara, Ricardo Toshio] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Imunol & Genom Parasitos, Belo Horizonte, MG, Brazil; [Correa-Oliveira, Rodrigo; Reis, Alexandre Barbosa] Fundacao Oswaldo Cruz, Ctr Pesquisa Rene Rachou, Lab Imunol Celular & Mol, Belo Horizonte, MG, Brazil; [da Silveira-Lemos, Denise; Martins-Filho, Olindo Assis; Silva Araujo, Marcio Sobreira; Giunchetti, Rodolfo Cordeiro] Fundacao Oswaldo Cruz, Ctr Pesquisa Rene Rachou, Lab Biomarcadores Diagnost & Monitoracao, Belo Horizonte, MG, Brazil; [Gontijo, Nelder Figueiredo] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Fisiol Insetos Hematofagos, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Ouro Preto; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Giunchetti, RC (corresponding author), Univ Fed Minas Gerais, Dept Morfol, Lab Biol Interacoes Celulares, Belo Horizonte, MG, Brazil.; Giunchetti, RC (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisa Rene Rachou, Lab Biomarcadores Diagnost & Monitoracao, Belo Horizonte, MG, Brazil.	giunchetti@icb.ufmg.br	Martins-Filho, Olindo Assis/ABE-6278-2021; Fujiwara, Ricardo Toshio/J-7579-2012; Reis, Alexandre Barbosa/I-9945-2014; Gontijo, Nelder F/D-2539-2013; de Oliveira Aguiar-Soares, Rodrigo Dian/ABB-7973-2020; Araujo, Marcio Sobreira Silva/ABE-7105-2021; Roatt, Bruno M/R-5502-2016	Martins-Filho, Olindo Assis/0000-0002-5494-4889; Fujiwara, Ricardo Toshio/0000-0002-4713-575X; Reis, Alexandre Barbosa/0000-0001-8123-4164; Gontijo, Nelder F/0000-0003-3357-2497; de Oliveira Aguiar-Soares, Rodrigo Dian/0000-0001-8705-7357; Araujo, Marcio Sobreira Silva/0000-0002-7532-3360; Roatt, Bruno M/0000-0001-5281-3263; de Oliveira Aguiar Soares, Rodrigo Dian/0000-0002-3390-7990; Reis, AlessanRSS/0000-0001-8486-7469; Silveira Lemos, Denise/0000-0003-0955-458X; Cordeiro Giunchetti, Rodolfo/0000-0003-4181-7546; Correa-Oliveira, Rodrigo/0000-0001-6419-9459	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil [CBB-APQ-02473-10/01225-11/01052-11/01698-12/02372-13, APQ-03576-13, CBB-PPM-00609-15, CBB-APQ-02007-12/02076-10/01225-11]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq, Brazil [482249/2012-9, 480979/2013-8]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/CAPES, Brazil	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil, grant CBB-APQ-02473-10/01225-11/01052-11/01698-12/02372-13, APQ-03576-13, CBB-PPM-00609-15: RCG. Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil, grant CBB-APQ-02007-12/02076-10/01225-11: DSL. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq, Brazil, grant 482249/2012-9: RCG. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq, Brazil, grant 480979/2013-8: DSL. RCO, OAMF, RTF, ABR, and RCG are grateful to Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/CAPES, Brazil, for fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar-Soares RDDO, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-61; Alves CF, 2009, VET IMMUNOL IMMUNOP, V128, P349, DOI 10.1016/j.vetimm.2008.11.020; Andrade HM, 1999, REV MED VET-TOULOUSE, V150, P809; Araujo MSS, 2008, VACCINE, V26, P2211, DOI 10.1016/j.vaccine.2008.02.044; Belkaid Y, 1998, J EXP MED, V188, P1941, DOI 10.1084/jem.188.10.1941; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; Borj-Cabrera GP, 2002, VACCINE, V20, P3277, DOI 10.1016/S0264-410X(02)00294-3; Bretagne S, 2001, CLIN DIAGN LAB IMMUN, V8, P828, DOI 10.1128/CDLI.8.4.828-831.2001; Carrillo E, 2007, VACCINE, V25, P1534, DOI 10.1016/j.vaccine.2006.10.036; Collin N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000441; Costa DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060535; de Moura TR, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000084; DEANE L. M., 1961, REV ASSOC MED BRASIL, V7, P161; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dye C, 1996, AM J TROP MED HYG, V55, P125, DOI 10.4269/ajtmh.1996.55.125; Fernandes AP, 2008, VACCINE, V26, P5888, DOI 10.1016/j.vaccine.2008.05.095; Fiuza JA, 2013, VACCINE, V31, P1785, DOI 10.1016/j.vaccine.2013.01.048; Gantt KR, 2003, J IMMUNOL, V170, P2613, DOI 10.4049/jimmunol.170.5.2613; Giunchetti RC, 2006, J COMP PATHOL, V135, P100, DOI 10.1016/j.jcpa.2006.06.005; Giunchetti RC, 2008, RES VET SCI, V85, P106, DOI 10.1016/j.rvsc.2007.09.008; Giunchetti RC, 2008, VACCINE, V26, P623, DOI 10.1016/j.vaccine.2007.11.057; Giunchetti RC, 2008, VET IMMUNOL IMMUNOP, V121, P23, DOI 10.1016/j.vetimm.2007.07.009; Giunchetti RC, 2008, RES VET SCI, V84, P269, DOI 10.1016/j.rvsc.2007.04.020; Giunchetti RC, 2007, VACCINE, V25, P7674, DOI 10.1016/j.vaccine.2007.08.009; Gomes R, 2008, P NATL ACAD SCI USA, V105, P7845, DOI 10.1073/pnas.0712153105; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; GUTMAN SI, 1992, CLIN CHEM, V38, P2152; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Holzmuller P, 2005, VET IMMUNOL IMMUNOP, V106, P247, DOI 10.1016/j.vetimm.2005.03.001; Hommel M, 1995, ANN TROP MED PARASIT, V89, P55, DOI 10.1080/00034983.1995.11813015; Kamhawi S, 2000, SCIENCE, V290, P1351, DOI 10.1126/science.290.5495.1351; Kaye PM, 2004, IMMUNOL REV, V201, P239, DOI 10.1111/j.0105-2896.2004.00188.x; Lage RS, 2007, VET IMMUNOL IMMUNOP, V115, P135, DOI 10.1016/j.vetimm.2006.10.001; Lemesre JL, 2007, VACCINE, V25, P4223, DOI 10.1016/j.vaccine.2007.02.083; Lima HC, 1996, INFECT IMMUN, V64, P5442, DOI 10.1128/IAI.64.12.5442-5445.1996; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maia C, 2011, J TROP MED, V2012, P541; Mauricio IL, 2000, PARASITOL TODAY, V16, P188, DOI 10.1016/S0169-4758(00)01637-9; Menezes-Souza D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001566; Menezes-Souza D, 2011, VET PARASITOL, V177, P39, DOI 10.1016/j.vetpar.2010.11.025; Michelin AD, 2011, ANN TROP MED PARASIT, V105, P373, DOI 10.1179/1364859411Y.0000000027; Moreira ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047907; Moreno J, 2002, TRENDS PARASITOL, V18, P399, DOI 10.1016/S1471-4922(02)02347-4; Moreno J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001683; MURRAY HW, 1992, J IMMUNOL, V148, P1858; Nicolato R de C, 2013, PLOS ONE, V23; Nylen S, 2007, TRENDS IMMUNOL, V28, P378, DOI 10.1016/j.it.2007.07.004; Palatnik-de-Sousa CB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00069; Panaro MA, 2009, PARASITOLOGY, V136, P823, DOI 10.1017/S0031182009006155; Panaro MA, 2001, COMP IMMUNOL MICROB, V24, P187, DOI 10.1016/S0147-9571(00)00026-6; Paranhos-Silva M, 2003, VET PARASITOL, V114, P97, DOI 10.1016/S0304-4017(03)00132-8; Pinelli E, 1999, VET IMMUNOL IMMUNOP, V69, P121, DOI 10.1016/S0165-2427(99)00048-3; PINELLI E, 1994, INFECT IMMUN, V62, P229, DOI 10.1128/IAI.62.1.229-235.1994; Rafati S, 2005, VACCINE, V23, P3716, DOI 10.1016/j.vaccine.2005.02.009; Reis AB, 2006, CLIN EXP IMMUNOL, V146, P303, DOI 10.1111/j.1365-2249.2006.03206.x; Reis AB, 2006, VET IMMUNOL IMMUNOP, V112, P102, DOI 10.1016/j.vetimm.2006.02.001; Reis AB, 2006, RES VET SCI, V81, P68, DOI 10.1016/j.rvsc.2005.09.011; Reis AB, 2010, TRENDS PARASITOL, V26, P341, DOI 10.1016/j.pt.2010.04.005; Resende LA, 2013, VET PARASITOL, V198, P371, DOI 10.1016/j.vetpar.2013.09.011; Roatt BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049780; Rodrigues V, 1998, INFECT IMMUN, V66, P1233, DOI 10.1128/IAI.66.3.1233-1236.1998; SAMUELSON J, 1991, J EXP MED, V173, P49, DOI 10.1084/jem.173.1.49; Santos-Gomes GM, 2002, VET IMMUNOL IMMUNOP, V88, P21, DOI 10.1016/S0165-2427(02)00134-4; Araujo MSS, 2009, VACCINE, V27, P1008, DOI 10.1016/j.vaccine.2008.11.104; Silva F, 2005, AM J TROP MED HYG, V72, P94, DOI 10.4269/ajtmh.2005.72.94; SQUIRES KE, 1989, J IMMUNOL, V143, P4244; Strauss-Ayali D, 2005, INT J PARASITOL, V35, P63, DOI 10.1016/j.ijpara.2004.10.015; Neto RGT, 2010, VET PARASITOL, V169, P248, DOI 10.1016/j.vetpar.2010.01.023; TESH RB, 1995, AM J TROP MED HYG, V52, P287, DOI 10.4269/ajtmh.1995.52.287; TITUS RG, 1988, SCIENCE, V239, P1306, DOI 10.1126/science.3344436; Titus RG, 2006, PARASITE IMMUNOL, V28, P131, DOI 10.1111/j.1365-3024.2006.00807.x; WARBURG A, 1994, PHILOS T R SOC B, V345, P223, DOI 10.1098/rstb.1994.0097; Williams DL, 1997, VET J, V153, P31, DOI 10.1016/S1090-0233(97)80006-8	73	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161169	10.1371/journal.pone.0161169	http://dx.doi.org/10.1371/journal.pone.0161169			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556586	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258100031
J	Hu, XD; Jogasuria, A; Wang, JY; Kim, C; Han, Y; Shen, H; Wu, JS; You, M				Hu, Xudong; Jogasuria, Alvin; Wang, Jiayou; Kim, Chunki; Han, Yoonhee; Shen, Hong; Wu, Jiashin; You, Min			MitoNEET Deficiency Alleviates Experimental Alcoholic Steatohepatitis in Mice by Stimulating Endocrine Adiponectin-Fgf15 Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adiponectin; alcohol; intestine; iron; liver injury	DRUG TARGET MITONEET; FATTY LIVER; PROTECTIVE ACTION; BETA-KLOTHO; GROWTH; PROTEIN; ETHANOL; INJURY; INFLAMMATION; METABOLISM	MitoNEET (mNT) (CDGSH iron-sulfur domain-containing protein 1 or CISD1) is an outer mitochondrial membrane protein that donates 2Fe-2S clusters to apo-acceptor proteins. In the present study, using a global mNT knock-out (mNTKO) mouse model, we investigated the in vivo functional role of mNT in the development of alcoholic steatohepatitis. Experimental alcoholic steatohepatitis was achieved by pair feeding wild-type (WT) and mNTKO mice with Lieber-DeCarli ethanol-containing diets for 4 weeks. Strikingly, chronically ethanol-fed mNTKO mice were completely resistant to ethanol-induced steatohepatitis as revealed by dramatically reduced hepatic triglycerides, decreased hepatic cholesterol level, diminished liver inflammatory response, and normalized serum ALT levels. Mechanistic studies demonstrated that ethanol administration to mNTKO mice induced two pivotal endocrine hormones, namely, adipose-derived adiponectin and gut-derived fibroblast growth factor 15 (Fgf15). The elevation in circulating levels of adiponectin and Fgf15 led to normalized hepatic and serum levels of bile acids, limited hepatic accumulation of toxic bile, attenuated inflammation, and amelioration of liver injury in the ethanol-fed mNTKO mice. Other potential mechanisms such as reduced oxidative stress, activated Sirt1 signaling, and diminished NF-B activity also contribute to hepatic improvement in the ethanol-fed mNTKO mice. In conclusion, the present study identified adiponectin and Fgf15 as pivotal adipose-gut-liver metabolic coordinators in mediating the protective action of mNT deficiency against development of alcoholic steatohepatitis in mice. Our findings may help to establish mNT as a novel therapeutic target and pharmacological inhibition of mNT may be beneficial for the prevention and treatment of human alcoholic steatohepatitis.	[Hu, Xudong; Jogasuria, Alvin; Wang, Jiayou; Kim, Chunki; Han, Yoonhee; Shen, Hong; Wu, Jiashin; You, Min] Northeast Ohio Med Univ, Coll Pharm, Rootstown, OH 44272 USA; [Hu, Xudong] Shanghai Univ Tradit Chinese Med, Dept Biol, Sch Basic Med Sci, Shanghai 201203, Peoples R China; [Shen, Hong] Guangdong Hosp Tradit Chinese Med Zhuhai, Dept Liver Dis, Zhuhai 519015, Peoples R China	Northeast Ohio Medical University (NEOMED); Shanghai University of Traditional Chinese Medicine; Guangxi University of Chinese Medicine; Guangzhou University of Chinese Medicine	You, M (corresponding author), 4209 State Route 44, Rootstown, OH 44272 USA.	myou@neomed.edu	Wang, Jiayou/AAN-4760-2021; hu, xudong/GNM-7161-2022	Wang, Jiayou/0000-0001-9697-2004; Kim, Chunki/0000-0003-2410-9118; JOGASURIA, ALVIN/0000-0002-8569-339X	National Institute on Alcoholism and Alcohol Abuse [AA013623, AA015951]; Natural Science Foundation of China [81273967]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013623, R01AA015951] Funding Source: NIH RePORTER	National Institute on Alcoholism and Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported in part by National Institute on Alcoholism and Alcohol Abuse Grants AA013623 and AA015951 (to M. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by Natural Science Foundation of China Grant 81273967.	Asimakopoulou A, 2016, HEPATOLOGY, V63, P669, DOI 10.1002/hep.27930; Bechmann LP, 2013, HEPATOLOGY, V57, P1394, DOI 10.1002/hep.26225; Bertola A, 2013, HEPATOLOGY, V58, P1814, DOI 10.1002/hep.26419; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Cai Y, 2016, AM J PATHOL, V186, P2417, DOI 10.1016/j.ajpath.2016.05.006; Chanda D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068845; Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Dong M, 2013, CELL METAB, V18, P118, DOI 10.1016/j.cmet.2013.06.003; Drafahl KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014412; Ferecatu I, 2014, J BIOL CHEM, V289, P28070, DOI 10.1074/jbc.M114.548438; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Ge HF, 2014, J BIOL CHEM, V289, P30470, DOI 10.1074/jbc.M114.592022; Geldenhuys WJ, 2014, DRUG DISCOV TODAY, V19, P1601, DOI 10.1016/j.drudis.2014.05.001; Hao YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072345; Hu M, 2013, HEPATOLOGY, V58, P1953, DOI 10.1002/hep.26589; Hunter RL, 2008, NEUROSCI LETT, V432, P198, DOI 10.1016/j.neulet.2007.12.019; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Jahn D, 2015, CYTOKINE GROWTH F R, V26, P625, DOI 10.1016/j.cytogfr.2015.07.016; Kohgo Y, 2008, J GASTROEN HEPATOL, V23, pS78, DOI 10.1111/j.1440-1746.2007.05290.x; Kolumam G, 2015, EBIOMEDICINE, V2, P730, DOI 10.1016/j.ebiom.2015.05.028; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Kusminski CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4962; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Landry AP, 2014, J BIOL CHEM, V289, P4307, DOI 10.1074/jbc.M113.542050; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Logan SJ, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0471-z; Luo YD, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-21; Moreno-Navarrete JM, 2016, OBESITY, V24, P139, DOI 10.1002/oby.21334; Mutanen A, 2015, J HEPATOL, V62, P1391, DOI [10.1016/j.jhep.2015.03.012, 10.1016/j.jhep.2015.01.004]; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; Park Pil-Hoon, 2015, Curr Pathobiol Rep, V3, P243; Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1_3; Salem AF, 2012, CELL CYCLE, V11, P4174, DOI 10.4161/cc.22376; Sanchez-Infantes D, 2015, INT J OBESITY, V39, P742, DOI 10.1038/ijo.2015.2; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Shen Z, 2009, AM J PHYSIOL-GASTR L, V296, pG1047, DOI 10.1152/ajpgi.00016.2009; Sjoholm K, 2005, J CLIN ENDOCR METAB, V90, P2233, DOI 10.1210/jc.2004-1830; Sohn YS, 2013, P NATL ACAD SCI USA, V110, P14676, DOI 10.1073/pnas.1313198110; Song BJ, 2014, REDOX BIOL, V3, P109, DOI 10.1016/j.redox.2014.10.004; Tamir S, 2015, BBA-MOL CELL RES, V1853, P1294, DOI 10.1016/j.bbamcr.2014.10.014; Tan GQ, 2012, BIOMETALS, V25, P1177, DOI 10.1007/s10534-012-9580-4; Tsai PH, 2015, STEM CELLS DEV, V24, P2561, DOI 10.1089/scd.2015.0066; Wang CH, 2014, HUM MOL GENET, V23, P4770, DOI 10.1093/hmg/ddu193; Wang DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081190; Wieser V, 2016, J HEPATOL, V64, P872, DOI 10.1016/j.jhep.2015.11.037; Wright MB, 2014, MOL ENDOCRINOL, V28, P1756, DOI 10.1210/me.2013-1427; Wu WB, 2014, BIOCHEM BIOPH RES CO, V443, P68, DOI 10.1016/j.bbrc.2013.11.057; Xie GX, 2013, FASEB J, V27, P3583, DOI 10.1096/fj.13-231860; Yin HQ, 2014, GASTROENTEROLOGY, V146, P801, DOI 10.1053/j.gastro.2013.11.008; You M, 2005, HEPATOLOGY, V42, P568, DOI 10.1002/hep.20821; You M, 2008, AM J PHYSIOL-GASTR L, V294, pG892, DOI 10.1152/ajpgi.00575.2007; You M, 2009, EXP BIOL MED, V234, P850, DOI 10.3181/0902-MR-61; Zhang R, 2014, DIGEST DIS SCI, V59, P89, DOI 10.1007/s10620-013-2877-5; Zhao YS, 2016, AM J PHYSIOL-ENDOC M, V310, pE289, DOI 10.1152/ajpendo.00356.2015; Zhong Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091308; Zhou M, 2016, HEPATOLOGY, V63, P914, DOI 10.1002/hep.28257; Zuris JA, 2012, J BIOL CHEM, V287, P11649, DOI 10.1074/jbc.M111.319731	58	22	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22482	22495		10.1074/jbc.M116.737015	http://dx.doi.org/10.1074/jbc.M116.737015			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27573244	Green Published, hybrid			2022-12-26	WOS:000386760600011
J	Duan, HQ; Wang, CL; Wang, M; Gao, XJ; Yan, MM; Akram, S; Peng, W; Zou, HF; Wang, D; Zhou, JJ; Chu, YJ; Dou, Z; Barrett, G; Green, HN; Wang, FJ; Tian, RJ; He, P; Wang, WW; Liu, X; Yao, XB				Duan, Hequan; Wang, Chunli; Wang, Ming; Gao, Xinjiao; Yan, Maomao; Akram, Saima; Peng, Wei; Zou, Hanfa; Wang, Dong; Zhou, Jiajia; Chu, Youjun; Dou, Zhen; Barrett, Gregory; Green, Hadiyah-Nichole; Wang, Fangjun; Tian, Ruijun; He, Ping; Wang, Wenwen; Liu, Xing; Yao, Xuebiao			Phosphorylation of PP1 Regulator Sds22 by PLK1 Ensures Accurate Chromosome Segregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 1; POLO-LIKE KINASE-1; AURORA B KINASE; SPINDLE-ASSEMBLY CHECKPOINT; THR-3 PHOSPHORYLATION; CELL-DIVISION; KINETOCHORE; MITOSIS; BINDING; HASPIN	During cell division, accurate chromosome segregation is tightly regulated by Polo-like kinase 1 (PLK1) and opposing activities of Aurora B kinase and protein phosphatase 1 (PP1). However, the regulatory mechanisms underlying the aforementioned hierarchical signaling cascade during mitotic chromosome segregation have remained elusive. Sds22 is a conserved regulator of PP1 activity, but how it regulates PP1 activity in space and time during mitosis remains elusive. Here we show that Sds22 is a novel and cognate substrate of PLK1 in mitosis, and the phosphorylation of Sds22 by PLK1 elicited an inhibition of PP1-mediated dephosphorylation of Aurora B at threonine 232 (Thr(232)) in a dose-dependent manner. Overexpression of a phosphomimetic mutant of Sds22 causes a dramatic increase in mitotic delay, whereas overexpression of a non-phosphorylatable mutant of Sds22 results in mitotic arrest. Mechanistically, the phosphorylation of Sds22 by PLK1 strengthens the binding of Sds22 to PP1 and inhibits the dephosphorylation of Thr(232) of Aurora B to ensure arobust, error-freemetaphase-anaphasetransition. Thesefindings delineate a conserved signaling hierarchy that orchestrates dynamic protein phosphorylation and dephosphorylation of critical mitotic regulators during chromosome segregation to guard chromosome stability.	[Duan, Hequan; Wang, Ming; Gao, Xinjiao; Yan, Maomao; Akram, Saima; Peng, Wei; Wang, Dong; Zhou, Jiajia; Chu, Youjun; Dou, Zhen; Wang, Wenwen; Liu, Xing; Yao, Xuebiao] Univ Sci & Technol China, MOE Collaborat Innovat Ctr Chem Life Sci, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China; [Duan, Hequan; Chu, Youjun; Barrett, Gregory; Green, Hadiyah-Nichole; Wang, Wenwen; Liu, Xing] Morehouse Sch Med, Atlanta, GA 30310 USA; [Duan, Hequan; Chu, Youjun; Barrett, Gregory; Green, Hadiyah-Nichole; Wang, Wenwen; Liu, Xing] Atlanta Clin & Translat Sci Inst, Atlanta, GA 30310 USA; [Wang, Chunli; Zou, Hanfa; Wang, Fangjun] Chinesse Acad Sci, Natl Chromatog Res & Anal Ctr, Dalian 116023, Peoples R China; [Tian, Ruijun; He, Ping] Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China; [Tian, Ruijun; He, Ping] South Univ Sci & Technol China, Ctr Mol Prote, Shenzhen 518055, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine; Southern University of Science & Technology	Wang, WW; Liu, X; Yao, XB (corresponding author), Univ Sci & Technol China, MOE Collaborat Innovat Ctr Chem Life Sci, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China.; Wang, WW; Liu, X (corresponding author), Morehouse Sch Med, Atlanta, GA 30310 USA.; Wang, WW; Liu, X (corresponding author), Atlanta Clin & Translat Sci Inst, Atlanta, GA 30310 USA.	wwwang@mail.ustc.edu.cn; xing1017@ustc.edu.cn; yaoxb@ustc.edu.cn	Liu, Xing/H-2989-2018; WANG, WENWEN/AAF-1080-2020; DOU, ZHEN/N-2022-2013; Tian, Ruijun/J-3019-2014; Yao, Xuebiao/P-5771-2014	Liu, Xing/0000-0002-7480-5085; WANG, WENWEN/0000-0002-1545-4369; Wang, Ming/0000-0002-7000-1063; Peng, Wei/0000-0001-7541-1494; Tian, Ruijun/0000-0001-9521-5124; DOU, ZHEN/0000-0003-3303-9393; Fangjun, Wang/0000-0002-8118-7019	Chinese Natural Science Foundation [31430054, 31320103904, 91313303, 31621002, 31501095, 31671405, 31371363, 31601097]; Chinese 973 Project [2012CB917204, 2012CB945002, 2002CB713700]; Anhui Province Key Project Grant [08040102005]; Chinese Academy of Sciences Center of Excellence Grant [2015HSC-UE010]; Anhui Provincial Natural Science Foundation [1508085SMC213]; National Institutes of Health [DK056292, CA164133]; NATIONAL CANCER INSTITUTE [R01CA164133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER	Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese 973 Project(National Basic Research Program of China); Anhui Province Key Project Grant; Chinese Academy of Sciences Center of Excellence Grant; Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Chinese Natural Science Foundation Grants 31430054, 31320103904, 91313303, 31621002, 31501095, 31671405, 31371363, and 31601097; Chinese 973 Project Grants 2012CB917204, 2012CB945002, and 2002CB713700; Anhui Province Key Project Grant 08040102005; Chinese Academy of Sciences Center of Excellence Grant 2015HSC-UE010; and Anhui Provincial Natural Science Foundation Grant 1508085SMC213. This work was also supported in part by National Institutes of Health Grants DK056292 and CA164133. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bian YY, 2014, J PROTEOMICS, V96, P253, DOI 10.1016/j.jprot.2013.11.014; Ceulemans H, 2002, J BIOL CHEM, V277, P47331, DOI 10.1074/jbc.M206838200; Chu YJ, 2011, J MOL CELL BIOL, V3, P260, DOI 10.1093/jmcb/mjq037; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; DeLuca KF, 2011, J CELL SCI, V124, P622, DOI 10.1242/jcs.072629; Dinischiotu A, 1997, FEBS LETT, V402, P141, DOI 10.1016/S0014-5793(96)01514-1; Dou Z, 2015, P NATL ACAD SCI USA, V112, pE4546, DOI 10.1073/pnas.1508791112; Eiteneuer A, 2014, EMBO J, V33, P2704, DOI 10.15252/embj.201489054; Ghenoiu C, 2013, MOL CELL, V52, P734, DOI 10.1016/j.molcel.2013.10.002; Han GH, 2008, PROTEOMICS, V8, P1346, DOI 10.1002/pmic.200700884; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Jiang H, 2015, J BIOL CHEM, V290, P28272, DOI 10.1074/jbc.M115.668855; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Kim Y, 2010, CELL, V142, P444, DOI 10.1016/j.cell.2010.06.039; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Li HC, 2010, EMBO J, V29, P2953, DOI 10.1038/emboj.2010.174; Liu D, 2012, J CELL BIOL, V198, P491, DOI 10.1083/jcb.201205090; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Meadows JC, 2011, DEV CELL, V20, P739, DOI 10.1016/j.devcel.2011.05.008; Meiselbach H, 2006, CHEM BIOL, V13, P49, DOI 10.1016/j.chembiol.2005.10.009; Mo F, 2016, NAT CHEM BIOL, V12, P226, DOI [10.1038/NCHEMBIO.2017, 10.1038/nchembio.2017]; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; OHKURA H, 1991, CELL, V64, P149, DOI 10.1016/0092-8674(91)90216-L; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Pinsky BA, 2006, MOL CELL BIOL, V26, P2648, DOI 10.1128/MCB.26.7.2648-2660.2006; Posch M, 2010, J CELL BIOL, V191, P61, DOI 10.1083/jcb.200912046; RENOUF S, 1995, FEBS LETT, V375, P75, DOI 10.1016/0014-5793(95)01180-M; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Rodrigues NTL, 2015, NATURE, V524, P489, DOI 10.1038/nature14496; Rosenberg JS, 2011, CURR BIOL, V21, P942, DOI 10.1016/j.cub.2011.04.011; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Shao HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12204; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Trinkle-Mulcahy L, 2003, MOL BIOL CELL, V14, P107, DOI 10.1091/mbc.E02-07-0376; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Wang XW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.406652; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Wurzenberger C, 2012, J CELL BIOL, V198, P173, DOI 10.1083/jcb.201112112; Xia P, 2014, J MOL CELL BIOL, V6, P240, DOI 10.1093/jmcb/mju016; Xia P, 2012, P NATL ACAD SCI USA, V109, P16564, DOI 10.1073/pnas.1202639109; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yuan K, 2009, J BIOL CHEM, V284, P23072, DOI 10.1074/jbc.M109.001990; Zannini L, 2014, J MOL CELL BIOL, V6, P442, DOI 10.1093/jmcb/mju045; Zhou LL, 2014, EMBO REP, V15, P273, DOI 10.1002/embr.201338080; Zhu LJ, 2015, J BIOL CHEM, V290, P27053, DOI 10.1074/jbc.M115.658534; Zitouni S, 2014, NAT REV MOL CELL BIO, V15, P433, DOI 10.1038/nrm3819	50	12	12	0	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21123	+		10.1074/jbc.M116.745372	http://dx.doi.org/10.1074/jbc.M116.745372			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27557660	Green Published, hybrid			2022-12-26	WOS:000385406200027
J	Roman, L; Schuyler, QA; Hardesty, BD; Townsend, KA				Roman, Lauren; Schuyler, Qamar A.; Hardesty, Britta Denise; Townsend, Kathy A.			Anthropogenic Debris Ingestion by Avifauna in Eastern Australia	PLOS ONE			English	Article							PLASTIC-DERIVED CHEMICALS; MARINE DEBRIS; NORTH PACIFIC; SEABIRDS; PARTICLES; DIET; ACCUMULATION; TENUIROSTRIS; ENVIRONMENT; POLLUTION	Anthropogenic debris in the world's oceans and coastal environments is a pervasive global issue that has both direct and indirect impacts on avifauna. The number of bird species affected, the feeding ecologies associated with an increased risk of debris ingestion, and selectivity of ingested debris have yet to be investigated in most of Australia's coastal and marine birds. With this study we aim to address the paucity of data regarding marine debris ingestion in Australian coastal and marine bird species. We investigated which Australian bird groups ingest marine debris, and whether debris-ingesting groups exhibit selectivity associated with their taxonomy, habitat or foraging methods. Here we present the largest multispecies study of anthropogenic debris ingestion in Australasian avifauna to date. We necropsied and investigated the gastrointestinal contents of 378 birds across 61 species, collected dead across eastern Australia. These species represented nine taxonomic orders, five habitat groups and six feeding strategies. Among investigated species, thirty percent had ingested debris, though ingestion did not occur uniformly within the orders of birds surveyed. Debris ingestion was found to occur in orders Procellariiformes, Suliformes, Charadriiformes and Pelecaniformes, across all surveyed habitats, and among birds that foraged by surface feeding, pursuit diving and search-by-sight. Procellariiformes, birds in pelagic habitats, and surface feeding marine birds ingested debris with the greatest frequency. Among birds which were found to ingest marine debris, we investigated debris selectivity and found that marine birds were selective with respect to both type and colour of debris. Selectivity for type and colour of debris significantly correlated with taxonomic order, habitat and foraging strategy. This study highlights the significant impact of feeding ecology on debris ingestion among Australia's avifauna.	[Roman, Lauren] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Schuyler, Qamar A.; Townsend, Kathy A.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Hardesty, Britta Denise] CSIRO, Oceans & Atmosphere Flagship, Hobart, Tas, Australia; [Townsend, Kathy A.] Univ Queensland, Moreton Bay Res Stn, Dunwich, Qld, Australia	University of Tasmania; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland	Roman, L (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	lauren.roman@utas.edu.au	Schuyler, Qamar A/L-2586-2014; Hardesty, Britta Denise/A-3189-2011; Roman, Lauren T/K-3804-2015; Townsend, Kathy Ann/K-9486-2016	Schuyler, Qamar A/0000-0002-2473-4311; Hardesty, Britta Denise/0000-0003-1948-5098; Roman, Lauren T/0000-0003-3591-4905; Townsend, Kathy Ann/0000-0002-2581-2158; Roman, Lauren/0000-0002-2959-2324	ARC Linkage grant [LP110200216]; DBH- CSIRO's Oceans and Atmosphere Flagship; Shell Social Investment Program; QS- Margaret Middleton Foundation; Australia Zoo Wildlife Hospital; Australian Seabird Rescue; Currumbin Sanctuary Wildlife Hospital; Department of Environment and Heritage Protection; Department of National Parks, Recreation, Sport and Racing; Pelican and Seabird Rescue; Earthwatch Australia (TeachWild); Queensland Museum; RSPCA QLD Wildlife Hospital; WildMob; CSIRO Oceans and Atmosphere; Margaret Middleton Foundation	ARC Linkage grant(Australian Research Council); DBH- CSIRO's Oceans and Atmosphere Flagship; Shell Social Investment Program; QS- Margaret Middleton Foundation; Australia Zoo Wildlife Hospital; Australian Seabird Rescue; Currumbin Sanctuary Wildlife Hospital; Department of Environment and Heritage Protection; Department of National Parks, Recreation, Sport and Racing; Pelican and Seabird Rescue; Earthwatch Australia (TeachWild); Queensland Museum; RSPCA QLD Wildlife Hospital; WildMob; CSIRO Oceans and Atmosphere; Margaret Middleton Foundation	The authors received no specific funding for this particular research project, first authored by LR, but co-authors are supported for similar research by: ARC Linkage grant LP110200216; DBH- CSIRO's Oceans and Atmosphere Flagship and the Shell Social Investment Program; QS- Margaret Middleton Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the following organizations who have supported this project: Australia Zoo Wildlife Hospital, Australian Seabird Rescue, Currumbin Sanctuary Wildlife Hospital, The Department of Environment and Heritage Protection, The Department of National Parks, Recreation, Sport and Racing, Pelican and Seabird Rescue, Earthwatch Australia (TeachWild), Queensland Museum, RSPCA QLD Wildlife Hospital, and WildMob. The authors would also like to thank the following people who have assisted in bird collection: L. Behrendorff, T. Bishop, B. Cumming, R. Ferris, K. Fleischfresser, H. Forrest, N. Forrest, A. Genninges, A. Gillet, M. Hines, H. Janetzki, C. Lacasse, M. Pyne, S. Shaw, L. Short, K. Southwell, D. Stewart, S. Hassard, P. Swift, and P. Taylor, and, with special thanks to J. Lesel who dedicated many weeks to assisting with data collection. Thanks also to the many volunteers who helped with gathering trawl samples; Libby Edge and EcoBarge Clean Seas, Belinda Cooper and the Twisted Sisters, TeachWild participants, Earthwatch volunteers, Wild Mob volunteers, and a special thanks to Julia Hazel who conducted countless trawls. We also acknowledge constructive feedback the editors and reviewers provided on an earlier version of this paper. This work was conducted under Scientific purposes permit no. WISP12620313, Department of Environment and Heritage Protection, Queensland Government. BDH acknowledges support from CSIRO Oceans and Atmosphere and the Shell Social Investment Program. Funding was provided by the ARC Linkage grant LP110200216 and Margaret Middleton Foundation.	Acampora H, 2014, MAR POLLUT BULL, V78, P63, DOI 10.1016/j.marpolbul.2013.11.009; [Anonymous], 1993, HDB AUSTR NZ ANTARCT; Barnes DKA, 2010, MAR ENVIRON RES, V70, P250, DOI 10.1016/j.marenvres.2010.05.006; Besseling E, 2013, ENVIRON SCI TECHNOL, V47, P593, DOI 10.1021/es302763x; Birdlife International, 2014, BIRDL TAX CHECKL VER; Boerger CM, 2010, MAR POLLUT BULL, V60, P2275, DOI 10.1016/j.marpolbul.2010.08.007; Browne MA, 2008, ENVIRON SCI TECHNOL, V42, P5026, DOI 10.1021/es800249a; Carey MJ, 2011, EMU, V111, P229, DOI 10.1071/MU10085; Ceccarelli D.M., 2009, IMPACTS PLASTIC DEBR; Choy CA, 2013, MAR ECOL PROG SER, V485, P155, DOI 10.3354/meps10342; Colabuono FI, 2010, MAR POLLUT BULL, V60, P630, DOI 10.1016/j.marpolbul.2010.01.018; CONNORS PG, 1982, MAR POLLUT BULL, V13, P18, DOI 10.1016/0025-326X(82)90490-8; COULSON R, 1993, EMU, V93, P50, DOI 10.1071/MU9930050; Croxall JP., 1987, SEABIRDS FEEDING ECO; Derraik JGB, 2002, MAR POLLUT BULL, V44, P842, DOI 10.1016/S0025-326X(02)00220-5; Engler RE, 2012, ENVIRON SCI TECHNOL, V46, P12302, DOI 10.1021/es3027105; Eriksen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111913; FURNESS RW, 1985, ENVIRON POLLUT A, V38, P261, DOI 10.1016/0143-1471(85)90131-X; Gregory MR, 2009, PHILOS T R SOC B, V364, P2013, DOI 10.1098/rstb.2008.0265; Hardesty B. D., 2014, UNDERSTANDING EFFECT; Hays H., 1974, MAR POLLUT BULL, V5, P44, DOI 10.1016/0025-326X(74)90234-3.; Higgins P.J., 1996, HDB AUSTR NZ ANTARCT; Hong S, 2013, MAR POLLUT BULL, V66, P117, DOI 10.1016/j.marpolbul.2012.10.022; Kuhn S, 2015, MARINE ANTHROPOGENIC LITTER, P75, DOI 10.1007/978-3-319-16510-3_4; Kukulka T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051116; Lavers JL, 2014, ENVIRON POLLUT, V187, P124, DOI 10.1016/j.envpol.2013.12.020; Lindborg VA, 2012, MAR POLLUT BULL, V64, P2351, DOI 10.1016/j.marpolbul.2012.08.020; Marchant S., 1993, RAPTORS LAPWINGS, V2; Martin GR, 1998, P ROY SOC B-BIOL SCI, V265, P665, DOI 10.1098/rspb.1998.0345; Moore CJ, 2008, ENVIRON RES, V108, P131, DOI 10.1016/j.envres.2008.07.025; NORMAN FI, 1987, EMU, V87, P179, DOI 10.1071/MU9870179; Oksanen J., **DATA OBJECT**; Pierce Kathryn E., 2004, Marine Ornithology, V32, P187; R Core Team, 2015, R LANGUAGE ENV STAT; ROBARDS MD, 1995, MAR POLLUT BULL, V30, P151, DOI 10.1016/0025-326X(94)00121-O; RYAN PG, 1988, MAR POLLUT BULL, V19, P125, DOI 10.1016/0025-326X(88)90708-4; RYAN PG, 1987, MAR ENVIRON RES, V23, P175, DOI 10.1016/0141-1136(87)90028-6; Schuyler Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040884; Schwemmer Philipp, 2012, Vogelwarte, V50, P141; Sileo L, 1990, P 2 INT C MAR DEBR; Tanaka K, 2013, MAR POLLUT BULL, V69, P219, DOI 10.1016/j.marpolbul.2012.12.010; Tourinho PS, 2010, MAR POLLUT BULL, V60, P396, DOI 10.1016/j.marpolbul.2009.10.013; van Franeker J., 2004, SAVE N SEA FULMAR LI, V672; van Franeker JA, 2011, ENVIRON POLLUT, V159, P2609, DOI 10.1016/j.envpol.2011.06.008; Verlis KM, 2013, MAR POLLUT BULL, V72, P244, DOI 10.1016/j.marpolbul.2013.03.017; Votier SC, 2001, BIRD STUDY, V48, P373, DOI 10.1080/00063650109461237; Weiser EL, 2011, ARCTIC, V64, P220	47	32	33	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0158343	10.1371/journal.pone.0158343	http://dx.doi.org/10.1371/journal.pone.0158343			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27574986	Green Published, gold			2022-12-26	WOS:000382877200002
J	Wang, BS; Boeckel, GR; Huynh, L; Nguyen, L; Cao, WX; De La Cruz, EM; Kaftan, EJ; Ehrlich, BE				Wang, Baisheng; Boeckel, Goran R.; Huynh, Larry; Lien Nguyen; Cao, Wenxiang; De La Cruz, Enrique M.; Kaftan, Edward J.; Ehrlich, Barbara E.			Neuronal Calcium Sensor 1 Has Two Variants with Distinct Calcium Binding Characteristics	PLOS ONE			English	Article							CONFORMATIONAL-CHANGES; PACLITAXEL; PROTEINS; RECEPTOR; LITHIUM; NCS-1	Neuronal calcium sensor-1 (NCS-1 Var1) is a calcium-binding protein expressed in most tissues. We examined a poorly characterized variant of NCS-1 (Var2), identified only in humans where the N-terminal 22 amino acid residues of native NCS-1(MGKSNSKLKPEV-VEELTRKTY) were replaced with 4 different residues (MATI). Because alterations in the level of expression of NCS-1 Var1 and the expression of NCS-1 variants have been correlated with several neurological diseases, the relative expression and functional role of NCS-1 Var2 was examined. We found that NCS-1 Var2 mRNA levels are not found in mouse tissues and are expressed at levels similar to 1000-fold lower than NCS-1 Var1 in three different human cell lines (SHSY5Y, HEK293, MB231). Protein expression of both variants was only identified in cell lines overexpressing exogenous NCS-1 Var2. The calcium binding affinity is similar to 100 times weaker in purified NCS-1 Var2 than NCS-1 Var1. Because truncation of NCS-1 Var1 has been linked to functional changes in neurons, we determined whether the differing properties of the NCS-1 variants could potentially contribute to the altered cell function. In contrast to previous reports showing that overexpression of NCS-1 Var1 increases calcium-dependent processes, functional differences in cells overexpressing NCS-1 Var2 were undetectable in assays for cell growth, cell death and drug (paclitaxel) potency. Our results suggest that NCS-1 Var1 is the primary functional version of NCS-1.	[Wang, Baisheng] Cent S Univ, Xiang Ya Hosp, Dept Stomatol, 87 Xiang Ya St, Changsha 410008, Hunan, Peoples R China; [Wang, Baisheng; Boeckel, Goran R.; Huynh, Larry; Lien Nguyen; Ehrlich, Barbara E.] Yale Univ, Dept Pharmacol, New Haven, CT USA; [Cao, Wenxiang; De La Cruz, Enrique M.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Kaftan, Edward J.; Ehrlich, Barbara E.] Yale Comprehens Canc Ctr, New Haven, CT USA; [Ehrlich, Barbara E.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT USA; [Boeckel, Goran R.] Univ Lubeck, Inst Physiol, Ratzeburger Allee 160, D-23562 Lubeck, Germany	Central South University; Yale University; Yale University; Yale University; Yale University; University of Lubeck	Ehrlich, BE (corresponding author), Yale Univ, Dept Pharmacol, New Haven, CT USA.; Ehrlich, BE (corresponding author), Yale Comprehens Canc Ctr, New Haven, CT USA.; Ehrlich, BE (corresponding author), Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT USA.	barbara.ehrlich@yale.edu	/AAX-8408-2021	/0000-0001-9657-9704; Huynh, Larry/0000-0002-1492-5931; Nguyen, Lien/0000-0001-8096-1570	NIH [5P30DK034989, OD020142, DK057751, DK090744, GM097348]; China Scholarship Council (CRC); German National Merit Foundation Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK057751, P30DK090744, P30DK034989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097348] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020142] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council (CRC)(China Scholarship Council); German National Merit Foundation Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors acknowledge funding from the NIH to support the Yale Cell Biology Microscopy Core (5P30DK034989, OD020142). NIH grant support is acknowledged: DK057751, DK090744 (BEE) and GM097348 (EMDLC). The Connecticut Department of Public Health also supplied support. BW was supported by the China Scholarship Council (CRC) and GRB was supported by a German National Merit Foundation Scholarship. All work was performed at Yale University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Yifei Yang and Lauren Moore for helpful discussions. We thank Lily Nguyen for technical assistance. We acknowledge funding from the NIH to support the Yale Cell Biology Microscopy Core (5P30DK034989, OD020142). NIH grant support is acknowledged: DK057751, DK090744 (BEE) and GM097348 (EMDLC). The Connecticut Department of Public Health also supplied support. BW was supported by the China Scholarship Council (CRC) and GRB was supported by a German National Merit Foundation Scholarship. All work was performed at Yale University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aravind P, 2008, J MOL BIOL, V376, P1100, DOI 10.1016/j.jmb.2007.12.033; Benbow JH, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.385070; Benbow JH, 2011, J BIOL CHEM, V286, P34575, DOI 10.1074/jbc.M111.265751; Blachford C, 2009, CELL CALCIUM; Boehmerle W, 2007, P NATL ACAD SCI USA, V104, P11103, DOI 10.1073/pnas.0701546104; Boehmerle W, 2006, P NATL ACAD SCI USA, V103, P18356, DOI 10.1073/pnas.0607240103; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Burgoyne RD, 2015, BBA-MOL CELL RES, V1853, P1921, DOI 10.1016/j.bbamcr.2014.10.029; Fisher JR, 2000, PROTEIN EXPRES PURIF, V20, P66, DOI 10.1006/prep.2000.1298; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Handley MTW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010534; Heidarsson PO, 2012, J MOL BIOL, V417, P51, DOI 10.1016/j.jmb.2011.12.049; Hilfiker S, 2003, BIOCHEM SOC T, V31, P828, DOI 10.1042/BST0310828; Jenney CB, 2016, BRAIN RES BULL, V123, P61, DOI 10.1016/j.brainresbull.2015.10.008; Jeromin A, 2004, J BIOL CHEM, V279, P27158, DOI 10.1074/jbc.M312172200; Jeromin A, 2004, J BIOL CHEM; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Koh PO, 2003, P NATL ACAD SCI USA, V100, P313, DOI 10.1073/pnas.232693499; Lernire S, 2016, COLLOID SURFACE B, V139, P138, DOI 10.1016/j.colsurfb.2015.11.065; Lim S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208868; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; Mo M, 2012, FASEB J, V26, P4696, DOI 10.1096/fj.12-214643; Multani PK, 2012, NEUROSCI LETT, V531, P46, DOI 10.1016/j.neulet.2012.09.014; Pandalaneni S, 2015, J BIOL CHEM, V290, P18744, DOI 10.1074/jbc.M114.627059; Schlecker C, 2006, J CLIN INVEST, V116, P1668, DOI 10.1172/JCI22466; Torres KCL, 2009, PROG NEURO-PSYCHOPH, V33, P229, DOI 10.1016/j.pnpbp.2008.11.011; Weiss JL, 2010, CELL MOL NEUROBIOL, V30, P1283, DOI 10.1007/s10571-010-9588-7; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853	31	8	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161414	10.1371/journal.pone.0161414	http://dx.doi.org/10.1371/journal.pone.0161414			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575489	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877200027
J	Diaz-Yanez, O; Mola-Yudego, B; Eriksen, R; Gonzalez-Olabarria, JR				Diaz-Yanez, Olalla; Mola-Yudego, Blas; Eriksen, Rune; Ramon Gonzalez-Olabarria, Jose			Assessment of the Main Natural Disturbances on Norwegian Forest Based on 20 Years of National Inventory	PLOS ONE			English	Article							EPIRRITA-AUTUMNATA LEPIDOPTERA; BEETLE IPS-TYPOGRAPHUS; BARK BEETLE; SNOW DAMAGE; PINUS-SYLVESTRIS; FIRE FREQUENCY; PICEA-ABIES; WIND DAMAGE; SCOTS PINE; SPRUCE	The re-measurement of permanent forest inventories offers a unique opportunity to assess the occurrence and impact of forest disturbances. The present study aims at exploring the main forest damages in Norway based on the extensive data of several consecutive national forest inventories during the period 1995-2014. Five of the most common disturbance agents in Norway are selected for analysis: wind, snow, browsing, fungus and insect damage. The analyses focuses on the frequency and variation along time, the average damage at stand level and the spatial patterns of damage occurrence, resulting in a characterization of the damage produced by disturbances in Norway. The highest damage occurrences by disturbance agent are due to browsing, snow and wind. Snow presents a decreasing temporally trend in damage frequency in the studied period. By forest type, mature and intermediate birch forest are found to be more affected by snow damage, whereas mature spruce forest is by wind damage. The results from this study provide support to the hypothesis that damages by autumnal moth (Epirrita autumnata) on birch are more common in mature stands. No major attacks from bark beetle (Ips typographus) are found, probably related to the lack of major storm damages in the period. Forest types susceptibility to fungus has no apparent variation over time except in the last years, as increased occurrence is observed on mature spruce stands probably correlated with warmer than average periods. Browsing damage causes the most severe losses, as expected, in young stands, and is allocated mainly on the most productive forests. Although some of the disturbances present locally moderate effects, the results show no major disturbances threatening Norwegian forests in the studied period. Finally, the Norwegian national forest inventory demonstrates its reliability as a basis to understand the occurrence and effects of major natural disturbances.	[Diaz-Yanez, Olalla; Mola-Yudego, Blas] Univ Eastern Finland, Sch Forest Sci, Joensuu, Finland; [Mola-Yudego, Blas; Eriksen, Rune] Norwegian Inst Bioeconomy Res, As, Norway; [Ramon Gonzalez-Olabarria, Jose] Forest Sci Ctr Catalonia, Solsona, Spain	University of Eastern Finland; Norwegian Institute of Bioeconomy Research; Centre Tecnologic Forestal de Catalunya (CTFC)	Diaz-Yanez, O (corresponding author), Univ Eastern Finland, Sch Forest Sci, Joensuu, Finland.	olalla.diaz@uef.fi	Mola-Yudego, Blas/E-9724-2010; Olabarria, Jose Ramon Gonzalez/D-2575-2009; Díaz-Yáñez, Olalla/K-5885-2016	Mola-Yudego, Blas/0000-0003-0286-0170; Olabarria, Jose Ramon Gonzalez/0000-0002-5040-712X; Díaz-Yáñez, Olalla/0000-0003-3829-5759	forest doctoral school of the University of Eastern Finland; Norwegian Institute for Bioeconomy Research; SIS-Redclim	forest doctoral school of the University of Eastern Finland; Norwegian Institute for Bioeconomy Research; SIS-Redclim	We are grateful to the forest doctoral school of the University of Eastern Finland for their kind economic support, as well as to the SIS-Redclim, funded by the Norwegian Institute for Bioeconomy Research.	Abramson IS, 1982, ANN STAT; Allen E, 2001, ECOSYST HEALTH, V7, P28; BAKKE A, 1983, Z ANGEW ENTOMOL, V96, P118; Bakke A, 1989, RECENT IPS TYPOGRAPH; Bebi P, 2009, FOREST ECOL MANAG, V257, P1883, DOI 10.1016/j.foreco.2009.01.050; Bergeron Y, 2001, CAN J FOREST RES, V31, P384, DOI 10.1139/cjfr-31-3-384; Bergstedt J, 2001, FOREST ECOL MANAG, V154, P105, DOI 10.1016/S0378-1127(00)00642-3; Bjorneraas K, 2011, WILDLIFE BIOL, V17, P44, DOI 10.2981/10-073; BOND WJ, 1995, OIKOS, V73, P79, DOI 10.2307/3545728; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bowman AW, 1997, APPL SMOOTHING TECHN; Bylund H, 1997, STAND AGE STRUCTURE, P319; Christiansen E, 1997, DOES DROUGHT REALLY, P163; Chuvieco E, 1999, REMOTE SENSING LARGE, P65, DOI [DOI 10.1007/978-3-642-60164-4, 10.1007/978-3-642-60164-4]; COLLINS MA, 1976, T BRIT MYCOL SOC, V67, P336, DOI 10.1016/S0007-1536(76)80143-X; Davies TM, 2011, J STAT SOFTW, V39, P1; de la Riva J, 2004, REMOTE SENS ENVIRON, V92, P288, DOI [10.1016/j.rse.2004.06.013, 10.1016/j.rse.2004.06.022]; Dobbertin Matthias, 2002, Forest Snow and Landscape Research, V77, P187; Fischer A, 2013, BIODIVERS CONSERV, V22, P1863, DOI 10.1007/s10531-013-0525-1; Franklin J, 1995, PROG PHYS GEOG, V19, P474, DOI 10.1177/030913339501900403; Franklin JF, 2002, FOREST ECOL MANAG, V155, P399, DOI 10.1016/S0378-1127(01)00575-8; Fridman J, 1998, SCAND J FOREST RES, V13, P348, DOI 10.1080/02827589809382994; Frolking S, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000911; Garcia-Gonzalo J, 2014, ANN OPER RES, V219, P379, DOI 10.1007/s10479-011-0908-1; Gonzalez JR, 2006, ANN FOREST SCI, V63, P169, DOI 10.1051/forest:2005109; Gonzalez-Olabarria JR, 2011, FOREST ECOL MANAG, V261, P278, DOI 10.1016/j.foreco.2010.10.017; HALL FG, 1991, ECOLOGY, V72, P628, DOI 10.2307/2937203; Hanewinkel M, 2008, CAN J FOREST RES, V38, P2249, DOI 10.1139/X08-070; Heikkila R, 1996, FOREST ECOL MANAG, V88, P179, DOI 10.1016/S0378-1127(96)03823-6; Ilisson T, 2005, SCAND J FOREST RES, V20, P88, DOI 10.1080/14004080510041020; Jalkanen A, 2001, SILVA FENN, V35, P159, DOI 10.14214/sf.593; Jalkanen A, 2000, FOREST ECOL MANAG, V135, P315, DOI 10.1016/S0378-1127(00)00289-9; Jalkanen R, 1998, EUR J FOREST PATHOL, V28, P373; JOHNSON EA, 1994, ADV ECOL RES, V25, P239, DOI 10.1016/S0065-2504(08)60216-0; Koutsias Nikos, 2004, Natural Resource Modeling, V17, P359; Landsskogtakseringens, 2008, LANDSSKOGTAKSERINGEN, P1; Marques S, 2012, FOREST SYST, V21, P111, DOI 10.5424/fs/2112211-11374; Martin-Alcon S, 2010, SILVA FENN, V44, P399, DOI 10.14214/sf.138; Netherer S, 2005, FOREST ECOL MANAG, V207, P99, DOI 10.1016/j.foreco.2004.10.020; Nevalainen S, 1999, SCAND J FOREST RES, V14, P111, DOI 10.1080/02827589950152836; Nevalainen S, 2000, FOREST ECOL MANAG, V135, P229, DOI 10.1016/S0378-1127(00)00313-3; Nevalainen S, 2015, ANN FOREST SCI, V72, P909, DOI 10.1007/s13595-014-0435-8; Nykanen ML, 1997, SILVA FENNICA, V31, P192; Okland B, 2006, ECOLOGY, V87, P283, DOI 10.1890/05-0135; Okland B, 2004, AGR FOREST ENTOMOL, V6, P141, DOI 10.1111/j.1461-9555.2004.00214.x; Okland B, 2003, POPUL ECOL, V45, P213, DOI 10.1007/s10144-003-0157-5; Oliver C.D., 1996, FOREST STAND DYNAMIC; Paatalo ML, 2000, SCAND J FOREST RES, V15, P530, DOI 10.1080/028275800750173474; Peltola H, 1997, FOREST ECOL MANAG, V95, P229, DOI 10.1016/S0378-1127(97)00037-6; Gonzalez JR, 2007, ANN FOREST SCI, V64, P733, DOI 10.1051/forest:2007053; Runkle J. R., 1985, The ecology of natural disturbance and patch dynamics, P17; Ruohomaki K, 1997, ENVIRON ENTOMOL, V26, P1096, DOI 10.1093/ee/26.5.1096; Ruohomaki K, 2000, POPUL ECOL, V42, P211, DOI 10.1007/PL00012000; Schelhaas MJ, 2003, GLOBAL CHANGE BIOL, V9, P1620, DOI 10.1046/j.1365-2486.2003.00684.x; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Seidl R, 2011, ECOL MODEL, V222, P903, DOI 10.1016/j.ecolmodel.2010.09.040; Stadelmann G, 2014, FOREST ECOL MANAG, V318, P167, DOI 10.1016/j.foreco.2014.01.022; Stadelmann G, 2013, ECOGRAPHY, V36, P1208, DOI 10.1111/j.1600-0587.2013.00177.x; Tenow O, 2007, J ANIM ECOL, V76, P258, DOI 10.1111/j.1365-2656.2006.01204.x; TERRELL GR, 1990, J AM STAT ASSOC, V85, P470, DOI 10.2307/2289786; Thom D, 2016, BIOL REV, V91, P760, DOI 10.1111/brv.12193; Valinger E, 1996, FORESTRY, V69, P25, DOI 10.1093/forestry/69.1.25; Valinger E, 1999, ENVIRON MANAGE, V24, P209, DOI 10.1007/s002679900227; von Gadow K, 2000, SILVA FENN, V34, P181, DOI 10.14214/sf.639; Vospernik S, 2006, SILVA FENN, V40, P589, DOI 10.14214/sf.316; Wermelinger B, 2004, FOREST ECOL MANAG, V202, P67, DOI 10.1016/j.foreco.2004.07.018; Wermelinger B, 2013, AGR FOREST ENTOMOL, V15, P301, DOI 10.1111/afe.12018; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Wulff S, 2006, CAN J FOREST RES, V36, P2605, DOI 10.1139/X06-148; Wulff S, 2013, SILVA FENN, V47, DOI 10.14214/sf.1000	70	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161361	10.1371/journal.pone.0161361	http://dx.doi.org/10.1371/journal.pone.0161361			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27570973	Green Published, gold, Green Submitted			2022-12-26	WOS:000382876700015
J	Lin, H; Zhu, P; Lin, QP; Huang, XQ; Xu, Y; Yang, XP				Lin, Han; Zhu, Ping; Lin, Qiuping; Huang, Xiaoqiong; Xu, Yue; Yang, Xiaoping			Comprehensive Analysis of Mandibular Residual Asymmetry after Bilateral Sagittal Split Ramus Osteotomy Correction of Menton Point Deviation	PLOS ONE			English	Article							BSSRO	Purpose Facial asymmetry often persists even after mandibular deviation corrected by the bilateral sagittal split ramus osteotomy (BSSRO) operation, since the reference facial sagittal plane for the asymmetry analysis is usually set up before the mandibular menton (Me) point correction. Our aim is to develop a predictive and quantitative method to assess the true asymmetry of the mandible after a midline correction performed by a virtual BSSRO, and to verify its availability by evaluation of the post-surgical improvement. Patients and Methods A retrospective cohort study was conducted at the Hospital of Stomatology, Sun Yat-sen University (China) of patients with pure hemi-mandibular elongation (HE) from September 2010 through May 2014. Mandibular models were reconstructed from CBCT images of patients with pre-surgical orthodontic treatment. After mandibular de-rotation and midline alignment with virtual BSSRO, the elongation hemi-mandible was virtually mirrored along the facial sagittal plane. The residual asymmetry, defined as the superimposition and boolean operation of the mirrored elongation side on the normal side, was calculated, including the volumetric differences and the length of transversal and vertical asymmetry discrepancy. For more specific evaluation, both sides of the hemi-mandible were divided into the symphysis and parasymphysis (SP), mandibular body (MB), and mandibular angle (MA) regions. Other clinical variables include deviation of Me point, dental midline and molar relationship. The measurement of volumetric discrepancy between the two sides of post-surgical hemi-mandible were also calculated to verify the availability of virtual surgery. Paired t-tests were computed and the P value was set at .05. Results This study included 45 patients. The volume differences were 407.8 +/- 64.8 mm(3), 2139.1 +/- 72.5 mm(3), and 422.5 +/- 36.9 mm(3); residual average transversal discrepancy, 1.9 mm, 1.0 mm, and 2.2 mm; average vertical discrepancy, 1.1 mm, 2.2 mm, and 2.2 mm (before virtual surgery). The post-surgical volumetric measurement showed no statistical differences between bilateral mandibular regions. Conclusions Mandibular asymmetry persists after Me point correction. A 3D quantification of mandibular residual asymmetry after Me point correction and mandible de-rotation with virtual BSSRO sets up a true reference mirror plane for comprehensive asymmetry assessment of bilateral mandibular structure, thereby providing an accurate guidance for orthognathic surgical planning.	[Lin, Han; Zhu, Ping; Huang, Xiaoqiong; Yang, Xiaoping] Sun Yat Sen Univ, Guangdong Prov Key Lab Stomatol, Hosp Stomatol, Dept Oral & Maxillofacial Surg,Guanghua Sch Stoma, Guangzhou, Guangdong, Peoples R China; [Lin, Qiuping; Xu, Yue] Sun Yat Sen Univ, Guangdong Prov Key Lab Stomatol, Hosp Stomatol, Dept Orthodont,Guanghua Sch Stomatol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Xu, Y (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Stomatol, Hosp Stomatol, Dept Orthodont,Guanghua Sch Stomatol, Guangzhou, Guangdong, Peoples R China.	kou9315@hotmail.com	Xu, yue/HGE-1737-2022					AlHadidi A, 2011, DENTOMAXILLOFAC RAD, V40, P351, DOI 10.1259/dmfr/13993523; Cevidanes LHS, 2005, DENTOMAXILLOFAC RAD, V34, P369, DOI 10.1259/dmfr/17102411; Cevidanes LHS, 2011, ORAL SURG ORAL MED O, V111, P757, DOI 10.1016/j.tripleo.2011.02.002; Choi KY, 2012, ARCH PLAST SURG-APS, V39, P291, DOI 10.5999/aps.2012.39.4.291; Lin H, 2013, HEAD FACE MED, V9, DOI 10.1186/1746-160X-9-42; Motta AT, 2010, DENT PRESS J ORTHOD, V15, P45; Pelo S, 2011, J CRANIOFAC SURG, V22, P2227, DOI 10.1097/SCS.0b013e31823200da; PIRTTINIEMI PM, 1994, AM J ORTHOD DENTOFAC, V106, P191, DOI 10.1016/S0889-5406(94)70038-9; Seres L, 2014, HEAD FACE MED, V10, DOI 10.1186/1746-160X-10-27; Shao Z, 2011, AESTHET PLAST SURG, V35, P382, DOI 10.1007/s00266-011-9652-9; Watson J, 2014, J CRANIOFAC SURG, V25, P1099, DOI 10.1097/SCS.0000000000000659; Xu MB, 2014, J CRANIOFAC SURG, V25, P355, DOI 10.1097/01.scs.0000436673.77122.00; Yang HJ, 2014, J CRANIO MAXILL SURG, V42, pE165, DOI 10.1016/j.jcms.2013.07.015; Yang HJ, 2014, J CRANIO MAXILL SURG, V42, P325, DOI 10.1016/j.jcms.2013.05.021; Yoo Han-su, 2014, Archives of Aesthetic Plastic Surgery, V20, P80	15	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161601	10.1371/journal.pone.0161601	http://dx.doi.org/10.1371/journal.pone.0161601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571364	Green Submitted, Green Published, gold			2022-12-26	WOS:000382876700024
J	Naeni, LM; Craig, H; Berretta, R; Moscato, P				Naeni, Leila M.; Craig, Hugh; Berretta, Regina; Moscato, Pablo			A Novel Clustering Methodology Based on Modularity Optimisation for Detecting Authorship Affinities in Shakespearean Era Plays	PLOS ONE			English	Article							COMMUNITY STRUCTURE; GENETIC ALGORITHM	In this study we propose a novel, unsupervised clustering methodology for analyzing large datasets. This new, efficient methodology converts the general clustering problem into the community detection problem in graph by using the Jensen-Shannon distance, a dissimilarity measure originating in Information Theory. Moreover, we use graph theoretic concepts for the generation and analysis of proximity graphs. Our methodology is based on a newly proposed memetic algorithm (iMA-Net) for discovering clusters of data elements by maximizing the modularity function in proximity graphs of literary works. To test the effectiveness of this general methodology, we apply it to a text corpus dataset, which contains frequencies of approximately 55,114 unique words across all 168 written in the Shakespearean era (16th and 17th centuries), to analyze and detect clusters of similar plays. Experimental results and comparison with state-of-the-art clustering methods demonstrate the remarkable performance of our new method for identifying high quality clusters which reflect the commonalities in the literary style of the plays.	[Naeni, Leila M.; Berretta, Regina; Moscato, Pablo] Univ Newcastle, Prior Res Ctr Bioinformat & Informat Based Med, Newcastle, NSW, Australia; [Naeni, Leila M.; Berretta, Regina; Moscato, Pablo] Univ Newcastle, Fac Engn & Built Environm, Sch Elect Engn & Comp Sci, Newcastle, NSW, Australia; [Naeni, Leila M.] Univ Technol Sydney, Fac Design Architecture & Bldg, Sch Built Environm, Sydney, NSW, Australia; [Craig, Hugh] Univ Newcastle, Sch Humanities & Social Sci, Ctr Literary & Linguist Comp, Newcastle, NSW, Australia	University of Newcastle; University of Newcastle; University of Technology Sydney; University of Newcastle	Naeni, LM (corresponding author), Univ Newcastle, Prior Res Ctr Bioinformat & Informat Based Med, Newcastle, NSW, Australia.; Naeni, LM (corresponding author), Univ Newcastle, Fac Engn & Built Environm, Sch Elect Engn & Comp Sci, Newcastle, NSW, Australia.; Naeni, LM (corresponding author), Univ Technol Sydney, Fac Design Architecture & Bldg, Sch Built Environm, Sydney, NSW, Australia.	Leila.MoslemiNaeni@uon.edu.au		Moscato, Pablo/0000-0003-2570-5966; Moslemi Naeni, Leila/0000-0002-3360-7680; Naeni, Leila/0000-0002-2577-3611; Berretta, Regina/0000-0002-4420-3446	Australian Research Council (ARC) [DP140104183]; Hugh Craig (Discovery Project) [DP120101955]	Australian Research Council (ARC)(Australian Research Council); Hugh Craig (Discovery Project)	The authors acknowledge support from the Australian Research Council (ARC, http://www.arc.gov.au/) to Pablo Moscato (Discovery Project, DP140104183) and Hugh Craig (Discovery Project, DP120101955). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal CC, 2014, CH CRC DATA MIN KNOW, P1; Amini A., 2011, 2011 Eighth International Conference on Fuzzy Systems and Knowledge Discovery (FSKD 2011), P1652, DOI 10.1109/FSKD.2011.6019867; [Anonymous], 1956, STUDIES BIBLIO, V8, P129; [Anonymous], 2014, DETERMINING SHAKESPE; [Anonymous], 2006, MAXIMIZING MODULARIT; Arabie P, 1994, ADV METHODS MARKETIN, P160; Arefin AS, 2015, LECT NOTES ARTIF INT, V8955, P373, DOI 10.1007/978-3-319-14803-8_29; Arefin AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045535; Arefin AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044000; Arthur D, 2007, PROCEEDINGS OF THE EIGHTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1027; Baldi P, 2002, DNA MICROARRAYS GENE; Barber MJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026129; Barthes Roland., 1977, IMAGE MUSIC TEXT; Berkhin P, 2006, GROUPING MULTIDIMENSIONAL DATA: RECENT ADVANCES IN CLUSTERING, P25; Berretta R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012262; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Capp A, 2009, RADIOTHER ONCOL, V90, P400, DOI 10.1016/j.radonc.2008.09.019; CHAN PK, 1994, IEEE T COMPUT AID D, V13, P1088, DOI 10.1109/43.310898; Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Craig H, 2009, EARLY MODERN LIT STU, V15, P1; Craig H, 2010, LIT LINGUIST COMPUT, V25, P37, DOI 10.1093/llc/fqp033; de Vries NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102768; Egan G, 2014, SHAKESPEARE SURV, V67, P18; Eliot S T, 1956, EASSYS ELIZABETHAN D; Elliott WEY, 2004, TENN LAW REV, V72, P323; Endres DM, 2003, IEEE T INFORM THEORY, V49, P1858, DOI 10.1109/TIT.2003.813506; Ester M., 1996, P 2 INT C KNOWLEDGE, P226; Feldmann AE, 2012, LECT NOTES COMPUT SC, V7464, P372, DOI 10.1007/978-3-642-32589-2_34; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Foucault M, 1994, AESTHETICS METHOD EP, P205; Fred ALN, 2003, PROC CVPR IEEE, P128; Gach O, 2012, MEMETIC ALGORITHM CO, P327; Gan G, 2007, ASA SIAM SER STAT AP, V20, P1, DOI 10.1137/1.9780898718348; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gleiser PM, 2003, ADV COMPLEX SYST, V6, P565, DOI 10.1142/S0219525903001067; Gong MG, 2014, IEEE T EVOLUT COMPUT, V18, P82, DOI 10.1109/TEVC.2013.2260862; Gong MG, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.056101; Grosse I, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041905; Han J, 2012, MOR KAUF D, P1; Harbage A. B., 1964, ANN ENGLISH DRAMA 97; Hathaway RJ, 2006, COMPUT STAT DATA AN, V51, P215, DOI 10.1016/j.csda.2006.02.008; Hope Jonathan, 1994, AUTHORSHIP SHAKESPEA; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Inostroza-Ponta M, 2007, LECT NOTES ARTIF INT, V4828, P156; Inostroza-Ponta M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014468; Jacques J, 2014, ADV DATA ANAL CLASSI, V8, P231, DOI 10.1007/s11634-013-0158-y; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Kaufman HA, 1959, PHILOLOGICAL Q, V38, P101; KING B, 1967, J AM STAT ASSOC, V62, P86, DOI 10.2307/2282912; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Li JW, 2013, SOFT COMPUT, V17, P925, DOI 10.1007/s00500-012-0942-1; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Liu DY, 2013, INT J COMPUT INT SYS, V6, P354, DOI 10.1080/18756891.2013.773175; Liu J, 2010, PHYSICA A, V389, P2300, DOI 10.1016/j.physa.2010.01.042; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Lyly J, 2006, WOMAN MOON J LYLY; Ma LJ, 2014, APPL SOFT COMPUT, V19, P121, DOI 10.1016/j.asoc.2014.02.003; Marsden J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066813; Murtagh F, 1985, COMPST LECT; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; Naeni LM, 2014, 2014 IEEE FOURTH INTERNATIONAL CONFERENCE ON BIG DATA AND CLOUD COMPUTING (BDCLOUD), P500, DOI 10.1109/BDCloud.2014.83; Naeni LM, 2015, MA NET RELIABLE MEME, P311; Neri F, 2012, STUD COMPUT INTELL, V379, P1, DOI 10.1007/978-3-642-23247-3; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Ng AY, 2002, ADV NEUR IN, V14, P849; Osterreicher F, 2003, ANN I STAT MATH, V55, P639, DOI 10.1007/BF02517812; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pizzuti C, 2012, IEEE T EVOLUT COMPUT, V16, P418, DOI 10.1109/TEVC.2011.2161090; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; RAO CR, 1985, IEEE T INFORM THEORY, V31, P589, DOI 10.1109/TIT.1985.1057082; Rokach L, 2005, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, P321, DOI 10.1007/0-387-25465-X_15; Schaeffer SE, 2007, COMPUT SCI REV, V1, P27, DOI 10.1016/j.cosrev.2007.05.001; Schuetz P, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.046112; Shang RH, 2013, PHYSICA A, V392, P1215, DOI 10.1016/j.physa.2012.11.003; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shi C, 2012, APPL SOFT COMPUT, V12, P850, DOI 10.1016/j.asoc.2011.10.005; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Sims GE, 2009, P NATL ACAD SCI USA, V106, P2677, DOI 10.1073/pnas.0813249106; Smyth P, 2000, STAT COMPUT, V10, P63, DOI 10.1023/A:1008940618127; Sneath Peter H.A, 1973, NUMERICAL TAXONOMY; Tasgin M, 2007, ARXIV ARXIV07110491, P1; Vickers B., 2002, COUNTERFEITING SHAKE; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wakita K, 2007, 16 INT WORLD WIDE WE, P1275, DOI [10.1145/1242572.1242805, DOI 10.1145/1242572.1242805]; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Watts DJ, 2007, NATURE, V445, P489, DOI 10.1038/445489a; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752	93	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0157988	10.1371/journal.pone.0157988	http://dx.doi.org/10.1371/journal.pone.0157988			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DV4DZ	27571416	Green Submitted, gold, Green Published			2022-12-26	WOS:000382876700002
J	Takacs-Vesbach, C; King, K; Van Horn, D; Larkin, K; Neiman, M				Takacs-Vesbach, Cristina; King, Kayla; Van Horn, David; Larkin, Katelyn; Neiman, Maurine			Distinct Bacterial Microbiomes in Sexual and Asexual Potamopyrgus antipodarum, a New Zealand Freshwater Snail	PLOS ONE			English	Article							GUT MICROBIOTA; DIVERSITY; PARASITES; PARTHENOGENESIS; MICROORGANISMS; ECOLOGY; PLOIDY	Different reproductive strategies and the transition to asexuality can be associated with microbial symbionts. Whether such a link exists within mollusks has never been evaluated. We took the first steps towards addressing this possibility by performing pyrosequencing of bacterial 16S rRNA genes associated with Potamopyrgus antipodarum, a New Zealand freshwater snail. A diverse set of 60 tissue collections from P. antipodarum that were genetically and geographically distinct and either obligately sexual or asexual were included, which allowed us to evaluate whether reproductive mode was associated with a particular bacterial community. 2624 unique operational taxonomic units (OTU, 97% DNA similarity) were detected, which were distributed across similar to 30 phyla. While alpha diversity metrics varied little among individual samples, significant differences in bacterial community composition and structure were detected between sexual and asexual snails, as well as among snails from different lakes and genetic backgrounds. The mean dissimilarity of the bacterial communities between the sexual and asexual P. antipodarum was 90%, largely driven by the presence of Rickettsiales in sexual snails and Rhodobacter in asexual snails. Our study suggests that there might be a link between reproductive mode and the bacterial microbiome of P. antipodarum, though a causal connection requires additional study.	[Takacs-Vesbach, Cristina; Van Horn, David] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [King, Kayla] Univ Oxford, Dept Zool, Oxford, England; [Larkin, Katelyn; Neiman, Maurine] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of New Mexico; University of Oxford; University of Iowa	Takacs-Vesbach, C (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	cvesbach@unm.edu		King, Kayla/0000-0003-1393-9220	NSF-MCB [1122176]; Iowa Center for Research by Undergraduates; Direct For Biological Sciences [1122176] Funding Source: National Science Foundation	NSF-MCB(National Science Foundation (NSF)); Iowa Center for Research by Undergraduates; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NSF-MCB grant 1122176 and the Iowa Center for Research by Undergraduates.; This work was supported by NSF-MCB grant 1122176 and the Iowa Center for Research by Undergraduates. The authors have no conflict of interests to state. We thank several anonymous reviewers for helpful feedback on earlier versions of the manuscript.	Alexander AD, 2006, MAMM GENOME, V17, P1093, DOI 10.1007/s00335-006-0063-1; Althoff K, 1998, MAR BIOL, V130, P529, DOI 10.1007/s002270050273; Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Azad AF, 1998, EMERG INFECT DIS, V4, P179, DOI 10.3201/eid0402.980205; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Braig HR, 2002, REPROD BIOL INVERTEB, VXI; BREEUWER JAJ, 1990, NATURE, V346, P558, DOI 10.1038/346558a0; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dillon RJ, 2005, ECOL LETT, V8, P1291, DOI 10.1111/j.1461-0248.2005.00828.x; Dillon RT., 2000, ECOLOGY FRESHWATER M, DOI [10.1017/CBO9780511542008, DOI 10.1017/CBO9780511542008]; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; DYBDAHL MF, 1995, P ROY SOC B-BIOL SCI, V260, P99, DOI 10.1098/rspb.1995.0065; Dybdahl MF, 1998, EVOLUTION, V52, P1057, DOI [10.1111/j.1558-5646.1998.tb01833.x, 10.2307/2411236]; Dykova I, 2003, FOLIA PARASIT, V50, P161, DOI 10.14411/fp.2003.030; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engelstadter J, 2009, AM NAT, V173, pE159, DOI 10.1086/597375; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Frost CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095122; Huigens ME, 2003, CONT T ENT, P247; Jokela J, 1995, EVOLUTION, V49, P1268, DOI 10.1111/j.1558-5646.1995.tb04453.x; Jokela J, 2009, AM NAT, V174, pS43, DOI 10.1086/599080; Kikuchi Y, 2002, APPL ENVIRON MICROB, V68, P999, DOI 10.1128/AEM.68.2.999-1004.2002; King KC, 2012, BIOL LETTERS, V8, P598, DOI 10.1098/rsbl.2011.1152; King KC, 2009, CURR BIOL, V19, P1438, DOI 10.1016/j.cub.2009.06.062; Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Koivisto RKK, 2003, BIOL J LINN SOC, V79, P43, DOI 10.1046/j.1095-8312.2003.00185.x; Krist AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085845; Leach IM, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P347, DOI 10.1007/978-90-481-2770-2_17; Li YY, 2014, SYMBIOSIS, V62, P1, DOI 10.1007/s13199-014-0267-1; Lively CM, 2004, AM NAT, V164, pS6, DOI 10.1086/424605; LIVELY CM, 1987, NATURE, V328, P519, DOI 10.1038/328519a0; Lively CM, 2002, EVOL ECOL RES, V4, P219; Lize A, 2014, ISME J, V8, P469, DOI 10.1038/ismej.2013.157; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Matsuura K, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P255, DOI 10.1007/978-90-481-3977-4_10; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Neiman M, 2004, MOL ECOL, V13, P3085, DOI 10.1111/j.1365-294X.2004.02292.x; Neiman M, 2012, HEREDITY, V109, P57, DOI 10.1038/hdy.2012.13; Neiman M, 2011, EVOLUTION, V65, P3202, DOI 10.1111/j.1558-5646.2011.01360.x; Neiman M, 2011, EVOL BIOL, V38, P115, DOI 10.1007/s11692-011-9113-z; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Osnas EE, 2006, J EVOLUTION BIOL, V19, P42, DOI 10.1111/j.1420-9101.2005.00994.x; Paczesniak D, 2013, MOL ECOL, V22, P4695, DOI 10.1111/mec.12422; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Qi WH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-172; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Somerfield PJ, 2002, J ANIM ECOL, V71, P581, DOI 10.1046/j.1365-2656.2002.00624.x; Vandekerckhove TTM, 2000, INT J SYST EVOL MICR, V50, P2197, DOI 10.1099/00207713-50-6-2197; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Zchori-Fein E, 1998, CURR MICROBIOL, V36, P1, DOI 10.1007/s002849900270	61	13	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161050	10.1371/journal.pone.0161050	http://dx.doi.org/10.1371/journal.pone.0161050			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27563725	Green Published, gold, Green Submitted			2022-12-26	WOS:000382496300006
J	Takada, N; Omodaka, K; Kikawa, T; Takagi, A; Matsumoto, A; Yokoyama, Y; Shiga, Y; Maruyama, K; Takahashi, H; Akiba, M; Nakazawa, T				Takada, Naoko; Omodaka, Kazuko; Kikawa, Tsutomu; Takagi, Airi; Matsumoto, Akiko; Yokoyama, Yu; Shiga, Yukihiro; Maruyama, Kazuichi; Takahashi, Hidetoshi; Akiba, Masahiro; Nakazawa, Toru			OCT-Based Quantification and Classification of Optic Disc Structure in Glaucoma Patients	PLOS ONE			English	Article							NERVE-FIBER LAYER; COHERENCE TOMOGRAPHY; VISUAL-FIELD; BLOOD-FLOW; HEAD; PARAMETERS; EYES; REPRODUCIBILITY; APPEARANCES; PROGRESSION	Purpose To objectively classify the optic discs of open-angle glaucoma (OAG) patients into Nicolela's four disc types, i.e., focal ischemic (FI), myopic (MY), senile sclerotic (SS), and generalized enlargement (GE), with swept-source optical coherence tomography (SS-OCT). Methods This study enrolled 113 eyes of 113 OAG patients (mean age: 62.5 +/- 12.6; Humphrey field analyzer-measured mean deviation: -9.4 +/- 7.3 dB). Newly developed software was used to quantify a total of 20 optic disc parameters in SS-OCT (DRI OCT-1, TOPCON) images of the optic disc. The most suitable reference plane (RP) above the plane of Bruch's membrane opening was determined by comparing, at various RP heights, the SS-OCT-measured rim parameters and spectral-domain OCT-measured circumpapillary retinal nerve fiber layer thickness (cpRNFLT), with Pearson's correlation analysis. To obtain a discriminant formula for disc type classification, a training group of 72 eyes of 72 OAG patients and a validation group of 60 eyes of 60 OAG patients were set up. Results Correlation with cpRNFLT differed with disc type and RP height, but overall, a height of 120 mu m minimized the influence of disc type. Six parameters were most significant for disc type discrimination: disc angle (horizontal), average cup depth, cup/disc ratio, rim-decentering ratio, average rim/disc ratio (upper and lower nasal). Classifying the validation group with these parameters returned an identification rate of 80.0% and a Cohen's Kappa of 0.73. Conclusion Our new, objective SS-OCT-based method enabled us to classify glaucomatous optic discs with high reproducibility and accuracy.	[Takada, Naoko; Omodaka, Kazuko; Yokoyama, Yu; Shiga, Yukihiro; Maruyama, Kazuichi; Takahashi, Hidetoshi; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan; [Kikawa, Tsutomu; Matsumoto, Akiko; Akiba, Masahiro] Topcon Corp, Tokyo, Japan; [Takagi, Airi] Tohoku Univ, Grad Sch Med, Div Biostat, Sendai, Miyagi, Japan; [Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Ophthalmol, Sendai, Miyagi, Japan; [Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi, Japan; [Omodaka, Kazuko; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalm Imaging & Informat Analyt, Sendai, Miyagi, Japan	Tohoku University; Topcon Corporation; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Ophthalmol, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Ophthalm Imaging & Informat Analyt, Sendai, Miyagi, Japan.	ntoru@oph.med.tohoku.ac.jp	Maruyama, Kazuichi/GRX-8129-2022	Maruyama, Kazuichi/0000-0001-6283-5466	JST grant from JSPS KAKENHI [26293372, 26670751]; JST Center for Revitalization Promotion	JST grant from JSPS KAKENHI; JST Center for Revitalization Promotion	Topcon Corporation provided support in the form of salaries for authors TK, AM, and MA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This paper was supported in part by a JST grant from JSPS KAKENHI Grants-in-Aid for Scientific Research (B) (T.N. 26293372) and for Exploratory Research (T.N. 26670751), and by the JST Center for Revitalization Promotion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chauhan BC, 2013, OPHTHALMOLOGY, V120, P535, DOI 10.1016/j.ophtha.2012.09.055; Chiba N, 2011, CLIN OPHTHALMOL, V5, P1549, DOI 10.2147/OPTH.S22097; Da Pozzo S, 2009, CLIN EXP OPHTHALMOL, V37, P68, DOI 10.1111/j.1442-9071.2008.01891.x; Guedes V, 2003, OPHTHALMOLOGY, V110, P177, DOI 10.1016/S0161-6420(02)01564-6; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Jeong JH, 2014, ACTA OPHTHALMOL, V92, pE185, DOI 10.1111/aos.12277; Lee EJ, 2011, AM J OPHTHALMOL, V152, P87, DOI 10.1016/j.ajo.2011.01.024; Leung CKS, 2005, INVEST OPHTH VIS SCI, V46, P891, DOI 10.1167/iovs.04-1107; Mansouri K, 2011, EYE, V25, P269, DOI 10.1038/eye.2010.202; Mwanza JC, 2010, INVEST OPHTH VIS SCI, V51, P5724, DOI 10.1167/iovs.10-5222; Nadler Z, 2013, BIOMED OPT EXPRESS, V4, P2596, DOI 10.1364/BOE.4.002596; Naithani P, 2007, INVEST OPHTH VIS SCI, V48, P3138, DOI 10.1167/iovs.06-1407; Nakazawa T, 2012, J GLAUCOMA, V21, P426, DOI 10.1097/IJG.0b013e3182182897; Nicolela MT, 2003, OPHTHALMOLOGY, V110, P2178, DOI 10.1016/S0161-6420(03)00801-7; Nicolela MT, 2001, AM J OPHTHALMOL, V132, P836, DOI 10.1016/S0002-9394(01)01254-5; Nicolela MT, 1996, OPHTHALMOLOGY, V103, P640, DOI 10.1016/S0161-6420(96)30640-4; Nitta K, 2011, J GLAUCOMA, V20, P189, DOI 10.1097/IJG.0b013e3181e0799c; Omodaka K, 2015, JPN J OPHTHALMOL; Omodaka K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122347; Omodaka K, 2010, CLIN OPHTHALMOL, V4, P765; Orgul S, 1996, INVEST OPHTH VIS SCI, V37, P1860; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Sawada Y, 2015, INVEST OPHTH VIS SCI, V56, P5777, DOI 10.1167/iovs.14-15942; Shin HY, 2014, OPHTHALMOLOGY, V121, P1990, DOI 10.1016/j.ophtha.2014.04.030; Sugiyama T, 2009, ARCH OPHTHALMOL-CHIC, V127, P454, DOI 10.1001/archophthalmol.2008.606; Takada N, 2015, CLIN EXP OPHTHALMOL, V43, P291, DOI 10.1111/ceo.12429; Tan JCH, 2003, INVEST OPHTH VIS SCI, V44, P1132, DOI 10.1167/iovs.02-0039; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Yokoyama Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099138; Zangwill L M, 2000, Semin Ophthalmol, V15, P206, DOI 10.3109/08820530009037872	30	15	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0160226	10.1371/journal.pone.0160226	http://dx.doi.org/10.1371/journal.pone.0160226			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27557112	Green Submitted, gold, Green Published			2022-12-26	WOS:000382258100009
J	Subramanian, C; Yun, MK; Yao, JW; Sharma, LK; Lee, RE; White, SW; Jackowski, S; Rock, CO				Subramanian, Chitra; Yun, Mi-Kyung; Yao, Jiangwei; Sharma, Lalit Kumar; Lee, Richard E.; White, Stephen W.; Jackowski, Suzanne; Rock, Charles O.			Allosteric Regulation of Mammalian Pantothenate Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl coenzyme A (acetyl-CoA); allosteric regulation; coenzyme A (CoA); cooperativity; enzyme kinetics; vitamin; X-ray crystallography	COENZYME-A; CONFORMATIONAL DYNAMICS; FEEDBACK-REGULATION; PROTEIN; MODEL; INHIBITION; DEFICIENCY; SOFTWARE; REVEALS; DOMAIN	Pantothenate kinase is the master regulator of CoA biosynthesis and is feedback-inhibited by acetyl-CoA. Comparison of the human PANK3acetyl-CoA complex to the structures of PANK3 in four catalytically relevant complexes, 5'-adenylyl-beta,gamma-imidodiphosphate (AMPPNP)center dot Mg2+, AMPPNP center dot Mg(2+)pantothenate, ADP center dot Mg(2+)phosphopantothenate, and AMP phosphoramidate (AMPPN)center dot Mg2+, revealed a large conformational change in the dimeric enzyme. The amino-terminal nucleotide binding domain rotates to close the active site, and this allows the P-loop to engage ATP and facilitates required substrate/product interactions at the active site. Biochemical analyses showed that the transition between the inactive and active conformations, as assessed by the binding of either ATP center dot Mg2+ or acyl-CoA to PANK3, is highly cooperative indicating that both protomers move in concert. PANK3(G19V) cannot bind ATP, and biochemical analyses of an engineered PANK3/PANK3(G19V) heterodimer confirmed that the two active sites are functionally coupled. The communication between the two protomers is mediated by an -helix that interacts with the ATP-binding site at its amino terminus and with the substrate/inhibitor-binding site of the opposite protomer at its carboxyl terminus. The two alpha-helices within the dimer together with the bound ligands create a ring that stabilizes the assembly in either the active closed conformation or the inactive open conformation. Thus, both active sites of the dimeric mammalian pantothenate kinases coordinately switch between the on and off states in response to intracellular concentrations of ATP and its key negative regulators, acetyl(acyl)-CoA.	[Subramanian, Chitra; Yao, Jiangwei; Jackowski, Suzanne; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Yun, Mi-Kyung; White, Stephen W.] St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA; [Sharma, Lalit Kumar; Lee, Richard E.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	charles.rock@stjude.org	Jackowski, Suzanne/N-8168-2018; Lee, Richard/J-4997-2013; Lee, Richard/AAX-3996-2021; Subramanian, Chitra/N-9210-2018; Chitra, S/GPX-8113-2022; White, Stephen W/N-8164-2018	Jackowski, Suzanne/0000-0002-6855-1429; Lee, Richard/0000-0002-2397-0443; Lee, Richard/0000-0002-2397-0443; Subramanian, Chitra/0000-0003-1101-5307; 	National Institutes of Health [GM034496, GM062896]; Cancer Center Support Grant [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034496, R01GM034496, R01GM062896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or in part by National Institutes of Health Grants GM034496 (to C. O. R.), GM062896 (to S. J.), and Cancer Center Support Grant CA21765 and the American Lebanese Syrian Associated Charities. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Alfonso-Pecchio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049509; BARRIO JR, 1972, P NATL ACAD SCI USA, V69, P2039, DOI 10.1073/pnas.69.8.2039; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; Cheek S, 2002, J MOL BIOL, V320, P855, DOI 10.1016/S0022-2836(02)00538-7; Dansie LE, 2014, BIOCHEM SOC T, V42, P1033, DOI 10.1042/BST20140096; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garcia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040871; Guo JJ, 2016, CHEM REV, V116, P6503, DOI 10.1021/acs.chemrev.5b00590; Hong BS, 2007, J BIOL CHEM, V282, P27984, DOI 10.1074/jbc.M701915200; Hong BS, 2006, STRUCTURE, V14, P1251, DOI 10.1016/j.str.2006.06.008; HSU KHL, 1975, P NATL ACAD SCI USA, V72, P4729, DOI 10.1073/pnas.72.12.4729; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; Kuo YM, 2005, HUM MOL GENET, V14, P49, DOI 10.1093/hmg/ddi005; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Leonardi R, 2005, J BIOL CHEM, V280, P3314, DOI 10.1074/jbc.M411608200; Leonardi R, 2007, FEBS LETT, V581, P4639, DOI 10.1016/j.febslet.2007.08.056; Leonardi R, 2007, P NATL ACAD SCI USA, V104, P1494, DOI 10.1073/pnas.0607621104; Leonardi R, 2014, DIABETOLOGIA, V57, P1466, DOI 10.1007/s00125-014-3245-5; Leonardi R, 2010, CHEM BIOL, V17, P892, DOI 10.1016/j.chembiol.2010.06.006; Leonardi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011107; Liu J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004966; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Mottaghi K., 2013, THESIS; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papaleo E, 2016, CHEM REV, V116, P6391, DOI 10.1021/acs.chemrev.5b00623; Rock CO, 2000, J BIOL CHEM, V275, P1377, DOI 10.1074/jbc.275.2.1377; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; SECRIST JA, 1972, SCIENCE, V177, P279, DOI 10.1126/science.177.4045.279; Sharma LK, 2015, J MED CHEM, V58, P1563, DOI 10.1021/jm501585q; Virga KG, 2006, BIOORGAN MED CHEM, V14, P1007, DOI 10.1016/j.bmc.2005.09.021; Zano SP, 2015, MOL GENET METAB, V116, P281, DOI 10.1016/j.ymgme.2015.10.011; Zhang YM, 2005, J BIOL CHEM, V280, P32594, DOI 10.1074/jbc.M506275200; Zhang YM, 2004, J BIOL CHEM, V279, P50969, DOI 10.1074/jbc.M409607200; Zhang YM, 2007, CHEM BIOL, V14, P291, DOI 10.1016/j.chembiol.2007.01.013; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	40	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22302	22314		10.1074/jbc.M116.748061	http://dx.doi.org/10.1074/jbc.M116.748061			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27555321	Green Published, hybrid			2022-12-26	WOS:000386332600040
J	Suzuki, H; Matsuoka, M				Suzuki, Hiroaki; Matsuoka, Masaaki			The Lysosomal Trafficking Transmembrane Protein 106B Is Linked to Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyotrophic lateral sclerosis (ALS) (Lou Gehrig's disease); cell death; lysosome; neurodegenerative disease; TAR DNA-binding protein 43 (TDP-43) (TARDBP); Frontotemporal lobar degeneration; Transmembrane protein 106B	FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; RISK-FACTOR; TMEM106B; DEMENTIA; PROGRANULIN; TDP-43; STRESS; ALS; NEUROPATHOLOGY	A common genetic variation in the transmembrane protein 106B (TMEM106B) gene has been suggested to be a risk factor for frontotemporal lobar degeneration (FTLD) with inclusions of transactive response DNA-binding protein-43 (TDP-43) (FTLD-TDP), the most common pathological subtype in FTLD. Furthermore, previous studies have shown that TMEM106B levels are up-regulated in the brains of FTLD-TDP patients, although the significance of this finding remains unknown. In this study, we show that the overexpression of TMEM106B and its N-terminal fragments induces cell death, enhances oxidative stress-induced cytotoxicity, and causes the cleavage of TDP-43, which represents TDP-43 pathology, using cell-based models. TMEM106B-induced death is mediated by the caspase-dependent mitochondrial cell death pathways and possibly by the lysosomal cell death pathway. These findings suggest that the up-regulation of TMEM106B may increase the risk of FTLD by directly causing neurotoxicity and a pathological phenotype linked to FTLD-TDP.	[Suzuki, Hiroaki; Matsuoka, Masaaki] Tokyo Med Univ, Dept Pharmacol, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan; [Matsuoka, Masaaki] Tokyo Med Univ, Dept Dermatol Neurosci, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan	Tokyo Medical University; Tokyo Medical University	Matsuoka, M (corresponding author), Tokyo Med Univ, Dept Pharmacol, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan.	sakimatu@tokyo-med.ac.jp			Japan Society for the Promotion of Science [15H04689, 25460342]; Japan ALS association (JALSA); Naito Foundation Natural Science Scholarship; Akaeda Medical Research Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan ALS association (JALSA); Naito Foundation Natural Science Scholarship; Akaeda Medical Research Foundation	This work was supported in part by Grant-in-Aid for Scientific Research (B) 15H04689 (to M. M.) and Grant-in-Aid for Scientific Research (C) 25460342 (to H. S.) from the Japan Society for the Promotion of Science, by a grant from the Japan ALS association (JALSA) (to H. S.), by a Naito Foundation Natural Science Scholarship (to M. M.), and by a research grant from the Akaeda Medical Research Foundation (to M. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Aits S, 2013, J CELL SCI, V126, P1905, DOI 10.1242/jcs.091181; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Brady OA, 2014, J BIOL CHEM, V289, P19670, DOI 10.1074/jbc.M113.515700; Brady OA, 2013, HUM MOL GENET, V22, P685, DOI 10.1093/hmg/dds475; Busch J. I., 2016, HUM MOL GENET, DOI [10.1093/hmg/ddw127, DOI 10.1093/HMG/DDW127]; Chen-Plotkin AS, 2012, J NEUROSCI, V32, P11213, DOI 10.1523/JNEUROSCI.0521-12.2012; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P581, DOI 10.1001/archneurol.2010.350; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Cruts M, 2013, TRENDS NEUROSCI, V36, P450, DOI 10.1016/j.tins.2013.04.010; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Finch N, 2011, NEUROLOGY, V76, P467, DOI 10.1212/WNL.0b013e31820a0e3b; Gallagher MD, 2014, ACTA NEUROPATHOL, V127, P407, DOI 10.1007/s00401-013-1239-x; Gotzl JK, 2014, ACTA NEUROPATHOL, V127, P845, DOI 10.1007/s00401-014-1262-6; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Ju JS, 2010, HUM MOL GENET, V19, pR38, DOI 10.1093/hmg/ddq157; Lang CM, 2012, J BIOL CHEM, V287, P19355, DOI 10.1074/jbc.M112.365098; Lattante S, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.06.023; Li Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7183; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nicholson AM, 2013, J NEUROCHEM, V126, P781, DOI 10.1111/jnc.12329; Peters OM, 2015, J CLIN INVEST, V125, P1767, DOI 10.1172/JCI71601; Pottier C, 2016, J NEUROCHEM, V138, P32, DOI 10.1111/jnc.13622; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Schwenk BM, 2014, EMBO J, V33, P450, DOI 10.1002/embj.201385857; Sieben A, 2012, ACTA NEUROPATHOL, V124, P353, DOI 10.1007/s00401-012-1029-x; Stagi M, 2014, MOL CELL NEUROSCI, V61, P226, DOI 10.1016/j.mcn.2014.07.006; Suzuki H, 2015, HUM MOL GENET, V24, P1513, DOI 10.1093/hmg/ddu563; Suzuki H, 2011, J BIOL CHEM, V286, P13171, DOI 10.1074/jbc.M110.197483; Suzuki H, 2009, J NEUROCHEM, V108, P973, DOI [10.1111/j.1471-4159.2008.05857.x, 10.1111/j.0022-3042.2008.05857.x]; Tanaka Y, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0078-x; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; van Blitterswijk M, 2014, ACTA NEUROPATHOL, V127, P397, DOI 10.1007/s00401-013-1240-4; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; van der Zee J, 2011, BRAIN, V134, P808, DOI 10.1093/brain/awr007; Vass R, 2011, ACTA NEUROPATHOL, V121, P373, DOI 10.1007/s00401-010-0782-y; Wils H, 2012, J PATHOL, V228, P67, DOI 10.1002/path.4043	40	8	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21448	21460		10.1074/jbc.M116.737171	http://dx.doi.org/10.1074/jbc.M116.737171			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27563066	hybrid, Green Published			2022-12-26	WOS:000385999200013
J	Ji, MD; Lu, YL; Zhao, CH; Gao, WX; He, FX; Zhang, J; Zhao, D; Qiu, W; Wang, YW				Ji, Mingde; Lu, Yanlai; Zhao, Chenhui; Gao, Wenxing; He, Fengxia; Zhang, Jing; Zhao, Dan; Qiu, Wen; Wang, Yingwei			C5a Induces the Synthesis of IL-6 and TNF-alpha in Rat Glomerular Mesangial Cells through MAPK Signaling Pathways	PLOS ONE			English	Article							SUBLYTIC C5B-9 COMPLEXES; IGA NEPHROPATHY; THY-1 NEPHRITIS; EPITHELIAL-CELLS; OXIDATIVE STRESS; RENAL INJURY; APOPTOSIS; ACTIVATION; RECEPTOR; GLOMERULONEPHRITIS	Inflammatory response has been reported to contribute to the renal lesions in rat Thy-1 nephritis (Thy-1N) as an animal model of human mesangioproliferative glomerulonephritis (MsPGN). Besides C5b-9 complex, C5a is also a potent pro-inflammatory mediator and correlated to severity of various nephritic diseases. However, the role of C5a in mediating pro-inflammatory cytokine production in rats with Thy-1N is poorly defined. In the present studies, the levels of C5a, interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) were first determined in the renal tissues of rats with Thy-1N. Then, the expression of IL-6 and TNF-alpha was detected in rat glomerular mesangial cells (GMC) stimulated with our recombinant rat C5a in vitro. Subsequently, the activation of mitogen-activated protein kinase (MAPK) signaling pathways (p38 MAPK, ERK1/2 and JNK) and their roles in the regulation of IL-6 and TNF-alpha production were examined in the GMC induced by C5a. The results showed that the levels of C5a, IL-6 and TNF-alpha were markedly increased in the renal tissues of Thy-1N rats. Rat C5a stimulation in vitro could up-regulate the expression of IL-6 and TNF-alpha in rat GMC, and the activation of MAPK signaling pathways was involved in the induction of IL-6 and TNF-alpha. Mechanically, p38 MAPK activation promoted IL-6 production, while either ERK1/2 or JNK activation promoted TNF-alpha production in the GMC with exposure to C5a. Taken together, these data implicate that C5a induces the synthesis of IL-6 and TNF-a in rat GMC through the activation of MAPK signaling pathways.	[Ji, Mingde; Lu, Yanlai; He, Fengxia; Zhang, Jing; Zhao, Dan; Qiu, Wen; Wang, Yingwei] Nanjing Med Univ, Dept Immunol, Nanjing 211166, Jiangsu, Peoples R China; [Ji, Mingde] Nanjing Univ Tradit Chinese Med, Dept Lab Med, Affiliated Hosp, Nanjing 210029, Jiangsu, Peoples R China; [Zhao, Chenhui] Nanjing Med Univ, Dept Med, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China; [Gao, Wenxing] Nanjing Med Univ, Basic Med Sci Basic Med Coll, Nanjing 211166, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing University of Chinese Medicine; Nanjing Medical University; Nanjing Medical University	Qiu, W (corresponding author), Nanjing Med Univ, Dept Immunol, Nanjing 211166, Jiangsu, Peoples R China.	qiuwen@njmu.edu.cn		He, Fengxia/0000-0002-1695-3127	National Natural Science Foundations of China [81273333, 81471626, 31470853]; Natural Science Foundations of Jiangsu Province in China [BK20131386]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; Excellent Young or Middle-aged Teachers Project of Nanjing Medical University	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundations of Jiangsu Province in China; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; Excellent Young or Middle-aged Teachers Project of Nanjing Medical University	This work was supported by National Natural Science Foundations of China (81273333, 81471626, https://isisn.nsfc.gov.cn/egrantweb/), YWW; National Natural Science Foundations of China (31470853, https://isisn.nsfc.gov.cn/egrantweb/), WQ; Natural Science Foundations of Jiangsu Province in China (BK20131386, http://www.jstd.gov.cn/), WQ; the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; and Excellent Young or Middle-aged Teachers Project of Nanjing Medical University, WQ.; The study was supported by the grants from National Natural Science Foundations of China (81273333, 81471626 and 31470853) and the grant from Natural Science Foundations of Jiangsu Province in China (BK20131386). The study was also supported by the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions and Excellent Young or Middle-aged Teachers Project of Nanjing Medical University.	Aizawa K, 2014, J NEPHROL, V27, P395, DOI 10.1007/s40620-014-0099-3; Alexander JJ, 2012, KIDNEY INT, V82, P961, DOI 10.1038/ki.2012.249; An LL, 2014, EUR J IMMUNOL, V44, P3669, DOI 10.1002/eji.201444560; Anower AKMM, 2012, EUR J PHARMACOL, V688, P76, DOI 10.1016/j.ejphar.2012.05.007; Bao LH, 2005, EUR J IMMUNOL, V35, P2496, DOI 10.1002/eji.200526327; Bao R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098636; Cao Q, 2012, AM J PHYSIOL-CELL PH, V302, pC1731, DOI 10.1152/ajpcell.00213.2011; Chihara Y, 2006, CLIN NEPHROL, V65, P385; Choi SJ, 2015, INT J NANOMED, V10, P3217, DOI 10.2147/IJN.S82061; Cina DP, 2011, AM J PHYSIOL-RENAL, V300, pF488, DOI 10.1152/ajprenal.00214.2010; Clemente MG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/697238; Cove-Smith A, 2013, AM J PATHOL, V183, P391, DOI 10.1016/j.ajpath.2013.04.029; CUI LX, 1994, PROTEIN SCI, V3, P1169, DOI 10.1002/pro.5560030803; Fehr S, 2015, CELL PHYSIOL BIOCHEM, V36, P2237, DOI 10.1159/000430188; Guo RF, 2004, FASEB J, V18, pA560; Hao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038317; HASLETT C, 1985, AM J PATHOL, V119, P101; Huang FX, 2001, J CLIN LAB ANAL, V15, P30, DOI 10.1002/1098-2825(2001)15:1<30::AID-JCLA6>3.0.CO;2-X; Jain U, 2015, J IMMUNOL, V194, P3414, DOI 10.4049/jimmunol.1401814; Liang Y, 2015, CELL PHYSIOL BIOCHEM, V36, P1793, DOI 10.1159/000430151; Liu LS, 2012, J BIOL CHEM, V287, P16410, DOI 10.1074/jbc.M111.319566; Liu XL, 2011, CELL PHYSIOL BIOCHEM, V27, P391, DOI 10.1159/000327966; Ma R, 2013, J CLIN IMMUNOL, V33, P172, DOI 10.1007/s10875-012-9772-2; Maeda Y, 2015, ONCOL REP, V33, P1844, DOI 10.3892/or.2015.3800; Mima A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017929; Nagai K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066759; Qin DP, 2013, J NEPHROL, V26, P199, DOI 10.5301/jn.5000125; Qiu W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.153; Qiu W, 2012, J PATHOL, V226, P619, DOI 10.1002/path.3011; Qiu W, 2009, EUR J IMMUNOL, V39, P3251, DOI 10.1002/eji.200939264; Rampino T, 2011, CLIN SCI, V120, P25, DOI 10.1042/CS20100147; Riedemann NC, 2003, J IMMUNOL, V170, P503, DOI 10.4049/jimmunol.170.1.503; Sadakane C, 2011, CLIN EXP NEPHROL, V15, P14, DOI 10.1007/s10157-010-0342-8; Schaeffer V, 2007, SHOCK, V27, P623, DOI 10.1097/SHK.0b013e31802fa0bd; Shimizu A, 2000, NEPHRON, V86, P152, DOI 10.1159/000045734; Shushakova N, 2002, J CLIN INVEST, V110, P1823, DOI 10.1172/JCI200216577; Tamouza H, 2012, KIDNEY INT, V82, P1284, DOI 10.1038/ki.2012.192; Tumlin JA, 2007, CLIN J AM SOC NEPHRO, V2, P1054, DOI 10.2215/CJN.04351206; Vaivoda R, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/250456; Wang YH, 2016, CLIN EXP MED, V16, P183, DOI 10.1007/s10238-015-0351-8; Xiao H, 2014, J AM SOC NEPHROL, V25, P225, DOI 10.1681/ASN.2013020143; Xu JH, 2006, CELL TISSUE RES, V326, P159, DOI 10.1007/s00441-006-0214-4; Yang JB, 2015, KOREAN J PARASITOL, V53, P371, DOI 10.3347/kjp.2015.53.4.371; Zhang JX, 2016, J APPL TOXICOL, V36, P271, DOI 10.1002/jat.3179; Zhang J, 2014, FASEB J, V28, P1511, DOI 10.1096/fj.13-242693; Zhao Y, 2014, MOL MED REP, V10, P45, DOI 10.3892/mmr.2014.2176; Zhu Y, 2015, MOL VIS, V21, P1122	47	17	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161867	10.1371/journal.pone.0161867	http://dx.doi.org/10.1371/journal.pone.0161867			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583546	gold, Green Submitted, Green Published			2022-12-26	WOS:000382855600068
J	Lee, MTG; Lee, CC; Wang, HM; Chou, TH; Wu, MC; Hsueh, KL; Chen, SC				Lee, Meng-Tse Gabriel; Lee, Chien-Chang; Wang, Hsuan-Mao; Chou, Tzung-Hsin; Wu, Meng-Che; Hsueh, Kuang-Lung; Chen, Shyr-Chyr			Hypothermia Increases Tissue Plasminogen Activator Expression and Decreases Post-Operative Intra-Abdominal Adhesion	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; PERITONEAL ADHESIONS; FIBRINOLYTIC-ACTIVITY; MODERATE HYPOTHERMIA; ABDOMINAL-SURGERY; PELVIC-SURGERY; PREVENTION; METALLOPROTEINASES; PATHOPHYSIOLOGY; TEMPERATURE	Background Therapeutic hypothermia during operation decreases postoperative intra-abdominal adhesion formation. We sought to determine the most appropriate duration of hypothermia, and whether hypothermia affects the expression of tissue plasminogen activator (tPA). Methods 80 male BALB/c mice weighing 25-30 g are randomized into one of five groups: adhesion model with infusion of 15 degrees C saline for 15 minutes (A); 30 minutes (B); 45 minute (C); adhesion model without infusion of cold saline (D); and sham operation without infusion of cold saline (E). Adhesion scores and tPA levels in the peritoneum fluid levels were analyzed on postoperative days 1, 7, and 14. Results On day 14, the cold saline infusion groups (A, B, and C) had lower adhesion scores than the without infusion of cold saline group (D). However, only group B (cold saline infusion for 30 minutes) had a significantly lower adhesion scores than group D. Also, group B was found to have 3.4 fold, 2.3 fold, and 2.2 fold higher levels of tPA than group D on days 1, 7, and 14 respectively. Conclusions Our results suggest that cold saline infusion for 30 minutes was the optimum duration to decrease postoperative intra-abdominal adhesion formation. The decrease in the adhesion formations could be partly due to an increase in the level of tPA.	[Lee, Meng-Tse Gabriel; Lee, Chien-Chang; Wang, Hsuan-Mao; Chou, Tzung-Hsin; Wu, Meng-Che; Chen, Shyr-Chyr] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Lee, Meng-Tse Gabriel; Lee, Chien-Chang; Wang, Hsuan-Mao; Chou, Tzung-Hsin; Wu, Meng-Che; Chen, Shyr-Chyr] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Lee, Chien-Chang] Natl Taiwan Univ Hosp, Dept Emergency Med, Yunlin Branch, Touliu, Taiwan; [Lee, Chien-Chang] Natl Taiwan Univ Hosp, Dept Gen Med, Yunlin Branch, Touliu, Taiwan; [Hsueh, Kuang-Lung] China Med Univ, Res Dept, China Med Univ Hosp, Res Ctr Tumor Med Sci, Taichung, Taiwan; [Hsueh, Kuang-Lung] China Med Univ, Ctr Chinese Med & Acupuncture, Taichung, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Chen, SC (corresponding author), Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan.; Chen, SC (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.	scchen@ntu.edu.tw	Lee, Chien-Chang/HHM-5986-2022; Wang, Hsuan Mao/AAG-3017-2021	WU, MENG-CHE/0000-0002-9584-3486; CHEN, SHYR-CHYR/0000-0002-5858-3013; LEE, CHIEN-CHANG/0000-0002-1243-2463; Lee, Meng-tse/0000-0002-2648-1522	Taiwan National Science Foundation [NSC 101-2314-B-002 -055-MY3]; Taiwan National Ministry of Science and Technology [MOST 104-2314-B-002-028, MOST 104-2811-B-002 -060]	Taiwan National Science Foundation; Taiwan National Ministry of Science and Technology	This work is supported by Taiwan National Science Foundation grant NSC 101-2314-B-002 -055-MY3, and Taiwan National Ministry of Science and Technology grants MOST 104-2314-B-002-028 and MOST 104-2811-B-002 -060. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, Fertil Steril, V55, P700; Arung W, 2011, WORLD J GASTROENTERO, V17, P4545, DOI 10.3748/wjg.v17.i41.4545; Badjatia N, 2004, NEUROCRIT CARE, V1, P201, DOI 10.1385/NCC:1:2:201; Binda MM, 2006, FERTIL STERIL, V86, P166, DOI 10.1016/j.fertnstert.2005.11.079; Binda MM, 2004, HUM REPROD, V19, P2626, DOI 10.1093/humrep/deh495; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Brokelman WJA, 2009, J SURG RES, V151, P89, DOI 10.1016/j.jss.2008.01.005; DIAMOND MP, 1994, FERTIL STERIL, V62, P984; diZerega GS, 1997, EUR J SURG, V163, P10; diZeregal GS, 2001, HUM REPROD UPDATE, V7, P547, DOI 10.1093/humupd/7.6.547; Ellis H, 1997, EUR J SURG, V163, P5; Ellis H, 1999, LANCET, V353, P1476, DOI 10.1016/S0140-6736(98)09337-4; EVANS DM, 1993, AM J SURG, V165, P229, DOI 10.1016/S0002-9610(05)80516-1; Fang CC, 2010, WORLD J SURG, V34, P721, DOI 10.1007/s00268-009-0378-7; GEHLBACH DL, 1994, INT J FERTIL MENOP S, V39, P172; Gonzalez-Ibarra Fernando Pavel, 2011, Front Neurol, V2, P4, DOI 10.3389/fneur.2011.00004; Hellebrekers BWJ, 2011, BRIT J SURG, V98, P1503, DOI 10.1002/bjs.7657; Hellebrekers BWJ, 2000, FERTIL STERIL, V74, P203, DOI 10.1016/S0015-0282(00)00656-7; HERSHLAG A, 1991, CLIN OBSTET GYNECOL, V34, P395, DOI 10.1097/00003081-199106000-00023; HillWest JL, 1995, J SURG RES, V59, P759, DOI 10.1006/jsre.1995.1236; Holmdahl L, 1997, EUR J SURG, V163, P24; Kato A, 2002, AM J PHYSIOL-GASTR L, V282, pG608, DOI 10.1152/ajpgi.00454.2001; Lai HS, 1998, J FORMOS MED ASSOC, V97, P323; Lee JE, 2005, J NEUROSURG, V103, P289, DOI 10.3171/jns.2005.103.2.0289; Liakakos T, 2001, DIGEST SURG, V18, P260, DOI 10.1159/000050149; Lin HF, 2014, AM J SURG, V208, P419, DOI 10.1016/j.amjsurg.2013.10.028; Luijendijk RW, 1996, ANN SURG, V223, P242, DOI 10.1097/00000658-199603000-00003; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MENZIES D, 1990, ANN ROY COLL SURG, V72, P60; MENZIES D, 1989, J ROY SOC MED, V82, P534, DOI 10.1177/014107688908200909; Oncel M, 2001, J SURG RES, V101, P52, DOI 10.1006/jsre.2001.6245; Patel S, 2000, J AM COLL SURGEONS, V191, P650, DOI 10.1016/S1072-7515(00)00736-5; SCOTTCOOMBES D, 1995, BRIT J SURG, V82, P414, DOI 10.1002/bjs.1800820346; ten Broek RPG, 2014, LANCET, V383, P48, DOI 10.1016/S0140-6736(13)61687-6; ten Broek RPG, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5588; THOMPSON JN, 1989, BRIT J SURG, V76, P382, DOI 10.1002/bjs.1800760422; Tjarnstrom J, 1999, EUR J SURG, V165, P834; VIPOND MN, 1990, LANCET, V335, P1120, DOI 10.1016/0140-6736(90)91125-T; VIPOND MN, 1994, ANN ROY COLL SURG, V76, P412; Wagner S, 2003, BRAIN RES, V984, P63, DOI 10.1016/S0006-8993(03)03088-9; Watts DD, 1998, J TRAUMA, V44, P846, DOI 10.1097/00005373-199805000-00017; WEIBEL MA, 1973, AM J SURG, V126, P345, DOI 10.1016/S0002-9610(73)80123-0	42	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0160627	10.1371/journal.pone.0160627	http://dx.doi.org/10.1371/journal.pone.0160627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583464	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600007
J	Reissig, F; Mamat, C; Steinbach, J; Pietzsch, HJ; Freudenberg, R; Navarro-Retamal, C; Caballero, J; Kotzerke, J; Wunderlich, G				Reissig, Falco; Mamat, Constantin; Steinbach, Joerg; Pietzsch, Hans-Juergen; Freudenberg, Robert; Navarro-Retamal, Carlos; Caballero, Julio; Kotzerke, Joerg; Wunderlich, Gerd			Direct and Auger Electron-Induced, Single- and Double-Strand Breaks on Plasmid DNA Caused by Tc-99m-Labeled Pyrene Derivatives and the Effect of Bonding Distance	PLOS ONE			English	Article							IN-VIVO; COMPLEXES; LIGANDS; BINDING; RADIONUCLIDES; BIOMOLECULES; EMITTERS; THERAPY; TC-99M; I-125	It is evident that Tc-99m causes radical-mediated DNA damage due to Auger electrons, which were emitted simultaneously with the known gamma-emission of Tc-99m. We have synthesized a series of new Tc-99m-labeled pyrene derivatives with varied distances between the pyrene moiety and the radionuclide. The pyrene motif is a common DNA intercalator and allowed us to test the influence of the radionuclide distance on damages of the DNA helix. In general, pUC 19 plasmid DNA enables the investigation of the unprotected interactions between the radiotracers and DNA that results in single-strand breaks (SSB) or double-strand breaks (DSB). The resulting DNA fragments were separated by gel electrophoresis and quantified by fluorescent staining. Direct DNA damage and radical-induced indirect DNA damage by radiolysis products of water were evaluated in the presence or absence of the radical scavenger DMSO. We demonstrated that Auger electrons directly induced both SSB and DSB in high efficiency when Tc-99m was tightly bound to the plasmid DNA and this damage could not be completely prevented by DMSO, a free radical scavenger. For the first time, we were able to minimize this effect by increasing the carbon chain lengths between the pyrene moiety and the Tc-99m nuclide. However, a critical distance between the Tc-99m atom and the DNA helix could not be determined due to the significantly lowered DSB generation resulting from the interaction which is dependent on the type of the Tc-99m binding motif. The effect of variable DNA damage caused by the different chain length between the pyrene residue and the Tc-core as well as the possible conformations of the applied Tc-complexes was supplemented with molecular dynamics (MD) calculations. The effectiveness of the DNA-binding Tc-99m-labeled pyrene derivatives was demonstrated by comparison to non-DNA- binding (TcO4-)-Tc-99m, since nearly all DNA damage caused by (TcO4-)-Tc-99m was prevented by incubating with DMSO.	[Reissig, Falco; Freudenberg, Robert; Kotzerke, Joerg; Wunderlich, Gerd] Tech Univ Dresden, Univ Hosp, Fac Med Carl Gustav Carus, Dept Nucl Med, Dresden, Germany; [Mamat, Constantin; Steinbach, Joerg; Pietzsch, Hans-Juergen] Inst Radiopharmaceut Canc Res, Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany; [Navarro-Retamal, Carlos; Caballero, Julio] Univ Talca, Ctr Bioinformat & Simulac Mol, Fac Ingn, 2 Norte 685,Casilla 721, Talca, Chile	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Universidad de Talca	Reissig, F; Wunderlich, G (corresponding author), Tech Univ Dresden, Univ Hosp, Fac Med Carl Gustav Carus, Dept Nucl Med, Dresden, Germany.	Falco.Reissig@uniklinikum-dresden.de; Gerd.Wunderlich@uniklinikum-dresden.de	Mamat, Constantin/V-9398-2017; Caballero, Julio/G-3654-2014; Steinbach, Joerg/B-5940-2015	Mamat, Constantin/0000-0003-1906-3186; Caballero, Julio/0000-0003-0182-1444; Steinbach, Joerg/0000-0002-1708-6440; Navarro-Retamal, Carlos/0000-0001-9581-0206; Reissig, Falco/0000-0002-5203-0776				Alberto R, 1998, J AM CHEM SOC, V120, P7987, DOI 10.1021/ja980745t; Alberto R, 2001, J AM CHEM SOC, V123, P3135, DOI 10.1021/ja003932b; Ardes-Guisot N, 2011, ORG BIOMOL CHEM, V9, P5373, DOI 10.1039/c1ob05119a; Balagurumoorthy P, 2008, RADIAT RES, V170, P70, DOI 10.1667/RR1072.1; Balagurumoorthy P, 2012, INT J RADIAT BIOL, V88, P998, DOI 10.3109/09553002.2012.706360; BLOOMER WD, 1977, NATURE, V265, P620, DOI 10.1038/265620a0; Chung WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108162; Cornelissen B, 2014, J LABELLED COMPD RAD, V57, P310, DOI 10.1002/jlcr.3152; Costantini DL, 2007, J NUCL MED, V48, P1357, DOI 10.2967/jnumed.106.037937; DeSombre ER, 2000, ACTA ONCOL, V39, P659, DOI 10.1080/028418600750063695; Goddu SM, 1996, ACTA ONCOL, V35, P901, DOI 10.3109/02841869609104044; Haefliger P, 2005, BIOCONJUGATE CHEM, V16, P582, DOI 10.1021/bc0500084; Hafliger P, 2005, CHEMBIOCHEM, V6, P414, DOI 10.1002/cbic.200400210; HOWELL RW, 1992, MED PHYS, V19, P1371, DOI 10.1118/1.596927; Jimenez-Mancilla N, 2013, J LABELLED COMPD RAD, V56, P663, DOI 10.1002/jlcr.3087; Kassis AI, 2000, ACTA ONCOL, V39, P721, DOI 10.1080/028418600750063785; Kassis AI, 2004, INT J RADIAT BIOL, V80, P789, DOI 10.1080/09553000400017663; Kotzerke J, 2012, NUKLEARMED-NUCL MED, V51, P170, DOI 10.3413/Nukmed-0506-12-05; Kotzerke J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104653; Lobachevsky PN, 2008, INT J RADIAT BIOL, V84, P991, DOI 10.1080/09553000802478091; Lobachevsky PN, 2004, INT J RADIAT BIOL, V80, P915, DOI 10.1080/09553000400017754; Pomplun E, 2004, INT J RADIAT BIOL, V80, P855, DOI 10.1080/09553000400017614; Pretze M, 2013, J FLUORINE CHEM, V150, P25, DOI 10.1016/j.jfluchem.2013.02.028; Schibli R, 2000, BIOCONJUGATE CHEM, V11, P345, DOI 10.1021/bc990127h; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Taborda A, 2015, MED PHYS, V42, P3661, DOI 10.1118/1.4925888; TANIOUS FA, 1992, BIOCHEMISTRY-US, V31, P3103, DOI 10.1021/bi00127a010; Xu Z, 2011, CHEM-ASIAN J, V6, P2113, DOI 10.1002/asia.201100120; Zobi F, 2005, CHEMBIOCHEM, V6, P1397, DOI 10.1002/cbic.200400453	29	20	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161973	10.1371/journal.pone.0161973	http://dx.doi.org/10.1371/journal.pone.0161973			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583677	Green Submitted, Green Published, gold			2022-12-26	WOS:000382855600080
J	Zhang, J; Zhou, Y; Wei, N; Yang, B; Wang, AX; Zhou, H; Zhao, XQ; Wang, YJ; Liu, LP; Ouyoung, M; Villegas, B; Groher, M				Zhang, Jing; Zhou, Yun; Wei, Na; Yang, Bo; Wang, Anxin; Zhou, Hai; Zhao, Xingquan; Wang, Yongjun; Liu, Liping; Ouyoung, Melody; Villegas, Brenda; Groher, Michael			Laryngeal Elevation Velocity and Aspiration in Acute Ischemic Stroke Patients	PLOS ONE			English	Article							DEGLUTITION LITERATURE; PREDICTING ASPIRATION; VARIABILITY; STIMULATION; IMPAIRMENTS; KINEMATICS; DYSPHAGIA; BOLUS	Objectives Aspiration after stroke has been associated with aspiration pneumonia, which contributes to increased mortality of stroke. Laryngeal elevation is a core mechanism for protection from aspiration. Few studies have explored the predictive value of laryngeal elevation velocity for aspiration after stroke. This study aimed to explore the ability of laryngeal elevation velocity to predict aspiration in patients with acute ischemic stroke. Methods This was a prospective cohort study that included consecutive acute ischemic stroke patients treated at a teaching hospital during a 10-month period. Patients underwent magnetic resonance imaging (MRI) to confirm the diagnosis of acute ischemic stroke. Patients who were at risk of aspiration and could swallow 5 ml of diluted barium (40%, w/v) for a videofluoroscopic swallowing (VFS) study were included. The association between abnormal indices in the oral and pharyngeal phase of the VFS study and aspiration was examined using univariate analyses. These indices included the lip closure, tongue movement and control, laryngeal elevation velocity and range, the latency of pharyngeal swallowing, pharyngeal transit time (PTT), abnormal epiglottis tilt, residual barium in the pharynx, and the duration of upper esophageal sphincter (UES) opening. The laryngeal elevation velocity (%/s) was calculated as the range of laryngeal elevation (%) from the resting position to the maximum superior position or to the position where the laryngeal vestibule is fully closed divided by the corresponding duration of laryngeal elevation. The range of laryngeal elevation (%) was the percentage calculated as the distance between the resting laryngeal position and the maximum superior excursion position or position where the laryngeal vestibule is fully closed divided by the distance between the resting laryngeal position and the lowest edge of the mandible. A logistic regression analysis was used to determine the predictive value for aspiration secondary to reduced laryngeal elevation velocity after adjusting for the effects of other indices. Intrarater and interrater reliability were calculated using Pearson's correlation coefficients. Results Data from 89 patients were analyzed. This cohort included 71 males and 18 females with a mean age of 59.31 +/- 11.46 years. The mean time from stroke onset to the VFS study was 3 days (1-7). Twenty one (23%) patients aspirated while swallowing 5 ml of diluted barium (40%, w/v). Aspiration was associated with age, the velocity (%/s) of laryngeal elevation and duration, delayed pharyngeal phase, pharyngeal transit time, abnormal epiglottic tilt, and invalid laryngeal elevation before true swallowing, and duration of upper esophageal sphincter (UES) opening. After adjusting for the effects of the indices mentioned above, logistic regression analysis revealed that a reduced of laryngeal elevation velocity before vestibule closure was predictive of aspiration independently (OR, 0.993; 95% CI, 0.987-1.000). Discussions Reduced laryngeal elevation velocity for laryngeal elevated to position where laryngeal vestibule is fully closed was an independent predictor of aspiration in patients with acute ischemic stroke. This may be related to a decreased contraction velocity of the muscles involved in hyolaryngeal elevation. Therapeutic methods aimed at improving laryngeal elevation velocity may decrease aspiration events and pneumonias after stroke.	[Zhang, Jing; Zhou, Yun; Wei, Na; Yang, Bo; Wang, Anxin; Zhao, Xingquan; Wang, Yongjun; Liu, Liping] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Zhang, Jing; Zhou, Yun; Wei, Na; Yang, Bo; Wang, Anxin; Zhao, Xingquan; Wang, Yongjun; Liu, Liping] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Zhang, Jing; Zhou, Yun; Wei, Na; Yang, Bo; Wang, Anxin; Zhao, Xingquan; Wang, Yongjun; Liu, Liping] Beijing Inst Brain Disorders, Stroke Ctr, Beijing, Peoples R China; [Zhang, Jing; Zhou, Yun; Wei, Na; Yang, Bo; Wang, Anxin; Zhao, Xingquan; Wang, Yongjun; Liu, Liping] Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China; [Zhou, Hai] Capital Med Univ, Beijing Tiantan Hosp, Dept Radiol, Beijing, Peoples R China; [Ouyoung, Melody] Univ Southern Calif, Keck Hosp, Dept Speech Pathol, Los Angeles, CA USA; [Villegas, Brenda] Univ Southern Calif, Dept Otolaryngol Head & Neck Surg, Los Angeles, CA USA; [Groher, Michael] Univ Redlands, Dept Commun Disorders, Redlands, CA 92373 USA	Capital Medical University; Capital Medical University; University of Southern California; University of Southern California Keck Hospital; University of Southern California	Liu, LP (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China.; Liu, LP (corresponding author), China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.; Liu, LP (corresponding author), Beijing Inst Brain Disorders, Stroke Ctr, Beijing, Peoples R China.; Liu, LP (corresponding author), Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China.	liping_sister@163.com			Ministry of Science and Technology; Ministry of Health of the People's Republic of China; National 11th & 12th Five-year S & T Major Project [2006BAI01A11, 2011BAI08B01, 2011BAI08B02]; National Science and Technology Major Project of China [2008ZX09312-008]; State Key Development Program for Basic Research of China [2009CB521905]; Beijing Municipal Science and Technology Commission [D101107049310005, Z12110000551 2016]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2013BAI09B03]; Beijing Institute for Brain Disorders [BIBD-PXM2013_014226_07_000084]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health of the People's Republic of China; National 11th & 12th Five-year S & T Major Project; National Science and Technology Major Project of China; State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Beijing Institute for Brain Disorders	This study was funded by the Ministry of Science and Technology and the Ministry of Health of the People's Republic of China. Individual grants include the National 11th & 12th Five-year S & T Major Project (2006BAI01A11, 2011BAI08B01, 2011BAI08B02), the National Science and Technology Major Project of China (2008ZX09312-008), the State Key Development Program for Basic Research of China (2009CB521905), the Beijing Municipal Science and Technology Commission (D101107049310005, Z12110000551 2016), the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2013BAI09B03), and Beijing Institute for Brain Disorders (BIBD-PXM2013_014226_07_000084). The funding institutions had no role in the study design, data collection or analysis, or in the decision to publish or preparation of the manuscript for publication.	Bernard R., 2002, DYSPHAGIA, V17, P57; Broniatowski M, 1999, OTOLARYNG HEAD NECK, V120, P464, DOI 10.1053/hn.1999.v120.a93228; Burnett TA, 2003, J APPL PHYSIOL, V94, P128, DOI 10.1152/japplphysiol.00406.2002; Cohen DL, 2016, INT J STROKE, V11, P399, DOI 10.1177/1747493016639057; Cvejic L, 2011, RESPIROLOGY, V16, P269, DOI 10.1111/j.1440-1843.2010.01875.x; Ertekin C, 2003, CLIN NEUROPHYSIOL, V114, P2226, DOI 10.1016/S1388-2457(03)00237-2; Gleeson DCL, 1999, J COMMUN DISORD, V32, P373, DOI 10.1016/S0021-9924(99)00017-9; Gonzalez-Fernandez Marlis, 2013, Curr Phys Med Rehabil Rep, V1, P187; Hadley AJ, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046013; Hammond CAS, 2009, CHEST, V135, P769, DOI 10.1378/chest.08-1122; Hart TR, 2001, ARCH PHYS MED REHAB, V82, P677, DOI 10.1053/apmr.2001.21939; Humbert IA, 2015, AM J SPEECH-LANG PAT, V24, P72, DOI 10.1044/2014_AJSLP-14-0045; Kahrilas PJ, 1997, GASTROENTEROLOGY, V113, P1457, DOI 10.1053/gast.1997.v113.pm9352847; Kim Y, 2010, DYSPHAGIA, V25, P20, DOI 10.1007/s00455-009-9224-1; Kuhl V, 2003, J NEUROL, V250, P333, DOI 10.1007/s00415-003-1007-2; LeBrasseur NK, 2006, PHYS THER, V86, P1342, DOI 10.2522/ptj.20050162; Li QT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079746; Logemann JA, 2000, J SPEECH LANG HEAR R, V43, P1264, DOI 10.1044/jslhr.4305.1264; Martin-Harris B, 2008, PHYS MED REH CLIN N, V19, P769, DOI 10.1016/j.pmr.2008.06.004; Molfenter SM, 2012, DYSPHAGIA, V27, P162, DOI 10.1007/s00455-012-9397-x; Molfenter SM, 2011, DYSPHAGIA, V26, P67, DOI 10.1007/s00455-010-9309-x; Morad Khosh M, 1997, OPERAT TECH OTOLARYN, V8, P182; Nagy A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/738971; Oommen ER, 2011, DYSPHAGIA, V26, P318, DOI 10.1007/s00455-010-9314-0; Paik NJ, 2008, J ELECTROMYOGR KINES, V18, P329, DOI 10.1016/j.jelekin.2006.09.011; Palmer JB, 2000, AM FAM PHYSICIAN, V61, P2453; Park T, 2013, AM J PHYS MED REHAB, V92, P320, DOI 10.1097/PHM.0b013e318269d935; Park T, 2010, DYSPHAGIA, V25, P177, DOI 10.1007/s00455-009-9237-9; Perlman A L, 1994, Dysphagia, V9, P90; Power ML, 2009, DYSPHAGIA, V24, P257, DOI 10.1007/s00455-008-9198-4; Rosenbek JC, 1996, DYSPHAGIA, V11, P93, DOI 10.1007/BF00417897; Steele CM, 2011, CLIN OTOLARYNGOL, V36, P30, DOI 10.1111/j.1749-4486.2010.02219.x; Steele CM, 2014, DYSPHAGIA, V29, P295, DOI 10.1007/s00455-014-9516-y; van der Kruis JGJ, 2011, DYSPHAGIA, V26, P171, DOI 10.1007/s00455-010-9318-9	34	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162257	10.1371/journal.pone.0162257	http://dx.doi.org/10.1371/journal.pone.0162257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583413	Green Submitted, Green Published, gold			2022-12-26	WOS:000382855600125
J	Ziros, P; Zagoriti, Z; Lagoumintzis, G; Kyriazopoulou, V; Iskrenova, RP; Habeos, EI; Sykiotis, GP; Chartoumpekis, DV; Habeos, IG				Ziros, Panos; Zagoriti, Zoi; Lagoumintzis, George; Kyriazopoulou, Venetsana; Iskrenova, Ralitsa P.; Habeos, Evagelia I.; Sykiotis, Gerasimos P.; Chartoumpekis, Dionysios V.; Habeos, Ioannis G.			Hepatic Fgf21 Expression Is Repressed after Simvastatin Treatment in Mice	PLOS ONE			English	Article							GROWTH-FACTOR 21; UNFOLDED PROTEIN RESPONSE; PPAR-ALPHA; INSULIN-RESISTANCE; CROSS-TALK; ANTIDIABETIC ACTIONS; INDUCED INHIBITION; CIRCULATING FGF21; LIPID-METABOLISM; STATINS	Fibroblast growth factor 21 (Fgf21) is a hormone with emerging beneficial roles in glucose and lipid homeostasis. The interest in Fgf21 as a potential antidiabetic drug and the factors that regulate its production and secretion is growing. Statins are the most widely prescribed drug for the treatment of dyslipidemia. However, the function of statins is not limited to the lowering of cholesterol as they are associated with pleiotropic actions such as antioxidant, anti-inflammatory and cytoprotective effects. The recently described effect of statins on mitochondrial function and the induction of Fgf21 by mitochondrial stress prompted us to investigate the effect of statin treatment on Fgf21 expression in the liver. To this end, C57BL6J male mice and primary mouse hepatocytes were treated with simvastatin, and Fgf21 expression was subsequently assessed by immunoblotting and quantitative real-time PCR. Hepatic Fgf21 protein and mRNA and circulating levels of FGF21significantly decreased in mice that had received simvastatin in their food (0.1% w/w) for 1 week. This effect was also observed with simvastatin doses as low as 0.01% w/w for 1 week or following 2 intraperitoneal injections within a single day. The reduction in Fgf21 mRNA levels was further verified in primary mouse hepatocytes, indicating that the effect of simvastatin is cell autonomous. In conclusion, simvastatin treatment reduced the circulating and hepatic Fgf21 levels and this effect warrants further investigation with reference to its role in metabolism.	[Ziros, Panos; Kyriazopoulou, Venetsana; Iskrenova, Ralitsa P.; Habeos, Evagelia I.; Sykiotis, Gerasimos P.; Chartoumpekis, Dionysios V.; Habeos, Ioannis G.] Univ Patras, Sch Med, Div Endocrinol, Dept Internal Med, Patras, Greece; [Zagoriti, Zoi; Lagoumintzis, George] Univ Patras, Dept Pharm, Patras, Greece; [Ziros, Panos; Sykiotis, Gerasimos P.] Univ Lausanne Hosp, Lausanne, Switzerland	University of Patras; University of Patras; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Habeos, IG (corresponding author), Univ Patras, Sch Med, Div Endocrinol, Dept Internal Med, Patras, Greece.	ihabeos@med.upatras.gr	Sykiotis, Gerasimos P/E-7407-2017; Chartoumpekis, Dionysios/L-8071-2017	Habeos, Evagelia Eva/0000-0001-5124-0942; Chartoumpekis, Dionysios/0000-0002-6139-6067; Lagoumintzis, George/0000-0002-0441-9023; Sykiotis, Gerasimos/0000-0002-9565-4941	Basic Research Program K. Karatheodori (University of Patras); Marie Curie (7th European Community Framework Programme) [PIOF-GA-2012-329442]	Basic Research Program K. Karatheodori (University of Patras); Marie Curie (7th European Community Framework Programme)	This work was partially supported by the Basic Research Program K. Karatheodori (University of Patras). DVC is supported by Marie Curie PIOF-GA-2012-329442 (7th European Community Framework Programme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by the Basic Research Program K. Karatheodori (University of Patras). DVC is supported by Marie Curie PIOF-GA-2012-329442 (7th European Community Framework Programme). The funders played no role in study design, data collection and analysis, decision to publish, or in preparation of the manuscript.	Adams AC, 2013, MOL METAB, V2, P205, DOI 10.1016/j.molmet.2013.05.005; Adams AC, 2013, MOL METAB, V2, P31, DOI 10.1016/j.molmet.2012.08.007; Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049977; Andreux PA, 2014, SCI REP-UK, V4, DOI 10.1038/srep05285; Arner P, 2008, FEBS LETT, V582, P1725, DOI 10.1016/j.febslet.2008.04.038; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Bae KH, 2014, ENDOCRINOL METAB, V29, P105, DOI 10.3803/EnM.2014.29.2.105; Bouitbir J, 2012, EUR HEART J, V33, P1397, DOI 10.1093/eurheartj/ehr224; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Chartoumpekis D, 2010, BIOCHEM BIOPH RES CO, V396, P463, DOI 10.1016/j.bbrc.2010.04.117; Chartoumpekis DV, 2011, MOL MED, V17, P736, DOI 10.2119/molmed.2011.00075; Chen JC, 2008, CARDIOVASC RES, V80, P138, DOI 10.1093/cvr/cvn160; Cheng XG, 2014, TOXICOL APPL PHARM, V278, P65, DOI 10.1016/j.taap.2014.04.013; Cornu M, 2014, P NATL ACAD SCI USA, V111, P11592, DOI 10.1073/pnas.1412047111; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; Dushay JR, 2015, MOL METAB, V4, P51, DOI 10.1016/j.molmet.2014.09.008; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Emanuelli B, 2014, J CLIN INVEST, V124, P515, DOI 10.1172/JCI67353; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Fisher FM, 2016, ANNU REV PHYSIOL, V78, P223, DOI 10.1146/annurev-physiol-021115-105339; Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005; Gazzerro P, 2012, PHARMACOL REV, V64, P102, DOI 10.1124/pr.111.004994; Gimeno RE, 2014, TRENDS ENDOCRIN MET, V25, P303, DOI 10.1016/j.tem.2014.03.001; Guridi M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3715; Helmers AJ, 2009, AM J TROP MED HYG, V81, P631, DOI 10.4269/ajtmh.2009.09-0204; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Ji KQ, 2015, FREE RADICAL BIO MED, V84, P161, DOI 10.1016/j.freeradbiomed.2015.03.020; Keipert S, 2014, AM J PHYSIOL-ENDOC M, V306, pE469, DOI 10.1152/ajpendo.00330.2013; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2015, TRENDS ENDOCRIN MET, V26, P608, DOI 10.1016/j.tem.2015.09.007; Kim H, 2015, MOL CELL BIOL, V35, P4121, DOI 10.1128/MCB.00665-15; Kim KH, 2014, DIABETES METAB J, V38, P245, DOI 10.4093/dmj.2014.38.4.245; Kim KH, 2013, BIOCHEM BIOPH RES CO, V440, P76, DOI 10.1016/j.bbrc.2013.09.026; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Kim SH, 2015, DIABETOLOGIA, V58, P809, DOI 10.1007/s00125-014-3475-6; Kosters A, 2003, J HEPATOL, V38, P710, DOI 10.1016/S0168-8278(03)00093-X; Laeger T, 2014, J CLIN INVEST, V124, P3913, DOI 10.1172/JCI74915; Lee MS, 2015, ANN NY ACAD SCI, V1350, P61, DOI 10.1111/nyas.12822; Liang QN, 2014, DIABETES, V63, P4064, DOI 10.2337/db14-0541; Liao JK, 2012, EUR HEART J, V33, P1299, DOI 10.1093/eurheartj/ehr287; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Liu TF, 2012, CELL METAB, V16, P213, DOI 10.1016/j.cmet.2012.06.014; Liu Y, 2014, NATURE, V508, P406, DOI 10.1038/nature13204; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Luo Yongde, 2013, Front Endocrinol (Lausanne), V4, P194, DOI 10.3389/fendo.2013.00194; Markan KR, 2016, SEMIN CELL DEV BIOL, V53, P85, DOI 10.1016/j.semcdb.2015.09.021; Markan KR, 2014, DIABETES, V63, P4057, DOI 10.2337/db14-0595; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Martin G, 2001, J CLIN INVEST, V107, P1423, DOI 10.1172/JCI10852; McFarlane SI, 2002, J CLIN ENDOCR METAB, V87, P1451, DOI 10.1210/jc.87.4.1451; Miyake M, 2016, FASEB J, V30, P798, DOI 10.1096/fj.15-275990; Morck C, 2009, P NATL ACAD SCI USA, V106, P18285, DOI 10.1073/pnas.0907117106; Moyers JS, 2007, J CELL PHYSIOL, V210, P1, DOI 10.1002/jcp.20847; Niknejad N, 2007, J BIOL CHEM, V282, P29748, DOI 10.1074/jbc.M705859200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Ranji P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100033; Roy A, 2015, CELL METAB, V22, P253, DOI 10.1016/j.cmet.2015.05.022; Slocum SL, 2016, ARCH BIOCHEM BIOPHYS, V591, P57, DOI 10.1016/j.abb.2015.11.040; So WY, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.80; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Toth JI, 2004, MOL CELL BIOL, V24, P8288, DOI 10.1128/MCB.24.18.8288-8300.2004; Tricarico PM, 2015, INT J MOL SCI, V16, P16067, DOI 10.3390/ijms160716067; Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310; van der Burgh R, 2014, J BIOL CHEM, V289, P5000, DOI 10.1074/jbc.M113.536920; Vernia S, 2014, CELL METAB, V20, P512, DOI 10.1016/j.cmet.2014.06.010; Wagner RJ, 2010, AM J PHYSIOL-CELL PH, V299, pC119, DOI 10.1152/ajpcell.00429.2009; Yang ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048392; Ye DW, 2014, HEPATOLOGY, V60, P977, DOI 10.1002/hep.27060; Yokoyama M, 2007, J LIPID RES, V48, P646, DOI 10.1194/jlr.M600301-JLR200; Zhang PX, 2014, CELL METAB, V20, P267, DOI 10.1016/j.cmet.2014.05.003; Zhang Y, 2011, MOL CELL ENDOCRINOL, V342, P41, DOI 10.1016/j.mce.2011.05.003	76	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162024	10.1371/journal.pone.0162024	http://dx.doi.org/10.1371/journal.pone.0162024			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583452	Green Published, gold, Green Submitted			2022-12-26	WOS:000382855600087
J	Rabin, J; Houser, B; Talbert, C; Patel, R				Rabin, Jeff; Houser, Brook; Talbert, Carolyn; Patel, Ruh			Blue-Black or White-Gold? Early Stage Processing and the Color of 'The Dress'	PLOS ONE			English	Article							ASYMMETRIES; PERCEPTION; VISION	Purpose In Feb 2015 an image of a dress posted on Tumblr triggered an internet phenomenon: Is the Dress blue and black (BB) or white and gold (WG)? Many claim BB and others insist WG while the true colors are BB. The prevailing theory is that assumptions about the illuminant govern perception of the Dress with WG due to bluish lighting and BB due to yellowish. Our purpose was to determine if early stage optical, retinal and/or neural factors also impact perception of the Dress. Methods Thirty-nine subjects were categorized as BB or WG based on their initial perception of the Dress and their perception reported when viewing the Dress on iPhone 5, iPad, and 22 '' LCD displays. Macular pigment optical density (MPOD) measured with the QuantifEye (TM) MPS II and visual brainwaves (VEPs) in response to brief presentations of a transparency of the Dress illuminated by a flashing light were measured on each subject and compared between BB and WG groups. Additionally, CIE chromaticity (color) and luminance (brightness) were measured from multiple areas of the Dress image to determine cone stimulation and contrast. Results Mean MPOD was higher in the WG group (0.49) vs. the BB (0.41, p = 0.04) and median values were higher as well (WG = 0.46, BB = 0.36, p = 0.03). There was no difference in VEP amplitude between groups (p > 0.85) but mean VEP latency was longer in WG (130 msec.) vs. the BB group (107 msec., p = 0.0005). Colorimetry of the Dress showed significantly greater stimulation of blue cones (contrast = 73%) vs. red and green sensitive cones (contrast = 13%). Conclusions Our findings indicate that observers with denser MPOD may be predisposed to perceive the Dress as WG due to great absorption of blue light by the macular pigment. Moreover, the novel, substantial stimulation of blue cones by the Dress may contribute to ambiguity and dichotomous perception since the blue cones are so sparse in the retina. Finally, the delayed WG VEPs indicate distinct neural processing in perception of the consistent with fMRI evidence that the WG percept is processed at higher cortical levels than the BB. These results do not fully explain the dichotomous perception of the Dress but do exemplify the need to consider early stage processing when elucidating ambiguous percepts and figures.	[Rabin, Jeff; Houser, Brook; Talbert, Carolyn; Patel, Ruh] Univ Incarnate Word, Rosenberg Sch Optometry, San Antonio, TX 78209 USA		Rabin, J (corresponding author), Univ Incarnate Word, Rosenberg Sch Optometry, San Antonio, TX 78209 USA.	rabin@uiwtx.edu						Bach M, 2015, OPHTHALMOLOGE, V112, P512, DOI 10.1007/s00347-015-0064-0; Beatty S, 2004, ARCH BIOCHEM BIOPHYS, V430, P70, DOI 10.1016/j.abb.2004.03.015; Bernstein PS, 2014, PROG RETIN EYE RES; COLE GR, 1992, BEHAV RES METH INSTR, V24, P22, DOI 10.3758/BF03203465; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Foster DH, 2011, VISION RES, V51, P674, DOI 10.1016/j.visres.2010.09.006; Gegenfurtner KR, 2015, CURR BIOL, V25, pR543, DOI 10.1016/j.cub.2015.04.043; KRAUSKOPF J, 1982, VISION RES, V22, P1123, DOI 10.1016/0042-6989(82)90077-3; Lafer-Sousa R, 2015, CURR BIOL, V25, pR545, DOI 10.1016/j.cub.2015.04.053; Makridaki M, 2009, OPHTHAL PHYSL OPT, V29, P338, DOI 10.1111/j.1475-1313.2009.00667.x; Rabin J, 2011, INVEST OPHTH VIS SCI, V52, P816, DOI 10.1167/iovs.10-6283; Schlaffke L, 2015, CORTEX, V73, P271, DOI 10.1016/j.cortex.2015.08.017; Shevell SK, 2008, ANNU REV PSYCHOL, V59, P143, DOI 10.1146/annurev.psych.59.103006.093619; SMITH VC, 1975, VISION RES, V15, P161, DOI 10.1016/0042-6989(75)90203-5; van der Veen RLP, 2009, OPHTHAL PHYSL OPT, V29, P127, DOI 10.1111/j.1475-1313.2008.00618.x; Vemuri K, 2016, J OPT SOC AM, V1, P37; Vingrys AJ, 1998, VISION RES, V38, P1085, DOI 10.1016/S0042-6989(97)00250-2; Werner A, 2014, VISION RES, V104, P80, DOI 10.1016/j.visres.2014.10.005; Winkler AD, 2015, CURR BIOL, V25, pR547, DOI 10.1016/j.cub.2015.05.004; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd ed., P117	20	16	16	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161090	10.1371/journal.pone.0161090	http://dx.doi.org/10.1371/journal.pone.0161090			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580077	Green Submitted, gold, Green Published			2022-12-26	WOS:000382877400015
J	Kast, V; Leukel, C				Kast, Volker; Leukel, Christian			Motor Experts Care about Consistency and Are Reluctant to Change Motor Outcome	PLOS ONE			English	Article							VARIABILITY; ADAPTATION	Thousands of hours of physical practice substantially change the way movements are performed. The mechanisms underlying altered behavior in highly-trained individuals are so far little understood. We studied experts (handballers) and untrained individuals (novices) in visuomotor adaptation of free throws, where subjects had to adapt their throwing direction to a visual displacement induced by prismatic glasses. Before visual displacement, experts expressed lower variability of motor errors than novices. Experts adapted and de-adapted slower, and also forgot the adaptation slower than novices. The variability during baseline was correlated with the learning rate during adaptation. Subjects adapted faster when variability was higher. Our results indicate that experts produced higher consistency of motor outcome. They were still susceptible to the sensory feedback informing about motor error, but made smaller adjustments than novices. The findings of our study relate to previous investigations emphasizing the importance of action exploration, expressed in terms of outcome variability, to facilitate learning.	[Kast, Volker; Leukel, Christian] Univ Freiburg, Dept Sport Sci, Freiburg, Germany; [Leukel, Christian] Univ Freiburg, Bemstein Ctr Freiburg, Freiburg, Germany	University of Freiburg; University of Freiburg	Leukel, C (corresponding author), Univ Freiburg, Dept Sport Sci, Freiburg, Germany.; Leukel, C (corresponding author), Univ Freiburg, Bemstein Ctr Freiburg, Freiburg, Germany.	christian.leukel@sport.uni-freiburg.de						Brennan AE, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004278; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Helmholtz HV, 1867, HDB PHYSL OPTIK; Huang VS, 2011, NEURON, V70, P787, DOI 10.1016/j.neuron.2011.04.012; Krakauer JW, 2009, ADV EXP MED BIOL, V629, P405, DOI 10.1007/978-0-387-77064-2_21; Leukel C, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/fnhurn.2015.00050, 10.3389/fnhum.2015.00050]; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; Pekny SE, 2015, J NEUROSCI, V35, P4015, DOI 10.1523/JNEUROSCI.3244-14.2015; Shmuelof L, 2012, J NEUROSCI, V32, P14617, DOI 10.1523/JNEUROSCI.2184-12.2012; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; WINSTEIN CJ, 1990, J EXP PSYCHOL LEARN, V16, P677, DOI 10.1037/0278-7393.16.4.677; Wolpert DM, 2001, TRENDS COGN SCI, V5, P487, DOI 10.1016/S1364-6613(00)01773-3; Woolley SC, 2015, NEUROSCIENCE, V296, P39, DOI 10.1016/j.neuroscience.2014.10.010; Wu HG, 2014, NAT NEUROSCI, V17, P312, DOI 10.1038/nn.3616	14	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161798	10.1371/journal.pone.0161798	http://dx.doi.org/10.1371/journal.pone.0161798			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575532	Green Submitted, Green Published, gold			2022-12-26	WOS:000382877200039
J	Kitchen, JL; van den Bosch, F; Paveley, ND; Helps, J; van den Berg, F				Kitchen, James L.; van den Bosch, Frank; Paveley, Neil D.; Helps, Joseph; van den Berg, Femke			The Evolution of Fungicide Resistance Resulting from Combinations of Foliar-Acting Systemic Seed Treatments and Foliar-Applied Fungicides: A Modeling Analysis	PLOS ONE			English	Article							MYCOSPHAERELLA-GRAMINICOLA; DISEASE-CONTROL; WINTER-WHEAT; SELECTION; RISK	For the treatment of foliar diseases of cereals, fungicides may be applied as foliar sprays or systemic seed treatments which are translocated to leaves. Little research has been done to assess the resistance risks associated with foliar-acting systemic seed treatments when used alone or in combination with foliar sprays, even though both types of treatment may share the same mode of action. It is therefore unknown to what extent adding a systemic seed treatment to a foliar spray programme poses an additional resistance risk and whether in the presence of a seed treatment additional resistance management strategies (such as limiting the total number of treatments) are necessary to limit the evolution of fungicide-resistance. A mathematical model was developed to simulate an epidemic and the resistance evolution of Zymoseptoria tritici on winter wheat, which was used to compare different combinations of seed and foliar treatments by calculating the fungicide effective life, i.e. the number of years before effective disease control is lost to resistance. A range of parameterizations for the seed treatment fungicide and different fungicide uptake models were compared. Despite the different parameterizations, the model consistently predicted the same trends in that i) similar levels of efficacy delivered either by a foliar-acting seed treatment, or a foliar application, resulted in broadly similar resistance selection, ii) adding a foliar-acting seed treatment to a foliar spray programme increased resistance selection and usually decreased effective life, and iii) splitting a given total dose-by adding a seed treatment to foliar treatments, but decreasing dose per treatment-gave effective lives that were the same as, or shorter than those given by the spray programme alone. For our chosen plantpathogen-fungicide system, the model results suggest that to effectively manage selection for fungicide-resistance, foliar acting systemic seed treatments should be included as one of the maximum number of permitted fungicide applications.	[Kitchen, James L.; van den Bosch, Frank; Helps, Joseph; van den Berg, Femke] Rothamsted Res, Computat & Syst Biol, Harpenden, Herts, England; [Paveley, Neil D.] Agr Dev & Advisory Serv, Dept Plant Pathol, Duggleby, N Yorkshire, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	van den Berg, F (corresponding author), Rothamsted Res, Computat & Syst Biol, Harpenden, Herts, England.	femke.vandenberg@rothamsted.ac.uk	Helps, Joseph/AAZ-6579-2020; van den Bosch, Frank C./ABH-3801-2020; van den Berg, Femke/AAX-6237-2020	Helps, Joseph/0000-0002-2720-5538; van den Bosch, Frank C./0000-0003-3236-2068; van den Berg, Femke/0000-0003-3885-1890	Agriculture and Horticulture Development Board [RD2012-3801]; UK Chemicals Regulation Directorate of the Health and Safety Executive and the Department for Environment, Food and Rural Affairs [PS2728]; Biotechnology and Biological Sciences Research Council of the United Kingdom	Agriculture and Horticulture Development Board; UK Chemicals Regulation Directorate of the Health and Safety Executive and the Department for Environment, Food and Rural Affairs; Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	JK and NP received support from the Agriculture and Horticulture Development Board (project RD2012-3801) and the UK Chemicals Regulation Directorate of the Health and Safety Executive and the Department for Environment, Food and Rural Affairs (project PS2728). JH, FvdBerg and FvdBosch received support from the Biotechnology and Biological Sciences Research Council of the United Kingdom. ADAS provided support in the form of salaries for authors [NP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bartlett DW, 2002, PEST MANAG SCI, V58, P649, DOI 10.1002/ps.520; Bliss CI, 1934, P NATL ACAD SCI USA, V79, P38; Brent K.J., 2007, FUNGICIDE RESISTANCE; Cunniffe NJ, 2012, PHYTOPATHOLOGY, V102, P365, DOI 10.1094/PHYTO-12-10-0338; Egorycheva M. T., 2009, Zashchita i Karantin Rastenii, P43; Fernandez-Ortuno D, 2008, INT MICROBIOL, V11, P1, DOI 10.2436/20.1501.01.38; FRAC, SDHI GUID CER 2015; GILL PE, 1972, COMPUT J, V15, P80, DOI 10.1093/comjnl/15.1.80; Grimmer MK, 2014, PEST MANAG SCI, V70, P1008, DOI 10.1002/ps.3646; Hobbelen PHF, 2013, PHYTOPATHOLOGY, V103, P690, DOI 10.1094/PHYTO-06-12-0142-R; Hobbelen PHF, 2011, PHYTOPATHOLOGY, V101, P1224, DOI 10.1094/PHYTO-10-10-0290; LINDSTROM O, 1958, J AGR FOOD CHEM, V6, P283, DOI 10.1021/jf60086a003; LIPPS PE, 1988, PLANT DIS, V72, P887, DOI 10.1094/PD-72-0887; Lockley D, 2005, 373 HGCA; Morais D, 2015, PLANT PATHOL, V64, P1429, DOI 10.1111/ppa.12372; Parker SR, 2001, BCPC SYMP SER, P181; Paveley N, HGCA WHEAT DIS MANAG; Paveley ND, 2000, PLANT PATHOL, V49, P748, DOI 10.1046/j.1365-3059.2000.00518.x; Poletine JP, 2012, J FOOD AGRIC ENVIRON, V10, P512; SHAW MW, 1987, PLANT PATHOL, V36, P201, DOI 10.1111/j.1365-3059.1987.tb02222.x; Sylvester Bradley R, 2008, HGCA WHEAT GROWTH GU; Thornley JHM., 1990, PLANT CROP MODELLING; van den Berg F, 2013, PHYTOPATHOLOGY, V103, P1209, DOI 10.1094/PHYTO-03-13-0061-R; van den Bosch F., 2015, FUNGICIDE RESISTANCE, P49; van den Bosch F, 2008, ANNU REV PHYTOPATHOL, V46, P123, DOI 10.1146/annurev.phyto.011108.135838; van den Bosch F, 2014, ANNU REV PHYTOPATHOL, V52, P175, DOI 10.1146/annurev-phyto-102313-050158; WAGGONER PE, 1987, PHYTOPATHOLOGY, V77, P393	27	15	15	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161887	10.1371/journal.pone.0161887	http://dx.doi.org/10.1371/journal.pone.0161887			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571208	Green Published, gold, Green Submitted			2022-12-26	WOS:000382876700040
J	Pinto, RC; de Castro, DB; de Albuquerque, BC; Sampaio, VD; dos Passos, RA; da Costa, CF; Sadahiro, M; Braga, JU				Pinto, Rosemary Costa; de Castro, Daniel Barros; de Albuquerque, Bernardino Claudio; Sampaio, Vanderson de Souza; dos Passos, Ricardo Augusto; da Costa, Cristiano Fernandes; Sadahiro, Megumi; Braga, Jose Ueleres			Mortality Predictors in Patients with Severe Dengue in the State of Amazonas, Brazil	PLOS ONE			English	Article							HEMORRHAGIC-FEVER	Dengue is a major public health problem in tropical and subtropical areas worldwide. There is a lack of information on the risk factors for death due to severe dengue fever in developing countries, including Brazil where the state of Amazonas is located. This knowledge is important for decision making and the implementation of effective measures for patient care. This study aimed to identify factors associated with death among patients with severe dengue, in Amazonas from 2001 to 2013. We conducted a retrospective cohort study based on secondary data from the epidemiological surveillance of dengue provided by the Fundacao de Vigilancia em Saude do Amazonas, FVS (Health Surveillance Foundation) of the Secretaria de Saude do Amazonas, SUSAM (Health Secretariat of the State of Amazonas). Data on dengue cases were obtained from the SINAN (Notifiable Diseases Information System) and SIM (Mortality Information System) databases. We selected cases of severe dengue with laboratory confirmation, including dengue-related deaths of residents in the state of Amazonas from January 1, 2001, to December 31, 2013. The explanatory variables analyzed were sex, age, level of education, spontaneous hemorrhagic manifestations, plasma extravasation and platelet count. Patients who died due to severe dengue had more hematuria, gastrointestinal bleeding, and thrombocytopenia than the survivors. Considering the simultaneous effects of demographic and clinical characteristics with a multiple logistic regression model, it was observed that the factors associated with death were age >55 years (odds ratio [OR] 4.98), gastrointestinal bleeding (OR 10.26), hematuria (OR 5.07), and thrombocytopenia (OR 2.55). Gastrointestinal bleeding was the clinical sign most strongly associated with death, followed by hematuria and age >55 years. The study results showed that the best predictor of death from severe dengue is based on the characteristic of age >55 years, together with the clinical signs of gastrointestinal bleeding, hematuria, and low platelet count.	[Pinto, Rosemary Costa; de Castro, Daniel Barros; de Albuquerque, Bernardino Claudio; Sampaio, Vanderson de Souza; dos Passos, Ricardo Augusto; da Costa, Cristiano Fernandes; Sadahiro, Megumi] Fundacao Vigilancia Saude Amazonas FVS, Hlth Surveillance Fdn Amazonas State, Manaus, Amazonas, Brazil; [de Castro, Daniel Barros; Braga, Jose Ueleres] Fiocruz MS, Sergio Arouca Natl Sch Publ Hlth, Rio De Janeiro, Brazil; [dos Passos, Ricardo Augusto] Fiocruz MS, Inst Oswaldo Cruz, Lab Physiol & Control Arthropod Vectors, Rio De Janeiro, Brazil; [Braga, Jose Ueleres] Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Brazil; [Braga, Jose Ueleres] Res Fdn State Amazonas, PECTI SAUDE, Manaus, Amazonas, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro	Braga, JU (corresponding author), Fiocruz MS, Sergio Arouca Natl Sch Publ Hlth, Rio De Janeiro, Brazil.; Braga, JU (corresponding author), Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Brazil.; Braga, JU (corresponding author), Res Fdn State Amazonas, PECTI SAUDE, Manaus, Amazonas, Brazil.	ueleres@gmail.com	Sampaio, Vanderson/AAQ-1418-2020; Sampaio, Vanderson/M-4337-2015; Braga, Jose Ueleres/AAB-1326-2021	Sampaio, Vanderson/0000-0001-7307-8851; Sampaio, Vanderson/0000-0001-7307-8851; Braga, Jose Ueleres/0000-0001-5247-007X; Dos Passos/0000-0002-2155-9351	government of the state of Amazonas, through the Fundacao de Amparo a Pesquisa do Estado do Amazonas, FAPEAM (Research Foundation of the State of Amazonas); Journal Articles Publishing Support Program (PAPAC);  [015/2014]	government of the state of Amazonas, through the Fundacao de Amparo a Pesquisa do Estado do Amazonas, FAPEAM (Research Foundation of the State of Amazonas); Journal Articles Publishing Support Program (PAPAC); 	This work was supported by the government of the state of Amazonas, through the Fundacao de Amparo a Pesquisa do Estado do Amazonas, FAPEAM (Research Foundation of the State of Amazonas), for granting scholarships by the RH-Doctoral Program (DBC has a fellowship) and publishing support by Journal Articles Publishing Support Program (PAPAC number 015/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Nucleo de Sistemas de Informacao em Saude da Fundacao de Vigilancia em Sause do Amazonas (Center for Health Information Systems of the Health Surveillance Foundation of Amazonas) for allowing us to access the SINAN and SIM database, and to the government of the state of Amazonas, through the Fundacao de Amparo a Pesquisa do Estado do Amazonas, FAPEAM (Research Foundation of the State of Amazonas), for granting scholarships. DBC is a fellow of the RH-Doctoral Program at FAPEAM. The authors declare that there is no conflict of interest.	Martins VDA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100535; Bethell DB, 2001, CLIN INFECT DIS, V32, P243, DOI 10.1086/318453; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Brazilian Ministry of Health, 2009, DIR NAC PREV CONTR E; Brazilian Ministry of Health, 2011, DENG DIAGN MAN CLIN; Brazilian Ministry of Health, 2014, B EP, V53; Costa MDCN, 2011, J EPIDEMIOL COMMUN H, V65, pA361, DOI 10.1136/jech.2011.142976m.35; De Figueiredo RMP, REV SOC BRAS MED TRO, V37, P476; Diaz-Quijano FA, 2012, AM J TROP MED HYG, V86, P328, DOI 10.4269/ajtmh.2012.11-0074; dos Passos RA, 2012, MONITORAMENTO CASOS; Figueiro AC, 2011, CAD SAUDE PUBLICA, V27, P2373, DOI 10.1590/S0102-311X2011001200009; Fundacao de Vigilancia em Saude do Amazonas, 2014, B VIG SAUD, V15; Fundagao de Vigilancia em Saude do Amazonas, 2012, B VIG SAUD; Fundagao Nacional de Saude, 2002, DENG DIAGN MAN CLIN; García-Rivera Enid J., 2003, Rev Panam Salud Publica, V13, P362, DOI 10.1590/S1020-49892003000500004; Gubler DJ, 1999, ADV VIRUS RES, V53, P35, DOI 10.1016/S0065-3527(08)60342-5; Hosmer Jr DW, 2004, APPL LOGISTIC REGRES; Hung N, 2003, DENGUE B; Instituto Brasileiro de Geografia e Estatistica-IBGE, 2011, CENS DEM 2010 CAR PO; Lye DC, 2008, SINGAP MED J, V49, P476; Moraes GH, 2013, AM J TROP MED HYG, V88, P670, DOI 10.4269/ajtmh.11-0774; Paixao ES, 2015, REV SOC BRAS MED TRO, V48, P399, DOI 10.1590/0037-8682-0145-2015; Pongpan S, 2013, INT J; Vicente CR, 2013, REV SOC BRAS MED TRO, V46, P629, DOI 10.1590/0037-8682-1579-2013; Rocha L, 2009, REV SOC BRAS MED TRO; WHO T, 2009, DENG GUID DIAGN TREA	27	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161884	10.1371/journal.pone.0161884	http://dx.doi.org/10.1371/journal.pone.0161884			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564084	Green Published, Green Submitted, gold			2022-12-26	WOS:000382496300031
J	Herrmann, B; Sistiaga, M; Santos, J; Sala, A				Herrmann, Bent; Sistiaga, Manu; Santos, Juan; Sala, Antonello			How Many Fish Need to Be Measured to Effectively Evaluate Trawl Selectivity?	PLOS ONE			English	Article							PAIRED-GEAR METHOD; SIZE-SELECTIVITY; SQUARE-MESH; DIAMOND-MESH; COD-END; CODENDS; FISHERIES; GRIDS; MM	The aim of this study was to provide practitioners working with trawl selectivity with general and easily understandable guidelines regarding the fish sampling effort necessary during sea trials. In particular, we focused on how many fish would need to be caught and length measured in a trawl haul in order to assess the selectivity parameters of the trawl at a designated uncertainty level. We also investigated the dependency of this uncertainty level on the experimental method used to collect data and on the potential effects of factors such as the size structure in the catch relative to the size selection of the gear. We based this study on simulated data created from two different fisheries: the Barents Sea cod (Gadus morhua) trawl fishery and the Mediterranean Sea multispecies trawl fishery represented by red mullet (Mullus barbatus). We used these two completely different fisheries to obtain results that can be used as general guidelines for other fisheries. We found that the uncertainty in the selection parameters decreased with increasing number of fish measured and that this relationship could be described by a power model. The sampling effort needed to achieve a specific uncertainty level for the selection parameters was always lower for the covered codend method compared to the paired-gear method. In many cases, the number of fish that would need to be measured to maintain a specific uncertainty level was around 10 times higher for the paired-gear method than for the covered codend method. The trends observed for the effect of sampling effort in the two fishery cases investigated were similar; therefore the guidelines presented herein should be applicable to other fisheries.	[Herrmann, Bent] SINTEF Fisheries & Aquaculture, Fishing Gear Technol, Willemoesvej 2, DK-9850 Hirtshals, Denmark; [Sistiaga, Manu] SFA, Brattorkaia 17C, N-7010 Trondheim, Norway; [Santos, Juan] Thunen Inst Balt Sea Fisheries, Alter Hafen Sud 2, D-18069 Rostock, Germany; [Sala, Antonello] CNR, Inst Marine Sci ISMAR, I-60125 Ancona, Italy; [Herrmann, Bent] Univ Tromso, Norwegian Coll Fishery & Aquat Sci, N-9037 Tromso, Norway	SINTEF; Johann Heinrich von Thunen Institute; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); UiT The Arctic University of Tromso	Sistiaga, M (corresponding author), SFA, Brattorkaia 17C, N-7010 Trondheim, Norway.	manu.sistiaga@sintef.no	Sala, Antonello/B-8517-2016	Sala, Antonello/0000-0001-7066-1152; Herrmann, Bent/0000-0003-1325-6198	SINTEF Fisheries and Aquaculture (Norway); National Research Council (CNR) - Institute of Marine Sciences (ISMAR) (Italy); Thunen Institute for Baltic Sea Fisheries (Germany)	SINTEF Fisheries and Aquaculture (Norway)(SINTEF); National Research Council (CNR) - Institute of Marine Sciences (ISMAR) (Italy); Thunen Institute for Baltic Sea Fisheries (Germany)	The following institutes funded this work: SINTEF Fisheries and Aquaculture (Norway)(www.sintef.no), National Research Council (CNR) - Institute of Marine Sciences (ISMAR) (Italy) (www.ismar.cnr.it) and the Thunen Institute for Baltic Sea Fisheries (Germany) (www.ti.bund.de).	Brook R. J., 2018, APPL REGRESSION ANAL; FRYER RJ, 1991, ICES J MAR SCI, V48, P281, DOI 10.1093/icesjms/48.3.281; Graham N, 2004, FISH RES, V67, P151, DOI 10.1016/j.fishres.2003.09.037; Grimaldo E, 2009, FISH RES, V95, P198, DOI 10.1016/j.fishres.2008.08.019; Grimaldo E, 2007, FISH RES, V85, P309; Herrmann B, 2007, FISH RES, V83, P175, DOI 10.1016/j.fishres.2006.09.011; Herrmann Bent, 2012, Journal of Northwest Atlantic Fishery Science, V44, P1, DOI 10.2960/J.v44.m680; Jorgensen T, 2006, FISH RES, V79, P337, DOI 10.1016/j.fishres.2006.01.017; Krag LA, 2010, FISH RES, V101, P20, DOI 10.1016/j.fishres.2009.09.001; MILLAR RB, 1992, J AM STAT ASSOC, V87, P962, DOI 10.2307/2290632; MILLAR RB, 1994, ICES J MAR SCI, V51, P293, DOI 10.1006/jmsc.1994.1030; Rees DG, 2001, ESSENTIAL STAT; Sala A, 2008, FISH RES, V93, P8, DOI 10.1016/j.fishres.2008.02.003; Sala A, 2006, AQUAT LIVING RESOUR, V19, P317, DOI 10.1051/alr:2007002; Sala A, 2007, FISH RES, V83, P192, DOI 10.1016/j.fishres.2006.09.013; Sala A, 2015, FISH RES, V161, P182, DOI 10.1016/j.fishres.2014.07.011; Sistiaga M, 2008, FISH RES, V93, P195, DOI 10.1016/j.fishres.2008.04.014; Sistiaga M, 2009, FISH RES, V97, P196, DOI 10.1016/j.fishres.2009.02.002; Sistiaga M, 2011, CAN J FISH AQUAT SCI, V68, P927, DOI 10.1139/F2011-017; Sparre P.E., 1989, 3061 FAO; Tokac A, 2014, FISH RES, V150, P76, DOI 10.1016/j.fishres.2013.10.015; Wileman D.A., 1996, 1126 ICES COOP	22	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161512	10.1371/journal.pone.0161512	http://dx.doi.org/10.1371/journal.pone.0161512			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560696	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258600052
J	Ishchuk, OP; Zeljko, TV; Schifferdecker, AJ; Wisen, SM; Hagstrom, AK; Rozpedowska, E; Andersen, MR; Hellborg, L; Ling, ZH; Sibirny, AA; Piskur, J				Ishchuk, Olena P.; Zeljko, Tanja Vojvoda; Schifferdecker, Anna J.; Wisen, Sofia Mebrahtu; Hagstrom, Asa K.; Rozpedowska, Elzbieta; Andersen, Mikael Rordam; Hellborg, Linda; Ling, Zhihao; Sibirny, Andrei A.; Piskur, Jure			Novel Centromeric Loci of the Wine and Beer Yeast Dekkera bruxellensis CEN1 and CEN2	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; DICENTRIC CHROMOSOMES; TRANSPOSABLE ELEMENTS; DEKKERA-BRUXELLENSIS; BRETTANOMYCES-BRUXELLENSIS; CANDIDA-ALBICANS; YARROWIA-LIPOLYTICA; NUCLEOTIDE-SEQUENCE; BUDDING YEAST; FISSION YEAST	The wine and beer yeast Dekkera bruxellensis thrives in environments that are harsh and limiting, especially in concentrations with low oxygen and high ethanol. Its different strains' chromosomes greatly vary in number (karyotype). This study isolates two novel centromeric loci (CEN1 and CEN2), which support both the yeast's autonomous replication and the stable maintenance of plasmids. In the sequenced genome of the D. bruxellensis strain CBS 2499, CEN1 and CEN2 are each present in one copy. They differ from the known "point" CEN elements, and their biological activity is retained within similar to 900-1300 bp DNA segments. CEN1 and CEN2 have features of both "point" and "regional" centromeres: They contain conserved DNA elements, ARSs, short repeats, one tRNA gene, and transposon-like elements within less than 1 kb. Our discovery of a miniature inverted-repeat transposable element (MITE) next to CEN2 is the first report of such transposons in yeast. The transformants carrying circular plasmids with cloned CEN1 and CEN2 undergo a phenotypic switch: They form fluffy colonies and produce three times more biofilm. The introduction of extra copies of CEN1 and CEN2 promotes both genome rearrangements and ploidy shifts, with these effects mediated by homologous recombination (between circular plasmid and genome centromere copy) or by chromosome breakage when integrated. Also, the proximity of the MITE-like transposon to CEN2 could translocate CEN2 within the genome or cause chromosomal breaks, so promoting genome dynamics. With extra copies of CEN1 and CEN2, the yeast's enhanced capacities to rearrange its genome and to change its gene expression could increase its abilities for exploiting new and demanding niches.	[Ishchuk, Olena P.; Zeljko, Tanja Vojvoda; Schifferdecker, Anna J.; Wisen, Sofia Mebrahtu; Hagstrom, Asa K.; Rozpedowska, Elzbieta; Hellborg, Linda; Ling, Zhihao; Piskur, Jure] Lund Univ, Dept Biol, Lund, Sweden; [Andersen, Mikael Rordam] Tech Univ Denmark, Dept Syst Biol, Lyngby, Denmark; [Ishchuk, Olena P.; Sibirny, Andrei A.] NAS Ukraine, Inst Cell Biol, Dept Mol Genet & Biotechnol, Lvov, Ukraine; [Zeljko, Tanja Vojvoda] Rudjer Boskovic Inst, Div Mol Biol, Zagreb, Croatia; [Sibirny, Andrei A.] Univ Rzeszow, Dept Biotechnol & Microbiol, Rzeszow, Poland	Lund University; Technical University of Denmark; National Academy of Sciences Ukraine; Institute of Cell Biology of NASU; Rudjer Boskovic Institute; University of Rzeszow	Ishchuk, OP (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.; Ishchuk, OP (corresponding author), NAS Ukraine, Inst Cell Biol, Dept Mol Genet & Biotechnol, Lvov, Ukraine.	olenkaishchuk@gmail.com	Andersen, Mikael Rørdam/P-6743-2019; Ishchuk, Olena/Q-4482-2019; Andersen, Mikael R/F-9377-2013	Andersen, Mikael Rørdam/0000-0003-4794-6808; Ishchuk, Olena/0000-0001-6485-9779; Andersen, Mikael R/0000-0003-4794-6808; Sibirny, Andriy/0000-0001-8579-1566	Sorensen Fondations; INTAS [05-1000005-7730]; Swedish Institute Visby programme; Crafoord; Futura; Triggers	Sorensen Fondations; INTAS(INTASEuropean Commission); Swedish Institute Visby programme; Crafoord; Futura; Triggers	This work was supported by the Crafoord, Futura, Triggers, Sorensen Fondations, INTAS #05-1000005-7730, and Swedish Institute Visby programme.; This work was supported by the Crafoord, Futura, Triggers, Sorensen Fondations, INTAS #05-1000005-7730, and Swedish Institute Visby programme. The authors thank Judith Berman for kindly providing CaCse4 antibodies, Magnus Carlquist for flowcytometry assistance, and James E. Blevins for suggestions on and editing of the manuscript. Jure Piskur passed away before the submission of the final version of this manuscript. Corresponding author Olena P. Ishchuk accepts responsibility for the integrity and validity of the data collected and analyzed.	Agudo M, 2000, CHROMOSOMA, V109, P190, DOI 10.1007/s004120050427; Ahmad KM, 2013, ANTON LEEUW INT J G, V104, P111, DOI 10.1007/s10482-013-9931-3; Andersen KS, 2014, G3-GENES GENOM GENET, V4, P1671, DOI 10.1534/g3.114.010892; Barth G, 2013, YARROWIA LIPOLYTICA; BAUM M, 1994, MOL BIOL CELL, V5, P747, DOI 10.1091/mbc.5.7.747; Bensasson D, 2008, GENETICS, V178, P2161, DOI 10.1534/genetics.107.083980; BLOOM KS, 1982, COLD SPRING HARB SYM, V47, P1175, DOI 10.1101/SQB.1983.047.01.133; Boretsky Y, 1999, CURR GENET, V36, P215, DOI 10.1007/s002940050493; Borneman AR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004161; BROCK JAK, 1994, J CELL SCI, V107, P891; Cambareri EB, 1998, MOL CELL BIOL, V18, P5465, DOI 10.1128/MCB.18.9.5465; CANNON RD, 1990, MOL GEN GENET, V221, P210, DOI 10.1007/BF00261723; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Crauwels S, 2015, APPL MICROBIOL BIOT, V99, P9123, DOI 10.1007/s00253-015-6769-9; Curtin CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033840; Curtin CD, 2014, FEMS YEAST RES, V14, P997, DOI 10.1111/1567-1364.12198; Dhar MK, 2012, RES MICROBIOL, V163, P243, DOI 10.1016/j.resmic.2012.03.003; Fattash I, 2013, GENOME, V56, P475, DOI 10.1139/gen-2012-0174; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; FITZGERALDHAYES M, 1982, CELL, V29, P235, DOI 10.1016/0092-8674(82)90108-8; FOURNIER P, 1993, P NATL ACAD SCI USA, V90, P4912, DOI 10.1073/pnas.90.11.4912; HABER JE, 1984, GENETICS, V106, P185; HABER JE, 1984, GENETICS, V106, P207; Hellborg L, 2009, EUKARYOT CELL, V8, P1739, DOI 10.1128/EC.00115-09; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; HIETER P, 1985, CELL, V40, P381, DOI 10.1016/0092-8674(85)90152-7; HILL A, 1989, MOL CELL BIOL, V9, P1368, DOI 10.1128/MCB.9.3.1368; HILL A, 1987, MOL CELL BIOL, V7, P2397, DOI 10.1128/MCB.7.7.2397; HSIAO CL, 1981, P NATL ACAD SCI-BIOL, V78, P3760, DOI 10.1073/pnas.78.6.3760; HYMAN BC, 1982, P NATL ACAD SCI-BIOL, V79, P1578, DOI 10.1073/pnas.79.5.1578; Ketel C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000400; KIKUCHI Y, 1983, CELL, V35, P487, DOI 10.1016/0092-8674(83)90182-4; Kobayashi N, 2015, CURR BIOL, V25, P2026, DOI 10.1016/j.cub.2015.06.023; Lochmann B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002739; Lopez V, 2015, GENE DEV, V29, P322, DOI 10.1101/gad.254664.114; Lu C, 2012, MOL BIOL EVOL, V29, P1005, DOI 10.1093/molbev/msr282; Malik HS, 2009, CELL, V138, P1067, DOI 10.1016/j.cell.2009.08.036; McFarlane RJ, 2010, TRENDS GENET, V26, P209, DOI 10.1016/j.tig.2010.02.005; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Mishra PK, 2007, MOL GENET GENOMICS, V278, P455, DOI 10.1007/s00438-007-0263-8; Mizuno H, 2006, DNA RES, V13, P267, DOI 10.1093/dnares/dsm001; NEWLON CS, 1993, CURR OPIN GENET DEV, V3, P752, DOI 10.1016/S0959-437X(05)80094-2; PALZKILL TG, 1988, CELL, V53, P441, DOI 10.1016/0092-8674(88)90164-X; Petersen RF, 1999, INT J SYST BACTERIOL, V49, P1925, DOI 10.1099/00207713-49-4-1925; Piskur J, 2012, INT J FOOD MICROBIOL, V157, P202, DOI 10.1016/j.ijfoodmicro.2012.05.008; Polakova S, 2009, P NATL ACAD SCI USA, V106, P2688, DOI 10.1073/pnas.0809793106; Prochazka E, 2010, FEMS YEAST RES, V10, P545, DOI 10.1111/j.1567-1364.2010.00644.x; ROSE MD, 1991, METHOD ENZYMOL, V194, P195; Rozpedowska E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1305; Sabatinos Sarah A., 2009, V521, P449, DOI [10.1007/978-1-60327-815-7_25, 10.1007/978-1-60327-817-5_25]; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanyal K, 2004, P NATL ACAD SCI USA, V101, P11374, DOI 10.1073/pnas.0404318101; Sato H, 2012, CURR BIOL, V22, P658, DOI 10.1016/j.cub.2012.02.062; Schifferdecker AJ, 2016, APPL MICROBIOL BIOT, V100, P3219, DOI 10.1007/s00253-015-7266-x; Schifferdecker AJ, 2014, YEAST, V31, P323, DOI 10.1002/yea.3023; Selmecki AM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000705; Stimpson KM, 2012, CHROMOSOME RES, V20, P595, DOI 10.1007/s10577-012-9302-3; Sullivan BA, 1998, NAT GENET, V20, P227, DOI 10.1038/3024; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; Tan ZH, 2013, P NATL ACAD SCI USA, V110, P12367, DOI 10.1073/pnas.1301047110; Thrower DA, 2003, J CELL SCI, V116, P561, DOI 10.1242/jcs.00251; Tinline-Purvis H, 2009, EMBO J, V28, P3400, DOI 10.1038/emboj.2009.265; TSCHUMPER G, 1983, GENE, V23, P221, DOI 10.1016/0378-1119(83)90054-9; Vachova L, 2011, J CELL BIOL, V194, P679, DOI 10.1083/jcb.201103129; Vernis L, 2001, J MOL BIOL, V305, P203, DOI 10.1006/jmbi.2000.4300; Verstrepen KJ, 2004, NAT REV MICROBIOL, V2, P533, DOI 10.1038/nrmicro927; Voordeckers K, 2012, MOL MICROBIOL, V86, P225, DOI 10.1111/j.1365-2958.2012.08192.x; Wach A, 1994, MOL GENETICS YEAST P; Wong LH, 2004, TRENDS GENET, V20, P611, DOI 10.1016/j.tig.2004.09.011; Woolfit M, 2007, EUKARYOT CELL, V6, P721, DOI 10.1128/EC.00338-06	72	13	13	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161741	10.1371/journal.pone.0161741	http://dx.doi.org/10.1371/journal.pone.0161741			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560164	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258600089
J	Yeh, CC; Wang, WC; Wu, CS; Sung, FC; Su, CT; Shieh, YH; Chang, SN; Su, FH				Yeh, Chih-Ching; Wang, Wen-Chang; Wu, Chien-Sheng; Sung, Fung-Chang; Su, Chien-Tien; Shieh, Ying-Hua; Chang, Shih-Ni; Su, Fu-Hsiung			Association of Sjogrens Syndrome in Patients with Chronic Hepatitis Virus Infection: A Population-Based Analysis	PLOS ONE			English	Article							C VIRUS; B-VIRUS; EXTRAHEPATIC MANIFESTATIONS; AUTOIMMUNE-DISEASES; RHEUMATIC-DISEASES; SALIVARY-GLANDS; PROTECTIVE ROLE; TAIWAN; PREVALENCE; SIALADENITIS	Objective The association between Sjogren's syndrome (SS) and chronic hepatitis virus infection is inconclusive. Hepatitis B (HBV) and hepatitis C virus (HCV) infections are highly prevalent in Taiwan. We used a population-based case-control study to evaluate the associations between SS and HBV and HCV infections. Materials and Methods We identified 9,629 SS patients without other concomitant autoimmune diseases and 38,516 sex- and age-matched controls without SS from the Taiwan National Health Insurance claims data between 2000 and 2011. We utilized multivariate logistic regression to estimate the odds ratios (ORs) and 95% confidence intervals (Cis) of the associations between SS and HBV and HCV infections. Sex- and age-specific (<55 and >= 55 years) risks of SS were evaluated. Results The risk of SS was higher in patients with HCV than in those without chronic viral hepatitis (OR = 2.49, 95% CI = 2.16-2.86). Conversely, HBV infection was not associated with SS (OR = 1.10, 95% CI = 0.98-1.24). Younger HCV patients were at a higher risk for SS (<55 years: OR = 3.37, 95% CI = 2.62-4.35; >= 55 years: OR = 2.20, 95% CI = 1.84-2.62). Men with HCV were at a greater risk for SS (women: OR = 2.26, 95% CI = 1.94-2.63; men: OR = 4.22, 95% CI = 2.90-6.16). Only men with chronic HBV exhibited a higher risk of SS (OR = 1.61, 95% CI = 1.21-2.14). Conclusion HCV infection was associated with SS; however, HBV only associated with SS in men.	[Yeh, Chih-Ching; Su, Chien-Tien] Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth & Nutr, Taipei, Taiwan; [Yeh, Chih-Ching] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Wang, Wen-Chang] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei, Taiwan; [Wu, Chien-Sheng] Far Eastern Mem Hosp, Div Allergy Immunol & Rheumatol, Taipei, Taiwan; [Sung, Fung-Chang] China Med Univ, Dept Hlth Serv Adm, Coll Publ Hlth, Taichung, Taiwan; [Sung, Fung-Chang] Mahidol Univ, Fac Publ Hlth, Bangkok, Thailand; [Su, Chien-Tien; Su, Fu-Hsiung] Taipei Med Univ Hosp, Dept Family Med, Taipei, Taiwan; [Shieh, Ying-Hua; Su, Fu-Hsiung] Taipei Med Univ, Sch Med, Dept Family Med, Taipei, Taiwan; [Shieh, Ying-Hua] Taipei Med Univ, Wan Fang Hosp, Dept Family Med, Taipei, Taiwan; [Chang, Shih-Ni] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Su, Fu-Hsiung] Taipei Med Univ, Coll Nursing, Master Program Long Term Care, Taipei, Taiwan; [Su, Fu-Hsiung] Flinders Univ S Australia, Sch Med, Bedford Pk, SA, Australia	Taipei Medical University; China Medical University Taiwan; Taipei Medical University; Far Eastern Memorial Hospital; China Medical University Taiwan; Mahidol University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taipei Medical University; Flinders University South Australia	Su, FH (corresponding author), Taipei Med Univ Hosp, Dept Family Med, Taipei, Taiwan.; Su, FH (corresponding author), Taipei Med Univ, Sch Med, Dept Family Med, Taipei, Taiwan.; Su, FH (corresponding author), Taipei Med Univ, Coll Nursing, Master Program Long Term Care, Taipei, Taiwan.; Su, FH (corresponding author), Flinders Univ S Australia, Sch Med, Bedford Pk, SA, Australia.	williamsufh1@yahoo.com.tw	Wu, Chien-Sheng/M-9151-2013; Su, Fu-Hsiung/AAO-5468-2021	Wu, Chien-Sheng/0000-0003-2815-1743; Su, Fu-Hsiung/0000-0002-9867-7655; Wang, Wen-Chang/0000-0003-3124-2136	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MONW104-TDU-B-212-113002]; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM104010092]; NRPB Stroke Clinical Trial Consortium [MOST 103-2325-B-039-006]; Taipei Medical University Hospital [TMUH104-AE1-602, 105TMU-TMUH19]	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Taipei Medical University Hospital	This study was supported in part by a grant from Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MONW104-TDU-B-212-113002) (FCS), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM104010092) (FCS), NRPB Stroke Clinical Trial Consortium (MOST 103-2325-B-039-006), and Taipei Medical University Hospital (TMUH104-AE1-602 and 105TMU-TMUH19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello V, 2004, J HEPATOL, V40, P341, DOI 10.1016/j.jhep.2003.10.009; APROSINA ZG, 1993, TERAPEVT ARKH, V65, P73; Arrieta JJ, 2001, AM J PATHOL, V158, P259, DOI 10.1016/S0002-9440(10)63964-8; Bach JF, 2001, J AUTOIMMUN, V16, P347, DOI 10.1006/jaut.2000.0478; Brito-Zeron P, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0766-3; Bureau of National Health Insurance Taiwan, REG EX NHI INS PERS; Carrozzo M, 2014, WORLD J GASTROENTERO, V20, P7534, DOI 10.3748/wjg.v20.i24.7534; Ceribelli A, 2008, AUTOIMMUN REV, V8, P92, DOI 10.1016/j.autrev.2008.07.003; Chen CH, 2007, J FORMOS MED ASSOC, V106, P148, DOI 10.1016/S0929-6646(09)60231-X; Chen MH, 2012, CLIN RHEUMATOL, V31, P309, DOI 10.1007/s10067-011-1814-2; Chu FY, 2011, J MED VIROL, V83, P1514, DOI 10.1002/jmv.22127; Chung WS, 2014, J RHEUMATOL, V41, P909, DOI 10.3899/jrheum.131345; De Vita S, 2002, ISRAEL MED ASSOC J, V4, P1101; Fanchiang C., 2004, TAIWAN TODAY; Ferri C, 2004, SEMIN ARTHRITIS RHEU, V33, P355, DOI 10.1016/j.semarthrit.2003.10.001; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; GarciaCarrasco M, 1997, ANN RHEUM DIS, V56, P173, DOI 10.1136/ard.56.3.173; HADDAD J, 1992, LANCET, V339, P321, DOI 10.1016/0140-6736(92)91645-O; Himoto T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/871401; Hsu YC, 2015, GUT, V64, P495, DOI 10.1136/gutjnl-2014-308163; Huang JF, 2007, AM J GASTROENTEROL, V102, P1237, DOI 10.1111/j.1572-0241.2007.01181.x; Igoe A, 2013, CURR OPIN RHEUMATOL, V25, P480, DOI 10.1097/BOR.0b013e32836200d2; Koike K, 1997, P NATL ACAD SCI USA, V94, P233, DOI 10.1073/pnas.94.1.233; Liu JY, 2008, CLIN INFECT DIS, V46, P1761, DOI 10.1086/587992; Lo YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139687; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Lu MC, 2014, RHEUMATOL INT, V34, P1555, DOI 10.1007/s00296-014-3003-5; Marcos M, 2009, AUTOIMMUN REV, V8, P616, DOI 10.1016/j.autrev.2009.02.007; Maya R, 2008, CLIN REV ALLERG IMMU, V34, P85, DOI 10.1007/s12016-007-8013-6; Nagao Y, 2003, J GASTROEN HEPATOL, V18, P258, DOI 10.1046/j.1440-1746.2003.02982.x; Qin BD, 2015, ANN RHEUM DIS, V74, P1983, DOI 10.1136/annrheumdis-2014-205375; Ram M, 2008, AUTOIMMUN REV, V7, P621, DOI 10.1016/j.autrev.2008.06.008; Ramos-Casals M, 2005, MEDICINE, V84, P81, DOI 10.1097/01.md.0000157397.30055.c9; Ramos-Casals M, 2005, ANN RHEUM DIS, V64, P347, DOI 10.1136/ard.2004.025676; Ramos-Casals M, 2008, RHEUM DIS CLIN N AM, V34, P869, DOI 10.1016/j.rdc.2008.08.007; Ramos-Casals M, 2009, J RHEUMATOL, V36, P1442, DOI 10.3899/jrheum.080874; Shen TC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003066; Sherman AC, 2015, CURR HIV-AIDS REP, V12, P353, DOI 10.1007/s11904-015-0274-8; Su FH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-495; Thong BYH, 2007, ANN ACAD MED SINGAP, V36, P100; Toussirot E, 2002, J RHEUMATOL, V29, P2382; Trejo O, 2001, MEDICINE, V80, P252, DOI 10.1097/00005792-200107000-00004; Tsai JC, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008406; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Vitali C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3361; Wang Y, 2014, MICROBIOL IMMUNOL, V58, P675, DOI 10.1111/1348-0421.12202; Wu CS, 2008, CLIN RHEUMATOL, V27, P365, DOI 10.1007/s10067-007-0783-y; Yu KH, 2013, ARTHRIT CARE RES, V65, P244, DOI 10.1002/acr.21820; Yu ML, 2001, J MED VIROL, V65, P58, DOI 10.1002/jmv.2001; Zignego AL, 2007, DIGEST LIVER DIS, V39, P2, DOI 10.1016/j.dld.2006.06.008	50	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161958	10.1371/journal.pone.0161958	http://dx.doi.org/10.1371/journal.pone.0161958			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560377	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258600120
J	Blaimer, BB; Lloyd, MW; Guillory, WX; Brady, SG				Blaimer, Bonnie B.; Lloyd, Michael W.; Guillory, Wilson X.; Brady, Sean G.			Sequence Capture and Phylogenetic Utility of Genomic Ultraconserved Elements Obtained from Pinned Insect Specimens	PLOS ONE			English	Article							LARGE CARPENTER BEES; GENUS XYLOCOPA HYMENOPTERA; MOLECULAR PHYLOGENY; MUSEUM SPECIMENS; DNA; COLLECTIONS; PRESERVATION; BIOGEOGRAPHY; THOUSANDS; SAMPLES	Obtaining sequence data from historical museum specimens has been a growing research interest, invigorated by next-generation sequencing methods that allow inputs of highly degraded DNA. We applied a target enrichment and next-generation sequencing protocol to generate ultraconserved elements (UCEs) from 51 large carpenter bee specimens (genus Xylocopa), representing 25 species with specimen ages ranging from 2-121 years. We measured the correlation between specimen age and DNA yield (pre- and post-library preparation DNA concentration) and several UCE sequence capture statistics (raw read count, UCE reads on target, UCE mean contig length and UCE locus count) with linear regression models. We performed piecewise regression to test for specific breakpoints in the relationship of specimen age and DNA yield and sequence capture variables. Additionally, we compared UCE data from newer and older specimens of the same species and reconstructed their phylogeny in order to confirm the validity of our data. We recovered 6-972 UCE loci from samples with pre-library DNA concentrations ranging from 0.06-9.8 ng/mu L. All investigated DNA yield and sequence capture variables were significantly but only moderately negatively correlated with specimen age. Specimens of age 20 years or less had significantly higher pre- and post-library concentrations, UCE contig lengths, and locus counts compared to specimens older than 20 years. We found breakpoints in our data indicating a decrease of the initial detrimental effect of specimen age on pre- and post-library DNA concentration and UCE contig length starting around 21-39 years after preservation. Our phylogenetic results confirmed the integrity of our data, giving preliminary insights into relationships within Xylocopa. We consider the effect of additional factors not measured in this study on our age-related sequence capture results, such as DNA fragmentation and preservation method, and discuss the promise of the UCE approach for large-scale projects in insect phylogenomics using museum specimens.	[Blaimer, Bonnie B.; Lloyd, Michael W.; Brady, Sean G.] Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20560 USA; [Guillory, Wilson X.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; University of Arkansas System; University of Arkansas Fayetteville	Blaimer, BB (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20560 USA.	bonnieblaimer@gmail.com	Lloyd, Michael/C-8430-2017	Lloyd, Michael/0000-0003-1021-8129	Smithsonian Institution Competitive Grants Program for Science; Smithsonian Global Genome Initiative; NHRE - NSF-REU program [EAR-1062692]	Smithsonian Institution Competitive Grants Program for Science; Smithsonian Global Genome Initiative; NHRE - NSF-REU program	Funding for this study was provided by the Smithsonian Institution Competitive Grants Program for Science and a Smithsonian Global Genome Initiative (www.ggi.si.edu) grant (to SGB). WXG was supported by an NHRE summer research internship for undergraduates funded by the NSF-REU program (grant number EAR-1062692, awarded to Elizabeth Cottrell and Gene Hunt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey SE, 2016, BIOL J LINN SOC, V117, P58, DOI 10.1111/bij.12620; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bi K, 2013, MOL ECOL, V22, P6018, DOI 10.1111/mec.12516; Blaimer BB, 2016, MOL PHYLOGENET EVOL, V102, P20, DOI 10.1016/j.ympev.2016.05.030; Blaimer BB, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0552-5; Blumenstiel B, 2010, CURR PROTOC HUM S66; Bolger AM, 2014, BIOINFORMATICS; Borowiec ML, 2016, PEERJ, V4, DOI 10.7717/peerj.1660; Buerki S, 2016, BIOL J LINN SOC, V117, P5, DOI 10.1111/bij.12721; Burrell AS, 2015, J HUM EVOL, V79, P35, DOI 10.1016/j.jhevol.2014.10.015; Campbell, 2014, DNA BANKING 21 CENTU, P9; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Crawford NG, 2012, BIOL LETTERS, V8, P783, DOI 10.1098/rsbl.2012.0331; Dillon N, 1996, INSECT MOL BIOL, V5, P21, DOI 10.1111/j.1365-2583.1996.tb00036.x; Droege G, 2013, NUCL ACIDS RES; Enk J, 2013, BIOTECHNIQUES, V55, P300, DOI 10.2144/000114114; Faircloth B., 2015, PHYLUCE IS SOFTWARE; Faircloth B.C., 2013, ILLUMIPROCESSOR TRIM; Faircloth BC, 2015, MOL ECOL RESOUR, V15, P489, DOI 10.1111/1755-0998.12328; Faircloth BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042543; Faircloth BC, 2012, SYST BIOL, V61, P717, DOI 10.1093/sysbio/sys004; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Frandsen PB, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0283-7; GERLING D, 1989, ANNU REV ENTOMOL, V34, P163, DOI 10.1146/annurev.en.34.010189.001115; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guschanski K, 2013, SYST BIOL, V62, P539, DOI 10.1093/sysbio/syt018; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Katoh K, 2013, BIOINFORMATICS DNA S, P39; Keasar Tamar, 2010, Psyche (Cambridge), V2010, P1, DOI 10.1155/2010/927463; Leys R, 2002, BIOL J LINN SOC, V77, P249, DOI 10.1046/j.1095-8312.2002.00108.x; Leys R, 2000, MOL PHYLOGENET EVOL, V17, P407, DOI 10.1006/mpev.2000.0851; Leys R, 2008, APIDOLOGIE, V39, P119, DOI 10.1051/apido:2007044; Lucia M, 2015, ZOOKEYS, P129, DOI 10.3897/zookeys.543.6300; McCormack JE, 2016, MOL ECOL RESOUR, V16, P1189, DOI 10.1111/1755-0998.12466; Michener C.D., 2007, BEES WORLD, Vsecond; Miller JA, 2013, ZOOKEYS, P245, DOI 10.3897/zookeys.365.5787; Mitchell A, 2015, MOL ECOL RESOUR, V15, P1102, DOI 10.1111/1755-0998.12380; Muggeo V.M., 2008, R NEWS, V8, P20; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; POST RJ, 1993, BIOCHEM SYST ECOL, V21, P85, DOI 10.1016/0305-1978(93)90012-G; Prendini L, 2002, METH TOOLS BIOSCI ME, P176; Prosser SWJ, 2016, MOL ECOL RESOUR, V16, P487, DOI 10.1111/1755-0998.12474; R Core Team, 2013, R LANG ENV STAT COMP; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Rowe KC, 2011, MOL ECOL RESOUR, V11, P1082, DOI 10.1111/j.1755-0998.2011.03052.x; Smith BT, 2014, SYST BIOL, V63, P83, DOI 10.1093/sysbio/syt061; Staats M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069189; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; Suchan T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151651; Timmermans MJTN, 2016, BIOL J LINN SOC, V117, P83, DOI 10.1111/bij.12552; Tin MMY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096793; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; Yeates DK, 2016, CURR OPIN INSECT SCI, V13, P16, DOI 10.1016/j.cois.2015.10.007	54	99	103	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161531	10.1371/journal.pone.0161531	http://dx.doi.org/10.1371/journal.pone.0161531			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556533	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258100049
J	Bolduc, F; Garant, JM; Allard, F; Perreault, JP				Bolduc, Francois; Garant, Jean-Michel; Allard, Felix; Perreault, Jean-Pierre			Irregular G-quadruplexes Found in the Untranslated Regions of Human mRNAs Influence Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G-quadruplex; gene expression; RNA; RNA structure; translation; in-line probing	TELOMERIC DNA; STABILITY; LOOP; OLIGONUCLEOTIDES; POLYADENYLATION; SUPPRESSION; EXPRESSION; CANCER; LENGTH; CELLS	G-quadruplex structures are composed of coplanar guanines and are found in both DNA and RNA. They are formed by the stacking of two or more G-quartets that are linked together by three loops. The current belief is that RNA G-quadruplexes include loops of l to 7 nucleotides in length, although recent evidence indicates that the central loop (loop 2) can be longer if loops 1 and 3 are limited to a single nucleotide each. With the objective of broadening the definition of irregular RNA G-quadruplexes, a bioinformatic search was performed to find potential G-quadruplexes located in the untranslated regions of human mRNAs (i.e. in the 5 and 3-UTRs) that contain either a long loop 1 or 3 of up to 40 nucleotides in length. RNA molecules including the potential sequences were then synthesized and examined in vitro by in-line probing for the formation of G-quadruplex structures. The sequences that adopted a G-quadruplex structure were cloned into a luciferase dual vector and examined for their ability to modulate translation in cellulo. Some irregular G-quadruplexes were observed to either promote or repress translation regardless of the position or the size of the long loop they possessed. Even if the composition of a RNA G-quadruplex is not quite completely understood, the results presented in this report clearly demonstrate that what defines a RNA G-quadruplex is much broader than what we previously believed.	[Bolduc, Francois; Garant, Jean-Michel; Allard, Felix; Perreault, Jean-Pierre] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, RNA Grp,Grp ARN, Pavillon Rech Appl Canc, Sherbrooke, PQ J1E 4K8, Canada; [Perreault, Jean-Pierre] CHUS, Ctr Rech, Paris, France	University of Sherbrooke	Perreault, JP (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Pavillon Rech Appl Canc,3201 Jean Mignault, Sherbrooke, PQ J1E 4K8, Canada.	jean-pierre.perreault@usherbrooke.ca	Garant, Jean-Michel/AAA-1692-2019	Garant, Jean-Michel/0000-0002-0559-5598	Universite de Sherbrooke	Universite de Sherbrooke	We thank Andrea Brumwell for technical assistance. The RNA group is supported by a grant from the Universite de Sherbrooke.	Agarwala P, 2015, ORG BIOMOL CHEM, V13, P5570, DOI 10.1039/c4ob02681k; Agarwala P, 2014, BBA-GEN SUBJECTS, V1840, P3503, DOI 10.1016/j.bbagen.2014.08.017; Agarwala P, 2013, BIOCHEMISTRY-US, V52, P1528, DOI 10.1021/bi301365g; Arora A, 2011, RNA BIOL, V8, P802, DOI 10.4161/rna.8.5.16038; Beaudoin JD, 2014, NUCLEIC ACIDS RES, V42, P1209, DOI 10.1093/nar/gkt904; Beaudoin JD, 2013, METHODS, V64, P79, DOI 10.1016/j.ymeth.2013.02.017; Beaudoin JD, 2013, NUCLEIC ACIDS RES, V41, P5898, DOI 10.1093/nar/gkt265; Beaudoin JD, 2010, NUCLEIC ACIDS RES, V38, P7022, DOI 10.1093/nar/gkq557; Bedrat A, 2016, NUCLEIC ACIDS RES, V44, P1746, DOI 10.1093/nar/gkw006; Biffi G, 2014, NAT CHEM, V6, P75, DOI [10.1038/NCHEM.1805, 10.1038/nchem.1805]; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Crenshaw E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143160; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; Decorsiere A, 2011, GENE DEV, V25, P220, DOI 10.1101/gad.607011; Dhayan H, 2014, ARCH BIOCHEM BIOPHYS, V560, P52, DOI 10.1016/j.abb.2014.07.016; Endoh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep22719; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Guedin A, 2010, NUCLEIC ACIDS RES, V38, P7858, DOI 10.1093/nar/gkq639; Halder K, 2011, METAL IONS LIFE SCI, V9, P125, DOI 10.1039/978184973251200125; Halder K, 2009, NUCLEIC ACIDS RES, V37, P6811, DOI 10.1093/nar/gkp696; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Joachimi A, 2009, BIOORGAN MED CHEM, V17, P6811, DOI 10.1016/j.bmc.2009.08.043; Jodoin R, 2014, RNA, V20, P1129, DOI 10.1261/rna.044578.114; Johnson JE, 2008, BIOCHIMIE, V90, P1250, DOI 10.1016/j.biochi.2008.02.013; Lin YF, 2012, NUCLEIC ACIDS RES, V40, P8460, DOI 10.1093/nar/gks637; Morris MJ, 2010, J AM CHEM SOC, V132, P17831, DOI 10.1021/ja106287x; Pandey S, 2013, J PHYS CHEM B, V117, P6896, DOI 10.1021/jp401739m; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Ribeiro MM, 2015, HUM GENET, V134, P37, DOI 10.1007/s00439-014-1485-6; Rouleau SG, 2015, NUCLEIC ACIDS RES, V43, P595, DOI 10.1093/nar/gku1311; Sacca B, 2005, NUCLEIC ACIDS RES, V33, P1182, DOI 10.1093/nar/gki257; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Subramanian M, 2011, EMBO REP, V12, P697, DOI 10.1038/embor.2011.76; Thandapani P, 2015, ELIFE, V4, DOI 10.7554/eLife.06234; Wang CQ, 2015, INT J BIOL SCI, V11, P316, DOI 10.7150/ijbs.10528; Wang SK, 2015, CURR TOP MED CHEM, V15, P1947, DOI 10.2174/1568026615666150515145733; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; Wolfe AL, 2014, NATURE, V513, P65, DOI 10.1038/nature13485; Zhang AYQ, 2011, BIOCHEMISTRY-US, V50, P7251, DOI 10.1021/bi200805j	41	31	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21751	21760		10.1074/jbc.M116.744839	http://dx.doi.org/10.1074/jbc.M116.744839			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27557661	Green Published, hybrid			2022-12-26	WOS:000385999200039
J	Kao, JH; Lin, SH; Lai, CF; Lin, YC; Kong, ZL; Wong, CS				Kao, Jen-Hsin; Lin, Sheng-Hsiung; Lai, Chun-Fu; Lin, Yu-Chieh; Kong, Zwe-Ling; Wong, Chih-Shung			Shea Nut Oil Triterpene Concentrate Attenuates Knee Osteoarthritis Development in Rats: Evidence from Knee Joint Histology	PLOS ONE			English	Article							CRUCIATE LIGAMENT TRANSECTION; ADJUVANT-INDUCED ARTHRITIS; NURVALA STEM BARK; SUBCHONDRAL BONE; ANTIINFLAMMATORY ACTIVITY; INTRAARTICULAR INJECTION; ARTICULAR-CARTILAGE; LUPEOL LINOLEATE; GLUCOSAMINE; CHONDROITIN	Background Shea nut oil triterpene concentrate is considered to have anti-inflammatory and antioxidant properties. Traditionally, it has been used to treat arthritic conditions in humans. This study aimed to investigate the effect of attenuating osteoarthritis (OA)-induced pain and joint destruction in rats by administering shea nut oil triterpene concentrate (SheaFlex75, which is more than 50% triterpenes). Methods An anterior cruciate ligament transaction (ACLT) with medial meniscectomy (MMx) was used to induce OA in male Wistar rats. Different doses of SheaFlex75 (111.6 mg/kg, 223.2 mg/kg, and 446.4 mg/kg) were then intragastrically administered daily for 12 weeks after surgery. Body weight and the width of the knee joint were measured weekly. Additionally, incapacitance tests were performed at weeks 2, 4, 6, 8, 10 and 12 to measure the weight bearing of the hind limbs, and the morphology and histopathology of the medial femoral condyles were examined and were evaluated using the Osteoarthritis Research Society International (OARSI) scoring system. Results This study showed that SheaFlex75 reduced the swelling of the knee joint with OA and rectified its weight bearing after ACLT plus MMx surgery in rats. Treatment with SheaFlex75 also decreased ACLT plus MMx surgery-induced knee joint matrix loss and cartilage degeneration. Conclusion SheaFlex75 relieves the symptoms of OA and protects cartilage from degeneration. SheaFlex75 thus has the potential to be an ideal nutraceutical supplement for joint protection, particularly for injured knee joints.	[Kao, Jen-Hsin] Cathay Gen Hosp, Dept Med Res, Taipei, Taiwan; [Lin, Sheng-Hsiung; Wong, Chih-Shung] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Lai, Chun-Fu] Natl Def Med Ctr, Dept Family & Community Med, Triserv Gen Hosp, Taipei, Taiwan; [Lai, Chun-Fu] Triserv Gen Hosp, Songshan Branch, Dept Family Med, Taipei, Taiwan; [Lin, Yu-Chieh] Natl Def Med Ctr, Dept Pathol, Triserv Gen Hosp, Taipei, Taiwan; [Lin, Yu-Chieh] Taoyuan Armed Forces Gen Hosp, Dept Pathol, Taoyuan, Taiwan; [Lin, Yu-Chieh] Natl Def Med Ctr, Taipei, Taiwan; [Kong, Zwe-Ling] Natl Taiwan Ocean Univ, Dept Food Sci, Keelung, Taiwan; [Wong, Chih-Shung] Cathay Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Kao, Jen-Hsin] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan	Cathay General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Taiwan Ocean University; Cathay General Hospital; National Defense Medical Center	Wong, CS (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.; Wong, CS (corresponding author), Cathay Gen Hosp, Dept Anesthesiol, Taipei, Taiwan.	w82556@gmail.com	Kong, Zwe-Ling/AAB-5261-2019; Kong, Zwe-Ling/E-8763-2013; Kong, Zwe-Ling/AAB-5328-2019	Kong, Zwe-Ling/0000-0002-4877-6524; Kong, Zwe-Ling/0000-0002-4877-6524; LAI, CHUN-FU/0000-0003-2109-1522	Universal Integrated Corp., Taipei, Taiwan	Universal Integrated Corp., Taipei, Taiwan	This study received financial support in the form of a contract from Universal Integrated Corp., Taipei, Taiwan, a commercial company. Universal Integrated Corp. was not involved in any part of the study design or conduct, data collection or data analysis, or manuscript writing.; The SheaFlex75 was provided by Universal Integrated CORP., Taipei, Taiwan. This study was supported by Universal Integrated CORP., Taipei, Taiwan. Financial disclosure statements have been submitted, and no conflict of interest has been reported by the authors.	Akihisa T, 1996, PHYTOCHEMISTRY, V43, P1255, DOI 10.1016/S0031-9422(96)00343-3; Akihisa T, 2010, J OLEO SCI, V59, P273, DOI 10.5650/jos.59.273; Ameye LG, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2016; Azebaze AGB, 2009, PLANTA MED, V75, P243, DOI 10.1055/s-0028-1088375; Banno N, 2006, J ETHNOPHARMACOL, V107, P249, DOI 10.1016/j.jep.2006.03.006; Baragi VM, 2009, ARTHRITIS RHEUM-US, V60, P2008, DOI 10.1002/art.24629; Bendele A. M., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P363; Bove SE, 2006, OSTEOARTHR CARTILAGE, V14, P1041, DOI 10.1016/j.joca.2006.05.001; Brown TD, 2006, J ORTHOP TRAUMA, V20, P739, DOI 10.1097/01.bot.0000246468.80635.ef; Chen SP, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/147163; Cheras PA, 2010, PHYTOTHER RES, V24, P1126, DOI 10.1002/ptr.3075; Chou MM, 2005, EXP BIOL MED, V230, P255; Creamer P, 2000, CURR OPIN RHEUMATOL, V12, P450, DOI 10.1097/00002281-200009000-00019; Ernst E, 2003, CLIN RHEUMATOL, V22, P285, DOI 10.1007/s10067-003-0731-4; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Felson DT, 2000, ANN INTERN MED, V133, P726, DOI 10.7326/0003-4819-133-9-200011070-00015; Fernihough J, 2004, PAIN, V112, P83, DOI 10.1016/j.pain.2004.08.004; Fransen M, 2015, ANN RHEUM DIS, V74, P851, DOI 10.1136/annrheumdis-2013-203954; Geetha T, 2001, J ETHNOPHARMACOL, V76, P77, DOI 10.1016/S0378-8741(01)00175-1; Geetha T, 1999, MOL CELL BIOCHEM, V201, P83, DOI 10.1023/A:1007056300503; Geetha T, 1999, GEN PHARMACOL-VASC S, V32, P495, DOI 10.1016/S0306-3623(98)00212-2; Geetha T, 1998, PHARMACOL RES, V37, P191, DOI 10.1006/phrs.1997.0278; Gerwin N, 2010, OSTEOARTHR CARTILAGE, V18, pS24, DOI 10.1016/j.joca.2010.05.030; Guzman RE, 2003, TOXICOL PATHOL, V31, P619, DOI 10.1080/01926230390241800; Hayami T, 2006, BONE, V38, P234, DOI 10.1016/j.bone.2005.08.007; Hayami T, 2004, ARTHRITIS RHEUM-US, V50, P1193, DOI 10.1002/art.20124; Henrotin YE, 1998, CLIN RHEUMATOL, V17, P31, DOI 10.1007/BF01450955; Honfo FG, 2014, CRIT REV FOOD SCI, V54, P673, DOI 10.1080/10408398.2011.604142; ITOH T, 1975, LIPIDS, V10, P808, DOI 10.1007/BF02532325; Janusz MJ, 2002, OSTEOARTHR CARTILAGE, V10, P785, DOI 10.1053/joca.2002.0823; Janusz MJ, 2001, OSTEOARTHR CARTILAGE, V9, P751, DOI 10.1053/joca.2001.0472; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; KWEIFIOOKAI G, 1995, J ETHNOPHARMACOL, V46, P7, DOI 10.1016/0378-8741(95)01222-Y; KWEIFIOOKAI G, 1994, RES COMMUN MOL PATH, V85, P45; Lozoya KAA, 2000, PATHOL RES PRACT, V196, P729; PEERS KE, 1977, J SCI FOOD AGR, V28, P1000, DOI 10.1002/jsfa.2740281109; de Andrade MAP, 2015, ARTHROSCOPY, V31, P785, DOI 10.1016/j.arthro.2014.11.021; Siddique HR, 2011, LIFE SCI, V88, P285, DOI 10.1016/j.lfs.2010.11.020; Thysen S, 2015, DIS MODEL MECH, V8, P17, DOI 10.1242/dmm.016881; Tsai WY, 2013, CONNECT TISSUE RES, V54, P49, DOI 10.3109/03008207.2012.734877; Van Vijven JPJ, 2012, OSTEOARTHR CARTILAGE, V20, P809, DOI 10.1016/j.joca.2012.04.008; Yang SB, 2015, ARTHRITIS RHEUMATOL, V67, P714, DOI 10.1002/art.38932; Yorimitsu M, 2008, OSTEOARTHR CARTILAGE, V16, P764, DOI 10.1016/j.joca.2007.11.006; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013	44	17	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162022	10.1371/journal.pone.0162022	http://dx.doi.org/10.1371/journal.pone.0162022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583436	Green Submitted, Green Published, gold			2022-12-26	WOS:000382855600086
J	Morineau, C; Gissot, L; Bellec, Y; Hematy, K; Tellier, F; Renne, C; Haslam, R; Beaudoin, F; Napier, J; Faure, JD				Morineau, Celine; Gissot, Lionel; Bellec, Yannick; Hematy, Kian; Tellier, Frederique; Renne, Charlotte; Haslam, Richard; Beaudoin, Frederic; Napier, Johnathan; Faure, Jean-Denis			Dual Fatty Acid Elongase Complex Interactions in Arabidopsis	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; SPHINGOLIPID SYNTHESIS; CELL-PROLIFERATION; SECRETORY PATHWAY; PASTICCINO GENES; PLASMA-MEMBRANE; PLANT; THALIANA; REDUCTASE; DIVISION	Very long chain fatty acids (VLCFAs) are involved in plant development and particularly in several cellular processes such as membrane trafficking, cell division and cell differentiation. However, the precise role of VLCFAs in these different cellular processes is still poorly understood in plants. In order to identify new factors associated with the biosynthesis or function of VLCFAs, a yeast multicopy suppressor screen was carried out in a yeast mutant strain defective for fatty acid elongation. Loss of function of the elongase 3 hydroxyacyl-CoA dehydratase PHS1 in yeast and PASTICCINO2 in plants prevents growth and induces cytokinesis defects. PROTEIN TYROSIN PHOSPHATASE-LIKE (PTPLA) previously characterized as an inactive dehydratase was able to restore yeast phs1 growth and VLCFAs elongation but not the plant pas2-1 defects. PTPLA interacted with elongase subunits in the Endoplasmic Reticulum (ER) and its absence induced the accumulation of 3-hydroxyacyl-CoA as expected from a dehydratase involved in fatty acid (FA) elongation. However, loss of PTPLA function increased VLCFA levels, an effect that was dependent on the presence of PAS2 indicating that PTPLA activity repressed FA elongation. The two dehydratases have specific expression profiles in the root with PAS2, mostly restricted to the endodermis, while PTPLA was confined in the vascular tissue and pericycle cells. Comparative ectopic expression of PTPLA and PAS2 in their respective domains confirmed the existence of two independent elongase complexes based on PAS2 or PTPLA dehydratase that are functionally interacting.	[Morineau, Celine; Gissot, Lionel; Bellec, Yannick; Hematy, Kian; Tellier, Frederique; Renne, Charlotte; Faure, Jean-Denis] Univ Paris Saclay, Inst Jean Pierre Bourgin, INRA, AgroParisTech,CNRS, Versailles, France; [Morineau, Celine] Univ Paris Saclay, Univ Paris 11, Orsay, France; [Haslam, Richard; Beaudoin, Frederic; Napier, Johnathan] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden, Herts, England	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Faure, JD (corresponding author), Univ Paris Saclay, Inst Jean Pierre Bourgin, INRA, AgroParisTech,CNRS, Versailles, France.	jean-denis.faure@versailles.inra.fr	Hématy, Kian/AAD-8989-2021	Hematy, Kian/0000-0002-3933-3852; Haslam, Richard/0000-0001-6226-5643; Napier, Johnathan/0000-0003-3580-3607; Faure, Jean-Denis/0000-0001-6867-6021	Ministere de l'Enseignement Superieur et de la Recherche (France); LabEx Saclay Plant Sciences-SPS [ANR-10-LABX-0040-SPS]; BBSRC [BBS/E/C/00005207] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005207] Funding Source: researchfish	Ministere de l'Enseignement Superieur et de la Recherche (France); LabEx Saclay Plant Sciences-SPS; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Ministere de l'Enseignement Superieur et de la Recherche (France) (doctoral fellowship to CM).; We thank the Plant Observatory imaging platform of the IJPB institute for providing microscopy technical support and the chemistry platform for the FAMES analysis. We thank also Frederic Beaudoin (Departement of Biological Chemistry and Crop Protection; Rothamsted Research; UK), Jerome Joubes (Laboratoire de Biogenese membranaire; CNRS UMR 5200, France) Ljerka Kunst (Department of Botany; University of British Columbia; Canada) and Sebastien Baud (IJPB, INRA, Versailles, France) for providing seeds and DNA as well as the European Arabidopsis Stock Center for providing Arabidopsis T-DNA insertion mutant. This work was funded by the Ministere de l'Enseignement Superieur et de la Recherche (France) (doctoral fellowship to C.M.). The IJPB benefits from the support of the LabEx Saclay Plant Sciences-SPS (ANR-10-LABX-0040-SPS).	Agbaga MP, 2008, P NATL ACAD SCI USA, V105, P12843, DOI 10.1073/pnas.0802607105; Bach L, 2008, P NATL ACAD SCI USA, V105, P14727, DOI 10.1073/pnas.0805089105; Bach L, 2011, J CELL SCI, V124, P3223, DOI 10.1242/jcs.074575; Beaudoin F, 2009, PLANT PHYSIOL, V150, P1174, DOI 10.1104/pp.109.137497; Bellec Y, 2002, PLANT J, V32, P713, DOI 10.1046/j.1365-313X.2002.01456.x; Blacklock BJ, 2006, BIOCHEM BIOPH RES CO, V346, P583, DOI 10.1016/j.bbrc.2006.05.162; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Denic V, 2007, CELL, V130, P663, DOI 10.1016/j.cell.2007.06.031; Faure JD, 1998, DEVELOPMENT, V125, P909; Franke RB, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00004; Gable K, 2004, J EXP BOT, V55, P543, DOI 10.1093/jxb/erh061; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gutierrez R, 2009, NAT CELL BIOL, V11, P797, DOI 10.1038/ncb1886; Harrar Y, 2003, PLANT PHYSIOL, V132, P1217, DOI 10.1104/pp.102.019026; Haslam TM, 2013, PLANT SCI, V210, P93, DOI 10.1016/j.plantsci.2013.05.008; Haynes CA, 2008, J LIPID RES, V49, P1113, DOI 10.1194/jlr.D800001-JLR200; Ianiri G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105147; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Joubes J, 2008, PLANT MOL BIOL, V67, P547, DOI 10.1007/s11103-008-9339-z; Kihara A, 2008, J BIOL CHEM, V283, P11199, DOI 10.1074/jbc.M708993200; Larson TR, 2001, PLANT J, V25, P115, DOI 10.1046/j.1365-313x.2001.00929.x; Lee SB, 2009, PLANT J, V60, P462, DOI 10.1111/j.1365-313X.2009.03973.x; Li YH, 2006, PHYTOCHEMISTRY, V67, P904, DOI 10.1016/j.phytochem.2006.02.015; Markham JE, 2006, J BIOL CHEM, V281, P22684, DOI 10.1074/jbc.M604050200; Markham JE, 2011, PLANT CELL, V23, P2362, DOI 10.1105/tpc.110.080473; Millar AA, 1998, PLANT CELL, V10, P1889, DOI 10.1105/tpc.10.11.1889; Millar AA, 1997, PLANT J, V12, P121, DOI 10.1046/j.1365-313X.1997.12010121.x; MINET M, 1992, PLANT J, V2, P417; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Molino D, 2014, BBA-MOL CELL BIOL L, V1841, P1422, DOI 10.1016/j.bbalip.2014.06.014; Muhammad E, 2013, HUM MOL GENET, V22, P5229, DOI 10.1093/hmg/ddt380; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nobusawa T, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001531; Nobusawa T, 2012, GENES CELLS, V17, P709, DOI 10.1111/j.1365-2443.2012.01619.x; Obara K, 2013, J LIPID RES, V54, P831, DOI 10.1194/jlr.M034678; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Park JA, 2005, FEBS LETT, V579, P4459, DOI 10.1016/j.febslet.2005.07.013; Pele M, 2005, HUM MOL GENET, V14, P1417, DOI 10.1093/hmg/ddi151; Pruitt RE, 2000, P NATL ACAD SCI USA, V97, P1311, DOI 10.1073/pnas.97.3.1311; Reina-Pinto JJ, 2009, PLANT CELL, V21, P1252, DOI 10.1105/tpc.109.065565; Roudier F, 2010, PLANT CELL, V22, P364, DOI 10.1105/tpc.109.071209; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Trenkamp S, 2004, P NATL ACAD SCI USA, V101, P11903, DOI 10.1073/pnas.0404600101; Van Leene J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.53; Yu L, 2006, MOL BIOL CELL, V17, P4736, DOI 10.1091/mbc.E06-04-0368; Zheng HQ, 2005, PLANT CELL, V17, P1467, DOI 10.1105/tpc.104.030155	48	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0160631	10.1371/journal.pone.0160631	http://dx.doi.org/10.1371/journal.pone.0160631			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583779	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600008
J	Paul, SP				Paul, Sharad P.			Golden Spirals and Scalp Whorls: Nature's Own Design for Rapid Expansion	PLOS ONE			English	Article							TISSUE EXPANSION; ADIPOSE-TISSUE; SKIN; LOCATIONS	This paper documents what began as an exercise in curiosity-logarithmic spiral designs abound in nature-in galaxies, flowers, even pinecones, and on human scalps as whorls. Why are humans the only primates to have whorls on the scalp? Is the formation of scalp whorls mechanical or genetic? A mechanical theory has long been postulated-the mechanical theory suggests that hair whorl patterning is determined by the tension on the epidermis during rapid expansion of the cranium while the hair follicle is growing downwards-however, this has never before, to the author's knowledge, been experimentally proven conclusively. We found, that under certain conditions, we were able to experimentally recreate spirals on the scalp to demonstrate that the basis of scalp whorls is indeed mechanical-and that logarithmic spirals may be nature's own design for rapid expansion of organic tissues. Given our experiments only created whorls when certain conditions were satisfied (and not in others), they have given us great insight into the mechanical formation of skin whorls and the physiology of skin stretch. We believe that these findings will lead to many more advances in understanding skin dynamics and indeed the changes that occur in tissue when confronted by stretch.	[Paul, Sharad P.] Univ Queensland, Sch Med, 288 Herston Rd, Herston, Qld 4006, Australia; [Paul, Sharad P.] Univ Auckland, Fac Surg, 2 Pk Rd, Auckland 1023, New Zealand; [Paul, Sharad P.] Auckland Univ Technol, 55 Wellesley St E, Auckland 1010, New Zealand	University of Queensland; University of Auckland; Auckland University of Technology	Paul, SP (corresponding author), Univ Queensland, Sch Med, 288 Herston Rd, Herston, Qld 4006, Australia.; Paul, SP (corresponding author), Univ Auckland, Fac Surg, 2 Pk Rd, Auckland 1023, New Zealand.; Paul, SP (corresponding author), Auckland Univ Technol, 55 Wellesley St E, Auckland 1010, New Zealand.	sharad@sharadpaul.com	Paul, Sharad P/A-3804-2017	Paul, Sharad P/0000-0001-9601-9109				ANDERSON DB, 1972, J LIPID RES, V13, P593; [Anonymous], 2005, NATURE, V436, P757; [Anonymous], 1933, J FRANKLIN I, V215, P352; BORGES AF, 1984, PLAST RECONSTR SURG, V73, P144, DOI 10.1097/00006534-198401000-00036; Catrakis H. J., 2011, J MATH RES, V3, P3; Chandawarkar RY, 2003, DERMATOL SURG, V29, P834, DOI 10.1046/j.1524-4725.2003.29218.x; Driskell RR, 2014, EXP DERMATOL, V23, P629, DOI 10.1111/exd.12450; GIBSON T, 1978, BRIT J PLAST SURG, V31, P1, DOI 10.1016/0007-1226(78)90002-4; Hakim V, 1997, PHYS REV LETT, V79, P665, DOI 10.1103/PhysRevLett.79.665; Herron A., 2009, P ACVP ASVCP CONC AN; INGROUILLE M, 1994, NATURE, V369, P718, DOI 10.1038/369718a0; Kwak M, 2014, WOUND REPAIR REGEN, V22, P678, DOI 10.1111/wrr.12206; LANGER K, 1978, BRIT J PLAST SURG, V31, P3, DOI 10.1016/0007-1226(78)90003-6; Leung KT, 2001, NATURE, V410, P166, DOI 10.1038/35065517; Li CR, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2728578; Ma J, NONLINEAR DYNAMICS, V73, P73; Naylor M., 2002, MATH MAG, V75, P163, DOI [10.1080/0025570x.2002.1517Iterations, DOI 10.1080/0025570X.2002.1517ITERATIONS]; Paine ML, 2004, J INVEST DERMATOL, V122, P1057, DOI 10.1111/j.0022-202X.2004.22420.x; Randle H., 2003, ANN REPORT LUNDY FIE, P67; SAMLASKA CP, 1989, J AM ACAD DERMATOL, V21, P553, DOI 10.1016/S0190-9622(89)70225-5; SASAKI GH, 1987, CLIN PLAST SURG, V14, P563; Schmook FP, 2001, INT J PHARM, V215, P51, DOI 10.1016/S0378-5173(00)00665-7; van Doorn WG, 2003, J EXP BOT, V54, P1801, DOI 10.1093/jxb/erg213; Wilhelmi BJ, 1998, ANN PLAS SURG, V41, P215, DOI 10.1097/00000637-199808000-00019; WUNDERLICH RC, 1975, CLIN PEDIATR, V14, P1045, DOI 10.1177/000992287501401111; Yang M, 2011, ARCH DERMATOL RES, V303, P125, DOI 10.1007/s00403-011-1123-2; Zhu YF, 2002, ARCH DERMATOL RES, V293, P560, DOI 10.1007/s00403-001-0277-8	27	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162026	10.1371/journal.pone.0162026	http://dx.doi.org/10.1371/journal.pone.0162026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583520	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600088
J	Umair, S; Deng, Q; Roberts, JM; Shaw, RJ; Sutherland, IA; Pernthaner, A				Umair, Saleh; Deng, Qing; Roberts, Joanna M.; Shaw, Richard J.; Sutherland, Ian A.; Pernthaner, Anton			Identification of Peptide Mimics of a Glycan Epitope on the Surface of Parasitic Nematode Larvae	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TRICHOSTRONGYLUS-COLUBRIFORMIS; CARBOHYDRATE ANTIGEN; TAENIA-SOLIUM; ANTIBODIES; MIMOTOPE; SHEEP; SEQUENCES; IMMUNITY; CARLA	Phage display was used to identify peptide mimics of an immunologically protective nematode glycan (CarLA) by screening a constrained C7C peptide library for ligands that bound to an anti-CarLA mAb (PAB1). Characterisation of these peptide mimotopes revealed functional similarities with an epitope that is defined by PAB1. Mimotope vaccinations of mice with three selected individual phage clones facilitated the induction of antibody responses that recognised the purified, native CarLA molecule which was obtained from Trichostrongylus colubriformis. Furthermore, these mimotopes are specifically recognised by antibodies in the saliva of animals that were immune to natural polygeneric nematode challenge. This shows that antibodies to the PAB1 epitope form part of the mucosal polyclonal anti-CarLA antibody response of nematode immune host animals. This demonstrates that the selected peptide mimotopes are of biological relevance. These peptides are the first to mimic the PAB1 epitope of CarLA, a defined larval glycan epitope which is conserved between many nematode species.	[Umair, Saleh; Deng, Qing; Roberts, Joanna M.; Shaw, Richard J.; Sutherland, Ian A.; Pernthaner, Anton] AgResearch, Hopkirk Res Inst, Palmerston North, New Zealand; [Roberts, Joanna M.] Flowjoanna Tapui Ltd, 1 Line, Palmerston North, New Zealand	AgResearch - New Zealand	Umair, S (corresponding author), AgResearch, Hopkirk Res Inst, Palmerston North, New Zealand.	saleh.umair@agresearch.co.nz		Sutherland, Ian/0000-0002-4884-6545; Shaw, Richard/0000-0001-7218-3836; Deng, Qing/0000-0003-1612-5185; Roberts, Joanna/0000-0003-0679-8976; Umair, Saleh/0000-0003-1390-7202	New Zealand Ministry for Business, Innovation and Employment	New Zealand Ministry for Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	This study was funded by the New Zealand Ministry for Business, Innovation and Employment. The funder did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We thank Drs. Haines, Roberts, Wedlock and Zheng for reviewing the manuscript and helpful suggestions. This study was funded by the New Zealand Ministry for Business, Innovation and Employment.	Bhunia A, 2010, J AM CHEM SOC, V132, P96, DOI 10.1021/ja904334s; Capelli-Peixoto J, 2011, VACCINE, V29, P9473, DOI 10.1016/j.vaccine.2011.10.027; Gazarian K, 2012, PEPTIDES, V38, P381, DOI 10.1016/j.peptides.2012.09.021; GNANN JW, 1987, J INFECT DIS, V156, P261, DOI 10.1093/infdis/156.2.261; Harrison GBL, 2008, PARASITE IMMUNOL, V30, P577, DOI 10.1111/j.1365-3024.2008.01058.x; Harrison GBL, 2003, PARASITE IMMUNOL, V25, P79, DOI 10.1046/j.1365-3024.2003.00606.x; Harrison GBL, 2003, PARASITE IMMUNOL, V25, P45, DOI 10.1046/j.1365-3024.2003.00602.x; Kieber-Emmons T, 1998, IMMUNOL RES, V17, P95, DOI 10.1007/BF02786435; Knittelfelder R, 2009, EXPERT OPIN BIOL TH, V9, P493, DOI [10.1517/14712590902870386, 10.1517/14712590902870386 ]; Maass DR, 2007, INT J PARASITOL, V37, P953, DOI 10.1016/j.ijpara.2007.02.005; Maass DR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000597; Matochko WL, 2014, NUCLEIC ACIDS RES, V42, P1784, DOI 10.1093/nar/gkt1104; Menendez A, 2004, J MOL BIOL, V338, P311, DOI 10.1016/j.jmb.2004.02.051; Mester B, 2009, BIOCHEMISTRY-US, V48, P7867, DOI 10.1021/bi900146g; Monzavi-Karbassi B, 2002, TRENDS BIOTECHNOL, V20, P207, DOI 10.1016/S0167-7799(02)01940-6; Moseri A, 2010, VIROLOGY, V401, P293, DOI 10.1016/j.virol.2010.03.007; Pernthaner A, 2012, VET IMMUNOL IMMUNOP, V148, P284, DOI 10.1016/j.vetimm.2012.06.024; Prudencio CR, 2010, VET PARASITOL, V172, P122, DOI 10.1016/j.vetpar.2010.04.012; Ramirez-Restrepo CA, 2010, ANIM FEED SCI TECH, V155, P99, DOI 10.1016/j.anifeedsci.2009.10.006; Riemer AB, 2007, IMMUNOL LETT, V113, P1, DOI 10.1016/j.imlet.2007.07.008; Shaw RJ, 2012, VET PARASITOL, V186, P109, DOI 10.1016/j.vetpar.2011.11.051; Shaw RJ, 1996, VET IMMUNOL IMMUNOP, V51, P235, DOI 10.1016/0165-2427(95)05530-4; Villa-Mancera A, 2011, J HELMINTHOL, V85, P51, DOI 10.1017/S0022149X1000026X; Wei JF, 2011, VACCINE, V29, P3162, DOI 10.1016/j.vaccine.2011.02.072	24	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0162016	10.1371/journal.pone.0162016	http://dx.doi.org/10.1371/journal.pone.0162016			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579674	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877400052
J	da Costa, TM; Morgado, PGM; Cavalcante, FS; Damasco, AP; Nouer, SA; dos Santos, KRN				da Costa, Thaina Miranda; Migueres Morgado, Priscylla Guimaraes; Cavalcante, Fernanda Sampaio; Damasco, Andreia Paredes; Nouer, Simone Aranha; Netto dos Santos, Katia Regina			Clinical and Microbiological Characteristics of Heteroresistant and Vancomycin-Intermediate Staphylococcus aureus from Bloodstream Infections in a Brazilian Teaching Hospital	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS; METHICILLIN-RESISTANT; SUSCEPTIBILITY; STRAINS; DISSEMINATION; SURVEILLANCE; DAPTOMYCIN; PATHOGENS; LINEAGES	This study analyzed clinical and microbiological characteristics of heteroresistant (hVISA) and vancomycin-intermediate Staphylococcus aureus (VISA) from bloodstream infections (BSI) in a Brazilian teaching hospital, between 2011 and 2013. Minimum inhibitory concentrations (MIC) of antimicrobials were determined by broth microdilution method and SCCmec was detected by PCR. Isolates with a vancomycin MIC >= 2mg/L were cultured on BHI agar with 3, 4 or 6 mg/L (BHIa3, BHIa4 or BHIa6) of vancomycin and BHIa4 with casein (BHIa4ca). Macromethod Etest (R) and Etest (R) Glicopeptides Resistance Detection were also used. VISA and hVISA isolates were confirmed by the population analysis profile then typed by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing. Medical data from the patients were obtained from their medical records. Among 110 consecutive isolates, 31 (28%) were MRSA and carried the SCCmec type II (15 isolates) or IV (16 isolates). Vancomycin MIC50 and MIC90 were 1 and 2 mg/L, respectively. MRSA isolates had increased non-susceptibility to daptomycin (p = 0.0003). Six (5%) isolates were VISA, four of which were MRSA, three SCCmec type II/USA100/ST5 and one type IV/USA800/ST3192. One MRSA SCCmec II isolate grew on agar BHIa3, BHIa4 and BHIa4ca, and it was confirmed as hVISA. Among the six VISA isolates, five (83%) grew on BHIa3 and three (50%) on BHI4ca. Four of the six VISA isolates and the one hVISA isolate were from patients who had undergone dialysis. Thus, a possible dissemination of the SCCmec II/USA100/ST5 lineage may have occurred in the hospital comprising the VISA, hVISA and daptomycin non-susceptible S. aureus Brazilian isolates from health care associated bloodstream infections.	[da Costa, Thaina Miranda; Migueres Morgado, Priscylla Guimaraes; Cavalcante, Fernanda Sampaio; Damasco, Andreia Paredes; Netto dos Santos, Katia Regina] Univ Fed Rio de Janeiro, Lab Infeccao Hosp, Dept Microbiol Med, Inst Microbiol Paulo Goes, Rio De Janeiro, Brazil; [Nouer, Simone Aranha] Univ Fed Rio de Janeiro, Fac Med, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	dos Santos, KRN (corresponding author), Univ Fed Rio de Janeiro, Lab Infeccao Hosp, Dept Microbiol Med, Inst Microbiol Paulo Goes, Rio De Janeiro, Brazil.	santoskrn@micro.ufrj.br	CAVALCANTE, FERNANDA SAMPAIO/AAA-5534-2021; Miranda da Costa, Thaina/AAZ-9665-2020; da Costa, Thaina/M-6726-2017	CAVALCANTE, FERNANDA SAMPAIO/0000-0003-3542-7031; Miranda da Costa, Thaina/0000-0002-3660-1786; da Costa, Thaina/0000-0002-3660-1786	grant of Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; grant of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	grant of Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; grant of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants of Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro to KRNS and SAN; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico to KRNS, TMC, PGMM and FSC. APD is sponsored by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannerman TL, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P390; Biedenbach DJ, 2016, ANTIMICROB AGENTS CH, V60, P343, DOI 10.1128/AAC.01867-15; Biedenbach DJ, 2015, ANTIMICROB AGENTS CH, V59, P4239, DOI 10.1128/AAC.00206-15; Burnham CAD, 2010, J CLIN MICROBIOL, V48, P949, DOI 10.1128/JCM.02295-09; Casapao AM, 2013, ANTIMICROB AGENTS CH, V57, P4252, DOI 10.1128/AAC.00380-13; Cavalcante Fernanda S, 2014, BMC Res Notes, V7, P759, DOI 10.1186/1756-0500-7-759; CLSI: Clinical Laboratory Standards Institute, 2013, M100S25 CLSI; Cui LZ, 2006, ANTIMICROB AGENTS CH, V50, P1079, DOI 10.1128/AAC.50.3.1079-1082.2006; Silveira ACDO, 2014, DIAGN MICR INFEC DIS, V79, P401, DOI 10.1016/j.diagmicrobio.2014.04.008; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; European Committee on Antimicrobial Susceptibility Testing Breakpoint, 2015, EUCAST TABL INT MICS; Caboclo RMF, 2013, AM J INFECT CONTROL, V41, pE21, DOI 10.1016/j.ajic.2012.08.008; Nunes APF, 2007, BRAZ J INFECT DIS, V11, P345, DOI 10.1590/S1413-86702007000300009; Flamm RK, 2014, BRAZ J INFECT DIS, V18, P187, DOI 10.1016/j.bjid.2013.11.005; Gomes DM, 2015, PHARMACOTHERAPY, V35, P424, DOI 10.1002/phar.1577; Grundmann H, 2014, Euro Surveill, V19, DOI 10.2807/1560-7917.ES2014.19.49.20987; Hafer C, 2012, ANTIMICROB AGENTS CH, V56, P5845, DOI 10.1128/AAC.01139-12; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Howe RA, 2004, EMERG INFECT DIS, V10, P855, DOI 10.3201/eid1005.030556; Hu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073300; Kos VN, 2012, MBIO, V3, DOI 10.1128/mBio.00112-12; Marra AR, 2011, J CLIN MICROBIOL, V49, P1866, DOI 10.1128/JCM.00376-11; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Oliveira GA, 2001, INFECT CONT HOSP EP, V22, P443, DOI 10.1086/501932; Pan America Health Organization/World Health Organization. PAHO/WHO, 2013, EP AL VANC RES STAPH; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Rodvold KA, 2014, CLIN INFECT DIS, V58, pS20, DOI 10.1093/cid/cit614; Satola SW, 2011, J CLIN MICROBIOL, V49, P177, DOI 10.1128/JCM.01128-10; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Sousa AGP, 2014, J INFECT DEV COUNTR, V8, P558, DOI 10.3855/jidc.4395; Van Belkum A, 2009, CLIN MICROBIOL INFEC, V13, P1; van Hal SJ, 2011, ANTIMICROB AGENTS CH, V55, P405, DOI 10.1128/AAC.01133-10; Vandecasteele SJ, 2011, SEMIN DIALYSIS, V24, P50, DOI 10.1111/j.1525-139X.2010.00803.x; Vivoni AM, 2005, INFECT CONT HOSP EP, V26, P662, DOI 10.1086/502599; Witte W, 2004, J VET MED B, V51, P370, DOI 10.1111/j.1439-0450.2004.00774.x; Wootton M, 2001, J ANTIMICROB CHEMOTH, V47, P399, DOI 10.1093/jac/47.4.399	39	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0160506	10.1371/journal.pone.0160506	http://dx.doi.org/10.1371/journal.pone.0160506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575698	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877200008
J	Duan, FS; Yu, YJ; Guan, RJ; Xu, ZL; Liang, HG; Hong, L				Duan, Fengsen; Yu, Yuejin; Guan, Rijian; Xu, Zhiliang; Liang, Huageng; Hong, Ling			Vitamin K2 Induces Mitochondria-Related Apoptosis in Human Bladder Cancer Cells via ROS and JNK/p38 MAPK Signal Pathways	PLOS ONE			English	Article							STRESS-INDUCED APOPTOSIS; LEUKEMIA-CELLS; INHIBITION; CHEMOTHERAPY; LINES; P53; PERSPECTIVES; PRESERVATION; ENHANCEMENT; ACTIVATION	The effects of vitamin K2 on apoptosis in a variety of cancer cells have been well established in previous studies. However, the apoptotic effect of vitamin K2 on bladder cancer cells has not been evaluated. The aim of this study is to examine the apoptotic activity of Vitamin K2 in bladder cancer cells and investigate the underlying mechanism. In this study, Vitamin K2 induced apoptosis in bladder cancer cells through mitochondria pathway including loss of mitochondria membrane potential, cytochrome C release and caspase-3 cascade. Furthermore, the phosphorylation of c-Jun N-terminal kinase (JNK) and p38 MAPK was detected in Vitamin K2-treated cells and both SP600125 (an inhibitor of JNK) and SB203580 (an inhibitor of p38 MAPK) completely abolished the Vitamin K2-induced apoptosis and loss of mitochondria membrane potential. Moreover, the generation of reactive oxygen species (ROS) was detected in bladder cancer cells, upon treatment of vitamin K2 and the anti-oxidant N-acetyl cysteine (NAC) almost blocked the Vitamin K2-triggered apoptosis, loss of mitochondria membrane potential and activation of JNK and p38 MAPK. Taken together, these findings revealed that Vitamin K2 induces apoptosis in bladder cancer cells via ROS-mediated JNK/p38 MAPK and Mitochondrial pathways.	[Duan, Fengsen; Xu, Zhiliang; Hong, Ling] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Genet & Dev Biol, Wuhan, Hubei, Peoples R China; [Yu, Yuejin; Guan, Rijian; Liang, Huageng] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Urol, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Hong, L (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Genet & Dev Biol, Wuhan, Hubei, Peoples R China.; Liang, HG (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Urol, Wuhan, Hubei, Peoples R China.	leonard19800318@hust.edu.cn; lhong@mail.hust.edu.cn			NSFC (P.R. China) [30971608]; NSF of the Hubei Province [2009CDB074]	NSFC (P.R. China)(National Natural Science Foundation of China (NSFC)); NSF of the Hubei Province	This work was supported by contract grant sponsor: NSFC (P.R. China), contract grant number 30971608; and contract grant sponsor NSF of the Hubei Province, contract grant number 2009CDB074.	Ebina K, 2016, J BONE MINER METAB, V34, P243, DOI 10.1007/s00774-015-0710-2; Feuerstein MA, 2015, CURR UROL REP, V16, DOI 10.1007/s11934-015-0547-1; Ghavami S, 2004, J LEUKOCYTE BIOL, V76, P169, DOI 10.1189/jlb.0903435; Hafeez S, 2014, EXPERT REV ANTICANC, V14, P1429, DOI 10.1586/14737140.2014.953938; Hermans TJN, 2016, EUR UROL, V69, P1156, DOI 10.1016/j.eururo.2016.02.023; Javadov S, 2014, PHARMACOL THERAPEUT, V144, P202, DOI 10.1016/j.pharmthera.2014.05.013; Juffs HG, 2002, LANCET ONCOL, V3, P738, DOI 10.1016/S1470-2045(02)00930-0; Karasawa S, 2013, MOL PHARMACOL, V83, P613, DOI 10.1124/mol.112.082602; Krilleke D, 2003, INT J CANCER, V107, P520, DOI 10.1002/ijc.11331; Lamson Davis W, 2003, Altern Med Rev, V8, P303; Latimer HR, 2016, MOL CELLS, V39, P40, DOI 10.14348/molcells.2016.2327; Li SG, 2010, CANCER LETT, V298, P222, DOI 10.1016/j.canlet.2010.07.009; Matsumoto K, 2006, INT J ONCOL, V29, P1501; Miyazawa K, 2001, LEUKEMIA, V15, P1111, DOI 10.1038/sj.leu.2402155; Nakagawa K, 2010, NATURE, V468, P117, DOI 10.1038/nature09464; O'Keefe JH, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2015-000325; Park GB, 2011, CANCER LETT, V313, P235, DOI 10.1016/j.canlet.2011.09.011; Samykutty A, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/287358; Santabarbara-Ruiz P, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005595; Schepisi G, 2016, BIODRUGS; Shearer MJ, 2014, J LIPID RES, V55, P345, DOI 10.1194/jlr.R045559; Shi Y, 2014, CELL DEATH DIFFER, V21, P612, DOI 10.1038/cdd.2013.186; Shibayama-Imazu T, 2006, APOPTOSIS, V11, P1535, DOI 10.1007/s10495-006-7979-5; Song IS, 2012, GASTROENTEROLOGY, V143, P1341, DOI 10.1053/j.gastro.2012.07.103; Stevenson SM, 2014, UROL ONCOL-SEMIN ORI, V32, P1172, DOI 10.1016/j.urolonc.2014.05.001; Tokita H, 2006, INT J MOL MED, V17, P235; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Wang H, 2013, CANCER BIOTHER RADIO, V28, P607, DOI 10.1089/cbr.2012.1468; Wei G, 2010, INT J CANCER, V127, P2949, DOI 10.1002/ijc.25498; Witjes JA, 2016, NAT REV UROL, V13, DOI 10.1038/nrurol.2015.272; Xiong XX, 2015, ACTA PHARMACOL SIN, V36, P362, DOI 10.1038/aps.2014.141; Yaguchi M, 1997, LEUKEMIA, V11, P779, DOI 10.1038/sj.leu.2400667; Yang CR, 2013, TOXICOL APPL PHARM, V273, P611, DOI 10.1016/j.taap.2013.10.007; Yoshida T, 2003, INT J ONCOL, V23, P627; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Zhang D, 2007, CELL DEATH DIFFER, V14, P703, DOI 10.1038/sj.cdd.4402072	36	35	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161886	10.1371/journal.pone.0161886	http://dx.doi.org/10.1371/journal.pone.0161886			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27570977	Green Submitted, Green Published, gold			2022-12-26	WOS:000382876700039
J	Lykkedegn, S; Sorensen, GL; Beck-Nielsen, SS; Pilecki, B; Duelund, L; Marcussen, N; Christesen, HT				Lykkedegn, Sine; Sorensen, Grith Lykke; Beck-Nielsen, Signe Sparre; Pilecki, Bartosz; Duelund, Lars; Marcussen, Niels; Christesen, Henrik Thybo			Vitamin D Depletion in Pregnancy Decreases Survival Time, Oxygen Saturation, Lung Weight and Body Weight in Preterm Rat Offspring	PLOS ONE			English	Article							D DEFICIENCY; RESPIRATORY-DISTRESS; SKELETAL DEVELOPMENT; MINERAL HOMEOSTASIS; 25-HYDROXYVITAMIN D; HIGH PREVALENCE; D-RECEPTOR; BONE MASS; II CELLS; FETAL	Animal studies suggest a role of vitamin D in fetal lung development although not studied in preterm animals. We tested the hypothesis that vitamin D depletion aggravates respiratory insufficiency in preterm rat offspring. Furthermore, the effects of vitamin D depletion on growth and lung surfactant were investigated. Female Sprague-Dawley rats were randomly assigned low vitamin D (VDL) or control diet before mating and followed with serum 25-hydroxyvitamin D (s-25(OH) D) determinations. After cesarean section at gestational day 19 (E19) or day 22 (E22), placental weight, birth weight, crown-rump-length (CRL), oxygenation (SaO(2)) at 30 min and survival time were recorded. The pup lungs were analyzed for phospholipid levels, surfactant protein A-D mRNA and the expression of the vitamin D receptor (VDR). S-25(OH) D was significantly lower in the VDL group at cesarean section (12 vs. 30nmol/L, p<0.0001). Compared to the controls, E19 VDL pups had lower birth weight (2.13 vs. 2.29g, p<0.001), lung weight (0.09 vs. 0.10g, p = 0.002), SaO(2) (54% vs. 69%, p = 0.002) as well as reduced survival time (0.50 vs. 1.25h, p<0.0001). At E22, the VDL-induced pulmonary differences were leveled out, but VDL pups had lower CRL (4.0 vs. 4.5cm, p<0.0001). The phospholipid levels and the surfactant protein mRNA expression did not differ between the dietary groups. In conclusion, Vitamin D depletion led to lower oxygenation and reduced survival time in the preterm offspring, associated with reduced lung weight and birth weight. Further studies of vitamin D depletion in respiratory insufficiency in preterm neonates are warranted.	[Lykkedegn, Sine; Beck-Nielsen, Signe Sparre; Christesen, Henrik Thybo] Odense Univ Hosp, Hans Christian Andersen Childrens Hosp, Odense, Denmark; [Lykkedegn, Sine; Beck-Nielsen, Signe Sparre; Christesen, Henrik Thybo] Univ Southern Denmark, Inst Clin, Fac Hlth Sci, Odense, Denmark; [Sorensen, Grith Lykke; Pilecki, Bartosz] Univ Southern Denmark, Fac Hlth Sci, Dept Canc & Inflammat, Inst Mol Med, Odense, Denmark; [Duelund, Lars] Univ Southern Denmark, MEMPHYS, Odense, Denmark; [Marcussen, Niels] Odense Univ Hosp, Inst Pathol, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; Odense University Hospital	Christesen, HT (corresponding author), Odense Univ Hosp, Hans Christian Andersen Childrens Hosp, Odense, Denmark.; Christesen, HT (corresponding author), Univ Southern Denmark, Inst Clin, Fac Hlth Sci, Odense, Denmark.	henrik.christesen@rsyd.dk	Pilecki, Bartosz/O-5031-2015; Duelund, Lars/AHB-2952-2022; Duelund, Lars/AAC-7110-2019; Christesen, Henrik/AAR-9023-2021	Pilecki, Bartosz/0000-0001-8636-2245; Duelund, Lars/0000-0002-3786-2822; Christesen, Henrik/0000-0001-5330-6853; Sorensen, Grith Lykke/0000-0002-5273-1097; Beck-Nielsen, Signe/0000-0002-7561-9217	Dagmar Marshalls foundation; Aase & Ejner Danielsens foundation; Takeda Pharma; A.P. Moeller Foundation for the Advancement of Medical Science; Odense University Hospital	Dagmar Marshalls foundation; Aase & Ejner Danielsens foundation; Takeda Pharma(Takeda Pharmaceutical Company Ltd); A.P. Moeller Foundation for the Advancement of Medical Science; Odense University Hospital	All studies were financially supported by: Dagmar Marshalls foundation, Aase & Ejner Danielsens foundation, Takeda Pharma, The A.P. Moeller Foundation for the Advancement of Medical Science and Odense University Hospital. The funding sources had no involvement in collection, analysis and interpretation of data, writing of the report, or decision to submit the article for publication.	Abbott SK, 2013, LIPIDS, V48, P307, DOI 10.1007/s11745-013-3760-z; Andersen LB, 2013, CLIN ENDOCRINOL, V79, P333, DOI 10.1111/cen.12147; BALLARD PL, 1995, AM J OBSTET GYNECOL, V173, P254, DOI 10.1016/0002-9378(95)90210-4; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bodnar LM, 2014, AM J EPIDEMIOL, V179, P168, DOI 10.1093/aje/kwt237; BROMMAGE R, 1984, AM J PHYSIOL, V246, pF526, DOI 10.1152/ajprenal.1984.246.4.F526; Chen G, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-2; CLEMENTS MR, 1988, J CLIN INVEST, V81, P1768, DOI 10.1172/JCI113518; Cools F, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000104.pub4; Dawodu A, 2011, PEDIATR INT, V53, P207, DOI 10.1111/j.1442-200X.2010.03209.x; De Paepe ME, 2005, PEDIATR PULM, V40, P445, DOI 10.1002/ppul.20218; Edelson JD, 1993, BIOCHIM BIOPHYS ACTA, V1221, P159; Evans KN, 2006, BIOL REPROD, V75, P816, DOI 10.1095/biolreprod.106.054056; Evans KN, 2004, J SOC GYNECOL INVEST, V11, P263, DOI 10.1016/j.jsgi.2004.02.002; Eyles DW, 2013, FRONT NEUROENDOCRIN, V34, P47, DOI 10.1016/j.yfrne.2012.07.001; Foong RE, 2014, PHYSL REP, V2, P1; Galthen-Sorensen M, 2014, ULTRASOUND OBST GYN, V44, P633, DOI 10.1002/uog.13431; Gernand AD, 2013, J CLIN ENDOCR METAB, V98, P398, DOI 10.1210/jc.2012-3275; GLAZIER JD, 1995, PEDIATR RES, V37, P720, DOI 10.1203/00006450-199506000-00008; Godfrey KM, 2002, PLACENTA, V23, pS20, DOI 10.1053/plac.2002.0773; Halliday HL, 2008, J PERINATOL, V28, pS47, DOI 10.1038/jp.2008.50; HALLORAN BP, 1981, ARCH BIOCHEM BIOPHYS, V209, P7, DOI 10.1016/0003-9861(81)90251-4; Hart PH, 2015, PEDIATRICS, V135, pE167, DOI 10.1542/peds.2014-1860; Hermansen CL, 2007, AM FAM PHYSICIAN, V76, P987; Javaid MK, 2006, LANCET, V367, P36, DOI 10.1016/S0140-6736(06)67922-1; Kaushal Manila, 2013, Indian J Endocrinol Metab, V17, P76, DOI 10.4103/2230-8210.107862; Kazemi A, 2009, J WOMENS HEALTH, V18, P835, DOI 10.1089/jwh.2008.0954; Kovacs CS, 2016, PHYSIOL REV, V96, P449, DOI 10.1152/physrev.00027.2015; Kovacs CS, 2014, PHYSIOL REV, V94, P1143, DOI 10.1152/physrev.00014.2014; Kovacs CS, 2013, SEMIN FETAL NEONAT M, V18, P129, DOI 10.1016/j.siny.2013.01.005; Kovacs CS, 2012, ANNU REV NUTR, V32, P97, DOI 10.1146/annurev-nutr-071811-150742; Kovacs CS, 2005, AM J PHYSIOL-ENDOC M, V289, pE133, DOI 10.1152/ajpendo.00354.2004; Lapillonne A, 2010, MED HYPOTHESES, V74, P71, DOI 10.1016/j.mehy.2009.07.054; Lieben L, 2013, BONE, V57, P123, DOI 10.1016/j.bone.2013.07.029; Lykkedegn S, 2015, AM J PHYSIOL-LUNG C, V308, pL587, DOI 10.1152/ajplung.00117.2014; Madkar C, 2015, INDIAN J OBSTET GYNA, V2, P1; Mandell E, 2015, AM J PHYSIOL-LUNG C, V309, pL1018, DOI 10.1152/ajplung.00253.2015; Mandell E, 2014, AM J PHYSIOL-LUNG C, V306, pL420, DOI 10.1152/ajplung.00344.2013; MARIN L, 1990, BIOL NEONATE, V57, P257; MARIN L, 1993, AM J PHYSIOL, V265, pL45, DOI 10.1152/ajplung.1993.265.1.L45; MILLER SC, 1983, CALCIFIED TISSUE INT, V35, P455, DOI 10.1007/BF02405076; Myatt L, 2006, J PHYSIOL-LONDON, V572, P25, DOI 10.1113/jphysiol.2006.104968; Nguyen M, 2004, J STEROID BIOCHEM, V89-90, P93, DOI 10.1016/j.jsbmb.2004.03.054; NGUYEN M, 1987, BIOL NEONATE, V52, P232, DOI 10.1159/000242714; Nguyen TM, 1996, AM J PHYSIOL-LUNG C, V271, pL392, DOI 10.1152/ajplung.1996.271.3.L392; NGUYEN TM, 1990, ENDOCRINOLOGY, V127, P1755, DOI 10.1210/endo-127-4-1755; O'Loan J, 2007, PSYCHONEUROENDOCRINO, V32, P227, DOI 10.1016/j.psyneuen.2006.12.006; Ochs M, 2013, AM J PHYSIOL-LUNG C, V305, pL15, DOI 10.1152/ajplung.00429.2012; Onwuneme C, 2015, J PEDIATR-US, V166, P1175, DOI 10.1016/j.jpeds.2015.01.055; Phokela SS, 2005, AM J PHYSIOL-LUNG C, V289, pL617, DOI 10.1152/ajplung.00129.2004; Polly P, 2014, FRONT PHYSIOL, V5, P1; Rehan VK, 2002, MOL GENET METAB, V76, P46, DOI 10.1016/S1096-7192(02)00022-7; Sakurai R, 2009, AM J PHYSIOL-LUNG C, V297, pL496, DOI 10.1152/ajplung.90539.2008; Salafia CM, 2006, CLIN OBSTET GYNECOL, V49, P236, DOI 10.1097/00003081-200606000-00007; Samtani MN, 2006, J PHARMACOL EXP THER, V317, P117, DOI 10.1124/jpet.105.095851; Shehata F, 2011, BJOG-INT J OBSTET GY, V118, P741, DOI 10.1111/j.1471-0528.2011.02892.x; Vandevijvere S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043868; Vannucchi CI, 2012, REPROD DOMEST ANIM, V47, P177, DOI 10.1111/rda.12078; Verder H, 2009, ACTA PAEDIATR, V98, P1400, DOI 10.1111/j.1651-2227.2009.01413.x; Vogeser M, 2007, EXP CLIN ENDOCR DIAB, V115, P559, DOI 10.1055/s-2007-981458; Wang YJ, 2012, ARCH BIOCHEM BIOPHYS, V523, P123, DOI 10.1016/j.abb.2012.04.001; Wang YJ, 2010, ARCH BIOCHEM BIOPHYS, V494, P166, DOI 10.1016/j.abb.2009.11.029; Yurt M, 2014, AM J PHYSIOL-LUNG C, V307, pL859, DOI 10.1152/ajplung.00032.2014; Zerwekh JE, 2008, AM J CLIN NUTR, V87, p1087S, DOI 10.1093/ajcn/87.4.1087S; Zosky GR, 2011, AM J RESP CRIT CARE, V183, P1336, DOI 10.1164/rccm.201010-1596OC	65	15	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0155203	10.1371/journal.pone.0155203	http://dx.doi.org/10.1371/journal.pone.0155203			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571350	Green Submitted, Green Published, gold			2022-12-26	WOS:000382876700001
J	Tsalach, A; Ratner, E; Lokshin, S; Silman, Z; Breskin, I; Budin, N; Kamar, M				Tsalach, Adi; Ratner, Eliahu; Lokshin, Stas; Silman, Zmira; Breskin, Ilan; Budin, Nahum; Kamar, Moshe			Cerebral Autoregulation Real-Time Monitoring	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; BLOOD-FLOW AUTOREGULATION; TRAUMATIC BRAIN-INJURY; CEREBROVASCULAR AUTOREGULATION; HEAD-INJURY; PRESSURE AUTOREGULATION; CARDIOPULMONARY BYPASS; INTRACRANIAL-PRESSURE; REACTIVITY; CIRCULATION	Cerebral autoregulation is a mechanism which maintains constant cerebral blood flow (CBF) despite changes in mean arterial pressure (MAP). Assessing whether this mechanism is intact or impaired and determining its boundaries is important in many clinical settings, where primary or secondary injuries to the brain may occur. Herein we describe the development of a new ultrasound tagged near infra red light monitor which tracks CBF trends, in parallel, it continuously measures blood pressure and correlates them to produce a real time autoregulation index. Its performance is validated in both in-vitro experiment and a pre-clinical case study. Results suggest that using such a tool, autoregulation boundaries as well as its impairment or functioning can be identified and assessed. It may therefore assist in individualized MAP management to ensure adequate organ perfusion and reduce the risk of postoperative complications, and might play an important role in patient care.	[Tsalach, Adi; Ratner, Eliahu; Lokshin, Stas; Silman, Zmira; Breskin, Ilan; Budin, Nahum; Kamar, Moshe] Ornim Med Ltd, Kefar Sava, Israel		Tsalach, A (corresponding author), Ornim Med Ltd, Kefar Sava, Israel.	adi@ornim.com			Ornim Medical LTD.; Ornim Medical LTD	Ornim Medical LTD.; Ornim Medical LTD	The study was sponsored by Ornim Medical LTD. Ornim Medical LTD provided support in the form of salaries for authors [AT, ER, SL, ZS, IB, NB, MK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Brady K, 2015, ANESTH ANALG, V121, P1121, DOI 10.1213/ANE.0000000000000952; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Brady K, 2010, STROKE, V41, P1951, DOI 10.1161/STROKEAHA.109.575159; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; Christensen DA, 1988, ULTRASONIC BIOINSTRU; Czosnyka M, 1997, J NEUROL NEUROSUR PS, V63, P721, DOI 10.1136/jnnp.63.6.721; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Czosnyka M, 1997, J NEUROSURGICAL ANES, V9, P200; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Diehl RR, 1998, CLIN AUTON RES, V8, P7, DOI 10.1007/BF02267598; GERMON TJ, 1994, BRIT J ANAESTH, V73, P503, DOI 10.1093/bja/73.4.503; GILLER CA, 1990, NEUROSURGERY, V27, P362, DOI 10.1227/00006123-199009000-00004; GOBIET W, 1975, ACTA NEUROCHIR, V32, P13, DOI 10.1007/BF01405899; Hori D, 2016, J CARDIOTHORACIC VAS; Hori D, 2016, INTERACT CARDIOV TH; Hori D, 2015, ANESTH ANALG, V121, P1187, DOI 10.1213/ANE.0000000000000930; Immink RV, 2005, STROKE, V36, P2595, DOI 10.1161/01.STR.0000189624.06836.03; Joshi B, 2010, ANESTH ANALG, V110, P321, DOI 10.1213/ANE.0b013e3181c6fd12; Kirkham SK, 2001, PHYSIOL MEAS, V22, P461, DOI 10.1088/0967-3334/22/3/305; Lagerkranser M, 1997, J NEUROSURG ANESTH, V9, P188, DOI 10.1097/00008506-199704000-00015; Lang EW, 2003, J NEUROTRAUM, V20, P69, DOI 10.1089/08977150360517191; Lassen NA, 1959, CEREBRAL BLOOD FLOW; Lee JK, 2011, CRIT CARE MED, V39, P2337, DOI 10.1097/CCM.0b013e318223b910; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; Murkin J M, 2009, Br J Anaesth, V103 Suppl 1, pi3, DOI 10.1093/bja/aep299; Murkin JM, 2015, J CARDIOTHORACIC VAS; Ono M, 2012, J CARDIOTHOR VASC AN, V26, P1022, DOI 10.1053/j.jvca.2012.07.014; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; Panerai RB, 2008, CARDIOVASC ENG, V8, P42, DOI 10.1007/s10558-007-9044-6; Paulson O.B., 1989, CEREBROVAS BRAIN MET, V2, P161; PAULSON OB, 1991, BLOOD VESSELS, V28, P231; Pesek M, 2014, NEUROSURGERY, V75, P163, DOI 10.1227/NEU.0000000000000367; Racheli N, 2012, SPIE BIOS; Schwarz M, 2015, NEUROCRIT CARE, P1; Schytz HW, 2012, NEUROCRIT CARE, V17, P139, DOI 10.1007/s12028-012-9720-2; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; STRANDGAARD S, 1973, BMJ-BRIT MED J, V1, P507, DOI 10.1136/bmj.1.5852.507; Strandgaard S, 1975, LOWER UPPER LIMITS A, P3; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Tsalach A, 2015, BIOMED OPT EXPRESS, V6, P4871, DOI 10.1364/BOE.6.004871; Utley J.R., 2000, CARDIOPULMONARY BYPA; van Beek AHEA, 2008, J CEREBR BLOOD F MET, V28, P1071, DOI 10.1038/jcbfm.2008.13	44	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161907	10.1371/journal.pone.0161907	http://dx.doi.org/10.1371/journal.pone.0161907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571474	Green Published, Green Submitted, gold			2022-12-26	WOS:000382876700043
J	Kasai, Y; Harayama, S				Kasai, Yuki; Harayama, Shigeaki			Construction of Marker-Free Transgenic Strains of Chlamydomonas reinhardtii Using a Cre/loxP-Mediated Recombinase System	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; TRANSFERRIN FUSION PROTEIN; COLONY-STIMULATING FACTOR; CRE RECOMBINASE; SELECTABLE MARKER; MAMMALIAN-CELLS; HOMOLOGOUS RECOMBINATION; OIL ACCUMULATION; GENETIC-ANALYSIS; DNA INTEGRATION	The Escherichia coli bacteriophage P1 encodes a site-specific recombinase called Cre and two 34-bp target sites of Cre recombinase called loxP. The Cre/loxP system has been used to achieve targeted insertion and precise deletion in many animal and plant genomes. The Cre/loxP system has particularly been used for the removal of selectable marker genes to create marker-free transgenic organisms. For the first time, we applied the Cre/loxP-mediated site-specific recombination system to Chlamydomonas reinhardtii to construct markerfree transgenic strains. Specifically, C. reinhardtii strains cc4350 and cc124 carrying an aphVIII expression cassette flanked by two direct repeats of loxP were constructed. Separately, a synthetic Cre recombinase gene (CrCRE), the codons of which were optimized for expression in C. reinhardtii, was synthesized, and a CrCRE expression cassette was introduced into strain cc4350 carrying a single copy of the loxP-flanked aphVIII expression cassette. Among 46 transformants carrying the CrCRE expression cassette stably, the excision of aphVIII by CrCre recombinase was observed only in one transformant. We then constructed an expression cassette of an in-frame fusion of ble to CrCRE via a short linker peptide. The product of ble (Ble) is a bleomycin-binding protein that confers resistance to bleomycin-related antibiotics such as Zeocin and localizes in the nucleus. Therefore, the ble-(linker)-CrCRE fusion protein is expected to localize in the nucleus. When the ble( linker)-CrCRE expression cassette was integrated into the genome of strain cc4350 carrying a single copy of the loxP-flanked aphVIII expression cassette, CrCre recombinase-mediated excision of the aphVIII expression cassette was observed at a frequency higher than that in stable transformants of the CrCRE expression cassette. Similarly, from strain cc124 carrying a single loxP-flanked aphVIII expression cassette, the aphVIII expression cassette was successfully excised after introduction of the ble-(linker)-CrCRE expression cassette. The ble-(linker)-CrCRE expression cassette remained in the genome after excision of the aphVIII expression cassette, and it was subsequently removed by crossing with the wildtype strain. This precise Cre-mediated deletion method applicable to transgenic C. reinhardtii could further increase the potential of this organism for use in basic and applied research.	[Kasai, Yuki; Harayama, Shigeaki] Chuo Univ, Fac Sci & Engn, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan	Chuo University	Kasai, Y (corresponding author), Chuo Univ, Fac Sci & Engn, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan.	ykasai@kc.chuo-u.ac.jp		Harayama, Shigeaki/0000-0003-2103-7796	New Energy and Industrial Technology Development Organization (NEDO) [P11502725-0]	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by the New Energy and Industrial Technology Development Organization (NEDO, P11502725-0)(http://www.nedo.go.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Takako Minoura and Ritsu Kamiya for advice concerning the Chlamydomonas mating experiments and for the kind gifts of the pSI103 plasmid and strains cc124 (mt-) and cc125 (mt+). We also thank Jun Abe for the kind gift of the pMF59 plasmid. This work was supported by the New Energy and Industrial Technology Development Organization (NEDO, P11502725-0).	ABREMSKI K, 1983, CELL, V32, P1301, DOI 10.1016/0092-8674(83)90311-2; Baba Y, 2005, MICROBIOL IMMUNOL, V49, P559, DOI 10.1111/j.1348-0421.2005.tb03753.x; Bai Y, 2005, P NATL ACAD SCI USA, V102, P7292, DOI 10.1073/pnas.0500062102; Bai Y, 2006, PHARM RES-DORDR, V23, P2116, DOI 10.1007/s11095-006-9059-5; Cao MQ, 2009, PROTOPLASMA, V235, P107, DOI 10.1007/s00709-009-0036-9; Chen LL, 1998, NAT BIOTECHNOL, V16, P1060, DOI 10.1038/3511; DALE EC, 1991, P NATL ACAD SCI USA, V88, P10558, DOI 10.1073/pnas.88.23.10558; DEBLOCK M, 1991, THEOR APPL GENET, V82, P257, DOI 10.1007/BF02190610; DeNeve M, 1997, PLANT J, V11, P15, DOI 10.1046/j.1365-313X.1997.11010015.x; DUMAS P, 1994, EMBO J, V13, P2483, DOI 10.1002/j.1460-2075.1994.tb06535.x; Dutcher SK, 2003, TRAFFIC, V4, P443, DOI 10.1034/j.1600-0854.2003.00104.x; Ebinuma H, 2001, PLANT CELL REP, V20, P383, DOI 10.1007/s002990100344; Endo S, 2002, PLANT J, V30, P115, DOI 10.1046/j.1365-313X.2002.01272.x; Fan JL, 2012, PLANT CELL PHYSIOL, V53, P1380, DOI 10.1093/pcp/pcs082; Fuhrmann M, 1999, PLANT J, V19, P353, DOI 10.1046/j.1365-313X.1999.00526.x; Gleave AP, 1999, PLANT MOL BIOL, V40, P223, DOI 10.1023/A:1006184221051; Gonzalez-Ballester D, 2005, PLANT PHYSIOL, V137, P522, DOI 10.1104/pp.104.050914; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Grossman AR, 2004, ANNU REV GENET, V38, P119, DOI 10.1146/annurev.genet.38.072902.092328; GUMPEL NJ, 1994, CURR GENET, V26, P438, DOI 10.1007/BF00309931; Heitzer M, 2007, BIOTECHNIQUES, V43, P324, DOI 10.2144/000112556; Hoa TTC, 2002, THEOR APPL GENET, V104, P518, DOI 10.1007/s001220100748; HOESS RH, 1985, J MOL BIOL, V181, P351, DOI 10.1016/0022-2836(85)90224-4; Houille-Vernes L, 2011, P NATL ACAD SCI USA, V108, P20820, DOI 10.1073/pnas.1110518109; Iwai M, 2014, PLANT BIOTECHNOL J, V12, P808, DOI 10.1111/pbi.12210; Janbandhu VC, 2014, CELL CYCLE, V13, P462, DOI 10.4161/cc.27271; Johnson X, 2014, PLANT PHYSIOL, V165, P438, DOI 10.1104/pp.113.233593; Kuhn Ralf, 2002, Methods Mol Biol, V180, P175; Lauersen KJ, 2015, APPL MICROBIOL BIOT, V99, P3491, DOI 10.1007/s00253-014-6354-7; Li RG, 2011, IN VITRO CELL DEV-PL, V47, P274, DOI 10.1007/s11627-011-9359-2; LLOYD AM, 1994, MOL GEN GENET, V242, P653, DOI 10.1007/BF00283419; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; LYZNIK LA, 1993, NUCLEIC ACIDS RES, V21, P969, DOI 10.1093/nar/21.4.969; MAESER S, 1991, MOL GEN GENET, V230, P170, DOI 10.1007/BF00290665; Matsuo T, 2008, GENE DEV, V22, P918, DOI 10.1101/gad.1650408; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mizutani O, 2012, APPL ENVIRON MICROB, V78, P4126, DOI 10.1128/AEM.00080-12; Ohnishi N, 2010, PLANT CELL, V22, P3105, DOI 10.1105/tpc.109.071811; Pazour GJ, 2000, METHODS, V22, P285, DOI 10.1006/meth.2000.1081; Periz G, 1997, MOL CELL BIOL, V17, P3858, DOI 10.1128/MCB.17.7.3858; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Pollock SV, 2003, PLANT PHYSIOL, V133, P1854, DOI 10.1104/pp.103.032078; Radchuk VV, 2005, PLANT SCI, V168, P1515, DOI 10.1016/j.plantsci.2005.02.021; Rasala BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043349; Rochaix JD, 1995, ANNU REV GENET, V29, P209, DOI 10.1146/annurev.ge.29.120195.001233; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Scaife MA, 2015, PLANT J, V82, P532, DOI 10.1111/tpj.12781; Shimogawara K, 1998, GENETICS, V148, P1821; Siaut M, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-7; Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3; SODEINDE OA, 1993, P NATL ACAD SCI USA, V90, P9199, DOI 10.1073/pnas.90.19.9199; Specht E, 2010, BIOTECHNOL LETT, V32, P1373, DOI 10.1007/s10529-010-0326-5; Sreekala C, 2005, PLANT CELL REP, V24, P86, DOI 10.1007/s00299-004-0909-5; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Sugita K, 2000, MOL BREEDING, V6, P529, DOI 10.1023/A:1026505615615; TAM LW, 1993, GENETICS, V135, P375; Wan MX, 2011, BIOTECHNOL LETT, V33, P1615, DOI 10.1007/s10529-011-0596-6; Wang Q, 2003, J BIOL CHEM, V278, P32936, DOI 10.1074/jbc.M303261200; Wu LY, 2002, TRANSGENIC RES, V11, P533, DOI 10.1023/A:1020331608590; Zhao HL, 2008, PROTEIN EXPRES PURIF, V61, P73, DOI 10.1016/j.pep.2008.04.013; Zorin B, 2005, EUKARYOT CELL, V4, P1264, DOI 10.1128/EC.4.7.1264-1272.2005	62	7	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161733	10.1371/journal.pone.0161733	http://dx.doi.org/10.1371/journal.pone.0161733			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564988	gold, Green Submitted, Green Published			2022-12-26	WOS:000382496300013
J	Dai, DN; Chen, B; Tang, HL; Wang, B; Zhao, ZP; Xie, XM; Wei, WD				Dai, Danian; Chen, Bo; Tang, Hailin; Wang, Bin; Zhao, Zhiping; Xie, Xiaoming; Wei, Weidong			Nomograms for Predicting the Prognostic Value of Pre-Therapeutic CA15-3 and CEA Serum Levels in TNBC Patients	PLOS ONE			English	Article							BREAST-CANCER PATIENTS; PLASMA-FIBRINOGEN LEVEL; CA 15-3; TUMOR-MARKERS; SURVIVAL; METASTASIS; RECOMMENDATIONS; PARAMETER; SUBTYPES	Previous studies have indicated that carcinoembryonic antigen (CEA) and cancer antigen 15-3 (CA15-3) levels are both independent prognostic factors in breast cancer. However, the utility of CEA and CA15-3 levels as conventional cancer biomarkers in patients with triple-negative breast cancer (TNBC) remains controversial. The current study was performed to explore the predictive value of pre-therapeutic serum CEA and CA15-3 levels, and nomograms were developed including these serum cancer biomarkers to improve the prognostic evaluation of TNBC patients. Pre-therapeutic CA15-3 and CEA concentrations were measured in 247 patients with stage I-IV TNBC. Kaplan-Meier analysis showed that TNBC patients with high levels of both CEA and CA15-3 had shorter overall survival (OS) and disease-free survival (DFS) rates than those in the low-level groups (p<0.05). Multivariate analysis suggested that pre-therapeutic CA15-3 and CEA levels are independent predictive elements for OS (p = 0.022 and p = 0.040, respectively) and DFS (p = 0.023 and p = 0.028, respectively). In addition, novel nomograms were established and validated to provide personal forecasts of OS and DFS for patients with TNBC. These novel nomograms may help physicians to select the optimal treatment plans to ensure the best outcomes for TNBC patients.	[Dai, Danian; Chen, Bo; Tang, Hailin; Xie, Xiaoming; Wei, Weidong] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Dept Breast Oncol,Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Wang, Bin] Chongqing Med Univ, Inst Life Sci, Chongqing, Peoples R China; [Zhao, Zhiping] Third Mil Med Univ, Inst Hepatopancreatobiliary Surg, Southwest Hosp, Chongqing, Peoples R China; [Wei, Weidong] Sun Yat Sen Univ, Ctr Canc, Dept Breast Oncol, 651 East Dongfeng Rd, Guangzhou 510060, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Chongqing Medical University; Army Medical University; Sun Yat Sen University	Xie, XM; Wei, WD (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Dept Breast Oncol,Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.; Wei, WD (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Breast Oncol, 651 East Dongfeng Rd, Guangzhou 510060, Guangdong, Peoples R China.	xiexm@sysucc.org.cn; weiwd@sysucc.org.cn			National Natural Science Foundation of China [81472575, 81472469, 81272514, 81372133]; Science and Technology Planning Projects of Guangdong and Guangzhou [2014J4100169, 2013B060300009, 2015B020211002, 2015B090901050, 2014A020212079]; Province Planning Project of Guangdong Province, China [2013B021800072]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Projects of Guangdong and Guangzhou; Province Planning Project of Guangdong Province, China	This study was supported by the National Natural Science Foundation of China (81472575, 81472469 and 81272514 81372133, XX), the Science and Technology Planning Projects of Guangdong and Guangzhou (2014J4100169, 2013B060300009, 2015B020211002, 2015B090901050 and 2014A020212079, HT), and Province Planning Project of Guangdong Province, China (2013B021800072, WW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahrami A., 2012, Eastern Mediterranean Health Journal, V18, P1055; Bast RC, 2001, J CLIN ONCOL, V19, P1865, DOI 10.1200/JCO.2001.19.6.1865; Basu S, 2015, ANTIOXID REDOX SIGN, V23, P1298, DOI 10.1089/ars.2015.6404; Bozkurt O, 2015, J BUON, V20, P1432; Brouckaert O, 2012, INT J WOMENS HEALTH, V4, P511, DOI 10.2147/IJWH.S18541; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Canizares F, 2001, TUMOR BIOL, V22, P273, DOI 10.1159/000050627; Chen Yan, 2011, Zhonghua Zhong Liu Za Zhi, V33, P842; Chu WG, 2016, ANN SURG TREAT RES, V90, P57, DOI 10.4174/astr.2016.90.2.57; Dai XF, 2015, AM J CANCER RES, V5, P2929; Delea Thomas, 2006, J Support Oncol, V4, P341; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Di Gioia D, 2015, CLIN CHIM ACTA, V440, P16, DOI 10.1016/j.cca.2014.11.001; Duffy MJ, 2004, CLIN CHEM, V50, P559, DOI 10.1373/clinchem.2003.025288; Frank EHJ, RMS REGRESSION MODEL; Haffty BG, 2006, J CLIN ONCOL, V24, P5652, DOI 10.1200/JCO.2006.06.5664; Iasonos A, 2008, J CLIN ONCOL, V26, P1364, DOI 10.1200/JCO.2007.12.9791; Krenn-Pilko S, 2015, BREAST, V24, P667, DOI 10.1016/j.breast.2015.08.003; Liang WH, 2015, J CLIN ONCOL, V33, P861, DOI 10.1200/JCO.2014.56.6661; Malyguine AM, 2012, CANCER IMMUNOL IMMUN, V61, P239, DOI 10.1007/s00262-011-1148-6; Melichar B, 2013, CLIN CHEM LAB MED, V51, P99, DOI 10.1515/cclm-2012-0496; Minami CA, 2011, BREAST CANCER-BASIC, V5, P175, DOI 10.4137/BCBCR.S6562; Molina R, 2005, TUMOR BIOL, V26, P281, DOI 10.1159/000089260; Molina R, 2010, TUMOR BIOL, V31, P171, DOI 10.1007/s13277-010-0025-9; Nicolini A, 2003, BIOMED PHARMACOTHER, V57, P452, DOI 10.1016/j.biopha.2003.09.004; O'Brien KM, 2010, CLIN CANCER RES, V16, P6100, DOI 10.1158/1078-0432.CCR-10-1533; Park BW, 2008, ANN ONCOL, V19, P675, DOI 10.1093/annonc/mdm538; Rakha EA, 2006, EUR J CANCER, V42, P3149, DOI 10.1016/j.ejca.2006.08.015; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; ROBERTSON JFR, 1995, BRIT J CANCER, V72, P174, DOI 10.1038/bjc.1995.297; Shao YB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133830; Shering SG, 1998, CANCER-AM CANCER SOC, V83, P2521, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2521::AID-CNCR17>3.0.CO;2-A; Sternberg CN, 2006, J CLIN ONCOL, V24, P3819, DOI 10.1200/JCO.2006.07.1290; Tang SF, 2016, BREAST CANCER-TOKYO, V23, P813, DOI 10.1007/s12282-016-0680-9; Tomita Masaki, 2015, Asian Pac J Cancer Prev, V16, P7809; Wang YZ, 2013, J CLIN ONCOL, V31, P1188, DOI 10.1200/JCO.2012.41.5984; Wen JH, 2015, BREAST, V24, P745, DOI 10.1016/j.breast.2015.09.007; Wu SG, 2016, J CANCER, V7, P37, DOI 10.7150/jca.13090; Wu SG, 2014, BREAST, V23, P88, DOI 10.1016/j.breast.2013.11.003; Zou Dawei, 2006, Zhongguo Fei Ai Za Zhi, V9, P337, DOI 10.3779/j.issn.1009-3419.2006.04.08	40	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161902	10.1371/journal.pone.0161902	http://dx.doi.org/10.1371/journal.pone.0161902			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27561099	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258600116
J	Anton, BP; Harhay, GP; Smith, TPL; Blom, J; Roberts, RJ				Anton, Brian P.; Harhay, Gregory P.; Smith, Timothy P. L.; Blom, Jochen; Roberts, Richard J.			Comparative Methylome Analysis of the Occasional Ruminant Respiratory Pathogen Bibersteinia trehalosi	PLOS ONE			English	Article							ANALYSIS REVEALS; RESTRICTION; METHYLATION; GENOMICS; METHYLTRANSFERASES; REARRANGEMENTS; SPECIFICITIES; TRANSCRIPTION; ADAPTATION; ANNOTATION	We examined and compared both the methylomes and the modification-related gene content of four sequenced strains of Bibersteinia trehalosi isolated from the nasopharyngeal tracts of Nebraska cattle with symptoms of bovine respiratory disease complex. The methylation patterns and the encoded DNA methyltransferase (MTase) gene sets were different between each strain, with the only common pattern being that of Dam (GATC). Among the observed patterns were three novel motifs attributable to Type I restriction-modification systems. In some cases the differences in methylation patterns corresponded to the gain or loss of MTase genes, or to recombination at target recognition domains that resulted in changes of enzyme specificity. However, in other cases the differences could be attributed to differential expression of the same MTase gene across strains. The most obvious regulatory mechanism responsible for these differences was slipped strand mispairing within short sequence repeat regions. The combined action of these evolutionary forces allows for alteration of different parts of the methylome at different time scales. We hypothesize that pleiotropic transcriptional modulation resulting from the observed methylomic changes may be involved with the switch between the commensal and pathogenic states of this common member of ruminant microflora.	[Anton, Brian P.; Roberts, Richard J.] New England Biolabs Inc, Ipswich, MA 01938 USA; [Harhay, Gregory P.; Smith, Timothy P. L.] ARS, USDA, US Meat Anim Res Ctr, Clay Ctr, NE USA; [Blom, Jochen] Univ Giessen, Bioinformat & Syst Biol, Giessen, Germany	New England Biolabs; United States Department of Agriculture (USDA); Justus Liebig University Giessen	Anton, BP (corresponding author), New England Biolabs Inc, Ipswich, MA 01938 USA.; Harhay, GP (corresponding author), ARS, USDA, US Meat Anim Res Ctr, Clay Ctr, NE USA.	anton@neb.com; gregory.harhay@ars.usda.gov	Harhay, Gregory/AAC-5411-2022	Harhay, Gregory/0000-0002-0129-6822	Small Business Innovation Research Program (NIGMS) of the National Institutes of Health [R44GM105125]; USDA, ARS [5438-32000-029-00D, 5438-31320-012-00D]; BMBF [FKZ 031A533]; New England Biolabs	Small Business Innovation Research Program (NIGMS) of the National Institutes of Health; USDA, ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); BMBF(Federal Ministry of Education & Research (BMBF)); New England Biolabs	This project was supported by the Small Business Innovation Research Program (NIGMS) of the National Institutes of Health under award R44GM105125 to RJR. Funding for this research was provided by the USDA, ARS appropriated projects 5438-32000-029-00D (GPH) and 5438-31320-012-00D (TPLS). The EDGAR platform is financially supported by the BMBF grant FKZ 031A533 within the de. NBI network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BPA and RJR are employed by New England Biolabs, a company that sells restriction enzymes, methyltransferases, and other enzymes. New England Biolabs provided support in the form of salaries for BPA and RJR and purchase of research materials, but did not play any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ABADJIEVA A, 1993, NUCLEIC ACIDS RES, V21, P4435, DOI 10.1093/nar/21.19.4435; Algire MA, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120115; Anton BP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127446; Ashby M., 2014, BACTERIAL BASEMOD AN; Atack JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8828; Blakeway LV, 2014, FASEB J, V28, P5197, DOI 10.1096/fj.14-256578; Blom J, 2016, NUCLEIC ACIDS RES, V44, pW22, DOI 10.1093/nar/gkw255; Blow MJ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005854; Clark TA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1146; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Decker KB, 2012, MICROBIOL-SGM, V158, P1665, DOI 10.1099/mic.0.058941-0; DeDonder KD, 2015, ANIM HEALTH RES REV, V16, P125, DOI 10.1017/S146625231500016X; Drozdz M, 2012, NUCLEIC ACIDS RES, V40, P2119, DOI 10.1093/nar/gkr1039; Dybvig K, 1998, P NATL ACAD SCI USA, V95, P13923, DOI 10.1073/pnas.95.23.13923; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Furuta Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004272; Furuta Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018819; Furuta Y, 2010, NUCLEIC ACIDS RES, V38, P2428, DOI 10.1093/nar/gkp1226; Gawthorne JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032337; Gonzalez D, 2014, NUCLEIC ACIDS RES, V42, P3720, DOI 10.1093/nar/gkt1352; Griffin D, 2014, ANIM HEALTH RES REV, V15, P138, DOI 10.1017/S1466252314000255; Guerry P, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00007; Harhay GP, 2014, GENOME ANNOUNCEMENTS, V2, DOI [10.1128/genomeA.00084-14, DOI 10.1128/GEN0MEA.00084-14]; Harhay GP, 2013, GENOME ANNOUNCEMENTS, V1, DOI [10.1128/genomeA.00188-13, DOI 10.1128/GEN0MEA.00188-13PMID:23682137]; Highlander SK, 1997, INFECT IMMUN, V65, P3970, DOI 10.1128/IAI.65.9.3970-3975.1997; Holman DB, 2015, VET MICROBIOL, V180, P90, DOI 10.1016/j.vetmic.2015.07.031; Jackson Robert W, 2011, Mob Genet Elements, V1, P55; Koren S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r101; Krebes J, 2014, NUCLEIC ACIDS RES, V42, P2415, DOI 10.1093/nar/gkt1201; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar Ritesh, 2013, Subcell Biochem, V61, P81, DOI 10.1007/978-94-007-4525-4_4; Lobner-Olesen A, 2005, CURR OPIN MICROBIOL, V8, P154, DOI 10.1016/j.mib.2005.02.009; Manso AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6055; Marinus MG, 2009, FEMS MICROBIOL REV, V33, P488, DOI 10.1111/j.1574-6976.2008.00159.x; Motherway MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094875; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Murray IA, 2012, NUCLEIC ACIDS RES, V40, P11450, DOI 10.1093/nar/gks891; O'Sullivan D, 2000, MOL MICROBIOL, V36, P866, DOI 10.1046/j.1365-2958.2000.01901.x; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pirone-Davies C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123639; Roberts RJ, 2015, NUCLEIC ACIDS RES, V43, pD298, DOI 10.1093/nar/gku1046; Seib KL, 2015, NUCLEIC ACIDS RES, V43, P4150, DOI 10.1093/nar/gkv219; Srikhanta YN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000400; Stewart AC, 2009, BIOINFORMATICS, V25, P962, DOI 10.1093/bioinformatics/btp097; Sun K, 2010, VET MICROBIOL, V141, P149, DOI 10.1016/j.vetmic.2009.09.004; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tian XP, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00998; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	49	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161499	10.1371/journal.pone.0161499	http://dx.doi.org/10.1371/journal.pone.0161499			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556252	gold, Green Published, Green Submitted			2022-12-26	WOS:000382258100047
J	Daneau, G; Gous, N; Scott, L; Potgieter, J; Kestens, L; Stevens, W				Daneau, Geraldine; Gous, Natasha; Scott, Lesley; Potgieter, Joachim; Kestens, Luc; Stevens, Wendy			Human Immunodeficiency Virus (HIV)-Infected Patients Accept Finger Stick Blood Collection for Point-Of-Care CD4 Testing	PLOS ONE			English	Article							DIABETES-MELLITUS; PRICK BLOOD; PIMA CD4; INSTRUMENT; TACROLIMUS; ACCURACY; SAMPLES	Introduction HIV-infected patients require antiretroviral treatment for life. To improve access to care, CD4 enumeration and viral load tests have been redesigned to be used as point-of-care techniques using finger-stick blood. Accurate CD4 counting in capillary blood requires a free flowing blood drop that is achieved by blade incision. The aim of this study was to assess the attitude of the patients toward blade-based finger-stick blood donation. Methods Four hundred and ninety-nine patients were included (299 patients from South Africa and 200 from Belgium). They completed a questionnaire to express their preference for finger stick or venipuncture, after undergoing both. The South African patient cohort was divided in two groups, receiving either single or multiple finger stick for CD4 and other HIV-related tests. The Belgian patients received a single finger stick for CD4 testing, and were asked to respond directly and again after two days. Results The majority of the patients preferred the finger stick to the venipuncture. The perceived pain using the blade was superior to a small needle, but similar to a large needle. They preferred up to three finger sticks over one venipuncture. Up to 30% of the patients changed their mind over two days. The main reason for choosing a finger stick was continued bleeding after venipuncture. The most cited objection to finger stick was pain/soreness. Conclusion Patient perceptions support the implementation of donating capillary blood with blade-based finger stick during CD4 point-of-care testing.	[Daneau, Geraldine; Kestens, Luc] Inst Trop Med, Dept Biomed Sci, Immunol Unit, Antwerp, Belgium; [Gous, Natasha; Scott, Lesley; Stevens, Wendy] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Dept Mol Med & Haematol, Johannesburg, South Africa; [Potgieter, Joachim] Natl Hlth Lab Serv, Tshwane Acad Div, Dept Haematol, Pretoria, South Africa; [Potgieter, Joachim] Univ Pretoria, Pretoria, South Africa; [Kestens, Luc] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Stevens, Wendy] Natl Hlth Lab Serv, Natl Prior Program, Johannesburg, South Africa	Institute of Tropical Medicine (ITM); University of Witwatersrand; Tshwane University of Technology; University of Pretoria; University of Antwerp; National Health Laboratory Service	Daneau, G (corresponding author), Inst Trop Med, Dept Biomed Sci, Immunol Unit, Antwerp, Belgium.	gdaneau@itg.be	Potgieter, Joachim JC/AAA-2963-2022	Potgieter, Joachim JC/0000-0001-5366-6744; Daneau, Geraldine/0000-0002-2570-0893; Scott, Lesley/0000-0001-6573-9525	Grand Challenges Canada [0007-02-01-01]	Grand Challenges Canada(CGIAR)	The study in South Africa was funded by Grand Challenges Canada [Grant number 0007-02-01-01, url http://www.grandchallenges.ca]. The study in Antwerp was independent of any funder.	Anderson David A, 2011, Curr HIV/AIDS Rep, V8, P31, DOI 10.1007/s11904-010-0067-z; [Anonymous], 2013, WHO GLOBAL HLTH OBSE; [Anonymous], 2014, GLOB UPD HLTH SECT R; Chapman DC, 1999, ANN PHARMACOTHER, V33, P775, DOI 10.1345/aph.18317; Chaudhry Rajeev, 2004, Manag Care Interface, V17, P44; Cheung CY, 2008, TRANSPL INT, V21, P140, DOI 10.1111/j.1432-2277.2007.00584.x; Diaw PA, 2011, JAIDS-J ACQ IMM DEF, V58, pE103, DOI 10.1097/QAI.0b013e318235b378; Fedele D, 2003, Diabetes Technol Ther, V5, P983, DOI 10.1089/152091503322641033; Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3; Gous N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085265; Greenhalgh S, 2004, ARCH DIS CHILD, V89, P516, DOI 10.1136/adc.2002.019307; Hinchliffe E, 2014, ANN CLIN BIOCHEM, V51, P106, DOI 10.1177/0004563213488759; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; MacLennan CA, 2007, AIDS, V21, P1643, DOI 10.1097/QAD.0b013e32823bcb03; Merton G, 2000, THER DRUG MONIT, V22, P594, DOI 10.1097/00007691-200010000-00015; Moore C, 2013, J HOSP INFECT, V85, P1, DOI 10.1016/j.jhin.2013.06.005; South African National Department of Health, 2015, NEW DEP HLTH NAT CON; Stone MA, 2007, DIABETIC MED, V24, P792, DOI 10.1111/j.1464-5491.2007.02175.x; ter Heine R, 2011, BIOANALYSIS, V3, P1093, DOI 10.4155/BIO.11.72; UNAIDS, 2014, 90 90 90 AMB TREATM; Wade D, 2014, JAIDS-J ACQ IMM DEF, V66, pE98, DOI 10.1097/QAI.0000000000000214; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2013, 2013 CONS GUID US AN; Yonan N, 2006, CLIN TRANSPLANT, V20, P221, DOI 10.1111/j.1399-0012.2005.00472.x	24	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161891	10.1371/journal.pone.0161891	http://dx.doi.org/10.1371/journal.pone.0161891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556894	Green Submitted, Green Published, gold			2022-12-26	WOS:000382258100069
J	Davies, C; Ward, VK				Davies, Colin; Ward, Vernon K.			Expression of the NS5 (VPg) Protein of Murine Norovirus Induces a G1/S Phase Arrest	PLOS ONE			English	Article							CELL-CYCLE ARREST; GENOME-LINKED PROTEIN; TRANSLATION REQUIRES; FELINE CALICIVIRUS; REPLICATION; INFECTION; COMPLEX; SHUTOFF; ROLES; BLOCK	Murine norovirus-1 (MNV-1) is known to subvert host cell division inducing an accumulation of cells in the G(0)/G(1) phase, creating conditions where viral replication is favored. This study identified that NS5 (VPg), is capable of inducing cell cycle arrest in the absence of viral replication or other viral proteins in an analogous manner to MNV-1 infection. NS5 expression induced an accumulation of cells in the G(0)/G(1) phase in an asynchronous population by inhibiting progression at the G(1)/S restriction point. Furthermore, NS5 expression resulted in a down-regulation of cyclin A expression in asynchronous cells and inhibited cyclin A expression in cells progressing from G(1) to S phase. The activity of NS5 on the host cell cycle occurs through an uncharacterized function. Amino acid substitutions of NS5(Y26A) and NS5(F123A) that inhibit the ability for NS5 to attach to RNA and recruit host eukaryotic translation initiation factors, respectively, retained the ability to induce an accumulation of cells in the G(0)/G(1) phase as identified for wild-type NS5. To the best of our knowledge, this is the first report of a VPg protein manipulating the host cell cycle.	[Davies, Colin; Ward, Vernon K.] Univ Otago, Otago Sch Med Sci, Dept Microbiol & Immunol, POB 56, Dunedin 9054, New Zealand	University of Otago	Ward, VK (corresponding author), Univ Otago, Otago Sch Med Sci, Dept Microbiol & Immunol, POB 56, Dunedin 9054, New Zealand.	vernon.ward@otago.ac.nz		Davies, Colin/0000-0002-3156-543X; Ward, Vernon/0000-0001-8692-5116	University of Otago Postgraduate Publishing Bursary	University of Otago Postgraduate Publishing Bursary	University of Otago Postgraduate Publishing Bursary to CD. www.otago.ac.nz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker E, 2012, THESIS; Belliot G, 2008, VIROLOGY, V374, P33, DOI 10.1016/j.virol.2007.12.028; Beretta L, 1996, J VIROL, V70, P8993, DOI 10.1128/JVI.70.12.8993-8996.1996; Bergin IL, 2009, EMERG INFECT DIS, V15, P1955, DOI 10.3201/eid1512.090839; Bresnahan WA, 1996, VIROLOGY, V224, P150, DOI 10.1006/viro.1996.0516; Chaudhry Y, 2006, J BIOL CHEM, V281, P25315, DOI 10.1074/jbc.M602230200; Chen CJ, 2004, J VIROL, V78, P5658, DOI 10.1128/JVI.78.11.5658-5669.2004; Chulu JLC, 2010, J VIROL, V84, P7683, DOI 10.1128/JVI.02604-09; Chung L, 2014, J BIOL CHEM, V289, P21738, DOI 10.1074/jbc.M114.550657; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; Daughenbaugh KF, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-33; Daughenbaugh KF, 2003, EMBO J, V22, P2852, DOI 10.1093/emboj/cdg251; Davies C, 2015, J VIROL, V89, P6057, DOI 10.1128/JVI.03673-14; Ehmann GL, 2000, VIROLOGY, V267, P335, DOI 10.1006/viro.1999.0147; Eskelin K, 2011, J VIROL, V85, P9210, DOI 10.1128/JVI.00052-11; Feuer R, 2002, J VIROL, V76, P4430, DOI 10.1128/JVI.76.9.4430-4440.2002; Furuno N, 1999, J CELL BIOL, V147, P295, DOI 10.1083/jcb.147.2.295; Gibbs JD, 2009, J VIROL, V83, P12424, DOI 10.1128/JVI.00806-09; Golzio M, 2002, BBA-BIOMEMBRANES, V1563, P23, DOI 10.1016/S0005-2736(02)00369-3; Goodfellow I, 2005, EMBO REP, V6, P968, DOI 10.1038/sj.embor.7400510; Goodfellow I, 2011, CURR OPIN VIROL, V1, P355, DOI 10.1016/j.coviro.2011.09.003; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; Hansman GS, 2007, REV MED VIROL, V17, P133, DOI 10.1002/rmv.533; He YA, 2010, J VIROL, V84, P12832, DOI 10.1128/JVI.01216-10; Hebrard E, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-23; Hosmillo M, 2014, J VIROL, V88, P12213, DOI 10.1128/JVI.01650-14; Hyde JL, 2010, VIROLOGY, V406, P138, DOI 10.1016/j.virol.2010.06.047; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; KRUH J, 1992, CR SOC BIOL, V186, P12; Leen EN, 2013, J VIROL, V87, P5318, DOI 10.1128/JVI.03151-12; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; McFadden N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002413; Naniche D, 1999, J VIROL, V73, P1894, DOI 10.1128/JVI.73.3.1894-1901.1999; Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1; Radford AD, 2009, J FELINE MED SURG, V11, P556, DOI 10.1016/j.jfms.2009.05.004; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Sosnovtsev SV, 2006, J VIROL, V80, P7816, DOI 10.1128/JVI.00532-06; Subba-Reddy CV, 2011, J VIROL, V85, P13027, DOI 10.1128/JVI.06191-11; Surjit M, 2006, J BIOL CHEM, V281, P10669, DOI 10.1074/jbc.M509233200; Ward VK, 2007, P NATL ACAD SCI USA, V104, P11050, DOI 10.1073/pnas.0700336104; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; XI JA, 1990, SCIENCE, V250, P1580, DOI 10.1126/science.2177224	43	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161582	10.1371/journal.pone.0161582	http://dx.doi.org/10.1371/journal.pone.0161582			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556406	Green Submitted, gold, Green Published			2022-12-26	WOS:000382258100057
J	Lin, ZX; Santos, S; Padilla, K; Printzenhoff, D; Castle, NA				Lin, Zhixin; Santos, Sonia; Padilla, Karen; Printzenhoff, David; Castle, Neil A.			Biophysical and Pharmacological Characterization of Nav1.9 Voltage Dependent Sodium Channels Stably Expressed in HEK-293 Cells	PLOS ONE			English	Article							ROOT GANGLION NEURONS; TETRODOTOXIN-RESISTANT; LOCAL-ANESTHETICS; SENSORY NEURONS; NA+ CHANNELS; NA(V)1.9; MOUSE; RAT; DEPOLARIZATION; IDENTIFICATION	The voltage dependent sodium channel Nav1.9, is expressed preferentially in peripheral sensory neurons and has been linked to human genetic pain disorders, which makes it target of interest for the development of new pain therapeutics. However, characterization of Nav1.9 pharmacology has been limited due in part to the historical difficulty of functionally expressing recombinant channels. Here we report the successful generation and characterization of human, mouse and rat Nav1.9 stably expressed in human HEK-293 cells. These cells exhibit slowly activating and inactivating inward sodium channel currents that have characteristics of native Nav1.9. Optimal functional expression was achieved by coexpression of Nav1.9 with beta 1/beta 2 subunits. While recombinantly expressed Nav1.9 was found to be sensitive to sodium channel inhibitors TC-N 1752 and tetracaine, potency was up to 100-fold less than reported for other Nav channel subtypes despite evidence to support an interaction with the canonical local anesthetic (LA) binding region on Domain 4 S6. Nav1.9 Domain 2 S6 pore domain contains a unique lysine residue (K799) which is predicted to be spatially near the local anesthetic interaction site. Mutation of this residue to the consensus asparagine (K799N) resulted in an increase in potency for tetracaine, but a decrease for TC-N 1752, suggesting that this residue can influence interaction of inhibitors with the Nav1.9 pore. In summary, we have shown that stable functional expression of Nav1.9 in the widely used HEK-293 cells is possible, which opens up opportunities to better understand channel properties and may potentially aid identification of novel Nav1.9 based pharmacotherapies.	[Lin, Zhixin; Santos, Sonia; Padilla, Karen; Printzenhoff, David; Castle, Neil A.] Pfizer Inc, Neurosci & Pain Res Unit, Durham, NC 27703 USA; [Lin, Zhixin; Santos, Sonia; Padilla, Karen; Printzenhoff, David; Castle, Neil A.] Icagen Inc, Durham, NC 27703 USA	Pfizer	Lin, ZX (corresponding author), Pfizer Inc, Neurosci & Pain Res Unit, Durham, NC 27703 USA.; Lin, ZX (corresponding author), Icagen Inc, Durham, NC 27703 USA.	zlin@icagen.com			Pfizer Inc.	Pfizer Inc.(Pfizer)	Pfizer Inc. provided support in the form of salaries for authors [ZL, SS, KP, DP, NC], but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bagneris C, 2014, P NATL ACAD SCI USA, V111, P8428, DOI 10.1073/pnas.1406855111; Baker MD, 2003, J PHYSIOL-LONDON, V548, P373, DOI 10.1113/jphysiol.2003.039131; Baker MD, 2005, J PHYSIOL-LONDON, V567, P851, DOI 10.1113/jphysiol.2005.089771; Bezanilla F, 2006, BIOL RES, V39, P425, DOI 10.4067/S0716-97602006000300005; Blum R, 2002, NATURE, V419, P687, DOI 10.1038/nature01085; Bregman H, 2011, J MED CHEM, V54, P4427, DOI 10.1021/jm200018k; Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204; Chen CL, 2012, J BIOL CHEM, V287, P39061, DOI 10.1074/jbc.M112.397646; Cummins TR, 2000, J NEUROSCI, V20, P8754; Cummins TR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0001.1999; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dib-Hajj S, 2002, TRENDS NEUROSCI, V25, P253, DOI 10.1016/S0166-2236(02)02150-1; Dib-Hajj SD, 1999, FEBS LETT, V462, P117, DOI 10.1016/S0014-5793(99)01519-7; Dib-Hajj SD, 1999, GENOMICS, V59, P309, DOI 10.1006/geno.1999.5890; Dib-Hajj SD, 1998, P NATL ACAD SCI USA, V95, P8963, DOI 10.1073/pnas.95.15.8963; Dib-Hajj SD, 2015, NAT REV NEUROSCI, V16, P511, DOI 10.1038/nrn3977; Fang X, 2002, J NEUROSCI, V22, P7425; Fang X, 2006, J NEUROSCI, V26, P7281, DOI 10.1523/JNEUROSCI.1072-06.2006; Herzog RI, 2001, J NEUROPHYSIOL, V86, P1351, DOI 10.1152/jn.2001.86.3.1351; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Li HL, 1999, MOL PHARMACOL, V55, P134, DOI 10.1124/mol.55.1.134; Liu CJ, 2001, J BIOL CHEM, V276, P46553, DOI 10.1074/jbc.M108699200; Maingret F, 2008, J GEN PHYSIOL, V131, P211, DOI 10.1085/jgp.200709935; Marban E, 1998, J PHYSIOL-LONDON, V508, P647, DOI 10.1111/j.1469-7793.1998.647bp.x; Matson DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138140; McCormack K, 2013, P NATL ACAD SCI USA, V110, pE2724, DOI 10.1073/pnas.1220844110; Nau C, 2004, J MEMBRANE BIOL, V201, P1, DOI 10.1007/s00232-004-0702-y; Panigel J, 2011, J NEUROGENET, V25, P134, DOI 10.3109/01677063.2011.629702; Patino GA, 2010, NEUROSCI LETT, V486, P53, DOI 10.1016/j.neulet.2010.06.050; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; Ruiz MD, 2015, J MED CHEM, V58, P7093, DOI 10.1021/jm501981g; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; Sleeper AA, 2000, J NEUROSCI, V20, P7279; Vanoye CG, 2013, J GEN PHYSIOL, V141, P193, DOI 10.1085/jgp.201210919; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123	37	28	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161450	10.1371/journal.pone.0161450	http://dx.doi.org/10.1371/journal.pone.0161450			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556810	Green Submitted, gold, Green Published			2022-12-26	WOS:000382258100042
J	Virgilio, S; Cupertino, FB; Bernardes, NE; Freitas, FZ; Takeda, AAS; Fontes, MRD; Bertolini, MC				Virgilio, Stela; Cupertino, Fernanda Barbosa; Bernardes, Natalia Elisa; Freitas, Fernanda Zanolli; Sekijima Takeda, Agnes Alessandra; de Mattos Fontes, Marcos Roberto; Bertolini, Maria Celia			Molecular Components of the Neurospora crassa pH Signaling Pathway and Their Regulation by pH and the PAC-3 Transcription Factor	PLOS ONE			English	Article							ASPERGILLUS-NIDULANS; AMBIENT PH; CANDIDA-ALBICANS; GENE-EXPRESSION; STRUCTURAL BASIS; IMPORTIN-ALPHA; CRYPTOCOCCUS-NEOFORMANS; DNA METHYLATION; PLASMA-MEMBRANE; PROTEIN	Environmental pH induces a stress response triggering a signaling pathway whose components have been identified and characterized in several fungi. Neurospora crassa shares all six components of the Aspergillus nidulans pH signaling pathway, and we investigate here their regulation during an alkaline pH stress response. We show that the N. crassa pal mutant strains, with the exception of Delta pal-9, which is the A. nidulans palI homolog, exhibit low conidiation and are unable to grow at alkaline pH. Moreover, they accumulate the pigment melanin, most likely via regulation of the tyrosinase gene by the pH signaling components. The PAC-3 transcription factor binds to the tyrosinase promoter and negatively regulates its gene expression. PAC-3 also binds to all pal gene promoters, regulating their expression at normal growth pH and/or alkaline pH, which indicates a feedback regulation of PAC-3 in the pal gene expression. In addition, PAC-3 binds to the pac-3 promoter only at alkaline pH, most likely influencing the pac-3 expression at this pH suggesting that the activation of PAC-3 in N. crassa results from proteolytic processing and gene expression regulation by the pH signaling components. In N. crassa, PAC-3 is proteolytically processed in a single cleavage step predominately at alkaline pH; however, low levels of the processed protein can be observed at normal growth pH. We also demonstrate that PAC-3 preferentially localizes in the nucleus at alkaline pH stress and that the translocation may require the N. crassa importin-alpha since the PAC-3 nuclear localization signal (NLS) has a strong in vitro affinity with importin-alpha. The data presented here show that the pH signaling pathway in N. crassa shares all the components with the A. nidulans and S. cerevisiae pathways; however, it exhibits some properties not previously described in either organism.	[Virgilio, Stela; Cupertino, Fernanda Barbosa; Freitas, Fernanda Zanolli; Bertolini, Maria Celia] Univ Estadual Paulista, Inst Quim, Dept Bioquim & Tecnol Quim, BR-14800060 Araraquara, SP, Brazil; [Bernardes, Natalia Elisa; Sekijima Takeda, Agnes Alessandra; de Mattos Fontes, Marcos Roberto] Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Fis & Biofis, BR-18618970 Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Bertolini, MC (corresponding author), Univ Estadual Paulista, Inst Quim, Dept Bioquim & Tecnol Quim, BR-14800060 Araraquara, SP, Brazil.	mcbertol@iq.unesp.br	Fontes, Marcos Roberto/B-1941-2009; Zanolli Freitas, Fernanda/J-9425-2012; Takeda, Agnes/AAH-3413-2020; Virgilio, Stela/M-3753-2016; Bertolini, Maria Celia/D-3654-2012; Zanolli Freitas, Fernanda/ABB-9297-2021	Fontes, Marcos Roberto/0000-0002-4634-6221; Zanolli Freitas, Fernanda/0000-0002-8810-2970; Takeda, Agnes/0000-0001-5000-6652; Bertolini, Maria Celia/0000-0001-5319-2710; Zanolli Freitas, Fernanda/0000-0002-8810-2970; Bernardes, Natalia/0000-0002-6498-0429; Virgilio, Stela/0000-0001-5195-9965	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP [2013/24705-3, 2012/09435-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq [444068/2014-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The work was supported by the following: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP, 2013/24705-3, 2012/09435-7, www.fapesp.br; and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, 444068/2014-7.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Arino J, 2010, OMICS, V14, P517, DOI 10.1089/omi.2010.0044; Arst HN, 2003, TRENDS GENET, V19, P224, DOI 10.1016/S0168-9525(03)00052-0; Bernardes NE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128687; Bertuzzi M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004413; Bussink HJ, 2015, MOL MICROBIOL, V98, P1051, DOI 10.1111/mmi.13173; Calcagno-Pizarelli AM, 2011, J CELL SCI, V124, P4064, DOI 10.1242/jcs.088344; Casadevall A, 2000, CURR OPIN MICROBIOL, V3, P354, DOI 10.1016/S1369-5274(00)00103-X; Chinnici JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110603; Christie M, 2016, J MOL BIOL, V428, P2060, DOI 10.1016/j.jmb.2015.10.023; Cornet M, 2014, EUKARYOT CELL, V13, P342, DOI 10.1128/EC.00313-13; Cornet M, 2009, RES MICROBIOL, V160, P219, DOI 10.1016/j.resmic.2009.02.002; Cupertino FB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044258; Cutress ML, 2008, J CELL SCI, V121, P957, DOI 10.1242/jcs.022103; da Silva MB, 2009, MEM I OSWALDO CRUZ, V104, P644, DOI 10.1590/S0074-02762009000400019; Davis D, 2003, CURR GENET, V44, P58, DOI [10.1007/s00294-003-0415-2, 10.1007/s00294-003-0431-2]; Diez E, 2002, EMBO J, V21, P1350, DOI 10.1093/emboj/21.6.1350; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; FOSS HM, 1993, SCIENCE, V262, P1737, DOI 10.1126/science.7505062; Galazka JM, 2016, GENOME RES, V26, P1069, DOI 10.1101/gr.203182.115; Galindo A, 2012, J CELL SCI, V125, P1784, DOI 10.1242/jcs.098897; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Gomez-Raja J, 2012, EUKARYOT CELL, V11, P683, DOI 10.1128/EC.05211-11; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Hervas-Aguilar A, 2010, J BIOL CHEM, V285, P18095, DOI 10.1074/jbc.M110.114371; HIRSCH HM, 1954, PHYSIOL PLANTARUM, V7, P72, DOI 10.1111/j.1399-3054.1954.tb07558.x; Klocko AD, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005083; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li MC, 2004, EUKARYOT CELL, V3, P741, DOI 10.1128/EC.3.3.741-751.2004; Li WS, 1997, GENETICS, V145, P63; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lott K, 2011, J BIOL CHEM, V286, P28160, DOI 10.1074/jbc.M111.228007; Lucena-Agell D, 2015, EUKARYOT CELL, V14, P545, DOI 10.1128/EC.00031-15; Marfori M, 2012, TRAFFIC, V13, P532, DOI 10.1111/j.1600-0854.2012.01329.x; Nosanchuk JD, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01463; Nozawa SR, 2003, FUNGAL GENET BIOL, V39, P286, DOI 10.1016/S1087-1845(03)00051-3; O'Meara TR, 2014, MOL CELL BIOL, V34, P673, DOI 10.1128/MCB.01359-13; Ost KS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005159; Park G, 2008, EUKARYOT CELL, V7, P2113, DOI 10.1128/EC.00466-07; Penalva MA, 2002, MICROBIOL MOL BIOL R, V66, P426, DOI 10.1128/MMBR.66.3.426-446.2002; Penalva MA, 2008, TRENDS MICROBIOL, V16, P291, DOI 10.1016/j.tim.2008.03.006; Penalva MA, 2014, CURR OPIN MICROBIOL, V22, P49, DOI 10.1016/j.mib.2014.09.005; Penas MM, 2007, EUKARYOT CELL, V6, P960, DOI 10.1128/EC.00047-07; PERKINS DD, 1982, MICROBIOL REV, V46, P426, DOI 10.1128/MMBR.46.4.426-570.1982; Porta A, 1999, J BACTERIOL, V181, P7516, DOI 10.1128/JB.181.24.7516-7523.1999; Rodriguez-Galan O, 2009, J BIOL CHEM, V284, P4404, DOI 10.1074/jbc.M808645200; SANCHEZFERRER A, 1995, BBA-PROTEIN STRUCT M, V1247, P1; Sokolovsky V., 1990, FUNGAL GENET NEWSLET, V37, P41; Squina FM, 2010, CELL STRESS CHAPERON, V15, P225, DOI 10.1007/s12192-009-0131-z; SU SSY, 1993, GENETICS, V133, P67; Takeda AAS, 2013, PROTEIN PEPTIDE LETT, V20, P8; Tamaru H, 2003, NAT GENET, V34, P75, DOI 10.1038/ng1143; TILBURN J, 1995, EMBO J, V14, P779, DOI 10.1002/j.1460-2075.1995.tb07056.x; Trevisan GL, 2011, FEBS LETT, V585, P3442, DOI 10.1016/j.febslet.2011.09.037; Vogel H.J., 1956, MICROB GENET B, V13, P42; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009	56	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161659	10.1371/journal.pone.0161659	http://dx.doi.org/10.1371/journal.pone.0161659			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27557053	Green Submitted, Green Published, gold			2022-12-26	WOS:000382258100061
J	Wu, FL; Xu, XB; Xie, J; Yi, SJ; Wang, J; Yang, XX; Yang, CJ; Liang, BB; Ma, QX; Li, H; Song, HB; Qiu, SF				Wu, Fuli; Xu, Xuebin; Xie, Jing; Yi, Shengjie; Wang, Jian; Yang, Xiaoxia; Yang, Chaojie; Liang, Beibei; Ma, Qiuxia; Li, Hao; Song, Hongbin; Qiu, Shaofu			Molecular Characterization of Salmonella enterica Serovar Aberdeen Negative for H2S Production in China	PLOS ONE			English	Article							GEL-ELECTROPHORESIS PROTOCOLS; HYDROGEN-SULFIDE; ANTIMICROBIAL RESISTANCE; PREVALENCE; INFLAMMATION; TYPHIMURIUM; SENFTENBERG; METABOLISM; MICROBIOTA; REDUCTION	Salmonella enterica infections continue to be a significant burden on public health worldwide. The ability of S. enterica to produce hydrogen sulfide (H2S) is an important phenotypic characteristic used to screen and identify Salmonella with selective medium; however, H2S-negative Salmonella have recently emerged. In this study, the H2S phenotype of Salmonella isolates was confirmed, and the selected isolates were subjected to antimicrobial susceptibility testing and molecular identification by multilocus sequence typing, pulsed-field gel electrophoresis, and clustered regularly interspaced short palindromic repeat (CRISPR) analysis. The phs genetic operon was also analyzed. A total of 160 S. enterica serovar Aberdeen isolates were detected between 2005 and 2013 in China. Of them, seven non-H2(S)-producing isolates were detected. Notably, four samples yielded four pairs of isolates with different H2S phenotypes, simultaneously. The data demonstrated that H2S-negative isolates were genetically closely related to H2S-positive isolates. Three new spacers (Abe1, Abe2, and Abe3) were identified in CRISPR locus 1 in four pairs of isolates with different H2S phenotypes from the same samples. Sequence analysis revealed a new nonsense mutation at position 208 in the phsA gene of all non-H2S-producing isolates. Additionally, we describe a new screening procedure to avoid H2S-negative Salmonella, which would normally be overlooked during laboratory and hospital screening. The prevalence of this pathogen may be underestimated; therefore, it is important to focus on improving surveillance of this organism to control its spread.	[Wu, Fuli; Xie, Jing; Yi, Shengjie; Wang, Jian; Yang, Xiaoxia; Yang, Chaojie; Liang, Beibei; Ma, Qiuxia; Li, Hao; Song, Hongbin; Qiu, Shaofu] Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing, Peoples R China; [Xu, Xuebin] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China	Academy of Military Medical Sciences - China; Shanghai Center for Disease Control & Prevention	Song, HB; Qiu, SF (corresponding author), Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing, Peoples R China.	hongbinsong@263.net; qiushf0613@hotmail.com	Qiu, Shaofu/CAJ-0602-2022		Mega-projects of Science and Technology Research [2016ZX10004215, AWS15J006]; National Nature Science Foundation of China [81371854, 81373053]; Beijing Science and Technology Nova program [Z131107000413061]	Mega-projects of Science and Technology Research; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Science and Technology Nova program	This work was supported by the Mega-projects of Science and Technology Research (grant nos. 2016ZX10004215 and AWS15J006), the National Nature Science Foundation of China (grant nos. 81371854 and 81373053), and the Beijing Science and Technology Nova program (grant no. Z131107000413061).	Albert MJ, 2014, J CLIN MICROBIOL, V52, P4090, DOI 10.1128/JCM.01775-14; Barton LL, 2014, METAL IONS LIFE SCI, V14, P237, DOI 10.1007/978-94-017-9269-1_10; Behravesh CB, 2011, J INFECT DIS, V204, P263, DOI 10.1093/infdis/jir263; BICKNELL SR, 1972, J HYG-CAMB, V70, P121, DOI 10.1017/S0022172400022166; Campioni F, 2015, APMIS, V123, P422, DOI 10.1111/apm.12367; Fabre L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036995; Grissa I, 2008, NUCLEIC ACIDS RES, V36, pW145, DOI 10.1093/nar/gkn228; HEINZINGER NK, 1995, J BACTERIOL, V177, P2813, DOI 10.1128/jb.177.10.2813-2820.1995; Hoelzer K, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-34; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; Ikwap K, 2014, PREV VET MED, V115, P39, DOI 10.1016/j.prevetmed.2014.03.009; Levitt MD, 1999, J CLIN INVEST, V104, P1107, DOI 10.1172/JCI7712; [李卫光 LI Wei-guang], 2009, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V19, P1954; Lin DC, 2014, FOOD MICROBIOL, V43, P1, DOI 10.1016/j.fm.2014.04.010; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Mao X., 2011, CHIN J DIS CONTROL P, V15, P622; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; Pires SM, 2010, FOODBORNE PATHOG DIS, V7, P1351, DOI 10.1089/fpd.2010.0564; PROST E, 1967, ANNU REV MICROBIOL, V21, P495, DOI 10.1146/annurev.mi.21.100167.002431; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rohmer L, 2011, TRENDS MICROBIOL, V19, P341, DOI 10.1016/j.tim.2011.04.003; Sakano C, 2013, J CLIN MICROBIOL, V51, P328, DOI 10.1128/JCM.02225-12; Shariat N, 2014, APPL ENVIRON MICROB, V80, P430, DOI 10.1128/AEM.02790-13; Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Stepan RM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-153; Sun JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113145; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Xie J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139115; Yi SJ, 2014, J CLIN MICROBIOL, V52, P2557, DOI 10.1128/JCM.00377-14; Zhang JM, 2015, INT J FOOD MICROBIOL, V210, P47, DOI 10.1016/j.ijfoodmicro.2015.04.019	32	5	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161352	10.1371/journal.pone.0161352	http://dx.doi.org/10.1371/journal.pone.0161352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27552230	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768800032
J	Baboolal, TG; Mashanov, GI; Nenasheva, TA; Peckham, M; Molloy, JE				Baboolal, Thomas G.; Mashanov, Gregory I.; Nenasheva, Tatiana A.; Peckham, Michelle; Molloy, Justin E.			A Combination of Diffusion and Active Translocation Localizes Myosin 10 to the Filopodial Tip	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; molecular imaging; myosin; single particle analysis; single-molecule biophysics; TIRF	SINGLE MOLECULES; MOTOR-ACTIVITY; UNCONVENTIONAL MYOSIN; CARGO RECOGNITION; STRUCTURAL BASIS; BUNDLED ACTIN; DOMAIN; FILAMENTS; CELLS; MOTILITY	Myosin 10 is an actin-based molecular motor that localizes to the tips of filopodia in mammalian cells. To understand how it is targeted to this distinct region of the cell, we have used total internal reflection fluorescence microscopy to study the movement of individual full-length and truncated GFP-tagged molecules. Truncation mutants lacking the motor region failed to localize to filopodial tips but still bound transiently at the plasma membrane. Deletion of the single -helical and anti-parallel coiled-coil forming regions, which lie between the motor and pleckstrin homology domains, reduced the instantaneous velocity of intrafilopodial movement but did not affect the number of substrate adherent filopodia. Deletion of the anti-parallel coiled-coil forming region, but not the EKR-rich region of the single -helical domain, restored intrafilopodial trafficking, suggesting this region is important in determining myosin 10 motility. We propose a model by which myosin 10 rapidly targets to the filopodial tip via a sequential reduction in dimensionality. Molecules first undergo rapid diffusion within the three-dimensional volume of the cell body. They then exhibit periods of slower two-dimensional diffusion in the plane of the plasma membrane. Finally, they move in a unidimensional, highly directed manner along the polarized actin filament bundle within the filopodium becoming confined to a single point at the tip. Here we have observed directly each phase of the trafficking process using single molecule fluorescence imaging of live cells and have quantified our observations using single particle tracking, autocorrelation analysis, and kymographs.	[Baboolal, Thomas G.; Peckham, Michelle] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Baboolal, Thomas G.; Peckham, Michelle] Univ Leeds, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Mashanov, Gregory I.; Nenasheva, Tatiana A.; Molloy, Justin E.] Francis Crick Inst, Mill Hill Lab, London NW7 1AA, England	University of Leeds; University of Leeds; Francis Crick Institute	Peckham, M (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.; Peckham, M (corresponding author), Univ Leeds, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.; Molloy, JE (corresponding author), Francis Crick Inst, Mill Hill Lab, London NW7 1AA, England.	m.peckham@leeds.ac.uk; justin.molloy@crick.ac.uk	Peckham, Michelle/J-4991-2015; Baboolal, Thomas/AAA-5491-2019; Nenasheva, Tatiana/AAM-8556-2020	Peckham, Michelle/0000-0002-3754-2028; Baboolal, Thomas/0000-0003-4444-0318; Nenasheva, Tatiana/0000-0002-1669-5244; Molloy, Justin/0000-0002-8307-2450	Francis Crick Institute [FC001119]; UK Medical Research Council [FC001119]; Wellcome Trust [FC001119]; Biotechnology and Biological Sciences Research Council, UK [BB/C004906/1, BB/M009114/1]; European Molecular Biology Organization Fellowship; Cancer Research UK; BBSRC [BB/M009114/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M009114/1, BB/C004906/1] Funding Source: researchfish; Medical Research Council [1106254] Funding Source: researchfish; The Francis Crick Institute [10119] Funding Source: researchfish	Francis Crick Institute; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Molecular Biology Organization Fellowship(European Molecular Biology Organization (EMBO)); Cancer Research UK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK Grant FC001119, UK Medical Research Council Grant FC001119, Wellcome Trust Grant FC001119, Biotechnology and Biological Sciences Research Council, UK, Grants BB/C004906/1 and BB/M009114/1, and a short term European Molecular Biology Organization Fellowship (to T. A. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; Berg JS, 2000, J CELL SCI, V113, P3439; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Billington N, 2015, CURR BIOL, V25, P942, DOI 10.1016/j.cub.2015.02.012; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Cramer LP, 1997, J CELL BIOL, V136, P1287, DOI 10.1083/jcb.136.6.1287; Creed SJ, 2011, EXP CELL RES, V317, P249, DOI 10.1016/j.yexcr.2010.10.019; Gunning PW, 2015, J CELL SCI, V128, P2009, DOI 10.1242/jcs.165563; Hartman MA, 2012, J CELL SCI, V125, P1627, DOI 10.1242/jcs.094300; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Hirano Y, 2011, EMBO J, V30, P2734, DOI 10.1038/emboj.2011.177; Kee AJ, 2015, TRAFFIC, V16, P691, DOI 10.1111/tra.12282; Kerber ML, 2009, CURR BIOL, V19, P967, DOI 10.1016/j.cub.2009.03.067; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Lister I, 2004, EMBO J, V23, P1729, DOI 10.1038/sj.emboj.7600180; Lu Q, 2012, P NATL ACAD SCI USA, V109, P17388, DOI 10.1073/pnas.1208642109; Lu Q, 2011, MOL BIOL CELL, V22, P4268, DOI 10.1091/mbc.E11-04-0354; Makowska KA, 2015, CELL REP, V13, P2118, DOI 10.1016/j.celrep.2015.11.012; Mashanov GI, 2007, BIOPHYS J, V92, P2199, DOI 10.1529/biophysj.106.081117; Mashanov GI, 2004, J BIOL CHEM, V279, P15274, DOI 10.1074/jbc.M312140200; Mashanov GI, 2003, METHODS, V29, P142, DOI 10.1016/S1046-2023(02)00305-5; Mashanov GI, 2010, J BIOL CHEM, V285, P3664, DOI 10.1074/jbc.M109.039974; Nagy S, 2008, P NATL ACAD SCI USA, V105, P9616, DOI 10.1073/pnas.0802592105; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Park H, 2006, MOL CELL, V21, P331, DOI 10.1016/j.molcel.2005.12.015; Peckham M, 2011, BIOCHEM SOC T, V39, P1142, DOI 10.1042/BST0391142; Plantard L, 2010, J CELL SCI, V123, P3525, DOI 10.1242/jcs.069609; Ricca BL, 2010, BIOPHYS J, V99, P1818, DOI 10.1016/j.bpj.2010.06.066; Sanders TA, 2013, NATURE, V497, P628, DOI 10.1038/nature12157; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Sun Y, 2010, NAT STRUCT MOL BIOL, V17, P485, DOI 10.1038/nsmb.1785; Svitkina TM, 2013, CURR OPIN CELL BIOL, V25, P574, DOI 10.1016/j.ceb.2013.04.003; Tacon D, 2004, BIOCHEM SOC T, V32, P689, DOI 10.1042/BST0320689; Takagi Y, 2014, P NATL ACAD SCI USA, V111, pE1833, DOI 10.1073/pnas.1320122111; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Tokuo H, 2007, J CELL BIOL, V179, P229, DOI 10.1083/jcb.200703178; Umeki N, 2011, NAT STRUCT MOL BIOL, V18, P783, DOI 10.1038/nsmb.2065; Umeki N, 2009, P NATL ACAD SCI USA, V106, P8483, DOI 10.1073/pnas.0812930106; Vavra KC, 2016, BIOPHYS J, V110, P2517, DOI 10.1016/j.bpj.2016.04.048; Watanabe TM, 2010, J BIOL CHEM, V285, P19605, DOI 10.1074/jbc.M109.093864; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; Wei ZY, 2011, P NATL ACAD SCI USA, V108, P3572, DOI 10.1073/pnas.1016567108; Wolny M, 2014, J BIOL CHEM, V289, P27825, DOI 10.1074/jbc.M114.585679; Yang Y, 2009, P NATL ACAD SCI USA, V106, P4189, DOI 10.1073/pnas.0808682106; Zhang HQ, 2004, NAT CELL BIOL, V6, P523, DOI 10.1038/ncb1136; Zhu XJ, 2007, NAT CELL BIOL, V9, P184, DOI 10.1038/ncb1535	49	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22373	22385		10.1074/jbc.M116.730689	http://dx.doi.org/10.1074/jbc.M116.730689			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27566544	Green Published, hybrid			2022-12-26	WOS:000386760600003
J	Cooper, JA; Loomis, GW; Amador, JA				Cooper, Jennifer A.; Loomis, George W.; Amador, Jose A.			Hell and High Water: Diminished Septic System Performance in Coastal Regions Due to Climate Change	PLOS ONE			English	Article							WASTE-WATER; SOIL RESPIRATION; VIRUS REMOVAL; NITROGEN; PURIFICATION; ATTENUATION; BACTERIA; GROWTH	Climate change may affect the ability of soil-based onsite wastewater treatment systems (OWTS) to treat wastewater in coastal regions of the Northeastern United States. Higher temperatures and water tables can affect treatment by reducing the volume of unsaturated soil and oxygen available for treatment, which may result in greater transport of pathogens, nutrients, and biochemical oxygen demand (BOD5) to groundwater, jeopardizing public and aquatic ecosystem health. The soil treatment area (STA) of an OWTS removes contaminants as wastewater percolates through the soil. Conventional STAs receive wastewater from the septic tank, with infiltration occurring deeper in the soil profile. In contrast, shallow narrow STAs receive pre-treated wastewater that infiltrates higher in the soil profile, which may make them more resilient to climate change. We used intact soil mesocosms to quantify the water quality functions of a conventional and two types of shallow narrow STAs under present climate (PC; 20 degrees C) and climate change (CC; 25 degrees C, 30 cm elevation in water table). Significantly greater removal of BOD5 was observed under CC for all STA types. Phosphorus removal decreased significantly from 75% (PC) to 66% (CC) in the conventional STA, and from 100% to 71-72% in shallow narrow STAs. No fecal coliform bacteria (FCB) were released under PC, whereas up to 17 and 20 CFU 100 mL(-1) were released in conventional and shallow narrow STAs, respectively, under CC. Total N removal increased from 14% (PC) to 19% (CC) in the conventional STA, but decreased in shallow narrow STAs, from 6-7% to less than 3.0%. Differences in removal of FCB and total N were not significant. Leaching of N in excess of inputs was also observed in shallow narrow STAs under CC. Our results indicate that climate change can affect contaminant removal from wastewater, with effects dependent on the contaminant and STA type.	[Cooper, Jennifer A.; Amador, Jose A.] Univ Rhode Isl, Lab Soil Ecol & Microbiol, Kingston, RI 02881 USA; [Loomis, George W.] Univ Rhode Isl, New England Onsite Wastewater Training Ctr, Kingston, RI 02881 USA; [Cooper, Jennifer A.] Univ Florida, Everglades Res & Educ Ctr, Belle Glade, FL 33430 USA	University of Rhode Island; University of Rhode Island; State University System of Florida; University of Florida	Cooper, JA (corresponding author), Univ Rhode Isl, Lab Soil Ecol & Microbiol, Kingston, RI 02881 USA.; Cooper, JA (corresponding author), Univ Florida, Everglades Res & Educ Ctr, Belle Glade, FL 33430 USA.	jencooper@ufl.edu			Rhode Island Sea Grant; Rhode Island Agricultural Experiment Station; University of Rhode Island Enhancement of Graduate Research Program	Rhode Island Sea Grant; Rhode Island Agricultural Experiment Station; University of Rhode Island Enhancement of Graduate Research Program	This study was funded by grants from Rhode Island Sea Grant (http://seagrant.gso.uri.edu/), the Rhode Island Agricultural Experiment Station (http://web.uri.edu/riaes/), by a grant from University of Rhode Island Enhancement of Graduate Research Program to J.A.C. (http://web.uri.edu/graduate-school/enhancement-of-graduate-research-awardsegra/), and by personal funds of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador JA, 2007, EVALUATION LEACHFIEL, P12; Anderson D. L., 1994, P 7 INT S IND SMALL, P209; [Anonymous], POTENTIAL EFFECTS SE; Beal CD, 2006, WATER RES, V40, P2327, DOI 10.1016/j.watres.2006.04.018; Bitton G., 1980, INTRO ENV VIROLOGY; Bradshaw JK, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2012.0150; Bunnell JF, 1999, J ENVIRON MANAGE, V56, P209, DOI 10.1006/jema.1999.0273; Byappanahalli MN, 1998, WATER SCI TECHNOL, V38, P171, DOI 10.1016/S0273-1223(98)00820-8; CAMPBELL CA, 1976, CAN J SOIL SCI, V56, P293, DOI 10.4141/cjss76-037; COGGER CG, 1988, J ENVIRON QUAL, V17, P401, DOI 10.2134/jeq1988.00472425001700030009x; Cooper JA, 2016, ECOL ENG, V94, P22, DOI 10.1016/j.ecoleng.2016.05.059; Cooper JA, 2015, J ENVIRON QUAL, V44, P953, DOI 10.2134/jeq2014.06.0277; Crites R.W., 1998, MCGRAW HILL SERIES W; Davidson EA, 2000, BIOGEOCHEMISTRY, V48, P53, DOI 10.1023/A:1006204113917; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Domenico PA, 1998, PHYS CHEM HYDROGEOLO, P296; Feachem R.G., 1980, HLTH ASPECTS EXCRETA; Fogler H.S., 2010, ESSENTIALS CHEM REAC; Gerba C.P., 1975, J IRRIGATION DRAINAG, V101, P157, DOI DOI 10.1061/JRCEA4.0001044; Howarth RW, 2006, LIMNOL OCEANOGR, V51, P364, DOI 10.4319/lo.2006.51.1_part_2.0364; Ishii S, 2006, APPL ENVIRON MICROB, V72, P612, DOI 10.1128/AEM.72.1.612-621.2006; Kanter RD, 1998, ON-SITE WASTEWATER TREATMENT, P509; KRISHNAMURTHY T, 1986, TOXICON, V24, P865, DOI 10.1016/0041-0101(86)90087-5; LINN DM, 1984, SOIL SCI SOC AM J, V48, P794, DOI 10.2136/sssaj1984.03615995004800040019x; Loomis GW, 2001, ON-SITE WASTEWATER TREATMENT, PROCEEDINGS, P52; Mallin MA, 2006, LIMNOL OCEANOGR, V51, P690, DOI 10.4319/lo.2006.51.1_part_2.0690; Michen B, 2010, J APPL MICROBIOL, V109, P388, DOI 10.1111/j.1365-2672.2010.04663.x; Morales I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158292; Morales I, 2015, J ENVIRON QUAL, V44, P1459, DOI 10.2134/jeq2014.12.0547; Nasser AM, 2002, WATER RES, V36, P2589, DOI 10.1016/S0043-1354(01)00461-4; NOAA. National Oceanic and Atmospheric Administration, 2011, STAT COAST US POP LI; Oakley SM, 2010, ECOL ENG, V36, P1520, DOI 10.1016/j.ecoleng.2010.04.030; Ocampo CJ, 2006, WATER RESOUR RES, V42, DOI 10.1029/2004WR003773; Paerl H W, 2001, ScientificWorldJournal, V1, P76; PALMSTROM N S, 1988, Lake and Reservoir Management, V4, P1; Potts DA, 2004, J ENVIRON QUAL, V33, P1828, DOI 10.2134/jeq2004.1828; POWELSON DK, 1994, WATER RES, V28, P2175, DOI 10.1016/0043-1354(94)90029-9; Quanrud DM, 2003, WATER RES, V37, P753, DOI 10.1016/S0043-1354(02)00393-7; RIDEM. Rhode Island Department of Environmental Management, 2013, GUID DES US MAINT PR; RIDEM. Rhode Island Department of Environmental Management, 2010, RUL EST MIN STAND RE; Robertson L. A., 1991, Microbial production and consumption of greenhouse gases: methane, nitrogen oxides, and halomethanes., P189; Robertson WD, 2012, GROUND WATER, V50, P541, DOI 10.1111/j.1745-6584.2011.00857.x; Robertson WD, 2003, GROUND WATER, V41, P48, DOI 10.1111/j.1745-6584.2003.tb02567.x; Schimel JP, 2015, MICROBIAL CONTROL CA, P155; SHUVAL HI, 1972, AM J PUBLIC HEALTH N, V62, P1045, DOI 10.2105/AJPH.62.8.1045; Siegrist RL, 2001, ON-SITE WASTEWATER TREATMENT, PROCEEDINGS, P1; Silberberg M. S., 2006, CHEM MOL NATURE MATT; Stevik TK, 2004, WATER RES, V38, P1355, DOI 10.1016/j.watres.2003.12.024; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; United States Environmental Protection Agency (USEPA), 2004, ONS WAST TREATM SYST; US Food and Drug Administration, 1992, BAD BUG BOOK FOODB P; Van Cuyk S, 2004, J ENVIRON QUAL, V33, P316, DOI 10.2134/jeq2004.0316; Wrage N, 2001, SOIL BIOL BIOCHEM, V33, P1723, DOI 10.1016/S0038-0717(01)00096-7	53	44	45	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162104	10.1371/journal.pone.0162104	http://dx.doi.org/10.1371/journal.pone.0162104			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583363	Green Submitted, Green Published, gold			2022-12-26	WOS:000382855600104
J	Kagawa, RMC; Fernald, LCH; Behrman, JR				Kagawa, Rose M. C.; Fernald, Lia C. H.; Behrman, Jere R.			Weight Status and Behavioral Problems among Very Young Children in Chile	PLOS ONE			English	Article							BODY-MASS INDEX; SCHOOL-AGED CHILDREN; MENTAL-HEALTH; PRESCHOOL-CHILDREN; CHILDHOOD OBESITY; SELF-ESTEEM; OVERWEIGHT; PSYCHOPATHOLOGY; DISORDER; ASSOCIATIONS	Background/Objectives Our objective was to explore the association between weight status and behavioral problems in children before school age. We examined whether the association between weight status and behavioral problems varied by age and sex. Subjects/Methods This study used cross-sectional data from a nationally-representative sample of children and their families in Chile (N = 11,207). These children were selected using a cluster-stratified random sampling strategy. Data collection for this study took place in 2012 when the children were 1.5-6 years of age. We used multivariable analyses to examine the association between weight status and behavioral problems (assessed using the Child Behavior Checklist), while controlling for child's sex, indigenous status, birth weight, and months breastfed; primary caregiver's BMI and education level; and household wealth. Results Approximately 24% of our sample was overweight or obese. Overweight or obese girls showed more behavioral problems than normal weight girls at age 6 (beta = 0.270 SD, 95% CI = 0.047, 0.493, P = 0.018). Among boys age 1 to 5 years, overweight/obesity was associated with a small reduction in internalizing behaviors (beta = -0.09 SD, 95% CI = -0.163, -0.006, P = 0.034). Conclusions Our data suggest that the associations between weight status and behavioral problems vary across age and sex.	[Kagawa, Rose M. C.; Fernald, Lia C. H.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Behrman, Jere R.] Univ Penn, Dept Econ, 3718 Locust Walk, Philadelphia, PA 19104 USA	University of California System; University of California Berkeley; University of Pennsylvania	Kagawa, RMC (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	rcalnin@berkeley.edu	Behrman, Jere R/A-9734-2009	Fernald, Lia C.H./0000-0003-1555-4607	Eunice Kennedy Shriver National Institute of Child Health and Human Development [NICHD R01HD065436]; Grand Challenges Canada [0072-03]; Berkeley Population Center [R24 HD073964]; Berkeley Research Impact Initiative (BRII) - UC Berkeley Library; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065436, R24HD073964] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Grand Challenges Canada(CGIAR); Berkeley Population Center; Berkeley Research Impact Initiative (BRII) - UC Berkeley Library; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD R01HD065436) grant on "Early Child Development Programs: Effective Interventions for Human Development" (URL: https://www.nichd.nih.gov/Pages/index.aspx), the Grand Challenges Canada (0072-03) grant on Saving Brains: "Team 1000+ Saving Brains: Economic Impacts of Poverty-Related Risk Factors During the First 1000 Days for Cognitive Development and Human Capital" (URL: http://www.grandchallenges.ca/), a pilot grant from the Berkeley Population Center (R24 HD073964) (URL: http://popcenter.berkeley.edu/grants/), and funding to support publication from the Berkeley Research Impact Initiative (BRII) sponsored by the UC Berkeley Library (URL: http://guides.lib.berkeley.edu/brii). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH TM, 1978, PSYCHOL BULL, V85, P1275, DOI 10.1037/0033-2909.85.6.1275; Achenbach TM, 1983, MANUAL CHILD BEHAV C; Achenbach TM, 2001, RELIABILITY INTERNAL; Achenbach TM, 2000, RELIABILITY CROSS IN; Albala C, 2002, PUBLIC HEALTH NUTR, V5, P123, DOI 10.1079/PHN2001283; Anderson SE, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-49; Behrman J. R., 2010, ENCUESTA LONGITUDINA; Bradley RH, 2008, J PEDIATR-US, V153, P629, DOI 10.1016/j.jpeds.2008.05.026; Bravo D., ENCUESTA LONGITUDINA; Brewis A, 2003, AM J HUM BIOL, V15, P446, DOI 10.1002/ajhb.10161; Clark C, 2000, J ABNORM CHILD PSYCH, V28, P403, DOI 10.1023/A:1005176320912; Cornette R, 2008, WORLDV EVID-BASED NU, V5, P136, DOI 10.1111/j.1741-6787.2008.00127.x; Cortese S, 2008, CRIT REV FOOD SCI, V48, P524, DOI 10.1080/10408390701540124; Cramer P, 1998, J APPL DEV PSYCHOL, V19, P429, DOI 10.1016/S0193-3973(99)80049-5; Datar A, 2004, ARCH PEDIAT ADOL MED, V158, P804, DOI 10.1001/archpedi.158.8.804; Davison KK, 2001, PEDIATRICS, V107, P46, DOI 10.1542/peds.107.1.46; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS15; Drukker M, 2009, INT J PEDIATR OBES, V4, P91, DOI 10.1080/17477160802395442; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Francis LA, 2009, ARCH PEDIAT ADOL MED, V163, P297, DOI 10.1001/archpediatrics.2008.579; Frey K. S., 1990, COMPETENCE CONSIDERE, P167; Gable S, 2009, APPL DEV SCI, V13, P88, DOI 10.1080/10888690902801970; Garthus-Niegel S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-626; Goossens L, 2009, EUR EAT DISORD REV, V17, P68, DOI 10.1002/erv.892; Griffiths LJ, 2006, ARCH DIS CHILD, V91, P121, DOI 10.1136/adc.2005.072314; Halfon N, 2013, ACAD PEDIATR, V13, P6, DOI 10.1016/j.acap.2012.10.007; Hesketh K, 2004, INT J OBESITY, V28, P1233, DOI 10.1038/sj.ijo.0802624; HILL AJ, 1994, INT J OBESITY, V18, P383; Hwang JW, 2006, J DEV BEHAV PEDIATR, V27, P18, DOI 10.1097/00004703-200602000-00003; Ivanova MY, 2010, J AM ACAD CHILD PSY, V49, P1215, DOI 10.1016/j.jaac.2010.08.019; Janssen I, 2004, PEDIATRICS, V113, P1187, DOI 10.1542/peds.113.5.1187; Lawlor DA, 2005, ARCH DIS CHILD, V90, P692, DOI 10.1136/adc.2004.062919; Levy P, 1999, SAMPLING POPULATIONS; Lumeng JC, 2003, PEDIATRICS, V112, P1138, DOI 10.1542/peds.112.5.1138; Mackenbach JD, 2012, J DEV BEHAV PEDIATR, V33, P641, DOI 10.1097/DBP.0b013e31826419b8; McArthur LH, 2005, ADOLESCENCE, V40, P801; Moser CON, 1998, WORLD DEV, V26, P1, DOI 10.1016/S0305-750X(97)10015-8; Mulder C, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-37; Mustillo S, 2003, PEDIATRICS, V111, P851, DOI 10.1542/peds.111.4.851; Nakamura BJ, 2009, J PSYCHOPATHOL BEHAV, V31, P178, DOI 10.1007/s10862-008-9119-8; Nederkoorn Chantal, 2006, Eat Behav, V7, P315, DOI 10.1016/j.eatbeh.2005.11.005; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Phillips RG, 1998, INT J OBESITY, V22, P287, DOI 10.1038/sj.ijo.0800582; Pillow BH, 1996, CHILD DEV, V67, P803, DOI 10.2307/1131862; Pine DS, 2001, PEDIATRICS, V107, P1049, DOI 10.1542/peds.107.5.1049; Pine DS, 1997, AM J PUBLIC HEALTH, V87, P1303, DOI 10.2105/AJPH.87.8.1303; Pitrou I, 2010, OBESITY, V18, P809, DOI 10.1038/oby.2009.278; Puder JJ, 2010, INT J OBESITY, V34, pS37, DOI 10.1038/ijo.2010.238; Puhl RM, 2007, PSYCHOL BULL, V133, P557, DOI 10.1037/0033-2909.133.4.557; Pulgaron ER, 2013, CLIN THER, V35, pA18, DOI 10.1016/j.clinthera.2012.12.014; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Rescorla LA, 2011, J CLIN CHILD ADOLESC, V40, P456, DOI 10.1080/15374416.2011.563472; Rofey DL, 2009, CHILD PSYCHIAT HUM D, V40, P517, DOI 10.1007/s10578-009-0141-1; Sawyer MG, 2006, AMBUL PEDIATR, V6, P306, DOI 10.1016/j.ambp.2006.08.005; Selvin S., 2004, STAT ANAL EPIDEMIOLO; Sikorski C, 2015, OBESITY, V23, P266, DOI 10.1002/oby.20952; Smolak Linda, 2004, Body Image, V1, P15, DOI 10.1016/S1740-1445(03)00008-1; STIPEK DJ, 1981, J EDUC PSYCHOL, V73, P404, DOI 10.1037/0022-0663.73.3.404; Stradmeijer M, 2000, INT J EAT DISORDER, V27, P110, DOI 10.1002/(SICI)1098-108X(200001)27:1<110::AID-EAT14>3.0.CO;2-5; Strauss RS, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.1.e15; Suchert V, 2015, PREV MED, V76, P48, DOI 10.1016/j.ypmed.2015.03.026; Tate T, 2006, PEDIATR RES, V60, P637, DOI 10.1203/00006450-200611000-00036; Vila G, 2004, PSYCHOSOM MED, V66, P387, DOI 10.1097/01.psy.0000126201.12813.eb; Vio F, 2008, PUBLIC HEALTH NUTR, V11, P405, DOI 10.1017/S136898000700050X; Vollrath ME, 2011, INT J PEDIATR OBES, V6, pE408, DOI 10.3109/17477166.2010.518240; World Health Organization, 2011, BURD MORT MORB RISK; World Health Organization, 2009, WHO ANTHR VERS 3 2 2	69	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161380	10.1371/journal.pone.0161380	http://dx.doi.org/10.1371/journal.pone.0161380			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV3WN	27583678	Green Published, gold			2022-12-26	WOS:000382855600027
J	Lord, E; Le Cam, M; Bapteste, E; Meheust, R; Makarenkov, V; Lapointe, FJ				Lord, Etienne; Le Cam, Margaux; Bapteste, Eric; Meheust, Raphael; Makarenkov, Vladimir; Lapointe, Francois-Joseph			BRIDES: A New Fast Algorithm and Software for Characterizing Evolving Similarity Networks Using Breakthroughs, Roadblocks, Impasses, Detours, Equals and Shortcuts	PLOS ONE			English	Article							DIVERSITY; PATHS; NODES	Various types of genome and gene similarity networks along with their characteristics have been increasingly used for retracing different kinds of evolutionary and ecological relationships. Here, we present a new polynomial time algorithm and the corresponding software (BRIDES) to provide characterization of different types of paths existing in evolving (or augmented) similarity networks under the constraint that such paths contain at least one node that was not present in the original network. These different paths are denoted as Breakthroughs, Roadblocks, Impasses, Detours, Equal paths, and Shortcuts. The analysis of their distribution can allow discriminating among different evolutionary hypotheses concerning genomes or genes at hand. Our approach is based on an original application of the popular shortest path Dijkstra's and Yen's algorithms. The C++ and R versions of the BRIDES program are freely available at: https://github.com/etiennelord/BRIDES.	[Lord, Etienne; Makarenkov, Vladimir] Univ Quebec, Dept Informat, Montreal, PQ, Canada; [Lord, Etienne; Le Cam, Margaux; Lapointe, Francois-Joseph] Univ Quebec, Dept Sci Biol, Montreal, PQ, Canada; [Bapteste, Eric; Meheust, Raphael] Univ Paris 06, Sorbonne Univ, Inst Biol Paris Seine, Paris, France; [Bapteste, Eric] Inst Biol Paris Seine, CNRS, UMR7138, Paris, France	University of Quebec; University of Quebec Montreal; University of Quebec; University of Quebec Montreal; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Lapointe, FJ (corresponding author), Univ Quebec, Dept Sci Biol, Montreal, PQ, Canada.	francois-joseph.lapointe@umontreal.ca		Meheust, Raphael/0000-0002-4847-426X; Bapteste, Eric/0000-0003-1966-1215	Natural Sciences and Engineering Research Council (NSERC); NSERC [OGP0155251, OGP249644]; European Research Council under the European Community's Seventh Framework Program FP7 [615274]	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); European Research Council under the European Community's Seventh Framework Program FP7	EL is supported by a Natural Sciences and Engineering Research Council (NSERC) scholarship. VM and FJL respectively hold NSERC discovery grants OGP0155251 and OGP249644. EB is funded by the European Research Council under the European Community's Seventh Framework Program FP7 (Grant Agreement no615274).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Aylward FO, 2015, P NATL ACAD SCI USA, V112, P5443, DOI 10.1073/pnas.1502883112; Bapteste E, 2013, TRENDS GENET, V29, P439, DOI 10.1016/j.tig.2013.05.007; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Burkard RE, 1998, SIAM REV, V40, P496, DOI 10.1137/S0036144596297514; Cheng S, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00072; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Forster D, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0125-5; GOLDBERG AV, 1993, APPL MATH LETT, V6, P3, DOI 10.1016/0893-9659(93)90022-F; Halary S, 2010, P NATL ACAD SCI USA, V107, P127, DOI 10.1073/pnas.0908978107; HART PE, 1968, IEEE T SYST SCI CYB, VSSC4, P100, DOI 10.1109/TSSC.1968.300136; Lynch MDJ, 2012, ISME J, V6, P2067, DOI 10.1038/ismej.2012.50; Martins EQV, 2003, 4OR-Q J OPER RES, V1, P121, DOI 10.1007/s10288-002-0010-2; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; OpenMP Forum, 1997, TECHNICAL REPORT; Orsini C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9627; Popa O, 2011, GENOME RES, V21, P599, DOI 10.1101/gr.115592.110; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Roberts B., 2007, J GRAPH ALGORITHMS A, V11, P195, DOI DOI 10.7155/jgaa.00142; Schbath S, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/616234; VALIANT LG, 1979, SIAM J COMPUT, V8, P410, DOI 10.1137/0208032; Vardhan H, 2009, 2009 IEEE INTERNATIONAL SYMPOSIUM ON MODELING, ANALYSIS & SIMULATION OF COMPUTER AND TELECOMMUNICATION SYSTEMS (MASCOTS), P607; VERWER BJH, 1989, IEEE T PATTERN ANAL, V11, P425, DOI 10.1109/34.19041; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wang B, 2014, NAT METHODS, V11, P333, DOI [10.1038/NMETH.2810, 10.1038/nmeth.2810]; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wuchty S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07187; YEN JY, 1970, Q APPL MATH, V27, P526, DOI 10.1090/qam/253822; Zeng W, 2009, INT J GEOGR INF SCI, V23, P531, DOI 10.1080/13658810801949850	34	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161474	10.1371/journal.pone.0161474	http://dx.doi.org/10.1371/journal.pone.0161474			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580188	Green Published, gold			2022-12-26	WOS:000382877400025
J	Xu, Y; Yu, XL; Hu, CM; Hao, G				Xu, Yuan; Yu, Xun-Lin; Hu, Chi-Ming; Hao, Gang			Morphological and Molecular Phylogenetic Data Reveal a New Species of Primula (Primulaceae) from Hunan, China	PLOS ONE			English	Article							CAROLINELLA PRIMULACEAE; SEQUENCES; MODEL	A new species of Primulaceae, Primula undulifolia, is described from the hilly area of Hunan province in south-central China. Its morphology and distributional range suggest that it is allied to P. kwangtungensis, both adapted to subtropical climate, having contiguous distribution and similar habitat, growing on shady and moist cliffs. Petioles, scapes and pedicels of them are densely covered with rusty multicellular hairs, but the new species can be easily distinguished by its smaller flowers and narrowly oblong leaves with undulate margins. Molecular phylogenetic analysis based on four DNA markers (ITS, matK, trnL-F and rps16) confirmed the new species as an independent lineage and constitutes a main clade together with P. kwangtungensis, P. kweichouensis, P. wangii and P. hunanensis of Primula sect. Carolinella.	[Xu, Yuan; Hu, Chi-Ming] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Yu, Xun-Lin] Cent South Univ Forestry & Technol, Coll Forestry, Changsha, Hunan, Peoples R China; [Xu, Yuan; Hao, Gang] South China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Central South University of Forestry & Technology; South China Agricultural University	Hao, G (corresponding author), South China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	haogang@scau.edu.cn			National Natural Science Foundation of China [31570193, 31570222]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grant no. 31570193, 31570222, www.nsfc.gov.cn) to Gang Hao and Hai-Fei Yan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderberg AA, 2000, NORD J BOT, V20, P5, DOI 10.1111/j.1756-1051.2000.tb00726.x; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; de Vos JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0075; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gong X, 2003, NOVON, V13, P193, DOI 10.2307/3393517; Hemsley WB, 1903, HOOKERS ICONES PLANT, V28, P2775; Hemsley WB, 1902, HOOKERS ICONES PLANT, V28; Hu C.M, 1996, FLORA CHINA, V15, P39; HU CM, 1990, NORD J BOT, V10, P399, DOI 10.1111/j.1756-1051.1990.tb01779.x; Hu CM, 1994, J TROPICAL SUBTROPIC, V2, P1; Hu CM, 1990, FLORA REIPUBLICAE PO, V59, P1; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; Kallersjo M, 2000, AM J BOT, V87, P1325, DOI 10.2307/2656725; Liu YJ, 2015, PLANT SYST EVOL, V301, P2057, DOI 10.1007/s00606-015-1207-0; Martins L, 2003, PLANT SYST EVOL, V237, P75, DOI 10.1007/s00606-002-0258-1; Mast AR, 2001, INT J PLANT SCI, V162, P1381, DOI 10.1086/323444; Mast AR, 2006, NEW PHYTOL, V171, P605, DOI [10.1111/j.1469-8137.2006.01700.x, 10.1111/j.1469-8137.2006.01833.x]; Pax F., 1905, PFLANZENREICH, V237, P1; Pax F, 1889, BOT JB SYSTEMATIK PF, V10, P75; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, 2013, TRACER VERSION 1 6; Richards A.J., 2002, PRIMULA; Smith WW, 1941, T P BOT SOC EDINBURG, V11, P1; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trift I, 2002, SYST BOT, V27, P396; Wendelbo P, 1961, ARBOK U BERGEN MAT N, V11, P1; Yan HF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122903; Yan HF, 2010, J SYST EVOL, V48, P123, DOI 10.1111/j.1759-6831.2010.00068.x; Yu XL, 2015, NORD J BOT, V33, P381, DOI 10.1111/njb.00713	32	7	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161172	10.1371/journal.pone.0161172	http://dx.doi.org/10.1371/journal.pone.0161172			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579832	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877400020
J	Chow, WZ; Bon, AH; Keating, S; Anderios, F; Halim, HA; Takebe, Y; Kamarulzaman, A; Busch, MP; Tee, KK				Chow, Wei Zhen; Bon, Abdul Hamid; Keating, Sheila; Anderios, Fread; Halim, Hazwan Abdul; Takebe, Yutaka; Kamarulzaman, Adeeba; Busch, Michael P.; Tee, Kok Keng			Extensive Genetic Diversity of HIV-1 in Incident and Prevalent Infections among Malaysian Blood Donors: Multiple Introductions of HIV-1 Genotypes from Highly Prevalent Countries	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DRUG-RESISTANCE MUTATIONS; CIRCULATING RECOMBINANT; GENOME SEQUENCE; TYPE-1 INFECTION; IDENTIFICATION; SUBTYPES; YUNNAN; CHINA; RISK	Transfusion-transmissible infections including HIV-1 continue to pose major risks for unsafe blood transfusions due to both window phase infections and divergent viruses that may not be detected by donor screening assays. Given the recent emergence of several HIV-1 circulating recombinant forms (CRFs) in high-risk populations in the Southeast Asia region, we investigated the genetic diversity of HIV-1 among the blood donors in Kuala Lumpur, Malaysia. A total of 211 HIV-positive plasma samples detected among 730,188 donations to the National Blood Centre between 2013 and 2014 were provided (90.5% male, median age: 27.0 years old). Recent or long-term infection status at the time of donation was determined using a limiting antigen avidity enzyme immunoassay (LAg-Avidity EIA). HIV-1 gagpol genes were amplified and sequenced from residual plasma for 149 cases followed by genotype determination using phylogenetic and recombination analyses. Transmitted anti-retroviral resistance mutations were not observed among the blood donors, among which 22.7% were classified as recent or incident infections. Major circulating HIV-1 genotypes determined by neighbour-joining phylogenetic inference included CRF01_AE at 40.9% (61/149), CRF33_01B at 21.5% (32/149), and subtype B at 10.1% (15/149). Newly-described CRFs including CRF54_01B circulated at 4.0%, CRF74_01B at 2.0%, and CRF53_01B and CRF48_01B at 0.7% each. Interestingly, unique HIV-1 genotypes including African subtype G (8.7%), CRF45_cpx (1.3%), CRF02_AG (0.7%) and CRF07_BC (0.7%) from China were detected for the first time in the country. A cluster of subtype G sequences formed a distinct founder sub-lineage within the African strains. In addition, 8.7% (13/149) of HIV-infected donors had unique recombinant forms (URFs) including CRF01_AE/B' (4.7%), B'/C (2.7%) and B'/G (1.3%) recombinants. Detailed analysis identified similar recombinant structures with shared parental strains among the B'/C and B'/G URFs, some of which were sequenced from recently infected individuals, indicating the possible emergence and on-going spread of foreign clades of CRF candidates among the local population. The findings demonstrate extensive molecular complexity of HIV-1 among the infected blood donors in Malaysia, driven in part by the increased spread of recently described CRFs and multiple introductions of previously unreported genotypes from highly prevalent countries.	[Chow, Wei Zhen; Takebe, Yutaka; Kamarulzaman, Adeeba; Tee, Kok Keng] Univ Malaya, Fac Med, CERiA, Kuala Lumpur, Malaysia; [Bon, Abdul Hamid; Anderios, Fread; Halim, Hazwan Abdul] Natl Blood Ctr Kuala Lumpur NBCKL, Kuala Lumpur, Malaysia; [Keating, Sheila; Busch, Michael P.] BSRI, San Francisco, CA USA; [Keating, Sheila; Busch, Michael P.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Takebe, Yutaka] Natl Inst Infect Dis, AIDS Res Ctr, Shinjuku Ku, Toyama, Tokyo, Japan; [Tee, Kok Keng] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia	Universiti Malaya; University of California System; University of California San Francisco; National Institute of Infectious Diseases (NIID); Universiti Malaya	Tee, KK (corresponding author), Univ Malaya, Fac Med, CERiA, Kuala Lumpur, Malaysia.; Tee, KK (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	k2tee@um.edu.my	Tee, Kok Keng/A-8148-2008; KAMARULZAMAN, ADEEBA/B-5216-2010	Tee, Kok Keng/0000-0002-7923-5448; Keating, Sheila/0000-0002-8324-3694	Ministry of Education, Malaysia (High Impact Research) [UM.C/625/1/HIR/MOE/CHAN/02/02]; U.S. Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272201000045C]	Ministry of Education, Malaysia (High Impact Research); U.S. Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services	This work was supported by grant from the Ministry of Education, Malaysia (High Impact Research UM.C/625/1/HIR/MOE/CHAN/02/02). This project has also been funded in part with U.S. Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272201000045C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencar CS, 2013, JAIDS-J ACQ IMM DEF, V63, P387, DOI 10.1097/QAI.0b013e31828ff979; Bobkova M, 2013, AIDS REV, V15, P204; Bruzzone B, 2015, AIDS RES HUM RETROV, V31, P837, DOI [10.1089/aid.2015.0105, 10.1089/AID.2015.0105]; Busch MP, 2006, TRANSFUSION, V46, P1663, DOI 10.1111/j.1537-2995.2006.00987.x; Busch MP, 2005, TRANSFUSION, V45, P254, DOI 10.1111/j.1537-2995.2004.04215.x; Carr JK, 1998, VIROLOGY, V247, P22, DOI 10.1006/viro.1998.9211; Cheong HT, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01220-15; Cheong HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133883; Chow WZ, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00139-14; Chow WZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085250; Chow WZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062560; Chow WZ, 2012, J VIROL, V86, P11398, DOI 10.1128/JVI.01932-12; Delatorre E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098908; Delwart E, 2012, J INFECT DIS, V205, P875, DOI 10.1093/infdis/jir862; DONEGAN E, 1990, ANN INTERN MED, V113, P733, DOI 10.7326/0003-4819-113-10-733; Duong YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114947; Duong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033328; Esteves A, 2002, AIDS RES HUM RETROV, V18, P313, DOI 10.1089/088922202753519089; Feng Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep19279; Han Xiaohua, 2013, Evid Based Complement Alternat Med, V2013, P156489, DOI 10.1155/2013/156489; Hara T, 2001, AIDS RES HUM RETROV, V17, P569, DOI 10.1089/08892220151126706; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Hsi J, 2014, AIDS RES HUM RETROV, V30, P389, DOI [10.1089/aid.2013.0234, 10.1089/AID.2013.0234]; Kondo M, 2013, J VIROL, V87, P5351, DOI 10.1128/JVI.02370-12; Li XX, 2013, J APPL MATH, DOI 10.1155/2013/245963; Li Y, 2010, JAIDS-J ACQ IMM DEF, V54, P129, DOI 10.1097/QAI.0b013e3181d82ce5; Liu YJ, 2012, AIDS RES HUM RETROV, V28, P1357, DOI 10.1089/aid.2011.0376; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Longosz AF, 2014, AIDS, V28, P1227, DOI 10.1097/QAD.0000000000000221; Longosz AF, 2014, AIDS RES HUM RETROV, V30, P339, DOI [10.1089/aid.2013.0169, 10.1089/AID.2013.0169]; Lu X, 2016, AIDS RES HUM RETROVI; Ly TD, 2012, J CLIN VIROL, V55, P121, DOI 10.1016/j.jcv.2012.06.012; Machado LY, 2012, AIDS RES HUM RETROV, V28, P956, DOI [10.1089/aid.2011.0295, 10.1089/AID.2011.0295]; Mastro Timothy D, 2010, J HIV AIDS Surveill Epidemiol, V2, P1; Ministry of Health Malaysia, 2015, GLOB AIDS RESP PROGR; Nafishah A, 2014, INDIAN J HEMATOL BLO, V30, P105, DOI 10.1007/s12288-012-0213-4; Ng KT, 2012, J VIROL, V86, P11405, DOI 10.1128/JVI.01949-12; Niama FR, 2009, AIDS RES HUM RETROV, V25, P1345, DOI 10.1089/aid.2009.0169; Ong LY, 2014, J MED VIROL, V86, P38, DOI 10.1002/jmv.23772; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Qiu ZZ, 2005, AIDS RES HUM RETROV, V21, P1051, DOI 10.1089/aid.2005.21.1051; Reid G, 2007, INT J DRUG POLICY, V18, P136, DOI 10.1016/j.drugpo.2006.12.015; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tee KK, 2006, AIDS RES HUM RETROV, V22, P121, DOI 10.1089/aid.2006.22.121; Tee KK, 2006, JAIDS-J ACQ IMM DEF, V43, P523; Wei HM, 2014, AIDS RES HUM RETROV, V30, P384, DOI [10.1089/aid.2013.0228, 10.1089/AID.2013.0228]; Wei HM, 2014, AIDS RES HUM RETROV, V30, P380, DOI [10.1089/aid.2013.0235, 10.1089/AID.2013.0235]; Wei XR, 2010, AIDS RES HUM RETROV, V26, P61, DOI 10.1089/aid.2009.0133; Yang JY, 2001, J FORMOS MED ASSOC, V100, P89; Zeng PB, 2012, TRANSFUSION, V52, P1041, DOI 10.1111/j.1537-2995.2011.03415.x; ZHENG XW, 1994, AIDS, V8, P1141, DOI 10.1097/00002030-199408000-00017; Zou SM, 2010, TRANSFUSION, V50, P1495, DOI 10.1111/j.1537-2995.2010.02622.x	56	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161853	10.1371/journal.pone.0161853	http://dx.doi.org/10.1371/journal.pone.0161853			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575746	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877200042
J	Kankare, M; Parker, DJ; Merisalo, M; Salminen, TS; Hoikkala, A				Kankare, Maaria; Parker, Darren J.; Merisalo, Mikko; Salminen, Tiina S.; Hoikkala, Anneli			Transcriptional Differences between Diapausing and Non-Diapausing D-montana Females Reared under the Same Photoperiod and Temperature	PLOS ONE			English	Article							NORTHERN HOUSE MOSQUITO; DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; REPRODUCTIVE DIAPAUSE; UP-REGULATION; COLD TOLERANCE; CYTOCHROME-P450 GENE; OVARIAN DIAPAUSE; STRESS TOLERANCE; PUPAL DIAPAUSE	Background A wide range of insects living at higher latitudes enter diapause at the end of the warm season, which increases their chances of survival through harsh winter conditions. In this study we used RNA sequencing to identify genes involved in adult reproductive diapause in a northern fly species, Drosophila montana. Both diapausing and non-diapausing flies were reared under a critical day length and temperature, where about half of the emerging females enter diapause enabling us to eliminate the effects of varying environmental conditions on gene expression patterns of the two types of female flies. Results RNA sequencing revealed large differences between gene expression patterns of diapausing and non-diapausing females, especially in genes involved with metabolism, fatty acid biosynthesis, and metal and nucleotide binding. Differently expressed genes included several gene groups, including myosin, actin and cytochromeP450 genes, which have been previously associated with diapause. This study also identified new candidate genes, including some involved in cuticular hydrocarbon synthesis or regulation (desat1 and desat2), and acyl-CoA Delta 11-desaturase activity (CG9747), and few odorant-binding protein genes (e.g. Obp44A). Also, several transposable elements (TEs) showed differential expression between the two female groups motivating future research on their roles in diapause. Conclusions Our results demonstrate that the adult reproductive diapause in D. montana involves changes in the expression level of a variety of genes involved in key processes (e.g.metabolism and fatty acid biosynthesis) which help diapausing females to cope with over-wintering. This is consistent with the view that diapause is a complex adaptive phenotype where not only sexual maturation is arrested, but also changes in adult physiology are required in order to survive over the winter.	[Kankare, Maaria; Parker, Darren J.; Merisalo, Mikko; Hoikkala, Anneli] Univ Jyvaskyla, Dept Biol & Environm Sci, POB 35, Jyvaskyla, Finland; [Parker, Darren J.] Univ St Andrews, Sch Biol, Ctr Biol Divers, St Andrews KY16 9TH, Fife, Scotland; [Salminen, Tiina S.] Univ Tampere, BioMediTech, Biokatu 6, Tampere, Finland	University of Jyvaskyla; University of St Andrews; Tampere University	Kankare, M (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, POB 35, Jyvaskyla, Finland.	maaria.kankare@jyu.fi		Kankare, Maaria/0000-0003-1541-9050; Salminen, Tiina Susanna/0000-0002-7232-0754; Hoikkala, Anneli/0000-0001-5407-7992; Parker, Darren James/0000-0003-4027-7779	NERC studentship;  [268214];  [272927];  [132619]	NERC studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ; ; 	This work was supported by projects 268214 and 272927 to Maaria Kankare and project 132619 to Anneli Hoikkala, http://www.aka.fi/en, and NERC studentship to Darren J. Parker, http://www.nerc.ac.uk/.	Abdrakhamanova A, 2003, PLANT CELL PHYSIOL, V44, P676, DOI 10.1093/pcp/pcg097; ADAMS AJ, 1985, PHYSIOL ENTOMOL, V10, P243, DOI 10.1111/j.1365-3032.1985.tb00043.x; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arrese EL, 2013, ANNU REV ENTOMOL, V55, P207; ASPI J, 1993, ECOGRAPHY, V16, P65, DOI 10.1111/j.1600-0587.1993.tb00059.x; Baker DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-242; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOWEN MF, 1992, J MED ENTOMOL, V29, P843, DOI 10.1093/jmedent/29.5.843; BRADSHAW WE, 1976, NATURE, V262, P384, DOI 10.1038/262384b0; Bradshaw WE, 2001, J INSECT PHYSIOL, V47, P809, DOI 10.1016/S0022-1910(01)00054-3; Bradshaw WE, 2001, P NATL ACAD SCI USA, V98, P14509, DOI 10.1073/pnas.241391498; Brun A, 1996, INSECT BIOCHEM MOLEC, V26, P697, DOI 10.1016/S0965-1748(96)00036-7; Burmester T, 1999, EUR J ENTOMOL, V96, P213; CALVERT W H, 1986, Journal of the Lepidopterists' Society, V40, P164; CARSON HL, 1948, P NATL ACAD SCI USA, V34, P124, DOI 10.1073/pnas.34.3.124; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Emerson KJ, 2009, TRENDS GENET, V25, P217, DOI 10.1016/j.tig.2009.03.009; Evgenev MB, 1997, P NATL ACAD SCI USA, V94, P196, DOI 10.1073/pnas.94.1.196; Graveley BR, 2010, DATABASE D MELANOGAS; Greenberg AJ, 2003, SCIENCE, V302, P1754, DOI 10.1126/science.1090432; Guo Q, 2015, GENE, V565, P106, DOI 10.1016/j.gene.2015.03.070; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Hahn DA, 2007, J INSECT PHYSIOL, V53, P760, DOI 10.1016/j.jinsphys.2007.03.018; Hahn DA, 2011, ANNU REV ENTOMOL, V56, P103, DOI 10.1146/annurev-ento-112408-085436; Herman WS, 2001, P ROY SOC B-BIOL SCI, V268, P2509, DOI 10.1098/rspb.2001.1765; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishiguro S, 2007, J INSECT PHYSIOL, V53, P392, DOI 10.1016/j.jinsphys.2006.12.014; Kankare Maaria, 2010, BMC Ecology, V10, P3, DOI 10.1186/1472-6785-10-3; Kauranen H, 2012, J BIOL RHYTHM, V27, P377, DOI 10.1177/0748730412455916; Kim M, 2009, INSECT MOL BIOL, V18, P295, DOI 10.1111/j.1365-2583.2009.00870.x; Kim M, 2006, J INSECT PHYSIOL, V52, P1226, DOI 10.1016/j.jinsphys.2006.09.007; Kirsch M, 2001, FASEB J, V15, P1569, DOI 10.1096/fj.00-0823hyp; Kohler K, 2009, AUTOPHAGY, V5, P980; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kostal V, 2011, J INSECT PHYSIOL, V57, P538, DOI 10.1016/j.jinsphys.2010.10.006; Kubrak OI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113051; Kucerova L, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2383-1; Lakovaara S., 1969, DROSOPH INF SERV, V44, P128; LANKINEN P, 1986, J COMP PHYSIOL A, V159, P123, DOI 10.1007/BF00612503; Lankinen P, 2013, J INSECT PHYSIOL, V59, P745, DOI 10.1016/j.jinsphys.2013.05.006; Le Goff G, 2003, INSECT BIOCHEM MOLEC, V33, P701, DOI 10.1016/S0965-1748(03)00064-X; Lee R.E. Jr, 1991, P17; Legan SK, 2008, J BIOL CHEM, V283, P32492, DOI 10.1074/jbc.M805832200; Li HM, 2008, INSECT MOL BIOL, V17, P325, DOI 10.1111/j.1365-2583.2008.00808.x; LIU N, 1995, PESTIC BIOCHEM PHYS, V52, P116, DOI 10.1006/pest.1995.1036; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumme J., 1978, P145; MacRae TH, 2010, CELL MOL LIFE SCI, V67, P2405, DOI 10.1007/s00018-010-0311-0; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Morales-Hojas R, 2011, MOL PHYLOGENET EVOL, V60, P249, DOI 10.1016/j.ympev.2011.04.022; Neville M, 2012, BRIEF FUNCT GENOMICS, V11, P395, DOI 10.1093/bfgp/els031; Nishizuka Makoto, 1998, Entomological Science, V1, P7; Paaby AB, 2009, FLY, V3, P29, DOI 10.4161/fly.3.1.7771; Parker DJ, 2015, HEREDITY, V115, P13, DOI 10.1038/hdy.2015.6; Parker DJ, 2016, G3-GENES GENOM GENET, V6, P1373, DOI 10.1534/g3.116.027870; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Pokorna J, 2004, PLANT CELL ENVIRON, V27, P641, DOI 10.1111/j.1365-3040.2004.01186.x; Reis M, 2015, PLOS ONE, P9; Reynolds JA, 2009, J EXP BIOL, V212, P2074, DOI 10.1242/jeb.027367; Riddell CE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1031; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Rinehart JP, 2000, INSECT BIOCHEM MOLEC, V30, P515, DOI 10.1016/S0965-1748(00)00021-7; Robich RM, 2007, J INSECT PHYSIOL, V53, P235, DOI 10.1016/j.jinsphys.2006.08.008; Rouault JD, 2004, GENETICA, V120, P195, DOI 10.1023/B:GENE.0000017641.75820.49; Salminen TS, 2015, SCI REP-UK, V5, DOI 10.1038/srep11197; Salminen TS, 2013, J INSECT PHYSIOL, V59, P450, DOI 10.1016/j.jinsphys.2013.02.005; Sasson A, 2010, BIOINFORMATICS, V26, P849, DOI 10.1093/bioinformatics/btq045; SAUNDERS DS, 1990, J INSECT PHYSIOL, V36, P195, DOI 10.1016/0022-1910(90)90122-V; SAUNDERS DS, 1989, P NATL ACAD SCI USA, V86, P3748, DOI 10.1073/pnas.86.10.3748; Saunders DS, 2002, INSECT CLOCKS; Schmidt PS, 2008, P NATL ACAD SCI USA, V105, P16207, DOI 10.1073/pnas.0805485105; Schmidt PS, 2008, EVOLUTION, V62, P1204, DOI 10.1111/j.1558-5646.2008.00351.x; Schmidt PS, 2005, EVOLUTION, V59, P2616, DOI 10.1111/j.0014-3820.2005.tb00974.x; Sim C, 2009, PHYSIOL GENOMICS, V39, P202, DOI 10.1152/physiolgenomics.00095.2009; STOREY KB, 1991, INSECT BIOCHEM, V21, P157, DOI 10.1016/0020-1790(91)90046-H; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Tatar M, 2001, AM NAT, V158, P248, DOI 10.1086/321320; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Tu XB, 2015, SCI REP-UK, V5, DOI 10.1038/srep11402; Tyukmaeva VI, 2011, ECOL EVOL, V1, P160, DOI 10.1002/ece3.14; Vesala L, 2012, INSECT MOL BIOL, V21, P107, DOI 10.1111/j.1365-2583.2011.01119.x; Vesala L, 2012, J EXP BIOL, V215, P2891, DOI 10.1242/jeb.069948; Vesala L, 2011, J INSECT PHYSIOL, V57, P46, DOI 10.1016/j.jinsphys.2010.09.007; Watanabe M, 2002, EUR J ENTOMOL, V99, P5, DOI 10.14411/eje.2002.002; Watanabe M, 1999, J INSECT PHYSIOL, V45, P167, DOI 10.1016/S0022-1910(98)00111-5; Xiao HJ, 2010, J INSECT PHYSIOL, V56, P1558, DOI 10.1016/j.jinsphys.2010.05.012; Yang P, 2008, J INSECT PHYSIOL, V54, P636, DOI 10.1016/j.jinsphys.2008.01.001; Yocum GD, 1998, INSECT BIOCHEM MOLEC, V28, P677, DOI 10.1016/S0965-1748(98)00046-0; Yocum GD, 2011, EUR J ENTOMOL, V108, P197, DOI 10.14411/eje.2011.027; Zhang J, 2011, J EXP BIOL, V214, P4021, DOI 10.1242/jeb.059535; Zhou GL, 2009, J INSECT PHYSIOL, V55, P40, DOI 10.1016/j.jinsphys.2008.10.002	93	25	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161852	10.1371/journal.pone.0161852	http://dx.doi.org/10.1371/journal.pone.0161852			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571415	Green Published, Green Submitted, gold			2022-12-26	WOS:000382876700037
J	Elidottir, AS; Halldorsson, TI; Gunnarsdottir, I; Ramel, A				Elidottir, Anita S.; Halldorsson, Thorhallur I.; Gunnarsdottir, Ingibjorg; Ramel, Alfons			Dietary Intake and Cardiovascular Risk Factors in Icelanders Following Voluntarily a Low Carbohydrate Diet	PLOS ONE			English	Article							WEIGHT-LOSS DIETS; LOW-FAT DIET; CORONARY-HEART-DISEASE; OBESE ADULTS; BODY-WEIGHT; OVERWEIGHT; MANAGEMENT; METAANALYSIS; TRIALS; YOUNG	Background/Aim Most studies regarding low-carbohydrate diets (LCDs) have been intervention studies. The aim of the current study was to investigate dietary intake and cardiovascular risk factors among individuals who voluntarily follow a LCD. Methods A cross-sectional study was conducted (N = 54, 20-66yrs) in Reykjavik, Iceland. Participants recorded food intake for three days. Blood samples were analyzed for cardiovascular risk factors. Results Nearly half of the participants were obese and around 60% had been on a LCD for >= 6 months. Fifty percent claimed they had lost weight during the past month. The median intake of carbohydrate, protein and fat were 8%, 22% and 68% E (hereof 25% saturated fatty acids), respectively. The consumption of bread and wholegrain cereals was very low (<5g/day), including the intake of dietary fiber (11g/day). Median fruit intake was 12 g/day. Intake of red meat and meat products was double that of the general population or similar to 900 g/week. Median intake of vitamins and minerals were mostly higher than the estimated average requirements. Cardiovascular risk factors were mostly within normal range. Mean blood lipids were slightly elevated although the high density lipoprotein/total cholesterol ratio was normal. Conclusion Despite poor diet quality and high prevalence of obesity, individuals who voluntarily follow a LCD have cardiovascular risk factors mostly within reference range. These individuals consume very low amounts of carbohydrates and high amounts of fat and saturated fat acids. Intake of red meat and processed meat exceeds recommended intake. Very low intake of whole grain cereals and fruits results in low intake of fiber. Long term health implications need to be examined further in longitudinal studies.	[Elidottir, Anita S.; Halldorsson, Thorhallur I.; Gunnarsdottir, Ingibjorg; Ramel, Alfons] Univ Iceland, Landspitali Natl Univ Hosp Iceland, Unit Nutr Res, Reykjavik, Iceland; [Elidottir, Anita S.; Halldorsson, Thorhallur I.; Gunnarsdottir, Ingibjorg; Ramel, Alfons] Univ Iceland, Fac Food Sci & Nutr, Reykjavik, Iceland; [Halldorsson, Thorhallur I.] Statens Serum Inst, Ctr Fetal Programming, Copenhagen, Denmark	University of Iceland; University of Iceland; Statens Serum Institut	Ramel, A (corresponding author), Univ Iceland, Landspitali Natl Univ Hosp Iceland, Unit Nutr Res, Reykjavik, Iceland.; Ramel, A (corresponding author), Univ Iceland, Fac Food Sci & Nutr, Reykjavik, Iceland.	alfonsra@hi.is		Gunnarsdottir, Ingibjorg/0000-0001-9447-8627				American Heart Association, 2010, LEV CHOL; [Anonymous], NEW ATKINS NEW YOU; Avenell A, 2004, HEALTH TECHNOL ASSES, V8, P1; Brehm BJ, 2003, J CLIN ENDOCR METAB, V88, P1617, DOI 10.1210/jc.2002-021480; Brinkworth GD, 2009, AM J CLIN NUTR, V90, P23, DOI 10.3945/ajcn.2008.27326; Bueno NB, 2013, BRIT J NUTR, V110, P1178, DOI 10.1017/S0007114513000548; Calton JB, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-24; Dalen JE, 2014, AM J MED, V127, P364, DOI 10.1016/j.amjmed.2013.12.014; Douketis JD, 2005, INT J OBESITY, V29, P1153, DOI 10.1038/sj.ijo.0802982; Dyson PA, 2007, DIABETIC MED, V24, P1430, DOI 10.1111/j.1464-5491.2007.02290.x; Englyst KN, 2005, BRIT J NUTR, V94, P1, DOI 10.1079/BJN20051457; Forsythe CE, 2010, LIPIDS, V45, P947, DOI 10.1007/s11745-010-3467-3; Frisch S, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-36; Gardner CD, 2010, AM J CLIN NUTR, V92, P304, DOI 10.3945/ajcn.2010.29468; Guldbrand H, 2012, DIABETOLOGIA, V55, P2118, DOI 10.1007/s00125-012-2567-4; Gunnarsdottir I, 2008, INT J OBESITY, V32, P1105, DOI 10.1038/ijo.2008.64; Hession M, 2009, OBES REV, V10, P36, DOI 10.1111/j.1467-789X.2008.00518.x; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004; Johnston BC, 2014, JAMA-J AM MED ASSOC, V312, P923, DOI 10.1001/jama.2014.10397; LeCheminant JD, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-36; LICHTMAN SW, 1992, NEW ENGL J MED, V327, P1893, DOI 10.1056/NEJM199212313272701; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Millan J, 2009, VASC HEALTH RISK MAN, V5, P757; Miller Bernard V, 2003, Metab Syndr Relat Disord, V1, P299, DOI 10.1089/1540419031361426; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Naude CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100652; Nordic Nutrition Recommendations, 2014, INT NUTR PHYS ACT; Ramel A, 2009, NUTR RES, V29, P305, DOI 10.1016/j.nutres.2009.05.004; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Salmeron J, 2001, AM J CLIN NUTR, V73, P1019; Santos FL, 2012, OBES REV, V13, P1048, DOI 10.1111/j.1467-789X.2012.01021.x; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Stern L, 2004, ANN INTERN MED, V140, P778, DOI 10.7326/0003-4819-140-10-200405180-00007; Thorgeirsdottir H, 2011, WHAT DO ICELANDERS E; US Department of Health and Human Services & US Department of Agriculture, 2010, DIET GUID AM 2010; Volek JS, 2009, LIPIDS, V44, P297, DOI 10.1007/s11745-008-3274-2; Volek Js, 2004, Nutr Metab (Lond), V1, P13, DOI 10.1186/1743-7075-1-13; WHO, 2008, WAIST CIRCUMFERENCE	39	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0156655	10.1371/journal.pone.0156655	http://dx.doi.org/10.1371/journal.pone.0156655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560647	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258600002
J	Kregting, L; Elsaesser, B; Kennedy, R; Smyth, D; O'Carroll, J; Savidge, G				Kregting, Louise; Elsaesser, Bjoern; Kennedy, Robert; Smyth, David; O'Carroll, Jack; Savidge, Graham			Do Changes in Current Flow as a Result of Arrays of Tidal Turbines Have an Effect on Benthic Communities?	PLOS ONE			English	Article							RENEWABLE ENERGY DEVELOPMENT; POWER EXTRACTION; ENGLISH-CHANNEL; HYDRODYNAMICS; ASSEMBLAGES; DISTURBANCE; SCALES	Arrays of tidal energy converters have the potential to provide clean renewable energy for future generations. Benthic communities may, however, be affected by changes in current speeds resulting from arrays of tidal converters located in areas characterised by strong currents. Current speed, together with bottom type and depth, strongly influence benthic community distributions; however the interaction of these factors in controlling benthic dynamics in high energy environments is poorly understood. The Strangford Lough Narrows, the location of SeaGen, the world's first single full-scale, grid-compliant tidal energy extractor, is characterised by spatially heterogenous high current flows. A hydrodynamic model was used to select a range of benthic community study sites that had median flow velocities between 1.5-2.4 m/s in a depth range of 25-30 m. 25 sites were sampled for macrobenthic community structure using drop down video survey to test the sensitivity of the distribution of benthic communities to changes in the flow field. A diverse range of species were recorded which were consistent with those for high current flow environments and corresponding to very tide-swept faunal communities in the EUNIS classification. However, over the velocity range investigated, no changes in benthic communities were observed. This suggested that the high physical disturbance associated with the high current flows in the Strangford Narrows reflected the opportunistic nature of the benthic species present with individuals being continuously and randomly affected by turbulent forces and physical damage. It is concluded that during operation, the removal of energy by marine tidal energy arrays in the far-field is unlikely to have a significant effect on benthic communities in high flow environments. The results are of major significance to developers and regulators in the tidal energy industry when considering the environmental impacts for site licences.	[Kregting, Louise; Elsaesser, Bjoern; Smyth, David] Queens Univ Belfast, Sch Nat & Built Environm, Belfast BT7 1NN, Antrim, North Ireland; [Kregting, Louise; Savidge, Graham] Queens Univ Belfast, Queens Univ, Marine Lab, The Strand BT22 1PF, Portaferry, North Ireland; [Kennedy, Robert; O'Carroll, Jack] Natl Univ Ireland Galway, Sch Nat Sci, Galway, Ireland; [Elsaesser, Bjoern] DHI Water & Environm, DK-2970 Horsholm, Denmark; [Smyth, David] Qatar Univ, Ctr Environm Studies, Doha, Qatar	Queens University Belfast; Queens University Belfast; Ollscoil na Gaillimhe-University of Galway; Qatar University	Kregting, L (corresponding author), Queens Univ Belfast, Sch Nat & Built Environm, Belfast BT7 1NN, Antrim, North Ireland.; Kregting, L (corresponding author), Queens Univ Belfast, Queens Univ, Marine Lab, The Strand BT22 1PF, Portaferry, North Ireland.	l.kregting@qub.ac.uk		O'Carroll, Jack/0000-0002-9205-7463	Technology Strategy Board (TSB) [TS10023231/1901]; UK Engineering and Physical Science Research Council [EP/J010065/1]; EPSRC [EP/J010065/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J010065/1] Funding Source: researchfish	Technology Strategy Board (TSB); UK Engineering and Physical Science Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work was funded by through a Technology Strategy Board (TSB) funded project (TS10023231/1901), awarded to Graham Savidge and UK Engineering and Physical Science Research Council funding agreement (grant number EP/J010065/1), awarded to Bjoern Elsaesser. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLER JY, 1989, DEEP-SEA RES, V36, P901, DOI 10.1016/0198-0149(89)90035-6; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Badcock-Broe A., 2014, STRATEGIC INITIATIVE; Boehlert GW, 2010, OCEANOGRAPHY, V23, P68, DOI 10.5670/oceanog.2010.46; Bolam SG, 2008, J MAR BIOL ASSOC UK, V88, P675, DOI 10.1017/S0025315408001276; Bolam SG, 2010, J SEA RES, V64, P166, DOI 10.1016/j.seares.2010.02.003; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Bryden IG, 2007, P I MECH ENG A-J POW, V221, P125, DOI 10.1243/09576509JPE238; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Coggan R, 2012, ESTUAR COAST SHELF S, V111, P118, DOI 10.1016/j.ecss.2012.06.017; Connor D.W., 1997, JNCC REP, V2; Defne Z, 2011, RENEW ENERG, V36, P3461, DOI 10.1016/j.renene.2011.05.027; Dutertre M, 2013, ICES J MAR SCI, V70, P294, DOI 10.1093/icesjms/fss170; EMP, 2012, ROYAL HASK SEAGEN EN; Frid C, 2012, ENVIRON IMPACT ASSES, V32, P133, DOI 10.1016/j.eiar.2011.06.002; Gorban' AN, 2001, J ENERG RESOUR-ASME, V123, P311, DOI 10.1115/1.1414137; Kregting L, 2014, J MAR SCI ENG, V2, P46, DOI 10.3390/jmse2010046; Leichter JJ, 1997, J EXP MAR BIOL ECOL, V209, P293, DOI 10.1016/S0022-0981(96)02702-5; Magagna D, 2014, WAVE TIDAL ENERGY ST; Magagna D, 2014, JRC OCEAN ENERGY STA; Miller RG, 2013, FRONT ECOL ENVIRON, V11, P433, DOI 10.1890/120089; Ocean Energy Systems, 2013, ANN REPORT; Ordines F, 2011, CONT SHELF RES, V31, P1835, DOI 10.1016/j.csr.2011.08.007; Savidge G, 2014, HUMANIT SEA, P153, DOI 10.1007/978-94-017-8002-5_12; SEBENS KP, 1991, HYDROBIOLOGIA, V216, P247; Sheehan EV, 2013, SCI WORLD J, DOI 10.1155/2013/906180; Sheehan EV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014461; Shields MA, 2011, OCEAN COAST MANAGE, V54, P2, DOI 10.1016/j.ocecoaman.2010.10.036; Snelgrove PVR, 1998, BIODIVERS CONSERV, V7, P1123, DOI 10.1023/A:1008867313340; SOUSA WP, 1979, ECOLOGY, V60, P1225, DOI 10.2307/1936969; SOUSA WP, 1979, ECOL MONOGR, V49, P227, DOI 10.2307/1942484; Terlizzi A, 2007, MAR ECOL PROG SER, V332, P25, DOI 10.3354/meps332025; Vennell R, 2015, RENEW SUST ENERG REV, V41, P454, DOI 10.1016/j.rser.2014.08.022; Vennell R, 2011, RENEW ENERG, V36, P3558, DOI 10.1016/j.renene.2011.05.011; WARWICK RM, 1980, MAR ECOL PROG SER, V3, P97, DOI 10.3354/meps003097	38	18	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161279	10.1371/journal.pone.0161279	http://dx.doi.org/10.1371/journal.pone.0161279			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560657	Green Published, gold			2022-12-26	WOS:000382258600032
J	Seravalli, P; de Oliveira, IB; Zago, BC; de Castro, I; Veras, MM; Alves-Rodrigues, EN; Heimann, JC				Seravalli, Priscila; de Oliveira, Ivone Braga; Zago, Breno Calazans; de Castro, Isac; Veras, Mariana Matera; Alves-Rodrigues, Edson Nogueira; Heimann, Joel C.			High and Low Salt Intake during Pregnancy: Impact on Cardiac and Renal Structure in Newborns	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; RENIN-ANGIOTENSIN SYSTEM; GROWTH RESTRICTION; BLOOD-PRESSURE; WISTAR RATS; BODY-WEIGHT; ADULT RATS; HYPERTROPHY; KIDNEY; DIET	Introduction Previous studies from our laboratory demonstrated that dietary salt overload and salt restriction during pregnancy were associated with cardiac and renal structural and/or functional alterations in adult offspring. The present study evaluated renal and cardiac structure and the local renin-angiotensin system in newborns from dams fed high-, normal-or low-salt diets during pregnancy. Methods Female Wistar rats were fed low-(LS, 0.15% NaCl), normal-(NS, 1.3% NaCl) or high-(HS, 8% NaCl) salt diets during pregnancy. Kidneys and hearts were collected from newborns (n = 6-8/group) during the first 24 hours after birth to evaluate possible changes in structure using stereology. Protein expression of renin-angiotensin system components was evaluated using an indirect enzyme-linked immunosorbent assay (ELISA). Results No differences between groups were observed in total renal volume, volume of renal compartments or number of glomeruli. The transverse diameter of the nuclei of cardiomyocytes was greater in HS than NS males in the left and right ventricles. Protein expression of the AT1 receptor was lower in the kidneys of the LS than in those of the NS and HS males but not females. Protein expression of the AT2 receptor was lower in the kidneys of the LS males and females than in those of the NS males and females. Conclusion High salt intake during pregnancy induced left and right ventricular hypertrophy in male newborns. Salt restriction during pregnancy reduced the expression of renal angiotensin II receptors in newborns.	[Seravalli, Priscila; de Oliveira, Ivone Braga; Zago, Breno Calazans; de Castro, Isac; Veras, Mariana Matera; Alves-Rodrigues, Edson Nogueira; Heimann, Joel C.] Univ Sao Paulo, Sch Med, Dept Internal Med, Sao Paulo, Brazil	Universidade de Sao Paulo	Heimann, JC (corresponding author), Univ Sao Paulo, Sch Med, Dept Internal Med, Sao Paulo, Brazil.	jheimann@usp.br	de Castro, Isac/AAA-8990-2021; Castro, Isac de/J-1984-2015; Veras, Mariana M/D-8575-2012	Castro, Isac de/0000-0002-1160-3064; Veras, Mariana M/0000-0002-8363-4329	FAPESP-Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo State Research Foundation) [2013/00458-7]; CAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	FAPESP-Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo State Research Foundation); CAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was funded by FAPESP-Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo State Research Foundation)-Grant number 2013/00458-7 and by CAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Rodrigues EN, 2013, NUTR METAB CARDIOVAS, V23, P481, DOI 10.1016/j.numecd.2011.10.006; [Anonymous], [No title captured]; BARKER DJP, 1989, LANCET, V2, P577; Basu S, 2009, OBESITY, V17, P1144, DOI 10.1038/oby.2008.667; Cardoso HD, 2009, PEDIATR NEPHROL, V24, P1959, DOI 10.1007/s00467-009-1247-1; Chahine MN, 2015, CARDIOVASC RES, V105, P31, DOI 10.1093/cvr/cvu218; CIUFFO GM, 1993, AM J PHYSIOL, V265, pF264, DOI 10.1152/ajprenal.1993.265.2.F264; Claycombe KJ, 2015, J NUTR BIOCHEM, V26, P729, DOI 10.1016/j.jnutbio.2015.01.008; Coelho MS, 2006, NUTR METAB CARDIOVAS, V16, P148, DOI 10.1016/j.numecd.2005.09.001; Cunha FD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118586; da Silva AA, 2003, NUTR METAB CARDIOVAS, V13, P133, DOI 10.1016/S0939-4753(03)80172-2; Ding Y, 2010, J HYPERTENS, V28, P1290, DOI 10.1097/HJH.0b013e328337da8f; Ferreira DN, 2010, J NUTR, V140, P1742, DOI 10.3945/jn.109.117473; GERDES AM, 1994, CARDIOSCIENCE, V5, P203; Gray C, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109595; Gray C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072682; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hallan S, 2008, AM J KIDNEY DIS, V51, P10, DOI 10.1053/j.ajkd.2007.09.013; Howard CV, 2005, UNBIASED STEREOLOGY, P103; Hoy WE, 1999, KIDNEY INT, V56, P1072, DOI 10.1046/j.1523-1755.1999.00633.x; Katayama IA, 2014, J NUTR, V144, P1571, DOI 10.3945/jn.114.192054; Khan LY, 2003, HYPERTENSION, V41, P168, DOI 10.1161/01.HYP.0000047511.97879.FC; Koleganova N, 2011, AM J PHYSIOL-RENAL, V301, pF344, DOI 10.1152/ajprenal.00626.2010; Leandro SM, 2008, PHYSIOL BEHAV, V95, P145, DOI 10.1016/j.physbeh.2008.05.011; Maruyama K, 2015, LIFE SCI, V136, P42, DOI 10.1016/j.lfs.2015.06.023; Oliveira SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086447; Papadopulos F, 2007, ULTRASTRUCT PATHOL, V31, P401, DOI 10.1080/01913120701719189; Price RL, 1997, DEV BIOL, V192, P572, DOI 10.1006/dbio.1997.8764; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241; Siqueira FR, 2016, PHYSIOL BEHAV, V154, P68, DOI 10.1016/j.physbeh.2015.11.013; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; van der Linde S, 2014, J DEV ORIG HLTH DIS, V5, P314, DOI 10.1017/S2040174414000245; Vidonho AF, 2004, PEDIATR RES, V56, P842, DOI 10.1203/01.PDR.0000145258.75160.5B; Xie ZD, 2012, RENAL FAILURE, V34, P754, DOI 10.3109/0886022X.2012.676526	34	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161598	10.1371/journal.pone.0161598	http://dx.doi.org/10.1371/journal.pone.0161598			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560182	Green Submitted, gold, Green Published			2022-12-26	WOS:000382258600059
J	Chilton, CH; Crowther, GS; Ashwin, H; Longshaw, CM; Wilcox, MH				Chilton, Caroline H.; Crowther, Grace S.; Ashwin, Helen; Longshaw, Chris M.; Wilcox, Mark H.			Association of Fidaxomicin with C. difficile Spores: Effects of Persistence on Subsequent Spore Recovery, Outgrowth and Toxin Production	PLOS ONE			English	Article							HUMAN GUT MODEL; CLOSTRIDIUM-DIFFICILE; IN-VITRO; INFECTION; VANCOMYCIN; ORITAVANCIN; RAMOPLANIN; EFFICACY; RELAPSE; BURDEN	Background We have previously shown that fidaxomicin instillation prevents spore recovery in an in-vitro gut model, whereas vancomycin does not. The reasons for this are unclear. Here, we have investigated persistence of fidaxomicin and vancomycin on C. difficile spores, and examined post-antibiotic exposure spore recovery, outgrowth and toxin production. Methods Prevalent UK C. difficile ribotypes (n = 10) were incubated with 200mg/L fidaxomicin, vancomycin or a non-antimicrobial containing control for 1 h in faecal filtrate or Phosphate Buffered Saline. Spores were washed three times with faecal filtrate or phosphate buffered saline, and residual spore-associated antimicrobial activity was determined by bioassay. For three ribotypes (027, 078, 015), antimicrobial-exposed, faecal filtrate-washed spores and controls were inoculated into broth. Viable vegetative and spore counts were enumerated on CCEYL agar. Percentage phase bright spores, phase dark spores and vegetative cells were enumerated by phase contrast microscopy at 0, 3, 6, 24 and 48 h post-inoculation. Toxin levels (24 and 48h) were determined by cell cytotoxicity assay. Results Fidaxomicin, but not vancomycin persisted on spores of all ribotypes following washing in saline (mean = 10.1mg/L; range = 4.0-14mg/L) and faecal filtrate (mean = 17.4mg/L; 8.422.1mg/L). Outgrowth and proliferation rates of vancomycin-exposed spores were similar to controls, whereas fidaxomicin-exposed spores showed no vegetative cell growth after 24 and 48 h. At 48h, toxin levels averaged 3.7 and 3.3 relative units (RU) in control and vancomycin-exposed samples, respectively, but were undetectable in fidaxomicin-exposed samples. Conclusion Fidaxomicin persists on C. difficile spores, whereas vancomycin does not. This persistence prevents subsequent growth and toxin production in vitro. This may have implications on spore viability, thereby impacting CDI recurrence and transmission rates.	[Chilton, Caroline H.; Ashwin, Helen; Wilcox, Mark H.] Univ Leeds, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England; [Crowther, Grace S.] Manchester Metropolitan Univ, Fac Sci & Engn, Manchester, Lancs, England; [Longshaw, Chris M.] Astellas Pharma Europe Ltd, Chertsey, Surrey, England; [Wilcox, Mark H.] Leeds Teaching Hosp NHS Trust, Gen Infirm, Old Med Sch, Dept Microbiol, Leeds, W Yorkshire, England	University of Leeds; Manchester Metropolitan University; Astellas Pharmaceuticals; Leeds General Infirmary; University of Leeds	Chilton, CH (corresponding author), Univ Leeds, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England.	c.h.chilton@leeds.ac.uk		Ashwin, Helen/0000-0003-1029-0032; Longshaw, Christopher/0000-0002-5586-7256	Astellas Pharma Europe Ltd	Astellas Pharma Europe Ltd(Astellas Pharmaceuticals)	This study was initiated and financially supported by Astellas Pharma Europe Ltd in the form of a research grant awarded to CC. The funder provided support in the form of salaries for author CL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Allen CA, 2013, ANTIMICROB AGENTS CH, V57, P664, DOI 10.1128/AAC.01611-12; Babakhani F, 2011, ANTIMICROB AGENTS CH, V55, P4427, DOI 10.1128/AAC.00104-11; Baines SD, 2009, J ANTIMICROB CHEMOTH, V63, P520, DOI 10.1093/jac/dkn502; Carlson PE, 2013, ANAEROBE, V24, P109, DOI 10.1016/j.anaerobe.2013.04.003; Chilton CH, 2015, J ANTIMICROB CHEMOTH, V70, P2598, DOI 10.1093/jac/dkv156; Chilton CH, 2014, J ANTIMICROB CHEMOTH, V69, P451, DOI 10.1093/jac/dkt347; Chilton CH, 2013, J ANTIMICROB CHEMOTH, V68, P2078, DOI 10.1093/jac/dkt160; Chilton CH, 2012, J ANTIMICROB CHEMOTH, V67, P2434, DOI 10.1093/jac/dks243; Chilton CH, 2014, P 25 EUR C CLIN MICR, P176; Cornely OA, 2012, LANCET INFECT DIS, V12, P281, DOI 10.1016/S1473-3099(11)70374-7; Crook DW, 2012, CLIN INFECT DIS, V55, pS93, DOI 10.1093/cid/cis499; Crowther GS, 2016, J ANTIMICROB CHEMOTH, V71, P986, DOI 10.1093/jac/dkv453; European Medicines Agency, 2011, DIFICLIR PUBL ASS RE; Figueroa I, 2012, CLIN INFECT DIS, V55, pS104, DOI 10.1093/cid/cis357; Freeman J, 2005, J ANTIMICROB CHEMOTH, V56, P717, DOI 10.1093/jac/dki321; Freeman J, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.09.017; Heeg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032381; Kelly CP, 2012, CLIN MICROBIOL INFEC, V18, P21, DOI 10.1111/1469-0691.12046; Kraus CN, 2015, ANTIMICROB AGENTS CH, V59, P2525, DOI 10.1128/AAC.04853-14; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; National Institiutes of Health, CLIN STUD REC DET PH; Paredes-Sabja D, 2012, J MED MICROBIOL, V61, P1208, DOI 10.1099/jmm.0.043687-0; WALTERS BAJ, 1983, GUT, V24, P206, DOI 10.1136/gut.24.3.206; Wiegand PN, 2012, J HOSP INFECT, V81, P1, DOI 10.1016/j.jhin.2012.02.004; Zidaric V, 2016, ANAEROBE, V39, P183, DOI 10.1016/j.anaerobe.2016.04.010	26	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161200	10.1371/journal.pone.0161200	http://dx.doi.org/10.1371/journal.pone.0161200			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556739	Green Published, gold			2022-12-26	WOS:000382258100032
J	Nuez-Ortin, WG; Carter, CG; Wilson, R; Cooke, I; Nichols, PD				Nuez-Ortin, Waldo G.; Carter, Chris G.; Wilson, Richard; Cooke, Ira; Nichols, Peter D.			Preliminary Validation of a High Docosahexaenoic Acid (DHA) and -Linolenic Acid (ALA) Dietary Oil Blend: Tissue Fatty Acid Composition and Liver Proteome Response in Atlantic Salmon (Salmo salar) Smolts	PLOS ONE			English	Article							LONG-CHAIN OMEGA-3-FATTY-ACIDS; BETA-OXIDATION CAPACITY; BREAM SPARUS-AURATA; FISH-OIL; LIPID-PEROXIDATION; ALDEHYDE DEHYDROGENASE; APPARENT DIGESTIBILITY; CARDIOVASCULAR-DISEASE; ALPHA-TOCOPHEROL; VEGETABLE-OIL	Marine oils are important to human nutrition as the major source of docosahexaenoic acid (DHA), a key omega-3 long-chain (>= C-20) polyunsaturated fatty acid (n-3 LC-PUFA) that is low or lacking in terrestrial plant or animal oils. The inclusion of fish oil as main source of n-3 LC-PUFA in aquafeeds is mostly limited by the increasing price and decreasing availability. Fish oil replacement with cheaper terrestrial plant and animal oils has considerably reduced the content of n-3 LC-PUFA in flesh of farmed Atlantic salmon. Novel DHA-enriched oils with high alpha-linolenic acid (ALA) content will be available from transgenic oilseeds plants in the near future as an alternative for dietary fish oil replacement in aquafeeds. As a preliminary validation, we formulated an oil blend (TOFX) with high DHA and ALA content using tuna oil (TO) high in DHA and the flaxseed oil (FX) high in ALA, and assessed its ability to achieve fish oil-like n-3 LC-PUFA tissue composition in Atlantic salmon smolts. We applied proteomics as an exploratory approach to understand the effects of nutritional changes on the fish liver. Comparisons were made between fish fed a fish oil-based diet (FO) and a commercial-like oil blend diet (fish oil + poultry oil, FOPO) over 89 days. Growth and feed efficiency ratio were lower on the TOFX diet. Fish muscle concentration of n-3 LC-PUFA was significantly higher for TOFX than for FOPO fish, but not higher than for FO fish, while retention efficiency of n-3 LC-PUFA was promoted by TOFX relative to FO. Proteomics analysis revealed an oxidative stress response indicative of the main adaptive physiological mechanism in TOFX fish. While specific dietary fatty acid concentrations and balances and antioxidant supplementation may need further attention, the use of an oil with a high content of DHA and ALA can enhance tissue deposition of n-3 LC-PUFA in relation to a commercially used oil blend.	[Nuez-Ortin, Waldo G.; Carter, Chris G.; Nichols, Peter D.] Univ Tasmania, Inst Marine & Antarctic Studies, Private Bag 49, Hobart, Tas 7001, Australia; [Nuez-Ortin, Waldo G.; Nichols, Peter D.] CSIRO Food Nutr & Biobased Prod Oceans & Atmosphe, GPO Box 1538, Hobart, Tas 7001, Australia; [Wilson, Richard] Univ Tasmania, Cent Sci Lab, Bag 74, Hobart, Tas 7001, Australia; [Cooke, Ira] James Cook Univ, Dept Mol & Cell Biol, Townsville, Qld 4811, Australia	University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania; James Cook University	Nuez-Ortin, WG (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Private Bag 49, Hobart, Tas 7001, Australia.; Nuez-Ortin, WG (corresponding author), CSIRO Food Nutr & Biobased Prod Oceans & Atmosphe, GPO Box 1538, Hobart, Tas 7001, Australia.	waldo.nuezortin@utas.edu.au	Wilson, Richard/H-8429-2012; Carter, Chris Guy/A-3438-2008; Cooke, Ira R/B-4409-2008	Wilson, Richard/0000-0003-0152-4394; Carter, Chris Guy/0000-0001-5210-1282; Cooke, Ira/0000-0001-6520-1397	International Postgraduate Research Scholarship - Australian Government; Nuseed Pty Ltd; CSIRO Ocean and Atmosphere; University of Tasmania	International Postgraduate Research Scholarship - Australian Government(Australian Government); Nuseed Pty Ltd; CSIRO Ocean and Atmosphere; University of Tasmania	W. G. Nuez-Ortin was supported by an International Postgraduate Research Scholarship funded by the Australian Government. This research was funded by Nuseed Pty Ltd and CSIRO Ocean and Atmosphere, formerly as the Food Futures Flagship and the University of Tasmania. The funder Nuseed approved the publication of the manuscript but had no role in study design, data collection and analysis, or preparation of the manuscript.	Agostoni C, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1461; Alhazzaa R, 2011, AQUACULTURE, V312, P162, DOI 10.1016/j.aquaculture.2010.12.023; Amunom I, 2011, CHEM RES TOXICOL, V24, P1223, DOI 10.1021/tx200080b; AOAC International, 1995, OFFICIAL METHODS ANA; Bell GA, 2014, AM J EPIDEMIOL, V179, P710, DOI 10.1093/aje/kwt326; Bell JG, 2002, J NUTR, V132, P222, DOI 10.1093/jn/132.2.222; Bell JG, 2004, LIPIDS, V39, P223, DOI 10.1007/s11745-004-1223-5; Bell JG, 2001, J NUTR, V131, P1535, DOI 10.1093/jn/131.5.1535; Betancor MB, 2015, FISH PHYSIOL BIOCHEM, V41, P705, DOI 10.1007/s10695-015-0040-2; Betancor MB, 2015, SCI REP-UK, V5, DOI 10.1038/srep08104; Blondeau N, 2016, BIOCHIMIE, V120, P49, DOI 10.1016/j.biochi.2015.06.005; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bransden MP, 2003, COMP BIOCHEM PHYS B, V135, P611, DOI 10.1016/S1096-4959(03)00143-X; Budge SM, 2011, J EXP MAR BIOL ECOL, V409, P267, DOI 10.1016/j.jembe.2011.09.002; Codabaccus BM, 2012, AQUACULTURE, V356, P135, DOI 10.1016/j.aquaculture.2012.05.024; Colquhoun D, 2008, REV EVIDENCE FISH FI; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Deckelbaum RJ, 2010, ARTERIOSCL THROM VAS, V30, P2325, DOI 10.1161/ATVBAHA.110.214353; Delgado-Lista J, 2012, BRIT J NUTR, V107, pS201, DOI 10.1017/S0007114512001596; Emery JA, 2016, AQUACULTURE, V451, P289, DOI 10.1016/j.aquaculture.2015.09.023; Emery JA, 2014, AQUACULTURE, V422, P98, DOI 10.1016/j.aquaculture.2013.12.004; Emery JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057463; Farombi EO, 2000, PHARMACOL RES, V42, P75; Fry JP, 2016, ENVIRON INT, V91, P201, DOI 10.1016/j.envint.2016.02.022; Ghisaura S, 2014, PROTEOME SCI, V12, DOI 10.1186/s12953-014-0044-3; Glencross BD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1810-z; Glencross BD, 2009, REV AQUACULT, V1, P71, DOI 10.1111/j.1753-5131.2009.01006.x; Henriques J, 2014, BRIT J NUTR, V112, P964, DOI 10.1017/S0007114514001603; Hixson SM, 2014, AQUACULTURE, V431, P44, DOI 10.1016/j.aquaculture.2014.04.042; Hixson SM, 2014, FOOD CHEM, V157, P51, DOI 10.1016/j.foodchem.2014.02.026; HJELLE JJ, 1983, PHARMACOL BIOCHEM BE, V18, P155, DOI 10.1016/0091-3057(83)90164-8; Hsu C-C, 2015, ROLE VITAMIN B6 STAT, V2015, P59, DOI [10.3402/fnr.v59.25702, DOI 10.3402/FNR.V59.25702]; Ibarz A, 2010, PROTEOMICS, V10, P963, DOI 10.1002/pmic.200900528; Jansen GA, 2006, BBA-MOL CELL RES, V1763, P1403, DOI 10.1016/j.bbamcr.2006.07.012; Javahery S, 2012, FISH PHYSIOL BIOCHEM, V38, P1545, DOI 10.1007/s10695-012-9682-5; Kannan K, 2004, FREE RADICAL BIO MED, V36, P423, DOI 10.1016/j.freeradbiomed.2003.09.012; Kitessa SM, 2014, NUTRIENTS, V6, P2035, DOI 10.3390/nu6052035; Kjaer MA, 2008, LIPIDS, V43, P813, DOI 10.1007/s11745-008-3208-z; Lee RF, 2005, MAR POLLUT BULL, V50, P705, DOI 10.1016/j.marpolbul.2005.04.036; Maynard, 1969, ANIM NUTR; McGuire SO, 1997, J NUTR, V127, P1388, DOI 10.1093/jn/127.7.1388; Melis R, 2014, FOOD RES INT, V63, P258, DOI 10.1016/j.foodres.2014.05.041; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Miller MR, 2007, COMP BIOCHEM PHYS A, V148, P382, DOI 10.1016/j.cbpa.2007.05.018; Moore MJ, 2003, MAR POLLUT BULL, V46, P107, DOI 10.1016/S0025-326X(02)00325-9; NHMRC (National Health and Medical Research Council), 2006, NUTR REF VAL AUSTR N; Nichols PD, 2014, NUTRIENTS, V6, P1063, DOI 10.3390/nu6031063; NRC, 2011, NUTR REQ FISH SHRIMP, DOI [10.1016/j.bbalip.2008.04.014, DOI 10.1016/J.BBALIP.2008.04.014]; Oelze M, 2011, J BIOL CHEM, V286, P8893, DOI 10.1074/jbc.M110.190017; Oliva ME, 2013, PROSTAG LEUKOTR ESS, V89, P279, DOI 10.1016/j.plefa.2013.09.010; Olsen RE, 1997, AQUACULT NUTR, V3, P227, DOI 10.1046/j.1365-2095.1997.00091.x; Olsen RE, 1999, FISH PHYSIOL BIOCHEM, V20, P13, DOI 10.1023/A:1007767827996; Ostbye TK, 2011, AQUACULT NUTR, V17, P177, DOI 10.1111/j.1365-2095.2009.00721.x; Pajaud J, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/137676; PARRISH CC, 1990, METABOLISM, V39, P217, DOI 10.1016/0026-0495(90)90038-E; Percival SB, 2001, AQUACULTURE, V201, P315, DOI 10.1016/S0044-8486(01)00506-3; Petrie JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085061; Petrie JR, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr011; Petrie JR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035214, 10.1371/journal.pone.0049165]; R Core Team, 2021, R LANGUAGE ENV STAT; Ritchie ME, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-261; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodrigues PM, 2012, J PROTEOMICS, V75, P4325, DOI 10.1016/j.jprot.2012.03.042; Ruiz-Lopez N, 2015, APPL MICROBIOL BIOT, V99, P143, DOI 10.1007/s00253-014-6217-2; Ruiz-Lopez N, 2014, PLANT J, V77, P198, DOI 10.1111/tpj.12378; Ruyter B, 2000, AQUACULT NUTR, V6, P119; Sanden M, 2011, J AGR FOOD CHEM, V59, P12697, DOI 10.1021/jf203289s; Schimke I, 1997, PROSTAG LEUKOTR ESS, V57, P545, DOI 10.1016/S0952-3278(97)90558-5; Senadheera SD, 2011, J AGR FOOD CHEM, V59, P1020, DOI 10.1021/jf104242y; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Simopoulos AP, 2011, MOL NEUROBIOL, V44, P203, DOI 10.1007/s12035-010-8162-0; Singh S, 2013, FREE RADICAL BIO MED, V56, P89, DOI 10.1016/j.freeradbiomed.2012.11.010; Sissener NH, 2010, MAR BIOTECHNOL, V12, P273, DOI 10.1007/s10126-009-9214-1; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Song JH, 2000, J NUTR, V130, P3028, DOI 10.1093/jn/130.12.3028; STEPHAN G, 1995, AQUACULTURE, V130, P251, DOI 10.1016/0044-8486(94)00322-F; Stubhaug I, 2007, AQUACULT NUTR, V13, P145, DOI 10.1111/j.1365-2095.2007.00462.x; Stubhaug I, 2005, BBA-MOL CELL BIOL L, V1734, P277, DOI 10.1016/j.bbalip.2005.04.003; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Thanuthong T, 2011, LIPIDS, V46, P1111, DOI 10.1007/s11745-011-3607-4; Thanuthong T, 2011, AQUACULTURE, V322, P99, DOI 10.1016/j.aquaculture.2011.09.026; Thomassen MS, 2012, AQUACULTURE, V360, P78, DOI 10.1016/j.aquaculture.2012.07.001; Tocher DR, 2003, LIPIDS, V38, P723, DOI 10.1007/s11745-003-1120-y; Todorcevic M, 2008, BBA-MOL CELL BIOL L, V1781, P326, DOI 10.1016/j.bbalip.2008.04.014; TOWELL JF, 1987, BIOCHEM PHARMACOL, V36, P2087, DOI 10.1016/0006-2952(87)90135-3; Turchini GM, 2009, BRIT J NUTR, V102, P69, DOI 10.1017/S0007114508137874; Vagner M, 2011, AQUACULTURE, V315, P131, DOI 10.1016/j.aquaculture.2010.11.031; van den Brink DM, 2004, MOL GENET METAB, V82, P33, DOI 10.1016/j.ymgme.2004.01.019; Ward DA, 2005, AQUACULT NUTR, V11, P49, DOI 10.1111/j.1365-2095.2004.00323.x; Watson RA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8365; Wedemeyer GA, 1996, PHYSL FISH INTENSIVE, DOI 10.1007/978-1-4615-6011-1; Wenzel P, 2007, J BIOL CHEM, V282, P792, DOI 10.1074/jbc.M606477200; Williams CD, 2011, NUTR RES, V31, P1, DOI 10.1016/j.nutres.2011.01.002; Wilson R, 2016, J PROTEOME RES, V15, P1033, DOI 10.1021/acs.jproteome.5b01115; Wu DY, 1996, AM J CLIN NUTR, V63, P273, DOI 10.1093/ajcn/63.2.273; YU TC, 1979, AQUACULTURE, V16, P31, DOI 10.1016/0044-8486(79)90169-8; Zheng XZ, 2005, BBA-MOL CELL BIOL L, V1734, P13, DOI 10.1016/j.bbalip.2005.01.006; Zheng XZ, 2004, AQUACULTURE, V236, P467, DOI 10.1016/j.aquaculture.2004.02.003; Zhou XH, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0006-5	100	6	6	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161513	10.1371/journal.pone.0161513	http://dx.doi.org/10.1371/journal.pone.0161513			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556399	Green Accepted, Green Published, gold			2022-12-26	WOS:000382258100048
J	Chen, KH; Liu, SH; Leysath, CE; Miller-Randolph, S; Zhang, Y; Fattah, R; Bugge, TH; Leppla, SH				Chen, Kuang-Hua; Liu, Shihui; Leysath, Clinton E.; Miller-Randolph, Sharmina; Zhang, Yi; Fattah, Rasem; Bugge, Thomas H.; Leppla, Stephen H.			Anthrax Toxin Protective Antigen Variants That Selectively Utilize either the CMG2 or TEM8 Receptors for Cellular Uptake and Tumor Targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anthrax toxin; mutagenesis in vitro; phage display; receptor; tumor therapy; CMG2; TEM8; protective antigen	CAPILLARY MORPHOGENESIS PROTEIN-2; CRYSTAL-STRUCTURE; LETHAL FACTOR; CELLS; INTERNALIZATION; PATHOGENESIS; PROTEASE; BINDING; FURIN; HOST	The protective antigen (PA) moiety of anthrax toxin binds to cellular receptors and mediates the translocation of the two enzymatic moieties of the toxin to the cytosol. Two PA receptors are known, with capillary morphogenesis protein 2 (CMG2) being the more important for pathogenesis and tumor endothelial marker 8 (TEM8) playing a minor role. The C-terminal PA domain 4 (PAD4) has extensive interactions with the receptors and is required for binding. Our previous study identified PAD4 variants having enhanced TEM8 binding specificity. To obtain PA variants that selectively bind to CMG2, here we performed phage display selections using magnetic beads having bound CMG2. We found that PA residue isoleucine 656 plays a critical role in PA binding to TEM8 but has a much lesser effect on PA binding to CMG2. We further characterized the role of residue 656 in distinguishing PA binding to CMG2 versus TEM8 by substituting it with the other 19 amino acids. Of the resulting variants, PA I656Q and PA I656V had significantly reduced activity on TEM8-expressing CHO cells but maintained their activity on CMG2-expressing CHO cells. The preference of these PA mutants for CMG2 over TEM8 was further demonstrated using mouse embryonic fibroblast cells and mice deficient in the CMG2 and/or the TEM8 receptors. The structural basis of the alterations in the receptor binding activities of these mutants is also discussed.	[Chen, Kuang-Hua; Liu, Shihui; Leysath, Clinton E.; Miller-Randolph, Sharmina; Zhang, Yi; Fattah, Rasem; Leppla, Stephen H.] NIAID, Parasit Dis Lab, NIH, Bldg 33,Rm 1W20B, Bethesda, MD 20892 USA; [Liu, Shihui; Bugge, Thomas H.] NIDCR, Proteases & Tissue Remodeling Sect, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Leysath, Clinton E.] Texas A&M Hlth Sci Ctr, Ctr Innovat Adv Dev & Mfg, Off Publ Hlth Preparedness & Response, 8441 State Hwy 47,Suite 3200, Bryan, TX 77807 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Leppla, SH (corresponding author), NIAID, Parasit Dis Lab, NIH, Bldg 33,Rm 1W20B, Bethesda, MD 20892 USA.	sleppla@niaid.nih.gov		Liu, Shihui/0000-0003-3444-1069	NIAID, National Institutes of Health; NIDCR, National Institutes of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the intramural research programs of the NIAID and the NIDCR, National Institutes of Health. K. H. C., S. L., C. E. L., T. H. B., and S. H. L. are inventors on patents of targeted toxins that have all been assigned to the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bachran C, 2016, TOXINS, V8, DOI 10.3390/toxins8070197; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Chen KH, 2007, J BIOL CHEM, V282, P9834, DOI 10.1074/jbc.M611142200; Gupta PK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003130; ITTELSON TR, 1973, NATURE, V242, P330, DOI 10.1038/242330b0; KLIMPEL KR, 1992, P NATL ACAD SCI USA, V89, P10277, DOI 10.1073/pnas.89.21.10277; Liu SH, 2000, CANCER RES, V60, P6061; Liu SH, 2003, J BIOL CHEM, V278, P5227, DOI 10.1074/jbc.M210321200; Liu SH, 2001, J BIOL CHEM, V276, P17976, DOI 10.1074/jbc.M011085200; Liu SH, 2007, CELL MICROBIOL, V9, P977, DOI 10.1111/j.1462-5822.2006.00845.x; Liu SH, 2016, P NATL ACAD SCI USA, V113, pE4079, DOI 10.1073/pnas.1600982113; Liu SH, 2015, COMPREHENSIVE SOURCEBOOK OF BACTERIAL PROTEIN TOXINS, 4TH EDITION, P361, DOI 10.1016/B978-0-12-800188-2.00013-6; Liu SH, 2014, TRENDS MICROBIOL, V22, P317, DOI 10.1016/j.tim.2014.02.012; Liu SH, 2013, NATURE, V501, P63, DOI 10.1038/nature12510; Liu SH, 2013, TOXINS, V5, P1, DOI 10.3390/toxins5010001; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Lui SH, 2010, CELL HOST MICROBE, V8, P455, DOI 10.1016/j.chom.2010.10.004; Martin EW, 2015, ONCOTARGET, V6, P33534, DOI 10.18632/oncotarget.5214; Mechaly A, 2012, MBIO, V3, DOI 10.1128/mBio.00088-12; Moayeri M, 2015, ANNU REV MICROBIOL, V69, P185, DOI 10.1146/annurev-micro-091014-104523; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Park S, 2000, PROTEIN EXPRES PURIF, V18, P293, DOI 10.1006/prep.2000.1208; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Phillips DD, 2013, J BIOL CHEM, V288, P9058, DOI 10.1074/jbc.M113.452110; Pomerantsev AP, 2011, PROTEIN EXPRES PURIF, V80, P80, DOI 10.1016/j.pep.2011.05.016; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Wein AN, 2015, SCI REP-UK, V5, DOI 10.1038/srep16267; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zaccolo M, 1996, J MOL BIOL, V255, P589, DOI 10.1006/jmbi.1996.0049	30	13	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22021	22029		10.1074/jbc.M116.753301	http://dx.doi.org/10.1074/jbc.M116.753301			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27555325	Green Published, hybrid			2022-12-26	WOS:000386332600017
J	Asencio-Hernandez, J; Kieffer, B; Delsuc, MA				Asencio-Hernandez, Julia; Kieffer, Bruno; Delsuc, Marc-Andre			NMR WaterLOGSY Reveals Weak Binding of Bisphenol A with Amyloid Fibers of a Conserved 11 Residue Peptide from Androgen Receptor	PLOS ONE			English	Article							PROSTATE-CANCER; DISEASE; DOMAIN; AGGREGATION; DISCOVERY; TERMINUS; PROTEINS; ESTROGEN; AFFINITY; HEALTH	There is growing evidence that bisphenol A (BPA), a molecule largely released in the environment, has detrimental effects on ecosystems and on human health. It acts as an endocrine disruptor targeting steroid hormone receptors, such as the estrogen receptor (ER), estrogen-related receptor (ERR) and androgen receptor (AR). BPA-derived molecules have recently been shown to interact with the AR N-terminal domain (AR-NTD), which is known to be largely intrinsically disordered. This N-terminal domain contains an 11 residue conserved domain that forms amyloid fibers upon oxidative dimerisation through its strictly conserved Cys240 residue. We investigate here the interaction of BPA, and other potential endocrine disruptors, with AR-NTD amyloid fibers using the WaterLOGSY NMR experiment. We observed a selective binding of these compounds to the amyloid fibers formed by the AR-NTD conserved region and glutamine homopolymers. This observation suggests that the high potency of endocrine disruptors may result, in part, from their ability to bind amyloid forms of nuclear receptors in addition to their cognate binding sites. This property may be exploited to design future therapeutic strategies targeting AR related diseases such as the spinal bulbar muscular atrophy or prostate cancer. The ability of NMR WaterLOGSY experiments to detect weak interactions between small ligands and amyloid fibers may prove to be of particular interest for identifying promising hit molecules.	[Asencio-Hernandez, Julia; Kieffer, Bruno; Delsuc, Marc-Andre] Univ Strasbourg, IGBMC, INSERM U596, CNRS UMR 7104, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Delsuc, MA (corresponding author), Univ Strasbourg, IGBMC, INSERM U596, CNRS UMR 7104, Illkirch Graffenstaden, France.	madelsuc@unistra.fr	Delsuc, Marc-André/ABI-5400-2020; Kieffer, Bruno/AAE-8999-2019	Delsuc, Marc-André/0000-0002-1400-5326; Asencio-Hernandez, Julia/0000-0002-8921-2805	European ITN "ReAD" Network, The ANR program blanc "ARIA"; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; Instruct part of the European Strategy Forum on Research Infrastructures (ESFRI); European ITN "ReAD" Network	European ITN "ReAD" Network, The ANR program blanc "ARIA"(French National Research Agency (ANR)); French Infrastructure for Integrated Structural Biology (FRISBI); Instruct part of the European Strategy Forum on Research Infrastructures (ESFRI); European ITN "ReAD" Network	This work was supported by The European ITN "ReAD" Network, The ANR program blanc2013 "ARIA". The French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INSB-05-01 Instruct part of the European Strategy Forum on Research Infrastructures (ESFRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the European ITN "ReAD" Network, and the ANR program blanc2013 "ARIA". Part of this work was supported by the French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INSB-05-01, and by Instruct part of the European Strategy Forum on Research Infrastructures (ESFRI) and through national member agreements. JAH thanks the European ITN "ReAD" Network for support. We thank Pascal Eberling for the peptides synthesis and Fabrice Klein for providing Q41 fibers. We thank Roland H. Stote for critical reading of the manuscript, as well as the editor Paul C. Driscoll and the anonymous reviewer for their valuable comments.	Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Andrushchenko VV, 2007, J PEPT SCI, V13, P37, DOI 10.1002/psc.793; Antanasijevic A, 2014, J BIOMOL NMR, V60, P37, DOI 10.1007/s10858-014-9848-9; Asencio-Hernandez J, 2014, CHEMBIOCHEM, V15, P2370, DOI 10.1002/cbic.201402420; Bates GP, 2005, NAT REV GENET, V6, P766, DOI 10.1038/nrg1686; BELSHAM DD, 1992, J NEUROL SCI, V112, P133, DOI 10.1016/0022-510X(92)90142-8; Bergerat JP, 2009, HUM MUTAT; Dalvit C, 2000, J BIOMOL NMR, V18, P65, DOI 10.1023/A:1008354229396; Dalvit C, 2001, J BIOMOL NMR, V21, P349, DOI 10.1023/A:1013302231549; Davranche A, 2011, HUM MOL GENET, V20, P2795, DOI 10.1093/hmg/ddr178; Delfosse V, 2012, P NATL ACAD SCI USA, V109, P14930, DOI 10.1073/pnas.1203574109; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Fichou Y, 2015, P NATL ACAD SCI USA, V112, P6365, DOI 10.1073/pnas.1422824112; Francioso A, 2015, BIOORGAN MED CHEM, V23, P1671, DOI 10.1016/j.bmc.2015.02.041; Godbole AM, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/918707; Jochum T, 2012, BBA-MOL BASIS DIS, V1822, P1070, DOI 10.1016/j.bbadis.2012.02.006; Kohler C, 2015, METHODS MOL BIOL, V1286, P279, DOI 10.1007/978-1-4939-2447-9_22; Kumar R, 2011, LIFE SCI, V88, P565, DOI 10.1016/j.lfs.2011.01.021; Matsumoto T, 2013, ANNU REV PHYSIOL, V75, P201, DOI 10.1146/annurev-physiol-030212-183656; McEwan IJ, 2012, MOL BIOSYST, V8, P82, DOI 10.1039/c1mb05249g; Myung JK, 2013, J CLIN INVEST, V123, P2948, DOI 10.1172/JCI66398; Paris F, 2002, MOL CELL ENDOCRINOL, V193, P43, DOI 10.1016/S0303-7207(02)00094-1; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5596, DOI 10.1073/pnas.042681599; Sledz P, 2012, LIGAND OBSERVED NMR; Srivastava S, 2015, J ENVIRON HEALTH, V77, P20; Stockman BJ, 2002, PROG NUCL MAG RES SP, V41, P187, DOI 10.1016/S0079-6565(02)00049-3; Takayanagi S, 2006, TOXICOL LETT, V167, P95, DOI 10.1016/j.toxlet.2006.08.012; TAM JP, 1991, J AM CHEM SOC, V113, P6657, DOI 10.1021/ja00017a044; Tan M H Eileen, 2015, Acta Pharmacol Sin, V36, P3, DOI 10.1038/aps.2014.18; Wan W, 2014, BIOCHEMISTRY-US, V53, P2366, DOI 10.1021/bi5002807; Zhang HY, 2007, TRENDS FOOD SCI TECH, V18, P492, DOI 10.1016/j.tifs.2007.04.008	31	5	5	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161948	10.1371/journal.pone.0161948	http://dx.doi.org/10.1371/journal.pone.0161948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583469	Green Submitted, Green Published, gold			2022-12-26	WOS:000382855600077
J	Boegemann, M; Schlack, K; Fischer, AK; Gerss, J; Steinestel, J; Semjonow, A; Schrader, AJ; Krabbe, LM				Boegemann, Martin; Schlack, Katrin; Fischer, Ann-Kathrin; Gerss, Joachim; Steinestel, Julie; Semjonow, Axel; Schrader, Andres Jan; Krabbe, Laura-Maria			Influence of Statins on Survival Outcome in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Abiraterone Acetate	PLOS ONE			English	Article							BIOCHEMICAL RECURRENCE; RADICAL PROSTATECTOMY; ANDROGEN DEPRIVATION; INCREASED EXPRESSION; CLINICAL-TRIALS; RISK; TESTOSTERONE; METAANALYSIS; SLCO2B1; PROGRESSION	Objective Even though the exact mechanism is largely unknown until now, statins are supposed to improve survival outcomes in various malignancies. For prostate cancer however, statins are known to compete with dehydroepiandrosterone (DHEAS) for the transport into the cytosol both using the cell by the Solute Carrier Transporter and thus diminish the cellular uptake of DHEAS as a precursor of androgens. Abiraterone inhibits CYP17A1 and thus effectively decreases the production of all relevant androgens including DHEAS. In this study we examined whether statins still affect survival outcome in patients with metastatic castration resistant prostate cancer (mCRPC) when treated with Abiraterone. Patients and Methods 108 men with mCRPC treated with Abiraterone from 02/2010 to 07/2015 with (n = 21) or without (n = 87) concomitant treatment with statins were investigated. Progression free survival (PFS) and overall survival (OS) were analyzed using Kaplan-Meier-estimates and univariate Cox-regression analysis. The influence on best clinical benefit under Abiraterone treatment was analyzed with bivariate and multivariate logistic regression analysis. Results PSA-decline >= 50% was not significantly different in both groups (57 vs. 53%; p = 0.73). The median PFS (9 vs. 10 months; p = 0.97) and OS (14 vs. 18 months; p = 0.77) did not differ significantly between those men treated with and without concomitant statin therapy, respectively. Accordingly, there was no improvement for best clinical benefit in patients using statins (odds ratio: 1.2 (CI: 0.4-4.2); p = 0.76). Conclusion Use of statins as concomitant medication did not improve survival outcomes or best clinical benefit in men with mCRPC treated with Abiraterone.	[Boegemann, Martin; Schlack, Katrin; Fischer, Ann-Kathrin; Steinestel, Julie; Semjonow, Axel; Schrader, Andres Jan; Krabbe, Laura-Maria] Muenster Univ, Med Ctr, Dept Urol, Munster, Germany; [Gerss, Joachim] Univ Munster, Inst Biostat & Clin Res, Schmeddingstr 56, D-48149 Munster, Germany; [Krabbe, Laura-Maria] Univ Texas Southwestern Med Ctr, Dept Urol, Dallas, TX USA	University of Munster; University of Munster; University of Texas System; University of Texas Southwestern Medical Center Dallas	Boegemann, M (corresponding author), Muenster Univ, Med Ctr, Dept Urol, Munster, Germany.	martin.boegemann@ukmuenster.de	Gerß, Joachim WO/B-5702-2013					Attard G, 2012, J CLIN ENDOCR METAB, V97, P507, DOI 10.1210/jc.2011-2189; Azad AA, 2015, CLIN CANCER RES, V21, P2315, DOI 10.1158/1078-0432.CCR-14-2666; Bansal D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046691; Bonovas S, 2008, INT J CANCER, V123, P899, DOI 10.1002/ijc.23550; Bremmer F, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-574; Chan KKW, 2003, CLIN CANCER RES, V9, P10; Chang SL, 2010, J CLIN ONCOL, V28, P3951, DOI 10.1200/JCO.2009.27.9406; Chen EJ, 2015, CLIN CANCER RES, V21, P1273, DOI 10.1158/1078-0432.CCR-14-1220; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fujimoto N, 2013, PROSTATE CANCER P D, V16, P336, DOI 10.1038/pcan.2013.23; Graaf MR, 2004, CANCER TREAT REV, V30, P609, DOI 10.1016/j.ctrv.2004.06.010; Hamilton RJ, 2010, CANCER-AM CANCER SOC, V116, P3389, DOI 10.1002/cncr.25308; Harshman LC, 2015, JAMA ONCOL, V1, P495, DOI 10.1001/jamaoncol.2015.0829; Joy TR, 2009, ANN INTERN MED, V150, P858, DOI 10.7326/0003-4819-150-12-200906160-00009; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Murtola TJ, 2009, PROSTATE, V69, P1017, DOI 10.1002/pros.20951; Park HS, 2013, ANN ONCOL, V24, P1427, DOI 10.1093/annonc/mdt077; Platz EA, 2006, JNCI-J NATL CANCER I, V98, P1819, DOI 10.1093/jnci/djj499; Pressler H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020372; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Scosyrev E, 2013, BJU INT, V111, pE71, DOI 10.1111/j.1464-410X.2012.11527.x; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Titus MA, 2005, CLIN CANCER RES, V11, P4653, DOI 10.1158/1078-0432.CCR-05-0525; Wright JL, 2011, CANCER EPIDEM BIOMAR, V20, P619, DOI 10.1158/1055-9965.EPI-10-1023; Yang M, 2011, J CLIN ONCOL, V29, P2565, DOI 10.1200/JCO.2010.31.2405	28	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161959	10.1371/journal.pone.0161959	http://dx.doi.org/10.1371/journal.pone.0161959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583544	Green Published, gold, Green Submitted			2022-12-26	WOS:000382855600078
J	Costa, T; Boccignone, G; Cauda, F; Ferraro, M				Costa, Tommaso; Boccignone, Giuseppe; Cauda, Franco; Ferraro, Mario			The Foraging Brain: Evidence of Levy Dynamics in Brain Networks	PLOS ONE			English	Article							EXTERNAL FORCE-FIELDS; ANOMALOUS DIFFUSION; RESTING-STATE; RANDOM-WALKS; MODELS; SIGNAL; DISTRIBUTIONS; FLUCTUATIONS; VARIABILITY; PATTERNS	In this research we have analyzed functional magnetic resonance imaging (fMRI) signals of different networks in the brain under resting state condition. To such end, the dynamics of signal variation, have been conceived as a stochastic motion, namely it has been modelled through a generalized Langevin stochastic differential equation, which combines a deterministic drift component with a stochastic component where the Gaussian noise source has been replaced with a-stable noise. The parameters of the deterministic and stochastic parts of the model have been fitted from fluctuating data. Results show that the deterministic part is characterized by a simple, linear decreasing trend, and, most important, the a-stable noise, at varying characteristic index a, is the source of a spectrum of activity modes across the networks, from those originated by classic Gaussian noise (a = 2), to longer tailed behaviors generated by the more general Levy noise (1 <= a < 2). Levy motion is a specific instance of scale-free behavior, it is a source of anomalous diffusion and it has been related to many aspects of human cognition, such as information foraging through memory retrieval or visual exploration. Finally, some conclusions have been drawn on the functional significance of the dynamics corresponding to different a values.	[Costa, Tommaso; Cauda, Franco] Univ Turin, Dept Psychol, Focus Lab, Turin, Italy; [Costa, Tommaso; Cauda, Franco] Koelliker Hosp, GCS FMRI, Turin, Italy; [Boccignone, Giuseppe] Univ Milan, Dept Comp Sci, PHuSe Lab, Milan, Italy; [Ferraro, Mario] Univ Turin, Dept Phys, Turin, Italy	University of Turin; University of Milan; University of Turin	Cauda, F (corresponding author), Univ Turin, Dept Psychol, Focus Lab, Turin, Italy.; Cauda, F (corresponding author), Koelliker Hosp, GCS FMRI, Turin, Italy.	franco.cauda@unito.it	Boccignone, Giuseppe/AAH-4459-2020; Boccignone, Giuseppe/G-7542-2012; Cauda, Franco/G-5021-2010	Boccignone, Giuseppe/0000-0002-5572-0924; Boccignone, Giuseppe/0000-0002-5572-0924; Cauda, Franco/0000-0003-1526-8475				Anderson T.W., 1952, ANN MATH STAT, V23, P193, DOI [DOI 10.1214/A0MS/1177729437, 10.1214/aoms/1177729437, DOI 10.1214/AOMS/1177729437]; ANDERSON TW, 1954, J AM STAT ASSOC, V49, P765, DOI 10.2307/2281537; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Bergstrom H., 1952, ARK MAT, V2, P375; Bianciardi M, 2009, NEUROIMAGE, V45, P160, DOI 10.1016/j.neuroimage.2008.10.034; Boccignone G, 2004, PHYSICA A, V331, P207, DOI 10.1016/j.physa.2003.09.011; Boccignone G, 2014, IEEE T CYBERNETICS, V44, P266, DOI 10.1109/TCYB.2013.2253460; BOUCHAUD JP, 1990, PHYS REP, V195, P127, DOI 10.1016/0370-1573(90)90099-N; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Brockmann D, 2002, CHEM PHYS, V284, P409, DOI 10.1016/S0301-0104(02)00671-7; Brockmann D, 2000, NEUROCOMPUTING, V32, P643, DOI 10.1016/S0925-2312(00)00227-7; CAPOCELLI RM, 1971, KYBERNETIK, V8, P214, DOI 10.1007/BF00288750; CHAMBERS JM, 1976, J AM STAT ASSOC, V71, P340, DOI 10.2307/2285309; Chang LJ, 2013, CEREB CORTEX, V23, P739, DOI 10.1093/cercor/bhs065; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; DARLING DA, 1957, ANN MATH STAT, V28, P823, DOI 10.1214/aoms/1177706788; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Dubkov AA, 2008, INT J BIFURCAT CHAOS, V18, P2649, DOI 10.1142/S0218127408021877; Engmann S, 2011, JAQM, V6, P1; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 2009, SCIENCE, V326, P399, DOI 10.1126/science.1174521; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Garrett DD, 2013, NEUROSCI BIOBEHAV R, V37, P610, DOI 10.1016/j.neubiorev.2013.02.015; GERSTEIN GL, 1964, BIOPHYS J, V4, P41, DOI 10.1016/S0006-3495(64)86768-0; Gnedenko B. V., 1954, LIMIT DISTRIBUTIONS; Grady CL, 2014, BRAIN IMAGING BEHAV, V8, P274, DOI 10.1007/s11682-013-9253-0; Guitart-Masip M, 2015, CEREB CORTEX; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; He BYJ, 2011, J NEUROSCI, V31, P13786, DOI 10.1523/JNEUROSCI.2111-11.2011; Higham DJ, 2001, SIAM REV, V43, P525, DOI 10.1137/S0036144500378302; Hills TT, 2006, COGNITIVE SCI, V30, P3, DOI 10.1207/s15516709cog0000_50; Janssen HK, 1999, EUR PHYS J B, V7, P137, DOI 10.1007/s100510050596; Jespersen S, 1999, PHYS REV E, V59, P2736, DOI 10.1103/PhysRevE.59.2736; KOUTROUVELIS IA, 1981, COMMUN STAT B-SIMUL, V10, P17, DOI 10.1080/03610918108812189; Linaro D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001102; Marlow CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139379; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Mendez V., 2013, STOCHASTIC FDN MOVEM; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Nolan J., 1997, COMMUN STAT STOCHAST, V13, P759, DOI [10.1080/15326349708807450, DOI 10.1080/15326349708807450]; Olshausen BA, 1996, NETWORK-COMP NEURAL, V7, P333, DOI 10.1088/0954-898X/7/2/014; Papo D, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00112; Pereira Francisco, 2009, Neuroimage, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Posadas A, 2002, J SEISMOL, V6, P61, DOI 10.1023/A:1014203530032; Rhodes T, 2007, PHYSICA A, V385, P255, DOI 10.1016/j.physa.2007.07.001; Risken H., 1989, SPRINGER SERIES SYNE, V18; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Scafetta N, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.031906; Siegert S, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.041107; TSALLIS C, 1995, PHYS REV LETT, V75, P3589, DOI 10.1103/PhysRevLett.75.3589; van Kampen N.G., 2001, STOCHASTIC PROCESSES; VanKampen N. G., 1992, STOCHASTIC PROCESSES, V1; Viswanathan G. M., 2011, PHYS FORAGING; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; West BJ, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00001; Wilson H.R., 1999, SPIKES DECISIONS ACT; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]	59	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161702	10.1371/journal.pone.0161702	http://dx.doi.org/10.1371/journal.pone.0161702			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583679	gold, Green Published, Green Submitted			2022-12-26	WOS:000382855600051
J	Fan, YR; Huang, TZ; Liu, J; Zhao, XL				Fan, Ya-Ru; Huang, Ting-Zhu; Liu, Jun; Zhao, Xi-Le			Compressive Sensing via Nonlocal Smoothed Rank Function	PLOS ONE			English	Article							ALTERNATING DIRECTION METHOD; IMAGE-RESTORATION; THRESHOLDING ALGORITHM; SIGNAL RECONSTRUCTION; MATRIX COMPLETION; SPARSITY; REGULARIZATION; MINIMIZATION; DECOMPOSITION; OPTIMIZATION	Compressive sensing (CS) theory asserts that we can reconstruct signals and images with only a small number of samples or measurements. Recent works exploiting the nonlocal similarity have led to better results in various CS studies. To better exploit the nonlocal similarity, in this paper, we propose a non-convex smoothed rank function based model for CS image reconstruction. We also propose an efficient alternating minimization method to solve the proposed model, which reduces a difficult and coupled problem to two tractable subproblems. Experimental results have shown that the proposed method performs better than several existing state-of-the-art CS methods for image reconstruction.	[Fan, Ya-Ru; Huang, Ting-Zhu; Zhao, Xi-Le] Univ Elect Sci & Technol, Sch Math Sci, Res Ctr Image & Vis Comp, Chengdu 611731, Sichuan, Peoples R China; [Liu, Jun] Northeast Normal Univ, Sch Math & Stat, Changchun 130024, Jilin, Peoples R China	University of Electronic Science & Technology of China; Northeast Normal University - China	Huang, TZ (corresponding author), Univ Elect Sci & Technol, Sch Math Sci, Res Ctr Image & Vis Comp, Chengdu 611731, Sichuan, Peoples R China.	tingzhuhuang@126.com		Huang, Ting-Zhu/0000-0001-7766-230X	973 Program [2013CB329404]; National Science Foundation of China (NSFC) [61370147, 61402082]; Fundamental Research Funds for the Central Universities [ZYGX2013Z005, ZYGX2013J106]	973 Program(National Basic Research Program of China); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by the 973 Program (2013CB329404), National Science Foundation of China (NSFC) (61370147, 61402082), the Fundamental Research Funds for the Central Universities (ZYGX2013Z005, ZYGX2013J106).	Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Buades A, 2005, INT CONF ACOUST SPEE, P25; Cai JF, 2010, SIAM J OPTIMIZ, V20, P1956, DOI 10.1137/080738970; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Chartrand R, 2007, IEEE SIGNAL PROC LET, V14, P707, DOI 10.1109/LSP.2007.898300; Chen C, 2015, IEEE T IMAGE PROCESS, V24, P33, DOI 10.1109/TIP.2014.2369953; Dabov K, 2007, IEEE T IMAGE PROCESS, V16, P2080, DOI 10.1109/TIP.2007.901238; Deng LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141199; Deng W, 2013, SPIE OPTICAL ENG APP, P88580; Dong WS, 2014, IEEE T IMAGE PROCESS, V23, P3618, DOI 10.1109/TIP.2014.2329449; Dong WS, 2012, SIGNAL PROCESS-IMAGE, V27, P1109, DOI 10.1016/j.image.2012.09.003; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; DONY RD, 1995, P IEEE, V83, P288, DOI 10.1109/5.364461; Du Q, 2007, IEEE GEOSCI REMOTE S, V4, P201, DOI 10.1109/LGRS.2006.888109; Egiazarian K, 2007, IEEE IMAGE PROC, P549; Gehm ME, 2007, OPT EXPRESS, V15, P14013, DOI 10.1364/OE.15.014013; Ghasemi H, 2011, INT CONF ACOUST SPEE, P3672; Gu SH, 2014, PROC CVPR IEEE, P2862, DOI 10.1109/CVPR.2014.366; Han DR, 2015, J MATH IMAGING VIS, V51, P145, DOI 10.1007/s10851-014-0510-7; He BS, 2012, SIAM J OPTIMIZ, V22, P313, DOI 10.1137/110822347; Huang JZ, 2011, J MACH LEARN RES, V12, P3371; Ji H, 2010, PROC CVPR IEEE, P1791, DOI 10.1109/CVPR.2010.5539849; Koltchinskii V, 2009, ANN I H POINCARE-PR, V45, P7, DOI 10.1214/07-AIHP146; Liu G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122562; Liu J, 2015, INFORM SCIENCES, V295, P232, DOI 10.1016/j.ins.2014.10.041; Lustig M, 2008, IEEE SIGNAL PROC MAG, V25, P72, DOI 10.1109/MSP.2007.914728; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Mairal J, 2009, IEEE I CONF COMP VIS, P2272, DOI 10.1109/ICCV.2009.5459452; Malek-Mohammadi M, 2014, IEEE T SIGNAL PROCES, V62, P981, DOI 10.1109/TSP.2013.2295557; Mohimani H, 2009, IEEE T SIGNAL PROCES, V57, P289, DOI 10.1109/TSP.2008.2007606; Romberg J, 2008, IEEE SIGNAL PROC MAG, V25, P14, DOI 10.1109/MSP.2007.914729; Wang YL, 2010, SIAM J IMAGING SCI, V3, P462, DOI 10.1137/090772447; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Zhang XQ, 2010, SIAM J IMAGING SCI, V3, P253, DOI 10.1137/090746379; Zhao XL, 2014, SIAM J IMAGING SCI, V7, P456, DOI 10.1137/13092472X; Zhao XL, 2013, SIAM J SCI COMPUT, V35, pB1304, DOI 10.1137/130915406; Zibulevsky M, 2010, IEEE SIGNAL PROC MAG, V27, P76, DOI 10.1109/MSP.2010.936023	37	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162041	10.1371/journal.pone.0162041	http://dx.doi.org/10.1371/journal.pone.0162041			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583683	Green Submitted, Green Published, gold			2022-12-26	WOS:000382855600091
J	Howey, MCL; Sullivan, FB; Tallant, J; Kopple, RV; Palace, MW				Howey, Meghan C. L.; Sullivan, Franklin B.; Tallant, Jason; Kopple, Robert Vande; Palace, Michael W.			Detecting Precontact Anthropogenic Microtopographic Features in a Forested Landscape with Lidar: A Case Study from the Upper Great Lakes Region, AD 1000-1600	PLOS ONE			English	Article							AIRBORNE LIDAR; ARCHAEOLOGICAL FEATURES; NORTHERN MICHIGAN; FOOD STORAGE; EXAMPLE	Forested settings present challenges for understanding the full extent of past human landscape modifications. Field-based archaeological reconnaissance in forests is low-efficiency and most remote sensing techniques are of limited utility, and together, this means many past sites and features in forests are unknown. Archaeologists have increasingly used light detection and ranging (lidar), a remote sensing tool that uses pulses of light to measure reflecting surfaces at high spatial resolution, to address these limitations. Archaeology studies using lidar have made significant progress identifying permanent structures built by large-scale complex agriculturalist societies. Largely unaccounted for, however, are numerous small and more practical modifications of landscapes by smaller-scale societies. Here we show these may also be detectable with lidar by identifying remnants of food storage pits (cache pits) created by mobile hunter-gatherers in the upper Great Lakes during Late Precontact (ca. AD 1000-1600) that now only exist as subtle microtopographic features. Years of intensive field survey identified 69 cache pit groups between two inland lakes in northern Michigan, almost all of which were located within similar to 500 m of a lakeshore. Applying a novel series of image processing techniques and statistical analyses to a high spatial resolution DTM we created from commercial-grade lidar, our detection routine identified 139 high potential cache pit clusters. These included most of the previously known clusters as well as several unknown clusters located >1500 m from either lakeshore, much further from lakeshores than all previously identified cultural sites. Food storage is understood to have emerged regionally as a risk-buffering strategy after AD 1000 but our results indicate the current record of hunter-gatherer cache pit food storage is markedly incomplete and this practice and its associated impact on the landscape may be greater than anticipated. Our study also demonstrates the potential of harnessing commercial-grade lidar for other fine-grained archaeology applications.	[Howey, Meghan C. L.] Univ New Hampshire, Dept Anthropol, Durham, NH 03824 USA; [Howey, Meghan C. L.; Sullivan, Franklin B.; Palace, Michael W.] Univ New Hampshire, Inst Study Earth Oceans & Space, Earth Syst Res Ctr, Durham, NH 03824 USA; [Tallant, Jason; Kopple, Robert Vande] Univ Michigan, Biol Stn, Pellston, MI USA; [Palace, Michael W.] Univ New Hampshire, Dept Earth Sci, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; University of Michigan System; University of Michigan; University System Of New Hampshire; University of New Hampshire	Howey, MCL (corresponding author), Univ New Hampshire, Dept Anthropol, Durham, NH 03824 USA.; Howey, MCL (corresponding author), Univ New Hampshire, Inst Study Earth Oceans & Space, Earth Syst Res Ctr, Durham, NH 03824 USA.	meghan.howey@unh.edu		Tallant, Jason/0000-0003-4790-8772	NASA Space Archaeology [NNH11ZDA001N SAP, NNX13AO40G]; National Science Foundation [0851096]	NASA Space Archaeology; National Science Foundation(National Science Foundation (NSF))	Spatial research supported by NASA Space Archaeology NNH11ZDA001N SAP (Grant Number NNX13AO40G) (PI Palace). Field research supported by the National Science Foundation under #0851096 (PI Howey). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert D.A., 1987, NATURAL ECOLOGY CULT; American Society for Photogrammetry & Remote Sensing (ASPRS), LAS SPEC VERS 1 4 R1; Artursson M, 2016, J ANTHROPOL ARCHAEOL, V41, P1, DOI 10.1016/j.jaa.2015.11.005; Brubaker K. M., 2013, APPL ENVIRON SOIL SC, V2013, DOI DOI 10.1155/2013/891534; Chase AF, 2012, P NATL ACAD SCI USA, V109, P12916, DOI 10.1073/pnas.1205198109; Chase AF, 2011, J ARCHAEOL SCI, V38, P387, DOI 10.1016/j.jas.2010.09.018; Crow P, 2007, FORESTRY, V80, P241, DOI 10.1093/forestry/cpm018; Densmore Frances, 1929, SMITHSONIAN I BUREAU, V86; Devereux BJ, 2005, ANTIQUITY, V79, P648, DOI 10.1017/S0003598X00114589; Doneus M, 2008, J ARCHAEOL SCI, V35, P882, DOI 10.1016/j.jas.2007.06.013; Dunham S.B., 2000, INTERPRETATIONS NATI, P225; Evans DH, 2013, P NATL ACAD SCI USA, V110, P12595, DOI 10.1073/pnas.1306539110; Farina, 2006, PRINCIPLES METHODS L; Grier C, 2014, CANADIAN J ARCHAEOLO, V38, P211; Heidemann HK, 2014, LIDAR BASE SPECIFICA; Holman M, 2008, ARCHAEOLOGY MOBILITY, P280; Holman M.B., 1995, MICH ARCHAEOL, V41, P47; Holman MB, 2011, WISCONSIN ARCHAEOLOG, V2, P7; Howey MCL, 2016, J ANTHROPOL ARCHAEOL, V42, P37, DOI 10.1016/j.jaa.2016.03.001; Howey MCL, 2015, J ARCHAEOL SCI, V64, P88, DOI 10.1016/j.jas.2015.10.007; INGOLD T, 1983, MAN, V18, P553, DOI 10.2307/2801597; Johnson KM, 2014, J ARCHAEOL SCI, V43, P9, DOI 10.1016/j.jas.2013.12.004; Lasaponara R, 2011, J ARCHAEOL SCI, V38, P2061, DOI 10.1016/j.jas.2010.10.003; Liebmann MJ, 2016, P NATL ACAD SCI USA, V113, pE696, DOI 10.1073/pnas.1521744113; LOVIS WA, 1976, AM ANTIQUITY, V41, P364, DOI 10.2307/279526; Lovis WA, 1978, MICH ACAD, V11, P39; Mccoy MD, 2011, J ARCHAEOL SCI, V38, P2141, DOI 10.1016/j.jas.2011.02.033; O'Shea JM., 2003, FARM ARCHAEOL OLD WO, V1, P68; Politis G., 2007, NUKAK ETHNOARCHAEOGY; Randall AR, 2014, J FIELD ARCHAEOL, V39, P162, DOI 10.1179/0093469014Z.00000000080; Schaetzl R. J., 1990, Geomorphology, V3, P113, DOI 10.1016/0169-555X(90)90040-W; Stular B, 2012, J ARCHAEOL SCI, V39, P3354, DOI 10.1016/j.jas.2012.05.029	32	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162062	10.1371/journal.pone.0162062	http://dx.doi.org/10.1371/journal.pone.0162062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DV3WN	27584031	Green Published, gold			2022-12-26	WOS:000382855600093
J	Ren, BZ; Zhang, JW; Dong, ST; Liu, P; Zhao, B				Ren, Baizhao; Zhang, Jiwang; Dong, Shuting; Liu, Peng; Zhao, Bin			Effects of Waterlogging on Leaf Mesophyll Cell Ultrastructure and Photosynthetic Characteristics of Summer Maize	PLOS ONE			English	Article							LIPID-PEROXIDATION; GROWTH; STRESS; YIELD; RESPONSES	A field experiment was performed to study the effects of waterlogging on the leaf mesophyll cell ultrastructure, chlorophyll content, gas exchange parameters, chlorophyll fluorescence, and malondialdehyde (MDA) content of summer maize (Zea mays L.) hybrids Denghai605 (DH605) and Zhengdan958 (ZD958). The waterlogging treatments were implemented for different durations (3 and 6 days) at the third leaf stage (V3), the sixth leaf stage (V6), and the 10th day after the tasseling stage (10VT). Leaf area index (LAI), chlorophyll content, photosynthetic rate (P-n), and actual photochemical efficiency (Phi(PSII)) were reduced after waterlogging, indicating that waterlogging significantly decreased photosynthetic capacity. The chloroplast shapes changed from long and oval to elliptical or circular after waterlogging. In addition, the internal structures of chloroplasts were degenerated after waterlogging. After waterlogging for 6 d at V3, the number of grana and grana lamellae of the third expanded leaf in DH605 were decreased by 26.83% and 55.95%, respectively, compared to the control (CK). Those in ZD958 were reduced by 30.08% and 31.94%, respectively. Waterlogging increased MDA content in both hybrids, suggesting an impact of waterlogging on membrane integrity and thus membrane deterioration. Waterlogging also damaged the biological membrane structure and mitochondria. Our results indicated that the physiological reactions to waterlogging were closely related to lower LAI, chlorophyll content, and Pn and to the destruction of chloroplast ultrastructure. These negative effects resulted in the decrease of grain yield in response to waterlogging. Summer maize was the most susceptible to damage when waterlogging occurred at V3, followed by V6 and 10VT, with damage increasing in the wake of waterlogging duration increasing.	[Zhang, Jiwang] Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; Shandong Agr Univ, Coll Agron, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Zhang, JW (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	jwzhang@sdau.edu.cn			National Basic Research Program of China (973) [2015CB150404]; National Modern Agricultural Technology & Industry System [CARS-02-20]; Shandong Province Key Agricultural Project for Application Technology Innovation	National Basic Research Program of China (973)(National Basic Research Program of China); National Modern Agricultural Technology & Industry System; Shandong Province Key Agricultural Project for Application Technology Innovation	The authors are grateful for grants from National Basic Research Program of China (973, Program: 2015CB150404), National Modern Agricultural Technology & Industry System (CARS-02-20), and Shandong Province Key Agricultural Project for Application Technology Innovation.	Araki H, 2012, FIELD CROP RES, V137, P27, DOI 10.1016/j.fcr.2012.09.006; Bertamini M, 2006, PHOTOSYNTHETICA, V44, P227, DOI 10.1007/s11099-006-0011-z; BURKEY KO, 1991, PLANT PHYSIOL, V97, P245, DOI 10.1104/pp.97.1.245; Chaoui A, 1997, PLANT SCI, V127, P139, DOI 10.1016/S0168-9452(97)00115-5; Crawford RMM, 1996, J EXP BOT, V47, P145, DOI 10.1093/jxb/47.2.145; DU ZY, 1992, J AGR FOOD CHEM, V40, P1566, DOI 10.1021/jf00021a018; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; GILES KL, 1976, PLANT PHYSIOL, V57, P11, DOI 10.1104/pp.57.1.11; HOWELL TA, 1974, T ASAE, V17, P286, DOI 10.13031/2013.36842; Irfan M, 2010, PROTOPLASMA, V241, P3, DOI 10.1007/s00709-009-0098-8; Jackson M.B., 2004, IMPACT FLOODING STRE; Li H.S., 2000, PRINCIPLES TECHNIQUE, P119; Liu XH, 2008, BIOTECHNOLOGY B S, VS1, P38; Mielke MS, 2003, ENV EXPT BOT, V50, P123; Montgomery E., 1911, NEB AGR EXP STN ANN, V24, P108; NIKI T, 1978, PLANT CELL PHYSIOL, V19, P139; Pessarakli M, 2005, HANDBOOKOF PHOTOSYNT, P730; Pezeshki SR, 2001, ENVIRON EXP BOT, V46, P299, DOI 10.1016/S0098-8472(01)00107-1; PFISTERSIEBER M, 1994, P ROY SOC EDINB B, V102, P313, DOI 10.1017/S0269727000014305; Pociecha E, 2008, ACTA PHYSIOL PLANT, V30, P529, DOI 10.1007/s11738-008-0151-9; Ren BZ, 2014, CAN J PLANT SCI, V94, P23, DOI 10.4141/CJPS2013-175; Sauter M, 2013, CURR OPIN PLANT BIOL, V16, P282, DOI 10.1016/j.pbi.2013.03.013; Shao QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085996; Smethurst CF, 2005, PLANT SOIL, V270, P31, DOI 10.1007/s11104-004-1082-x; Vandoorne B, 2014, PLANT SOIL, V376, P291, DOI 10.1007/s11104-013-1933-4; Waldhoff D, 2002, ENVIRON EXP BOT, V48, P225, DOI 10.1016/S0098-8472(02)00037-0; Weston E, 2000, PLANTA, V211, P807, DOI 10.1007/s004250000392; Xu PL, 2008, PHYSIOL PLANTARUM, V132, P467, DOI 10.1111/j.1399-3054.2007.01036.x; Xu S, 2006, ENVIRON EXP BOT, V56, P274, DOI 10.1016/j.envexpbot.2005.03.002; Yordanova RY, 2007, ACTA PHYSIOL PLANT, V29, P535, DOI 10.1007/s11738-007-0064-z; [郁凌华 Yu Linghua], 2013, [灾害学, Journal of Catastrophology], V28, P71; Zhou WJ, 1995, FIELD CROP RES, V44, P103, DOI 10.1016/0378-4290(95)00075-5	32	53	60	5	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161424	10.1371/journal.pone.0161424	http://dx.doi.org/10.1371/journal.pone.0161424			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583803	Green Published, gold, Green Submitted			2022-12-26	WOS:000382855600028
J	Tsui, SL; Wang, J; Wang, L; Dai, W; Lu, L				Tsui, Shanli; Wang, Jie; Wang, Ling; Dai, Wei; Lu, Luo			CTCF-Mediated and Pax6-Associated Gene Expression in Corneal Epithelial Cell-Specific Differentiation	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; CCCTC BINDING-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOLIPASE C-GAMMA-1; INDUCED PROLIFERATION; PAX6 TRANSCRIPTION; EGF; GENOME; KINASE; ACTIVATION	Background The purpose of the study is to elicit the epigenetic mechanism involving CCCTC binding factor (CTCF)-mediated chromatin remodeling that regulates PAX6 gene interaction with differentiation-associated genes to control corneal epithelial differentiation. Methods Cell cycle progression and specific keratin expressions were measured to monitor changes of differentiation- induced primary human limbal stem/progenitor (HLS/P), human corneal epithelial (HCE) and human telomerase-immortalized corneal epithelial (HTCE) cells. PAX6-interactive and differentiation- associated genes in chromatin remodeling mediated by the epigenetic factor CTCF were detected by circular chromosome conformation capture (4C) and ChIP (Chromatin immunoprecipitation)-on-chip approaches, and verified by FISH (Fluorescent in situ hybridization). Furthermore, CTCF activities were altered by CTCF-shRNA to study the effect of CTCF on mediating interaction of Pax6 and differentiation-associated genes in corneal epithelial cell fate. Results Our results demonstrated that differentiation- induced human corneal epithelial cells expressed typical corneal epithelial characteristics including morphological changes, increased keratin 12 expression and G(0)/G(1) accumulations. Expressions of CTCF and PAX6 were suppressed and elevated following the process of differentiation, respectively. During corneal epithelial cell differentiation, differentiation- induced RCN1 and ADAM17 were found interacting with PAX6 in the process of CTCF-mediated chromatin remodeling detected by 4C and verified by ChIP-on-chip and FISH. Diminished CTCF mRNA with CTCF-shRNA in HTCE cells weakened the interaction of PAX6 gene in controlling RCN1/ADAM17 and enhanced early onset of the genes in cell differentiation. Conclusion Our results explain how epigenetic factor CTCF-mediated chromatin remodeling regulates interactions between eye-specific PAX6 and those genes that are induced/associated with cell differentiation to modulate corneal epithelial cell-specific differentiation.	[Tsui, Shanli; Wang, Jie; Wang, Ling; Lu, Luo] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Torrance, CA 90502 USA; [Dai, Wei] NYU, Dept Environm Med, Sch Med, Tuxedo Pk, NY 10987 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; New York University	Lu, L (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Torrance, CA 90502 USA.	lluou@ucla.edu		Dai, Wei/0000-0003-0169-8327	NIH [EY15282, CA074229]; NATIONAL EYE INSTITUTE [R01EY022364, R01EY015281] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grants EY15282 to LL and CA074229 to WD.	Antes TJ, 2001, BIOCHEMISTRY-US, V40, P6731, DOI 10.1021/bi0100743; Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Cartier L, 2006, J NEUROBIOL, V66, P421, DOI 10.1002/neu.20225; Davis JA, 1996, J NEUROSCI, V16, P5082; Dobrovic A, 1997, CANCER RES, V57, P3347; Farrell CM, 2002, MOL CELL BIOL, V22, P3820, DOI 10.1128/MCB.22.11.3820-3831.2002; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Islam M, 2000, EXP EYE RES, V70, P261, DOI 10.1006/exer.1999.0783; Islam M, 2001, INVEST OPHTH VIS SCI, V42, P1472; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kang SS, 2000, INVEST OPHTH VIS SCI, V41, P2164; Kang SS, 2001, CURR EYE RES, V23, P397, DOI 10.1076/ceyr.23.6.397.6965; Klenova E, 2002, METHODS, V26, P254, DOI 10.1016/S1046-2023(02)00029-4; Koroma BM, 1997, INVEST OPHTH VIS SCI, V38, P108; Li T, 2005, J BIOL CHEM, V280, P12988, DOI 10.1074/jbc.M412458200; Li T, 2004, J BIOL CHEM, V279, P27575, DOI 10.1074/jbc.M313942200; Li T, 2006, INVEST OPHTH VIS SCI, V47, P5218, DOI 10.1167/iovs.06-0254; Lu L, 2010, J BIOL CHEM, V285, P9373, DOI 10.1074/jbc.M109.094425; MARTIN P, 1992, ONCOGENE, V7, P1721; Nikoletopoulou V, 2007, CELL STEM CELL, V1, P529, DOI 10.1016/j.stem.2007.08.011; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; Ouyang J, 2006, INVEST OPHTH VIS SCI, V47, P2397, DOI 10.1167/iovs.05-1083; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; PLAZA S, 1993, CELL GROWTH DIFFER, V4, P1041; PLAZA S, 1995, MOL CELL BIOL, V15, P3344; Ramaesh T, 2006, INVEST OPHTH VIS SCI, V47, P1911, DOI 10.1167/iovs.05-1028; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wang J, 2010, INVEST OPHTH VIS SCI, V51, P2943, DOI 10.1167/iovs.09-4639; Wang L, 2012, INVEST OPHTH VIS SCI, V53, P946, DOI 10.1167/iovs.11-8747; Williams SC, 1998, MECH DEVELOP, V73, P225, DOI 10.1016/S0925-4773(98)00057-4; WILSON SE, 1992, INVEST OPHTH VIS SCI, V33, P1987; Wu D, 2006, INVEST OPHTH VIS SCI, V47, P2422, DOI 10.1167/iovs.05-0536; Xu PX, 1999, DEVELOPMENT, V126, P383; Zhang Y, 1999, INVEST OPHTH VIS SCI, V40, P2819; Zhang Y, 1998, CURR EYE RES, V17, P294, DOI 10.1076/ceyr.17.3.294.5223; Zhang Y, 1996, EXP EYE RES, V63, P265, DOI 10.1006/exer.1996.0115; Zhang Y, 1997, INVEST OPHTH VIS SCI, V38, P1139	43	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162071	10.1371/journal.pone.0162071	http://dx.doi.org/10.1371/journal.pone.0162071			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583466	Green Published, gold, Green Submitted			2022-12-26	WOS:000382855600097
J	Carr, T; Yang, HS; Ray, C				Carr, Tony; Yang, Haishun; Ray, Chittaranjan			Temporal Variations of Water Productivity in Irrigated Corn: An Analysis of Factors Influencing Yield and Water Use across Central Nebraska	PLOS ONE			English	Article							MAIZE SIMULATION-MODEL; HYBRID-MAIZE; MANAGEMENT; SYSTEM; AGRICULTURE; WHEAT	Water Productivity (WP) of a crop defines the relationship between the economic or physical yield of the crop and its water use. With this concept it is possible to identify disproportionate water use or water-limited yield gaps and thereby support improvements in agricultural water management. However, too often important qualitative and quantitative environmental factors are not part of a WP analysis and therefore neglect the aspect of maintaining a sustainable agricultural system. In this study, we examine both the physical and economic WP in perspective with temporally changing environmental conditions. The physical WP analysis was performed by comparing simulated maximum attainable corn yields per unit of water using the crop model Hybrid-Maize with observed data from 2005 through 2013 from 108 farm plots in the Central Platte and the Tri Basin Natural Resource Districts of Nebraska. In order to expand the WP analysis on external factors influencing yields, a second model, Maize-N, was used to estimate optimal nitrogen (N)-fertilizer rate for specific fields in the study area. Finally, a vadose zone flow and transport model, HYDRUS-1D for simulating vertical nutrient transport in the soil, was used to estimate locations of nitrogen pulses in the soil profile. The comparison of simulated and observed data revealed that WP was not on an optimal level, mainly due to large amounts of irrigation used in the study area. The further analysis illustrated year-to-year variations of WP during the nine consecutive years, as well as the need to improve fertilizer management to favor WP and environmental quality. In addition, we addressed the negative influence of groundwater depletion on the economic WP through increasing pumping costs. In summary, this study demonstrated that involving temporal variations of WP as well as associated environmental and economic issues can represent a bigger picture of WP that can help to create incentives to sustainably improve agricultural production.	[Carr, Tony; Ray, Chittaranjan] Univ Nebraska Lincoln, Nebraska Water Ctr, Water Food Global Inst, Lincoln, NE 68588 USA; [Yang, Haishun] Univ Nebraska Lincoln, Inst Agr & Nat Resources, Dept Agron & Hort, Lincoln, NE 68527 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Ray, C (corresponding author), Univ Nebraska Lincoln, Nebraska Water Ctr, Water Food Global Inst, Lincoln, NE 68588 USA.	cray@nebraska.edu	PAN, ZEQIANG/X-6341-2018					Alexandratos N, 2012, 03 UN FAO AGR DEV EC; Cameron KC, 2013, ANN APPL BIOL, V162, P145, DOI 10.1111/aab.12014; CROSS HZ, 1972, AGRON J, V64, P351, DOI 10.2134/agronj1972.00021962006400030029x; Farmaha BS, 2016, FIELD CROP RES, V186, P124, DOI 10.1016/j.fcr.2015.10.020; Grassini P, 2012, EVALUATION WATER PRO, pEC105; Grassini P, 2011, FIELD CROP RES, V120, P133, DOI 10.1016/j.fcr.2010.09.013; Irmak S, 2012, T ASABE, V55, P881; Jones JW, 2003, EUR J AGRON, V18, P235, DOI 10.1016/S1161-0301(02)00107-7; Kijne J. W, 2003, ENSURING FOOD SECURI; Liu X, 2015, EARTH INTERACT, V19, DOI 10.1175/EI-D-15-0005.1; Ma L, 2001, ADV AGRON, V71, P233, DOI 10.1016/S0065-2113(01)71016-4; Mainuddin M, 2012, WATER INT, V37, P53, DOI 10.1080/02508060.2012.645192; McMaster GS, 1997, AGR FOREST METEOROL, V87, P291, DOI 10.1016/S0168-1923(97)00027-0; Mekuria W, 2016, ARCH AGRON SOIL SCI, V62, P53, DOI 10.1080/03650340.2015.1037297; Molden D, 2007, WATER FOOD WATER LIF, P279; NEO, NEBR EN STAT 2015; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Ritchie J.T., 1991, AGRON MONOGR, V31, P5, DOI [10.2134/AGRONMONOGR31.C2, DOI 10.2134/AGR0NM0N0GR31.C2]; Rosegrant MW, 2009, ANNU REV ENV RESOUR, V34, P205, DOI 10.1146/annurev.environ.030308.090351; Schreiber JD, 1999, J ENVIRON QUAL, V28, P1864, DOI 10.2134/jeq1999.00472425002800060024x; Setiyono TD, 2011, AGRON J, V103, P1276, DOI 10.2134/agronj2011.0053; Simunek J, 2013, THE HYDRUS 1D SOFTWA; Steward DR, 2013, P NATL ACAD SCI USA, V110, pE3477, DOI 10.1073/pnas.1220351110; Su LJ, 2013, THEOR APPL CLIMATOL, V113, P711, DOI 10.1007/s00704-012-0814-8; Thompson LJ, 2015, AGRON J, V107, P2020, DOI 10.2134/agronj15.0116; USDA-NASS, QUICK STATS 2015; USDA-NRSC, 2015, SOIL SURV GEOGR DAT; Yang H, 2013, HYBRID MAIZE SIMULAT; Yang HS, 2006, AGRON J, V98, P737, DOI 10.2134/agronj2005.0162; Yang HS, 2004, FIELD CROP RES, V87, P131, DOI 10.1016/j.fcr.2003.10.003; Zwart SJ, 2007, AGR WATER MANAGE, V89, P287, DOI 10.1016/j.agwat.2007.02.002; Zwart SJ, 2004, AGR WATER MANAGE, V69, P115, DOI 10.1016/j.agwat.2004.04.007	32	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161944	10.1371/journal.pone.0161944	http://dx.doi.org/10.1371/journal.pone.0161944			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575368	Green Published, gold			2022-12-26	WOS:000382877200047
J	Gomes, A; Guillaume, L; Grimes, DR; Fehrenbach, J; Lobjois, V; Ducommun, B				Gomes, Aurelie; Guillaume, Ludivine; Grimes, David Robert; Fehrenbach, Jerome; Lobjois, Valerie; Ducommun, Bernard			Oxygen Partial Pressure Is a Rate-Limiting Parameter for Cell Proliferation in 3D Spheroids Grown in Physioxic Culture Condition	PLOS ONE			English	Article							MULTICELLULAR SPHEROIDS; HYPOXIA; DIFFERENTIATION	The in situ oxygen partial pressure in normal and tumor tissues is in the range of a few percent. Therefore, when studying cell growth in 3D culture systems, it is essential to consider how the physiological oxygen concentration, rather than the one in the ambient air, influences the proliferation parameters. Here, we investigated the effect of reducing oxygen partial pressure from 21% to 5% on cell proliferation rate and regionalization in a 3D tumor spheroid model. We found that 5% oxygen concentration strongly inhibited spheroid growth, changed the proliferation gradient and reduced the 50% In Depth Proliferation index (IDP50), compared with culture at 21% oxygen. We then modeled the oxygen partial pressure profiles using the experimental data generated by culturing spheroids in physioxic and normoxic conditions. Although hypoxia occurred at similar depth in spheroids grown in the two conditions, oxygen partial pressure was a major rate-limiting factor with a critical effect on cell proliferation rate and regionalization only in spheroids grown in physioxic condition and not in spheroids grown at atmospheric normoxia. Our findings strengthen the need to consider conducting experiment in physioxic conditions (i.e., tissue normoxia) for proper understanding of cancer cell biology and the evaluation of anticancer drugs in 3D culture systems.	[Gomes, Aurelie; Guillaume, Ludivine; Fehrenbach, Jerome; Lobjois, Valerie; Ducommun, Bernard] UPS, Univ Toulouse, CNRS, ITAV, Toulouse, France; [Grimes, David Robert] Univ Oxford, Oxford, England; [Fehrenbach, Jerome] UPS, Univ Toulouse, CNRS, IMT, Toulouse, France; [Ducommun, Bernard] CHU Toulouse, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Oxford; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Lobjois, V; Ducommun, B (corresponding author), UPS, Univ Toulouse, CNRS, ITAV, Toulouse, France.; Ducommun, B (corresponding author), CHU Toulouse, Toulouse, France.	valerie.lobjois@itav.fr; bernard.ducommun@itav.fr	Grimes, David Robert/J-7384-2013	Grimes, David Robert/0000-0003-3140-3278; DUCOMMUN, Bernard/0000-0002-7126-8368; Lobjois, Valerie/0000-0003-2428-2084	CNRS; Universite Paul Sabatier; Region Midi-Pyrenees; ITMO Cancer AVIESAN (Alliance Nationale pour les Sciences de la Vie et de la Sante, National Alliance for Life Sciences & Health) within the framework of the Cancer Plan; Agence Nationale de la Recherche ANR [12-BSV5-0008-01]; Cancer Research UK [19834] Funding Source: researchfish	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paul Sabatier; Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); ITMO Cancer AVIESAN (Alliance Nationale pour les Sciences de la Vie et de la Sante, National Alliance for Life Sciences & Health) within the framework of the Cancer Plan; Agence Nationale de la Recherche ANR(French National Research Agency (ANR)); Cancer Research UK(Cancer Research UK)	This work was supported by grants to Bernard Ducommun from the CNRS, Universite Paul Sabatier, Region Midi-Pyrenees, ITMO Cancer AVIESAN (Alliance Nationale pour les Sciences de la Vie et de la Sante, National Alliance for Life Sciences & Health) within the framework of the Cancer Plan, and Agence Nationale de la Recherche ANR (12-BSV5-0008-01).	Ansari N, 2012, METHOD CELL BIOL, V113, P295, DOI 10.1016/B978-0-12-407239-8.00013-6; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Chou SC, 2004, BRIT J CANCER, V90, P728, DOI 10.1038/sj.bjc.6601585; Desoize B, 2000, CRIT REV ONCOL HEMAT, V36, P59, DOI 10.1016/S1040-8428(00)00076-7; Grimes BA, 2015, BIOMEDICAL PHYS ENG, V1; Grimes DR, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140080; Grimes DR, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1124; GROSS MW, 1995, INT J CANCER, V61, P567, DOI 10.1002/ijc.2910610422; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Ivanovic Z, 2009, J CELL PHYSIOL, V219, P271, DOI 10.1002/jcp.21690; Karlsson H, 2012, EXP CELL RES, V318, P1577, DOI 10.1016/j.yexcr.2012.03.026; KOCH CJ, 1995, BRIT J CANCER, V72, P869, DOI 10.1038/bjc.1995.426; Laurent J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-73; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Pampaloni Francesco, 2009, Recent Pat Biotechnol, V3, P103; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; SUTHERLAND RM, 1986, CANCER RES, V46, P5320; Vaupel P, 2007, ANTIOXID REDOX SIGN, V9, P1221, DOI 10.1089/ars.2007.1628; Yeom CJ, 2012, INT J MOL SCI, V13, P13949, DOI 10.3390/ijms131113949	19	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161239	10.1371/journal.pone.0161239	http://dx.doi.org/10.1371/journal.pone.0161239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575790	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877200020
J	Moshkanbaryans, L; Xue, J; Wark, JR; Robinson, PJ; Graham, ME				Moshkanbaryans, Lia; Xue, Jing; Wark, Jesse Ray; Robinson, Phillip James; Graham, Mark Evan			A Novel Sequence in AP180 and CALM Promotes Efficient Clathrin Binding and Assembly	PLOS ONE			English	Article							NUCLEAR EXPORT SIGNAL; SYNAPTIC VESICLE ENDOCYTOSIS; MYELOID-LEUKEMIA CALM; N-TERMINAL DOMAIN; BETA-PROPELLER; HEAVY-CHAIN; PROTEIN; MEMBRANES; AUXILIN; SITES	The clathrin heavy chain N-terminal domain interacts with endocytic adapter proteins via clathrin binding motifs to assemble clathrin triskelia into cages. However, the precise mechanism of clathrin assembly is not yet known. Clathrin assembly protein AP180 has more clathrin binding motifs than any other endocytic protein and has a major role in the assembly of the clathrin coat during synaptic vesicle biogenesis. We now demonstrate that some of the previously identified binding motifs in AP180 may be non-functional and that a non-conventional clathrin binding sequence has a major influence on AP180 function. The related protein, clathrin assembly lymphoid myeloid leukemia protein (CALM), has fewer clathrin binding motifs and functions ubiquitously in clathrin-mediated endocytosis. The C-terminal similar to 16 kDa sub-domain in AP180, which has relatively high similarity with CALM, was shown in earlier work to have an unexplained role in clathrin binding. We identified the specific sequences in this sub-domain that bind to clathrin. Evidence for a role for these sequences in promoting clathrin binding was examined using in vitro and ex vivo experiments that compared the clathrin binding ability of site mutants with the wild type sequence. A sequence conserved in both AP180 and CALM (LDSSLA[S/N] LVGNLGI) was found to be the major interaction site and mutation caused a deficit in clathrin assembly, which is the first example of a mutation having this effect. In contrast, single or double mutation of DL(L/F) motifs in full length AP180 had no significant effect on clathrin binding, despite higher clathrin affinity for isolated peptides containing these motifs. We conclude that the novel clathrin interaction sites identified here in CALM and AP180 have a major role in how these proteins interface with clathrin. This work advances the case that AP180 and CALM are required to use a combination of standard clathrin N-terminal domain binding motifs and the sequence identified here for optimal binding and assembling clathrin.	[Moshkanbaryans, Lia; Wark, Jesse Ray; Graham, Mark Evan] Univ Sydney, Synapse Prote Grp, Childrens Med Res Inst, Westmead, NSW 2145, Australia; [Xue, Jing; Robinson, Phillip James] Univ Sydney, Cell Signalling Unit, Med Res Inst, Westmead, NSW 2145, Australia	Children's Medical Research Institute - Australia; University of Sydney; University of Sydney	Graham, ME (corresponding author), Univ Sydney, Synapse Prote Grp, Childrens Med Res Inst, Westmead, NSW 2145, Australia.	mgraham@cmri.org.au	Robinson, Phillip J/G-4008-2011; Graham, Mark E/A-6480-2014	Robinson, Phillip J/0000-0002-7878-0313; Graham, Mark E/0000-0002-7290-1217	National Health and Medical Research Council Project [1052494, 1079160, 1069493, 1047070]; Rebecca L. Cooper Foundation Medical Research Foundation grant; National Health and Medical Research Council Biomedical (Dora Lush) Postgraduate Research Scholarship; University of Sydney Postgraduate Award; Children's Medical Research Institute PhD Scholarship	National Health and Medical Research Council Project(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L. Cooper Foundation Medical Research Foundation grant; National Health and Medical Research Council Biomedical (Dora Lush) Postgraduate Research Scholarship(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney Postgraduate Award(University of Sydney); Children's Medical Research Institute PhD Scholarship	MEG and PJR were funded by National Health and Medical Research Council Project Grants (1052494, 1079160, 1069493, 1047070) and a Rebecca L. Cooper Foundation Medical Research Foundation grant. LM was funded by a National Health and Medical Research Council Biomedical (Dora Lush) Postgraduate Research Scholarship, a University of Sydney Postgraduate Award and Children's Medical Research Institute PhD Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan LS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110557; Conway AE, 2013, BLOOD, V121, P4758, DOI 10.1182/blood-2012-06-435792; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Giani M, 2016, BIOPHYS J, V111, P222, DOI 10.1016/j.bpj.2016.06.003; Hao WH, 1999, J BIOL CHEM, V274, P22785, DOI 10.1074/jbc.274.32.22785; ISHIKAWA Y, 2014, HAEMATOLOGICA, V100, P439, DOI DOI 10.3324/HAEMAT0L.2014.119537; Koo SJ, 2011, P NATL ACAD SCI USA, V108, P13540, DOI 10.1073/pnas.1107067108; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Meyerholz A, 2005, TRAFFIC, V6, P1225, DOI 10.1111/j.1600-0854.2005.00355.x; Miele AE, 2004, NAT STRUCT MOL BIOL, V11, P242, DOI 10.1038/nsmb736; Morgan JR, 2013, J NEUROSCI, V33, P8009, DOI 10.1523/JNEUROSCI.4505-12.2013; Morgan JR, 2000, J NEUROSCI, V20, P8667; Moshkanbaryans L, 2014, MEMBRANES, V4, P388, DOI 10.3390/membranes4030388; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Saheki Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005645; Scheele U, 2003, J BIOL CHEM, V278, P25357, DOI 10.1074/jbc.M303738200; Scotland PB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044252; Stoddart A, 2012, ONCOGENE, V31, P494, DOI 10.1038/onc.2011.251; Suzuki M, 2014, CANCER SCI, V105, P315, DOI 10.1111/cas.12347; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; UNANUE ER, 1981, CELL, V26, P439, DOI 10.1016/0092-8674(81)90213-0; Wendland B, 1999, EMBO J, V18, P4383, DOI 10.1093/emboj/18.16.4383; Willox AK, 2012, TRAFFIC, V13, P70, DOI 10.1111/j.1600-0854.2011.01289.x; YE W, 1995, J NEUROSCI RES, V41, P15, DOI 10.1002/jnr.490410104; YE WL, 1995, J BIOL CHEM, V270, P10933, DOI 10.1074/jbc.270.18.10933; Zhao XH, 2001, J CELL SCI, V114, P353; Zhuo Y, 2015, BIOCHEMISTRY-US, V54, P2571, DOI 10.1021/acs.biochem.5b00065; Zhuo Y, 2010, J MOL BIOL, V404, P274, DOI 10.1016/j.jmb.2010.09.044	29	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0162050	10.1371/journal.pone.0162050	http://dx.doi.org/10.1371/journal.pone.0162050			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27574975	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877200056
J	Windmuller-Campione, MA; Long, JN				Windmuller-Campione, Marcella A.; Long, James N.			Limber Pine (Pinus flexilis James), a Flexible Generalist of Forest Communities in the Intermountain West	PLOS ONE			English	Article							COLORADO FRONT RANGE; BLISTER RUST; REGENERATION NICHE; CLIMATE-CHANGE; UNITED-STATES; WHITE PINES; RESISTANCE; DIVERSITY; MECHANISMS; SUCCESSION	As forest communities continue to experience interactions between climate change and shifting disturbance regimes, there is an increased need to link ecological understanding to applied management. Limber pine (Pinus flexilis James.), an understudied species of western North America, has been documented to dominate harsh environments and thought to be competitively excluded from mesic environments. An observational study was conducted using the Forest Inventory and Analysis Database (FIAD) to test the competitive exclusion hypothesis across a broad elevational and geographic area within the Intermountain West, USA. We anticipated that competitive exclusion would result in limber pine's absence from mid-elevation forest communities, creating a bi-modal distribution. Using the FIAD database, limber pine was observed to occur with 22 different overstory species, which represents a surprising number of the woody, overstory species commonly observed in the Intermountain West. There were no biologically significant relationships between measures of annual precipitation, annual temperature, or climatic indices (i.e. Ombrothermic Index) and limber pine dominance. Limber pine was observed to be a consistent component of forest communities across elevation classes. Of the plots that contained limber pine regeneration, nearly half did not have a live or dead limber pine in the overstory. However, limber pine regeneration was greater in plots with higher limber pine basal area and higher average annual precipitation. Our results suggest limber pine is an important habitat generalist, playing more than one functional role in forest communities. Generalists, like limber pine, may be increasingly important, as managers are challenged to build resistance and resilience to future conditions in western forests. Additional research is needed to understand how different silvicultural systems can be used to maintain multi-species forest communities.	[Windmuller-Campione, Marcella A.] Univ Minnesota, Dept Forest Resources, Coll Food Agr & Nat Resource Sci, St Paul, MN 55108 USA; [Windmuller-Campione, Marcella A.; Long, James N.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Windmuller-Campione, Marcella A.; Long, James N.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA	University of Minnesota System; University of Minnesota Twin Cities; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Windmuller-Campione, MA (corresponding author), Univ Minnesota, Dept Forest Resources, Coll Food Agr & Nat Resource Sci, St Paul, MN 55108 USA.; Windmuller-Campione, MA (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.; Windmuller-Campione, MA (corresponding author), Utah State Univ, Ctr Ecol, Logan, UT 84322 USA.	mwind@umn.edu			Utah Agricultural Experiment Station; USDA Forest Service Forest Health Monitoring [INT-EM-B-14-01]; USDA NIFA National Needs Graduate Fellowship Competitive Grant [2011-38420-20087]; T.W. Daniel Endowment	Utah Agricultural Experiment Station; USDA Forest Service Forest Health Monitoring; USDA NIFA National Needs Graduate Fellowship Competitive Grant; T.W. Daniel Endowment	This study was supported in part by a Utah Agricultural Experiment Station (http://uaes.usu.edu/), and USDA Forest Service Forest Health Monitoring (INT-EM-B-14-01) (http://fhm.fs.fed.us/em/funded/14/INT-EM-B-14-01.pdf). Additional support for MAW came from the USDA NIFA National Needs Graduate Fellowship Competitive Grant (NO. 2011-38420-20087) (http://nifa.usda.gov/program/national-needs-graduate-and-postgraduate-fellowship-grants-program-funding-opportunity-nnf) and the T.W. Daniel Endowment (http://danielforest.usu.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey R.G., 1998, ECOREGIONS ECOSYSTEM; Baumeister D, 2006, ECOLOGY, V87, P1816, DOI 10.1890/0012-9658(2006)87[1816:FBPFDS]2.0.CO;2; Bechtold WA, 2005, USDA GEN TECH REP, DOI 10.1371/journal.pone.0044795; Beniz B, 2014, FOREST SCI, V60, P434, DOI 10.5849/forsci.13-056; Bockino NK, 2012, NAT AREA J, V32, P31, DOI 10.3375/043.032.0105; Borgman EM, 2015, CAN J FOREST RES, V45, P496, DOI 10.1139/cjfr-2014-0399; BURNS RM, 1990, SILVICS N AM, V2, P1; Burns RM, 1990, SILVICS N AM, P348; Carmean W. H., 1975, ADV AGRONOMY, V27; Cary M, 1917, LIFE ZONE INVESTIGAT, P1; Castagneyrol B, 2013, J ECOL, V101, P418, DOI 10.1111/1365-2745.12055; Cleaver CM, 2015, FOREST ECOL MANAG, V358, P139, DOI 10.1016/j.foreco.2015.09.010; COLLINS SL, 1987, OIKOS, V48, P89, DOI 10.2307/3565692; Daubenmire R. F., 1943, BOT REV, V9, P325, DOI 10.1007/BF02872481; de Martonne E, 1926, METEOROLOGIE, V2, P449; DeByle N.V., 1985, RMGTR119 USDA FOR SE; DeRose RJ, 2014, FOREST SCI, V60, P1205, DOI 10.5849/forsci.13-507; Donnegan JA, 1999, ECOLOGY, V80, P1370, DOI 10.1890/0012-9658(1999)080[1370:RAMOSF]2.0.CO;2; Ferrenberg S, 2014, OECOLOGIA, V174, P1283, DOI 10.1007/s00442-013-2841-2; Fettig CJ, 2013, J FOREST, V111, P214, DOI 10.5849/jof.12-085; Garbarino M, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00342.1; GILLIES R. R., 2009, RANGELAND RESOURCES, P39; Grime J.P., 1988, PLANT EVOLUTIONARY B, P371, DOI DOI 10.1007/978-94-009-1207-6_14; HADLEY KS, 1993, CAN J FOREST RES, V23, P479, DOI 10.1139/x93-066; Harper J. L, 1977, POPULATION BIOL PLAN; HART GE, 1979, WATER RESOUR RES, V15, P1598, DOI 10.1029/WR015i006p01598; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Jactel H, 2007, ECOL LETT, V10, P835, DOI 10.1111/j.1461-0248.2007.01073.x; Janowiak MK, 2014, J FOREST, V112, P424, DOI 10.5849/jof.13-094; Johnson D. W., 2000, Plant Disease, V84, P595, DOI 10.1094/PDIS.2000.84.5.595D; Jorgensen S, 2002, AM J BOT, V89, P792, DOI 10.3732/ajb.89.5.792; Keane RE, 2010, P HIGH 5 S JUN 28 30; KEDDY PA, 1990, OIKOS, V59, P75, DOI 10.2307/3545125; Kendall K.C., 1983, BEARS BIOL MANAG, V5, P166, DOI [10.2307/3872534, DOI 10.2307/3872534]; Knapp PA, 1997, PROF GEOGR, V49, P39, DOI 10.1111/0033-0124.00054; Knight DH, 1976, POTENTIAL NATURAL LA; KNOWLES P, 1983, ECOLOGY, V64, P1, DOI 10.2307/1937322; Letts MG, 2009, CAN J FOREST RES, V81, P1425; Logan J.A., 2001, AM ENTOMOL, V47, P160; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; McCaughey WW, 1986, CONIFER TREE SEED IN, P50; McCutchen HE, 1996, GREAT BASIN NAT, V56, P90; Means R.E., 2011, FUTURE HIGH ELEVATIO, P47; Millar CI, 2007, CAN J FOREST RES, V37, P2508, DOI 10.1139/X07-097; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; Millar CI, 2015, CAN J FOREST RES, V45, P1299, DOI 10.1139/cjfr-2015-0025; Mock CJ, 1996, J CLIMATE, V9, P1111, DOI 10.1175/1520-0442(1996)009<1111:CCASVO>2.0.CO;2; Moyes AB, 2013, OECOLOGIA, V171, P271, DOI 10.1007/s00442-012-2410-0; Myers JA, 2011, ECOLOGY, V92, P676, DOI 10.1890/10-1001.1; OConnell B. M, 2015, FOREST INVENTORY ANA; Oliver C.D., 1996, FOREST STAND DYNAMIC; Peet R.K., 2000, N AM TERRESTRIAL VEG, P75; PEET RK, 1978, VEGETATIO, V37, P65, DOI 10.1007/BF00126830; Poorter L, 2007, AM NAT, V169, P433, DOI 10.1086/512045; PRISM Climate Group, 2004, 30 YEAR NORM; REBERTUS AJ, 1991, J VEG SCI, V2, P445, DOI 10.2307/3236026; REED RM, 1976, AM MIDL NAT, V95, P159, DOI 10.2307/2424242; Rigot T, 2014, ECOGRAPHY, V37, P648, DOI 10.1111/j.1600-0587.2013.00447.x; Rivas-Martinez S., 2004, GLOBAL BIOCLIMATICS; Rogers PC, 2014, FOREST SCI, V60, P345, DOI 10.5849/forsci.12-156; Romme WH, 2009, RANGELAND ECOL MANAG, V62, P203, DOI 10.2111/08-188R1.1; Sanders NJ, 2012, ECOGRAPHY, V35, P1, DOI 10.1111/j.1600-0587.2011.07338.x; Schoettle A, 2004, BREEDING GENETIC RES, P124; Schoettle AW, 2014, PHYTOPATHOLOGY, V104, P163, DOI 10.1094/PHYTO-04-13-0092-R; Schoettle AW, 2000, AM J BOT, V87, P1797, DOI 10.2307/2656832; Schuster WSF, 2000, HEREDITY, V84, P348, DOI 10.1046/j.1365-2540.2000.00684.x; Seidl R, 2014, BIOSCIENCE, V64, P1159, DOI 10.1093/biosci/biu172; Tomback DF, 2010, FOREST PATHOL, V40, P186, DOI 10.1111/j.1439-0329.2010.00655.x; Tomback DF, 2005, ECOSCIENCE, V12, P519, DOI 10.2980/i1195-6860-12-4-519.1; TOMBACK DF, 1990, EVOL ECOL, V4, P185, DOI 10.1007/BF02214330; Tomback DF, 2001, ROCKY MOUNTAIN FUTUR, P153; Tomback DF, 2011, US FOR SERV RMRS-P, V63, P2; Veblen TT, 1986, J TORREY BOT SOC, V113, P225, DOI DOI 10.2307/2996361; Wang SY, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036329; WHITTAKER RH, 1956, ECOL MONOGR, V26, P1, DOI 10.2307/1943577; Wise EK, 2012, PROG PHYS GEOG, V36, P458, DOI 10.1177/0309133312446538	76	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0160324	10.1371/journal.pone.0160324	http://dx.doi.org/10.1371/journal.pone.0160324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575596	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877200007
J	Sun, LY; Pereira, D; Wang, QB; Barata, DB; Truckenmuller, R; Li, ZY; Xu, X; Habibovic, P				Sun, Lanying; Pereira, Daniel; Wang, Qibao; Barata, David Baiao; Truckenmuller, Roman; Li, Zhaoyuan; Xu, Xin; Habibovic, Pamela			Controlling Growth and Osteogenic Differentiation of Osteoblasts on Microgrooved Polystyrene Surfaces	PLOS ONE			English	Article								Surface topography is increasingly being recognized as an important factor to control the response of cells and tissues to biomaterials. In the current study, the aim was to obtain deeper understanding of the effect of microgrooves on shape and orientation of osteoblast-like cells and to relate this effect to their proliferation and osteogenic differentiation. To this end, two microgrooved polystyrene (PS) substrates, differing in the width of the grooves (about 2 mu m and 4 mu m) and distance between individual grooves (about 6 mu m and 11 mu m, respectively) were fabricated using a combination of photolithography and hot embossing. MG-63 human osteosarcoma cells were cultured on these microgrooved surfaces, with unpatterned hot-embossed PS substrate as a control. Scanning electron-and fluorescence microscopy analyses showed that on patterned surfaces, the cells aligned along the microgrooves. The cells cultured on 4 mu m-grooves / 11 mu m-ridges surface showed a more pronounced alignment and a somewhat smaller cell area and cell perimeter as compared to cells cultured on surface with 2 mu m-grooves / 6 mu m-ridges or unpatterned PS. PrestoBlue analysis and quantification of DNA amounts suggested that microgrooves used in this experiment did not have a strong effect on cell metabolic activity or proliferation. However, cell differentiation towards the osteogenic lineage was significantly enhanced when MG-63 cells were cultured on the 2/6 substrate, as compared to the 4/11 substrate or unpatterned PS. This effect on osteogenic differentiation may be related to differences in cell spreading between the substrates.	[Sun, Lanying; Xu, Xin] Shandong Univ, Sch Stomatol, Shandong Prov Key Lab Oral Tissue Regenerat, Jinan, Shandong, Peoples R China; [Sun, Lanying; Wang, Qibao; Li, Zhaoyuan] Stomatol Hosp Jinan, Oral Implantol Ctr, Jinan, Shandong, Peoples R China; [Sun, Lanying; Pereira, Daniel; Barata, David Baiao; Truckenmuller, Roman; Habibovic, Pamela] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, Enschede, Overijssel, Netherlands; [Pereira, Daniel; Barata, David Baiao; Truckenmuller, Roman; Habibovic, Pamela] Maastricht Univ, MERLN Inst Technol Inspired Regenerat Med, Maastricht, Limburg, Netherlands	Shandong University; University of Twente; Maastricht University; Maastricht University Medical Centre (MUMC)	Xu, X (corresponding author), Shandong Univ, Sch Stomatol, Shandong Prov Key Lab Oral Tissue Regenerat, Jinan, Shandong, Peoples R China.; Habibovic, P (corresponding author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, Enschede, Overijssel, Netherlands.; Habibovic, P (corresponding author), Maastricht Univ, MERLN Inst Technol Inspired Regenerat Med, Maastricht, Limburg, Netherlands.	Xinxu@sdu.edu.cn; p.habibovic@maastrichtuniversity.nl	Barata, David/A-5750-2011	Barata, David/0000-0002-8753-7403; Truckenmuller, Roman/0000-0001-7541-525X; Habibovic, Pamela/0000-0001-8249-5155	Open Foundation of Shandong Provincial Key Laboratory of Oral Tissue Regeneration [SDKQ201504]; Sci-Tech Development Program of Jinan City [201221055]; Medical Sci-Tech Development Program of Jinan City [2008-30]; NIRM (Netherlands Institute of Regenerative Medicine); Dutch Province of Limburg	Open Foundation of Shandong Provincial Key Laboratory of Oral Tissue Regeneration; Sci-Tech Development Program of Jinan City; Medical Sci-Tech Development Program of Jinan City; NIRM (Netherlands Institute of Regenerative Medicine); Dutch Province of Limburg	This work was supported by the Open Foundation of Shandong Provincial Key Laboratory of Oral Tissue Regeneration (SDKQ201504, LS), the Sci-Tech Development Program of Jinan City (201221055, LS) and the Medical Sci-Tech Development Program of Jinan City (No. 2008-30, LS). DBB gratefully acknowledges the financial support of the NIRM (Netherlands Institute of Regenerative Medicine, PH). This research has been in part made possible with the support of the Dutch Province of Limburg (PH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBADIA Z, 1993, FEBS LETT, V335, P161, DOI 10.1016/0014-5793(93)80721-6; Advincula MC, 2006, BIOMATERIALS, V27, P2201, DOI 10.1016/j.biomaterials.2005.11.014; Anselme K, 2002, J BIOMEDICAL MAT RES, V60; Anselme K, 2006, J MAT SCI MAT MED, V17; Barata D, 2016, J MAT CHEM B, V4; Barrere F., 2006, INT J NANOMEDICINE, P1; Brunette DM, 1986, EXPT CELL RES, V164; Charest JL, 2004, BIOMATERIALS, V25, P4767, DOI 10.1016/j.biomaterials.2003.12.011; Chen X, 2013, BIOMATERIALS, V34; Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0; Czekanska EM, 2012, EUROPEAN CELLS MAT, V24; den Braber ET, 1996, BIOMATERIALS, V17; Ergun A, 2012, ANN BIOMEDICAL ENG, V40; Erisken C, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/16/165302; Feighan JE, 1995, J BONE JOINT SURG, V77; Franssila S, 2010, INTRO MICROFABRICATI; Grew JC, 2008, J BIOMEDICAL MAT R A, V85; Hayman MW, 2004, BIOCH BIOPHYSICAL RE, V314; Holthaus MG, 2012, ACTA BIOMATERIALIA, V8; Honda Y, 2006, BIOCH BIOPHYSICAL RE, V345; Huang HH, 2004, BIOMOLECULAR ENG, V21; Ismail FS, 2007, J MAT SCI MAT MED, V18; Jiang L, 2012, MAT SCI ENG C, V32; Kenar H, 2006, BIOMATERIALS, V27, P885, DOI 10.1016/j.biomaterials.2005.07.001; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Lajeunesse D, 1994, BONE MINERAL, V24; le Digabel J, 2010, MED BIOL ENG COMPUT, V48, P965, DOI 10.1007/s11517-010-0619-9; Li J, 2014, BIOCH BIOPHYSICAL RE, V444; Liu X, 2007, BIOMATERIALS, V28; Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030; Lu X, 2003, J BIOMEDICAL MAT R A, V66; Madou M., 2002, FUNDAMENTALS MICROFA; Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0; Matsuzaka K, 2000, CLIN ORAL IMPLANTS R, V11; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Nikkhah M, 2012, BIOMATERIALS, V33; Ozkan S, 2010, J BIOMEDICAL MAT R A, V92; Raimbault O, 2016, MAT SCI ENG C, P69; Ricci JL, 2008, J BIOMEDICAL MAT R A, V85; Rosen V., 2009, CYTOKINE GROWTH FACT, V20; Seyedjafari E, 2010, BIOMACROMOLECULES, V11, P3118, DOI 10.1021/bm1009238; Siggelkow H, 1999, J CELLULAR BIOCH, V75; Song W, 2011, J NANOMATER, V2011, DOI 10.1155/2011/265251; Sun L, 2016, ACTA BIOMATERIALIA; Suzuki K, 1997, BONE, V21, P507, DOI 10.1016/S8756-3282(97)00204-4; Tan J, 2004, BIOMATERIALS, V25, P3593, DOI 10.1016/j.biomaterials.2003.10.034; Thakar RG, 2003, BIOCH BIOPHYSICAL RE, V307; Tsimbouri PM, 2013, BIOMATERIALS, V34; Walboomers XF, 1998, BIOMATERIALS, V19, P1861, DOI 10.1016/S0142-9612(98)00093-3; Wiontzek M, 2006, CLIN EXPT RHEUMATOLO, V24; Yang S, 2012, MAT SCI ENG C, V32; Zhou F, 2009, CHINESE SCI B, V54	52	19	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161466	10.1371/journal.pone.0161466	http://dx.doi.org/10.1371/journal.pone.0161466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571520	Green Published, Green Submitted, gold			2022-12-26	WOS:000382876700020
J	Foolen, J; Shiu, JY; Mitsi, M; Zhang, Y; Chen, CS; Vogel, V				Foolen, Jasper; Shiu, Jau-Ye; Mitsi, Maria; Zhang, Yang; Chen, Christopher S.; Vogel, Viola			Full-Length Fibronectin Drives Fibroblast Accumulation at the Surface of Collagen Microtissues during Cell-Induced Tissue Morphogenesis	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; MIGRATION; FORCES; CONTRACTILITY; BINDING; STRESS; MODEL; ALPHA(5)BETA(1); POLYMERIZATION; RECEPTOR	Generating and maintaining gradients of cell density and extracellular matrix (ECM) components is a prerequisite for the development of functionality of healthy tissue. Therefore, gaining insights into the drivers of spatial organization of cells and the role of ECM during tissue morphogenesis is vital. In a 3D model system of tissue morphogenesis, a fibronectin-FRET sensor recently revealed the existence of two separate fibronectin populations with different conformations in microtissues, i.e. 'compact and adsorbed to collagen' versus 'extended and fibrillar' fibronectin that does not colocalize with the collagen scaffold. Here we asked how the presence of fibronectin might drive this cell-induced tissue morphogenesis, more specifically the formation of gradients in cell density and ECM composition. Microtissues were engineered in a high-throughput model system containing rectangular microarrays of 12 posts, which constrained fibroblast-populated collagen gels, remodeled by the contractile cells into trampoline-shaped microtissues. Fibronectin's contribution during the tissue maturation process was assessed using fibronectin-knockout mouse embryonic fibroblasts (Fn(-/-) MEFs) and floxed equivalents (Fn(f/f) MEFs), in fibronectin-depleted growth medium with and without exogenously added plasma fibronectin (full-length, or various fragments). In the absence of full-length fibronectin, Fn(-/-)MEFs remained homogenously distributed throughout the cell-contracted collagen gels. In contrast, in the presence of full-length fibronectin, both cell types produced shell-like tissues with a predominantly cell-free compacted collagen core and a peripheral surface layer rich in cells. Single cell assays then revealed that Fn(-/-) MEFs applied lower total strain energy on nanopillar arrays coated with either fibronectin or vitronectin when compared to Fnf/f MEFs, but that the presence of exogenously added plasma fibronectin rescued their contractility. While collagen decoration of single fibronectin fibers enhanced the non-persistent migration of both Fnf/f and Fn(-/-)MEFs, the migration speed was increased for Fn(-/-)MEFs on plasma fibronectin fibers compared to Fn(f/f) MEFs. In contrast, the average speed was the same for all cells on collagen-coated Fn fibers. A Fn-FRET sensor revealed that fibronectin on average was more extended on the microtissue surface compared to fibronectin in the core. Gradients of collagen-to-fibronectin ratios and of the fraction of collagen-adsorbed to stretched fibrillar fibronectin conformations might thereby provide critical cell migration cues. This study highlights a dominant role for fibronectin in tissue morphogenesis and the development of tissue heterogeneities.	[Foolen, Jasper; Shiu, Jau-Ye; Mitsi, Maria; Zhang, Yang; Vogel, Viola] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Lab Appl Mechanobiol, Vladimir Prelog Weg 4, Zurich, Switzerland; [Chen, Christopher S.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Chen, Christopher S.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Mitsi, Maria] Paul Scherrer Inst, Villigen, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Boston University; Harvard University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Foolen, J (corresponding author), Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Lab Appl Mechanobiol, Vladimir Prelog Weg 4, Zurich, Switzerland.	jasper.foolen@hest.ethz.ch	Chen, Christopher S./ABD-8499-2021; Vogel, Viola/O-8025-2015; Mitsi, Maria/S-2519-2017	Chen, Christopher S./0000-0003-2445-8449; Vogel, Viola/0000-0003-2898-7671; Mitsi, Maria/0000-0001-8983-1983; Foolen, Jasper/0000-0002-1065-7423	European Union Seventh Framework Programme (FP7) [PIEF-GA-2013-628585]; Competence Center for Materials Science and Technology CCMX [0-21108-11]; NIH [GM74048]; RESBIO Technology Resource for Polymeric Biomaterials; SwissTransMed [33/2013]; NCCR Molecular Systems Engineering; European Research Council ERC advanced Grant [233157]; Swiss National Science Foundation [SNF-310030B_133122]	European Union Seventh Framework Programme (FP7); Competence Center for Materials Science and Technology CCMX; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RESBIO Technology Resource for Polymeric Biomaterials; SwissTransMed; NCCR Molecular Systems Engineering; European Research Council ERC advanced Grant(European Research Council (ERC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The following funding sources are furthermore acknowledged: The research performed by Jasper Foolen leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. PIEF-GA-2013-628585 (JF); the Competence Center for Materials Science and Technology CCMX, Grant 0-21108-11 (MM); NIH grant GM74048 and the RESBIO Technology Resource for Polymeric Biomaterials (CC); SwissTransMed grant 33/2013 LifeMatrix (VV); NCCR Molecular Systems Engineering (VV); European Research Council ERC advanced Grant 233157 (VV); Swiss National Science Foundation, Grant SNF-310030B_133122 (VV).	ASAGA H, 1991, EXP CELL RES, V193, P167, DOI 10.1016/0014-4827(91)90552-6; Baneyx G, 2002, P NATL ACAD SCI USA, V99, P5139, DOI 10.1073/pnas.072650799; Baugh L, 2004, J BIOMED MATER RES A, V69A, P525, DOI 10.1002/jbm.a.30026; Bellas E, 2014, CURR OPIN CELL BIOL, P3192; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Brekhman V, 2009, BMC CANCER, P9415; Brown RA, 1996, J CELL PHYSIOL, V169, P439, DOI 10.1002/(SICI)1097-4652(199612)169:3<439::AID-JCP4>3.0.CO;2-P; Chabria M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1135; Cho NS, 2011, CLIN ORTHOP RELAT R, V469, P3172, DOI 10.1007/s11999-011-2000-1; da Rocha-Azevedo B, 2013, EXP CELL RES, V319, P2440, DOI 10.1016/j.yexcr.2013.05.003; Dijkman PE, 2012, BIOMATERIALS, V33, P4545, DOI 10.1016/j.biomaterials.2012.03.015; Doras C, 2011, OPT EXPRESS, V19, P15062, DOI 10.1364/OE.19.015062; Fernandez-Sanchez ME, 2015, ANNU REV CELL DEV BI, P31373; Fontana L, 2005, FASEB J, V19, P1798, DOI 10.1096/fj.05-4134com; Foolen J, 2012, BIOMATERIALS, V33, P7508, DOI 10.1016/j.biomaterials.2012.06.103; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Grinnell F, 2006, EXP CELL RES, V312, P86, DOI 10.1016/j.yexcr.2005.010.001; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Hertig S, 2012, NANO LETT, V12, P5162, DOI 10.1021/nl302153h; Hocking DC, 2000, J BIOL CHEM, V275, P10673, DOI 10.1074/jbc.275.14.10673; Hocking DC, 2003, AM J PHYSIOL-LUNG C, V285, pL169, DOI 10.1152/ajplung.00371.2002; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; KNOX P, 1986, J CELL BIOL, V102, P2318, DOI 10.1083/jcb.102.6.2318; Kosmehl H, 1996, VIRCHOWS ARCH, V429, P311; Kubow KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9026; Kubow KE, 2009, INTEGR BIOL-UK, V1, P635, DOI 10.1039/b914996a; Kuo CW, 2010, ELECTROPHORESIS, V31, P3152, DOI 10.1002/elps.201000212; Legant WR, 2012, INTEGR BIOL-UK, V4, P1164, DOI 10.1039/c2ib20059g; Legant WR, 2009, P NATL ACAD SCI USA, V106, P10097, DOI 10.1073/pnas.0900174106; Lemmon CA, 2009, BIOPHYS J, V96, P729, DOI 10.1016/j.bpj.2008.10.009; Li B, 2013, SCI REP, P32425; Little WC, 2008, MATRIX BIOL, V27, P451, DOI 10.1016/j.matbio.2008.02.003; Liu J, 2013, J TISSUE ENG REGEN M, DOI [10.1002/term, DOI 10.1002/TERM]; Lutz R, 2010, J CELL SCI, V123, P1511, DOI 10.1242/jcs.060905; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; MARSHALL JF, 1995, J CELL SCI, V108, P1227; Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282; Mitsi M, 2006, BIOCHEMISTRY-US, V45, P10319, DOI 10.1021/bi060974p; Mitsi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145210; Mol A, 2005, BIOMATERIALS, V26, P3113, DOI 10.1016/j.biomaterials.2004.08.007; Murrell M, 2015, NAT REV MOL CELL BIO, V16, P486, DOI 10.1038/nrm4012; NICOSIA RF, 1993, J CELL PHYSIOL, V154, P654, DOI 10.1002/jcp.1041540325; Obbink-Huizer C, 2014, BIOMECH MODEL MECHAN; Obbink-Huizer C, 2014, BIOMECH MODEL MECHAN, V13, P1053, DOI 10.1007/s10237-014-0554-z; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pujadas S, 2005, Heart, V91, P582, DOI 10.1136/hrt.2004.041327; Rajagopalan P, 2004, BIOPHYS J, V87, P2818, DOI 10.1529/biophysj.103.037218; Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613; Roca-Cusachs P, 2009, P NATL ACAD SCI USA, V106, P16245, DOI 10.1073/pnas.0902818106; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; RUOSLAHTI E, 1981, J BIOL CHEM, V256, P7277; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Sakar MS, 2016, NAT COMMUN; Schiller HB, 2013, NAT CELL BIOL, V15, P625, DOI 10.1038/ncb2747; SCHWARZBAUER JE, 1991, J CELL BIOL, V113, P1463, DOI 10.1083/jcb.113.6.1463; Seong J, 2013, P NATL ACAD SCI USA, V110, P19372, DOI 10.1073/pnas.1307405110; Sevilla CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077316; Sevilla CA, 2010, TISSUE ENG PT A, V16, P3805, DOI [10.1089/ten.tea.2010.0316, 10.1089/ten.TEA.2010.0316]; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; Sniadecki NJ, 2007, P NATL ACAD SCI USA, V104, P14553, DOI 10.1073/pnas.0611613104; Sottile J, 2007, AM J PHYSIOL-CELL PH, V293, pC1934, DOI 10.1152/ajpcell.00130.2007; To WS, 2011, TISSUE REPAIR, P421; Van Obberghen-Schilling E, 2011, INT J DEV BIOL, V55, P511, DOI 10.1387/ijdb.103243eo; van Spreeuwel ACC, 2014, INTEGR BIOL-UK, V6, P422, DOI 10.1039/c3ib40219c; Vaz R, 2012, CELL TISSUE RES, V348, P569, DOI 10.1007/s00441-012-1364-1; Vogel V., 2006, ANNU REV BIOPH BIOM, P35459; WEBER KT, 1990, CIRCULATION, V82, P1387, DOI 10.1161/01.CIR.82.4.1387; White ES, 2008, J PATHOL, V216, P1, DOI 10.1002/path.2388; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Yang MT, 2011, INTEGR BIOL-UK, V3, P663, DOI 10.1039/c0ib00156b; Yousif NG, 2014, CELL BIOL INT, V38, P85, DOI 10.1002/cbin.10184; Yu CH, 2011, P NATL ACAD SCI USA, V108, P20585, DOI 10.1073/pnas.1109485108; Zhang Y, 2014, MATRIX BIOL, V40, P62, DOI 10.1016/j.matbio.2014.09.001; ZHANG ZH, 1995, P NATL ACAD SCI USA, V92, P6161, DOI 10.1073/pnas.92.13.6161; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539; Zhu J, 2014, J INVEST DERMATOL, V134, P895, DOI 10.1038/jid.2013.484	77	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0160369	10.1371/journal.pone.0160369	http://dx.doi.org/10.1371/journal.pone.0160369			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564551	Green Published, gold, Green Submitted			2022-12-26	WOS:000382496300003
J	Kokabu, T; Sudo, H; Abe, Y; Ito, M; Ito, YM; Iwasaki, N				Kokabu, Terufumi; Sudo, Hideki; Abe, Yuichiro; Ito, Manabu; Ito, Yoichi M.; Iwasaki, Norimasa			Effects of Multilevel Facetectomy and Screw Density on Postoperative Changes in Spinal Rod Contour in Thoracic Adolescent Idiopathic Scoliosis Surgery	PLOS ONE			English	Article							PEDICLE SCREW; CURVE-CORRECTION; ROTATION TECHNIQUE; SURGICAL-TREATMENT; KYPHOSIS; INSTRUMENTATION; MAINTENANCE; CONSTRUCTS; DEFORMITY	Flattening of the preimplantation rod contour in the sagittal plane influences thoracic kyphosis (TK) restoration in adolescent idiopathic scoliosis (AIS) surgery. The effects of multilevel facetectomy and screw density on postoperative changes in spinal rod contour have not been documented. This study aimed to evaluate the effects of multilevel facetectomy and screw density on changes in spinal rod contour from before implantation to after surgical correction of thoracic curves in patients with AIS prospectively. The concave and convex rod shapes from patients with thoracic AIS (n = 49) were traced prior to insertion. Postoperative sagittal rod shape was determined by computed tomography. The angle of intersection of the tangents to the rod end points was measured. Multiple stepwise linear regression analysis was used to identify variables independently predictive of change in rod contour (Delta theta). Average Delta theta at the concave and convex side were 13.6 degrees +/- 7.5 degrees and 4.3 degrees +/- 4.8 degrees, respectively. The Delta theta at the concave side was significantly greater than that of the convex side (P < 0.0001) and significantly correlated with Risser sign (P = 0.032), the preoperative main thoracic Cobb angle (P = 0.031), the preoperative TK angle (P = 0.012), and the number of facetectomy levels (P = 0.007). Furthermore, a Delta theta at the concave side +/- 14 degrees significantly correlated with the postoperative TK angle (P = 0.003), the number of facetectomy levels (P = 0.021), and screw density at the concave side (P = 0.008). Rod deformation at the concave side suggests that corrective forces acting on that side are greater than on the convex side. Multilevel facetectomy and/or screw density at the concave side have positive effects on reducing the rod deformation that can lead to a loss of TK angle postoperatively.	[Kokabu, Terufumi; Sudo, Hideki; Iwasaki, Norimasa] Hokkaido Univ Hosp, Dept Orthopaed Surg, Sapporo, Hokkaido, Japan; [Abe, Yuichiro] Eniwa Hosp, Eniwa, Hokkaido, Japan; [Ito, Manabu] Hokkaido Med Ctr, Dept Spine & Spinal Cord Disorders, Sapporo, Hokkaido, Japan; [Ito, Yoichi M.] Hokkaido Univ, Grad Sch Med, Dept Biostat, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Sudo, H (corresponding author), Hokkaido Univ Hosp, Dept Orthopaed Surg, Sapporo, Hokkaido, Japan.	hidekisudo@yahoo.co.jp	Sudo, Hideki/G-2748-2012	Ito, Yoichi M./0000-0001-5073-0827				Abe Y, 2015, SCOLIOSIS SPINAL DIS, V10, DOI 10.1186/1748-7161-10-S2-S2; Bharucha NJ, 2013, SPINE J, V13, P375, DOI 10.1016/j.spinee.2012.05.029; Cidambi KR, 2012, SPINE, V37, P1566, DOI 10.1097/BRS.0b013e318252ccbe; Delorme S, 2000, J SPINAL DISORD, V13, P93, DOI 10.1097/00002517-200004000-00001; Halanski MA, 2013, J SPINAL DISORD TECH, V26, P252, DOI 10.1097/BSD.0b013e318241e3cf; Ito M, 2010, J NEUROSURG-SPINE, V12, P293, DOI 10.3171/2009.9.SPINE09377; Kim YJ, 2006, SPINE, V31, P291, DOI 10.1097/01.brs.0000197865.20803.d4; Larson AN, 2014, SPINE, V39, P571, DOI 10.1097/BRS.0000000000000204; Le Naveaux F, 2015, SPINE, V40, P462, DOI 10.1097/BRS.0000000000000793; Liu H, 2015, J NEUROSURG-SPINE, V22, P259, DOI 10.3171/2014.10.SPINE1496; Lonner BS, 2012, SPINE, V37, P1297, DOI 10.1097/BRS.0b013e318247e9a6; Lowenstein JE, 2007, SPINE, V32, P448, DOI 10.1097/01.brs.0000255030.78293.fd; Newton PO, 2010, SPINE, V35, P1365, DOI 10.1097/BRS.0b013e3181dccd63; Roussouly P, 2010, EUR SPINE J, V19, P1824, DOI 10.1007/s00586-010-1476-9; Salmingo RA, 2014, SPINE J, V14, P1432, DOI 10.1016/j.spinee.2013.08.042; Sudo H, SPINE J; Sudo H, 2016, EUR SPINE J, V25, P569, DOI 10.1007/s00586-015-4139-z; Sudo H, 2014, SPINE, V39, P1163, DOI 10.1097/BRS.0000000000000364; WINTER RB, 1975, J BONE JOINT SURG AM, V57, P972, DOI 10.2106/00004623-197557070-00016	19	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161906	10.1371/journal.pone.0161906	http://dx.doi.org/10.1371/journal.pone.0161906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564683	gold, Green Submitted, Green Published			2022-12-26	WOS:000382496300036
J	Akulenko, R; Merl, M; Helms, V				Akulenko, Ruslan; Merl, Markus; Helms, Volkhard			BEclear: Batch Effect Detection and Adjustment in DNA Methylation Data	PLOS ONE			English	Article							POSITIVE BREAST-CANCER; H-RAS; EXPRESSION; GENES; CELLS; MICROARRAYS; ONCOGENE; P53	Batch effects describe non-natural variations of, for example, large-scale genomic data sets. If not corrected by suitable numerical algorithms, batch effects may seriously affect the analysis of these datasets. The novel array platform independent software tool BEclear enables researchers to identify those portions of the data that deviate statistically significant from the remaining data and to replace these portions by typical values reconstructed from neighboring data entries based on latent factor models. In contrast to other comparable methods that often use some sort of global normalization of the data, BEclear avoids changing the apparently unaffected parts of the data. We tested the performance of this approach on DNA methylation data for various tumor data sets taken from The Cancer Genome Atlas and compared the results to those obtained with the existing algorithms ComBat, Surrogate Variable Analysis, RUVm and Functional normalization. BEclear constantly performed at par with or better than these methods. BEclear is available as an R package at the Bioconductor project http://bioconductor.org/packages/release/bioc/html/BEclear.html.	[Akulenko, Ruslan; Merl, Markus; Helms, Volkhard] Univ Saarland, Ctr Bioinformat, Saarbrucken, Germany; [Akulenko, Ruslan] Univ Saarland, Grad Sch Comp Sci, Saarbrucken, Germany	Saarland University; Saarland University	Helms, V (corresponding author), Univ Saarland, Ctr Bioinformat, Saarbrucken, Germany.	volkhard.helms@bioinformatik.uni-saarland.de		Helms, Volkhard/0000-0002-2180-9154	Deutsche Forschungsgemeinschaft [HE3875/12-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (HE3875/12-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The project was supported by Deutsche Forschungsgemeinschaft (HE3875/12-1).	Akulenko R, 2013, HUM MOL GENET, V22, P3016, DOI 10.1093/hmg/ddt158; Alluri PG, 2014, CELL RES, V24, P899, DOI 10.1038/cr.2014.90; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Ashraf N, 2006, BRIT J CANCER, V95, P1056, DOI 10.1038/sj.bjc.6603384; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; BIRNBAUM ZW, 1951, ANN MATH STAT, V22, P592, DOI 10.1214/aoms/1177729550; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Bushel P., PVCA PRINCIPAL VARIA; Candes E, 2012, COMMUN ACM, V55, P111, DOI 10.1145/2184319.2184343; Chambers JM., 1992, STAT MODELS S; Chanock SJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1637; Conover W.J., 1971, PRACTICAL NONPARAMET, P295; Dreos R, 2015, NUCLEIC ACIDS RES, V43, pD92, DOI 10.1093/nar/gku1111; Durbin J., 1973, SOC IND APPL MATH; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Fortin JP, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0503-2; Guo ZK, 2007, MOL BIOL REP, V34, P137, DOI 10.1007/s11033-006-9023-9; Hamed M, 2015, INFECT GENET EVOL, V36, P475, DOI 10.1016/j.meegid.2015.08.020; Hayes NVL, 2007, CLIN CANCER RES, V13, P3147, DOI 10.1158/1078-0432.CCR-06-2237; Hoenerhoff MJ, 2009, ONCOGENE, V28, P3022, DOI 10.1038/onc.2009.165; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kelley MJ, 2001, J NATL CANCER I, V93, P1886, DOI 10.1093/jnci/93.24.1886; Klein C, 2001, J BIOL CHEM, V276, P37390, DOI 10.1074/jbc.M103801200; Koren Y, 2009, COMPUTER, V42, P30, DOI 10.1109/MC.2009.263; Kuemmerle NB, 2011, MOL CANCER THER, V10, P427, DOI 10.1158/1535-7163.MCT-10-0802; Lazar C, 2013, BRIEF BIOINFORM, V14, P469, DOI 10.1093/bib/bbs037; Leek JT, SVA SURROGATE VARIAB; Li J, 2013, STAT METHODS MED RES, V22, P519, DOI 10.1177/0962280211428386; Lim JY, 2012, WORLD J GASTROENTERO, V18, P5581, DOI 10.3748/wjg.v18.i39.5581; Maksimovic J, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv526; Marsaglia G., 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i18, DOI 10.18637/JSS.V008.I18]; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Parker HS, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1766; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; RORABACHER DB, 1991, ANAL CHEM, V63, P139, DOI 10.1021/ac00002a010; Ruffing U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052487; Strauss L, 2016, J CLIN MICROBIOL, V54, P1008, DOI 10.1128/JCM.03022-15; Sun ZF, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-84; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang X, 2008, BREAST CANCER RES TR, V111, P103, DOI 10.1007/s10549-007-9765-7; WATSON DMA, 1991, BREAST CANCER RES TR, V17, P161, DOI 10.1007/BF01806365	43	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0159921	10.1371/journal.pone.0159921	http://dx.doi.org/10.1371/journal.pone.0159921			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27559732	gold, Green Published, Green Submitted			2022-12-26	WOS:000382258600007
J	Chen, YH; Zhao, YY; Qin, B; Liu, T				Chen, Yiheng; Zhao, Yanyan; Qin, Bing; Liu, Ting			Product Aspect Clustering by Incorporating Background Knowledge for Opinion Mining	PLOS ONE			English	Article								Product aspect recognition is a key task in fine-grained opinion mining. Current methods primarily focus on the extraction of aspects from the product reviews. However, it is also important to cluster synonymous extracted aspects into the same category. In this paper, we focus on the problem of product aspect clustering. The primary challenge is to properly cluster and generalize aspects that have similar meanings but different representations. To address this problem, we learn two types of background knowledge for each extracted aspect based on two types of effective aspect relations: relevant aspect relations and irrelevant aspect relations, which describe two different types of relationships between two aspects. Based on these two types of relationships, we can assign many relevant and irrelevant aspects into two different sets as the background knowledge to describe each product aspect. To obtain abundant background knowledge for each product aspect, we can enrich the available information with background knowledge from the Web. Then, we design a hierarchical clustering algorithm to cluster these aspects into different groups, in which aspect similarity is computed using the relevant and irrelevant aspect sets for each product aspect. Experimental results obtained in both camera and mobile phone domains demonstrate that the proposed product aspect clustering method based on two types of background knowledge performs better than the baseline approach without the use of background knowledge. Moreover, the experimental results also indicate that expanding the available background knowledge using the Web is feasible.	[Chen, Yiheng; Qin, Bing; Liu, Ting] Harbin Inst Technol, Dept Comp Sci & Technol, Harbin, Peoples R China; [Zhao, Yanyan] Harbin Inst Technol, Dept Media Technol & Art, Harbin, Peoples R China	Harbin Institute of Technology; Harbin Institute of Technology	Zhao, YY (corresponding author), Harbin Inst Technol, Dept Media Technol & Art, Harbin, Peoples R China.	yyzhao@ir.hit.edu.cn	liu, ting/GZM-3326-2022; zhao, yanyan/AIC-1784-2022	Zhao, Yanyan/0000-0001-5852-7962	National Natural Science Foundation of China (NSFC) [61202277, 61300113, 61273321]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (NSFC) via grant 61202277, 61300113 and 61273321.	Bloom K., 2007, P HLT NAACL, V2007, P308; Bo Pang, 2008, Foundations and Trends in Information Retrieval, V2, P1, DOI 10.1561/1500000001; Branavan S. R. K., 2008, ACL, P263; Chen ZY, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P347; Deng Z, 2016, IEEE T FUZZY SYSTEM; Havens TC, 2012, IEEE T FUZZY SYST, V20, P1130, DOI 10.1109/TFUZZ.2012.2201485; Hsieh Wen-Tai, 2012, P ACL 2012 SYST DEM, P163; Hu M., 2004, P 10 ACM SIGKDD INT, P168, DOI DOI 10.1145/1014052.1014073; Jakob N., 2010, P 2010 C EMP METH NA, P1035; Jiang YZ, 2015, IEEE T CYBERNETICS, V45, P688, DOI 10.1109/TCYB.2014.2334595; Kim Soo-Min, 2006, P WORKSHOP SENTIMENT, P1, DOI DOI 10.3115/1654641.1654642; Li S., 2012, P AAAI, P1671; Liu B, 2006, WEB DATA MINING EXPL; Liu B., 2012, SENTIMENT ANAL OPINI; Liu B, 2005, WWW, P342, DOI DOI 10.1145/1060745.1060797; Liu K, 2013, ACL, V1, P1754; Liu K, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P314; Mohammad Saif, 2013, P 7 INT WORKSH SEM E; Mukherjee A., 2012, P 50 ANN M ASS COMPU, V1, P339; Pang B, 2002, PROCEEDINGS OF THE 2002 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING, P79, DOI 10.3115/1118693.1118704; Qiu GA, 2011, COMPUT LINGUIST, V37, P9, DOI 10.1162/coli_a_00034; Reschke K, 2013, P 51 ANN M ASS COMP, V2, P499; Sauper Christina, 2011, P 49 ANN M ASS COMPU, P350; Schutze H., 2008, INTRO INFORM RETRIEV, V39; Titov Ivan, 2008, P ANN M ASS COMP LIN, P308; Turney PD, 2004, SENSEVAL 3; Velikovich L., 2010, HUMAN LANGUAGE TECHN, P777, DOI DOI 10.1056/NEJM199902113400601; Wei W, 2010, ACL 2010: 48TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, P404; Woodsend K., 2012, EMNLP CONLL 12 P 201, P233; Xu LH, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P336; Yang B., 2013, P ACL, V1, P1640; Yang F, 2009, P ASS COMPUTATIONAL; Yu J., 2011, P 49 C ASS COMP LING, P1496, DOI DOI 10.1109/CC.2013.6488828; Zhai Z, 2011, P 4 ACM INT C WEB SE, P347, DOI DOI 10.1145/1935826.1935884; Zhai ZW, 2012, IEEE INTELL SYST, V27, P37, DOI 10.1109/MIS.2011.38; Zhao Y., 2010, HUMAN LANGUAGE TECHN, P377; Zhao Yan-Yan, 2010, Journal of Software, V21, P1834, DOI 10.3724/SP.J.1001.2010.03832; Zhao YY, 2014, LECT NOTES COMPUT SC, V8801, P120, DOI 10.1007/978-3-319-12277-9_11; Zhou X., 2013, P 2013 C EMP METH NA, V13, P1840	39	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0159901	10.1371/journal.pone.0159901	http://dx.doi.org/10.1371/journal.pone.0159901			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27561001	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258600006
J	Liu, F; Xu, YJ; Han, GM; Zhou, LY; Ali, A; Zhu, SW; Li, XY				Liu, Fang; Xu, Yunjian; Han, Guomin; Zhou, Lingyan; Ali, Asif; Zhu, Suwen; Li, Xiaoyu			Molecular Evolution and Genetic Variation of G2-Like Transcription Factor Genes in Maize	PLOS ONE			English	Article							SHOOT APEX; EXPRESSION; ARABIDOPSIS; PROTEINS; DIFFERENTIATION; BIOGENESIS; REGULATORS; DYNAMICS; ELEMENTS; PAIRS	The productivity of maize (Zea mays L.) depends on the development of chloroplasts, and G2-like transcription factors play a central role in regulating chloroplast development. In this study, we identified 59 G2-like genes in the B73 maize genome and systematically analyzed these genes at the molecular and evolutionary levels. Based on gene structure character, motif compositions and phylogenetic analysis, maize G2-like genes (ZmG1-ZmG59) were divided into seven groups (I-VII). By synteny analysis, 18 collinear gene pairs and strongly conserved microsyntny among regions hosting G2-like genes across maize and sorghum were found. Here, we showed that the vast majority of ZmG gene duplications resulted from whole genome duplication events rather than tandem duplications. After gene duplication events, some ZmG genes were silenced. The functions of G2-like genes were multifarious and most genes that are expressed in green tissues may relate to maize photosynthesis. The qRT-PCR showed that the expression of these genes was sensitive to low temperature and drought. Furthermore, we analyzed differences of ZmGs specific to cultivars in temperate and tropical regions at the population level. Interestingly, the single nucleotide polymorphism (SNP) analysis revealed that nucleotide polymorphism associated with different temperature zones. Above all, G2-like genes were highly conserved during evolution, but polymorphism could be caused due to a different geographical location. Moreover, G2-like genes might be related to cold and drought stresses.	[Liu, Fang; Xu, Yunjian; Han, Guomin; Zhou, Lingyan; Ali, Asif; Zhu, Suwen; Li, Xiaoyu] Anhui Agr Univ, Key Lab Crop Biol Anhui Prov, Hefei, Peoples R China	Anhui Agricultural University	Li, XY (corresponding author), Anhui Agr Univ, Key Lab Crop Biol Anhui Prov, Hefei, Peoples R China.	lixiaoyu@ahau.edu.cn	li, xiao/GSN-6181-2022; li, xiaofeng/GXF-9442-2022					Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Becker SFS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085717; Bravo-Garcia A, 2009, NEW PHYTOL, V183, P133, DOI 10.1111/j.1469-8137.2009.02829.x; Charuvi D, 2012, PLANT CELL, V24, P1143, DOI 10.1105/tpc.111.094458; Cinquin O, 2005, J THEOR BIOL, V233, P391, DOI 10.1016/j.jtbi.2004.10.027; Douglas SE, 1998, CURR OPIN GENET DEV, V8, P655, DOI 10.1016/S0959-437X(98)80033-6; Eberhard S, 2008, ANNU REV GENET, V42, P463, DOI 10.1146/annurev.genet.42.110807.091452; Fitter DW, 2002, PLANT J, V31, P713, DOI 10.1046/j.1365-313X.2002.01390.x; Gao HB, 2003, P NATL ACAD SCI USA, V100, P4328, DOI 10.1073/pnas.0530206100; Hall LN, 1998, PLANT CELL, V10, P925, DOI 10.1105/tpc.10.6.925; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; HUDSON RR, 1990, SCIENCE, V250, P575, DOI 10.1126/science.250.4980.575; Jarvis P, 2013, NAT REV MOL CELL BIO, V14, P787, DOI 10.1038/nrm3702; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Kretschmer M, 2014, INFECT IMMUN, V82, P2697, DOI 10.1128/IAI.01607-14; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; La Marca M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083538; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lopez-Juez E, 2005, INT J DEV BIOL, V49, P557, DOI 10.1387/ijdb.051997el; Lopez-Juez E, 2008, PLANT CELL, V20, P947, DOI 10.1105/tpc.107.057075; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Moreira D, 2000, NATURE, V405, P69, DOI 10.1038/35011054; Murmu J, 2014, MOL PLANT PATHOL, V15, P174, DOI 10.1111/mpp.12077; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Neuhaus HE, 2000, ANNU REV PLANT PHYS, V51, P111, DOI 10.1146/annurev.arplant.51.1.111; Parente DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084398; Park J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085221; Powell ALT, 2012, SCIENCE, V336, P1711, DOI 10.1126/science.1222218; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Rossini L, 2001, PLANT CELL, V13, P1231, DOI 10.1105/tpc.13.5.1231; Savitch LV, 2005, PLANT CELL PHYSIOL, V46, P1525, DOI 10.1093/pcp/pci165; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sekhon RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061005; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Seu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084091; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan XP, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-56; Tang WJ, 2012, PLANT CELL, V24, P1984, DOI 10.1105/tpc.112.097022; Wang P, 2013, PLANTA, V237, P481, DOI 10.1007/s00425-012-1754-3; Wang Y, 2012, NUCLEIC ACIDS RES, V40, P11155, DOI 10.1093/nar/gks840; Waters MT, 2009, EMBO J, V28, P2861, DOI 10.1038/emboj.2009.264; Waters MT, 2009, PLANT CELL, V21, P1109, DOI 10.1105/tpc.108.065250; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yang ZF, 2008, GENOMICS, V92, P246, DOI 10.1016/j.ygeno.2008.06.001; Yasumura Y, 2005, PLANT CELL, V17, P1894, DOI 10.1105/tpc.105.033191	48	20	25	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161763	10.1371/journal.pone.0161763	http://dx.doi.org/10.1371/journal.pone.0161763			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560803	Green Submitted, gold, Green Published			2022-12-26	WOS:000382258600093
J	Pan, XX; Ouyang, Y; Wang, ZH; Ren, H; Shen, PY; Wang, WM; Xu, YW; Ni, LY; Yu, XL; Chen, XN; Zhang, W; Yang, L; Li, X; Xu, J; Chen, N				Pan, Xiaoxia; Ouyang, Yan; Wang, Zhaohui; Ren, Hong; Shen, Pingyan; Wang, Weiming; Xu, Yaowen; Ni, Liyan; Yu, Xialian; Chen, Xiaonong; Zhang, Wen; Yang, Li; Li, Xiao; Xu, Jing; Chen, Nan			Genotype: A Crucial but Not Unique Factor Affecting the Clinical Phenotypes in Fabry Disease	PLOS ONE			English	Article							GALACTOSIDASE-A-GENE; ALPHA-GALACTOSIDASE; GLA GENE; JAPANESE PATIENTS; MUTATIONS; IDENTIFICATION; VARIANT; HETEROZYGOTES; FREQUENCY; DIAGNOSIS	Numerous alpha-galactosidase A (alpha-gal A) gene (GLA) mutations have been identified in Fabry disease (FD), but studies on genotype-phenotype correlation are limited. This study evaluated the features of GLA gene mutations and genotype-phenotype relationship in Chinese FD patients. Gene sequencing results, demographic information, clinical history, and laboratory findings were collected from 73 Chinese FD patients. Totally 47 mutations were identified, including 23 novel mutations which might be pathogenic. For male patients, those with frameshift and nonsense mutations presented the classical FD, whereas those with missense mutations presented both of classical and atypical phenotypes. Interestingly, two male patients with missense mutation p. R356G from two unrelated families, and two with p. R301Q from one family presented different phenotypes. A statistically significant association was found between the levels of alpha-gal A enzyme activity and ocular changes in males, though no significant association was found between residual enzyme activity level and genotype or clinical phenotypes. For female patients, six out of seven with frameshift mutations and one out of nine with missense mutation presented the classical FD, and alpha-gal A activity in those patients was found to be significantly lower than that of patients with atypical phenotypes (13.73 vs. 46.32 nmol/ml/h/mg). Our findings suggest that the alpha-gal A activity might be associated with the clinical severity in female patients with FD. But no obvious associations between activity level of alpha-gal A and genotype or clinical phenotypes were found for male patients.	[Pan, Xiaoxia; Ouyang, Yan; Wang, Zhaohui; Ren, Hong; Shen, Pingyan; Wang, Weiming; Xu, Yaowen; Ni, Liyan; Yu, Xialian; Chen, Xiaonong; Zhang, Wen; Yang, Li; Li, Xiao; Xu, Jing; Chen, Nan] Shanghai Jiao Tong Univ, Dept Nephrol, Ruijin Hosp, Sch Med, Shanghai, Peoples R China	Shanghai Jiao Tong University	Chen, N (corresponding author), Shanghai Jiao Tong Univ, Dept Nephrol, Ruijin Hosp, Sch Med, Shanghai, Peoples R China.	cnrj100@126.com			national Basic Research Program of China 973 [2012CB517600, 2012CB517604]; Shanghai Science and Technology Commission [08dz1900502]; National Natural Science Foundation of China [30871001]	national Basic Research Program of China 973(National Basic Research Program of China); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	NC is supported by the national Basic Research Program of China 973 No. 2012CB517600 (No. 2012CB517604, [http://www.nsfc.gov.cn/]) and Key Program of Shanghai Science and Technology Commission (No. 08dz1900502, [http://www.stcsm.gov.cn]). XP is sponsored by the National Natural Science Foundation of China (No. 30871001, [http://www.nsfc.gov.cn]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altarescu GM, 2001, CLIN GENET, V60, P46, DOI 10.1034/j.1399-0004.2001.600107.x; Ashley GA, 2001, J HUM GENET, V46, P192, DOI 10.1007/s100380170088; Beyer EM, 1999, CLIN CHIM ACTA, V280, P81, DOI 10.1016/S0009-8981(98)00133-8; BISHOP DF, 1988, P NATL ACAD SCI USA, V85, P3903, DOI 10.1073/pnas.85.11.3903; Blanch LC, 1996, HUM MUTAT, V8, P38, DOI 10.1002/(SICI)1098-1004(1996)8:1<38::AID-HUMU5>3.3.CO;2-3; DAVIES JP, 1993, HUM MOL GENET, V2, P1051, DOI 10.1093/hmg/2.7.1051; DESNICK RJ, 1973, J LAB CLIN MED, V81, P157; Dobrovolny R, 2005, J MOL MED, V83, P647, DOI 10.1007/s00109-005-0656-2; Echevarria L, 2016, CLIN GENET, V89, P44, DOI 10.1111/cge.12613; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; ENG CM, 1994, HUM MOL GENET, V3, P1795, DOI 10.1093/hmg/3.10.1795; Eng CM, 1997, MOL MED, V3, P174, DOI 10.1007/BF03401671; ENG CM, 1993, AM J HUM GENET, V53, P1186; Ferri L, 2012, CLIN GENET, V81, P224, DOI 10.1111/j.1399-0004.2011.01689.x; Filoni C, 2010, BBA-MOL BASIS DIS, V1802, P247, DOI 10.1016/j.bbadis.2009.11.003; Garman SC, 2004, J MOL BIOL, V337, P319, DOI 10.1016/j.jmb.2004.01.035; Germain DP, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-30; Germain DP, 2002, MOL MED, V8, P304, DOI 10.1007/BF03402156; HIGUCHI R, 1988, NATURE, V332, P543, DOI 10.1038/332543a0; Iemolo Francesco, 2014, BMC Res Notes, V7, P11, DOI 10.1186/1756-0500-7-11; Lee BH, 2010, J HUM GENET, V55, P512, DOI 10.1038/jhg.2010.58; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lin HY, 2009, CIRC-CARDIOVASC GENE, V2, P450, DOI 10.1161/CIRCGENETICS.109.862920; LYON MF, 1992, ANNU REV GENET, V26, P17, DOI 10.1146/annurev.ge.26.120192.000313; Meng Yan, 2010, Zhonghua Yi Xue Za Zhi, V90, P551; Putko BN, 2015, HEART FAIL REV, V20, P179, DOI 10.1007/s10741-014-9452-9; Schafer Ellen, 2005, Hum Mutat, V25, P412; Shabbeer J, 2002, MOL GENET METAB, V76, P23, DOI 10.1016/S1096-7192(02)00012-4; Shabbeer Junaid, 2006, Human Genomics, V2, P297; Shimotori M, 2008, HUM MUTAT, V29, P331, DOI 10.1002/humu.9520; SHOWS TB, 1978, CYTOGENET CELL GENET, V22, P541, DOI 10.1159/000131020; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; Takata T, 1997, BRAIN DEV-JPN, V19, P111, DOI 10.1016/S0387-7604(96)00486-X; Topaloglu AK, 1999, MOL MED, V5, P806, DOI 10.1007/BF03401993; Turaca LT, 2012, J HUM GENET, V57, P347, DOI 10.1038/jhg.2012.32; Tuttolomondo A, 2013, CURR PHARM DESIGN, V19, P5974; Utsumi Kouichi, 2006, Nihon Rinsho, V64 Suppl 2, P537; Wang RY, 2007, GENET MED, V9, P34, DOI 10.1097/GIM.0b013e31802d8321	38	19	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161330	10.1371/journal.pone.0161330	http://dx.doi.org/10.1371/journal.pone.0161330			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560961	gold, Green Published, Green Submitted			2022-12-26	WOS:000382258600035
J	Dvornikov, AV; Smolin, N; Zhang, MJ; Martin, JL; Robia, SL; de Tombe, PP				Dvornikov, Alexey V.; Smolin, Nikolai; Zhang, Mengjie; Martin, Jody L.; Robia, Seth L.; de Tombe, Pieter P.			Restrictive Cardiomyopathy Troponin I R145W Mutation Does Not Perturb Myofilament Length-dependent Activation in Human Cardiac Sarcomeres	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						contractile protein; heart; molecular dynamics; phosphorylation; troponin; contractility; length-dependent activation; myocardium; myofilament	PROTEIN-KINASE-A; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; MOLECULAR-DYNAMICS SIMULATIONS; CALCIUM SENSITIVITY; HUMAN CARDIOMYOCYTES; FORCE GENERATION; THIN-FILAMENTS; GENE-MUTATIONS; PHOSPHORYLATION; MUSCLE	The cardiac troponin I (cTnI) R145W mutation is associated with restrictive cardiomyopathy (RCM). Recent evidence suggests that this mutation induces perturbed myofilament length-dependent activation (LDA) under conditions of maximal protein kinase A (PKA) stimulation. Some cardiac disease-causing mutations, however, have been associated with a blunted response to PKA-mediated phosphorylation; whether this includes LDA is unknown. Endogenous troponin was exchanged in isolated skinned human myocardium for recombinant troponin containing either cTnI R145W, PKA/PKC phosphomimetic charge mutations (S23D/S24D and T143E), or various combinations thereof. Myofilament Ca2+ sensitivity of force, tension cost, LDA, and single myofibril activation/relaxation parameters were measured. Our results show that both R145W and T143E uncouple the impact of S23D/S24D phosphomimetic on myofilament function, including LDA. Molecular dynamics simulations revealed a marked reduction in interactions between helix C of cTnC (residues 56, 59, and 63), and cTnI (residue 145) in the presence of either cTnI RCM mutation or cTnI PKC phosphomimetic. These results suggest that the RCM-associated cTnI R145W mutation induces a permanent structural state that is similar to, but more extensive than, that induced by PKC-mediated phosphorylation of cTnI Thr-143. We suggest that this structural conformational change induces an increase in myofilament Ca2+ sensitivity and, moreover, uncoupling from the impact of phosphorylation of cTnI mediated by PKA at the Ser-23/Ser-24 target sites. The R145W RCM mutation by itself, however, does not impact LDA. These perturbed biophysical and biochemical myofilament properties are likely to significantly contribute to the diastolic cardiac pump dysfunction that is seen in patients suffering from a restrictive cardiomyopathy that is associated with the cTnI R145W mutation.	[Dvornikov, Alexey V.; Smolin, Nikolai; Zhang, Mengjie; Martin, Jody L.; Robia, Seth L.; de Tombe, Pieter P.] Loyola Univ Chicago, Div Hlth Sci, Dept Cell & Mol Physiol, 2160 S First Ave, Maywood, IL 60153 USA	Loyola University Chicago	de Tombe, PP (corresponding author), Loyola Univ Chicago, Div Hlth Sci, Dept Cell & Mol Physiol, 2160 S First Ave, Maywood, IL 60153 USA.	pdetombe@luc.edu	Smolin, Nikolai/C-6606-2008		National Science Foundation [ACI-1053575]; National Institute of Health [1G20RR030939]; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR030939] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092321, R01HL075494, P01HL062426] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are indebted to Drs. Yuanhua Cheng and Stefan Lindert for sharing the troponin Protein Data Bank structure (40) used in the MD simulations. This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation Grant ACI-1053575. This research was supported by equipment and facilities provided by National Institute of Health Grant "Loyola Research Computing Core" 1G20RR030939.	Ait-Mou Y, 2016, P NATL ACAD SCI USA, V113, P2306, DOI 10.1073/pnas.1516732113; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Biesiadecki BJ, 2007, CIRC RES, V100, P1486, DOI 10.1161/01.RES.0000267744.92677.7f; BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; Chandra M, 2001, AM J PHYSIOL-HEART C, V280, pH705, DOI 10.1152/ajpheart.2001.280.2.H705; Cheng YH, 2015, J BIOL CHEM, V290, P27749, DOI 10.1074/jbc.M115.683045; Cheng YH, 2014, BIOPHYS J, V107, P1675, DOI 10.1016/j.bpj.2014.08.008; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davis J, 2008, J MOL CELL CARDIOL, V44, P891, DOI 10.1016/j.yjmcc.2008.02.274; de Tombe PP, 2007, J PHYSIOL-LONDON, V584, P591, DOI 10.1113/jphysiol.2007.138693; de Tombe PP, 2010, J MOL CELL CARDIOL, V48, P851, DOI 10.1016/j.yjmcc.2009.12.017; Deng Y, 2001, BIOCHEMISTRY-US, V40, P14593, DOI 10.1021/bi0115232; Dvornikov AV, 2014, J PHYSIOL-LONDON, V592, P1949, DOI 10.1113/jphysiol.2014.270678; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Gomes AV, 2004, MOL CELL BIOCHEM, V263, P99, DOI 10.1023/B:MCBI.0000041852.42291.aa; Hanft LM, 2013, J PHYSIOL-LONDON, V591, P4535, DOI 10.1113/jphysiol.2013.258400; Hanft LM, 2009, AM J PHYSIOL-HEART C, V296, pH1524, DOI 10.1152/ajpheart.00864.2008; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Konhilas JP, 2003, J PHYSIOL-LONDON, V547, P951, DOI 10.1113/jphysiol.2002.038117; Kruger M, 2005, J PHYSIOL-LONDON, V564, P347, DOI 10.1113/jphysiol.2004.079095; Kumar M, 2015, J BIOL CHEM, V290, P29241, DOI 10.1074/jbc.M115.686790; Lang R, 2002, J BIOL CHEM, V277, P11670, DOI 10.1074/jbc.M108912200; Lindert S, 2015, BIOPHYS J, V108, P395, DOI 10.1016/j.bpj.2014.11.3461; Lindhout DA, 2002, BIOCHEMISTRY-US, V41, P7267, DOI 10.1021/bi020100c; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086279; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; Mogensen J, 2003, J CLIN INVEST, V111, P209, DOI 10.1172/JCI200316336; Nixon BR, 2012, J BIOL CHEM, V287, P19136, DOI 10.1074/jbc.M111.323048; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; NOSE S, 1986, PHYS REV B, V33, P339, DOI 10.1103/PhysRevB.33.339; Papadaki M, 2015, CARDIOVASC RES, V108, P99, DOI 10.1093/cvr/cvv181; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Poggesi C, 2005, PFLUG ARCH EUR J PHY, V449, P505, DOI 10.1007/s00424-004-1363-5; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rao VS, 2013, J PHYSIOL-LONDON, V591, P475, DOI 10.1113/jphysiol.2012.241604; Seidman CE, 2011, CIRC RES, V108, P743, DOI 10.1161/CIRCRESAHA.110.223834; Sen-Chowdhry Srijita, 2010, Heart Fail Clin, V6, P179, DOI 10.1016/j.hfc.2009.11.005; Sequeira V, 2013, CIRC RES, V112, P1491, DOI 10.1161/CIRCRESAHA.111.300436; Stehle R, 2009, PFLUG ARCH EUR J PHY, V458, P337, DOI 10.1007/s00424-008-0630-2; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; Takahashi-Yanaga F, 2001, J MOL CELL CARDIOL, V33, P2095, DOI 10.1006/jmcc.2001.1473; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Towbin JA, 2014, CIRC J, V78, P2347, DOI 10.1253/circj.CJ-14-0893; Ulrich E, 1995, J CHEM PHYS, V103, P8577; van der Velden J, 2000, CARDIOVASC RES, V46, P487, DOI 10.1016/S0008-6363(00)00050-X; van der Velden J, 2014, PFLUG ARCH EUR J PHY, V466, P1023, DOI 10.1007/s00424-014-1531-1; Walker JS, 2011, AM J PHYSIOL-HEART C, V301, pH138, DOI 10.1152/ajpheart.00838.2010; Wen YH, 2009, J MOL BIOL, V392, P1158, DOI 10.1016/j.jmb.2009.07.080; Wijnker PJM, 2014, AM J PHYSIOL-HEART C, V306, pH1171, DOI 10.1152/ajpheart.00580.2013; Wijnker PJM, 2013, AM J PHYSIOL-HEART C, V304, pH260, DOI 10.1152/ajpheart.00498.2012; Witayavanitkul N, 2014, J BIOL CHEM, V289, P8818, DOI 10.1074/jbc.M113.541128; Yumoto F, 2005, BIOCHEM BIOPH RES CO, V338, P1519, DOI 10.1016/j.bbrc.2005.10.116; Zamora JE, 2016, PHYS CHEM CHEM PHYS, V18, P20691, DOI 10.1039/c6cp02610a; Zhang MJ, 2015, AM J PHYSIOL-HEART C, V309, pH1509, DOI 10.1152/ajpheart.00598.2015; Zhang PB, 2012, CIRCULATION, V126, P1828, DOI 10.1161/CIRCULATIONAHA.112.096388	58	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21817	21828		10.1074/jbc.M116.746172	http://dx.doi.org/10.1074/jbc.M116.746172			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27557662	Green Published, hybrid			2022-12-26	WOS:000385999200044
J	Nguyen, CT; Tanaka, K; Cao, YR; Cho, SH; Xu, D; Stacey, G				Cuong The Nguyen; Tanaka, Kiwamu; Cao, Yangrong; Cho, Sung-Hwan; Xu, Dong; Stacey, Gary			Computational Analysis of the Ligand Binding Site of the Extracellular ATP Receptor, DORN1	PLOS ONE			English	Article							LEGUME LECTIN; CRYSTALLOGRAPHIC STRUCTURE; SIGNALING ROLE; TRIPHOSPHATE; RECOGNITION; PHYTOHEMAGGLUTININ; VISUALIZATION; DOCKING; GROWTH; GENES	DORN1 (also known as P2K1) is a plant receptor for extracellular ATP, which belongs to a large gene family of legume-type (L-type) lectin receptor kinases. Extracellular ATP binds to DORN1 with strong affinity through its lectin domain, and the binding triggers a variety of intracellular activities in response to biotic and abiotic stresses. However, information on the tertiary structure of the ligand binding site of DORN1 is lacking, which hampers efforts to fully elucidate the mechanism of receptor action. Available data of the crystal structures from more than 50 L-type lectins enable us to perform an in silico study of molecular interaction between DORN1 and ATP. In this study, we employed a computational approach to develop a tertiary structure model of the DORN1 lectin domain. A blind docking analysis demonstrated that ATP binds to a cavity made by four loops (defined as loops A B, C and D) of the DORN1 lectin domain with high affinity. In silico target docking of ATP to the DORN1 binding site predicted interaction with 12 residues, located on the four loops, via hydrogen bonds and hydrophobic interactions. The ATP binding pocket is structurally similar in location to the carbohydrate binding pocket of the canonical L-type lectins. However, four of the residues predicted to interact with ATP are not conserved between DORN1 and the other carbohydrate-binding lectins, suggesting that diversifying selection acting on these key residues may have led to the ATP binding activity of DORN1. The in silico model was validated by in vitro ATP binding assays using the purified extracellular lectin domain of wild-type DORN1, as well as mutated DORN1 lacking key ATP binding residues.	[Cuong The Nguyen; Cao, Yangrong; Cho, Sung-Hwan; Stacey, Gary] Univ Missouri, Div Plant Sci & Biochem, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA; [Tanaka, Kiwamu] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Xu, Dong] Univ Missouri, Inst Informat, Dept Comp Sci, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA; [Cao, Yangrong] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan 430070, Peoples R China	University of Missouri System; University of Missouri Columbia; Washington State University; University of Missouri System; University of Missouri Columbia; Huazhong Agricultural University	Stacey, G (corresponding author), Univ Missouri, Div Plant Sci & Biochem, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA.	staceyg@missouri.edu	Tanaka, Kiwamu/E-9942-2013; Xu, Dong/Y-8605-2018; Cho, Sung-Hwan/AFO-8760-2022	Tanaka, Kiwamu/0000-0001-5045-560X; Cho, Sung-Hwan/0000-0003-2230-2037; Nguyen, Cuong/0000-0002-8700-9598	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-08ER15309]; Next-Generation BioGreen 21 Program Systems and Synthetic Agrobiotech Center, Rural Development Administration, Republic of Korea [PJ009068]; National Institute of Health [R01-GM100701]; Vietnam Education Development (VIED) scholarship; Division Of Integrative Organismal Systems [1557813] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100701] Funding Source: NIH RePORTER	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE)); Next-Generation BioGreen 21 Program Systems and Synthetic Agrobiotech Center, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vietnam Education Development (VIED) scholarship; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was financially supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy through grant DE-FG02-08ER15309, the Next-Generation BioGreen 21 Program Systems and Synthetic Agrobiotech Center, Rural Development Administration, Republic of Korea (grant no. PJ009068) to GS, and the National Institute of Health grant # R01-GM100701 to DX. The Cuong T. Nguyen study program was partly funded by the Vietnam Education Development (VIED) scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was financially supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy through grant DE-FG02-08ER15309, the Next-Generation BioGreen 21 Program Systems and Synthetic Agrobiotech Center, Rural Development Administration, Republic of Korea (grant no. PJ009068) to GS, the National Institute of Health (grant no. R01-GM100701) to DX, and the Vietnam Education Development (VIED) scholarship to CTN.	Bardor M, 1999, TRENDS PLANT SCI, V4, P376, DOI 10.1016/S1360-1385(99)01461-2; Bouckaert J, 1995, PROTEINS, V23, P510, DOI 10.1002/prot.340230406; Boyum R, 1997, MICROBIOL-SGM, V143, P1901, DOI 10.1099/00221287-143-6-1901; Brylinski M, 2008, P NATL ACAD SCI USA, V105, P129, DOI 10.1073/pnas.0707684105; Chivasa S, 2005, PLANT CELL, V17, P3019, DOI 10.1105/tpc.105.036806; Choi J, 2014, SCIENCE, V343, P290, DOI 10.1126/science.343.6168.290; Clark G, 2010, PLANT PHYSIOL, V152, P1073, DOI 10.1104/pp.109.147637; Cole JC, 2005, PROTEINS, V60, P325, DOI 10.1002/prot.20497; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Eswar N, 2001, COMPARATIVE PROTEIN; Etzler ME, 2009, CUMMINGS RD L TYPE L; Geethanandan K, 2011, INT J BIOL MACROMOL, V49, P992, DOI 10.1016/j.ijbiomac.2011.08.021; Gouget A, 2006, PLANT PHYSIOL, V140, P81, DOI 10.1104/pp.105.066464; Hamelryck TW, 1999, J MOL BIOL, V286, P1161, DOI 10.1006/jmbi.1998.2534; Hamelryck TW, 1996, J BIOL CHEM, V271, P20479, DOI 10.1074/jbc.271.34.20479; HOLTON P, 1959, J PHYSIOL-LONDON, V145, P494, DOI 10.1113/jphysiol.1959.sp006157; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Illergard K, 2009, PROTEINS, V77, P499, DOI 10.1002/prot.22458; Ivanova EP, 2006, INT MICROBIOL, V9, P37; Jeter CR, 2004, PLANT CELL, V16, P2652, DOI 10.1105/tpc.104.023945; Khakh BS, 2009, SCI AM, V301, P84, DOI 10.1038/scientificamerican1209-84; Kim SH, 2009, BIOSCI BIOTECH BIOCH, V73, P1252, DOI 10.1271/bbb.80660; Kim SY, 2006, PLANT PHYSIOL, V142, P984, DOI 10.1104/pp.106.085670; Loris R, 1998, BBA-PROTEIN STRUCT M, V1383, P9, DOI 10.1016/S0167-4838(97)00182-9; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; PARISH RW, 1980, FEBS LETT, V118, P263, DOI 10.1016/0014-5793(80)80234-1; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rose PW, 2013, NUCLEIC ACIDS RES, V41, pD475, DOI 10.1093/nar/gks1200; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; Sharma V, 1997, J MOL BIOL, V267, P433, DOI 10.1006/jmbi.1996.0863; SHARON N, 1990, FASEB J, V4, P3198, DOI 10.1096/fasebj.4.14.2227211; Sharon N, 2007, LECTINS; Shetty KN, 2013, IUBMB LIFE, V65, P633, DOI 10.1002/iub.1177; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Song CJ, 2006, PLANT PHYSIOL, V140, P1222, DOI 10.1104/pp.105.073072; Srobarova A, 2009, CHEM BIODIVERS, V6, P1208, DOI 10.1002/cbdv.200800158; STURM A, 1986, PLANT PHYSIOL, V81, P320, DOI 10.1104/pp.81.1.320; STURM A, 1992, EUR J BIOCHEM, V204, P313, DOI 10.1111/j.1432-1033.1992.tb16639.x; Tanaka K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00446; Thomas C, 2000, PLANT CELL, V12, P519, DOI 10.1105/tpc.12.4.519; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Van Damme EJ, 1998, HANDBOOK OF PLANT LE; Van Damme EJM, 1998, CRIT REV PLANT SCI, V17, P575, DOI 10.1016/S0735-2689(98)00365-7; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Weerasinghe RR, 2009, FEBS LETT, V583, P2521, DOI 10.1016/j.febslet.2009.07.007; Wu J, 2007, PLANT PHYSIOL, V144, P961, DOI 10.1104/pp.107.097568; Wu SJ, 2008, PLANT CELL PHYSIOL, V49, P617, DOI 10.1093/pcp/pcn033; Yang JY, 2013, BIOINFORMATICS, V29, P2588, DOI 10.1093/bioinformatics/btt447	55	14	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161894	10.1371/journal.pone.0161894	http://dx.doi.org/10.1371/journal.pone.0161894			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583834	gold, Green Published, Green Submitted			2022-12-26	WOS:000382855600071
J	Fontana, MF; Baccarella, A; Craft, JF; Boyle, MJ; McIntyre, TI; Wood, MD; Thorn, KS; Anidi, C; Bayat, A; Chung, MR; Hamburger, R; Kim, CY; Pearman, E; Pham, J; Tang, JJ; Boon, L; Kamya, MR; Dorsey, G; Feeney, ME; Kim, CC				Fontana, Mary F.; Baccarella, Alyssa; Craft, Joshua F.; Boyle, Michelle J.; McIntyre, Tara I.; Wood, Matthew D.; Thorn, Kurt S.; Anidi, Chioma; Bayat, Aqieda; Chung, Me Ree; Hamburger, Rebecca; Kim, Chris Y.; Pearman, Emily; Pham, Jennifer; Tang, Jia J.; Boon, Louis; Kamya, Moses R.; Dorsey, Grant; Feeney, Margaret E.; Kim, Charles C.			A Novel Model of Asymptomatic Plasmodium Parasitemia That Recapitulates Elements of the Human Immune Response to Chronic Infection	PLOS ONE			English	Article							MEMORY B-CELLS; CD4 T-CELLS; MALARIA TRANSMISSION; FALCIPARUM INFECTION; PROTECTIVE IMMUNITY; ERYTHROCYTIC STAGES; ACQUIRED-IMMUNITY; CHABAUDI-ADAMI; HEPATITIS-C; 3 SITES	In humans, immunity to Plasmodium sp. generally takes the form of protection from symptomatic malaria (i.e., 'clinical immunity') rather than infection ('sterilizing immunity'). In contrast, mice infected with Plasmodium develop sterilizing immunity, hindering progress in understanding the mechanistic basis of clinical immunity. Here we present a novel model in which mice persistently infected with P. chabaudi exhibit limited clinical symptoms despite sustaining patent parasite burdens for many months. Characterization of immune responses in persistently infected mice revealed development of CD4(+) T cell exhaustion, increased production of IL-10, and expansion of B cells with an atypical surface phenotype. Additionally, persistently infected mice displayed a dramatic increase in circulating nonclassical monocytes, a phenomenon that we also observed in humans with both chronic Plasmodium exposure and asymptomatic infection. Following pharmacological clearance of infection, previously persistently infected mice could not control a secondary challenge, indicating that persistent infection disrupts the sterilizing immunity that typically develops in mouse models of acute infection. This study establishes an animal model of asymptomatic, persistent Plasmodium infection that recapitulates several central aspects of the immune response in chronically exposed humans. As such, it provides a novel tool for dissection of immune responses that may prevent development of sterilizing immunity and limit pathology during infection.	[Fontana, Mary F.; Baccarella, Alyssa; Craft, Joshua F.; Boyle, Michelle J.; McIntyre, Tara I.; Anidi, Chioma; Bayat, Aqieda; Chung, Me Ree; Hamburger, Rebecca; Kim, Chris Y.; Pearman, Emily; Pham, Jennifer; Tang, Jia J.; Feeney, Margaret E.; Kim, Charles C.] Univ Calif San Francisco, Div Expt Med, Dept Med, San Francisco, CA 94143 USA; [Boyle, Michelle J.] Bumet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Wood, Matthew D.] Univ Calif San Francisco, Div Neuropathol, Dept Pathol, San Francisco, CA 94143 USA; [Thorn, Kurt S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Boon, Louis] EPIRUS Biopharmaceut, Utrecht, Netherlands; [Kamya, Moses R.] Makerere Univ, Sch Med, Coll Hlth Sci, Kampala, Uganda; [Dorsey, Grant] Univ Calif San Francisco, Div Infect Dis, Dept Med, San Francisco, CA 94143 USA; [Feeney, Margaret E.] Univ Calif San Francisco, Div Pediat Infect Dis & Global Hlth, Dept Pediat, San Francisco, CA 94143 USA; [Kim, Charles C.] Verily, Mountain View, CA 94043 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Makerere University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kim, CC (corresponding author), Univ Calif San Francisco, Div Expt Med, Dept Med, San Francisco, CA 94143 USA.	cckim47@gmail.com	Boon, Laurence/HCI-3629-2022; Boyle, Michelle/D-4223-2018; Wood, Matthew/HDN-1469-2022; Boyle, Michelle/P-7297-2019; Anidi, Chioma/AAC-2512-2019	Boyle, Michelle/0000-0002-0268-232X; Boyle, Michelle/0000-0002-0268-232X; Anidi, Chioma/0000-0002-2457-2893; Baccarella, Alyssa/0000-0001-8200-9751; Boon, Louis/0000-0002-0937-9171; Kim, Charles/0000-0001-6474-8227; Fontana, Mary/0000-0003-3630-181X; McIntyre, Tara/0000-0001-6670-9977	National Institute of Allergy and Infectious Disease (NIAID) [T32 AI060537, T32 AI007334]; National Health and Medical Research Council Australia [R00 AI085035, R21 AI114916]; UCSF Program for Breakthrough Biomedical Research; National Health and Medical Research Council Australia Infrastructure for Research Institutes Support Scheme; Victorian State Government Operational Infrastructure Support; National Institutes of Health, International Centers of Excellence in Malaria Research (ICEMR) program [U19 AI089674]; EPIRUS Biopharmeceuticals; University of California San Francisco; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334, T32AI060537] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); UCSF Program for Breakthrough Biomedical Research; National Health and Medical Research Council Australia Infrastructure for Research Institutes Support Scheme(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support; National Institutes of Health, International Centers of Excellence in Malaria Research (ICEMR) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPIRUS Biopharmeceuticals; University of California San Francisco(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Disease (NIAID), T32 AI060537 and T32 AI007334 (MFF); the Dean's Office Medical Student Research Program at the University of California San Francisco (ABac); The National Health and Medical Research Council Australia (https://www.nhmrc.gov.au/) Early-Career Fellowship (MJB); and R00 AI085035, R21 AI114916, and the UCSF Program for Breakthrough Biomedical Research (CCK). The Burnet Institute is supported by the National Health and Medical Research Council Australia Infrastructure for Research Institutes Support Scheme and by the Victorian State Government Operational Infrastructure Support. Funding for human studies was provided by the National Institutes of Health as part of the International Centers of Excellence in Malaria Research (ICEMR) program (U19 AI089674). EPIRUS Biopharmeceuticals provided support in the form of salary for LB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "Author Contributions" section. None of the funders had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres JS, 2012, ANNU REV IMMUNOL, V30, P271, DOI 10.1146/annurev-immunol-020711-075030; Batchelder JM, 2003, EXP PARASITOL, V105, P159, DOI 10.1016/j.exppara.2003.12.003; Bergmann B, 2013, SCAND J IMMUNOL, V78, P149, DOI 10.1111/sji.12073; Boutlis CS, 2006, TRENDS PARASITOL, V22, P371, DOI 10.1016/j.pt.2006.06.002; Boyle MJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005041; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; CAVACINI LA, 1990, INFECT IMMUN, V58, P2946, DOI 10.1128/IAI.58.9.2946-2950.1990; Chandele A, 2011, IMMUNOLOGY, V132, P273, DOI 10.1111/j.1365-2567.2010.03363.x; Chen I, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001942; Chu VT, 2013, IMMUNOL REV, V251, P177, DOI 10.1111/imr.12011; Costa PAC, 2015, J INFECT DIS, V212, P1999, DOI 10.1093/infdis/jiv306; Crompton PD, 2009, J IMMUNOL, V182, P3318, DOI 10.4049/jimmunol.0803596; de Mast Q, 2015, J INFECTION, V71, P587, DOI 10.1016/j.jinf.2015.08.005; del Portillo HA, 2012, CELL MICROBIOL, V14, P343, DOI 10.1111/j.1462-5822.2011.01741.x; DUARTE MIS, 1985, AM J TROP MED HYG, V34, P31, DOI 10.4269/ajtmh.1985.34.31; ELASED K, 1994, INFECT IMMUN, V62, P5157, DOI 10.1128/IAI.62.11.5157-5160.1994; do Rosario APF, 2008, J IMMUNOL, V181, P8344, DOI 10.4049/jimmunol.181.12.8344; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; GOOD MF, 1995, PARASITE IMMUNOL, V17, P55, DOI 10.1111/j.1365-3024.1995.tb00966.x; GRUN JL, 1981, NATURE, V290, P143, DOI 10.1038/290143a0; Hafalla JCR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002504; Hall C., 1932, U CALIF PUBL PSYCHOL, V6, P1; Hansen DS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000771; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Horne-Debets JM, 2013, CELL REP, V5, P1204, DOI 10.1016/j.celrep.2013.11.002; Huang BW, 2015, BIO PROTOC, V5; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Illingworth J, 2013, J IMMUNOL, V190, P1038, DOI 10.4049/jimmunol.1202438; Jagannathan P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009793; Jagannathan P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003864; Kamya MR, 2015, AM J TROP MED HYG, V92, P903, DOI 10.4269/ajtmh.14-0312; Kilama M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-111; Kim CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048126; LANGHORNE J, 1989, IMMUNOL REV, V112, P71, DOI 10.1111/j.1600-065X.1989.tb00553.x; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Li FJ, 2014, CURR TOP MICROBIOL, V382, P29, DOI 10.1007/978-3-319-07911-0_2; Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/eri.13.45, 10.1586/ERI.13.45]; LONG CA, 1994, AM J TROP MED HYG, V50, P27, DOI 10.4269/ajtmh.1994.50.27; Mastelic B, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00085; MCCOLM AA, 1983, ANN TROP MED PARASIT, V77, P355, DOI 10.1080/00034983.1983.11811724; McDermott DS, 2011, J IMMUNOL, V187, P5568, DOI 10.4049/jimmunol.1102104; Milner D, 2013, HUM PATHOL, V44, P2719, DOI 10.1016/j.humpath.2013.07.018; Mosha JF, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-221; Nankabirwa J, 2013, AM J TROP MED HYG, V88, P1102, DOI 10.4269/ajtmh.12-0633; PODOBA JE, 1991, INFECT IMMUN, V59, P51, DOI 10.1128/IAI.59.1.51-58.1991; Portugal S, 2015, ELIFE, V4, DOI 10.7554/eLife.07218; Portugal S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004079; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Riley EM, 2006, PARASITE IMMUNOL, V28, P35, DOI 10.1111/j.1365-3024.2006.00775.x; Rodriguez-Munoz Y, 2011, ALIMENT PHARM THER, V34, P960, DOI 10.1111/j.1365-2036.2011.04807.x; Rubtsova K, 2015, J IMMUNOL, V195, P1933, DOI 10.4049/jimmunol.1501209; Schofield L, 2006, CURR MOL MED, V6, P205, DOI 10.2174/156652406776055221; Seu L, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-27; Speiser DE, 2014, NAT REV IMMUNOL, V14, P768, DOI 10.1038/nri3740; Srivastava A, 1996, Trop Gastroenterol, V17, P172; Stephens R, 2012, TRENDS PARASITOL, V28, P73, DOI 10.1016/j.pt.2011.10.006; Stephens R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001208; Su Z, 2002, J IMMUNOL, V168, P1348, DOI 10.4049/jimmunol.168.3.1348; Sullivan RT, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004894; SUSS G, 1988, INFECT IMMUN, V56, P3081; Tran TM, 2013, CLIN INFECT DIS, V57, P40, DOI 10.1093/cid/cit174; Traore B, 2009, VACCINE, V27, P7299, DOI 10.1016/j.vaccine.2009.08.023; VANDERHEYDE HC, 1994, J IMMUNOL, V152, P4557; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wykes MN, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00249; Zhang JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017484; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	68	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162132	10.1371/journal.pone.0162132	http://dx.doi.org/10.1371/journal.pone.0162132			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583554	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600110
J	Hesson, JC; Lundstrom, JO; Tok, A; Ostman, O; Lundkvist, A				Hesson, Jenny Christina; Lundstrom, Jan O.; Tok, Atalay; Ostman, Orjan; Lundkvist, Ake			Temporal Variation in Sindbis Virus Antibody Prevalence in Bird Hosts in an Endemic Area in Sweden	PLOS ONE			English	Article							WESTERN EQUINE ENCEPHALOMYELITIS; LOUIS ENCEPHALITIS VIRUSES; SPARROW PASSER-DOMESTICUS; OCKELBO VIRUS; POGOSTA DISEASE; NILE-VIRUS; NEUTRALIZING ANTIBODIES; EPIDEMIOLOGIC ANALYSIS; CALIFORNIA BIRDS; CULEX-TORRENTIUM	Sindbis virus (SINV) is a mosquito-borne bird virus that occasionally causes human disease in Fennoscandia, suggested to have cyclic 7-year intervals between outbreaks. Reliable data on human infections in Sweden is however lacking. Here we investigated the SINV antibody prevalence among birds in a Swedish area endemic to SINV to scrutinize if a cyclic variation in antibody prevalence is present in the natural host of SINV. Serum from birds were sampled in the summers of 2002-2004 and 2009 in the floodplains of the River Dalalven in central Sweden, with 2002 and 2009 representing hypothesized years of SINV outbreaks. A total of 963 birds from 52 species (mainly passerines) were tested for the presence of SINV antibodies using a plaque reduction neutralization test. The highest SINV antibody prevalence was found in Turdidae species, specifically Fieldfare, Redwing and Song thrush in which more than 70% of sampled individuals had antibodies to SINV in 2009. The SINV antibody prevalence significantly varied between years with 2% in 2002, 8% in 2003, 14% in 2004 and 37% in 2009. Antibodies were found equally often in hatchlings and in adults and increased from early to late in the season. Clearly, the SINV antibody prevalence was not elevated in the bird hosts in the predicted outbreak year 2002, thus solid evidence of a cyclic occurrence of SINV in Sweden is still lacking.	[Hesson, Jenny Christina; Lundstrom, Jan O.; Tok, Atalay; Lundkvist, Ake] Uppsala Univ, Dept Med Biochem & Microbiol IMBIM, Zoonosis Sci Ctr, Uppsala, Sweden; [Hesson, Jenny Christina] Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Liverpool, Merseyside, England; [Lundstrom, Jan O.] Nedre Dalalvens Utvecklings AB, Swedish Biol Mosquito Control Project, Gysinge, Sweden; [Ostman, Orjan] Swedish Univ Agr Sci, Inst Coastal Res, Dept Aquat Resources, Oregrund, Sweden; [Lundkvist, Ake] Univ Uppsala Hosp, Lab Clin Microbiol, Uppsala, Sweden; [Ostman, Orjan] Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Germany	Uppsala University; University of Liverpool; Swedish University of Agricultural Sciences; Uppsala University; Uppsala University Hospital; Ruprecht Karls University Heidelberg	Hesson, JC (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol IMBIM, Zoonosis Sci Ctr, Uppsala, Sweden.; Hesson, JC (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Liverpool, Merseyside, England.	jenny.hesson@imbim.uu.se	Östman, Örjan/ABF-8714-2020	Östman, Örjan/0000-0002-1930-0148	Nedre Dalalvens Utvecklings AB; BBSRC [BB/K018507/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K018507/1] Funding Source: researchfish	Nedre Dalalvens Utvecklings AB; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The funder, Nedre Dalalvens Utvecklings AB, provided support in the form of salary for the author [JL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergqvist J, 2015, VECTOR-BORNE ZOONOT, V15, P133, DOI 10.1089/vbz.2014.1717; Brummer-Korvenkontio M, 2002, EPIDEMIOL INFECT, V129, P335, DOI 10.1017/S0950268802007409; Fox J., 2019, R COMPANION APPL REG, V.; FRANCY DB, 1989, AM J TROP MED HYG, V41, P355, DOI 10.4269/ajtmh.1989.41.355; Gylfe A, 2000, NATURE, V403, P724, DOI 10.1038/35001663; Hesson JC, 2015, EMERG INFECT DIS, V21, P875, DOI 10.3201/eid2105.141577; Jalava K, 2013, EPIDEMIOL INFECT, V141, P1857, DOI 10.1017/S095026881200249X; Kallio ER, 2009, EPIDEMICS-NETH, V1, P101, DOI 10.1016/j.epidem.2009.03.002; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Kurkela S, 2005, J INFECT DIS, V191, P1820, DOI 10.1086/430007; Kurkela S, 2004, EMERG INFECT DIS, V10, P889, DOI 10.3201/eid1005.030689; Kurkela S, 2008, SCAND J INFECT DIS, V40, P167, DOI 10.1080/00365540701586996; Kurkela S, 2008, EMERG INFECT DIS, V14, P41, DOI 10.3201/eid1401.070510; Lundstrom JO, 2010, VECTOR-BORNE ZOONOT, V10, P889, DOI 10.1089/vbz.2009.0069; LUNDSTROM JO, 1991, EPIDEMIOL INFECT, V106, P567, DOI 10.1017/S0950268800067637; Lundstrom JO, 1996, J WILDLIFE DIS, V32, P87, DOI 10.7589/0090-3558-32.1.87; LUNDSTROM JO, 1992, J WILDLIFE DIS, V28, P144, DOI 10.7589/0090-3558-28.1.144; Lundstrom JO, 2001, J MED ENTOMOL, V38, P289, DOI 10.1603/0022-2585-38.2.289; LUNDSTROM JO, 1993, J WILDLIFE DIS, V29, P189, DOI 10.7589/0090-3558-29.2.189; LUNDSTROM JO, 1990, J MED ENTOMOL, V27, P561, DOI 10.1093/jmedent/27.4.561; Manni T, 2008, VECTOR-BORNE ZOONOT, V8, P303, DOI 10.1089/vbz.2007.0623; MCINTOSH BM, 1976, S AFR J SCI, V72, P295; MCLEAN RG, 1983, AM J TROP MED HYG, V32, P1120, DOI 10.4269/ajtmh.1983.32.1120; Molaei G, 2006, EMERG INFECT DIS, V12, P468, DOI 10.3201/eid1203.051004; Molaei G, 2013, VECTOR-BORNE ZOONOT, V13, P312, DOI 10.1089/vbz.2012.1099; Nemeth N, 2009, ARCH VIROL, V154, P783, DOI 10.1007/s00705-009-0369-x; Nemeth NM, 2008, AM J TROP MED HYG, V79, P283, DOI 10.4269/ajtmh.2008.79.283; Nemeth NM, 2009, AM J TROP MED HYG, V80, P864, DOI 10.4269/ajtmh.2009.80.864; NIKLASSON B, 1988, J INFECT DIS, V157, P832, DOI 10.1093/infdis/157.4.832; R Core Team, 2012, R LANG ENV STAT COMP; REEVES WC, 1958, P SOC EXP BIOL MED, V97, P733, DOI 10.3181/00379727-97-23862; Reisen WK, 2005, J MED ENTOMOL, V42, P367, DOI 10.1603/0022-2585(2005)042[0367:AHAMDC]2.0.CO;2; Reisen WK, 2001, J MED ENTOMOL, V38, P393, DOI 10.1603/0022-2585-38.3.393; Reisen WK, 2000, J MED ENTOMOL, V37, P507, DOI 10.1603/0022-2585-37.4.507; Reisen WK, 2003, J MED ENTOMOL, V40, P968, DOI 10.1603/0022-2585-40.6.968; Rossow H, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES2015.20.33.21209; Sane J, 2010, EUROSURVEILLANCE, V15, P6; Sane J, 2012, J GEN VIROL, V93, P1984, DOI 10.1099/vir.0.042853-0; Sane J, 2012, J INFECT DIS, V206, P407, DOI 10.1093/infdis/jis358; Sane J, 2012, J VIROL METHODS, V179, P185, DOI 10.1016/j.jviromet.2011.10.021; Sane J, 2011, J INFECT DIS, V204, P459, DOI 10.1093/infdis/jir267; Svensson L., 1992, IDENTIFICATION GUIDE; TURELL MJ, 1990, J MED ENTOMOL, V27, P266, DOI 10.1093/jmedent/27.3.266; Ulfstrand S., 1976, Anser, V15, P1	44	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0162005	10.1371/journal.pone.0162005	http://dx.doi.org/10.1371/journal.pone.0162005			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579607	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000382877400051
J	Fatima, N; Faisal, SM; Zubair, S; Ajmal, M; Siddiqui, SS; Moin, S; Owais, M				Fatima, Naureen; Faisal, Syed Mohd; Zubair, Swaleha; Ajmal, Mohd; Siddiqui, Sheelu Shafiq; Moin, Shagufta; Owais, Mohammad			Role of Pro-Inflammatory Cytokines and Biochemical Markers in the Pathogenesis of Type 1 Diabetes: Correlation with Age and Glycemic Condition in Diabetic Human Subjects	PLOS ONE			English	Article							OXIDATIVE STRESS; ANTIOXIDANT STATUS; SULFHYDRYL-GROUPS; NITRIC-OXIDE; GLUTATHIONE; PLASMA; ERYTHROCYTES; CHILDREN; GLUCOSE; POPULATION	Background Type 1 diabetes mellitus is a chronic inflammatory disease involving insulin producing beta-cells destroyed by the conjoined action of auto reactive T-cells, inflammatory cytokines and monocytic cells. The aim of this study was to elucidate the status of pro-inflammatory cytokines and biochemical markers and possible correlation of these factors towards outcome of the disease. Methods The study was carried out on 29 T1D subjects and 20 healthy subjects. Plasma levels of oxidative stress markers, enzymatic and non-enzymatic antioxidants were estimated employing biochemical assays. The levels of pro-inflammatory cytokines such as by IL-1 beta & IL-17 in the serum were determined by ELISA, while the expression of TNF-alpha, IL-23 & IFN-gamma was ascertained by qRT-PCR. Results The onset of T1D disease was accompanied with elevation in levels of Plasma malondialdehyde, protein carbonyl content and nitric oxide while plasma vitamin C, reduced glutathione and erythrocyte sulfhydryl groups were found to be significantly decreased in T1D patients as compared to healthy control subjects. Activity of antioxidant enzymes, superoxide dismutase, catalase, glutathione reductase and glutathione-s-transferase showed a significant suppression in the erythrocytes of T1D patients as compared to healthy subjects. Nevertheless, the levels of pro-inflammatory cytokines IL-1 beta and IL-17A were significantly augmented (*** p <=.001) on one hand, while expression of T cell based cytokines IFN-gamma, TNF-alpha and IL-23 was also up-regulated (*p <=.05) as compared to healthy human subjects. Conclusion The level of pro-inflammatory cytokines and specific biochemical markers in the serum of the patient can be exploited as potential markers for type 1 diabetes pathogenesis. The study suggests that level of inflammatory markers is up-regulated in T1D patients in an age dependent manner.	[Fatima, Naureen; Moin, Shagufta] Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Dept Biochem, Aligarh 202002, Uttar Pradesh, India; [Faisal, Syed Mohd; Owais, Mohammad] Aligarh Muslim Univ, Mol Immunol Lab, Interdisciplinary Biotechnol Unit, Aligarh 202002, Uttar Pradesh, India; [Zubair, Swaleha] Aligarh Muslim Univ, Womens Coll, Aligarh 202002, Uttar Pradesh, India; [Ajmal, Mohd] Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Dept Anat, Aligarh 202002, Uttar Pradesh, India; [Siddiqui, Sheelu Shafiq] Aligarh Muslim Univ, Rajiv Gandhi Ctr Diabet & Endocrinol, Aligarh 202002, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University; Aligarh Muslim University; Aligarh Muslim University; Aligarh Muslim University	Owais, M (corresponding author), Aligarh Muslim Univ, Mol Immunol Lab, Interdisciplinary Biotechnol Unit, Aligarh 202002, Uttar Pradesh, India.	owais_lakhnawi@yahoo.com	Fatima, Naureen/AFK-6203-2022; Khan, Rehan/AAR-4803-2020; Fatima, Naureen/AAG-4508-2022; Syed, Mohammad Faisal/AAM-7496-2020	Fatima, Naureen/0000-0002-7839-8827; Khan, Rehan/0000-0001-8724-5788; Fatima, Naureen/0000-0002-7839-8827; Syed, Mohammad Faisal/0000-0002-3968-7810; Mohammad, Owais/0000-0001-7377-7388	Department of Biotechnology, Govt. of India	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	This work was supported in part by the Department of Biotechnology, Govt. of India, through a Senior Research Fellowship grant (SRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055; Arif S, 2011, DIABETES, V60, P2112, DOI 10.2337/db10-1643; Astaneie F, 2005, ARCH MED RES, V36, P376, DOI 10.1016/j.arcmed.2005.03.007; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Cacciatore I, 2010, MOLECULES, V15, P1242, DOI 10.3390/molecules15031242; CARLBERG I, 1975, J BIOL CHEM, V250, P5475; Claiborne A., 1985, CRC HDB METHODS OXYG, P283; Cosentino F, 1997, CIRCULATION, V96, P25; CROLL AD, 1986, IMMUNOLOGY, V58, P641; Dave GS, 2007, CELL MOL BIOL, V53, P68, DOI 10.1170/T820; Dean RT, 1997, BIOCHEM J, V324, P1; Delmastro MM, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/593863; Deng T, 2013, OBESITY INFLAMMATION, V2013, P25; Dib SA, 2009, DIABETOL METAB SYNDR, V1, DOI 10.1186/1758-5996-1-25; Dominguez C, 1998, DIABETES CARE, V21, P1736, DOI 10.2337/diacare.21.10.1736; Elhadd TA, 1998, DIABETES CARE, V21, P1990, DOI 10.2337/diacare.21.11.1990; Erden-Inal M, 2002, CELL BIOCHEM FUNCT, V20, P61, DOI 10.1002/cbf.937; Firoozrai M, 2007, DIABETES RES CLIN PR, V77, P427, DOI 10.1016/j.diabres.2007.02.001; Gleisner A, 2006, J PEDIATR ENDOCR MET, V19, P995; Grisham MB, 1996, METHOD ENZYMOL, V268, P237; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hoarau E, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.441; Hoeldtke RD, 2003, J CLIN ENDOCR METAB, V88, P1624, DOI 10.1210/jc.2002-021525; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; JOLLOW DJ, 1974, PHARMACOLOGY, V11, P151, DOI 10.1159/000136485; Kahaly GJ, 2016, AUTOIMMUN REV, V15, P644, DOI 10.1016/j.autrev.2016.02.017; KAWAMURA N, 1992, J CLIN ENDOCR METAB, V74, P1352, DOI 10.1210/jc.74.6.1352; Komosinska-Vassev K, 2005, DIABETES RES CLIN PR, V68, P207, DOI 10.1016/j.diabres.2004.10.004; Kumar P, 2015, HEALTHY AGING RES, V4; KYAW A, 1978, CLIN CHIM ACTA, V86, P153, DOI 10.1016/0009-8981(78)90128-6; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Li M, 2014, J CELL MOL MED, V18, P749, DOI 10.1111/jcmm.12270; Lin CC, 2014, J TRACE ELEM MED BIO, V28, P18, DOI 10.1016/j.jtemb.2013.11.001; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Martin-Gallan P, 2003, FREE RADICAL BIO MED, V34, P1563, DOI 10.1016/S0891-5849(03)00185-0; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Menon V, 2004, DIABETIC MED, V21, P1346, DOI 10.1111/j.1464-5491.2004.01417.x; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Nielsen F, 1997, CLIN CHEM, V43, P1209; Obregon C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120134; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; OU PM, 1994, BIOCHEM J, V303, P935, DOI 10.1042/bj3030935; Padgett LE, 2013, ANN NY ACAD SCI, V1281, P16, DOI 10.1111/j.1749-6632.2012.06826.x; Pandey KB, 2010, OXID MED CELL LONGEV, V3, P2, DOI 10.4161/oxim.3.1.10476; Poljsak B, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/956792; Ramakrishna V, 2007, DIAGN PATHOL, V2, DOI 10.1186/1746-1596-2-22; Ruiz C, 1999, SCAND J CLIN LAB INV, V59, P99, DOI 10.1080/00365519950185823; Sadi J, 2013, TURK J BIOCHEM, V38, P106; Seckin D, 2006, DIABETES RES CLIN PR, V73, P191, DOI 10.1016/j.diabres.2006.01.001; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Shi XX, 2015, J STEROID BIOCHEM, V145, P103, DOI 10.1016/j.jsbmb.2014.10.014; Stambouli-Guerriche AB, 2015, J DIABETES ENDOCRINO, V6, P5; Steck AK, 2011, CLIN CHEM, V57, P176, DOI 10.1373/clinchem.2010.148221; Szablewski L, 2014, INT IMMUNOPHARMACOL, V22, P182, DOI 10.1016/j.intimp.2014.06.033; Teodoro JS, 2013, MOL CELL BIOCHEM, V376, P103, DOI 10.1007/s11010-012-1555-9; Valabhji J, 2001, DIABETES CARE, V24, P1608, DOI 10.2337/diacare.24.9.1608; Varvarovska J, 2004, BIOMED PHARMACOTHER, V58, P539, DOI 10.1016/j.biopha.2004.09.011; Vessby J, 2002, J INTERN MED, V251, P69, DOI 10.1046/j.1365-2796.2002.00927.x; Yaochite JNU, 2012, J CLIN CELL IMMUNO S, pS10; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Ziobro A, 2013, MOL CELL BIOCHEM, V378, P267, DOI 10.1007/s11010-013-1617-7	65	52	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161548	10.1371/journal.pone.0161548	http://dx.doi.org/10.1371/journal.pone.0161548			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575603	Green Submitted, Green Published, gold			2022-12-26	WOS:000382877200029
J	Garringer, HJ; Irimia, JM; Li, W; Goodwin, CB; Richine, B; Acton, A; Chan, RJ; Peacock, M; Muhoberac, BB; Ghetti, B; Vidal, R				Garringer, Holly J.; Irimia, Jose M.; Li, Wei; Goodwin, Charles B.; Richine, Briana; Acton, Anthony; Chan, Rebecca J.; Peacock, Munro; Muhoberac, Barry B.; Ghetti, Bernardino; Vidal, Ruben			Effect of Systemic Iron Overload and a Chelation Therapy in a Mouse Model of the Neurodegenerative Disease Hereditary Ferritinopathy	PLOS ONE			English	Article							LIGHT-POLYPEPTIDE GENE; CLINICAL-FEATURES; HYDROGEN-PEROXIDE; MUTANT FORM; ACCUMULATION; HOMEOSTASIS; MICE; MUTATION; DEFERIPRONE; METABOLISM	Mutations in the ferritin light chain (FTL) gene cause the neurodegenerative disease neuro-ferritinopathy or hereditary ferritinopathy (HF). HF is characterized by a severe movement disorder and by the presence of nuclear and cytoplasmic iron-containing ferritin inclusion bodies (IBs) in glia and neurons throughout the central nervous system (CNS) and in tissues of multiple organ systems. Herein, using primary mouse embryonic fibroblasts from a mouse model of HF, we show significant intracellular accumulation of ferritin and an increase in susceptibility to oxidative damage when cells are exposed to iron. Treatment of the cells with the iron chelator deferiprone (DFP) led to a significant improvement in cell viability and a decrease in iron content. In vivo, iron overload and DFP treatment of the mouse model had remarkable effects on systemic iron homeostasis and ferritin deposition, without significantly affecting CNS pathology. Our study highlights the role of iron in modulating ferritin aggregation in vivo in the disease HF. It also puts emphasis on the potential usefulness of a therapy based on chelators that can target the CNS to remove and redistribute iron and to resolubilize or prevent ferritin aggregation while maintaining normal systemic iron stores.	[Garringer, Holly J.; Irimia, Jose M.; Li, Wei; Ghetti, Bernardino; Vidal, Ruben] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Goodwin, Charles B.; Richine, Briana; Chan, Rebecca J.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Acton, Anthony] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Muhoberac, Barry B.] Indiana Univ Purdue Univ, Dept Chem & Chem Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Vidal, R (corresponding author), Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA.	rvidal@iupui.edu			National Institute on Neurological Disorders and Stroke [NS050227, NS063056]; National Institute on Aging [AG10133]; NATIONAL CANCER INSTITUTE [R01CA134777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK097512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063056, R01NS050227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010133] Funding Source: NIH RePORTER	National Institute on Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants from the National Institute on Neurological Disorders and Stroke NS050227 and NS063056 and the National Institute on Aging AG10133. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants from the National Institute on Neurological Disorders and Stroke NS050227 and NS063056 and the National Institute on Aging AG10133. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors are grateful to D. Lucas and R. Richardson for technical help.	Baraibar MA, 2008, J BIOL CHEM, V283, P31679, DOI 10.1074/jbc.M805532200; Baraibar MA, 2012, FREE RADICAL BIO MED, V52, P1692, DOI 10.1016/j.freeradbiomed.2012.02.015; Baraibar MA, 2010, J BIOL CHEM, V285, P1950, DOI 10.1074/jbc.M109.042986; Barbeito AG, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-50; Barbeito AG, 2009, J NEUROCHEM, V109, P1067, DOI 10.1111/j.1471-4159.2009.06028.x; Benarroch EE, 2009, NEUROLOGY, V72, P1436, DOI 10.1212/WNL.0b013e3181a26b30; BERDOUKAS V, 1993, LANCET, V341, P1088, DOI 10.1016/0140-6736(93)92443-W; Capoccia S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118990; Chinnery PF, 2007, BRAIN, V130, P110, DOI 10.1093/brain/awl319; Cossu G, 2014, PARKINSONISM RELAT D, V20, P651, DOI 10.1016/j.parkreldis.2014.03.002; Deng XL, 2010, NEUROSCI LETT, V479, P44, DOI 10.1016/j.neulet.2010.05.025; Dev S, 2015, FREE RADICAL BIO MED, V86, P78, DOI 10.1016/j.freeradbiomed.2015.05.025; Galanello Renzo, 2007, Ther Clin Risk Manag, V3, P795; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Hider RC, 2011, METALLOMICS, V3, P239, DOI 10.1039/c0mt00087f; Jia CH, 2013, CELL DEATH DIFFER, V20, P248, DOI 10.1038/cdd.2012.115; Kubota A, 2009, MOVEMENT DISORD, V24, P441, DOI 10.1002/mds.22435; Li W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117435; Moon SN, 2011, PEDIATR CARDIOL, V32, P947, DOI 10.1007/s00246-011-0019-4; Muhoberac BB, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00032; Muhoberac BB, 2011, BBA-MOL BASIS DIS, V1812, P544, DOI 10.1016/j.bbadis.2010.10.010; PORTER JB, 1991, BLOOD, V78, P2727; SCHUERMANN M, 1990, NUCLEIC ACIDS RES, V18, P4945, DOI 10.1093/nar/18.16.4945; Vidal R, 2004, J NEUROPATH EXP NEUR, V63, P363, DOI 10.1093/jnen/63.4.363; Vidal R, 2008, J NEUROSCI, V28, P60, DOI 10.1523/JNEUROSCI.3962-07.2008; Vidal R, 2015, NEUROPATHOLOGY OF NEURODEGENERATIVE DISEASES: A PRACTICAL GUIDE, P263; Yatmark P, 2014, EXP TOXICOL PATHOL, V66, P333, DOI 10.1016/j.etp.2014.03.002	27	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161341	10.1371/journal.pone.0161341	http://dx.doi.org/10.1371/journal.pone.0161341			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27574973	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877200023
J	Wu, SJ; Zhang, XM; Han, JQ				Wu, Sijia; Zhang, Xinman; Han, Jiuqiang			A Computational Model for Predicting RNase H Domain of Retrovirus	PLOS ONE			English	Article							RIBONUCLEASE H; SEQUENCE; IDENTIFICATION	RNase H (RNH) is a pivotal domain in retrovirus to cleave the DNA-RNA hybrid for continuing retroviral replication. The crucial role indicates that RNH is a promising drug target for therapeutic intervention. However, annotated RNHs in UniProtKB database have still been insufficient for a good understanding of their statistical characteristics so far. In this work, a computational RNH model was proposed to annotate new putative RNHs (np-RNHs) in the retroviruses. It basically predicts RNH domains through recognizing their start and end sites separately with SVM method. The classification accuracy rates are 100%, 99.01% and 97.52% respectively corresponding to jack-knife, 10-fold cross-validation and 5-fold cross-validation test. Subsequently, this model discovered 14,033 np-RNHs after scanning sequences without RNH annotations. All these predicted np-RNHs and annotated RNHs were employed to analyze the length, hydrophobicity and evolutionary relationship of RNH domains. They are all related to retroviral genera, which validates the classification of retroviruses to a certain degree. In the end, a software tool was designed for the application of our prediction model. The software together with datasets involved in this paper can be available for free download at https://sourceforge.net/projects/rhtool/files/?source=navbar.	[Wu, Sijia; Zhang, Xinman; Han, Jiuqiang] Xi An Jiao Tong Univ, Sch Elect & Informat Engn, Xian, Peoples R China	Xi'an Jiaotong University	Zhang, XM; Han, JQ (corresponding author), Xi An Jiao Tong Univ, Sch Elect & Informat Engn, Xian, Peoples R China.	zhangxinman@mail.xjtu.edu.cn; jqhan@mail.xjtu.edu.cn			Ph.D. Program Foundation of the Ministry of Education of China [20110201110010]	Ph.D. Program Foundation of the Ministry of Education of China(Ministry of Education, China)	This work was supported by grants from the Ph.D. Program Foundation of the Ministry of Education of China (No. 20110201110010). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Beilhartz GL, 2010, VIRUSES-BASEL, V2, P900, DOI 10.3390/v2040900; Biegert A, 2009, P NATL ACAD SCI USA, V106, P3770, DOI 10.1073/pnas.0810767106; Byvatov Evgeny, 2003, Appl Bioinformatics, V2, P67; Champoux JJ, 2009, FEBS J, V276, P1506, DOI 10.1111/j.1742-4658.2009.06909.x; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Coffin JM, 1992, STRUCTURE CLASSIFICA, P19; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cui Y, 2013, BIOCHEM BIOPH RES CO, V431, P221, DOI 10.1016/j.bbrc.2012.12.131; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Ho MH, 2010, J AM CHEM SOC, V132, P13702, DOI 10.1021/ja102933y; Imamichi T, 2004, CURR PHARM DESIGN, V10, P4039, DOI 10.2174/1381612043382440; Johnson WE, 2007, NAT BIOTECHNOL, V25, P643, DOI 10.1038/nbt0607-643; KATAYANAGI K, 1993, PROTEINS, V17, P337, DOI 10.1002/prot.340170402; Klarmann George J., 2002, AIDS Reviews, V4, P183; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lv H, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Miller JT, 2001, EVALUATION RETROVIRA, P335; Nowotny M, 2006, EMBO J, V25, P1924, DOI 10.1038/sj.emboj.7601076; ONEILL HC, 1992, IMMUNOL CELL BIOL, V70, P193, DOI 10.1038/icb.1992.24; Rosenberg N, 2011, RETROVIRUSES AND INSIGHTS INTO CANCER, P1, DOI 10.1007/978-0-387-09581-3_1; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sinha S, 2006, BIOINFORMATICS, V22, pE454, DOI 10.1093/bioinformatics/btl227; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Telesnitsky A, 1997, REVERSE TRANSCRIPTAS; TEMIN HM, 1993, P NATL ACAD SCI USA, V90, P6900, DOI 10.1073/pnas.90.15.6900; Weiss RA, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-67; Wu SJ, 2016, COMPUT BIOL CHEM, V61, P245, DOI 10.1016/j.compbiolchem.2016.02.013; Xia XH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/917540	36	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161913	10.1371/journal.pone.0161913	http://dx.doi.org/10.1371/journal.pone.0161913			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27574780	gold, Green Published, Green Submitted			2022-12-26	WOS:000382877200044
J	Gieldon, A; Zurawa-Janicka, D; Jarzab, M; Wenta, T; Golik, P; Dubin, G; Lipinska, B; Ciarkowski, J				Gieldon, Artur; Zurawa-Janicka, Dorota; Jarzab, Miroslaw; Wenta, Tomasz; Golik, Przemyslaw; Dubin, Grzegorz; Lipinska, Barbara; Ciarkowski, Jerzy			Distinct 3D Architecture and Dynamics of the Human HtrA2(Omi) Protease and Its Mutated Variants	PLOS ONE			English	Article							MITOCHONDRIAL QUALITY-CONTROL; SERINE-PROTEASE; CRYSTAL-STRUCTURE; HTRA-FAMILY; PARKINSONS-DISEASE; MOLECULAR-DYNAMICS; STRUCTURAL BASIS; STRESS SENSOR; ACTIVATION; DOMAIN	HtrA2(Omi) protease controls protein quality in mitochondria and plays a major role in apoptosis. Its HtrA2(S306A) mutant (with the catalytic serine routinely disabled for an X-ray study to avoid self-degradation) is a homotrimer whose subunits contain the serine protease domain (PD) and the regulatory PDZ domain. In the inactive state, a tight inter-domain interface limits penetration of both PDZ-activating ligands and PD substrates into their respective target sites. We successfully crystalized HtrA2(V226K/S306A), whose active counterpart HtrA2(V226K) has had higher proteolytic activity, suggesting higher propensity to opening the PD-PDZ interface than that of the wild type HtrA2. Yet, the crystal structure revealed the HtrA2(V226K/S306A) architecture typical of the inactive protein. To get a consistent interpretation of crystallographic data in the light of kinetic results, we employed molecular dynamics (MD). V325D inactivating mutant was used as a reference. Our simulations demonstrated that upon binding of a specific peptide ligand NH2-GWTMFWV-COOH, the PDZ domains open more dynamically in the wild type protease compared to the V226K mutant, whereas the movement is not observed in the V325D mutant. The movement relies on a PDZ vs. PD rotation which opens the PD-PDZ interface in a lid-like (budding flower-like in trimer) fashion. The noncovalent hinges A and B are provided by two clusters of interfacing residues, harboring V325D and V226K in the C- and N-terminal PD barrels, respectively. The opening of the subunit interfaces progresses in a sequential manner during the 50 ns MD simulation. In the systems without the ligand only minor PDZ shifts relative to PD are observed, but the interface does not open. Further activation-associated events, e.g. PDZ-L3 positional swap seen in any active HtrA protein (vs. HtrA2), were not observed. In summary, this study provides hints on the mechanism of activation of wtHtrA2, the dynamics of the inactive HtrA2(V325D), but does not allow to explain an increased activity of HtrA2(V226K).	[Gieldon, Artur; Ciarkowski, Jerzy] Univ Gdansk, Fac Chem, Wita Stwosza 63, PL-80308 Gdansk, Poland; [Zurawa-Janicka, Dorota; Jarzab, Miroslaw; Wenta, Tomasz; Lipinska, Barbara] Univ Gdansk, Dept Biochem, Fac Biol, PL-80308 Gdansk, Poland; [Golik, Przemyslaw; Dubin, Grzegorz] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Gronostajowa 7, PL-30387 Krakow, Poland; [Dubin, Grzegorz] Malopolska Ctr Biotechnol, Ul Gronostajowa 7A, PL-30387 Krakow, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk; Jagiellonian University; Jagiellonian University	Ciarkowski, J (corresponding author), Univ Gdansk, Fac Chem, Wita Stwosza 63, PL-80308 Gdansk, Poland.; Dubin, G (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Gronostajowa 7, PL-30387 Krakow, Poland.; Dubin, G (corresponding author), Malopolska Ctr Biotechnol, Ul Gronostajowa 7A, PL-30387 Krakow, Poland.	grzegorz.dubin@uj.edu.pl; jerzy.ciarkowski@ug.edu.pl	Lipinska, Barbara/ABA-6124-2020; Dubin, Grzegorz/J-8168-2014	Lipinska, Barbara/0000-0001-9510-4811; Dubin, Grzegorz/0000-0002-5535-5760; Wenta, Tomasz/0000-0002-1927-9959; Gieldon, Artur/0000-0003-0415-9214; Zurawa-Janicka, Dorota/0000-0001-5048-2245; Jarzab, Miroslaw/0000-0002-6097-3555	Ministry of Science and Higher Education of the Republic of Poland [DS-530-530-8370-D498-16, DS/530-L130-D241-15]; National Science Centre Poland [2012/07/E/NZ1/01907, UMO-2011/01/D/NZ1/01169]; European Union Structural Funds [POIG.02.01.0012-064/08, POIG.02.01.00-12-167/08]	Ministry of Science and Higher Education of the Republic of Poland(Ministry of Science and Higher Education, Poland); National Science Centre Poland(National Science Centre, Poland); European Union Structural Funds(European Commission)	This work was supported by Ministry of Science and Higher Education of the Republic of Poland, http://www.nauka.gov.pl/ DS-530-530-8370-D498-16, to AG, JC; DS/530-L130-D241-15, to DZ-J, BL; National Science Centre Poland, https://www.ncn.gov.pl/ 2012/07/E/NZ1/01907 and UMO-2011/01/D/NZ1/01169, to GD; European Union Structural Funds, http://ec.europa.eu/, POIG.02.01.0012-064/08 and POIG.02.01.00-12-167/08, to Jagiellonian University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Behbahani H, 2010, NEUROCHEM INT, V57, P668, DOI 10.1016/j.neuint.2010.08.004; Bejugam PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055416; Bhuiyan MS, 2009, CURR DRUG TARGETS, V10, P372, DOI 10.2174/138945009787846399; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chaganti LK, 2013, FASEB J, V27, P3054, DOI 10.1096/fj.13-227256; Chien J, 2009, CURR CANCER DRUG TAR, V9, P451, DOI 10.2174/156800909788486704; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Dagda RK, 2009, J BIOENERG BIOMEMBR, V41, P473, DOI 10.1007/s10863-009-9255-1; de Castro IP, 2011, MOL NEUROBIOL, V43, P80, DOI 10.1007/s12035-010-8150-4; de Regt AK, 2015, STRUCTURE, V23, P517, DOI 10.1016/j.str.2015.01.012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Glaza P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131142; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Gray CW, 2000, EUR J BIOCHEM, V267, P5699, DOI 10.1046/j.1432-1327.2000.01589.x; Gupta S, 2004, J BIOL CHEM, V279, P45844, DOI 10.1074/jbc.M404940200; Hansen G, 2013, CELL MOL LIFE SCI, V70, P761, DOI 10.1007/s00018-012-1076-4; Hartkamp J, 2010, MOL CELL, V37, P159, DOI 10.1016/j.molcel.2009.12.023; Jarzab M, 2016, BBA-PROTEINS PROTEOM, V1864, P283, DOI 10.1016/j.bbapap.2015.12.002; Jiang JS, 2008, P NATL ACAD SCI USA, V105, P11939, DOI 10.1073/pnas.0805464105; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim DY, 2003, J BIOL CHEM, V278, P6543, DOI 10.1074/jbc.M208148200; Kim S, 2011, CELL, V145, P67, DOI 10.1016/j.cell.2011.02.024; Kley J, 2011, NAT STRUCT MOL BIOL, V18, P728, DOI 10.1038/nsmb.2055; Kooistra J, 2009, J ALZHEIMERS DIS, V17, P281, DOI 10.3233/JAD-2009-1037; Krick S, 2008, P NATL ACAD SCI USA, V105, P14106, DOI 10.1073/pnas.0801146105; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Krojer T, 2010, NAT STRUCT MOL BIOL, V17, P844, DOI 10.1038/nsmb.1840; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Li WY, 2002, NAT STRUCT BIOL, V9, P436, DOI 10.1038/nsb795; LIPINSKA B, 1990, J BACTERIOL, V172, P1791, DOI 10.1128/jb.172.4.1791-1797.1990; LIU DC, 1989, MATH PROGRAM, V45, P503, DOI 10.1007/BF01589116; Mansoor SE, 2010, BIOCHEMISTRY-US, V49, P9722, DOI 10.1021/bi100907m; Martins LM, 2003, J BIOL CHEM, V278, P49417, DOI 10.1074/jbc.M308659200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MohamedMohaideen NN, 2008, BIOCHEMISTRY-US, V47, P6092, DOI 10.1021/bi701929m; Moisoi N, 2009, CELL DEATH DIFFER, V16, P449, DOI 10.1038/cdd.2008.166; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nickolls John, 2008, ACM Queue, V6, DOI 10.1145/1365490.1365500; Park HJ, 2004, NEUROSCI LETT, V357, P63, DOI 10.1016/j.neulet.2003.11.068; Park HJ, 2006, J BIOL CHEM, V281, P34277, DOI 10.1074/jbc.M603443200; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Pierce LCT, 2012, J CHEM THEORY COMPUT, V8, P2997, DOI 10.1021/ct300284c; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sawa J, 2011, J BIOL CHEM, V286, P30680, DOI 10.1074/jbc.M111.243832; Singh N, 2014, FEBS J, V281, P2456, DOI 10.1111/febs.12799; Singh N, 2011, ARCH BIOCHEM BIOPHYS, V516, P85, DOI 10.1016/j.abb.2011.10.007; Sohn J, 2007, CELL, V131, P572, DOI 10.1016/j.cell.2007.08.044; Sohn J, 2010, J BIOL CHEM, V285, P34039, DOI 10.1074/jbc.M110.135541; Truebestein L, 2011, NAT STRUCT MOL BIOL, V18, P386, DOI 10.1038/nsmb.2013; Vande Walle L, 2008, CELL DEATH DIFFER, V15, P453, DOI 10.1038/sj.cdd.4402291; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Wrase R, 2011, P NATL ACAD SCI USA, V108, P10490, DOI 10.1073/pnas.1101084108; Zhang YN, 2007, PROTEIN SCI, V16, P1738, DOI 10.1110/ps.072833207; Zurawa-Janicka D, 2013, CELL STRESS CHAPERON, V18, P35, DOI 10.1007/s12192-012-0355-1; Zurawa-Janicka D, 2010, EXPERT OPIN THER TAR, V14, P665, DOI 10.1517/14728222.2010.487867	62	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161526	10.1371/journal.pone.0161526	http://dx.doi.org/10.1371/journal.pone.0161526			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571206	gold, Green Published, Green Submitted			2022-12-26	WOS:000382876700022
J	Park, IH; Kang, JH; Shin, JM; Lee, HM				Park, Il-Ho; Kang, Ju-Hyung; Shin, Jae-Min; Lee, Heung-Man			Trichostatin A Inhibits Epithelial Mesenchymal Transition Induced by TGF-beta 1 in Airway Epithelium	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; CHRONIC RHINOSINUSITIS; BARRIER FUNCTION; ASTHMA; SUPPRESSES; INDUCTION; FEATURES; THERAPY; CELLS; BETA	Background and Objectives Tissue remodeling is believed to cause recalcitrant chronic rhinosinusitis (CRS). Epithelial-mesenchymal transition (EMT) is a novel clinical therapeutic target in many chronic airway diseases related with tissue remodeling. The aim of this study was to investigate the effect of trichostatin A (TSA) on transforming growth factor (TGF)-beta 1-induced EMT in airway epithelium and nasal tissue. Materials and Methods A549 cells, primary nasal epithelial cells (PNECs), or inferior nasal turbinate organ culture were exposed to TSA prior to stimulation with TGF-beta 1. Expression levels of E-cadherin, vimentin, fibronectin, a-smooth muscle actin (SMA), histone deacetylase 2 (HDAC2), and HDAC4 were determined by western blotting and/or immunofluorescent staining. Hyperacetylation of histone H2 and H4 by TSA was measured by western blotting. After siHDAC transfection, the effects of HDAC2 and HDAC4 silencing on expression of E-cadherin, vimentin, fibronectin, alpha-SMA, HDAC2, and HDAC4 in TGF-beta 1-induced A549 were determined by RT-PCR and/or western blotting. We assessed the change in migration capacity of A549 cells by using cell migration assay and transwell invasion assay. Results TGF-beta 1 altered mRNA and protein expression levels of EMT markers including E-cadherin, vimentin, fibronectin, alpha-SMA, slug, and snail in A549 cells. Inhibition and silencing of HDAC2 and HDAC4 by TSA and siRNA enhanced TGF-beta 1-induced EMT in A549 cells. TSA blocked the effect of TGF-beta 1 on the migratory ability of A549 cells. In experiments using PNECs and inferior turbinate organ cultures, TSA suppressed expression of EMT markers induced by TGF-beta 1. Conclusions We showed that EMT is induced by TGF-beta 1 in airway epithelial cells and nasal tissue via activation of HDAC2 and HDAC4, and that inhibition of HDAC2 and HDAC4 by TSA reduces TGF-beta 1-induced EMT. This observation indicates that histone deacetylase inhibitors such as TSA could be potential candidates for treatment of recalcitrant CRS related with tissue remodeling.	[Park, Il-Ho; Shin, Jae-Min; Lee, Heung-Man] Korea Univ, Guro Hosp, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea; [Kang, Ju-Hyung; Lee, Heung-Man] Korea Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Lee, Heung-Man] Korea Univ, Guro Hosp, Coll Med, Med Devices Support Ctr, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University; Korea University Medicine (KU Medicine)	Lee, HM (corresponding author), Korea Univ, Guro Hosp, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea.; Lee, HM (corresponding author), Korea Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea.; Lee, HM (corresponding author), Korea Univ, Guro Hosp, Coll Med, Med Devices Support Ctr, Seoul, South Korea.	lhman@korea.ac.kr	Park, Il-Ho/AAI-1394-2019	Park, Il-Ho/0000-0002-7011-6071	Korean Health Technology RAMP;D Project, Ministry of Health AMP; Welfare, Republic of Korea [HI15C1512]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT AMP; Future Planning [NRF-2015R1C1A1A02037312]	Korean Health Technology RAMP;D Project, Ministry of Health AMP; Welfare, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT AMP; Future Planning	This work was supported by Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI15C1512), HML, https://www.htdream.kr/index.do and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2015R1C1A1A02037312), IHP, http://www.nrf.re.kr/nrf_tot_cms/index.jsp?pmi-sso-return2=none. The funders had no role in study design, data collectionr This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI15C1512) and Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2015R1C1A1A02037312)	Baguley C, 2014, INT FORUM ALLERGY RH, V4, P525, DOI 10.1002/alr.21315; Bassiouni A, 2012, LARYNGOSCOPE, V122, P460, DOI 10.1002/lary.22461; Bhavsar P, 2008, J ALLERGY CLIN IMMUN, V121, P580, DOI 10.1016/j.jaci.2007.12.1156; Blumenthal MN, 2012, ANN ALLERG ASTHMA IM, V108, P69, DOI 10.1016/j.anai.2011.12.003; Camelo S, 2005, J NEUROIMMUNOL, V164, P10, DOI 10.1016/j.jneuroim.2005.02.022; Cho JS, 2012, CLIN EXP ALLERGY, V42, P872, DOI 10.1111/j.1365-2222.2011.03931.x; Cho JS, 2013, AM J RHINOL ALLERGY, V27, P18, DOI 10.2500/ajra.2013.27.3827; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Georas SN, 2014, J ALLERGY CLIN IMMUN, V134, P509, DOI 10.1016/j.jaci.2014.05.049; Hackett TL, 2009, AM J RESP CRIT CARE, V180, P122, DOI 10.1164/rccm.200811-1730OC; Hodge S, 2009, AM J TRANSPLANT, V9, P727, DOI 10.1111/j.1600-6143.2009.02558.x; Hupin C, 2014, ALLERGY, V69, P1540, DOI 10.1111/all.12503; Kaimori A, 2010, HEPATOLOGY, V52, P1033, DOI 10.1002/hep.23765; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li MR, 2016, EXP BIOL MED, V241, P1, DOI 10.1177/1535370215597194; Milara J, 2013, THORAX, V68, P410, DOI 10.1136/thoraxjnl-2012-201761; Nawshad A, 2005, CELLS TISSUES ORGANS, V179, P11, DOI 10.1159/000084505; Ponikau JU, 2003, J ALLERGY CLIN IMMUN, V112, P877, DOI 10.1016/j.jaci.2003.08.009; Shin HW, 2012, AM J RESP CRIT CARE, V185, P944, DOI 10.1164/rccm.201109-1706OC; Smith TL, 2013, INT FORUM ALLERGY RH, V3, P4, DOI 10.1002/alr.21065; Sumi Yuki, 2007, Allergol Int, V56, P341, DOI 10.2332/allergolint.R-07-153; Vignola AM, 2000, J ALLERGY CLIN IMMUN, V105, P1041, DOI 10.1067/mai.2000.107195; Wang XX, 2015, BIOCHEM BIOPH RES CO, V456, P320, DOI 10.1016/j.bbrc.2014.11.079; Weber CE, 2012, J BURN CARE RES, V33, P311, DOI 10.1097/BCR.0b013e318240541e; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Yoshikawa M, 2007, J AM SOC NEPHROL, V18, P58, DOI 10.1681/ASN.2005111187	29	15	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0162058	10.1371/journal.pone.0162058	http://dx.doi.org/10.1371/journal.pone.0162058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571418	gold, Green Published, Green Submitted			2022-12-26	WOS:000382876700055
J	Hristozova, N; Tompa, P; Kovacs, D				Hristozova, Nevena; Tompa, Peter; Kovacs, Denes			A Novel Method for Assessing the Chaperone Activity of Proteins	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; ALCOHOL-DEHYDROGENASE; THERMAL AGGREGATION; KINETIC-PROPERTIES; CITRATE SYNTHASE; STRESS; MECHANISMS; ROLES; LOCALIZATION	Protein chaperones are molecular machines which function both during homeostasis and stress conditions in all living organisms. Depending on their specific function, molecular chaperones are involved in a plethora of cellular processes by playing key roles in nascent protein chain folding, transport and quality control. Among stress protein families-molecules expressed during adverse conditions, infection, and diseases-chaperones are highly abundant. Their molecular functions range from stabilizing stress-susceptible molecules and membranes to assisting the refolding of stress-damaged proteins, thereby acting as protective barriers against cellular damage. Here we propose a novel technique to test and measure the capability for protective activity of known and putative chaperones in a semi-high throughput manner on a plate reader. The current state of the art does not allow the in vitro measurements of chaperone activity in a highly parallel manner with high accuracy or high reproducibility, thus we believe that the method we report will be of significant benefit in this direction. The use of this method may lead to a considerable increase in the number of experimentally verified proteins with such functions, and may also allow the dissection of their molecular mechanism for a better understanding of their function.	[Hristozova, Nevena; Tompa, Peter; Kovacs, Denes] Flemish Inst Biotechnol, Dept Biol Struct, Brussels, Belgium; [Hristozova, Nevena; Tompa, Peter; Kovacs, Denes] Free Univ Brussels, Dept Biol Struct, Brussels, Belgium; [Tompa, Peter] Hungarian Acad Sci, Inst Enzymol, Budapest, Hungary	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Kovacs, D (corresponding author), Flemish Inst Biotechnol, Dept Biol Struct, Brussels, Belgium.; Kovacs, D (corresponding author), Free Univ Brussels, Dept Biol Struct, Brussels, Belgium.	dkovacs@vub.ac.be	Kovacs, Denes/N-9923-2017	Kovacs, Denes/0000-0003-1795-2609; Hristozova, Nevena/0000-0003-2600-9196; Tompa, Peter/0000-0001-8042-9939	Fonds Wetenschappelijk Onderzoek (FWO) [G.0029.12]; FWO postdoctoral fellowship [1.2.734.13]	Fonds Wetenschappelijk Onderzoek (FWO)(FWO); FWO postdoctoral fellowship(FWO)	This work was supported by the Odysseus grant G.0029.12 from the Fonds Wetenschappelijk Onderzoek (FWO, http://www.fwo.be) to PT, and DK is supported by a FWO postdoctoral fellowship 1.2.734.13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarraberes FA, 2001, J CELL SCI, V114, P2491; Alder NN, 2005, J CELL BIOL, V168, P389, DOI 10.1083/jcb.200409174; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Benjamin IJ, 1998, CIRC RES, V83, P117, DOI 10.1161/01.RES.83.2.117; BLOCH MA, 1995, J CELL SCI, V108, P3541; Borgmann U, 2002, MOL KINETICS BEEF HE; Buchner J, 1998, METHOD ENZYMOL, V290, P323, DOI 10.1016/S0076-6879(98)90029-5; Calderwood SK, 2007, ANN NY ACAD SCI, V1113, P28, DOI 10.1196/annals.1391.019; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103; DeLuca MA, 1978, METHOD ENZYMOL, P3; DONG AC, 1995, J PHARM SCI-US, V84, P415, DOI 10.1002/jps.2600840407; ELLIS RJ, 1993, MOL CHAPERONES; FALOONA GR, 1969, BIOCHEMISTRY-US, V8, P4497, DOI 10.1021/bi00839a041; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; Freeman BC, 1996, EMBO J, V15, P2969, DOI 10.1002/j.1460-2075.1996.tb00660.x; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; HAUGAARD N, 1959, BIOCHIM BIOPHYS ACTA, V31, P66, DOI 10.1016/0006-3002(59)90439-1; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; Henderson B, 2006, INFECT IMMUN, V74, P3693, DOI 10.1128/IAI.01882-05; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Kim SY, 2010, PLANT CELL REP, V29, P203, DOI 10.1007/s00299-009-0813-0; Kovacs D, 2008, PLANT PHYSIOL, V147, P381, DOI 10.1104/pp.108.118208; Kovacs D, 2008, PLANT SIGNAL BEHAV, V3, P710, DOI 10.4161/psb.3.9.6434; Li S, 2001, INT J BIOCHEM CELL B, V33, P279, DOI 10.1016/S1357-2725(01)00003-6; Li W, 2013, INT REV CEL MOL BIO, V303, P203, DOI 10.1016/B978-0-12-407697-6.00005-2; Macario AJL, 2005, NEW ENGL J MED, V353, P1489, DOI 10.1056/NEJMra050111; Macario AJL, 2001, FRONT BIOSCI-LANDMRK, V6, pD262, DOI 10.2741/Macario; Macario AJL, 2007, FRONT BIOSCI-LANDMRK, V12, P2588, DOI 10.2741/2257; MAKEMSON JC, 1986, J BACTERIOL, V165, P461, DOI 10.1128/jb.165.2.461-466.1986; Marini I, 2005, CELL MOL LIFE SCI, V62, P3092, DOI 10.1007/s00018-005-5397-4; Markossian KA, 2008, BBA-PROTEINS PROTEOM, V1784, P1286, DOI 10.1016/j.bbapap.2008.04.030; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mayer MP, 1999, CURR BIOL, V9, pR322, DOI 10.1016/S0960-9822(99)80203-6; Muchowskil PJ, 2002, NEURON, V35, P9, DOI 10.1016/S0896-6273(02)00761-4; NEALSON KH, 1970, J BACTERIOL, V104, P313, DOI 10.1128/JB.104.1.313-322.1970; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; PINTO M, 1991, J BIOL CHEM, V266, P13941; Quan S, 2012, BIOESSAYS, V34, P973, DOI 10.1002/bies.201200059; Rasouli S, 2011, APPL BIOCHEM BIOTECH, V165, P572, DOI 10.1007/s12010-011-9276-1; Rassow J, 1997, TRENDS CELL BIOL, V7, P129, DOI 10.1016/S0962-8924(96)10056-8; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Schumacher Robert J, 1996, COOPERATIVE ACTION H; SKOWYRA D, 1990, CELL, V62, P939, DOI 10.1016/0092-8674(90)90268-J; Slavotinek AM, 2001, TRENDS GENET, V17, P528, DOI 10.1016/S0168-9525(01)02413-1; Soltys BJ, 1997, CELL BIOL INT, V21, P315, DOI 10.1006/cbir.1997.0144; Sorensen JG, 2005, CELL STRESS CHAPERON, V10, P312, DOI 10.1379/CSC-128R1.1; Srivastava P, 2003, INTERACTION HEAT SHO; Teshima T, 1997, APPL MICROBIOL BIOT, V48, P41, DOI 10.1007/s002530051012; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; WAGNER FW, 1983, BIOCHEMISTRY-US, V22, P1857, DOI 10.1021/bi00277a018; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wyatt AR, 2013, ANNU REV BIOCHEM, V82, P295, DOI 10.1146/annurev-biochem-072711-163904; Yang WB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00406	56	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161970	10.1371/journal.pone.0161970	http://dx.doi.org/10.1371/journal.pone.0161970			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564234	Green Published, Green Accepted, gold			2022-12-26	WOS:000382496300040
J	Garbuglia, AR; Visco-Comandini, U; Lionetti, R; Lapa, D; Castiglione, F; D'Offizi, G; Taibi, C; Montalbano, M; Capobianchi, MR; Paci, P				Garbuglia, Anna Rosa; Visco-Comandini, Ubaldo; Lionetti, Raffaella; Lapa, Daniele; Castiglione, Filippo; D'Offizi, Gianpiero; Taibi, Chiara; Montalbano, Marzia; Capobianchi, Maria Rosaria; Paci, Paola			Ultrasensitive HCV RNA Quantification in Antiviral Triple Therapy: New Insight on Viral Clearance Dynamics and Treatment Outcome Predictors	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; C VIRUS-INFECTION; HEPATITIS-C; TELAPREVIR; KINETICS; EFFICACY; ASSAYS; BOCEPREVIR; SIMEPREVIR; MANAGEMENT	Objectives Identifying the predictive factors of Sustained Virological Response (SVR) represents an important challenge in new interferon-based DAA therapies. Here, we analyzed the kinetics of antiviral response associated with a triple drug regimen, and the association between negative residual viral load at different time points during treatment. Methods Twenty-three HCV genotype 1 (GT 1a n = 11; GT1b n = 12) infected patients were included in the study. Linear Discriminant Analysis (LDA) was used to establish possible association between HCV RNA values at days 1 and 4 from start of therapy and SVR. Principal component analysis (PCA) was applied to analyze the correlation between HCV RNA slope and SVR. A ultrasensitive (US) method was established to measure the residual HCV viral load in those samples which resulted "detected <12IU/ml" or undetectable with ABBOTT standard assay, and was retrospectively used on samples collected at different time points to establish its predictive power for SVR. Results According to LDA, there was no association between SVR and viral kinetics neither at time points earlier than 1 week (days 1 and 4) after therapy initiation nor later. The slopes were not relevant for classifying patients as SVR or no-SVR. No significant differences were observed in the median HCV RNA values at T0 among SVR and no-SVR patients. HCV RNA values with US protocol (LOD 1.2 IU/ml) after 1 month of therapy were considered; the area under the ROC curve was 0.70. Overall, PPV and NPV of undetectable HCV RNA with the US method for SVR was 100% and 46.7%, respectively; sensitivity and specificity were 38.4% and 100% respectively. Conclusion HCV RNA "not detected" by the US method after 1 month of treatment is predictive of SVR in first generation Protease inhibitor (PI)-based triple therapy. The US method could have clinical utility for advanced monitoring of virological response in new interferon based DAA combination regimens.	[Garbuglia, Anna Rosa; Lapa, Daniele; Capobianchi, Maria Rosaria] IRCCS, Virol Lab, Lazzaro Spallanzani Natl Inst Infect Dis, Rome, Italy; [Visco-Comandini, Ubaldo; Lionetti, Raffaella; D'Offizi, Gianpiero; Taibi, Chiara; Montalbano, Marzia] IRCCS, Lazzaro Spallanzani Natl Inst Infect Dis, Clin Dept, Rome, Italy; [Castiglione, Filippo] CNR, IAC, Rome, Italy; [Paci, Paola] CNR, Ist Analisi Sistemi & Informat Antonio Ruberti IA, Rome, Italy	IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani; Consiglio Nazionale delle Ricerche (CNR); Istituto per le Applicazioni del Calcolo "Mauro Picone" (IAC-CNR); Consiglio Nazionale delle Ricerche (CNR)	Garbuglia, AR (corresponding author), IRCCS, Virol Lab, Lazzaro Spallanzani Natl Inst Infect Dis, Rome, Italy.	argarbuglia@iol.it	Castiglione, Filippo/B-1366-2010; GARBUGLIA, ANNA ROSA/AAC-6556-2022	Castiglione, Filippo/0000-0002-1442-3552; GARBUGLIA, ANNA ROSA/0000-0002-2687-8642	Italian Ministry of Health; "Ricerca Corrente" Fund	Italian Ministry of Health(Ministry of Health, Italy); "Ricerca Corrente" Fund	This work was partially supported by the Italian Ministry of Health (fondi Ricerca Corrente to National Institute for Infectious Diseases INMI IRCCS "L. Spallanzani").; We wish to kindly acknowledge Dr Stefano Belladonna for technical support. This work was supported by "Ricerca Corrente" Fund.	Abbott Molecular Inc, 2011, ABB REAL TIM HCV PAC; Awad T, 2010, HEPATOLOGY, V51, P1176, DOI 10.1002/hep.23504; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen JM, 2013, GASTROENTEROLOGY, V144, P1450, DOI 10.1053/j.gastro.2013.02.039; Dahari H, 2009, GASTROENTEROLOGY, V136, P1402, DOI 10.1053/j.gastro.2008.12.060; Duda R.O., 2000, PATTERN CLASSIFICATI; Ferenci P, 2015, NAT REV GASTRO HEPAT, V12, P10, DOI 10.1038/nrgastro.2014.198; Fevery B, 2014, ANTIVIR THER, V19, P559, DOI 10.3851/IMP2760; Galen R S, 1982, Clin Lab Med, V2, P685; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Harrington PR, 2012, HEPATOLOGY, V55, P1048, DOI 10.1002/hep.24791; Jackson JE, 1991, USERS GUIDE PRINCIPA; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Jolliffe I.T., 1986, PRINCIPAL COMPONENT, P487, DOI [DOI 10.1007/B98835, 10.1007/978-1-4757-1904-8_8]; Kanda T, 2016, INT J MED SCI, V13, P310, DOI 10.7150/ijms.14953; Kinai E, 2007, J MED VIROL, V79, P1113, DOI 10.1002/jmv.20908; Maasoumy B, 2014, ALIMENT PHARM THER, V39, P85, DOI 10.1111/apt.12544; Moreno C, 2015, J HEPATOL, V62, P1047, DOI 10.1016/j.jhep.2014.12.031; Moreno C, 2010, J HEPATOL, V52, P25, DOI 10.1016/j.jhep.2009.10.003; Nishida N, 2015, DIGEST DIS, V33, P708, DOI 10.1159/000439075; Ogawa E, 2016, ANTIVIR RES, V126, P35, DOI 10.1016/j.antiviral.2015.12.001; Ogawa E, 2013, ANTIVIR RES, V99, P119, DOI 10.1016/j.antiviral.2013.05.002; Sarrazin C, 2012, Z GASTROENTEROL, V50, P57, DOI 10.1055/s-0031-1282015; Sarrazin C, 2015, J CLIN MICROBIOL, V53, P1264, DOI 10.1128/JCM.03030-14; Sarrazin C, 2015, J VIROL METHODS, V214, P29, DOI 10.1016/j.jviromet.2014.11.027; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Soriano V, 2011, J ANTIMICROB CHEMOTH, V66, P1673, DOI 10.1093/jac/dkr215; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Vermehren J, 2014, J HEPATOL, V60, P913, DOI 10.1016/j.jhep.2014.01.002; Visco-Comandini U, 2014, DIGEST LIVER DIS, V46, P348, DOI 10.1016/j.dld.2013.11.006; Wiesmann F, 2015, MED MICROBIOL IMMUN, V204, P515, DOI 10.1007/s00430-014-0364-z; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	35	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0158989	10.1371/journal.pone.0158989	http://dx.doi.org/10.1371/journal.pone.0158989			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560794	gold, Green Published, Green Submitted			2022-12-26	WOS:000382258600003
J	Jelinek, GA; De Livera, AM; Marck, CH; Brown, CR; Neate, SL; Taylor, KL; Weiland, TJ				Jelinek, George A.; De Livera, Alysha M.; Marck, Claudia H.; Brown, Chelsea R.; Neate, Sandra L.; Taylor, Keryn L.; Weiland, Tracey J.			Associations of Lifestyle, Medication, and Socio-Demographic Factors with Disability in People with Multiple Sclerosis: An International Cross-Sectional Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; ALCOHOL-CONSUMPTION; DISEASE-ACTIVITY; RISK; QUESTIONNAIRE; METAANALYSIS; STEPS; DIET	Objective Emerging evidence links modifiable lifestyle risk factors to disease progression in multiple sclerosis (MS). We sought further evidence around this hypothesis through detailed analysis of the association with disability of lifestyle behaviours of a large international sample of people with MS. Materials and Methods A total of 2469 people with MS from 57 countries provided self-reported data via cross-sectional online survey on lifestyle (mostly with validated tools) and the primary outcome measure, disability (Patient Determined Disease Steps), categorised from 8 steps into 3 categories, mild, moderate and major disability. Multinomial logistic regression modelling derived relative risk ratios (RRRs) for disability categories. Results RRRs of having moderate vs mild disability were: diet (per 30 points on 100 point scale) 0.72 (95% CI 0.52-0.98), ever smoking 1.32 (1.06-1.65), exercise (moderate/high vs low) 0.35 (0.28-0.44), latitude (per degree from the equator) 1.02 (1.01-1.04), and number of comorbidities (2 vs none) 1.43 (1.04-1.95), (3 vs none) 1.56 (1.13-2.16). RRRs of having major vs mild disability were: exercise (moderate/high vs low) 0.07 (0.04-0.11), alcohol consumption (moderate vs low) 0.45 (0.30-0.68), plant-based omega 3 supplementation 0.39 (0.18-0.86), and disease-modifying medication use 0.45 (0.29-0.70). Conclusions Healthier lifestyle has strong associations with disability in our large international sample of people with MS, supporting further investigation into the role of lifestyle risk factors in MS disease progression.	[Jelinek, George A.; De Livera, Alysha M.; Marck, Claudia H.; Brown, Chelsea R.; Neate, Sandra L.; Taylor, Keryn L.; Weiland, Tracey J.] Univ Melbourne, Neuroepidemiol Unit, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia	University of Melbourne	Jelinek, GA (corresponding author), Univ Melbourne, Neuroepidemiol Unit, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia.	g.jelinek@unimelb.edu.au	De Livera, Alysha/AAU-6661-2021; Weiland, Tracey/Y-2029-2018	De Livera, Alysha/0000-0003-4981-4155; Weiland, Tracey/0000-0002-4053-5507; TAYLOR, KERYN/0000-0001-7543-4362; Marck, Claudia/0000-0002-3173-1522; BROWN, CHELSEA/0000-0002-4168-0319	philanthropic donations from Bloom Foundation; Horne Family Foundation	philanthropic donations from Bloom Foundation; Horne Family Foundation	This work was funded by philanthropic donations from the Bloom Foundation and the Horne Family Foundation. Funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Albert BB, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/464921; BLAKE RL, 1986, J FAM PRACTICE, V22, P82; Corthals AP, 2011, Q REV BIOL, V86, P287, DOI 10.1086/662453; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Ebers GC, 2008, NEUROL; Fernandez O, 2013, J NEUROL SCI, V331, P10, DOI 10.1016/j.jns.2013.04.021; Grant WB, 2016, NEUROLOGY; Hadgkiss EJ, 2015, NUTR NEUROSCI, V18, P125, DOI 10.1179/1476830514Y.0000000117; Hadgkiss EJ, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/580596; HOHOL MJ, 1995, NEUROLOGY, V45, P251, DOI 10.1212/WNL.45.2.251; Hohol MJ, 1999, MULT SCLER, V5, P349, DOI 10.1177/135245859900500508; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; Jelinek G., 2016, OVERCOMING MULTIPLE; Jelinek GA, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0394-1; Jelinek GA, 2013, INT J NEUROSCI, V123, P792, DOI 10.3109/00207454.2013.803104; Jelinek George A, 2009, Qual Prim Care, V17, P55; Kavaliunas A, 2015, ADV EXP MED BIOL, V822, P19, DOI 10.1007/978-3-319-08927-0_5; Marck CH, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-143; Marck CH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148573; Marrie RA, 2006, NEUROLOGY, V66, P1235, DOI 10.1212/01.wnl.0000208505.81912.82; Marrie RA, 2005, NEUROLOGY, V65, P1066, DOI 10.1212/01.wnl.0000178891.20579.64; McKellar S, 2008, AUST J PRIM HEALTH, V14, P43, DOI 10.1071/PY08035; Mitsonis CI, 2009, INT J NEUROSCI, V119, P315, DOI 10.1080/00207450802480192; Motl RW, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0585-6; Ramanujam R, 2015, JAMA NEUROL, V72, P1117, DOI 10.1001/jamaneurol.2015.1788; Riccio P, 2015, ASN NEURO, V7, DOI 10.1177/1759091414568185; Rietberg MB, 2011, COCHRANE DATABASE SY; Roerecke M, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0182-6; Sadovnick AD, 1996, LANCET, V347, P1728, DOI 10.1016/S0140-6736(96)90807-7; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Shirani A, 2012, JAMA-J AM MED ASSOC, V308, P247, DOI 10.1001/jama.2012.7625; Stockwell T, 2016, J STUD ALCOHOL DRUGS, V77, P185, DOI 10.15288/jsad.2016.77.185; SWANK RL, 1990, LANCET, V336, P37, DOI 10.1016/0140-6736(90)91533-G; Tettey P, 2016, NEUROEPIDEMIOLOGY, V46, P106, DOI 10.1159/000442203; Van Buuren S, 2006, J STAT COMPUT SIM, V76, P1049, DOI 10.1080/10629360600810434; Weiland TJ, 2014, J NEUROL SCI, V336, P211, DOI 10.1016/j.jns.2013.10.046; Wingerchuk DM, 2014, MAYO CLIN PROC, V89, P225, DOI 10.1016/j.mayocp.2013.11.002; Zhang C, 2014, INT J CARDIOL, V174, P669, DOI 10.1016/j.ijcard.2014.04.225	40	31	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161701	10.1371/journal.pone.0161701	http://dx.doi.org/10.1371/journal.pone.0161701			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560626	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258600081
J	Lee, WJ; Peng, LN; Chiou, ST; Chen, LK				Lee, Wei-Ju; Peng, Li-Ning; Chiou, Shu-Ti; Chen, Liang-Kung			Relative Handgrip Strength Is a Simple Indicator of Cardiometabolic Risk among Middle-Aged and Older People: A Nationwide Population-Based Study in Taiwan	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MUSCLE STRENGTH; METABOLIC SYNDROME; GRIP STRENGTH; ASSOCIATION; SARCOPENIA; CONSENSUS; PROFILE; COHORT; MEN	Background Muscle strength may play an important role in cardiovascular health. The study was intended to evaluate the association between cardiometabolic risk, risk of coronary artery disease and handgrip strength by using the relative handgrip strength. Materials and Methods Data of 927 Taiwanese aged 53 years and older (510 men and 417 women) were retrieved from a nationwide representative population-based cohort cross-sectional study in 2006. All participants were interviewed face-to-face and received measures of anthropometry, dominant handgrip strength, relative handgrip strength (summation of both handgrip strength divided by body mass index) and serum biomarkers. Results Multivariate linear regression analysis showed the significant association between relative handgrip strength and favorable cardiometabolic risk factors including blood pressure, triglyceride, total cholesterol to high density cholesterol(HDL-C) ratio, glycohemoglobin (HbA1c), uric acid, Framingham risk score in men, and HDL-C, fasting glucose, HbA1c, log hsCRP in women. Dominant hand grip strength was only associated with log hsCRP in women. (p<0.05 for all), but was not significant associated with all cardiovascular biomarkers and FRS in both sex. Conclusions Joint with handgrip strength and body size, as relative handgrip strength, may be a better tool to capture conceptual concomitant health, which may be a simple, inexpensive, and easy-to-use tool when targeting cardiovascular health in public health level.	[Lee, Wei-Ju; Peng, Li-Ning; Chen, Liang-Kung] Natl Yang Ming Univ, Aging & Hlth Res Ctr, Taipei, Taiwan; [Lee, Wei-Ju; Peng, Li-Ning; Chiou, Shu-Ti] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Lee, Wei-Ju] Taipei Vet Gen Hosp, Yuanshan Branch, Dept Family Med, Taipei, Yilan County, Taiwan; [Peng, Li-Ning; Chen, Liang-Kung] Taipei Vet Gen Hosp, Ctr Geriatr & Gerontol, Taipei, Taiwan; [Chiou, Shu-Ti] Minist Hlth & Welf, Hlth Promot Adm, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Chen, LK (corresponding author), Natl Yang Ming Univ, Aging & Hlth Res Ctr, Taipei, Taiwan.; Chen, LK (corresponding author), Taipei Vet Gen Hosp, Ctr Geriatr & Gerontol, Taipei, Taiwan.	lkchen2@vghtpe.gov.tw	Lee, Wei-Ju/AAK-1549-2021	Lee, Wei-Ju/0000-0003-4326-333X; Chen, Liang-Kung/0000-0002-2387-8508	Ministry of Science and Technology of Taiwan [MOST 103-2633-B-400-002, MOST 105-3011-B-010-001]; Aging and Health Research Center, National Yang Ming University; Center for Geriatrics and Gerontology, Taipei Veterans General Hospital	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Aging and Health Research Center, National Yang Ming University; Center for Geriatrics and Gerontology, Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This study was supported by the Aging and Health Research Center, National Yang Ming University; Center for Geriatrics and Gerontology, Taipei Veterans General Hospital, as well as the Ministry of Science and Technology of Taiwan (MOST 103-2633-B-400-002 and MOST 105-3011-B-010-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We express our gratitude to the staff from Health Promotion Administration, Ministry of Health and Welfare, Taiwan for data gathering and to all the participants for their assistance. This study was supported by the Aging and Health Research Center, National Yang Ming University; Center for Geriatrics and Gerontology, Taipei Veterans General Hospital, as well as the Ministry of Science and Technology of Taiwan (MOST 103-2633-B-400-002); and MOST 105-3011-B-010-001).	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Aoyama T, 2011, J PHYSIOL ANTHROPOL, V30, P133, DOI 10.2114/jpa2.30.133; Babyak MA, 2009, STAT TIPS EDITORS PS; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen LK, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2016.05.016; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Chen PJ, 2012, J AM MED DIR ASSOC, V13, P517, DOI 10.1016/j.jamda.2012.02.002; Chia YC, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007324; Choquette S, 2010, J NUTR HEALTH AGING, V14, P190, DOI 10.1007/s12603-010-0047-4; Conry MC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-692; Cornman JC, 2016, INT J EPIDEMIOL, V45, P54, DOI 10.1093/ije/dyu179; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; de Ruijter W, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3083; Dong RW, 2016, J GERONTOL A-BIOL, V71, P96, DOI 10.1093/gerona/glv168; Elbaz A, 2014, INT J CARDIOL, V172, P96, DOI 10.1016/j.ijcard.2013.12.051; Fowles J, 2014, HEALTH REP, V25, P13; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Jurca R, 2004, MED SCI SPORT EXER, V36, P1301, DOI 10.1249/01.MSS.0000135780.88930.A9; Kawamoto R, 2016, CLIN EXP HYPERTENS, P1; Kleber ME, 2015, J AM SOC NEPHROL, V26, P2831, DOI 10.1681/ASN.2014070660; Lawman HG, 2016, AM J PREV MED, V50, P677, DOI 10.1016/j.amepre.2015.10.022; Lee WJ, 2013, J AM MED DIR ASSOC, V14, P528, DOI 10.1016/j.jamda.2013.03.019; Leong DP, 2015, LANCET, V386, P266, DOI 10.1016/S0140-6736(14)62000-6; Ling CHY, 2010, CAN MED ASSOC J, V182, P429, DOI 10.1503/cmaj.091278; Liu LK, 2014, GERIATR GERONTOL INT, V14, P36, DOI 10.1111/ggi.12208; Mainous AG, 2015, AM J PREV MED, V49, P850, DOI 10.1016/j.amepre.2015.05.025; Pereira LSM, 2009, ARCH GERONTOL GERIAT, V48, P313, DOI 10.1016/j.archger.2008.02.012; Minneci C, 2015, J AM GERIATR SOC, V63, P136, DOI 10.1111/jgs.13195; Nofuji Y, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2015.11.003; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Panza GA, 2014, AM J CARDIOL, V114, P1215, DOI 10.1016/j.amjcard.2014.07.042; Rodondi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034287; Sayer AA, 2007, QJM-INT J MED, V100, P707, DOI 10.1093/qjmed/hcm095; Silventoinen K, 2009, INT J EPIDEMIOL, V38, P110, DOI 10.1093/ije/dyn231; Studenski SA, 2014, J GERONTOL A-BIOL, V69, P547, DOI 10.1093/gerona/glu010; van Dijk SC, 2015, J NUTR HEALTH AGING, V19, P779, DOI 10.1007/s12603-015-0519-7; Wu SW, 2009, APPL ERGON, V40, P811, DOI 10.1016/j.apergo.2008.08.006; Yang EF, 2012, METABOLISM, V61, P317, DOI 10.1016/j.metabol.2011.07.005; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	40	84	85	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0160876	10.1371/journal.pone.0160876	http://dx.doi.org/10.1371/journal.pone.0160876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27559733	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258600017
J	Wang, XK; Xing, YY				Wang, Xiukang; Xing, Yingying			Effects of Mulching and Nitrogen on Soil Nitrate-N Distribution, Leaching and Nitrogen Use Efficiency of Maize (Zea mays L.)	PLOS ONE			English	Article							NORTH CHINA PLAIN; SEMIARID LOESS PLATEAU; DOUBLE CROPPING SYSTEM; WATER-USE EFFICIENCY; WINTER-WHEAT; CONSTRUCTED WETLANDS; TOMATO CROP; YIELD; IRRIGATION; FERTILIZER	Mulching and nitrogen are critical drivers of crop production for smallholders of the Loess Plateau in China. The purpose of this study was to investigate the effect of mulching and nitrogen fertilizer on the soil water content, soil nitrate-N content and vertical distribution in maize root-zone. The experiment was conducted over two consecutive years and used randomly assigned field plots with three replicates. The six treatments consisted of no fertilizer without plastic film (CK), plastic film mulching with no basal fertilizer and no top dressing (MN0), basal fertilizer with no top dressing and no mulching (BN1), plastic film mulching and basal fertilizer with no top dressing (MN1), basal fertilizer and top dressing with no mulching (BN2) and plastic film mulching with basal fertilizer and top dressing (MN2). In the top soil layers, the soil water content was a little high in the plastic film mulching than that without mulching. The mean soil water content from 0 to 40 cm without mulching were 3.35% lower than those measured in the corresponding mulching treatments in 31 days after sowing in 2012. The mulching treatment increased the soil nitrate-N content was observed in the 0-40-cm soil layers. The results indicate that high contents of soil nitrate-N were mainly distributed at 0-20-cm at 31 days after sowing in 2012, and the soil nitrate-N concentration in the MN2 treatment was 1.58 times higher than that did not receive fertilizer. The MN2 treatment greatly increased the soil nitrate-N content in the upper layer of soil (0-40-cm), and the mean soil nitrate-N content was increased nearly 50 mg kg(-1) at 105 days after sowing compared with CK treatment in 2012. The soil nitrate-N leaching amount in MN1 treatment was 28.61% and 39.14% lower than BN1 treatment, and the mulch effect attained to 42.55% and 65.27% in MN2 lower than BN2 in both years. The yield increased with an increase in the basal fertilizer, top dressing and plastic film mulching, and the grain yield increase ranged from 31.41% to 83.61% in two consecutive years. The MN1 and MN2 treatment is recommended because it increased the grain yield and improved the fertilizer use efficiency, compared with the no-mulching treatment.	[Wang, Xiukang; Xing, Yingying] Yanan Univ, Coll Life Sci, Yanan 716000, Shaanxi, Peoples R China; [Xing, Yingying] Chinese Acad Sci, State Key Lab Soil Eros & Dryland Farming Loess P, Inst Soil & Water Conservat, Yangling 712100, Shaanxi, Peoples R China; [Xing, Yingying] Minist Water Resources, Yangling 712100, Shaanxi, Peoples R China	Yanan University; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources	Wang, XK (corresponding author), Yanan Univ, Coll Life Sci, Yanan 716000, Shaanxi, Peoples R China.	wangxiukang@126.com	MENG, Fanqiao/J-1514-2014	MENG, Fanqiao/0000-0002-0172-7776; Xiukang, Wang/0000-0001-5638-809X	Specialized Research Fund for the Doctoral Program of Yan'an University [205040119, 205040123]; Shaanxi province high-level university construction special fund projects of ecology [2012SXTC03]; Special research in Shaanxi province department of education [16JK1853]	Specialized Research Fund for the Doctoral Program of Yan'an University; Shaanxi province high-level university construction special fund projects of ecology; Special research in Shaanxi province department of education	This research was supported by Specialized Research Fund for the Doctoral Program of Yan'an University (205040119, 205040123), Shaanxi province high-level university construction special fund projects of ecology (2012SXTC03), and Special research in Shaanxi province department of education (16JK1853).	ANDREW RH, 1976, AGRON J, V68, P422, DOI 10.2134/agronj1976.00021962006800020056x; BARBANO DM, 1990, J ASSOC OFF ANA CHEM, V73, P849; Bu LD, 2013, AGR WATER MANAGE, V123, P71, DOI 10.1016/j.agwat.2013.03.015; Chen XP, 2014, NATURE, V514, P486, DOI 10.1038/nature13609; Chilundo M, 2016, AGR WATER MANAGE, V168, P68, DOI 10.1016/j.agwat.2016.02.004; Clark LJ, 2003, PLANT SOIL, V255, P93, DOI 10.1023/A:1026140122848; Cook HF, 2006, SOIL TILL RES, V91, P227, DOI 10.1016/j.still.2005.12.007; de Silva SHSA, 2003, COMMUN SOIL SCI PLAN, V34, P1039, DOI 10.1081/CSS-120019108; Dharmakeerthi RS, 2013, COMMUN SOIL SCI PLAN, V44, P2271, DOI 10.1080/00103624.2013.800099; Djaman K, 2013, AGRON J, V105, P527, DOI 10.2134/agronj2012.0269; Elia A, 2012, EUR J AGRON, V40, P64, DOI 10.1016/j.eja.2012.02.001; Fang QX, 2013, J ENVIRON QUAL, V42, P1466, DOI 10.2134/jeq2013.03.0086; Fang QX, 2006, PLANT SOIL, V284, P335, DOI 10.1007/s11104-006-0055-7; Fernandez-Escobar R, 2014, SCI HORTIC-AMSTERDAM, V167, P1, DOI 10.1016/j.scienta.2013.12.026; FIEZ TE, 1995, SOIL SCI SOC AM J, V59, P1666, DOI 10.2136/sssaj1995.03615995005900060023x; Gao YH, 2014, FIELD CROP RES, V156, P40, DOI 10.1016/j.fcr.2013.10.016; Gentry LE, 2014, J ENVIRON QUAL, V43, P1467, DOI 10.2134/jeq2013.12.0499; Griffin G, 2009, COOP BULLET, P27; Hartmann TE, 2014, FIELD CROP RES, V160, P22, DOI 10.1016/j.fcr.2014.02.014; Hernandez M, 2015, FIELD CROP RES, V178, P8, DOI 10.1016/j.fcr.2015.03.017; Hopen H.J., 1964, J AM SOC HORTIC SCI, V89, P415; Jia XC, 2014, AGR WATER MANAGE, V137, P92, DOI 10.1016/j.agwat.2014.02.010; Jia Y, 2006, FIELD CROP RES, V97, P167, DOI 10.1016/j.fcr.2005.09.009; Jordan A, 2010, CATENA, V81, P77, DOI 10.1016/j.catena.2010.01.007; Kang SZ, 2003, AGR WATER MANAGE, V59, P239, DOI 10.1016/S0378-3774(02)00150-6; Kim Y, 2015, SCI TOTAL ENVIRON, V529, P40, DOI 10.1016/j.scitotenv.2015.04.098; LAL R, 1974, PLANT SOIL, V40, P129, DOI 10.1007/BF00011415; Leach AM, 2012, ENVIRON DEV, V1, P40, DOI 10.1016/j.envdev.2011.12.005; Li FM, 2004, SOIL TILL RES, V78, P9, DOI 10.1016/j.still.2003.12.009; Li P, 2015, J EXP BOT; Li R, 2013, AGR WATER MANAGE, V116, P101, DOI 10.1016/j.agwat.2012.10.001; Li XY, 2001, AGR WATER MANAGE, V50, P173, DOI 10.1016/S0378-3774(01)00105-6; Li YL, 2016, EXP THERM FLUID SCI, V75, P1, DOI 10.1016/j.expthermflusci.2016.01.012; Liu CA, 2014, EUR J AGRON, V52, P103, DOI 10.1016/j.eja.2013.10.001; Liu CM, 2002, AGR FOREST METEOROL, V111, P109, DOI 10.1016/S0168-1923(02)00015-1; Liu XJ, 2003, FIELD CROP RES, V83, P111, DOI 10.1016/S0378-4290(03)00068-6; Lu XJ, 2015, AGRON J, V107, P406, DOI 10.2134/agronj14.0454; Mancinelli R, 2015, SOIL TILL RES, V152, P39, DOI 10.1016/j.still.2015.04.001; McCullough BD, 2002, COMPUT STAT DATA AN, V40, P713, DOI 10.1016/S0167-9473(02)00095-6; Medrano H, 2015, AGRON SUSTAIN DEV, V35, P499, DOI 10.1007/s13593-014-0280-z; Mekonnen MM, 2016, WATER-SUI, V8, DOI 10.3390/w8010030; Mupangwa W, 2016, INT J AGR SUSTAIN, V14, P13, DOI 10.1080/14735903.2015.1011393; Murungu FS, 2011, SOIL TILL RES, V112, P58, DOI 10.1016/j.still.2010.11.005; Nin A, 2003, AM J AGR ECON, V85, P928, DOI 10.1111/1467-8276.00498; Olk DC, 1999, NUTR CYCL AGROECOSYS, V53, P35; Placella SA, 2013, APPL ENVIRON MICROB, V79, P3294, DOI 10.1128/AEM.00404-13; Qin W, 2015, SCI REP-UK, V5, DOI 10.1038/srep17514; Qin W, 2015, SCI REP-UK, V5, DOI 10.1038/srep16210; Sieling K, 2014, EUR J AGRON, V59, P13, DOI 10.1016/j.eja.2014.05.003; Ssali H, 2003, NUTR CYCL AGROECOSYS, V65, P141, DOI 10.1023/A:1022184927506; STAPLETON JJ, 1985, SOIL BIOL BIOCHEM, V17, P369, DOI 10.1016/0038-0717(85)90075-6; Sturm M, 2010, SCI HORTIC-AMSTERDAM, V125, P103, DOI 10.1016/j.scienta.2010.03.017; Wang XK, 2015, AGR WATER MANAGE, V161, P53, DOI 10.1016/j.agwat.2015.07.019; Wang YJ, 2009, AGR WATER MANAGE, V96, P374, DOI 10.1016/j.agwat.2008.09.012; Windham-Myers L, 2014, SCI TOTAL ENVIRON, V484, P221, DOI 10.1016/j.scitotenv.2014.01.033; Wu HM, 2013, ENVIRON SCI POLLUT R, V20, P443, DOI 10.1007/s11356-012-0996-8; Yadav RL, 1998, EXP AGR, V34, P1, DOI 10.1017/S0014479798001070; Yagioka A, 2015, AGR ECOSYST ENVIRON, V200, P42, DOI 10.1016/j.agee.2014.09.011; Yang JF, 2007, HYDROL PROCESS, V21, P717, DOI 10.1002/hyp.6246; Yang XL, 2015, AGR ECOSYST ENVIRON, V199, P34, DOI 10.1016/j.agee.2014.08.019; Yang ZC, 2016, WATER-SUI, V8, DOI 10.3390/w8010024; Zhang GX, 2007, HYDROL PROCESS, V21, P1055, DOI 10.1002/hyp.6286; Zhang WF, 2013, P NATL ACAD SCI USA, V110, P8375, DOI 10.1073/pnas.1210447110; Zhao W, 2015, SOIL SCI PLANT NUTR, V61, P846, DOI 10.1080/00380768.2015.1066232; Zhou LM, 2009, FIELD CROP RES, V113, P41, DOI 10.1016/j.fcr.2009.04.005; Zhou MH, 2014, PLANT SOIL, V374, P977, DOI 10.1007/s11104-013-1876-9; Zhou S, 2008, ECOL ENG, V32, P147, DOI 10.1016/j.ecoleng.2007.10.004; Ziadi N, 2012, CAN J PLANT SCI, V92, P331, DOI [10.4141/CJPS2011-086, 10.4141/cjps2011-086]; Zingore S, 2008, NUTR CYCL AGROECOSYS, V80, P267, DOI 10.1007/s10705-007-9142-2	69	35	35	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161612	10.1371/journal.pone.0161612	http://dx.doi.org/10.1371/journal.pone.0161612			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560826	Green Submitted, Green Published, gold			2022-12-26	WOS:000382258600063
J	Larrayoz, IM; Rey-Funes, M; Contartese, DS; Rolon, F; Sarotto, A; Dorfman, VB; Loidl, CF; Martinez, A				Larrayoz, Ignacio M.; Rey-Funes, Manuel; Contartese, Daniela S.; Rolon, Federico; Sarotto, Anibal; Dorfman, Veronica B.; Loidl, Cesar F.; Martinez, Alfredo			Cold Shock Proteins Are Expressed in the Retina Following Exposure to Low Temperatures	PLOS ONE			English	Article							LOCAL HYPOTHERMIA PROTECTS; THERAPEUTIC HYPOTHERMIA; BINDING; ISCHEMIA; CIRP; RBM3; STRESS; BRAIN; CELLS; NEUROPROTECTION	Hypothermia has been proposed as a therapeutic intervention for some retinal conditions, including ischemic insults. Cold exposure elevates expression of cold-shock proteins (CSP), including RNA-binding motif protein 3 (RBM3) and cold inducible RNA-binding protein (CIRP), but their presence in mammalian retina is so far unknown. Here we show the effects of hypothermia on the expression of these CSPs in retina-derived cell lines and in the retina of newborn and adult rats. Two cell lines of retinal origin, R28 and mRPE, were exposed to 32 degrees C for different time periods and CSP expression was measured by qRTPCR and Western blotting. Neonatal and adult Sprague-Dawley rats were exposed to a cold environment (8 degrees C) and expression of CSPs in their retinas was studied by Western blotting, multiple inmunofluorescence, and confocal microscopy. RBM3 expression was upregulated by cold in both R28 and mRPE cells in a time-dependent fashion. On the other hand, CIRP was upregulated in R28 cells but not in mRPE. In vivo, expression of CSPs was negligible in the retina of newborn and adult rats kept at room temperature (24 degrees C). Exposure to a cold environment elicited a strong expression of both proteins, especially in retinal pigment epithelium cells, photoreceptors, bipolar, amacrine and horizontal cells, Muller cells, and ganglion cells. In conclusion, CSP expression rapidly rises in the mammalian retina following exposure to hypothermia in a cell type-specific pattern. This observation may be at the basis of the molecular mechanism by which hypothermia exerts its therapeutic effects in the retina.	[Larrayoz, Ignacio M.; Martinez, Alfredo] Ctr Biomed Res La Rioja CIBIR, Angiogenesis Study Grp, Logrono 26006, Spain; [Rey-Funes, Manuel; Contartese, Daniela S.; Rolon, Federico; Sarotto, Anibal; Loidl, Cesar F.] Univ Buenos Aires, CONICET, Fac Med, Lab Neuropatol Expt,Inst Biol Celular & Neurocien, Paraguay 2155 C1428ABG, Buenos Aires, DF, Argentina; [Dorfman, Veronica B.] Univ Maimonides, CEBBAD, Hidalgo 775 C1405BCK, Buenos Aires, DF, Argentina; [Loidl, Cesar F.] Univ Catolica Cuyo, Fac Ciencias Med, Lab Neurociencia, San Juan, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Larrayoz, IM (corresponding author), Ctr Biomed Res La Rioja CIBIR, Angiogenesis Study Grp, Logrono 26006, Spain.	ilarrayoz@riojasalud.es	Dorfman, Verónica/GXH-2015-2022; Larrayoz, Ignacio M/I-5613-2012; Martinez, Alfredo/GQH-5998-2022	Larrayoz, Ignacio M/0000-0003-1629-152X; Martinez, Alfredo/0000-0003-4882-4044; Dorfman, Veronica/0000-0002-7950-1400; Rey-Funes, Manuel/0000-0002-0213-3056	US Department of Defense [MR130239]; "Secretaria de Ciencia y Tecnica de la Universidad de Buenos Aires" UBACyT [20020090100254]	US Department of Defense(United States Department of Defense); "Secretaria de Ciencia y Tecnica de la Universidad de Buenos Aires" UBACyT(Secretaria de Ciencia y Tecnologia (SECYT))	This work was supported by the US Department of Defense, Grant MR130239 (to AM) and by "Secretaria de Ciencia y Tecnica de la Universidad de Buenos Aires" UBACyT, Grant 20020090100254 (to CFL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrich J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004128.pub3; Austin T, 2013, ARCH DIS CHILD-FETAL, V98, pF451, DOI 10.1136/archdischild-2012-302069; Azzopardi D, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-17; Boriushkin E, 2015, INVEST OPHTH VIS SCI, V56, P1374, DOI 10.1167/iovs.14-15196; Chip S, 2011, NEUROBIOL DIS, V43, P388, DOI 10.1016/j.nbd.2011.04.010; Coassin M, 2010, BRIT J OPHTHALMOL, V94, P1678, DOI 10.1136/bjo.2009.168864; Cornette L, 2012, FACTS VIEWS VIS OBGY, V4, P133; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; FABEROWSKI N, 1989, INVEST OPHTH VIS SCI, V30, P2309; Ikeda K, 2012, MED SCI MONITOR, V18, pCR409, DOI 10.12659/MSM.883208; Kunikata H, 2006, AM J OPHTHALMOL, V141, P754, DOI 10.1016/j.ajo.2005.10.054; Liu AJ, 2010, BRAIN RES, V1347, P104, DOI 10.1016/j.brainres.2010.05.029; Liu YT, 2013, SCI REP-UK, V3, DOI 10.1038/srep02054; LLeonart ME, 2010, BBA-REV CANCER, V1805, P43, DOI 10.1016/j.bbcan.2009.11.001; Lyden P, 2012, NEUROCRIT CARE, V16, P413, DOI 10.1007/s12028-012-9688-y; Lyden PD, 2014, INT J STROKE, V9, P117, DOI 10.1111/ijs.12151; Mandal NA, 2013, EXP EYE RES, V106, P24, DOI 10.1016/j.exer.2012.10.014; Martinez-Navarrete G, 2011, EXP EYE RES, V92, P227, DOI 10.1016/j.exer.2010.12.001; Maynard KI, 1999, ANN NY ACAD SCI, V890, P240, DOI 10.1111/j.1749-6632.1999.tb07999.x; Minnerup J, 2012, INT J MOL SCI, V13, P11753, DOI 10.3390/ijms130911753; Mowat FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011103; Nakajima E, 2014, EYE, V28, P85, DOI 10.1038/eye.2013.239; Quinones-Hinojosa A, 2003, NEUROSURGERY, V52, P1178, DOI 10.1227/01.NEU.0000057836.64972.A0; Rey-Funes M, 2013, INVEST OPHTH VIS SCI, V54, P2836, DOI 10.1167/iovs.12-11198; Rey-Funes M, 2011, J NEUROSCI RES, V89, P729, DOI 10.1002/jnr.22556; Rey-Funes M, 2010, EXP EYE RES, V90, P113, DOI 10.1016/j.exer.2009.09.019; Rogers EE, 2014, PEDIATR NEUROL, V51, P657, DOI 10.1016/j.pediatrneurol.2014.08.010; Saito K, 2010, BRAIN RES, V1358, P20, DOI 10.1016/j.brainres.2010.08.048; Salido EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061656; Schmitt KRL, 2007, J NEUROIMMUNOL, V189, P7, DOI 10.1016/j.jneuroim.2007.06.010; Sirvinskas E, 2014, PERFUSION-UK, V29, P124, DOI 10.1177/0267659113497074; STIEHL WL, 1986, J PHYSIOL-PARIS, V81, P26; Sugimoto K, 2008, COMP BIOCHEM PHYS A, V151, P628, DOI 10.1016/j.cbpa.2008.07.027; TAMAI K, 1995, JPN J OPHTHALMOL, V39, P43; Tamai K, 1997, BRIT J OPHTHALMOL, V81, P789, DOI 10.1136/bjo.81.9.789; Tong G, 2013, BRAIN RES, V1504, P74, DOI 10.1016/j.brainres.2013.01.041; Wang XD, 2002, NEUROL RES, V24, P730, DOI 10.1179/016164102101200663; Wellmann S, 2004, J CELL SCI, V117, P1785, DOI 10.1242/jcs.01026; Wellmann S, 2010, PEDIATR RES, V67, P35, DOI 10.1203/PDR.0b013e3181c13326; Xia ZP, 2012, FEBS LETT, V586, P3299, DOI 10.1016/j.febslet.2012.07.004; ZEEVALK GD, 1993, J NEUROCHEM, V61, P1445, DOI 10.1111/j.1471-4159.1993.tb13639.x	41	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161458	10.1371/journal.pone.0161458	http://dx.doi.org/10.1371/journal.pone.0161458			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556928	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258100043
J	Zheng, HD; Zhang, X; Castillo, EF; Luo, Y; Liu, ML; Yang, XXO				Zheng, Handong; Zhang, Xing; Castillo, Eliseo F.; Luo, Yan; Liu, Meilian; Yang, Xuexian O.			Leptin Enhances TH2 and ILC2 Responses in Allergic Airway Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						asthma; inflammation; innate immunity; leptin; T helper cells	INNATE LYMPHOID-CELLS; T-CELLS; TGF-BETA; PROMOTES; ASTHMA; SURVIVAL; IMMUNITY; IL-9; PROLIFERATION; INITIATION	Allergic asthma and obesity are the leading health problems in the world. Many studies have shown that obesity is a risk factor of development of asthma. However, the underlying mechanism has not been well established. In this study, we demonstrate that leptin, an adipokine elevated in obese individuals, promoted proliferation and survival of pro-allergic type 2 helper T cells and group 2 innate lymphoid cells and production of type 2 cytokines, which together contribute to allergic responses. Leptin activates mTORC1, MAPK, and STAT3 pathways in TH2 cells. The effects of leptin on TH2 cell proliferation, survival, and cytokine production are dependent on the mTORC1 and MAPK pathways as revealed by specific inhibitors. In vivo, leptin-deficiency led to attenuated experimental allergic airway inflammation. Our results thus support that obesity-associated elevation of leptin contributes to the increased susceptibility of asthma via modulation of pro-allergic lymphocyte responses.	[Zheng, Handong; Zhang, Xing; Castillo, Eliseo F.; Yang, Xuexian O.] Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, Pathol, Albuquerque, NM 87131 USA; [Zhang, Xing; Luo, Yan; Liu, Meilian] Univ New Mexico, Hlth Sci Ctr, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA; [Luo, Yan] Cent S Univ, Xiangya Hosp 2, Dept Endocrinol & Metab,Natl Clin Res Ctr Metab D, Metab Syndrome Res Ctr,Key Lab Diabet Immunol,Min, Changsha 410011, Hunan, Peoples R China	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; Central South University	Yang, XXO (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, Pathol, Albuquerque, NM 87131 USA.; Liu, ML (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA.	meilianliu@salud.unm.edu; xyang@salud.unm.edu	Yang, Xuexian/Y-2472-2019	Yang, Xuexian/0000-0001-6816-7024; Castillo, Eliseo/0000-0002-5083-560X; Zhang, Xing/0000-0002-5877-627X	National Institutes of Health [R56AI110442, R56AI116772]; American Lung Association [RG-268131]; UNM Cancer Center Pilot Award through contract National Institutes of Health Grant [P30CA118100]; American Diabetes Association [1-13-JF-37]; American Heart Association [15GRNT24940018]; CoBRE Pilot Award through National Institutes of Health [P30GM103400]; UNM RAC Pilot Awards; American Association of Immunologists; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI110442, R56AI116772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; UNM Cancer Center Pilot Award through contract National Institutes of Health Grant; American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); CoBRE Pilot Award through National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNM RAC Pilot Awards; American Association of Immunologists; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R56AI110442 and R56AI116772, American Lung Association Grant RG-268131, and UNM Cancer Center Pilot Award through contract National Institutes of Health Grant P30CA118100 (to X. O. Y.), and American Diabetes Association Junior Faculty Research Award 1-13-JF-37, American Heart Association Grant-in-Aid Award 15GRNT24940018, and CoBRE Pilot Award through National Institutes of Health Grant P30GM103400 and UNM RAC Pilot Awards (to M. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of a Careers in Immunology Fellowship from the American Association of Immunologists.	Bapat SP, 2015, NATURE, V528, P137, DOI 10.1038/nature16151; Batra A, 2010, ENDOCRINOLOGY, V151, P56, DOI 10.1210/en.2009-0565; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Camargo CA, 1999, ARCH INTERN MED, V159, P2582, DOI 10.1001/archinte.159.21.2582; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Dixon Anne E, 2010, Proc Am Thorac Soc, V7, P325, DOI 10.1513/pats.200903-013ST; Doherty T, 2007, CURR OPIN IMMUNOL, V19, P676, DOI 10.1016/j.coi.2007.07.017; Fanta CH, 2009, NEW ENGL J MED, V360, P1002, DOI 10.1056/NEJMra0804579; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Fernandez-Riejos P, 2008, CLIN EXP IMMUNOL, V151, P505, DOI 10.1111/j.1365-2249.2007.03563.x; Guo ZH, 2008, J BIOL CHEM, V283, P1754, DOI 10.1074/jbc.M703753200; Halim TYF, 2016, NAT IMMUNOL, V17, P57, DOI 10.1038/ni.3294; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Matarese G, 2005, J IMMUNOL, V174, P3137, DOI 10.4049/jimmunol.174.6.3137; Mattioli B, 2009, FEBS LETT, V583, P1102, DOI 10.1016/j.febslet.2009.02.029; MILNE J, 1975, BRIT J IND MED, V32, P302; Mirchandani AS, 2014, J IMMUNOL, V192, P2442, DOI 10.4049/jimmunol.1300974; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Oriss TB, 1997, J IMMUNOL, V158, P3666; Ozata M, 1999, J CLIN ENDOCR METAB, V84, P3686, DOI 10.1210/jc.84.10.3686; Pascual RM, 2005, J ALLERGY CLIN IMMUN, V116, P477, DOI 10.1016/j.jaci.2005.07.011; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sanos SL, 2013, IMMUNOL CELL BIOL, V91, P215, DOI 10.1038/icb.2013.3; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Soroosh P, 2009, IMMUNOLOGY, V127, P450, DOI 10.1111/j.1365-2567.2009.03114.x; Soto-Mera MT, 2000, ALLERGY, V55, P983, DOI 10.1034/j.1398-9995.2000.00780.x; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Takeda K, 1998, J IMMUNOL, V161, P4652; Townsend MJ, 2000, IMMUNITY, V13, P573, DOI 10.1016/S1074-7613(00)00056-X; Turner JE, 2013, J EXP MED, V210, P2951, DOI 10.1084/jem.20130071; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Walker JA, 2013, CURR OPIN IMMUNOL, V25, P148, DOI 10.1016/j.coi.2013.02.010; Wilhelm C, 2012, NAT IMMUNOL, V13, P637, DOI 10.1038/ni.2303; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wojno EDT, 2012, CELL HOST MICROBE, V12, P445, DOI 10.1016/j.chom.2012.10.003; Yang XXO, 2013, NAT IMMUNOL, V14, P732, DOI 10.1038/ni.2633; Youssef DM, 2013, J BRAS PNEUMOL, V39, P562, DOI 10.1590/S1806-37132013000500006; Yu HS, 2010, J KOREAN MED SCI, V25, P829, DOI 10.3346/jkms.2010.25.6.829	45	49	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22043	22052		10.1074/jbc.M116.743187	http://dx.doi.org/10.1074/jbc.M116.743187			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27566543	Green Published, hybrid			2022-12-26	WOS:000386332600019
J	Choi, JY; Patra, A; Yeom, M; Lee, YS; Zhang, QQ; Egli, M; Guengerich, FP				Choi, Jeong-Yun; Patra, Amritaj; Yeom, Mina; Lee, Young-Sam; Zhang, Qianqian; Egli, Martin; Guengerich, F. Peter			Kinetic and Structural Impact of Metal Ions and Genetic Variations on Human DNA Polymerase iota	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERROR-PRONE BYPASS; TRANSLESION SYNTHESIS; LESION-BYPASS; B-FAMILY; REPLICATION; ADDUCTS; OPPOSITE; ETA; BASE; FIDELITY	DNA polymerase (pol) iota is a Y-family polymerase involved in translesion synthesis, exhibiting higher catalytic activity with Mn2+ than Mg2+. The human germline R96G variant impairs both Mn2+-dependent and Mg2+-dependent activities of pol iota, whereasthe Delta 1-25 variant selectively enhances its Mg2+-dependent activity. We analyzed pre-steady-state kinetic and structural effects of these two metal ions and genetic variations on pol iota using pol iota core (residues 1-445) proteins. The presence of Mn2+ (0.15 mM) instead of Mg2+ (2 mM) caused a 770-fold increase in efficiency (k(pol)/K-d,K-dCTP) of pol iota for dCTP insertion opposite G, mainly due to a 450-fold decrease in K-d,K-dCTP. The R96G and Delta 1-25 variants displayed a 53-fold decrease and a 3-fold increase, respectively, in k(pol)/K-d,K-dCTP for dCTP insertion opposite G with Mg2+ when compared with wild type, substantially attenuated by substitution with Mn2+. Crystal structures of pol (iota) ternary complexes, including the primer terminus 3'-OH and a non-hydrolyzable dCTP analogue opposite G with the active-site Mg2+ or Mn2+, revealed that Mn2+ achieves more optimal octahedral coordination geometry than Mg2+, with lower values in average coordination distance geometry in the catalytic metal A-site. Crystal structures of R96G revealed the loss of three H-bonds of residues Gly-96 and Tyr-93 with an incoming dNTP, due to the lack of an arginine, as well as a destabilized Tyr-93 side chain secondary to the loss of a cation-pi interaction between both side chains. These results provide a mechanistic basis for alteration in pol iota catalytic function with coordinating metals and genetic variation.	[Choi, Jeong-Yun; Yeom, Mina] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Div Pharmacol,Dept Mol Cell Biol, Gyeonggi Do 16419, South Korea; [Patra, Amritaj; Zhang, Qianqian; Egli, Martin; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA; [Lee, Young-Sam] Daegu Gyeongbuk Inst Sci & Technol, Dept New Biol, Daegu 42988, South Korea	Sungkyunkwan University (SKKU); Vanderbilt University; Daegu Gyeongbuk Institute of Science & Technology (DGIST)	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu			National Institutes of Health [R01 ES010375, R01 ES010546, P01 CA160032]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [NRF-2015R1D1A1A01057577]; DGIST R&D Program of the Ministry of Science, ICT and Technology of Korea [20160165]; NATIONAL CANCER INSTITUTE [P01CA160032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010375, R01ES010546] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education; DGIST R&D Program of the Ministry of Science, ICT and Technology of Korea; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES010375 and R01 ES010546 (to F. P. G.) and P01 CA160032 (to M. E.). This work was also supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (Grant NRF-2015R1D1A1A01057577) (to J.-Y. C.) and the DGIST R&D Program of the Ministry of Science, ICT and Technology of Korea (20160165) (to Y.-S. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albertella MR, 2005, DNA REPAIR, V4, P583, DOI 10.1016/j.dnarep.2005.01.005; Avkin S, 2004, J BIOL CHEM, V279, P53298, DOI 10.1074/jbc.M409155200; Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Blanca G, 2003, BIOCHEMISTRY-US, V42, P7467, DOI 10.1021/bi034198m; Choi JY, 2008, J BIOL CHEM, V283, P23645, DOI 10.1074/jbc.M801686200; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; Choi JY, 2011, CURR CANCER RES, P345, DOI 10.1007/978-1-61737-995-6_16; Choi JY, 2010, J MOL BIOL, V404, P34, DOI 10.1016/j.jmb.2010.09.015; Choi JY, 2009, J MOL BIOL, V389, P264, DOI 10.1016/j.jmb.2009.04.023; Choi JY, 2006, J BIOL CHEM, V281, P12315, DOI 10.1074/jbc.M600112200; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; Dumstorf CA, 2006, P NATL ACAD SCI USA, V103, P18083, DOI 10.1073/pnas.0605247103; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank EG, 2002, NUCLEIC ACIDS RES, V30, P5284, DOI 10.1093/nar/gkf643; Frank EG, 2007, J BIOL CHEM, V282, P24689, DOI 10.1074/jbc.M702159200; Gao Y, 2016, SCIENCE, V352, P1334, DOI 10.1126/science.aad9633; Garcia-Gomez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Iguchi M, 2014, ONCOGENE, V33, P3612, DOI 10.1038/onc.2013.331; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; Joyce CM, 2010, BBA-PROTEINS PROTEOM, V1804, P1032, DOI 10.1016/j.bbapap.2009.07.021; Kim J, 2014, CHEM RES TOXICOL, V27, P1837, DOI 10.1021/tx5002755; Kirouac KN, 2009, EMBO J, V28, P1644, DOI 10.1038/emboj.2009.122; Koag MC, 2014, NUCLEIC ACIDS RES, V42, P11233, DOI 10.1093/nar/gku789; Koag MC, 2014, J BIOL CHEM, V289, P31341, DOI 10.1074/jbc.M114.605451; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Loeb LA, 2008, NAT REV GENET, V9, P594, DOI 10.1038/nrg2345; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nair DT, 2006, STRUCTURE, V14, P749, DOI 10.1016/j.str.2006.01.010; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Ohkumo T, 2006, MOL CELL BIOL, V26, P7696, DOI 10.1128/MCB.01076-06; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pence MG, 2009, J BIOL CHEM, V284, P1732, DOI 10.1074/jbc.M807296200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Song I, 2014, CHEM RES TOXICOL, V27, P919, DOI 10.1021/tx500072m; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; Vaisman A, 2003, DNA REPAIR, V2, P991, DOI 10.1016/S1568-7864(03)00094-6; Vashishtha AK, 2016, BIOCHEMISTRY-US, V55, P2661, DOI 10.1021/acs.biochem.5b01350; Xia SL, 2011, BIOCHEMISTRY-US, V50, P9114, DOI 10.1021/bi201260h; Yang J, 2004, CANCER RES, V64, P5597, DOI 10.1158/0008-5472.CAN-04-0603; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Yeom M, 2016, CHEM RES TOXICOL, V29, P367, DOI 10.1021/acs.chemrestox.5b00513; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106; Yuan F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069317; Zhang YB, 2002, MUTAT RES-FUND MOL M, V510, P23, DOI 10.1016/S0027-5107(02)00249-X; Zhang YB, 2002, NUCLEIC ACIDS RES, V30, P1630, DOI 10.1093/nar/30.7.1630; Zhao Y, 2012, P NATL ACAD SCI USA, V109, P7269, DOI 10.1073/pnas.1202681109; Zhou JD, 2012, CANCER SCI, V103, P1574, DOI 10.1111/j.1349-7006.2012.02309.x	54	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21063	+		10.1074/jbc.M116.748285	http://dx.doi.org/10.1074/jbc.M116.748285			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27555320	hybrid, Green Published			2022-12-26	WOS:000385406200022
J	Cale, JA; Collignon, RM; Klutsch, JG; Kanekar, SS; Hussain, A; Erbilgin, N				Cale, Jonathan A.; Collignon, R. Maxwell; Klutsch, Jennifer G.; Kanekar, Sanat S.; Hussain, Altaf; Erbilgin, Nadir			Fungal Volatiles Can Act as Carbon Sources and Semiochemicals to Mediate Interspecific Interactions Among Bark Beetle-Associated Fungal Symbionts	PLOS ONE			English	Article							MOUNTAIN PINE-BEETLE; BLUE-STAIN FUNGUS; DENDROCTONUS-PONDEROSAE; ORGANIC-COMPOUNDS; GROSMANNIA-CLAVIGERA; RANGE EXPANSION; COLEOPTERA; DYNAMICS; GROWTH; IDENTIFICATION	Mountain pine beetle (Dendroctonus ponderosae) has killed millions of hectares of pine forests in western North America. Beetle success is dependent upon a community of symbiotic fungi comprised of Grosmannia clavigera, Ophiostoma montium, and Leptographium longiclavatum. Factors regulating the dynamics of this community during pine infection are largely unknown. However, fungal volatile organic compounds (FVOCs) help shape fungal interactions in model and agricultural systems and thus may be important drivers of interactions among bark beetle-associated fungi. We investigated whether FVOCs can mediate interspecific interactions among mountain pine beetle's fungal symbionts by affecting fungal growth and reproduction. Headspace volatiles were collected and identified to determine species-specific volatile profiles. Interspecific effects of volatiles on fungal growth and conidia production were assessed by pairing physically-separated fungal cultures grown either on a carbon-poor or -rich substrate, inside a shared-headspace environment. Fungal VOC profiles differed by species and influenced the growth and/or conidia production of the other species. Further, our results showed that FVOCs can be used as carbon sources for fungi developing on carbon-poor substrates. This is the first report demonstrating that FVOCs can drive interactions among bark beetle fungal symbionts, and thus are important factors in beetle attack success.	[Cale, Jonathan A.; Klutsch, Jennifer G.; Kanekar, Sanat S.; Hussain, Altaf; Erbilgin, Nadir] Univ Alberta, Dept Renewable Resources, 4-42 Earth Sci Bldg, Edmonton, AB T6G 2E3, Canada; [Collignon, R. Maxwell] Univ Calif Riverside, Dept Entomol, Entomol Bldg, Riverside, CA 92521 USA	University of Alberta; University of California System; University of California Riverside	Cale, JA (corresponding author), Univ Alberta, Dept Renewable Resources, 4-42 Earth Sci Bldg, Edmonton, AB T6G 2E3, Canada.	jacale@ualberta.ca	Erbilgin, Nadir/F-3675-2014; Collignon, Max/ABE-4488-2020; Hussain, Altaf/P-4178-2019	Erbilgin, Nadir/0000-0001-9912-8095; Klutsch, Jennifer/0000-0001-8839-972X; Kanekar, Sanat/0000-0003-4709-0376; Cale, Jonathan/0000-0002-8902-2032	National Sciences and Engineering Research Council of Canada; Izaak Walton Killam Memorial Student Scholarship from the University of Alberta	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Izaak Walton Killam Memorial Student Scholarship from the University of Alberta	This work was partially supported by the National Sciences and Engineering Research Council of Canada (Discovery grant to NE; http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp) and the Izaak Walton Killam Memorial Student Scholarship from the University of Alberta (to JGK).	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams AS, 2008, MICROB ECOL, V56, P460, DOI 10.1007/s00248-008-9364-0; Barriuso J, 2015, AIMS MICROBIOL, V1, P37, DOI 10.3934/microbiol.2015.1.37; Bennett JW, 2012, THE MYCOTA, P229; Bentz B.J., 2009, BARK BEETLE OUTBREAK; Bentz BJ, 2010, BIOSCIENCE, V60, P602, DOI 10.1525/bio.2010.60.8.6; Bentz BJ, 2006, ANN ENTOMOL SOC AM, V99, P189, DOI 10.1603/0013-8746(2006)099[0189:ECOFAW]2.0.CO;2; Bleiker KP, 2007, ENVIRON ENTOMOL, V36, P1384, DOI 10.1603/0046-225X(2007)36[1384:DBOFAT]2.0.CO;2; Bleiker KP, 2009, CAN ENTOMOL, V141, P503, DOI 10.4039/n09-034; Bleiker KP, 2009, MYCOL RES, V113, P3, DOI 10.1016/j.mycres.2008.06.004; Bracewell RR, 2015, ECOL EVOL, V5, P5109, DOI 10.1002/ece3.1772; BRAND JM, 1977, J CHEM ECOL, V3, P657, DOI 10.1007/BF00988065; British Columbia Ministry of Forests L and NRO, 2012, FACTS BCS MOUNT PIN; Chitarra GS, 2004, APPL ENVIRON MICROB, V70, P2823, DOI 10.1128/AEM.70.5.2823-2829.2004; Davis TS, 2011, MICROB ECOL, V61, P626, DOI 10.1007/s00248-010-9773-8; Davis TS, 2013, J CHEM ECOL, V39, P840, DOI 10.1007/s10886-013-0306-z; Davis TS, 2013, J CHEM ECOL, V39, P860, DOI 10.1007/s10886-013-0278-z; Del Giudice L, 2008, ENVIRON MICROBIOL, V10, P2824, DOI 10.1111/j.1462-2920.2008.01703.x; DiGuistini S, 2011, P NATL ACAD SCI USA, V108, P2504, DOI 10.1073/pnas.1011289108; El Ariebi N, 2016, FUNGAL ECOL, V20, P144, DOI 10.1016/j.funeco.2015.12.013; Faheem Amin, 2010, Journal of Phytology, V2, P34; Goodsman DW, 2013, NEW PHYTOL, V197, P586, DOI 10.1111/nph.12019; Goodsman DW, 2012, ENVIRON ENTOMOL, V41, P478, DOI 10.1603/EN11205; Hanssen H, 1993, CERATOCYSTIS OPHIOST, P117; Hesse-Orce U, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-536; Hofstetter RW, 2014, ANNU REV ENTOMOL, V59, P537, DOI 10.1146/annurev-ento-011613-162039; Hulcr J, 2011, J CHEM ECOL, V37, P1374, DOI 10.1007/s10886-011-0046-x; Hung R., 2014, MYCOLOGY, V5, P1, DOI DOI 10.1080/21501203.2014.902401; Hung R, 2015, APPL MICROBIOL BIOT, V99, P3395, DOI 10.1007/s00253-015-6494-4; Hung R, 2013, FUNGAL ECOL, V6, P19, DOI 10.1016/j.funeco.2012.09.005; Karst J, 2015, NEW PHYTOL, V208, P904, DOI 10.1111/nph.13492; Kendrick B., 2000, 5 KINGDOM; Lee S, 2005, MYCOL RES, V109, P1162, DOI 10.1017/S0953756205003588; Macias-Rodriguez L, 2015, FUNGAL BIOMOLECULES: SOURCES, APPLICATIONS AND RECENT DEVELOPMENTS, P87; Man G, 2012, FS1000 USDA; Morath Shannon U., 2012, Fungal Biology Reviews, V26, P73, DOI 10.1016/j.fbr.2012.07.001; Muller A, 2013, FUNGAL GENET BIOL, V54, P25, DOI 10.1016/j.fgb.2013.02.005; Nemcovic M, 2008, FEMS MICROBIOL LETT, V284, P231, DOI 10.1111/j.1574-6968.2008.01202.x; Nishino S, 2013, J PHYTOPATHOL, V161, P515, DOI 10.1111/jph.12100; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Pec GJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124691; Polizzi V, 2012, FUNGAL BIOL-UK, V116, P941, DOI 10.1016/j.funbio.2012.06.001; Prenafeta-Boldu FX, 2001, MYCOL RES, V105, P477, DOI 10.1017/S0953756201003719; Pureswaran DS, 2000, CHEMOECOLOGY, V10, P153, DOI 10.1007/PL00001818; Qi B, 2002, APPL MICROBIOL BIOT, V58, P684, DOI 10.1007/s00253-002-0938-3; R Core Team, 2013, R LANG ENV STAT COMP; Raffa K. F., 1980, Proceedings of the second IUFRO conference on dispersal of forest insects: evaluation, theory and management implications., P213; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Reino Jose Luis, 2008, Phytochemistry Reviews, V7, P89, DOI 10.1007/s11101-006-9032-2; RENWICK JAA, 1976, NATURWISSENSCHAFTEN, V63, P198, DOI 10.1007/BF00624228; Roe AD, 2011, MICROB ECOL, V62, P347, DOI 10.1007/s00248-011-9841-8; Roze LV, 2007, APPL ENVIRON MICROB, V73, P7268, DOI 10.1128/AEM.00801-07; Safranyik L, 2010, CAN ENTOMOL, V142, P415, DOI 10.4039/n08-CPA01; Shepherd WP, 2013, J CHEM ECOL, V39, P481, DOI 10.1007/s10886-013-0265-4; Six DL, 2013, J CHEM ECOL, V39, P989, DOI 10.1007/s10886-013-0318-8; Six Diana L., 2012, Insects, V3, P339, DOI 10.3390/insects3010339; Six DL, 2003, CAN J FOREST RES, V33, P1331, DOI [10.1139/x03-047, 10.1139/X03-047]; SOLHEIM H, 1995, CAN J BOT, V73, P70, DOI 10.1139/b95-009; Splivallo R, 2007, PHYTOCHEMISTRY, V68, P2584, DOI 10.1016/j.phytochem.2007.03.030; Stoppacher N, 2010, J MICROBIOL METH, V81, P187, DOI 10.1016/j.mimet.2010.03.011; Strobel GA, 2001, MICROBIOL-SGM, V147, P2943, DOI 10.1099/00221287-147-11-2943; Tarkka MT, 2007, NEW PHYTOL, V175, P381, DOI 10.1111/j.1469-8137.2007.02165.x; Tewari S, 2014, INTEGRATED PEST MANAGEMENT: CURRENT CONCEPTS AND ECOLOGICAL PERSPECTIVE, P141, DOI 10.1016/B978-0-12-398529-3.00010-5; Therrien J, 2015, OECOLOGIA, V179, P467, DOI 10.1007/s00442-015-3356-9; Treu R, 2014, ECOLOGY, V95, P1096, DOI 10.1890/13-1233.1; Viiri H, 2001, TREES-STRUCT FUNCT, V15, P327, DOI 10.1007/s004680100117; WHITNEY HS, 1970, SCIENCE, V167, P54, DOI 10.1126/science.167.3914.54; Zhang QH, 2015, PLANT SOIL, V392, P101, DOI 10.1007/s11104-015-2448-y	68	23	23	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162197	10.1371/journal.pone.0162197	http://dx.doi.org/10.1371/journal.pone.0162197			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583519	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600118
J	Fiskaa, T; Knutsen, E; Nikolaisen, MA; Jorgensen, TE; Johansen, SD; Perander, M; Seternes, OM				Fiskaa, Tonje; Knutsen, Erik; Nikolaisen, Marlen Aas; Jorgensen, Tor Erik; Johansen, Steinar Daae; Perander, Maria; Seternes, Ole Morten			Distinct Small RNA Signatures in Extracellular Vesicles Derived from Breast Cancer Cell Lines	PLOS ONE			English	Article							INTERCELLULAR TRANSFER; TRANSFERRIN RECEPTOR; MICRORNA SIGNATURES; GENE-EXPRESSION; EXOSOMES; MICROVESICLES; PROMOTE; PLASMA; STAGE; ANGIOGENESIS	Breast cancer is a heterogeneous disease, and different subtypes of breast cancer show distinct cellular morphology, gene expression, metabolism, motility, proliferation, and metastatic potential. Understanding the molecular features responsible for this heterogeneity is important for correct diagnosis and better treatment strategies. Extracellular vesicles (EVs) and their associated molecules have gained much attention as players in intercellular communication, ability to precondition specific organs for metastatic invasion, and for their potential role as circulating cancer biomarkers. EVs are released from the cells and contain proteins, DNA, and long and small RNA species. Here we show by high-throughput small RNA-sequencing that EVs from nine different breast cancer cell lines share common characteristics in terms of small RNA content that are distinct from their originating cells. Most strikingly, a highly abundant small RNA molecule derived from the nuclear 28S rRNA is vastly enriched in EVs. The miRNA profiles in EVs correlate with the cellular miRNA expression pattern, but with a few exceptions that includes miR-21. This cancer-associated miRNA is retained in breast cancer cell lines. Finally, we report that EVs from breast cancer cell lines cluster together based on their small RNA signature when compared to EVs derived from other cancer cell lines. Altogether, our data demonstrate that breast cancer cell lines manifest a specific small RNA signature in their released EVs. This opens up for further evaluation of EVs as breast cancer biomarkers.	[Fiskaa, Tonje; Knutsen, Erik; Johansen, Steinar Daae; Perander, Maria] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, MH Bldg Breivika, N-9037 Tromso, Norway; [Fiskaa, Tonje; Nikolaisen, Marlen Aas; Seternes, Ole Morten] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Pharm, MH Bldg Breivika, N-9037 Tromso, Norway; [Jorgensen, Tor Erik; Johansen, Steinar Daae] Nord Univ, Fac Biosci & Aquaculture, Marine Genom Grp, Bodo, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; Nord University	Fiskaa, T (corresponding author), UiT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, MH Bldg Breivika, N-9037 Tromso, Norway.; Fiskaa, T (corresponding author), UiT Arctic Univ Norway, Fac Hlth Sci, Dept Pharm, MH Bldg Breivika, N-9037 Tromso, Norway.	Tonje.Fiskaa@uit.no	Seternes, Ole Morten/M-9520-2019; Knutsen, Erik/ABH-6287-2020	Seternes, Ole Morten/0000-0001-8537-3612; Knutsen, Erik/0000-0002-4903-0150; Jorgensen, Tor Erik/0000-0002-6401-0713; Perander, Maria/0000-0002-1177-2407	University of Tromso (Strategic miRNA Initiative); Norwegian Cancer Society; Northern Norway Regional Health Authority/Helse Nord RHF	University of Tromso (Strategic miRNA Initiative); Norwegian Cancer Society(Norwegian Cancer Society); Northern Norway Regional Health Authority/Helse Nord RHF	The work was supported by University of Tromso (Strategic miRNA Initiative, SDJ, OMS), The Norwegian Cancer Society (OMS), and Northern Norway Regional Health Authority/Helse Nord RHF (TF and MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the University of Tromso (Strategic miRNA Initiative, Steinar Daae Johansen and Ole Morten Seternes), The Norwegian Cancer Society (Ole Morten Seternes) and Northern Norway Regional Health Authority/Helse Nord RHF (Tonje Fiskaa and Maria Perander).	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Antonyak MA, 2014, METHODS MOL BIOL, V1165, P147, DOI 10.1007/978-1-4939-0856-1_11; Asaga S, 2011, CLIN CHEM, V57, P84, DOI 10.1373/clinchem.2010.151845; Bellingham SA, 2012, NUCLEIC ACIDS RES, V40, P10937, DOI 10.1093/nar/gks832; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Chan M, 2013, CLIN CANCER RES, V19, P4477, DOI 10.1158/1078-0432.CCR-12-3401; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Choi DS, 2013, PROTEOMICS, V13, P1554, DOI 10.1002/pmic.201200329; Choudhuri K, 2014, NATURE, V507, P118, DOI 10.1038/nature12951; Cocucci E, 2015, TRENDS CELL BIOL, V25, P364, DOI 10.1016/j.tcb.2015.01.004; Cookson VJ, 2012, CELL ONCOL, V35, P301, DOI 10.1007/s13402-012-0089-1; Corcoran C, 2011, CLIN CHEM, V57, P18, DOI 10.1373/clinchem.2010.150730; Corrado C, 2013, INT J MOL SCI, V14, P5338, DOI 10.3390/ijms14035338; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Fabbri M, 2008, CANCER J, V14, P1, DOI 10.1097/PPO.0b013e318164145e; Filipazzi P, 2012, SEMIN CANCER BIOL, V22, P342, DOI 10.1016/j.semcancer.2012.02.005; Graves LE, 2004, CANCER RES, V64, P7045, DOI 10.1158/0008-5472.CAN-04-1800; Guduric-Fuchs J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-357; Guo L, 2013, MOL BIOL REP, V40, P2175, DOI 10.1007/s11033-012-2277-5; Guzman N, 2015, MOL CANCER RES, V13, P891, DOI 10.1158/1541-7786.MCR-14-0533; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hakulinen J, 2004, EUR J IMMUNOL, V34, P2620, DOI 10.1002/eji.200424969; Hannafon BN, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0400-7; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Hoffman RM, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3426; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Hussein MNA, 2007, THROMB HAEMOSTASIS, V98, P1096, DOI 10.1160/TH05-04-0231; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Janowska-Wieczorek A, 2005, INT J CANCER, V113, P752, DOI 10.1002/ijc.20657; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jenjaroenpun P, 2013, PEERJ, V1, DOI 10.7717/peerj.201; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Khan S, 2011, APOPTOSIS, V16, P1, DOI 10.1007/s10495-010-0534-4; Khoshnaw SM, 2012, BREAST CANCER RES TR, V135, P403, DOI 10.1007/s10549-012-2169-3; Knutsen E, 2015, NEXT GENERATION SEQU, V2; Kodahl AR, 2014, MOL ONCOL, V8, P874, DOI 10.1016/j.molonc.2014.03.002; Koga K, 2005, ANTICANCER RES, V25, P3703; Koppers-Lalic D, 2014, CELL REP, V8, P1649, DOI 10.1016/j.celrep.2014.08.027; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kucharzewska P, 2013, P NATL ACAD SCI USA, V110, P7312, DOI 10.1073/pnas.1220998110; Lambertz U, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1260-7; Liu J, 2011, INT J ORAL SCI, V3, P165, DOI 10.4248/IJOS11063; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Lundholm M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108925; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Miranda KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096094; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Nolte-'t Hoen ENM, 2012, NUCLEIC ACIDS RES, V40, P9272, DOI 10.1093/nar/gks658; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; Tosar JP, 2015, NUCLEIC ACIDS RES, V43, P5601, DOI 10.1093/nar/gkv432; Palmero EI, 2011, GENET MOL BIOL, V34, P363, DOI 10.1590/S1415-47572011000300001; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Prasmickaite L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010731; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rye PD, 1996, INT J CANCER, V68, P682, DOI 10.1002/(SICI)1097-0215(19961127)68:5<682::AID-IJC20>3.0.CO;2-2; Safaei R, 2005, MOL CANCER THER, V4, P1595, DOI 10.1158/1535-7163.MCT-05-0102; Sant M, 2003, INT J CANCER, V106, P416, DOI 10.1002/ijc.11226; Shedden K, 2003, CANCER RES, V63, P4331; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Slrnalley DM, 2008, J PROTEOME RES, V7, P2088, DOI 10.1021/pr700775x; Sopik V, 2016, BREAST CANCER RES TR, V155, P175, DOI 10.1007/s10549-015-3666-y; STEIN JM, 1991, BIOCHEM J, V274, P381, DOI 10.1042/bj2740381; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valenti R, 2006, CANCER RES, V66, P9290, DOI 10.1158/0008-5472.CAN-06-1819; van Balkom BWM, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26760; van Doormaal FF, 2009, NETH J MED, V67, P266; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; Webber J, 2010, CANCER RES, V70, P9621, DOI 10.1158/0008-5472.CAN-10-1722; Wei HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056842; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; Zhang ZJ, 2012, ONCOL REP, V27, P903, DOI 10.3892/or.2011.1611; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007	81	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161824	10.1371/journal.pone.0161824	http://dx.doi.org/10.1371/journal.pone.0161824			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579604	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000382877400043
J	de Melo, NFS; de Macedo, CG; Bonfante, R; Abdalla, HB; da Silva, CMG; Pasquoto, T; de Lima, R; Fraceto, LF; Clemente-Napimoga, JT; Napimoga, MH				Silva de Melo, Nathalie Ferreira; de Macedo, Cristina Gomes; Bonfante, Ricardo; Abdalla, Henrique Ballassini; Goncalves da Silva, Camila Morais; Pasquoto, Tatiane; de Lima, Renata; Fraceto, Leonardo Fernandes; Clemente-Napimoga, Juliana Trindade; Napimoga, Marcelo Henrique			15d-PGJ(2)-Loaded Solid Lipid Nanoparticles: Physicochemical Characterization and Evaluation of Pharmacological Effects on Inflammation	PLOS ONE			English	Article							DRUG-DELIVERY; NANOCAPSULES; CARRIERS; RECEPTOR; RELEASE; HYPERNOCICEPTION; SYSTEMS; MODEL; OIL	15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)), a peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist, has physiological properties including pronounced anti-inflammatory activity, though it binds strongly to serum albumin. The use of solid lipid nanoparticles (SLN) can improve therapeutic properties increasing drug efficiency and availability. 15d-PGJ(2)-SLN was therefore developed and investigated in terms of its immunomodulatory potential. 15d-PGJ(2)-SLN and unloaded SLN were physicochemically characterized and experiments in vivo were performed. Animals were pretreated with 15d-PGJ(2)-SLN at concentrations of 3, 10 or 30 mu g.kg(-1) before inflammatory stimulus with carrageenan (Cg), lipopolysaccharide (LPS) or mBSA (immune response). Interleukins (IL-1 beta, IL-10 and IL-17) levels were also evaluated in exudates. The 15d-PGJ(2)-SLN system showed good colloidal parameters and encapsulation efficiency of 96%. The results showed that the formulation was stable for up to 120 days with low hemolytic effects. The 15d-PGJ(2)-SLN formulation was able to reduce neutrophil migration in three inflammation models tested using low concentrations of 15d-PGJ(2). Additionally, 15d-PGJ(2)-SLN increased IL-10 levels and reduced IL-1 beta as well as IL-17 in peritoneal fluid. The new 15d-PGJ(2)-SLN formulation highlights perspectives of a potent anti-inflammatory system using low concentrations of 15d-PGJ(2).	[Silva de Melo, Nathalie Ferreira; Napimoga, Marcelo Henrique] Sao Leopoldo Mandic Inst & Researcher Ctr, Lab Immunol & Mol Biol, Campinas, SP, Brazil; [Silva de Melo, Nathalie Ferreira; Fraceto, Leonardo Fernandes] Sao Paulo State Univ UNESP, Dept Environm Engn, Sorocaba, Brazil; [de Macedo, Cristina Gomes; Bonfante, Ricardo; Abdalla, Henrique Ballassini; Clemente-Napimoga, Juliana Trindade] Univ Estadual Campinas, Dept Physiol Sci, Piracicaba Dent Sch, Campinas, SP, Brazil; [Goncalves da Silva, Camila Morais] State Univ Campinas UNICAMP, Dept Biochem, Campinas, SP, Brazil; [Pasquoto, Tatiane; de Lima, Renata] Univ Sorocaba UNISO, Dept Biotechnol, Sorocaba, Brazil	Faculdade Sao Leopoldo Mandic; Universidade Estadual Paulista; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sorocaba	Napimoga, MH (corresponding author), Sao Leopoldo Mandic Inst & Researcher Ctr, Lab Immunol & Mol Biol, Campinas, SP, Brazil.	marcelo.napimoga@gmail.com	de Melo, Nathalie Ferreira Silva/F-8719-2014; Lima, Renata/AAC-6777-2020; Napimoga, Marcelo/S-2434-2019; Fraceto, Leonardo Fernandes/ABF-2797-2021; Clemente-Napimoga, Juliana T/E-5163-2013; Fraceto, Leonardo/C-4468-2012; Abdalla, Henrique Ballassini/M-2565-2014	de Melo, Nathalie Ferreira Silva/0000-0003-0765-4421; Lima, Renata/0000-0001-8712-1144; Napimoga, Marcelo/0000-0003-4472-365X; Fraceto, Leonardo Fernandes/0000-0002-2827-2038; Clemente-Napimoga, Juliana T/0000-0003-1068-3039; Abdalla, Henrique Ballassini/0000-0002-7517-2830	Brazilian funding agency Sao Paulo Research Foundation (FAPESP); Brazilian funding agency National Council for Scientific and Technological Development (CNPq); Sao Paulo Research Foundation [2014/11016-8]; CNPq [303555/2013-0]	Brazilian funding agency Sao Paulo Research Foundation (FAPESP); Brazilian funding agency National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors gratefully acknowledge financial support from the Brazilian funding agencies Sao Paulo Research Foundation (FAPESP) and National Council for Scientific and Technological Development (CNPq). NFSM was supported by a research fellowship grant# 2014/11016-8, Sao Paulo Research Foundation. MHN was supported by a research fellowship grant # 303555/2013-0 (CNPq).	Abbasi S, 2016, INT J NANOMED, V11, P2685, DOI 10.2147/IJN.S106297; Alves CF, 2011, BRIT J PHARMACOL, V162, P623, DOI 10.1111/j.1476-5381.2010.01057.x; [Anonymous], 2014, EUR J PHARM BIOPHARM, V87, P1, DOI 10.1016/j.ejpb.2014.02.005; Baek JS, 2015, INT J PHARMACEUT, V478, P617, DOI 10.1016/j.ijpharm.2014.12.018; Battaglia L, 2012, EXPERT OPIN DRUG DEL, V9, P497, DOI 10.1517/17425247.2012.673278; Calixto G, 2014, INT J NANOMED, V9, P3719, DOI 10.2147/IJN.S61670; Chen X, 2013, INT J PHARMACEUT, V447, P171, DOI 10.1016/j.ijpharm.2013.02.054; Choo J, 2015, J BIOL CHEM, V290, P25609, DOI 10.1074/jbc.M115.673046; Clemente-Napimoga JT, 2012, LIFE SCI, V90, P944, DOI 10.1016/j.lfs.2012.04.035; de Oliveira JL, 2015, J AGR FOOD CHEM, V63, P422, DOI 10.1021/jf5059045; Fonseca-Santos B, 2015, INT J NANOMED, V10, DOI 10.2147/IJN.S87148; How CW, 2013, IEEE T NANOBIOSCI, V12, P72, DOI 10.1109/TNB.2012.2232937; Li XY, 2015, GENET MOL RES, V14, P14037, DOI 10.4238/2015.October.29.22; Liu X, 2015, PPAR RES, V2015, DOI 10.1155/2015/876160; Madan JR, 2014, INT J PHARM INVESTIG, V4, P60, DOI 10.4103/2230-973X.133047; Malheiros SVP, 2004, BIOPHYS CHEM, V110, P213, DOI 10.1016/j.bpc.2004.01.013; Marcato PD, 2008, J NANOSCI NANOTECHNO, V8, P2216, DOI 10.1166/jnn.2008.274; Marin E, 2013, INT J NANOMED, V8, P3071, DOI 10.2147/IJN.S47186; Nafee N, 2009, INT J PHARMACEUT, V381, P130, DOI 10.1016/j.ijpharm.2009.04.049; Napimoga MH, 2008, J IMMUNOL, V180, P609, DOI 10.4049/jimmunol.180.1.609; Napimoga MH, 2008, J PHARMACOL EXP THER, V324, P313, DOI 10.1124/jpet.107.126045; Napimoga MH, 2012, J IMMUNOL, V189, P1043, DOI 10.4049/jimmunol.1200730; Naseri N, 2015, ADV PHARM BULL, V5, P305, DOI 10.15171/apb.2015.043; Pena-Dos-Santos DR, 2009, NEUROSCIENCE, V163, P1211, DOI 10.1016/j.neuroscience.2009.07.052; Campos EVR, 2015, SCI REP-UK, V5, DOI 10.1038/srep13809; Rostami E, 2014, CHEM PHYS LIPIDS, V181, P56, DOI 10.1016/j.chemphyslip.2014.03.006; Scher JU, 2005, CLIN IMMUNOL, V114, P100, DOI 10.1016/j.clim.2004.09.008; Siepmann J, 2008, INT J PHARMACEUT, V364, P328, DOI 10.1016/j.ijpharm.2008.09.004; de Melo NFS, 2014, COLLOID SURFACE B, V121, P66, DOI 10.1016/j.colsurfb.2014.05.035; Silva MD, 2011, J HAZARD MATER, V190, P366, DOI 10.1016/j.jhazmat.2011.03.057; Vieira SM, 2009, BRIT J PHARMACOL, V158, P779, DOI 10.1111/j.1476-5381.2009.00367.x; Vitorino C, 2011, COLLOID SURFACE B, V84, P117, DOI 10.1016/j.colsurfb.2010.12.024; Xie SY, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-33; Yap WH, 2015, BIOCHEM RES INT, V2015, DOI 10.1155/2015/279356; Zhou J, 2015, DRUG DES DEV THER, V9, P5269, DOI 10.2147/DDDT.S90016	35	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161796	10.1371/journal.pone.0161796	http://dx.doi.org/10.1371/journal.pone.0161796			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575486	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877200038
J	Puccinelli, E; McQuaid, CD; Noyon, M				Puccinelli, Eleonora; McQuaid, Christopher David; Noyon, Margaux			Spatio-Temporal Variation in Effects of Upwelling on the Fatty Acid Composition of Benthic Filter Feeders in the Southern Benguela Ecosystem: Not All Upwelling Is Equal	PLOS ONE			English	Article							MYTILUS-GALLOPROVINCIALIS; BOTTOM-UP; REPRODUCTIVE OUTPUT; LIPID-CONTENT; VARIABILITY; PHYTOPLANKTON; RECRUITMENT; SETTLEMENT; GROWTH; SHELF	Variability in mesoscale nearshore oceanographic conditions plays an important role in the distribution of primary production and food availability for intertidal consumers. Advection of nutrient rich waters by upwelling usually allows the proliferation of diatoms, later replaced by dinoflagellates. We examined upwelling effects on the fatty acid (FA) signature of a benthic intertidal filter feeder to identify its response to pulsed variability in food availability. The study took place in two contrasting seasons and at two upwelling and two non-upwelling sites interspersed within the southern Benguela upwelling system of South Africa. We investigated the FA composition of the adductor muscles and gonads of the mussel Mytilus galloprovincialis to assess how FA are apportioned to the different tissues and whether this changes between upwelling and non-upwelling conditions. In situ temperature loggers used to identify upwelling conditions at the four sites indicated that such events occurred only at the upwelling centres and only in summer. Tissues differed strongly, with gonads presenting a higher proportion of essential FAs. This could reflect the faster turnover rate of gonad tissue or preferential retention of specific FA for reproductive purposes. FA composition did not vary as a direct function of upwelling, but there were strong dissimilarities among sites. Upwelling influenced mussel diets at one upwelling site while at the other, the expected signature of upwelling was displaced downstream of the core of upwelling. Condition Index (CI) and Gonad Index (GI) differed among sites and were not influenced by upwelling, with GI being comparable among sites. In addition, FA proportions were consistent among sites, indicating similar food quality and quantity over time and under upwelling and non-upwelling conditions. This suggests that the influence of upwelling on the west coast of South Africa is pervasive and diffuse, rather than discrete; while nearshore retention or advection of upwelled water is critical and site-specific so that the effects of upwelling differ even among sites categorised as upwelling centres.	[Puccinelli, Eleonora; McQuaid, Christopher David; Noyon, Margaux] Rhodes Univ, Dept Zool & Entomol, Grahamstown, South Africa; [Puccinelli, Eleonora] Univ Cape Town, Marine Res Inst, Dept Oceanog, ZA-7701 Cape Town, South Africa; [Noyon, Margaux] Univ Cape Town, Marine Res Inst, Dept Biol Sci, ZA-7701 Cape Town, South Africa	Rhodes University; University of Cape Town; University of Cape Town	Puccinelli, E (corresponding author), Rhodes Univ, Dept Zool & Entomol, Grahamstown, South Africa.; Puccinelli, E (corresponding author), Univ Cape Town, Marine Res Inst, Dept Oceanog, ZA-7701 Cape Town, South Africa.	eleonorapuccinelli@gmail.com	Puccinelli, Eleonora/Q-6544-2019; Puccinelli, Eleonora/AAL-6468-2020; Puccinelli, Eleonora/M-3562-2018; Noyon, Margaux/AAN-9261-2021; McQuaid, Christopher/AAT-3725-2020	Puccinelli, Eleonora/0000-0002-6144-6650; Puccinelli, Eleonora/0000-0002-6144-6650; Noyon, Margaux/0000-0002-0761-4174; McQuaid, Christopher/0000-0002-3473-8308	Andrew Mellon Foundation; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; National Research Foundation of South Africa	Andrew Mellon Foundation; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; National Research Foundation of South Africa(National Research Foundation - South Africa)	This work was supported by funding from the Andrew Mellon Foundation and the South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation awarded by Prof Christopher D. McQuaid.; This work was supported by funding from the Andrew Mellon Foundation and the South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation of South Africa. Fatty acid processing was accomplished at the Fatty Acid Facility at Rhodes University provided by the National Research Foundation of South Africa and Rhodes University. Special thanks to the Coastal Research Group of Rhodes University, Grahamstown, South Africa. We gratefully acknowledge the contributions of anonymous referees whose comments greatly improved the manuscript.	Ackman RG, 2002, ANAL CHIM ACTA, V465, P175, DOI 10.1016/S0003-2670(02)00098-3; ADAMEC D, 1978, J PHYS OCEANOGR, V8, P1050, DOI 10.1175/1520-0485(1978)008<1050:TSUITG>2.0.CO;2; Alkanani T, 2007, J EXP MAR BIOL ECOL, V348, P33, DOI 10.1016/j.jembe.2007.02.017; Allan EL, 2010, ESTUAR COAST SHELF S, V87, P463, DOI 10.1016/j.ecss.2010.02.004; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ANDREWS W R H, 1980, Progress in Oceanography, V9, P1, DOI 10.1016/0079-6611(80)90015-4; Anestis A, 2010, COMP BIOCHEM PHYS A, V156, P57, DOI 10.1016/j.cbpa.2009.12.018; Archambault P, 1999, ESTUAR COAST SHELF S, V49, P193, DOI 10.1006/ecss.1999.0481; Arts MT, 2001, CAN J FISH AQUAT SCI, V58, P122, DOI 10.1139/cjfas-58-1-122; Basterretxea G, 2000, MAR ECOL PROG SER, V197, P27, DOI 10.3354/meps197027; BESNARD JY, 1989, COMP BIOCHEM PHYS B, V93, P21, DOI 10.1016/0305-0491(89)90210-1; Blanchard G, 2005, J FISH BIOL, V66, P73, DOI 10.1111/j.0022-1112.2005.00578.x; Blanchette CA, 2006, MAR BIOL, V149, P689, DOI 10.1007/s00227-005-0239-3; BOSMAN AL, 1987, OECOLOGIA, V72, P226, DOI 10.1007/BF00379273; BROWN PC, 1986, J PLANKTON RES, V8, P55, DOI 10.1093/plankt/8.1.55; Budge SM, 1998, ORG GEOCHEM, V29, P1547, DOI 10.1016/S0146-6380(98)00177-6; Budge SM, 2006, MAR MAMMAL SCI, V22, P759, DOI 10.1111/j.1748-7692.2006.00079.x; BUSTAMANTE RH, 1995, OECOLOGIA, V102, P189, DOI 10.1007/BF00333251; Camacho AP, 1995, AQUACULTURE, V138, P349, DOI 10.1016/0044-8486(95)01139-0; Chavez FP, 2009, PROG OCEANOGR, V83, P80, DOI 10.1016/j.pocean.2009.07.032; Chenillat F, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049966; CONNELL JH, 1985, J EXP MAR BIOL ECOL, V93, P11, DOI 10.1016/0022-0981(85)90146-7; Corbisier TN, 2014, MAR ECOL PROG SER, V512, P23, DOI 10.3354/meps10947; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; CURY P, 1989, CAN J FISH AQUAT SCI, V46, P670, DOI 10.1139/f89-086; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; DAVENPORT J, 1987, J MOLLUS STUD, V53, P293, DOI 10.1093/mollus/53.3.293; De Leo FC, 2006, J MARINE SYST, V60, P268, DOI 10.1016/j.jmarsys.2006.02.002; Demarcq H, 2009, PROG OCEANOGR, V83, P376, DOI 10.1016/j.pocean.2009.07.022; Estefanell J, 2015, AQUACULT NUTR, V21, P274, DOI 10.1111/anu.12163; Ezgeta-Balic D, 2014, MAR BIOL RES, V10, P625, DOI 10.1080/17451000.2013.833338; FARRELL TM, 1991, LIMNOL OCEANOGR, V36, P279, DOI 10.4319/lo.1991.36.2.0279; FIELD JG, 1980, ESTUAR COAST MAR SCI, V11, P133, DOI 10.1016/S0302-3524(80)80037-5; Field JG, 2006, VARIABILITY BENGUELA, P835; Figueiras FG, 2002, HYDROBIOLOGIA, V484, P121, DOI 10.1023/A:1021309222459; Fly EK, 2013, OECOLOGIA, V172, P35, DOI 10.1007/s00442-012-2486-6; Garcia-Reyes M, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007629; GIESE AC, 1967, COMP BIOCHEM PHYSIOL, V22, P549, DOI 10.1016/0010-406X(67)90617-2; Gorley C.K., 2006, GETTING STARTED PRIM; Gorokhova E, 1999, CAN J FISH AQUAT SCI, V56, P2203, DOI 10.1139/cjfas-56-11-2203; Humborg C, 2000, AMBIO, V29, P45, DOI 10.1639/0044-7447(2000)029[0045:SRIRBF]2.0.CO;2; Indarti E, 2005, J FOOD COMPOS ANAL, V18, P161, DOI 10.1016/j.jfca.2003.12.007; Kattner G, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P257, DOI 10.1007/978-0-387-89366-2_11; Kelly JR, 2012, MAR ECOL PROG SER, V446, P1, DOI 10.3354/meps09559; LEWIS RK, 1981, AUST J MAR FRESH RES, V32, P843; Lutjeharms JRE, 2000, CONT SHELF RES, V20, P737, DOI 10.1016/S0278-4343(99)00092-8; Martin-Jezequel V, 2000, J PHYCOL, V36, P821, DOI 10.1046/j.1529-8817.2000.00019.x; Maxwell MR, 2000, MAR ECOL PROG SER, V199, P159, DOI 10.3354/meps199159; McQuaid CD, 1998, S AFR J SCI, V94, P433; MEEUWIS JM, 1990, S AFR J MARINE SCI, V9, P261; Menge BA, 1997, P NATL ACAD SCI USA, V94, P14530, DOI 10.1073/pnas.94.26.14530; NAPOLITANO GE, 1993, MAR BIOL, V117, P647, DOI 10.1007/BF00349777; Nielsen KJ, 2004, ECOL LETT, V7, P31, DOI 10.1046/j.1461-0248.2003.00542.x; Nielsen KJ, 2003, P NATL ACAD SCI USA, V100, P7660, DOI 10.1073/pnas.0932534100; Pampanin DM, 2005, COMP BIOCHEM PHYS A, V140, P41, DOI 10.1016/j.cbpb.2004.10.016; Parrish CC, 2000, HANDB ENVIRON CHEM, V5, P193; Pirini M, 2007, COMP BIOCHEM PHYS B, V147, P616, DOI 10.1016/j.cbpb.2007.04.003; PITCHER GC, 1992, S AFR J MARINE SCI, V12, P439; POLLERO RJ, 1983, COMP BIOCHEM PHYS B, V76, P927, DOI 10.1016/0305-0491(83)90414-5; Porri F, 2006, MAR ECOL PROG SER, V315, P141, DOI 10.3354/meps315141; Puccinelli E, 2016, MAR ECOL PROG SER, V543, P37, DOI 10.3354/meps11567; RAIMONDI PT, 1990, ECOL MONOGR, V60, P283, DOI 10.2307/1943059; Robinson TB, 2005, AFR J MAR SCI, V27, P297, DOI 10.2989/18142320509504088; Roughan M, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2005JC002898; RYTHER JH, 1969, SCIENCE, V166, P72, DOI 10.1126/science.166.3901.72; Sanford E, 2001, MAR ECOL PROG SER, V209, P143, DOI 10.3354/meps209143; SCHURINK CV, 1991, MAR ECOL PROG SER, V76, P123; SHANNON L V, 1984, South African Journal of Marine Science, P109; Shannon LV, 1996, SOUTH ATLANTIC, P163; SHANNON LV, 1983, J PLANKTON RES, V5, P565, DOI 10.1093/plankt/5.4.565; Skinner LF, 2011, BRAZ J OCEANOGR, V59, P349, DOI 10.1590/S1679-87592011000400005; Smith JR, 2009, J SEA RES, V61, P165, DOI 10.1016/j.seares.2008.10.009; Soares LSH, 2014, MAR ECOL PROG SER, V512, P9, DOI 10.3354/meps10948; Soudant P, 1996, J EXP MAR BIOL ECOL, V205, P149, DOI 10.1016/S0022-0981(96)02608-1; Stenseth NC, 2006, P ROY SOC B-BIOL SCI, V273, P2831, DOI 10.1098/rspb.2006.3658; Suchanek TH, 1997, BIOL BULL, V193, P187, DOI 10.2307/1542764; Sushchik NN, 2008, ZH OBSHCH BIOL, V69, P299; Tagliarolo M, 2015, MAR ECOL PROG SER, V535, P145, DOI 10.3354/meps11434; Tilstone GH, 2000, MAR ECOL PROG SER, V205, P23, DOI 10.3354/meps205023; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Ventura CRR, 1997, INVERTEBR REPROD DEV, V31, P135, DOI 10.1080/07924259.1997.9672571; VERHEYEDUA F, 1988, MAR ECOL PROG SER, V47, P271, DOI 10.3354/meps047271; Wieters EA, 2005, MAR ECOL PROG SER, V301, P43, DOI 10.3354/meps301043; Wieters EA, 2003, MAR ECOL PROG SER, V249, P93, DOI 10.3354/meps249093; Williams JR, 2005, NEW ZEAL J MAR FRESH, V39, P851, DOI 10.1080/00288330.2005.9517357; WING SR, 1995, LIMNOL OCEANOGR, V40, P316, DOI 10.4319/lo.1995.40.2.0316; Xavier BM, 2007, MAR ECOL PROG SER, V346, P189, DOI 10.3354/meps07007	89	14	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161919	10.1371/journal.pone.0161919	http://dx.doi.org/10.1371/journal.pone.0161919			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27570968	Green Published, gold, Green Submitted			2022-12-26	WOS:000382876700045
J	Srivastava, A; Asahara, H; Zhang, M; Zhang, WJ; Liu, HY; Cui, S; Jin, Q; Chong, SR				Srivastava, Aashish; Asahara, Haruichi; Zhang, Meng; Zhang, Weijia; Liu, Haiying; Cui, Sheng; Jin, Qi; Chong, Shaorong			Reconstitution of Protein Translation of Mycobacterium Reveals Functional Conservation and Divergence with the Gram-Negative Bacterium Escherichia coli	PLOS ONE			English	Article							TUBERCULOSIS; INITIATION; SUFFICIENT; RESISTANCE; RIBOSOME; SYSTEM	Protein translation is essential for all bacteria pathogens. It has also been a major focus of structural and functional studies and an important target of antibiotics. Here we report our attempts to biochemically reconstitute mycobacterial protein translation in vitro from purified components. This mycobacterial translation system consists of individually purified recombinant translation factors from Mycobacterium tuberculosis (M. tuberculosis), purified tRNAs and ribosomes from Mycobacterium smegmatis (M. smegmatis), and an aminoacylt-RNA synthetase (AARS) mixture from the cell-extract of M. smegmatis. We demonstrate that such mycobacterial translation system was efficient in in vitro protein synthesis, and enabled functional comparisons of translational components between the gram-positive Mycobacterium and the gram-negative E. coli. Although mycobacterial translation factors and ribosomes were highly compatible with their E. coli counterparts, M. smegmatis tRNAs were not properly charged by the E. coli AARSs to allow efficient translation of a reporter. In contrast, both E. coli and M. smegmatis tRNAs exhibited similar activity with the semi-purified M. smegmatis AARSs mixture for in vitro translation. We further demonstrated the use of both mycobacterial and E. coli translation systems as comparative in vitro assays for small-molecule antibiotics that target protein translation. While mycobacterial and E. coli translation were both inhibited at the same IC50 by the antibiotic spectinomycin, mycobacterial translation was preferentially inhibited by the antibiotic tetracycline, suggesting that there may be structural differences at the antibiotic binding sites between the ribosomes of Mycobacterium and E. coli. Our results illustrate an alternative approach for antibiotic discovery and functional studies of protein translation in mycobacteria and possibly other bacterial pathogens.	[Srivastava, Aashish; Asahara, Haruichi; Chong, Shaorong] New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA; [Zhang, Meng; Zhang, Weijia; Liu, Haiying; Cui, Sheng; Jin, Qi] Chinese Acad Med Sci, Inst Pathogen Biol, Key Lab Syst Biol Pathogens, Beijing 100176, Peoples R China; [Zhang, Meng; Zhang, Weijia; Liu, Haiying; Cui, Sheng; Jin, Qi] Peking Union Med Coll, Beijing 100176, Peoples R China; [Srivastava, Aashish] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	New England Biolabs; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Texas A&M University System; Texas A&M University College Station	Chong, SR (corresponding author), New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA.	chong@neb.com	Sheng, CUI/M-6405-2013; Cui, Sheng/AAQ-1721-2020	Sheng, CUI/0000-0001-6329-3582; Chong, shaorong/0000-0002-6525-3389	Melinda & Bill Gates Foundation [GCE OPP1057809]; National Science and Technology Major Project of China [2013ZX10004601]; Institute of Pathogen Biology, Chinese Academy of Medical Sciences; New England Biolabs	Melinda & Bill Gates Foundation; National Science and Technology Major Project of China; Institute of Pathogen Biology, Chinese Academy of Medical Sciences; New England Biolabs	This study was supported by the Melinda & Bill Gates Foundation, GCE OPP1057809, www.gatesfoundation.org, SCh; National Science and Technology Major Project of China [2013ZX10004601], http://www.most.gov.cn/eng/programmes1, MZ; and Institute of Pathogen Biology, Chinese Academy of Medical Sciences. Drs. Haruichi Asahara and Shaorong Chong are employed by New England Biolabs. This funder provided support in the form of salaries for these authors [HA and S. Chong], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq377; Borovinskaya MA, 2007, ACS CHEM BIOL, V2, P545, DOI 10.1021/cb700100n; Bruell CM, 2008, BIOCHEMISTRY-US, V47, P8828, DOI 10.1021/bi800527k; Bulkley D, 2010, P NATL ACAD SCI USA, V107, P17158, DOI 10.1073/pnas.1008685107; Carter AP, 2001, SCIENCE, V291, P498, DOI 10.1126/science.1057766; Chiba S, 2011, P NATL ACAD SCI USA, V108, P6073, DOI 10.1073/pnas.1018343108; Dunkle JA, 2010, P NATL ACAD SCI USA, V107, P17152, DOI 10.1073/pnas.1007988107; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Javid B, 2014, P NATL ACAD SCI USA, V111, P1132, DOI 10.1073/pnas.1317580111; Keshavjee S, 2012, NEW ENGL J MED, V367, P931, DOI 10.1056/NEJMra1205429; Ohashi H, 2007, BIOCHEM BIOPH RES CO, V352, P270, DOI 10.1016/j.bbrc.2006.11.017; Pai M, 2015, J INFECT DIS, V211, pS21, DOI 10.1093/infdis/jiu803; Pioletti M, 2001, EMBO J, V20, P1829, DOI 10.1093/emboj/20.8.1829; Pratt J.M., 1984, TRANSCRIPTION TRANSL, P179; Ramon-Garcia S, 2007, J ANTIMICROB CHEMOTH, V59, P544, DOI 10.1093/jac/dkl510; Shasmal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031742; Sheppard K, 2008, J MOL BIOL, V377, P831, DOI 10.1016/j.jmb.2008.01.016; Shi WL, 2011, SCIENCE, V333, P1630, DOI 10.1126/science.1208813; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; World Health Organization, 2014, GLOB TUB REP; Zhang Y, 2006, DRUG DISCOV TODAY, V11, P21, DOI 10.1016/S1359-6446(05)03626-3; Zhou Y, 2014, J AM CHEM SOC, V136, P14031, DOI 10.1021/ja502512g; Zhou Y, 2012, NUCLEIC ACIDS RES, V40, P7932, DOI 10.1093/nar/gks568	23	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0162020	10.1371/journal.pone.0162020	http://dx.doi.org/10.1371/journal.pone.0162020			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564552	gold, Green Published, Green Submitted			2022-12-26	WOS:000382496300043
J	Karanovic, D; Grujic-Milanovic, J; Miloradovic, Z; Ivanov, M; Jovovic, D; Vajic, UJ; Zivotic, M; Markovic-Lipkovski, J; Mihailovic-Stanojevic, N				Karanovic, Danijela; Grujic-Milanovic, Jelica; Miloradovic, Zoran; Ivanov, Milan; Jovovic, Djurdjica; Vajic, Una-Jovana; Zivotic, Maja; Markovic-Lipkovski, Jasmina; Mihailovic-Stanojevic, Nevena			Effects of Single and Combined Losartan and Tempol Treatments on Oxidative Stress, Kidney Structure and Function in Spontaneously Hypertensive Rats with Early Course of Proteinuric Nephropathy	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; NITRIC-OXIDE; ANGIOTENSIN-II; ADRIAMYCIN NEPHROPATHY; DOXORUBICIN; NEPHROTOXICITY; PEROXYNITRITE; ERYTHROCYTE; RADICALS; PROTECTS	Oxidative stress has been widely implicated in both hypertension and chronic kidney disease (CKD). Hypertension is a major risk factor for CKD progression. In the present study we have investigated the effects of chronic single tempol (membrane-permeable radical scavenger) or losartan (angiotensin II type 1 receptor blocker) treatment, and their combination on systemic oxidative status (plasma thiobarbituric acid-reactive substances (pTBARS) production, plasma antioxidant capacity (2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid, pABTS), erythrocyte antioxidant enzymes activities) and kidney oxidative stress (kTBARS, kABTS, kidney antioxidant enzymes activities), kidney function and structure in spontaneously hypertensive rats (SHR) with the early course of adriamycin-induced nephropathy. Adult SHR were divided into five groups. The control group received vehicle, while the other groups received adriamycin (2 mg/kg, i.v.) twice in a 21-day interval, followed by vehicle, losartan (L, 10 mg/kg/day), tempol (T, 100 mg/kg/day) or combined T+L treatment (by gavage) during a six-week period. Adriamycin significantly increased proteinuria, plasma lipid peroxidation, kidney protein oxidation, nitrite excretion, matrix metalloproteinase-1 (MMP-1) protein expression and nestin immunostaining in the kidney. Also, it decreased kidney antioxidant defense, kidney NADPH oxidase 4 (kNox4) protein expression and abolished anti-inflammatory response due to significant reduction of kidney NADPH oxidase 2 (kNox2) protein expression in SHR. All treatments reduced protein-to-creatinine ratio (marker of proteinuria), pTBARS production, kidney protein carbonylation, nitrite excretion, increased antioxidant capacity and restored kidney nestin expression similar to control. Both single treatments significantly improved systemic and kidney antioxidant defense, bioavailability of renal nitric oxide, reduced kMMP-1 protein expression and renal injury, thus retarded CKD progression. Losartan improved blood pressure, as well astubular injury and restored anti-inflammatory defense by reverting kNox2 expression to the control level. Interestingly, tempol was more successful in reducing systemic oxidative stress, proteinuria, kMMP-1 and glomerulosclerosis. However, combined treatment failed to overcome the beneficial effects of single treatments in slowing down the progression of ADR-induced nephropathy in SHR.	[Karanovic, Danijela; Grujic-Milanovic, Jelica; Miloradovic, Zoran; Ivanov, Milan; Jovovic, Djurdjica; Vajic, Una-Jovana; Mihailovic-Stanojevic, Nevena] Univ Belgrade, Dept Cardiovasc Physiol, Inst Med Res, Belgrade 11129, Serbia; [Zivotic, Maja; Markovic-Lipkovski, Jasmina] Univ Belgrade, Fac Med, Inst Pathol, Belgrade 11000, Serbia	University of Belgrade; University of Belgrade	Karanovic, D (corresponding author), Univ Belgrade, Dept Cardiovasc Physiol, Inst Med Res, Belgrade 11129, Serbia.	danijela.karanovic@imi.bg.ac.rs	Ivanov, Milan/ABD-4357-2021; Milanovic, Jelica Grujic/D-7052-2015; Karanovic, Danijela/GVT-7443-2022; Zivotic, Maja/N-9508-2017	Milanovic, Jelica Grujic/0000-0001-8014-3121; Ivanov, Milan/0000-0001-8683-5751; Vajic, Una-Jovana/0000-0002-9121-4762; Zivotic, Maja/0000-0002-5833-6661; Karanovic, Danijela/0000-0001-5746-746X; Mihailovic-Stanojevic, Nevena/0000-0001-5356-8706	Ministry of Education, Science and Technological development of Serbia [OI175096]	Ministry of Education, Science and Technological development of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by a grant (project OI175096) from the Ministry of Education, Science and Technological development of Serbia (http://www.mpn.gov.rs/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a Grant (Project OI175096) from the Ministry of Education, Science and Technological development of the Republic of Serbia. The authors gratefully acknowledge the professional English language assistance provided to us by Vladana Ivanov, MA in English language.	Ahmed AK, 2007, KIDNEY INT, V71, P755, DOI 10.1038/sj.ki.5002108; Ahmed LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108889; Arozal W, 2010, TOXICOLOGY, V274, P18, DOI 10.1016/j.tox.2010.05.003; Aryal B, 2014, P NATL ACAD SCI USA, V111, P2011, DOI 10.1073/pnas.1321783111; Asaba K, 2007, J CARDIOVASC PHARM, V49, P13, DOI 10.1097/FJC.0b013e31802b6530; ASAHI M, 1995, J BIOL CHEM, V270, P21035, DOI 10.1074/jbc.270.36.21035; Babelova A, 2012, FREE RADICAL BIO MED, V53, P842, DOI 10.1016/j.freeradbiomed.2012.06.027; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Beutler E., 1982, CATALASE RED CELL ME; BIANCHI AL, 1995, PHYSIOL REV, V75, P1, DOI 10.1152/physrev.1995.75.1.1; Chatterjee PK, 2000, KIDNEY INT, V58, P658, DOI 10.1046/j.1523-1755.2000.00212.x; Chuang YC, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-66; Dobrian AD, 2001, HYPERTENSION, V38, P361, DOI 10.1161/01.HYP.38.3.361; Ebenezer PJ, 2009, OBESITY, V17, P1994, DOI 10.1038/oby.2009.137; Elmarakby AA, 2007, VASC PHARMACOL, V46, P144, DOI 10.1016/j.vph.2006.09.004; Fadillioglu E, 2003, PHARMACOL RES, V47, P317, DOI 10.1016/S1043-6618(03)00010-0; Fujita H, 2012, HYPERTENS RES, V35, P213, DOI 10.1038/hr.2011.176; Jani NV, 2012, EUR J PHARMACOL, V695, P96, DOI 10.1016/j.ejphar.2012.08.003; Javaid B, 2001, J AM SOC NEPHROL, V12, P1391, DOI 10.1681/ASN.V1271391; Jovanovic Dijana B, 2002, Srp Arh Celok Lek, V130, P73; Lassegue B, 2004, AM J HYPERTENS, V17, P852, DOI 10.1016/j.amjhyper.2004.02.004; Lee VWS, 2011, NEPHROLOGY, V16, P30, DOI 10.1111/j.1440-1797.2010.01383.x; Luan JJ, 2012, J PHARMACOL SCI, V119, P167, DOI 10.1254/jphs.12002FP; Lynch TL, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/424751; McBride AG, 1999, BBA-MOL BASIS DIS, V1454, P275, DOI 10.1016/S0925-4439(99)00046-0; MCCORD JM, 1969, J BIOL CHEM, V244, P6056; Mihailovic-Stanojevic N, 2009, GEN PHYSIOL BIOPHYS, V28, P112; Mihailovic-Stanojevic N, 2009, NEPHROL DIAL TRANSPL, V24, P1142, DOI 10.1093/ndt/gfn596; Milic VD, 2009, TOXICOL MECH METHOD, V19, P24, DOI 10.1080/01612840802203098; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Quiles JL, 2002, TOXICOLOGY, V180, P79, DOI 10.1016/S0300-483X(02)00383-9; Rashikh A, 2013, J RENIN-ANGIO-ALDO S, V14, P14, DOI 10.1177/1470320312459980; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Sainz J, 2005, AM J HYPERTENS, V18, P871, DOI 10.1016/j.amjhyper.2004.12.022; Sedeek M, 2013, J AM SOC NEPHROL, V24, P1512, DOI 10.1681/ASN.2012111112; Sung CC, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/301982; Tan RJ, 2015, J AM SOC NEPHROL, V26, P2447, DOI 10.1681/ASN.2014060613; Tesar Vladimir, 2002, Med Sci Monit, V8, pBR69; Wilcox CS, 2010, PHARMACOL THERAPEUT, V126, P119, DOI 10.1016/j.pharmthera.2010.01.003; Yagmurca M, 2004, CLIN CHIM ACTA, V348, P27, DOI 10.1016/j.cccn.2004.03.035; Yanes L, 2005, AM J PHYSIOL-REG I, V288, pR903, DOI 10.1152/ajpregu.00530.2004; Zhang WJ, 2009, FREE RADICAL BIO MED, V46, P791, DOI 10.1016/j.freeradbiomed.2008.12.003; Zima T, 1998, NEPHROL DIAL TRANSPL, V13, P1975, DOI 10.1093/ndt/13.8.1975; Zou J, 2006, VIRCHOWS ARCH, V448, P485, DOI 10.1007/s00428-005-0134-9	46	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161706	10.1371/journal.pone.0161706	http://dx.doi.org/10.1371/journal.pone.0161706			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560781	gold, Green Published, Green Submitted			2022-12-26	WOS:000382258600082
J	Mutschler, I; Ball, T; Kirmse, U; Wieckhorst, B; Pluess, M; Klarhofer, M; Meyer, AH; Wilhelm, FH; Seifritz, E				Mutschler, Isabella; Ball, Tonio; Kirmse, Ursula; Wieckhorst, Birgit; Pluess, Michael; Klarhofer, Markus; Meyer, Andrea H.; Wilhelm, Frank H.; Seifritz, Erich			The Role of the Subgenual Anterior Cingulate Cortex and Amygdala in Environmental Sensitivity to Infant Crying	PLOS ONE			English	Article							SENSORY-PROCESSING SENSITIVITY; DIFFERENTIAL SUSCEPTIBILITY; AUDITORY-CORTEX; CEREBRAL-CORTEX; FUNCTIONAL MRI; INSULAR CORTEX; FRONTAL-CORTEX; HABITUATION; RESPONSES; NEUROTICISM	Newborns and infants communicate their needs and physiological states through crying and emotional facial expressions. Little is known about individual differences in responding to infant crying. Several theories suggest that people vary in their environmental sensitivity with some responding generally more and some generally less to environmental stimuli. Such differences in environmental sensitivity have been associated with personality traits, including neuroticism. This study investigated whether neuroticism impacts neuronal, physiological, and emotional responses to infant crying by investigating blood-oxygenation-level dependent (BOLD) responses using functional magnetic resonance imaging (fMRI) in a large sample of healthy women (N = 102) with simultaneous skin conductance recordings. Participants were repeatedly exposed to a video clip that showed crying infants and emotional responses (valence, arousal, and irritation) were assessed after every video clip presentation. Increased BOLD signal during the perception of crying infants was found in brain regions that are associated with emotional responding, the amygdala and anterior insula. Significant BOLD signal decrements (i.e., habituation) were found in the fusiform gyrus, middle temporal gyrus, superior temporal gyrus, Broca's homologue on the right hemisphere, (laterobasal) amygdala, and hippocampus. Individuals with high neuroticism showed stronger activation in the amygdala and subgenual anterior cingulate cortex (sgACC) when exposed to infant crying compared to individuals with low neuroticism. In contrast to our prediction we found no evidence that neuroticism impacts fMRI-based measures of habituation. Individuals with high neuroticism showed elevated skin conductance responses, experienced more irritation, and perceived infant crying as more unpleasant. The results support the hypothesis that individuals high in neuroticism are more emotionally responsive, experience more negative emotions, and may show enhanced cognitive control during the exposure to infant distress, which may impact infant-directed behavior.	[Mutschler, Isabella; Wieckhorst, Birgit; Meyer, Andrea H.] Univ Basel, Dept Psychol, Div Clin Psychol & Epidemiol, Basel, Switzerland; [Mutschler, Isabella] Univ San Diego, Dept Psychol Sci, San Diego, CA 92110 USA; [Ball, Tonio] Univ Freiburg, Bernstein Ctr Freiburg, Freiburg, Germany; [Ball, Tonio] Univ Freiburg, Intracranial EEG & Funct Brain Imaging Res Grp, Freiburg, Germany; [Kirmse, Ursula] Univ Konstanz, Dept Psychol, Div Gen & Biol Psychol, Constance, Germany; [Pluess, Michael] Queen Mary Univ London, Dept Biol & Expt Psychol, Sch Biol & Chem Sci, London, England; [Klarhofer, Markus] Univ Basel Hosp, MR Phys, Basel, Switzerland; [Wilhelm, Frank H.] Salzburg Univ, Dept Psychol, Div Clin Psychol Psychotherapy & Hlth Psychol, Salzburg, Austria; [Seifritz, Erich] Univ Zurich, Hosp Psychiat, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland	University of Basel; University of San Diego; University of Freiburg; University of Freiburg; University of Konstanz; University of London; Queen Mary University London; University of Basel; Salzburg University; University of Zurich	Mutschler, I (corresponding author), Univ Basel, Dept Psychol, Div Clin Psychol & Epidemiol, Basel, Switzerland.; Mutschler, I (corresponding author), Univ San Diego, Dept Psychol Sci, San Diego, CA 92110 USA.	isabella.mutschler@unibas.ch	Meyer, Axel/C-9826-2009; Pluess, Michael/D-6526-2011	Meyer, Axel/0000-0002-0888-8193; Pluess, Michael/0000-0001-5071-2047; Mutschler Collins, Isabella/0000-0003-2738-5943; Kirmse, Ursula/0000-0002-1141-3527; Wilhelm, Frank H./0000-0002-4414-7085	Swiss National Science Foundation (SNF) [51A240-104890, PA00P1_145418]; Freiwillige Akademische Gesellschaft	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Freiwillige Akademische Gesellschaft	This work was supported by the Swiss National Science Foundation (SNF): Grant 51A240-104890 to FHW and ES, and the Swiss National Science Foundation (SNF): Grant PA00P1_145418 to IM and the Freiwillige Akademische Gesellschaft to IM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Amunts K, 2001, NEUROIMAG CLIN N AM, V11, P151; Arnal LH, 2015, CURR BIOL, V25, P2051, DOI 10.1016/j.cub.2015.06.043; Aron EN, 2012, PERS SOC PSYCHOL REV, V16, P262, DOI 10.1177/1088868311434213; Aron EN, 1997, J PERS SOC PSYCHOL, V73, P345, DOI 10.1037/0022-3514.73.2.345; Ball T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000307; Ball T, 2009, J NEUROSCI METH, V180, P57, DOI 10.1016/j.jneumeth.2009.02.022; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Belsky J, 2009, PSYCHOL BULL, V135, P885, DOI 10.1037/a0017376; Boucsein W, 2012, PSYCHOPHYSIOLOGY, V49, P1017, DOI 10.1111/j.1469-8986.2012.01384.x; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Britton JC, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-44; BUSH LK, 1993, PSYCHOL BULL, V113, P566, DOI 10.1037/0033-2909.113.3.566; De Pisapia N, 2013, NEUROREPORT, V24, P142, DOI 10.1097/WNR.0b013e32835df4fa; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Ellis BJ, 2011, DEV PSYCHOPATHOL, V23, P7, DOI 10.1017/S0954579410000611; Fischer H, 2003, BRAIN RES BULL, V59, P387, DOI 10.1016/S0361-9230(02)00940-1; Haas BW, 2007, BEHAV NEUROSCI, V121, P249, DOI 10.1037/0735-7044.121.2.249; IACONO WG, 1983, ARCH GEN PSYCHIAT, V40, P557; Koenig JL, 2010, PARENT-SCI PRACT, V10, P258, DOI 10.1080/15295192.2010.492038; Kokkonen M, 2001, EUR J PERSONALITY, V15, P407, DOI 10.1002/per.425; Korner A., 2008, Z FUER MEDIZINISCHE, V17, P133; Leitman DI, 2011, FRONT HUM NEUROSCI, V5, DOI [10.3389/fnhum.2011.00096, 10.3389/fnhum.2010.00019]; LENHART RE, 1985, J ABNORM PSYCHOL, V94, P649; Lin HC, 2012, INFANT BEHAV DEV, V35, P887, DOI 10.1016/j.infbeh.2012.08.001; Lorberbaum JP, 2002, BIOL PSYCHIAT, V51, P431, DOI 10.1016/S0006-3223(01)01284-7; LYKKEN DT, 1972, PSYCHOPHYSIOLOGY, V9, P373, DOI 10.1111/j.1469-8986.1972.tb03222.x; MCCRAE RR, 1991, J COUNS DEV, V69, P367, DOI 10.1002/j.1556-6676.1991.tb01524.x; Morosan P, 2005, ANAT EMBRYOL, V210, P401, DOI 10.1007/s00429-005-0029-1; Moser E, 2007, J NEUROSCI METH, V161, P126, DOI 10.1016/j.jneumeth.2006.10.016; Musser ED, 2012, DEV COGN NEUROS-NETH, V2, P428, DOI 10.1016/j.dcn.2012.04.003; Mutschler I, 2014, NEUROSCI LETT, V583, P81, DOI 10.1016/j.neulet.2014.09.021; Mutschler I, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00177; Mutschler I, 2012, NEUROSCI LETT, V520, P204, DOI 10.1016/j.neulet.2012.03.095; Mutschler I, 2010, CEREB CORTEX, V20, P2531, DOI 10.1093/cercor/bhq001; Mutschler I, 2009, NEUROSCI LETT, V457, P66, DOI 10.1016/j.neulet.2009.03.101; Nakamura K, 1999, J NEUROPHYSIOL, V82, P1610, DOI 10.1152/jn.1999.82.3.1610; Nili U, 2010, NEURON, V66, P949, DOI 10.1016/j.neuron.2010.06.009; Norris CJ, 2007, PSYCHOPHYSIOLOGY, V44, P823, DOI 10.1111/j.1469-8986.2007.00551.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ormel J, 2013, NEUROSCI BIOBEHAV R, V37, P59, DOI 10.1016/j.neubiorev.2012.09.004; Piallini G, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01625; Pluess M, 2015, CHILD DEV PERSPECT, V9, P138, DOI 10.1111/cdep.12120; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Reijneveld SA, 2004, LANCET, V364, P1340, DOI 10.1016/S0140-6736(04)17191-2; Reynaud E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032413; Riem MME, 2012, ATTACH HUM DEV, V14, P533, DOI 10.1080/14616734.2012.727252; Riem MME, 2012, NEUROPSYCHOPHARMACOL, V37, P1257, DOI 10.1038/npp.2011.313; Riem MME, 2011, BIOL PSYCHIAT, V70, P291, DOI 10.1016/j.biopsych.2011.02.006; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Sander K, 2005, J COGNITIVE NEUROSCI, V17, P1519, DOI 10.1162/089892905774597227; Sander K, 2007, HUM BRAIN MAPP, V28, P1007, DOI 10.1002/hbm.20333; Schuyler BS, 2014, SOC COGN AFFECT NEUR, V9, P176, DOI 10.1093/scan/nss131; Seifritz E, 2003, BIOL PSYCHIAT, V54, P1367, DOI 10.1016/S0006-3223(03)00697-8; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stein JL, 2007, NEUROIMAGE, V36, P736, DOI 10.1016/j.neuroimage.2007.03.022; Weiland BJ, 2008, NEUROIMAGE, V42, P827, DOI 10.1016/j.neuroimage.2008.05.042; Weisberg YJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00178; Zaitsev M, 2004, MAGNET RESON MED, V52, P1156, DOI 10.1002/mrm.20261	60	8	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161181	10.1371/journal.pone.0161181	http://dx.doi.org/10.1371/journal.pone.0161181			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU5NN	27560361	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000382258600030
J	Lv, MY; Mohamed, AA; Zhang, LW; Zhang, PF; Zhang, L				Lv, Mingyue; Mohamed, Amr Ahmed; Zhang, Liwei; Zhang, Pengfei; Zhang, Long			A Family of CS alpha beta Defensins and Defensin-Like Peptides from the Migratory Locust, Locusta migratoria, and Their Expression Dynamics during Mycosis and Nosemosis	PLOS ONE			English	Article							INSECT ANTIMICROBIAL PEPTIDES; BEE APIS-MELLIFERA; NF-KAPPA-B; IMMUNE-RESPONSE; ANTIBACTERIAL ACTIVITY; SCHISTOCERCA-GREGARIA; DESERT LOCUST; DROSOPHILA-MELANOGASTER; CANDIDA-ALBICANS; MICROSPORIDIA	Insect defensins are effector components of the innate defense system. During infection, these peptides may play a role in the control of pathogens by providing protective antimicrobial barriers between epithelial cells and the hemocoel. The cDNAs encoding four defensins of the migratory locust, Locusta migratoria, designated LmDEF 1, 3-5, were identified for the first time by transcriptome-targeted analysis. Three of the members of this CS alpha beta defensin family, LmDEF 1, 3, and 5, were detected in locust tissues. The pro regions of their sequences have little-shared identities with other insect defensins, though the predicted mature peptides align well with other insect defensins. Phylogenetic analysis indicates a completely novel position of both LmDEF 1 and 3, compared to defensins from hymenopterans. The expression patterns of the genes encoding LmDEFs in the fat body and salivary glands were studied in response to immune-challenge by the microsporidian pathogen Nosema locustae and the fungus Metarhizium anisopliae after feeding or topical application, respectively. Focusing on Nosema-induced immunity, qRT-PCR was employed to quantify the transcript levels of LmDEFs. A higher transcript abundance of LmDEF5 was distributed more or less uniformly throughout the fat body along time. A very low baseline transcription of both LmDEFs 1 and 3 in naive insects was indicated, and that transcription increases with time or is latent in the fat body or salivary glands of infected nymphs. In the salivary glands, expression of LmDEF3 was 20-40-times higher than in the fat body post-microbial infection. A very low expression of LmDEF3 could be detected in the fat body, but eventually increased with time up to a maximum at day 15. Delayed induction of transcription of these peptides in the fat body and salivary glands 5-15 days post-activation and the differential expression patterns suggest that the fat body/salivary glands of this species are active in the immune response against pathogens. The ability of N. locustae to induce salivary glands as well as fat body expression of defensins raises the possibility that these AMPs might play a key role in the development and/or tolerance of parasitic infections.	[Lv, Mingyue; Zhang, Liwei; Zhang, Pengfei; Zhang, Long] China Agr Univ, Minist Agr, Key Lab Biol Control, Dept Entomol, Beijing, Peoples R China; [Mohamed, Amr Ahmed] Cairo Univ, Fac Sci, Dept Entomol, Giza, Egypt	China Agricultural University; Ministry of Agriculture & Rural Affairs; Egyptian Knowledge Bank (EKB); Cairo University	Zhang, L (corresponding author), China Agr Univ, Minist Agr, Key Lab Biol Control, Dept Entomol, Beijing, Peoples R China.	locust@cau.edu.cn		Mohamed, Amr/0000-0003-2788-5534	Chinese Universities Scientific Fund [2015NX001]; Research Support Fund Program of the Faculty of Science, Cairo University, Egypt	Chinese Universities Scientific Fund; Research Support Fund Program of the Faculty of Science, Cairo University, Egypt	This work was supported by the Chinese Universities Scientific Fund (2015NX001). AAM acknowledges a limited funding via The Research Support Fund Program of the Faculty of Science, Cairo University, Egypt.	Aerts AM, 2008, CELL MOL LIFE SCI, V65, P2069, DOI 10.1007/s00018-008-8035-0; Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Boulanger N, 2004, INFECT IMMUN, V72, P7140, DOI 10.1128/IAI.72.12.7140-7146.2004; Boulanger N, 2001, INSECT BIOCHEM MOLEC, V31, P129, DOI 10.1016/S0965-1748(00)00096-5; Brooks W.M., 1988, P1; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Bulet P, 2005, PROTEIN PEPTIDE LETT, V12, P3, DOI 10.2174/0929866053406011; BULET P, 1992, EUR J BIOCHEM, V209, P977, DOI 10.1111/j.1432-1033.1992.tb17371.x; Bulmer MS, 2010, INSECT MOL BIOL, V19, P669, DOI 10.1111/j.1365-2583.2010.01023.x; CANNING EU, 1962, J INSECT PATHOL, V4, P248; Capella-Gutierrez S, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-47; Cerovsky V, 2014, PHARMACEUTICALS-BASE, V7, P251, DOI 10.3390/ph7030251; Chaimanee V, 2012, J INSECT PHYSIOL, V58, P1090, DOI 10.1016/j.jinsphys.2012.04.016; COCIANCICH S, 1993, J BIOL CHEM, V268, P19239; CORNET B, 1995, STRUCTURE, V3, P435, DOI 10.1016/S0969-2126(01)00177-0; Dassanayake RS, 2007, PEPTIDES, V28, P62, DOI 10.1016/j.peptides.2006.09.022; de la Vega RCR, 2005, TRENDS GENET, V21, P330, DOI 10.1016/j.tig.2005.03.009; Dworkin I, 2009, GENETICS, V181, P721, DOI 10.1534/genetics.108.093419; Eggleston P, 2000, INSECT MOL BIOL, V9, P481, DOI 10.1046/j.1365-2583.2000.00212.x; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Gillespie JP, 2000, J INSECT PHYSIOL, V46, P429, DOI 10.1016/S0022-1910(99)00128-6; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Hassanali A, 2005, ANNU REV ENTOMOL, V50, P223, DOI 10.1146/annurev.ento.50.071803.130345; He Z, 2013, INSECT MOL BIOL, V22, P389, DOI 10.1111/imb.12029; Hedengren-Olcott M, 2004, J BIOL CHEM, V279, P21121, DOI 10.1074/jbc.M313856200; Henry J. E., 1981, Microbial control of pests and plant diseases 1970-1980., P573; Hillyer JF, 2016, DEV COMP IMMUNOL, V58, P102, DOI 10.1016/j.dci.2015.12.006; HOFFMANN JA, 1992, IMMUNOL TODAY, V13, P411, DOI 10.1016/0167-5699(92)90092-L; Holzl G, 2005, GLYCOBIOLOGY, V15, P874, DOI 10.1093/glycob/cwi066; HULTMARK D, 1982, EUR J BIOCHEM, V127, P207, DOI 10.1111/j.1432-1033.1982.tb06857.x; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; Keeling PJ, 2000, MOL BIOL EVOL, V17, P23, DOI 10.1093/oxfordjournals.molbev.a026235; Landon C, 2008, PROTEINS, V72, P229, DOI 10.1002/prot.21912; Lange Carlos E., 2005, Journal of Orthoptera Research, V14, P137, DOI 10.1665/1082-6467(2005)14[137:THAGRO]2.0.CO;2; Lange CE, 1996, BIOL CONTROL, V7, P24, DOI 10.1006/bcon.1996.0059; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Lee J, 2012, FREE RADICAL BIO MED, V52, P2302, DOI 10.1016/j.freeradbiomed.2012.03.012; Lee YS, 2004, INSECT MOL BIOL, V13, P65, DOI 10.1111/j.1365-2583.2004.00462.x; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Li YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121884; Lockwood Jeffrey A., 1999, Insect Science and its Application, V19, P333; Lomer CJ, 2001, ANNU REV ENTOMOL, V46, P667, DOI 10.1146/annurev.ento.46.1.667; Ma ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-11; Matskevich AA, 2010, EUR J IMMUNOL, V40, P1244, DOI 10.1002/eji.200940164; Meredith JM, 2006, INSECT MOL BIOL, V15, P393, DOI 10.1111/j.1365-2583.2006.00635.x; Mohamed AA, 2016, DEV COMP IMMUNOL, V61, P60, DOI 10.1016/j.dci.2016.03.018; Mohamed AA, 2013, EUR J ENTOMOL, V110, P559, DOI 10.14411/eje.2013.076; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Raj PA, 2002, FEMS MICROBIOL LETT, V206, P9, DOI 10.1111/j.1574-6968.2002.tb10979.x; Roberts DW, 2004, ADV APPL MICROBIOL, V54, P1, DOI 10.1016/S0065-2164(04)54001-7; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sokolova YY, 2002, ACTA PROTOZOOL, V41, P229; Solter L.F., 2012, MANUAL TECHNIQUES IN, V2, P329, DOI DOI 10.1016/B978-0-12-386899-2.00011-7; Takeuchi K, 2004, J BIOL CHEM, V279, P4981, DOI 10.1074/jbc.M307815200; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Taupin V, 2007, GLYCOBIOLOGY, V17, P56, DOI 10.1093/glycob/cwl050; Thevissen K, 2004, J BIOL CHEM, V279, P3900, DOI 10.1074/jbc.M311165200; Thevissen K, 2006, MINI-REV MED CHEM, V6, P699, DOI 10.2174/138955706777435643; Tian CH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-187; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Varkey J, 2006, PEPTIDES, V27, P2614, DOI 10.1016/j.peptides.2006.06.010; Viljakainen L, 2015, BRIEF FUNCT GENOMICS, V14, P407, DOI 10.1093/bfgp/elv002; Wang CS, 2005, EUKARYOT CELL, V4, P937, DOI 10.1128/EC.4.5.937-947.2005; Wang YD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003102; Wang ZZ, 2013, J INSECT PHYSIOL, V59, P1095, DOI 10.1016/j.jinsphys.2013.08.011; Wei L, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0669-9; Wen HX, 2009, MOL BIOL REP, V36, P711, DOI 10.1007/s11033-008-9233-4; Xu CQ, 2004, J BIOL CHEM, V279, P34562, DOI 10.1074/jbc.M312798200; YAMADA K, 1994, BIOCHEM J, V298, P623, DOI 10.1042/bj2980623; Yi HY, 2014, APPL MICROBIOL BIOT, V98, P5807, DOI 10.1007/s00253-014-5792-6; Zhang W, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2089-9; Zhao BC, 2016, CURR TOP MED CHEM, V16, P206, DOI 10.2174/1568026615666150701115911; Zheng XL, 2012, DEV COMP IMMUNOL, V36, P602, DOI 10.1016/j.dci.2011.10.010	77	13	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161585	10.1371/journal.pone.0161585	http://dx.doi.org/10.1371/journal.pone.0161585			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556587	gold, Green Submitted, Green Published			2022-12-26	WOS:000382258100058
J	Traxlmayr, MW; Kiefer, JD; Srinivas, RR; Lobner, E; Tisdale, AW; Mehta, NK; Yang, NJ; Tidor, B; Wittrup, KD				Traxlmayr, Michael W.; Kiefer, Jonathan D.; Srinivas, Raja R.; Lobner, Elisabeth; Tisdale, Alison W.; Mehta, Naveen K.; Yang, Nicole J.; Tidor, Bruce; Wittrup, K. Dane			Strong Enrichment of Aromatic Residues in Binding Sites from a Charge-neutralized Hyperthermostable Sso7d Scaffold Library	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						directed evolution; epidermal growth factor receptor (EGFR); molecular evolution; protein stability; scaffold protein; aromatic amino acids; protein charge; yeast display	YEAST SURFACE DISPLAY; IN-VIVO; SULFOLOBUS-SOLFATARICUS; DIRECTED EVOLUTION; PROTEIN INTERFACES; HUMAN-ANTIBODIES; STABILITY; AFFINITY; RECEPTOR; SPECIFICITY	The Sso7d protein from the hyperthermophilic archaeon Sulfolobus solfataricus is an attractive binding scaffold because of its small size (7 kDa), high thermal stability (T-m of 98 degrees C), and absence of cysteines and glycosylation sites. However, as a DNA-binding protein, Sso7d is highly positively charged, introducing a strong specificity constraint for binding epitopes and leading to nonspecific interaction with mammalian cell membranes. In the present study, we report charge-neutralized variants of Sso7d that maintain high thermal stability. Yeast-displayed libraries that were based on this reduced charge Sso7d (rcSso7d) scaffold yielded binders with low nanomolar affinities against mouse serum albumin and several epitopes on human epidermal growth factor receptor. Importantly, starting from a charge-neutralized scaffold facilitated evolutionary adaptation of binders to differentially charged epitopes on mouse serum albumin and human epidermal growth factor receptor, respectively. Interestingly, the distribution of amino acids in the small and rigid binding surface of enriched rcSso7d-based binders is very different from that generally found in more flexible antibody complementarity-determining region loops but resembles the composition of antibody-binding energetic hot spots. Particularly striking was a strong enrichment of the aromatic residues Trp, Tyr, and Phe in rcSso7d-based binders. This suggests that the rigidity and small size of this scaffold determines the unusual amino acid composition of its binding sites, mimicking the energetic core of antibody paratopes. Despite the high frequency of aromatic residues, these rcSso7d-based binders are highly expressed, thermostable, and monomeric, suggesting that the hyperstability of the starting scaffold and the rigidness of the binding surface confer a high tolerance to mutation.	[Traxlmayr, Michael W.; Kiefer, Jonathan D.; Tisdale, Alison W.; Mehta, Naveen K.; Yang, Nicole J.; Wittrup, K. Dane] MIT, Koch Inst Integrat Canc Res, 500 Main St, Cambridge, MA 02139 USA; [Srinivas, Raja R.; Tisdale, Alison W.; Mehta, Naveen K.; Tidor, Bruce; Wittrup, K. Dane] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Traxlmayr, Michael W.; Yang, Nicole J.; Wittrup, K. Dane] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Lobner, Elisabeth] BOKU Univ Nat Resources & Life Sci, Div Biochem, Dept Chem, A-1190 Vienna, Austria	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Natural Resources & Life Sciences, Vienna	Wittrup, KD (corresponding author), MIT, Koch Inst Integrat Canc Res, 500 Main St, Cambridge, MA 02139 USA.; Traxlmayr, MW (corresponding author), BOKU Univ Nat Resources & Life Sci, Dept Chem, Muthgasse 18, A-1190 Vienna, Austria.	michael.traxlmayr@boku.ac.at; wittrup@mit.edu		Traxlmayr, Michael/0000-0002-2108-582X; Laurent, Elisabeth/0000-0002-5234-5524; /0000-0002-3320-3969	Koch Institute Genomics Core; Koch Institute Flow Cytometry Core; Koch Institute Support (core) Grant from the National Cancer Institute [P30CA14051]; National Science Foundation [0070319]; National Institutes of Health [S10 OD016326]; Austrian Science Fund (FWF) [J 3496] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA096504, P30CA014051, R01CA174795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082209] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016326] Funding Source: NIH RePORTER	Koch Institute Genomics Core; Koch Institute Flow Cytometry Core; Koch Institute Support (core) Grant from the National Cancer Institute; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge support by the Koch Institute Genomics Core and the Koch Institute Flow Cytometry Core, which is supported in part by Koch Institute Support (core) Grant P30CA14051 from the National Cancer Institute. The Biophysical Instrumentation Facility for the Study of Complex Macromolecular Systems (National Science Foundation Grant 0070319) is gratefully acknowledged for enabling use of the Octet biolayer interferometry system (National Institutes of Health Grant S10 OD016326).	Ackerman M, 2009, BIOTECHNOL PROGR, V25, P774, DOI 10.1002/btpr.174; Angelini A, 2015, METHODS MOL BIOL, V1319, P3, DOI 10.1007/978-1-4939-2748-7_1; BAUMANN H, 1994, NAT STRUCT BIOL, V1, P808, DOI 10.1038/nsb1194-808; Beehar G, 2013, PROTEIN ENG DES SEL, V26, P267, DOI 10.1093/protein/gzs106; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Birtalan S, 2008, J MOL BIOL, V377, P1518, DOI 10.1016/j.jmb.2008.01.093; Birtalan S, 2010, MOL BIOSYST, V6, P1186, DOI 10.1039/b927393j; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Boswell CA, 2010, BIOCONJUGATE CHEM, V21, P2153, DOI 10.1021/bc100261d; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen TF, 2013, METHOD ENZYMOL, V523, P303, DOI 10.1016/B978-0-12-394292-0.00014-X; Cronican JJ, 2011, CHEM BIOL, V18, P833, DOI 10.1016/j.chembiol.2011.07.003; de Picciotto S, 2016, J MOL BIOL, V428, P4228, DOI 10.1016/j.jmb.2016.07.004; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; Gera N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048928; Gera N, 2011, J MOL BIOL, V409, P601, DOI 10.1016/j.jmb.2011.04.020; Gilbreth RN, 2008, J MOL BIOL, V381, P407, DOI 10.1016/j.jmb.2008.06.014; Hackel BJ, 2010, J MOL BIOL, V401, P84, DOI 10.1016/j.jmb.2010.06.004; Kangas E, 1999, PHYS REV E, V59, P5958, DOI 10.1103/PhysRevE.59.5958; Knapp S, 1996, J MOL BIOL, V264, P1132, DOI 10.1006/jmbi.1996.0701; Koide A, 2007, P NATL ACAD SCI USA, V104, P6632, DOI 10.1073/pnas.0700149104; Kolmar H, 2008, FEBS J, V275, P2684, DOI 10.1111/j.1742-4658.2008.06440.x; Lahti JL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000499; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Lippow SM, 2007, NAT BIOTECHNOL, V25, P1171, DOI 10.1038/nbt1336; McCrary BS, 1996, J MOL BIOL, V264, P784, DOI 10.1006/jmbi.1996.0677; McNaughton BR, 2009, P NATL ACAD SCI USA, V106, P6111, DOI 10.1073/pnas.0807883106; Miller EA, 2016, MOL SYST DES ENG, V1, P377, DOI [10.1039/c6me00032k, 10.1039/C6ME00032K]; Mouratou B, 2007, P NATL ACAD SCI USA, V104, P17983, DOI 10.1073/pnas.0702963104; Nygren PA, 2008, FEBS J, V275, P2668, DOI 10.1111/j.1742-4658.2008.06438.x; Pechmann S, 2009, P NATL ACAD SCI USA, V106, P10159, DOI 10.1073/pnas.0812414106; Pluckthun A, 2015, ANNU REV PHARMACOL, V55, P489, DOI 10.1146/annurev-pharmtox-010611-134654; Robin G, 2014, J MOL BIOL, V426, P3729, DOI 10.1016/j.jmb.2014.08.013; Schlehuber S, 2002, BIOPHYS CHEM, V96, P213, DOI 10.1016/S0301-4622(02)00026-1; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; Shusta EV, 2000, NAT BIOTECHNOL, V18, P754, DOI 10.1038/77325; Silverman AP, 2011, J MOL RECOGNIT, V24, P127, DOI 10.1002/jmr.1036; Skerra A, 2008, FEBS J, V275, P2677, DOI 10.1111/j.1742-4658.2008.06439.x; Steemson JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086050; Stumpp MT, 2008, DRUG DISCOV TODAY, V13, P695, DOI 10.1016/j.drudis.2008.04.013; Traxlmayr MW, 2012, ARCH BIOCHEM BIOPHYS, V526, P174, DOI 10.1016/j.abb.2012.04.022; Velikovsky CA, 2009, NAT STRUCT MOL BIOL, V16, P725, DOI 10.1038/nsmb.1619; Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007	46	29	33	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22496	22508		10.1074/jbc.M116.741314	http://dx.doi.org/10.1074/jbc.M116.741314			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27582495	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000386760600012
J	Zemoura, K; Trumpler, C; Benke, D				Zemoura, Khaled; Truempler, Claudia; Benke, Dietmar			Lys-63-linked Ubiquitination of -Aminobutyric Acid (GABA), Type B1, at Multiple Sites by the E3 Ligase Mind Bomb-2 Targets GABA(B) Receptors to Lysosomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; GABA receptor; lysosome; protein degradation; ubiquitylation (ubiquitination)	DIFFERENTIAL REGULATION; PROXIMITY LIGATION; IN-SITU; TRAFFICKING; PROTEIN; INTERNALIZATION; ACTIVATION; COMPLEXES; GLUTAMATE; NETWORK	GABA(B) receptors are heterodimeric G protein-coupled receptors, which control neuronal excitability by mediating prolonged inhibition. The magnitude of GABA(B) receptor-mediated inhibition essentially depends on the amount of receptors in the plasma membrane. However, the factors regulating cell surface expression of GABA(B) receptors are poorly characterized. Cell surface GABA(B) receptors are constitutively internalized and either recycled to the plasma membrane or degraded in lysosomes. The signal that sorts GABA(B) receptors to lysosomes is currently unknown. Here we show that Mind bomb-2 (MIB2)-mediated Lys-63-linked ubiquitination of the GABA(B1) subunit at multiple sites is the lysosomal sorting signal for GABA(B) receptors. We found that inhibition of lysosomal activity in cultured rat cortical neurons increased the fraction of Lys-63-linked ubiquitinated GABA(B) receptors and enhanced the expression of total as well as cell surface GABA(B) receptors. Mutational inactivation of four putative ubiquitination sites in the GABA(B1) subunit significantly diminished Lys-63-linked ubiquitination of GABA(B) receptors and prevented their lysosomal degradation. We identified MIB2 as the E3 ligase triggering Lys-63-linked ubiquitination and lysosomal degradation of GABA(B) receptors. Finally, we show that sustained activation of glutamate receptors, a condition occurring in brain ischemia that down-regulates GABA(B) receptors, considerably increased the expression of MIB2 and Lys-63-linked ubiquitination of GABA(B) receptors. Interfering with Lys-63-linked ubiquitination by overexpressing ubiquitin mutants or GABA(B1) mutants deficient in Lys-63-linked ubiquitination prevented glutamate-induced down-regulation of the receptors. These findings indicate that Lys-63-linked ubiquitination of GABA(B1) at multiple sites by MIB2 controls sorting of GABA(B) receptors to lysosomes for degradation under physiological and pathological conditions.	[Zemoura, Khaled; Truempler, Claudia; Benke, Dietmar] Univ Zurich, Inst Pharmacol & Toxicol, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Benke, Dietmar] Univ Zurich, Neuroscience Ctr Zurich, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Benke, Dietmar] Swiss Fed Inst Technol, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Benke, Dietmar] Drug Discovery Network Zurich, Winterthurerstr 190, CH-8057 Zurich, Switzerland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Benke, D (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	benke@pharma.uzh.ch			Swiss National Science Foundation [31003A_138382]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant 31003A_138382 (to D. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Benke D, 1999, J BIOL CHEM, V274, P27323, DOI 10.1074/jbc.274.38.27323; Benke D, 2002, J RECEPT SIGNAL TR R, V22, P253, DOI 10.1081/RRS-120014600; Benke Dietmar, 2012, World J Biol Chem, V3, P61, DOI 10.4331/wjbc.v3.i4.61; Benke D, 2010, ADV PHARMACOL, V58, P93, DOI 10.1016/S1054-3589(10)58004-9; Buerli T, 2007, NAT PROTOC, V2, P3090, DOI 10.1038/nprot.2007.445; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Craig MT, 2014, CURR OPIN NEUROBIOL, V26, P15, DOI 10.1016/j.conb.2013.10.002; Dores MR, 2014, CURR OPIN CELL BIOL, V27, P44, DOI 10.1016/j.ceb.2013.11.004; Gaiarsa JL, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00206; Grampp T, 2007, J BIOL CHEM, V282, P24157, DOI 10.1074/jbc.M702626200; Grampp T, 2008, MOL CELL NEUROSCI, V39, P628, DOI 10.1016/j.mcn.2008.09.004; Guetg N, 2010, P NATL ACAD SCI USA, V107, P13924, DOI 10.1073/pnas.1000909107; Guo BQ, 2016, CURR OPIN STRUC BIOL, V41, P38, DOI 10.1016/j.sbi.2016.05.012; Hannan S, 2011, J BIOL CHEM, V286, P24324, DOI 10.1074/jbc.M110.220814; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Jurd R, 2008, J BIOL CHEM, V283, P301, DOI 10.1074/jbc.M705580200; Kantamneni S, 2008, J NEUROCHEM, V107, P86, DOI 10.1111/j.1471-4159.2008.05580.x; Kantamneni S, 2014, J BIOL CHEM, V289, P6681, DOI 10.1074/jbc.M113.487348; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kim S, 2015, KOREAN J PHYSIOL PHA, V19, P515, DOI 10.4196/kjpp.2015.19.6.515; Kohl MM, 2010, ADV PHARMACOL, V58, P205, DOI 10.1016/S1054-3589(10)58009-8; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Koo BK, 2005, J BIOL CHEM, V280, P22335, DOI 10.1074/jbc.M501631200; Laffray S, 2007, EUR J NEUROSCI, V25, P1402, DOI 10.1111/j.1460-9568.2007.05398.x; Lahaie N, 2016, J BIOL CHEM, V291, P7156, DOI 10.1074/jbc.M115.686907; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Leuchowius KJ, 2010, MOL CELL PROTEOMICS, V9, P178, DOI 10.1074/mcp.M900331-MCP200; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Maier PJ, 2014, J BIOL CHEM, V289, P12896, DOI 10.1074/jbc.M114.550517; Maier PJ, 2010, J BIOL CHEM, V285, P35606, DOI 10.1074/jbc.M110.142406; Ng EL, 2012, CELL BIOCHEM FUNCT, V30, P515, DOI 10.1002/cbf.2827; Pagano A, 2001, J NEUROSCI, V21, P1189; Pinard A, 2010, ADV PHARMACOL, V58, P231, DOI 10.1016/S1054-3589(10)58010-4; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Schwenk J, 2016, NAT NEUROSCI, V19, P233, DOI 10.1038/nn.4198; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stempin CC, 2011, J BIOL CHEM, V286, P37147, DOI 10.1074/jbc.M111.263384; Terunuma M, 2010, P NATL ACAD SCI USA, V107, P13918, DOI 10.1073/pnas.1000853107; Tseng LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093394; Vargas KJ, 2008, J BIOL CHEM, V283, P24641, DOI 10.1074/jbc.M802419200; Wilkins ME, 2008, J BIOL CHEM, V283, P34745, DOI 10.1074/jbc.M803197200; Ye JS, 2014, J VIROL, V88, P12765, DOI 10.1128/JVI.02037-14; Zemoura K, 2014, J BIOL CHEM, V289, P7738, DOI 10.1074/jbc.M113.541987; Zemoura K, 2013, J BIOL CHEM, V288, P34897, DOI 10.1074/jbc.M113.514745	46	11	11	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21682	21693		10.1074/jbc.M116.750968	http://dx.doi.org/10.1074/jbc.M116.750968			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27573246	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000385999200033
J	Lindberg, MF; Miaskowski, C; Rustoen, T; Rosseland, LA; Paul, SM; Lerdal, A				Lindberg, Maren Falch; Miaskowski, Christine; Rustoen, Tone; Rosseland, Leiv Arne; Paul, Steven M.; Lerdal, Anners			Preoperative Pain, Symptoms, and Psychological Factors related to Higher Acute Pain Trajectories during Hospitalization for Total Knee Arthroplasty	PLOS ONE			English	Article							POSTOPERATIVE PAIN; POSTSURGICAL PAIN; SLEEP DISTURBANCE; PERSISTENT PAIN; OLDER-ADULTS; RISK-FACTORS; PREDICTORS; OSTEOARTHRITIS; CANCER; HIP	Objectives Unrelieved postoperative pain after total knee arthroplasty (TKA) is a significant problem. This longitudinal study investigated how preoperative pain intensity, as well as a comprehensive list of preoperative and perioperative factors, influenced the severity of acute average and worst pain after TKA. Methods Prior to surgery, 203 patients completed a demographic questionnaire, Lee Fatigue Scale, Fatigue Severity Scale, Hospital Anxiety and Depression Scale, and Brief Illness Perception Questionnaire. Brief Pain Inventory was completed prior to surgery as well as through postoperative days (POD) 0 to 4. Clinical data were extracted from medical records. Results Several factors were associated with higher levels of preoperative and postoperative pain. Lower preoperative average and worst pain intensity scores were associated with increases in average and worst postoperative pain from POD1 to POD4. A higher number of comorbidities, higher C-reactive protein values, and higher pain interference with function were associated with higher preoperative levels of average pain. Older age, higher fatigue levels, and higher scores on identity and emotional responses to osteoarthritis (OA) were associated with higher preoperative levels of worst pain. Lower perceived consequences of OA were associated with higher pain from POD1 to POD4. Males and patients with lower preoperative scores for average pain had higher worst pain following surgery. Discussion Patients at higher risk for more severe postoperative pain can be identified through an assessment of pain and other risk factors identified in this study. Future research needs to test the efficacy of interventions that modify patients' perceptions of living with OA and pain intensity before surgery on short and long term postoperative outcomes.	[Lindberg, Maren Falch] Lovisenberg Diakonale Hosp, Dept Surg, Oslo, Norway; [Lindberg, Maren Falch; Rustoen, Tone; Lerdal, Anners] Univ Oslo, Fac Med, Dept Nursing Sci, Inst Hlth & Soc, Oslo, Norway; [Miaskowski, Christine; Paul, Steven M.] Univ Calif San Francisco, Sch Nursing, San Francisco, CA 94143 USA; [Rustoen, Tone; Rosseland, Leiv Arne] Oslo Univ Hosp, Dept Res & Dev, Div Emergencies & Crit Care, Oslo, Norway; [Rosseland, Leiv Arne] Univ Oslo, Inst Clin Med, Oslo, Norway; [Lerdal, Anners] Lovisenberg Diakonale Hosp, Dept Patient Safety & Res, Oslo, Norway	University of Oslo; University of California System; University of California San Francisco; University of Oslo; University of Oslo	Lerdal, A (corresponding author), Univ Oslo, Fac Med, Dept Nursing Sci, Inst Hlth & Soc, Oslo, Norway.; Lerdal, A (corresponding author), Lovisenberg Diakonale Hosp, Dept Patient Safety & Res, Oslo, Norway.	anners.lerdal@medisin.uio.no	Paul, Steve/ABE-5400-2020; Lerdal, Anners/AAE-9429-2021	Lerdal, Anners/0000-0002-7144-5096; Lindberg, Maren Falch/0000-0003-2074-2071	Lovisenberg Diakonale Hospital; Norwegian Nursing Organization; United States-Norway Fulbright Foundation	Lovisenberg Diakonale Hospital; Norwegian Nursing Organization; United States-Norway Fulbright Foundation	The study was funded by Lovisenberg Diakonale Hospital. The PhD fellowship for M.F. Lindberg was provided by Lovisenberg Diakonale Hospital (url: www.lds.no), the Norwegian Nursing Organization (url: www.nsf.no), and the United States-Norway Fulbright Foundation (url: http://www.fulbright.no/). None of the funding sources were involved in any stage of the study.	Aasvang EK, 2016, ACTA ANAESTH SCAND, V60, P529, DOI 10.1111/aas.12667; Andersen LO, 2009, ANAESTHESIA, V64, P508, DOI 10.1111/j.1365-2044.2008.05831.x; Bertakis KD, 2004, ANN FAM MED, V2, P224, DOI 10.1370/afm.66; Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020; Bruehl S, 2008, J BEHAV MED, V31, P71, DOI 10.1007/s10865-007-9133-4; Campesi Ilaria, 2012, Handb Exp Pharmacol, P265, DOI 10.1007/978-3-642-30726-3_13; Caraceni A, 2012, LANCET ONCOL, V13, pE58, DOI 10.1016/S1470-2045(12)70040-2; Chapman CR, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/608359; Chapman CR, 2011, J PAIN, V12, P257, DOI 10.1016/j.jpain.2010.08.005; Cleeland CS, 1985, SEMIN ONCOL NURS, V1, P92; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dekker J, 2009, CURR OPIN RHEUMATOL, V21, P520, DOI 10.1097/BOR.0b013e32832e6eaa; Dihle A, 2006, J PAIN, V7, P272, DOI 10.1016/j.jpain.2005.11.005; Fishbain DA, 2003, PAIN MED, V4, P51, DOI 10.1046/j.1526-4637.2003.03008.x; Ghomrawi HMK, 2013, CLIN ORTHOP RELAT R, V471, P175, DOI 10.1007/s11999-012-2484-3; Halket A, 2010, J ARTHROPLASTY, V25, P254, DOI 10.1016/j.arth.2009.01.007; Havelin LI, 2013, REPORT; Hawker GA, 2008, OSTEOARTHR CARTILAGE, V16, P415, DOI 10.1016/j.joca.2007.12.017; Ip HYV, 2009, ANESTHESIOLOGY, V111, P657, DOI 10.1097/ALN.0b013e3181aae87a; Jenkins JB, 2015, ORTHOP NURS, V34, P36, DOI 10.1097/NOR.0000000000000112; Jin X, 2013, ANN RHEUM DIS; Joshi Girish P, 2005, Anesthesiol Clin North Am, V23, P21, DOI 10.1016/j.atc.2004.11.013; Kauppila AM, 2009, DISABIL REHABIL, V31, P370, DOI 10.1080/09638280801976159; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Klepstad P, 2002, J PAIN SYMPTOM MANAG, V24, P517, DOI 10.1016/S0885-3924(02)00526-2; Langford DJ, 2011, J PAIN, V12, P652, DOI 10.1016/j.jpain.2010.12.003; Langford DJ, 2011, J PAIN, V12, P495, DOI 10.1016/j.jpain.2010.10.015; Lavand'homme PM, 2014, CLIN ORTHOP RELAT R, V472, P1409, DOI 10.1007/s11999-013-3389-5; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lee BO, 2010, J CLIN NURS, V19, P556, DOI 10.1111/j.1365-2702.2009.02972.x; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Lerdal A, 2005, SCAND J PUBLIC HEALT, V33, P123, DOI 10.1080/14034940410028406; Lerdal A, 2013, QUAL LIFE RES, V22, P1467, DOI 10.1007/s11136-012-0279-3; Lindberg MF, 2017, PAIN MED, V18, P124, DOI 10.1093/pm/pnw080; Lindviksmoen G, CANCER; Liu SS, 2007, ANESTH ANALG, V104, P689, DOI 10.1213/01.ane.0000255040.71600.41; Liu SS, 2012, INT ORTHOP, V36, P2261, DOI 10.1007/s00264-012-1623-5; Lunn TH, 2013, PAIN, V154, P1878, DOI 10.1016/j.pain.2013.06.008; Merriman JD, 2010, ONCOL NURS FORUM, V37, P423, DOI 10.1188/10.ONF.423-432; Miaskowski C, 2011, SLEEP, V34, P171, DOI 10.1093/sleep/34.2.171; Morze CJ, 2013, J ARTHROPLASTY, V28, P1565, DOI 10.1016/j.arth.2013.02.029; Mosleh SM, 2014, EUR J CARDIOVASC NUR, V13, P201, DOI 10.1177/1474515113491348; Murphy L, 2012, AM J NURS, V112, pS13, DOI 10.1097/01.NAJ.0000412646.80054.21; Murphy SL, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3449; Mykletun A, 2001, BRIT J PSYCHIAT, V179, P540, DOI 10.1192/bjp.179.6.540; OWENS WD, 1978, ANESTHESIOLOGY, V49, P239, DOI 10.1097/00000542-197810000-00003; Petrie KJ, 2002, PSYCHOSOM MED, V64, P580, DOI 10.1097/00006842-200207000-00007; Pinto PR, 2013, J PAIN, V14, P502, DOI 10.1016/j.jpain.2012.12.020; Puolakka PAE, 2010, EUR J ANAESTH, V27, P455, DOI 10.1097/EJA.0b013e328335b31c; Rakel BA, 2012, PAIN, V153, P2192, DOI 10.1016/j.pain.2012.06.021; Raudenbush B, 2002, HIERARCHICAL LINEAR; Roth ML, 2007, PAIN RES MANAG, V12, P185, DOI 10.1155/2007/394960; Turk DC, 2006, PAIN, V125, P208, DOI 10.1016/j.pain.2006.09.028; Van Onselen C, 2013, J PAIN SYMPTOM MANAG, V45, P244, DOI 10.1016/j.jpainsymman.2012.02.020; Weinstein AM, 2013, J BONE JOINT SURG AM, V95A, P385, DOI 10.2106/JBJS.L.00206; Wylde V, 2011, ORTHOP TRAUMATOL-SUR, V97, P139, DOI 10.1016/j.otsr.2010.12.003; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	58	28	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161681	10.1371/journal.pone.0161681	http://dx.doi.org/10.1371/journal.pone.0161681			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583551	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600049
J	Chapman, PA; Traub, RJ; Kyaw-Tanner, MT; Owen, H; Flint, M; Cribb, TH; Mills, PC				Chapman, Phoebe A.; Traub, Rebecca J.; Kyaw-Tanner, Myat T.; Owen, Helen; Flint, Mark; Cribb, Thomas H.; Mills, Paul C.			Terminal Restriction Fragment Length Polymorphism for the Identification of Spirorchiid Ova in Tissues from the Green Sea Turtle, Chelonia mydas	PLOS ONE			English	Article							CARETTA-CARETTA; DIGENEA; PATHOLOGY; INFECTIONS; AUSTRALIA; GENUS	Blood flukes are among the most common disease causing pathogens infecting vertebrates, including humans and some of the world's most globally endangered fauna. Spirorchiid blood flukes are parasites of marine turtles, and are associated with pathology, strandings and mortalities worldwide. Their ova embolize in tissues and incite significant inflammatory responses, however attempts to draw correlations between species and lesions are frustrated by difficulties in identifying ova beyond the genus level. In this study, a newly developed terminal restriction fragment length polymorphism(T-RFLP) method was validated as a tool for differentiating between mixed spirorchiid ova in turtle tissue. Initially, a multiplex PCR was used to differentiate between the five genera of spirorchiid flukes. Following this, PCR was performed using genus/genera-specific fluorescently tagged primer pairs and PCR products digested analysis using restriction endonucleases. Using capillary electrophoresis, this T-RFLP method could differentiate between twelve species and genotypes of spirorchiid flukes in turtles. It was applied to 151 tissue samples and successfully identified the spirorchiid species present. It was found to be more sensitive than visual diagnosis, detecting infections in 28 of 32 tissues that were negative on histology. Spirorchiids were present in 96.7% of tissues tested, with Neospirorchis genotype 2 being the most prevalent, present in 93% of samples. Mixed infections were common, being present in 60.7% of samples tested. The method described here is, to our knowledge, the first use of the T-RFLP technique on host tissues or in an animal ecology context, and describes a significant advancement in the clinical capacity to diagnose a common cause of illness in our environment. It is proven as a sensitive, specific and cost-efficient means of identifying spirorchiid flukes and ova in turtles, with the potential to contribute valuable information to epidemiological and pathological studies as well as future diagnostics for this poorly understood disease.	[Chapman, Phoebe A.; Kyaw-Tanner, Myat T.; Owen, Helen; Flint, Mark; Mills, Paul C.] Univ Queensland, Vet Marine Anim Res Teaching & Investigat, Sch Vet Sci, Gatton, Qld, Australia; [Traub, Rebecca J.] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic, Australia; [Flint, Mark] Univ Florida, Sch Forest Resources & Conservat, Florida Aquariums Ctr Conservat, Apollo Beach, FL USA; [Cribb, Thomas H.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia	University of Queensland; University of Melbourne; State University System of Florida; University of Florida; University of Queensland	Chapman, PA (corresponding author), Univ Queensland, Vet Marine Anim Res Teaching & Investigat, Sch Vet Sci, Gatton, Qld, Australia.	p.chapman3@uq.edu.au	Traub, Rebecca/A-4273-2013; Cribb, Thomas/C-4449-2008; Chapman, Phoebe/E-5044-2016	Traub, Rebecca/0000-0002-7484-7592; Cribb, Thomas/0000-0003-1092-9705; Chapman, Phoebe/0000-0002-3303-9134	Australian Research Council Linkage Project [LP110100569]	Australian Research Council Linkage Project(Australian Research Council)	This project was funded by Australian Research Council Linkage Project Grant LP110100569 (URL http://www.arc.gov.au/default.htm) awarded to PCM as first investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AA, 1998, J WILDLIFE DIS, V34, P91, DOI 10.7589/0090-3558-34.1.91; Asher AJ, 2012, PARASITOLOGY, V139, P1005, DOI 10.1017/S0031182012000388; Chapman PA, 2015, SYST PARASITOL, V90, P67, DOI 10.1007/s11230-014-9535-y; Chen HC, 2012, J PARASITOL, V98, P437, DOI 10.1645/GE-2875.1; Fajardo V, 2008, MEAT SCI, V79, P289, DOI 10.1016/j.meatsci.2007.09.013; Flint M, 2010, ECOHEALTH, V7, P135, DOI 10.1007/s10393-010-0300-7; GLAZEBROOK JS, 1981, J COMP PATHOL, V91, P361, DOI 10.1016/0021-9975(81)90006-2; GLAZEBROOK JS, 1989, J COMP PATHOL, V101, P231, DOI 10.1016/0021-9975(89)90033-9; GLAZEBROOK JS, 1990, DIS AQUAT ORGAN, V9, P97, DOI 10.3354/dao009097; Glazebrook JS, 1982, P 4 INT C WILDL DIS, P159; Gordon AN, 1998, VET PATHOL, V35, P21, DOI 10.1177/030098589803500102; Greiner EC, 2013, CRC MAR BIOL SER, P427; Jacobson ER, 2006, DIS AQUAT ORGAN, V70, P139, DOI 10.3354/dao070139; Marsh TL, 1999, CURR OPIN MICROBIOL, V2, P323, DOI 10.1016/S1369-5274(99)80056-3; Platt TR, 1998, J PARASITOL, V84, P594, DOI 10.2307/3284729; Santoro M, 2007, VET REC, V161, P482, DOI 10.1136/vr.161.14.482; Smith A, 2003, CURR PROTOC NUCLEIC; Smith J. W., 1997, Helminthological Abstracts, V66, P329; Smith J. W., 1997, Helminthological Abstracts, V66, P255; Stacy BA, 2010, DIS AQUAT ORGAN, V89, P237, DOI 10.3354/dao02195; Waldron LS, 2009, APPL ENVIRON MICROB, V75, P108, DOI 10.1128/AEM.01341-08; WOLKE RE, 1982, J WILDLIFE DIS, V18, P175, DOI 10.7589/0090-3558-18.2.175; Work TM, 2005, J PARASITOL, V91, P871, DOI 10.1645/GE-454R.1	23	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0162114	10.1371/journal.pone.0162114	http://dx.doi.org/10.1371/journal.pone.0162114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579605	Green Published, gold			2022-12-26	WOS:000382877400059
J	Maaroufi, NI; Nordin, A; Palmqvist, K; Gundale, MJ				Maaroufi, Nadia I.; Nordin, Annika; Palmqvist, Kristin; Gundale, Michael J.			Chronic Nitrogen Deposition Has a Minor Effect on the Quantity and Quality of Aboveground Litter in a Boreal Forest	PLOS ONE			English	Article							SOIL ORGANIC-MATTER; LONG-TERM; HYLOCOMIUM-SPLENDENS; CARBON SEQUESTRATION; TERRESTRIAL ECOSYSTEMS; PHOSPHORUS LIMITATION; POLYTRICHUM-COMMUNE; PLANT LITTER; N ADDITIONS; DECOMPOSITION	There is evidence that anthropogenic nitrogen (N) deposition enhances carbon (C) sequestration in boreal soils. However, key underlying mechanisms explaining this increase have not been resolved. Two potentially important mechanisms are that aboveground litter production increases, or that litter quality changes in response to N enrichment. As such, our aim was to quantify whether simulated chronic N deposition caused changes in aboveground litter production or quality in a boreal forest. We conducted a long-term (17 years) stand-scale (0.1 ha) forest experiment, consisting of three N addition levels (0, 12.5, and 50 kg N ha(-1) yr(-1)) in northern Sweden, where background N deposition rates are very low. We measured the annual quantity of litter produced for 8 different litter categories, as well as their concentrations of C, N, phosphorus (P), lignin, cellulose and hemi-cellulose. Our results indicate that mosses were the only major litter component showing significant quantitative and qualitative alterations in response to the N additions, indicative of their ability to intercept a substantial portion of the N added. These effects were, however, offset by the other litter fractions where we found no changes in the total litter fluxes, or individual chemical constituents when all litter categories were summed. This study indicates that the current annual litter fluxes cannot explain the increase in soil C that has occurred in our study system in response to simulated chronic N application. These results suggest that other mechanisms are likely to explain the increased soil C accumulation rate we have observed, such as changes in soil microbial activity, or potentially transient changes in aboveground litter inputs that were no longer present at the time of our study.	[Maaroufi, Nadia I.; Gundale, Michael J.] Swedish Univ Agr Sci SLU, Dept Forest Ecol & Management, Umea, Sweden; [Nordin, Annika] Swedish Univ Agr Sci, UPSC, Dept Forest Genet & Plant Physiol, Umea, Sweden; [Palmqvist, Kristin] Umea Univ, Dept Ecol & Environm Sci EMG, Umea, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Umea University	Maaroufi, NI (corresponding author), Swedish Univ Agr Sci SLU, Dept Forest Ecol & Management, Umea, Sweden.	Nadia.Maaroufi@slu.se	Gundale, Michael J/O-1265-2013; Maaroufi, Nadia/AAL-3857-2021; Palmqvist, Kristin/D-5589-2016	Gundale, Michael J/0000-0003-2447-609X; Maaroufi, Nadia/0000-0002-8028-1409; Palmqvist, Kristin/0000-0002-3923-1338	Center for Environmental Research in Umea [CMF1122373]; Swedish Research Council for the project Sustainable Management of Carbon and Nitrogen in Future Forests (NiCaf) [2010-67230]; Royal Swedish Academy of Agriculture and Forestry KSLA [H14-0018-GBN]	Center for Environmental Research in Umea; Swedish Research Council for the project Sustainable Management of Carbon and Nitrogen in Future Forests (NiCaf); Royal Swedish Academy of Agriculture and Forestry KSLA	The authors received funding from the Center for Environmental Research in Umea (grant number: CMF1122373; http://www8.umu.se/cmf/index_eng.htm), the Swedish Research Council for the project Sustainable Management of Carbon and Nitrogen in Future Forests (NiCaf) (grant number: 2010-67230; http://www.formas.se/en/) and the Royal Swedish Academy of Agriculture and Forestry KSLA (grant number: H14-0018-GBN; http://www.ksla.se/en/).	Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Ahti T, 1968, FINNISH ZOOL BOT PUB, V5, P169; BassiriRad H, 2015, OECOLOGIA, V177, P53, DOI 10.1007/s00442-014-3119-z; Bauer GA, 2004, FOREST ECOL MANAG, V196, P173, DOI 10.1016/j.foreco.2004.03.032; Berg B., 2008, PLANT LITTER DECOMPO, DOI [DOI 10.1007/978-3-662-05349-2, 10.1007/978-3-662-05349-2]; Berg Bjorn, 1997, Environmental Reviews, V5, P1, DOI 10.1139/er-5-1-1; Bowden RD, 2004, FOREST ECOL MANAG, V196, P43, DOI 10.1016/j.foreco.2004.03.011; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; CALLAGHAN TV, 1978, OIKOS, V31, P73, DOI 10.2307/3543386; CHAPIN FS, 1987, OECOLOGIA, V74, P310, DOI 10.1007/BF00379375; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Cotrufo MF, 2015, NAT GEOSCI, V8, P776, DOI [10.1038/ngeo2520, 10.1038/NGEO2520]; Cotrufo MF, 2013, GLOBAL CHANGE BIOL, V19, P988, DOI 10.1111/gcb.12113; de Vries W, 2014, CURR OPIN ENV SUST, V9-10, P90, DOI 10.1016/j.cosust.2014.09.001; de Vries W, 2014, NAT CLIM CHANGE, V4, P425, DOI 10.1038/nclimate2255; Demoling F, 2008, SOIL BIOL BIOCHEM, V40, P370, DOI 10.1016/j.soilbio.2007.08.019; Dentener F, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002672; Du EZ, 2014, ENVIRON POLLUT, V188, P166, DOI 10.1016/j.envpol.2014.02.011; Eckstein RL, 1999, OIKOS, V86, P87, DOI 10.2307/3546572; Eckstein RL, 2000, J ECOL, V88, P506, DOI 10.1046/j.1365-2745.2000.00480.x; ENTRY JA, 1995, CAN J FOREST RES, V25, P1231, DOI 10.1139/x95-135; FLANAGAN PW, 1983, CAN J FOREST RES, V13, P795, DOI 10.1139/x83-110; Franklin O, 2003, ECOSYSTEMS, V6, P644, DOI 10.1007/s10021-002-0149-x; Frey SD, 2014, BIOGEOCHEMISTRY, V121, P305, DOI 10.1007/s10533-014-0004-0; From F., 2014, LONG TERM EFFECTS NI; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Gundale MJ, 2014, GLOBAL CHANGE BIOL, V20, P276, DOI 10.1111/gcb.12422; Gundale MJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0797; Gundale MJ, 2011, GLOBAL CHANGE BIOL, V17, P2743, DOI 10.1111/j.1365-2486.2011.02407.x; Haukioja E, 1998, CHEMOECOLOGY, V8, P133, DOI 10.1007/s000490050018; Hogberg P, 2006, GLOBAL CHANGE BIOL, V12, P489, DOI 10.1111/j.1365-2486.2006.01102.x; Hyvonen R, 2008, BIOGEOCHEMISTRY, V89, P121, DOI 10.1007/s10533-007-9121-3; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Ishida TA, 2010, SOIL BIOL BIOCHEM, V42, P234, DOI 10.1016/j.soilbio.2009.10.021; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/ngeo844, 10.1038/NGEO844]; Johnson DW, 2000, SOIL SCI SOC AM J, V64, P1503, DOI 10.2136/sssaj2000.6441503x; Kaiser K, 2012, SOIL BIOL BIOCHEM, V52, P29, DOI 10.1016/j.soilbio.2012.04.002; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; Krause K, 2012, TREE PHYSIOL, V32, P1471, DOI 10.1093/treephys/tps109; Kumordzi BB, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00339.1; Lal R, 2005, FOREST ECOL MANAG, V220, P242, DOI 10.1016/j.foreco.2005.08.015; Lindo Z, 2013, GLOBAL CHANGE BIOL, V19, P2022, DOI 10.1111/gcb.12175; Lindo Z, 2010, ECOSYSTEMS, V13, P612, DOI 10.1007/s10021-010-9336-3; Lu M, 2011, AGR ECOSYST ENVIRON, V140, P234, DOI 10.1016/j.agee.2010.12.010; Maaroufi NI, 2015, GLOBAL CHANGE BIOL, V21, P3169, DOI 10.1111/gcb.12904; Malhi Y, 1999, PLANT CELL ENVIRON, V22, P715, DOI 10.1046/j.1365-3040.1999.00453.x; Marklein AR, 2012, NEW PHYTOL, V193, P696, DOI 10.1111/j.1469-8137.2011.03967.x; Meunier CL, 2016, GLOBAL CHANGE BIOL, V22, P164, DOI 10.1111/gcb.12967; Misson L, 2007, AGR FOREST METEOROL, V144, P14, DOI 10.1016/j.agrformet.2007.01.006; Nakatsubo T, 1997, ECOL RES, V12, P47, DOI 10.1007/BF02523609; Nohrstedt HO, 2001, SCAND J FOREST RES, V16, P555, DOI 10.1080/02827580152699385; Nordin A, 2006, ENVIRON POLLUT, V141, P167, DOI 10.1016/j.envpol.2005.08.017; Nordin A, 2005, AMBIO, V34, P20, DOI 10.1639/0044-7447(2005)034[0020:NDATBO]2.0.CO;2; Nordin A, 2009, ECOSYSTEMS, V12, P1204, DOI 10.1007/s10021-009-9287-8; Olsson P, 2005, GLOBAL CHANGE BIOL, V11, P1745, DOI 10.1111/j.1365-2486.2005.001033.x; Osborne J.W., 2010, PRACTICAL ASSESS RES, V15, P1, DOI [10.7275/qbpc-gk17, DOI 10.7275/QBPC-GK17]; Palmroth S, 2014, OECOLOGIA, V175, P457, DOI 10.1007/s00442-014-2923-9; Penuelas J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3934; Phuyal M, 2008, PLANT ECOL, V196, P111, DOI 10.1007/s11258-007-9338-1; Pihl-Karlsson G, 2009, OVERVAKNING LUFTFORO; Pregitzer KS, 2008, GLOBAL CHANGE BIOL, V14, P142, DOI 10.1111/j.1365-2486.2007.01465.x; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Schaberg PG, 1997, CAN J FOREST RES, V27, P1622, DOI 10.1139/cjfr-27-10-1622; Schlesinger WH, 2009, P NATL ACAD SCI USA, V106, P203, DOI 10.1073/pnas.0810193105; Scott NA, 1997, OECOLOGIA, V111, P151, DOI 10.1007/s004420050219; Skre O., 1979, ECOGRAPHY, V2, P249; Strengbom J, 2002, J ECOL, V90, P61, DOI 10.1046/j.0022-0477.2001.00629.x; Sundqvist MK, 2012, FUNCT ECOL, V26, P1090, DOI 10.1111/j.1365-2435.2012.02034.x; Tamm C., 1991, NITROGEN TERRESTRIAL, DOI DOI 10.2307/2260680; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; Treseder KK, 2001, ECOLOGY, V82, P946, DOI 10.1890/0012-9658(2001)082[0946:EOSNAO]2.0.CO;2; Turetsky MR, 2012, NEW PHYTOL, V196, P49, DOI 10.1111/j.1469-8137.2012.04254.x; Van Der Heijden E, 2000, GLOBAL CHANGE BIOL, V6, P201, DOI 10.1046/j.1365-2486.2000.00303.x; van der Wal R, 2005, OECOLOGIA, V142, P159, DOI 10.1007/s00442-004-1706-0; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Vries W. de, 2009, Forest Ecology and Management, V258, P1814, DOI 10.1016/j.foreco.2009.02.034; WARING RH, 1985, OECOLOGIA, V66, P157, DOI 10.1007/BF00379849; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zhang DQ, 2008, J PLANT ECOL, V1, P85, DOI 10.1093/jpe/rtn002	81	11	13	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0162086	10.1371/journal.pone.0162086	http://dx.doi.org/10.1371/journal.pone.0162086			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580120	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877400057
J	Subramanian, P; Kim, K; Krishnamoorthy, R; Mageswari, A; Selvakumar, G; Sa, T				Subramanian, Parthiban; Kim, Kiyoon; Krishnamoorthy, Ramasamy; Mageswari, Anbazhagan; Selvakumar, Gopal; Sa, Tongmin			Cold Stress Tolerance in Psychrotolerant Soil Bacteria and Their Conferred Chilling Resistance in Tomato (Solanum lycopersicum Mill.) under Low Temperatures	PLOS ONE			English	Article							SP-NOV.; GROWTH; GENE; L.; GRAPEVINE; STRAINS; ACID	The present work aimed to study the culturable diversity of psychrotolerant bacteria persistent in soil under overwintering conditions, evaluate their ability to sustain plant growth and alleviate chilling stress in tomato. Psychrotolerant bacteria were isolated from agricultural field soil samples colleced during winter and then used to study chilling stress alleviation in tomato plants (Solanum lycopersicum cv Mill). Selective isolation after enrichment at 5 degrees C yielded 40 bacterial isolates. Phylogenetic studies indicated their distribution in genera Arthrobacter, Flavimonas, Flavobacterium, Massilia, Pedobacter and Pseudomonas. Strains OS211, OB146, OB155 and OS261 consistently improved germination and plant growth when a chilling stress of 15 degrees C was imposed and therefore were selected for pot experiments. Tomato plants treated with the selected four isolates exhibited significant tolerance to chilling as observed through reduction in membrane damage and activation of antioxidant enzymes along with proline synthesis in the leaves when exposed to chilling temperature conditions (15 degrees C). Psychrotolerant physiology of the isolated bacteria combined with their ability to improve germination, plant growth and induce antioxidant capacity in tomato plants can be employed to protect plants against chilling stress.	[Subramanian, Parthiban; Kim, Kiyoon; Krishnamoorthy, Ramasamy; Selvakumar, Gopal; Sa, Tongmin] Chungbuk Natl Univ, Dept Environm & Biol Chem, Cheongju 361763, Chungbuk, South Korea; [Mageswari, Anbazhagan] VIT Univ, Sch Biosci & Technol, Vellore 632014, Tamil Nadu, India; [Subramanian, Parthiban] Rural Dev Adm, Natl Inst Agr Sci, Dept Agr Biotechnol, Metab Engn Div, Jeonju, South Korea; [Krishnamoorthy, Ramasamy] Tamil Nadu Agr Univ, Agr Coll & Res Inst, Dept Agr Microbiol, Madurai, Tamil Nadu, India; [Mageswari, Anbazhagan] Rural Dev Adm, Natl Inst Agr Sci, Dept Agr Biol, Jeonju, South Korea; [Selvakumar, Gopal] Rural Dev Adm, Natl Inst Hort & Herbal Sci, Hort & Herbal Crop Environm Div, Wonju, South Korea	Chungbuk National University; Vellore Institute of Technology; National Institute of Agricultural Sciences; Rural Development Administration (RDA), Republic of Korea; Tamil Nadu Agricultural University; National Institute of Agricultural Sciences; Rural Development Administration (RDA), Republic of Korea; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Sa, T (corresponding author), Chungbuk Natl Univ, Dept Environm & Biol Chem, Cheongju 361763, Chungbuk, South Korea.	tomsa@chungbuk.ac.kr	Anbazhagan, Mageswari/ADJ-3389-2022; Subramanian, Parthiban/CAJ-0756-2022	Anbazhagan, Mageswari/0000-0002-9278-2614; Subramanian, Parthiban/0000-0002-4797-5791; Gopal, Selvakumar/0000-0001-7575-7022	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2015R1A2A1A05001885]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2015R1A2A1A05001885).	ALEXANDER DB, 1991, BIOL FERT SOILS, V12, P39, DOI 10.1007/BF00369386; Antony R, 2012, MICROBIOL RES, V167, P372, DOI 10.1016/j.micres.2012.03.003; Bajerski F, 2011, INT J SYST EVOL MICR, V61, P1849, DOI 10.1099/ijs.0.027128-0; Bano N, 2003, CURR MICROBIOL, V46, P324, DOI 10.1007/s00284-002-3857-8; Barka EA, 2006, APPL ENVIRON MICROB, V72, P7246, DOI 10.1128/AEM.01047-06; Bowman JP, 2001, METHOD MICROBIOL, V30, P591, DOI 10.1016/S0580-9517(01)30064-8; Cai GH, 2014, PLANT SCI, V214, P57, DOI 10.1016/j.plantsci.2013.09.014; Chattopadhyay MK, 2006, J BIOSCIENCES, V31, P157, DOI 10.1007/BF02705244; Christner BC, 2000, ICARUS, V144, P479, DOI 10.1006/icar.1999.6288; D'Amico S, 2006, EMBO REP, V7, P385, DOI 10.1038/sj.embor.7400662; De Maayer P, 2014, EMBO REP, V15, P508, DOI 10.1002/embr.201338170; Ding S, 2011, PHYSIOL PLANTARUM, V141, P141, DOI 10.1111/j.1399-3054.2010.01428.x; ElSayed AI, 2014, PLANT BIOLOGY, V16, P1, DOI 10.1111/plb.12053; Emborg J, 2006, INT J SYST EVOL MICR, V56, P2473, DOI 10.1099/ijs.0.64357-0; Fernandez O, 2012, MOL PLANT MICROBE IN, V25, P496, DOI 10.1094/MPMI-09-11-0245; Foolad MR, 2000, J AM SOC HORTIC SCI, V125, P679, DOI 10.21273/JASHS.125.6.679; Francis KP, 1998, APPL ENVIRON MICROB, V64, P3525; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gulati A, 2009, CURR MICROBIOL, V58, P371, DOI 10.1007/s00284-008-9339-x; Hantsis-Zacharov E, 2008, INT J SYST EVOL MICR, V58, P2635, DOI 10.1099/ijs.0.65819-0; Hantsis-Zacharov E, 2007, INT J SYST EVOL MICR, V57, P2344, DOI 10.1099/ijs.0.65115-0; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kost T, 2014, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00421; Lee JW, 2012, KMAS BRIEFING CLIMAT; Margesin R, 2009, EXTREMOPHILES, V13, P257, DOI 10.1007/s00792-008-0213-3; Mehta S, 2001, CURR MICROBIOL, V43, P51, DOI 10.1007/s002840010259; Mercado-Blanco J, 2001, J BACTERIOL, V183, P1909, DOI 10.1128/JB.183.6.1909-1920.2001; Mishra PK, 2011, ARCH MICROBIOL, V193, P497, DOI 10.1007/s00203-011-0693-x; Mishra PK, 2010, MICROBIOL MONOGR, V18, P273, DOI 10.1007/978-3-642-13612-2_12; Miura K, 2013, INT J MOL SCI, V14, P5312, DOI 10.3390/ijms14035312; Moyer CL., 2007, ENCY LIFE SCI, P1, DOI [10.1002/9780470015902.a0000402.pub2, DOI 10.1002/9780470015902.A0000402.PUB2]; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Penrose DM, 2003, PHYSIOL PLANTARUM, V118, P10, DOI 10.1034/j.1399-3054.2003.00086.x; Ray MK, 2006, STRESS RESPONSE MOL, P1; ROBERTSON GP, 2006, BIOL APPROACHES SUST, P27; Rodrigues DF, 2008, APPL ENVIRON MICROB, V74, P1677, DOI 10.1128/AEM.02000-07; Ruelland E, 2009, ADV BOT RES, V49, P35, DOI 10.1016/S0065-2296(08)00602-2; Sahu B, 2008, J BASIC MICROB, V48, P38, DOI 10.1002/jobm.200700185; Saltveit ME, 1990, CHILLING INJURY HORT, P4; Selbmann L, 2010, POLAR BIOL, V33, P71, DOI 10.1007/s00300-009-0686-2; Selvakumar G, 2008, WORLD J MICROB BIOT, V24, P955, DOI 10.1007/s11274-007-9558-5; Shivaji S, 2005, INT J SYST EVOL MICR, V55, P1453, DOI 10.1099/ijs.0.63478-0; Shivaji S, 2011, EXTREMOPHILES, V15, P1, DOI 10.1007/s00792-010-0333-4; Siddiqui KS, 2013, ANNU REV EARTH PL SC, V41, P87, DOI 10.1146/annurev-earth-040610-133514; Solanke Amolkumar U., 2008, Physiology and Molecular Biology of Plants, V14, P69, DOI 10.1007/s12298-008-0006-2; Subramanian P, 2015, MOL PLANT MICROBE IN, V28, P1073, DOI 10.1094/MPMI-01-15-0021-R; Suzuki N, 2006, PHYSIOL PLANTARUM, V126, P45, DOI 10.1111/j.0031-9317.2005.00582.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taulavuori E, 2001, J EXP BOT, V52, P2375, DOI 10.1093/jexbot/52.365.2375; Templer PH, 2012, PLANT SOIL, V353, P15, DOI 10.1007/s11104-011-1064-8; Theocharis A, 2012, MOL PLANT MICROBE IN, V25, P241, DOI 10.1094/MPMI-05-11-0124; Van Der Ploeg A, 2005, J HORTIC SCI BIOTECH, V80, P652; von Stetten F, 1998, J MICROBIOL METH, V34, P99, DOI 10.1016/S0167-7012(98)00077-3; Yumoto I, 2004, ARCH MICROBIOL, V181, P345, DOI 10.1007/s00203-004-0662-8; Zhang N, 2015, J EXP BOT, V66, P647, DOI 10.1093/jxb/eru336	55	57	58	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161592	10.1371/journal.pone.0161592	http://dx.doi.org/10.1371/journal.pone.0161592			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580055	Green Submitted, Green Published, gold			2022-12-26	WOS:000382877400030
J	Doolette, CL; Gupta, VVSR; Lu, Y; Payne, JL; Batstone, DJ; Kirby, JK; Navarro, DA; McLaughlin, MJ				Doolette, Casey L.; Gupta, Vadakattu V. S. R.; Lu, Yang; Payne, Justin L.; Batstone, Damien J.; Kirby, Jason K.; Navarro, Divina A.; McLaughlin, Mike J.			Quantifying the Sensitivity of Soil Microbial Communities to Silver Sulfide Nanoparticles Using Metagenome Sequencing	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; DOSE-RESPONSE; TOXICITY; METAL; IMPACT; BIOAVAILABILITY; TRANSFORMATION; NANOMATERIALS; INVERTEBRATES; DISTRIBUTIONS	Soils are a sink for sulfidised-silver nanoparticles (Ag2S-NPs), yet there are limited ecotoxicity data for their effects on microbial communities. Conventional toxicity tests typically target a single test species or function, which does not reflect the broader community response. Using a combination of quantitative PCR, 16S rRNA amplicon sequencing and species sensitivity distribution (SSD) methods, we have developed a new approach to calculate silver-based NP toxicity thresholds (HCx, hazardous concentrations) that are protective of specific members (operational taxonomic units, OTUs) of the soil microbial community. At the HC20 (80% of species protected), soil OTUs were significantly less sensitive to Ag2S-NPs compared to AgNPs and Ag+ (5.9, 1.4 and 1.4 mg Ag kg(-1), respectively). However at more conservative HC values, there were no significant differences. These trends in OTU responses matched with those seen in a specific microbial function (rate of nitrification) and amoA-bacteria gene abundance. This study provides a novel molecular-based framework for quantifying the effect of a toxicant on whole soil microbial communities while still determining sensitive genera/species. Methods and results described here provide a benchmark for microbial community ecotoxicological studies and we recommend that future revisions of Soil Quality Guidelines for AgNPs and other such toxicants consider this approach.	[Doolette, Casey L.; Navarro, Divina A.; McLaughlin, Mike J.] Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia; [Gupta, Vadakattu V. S. R.] CSIRO Agr, Funct Microbial Ecol, Adelaide, SA, Australia; [Lu, Yang; Batstone, Damien J.] Univ Queensland, Adv Water Management Ctr AWMC, St Lucia, Qld, Australia; [Payne, Justin L.] Univ South Australia, Sch Nat & Built Environm, Adelaide, SA, Australia; [Kirby, Jason K.; Navarro, Divina A.; McLaughlin, Mike J.] CSIRO Land & Water, Environm Contaminant Mitigat & Technol Res Progra, Adelaide, SA, Australia	University of Adelaide; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; University of South Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Doolette, CL (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia.	casey.doolette@adelaide.edu.au	Doolette, Casey/D-3632-2017; vvsr, Gupta/C-1722-2009; Lu, Yang/GSD-1477-2022; McLaughlin, Mike J/F-2931-2010; Kirby, Jason K/F-5942-2013; McLaughlin, Michael J/N-5888-2017; Navarro, Divina/F-5733-2013; Doolette, Casey/P-1236-2019; Payne, Justin L/B-8260-2013; Batstone, Damien/N-1896-2014	Doolette, Casey/0000-0002-8092-3520; vvsr, Gupta/0000-0001-9774-6471; Lu, Yang/0000-0003-1976-8872; McLaughlin, Mike J/0000-0001-6796-4144; McLaughlin, Michael J/0000-0001-6796-4144; Navarro, Divina/0000-0002-8271-3578; Doolette, Casey/0000-0002-8092-3520; Payne, Justin L/0000-0002-3953-7783; Kirby, Jason/0000-0001-6867-0332; Batstone, Damien/0000-0002-4294-3942	Australian Research Council [DP0879165]	Australian Research Council(Australian Research Council)	This study was supported by Australian Research Council Discovery Grant DP0879165. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angly FE, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-11; Arnaout CL, 2012, ENVIRON SCI TECHNOL, V46, P5387, DOI 10.1021/es204540z; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolz R. E., 1973, CRC HDB TABLES APPL; BRAIN P, 1989, WEED RES, V29, P93, DOI 10.1111/j.1365-3180.1989.tb00845.x; Calder AJ, 2012, SCI TOTAL ENVIRON, V429, P215, DOI 10.1016/j.scitotenv.2012.04.049; Campbell E, 2000, COMPUTER PROGRAM CAL, DOI [10.1021/es203732x, DOI 10.1021/ES203732X]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Checkai R, 2014, INTEGR ENVIRON ASSES, V10, P346, DOI 10.1002/ieam.1528; Colman BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057189; Cornelis G, 2013, SCI TOTAL ENVIRON, V463, P120, DOI 10.1016/j.scitotenv.2013.05.089; Cornelis G, 2012, SOIL SCI SOC AM J, V76, P891, DOI 10.2136/sssaj2011.0360; Doolette CL, 2015, J HAZARD MATER, V300, P788, DOI 10.1016/j.jhazmat.2015.08.012; Doolette CL, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-46; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Fajardo C, 2014, SCI TOTAL ENVIRON, V473, P254, DOI 10.1016/j.scitotenv.2013.12.043; Farkas J, 2011, ENVIRON INT, V37, P1057, DOI 10.1016/j.envint.2011.03.006; Frampton GK, 2006, ENVIRON TOXICOL CHEM, V25, P2480, DOI 10.1897/05-438R.1; Garner KL, 2015, ENVIRON SCI TECHNOL, V49, P5753, DOI 10.1021/acs.est.5b00081; Geranio L, 2009, ENVIRON SCI TECHNOL, V43, P8113, DOI 10.1021/es9018332; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gremion F, 2004, FEMS MICROBIOL ECOL, V48, P273, DOI 10.1016/j.femsec.2004.02.004; Gupta VVSR, 2010, 19 WORLD C SOIL SCI, P1; Hansch M, 2010, J PLANT NUTR SOIL SC, V173, P554, DOI 10.1002/jpln.200900358; Holden PA, 2014, CURR OPIN BIOTECH, V27, P73, DOI 10.1016/j.copbio.2013.11.008; HSUEH YH, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0144306; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Judy JD, 2014, ADV AGRON, V123, P1, DOI 10.1016/B978-0-12-420225-2.00001-7; Kim B, 2010, ENVIRON SCI TECHNOL, V44, P7509, DOI 10.1021/es101565j; Knezevic SZ, 2007, WEED TECHNOL, V21, P840, DOI 10.1614/WT-06-161.1; Knox OGG, 2014, SOIL RES, V52, P203, DOI 10.1071/SR12361; KOBERL M, 2011, PLOS ONE, V6, DOI DOI 10.1371/J0URNAL.P0NE.0024452; Kumar N, 2014, PLOS ONE, DOI [10.1371/ journal. pone. 0099953, DOI 10.1371/J0URNAL.P0NE.0099953]; Kumari M, 2009, SCI TOTAL ENVIRON, V407, P5243, DOI 10.1016/j.scitotenv.2009.06.024; Langdon KA, 2014, ENVIRON TOXICOL CHEM, V33, P1170, DOI 10.1002/etc.2543; Levard C, 2013, ENVIRON SCI TECHNOL, V47, P13440, DOI 10.1021/es403527n; Li LXY, 2016, ENVIRON SCI TECHNOL, V50, P188, DOI 10.1021/acs.est.5b03982; Li RG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037127, 10.1371/journal.pone.0029392, 10.1371/journal.pone.0051897]; Lukacheva EG, 2013, BIOL BULL+, V40, P19, DOI 10.1134/S1062359012060076; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Masrahi A, 2014, ARCH ENVIRON CON TOX, V66, P504, DOI 10.1007/s00244-013-9994-1; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; R Core Team, 2021, R LANGUAGE ENV STAT; Reinsch BC, 2012, ENVIRON SCI TECHNOL, V46, P6992, DOI 10.1021/es203732x; Ritz C, 2014, ANAL DOSE RESPONSE C; Roh JY, 2009, ENVIRON SCI TECHNOL, V43, P3933, DOI 10.1021/es803477u; Salminen R., 2005, GEOCHEMICAL ATLAS EU; Schabenberger O, 1999, AGRON J, V91, P713, DOI 10.2134/agronj1999.914713x; Schlich K, 2015, ENVIRON POLLUT, V196, P321, DOI 10.1016/j.envpol.2014.10.021; Settimio L, 2014, ENVIRON POLLUT, V191, P151, DOI 10.1016/j.envpol.2014.04.030; Settimio L, 2014, ENVIRON CHEM, V11, P63, DOI 10.1071/EN13163; Shah V, 2014, J HAZARD MATER, V274, P399, DOI 10.1016/j.jhazmat.2014.04.003; Shao QX, 2000, ENVIRONMETRICS, V11, P583, DOI 10.1002/1099-095X(200009/10)11:5<583::AID-ENV456>3.0.CO;2-X; Simonin M, 2015, ENVIRON SCI POLLUT R, V22, P13710, DOI 10.1007/s11356-015-4171-x; Smolders E, 2001, ENVIRON TOXICOL CHEM, V20, P2469, DOI [10.1897/1551-5028(2001)020&lt;2469:PNRAAT&gt;2.0.CO;2, 10.1002/etc.5620201111]; Sorokin DY, 2012, ISME J, V6, P2245, DOI 10.1038/ismej.2012.70; Starnes DL, 2015, ENVIRON POLLUT, V196, P239, DOI 10.1016/j.envpol.2014.10.009; Stephen JR, 1999, APPL ENVIRON MICROB, V65, P95; STREIBIG JC, 1980, ACTA AGR SCAND, V30, P59, DOI 10.1080/00015128009435696; Sun TY, 2014, ENVIRON POLLUT, V185, P69, DOI 10.1016/j.envpol.2013.10.004; Vandevoort A., 2012, IND BIOTECHNOL, V8, P358, DOI [DOI 10.1089/IND.2012.0026, 10.1089/ind.2012.0026]; Vanwonterghem Inka, 2014, ISME J, V8, P2015, DOI 10.1038/ismej.2014.50; Wang P, 2015, NANOTOXICOLOGY, V9, P1041, DOI 10.3109/17435390.2014.999139; Wang XN, 2015, SCI TOTAL ENVIRON, V508, P122, DOI 10.1016/j.scitotenv.2014.11.079; Wang XN, 2014, ENVIRON SCI POLLUT R, V21, P168, DOI 10.1007/s11356-013-2110-2; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Xia WW, 2011, ISME J, V5, P1226, DOI 10.1038/ismej.2011.5; Yang Y, 2014, WATER RES, V48, P317, DOI 10.1016/j.watres.2013.09.046; Yang Y, 2013, ENVIRON TOXICOL CHEM, V32, P1488, DOI 10.1002/etc.2230; Yin LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047674	73	34	34	5	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161979	10.1371/journal.pone.0161979	http://dx.doi.org/10.1371/journal.pone.0161979			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575719	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000382877200050
J	Spieker, J; Ackermann, A; Salfelder, A; Vogel-Hopker, A; Layer, PG				Spieker, Janine; Ackermann, Anica; Salfelder, Anika; Vogel-Hoepker, Astrid; Layer, Paul G.			Acetylcholinesterase Regulates Skeletal In Ovo Development of Chicken Limbs by ACh-Dependent and -Independent Mechanisms	PLOS ONE			English	Article							ARYL ACYLAMIDASE ACTIVITY; CHOLINE-ACETYLTRANSFERASE; MONOCLONAL-ANTIBODY; CELL-PROLIFERATION; NEURITE GROWTH; CHOLINESTERASES; EXPRESSION; SYSTEM; APOPTOSIS; DIFFERENTIATION	Formation of the vertebrate limb presents an excellent model to analyze a non-neuronal cholinergic system (NNCS). Here, we first analyzed the expression of acetylcholinesterase (AChE) by IHC and of choline acetyltransferase (ChAT) by ISH in developing embryonic chicken limbs (stages HH17-37). AChE outlined formation of bones, being strongest at their distal tips, and later also marked areas of cell death. At onset, AChE and ChAT were elevated in two organizing centers of the limb anlage, the apical ectodermal ridge (AER) and zone of polarizing activity (ZPA), respectively. Thereby ChAT was expressed shortly after AChE, thus strongly supporting a leading role of AChE in limb formation. Then, we conducted loss-of-function studies via unilateral implantation of beads into chicken limb anlagen, which were soaked in cholinergic components. After varying periods, the formation of cartilage matrix and of mineralizing bones was followed by Alcian blue (AB) and Alizarin red (AR) stainings, respectively. Both acetylcholine (ACh)- and ChAT-soaked beads accelerated bone formation in ovo. Notably, inhibition of AChE by BW284c51, or by the monoclonal antibody MAB304 delayed cartilage formation. Since bead inhibition of BChE was mostly ineffective, an ACh-independent action during BW284c51 and MAB304 inhibition was indicated, which possibly could be due to an enzymatic side activity of AChE. In conclusion, skeletogenesis in chick is regulated by an ACh-dependent cholinergic system, but to some extent also by an ACh-independent aspect of the AChE protein.	[Spieker, Janine; Ackermann, Anica; Salfelder, Anika; Vogel-Hoepker, Astrid; Layer, Paul G.] Tech Univ Darmstadt, Dev Biol & Neurogenet, Schnittspahnstr 13, D-64287 Darmstadt, Germany	Technical University of Darmstadt	Layer, PG (corresponding author), Tech Univ Darmstadt, Dev Biol & Neurogenet, Schnittspahnstr 13, D-64287 Darmstadt, Germany.	layer@bio.tu-darmstadt.de			DFG [La379/20-4]	DFG(German Research Foundation (DFG))	This work was supported by DFG La379/20-4.	Abreu-Villaca Y, 2011, BEHAV BRAIN RES, V221, P367, DOI 10.1016/j.bbr.2009.12.049; ALBER R, 1994, ANAT EMBRYOL, V190, P429; Bellier JP, 2011, J CHEM NEUROANAT, V42, P225, DOI 10.1016/j.jchemneu.2011.02.005; Boopathy R, 2004, PROTEIN J, V23, P325, DOI 10.1023/B:JOPC.0000032652.99257.19; Chinnadurai RK, 2015, ARCH BIOCHEM BIOPHYS, V580, P1, DOI 10.1016/j.abb.2015.06.002; Drews U, 1975, Prog Histochem Cytochem, V7, P1; FAMBROUGH DM, 1982, P NATL ACAD SCI-BIOL, V79, P1078, DOI 10.1073/pnas.79.4.1078; Farchi N, 2007, NEURODEGENER DIS, V4, P171, DOI 10.1159/000101842; Garcia-Rates S, 2016, NEUROPHARMACOLOGY, V105, P487, DOI 10.1016/j.neuropharm.2016.02.006; Genever PG, 1999, BONE, V24, P297, DOI 10.1016/S8756-3282(98)00187-2; Grando SA, 2015, INT IMMUNOPHARMACOL, V29, P1, DOI 10.1016/j.intimp.2015.08.023; Grisaru D, 1999, MOL CELL BIOL, V19, P788; Grisaru D, 1999, EUR J BIOCHEM, V264, P672, DOI 10.1046/j.1432-1327.1999.00693.x; Guo J, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-72; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Johnson G, 2009, J MOL RECOGNIT, V22, P188, DOI 10.1002/jmr.931; Karczmar AG, 2010, CHEM-BIOL INTERACT, V187, P34, DOI 10.1016/j.cbi.2010.03.009; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; Kawakita A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003945; Layer PG, 2013, CHEM-BIOL INTERACT, V203, P269, DOI 10.1016/j.cbi.2012.09.014; LAYER PG, 1988, DEVELOPMENT, V102, P387; LAYER PG, 1993, CELL TISSUE RES, V273, P219, DOI 10.1007/BF00312823; LAYER PG, 1988, CELL TISSUE RES, V251, P587, DOI 10.1007/BF00214007; LAYER PG, 1995, PROG HISTOCHEM CYTOC, V29, P1; MADERDRUT JL, 1995, NEUROCHEM RES, V20, P69, DOI 10.1007/BF00995155; Masha'our RS, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00069; McAllen RM, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0597-2; Ofek K, 2013, CHEM-BIOL INTERACT, V203, P113, DOI 10.1016/j.cbi.2012.07.007; Oikawa S, 2015, INT IMMUNOPHARMACOL, V29, P31, DOI 10.1016/j.intimp.2015.04.057; OLSON CE, 1990, ARCH BIOCHEM BIOPHYS, V277, P361, DOI 10.1016/0003-9861(90)90591-L; Paraoanu LE, 2008, FEBS J, V275, P618, DOI 10.1111/j.1742-4658.2007.06237.x; Paraoanu LE, 2005, CHEM-BIOL INTERACT, V157, P411, DOI 10.1016/j.cbi.2005.10.081; Pegan K, 2010, CHEM-BIOL INTERACT, V187, P96, DOI 10.1016/j.cbi.2010.03.034; REICH A, 1983, HISTOCHEMISTRY, V78, P383, DOI 10.1007/BF00496624; Reissmann E, 1996, DEVELOPMENT, V122, P2079; Robitzki A, 1998, J NEUROCHEM, V71, P1413; Rotundo RL, 2003, J NEUROCYTOL, V32, P743, DOI 10.1023/B:NEUR.0000020621.58197.d4; Sato T, 2010, FEBS LETT, V584, P817, DOI 10.1016/j.febslet.2010.01.001; Scholl FG, 2003, TRENDS NEUROSCI, V26, P618, DOI 10.1016/j.tins.2003.09.004; Sharma KV, 1998, J NEUROSCI RES, V53, P454, DOI 10.1002/(SICI)1097-4547(19980815)53:4<454::AID-JNR7>3.3.CO;2-E; Silman I, 2005, CURR OPIN PHARMACOL, V5, P293, DOI 10.1016/j.coph.2005.01.014; SORENSEN K, 1987, BIOCHIM BIOPHYS ACTA, V912, P56, DOI 10.1016/0167-4838(87)90247-0; Thangaraj G, 2016, CHEM-BIOL INTERACT, V259, P313, DOI 10.1016/j.cbi.2016.03.027; Thangaraj G, 2012, J COMP NEUROL, V520, P3181, DOI 10.1002/cne.23083; Vogel-Hopker A, 2012, PROTEIN PEPTIDE LETT, V19, P155; Vogel-Hopker A, 2000, MECH DEVELOP, V94, P25, DOI 10.1016/S0925-4773(00)00320-8; WEIKERT T, 1990, J NEUROBIOL, V21, P482, DOI 10.1002/neu.480210309; Weiner L, 2009, BIOCHEMISTRY-US, V48, P563, DOI 10.1021/bi801196y; Wessler I, 1999, CLIN EXP PHARMACOL P, V26, P198, DOI 10.1046/j.1440-1681.1999.03016.x; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Wlodek ST, 1997, J AM CHEM SOC, V119, P9513, DOI 10.1021/ja971226d; WOLFE AD, 1993, MOL PHARMACOL, V44, P1152; Xie J, 2011, J MOL CELL BIOL, V3, P250, DOI 10.1093/jmcb/mjq047; Xu ML, 2016, CHEM-BIOL INTERACT, V259, P295, DOI 10.1016/j.cbi.2016.03.025; Zhang XJ, 2002, CELL DEATH DIFFER, V9, P790, DOI 10.1038/sj.cdd.4401034; Zhang XJ, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00040	56	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161675	10.1371/journal.pone.0161675	http://dx.doi.org/10.1371/journal.pone.0161675			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27574787	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877200033
J	Weernink, MGM; van Til, JA; van Vugt, JPP; Movig, KLL; Groothuis-Oudshoorn, CGM; IJzerman, MJ				Weernink, Marieke G. M.; van Til, Janine A.; van Vugt, Jeroen P. P.; Movig, Kris L. L.; Groothuis-Oudshoorn, Catharina G. M.; IJzerman, Maarten J.			Involving Patients in Weighting Benefits and Harms of Treatment in Parkinson's Disease	PLOS ONE			English	Article							DISCRETE-CHOICE EXPERIMENTS; QUALITY-OF-LIFE; DEEP BRAIN-STIMULATION; DECISION-MAKING; CENTERED CARE; QUESTIONNAIRE; VALIDATION; THERAPY	Introduction Little is known about how patients weigh benefits and harms of available treatments for Parkinson's Disease (oral medication, deep brain stimulation, infusion therapy). In this study we have (1) elicited patient preferences for benefits, side effects and process characteristics of treatments and (2) measured patients' preferred and perceived involvement in decision-making about treatment. Methods Preferences were elicited using a best-worst scaling case 2 experiment. Attributes were selected based on 18 patient-interviews: treatment modality, tremor, slowness of movement, posture and balance problems, drowsiness, dizziness, and dyskinesia. Subsequently, a questionnaire was distributed in which patients were asked to indicate the most and least desirable attribute in nine possible treatment scenarios. Conditional logistic analysis and latent class analysis were used to estimate preference weights and identify subgroups. Patients also indicated their preferred and perceived degree of involvement in treatment decision-making (ranging from active to collaborative to passive). Results Two preference patterns were found in the patient sample (N = 192). One class of patients focused largely on optimising the process of care, while the other class focused more on controlling motor-symptoms. Patients who had experienced advanced treatments, had a shorter disease duration, or were still employed were more likely to belong to the latter class. For both classes, the benefits of treatment were more influential than the described side effects. Furthermore, many patients (45%) preferred to take the lead in treatment decisions, however 10.8% perceived a more passive or collaborative role instead. Discussion Patients weighted the benefits and side effects of treatment differently, indicating there is no "one-size-fits-all" approach to choosing treatments. Moreover, many patients preferred an active role in decision-making about treatment. Both results stress the need for physicians to know what is important to patients and to share treatment decisions to ensure that patients receive the treatment that aligns with their preferences.	[Weernink, Marieke G. M.; van Til, Janine A.; Groothuis-Oudshoorn, Catharina G. M.; IJzerman, Maarten J.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Hlth Technol & Serv Res, Enschede, Netherlands; [van Vugt, Jeroen P. P.] Med Spectrum Twente, Dept Neurol, Enschede, Netherlands; [Movig, Kris L. L.] Med Spectrum Twente, Dept Clin Pharm, Enschede, Netherlands	University of Twente; Medical Spectrum Twente; Medical Spectrum Twente	Weernink, MGM (corresponding author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Hlth Technol & Serv Res, Enschede, Netherlands.	m.g.m.weernink@utwente.nl	IJzerman, Maarten J/Q-8963-2016; IJzerman, Maarten/AAB-6894-2020	IJzerman, Maarten J/0000-0001-5788-5805; IJzerman, Maarten/0000-0001-5788-5805; van Til, Janine/0000-0002-5416-5893; Groothuis-Oudshoorn, Catharina/0000-0002-4875-5379	ZonMw, the Netherlands Organization for Health Research and Development;  [80-82500-98-11234]	ZonMw, the Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and DevelopmentNetherlands Government); 	This study was funded by ZonMw, the Netherlands Organization for Health Research and Development, http://www.zonmw.nl/nl. Janine van Til received the grant to conduct this study (grant number 80-82500-98-11234). Besides the initial review process before funding and amendments, ZonMw did not have any involvement. All researcher activities were independent of the funding source. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abendroth M, 2012, INT J NURS STUD, V49, P445, DOI 10.1016/j.ijnurstu.2011.10.003; Ali S, 2012, BRIT MED BULL, V103, P21, DOI 10.1093/bmb/lds020; Arbouw MEL, 2008, EUR J CLIN PHARMACOL, V64, P1021, DOI 10.1007/s00228-008-0518-2; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Clarke CE, 2009, PARKINSONISM RELAT D, V15, P728, DOI 10.1016/j.parkreldis.2009.09.005; Degner L F, 1997, Can J Nurs Res, V29, P21; Flynn TN, 2007, J HEALTH ECON, V26, P171, DOI 10.1016/j.jhealeco.2006.04.002; Grosset KA, 2005, MOVEMENT DISORD, V20, P616, DOI 10.1002/mds.20393; Hamberg K, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-89; Hattori N, 2012, PATIENT-RELAT OUTCOM, V3, P31, DOI 10.2147/PROM.S29443; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Hung SW, 2010, J NEUROL NEUROSUR PS, V81, P1112, DOI 10.1136/jnnp.2009.173286; Jankovic J, 2000, CLIN NEUROPHARMACOL, V23, P252, DOI 10.1097/00002826-200009000-00003; Jenkinson C, 1997, AGE AGEING, V26, P353, DOI 10.1093/ageing/26.5.353; Jenkinson C, 1997, PSYCHOL HEALTH, V12, P805, DOI 10.1080/08870449708406741; Johnson FR, 2013, VALUE HEALTH, V16, P3, DOI 10.1016/j.jval.2012.08.2223; Kim MR, 2016, PARKINSONISM RELAT D, V23, P91, DOI 10.1016/j.parkreldis.2015.11.010; Kurlan R, 2005, NEUROLOGY, V64, P923, DOI 10.1212/01.WNL.0000152880.77812.5B; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Leopold NA, 2004, MOVEMENT DISORD, V19, P513, DOI 10.1002/mds.20041; Louviere J. J., 2015, BEST WORST SCALING T; Martinez-Martin P, 2012, THER ADV NEUROL DISO, V5, P105, DOI 10.1177/1756285611431974; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462; Martinez-Martin Pablo, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P401, DOI 10.1586/14737167.8.4.401; Muhlbacher AC, 2013, APPL HEALTH ECON HEA, V11, P163, DOI 10.1007/s40258-013-0023-3; Muller B, 2013, PARKINSONISM RELAT D, V19, P1027, DOI 10.1016/j.parkreldis.2013.07.010; Murphy R, 2013, IRISH J MED SCI, V182, P415, DOI 10.1007/s11845-013-0902-5; Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95; Potoglou D, 2011, SOC SCI MED, V72, P1717, DOI 10.1016/j.socscimed.2011.03.027; Ryan M, 2014, SOC SCI MED, V106, P194, DOI 10.1016/j.socscimed.2014.01.013; STRULL WM, 1984, JAMA-J AM MED ASSOC, V252, P2990, DOI 10.1001/jama.252.21.2990; Swait J., 1994, J RETAIL CONSUM SERV, V1, P77, DOI [10.1016/0969-6989(94)90002-7, DOI 10.1016/0969-6989(94)90002-7]; van der Eijk M, 2013, PARKINSONISM RELAT D, V19, P923, DOI 10.1016/j.parkreldis.2013.04.022; Warren C, 2011, WIRES COGN SCI, V2, P193, DOI 10.1002/wcs.98; Watt Susan, 2000, Health Expect, V3, P6, DOI 10.1046/j.1369-6513.2000.00076.x; Wertheimer Albert, 2010, South Med Rev, V3, P24	36	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0160771	10.1371/journal.pone.0160771	http://dx.doi.org/10.1371/journal.pone.0160771			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EE	27575744	gold, Green Published			2022-12-26	WOS:000382877200009
J	Garita-Cambronero, J; Palacio-Bielsa, A; Lopez, MM; Cubero, J				Garita-Cambronero, Jerson; Palacio-Bielsa, Ana; Lopez, Maria M.; Cubero, Jaime			Comparative Genomic and Phenotypic Characterization of Pathogenic and Non-Pathogenic Strains of Xanthomonas arboricola Reveals Insights into the Infection Process of Bacterial Spot Disease of Stone Fruits	PLOS ONE			English	Article							ORYZAE PV. ORYZAE; EVOLUTIONARY EVENTS; SIGNAL-TRANSDUCTION; SECRETION SYSTEMS; SEQUENCE-ANALYSIS; CITRUS CANKER; II SECRETION; CAMPESTRIS; PROTEIN; VIRULENCE	Xanthomonas arboricola pv. pruni is the causal agent of bacterial spot disease of stone fruits, a quarantinable pathogen in several areas worldwide, including the European Union. In order to develop efficient control methods for this disease, it is necessary to improve the understanding of the key determinants associated with host restriction, colonization and the development of pathogenesis. After an initial characterization, by multilocus sequence analysis, of 15 strains of X. arboricola isolated from Prunus, one strain did not group into the pathovar pruni or into other pathovars of this species and therefore it was identified and defined as a X. arboricola pv. pruni look-a-like. This non-pathogenic strain and two typical strains of X. arboricola pv. pruni were selected for a whole genome and phenotype comparative analysis in features associated with the pathogenesis process in Xanthomonas. Comparative analysis among these bacterial strains isolated from Prunus spp. and the inclusion of 15 publicly available genome sequences from other pathogenic and non-pathogenic strains of X. arboricola revealed variations in the phenotype associated with variations in the profiles of TonB-dependent transporters, sensors of the two-component regulatory system, methyl accepting chemotaxis proteins, components of the flagella and the type IV pilus, as well as in the repertoire of cell-wall degrading enzymes and the components of the type III secretion system and related effectors. These variations provide a global overview of those mechanisms that could be associated with the development of bacterial spot disease. Additionally, it pointed out some features that might influence the host specificity and the variable virulence observed in X. arboricola.	[Garita-Cambronero, Jerson; Cubero, Jaime] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Madrid, Spain; [Palacio-Bielsa, Ana] Univ Zaragoza, Ctr Invest & Tecnol Agroalimentaria Agron, Inst Agroalimentario Aragon IA2 CITA, Zaragoza, Spain; [Lopez, Maria M.] IVIA, Valencia, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); University of Zaragoza	Cubero, J (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Madrid, Spain.	cubero@inia.es	Cubero, Jaime/D-2322-2017; Palacio-Bielsa, Ana/AAB-9719-2020; Lopez, Maria/HHC-3659-2022; Garita-Cambronero, Jerson/B-6502-2016; López, Maria M/D-2584-2015	Cubero, Jaime/0000-0002-4314-857X; Palacio-Bielsa, Ana/0000-0002-3777-8612; Garita-Cambronero, Jerson/0000-0001-8055-0747; 	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria [RTA2011-00140-C03-02, RTA2014-00019-C02-01]; Ministerio de Educacion, Cultura y Deporte [FPU1000/2012]	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria(Instituto de Investigacion Agropecuaria (INIA)); Ministerio de Educacion, Cultura y Deporte	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria, www.inia.es, Grants: RTA2011-00140-C03-02, RTA2014-00019-C02-01. Fellowship to Jerson Garita-Cambronero: Ministerio de Educacion, Cultura y Deporte FPU1000/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abby SS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002983; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Blanvillain S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000224; Blocker A, 2003, P NATL ACAD SCI USA, V100, P3027, DOI 10.1073/pnas.0535335100; Bogdanove AJ, 2011, J BACTERIOL, V193, P5450, DOI 10.1128/JB.05262-11; BONAS U, 1989, MOL GEN GENET, V218, P127, DOI 10.1007/BF00330575; Boudon S, 2005, PHYTOPATHOLOGY, V95, P1081, DOI 10.1094/PHYTO-95-1081; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Burch AY, 2010, APPL ENVIRON MICROB, V76, P5363, DOI 10.1128/AEM.00592-10; Burokiene D, 2012, J PLANT PATHOL, V94, DOI 10.4454/jpp.v94i1sup.005; Caballero JI, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00246-13; Cesbron S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01126; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Crossman L, 2004, MICROBES INFECT, V6, P623, DOI 10.1016/j.micinf.2004.01.013; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Das A, 2009, MOL PLANT MICROBE IN, V22, P73, DOI 10.1094/MPMI-22-1-0073; Denance N, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00071; Dunger G, 2016, CURR OPIN MICROBIOL, V30, P88, DOI 10.1016/j.mib.2016.01.007; EFSA Panel on Plant Health (PLH), 2014, EFSA Journal, V12, P3857; Essakhi S, 2015, APPL ENVIRON MICROB, V81, P5395, DOI 10.1128/AEM.00835-15; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Garita-Cambronero J, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00440-14; Garita-Cambronero J, 2016, STAND GENOMIC SCI, V11, DOI 10.1186/s40793-016-0132-3; Gordon JL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2310-x; Gottig N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004358; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; GRAHAM JH, 1991, PLANT DIS, V75, P1193, DOI 10.1094/PD-75-1193; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Guo YP, 2011, MOL PLANT MICROBE IN, V24, P649, DOI 10.1094/MPMI-09-10-0209; Hajri A, 2012, APPL ENVIRON MICROB, V78, P371, DOI 10.1128/AEM.06119-11; Hall T., 2011, GERF B BIOSCI, V2, P60; Harrison J, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01705-15; He YW, 2008, FEMS MICROBIOL REV, V32, P842, DOI 10.1111/j.1574-6976.2008.00120.x; Higuera G, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01160-15; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Ignatov AN, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01572-14; Ikeda T, 1996, J MOL BIOL, V259, P679, DOI 10.1006/jmbi.1996.0349; Jacobs JM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00431; Jalan N, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00235-13; Jalan N, 2011, J BACTERIOL, V193, P6342, DOI 10.1128/JB.05777-11; Kaluzna M, 2014, PLANT PATHOL, V63, P1404, DOI 10.1111/ppa.12211; KAMOUN S, 1990, APPL ENVIRON MICROB, V56, P3855, DOI 10.1128/AEM.56.12.3855-3860.1990; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katzen F, 1998, J BACTERIOL, V180, P1607, DOI 10.1128/JB.180.7.1607-1617.1998; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Kim JS, 1999, J BACTERIOL, V181, P6969; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li RF, 2014, ENVIRON MICROBIOL, V16, P2053, DOI 10.1111/1462-2920.12207; Maharjan RP, 2007, J BACTERIOL, V189, P2350, DOI 10.1128/JB.01414-06; Malamud F, 2011, MICROBIOL-SGM, V157, P819, DOI 10.1099/mic.0.044255-0; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Massomo SMS, 2003, EUR J PLANT PATHOL, V109, P775, DOI 10.1023/A:1026194402701; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Mhedbi-Hajri N, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-67; Moreira LM, 2015, FUNCT INTEGR GENOMIC, V15, P197, DOI 10.1007/s10142-014-0414-z; Nascimento R, 2016, SCI REP-UK, V6, DOI 10.1038/srep18598; National Center for Biotechnology Information (NCBI), 2016, FIND HOM GEN AN ORG; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Pereira UP, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01126-15; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pieretti I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-658; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pothier JF, 2011, PHYTOPATHOLOGY, V101, pS144; Pothier JF, 2011, FEMS MICROBIOL LETT, V323, P52, DOI 10.1111/j.1574-6968.2011.02352.x; Potnis N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-146; Qian W, 2008, MOL PLANT MICROBE IN, V21, P151, DOI 10.1094/MPMI-21-2-0151; Ray SK, 2002, MOL MICROBIOL, V46, P637, DOI 10.1046/j.1365-2958.2002.03188.x; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; Saux MFL, 2015, APPL ENVIRON MICROB, V81, P4651, DOI 10.1128/AEM.00050-15; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Sena-Velez M, 2015, PLANT PATHOL, V64, P767, DOI 10.1111/ppa.12311; Sena-Velez M, 2015, THESIS; Shen YW, 2001, MOL PLANT MICROBE IN, V14, P204, DOI 10.1094/MPMI.2001.14.2.204; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stefani E, 2010, J PLANT PATHOL S, V92, DOI DOI 10.4454/JPP.V92I1SUP.2511; Stoyanova M, 2014, INT J MICROBIOL, V2014, DOI [10.1155/2014/495476, DOI 10.1155/2014/49547]; Subramoni S., 2010, HDB HYDROCARBON LIPI, P3269, DOI DOI 10.1007/978-3-540-77587-4_248; Sun WX, 2006, PLANT CELL, V18, P764, DOI 10.1105/tpc.105.037648; Szczesny R, 2010, NEW PHYTOL, V187, P983, DOI 10.1111/j.1469-8137.2010.03312.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Triplett LR, 2011, APPL ENVIRON MICROB, V77, P3930, DOI 10.1128/AEM.00028-11; Vandroemme J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-829; VAUTERIN L, 1995, INT J SYST BACTERIOL, V45, P472, DOI 10.1099/00207713-45-3-472; VERNIERE C, 1993, APPL ENVIRON MICROB, V59, P243, DOI 10.1128/AEM.59.1.243-249.1993; Verniere CJ, 2003, PHYTOPATHOLOGY, V93, P832, DOI 10.1094/PHYTO.2003.93.7.832; Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004; Vorhoelter FJ, 2008, J BIOTECHNOL, V134, P33, DOI 10.1016/j.jbiotec.2007.12.013; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; White FF, 2009, MOL PLANT PATHOL, V10, P749, DOI 10.1111/j.1364-3703.2009.00590.x; Young JM, 2008, SYST APPL MICROBIOL, V31, P366, DOI 10.1016/j.syapm.2008.06.004; Yun MH, 2006, PLANT PHYSIOL, V141, P178, DOI 10.1104/pp.105.074542	98	24	24	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161977	10.1371/journal.pone.0161977	http://dx.doi.org/10.1371/journal.pone.0161977			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571391	Green Published, gold, Green Submitted			2022-12-26	WOS:000382876700048
J	Petrillo, A; Fusco, R; Filice, S; Granata, V; Catalano, O; Vallone, P; Di Bonito, M; D'Aiuto, M; Rinaldo, M; Capasso, I; Sansone, M				Petrillo, Antonella; Fusco, Roberta; Filice, Salvatore; Granata, Vincenza; Catalano, Orlando; Vallone, Paolo; Di Bonito, Maurizio; D'Aiuto, Massimiliano; Rinaldo, Massimo; Capasso, Immacolata; Sansone, Mario			Breast Contrast Enhanced MR Imaging: Semi-Automatic Detection of Vascular Map and Predominant Feeding Vessel	PLOS ONE			English	Article							IPSILATERAL INCREASED VASCULARITY; MAGNETIC-RESONANCE; DCE-MRI; CANCER; ALGORITHM; LESIONS; ANGIOGRAPHY; DIAGNOSIS; TUMOR; SIGN	Purpose To obtain breast vascular map and to assess correlation between predominant feeding vessel and tumor location with a semi-automatic method compared to conventional radiologic reading. Methods 148 malignant and 75 benign breast lesions were included. All patients underwent bilateral MR imaging. Written informed consent was obtained from the patients before MRI. The local ethics committee granted approval for this study. Semi-automatic breast vascular map and predominant vessel detection was performed on MRI, for each patient. Semi-automatic detection (depending on grey levels threshold manually chosen by radiologist) was compared with results of two expert radiologists; inter-observer variability and reliability of semiautomatic approach were assessed. Results Anatomic analysis of breast lesions revealed that 20% of patients had masses in internal half, 50% in external half and the 30% in subareolar/central area. As regards the 44 tumors in internal half, based on radiologic consensus, 40 demonstrated a predominant feeding vessel (61% were supplied by internal thoracic vessels, 14% by lateral thoracic vessels, 16% by both thoracic vessels and 9% had no predominant feeding vessel-p<0.01), based on semi-automatic detection, 38 tumors demonstrated a predominant feeding vessel (66% were supplied by internal thoracic vessels, 11% by lateral thoracic vessels, 9% by both thoracic vessels and 14% had no predominant feeding vessel-p<0.01). As regards the 111 tumors in external half, based on radiologic consensus, 91 demonstrated a predominant feeding vessel (25% were supplied by internal thoracic vessels, 39% by lateral thoracic vessels, 18% by both thoracic vessels and 18% had no predominant feeding vessel-p<0.01), based on semi-automatic detection, 94 demonstrated a predominant feeding vessel (27% were supplied by internal thoracic vessels, 45% by lateral thoracic vessels, 4% by both thoracic vessels and 24% had no predominant feeding vessel-p<0.01). An excellent agreement between two radiologic assessments (k = 0.81) and between radiologic consensus and semi-automatic assessment (k = 0.80) was found to identify origin of predominant feeding vessel. An excellent reliability for semi-automatic assessment (Cronbach's alpha = 0.96) was reported. Conclusions Predominant feeding vessel location was correlated with breast lesion location: internal thoracic artery supplied the highest proportion of breasts with tumor in internal half and lateral thoracic artery supplied the highest proportion of breasts with lateral tumor.	[Petrillo, Antonella; Fusco, Roberta; Filice, Salvatore; Granata, Vincenza; Catalano, Orlando; Vallone, Paolo] Ist Nazl Tumori Fdn Giovanni Pascale IRCCS, Dept Diagnost Imaging Radiant & Metab Therapy, Div Radiol, Via Mariano Semmola, Naples, Italy; [Di Bonito, Maurizio] Ist Nazl Tumori Fdn Giovanni Pascale IRCCS, Dept Diagnost & Lab Pathol, Div Diagnost Pathol, Via Mariano Semmola, Naples, Italy; [D'Aiuto, Massimiliano; Rinaldo, Massimo; Capasso, Immacolata] Ist Nazl Tumori Fdn Giovanni Pascale IRCCS, Dept Senol, Div Senol Surg, Via Mariano Semmola, Naples, Italy; [Sansone, Mario] Univ Naples Federico II, Dept Elect Engn & Informat Technol, Via Claudio, Naples, Italy	IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; University of Naples Federico II	Fusco, R (corresponding author), Ist Nazl Tumori Fdn Giovanni Pascale IRCCS, Dept Diagnost Imaging Radiant & Metab Therapy, Div Radiol, Via Mariano Semmola, Naples, Italy.	r.fusco@istitutotumori.na.it	Sansone, Mario/H-3556-2019; Granata, Vincenza/K-6733-2016; Petrillo, Antonella/J-5450-2018; Rinaldo, Massimo/AAA-8913-2020; Fusco, Roberta/I-4062-2018	Sansone, Mario/0000-0003-3556-7771; Granata, Vincenza/0000-0002-6601-3221; Petrillo, Antonella/0000-0003-2465-5370; Rinaldo, Massimo/0000-0001-8609-1182; Fusco, Roberta/0000-0002-0469-9969; Cantile, Monica/0000-0001-7840-3369				Carriero A, 2002, J EXP CLIN CANC RES, V21, P77; Crispo A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-15; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Dietzel M, 2010, KOREAN J RADIOL, V11, P178, DOI 10.3348/kjr.2010.11.2.178; Fischer DR, 2005, INVEST RADIOL, V40, P430, DOI 10.1097/01.rli.0000167138.52283.aa; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Fusco R, 2016, BREAST CANCER-TOKYO, V23, P266, DOI 10.1007/s12282-014-0565-8; Grubstein A, 2010, EUR J RADIOL, V75, pE9, DOI 10.1016/j.ejrad.2009.10.020; Krag D, 1998, NEW ENGL J MED, V339, P941, DOI 10.1056/NEJM199810013391401; Kul S, 2010, AM J ROENTGENOL, V195, P1250, DOI 10.2214/AJR.10.4368; Lin MQ, 2009, J MAGN RESON IMAGING, V30, P817, DOI 10.1002/jmri.21915; Lohrisch C, 2000, J CLIN ONCOL, V18, P2828, DOI 10.1200/JCO.2000.18.15.2828; Mahfouz AE, 2001, EUR RADIOL, V11, P965, DOI 10.1007/s003300000668; Malich A, 2005, AM J ROENTGENOL, V185, P964, DOI 10.2214/AJR.04.1073; Orguc S, 2012, DIAGN INTERV RADIOL, V18, P454, DOI 10.4261/1305-3825.DIR.5280-11.2; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Peters NHGM, 2008, RADIOLOGY, V246, P116, DOI 10.1148/radiol.2461061298; Petrillo A, 2011, BREAST J, V17, P525, DOI 10.1111/j.1524-4741.2011.01121.x; Sardanelli F, 2005, RADIOLOGY, V235, P791, DOI 10.1148/radiol.2353040733; Sardanelli F, 2007, EUR RADIOL, V17, P873, DOI 10.1007/s00330-006-0389-9; Sardanelli F, 2010, AM J ROENTGENOL, V195, P1246, DOI 10.2214/AJR.10.4984; Schmitz AC, 2008, EUR RADIOL, V18, P355, DOI 10.1007/s00330-007-0766-z; Verardi N, 2013, RADIOL MED, V118, P239, DOI 10.1007/s11547-012-0864-0; Vignati A, 2014, COMPUT METH PROG BIO, V117, P482, DOI 10.1016/j.cmpb.2014.09.003; Vignati A, 2012, INVEST RADIOL, V47, P705, DOI 10.1097/RLI.0b013e31826dc3a4; Wright H, 2005, AM J SURG, V190, P576, DOI 10.1016/j.amjsurg.2005.06.015	26	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161691	10.1371/journal.pone.0161691	http://dx.doi.org/10.1371/journal.pone.0161691			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571255	Green Published, Green Submitted, gold			2022-12-26	WOS:000382876700029
J	Dai, BS; Wu, XQ; Bu, W				Dai, Baisheng; Wu, Xiangqian; Bu, Wei			Retinal Microaneurysms Detection Using Gradient Vector Analysis and Class Imbalance Classification	PLOS ONE			English	Article							DIABETIC-RETINOPATHY; AUTOMATIC DETECTION; RECONSTRUCTION; TRANSFORM; SYSTEM	Retinal microaneurysms (MAs) are the earliest clinically observable lesions of diabetic retinopathy. Reliable automated MAs detection is thus critical for early diagnosis of diabetic retinopathy. This paper proposes a novel method for the automated MAs detection in color fundus images based on gradient vector analysis and class imbalance classification, which is composed of two stages, i. e. candidate MAs extraction and classification. In the first stage, a candidate MAs extraction algorithm is devised by analyzing the gradient field of the image, in which a multi-scale log condition number map is computed based on the gradient vectors for vessel removal, and then the candidate MAs are localized according to the second order directional derivatives computed in different directions. Due to the complexity of fundus image, besides a small number of true MAs, there are also a large amount of nonMAs in the extracted candidates. Classifying the true MAs and the non-MAs is an extremely class imbalanced classification problem. Therefore, in the second stage, several types of features including geometry, contrast, intensity, edge, texture, region descriptors and other features are extracted from the candidate MAs and a class imbalance classifier, i. e., RUSBoost, is trained for the MAs classification. With the Retinopathy Online Challenge (ROC) criterion, the proposed method achieves an average sensitivity of 0.433 at 1/8, 1/4, 1/2, 1, 2, 4 and 8 false positives per image on the ROC database, which is comparable with the stateof- the-art approaches, and 0.321 on the DiaRetDB1 V2.1 database, which outperforms the state-of-the-art approaches.	[Dai, Baisheng; Wu, Xiangqian] Harbin Inst Technol, Sch Comp Sci & Technol, Harbin, Peoples R China; [Bu, Wei] Harbin Inst Technol, Dept New Media Technol & Arts, Harbin, Peoples R China	Harbin Institute of Technology; Harbin Institute of Technology	Wu, XQ (corresponding author), Harbin Inst Technol, Sch Comp Sci & Technol, Harbin, Peoples R China.	xqwu@hit.edu.cn			National Natural Science Foundation of China [61472102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) under Grants 61472102 (Received by WB).	Abdelazeem S, 2002, 2002 IEEE PROCEEDINGS OF THE NINETEENTH NATIONAL RADIO SCIENCE CONFERENCE, VOLS 1 AND 2, P421, DOI 10.1109/NRSC.2002.1022650; Adal KM, 2014, COMPUT METH PROG BIO, V114, DOI 10.1016/j.cmpb.2013.12.009; [Anonymous], 2000, MATH HDB SCI ENG DEF; Antal B, 2012, IEEE T BIO-MED ENG, V59, P1720, DOI 10.1109/TBME.2012.2193126; Antal B, 2012, PATTERN RECOGN, V45, P264, DOI 10.1016/j.patcog.2011.06.010; Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; Bernardes R, 2009, OPHTHALMOLOGICA, V223, P284, DOI 10.1159/000213638; Browning DJ, 2010, DIABETIC RETINOPATHY: EVIDENCE-BASED MANAGEMENT, P1, DOI 10.1007/978-0-387-85900-2; Cree M.J., 2008, WAIKATO MICROANEURYS; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Dubow M, 2014, INVEST OPHTH VIS SCI, V55, P1299, DOI 10.1167/iovs.13-13122; Farbman Z, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1360612.1360666; Fegyver Z., 2012, GRADIENT BASED MICRO; Fleming AD, 2006, IEEE T MED IMAGING, V25, P1223, DOI 10.1109/TMI.2006.879953; Freund Y., 1996, Machine Learning. Proceedings of the Thirteenth International Conference (ICML '96), P148; Giancardo L, 2011, IEEE ENG MED BIO, P5939, DOI 10.1109/IEMBS.2011.6091562; Giancardo L., 2010, P SPIE MED IMAGING, V7623, P7623; HARALICK RM, 1984, IEEE T PATTERN ANAL, V6, P58, DOI 10.1109/TPAMI.1984.4767475; Hatanaka Y., 2012, COMPUTER BASED MEDIC, P1, DOI DOI 10.1109/CBMS.2012.6266339; Jelinek HF, 2010, AUTOMATED IMAGE DETECTION OF RETINAL PATHOLOGY, P1; Kauppi T, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/368514; Kobatake H, 1999, IEEE T IMAGE PROCESS, V8, P1029, DOI 10.1109/83.777084; Lankton S, 2008, IEEE T IMAGE PROCESS, V17, P2029, DOI 10.1109/TIP.2008.2004611; Lazar I, 2013, IEEE T MED IMAGING, V32, P400, DOI 10.1109/TMI.2012.2228665; Lazar I, 2011, I S BIOMED IMAGING, P1405, DOI 10.1109/ISBI.2011.5872663; Liu XY, 2009, IEEE T SYST MAN CY B, V39, P539, DOI 10.1109/TSMCB.2008.2007853; Mizutani A, 2009, P SOC PHOTO-OPT INS, V7260; Niemeijer M, 2005, IEEE T MED IMAGING, V24, P584, DOI 10.1109/TMI.2005.843738; Niemeijer M, 2010, IEEE T MED IMAGING, V29, P185, DOI 10.1109/TMI.2009.2033909; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Orient JM, 2012, SAPIRAS ART SCI BEDS; Pereira C, 2014, ARTIF INTELL MED, V60, P179, DOI 10.1016/j.artmed.2013.12.005; Quellec G, 2008, IEEE T MED IMAGING, V27, P1230, DOI 10.1109/TMI.2008.920619; Ram K, 2011, IEEE T BIO-MED ENG, V58, P664, DOI 10.1109/TBME.2010.2096223; Rosas-Romero R, 2015, COMPUT MED IMAG GRAP, V44, P41, DOI 10.1016/j.compmedimag.2015.07.001; Sanchez CI, 2009, P SOC PHOTO-OPT INS, V7260; Seiffert C, 2010, IEEE T SYST MAN CY A, V40, P185, DOI 10.1109/TSMCA.2009.2029559; Seoud L, 2014, I S BIOMED IMAGING, P101, DOI 10.1109/ISBI.2014.6867819; Sinthanayothin C, 2002, DIABETIC MED, V19, P105, DOI 10.1046/j.1464-5491.2002.00613.x; Sjolie AK, 2011, DIABETIC MED, V28, P345, DOI 10.1111/j.1464-5491.2010.03210.x; Soares I., 2014, P OPHTHALMIC MED IMA, P65; Spencer T, 1996, COMPUT BIOMED RES, V29, P284, DOI 10.1006/cbmr.1996.0021; Tico M, 2002, EURASIP J ADV SIG PR, V2002; Torrent-Solans T, 2004, INVEST OPHTH VIS SCI, V45, pU45; Vincent L, 1993, IEEE T IMAGE PROCESS, V2, P176, DOI 10.1109/83.217222; Walter T, 2007, MED IMAGE ANAL, V11, P555, DOI 10.1016/j.media.2007.05.001; Whitaker RT, 1998, INT J COMPUT VISION, V29, P203, DOI 10.1023/A:1008036829907; Zhang B, 2012, INFORM SCIENCES, V200, P78, DOI 10.1016/j.ins.2012.03.003; Zhang B, 2010, PATTERN RECOGN, V43, P2237, DOI 10.1016/j.patcog.2009.12.017; Zheng YL, 2012, INVEST OPHTH VIS SCI, V53, P8310, DOI 10.1167/iovs.12-9576	50	31	32	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161556	10.1371/journal.pone.0161556	http://dx.doi.org/10.1371/journal.pone.0161556			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564376	Green Submitted, gold, Green Published			2022-12-26	WOS:000382496300008
J	Martin-Saldana, S; Trinidad, A; Ramil, E; Sanchez-Lopez, AJ; Coronado, MJ; Martinez-Martinez, E; Garcia, JM; Garcia-Berrocal, JR; Ramirez-Camacho, R				Martin-Saldana, Sergio; Trinidad, Almudena; Ramil, Elvira; Sanchez-Lopez, Antonio J.; Jose Coronado, Maria; Martinez-Martinez, Esther; Miguel Garcia, Jose; Ramon Garcia-Berrocal, Jose; Ramirez-Camacho, Rafael			Spontaneous Cannabinoid Receptor 2 (CB2) Expression in the Cochlea of Adult Albino Rat and Its Up-Regulation after Cisplatin Treatment	PLOS ONE			English	Article							ENDOCANNABINOID SYSTEM; INFLAMMATION; NEPHROPATHY; AGONIST; MODELS; NERVE	We provide evidence for the presence of cannabinoid CB2 receptors in some cellular types of the cochlea of the adult albino rat. Cannabinoids and their receptors are increasingly being studied because of their high potential for clinical use. As a hyperspecialized portion of the peripheral nervous system, study of the expression and function of cannabinoid receptors in the hearing organ is of high interest. Stria vascularis and inner hair cells express CB2 receptor, as well as neurites and cell bodies of the spiral ganglion. Cellular types such as supporting cells and outer hair cells, in which the expression of other types of functional receptors has been reported, do not significantly express CB2 receptors in this study. An up-regulation of CB2 gene expression was detected after an ototoxic event such as cisplatin treatment, probably due to pro-inflammatory events triggered by the drug. That fact suggests promising potential of CB2 receptor as a therapeutic target for new treatments to palliate cisplatin-induced hearing loss and other ototoxic events which triggers inflammatory pathways.	[Martin-Saldana, Sergio; Trinidad, Almudena; Ramon Garcia-Berrocal, Jose; Ramirez-Camacho, Rafael] Univ Hosp Puerta de Hierro Majadahonda, Hlth Res Inst Puerta de Hierro, Ear Res Grp, Madrid, Spain; [Ramil, Elvira] Univ Hosp Puerta de Hierro Majadahonda, Hlth Res Inst Puerta de Hierro, Sequencing & Mol Biol Unit, Madrid, Spain; [Sanchez-Lopez, Antonio J.] Univ Hosp Puerta de Hierro Majadahonda, Hlth Res Inst Puerta de Hierro, Neuroimmunol Unit, Madrid, Spain; [Jose Coronado, Maria] Univ Hosp Puerta de Hierro Majadahonda, Hlth Res Inst Puerta de Hierro, Confocal Microscopy Unit, Madrid, Spain; [Martinez-Martinez, Esther; Miguel Garcia, Jose] Univ Hosp Puerta de Hierro Majadahonda, Hlth Res Inst Puerta de Hierro, Dept Med Oncol, Madrid, Spain	Hospital Puerta de Hierro-Majadahonda; Hospital Puerta de Hierro-Majadahonda; Hospital Puerta de Hierro-Majadahonda; Hospital Puerta de Hierro-Majadahonda; Hospital Puerta de Hierro-Majadahonda	Martin-Saldana, S (corresponding author), Univ Hosp Puerta de Hierro Majadahonda, Hlth Res Inst Puerta de Hierro, Ear Res Grp, Madrid, Spain.	smartinsaldana@gmail.com	García-Berrocal, José Ramón/AAB-2005-2022; Sánchez-López, Antonio J/E-3037-2018; Sánchez-López, Antonio J./AAF-3383-2021; Coronado, Maria José/AAB-2112-2019; Martin-Saldaña, Sergio/A-9980-2018; Tojeiro, Elvira Ramil/AAB-2476-2019	García-Berrocal, José Ramón/0000-0003-2747-2991; Sánchez-López, Antonio J/0000-0001-7168-6175; Sánchez-López, Antonio J./0000-0001-7168-6175; Tojeiro, Elvira Ramil/0000-0003-0785-3826; Martinez-Martinez, Esther/0000-0003-1016-209X; Martin Saldana, Sergio/0000-0002-9506-8483; Coronado Albi, Maria Jose/0000-0003-0281-3366	Instituto de Salud Carlos III [PI 11/00742]; Plan Nacionall I+D+I; Fondo Europeo de Desarrollo Regional; Universidad Autonoma de Madrid; Fundacion Universidad Autonoma de Madrid	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Plan Nacionall I+D+I; Fondo Europeo de Desarrollo Regional(European Commission); Universidad Autonoma de Madrid; Fundacion Universidad Autonoma de Madrid	This work was supported by Instituto de Salud Carlos III PI 11/00742 (to RRC) http://www.isciii.es/, Plan Nacionall I+D+I 2008-2011 (to RRC) http://www.idi.mineco.gob. es/portal/site/MICINN/menuitem.7eeac5cd345b4f34f09dfd1001432ea0/?vgnextoid= fe5aec1eb658c310VgnVCM1000001d04140aRCRD, Fondo Europeo de Desarrollo Regional as a cofunder (to RRC) http://www.red.es/redes/%C2%BFquienes-somos/feder, Universidad Autonoma de Madrid (to RRC) http://www.uam.es/, Fundacion Universidad Autonoma de Madrid SMS http://fuam.es/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek JH, 2008, ACTA OTO-LARYNGOL, V128, P961, DOI 10.1080/00016480701796944; Barutta F, 2011, DIABETES, V60, P2386, DOI 10.2337/db10-1809; Berdyshev EV, 2000, CHEM PHYS LIPIDS, V108, P169, DOI 10.1016/S0009-3084(00)00195-X; Berrocal JRG, 2000, J LARYNGOL OTOL, DOI [10.1258/0022215001905021, DOI 10.1258/0022215001905021]; Bokemeyer C, 1998, BRIT J CANCER, DOI [10.1016/S0022-5347(01)62317-6, DOI 10.1016/S0022-5347(01)62317-6]; Casares C, 2012, EUR ARCH OTO-RHINO-L, V269, P2455, DOI 10.1007/s00405-012-2029-0; Demuth DG, 2006, LIFE SCI, V78, P549, DOI 10.1016/j.lfs.2005.05.055; Deutsch DG, 1997, J CLIN INVEST, V100, P1538, DOI 10.1172/JCI119677; Devane WA, 1988, MOL PHARM; Fernandez-Ruiz J, 2007, TRENDS PHARMACOL SCI, V28, P39, DOI 10.1016/j.tips.2006.11.001; Fernandez-Ruiz J, 2015, NEUROTHERAPEUTICS, V12, P793, DOI 10.1007/s13311-015-0381-7; Grimaldi P, 2009, P NATL ACAD SCI USA, V106, P11131, DOI 10.1073/pnas.0812789106; He F, 2007, MOL VIS; Hsieh GC, 2011, BRIT J PHARMACOL, V162, P428, DOI 10.1111/j.1476-5381.2010.01046.x; Jeong HJ, 2007, J NEUROSCI RES, V85, P896, DOI 10.1002/jnr.21168; Julien B, 2005, GASTROENTEROLOGY, V128, P742, DOI 10.1053/j.gastro.2004.12.050; Kaur T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.63; Lim D., 1992, DEV AUDITORY VESTIBU, P33; Lim DJ, 1985, ACTA OTOLARYNGOL S; Maccarrone M, 2008, BRIT J PHARMACOL, V153, P189, DOI 10.1038/sj.bjp.0707444; Mallat A, 2011, BRIT J PHARMACOL, V163, P1432, DOI 10.1111/j.1476-5381.2011.01397.x; McHugh D, 2008, MOL PHARMACOL, V73, P441, DOI 10.1124/mol.107.041863; Mukherjee S, 2004, EUR J PHARMACOL, V505, P1, DOI 10.1016/j.ejphar.2004.09.058; Mukhopadhyay P, 2016, BRIT J PHARMACOL, V173, P446, DOI 10.1111/bph.13338; Mukhopadhyay P, 2010, BRIT J PHARMACOL, V160, P657, DOI 10.1111/j.1476-5381.2010.00769.x; Mukhopadhyay P, 2010, FREE RADICAL BIO MED, V48, P457, DOI 10.1016/j.freeradbiomed.2009.11.022; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Ofek O, 2006, P NATL ACAD SCI USA, V103, P696, DOI 10.1073/pnas.0504187103; Oka S, 2005, J BIOL CHEM, V280, P18488, DOI 10.1074/jbc.M413260200; Osen KK, 2011, HEARING RES, V277, P44, DOI 10.1016/j.heares.2011.03.012; Patil KV, 2015, HEARING RES, V325, P42, DOI 10.1016/j.heares.2015.03.008; Perez-Gomez E, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv077; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Roche R, 2006, HISTOCHEM CELL BIOL, V126, P177, DOI 10.1007/s00418-005-0127-4; Rybak LP, 2007, HEARING RES, V226, P157, DOI 10.1016/j.heares.2006.09.015; Santi PA, 2005, 28 ANN MIDW RES M AS; SHIRE D, 1995, J BIOL CHEM, V270, P3726, DOI 10.1074/jbc.270.8.3726; Stander S, 2005, J DERMATOL SCI, V38, P177, DOI 10.1016/j.jdermsci.2005.01.007; Storr M, 2002, CAN J PHYSIOL PHARM, V80, P67, DOI 10.1139/Y02-005; Toal KL, 2016, HEARING RES, V332, P217, DOI 10.1016/j.heares.2015.09.013; Watanabe K, 2001, ANTICANCER RES; Zheng YW, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00060; Zine A, 1996, BRAIN RES, V721, P49, DOI 10.1016/0006-8993(96)00147-3; Zoratti C, 2003, BRIT J PHARMACOL, V140, P1351, DOI 10.1038/sj.bjp.0705529	44	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161954	10.1371/journal.pone.0161954	http://dx.doi.org/10.1371/journal.pone.0161954			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564061	Green Published, Green Submitted, gold			2022-12-26	WOS:000382496300039
J	Yamakawa, H; Hagiwara, E; Kitamura, H; Yamanaka, Y; Ikeda, S; Sekine, A; Baba, T; Iso, S; Okudela, K; Iwasawa, T; Takemura, T; Kuwano, K; Ogura, T				Yamakawa, Hideaki; Hagiwara, Eri; Kitamura, Hideya; Yamanaka, Yumie; Ikeda, Satoshi; Sekine, Akimasa; Baba, Tomohisa; Iso, Shinichiro; Okudela, Koji; Iwasawa, Tae; Takemura, Tamiko; Kuwano, Kazuyoshi; Ogura, Takashi			Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic Sclerosis	PLOS ONE			English	Article							CONNECTIVE-TISSUE DISEASE; RESOLUTION COMPUTED-TOMOGRAPHY; COLLAGEN VASCULAR-DISEASE; LUNG-DISEASE; PULMONARY-FIBROSIS; AUTOIMMUNE FEATURES; LUPUS-ERYTHEMATOSUS; DISTINCT ENTITY; SOCIETY; MANIFESTATIONS	Background Patients with idiopathic interstitial pneumonias sometimes have a few features of connective tissue disease (CTD) and yet do not fulfil the diagnostic criteria for any specific CTD. Objective This study was conducted to elucidate the characteristics, prognosis, and disease behavior in patients with interstitial lung disease (ILD) associated with systemic sclerosis (SSc)-related autoantibodies. Methods We retrospectively analyzed medical records of 72 ILD patients: 40 patients with SSc (SSc-ILD) and 32 patients with SSc-related autoantibody-positive ILD but not with CTD (ScAb-ILD), indicating lung-dominant CTD with SSc-related autoantibody. Results Patients with SSc-ILD were predominantly females and non-smokers, and most had nonspecific interstitial pneumonia confirmed by high-resolution computed tomography (HRCT) and pathological analysis. However, about half of the patients with ScAb-ILD were male and current or ex-smokers. On HRCT analysis, honeycombing was more predominant in patients with ScAb-ILD than with SSc-ILD. Pathological analysis showed the severity of vascular intimal or medial thickening in the SSc-ILD patients to be significantly higher than that in the ScAb-ILD patients. Survival curves showed that the patients with ScAb-ILD had a significantly poorer outcome than those with SSc-ILD. Conclusion Data from this study suggest that lung-dominant CTD with SSc-related autoantibody is a different disease entity from SSc-ILD.	[Yamakawa, Hideaki; Hagiwara, Eri; Kitamura, Hideya; Yamanaka, Yumie; Ikeda, Satoshi; Sekine, Akimasa; Baba, Tomohisa; Ogura, Takashi] Kanagawa Cardiovasc & Resp Ctr, Dept Resp Med, Yokohama, Kanagawa, Japan; [Iso, Shinichiro] Yokohama Rousai Hosp Labour Welf Corp, Dept Radiol, Yokohama, Kanagawa, Japan; [Okudela, Koji] Yokohama City Univ, Grad Sch Med, Dept Pathobiol, Yokohama, Kanagawa, Japan; [Iwasawa, Tae] Kanagawa Cardiovasc & Resp Ctr, Dept Radiol, Yokohama, Kanagawa, Japan; [Takemura, Tamiko] Japanese Red Cross Med Ctr, Dept Pathol, Tokyo, Japan; [Yamakawa, Hideaki; Kitamura, Hideya; Yamanaka, Yumie; Kuwano, Kazuyoshi] Tokyo Jikei Univ Hosp, Dept Resp Med, Tokyo, Japan	Kanagawa Cardiovascular & Respiratory Center; Yokohama City University; Kanagawa Cardiovascular & Respiratory Center; Japanese Red Cross Medical Center; University of Tokyo; Jikei University	Yamakawa, H (corresponding author), Kanagawa Cardiovasc & Resp Ctr, Dept Resp Med, Yokohama, Kanagawa, Japan.; Yamakawa, H (corresponding author), Tokyo Jikei Univ Hosp, Dept Resp Med, Tokyo, Japan.	hide1144@jikei.ac.jp	Ikeda, Satoshi/P-3144-2015	Ikeda, Satoshi/0000-0001-5203-7911; Yamakawa, Hideaki/0000-0003-2480-6087				American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Aringer M, 2005, RHEUM DIS CLIN N AM, V31, P411, DOI 10.1016/j.rdc.2005.04.007; Best AC, 2008, RADIOLOGY, V246, P935, DOI 10.1148/radiol.2463062200; Cappelli S, 2012, SEMIN ARTHRITIS RHEU, V41, P589, DOI 10.1016/j.semarthrit.2011.07.010; Corte TJ, 2012, EUR RESPIR J, V39, P661, DOI 10.1183/09031936.00174910; Enomoto Y, 2014, RESPIR INVESTIG, V52, P227, DOI 10.1016/j.resinv.2014.02.003; Fischer A, 2015, EUR RESPIR J, V46, P976, DOI 10.1183/13993003.00150-2015; Fischer A, 2012, LANCET, V380, P689, DOI 10.1016/S0140-6736(12)61079-4; Fischer A, 2012, RESP MED, V106, P1040, DOI 10.1016/j.rmed.2012.03.006; Fischer A, 2010, CHEST, V138, P251, DOI 10.1378/chest.10-0194; Flaherty KR, 2003, AM J RESP CRIT CARE, V167, P1410, DOI 10.1164/rccm.200204-373OC; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Goh NSL, 2008, AM J RESP CRIT CARE, V177, P1248, DOI 10.1164/rccm.200706-877OC; Gutsche M, 2012, CURR PULMONOL REP, V1, P224, DOI 10.1007/s13665-012-0028-7; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hasegawa M, 2012, RHEUMATOLOGY, V51, P129, DOI 10.1093/rheumatology/ker333; Hoffmann-Vold AM, 2015, ARTHRITIS RHEUMATOL, V67, P2205, DOI 10.1002/art.39166; Iwasawa T, 2016, JPN J RADIOL, V34, P16, DOI 10.1007/s11604-015-0496-0; Iwasawa T, 2014, AM J ROENTGENOL, V203, pW166, DOI 10.2214/AJR.13.11409; Keane MP, 2000, THORAX, V55, P159, DOI 10.1136/thorax.55.2.159; Kim HC, 2015, CHEST, V147, P165, DOI 10.1378/chest.14-0272; Kinder BW, 2007, AM J RESP CRIT CARE, V176, P691, DOI 10.1164/rccm.200702-220OC; Lynch DA, 2005, AM J RESP CRIT CARE, V172, P488, DOI 10.1164/rccm.200412-1756OC; NIMELSTEIN SH, 1980, MEDICINE, V59, P239, DOI 10.1097/00005792-198007000-00001; Nunes H, 2015, EUR RESPIR J, V45, P746, DOI 10.1183/09031936.00148613; Oldham JM, 2016, EUR RESPIR J, V47, P1767, DOI 10.1183/13993003.01565-2015; Omote N, 2015, CHEST, V148, P1438, DOI 10.1378/chest.14-3174; Reddy TL, 2012, EUR RESPIR J, V40, P377, DOI 10.1183/09031936.00165111; SHARP GC, 1976, NEW ENGL J MED, V295, P1149, DOI 10.1056/NEJM197611182952101; Silver RM, 1996, RHEUM DIS CLIN N AM, V22, P825, DOI 10.1016/S0889-857X(05)70303-3; Smolen JS, 1998, ARTHRITIS RHEUM, V41, P768, DOI 10.1002/1529-0131(199805)41:5<768::AID-ART3>3.0.CO;2-Z; Solomon JJ, 2013, EUR RESPIR REV, V22, P6, DOI 10.1183/09059180.00005512; Song JW, 2009, CHEST, V136, P23, DOI 10.1378/chest.08-2572; Takato H, 2013, RESP MED, V107, P128, DOI 10.1016/j.rmed.2012.09.005; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098; Vij R, 2011, CHEST, V140, P1292, DOI 10.1378/chest.10-2662; Wells AU, 2014, PRESSE MED, V43, pE329, DOI 10.1016/j.lpm.2014.08.002; Winstone TA, 2014, CHEST, V146, P422, DOI 10.1378/chest.13-2626; Yokoyama A, 2006, RESPIROLOGY, V11, P164, DOI 10.1111/j.1440-1843.2006.00834.x	40	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161908	10.1371/journal.pone.0161908	http://dx.doi.org/10.1371/journal.pone.0161908			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564852	Green Published, gold			2022-12-26	WOS:000382496300037
J	Choi, Y; Kim, JO; Shim, SH; Lee, Y; Kim, JH; Jeon, YJ; Ko, JJ; Lee, WS; Kim, NK				Choi, Youngsok; Kim, Jung Oh; Shim, Sung Han; Lee, Yubin; Kim, Ji Hyang; Jeon, Young Joo; Ko, Jung Jae; Lee, Woo Sik; Kim, Nam Keun			Genetic Variation of Methylenetetrahydrofolate Reductase (MTHFR) and Thymidylate Synthase (TS) Genes Is Associated with Idiopathic Recurrent Implantation Failure	PLOS ONE			English	Article							SPONTANEOUSLY ABORTED EMBRYOS; FOLATE METABOLISM; MASS-SPECTROMETRY; CLINICAL APPROACH; POLYMORPHISMS; REGION; PLASMA; CANCER; WOMEN; C677T	The one-carbon metabolism pathway disorder was important role in successful pregnancy. The MTHFR and TS protein were crucial factor in one-carbon metabolism. To investigate the association between recurrent implantation failure (RIF) and enzymes in the one-carbon metabolism pathway. A total of 120 women diagnosed with RIF and 125 control subjects were genotyped for MTHFR 677C>T, 1298A>C, TSER 2R/3R and TS 1494del/ins by a polymerase chain reaction-restriction fragment length polymorphism assay. According to the gene-gene combination analysis, the MTHFR 677/MTHFR 1298 (TT/AA) and MTHFR 677/TS 1494 (TT/6bp6bp) genetic combinations were associated with relatively higher risks [adjusted odds ratio (AOR), 2.764; 95% CI, 1.065-7.174; P = 0.037 and AOR, 3.186; 95% CI, 1.241-8.178; P = 0.016] in RIF patients compared to the CC/AA (MTHFR 677/MTHFR 1298) and TT/6bp6bp (MTHFR 677/TS 1494) combinations, respectively. The results suggested that the combined MTHFR 677/MTHFR 1298 genotype might be associated with increased risk of RIF. To the best of our knowledge, this study is the first to elucidate the potential association of MTHFR, TS and TSER polymorphisms with RIF risk in Korean patients.	[Choi, Youngsok; Kim, Jung Oh; Shim, Sung Han; Jeon, Young Joo; Ko, Jung Jae; Kim, Nam Keun] CHA Univ, Coll Life Sci, Dept Biomed Sci, Songnam, South Korea; [Choi, Youngsok; Shim, Sung Han; Lee, Yubin; Lee, Woo Sik] CHA Univ, CHA Gangnam Med Ctr, Fertil Ctr, Seoul, South Korea; [Kim, Jung Oh; Jeon, Young Joo; Kim, Nam Keun] CHA Univ, Sch Med, CHA Bundang Med Ctr, Inst Clin Res, Songnam, South Korea; [Kim, Ji Hyang] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Obstet & Gynecol, Songnam, South Korea	Pochon Cha University; Pochon Cha University; Pochon Cha University; Pochon Cha University	Kim, NK (corresponding author), CHA Univ, Coll Life Sci, Dept Biomed Sci, Songnam, South Korea.; Lee, WS (corresponding author), CHA Univ, CHA Gangnam Med Ctr, Fertil Ctr, Seoul, South Korea.; Kim, NK (corresponding author), CHA Univ, Sch Med, CHA Bundang Med Ctr, Inst Clin Res, Songnam, South Korea.	wooslee@cha.ac.kr; nkkim@cha.ac.kr		Kim, Jung Oh/0000-0002-4171-2034; Choi, Youngsok/0000-0002-3862-4105	Korea Healthcare technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [HI15C1972010015]; Basic Science Research Program through National Research Foundation of Korea Grants - Korean Government, Republic of Korea [2014R1A2A2A01003994, 2015R1 D1A1A09057432, 2009-0093821];  [20090093821]	Korea Healthcare technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea; Basic Science Research Program through National Research Foundation of Korea Grants - Korean Government, Republic of Korea; 	Support was provided by: HI15C1972010015: [https://www.htdream.kr/]; 2009-0093821: [http://www.nrf.re.kr/]; 2014R1A2A2A01003994: [http://www.nrf.re.kr/]; 2015R1 D1A1A09057432: [http://www.nrf.re.kr/]. This study was partly supported by a grant of the Korea Healthcare technology R&D Project (HI15C1972010015), Ministry for Health, Welfare & Family Affairs, Republic of Korea and by Basic Science Research Program through National Research Foundation of Korea Grants funded by the Korean Government (2009-0093821, 2014R1A2A2A01003994 and 2015R1 D1A1A09057432), Republic of Korea.	Ashworth CJ, 2001, REPRODUCTION, V122, P527, DOI 10.1530/rep.0.1220527; Bae J, 2007, FERTIL STERIL, V87, P351, DOI 10.1016/j.fertnstert.2006.06.027; Bae J, 2009, FERTIL STERIL, V91, P1560, DOI 10.1016/j.fertnstert.2008.09.060; CHU E, 1991, P NATL ACAD SCI USA, V88, P8977, DOI 10.1073/pnas.88.20.8977; Coulam CB, 2009, FERTIL STERIL, V91, P1516, DOI 10.1016/j.fertnstert.2008.07.1782; Ghandour H, 2004, J NUTR, V134, P2975, DOI 10.1093/jn/134.11.2975; GOYETTE P, 1994, NAT GENET, V7, P551, DOI 10.1038/ng0894-551a; HARDY LW, 1987, SCIENCE, V235, P448, DOI 10.1126/science.3099389; Hart DJ, 2002, ANAL BIOCHEM, V305, P206, DOI 10.1006/abio.2002.5662; HORIE N, 1995, CELL STRUCT FUNCT, V20, P191, DOI 10.1247/csf.20.191; Kim JH, 2013, FERTIL STERIL, V99, P1674, DOI 10.1016/j.fertnstert.2013.01.108; Kim NK, 2006, THROMB RES, V117, P653, DOI 10.1016/j.thromres.2005.05.025; Kobashi G, 2005, SEMIN THROMB HEMOST, V31, P266, DOI 10.1055/s-2005-872430; Laufer N, 2012, FERTIL STERIL, V97, P1019, DOI 10.1016/j.fertnstert.2012.03.033; Margalioth EJ, 2006, HUM REPROD, V21, P3036, DOI 10.1093/humrep/del305; Nazki FH, 2014, GENE, V533, P11, DOI 10.1016/j.gene.2013.09.063; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; Park HM, 2008, FERTIL STERIL, V90, P1605, DOI 10.1016/j.fertnstert.2007.09.046; Peters GJ, 2002, BBA-MOL BASIS DIS, V1587, P194, DOI 10.1016/S0925-4439(02)00082-0; Poursadegh Zonouzi A, 2012, ISRN OBSTET GYNECOL, V2012, DOI DOI 10.5402/2012/945486; Rah H, 2012, MENOPAUSE, V19, P1260, DOI 10.1097/gme.0b013e3182556b08; Reilly R, 2013, P NUTR SOC, P1; Rotondo JC, 2012, HUM REPROD, V27, P3632, DOI 10.1093/humrep/des319; Rozen R, 1997, THROMB HAEMOSTASIS, V78, P523; Safdarian Leila, 2014, Iran J Reprod Med, V12, P467; Simon A, 2012, FERTIL STERIL, V97, P1039, DOI 10.1016/j.fertnstert.2012.03.010; Smith DEC, 2006, CLIN CHEM LAB MED, V44, P450, DOI 10.1515/CCLM.2006.085; Stephenson MD, 2000, FERTIL STERIL, V74, P1108, DOI 10.1016/S0015-0282(00)01622-8; Taparia S, 2007, CLIN CHEM LAB MED, V45, P1717, DOI 10.1515/CCLM.2007.345; Ulrich CM, 2000, CANCER EPIDEM BIOMAR, V9, P1381; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Yajnik CS, 2012, REV ENDOCR METAB DIS, V13, P121, DOI 10.1007/s11154-012-9214-8; Yamada K, 2001, P NATL ACAD SCI USA, V98, P14853, DOI 10.1073/pnas.261469998; Yang Y, 2016, ARCH GYNECOL OBSTET, V293, P1197, DOI 10.1007/s00404-015-3944-2; Yim DJ, 2010, ANTICANCER RES, V30, P2325; Zhou JY, 2012, INT J CANCER, V131, P2103, DOI 10.1002/ijc.27465	36	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0160884	10.1371/journal.pone.0160884	http://dx.doi.org/10.1371/journal.pone.0160884			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560137	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258600018
J	Connahs, H; Rhen, T; Simmons, RB				Connahs, Heidi; Rhen, Turk; Simmons, Rebecca B.			Physiological Perturbation Reveals Modularity of Eyespot Development in the Painted Lady Butterfly, Vanessa cardui	PLOS ONE			English	Article							COLOR-PATTERN MODIFICATIONS; PRECIS-COENIA LEPIDOPTERA; PHENOTYPIC PLASTICITY; POSITIONAL INFORMATION; BICYCLUS-ANYNANA; DISTAL-LESS; WING PATTERNS; EVOLUTION; INTEGRATION; NYMPHALIDAE	Butterfly eyespots are complex morphological traits that can vary in size, shape and color composition even on the same wing surface. Homology among eyespots suggests they share a common developmental basis and function as an integrated unit in response to selection. Despite strong evidence of genetic integration, eyespots can also exhibit modularity or plasticity, indicating an underlying flexibility in pattern development. The extent to which particular eyespots or eyespot color elements exhibit modularity or integration is poorly understood, particularly following exposure to novel conditions. We used perturbation experiments to explore phenotypic correlations among different eyespots and their color elements on the ventral hindwing of V. cardui. Specifically, we identified which eyespots and eyespot features are most sensitive to perturbation by heat shock and injection of heparin-a cold shock mimic. For both treatments, the two central eyespots (3 + 4) were most affected by the experimental perturbations, whereas the outer eyespot border was more resistant to modification than the interior color elements. Overall, the individual color elements displayed a similar response to heat shock across all eyespots, but varied in their response to each other. Graphical modeling also revealed that although eyespots differ morphologically, regulation of eyespot size and colored elements appear to be largely integrated across the wing. Patterns of integration, however, were disrupted following heat shock, revealing that the strength of integration varies across the wing and is strongest between the two central eyespots. These findings support previous observations that document coupling between eyespots 3 + 4 in other nymphalid butterflies.	[Connahs, Heidi; Rhen, Turk; Simmons, Rebecca B.] Univ North Dakota, Dept Biol, Grand Forks, ND 58202 USA; [Connahs, Heidi] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore	University of North Dakota Grand Forks; National University of Singapore	Connahs, H (corresponding author), Univ North Dakota, Dept Biol, Grand Forks, ND 58202 USA.; Connahs, H (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore.	hconnahs@gmail.com		Simmons, Rebecca/0000-0003-0718-6461; Connahs, Heidi/0000-0002-6615-5668	National Science Foundation North Dakota; Experimental Program to Stimulate Competitive Research, EPSCoR Doctoral Dissertation Award grant [EPS-0184442]; Adele Lewis Grant Fellowship; Graduate Women in Science; Diana Wheeler Award (Biology Department, University of North Dakota); Summer Research Fellowship (School of Graduate Studies, University of North Dakota); undergraduate National Science Foundation [EPS-0814442, UND0018877]; National Science Foundation Research Experience for Undergraduates [0851869]; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM103442]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103442] Funding Source: NIH RePORTER; Direct For Biological Sciences [1359243] Funding Source: National Science Foundation	National Science Foundation North Dakota; Experimental Program to Stimulate Competitive Research, EPSCoR Doctoral Dissertation Award grant; Adele Lewis Grant Fellowship; Graduate Women in Science; Diana Wheeler Award (Biology Department, University of North Dakota); Summer Research Fellowship (School of Graduate Studies, University of North Dakota); undergraduate National Science Foundation; National Science Foundation Research Experience for Undergraduates(National Science Foundation (NSF)); Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided to HC by National Science Foundation North Dakota (http://www.nsf.gov/od/oia/programs/epscor/index.jsp), Experimental Program to Stimulate Competitive Research, EPSCoR Doctoral Dissertation Award grant #EPS-0184442, Funding provided to HC by an Adele Lewis Grant Fellowship, Graduate Women in Science (http://www.gwis.org/), Funding provided to HC by Diana Wheeler Award (Biology Department, University of North Dakota), Funding provided to HC by a Summer Research Fellowship (School of Graduate Studies, University of North Dakota). KC was supported by an undergraduate National Science Foundation (www.nsf.gov/awardsearch/showAward?AWD_ID=0418889) AURA award through grant #EPS-0814442, project #UND0018877. WR was supported through the National Science Foundation (http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5517&from=fund) Research Experience for Undergraduates Grant 0851869 and by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (http://www.nigms.nih.gov/Research/CRCB/IDeA/Pages/default.aspx) under grant number P20GM103442. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi R, 2015, J EVOLUTION BIOL, V28, P2009, DOI 10.1111/jeb.12716; Allen CE, 2008, J EXP BIOL, V190, P179; Beldade P, 2002, NATURE, V415, P315, DOI 10.1038/415315a; Beldade P, 2003, EVOL DEV, V5, P169, DOI 10.1046/j.1525-142X.2003.03025.x; Beldade P, 2002, P NATL ACAD SCI USA, V99, P14262, DOI 10.1073/pnas.222236199; Beldade P, 2008, J EXP ZOOL PART B, V310B, P191, DOI 10.1002/jez.b.21173; Binari RC, 1997, DEVELOPMENT, V124, P2623; Brakefield PM, 1999, BIOESSAYS, V21, P391, DOI 10.1002/(SICI)1521-1878(199905)21:5&lt;391::AID-BIES6&gt;3.0.CO;2-Q; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; Brakefield PM, 2003, ZOOLOGY, V106, P283, DOI 10.1078/0944-2006-00124; Brakefield PM, 2001, J EXP ZOOL, V291, P93, DOI 10.1002/jez.1062; Brakefield PM, 1998, AM NAT, V152, P853, DOI 10.1086/286213; Brakefield PM, 1996, TRENDS ECOL EVOL, V11, P275, DOI 10.1016/0169-5347(96)30025-6; Brunetti CR, 2001, CURR BIOL, V11, P1578, DOI 10.1016/S0960-9822(01)00502-4; CARROLL SB, 1994, SCIENCE, V265, P109, DOI 10.1126/science.7912449; Dilao R, 2004, P ROY SOC B-BIOL SCI, V271, P1565, DOI 10.1098/rspb.2004.2761; FRENCH V, 1995, DEV BIOL, V168, P112, DOI 10.1006/dbio.1995.1065; Gibbs M, 2006, ENTOMOL EXP APPL, V118, P41, DOI 10.1111/j.1570-7458.2006.00361.x; Gibert JM, 2007, PLOS GENET, V3, P266, DOI 10.1371/journal.pgen.0030030; Green JBA, 2015, DEVELOPMENT, V142, P1203, DOI 10.1242/dev.114991; Hiyama Atsuki, 2012, Frontiers in Genetics, V3, P15, DOI 10.3389/fgene.2012.00015; Ho S, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150614; Keys DN, 1999, SCIENCE, V283, P532, DOI 10.1126/science.283.5401.532; Klingenberg CP, 2008, ANNU REV ECOL EVOL S, V39, P115, DOI 10.1146/annurev.ecolsys.37.091305.110054; Koch PB, 2003, DEV GENES EVOL, V212, P571, DOI 10.1007/s00427-002-0277-5; Kodandaramaiah U, 2009, EVOL DEV, V11, P489, DOI 10.1111/j.1525-142X.2009.00357.x; Magwene PM, 2001, EVOLUTION, V55, P1734; Mahdi SHA, 2011, J THERM BIOL, V36, P312, DOI 10.1016/j.jtherbio.2011.06.002; Martin A, 2014, DEV BIOL, V395, P367, DOI 10.1016/j.ydbio.2014.08.031; Martin A, 2012, P NATL ACAD SCI USA, V109, P12632, DOI 10.1073/pnas.1204800109; Mateus ARA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0097-x; Moczek AP, 2010, PHILOS T R SOC B, V365, P593, DOI 10.1098/rstb.2009.0263; Montague MJ, 2012, BEHAV ECOL, P342; Monteiro A, 1997, J EVOLUTION BIOL, V10, P787, DOI 10.1007/s000360050054; Monteiro A, 1997, EVOLUTION, V51, P1207, DOI 10.1111/j.1558-5646.1997.tb03968.x; Monteiro A, 2003, EVOL DEV, V5, P180, DOI 10.1046/j.1525-142X.2003.03029.x; MONTEIRO AF, 1994, EVOLUTION, V48, P1147, DOI [10.1111/j.1558-5646.1994.tb05301.x, 10.2307/2410374]; Monteiro A, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-22; Monteiro A, 2015, ANNU REV ENTOMOL, V60, P253, DOI 10.1146/annurev-ento-010814-020942; Monteiro A, 2013, J EXP ZOOL PART B, V320B, P321, DOI 10.1002/jez.b.22503; Morange M, 2009, J BIOSCIENCES, V34, P495, DOI 10.1007/s12038-009-0068-5; Murren CJ, 2002, AM J BOT, V89, P655, DOI 10.3732/ajb.89.4.655; NIJHOUT HF, 1980, DEV BIOL, V80, P267, DOI 10.1016/0012-1606(80)90403-0; NIJHOUT HF, 1984, J EMBRYOL EXP MORPH, V81, P287; Nijhout HF, 1996, NATURE, V384, P209, DOI 10.1038/384209a0; Oliver JC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3262; Oliver JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065830; Oliver JC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002893; Otaki JM, 2005, ZOOL SCI, V22, P635, DOI 10.2108/zsj.22.635; Otaki JM, 2004, ZOOL SCI, V21, P967, DOI 10.2108/zsj.21.967; Otaki JM, 1998, J INSECT PHYSIOL, V44, P1181, DOI 10.1016/S0022-1910(98)00083-3; Otaki Joji M., 2008, Transactions of the Lepidopterological Society of Japan, V59, P87; Otaki JM, 2008, J INSECT PHYSIOL, V54, P1099, DOI 10.1016/j.jinsphys.2008.05.006; Otaki JM, 2007, ZOOL SCI, V24, P811, DOI 10.2108/zsj.24.811; Otaki JM, 2007, J INSECT PHYSIOL, V53, P526, DOI 10.1016/j.jinsphys.2007.02.005; Otaki JM, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-17; Otaki JM, 2011, ZOOL SCI, V28, P403, DOI 10.2108/zsj.28.403; PAULSEN SM, 1993, EVOLUTION, V47, P593, DOI 10.1111/j.1558-5646.1993.tb02115.x; Plaistow SJ, 2004, J EVOLUTION BIOL, V27, P1913; Prudic KL, 2011, SCIENCE, V331, P73, DOI 10.1126/science.1197114; Reed RD, 2007, EVOL DEV, V9, P2, DOI 10.1111/j.1525-142X.2006.00133.x; SCHLICHTING CD, 1989, OECOLOGIA, V78, P496, DOI 10.1007/BF00378740; Serfas MS, 2005, DEV BIOL, V287, P416, DOI 10.1016/j.ydbio.2005.09.014; Snell-Rood EC, 2010, BIOESSAYS, V32, P71, DOI 10.1002/bies.200900132; Stevens M, 2008, BEHAV ECOL, V19, P525, DOI 10.1093/beheco/arm162; Takayama E, 1997, DEV GROWTH DIFFER, V39, P23, DOI 10.1046/j.1440-169X.1997.00004.x; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Yan D, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002493	68	5	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161745	10.1371/journal.pone.0161745	http://dx.doi.org/10.1371/journal.pone.0161745			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560365	Green Published, gold			2022-12-26	WOS:000382258600090
J	Ichikura, K; Okumura, Y; Takeuchi, T				Ichikura, Kanako; Okumura, Yasuyuki; Takeuchi, Takashi			Associations of Adverse Clinical Course and Ingested Substances among Patients with Deliberate Drug Poisoning: A Cohort Study from an Intensive Care Unit in Japan	PLOS ONE			English	Article							ASPIRATION PNEUMONITIS; RISK-FACTORS; OVERDOSE; HOSPITALS; ADMISSION; OUTCOMES; IMPACT; OSLO	Objectives Some patients with deliberate drug poisoning subsequently have an adverse clinical course. The present study aimed to examine whether the type of drugs ingested and psychiatric diagnoses were related to an adverse clinical course. Methods We conducted a cohort study of patients with deliberate drug poisoning admitted to the intensive care unit of a university hospital located in Tokyo, Japan, between September 2006 and June 2013. Intensive care unit (ICU) stay of >= 4 days was used as a primary outcome measure, while the incidence of aspiration pneumonitis was used as a secondary outcome measure. Ingested substances and psychiatric diagnoses were used as explanatory variables. Results Of the 676 patients with deliberate drug poisoning, 88% had a history of psychiatric treatment and 82% had ingested psychotropic drugs. Chlorpromazine-promethazine-phenobarbital combination drug (Vegetamin (R)) ranked fifth among the most frequently ingested substances in cases of deliberate drug poisoning and had the highest incidence of prolonged ICU stay (20%) and aspiration pneumonitis (29%). The top three major classes consisted of benzodiazepines (79%), new-generation antidepressants (25%), and barbiturates/non-barbiturates (23%). Barbiturate overdose was independently associated with increased odds of both prolonged ICU stay (8% vs. 17%; odds ratio [OR], 2.97; 95% confidence interval [CI], 1.60-5.55) and aspiration pneumonitis (8% vs. 24%; OR, 3.83; 95% CI, 2.18-6.79) relative to those associated with overdose of only other sedative-hypnotics (i.e., benzodiazepines). Conclusion These results suggest that judicious prescribing of barbiturates by psychiatrists could reduce the risk of an adverse clinical course when a patient attempts an overdose.	[Ichikura, Kanako] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Liaison Psychiat & Palliat Med, Tokyo, Japan; [Ichikura, Kanako; Okumura, Yasuyuki] Assoc Hlth Econ Res & Social Insurance & Welf, Inst Hlth Econ & Policy, Res Dept, Tokyo, Japan; [Takeuchi, Takashi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Psychiat & Behav Sci, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Okumura, Y (corresponding author), Assoc Hlth Econ Res & Social Insurance & Welf, Inst Hlth Econ & Policy, Res Dept, Tokyo, Japan.	yokumura@blue.zero.jp		Okumura, Yasuyuki/0000-0001-5851-8919	 [26870914]; Grants-in-Aid for Scientific Research [26870914] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding for this study was provided by a Grant-in-Aid for Young Scientists (B) (No. 26870914) by the Japan Society for the Promotion of Science. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando S, 2009, CLIN PSYCHIATR, V51, P749; Ando S, 2014, PSYCHIAT CLIN NEUROS, V68, P721, DOI 10.1111/pcn.12198; BOUKNIGHT RR, 1986, J FAM PRACTICE, V23, P223; Christ A, 2006, INTENS CARE MED, V32, P1423, DOI 10.1007/s00134-006-0277-4; Dobson AJ, 2008, AN INTRODUCTION TO G; Eddleston M, 2002, LANCET, V360, P1163, DOI 10.1016/S0140-6736(02)11204-9; Eyer F, 2009, HUM EXP TOXICOL, V28, P511, DOI 10.1177/0960327109106970; Foundation for Promotion of Cancer Research, 2014, CANC STAT JAP 2014; Hendrix L, 2013, EMERG MED J, V30, DOI 10.1136/emermed-2011-201033; Heyerdahl F, 2009, BRIT J PSYCHIAT, V194, P73, DOI 10.1192/bjp.bp.107.048322; Hirata K, 1998, JPN J HOSP PHARM, V24, P340, DOI DOI 10.5649/JJPHCS1975.24.340; Hovda KE, 2008, CLIN TOXICOL, V46, P35, DOI 10.1080/15563650601185969; Isbister GK, 2004, CRIT CARE MED, V32, P88, DOI 10.1097/01.CCM.0000104207.42729.E4; Kamijo Y, 2007, PSYCHIATRY, V10, P297; Liisanantti J, 2003, RESUSCITATION, V56, P49, DOI 10.1016/S0300-9572(02)00284-8; Mactier R, 2014, AM J KIDNEY DIS, V64, P347, DOI 10.1053/j.ajkd.2014.04.031; Maignan M, 2014, BASIC CLIN PHARMACOL, V114, P281, DOI 10.1111/bcpt.12132; Manini AF, 2015, ACAD EMERG MED, V22, P499, DOI 10.1111/acem.12658; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; Mowry JB, 2013, CLIN TOXICOL, V51, P949, DOI 10.3109/15563650.2013.863906; Novack V, 2006, EUR J INTERN MED, V17, P485, DOI 10.1016/j.ejim.2006.02.029; Okumura Y, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001857; Okumura Y, 2012, GEN HOSP PSYCHIAT, V34, P681, DOI 10.1016/j.genhosppsych.2012.07.009; Prescott K, 2009, BRIT J CLIN PHARMACO, V68, P260, DOI 10.1111/j.1365-2125.2009.03458.x; Schwake L, 2009, INTENS CARE MED, V35, P266, DOI 10.1007/s00134-008-1250-1; Shimizu S., 2015, JPN J CLIN PHARM, V18, P1173; Tournier M, 2009, PHARMACOPSYCHIATRY, V42, P51, DOI 10.1055/s-0028-1100426; Varnik A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-61; Wada K, 2009, JAPANESE J GEN HOSP, V21, P258; Wilkinson S, 2002, J PUBLIC HEALTH MED, V24, P179, DOI 10.1093/pubmed/24.3.179; Xiang YX, 2012, AM J EMERG MED, V30, P293, DOI 10.1016/j.ajem.2010.11.031; Zyoud SH, 2010, HUM PSYCHOPHARM CLIN, V25, P500, DOI 10.1002/hup.1140	32	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161996	10.1371/journal.pone.0161996	http://dx.doi.org/10.1371/journal.pone.0161996			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560966	gold, Green Submitted, Green Published			2022-12-26	WOS:000382258600125
J	Schuijs, MJ; Hartmann, S; Selkirk, ME; Roberts, LB; Openshaw, PJM; Schnoeller, C				Schuijs, Martijn J.; Hartmann, Susanne; Selkirk, Murray E.; Roberts, Luke B.; Openshaw, Peter J. M.; Schnoeller, Corinna			The Helminth-Derived Immunomodulator AvCystatin Reduces Virus Enhanced Inflammation by Induction of Regulatory IL-10(+) T Cells	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; PRETERM INFANTS; 1ST YEAR; RESPONSES; INFECTION; DISEASE; ALLERGY; RSV; SUPPRESSION; MECHANISM	Respiratory Syncytial Virus (RSV) is a major pathogen causing low respiratory tract disease (bronchiolitis), primarily in infants. Helminthic infections may alter host immune responses to both helminths and to unrelated immune triggers. For example, we have previously shown that filarial cystatin (AvCystatin/Av17) ameliorates allergic airway inflammation. However, helminthic immunomodulators have so far not been tested in virus-induced disease. We now report that AvCystatin prevents Th2-based immunopathology in vaccine-enhanced RSV lung inflammation, a murine model for bronchiolitis. AvCystatin ablated eosinophil influx, reducing both weight loss and neutrophil recruitment without impairing anti-viral immune responses. AvCystatin also protected mice from excessive inflammation following primary RSV infection, significantly reducing neutrophil influx and cytokine production in the airways. Interestingly, we found that AvCystatin induced an influx of CD4(+) FoxP3(+) interleukin-10-producing T cells in the airway and lungs, correlating with immuno-protection, and the corresponding cells could also be induced by adoptive transfer of AvCystatin-primed F4/80(+) macrophages. Thus, AvCystatin ameliorates enhanced RSV pathology without increasing susceptibility to, or persistence of, viral infection and warrants further investigation as a possible therapy for virus-induced airway disease.	[Schuijs, Martijn J.; Openshaw, Peter J. M.; Schnoeller, Corinna] Imperial Coll London, Natl Heart & Lung Inst, Div Resp Sci, London, England; [Selkirk, Murray E.; Roberts, Luke B.; Schnoeller, Corinna] Imperial Coll London, Dept Life Sci, London, England; [Hartmann, Susanne] Free Univ Berlin, Inst Immunol, Ctr Infect Med, Berlin, Germany; [Schuijs, Martijn J.] VIB Inflammat Res Ctr, Lab Immunoregulat & Mucosal Immunol, Ghent, Belgium; [Schuijs, Martijn J.] Univ Ghent, Dept Resp Med, Ghent, Belgium	Imperial College London; Imperial College London; Free University of Berlin; Flanders Institute for Biotechnology (VIB); Ghent University	Openshaw, PJM; Schnoeller, C (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Div Resp Sci, London, England.; Schnoeller, C (corresponding author), Imperial Coll London, Dept Life Sci, London, England.	p.openshaw@imperial.ac.uk; c.schnoeller@imperial.ac.uk	Openshaw, Peter/AAL-9442-2020	Openshaw, Peter/0000-0002-7220-2555; Roberts, Luke/0000-0003-1143-304X; Selkirk, Murray/0000-0002-6274-6014	Wellcome Trust Program [087805/Z/08/Z]; Erasmus Placement grant from the European Commission Life-Long Learning programme [UU-ER/2010/010744]; Medical Research Council [G1000758] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10150] Funding Source: researchfish; Asthma UK [MRC-Asthma UK Centre, MRC-AsthmaUKCentre] Funding Source: researchfish	Wellcome Trust Program(Wellcome Trust); Erasmus Placement grant from the European Commission Life-Long Learning programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK	This study was supported by a Wellcome Trust Program grant to PO (087805/Z/08/Z). MJS was supported by an Erasmus Placement grant (UU-ER/2010/010744) from the European Commission Life-Long Learning programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a Wellcome Trust Program grant to PO (087805/Z/08/Z). MJS was supported by an Erasmus Placement grant (UU-ER/2010/010744) from the European Commission Life-Long Learning program.	Blanken MO, 2013, NEW ENGL J MED, V368, P1791, DOI 10.1056/NEJMoa1211917; Boeckh M, 2010, AM J RESP CRIT CARE, V182, P1217, DOI 10.1164/rccm.201008-1230ED; Danilowicz-Luebert E, 2013, INT J PARASITOL, V43, P201, DOI 10.1016/j.ijpara.2012.10.014; Danilowicz-Luebert E, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/821578; Dienz O, 2012, MUCOSAL IMMUNOL, V5, P258, DOI 10.1038/mi.2012.2; Dodd JS, 2009, J IMMUNOL, V183, P7006, DOI 10.4049/jimmunol.0900085; Durant LR, 2013, J VIROL, V87, P10946, DOI 10.1128/JVI.01295-13; Edwards MJ, 2005, J IMMUNOL, V175, P6275, DOI 10.4049/jimmunol.175.10.6275; Erb KJ, 2009, TRENDS IMMUNOL, V30, P75, DOI 10.1016/j.it.2008.11.005; Fallon PG, 2007, NAT REV IMMUNOL, V7, P220, DOI 10.1038/nri2039; Geerdink RJ, 2015, J ALLERGY CLIN IMMUN, V136, P838, DOI 10.1016/j.jaci.2015.06.034; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Guvenel AK, 2014, EXPERT REV VACCINES, V13, P333, DOI 10.1586/14760584.2014.878653; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Hartmann S, 2009, CLIN EXP ALLERGY, V39, P1585, DOI 10.1111/j.1365-2222.2009.03290.x; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Kamal SM, 2006, PARASITE IMMUNOL, V28, P483, DOI 10.1111/j.1365-3024.2006.00909.x; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Kitagaki K, 2006, J IMMUNOL, V177, P1628, DOI 10.4049/jimmunol.177.3.1628; Klotz C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001248; Lee DCP, 2010, J VIROL, V84, P8790, DOI 10.1128/JVI.00796-10; Loebbermann J, 2012, MUCOSAL IMMUNOL, V5, P161, DOI 10.1038/mi.2011.62; Loebbermann J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032371; Mahadevia Parthiv J, 2012, J Med Econ, V15, P987, DOI 10.3111/13696998.2012.690013; Maizels RM, 2014, CLIN EXP IMMUNOL, V177, P38, DOI 10.1111/cei.12353; Maizels Rick M., 2008, V94, P112, DOI 10.1159/000154944; Mills KHG, 2014, AM J RESP CRIT CARE, V189, P126, DOI 10.1164/rccm.201312-2158ED; Moghaddam A, 2006, NAT MED, V12, P905, DOI 10.1038/nm1456; Nagata DED, 2015, MUCOSAL IMMUNOL, V8, P1131, DOI 10.1038/mi.2015.4; Openshaw PJ, 2013, CURR OPIN VIROL, V3, P468, DOI 10.1016/j.coviro.2013.05.005; OPENSHAW PJM, 1992, INT IMMUNOL, V4, P493, DOI 10.1093/intimm/4.4.493; Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942; Pribul PK, 2008, J VIROL, V82, P4441, DOI 10.1128/JVI.02541-07; Reese TA, 2014, SCIENCE, V345, P573, DOI 10.1126/science.1254517; Schnoeller C, 2008, J IMMUNOL, V180, P4265, DOI 10.4049/jimmunol.180.6.4265; Schnoeller C, 2014, AM J RESP CRIT CARE, V189, P194, DOI [10.1164/rccm.201307-1227OC, 10.1164/rccm.201307-227OC]; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Shor DB, 2013, CLIN REV ALLERG IMMU, V45, P211, DOI 10.1007/s12016-012-8352-9; Sigurs N, 2010, THORAX, V65, P1045, DOI 10.1136/thx.2009.121582; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Stewart DL, 2009, CURR MED RES OPIN, V25, P2795, DOI 10.1185/03007990903290894; Sun J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002173; Weiss KA, 2011, J IMMUNOL, V187, P3145, DOI 10.4049/jimmunol.1100764; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572; Xie XH, 2012, INFLAMMATION, V35, P1392, DOI 10.1007/s10753-012-9452-7; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490; Ziegler T, 2015, J IMMUNOL, V194, P1555, DOI 10.4049/jimmunol.1401217	47	13	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161885	10.1371/journal.pone.0161885	http://dx.doi.org/10.1371/journal.pone.0161885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560829	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258600113
J	Zhang, LH; Chen, J; Wang, M; Li, YJ; Xue, SW; Tang, YY; Sun, BL				Zhang, Lanhua; Chen, Juan; Wang, Mei; Li, Yujuan; Xue, Shaowei; Tang, Yiyuan; Sun, Baoliang			Topology Universality and Dissimilarity in a Class of Scale-Free Networks	PLOS ONE			English	Article							COMPLEX NETWORKS	We study the effect of subtle changes on the evolution in the scale-free (SF) networks. Three extended models are evolved based on competition and inner anti-preferential deletion in growth and preferential attachment processes. By nonlinear and dynamic controlling on randomness and determinacy, three models can self-organize into scale-free networks, and diverse scaling exponents appear. Moreover, the model with more determinacy has more stringent parameter control than randomness, especially in the edge deletion. Our results suggest that the nature of the topology universality and dissimilarity in SF networks may be the subtle changes of randomness and determinacy.	[Zhang, Lanhua; Chen, Juan; Wang, Mei; Li, Yujuan] Taishan Med Univ, Coll Informat & Engn, Tai An 271016, Shandong, Peoples R China; [Xue, Shaowei] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Dept Psychol, Hangzhou 310036, Zhejiang, Peoples R China; [Tang, Yiyuan] Texas Tech Univ, Dept Psychol Sci, Lubbock, TX 79409 USA; [Sun, Baoliang] Taishan Med Univ, Key Lab Cerebral Microcirculat Univ Shandong, Tai An 271016, Shandong, Peoples R China; [Sun, Baoliang] Taishan Med Univ, Affiliated Hosp, Dept Neurol, Tai An 271000, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Hangzhou Normal University; Texas Tech University System; Texas Tech University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences	Sun, BL (corresponding author), Taishan Med Univ, Key Lab Cerebral Microcirculat Univ Shandong, Tai An 271016, Shandong, Peoples R China.; Sun, BL (corresponding author), Taishan Med Univ, Affiliated Hosp, Dept Neurol, Tai An 271000, Shandong, Peoples R China.	blsun88@163.com	li, yu/HGL-9518-2022; Xue, Shao-Wei/AAA-1384-2022; Li, yu/HHZ-5236-2022	Xue, Shao-Wei/0000-0001-5441-4522	Natural Science Foundation of China [81471212, 81271275]; Natural Science Foundation of Shandong [ZR2013FL031]; Institutes of Higher Education Science and Technique Foundation of Shandong Province [J15LE12]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province); Institutes of Higher Education Science and Technique Foundation of Shandong Province	This research was supported by the Natural Science Foundation of China (Grant No. 81471212 and No. 81271275), the Natural Science Foundation of Shandong (Grant No. ZR2013FL031), and the Institutes of Higher Education Science and Technique Foundation of Shandong Province (Grant No. J15LE12).	Albert R, 2000, PHYS REV LETT, V85, P5234, DOI 10.1103/PhysRevLett.85.5234; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Anishchenko A, 2006, J PHYSIOL-PARIS, V100, P225, DOI 10.1016/j.jphysparis.2007.01.004; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bianconi G, 2001, EUROPHYS LETT, V54, P436, DOI 10.1209/epl/i2001-00260-6; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Cao HD, 2014, CHAOS, V24, DOI 10.1063/1.4868258; Chen QH, 2004, PHYSICA A, V335, P240, DOI 10.1016/j.physa.2003.12.014; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Dorogovtsev SN, 2000, PHYS REV E, V62, P1842, DOI 10.1103/PhysRevE.62.1842; Dorogovtsev SN, 2002, ADV PHYS, V51, P1079, DOI 10.1080/00018730110112519; ERDOS P, 1960, B INT STATIST INST, V38, P343; Fischer J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117312; Liu Q, 2014, FRONT PHYS-BEIJING, V9, P240, DOI 10.1007/s11467-013-0389-6; Luo C, 2014, SCI REP-UK, V4, DOI 10.1038/srep07522; Luo C, 2014, CHAOS, V24, DOI 10.1063/1.4887278; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; Niizato T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127284; Papalexakis E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151027; Stefan B, 2003, HDB GRAPHS NETWORKS; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Takemoto K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157868; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhang LH, 2014, NONLINEAR DYNAM, V76, P1569, DOI 10.1007/s11071-013-1229-5; Zhang LH, 2012, NONLINEAR DYNAM, V69, P1517, DOI 10.1007/s11071-012-0366-6	25	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161653	10.1371/journal.pone.0161653	http://dx.doi.org/10.1371/journal.pone.0161653			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560938	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258600074
J	Antignani, A; Griner, LM; Guha, R; Simon, N; Pasetto, M; Keller, J; Huang, M; Angelus, E; Pastan, I; Ferrer, M; FitzGerald, DJ; Thomas, CJ				Antignani, Antonella; Griner, Lesley Mathews; Guha, Rajarshi; Simon, Nathan; Pasetto, Matteo; Keller, Jonathan; Huang, Manjie; Angelus, Evan; Pastan, Ira; Ferrer, Marc; FitzGerald, David J.; Thomas, Craig J.			Chemical Screens Identify Drugs that Enhance or Mitigate Cellular Responses to Antibody-Toxin Fusion Proteins	PLOS ONE			English	Article							PHASE-I TRIAL; IMMUNOTOXIN RFB4(DSFV)-PE38 BL22; ADP-RIBOSYLATING TOXINS; ANTIMESOTHELIN IMMUNOTOXIN; PSEUDOMONAS EXOTOXIN; CANCER-CELLS; CLINICAL-EXPERIENCE; BREAST-CANCER; SS1P; COMBINATION	The intersection of small molecular weight drugs and antibody-based therapeutics is rarely studied in large scale. Both types of agents are currently part of the cancer armamentarium. However, very little is known about how to combine them in optimal ways. Immunotoxins are antibody-toxin gene fusion proteins engineered to target cancer cells via antibody binding to surface antigens. For fusion proteins derived from Pseudomonas exotoxin (PE), potency relies on the enzymatic domain of the toxin which catalyzes the ADP-ribosylation of EF2 causing inhibition of protein synthesis leading to cell death. Candidate immunotoxins have demonstrated clear value in clinical trials but generally have not been curative as single agents. Therefore we undertook three screens to discover effective combinations that could act synergistically. From the MIPE-3 library of compounds we identified various enhancers of immunotoxin action and at least one major class of inhibitor. Follow-up experiments confirmed the screening data and suggested that immunotoxins when administered with everolimus or nilotinib exhibit favorable combinatory activity and would be candidates for preclinical development. Mechanistic studies revealed that everolimus-immunotoxin combinations acted synergistically on elements of the protein synthetic machinery, including S61 kinase and 4E-BP1 of the mTORC1 pathway. Conversely, PARP inhibitors antagonized immunotoxins and also blocked the toxicity due to native ADP-ribosylating toxins. Thus, our goal of investigating a chemical library was justified based on the identification of several approved compounds that could be developed preclinically as 'enhancers' and at least one class of mitigator to be avoided.	[Antignani, Antonella; Simon, Nathan; Pasetto, Matteo; Huang, Manjie; Angelus, Evan; Pastan, Ira; FitzGerald, David J.] NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA; [Griner, Lesley Mathews; Guha, Rajarshi; Keller, Jonathan; Ferrer, Marc; Thomas, Craig J.] NIH, Div Preclin Innovat, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA; [Pasetto, Matteo] Univ Verona, Dept Pathol, Verona, Italy	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University of Verona	FitzGerald, DJ (corresponding author), NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA.; Thomas, CJ (corresponding author), NIH, Div Preclin Innovat, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA.	fitzgerd@helix.nih.gov; craigt@mail.nih.gov	pastan, ira/P-9319-2019	pastan, ira/0000-0002-9223-0270; Thomas, Craig/0000-0001-9386-9001	National Cancer Institute; National Center for Advancing Translational Sciences; NATIONAL CANCER INSTITUTE [ZIABC008757] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the intramural programs of the National Cancer Institute and the National Center for Advancing Translational Sciences. There are no grant or award numbers as the funding is "in-house".	Ali-Rahmani F, 2016, CANCER RES, V76, P1560, DOI 10.1158/0008-5472.CAN-15-2401; Andersson Y, 2004, INT J CANCER, V112, P475, DOI 10.1002/ijc.20371; Antignani A, 2014, MOL CANCER THER, V13, P1655, DOI 10.1158/1535-7163.MCT-13-0998; Atkins MB, 2009, NAT REV DRUG DISCOV, V8, P535, DOI 10.1038/nrd2924; Callaway T R, 2003, Curr Issues Intest Microbiol, V4, P43; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; Du X, 2011, CLIN CANCER RES, V17, P5926, DOI 10.1158/1078-0432.CCR-11-1235; Griner LAM, 2014, P NATL ACAD SCI USA, V111, P2349, DOI 10.1073/pnas.1311846111; Guha R, 2016, J BIOMOLECU IN PRESS; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hassan R, 2007, CLIN CANCER RES, V13, P5144, DOI 10.1158/1078-0432.CCR-07-0869; Hassan R, 2014, CANCER-AM CANCER SOC, V120, P3311, DOI 10.1002/cncr.28875; Hollevoet K, 2014, J IMMUNOTHER, V37, P8, DOI 10.1097/CJI.0000000000000010; Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566; King TD, 2012, J CELL BIOCHEM, V113, P13, DOI 10.1002/jcb.23350; Kreitman RJ, 2005, J CLIN ONCOL, V23, P6719, DOI 10.1200/JCO.2005.11.437; Kreitman RJ, 2012, J CLIN ONCOL, V30, P1822, DOI 10.1200/JCO.2011.38.1756; Kreitman RJ, 2009, CLIN CANCER RES, V15, P5274, DOI 10.1158/1078-0432.CCR-09-0062; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Mattoo AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075576; Mattoo AR, 2013, INT J CANCER, V132, P978, DOI 10.1002/ijc.27732; Onda Masanori, 2012, Methods Mol Biol, V907, P627, DOI 10.1007/978-1-61779-974-7_35; Ortolani S, 2015, FUTURE ONCOL, V11, P1809, DOI [10.2217/FON.15.81, 10.2217/fon.15.81]; Pasetto M, 2015, P NATL ACAD SCI USA, V112, pE1135, DOI 10.1073/pnas.1501958112; Pastan I, 2007, ANNU REV MED, V58, P221, DOI 10.1146/annurev.med.58.070605.115320; Pastan I, 2006, NAT REV CANCER, V6, P559, DOI 10.1038/nrc1891; Reichardt P, 2011, SEMIN ONCOL, V38, pS20, DOI 10.1053/j.seminoncol.2011.01.015; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Simon NC, 2014, NAT REV MICROBIOL, V12, P599, DOI 10.1038/nrmicro3310; Steelman LS, 2016, BR J CLIN PHARM; Traini R, 2010, MOL CANCER THER, V9, P2007, DOI 10.1158/1535-7163.MCT-10-0257; Turgeon Z, 2011, ANTIMICROB AGENTS CH, V55, P983, DOI 10.1128/AAC.01164-10; Wayne AS, 2010, CLIN CANCER RES, V16, P1894, DOI 10.1158/1078-0432.CCR-09-2980; Wei H, 2012, P NATL ACAD SCI USA, V109, P6898, DOI 10.1073/pnas.1204523109	38	5	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161415	10.1371/journal.pone.0161415	http://dx.doi.org/10.1371/journal.pone.0161415			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556570	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258100040
J	Hussain, MA; Al Mamun, A; Reid, C; Huxley, RR				Hussain, Mohammad Akhtar; Al Mamun, Abdullah; Reid, Christopher; Huxley, Rachel R.			Prevalence, Awareness, Treatment and Control of Hypertension in Indonesian Adults Aged >= 40 Years: Findings from the Indonesia Family Life Survey (IFLS)	PLOS ONE			English	Article							BODY-MASS INDEX; BLOOD-PRESSURE; RISK-FACTORS; ASSOCIATION; MORTALITY; CHENNAI; BURDEN	Objective Hypertension is the major driver of the cardiovascular epidemic facing Indonesia in the 21st century. Understanding the socioeconomic inequalities associated with hypertension is essential for designing effective intervention strategies. The aim of the current study was to use sub-nationally representative survey data to examine socio-demographic inequalities in the prevalence, diagnosis and management of hypertension in Indonesian adults. Methods We investigated factors associated with hypertension prevalence, diagnosis, treatment and control using data on self-reported diagnosis and treatment, and blood pressure measurements, collected from 9755 respondents aged 40 years and up in the 2007 Indonesian Family Life Survey (IFLS 4). Results Age-standardized prevalence of hypertension among the study participants was 47.8% (95% CI: 46.8, 48.9), of which almost 70% were undiagnosed. Hypertension was significantly higher in women than men (52.3% versus 43.1%, p-value<0.001). Prevalence of hypertension increased significantly with ageing (P-for trend <0.001). Over 91% (men: 92.1%, women: 90.0%) of hypertension cases were uncontrolled. Gender, education and socioeconomic status had differential impact on the diagnosis of hypertension and in receiving treatment. Conclusions Overall, less than a third were aware of their hypertension and a quarter of those on medication had their blood pressure effectively controlled. Men and those of younger age were more vulnerable to have undiagnosed and untreated hypertension. Substantial effort should be given to improve awareness about the condition and making provision for early diagnosis and treatment.	[Hussain, Mohammad Akhtar; Al Mamun, Abdullah] Univ Queensland, Sch Publ Hlth, Div Epidemiol & Biostat, Brisbane, Qld, Australia; [Reid, Christopher; Huxley, Rachel R.] Curtin Univ, Sch Publ Hlth, Perth, WA, Australia	University of Queensland; Curtin University	Hussain, MA (corresponding author), Univ Queensland, Sch Publ Hlth, Div Epidemiol & Biostat, Brisbane, Qld, Australia.	drakhtarhussain@gmail.com	Mamun, Abdullah/HHM-9898-2022; Huxley, Rachel R/C-7032-2013; Hussain, Mohammad Akhtar/G-8446-2012; Mamun, Abdullah A/A-4673-2011; Reid, Christopher M/AAP-8135-2021	Huxley, Rachel R/0000-0002-2705-6616; Hussain, Mohammad Akhtar/0000-0002-6012-3702; Mamun, Abdullah A/0000-0002-1535-8086; Reid, Christopher/0000-0001-9173-3944				Agyemang C, 2006, PUBLIC HEALTH, V120, P525, DOI 10.1016/j.puhe.2006.02.002; [Anonymous], 2015, GLOBAL HEALTH OBSERV; [Anonymous], 2011, GLOBAL ATLAS ON CARD; [Anonymous], 2007, PREVENTION OF CARDIO; Badan Penelitian Dan Pengembangan Kesehatan. Kementerian Kesehatan. Republik Indonesia, 2013, RISET KESEHATAN DASA; Benetou V, 2004, EUR J EPIDEMIOL, V19, P803, DOI 10.1023/B:EJEP.0000036582.38987.ca; Boedhi-Darmojo R., 1993, World Health Statistics Quarterly, V46, P119; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Dans A, 2011, LANCET, V377, P680, DOI 10.1016/S0140-6736(10)61506-1; Deepa R, 2003, J Assoc Physicians India, V51, P153; Ezzati M, 2015, NAT REV CARDIOL, V12, P508, DOI 10.1038/nrcardio.2015.82; Greenland S, 2008, MODERN EPIDEMIOLOGY, P219; Minh HV, 2009, GLOBAL HEALTH ACTION, V2, P60, DOI 10.3402/gha.v2i0.2010; Houweling Tanja AJ, 2003, Int J Equity Health, V2, P8, DOI 10.1186/1475-9276-2-8; Kearney PM, 2004, J HYPERTENS, V22, P11, DOI 10.1097/00004872-200401000-00003; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mohan V, 2007, J Assoc Physicians India, V55, P326; Ng N, 2006, B WORLD HEALTH ORGAN, V84, P305, DOI 10.2471/BLT.05.023721; Pereira M, 2009, J HYPERTENS, V27, P963, DOI 10.1097/HJH.0b013e3283282f65; Perkovic V, 2007, HYPERTENSION, V50, P991, DOI 10.1161/HYPERTENSIONAHA.107.095497; Rahajeng E, 2009, J INDONESIAN MED ASS, V59, P580; RAND, INDONESIAN FAMILY LI; Rao V, 2014, NATL J COMMUNITY MED, V5, P333; Roemling C, 2012, APPETITE, V58, P1005, DOI 10.1016/j.appet.2012.02.053; Rutstein S.O., 2004, DHS COMP REPORTS; Sairin S., 2011, J GOVERNANCE DEV, V7, P1, DOI [https://doi.org/10.32890/jgd, DOI 10.32890/JGD]; Seaman SR, 2013, STAT METHODS MED RES, V22, P278, DOI 10.1177/0962280210395740; Soemantri S, 2001, NATIONAL HOUSEHOLD H; Statistics Indonesia, 2010, POPULATION CENSUS DA; Strauss J, 2009, THE FOURTH WAVE OF I; Susilowati D, 2010, B HLTH SYST RES, V13, P123; Tesfaye F, 2007, J HUM HYPERTENS, V21, P28, DOI 10.1038/sj.jhh.1002104; Thawornchaisit P, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002826; Umberger WJ, 2015, AM J AGR ECON, V97, P510, DOI 10.1093/ajae/aau111; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; World Health Organization, 2011, NONC DIS S E AS REG; World Health Organization, 2013, GLOBAL ACTION PLAN F; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166	42	48	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0160922	10.1371/journal.pone.0160922	http://dx.doi.org/10.1371/journal.pone.0160922			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU5NI	27556532	Green Submitted, gold, Green Published			2022-12-26	WOS:000382258100022
J	Shan, S; Min, HW; Liu, T; Jiang, DQ; Rao, ZH				Shan, Shan; Min, Haowei; Liu, Ting; Jiang, Dunquan; Rao, Zihe			Structural insight into dephosphorylation by trehalose 6-phosphate phosphatase (OtsB2) from Mycobacterium tuberculosis	FASEB JOURNAL			English	Article						crystal structure; drug discovery; MtbTPP	PHOSPHOSERINE PHOSPHATASE; CRYSTAL-STRUCTURE; 3 PATHWAYS; BIOSYNTHESIS; CLONING; CONSERVATION; PURIFICATION; SUPERFAMILY; EXPRESSION; PROTEIN	Trehalose serves as a key structural component in the cell wall of Mycobacterium tuberculosis. M. tuberculosis trehalose-6-phosphate phosphatase (MtbTPP), an essential enzyme in the trehalose biosynthesis OtsAB pathway, catalyzes the dephosphorylation of trehalose-6-phosphate (trehalose-6-P) to generate trehalose, and plays a critical role in M. tuberculosis survival-associated cell wall formation and permeability. Therefore, MtbTPP (OtsB2) is considered a promising potential target for discovery of antimicrobial drugs. However, the absence of structural information of MtbTPP restrains our understanding of its underlying catalytic mechanism. Here, we report the high-resolution crystal structures of apo active MtbTPP and its trehalose-6-P bound complex. The apo structure presents a canonical haloacid dehalogenase superfamily structural fold plus an extra N-terminal domain. The catalytic center is located in a positively charged cleft between the hydrolase domain and the cap domain, demonstrating a highly conserved substrate binding pocket. The role of residues interacting with the substrate in catalysis were probed by site-directed mutagenesis. Asp147, Asp149, Asp330, and Asp331 were found to be pivotal for the enzymatic activity of MtbTPP. The MtbTPP structures reported here provide insight into a key step in the biosynthesis of trehalose, which would facilitate future development of anti-TB therapeutics.-Shan, S., Min, H., Liu, T., Jiang, D., Rao, Z. Structural insight into dephosphorylation by trehalose 6-phosphate phosphatase (OtsB2) from Mycobacterium tuberculosis.	[Shan, Shan; Rao, Zihe] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China; [Min, Haowei] Chinese Acad Sci, State Key Lab Plant Genom, Beijing, Peoples R China; [Min, Haowei] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res Beijing, Beijing, Peoples R China; [Liu, Ting; Jiang, Dunquan; Rao, Zihe] Nankai Univ, Coll Life Sci, Tianjin, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Nankai University	Shan, S (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	shanshan@moon.ibp.ac.cn	Rao, Zihe/HCH-6944-2022; Jiang, Quan/GQA-6586-2022					Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; De Smet KAL, 2000, MICROBIOL-UK, V146, P199, DOI 10.1099/00221287-146-1-199; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Edavana VK, 2004, ARCH BIOCHEM BIOPHYS, V426, P250, DOI 10.1016/j.abb.2004.02.014; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friedland N, 2007, BIOCHEMISTRY-US, V46, P6733, DOI 10.1021/bi602546q; GIAEVER HM, 1988, J BACTERIOL, V170, P2841, DOI 10.1128/jb.170.6.2841-2849.1988; Goude R, 2008, FUTURE MICROBIOL, V3, P299, DOI 10.2217/17460913.3.3.299; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang H, 2011, BIOCHEMISTRY-US, V50, P8937, DOI 10.1021/bi201181q; Klutts S, 2003, J BIOL CHEM, V278, P2093, DOI 10.1074/jbc.M209937200; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lu ZB, 2005, BIOCHEMISTRY-US, V44, P8684, DOI 10.1021/bi050009j; Maruta K, 1996, BBA-GEN SUBJECTS, V1291, P177, DOI 10.1016/S0304-4165(96)00082-7; MATULA M, 1971, J BACTERIOL, V107, P217, DOI 10.1128/JB.107.1.217-222.1971; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murphy HN, 2005, J BIOL CHEM, V280, P14524, DOI 10.1074/jbc.M414232200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peeraer Y, 2003, ACTA CRYSTALLOGR D, V59, P971, DOI 10.1107/S0907444903005407; Rao KN, 2006, PROTEIN SCI, V15, P1735, DOI 10.1110/ps.062096606; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Ryll R, 2001, MICROBIOL IMMUNOL, V45, P801, DOI 10.1111/j.1348-0421.2001.tb01319.x; Shan S, 2011, ACTA CRYSTALLOGR F, V67, P821, DOI 10.1107/S1744309111019567; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Wang WR, 2001, STRUCTURE, V9, P65, DOI 10.1016/S0969-2126(00)00558-X; Wolf A, 2003, MOL MICROBIOL, V49, P1119, DOI 10.1046/j.1365-2958.2003.03625.x; ZHANG MH, 2007, COMPUTER SCI, V6, P68; Zhao HY, 2009, ACTA CRYSTALLOGR F, V65, P719, DOI 10.1107/S1744309109022696	35	12	14	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					3989	3996		10.1096/fj.201600463R	http://dx.doi.org/10.1096/fj.201600463R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27572957				2022-12-26	WOS:000388201500007
J	Liu, ZL; Huang, X; Hu, LN; Pham, L; Poole, KM; Tang, Y; Mahon, BP; Tang, WX; Li, KH; Goldfarb, NE; Dunn, BM; McKenna, R; Fanucci, GE				Liu, Zhanglong; Huang, Xi; Hu, Lingna; Linh Pham; Poole, Katye M.; Tang, Yan; Mahon, Brian P.; Tang, Wenxing; Li, Kunhua; Goldfarb, Nathan E.; Dunn, Ben M.; McKenna, Robert; Fanucci, Gail E.			Effects of Hinge-region Natural Polymorphisms on Human Immunodeficiency Virus-Type 1 Protease Structure, Dynamics, and Drug Pressure Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; drug resistance; enzyme inhibitor; enzyme kinetics; HIV-1 protease; nuclear magnetic resonance (NMR); PELDOR; site-directed spin-labeling; backbone dynamics; double electron-electron resonance (DEER)	RESISTANT HIV-1 PROTEASE; ACTIVE-SITE; INHIBITOR RESISTANCE; PULSED EPR; SUBTYPE-B; ANTIRETROVIRAL THERAPY; GENETIC DIVERSITY; 20 MUTATIONS; BINDING; STABILITY	Multidrug resistance to current Food and Drug Administration-approved HIV-1 protease (PR) inhibitors drives the need to understand the fundamental mechanisms of how drug pressure-selected mutations, which are oftentimes natural polymorphisms, elicit their effect on enzyme function and resistance. Here, the impacts of the hinge-region natural polymorphism at residue 35, glutamate to aspartate (E35D), alone and in conjunction with residue 57, arginine to lysine (R57K), are characterized with the goal of understanding how altered salt bridge interactions between the hinge and flap regions are associated with changes in structure, motional dynamics, conformational sampling, kinetic parameters, and inhibitor affinity. The combined results reveal that the single E35D substitution leads to diminished salt bridge interactions between residues 35 and 57 and gives rise to the stabilization of open-like conformational states with overall increased backbone dynamics. In HIV-1 PR constructs where sites 35 and 57 are both mutated (e.g. E35D and R57K), x-ray structures reveal an altered network of interactions that replace the salt bridge thus stabilizing the structural integrity between the flap and hinge regions. Despite the altered conformational sampling and dynamics when the salt bridge is disrupted, enzyme kinetic parameters and inhibition constants are similar to those obtained for subtype B PR. Results demonstrate that these hinge-region natural polymorphisms, which may arise as drug pressure secondary mutations, alter protein dynamics and the conformational landscape, which are important thermodynamic parameters to consider for development of inhibitors that target for non-subtype B PR.	[Liu, Zhanglong; Huang, Xi; Hu, Lingna; Linh Pham; Li, Kunhua; Fanucci, Gail E.] Univ Florida, Dept Chem, POB 117200, Gainesville, FL 32611 USA; [Poole, Katye M.; Tang, Yan; Mahon, Brian P.; Tang, Wenxing; Goldfarb, Nathan E.; Dunn, Ben M.; McKenna, Robert] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Huang, Xi] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA; [Hu, Lingna] Baxter Int Inc, SIP, B3 1 Pk, Suzhou 215021, Peoples R China; [Linh Pham] Texas A&M Univ Cent Texas, Dept Sci & Math, Killeen, TX 76549 USA; [Goldfarb, Nathan E.] Calif Hlth Sci Univ, 120 North Clovis Ave, Clovis, CA 93612 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Gilead Sciences; Texas A&M University System; California Health Sciences University (CHSU)	Fanucci, GE (corresponding author), Univ Florida, Dept Chem, POB 117200, Gainesville, FL 32611 USA.	fanucci@chem.ufl.edu	hu, ling/GWC-1104-2022	Li, Kunhua/0000-0002-9139-4257; Mahon, Brian/0000-0002-5571-8058	National Institutes of Health [GM105409, S10RR031603, R37 A128571]; National Science Foundation [DMR-1157490]; State of Florida; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); State of Florida; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM105409 (to G. E. F.), S10RR031603 (to G. E. F.), and R37 A128571 (to B. M. D.). A portion of this work was performed at the McKnight Brain Institute at the National High Magnetic Field Laboratory AMRIS Facility, which is supported by National Science Foundation Cooperative Agreement No. DMR-1157490 and the State of Florida. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Agniswamy J, 2013, J MED CHEM, V56, P4017, DOI 10.1021/jm400231v; Agniswamy J, 2012, BIOCHEMISTRY-US, V51, P2819, DOI 10.1021/bi2018317; Agniswamy J, 2012, BIOCHEMISTRY-US, V51, P1041, DOI 10.1021/bi201809s; Ariyoshi K, 2003, JAIDS-J ACQ IMM DEF, V33, P336, DOI 10.1097/00126334-200307010-00007; Bandaranayake RM, 2008, J VIROL, V82, P6762, DOI 10.1128/JVI.00018-08; Bandaranayake RM, 2010, J VIROL, V84, P9995, DOI 10.1128/JVI.00505-10; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Batista PR, 2006, CELL BIOCHEM BIOPHYS, V44, P395, DOI 10.1385/CBB:44:3:395; Bieri M, 2011, J BIOMOL NMR, V50, P147, DOI 10.1007/s10858-011-9509-1; Blackburn ME, 2009, BIOCHEMISTRY-US, V48, P8765, DOI 10.1021/bi901201q; Cai YF, 2014, J CHEM THEORY COMPUT, V10, P3438, DOI 10.1021/ct4010454; Carter JD, 2014, FEBS LETT, V588, P3123, DOI 10.1016/j.febslet.2014.06.051; Casey TM, 2015, METHOD ENZYMOL, V564, P153, DOI 10.1016/bs.mie.2015.07.019; Chang MW, 2011, J MOL BIOL, V410, P756, DOI 10.1016/j.jmb.2011.03.038; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clemente JC, 2006, BIOCHEMISTRY-US, V45, P5468, DOI 10.1021/bi051886s; Clemente JC, 2003, BIOCHEMISTRY-US, V42, P15029, DOI 10.1021/bi035701y; Coman RM, 2008, BIOCHEMISTRY-US, V47, P731, DOI 10.1021/bi7018332; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P121, DOI 10.1007/s10858-007-9213-3; de Vera IMS, 2013, BIOCHEMISTRY-US, V52, P3278, DOI 10.1021/bi400109d; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ding F, 2008, J AM CHEM SOC, V130, P7184, DOI 10.1021/ja800893d; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Foulkes-Murzycki JE, 2007, STRUCTURE, V15, P225, DOI 10.1016/j.str.2007.01.006; Galiano L, 2007, J AM CHEM SOC, V129, P11004, DOI 10.1021/ja073684k; Galiano L, 2009, J AM CHEM SOC, V131, P430, DOI 10.1021/ja807531v; GALLO RC, 1983, SCIENCE, V220, P865, DOI 10.1126/science.6601823; Ghosh AK, 2016, J MED CHEM, V59, P5172, DOI 10.1021/acs.jmedchem.5b01697; Ghosh AK, 2012, ANGEW CHEM INT EDIT, V51, P1778, DOI 10.1002/anie.201102762; Goldfarb NE, 2015, BIOCHEMISTRY-US, V54, P422, DOI 10.1021/bi501088e; Hornak V, 2006, P NATL ACAD SCI USA, V103, P915, DOI 10.1073/pnas.0508452103; Huang X, 2014, J BIOL CHEM, V289, P17203, DOI 10.1074/jbc.M114.571836; Huang X, 2012, J PHYS CHEM B, V116, P14235, DOI 10.1021/jp308207h; Jeschke G, 2004, APPL MAGN RESON, V26, P223, DOI 10.1007/BF03166574; Jeschke G, 2006, PHYS CHEM CHEM PHYS, V8, P4095, DOI 10.1039/b607826e; Kantor R, 2005, PLOS MED, V2, P325, DOI 10.1371/journal.pmed.0020112; Kantor R, 2002, ANTIMICROB AGENTS CH, V46, P1086, DOI 10.1128/AAC.46.4.1086-1092.2002; Kear J. L., 2010, THESIS; Kear JL, 2009, J AM CHEM SOC, V131, P14650, DOI 10.1021/ja907088a; King NM, 2012, ACS CHEM BIOL, V7, P1536, DOI 10.1021/cb300191k; King NM, 2004, J VIROL, V78, P12012, DOI 10.1128/JVI.78.21.12012-12021.2004; Kozisek M, 2014, FEBS J, V281, P1834, DOI 10.1111/febs.12743; Laco GS, 2015, BIOCHIMIE, V118, P90, DOI 10.1016/j.biochi.2015.08.009; Lafont V, 2007, CHEM BIOL DRUG DES, V69, P413, DOI 10.1111/j.1747-0285.2007.00519.x; Langs-Barlow A, 2014, VIRUSES-BASEL, V6, P3855, DOI 10.3390/v6103855; Lazaro E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026244; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lisovsky I, 2010, ANTIMICROB AGENTS CH, V54, P2878, DOI 10.1128/AAC.01828-09; Liu ZL, 2016, PHYS CHEM CHEM PHYS, V18, P5819, DOI 10.1039/c5cp04556h; Louis JM, 2011, P NATL ACAD SCI USA, V108, P9072, DOI 10.1073/pnas.1102278108; Martinez-Cajas JL, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-11; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER M, 1989, NATURE, V337, P576, DOI 10.1038/337576a0; Muzammil S, 2003, BIOCHEMISTRY-US, V42, P631, DOI 10.1021/bi027019u; Naicker P, 2014, FEBS J, V281, P5395, DOI 10.1111/febs.13084; Naicker P, 2014, BIOL CHEM, V395, P1151, DOI 10.1515/hsz-2014-0162; NICHOLSON LK, 1995, NAT STRUCT BIOL, V2, P274, DOI 10.1038/nsb0495-274; Olajuyigbe FM, 2010, ACS MED CHEM LETT, V1, P254, DOI 10.1021/ml100046d; PEARL LH, 1987, NATURE, V329, P351, DOI 10.1038/329351a0; Piana S, 2002, PROTEIN SCI, V11, P2393, DOI 10.1110/ps.0206702; Ragland DA, 2014, J AM CHEM SOC, V136, P11956, DOI 10.1021/ja504096m; Robbins AH, 2010, ACTA CRYSTALLOGR D, V66, P233, DOI 10.1107/S0907444909054298; Santoro MM, 2013, ISRN MICROBIOL, V2013, DOI DOI 10.1155/2013/481314; Santos AF, 2010, VIRUSES-BASEL, V2, P503, DOI 10.3390/v2020503; Saskova KG, 2009, J VIROL, V83, P8810, DOI 10.1128/JVI.00451-09; Sayer JM, 2008, J BIOL CHEM, V283, P13459, DOI 10.1074/jbc.M708506200; Shafer RW, 2008, AIDS REV, V10, P67; Shen CH, 2015, J MOL GRAPH MODEL, V62, P87, DOI 10.1016/j.jmgm.2015.09.006; Silver NW, 2013, J CHEM THEORY COMPUT, V9, P5098, DOI 10.1021/ct400383v; Soares EAJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000730; SPINELLI S, 1991, BIOCHIMIE, V73, P1391, DOI 10.1016/0300-9084(91)90169-2; Tsvetkov YD, 2009, INSTRUM EXP TECH+, V52, P615, DOI 10.1134/S0020441209050017; UNAIDS, 2016, UNAIDS REP GLOB AIDS; Venkatakrishnan B, 2012, VIRUSES-BASEL, V4, P348, DOI 10.3390/v4030348; Weber IT, 2015, FUTURE MED CHEM, V7, P1023, DOI [10.4155/FMC.15.44, 10.4155/fmc.15.44]; Wilson SI, 1997, BBA-PROTEIN STRUCT M, V1339, P113, DOI 10.1016/S0167-4838(96)00224-5; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WLODAWER A, 1993, ANNU REV BIOCHEM, V62, P543, DOI 10.1146/annurev.bi.62.070193.002551; Yedidi RS, 2014, ANTIMICROB AGENTS CH, V58, P3679, DOI 10.1128/AAC.00107-14; Yilmaz NK, 2016, TRENDS MICROBIOL, V24, P547, DOI 10.1016/j.tim.2016.03.010; Zhang Y, 2014, ACS CHEM BIOL, V9, P1351, DOI 10.1021/cb4008875; Zhou QB, 2014, MOL THER, V22, P378, DOI 10.1038/mt.2013.243	87	16	16	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22741	22756		10.1074/jbc.M116.747568	http://dx.doi.org/10.1074/jbc.M116.747568			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27576689	Green Published, hybrid			2022-12-26	WOS:000386760600032
J	Luo, MC; Zhou, SY; Feng, DY; Xiao, J; Li, WY; Xu, CD; Wang, HY; Zhou, T				Luo, Mao-Cai; Zhou, Si-Yuan; Feng, Dan-Ying; Xiao, Jun; Li, Wei-Yun; Xu, Chun-Di; Wang, Hong-Yan; Zhou, Tong			Runt-related Transcription Factor 1 (RUNX1) Binds to p50 in Macrophages and Enhances TLR4-triggered Inflammation and Septic Shock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; lipopolysaccharide (LPS); NF-B (NF-KB); sepsis; Toll-like receptor 4 (TLR4); RUNX1; p50	NF-KAPPA-B; ACUTE KIDNEY INJURY; REGULATORY T-CELLS; GENE-EXPRESSION; TLR4 ACTIVATION; DNA-BINDING; LEUKEMIA; SEPSIS; PHOSPHORYLATION; HEMATOPOIESIS	An appropriate inflammatory response plays critical roles in eliminating pathogens, whereas an excessive inflammatory response can cause tissue damage. Runt-related transcription factor 1 (RUNX1), a master regulator of hematopoiesis, plays critical roles in T cells; however, its roles in Toll-like receptor 4 (TLR4)-mediated inflammation in macrophages are unclear. Here, we demonstrated that upon TLR4 ligand stimulation by lipopolysaccharide (LPS), macrophages reduced the expression levels of RUNX1. Silencing of Runx1 attenuated the LPS-induced IL-1 and IL-6 production levels, but the TNF- levels were not affected. Overexpression of RUNX1 promoted IL-1 and IL-6 production in response to LPS stimulation. Moreover, RUNX1 interacted with the NF-B subunit p50, and coexpression of RUNX1 with p50 further enhanced the NF-B luciferase activity. Importantly, treatment with the RUNX1 inhibitor, Ro 5-3335, protected mice from LPS-induced endotoxic shock and substantially reduced the IL-6 levels. These findings suggest that RUNX1 may be a new potential target for resolving TLR4-associated uncontrolled inflammation and preventing sepsis.	[Luo, Mao-Cai; Zhou, Si-Yuan; Feng, Dan-Ying; Xu, Chun-Di; Zhou, Tong] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Pediat, Sch Med, 197 Ruijin Rd 2, Shanghai 200025, Peoples R China; [Xiao, Jun; Li, Wei-Yun; Wang, Hong-Yan] Chinese Acad Sci, Key Lab Syst Biol, Ctr Excellence Mol Cell Sci,Shanghai Inst Biol Sc, Innovat Ctr Cell Signaling Network,Inst Biochem &, 320 Yue Yang Rd, Shanghai 200031, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences	Zhou, T (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Pediat, Sch Med, 197 Ruijin Rd 2, Shanghai 200025, Peoples R China.; Wang, HY (corresponding author), Chinese Acad Sci, Key Lab Syst Biol, Ctr Excellence Mol Cell Sci,Shanghai Inst Biol Sc, Innovat Ctr Cell Signaling Network,Inst Biochem &, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	hongyanwang@sibcb.ac.cn; zhoutong_cn@hotmail.com	, 肖俊/AAO-9118-2020		Ministry of Science and Technology of China [2016YFD05002007, 2016YFC0902200, 2012CB910800]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19000000]; National Natural Science Foundation of China [81270801, 81470941, 31422018, 81571617, 81570508]; Instrument Developing Project of the Chinese Academy of Sciences [YZ201339]; Chinese Academy of Sciences	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Instrument Developing Project of the Chinese Academy of Sciences; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported in part by Ministry of Science and Technology of China Grants 2016YFD05002007, 2016YFC0902200, and 2012CB910800, Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB19000000, National Natural Science Foundation of China Grants 81270801, 81470941, 31422018, 81571617, and 81570508, and Instrument Developing Project of the Chinese Academy of Sciences Grant YZ201339. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Hundred Talents Program of the Chinese Academy of Sciences. To whom correspondence may be addressed. Tel.: 86-21-54921086; E-mail: hongyanwang@sibcb.ac.cn.	Aderem A, 2001, CRIT CARE MED, V29, pS16, DOI 10.1097/00003246-200107001-00008; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Bernardin-Fried F, 2004, J BIOL CHEM, V279, P15678, DOI 10.1074/jbc.M310023200; Bottero V, 2006, CELL DEATH DIFFER, V13, P785, DOI 10.1038/sj.cdd.4401888; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Cai XS, 2015, POWDER TECHNOL, V282, P1, DOI 10.1016/j.powtec.2015.06.012; Collins PE, 2015, J BIOL CHEM, V290, P15687, DOI 10.1074/jbc.M115.643700; Cunningham L, 2012, P NATL ACAD SCI USA, V109, P14592, DOI 10.1073/pnas.1200037109; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Elliott J, 2004, TRENDS IMMUNOL, V25, P434, DOI 10.1016/j.it.2004.05.012; Frank R, 1995, ONCOGENE, V11, P2667; Fujimoto T, 2007, EMBO J, V26, P2361, DOI 10.1038/sj.emboj.7601675; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Hommes DW, 2003, GUT, V52, P144, DOI 10.1136/gut.52.1.144; Ito Y, 2015, NAT REV CANCER, V15, P81, DOI 10.1038/nrc3877; Kim WY, 1999, EMBO J, V18, P1609, DOI 10.1093/emboj/18.6.1609; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Komeno Y, 2014, BLOOD, V123, P3760, DOI 10.1182/blood-2013-08-521252; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Lee K, 2012, J NEUROCHEM, V122, P272, DOI 10.1111/j.1471-4159.2012.07786.x; Li WY, 2015, J CLIN INVEST, V125, P4239, DOI 10.1172/JCI81203; Liu X, 2009, LEUKEMIA, V23, P739, DOI 10.1038/leu.2008.350; Nakagawa M, 2011, BLOOD, V118, P6626, DOI 10.1182/blood-2010-12-326710; Nechemia-Arbely Y, 2008, J AM SOC NEPHROL, V19, P1106, DOI 10.1681/ASN.2007070744; Osato M, 2004, ONCOGENE, V23, P4284, DOI 10.1038/sj.onc.1207779; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Ran D, 2013, BLOOD, V121, P2882, DOI 10.1182/blood-2012-08-451641; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; Scheitz CJF, 2012, EMBO J, V31, P4124, DOI 10.1038/emboj.2012.270; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shalova IN, 2015, IMMUNITY, V42, P484, DOI 10.1016/j.immuni.2015.02.001; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Tauseef M, 2012, J EXP MED, V209, P1953, DOI 10.1084/jem.20111355; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Uchida H, 1997, J IMMUNOL, V158, P2251; URBAN MB, 1991, EMBO J, V10, P1817, DOI 10.1002/j.1460-2075.1991.tb07707.x; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang Y, 2014, IMMUNITY, V40, P355, DOI 10.1016/j.immuni.2014.01.002; Wildey GM, 2009, J BIOL CHEM, V284, P20227, DOI 10.1074/jbc.M109.027201; Wong WF, 2012, J IMMUNOL, V188, P5408, DOI 10.4049/jimmunol.1102991; Wong WF, 2011, J BIOL CHEM, V286, P11110, DOI 10.1074/jbc.M110.166694; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Xia M, 2013, IMMUNITY, V39, P470, DOI 10.1016/j.immuni.2013.08.016; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yoshida N, 2005, MOL CELL BIOL, V25, P1003, DOI 10.1128/MCB.25.3.1003-1012.2005; Zarjou A, 2011, J AM SOC NEPHROL, V22, P999, DOI 10.1681/ASN.2010050484; Zhang DE, 1996, MOL CELL BIOL, V16, P1231; Zhang LS, 2008, BLOOD, V111, P1193, DOI 10.1182/blood-2007-08-109702; Zhang YB, 2014, IMMUNITY, V40, P501, DOI 10.1016/j.immuni.2014.01.013; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	56	37	40	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22011	22020		10.1074/jbc.M116.715953	http://dx.doi.org/10.1074/jbc.M116.715953			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27573239	Green Published, hybrid			2022-12-26	WOS:000386332600016
J	Guo, M; Wang, XM; Lu, XW; Wang, HZ; Brodelius, PE				Guo, Ming; Wang, Xiaomeng; Lu, Xiaowang; Wang, Hongzheng; Brodelius, Peter E.			alpha-Mangostin Extraction from the Native Mangosteen (Garcinia mangostana L.) and the Binding Mechanisms of alpha-Mangostin to HSA or TRF	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; DRUG; PROTEOMICS; DYNAMICS; THERMODYNAMICS; SPECTROSCOPIES; IDENTIFICATION; TRANSFERRIN; XANTHONES; NETWORKS	In order to obtain the biological active compound, alpha-mangostin, from the traditional native mangosteen (Garcinia mangostana L.), an extraction method for industrial application was explored. A high yield of a-mangostin (5.2%) was obtained by extraction from dried mangosteen pericarps with subsequent purification on macroporous resin HPD-400. The chemical structure of alpha-mangostin was verified mass spectrometry (MS), nuclear magnetic resonance (H-1 NMR and C-13 NMR), infrared spectroscopy (IR) and UV-Vis spectroscopy. The purity of the obtained alpha-mangostin was 95.6% as determined by HPLC analysis. The binding of native alpha-mangostin to human serum albumin (HSA) or transferrin (TRF) was explored by combining spectral experiments with molecular modeling. The results showed that amangostin binds to HSA or TRF as static complexes but the binding affinities were different in different systems. The binding constants and thermodynamic parameters were measured by fluorescence spectroscopy and absorbance spectra. The association constant of HSA or TRF binding to alpha-mangostin is 6.4832x10(5) L/mol and 1.4652x10(5) L/mol at 298 K and 7.8619x10(5) L/mol and 1.1582x10(5) L/mol at 310 K, respectively. The binding distance, the energy transfer efficiency between alpha-mangostin and HSA or TRF were also obtained by virtue of the Forster theory of non-radiation energy transfer. The effect of alpha-mangostin on the HSA or TRF conformation was analyzed by synchronous spectrometry and fluorescence polarization studies. Molecular docking results reveal that the main interaction between amangostin and HSA is hydrophobic interactions, while the main interaction between alpha-mangostin and TRF is hydrogen bonding and Van der Waals forces. These results are consistent with spectral results.	[Guo, Ming; Wang, Xiaomeng; Lu, Xiaowang] Zhejiang Agr & Forestry Univ, Sch Sci, Linan 311300, Peoples R China; [Wang, Hongzheng] Zhejiang Agr & Forestry Univ, Sch Forestry & Biotechnol, Linan 311300, Peoples R China; [Brodelius, Peter E.] Linnaeus Univ, Dept Chem & Biomed Sci, S-39182 Kalmar, Sweden	Zhejiang A&F University; Zhejiang A&F University; Linnaeus University	Guo, M (corresponding author), Zhejiang Agr & Forestry Univ, Sch Sci, Linan 311300, Peoples R China.; Brodelius, PE (corresponding author), Linnaeus Univ, Dept Chem & Biomed Sci, S-39182 Kalmar, Sweden.	tdky@hotmail.com; peter.brodelius@lnu.se			Zhejiang Provincial Natural Science Foundation of China [LY14E030016]; Pre-research Project of Research Center of Biomass Resource Utilization of Zhejiang A F University [2013SWZ02-1]; Open Fund of Zhejiang Provincial Top Key Discipline of Forestry Engineering [2014LYGCZ017]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Pre-research Project of Research Center of Biomass Resource Utilization of Zhejiang A F University; Open Fund of Zhejiang Provincial Top Key Discipline of Forestry Engineering	This work was financially supported by grants to MG from the Zhejiang Provincial Natural Science Foundation of China (No. LY14E030016), the Pre-research Project of Research Center of Biomass Resource Utilization of Zhejiang A & F University (2013SWZ02-1), the Open Fund of Zhejiang Provincial Top Key Discipline of Forestry Engineering (2014LYGCZ017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2015, PLANT SCI, V233, P95, DOI 10.1016/j.plantsci.2014.12.016; [Anonymous], 2008, THESIS; Ba Q, 2015, TOXICOL APPL PHARM, V283, P83, DOI 10.1016/j.taap.2015.01.006; BarnumHuckins KM, 1997, TOXICOLOGY, V118, P11, DOI 10.1016/S0300-483X(96)03586-X; Cordova-Sintjago TC, 2015, MOL PHYS, V113, P348, DOI 10.1080/00268976.2014.952695; Csermely P, 2013, PHARMACOL THERAPEUT, V138, P333, DOI 10.1016/j.pharmthera.2013.01.016; Cui FL, 2009, J PHOTOCH PHOTOBIO B, V95, P162, DOI 10.1016/j.jphotobiol.2009.03.001; Dangkoob F, 2015, SPECTROCHIM ACTA A, V137, P1106, DOI 10.1016/j.saa.2014.08.149; Ding KK, 2015, J HAZARD MATER, V299, P486, DOI 10.1016/j.jhazmat.2015.07.050; Dogan A, 2014, EXPERT REV PROTEOMIC, V11, P531, DOI 10.1586/14789450.2014.953062; Ee GCL, 2006, NAT PROD RES, V20, P1067, DOI 10.1080/14786410500463114; Ge F, 2011, ANAL SCI, V27, P79, DOI 10.2116/analsci.27.79; Guo M, 2004, ANAL SCI, V20, P465, DOI 10.2116/analsci.20.465; Guo M, 2008, EUR J MED CHEM, V43, P2140, DOI 10.1016/j.ejmech.2007.11.006; He WY, 2006, J PHOTOCH PHOTOBIO A, V182, P158, DOI 10.1016/j.jphotochem.2006.02.004; Hu YJ, 2006, J PHOTOCH PHOTOBIO A, V179, P324, DOI 10.1016/j.jphotochem.2005.08.037; Ketsa S, 2011, WOODHEAD PUBL FOOD S, P1; Khan SN, 2008, EUR J PHARM SCI, V35, P371, DOI 10.1016/j.ejps.2008.07.010; Kosem N, 2013, J NAT MED-TOKYO, V67, P255, DOI 10.1007/s11418-012-0673-8; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Li Y, 2012, ACTA CHIM SINICA, V70, P143, DOI 10.6023/A1109211; Lin XG, 2015, INT J THERMOPHYS, V36, P919, DOI 10.1007/s10765-014-1657-6; Liu LS, 2011, ACTA CHIM SINICA, V69, P2589; Liu XC, 2007, PROG MOD BIOMED, V7, P325; Liu Y, 2009, ACTA CHIM SINICA, V67, P629; McMorran LM, 2014, ARCH BIOCHEM BIOPHYS, V564, P265, DOI 10.1016/j.abb.2014.02.011; Mendoza-Martinez C, 2015, EUR J MED CHEM, V92, P314, DOI 10.1016/j.ejmech.2014.12.051; Moongkarndi P, 2014, J PHARM PHARMACOL, V66, P1171, DOI 10.1111/jphp.12239; Mottarella SE, 2014, J CHEM INF MODEL, V54, P2068, DOI 10.1021/ci500115j; Pedraza-Chaverri J, 2008, FOOD CHEM TOXICOL, V46, P3227, DOI 10.1016/j.fct.2008.07.024; Petitpas I, 2001, J BIOL CHEM, V276, P22804, DOI 10.1074/jbc.M100575200; Rai AJ, 2005, PROTEOMICS, V5, P3262, DOI 10.1002/pmic.200401245; Ray S, 2012, J PROTEOMICS, V75, P2515, DOI 10.1016/j.jprot.2012.03.014; Ross PD, 1996, BIOPHYS J, V71, P2144, DOI 10.1016/S0006-3495(96)79415-8; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; SEN AK, 1982, PHYTOCHEMISTRY, V21, P1747, DOI 10.1016/0031-9422(82)85052-8; Shahraki S, 2016, J IRAN CHEM SOC, V13, P723, DOI 10.1007/s13738-015-0784-8; Shao X, 2016, SPECTROCHIM ACTA A, V161, P1, DOI 10.1016/j.saa.2016.02.015; Tabassum S, 2012, MOL BIOSYST, V8, P2424, DOI 10.1039/c2mb25119a; Tabassum S, 2012, J PHOTOCH PHOTOBIO B, V114, P132, DOI 10.1016/j.jphotobiol.2012.05.021; Tian ZY, 2015, J PHOTOCH PHOTOBIO B, V142, P103, DOI 10.1016/j.jphotobiol.2014.10.013; Vizcaino JA, 2010, J PROTEOMICS, V73, P2136, DOI 10.1016/j.jprot.2010.06.008; Vlasova IM, 2013, J MOL STRUCT, V1034, P89, DOI 10.1016/j.molstruc.2012.08.053; Weecharangsan W, 2006, MED PRIN PRACT, V15, P281, DOI 10.1159/000092991; Wetie AGN, 2014, CELL MOL LIFE SCI, V71, P205, DOI 10.1007/s00018-013-1333-1; Xiong L. M., 2011, CHEM RES, V22, P9; Yu LM, 2014, MOD FOOD SCI TECHNOL, V30, P296; Yu LM, 2014, MOD FOOD SCI TECHNOL, V30, P287; Yuan JL, 2007, J PHOTOCH PHOTOBIO A, V191, P104, DOI 10.1016/j.jphotochem.2007.04.010; Zarena AS, 2012, FOOD CHEM, V130, P665, DOI 10.1016/j.foodchem.2011.07.106; Zhang C, 2011, THESIS; Zhang MX, 2004, J AM SOC MASS SPECTR, V15, P1658, DOI 10.1016/j.jasms.2004.08.009; Zhao Xin, 2009, Chinese Pharmacological Bulletin, V25, P988; Zhuang SL, 2016, CHEMOSPHERE, V144, P1050, DOI 10.1016/j.chemosphere.2015.09.085	54	19	19	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161566	10.1371/journal.pone.0161566	http://dx.doi.org/10.1371/journal.pone.0161566			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584012	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600041
J	Imtiaz, M; Hayat, T; Alsaedi, A				Imtiaz, Maria; Hayat, Tasawar; Alsaedi, Ahmed			MHD Convective Flow of Jeffrey Fluid Due to a Curved Stretching Surface with Homogeneous-Heterogeneous Reactions	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; HEAT-TRANSFER; NANOFLUID FLOW; THERMAL-RADIATION; MIXED CONVECTION; COMPLEX NETWORK; PARTIAL SLIP; MODEL; MAGNETOHYDRODYNAMICS; SERIES	This paper looks at the flow of Jeffrey fluid due to a curved stretching sheet. Effect of homogeneous-heterogeneous reactions is considered. An electrically conducting fluid in the presence of applied magnetic field is considered. Convective boundary conditions model the heat transfer analysis. Transformation method reduces the governing nonlinear partial differential equations into the ordinary differential equations. Convergence of the obtained series solutions is explicitly discussed. Characteristics of sundry parameters on the velocity, temperature and concentration profiles are analyzed by plotting graphs. Computations for pressure, skin friction coefficient and surface heat transfer rate are presented and examined. It is noted that fluid velocity and temperature through curvature parameter are enhanced. Increasing values of Biot number correspond to the enhancement in temperature and Nusselt number.	[Imtiaz, Maria; Hayat, Tasawar] Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed] King Abdulaziz Univ, NAAM Res Grp, Dept Math, Fac Sci, Jeddah 21589, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Imtiaz, M (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan.	mi_qau@gmail.com	Hayat, Tasawar/Y-2524-2019; Imtiaz, Maria/AAE-2547-2021; Alsaedi, Ahmed/A-2094-2013	Alsaedi, Ahmed/0000-0003-3452-8922				Abbas Z, 2016, J MOL LIQ, V215, P756, DOI 10.1016/j.molliq.2016.01.012; Abbasbandy Saeid, 2014, Mathematical and Computational Applications, V19, P124; [Anonymous], 2014, J KING SAUD UNIV SCI, DOI DOI 10.1016/j.jksus.2013.08.004; Bachok N, 2011, COMMUN NONLINEAR SCI, V16, P4296, DOI 10.1016/j.cnsns.2011.01.008; CHAUDHARY MA, 1995, FLUID DYN RES, V16, P311, DOI 10.1016/0169-5983(95)00015-6; CRANE LJ, 1970, Z ANGEW MATH PHYS, V21, P645, DOI 10.1007/BF01587695; Das K., 2012, INDIAN J MATH, V54, P19; Ellahi R, 2015, J MAGN MAGN MATER, V393, P284, DOI 10.1016/j.jmmm.2015.05.071; Ellahi R, 2015, INT J HEAT MASS TRAN, V81, P449, DOI 10.1016/j.ijheatmasstransfer.2014.10.041; Farooq M, 2015, J MECH, V33, P1; Farooq U, 2015, NUMER ALGORITHMS, V70, P43, DOI 10.1007/s11075-014-9934-9; Ganji DD, 2014, FRONT MECH ENG-PRC, V9, P270, DOI 10.1007/s11465-014-0303-0; Gao ZK, 2016, CHEM ENG J, V291, P74, DOI 10.1016/j.cej.2016.01.039; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2016, IEEE T INSTRUM MEAS, V65, P1690, DOI 10.1109/TIM.2016.2540862; Hamad M. A. A., 2013, J FLUIDS, V2013, P8; Hatami M, 2013, J MOL LIQ, V187, P294, DOI 10.1016/j.molliq.2013.08.008; Hayat T, 2009, NONLINEAR ANAL-REAL, V10, P966, DOI 10.1016/j.nonrwa.2007.11.020; Hayat T, 2015, J AEROSPACE ENG, DOI [10.1061/(ASCE)AS.1943-5525.0000568,04015063, DOI 10.1061/(ASCE)AS.1943-5525.0000568,04015063]; Hayat T, 2016, J MAGN MAGN MATER, V413, P39, DOI 10.1016/j.jmmm.2016.04.025; Hayat T, 2016, J MAGN MAGN MATER, V401, P296, DOI 10.1016/j.jmmm.2015.10.039; Hayat T, 2015, J MAGN MAGN MATER, V395, P294, DOI 10.1016/j.jmmm.2015.07.092; Hsiao KL, 2016, APPL THERM ENG, V98, P850, DOI 10.1016/j.applthermaleng.2015.12.138; Hsiao KL, 2011, INT J NONLIN MECH, V46, P1, DOI 10.1016/j.ijnonlinmec.2010.06.005; Hsiao KL, 2010, COMMUN NONLINEAR SCI, V15, P1803, DOI 10.1016/j.cnsns.2009.07.006; Kameswaran PK, 2013, INT J HEAT MASS TRAN, V57, P465, DOI 10.1016/j.ijheatmasstransfer.2012.10.047; Khan WA, 2012, J HEAT TRANS-T ASME, V134, DOI 10.1115/1.4007138; Lin YH, 2015, POWDER TECHNOL, V274, P324, DOI 10.1016/j.powtec.2015.01.039; Mabood F, 2016, EUR PHYS J PLUS, V131, DOI 10.1140/epjp/i2016-16003-1; Malvandi A, 2014, POWDER TECHNOL, V253, P377, DOI 10.1016/j.powtec.2013.11.049; Merkin JH, 1996, MATH COMPUT MODEL, V24, P125, DOI 10.1016/0895-7177(96)00145-8; Mustafa M, 2015, AIP ADV, V5, DOI 10.1063/1.4917306; Naveed M, 2016, ENG SCI TECHNOL, V19, P841, DOI 10.1016/j.jestch.2015.11.009; Reddy GB, 2015, AIN SHAMS ENG J, V6, P355, DOI 10.1016/j.asej.2014.09.004; Rosca NC, 2015, EUR J MECH B-FLUID, V51, P61, DOI 10.1016/j.euromechflu.2015.01.001; Sajid M, 2010, CHINESE PHYS LETT, V27, DOI 10.1088/0256-307X/27/2/024703; Shaw S, 2013, BOUND VALUE PROBL, DOI 10.1186/1687-2770-2013-77; Shehzad SA, 2014, APPL MATH COMPUT, V248, P273, DOI 10.1016/j.amc.2014.09.091; Sheikholeslami M, 2015, J MAGN MAGN MATER, V374, P36, DOI 10.1016/j.jmmm.2014.08.021; Sui JZ, 2015, INT J HEAT MASS TRAN, V85, P1023, DOI 10.1016/j.ijheatmasstransfer.2015.02.014; [特里帕蒂D Tripathi D], 2011, [应用数学和力学, Applied Mathematics and Mechanics], V32, P1148	42	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161641	10.1371/journal.pone.0161641	http://dx.doi.org/10.1371/journal.pone.0161641			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583457	Green Submitted, gold, Green Published			2022-12-26	WOS:000382855600047
J	Koch, J; Flemming, J; Zeffiro, T; Rufer, M; Orr, SP; Mueller-Pfeiffer, C				Koch, Jennifer; Flemming, Jan; Zeffiro, Thomas; Rufer, Michael; Orr, Scott P.; Mueller-Pfeiffer, Christoph			Effects of Posture and Stimulus Spectral Composition on Peripheral Physiological Responses to Loud Sounds	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; STARTLING TONES; VIETNAM VETERANS; TRAUMA SURVIVORS; HEART-RATE; INTENSITY; REACTIVITY; AMPLITUDE; DURATION; WOMEN	In the "loud-tone" procedure, a series of brief, loud, pure-tone stimuli are presented in a task-free situation. It is an established paradigm for measuring autonomic sensitization in posttraumatic stress disorder (PTSD). Successful use of this procedure during fMRI requires elicitation of brain responses that have sufficient signal-noise ratios when recorded in a supine, rather than sitting, position. We investigated the modulating effects of posture and stimulus spectral composition on peripheral psychophysiological responses to loud sounds. Healthy subjects (N = 24) weekly engaged in a loud-tone-like procedure that presented 500 msec, 95 dB sound pressure level, pure-tone or white-noise stimuli, either while sitting or supine and while peripheral physiological responses were recorded. Heart rate, skin conductance, and eye blink electromyographic responses were larger to white-noise than pure-tone stimuli (p's < 0.001, generalized eta squared 0.073-0.076). Psychophysiological responses to the stimuli were similar in the sitting and supine position (p's >= 0.082). Presenting white noise, rather than pure-tone, stimuli may improve the detection sensitivity of the neural concomitants of heightened autonomic responses by generating larger responses. Recording in the supine position appears to have little or no impact on psychophysiological response magnitudes to the auditory stimuli.	[Koch, Jennifer; Flemming, Jan; Rufer, Michael; Mueller-Pfeiffer, Christoph] Univ Zurich Hosp, Dept Psychiat & Psychotherapy, Zurich, Switzerland; [Zeffiro, Thomas] Massachusetts Gen Hosp, Neural Syst Grp, Boston, MA 02114 USA; [Orr, Scott P.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Orr, Scott P.] Harvard Med Sch, Boston, MA USA	University of Zurich; University Zurich Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Mueller-Pfeiffer, C (corresponding author), Univ Zurich Hosp, Dept Psychiat & Psychotherapy, Zurich, Switzerland.	christoph.mueller-pfeiffer@access.uzh.ch	Zeffiro, Thomas/AAE-3441-2019	Zeffiro, Thomas/0000-0002-0846-4577; Rufer, Michael/0000-0003-4964-4213				BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BLUMENTHAL TD, 1988, PSYCHOPHYSIOLOGY, V25, P607, DOI 10.1111/j.1469-8986.1988.tb01897.x; BLUMENTHAL TD, 1986, PSYCHOPHYSIOLOGY, V23, P635, DOI 10.1111/j.1469-8986.1986.tb00682.x; Boucsein W, 2012, ELECTRODERMAL ACTIVITY, SECOND EDITION, P1, DOI 10.1007/978-1-4614-1126-0; Carson MA, 2007, J TRAUMA STRESS, V20, P657, DOI 10.1002/jts.20218; Derogatis L, 1983, BRIEF SYMPTOM INVENT, V13, P595, DOI DOI 10.1017/S0033291700048017; Edelberg R., 1972, Handbook Psychophysiol, V1972, P367; Franke GH., 2000, BRIEF SYMPTOM INVENT; GRAHAM FK, 1973, PSYCHOPHYSIOLOGY, V10, P347, DOI 10.1111/j.1469-8986.1973.tb00792.x; Hautzinger M, 1994, BECK DEPRESSIONS INV; Jones AYM, 2004, HEART LUNG, V33, P281, DOI 10.1016/j.hrtlng.2004.04.004; Jones AYM, 2003, CHINESE J PHYSIOL, V46, P63; Knight DC, 2005, NEUROIMAGE, V26, P1193, DOI 10.1016/j.neuroimage.2005.03.020; Laux L., 1981, STATE TRAIT ANGSTINV; Metzger LJ, 1999, J ABNORM PSYCHOL, V108, P347, DOI 10.1037/0021-843X.108.2.347; Miles-Chan JL, 2014, CLIN NUTR, V33, P175, DOI 10.1016/j.clnu.2013.11.009; Mueller-Pfeiffer C, 2014, PSYCHOPHYSIOLOGY, V51, P60, DOI 10.1111/psyp.12142; Orr S. P., 2004, ASSESSING PSYCHOL TR, P289; Orr SP, 1998, J CONSULT CLIN PSYCH, V66, P906, DOI 10.1037/0022-006X.66.6.906; Orr SP, 1997, PSYCHIAT RES, V73, P103, DOI 10.1016/S0165-1781(97)00110-8; Orr SP, 2003, ARCH GEN PSYCHIAT, V60, P283, DOI 10.1001/archpsyc.60.3.283; Orr SP, 1997, BIOL PSYCHIAT, V41, P319, DOI 10.1016/S0006-3223(95)00671-0; ORR SP, 1995, J ABNORM PSYCHOL, V104, P75, DOI 10.1037/0021-843X.104.1.75; Pavlov I.P., 1927, CONDITIONED REFLEXES; Pole N, 2007, PSYCHOL BULL, V133, P725, DOI 10.1037/0033-2909.133.5.725; SHALEV AY, 1992, ARCH GEN PSYCHIAT, V49, P870; Shalev AY, 1997, PSYCHIAT RES, V69, P1, DOI 10.1016/S0165-1781(96)03001-6; Shalev AY, 2000, AM J PSYCHIAT, V157, P255, DOI 10.1176/appi.ajp.157.2.255; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Stam R, 2007, NEUROSCI BIOBEHAV R, V31, P530, DOI 10.1016/j.neubiorev.2006.11.010; STEVENS SS, 1957, PSYCHOL REV, V64, P153, DOI 10.1037/h0046162; Team RDC, 2014, R LANG ENV STAT COMP; TURPIN G, 1986, PSYCHOPHYSIOLOGY, V23, P1, DOI 10.1111/j.1469-8986.1986.tb00583.x; TURPIN G, 1983, PSYCHOPHYSIOLOGY, V20, P611, DOI 10.1111/j.1469-8986.1983.tb00927.x; Turpin G, 1999, PSYCHOPHYSIOLOGY, V36, P453, DOI 10.1017/S0048577299971974; TURPIN G, 1979, PSYCHOPHYSIOLOGY, V16, P582, DOI 10.1111/j.1469-8986.1979.tb01525.x; ZAHEJSKY J, 1968, ARCH KLIN EXP DERM, V233, P227, DOI 10.1007/BF00496441	37	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161237	10.1371/journal.pone.0161237	http://dx.doi.org/10.1371/journal.pone.0161237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583659	Green Published, Green Accepted, gold			2022-12-26	WOS:000382855600017
J	Kramer, B; Finnemann, C; Sastre, B; Lutz, P; Glassner, A; Wolter, F; Goeser, F; Kokordelis, P; Kaczmarek, D; Nischalke, HD; Strassburg, CP; Spengler, U; Nattermann, J				Kraemer, Benjamin; Finnemann, Claudia; Sastre, Beatriz; Lutz, Philipp; Glaessner, Andreas; Wolter, Franziska; Goeser, Felix; Kokordelis, Pavlos; Kaczmarek, Dominik; Nischalke, Hans-Dieter; Strassburg, Christian P.; Spengler, Ulrich; Nattermann, Jacob			IL-28B Genetic Variants Determine the Extent of Monocyte-Induced Activation of NK Cells in Hepatitis C	PLOS ONE			English	Article							INTERFERON-STIMULATED GENES; GENOME-WIDE ASSOCIATION; NATURAL-KILLER-CELLS; VIRUS-INFECTION; TREATMENT FAILURE; IL28B GENOTYPE; UP-REGULATION; IFN-GAMMA; IN-VIVO; EXPRESSION	Background Immuno-genetic studies suggest a functional link between NK cells and lambda-IFNs. We recently showed that NK cells are negative for the IFN-lambda receptor IFN-lambda R1 and do not respond to IFN-lambda, suggesting a rather indirect association between IL-28B genotype and NK cell activity. Methods A total of 75 HCV(+) patients and 67 healthy controls were enrolled into this study. IL-28B (rs12979860) and IFNL-4 (rs368234815) genotypes were determined by rtPCR. Total PBMC, monocytes, and NK cells were stimulated with IL-29, the TLR-7/8 agonist R848, or a combination of both. NK cell IFN-. response was analysed by FACS. IL-12 and IL-18 secretion of monocytes was studied by ELISA. In blocking experiments anti-IL-12/anti-IL-18 were used. Results Following stimulation of total PBMCs with R848 we found NK cell IFN-. responses to vary with the IL-28B genotype, with carriers of a T/T genotype displaying the lowest frequency of IFN-lambda(+) NK cells. When isolated NK cells were studied no such associations were observed, indicating an indirect association between IL-28B genotype and NK cell activity. Accordingly, we found R848-stimulated monocytes of patients with a T/T genotype to be significantly less effective in triggering NK cell IFN-. production than monocytes from carriers of a non-T/T genotype. In line with these findings we observed monocytes from T/T patients to secrete significantly lower concentrations of IL-12 than monocytes from non-T/T individuals. Conclusions Our data indicate that monocytes from carriers of an IL-28B T/T genotype display a reduced ability to stimulate NK cell activity and, thus, provide a link between IL-28B genotype and NK functions.	[Kraemer, Benjamin; Finnemann, Claudia; Lutz, Philipp; Glaessner, Andreas; Wolter, Franziska; Goeser, Felix; Kokordelis, Pavlos; Kaczmarek, Dominik; Nischalke, Hans-Dieter; Strassburg, Christian P.; Spengler, Ulrich; Nattermann, Jacob] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Kraemer, Benjamin; Finnemann, Claudia; Lutz, Philipp; Glaessner, Andreas; Wolter, Franziska; Goeser, Felix; Kokordelis, Pavlos; Kaczmarek, Dominik; Nischalke, Hans-Dieter; Strassburg, Christian P.; Spengler, Ulrich; Nattermann, Jacob] German Ctr Infect Res DZIF, Bonn, Germany; [Sastre, Beatriz] Univ Hosp Ramon y Cajal, Inst Hlth Res IRYCIS, Dept Infect Dis, Madrid, Spain; [Sastre, Beatriz] AIDS Res Network RIS RETICS, Madrid, Spain	University of Bonn; German Center for Infection Research; Hospital Universitario Ramon y Cajal	Kramer, B (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.; Kramer, B (corresponding author), German Ctr Infect Res DZIF, Bonn, Germany.	Benjamin.Kraemer@ukb.uni-bonn.de	Goeser, Felix/AAT-4315-2021; Sastre, Beatriz/AAL-3652-2021; Sastre, Beatriz/F-1715-2015; Krämer, Benjamin/AAC-9618-2019	Goeser, Felix/0000-0003-3190-9981; Sastre, Beatriz/0000-0002-2394-6849; Krämer, Benjamin/0000-0002-1385-9709; Nischalke, Hans Dieter/0000-0002-3457-0023; Kaczmarek, Dominik/0000-0003-0093-7832; Lutz, Philipp/0000-0002-4921-200X	German Research Foundation [DFG KR 4521/1-1, DFG SFB/TR 57]; H. W. and J. Hector Foundation [M69]; DFG [KR 4521/1-1, SFB/TR 57]; H. W. and J. Hector Foundation	German Research Foundation(German Research Foundation (DFG)); H. W. and J. Hector Foundation; DFG(German Research Foundation (DFG)); H. W. and J. Hector Foundation	This work was supported by the German Research Foundation (DFG KR 4521/1-1 to BK, and DFG SFB/TR 57 to US and JN) and the H. W. and J. Hector Foundation (M69 to JN). PhD position for BK was funded by DFG KR 4521/1-1. Technician position for CF was funded by DFG SFB/TR 57. Laboratory material was funded by DFG KR 4521/1-1, DFG SFB/TR 57 and the H. W. and J. Hector Foundation. DFG and H. W. and J. Hector Foundation are external funding organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, 2008, J CLIN INVEST, V118, P1017, DOI 10.1172/JCI32400; Arima K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000567; Bibert S, 2013, J EXP MED, V210, P1109, DOI 10.1084/jem.20130012; Binder M, 2007, J VIROL, V81, P5270, DOI 10.1128/JVI.00032-07; Chen LM, 2010, GASTROENTEROLOGY, V138, P1123, DOI 10.1053/j.gastro.2009.10.046; Chen Yi, 2016, J INFECT DIS, DOI [10.1093/infdis/jiw235, DOI 10.1093/INFDIS/JIW23534]; Dickensheets H, 2013, J LEUKOCYTE BIOL, V93, P377, DOI 10.1189/jlb.0812395; Dring MM, 2011, P NATL ACAD SCI USA, V108, P5736, DOI 10.1073/pnas.1016358108; Dultz G, 2016, J VIRAL HEPATITIS, V23, P267, DOI 10.1111/jvh.12488; Fehniger TA, 1999, J IMMUNOL, V162, P4511; de Sa KSG, 2016, CYTOKINE, V77, P79, DOI 10.1016/j.cyto.2015.11.004; Hart OM, 2005, J IMMUNOL BALTIM MD, V1950, P175; Honda M, 2014, HEPATOLOGY, V59, P828, DOI 10.1002/hep.26788; Jouvin-Marche E, 2014, J INFECT DIS, V209, P1907, DOI 10.1093/infdis/jiu016; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Knapp S, 2010, HEPATOLOGY, V51, P1168, DOI 10.1002/hep.23477; Kramer B, 2012, HEPATOLOGY, V56, P1201, DOI 10.1002/hep.25804; Kramer B, 2011, P NATL ACAD SCI USA, V108, pE519, DOI 10.1073/pnas.1108850108; Larange A, 2009, J LEUKOCYTE BIOL, V85, P673, DOI 10.1189/jlb.0808504; Matsuura K, 2016, J MED VIROL, V88, P185, DOI 10.1002/jmv.24334; McGilvray I, 2012, GASTROENTEROLOGY, V142, P1122, DOI 10.1053/j.gastro.2012.01.028; Metz P, 2013, J HEPATOL, V59, P1331, DOI 10.1016/j.jhep.2013.07.033; Mizukoshi E, 1999, J INTERF CYTOK RES, V19, P1019, DOI 10.1089/107999099313235; Morrison MH, 2014, HUM IMMUNOL, V75, P996, DOI 10.1016/j.humimm.2014.06.016; Naggie S, 2012, HEPATOLOGY, V56, P444, DOI 10.1002/hep.25647; Par G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067770; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Puig M, 2012, J LEUKOCYTE BIOL, V91, P147, DOI 10.1189/jlb.0711371; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Serti E, 2014, GASTROENTEROLOGY, V147, P209, DOI 10.1053/j.gastro.2014.03.046; Shirey KA, 2006, J INTERF CYTOK RES, V26, P53, DOI 10.1089/jir.2006.26.53; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Souza-Fonseca-Guimaraes F, 2015, P NATL ACAD SCI USA, V112, pE2376, DOI 10.1073/pnas.1424241112; Sung PS, 2015, P NATL ACAD SCI USA, V112, P10443, DOI 10.1073/pnas.1513341112; Suppiah V, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001092; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Umemura T, 2011, ANTIVIR THER, V16, P1073, DOI 10.3851/IMP1869; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Vidal-Castineira JR, 2010, J VIROL, V84, P475, DOI 10.1128/JVI.01285-09; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Zhang YL, 2009, J HEPATOL, V51, P29, DOI 10.1016/j.jhep.2009.03.012	43	4	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162068	10.1371/journal.pone.0162068	http://dx.doi.org/10.1371/journal.pone.0162068			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583440	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600096
J	Zhou, FC; Resendiz, M; Lo, CL; Chen, YY				Zhou, Feng C.; Resendiz, Marisol; Lo, Chiao-Ling; Chen, Yuanyuan			Cell-Wide DNA De-Methylation and Re-Methylation of Purkinje Neurons in the Developing Cerebellum	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; EMBRYONIC STEM-CELLS; POSTMITOTIC NEURONS; GENE-REGULATION; MAMMALIAN DNA; TET PROTEINS; MOUSE; 5-HYDROXYMETHYLCYTOSINE; GENOME; DEMETHYLATION	Global DNA de-methylation is thought to occur only during pre-implantation and gametogenesis in mammals. Scalable, cell-wide de-methylation has not been demonstrated beyond totipotent stages. Here, we observed a large scale de-methylation and subsequent re-methylation (CDR) (including 5-methylcytosine (5mC) and 5-hydroxylmethylcytosine (5hmC)) in post-mitotic cerebellar Purkinje cells (PC) through the course of normal development. Through single cell immuno-identification and cell-specific quantitative methylation assays, we demonstrate that the CDR event is an intrinsically scheduled program, occurring in nearly every PC. Meanwhile, cerebellar granule cells and basket interneurons adopt their own DNA methylation program, independent of PCs. DNA de-methylation was further demonstrated at the gene level, on genes pertinent to PC development. The PC, being one of the largest neurons in the brain, may showcase an amplified epigenetic cycle which may mediate stage transformation including cell cycle arrest, vast axonal-dendritic growth, and synaptogenesis at the onset of neuronal specificity. This discovery is a key step toward better understanding the breadth and role of DNA methylation and de-methylation during neural ontology.	[Zhou, Feng C.; Lo, Chiao-Ling; Chen, Yuanyuan] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Zhou, Feng C.; Resendiz, Marisol] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Zhou, FC (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA.; Zhou, FC (corresponding author), Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA.	imce100@iu.edu			NIH [AA016698, AA024216, P50 AA07611]; W. M. Keck Foundation; Indiana CTSI Cohort 11 core pilot grant [UL1 TR001108]; IUCR grant from Indiana University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016698, P50AA007611, R21AA024216] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); Indiana CTSI Cohort 11 core pilot grant; IUCR grant from Indiana University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by NIH awards AA016698, AA024216, and P50 AA07611. Additional funding was made possible by the W. M. Keck Foundation, Indiana CTSI Cohort 11 core pilot grant UL1 TR001108 and an IUCR grant from Indiana University to FCZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by NIH awards AA016698, AA024216, and P50 AA07611. Additional funding was made possible by the W. M. Keck Foundation, Indiana CTSI Cohort 11 core pilot grant UL1 TR001108 and an IUCR grant from Indiana University to FCZ. No conflicts of interest played a role in the design, interpretation, or submission of this study.	ALTMAN J, 1969, J COMP NEUROL, V136, P269, DOI 10.1002/cne.901360303; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; Arancillo M, 2015, J NEUROPHYSIOL, V113, P578, DOI 10.1152/jn.00586.2014; Chen YY, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00046; Chen YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060503; Fox C A, 1967, Prog Brain Res, V25, P174; Gavin DP, 2013, NEUROPHARMACOLOGY, V75, P233, DOI 10.1016/j.neuropharm.2013.07.036; Geiman TM, 2010, MOL REPROD DEV, V77, P105, DOI 10.1002/mrd.21118; GOODLETT CR, 1990, DEV BRAIN RES, V53, P131, DOI 10.1016/0165-3806(90)90133-J; Guo Junjie U, 2014, Front Biol (Beijing), V9, P66; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hales BF, 2011, BIRTH DEFECTS RES A, V91, P652, DOI 10.1002/bdra.20781; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jin SG, 2011, NUCLEIC ACIDS RES, V39, P5015, DOI 10.1093/nar/gkr120; Kagami Yoshihiro, 2001, Gene Expression Patterns, V1, P39, DOI 10.1016/S1567-133X(01)00007-2; Kim M, 2014, HUM MOL GENET, V23, P657, DOI 10.1093/hmg/ddt453; Klug M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r63; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; McKay BE, 2005, J PHYSIOL-LONDON, V567, P829, DOI 10.1113/jphysiol.2005.089383; Meng H, 2014, INT J MOL SCI, V15, P22604, DOI 10.3390/ijms151222604; Miller G, 2010, SCIENCE, V329, P27, DOI 10.1126/science.329.5987.27; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; Nishioka M, 2013, INT J DEV NEUROSCI, V31, P89, DOI 10.1016/j.ijdevneu.2012.11.007; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Paul A, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00037; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt091; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wright EM, 2008, ANNOTATION REPORT CE; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Xu GL, 2014, BMB REP, V47, P609, DOI 10.5483/BMBRep.2014.47.11.223; Yamazaki Y, 2003, P NATL ACAD SCI USA, V100, P12207, DOI 10.1073/pnas.2035119100; Zhou Feng C, 2012, Front Biol (Beijing), V7, P485; Zhou FC, 2011, BIRTH DEFECTS RES A, V91, P703, DOI 10.1002/bdra.20820	49	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162063	10.1371/journal.pone.0162063	http://dx.doi.org/10.1371/journal.pone.0162063			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583369	Green Published, gold			2022-12-26	WOS:000382855600094
J	Chapman, CA; Friant, S; Godfrey, K; Liu, C; Sakar, D; Schoof, VAM; Sengupta, R; Twinomugisha, D; Valenta, K; Goldberg, TL				Chapman, Colin A.; Friant, Sagan; Godfrey, Kathleen; Liu, Cynthia; Sakar, Dipto; Schoof, Valerie A. M.; Sengupta, Raja; Twinomugisha, Dennis; Valenta, Kim; Goldberg, Tony L.			Social Behaviours and Networks of Vervet Monkeys Are Influenced by Gastrointestinal Parasites	PLOS ONE			English	Article							INFECTIOUS-DISEASES; NONHUMAN-PRIMATES; COLOBUS MONKEYS; ENERGY; ECOLOGY; TRANSMISSION; CHIMPANZEES; IVERMECTIN; NUTRITION; NEMATODES	Substantial research has shown that while some parasite infections can be fatal to hosts, most infections are sub-clinical and non-lethal. Such sub-clinical infections can nonetheless have negative consequences for the long-term fitness of the host such as reducing juvenile growth and the host's ability to compete for food and mates. With such effects, infected individuals are expected to exhibit behavioural changes. Here we use a parasite removal experiment to quantify how gastrointestinal parasite infections affect the behaviour of vervet monkeys (Chlorocebus aethiops) at Lake Nabugabo, Uganda. Behavioural profiles and the structure of nearest neighbour relationships varied significantly. As predicted, after deworming the duration of the resting events decreased, which is consistent with the idea that parasite infections are energetically costly. In contrast to what was predicted, we could not reject the null hypothesis and we observed no change in either the frequency or duration of grooming, but we found that the duration of travel events increased. A network analysis revealed that after deworming, individuals tended to have more nearest neighbours and hence probably more frequent interactions, with this effect being particularly marked for juveniles. The heightened response by juveniles may indicate that they are avoiding infected individuals more than other age classes because it is too costly to move energy away from growth. We consider that populations with high parasite burden may have difficulties developing social networks and behaviours that could have cascading effects that impact the population in general.	[Chapman, Colin A.; Valenta, Kim] McGill Univ, McGill Sch Environm, Montreal, PQ H3A 2T7, Canada; [Chapman, Colin A.; Valenta, Kim] McGill Univ, Dept Anthropol, Montreal, PQ H3A 2T7, Canada; [Chapman, Colin A.] Wildlife Conservat Soc, Bronx, NY 10460 USA; [Chapman, Colin A.; Twinomugisha, Dennis; Goldberg, Tony L.] Makerere Univ, Biol Field Stn, POB 967, Ft Portal, Uganda; [Friant, Sagan; Goldberg, Tony L.] Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI 53715 USA; [Godfrey, Kathleen] McGill Univ, Dept Anthropol, Montreal, PQ H3A 1B1, Canada; [Liu, Cynthia] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Sakar, Dipto; Sengupta, Raja] McGill Univ, Dept Geog, Montreal, PQ H3A 2T7, Canada; [Schoof, Valerie A. M.] York Univ, Bilingual Biol Program, Dept Multidisciplinary Studies, Glendon Campus, Toronto, ON M3J 1P3, Canada; [Goldberg, Tony L.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA	McGill University; McGill University; Wildlife Conservation Society; Makerere University; University of Wisconsin System; University of Wisconsin Madison; McGill University; McGill University; McGill University; York University - Canada; University of Wisconsin System; University of Wisconsin Madison	Chapman, CA (corresponding author), McGill Univ, McGill Sch Environm, Montreal, PQ H3A 2T7, Canada.; Chapman, CA (corresponding author), McGill Univ, Dept Anthropol, Montreal, PQ H3A 2T7, Canada.; Chapman, CA (corresponding author), Wildlife Conservat Soc, Bronx, NY 10460 USA.; Chapman, CA (corresponding author), Makerere Univ, Biol Field Stn, POB 967, Ft Portal, Uganda.	Colin.Chapman@McGill.ca	Chapman, Colin/S-1911-2019	Chapman, Colin/0000-0002-8827-8140; Sengupta, Raja/0000-0003-4914-5844; Sarkar, Dipto/0000-0003-2254-049X	Canada Research Chair Program; Natural Science and Engineering Research Council of Canada; Fonds Quebecois de la Recherche sur la Nature et les Technologies; National Geographic Society; National Institute of Health [TW009237]; UK Economic and Social Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007414] Funding Source: NIH RePORTER	Canada Research Chair Program(Canada Research Chairs); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds Quebecois de la Recherche sur la Nature et les Technologies(FQRNT); National Geographic Society(National Geographic Society); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for the research was provided by the Canada Research Chair Program (CAC), Natural Science and Engineering Research Council of Canada (CAC), Fonds Quebecois de la Recherche sur la Nature et les Technologies (CAC), National Geographic Society (CAC), National Institute of Health Grant TW009237 (TLG, CAC), and the UK Economic and Social Research Council (TLG, CAC).	Altizer S, 2007, J ANIM ECOL, V76, P304, DOI 10.1111/j.1365-2656.2007.01214.x; Beros S, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1473; Chapman CA, 2005, EVOL ANTHROPOL, V14, P134, DOI 10.1002/evan.20068; Chapman CA, 2006, AM J PHYS ANTHROPOL, V131, P525, DOI 10.1002/ajpa.20477; Cheng TC, 1973, GEN PARISITOLOGY; COLLIAS NICHOLAS, 1952, PROC AMER PHIL SOC, V96, P143; Deputte BL, 2000, ADV STUD BEHAV, V29, P99, DOI 10.1016/S0065-3454(08)60104-7; Despommier DD., 1995, PARASITIC DIS; Dufour JP, 2006, J MED PRIMATOL, V35, P172, DOI 10.1111/j.1600-0684.2006.00154.x; EWALD PW, 1983, ANNU REV ECOL SYST, V14, P465, DOI 10.1146/annurev.es.14.110183.002341; Gaetano TJ, 2014, S AFR J WILDL RES, V44, P56, DOI 10.3957/056.044.0105; Garcia LS., 1999, PRACTICAL GUIDE DIAG; Gasser RB, 2006, PARASITOLOGY, V132, P453, DOI 10.1017/S0031182005009406; Ghai RR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003256; Ghai RR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002641; Ghai RR, P ROYAL SOC IN PRESS; Gillespie TR, 2005, J PARASITOL, V91, P569, DOI 10.1645/GE-434R; GLANDER K E, 1982, Yearbook of Physical Anthropology, V25, P1; Goldberg TL, 2008, EMERG INFECT DIS, V14, P801, DOI 10.3201/eid1405.071686; Greiner EC, 2009, CAM S BIO EVOL ANTHR, V57, P3; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; HART BL, 1990, NEUROSCI BIOBEHAV R, V14, P273, DOI 10.1016/S0149-7634(05)80038-7; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Hasegawa H, 2009, CAM S BIO EVOL ANTHR, V57, P29; Hechinger RF, 2013, AM NAT, V182, P234, DOI 10.1086/670820; HOLMES PH, 1993, P NUTR SOC, V52, P113, DOI 10.1079/PNS19930043; HUDSON PJ, 1992, J ANIM ECOL, V61, P681, DOI 10.2307/5623; Hudson PJ, 2001, ECOLOGY WILDLIFE DIS; Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679; JAMES C, 1983, T ROY SOC TROP MED H, V77, P51, DOI 10.1016/0035-9203(83)90012-3; James R, 2009, BEHAV ECOL SOCIOBIOL, V63, P989, DOI 10.1007/s00265-009-0742-5; Johnson-Delaney Cathy A, 2009, Vet Clin North Am Exot Anim Pract, V12, P563, DOI 10.1016/j.cvex.2009.07.002; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Krief S, 2005, J ETHNOPHARMACOL, V101, P1, DOI 10.1016/j.jep.2005.03.024; Kynkaanniemi SM, 2014, PARASITOL RES, V113, P1489, DOI 10.1007/s00436-014-3790-3; Lynn RC., 1999, GEORGIS PARASITOLOGY; Mukaratirwa S, 2008, ONDERSTEPOORT J VET, V75, P173; MUNGER JC, 1994, CAN J ZOOL, V72, P166, DOI 10.1139/z94-021; MUNGER JC, 1989, ECOLOGY, V70, P904, DOI 10.2307/1941358; Murray DL, 1997, J ANIM ECOL, V66, P250, DOI 10.2307/6026; Navarro V.P, 2002, ARAGON AGER, V2, P101; Nilsson JA, 2003, BEHAV ECOL, V14, P175, DOI 10.1093/beheco/14.2.175; Nunn CL, 2008, EVOL ECOL, V22, P519, DOI 10.1007/s10682-007-9180-x; Nunn CL, 2006, INFECT DIS PRIMATES; Parkins J J, 1989, Nutr Res Rev, V2, P227, DOI 10.1079/NRR19890016; Pedersen AB, 2007, CONSERV BIOL, V21, P1269, DOI 10.1111/j.1523-1739.2007.00776.x; POLDERMAN AM, 1995, PARASITOL TODAY, V11, P451, DOI 10.1016/0169-4758(95)80058-1; POPPI DP, 1990, PROC NEW ZEAL SOC AN, V50, P237; Poulin R, 1995, INT J PARASITOL, V25, P1371, DOI 10.1016/0020-7519(95)00100-X; Robar N, 2011, CAN J ZOOL, V89, P1146, DOI 10.1139/Z11-084; Sa RM, 2013, AM J PRIMATOL, V75, P1032, DOI 10.1002/ajp.22170; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Sloss M., 1994, VET CLIN PARASITOLOG; Stampone M. D., 2011, Research Journal of Environmental and Earth Sciences, V3, P14; Sueur C, 2011, AM J PRIMATOL, V73, P703, DOI 10.1002/ajp.20915; SYKES AR, 1994, ANIM PROD, V59, P155, DOI 10.1017/S0003356100007649; Teichroeb JA, 2014, ANIM COGN, V17, P517, DOI 10.1007/s10071-013-0683-2; Mati VLT, 2013, J PARASITOL, V99, P1009, DOI 10.1645/13-288.1; Tutin CEG, 2000, B SOC PATHOL EXOT, V93, P157; Valenta K, INTEGRATIVE ZO UNPUB; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Wang T, 2008, VET PARASITOL, V153, P121, DOI 10.1016/j.vetpar.2008.01.012; Wren BT, 2015, COMP PARASITOL, V82, P101, DOI 10.1654/4712RR.1; Wren BT, 2006, 122 ANN M IND AC SCI, V1, P42; YOUNG TP, 1994, CONSERV BIOL, V8, P410, DOI 10.1046/j.1523-1739.1994.08020410.x	66	24	24	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161113	10.1371/journal.pone.0161113	http://dx.doi.org/10.1371/journal.pone.0161113			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580121	Green Published, gold			2022-12-26	WOS:000382877400016
J	Zhang, M; Mo, H; Sun, W; Guo, Y; Li, J				Zhang, Mei; Mo, Hui; Sun, Wen; Guo, Yan; Li, Jing			Systematic Isolation and Characterization of Cadmium Tolerant Genes in Tobacco: A cDNA Library Construction and Screening Approach	PLOS ONE			English	Article							HEAVY-METAL DETOXIFICATION; DEFENSE HYPOTHESIS; RESISTANCE PROTEIN; NICOTIANA-TABACUM; HYDROGEN-PEROXIDE; STRESS; TRANSCRIPTION; METALLOTHIONEINS; ACCUMULATION; GLUTATHIONE	Heavy metal pollution is a major limiting factor that severely affects plant growth worldwide, and the accumulation of heavy metal in the plant may be hazardous to human health. To identify the processes involved in cadmium detoxification, we constructed a cDNA library of tobacco roots acclimated to cadmium (Cd) stress. According to the results of functional screening cDNA library with a yeast Cd-sensitive mutant, ycf1 Delta, we obtained a series of candidate genes that were involved in Cd response. Sequence analysis and yeast functional complementation of 24 positive cDNA clones revealed that, in addition to antioxidant genes, genes implicated in abiotic and biotic stress defenses, cellular metabolism, and signal transduction showed Cd detoxification effects in yeast. The real time RT-PCR analyses revealed that some Cd tolerance/detoxification genes may be able to anticipate in other stresses such as biotic defense and water balance in tobacco. Taken together, our data suggest that plants' acclimation to Cd stress is a highly complex process associated with broad gene functions. Moreover, our results provide insights into the Cd detoxification mechanisms along with the antioxidant system, defense gene induction, and calcium signal pathway.	[Zhang, Mei; Mo, Hui; Sun, Wen; Guo, Yan; Li, Jing] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou 510650, Guangdong, Peoples R China; [Sun, Wen; Guo, Yan; Li, Jing] Univ Chinese Acad Sci, Beijing 100039, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, M (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou 510650, Guangdong, Peoples R China.	zhangmei@scbg.ac.cn		Zhang, Mei/0000-0003-0976-3867	National Natural Sciences Foundation of China [31271702, 31570257]; Knowledge Innovation Project for Young Scientists of the South China Botanical Garden	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Project for Young Scientists of the South China Botanical Garden	This research was supported by the National Natural Sciences Foundation of China (Grant no. 31271702 and 31570257) and Knowledge Innovation Project for Young Scientists of the South China Botanical Garden, awarded to M. Zhang. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2005, PLANT BIOTECHNOL, V22, P157, DOI [10.5511/plantbiotechnology.22.157, DOI 10.5511/PLANTBIOTECHNOLOGY.22.157]; Bekesiova B, 2008, MOL BIOL REP, V35, P579, DOI 10.1007/s11033-007-9127-x; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Boulila-Zoghlami L, 2011, PLANTA, V234, P857, DOI 10.1007/s00425-011-1468-y; Boyd RS, 2007, PLANT SOIL, V293, P153, DOI 10.1007/s11104-007-9240-6; Cao Chen-liang, 2015, Yingyong Shengtai Xuebao, V26, P1279; Chaumont F, 2014, PLANT PHYSIOL, V164, P1600, DOI 10.1104/pp.113.233791; CLARKE BB, 1989, JAPCA J AIR WASTE MA, V39, P1319, DOI 10.1080/08940630.1989.10466625; Clemens S, 2013, TRENDS PLANT SCI, V18, P92, DOI 10.1016/j.tplants.2012.08.003; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; DalCorso G, 2008, J INTEGR PLANT BIOL, V50, P1268, DOI 10.1111/j.1744-7909.2008.00737.x; Fones H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001093; Ghanta S, 2011, PLANT SIGNAL BEHAV, V6, P607, DOI [10.4161/psb.6.4.15402, 10.4161/psb.6.6.15147]; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Hassinen VH, 2011, PLANT BIOLOGY, V13, P225, DOI 10.1111/j.1438-8677.2010.00398.x; Horger AC, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00395; Hu LX, 2012, J PLANT PHYSIOL, V169, P146, DOI 10.1016/j.jplph.2011.08.020; Janiak A, 2016, J EXP BOT, V67, P1003, DOI 10.1093/jxb/erv512; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Kramer U, 2005, CURR OPIN BIOTECH, V16, P133, DOI 10.1016/j.copbio.2005.02.006; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Li GW, 2014, BBA-GEN SUBJECTS, V1840, P1574, DOI 10.1016/j.bbagen.2013.11.004; Li ZS, 1996, J BIOL CHEM, V271, P6509, DOI 10.1074/jbc.271.11.6509; Liu YL, 2004, J BIOL CHEM, V279, P2101, DOI 10.1074/jbc.M310029200; Meharg AA, 2013, ENVIRON SCI TECHNOL, V47, P5613, DOI 10.1021/es400521h; Ministry of Environmental Protection & Ministry of Land and Resources of People's Republic of China, 2014, COMM SOIL POLL STAT; Nahirnak V, 2012, PLANT SIGNAL BEHAV, V7, P1004, DOI 10.4161/psb.20813; O'Connor RJ, 2010, TOB CONTROL, V19, DOI 10.1136/tc.2009.030163; Oono Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096946; Palmgren MG, 2008, TRENDS PLANT SCI, V13, P464, DOI 10.1016/j.tplants.2008.06.005; PONSTEIN AS, 1994, PLANT PHYSIOL, V104, P109, DOI 10.1104/pp.104.1.109; Poschenrieder C, 2006, TRENDS PLANT SCI, V11, P288, DOI 10.1016/j.tplants.2006.04.007; Rubinovich L, 2014, MOL PLANT, V7, P244, DOI 10.1093/mp/sst141; Schluttenhofer C, 2015, PLANT PHYSIOL, V167, P295, DOI 10.1104/pp.114.251769; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Schutzendubel A, 2001, PLANT PHYSIOL, V127, P887, DOI 10.1104/pp.010318; Sewelam N, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00187; Shang YL, 2006, P NATL ACAD SCI USA, V103, P19200, DOI 10.1073/pnas.0607279103; Sharma SS, 2016, PLANT CELL ENVIRON, V39, P1112, DOI 10.1111/pce.12706; Song WY, 2010, PLANT CELL, V22, P2237, DOI 10.1105/tpc.109.070185; Song WY, 2004, PLANT PHYSIOL, V135, P1027, DOI 10.1104/pp.103.037739; SZCZYPKA MS, 1994, J BIOL CHEM, V269, P22853; Tamas L, 2010, PLANTA, V231, P221, DOI 10.1007/s00425-009-1042-z; Ueki S, 2002, NAT CELL BIOL, V4, P478, DOI 10.1038/ncb806; Verbruggen N, 2009, CURR OPIN PLANT BIOL, V12, P364, DOI 10.1016/j.pbi.2009.05.001; WARD ER, 1991, PLANT CELL, V3, P1085, DOI 10.1105/tpc.3.10.1085; Yamamoto S, 2004, BBA-GENE STRUCT EXPR, V1679, P279, DOI 10.1016/j.bbaexp.2004.07.005; Zhang HJ, 2012, MOL PLANT MICROBE IN, V25, P1639, DOI 10.1094/MPMI-11-11-0293; Zhang J, 2015, J PLANT PHYSIOL, V178, P17, DOI 10.1016/j.jplph.2015.01.017; Zhang XT, 2013, MOL BIOL REP, V40, P1407, DOI 10.1007/s11033-012-2184-9	51	12	12	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161147	10.1371/journal.pone.0161147	http://dx.doi.org/10.1371/journal.pone.0161147			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579677	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877400019
J	Chwojnicki, K; Krol, E; Wierucki, L; Kozera, G; Sobolewski, P; Nyka, WM; Zdrojewski, T				Chwojnicki, Kamil; Krol, Ewa; Wierucki, Lukasz; Kozera, Grzegorz; Sobolewski, Piotr; Nyka, Walenty M.; Zdrojewski, Tomasz			Renal Dysfunction in Post-Stroke Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; STROKE; RISK; EPIDEMIOLOGY; PREVALENCE; PREDICTORS; COMMUNITY; URBAN	Background The presence of chronic kidney disease (CKD) is an indicator of a worse long-term prognosis in patients with ischemic stroke (IS). Unfortunately, not much is known about renal function in the population of post-IS subjects. The aim of our study was to assess the prevalence of renal damage and impaired renal function (IRF) in the population of post-IS subjects. Methods This prospective analysis concerned 352 consecutive post-IS survivors hospitalized in Pomeranian stroke centers (Poland) in 2009. In this group estimated glomerular filtration rate (eGFR) according to MDRD (modification of diet in renal diseases) and CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) formulas and urine albumin/creatinine ratio (ACR) were determined. Results Among survivors decreased eGFR (<60 mL/min./1.73m(2) according to MDRD or CKD-EPI) or ACR >= 30mg/g were detected in 40.38% (23.07% Men, 55.32% Women; P<0.01). The highest prevalence of IRF was noted in post-IS subjects with atheromatic and lacunar IS. In multivariate analysis the ACR >= 30mg/g was predicted by older age, diabetes mellitus (DM) and physical disability (modified Rankin scale 3-5 pts.). The association with reduced eGFR was proved for sex (female), DM and physical disability. Conclusions CKD is a frequently occurring problem in the group of post-IS subjects, especially after lacunar and atheromatic IS. Post-IS patients, mainly the elderly women, with physical disability and diabetes mellitus, should be regularly screened for CKD. This could reduce the risk of further cardiovascular events and delay the progression of IRF.	[Chwojnicki, Kamil; Kozera, Grzegorz; Nyka, Walenty M.] Med Univ Gdansk, Dept Neurol, Gdansk, Poland; [Krol, Ewa] Med Univ Gdansk, Dept Nephrol, Gdansk, Poland; [Wierucki, Lukasz; Zdrojewski, Tomasz] Med Univ Gdansk, Dept Arterial Hypertens & Diabetol, Gdansk, Poland; [Sobolewski, Piotr] Hosp Sandomierz, Dept Neurol, Sandomierz, Poland; [Sobolewski, Piotr] Hosp Sandomierz, Stroke Unit, Sandomierz, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Chwojnicki, K (corresponding author), Med Univ Gdansk, Dept Neurol, Gdansk, Poland.	kchwoj@gumed.edu.pl	Zdrojewski, Tomasz/AAA-8875-2020; Chwojnicki, Kamil/AAK-6739-2020; Kozera, Grzegorz/AAS-8413-2020	Zdrojewski, Tomasz/0000-0001-6015-8561; Chwojnicki, Kamil/0000-0002-1361-8796; Kozera, Grzegorz/0000-0001-7704-2434; Wierucki, Lukasz/0000-0003-2995-6180	Office of the Marshal of Pomeranian Voivodeship, Poland	Office of the Marshal of Pomeranian Voivodeship, Poland	This work was supported by Office of the Marshal of Pomeranian Voivodeship, Poland.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Al-Aly Z, 2010, J AM SOC NEPHROL, V21, P1961, DOI 10.1681/ASN.2009121210; [Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; [Anonymous], 2009, FRES MED CAR 2010, P3; Bao YS, 2013, EUR J CLIN INVEST, V43, P829, DOI 10.1111/eci.12113; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chudek J, 2013, NEPHROL DIAL TRANSPL, P1; Fabjan T, EUROPEAN J NEUROLOGY, V14, P1351; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Hung PH, 2014, NEPHROL DIAL TRANSPL, V29, P873, DOI 10.1093/ndt/gft534; Kozera G, 2012, ACTA NEUROL SCAND, V126, P171, DOI 10.1111/j.1600-0404.2011.01616.x; Krol E, 2009, AM J NEPHROL, V29, P264, DOI 10.1159/000158526; Kumai Y, 2012, Neurology, V78, P1909, DOI 10.1212/WNL.0b013e318259e110; Lee Meng, 2010, BMJ, V341, pc4249, DOI 10.1136/bmj.c4249; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MacWalter RS, 2002, STROKE, V33, P1630, DOI 10.1161/01.STR.0000016344.49819.F7; Missouris CG, 1998, NEPHROL DIAL TRANSPL, V13, P945, DOI 10.1093/ndt/13.4.945; Ninomiya T, 2009, AM J KIDNEY DIS, V53, P417, DOI 10.1053/j.ajkd.2008.08.032; Oksala NKJ, 2010, STROKE, V41, P1914, DOI 10.1161/STROKEAHA.110.587352; Rutkowski B., 2010, PRZEW LEK, V2, P64; Rutkowski B, 2009, REPORT RENAL REPLACE; SACCO RL, 1994, NEUROLOGY, V44, P626, DOI 10.1212/WNL.44.4.626; Tanner RM, 2013, AM J KIDNEY DIS, V61, P395, DOI 10.1053/j.ajkd.2012.10.018; Tsagalis G, 2009, NEPHROL DIAL TRANSPL, V24, P194, DOI 10.1093/ndt/gfn471; Tsukamoto Y, 2012, J STROKE CEREBROVASC, V21, P547, DOI 10.1016/j.jstrokecerebrovasdis.2010.12.005; US Renal Data System, 2008, USRDS 2008 ANN DAT R; USRDS. United States Renal Data System, 2010, US REN DAT SYST 2010; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Yahalom G, 2009, STROKE, V40, P1296, DOI 10.1161/STROKEAHA.108.520882	34	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0159775	10.1371/journal.pone.0159775	http://dx.doi.org/10.1371/journal.pone.0159775			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575370	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877200004
J	Ghatalia, P; Yang, ES; Lasseigne, BN; Ramaker, RC; Cooper, SJ; Chen, DQ; Sudarshan, S; Wei, S; Guru, AS; Zhao, A; Cooper, T; Della Manna, DL; Naik, G; Myers, RM; Sonpavde, G				Ghatalia, Pooja; Yang, Eddy S.; Lasseigne, Brittany N.; Ramaker, Ryne C.; Cooper, Sara J.; Chen, Dongquan; Sudarshan, Sunil; Wei, Shi; Guru, Arjun S.; Zhao, Amy; Cooper, Tiffiny; Della Manna, Deborah L.; Naik, Gurudatta; Myers, Richard M.; Sonpavde, Guru			Kinase Gene Expression Profiling of Metastatic Clear Cell Renal Cell Carcinoma Tissue Identifies Potential New Therapeutic Targets	PLOS ONE			English	Article							INTERFERON-ALPHA; EPHB2 EXPRESSION; RECURRENCE; EVEROLIMUS; ACTIVATION; CANCER; RISK; PHOSPHORYLATION; INTERLEUKIN-2; SIGNATURE	Kinases are therapeutically actionable targets. Kinase inhibitors targeting vascular endothelial growth factor receptors (VEGFR) and mammalian target of rapamycin (mTOR) improve outcomes in metastatic clear cell renal cell carcinoma (ccRCC), but are not curative. Metastatic tumor tissue has not been comprehensively studied for kinase gene expression. Paired intra-patient kinase gene expression analysis in primary tumor (T), matched normal kidney (N) and metastatic tumor tissue (M) may assist in identifying drivers of metastasis and prioritizing therapeutic targets. We compared the expression of 519 kinase genes using NanoString in T, N and M in 35 patients to discover genes over-expressed in M compared to T and N tissue. RNA-seq data derived from ccRCC tumors in The Cancer Genome Atlas (TCGA) were used to demonstrate differential expression of genes in primary tumor tissue from patients that had metastasis at baseline (n = 79) compared to those that did not develop metastasis for at least 2 years (n = 187). Functional analysis was conducted to identify key signaling pathways by using Ingenuity Pathway Analysis. Of 10 kinase genes overexpressed in metastases compared to primary tumor in the discovery cohort, 9 genes were also differentially expressed in TCGA primary tumors with metastasis at baseline compared to primary tumors without metastasis for at least 2 years: EPHB2, AURKA, GSG2, IKBKE, MELK, CSK, CHEK2, CDC7 and MAP3K8; p<0.001). The top pathways overexpressed in M tissue were pyridoxal 5'-phosphate salvage, salvage pathways of pyrimidine ribonucleotides, NF-kB signaling, NGF signaling and cell cycle control of chromosomal replication. The 9 kinase genes validated to be over-expressed in metastatic ccRCC may represent currently unrecognized but potentially actionable therapeutic targets that warrant functional validation.	[Ghatalia, Pooja] Univ Alabama Birmingham, Dept Internal Med, Birmingham, AL 35294 USA; [Yang, Eddy S.; Guru, Arjun S.; Zhao, Amy; Cooper, Tiffiny; Della Manna, Deborah L.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35294 USA; [Lasseigne, Brittany N.; Ramaker, Ryne C.; Cooper, Sara J.; Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Ramaker, Ryne C.] UAB, Dept Genet, Birmingham, AL 35294 USA; [Chen, Dongquan] UAB, Dept Prevent Med, Birmingham, AL 35294 USA; [Sudarshan, Sunil] UAB, Dept Urol, Birmingham, AL 35294 USA; [Wei, Shi] UAB, Dept Urol Pathol, Birmingham, AL 35294 USA; [Naik, Gurudatta; Sonpavde, Guru] UAB, Dept Med, Hematol Oncol Sect, Birmingham, AL 35294 USA; [Naik, Gurudatta; Sonpavde, Guru] UAB, Ctr Comprehens Canc, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; HudsonAlpha Institute for Biotechnology; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sonpavde, G (corresponding author), UAB, Dept Med, Hematol Oncol Sect, Birmingham, AL 35294 USA.; Sonpavde, G (corresponding author), UAB, Ctr Comprehens Canc, Birmingham, AL 35294 USA.	gsonpavde@uabmc.edu	naik, Gurudatta/O-7284-2015; Cooper, Sara/K-3142-2019; Sonpavde/L-7107-2019	naik, Gurudatta/0000-0001-7265-6605; Sonpavde/0000-0002-1010-9611; Lasseigne, Brittany/0000-0002-1642-8904; Cooper, Sara/0000-0002-9627-0309; Zhao, Amy/0000-0002-0494-4223	NIH-National Institute of General Medical Sciences Medical Scientist Training Program [5T32GM008361-21]; cancer research fund from the state of Alabama; UAB Department of Medicine; cancer research fund from the Alabama Cancer Research Consortium; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103434, T32GM008361] Funding Source: NIH RePORTER	NIH-National Institute of General Medical Sciences Medical Scientist Training Program; cancer research fund from the state of Alabama; UAB Department of Medicine; cancer research fund from the Alabama Cancer Research Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by genitourinary oncology research support grant provided to Guru Sonpavde by the UAB Department of Medicine. Additionally, Ryne Ramaker was supported by the NIH-National Institute of General Medical Sciences Medical Scientist Training Program (5T32GM008361-21) and Brittany Lasseigne and Richard Myers were supported by a cancer research fund from the state of Alabama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funded by genitourinary oncology research support grant provided to Guru Sonpavde by the UAB Department of Medicine. Additionally, Ryne Ramaker was supported by the NIH-National Institute of General Medical Sciences Medical Scientist Training Program (5T32GM008361-21) and Brittany Lasseigne and Richard Myers were supported by a cancer research fund from the Alabama Cancer Research Consortium.	Beard RE, 2013, CLIN CANCER RES, V19, P4941, DOI 10.1158/1078-0432.CCR-13-1253; Behbahani TE, 2012, WORLD J UROL, V30, P559, DOI 10.1007/s00345-011-0767-z; Brugarolas J, 2014, J CLIN ONCOL, V32, P1968, DOI 10.1200/JCO.2012.45.2003; Carlo MI, 2016, ONCOLOGIST, V21, P787, DOI 10.1634/theoncologist.2016-0145; Choueiri TK, 2015, NEW ENGL J MED, V373, P1814, DOI 10.1056/NEJMoa1510016; Chung SY, 2012, ONCOTARGET, V3, P1629; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Cybulski C, 2004, AM J HUM GENET, V75, P1131, DOI 10.1086/426403; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Dowsett M, 2013, J CLIN ONCOL, V31, P2783, DOI 10.1200/JCO.2012.46.1558; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Feng X, 2009, ONCOGENE, V28, P3320, DOI 10.1038/onc.2009.185; FYFE G, 1995, J CLIN ONCOL, V13, P688, DOI 10.1200/JCO.1995.13.3.688; Gao Q, 2014, HUM PATHOL, V45, P372, DOI 10.1016/j.humpath.2013.10.001; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gu CY, 2013, STEM CELLS, V31, P870, DOI 10.1002/stem.1322; Hildebrandt MAT, 2012, CARCINOGENESIS, V33, P799, DOI 10.1093/carcin/bgs018; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Huertas D, 2012, ONCOGENE, V31, P1408, DOI 10.1038/onc.2011.335; Joshi K, 2013, STEM CELLS, V31, P1051, DOI 10.1002/stem.1358; Jubb AM, 2005, CLIN CANCER RES, V11, P5181, DOI 10.1158/1078-0432.CCR-05-0143; Kandouz M, 2010, CELL CYCLE, V9, P398, DOI 10.4161/cc.9.2.10505; Khansaard W, 2014, TUMOR BIOL, V35, P10031, DOI 10.1007/s13277-014-2295-0; Kulkarni Meghana M, 2011, Curr Protoc Mol Biol, VChapter 25, DOI 10.1002/0471142727.mb25b10s94; Lohavanichbutr P, 2013, CLIN CANCER RES, V19, P1197, DOI 10.1158/1078-0432.CCR-12-2647; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lugli A, 2005, CLIN CANCER RES, V11, P6450, DOI 10.1158/1078-0432.CCR-04-2458; Mao WG, 2004, CANCER RES, V64, P781, DOI 10.1158/0008-5472.CAN-03-1047; McDermott DF, 2005, J CLIN ONCOL, V23, P133, DOI 10.1200/JCO.2005.03.206; Minata M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092546; Mosch B, 2010, J ONCOL, V2010, DOI 10.1155/2010/135285; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2015, LANCET ONCOL, V16, P1473, DOI 10.1016/S1470-2045(15)00290-9; Pal SK, 2015, MOL CANCER RES, V13, P130, DOI 10.1158/1541-7786.MCR-14-0352; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Peri S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076746; Powles T, 2016, J CLIN ONCOL, V34, P1660, DOI 10.1200/JCO.2015.64.8808; Rini B, 2015, LANCET ONCOL, V16, P676, DOI 10.1016/S1470-2045(15)70167-1; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Schutz FAB, 2013, LANCET ONCOL, V14, P81, DOI 10.1016/S1470-2045(12)70517-X; Sestak I, 2013, JNCI-J NATL CANCER I, V105, P1504, DOI 10.1093/jnci/djt244; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Stricker TP, 2014, MOL ONCOL, V8, P669, DOI 10.1016/j.molonc.2014.01.010; Sultmann H, 2005, CLIN CANCER RES, V11, P646; Vlahovic G, 2003, ONCOLOGIST, V8, P531, DOI 10.1634/theoncologist.8-6-531; Wu P, 2015, TRENDS PHARMACOL SCI, V36, P422, DOI 10.1016/j.tips.2015.04.005	52	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0160924	10.1371/journal.pone.0160924	http://dx.doi.org/10.1371/journal.pone.0160924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27574806	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877200011
J	Ennour-Idrissi, K; Tetu, B; Maunsell, E; Poirier, B; Montoni, A; Rochette, PJ; Diorio, C				Ennour-Idrissi, Kaoutar; Tetu, Bernard; Maunsell, Elizabeth; Poirier, Brigitte; Montoni, Alicia; Rochette, Patrick J.; Diorio, Caroline			Association of Telomere Length with Breast Cancer Prognostic Factors	PLOS ONE			English	Article							PHYSICAL-ACTIVITY GUIDELINES; SURVIVORS; WOMEN; CHEMOTHERAPY	Introduction Telomere length, a marker of cell aging, seems to be affected by the same factors thought to be associated with breast cancer prognosis. Objective To examine associations of peripheral blood cell-measured telomere length with traditional and potential prognostic factors in breast cancer patients. Methods We conducted a cross-sectional analysis of data collected before surgery from 162 breast cancer patients recruited consecutively between 01/2011 and 05/2012, at a breast cancer reference center. Data on the main lifestyle factors (smoking, alcohol consumption, physical activity) were collected using standardized questionnaires. Anthropometric factors were measured. Tumor biological characteristics were extracted from pathology reports. Telomere length was measured using a highly reproducible quantitative PCR method in peripheral white blood cells. Spearman partial rank-order correlations and multivariate general linear models were used to evaluate relationships between telomere length and prognostic factors. Results Telomere length was positively associated with total physical activity (r(s) = 0.17, P = 0.033; P-trend = 0.069), occupational physical activity (r(s) = 0.15, P = 0.054; P-trend = 0.054) and transportation-related physical activity (r(s) = 0.19, P = 0.019; P = 0.005). Among post-menopausal women, telomere length remained positively associated with total physical activity (r(s) = 0.27, P = 0.016; P-trend = 0.054) and occupational physical activity (r(s) = 0.26, P = 0.021; P-trend = 0.056) and was only associated with transportation-related physical activity among pre-menopausal women (r(s) = 0.27, P = 0.015; P = 0.004). No association was observed between telomere length and recreational or household activities, other lifestyle factors or traditional prognostic factors. Conclusions Telomeres are longer in more active breast cancer patients. Since white blood cells are involved in anticancer immune responses, these findings suggest that even regular low-intensity physical activity, such as that related to transportation or occupation, could be recommended to breast cancer patients.	[Ennour-Idrissi, Kaoutar; Tetu, Bernard; Maunsell, Elizabeth; Poirier, Brigitte; Diorio, Caroline] Univ Laval, CHU Quebec, Ctr Rech, Axe Oncol, Quebec City, PQ, Canada; [Ennour-Idrissi, Kaoutar; Tetu, Bernard; Maunsell, Elizabeth; Poirier, Brigitte; Diorio, Caroline] Univ Laval, Ctr Rech Canc, Quebec City, PQ, Canada; [Ennour-Idrissi, Kaoutar; Maunsell, Elizabeth; Diorio, Caroline] Univ Laval, Fac Med, Dept Med Sociale & Prevent, Quebec City, PQ, Canada; [Tetu, Bernard] Univ Laval, Fac Med, Dept Biol Mol Biochim Med & Pathol, Quebec City, PQ, Canada; [Tetu, Bernard; Maunsell, Elizabeth; Poirier, Brigitte; Diorio, Caroline] Hop St Sacrement, Ctr Malad Sein Deschenes Fabia, Quebec City, PQ, Canada; [Poirier, Brigitte] Univ Laval, Fac Med, Dept Chirurg, Quebec City, PQ, Canada; [Montoni, Alicia; Rochette, Patrick J.] Univ Laval, CHU Quebec, Ctr Rech, Axe Med Regenerat, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University; Laval University; Laval University; Laval University	Diorio, C (corresponding author), Univ Laval, CHU Quebec, Ctr Rech, Axe Oncol, Quebec City, PQ, Canada.; Diorio, C (corresponding author), Univ Laval, Ctr Rech Canc, Quebec City, PQ, Canada.; Diorio, C (corresponding author), Univ Laval, Fac Med, Dept Med Sociale & Prevent, Quebec City, PQ, Canada.	Caroline.Diorio@crchudequebec.ulaval.ca	Rochette, Patrick/HHN-2300-2022	Rochette, Patrick/0000-0002-0678-8869	Fondation des Hopitaux Enfant-Jesus - Saint-Sacrement; Canadian Breast Cancer Research Alliance [20460]; Cancer Research Centre at Laval University; Canadian Breast Cancer Foundation-Canadian Cancer Society Capacity Development award [703003]; FRQS Research Scholar	Fondation des Hopitaux Enfant-Jesus - Saint-Sacrement; Canadian Breast Cancer Research Alliance; Cancer Research Centre at Laval University; Canadian Breast Cancer Foundation-Canadian Cancer Society Capacity Development award; FRQS Research Scholar	This project was funded by the "Fondation des Hopitaux Enfant-Jesus - Saint-Sacrement" (http://tmdesign.ca/client/fondation-hopital/) and the Canadian Breast Cancer Research Alliance (http://www.cwhn.ca/fr/node/20460). Biological specimens were provided by the Fondation du cancer du sein du Quebec (http://www.rubanrose.org) and the Banque de tissus et de donnees of the Reseau de recherche sur le cancer of the FRQS (https://www.economie.gouv.qc.ca/objectifs/informer/recherche-et-innovation/page/intervenants-du-milieu18854/?tx_igaffichagepages_pi1%5BbackPid%5D=18870&tx_igaffichagepages_pi1%5BcurrentCat%5D=&tx_igaffichagepages_pi1%5Bmode%5D=single&tx_igaffichagepages_pi1%5BparentPid%5D=18800&cHash=d57df5997e5aacb60db91a754b089dda), which is affiliated with the Canadian Tumour Repository Network. KEI received a training award from the "Cancer Research Centre at Laval University" (https://www.crc.ulaval.ca/no_cache/en/home/). CD is a recipient of the Canadian Breast Cancer Foundation-Canadian Cancer Society Capacity Development award (award #703003) (http://www.cbcf.org/Pages/default.aspx-http://www.cancer.ca/en/?region=on) and the FRQS Research Scholar (http://www.frqs.gouv.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Baird DM, 2008, EXP GERONTOL, V43, P15, DOI 10.1016/j.exger.2007.10.002; Benitez-Buelga C, 2015, BREAST CANCER RES TR, V149, P385, DOI 10.1007/s10549-014-3246-6; Braithwaite D, 2012, BREAST CANCER RES TR, V136, P521, DOI 10.1007/s10549-012-2276-1; Browner WS, 2007, DESIGNING CLIN RES, P65; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Diker-Cohen T, 2013, LEUKEMIA LYMPHOMA, V54, P2023, DOI 10.3109/10428194.2012.757765; Du MM, 2012, AM J EPIDEMIOL, V175, P414, DOI 10.1093/aje/kwr330; Edge SB BD, 2010, BREAST; Ennour-Idrissi K, 2016, CANC EPIDEM IN PRESS; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Friedenreich CM, 2006, AM J EPIDEMIOL, V163, P959, DOI 10.1093/aje/kwj112; Garland SN, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0413-y; Gou YJ, 2013, ASIAN PAC J CANCER P, V14, P4785, DOI 10.7314/APJCP.2013.14.8.4785; Hanna M, 2015, MENOPAUSE, V22, P964, DOI 10.1097/GME.0000000000000433; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; Lakhani SR, 2012, WHO CLASSIFICATION T; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu WS, 2013, EXP CELL RES, V319, P133, DOI 10.1016/j.yexcr.2012.09.005; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Rock CL, 2012, CA-CANCER J CLIN, V62, P243, DOI 10.3322/caac.21142; Spark LC, 2013, J CANCER SURVIV, V7, P74, DOI 10.1007/s11764-012-0246-6; Sun Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038374; Svenson U, 2008, CANCER RES, V68, P3618, DOI 10.1158/0008-5472.CAN-07-6497; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tremblay MS, 2011, APPL PHYSIOL NUTR ME, V36, P36, DOI [10.1139/H11-009, 10.1139/H11-010]; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39; Xiao H, 2007, DRUG DISCOVERY SERIE; Yang IV, 2002, GENOME BIOL, V3	32	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161903	10.1371/journal.pone.0161903	http://dx.doi.org/10.1371/journal.pone.0161903			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571273	Green Submitted, Green Published, gold			2022-12-26	WOS:000382876700041
J	Delerce, S; Dorado, H; Grillon, A; Rebolledo, MC; Prager, SD; Patio, VH; Varon, GG; Jimenez, D				Delerce, Sylvain; Dorado, Hugo; Grillon, Alexandre; Camila Rebolledo, Maria; Prager, Steven D.; Hugo Patio, Victor; Garces Varon, Gabriel; Jimenez, Daniel			Assessing Weather-Yield Relationships in Rice at Local Scale Using Data Mining Approaches	PLOS ONE			English	Article							CLIMATE VARIABILITY; CROP MANAGEMENT; TEMPERATURE; MODELS; CLASSIFICATION; APPROXIMATION; PRODUCTIVITY; THRESHOLDS; IMPACTS; DROUGHT	Seasonal and inter-annual climate variability have become important issues for farmers, and climate change has been shown to increase them. Simultaneously farmers and agricultural organizations are increasingly collecting observational data about in situ crop performance. Agriculture thus needs new tools to cope with changing environmental conditions and to take advantage of these data. Data mining techniques make it possible to extract embedded knowledge associated with farmer experiences from these large observational datasets in order to identify best practices for adapting to climate variability. We introduce new approaches through a case study on irrigated and rainfed rice in Colombia. Preexisting observational datasets of commercial harvest records were combined with in situ daily weather series. Using Conditional Inference Forest and clustering techniques, we assessed the relationships between climatic factors and crop yield variability at the local scale for specific cultivars and growth stages. The analysis showed clear relationships in the various location-cultivar combinations, with climatic factors explaining 6 to 46% of spatiotemporal variability in yield, and with crop responses to weather being non-linear and cultivar-specific. Climatic factors affected cultivars differently during each stage of development. For instance, one cultivar was affected by high nighttime temperatures in the reproductive stage but responded positively to accumulated solar radiation during the ripening stage. Another was affected by high nighttime temperatures during both the vegetative and reproductive stages. Clustering of the weather patterns corresponding to individual cropping events revealed different groups of weather patterns for irrigated and rainfed systems with contrasting yield levels. Best-suited cultivars were identified for some weather patterns, making weather-site-specific recommendations possible. This study illustrates the potential of data mining for adding value to existing observational data in agriculture by allowing embedded knowledge to be quickly leveraged. It generates site-specific information on cultivar response to climatic factors and supports on-farm management decisions for adaptation to climate variability.	[Delerce, Sylvain; Dorado, Hugo; Prager, Steven D.; Hugo Patio, Victor; Jimenez, Daniel] Ctr Int Agr Trop, Decis & Policy Anal DAPA, Cali, Colombia; [Grillon, Alexandre] Haute Ecole Ingn & Gest Canton Vaud HEIG VD, Yverdon, Switzerland; [Camila Rebolledo, Maria] Ctr Int Agr Trop, Agrobiodivers Rice Dept, Cali, Colombia; [Garces Varon, Gabriel] Colombian Natl Rice Growers Federat Fedearroz, Bogota, Colombia	Alliance; International Center for Tropical Agriculture - CIAT; Alliance; International Center for Tropical Agriculture - CIAT	Delerce, S (corresponding author), Ctr Int Agr Trop, Decis & Policy Anal DAPA, Cali, Colombia.	s.delerce@cgiar.org	Prager, Steven/ABD-2092-2020; rebolledo, maria/AAQ-4981-2021	Prager, Steven/0000-0001-9830-7008; Jimenez, Daniel/0000-0003-4218-4306; Dorado, Hugo Andres/0000-0002-0103-7505	Colombian Ministry of Agriculture (MADR for its acronym in Spanish); Consultative Group on International Agricultural Research (CGIAR) Research Program on Climate Change, Agriculture and Food Security (CCAFS); Colombian Ministry of Agriculture (MADR); CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS)	Colombian Ministry of Agriculture (MADR for its acronym in Spanish); Consultative Group on International Agricultural Research (CGIAR) Research Program on Climate Change, Agriculture and Food Security (CCAFS)(CGIAR); Colombian Ministry of Agriculture (MADR); CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS)(CGIAR)	This research was funded by: the Colombian Ministry of Agriculture (MADR for its acronym in Spanish); https://www.minagricultura.gov.co/Paginas/default.aspx and the Consultative Group on International Agricultural Research (CGIAR) Research Program on Climate Change, Agriculture and Food Security (CCAFS). https://ccafs.cgiar.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The project was carried out in close collaboration with the Colombian National Rice Growers Federation (Fedearroz) who made this study possible by providing the rice production data and contributing to the interpretation and evaluation of the results. Authors also thank the Instituto de Hidrologia, Meteorologia y Estudios Ambientales (IDEAM) for providing the weather data. The open access data policy of IDEAM has been a critical element in accelerating the research processes. We also thank Julian Ramirez-Villegas from CIAT for his thorough review of an earlier version of this manuscript, and James Cock who is a key mentor to the team. This research was funded by the Colombian Ministry of Agriculture (MADR) and the CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS).	Allen R. G., 1998, FAO Irrigation and Drainage Paper; Merlos FA, 2015, FIELD CROP RES, V184, P145, DOI 10.1016/j.fcr.2015.10.001; Archer KJ, 2008, COMPUT STAT DATA AN, V52, P2249, DOI 10.1016/j.csda.2007.08.015; Barnston AG, 1999, B AM METEOROL SOC, V80, P217, DOI 10.1175/1520-0477(1999)080<0217:PSOSAD>2.0.CO;2; Bheemanahalli R, 2016, AGR FOREST METEOROL, V221, P122, DOI 10.1016/j.agrformet.2016.02.003; Bojanowski JS, 2015, SIRAD FUNCTIONS CALC; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 1996, BIAS VARIANCE ARCING; Castilla-Lozano LA, 2011, ECOLOGIA MICROORGANI, P33; Challinor AJ, 2014, NAT CLIM CHANGE, V4, P287, DOI [10.1038/NCLIMATE2153, 10.1038/nclimate2153]; Chapman SC, 2008, EUPHYTICA, V161, P195, DOI 10.1007/s10681-007-9623-z; Chen CC, 2004, CLIMATIC CHANGE, V66, P239, DOI 10.1023/B:CLIM.0000043159.33816.e5; Chenu K, 2015, CROP PHYSIOLOGY: APPLICATIONS FOR GENETIC IMPROVEMENT AND AGRONOMY, 2ND EDITION, P321, DOI 10.1016/B978-0-12-417104-6.00013-3; Cock J, 2011, AGR SYST, V104, P755, DOI 10.1016/j.agsy.2011.07.001; CONNOR JT, 1994, IEEE T NEURAL NETWOR, V5, P240, DOI 10.1109/72.279188; Cordano E, 2012, RMAWGEN SOFTWARE PRO; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; DANE, 2015, DANE B TECN; Das A, 2009, J SAFETY RES, V40, P317, DOI 10.1016/j.jsr.2009.05.003; De Mendiburu F., 2014, AGRICOLAE STAT PROCE, DOI [10.1186/1471-2105-11-110, DOI 10.1186/1471-2105-11-110]; Deller Jr J. R., 1993, DISCRETE TIME PROCES; Delmotte S, 2011, EUR J AGRON, V35, P223, DOI 10.1016/j.eja.2011.06.006; Dilley M, 2000, CLIMATIC CHANGE, V45, P63, DOI 10.1023/A:1005636932536; Drummond ST, 2003, STAT NEURAL METHODS, V46, P1; Fageria N.K, 2013, MINERAL NUTR RICE; FAO, 2015, CROPS PROD LEV; Fedearroz, 2000, FICH TECN F733; Fedearroz DANE, 2015, AR PROD REND ARR COL; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Garces Varon G., 2008, REV ARROZ, P4; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Giorgino T, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i07; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Heinemann AB, 2015, J EXP BOT, V66, P3625, DOI 10.1093/jxb/erv126; Henderson J, 2008, J ALLERGY CLIN IMMUN, V121; HORNIK K, 1991, NEURAL NETWORKS, V4, P251, DOI 10.1016/0893-6080(91)90009-T; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Iizumi T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4712; Jha S, 2010, BIOL CONSERV, V143, P1423, DOI 10.1016/j.biocon.2010.03.017; Jimenez D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150015; Jimenez D, 2011, AGR SYST, V104, P258, DOI 10.1016/j.agsy.2010.10.004; Jimenez D, 2009, COMPUT ELECTRON AGR, V69, P198, DOI 10.1016/j.compag.2009.08.008; Kuhn M., 2014, CARET CLASSIFICATION; Lavelle P, 2014, AGR ECOSYST ENVIRON, V185, P106, DOI 10.1016/j.agee.2013.12.020; Leal B, 2010, INTERNET OF THINGS-BOOK, P3, DOI 10.1007/978-1-4419-1674-7_1; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Magrin GO, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1499; Mayer-Sch?nber V., 2013, BIG DATA REVOLUTION; MCQUEEN RJ, 1995, COMPUT ELECTRON AGR, V12, P275, DOI 10.1016/0168-1699(95)98601-9; Meinke H, 2005, CLIMATIC CHANGE, V70, P221, DOI 10.1007/s10584-005-5948-6; Moore FC, 2015, P NATL ACAD SCI USA, V112, P2670, DOI 10.1073/pnas.1409606112; Muller J, 2010, EUR J FOREST RES, V129, P981, DOI 10.1007/s10342-010-0400-5; Nicodemus KK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-110; Osborne TM, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024001; Overeem A, 2013, P NATL ACAD SCI USA, V110, P2741, DOI 10.1073/pnas.1217961110; Parsa S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036533; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Perez de Vida F, 2013, ASPECTOS ECOFISIOLOG; Pons Maite, 2009, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V64, P2443; R Core Team, 2021, R LANGUAGE ENV STAT; Risbey J., 1999, MITIG ADAPT STRATEG, V4, P137, DOI 10.1023/A:1009636607038; Rob A, 1996, NINO SO OSCILLATION; Rosenheim JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080518; SAKOE H, 1978, IEEE T ACOUST SPEECH, V26, P43, DOI 10.1109/TASSP.1978.1163055; Salinger MJ, 2000, AGR FOREST METEOROL, V103, P167, DOI 10.1016/S0168-1923(00)00110-6; Sanchez B, 2014, GLOBAL CHANGE BIOL, V20, P408, DOI 10.1111/gcb.12389; SESHU DV, 1984, CROP SCI, V24, P649, DOI 10.2135/cropsci1984.0011183X002400040006x; Shah F, 2011, J AGR SCI-CAMBRIDGE, V149, P545, DOI 10.1017/S0021859611000360; Sheehy JE, 2006, FIELD CROP RES, V98, P151, DOI 10.1016/j.fcr.2006.01.001; Shekoofa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097288; Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330; Stocker T.F., 2013, CLIMATE CHANGE 2013, P1447, DOI DOI 10.1017/CBO9781107415324.031; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; Tittonell P, 2008, AGR ECOSYST ENVIRON, V123, P137, DOI 10.1016/j.agee.2007.05.005; Tuzcu V, 2005, IEEE SYS MAN CYBERN, P182; Welch JR, 2010, P NATL ACAD SCI USA, V107, P14562, DOI 10.1073/pnas.1001222107; World Meteorological Organization, 100 WMO; Xu L., 2006, PROC 21 AAAI C ARTIF, P536; Yoshida S., 1981, Fundamentals of rice crop science.	82	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161620	10.1371/journal.pone.0161620	http://dx.doi.org/10.1371/journal.pone.0161620			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560980	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258600065
J	Doerr, N; Wang, YD; Kipp, KR; Liu, GY; Benza, JJ; Pletnev, V; Pavlov, TS; Staruschenko, A; Mohieldin, AM; Takahashi, M; Nauli, SM; Weimbs, T				Doerr, Nicholas; Wang, Yidi; Kipp, Kevin R.; Liu, Guangyi; Benza, Jesse J.; Pletnev, Vladimir; Pavlov, Tengis S.; Staruschenko, Alexander; Mohieldin, Ashraf M.; Takahashi, Maki; Nauli, Surya M.; Weimbs, Thomas			Regulation of Polycystin-1 Function by Calmodulin Binding	PLOS ONE			English	Article							RIGHT DETERMINANT INVERSIN; HETEROTRIMERIC G-PROTEINS; N-TERMINAL KINASE; KIDNEY-DISEASE; ANGSTROM RESOLUTION; SCALLOP MYOSIN; C-TERMINUS; DOMAIN; ACTIVATION; CELLS	Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a common genetic disease that leads to progressive renal cyst growth and loss of renal function, and is caused by mutations in the genes encoding polycystin-1 (PC1) and polycystin-2 (PC2), respectively. The PC1/PC2 complex localizes to primary cilia and can act as a flow-dependent calcium channel in addition to numerous other signaling functions. The exact functions of the polycystins, their regulation and the purpose of the PC1/PC2 channel are still poorly understood. PC1 is an integral membrane protein with a large extracytoplasmic N-terminal domain and a short, -200 amino acid C-terminal cytoplasmic tail. Most proteins that interact with PC1 have been found to bind via the cytoplasmic tail. Here we report that the PC1 tail has homology to the regulatory domain of myosin heavy chain including a conserved calmodulin-binding motif. This motif binds to CaM in a calcium-dependent manner. Disruption of the CaM-binding motif in PC1 does not affect PC2 binding, cilia targeting, or signaling via heterotrimeric G-proteins or STAT3. However, disruption of CaM binding inhibits the PC1/PC2 calcium channel activity and the flow-dependent calcium response in kidney epithelial cells. Furthermore, expression of CaM-binding mutant PC1 disrupts cellular energy metabolism. These results suggest that critical functions of PC1 are regulated by its ability to sense cytosolic calcium levels via binding to CaM.	[Doerr, Nicholas; Wang, Yidi; Kipp, Kevin R.; Liu, Guangyi; Benza, Jesse J.; Weimbs, Thomas] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Doerr, Nicholas; Wang, Yidi; Kipp, Kevin R.; Liu, Guangyi; Benza, Jesse J.; Weimbs, Thomas] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Pletnev, Vladimir] Russian Acad Sci, Dept Biol Struct, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Pavlov, Tengis S.; Staruschenko, Alexander] Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Mohieldin, Ashraf M.; Takahashi, Maki; Nauli, Surya M.] Chapman Univ, Sch Pharm, Dept Biomed & Pharmaceut Sci, Irvine, CA USA; [Mohieldin, Ashraf M.; Takahashi, Maki; Nauli, Surya M.] Univ Calif Irvine, Med Campus, Orange, CA 92668 USA; [Liu, Guangyi] Shandong Univ, Dept Nephrol, Qilu Hosp, Jinan, Peoples R China	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Medical College of Wisconsin; Chapman University System; Chapman University; University of California System; University of California Irvine; Shandong University	Weimbs, T (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.; Weimbs, T (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA.	weimbs@ucsb.edu	Pletnev, Vladimir/Q-6151-2016	Wang, Yidi/0000-0003-2384-3812; Weimbs, Thomas/0000-0001-9423-5561; Staruschenko, Alexander/0000-0002-5190-8356; Doerr, Nicholas/0000-0001-9770-1206	National Institutes of Health, USA [R01 DK62338]; American Heart Association [16EIA26720006]; Office of China Postdoctoral Council	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Office of China Postdoctoral Council	This work was supported by a grant from the National Institutes of Health, USA (R01 DK62338), and a gift from the Lillian Goldman Charitable Trust (to TW), a grant from the American Heart Association (16EIA26720006, to AS), and a fellowship from the International Postdoctoral Exchange Fellowship Program 2014 from the Office of China Postdoctoral Council (to GL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouAlaiwi WA, 2009, CIRC RES, V104, P860, DOI 10.1161/CIRCRESAHA.108.192765; [Anonymous], 2002, CALMODULIN TARGET DA; Arnould T, 1998, J BIOL CHEM, V273, P6013, DOI 10.1074/jbc.273.11.6013; Babich V, 2004, J BIOL CHEM, V279, P25582, DOI 10.1074/jbc.M402829200; BARNES JA, 1995, MOL CELL BIOCHEM, V149, P17, DOI 10.1007/BF01076559; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boulay G, 2002, CELL CALCIUM, V32, P201, DOI 10.1016/S0143416002001550; Bycroft M, 1999, EMBO J, V18, P297, DOI 10.1093/emboj/18.2.297; Chauvet V, 2004, J CLIN INVEST, V114, P1433, DOI 10.1172/JCI200421753; Chiaravalli M, 2016, J AM SOC NEPHROL, V27, P1958, DOI 10.1681/ASN.2015030231; de Groot T, 2011, MOL CELL BIOL, V31, P2845, DOI 10.1128/MCB.01319-10; Delmas P, 2002, J BIOL CHEM, V277, P11276, DOI 10.1074/jbc.M110483200; Delmas P, 2004, FASEB J, V18, P740, DOI 10.1096/fj.03-0319fje; Dere R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009239; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Distefano G, 2009, MOL CELL BIOL, V29, P2359, DOI 10.1128/MCB.01259-08; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erickson KF, 2013, ANN INTERN MED, V159, P382, DOI 10.7326/0003-4819-159-6-201309170-00004; Grimm DH, 2003, J BIOL CHEM, V278, P36786, DOI 10.1074/jbc.M306536200; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hofherr A, 2011, ADV EXP MED BIOL, V704, P287, DOI 10.1007/978-94-007-0265-3_16; Hooper KM, 2005, AM J PHYSIOL-RENAL, V289, pF521, DOI 10.1152/ajprenal.00355.2004; Houdusse A, 1996, STRUCTURE, V4, P21, DOI 10.1016/S0969-2126(96)00006-8; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; Kim E, 1999, J BIOL CHEM, V274, P4947, DOI 10.1074/jbc.274.8.4947; Kim H, 2014, EXP CELL RES, V320, P62, DOI 10.1016/j.yexcr.2013.10.012; Kollmar M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-183; Kwon M, 2012, P NATL ACAD SCI USA, V109, P21462, DOI 10.1073/pnas.1216830110; Lal M, 2008, HUM MOL GENET, V17, P3105, DOI 10.1093/hmg/ddn208; Li Y, 2009, J BIOL CHEM, V284, P36431, DOI 10.1074/jbc.M109.068916; Low SH, 2006, DEV CELL, V10, P57, DOI 10.1016/j.devcel.2005.12.005; Merrick D, 2012, DEV CELL, V22, P197, DOI 10.1016/j.devcel.2011.10.028; Morgan D, 2002, HUM GENET, V110, P377, DOI 10.1007/s00439-002-0696-4; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2008, CIRCULATION, V117, P1161, DOI 10.1161/CIRCULATIONAHA.107.710111; Newby LJ, 2002, J BIOL CHEM, V277, P20763, DOI 10.1074/jbc.M107788200; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Olsan EE, 2011, P NATL ACAD SCI USA, V108, P18067, DOI 10.1073/pnas.1111966108; Ong ACM, 2015, KIDNEY INT, V88, P699, DOI 10.1038/ki.2015.207; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Parnell SC, 1998, BIOCHEM BIOPH RES CO, V251, P625, DOI 10.1006/bbrc.1998.9514; Parnell SC, 2002, J BIOL CHEM, V277, P19566, DOI 10.1074/jbc.M201875200; Pletnev V, 2007, J MOL MODEL, V13, P891, DOI 10.1007/s00894-007-0201-z; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rossetti S, 2007, J AM SOC NEPHROL, V18, P2143, DOI 10.1681/ASN.2006121387; Rowe I, 2013, NAT MED, V19, P488, DOI 10.1038/nm.3092; Santoso NG, 2011, CELL PHYSIOL BIOCHEM, V27, P715, DOI 10.1159/000330080; Semmo M, 2014, HANDB EXP PHARMACOL, V222, P675, DOI 10.1007/978-3-642-54215-2_27; Sharma N, 2006, J CELL BIOL, V173, P937, DOI 10.1083/jcb.200603132; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Singh BB, 2002, MOL CELL, V9, P739, DOI 10.1016/S1097-2765(02)00506-3; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Talbot JJ, 2014, J AM SOC NEPHROL, V25, P1737, DOI 10.1681/ASN.2013091026; Talbot JJ, 2011, P NATL ACAD SCI USA, V108, P7985, DOI 10.1073/pnas.1103816108; Tong Q, 2006, J BIOL CHEM, V281, P9076, DOI 10.1074/jbc.M510422200; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Watanabe D, 2003, DEVELOPMENT, V130, P1725, DOI 10.1242/dev.00407; Wilson PD, 2001, J AM SOC NEPHROL, V12, P834, DOI 10.1681/ASN.V124834; Woodward OM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012305; XIE X, 1994, NATURE, V368, P306, DOI 10.1038/368306a0; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Zhang ZM, 2001, P NATL ACAD SCI USA, V98, P3168, DOI 10.1073/pnas.051632698	66	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161525	10.1371/journal.pone.0161525	http://dx.doi.org/10.1371/journal.pone.0161525			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560828	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258600053
J	Nukarinen, E; Lindstrom, O; Kuuliala, K; Kylanpaa, L; Pettila, V; Puolakkainen, P; Kuuliala, A; Hamalainen, M; Moilanen, E; Repo, H; Hastbacka, J				Nukarinen, Eija; Lindstrom, Outi; Kuuliala, Krista; Kylanpaa, Leena; Pettila, Ville; Puolakkainen, Pauli; Kuuliala, Antti; Hamalainen, Mari; Moilanen, Eeva; Repo, Heikki; Hastbacka, Johanna			Association of Matrix Metalloproteinases-7,-8 and-9 and TIMP-1 with Disease Severity in Acute Pancreatitis. A Cohort Study	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; PREDICTING SEVERITY; TISSUE INHIBITOR; SERUM CREATININE; MATRIX-METALLOPROTEINASE-9; MARKERS; COLLAGENASE; PROGRESSION; EXPRESSION; MATRILYSIN	Objectives Several biomarkers for early detection of severe acute pancreatitis (SAP) have been presented. Matrix metalloproteinases (MMP) and their tissue inhibitors (TIMP) are released early in inflammation. We aimed to assess levels of MMP-7, -8, -9 and TIMP-1 in acute pancreatitis (AP) and explore their ability to detect disease severity. Our second aim was to find an association between MMPs, TIMP and creatinine. Methods We collected plasma samples for MMP-7, -8, -9 and TIMP-1 analyses from 176 patients presenting within 96 h from onset of acute pancreatitis (AP) symptoms. We used samples from 32 control subjects as comparison. The revised Atlanta Classification was utilised to assess severity of disease. Receiver operating characteristic curve analysis and Spearman's Rho-test were utilised for statistical calculations. Results Compared with controls, patients showed higher levels of all studied markers. MMP-8 was higher in moderately severe AP than in mild AP (p = 0.005) and MMP-8, -9 and TIMP-1 were higher in severe than in mild AP (p<0.001, p = 0.005 and p = 0.019). MMP-8 detected SAP with an AUC of 0.939 [95% CI 0.894-0.984], LR+9.03 [5.30-15.39]. MMP-8, -9 and TIMP-1 failed to discern moderately severe AP from SAP. MMP-7 was not different between patient groups. MMP-7 and TIMP-1 correlated weakly with creatinine (Rho = 0.221 and 0.243). MMP-8 might be a useful biomarker in early detection of SAP.	[Nukarinen, Eija; Pettila, Ville; Hastbacka, Johanna] Univ Helsinki, Dept Perioperat Intens Care & Pain Med, Helsinki, Finland; [Nukarinen, Eija; Lindstrom, Outi; Kuuliala, Krista; Kylanpaa, Leena; Pettila, Ville; Puolakkainen, Pauli; Kuuliala, Antti; Repo, Heikki; Hastbacka, Johanna] Helsinki Univ Hosp, Helsinki, Finland; [Lindstrom, Outi; Kylanpaa, Leena; Puolakkainen, Pauli] Univ Helsinki, Dept GI Surg, Helsinki, Finland; [Kuuliala, Krista; Kuuliala, Antti; Repo, Heikki] Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland; [Hamalainen, Mari; Moilanen, Eeva] Univ Tampere, Sch Med, Immunopharmacol Res Grp, Tampere, Finland; [Hamalainen, Mari; Moilanen, Eeva] Tampere Univ Hosp, Tampere, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Tampere University; Tampere University; Tampere University Hospital	Nukarinen, E (corresponding author), Univ Helsinki, Dept Perioperat Intens Care & Pain Med, Helsinki, Finland.; Nukarinen, E (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.	eija.nukarinen@hus.fi		Kuuliala, Antti/0000-0002-3190-207X; Hastbacka, Johanna/0000-0002-3613-7231; Hamalainen, Mari/0000-0002-6409-3758	Helsinki University Central Hospital Research Foundation [VTR-Y10201191, TYH2016121]; Tampere University Hospital, Tampere, Finland	Helsinki University Central Hospital Research Foundation; Tampere University Hospital, Tampere, Finland	This work was supported by Helsinki University Central Hospital Research Foundation, grant numbers VTR-Y10201191 to VP and TYH2016121 to LK. This work was also supported by the competitive research funding of Tampere University Hospital, Tampere, Finland to EM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, KIDNEY INT SUPPL, V2, P8, DOI 10.1038/kisup.2012.6; Awla D, 2012, J LEUKOCYTE BIOL, V91, P711, DOI 10.1189/jlb.0811443; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Basu RK, 2011, CRIT CARE, V15, DOI 10.1186/cc10554; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Bojic S, 2015, TOHOKU J EXP MED, V237, P103, DOI 10.1620/tjem.237.103; Chen P, 2006, TOHOKU J EXP MED, V208, P261, DOI 10.1620/tjem.208.261; CLAVE P, 1995, CLIN CHEM, V41, P1129; De Waele JJ, 2014, CURR OPIN CRIT CARE, V20, P189, DOI 10.1097/MCC.0000000000000068; Dejonckheere E, 2011, CYTOKINE GROWTH F R, V22, P73, DOI 10.1016/j.cytogfr.2011.02.002; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Herr AE, 2007, P NATL ACAD SCI USA, V104, P5268, DOI 10.1073/pnas.0607254104; Johnson CD, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4859; Keck T, 2002, GASTROENTEROLOGY, V122, P188, DOI 10.1053/gast.2002.30348; Kuhlmann KFD, 2007, CANCER EPIDEM BIOMAR, V16, P886, DOI 10.1158/1055-9965.EPI-06-0779; Lauhio A, 2011, PHARMACOL RES, V64, P590, DOI 10.1016/j.phrs.2011.06.019; Li HT, 2015, DIGEST DIS SCI, V60, P3647, DOI 10.1007/s10620-015-3820-8; Lipinski M, 2013, PANCREATOLOGY, V13, P207, DOI 10.1016/j.pan.2013.02.002; Martin G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05002; Mikami Y, 2009, SURGERY, V145, P147, DOI 10.1016/j.surg.2008.08.036; Muddana V, 2009, AM J GASTROENTEROL, V104, P164, DOI 10.1038/ajg.2008.66; Nieminen A, 2014, CRIT CARE, V18, DOI 10.1186/cc13885; Nisula S, 2013, INTENS CARE MED, V39, P420, DOI 10.1007/s00134-012-2796-5; Opdenakker G, 2001, TRENDS IMMUNOL, V22, P571, DOI 10.1016/S1471-4906(01)02023-3; Owen CA, 2004, J IMMUNOL, V172, P7791, DOI 10.4049/jimmunol.172.12.7791; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Pavlidis TE, 2010, HEPATOB PANCREAT DIS, V9, P482; Purkayastha S, 2006, WORLD J SURG, V30, P1713, DOI 10.1007/s00268-006-0167-5; Qiu Z, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/747426; SaarialhoKere UK, 1996, AM J PATHOL, V148, P519; Sarr MG, 2013, SURG CLIN N AM, V93, P549, DOI 10.1016/j.suc.2013.02.012; Schutte K, 2008, BEST PRACT RES CL GA, V22, P75, DOI 10.1016/j.bpg.2007.10.013; Staubli SM, 2015, CRIT REV CL LAB SCI, V52, P273, DOI 10.3109/10408363.2015.1051659; Surendran K, 2004, KIDNEY INT, V65, P2212, DOI 10.1111/j.1523-1755.2004.00641.x; Szabo K.A., 2004, CLIN APPL IMMUNOL RE, V4, P295, DOI DOI 10.1016/J.CAIR.2004.02.001; Van Lint P, 2007, J LEUKOCYTE BIOL, V82, P1375, DOI 10.1189/jlb.0607338; Van Lint P, 2006, CYTOKINE GROWTH F R, V17, P217, DOI 10.1016/j.cytogfr.2006.04.001; Vanlaere I, 2009, CLIN MICROBIOL REV, V22, P224, DOI 10.1128/CMR.00047-08; Wen T, 2009, EMERG MED J, V26, P715, DOI 10.1136/emj.2008.067645; Wereszczynska-Siemiatkowska U, 2015, Z GASTROENTEROL, V53, P199, DOI 10.1055/s-0034-1385705; Werner J, 2003, PANCREATOLOGY, V3, P115, DOI 10.1159/000070079; Zerem E, 2014, WORLD J GASTROENTERO, V20, P13879, DOI 10.3748/wjg.v20.i38.13879	42	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161480	10.1371/journal.pone.0161480	http://dx.doi.org/10.1371/journal.pone.0161480			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27561093	Green Published, gold			2022-12-26	WOS:000382258600046
J	Seman-Kamarulzaman, AF; Mohamed-Hussein, ZA; Ng, CL; Hassan, M				Seman-Kamarulzaman, Ahmad-Faris; Mohamed-Hussein, Zeti-Azura; Ng, Chyan Leong; Hassan, Maizom			Novel NAD(+)-Farnesal Dehydrogenase from Polygonum minus Leaves. Purification and Characterization of Enzyme in Juvenile Hormone III Biosynthetic Pathway in Plant	PLOS ONE			English	Article							BETAINE ALDEHYDE DEHYDROGENASE; CORPORA-ALLATA; UTILIZES 3-HYDROXYPROPIONALDEHYDE; ALCOHOL-DEHYDROGENASE; PSEUDOMONAS-PUTIDA; ESSENTIAL OIL; FARNESOL; CLONING; EXPRESSION; METAMORPHOSIS	Juvenile Hormone III is of great concern due to negative effects on major developmental and reproductive maturation in insect pests. Thus, the elucidation of enzymes involved JH III biosynthetic pathway has become increasing important in recent years. One of the enzymes in the JH III biosynthetic pathway that remains to be isolated and characterized is farnesal dehydrogenase, an enzyme responsible to catalyze the oxidation of farnesal into farnesoic acid. A novel NAD(+)-farnesal dehydrogenase of Polygonum minus was purified (315-fold) to apparent homogeneity in five chromatographic steps. The purification procedures included Gigacap S-Toyopearl 650M, Gigacap Q-Toyopearl 650M, and AF-Blue Toyopearl 650ML, followed by TSK Gel G3000SW chromatographies. The enzyme, with isoelectric point of 6.6 is a monomeric enzyme with a molecular mass of 70 kDa. The enzyme was relatively active at 40 degrees C, but was rapidly inactivated above 45 degrees C. The optimal temperature and pH of the enzyme were found to be 35 degrees C and 9.5, respectively. The enzyme activity was inhibited by sulfhydryl agent, chelating agent, and metal ion. The enzyme was highly specific for farnesal and NAD(+). Other terpene aldehydes such as trans-cinnamaldehyde, citral and alpha-methyl cinnamaldehyde were also oxidized but in lower activity. The K-m values for farnesal, citral, trans-cinnamaldehyde, a-methyl cinnamaldehyde and NAD(+) were 0.13, 0.69, 0.86, 1.28 and 0.31 mM, respectively. The putative P. minus farnesal dehydrogenase that's highly specific towards farnesal but not to aliphatic aldehydes substrates suggested that the enzyme is significantly different from other aldehyde dehydrogenases that have been reported. The MALDI-TOF/TOF-MS/MS spectrometry further identified two peptides that share similarity to those of previously reported aldehyde dehydrogenases. In conclusion, the P. minus farnesal dehydrogenase may represent a novel plant farnesal dehydrogenase that exhibits distinctive substrate specificity towards farnesal. Thus, it was suggested that this novel enzyme may be functioning specifically to oxidize farnesal in the later steps of JH III pathway. This report provides a basic understanding for recombinant production of this particular enzyme. Other strategies such as adding His-tag to the protein makes easy the purification of the protein which is completely different to the native protein. Complete sequence, structure and functional analysis of the enzyme will be important for developing insect-resistant crop plants by deployment of transgenic plant.	[Seman-Kamarulzaman, Ahmad-Faris; Mohamed-Hussein, Zeti-Azura; Ng, Chyan Leong; Hassan, Maizom] Univ Kebangsaan Malaysia, Inst Syst Biol, Bangi 43600, Selangor, Malaysia; [Mohamed-Hussein, Zeti-Azura] Univ Kebangsaan Malaysia, Sch Biosci & Biotechnol, Fac Sci & Technol, Bangi 43600, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Hassan, M (corresponding author), Univ Kebangsaan Malaysia, Inst Syst Biol, Bangi 43600, Selangor, Malaysia.	maizom@ukm.edu.my	Ng, Chyan Leong/ABB-1385-2021; Mohamed-Hussein, Zeti-Azura/R-9631-2018; SEMAN-KAMARULZAMAN, AHMAD-FARIS/E-5544-2018; Ng, Chyan Leong/E-9689-2014	Mohamed-Hussein, Zeti-Azura/0000-0002-5386-7260; SEMAN-KAMARULZAMAN, AHMAD-FARIS/0000-0002-3021-2077; Ng, Chyan Leong/0000-0001-8590-7418	Kementerian Sains, Teknologi dan Inovasi [2-01-02-SF0852]; Ministry of Higher Education (MOHE); Universiti Teknologi MARA (UiTM) under Young Lecturers Scheme (TPM)	Kementerian Sains, Teknologi dan Inovasi; Ministry of Higher Education (MOHE)(Ministry of Higher Education & Scientific Research (MHESR)); Universiti Teknologi MARA (UiTM) under Young Lecturers Scheme (TPM)	This work was supported by Kementerian Sains, Teknologi dan Inovasi, Grant number: 02-01-02-SF0852, http://www.mosti.gov.my/, MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thanks Mohd Fauzi Abd Razak, Nor Ain Shahajar Ahmad Sohdi, Nik Rashida Nik Abdul Ghani, De-Sheng Ker, Norzamzurina and Saidi Adha Suhaimi for technical assistance. We would like to acknowledge Ministry of Higher Education (MOHE) and Universiti Teknologi MARA (UiTM) for awarding a scholarship under Young Lecturers Scheme (TPM) to one of the authors.	Abd El-Mawla AMA, 2002, PLANTA, V214, P727, DOI 10.1007/s004250100657; ADACHI O, 1980, AGR BIOL CHEM TOKYO, V44, P503, DOI 10.1080/00021369.1980.10863997; Ahmad-Sohdi NAS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143310; AMY NK, 1974, PLANT PHYSIOL, V54, P629, DOI 10.1104/pp.54.4.629; Baharum SN, 2010, MOLECULES, V15, P7006, DOI 10.3390/molecules15107006; BAKER FC, 1983, J LIPID RES, V24, P1586; Bede JC, 1999, PHYTOCHEMISTRY, V52, P1269, DOI 10.1016/S0031-9422(99)00438-0; Bede JC, 2001, PLANT PHYSIOL, V127, P584, DOI 10.1104/pp.010264; BEDINO S, 1990, BIOL CHEM H-S, V371, P95, DOI 10.1515/bchm3.1990.371.1.95; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; BOSWELL J. G., 1961, NEW PHYTOL, V60, P1, DOI 10.1111/j.1469-8137.1961.tb06234.x; Cao L, 2009, BIOCHEM BIOPH RES CO, V380, P188, DOI 10.1016/j.bbrc.2009.01.079; CHALMERS RM, 1989, BIOCHEM J, V263, P913, DOI 10.1042/bj2630913; De Loof A, 2015, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00222; Fu KY, 2016, PEST MANAG SCI, V72, P1231, DOI 10.1002/ps.4103; Furstenberg-Hagg J, 2013, INT J MOL SCI, V14, P10242, DOI 10.3390/ijms140510242; Furuta K, 2010, J PESTIC SCI, V35, P494, DOI 10.1584/jpestics.J10-03; Garbis S, 2005, J CHROMATOGR A, V1077, P1, DOI 10.1016/j.chroma.2005.04.059; Gelifesciences.com, 28937207AA GEL; Giebultowicz J, 2009, MOLECULES, V14, P2363, DOI 10.3390/molecules14072363; Hassan M, 2012, BIOSCI BIOTECH BIOCH, V76, P1463, DOI 10.1271/bbb.120137; Helvig C, 2004, P NATL ACAD SCI USA, V101, P4024, DOI 10.1073/pnas.0306980101; HORECKER BL, 1948, J BIOL CHEM, V175, P385; Huang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117291; Huda-Faujan N, 2009, AFR J BIOTECHNOL, V8, P484; Ishaaya I., 2012, ADV TECHNOLOGIEMAN; Ishige T, 2000, APPL ENVIRON MICROB, V66, P3481, DOI 10.1128/AEM.66.8.3481-3486.2000; Jadhav S., 2014, ADV PHARM TOXICOL, V15, P13; Jaureguibeitia A, 2007, APPL MICROBIOL BIOT, V73, P1073, DOI 10.1007/s00253-006-0558-4; Jindra M, 2015, CURR OPIN INSECT SCI, V11, P39, DOI 10.1016/j.cois.2015.08.004; Jindra M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005394; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Jo JE, 2008, APPL MICROBIOL BIOT, V81, P51, DOI 10.1007/s00253-008-1608-x; Keller MA, 2010, J LIPID RES, V51, P1554, DOI 10.1194/jlr.D002220; Kim HJ, 2006, J PROTEOME RES, V5, P192, DOI 10.1021/pr050258u; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Kotchoni SO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011516; Kuribayashi T, 2002, J AGR FOOD CHEM, V50, P1247, DOI 10.1021/jf0112217; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Livingstone JR, 2003, J PLANT RES, V116, P133, DOI 10.1007/s10265-003-0077-7; Lloyd MD, 2007, J ENZYM INHIB MED CH, V22, P584, DOI 10.1080/14756360701425360; Lo HF, 2010, MOL BIOTECHNOL, V46, P157, DOI 10.1007/s12033-010-9290-5; Lopez O, 2005, GREEN CHEM, V7, P431, DOI 10.1039/b500733j; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luddeke F, 2012, APPL ENVIRON MICROB, V78, P2128, DOI 10.1128/AEM.07226-11; MACGIBBON AKH, 1979, EUR J BIOCHEM, V96, P585, DOI 10.1111/j.1432-1033.1979.tb13073.x; Mackeen MM, 1997, INT J PHARMACOGN, V35, P174, DOI 10.1076/phbi.35.3.174.13294; MACKINTOSH RW, 1988, BIOCHEM J, V255, P653; MADHAVAN K, 1973, J INSECT PHYSIOL, V19, P235, DOI 10.1016/0022-1910(73)90236-9; Malone VF, 1999, APPL ENVIRON MICROB, V65, P2622; Marchal E, 2011, INSECT BIOCHEM MOLEC, V41, P219, DOI 10.1016/j.ibmb.2010.12.007; Mayoral JG, 2009, P NATL ACAD SCI USA, V106, P21091, DOI 10.1073/pnas.0909938106; Miyakawa H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2868; Miyazawa M, 2007, FLAVOUR FRAG J, V22, P188, DOI 10.1002/ffj.1779; MOREAU RA, 1979, ARCH BIOCHEM BIOPHYS, V194, P422, DOI 10.1016/0003-9861(79)90636-2; Murakami A, 2000, BIOSCI BIOTECH BIOCH, V64, P9, DOI 10.1271/bbb.64.9; Nagai T., 2001, Food Science and Technology Research, V7, P22, DOI 10.3136/fstr.7.22; Nakamura T, 2010, BIOCHEM BIOPH RES CO, V394, P470, DOI 10.1016/j.bbrc.2010.01.131; Nouzova M, 2011, INSECT BIOCHEM MOLEC, V41, P660, DOI 10.1016/j.ibmb.2011.04.008; OGUSHI S, 1984, J BIOCHEM-TOKYO, V96, P1587; PAN SM, 1988, BOT BULL ACAD SINICA, V29, P255; Pappa A, 2003, BIOCHEM J, V376, P615, DOI 10.1042/BJ20030810; Raj SM, 2010, BIOTECHNOL BIOPROC E, V15, P131, DOI [10.1007/s12257-010-0030-2, 10.1007/S12257-010-0030-2]; Riddiford LM, 2012, GEN COMP ENDOCR, V179, P477, DOI 10.1016/j.ygcen.2012.06.001; Rivera-Perez C, 2014, INSECT BIOCHEM MOLEC, V51, P1, DOI 10.1016/j.ibmb.2014.05.001; Rivera-Perez C, 2013, INSECT BIOCHEM MOLEC, V43, P675, DOI 10.1016/j.ibmb.2013.04.002; Sarah S. A., 2013, International Food Research Journal, V20, P897; Seager S, 2013, ARCH BIOCH BIOPHYS; Sen SE, 2007, INSECT BIOCHEM MOLEC, V37, P819, DOI 10.1016/j.ibmb.2007.05.012; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Sperry AE, 2001, INSECT BIOCHEM MOLEC, V31, P171, DOI 10.1016/S0965-1748(00)00115-6; Stiti N, 2011, BIOCHEM J, V434, P459, DOI 10.1042/BJ20101337; Suhailah Wasman Qader, 2012, Scientific Research and Essays, V7, P90; TAKEUCHI A, 1981, AGR BIOL CHEM TOKYO, V45, P1753, DOI 10.1080/00021369.1981.10864785; Tejirian A, 2010, APPL ENVIRON MICROB, V76, P7673, DOI 10.1128/AEM.01376-10; Teoh KH, 2009, BOTANY, V87, P635, DOI 10.1139/B09-032; TOONG YC, 1988, NATURE, V333, P170, DOI 10.1038/333170a0; Wang XC, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-35; Wasman SQ, 2010, J MED PLANTS RES, V4, P2658; Wei Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-10; Widmann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010546; YAMAURA I, 1988, AGR BIOL CHEM TOKYO, V52, P2929, DOI 10.1080/00021369.1988.10869135; Yang H, 2013, PHYTOCHEMISTRY, V94, P277, DOI 10.1016/j.phytochem.2013.06.010	84	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161707	10.1371/journal.pone.0161707	http://dx.doi.org/10.1371/journal.pone.0161707			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560927	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258600083
J	Arens, AIJ; Postema, JWA; Schreurs, WMJ; Lafeber, A; Hendrickx, BW; Oyen, WJG; Vogel, WV				Arens, Anne I. J.; Postema, Jan W. A.; Schreurs, Wendy M. J.; Lafeber, Albert; Hendrickx, Baudewijn W.; Oyen, Wim J. G.; Vogel, Wouter V.			FDG-PET/CT Limited to the Thorax and Upper Abdomen for Staging and Management of Lung Cancer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; UNSUSPECTED DISTANT METASTASES; SOLITARY PULMONARY NODULES; COMPUTED-TOMOGRAPHY; F-18-FDG PET; MALIGNANCIES; PERFORMANCE; PATTERNS; THERAPY; LESIONS	Purpose This study evaluates the diagnostic accuracy of [F-18]-fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) of the chest/upper abdomen compared to the generally performed scan from head to upper thighs, for staging and management of (suspected) lung cancer in patients with no history of malignancy or complaints outside the thorax. Methods FDG-PET/CT scans of 1059 patients with suspected or recently proven lung cancer, with no history of malignancy or complaints outside the thorax, were analysed in a retrospective multi-centre trial. Suspect FDG-avid lesions in the chest and upper abdomen, the head and neck area above the shoulder line and in the abdomen and pelvis below the caudal tip of the liver were noted. The impact of lesions detected in the head and neck area and abdomen and pelvis on additional diagnostic procedures, staging and treatment decisions was evaluated. Results The head and neck area revealed additional suspect lesions in 7.2%, and the abdomen and pelvis in 15.8% of patients. Imaging of the head and neck area and the abdomen and pelvic area showed additional lesions in 19.5%, inducing additional diagnostic procedures in 7.8%. This resulted in discovery of additional lesions considered malignant in 10.7%,changing patient management for lung cancer in 1.2%. In (suspected) lung cancer, PET/CT limited to the chest and upper abdomen resulted in correct staging in 98.7% of patients, which led to the identical management as full field of view PET in 98.8% of patients. Conclusion High value of FDG-PET/CT for staging and correct patient management is already achieved with chest and upper abdomen. Findings in head and neck area and abdomen and pelvis generally induce investigations with limited or no impact on staging and treatment of NSCLC, and can be interpreted accordingly.	[Arens, Anne I. J.] Dr Bernard Verbeeten Inst, Dept Nucl Med, Tilburg, Netherlands; [Postema, Jan W. A.; Oyen, Wim J. G.] Radboud Univ Nijmegen, Med Ctr, Dept Nucl Med, Nijmegen, Netherlands; [Schreurs, Wendy M. J.] Atrium Med Ctr, Dept Nucl Med, Heerlen, Netherlands; [Lafeber, Albert; Vogel, Wouter V.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Nucl Med, Amsterdam, Netherlands; [Hendrickx, Baudewijn W.] Rijnstate Hosp, Dept Nucl Med, Arnhem, Netherlands; [Arens, Anne I. J.] Radboud Univ Nijmegen, Med Ctr, Dept Radiol & Nucl Med, Nijmegen, Netherlands; [Postema, Jan W. A.; Lafeber, Albert] Reinier de Graaf Hosp, Dept Nucl Med, Delft, Netherlands; [Oyen, Wim J. G.] Inst Canc Res, Dept Nucl Med, London, England; [Oyen, Wim J. G.] Royal Marsden NHS Fdn Trust, London, England	Instituut Verbeeten; Radboud University Nijmegen; Atrium Medical Center; Netherlands Cancer Institute; Rijnstate Hospital; Radboud University Nijmegen; Reinier de Graaf Hospital; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust	Arens, AIJ (corresponding author), Dr Bernard Verbeeten Inst, Dept Nucl Med, Tilburg, Netherlands.; Arens, AIJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Radiol & Nucl Med, Nijmegen, Netherlands.	anne.arens@radboudumc.nl	Arens, Anne I.J./A-5837-2016; Oyen, Wim J.G./AAD-3373-2020; Oyen, Wim J.G./D-4178-2009	Arens, Anne I.J./0000-0001-7066-5372; Oyen, Wim J.G./0000-0001-8235-7078; Oyen, Wim J.G./0000-0001-8235-7078				Alberg AJ, 2005, J CLIN ONCOL, V23, P3175, DOI 10.1200/JCO.2005.10.462; Alkhawaldeh K, 2008, EUR J NUCL MED MOL I, V35, P246, DOI 10.1007/s00259-007-0584-1; Antoch G, 2003, RADIOLOGY, V229, P526, DOI 10.1148/radiol.2292021598; Aquino SL, 2004, CHEST, V126, P755, DOI 10.1378/chest.126.3.755; Craanen Mikael E, 2007, Interact Cardiovasc Thorac Surg, V6, P433, DOI 10.1510/icvts.2006.150342; de Geus-Oei LF, 2007, CANCER-AM CANCER SOC, V110, P1654, DOI 10.1002/cncr.22979; De Wever W, 2007, EUR RADIOL, V17, P23, DOI 10.1007/s00330-006-0284-4; Eschmann SM, 2007, EUR J NUCL MED MOL I, V34, P54, DOI 10.1007/s00259-006-0197-0; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Freudenberg LS, 2007, RADIOL CLIN N AM, V45, P639, DOI 10.1016/j.rcl.2007.05.003; Gould MK, 2003, ANN INTERN MED, V139, P879, DOI 10.7326/0003-4819-139-11-200311180-00013; Gugiatti A, 2004, Q J NUCL MED MOL IM, V48, P49; Gutman F, 2005, AM J ROENTGENOL, V185, P495, DOI 10.2214/ajr.185.2.01850495; HEITZMAN ER, 1986, CHEST, V89, pS237; Ishimori T, 2005, J NUCL MED, V46, P752; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Knoepp UW, 2006, CRIT REV ONCOL HEMAT, V58, P15, DOI 10.1016/j.critrevonc.2005.09.001; Lardinois D, 2003, NEW ENGL J MED, V348, P2500, DOI 10.1056/NEJMoa022136; Lardinois D, 2005, J CLIN ONCOL, V23, P6846, DOI 10.1200/JCO.2005.10.116; Lau C L, 2000, Chest Surg Clin N Am, V10, P781; Lee P, 2007, INT J RADIAT ONCOL, V69, P328, DOI 10.1016/j.ijrobp.2007.04.036; Leusden van HAIM, 2003, DIAGNOSTISCH KOMPAS; Mac Manus MP, 2001, INT J RADIAT ONCOL, V50, P287, DOI 10.1016/S0360-3016(01)01477-8; Marom EM, 2006, J THORAC IMAG, V21, P154, DOI 10.1097/00005382-200605000-00007; Metser U, 2007, AM J ROENTGENOL, V189, P1203, DOI 10.2214/AJR.07.2083; Minamimoto R, 2007, ANN NUCL MED, V21, P481, DOI 10.1007/s12149-007-0061-8; Morgensztern D, 2008, J THORAC ONCOL, V3, P135, DOI 10.1097/JTO.0b013e3181622c2c; Nguyen Nghi C, 2007, BMC Med Imaging, V7, P8, DOI 10.1186/1471-2342-7-8; Niho S, 2007, LUNG CANCER, V57, P328, DOI 10.1016/j.lungcan.2007.04.001; ONUIGBO WI, 1961, CANCER RES, V21, P1077; Quint Leslie Eisenbud, 2007, Cancer Imaging, V7, P148, DOI 10.1102/1470-7330.2007.0026; Reed CE, 2003, J THORAC CARDIOV SUR, V126, P1943, DOI 10.1016/j.jtcvs.2003.07.030; Schimmer Christoph, 2006, Interact Cardiovasc Thorac Surg, V5, P418, DOI 10.1510/icvts.2006.129478; Schrevens L, 2004, ONCOLOGIST, V9, P633, DOI 10.1634/theoncologist.9-6-633; Spence AM, 2004, J NUCL MED, V45, P1653; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; van Tinteren H, 2002, LANCET, V359, P1388, DOI 10.1016/S0140-6736(02)08352-6; Veronesi G, 2007, ANN THORAC SURG, V84, P959, DOI 10.1016/j.athoracsur.2007.04.058; Vogel WV, 2005, EUR J NUCL MED MOL I, V32, P1276, DOI 10.1007/s00259-005-1849-1	39	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0160539	10.1371/journal.pone.0160539	http://dx.doi.org/10.1371/journal.pone.0160539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556809	Green Submitted, gold, Green Published			2022-12-26	WOS:000382258100015
J	Wang, YM; Shao, Q; Hall, CK				Wang, Yiming; Shao, Qing; Hall, Carol K.			N-terminal Prion Protein Peptides (PrP(120-144)) Form Parallel In-register beta-Sheets via Multiple Nucleation-dependent Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibril; kinetics; prion disease; protein aggregation; thermodynamics; amino acid substitution; amyloid core; discontinuous molecular dynamics	MOLECULAR-DYNAMICS SIMULATIONS; AMYLOID CORE STRUCTURE; FIBRIL FORMATION; NEURODEGENERATIVE DISEASES; AGGREGATION KINETICS; MAMMALIAN PRIONS; Y145STOP VARIANT; STOP MUTANTS; RESIDUE 129; TEMPERATURE	The prion diseases are a family of fatal neurodegenerative diseases associated with the misfolding and accumulation of normal prion protein (PrPC) into its pathogenic scrapie form (PrPSc). Understanding the fundamentals of prion protein aggregation and the molecular architecture of PrPSc is key to unraveling the pathology of prion diseases. Our work investigates the early-stage aggregation of three prion protein peptides, corresponding to residues 120-144 of human (Hu), bank vole (BV), and Syrian hamster (SHa) prion protein, from disordered monomers to -sheet-rich fibrillar structures. Using 12 s discontinuous molecular dynamics simulations combined with the PRIME20 force field, we find that the Hu-, BV-, and SHaPrP(120-144) aggregate via multiple nucleation-dependent pathways to form U-shaped, S-shaped, and -shaped protofilaments. The S-shaped HuPrP(120-144) protofilament is similar to the amyloid core structure of HuPrP(112-141) predicted by Zweckstetter. HuPrP(120-144) has a shorter aggregation lag phase than BVPrP(120-144) followed by SHaPrP(120-144), consistent with experimental findings. Two amino acid substitutions I138M and I139M retard the formation of parallel in-register -sheet dimers during the nucleation stage by increasing side chain-side chain association and reducing side chain interaction specificity. On average, HuPrP(120-144) aggregates contain more parallel -sheet content than those formed by BV- and SHaPrP(120-144). Deletion of the C-terminal residues 138-144 prevents formation of fibrillar structures in agreement with the experiment. This work sheds light on the amyloid core structures underlying prion strains and how I138M, I139M, and S143N affect prion protein aggregation kinetics.	[Wang, Yiming; Shao, Qing; Hall, Carol K.] North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Hall, CK (corresponding author), North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.	hall@ncsu.edu	Wang, Yiming/T-4946-2017; Wang, Yiming/K-9382-2019	Wang, Yiming/0000-0003-3657-6100; Wang, Yiming/0000-0003-3657-6100; Hall, Carol/0000-0002-7425-587X	National Institutes of Health [GM056766, EB006006]; National Science Foundation Research Triangle Materials Research Science and Engineering Centers (MRSEC) [DMR-1121107]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056766] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Research Triangle Materials Research Science and Engineering Centers (MRSEC); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM056766 and EB006006 and in part by National Science Foundation Research Triangle Materials Research Science and Engineering Centers (MRSEC) Grant DMR-1121107. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; ALDER BJ, 1959, J CHEM PHYS, V31, P459, DOI 10.1063/1.1730376; ANDERSEN HC, 1980, J CHEM PHYS, V72, P2384, DOI 10.1063/1.439486; Andrews JM, 2007, J PHYS CHEM B, V111, P7897, DOI 10.1021/jp070212j; Apostol MI, 2011, BIOCHEMISTRY-US, V50, P2456, DOI 10.1021/bi101803k; Apostol MI, 2010, J BIOL CHEM, V285, P29671, DOI 10.1074/jbc.C110.158303; Baftizadeh F, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.168103; Berka K, 2010, J CHEM THEORY COMPUT, V6, P2191, DOI 10.1021/ct100007y; Biswal HS., 2015, NONCOVALENT FORCES, V9(2), P15; Chatterjee B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067967; Cheon M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004258; Cheon M, 2012, PROTEIN SCI, V21, P1514, DOI 10.1002/pro.2141; Cheon M, 2011, BIOPHYS J, V101, P2493, DOI 10.1016/j.bpj.2011.08.042; Cheon M, 2010, PROTEINS, V78, P2950, DOI 10.1002/prot.22817; Cho KR, 2011, J AM CHEM SOC, V133, P8586, DOI 10.1021/ja1117446; Chuang CC, 2013, AMINO ACIDS, V45, P785, DOI 10.1007/s00726-013-1522-0; Ciryam P, 2015, TRENDS PHARMACOL SCI, V36, P72, DOI 10.1016/j.tips.2014.12.004; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; Debenedetti P.G., 1996, METASTABLE LIQUIDS C; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Dougherty RC, 1998, J CHEM PHYS, V109, P7372, DOI 10.1063/1.477343; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Ghetti B, 1996, BRAIN PATHOL, V6, P127, DOI 10.1111/j.1750-3639.1996.tb00796.x; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Groveman BR, 2014, J BIOL CHEM, V289, P24129, DOI 10.1074/jbc.M114.578344; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Helmus JJ, 2011, J AM CHEM SOC, V133, P13934, DOI 10.1021/ja206469q; Helmus JJ, 2010, J AM CHEM SOC, V132, P2393, DOI 10.1021/ja909827v; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jones EM, 2011, J BIOL CHEM, V286, P42777, DOI 10.1074/jbc.M111.302539; KIM CWA, 1993, NATURE, V362, P267, DOI 10.1038/362267a0; Kundu B, 2003, P NATL ACAD SCI USA, V100, P12069, DOI 10.1073/pnas.2033281100; Kuwata K, 2003, P NATL ACAD SCI USA, V100, P14790, DOI 10.1073/pnas.2433563100; Latshaw DC, 2014, J PHYS CHEM B, V118, P13513, DOI 10.1021/jp508970q; Latshaw DC, 2015, BIOPHYS J, V109, P124, DOI 10.1016/j.bpj.2015.05.032; Li HC, 2012, LANGMUIR, V28, P16979, DOI 10.1021/la302655p; Li SC, 1996, P NATL ACAD SCI USA, V93, P6676, DOI 10.1073/pnas.93.13.6676; Lin NS, 2010, CHEM-EUR J, V16, P5492, DOI 10.1002/chem.200903290; Marchut AJ, 2006, COMPUT BIOL CHEM, V30, P215, DOI 10.1016/j.compbiolchem.2006.01.003; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Morales R, 2007, BBA-MOL BASIS DIS, V1772, P681, DOI 10.1016/j.bbadis.2006.12.006; MUNOZ V, 1995, J MOL BIOL, V245, P297, DOI 10.1006/jmbi.1994.0024; Natalello A, 2008, J MOL BIOL, V381, P1349, DOI 10.1016/j.jmb.2008.06.063; Nguyen HD, 2004, P NATL ACAD SCI USA, V101, P16180, DOI 10.1073/pnas.0407273101; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Ricchiuto P, 2012, J PHYS CHEM B, V116, P5384, DOI 10.1021/jp302797c; Skora L, 2013, J BIOL CHEM, V288, P2994, DOI 10.1074/jbc.M112.423715; Skora L, 2012, PROTEIN SCI, V21, P1948, DOI 10.1002/pro.2170; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Smith AV, 2001, PROTEINS, V44, P344, DOI 10.1002/prot.1100; Solforosi L, 2007, J BIOL CHEM, V282, P7465, DOI 10.1074/jbc.M610051200; Soto C, 2006, TRENDS BIOCHEM SCI, V31, P150, DOI 10.1016/j.tibs.2006.01.002; TAGLIAVINI F, 1993, P NATL ACAD SCI USA, V90, P9678, DOI 10.1073/pnas.90.20.9678; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Wagoner VA, 2012, J MOL BIOL, V416, P598, DOI 10.1016/j.jmb.2011.12.038; Walker LC, 2015, ANNU REV NEUROSCI, V38, P87, DOI 10.1146/annurev-neuro-071714-033828; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Zweckstetter M, 2013, PRION, V7, P193, DOI 10.4161/pri.23956	62	23	23	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22093	22105		10.1074/jbc.M116.744573	http://dx.doi.org/10.1074/jbc.M116.744573			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27576687	Green Published, hybrid			2022-12-26	WOS:000386332600024
J	Han, KH; Kim, AR; Kim, MY; Ahn, S; Oh, SH; Song, JH; Choi, BY				Han, Kyu-Hee; Kim, Ah Reum; Kim, Min Young; Ahn, Soyeon; Oh, Seung-Ha; Song, Ju Hun; Choi, Byung Yoon			Establishment of a Flexible Real-Time Polymerase Chain Reaction-Based Platform for Detecting Prevalent Deafness Mutations Associated with Variable Degree of Sensorineural Hearing Loss in Koreans	PLOS ONE			English	Article							EMBEDDED TISSUE SPECIMENS; CELL LUNG-CANCER; MITOCHONDRIAL GENE-MUTATIONS; ANALYTIC PERFORMANCE; VESTIBULAR AQUEDUCT; CDH23 MUTATIONS; PCR ASSAY; IDENTIFICATION; FREQUENCIES; CHINA	Many cutting-edge technologies based on next-generation sequencing (NGS) have been employed to identify candidate variants responsible for sensorineural hearing loss (SNHL). However, these methods have limitations preventing their wide clinical use for primary screening, in that they remain costly and it is not always suitable to analyze massive amounts of data. Several different DNA chips have been developed for screening prevalent mutations at a lower cost. However, most of these platforms do not offer the flexibility to add or remove target mutations, thereby limiting their wider use in a field that requires frequent updates. Therefore, we aimed to establish a simpler and more flexible molecular diagnostic platform based on ethnicity-specific mutation spectrums of SNHL, which would enable bypassing unnecessary filtering steps in a substantial portion of cases. In addition, we expanded the screening platform to cover varying degrees of SNHL. With this aim, we selected 11 variants of 5 genes (GJB2, SLC26A4, MTRNR1, TMPRSS3, and CDH23) showing high prevalence with varying degrees in Koreans and developed the U-TOP (TM) HL Genotyping Kit, a real-time PCR-based method using the MeltingArray technique and peptide nucleic acid probes. The results of 271 DNA samples with wild type sequences or mutations in homo-or heterozygote form were compared between the U-TOP (TM) HL Genotyping Kit and Sanger sequencing. The positive and negative predictive values were 100%, and this method showed perfect agreement with Sanger sequencing, with a Kappa value of 1.00. The U-TOP (TM) HL Genotyping Kit showed excellent performance in detecting varying degrees and phenotypes of SNHL mutations in both homozygote and heterozygote forms, which are highly prevalent in the Korean population. This platform will serve as a useful and cost-effective first-line screening tool for varying degrees of genetic SNHL and facilitate genome-based personalized hearing rehabilitation for the Korean population.	[Han, Kyu-Hee; Song, Ju Hun] Natl Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Kim, Ah Reum; Kim, Min Young; Choi, Byung Yoon] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Songnam, South Korea; [Kim, Ah Reum] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea; [Ahn, Soyeon] Seoul Natl Univ, Bundang Hosp, Med Res Collaborating Ctr, Songnam, South Korea; [Oh, Seung-Ha] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Choi, Byung Yoon] Seoul Natl Univ, Coll Med, Wide River Inst Immunol, Hongcheon, South Korea	National Medical Center - Korea; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Choi, BY (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Songnam, South Korea.; Choi, BY (corresponding author), Seoul Natl Univ, Coll Med, Wide River Inst Immunol, Hongcheon, South Korea.	choiby@snubh.org			Daejeon IRPE (Institute for Regional Program Evaluation Promotion) Project through Research and Development for Regional Industry of the MOTIE (Ministry of Trade, Industry and Energy) Republic of Korea [R0004264]; Korean Healthcare Technology R&D Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea [HI14C1867, H12C0014]	Daejeon IRPE (Institute for Regional Program Evaluation Promotion) Project through Research and Development for Regional Industry of the MOTIE (Ministry of Trade, Industry and Energy) Republic of Korea; Korean Healthcare Technology R&D Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea	This research was supported by the Daejeon IRPE (Institute for Regional Program Evaluation Promotion) Project (R0004264) through the Research and Development for Regional Industry of the MOTIE (Ministry of Trade, Industry and Energy) Republic of Korea. This study was also supported by funding from the Korean Healthcare Technology R&D Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea (HI14C1867 and H12C0014 to BYC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson S, 2012, ARCH PATHOL LAB MED, V136, P1385, DOI 10.5858/arpa.2011-0505-OA; Bae JW, 2008, INT J MOL MED, V22, P175, DOI 10.3892/ijmm_00000005; Bae JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042463; Catteau A, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-58; Chang MY, 2015, MOL CELLS, V38, P781, DOI 10.14348/molcells.2015.0078; Chang YS, 2014, CLIN CHIM ACTA, V436, P169, DOI 10.1016/j.cca.2014.05.008; Choi BY, 2009, GENET TEST MOL BIOMA, V13, P679, DOI 10.1089/gtmb.2009.0054; Choi SY, 2009, CLIN EXP OTORHINOLAR, V2, P44, DOI 10.3342/ceo.2009.2.1.44; Chun JY, 2014, J MOL DIAGN, V16, P573, DOI 10.1016/j.jmoldx.2014.04.006; Chung J, 2014, J MOL MED, V92, P651, DOI 10.1007/s00109-014-1128-3; Svidnicki MCCM, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0232-8; de Castro DG, 2012, BRIT J CANCER, V107, P345, DOI 10.1038/bjc.2012.259; Eriksson M, 1996, NAT STRUCT BIOL, V3, P410, DOI 10.1038/nsb0596-410; Hur D, 2015, BIOL PROCED ONLINE, V17, DOI 10.1186/s12575-015-0027-5; Kenneth J., 2011, ASCO ANN M, P10523; Kim SY, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0624-8; Kim SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125416; Kim SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061592; Kimura H, 2014, LUNG CANCER, V83, P329, DOI 10.1016/j.lungcan.2013.12.012; Kudo T, 2000, AM J MED GENET, V90, P141, DOI 10.1002/(SICI)1096-8628(20000117)90:2<141::AID-AJMG10>3.0.CO;2-G; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee S, 2012, VIRCHOWS ARCH, V460, P141, DOI 10.1007/s00428-011-1180-0; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036621; Li ZY, 2005, HUM GENET, V117, P9, DOI 10.1007/s00439-005-1276-1; Liu XZ, 2001, ANN OTO RHINOL LARYN, V110, P356, DOI 10.1177/000348940111000412; Lopez-Rios F, 2013, J CLIN PATHOL, V66, P381, DOI 10.1136/jclinpath-2012-201240; Lopez-Rios F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053733; Miyagawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040366; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Moy AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053753; O'Donnell P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-210; Park HJ, 2005, CLIN GENET, V67, P160, DOI 10.1111/j.1399-0004.2004.00386.x; Park HJ, 2003, J MED GENET, V40, P242, DOI 10.1136/jmg.40.4.242; Park HJ, 2000, LARYNGOSCOPE, V110, P1535, DOI 10.1097/00005537-200009000-00023; Park JH, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0167-8; Qiu T, 2015, SCI REP-UK, V5, DOI 10.1038/srep09211; Rah YC, 2015, LARYNGOSCOPE, V125, pE216, DOI 10.1002/lary.25079; Rebscher SJ, 2008, J REHABIL RES DEV, V45, P731, DOI 10.1682/JRRD.2007.08.0119; Sagong B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057237; Usami S, 2000, J MED GENET, V37, P38, DOI 10.1136/jmg.37.1.38; Wagatsuma M, 2007, CLIN GENET, V72, P339, DOI 10.1111/j.1399-0004.2007.00833.x; Wang QJ, 2007, CLIN GENET, V72, P245, DOI 10.1111/j.1399-0004.2007.00862.x; Weegerink NJD, 2011, JARO-J ASSOC RES OTO, V12, P753, DOI 10.1007/s10162-011-0282-3; Woo HM, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-46; 정한신, 2004, [Korean Journal of Otorhinolaryngology Head and Neck Surgery, 대한이비인후과학회지 두경부외과학], V47, P206	45	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161756	10.1371/journal.pone.0161756	http://dx.doi.org/10.1371/journal.pone.0161756			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583405	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600055
J	Schaker, PDC; Palhares, AC; Taniguti, LM; Peters, LP; Creste, S; Aitken, KS; Van Sluys, MA; Kitajima, JP; Vieira, MLC; Monteiro-Vitorello, CB				Schaker, Patricia D. C.; Palhares, Alessandra C.; Taniguti, Lucas M.; Peters, Leila P.; Creste, Silvana; Aitken, Karen S.; Van Sluys, Marie-Anne; Kitajima, Joao P.; Vieira, Maria L. C.; Monteiro-Vitorello, Claudia B.			RNAseq Transcriptional Profiling following Whip Development in Sugarcane Smut Disease	PLOS ONE			English	Article							RESISTANCE; PROTEINS; PATHOGEN; SUCROSE; SEQ	Sugarcane smut disease is caused by the biotrophic fungus Sporisorium scitamineum. The disease is characterized by the development of a whip-like structure from the primary meristems, where billions of teliospores are produced. Sugarcane smut also causes tillering and low sucrose and high fiber contents, reducing cane productivity. We investigated the biological events contributing to disease symptoms in a smut intermediate-resistant sugarcane genotype by examining the transcriptional profiles (RNAseq) shortly after inoculating the plants and immediately after whip emission. The overall picture of disease progression suggests that premature transcriptional reprogramming of the shoot meristem functions continues until the emergence of the whip. The guidance of this altered pattern is potentially primarily related to auxin mobilization in addition to the involvement of other hormonal imbalances. The consequences associated with whip emission are the modulation of typical meristematic functions toward reproductive organ differentiation, requiring strong changes in carbon partitioning and energy production. These changes include the overexpression of genes coding for invertases and trehalose-6P synthase, as well as other enzymes from key metabolic pathways, such as from lignin biosynthesis. This is the first report describing changes in the transcriptional profiles following whip development, providing a hypothetical model and candidate genes to further study sugarcane smut disease progression.	[Schaker, Patricia D. C.; Palhares, Alessandra C.; Taniguti, Lucas M.; Peters, Leila P.; Vieira, Maria L. C.; Monteiro-Vitorello, Claudia B.] Univ Sao Paulo, Dept Genet, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil; [Creste, Silvana] Ctr Cana, Inst Agron Campinas, Ribeirao Preto, SP, Brazil; [Aitken, Karen S.] CSIRO Agr, Queensland Biosci Precinct, St Lucia, Qld, Australia; [Van Sluys, Marie-Anne] Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, Qld, Brazil; [Kitajima, Joao P.] Mendel Anal Genom, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Instituto Agronomico de Campinas (IAC); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Universidade de Sao Paulo	Monteiro-Vitorello, CB (corresponding author), Univ Sao Paulo, Dept Genet, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil.	cbmontei@usp.br	Dayane Carvalho Schaker, Patricia/G-4268-2012; aitken, karen/I-5817-2012; Vieira, Maria Lucia Carneiro/D-1628-2012; Monteiro-Vitorello, Claudia B/F-2436-2012; Van Sluys, Marie-Anne/A-8483-2012	Dayane Carvalho Schaker, Patricia/0000-0002-1215-9735; aitken, karen/0000-0003-4372-0721; Vieira, Maria Lucia Carneiro/0000-0003-0341-5714; Monteiro-Vitorello, Claudia B/0000-0002-1238-9354; Van Sluys, Marie-Anne/0000-0002-6506-2734; Creste, Silvana/0000-0002-3315-3332; Peters, Leila Priscila/0000-0002-9469-5290; Taniguti, Lucas Mitsuo/0000-0002-2682-7343	Brazilian institution FAPESP [2010/05591-9, 2015/07112-4, 2012/09524-0, 2013/25599-2, 2014/17034-8, 2013/150147]; Mendelics Analise Genomica	Brazilian institution FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Mendelics Analise Genomica	The authors acknowledge the support of the Brazilian institution FAPESP (grant numbers 2010/05591-9; 2015/07112-4 [C.B.M.-V.] and fellowships to A.C.P. (2012/09524-0); P.D.C.S (2013/25599-2); L.M.T (2014/17034-8); L.P.P (2013/150147). We thank the sequencing facility Center of Functional Genomics (USP, Campus "Luiz de Queiroz"); NAP/MEPA (Nucleo de Apoio a Pesquisa em Microscopia Eletronica Aplicada a Agricultura) and Laboratorios de Genetica Molecular, Departamento de Fitopatologia e Nematologia, and Plantas Horticulas, Departamento de Producao Vegetal, ESALQ. Mendelics Analise Genomica provided support in the form of a salary for author JPK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of JPK are articulated in the 'author contributions' section.	Afzal AJ, 2008, MOL PLANT MICROBE IN, V21, P507, DOI 10.1094/MPMI-21-5-0507; [Anonymous], 2015, NUCLEIC ACIDS RES, V28, P43; Bakkeren G, 2008, FUNGAL GENET BIOL, P45; Barnabas L, 2016, PROTEOMICS, V16, P1111, DOI 10.1002/pmic.201500245; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson DA, 2000, NUCLEIC ACIDS RES, V28, P15, DOI 10.1093/nar/28.1.15; Borras-Hidalgo O, 2005, PLANT PHYSIOL BIOCH, V43, P12; Brefort T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003866; Bruce SA, 2011, J PLANT GROWTH REGUL, V30, P51, DOI 10.1007/s00344-010-9166-8; Bueno C. R. N. C, 2011, THESIS; Cardoso-Silva CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088462; CHAO CP, 1990, PHYTOPATHOLOGY, V80, P622, DOI 10.1094/Phyto-80-622; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; de Castro E, 2006, NUCLEIC ACIDS RES, V1, P34; de Setta N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-540; Dean JFD, 1998, LIGNIN LIGNAN BIOSYN, P8; DeYoung BJ, 2006, PLANT J, V45, P1, DOI 10.1111/j.1365-313X.2005.02592.x; DHont A, 1996, MOL GEN GENET, V250, P405, DOI [10.1007/BF02174028, 10.1007/s004380050092]; Eckardt NA., 2010, PLANT CELL, V22, P5; ECKER JR, 1987, P NATL ACAD SCI USA, V84, P5202, DOI 10.1073/pnas.84.15.5202; FAOSTAT (Food and Agriculture Organization Statistics), 2013, FOOD AGR ORG STAT DA; Forsthoefel NR, 2005, PLANT CELL PHYSL, V46, P6; Gao L, 2013, PLANT J, V75, P903, DOI 10.1111/tpj.12270; Garcia AAF, 2013, SCI REP-UK, V3, DOI 10.1038/srep03399; Ghareeb H, 2011, PLANT PHYSIOL, V156, P4; Gomez LD, 2006, PLANT J, V46, P69, DOI 10.1111/j.1365-313X.2006.02662.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; He J-X, 2005, SCI, V307, P5715; Hector E, 1992, 21 C INT SOC SUG TEC, P565; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; Iskandar H, 2004, PLANT MOL BIOL REP, V22, P4; Jain M, 2007, PLANT PHYSIOL, V143, P4; James GL, 1973, P S AFRICAN SUGAR TE, P179; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kaufmann K, 2010, SCI, V328, P5974; Kawahara Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049423; Kim Dong-Hwan, 2014, Arabidopsis Book, V12, pe0171, DOI 10.1199/tab.0171; Kolbe A, 2005, P NATL ACAD SCI USA, V102, P11118, DOI 10.1073/pnas.0503410102; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lagercrantz U, 2000, MOL BIOL EVOL, V17, P1499, DOI 10.1093/oxfordjournals.molbev.a026249; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lao M, 2008, PLANT CELL REP, V27, P1103, DOI 10.1007/s00299-008-0524-y; Lee YK, 2006, FOR SCI TECHNOL, V2, P1, DOI 10.1080/21580103.2006.9656293; Legaz ME, 1998, J EXP BOT, V49, P1723, DOI 10.1093/jexbot/49.327.1723; Legaz ME, 2011, SCI MICROBIAL PATHOG; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Liu Y, 2011, CROP SCI, V51, P2749, DOI 10.2135/cropsci2011.02.0083; Lloyd H. L., 1980, South African Sugar Journal, V64, P347; LLOYD HL, 1983, PLANT DIS, V67, P1103, DOI 10.1094/PD-67-1103; Lo SF, 2008, PLANT CELL, V20, P2603, DOI 10.1105/tpc.108.060913; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lowe RGT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103098; Mason MG, 2014, P NATL ACAD SCI USA, V111, P16; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Morkunas I, 2014, ACTA PHYSIOL PLANT, V36, P1607, DOI 10.1007/s11738-014-1559-z; Murai K, 2013, PLANTS, V2, P3; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Palhares AC, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-51; Papini-Terzi FS, 2005, DNA RES, V12, P27, DOI 10.1093/dnares/12.1.27; Pastuglia M, 1997, PLANT CELL, V9, P11; PEROS JP, 1983, AGRONOMIE, V3, P629, DOI 10.1051/agro:19830703; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pinon D, 1999, PLANT PHYSIOL BIOCH, V37, P57, DOI 10.1016/S0981-9428(99)80067-9; Que YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080140; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Robert-Seilaniantz A, 2007, CURR OPIN PLANT BIOL, V10, P4; Roitsch T, 2004, TRENDS PLANT SCI, V9, P606, DOI 10.1016/j.tplants.2004.10.009; Rossi M, 2003, MOL GENET GENOMICS, V269, P406, DOI 10.1007/s00438-003-0849-8; Ruan YL, 2014, ANNU REV PLANT BIOL, V65, P33, DOI 10.1146/annurev-arplant-050213-040251; Santiago R, 2012, PHYSIOL PLANTARUM, V145, P245, DOI 10.1111/j.1399-3054.2012.01577.x; Simon R, 1996, NATURE, V384, P59, DOI 10.1038/384059a0; Song W-Y, 1995, SCI, V270, P5243; Su YH, 2011, MOL PLANT, V4, P616, DOI 10.1093/mp/ssr007; Suga S, 2005, PLANT CELL PHYSIOL, V46, pS17; Sundar A.R., 2012, BOTANY, P107; Taniguti LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129318; Tauzin AS, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00293; Thokoane L. N., 2001, Proceedings of the Annual Congress - South African Sugar Technologists' Association, P104; Thomas SG, 1999, P NATL ACAD SCI USA, V96, P8; To JPC, 2007, PLANT CELL, V19, P3901, DOI 10.1105/tpc.107.052662; Tremblay A, 2011, SEQUENCING, V2011, P1, DOI DOI 10.1155/2011/827250; van Ooijen G, 2008, MOL PLANT, V1, P401, DOI 10.1093/mp/ssn009; Waclawovsky AJ, 2010, PLANT BIOTECHNOL J, V8, P263, DOI 10.1111/j.1467-7652.2009.00491.x; Wahl V, 2013, SCI, V339, P6120; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852; Wu QB, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/298920; Yazawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062460; You-Xiong Q, 2011, J BIOMED BIOTECHNOL, V14, P2011; Zhu QH, 2013, GENE, V512, P259, DOI 10.1016/j.gene.2012.10.036	93	35	37	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162237	10.1371/journal.pone.0162237	http://dx.doi.org/10.1371/journal.pone.0162237			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583836	gold, Green Published, Green Submitted			2022-12-26	WOS:000382855600121
J	Wang, L; Cui, Y; Zhang, L; Sheng, JD; Yang, Y; Kuang, GY; Fan, Y; Zhang, Q; Jin, J				Wang, Lu; Cui, Yun; Zhang, Lian; Sheng, Jindong; Yang, Yang; Kuang, Guanyu; Fan, Yu; Zhang, Qian; Jin, Jie			The Silencing of CCND2 by Promoter Aberrant Methylation in Renal Cell Cancer and Analysis of the Correlation between CCND2 Methylation Status and Clinical Features	PLOS ONE			English	Article							CYCLIN D2 EXPRESSION; TUMOR-SUPPRESSOR; DNA METHYLATION; CARCINOMA; GENE; HYPERMETHYLATION; OVEREXPRESSION; PROLIFERATION; INACTIVATION; PROTEIN	Cyclin D2 (CCND2) is a member of the D-type cyclins, which plays a pivotal role in cell cycle regulation, differentiation and malignant transformation. However, its expression status and relative regulation mechanism remains unclear in renal cell cancer (RCC). In our study, the mRNA expression level of CCND2 is down-regulated in 22/23 paired RCC tissues (p<0.05). In addition, its protein expression level is also decreased in 43/43 RCC tumor tissues compared with its corresponding non-malignant tissues (p<0.001). We further detected that CCND2 was down-regulated or silenced in 6/7 RCC cell lines, but expressed in "normal" human proximal tubular (HK-2) cell line. Subsequently, MSP and BGS results showed that the methylation status in CCND2 promoter region is closely associated with its expression level in RCC cell lines. Treatment with 5-Aza with or without TSA restored CCND2 expression in several methylated RCC cell lines. Among the 102 RCC tumors, methylation of CCND2 was detected in 29/102 (28%) cases. Only 2/23 (8.7%) adjacent non-malignant tissues showed methylation. We then analyzed the correlation of clinical features and its promoter methylation. Collectively, our data suggested that loss of CCND2 expression is closely associated with the promoter aberrant methylation.	[Wang, Lu; Cui, Yun; Sheng, Jindong; Kuang, Guanyu; Fan, Yu; Zhang, Qian; Jin, Jie] Peking Univ, Hosp 1, Dept Urol, Beijing 100034, Peoples R China; [Wang, Lu; Cui, Yun; Sheng, Jindong; Kuang, Guanyu; Fan, Yu; Zhang, Qian; Jin, Jie] Peking Univ, Inst Urol, Beijing 100034, Peoples R China; [Zhang, Lian] Natl Res Ctr Genitourinary Oncol, Beijing 100034, Peoples R China; [Cui, Yun] Urogenital Dis Male Mol Diag & Treatment Ctr, Beijing 100034, Peoples R China; [Yang, Yang] Natl Urol Canc Ctr, Beijing 100034, Peoples R China	Peking University; Peking University	Zhang, Q; Jin, J (corresponding author), Peking Univ, Hosp 1, Dept Urol, Beijing 100034, Peoples R China.; Zhang, Q; Jin, J (corresponding author), Peking Univ, Inst Urol, Beijing 100034, Peoples R China.	zhangqian@bjmu.edu.cn; jinjie@vip.163.com			National Natural Science Foundation [81272290, 81572510, 81370858, 81570683]; Beijing Municipal Science and Technology Commission [Z131107002213130]; Beijing Natural Science Foundation [7142161]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was supported by grants from the National Natural Science Foundation (No. 81272290, No. 81572510, No. 81370858 and No. 81570683), Beijing Municipal Science and Technology Commission (No. Z131107002213130) and Beijing Natural Science Foundation (No. 7142161).	[Anonymous], J MOL MED, V93, P691; Baylin SB, 1998, ADV CANCER RES, V72, P141; BUCKLEY MF, 1993, ONCOGENE, V8, P2127; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Du ZF, 2016, ONCOTARGET, V7, P21618, DOI 10.18632/oncotarget.7822; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Evron E, 2001, CANCER RES, V61, P2782; Fackler MJ, 2003, INT J CANCER, V107, P970, DOI 10.1002/ijc.11508; Hedberg Y, 2002, ACTA ONCOL, V41, P175, DOI 10.1080/028418602753669562; Henrique R, 2006, J MOL MED, V84, P911, DOI 10.1007/s00109-006-0099-4; Hsu A, 2011, CLIN EPIGENETICS, V3, DOI 10.1186/1868-7083-3-3; Lima MS, 2014, INT UROL NEPHROL, V46, P905, DOI 10.1007/s11255-013-0602-0; Matsubayashi H, 2003, CLIN CANCER RES, V9, P1446; Mermelshtein A, 2005, BRIT J CANCER, V93, P338, DOI 10.1038/sj.bjc.6602709; Meyyappan M, 1998, MOL CELL BIOL, V18, P3163, DOI 10.1128/MCB.18.6.3163; Meyyappan M, 1996, BIOL SIGNAL, V5, P130; Padar A, 2003, CLIN CANCER RES, V9, P4730; SHAPIRO GI, 1995, CANCER RES, V55, P6200; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; SINCLAIR AJ, 1995, J VIROL, V69, P1292, DOI 10.1128/JVI.69.2.1292-1295.1995; Takano Y, 1999, J PATHOL, V189, P194; Takano Y, 2000, AM J PATHOL, V156, P585, DOI 10.1016/S0002-9440(10)64763-3; Tao Q, 1999, AM J PATHOL, V155, P619, DOI 10.1016/S0002-9440(10)65157-7; Tsihlias J, 1999, ANNU REV MED, V50, P401; Uchida K, 2002, INT J UROL, V9, P19, DOI 10.1046/j.1442-2042.2002.00418.x; Virmani A, 2003, INT J CANCER, V107, P341, DOI 10.1002/ijc.11393; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Xu B, 2015, INT J MOL SCI, V16, P1051, DOI 10.3390/ijms16011051; Yu J, 2003, BRIT J CANCER, V88, P1560, DOI 10.1038/sj.bjc.6600940; Zhang L, 2015, BIOMED RES INT, V2015, P1, DOI DOI 10.1371/J0URNAL.PGEN.1005164; Zhang PM, 1999, CURR OPIN CELL BIOL, V11, P655, DOI 10.1016/S0955-0674(99)00032-0; Zhang Q, 2014, CANCER LETT, V354, P227, DOI 10.1016/j.canlet.2014.07.040; Zhang Q, 2014, MOL CELL ENDOCRINOL, V382, P583, DOI 10.1016/j.mce.2013.03.016; Zhang QA, 2010, J UROLOGY, V184, P731, DOI 10.1016/j.juro.2010.03.108; Zhang Q, 2007, CANCER LETT, V249, P220, DOI 10.1016/j.canlet.2006.08.019	37	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161859	10.1371/journal.pone.0161859	http://dx.doi.org/10.1371/journal.pone.0161859			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583477	Green Published, gold, Green Submitted			2022-12-26	WOS:000382855600067
J	Wei, Z; Du, YG; Zhang, J; Tai, BJ; Du, MQ; Jiang, H				Wei, Zhao; Du, Yangge; Zhang, Jing; Tai, Baojun; Du, Minquan; Jiang, Han			Prevalence and Indicators of Tooth Wear among Chinese Adults	PLOS ONE			English	Article							DENTAL EROSIVE WEAR; EXAMINATION BEWE; SCORING SYSTEM; ADOLESCENTS; TEETH; RISK; AGE; BEVERAGES; SURFACES; OPTIONS	Numerous epidemiological studies have focused on the prevalence and related indicators of tooth wear. However, no sufficient studies have been conducted with Chinese adults. The purpose of this study was to assess the prevalence of tooth wear and identify related indicators among adults aged 36 to 74 years in Wuhan City, P.R. China. A cross-sectional and analytic study was conducted with 720 participants, aged 35-49 yrs and 50-74 yrs, in 2014. Each age group included 360 participants, of which 50% were males and 50% were females. All participants completed a questionnaire before examination. Tooth wear was assessed using the modified Basic Erosive Wear Examination (BEWE) index. The data were analyzed using the chi-square test and binary logistic regression analysis. The prevalence of tooth wear was 67.5% and 100% in the 35-49 and 50-74 age groups, respectively. The prevalence of dentin exposure was 64.7% and 98.3%, respectively. A significantly higher prevalence of tooth wear and dentin exposure was found in the 50-74 yr group than in the 35-49 yr group (p < 0.05). Critical indicators of tooth wear and dentin exposure included high frequency of acidic drinks and foods consumption, low socio-economic status, and unilateral chewing. The frequency of changing toothbrushes and the habit of drinking water during meals were associated with tooth wear. In addition, the usage of hard-bristle toothbrushes and consuming vitamin C and aspirin were found to be linked with dentin exposure. In conclusion, the prevalence of tooth wear and dentin exposure observed in Chinese adults was high, and the results revealed an association between tooth wear and socio-behavioral risk indicators.	[Du, Minquan; Jiang, Han] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan, Peoples R China; Wuhan Univ, Sch & Hosp Stomatol, Key Lab Oral Biomed, Minist Educ, Wuhan, Peoples R China	Wuhan University; Wuhan University	Du, MQ; Jiang, H (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan, Peoples R China.	duminquan@whu.edu.cn; jhqwe55@hotmail.com	Du, Min Quan/V-7359-2018	Du, Min Quan/0000-0002-5043-9981				Al-Dlaigan YH, 2001, BRIT DENT J, V190, P145; Bahal P, 2014, CASE REP DENT, V2014, DOI 10.1155/2014/485387; Barbour Michele E, 2006, J Clin Dent, V17, P88; Bartlett D, 2008, CLIN ORAL INVEST, V12, pS65, DOI 10.1007/s00784-007-0181-5; Bartlett DW, 2013, J DENT, V41, P1007, DOI 10.1016/j.jdent.2013.08.018; Bartlett D, 2008, CLIN ORAL INVEST, V12, pS27, DOI 10.1007/s00784-007-0177-1; Burke FM, 2010, COMMUNITY DENT ORAL, V38, P415, DOI 10.1111/j.1600-0528.2010.00550.x; Dixon B, 2012, BRIT DENT J, V213, DOI 10.1038/sj.bdj.2012.670; Eccles J D, 1982, Dent Update, V9, P373; Ehlen LA, 2008, NUTR RES, V28, P299, DOI 10.1016/j.nutres.2008.03.001; Gomes SGF, 2011, BRAZ ORAL RES, V25, P446, DOI 10.1590/S1806-83242011000500012; Ganss C, 2006, CARIES RES, V40, P208, DOI 10.1159/000092227; Pineda AEGA, 2016, J AM DENT ASSOC, V147, P92, DOI 10.1016/j.adaj.2015.07.016; Grace EG, 2004, J AM DENT ASSOC, V135, P911, DOI 10.14219/jada.archive.2004.0337; Gupta Vivek V, 2015, J Clin Exp Dent, V7, pe649, DOI 10.4317/jced.52332; Hays G L, 1992, Am J Dent, V5, P269; Iwashita H, 2014, J PROSTHODONT RES, V58, P223, DOI 10.1016/j.jpor.2014.04.002; Kakudo Y, 1969, J Osaka Dent Univ, V3, P187; Kitasako Y, 2015, J DENT, V43, P418, DOI 10.1016/j.jdent.2015.02.004; Li HG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034566; Liu B, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-65; MANLY RS, 1965, J DENT RES, V44, P533, DOI 10.1177/00220345650440031601; McCracken M, 2000, J Prosthodont, V9, P95, DOI 10.1111/j.1532-849X.2000.00095.x; Milosevic A, 2004, BRIT DENT J, V197, P475, DOI 10.1038/sj.bdj.4811747; Mulic A, 2010, CARIES RES, V44, P294, DOI 10.1159/000314811; Muller-Bolla M, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0133-4; Muts EJ, 2014, J PROSTHET DENT, V112, P752, DOI 10.1016/j.prosdent.2014.01.018; Ramalho A, 2006, WEAR, V260, P361, DOI 10.1016/j.wear.2005.02.121; Schierz O, 2014, J PROSTHET DENT, V112, P465, DOI 10.1016/j.prosdent.2013.12.005; SMITH BGN, 1984, BRIT DENT J, V156, P435, DOI 10.1038/sj.bdj.4805394; Tate DF, 2012, AM J CLIN NUTR, V95, P555, DOI 10.3945/ajcn.111.026278; Vered Y, 2014, CLIN ORAL INVEST, V18, P1985, DOI 10.1007/s00784-013-1175-0; Zhang J, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0104-9	33	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162181	10.1371/journal.pone.0162181	http://dx.doi.org/10.1371/journal.pone.0162181			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583435	Green Published, gold, Green Submitted			2022-12-26	WOS:000382855600116
J	Zhu, LL; Niu, ZD; Nie, YX; Yang, Y; Li, K; Jin, Z; Wei, JY				Zhu, Linlin; Niu, Zhendong; Nie, Yaoxin; Yang, Yang; Li, Ke; Jin, Zhen; Wei, Jieyao			The Brain Effective Connectivity of Chinese during Rhyming Task	PLOS ONE			English	Article							EVENT-RELATED FMRI; INFERIOR PREFRONTAL CORTEX; CORTICAL ORGANIZATION; SPEECH-PERCEPTION; ALPHABETIC WORDS; SPOKEN LANGUAGE; JAPANESE KANJI; APHASIA; METAANALYSIS; CHARACTERS	With regard to brain language processing, the activation patterns have been well studied, and recently there are great interest in the connectivity models. The crucial brain areas for phonological processing involves left inferior frontal gyrus (LIFG), left inferior parietal lobule (LIPL) and left posterior middle temporal gyrus (LpMTG). Specially in Chinese processing, the left middle frontal gyrus (LMFG) is considered as an essential region. However, the connectivity pattern among these brain areas is not well understood. In this study, a rhyming experiment of Chinese was conducted, and the Dynamic causal modeling (DCM) and the Bayesian model selection (BMS) were used to examine the interaction between brain regions and choose the best model for rhyming task of Chinese. By examining the interactions, it was found that LMFG exerted inhibitory modulation on LIPL and LIFG; the phonological processing enhanced the connection from LIPL to LIFG and LMFG, which suggested the important roles of these connections for the increased phonological load; And LpMTG modulated LIFG and LMFG negatively, and LIPL positively under rhyming judgment task.	[Zhu, Linlin; Niu, Zhendong; Nie, Yaoxin; Wei, Jieyao] Beijing Inst Technol, Sch Comp Sci & Technol, Beijing, Peoples R China; [Yang, Yang] Univ Hong Kong, Dept Linguist, Hong Kong, Hong Kong, Peoples R China; [Li, Ke; Jin, Zhen] 306th Hosp PLA, Beijing, Peoples R China	Beijing Institute of Technology; University of Hong Kong	Niu, ZD (corresponding author), Beijing Inst Technol, Sch Comp Sci & Technol, Beijing, Peoples R China.	zniu@bit.edu.cn			National Strategic Basic Research Program ("973" Program) of the Ministry of Science and Technology of China [2012CB720702]	National Strategic Basic Research Program ("973" Program) of the Ministry of Science and Technology of China	This study was supported by the National Strategic Basic Research Program ("973" Program) of the Ministry of Science and Technology of China (Grant No.: 2012CB720702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baoguo C, 2003, ACTA PSYCHOL SINICA, V35, P576; BATES E, 1991, BRAIN LANG, V41, P203, DOI 10.1016/0093-934X(91)90153-R; Bitan T, 2005, J NEUROSCI, V25, P5397, DOI 10.1523/JNEUROSCI.0864-05.2005; Bitan T, 2007, NEUROIMAGE, V38, P564, DOI 10.1016/j.neuroimage.2007.07.048; Bitan T, 2009, J COGNITIVE NEUROSCI, V21, P1135, DOI 10.1162/jocn.2009.21065; Booth JR, 2008, BRAIN RES, V1189, P78, DOI 10.1016/j.brainres.2007.10.080; Booth JR, 2006, BRAIN RES, V1071, P197, DOI 10.1016/j.brainres.2005.11.097; Brambati SM, 2009, NEUROPSYCHOLOGIA, V47, P1893, DOI 10.1016/j.neuropsychologia.2009.02.033; Cao F, 2011, NEUROIMAGE, V57, P750, DOI 10.1016/j.neuroimage.2010.09.047; Cao F, 2009, HUM BRAIN MAPP, V30, P797, DOI 10.1002/hbm.20546; Chen RL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050957, 10.1371/journal.pone.0051246]; Chen S, 1998, APHASIOLOGY, V12, P5, DOI 10.1080/02687039808249441; Crepaldi D, 2011, BRAIN LANG, V116, P33, DOI 10.1016/j.bandl.2010.09.005; de Zubicaray GI, 2001, HUM BRAIN MAPP, V14, P218, DOI 10.1002/hbm.1054; Devlin JT, 2003, J COGNITIVE NEUROSCI, V15, P71, DOI 10.1162/089892903321107837; Dong Y, 2005, NEUROSCI RES, V52, P139, DOI 10.1016/j.neures.2005.02.005; Duncan KJK, 2014, CEREB CORTEX, V24, P1601, DOI 10.1093/cercor/bht015; Fiez JA, 1997, HUM BRAIN MAPP, V5, P79, DOI 10.1002/(SICI)1097-0193(1997)5:2<79::AID-HBM1>3.3.CO;2-M; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Gow DW, 2012, BRAIN LANG, V121, P273, DOI 10.1016/j.bandl.2012.03.005; Graves WW, 2008, J COGNITIVE NEUROSCI, V20, P1698, DOI 10.1162/jocn.2008.20113; Graves WW, 2007, J COGNITIVE NEUROSCI, V19, P617, DOI 10.1162/jocn.2007.19.4.617; Heim S, 2009, HUM BRAIN MAPP, V30, P392, DOI 10.1002/hbm.20512; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hickok G, 2011, BRAIN LANG, V119, P214, DOI 10.1016/j.bandl.2011.08.001; Hoffman P, 2012, APHASIOLOGY, V26, P1119, DOI 10.1080/02687038.2011.608838; Hu ZH, 2012, BRAIN TOPOGR, V25, P362, DOI 10.1007/s10548-012-0230-5; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Kellmeyer P, 2013, BRAIN LANG, V127, P241, DOI 10.1016/j.bandl.2013.09.011; Kuo WJ, 2004, NEUROIMAGE, V21, P1721, DOI 10.1016/j.neuroimage.2003.12.007; Kuo WJ, 2003, NEUROIMAGE, V18, P720, DOI 10.1016/S1053-8119(03)00015-6; Kuo WJ, 2001, NEUROREPORT, V12, P3997, DOI 10.1097/00001756-200112210-00029; Lee CY, 2004, NEUROIMAGE, V23, P1235, DOI 10.1016/j.neuroimage.2004.07.064; Liu L, 2006, NEUROIMAGE, V29, P515, DOI 10.1016/j.neuroimage.2005.07.046; Liu L, 2009, J COGNITIVE NEUROSCI, V21, P1473, DOI 10.1162/jocn.2009.21141; Liu YY, 2007, BEHAV RES METHODS, V39, P192, DOI 10.3758/BF03193147; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Price CJ, 2009, YEAR COGNITIVE NEURO, P62; Richardson FM, 2011, J NEUROSCI, V31, P8239, DOI 10.1523/JNEUROSCI.6519-10.2011; Richlan F, 2009, HUM BRAIN MAPP, V30, P3299, DOI 10.1002/hbm.20752; Rimol LM, 2005, NEUROIMAGE, V26, P1059, DOI 10.1016/j.neuroimage.2005.03.028; Rissman J, 2003, J COGNITIVE NEUROSCI, V15, P1160, DOI 10.1162/089892903322598120; Sass K, 2009, NEUROIMAGE, V45, P224, DOI 10.1016/j.neuroimage.2008.10.014; Seghier ML, 2010, CEREB CORTEX, V20, P570, DOI 10.1093/cercor/bhp123; Siok WT, 2004, NATURE, V431, P71, DOI 10.1038/nature02865; Siok WT, 2003, HUM BRAIN MAPP, V18, P201, DOI 10.1002/hbm.10094; Stephan KE, 2010, WIRES COGN SCI, V1, P446, DOI 10.1002/wcs.58; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; Tan LH, 2001, NEUROREPORT, V12, P83, DOI 10.1097/00001756-200101220-00024; Tan LH, 2005, HUM BRAIN MAPP, V25, P83, DOI 10.1002/hbm.20134; Tan LH, 2001, NEUROIMAGE, V13, P836, DOI 10.1006/nimg.2001.0749; Vigliocco G, 2011, NEUROSCI BIOBEHAV R, V35, P407, DOI 10.1016/j.neubiorev.2010.04.007; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Wu CY, 2014, BRAIN LANG, V135, P32, DOI 10.1016/j.bandl.2014.04.005; Xiao ZW, 2005, HUM BRAIN MAPP, V25, P212, DOI 10.1002/hbm.20105; Xing, 1997, 5 WORLD CHIN TEACH S; Xu M, 2015, HUM BRAIN MAPP, V36, P2580, DOI 10.1002/hbm.22792; Zhu LL, 2014, HUM BRAIN MAPP, V35, P2607, DOI 10.1002/hbm.22354; 陈宝国, 2001, [心理学报, Acta Psychologica Sinica], V33, P1	64	4	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162158	10.1371/journal.pone.0162158	http://dx.doi.org/10.1371/journal.pone.0162158			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583349	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600114
J	Goldman, SE; Moshkovits, I; Shemesh, A; Filiba, A; Tsirulsky, Y; Vronov, E; Shagan, M; Apte, RN; Benharroch, D; Karo-Atar, D; Dagan, R; Munitz, A; Nebenzahl, YM; Porgador, A				Goldman, Shirin Elhaik; Moshkovits, Itay; Shemesh, Avishai; Filiba, Ayelet; Tsirulsky, Yevgeny; Vronov, Elena; Shagan, Marilou; Apte, Ron N.; Benharroch, Daniel; Karo-Atar, Danielle; Dagan, Ron; Munitz, Ariel; Nebenzahl, Yaffa Mizrachi; Porgador, Angel			Natural Killer Receptor 1 Dampens the Development of Allergic Eosinophilic Airway Inflammation	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; VIRUS-INFECTED CELLS; HUMAN NK CELLS; CC-CHEMOKINE; CYTOTOXICITY RECEPTORS; EPITHELIAL-CELLS; ACTIVATING RECEPTORS; CYTOKINE PRODUCTION; PERIPHERAL-BLOOD; INTERFERON-GAMMA	The function of NCR1 was studied in a model of experimental asthma, classified as a type 1 hypersensitivity reaction, in mice. IgE levels were significantly increased in the serum of OVA immunized NCR1 deficient (NCR1(gfp/gfp)) mice in comparison to OVA immunized wild type (NCR1(+/+)) and adjuvant immunized mice. Histological analysis of OVA immunized NCR1(gfp/gfp) mice revealed no preservation of the lung structure and overwhelming peribronchial and perivascular granulocytes together with mononuclear cells infiltration. OVA immunized NCR+/+ mice demonstrated preserved lung structure and peribronchial and perivascular immune cell infiltration to a lower extent than that in NCR1(gfp/gfp) mice. Adjuvant immunized mice demonstrated lung structure preservation and no immune cell infiltration. OVA immunization caused an increase in PAS production independently of NCR1 presence. Bronchoalveolar lavage (BAL) revealed NCR1 dependent decreased percentages of eosinophils and increased percentages of lymphocytes and macrophages following OVA immunization. In the OVA immunized NCR1(gfp/gfp) mice the protein levels of eosinophils' (CCL24) and Th2 CD4(+) T-cells' chemoattractants (CCL17, and CCL24) in the BAL are increased in comparison with OVA immunized NCR+/+ mice. In the presence of NCR1, OVA immunization caused an increase in NK cells numbers and decreased NCR1 ligand expression on CD11c(+) GR1(+) cells and decreased NCR1 mRNA expression in the BAL. OVA immunization resulted in significantly increased IL-13, IL-4 and CCL17 mRNA expression in NCR1(+/+) and NCR1(gfp/gfp) mice. IL-17 and TNF alpha expression increased only in OVA-immunized NCR1(+/+) mice. IL-6 mRNA increased only in OVA immunized NCR1(gfp/gfp) mice. Collectively, it is demonstrated that NCR1 dampens allergic eosinophilic airway inflammation.	[Goldman, Shirin Elhaik; Shemesh, Avishai; Filiba, Ayelet; Tsirulsky, Yevgeny; Vronov, Elena; Shagan, Marilou; Apte, Ron N.; Nebenzahl, Yaffa Mizrachi; Porgador, Angel] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol Immunol & Genet, IL-84105 Beer Sheva, Israel; [Moshkovits, Itay; Karo-Atar, Danielle; Munitz, Ariel; Nebenzahl, Yaffa Mizrachi] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, Tel Aviv, Israel; [Benharroch, Daniel] Soroka Univ, Med Ctr, Dept Pathol, Bear Sheva, Israel; [Dagan, Ron] Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; [Porgador, Angel] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, Beer Sheva, Israel	Ben Gurion University; Tel Aviv University; Sackler Faculty of Medicine; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Ben Gurion University	Nebenzahl, YM; Porgador, A (corresponding author), Ben Gurion Univ Negev, Shraga Segal Dept Microbiol Immunol & Genet, IL-84105 Beer Sheva, Israel.; Nebenzahl, YM (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, Tel Aviv, Israel.; Porgador, A (corresponding author), Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, Beer Sheva, Israel.	ymizr@bgu.ac.il; angel@bgu.ac.il	Goldman, Shirin/AAU-9596-2020	Karo-Atar, Danielle/0000-0002-0225-8836; Porgador, Angel/0000-0003-1540-4449	Israel Cancer Research Foundation Research Career Development Award [4476, 5540, 3000003867]; Center for Emerging Diseases [2506]; Israel Science Foundation [613/04, 304/12, 955/11]; US/Israel Binational Science Foundation [2011123]; Israeli Ministry of Science and Technology/German Cancer Research Center program [CA142]; US / Israel Bi-national Science Foundation [2009222, 2011244]; Israel Cancer Association [20150002]; Israel Ministry of Health [3-10117]; Boaz and Varda Dotan Center Grant for Hemato-oncology Research; ISEF Foundation	Israel Cancer Research Foundation Research Career Development Award; Center for Emerging Diseases; Israel Science Foundation(Israel Science Foundation); US/Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israeli Ministry of Science and Technology/German Cancer Research Center program; US / Israel Bi-national Science Foundation(US-Israel Binational Science Foundation); Israel Cancer Association; Israel Ministry of Health; Boaz and Varda Dotan Center Grant for Hemato-oncology Research; ISEF Foundation	This work was supported by the Israel Cancer Research Foundation Research Career Development Award, 4476; 5540; 3000003867; The Center for Emerging Diseases, 2506; The Israel Science Foundation, 613/04; to Yaffa Mizrachi Nebenzahl. US/Israel Binational Science Foundation, 2011123; Israel Science Foundation, 304/12; Israeli Ministry of Science and Technology/German Cancer Research Center program, CA142 to Angel Porgador. The US / Israel Bi-national Science Foundation, 2009222; 2011244; The Israel Science Foundation, 955/11; The Israel Cancer Association, 20150002; the Israel Ministry of Health, 3-10117; the Boaz and Varda Dotan Center Grant for Hemato-oncology Research to Ariel Munitz; ISEF Foundation to Shirin Elhaik Goldman. The funders/sponsors had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal DK, 2010, CURR ALLERGY ASTHM R, V10, P39, DOI 10.1007/s11882-009-0081-7; Akahira-Azuma M, 2004, IMMUNOLOGY, V111, P306, DOI 10.1111/j.0019-2805.2004.01818.x; Andrew DP, 1998, J IMMUNOL, V161, P5027; Arase H, 2004, REV MED VIROL, V14, P83, DOI 10.1002/rmv.422; Arnon TI, 2004, BLOOD, V103, P664, DOI 10.1182/blood-2003-05-1716; Awad A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094492; Barnig C, 2015, EUR RESPIR REV, V24, P141, DOI 10.1183/09059180.00012514; Basil MC, 2016, NAT REV IMMUNOL, V16, P51, DOI 10.1038/nri.2015.4; Blery M, 2000, HUM IMMUNOL, V61, P51, DOI 10.1016/S0198-8859(99)00157-3; Brewer JM, 1999, J IMMUNOL, V163, P6448; Cantoni C, 1999, J EXP MED, V189, P787, DOI 10.1084/jem.189.5.787; Chang MS, 1997, J BIOL CHEM, V272, P25229, DOI 10.1074/jbc.272.40.25229; Cooper MA, 2004, TRENDS IMMUNOL, V25, P47, DOI 10.1016/j.it.2003.10.012; Crapster-Pregont M, 2012, J ALLERGY CLIN IMMUN, V129, P1621, DOI 10.1016/j.jaci.2012.01.052; Das R, 2014, MED MICROBIOL IMMUN, V203, P303, DOI 10.1007/s00430-014-0338-1; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Deniz G, 2013, J ALLERGY CLIN IMMUN, V132, P527, DOI 10.1016/j.jaci.2013.07.030; Moreira-Silva EAD, 2014, VIRUS RES, V184, P20, DOI 10.1016/j.virusres.2014.02.001; Elhaik-Goldman S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023472; Farhadi N, 2014, J ALLERGY CLIN IMMUN, V133, P827, DOI 10.1016/j.jaci.2013.09.048; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Funamizu A, 2014, AM J REPROD IMMUNOL, V71, P359, DOI 10.1111/aji.12206; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Ghadially H, 2005, J IMMUNOL, V174, P5620, DOI 10.4049/jimmunol.174.9.5620; Ghadially H, 2013, EUR J IMMUNOL, V43, P3006, DOI 10.1002/eji.201343388; Hamid Q, 2009, ANNU REV PHYSIOL, V71, P489, DOI 10.1146/annurev.physiol.010908.163200; Haworth O, 2008, NAT IMMUNOL, V9, P873, DOI 10.1038/ni.1627; Haworth O, 2011, J IMMUNOL, V186, P6129, DOI 10.4049/jimmunol.1004007; Hayakawa Y, 2006, IMMUNOL REV, V214, P47, DOI 10.1111/j.1600-065X.2006.00454.x; JIRA M, 1988, ALLERGY, V43, P294, DOI 10.1111/j.1398-9995.1988.tb00903.x; Jovanovic K, 2014, CLIN EXP IMMUNOL, V178, P201, DOI 10.1111/cei.12409; Kelly EAB, 2003, J ALLERGY CLIN IMMUN, V111, P79, DOI 10.1067/mai.2003.28; Kirwan SE, 2007, CURR OPIN IMMUNOL, V19, P46, DOI 10.1016/j.coi.2006.11.012; Korsgren M, 1999, J EXP MED, V189, P553, DOI 10.1084/jem.189.3.553; Kubo T, 2008, J INTERF CYTOK RES, V28, P725, DOI 10.1089/jir.2008.0035; Lin SJ, 2003, ALLERGY, V58, P67, DOI 10.1034/j.1398-9995.2003.t01-1-23697.x; Makita N, 2015, INT IMMUNOL, V27, P131, DOI 10.1093/intimm/dxu090; Mandelboim O, 2001, INT J BIOCHEM CELL B, V33, P1147, DOI 10.1016/S1357-2725(01)00078-4; Marashian SM, 2015, IRAN J ALLERGY ASTHM, V14, P346; Mathias CB, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-014-0500-2; Mavoungou E, 2005, CLIN EXP IMMUNOL, V139, P287, DOI 10.1111/j.1365-2249.2004.02686.x; Mesdaghi M, 2010, INT ARCH ALLERGY IMM, V153, P234, DOI 10.1159/000314363; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; O'Connor GM, 2006, IMMUNOLOGY, V117, P1, DOI 10.1111/j.1365-2567.2005.02256.x; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Ple C, 2010, SCAND J IMMUNOL, V72, P118, DOI 10.1111/j.1365-3083.2010.02419.x; Poggi A, 2006, CLIN DEV IMMUNOL, V13, P325, DOI 10.1080/17402520600578194; Proud D, 2011, IMMUNOL REV, V242, P186, DOI 10.1111/j.1600-065X.2011.01033.x; Rosental B, 2011, J IMMUNOL, V187, P5693, DOI 10.4049/jimmunol.1102267; Ross R, 1999, J INVEST DERMATOL, V113, P991, DOI 10.1046/j.1523-1747.1999.00803.x; Salazar F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00356; Schaniel C, 1998, J EXP MED, V188, P451, DOI 10.1084/jem.188.3.451; Scordamaglia F, 2008, J ALLERGY CLIN IMMUN, V121, P479, DOI 10.1016/j.jaci.2007.09.047; Shao ZF, 2009, J ALLERGY CLIN IMMUN, V123, P917, DOI 10.1016/j.jaci.2009.01.052; Shum Bennett O. V., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000707; Sivori S, 1999, EUR J IMMUNOL, V29, P1656, DOI 10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1; Stables MJ, 2010, BLOOD, V116, P2950, DOI 10.1182/blood-2010-05-284844; Tang HL, 1999, SCIENCE, V284, P819, DOI 10.1126/science.284.5415.819; Thoren FB, 2012, J IMMUNOL, V188, P1668, DOI 10.4049/jimmunol.1102002; TIMONEN T, 1985, CLIN EXP IMMUNOL, V59, P85; Tomasello E, 2000, SEMIN IMMUNOL, V12, P139, DOI 10.1006/smim.2000.0216; von Bubnoff D, 2010, J ALLERGY CLIN IMMUN, V125, P60, DOI 10.1016/j.jaci.2009.11.020; Walsh GM, 2015, EXPERT OPIN EMERG DR, V20, P349, DOI 10.1517/14728214.2015.1050377; Woo Yeonduk, 2014, Immune Netw, V14, P171, DOI 10.4110/in.2014.14.4.171; Yokota M, 2013, AM J REPROD IMMUNOL, V69, P202, DOI 10.1111/aji.12062; Yossef R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118936; Zimmermann N, 2003, J CLIN INVEST, V111, P1863, DOI 10.1172/JCI200317912; Zitvogel L, 2002, J EXP MED, V195, pf9, DOI 10.1084/jem.20012040	70	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0160779	10.1371/journal.pone.0160779	http://dx.doi.org/10.1371/journal.pone.0160779			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580126	gold, Green Published, Green Submitted			2022-12-26	WOS:000382877400009
J	Koch, A; Gulani, J; King, G; Hieber, K; Chappell, M; Ossetrova, N				Koch, Amory; Gulani, Jatinder; King, Gregory; Hieber, Kevin; Chappell, Mark; Ossetrova, Natalia			Establishment of Early Endpoints in Mouse Total-Body Irradiation Model	PLOS ONE			English	Article							ACUTE-RADIATION-SYNDROME; BIODOSIMETRY APPLICATIONS; MEDICAL COUNTERMEASURES; INJURY ASSESSMENT; EXPOSURE; BIOMARKERS; PROTEIN; MICE	Acute radiation sickness (ARS) following exposure to ionizing irradiation is characterized by radiation-induced multiorgan dysfunction/failure that refers to progressive dysfunction of two or more organ systems, the etiological agent being radiation damage to cells and tissues over time. Radiation sensitivity data on humans and animals has made it possible to describe the signs associated with ARS. A mouse model of total-body irradiation (TBI) has previously been developed that represents the likely scenario of exposure in the human population. Herein, we present the Mouse Intervention Scoring System (MISS) developed at the Veterinary Sciences Department (VSD) of the Armed Forces Radiobiology Research Institute (AFRRI) to identify moribund mice and decrease the numbers of mice found dead, which is therefore a more humane refinement to death as the endpoint. Survival rates were compared to changes in body weights and temperatures in the mouse (CD2F1 male) TBI model (6-14 Gy, Co-60 gamma-rays at 0.6 Gy min(-1)), which informed improvements to the Scoring System. Individual tracking of animals via implanted microchips allowed for assessment of criteria based on individuals rather than by group averages. From a total of 132 mice (92 irradiated), 51 mice were euthanized versus only four mice that were found dead (7% of non-survivors). In this case, all four mice were found dead after overnight periods between observations. Weight loss alone was indicative of imminent succumbing to radiation injury, however mice did not always become moribund within 24 hours while having weight loss >30%. Only one survivor had a weight loss of greater than 30%. Temperature significantly dropped only 2-4 days before death/euthanasia in 10 and 14 Gy animals. The score system demonstrates a significant refinement as compared to using subjective assessment of morbidity or death as the endpoint for these survival studies.	[Koch, Amory; Gulani, Jatinder; Chappell, Mark] Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Dept Vet Sci, Bethesda, MD 20814 USA; [Gulani, Jatinder; Hieber, Kevin] Henry M Jackson Fdn, Bethesda, MD USA; [King, Gregory; Hieber, Kevin; Ossetrova, Natalia] Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Sci Res Dept, Bethesda, MD USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Uniformed Services University of the Health Sciences - USA; United States Department of Defense	Koch, A (corresponding author), Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Dept Vet Sci, Bethesda, MD 20814 USA.	amory.l.koch.mil@mail.mil			Defense Threat Reduction Agency (DTRA) grant CBM [RAD.03.10.AR.002]; AFRRI Veterinary and Radiation Sciences Departments	Defense Threat Reduction Agency (DTRA) grant CBM; AFRRI Veterinary and Radiation Sciences Departments	This work was supported by Defense Threat Reduction Agency (DTRA) grant CBM. RAD.03.10.AR.002 (awarded to NO FY10-12). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research was supported by the Defense Threat Reduction Agency (DTRA) grant CBM. RAD.03.10.AR.002 (awarded to Dr. Natalia Ossetrova). We would like to thank the AFRRI Veterinary and Radiation Sciences Departments for their support, Dr. William F. Blakely for helpful discussions, David Sandgren, Donald Condliffe, Patrick Ney, Katya Krasnopolsky, and Arifur Rahman for technical contributions, and Mark Whitnall and Francis Duffy for editing assistance. The opinions, conclusions, and recommendations expressed or implied do not necessarily reflect the view of the Department of Defense or any other department or agency of the U.S. federal government.	Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; Blakely WF, 2007, RADIAT MEAS, V42, P1164, DOI 10.1016/j.radmeas.2007.05.013; Blakely WF, 2014, RADIAT PROT DOSIM, V159, P46, DOI 10.1093/rpd/ncu127; Blakely WF, 2011, RADIAT MEAS, V46, P898, DOI 10.1016/j.radmeas.2011.05.006; Blakely WF, 2010, HEALTH PHYS, V98, P153, DOI 10.1097/HP.0b013e3181b0306d; Booth C, 2012, HEALTH PHYS, V103, P383, DOI 10.1097/HP.0b013e318266ee13; DiCarlo AL, DISASTER MED PUBLIC, V5, pS32; DiCarlo AL, 2008, RADIAT RES, V169, P712, DOI 10.1667/RR1295.1; Farese AM, 2012, HEALTH PHYS, V103, P367, DOI 10.1097/HP.0b013e31825f75a7; Ghosh SP, 2009, INT J RADIAT BIOL, V85, P598, DOI 10.1080/09553000902985128; Goans RE, 2013, TXB MILITARY MED, P17; Kumar K. S., 2009, TOCOTRIENOLS VITAMIN, P379; Landauer MR, 2005, TRG099 NATO, V17, P1; Layton RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020641; LUSHBAUGH C C, 1969, Advances in Radiation Biology, P277; MacVittie TJ, 2005, HEALTH PHYS, V89, P546, DOI 10.1097/01.HP.0000173143.69659.5b; Nunamaker EA, 2013, COMPARATIVE MED, V63, P22; Ossetrova NI, 2007, RADIAT MEAS, V42, P1158, DOI 10.1016/j.radmeas.2007.05.031; Ossetrova NI, 2011, RADIAT MEAS, V46, P1019, DOI 10.1016/j.radmeas.2011.05.021; Ossetrova NI, 2014, RADIAT PROT DOSIM, V159, P61, DOI 10.1093/rpd/ncu165; Ossetrova NI, 2014, HEALTH PHYS, V106, P772, DOI 10.1097/HP.0000000000000094; Ossetrova NI, 2010, HEALTH PHYS, V98, P204, DOI 10.1097/HP.0b013e3181abaabf; Ossetrova NI, 2009, INT J RADIAT BIOL, V85, P837, DOI 10.3109/09553000903154799; Ossetrova NI, 2011, 3 INT S RAD EM MED H, P105; Plett PA, 2012, HEALTH PHYS, V103, P343, DOI 10.1097/HP.0b013e3182667309; Plourde JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046605; Satyamitra M, 2011, RADIAT RES, V175, P746, DOI 10.1667/RR2462.1; Shang SB, 2012, VACCINE, V30, P1572, DOI 10.1016/j.vaccine.2011.12.114; Srinivasan V, 2008, IMMUNOPHARM IMMUNOT, V30, P271, DOI [10.1080/08923970801925331, 10.1080/08923970801925331 ]; Vriesendorp H M, 1980, Haematol Blood Transfus, V25, P349; Waselenko SK, 2004, ANN INTERN MED, V140, P1087; Williams JP, 2010, RADIAT RES, V173, P557, DOI 10.1667/RR1880.1	32	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161079	10.1371/journal.pone.0161079	http://dx.doi.org/10.1371/journal.pone.0161079			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579862	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877400014
J	Masaki, Y; Shimizu, Y; Yoshioka, T; Feng, F; Zhao, SJ; Higashino, K; Numata, Y; Kuge, Y				Masaki, Yukiko; Shimizu, Yoichi; Yoshioka, Takeshi; Feng, Fei; Zhao, Songji; Higashino, Kenichi; Numata, Yoshito; Kuge, Yuji			Imaging Mass Spectrometry Revealed the Accumulation Characteristics of the 2-Nitroimidazole-Based Agent "Pimonidazole" in Hypoxia	PLOS ONE			English	Article							DRUG DEVELOPMENT; GLUTATHIONE; 1-METHYL-2-NITROSOIMIDAZOLE; MALDI; CYTOTOXICITY; IONIZATION; DEPLETION; THIOLS; CELLS	Hypoxia, or low oxygen concentration, is a key factor promoting tumor progression and angiogenesis and resistance of cancer to radiotherapy and chemotherapy. 2-Nitroimidazole- based agents have been widely used in pathological and nuclear medicine examinations to detect hypoxic regions in tumors; in particular, pimonidazole is used for histochemical staining of hypoxic regions. It is considered to accumulate in hypoxic cells via covalent binding with macromolecules or by forming reductive metabolites after reduction of its nitro group. However, the detailed mechanism of its accumulation remains unknown. In this study, we investigated the accumulation mechanism of pimonidazole in hypoxic tumor tissues in a mouse model by mass spectrometric analyses including imaging mass spectrometry (IMS). Pimonidazole and its reductive metabolites were observed in the tumor tissues. However, their locations in the tumor sections were not similar to the positively stained areas in pimonidazole-immunohistochemistry, an area considered hypoxic. The glutathione conjugate of reduced pimonidazole, a low-molecular-weight metabolite of pimonidazole, was found in tumor tissues by LC-MS analysis, and our IMS study determined that the intratumor localization of the glutathione conjugate was consistent with the area positively immunostained for pimonidazole. We also found complementary localization of the glutathione conjugate and reduced glutathione (GSH), implying that formation of the glutathione conjugate occurred in the tumor tissue. These results suggest that in hypoxic tumor cells, pimonidazole is reduced at its nitro group, followed by conjugation with GSH.	[Masaki, Yukiko; Yoshioka, Takeshi; Higashino, Kenichi; Numata, Yoshito; Kuge, Yuji] Shionogi & Co Ltd, Discovery Res Lab Innovat Frontier Med, Shionogi Innovat Ctr Drug Discovery, Sapporo, Hokkaido, Japan; [Shimizu, Yoichi] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido, Japan; [Shimizu, Yoichi; Kuge, Yuji] Hokkaido Univ, Cent Inst Isotope Sci, Sapporo, Hokkaido, Japan; [Feng, Fei; Zhao, Songji; Kuge, Yuji] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan	Shionogi & Company Limited; Hokkaido University; Hokkaido University; Hokkaido University	Shimizu, Y (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido, Japan.; Shimizu, Y (corresponding author), Hokkaido Univ, Cent Inst Isotope Sci, Sapporo, Hokkaido, Japan.	yshimizu@pharm.hokudai.ac.jp		Yoshioka, Takeshi/0000-0002-8658-8081	Shionogi Co., Ltd.; Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program, Ministry of Education, Culture, Sports, Science and Technology, Japan	Shionogi Co., Ltd.; Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program, Ministry of Education, Culture, Sports, Science and Technology, Japan	This study was supported by the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program, Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.jst.go.jp/shincho/sentanyugo/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also funded by Shionogi & Co., Ltd. (http://www.shionogi.co.jp/index.html). The funder provided support in the form of salaries for authors [YM TY KH YN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstrom M, 2003, EUR J CLIN PHARMACOL, V59, P357, DOI 10.1007/s00228-003-0643-x; BERUBE LR, 1992, INT J RADIAT ONCOL, V22, P817, DOI 10.1016/0360-3016(92)90531-L; BERUBE LR, 1991, BIOCHEM PHARMACOL, V42, P2153, DOI 10.1016/0006-2952(91)90351-5; BREZDEN CB, 1994, BIOCHEM PHARMACOL, V48, P361, DOI 10.1016/0006-2952(94)90108-2; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Castellino S, 2011, BIOANALYSIS, V3, P2427, DOI [10.4155/bio.11.232, 10.4155/BIO.11.232]; Fatema CN, 2013, ANN NUCL MED, V27, P355, DOI 10.1007/s12149-013-0693-9; Gobey J, 2005, ANAL CHEM, V77, P5643, DOI 10.1021/ac0506130; Horsman MR, 2012, NAT REV CLIN ONCOL, V9, P674, DOI 10.1038/nrclinonc.2012.171; Inazawa K, 2004, EXP MOL PATHOL, V76, P153, DOI 10.1016/j.yexmp.2003.11.002; Krohn KA, 2008, J NUCL MED, V49, p129S, DOI 10.2967/jnumed.107.045914; Ma SG, 2009, CHEM-BIOL INTERACT, V179, P25, DOI 10.1016/j.cbi.2008.09.014; MARTO JA, 1995, ANAL CHEM, V67, P3979, DOI 10.1021/ac00117a025; Masaki Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep16802; MULCAHY RT, 1989, BIOCHEM PHARMACOL, V38, P1667, DOI 10.1016/0006-2952(89)90315-8; NUNN A, 1995, EUR J NUCL MED, V22, P265, DOI 10.1007/BF01081524; RALEIGH JA, 1990, BIOCHEM PHARMACOL, V40, P2457, DOI 10.1016/0006-2952(90)90086-Z; Vaidyanathan S, 2006, RAPID COMMUN MASS SP, V20, P1192, DOI 10.1002/rcm.2434; VARGHESE AJ, 1981, CHEM-BIOL INTERACT, V36, P141, DOI 10.1016/0009-2797(81)90016-8; VARGHESE AJ, 1983, BIOCHEM BIOPH RES CO, V112, P1013, DOI 10.1016/0006-291X(83)91719-9; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Xie C, 2013, ANAL CHIM ACTA, V788, P89, DOI 10.1016/j.aca.2013.06.022; Xue YJ, 2012, BIOANALYSIS, V4, P2637, DOI [10.4155/BIO.12.252, 10.4155/bio.12.252]	23	18	18	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161639	10.1371/journal.pone.0161639	http://dx.doi.org/10.1371/journal.pone.0161639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580239	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877400033
J	Doering, S; Bose-O'Reilly, S; Berger, U				Doering, Stefan; Bose-O'Reilly, Stephan; Berger, Ursula			Essential Indicators Identifying Chronic Inorganic Mercury Intoxication: Pooled Analysis across Multiple Cross-Sectional Studies	PLOS ONE			English	Article							GOLD MINING AREAS; ENVIRONMENTAL ASSESSMENT; RISK-ASSESSMENT; MISSING DATA; EXPOSURE; CONTAMINATION; HEALTH; MINERS; PHILIPPINES; CHILDREN	Background The continuous exposure to inorganic mercury vapour in artisanal small-scale gold mining (ASGM) areas leads to chronic health problems. It is therefore essential to have a quick, but reliable risk assessing tool to diagnose chronic inorganic mercury intoxication. This study re-evaluates the state-of-the-art toolkit to diagnose chronic inorganic mercury intoxication by analysing data from multiple pooled cross-sectional studies. The primary research question aims to reduce the currently used set of indicators without affecting essentially the capability to diagnose chronic inorganic mercury intoxication. In addition, a sensitivity analysis is performed on established biomonitoring exposure limits for mercury in blood, hair, urine and urine adjusted by creatinine, where the biomonitoring exposure limits are compared to thresholds most associated with chronic inorganic mercury intoxication in artisanal small-scale gold mining. Methods Health data from miners and community members in Indonesia, Tanzania and Zimbabwe were obtained as part of the Global Mercury Project and pooled into one dataset together with their biomarkers mercury in urine, blood and hair. The individual prognostic impact of the indicators on the diagnosis of mercury intoxication is quantified using logistic regression models. The selection is performed by a stepwise forward/backward selection. Different models are compared based on the Bayesian information criterion (BIC) and Cohen's kappa is used to evaluate the level of agreement between the diagnosis of mercury intoxication based on the currently used set of indicators and the result based on our reduced set of indicators. The sensitivity analysis of biomarker exposure limits of mercury is based on a sequence of chi square tests. Results The variable selection in logistic regression reduced the number of medical indicators from thirteen to ten in addition to the biomarkers. The estimated level of agreement using ten of thirteen medical indicators and all four biomarkers to diagnose chronic inorganic mercury intoxication yields a Cohen's Kappa of 0.87. While in an additional stepwise selection the biomarker blood was not selected, the level of agreement based on ten medical indicators and only the three biomarkers urine, urine/creatinine and hair reduced Cohen's Kappa to 0.46. The optimal cut-point for the biomarkers blood, hair, urine and urine/creatinine were estimated at 11. 6 mu g/l, 3.84 mu g/g, 24.4 mu g/l and 4.26 mu g/g, respectively. Conclusion The results show that a reduction down to only ten indicators still allows a reliable diagnosis of chronic inorganic mercury intoxication. This reduction of indicators will simplify health assessments in artisanal small-scale gold mining areas.	[Doering, Stefan; Bose-O'Reilly, Stephan] Univ Hosp Munich, WHO Collaborating Ctr Occupat Hlth, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany; [Doering, Stefan; Berger, Ursula] Univ Munich, Dept Med Informat Sci Biometr & Epidemiol IBE, Munich, Germany; [Bose-O'Reilly, Stephan] UMIT Univ Hlth Sci Med Informat & Technol, Inst Publ Hlth Med Decis Making & Hlth Technol As, Dept Publ Hlth Hlth Serv Res & Hlth Technol Asses, Innsbruck, Austria	University of Munich; University of Munich; UMIT - Private University for Health Sciences, Medical Informatics & Technology GmbH	Bose-O'Reilly, S (corresponding author), Univ Hosp Munich, WHO Collaborating Ctr Occupat Hlth, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany.; Bose-O'Reilly, S (corresponding author), UMIT Univ Hlth Sci Med Informat & Technol, Inst Publ Hlth Med Decis Making & Hlth Technol As, Dept Publ Hlth Hlth Serv Res & Hlth Technol Asses, Innsbruck, Austria.	stephan.boeseoreilly@med.uni-muenchen.de	Berger, Ursula/ABI-7872-2020	Berger, Ursula/0000-0002-9809-4177	"Global Environment Facility" (GEF), via "United Nations Industrial Organization" (UNIDO); World Health Organization" (WHO); "Ministry of Health of Mongolia"; DG Research [603946]	"Global Environment Facility" (GEF), via "United Nations Industrial Organization" (UNIDO); World Health Organization" (WHO)(World Health Organization); "Ministry of Health of Mongolia"; DG Research(European Commission)	"Global Environment Facility" (GEF) funded, via "United Nations Industrial Organization" (UNIDO), the projects in the Philippines, Indonesia, Tanzania and Zimbabwe as part of the "Global Mercury Project" (GMP). The second project in Zimbabwe in 2006 was funded by a personal grant from Beate Lettmeier including in kind contributions from the "University of Munich" (LMU, Munich, Germany) and the "University for Health Sciences, Medical Informatics and Technology" (UMIT, Hall in Tirol, Austria). "World Health Organization" (WHO) and the "Ministry of Health of Mongolia" funded the projects in Mongolia. Additionally the "National Institute of Minamata Disease" (Minamata, Kumamoto, Japan) and the "Health and Safety Laboratory" (Harpur Hill, Buxton, United Kingdom gave in kind contributions to the Mongolian project. Two of the authors (SD, SB) receive money for the European Union project HEALS (Health and Environment-wide Associations based on Large Population Surveys). HEALS is funded by DG Research (Grant agreement no: 603946).	Akagi H, 2000, SCI TOTAL ENVIRON, V259, P31, DOI 10.1016/S0048-9697(00)00547-7; Appleton JD, 2006, SCI TOTAL ENVIRON, V354, P198, DOI 10.1016/j.scitotenv.2005.01.042; Appleton JD, 1999, SCI TOTAL ENVIRON, V228, P95, DOI 10.1016/S0048-9697(99)00016-9; Appleton JD, 2004, CR04129 UNIDO EGGLO0; Ashe K., 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033305, DOI 10.1371/J0URNAL.P0NE.0033305]; Baeuml J, 2011, MINERALS-BASEL, V1, P122, DOI 10.3390/min1010122; Baeuml J, 2011, INT J HYG ENVIR HEAL, V215, P64, DOI 10.1016/j.ijheh.2011.06.005; Basu N, 2015, INT J ENV RES PUB HE, V12, P5143, DOI 10.3390/ijerph120505143; Beate L, 2010, SCI TOTAL ENVIRON, V408, P3530, DOI 10.1016/j.scitotenv.2010.04.027; Bose-O'Reilly S, 2004, 03089 UNIDO EGGLO01G; Bose-O'Reilly S, 2009, FIELD MISSION STUDY; Bose-O'Reilly S, 2008, ENVIRON RES, V107, P89, DOI 10.1016/j.envres.2008.01.009; Bose-O'Reilly S, 2010, SCI TOTAL ENVIRON, V408, P796, DOI 10.1016/j.scitotenv.2009.10.051; Bose-O'Reilly S, 2010, SCI TOTAL ENVIRON, V408, P713, DOI 10.1016/j.scitotenv.2009.10.070; Castilhos Z, 2015, ENVIRON SCI POLLUT R, V22, P11255, DOI 10.1007/s11356-015-4340-y; Castilhos ZC, 2006, SCI TOTAL ENVIRON, V368, P320, DOI 10.1016/j.scitotenv.2006.01.039; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Cordy P, 2011, SCI TOTAL ENVIRON, V410, P154, DOI 10.1016/j.scitotenv.2011.09.006; Corral S, 2013, TOXICOL ENVIRON CHEM, V95, P344, DOI 10.1080/02772248.2013.766191; Cortes-Maramba N, 2006, J ENVIRON MANAGE, V81, P126, DOI 10.1016/j.jenvman.2006.01.019; Counter SA, 2006, INT J OCCUP ENV HEAL, V12, P209, DOI 10.1179/oeh.2006.12.3.209; Counter SA, 2005, INT J OCCUP ENV HEAL, V11, P132, DOI 10.1179/oeh.2005.11.2.132; da Costa GM, 2008, ENVIRON RES, V107, P98, DOI [10.1016/j.envres.2007.08.004, 10.1016/j.envres.2007.10.007]; de Kom JFM, 1998, ENVIRON RES, V77, P91, DOI 10.1006/enrs.1998.3835; Drasch G, 2001, SCI TOTAL ENVIRON, V267, P151, DOI 10.1016/S0048-9697(00)00806-8; Drasch G, 2004, ELEMENTS THEIR COMPO, P931, DOI DOI 10.1002/9783527619634; Gibb H, 2014, ENVIRON HEALTH PERSP, V122, P667, DOI 10.1289/ehp.1307864; Hallgren Kevin A, 2012, Tutor Quant Methods Psychol, V8, P23; Harari R, 1997, AM J IND MED, V32, P185, DOI 10.1002/(SICI)1097-0274(199709)32:3<185::AID-AJIM1>3.3.CO;2-O; Kristensen AKB, 2014, INT ARCH OCC ENV HEA, V87, P579, DOI 10.1007/s00420-013-0902-9; Lockowandt O, 1996, FROSTIGS DEV TEST VI, DOI [10.1016/j.ijheh.2011.06.007, DOI 10.1016/J.IJHEH.2011.06.007]; Masur H, 2000, SCALES SCORES NEUROL; Mazzachi B C, 2000, Clin Lab, V46, P53; Nordberg GF, 2015, HDB TOXICOLOGY METAL; Olivero-Verbel J, 2011, BIOL TRACE ELEM RES, V144, P118, DOI 10.1007/s12011-011-9046-5; Paruchuri Y, 2010, SCI TOTAL ENVIRON, V408, P6079, DOI 10.1016/j.scitotenv.2010.08.022; RISHER J, 2004, TOXICOLOGICAL PROFIL; Rodrigues-Filho S.P., 2004, ENV HLTH ASSESSMENT; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Saunders JE, 2013, AUDIOL NEURO-OTOL, V18, P101, DOI 10.1159/000345470; Schmidt CW, 2012, ENVIRON HEALTH PERSP, V120, pA424, DOI 10.1289/ehp.120-a424; Schulz C, 2011, INT J HYG ENVIR HEAL, V215, P26, DOI 10.1016/j.ijheh.2011.06.007; Shah AD, 2014, AM J EPIDEMIOL, V179, P764, DOI 10.1093/aje/kwt312; Spiegel SJ, 2005, LANCET, V366, P2070, DOI 10.1016/S0140-6736(05)67868-3; Steckling N, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-111; Steckling N, 2011, SCI TOTAL ENVIRON, V409, P994, DOI 10.1016/j.scitotenv.2010.11.029; Suvd D, 2015, PROCEDIA ENVIRON SCI, V30, P97, DOI 10.1016/j.proenv.2015.10.017; Taylor H, 2005, SCI TOTAL ENVIRON, V343, P111, DOI 10.1016/j.scitotenv.2004.09.042; Tomicic C, 2011, INT ARCH OCC ENV HEA, V84, P539, DOI 10.1007/s00420-011-0615-x; UNEP Chemicals Branch, 2013, GLOB MERC ASS, DOI [10.1016/j.scitotenv.2010.08.022, DOI 10.1016/J.SCITOTENV.2010.08.022]; van Straaten P, 2000, SCI TOTAL ENVIRON, V259, P105, DOI 10.1016/S0048-9697(00)00553-2; van Wijngaarden E, 2013, NEUROTOXICOL TERATOL, V39, P19, DOI 10.1016/j.ntt.2013.06.003; Williams BA, 2006, FINDING OPTIMAL CUTP; Wood AM, 2008, STAT MED, V27, P3227, DOI 10.1002/sim.3177; Yard EE, 2012, J MED TOXICOL, V8, P441, DOI 10.1007/s13181-012-0252-0; Zimmer R, 1987, MOTOR FUNCTION TEST	56	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0160323	10.1371/journal.pone.0160323	http://dx.doi.org/10.1371/journal.pone.0160323			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575533	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877200006
J	Huang, YY; Vemer, P; Zhu, JJ; Postma, MJ; Chen, W				Huang, Yunyu; Vemer, Pepijn; Zhu, Jingjing; Postma, Maarten J.; Chen, Wen			Economic Burden in Chinese Patients with Diabetes Mellitus Using Electronic Insurance Claims Data	PLOS ONE			English	Article							BIPHASIC INSULIN ASPART; COST-UTILITY ANALYSIS; ADD-ON; TYPE-2; GLARGINE; PREVALENCE; METFORMIN; CARE	Background There is a paucity of studies that focus on the economic burden in daily care in China using electronic health data. The aim of this study is to describe the development of the economic burden of diabetic patients in a sample city in China from 2009 to 2011 using electronic data of patients' claims records. Methods This study is a retrospective, longitudinal study in an open cohort of Chinese patients with diabetes. The patient population consisted of people living in a provincial capital city in east China, covered by the provincial urban employee basic medical insurance (UEBMI). We included any patient who had at least one explicit diabetes diagnosis or received blood glucose lowering medication in at least one registered outpatient visit or hospitalization during a calendar year in the years 2009-2011. Cross-sectional descriptions of different types of costs, prevalence of diabetic complications and related diseases, medication use were performed for each year separately and differences between three years were compared using a chi-square test or the non-parametric Kruskal-Wallis H test. Results Our results showed an increasing trend in total medical cost (from 2,383 to 2,780 USD, p = 0.032) and diabetes related cost (from 1,655 to 1,857 USD) for those diabetic patients during the study period. The diabetes related economic burden was significantly related to the prevalence of complications and related diseases (p<0.001). The overall medication cost during diabetes related visits also increased (from 1,335 to 1,383 USD, p = 0.021). But the use pattern and cost of diabetes-related medication did not show significant changes during the study period. Conclusion The economic burden of diabetes increased significantly in urban China. It is important to improve the prevention and treatment of diabetes to contribute to the sustainability of the Chinese health-care system.	[Huang, Yunyu; Vemer, Pepijn; Postma, Maarten J.] Univ Groningen, Dept Pharm, Unit PharmacoTherapy Epidemiol & Econ, Groningen, Netherlands; [Huang, Yunyu; Zhu, Jingjing; Chen, Wen] Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China; [Vemer, Pepijn; Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Inst Sci Hlth Aging & healthcaRE SHARE, Groningen, Netherlands; [Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; Fudan University; University of Groningen; University of Groningen	Chen, W (corresponding author), Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China.	wenchen@fudan.edu.cn		Postma, Maarten/0000-0002-6306-3653				Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Chen X, 2003, CHIN J DIABETES, V11, P238; Chinese Medical Association Dm Credit Association, 2014, CHINESE J DIABETES, V6, P447, DOI DOI 10.3760/CMA.J.ISSN.1674-5809.2014.07.004; Deng J, 2015, J MED ECON, V18, P974, DOI 10.3111/13696998.2015.1067622; Gao L, 2012, INT J TECHNOL ASSESS, V28, P436, DOI 10.1017/S0266462312000608; Geng JS, 2015, PHARMACOECONOMICS, V33, P581, DOI 10.1007/s40273-015-0266-y; He M, 2009, CHIN HLTH EC, V28, P22; Hu HM, 2015, DIABETES THER, V6, P7, DOI 10.1007/s13300-015-0096-0; Hu SL, 2008, CHINESE HLTH EC, V27, P5; HZ Bureau of Statistics, 2012, HZ STAT YB 2012; *INT DIAB FED, 2014, DIABETES ATLAS; International Diabetes Federation (IDF), 2012, GLOB GUID TYP 2 DIAB; Karvonen M, 2000, DIABETES CARE, V23, P1516, DOI 10.2337/diacare.23.10.1516; Li Qing-na, 2012, Zhong Xi Yi Jie He Xue Bao, V10, P841; Liu K.J., 2005, CHINA HLTH EC, V24, P77, DOI DOI 10.3969/j.issn.1003-0743.2005.10.031; Lord J.M., 2003, COCHRANE DATABASE SY, DOI [10.1002/14651858.Cd003053, DOI 10.1002/14651858.CD003053]; National Bureau of Statistics of China, CHIN STAT YB 2011; Palmer JL, 2008, ADV THER, V25, P752, DOI 10.1007/s12325-008-0080-4; Palmer JL, 2010, ADV THER, V27, P814, DOI 10.1007/s12325-010-0078-6; Shu T, 2014, INT J MED INFORM, V83, P113, DOI 10.1016/j.ijmedinf.2013.08.008; Wang WB, 2009, AM J MANAG CARE, V15, P593; Wang WB, 2009, VALUE HEALTH, V12, P923, DOI 10.1111/j.1524-4733.2009.00561.x; Wei F, 2013, HZ WAS ELECTED ROLE; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Xie XQ, 2008, VALUE HEALTH, V11, pS23, DOI 10.1111/j.1524-4733.2008.00363.x; Xin-Jian LI., 2005, CHINESE HLTH RESOURC, V8, P69; Yang L, 2012, VALUE HEALTH, V15, pS56, DOI 10.1016/j.jval.2011.11.018; Yang WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039513; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang D, 2012, SHANGHAI J PREVENTIV, V24, P492; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026; Zhang Z, 2007, CHINESE HLTH RESOURC, V10, P162; [郑亚明 Zheng Yaming], 2012, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V28, P821; 纪立农, 2012, [中国药学杂志, Chinese Pharmaceutical Journal], V47, P736	34	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0159297	10.1371/journal.pone.0159297	http://dx.doi.org/10.1371/journal.pone.0159297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27570976	Green Published, Green Submitted, gold			2022-12-26	WOS:000382876700003
J	Osgood, ND; Paul, T; Stanley, KG; Qian, WC				Osgood, Nathaniel D.; Paul, Tuhin; Stanley, Kevin G.; Qian, Weicheng			A Theoretical Basis for Entropy-Scaling Effects in Human Mobility Patterns	PLOS ONE			English	Article							PREDICTABILITY	Characterizing how people move through space has been an important component of many disciplines. With the advent of automated data collection through GPS and other location sensing systems, researchers have the opportunity to examine human mobility at spatio-temporal resolution heretofore impossible. However, the copious and complex data collected through these logging systems can be difficult for humans to fully exploit, leading many researchers to propose novel metrics for encapsulating movement patterns in succinct and useful ways. A particularly salient proposed metric is the mobility entropy rate of the string representing the sequence of locations visited by an individual. However, mobility entropy rate is not scale invariant: entropy rate calculations based on measurements of the same trajectory at varying spatial or temporal granularity do not yield the same value, limiting the utility of mobility entropy rate as a metric by confounding inter-experimental comparisons. In this paper, we derive a scaling relationship for mobility entropy rate of non-repeating straight line paths from the definition of Lempel-Ziv compression. We show that the resulting formulation predicts the scaling behavior of simulated mobility traces, and provides an upper bound on mobility entropy rate under certain assumptions. We further show that this formulation has a maximum value for a particular sampling rate, implying that optimal sampling rates for particular movement patterns exist.	[Osgood, Nathaniel D.; Paul, Tuhin; Stanley, Kevin G.; Qian, Weicheng] Univ Saskatchewan, Dept Comp Sci, Saskatoon, SK, Canada; [Osgood, Nathaniel D.] Univ Saskatchewan, Dept Community Hlth & Epidemiol, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan	Paul, T (corresponding author), Univ Saskatchewan, Dept Comp Sci, Saskatoon, SK, Canada.	tuhin.paul@usask.ca			Natural Sciences and Engineering Research Council of Canada [356043-2008, 327290-06]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	KGS received funding (Grant Number: 356043-2008) from "Natural Sciences and Engineering Research Council of Canada". Funder's website: http://www.nserc-crsng.gc.ca/. NDO received funding (Grant Number: 327290-06) from "Natural Sciences and Engineering Research Council of Canada". Funder's website: http://www.nserc-crsng.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann P, 2013, IEEE INT WORK SIGN P, P535, DOI 10.1109/SPAWC.2013.6612107; Brown BB, 2015, AM J PUBLIC HEALTH, V105, P1468, DOI 10.2105/AJPH.2015.302561; Cho Eunjoon, 2011, KDD, P1082, DOI [10.1145/2020408.2020579, DOI 10.1145/2020408.2020579]; Chon Y, 2012, INT CONF PERVAS COMP, P206, DOI 10.1109/PerCom.2012.6199868; Draghici A, 2015, ROEDUNET IEEE, P152, DOI 10.1109/RoEduNet.2015.7311985; Eagle N, 2006, PERS UBIQUIT COMPUT, V10, P255, DOI 10.1007/s00779-005-0046-3; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Hashemian MS., 2012, PROC 2 ACM SIGHIT IN, P255, DOI [10.1145/2110363.2110394, DOI 10.1145/2110363.2110394]; Hossmann T., 2011, P 12 ACM INT S MOB A, P18; Jensen Bjorn Sand, 2010, Proceedings of the 2010 IEEE International Workshop on Machine Learning for Signal Processing (MLSP), P196, DOI 10.1109/MLSP.2010.5588997; Kontoyiannis I, 1998, IEEE T INFORM THEORY, V44, P1319, DOI 10.1109/18.669425; Lee K, 2009, IEEE INFOCOM SER, P855, DOI 10.1109/INFCOM.2009.5061995; Lin M, 2012, UBICOMP'12: PROCEEDINGS OF THE 2012 ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P381; Mathew W, 2012, UBICOMP'12: PROCEEDINGS OF THE 2012 ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P911; Paul T, 2016, SCALING BEH IN PRESS; Pu J., 2011, P 2011 VIS INF COMM, P1; Research M, 2014, GEOLIFE BUILDING SOC; Rhee I, 2011, IEEE ACM T NETWORK, V19, P630, DOI 10.1109/TNET.2011.2120618; Rodriguez-Carrion A, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON PERVASIVE COMPUTING AND COMMUNICATION WORKSHOPS (PERCOM WORKSHOPS), P451, DOI 10.1109/PERCOMW.2015.7134080; Roy B., 2002, FUNDAMENTALS CLASSIC; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shoval N, 2006, PROF GEOGR, V58, P172, DOI 10.1111/j.1467-9272.2006.00524.x; Smith G, 2014, INT CONF PERVAS COMP, P88, DOI 10.1109/PerCom.2014.6813948; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Stanley K.G., 2012, P3, DOI DOI 10.1145/2248341.2248345; Weicheng Qian, 2013, Web and Wireless Geographical Information Systems. 12th International Symposium, W2GIS 2013. Proceedings, P25, DOI 10.1007/978-3-642-37087-8_3; Xu KS, 2013, ARXIV13061271	28	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161630	10.1371/journal.pone.0161630	http://dx.doi.org/10.1371/journal.pone.0161630			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571423	gold, Green Submitted, Green Published			2022-12-26	WOS:000382876700025
J	Nicholson, JD; Guo, Y; Bernstein, SL				Nicholson, James D.; Guo, Yan; Bernstein, Steven L.			SUR1-Associated Mechanisms Are Not Involved in Ischemic Optic Neuropathy 1 Day Post-Injury	PLOS ONE			English	Article							K-ATP CHANNELS; SINGLE INTRAVITREAL INJECTION; SUSTAINED NEUROPROTECTION; SUBARACHNOID HEMORRHAGE; A(2A) RECEPTORS; PRIMATE MODEL; RODENT MODEL; ADENOSINE; GLIBENCLAMIDE; STROKE	Ischemia-reperfusion injury after central nervous system (CNS) injury presents a major health care challenge with few promising treatments. Recently, it has become possible to reduce edema after CNS injury by antagonizing a sulfonylurea receptor 1 (SUR1) regulated ion channel expressed after injury. SUR1 upregulation after injury is a necessary precondition for the formation of this channel, and has been implicated in white matter injury after clinical spinal cord trauma. Glibenclamide, an SUR1 antagonist, appears to have neuroprotective effect against cerebral stroke in an open-label small clinical trial and great effectiveness in reducing damage after varied experimental CNS injury models. Despite its importance in CNS injuries, SUR1 upregulation appears to play no part in rodent anterior ischemic optic neuropathy (rAION) injury as tested by real-time PCR and immunohistochemical staining of rAION-injured rat optic nerve (ON). Furthermore, the SUR1 antagonist glibenclamide administered immediately after rAION injury provided no protection to proximal ON microvasculature 1 day post-injury but may reduce optic nerve head edema in a manner unrelated to ON SUR1 expression. Our results suggest that there may be fundamental differences between rAION optic nerve ischemia and other CNS white matter injuries where SUR1 appears to play a role.	[Nicholson, James D.; Guo, Yan; Bernstein, Steven L.] UMB Sch Med, Dept Ophthalmol Visual Sci, Baltimore, MD 21201 USA; [Bernstein, Steven L.] UMB Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Bernstein, SL (corresponding author), UMB Sch Med, Dept Ophthalmol Visual Sci, Baltimore, MD 21201 USA.; Bernstein, SL (corresponding author), UMB Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	sbernstein@som.umaryland.edu		Bernstein, Steven/0000-0001-7758-0136	NIH grants from NEI [RO1-EY015304, RO1-EY019529]; NATIONAL EYE INSTITUTE [R01EY019529, R01EY015304] Funding Source: NIH RePORTER	NIH grants from NEI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by NIH grants RO1-EY015304 and RO1-EY019529 from the NEI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by NIH grants RO1-EY015304 and RO1-EY019529 from the NEI.	Arnold Anthony C, 2002, Semin Ophthalmol, V17, P39, DOI 10.1076/soph.17.1.39.10292; Bernstein SL, 2003, INVEST OPHTH VIS SCI, V44, P4153, DOI 10.1167/iovs.03-0274; Bernstein SL, 2011, PROG RETIN EYE RES, V30, P167, DOI 10.1016/j.preteyeres.2011.02.003; Chen CS, 2008, INVEST OPHTH VIS SCI, V49, P2985, DOI 10.1167/iovs.07-1651; Chen MK, 2003, J NEUROSCI, V23, P8568; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fukuen S, 2005, J BIOL CHEM, V280, P23653, DOI 10.1074/jbc.M412113200; Geng Z, 2009, DUAL ROLE NF KB ACTI; Gidday JM, 1996, INVEST OPHTH VIS SCI, V37, P2624; Goldenberg-Cohen N, 2005, INVEST OPHTH VIS SCI, V46, P2716, DOI 10.1167/iovs.04-0547; Hayreh SS, 2009, PROG RETIN EYE RES, V28, P34, DOI 10.1016/j.preteyeres.2008.11.002; Hein TW, 2005, INVEST OPHTH VIS SCI, V46, P2113, DOI 10.1167/iovs.04-1438; Hirao M, 2004, EXP EYE RES, V79, P729, DOI 10.1016/j.exer.2004.08.008; Jeppesen P, 2002, CURR EYE RES, V25, P23, DOI 10.1076/ceyr.25.1.23.9966; Li Q, 2001, BRAIN RES, V907, P93, DOI 10.1016/S0006-8993(01)02607-5; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Miller NR, 2014, INVEST OPHTH VIS SCI, V55, P7047, DOI 10.1167/iovs.14-14063; Nicholson JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050021; Sheth KN, 2014, STROKE, V45, P281, DOI 10.1161/STROKEAHA.113.003352; Simard JM, 2012, TRANSL STROKE RES, V3, P286, DOI 10.1007/s12975-012-0149-x; Simard JM, 2010, J NEUROSURG, V113, P622, DOI 10.3171/2009.11.JNS081052; Simard JM, 2010, STROKE, V41, P531, DOI 10.1161/STROKEAHA.109.572644; Simard JM, 2009, J CEREBR BLOOD F MET, V29, P317, DOI 10.1038/jcbfm.2008.120; Simard JM, 2009, STROKE, V40, P604, DOI 10.1161/STROKEAHA.108.522409; Simard JM, 2013, J SPINE S4; Slater BJ, 2008, INVEST OPHTH VIS SCI, V49, P3671, DOI 10.1167/iovs.07-0504; Tosun C, 2013, STROKE, V44, P3522, DOI 10.1161/STROKEAHA.113.002904; Touitou V, 2013, INVEST OPHTH VIS SCI, V54, P7402, DOI 10.1167/iovs.13-12055; Walcott BP, 2013, NEUROCRIT CARE; Woo SK, 2013, J BIOL CHEM, V288, P3655, DOI 10.1074/jbc.M112.428219	30	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0148855	10.1371/journal.pone.0148855	http://dx.doi.org/10.1371/journal.pone.0148855			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560494	Green Submitted, Green Published, gold			2022-12-26	WOS:000382258600001
J	Sherman, ME; Ichikawa, L; Pfeiffer, RM; Miglioretti, DL; Kerlikowske, K; Tice, J; Vacek, PM; Gierach, GL				Sherman, Mark E.; Ichikawa, Laura; Pfeiffer, Ruth M.; Miglioretti, Diana L.; Kerlikowske, Karla; Tice, Jeffery; Vacek, Pamela M.; Gierach, Gretchen L.			Relationship of Predicted Risk of Developing Invasive Breast Cancer, as Assessed with Three Models, and Breast Cancer Mortality among Breast Cancer Patients	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; VALIDATION; PREVENTION; REDUCTION; PROGNOSIS; ONCOLOGY; SUBTYPES; AGE	Purpose Breast cancer risk prediction models are used to plan clinical trials and counsel women; however, relationships of predicted risks of breast cancer incidence and prognosis after breast cancer diagnosis are unknown. Methods Using largely pre-diagnostic information from the Breast Cancer Surveillance Consortium (BCSC) for 37,939 invasive breast cancers (1996-2007), we estimated 5-year breast cancer risk (< 1%; 1-1.66%; >= 1.67%) with three models: BCSC 1-year risk model (BCSC-1; adapted to 5-year predictions); Breast Cancer Risk Assessment Tool (BCRAT); and BCSC 5-year risk model (BCSC-5). Breast cancer-specific mortality post-diagnosis (range: 1-13 years; median: 5.4-5.6 years) was related to predicted risk of developing breast cancer using unadjusted Cox proportional hazards models, and in age-stratified (35-44; 45-54; 55-69; 70-89 years) models adjusted for continuous age, BCSC registry, calendar period, income, mode of presentation, stage and treatment. Mean age at diagnosis was 60 years. Results Of 6,021 deaths, 2,993 (49.7%) were ascribed to breast cancer. In unadjusted case-only analyses, predicted breast cancer risk >= 1.67% versus < 1.0% was associated with lower risk of breast cancer death; BCSC-1: hazard ratio (HR) = 0.82 (95% CI = 0.75-0.90); BCRAT: HR = 0.72 (95% CI = 0.65-0.81) and BCSC-5: HR = 0.84 (95% CI = 0.75-0.94). Age-stratified, adjusted models showed similar, although mostly non-significant HRs. Among women ages 55-69 years, HRs approximated 1.0. Generally, higher predicted risk was inversely related to percentages of cancers with unfavorable prognostic characteristics, especially among women 35-44 years. Conclusions Among cases assessed with three models, higher predicted risk of developing breast cancer was not associated with greater risk of breast cancer death; thus, these models would have limited utility in planning studies to evaluate breast cancer mortality reduction strategies. Further, when offering women counseling, it may be useful to note that high predicted risk of developing breast cancer does not imply that if cancer develops it will behave aggressively.	[Sherman, Mark E.] NCI, Canc Prevent Div, Bethesda, MD 20892 USA; [Sherman, Mark E.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Ichikawa, Laura; Miglioretti, Diana L.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Pfeiffer, Ruth M.; Gierach, Gretchen L.] Div Canc Epidemiol & Genet, Bethesda, MD USA; [Miglioretti, Diana L.] Univ Calif Davis, Dept Publ Hlth, Davis, CA 95616 USA; [Kerlikowske, Karla; Tice, Jeffery] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Kerlikowske, Karla] Univ Calif San Francisco, Dept Epidemiol Biostat, San Francisco, CA 94143 USA; [Vacek, Pamela M.] Univ Vermont, Sch Med, Dept Med Biostat, Burlington, VT 05405 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Group Health Cooperative; University of California System; University of California Davis; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Vermont	Sherman, ME (corresponding author), NCI, Canc Prevent Div, Bethesda, MD 20892 USA.; Sherman, ME (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	ShermanM@mail.nih.gov	Gierach, Gretchen L/E-1817-2016	Gierach, Gretchen L/0000-0002-0165-5522; Tice, Jeffrey/0000-0002-9857-2028	Intramural Research Program of the National Cancer Institute [HHSN261201100031C]; several state public health departments and cancer registries throughout the US	Intramural Research Program of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); several state public health departments and cancer registries throughout the US	This was funded in part by the Intramural Research Program of the National Cancer Institute (HHSN261201100031C). The collection of cancer and vital status data used in this study was supported in part by several state public health departments and cancer registries throughout the US. For a full description of these sources, please see: http://breastscreening.cancer.gov/work/acknowledgement.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SV, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-36; Allgood PC, 2011, BRIT J CANCER, V104, P1680, DOI 10.1038/bjc.2011.144; Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558; Amir E, 2003, J MED GENET, V40, P807, DOI 10.1136/jmg.40.11.807; Anderson WF, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju165; Anothaisintawee T, 2012, BREAST CANCER RES TR, V133, P1, DOI 10.1007/s10549-011-1853-z; Arcaro KF, 2008, FUTURE ONCOL, V4, P595, DOI 10.2217/14796694.4.5.595; BallardBarbash R, 1997, AM J ROENTGENOL, V169, P1001, DOI 10.2214/ajr.169.4.9308451; Barlow WE, 2006, JNCI-J NATL CANCER I, V98, P1204, DOI 10.1093/jnci/djj331; Bousquet G, 2015, J CLIN ONCOL, V33, P2437, DOI 10.1200/JCO.2014.59.6759; Burke JP, 2008, EJSO-EUR J SURG ONC, V34, P149, DOI 10.1016/j.ejso.2007.03.025; Casbas-Hernandez P, 2015, CANCER EPIDEM BIOMAR, V24, P406, DOI 10.1158/1055-9965.EPI-14-0934; Chlebowski RT, 2007, JNCI-J NATL CANCER I, V99, P1695, DOI 10.1093/jnci/djm224; Costantino JP, 1999, J NATL CANCER I, V91, P1541, DOI 10.1093/jnci/91.18.1541; Crispo A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-15; Cummings SR, 2009, JNCI-J NATL CANCER I, V101, P384, DOI 10.1093/jnci/djp018; Cuzick J, 2015, LANCET ONCOL, V16, P67, DOI 10.1016/S1470-2045(14)71171-4; D'Orsi C, 2003, BREAST IMAGING REPOR; Emond JA, 2011, CANCER EPIDEM BIOMAR, V20, P939, DOI 10.1158/1055-9965.EPI-10-1240; Figueroa JD, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju286; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Howell A, 2012, J INTERN MED, V271, P321, DOI 10.1111/j.1365-2796.2012.02525.x; Iyengar NM, 2016, CLIN CANCER RES, V22, P2283, DOI 10.1158/1078-0432.CCR-15-2239; Liu YR, 2015, ANN SURG ONCOL, V22, P1102, DOI 10.1245/s10434-014-4108-5; Ma HY, 2006, BREAST CANCER RES, V8, DOI [10.1186/bcr1525, 10.1186/bcr1512]; Matsuno RK, 2011, J NATL CANCER I, V103, P951, DOI 10.1093/jnci/djr154; Meads C, 2012, BREAST CANCER RES TR, V132, P365, DOI 10.1007/s10549-011-1818-2; Milanese TR, 2006, J NATL CANCER I, V98, P1600, DOI 10.1093/jnci/djj439; Moyer VA, 2013, ANN INTERN MED, V159, P698, DOI [10.7326/0003-4819-159-10-201311190-00717, 10.7326/0003-4819-159-10-201311190-00718]; Nagtegaal ID, 2011, CANCER-AM CANCER SOC, V117, P1360, DOI 10.1002/cncr.25613; Pace LE, 2014, JAMA-J AM MED ASSOC, V311, P1327, DOI 10.1001/jama.2014.1398; Pearce CL, 2015, CANCER EPIDEM BIOMAR, V24, P671, DOI 10.1158/1055-9965.EPI-14-1128; Schmitz KH, 2013, JNCI-J NATL CANCER I, V105, P1344, DOI 10.1093/jnci/djt223; Sihto H, 2008, CLIN CANCER RES, V14, P4103, DOI 10.1158/1078-0432.CCR-07-5003; Tartter PI, 2002, AM J SURG, V184, P11, DOI 10.1016/S0002-9610(02)00885-1; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; Visvanathan K, 2013, J CLIN ONCOL, V31, P2942, DOI 10.1200/JCO.2013.49.3122; Yang XHR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3170; Yang XR, 2011, JNCI-J NATL CANCER I, V103, P250, DOI 10.1093/jnci/djq526	39	4	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0160966	10.1371/journal.pone.0160966	http://dx.doi.org/10.1371/journal.pone.0160966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560501	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258600021
J	Weilnhammer, VA; Sterzer, P; Hesselmann, G				Weilnhammer, Veith A.; Sterzer, Philipp; Hesselmann, Guido			Perceptual Stability of the Lissajous Figure Is Modulated by the Speed of Illusory Rotation	PLOS ONE			English	Article							BISTABLE PERCEPTION; REPRESENTATIONAL MOMENTUM; INFERENCE; CORTEX; MEMORY	Lissajous figures represent ambiguous structure-from-motion stimuli rotating in depth and have proven to be a versatile tool to explore the cognitive and neural mechanisms underlying bistable perception. They are generated by the intersection of two sinusoids with perpendicular axes and increasing phase-shift whose frequency determines the speed of illusory 3D rotation. Recently, we found that Lissajous figures of higher shifting frequencies elicited longer perceptual phase durations and tentatively proposed a "representational momentum" account. In this study, our aim was twofold. First, we aimed to gather more behavioral evidence related to the perceptual dynamics of the Lissajous figure by simultaneously varying its shifting frequency and size. Using a conventional analysis, we investigated the effects of our experimental manipulations on transition probability (i.e., the probability that the current percept will change at the next critical stimulus configuration). Second, we sought to test the impact of our experimental factors on the occurrence of transitions in bistable perception by means of a Bayesian approach that can be used to directly quantify the impact of contextual cues on perceptual stability. We thereby estimated the implicit prediction of perceptual stability and how it is modulated by experimental manipulations.	[Weilnhammer, Veith A.; Sterzer, Philipp; Hesselmann, Guido] Charite, Dept Psychiat & Psychotherapy, Visual Percept Lab, Campus Charite Mitte, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Weilnhammer, VA (corresponding author), Charite, Dept Psychiat & Psychotherapy, Visual Percept Lab, Campus Charite Mitte, D-10117 Berlin, Germany.	veith-andreas.weilnhammer@charite.de	Hesselmann, Guido/I-2880-2016	Hesselmann, Guido/0000-0002-8873-7212; Weilnhammer, Veith/0000-0002-3332-0006	German Research Foundation [HE 6244/1-2, STE 1430/7-1]; Studienstiftung des deutschen Volkes (German National Academic Foundation)	German Research Foundation(German Research Foundation (DFG)); Studienstiftung des deutschen Volkes (German National Academic Foundation)	GH and PS were supported by the German Research Foundation (grants HE 6244/1-2, STE 1430/7-1). VAW was supported by the Studienstiftung des deutschen Volkes (German National Academic Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; GH and PS were supported by the German Research Foundation (grants HE 6244/1-2, STE 1430/7-1). VAW was supported by the Studienstiftung des deutschen Volkes (German National Academic Foundation). We thank Kerstin Wolf for her help with data acquisition.	Albright TD, 2002, ANNU REV NEUROSCI, V25, P339, DOI 10.1146/annurev.neuro.25.112701.142900; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brouwer GJ, 2006, VISION RES, V46, P3393, DOI 10.1016/j.visres.2006.03.016; Cooper LA, 1993, SPATIAL REPRESENTATI, P112; FINKE RA, 1986, J EXP PSYCHOL GEN, V115, P175, DOI 10.1037/0096-3445.115.2.175; FISICHELLI VR, 1947, AM J PSYCHOL, V60, P240, DOI 10.2307/1417873; Friston KJ, 2007, SYNTHESE, V159, P417, DOI 10.1007/s11229-007-9237-y; Friston KJ, 2012, INT J PSYCHOPHYSIOL, V83, P248, DOI 10.1016/j.ijpsycho.2011.11.014; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Hesselmann G, 2011, NEUROIMAGE, V56, P1608, DOI 10.1016/j.neuroimage.2011.03.017; Hohwy J, 2008, COGNITION, V108, P687, DOI 10.1016/j.cognition.2008.05.010; Hubbard T.L., 2010, SPACE TIME PERCEPTIO, P338, DOI [10.1017/CBO9780511750540.020, DOI 10.1017/CBO9780511750540.020]; Hubbard TL, 2005, PSYCHON B REV, V12, P822, DOI 10.3758/BF03196775; HUBBARD TL, 1988, PERCEPT PSYCHOPHYS, V44, P211, DOI 10.3758/BF03206290; Hubbard TL, 1993, SCI CONSCIOUSNESS, V2, P338; Jarrett Christian B, 2002, Cogn Neuropsychiatry, V7, P1, DOI 10.1080/13546800143000104; Lee TS, 2003, J OPT SOC AM A, V20, P1434, DOI 10.1364/JOSAA.20.001434; Mamassian P, 2005, J VISION, V5, P361, DOI 10.1167/5.4.7; Mathys CD, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00825; Pastukhov A, 2012, J VISION, V12, DOI 10.1167/12.1.17; Schmack Katharina, 2015, Schizophr Res Cogn, V2, P72, DOI 10.1016/j.scog.2015.03.005; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; Sterzer P, 2007, P NATL ACAD SCI USA, V104, P323, DOI 10.1073/pnas.0609006104; Sundareswara R, 2008, J VISION, V8, DOI 10.1167/8.5.12; VERFAILLIE K, 1991, J EXP PSYCHOL LEARN, V17, P302, DOI 10.1037/0278-7393.17.2.302; Weilnhammer VA, 2014, VISION RES, V98, P107, DOI 10.1016/j.visres.2014.03.013; Weilnhammer VA, 2013, J NEUROSCI, V33, P16009, DOI 10.1523/JNEUROSCI.1418-13.2013	27	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0160772	10.1371/journal.pone.0160772	http://dx.doi.org/10.1371/journal.pone.0160772			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU5NN	27560958	Green Submitted, Green Published, gold			2022-12-26	WOS:000382258600015
J	Geevarghese, R; Lumsden, DE; Costello, A; Hulse, N; Ayis, S; Samuel, M; Ashkan, K				Geevarghese, Ruben; Lumsden, Daniel E.; Costello, Angela; Hulse, Natasha; Ayis, Salma; Samuel, Michael; Ashkan, Keyoumars			Verbal Memory Decline following DBS for Parkinson's Disease: Structural Volumetric MRI Relationships	PLOS ONE			English	Article							DEEP-BRAIN-STIMULATION; NUCLEUS-REUNIENS-THALAMI; SUBTHALAMIC NUCLEUS; BASAL GANGLIA; HIPPOCAMPUS; PERFORMANCE; RAT; ACCURATE; SURGERY; IMAGES	Background Parkinson's disease is a chronic degenerative movement disorder. The mainstay of treatment is medical. In certain patients Deep Brain Stimulation (DBS) may be offered. However, DBS has been associated with post-operative neuropsychology changes, especially in verbal memory. Objectives Firstly, to determine if pre-surgical thalamic and hippocampal volumes were related to verbal memory changes following DBS. Secondly, to determine if clinical factors such as age, duration of symptoms or motor severity (UPDRS Part III score) were related to verbal memory changes. Methods A consecutive group of 40 patients undergoing bilateral Subthalamic Nucleus (STN)-DBS for PD were selected. Brain MRI data was acquired, pre-processed and structural volumetric data was extracted using FSL. Verbal memory test scores for pre- and post-STN-DBS surgery were recorded. Linear regression was used to investigate the relationship between score change and structural volumetric data. Results A significant relationship was demonstrated between change in List Learning test score and thalamic (left, p = 0.02) and hippocampal (left, p = 0.02 and right p = 0.03) volumes. Duration of symptoms was also associated with List Learning score change (p = 0.02 to 0.03).Conclusion Verbal memory score changes appear to have a relationship to pre-surgical MRI structural volumetric data. The findings of this study provide a basis for further research into the use of pre-surgical MRI to counsel PD patients regarding post-surgical verbal memory changes. Conclusion Verbal memory score changes appear to have a relationship to pre-surgical MRI structural volumetric data. The findings of this study provide a basis for further research into the use of pre-surgical MRI to counsel PD patients regarding post-surgical verbal memory changes.	[Geevarghese, Ruben; Ashkan, Keyoumars] Kings Coll Hosp NHS Fdn Trust, Kings Hlth Partners, Dept Neurosurg, London, England; [Geevarghese, Ruben] Charing Cross Hosp, Dept Neurosurg, London, England; [Lumsden, Daniel E.] Guys & St Thomas NHS Fdn Trust, Evelina Childrens Hosp, Complex Motor Disorders Serv, London, England; [Costello, Angela] Kings Coll Hosp NHS Fdn Trust, Kings Hlth Partners, Dept Neuropsychol, London, England; [Hulse, Natasha; Samuel, Michael] Kings Coll Hosp NHS Fdn Trust, Kings Hlth Partners, Dept Neurol, London, England; [Ayis, Salma] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England; [Ashkan, Keyoumars] Inst Psychiat Psychol & Neurosci, Clin Neurosci, London, England	King's College Hospital NHS Foundation Trust; University of London; King's College London; Imperial College London; Guy's & St Thomas' NHS Foundation Trust; King's College Hospital NHS Foundation Trust; University of London; King's College London; King's College Hospital NHS Foundation Trust; University of London; King's College London; University of London; King's College London	Geevarghese, R (corresponding author), Kings Coll Hosp NHS Fdn Trust, Kings Hlth Partners, Dept Neurosurg, London, England.; Geevarghese, R (corresponding author), Charing Cross Hosp, Dept Neurosurg, London, England.	r.g@doctors.org.uk	Ayis, Salma/AAD-5336-2019	Lumsden, Daniel/0000-0002-5524-6177; Ayis, Salma/0000-0002-0449-869X	National Institute for Health Research (NIHR) Biomedical Research Center based at Guy's and St Thomas' NHS Foundation Trust; King's College London	National Institute for Health Research (NIHR) Biomedical Research Center based at Guy's and St Thomas' NHS Foundation Trust; King's College London	The statistical analysis was supported by the National Institute for Health Research (NIHR) Biomedical Research Center based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Anderson VC, 2005, ARCH NEUROL-CHICAGO, V62, P554, DOI 10.1001/archneur.62.4.554; Baier B, 2010, J NEUROSCI, V30, P9788, DOI 10.1523/JNEUROSCI.1513-10.2010; Beyer MK, 2013, J NEUROL NEUROSUR PS, V84, P23, DOI 10.1136/jnnp-2012-303054; Costello A, 2011, BASAL GANGLIA, V1, P213, DOI 10.1016/j.baga.2011.10.003; Follett KA, 2010, NEW ENGL J MED, V362, P2077, DOI 10.1056/NEJMoa0907083; Funkiewiez A, 2004, J NEUROL NEUROSUR PS, V75, P834, DOI 10.1136/jnnp.2002.009803; Hasegawa H, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.02.001; HERKENHAM M, 1978, J COMP NEUROL, V177, P589, DOI 10.1002/cne.901770405; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M PM, 2005, ELEVENTH ANNUAL MEET; Machado A, 2006, MOVEMENT DISORD, V21, pS247, DOI 10.1002/mds.20959; Nutt JG, 2001, PARKINSONISM RELAT D, V8, P101, DOI 10.1016/S1353-8020(01)00024-4; Odekerken VJJ, 2013, LANCET NEUROL, V12, P37, DOI 10.1016/S1474-4422(12)70264-8; OJEMANN GA, 1971, BRAIN, V94, P225, DOI 10.1093/brain/94.2.225; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Philp DJ, 2014, NEUROIMAGE, V91, P77, DOI 10.1016/j.neuroimage.2013.12.057; Pigott K, 2015, NEUROLOGY, V85, P1276, DOI 10.1212/WNL.0000000000002001; Reetz K, 2009, MOVEMENT DISORD, V24, P99, DOI 10.1002/mds.22333; Reitz C, 2009, ARCH NEUROL-CHICAGO, V66, P1385, DOI 10.1001/archneurol.2009.214; Saint-Cyr JA, 2006, NEUROLOGY, V66, P1799, DOI 10.1212/01.wnl.0000227468.17113.07; Schmidt-Wilcke T, 2009, NEUROIMAGE, V47, P1914, DOI 10.1016/j.neuroimage.2009.04.092; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stewart CC, 2009, BRAIN COGNITION, V69, P65, DOI 10.1016/j.bandc.2008.05.005; SU HS, 1990, J COMP NEUROL, V297, P582, DOI 10.1002/cne.902970410; Witt Karsten, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS168, DOI 10.1016/S1353-8020(11)70052-9; WOUTERLOOD FG, 1990, J COMP NEUROL, V296, P179, DOI 10.1002/cne.902960202; Yaguez L, 2014, J CLIN NEUROSCI, V21, P445, DOI 10.1016/j.jocn.2013.06.005; Zahodne LB, 2011, CLIN NEUROPSYCHOL, V25, P348, DOI 10.1080/13854046.2011.562869; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	30	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0160583	10.1371/journal.pone.0160583	http://dx.doi.org/10.1371/journal.pone.0160583			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27557088	Green Submitted, Green Published, gold			2022-12-26	WOS:000382258100017
J	Nielson, RM; Murphy, RK; Millsap, BA; Howe, WH; Gardner, G				Nielson, Ryan M.; Murphy, Robert K.; Millsap, Brian A.; Howe, William H.; Gardner, Grant			Modeling Late-Summer Distribution of Golden Eagles (Aquila chrysaetos) in the Western United States	PLOS ONE			English	Article							WINTER HABITAT SELECTION; RESOURCE SELECTION; ABUNDANCE; DYNAMICS	Increasing development across the western United States (USA) elevates concerns about effects on wildlife resources; the golden eagle (Aquila chrysaetos) is of special concern in this regard. Knowledge of golden eagle abundance and distribution across the western USA must be improved to help identify and conserve areas of major importance to the species. We used distance sampling and visual mark-recapture procedures to estimate golden eagle abundance from aerial line-transect surveys conducted across four Bird Conservation Regions in the western USA between 15 August and 15 September in 2006-2010, 2012, and 2013. To assess golden eagle-habitat relationships at this scale, we modeled counts of golden eagles seen during surveys in 2006-2010, adjusted for probability of detection, and used land cover and other environmental factors as predictor variables within 20-km(2) sampling units randomly selected from survey transects. We found evidence of positive relationships between intensity of use by golden eagles and elevation, solar radiation, and mean wind speed, and of negative relationships with the proportion of landscape classified as forest or as developed. The model accurately predicted habitat use observed during surveys conducted in 2012 and 2013. We used the model to construct a map predicting intensity of use by golden eagles during late summer across our similar to 2 million-km(2) study area. The map can be used to help prioritize landscapes for conservation efforts, identify areas where mitigation efforts may be most effective, and identify regions for additional research and monitoring. In addition, our map can be used to develop region-specific (e.g., state-level) density estimates based on the latest information on golden eagle abundance from a late-summer survey and aid designation of geographic management units for the species.	[Nielson, Ryan M.; Gardner, Grant] Western EcoSyst Technol Inc, Cheyenne, WY 82001 USA; [Murphy, Robert K.; Millsap, Brian A.; Howe, William H.] US Fish & Wildlife Serv, Div Migratory Birds, Albuquerque, NM USA	United States Department of the Interior; US Fish & Wildlife Service	Nielson, RM (corresponding author), Western EcoSyst Technol Inc, Cheyenne, WY 82001 USA.	rnielson@west-inc.com		Millsap, Brian/0000-0003-3969-249X	United States Fish and Wildlife Service under a contract with Western EcoSystems Technology, Inc.	United States Fish and Wildlife Service under a contract with Western EcoSystems Technology, Inc.	Funding was provided by the United States Fish and Wildlife Service under a contract with Western EcoSystems Technology, Inc. Ryan M. Nielson and Grant Gardner are employed by Western EcoSystems Technology, Inc. Western EcoSystems Technology, Inc., provided support in the form of salaries for authors RMN and GG and were involved in design, analysis, and writing of the manuscript.	[Anonymous], 2002, BIRDS N AM; Baglien JW, 1975, THESIS; Braham M, 2015, BIOL CONSERV, V186, P225, DOI 10.1016/j.biocon.2015.03.020; Buckland S.T., 2001, pi; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Chamberlain DE, 2006, IBIS, V148, P198, DOI 10.1111/j.1474-919X.2006.00507.x; Chambers JC, 2007, ECOL MONOGR, V77, P117, DOI 10.1890/05-1991; Crandall RH, 2015, J RAPTOR RES, V49, P413, DOI 10.3356/rapt-49-04-413-428.1; Deering DW, 1978, THESIS TEXAS A M U C, P338; Ernest SKM, 2000, OIKOS, V88, P470, DOI 10.1034/j.1600-0706.2000.880302.x; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Fuller M, 2001, POPULATION MONITORIN; Grubb TG, 2010, J WILDLIFE MANAGE, V74, P1275, DOI 10.2193/2009-337; Hilbe J., 2008, NEGATIVE BINOMIAL RE; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Katzner TE, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0530; Kerlinger P., 1989, FLIGHT STRATEGIES MI; Kochert MN, 2002, J RAPTOR RES, V36, P32; Kochert MN, 1999, J WILDLIFE MANAGE, V63, P773, DOI 10.2307/3802790; Lightfoot DC, 2010, WEST N AM NATURALIST, V70, P490, DOI 10.3398/064.070.0409; Manly B.F.J., 2006, RANDOMIZATION BOOTST, V3rd, DOI DOI 10.1201/9781315273075; Manly B.F.J., 2002, RESOURCE SELECTION A; Marzluff JM, 1997, AUK, V114, P673, DOI 10.2307/4089287; McGrady MJ, 2002, J RAPTOR RES, V36, P62; Millsap BA, 2013, J WILDLIFE MANAGE, V77, P1436, DOI 10.1002/jwmg.588; Millspaugh JJ, 2006, J WILDLIFE MANAGE, V70, P384, DOI 10.2193/0022-541X(2006)70[384:AORSUU]2.0.CO;2; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nielson RM, 2013, SURVEY GOLDEN EAGLES; Nielson RM, 2014, J WILDLIFE MANAGE, V78, P721, DOI 10.1002/jwmg.704; Nielson RM, 2013, ECOL EVOL, V3, P2233, DOI 10.1002/ece3.617; North American Bird Conservation Initiative, 2000, N AM BIRD CONS IN S; PHILLIPS RL, 1984, WILDLIFE SOC B, V12, P269; R Core Team, 2021, R LANGUAGE ENV STAT; Reisner MD, 2015, J VEG SCI, V26, P1212, DOI 10.1111/jvs.12327; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Sawyer H, 2007, J WILDLIFE MANAGE, V71, P868, DOI 10.2193/2006-131; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; Sawyer H, 2009, J WILDLIFE MANAGE, V73, P1052, DOI 10.2193/2008-478; Tack JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134781; Tapia L, 2007, BIODIVERS CONSERV, V16, P3559, DOI 10.1007/s10531-006-9093-y; Thompson S.K., 2012, SAMPLING, V2nd; U.S. Fish and Wildlife Service, 2012, EAGL CONS PLAN GUID; U.S. Fish and Wildlife Service, 2009, FIN ENV ASS PROP PER; Van Vuren DH, 2001, AM MIDL NAT, V145, P94, DOI 10.1674/0003-0031(2001)145[0094:POYBMM]2.0.CO;2; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; White GC, 1996, ECOLOGY, V77, P2549, DOI 10.2307/2265753; Whitfield DP, 2004, BIOL CONSERV, V119, P319, DOI 10.1016/j.biocon.2003.11.015	49	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0159271	10.1371/journal.pone.0159271	http://dx.doi.org/10.1371/journal.pone.0159271			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556735	Green Submitted, Green Published, gold			2022-12-26	WOS:000382258100005
J	Doherty, CM; Visse, R; Dinakarpandian, D; Strickland, DK; Nagase, H; Troeberg, L				Doherty, Christine M.; Visse, Robert; Dinakarpandian, Deendayal; Strickland, Dudley K.; Nagase, Hideaki; Troeberg, Linda			Engineered Tissue Inhibitor of Metalloproteinases-3 Variants Resistant to Endocytosis Have Prolonged Chondroprotective Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAM; ADAMTS; extracellular matrix; glycosaminoglycan; osteoarthritis; receptor; tissue inhibitor of metalloproteinase (TIMP); low-density lipoprotein receptor-related protein 1	RECEPTOR-RELATED PROTEIN; PLASMINOGEN-ACTIVATOR INHIBITOR-1; ALPHA-CONVERTING-ENZYME; COAGULATION-FACTOR-VIII; BINDING-SITE; SULFATED GLYCOSAMINOGLYCANS; MATRIX-METALLOPROTEINASES; PROTEOLYTIC ACTIVITIES; EXTRACELLULAR-MATRIX; PENTOSAN POLYSULFATE	Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a central inhibitor of matrix-degrading and sheddase families of metalloproteinases. Extracellular levels of the inhibitor are regulated by the balance between its retention on the extracellular matrix and its endocytic clearance by the scavenger receptor low density lipoprotein receptor-related protein 1 (LRP1). Here, we used molecular modeling to predict TIMP-3 residues potentially involved in binding to LRP1 based on the proposed LRP1 binding motif of 2 lysine residues separated by about 21 and mutated the candidate lysine residues to alanine individually and in pairs. Of the 22 mutants generated, 13 displayed a reduced rate of uptake by HTB94 chondrosarcoma cells. The two mutants (TIMP-3 K26A/K45A and K42A/K110A) with lowest rates of uptake were further evaluated and found to display reduced binding to LRP1 and unaltered inhibitory activity against prototypic metalloproteinases. TIMP-3 K26A/K45A retained higher affinity for sulfated glycosaminoglycans than K42A/K110A and exhibited increased affinity for ADAMTS-5 in the presence of heparin. Both mutants inhibited metalloproteinase-mediated degradation of cartilage at lower concentrations and for longer than wild-type TIMP-3, indicating that their increased half-lives improved their ability to protect cartilage. These mutants may be useful in treating connective tissue diseases associated with increased metalloproteinase activity.	[Doherty, Christine M.; Visse, Robert; Nagase, Hideaki; Troeberg, Linda] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Arthrit Res UK Ctr Osteoarthrit Pathogenesis, Roosevelt Dr, Oxford OX3 7FY, England; [Dinakarpandian, Deendayal] Univ Missouri, Sch Comp & Engn, Kansas City, MO 64111 USA; [Strickland, Dudley K.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA	University of Oxford; University of Missouri System; University of Missouri Kansas City; University System of Maryland; University of Maryland Baltimore	Troeberg, L (corresponding author), Univ Oxford, Arthrit Res UK Ctr Excellence Osteoarthrit Pathog, Kennedy Inst Rheumatol, Roosevelt Dr, Oxford OX3 7FY, England.	linda.troeberg@kennedy.ox.ac.uk		/0000-0003-0939-4651	Kennedy Trust for Rheumatology Research Doctoral Scholarship; Arthritis Research UK Career Development Fellowship [19466]; Arthritis Research UK Centre for Osteoarthritis Pathogenesis [20205]; NIAMS, National Institutes of Health [AR40994]; NHLBI, National Institutes of Health [HL114379, HL120388]; Versus Arthritis [19466] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120388, R01HL114379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER	Kennedy Trust for Rheumatology Research Doctoral Scholarship; Arthritis Research UK Career Development Fellowship(Versus Arthritis); Arthritis Research UK Centre for Osteoarthritis Pathogenesis(Versus Arthritis); NIAMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Versus Arthritis(Versus Arthritis); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a Kennedy Trust for Rheumatology Research Doctoral Scholarship (to C. D.) and an Arthritis Research UK Career Development Fellowship (Grant 19466) (to L. T.). The work was additionally supported by the Arthritis Research UK Centre for Osteoarthritis Pathogenesis (Grant 20205); NIAMS, National Institutes of Health, Grant AR40994 (to H. N.); and NHLBI, National Institutes of Health, Grants HL114379 and HL120388 (to D. K. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arandjelovic S, 2005, ARCH BIOCHEM BIOPHYS, V438, P29, DOI 10.1016/j.abb.2005.03.019; Baker AH, 1999, BRIT J CANCER, V79, P1347, DOI 10.1038/sj.bjc.6690217; BIETH JG, 1995, METHOD ENZYMOL, V248, P59; Black R.A., 2006, OSTEOARTHR CARTIL, V14, pS23, DOI [10.1016/S1063-4584(07)60467-1, DOI 10.1016/S1063-4584(07)60467-1, 10.1101/2020.08.25.266775, DOI 10.1101/2020.08.25.266775]; BLENIS J, 1983, P NATL ACAD SCI-BIOL, V80, P770, DOI 10.1073/pnas.80.3.770; Bond M, 2002, J BIOL CHEM, V277, P13787, DOI 10.1074/jbc.M111507200; Bovenschen N, 2003, J BIOL CHEM, V278, P9370, DOI 10.1074/jbc.M212053200; Chung L, 2000, J BIOL CHEM, V275, P29610, DOI 10.1074/jbc.M004039200; Dolmer K, 2013, J BIOL CHEM, V288, P24081, DOI 10.1074/jbc.M113.473728; Elzie CA, 2004, INT J BIOCHEM CELL B, V36, P1090, DOI 10.1016/j.biocel.2003.12.012; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Fata JE, 2001, J CLIN INVEST, V108, P831, DOI 10.1172/JCI13171; Fedak PWM, 2004, CIRCULATION, V110, P2401, DOI 10.1161/01.CIR.0000134959.83967.2D; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Gendron C, 2003, FEBS LETT, V555, P431, DOI 10.1016/S0014-5793(03)01295-X; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Horn IR, 1998, THROMB HAEMOSTASIS, V80, P822; Ismail HM, 2015, ARTHRITIS RHEUMATOL, V67, P1826, DOI 10.1002/art.39099; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; Jensen JK, 2009, J BIOL CHEM, V284, P17989, DOI 10.1074/jbc.M109.009530; Jin GX, 2002, ANAL BIOCHEM, V302, P269, DOI 10.1006/abio.2001.5549; Kadomatsu K, 2013, J BIOCHEM, V153, P511, DOI 10.1093/jb/mvt035; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; Krenn EC, 2008, BIOCHEM BIOPH RES CO, V375, P297, DOI 10.1016/j.bbrc.2008.07.144; Leco KJ, 2001, J CLIN INVEST, V108, P817, DOI 10.1172/JCI12067; Lee MH, 2007, J BIOL CHEM, V282, P6887, DOI 10.1074/jbc.M610490200; Lee MH, 2004, J BIOL CHEM, V279, P17562, DOI 10.1074/jbc.M312589200; Lee MH, 2002, FEBS LETT, V520, P102, DOI 10.1016/S0014-5793(02)02776-X; Lim NH, 2010, BIOCHEM J, V431, P113, DOI 10.1042/BJ20100725; Meems H, 2011, INT J BIOCHEM CELL B, V43, P1114, DOI 10.1016/j.biocel.2011.03.014; Migliorini MM, 2003, J BIOL CHEM, V278, P17986, DOI 10.1074/jbc.M212592200; Huynh MB, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.030; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Morris KJ, 2010, CONNECT TISSUE RES, V51, P478, DOI 10.3109/03008201003686958; NAGASE H, 1994, J BIOL CHEM, V269, P20952; Nakamura H, 2000, J BIOL CHEM, V275, P38885, DOI 10.1074/jbc.M003875200; Neels JG, 2000, BLOOD, V96, P3459, DOI 10.1182/blood.V96.10.3459.h8003459_3459_3465; Nilsson SK, 2007, BIOCHEMISTRY-US, V46, P3896, DOI 10.1021/bi7000533; Nishida T, 2003, J CELL PHYSIOL, V196, P265, DOI 10.1002/jcp.10277; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; Qi JH, 2015, APOPTOSIS, V20, P523, DOI 10.1007/s10495-014-1076-y; Rajalingam D, 2009, PROTEIN SCI, V18, P980, DOI 10.1002/pro.108; Rider CC, 2006, BIOCHEM SOC T, V34, P458, DOI 10.1042/BST0340458; Sahebjam S, 2007, ARTHRITIS RHEUM, V56, P905, DOI 10.1002/art.22427; SAKAMOTO S, 1973, CALC TISS RES, V12, P247, DOI 10.1007/BF02013739; Scilabra SD, 2013, J BIOL CHEM, V288, P332, DOI 10.1074/jbc.M112.393322; Stefansson S, 1998, J BIOL CHEM, V273, P6358, DOI 10.1074/jbc.273.11.6358; Suzuki K, 1998, BIOL CHEM, V379, P185, DOI 10.1515/bchm.1998.379.2.185; Troeberg L, 2008, FASEB J, V22, P3515, DOI 10.1096/fj.08-112680; Troeberg L, 2014, CHEM BIOL, V21, P1300, DOI 10.1016/j.chembiol.2014.07.014; Troeberg L, 2012, BIOCHEM J, V443, P307, DOI 10.1042/BJ20112159; Troeberg L, 2009, MATRIX BIOL, V28, P463, DOI 10.1016/j.matbio.2009.07.005; Tuuttila A, 1998, J MOL BIOL, V284, P1133, DOI 10.1006/jmbi.1998.2223; van den Biggelaar M, 2015, J BIOL CHEM, V290, P16463, DOI 10.1074/jbc.M115.650911; van den Biggelaar M, 2011, INT J BIOCHEM CELL B, V43, P431, DOI 10.1016/j.biocel.2010.11.017; Wayne GJ, 2007, J BIOL CHEM, V282, P20991, DOI 10.1074/jbc.M610721200; Wei S, 2005, J BIOL CHEM, V280, P32877, DOI 10.1074/jbc.C500220200; Westein E, 2002, J BIOL CHEM, V277, P2511, DOI 10.1074/jbc.M102293200; Wisniewska M, 2008, J MOL BIOL, V381, P1307, DOI 10.1016/j.jmb.2008.06.088; Yamamoto K, 2013, FASEB J, V27, P511, DOI 10.1096/fj.12-216671; Yu WH, 2000, J BIOL CHEM, V275, P31226, DOI 10.1074/jbc.M000907200; Zeng WL, 2006, BBA-GEN SUBJECTS, V1760, P517, DOI 10.1016/j.bbagen.2006.01.013	64	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22160	22172		10.1074/jbc.M116.733261	http://dx.doi.org/10.1074/jbc.M116.733261			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27582494	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000386332600029
J	Hu, MT; Hsu, AT; Su, FC				Hu, Meng-Tzu; Hsu, Ar-Tyan; Su, Fong-Chin			Kinematic Analyses of the Thumb during Simulated Posteroanterior Glide Mobilization	PLOS ONE			English	Article							BASAL JOINT; PHYSIOTHERAPISTS; HYPERMOBILITY; MANIPULATION; VARIABILITY; PERFORMANCE; PREVALENCE; WORKSPACE; POSITION	Objective Thumb problems are common in some health professionals such as physical therapists. The purpose of this case-control study is to investigate the influence of clinical experience and different mobilization techniques on the kinematics of the thumb. Methods Twenty-three participants without exposure to manual techniques (the Novice Group) and fifteen physical therapists with at least 3 years of orthopedic experience (the Experienced Group) participated. The kinematics of the thumb while performing 3 different simulated posteroanterior (PA) glide mobilization techniques on a load cell was monitored. These 3 techniques were: 1) unsupported, 2) with digital support and 3) with thumb interphalangeal joint supported by the index finger. The amount of forces exerted were 25% to 100% of maximum effort at 25% increments. The main effects of experience and technique on thumb kinematics were assessed. Results Both experience and technique had main effects on the flexion/extension angles of the thumb joints. Experienced participants assumed a more flexed position at the carpometacarpal (CMC) joint, and the novice participants performed with angles closer to the neutral position (F = 7.593, p = 0.010). Participants' metacarpophalangeal (MCP) joints were in a more flexed position while performing PA glide with thumb interphalangeal (IP) joint supported by the index as compared to the other two techniques (p < .001). Conclusions Negative correlations were generally obtained between the sagittal plane angles of adjacent thumb joints during mobilization/manipulation. Therapists are recommended to treat patient with more stable PA glide mobilization techniques, such as PA glide with thumb interphalangeal joint supported by the index finger, to prevent potential mobilization-related thumb disorders.	[Hu, Meng-Tzu; Su, Fong-Chin] Natl Cheng Kung Univ, Inst Biomed Engn, Tainan, Taiwan; [Hsu, Ar-Tyan] Natl Cheng Kung Univ, Coll Med, Dept Phys Therapy, Tainan, Taiwan; [Hsu, Ar-Tyan] Natl Cheng Kung Univ, Coll Med, Inst Allied Hlth Sci, Tainan, Taiwan; [Su, Fong-Chin] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan, Taiwan; [Hu, Meng-Tzu] Tzu Hui Inst Technol, Dept Phys Therapy, Pingtung, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Su, FC (corresponding author), Natl Cheng Kung Univ, Inst Biomed Engn, Tainan, Taiwan.; Su, FC (corresponding author), Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan, Taiwan.	fcsu@mail.ncku.edu.tw	SU, FONG-CHIN/C-8094-2011	SU, FONG-CHIN/0000-0002-3870-4842	National Science Council, Taiwan [NSC93-2320-B-006-063]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by grant (NSC93-2320-B-006-063) from the National Science Council, Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaudette B, 2014, J MED BIOL ENG, V34, P448, DOI 10.5405/jmbe.1697; BEIGHTON P, 1973, ANN RHEUM DIS, V32, P413, DOI 10.1136/ard.32.5.413; Brand PW, 1993, CLIN MECH HAND, P192; Buckingham G, 2007, AUST J PHYSIOTHER, V53, P55, DOI 10.1016/S0004-9514(07)70062-4; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cromie JE, 2000, PHYS THER, V80, P336, DOI 10.1093/ptj/80.4.336; DARLING WG, 1987, J MOTOR BEHAV, V19, P291; Descarreaux M, 2010, J MANIP PHYSIOL THER, V33, P226, DOI 10.1016/j.jmpt.2010.01.011; EATON RG, 1969, J BONE JOINT SURG AM, VA 51, P661, DOI 10.2106/00004623-196951040-00004; EATON RG, 1973, J BONE JOINT SURG AM, VA 55, P1655, DOI 10.2106/00004623-197355080-00010; Fattapposta F, 1996, ELECTROEN CLIN NEURO, V99, P495, DOI 10.1016/S0013-4694(96)96560-8; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gabriel DA, 2002, J ELECTROMYOGR KINES, V12, P407, DOI 10.1016/S1050-6411(02)00026-3; Halilaj E, 2014, CLIN ORTHOP RELAT R, V472, P1114, DOI 10.1007/s11999-013-3063-y; Hu MT, 2014, MANUAL THER, V19, P484, DOI 10.1016/j.math.2014.05.003; Hu MT, 2009, MANUAL THER, V14, P490, DOI 10.1016/j.math.2008.10.003; Kuo LC, 2009, J ELECTROMYOGR KINES, V19, P829, DOI 10.1016/j.jelekin.2008.07.008; Li ZM, 2008, J ORTHOP RES, V26, P1289, DOI 10.1002/jor.20641; Li ZM, 2007, J BIOMECH, V40, P502, DOI 10.1016/j.jbiomech.2006.02.019; Lin HT, 2011, CLIN BIOMECH, V26, P371, DOI 10.1016/j.clinbiomech.2010.11.009; Maitland G., 2001, MAITLANDS VERTEBRAL, V6th; MALLIK AK, 1994, BRIT J RHEUMATOL, V33, P631; Marzke MW, 2000, J ANAT, V197, P121, DOI 10.1046/j.1469-7580.2000.19710121.x; McMahon M, 2006, AUST J PHYSIOTHER, V52, P287, DOI 10.1016/S0004-9514(06)70009-5; Moulton MJR, 2001, J BONE JOINT SURG AM, V83A, P709, DOI 10.2106/00004623-200105000-00009; Nordin M, 1989, BASIC BIOMECHANICS M; Tang J, 2008, ERGONOMICS, V51, P1109, DOI 10.1080/00140130801958667; Wajon A, 2007, MANUAL THER, V12, P12, DOI 10.1016/j.math.2005.09.003; Wajon Anne, 2003, J Hand Ther, V16, P237, DOI 10.1016/S0894-1130(03)00039-5; West DJ, 2001, AUST J PHYSIOTHER, V47, P179, DOI 10.1016/S0004-9514(14)60265-8; Wolf JM, 2011, J AM ACAD ORTHOP SUR, V19, P463, DOI 10.5435/00124635-201108000-00002; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Zancolli EA, 2001, HAND CLIN, V17, P13	33	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161624	10.1371/journal.pone.0161624	http://dx.doi.org/10.1371/journal.pone.0161624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583407	Green Published, gold, Green Submitted			2022-12-26	WOS:000382855600045
J	Li, XH; Zhuang, L; Zhang, XM; Wang, J; Chen, TW; Li, LJ; Aduah, EA; Hu, JN				Li, Xinghui; Zhuang, Ling; Zhang, Xiaoming; Wang, Jian; Chen, Tianwu; Li, Liangjun; Aduah, Emmanuel Ajedichiga; Hu, Jiani			Preliminary Study of MR Diffusion Tensor Imaging of Pancreas for the Diagnosis of Acute Pancreatitis	PLOS ONE			English	Article							LIVER FIBROSIS; WHITE-MATTER; TRACTOGRAPHY; INFLAMMATION; SEVERITY; EFFICACY; MOTOR; DTI; CT	Objectives To evaluate the feasibility of differentiating between acute pancreatitis (AP) and healthy pancreas using diffusion tensor imaging (DTI) and correlate apparent diffusion coefficient (ADC)/fractional anisotropy (FA) values with the severity of AP. Material and Methods 66 patients diagnosed with AP and 20 normal controls (NC) underwent DTI sequences and routine pancreatic MR sequences on a 3.0T MRI scanner. Average ADC and FA values of the pancreatic were measured. Differences of FA and ADC values between the AP group and the NC group with AP and healthy pancreas were compared by two-sample independent t-test. The severity of AP on MRI was classified into subgroups using MR severity index (MRSI), where the mean FA and ADC values were calculated. Relationship among the FA values, ADC values and MRSI were analyzed using Spearman's rank correlation coefficients. Results The pancreatic mean ADC value in the AP group (1.68 +/- 0.45x10(-3)mm(2)/s) was significantly lower than in the NC group (2.09 +/- 0.55x10(-3)mm(2)/s) (P = 0.02); the same as mean FA value (0.39 +/- 0.23 vs 0.54 +/- 0.12, P = 0.00). In the subgroup analysis, the pancreatic ADC and FA value of edema AP patients was significantly higher than necrosis AP patients with P = 0.000 and P = 0.001 respectively. In addition, as severity of pancreatitis increased according to MRSI, lower pancreatic ADC (r = -0.635) and FA value (r = -0.654) were noted. Conclusion Both FA and ADC value from DTI can be used to differentiate AP patients from NC. Both ADC and FA value of pancreas have a negative correlation with the severity of AP.	[Li, Xinghui; Zhang, Xiaoming; Wang, Jian; Chen, Tianwu; Li, Liangjun] First Mil Med Univ, Affiliated Hosp 1, Dept Radiol, Chongqing, Peoples R China; [Li, Xinghui; Zhang, Xiaoming; Wang, Jian; Chen, Tianwu; Li, Liangjun] North Sichuan Med Coll, Dept Radiol, Affiliated Hosp, Nanchong, Peoples R China; [Zhuang, Ling] Wayne State Univ, Dept Radiat Oncol, Detroit, MI 48202 USA; [Aduah, Emmanuel Ajedichiga] North Sichuan Med Coll, Dept Surg, Affiliated Hosp, Nanchong, Peoples R China; [Hu, Jiani] Wayne State Univ, Dept Radiol, Detroit, MI USA	Southern Medical University - China; North Sichuan Medical University; Wayne State University; North Sichuan Medical University; Wayne State University	Zhang, XM; Wang, J (corresponding author), First Mil Med Univ, Affiliated Hosp 1, Dept Radiol, Chongqing, Peoples R China.; Zhang, XM; Wang, J (corresponding author), North Sichuan Med Coll, Dept Radiol, Affiliated Hosp, Nanchong, Peoples R China.	cjr.zhxm@vip.163.com; wangjian811@tom.com	Zhang, Xiao Ming/H-7104-2019	Zhang, Xiao Ming/0000-0001-5327-8506				Akisik MF, 2009, RADIOLOGY, V250, P103, DOI 10.1148/radiol.2493080160; al-Eryani S, 1998, Bratisl Lek Listy, V99, P303; Arvanitakis M, 2004, GASTROENTEROLOGY, V126, P715, DOI 10.1053/j.gastro.2003.12.006; Bagadia A, 2011, J CLIN NEUROSCI, V18, P633, DOI 10.1016/j.jocn.2010.08.026; BALTHAZAR EJ, 1990, RADIOLOGY, V174, P331, DOI 10.1148/radiology.174.2.2296641; Baron T, 2013, CLEV CLIN J MED, V80, P350, DOI 10.3949/ccjm.80gr.13001; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bello L, 2008, NEUROIMAGE, V39, P369, DOI 10.1016/j.neuroimage.2007.08.031; Busireddy Kiran K, 2014, World J Gastrointest Pathophysiol, V5, P252, DOI 10.4291/wjgp.v5.i3.252; Cheung JS, 2010, NMR BIOMED, V23, P496, DOI 10.1002/nbm.1486; Dembinski A, 2003, EUR J PHARMACOL, V473, P207, DOI 10.1016/S0014-2999(03)01994-0; Erturk SM, 2014, ACTA RADIOL, V55, P654, DOI 10.1177/0284185113504916; In't Veld P, 2010, ADV EXP MED BIOL, V654, P1, DOI 10.1007/978-90-481-3271-3_1; KLAR E, 1992, HELV CHIR ACTA, V59, P7; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Kovanlikaya I, 2011, EUR J RADIOL, V77, P383, DOI 10.1016/j.ejrad.2009.08.012; Lecesne R, 1999, RADIOLOGY, V211, P727, DOI 10.1148/radiology.211.3.r99jn08727; Li XH, 2012, EUR J RADIOL, V81, pE880, DOI 10.1016/j.ejrad.2012.04.032; Li XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135568; Lund H, 2006, SCAND J GASTROENTERO, V41, P234, DOI 10.1080/00365520510024133; Meng X, 2013, CLIN RADIOL, V68, P815, DOI 10.1016/j.crad.2013.03.009; Miller FH, 2004, AM J ROENTGENOL, V183, P1637, DOI 10.2214/ajr.183.6.01831637; Nissan N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115783; Shinya S, 2009, HEPATO-GASTROENTEROL, V56, P1407; Stimac D, 2007, AM J GASTROENTEROL, V102, P997, DOI 10.1111/j.1572-0241.2007.01164.x; Tang W, 2011, EUR J RADIOL, V80, P637, DOI 10.1016/j.ejrad.2010.08.020; Taniguchi T, 2009, JPN J RADIOL, V27, P138, DOI 10.1007/s11604-008-0311-2; Taouli B, 2008, J MAGN RESON IMAGING, V28, P89, DOI 10.1002/jmri.21227; Taylor SL, 2005, AM J SURG, V189, P219, DOI 10.1016/j.amjsurg.2004.11.010; Thoeny HC, 2005, RADIOLOGY, V235, P911, DOI 10.1148/radiol.2353040554; Thomas S, 2012, EMERG RADIOL, V19, P5, DOI 10.1007/s10140-011-0983-2; Tosun M, 2013, EUR J RADIOL, V82, P203, DOI 10.1016/j.ejrad.2012.09.009; Viremouneix L, 2007, J MAGN RESON IMAGING, V26, P331, DOI 10.1002/jmri.21037; Watanabe T, 1999, PANCREAS, V18, P349, DOI 10.1097/00006676-199905000-00004; Yencilek E, 2014, TURK J GASTROENTEROL, V25, P553, DOI 10.5152/tjg.2014.6416; Zheng ZF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113469; Zhu FP, 2012, NEUROSURGERY, V71, P1170, DOI 10.1227/NEU.0b013e318271bc61	37	5	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0160115	10.1371/journal.pone.0160115	http://dx.doi.org/10.1371/journal.pone.0160115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584016	Green Submitted, Green Published, gold			2022-12-26	WOS:000382855600003
J	Desta, K; Woldeamanuel, Y; Azazh, A; Mohammod, H; Desalegn, D; Shimelis, D; Gulilat, D; Lamisso, B; Makonnen, E; Worku, A; Mannerqvist, K; Struwe, J; Aspevall, O; Aklillu, E				Desta, Kassu; Woldeamanuel, Yimtubezinash; Azazh, Aklilu; Mohammod, Halima; Desalegn, Dawit; Shimelis, Damte; Gulilat, Dereje; Lamisso, Biruk; Makonnen, Eyasu; Worku, Alemayehu; Mannerqvist, Kerstin; Struwe, Johan; Aspevall, Olov; Aklillu, Eleni			High Gastrointestinal Colonization Rate with Extended-Spectrum beta-Lactamase-Producing Enterobacteriaceae in Hospitalized Patients: Emergence of Carbapenemase-Producing K. pneumoniae in Ethiopia	PLOS ONE			English	Article							(ESBL)-PRODUCING ESCHERICHIA-COLI; ANTIMICROBIAL DRUG-RESISTANCE; INTENSIVE-CARE-UNIT; KLEBSIELLA-PNEUMONIAE; RISK-FACTORS; ADDIS-ABABA; TRACT COLONIZATION; INFECTIONS; OUTBREAK; EPIDEMIOLOGY	We investigated the gastrointestinal colonization rate and antibiotic resistance patterns of Extended-Spectrum Beta-Lactamase (ESBL)- producing Escherichia coli and Klebsiella pneumoniae in hospitalized patients admitted at Ethiopia's largest tertiary hospital. Fecal samples/swabs from 267 patients were cultured on chrome agar. ESBL. Bacterial species identification, verification of ESBL production and antibiotic susceptibility testing were done using Vitek 2 system (bioMerieux, France). Phenotype characterization of ESBL-E.coli and ESBL-K.pneumoniae was done using Neo-Sensitabs (TM). ESBL positivity rate was much higher in K. pneumoniae (76%) than E. coli (45%). The overall gastrointestinal colonization rate of ESBL producing Enterobacteriaceae (ESBL-E) in hospitalized patients was 52% (95% CI; 46%-58%) of which, ESBL-E. coli and K. pneumoniae accounted for 68% and 32% respectively. Fecal ESBL-E carriage rate in neonates, children and adults was 74%, 59% and 46% respectively. Gastrointestinal colonization rate of ESBL-E.coli in neonates, children and adults was 11%, 42% and 42% respectively. Of all E. coli strains isolated from adults, children and neonates, 44%, 49% and 22% were ESBL positive (p = 0.28). The prevalence of ESBL-K.pneumoniae carriage in neonates, children and adults was 68%, 22% and 7% respectively. All K. pneumoniae isolated from neonates (100%) and 88% of K. pneumoniae isolated from children were ESBL positive, but only 50% of K.pneumoniae isolated from adults were ESBL positive (p = 0.001). Thirteen patients (5%) were carriers of both ESBL-E. coli and ESBL-KP. The overall carrier rate of ESBL producing isolates resistant to carbapenem was 2% (5/267), all detected in children; three with E.coli HL cephalosporinase (AmpC), resistant to ertapenem and two with K. pneumoniae Carbapenemase (KPC) resistant to meropenem, ertapenem and impenem. We report a high gastrointestinal colonization rate with ESBL-E and the emergence of carbapenems-resistant K. pneumoniae in Ethiopia. Urgent implementation of infection control measures, and surveillance are urgently needed to limit the spread within healthcare facilities and further to the community.	[Desta, Kassu; Woldeamanuel, Yimtubezinash] Univ Addis Ababa, Dept Microbiol Immunol & Parasitol, Sch Med, Coll Hlth Sci, Addis Ababa, Ethiopia; [Azazh, Aklilu; Mohammod, Halima] Univ Addis Ababa, Dept Internal Med, Sch Med, Coll Hlth Sci, Addis Ababa, Ethiopia; [Desalegn, Dawit] Univ Addis Ababa, Dept Gynecol & Obstet, Sch Med, Coll Hlth Sci, Addis Ababa, Ethiopia; [Shimelis, Damte] Univ Addis Ababa, Dept Pediat, Sch Med, Coll Hlth Sci, Addis Ababa, Ethiopia; [Gulilat, Dereje] Univ Addis Ababa, Dept Surg, Sch Med, Coll Hlth Sci, Addis Ababa, Ethiopia; [Lamisso, Biruk] Univ Addis Ababa, Dept Orthoped, Sch Med, Coll Hlth Sci, Addis Ababa, Ethiopia; [Makonnen, Eyasu] Univ Addis Ababa, Dept Pharmacol, Sch Med, Coll Hlth Sci, Addis Ababa, Ethiopia; [Worku, Alemayehu] Univ Addis Ababa, Sch Publ Hlth, Coll Hlth Sci, Addis Ababa, Ethiopia; [Mannerqvist, Kerstin; Struwe, Johan; Aspevall, Olov] Publ Hlth Agcy Sweden, Stockholm, Sweden; [Aklillu, Eleni] Karolinska Inst, Div Clin Pharmacol, Dept Lab Med, SE-14186 Stockholm, Sweden	Addis Ababa University; Addis Ababa University; Addis Ababa University; Addis Ababa University; Addis Ababa University; Addis Ababa University; Addis Ababa University; Addis Ababa University; Public Health Agency of Sweden; Karolinska Institutet	Aklillu, E (corresponding author), Karolinska Inst, Div Clin Pharmacol, Dept Lab Med, SE-14186 Stockholm, Sweden.	Eleni.Aklillu@ki.se	Aklillu, Eleni/ABG-3461-2021; Woldeamanuel, YImtubezinash/AAX-9402-2020	Woldeamanuel, YImtubezinash/0000-0001-6606-8903; WAMISHO, Biruk Lambisso/0000-0002-9902-5931; Aklillu, Eleni/0000-0002-9788-0790	Vetenskapsradet (Swedish research council) [VR 521-2011-3437, VR 348-2011-7383]; Myndigheten for Samhallsskydd och Beredskap (Swedish civil contingency Agency) [2010-7878]	Vetenskapsradet (Swedish research council)(Swedish Research Council); Myndigheten for Samhallsskydd och Beredskap (Swedish civil contingency Agency)	The study was supported by grants from Vetenskapsradet (Swedish research council grants, VR 521-2011-3437; VR 348-2011-7383) to EA and Myndigheten for Samhallsskydd och Beredskap (Swedish civil contingency Agency grant, 2010-7878) to EA.	Bhutta ZA, 2009, PEDIATR INFECT DIS J, V28, pS22, DOI 10.1097/INF.0b013e31819588ac; Calbo E, 2015, FUTURE MICROBIOL, V10, P1063, DOI [10.2217/fmb.15.22, 10.2217/FMB.15.22]; Chereau F, 2015, ANTIMICROB AGENTS CH, V59, P3652, DOI 10.1128/AAC.00029-15; Christiaens G, 2006, J HOSP INFECT, V62, P386, DOI 10.1016/j.jhin.2005.09.014; Datta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112101; De Rosa FG, 2015, FUTURE MICROBIOL, V10, P285, DOI [10.2217/fmb.14.121, 10.2217/FMB.14.121]; Denkel LA, 2014, J ANTIMICROB CHEMOTH, V69, P2230, DOI 10.1093/jac/dku097; Ducomble T, 2015, J HOSP INFECT, V89, P179, DOI 10.1016/j.jhin.2014.11.012; Farra A, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.07.001; GEDEBOU M, 1987, ACTA PATH MICRO IM B, V95, P331; GEDEBOU M, 1988, J HOSP INFECT, V11, P50, DOI 10.1016/0195-6701(88)90039-4; Gesualdo F, 2013, PEDIATR INFECT DIS J, V32, P479, DOI 10.1097/INF.0b013e3182864e4c; Han JH, 2012, INFECT CONT HOSP EP, V33, P1242, DOI 10.1086/668443; Hoban DJ, 2012, DIAGN MICR INFEC DIS, V74, P62, DOI 10.1016/j.diagmicrobio.2012.05.024; Huang SS, 2006, CLIN INFECT DIS, V43, P971, DOI 10.1086/507636; Isendahl J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051981; Kuenzli E, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-528; Lonchel CM, 2013, EUR J CLIN MICROBIOL, V32, P79, DOI 10.1007/s10096-012-1717-4; Lukac PJ, 2015, CLIN INFECT DIS, V60, P1389, DOI 10.1093/cid/civ020; MacPherson DW, 2009, EMERG INFECT DIS, V15, P1727, DOI 10.3201/eid1511.090419; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Martins IS, 2006, J HOSP INFECT, V64, P305, DOI 10.1016/j.jhin.2006.07.011; Miranda IB, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav024; Nordberg V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076597; Obeng-Nkrumah N, 2013, AM J TROP MED HYG, V89, P960, DOI 10.4269/ajtmh.12-0642; Ostholm-Balkhed A, 2013, J ANTIMICROB CHEMOTH, V68, P2144, DOI 10.1093/jac/dkt167; Pena C, 1998, ANTIMICROB AGENTS CH, V42, P53, DOI 10.1128/AAC.42.1.53; Reuland EA, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.05.003; RINGERTZ S, 1990, B WORLD HEALTH ORGAN, V68, P61; Sangare SA, 2015, MED MALADIES INFECT, V45, P374, DOI 10.1016/j.medmal.2015.08.003; Schaumburg F, 2013, J ANTIMICROB CHEMOTH, V68, P2140, DOI 10.1093/jac/dkt164; Shitaye Demissie, 2010, Ethiop Med J, V48, P11; Shitrit P, 2006, INFECT CONT HOSP EP, V27, P1004, DOI 10.1086/507914; Somily AM, 2014, AM J INFECT CONTROL, V42, P277, DOI 10.1016/j.ajic.2013.09.028; Sonda T, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0117-4; Storberg Viktor, 2014, Infection Ecology & Epidemiology, V4, P20342, DOI 10.3402/iee.v4.20342; Tansarli GS, 2014, J ANTIMICROB CHEMOTH, V69, P1177, DOI 10.1093/jac/dkt500; Vialle-Valentin CE, 2012, TROP MED INT HEALTH, V17, P211, DOI 10.1111/j.1365-3156.2011.02895.x; von Wintersdorff CJH, 2014, EMERG INFECT DIS, V20, P649, DOI [10.3201/eid2004.131718, 10.3201/eid.2004.131718]; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1; Woldehanna T D, 2005, Cent Afr J Med, V51, P30; Worku B, 1997, ETHIOPIAN MED J, V35, P177; World Health Organization, 2014, ANT RES GLOB REP SUR; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X	44	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161685	10.1371/journal.pone.0161685	http://dx.doi.org/10.1371/journal.pone.0161685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27574974	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877200034
J	Velkoska, E; Patel, SK; Griggs, K; Burrell, LM				Velkoska, Elena; Patel, Sheila K.; Griggs, Karen; Burrell, Louise M.			Diminazene Aceturate Improves Cardiac Fibrosis and Diastolic Dysfunction in Rats with Kidney Disease	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; ACE2; INHIBITION; EXPRESSION; REGULATOR; INFECTION; CLEAVAGE; INJURY; MODEL	Angiotensin converting enzyme (ACE) 2 is a negative regulator of the renin angiotensin system (RAS) through its role to degrade angiotensin II. In rats with subtotal nephrectomy (STNx), adverse cardiac remodelling occurs despite elevated cardiac ACE2 activity. We hypothesised that diminazene aceturate (DIZE), which has been described as having an off-target effect to activate ACE2, would have beneficial cardiac effects in STNx rats. STNx led to hypertension, diastolic dysfunction, left ventricular hypertrophy, cardiac fibrosis, and increased cardiac ACE, ACE2, Ang II and Ang 1-7 levels. Cardiac gene expression of ADAM17 was also increased. In STNx, two-weeks of subcutaneous DIZE (15mg/kg/d) had no effect on blood pressure but improved diastolic dysfunction and cardiac fibrosis, reduced ADAM17 mRNA and shifted the cardiac RAS balance to a cardioprotective profile with reduced ACE and Ang II. There was no change in cardiac ACE2 activity or in cardiac Ang 1-7 levels with DIZE. In conclusion, our results suggest that DIZE exerts a protective effect on the heart under the pathological condition of kidney injury. This effect was not due to improved kidney function, a fall in blood pressure or a reduction in LVH but was associated with a reduction in cardiac ACE and cardiac Ang II levels. As in vitro studies showed no direct effect of DIZE on ACE2 or ACE activity, the precise mechanism of action of DIZE remains to be determined.	[Velkoska, Elena; Patel, Sheila K.; Griggs, Karen; Burrell, Louise M.] Univ Melbourne, Austin Hlth, Dept Med, Heidelberg, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Burrell, LM (corresponding author), Univ Melbourne, Austin Hlth, Dept Med, Heidelberg, Vic, Australia.	l.burrell@unimelb.edu.au			National Health and Medical Research Council of Australia [APP1048285]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funding granted to EV from National Health and Medical Research Council of Australia (APP1048285).	Burchill L, 2008, EXP PHYSIOL, V93, P622, DOI 10.1113/expphysiol.2007.040386; Burrell LM, 2012, EXP PHYSIOL, V97, P477, DOI 10.1113/expphysiol.2011.063156; Burrell LM, 2005, EUR HEART J, V26, P369, DOI 10.1093/eurheartj/ehi114; Burrell LM, 2004, TRENDS ENDOCRIN MET, V15, P166, DOI 10.1016/j.tem.2004.03.001; Candido R, 2008, BRENNER RECTORS KIDN, P333; Cao ZM, 2001, SEMIN NEPHROL, V21, P554, DOI 10.1053/snep.2001.26794; Cao ZM, 2001, KIDNEY INT, V60, P715, DOI 10.1046/j.1523-1755.2001.060002715.x; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Dales NA, 2002, J AM CHEM SOC, V124, P11852, DOI 10.1021/ja0277226; Dean RG, 2005, J HISTOCHEM CYTOCHEM, V53, P1245, DOI 10.1369/jhc.4A6560.2005; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Grobe JL, 2007, AM J PHYSIOL-HEART C, V292, pH736, DOI 10.1152/ajpheart.00937.2006; Grobe JL, 2006, AM J PHYSIOL-HEART C, V290, pH2417, DOI 10.1152/ajpheart.01170.2005; Haber PK, 2014, HYPERTENSION, V63, P774, DOI 10.1161/HYPERTENSIONAHA.113.02856; HOMEIDA AM, 1981, J COMP PATHOL, V91, P355, DOI 10.1016/0021-9975(81)90005-0; Kennedy DJ, 2008, AM J PHYSIOL-RENAL, V294, pF450, DOI 10.1152/ajprenal.00472.2007; Kulemina LV, 2011, J BIOMOL SCREEN, V16, P878, DOI 10.1177/1087057111413919; Lai ZW, 2011, BIOCHEMISTRY-US, V50, P5182, DOI 10.1021/bi200525y; Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Lew RA, 2006, INT J PEPT RES THER, V12, P283, DOI 10.1007/s10989-006-9031-6; Malek Maryam, 2014, Adv Prev Med, V2014, P740647, DOI 10.1155/2014/740647; Oudit GY, 2010, DIABETES, V59, P529, DOI 10.2337/db09-1218; Patel VB, 2014, J MOL CELL CARDIOL, V66, P167, DOI 10.1016/j.yjmcc.2013.11.017; Qi YF, 2013, HYPERTENSION, V62, P746, DOI 10.1161/HYPERTENSIONAHA.113.01337; Raffai G, 2014, J CARDIOVASC PHARM, V63, P453, DOI 10.1097/FJC.0000000000000069; RUEBUSH TK, 1979, AM J TROP MED HYG, V28, P184, DOI 10.4269/ajtmh.1979.28.184; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; SHARMA SP, 1984, RES VET SCI, V37, P126, DOI 10.1016/S0034-5288(18)31941-6; Shenoy V, 2013, AM J RESP CRIT CARE, V187, P648, DOI 10.1164/rccm.201205-0880OC; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Taal MW, 2008, BRENNER RECTORS KIDN, V8, P783; Thatcher SE, 2014, ARTERIOSCL THROM VAS, V34, P2617, DOI 10.1161/ATVBAHA.114.304613; Tikellis C, 2008, DIABETES, V57, P1018, DOI 10.2337/db07-1212; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Velkoska E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118758; Velkoska E, 2011, CLIN SCI, V120, P335, DOI 10.1042/CS20100280; Velkoska E, 2010, CLIN SCI, V118, P269, DOI 10.1042/CS20090318; Zhong JC, 2011, HYPERTENSION, V57, P314, DOI 10.1161/HYPERTENSIONAHA.110.164244	39	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161760	10.1371/journal.pone.0161760	http://dx.doi.org/10.1371/journal.pone.0161760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571511	Green Published, gold			2022-12-26	WOS:000382876700032
J	Ramkumar, P; Dekleva, B; Cooler, S; Miller, L; Kording, K				Ramkumar, Pavan; Dekleva, Brian; Cooler, Sam; Miller, Lee; Kording, Konrad			Premotor and Motor Cortices Encode Reward	PLOS ONE			English	Article							NEURONAL-ACTIVITY; PREFRONTAL CORTEX; DOPAMINE NEURONS; DECISION-MAKING; HUMAN BRAIN; FORCE; ADAPTATION; PREDICTION; MOTIVATION; MOVEMENT	Rewards associated with actions are critical for motivation and learning about the consequences of one's actions on the world. The motor cortices are involved in planning and executing movements, but it is unclear whether they encode reward over and above limb kinematics and dynamics. Here, we report a categorical reward signal in dorsal premotor (PMd) and primary motor (M1) neurons that corresponds to an increase in firing rates when a trial was not rewarded regardless of whether or not a reward was expected. We show that this signal is unrelated to error magnitude, reward prediction error, or other task confounds such as reward consumption, return reach plan, or kinematic differences across rewarded and unrewarded trials. The availability of reward information in motor cortex is crucial for theories of reward-based learning and motivational influences on actions.	[Ramkumar, Pavan; Kording, Konrad] Rehabil Inst Chicago, Sensorimotor Performance Program, Chicago, IL 60611 USA; [Ramkumar, Pavan; Kording, Konrad] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Dekleva, Brian] Northwestern Univ, Dept Biomed Engn, Chicago, IL 60611 USA; [Dekleva, Brian; Miller, Lee] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Cooler, Sam] Northwestern Univ, Interdept Neurosci Program, Chicago, IL 60611 USA	Shirley Ryan AbilityLab; Northwestern University; Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University	Ramkumar, P (corresponding author), Rehabil Inst Chicago, Sensorimotor Performance Program, Chicago, IL 60611 USA.; Ramkumar, P (corresponding author), Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.	pavan.ramkumar@northwestern.edu	; Kording, Konrad/A-1233-2007	Cooler, Sam/0000-0002-9794-4635; Kording, Konrad/0000-0001-8408-4499	National Institute of Neurological Disorders and Stroke (NINDS); NATIONAL EYE INSTITUTE [T32EY025202] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institute of Neurological Disorders and Stroke (NINDS).	Abe M, 2011, CURR BIOL, V21, P557, DOI 10.1016/j.cub.2011.02.030; ASHE J, 1994, CEREB CORTEX, V4, P590, DOI 10.1093/cercor/4.6.590; CHENEY PD, 1980, J NEUROPHYSIOL, V44, P773, DOI 10.1152/jn.1980.44.4.773; Churchland MM, 2006, J NEUROPHYSIOL, V96, P3130, DOI 10.1152/jn.00307.2006; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Dekleva BM, 2016, ELIFE, V5, DOI [10.7554/eLife.14316, 10.7554/eLife:14316]; Diedrichsen J, 2005, J NEUROSCI, V25, P9919, DOI 10.1523/JNEUROSCI.1874-05.2005; Dommett E, 2005, SCIENCE, V307, P1476, DOI 10.1126/science.1107026; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; Even-Chen N, 2015, IEEE ENG MED BIO, P71, DOI 10.1109/EMBC.2015.7318303; Fernandes HL, 2014, CEREB CORTEX, V24, P3232, DOI 10.1093/cercor/bht179; Fouragnan E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9107; Galea JM, 2015, NAT NEUROSCI, V18, P597, DOI 10.1038/nn.3956; GEORGOPOULOS AP, 1992, SCIENCE, V256, P1692, DOI 10.1126/science.256.5064.1692; Haber SN., 1991, NEUROBIOLOGY SENSATI; Holdefer RN, 2002, EXP BRAIN RES, V146, P233, DOI 10.1007/s00221-002-1166-x; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; Krakauer JW, 2011, CURR OPIN NEUROBIOL, V21, P636, DOI 10.1016/j.conb.2011.06.012; Marsh BT, 2015, J NEUROSCI, V35, P7374, DOI 10.1523/JNEUROSCI.1802-14.2015; McFadden D., 1974, CONDITIONAL LOGIT AN; Morrow MM, 2007, J NEUROPHYSIOL, V97, P1786, DOI 10.1152/jn.00150.2006; Nikooyan AA, 2015, J NEUROPHYSIOL, V113, P633, DOI 10.1152/jn.00032.2014; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Park IM, 2014, NAT NEUROSCI, V17, P1395, DOI 10.1038/nn.3800; Qian J, 2013, GLMNET FOR MATLAB; Ramkumar P, 2016, J NEUROPHYSIOLOGY; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Roesch MR, 2005, J NEUROPHYSIOL, V94, P2457, DOI 10.1152/jn.00373.2005; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SCOTT SH, 1995, J NEUROPHYSIOL, V73, P2563, DOI 10.1152/jn.1995.73.6.2563; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Shmuelof L, 2011, NEURON, V72, P469, DOI 10.1016/j.neuron.2011.10.017; Wallis JD, 2010, CURR OPIN NEUROBIOL, V20, P191, DOI 10.1016/j.conb.2010.02.009; Wei KL, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00011; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	41	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0160851	10.1371/journal.pone.0160851	http://dx.doi.org/10.1371/journal.pone.0160851			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564707	Green Published, gold, Green Submitted			2022-12-26	WOS:000382496300004
J	Aspaas, S; Grefsrud, ES; Ferno, A; Jensen, KH; Trengereid, H; Agnalt, AL				Aspaas, Stian; Grefsrud, Ellen Sofie; Ferno, Anders; Jensen, Knut Helge; Trengereid, Henrik; Agnalt, Ann-Lisbeth			An Enriched Environment Promotes Shelter-Seeking Behaviour and Survival of Hatchery-Produced Juvenile European Lobster (Homarus gammarus)	PLOS ONE			English	Article							AGONISTIC BEHAVIOR; PREDATION; CRAYFISH; GROWTH; STOCK; LIFE	The high loss of newly released hatchery-reared European lobster (Homarus gammarus) juveniles for stock enhancement is believed to be the result of maladaptive anti-predator behaviour connected to deprived stimuli in the hatchery environment. Our objective was to learn if an enriched hatchery environment enhances shelter-seeking behaviour and survival. In the "naive" treatment, the juveniles were raised in single compartments without substrate and shelter whereas juveniles in the "exposed" treatment experienced substrate, shelter and interactions with conspecifics. Three experiments with increasing complexity were conducted. Few differences in shelter-seeking behaviour were found between treatments when one naive or one exposed juvenile were observed alone. When observing interactions between one naive and one exposed juvenile competing for shelter, naive juveniles more often initiated the first aggressive encounter. The third experiment was set up to simulate a release for stock enhancement. Naive and exposed juveniles were introduced to a semi-natural environment including substrate, a limited number of shelters and interactions with conspecifics. Shelter occupancy was recorded three times during a period of 35 days. Exposed juveniles occupied more shelters, grew larger and had higher survival compared with naive juveniles. Our results demonstrate that experience of environmental complexity and social interactions increase shelter-seeking ability and survival in hatchery reared lobster juveniles.	[Aspaas, Stian] Hammervegen 3A, N-7350 Buvika, Norway; [Grefsrud, Ellen Sofie; Ferno, Anders; Agnalt, Ann-Lisbeth] Inst Marine Res, POB 1870 Nordnes, N-5817 Bergen, Norway; [Ferno, Anders; Jensen, Knut Helge] Univ Bergen, Dept Biol, POB 7803, N-5020 Bergen, Norway; [Trengereid, Henrik] Myrdalhovden 48, N-5131 Nyborg, Norway	Institute of Marine Research - Norway; University of Bergen	Agnalt, AL (corresponding author), Inst Marine Res, POB 1870 Nordnes, N-5817 Bergen, Norway.	ann-lisbeth.agnalt@imr.no		Grefsrud, Ellen Sofie/0000-0003-1309-4299	Institute of Marine Research [82120-02]	Institute of Marine Research	The study was funded by the Institute of Marine Research (www.imr.no). Grant number: 82120-02. The project name is: Ecological effects of sea-ranching. Three of the authors are affiliated with the Institute of Marine Research (A-LA, ESG and AF), the grant recipient is author A-LA. The funder has participated as a supervisor in the study design and analysis, and played a key role in the decision to publish and preparation of the manuscript.	Agnalt A.-L., 2004, STOCK ENHANCEMENT SE, P415, DOI DOI 10.1002/9780470751329.CH30; Agnalt A-L, 2008, THESIS; Agnalt AL, 1999, STOCK ENHANCEMENT AND SEA RANCHING, P401; Agnalt AL, 2007, ICES J MAR SCI, V64, P288, DOI 10.1093/icesjms/fsl020; Atema Jelle, 1995, P313, DOI 10.1016/B978-012247570-2/50035-9; Bannister RCA, 1998, B MAR SCI, V62, P369; Bell JD, 2005, ADV MAR BIOL, P43; Bergman DA, 2003, BIOL BULL-US, V205, P26, DOI 10.2307/1543442; BERRILL M, 1974, J MAR BIOL ASSOC UK, V54, P797, DOI 10.1017/S0025315400057581; Blaxter JHS, 2000, ADV MAR BIOL, V38, P1, DOI 10.1016/S0065-2881(00)38002-6; Brown C, 2001, J FISH BIOL, V59, P471, DOI [10.1006/jfbi.2001.1689, 10.1111/j.1095-8649.2001.tb02354.x]; Carere C, 2015, REND LINCEI-SCI FIS, V26, P59, DOI 10.1007/s12210-014-0361-6; Cenni F, 2010, APPL ANIM BEHAV SCI, V122, P63, DOI 10.1016/j.applanim.2009.11.007; Crawley M.J., 2007, R BOOK; Dannevig A., 1928, Report Norwegian Fishery Investigations, V3, P1; Daws AG, 2002, MAR FRESHW BEHAV PHY, V35, P139, DOI 10.1080/1023624021000014725; DUNHAM PJ, 1972, J FISH RES BOARD CAN, V29, P598, DOI 10.1139/f72-102; Ellis CD., 2014, AQUAC RES, V46, P1; Ferno A., 2011, FISH COGN BEHAV, P359; Gherardi F, 2010, ANIM BEHAV, V80, P713, DOI 10.1016/j.anbehav.2010.07.008; HUBER R, 1995, BRAIN BEHAV EVOLUT, V46, P72, DOI 10.1159/000113260; Jorstad KE, 2001, MAR FRESHWATER RES, V52, P1431, DOI 10.1071/MF01065; Karavanich C, 1998, ANIM BEHAV, V56, P1553, DOI 10.1006/anbe.1998.0914; Linnane A, 2000, J EXP MAR BIOL ECOL, V249, P51, DOI 10.1016/S0022-0981(00)00190-8; Linnane A, 1998, AQUACULTURE, V163, P195, DOI 10.1016/S0044-8486(98)00247-6; Martin CW, 2014, PEERJ, V2, DOI 10.7717/peerj.665; Munro J.L., 1997, Reviews in Fisheries Science, V5, P185; Nicosia F., 1999, MAR FISH REV, V61, P1; Peeke HVS, 1998, J EXP MAR BIOL ECOL, V229, P149, DOI 10.1016/S0022-0981(98)00045-8; Salvanes AGV, 2006, ICES J MAR SCI, V63, P345, DOI 10.1016/j.icesjms.2005.11.010; Strand O, 2004, STOCK ENHANCEMENT SE, P544; Svasand T., 1998, Fisheries Management and Ecology, V5, P473, DOI 10.1046/j.1365-2400.1998.560473.x; Svasand T, 2004, STOCK ENHANCEMENT SE, P59; Tveite Stein, 1995, ICES Marine Science Symposia, V199, P73; Uglem I, 1996, AQUACULT ENG, V15, P499, DOI 10.1016/S0144-8609(96)01005-9; van der Meeren GI, 2000, CAN J FISH AQUAT SCI, V57, P1794, DOI 10.1139/cjfas-57-9-1794; Venables WN., 2002, MODERN APPL STAT S 4; WAHLE RA, 1992, J EXP MAR BIOL ECOL, V157, P91, DOI 10.1016/0022-0981(92)90077-N; Wickins JF, 1996, MAR FRESHW BEHAV PHY, V28, P211, DOI 10.1080/10236249609378993; Wickins JF, 2002, CRUSTACEAN FARMING R; Zuur Alain F., 2009, P1	41	11	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0159807	10.1371/journal.pone.0159807	http://dx.doi.org/10.1371/journal.pone.0159807			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560932	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258600004
J	Basu, S; Wallner, B				Basu, Sankar; Wallner, Bjorn			DockQ: A Quality Measure for Protein-Protein Docking Models	PLOS ONE			English	Article							STRUCTURE PREDICTION; STRUCTURAL BASIS; CAPRI; GLYCOPROTEIN; COMPLEXES	The state-of-the-art to assess the structural quality of docking models is currently based on three related yet independent quality measures: F-nat, LRMS, and iRMS as proposed and standardized by CAPRI. These quality measures quantify different aspects of the quality of a particular docking model and need to be viewed together to reveal the true quality, e.g. a model with relatively poor LRMS (> 10 angstrom) might still qualify as 'acceptable' with a descent F-nat (> 0.50) and iRMS (< 3.0 angstrom). This is also the reason why the so called CAPRI criteria for assessing the quality of docking models is defined by applying various ad-hoc cutoffs on these measures to classify a docking model into the four classes: Incorrect, Acceptable, Medium, or High quality. This classification has been useful in CAPRI, but since models are grouped in only four bins it is also rather limiting, making it difficult to rank models, correlate with scoring functions or use it as target function in machine learning algorithms. Here, we present DockQ, a continuous protein-protein docking model quality measure derived by combining F-nat, LRMS, and iRMS to a single score in the range [0, 1] that can be used to assess the quality of protein docking models. By using DockQ on CAPRI models it is possible to almost completely reproduce the original CAPRI classification into Incorrect, Acceptable, Medium and High quality. An average PPV of 94% at 90% Recall demonstrating that there is no need to apply predefined ad-hoc cutoffs to classify docking models. Since DockQ recapitulates the CAPRI classification almost perfectly, it can be viewed as a higher resolution version of the CAPRI classification, making it possible to estimate model quality in a more quantitative way using Z-scores or sum of top ranked models, which has been so valuable for the CASP community. The possibility to directly correlate a quality measure to a scoring function has been crucial for the development of scoring functions for protein structure prediction, and DockQ should be useful in a similar development in the protein docking field.	[Basu, Sankar; Wallner, Bjorn] Linkoping Univ, Dept Phys Chem & Biol, Bioinformat Div, Linkoping, Sweden; [Wallner, Bjorn] Linkoping Univ, Swedish E Sci Res Ctr, Linkoping, Sweden	Linkoping University; Linkoping University	Wallner, B (corresponding author), Linkoping Univ, Dept Phys Chem & Biol, Bioinformat Div, Linkoping, Sweden.; Wallner, B (corresponding author), Linkoping Univ, Swedish E Sci Res Ctr, Linkoping, Sweden.	bjornw@ifm.liu.se	Basu, Sankar/AAD-7202-2019; Wallner, Björn/R-1030-2018	Basu, Sankar/0000-0003-1393-1982; Wallner, Björn/0000-0002-3772-8279	Swedish Research Council [621-2012-5270]; Swedish e-Science Research Center	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish e-Science Research Center	This work was funded by the Swedish Research Council (621-2012-5270) and the Swedish e-Science Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2016, BIOINFORMATICS, V32, P262, DOI 10.1093/bioinformatics/btw257; Bernauer J, 2007, BIOINFORMATICS, V23, P555, DOI 10.1093/bioinformatics/btl654; Cao RZ, 2015, BIOINFORMATICS, V31, P116, DOI 10.1093/bioinformatics/btv235; Chen R., 2003, PROTEINS, V52; Cristobal S, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-5; Gao M, 2011, PROTEINS, V79, P1623, DOI 10.1002/prot.22987; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Halldorsson S, 2016, P NATL ACAD SCI USA, V113, P7154, DOI 10.1073/pnas.1603827113; Hwang H, 2010, PROTEINS, V78, P3104, DOI 10.1002/prot.22764; Kong L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12040; Lensink MF, 2007, PROTEINS, V69, P704, DOI 10.1002/prot.21804; Lensink MF, 2014, PROTEINS, V82, P3163, DOI 10.1002/prot.24678; Lensink MF, 2013, PROTEINS, V81, P2082, DOI 10.1002/prot.24428; Mendez R, 2003, PROTEINS, V52, P51, DOI 10.1002/prot.10393; Moal IH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-286; Ray A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-224; Siew N, 2000, BIOINFORMATICS, V16, P776, DOI 10.1093/bioinformatics/16.9.776; Soto C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157409; Stewart M, 1998, J MOL BIOL, V277, P635, DOI 10.1006/jmbi.1997.1602; Torchala M, 2013, BIOINFORMATICS, V29, P807, DOI 10.1093/bioinformatics/btt038; Zemla A, 1999, PROTEINS, P22; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhao YG, 2016, NATURE, V535, P169, DOI 10.1038/nature18615	24	64	64	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161879	10.1371/journal.pone.0161879	http://dx.doi.org/10.1371/journal.pone.0161879			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560519	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258600111
J	Cantiani, C; Choudhury, NA; Yu, YH; Shafer, VL; Schwartz, RG; Benasich, AA				Cantiani, Chiara; Choudhury, Naseem A.; Yu, Yan H.; Shafer, Valerie L.; Schwartz, Richard G.; Benasich, April A.			From Sensory Perception to Lexical-Semantic Processing: An ERP Study in Non-Verbal Children with Autism	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; BRAIN POTENTIALS; SPECTRUM DISORDERS; 6-MONTH-OLD INFANTS; EVOKED-POTENTIALS; SPEECH; WORDS; AGE; DISCRIMINATION; COMPONENTS	This study examines electrocortical activity associated with visual and auditory sensory perception and lexical-semantic processing in nonverbal (NV) or minimally-verbal (MV) children with Autism Spectrum Disorder (ASD). Currently, there is no agreement on whether these children comprehend incoming linguistic information and whether their perception is comparable to that of typically developing children. Event-related potentials (ERPs) of 10 NV/MV children with ASD and 10 neurotypical children were recorded during a picture-word matching paradigm. Atypical ERP responses were evident at all levels of processing in children with ASD. Basic perceptual processing was delayed in both visual and auditory domains but overall was similar in amplitude to typically-developing children. However, significant differences between groups were found at the lexical-semantic level, suggesting more atypical higher-order processes. The results suggest that although basic perception is relatively preserved in NV/MV children with ASD, higher levels of processing, including lexical- semantic functions, are impaired. The use of passive ERP paradigms that do not require active participant response shows significant potential for assessment of non-compliant populations such as NV/MV children with ASD.	[Cantiani, Chiara; Choudhury, Naseem A.; Benasich, April A.] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; [Cantiani, Chiara] Sci Inst IRCCS Eugenio Medea, Child Psychopathol Unit, Bosisio Parini, Lecco, Italy; [Choudhury, Naseem A.] Ramapo Coll, Psychol, SSHS, Mahwah, NJ USA; [Yu, Yan H.; Shafer, Valerie L.; Schwartz, Richard G.] CUNY, Grad Ctr, New York, NY 10021 USA; [Yu, Yan H.] St Johns Univ, Dept Commun Sci & Disorders, New York, NY USA	Rutgers State University Newark; Rutgers State University New Brunswick; IRCCS Eugenio Medea; Ramapo College New Jersey (RCNJ); City University of New York (CUNY) System; Saint John's University	Cantiani, C (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.; Cantiani, C (corresponding author), Sci Inst IRCCS Eugenio Medea, Child Psychopathol Unit, Bosisio Parini, Lecco, Italy.	chiara.cantiani@lanostrafamiglia.it	Schwartz, Richard/AAT-2639-2020; Cantiani, Chiara/AAM-7557-2020; Choudhury, Naseem A/GOV-7222-2022; Cantiani, Chiara/K-4596-2016; YU, YAN/Y-8898-2018	Schwartz, Richard/0000-0001-9153-1349; Cantiani, Chiara/0000-0001-6482-6627; Cantiani, Chiara/0000-0001-6482-6627; YU, YAN/0000-0001-6322-4800; Shafer, Valerie/0000-0001-8551-1878	Autism Speaks High Risk/High Impact Grant [5664]; Elizabeth H. Solomon Center for Neurodevelopmental Research	Autism Speaks High Risk/High Impact Grant; Elizabeth H. Solomon Center for Neurodevelopmental Research	This work was funded with Autism Speaks High Risk/High Impact Grant # 5664 to AAB, (https://www.autismspeaks.org) with additional support from the Elizabeth H. Solomon Center for Neurodevelopmental Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN TEXT; ASLIN RN, 1989, J ACOUST SOC AM, V86, P582, DOI 10.1121/1.398237; Baath R., 2010, LUCS MINOR, V16; Behrmann M, 2006, TRENDS COGN SCI, V10, P258, DOI 10.1016/j.tics.2006.05.001; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Boeschoten MA, 2007, CLIN NEUROPHYSIOL, V118, P2076, DOI 10.1016/j.clinph.2007.05.004; Bruneau N, 2003, INT J PSYCHOPHYSIOL, V51, P17, DOI 10.1016/S0167-8760(03)00149-1; Byrne JM, 1999, DEV MED CHILD NEUROL, V41, P740, DOI 10.1017/S0012162299001504; Cardy JEO, 2005, NEUROREPORT, V16, P521, DOI 10.1097/00001756-200504040-00021; Ceponiene R, 2002, CLIN NEUROPHYSIOL, V113, P870, DOI 10.1016/S1388-2457(02)00078-0; Clark VP, 1996, J COGNITIVE NEUROSCI, V8, P387, DOI 10.1162/jocn.1996.8.5.387; Connolly JF, 2000, INT J PSYCHOPHYSIOL, V38, P55, DOI 10.1016/S0167-8760(00)00130-6; Cummings A, 2008, BRAIN RES, V1208, P137, DOI 10.1016/j.brainres.2008.02.015; deHaan M, 1997, CHILD DEV, V68, P187, DOI 10.2307/1131845; Dien J, 2006, CLIN NEUROPHYSIOL, V117, P699, DOI 10.1016/j.clinph.2005.09.029; Dien J, 2003, COGNITIVE BRAIN RES, V15, P137, DOI 10.1016/S0926-6410(02)00147-7; Dunn M, 1999, DEV NEUROPSYCHOL, V16, P79, DOI 10.1207/S15326942DN160105; Dunn MA, 2005, J AUTISM DEV DISORD, V35, P361, DOI 10.1007/s10803-005-3304-3; Duta MD, 2012, DEV COGN NEUROS-NETH, V2, P223, DOI 10.1016/j.dcn.2012.01.003; Eagle RS, 2003, J DEV DISABILITIES, V9, P45; EILERS RE, 1981, J ACOUST SOC AM, V70, P955, DOI 10.1121/1.387024; Ferri R, 2003, CLIN NEUROPHYSIOL, V114, P1671, DOI 10.1016/S1388-2457(03)00153-6; Friederici AD, 2005, TRENDS COGN SCI, V9, P481, DOI 10.1016/j.tics.2005.08.008; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Friedrich M, 2004, J COGNITIVE NEUROSCI, V16, P1465, DOI 10.1162/0898929042304705; Gage NM, 2003, NEUROREPORT, V14, P2047, DOI 10.1097/00001756-200311140-00008; Garcia-Larrea L, 1998, EVOKED POTENTIAL, V108, P260, DOI 10.1016/S0168-5597(97)00085-3; Gilley PM, 2005, CLIN NEUROPHYSIOL, V116, P648, DOI 10.1016/j.clinph.2004.09.009; GonzalezGarrido AA, 1997, ARCH MED RES, V28, P109; Hagoort P, 2008, PHILOS T R SOC B, V363, P1055, DOI 10.1098/rstb.2007.2159; Hahne A, 2004, J COGNITIVE NEUROSCI, V16, P1302, DOI 10.1162/0898929041920504; Halberda J, 2003, COGNITION, V87, pB23, DOI 10.1016/S0010-0277(02)00186-5; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; HOLCOMB PJ, 1992, DEV NEUROPSYCHOL, V8, P203, DOI 10.1080/87565649209540525; HOLCOMB PJ, 1990, LANG COGNITIVE PROC, V5, P281, DOI 10.1080/01690969008407065; Jeste SS, 2009, J AUTISM DEV DISORD, V39, P495, DOI 10.1007/s10803-008-0652-9; Jing HK, 2006, BRAIN DEV-JPN, V28, P207, DOI 10.1016/j.braindev.2005.07.005; Juottonen K, 1996, COGNITIVE BRAIN RES, V4, P99; Kamio Y, 2000, J CHILD PSYCHOL PSYC, V41, P859, DOI 10.1017/S0021963099006137; KEMNER C, 1995, BIOL PSYCHIAT, V38, P150, DOI 10.1016/0006-3223(94)00247-Z; Korpilahti P, 2007, J AUTISM DEV DISORD, V37, P1539, DOI 10.1007/s10803-006-0271-2; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M., 1994, HDB PSYCHOLINGUISTIC, P83, DOI DOI 10.1016/8978-012369374-7/50018-3; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; LINCOLN AJ, 1995, J AUTISM DEV DISORD, V25, P521, DOI 10.1007/BF02178298; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; MacRoy-Higgins M, 2013, INT J LANG COMM DIS, V48, P188, DOI 10.1111/j.1460-6984.2012.00198.x; Maekawa T, 2011, RES AUTISM SPECT DIS, V5, P201, DOI 10.1016/j.rasd.2010.03.012; MANGUN GR, 1991, J EXP PSYCHOL HUMAN, V17, P1057, DOI 10.1037/0096-1523.17.4.1057; MANGUN GR, 1993, ATTENTION PERFORM, V14, P219; MANGUN GR, 1995, OX PSYCH S, P40; Marco EJ, 2011, PEDIATR RES, V69, p48R, DOI [10.1203/PDR.0b013e3182130c54, 10.1109/SPL.2011.5782616]; MARTINEAU J, 1984, ANN NY ACAD SCI, V425, P362, DOI 10.1111/j.1749-6632.1984.tb23557.x; McCleery JP, 2010, J CHILD PSYCHOL PSYC, V51, P277, DOI 10.1111/j.1469-7610.2009.02157.x; Milne E, 2009, BIOL PSYCHIAT, V65, P22, DOI 10.1016/j.biopsych.2008.07.017; Murray MM, 2004, NEUROIMAGE, V21, P125, DOI 10.1016/j.neuroimage.2003.09.035; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Nelson CA, 2001, DEV COGN NEUROSCI, P125; Nunez PL, 2000, BRAIN TOPOGR, V13, P79, DOI 10.1023/A:1026683200895; O'Connor K, 2012, NEUROSCI BIOBEHAV R, V36, P836, DOI 10.1016/j.neubiorev.2011.11.008; Osterhout L, 1995, ELECTROPHYSIOLOGY MI; Pang EW, 2000, CLIN NEUROPHYSIOL, V111, P388, DOI 10.1016/S1388-2457(99)00259-X; Park J, 2015, J SPEECH LANG HEAR R, V58, P954, DOI 10.1044/2015_JSLHR-L-14-0092; Pascalis O, 1998, J EXP PSYCHOL LEARN, V24, P249, DOI 10.1037/0278-7393.24.1.249; Pereyra JFS, 2005, NEUROREPORT, V16, P645, DOI 10.1097/00001756-200504250-00026; Plesa Skwerer D, 2015, AUTISM; Port Russell G., 2015, Yale Journal of Biology and Medicine, V88, P25; Roberts TPL, 2010, AUTISM RES, V3, P8, DOI 10.1002/aur.111; Roesler CP, 2013, COMMUN DISORD Q, V35, P14, DOI 10.1177/1525740113489167; Russo N, 2012, NEUROPSYCHOLOGIA, V50, P2131, DOI 10.1016/j.neuropsychologia.2012.05.003; Schcrg M, 1989, J COGNITIVE NEUROSCI, V1, P336, DOI [10.1162/jocn.1989.1.4.336, DOI 10.1162/JOCN.1989.1.4.336]; Shafer VL, 2015, INT J PSYCHOPHYSIOL, V95, P77, DOI 10.1016/j.ijpsycho.2014.08.1390; Shafer VL, 2011, CLIN NEUROPHYSIOL, V122, P1137, DOI 10.1016/j.clinph.2010.10.046; Silva-Pereyra J, 2005, COGNITIVE BRAIN RES, V23, P247, DOI 10.1016/j.cogbrainres.2004.10.015; Sokhadze E, 2009, APPL PSYCHOPHYS BIOF, V34, P37, DOI 10.1007/s10484-009-9074-5; Sussman ES, 2011, DEV COGN NEUROS-NETH, V1, P351, DOI 10.1016/j.dcn.2011.01.003; Tager-Flusberg H, 2000, METHODS FOR STUDYING LANGUAGE PRODUCTION, P313; Tager-Flusberg H., 2005, HDB AUTISM PERVASIVE, V3rd, P335; Tager-Flusberg H, 2013, AUTISM RES, V6, P468, DOI 10.1002/aur.1329; Tecchio F, 2003, BIOL PSYCHIAT, V54, P647, DOI 10.1016/S0006-3223(03)00295-6; Torkildsen JV, 2006, J NEUROLINGUIST, V19, P431, DOI 10.1016/j.jneuroling.2006.01.002; Vandenbroucke MWG, 2008, BRAIN, V131, P1013, DOI 10.1093/brain/awm321; Visser M, 2010, J COGNITIVE NEUROSCI, V22, P1083, DOI 10.1162/jocn.2009.21309; Werker JF, 2005, DEV PSYCHOBIOL, V46, P233, DOI 10.1002/dev.20060	86	31	31	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161637	10.1371/journal.pone.0161637	http://dx.doi.org/10.1371/journal.pone.0161637			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU5NN	27560378	Green Published, gold			2022-12-26	WOS:000382258600070
J	Chodur, GM; Shen, Y; Kodish, S; Oddo, VM; Antiporta, DA; Jock, B; Jones-Smith, JC				Chodur, Gwen M.; Shen, Ye; Kodish, Stephen; Oddo, Vanessa M.; Antiporta, Daniel A.; Jock, Brittany; Jones-Smith, Jessica C.			Food Environments around American Indian Reservations: A Mixed Methods Study	PLOS ONE			English	Article							SUPERMARKETS; ACCESS; ACCESSIBILITY; AVAILABILITY; COMMUNITIES; OBESITY; COST	Objectives To describe the food environments experienced by American Indians living on tribal lands in California. Methods Geocoded statewide food business data were used to define and categorize existing food vendors into healthy, unhealthy, and intermediate composite categories. Distance to and density of each of the composite food vendor categories for tribal lands and nontribal lands were compared using multivariate linear regression. Quantitative results were concurrently triangulated with qualitative data from in-depth interviews with tribal members (n = 24). Results After adjusting for census tract-level urbanicity and per capita income, results indicate there were significantly fewer healthy food outlets per square mile for tribal areas compared to non-tribal areas. Density of unhealthy outlets was not significantly different for tribal versus non-tribal areas. Tribal members perceived their food environment negatively and reported barriers to the acquisition of healthy food. Conclusions Urbanicity and per capita income do not completely account for disparities in food environments among American Indians tribal lands compared to nontribal lands. This disparity in access to healthy food may present a barrier to acting on the intention to consume healthy food.	[Chodur, Gwen M.; Shen, Ye; Oddo, Vanessa M.; Jones-Smith, Jessica C.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Human Nutr, Dept Int Hlth, Baltimore, MD 21205 USA; [Kodish, Stephen] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Antiporta, Daniel A.; Jones-Smith, Jessica C.] Johns Hopkins Bloomberg Sch Publ Hlth, Global Obes Prevent Ctr, Baltimore, MD USA; [Jock, Brittany] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Social & Behav Intervent, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Shen, Y (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Human Nutr, Dept Int Hlth, Baltimore, MD 21205 USA.	yshen33@jhu.edu	Chodur, Gwen/J-5767-2019	Chodur, Gwen/0000-0003-1866-8319; Jock, Brittany/0000-0002-3321-7463; Shen, Ye/0000-0003-3410-6762; Jones-Smith, Jessica/0000-0001-8962-1695	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development [4R00HD073327, U54HD070725]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD073327, U54HD070725] Funding Source: NIH RePORTER	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (https://www.nichd.nih.gov/Pages/index.aspx) Grant 4R00HD073327 and U54HD070725. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aggarwal A, 2014, AM J PUBLIC HEALTH, V104, P917, DOI 10.2105/AJPH.2013.301763; [Anonymous], 2015, 2014 BEHAV RISK FACT; Barnes TL, 2015, PUBLIC HEALTH NUTR, V2, P1; Bauer KW, 2012, AM J PUBLIC HEALTH, V102, P1346, DOI 10.2105/AJPH.2011.300522; Belasco EJ, 2014, APPL HEALTH ECON HEA, V12, P461, DOI 10.1007/s40258-014-0099-4; Bernard H.R., 2006, RES METHODS ANTHR, V4th; Christian WJ, 2012, SPAT SPATIO-TEMPORAL, V3, P287, DOI 10.1016/j.sste.2012.09.001; Christine PJ, 2015, JAMA INTERN MED, V175, P1311, DOI 10.1001/jamainternmed.2015.2691; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Crabtree BF, 1992, DOING QUALITATIVE RE; Creswell J. W., 2007, QUALITATIVE INQUIRY; Creswell JW, 2009, MIXED METHODS PROCED, P203; De Vries H, 2008, FIELD METHOD, V20, P272, DOI 10.1177/1525822X08317166; Drewnowski Adam, 2012, Am J Public Health, V102, pe74, DOI 10.2105/AJPH.2012.300660; Glaser Barney G., 1967, DISCOV GROUNDED THEO; Hardin-Fanning F, 2015, HEALTH PROMOT PRACT, V16, P383, DOI 10.1177/1524839914554454; Hruschka D., 2004, FIELD METHOD, V16, P307, DOI [10.1177/1525822X04266540, DOI 10.1177/1525822X04266540]; Jernigan VBB, 2012, HEALTH EDUC RES, V27, P645, DOI 10.1093/her/cyr089; Kwate NOA, 2009, HEALTH PLACE, V15, P364, DOI 10.1016/j.healthplace.2008.07.003; Lamichhane AP, 2013, HEALTH PLACE, V23, P157, DOI 10.1016/j.healthplace.2013.07.002; Larson NI, 2009, AM J PREV MED, V36, P74, DOI 10.1016/j.amepre.2008.09.025; MacPhail C, 2016, QUAL RES, V16, P198, DOI 10.1177/1468794115577012; MacQueen K.M., 1998, CAM J, V10, P31, DOI [10.1177/1525822X980100020301, DOI 10.1177/1525822X980100020301, 10.1177/1525822x980100020301]; Maxwell J., 2004, QUALITATIVE RES DESI, DOI DOI 10.1177/1094428106290193; Morgan D.L, 1996, FOCUS GROUPS QUALITA; Mullany B, 2013, PUBLIC HEALTH NUTR, V16, P752, DOI 10.1017/S136898001200300X; Norris Tina., 2012, AM INDIAN ALASKA NAT; O'Connell M, 2011, J AM DIET ASSOC, V111, P1375, DOI 10.1016/j.jada.2011.06.002; Pan LP, 2015, AM J PREV MED, V48, P570, DOI 10.1016/j.amepre.2014.11.009; Parry I., 2012, 14 OXCARRE; Powell LM, 2007, PREV MED, V44, P189, DOI 10.1016/j.ypmed.2006.08.008; Richardson AS, 2014, HEALTH PLACE, V30, P145, DOI 10.1016/j.healthplace.2014.08.011; Rose D, 2010, J NUTR, V140, P1170, DOI 10.3945/jn.109.113159; Rundle A, 2009, ENVIRON HEALTH PERSP, V117, P442, DOI 10.1289/ehp.11590; Sandelowski M, 2000, RES NURS HEALTH, V23, P246, DOI 10.1002/1098-240X(200006)23:3<246::AID-NUR9>3.0.CO;2-H; Sawchuk CN, 2011, PREV CHRONIC DIS, V8; Singh GK, 2010, ANN EPIDEMIOL, V20, P40, DOI 10.1016/j.annepidem.2009.09.008; Slagle A., 1989, AM INDIAN Q, V13, P325, DOI DOI 10.2307/1184519; Thompson C, 2004, INT J NURS STUD, V41, P15, DOI 10.1016/j.ijnurstu.2003.03.001; US Census Bureau, 2010, GEOGR TERMS CONC TRI; Zenk SN, 2014, AM J PUBLIC HEALTH, V104, P2170, DOI 10.2105/AJPH.2014.302113; Zenk SN, 2005, AM J PUBLIC HEALTH, V95, P660, DOI 10.2105/AJPH.2004.042150	42	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161132	10.1371/journal.pone.0161132	http://dx.doi.org/10.1371/journal.pone.0161132			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU5NN	27560132	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258600028
J	Clausen, TD; Bergholt, T; Bouaziz, O; Arpi, M; Eriksson, F; Rasmussen, S; Keiding, N; Lokkegaard, EC				Clausen, Tine D.; Bergholt, Thomas; Bouaziz, Olivier; Arpi, Magnus; Eriksson, Frank; Rasmussen, Steen; Keiding, Niels; Lokkegaard, Ellen C.			Broad-Spectrum Antibiotic Treatment and Subsequent Childhood Type 1 Diabetes: A Nationwide Danish Cohort Study	PLOS ONE			English	Article							CESAREAN-SECTION; NO ASSOCIATION; INCREASED RISK; EARLY-LIFE; INFECTIONS; MICROBIOTA; MORTALITY; REGISTER; MELLITUS; DELIVERY	Background Studies link antibiotic treatment and delivery by cesarean section with increased risk of chronic diseases through changes of the gut-microbiota. We aimed to evaluate the association of broad-spectrum antibiotic treatment during the first two years of life with subsequent onset of childhood type 1 diabetes and the potential effect-modification by mode of delivery. Materials and Methods A Danish nationwide cohort study including all singletons born during 1997-2010. End of follow-up by December 2012. Four national registers provided information on antibiotic redemptions, outcome and confounders. Redemptions of antibiotic prescriptions during the first two years of life was classified into narrow-spectrum or broad-spectrum antibiotics. Children were followed from age two to fourteen, both inclusive. The risk of type 1 diabetes with onset before the age of 15 years was assessed by Cox regression. A total of 858,201 singletons contributed 5,906,069 person-years, during which 1,503 children developed type 1 diabetes. Results Redemption of broad-spectrum antibiotics during the first two years of life was associated with an increased rate of type 1 diabetes during the following 13 years of life (HR 1.13; 95% CI 1.02 to 1.25), however, the rate was modified by mode of delivery. Broad-spectrum antibiotics were associated with an increased rate of type 1 diabetes in children delivered by either intrapartum cesarean section (HR 1.70; 95% CI 1.15 to 2.51) or prelabor cesarean section (HR 1.63; 95% CI 1.11 to 2.39), but not in vaginally delivered children. Number needed to harm was 433 and 562, respectively. The association with broad-spectrum antibiotics was not modified by parity, genetic predisposition or maternal redemption of antibiotics during pregnancy or lactation. Conclusions Redemption of broad-spectrum antibiotics during infancy is associated with an increased risk of childhood type 1 diabetes in children delivered by cesarean section.	[Clausen, Tine D.; Lokkegaard, Ellen C.] Univ Copenhagen, Dept Gynecol & Obstet, Nordsjaellands Hosp, Hillerod, Denmark; [Bergholt, Thomas] Univ Copenhagen, Dept Obstet, Rigshosp, Copenhagen OE, Denmark; [Bouaziz, Olivier; Eriksson, Frank; Keiding, Niels] Univ Copenhagen, Dept Publ Hlth, Biostat Sect, Copenhagen K, Denmark; [Bouaziz, Olivier] Univ Paris 05, Lab MAP5, Paris, France; [Bouaziz, Olivier] Sorbonne Paris Cite, CNRS, Paris, France; [Arpi, Magnus] Univ Copenhagen, Herlev Hosp, Dept Clin Microbiol, Herlev, Denmark; [Rasmussen, Steen] Univ Copenhagen, Hvidovre Hosp, Dept Clin Microbiol, Hvidovre, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen	Clausen, TD (corresponding author), Univ Copenhagen, Dept Gynecol & Obstet, Nordsjaellands Hosp, Hillerod, Denmark.	tine.dalsgaard.clausen@dadlnet.dk	Clausen, Tine Dalsgaard/X-3720-2019; Bouaziz, Olivier/ABG-9841-2020; Bergholt, Thomas/J-4130-2013	Bouaziz, Olivier/0000-0003-3556-9531; Bergholt, Thomas/0000-0002-7284-6094; Clausen, Tine Dalsgaard/0000-0001-5585-2153; Lokkegaard, Ellen/0000-0003-4149-5663	Nordsjaellands Hospital, Hillerod, Denmark [473]	Nordsjaellands Hospital, Hillerod, Denmark	TDC received funding from Nordsjaellands Hospital, Hillerod, Denmark, Grant number 473 (https://www.nordsjaellandshospital.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar Jacques, 1997, Clin Microbiol Infect, V3, P395, DOI 10.1111/j.1469-0691.1997.tb00274.x; Andersen TF, 1999, DAN MED BULL, V46, P263; Bailey LC, 2014, JAMA PEDIATR, V168, P1063, DOI 10.1001/jamapediatrics.2014.1539; Brugman S, 2006, DIABETOLOGIA, V49, P2105, DOI 10.1007/s00125-006-0334-0; Cardwell CR, 2008, DIABETOLOGIA, V51, P726, DOI 10.1007/s00125-008-0941-z; Cardwell CR, 2008, DIABETIC MED, V25, P261, DOI 10.1111/j.1464-5491.2007.02351.x; Clausen TD, 2016, EPIDEMIOLOGY, V27, P547, DOI 10.1097/EDE.0000000000000488; Farsani SF, 2014, ANTIMICROB AGENTS CH, V58, P4666, DOI 10.1128/AAC.03080-14; Hansen CHF, 2012, DIABETOLOGIA, V55, P2285, DOI 10.1007/s00125-012-2564-7; Hviid A, 2009, AM J EPIDEMIOL, V169, P1079, DOI 10.1093/aje/kwp038; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Khashan AS, 2014, PEDIATRICS, V134, pE806, DOI 10.1542/peds.2014-0819; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kilkkinen A, 2006, DIABETOLOGIA, V49, P66, DOI 10.1007/s00125-005-0078-2; Knudsen LB, 1998, DAN MED BULL, V45, P221; Knudsen LB, 1998, DAN MED BULL, V45, P320; Kronman MP, 2014, PEDIATRICS, V134, pE956, DOI 10.1542/peds.2014-0605; Laubender RP, 2010, STAT MED, V29, P851, DOI 10.1002/sim.3793; Lind M, 2014, NEW ENGL J MED, V371, P1972, DOI 10.1056/NEJMoa1408214; Muller LMAJ, 2005, CLIN INFECT DIS, V41, P281, DOI 10.1086/431587; Nielsen G L, 1996, J Med Syst, V20, P1, DOI 10.1007/BF02260869; Pedersen CB, 2006, DAN MED BULL, V53, P441; Salminen S, 2004, GUT, V53, P1388, DOI 10.1136/gut.2004.041640; Sanchez GV, 2014, EMERG INFECT DIS, V20, P2041, DOI 10.3201/eid2012.140331; Sevelsted A, 2015, PEDIATRICS, V135, pE92, DOI 10.1542/peds.2014-0596; Stene LC, 2012, CLIN EXP IMMUNOL, V168, P12, DOI 10.1111/j.1365-2249.2011.04555.x; Stene LC, 2003, PEDIATR RES, V54, P487, DOI 10.1203/01.PDR.0000081301.25600.5D; Svensson Jannet, 2007, Ugeskr Laeger, V169, P122; Thysen AH, 2015, J ALLERGY CLIN IMMUN; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Vaarala Outi, 2012, Rev Diabet Stud, V9, P251, DOI 10.1900/RDS.2012.9.251; van Saene Rick, 1998, Clin Microbiol Infect, V4, P56; Vangay P, 2015, CELL HOST MICROBE, V17, P553, DOI 10.1016/j.chom.2015.04.006; WEINSTEIN L, 1977, MT SINAI J MED, V44, P100; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Ye J, 2016, BJOG-INT J OBSTET GY, V123, P745, DOI 10.1111/1471-0528.13592	36	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161654	10.1371/journal.pone.0161654	http://dx.doi.org/10.1371/journal.pone.0161654			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560963	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258600075
J	Colmorn, LB; Krebs, L; Langhoff-Roos, J				Colmorn, Lotte Berdiin; Krebs, Lone; Langhoff-Roos, Jens		NOSS Study Grp	Potentially Avoidable Peripartum Hysterectomies in Denmark: A Population Based Clinical Audit	PLOS ONE			English	Article							COMPRESSION SUTURE; CESAREAN DELIVERY; UTERINE SANDWICH; UK	Objective To audit the clinical management preceding peripartum hysterectomy and evaluate if peripartum hysterectomies are potentially avoidable and by which means. Material and Methods We developed a structured audit form based on explicit criteria for the minimal mandatory management of the specific types of pregnancy and delivery complications leading to peripartum hysterectomy. We evaluated medical records of the 50 Danish women with peripartum hysterectomy identified in the Nordic Obstetric Surveillance Study 2009-2012 and made short narratives of all cases. Results The most frequent indication for hysterectomy was hemorrhage. The two main initial causes were abnormally invasive placenta (26%) and lacerations (26%). Primary atony was third and occurred in 20%. Before hysterectomy another 26% had secondary atony following complications such as lacerations, retained placental tissue or coagulation defects. Of the 50 cases, 24% were assessed to be avoidable and 30% potentially avoidable. Hysterectomy following primary and secondary atony was assessed to be avoidable in 4/10 and 4/13 cases, respectively. Early sufficient suturing of lacerations and uterine ruptures, as well as a more widespread use of intrauterine balloons alone or in combination with uterine compression sutures (the sandwich model), could presumably have prevented about one fourth of the peripartum hysterectomies. Conclusion More than 50% of peripartum hysterectomies seem to be avoidable by simple measures. In order to minimize the number of unnecessary peripartum hysterectomies, obstetricians and anesthesiologists should investigate individual cases by structured clinical audit, and disseminate and discuss the results for educational purposes. An international collaboration is warranted to strengthen our recommendations and reveal if they are generally applicable.	[Colmorn, Lotte Berdiin; Langhoff-Roos, Jens] Univ Copenhagen, Copenhagen Univ Hosp, Rigshosp, Dept Obstet, Copenhagen, Denmark; [Krebs, Lone] Univ Copenhagen, Holbaek Hosp, Dept Obstet & Gynecol, Holbaek, Denmark	Rigshospitalet; University of Copenhagen; Holbaek Hospital; University of Copenhagen	Colmorn, LB (corresponding author), Univ Copenhagen, Copenhagen Univ Hosp, Rigshosp, Dept Obstet, Copenhagen, Denmark.	Lotte.Berdiin.Colmorn@regionh.dk	Krebs, Lone/AAD-8273-2021	Krebs, Lone/0000-0001-5433-4776; Thurn, Lars/0000-0001-9813-029X	TRYGFonden [7-12-0170]; Nordic Federation of societies of Obstetrics and Gynecology [NF1203, NF12035, NF13035]	TRYGFonden; Nordic Federation of societies of Obstetrics and Gynecology	The work was supported by the following: TRYGFonden, www.TRYGFonden.dk. Jnr 7-12-0170; LBC; The Nordic Federation of societies of Obstetrics and Gynecology, www.NFOG.ord; NF1203, NF12035, NF13035; LBC LK JLR KBP AMT MJ PL PB IR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergsjo P, 2003, ACTA OBSTET GYN SCAN, V82, P780, DOI 10.1034/j.1600-0412.2003.00224.x; Brennan DJ, 2015, ACTA OBSTET GYN SCAN, V94, P1380, DOI 10.1111/aogs.12768; Dahlke JD, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.02.023; Glaze S, 2008, OBSTET GYNECOL, V111, P732, DOI 10.1097/AOG.0b013e31816569f2; Jakobsson M, 2015, ACTA OBSTET GYN SCAN, V94, P745, DOI 10.1111/aogs.12644; Knight M, 2007, BJOG-INT J OBSTET GY, V114, P1380, DOI 10.1111/j.1471-0528.2007.01507.x; Knight M, 2014, BJOG-INT J OBSTET GY, V121, P112, DOI 10.1111/1471-0528.12802; Knight M, 2008, OBSTET GYNECOL, V111, P97, DOI 10.1097/01.AOG.0000296658.83240.6d; Knight M, 2014, ACTA OBSTET GYN SCAN, V93, P127, DOI 10.1111/aogs.12316; Krebs L, 2002, J PERINAT MED, V30, P220, DOI 10.1515/JPM.2002.030; Kwee A, 2006, EUR J OBSTET GYN R B, V124, P187, DOI 10.1016/j.ejogrb.2005.06.012; Melman S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145771; Nelson WL, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.10.887; Richardus J H, 2003, J Matern Fetal Neonatal Med, V14, P267, DOI 10.1080/713606659; Stivanello E, 2010, ACTA OBSTET GYN SCAN, V89, P321, DOI 10.3109/00016340903508627; Whiteman MK, 2006, OBSTET GYNECOL, V108, P1486, DOI 10.1097/01.AOG.0000245445.36116.c6; Yoong W, 2012, ACTA OBSTET GYN SCAN, V91, P147, DOI 10.1111/j.1600-0412.2011.01153.x; Zwart JJ, 2010, AM J OBSTET GYNECOL, V150, pe 151	18	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161302	10.1371/journal.pone.0161302	http://dx.doi.org/10.1371/journal.pone.0161302			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560802	Green Submitted, Green Published, gold			2022-12-26	WOS:000382258600033
J	Geertsen, SS; Thomas, R; Larsen, MN; Dahn, IM; Andersen, JN; Krause-Jensen, M; Korup, V; Nielsen, CM; Wienecke, J; Ritz, C; Krustrup, P; Lundbye-Jensen, J				Geertsen, Svend Sparre; Thomas, Richard; Larsen, Malte Nejst; Dahn, Ida Marie; Andersen, Josefine Needham; Krause-Jensen, Matilde; Korup, Vibeke; Nielsen, Claus Malta; Wienecke, Jacob; Ritz, Christian; Krustrup, Peter; Lundbye-Jensen, Jesper			Motor Skills and Exercise Capacity Are Associated with Objective Measures of Cognitive Functions and Academic Performance in Preadolescent Children	PLOS ONE			English	Article							AEROBIC FITNESS; PHYSICAL-ACTIVITY; ACHIEVEMENT; SCHOOL; BRAIN	Objective To investigate associations between motor skills, exercise capacity and cognitive functions, and evaluate how they correlate to academic performance in mathematics and reading comprehension using standardised, objective tests. Methods This cross-sectional study included 423 Danish children (age: 9.29 +/- 0.35 years, 209 girls). Fine and gross motor skills were evaluated in a visuomotor accuracy-tracking task, and a whole-body coordination task, respectively. Exercise capacity was estimated from the YoYo intermittent recovery level 1 children's test (YYIR1C). Selected tests from the Cambridge Neuropsychological Test Automated Battery (CANTAB) were used to assess different domains of cognitive functions, including sustained attention, spatial working memory, episodic and semantic memory, and processing speed. Linear mixed-effects models were used to investigate associations between these measures and the relationship with standard tests of academic performance in mathematics and reading comprehension. Results Both fine and gross motor skills were associated with better performance in all five tested cognitive domains (all P<0.001), whereas exercise capacity was only associated with better sustained attention (P<0.046) and spatial working memory (P<0.038). Fine and gross motor skills (all P<0.001), exercise capacity and cognitive functions such as working memory, episodic memory, sustained attention and processing speed were all associated with better performance in mathematics and reading comprehension. Conclusions The data demonstrate that fine and gross motor skills are positively correlated with several aspects of cognitive functions and with academic performance in both mathematics and reading comprehension. Moreover, exercise capacity was associated with academic performance and performance in some cognitive domains. Future interventions should investigate associations between changes in motor skills, exercise capacity, cognitive functions, and academic performance to elucidate the causality of these associations.	[Geertsen, Svend Sparre; Thomas, Richard; Larsen, Malte Nejst; Dahn, Ida Marie; Andersen, Josefine Needham; Krause-Jensen, Matilde; Korup, Vibeke; Wienecke, Jacob; Ritz, Christian; Krustrup, Peter; Lundbye-Jensen, Jesper] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Geertsen, Svend Sparre; Thomas, Richard; Wienecke, Jacob; Lundbye-Jensen, Jesper] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Geertsen, Svend Sparre; Thomas, Richard; Larsen, Malte Nejst; Nielsen, Claus Malta; Krustrup, Peter; Lundbye-Jensen, Jesper] Univ Copenhagen, Copenhagen Ctr Team Sport & Hlth, Copenhagen, Denmark; [Nielsen, Claus Malta] Frederikssund Municipal, Frederikssund, Denmark; [Krustrup, Peter] Univ Exeter, Coll Life & Environm Sci, Sport & Hlth Sci, Exeter, Devon, England	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Exeter	Geertsen, SS (corresponding author), Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark.; Geertsen, SS (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark.; Geertsen, SS (corresponding author), Univ Copenhagen, Copenhagen Ctr Team Sport & Hlth, Copenhagen, Denmark.	ssgeertsen@nexs.ku.dk	Lundbye-Jensen, Jesper/ABH-4025-2020; Geertsen, Svend/ABG-6254-2020; Krustrup, Peter/D-2659-2019; Krause-Jensen, Dorte/J-5666-2013; Ritz, Christian/P-6159-2014	Lundbye-Jensen, Jesper/0000-0003-3144-861X; Geertsen, Svend/0000-0003-4497-3616; Krustrup, Peter/0000-0002-1461-9838; Krause-Jensen, Dorte/0000-0001-9792-256X; Wienecke, Jacob/0000-0001-9786-4689; Ritz, Christian/0000-0002-5095-0624	Nordea-fonden [02-2011-4360]; FIFA Medical Assessment and Research Centre (F-MARC) [31964]; Danish Football Association (DBU) [31964]; Danish Ministry of Culture [1045171001]; Aase and Ejnar Danielsens Foundation [1047491001]; Augustinus Fonden [1042861001]; Frederikssund Municipality	Nordea-fonden; FIFA Medical Assessment and Research Centre (F-MARC); Danish Football Association (DBU); Danish Ministry of Culture; Aase and Ejnar Danielsens Foundation; Augustinus Fonden; Frederikssund Municipality	This project was supported by a grant from Nordea-fonden 02-2011-4360 nordeafonden.dk/english, the FIFA Medical Assessment and Research Centre (F-MARC) 31964 www.f-marc.com, the Danish Football Association (DBU) 31964 www.dbu.dk, the Danish Ministry of Culture 1045171001 english.kum.dk, Aase and Ejnar Danielsens Foundation 1047491001 www.danielsensfond.dk and Augustinus Fonden 1042861001 www.augustinusfonden.dk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the participating pupils, teachers and schools in Frederikssund and Copenhagen for their contribution, as well as Frederikssund Municipality for collaboration and support.	Aberg MAI, 2009, P NATL ACAD SCI USA, V106, P20906, DOI 10.1073/pnas.0905307106; Ahler T, 2012, EUR J APPL PHYSIOL, V112, P871, DOI 10.1007/s00421-011-2039-4; Bates D, 2014, ARXIV14065823; CANTAB, 2012, CANTABECLIPSE 5 TEST; Castelli DM, 2007, J SPORT EXERCISE PSY, V29, P239, DOI 10.1123/jsep.29.2.239; Censor N, 2012, NAT REV NEUROSCI, V13, P658, DOI 10.1038/nrn3315; Chaddock L, 2012, J SPORT SCI, V30, P421, DOI 10.1080/02640414.2011.647706; Chaddock L, 2010, BRAIN RES, V1358, P172, DOI 10.1016/j.brainres.2010.08.049; Diamond A, 2000, CHILD DEV, V71, P44, DOI 10.1111/1467-8624.00117; Donnelly JE, 2016, MED SCI SPORT EXER, V48, P1197, DOI 10.1249/MSS.0000000000000901; Eadie BD, 2005, J COMP NEUROL, V486, P39, DOI 10.1002/cne.20493; Ericsson I, 2014, SCAND J MED SCI SPOR, V24, P273, DOI 10.1111/j.1600-0838.2012.01458.x; Essendrop M, 1997, BALANCE COORDINATION; Grissmer D, 2010, DEV PSYCHOL, V46, P1008, DOI 10.1037/a0020104; Haapala EA, 2014, MED SCI SPORT EXER, V46, P1016, DOI 10.1249/MSS.0000000000000186; Hansen KF, 2012, MG FG 3 MATEMATIK GR; Hillman CH, 2005, MED SCI SPORT EXER, V37, P1967, DOI 10.1249/01.mss.0000176680.79702.ce; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hillman CH, 2014, PEDIATRICS, V134, pE1063, DOI 10.1542/peds.2013-3219; Hillman CH, 2009, DEV PSYCHOL, V45, P114, DOI 10.1037/a0014437; Huang T, 2015, J PEDIATR-US, V167, P810, DOI 10.1016/j.jpeds.2015.07.009; Kantomaaa MT, 2013, P NATL ACAD SCI USA, V110, P1917, DOI 10.1073/pnas.1214574110; Luciana M, 2002, DEV NEUROPSYCHOL, V22, P595, DOI 10.1207/S15326942DN2203_3; Moller L, 2012, VEJLEDNING SAETNINGS; PAIVIO A, 1968, J EXP PSYCHOL, V76, P1, DOI 10.1037/h0025327; Pesce C., 2009, MENT HEALTH PHYS ACT, V2, P16, DOI [10.1016/j.mhpa.2009.02.001, DOI 10.1016/J.MHPA.2009.02.001]; Pontifex MB, 2011, J COGNITIVE NEUROSCI, V23, P1332, DOI 10.1162/jocn.2010.21528; Riggs MR, 2008, J WILDLIFE MANAGE, V72, P34, DOI 10.2193/2007-315; Robertson EM, 2012, CURR BIOL, V22, pR66, DOI 10.1016/j.cub.2011.11.051; Roig M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044594; TANNER JM, 1986, CLIN ENDOCRINOL META, V15, P411, DOI 10.1016/S0300-595X(86)80005-6; Thomas R, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6205452; Tomporowski PD, 2008, EDUC PSYCHOL REV, V20, P111, DOI 10.1007/s10648-007-9057-0; US Department of Health and Human Services, 2008 PHYS ACT GUID A; Van Dusen DP, 2011, J SCHOOL HEALTH, V81, P733, DOI 10.1111/j.1746-1561.2011.00652.x; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; WORLD HEALTH ORGANIZATION (WHO), GLOB STRAT DIET PHYS	37	61	63	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161960	10.1371/journal.pone.0161960	http://dx.doi.org/10.1371/journal.pone.0161960			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU5NN	27560512	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258600121
J	Hashimoto, S; Yamamoto, S; Ogasawara, N; Sato, T; Yamamoto, K; Katoh, H; Kubota, T; Shiraishi, T; Kojima, T; Himi, T; Tsutsumi, H; Yokota, S				Hashimoto, Shin; Yamamoto, Soh; Ogasawara, Noriko; Sato, Toyotaka; Yamamoto, Keisuke; Katoh, Hiroshi; Kubota, Toru; Shiraishi, Tsukasa; Kojima, Takashi; Himi, Tetsuo; Tsutsumi, Hiroyuki; Yokota, Shin-ichi			Mumps Virus Induces Protein-Kinase-R-Dependent Stress Granules, Partly Suppressing Type III Interferon Production	PLOS ONE			English	Article							HEPATITIS-C VIRUS; FACTOR 2-ALPHA KINASE; DOUBLE-STRANDED-RNA; MESSENGER-RNA; V-PROTEIN; TRANSCRIPTION FACTORS; VIRAL REPLICATION; MOLECULAR-CLONING; IMMUNE-RESPONSES; INNATE IMMUNITY	Stress granules (SGs) are cytoplasmic granular aggregations that are induced by cellular stress, including viral infection. SGs have opposing antiviral and proviral roles, which depend on virus species. The exact function of SGs during viral infection is not fully understood. Here, we showed that mumps virus (MuV) induced SGs depending on activation of protein kinase R (PKR). MuV infection strongly induced interferon (IFN)-lambda 1, 2 and 3, and IFN-beta through activation of IFN regulatory factor 3 (IRF3) via retinoic acid inducible gene-I (RIG-I) and the mitochondrial antiviral signaling (MAVS) pathway. MuV-induced IFNs were strongly upregulated in PKR-knockdown cells. MuV-induced SG formation was suppressed by knockdown of PKR and SG marker proteins, Ras-GTPase-activating protein SH3-domain-binding protein 1 and T-cell-restricted intracellular antigen-1, and significantly increased the levels of MuV-induced IFN-lambda 1. However, viral titer was not altered by suppression of SG formation. PKR was required for induction of SGs by MuV infection and regulated type III IFN (IFN-lambda 1) mRNA stability. MuV-induced SGs partly suppressed type III IFN production by MuV; however, the limited suppression was not sufficient to inhibit MuV replication in cell culture. Our results provide insight into the relationship between SGs and IFN production induced by MuV infection.	[Hashimoto, Shin; Shiraishi, Tsukasa; Tsutsumi, Hiroyuki] Sapporo Med Univ, Sch Med, Dept Pediat, Sapporo, Hokkaido, Japan; [Yamamoto, Soh; Ogasawara, Noriko; Sato, Toyotaka; Yokota, Shin-ichi] Sapporo Med Univ, Sch Med, Dept Microbiol, Sapporo, Hokkaido, Japan; [Ogasawara, Noriko; Yamamoto, Keisuke; Himi, Tetsuo] Sapporo Med Univ, Sch Med, Dept Otorhinolaryngol, Sapporo, Hokkaido, Japan; [Katoh, Hiroshi; Kubota, Toru] Natl Inst Infect Dis, Dept Virol 3, Tokyo, Japan; [Kojima, Takashi] Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Cell Sci, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; National Institute of Infectious Diseases (NIID); Sapporo Medical University	Yamamoto, S (corresponding author), Sapporo Med Univ, Sch Med, Dept Microbiol, Sapporo, Hokkaido, Japan.	sohyama@sapmed.ac.jp	Ogasawara, Noriko/ABE-5531-2021; Yokota, Shin-ichi/K-8139-2019; Ogasawara, Noriko/K-6453-2019; Sato, Toyotaka/J-4685-2019	Yokota, Shin-ichi/0000-0002-0831-3429; Ogasawara, Noriko/0000-0002-6014-3607; 	GSK Japan Research Grant;  [25861574];  [26293370];  [26670746];  [16K20266];  [15H06521];  [15k08350]; Grants-in-Aid for Scientific Research [16K19146] Funding Source: KAKEN	GSK Japan Research Grant; ; ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	N. O. was supported by a Grant-in-Aid for Young Scientists (B) (25861574) and GSK Japan Research Grant 2015. H. T. was supported by a Grant-in-Aid for Scientific Research (B) (26293370) and Challenging Exploratory Research (26670746). T. Kojima was supported by a Grant-in-Aid for Scientific Research (C) (15k08350). K. Y. was supported by a Grant-in-Aid for Young Scientists (B) (16K20266). T. Sato was supported by a Grant-in-Aid for Young Scientists (start-up) (15H06521). None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; NO was supported by a Grant-in-Aid for Young Scientists (B) (25861574). HT was supported by a Grant-in-Aid for Scientific Research (B) (26293370) and Challenging Exploratory Research (26670746). KY was supported by a Grant-in-Aid for Young Scientists (B) (16K20266). TK was supported by a Grant-in-Aid for Scientific Research (C) (15k08350). TS was supported by a Grant-in-Aid for Young Scientists (start-up) (15H06521). NO was supported by GSK Japan Research Grant 2015. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; Bounedjah O, 2014, NUCLEIC ACIDS RES, V42, P8678, DOI 10.1093/nar/gku582; Buchan JR, 2014, RNA BIOL, V11, P1019, DOI 10.4161/15476286.2014.972208; Egli A, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.51; ELANGO N, 1988, J GEN VIROL, V69, P2893, DOI 10.1099/0022-1317-69-11-2893; Garaigorta U, 2012, J VIROL, V86, P11043, DOI 10.1128/JVI.07101-11; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Gurtler C, 2013, TRENDS MICROBIOL, V21, P413, DOI 10.1016/j.tim.2013.04.004; Herdy B, 2015, EUR J IMMUNOL, V45, P1500, DOI 10.1002/eji.201444979; Hermant P, 2014, J INNATE IMMUN, V6, P563, DOI 10.1159/000360084; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hviid A, 2008, LANCET, V371, P932, DOI 10.1016/S0140-6736(08)60419-5; Iseni F, 2002, EMBO J, V21, P5141, DOI 10.1093/emboj/cdf513; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Katoh H, 2015, J VIROL, V89, P3188, DOI 10.1128/JVI.03343-14; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Khaperskyy DA, 2012, FASEB J, V26, P1629, DOI 10.1096/fj.11-196915; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Kubota T, 2005, J VIROL, V79, P4451, DOI 10.1128/JVI.79.7.4451-4459.2005; Kubota T, 2001, BIOCHEM BIOPH RES CO, V283, P255, DOI 10.1006/bbrc.2001.4764; Lee HC, 2014, J BIOL CHEM, V289, P5310, DOI 10.1074/jbc.M113.536102; Lindcluist ME, 2011, VIROLOGY, V413, P103, DOI 10.1016/j.virol.2011.02.009; Lindquist ME, 2010, J VIROL, V84, P12274, DOI 10.1128/JVI.00260-10; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Masuda K, 2013, P NATL ACAD SCI USA, V110, P9409, DOI 10.1073/pnas.1307419110; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; Minor RAC, 2010, J INTERF CYTOK RES, V30, P263, DOI 10.1089/jir.2009.0051; Montero H, 2011, VIRUSES-BASEL, V3, P2328, DOI 10.3390/v3112328; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; Okonski KM, 2013, J VIROL, V87, P756, DOI 10.1128/JVI.02270-12; Onomoto K, 2014, TRENDS IMMUNOL, V35, P420, DOI 10.1016/j.it.2014.07.006; Onomoto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043031; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Rima BK., 1999, ENCY VIROLOGY, V2nd, P988, DOI [10.1006/rwvi.1999.0185, DOI 10.1006/RWVI.1999.0185]; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; SCHINDLER U, 1994, MOL CELL BIOL, V14, P5820, DOI 10.1128/MCB.14.9.5820; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; TAKEUCHI K, 1988, J GEN VIROL, V69, P2043, DOI 10.1099/0022-1317-69-8-2043; TAKEUCHI K, 1990, VIROLOGY, V178, P247, DOI 10.1016/0042-6822(90)90400-L; Takeuchi K, 2008, J VIROL, V82, P10102, DOI 10.1128/JVI.00599-08; Takeuchi O, 2015, EUR J IMMUNOL, V45, P1296, DOI 10.1002/eji.201545616; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; White JP, 2012, TRENDS MICROBIOL, V20, P175, DOI 10.1016/j.tim.2012.02.001; YAMADA A, 1988, VIROLOGY, V165, P268, DOI 10.1016/0042-6822(88)90681-2; Yamamoto K, 2016, PHARMACOL RES, V111, P804, DOI 10.1016/j.phrs.2016.07.033; Yokosawa N, 2002, J VIROL, V76, P12683, DOI 10.1128/JVI.76.24.12683-12690.2002; Yokota S, 1999, J BIOL CHEM, V274, P37070, DOI 10.1074/jbc.274.52.37070	54	6	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161793	10.1371/journal.pone.0161793	http://dx.doi.org/10.1371/journal.pone.0161793			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560627	gold, Green Submitted, Green Published			2022-12-26	WOS:000382258600101
J	Hotta, R; Ohira, M; Matsuura, T; Muraoka, I; Tryphonopoulos, P; Fan, J; Tekin, A; Selvaggi, G; Levi, D; Ruiz, P; Ricordi, C; Vianna, R; Ohdan, H; Waldmann, H; Tzakis, AG; Nishida, S				Hotta, Ryuichi; Ohira, Masahiro; Matsuura, Toshiharu; Muraoka, Izumi; Tryphonopoulos, Panagiotis; Fan, Ji; Tekin, Akin; Selvaggi, Gennaro; Levi, David; Ruiz, Phillip; Ricordi, Camillo; Vianna, Rodrigo; Ohdan, Hideki; Waldmann, Herman; Tzakis, Andreas G.; Nishida, Seigo			CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab Treatment	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; HEPATOCELLULAR-CARCINOMA; KUPFFER CELLS; T-CELLS; CYTOTOXICITY; FEATURES; TRAIL; ORGAN; CD52; MICE	Background T-cell depleting strategies have become an integral part of immunosuppressive regimens in organ transplantation. Alemtuzumab is a humanized monoclonal antibody against CD52, a cell-surface antigen on several immune cells. It has been suggested that lymphocyte depletion increases the risk of serious infections. However, this has not been observed with short-term alemtuzumab treatment in an organ transplant setting. For induction therapy using alemtuzumab following liver transplantation, we found that T-and B-cell numbers declined rapidly after alemtuzumab therapy; however, the natural killer (NK) cell number was sustained. NK cells are important effectors of innate immunity. Since the effects of alemtuzumab on NK cell functions, especially those of liver NK cells, are unknown, this study aimed to investigate this in detail. Methods To assess the effect of alemtuzumab on NK cells, samples were obtained from 7 organ donors and examined by flow cytometry using Annexin V and propidium iodide. Phenotypical and functional differences within subsets of NK cells with different levels of CD52 expression were determined by flow cytometry and in vitro cytotoxicity assays. Results CD52 expression on NK cells was lower than that on other lymphocyte subsets. The liver contained a large number of CD52(-) NK cells compared with the peripheral blood. In vitro treatment of liver-derived NK cells with alemtuzumab did not result in cell death. In contrast, co-incubation with alemtuzumab induced cell death in peripheral blood mononuclear cells and non-NK cells in the liver. Furthermore, CD52(-) liver NK cells were more cytotoxic and produced more IFN-gamma than CD52(+) NK cells after cytokine activation. Conclusion The liver contains a large number of CD52(-) NK cells. These cells are refractory to alemtuzumab and have robust activity. These findings indicate that CD52(-) NK cells persist and could protect against infection after alemtuzumab-based lymphocyte depletion.	[Hotta, Ryuichi; Ohira, Masahiro; Matsuura, Toshiharu; Muraoka, Izumi; Tryphonopoulos, Panagiotis; Fan, Ji; Tekin, Akin; Selvaggi, Gennaro; Levi, David; Vianna, Rodrigo; Nishida, Seigo] Univ Miami, Miller Sch Med, Dept Surg, Div Liver & Gastrointestinal Transplantat, Miami, FL 33136 USA; [Ruiz, Phillip] Univ Miami, Miller Sch Med, Dept Pathol & Surg, Miami, FL 33136 USA; [Ricordi, Camillo] Univ Miami, Miller Sch Med, Cell Transplant Ctr, Diabet Res Inst, Miami, FL 33136 USA; [Ohira, Masahiro; Ohdan, Hideki] Hiroshima Univ, Div Frontier Med Sci, Programs Biomed Res, Grad Sch Biomed Sci,Dept Surg, Hiroshima, Japan; [Waldmann, Herman] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England; [Tzakis, Andreas G.] Cleveland Clin Florida, Weston, FL USA	University of Miami; University of Miami; University of Miami; Hiroshima University; University of Oxford; Cleveland Clinic Foundation	Nishida, S (corresponding author), Univ Miami, Miller Sch Med, Dept Surg, Div Liver & Gastrointestinal Transplantat, Miami, FL 33136 USA.	snishida@med.miami.edu	Selvaggi, Gennaro/GSN-9593-2022; RICORDI, CAMILLO/AAA-4740-2019; Ohdan, Hideki/G-4719-2019	Selvaggi, Gennaro/0000-0003-4675-7095; Ohira, Masahiro/0000-0002-5433-5303; Waldmann, Herman/0000-0001-7519-6720; Ohdan, Hideki/0000-0002-9066-1288	Florida Department of Health; Bankhead-Coley Cancer Research Program [1BG-08]; JSPS [15K19893]	Florida Department of Health; Bankhead-Coley Cancer Research Program; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Florida Department of Health and the Bankhead-Coley Cancer Research Program (1BG-08), http://www.floridahealth.gov/index.html, S.N.; JSPS Grant-in-Aid for Young Scientists (B) Grant Number 15K19893, M. O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buggins AGS, 2002, BLOOD, V100, P1715, DOI 10.1182/blood.V100.5.1715.h81702001715_1715_1720; Crispe IN, 2006, IMMUNOL REV, V213, P101, DOI 10.1111/j.1600-065X.2006.00435.x; DYER MJS, 1990, LEUKEMIA LYMPHOMA, V2, P179, DOI 10.3109/10428199009053522; HALE G, 1990, TISSUE ANTIGENS, V35, P118, DOI 10.1111/j.1399-0039.1990.tb01767.x; Hu YP, 2009, IMMUNOLOGY, V128, P260, DOI 10.1111/j.1365-2567.2009.03115.x; Ishiyama K, 2006, HEPATOLOGY, V43, P362, DOI 10.1002/hep.21035; Lanier LL, 2003, CURR OPIN IMMUNOL, V15, P308, DOI 10.1016/S0952-7915(03)00039-6; Ochi M, 2004, HEPATOLOGY, V39, P1321, DOI 10.1002/hep.20204; Ohira M, 2012, CELL TRANSP IN PRESS; Ohira M, 2006, TRANSPLANTATION, V82, P1712, DOI 10.1097/01.tp.0000250935.41034.2d; Ohira M, 2009, J CLIN INVEST, V119, P3226, DOI 10.1172/JCI38374; Rao SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039416; Sageshima J, 2011, TRANSPL IMMUNOL, V25, P104, DOI 10.1016/j.trim.2011.07.002; Seki S, 2000, IMMUNOL REV, V174, P35, DOI 10.1034/j.1600-0528.2002.017404.x; Shi FD, 2011, NAT REV IMMUNOL, V11, P658, DOI 10.1038/nri3065; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Takahashi M, 1996, J IMMUNOL, V156, P2436; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Upadhyay K, 2012, PEDIATR TRANSPLANT, V16, P286, DOI 10.1111/j.1399-3046.2011.01615.x	19	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161618	10.1371/journal.pone.0161618	http://dx.doi.org/10.1371/journal.pone.0161618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560943	gold, Green Published, Green Submitted			2022-12-26	WOS:000382258600064
J	Mukumbang, FC; van Belle, S; Marchal, B; van Wyk, B				Mukumbang, Ferdinand C.; van Belle, Sara; Marchal, Bruno; van Wyk, Brian			Towards Developing an Initial Programme Theory: Programme Designers and Managers Assumptions on the Antiretroviral Treatment Adherence Club Programme in Primary Health Care Facilities in the Metropolitan Area of Western Cape Province, South Africa	PLOS ONE			English	Article							HIV; MECHANISMS; RETENTION; TANZANIA; BARRIERS	Background The antiretroviral adherence club intervention was rolled out in primary health care facilities in theWestern Cape province of South Africa to relieve clinic congestion, and improve retention in care, and treatment adherence in the face of growing patient loads. We adopted the realist evaluation approach to evaluate what aspects of antiretroviral club intervention works, for what sections of the patient population, and under which community and health systems contexts, to inform guidelines for scaling up of the intervention. In this article, we report on a step towards the development of a programme theory-the assumptions of programme designers and health service managers with regard to how and why the adherence club intervention is expected to achieve its goals and perceptions on how it has done so (or not). Methods We adopted an exploratory qualitative research design. We conducted a document review of 12 documents on the design and implementation of the adherence club intervention, and key informant interviews with 12 purposively selected programme designers and managers. Thematic content analysis was used to identify themes attributed to the programme actors, context, mechanisms, and outcomes. Using the context-mechanism-outcome configurational tool, we provided an explanatory focus of how the adherence club intervention is roll-out and works guided by the realist perspective. Results We classified the assumptions of the adherence club designers and managers into the roll-out, implementation, and utilisation of the adherence club programme, constructed around the providers, management/operational staff, and patients, respectively. Two rival theories were identified at the patient-perspective level. We used these perspectives to develop an initial programme theory of the adherence club intervention, which will be tested in a later phase. Conclusion The perspectives of the programme designers and managers provided an important step towards developing an initial programme theory, which will guide our realist evaluation of the adherence club programme in South Africa.	[Mukumbang, Ferdinand C.; Marchal, Bruno; van Wyk, Brian] Univ Western Cape, Sch Publ Hlth, Bellville, Western Cape Pr, South Africa; [Mukumbang, Ferdinand C.; van Belle, Sara; Marchal, Bruno] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [van Belle, Sara] Univ Antwerp, Inst Dev & Management, Antwerp, Belgium	University of the Western Cape; Institute of Tropical Medicine (ITM); University of Antwerp	Mukumbang, FC (corresponding author), Univ Western Cape, Sch Publ Hlth, Bellville, Western Cape Pr, South Africa.; Mukumbang, FC (corresponding author), Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium.	mukumbang@gmail.com	Mukumbang, Ferdinand C/J-4215-2019; Van Belle, Sara/HHN-6814-2022; Mukumbang, Ferdinand/GQB-3347-2022	Mukumbang, Ferdinand C/0000-0003-1441-2172; 	Medical Research Council of South Africa; African Doctoral Dissertation Research Fellowship (ADDRF) award by the Africa Population and Health Research Center (APHRC); International Development Research Centre (IDRC)	Medical Research Council of South Africa(South African Medical Research Council); African Doctoral Dissertation Research Fellowship (ADDRF) award by the Africa Population and Health Research Center (APHRC); International Development Research Centre (IDRC)	The PhD from which this study emanated was funded by the Medical Research Council of South Africa in terms of the National Health Scholars Programme from funds provided for this purpose by the National Department of Health, http://www.mrc.ac.za/. This research was partially funded by an African Doctoral Dissertation Research Fellowship (ADDRF) award offered by the Africa Population and Health Research Center (APHRC) in partnership with the International Development Research Centre (IDRC), http://aphrc.org/.	Adefolalu AO., 2013, DISEASES-BASEL, V1, P18, DOI [10.3390/diseases1010018, DOI 10.3390/DISEASES1010018, 0.3390/diseases1010018]; Astbury B, 2010, AM J EVAL, V31, P363, DOI 10.1177/1098214010371972; Bateman C, 2013, SAMJ S AFR MED J, V103, P71, DOI [10.7196/samj.6666, 10.7196/SAMJ.6666]; Bemelmans M, 2014, TROP MED INT HEALTH, V19, P968, DOI 10.1111/tmi.12332; Berman P., 1978, STUDY MACRO MICROIMP; Bezabhe WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097353; Birckmayer JD, 2000, THEORY BASED EVALUAT; Blamey A., 2007, EVALUATION-US, V13, P439, DOI [DOI 10.1177/1356389007082129, 10.1177/1356389007082129]; Bowen GA, 2009, QUAL RES J, V9, P27, DOI 10.3316/QRJ0902027; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Campion EW, 2015, NEW ENGL J MED, V372, P301, DOI 10.1056/NEJMp1414213; Creswell J.W., 2018, RES DESIGN, V5th; Decroo T, 2013, INT HEALTH, V5, P169, DOI 10.1093/inthealth/iht016; Ford N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001060; Gerbic P., 2005, Internet and Higher Education, V8, P45, DOI 10.1016/j.iheduc.2004.12.003; Grimsrud A, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19984; Kagee A, 2011, GLOB PUBLIC HEALTH, V6, P83, DOI 10.1080/17441691003796387; Kheswa J., 2014, MEDITERR J SOC SCI, V5, P450, DOI [10. 5901/mjss.2014.95914p450, DOI 10.5901/MJSS.2014.95914P450]; Leeuw FL, 2003, AM J EVAL, V24, P5, DOI 10.1177/109821400302400102; Linsley P, 2015, NURSE RES, V22, P28, DOI 10.7748/nr.22.3.28.e1306; Luque-Fernandez MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056088; Manzano A, 2016, EVALUATION-US, V22, P342, DOI 10.1177/1356389016638615; Marsland R, 2012, MED ANTHROPOL Q, V26, P470, DOI 10.1111/maq.12002; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Mukumbang FC, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009977; O'Reilly M, 2013, QUAL RES, V13, P190, DOI 10.1177/1468794112446106; Pawson R, 2003, ESRC UK CTR EVIDENCE, V18, P1; Pawson R., 2006, EVIDENCE BASED POLIC, DOI DOI 10.4135/9781849209120; Pawson R., 2009, EVIDENCE BASED PUBLI, P43, DOI [DOI 10.1093/ACPROF:OSO/9780199563623.003.04, DOI 10.1093/ACPROF:0S0/9780199563623.001.0001]; Pawson R., 1997, REALISTIC EVALUATION; Pawson R, 2004, REALIST EVALUATION; Pawson Ray, 2005, J Health Serv Res Policy, V10 Suppl 1, P21, DOI 10.1258/1355819054308530; Pawson R, 2012, EVALUATION-US, V18, P176, DOI 10.1177/1356389012440912; Pedersen LH, 2008, EVALUATION, V14, P271, DOI [10.1177/1356389008090856, DOI 10.1177/1356389008090856]; Porter S, 2007, J ADV NURS, V60, P79, DOI 10.1111/j.1365-2648.2007.04360.x; Rasschaert F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091544; Roura M, 2009, AIDS PATIENT CARE ST, V23, P203, DOI 10.1089/apc.2008.0129; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Shenton A.K., 2004, ED INF, V22, P63, DOI DOI 10.3233/EFI-2004-22201; Thaler R.H., 2021, NUDGE FINAL EDITION; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Treatment Action Campaign, 2015, 12 TREATM ACT CAMP, P57; Tufford L, 2012, QUAL SOC WORK, V11, P80, DOI 10.1177/1473325010368316; Uebel KE, 2013, JAIDS-J ACQ IMM DEF, V63, pE94, DOI 10.1097/QAI.0b013e318291cd08; UNAIDS, 2016, NUMB PEOPL LIV HIV; Vandendyck M, 2015, AIDS RES TREAT OPEN, V2, P44, DOI [10.17140/HARTOJ-2-107, DOI 10.17140/HARTOJ-2-107]; Wand T, 2011, NURS HEALTH SCI, V13, P199, DOI 10.1111/j.1442-2018.2011.00601.x; Westhorp G., 2014, REALIST IMPACT EVALU; Wilkinson LS, 2013, S AFR J HIV MED, V14, P48, DOI [10.7196/SAJHIVMED.924, 10.7196/sajhivmed.924]; Wong G., 2013, REALIST SYNTHESIS RA	50	23	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161790	10.1371/journal.pone.0161790	http://dx.doi.org/10.1371/journal.pone.0161790			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU5NN	27560352	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258600099
J	Zhao, JH; Bhanot, P; Hu, JJ; Wang, Q				Zhao, Jinghua; Bhanot, Purnima; Hu, Junjie; Wang, Qian			A Comprehensive Analysis of Plasmodium Circumsporozoite Protein Binding to Hepatocytes	PLOS ONE			English	Article							SPOROZOITE ATTACHMENT; HEPARAN-SULFATE; CELL INVASION; TERMINUS; TARGET	Circumsporozoite protein (CSP) is the dominant protein on the surface of Plasmodium sporozoites and plays a critical role in the invasion by sporozoites of hepatocytes. Contacts between CSP and heparin sulfate proteoglycans (HSPGs) lead to the attachment of sporozoites to hepatocytes and trigger signaling events in the parasite that promote invasion of hepatocytes. The precise sequence elements in CSP that bind HSPGs have not been identified. We performed a systematic in vitro analysis to dissect the association between Plasmodium falciparum CSP (PfCSP) and hepatocytes. We demonstrate that interactions between PfCSP and heparin or a cultured hepatoma cell line, HepG2, are mediated primarily by a lysine-rich site in the amino terminus of PfCSP. Importantly, the carboxyl terminus of PfCSP facilitates heparin-binding by the amino-terminus but does not interact directly with heparin. These findings provide insights into how CSP recognizes hepatocytes and useful information for further functional studies of CSP.	[Zhao, Jinghua; Hu, Junjie] Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, Tianjin, Peoples R China; [Zhao, Jinghua; Hu, Junjie] Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China; [Bhanot, Purnima] Rutgers State Univ, Dept Microbiol Biochem & Mol Genet, Rutgers New Jersey Med Sch, Newark, NJ USA; [Hu, Junjie] Chinese Acad Sci, Natl Lab Biomacromol, Inst Biophys, Beijing 100101, Peoples R China; [Wang, Qian] Tianjin Med Univ, Sch Basic Med Sci, Dept Immunol, Tianjin 300070, Peoples R China; [Wang, Qian] Tianjin Key Lab Cellular & Mol Immunol, Tianjin 300070, Peoples R China	Nankai University; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Chinese Academy of Sciences; Institute of Biophysics, CAS; Tianjin Medical University	Wang, Q (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Dept Immunol, Tianjin 300070, Peoples R China.; Wang, Q (corresponding author), Tianjin Key Lab Cellular & Mol Immunol, Tianjin 300070, Peoples R China.	wangq@tmu.edu.cn			Tianjin Medical University; National Natural Science Foundation of China [31225006]; Howard Hughes Medical Institute	Tianjin Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Q. Wang is supported by startup funds from Tianjin Medical University. J. Hu is supported by the National Natural Science Foundation of China (grant 31225006), and an International Early Career Scientist grant from Howard Hughes Medical Institute.	Adams JC, 2000, DEV DYNAM, V218, P280; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Aldrich C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032524; Ancsin JB, 2004, J BIOL CHEM, V279, P21824, DOI 10.1074/jbc.M401979200; Coppi A, 2005, J EXP MED, V201, P27, DOI 10.1084/jem.20040989; Coppi A, 2011, J EXP MED, V208, P341, DOI 10.1084/jem.20101488; Doud MB, 2012, P NATL ACAD SCI USA, V109, P7817, DOI 10.1073/pnas.1205737109; Ghosh AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000265; Kariu T, 2002, J EXP MED, V195, P1317, DOI 10.1084/jem.20011876; Kojin BB, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1207-8; McCutchan TF, 1996, P NATL ACAD SCI USA, V93, P11889, DOI 10.1073/pnas.93.21.11889; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; Noe AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107764; Pinzon-Ortiz C, 2001, J BIOL CHEM, V276, P26784, DOI 10.1074/jbc.M104038200; Plassmeyer ML, 2009, J BIOL CHEM, V284, P26951, DOI 10.1074/jbc.M109.013706; Rathore D, 2005, J BIOL CHEM, V280, P20524, DOI 10.1074/jbc.M414254200; Rathore D, 2002, J BIOL CHEM, V277, P7092, DOI 10.1074/jbc.M106862200; Rathore D, 2001, BIOCHEMISTRY-US, V40, P11518, DOI 10.1021/bi0105476; SINNIS P, 1994, J EXP MED, V180, P297, DOI 10.1084/jem.180.1.297; Swearingen KE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005606; Tewari R, 2002, J BIOL CHEM, V277, P47613, DOI 10.1074/jbc.M208453200; Thathy V, 2002, EMBO J, V21, P1586, DOI 10.1093/emboj/21.7.1586; Wang Q, 2005, CELL MICROBIOL, V7, P1616, DOI 10.1111/j.1462-5822.2005.00579.x; Wang Q, 2005, PLOS PATHOG, V1, P72, DOI 10.1371/journal.ppat.0010009	24	12	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161607	10.1371/journal.pone.0161607	http://dx.doi.org/10.1371/journal.pone.0161607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560376	Green Submitted, Green Published, gold			2022-12-26	WOS:000382258600060
J	Pedrotti, ML; Petit, S; Elineau, A; Bruzaud, S; Crebassa, JC; Dumontet, B; Marti, E; Gorsky, G; Cozar, A				Pedrotti, Maria Luiza; Petit, Stephanie; Elineau, Amanda; Bruzaud, Stephane; Crebassa, Jean-Claude; Dumontet, Bruno; Marti, Elisa; Gorsky, Gabriel; Cozar, Andres			Changes in the Floating Plastic Pollution of the Mediterranean Sea in Relation to the Distance to Land	PLOS ONE			English	Article							MARINE DEBRIS; MICROPLASTICS; ACCUMULATION; ZOOPLANKTON; TRANSPORT; ABUNDANCE; BIVALVES; IMPACTS	The composition, size distribution, and abundance of floating plastic debris in surface waters of the Mediterranean Sea were analyzed in relation to distance to land. We combined data from previously published reports with an intensive sampling in inshore waters of the Northwestern Mediterranean. The highest plastic concentrations were found in regions distant from from land as well as in the first kilometer adjacent to the coastline. In this nearshore water strip, plastic concentrations were significantly correlated with the nearness to a coastal human population, with local areas close to large human settlements showing hundreds of thousands of plastic pieces per km(2). The ratio of plastic to plankton abundance reached particularly high values for the coastal surface waters. Polyethylene, polypropylene and polyamides were the predominant plastic polymers at all distances from coast (86 to 97% of total items), although the diversity of polymers was higher in the 1-km coastal water strip due to a higher frequency of polystyrene or polyacrylic fibers. The plastic size distributions showed a gradual increase in abundance toward small sizes indicating an efficient removal of small plastics from the surface. Nevertheless, the relative abundance of small fragments (< 2 mm) was higher within the 1-km coastal water strip, suggesting a rapid fragmentation down along the shoreline, likely related with the washing ashore on the beaches. This study constitutes a first attempt to determine the impact of plastic debris in areas closest to Mediterranean coast. The presence of a high concentration of plastic including tiny plastic items could have significant environmental, health and economic impacts.	[Pedrotti, Maria Luiza; Petit, Stephanie; Elineau, Amanda; Gorsky, Gabriel] Univ Paris 06, Sorbonne Univ, UMR 7093, LOV, Villefranche Sur Mer, France; [Pedrotti, Maria Luiza; Petit, Stephanie; Elineau, Amanda; Gorsky, Gabriel] CNRS, UMR 7093, LOV, Villefranche Sur Mer, France; [Bruzaud, Stephane] Univ Bretagne Sud, Lab Ingn Mat Bretagne, Rue St Maude, F-56321 Lorient, France; [Crebassa, Jean-Claude; Dumontet, Bruno] Expedit MED, 4 Allee Avettes, F-56230 Questembert, France; [Marti, Elisa; Cozar, Andres] Univ Cadiz, Fac Ciencias Mar & Ambientales, Dept Biol, Campus Excelencia Int Mar, E-11510 Puerto Real, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universidad de Cadiz	Pedrotti, ML (corresponding author), Univ Paris 06, Sorbonne Univ, UMR 7093, LOV, Villefranche Sur Mer, France.; Pedrotti, ML (corresponding author), CNRS, UMR 7093, LOV, Villefranche Sur Mer, France.	pedrotti@obs-vlfr.fr	Cozar, Andres/G-2141-2016; Marti, Elisa/AAA-1559-2020	Cozar, Andres/0000-0003-1370-9935; Gorsky, Gabriel/0000-0002-1099-8711; BRUZAUD, STEPHANE/0000-0002-4576-7681; pedrotti, Maria Luiza/0000-0002-9963-0402	French GDF Suez Foundation through the ECOSEASTEM project; French Ministry of Research; EU's Framework Programme 7 MedSeA (EU) [FP7-2010-265103]; Spanish Ministry of Education, Culture and Sport [PRX14/00743]	French GDF Suez Foundation through the ECOSEASTEM project; French Ministry of Research(Ministry of Research, FranceEuropean Commission); EU's Framework Programme 7 MedSeA (EU); Spanish Ministry of Education, Culture and Sport	The present study was funded by the French GDF Suez Foundation through the ECOSEASTEM project, French Ministry of Research and EU's Framework Programme 7 MedSeA (EU contract number FP7-2010-265103). Sampling was conducted by the French citizen science NGO ExpeditionMED and analysed in the framework of the European Marine Biological Resource Centre (EMBRC-France) research infrastructure in Villefranche sur Mer. The present work resulted in part from a short stay of A. Cozar in the Laboratory of Oceanography of Villefranche (LOV), supported by the "Salvador de Madariaga" Mobility Program of the Spanish Ministry of Education, Culture and Sport (ref. PRX14/00743).	Andrady A.L, 1990, P 2 INT C MAR DEBR 2; Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030; [Anonymous], MUN SOL WAST GEN REC; Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205; Bethoux J. P., 1988, OCEANOL ACTA, P59; Browne MA, 2013, CURR BIOL, V23, P2388, DOI 10.1016/j.cub.2013.10.012; Browne MA, 2011, ENVIRON SCI TECHNOL, V45, P9175, DOI 10.1021/es201811s; Collignon A, 2012, MAR POLLUT BULL, V64, P861, DOI 10.1016/j.marpolbul.2012.01.011; Cozar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121762; Cozar A, 2014, P NATL ACAD SCI USA, V111, P10239, DOI 10.1073/pnas.1314705111; Critchell K, 2015, ESTUAR COAST SHELF S, V167, P414, DOI 10.1016/j.ecss.2015.10.018; Critchell K, 2016, ESTUAR COAST SHELF S, V171, P111, DOI 10.1016/j.ecss.2016.01.036; de Lucia GA, 2014, MAR ENVIRON RES, V100, P10, DOI 10.1016/j.marenvres.2014.03.017; Eriksen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111913; Gilfillan LR, 2009, CAL COOP OCEAN FISH, V50, P123; Goldstein MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080020; Gorsky G, 2010, J PLANKTON RES, V32, P285, DOI 10.1093/plankt/fbp124; Hidalgo-Ruz V, 2012, ENVIRON SCI TECHNOL, V46, P3060, DOI 10.1021/es2031505; Islam MS, 2004, MAR POLLUT BULL, V48, P624, DOI 10.1016/j.marpolbul.2003.12.004; Isobe A, 2014, MAR POLLUT BULL, V89, P324, DOI 10.1016/j.marpolbul.2014.09.041; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Kukulka T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051116; Law KL, 2014, ENVIRON SCI TECHNOL, V48, P4732, DOI 10.1021/es4053076; Law KL, 2010, SCIENCE, V329, P1185, DOI 10.1126/science.1192321; Lebreton LCM, 2012, MAR POLLUT BULL, V64, P653, DOI 10.1016/j.marpolbul.2011.10.027; Levitus S., 1982, 13 NOAA; Li JN, 2015, ENVIRON POLLUT, V207, P190, DOI 10.1016/j.envpol.2015.09.018; Mansui J, 2015, MAR POLLUT BULL, V91, P249, DOI 10.1016/j.marpolbul.2014.11.037; Maximenko N, 2012, MAR POLLUT BULL, V65, P51, DOI 10.1016/j.marpolbul.2011.04.016; Millot C, 2005, HANDB ENVIRON CHEM, V5, P29, DOI 10.1007/b107143; Moret-Ferguson S, 2010, MAR POLLUT BULL, V60, P1873, DOI 10.1016/j.marpolbul.2010.07.020; MSFD GES Technical Subgroup on Marine Litter, 2011, 25009 EUR MSFD GES T; Panti C, 2015, ENVIRON CHEM, V12, P618, DOI 10.1071/EN14234; Picco P, 2010, OCEAN SCI, V6, P825, DOI 10.5194/os-6-825-2010; Poulain PM, 2013, OCEANOGRAPHY, V26, P38, DOI 10.5670/oceanog.2013.03; Reisser J, 2015, BIOGEOSCIENCES, V12, P1249, DOI 10.5194/bg-12-1249-2015; Reisser J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080466; Rochman CM, 2013, NATURE, V494, P169, DOI 10.1038/494169a; Ryan PG, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/8/084019; Ryan PG, 2009, PHILOS T R SOC B, V364, P1999, DOI 10.1098/rstb.2008.0207; Sadri SS, 2014, MAR POLLUT BULL, V81, P55, DOI 10.1016/j.marpolbul.2014.02.020; Suaria G, 2014, MAR POLLUT BULL, V86, P494, DOI 10.1016/j.marpolbul.2014.06.025; UNEP-MAP, 2012, STATE MEDITERRANEAN; Van Cauwenberghe L, 2014, ENVIRON POLLUT, V193, P65, DOI 10.1016/j.envpol.2014.06.010; van Sebille E, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/124006; van Sebille E, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044040; Vegter AC, 2014, ENDANGER SPECIES RES, V25, P225, DOI 10.3354/esr00623	47	172	176	4	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161581	10.1371/journal.pone.0161581	http://dx.doi.org/10.1371/journal.pone.0161581			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556233	Green Submitted, Green Published, gold			2022-12-26	WOS:000382258100056
J	Reveles, KR; Duhon, BM; Moore, RJ; Hand, EO; Howell, CK				Reveles, Kelly R.; Duhon, Bryson M.; Moore, Robert J.; Hand, Elizabeth O.; Howell, Crystal K.			Epidemiology of Methicillin-Resistant Staphylococcus aureus Diabetic Foot Infections in a Large Academic Hospital: Implications for Antimicrobial Stewardship	PLOS ONE			English	Article							SOFT-TISSUE INFECTIONS; UNITED-STATES; RISK-FACTORS; SKIN; ULCER	Introduction Diabetic foot infections (DFIs) are the leading cause of non-traumatic lower extremity amputations in the United States. Antimicrobials active against methicillin-resistant Staphylococcus aureus (MRSA) are recommended in patients with associated risk factors; however, limited data exist to support these recommendations. Due to the changing epidemiology of MRSA, and the consequences of unnecessary antibiotic therapy, guidance regarding the necessity of empirical MRSA coverage in DFIs is needed. We sought to 1) describe the prevalence of MRSA DFIs at our institution and compare to the proportion of patients who receive MRSA antibiotic coverage and 2) identify risk factors for MRSA DFI. Methods This was a retrospective cohort study of all adult, culture-positive DFI patients managed at University Hospital, San Antonio, TX between January 1, 2010 and September 1, 2014. Patient eligibility included a principal ICD-9-CM discharge diagnosis code for foot infection and a secondary diagnosis of diabetes. The primary outcome was MRSA identified in the wound culture. Independent variables assessed included patient demographics, comorbidities, prior hospitalization, DFI therapies, prior antibiotics, prior MRSA infection, and laboratory values. Multivariable logistic regression was used to identify risk factors for MRSA DFI. Results Overall, 318 patients met inclusion criteria. Patients were predominantly Hispanic (79%) and male (69%). Common comorbidities included hypertension (76%), dyslipidemia (52%), and obesity (49%). S. aureus was present in 46% of culture-positive DFIs (MRSA, 15%). A total of 273 patients (86%) received MRSA antibiotic coverage, resulting in 71% unnecessary use. Male gender (OR 3.09, 95% CI 1.37-7.99) and bone involvement (OR 1.93, 1.00-3.78) were found to be independent risk factors for MRSA DFI. Conclusions Although MRSA was the causative pathogen in a small number of DFI, antibiotic coverage targeted against MRSA was unnecessarily high.	[Reveles, Kelly R.; Duhon, Bryson M.; Moore, Robert J.; Hand, Elizabeth O.; Howell, Crystal K.] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA; [Reveles, Kelly R.; Duhon, Bryson M.; Moore, Robert J.; Hand, Elizabeth O.; Howell, Crystal K.] Univ Texas Hlth Sci Ctr San Antonio, Pharmacotherapy Educ & Res Ctr, San Antonio, TX 78229 USA; [Duhon, Bryson M.; Hand, Elizabeth O.] Univ Hlth Syst, San Antonio, TX USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Health San Antonio	Reveles, KR (corresponding author), Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA.; Reveles, KR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Pharmacotherapy Educ & Res Ctr, San Antonio, TX 78229 USA.	kdaniels46@utexas.edu	Reveles, Kelly/AAI-1575-2021		Texas Society of Health-System Pharmacists Research & Education Foundation C.A.B. Bond Memorial Grant; National Institutes of Health/National Institute on Aging San Antonio Claude D. Pepper Older Americans Independence Center [1P30AG044271-01A1]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120] Funding Source: NIH RePORTER	Texas Society of Health-System Pharmacists Research & Education Foundation C.A.B. Bond Memorial Grant; National Institutes of Health/National Institute on Aging San Antonio Claude D. Pepper Older Americans Independence Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	KRR, BMD, EOH, and CKH received funding for this project from the Texas Society of Health-System Pharmacists Research & Education Foundation C.A.B. Bond Memorial Grant (http://www.tshp.org/index.html). KRR is also supported by the National Institutes of Health/National Institute on Aging San Antonio Claude D. Pepper Older Americans Independence Center (1P30AG044271-01A1) Career Development (KL2) Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon-Sanchez J, 2009, DIABETIC MED, V26, P552, DOI 10.1111/j.1464-5491.2009.02714.x; Centers for Disease Control and Prevention, 2014 NAT DIAB STAT R; Dang CN, 2003, DIABETIC MED, V20, P159, DOI 10.1046/j.1464-5491.2003.00860.x; Dantes R, 2013, JAMA INTERN MED, V173, P1970, DOI 10.1001/jamainternmed.2013.10423; Eleftheriadou L, 2010, DRUGS, V70, P1785, DOI 10.2165/11538070-000000000-00000; Haleem A, 2014, DIAGN MICR INFEC DIS, V79, P85, DOI 10.1016/j.diagmicrobio.2014.01.014; Hartemann-Heurtier A, 2004, DIABETIC MED, V21, P710, DOI 10.1111/j.1464-5491.2004.01237.x; Kett DH, 2011, LANCET INFECT DIS, V11, P181, DOI 10.1016/S1473-3099(10)70314-5; Kupfer M, 2010, GMS HYG INFECT CONTR, V5, DOI 10.3205/dgkh000154; Landrum ML, 2012, JAMA-J AM MED ASSOC, V308, P50, DOI 10.1001/jama.2012.7139; Lipsky BA, 2005, LANCET, V366, P1695, DOI 10.1016/S0140-6736(05)67694-5; Lipsky BA, 2013, J AM PODIAT MED ASSN, V103, P2, DOI 10.7547/1030002; Noel GJ, 2008, CLIN INFECT DIS, V46, P647, DOI 10.1086/526527; Rennie RP, 2003, DIAGN MICR INFEC DIS, V45, P287, DOI 10.1016/S0732-8893(02)00543-6; Richard JL, 2008, DIABETES METAB, V34, P363, DOI 10.1016/j.diabet.2008.02.005; Yates C, 2009, DIABETES CARE, V32, P1907, DOI 10.2337/dc09-0295	16	34	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161658	10.1371/journal.pone.0161658	http://dx.doi.org/10.1371/journal.pone.0161658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556897	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258100060
J	Zurawik, TM; Pomorski, A; Belczyk-Ciesielska, A; Goch, G; Niedzwiedzka, K; Kucharczyk, R; Krezel, A; Bal, W				Zurawik, Tomasz Michal; Pomorski, Adam; Belczyk-Ciesielska, Agnieszka; Goch, Grazyna; Niedzwiedzka, Katarzyna; Kucharczyk, Roza; Krezel, Artur; Bal, Wojciech			Revisiting Mitochondrial pH with an Improved Algorithm for Calibration of the Ratiometric 5(6)-carboxy-SNARF-1 Probe Reveals Anticooperative Reaction with H+ Ions and Warrants Further Studies of Organellar pH	PLOS ONE			English	Article							PERMEABILITY TRANSITION; ATP SYNTHASE; LIVING CELLS; YEAST	Fluorescence measurements of pH and other analytes in the cell rely on accurate calibrations, but these have routinely used algorithms that inadequately describe the properties of indicators. Here, we have established a more accurate method for calibrating and analyzing data obtained using the ratiometric probe 5(6)-carboxy-SNARF-1. We tested the implications of novel approach to measurements of pH in yeast mitochondria, a compartment containing a small number of free H+ ions. Our findings demonstrate that 5(6)-carboxy-SNARF-1 interacts with H+ ions inside the mitochondria in an anticooperative manner (Hill coefficient n of 0.5) and the apparent pH inside the mitochondria is similar to 0.5 unit lower than had been generally assumed. This result, at odds with the current consensus on the mechanism of energy generation in the mitochondria, is in better agreement with theoretical considerations and warrants further studies of organellar pH.	[Zurawik, Tomasz Michal; Belczyk-Ciesielska, Agnieszka; Goch, Grazyna; Niedzwiedzka, Katarzyna; Kucharczyk, Roza; Bal, Wojciech] Polish Acad Sci, Inst Biochem & Biophys, Pawinskiego 5a, PL-02106 Warsaw, Poland; [Pomorski, Adam; Krezel, Artur] Univ Wroclaw, Fac Biotechnol, Dept Biol Chem, F Joliot Curie 14A, PL-50383 Wroclaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Wroclaw	Bal, W (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Pawinskiego 5a, PL-02106 Warsaw, Poland.; Krezel, A (corresponding author), Univ Wroclaw, Fac Biotechnol, Dept Biol Chem, F Joliot Curie 14A, PL-50383 Wroclaw, Poland.	artur.krezel@uwr.edu.pl; wbal@ibb.waw.pl	Pomorski, Adam/ABC-9677-2021; Krezel, Artur/E-7047-2011; Krezel, Artur/AAG-8729-2021	Krezel, Artur/0000-0001-9252-5784; Bal, Wojciech/0000-0003-3780-083X; Niedzwiecka, Katarzyna/0000-0002-9482-3918; Kucharczyk, Roza/0000-0002-8712-7535; Pomorski, Adam/0000-0002-0669-3421	Narodowe Centrum Nauki (National Science Center of Poland) [UMO-2013/11/B/NZ1/02102, UMO-2012/07/E/NZ1/01894, UMO-2011/01/B/ST4/06144]	Narodowe Centrum Nauki (National Science Center of Poland)	The work was supported by Narodowe Centrum Nauki (National Science Center of Poland) grants: UMO-2013/11/B/NZ1/02102 to RK, UMO-2012/07/E/NZ1/01894 to AK and UMO-2011/01/B/ST4/06144 to WB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Acerenza L, 1997, BBA-PROTEIN STRUCT M, V1339, P155, DOI 10.1016/S0167-4838(96)00228-2; [Anonymous], 2006, PROB MOL PH IND; Bal W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045832; Balut C, 2008, KIDNEY INT, V73, P226, DOI 10.1038/sj.ki.5002632; Boczek T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102352; Goutelle S, 2008, FUND CLIN PHARMACOL, V22, P633, DOI 10.1111/j.1472-8206.2008.00633.x; Guerin B, 1979, Methods Enzymol, V55, P149; Han JY, 2009, J AM CHEM SOC, V131, P1642, DOI 10.1021/ja8073374; Harper IS., 2009, FLUORESCENCE APPL BI, P34; Hill AV., J PHYSL, V10, piv; Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P817, DOI 10.1016/j.bbamcr.2009.02.011; Lim MLR, 2001, FEBS LETT, V503, P69, DOI 10.1016/S0014-5793(01)02693-X; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARTINEZZAGUILAN R, 1993, AM J PHYSIOL, V265, pC1015, DOI 10.1152/ajpcell.1993.265.4.C1015; Masuda A, 1998, BRAIN RES, V807, P70, DOI 10.1016/S0006-8993(98)00737-9; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; Owen C S, 1992, J Fluoresc, V2, P75, DOI 10.1007/BF00867666; OWEN CS, 1992, ANAL BIOCHEM, V204, P65, DOI 10.1016/0003-2697(92)90140-3; Pomorski A, 2013, ANAL CHEM, V85, P11479, DOI 10.1021/ac402637h; Poznanski J, 2013, BIOCHEM BIOPH RES CO, V430, P741, DOI 10.1016/j.bbrc.2012.11.079; Qian T, 1997, AM J PHYSIOL-CELL PH, V273, pC1783, DOI 10.1152/ajpcell.1997.273.6.C1783; Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200; Ramshesh VK, 2012, METHODS MOL BIOL, V810, P243, DOI 10.1007/978-1-61779-382-0_16; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; SEKSEK O, 1991, ANAL BIOCHEM, V193, P49, DOI 10.1016/0003-2697(91)90042-R; Takahashi A, 2001, BIOTECHNIQUES, V30, P804, DOI 10.2144/01304rv01; WHITAKER JE, 1991, ANAL BIOCHEM, V194, P330, DOI 10.1016/0003-2697(91)90237-N; WIEDER ED, 1993, CYTOMETRY, V14, P916, DOI 10.1002/cyto.990140810	30	14	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161353	10.1371/journal.pone.0161353	http://dx.doi.org/10.1371/journal.pone.0161353			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27557123	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258100037
J	Butin-Israeli, V; Houser, MC; Feng, ML; Thorp, EB; Nusrat, A; Parkos, CA; Sumagin, R				Butin-Israeli, Veronika; Houser, Madelyn C.; Feng, Mingli; Thorp, Edward B.; Nusrat, Asma; Parkos, Charles A.; Sumagin, Ronen			Deposition of microparticles by neutrophils onto inflamed epithelium: a new mechanism to disrupt epithelial intercellular adhesions and promote transepithelial migration	FASEB JOURNAL			English	Article						inflammation; injury; transmigration; intestine; barrier	INFLAMMATORY-BOWEL-DISEASE; ENDOTHELIAL-CELLS; E-CADHERIN; PROTEIN; RELEASE; MATRIX-METALLOPROTEINASE-9; TRANSMIGRATION; DESMOGLEIN-2; PATHOGENESIS; ACTIVATION	Neutrophil [polymorphonuclear leukocyte (PMN)] transepithelial migration (TEM) is a hallmark of inflammatory mucosal disorders. PMN TEM is associated with epithelial injury; however, mechanisms involved in this process are not well defined. The current work describes a new mechanism whereby deposition of PMN membrane-derived microparticles (PMN-MPs) onto intestinal epithelial cells (IECs) during TEM leads to loss of epithelial cadherins, thus promoting epithelial injury and increased PMN recruitment. PMN-MPs secreted by activated PMNs during TEM displayed a high level of enzymatically active matrix metalloproteinase 9 (MMP-9), and were capable of mediating potent effects on IEC integrity. Isolated PMN-MPs efficiently bound to IEC monolayers and induced cleavage of desmoglein-2 (DSG-2) but not E-cadherin, leading to disruption of IEC intercellular adhesions. Furthermore, PMN-MP binding to intestinal epithelium in vitro in transwell assays and in vivo in ligated intestinal loop preparations facilitated increases in PMN TEM. These effects were MMP-9 dependent and were reversed in the presence of specific pharmacological inhibitors. Finally, we demonstrated that IEC Dsg-2 serves as a barrier for migrating PMNs, and its removal by PMN-MP-associated MMP-9 facilitates PMN trafficking across epithelial layers. Our findings thus implicate PMN-MPs in PMN-mediated inflammation and epithelial damage, as observed in inflammatory disorders of mucosal surfaces.-Butin-Israeli, V., Houser, M. C., Feng, M., Thorp, E. B., Nusrat, A., Parkos, C. A, Sumagin, R. Deposition of microparticles by neutrophils onto inflamed epithelium: a new mechanism to disrupt epithelial intercellular adhesions and promote transepithelial migration.	[Butin-Israeli, Veronika; Thorp, Edward B.; Sumagin, Ronen] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Houser, Madelyn C.] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA; [Feng, Mingli; Nusrat, Asma; Parkos, Charles A.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	Northwestern University; Feinberg School of Medicine; Emory University; University of Michigan System; University of Michigan	Sumagin, R (corresponding author), Northwestern Univ, Tarry Res Bldg,Room 3-707,303 E Chicago Ave, Chicago, IL 60611 USA.	ronen.sumagin@northwestern.edu	Butin-Israeli, Veronika/AAQ-2391-2020; Houser, Madelyn/AAK-8387-2021	Houser, Madelyn/0000-0002-4049-9876; Thorp, Edward/0000-0003-1387-7058	U.S. National Institutes of Health (NIH), National Cancer Institute Grant [CCSG P30 CA060553]; NIH, National Institute of Diabetes and Digestive and Kidney Diseases [DK072564, DK061379, DK079392, DK055679, DK059888, DK101675]; American Cancer Society [IRG-9303718]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072564, R01DK059888, R29DK055679, R01DK055679, R01DK061379, R01DK079392, K01DK101675] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Cancer Institute Grant; NIH, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. J. Koch (Northwestern University) and the Northwestern University Center for Advanced Microscopy Core Facility [supported by U.S. National Institutes of Health (NIH), National Cancer Institute Grant CCSG P30 CA060553 awarded to the Robert H. Lurie, Comprehensive Cancer Center] for help with electron microscopic imaging of the PMN-MPs. The authors also thank Lorrain Mascarenhas (Northwestern University) for technical assistance and proofreading of the manuscript. This work was supported by NIH, National Institute of Diabetes and Digestive and Kidney Diseases Grants DK072564, DK061379, and DK079392 (to C.A.P.); DK055679 and DK059888 (to A.N.); and DK101675, as well as American Cancer Society IRG-9303718 (to R.S.). The authors declare no conflicts of interest.	Almkvist J, 2001, INFECT IMMUN, V69, P832, DOI 10.1128/IAI.69.2.832-837.2001; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Bornslaeger EA, 1996, J CELL BIOL, V134, P985, DOI 10.1083/jcb.134.4.985; Brazil JC, 2013, INFLAMM BOWEL DIS, V19, P1556, DOI 10.1097/MIB.0b013e318281f54e; Chakrabarti S, 2006, J LEUKOCYTE BIOL, V79, P214, DOI 10.1189/jlb.0605353; Chakrabarti S, 2005, J LEUKOCYTE BIOL, V78, P279, DOI 10.1189/jlb.1004612; Chin AC, 2009, J IMMUNOL, V183, P5957, DOI 10.4049/jimmunol.0900789; Chun J, 2009, CELL HOST MICROBE, V5, P47, DOI 10.1016/j.chom.2008.11.009; Corry DB, 2004, FASEB J, V18, P995, DOI 10.1096/fj.03-1412fje; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dalli J, 2008, BLOOD, V112, P2512, DOI 10.1182/blood-2008-02-140533; Dalli J, 2013, MOL CELL PROTEOMICS, V12, P2205, DOI 10.1074/mcp.M113.028589; Daniel L, 2006, KIDNEY INT, V69, P1416, DOI 10.1038/sj.ki.5000306; Du D, 2010, DEV CELL, V18, P52, DOI 10.1016/j.devcel.2009.12.008; ERLANDSEN SL, 1993, J HISTOCHEM CYTOCHEM, V41, P327, DOI 10.1177/41.3.7679125; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Gaborski TR, 2013, EUR BIOPHYS J BIOPHY, V42, P851, DOI 10.1007/s00249-013-0931-z; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Gasser O, 2004, BLOOD, V104, P2543, DOI 10.1182/blood-2004-01-0361; Ginzberg HH, 2001, AM J PHYSIOL-GASTR L, V281, pG705, DOI 10.1152/ajpgi.2001.281.3.G705; Headland SE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5608; Jiang K, 2014, J BIOL CHEM, V289, P10510, DOI 10.1074/jbc.M113.538538; Johnson BL, 2014, ENDOCR METAB IMMUNE, V14, P210, DOI 10.2174/1871530314666140722083717; Kamekura R, 2014, ONCOGENE, V33, P4531, DOI 10.1038/onc.2013.442; Kamekura R, 2015, MOL BIOL CELL, V26, P3165, DOI 10.1091/mbc.E15-03-0147; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kolegraff K, 2011, MOL BIOL CELL, V22, P1121, DOI 10.1091/mbc.E10-10-0845; Kucharzik T, 2001, AM J PATHOL, V159, P2001, DOI 10.1016/S0002-9440(10)63051-9; Kunder CA, 2009, J EXP MED, V206, P2455, DOI 10.1084/jem.20090805; Langhorst J, 2005, INFLAMM BOWEL DIS, V11, P1085, DOI 10.1097/01.MIB.0000187980.08686.18; Lie PPY, 2010, INT J BIOCHEM CELL B, V42, P975, DOI 10.1016/j.biocel.2010.02.010; Lindsey M, 2001, CIRCULATION, V103, P2181; Liu Y, 2002, J BIOL CHEM, V277, P10028, DOI 10.1074/jbc.M109720200; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Mackarel AJ, 2000, AM J RESP CELL MOL, V23, P154, DOI 10.1165/ajrcmb.23.2.3853; Matsuda M, 2004, J CELL SCI, V117, P1247, DOI 10.1242/jcs.00972; Mayerle J, 2005, GASTROENTEROLOGY, V129, P1251, DOI 10.1053/j.gastro.2005.08.002; Multhoff G, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00098; Nava P, 2007, MOL BIOL CELL, V18, P4565, DOI 10.1091/mbc.E07-05-0426; Nava P, 2011, EMBO REP, V12, P314, DOI 10.1038/embor.2011.16; PARKOS CA, 1992, J CELL BIOL, V117, P757, DOI 10.1083/jcb.117.4.757; Pecina-Slaus N, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-17; Pitanga TN, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-21; Pliyev BK, 2014, CYTOKINE, V65, P126, DOI 10.1016/j.cyto.2013.11.010; Schulte D, 2011, EMBO J, V30, P4157, DOI 10.1038/emboj.2011.304; Semb H, 1998, AM J HUM GENET, V63, P1588, DOI 10.1086/302173; Severson EA, 2008, MOL BIOL CELL, V19, P1862, DOI 10.1091/mbc.E07-09-0869; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Sumagin R, 2016, MUCOSAL IMMUNOL, V9, P1151, DOI 10.1038/mi.2015.135; Sumagin R, 2014, MUCOSAL IMMUNOL, V7, P905, DOI 10.1038/mi.2013.106; Sumagin R, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688362.2014.969100; Swamydas M, 2013, JOVE-J VIS EXP, DOI 10.3791/50586; Wang Q, 2001, J IMMUNOL, V166, P6877, DOI 10.4049/jimmunol.166.11.6877; Weber DA, 2014, MUCOSAL IMMUNOL, V7, P1221, DOI 10.1038/mi.2014.12; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zihni C, 2014, J CELL SCI, V127, P3401, DOI 10.1242/jcs.145029	57	42	44	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4007	4020		10.1096/fj.201600734R	http://dx.doi.org/10.1096/fj.201600734R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27553226	Green Submitted, Green Published			2022-12-26	WOS:000388201500009
J	Min, HK; Maruyama, H; Jang, BK; Shimada, M; Mirshahi, F; Ren, SL; Oh, YM; Puri, P; Sanyal, AJ				Min, Hae-Ki; Maruyama, Hitoshi; Jang, Byoung Kuk; Shimada, Masahiko; Mirshahi, Faridoddin; Ren, Shunlin; Oh, Youngman; Puri, Puneet; Sanyal, Arun J.			Suppression of IGF binding protein-3 by palmitate promotes hepatic inflammatory responses	FASEB JOURNAL			English	Article						NAFLD; nonalcoholic steatohepatitis; lipotoxicity; interleukin-8; IGFBP-3	FATTY LIVER-DISEASE; BREAST-CANCER CELLS; INSULIN-RESISTANCE; NONALCOHOLIC STEATOHEPATITIS; HEPATOCELLULAR-CARCINOMA; IGFBP-3; LIPOTOXICITY; RECEPTOR; AXIS; DIFFERENTIATION	IGF-binding protein-3 (IGFBP-3) is a liver-derived, anti-inflammatory molecule that is decreased in obesity, a key risk factor for nonalcoholic fatty liver disease (NAFLD). It was not known whether IGFBP-3 levels were altered in NAFLD, whether such alterations could be the result of lipotoxicity, and whether altered IGFBP-3 could affect pathways that are involved in hepatic and systemic inflammation. Serum IGFBP-3 was decreased in patients with NAFLD, whereas liver and circulating IL-8 levels were increased. Palmitate inhibited IGFBP-3 secretion by THP-1macrophages and enhanced IL-8 expression. Exposure of palmitate-treated THP-1macrophages to IGFBP-3-deficient conditioned medium led to a 20-fold increase in palmitate-induced IL-8 expression by hepato-cytes. Conversely, overexpression of IGFBP-3 suppressed JNK and NF-kappa B activation and blocked palmitate-induced IL-8 expression in hepatocytes. Silencing IGFBP-3 in Huh7 cells enhanced JNK and NF-kappa B activity and increased palmitate-induced IL-8 secretion. These data indicate that IGFBP-3 serves as an anti-inflammatory brake in hepatocytes against JNK and NF-kappa B and limits their activation and downstream production of proinflammatory cytokines. Under lipotoxic conditions, palmitate inhibits hepatic macrophage secretion of IGFBP-3, thereby releasing the brake and enhancing palmitate-induced IL-8 synthesis and secretion.	[Min, Hae-Ki; Maruyama, Hitoshi; Jang, Byoung Kuk; Shimada, Masahiko; Mirshahi, Faridoddin; Ren, Shunlin; Puri, Puneet; Sanyal, Arun J.] Virginia Commonwealth Univ, Sch Med, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Richmond, VA USA; [Oh, Youngman] Virginia Commonwealth Univ, Sch Med, Dept Pathol, Div Cellular & Mol Pathogenesis, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University	Min, HK; Sanyal, AJ (corresponding author), Virginia Commonwealth Univ, Med Ctr, 1220 E Broad St, Richmond, VA 23219 USA.	hae-ki.min@vcuhealth.org; arun.sanyal@vcuhealth.org		Jang, Byoung Kuk/0000-0002-8950-0866	U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases) [DK081450, T32 DK07150]; U.S. National Institutes of Health (National Institute on Alcohol Abuse and Alcoholism) [AA020758]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081410, T32DK007150, R03DK081450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020758] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [16K01406] Funding Source: KAKEN	U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. National Institutes of Health (National Institute on Alcohol Abuse and Alcoholism); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by U.S. National Institutes of Health Grants DK081450 and T32 DK07150 (National Institute of Diabetes and Digestive and Kidney Diseases) and AA020758 (National Institute on Alcohol Abuse and Alcoholism) (to A.J.S.). This is original work and is not under consideration for publication elsewhere. It has been previously presented in part at the 2012 annual meeting of the American Association for Study of Liver Diseases (Digestive Diseases Week; San Diego, CA, USA; May 2012).	Alkhouri Naim, 2009, Expert Rev Gastroenterol Hepatol, V3, P445, DOI 10.1586/egh.09.32; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; ARANY E, 1994, J CLIN ENDOCR METAB, V79, P1871, DOI 10.1210/jc.79.6.1871; Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019; Baffy G, 2012, J HEPATOL, V56, P1384, DOI 10.1016/j.jhep.2011.10.027; Baxter RC, 2001, J CLIN PATHOL-MOL PA, V54, P145, DOI 10.1136/mp.54.3.145; Baxter RC, 2014, NAT REV CANCER, V14, P329, DOI 10.1038/nrc3720; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Brunt EM, 2007, MODERN PATHOL, V20, pS40, DOI 10.1038/modpathol.3800680; Brunt EM, 1999, LIVER, V19, P263, DOI 10.1111/j.1478-3231.1999.tb00047.x; Butt AJ, 1999, IMMUNOL CELL BIOL, V77, P256, DOI 10.1046/j.1440-1711.1999.00822.x; Cha SJ, 2015, J EXP MED, V212, P1391, DOI 10.1084/jem.20110575; Chitturi S, 2002, HEPATOLOGY, V35, P373, DOI 10.1053/jhep.2002.30692; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Frystyk J, 1999, DIABETES-METAB RES, V15, P314, DOI 10.1002/(SICI)1520-7560(199909/10)15:5<314::AID-DMRR56>3.0.CO;2-E; Fuchs M, 2012, J HEPATOL, V56, P291, DOI 10.1016/j.jhep.2011.05.019; Ganz M, 2013, HEPATOL INT, V7, pS771, DOI 10.1007/s12072-013-9468-6; Grkovic S, 2013, ONCOGENE, V32, P2412, DOI 10.1038/onc.2012.264; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Hoque R, 2013, J HEPATOL, V58, P1047, DOI 10.1016/j.jhep.2012.12.017; Ibanez de Caceres I, 2010, ONCOGENE, V29, P1681, DOI 10.1038/onc.2009.454; Ingermann AR, 2010, J BIOL CHEM, V285, P30233, DOI 10.1074/jbc.M110.122226; Jogie-Brahim S, 2009, ENDOCR REV, V30, P417, DOI 10.1210/er.2008-0028; Joshi-Barve S, 2007, HEPATOLOGY, V46, P823, DOI 10.1002/hep.21752; Kim HS, 2007, PEDIATR RES, V61, P159, DOI 10.1203/pdr.0b013e31802d8a30; Kim Ho-Seong, 2013, Ann Pediatr Endocrinol Metab, V18, P9, DOI 10.6065/apem.2013.18.1.9; Lam CSP, 2010, ARTERIOSCL THROM VAS, V30, P1479, DOI 10.1161/ATVBAHA.110.203943; Lapointe A, 2009, METABOLISM, V58, P180, DOI 10.1016/j.metabol.2008.09.011; Lee YC, 2011, J BIOL CHEM, V286, P17898, DOI 10.1074/jbc.M111.231035; Leung C, 2015, WORLD J GASTROENTERO, V21, P1189, DOI 10.3748/wjg.v21.i4.1189; Li JW, 2013, BIOCHEM BIOPH RES CO, V436, P632, DOI 10.1016/j.bbrc.2013.04.111; Lomonaco R, 2012, HEPATOLOGY, V55, P1389, DOI 10.1002/hep.25539; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Martin JL, 2014, MOL CANCER THER, V13, P316, DOI 10.1158/1535-7163.MCT-13-0367; Martin JL, 1999, J BIOL CHEM, V274, P16407, DOI 10.1074/jbc.274.23.16407; Mehta HH, 2011, CANCER RES, V71, P5154, DOI 10.1158/0008-5472.CAN-10-4513; Min HK, 2015, AM J PHYSIOL-GASTR L, V308, pG794, DOI 10.1152/ajpgi.00390.2014; Min HK, 2012, CELL METAB, V15, P665, DOI 10.1016/j.cmet.2012.04.004; Mohanraj L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055084; Oy GF, 2010, INT J CANCER, V126, P350, DOI 10.1002/ijc.24727; Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5; Roelfsema V, 2001, J AM SOC NEPHROL, V12, P1297, DOI 10.1681/ASN.V1261297; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Schedlich LJ, 2007, ARCH BIOCHEM BIOPHYS, V465, P359, DOI 10.1016/j.abb.2007.06.013; Schulz N, 2013, INT J MOL SCI, V14, P18989, DOI 10.3390/ijms140918989; Williams AC, 2007, CELL DEATH DIFFER, V14, P137, DOI 10.1038/sj.cdd.4401919; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	50	14	14	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4071	4082		10.1096/fj.201600427R	http://dx.doi.org/10.1096/fj.201600427R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27553225	Green Published, Green Submitted			2022-12-26	WOS:000388201500014
J	Beerepoot, P; Lam, VM; Salahpour, A				Beerepoot, Pieter; Lam, Vincent M.; Salahpour, Ali			Pharmacological Chaperones of the Dopamine Transporter Rescue Dopamine Transporter Deficiency Syndrome Mutations in Heterologous Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; COPII; dopamine transporter; membrane protein; protein folding; DTDS; SEC24D; bupropion; ibogaine; pharmacological chaperone	SURFACE EXPRESSION; ENDOPLASMIC-RETICULUM; SEROTONIN TRANSPORTER; MEMBRANE-PROTEINS; BINDING-SITES; C-TERMINUS; COCAINE; AMPHETAMINE; RECEPTOR; EXPORT	A number of pathological conditions have been linked to mutations in the dopamine transporter gene, including hereditary dopamine transporter deficiency syndrome (DTDS). DTDS is a rare condition that is caused by autosomal recessive loss-of-function mutations in the dopamine transporter (DAT), which often affects transporter trafficking and folding. We examined the possibility of using pharmacological chaperones of DAT to rescue DTDS mutations. After screening a set of known DAT ligands for their ability to increase DAT surface expression, we found that bupropion and ibogaine increased DAT surface expression, whereas others, including cocaine and methylphenidate, had no effect. Bupropion and ibogaine increased wild type DAT protein levels and also promoted maturation of the endoplasmic reticulum (ER)-retained DAT mutant K590A. Rescue of K590A could be blocked by inhibiting ER to Golgi transport using brefeldin A. Furthermore, knockdown of coat protein complex II (COPII) component SEC24D, which is important in the ER export of wild type DAT, also blocked the rescue effects of bupropion and ibogaine. These data suggest that bupropion and ibogaine promote maturation of DAT by acting as pharmacological chaperones in the ER. Importantly, both drugs rescue DAT maturation and functional activity of the DTDS-associated mutations A314V and R445C. Together, these results are the first demonstration of pharmacological chaperoning of DAT and suggest this may be a viable approach to increase DAT levels in DTDS and other conditions associated with reduced DAT function.	[Beerepoot, Pieter; Lam, Vincent M.; Salahpour, Ali] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A8, Canada	University of Toronto	Salahpour, A (corresponding author), Dept Pharmacol & Toxicol, Rm 4302,Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	ali.salahpour@utoronto.ca	Beerepoot, Pieter/AAA-3156-2019	Beerepoot, Pieter/0000-0003-3721-3213	ERA/MRI (Early Research Award/Ministry of Research and Innovation) Ontario grant; OGS (Ontario Graduate Scholarship); CIHR (Canadian Institutes of Health Research); NSERC (Natural Science and Engineering Research Council)	ERA/MRI (Early Research Award/Ministry of Research and Innovation) Ontario grant; OGS (Ontario Graduate Scholarship)(Ontario Graduate Scholarship); CIHR (Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR)); NSERC (Natural Science and Engineering Research Council)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by an ERA/MRI (Early Research Award/Ministry of Research and Innovation) Ontario grant (to A.S.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by OGS (Ontario Graduate Scholarship) and CIHR (Canadian Institutes of Health Research) awards.; Supported by OGS and NSERC (Natural Science and Engineering Research Council) awards.	Alper K R, 2001, Alkaloids Chem Biol, V56, P1, DOI 10.1016/S0099-9598(01)56005-8; Beerepoot P., 2015, METHODS MOL BIOL, V1270, P107, DOI [10.1007/978-1-4939-2309-0_8, DOI 10.1007/978-1-4939-2309-0_8]; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Bjerggaard C, 2004, J NEUROSCI, V24, P7024, DOI 10.1523/JNEUROSCI.1863-04.2004; Bulling S, 2012, J BIOL CHEM, V287, P18524, DOI 10.1074/jbc.M112.343681; Cemma M, 2011, AUTOPHAGY, V7, P341, DOI 10.4161/auto.7.3.14046; Chiba P, 2014, PHARMACOL RES, V83, P63, DOI 10.1016/j.phrs.2013.11.009; Daws LC, 2002, BIOCHEM BIOPH RES CO, V290, P1545, DOI 10.1006/bbrc.2002.6384; El-Kasaby A, 2010, J BIOL CHEM, V285, P39201, DOI 10.1074/jbc.M110.118000; Eshaq RS, 2010, BRAIN RES, V1346, P1, DOI 10.1016/j.brainres.2010.05.030; Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200; Fortin JP, 2006, MOL PHARMACOL, V69, P1146, DOI 10.1124/mol.105.019976; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gorentla BK, 2005, NEUROPHARMACOLOGY, V49, P759, DOI 10.1016/j.neuropharm.2005.08.011; Hamilton PJ, 2013, MOL PSYCHIATR, V18, P1315, DOI 10.1038/mp.2013.102; Hansen FH, 2014, J CLIN INVEST, V124, P3107, DOI 10.1172/JCI73778; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; Koban F, 2015, J BIOL CHEM, V290, P13263, DOI 10.1074/jbc.M115.641357; Kurian MA, 2011, LANCET NEUROL, V10, P54, DOI 10.1016/S1474-4422(10)70269-6; Kurian MA, 2009, J CLIN INVEST, V119, P1595, DOI 10.1172/JCI39060; Lam VM, 2013, TRAFFIC, V14, P778, DOI 10.1111/tra.12073; Little KY, 2002, MOL PHARMACOL, V61, P436, DOI 10.1124/mol.61.2.436; Loland CJ, 2004, J BIOL CHEM, V279, P3228, DOI 10.1074/jbc.M304755200; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Miranda M, 2004, J BIOL CHEM, V279, P30760, DOI 10.1074/jbc.M312774200; Morello JP, 2000, TRENDS PHARMACOL SCI, V21, P466, DOI 10.1016/S0165-6147(00)01575-3; Ng J, 2014, BRAIN, V137, P1107, DOI 10.1093/brain/awu022; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Pinsonneault JK, 2011, NEUROPSYCHOPHARMACOL, V36, P1644, DOI 10.1038/npp.2011.45; Salahpour A, 2008, P NATL ACAD SCI USA, V105, P4405, DOI 10.1073/pnas.0707646105; Sanders CR, 2004, ANNU REV BIOPH BIOM, V33, P25, DOI 10.1146/annurev.biophys.33.110502.140348; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Schmitt KC, 2013, J PHARMACOL EXP THER, V346, P2, DOI 10.1124/jpet.111.191056; Schmitt KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025790; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Seibert FS, 1997, J BIOENERG BIOMEMBR, V29, P429, DOI 10.1023/A:1022478822214; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Sucic S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230037; Vecchio LM, 2014, MOL CELL NEUROSCI, V61, P123, DOI 10.1016/j.mcn.2014.05.007	42	24	24	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22053	22062		10.1074/jbc.M116.749119	http://dx.doi.org/10.1074/jbc.M116.749119			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27555326	hybrid, Green Published			2022-12-26	WOS:000386332600020
J	Sommese, RF; Sivaramakrishnan, S				Sommese, Ruth F.; Sivaramakrishnan, Sivaraj			Substrate Affinity Differentially Influences Protein Kinase C Regulation and Inhibitor Potency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence resonance energy transfer (FRET); inhibitor; phosphorylation; protein kinase C (PKC); substrate specificity	STRUCTURAL BASIS; PHOSPHORYLATION; PKC; DOMAIN; MOTIFS; SPECIFICITY; MECHANISMS; DISORDER; PATHWAY; CANCER	The overlapping network of kinase-substrate interactions provides exquisite specificity in cell signaling pathways, but also presents challenges to our ability to understand the mechanistic basis of biological processes. Efforts to dissect kinase-substrate interactions have been particularly limited by their inherently transient nature. Here, we use a library of FRET sensors to monitor these transient complexes, specifically examining weak interactions between the catalytic domain of protein kinase C and 14 substrate peptides. Combining results from this assay platform with those from standard kinase activity assays yields four novel insights into the kinase-substrate interaction. First, preferential binding of non-phosphorylated versus phosphorylated substrates leads to enhanced kinase-specific activity. Second, kinase-specific activity is inversely correlated with substrate binding affinity. Third, high affinity substrates can suppress phosphorylation of their low affinity counterparts. Finally, the substrate-competitive inhibitor bisindolylmaleimide I displaces low affinity substrates more potently leading to substrate selective inhibition of kinase activity. Overall, our approach complements existing structural and biophysical approaches to provide generalizable insights into the regulation of kinase activity.	[Sommese, Ruth F.; Sivaramakrishnan, Sivaraj] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Sivaramakrishnan, S (corresponding author), Univ Minnesota, 4-130 MCB,420 Washington Ave SE, Minneapolis, MN 55455 USA.	sivaraj@umn.edu			American Heart Association [13SDG14270009]; National Institutes of Health [1DP2 CA186752-01, 1-R01-GM-105646-01-A1]; NATIONAL CANCER INSTITUTE [DP2CA186752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105646] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the American Heart Association Scientist Development Grant 13SDG14270009 and National Institutes of Health Grants 1DP2 CA186752-01 and 1-R01-GM-105646-01-A1 (to S. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Altman D, 2007, PLOS BIOL, V5, P1712, DOI 10.1371/journal.pbio.0050210; AMESS B, 1992, FEBS LETT, V297, P285; Autry JM, 2012, J BIOL CHEM, V287, P39070, DOI 10.1074/jbc.M112.404434; Bauman AL, 2002, NAT CELL BIOL, V4, pE203, DOI 10.1038/ncb0802-e203; Chen CH, 2015, ONCOTARGET, V6, P15194, DOI 10.18632/oncotarget.3827; de Oliveira PSL, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad4016; DEKKER LV, 1993, FEBS LETT, V329, P129, DOI 10.1016/0014-5793(93)80208-C; DEKKER LV, 1993, J BIOL CHEM, V268, P19498; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Foda ZH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6939; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hirschi A, 2010, NAT STRUCT MOL BIOL, V17, P1051, DOI 10.1038/nsmb.1868; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; Kim J, 2016, STRUCTURE, V24, P353, DOI 10.1016/j.str.2015.11.016; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lopez-Sanchez I, 2013, P NATL ACAD SCI USA, V110, P5510, DOI 10.1073/pnas.1303392110; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Meng ZP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9357; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Schulz S, 2013, CELL SIGNAL, V25, P2485, DOI 10.1016/j.cellsig.2013.08.003; Shaffer J, 1999, BIOCHEMISTRY-US, V38, P12072, DOI 10.1021/bi991109q; Sim ATR, 1999, CELL CALCIUM, V26, P209, DOI 10.1054/ceca.1999.0072; Sivaramakrishnan S, 2011, P NATL ACAD SCI USA, V108, P20467, DOI 10.1073/pnas.1116066108; Smith IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026338; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Swanson CJ, 2014, J BIOL CHEM, V289, P17812, DOI 10.1074/jbc.M113.534750; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Verma SK, 2008, FEBS LETT, V582, P2270, DOI 10.1016/j.febslet.2008.05.028; WOODS A, 1992, J CELL SCI, V101, P277; Zhou J, 1997, BIOCHEMISTRY-US, V36, P15733, DOI 10.1021/bi971438n; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	46	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21963	21970		10.1074/jbc.M116.737601	http://dx.doi.org/10.1074/jbc.M116.737601			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27555323	Green Published, hybrid			2022-12-26	WOS:000386332600012
J	Mehmood, S; Corradi, V; Choudhury, HG; Hussain, R; Becker, P; Axford, D; Zirah, S; Rebuffat, S; Tieleman, DP; Robinson, CV; Beis, K				Mehmood, Shahid; Corradi, Valentina; Choudhury, Hassanul G.; Hussain, Rohanah; Becker, Patrick; Axford, Danny; Zirah, Severine; Rebuffat, Sylvie; Tieleman, D. Peter; Robinson, Carol V.; Beis, Konstantinos			Structural and Functional Basis for Lipid Synergy on the Activity of the Antibacterial Peptide ABC Transporter McjD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; circular dichroism (CD); lipid; membrane protein; membrane transport; molecular dynamics; structural biology; structure-function; delipidation; non-denaturing mass spectrometry	BACTERIAL RNA-POLYMERASE; DIAMOND LIGHT-SOURCE; MEMBRANE-PROTEIN; MOLECULAR-DYNAMICS; CIRCULAR-DICHROISM; MICROCIN J25; FORCE-FIELD; MACROMOLECULAR CRYSTALLOGRAPHY; MAXIMUM-LIKELIHOOD; MASS-SPECTROMETER	The lipid bilayer is a dynamic environment that consists of a mixture of lipids with different properties that regulate the function of membrane proteins; these lipids are either annular, masking the protein hydrophobic surface, or specific lipids, essential for protein function. In this study, using tandem mass spectrometry, we have identified specific lipids associated with the Escherichia coli ABC transporter McjD, which translocates the antibacterial peptide MccJ25. Using non-denaturing mass spectrometry, we show that McjD in complex with MccJ25 survives the gas phase. Partial delipidation of McjD resulted in reduced ATPase activity and thermostability as shown by circular dichroism, both of which could be restored upon addition of defined E. coli lipids. We have resolved a phosphatidylglycerol lipid associated with McjD at 3.4 angstrom resolution, whereas molecular dynamic simulations carried out in different lipid environments assessed the binding of specific lipids to McjD. Combined, our data show a synergistic effect of zwitterionic and negatively charged lipids on the activity of McjD; the zwitterionic lipids provide structural stability to McjD, whereas the negatively charged lipids are essential for its function.	[Mehmood, Shahid; Robinson, Carol V.] Univ Oxford, Dept Chem, S Parks Rd, Oxford OX1 3QZ, England; [Corradi, Valentina; Tieleman, D. Peter] Univ Calgary, Ctr Mol Simulat, Calgary, AB T2N 1N4, Canada; [Corradi, Valentina; Tieleman, D. Peter] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Choudhury, Hassanul G.; Becker, Patrick; Beis, Konstantinos] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England; [Choudhury, Hassanul G.; Becker, Patrick; Beis, Konstantinos] Harwell Sci & Innovat Campus, Membrane Prot Lab, Didcot OX11 0DE, Oxon, England; [Hussain, Rohanah; Axford, Danny] Harwell Sci & Innovat Campus, Diamond Light Source, Didcot OX11 0DE, Oxon, England; [Choudhury, Hassanul G.; Becker, Patrick; Beis, Konstantinos] Res Complex Harwell, Rutherford Appleton Lab, Didcot OX11 0DE, Oxon, England; [Zirah, Severine; Rebuffat, Sylvie] Univ Paris 04, Museum Natl Hist Nat, CNRS, Commun Mol & Adaptat Microorganisms Lab MCAM,UMR, CP 54,57 Rue Cuvier, F-75005 Paris, France; [Choudhury, Hassanul G.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia	University of Oxford; University of Calgary; University of Calgary; Imperial College London; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Diamond Light Source; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Queensland	Robinson, CV (corresponding author), Univ Oxford, Dept Chem, S Parks Rd, Oxford OX1 3QZ, England.; Beis, K (corresponding author), Imperial Coll London, Dept Life Sci, London SW7 2AZ, England.; Beis, K (corresponding author), Harwell Sci & Innovat Campus, Membrane Prot Lab, Didcot OX11 0DE, Oxon, England.; Beis, K (corresponding author), Res Complex Harwell, Rutherford Appleton Lab, Didcot OX11 0DE, Oxon, England.	carol.robinson@chem.ox.ac.uk; kbeis@imperial.ac.uk	Corradi, Valentina/G-3937-2017; Rebuffat, Sylvie/AAE-4194-2021; Corradi, Valentina/N-9312-2019; Zirah, Severine/C-9193-2012; Rebuffat, Sylvie/AAO-2072-2020	Zirah, Severine/0000-0001-6082-8414; robinson, carol/0000-0001-7829-5505; Rebuffat, Sylvie/0000-0002-5257-5039; Beis, Konstantinos/0000-0001-5727-4721	Wellcome Trust [WT/099165/Z/12/Z]; ERC IMPRESS Grant [26851]; Medical Research Council [98101]; BBSRC [BB/H01778X/1] Funding Source: UKRI; MRC [MR/N020413/1, G1000819] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H01778X/1] Funding Source: researchfish; Medical Research Council [MR/N020413/1, G1000819] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); ERC IMPRESS Grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to NanoTemper Technologies GmbH and Dr. James Wilkinson for kindly providing the Prometheus NT.48 instrument for the nano-DSF measurements; we also thank Dr. Wilkinson for help with data analysis. We thank C. Bechara (University of Oxford) for help with the LC-MS experiments. We thank the Diamond Light Source for beam time allocation and access. We thank Dr. Gurpreet Singh, Department of Biological Sciences, University of Calgary, for suggestions and help with the programming component of the MD simulations analyses. MD simulations were carried out on WestGrid/Compute Canada facilities. Membrane Protein Lab is funded by Wellcome Trust Grant WT/099165/Z/12/Z (to Professor So Iwata). The Oxford University Mass Spectrometry facility is funded by ERC IMPRESS Grant 26851 and Medical Research Council Grant 98101.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Bechara C, 2015, NAT CHEM, V7, P255, DOI [10.1038/NCHEM.2172, 10.1038/nchem.2172]; Benesch JLP, 2009, ANAL CHEM, V81, P1270, DOI 10.1021/ac801950u; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choudhury HG, 2014, P NATL ACAD SCI USA, V111, P9145, DOI 10.1073/pnas.1320506111; Contreras FX, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004705; Corbalan N, 2013, J BACTERIOL, V195, P5352, DOI 10.1128/JB.00824-13; Dahlberg M, 2010, J CHEM THEORY COMPUT, V6, P1638, DOI 10.1021/ct900654e; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Drachmann ND, 2014, FEBS J, V281, P4249, DOI 10.1111/febs.12957; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Habeck M, 2015, J BIOL CHEM, V290, P4829, DOI 10.1074/jbc.M114.611384; Haviv H, 2013, J BIOL CHEM, V288, P10073, DOI 10.1074/jbc.M112.446997; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hussain R, 2015, J SYNCHROTRON RADIAT, V22, P862, DOI 10.1107/S1600577515007602; Hussain R, 2012, J SYNCHROTRON RADIAT, V19, P132, DOI 10.1107/S0909049511038982; Javorfi T, 2010, CHIRALITY, V22, pE149, DOI 10.1002/chir.20924; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kalli AC, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004123; Kim JM, 2015, NATURE, V517, P396, DOI 10.1038/nature13872; Koshy C, 2013, EMBO J, V32, P3096, DOI 10.1038/emboj.2013.226; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lee AG, 2011, BIOCHEM SOC T, V39, P761, DOI 10.1042/BST0390761; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Marcoux J, 2013, P NATL ACAD SCI USA, V110, P9704, DOI 10.1073/pnas.1303888110; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Martens C, 2016, NAT STRUCT MOL BIOL, V23, P744, DOI 10.1038/nsmb.3262; Mathavan I, 2014, NAT CHEM BIOL, V10, P340, DOI [10.1038/nchembio.1499, 10.1038/NCHEMBIO.1499]; Mathavan I, 2012, BIOCHEM SOC T, V40, P1539, DOI 10.1042/BST20120176; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Periole X, 2009, J CHEM THEORY COMPUT, V5, P2531, DOI 10.1021/ct9002114; Picas L, 2010, BBA-BIOMEMBRANES, V1798, P291, DOI 10.1016/j.bbamem.2009.06.024; Reading E, 2015, CHEM BIOL, V22, P593, DOI 10.1016/j.chembiol.2015.04.016; Rosengren KJ, 2003, J AM CHEM SOC, V125, P12464, DOI 10.1021/JA0367703; Semenova E, 2005, J BACTERIOL, V187, P3859, DOI 10.1128/JB.187.11.3859-3863.2005; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Sonntag Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1307; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; Szewczyk P, 2015, ACTA CRYSTALLOGR D, V71, P732, DOI 10.1107/S1399004715000978; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vincent PA, 2005, BIOCHEM BIOPH RES CO, V331, P549, DOI 10.1016/j.bbrc.2005.03.220; Vitrac H, 2013, J BIOL CHEM, V288, P5873, DOI 10.1074/jbc.M112.442988; Wassenaar TA, 2015, J CHEM THEORY COMPUT, V11, P2144, DOI 10.1021/acs.jctc.5b00209; Wilson KA, 2003, J AM CHEM SOC, V125, P12475, DOI 10.1021/JA036756q; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Zirah S, 2011, J AM SOC MASS SPECTR, V22, P467, DOI 10.1007/s13361-010-0028-1	58	22	23	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21656	21668		10.1074/jbc.M116.732107	http://dx.doi.org/10.1074/jbc.M116.732107			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27555327	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000385999200031
J	Cardoso, J; Mesquita, M; Pereira, AD; Bettencourt-Dias, M; Chaves, P; Pereira-Leal, JB				Cardoso, Joana; Mesquita, Marta; Pereira, Antonio Dias; Bettencourt-Dias, Monica; Chaves, Paula; Pereira-Leal, Jose B.			CYR61 and TAZ Upregulation and Focal Epithelial to Mesenchymal Transition May Be Early Predictors of Barrett's Esophagus Malignant Progression	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; GENE-EXPRESSION; PROGNOSTIC-SIGNIFICANCE; COLORECTAL-CANCER; POOR-PROGNOSIS; ADENOCARCINOMA; BIOMARKERS; SURVEILLANCE; GROWTH; PROLIFERATION	Barrett's esophagus is the major risk factor for esophageal adenocarcinoma. It has a low but non-neglectable risk, high surveillance costs and no reliable risk stratification markers. We sought to identify early biomarkers, predictive of Barrett's malignant progression, using a meta-analysis approach on gene expression data. This in silico strategy was followed by experimental validation in a cohort of patients with extended follow up from the Instituto Portugues de Oncologia de Lisboa de Francisco Gentil EPE (Portugal). Bioinformatics and systems biology approaches singled out two candidate predictive markers for Barrett's progression, CYR61 and TAZ. Although previously implicated in other malignancies and in epithelial-to-mesenchymal transition phenotypes, our experimental validation shows for the first time that CYR61 and TAZ have the potential to be predictive biomarkers for cancer progression. Experimental validation by reverse transcriptase quantitative PCR and immunohistochemistry confirmed the up-regulation of both genes in Barrett's samples associated with high-grade dysplasia/adenocarcinoma. In our cohort CYR61 and TAZ up-regulation ranged from one to ten years prior to progression to adenocarcinoma in Barrett's esophagus index samples. Finally, we found that CYR61 and TAZ over-expression is correlated with early focal signs of epithelial to mesenchymal transition. Our results highlight both CYR61 and TAZ genes as potential predictive biomarkers for stratification of the risk for development of adenocarcinoma and suggest a potential mechanistic route for Barrett's esophagus neoplastic progression.	[Cardoso, Joana; Bettencourt-Dias, Monica; Pereira-Leal, Jose B.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Cardoso, Joana; Pereira-Leal, Jose B.] Ophi Precis Med, Lisbon, Portugal; [Mesquita, Marta; Chaves, Paula] EPE, Inst Portugues Oncol Lisboa Francisco Gentil, Serv Anat Patol, Lisbon, Portugal; [Mesquita, Marta; Pereira, Antonio Dias; Chaves, Paula] Univ Beira Interior, Fac Ciencias Saude, Covilha, Portugal; [Pereira, Antonio Dias] EPE, Inst Portugues Oncol Lisboa Francisco Gentil, Serv Gastrenterol, Lisbon, Portugal	Instituto Gulbenkian de Ciencia; Universidade da Beira Interior	Cardoso, J (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.; Cardoso, J (corresponding author), Ophi Precis Med, Lisbon, Portugal.	jvaz@ophiomics.com	Bettencourt-Dias, Monica/B-5176-2015	Bettencourt-Dias, Monica/0000-0003-1987-5598; Dias Pereira, Antonio/0000-0002-7695-974X; Chaves, Paula/0000-0002-0732-2059; Cardoso, Joana/0000-0002-8720-8845; Pereira Leal, Jose/0000-0002-3111-7119; Mesquita, Marta/0000-0003-4738-8949	FCT [HMSP-CTSAU-ICT-0075-2009, SFRH-BPD-26487-2006]; Ophiomics Precision Medicine; Fundação para a Ciência e a Tecnologia [HMSP-CT/SAU-ICT/0075/2009] Funding Source: FCT	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Ophiomics Precision Medicine; Fundação para a Ciência e a Tecnologia	This work was supported by funding from FCT grants HMSP-CTSAU-ICT-0075-2009 and SFRH-BPD-26487-2006. Ophiomics Precision Medicine provided support in the form of salaries for authors JC and JPL but these funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aldulaimi DM, 2005, EUR J GASTROEN HEPAT, V17, P943, DOI 10.1097/00042737-200509000-00010; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bhat KPL, 2011, GENE DEV, V25, P2594, DOI 10.1101/gad.176800.111; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chandrasoma PT, 2001, AM J SURG PATHOL, V25, P1188, DOI 10.1097/00000478-200109000-00010; Chaqour B, 2006, FEBS J, V273, P3639, DOI 10.1111/j.1742-4658.2006.05360.x; Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chen G, 2011, AFR J PHARM PHARMACO, V5, P2517, DOI 10.5897/AJPP11.708; Chintalapudi MR, 2008, CARCINOGENESIS, V29, P696, DOI 10.1093/carcin/bgn019; Cook MB, 2007, CANCER EPIDEM BIOMAR, V16, P2090, DOI 10.1158/1055-9965.EPI-07-0432; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; D'Antonio KB, 2010, J UROLOGY, V183, P1604, DOI 10.1016/j.juro.2009.12.006; de Cristofaro T, 2011, EUR J CANCER, V47, P926, DOI 10.1016/j.ejca.2010.11.008; Di Martino E, 2006, BIOMARKERS, V11, P547, DOI 10.1080/13547500600896791; Duggan SP, 2006, CARCINOGENESIS, V27, P319, DOI 10.1093/carcin/bgi211; Edgren G, 2013, GUT, V62, P1406, DOI 10.1136/gutjnl-2012-302412; Errani C, 2011, GENE CHROMOSOME CANC, V50, P644, DOI 10.1002/gcc.20886; Farragher SM, 2008, HISTOCHEM CELL BIOL, V130, P435, DOI 10.1007/s00418-008-0479-7; Fitzgerald R, 2011, PRE-INVASIVE DISEASE: PATHOGENESIS AND CLINICAL MANAGEMENT, P315, DOI 10.1007/978-1-4419-6694-0_16; Fitzgerald RC, 2014, GUT, V63, P7, DOI 10.1136/gutjnl-2013-305372; Franzen CA, 2009, MOL CANCER RES, V7, P1045, DOI 10.1158/1541-7786.MCR-09-0017; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Haque I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-8; Hirst NG, 2011, J GASTROEN HEPATOL, V26, P247, DOI 10.1111/j.1440-1746.2010.06506.x; Hong Y, 2007, CLIN CANCER RES, V13, P1107, DOI 10.1158/1078-0432.CCR-06-1633; Hsu YL, 2015, ONCOGENE, V34, P4056, DOI 10.1038/onc.2014.333; Hvid-Jensen F, 2011, NEW ENGL J MED, V365, P1375, DOI 10.1056/NEJMoa1103042; Jechlinger M, 2003, ONCOGENE, V22, P7155, DOI 10.1038/sj.onc.1206887; Kim H, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-51; Kimchi ET, 2005, CANCER RES, V65, P3146, DOI 10.1158/0008-5472.CAN-04-2490; Kok SH, 2010, HEAD NECK-J SCI SPEC, V32, P1665, DOI 10.1002/hed.21381; Ladwa R, 2011, J CLIN PATHOL, V64, P58, DOI 10.1136/jcp.2010.082768; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Leopold PL, 2012, SEMIN CANCER BIOL, V22, P471, DOI 10.1016/j.semcancer.2012.07.003; Li ZY, 2012, COMPUT ENG APPL, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0040132; Lin MT, 2007, J BIOL CHEM, V282, P34594, DOI 10.1074/jbc.M706600200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maity G, 2014, SCI REP-UK, V4, DOI 10.1038/srep04995; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Modak C, 2010, BIOCHEM BIOPH RES CO, V392, P533, DOI 10.1016/j.bbrc.2010.01.057; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Moyes LH, 2011, J CLIN PATHOL, V64, P742, DOI 10.1136/jclinpath-2011-200084; Nancarrow DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022513; Ong CAJ, 2010, WORLD J GASTROENTERO, V16, P5669, DOI 10.3748/wjg.v16.i45.5669; Paik S, 2005, NAT CLIN PRACT ONCOL, V2, P246, DOI 10.1038/ncponc0171; Pan J, 2012, ONCOL REP, V28, P179, DOI 10.3892/or.2012.1751; Park WG, 2015, AM J GASTROENTEROL, V110, P60, DOI 10.1038/ajg.2014.384; R Development Core Team, 2009, R A LANGUAGE AND ENV; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Sabile AA, 2012, J BONE MINER RES, V27, P58, DOI 10.1002/jbmr.535; Selaru FM, 2007, BIOINFORM BIOL INSIG, V1, P127; Shen HM, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0117-2; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Somerville M, 2008, EUR J CANCER, V44, P588, DOI 10.1016/j.ejca.2008.01.015; Spechler SJ, 2010, GASTROENTEROLOGY, V138, P854, DOI 10.1053/j.gastro.2010.01.002; Stairs DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003534; Tang QL, 2011, ORAL ONCOL, V47, P365, DOI 10.1016/j.oraloncology.2011.02.022; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Terada N, 2012, PROSTATE, V72, P966, DOI 10.1002/pros.21501; Terada N, 2012, ASIAN J ANDROL, V14, P405, DOI 10.1038/aja.2011.149; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tomizawa Y, 2012, ONCOL LETT, V3, P1059, DOI 10.3892/ol.2012.632; Tsai MS, 2002, ONCOGENE, V21, P8178, DOI 10.1038/sj.onc.1205682; Varghese S, 2012, GASTROENTEROLOGY, V142, P435, DOI 10.1053/j.gastro.2012.01.013; Wang J, 2009, J GASTROENTEROL, V44, P897, DOI 10.1007/s00535-009-0082-2; Wang KK, 2008, AM J GASTROENTEROL, V103, P788, DOI 10.1111/j.1572-0241.2008.01835.x; Watts GS, 2007, INT J CANCER, V121, P2132, DOI 10.1002/ijc.22898; Whiteman DC, 2015, J GASTROEN HEPATOL, V30, P804, DOI 10.1111/jgh.12913; Xie D, 2004, CLIN CANCER RES, V10, P2072, DOI 10.1158/1078-0432.CCR-0659-03; Xie JJ, 2011, INT J MOL MED, V27, P429, DOI 10.3892/ijmm.2011.603; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao ZS, 2011, J SURG ONCOL, V104, P525, DOI 10.1002/jso.21984; Zhou Z, 2011, ONCOGENE, V30, P2181, DOI 10.1038/onc.2010.606; Zhou ZQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-291; Zilliox MJ, 2007, NAT METHODS, V4, P911, DOI 10.1038/NMETH1102	82	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161967	10.1371/journal.pone.0161967	http://dx.doi.org/10.1371/journal.pone.0161967			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583562	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600079
J	Constant, D; Harries, J; Malaba, T; Myer, L; Patel, M; Petro, G; Grossman, D				Constant, Deborah; Harries, Jane; Malaba, Thokozile; Myer, Landon; Patel, Malika; Petro, Gregory; Grossman, Daniel			Clinical Outcomes and Women's Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa	PLOS ONE			English	Article							2ND TRIMESTER ABORTION; RANDOMIZED CONTROLLED-TRIAL; PREGNANCY; TERMINATION; MISOPROSTOL; ACCEPTABILITY; INTERVALS; SAFETY; INDIA; CARE	Objective To document clinical outcomes and women's experiences following the introduction of mifepristone into South African public sector second-trimester medical abortion services, and compare with historic cohorts receiving misoprostol-only. Methods Repeated cross-sectional observational studies documented service delivery and experiences of women undergoing second-trimester medical abortion in public sector hospitals in the Western Cape, South Africa. Women recruited to the study in 2008 (n = 84) and 2010 (n = 58) received misoprostol only. Those recruited in 2014 (n = 208) received mifepristone and misoprostol. Consenting women were interviewed during hospitalization by study field-workers with respect to socio-demographic information, reproductive history, and their experiences with the abortion. Clinical details were extracted from medical charts following discharge. Telephone follow-up interviews to record delayed complications were conducted 2-4 weeks after discharge for the 2014 cohort. Results The 2014 cohort received 200 mg mifepristone, which was self-administered 24-48 hours prior to admission. For all cohorts, following hospital admission, initial misoprostol doses were generally administered vaginally: 800 mcg in the 2014 cohort and 600 mcg in the earlier cohorts. Women received subsequent doses of misoprostol 400 mcg orally every 3-4 hours until fetal expulsion. Thereafter, uterine evacuation of placental tissue was performed as needed. With one exception, all women in all cohorts expelled the fetus. Median time-to-fetal expulsion was reduced to 8.0 hours from 14.5 hours (p<0.001) in the mifepristone compared to the 2010 misoprostol-only cohort (time of fetal expulsion was not recorded in 2008). Uterine evacuation of placental tissue using curettage or vacuum aspiration was more often performed (76% vs. 58%, p<0.001) for those receiving mifepristone; major complication rates were unchanged. Hospitalization duration and extreme pain levels were reduced (p<0.001), but side effects of medication were similar or more common for the mifepristone cohort. Overall satisfaction remained unchanged (95% vs. 91%), while other acceptability measures were higher (p<0.001) for the mifepristone compared to the misoprostol-only cohorts. Conclusion The introduction of a combined mifepristone-misoprostol regimen into public sector second-trimester medical abortion services in South Africa has been successful with shorter time-to-abortion events, less extreme pain and greater acceptability for women. High rates of uterine evacuation for placental tissue need to be addressed.	[Constant, Deborah; Harries, Jane; Malaba, Thokozile] Univ Cape Town, Sch Publ Hlth & Family Med, Womens Hlth Res Unit, Cape Town, South Africa; [Constant, Deborah; Malaba, Thokozile; Myer, Landon] Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, Cape Town, South Africa; [Patel, Malika; Petro, Gregory] Univ Cape Town, Dept Obstet & Gynaecol, Cape Town, South Africa; [Patel, Malika] Groote Schuur Hosp, Cape Town, South Africa; [Petro, Gregory] New Somerset Hosp, Cape Town, South Africa; [Grossman, Daniel] Ibis Reprod Hlth, Oakland, CA USA; [Grossman, Daniel] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod, Bixby Ctr Global Reprod Hlth, ANSIRH, Oakland, CA USA	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; University of California System; University of California San Francisco	Constant, D (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Womens Hlth Res Unit, Cape Town, South Africa.; Constant, D (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, Cape Town, South Africa.	Deborah.constant@uct.ac.za	Harries, Jane/R-6504-2019; Petro, Gregory A/I-6563-2016	Harries, Jane/0000-0001-7359-8419; Petro, Gregory A/0000-0003-4529-2820; Malaba, Thokozile/0000-0003-0938-5587; Constant, Deborah/0000-0002-7176-9963	Safe Abortion Action Fund; William and Flora Hewlett Foundation; University of Cape Town Research office; South African Medical Research Council; Harry Crossley Clinical Research Fellowship	Safe Abortion Action Fund; William and Flora Hewlett Foundation; University of Cape Town Research office; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Harry Crossley Clinical Research Fellowship	The study was funded by the Safe Abortion Action Fund with contributions from the William and Flora Hewlett Foundation, the University of Cape Town Research office, the South African Medical Research Council and the Harry Crossley Clinical Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson IM, 2014, CONTRACEPTION, V89, P460, DOI 10.1016/j.contraception.2014.01.012; [Anonymous], 2013, Obstet Gynecol, V121, P1394, DOI 10.1097/01.AOG.0000431056.79334.cc; [Anonymous], 2014, SINJ TOPS 2014 2015; Ashok PW, 2004, CONTRACEPTION, V69, P51, DOI 10.1016/j.contraception.2003.09.006; Baldwin M, 2014, CONTRACEPTION, V90, P562, DOI 10.1016/j.contraception.2014.08.010; Basu J. K., 2012, Southern African Journal of Epidemiology & Infection, V27, P34; Berer M, 2008, REPROD HEALTH MATTER, V16, P3, DOI 10.1016/S0968-8080(08)31395-0; Cleeve A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149172; Dabash R, 2015, INT J GYNECOL OBSTET, V130, P40, DOI 10.1016/j.ijgo.2015.02.023; Dalvie SS, 2008, REPROD HEALTH MATTER, V16, P37, DOI 10.1016/S0968-8080(08)31384-6; Dickinson JE, 2010, AUST NZ J OBSTET GYN, V50, P60, DOI 10.1111/j.1479-828X.2009.01117.x; Edelman A, 2015, INT J GYNECOL OBSTET, V128, P177, DOI 10.1016/j.ijgo.2014.07.035; Gewell-Danielsson K, 2008, REPROD HEALTH MATTER, V16, P162, DOI 10.1016/S0968-8080(08)31371-8; Goh SE, 2006, CONTRACEPTION, V73, P516, DOI 10.1016/j.contraception.2005.12.004; Grossman D, 2008, REPROD HEALTH MATTER, V16, P173, DOI 10.1016/S0968-8080(08)31379-2; Grossman D, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-224; Harries J, 2012, J BIOSOC SCI, V44, P197, DOI 10.1017/S0021932011000678; Harries J, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-16; Harris LH, 2008, REPROD HEALTH MATTER, V16, P74, DOI 10.1016/S0968-8080(08)31396-2; Harris LH, 2011, INT J GYNECOL OBSTET, V115, P77, DOI 10.1016/j.ijgo.2011.05.018; Hoang TTD, 2008, REPROD HEALTH MATTER, V16, P145, DOI 10.1016/S0968-8080(08)31393-7; Hou SP, 2010, INT J GYNECOL OBSTET, V111, P126, DOI 10.1016/j.ijgo.2010.06.008; Kallner HK, 2015, BJOG-INT J OBSTET GY, V122, P510, DOI 10.1111/1471-0528.12982; Kallner HK, 2012, CONTRACEPTION, V85, P394, DOI 10.1016/j.contraception.2011.08.009; Kapp N, 2007, OBSTET GYNECOL, V110, P1304, DOI 10.1097/01.AOG.0000289577.32274.a5; Kranti KK, 2014, J OBSTET GYN INDIA, V64, P102, DOI 10.1007/s13224-013-0472-5; Lalitkumar S, 2007, HUM REPROD UPDATE, V13, P37, DOI 10.1093/humupd/dml049; Mentula M, 2011, HUM REPROD, V26, P2690, DOI 10.1093/humrep/der218; Ngo TD, 2011, B WORLD HEALTH ORGAN, V89, P360, DOI 10.2471/BLT.10.084046; Ngoc Nguyen Thi Nhu, 2011, Obstet Gynecol, V118, P601, DOI 10.1097/AOG.0b013e318227214e; Paul M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133354; Rose SB, 2006, AUST NZ J OBSTET GYN, V46, P479, DOI 10.1111/j.1479-828X.2006.00646.x; Samandari G, 2012, REPROD HLTH, V9, P1742; Tripti N, 2011, J OBSTET GYN INDIA, V61, P659, DOI 10.1007/s13224-011-0118-4; World Health Organization, 2014, CLIN PRACT HDB SAF A; Zavier AJF, 2012, GLOB PUBLIC HEALTH, V7, P897, DOI 10.1080/17441692.2011.651734; Zhirova IA, 2004, STUD FAMILY PLANN, V35, P178, DOI 10.1111/j.1728-4465.2004.00021.x	37	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161843	10.1371/journal.pone.0161843	http://dx.doi.org/10.1371/journal.pone.0161843			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583448	Green Submitted, Green Published, gold			2022-12-26	WOS:000382855600066
J	Huang, CH; Li, HJ; Wu, NL; Hsiao, CY; Lin, CN; Chang, HH; Hung, CF				Huang, Cheng-Hua; Li, Hsin-Ju; Wu, Nan-Lin; Hsiao, Chien-Yu; Lin, Chun-Nan; Chang, Hsun-Hsien; Hung, Chi-Feng			Photoprotective Effects of Cycloheterophyllin against UVA-Induced Damage and Oxidative Stress in Human Dermal Fibroblasts	PLOS ONE			English	Article							ULTRAVIOLET-B IRRADIATION; EPIDERMAL-GROWTH-FACTOR; HAIR FOLLICLE; SIGNAL-TRANSDUCTION; HUMAN KERATINOCYTES; MELANIN; ACTIVATION; RECEPTOR; STIMULATION; ANTIOXIDANT	Ultraviolet (UV) radiation, particularly ultraviolet A (UVA), is known to play a major role in photoaging of the human skin. Many studies have demonstrated that UV exposure causes the skin cells to generate reactive oxygen species and activates the mitogen-activated protein kinase (MAPK) pathway. Previous studies have also demonstrated that cycloheterophyllin has an antioxidant effect and can effectively scavenge free radicals. Extending the aforementioned investigations, in this study, human dermal fibroblasts were used to investigate the protective effect of cycloheterophyllin against UV-induced damage. We found that cycloheterophyllin not only significantly increased cell viability, but also attenuated the phosphorylation of MAPK after UVA exposure. Furthermore, cycloheterophyllin could reduce hydrogen peroxide (H2O2) generation and down-regulate H2O2-induced MAPK phosphorylation. In the in vivo studies, the topical application of cycloheterophyllin before UVA irradiation significantly decreased trans-epidermal water loss (TEWL), erythema, and blood flow rate. These results indicate that cycloheterophyllin is a photoprotective agent that inhibits UVA-induced oxidative stress and damage, and could be used in the research on and prevention of skin photoaging.	[Huang, Cheng-Hua; Hung, Chi-Feng] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Huang, Cheng-Hua] Cathay Gen Hosp, Dept Internal Med, Taipei, Taiwan; [Li, Hsin-Ju] Fu Jen Catholic Univ, Dept Chem, New Taipei, Taiwan; [Wu, Nan-Lin] Mackay Med Coll, Dept Med, New Taipei, Taiwan; [Wu, Nan-Lin] Mackay Mem Hosp, Dept Dermatol, Taipei, Taiwan; [Wu, Nan-Lin] Mackay Jr Coll Med Nursing & Management, New Taipei, Taiwan; [Hsiao, Chien-Yu] Chang Gung Univ Sci & Technol, Dept Nutr & Hlth Sci, Taoyuan, Taiwan; [Hsiao, Chien-Yu] Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Taoyuan, Taiwan; [Lin, Chun-Nan] Kaohsiung Med Univ, Coll Pharm, Kaohsiung, Taiwan; [Chang, Hsun-Hsien] Harvard Med Sch, Biomed Cybernet Lab, Boston, MA USA	Fu Jen Catholic University; Cathay General Hospital; Fu Jen Catholic University; Mackay Medical College; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; Kaohsiung Medical University; Harvard University; Harvard Medical School	Hung, CF (corresponding author), Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan.	skin@mail.fju.edu.tw	Hung, Chi-Feng/AAL-4977-2021	Hung, Chi-Feng/0000-0003-3478-5451	Fu-Jen Catholic University; Ministry of Science and Technology and Cathay General Hospital in Taiwan	Fu-Jen Catholic University; Ministry of Science and Technology and Cathay General Hospital in Taiwan	This work is supported by research grants from Fu-Jen Catholic University, Ministry of Science and Technology and Cathay General Hospital in Taiwan.r This work was supported by research grants from the Fu-Jen Catholic University, the Ministry of Science and Technology, and the Cathay General Hospital in Taiwan.	Afaq F, 2011, ARCH BIOCHEM BIOPHYS, V508, P144, DOI 10.1016/j.abb.2010.12.007; Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Ashida M, 2003, EXP DERMATOL, V12, P445, DOI 10.1034/j.1600-0625.2003.00101.x; Assefa Z, 1997, J INVEST DERMATOL, V108, P886, DOI 10.1111/1523-1747.ep12292595; Bikle DD, 2011, DISCOV MED, V11, P7; Brenner M, 2008, PHOTOCHEM PHOTOBIOL, V84, P539, DOI 10.1111/j.1751-1097.2007.00226.x; BUSTAMANTE J, 1993, PIGM CELL RES, V6, P348, DOI 10.1111/j.1600-0749.1993.tb00612.x; Cao C, 2008, J CELL PHYSIOL, V215, P506, DOI 10.1002/jcp.21336; CHASE HB, 1954, PHYSIOL REV, V34, P113, DOI 10.1152/physrev.1954.34.1.113; Chouinard N, 2002, BIOCHEM J, V365, P133, DOI 10.1042/BJ20020072; Fisher G J, 1998, J Investig Dermatol Symp Proc, V3, P61; Geyfman M, 2015, BIOL REV, V90, P1179, DOI 10.1111/brv.12151; Guo W, 2010, PHYTOTHER RES, V24, P352, DOI 10.1002/ptr.2943; Hema M. R., 2011, Research Journal of Pharmaceutical, Biological and Chemical Sciences, V2, P886; Hou LC, 2013, EXP TOXICOL PATHOL, V65, P1145, DOI 10.1016/j.etp.2013.05.006; Huang CC, 2005, ARCH DERMATOL RES, V296, P473, DOI 10.1007/s00403-005-0540-5; Hung CF, 2013, FASEB J, P27; Ito T, 2010, J DERMATOL SCI, V60, P67, DOI 10.1016/j.jdermsci.2010.09.006; Jantan I, 2010, J NAT MED-TOKYO, V64, P365, DOI 10.1007/s11418-010-0410-0; KAIDBEY KH, 1979, J AM ACAD DERMATOL, V1, P249, DOI 10.1016/S0190-9622(79)70018-1; Ko FN, 1998, FREE RADICAL BIO MED, V25, P160, DOI 10.1016/S0891-5849(98)00031-8; Lin CN, 1996, J NAT PROD, V59, P834, DOI 10.1021/np960376j; Liu HS, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-18; Matsumura Yasuhiro, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S146239940200532X; McCord JM, 2000, AM J MED, V108, P652, DOI 10.1016/S0002-9343(00)00412-5; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Muthusamy V, 2010, ARCH DERMATOL RES, V302, P5, DOI 10.1007/s00403-009-0994-y; Nichols JA, 2010, ARCH DERMATOL RES, V302, P71, DOI 10.1007/s00403-009-1001-3; Ohnemus U, 2006, ENDOCR REV, V27, P677, DOI 10.1210/er.2006-0020; Ortonne JP, 2002, BRIT J DERMATOL, V146, P7, DOI 10.1046/j.1365-2133.146.s61.3.x; Pattison DI, 2006, EXP SUPPL, V96, P131; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Rittie L, 2002, AGEING RES REV, V1, P705, DOI 10.1016/S1568-1637(02)00024-7; Rzepka Z, 2016, POSTEP HIG MED DOSW, V70, P695, DOI 10.5604/17322693.1208033; Schieke SM, 2005, J INVEST DERMATOL, V124, P857, DOI 10.1111/j.0022-202X.2005.23671.x; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Sim GS, 2007, ARCH PHARM RES, V30, P290, DOI 10.1007/BF02977608; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2014, INT J MOL SCI, V15, P17705, DOI 10.3390/ijms151017705; SLOMINSKI AT, 2014, ANTI-CANCER AGENT ME, V14, P77, DOI DOI 10.2174/18715206113139990308; Sodhi A, 2003, IMMUNOL LETT, V90, P123, DOI 10.1016/j.imlet.2003.08.008; Solano F., 2014, NEW J SCI, V2014, P498276, DOI [10.1155/2014/498276, DOI 10.1155/2014/498276]; Song XZ, 2008, INT J MOL MED, V22, P9; Svobodova A, 2007, J DERMATOL SCI, V46, P21, DOI 10.1016/j.jdermsci.2006.12.009; TYRRELL RM, 1986, PHOTOCHEM PHOTOBIOL, V44, P561, DOI 10.1111/j.1751-1097.1986.tb04709.x; van Beek N, 2008, J CLIN ENDOCR METAB, V93, P4381, DOI 10.1210/jc.2008-0283; Vanhooke JL, 2006, P NATL ACAD SCI USA, V103, P75, DOI 10.1073/pnas.0509734103; Wang JP, 1997, N-S ARCH PHARMACOL, V355, P551, DOI 10.1007/PL00004982; Wei BL, 2005, J AGR FOOD CHEM, V53, P3867, DOI 10.1021/jf047873n; Wu NL, 2011, J AGR FOOD CHEM, V59, P8391, DOI 10.1021/jf200931t; Xu YR, 2006, AM J PATHOL, V169, P823, DOI 10.2353/ajpath.2006.050449; Yusuf N, 2007, PHOTODERMATOL PHOTO, V23, P48, DOI 10.1111/j.1600-0781.2007.00262.x	52	18	18	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161767	10.1371/journal.pone.0161767	http://dx.doi.org/10.1371/journal.pone.0161767			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583973	Green Published, gold, Green Submitted			2022-12-26	WOS:000382855600058
J	Matson, PG; Ladd, TM; Halewood, ER; Sangodkar, RP; Chmelka, BF; Iglesias-Rodriguez, D				Matson, Paul G.; Ladd, Tanika M.; Halewood, Elisa R.; Sangodkar, Rahul P.; Chmelka, Bradley F.; Iglesias-Rodriguez, Debora			Intraspecific Differences in Biogeochemical Responses to Thermal Change in the Coccolithophore Emiliania huxleyi	PLOS ONE			English	Article							SOLID-STATE NMR; AMORPHOUS CALCIUM-CARBONATE; INTRACELLULAR CALCIFICATION; GENETIC DIFFERENTIATION; ELEVATED PCO(2); CA-43 NMR; GROWTH; OCEAN; TEMPERATURE; MORPHOLOGY	The species concept in marine phytoplankton is defined based on genomic, morphological, and functional properties. Reports of intraspecific diversity are widespread across major phytoplankton groups but the impacts of this variation on ecological and biogeochemical processes are often overlooked. Intraspecific diversity is well known within coccolitho-phores, which play an important role in the marine carbon cycle via production of particulate inorganic carbon. In this study, we investigated strain-specific responses to temperature in terms of morphology, carbon production, and carbonate mineralogy using a combination of microscopy, elemental analysis, flow cytometry, and nuclear magnetic resonance. Two strains of the cosmopolitan coccolithophore E. huxleyi isolated from different regions (subtropical, CCMP371; temperate, CCMP3266) were cultured under a range of temperature conditions (10 degrees C, 15 degrees C, and 20 degrees C) using batch cultures and sampled during both exponential and stationary growth. Results for both strains showed that growth rates decreased at lower temperatures while coccosphere size increased. Between 15 degrees C and 20 degrees C, both strains produced similar amounts of total carbon, but differed in allocation of that carbon between particulate inorganic carbon (PIC) and particulate organic carbon (POC), though temperature effects were not detected. Between 10 degrees C and 20 degrees C, temperature effects on daily production of PIC and POC, as well as the cellular quota of POC were detected in CCMP3266. Strain-specific differences in coccolith shedding rates were found during exponential growth. In addition, daily shedding rates were negatively related to temperature in CCMP371 but not in CCMP3266. Despite differences in rates of particulate inorganic carbon production, both strains were found to produce coccoliths composed entirely of pure calcite, as established by solid-state C-13 and Ca-43 NMR and X-ray diffraction measurements. These results highlight the limitations of the species concept and the need for a trait-based system to better quantify diversity within marine phytoplankton communities.	[Matson, Paul G.; Ladd, Tanika M.; Iglesias-Rodriguez, Debora] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Matson, Paul G.; Halewood, Elisa R.; Iglesias-Rodriguez, Debora] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Sangodkar, Rahul P.; Chmelka, Bradley F.] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Matson, PG (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.; Matson, PG (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA.	pmatson@gmail.com	Matson, Paul/AAB-9767-2019; Sangodkar, Rahul/ABD-3007-2020	Matson, Paul/0000-0003-2105-7308; Ladd, Tanika/0000-0001-5834-8358	U.S. National Science Foundation [MRI-1337400, CBET-1335694]; Materials Research Science and Engineering Center program of the U.S. National Science Foundation [DMR-1121053]	U.S. National Science Foundation(National Science Foundation (NSF)); Materials Research Science and Engineering Center program of the U.S. National Science Foundation	This work was supported in part by a grant to MDIR from the U.S. National Science Foundation award number MRI-1337400. Additional support was provided in part by a grant to BFC from the U.S. National Science Foundation award number CBET-1335694. Solid-state 13C MAS NMR measurements were conducted using the Central Facilities of the UCSB Materials Research Laboratory supported by the Materials Research Science and Engineering Center program of the U.S. National Science Foundation under award number DMR-1121053. Solid-state 43Ca MAS NMR measurements that were conducted at the U.S. National High Magnetic Field Laboratory in Tallahassee, Florida, which is supported by the U.S National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes F, 1999, OCEANOL ACTA, V22, P67, DOI 10.1016/S0399-1784(99)80034-6; Akiva-Tal A, 2011, P NATL ACAD SCI USA, V108, P14763, DOI 10.1073/pnas.1102608108; ALLDREDGE AL, 1991, DEEP-SEA RES, V38, P431, DOI 10.1016/0198-0149(91)90045-H; Andersen R. A., 2005, ALGAL CULTURING TECH; Atkinson D, 2003, P ROY SOC B-BIOL SCI, V270, P2605, DOI 10.1098/rspb.2003.2538; BALCH WM, 1993, J PHYCOL, V29, P566, DOI 10.1111/j.0022-3646.1993.00566.x; BALCH WM, 1992, CONT SHELF RES, V12, P1353, DOI 10.1016/0278-4343(92)90059-S; Balch WM, 1996, LIMNOL OCEANOGR, V41, P1684, DOI 10.4319/lo.1996.41.8.1684; Balint M, 2011, NAT CLIM CHANGE, V1, P313, DOI 10.1038/NCLIMATE1191; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Ben Shir I, 2014, ISR J CHEM, V54, P74, DOI 10.1002/ijch.201300121; Ben Shir I, 2013, CHEM MATER, V25, P4595, DOI 10.1021/cm4028226; Blanco-Ameijeiras S., 2016, PLOS ONE, V11, P1, DOI DOI 10.1371/J0URNAL.P0NE.0157697; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Bonachela JA, 2016, J PLANKTON RES, V38, P1021, DOI 10.1093/plankt/fbv087; BRAND LE, 1982, LIMNOL OCEANOGR, V27, P236, DOI 10.4319/lo.1982.27.2.0236; Bryce DL, 2008, J AM CHEM SOC, V130, P9282, DOI 10.1021/ja8017253; Bryce DL, 2010, DALTON T, V39, P8593, DOI 10.1039/c0dt00416b; Burkholder JM, 2009, HARMFUL ALGAE, V8, P744, DOI 10.1016/j.hal.2009.03.006; Cook SS, 2013, PHYCOLOGIA, V52, P368, DOI 10.2216/12-111.1; Crawford DW, 1997, LIMNOL OCEANOGR, V42, P365, DOI 10.4319/lo.1997.42.2.0365; De Bodt C, 2010, BIOGEOSCIENCES, V7, P1401, DOI 10.5194/bg-7-1401-2010; Degerlund M, 2012, J PLANKTON RES, V34, P416, DOI 10.1093/plankt/fbs004; DEJONG E, 1979, EUR J BIOCHEM, V99, P559; DEJONG EW, 1976, EUR J BIOCHEM, V70, P611; Engel A, 2009, DEEP-SEA RES PT II, V56, P1396, DOI 10.1016/j.dsr2.2008.11.027; Feng Y, 2008, EUR J PHYCOL, V43, P87, DOI 10.1080/09670260701664674; Fiorini S, 2011, J PHYCOL, V47, P1281, DOI 10.1111/j.1529-8817.2011.01080.x; Fritz JJ, 1996, J EXP MAR BIOL ECOL, V207, P127, DOI 10.1016/S0022-0981(96)02633-0; Fritz JJ, 1999, MAR BIOL, V133, P509, DOI 10.1007/s002270050491; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Gamfeldt L, 2015, OIKOS, V124, P252, DOI 10.1111/oik.01549; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; Gertman R, 2008, J AM CHEM SOC, V130, P13425, DOI 10.1021/ja803985d; Gervais C, 2008, CHEM PHYS LETT, V464, P42, DOI 10.1016/j.cplett.2008.09.004; GIRAUDEAU J, 1995, CONT SHELF RES, V15, P1825, DOI 10.1016/0278-4343(94)00095-5; Godoi RHM, 2009, MICROCHEM J, V91, P266, DOI 10.1016/j.microc.2008.12.009; Harvey EL, 2015, J PLANKTON RES, V37, P1137, DOI 10.1093/plankt/fbv081; HAYASHI S, 1991, B CHEM SOC JPN, V64, P685, DOI 10.1246/bcsj.64.685; Henderiks J, 2012, MAR ECOL PROG SER, V448, P51, DOI 10.3354/meps09535; Hoffmann R, 2015, BIOGEOSCIENCES, V12, P825, DOI 10.5194/bg-12-825-2015; HOLLIGAN PM, 1993, GLOBAL BIOGEOCHEM CY, V7, P879, DOI 10.1029/93GB01731; HONJO S, 1982, DEEP-SEA RES, V29, P609, DOI 10.1016/0198-0149(82)90079-6; Hoppe CJM, 2011, J EXP MAR BIOL ECOL, V406, P54, DOI 10.1016/j.jembe.2011.06.008; Hutchins DA, 2011, NATURE, V476, P41, DOI 10.1038/476041a; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Iglesias-Rodriguez MD, 2006, J PHYCOL, V42, P526; Iglesias-Rodriguez MD, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001454; Iglesias-Rodriguez MD., 2002, EOS T AM GEOPHYS UN, V83, P365, DOI [10.1029/2002EO000267, DOI 10.1029/2002EO000267]; Jones RH, 2002, MAR ECOL PROG SER, V235, P147, DOI 10.3354/meps235147; Kim JH, 2015, J PHYCOL, V51, P159, DOI 10.1111/jpy.12263; Kolb A, 2013, LIMNOL OCEANOGR, V58, P932, DOI 10.4319/lo.2013.58.3.0932; Kottmeier DM, 2014, PHOTOSYNTH RES, V121, P265, DOI 10.1007/s11120-014-9984-9; Langer G, 2009, BIOGEOSCIENCES, V6, P2637, DOI 10.5194/bg-6-2637-2009; Lefebvre SC, 2012, GLOBAL CHANGE BIOL, V18, P493, DOI 10.1111/j.1365-2486.2011.02575.x; MANN S, 1988, PROC R SOC SER B-BIO, V234, P441, DOI 10.1098/rspb.1988.0057; Marie D, 2014, CYTOM PART A, V85A, P962, DOI 10.1002/cyto.a.22517; Michel FM, 2008, CHEM MATER, V20, P4720, DOI 10.1021/cm800324v; MILLIMAN JD, 1993, GLOBAL BIOGEOCHEM CY, V7, P927, DOI 10.1029/93GB02524; Moudrakovski IL, 2013, ANNU REP NMR SPECTRO, V79, P129, DOI 10.1016/B978-0-12-408098-0.00004-5; Nebel H, 2008, INORG CHEM, V47, P7874, DOI 10.1021/ic8007409; Oviedo AM, 2014, J EXP MAR BIOL ECOL, V459, P105, DOI 10.1016/j.jembe.2014.04.021; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Rouco M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00155; Rynearson TA, 2005, MOL ECOL, V14, P1631, DOI 10.1111/j.1365-294X.2005.02526.x; Saruwatari K, 2015, BIOGEOSCIENCES DISCU, V2015, P17751, DOI [10.5194/bgd-12-17751-2015, DOI 10.5194/BGD-12-17751-2015]; Satoh M, 2009, MAR BIOTECHNOL, V11, P327, DOI 10.1007/s10126-008-9147-0; Schmidt K, 2014, BIOGEOSCIENCES, V11, P135, DOI 10.5194/bg-11-135-2014; Sett S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088308; Singer JW, 2012, CHEM MATER, V24, P1828, DOI 10.1021/cm300389q; Smith C.E., 2014, J DATA SCI, V12, P385, DOI 10.6339/jds.201407_12(3).0001; Sorrosa JM, 2005, MAR BIOTECHNOL, V7, P128, DOI 10.1007/s10126-004-0478-1; Stanley SM, 2005, GEOLOGY, V33, P593, DOI 10.1130/G21405.1; Thomas MK, 2012, SCIENCE, V338, P1085, DOI 10.1126/science.1224836; WESTBROEK P, 1989, J PROTOZOOL, V36, P368, DOI 10.1111/j.1550-7408.1989.tb05528.x; WILBUR KM, 1963, ANN NY ACAD SCI, V109, P82, DOI 10.1111/j.1749-6632.1963.tb13463.x; Winter A, 2014, J PLANKTON RES, V36, P316, DOI 10.1093/plankt/fbt110; YOUNG JR, 1991, MAR MICROPALEONTOL, V18, P5, DOI 10.1016/0377-8398(91)90004-P; Zuur Alain F., 2009, P1	80	12	13	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162313	10.1371/journal.pone.0162313	http://dx.doi.org/10.1371/journal.pone.0162313			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584038	gold, Green Submitted, Green Published			2022-12-26	WOS:000382855600129
J	Ochoa, M; Malbert, CH; Meurice, P; Val-Laillet, D				Ochoa, Melissa; Malbert, Charles-Henri; Meurice, Paul; Val-Laillet, David			Effects of Chronic Consumption of Sugar-Enriched Diets on Brain Metabolism and Insulin Sensitivity in Adult Yucatan Minipigs	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; EATING BEHAVIOR; PALATABLE FOOD; D2 RECEPTORS; FRUCTOSE; GLUCOSE; DOPAMINE; REWARD; RESISTANCE; OBESITY	Excessive sugar intake might increase the risk to develop eating disorders via an altered reward circuitry, but it remains unknown whether different sugar sources induce different neural effects and whether these effects are dependent from body weight. Therefore, we compared the effects of three high-fat and isocaloric diets varying only in their carbohydrate sources on brain activity of reward-related regions, and assessed whether brain activity is dependent on insulin sensitivity. Twenty-four minipigs underwent (18)FDG PET brain imaging following 7-month intake of high-fat diets of which 20% in dry matter weight (36.3% of metabolisable energy) was provided by starch, glucose or fructose (n = 8 per diet). Animals were then subjected to a euglycemic hyperinsulinemic clamp to determine peripheral insulin sensitivity. After a 7-month diet treatment, all groups had substantial increases in body weight (from 36.02 +/- 0.85 to 63.33 +/- 0.81 kg; P<0.0001), regardless of the diet. All groups presented similar insulin sensitivity index (ISI = 1.39 +/- 0.10 mL.min(-1).mu UI.kg). Compared to starch, chronic exposure to fructose and glucose induced bilateral brain activations, i.e. increased basal cerebral glucose metabolism, in several reward-related brain regions including the anterior and dorsolateral prefrontal cortex, the orbitofrontal cortex, the anterior cingulate cortex, the caudate and putamen. The lack of differences in insulin sensitivity index and body weight suggests that the observed differences in basal brain glucose metabolism are not related to differences in peripheral insulin sensitivity and weight gain. The differences in basal brain metabolism in reward-related brain areas suggest the onset of cerebral functional alterations induced by chronic consumption of dietary sugars. Further studies should explore the underlying mechanisms, such as the availability of intestinal and brain sugar transporter, or the appearance of addictive-like behavioral correlates of these brain functional characteristics.	[Ochoa, Melissa; Meurice, Paul; Val-Laillet, David] INRA, ADNC UR1341, St Gilles, France; [Malbert, Charles-Henri] INRA, Ani Scans US1395, St Gilles, France	INRAE; INRAE	Val-Laillet, D (corresponding author), INRA, ADNC UR1341, St Gilles, France.	david.val-laillet@rennes.inra.fr	VAL-LAILLET, David/AAH-6454-2021; Val-Laillet, David/B-4328-2008	Val-Laillet, David/0000-0002-6256-7737; Malbert, Charles-Henri/0000-0002-0665-4545	INRA, Human Nutrition division	INRA, Human Nutrition division	The PhD grant of Melissa Ochoa was provided by INRA, Human Nutrition division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received no specific funding for this work and have declared that no specific interests exist. The PhD grant of Melissa Ochoa was provided by INRA, Human Nutrition division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors gratefully acknowledge the efforts and cooperation of the scientific and technical staff who contributed to this study and/or took care of the animals: Isabelle Nogret, Sylvie Guerin, Eric Bobilier, Alain Chauvin, Mickael Genissel, Julien Georges, Regis Janvier, Vincent Piedvache and Francis Legouevec.	Alsio J, 2010, NEUROSCIENCE, V171, P779, DOI 10.1016/j.neuroscience.2010.09.046; Bello NT, 2002, NEUROREPORT, V13, P1575, DOI 10.1097/00001756-200208270-00017; Bingham EM, 2002, DIABETES, V51, P3384, DOI 10.2337/diabetes.51.12.3384; Burger KS, 2011, NEUROIMAGE, V55, P233, DOI 10.1016/j.neuroimage.2010.12.009; Christoffersen B, 2009, AM J PHYSIOL-REG I, V297, pR1195, DOI 10.1152/ajpregu.90851.2008; Clouard C, 2012, ANIMAL, V6, P118, DOI 10.1017/S1751731111001315; Colantuoni C, 2001, NEUROREPORT, V12, P3549, DOI 10.1097/00001756-200111160-00035; Daly ME, 1997, AM J CLIN NUTR, V66, P1072, DOI 10.1093/ajcn/66.5.1072; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Douard V, 2008, AM J PHYSIOL-ENDOC M, V295, pE227, DOI 10.1152/ajpendo.90245.2008; Escott-Stump, 2008, KRAUSES FOOD NUTR TH; Figlewicz DP, 2004, BEHAV NEUROSCI, V118, P479, DOI 10.1037/0735-7044.118.3.479; Franklin TR, 2007, NEUROPSYCHOPHARMACOL, V32, P2301, DOI 10.1038/sj.npp.1301371; Gearhardt AN, 2011, ARCH GEN PSYCHIAT, V68, P808, DOI 10.1001/archgenpsychiatry.2011.32; Havel PJ, 2005, NUTR REV, V63, P133, DOI [10.1301/nr.2005.may.133-157, 10.1111/j.1753-4887.2005.tb00132.x]; Havel PJ, 1997, EXP CLIN ENDOCRINOL, V105, P37, DOI DOI 10.1055/S-0029-1211853; HWANG IS, 1987, HYPERTENSION, V10, P512, DOI 10.1161/01.HYP.10.5.512; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Johnson RJ, 2013, DIABETES, V62, P3307, DOI 10.2337/db12-1814; Kelley AE, 2003, EUR J NEUROSCI, V18, P2592, DOI 10.1046/j.1460-9568.2003.02991.x; Le DSNT, 2007, AM J CLIN NUTR, V86, P573, DOI 10.1093/ajcn/86.3.573; Lee L, 2009, HEPATOLOGY, V50, P56, DOI 10.1002/hep.22904; Luo S, 2015, P NATL ACAD SCI USA, V112, P6509, DOI 10.1073/pnas.1503358112; Lustig RH, 2010, J AM DIET ASSOC, V110, P1307, DOI 10.1016/j.jada.2010.06.008; MARTINEZ FJ, 1994, HYPERTENSION, V23, P456, DOI 10.1161/01.HYP.23.4.456; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Ng J, 2011, APPETITE, V57, P65, DOI 10.1016/j.appet.2011.03.017; Ochoa M, 2015, EUR J NUTR, V54, P1, DOI 10.1007/s00394-014-0776-y; Ochoa M, 2014, APPL ANIM BEHAV SCI, V157, P61, DOI 10.1016/j.applanim.2014.05.010; ONO T, 1984, BRAIN RES, V311, P323, DOI 10.1016/0006-8993(84)90095-7; Page KA, 2013, JAMA-J AM MED ASSOC, V309, P63, DOI 10.1001/jama.2012.116975; Pritchett CE, 2011, PHYSIOL BEHAV, V104, P111, DOI 10.1016/j.physbeh.2011.04.048; Rorabaugh JM, 2015, NEUROSCIENCE, V301, P213, DOI 10.1016/j.neuroscience.2015.06.015; Roura E, 2016, NUTRITION RESEARCH R; Saikali S, 2010, J NEUROSCI METH, V192, P102, DOI 10.1016/j.jneumeth.2010.07.041; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Sauleau P, 2009, ANIMAL, V3, P1138, DOI 10.1017/S1751731109004649; Sauvant D., 2004, Tables of composition and nutritional value of feed materials: pigs, poultry, cattle, sheep, goats, rabbits, horses and fish; Schmidt KC, 2002, Q J NUCL MED, V46, P70; Sebert SP, 2005, INT J OBESITY, V29, P324, DOI 10.1038/sj.ijo.0802823; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Stice E, 2013, NEUROSCI BIOBEHAV R, V37, P2047, DOI 10.1016/j.neubiorev.2012.12.001; Stice E, 2013, AM J CLIN NUTR, V98, P1377, DOI 10.3945/ajcn.113.069443; Stice E, 2010, J NEUROSCI, V30, P13105, DOI 10.1523/JNEUROSCI.2105-10.2010; Tappy L, 2010, NUTRITION, V26, P1044, DOI 10.1016/j.nut.2010.02.014; Teff KL, 2004, J CLIN ENDOCR METAB, V89, P2963, DOI 10.1210/jc.2003-031855; Val-Laillet D, 2015, NEUROIMAGE-CLIN, V8, P1, DOI 10.1016/j.nicl.2015.03.016; Val-Laillet D, 2010, BRIT J NUTR, V104, P1719, DOI 10.1017/S0007114510002667; Val-Laillet D, 2010, PHYSIOL BEHAV, V101, P462, DOI 10.1016/j.physbeh.2010.07.014; Val-Laillet D, 2010, APPETITE, V55, P245, DOI 10.1016/j.appet.2010.06.008; Val-Laillet D, 2011, OBESITY, V19, P749, DOI 10.1038/oby.2010.292; Ventura EE, 2011, OBESITY, V19, P868, DOI 10.1038/oby.2010.255; Verhagen JV, 2003, J NEUROPHYSIOL, V90, P1514, DOI 10.1152/jn.00320.2003; Volkow N D, 2012, Curr Top Behav Neurosci, V11, P1, DOI 10.1007/7854_2011_169; Volkow ND, 2008, NEUROIMAGE, V42, P1537, DOI 10.1016/j.neuroimage.2008.06.002; Wang GJ, 2008, OBESITY, V16, pS88, DOI 10.1038/oby.2008.469	58	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161228	10.1371/journal.pone.0161228	http://dx.doi.org/10.1371/journal.pone.0161228			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583555	Green Published, gold, Green Submitted			2022-12-26	WOS:000382855600016
J	Santos, JD; Coelho, FC; Bliman, PA				Santos, Joyce de Figueiro; Coelho, Flavio Codeco; Bliman, Pierre-Alexandre			Behavioral Modulation of Infestation by Varroa destructor in Bee Colonies. Implications for Colony Stability	PLOS ONE			English	Article							AFRICANIZED HONEY-BEES; APIS-MELLIFERA; HYGIENIC BEHAVIOR; JACOBSONI; BRAZIL; REPRODUCTION; RESISTANCE; ANDERSON; SYSTEMS; TRUEMAN	Colony Collapse Disorder (CCD) has become a global problem for beekeepers and for the crops that depend on bee pollination. While many factors are known to increase the risk of colony collapse, the ectoparasitic mite Varroa destructor is considered to be the most serious one. Although this mite is unlikely to cause the collapse of hives itself, it is the vector for many viral diseases which are among the likely causes for Colony Collapse Disorder. The effects of V. destructor infestation differ from one part of the world to another, with greater morbidity and higher colony losses in European honey bees (EHB) in Europe, Asia and North America. Although this mite has been present in Brazil for many years, there have been no reports of colony losses amongst Africanized Honey Bees (AHB). Studies carried out in Mexico have highlighted different behavioral responses by the AHB to the presence of the mite, notably as far as grooming and hygienic behavior are concerned. Could these explain why the AHB are less susceptible to Colony Collapse Disorder? In order to answer this question, we have developed a mathematical model of the infestation dynamics to analyze the role of resistance behavior by bees in the overall health of the colony, and as a consequence, its ability to face epidemiological challenges.	[Santos, Joyce de Figueiro; Coelho, Flavio Codeco; Bliman, Pierre-Alexandre] Getulio Vargas Fdn, Appl Math Sch, Rio De Janeiro, RJ, Brazil; [Bliman, Pierre-Alexandre] Univ Paris 06, Sorbonne Univ, Inria, Lab JL Lions UMR CNRS 7598, Paris, France	Getulio Vargas Foundation; Inria; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Coelho, FC (corresponding author), Getulio Vargas Fdn, Appl Math Sch, Rio De Janeiro, RJ, Brazil.	fccoelho@fgv.br	Coelho, Flavio Codeço/L-1089-2018; Coelho, Flavio/L-1089-2018	Coelho, Flavio Codeço/0000-0003-0635-8989; Coelho, Flavio/0000-0003-3868-4391				Angeli D, 2004, LECT NOTES CONTR INF, V301, P135; Angeli D, 2003, IEEE T AUTOMAT CONTR, V48, P1684, DOI 10.1109/TAC.2003.817920; Arechavaleta-Velasco ME, 2001, APIDOLOGIE, V32, P157, DOI 10.1051/apido:2001121; Becher MA, 2013, J APPL ECOL, V50, P868, DOI 10.1111/1365-2664.12112; Calderon RA, 2010, EXP APPL ACAROL, V50, P281, DOI 10.1007/s10493-009-9325-4; Carneiro FE, 2007, NEOTROP ENTOMOL, V36, P949, DOI 10.1590/S1519-566X2007000600018; Coppel WA, 1965, STABILITY ASYMPTOTIC, V11; Correa-Marques MH, 1998, APIDOLOGIE, V29, P283, DOI 10.1051/apido:19980307; FdM Pereira, 2002, ORG SOCIAL DESENVOLV; Gouze JL, 1988, RR0894; HIRSCH MW, 1988, J REINE ANGEW MATH, V383, P1, DOI 10.1515/crll.1988.383.1; Khoury DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018491; Medina LM, 1999, EXP APPL ACAROL, V23, P659, DOI 10.1023/A:1006275525463; Mondragon L, 2005, APIDOLOGIE, V36, P345, DOI 10.1051/apido:2005022; MORETTO G, 1993, REV BRAS GENET, V16, P71; MORETTO G, 1991, APIDOLOGIE, V22, P197, DOI 10.1051/apido:19910303; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Pinto FA, 2012, ARQ BRAS MED VET ZOO, V64, P1194, DOI 10.1590/S0102-09352012000500017; Ratti V, 2012, CANADIAN APPL MATH Q; Smith H. L, 2008, MONOTONE DYNAMICAL S, V41; Spivak M, 1996, APIDOLOGIE, V27, P245, DOI 10.1051/apido:19960407; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Vandame R, 2000, CAN J ZOOL, V78, P2037, DOI 10.1139/cjz-78-11-2037; Vandame R, 2002, APIDOLOGIE, V33, P433, DOI 10.1051/apido:2002025	24	6	6	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0160465	10.1371/journal.pone.0160465	http://dx.doi.org/10.1371/journal.pone.0160465			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583438	gold, Green Published, Green Submitted			2022-12-26	WOS:000382855600006
J	Huang, YH; Chang, HY; Tsai, SW; Chou, LW; Chen, SL; Lin, YH				Huang, Yu-Hui; Chang, Hsiao-Yun; Tsai, Sen-Wei; Chou, Li-Wei; Chen, Sung-Lang; Lin, Yu-Hao			Comparison of Autonomic Reactions during Urodynamic Examination in Patients with Spinal Cord Injuries and Able-Bodied Subjects	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; BLOOD-PRESSURE; VESICOVASCULAR REFLEX; BLADDER DISTENSION; SPECTRAL-ANALYSIS; LOWER URINARY; DYSREFLEXIA; INDIVIDUALS; RESPONSES	Background/Purpose This study compares heart rate variability (HRV) and systolic blood pressure (SBP) changes of spinal cord injury (SCI) patients during urodynamic study (UDS) with able-bodied controls. Methods Twenty four complete suprasacral SCI patients (12 tetraplegia and 12 paraplegia) and 12 age-matched able-bodied volunteers received BP and HRV evaluation throughout urodynamic examination. We chose seven time points during the examinations: resting, Foley catheter insertion, start of infusion, and infused volume reaching 1/4, 2/4, 3/4 and 4/4 of maximal capacity. At each time point, electrocardiogram with a duration of 5 min was used for power spectral density analysis of HRV. Results Only control subjects displayed significant elevation of SBP during Foley catheter insertion compared to resting values. Both control and tetraplegic groups experienced significant elevation of SBP at maximal bladder capacity compared to resting values. Tetraplegic values were also significantly greater than the other two groups. Control subjects displayed significant elevation of low frequency/high frequency (LF/HF) ratios during Foley catheter insertion and when approaching maximum bladder capacity. These findings were not seen in the paraplegic and tetraplegic groups. However, subgroup analysis of tetraplegic subjects with SBP elevation >50 mmHg demonstrated a similar LF/HF response to the able-bodied controls. Conclusion Tetraplegic patients experienced BP elevation but did not experience significant changes in HRV during bladder distension. This finding may imply that different neurological pathways contribute to AD reaction and HRV changes during bladder distension. However, profound AD during UDS in tetraplegic patients was associated with corresponding changes in HRV. Whether HRV monitoring would be beneficial in SCI patients presenting with significant AD, it needs further studies to elucidate.	[Huang, Yu-Hui; Lin, Yu-Hao] Chung Shan Med Univ Hosp, Dept Phys Med & Rehabil, Taichung, Taiwan; [Huang, Yu-Hui; Chen, Sung-Lang] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chang, Hsiao-Yun] Chung Shan Med Univ, Sch Phys Therapy, Taichung, Taiwan; [Chang, Hsiao-Yun] Chung Shan Med Univ Hosp, Room Phys Therapy, Taichung, Taiwan; [Tsai, Sen-Wei] Taichung Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Phys Med & Rehabil, Taichung, Taiwan; [Tsai, Sen-Wei] Tzu Chi Univ, Sch Med, Dept Phys Med & Rehabil, Hualien, Taiwan; [Chou, Li-Wei] China Med Univ Hosp, Dept Phys Med & Rehabil, Taichung, Taiwan; [Chou, Li-Wei] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan; [Chen, Sung-Lang] Chung Shan Med Univ Hosp, Dept Urol, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Tzu Chi University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital	Chen, SL (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Chen, SL (corresponding author), Chung Shan Med Univ Hosp, Dept Urol, Taichung, Taiwan.	cshy650@csh.org.tw	Chou, Li-Wei/K-8875-2019; Chang, Hsiao-Yun/AAI-4179-2021	Chou, Li-Wei/0000-0002-3540-6225; Chang, Hsiao-Yun/0000-0002-8470-566X	Chung Shan Medical University Hospital [CSH 2012-C-031]	Chung Shan Medical University Hospital	This work was supported by a research grant from the Chung Shan Medical University Hospital (grant no. CSH 2012-C-031).	Agiovlasitis S, 2010, AM J PHYS MED REHAB, V89, P817, DOI 10.1097/PHM.0b013e3181f1b6e7; Billman GE, 2013, FRONT PHYSIOL, V4, DOI [10.3389/fphys.2013.00222, 10.3389/fphys.2013.00026]; Bothig R, 2013, SPINAL CORD, V51, P70, DOI 10.1038/sc.2012.107; Camm AJ, 1996, EUR HEART J, V17, P354; CHENG CL, 1993, AM J PHYSIOL, V265, pR132, DOI 10.1152/ajpregu.1993.265.1.R132; Chien CT, 2000, J PHYSIOL-LONDON, V526, P397, DOI 10.1111/j.1469-7793.2000.t01-1-00397.x; Chuang YC, 2001, AM J PHYSIOL-REG I, V281, pR1302, DOI 10.1152/ajpregu.2001.281.4.R1302; Claydon VE, 2006, J NEUROTRAUM, V23, P1713, DOI 10.1089/neu.2006.23.1713; Consortium for Spinal Cord Medicine, 2002, J Spinal Cord Med, V25 Suppl 1, pS67; de Groat WC, 2010, NEUROUROL URODYNAM, V29, P63, DOI 10.1002/nau.20761; Ditor DS, 2005, CLIN AUTON RES, V15, P387, DOI 10.1007/s10286-005-0293-4; Drake MJ, 2010, NEUROUROL URODYNAM, V29, P119, DOI 10.1002/nau.20841; FAGIUS J, 1989, HYPERTENSION, V14, P511, DOI 10.1161/01.HYP.14.5.511; Gao SA, 2002, CLIN AUTON RES, V12, P457, DOI 10.1007/s10286-002-0068-0; Giannantoni A, 1998, SPINAL CORD, V36, P756, DOI 10.1038/sj.sc.3100684; GRIMM DR, 1995, AM J PHYSIOL-HEART C, V268, pH2239, DOI 10.1152/ajpheart.1995.268.6.H2239; Haylen BT, 2010, INT UROGYNECOL J, V21, P5, DOI [10.1007/s00192-009-0976-9, 10.1590/S1677-55382010000100032]; Huang YH, 2011, ARCH PHYS MED REHAB, V92, P1450, DOI 10.1016/j.apmr.2011.03.024; INOUE K, 1995, J AUTONOM NERV SYST, V54, P225, DOI 10.1016/0165-1838(95)00012-M; KEWALRAMANI LS, 1980, AM J PHYS MED REHAB, V59, P1; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Krassioukov A, 2009, RESP PHYSIOL NEUROBI, V169, P157, DOI 10.1016/j.resp.2009.08.003; Krassioukov A, 2009, ARCH PHYS MED REHAB, V90, P682, DOI 10.1016/j.apmr.2008.10.017; Liu N, 2013, SPINAL CORD, V51, P863, DOI 10.1038/sc.2013.113; MATHIAS CJ, 1976, BRAIN, V99, P757, DOI 10.1093/brain/99.4.757; MEDDA BK, 1995, JPN J PHYSIOL, V45, P265, DOI 10.2170/jjphysiol.45.265; Mehnert U, 2009, NEUROUROL URODYNAM, V28, P313, DOI 10.1002/nau.20641; Monfredi O, 2014, HYPERTENSION, V64, P1334, DOI 10.1161/HYPERTENSIONAHA.114.03782; PARATI G, 1995, HYPERTENSION, V25, P1276, DOI 10.1161/01.HYP.25.6.1276; Pumprla J, 2002, INT J CARDIOL, V84, P1, DOI 10.1016/S0167-5273(02)00057-8; Routledge FS, 2010, CAN J CARDIOL, V26, P303, DOI 10.1016/S0828-282X(10)70395-0; Sacha J, 2005, J ELECTROCARDIOL, V38, P47, DOI 10.1016/j.jelectrocard.2004.09.015; Sacha J, 2008, INT J CARDIOL, V128, P444, DOI 10.1016/j.ijcard.2007.06.047; Sacha J, 2013, INT J CARDIOL, V168, P4257, DOI 10.1016/j.ijcard.2013.04.160; Sacha J, 2014, ANN NONINVAS ELECTRO, V19, P207, DOI 10.1111/anec.12148; Sacha J, 2013, INT J CARDIOL, V168, P1660, DOI 10.1016/j.ijcard.2013.03.038; Seki S, 2002, J UROLOGY, V168, P2269, DOI 10.1016/S0022-5347(05)64369-8; Stohrer M, 2009, EUR UROL, V56, P81, DOI 10.1016/j.eururo.2009.04.028; WEAVER LC, 1985, AM J PHYSIOL, V248, pR236, DOI 10.1152/ajpregu.1985.248.2.R236; West Christopher R, 2013, Top Spinal Cord Inj Rehabil, V19, P267, DOI 10.1310/sci1904-267; WURSTER RD, 1975, AM J PHYSIOL, V228, P1288, DOI 10.1152/ajplegacy.1975.228.4.1288; Zahner MR, 2005, AM J PHYSIOL-REG I, V288, pR420, DOI 10.1152/ajpregu.00563.2004; Zaza A, 2001, CARDIOVASC RES, V50, P434, DOI 10.1016/S0008-6363(01)00240-1	43	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161976	10.1371/journal.pone.0161976	http://dx.doi.org/10.1371/journal.pone.0161976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575616	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877200049
J	Muir, P; Hans, EC; Racette, M; Volstad, N; Sample, SJ; Heaton, C; Holzman, G; Schaefer, SL; Bloom, DD; Bleedorn, JA; Hao, ZL; Amene, E; Suresh, M; Hematti, P				Muir, Peter; Hans, Eric C.; Racette, Molly; Volstad, Nicola; Sample, Susannah J.; Heaton, Caitlin; Holzman, Gerianne; Schaefer, Susan L.; Bloom, Debra D.; Bleedorn, Jason A.; Hao, Zhengling; Amene, Ermias; Suresh, M.; Hematti, Peiman			Autologous Bone Marrow-Derived Mesenchymal Stem Cells Modulate Molecular Markers of Inflammation in Dogs with Cruciate Ligament Rupture	PLOS ONE			English	Article							C-REACTIVE PROTEIN; PLATEAU LEVELING OSTEOTOMY; STROMAL CELLS; RADIOGRAPHIC PROGRESSION; ACL RECONSTRUCTION; SYNOVIAL-FLUID; STIFLE JOINT; OSTEOARTHRITIS; SUBLUXATION; ARTHRITIS	Mid-substance rupture of the canine cranial cruciate ligament rupture (CR) and associated stifle osteoarthritis (OA) is an important veterinary health problem. CR causes stifle joint instability and contralateral CR often develops. The dog is an important model for human anterior cruciate ligament (ACL) rupture, where rupture of graft repair or the contralateral ACL is also common. This suggests that both genetic and environmental factors may increase ligament rupture risk. We investigated use of bone marrow-derived mesenchymal stem cells (BM-MSCs) to reduce systemic and stifle joint inflammatory responses in dogs with CR. Twelve dogs with unilateral CR and contralateral stable partial CR were enrolled prospectively. BM-MSCs were collected during surgical treatment of the unstable CR stifle and culture-expanded. BM-MSCs were subsequently injected at a dose of 2x10(6) BMMSCs/kg intravenously and 5x10(6) BM-MSCs by intra-articular injection of the partial CR stifle. Blood (entry, 4 and 8 weeks) and stifle synovial fluid (entry and 8 weeks) were obtained after BM-MSC injection. No adverse events after BM-MSC treatment were detected. Circulating CD8(+) T lymphocytes were lower after BM-MSC injection. Serum C-reactive protein (CRP) was decreased at 4 weeks and serum CXCL8 was increased at 8 weeks. Synovial CRP in the complete CR stifle was decreased at 8 weeks. Synovial IFN gamma was also lower in both stifles after BM-MSC injection. Synovial/serum CRP ratio at diagnosis in the partial CR stifle was significantly correlated with development of a second CR. Systemic and intra-articular injection of autologous BM-MSCs in dogs with partial CR suppresses systemic and stifle joint inflammation, including CRP concentrations. Intra-articular injection of autologous BM-MSCs had profound effects on the correlation and conditional dependencies of cytokines using causal networks. Such treatment effects could ameliorate risk of a second CR by modifying the stifle joint inflammatory response associated with cranial cruciate ligament matrix degeneration or damage.	[Muir, Peter; Hans, Eric C.; Racette, Molly; Volstad, Nicola; Sample, Susannah J.; Heaton, Caitlin; Schaefer, Susan L.; Bleedorn, Jason A.; Hao, Zhengling] Univ Wisconsin Madison, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA; [Sample, Susannah J.] Univ Wisconsin Madison, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA; [Holzman, Gerianne] Univ Wisconsin Madison, Sch Vet Med, UW Vet Care Hosp, Madison, WI USA; [Bloom, Debra D.; Hematti, Peiman] Univ Wisconsin Madison, Dept Med, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Amene, Ermias] Univ Wisconsin Madison, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA; [Suresh, M.] Univ Wisconsin Madison, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Hematti, Peiman] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Muir, P (corresponding author), Univ Wisconsin Madison, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA.	peter.muir@wisc.edu	Bleedorn, Jason A/AAE-2115-2019; Muir, Peter/AAH-8057-2021	Bleedorn, Jason A/0000-0003-2987-7722; Muir, Peter/0000-0003-0028-6005; Hans, Eric/0000-0001-7488-9728; Suresh, Marulasiddappa/0000-0003-1794-3358	Hohn-Johnson Award, Veterinary Orthopaedic Society; Melita Grunow Family Professorship in Companion Animal Health; NIH [K01 FOA PA-14-044]; Hohn-Johnson Award from Veterinary Orthopaedic Society; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T35OD011078, K01OD019743] Funding Source: NIH RePORTER	Hohn-Johnson Award, Veterinary Orthopaedic Society; Melita Grunow Family Professorship in Companion Animal Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hohn-Johnson Award from Veterinary Orthopaedic Society; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the Hohn-Johnson Award, Veterinary Orthopaedic Society (http://www.vosdvm.org/hohn-johnson-brinkerawards/) to PM, and the Melita Grunow Family Professorship in Companion Animal Health to PM. Susannah J. Sample was supported by the NIH (K01 FOA PA-14-044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the help of Dr. David Gasper for advice regarding flow cytometry. This study was supported by a Hohn-Johnson Award from the Veterinary Orthopaedic Society and the Melita Grunow Family Professorship in Companion Animal Health. Susannah J. Sample was supported by the NIH (K01 FOA PA-14-044). Parts of this work were presented in abstract form at the Orthopaedic Research Society 2016 Annual Meeting.	Bennett D, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-42; Bergh MS, 2014, J AM ANIM HOSP ASSOC, V50, P315, DOI 10.5326/JAAHA-MS-6356; Bleedorn JA, 2011, VET SURG, V40, P531, DOI 10.1111/j.1532-950X.2011.00841.x; Bloom DD, 2015, CYTOTHERAPY, V17, P140, DOI 10.1016/j.jcyt.2014.10.002; Bouffi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014247; Bozynski CC, 2015, J KNEE SURG, V28, P404, DOI 10.1055/s-0035-1544975; Chuang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106389; Conrozier T, 1998, REV RHUM, V65, P759; DASILVA ML, 2006, J CELL SCI, V119, P2204, DOI DOI 10.1242/JCS.02932; Djouad F, 2009, NAT REV RHEUMATOL, V5, P392, DOI 10.1038/nrrheum.2009.104; Dusick A, 2014, VET J, V202, P550, DOI 10.1016/j.tvjl.2014.08.010; El-Hadi M, 2012, CAN J VET RES, V76, P8; Erne JB, 2009, JAVMA-J AM VET MED A, V235, P386, DOI 10.2460/javma.235.4.386; Fleming BC, 2009, AM J SPORT MED, V37, P1554, DOI 10.1177/0363546509332257; Flynn RK, 2005, AM J SPORT MED, V33, P23, DOI 10.1177/0363546504265678; Foster JD, 2014, J VET INTERN MED, V28, P905, DOI 10.1111/jvim.12351; Fuller MC, 2014, JAVMA-J AM VET MED A, V244, P328, DOI 10.2460/javma.244.3.328; Ghannam S, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt2; Gianotti SM, 2009, J SCI MED SPORT, V12, P622, DOI 10.1016/j.jsams.2008.07.005; GOLDBERG VM, 1982, J BONE JOINT SURG AM, V64, P900, DOI 10.2106/00004623-198264060-00014; Gonzalez-Rey E, 2010, ANN RHEUM DIS, V69, P241, DOI 10.1136/ard.2008.101881; Goto KT, 2011, J DENT RES, V90, P793, DOI 10.1177/0022034511400742; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Innes JF, 2004, VET RADIOL ULTRASOUN, V45, P143, DOI 10.1111/j.1740-8261.2004.04024.x; Jin XZ, 2015, ANN RHEUM DIS, V74, P703, DOI 10.1136/annrheumdis-2013-204494; Jin Y, 2015, CYTOKINE, V71, P145, DOI 10.1016/j.cyto.2014.10.003; Kanaya A, 2007, ARTHROSCOPY, V23, P610, DOI 10.1016/j.arthro.2007.01.013; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; Kim SE, 2012, VET SURG, V41, P465, DOI 10.1111/j.1532-950X.2012.00973.x; Kim SE, 2011, AM J VET RES, V72, P410, DOI 10.2460/ajvr.72.3.410; Kobayashi S, 2006, J ORTHOP RES, V24, P1509, DOI 10.1002/jor.20183; Laranjeira P, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/819084; Little JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097329; Liu QL, 2015, CELL MOL IMMUNOL, V12, P708, DOI 10.1038/cmi.2014.118; Liu YY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3187; Maccoux LJ, 2007, VET IMMUNOL IMMUNOP, V118, P59, DOI 10.1016/j.vetimm.2007.04.006; Might KR, 2013, VET SURG, V42, P392, DOI 10.1111/j.1532-950X.2012.01064.x; Muir P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025331; Muir P, 2011, VET SURG, V40, P753, DOI 10.1111/j.1532-950X.2011.00867.x; Murray MM, 2007, J ORTHOP RES, V25, P1007, DOI 10.1002/jor.20367; Nishida H, 2012, VET SURG, V41, P437, DOI 10.1111/j.1532-950X.2011.00959.x; Oe K, 2011, STEM CELLS DEV, V20, P671, DOI 10.1089/scd.2010.0182; Ohno K, 2006, J VET MED SCI, V68, P1275, DOI 10.1292/jvms.68.1275; Park KH, 2016, CELL TRANSPLANT, V25, P1057, DOI 10.3727/096368915X687949; Pearle AD, 2007, OSTEOARTHR CARTILAGE, V15, P516, DOI 10.1016/j.joca.2006.10.010; Raicevic G, 2011, CELL IMMUNOL, V270, P207, DOI 10.1016/j.cellimm.2011.05.010; Reinders MEJ, 2013, STEM CELL TRANSL MED, V2, P107, DOI 10.5966/sctm.2012-0114; Sharif M, 2000, ANN RHEUM DIS, V59, P71, DOI 10.1136/ard.59.1.71; Spindler KP, 2009, J ORTHOP RES, V27, P631, DOI 10.1002/jor.20785; TOWNLEY CO, 1985, CLIN ORTHOP RELAT R, P266; Vela DC, 2009, J HISTOCHEM CYTOCHEM, V57, P167, DOI 10.1369/jhc.2008.952507; Wang DD, 2014, ARTHRITIS RHEUMATOL, V66, P2234, DOI 10.1002/art.38674; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; Weiss DJ, 2013, CHEST, V143, P1590, DOI 10.1378/chest.12-2094; Williams DL, 1997, VET J, V153, P31, DOI 10.1016/S1090-0233(97)80006-8; Witsberger TH, 2008, JAVMA-J AM VET MED A, V232, P1818, DOI 10.2460/javma.232.12.1818; Wright RW, 2011, J BONE JOINT SURG AM, V93A, P1159, DOI [10.2106/JBJS.J.00898, 10.2106/JBJSJ.00898]; Ylostalo JH, 2012, STEM CELLS, V30, P2283, DOI 10.1002/stem.1191; Yoo C, 2004, ARTIF INTELL MED, V31, P169, DOI 10.1016/j.artmed.2004.01.018	59	30	33	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0159095	10.1371/journal.pone.0159095	http://dx.doi.org/10.1371/journal.pone.0159095			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575050	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877200003
J	Martinez, NJ; Rai, G; Yasgar, A; Lea, WA; Sun, HM; Wang, YH; Luci, DK; Yang, SM; Nishihara, K; Takeda, S; Sagor, M; Earnshaw, I; Okada, T; Mori, K; Wilson, K; Riggins, GJ; Xia, MH; Grimaldi, M; Jadhav, A; Maloney, DJ; Simeonov, A				Martinez, Natalia J.; Rai, Ganesha; Yasgar, Adam; Lea, Wendy A.; Sun, Hongmao; Wang, Yuhong; Luci, Diane K.; Yang, Shyh-Ming; Nishihara, Kana; Takeda, Shunichi; Sagor, Mohiuddin; Earnshaw, Irina; Okada, Tetsuya; Mori, Kazutoshi; Wilson, Kelli; Riggins, Gregory J.; Xia, Menghang; Grimaldi, Maurizio; Jadhav, Ajit; Maloney, David J.; Simeonov, Anton			A High-Throughput Screen Identifies 2,9-Diazaspiro[5.5]Undecanes as Inducers of the Endoplasmic Reticulum Stress Response with Cytotoxic Activity in 3D Glioma Cell Models	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; ER STRESS; MALIGNANT GLIOMA; DEATH; CA2+; CANCER; ACTIVATION; GRP78/BIP; AUTOPHAGY; XBP1	The endoplasmic reticulum (ER) is involved in Ca2+ signaling and protein folding. ER Ca2+ depletion and accumulation of unfolded proteins activate the molecular chaperone GRP78 (glucose-regulated protein 78) which in turn triggers the ER stress response (ERSR) pathway aimed to restore ER homeostasis. Failure to adapt to stress, however, results in apoptosis. We and others have shown that malignant cells are more susceptible to ERSR-induced apoptosis than their normal counterparts, implicating the ERSR as a potential target for cancer therapeutics. Predicated on these findings, we developed an assay that uses a GRP78 biosensor to identify small molecule activators of ERSR in glioma cells. We performed a quantitative high-throughput screen (qHTS) against a collection of similar to 425,000 compounds and a comprehensive panel of orthogonal secondary assays was formulated for stringent compound validation. We identified novel activators of ERSR, including a compound with a 2,9-diazaspiro[5.5]undecane core, which depletes intracellular Ca2+ stores and induces apoptosis-mediated cell death in several cancer cell lines, including patient-derived and 3D cultures of glioma cells. This study demonstrates that our screening platform enables the identification and profiling of ERSR inducers with cytotoxic activity and advocates for characterization of these compound in in vivo models.	[Martinez, Natalia J.; Rai, Ganesha; Yasgar, Adam; Lea, Wendy A.; Sun, Hongmao; Wang, Yuhong; Luci, Diane K.; Yang, Shyh-Ming; Nishihara, Kana; Wilson, Kelli; Xia, Menghang; Jadhav, Ajit; Maloney, David J.; Simeonov, Anton] NIH, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA; [Nishihara, Kana; Sagor, Mohiuddin; Earnshaw, Irina] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Sakyo Ku, Kyoto 6068501, Japan; [Okada, Tetsuya; Mori, Kazutoshi] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; [Takeda, Shunichi; Wilson, Kelli; Riggins, Gregory J.] Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD 21231 USA; [Grimaldi, Maurizio] Southern Res Inst, Dept Biochem & Mol Biol, Neuropharmacol Lab, Birmingham, AL 35205 USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Kyoto University; Kyoto University; Johns Hopkins University	Maloney, DJ; Simeonov, A (corresponding author), NIH, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA.	maloneyd@mail.nih.gov; asimeono@mail.nih.gov	Mori, Kazutoshi/AAW-5449-2020; Mohiuddin, Mohiuddin/AAD-5338-2022	Mohiuddin, Mohiuddin/0000-0003-1899-6734; Yasgar, Adam/0000-0001-7350-1402; Earnshaw, Irina/0000-0002-9546-6641; Jadhav, Ajit/0000-0001-7955-1451; Okada, Tetsuya/0000-0002-2513-1301; Takeda, Shunichi/0000-0002-7924-7991	National Center for Advancing Translational Sciences; Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research [U54MH084681, DA031669]	National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NJM, GR, AY, WAL, HS, YW, DKL, SMY, MX, AJ, DJM and AS were supported by the intramural research program of the National Center for Advancing Translational Sciences and the Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research (U54MH084681 and DA031669).	Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bi K, 2015, ANAL BIOANAL CHEM, V407, P5343, DOI 10.1007/s00216-015-8694-2; Binder ZA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150271; Ciechomska IA, 2013, ONCOGENE, V32, P1518, DOI 10.1038/onc.2012.174; de Martin PE, 2005, BIOCHEM CELL BIOL, V83, P752, DOI 10.1139/O05-159; Dexheimer TS, 2014, J MED CHEM, V57, P8099, DOI 10.1021/jm5010495; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; Flaherty DP, 2014, ACS MED CHEM LETT, V5, P1278, DOI 10.1021/ml5003234; Free RB, 2014, MOL PHARMACOL, V86, P96, DOI 10.1124/mol.113.090563; Griner LAM, 2014, P NATL ACAD SCI USA, V111, P2349, DOI 10.1073/pnas.1311846111; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hongisto V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077232; Honma M, 2003, ENVIRON MOL MUTAGEN, V42, P288, DOI 10.1002/em.10201; Huang HJ, 2015, CANCER LETT, V360, P257, DOI 10.1016/j.canlet.2015.02.029; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Johnson GG, 2014, NEURO-ONCOLOGY, V16, P1086, DOI 10.1093/neuonc/nou012; Johnson GG, 2011, CURR PHARM DESIGN, V17, P284; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kudo T, 2008, CELL DEATH DIFFER, V15, P364, DOI 10.1038/sj.cdd.4402276; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; Mimura N, 2012, BLOOD, V119, P5772, DOI 10.1182/blood-2011-07-366633; Mott BT, 2015, SCI REP-UK, V5, DOI 10.1038/srep13891; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pyrko P, 2007, CANCER RES, V67, P10920, DOI 10.1158/0008-5472.CAN-07-0796; Pyrko P, 2007, CANCER RES, V67, P9809, DOI 10.1158/0008-5472.CAN-07-0625; Pyrko P, 2007, MOL CANCER THER, V6, P1262, DOI 10.1158/1535-7163.MCT-06-0629; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Schonthal Axel H, 2012, Front Biosci (Schol Ed), V4, P412; Seethala R, 2009, HDB DRUG SCREENING; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Soboloff J, 2002, J BIOL CHEM, V277, P13812, DOI 10.1074/jbc.M112129200; Sun S, 2013, NEURO-ONCOLOGY, V15, P562, DOI 10.1093/neuonc/not005; Wang Y, 2000, J BIOL CHEM, V275, P27013; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; White MC, 2013, J NEUROSCI RES, V91, P393, DOI 10.1002/jnr.23169; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Yorimitsu T, 2007, AUTOPHAGY, V3, P160, DOI 10.4161/auto.3653; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida I, 2006, NEUROCHEM INT, V48, P696, DOI 10.1016/j.neuint.2005.12.012; Zhong JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039378	45	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161486	10.1371/journal.pone.0161486	http://dx.doi.org/10.1371/journal.pone.0161486			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27570969	gold, Green Published			2022-12-26	WOS:000382876700021
J	Shinohara, Y; Konno, A; Takahashi, N; Matsuzaki, Y; Kishi, S; Hirai, H				Shinohara, Yoichiro; Konno, Ayumu; Takahashi, Nobutaka; Matsuzaki, Yasunori; Kishi, Shoji; Hirai, Hirokazu			Viral Vector-Based Dissection of Marmoset GFAP Promoter in Mouse and Marmoset Brains	PLOS ONE			English	Article							TRANSGENE EXPRESSION; BERGMANN GLIA; TRANSDUCTION; CELL	Adeno-associated virus (AAV) vectors are small in diameter, diffuse easily in the brain, and represent a highly efficient means by which to transfer a transgene to the brain of a large animal. A major demerit of AAV vectors is their limited accommodation capacity for transgenes. Thus, a compact promoter is useful when delivering large transgenes via AAV vectors. In the present study, we aimed to identify the shortest astrocyte-specific GFAP promoter region that could be used for AAV-vector-mediated transgene expression in the marmoset brain. The 2.0-kb promoter region upstream of the GFAP gene was cloned from the marmoset genome, and short promoters (1.6 kb, 1.4 kb, 0.6 kb, 0.3 kb and 0.2 kb) were obtained by progressively deleting the original 2.0-kb promoter from the 5' end. The short promoters were screened in the mouse cerebellum in terms of their strength and astrocyte specificity. We found that the 0.3-kb promoter maintained 40% of the strength of the original 2.0-kb promoter, and approximately 90% of its astrocyte specificity. These properties were superior to those of the 1.4-kb, 0.6-kb (20% promoter strength) and 0.2-kb (70% astrocyte specificity) promoters. Then, we verified whether the 0.3-kb GFAP promoter retained astrocyte specificity in the marmoset cerebral cortex. Injection of viral vectors carrying the 0.3-kb marmoset GFAP promoter specifically transduced astrocytes in both the cerebral cortex and cerebellar cortex of the marmoset. These results suggest that the compact 0.3-kb promoter region serves as an astrocyte-specific promoter in the marmoset brain, which permits us to express a large gene by AAV vectors that have a limited accommodation capacity.	[Shinohara, Yoichiro; Konno, Ayumu; Takahashi, Nobutaka; Matsuzaki, Yasunori; Hirai, Hirokazu] Gunma Univ, Grad Sch Med, Dept Neurophysiol & Neural Repair, Maebashi, Gunma, Japan; [Shinohara, Yoichiro; Kishi, Shoji] Gunma Univ, Grad Sch Med, Dept Ophthalmol, Maebashi, Gunma, Japan; [Hirai, Hirokazu] Gunma Univ Initiat Adv Res, Div Endocrinol Metab & Signal Res, Res Program Neural Signalling, Maebashi, Gunma, Japan	Gunma University; Gunma University	Hirai, H (corresponding author), Gunma Univ, Grad Sch Med, Dept Neurophysiol & Neural Repair, Maebashi, Gunma, Japan.; Hirai, H (corresponding author), Gunma Univ Initiat Adv Res, Div Endocrinol Metab & Signal Res, Res Program Neural Signalling, Maebashi, Gunma, Japan.	hirai@gunma-u.ac.jp	Hirai, Hirokazu/ABP-1143-2022; Konno, Ayumu/J-1667-2017	Konno, Ayumu/0000-0001-9382-396X; Hirai, Hirokazu/0000-0002-0721-4293	program for Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and Development, AMED; MEXT KAKENHI [15K18330]	program for Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research is (partially) supported by the program for Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and the Japan Agency for Medical Research and Development, AMED, to HH and the MEXT KAKENHI (15K18330) to AK.; The authors are very grateful to the technicians Motoko Uchiyama and Minako Noguchi for raising the marmosets, Asako Ohnishi for AAV9 vector production and Junko Sugiyama for maintenance of mice. This research is (partially) supported by the program for Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and the Japan Agency for Medical Research and Development, AMED to HH and the MEXT KAKENHI (15K18330) to AK.	BESNARD F, 1991, J BIOL CHEM, V266, P18877; Bradford JW, 2010, CELL RES, V20, P400, DOI 10.1038/cr.2010.32; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; BRENNER M, 1994, BRAIN PATHOL, V4, P245, DOI 10.1111/j.1750-3639.1994.tb00840.x; Correale J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00180; Custer SK, 2006, NAT NEUROSCI, V9, P1302, DOI 10.1038/nn1750; Cvetanovic M, 2015, CEREBELLUM, V14, P8, DOI 10.1007/s12311-014-0605-0; de Leeuw B, 2006, J NEUROSCI RES, V83, P744, DOI 10.1002/jnr.20776; Donello JE, 1998, J VIROL, V72, P5085, DOI 10.1128/JVI.72.6.5085-5092.1998; Han J, 2012, CELL, V148, P1039, DOI 10.1016/j.cell.2012.01.037; Hirai H, 2008, CEREBELLUM, V7, P273, DOI 10.1007/s12311-008-0012-5; Huda F, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.32; Jakobsson J, 2003, J NEUROSCI RES, V73, P876, DOI 10.1002/jnr.10719; Kishi N, 2014, DEV GROWTH DIFFER, V56, P53, DOI 10.1111/dgd.12109; Konno A, 2014, CEREBELLUM, V13, P29, DOI 10.1007/s12311-013-0516-5; Lee Y, 2006, GLIA, V53, P677, DOI 10.1002/glia.20320; Lee Y, 2008, GLIA, V56, P481, DOI 10.1002/glia.20622; Matsuzaki Y, 2017, MOL NEUROBIOL, V54, P1745, DOI 10.1007/s12035-016-9777-6; Saab AS, 2012, SCIENCE, V337, P749, DOI 10.1126/science.1221140; Shiwaku H, 2010, EMBO J, V29, P2446, DOI 10.1038/emboj.2010.116; Torashima T, 2006, EUR J NEUROSCI, V24, P371, DOI 10.1111/j.1460-9568.2006.04927.x; Yeo S, 2013, GLIA, V61, P1488, DOI 10.1002/glia.22536; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	23	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0162023	10.1371/journal.pone.0162023	http://dx.doi.org/10.1371/journal.pone.0162023			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571575	gold, Green Published			2022-12-26	WOS:000382876700050
J	Egger, M; Lenstra, W; Jong, D; Meysman, FJR; Sapart, CJ; van der Veen, C; Rockmann, T; Gonzalez, S; Slomp, CP				Egger, Matthias; Lenstra, Wytze; Jong, Dirk; Meysman, Filip J. R.; Sapart, Celia J.; van der Veen, Carina; Rockmann, Thomas; Gonzalez, Santiago; Slomp, Caroline P.			Rapid Sediment Accumulation Results in High Methane Effluxes from Coastal Sediments	PLOS ONE			English	Article							CONTINENTAL-MARGIN SEDIMENTS; MEDIATED ANAEROBIC OXIDATION; BACTERIAL SULFATE REDUCTION; SOUTHERN BALTIC SEA; MARINE-SEDIMENTS; REACTIVE TRANSPORT; BLACK-SEA; BIOGEOCHEMICAL PROCESSES; METHANOTROPHIC ARCHAEA; PHOSPHORUS DYNAMICS	Globally, the methane (CH4) efflux from the ocean to the atmosphere is small, despite high rates of CH4 production in continental shelf and slope environments. This low efflux results from the biological removal of CH4 through anaerobic oxidation with sulfate in marine sediments. In some settings, however, pore water CH4 is found throughout the sulfate-bearing zone, indicating an apparently inefficient oxidation barrier for CH4. Here we demonstrate that rapid sediment accumulation can explain this limited capacity for CH4 removal in coastal sediments. In a saline coastal reservoir (Lake Grevelingen, The Netherlands), we observed high diffusive CH4 effluxes from the sediment into the overlying water column (0.2-0.8 mol m(-2) yr(-1)) during multiple years. Linear pore water CH4 profiles and the absence of an isotopic enrichment commonly associated with CH4 oxidation in a zone with high rates of sulfate reduction (50-170 nmol cm(-3) d(-1)) both suggest that CH4 is bypassing the zone of sulfate reduction. We propose that the rapid sediment accumulation at this site (similar to 13 cm yr(-1)) reduces the residence time of the CH4 oxidizing microorganisms in the sulfate/methane transition zone (<5 years), thus making it difficult for these slow growing methanotrophic communities to build-up sufficient biomass to efficiently remove pore water CH4. In addition, our results indicate that the high input of organic matter (similar to 91 mol C m(-2) yr(-1)) allows for the co-occurrence of different dissimilatory respiration processes, such as (acetotrophic) methanogenesis and sulfate reduction in the surface sediments by providing abundant substrate. We conclude that anthropogenic eutrophication and rapid sediment accumulation likely increase the release of CH4 from coastal sediments.	[Egger, Matthias; Lenstra, Wytze; Jong, Dirk; Slomp, Caroline P.] Univ Utrecht, Fac Geosci, Dept Earth Sci Geochem, Utrecht, Netherlands; [Meysman, Filip J. R.] Royal Netherlands Inst Sea Res, Dept Estuarine & Delta Studies, Yerseke, Netherlands; [Meysman, Filip J. R.] Vrije Univ Brussel, Dept Analyt Environm & Geochem, Brussels, Belgium; [Sapart, Celia J.; van der Veen, Carina; Rockmann, Thomas] Univ Utrecht, Inst Marine & Atmospher Res Utrecht, Utrecht, Netherlands; [Sapart, Celia J.] Univ Libre Bruxelles, Lab Glaciol, Brussels, Belgium; [Gonzalez, Santiago] Royal Netherlands Inst Sea Res NIOZ, Dept Marine Microbiol & Biogeochem, Texel, Netherlands	Utrecht University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Vrije Universiteit Brussel; Utrecht University; Universite Libre de Bruxelles; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Egger, M (corresponding author), Univ Utrecht, Fac Geosci, Dept Earth Sci Geochem, Utrecht, Netherlands.	m.j.egger@uu.nl	van der Veen, Carina/F-5344-2011; Slomp, Caroline P/A-9406-2012; Röckmann, Thomas/F-4479-2015; Meysman, Filip JR/C-9585-2009	Slomp, Caroline P/0000-0002-7272-0109; Röckmann, Thomas/0000-0002-6688-8968; Meysman, Filip JR/0000-0001-5334-7655; Egger, Matthias/0000-0002-1791-1842; Lenstra, Wytze/0000-0003-0979-5594; Egger, Matthias/0000-0001-7462-5132; Jong, Dirk/0000-0001-7906-8486	ERC Grant [278364, 306933]; NWO (Netherlands Organisation for Scientific Research) [865.13.005]; Ministry of Education, Culture and Science (OCW)	ERC Grant; NWO (Netherlands Organisation for Scientific Research)(Netherlands Organization for Scientific Research (NWO)); Ministry of Education, Culture and Science (OCW)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was financially supported by ERC Grant 278364 and NWO (Netherlands Organisation for Scientific Research) Vici Grant 865.13.005 to CPS, as well as ERC Grant 306933 to FJRM. This work was carried out under the program of the Netherlands Earth System Science Center (NESSC), financially supported by the Ministry of Education, Culture and Science (OCW).	ACHTNICH C, 1995, BIOL FERT SOILS, V19, P65, DOI 10.1007/BF00336349; Algeo TJ, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2004PA001112; Alperin MI, 1988, GLOBAL BIOGEOCHEM CY, V2, P279, DOI 10.1029/GB002i003p00279; Amos RT, 2012, GEOBIOLOGY, V10, P506, DOI 10.1111/j.1472-4669.2012.00341.x; BANGE HW, 1994, GLOBAL BIOGEOCHEM CY, V8, P465, DOI 10.1029/94GB02181; Beal EJ, 2009, SCIENCE, V325, P184, DOI 10.1126/science.1169984; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Bond DR, 2002, ENVIRON MICROBIOL, V4, P115, DOI 10.1046/j.1462-2920.2002.00279.x; Borges AV, 2011, TREATISE ON ESTUARINE AND COASTAL SCIENCE, VOL 5: BIOGEOCHEMISTRY, P119; Borowski WS, 1997, MAR CHEM, V57, P299, DOI 10.1016/S0304-4203(97)00019-4; Boudreau B. P., 1997, MODELLING TRANSPORT, V171, DOI 10.1016/s0264-8172(98)80005-6; Boudreau BP, 1996, GEOCHIM COSMOCHIM AC, V60, P3139, DOI 10.1016/0016-7037(96)00158-5; Bowles MW, 2014, SCIENCE, V344, P889, DOI 10.1126/science.1249213; Brass M, 2010, ATMOS MEAS TECH, V3, P1707, DOI 10.5194/amt-3-1707-2010; Burton ED, 2008, APPL GEOCHEM, V23, P2759, DOI 10.1016/j.apgeochem.2008.07.007; Canfield DE, 2005, ADV MAR BIOL, V48, P1; CLAYPOOL GE, 1983, ANNU REV EARTH PL SC, V11, P299, DOI 10.1146/annurev.ea.11.050183.001503; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; CRILL PM, 1983, LIMNOL OCEANOGR, V28, P1117, DOI 10.4319/lo.1983.28.6.1117; Crowe SA, 2011, GEOBIOLOGY, V9, P61, DOI 10.1111/j.1472-4669.2010.00257.x; Dale AW, 2008, EARTH PLANET SC LETT, V265, P329, DOI 10.1016/j.epsl.2007.09.026; DEVOL AH, 1984, GEOCHIM COSMOCHIM AC, V48, P993, DOI 10.1016/0016-7037(84)90191-1; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dickens GR, 2001, ORG GEOCHEM, V32, P1179, DOI 10.1016/S0146-6380(01)00086-9; Egger M, 2016, BIOGEOSCIEN IN PRESS, DOI [10.5194/bg-2016-64, DOI 10.5194/BG-2016-64]; Egger M, 2015, ENVIRON SCI TECHNOL, V49, P277, DOI 10.1021/es503663z; Erickson BE, 2000, GEOCHIM COSMOCHIM AC, V64, P1149, DOI 10.1016/S0016-7037(99)00423-8; FOSSING H, 1989, BIOGEOCHEMISTRY, V8, P205; Gelesh L, 2016, METHANE CONCENTRATIO; Hagens M, 2015, BIOGEOSCIENCES, V12, P1561, DOI 10.5194/bg-12-1561-2015; Hartnett HE, 1998, NATURE, V391, P572, DOI 10.1038/35351; Heyer J, 2000, ESTUAR COAST SHELF S, V51, P13, DOI 10.1006/ecss.2000.0616; Hindmarsh AC, 1983, SCI COMPUT, V1, P55; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; Holler T, 2012, P NATL ACAD SCI USA, V109, P21170, DOI 10.1073/pnas.1218683109; Holmkvist L, 2014, GEOCHIM COSMOCHIM AC, V142, P75, DOI 10.1016/j.gca.2014.07.030; Holmkvist L, 2011, GEOCHIM COSMOCHIM AC, V75, P3581, DOI 10.1016/j.gca.2011.03.033; Holmkvist L, 2011, DEEP-SEA RES PT I, V58, P493, DOI 10.1016/j.dsr.2011.02.009; IVERSEN N, 1985, LIMNOL OCEANOGR, V30, P944, DOI 10.4319/lo.1985.30.5.0944; Jorgensen B. B, 2006, MARINE GEOCHEMISTRY, P271, DOI DOI 10.1007/3-540-32144-6_8; JORGENSEN BB, 1978, GEOMICROBIOL J, V1, P29; JORGENSEN BB, 1974, MAR BIOL, V24, P189, DOI 10.1007/BF00391893; Jorgensen BB, 2001, DEEP-SEA RES PT I, V48, P2097, DOI 10.1016/S0967-0637(01)00007-3; Kallmeyer J, 2004, LIMNOL OCEANOGR-METH, V2, P171, DOI 10.4319/lom.2004.2.171; Kato S, 2012, ENVIRON MICROBIOL, V14, P1646, DOI 10.1111/j.1462-2920.2011.02611.x; Kemp WM, 2009, BIOGEOSCIENCES, V6, P2985, DOI 10.5194/bg-6-2985-2009; Knab NJ, 2009, BIOGEOSCIENCES, V6, P1505, DOI 10.5194/bg-6-1505-2009; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Kraal P, 2013, ENVIRON SCI TECHNOL, V47, P3114, DOI 10.1021/es304868t; KRISTJANSSON JK, 1982, ARCH MICROBIOL, V131, P278, DOI 10.1007/BF00405893; Leloup J, 2007, ENVIRON MICROBIOL, V9, P131, DOI 10.1111/j.1462-2920.2006.01122.x; Leloup J, 2009, ENVIRON MICROBIOL, V11, P1278, DOI 10.1111/j.1462-2920.2008.01855.x; Li HJ, 2015, ENVIRON MICROBIOL, V17, P1533, DOI 10.1111/1462-2920.12576; Liu D, 2011, CHEM GEOL, V288, P53, DOI 10.1016/j.chemgeo.2011.06.013; LOVLEY DR, 1989, APPL ENVIRON MICROB, V55, P700, DOI 10.1128/AEM.55.3.700-706.1989; Lovley DR, 1987, APPL ENVIRON MICROB, P53; Maltby J, 2016, BIOGEOSCIENCES, V13, P283, DOI 10.5194/bg-13-283-2016; Martens CS, 1999, AM J SCI, V299, P589, DOI 10.2475/ajs.299.7-9.589; McGlynn SE, 2015, NATURE, V526, P531, DOI 10.1038/nature15512; Meyerdierks A, 2010, ENVIRON MICROBIOL, V12, P422, DOI 10.1111/j.1462-2920.2009.02083.x; Meysman FJR, 2005, GEOCHIM COSMOCHIM AC, V69, P3601, DOI 10.1016/j.gca.2005.01.004; Middelburg J.J., 2009, BIOGEOSCI DISCUSS, V6, P3655, DOI DOI 10.5194/BGD-6-3655-2009; Middelburg JJ, 1996, MAR ECOL PROG SER, V132, P157, DOI 10.3354/meps132157; Milucka J, 2012, NATURE, V491, P541, DOI 10.1038/nature11656; Mogollon JM, 2013, GEO-MAR LETT, V33, P299, DOI 10.1007/s00367-013-0329-z; Moran JJ, 2008, ENVIRON MICROBIOL, V10, P162, DOI 10.1111/j.1462-2920.2007.01441.x; Nauhaus K, 2007, ENVIRON MICROBIOL, V9, P187, DOI 10.1111/j.1462-2920.2006.01127.x; Thang NM, 2013, ESTUAR COAST, V36, P98, DOI 10.1007/s12237-012-9557-0; Niemann H, 2005, BIOGEOSCIENCES, V2, P335, DOI 10.5194/bg-2-335-2005; Parkes RJ, 2007, ENVIRON MICROBIOL, V9, P1146, DOI 10.1111/j.1462-2920.2006.01237.x; Piker L, 1998, AQUAT MICROB ECOL, V14, P183, DOI 10.3354/ame014183; Poulton SW, 2005, CHEM GEOL, V214, P209, DOI 10.1016/j.chemgeo.2004.09.003; Rak D, 2012, OCEANOLOGIA, V54, P339, DOI 10.5697/oc.54-3.339; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; REEBURGH WS, 1983, ANNU REV EARTH PL SC, V11, P269, DOI 10.1146/annurev.ea.11.050183.001413; Reed DC, 2011, LIMNOL OCEANOGR, V56, P1075, DOI 10.4319/lo.2011.56.3.1075; Reiche M, 2008, FEMS MICROBIOL ECOL, V65, P88, DOI 10.1111/j.1574-6941.2008.00523.x; Riedinger N, 2014, GEOBIOLOGY, V12, P172, DOI 10.1111/gbi.12077; Rooze J, 2016, LIMNOL OCEANOGR; Rotaru AE, 2016, SCIENCE, V351, P658, DOI 10.1126/science.aaf0741; Sapart CJ, 2011, ATMOS MEAS TECH, V4, P2607, DOI 10.5194/amt-4-2607-2011; Scheller S, 2016, SCIENCE, V351, P703, DOI 10.1126/science.aad7154; SCHONHEIT P, 1982, ARCH MICROBIOL, V132, P285, DOI 10.1007/BF00407967; Scott C, 2012, CHEM GEOL, V324, P19, DOI 10.1016/j.chemgeo.2012.05.012; Seeberg-Elverfeldt J, 2005, LIMNOL OCEANOGR-METH, V3, P361, DOI 10.4319/lom.2005.3.361; Segarra KEA, 2013, GEOCHIM COSMOCHIM AC, V115, P15, DOI 10.1016/j.gca.2013.03.029; Seifert R, 2006, ORG GEOCHEM, V37, P1411, DOI 10.1016/j.orggeochem.2006.03.007; Seitaj D, 2015, P NATL ACAD SCI USA, V112, P13278, DOI 10.1073/pnas.1510152112; Sivan O, 2016, GEOBIOLOGY, V14, P190, DOI 10.1111/gbi.12172; Sivan O, 2014, P NATL ACAD SCI USA, V111, pE4139, DOI 10.1073/pnas.1412269111; Sivan O, 2011, LIMNOL OCEANOGR, V56, P1536, DOI 10.4319/lo.2011.56.4.1536; Slomp CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062386; Soetaert K, 1996, GEOCHIM COSMOCHIM AC, V60, P1019, DOI 10.1016/0016-7037(96)00013-0; Soetaert K., 2010, MARELAC TOOLS AQUATI; Soetaert K, 2012, ENVIRON MODELL SOFTW, V32, P49, DOI 10.1016/j.envsoft.2011.08.011; Sulu-Gambari F, 2016, ENVIRON SCI TECHNOL, V50, P1227, DOI 10.1021/acs.est.5b04369; Treude T, 2005, LIMNOL OCEANOGR, V50, P1771, DOI 10.4319/lo.2005.50.6.1771; Treude T, 2014, GEOCHIM COSMOCHIM AC, V144, P217, DOI 10.1016/j.gca.2014.08.018; Ulyanova M, 2012, GEO-MAR LETT, V32, P535, DOI 10.1007/s00367-012-0304-0; Valentine DL, 2002, ANTON LEEUW INT J G, V81, P271, DOI 10.1023/A:1020587206351; van Bodegom PM, 2004, FEMS MICROBIOL ECOL, V49, P261, DOI 10.1016/j.femsec.2004.03.017; Van Santvoort PJM, 2002, AQUAT GEOCHEM, V8, P153, DOI 10.1023/A:1024271706896; Vargas M, 1998, NATURE, V395, P65, DOI 10.1038/25720; Viggi CC, 2014, ENVIRON SCI TECHNOL, V48, P7536, DOI 10.1021/es5016789; Wagner M, 2015, NATURE, V526, P513, DOI 10.1038/526513a; Wang YF, 1996, GEOCHIM COSMOCHIM AC, V60, P2993, DOI 10.1016/0016-7037(96)00140-8; Wankel SD, 2012, ENVIRON MICROBIOL, V14, P2726, DOI 10.1111/j.1462-2920.2012.02825.x; Wegener G, 2015, NATURE, V526, P587, DOI 10.1038/nature15733; Wetsteyn L. P. M. J, 2011, GREVELINGENMEER MEER; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; Yoshinaga MY, 2014, NAT GEOSCI, V7, P190, DOI [10.1038/NGEO2069, 10.1038/ngeo2069]; Zhou SG, 2014, FEMS MICROBIOL ECOL, V88, P107, DOI 10.1111/1574-6941.12274; Zhuang L, 2015, J GEOPHYS RES-BIOGEO, V120, P876, DOI 10.1002/2014JG002893	113	52	52	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161609	10.1371/journal.pone.0161609	http://dx.doi.org/10.1371/journal.pone.0161609			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560511	Green Published, gold			2022-12-26	WOS:000382258600061
J	Landgraf, K; Scholz, M; Kovacs, P; Kiess, W; Korner, A				Landgraf, Kathrin; Scholz, Markus; Kovacs, Peter; Kiess, Wieland; Koerner, Antje			FTO Obesity Risk Variants Are Linked to Adipocyte IRX3 Expression and BMI of Children - Relevance of FTO Variants to Defend Body Weight in Lean Children?	PLOS ONE			English	Article							ADULT OBESITY; FOOD-INTAKE; GENE; ASSOCIATION; ADIPOSITY; CHILDHOOD; BIOLOGY	Background Genome-wide association studies have identified variants within the FTO (fat mass and obesity associated) locus as the strongest predictors of obesity amongst all obesity-associated gene loci. Recent evidence suggests that variants in FTO directly affect human adipocyte function through targeting IRX3 and IRX5 and thermogenesis regulation. Aim We addressed the relevance of this proposed FTO-IRX pathway in adipose tissue (AT) of children. Results Expression of IRX3 was higher in adipocytes compared to SVF. We found increased adipocyte-specific expression of IRX3 and IRX5 with the presence of the FTO risk haplotype in lean children, whereas it was unaffected by risk variants in obese peers. We further show that IRX3 expression was elevated in isolated adipocytes and AT of lean compared to obese children, particularly in UCP1-negative adipocytes, and inversely correlated with BMI SDS. Independent of BMI, IRX3 expression in adipocytes was significantly related to adipocyte hypertrophy, and subsequent associations with AT inflammation and HOMA-IR in the children. Conclusion One interpretation of our observation of FTO risk variants linked to IRX3 expression and adipocyte size restricted to lean children, along with the decreased IRX3 expression in obesecompared to lean peers, may reflect a defense mechanism for protecting body-weight, which is pertinent for lean children.	[Landgraf, Kathrin; Kiess, Wieland; Koerner, Antje] Univ Leipzig, Univ Hosp Children & Adolescents, Ctr Pediat Res Leipzig CPL, Leipzig, Germany; [Landgraf, Kathrin; Kovacs, Peter; Koerner, Antje] Univ Leipzig, Integrated Res & Treatment Ctr IFB Adipos Dis, Leipzig, Germany; [Scholz, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany; [Scholz, Markus] Univ Leipzig, LIFE Res Ctr Civilizat Dis, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University	Korner, A (corresponding author), Univ Leipzig, Univ Hosp Children & Adolescents, Ctr Pediat Res Leipzig CPL, Leipzig, Germany.; Korner, A (corresponding author), Univ Leipzig, Integrated Res & Treatment Ctr IFB Adipos Dis, Leipzig, Germany.	Antje.Koerner@medizin.uni-leipzig.de	Körner, Antje/B-3988-2015; Landgraf, Kathrin/J-4937-2016	Körner, Antje/0000-0001-6001-0356; Landgraf, Kathrin/0000-0002-6878-6033; Kovacs, Peter/0000-0002-0290-5423	German Research Council (DFG) for the Collaborative Research Center "Obesity Mechanisms" [CRC1052]; Federal Ministry of Education and Research (BMBF), Germany (IFB AdiposityDiseases) [FKZ: 01EO1501]; European Community's 7th Framework Programme project Beta-JUDO [279153]; European Union; European Regional Development Fund (ERFD); German Research Foundation (DFG); University of Leipzig within the program of Open Access Publishing	German Research Council (DFG) for the Collaborative Research Center "Obesity Mechanisms"(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF), Germany (IFB AdiposityDiseases)(Federal Ministry of Education & Research (BMBF)); European Community's 7th Framework Programme project Beta-JUDO; European Union(European Commission); European Regional Development Fund (ERFD)(European Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Leipzig within the program of Open Access Publishing	This work was supported by the German Research Council (DFG) for the Collaborative Research Center "Obesity Mechanisms" CRC1052, the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1501 (IFB AdiposityDiseases), and the European Community's 7th Framework Programme project Beta-JUDO no 279153. Genotyping was facilitated the LIFE Child study (Leipzig Research Center for Civilization Diseases, Universitat Leipzig), funded by the European Union, by the European Regional Development Fund (ERFD) by means of the Free State of Saxony within the framework of the excellence initiative.; We thank Antje Berthold and Roy Tauscher for technical assistance. This work was supported by the German Research Council (DFG) for the Collaborative Research Center "Obesity Mechanisms" CRC1052, the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1501 (IFB AdiposityDiseases), and the European Community's 7th Framework Programme project Beta-JUDO no 279153. Genotyping was facilitated the LIFE Child study (Leipzig Research Center for Civilization Diseases, Universitat Leipzig), funded by the European Union, by the European Regional Development Fund (ERFD) by means of the Free State of Saxony within the framework of the excellence initiative. We acknowledge support from the German Research Foundation (DFG) and University of Leipzig within the program of Open Access Publishing.	Bernhard F, 2013, DIABETOLOGIA, V56, P311, DOI 10.1007/s00125-012-2773-0; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Flier JS, 1998, J CLIN ENDOCR METAB, V83, P1407, DOI 10.1210/jc.83.5.1407; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Landgraf K, 2015, DIABETES, V64, P1249, DOI 10.2337/db14-0744; Loos RJF, 2014, NAT REV ENDOCRINOL, V10, P51, DOI 10.1038/nrendo.2013.227; Qi QB, 2015, DIABETES, V64, P2467, DOI 10.2337/db14-1629; Ragvin A, 2010, P NATL ACAD SCI USA, V107, P775, DOI 10.1073/pnas.0911591107; Rockstroh D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117841; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Stratigopoulos G, 2014, CELL METAB, V19, P767, DOI 10.1016/j.cmet.2014.04.009; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771	17	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161739	10.1371/journal.pone.0161739	http://dx.doi.org/10.1371/journal.pone.0161739			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560134	Green Published, gold			2022-12-26	WOS:000382258600088
J	Smith, MP; Berdel, D; Bauer, CP; Koletzko, S; Nowak, D; Heinrich, J; Schulz, H				Smith, Maia P.; Berdel, Dietrich; Bauer, Carl-Peter; Koletzko, Sibylle; Nowak, Dennis; Heinrich, Joachim; Schulz, Holger			Asthma and Rhinitis Are Associated with Less Objectively-Measured Moderate and Vigorous Physical Activity, but Similar Sport Participation, in Adolescent German Boys: GINIplus and LISAplus Cohorts	PLOS ONE			English	Article							CHILDHOOD; CHILDREN; EXERCISE; ECZEMA; ADULTHOOD; SYMPTOMS; EXPOSURE; FITNESS; IMPACT; AGE	Introduction Physical activity (PA) protects against most noncommunicable diseases and has been associated with decreased risk of allergic phenotype, which is increasing worldwide. However, the association is not always present; furthermore it is not clear whether it is strongest for asthma, rhinitis, symptoms of these, or atopic sensitization; which sex is most affected; or whether it can be explained by either avoidance of sport or exacerbation of symptoms by exercise. Interventions are thus difficult to target. Methods PA was measured by one-week accelerometry in 1137 Germans (mean age 15.6 years, 47% boys) from the GINIplus and LISAplus birth cohorts, and modeled as a correlate of allergic symptoms, sensitization, or reported doctor-diagnosed asthma or rhinitis. Results 8.3% of children had asthma, of the remainder 7.9% had rhinitis, and of the remainder 32% were sensitized to aero-allergens (atopic). 52% were lung-healthy controls. Lung-healthy boys and girls averaged 46.4 min and 37.8 min moderate-to-vigorous PA per day, of which 14.6 and 11.4 min was vigorous. PA in allergic girls was not altered, but boys with asthma got 13% less moderate and 29% less vigorous PA, and those with rhinitis with 13% less moderate PA, than lung-healthy boys. Both sexes participated comparably in sport (70 to 84%). Adolescents with wheezing (up to 68%, in asthma) and/ or nose/eye symptoms (up to 88%, in rhinitis) were no less active. Conclusions We found that asthma and rhinitis, but not atopy, were independently associated with low PA in boys, but not in girls. These results indicate that allergic boys remain a high-risk group for physical inactivity even if they participate comparably in sport. Research into the link between PA and allergy should consider population-specific and sex-specific effects, and clinicians, parents, and designers of PA interventions should specifically address PA in allergic boys to ensure full participation.	[Smith, Maia P.; Heinrich, Joachim; Schulz, Holger] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 1, Neuherberg, Germany; [Berdel, Dietrich] Marien Hosp Wesel, Dept Pediat, Res Inst, Wesel, Germany; [Nowak, Dennis; Heinrich, Joachim; Schulz, Holger] German Ctr Lung Res, CPC M, Munich, Germany; [Smith, Maia P.; Nowak, Dennis] Univ Munich, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany; [Koletzko, Sibylle] Univ Munich, Dr von Hauner Childrens Hosp, Munich, Germany; [Bauer, Carl-Peter] Tech Univ Munich, Dept Pediat, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; St. Marien Hospital; University of Munich; University of Munich; Technical University of Munich	Smith, MP (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 1, Neuherberg, Germany.; Smith, MP (corresponding author), Univ Munich, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany.	maia.smith@helmholtz-muenchen.de	Heinrich, Joachim/N-1720-2013; Schulz, Holger/J-5643-2015	Heinrich, Joachim/0000-0002-9620-1629; Schulz, Holger/0000-0002-1157-200X; Smith, Maia Phillips/0000-0002-1154-1158	Federal Ministry for Environment (IUF Dusseldorf) [FKZ 20462296]; Federal Ministry for Education, Science, Research and Technology; Helmholtz Zentrum Munich; Helmholtz Centre for Environmental Research - UFZ; Leipzig; Research Institute at Marien-Hospital Wesel; Pediatric Practice; Comprehensive Pneumology Center Munich (CPC-M) as member of the German Center for Lung Research	Federal Ministry for Environment (IUF Dusseldorf); Federal Ministry for Education, Science, Research and Technology; Helmholtz Zentrum Munich; Helmholtz Centre for Environmental Research - UFZ(Helmholtz Association); Leipzig; Research Institute at Marien-Hospital Wesel; Pediatric Practice; Comprehensive Pneumology Center Munich (CPC-M) as member of the German Center for Lung Research	This study was part of the 15-year followup of two German birth cohorts, GINIplus (German Infant Study on the influence of Nutrition Intervention PLUS environmental and genetic influences on allergy development) and LISAplus (Influence of lifestyle factors on the development of the immune system and allergies Plus the influence of traffic emissions and genetics). We thank the GINIplus and LISAplus Study Groups for all their excellent work. The GINIplus Study Group includes the following: Institute of Epidemiology I, Helmholtz Zentrum Munchen German Research Center for Environmental Health, Neuherberg (J. Heinrich, I. Bruske, H. Schulz, C. Flexeder, C. Zeller, M. Standl, M. Schnappinger, M. Sussmann, E. Thiering, C. Tiesler); Research Institute, Department of Pediatrics, Marien-Hospital, Wesel (D. Berdel, A. von Berg, B. Filipiak-Pittroff); Ludwig-Maximilians-University of Munich, Dr von Hauner Children's Hospital (S. Koletzko, K. Werkstetter); Department of Pediatrics, Technische Universitat Munchen and Deutsche Rentenversicherung Bayern (C.P. Bauer, U. Hoffmann); and IUF-Leibniz Institute for Environmental Research, Dusseldorf (B. Hoffmann, E. Link, C. Klumper, U. Kramer). The LISAplus Study Group includes the following: Institute of Epidemiology I, Helmholtz Zentrum Munchen, German Research Center for Environmental Health (J. Heinrich, I. Bruske, H. Schulz, M. Standl, M. Schnappinger, M. Sussmann, E. Thiering, C. Tiesler, C. Flexeder, C. Zeller); Department of Pediatrics, Marien Hospital Wesel, Wesel (A. von Berg); Pediatric Practice, Bad Honnef (B. Schaaf); Technical University, Munich (C.P. Bauer, U. Hoffmann); Helmholtz Centre for Environmental Research -UFZ, Department of Environmental Immunology/Core Facility Studies, Leipzig (I. Lehmann, M. Bauer, G. Herberth, J. Muller, S. Roder and M. Schilde); Department of Pediatrics, Municipal Hospital 'St. Georg', Leipzig (M. Borte, U. Diez, C. Dorn, E. Braun); and ZAUM-Center for Allergy and Environment, Technical University Munich (M. Ollert, J. Grosch). The GINIplus study was mainly supported for the first 3 years of the Federal Ministry for Education, Science, Research and Technology (interventional arm) and Helmholtz Zentrum Munich (former GSF) (observational arm). The 4 year, 6 year, and 10 year follow-up examinations of the GINIplus study were covered from the respective budgets of the 4 study centres: Helmholtz Zentrum Munich, Research Institute at Marien-Hospital Wesel, Ludwig-Maximilians-University Munich, Technical University Munich, and from 6 years onwards also from IUF Leibniz Research-Institute for Environmental Medicine at the University of Dusseldorf, and a grant from the Federal Ministry for Environment (IUF Dusseldorf, FKZ 20462296). The LISAplus study was mainly supported by grants from the Federal Ministry for Education, Science, Research and Technology and in addition from Helmholtz Zentrum Munich (former GSF), Helmholtz Centre for Environmental Research - UFZ, Leipzig, Research Institute at Marien-Hospital Wesel, Pediatric Practice, Bad Honnef for the first 2 years.; The 4 year, 6 year, and 10 year follow-up examinations of the LISAplus study were covered from the respective budgets of the involved partners (Helmholtz Zentrum Munich (former GSF), Helmholtz Centre for Environmental Research - UFZ, Leipzig, Research Institute at Marien-Hospital Wesel, Pediatric Practice, Bad Honnef, IUF - Leibniz-Research Institute for Environmental Medicine at the University of Dusseldorf) and in addition by a grant from the Federal Ministry for Environment (IUF Dusseldorf, FKZ 20462296). This work was supported by the Comprehensive Pneumology Center Munich (CPC-M) as member of the German Center for Lung Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballardini N, 2012, ALLERGY, V67, P537, DOI 10.1111/j.1398-9995.2012.02786.x; Beckett WS, 2001, AM J RESP CRIT CARE, V164, P2045, DOI 10.1164/ajrccm.164.11.2004235; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Chen CM, 2007, J ALLERGY CLIN IMMUN, V119, P1148, DOI 10.1016/j.jaci.2007.02.017; Claudia F, 2016, PEDIATR PULM, V51, P147, DOI 10.1002/ppul.23216; Day A, 2010, CANADIAN RESP J SA, V17, p11a; De Cocker K, 2011, PUBLIC HEALTH NUTR, V14, P246, DOI 10.1017/S1368980010000558; Dryden DM, 2010, EXERCISE INDUCED BRO; Firrincieli V, 2005, PEDIATR PULM, V40, P57, DOI 10.1002/ppul.20214; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Gergen P, 2005, ETHNIC DISPARITIES B; Groth SW, 2016, J ASTHMA, V53, P19, DOI 10.3109/02770903.2015.1063646; Guldberg-Moller J, 2015, CLIN RESPIR J, V9, P314, DOI 10.1111/crj.12145; Heinrich J, LISAPLUS INFLUENCE L; Heinrich J, GERMAN INTERVENTIONA; Jarvis D, 2012, ALLERGY, V67, P91, DOI 10.1111/j.1398-9995.2011.02709.x; Klinker Charlotte D, 2014, Int J Behav Nutr Phys Act, V11, P8, DOI 10.1186/1479-5868-11-8; Li JT, 2005, J ALLERGY CLIN IMMUN, V116, pS3, DOI 10.1016/j.jaci.2005.08.017; Lucas SR, 2005, J ALLERGY CLIN IMMUN, V115, P928, DOI 10.1016/j.jaci.2005.01.033; MCFADDEN ER, 1994, NEW ENGL J MED, V330, P1362, DOI 10.1056/NEJM199405123301907; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mitchell EA, 2013, CLIN EXP ALLERGY, V43, P73, DOI 10.1111/cea.12024; Molter A, 2015, EUR RESPIR J, V45, P610, DOI 10.1183/09031936.00083614; Olds T., 2009, ACHPER Healthy Lifestyles Journal, V56, P11; Ottevaere C, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-8; Parsons JP, 2013, AM J RESP CRIT CARE, V187, P1016, DOI 10.1164/rccm.201303-0437ST; Pawankar R, 2004, CURR OPIN ALLERGY CL, V4; Pawankar R, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-12; Pfitzner R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065192; Rasmussen F, 2000, EUR RESPIR J, V16, P866, DOI 10.1183/09031936.00.16586600; Smith M. P., 2016, EUROPEAN RESP J, V47; Smith M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135630; Smith MP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152217; Smith MP, 2015, EUR C EP HLTH LIV 20; Sugimoto M, 2012, J ALLERGY CLIN IMMUN, V129, pAB238, DOI 10.1016/j.jaci.2011.12.025; Telama R, 2009, OBESITY FACTS, V2, P187, DOI 10.1159/000222244; Troiano RP, 2007, MED SCI SPORT EXER, V39, P1501, DOI 10.1097/mss.0b013e318150d42e; US CDC, 2012, SAS PROGR AN NHANES; von Berg A, 2016, ALLERGY, V71, P210, DOI 10.1111/all.12790; von Berg A, 2010, CLIN EXP ALLERGY, V40, P627, DOI 10.1111/j.1365-2222.2009.03444.x; Wahn U, 2015, ADV ALLERGIC DIS LIF; Weisgerber M, 2008, PEDIATR PULM, V43, P1175, DOI 10.1002/ppul.20895; WHO, 2011, WHO INF SHEET GLOBAL; Wickel EE, 2007, MED SCI SPORT EXER, V39, P1493, DOI 10.1249/mss.0b013e318093f56a; Williams B, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X515070; Williams B, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-40; Yiallouros PK, 2015, PEDIATR PULM, V50, P317, DOI 10.1002/ppul.23045	48	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161461	10.1371/journal.pone.0161461	http://dx.doi.org/10.1371/journal.pone.0161461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560942	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258600044
J	Dick, JJ; Soulsby, C; Birkel, C; Malcolm, I; Tetzlaff, D				Dick, Jonathan J.; Soulsby, Chris; Birkel, Christian; Malcolm, Iain; Tetzlaff, Doerthe			Continuous Dissolved Oxygen Measurements and Modelling Metabolism in Peatland Streams	PLOS ONE			English	Article							ECOSYSTEM METABOLISM; ORGANIC-MATTER; WATER; PRODUCTIVITY; DYNAMICS; RESPIRATION; VARIABILITY; REAERATION; EXCHANGE; TRACERS	Stream water dissolved oxygen was monitored in a 3.2km(2) moorland headwater catchment in the Scottish Highlands. The stream consists of three 1st order headwaters and a 2nd order main stem. The stream network is fringed by peat soils with no riparian trees, though dwarf shrubs provide shading in the lower catchment. Dissolved oxygen (DO) is regulated by the balance between atmospheric re-aeration and the metabolic processes of photosynthesis and respiration. DO was continuously measured for > 1 year and the data used to calibrate a mass balance model, to estimate primary production, respiration and re-aeration for a 1st order site and in the 2nd order main stem. Results showed that the stream was always heterotrophic at both sites. Sites were most heterotrophic in the summer reflecting higher levels of stream metabolism. The 1st order stream appeared more heterotrophic which was consistent with the evident greater biomass of macrophytes in the 2nd order stream, with resulting higher primary productivity. Comparison between respiration, primary production, reaeration and potential physical controls revealed only weak relationships. However, the most basic model parameters (e.g. the parameter linking light and photosynthesis) controlling ecosystem processes resulted in significant differences between the sites which seem related to the stream channel geometry.	[Dick, Jonathan J.; Soulsby, Chris; Birkel, Christian; Tetzlaff, Doerthe] Univ Aberdeen, Northern Rivers Inst, Sch Geosci, Aberdeen AB24 3UF, Scotland; [Birkel, Christian] Univ Costa Rica, Dept Geog, San Jose 2060, Costa Rica; [Malcolm, Iain] Marine Sci Scotland, Freshwater Lab, Pitlochry, Scotland	University of Aberdeen; Universidad Costa Rica	Dick, JJ (corresponding author), Univ Aberdeen, Northern Rivers Inst, Sch Geosci, Aberdeen AB24 3UF, Scotland.	jonathan.dick@abdn.ac.uk	Dick, Jonathan/G-3811-2018; Soulsby, Chris/AAR-1100-2021; Tetzlaff, Doerthe/D-1818-2018	Dick, Jonathan/0000-0002-4875-6574; Tetzlaff, Doerthe/0000-0002-7183-8674	European Research Council ERC [GA 335910 VEWA]; Leverhulme Trust [RPG-2014-016]	European Research Council ERC(European Research Council (ERC)); Leverhulme Trust(Leverhulme Trust)	This work was supported by the following sources of funding: European Research Council ERC (project GA 335910 VEWA) for funding through the VeWa project (DT); Leverhulme Trust for funding through PLATO (RPG-2014-016) (DT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali G, 2014, EARTH SURF PROC LAND, V39, P399, DOI 10.1002/esp.3506; Aristegi L, 2009, HYDROBIOLOGIA, V635, P113, DOI 10.1007/s10750-009-9904-8; Birkel C, 2010, HYDROL PROCESS, V24, P260, DOI 10.1002/hyp.7478; Birkel C, 2015, HYDROL PROCESS, V29, P2956, DOI 10.1002/hyp.10414; Birkel C, 2013, WATER RESOUR RES, V49, P5260, DOI 10.1002/wrcr.20409; Bishop K, 2008, HYDROL PROCESS, V22, P1239, DOI 10.1002/hyp.7049; Blumstock M, 2015, J HYDROL, V527, P1021, DOI 10.1016/j.jhydrol.2015.05.019; Bragg OM, 2001, CATENA, V42, P345, DOI 10.1016/S0341-8162(00)00146-6; Brown LE, 2010, HYDROL PROCESS, V24, P3206, DOI 10.1002/hyp.7746; Brun R, 2001, WATER RESOUR RES, V37, P1015, DOI 10.1029/2000WR900350; Bunn SE, 1999, FRESHWATER BIOL, V41, P333, DOI 10.1046/j.1365-2427.1999.00434.x; Ciavatta S, 2008, ECOL MODEL, V212, P28, DOI 10.1016/j.ecolmodel.2007.10.025; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Cole JJ, 2000, LIMNOL OCEANOGR, V45, P1718, DOI 10.4319/lo.2000.45.8.1718; Corcoran AA, 2012, J MICROBIOL METH, V91, P377, DOI 10.1016/j.mimet.2012.09.020; Covar, 1976, P C ENV MOD SIM CINC; Crawford JT, 2014, GLOBAL BIOGEOCHEM CY, V28; Cushing C. E, 2006, RIV STREAM EC WORLD; DaSilva A, 2013, WATER-SUI, V5, P747, DOI 10.3390/w5020747; DaSilva A, 2013, FOREST SCI, V59, P127, DOI 10.5849/forsci.11-038; Dawson JJC, 2008, BIOGEOCHEMISTRY, V90, P93, DOI 10.1007/s10533-008-9234-3; Dawson J. J. C, 2013, ECOSYSTEM SERVICES C, P183; Dawson JJC, 2009, HYDROL PROCESS, V23, P2929, DOI 10.1002/hyp.7402; Demars BOL, 2013, WATER RES, V47, P1, DOI 10.1016/j.watres.2012.09.054; Demars BOL, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011046; Demars BOL, 2015, LIMNOL OCEANOGR-METH, V13, P356, DOI 10.1002/lom3.10030; Demars BOL, 2011, FRESHW BIOL; Dick J, HYDROL PROC IN PRESS; Dick JJ, 2015, HYDROL PROCESS, V29, P3098, DOI 10.1002/hyp.10423; Dick J. J., 2014, BIOGEOCHEMISTRY, P1; Dinsmore KJ, 2010, GLOBAL CHANGE BIOL, V16, P2750, DOI 10.1111/j.1365-2486.2009.02119.x; Duarte CM, 1998, SCIENCE, V281, P234, DOI 10.1126/science.281.5374.234; Edwards AC, 2000, J APPL ECOL, V37, P159, DOI 10.1046/j.1365-2664.2000.00500.x; Elmore HL, 1961, EFFECT WATER TEMPERA; GENEREUX DP, 1992, WATER RESOUR RES, V28, P2365, DOI 10.1029/92WR01083; Giling DP, 2013, FRESHWATER BIOL, V58, P2601, DOI 10.1111/fwb.12236; Gore AJP, 1983, MIRES SWAMP BOG FEN, VA; GRIMM NB, 1984, HYDROBIOLOGIA, V111, P219, DOI 10.1007/BF00007202; Halbedel S, 2013, BIOGEOSCIENCES, V10, P5555, DOI 10.5194/bg-10-5555-2013; Hoellein TJ, 2013, LIMNOL OCEANOGR, V58, P2089, DOI 10.4319/lo.2013.58.6.2089; Holden J, 2007, EARTH-SCI REV, V82, P75, DOI 10.1016/j.earscirev.2007.01.003; Holtgrieve GW, 2016, LIMNOL OCEANOGR-METH, V14, P110, DOI 10.1002/lom3.10075; Holtgrieve GW, 2010, LIMNOL OCEANOGR, V55, P1047, DOI 10.4319/lo.2010.55.3.1047; HORNBERGER GM, 1975, J ENV ENG DIV-ASCE, V101, P729; Huryn AD, 2014, ECOLOGY; Izagirre O, 2008, J N AM BENTHOL SOC, V27, P252, DOI 10.1899/07-022.1; Jin HS, 2012, WATER AIR SOIL POLL, V223, P5297, DOI 10.1007/s11270-012-1280-8; Kaenel BR, 2000, FRESHWATER BIOL, V45, P85, DOI 10.1046/j.1365-2427.2000.00618.x; KOSINSKI RJ, 1984, HYDROBIOLOGIA, V119, P139, DOI 10.1007/BF00011953; Lopez-Archilla AI, 2004, WETLANDS, V24, P848, DOI 10.1672/0277-5212(2004)024[0848:EMIAMS]2.0.CO;2; Malcolm IA, 2009, HYDROGEOL J, V17, P161, DOI 10.1007/s10040-008-0339-5; Malcolm IA, 2006, HYDROL PROCESS, V20, P615, DOI 10.1002/hyp.6107; MARZOLF ER, 1994, CAN J FISH AQUAT SCI, V51, P1591, DOI 10.1139/f94-158; Montanarella L., 2006, DISTRIBUTION PEATLAN; Mulholland PJ, 2005, ECOL INDIC, V5, P243, DOI 10.1016/j.ecolind.2005.03.004; Mulholland PJ, 2001, FRESHWATER BIOL, V46, P1503, DOI 10.1046/j.1365-2427.2001.00773.x; Mullen K. M, 2009, DEOPTIM R PACKAGE GL; Murphy PNC, 2011, ECOL MODEL, V222, P2314, DOI 10.1016/j.ecolmodel.2011.01.003; NAIMAN RJ, 1980, CAN J FISH AQUAT SCI, V37, P834, DOI 10.1139/f80-112; Nepf HM, 1999, WATER RESOUR RES, V35, P479, DOI 10.1029/1998WR900069; O'Connor BL, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011488; O'Driscoll C, 2016, J ENVIRON MANAGE, V166, P250, DOI 10.1016/j.jenvman.2015.10.031; ODUM HT, 1956, LIMNOL OCEANOGR, V1, P102, DOI 10.4319/lo.1956.1.2.0102; Parkhill KL, 1998, HYDROBIOLOGIA, V389, P7, DOI 10.1023/A:1003519302002; Pusch M, 1996, HYDROBIOLOGIA, V323, P107, DOI 10.1007/BF00017588; Rasmussen JJ, 2011, AQUAT ECOL, V45, P231, DOI 10.1007/s10452-010-9349-1; RATHBUN RE, 1978, J ENV ENG DIV-ASCE, V104, P215; Raymond P.A., 2012, LIMNOL OCEANOGR FLUI, V2, P41, DOI [10.1215/21573689-1597669, DOI 10.1215/21573689-1597669]; Reichert P, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000917; Riley AJ, 2013, FRESHW SCI, V32, P56, DOI 10.1899/12-058.1; Roberts BJ, 2007, ECOSYSTEMS, V10, P588, DOI 10.1007/s10021-007-9059-2; Roberts BJ, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2007JG000422; Sanchez E, 2007, ECOL INDIC, V7, P315, DOI 10.1016/j.ecolind.2006.02.005; Schade JD, 2011, FRESHWATER BIOL, V56, P424, DOI 10.1111/j.1365-2427.2010.02509.x; Soetaert KER, 2010, SOLVING DIFFERENTIAL, V2; Staehr PA, 2012, AQUAT SCI, V74, P15, DOI 10.1007/s00027-011-0199-2; Tank JL, 2010, J N AM BENTHOL SOC, V29, P118, DOI 10.1899/08-170.1; Tetzlaff D, 2007, HYDROL PROCESS, V21, P1289, DOI 10.1002/hyp.6309; Tetzlaff D, 2014, WATER RESOUR RES; Tobias CR, 2007, LIMNOL OCEANOGR, V52, P1439, DOI 10.4319/lo.2007.52.4.1439; Uehlinger U, 2000, FRESHWATER BIOL, V44, P493, DOI 10.1046/j.1365-2427.2000.00602.x; Venkiteswaran JJ, 2007, OECOLOGIA, V153, P385, DOI 10.1007/s00442-007-0744-9; Watters JR, 2007, GEOMORPHOLOGY, V89, P97, DOI 10.1016/j.geomorph.2006.07.015; Wilcock RJ, 1998, NEW ZEAL J MAR FRESH, V32, P67, DOI 10.1080/00288330.1998.9516806; Young RG, 1996, CAN J FISH AQUAT SCI, V53, P2199, DOI 10.1139/cjfas-53-10-2199	85	8	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161363	10.1371/journal.pone.0161363	http://dx.doi.org/10.1371/journal.pone.0161363			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27556278	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000382258100038
J	Hou, S; Hang, Q; Isaji, T; Lu, J; Fukuda, T; Gu, J				Hou, Sicong; Hang, Qinglei; Isaji, Tomoya; Lu, Jishun; Fukuda, Tomohiko; Gu, Jianguo			Importance of membrane-proximal N-glycosylation on integrin beta 1 in its activation and complex formation	FASEB JOURNAL			English	Article						cell migration; cell signaling; sialylation	GROWTH-FACTOR RECEPTOR; I-LIKE DOMAIN; CELL-MIGRATION; ALPHA-5-BETA-1 INTEGRIN; CANCER-CELLS; BIOLOGICAL FUNCTION; PROPELLER DOMAIN; BISECTING GLCNAC; EXPRESSION; ADHESION	N-Glycosylation of integrin alpha 5 beta 1 plays important roles in cell biologic functions; however, the mechanisms that underlie those roles remain poorly understood. Here, we present evidence that the membrane-proximal N-glycosylation on integrin beta 1 could positively regulate cell migration by promoting beta 1 activation. The S4-6 beta 1 mutant contains only 3 N-glycosylation sites, which are essential for alpha 5 and beta 1 heterodimer formation, and despite only a small difference in expression levels of alpha 5 beta 1 between wild-type and S4-6 mutant, cell spreading and migration of the S4-6 mutant was significantly decreased compared with that of control. Consistent with these phenotypes, beta 1-mediated cellular signaling and its activation were clearly suppressed in the S4-6 mutant. Of note, these developments could be rescued by restoration of N-glycosylation sites in the membrane-proximal domain. Further study on the regulatory mechanisms suggested that membrane-proximal N-glycosylation is critical for intermolecular interactions between integrin beta 1 and other cell membrane proteins, such as syndecan-4 and epidermal growth factor receptor. Moreover, alpha 2,6-sialylation is required for beta 1 activation. These data suggest a novel regulatory mechanism where in N-glycosylation near the cell membraneon beta 1 may serve as a platform that facilitates its complex formation on the cell membrane, thereby affecting integrin-mediated functions.	[Hou, Sicong; Hang, Qinglei; Isaji, Tomoya; Lu, Jishun; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Sendai, Miyagi, Japan	Tohoku Medical & Pharmaceutical University	Gu, J (corresponding author), Tohoku Med & Pharmaceut Univ, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi, Japan.	jgu@tohoku-mpu.ac.jp	Hang, Qinglei/GOP-0218-2022; Isaji, Tomoya/ABC-9285-2021; Gu, Jianguo/ABC-9257-2020	Hang, Qinglei/0000-0003-0419-6621; 	Japan Society for the Promotion of Science [15K14408, 15H04354]; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research (15H04354; to J.G.), a grant for Challenging Exploratory Research (15K14408; to J.G.) from the Japan Society for the Promotion of Science, and by a Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Asada M, 1997, CANCER RES, V57, P1073; Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Bendas Gerd, 2012, Int J Cell Biol, V2012, P676731, DOI 10.1155/2012/676731; Bull C, 2014, CANCER RES, V74, P3199, DOI 10.1158/0008-5472.CAN-14-0728; Byron A, 2016, CURR OPIN CELL BIOL, V39, P93, DOI 10.1016/j.ceb.2016.02.013; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; Danguy A, 2002, BBA-GEN SUBJECTS, V1572, P285, DOI 10.1016/S0304-4165(02)00315-X; Fiore VF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5886; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Gu JG, 2009, BIOL PHARM BULL, V32, P780, DOI 10.1248/bpb.32.780; Guo HB, 2002, CANCER RES, V62, P6837; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hang QL, 2015, J BIOL CHEM, V290, P29345, DOI 10.1074/jbc.M115.682229; Hou S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18430; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Isaji T, 2014, J BIOL CHEM, V289, P20694, DOI 10.1074/jbc.M113.542688; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; Josefsson EC, 2005, J BIOL CHEM, V280, P18025, DOI 10.1074/jbc.M501178200; Kariya Y, 2010, J BIOL CHEM, V285, P3330, DOI 10.1074/jbc.M109.038836; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Lu JS, 2016, J BIOL CHEM, V291, P5708, DOI 10.1074/jbc.M115.712836; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Margadant C, 2012, CURR BIOL, V22, P1554, DOI 10.1016/j.cub.2012.06.060; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Morini M, 2000, INT J CANCER, V87, P336, DOI 10.1002/1097-0215(20000801)87:3<336::AID-IJC5>3.0.CO;2-3; Nagae M, 2012, J CELL BIOL, V197, P131, DOI 10.1083/jcb.201111077; Pan D, 2010, BIOPHYS J, V99, P208, DOI 10.1016/j.bpj.2010.03.063; Paszek MJ, 2014, NATURE, V511, P319, DOI 10.1038/nature13535; Petrich BG, 2007, J CLIN INVEST, V117, P2250, DOI 10.1172/JCI31024; Pillozzi S, 2007, BLOOD, V110, P1238, DOI 10.1182/blood-2006-02-003772; Pochec E, 2013, EUR J CELL BIOL, V92, P355, DOI 10.1016/j.ejcb.2013.10.007; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Saito Y, 2007, J BIOL CHEM, V282, P34929, DOI 10.1074/jbc.M705608200; Sato Y, 2009, J BIOL CHEM, V284, P11873, DOI 10.1074/jbc.M807660200; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Vial D, 2012, J BIOL CHEM, V287, P40371, DOI 10.1074/jbc.M112.389577; Wang HY, 2014, J BIOL CHEM, V289, P30318, DOI 10.1074/jbc.M114.586438; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	51	28	28	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4120	4131		10.1096/fj.201600665R	http://dx.doi.org/10.1096/fj.201600665R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27565712				2022-12-26	WOS:000388201500018
J	Sjolander, J; Byman, E; Kulak, K; Nilsson, SC; Zhang, EM; Krus, U; Westermark, GT; Storm, P; King, BC; Renstrom, E; Blom, AM				Sjolander, Jonatan; Byman, Elin; Kulak, Klaudia; Nilsson, Sara C.; Zhang, Enming; Krus, Ulrika; Westermark, Gunilla T.; Storm, Petter; King, Ben C.; Renstrom, Erik; Blom, Anna M.			C4b-binding Protein Protects -Cells from Islet Amyloid Polypeptide-induced Cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; beta cell (B-cell); cell death; cholesterol; complement system	HEPARAN-SULFATE PROTEOGLYCANS; INSULIN-SECRETION; COMPLEMENT ACTIVATION; ALPHA-CHAIN; FACTOR-H; MEMBRANE; CHOLESTEROL; OLIGOMERS; MECHANISM; APOPTOSIS	C4BP (C4b-binding protein) is a polymer of seven identical chains and one unique chain synthesized in liver and pancreas. We showed previously that C4BP enhances islet amyloid polypeptide (IAPP) fibril formation in vitro. Now we report that polymeric C4BP strongly inhibited lysis of human erythrocytes incubated with monomeric IAPP, whereas no lysis was observed after incubation with preformed IAPP fibrils. In contrast, incubation with the monomeric -chain of C4BP was less effective. These data indicate that polymeric C4BP with multiple binding sites for IAPP neutralizes lytic activity of IAPP. Furthermore, addition of monomeric IAPP to a rat insulinoma cell line (INS-1) resulted in decreased cell viability, which was restored in the presence of physiological concentrations of C4BP. Treatment of INS-1 cells and primary rat islets with IAPP also diminished their ability to secrete insulin upon stimulation with glucose, which was reversed in the presence of C4BP. Further, C4BP was internalized together with IAPP into INS-1 cells. Pathway analyses of mRNA expression microarray data indicated that cells exposed to C4BP and IAPP in comparison with IAPP alone increased expression of genes involved in cholesterol synthesis. Depletion of cholesterol through methyl--cyclodextrin or cholesterol oxidase abolished the protective effect of C4BP on IAPP cytotoxicity of INS-1 cells. Also, inhibition of phosphoinositide 3-kinase but not NF-B had a similar effect. Taken together, C4BP protects -cells from IAPP cytotoxicity by modulating IAPP fibril formation extracellularly and also, after uptake by the cells, by enhancing cholesterol synthesis.	[Sjolander, Jonatan; Byman, Elin; Kulak, Klaudia; Nilsson, Sara C.; King, Ben C.; Blom, Anna M.] Lund Univ, Dept Translat Med, S-20502 Malmo, Sweden; [Zhang, Enming; Krus, Ulrika; Storm, Petter; Renstrom, Erik] Lund Univ, Dept Clin Sci, S-20502 Malmo, Sweden; [Westermark, Gunilla T.] Uppsala Univ, Dept Med Cell Biol, S-75123 Uppsala, Sweden	Lund University; Lund University; Uppsala University	Blom, AM (corresponding author), Lund Univ, Dept Translat Med, Sect Med Prot Chem, S-20502 Malmo, Sweden.	anna.blom@med.lu.se	Blom, Anna/B-9607-2009; Blom, Anna/AFS-7369-2022	Blom, Anna/0000-0002-1348-1734; King, Benjamin/0000-0001-6776-8741; Storm, Petter/0000-0002-7655-3731; Zhang, Enming/0000-0002-0401-4608	Knut and Alice Wallenberg Foundation; Swedish Research Council [K2012-66X-14928-09-5]	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Knut and Alice Wallenberg Foundation and by Swedish Research Council Grants K2012-66X-14928-09-5. The authors declare that they have no conflicts of interest with the contents of this article.	Blom AM, 2004, ARCH IMMUNOL THER EX, V52, P83; Blom AM, 1999, J BIOL CHEM, V274, P19237, DOI 10.1074/jbc.274.27.19237; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; Blom AM, 2008, J IMMUNOL, V180, P6385, DOI 10.4049/jimmunol.180.9.6385; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; Caillon L, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/5639875; Cavaghan MK, 2000, J CLIN INVEST, V106, P329, DOI 10.1172/JCI10761; Cho WJ, 2008, METHOD CELL BIOL, V90, P267, DOI 10.1016/S0091-679X(08)00813-3; DAHLBACK B, 1983, BIOCHEM J, V209, P857, DOI 10.1042/bj2090857; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; HILLARP A, 1990, P NATL ACAD SCI USA, V87, P1183, DOI 10.1073/pnas.87.3.1183; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jurgens CA, 2011, AM J PATHOL, V178, P2632, DOI 10.1016/j.ajpath.2011.02.036; Jusko M, 2014, J INNATE IMMUN, V6, P31, DOI 10.1159/000351458; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Lin CY, 2005, J CLIN ENDOCR METAB, V90, P6678, DOI 10.1210/jc.2005-0079; Lopes DHJ, 2007, BIOPHYS J, V93, P3132, DOI 10.1529/biophysj.107.110635; Magzoub M, 2012, FASEB J, V26, P1228, DOI 10.1096/fj.11-194613; MANDERS EMM, 1992, J CELL SCI, V103, P857; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Mohlin FC, 2013, EUR J IMMUNOL, V43, P1617, DOI 10.1002/eji.201243196; Negi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030415; Olivar R, 2013, J IMMUNOL, V190, P2857, DOI 10.4049/jimmunol.1200503; Oskarsson ME, 2015, J BIOL CHEM, V290, P15121, DOI 10.1074/jbc.M114.631697; Paulsson JF, 2008, EXP DIABETES RES, DOI 10.1155/2008/865850; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ritzel RA, 2007, DIABETES, V56, P65, DOI 10.2337/db06-0734; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Singh S, 2015, ADV EXP MED BIOL, V855, P95, DOI 10.1007/978-3-319-17344-3_4; Sjoberg AP, 2008, MOL IMMUNOL, V45, P3213, DOI 10.1016/j.molimm.2008.02.023; Sjolander J, 2012, J BIOL CHEM, V287, P10824, DOI 10.1074/jbc.M111.244285; Spijkers PP, 2008, EUR J IMMUNOL, V38, P809, DOI 10.1002/eji.200737722; TENNER AJ, 1981, J IMMUNOL, V127, P648; Trikha S, 2011, J BIOL CHEM, V286, P36086, DOI 10.1074/jbc.M111.240762; Trouw LA, 2005, J EXP MED, V201, P1937, DOI 10.1084/jem.20050189; Trouw LA, 2008, MOL IMMUNOL, V45, P3649, DOI 10.1016/j.molimm.2008.04.025; Trouw LA, 2007, J BIOL CHEM, V282, P28540, DOI 10.1074/jbc.M704354200; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Vrielink A, 2010, SUBCELL BIOCHEM, V51, P137, DOI 10.1007/978-90-481-8622-8_5	43	8	8	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21644	21655		10.1074/jbc.M116.731141	http://dx.doi.org/10.1074/jbc.M116.731141			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27566545	hybrid, Green Published			2022-12-26	WOS:000385999200030
J	Harada, N; Ishihara, M; Horiuchi, H; Ito, Y; Tabata, H; Suzuki, YA; Nakano, Y; Yamaji, R; Inui, H				Harada, Naoki; Ishihara, Mikako; Horiuchi, Hiroko; Ito, Yuta; Tabata, Hiromitsu; Suzuki, Yasushi A.; Nakano, Yoshihisa; Yamaji, Ryoichi; Inui, Hiroshi			Mogrol Derived from Siraitia grosvenorii Mogrosides Suppresses 3T3-L1 Adipocyte Differentiation by Reducing cAMP-Response Element-Binding Protein Phosphorylation and Increasing AMP-Activated Protein Kinase Phosphorylation	PLOS ONE			English	Article							MITOTIC CLONAL EXPANSION; ADIPOSE CONVERSION; CUCURBITANE-GLYCOSIDES; NUCLEAR RECEPTORS; C/EBP-BETA; CELLS; ADIPOGENESIS; EXPRESSION; OBESITY; AICAR	This study investigated the effects of mogrol, an aglycone of mogrosides from Siraitia grosvenorii, on adipogenesis in 3T3-L1 preadipocytes. Mogrol, but not mogrosides, suppressed triglyceride accumulation by affecting early (days 0-2) and late (days 4-8), but not middle (days 2-4), differentiation stages. At the late stage, mogrol increased AMP-activated protein kinase (AMPK) phosphorylation and reduced glycerol-3-phosphate dehydrogenase activity. At the early stage, mogrol promoted AMPK phosphorylation, inhibited the induction of CCAAT/enhancer-binding protein beta (C/EBP beta; a master regulator of adipogenesis), and reduced 3T3-L1 cell contents (e.g., clonal expansion). In addition, mogrol, but not the AMPK activator AICAR, suppressed the phosphorylation and activity of the cAMP response element-binding protein (CREB), which regulates C/EBP beta expression. These results indicated that mogrol suppressed adipogenesis by reducing CREB activation in the initial stage of cell differentiation and by activating AMPK signaling in both the early and late stages of this process.	[Harada, Naoki; Ishihara, Mikako; Horiuchi, Hiroko; Ito, Yuta; Yamaji, Ryoichi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Sakai, Osaka, Japan; [Ito, Yuta; Tabata, Hiromitsu; Suzuki, Yasushi A.] Saraya Co Ltd, Biochem Lab, Kashiwara, Osaka, Japan; [Nakano, Yoshihisa; Inui, Hiroshi] Osaka Prefecture Univ, Ctr Res & Dev Bioresources, Sakai, Osaka, Japan; [Inui, Hiroshi] Osaka Prefecture Univ, Dept Nutr, Habikino, Osaka, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University	Harada, N (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Sakai, Osaka, Japan.; Inui, H (corresponding author), Osaka Prefecture Univ, Ctr Res & Dev Bioresources, Sakai, Osaka, Japan.; Inui, H (corresponding author), Osaka Prefecture Univ, Dept Nutr, Habikino, Osaka, Japan.	harada@biochem.osakafu-u.ac.jp; inui@biochem.osakafu-u.ac.jp	Harada, Naoki/AAP-2868-2020	Harada, Naoki/0000-0003-3846-388X	Japan Society for the Promotion of Science [20580140, 15H02900]; Saraya Company Ltd.	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Saraya Company Ltd.	This work was funded by the Japan Society for the Promotion of Science, grant numbers: 20580140 and 15H02900, https://kaken.nii.ac.jp/ja/index (HI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder Saraya Company Ltd. provided support in the form of salaries for authors YI, HT, and YAS, but did not have any role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contribution' section.	Ahn J, 2008, BIOCHEM BIOPH RES CO, V373, P545, DOI 10.1016/j.bbrc.2008.06.077; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Chen SF, 2011, CAN J PHYSIOL PHARM, V89, P793, DOI 10.1139/Y11-077; Chen XB, 2011, BIOORGAN MED CHEM, V19, P5776, DOI 10.1016/j.bmc.2011.08.030; Choi Y, 2011, J AGR FOOD CHEM, V59, P12843, DOI 10.1021/jf2033208; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Daval M, 2005, J BIOL CHEM, V280, P25250, DOI 10.1074/jbc.M414222200; Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; FOLCH J, 1957, J BIOL CHEM, V226, P497; Furuyashiki T, 2004, BIOSCI BIOTECH BIOCH, V68, P2353, DOI 10.1271/bbb.68.2353; Giri S, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-31; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Habinowski SA, 2001, BIOCHEM BIOPH RES CO, V286, P852, DOI 10.1006/bbrc.2001.5484; Harada N, 2007, J BIOL CHEM, V282, P22651, DOI 10.1074/jbc.M610724200; Harmon AW, 2002, BIOCHEM J, V367, P203, DOI 10.1042/BJ20020300; Horiuchi H, 2014, J NUTR SCI VITAMINOL, V60, P291, DOI 10.3177/jnsv.60.291; Hsu CL, 2006, MOL NUTR FOOD RES, V50, P1072, DOI 10.1002/mnfr.200600040; Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195; KASAI R, 1989, AGR BIOL CHEM TOKYO, V53, P3347, DOI 10.1080/00021369.1989.10869815; Kawada T, 2000, BIOFACTORS, V13, P103, DOI 10.1002/biof.5520130117; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; KURIHARCUCH W, 1978, CELL, V14, P53, DOI 10.1016/0092-8674(78)90300-8; Lee H, 2011, INT J MOL MED, V28, P65, DOI 10.3892/ijmm.2011.674; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Leff T, 2003, BIOCHEM SOC T, V31, P224; Li SF, 2013, AM J PHYSIOL-ENDOC M, V304, pE990, DOI 10.1152/ajpendo.00608.2012; MATSUMOTO K, 1990, CHEM PHARM BULL, V38, P2030, DOI 10.1248/cpb.38.2030; Murata Y, 2010, BIOSCI BIOTECH BIOCH, V74, P673, DOI 10.1271/bbb.90832; Ono M, 2011, J AGR FOOD CHEM, V59, P13346, DOI 10.1021/jf203490a; Rayalam S, 2008, J NUTR BIOCHEM, V19, P717, DOI 10.1016/j.jnutbio.2007.12.007; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Suzuki YA, 2005, J AGR FOOD CHEM, V53, P2941, DOI 10.1021/jf0478105; Suzuki YA, 2007, BRIT J NUTR, V97, P770, DOI 10.1017/S0007114507381300; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; WISE LS, 1979, J BIOL CHEM, V254, P273; Xu F, 2015, J PHARMACEUT BIOMED, V115, P418, DOI 10.1016/j.jpba.2015.07.024; Yang WB, 2001, J BIOL CHEM, V276, P38341, DOI 10.1074/jbc.C100316200; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Yin W, 2003, J BIOL CHEM, V278, P43074, DOI 10.1074/jbc.M308484200; Zhang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125667; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101	44	19	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162252	10.1371/journal.pone.0162252	http://dx.doi.org/10.1371/journal.pone.0162252			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583359	Green Published, gold, Green Submitted			2022-12-26	WOS:000382855600124
J	Christophersen, DV; Jacobsen, NR; Jensen, DM; Kermanizadeh, A; Sheykhzade, M; Loft, S; Vogel, U; Wallin, H; Moller, P				Christophersen, Daniel Vest; Jacobsen, Nicklas Raun; Jensen, Ditte Marie; Kermanizadeh, Ali; Sheykhzade, Majid; Loft, Steffen; Vogel, Ulla; Wallin, Hakan; Moller, Peter			Inflammation and Vascular Effects after Repeated Intratracheal Instillations of Carbon Black and Lipopolysaccharide	PLOS ONE			English	Article							LUNG EPITHELIAL-CELLS; ACUTE-PHASE RESPONSE; AMERICAN-HEART-ASSOCIATION; KILLER T-CELLS; PARTICULATE MATTER; ENDOTHELIAL DYSFUNCTION; OXIDATIVE STRESS; DIESEL EXHAUST; AIR-POLLUTION; CARDIOVASCULAR-DISEASE	Inflammation and oxidative stress are considered the main drivers of vasomotor dysfunction and progression of atherosclerosis after inhalation of particulate matter. In addition, new studies have shown that particle exposure can induce the level of bioactive mediators in serum, driving vascular-and systemic toxicity. We aimed to investigate if pulmonary inflammation would accelerate nanoparticle-induced atherosclerotic plaque progression in Apolipoprotein E knockout (ApoE(-/-)) mice. ApoE(-/-) mice were exposed to vehicle, 8.53 or 25.6 mu g nanosized carbon black (CB) alone or spiked with LPS (0.2 mu g/mouse/exposure; once a week for 10 weeks). Inflammation was determined by counting cells in bronchoalveolar lavage fluid. Serum Amyloid A3 (Saa3) expression and glutathione status were determined in lung tissue. Plaque progression was assessed in the aorta and the brachiocephalic artery. The effect of vasoactive mediators in plasma of exposed ApoE(-/-) mice was assessed in aorta rings isolated from naive C57BL/6 mice. Pulmonary exposure to CB and/or LPS resulted in pulmonary inflammation with a robust influx of neutrophils. The CB exposure did not promote plaque progression in aorta or BCA. Incubation with 0.5% plasma extracted from CB-exposed ApoE(-/-) mice caused vasoconstriction in aorta rings isolated from naive mice; this effect was abolished by the treatment with the serotonin receptor antagonist Ketanserin. In conclusion, repeated pulmonary exposure to nanosized CB and LPS caused lung inflammation without progression of atherosclerosis in ApoE(-/-) mice. Nevertheless, plasma extracted from mice exposed to nanosized CB induced vasoconstriction in aortas of naive wild-type mice, an effect possibly related to increased plasma serotonin.	[Christophersen, Daniel Vest; Jensen, Ditte Marie; Kermanizadeh, Ali; Loft, Steffen; Wallin, Hakan; Moller, Peter] Univ Copenhagen, Environm Hlth Sect, Dept Publ Hlth, Copenhagen K, Denmark; [Jacobsen, Nicklas Raun; Vogel, Ulla; Wallin, Hakan] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Sheykhzade, Majid] Univ Copenhagen, Fac Hlth Sci, Sect Mol & Cellular Pharmacol, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Vogel, Ulla] Tech Univ Denmark, Dept Micro & Nanotechnol, Lyngby, Denmark	University of Copenhagen; National Research Centre for the Working Environment; University of Copenhagen; Technical University of Denmark	Moller, P (corresponding author), Univ Copenhagen, Environm Hlth Sect, Dept Publ Hlth, Copenhagen K, Denmark.	Pemo@sund.ku.dk	Vogel, Ulla/ABC-2212-2020; Vogel, Ulla B/I-5048-2012; Kermanizadeh, Ali/AAD-6281-2019; Wallin, Håkan/I-6459-2012	Vogel, Ulla/0000-0001-6807-1524; Vogel, Ulla B/0000-0001-6807-1524; Kermanizadeh, Ali/0000-0002-2989-9078; Wallin, Håkan/0000-0001-7716-0166; Jensen, Ditte Marie/0000-0003-2623-6882; Moller, Peter/0000-0002-2021-1249; Sheykhzade, Majid/0000-0002-4561-0326; Loft, Steffen/0000-0001-9552-8518; Jacobsen, Nicklas Raun/0000-0002-2504-2229	Danish Nanosafety Centre from the Danish Working Environment Research Foundation [20110092173-3]	Danish Nanosafety Centre from the Danish Working Environment Research Foundation	The work was supported by the Danish Nanosafety Centre (grant no. 20110092173-3) from the Danish Working Environment Research Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoh Y, 2013, IMMUNOBIOLOGY, V218, P561, DOI 10.1016/j.imbio.2012.07.022; Aragon MJ, 2016, CARDIOVASC TOXICOL, V16, P163, DOI 10.1007/s12012-015-9325-z; Araujo JA, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-24; Bakker ENTP, 2000, AM J PHYSIOL-HEART C, V278, pH1233; Bourdon JA, 2012, ENVIRON MOL MUTAGEN, V53, P462, DOI 10.1002/em.21706; Bourdon JA, 2012, TOXICOL SCI, V127, P474, DOI 10.1093/toxsci/kfs119; Bourdon JA, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-5; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brown DM, 2001, TOXICOL APPL PHARM, V175, P191, DOI 10.1006/taap.2001.9240; Cai XN, 2013, NANOMED-NANOTECHNOL, V9, P583, DOI 10.1016/j.nano.2012.09.004; Corbel M, 2001, INFLAMM RES, V50, P129, DOI 10.1007/s000110050736; Courtois A, 2008, ENVIRON HEALTH PERSP, V116, P1294, DOI 10.1289/ehp.11021; DEMEY JGR, 1989, CIRC RES, V65, P1125, DOI 10.1161/01.RES.65.4.1125; Folkmann JK, 2012, TOXICOL SCI, V129, P98, DOI 10.1093/toxsci/kfs180; Fuks KB, 2014, ENVIRON HEALTH PERSP, V122, P896, DOI 10.1289/ehp.1307725; Gilmour PS, 2004, TOXICOL APPL PHARM, V195, P35, DOI 10.1016/j.taap.2003.10.003; Gitlin JM, 2009, CARDIOVASC RES, V81, P400, DOI 10.1093/cvr/cvn286; Hansen CS, 2007, TOXICOL APPL PHARM, V219, P24, DOI 10.1016/j.taap.2006.10.032; Harder V, 2005, INHAL TOXICOL, V17, P29, DOI 10.1080/08958370590885681; Hogsberg T, 2013, EXP DERMATOL, V22, P464, DOI 10.1111/exd.12178; Holzer M, 2014, J APPL TOXICOL, V34, P1167, DOI 10.1002/jat.2996; Jackson P, 2012, NANOTOXICOLOGY, V6, P486, DOI 10.3109/17435390.2011.587902; Jacobsen NR, 2008, ENVIRON MOL MUTAGEN, V49, P476, DOI 10.1002/em.20406; Jacobsen NR, 2007, ENVIRON MOL MUTAGEN, V48, P451, DOI 10.1002/em.20300; Jacobsen NR, 2015, FOOD CHEM TOXICOL, V85, P84, DOI 10.1016/j.fct.2015.08.008; Jacobsen NR, 2011, ENVIRON MOL MUTAGEN, V52, P331, DOI 10.1002/em.20629; Jacobsen NR, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-2; Kennedy AJ, 2010, DIS MODEL MECH, V3, P156, DOI 10.1242/dmm.003467; Kermanizadeh A, 2015, CRIT REV TOXICOL, V45, P837, DOI 10.3109/10408444.2015.1058747; Kido T, 2011, AM J RESP CELL MOL, V44, P197, DOI 10.1165/rcmb.2009-0427OC; Kim H, 2012, J TOXICOL ENV HEAL A, V75, P1471, DOI 10.1080/15287394.2012.722519; Kim JK, 2011, SAF HEALTH WORK, V2, P282, DOI 10.5491/SHAW.2011.2.3.282; KOCH DD, 1980, ANAL CHEM, V52, P27, DOI 10.1021/ac50051a008; Kyjovska ZO, 2015, MUTAGENESIS, V30, P499, DOI 10.1093/mutage/gev009; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Lee GS, 2014, J BONE MINER RES, V29, P976, DOI 10.1002/jbmr.2086; Lee KS, 2007, EXP MOL MED, V39, P756, DOI 10.1038/emm.2007.82; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mikkelsen L, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-32; Moller P, 2016, CRIT REV TOXICOL, V46, P437, DOI 10.3109/10408444.2016.1149451; Moller P, 2014, ARCH TOXICOL, V88, P1939, DOI 10.1007/s00204-014-1356-x; Moller P, 2011, CRIT REV TOXICOL, V41, P339, DOI 10.3109/10408444.2010.533152; Moller P, 2010, FREE RADICAL RES, V44, P1, DOI 10.3109/10715760903300691; Niwa Y, 2007, CIRC J, V71, P1157, DOI 10.1253/circj.71.1157; Nurkiewicz TR, 2006, ENVIRON HEALTH PERSP, V114, P412, DOI 10.1289/ehp.8413; Ostos MA, 2002, FEBS LETT, V519, P23, DOI 10.1016/S0014-5793(02)02692-3; Paffett ML, 2015, TOXICOL SCI, V146, P244, DOI 10.1093/toxsci/kfv093; Provost EB, 2016, ENVIRON INT, V88, P228, DOI 10.1016/j.envint.2015.12.023; Robertson S, 2013, TOXICOL SCI, V134, P304, DOI 10.1093/toxsci/kft107; Saber AT, 2014, WIRES NANOMED NANOBI, V6, P517, DOI 10.1002/wnan.1279; Saber AT, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-12; Saber AT, 2012, NANOTOXICOLOGY, V6, P453, DOI 10.3109/17435390.2011.587900; Saber AT, 2012, NANOTOXICOLOGY, V6, P776, DOI 10.3109/17435390.2011.620745; Saber AT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069020; Senft AP, 2000, ANAL BIOCHEM, V280, P80, DOI 10.1006/abio.2000.4498; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003; Tin-Tin-Win-Shwe, 2005, TOXICOL APPL PHARM, V209, P51, DOI 10.1016/j.taap.2005.03.014; Tong HY, 2009, TOXICOL APPL PHARM, V239, P224, DOI 10.1016/j.taap.2009.05.019; VANHOUTTE P, 1988, HYPERTENSION, V11, P111, DOI 10.1161/01.HYP.11.2.111; Vesterdal LK, 2014, NANOTOXICOLOGY, V8, P61, DOI 10.3109/17435390.2012.750385; Vesterdal LK, 2012, TOXICOL LETT, V214, P19, DOI 10.1016/j.toxlet.2012.07.022; Vesterdal LK, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-33; Vesterdal LK, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-5	66	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0160731	10.1371/journal.pone.0160731	http://dx.doi.org/10.1371/journal.pone.0160731			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571356	Green Published, Green Submitted, gold			2022-12-26	WOS:000382876700006
J	Sawada, Y; Hangai, M; Ishikawa, M; Yoshitomi, T				Sawada, Yu; Hangai, Masanori; Ishikawa, Makoto; Yoshitomi, Takeshi			Association of Myopic Optic Disc Deformation with Visual Field Defects in Paired Eyes with Open-Angle Glaucoma: A Cross-Sectional Study	PLOS ONE			English	Article							LOW-TENSION GLAUCOMA; COHERENCE TOMOGRAPHY; INTRAOCULAR-PRESSURE; POPULATION; PROGRESSION; SCLERA; DAMAGE	Purpose To examine the association of myopia with the visual field (VF) defects in open-angle glaucoma (OAG) using paired eyes to eliminate the effect of unknown confounding factors that are diverse among individuals. Methods One hundred eighteen eyes of 59 subjects with myopia (spherical equivalent [SE] >= -2 diopter [D] and axial length >= 24.0 mm) whose intra-ocular pressure between paired eyes was similar and the mean deviation (MD) of the Humphrey VF test differed by more than 6 dB were included. Refractive errors (SE, axial length) and parameters associated with the papillary and parapapillary myopic deformation (tilt ratio, torsion angle, and beta-zone parapapillary atrophy [PPA] area without Bruch's membrane) were measured in each eye. The paired eyes were divided into worse and better eyes according to the MD of the VF, and parameters were compared between them. Further, multiple linear regression analysis was performed to examine the correlation of the difference in various parameters with the MD difference between paired eyes. Results The SE of all eyes was -6.39 +/- 2.15 D (mean +/- standard deviation) and axial length was 26.42 +/- 1.07 mm. MD of the worse and better VF eyes were -13.56 +/- 6.65 dB and -4.87 +/- 5.32 dB, respectively. Eyes with worse VFs had significantly greater SE, axial length, tilt ratio, and PPA area without Bruch's membrane than those with better VFs (all P < 0.05). In multiple linear regression analysis, the difference of the MD between paired eyes was significantly correlated with the difference in the tilt ratio and PPA area without Bruch's membrane. Conclusion The myopic papillary and parapapillary deformations, but not refractive error itself, were related to the worse VF in paired eyes with OAG. This suggests that myopia influences the severity of the glaucomatous VF defects via structural deformation.	[Sawada, Yu; Ishikawa, Makoto; Yoshitomi, Takeshi] Akita Univ, Grad Sch Med, Dept Ophthalmol, Akita, Japan; [Hangai, Masanori] Saitama Med Univ, Dept Ophthalmol, Saitama, Japan	Akita University; Saitama Medical University	Sawada, Y (corresponding author), Akita Univ, Grad Sch Med, Dept Ophthalmol, Akita, Japan.	sawadayu@doc.med.akita-u.ac.jp		Ishikawa, Makoto/0000-0002-1808-1799				CARTWRIGHT MJ, 1988, ARCH OPHTHALMOL-CHIC, V106, P898; Coudrillier B, 2012, INVEST OPHTH VIS SCI, V53, P1714, DOI 10.1167/iovs.11-8009; CRICHTON A, 1989, OPHTHALMOLOGY, V96, P1312; Doshi A, 2007, OPHTHALMOLOGY, V114, P472, DOI 10.1016/j.ophtha.2006.07.036; Dueker DK, 2007, OPHTHALMOLOGY, V114, P1779, DOI 10.1016/j.ophtha.2007.04.068; Ernest PJ, 2013, OPHTHALMOLOGY, V120, P512, DOI 10.1016/j.ophtha.2012.09.005; Fazio MA, 2012, INVEST OPHTH VIS SCI, V53, P5326, DOI 10.1167/iovs.12-9668; HAEFLIGER IO, 1990, ACTA OPHTHALMOL, V68, P564; Hassenstein A, 2009, CLIN EXP OPHTHALMOL, V37, P130, DOI 10.1111/j.1442-9071.2009.02017.x; Hayashi K, 2012, INVEST OPHTH VIS SCI, V53, P1499, DOI 10.1167/iovs.11-8572; JONAS JB, 1988, GRAEF ARCH CLIN EXP, V226, P587, DOI 10.1007/BF02169209; Jonas JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047237; Kim M, 2013, OPHTHALMOLOGY, V120, P1790, DOI 10.1016/j.ophtha.2013.02.011; Kim TW, 2012, OPHTHALMOLOGY, V119, P21, DOI 10.1016/j.ophtha.2011.07.051; Lee JY, 2015, INVEST OPHTH VIS SCI, V56, P1775, DOI 10.1167/iovs.14-16002; Marcus MW, 2011, OPHTHALMOLOGY, V118, P1989, DOI 10.1016/j.ophtha.2011.03.012; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Murata K, 2002, MED STAT EV BAS MED, P1; Nicolela MT, 1996, AM J OPHTHALMOL, V121, P502, DOI 10.1016/S0002-9394(14)75424-8; Park HYL, 2012, OPHTHALMOLOGY, V119, P1844, DOI 10.1016/j.ophtha.2012.03.006; Plange N, 2006, GRAEF ARCH CLIN EXP, V244, P978, DOI 10.1007/s00417-005-0227-9; Reis ASC, 2012, OPHTHALMOLOGY, V119, P738, DOI 10.1016/j.ophtha.2011.09.054; Samarawickrama C, 2011, OPHTHALMOLOGY, V118, P2050, DOI 10.1016/j.ophtha.2011.02.040; Sawada Y, 2011, J GLAUCOMA, V20, P445, DOI 10.1097/IJG.0b013e3181f3eb20; Seo JH, 2014, INVEST OPHTH VIS SCI, V55, P1241, DOI 10.1167/iovs.13-12536; Sohn SW, 2010, AM J OPHTHALMOL, V149, P831, DOI 10.1016/j.ajo.2009.12.033; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; Vongphanit J, 2002, AM J OPHTHALMOL, V133, P679, DOI 10.1016/S0002-9394(02)01339-9	28	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161961	10.1371/journal.pone.0161961	http://dx.doi.org/10.1371/journal.pone.0161961			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571303	Green Submitted, Green Published, gold			2022-12-26	WOS:000382876700047
J	Dittrich, S; Tadesse, BT; Moussy, F; Chua, A; Zorzet, A; Tangden, T; Dolinger, DL; Page, AL; Crump, JA; D'Acremont, V; Bassat, Q; Lubell, Y; Newton, PN; Heinrich, N; Rodwell, TJ; Gonzalez, IJ				Dittrich, Sabine; Tadesse, Birkneh Tilahun; Moussy, Francis; Chua, Arlene; Zorzet, Anna; Tangden, Thomas; Dolinger, David L.; Page, Anne-Laure; Crump, John A.; D'Acremont, Valerie; Bassat, Quique; Lubell, Yoel; Newton, Paul N.; Heinrich, Norbert; Rodwell, Timothy J.; Gonzalez, Iveth J.			Target Product Profile for a Diagnostic Assay to Differentiate between Bacterial and Non-Bacterial Infections and Reduce Antimicrobial Overuse in Resource-Limited Settings: An Expert Consensus	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ANTIBIOTIC-TREATMENT; FEVER; PROCALCITONIN; MALARIA; CHILDREN; CULTURE; TESTS; PNEUMONIA; INFANTS	Acute fever is one of the most common presenting symptoms globally. In order to reduce the empiric use of antimicrobial drugs and improve outcomes, it is essential to improve diagnostic capabilities. In the absence of microbiology facilities in low-income settings, an assay to distinguish bacterial from non-bacterial causes would be a critical first step. To ensure that patient and market needs are met, the requirements of such a test should be specified in a target product profile (TPP). To identify minimal/optimal characteristics for a bacterial vs. non-bacterial fever test, experts from academia and international organizations with expertise in infectious diseases, diagnostic test development, laboratory medicine, global health, and health economics were convened. Proposed TPPs were reviewed by this working group, and consensus characteristics were defined. The working group defined non-severely ill, non-malaria infected children as the target population for the desired assay. To provide access to the most patients, the test should be deployable to community health centers and informal health settings, and staff should require <2 days of training to perform the assay. Further, given that the aim is to reduce inappropriate antimicrobial use as well as to deliver appropriate treatment for patients with bacterial infections, the group agreed on minimal diagnostic performance requirements of >90% and >80% for sensitivity and specificity, respectively. Other key characteristics, to account for the challenging environment at which the test is targeted, included: i) time-to-result <10 min (but maximally <2 hrs); ii) storage conditions at 0-40 degrees C, <= 90% non-condensing humidity with a minimal shelf life of 12 months; iii) operational conditions of 5-40 degrees C, <= 90% non-condensing humidity; and iv) minimal sample collection needs (50-100 mu L, capillary blood). This expert approach to define assay requirements for a bacterial vs. non-bacterial assay should guide product development, and enable targeted and timely efforts by industry partners and academic institutions.	[Dittrich, Sabine; Tadesse, Birkneh Tilahun; Dolinger, David L.; Rodwell, Timothy J.; Gonzalez, Iveth J.] FIND, 9 Chemin Mines, CH-1202 Geneva, Switzerland; [Tadesse, Birkneh Tilahun] WHO, Special Programme Res & Training Trop Dis TDR, Ave Appia 20, CH-1211 Geneva 27, Switzerland; [Tadesse, Birkneh Tilahun] Hawassa Univ, Dept Pediat, Coll Med & Hlth Sci, Hawassa, Ethiopia; [Moussy, Francis; Dolinger, David L.] WHO, 20 Ave Appia, CH-1211 Geneva 27, Switzerland; [Chua, Arlene; Dolinger, David L.] Tan Took Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore; [Zorzet, Anna; Tangden, Thomas] Uppsala Univ, ReAct Europe, Box 256, S-75105 Uppsala, Sweden; [Page, Anne-Laure] Epicentre, Epidemiol & Populat Hlth, Paris, France; [Crump, John A.] Univ Otago, Ctr Int Hlth, POB 56, Dunedin 9054, New Zealand; [Crump, John A.] Duke Univ, Duke Global Hlth Inst, Box 90519, Durham, NC 27708 USA; [Crump, John A.] Duke Univ, Med Ctr, Div Infect Dis & Int Hlth, Box 102359, Durham, NC 27710 USA; [D'Acremont, Valerie] Swiss Trop & Publ Hlth Inst, CH-4002 Basel, Switzerland; [D'Acremont, Valerie] Univ Lausanne, Dept Ambulatory Care & Community Med, Bugnon 44, CH-1011 Lausanne, Switzerland; [Bassat, Quique] Hosp Clin Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Bassat, Quique] CISM, Maputo, Mozambique; [Lubell, Yoel; Newton, Paul N.] Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England; [Lubell, Yoel] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Newton, Paul N.] Lao Oxford Mahosot Hosp, Wellcome Trust Res Unit, Viangchan, Laos; [Heinrich, Norbert] Univ Munich LMU, Med Ctr, Div Infect Dis & Trop Med, Munich, Germany; [Heinrich, Norbert] German Ctr Infect Res, Munich Partner Site,Leopoldstr 5, D-80802 Munich, Germany	Foundation For Innovative New Diagnostics; World Health Organization; Hawassa University; World Health Organization; Tan Tock Seng Hospital; Uppsala University; University of Otago; Duke University; Duke University; University of Basel; Swiss Tropical & Public Health Institute; University of Lausanne; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Munich; German Center for Infection Research	Dittrich, S (corresponding author), FIND, 9 Chemin Mines, CH-1202 Geneva, Switzerland.	Sabine.Dittrich@finddx.org	N, Heinrich/B-3750-2014; Crump, John A./AAZ-6289-2020; Bassat, Quique/P-2341-2016; Crump, John A./AAZ-6412-2020	N, Heinrich/0000-0001-9252-7106; Crump, John A./0000-0002-4529-102X; Bassat, Quique/0000-0003-0875-7596; Crump, John A./0000-0002-4529-102X; Lubell, Yoel/0000-0002-0237-1070; Tadesse, Birkneh Tilahun/0000-0003-4005-8605; Newton, Paul/0000-0002-4608-6431; Chua, Arlene/0000-0001-6428-9083	Product Development Partnership Grant III from the Dutch Government; program Miguel Servet of the ISCIII (Plan Nacional de I+D+I) [CP11/00269]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI121378] Funding Source: NIH RePORTER	Product Development Partnership Grant III from the Dutch Government; program Miguel Servet of the ISCIII (Plan Nacional de I+D+I); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported with funds from the Product Development Partnership Grant III from the Dutch Government, with aid from the UK government and the Australian Government. QB has a fellowship from the program Miguel Servet of the ISCIII (Plan Nacional de I+D+I 2008-2011, grant number: CP11/00269). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; BATWALA V, 2011, MALARIA J, V10, DOI DOI 10.1186/1475-; Castonguay-Vanier J, 2013, J CLIN MICROBIOL, V51, P142, DOI 10.1128/JCM.02360-12; Chappuis F, 2013, CLIN MICROBIOL INFEC, V19, P422, DOI 10.1111/1469-0691.12154; Chua AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003734; Crump JA, 2003, EMERG INFECT DIS, V9, P539, DOI 10.3201/eid0905.020428; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; Derda R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003676; Diez-Padrisa N, 2012, TROP MED INT HEALTH, V17, P1100, DOI 10.1111/j.1365-3156.2012.03035.x; Diez-Padrisa N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013226; Do NTT, 2016, LANCET GLOB HEALTH, V4, pE633, DOI 10.1016/S2214-109X(16)30142-5; Erdman LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137592; Esposito S, 2011, RESP MED, V105, P1939, DOI 10.1016/j.rmed.2011.09.003; Farrar JJ, 2009, MANSONS TROPICAL DIS, V22nd; Feikin DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016085; Gething PW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000301; Ghani AC, 2015, NATURE, V528, pS50, DOI 10.1038/nature16038; Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Kapasi AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160278; Knoppert D, 2007, POSITION PAPER PAEDI; Liaw LCT, 2000, BRIT MED J, V320, P1312, DOI 10.1136/bmj.320.7245.1312; Lim Yee-Wei, 2006, Nature, V444 Suppl 1, P9, DOI 10.1038/nature05442; Lubell Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152420; Lubell Y, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1272-6; Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841; Manzano S, 2010, AM J EMERG MED, V28, P647, DOI 10.1016/j.ajem.2009.02.022; Mayxay M, 2013, LANCET GLOB HEALTH, V1, pE46, DOI 10.1016/S2214-109X(13)70008-1; Ndhlovu M, 2015, TROP MED INT HEALTH, V20, P1696, DOI 10.1111/tmi.12591; O'Neill J, 2016, REV LARYNGOL OTOL RH; Obama B., 2014, EXECUTIVE ORDER COMB; Page AL, 2014, PEDIATRICS, V133, pE363, DOI 10.1542/peds.2013-2112; Patel V, 2015, LANCET, V386, P2422, DOI 10.1016/S0140-6736(15)00955-1; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Prasad N, 2015, AM J TROP MED HYG, V93, P178, DOI 10.4269/ajtmh.14-0646; Schuetz P, 2012, CLIN INFECT DIS, V55, P651, DOI 10.1093/cid/cis464; Senn N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090990; Shao AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132316; Van den Bruel A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3082; Visser T, 2015, B WORLD HEALTH ORGAN, V93, P862, DOI 10.2471/BLT.14.151167; White LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044545; WHO, 2014, ANT RES GLOB REP SUR; WHO FIND ReAct Campaign MA, M EXP BIOM DISCR BAC; World Health Organization, INT MAN AD AD ILLN I; World Health Organization, 2004, LAB BIOS MAN, V3rd; World Health Organization, 2016, WHO INF CONS FEV MAN; Yansouni CP, 2012, CLIN INFECT DIS, V55, P610, DOI 10.1093/cid/cis466; Yebyo H, 2016, NPJ PRIM CARE RESP M, V26, DOI 10.1038/npjpcrm.2015.76	48	38	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161721	10.1371/journal.pone.0161721	http://dx.doi.org/10.1371/journal.pone.0161721			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27559728	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000382258600087
J	Giuliano, A; Swift, R; Arthurs, C; Marote, G; Abramo, F; McKay, J; Thomson, C; Beltran, M; Millar, M; Priestnall, S; Dobson, J; Costantino-Casas, F; Petrou, T; McGonnell, IM; Davies, AJ; Weetman, M; Garden, OA; Masters, JR; Thrasivoulou, C; Ahmed, A				Giuliano, Antonio; Swift, Rebecca; Arthurs, Callum; Marote, Georgina; Abramo, Francesca; McKay, Jenny; Thomson, Calum; Beltran, Mariana; Millar, Michael; Priestnall, Simon; Dobson, Jane; Costantino-Casas, Fernando; Petrou, Terry; McGonnell, Imelda M.; Davies, Anthony J.; Weetman, Malcolm; Garden, Oliver A.; Masters, John R.; Thrasivoulou, Christopher; Ahmed, Aamir			Quantitative Expression and Co-Localization of Wnt Signalling Related Proteins in Feline Squamous Cell Carcinoma	PLOS ONE			English	Article							MAMMARY-TUMORS; TRANSCRIPTION FACTORS; TISSUE MICROARRAY; UP-REGULATION; BETA-CATENIN; FOS PROTEINS; CYCLIN D1; MYC GENE; CANCER; DNA	Feline oral squamous cell carcinoma (FOSCC) is an aggressive neoplasm in cats. Little is known about the possible molecular mechanisms that may be involved in the initiation, maintenance and progression of FOSCC. Wnt signalling is critical in development and disease, including many mammalian cancers. In this study, we have investigated the expression of Wnt signalling related proteins using quantitative immunohistochemical techniques on tissue arrays. We constructed tissue arrays with 58 individual replicate tissue samples. We tested for the expression of four key Wnt/beta-catenin transcription targets, namely Cyclin D1 (CCND1 or CD1), FRA1, c-Myc and MMP7. All antibodies showed cross reactivity in feline tissue except MMP7. Quantitative immunohistochemical analysis of single proteins (expressed as area fraction / amount of tissue for normal vs tumor, mean +/- SE) showed that the expression of CD1 (3.9 +/- 0.5 vs 12.2 +/- 0.9), FRA1 (5.5 +/- 0.6 vs 16.8 +/- 1.1) and c-Myc (5.4 +/- 0.5 vs 12.5 +/- 0.9) was increased in FOSCC tissue by 2.3 to 3 fold compared to normal controls (p<0.0001). By using a multilabel, quantitative fluorophore technique we further investigated if the co-localization of these proteins (all transcription factors) with each other and in the nucleus (stained with 4', 6-diamidino-2-phenylindole, DAPI) was altered in FOSCC compared to normal tissue. The global intersection coefficients, a measure of the proximity of two fluorophore labeled entities, showed that there was a significant change (p < 0.01) in the co-localization for all permutations (e.g. CD1/FRA1 etc), except for the nuclear localization of CD1. Our results show that putative targets of Wnt signalling transcription are up-regulated in FOSCC with alterations in the co-localization of these proteins and could serve as a useful marker for the disease.	[Giuliano, Antonio; Dobson, Jane; Costantino-Casas, Fernando] Univ Cambridge, Dept Vet Med, Cambridge, England; [Swift, Rebecca; Marote, Georgina; Garden, Oliver A.] Royal Vet Coll, Dept Clin Sci & Serv, London, England; [Swift, Rebecca; Marote, Georgina] UCL, Div Surg, London, England; [Arthurs, Callum; Petrou, Terry; Ahmed, Aamir] Kings Coll London, Prostate Canc Res Ctr, Ctr Stem Cells & Regenerat Med, London, England; [Abramo, Francesca] Univ Pisa, Dept Vet Sci, Pisa, Italy; [McKay, Jenny] IDEXX Labs Ltd, Grange House, Wetherby, W Yorkshire, England; [Thomson, Calum; Beltran, Mariana] Univ Dundee, Dundee Imaging Facil, Coll Life Sci, Dundee, Scotland; [Millar, Michael] Univ Edinburgh, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Priestnall, Simon] Royal Vet Coll, Dept Pathol & Pathogen Biol, London, England; [McGonnell, Imelda M.] Royal Vet Coll, Dept Comparat Biomed Sci, London, England; [Masters, John R.; Ahmed, Aamir] UCL, Div Surg, London, England; [Davies, Anthony J.] Univ London, London, England; [Weetman, Malcolm] Independent Vetcare, Bath, Avon, England; [Thrasivoulou, Christopher] UCL, Res Dept Cell & Dev Biol, Ctr Cell & Mol Dynam, Rockefeller Bldg, London, England	University of Cambridge; University of London; University of London Royal Veterinary College; University of London; University College London; University of London; King's College London; University College London; University of Pisa; University of Dundee; University of Edinburgh; University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of London; University College London; University of London; University of London; University College London	Ahmed, A (corresponding author), Kings Coll London, Prostate Canc Res Ctr, Ctr Stem Cells & Regenerat Med, London, England.; Ahmed, A (corresponding author), UCL, Div Surg, London, England.	aamir.ahmed@kcl.ac.uk	Thrasivoulou, Christopher/F-7087-2010; McGonnell, Imelda/AGG-3394-2022	Thrasivoulou, Christopher/0000-0001-9425-8624; McGonnell, Imelda/0000-0002-9800-7248; Dobson, Jane Margaret/0000-0002-7121-014X; GIULIANO, Antonio/0000-0003-3993-038X; Ahmed, Aamir/0000-0001-7405-5336; Priestnall, Simon/0000-0002-6027-1879	Prostate Cancer Research Centre charity [1156027, AA1]; Royal Veterinary College	Prostate Cancer Research Centre charity; Royal Veterinary College	This research was funded by the Prostate Cancer Research Centre charity (registered UK charity no. 1156027), Grant Number AA1. A small financial contribution was also made through intramural funds from the Royal Veterinary College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen H, 2002, ONCOGENE, V21, P4843, DOI 10.1038/sj.onc.1205590; Angadi PV, 2007, ORAL SURG ORAL MED O, V103, pE30, DOI 10.1016/j.tripleo.2006.09.011; Arya M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124395; Bertone ER, 2003, J VET INTERN MED, V17, P557, DOI 10.1892/0891-6640(2003)017&lt;0557:EALRFF&gt;2.3.CO;2; Brown ME, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0505-7; Brunetti B, 2013, J COMP PATHOL, V148, P206, DOI 10.1016/j.jcpa.2012.05.012; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Chiappetta G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-17; CURRAN T, 1984, CELL, V36, P259; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Desmet CJ, 2013, P NATL ACAD SCI USA, V110, P5139, DOI 10.1073/pnas.1222085110; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Foran E, 2010, MOL CANCER RES, V8, P471, DOI 10.1158/1541-7786.MCR-09-0496; Gardner D G, 1996, Oral Dis, V2, P148; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Hu YC, 2001, CLIN CANCER RES, V7, P2213; Kappelmann M, 2014, EUR J CELL BIOL, V93, P76, DOI 10.1016/j.ejcb.2013.10.003; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; KOVARY K, 1991, MOL CELL BIOL, V11, P2451, DOI 10.1128/MCB.11.5.2451; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Leethanakul C, 2000, ONCOGENE, V19, P3220, DOI 10.1038/sj.onc.1203703; LEVY LS, 1984, NATURE, V308, P853, DOI 10.1038/308853a0; Liu LK, 2010, MODERN PATHOL, V23, P213, DOI 10.1038/modpathol.2009.160; Luo YP, 2010, ONCOGENE, V29, P662, DOI 10.1038/onc.2009.308; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Martin-Ezquerra G, 2010, BRIT J DERMATOL, V163, P1028, DOI 10.1111/j.1365-2133.2010.09947.x; MATSUI M, 1990, ONCOGENE, V5, P249; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; MULLINS JI, 1984, NATURE, V308, P856, DOI 10.1038/308856a0; Munday JS, 2008, VET DERMATOL, V19, P259, DOI 10.1111/j.1365-3164.2008.00685.x; Murakami Y, 2000, J VET MED SCI, V62, P743, DOI 10.1292/jvms.62.743; Muscatello LV, 2015, J COMP PATHOL, V152, P153, DOI 10.1016/j.jcpa.2014.12.014; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; NEIL JC, 1984, NATURE, V308, P814, DOI 10.1038/308814a0; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; Nusse R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011163; Pai RB, 2009, ECANCERMEDICALSCIENC, V3, DOI 10.3332/ecancer.2008.128; Pearson K., 1896, PHILOS T ROYAL SOC A, V187, P253, DOI [DOI 10.1098/RSTA.1896.0007, 10.1098/rsta.1896.0007]; PEIFER M, 1992, J CELL BIOL, V118, P681, DOI 10.1083/jcb.118.3.681; Poirier VJ, 2013, VET RADIOL ULTRASOUN, V54, P81, DOI 10.1111/j.1740-8261.2012.01970.x; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Rasband W. S., 1997, IMAGEJ SOFTWARE; Rutsch S, 2010, BLOOD, V115, P1746, DOI 10.1182/blood-2009-08-237941; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Snyder LA, 2004, VET PATHOL, V41, P209, DOI 10.1354/vp.41-3-209; Symes AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084295; Thrasivoulou C, 2013, J BIOL CHEM, V288, P35651, DOI 10.1074/jbc.M112.437913; Toth ZE, 2007, J HISTOCHEM CYTOCHEM, V55, P545, DOI 10.1369/jhc.6A7134.2007; Uraguchi M, 2004, J DENT RES, V83, P327, DOI 10.1177/154405910408300411; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010456; Wohlsein P, 2012, J COMP PATHOL, V146, P320, DOI 10.1016/j.jcpa.2011.08.006; Wypij J. M., 2013, PATHOL RES INT, V2013, DOI DOI 10.1155/2013/502197; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Young MR, 2006, GENE, V379, P1, DOI 10.1016/j.gene.2006.05.001; Zhao YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093210	59	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161103	10.1371/journal.pone.0161103	http://dx.doi.org/10.1371/journal.pone.0161103			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27559731	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000382258600027
J	Prabhune, M; von Roden, K; Rehfeldt, F; Schmidt, CF				Prabhune, Meenakshi; von Roden, Kerstin; Rehfeldt, Florian; Schmidt, Christoph F.			Sulfo-SMCC Prevents Annealing of Taxol-Stabilized Microtubules In Vitro	PLOS ONE			English	Article							FOCAL ADHESION DYNAMICS; TUBULIN POLYMERIZATION; ACTIN; NETWORKS; CELLS; ORIENTATION; CYSTEINES; MECHANISM; OXIDATION; MOTORS	Microtubule structure and functions have been widely studied in vitro and in cells. Research has shown that cysteines on tubulin play a crucial role in the polymerization of microtubules. Here, we show that blocking sulfhydryl groups of cysteines in taxol-stabilized polymerized microtubules with a commonly used chemical crosslinker prevents temporal end-to-end annealing of microtubules in vitro. This can dramatically affect the length distribution of the microtubules. The crosslinker sulfosuccinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate, sulfo-SMCC, consists of a maleimide and an N-hydroxysuccinimide ester group to bind to sulfhydryl groups and primary amines, respectively. Interestingly, addition of a maleimide dye alone does not show the same interference with annealing in stabilized microtubules. This study shows that the sulfhydryl groups of cysteines of tubulin that are vital for the polymerization are also important for the subsequent annealing of microtubules.	[Prabhune, Meenakshi; von Roden, Kerstin; Rehfeldt, Florian; Schmidt, Christoph F.] Univ Gottingen, Inst Phys Biophys 3, Gottingen, Germany	University of Gottingen	Schmidt, CF (corresponding author), Univ Gottingen, Inst Phys Biophys 3, Gottingen, Germany.	christoph.schmidt@phys.uni-goettingen.de	Rehfeldt, Florian/A-1078-2007	Rehfeldt, Florian/0000-0001-9086-3835	Deutsche Forschungsgemeinschaft [SFB 755, EXC 171]; Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich (SFB) 755]; Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB); CNMPB	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB); CNMPB	This work was supported by Deutsche Forschungsgemeinschaft, SFB 755, project A3, CFS, FR, MP, http://www.dfg.de/, and Deutsche Forschungsgemeinschaft, Excellence Cluster EXC 171, CNMPB, CFS, http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Siddharth Deshpande, Abhinav Sharma, and Narain Karedla for advise on data analysis. This project was supported by the Deutsche Forschungsgemeinschaft (DFG) through Sonderforschungsbereich (SFB) 755 Project A3 and the Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB).	Alberts B, 2013, GARLAND SCI, P571; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Brangwynne CP, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118104; Broedersz CP, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061914; Broedersz CP, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.118103; Clark HM, 2014, ARCH BIOCHEM BIOPHYS, V541, P67, DOI 10.1016/j.abb.2013.10.026; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Das M, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061906; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dogan MY, 2015, CELL REP, V10, P1967, DOI 10.1016/j.celrep.2015.02.061; Eltzner B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126346; Erben C. M., 2006, ANGEW CHEM, V118, P7574, DOI DOI 10.1002/ANGE.200603392; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Fakhri N, 2014, SCIENCE, V344, P1031, DOI 10.1126/science.1250170; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Heidemann KM, 2015, SOFT MATTER, V11, P343, DOI 10.1039/c4sm01789g; Huber F, 2015, CURR OPIN CELL BIOL, V32, P39, DOI 10.1016/j.ceb.2014.10.005; Huber K, 2008, MOL CANCER THER, V7, P143, DOI 10.1158/1535-7163.MCT-07-0486; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; HYMAN AA, 1991, J CELL SCI, P125; KAWAMURA M, 1970, J BIOCHEM-TOKYO, V67, P437, DOI 10.1093/oxfordjournals.jbchem.a129267; KOSHLAND DE, 1988, NATURE, V331, P499, DOI 10.1038/331499a0; Kuhlman PA, 2005, CELL MOTIL CYTOSKEL, V61, P1, DOI 10.1002/cm.20061; KURIYAMA R, 1974, J BIOCHEM-TOKYO, V76, P651, DOI 10.1093/oxfordjournals.jbchem.a130609; Landino LM, 2007, CHEM RES TOXICOL, V20, P1693, DOI 10.1021/tx7001492; Lin YC, 2007, MACROMOLECULES, V40, P7714, DOI 10.1021/ma070862l; LUDUENA RF, 1991, PHARMACOL THERAPEUT, V49, P133, DOI 10.1016/0163-7258(91)90027-J; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; Mamedova AA, 2004, J BIOL CHEM, V279, P23830, DOI 10.1074/jbc.M401539200; Mi LX, 2008, J BIOL CHEM, V283, P22136, DOI 10.1074/jbc.M802330200; Mizuno D, 2007, SCIENCE, V315, P370, DOI 10.1126/science.1134404; OOSAWA F, 1962, J MOL BIOL, V4, P10, DOI 10.1016/S0022-2836(62)80112-0; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Pelletier V, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.188303; Phelps KK, 2000, BIOCHEMISTRY-US, V39, P3877, DOI 10.1021/bi992200x; Robert A, 2014, FASEB J, V28, P2879, DOI 10.1096/fj.14-250019; ROTHWELL SW, 1986, J CELL BIOL, V102, P619, DOI 10.1083/jcb.102.2.619; Ruddies R., 1993, Biochemical Society Transactions, V21, p37S; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sharma A, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.052705; Shin JH, 2004, P NATL ACAD SCI USA, V101, P9636, DOI 10.1073/pnas.0308733101; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; YAMADA KM, 1971, J CELL BIOL, V49, P614, DOI 10.1083/jcb.49.3.614; Yang YL, 2013, SOFT MATTER, V9, P383, DOI 10.1039/c2sm26934a; Yue JP, 2014, DEV CELL, V31, P572, DOI 10.1016/j.devcel.2014.10.025	48	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161623	10.1371/journal.pone.0161623	http://dx.doi.org/10.1371/journal.pone.0161623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27561096	Green Submitted, Green Published, gold			2022-12-26	WOS:000382258600066
J	Wang, X; Wang, MP; Viswanath, K; Wan, A; Lam, TH; Chan, SS				Wang, Xin; Wang, Man Ping; Viswanath, Kasisomayajula; Wan, Alice; Lam, Tai Hing; Chan, Sophia S.			Smoking and Secondhand Smoke Exposure at Home Were Associated with Poor Perceived Family Well-Being: Findings of FAMILY Project	PLOS ONE			English	Article							HONG-KONG; TOBACCO CONTROL; HARMONY; HEALTH; PERSPECTIVES; HAPPINESS; CONFLICT; CHINA; MODEL	Introduction To investigate the associations of cigarette smoking and secondhand (SHS) exposure at home with family well-being among Chinese adults in Hong Kong. Methods Telephone surveys were conducted among 3043 randomly selected adults (response rate 70%) in 2010 and 2012 to monitor family health information and tobacco use in Hong Kong. Family well-being was measured using three questions of perceived family harmony, happiness and health (3Hs) with responses ranging from 0-10 and a higher score indicating better family well-being. Smoking status, nicotine dependence, quitting behaviours and SHS exposure at home were recorded. Multiple linear regressions were used to calculate beta-coefficients for individual family 3Hs component and an overall composite score representing family well-being. Results Compared with never smokers, current smokers reported lower levels of family harmony (adjusted beta = -0.15, 95% CI: -0.35 to -0.10), happiness (adjusted beta = -0.12, 95% CI: -0.28 to -0.02), health (adjusted beta = -0.15, 95% CI: -0.30 to -0.03) and overall family well-being (adjusted beta = -0.17, 95% CI: -0.32 to -0.06). Quit attempt and intention to quit were not associated with family well-being. SHS exposure at home was associated with lower levels of family harmony (adjusted beta = -0.17, 95% CI: -0.30 to -0.07), happiness (adjusted beta = -0.19, 95% CI: -0.32 to -0.08), health (adjusted beta = -0.13, 95% CI: -0.26 to -0.03) and family wellbeing (adjusted beta = -0.19, 95% CI: -0.32 to -0.09). Conclusions Smoking and SHS exposure at home were associated with the lower levels of perceived family well-being. Prospective studies are needed to confirm the results.	[Wang, Xin; Wan, Alice; Lam, Tai Hing] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Wang, Man Ping; Chan, Sophia S.] Univ Hong Kong, Sch Nursing, Hong Kong, Hong Kong, Peoples R China; [Viswanath, Kasisomayajula] Harvard Sch Publ Hlth, Dept Social & Behav Sci, Dana Farber Canc Inst, Ctr Community Based Res, Boston, MA USA	University of Hong Kong; University of Hong Kong; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health	Lam, TH (corresponding author), Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	hrmrlth@hku.hk	; Lam, Tai Hing/C-4317-2009	Wang, Man Ping/0000-0003-4000-2388; Lam, Tai Hing/0000-0002-2033-9971	Hong Kong Jockey Club Charities Trust	Hong Kong Jockey Club Charities Trust	This study was a part of the project "FAMILY: A Jockey Club Initiative for a Harmonious Society," which was funded by The Hong Kong Jockey Club Charities Trust.	Baumrind D., 1991, J EARLY ADOLESC, V11, P56, DOI [DOI 10.1177/0272431691111004, 10.1177/0272431691111004]; Chaloupka FJ, 2011, TOB CONTROL, V20, P235, DOI 10.1136/tc.2010.039982; Chan SSC, 2011, HEALTH EDUC RES, V26, P664, DOI 10.1093/her/cyr026; Chassin L, 2005, J PEDIATR PSYCHOL, V30, P333, DOI 10.1093/jpepsy/jsi028; Coste J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091562; Davies PT, 2002, MONOGR SOC RES CHILD, V67, P1, DOI 10.1111/1540-5834.00206; Dube SR, 2013, NICOTINE TOB RES, V15, P492, DOI 10.1093/ntr/nts163; Ho SY, 2010, TOB CONTROL, V19, P129, DOI 10.1136/tc.2009.032003; Ho SSM, 2009, SOC INDIC RES, V91, P37, DOI 10.1007/s11205-007-9152-0; Information Services Department, 2012, FACT SHEET HONG KONG; JEHN KA, 1995, ADMIN SCI QUART, V40, P256, DOI 10.2307/2393638; Kaufman E, 2008, TREATMENT IMPROVEMEN, V39, P233; Koplan JP, 2010, LANCET, V375, P1330, DOI 10.1016/S0140-6736(10)60398-4; Lam WWT, 2012, HEALTH EDUC RES, V27, P767, DOI 10.1093/her/cys087; Lun VMC, 2006, ASIAN J SOC PSYCHOL, V9, P195, DOI 10.1111/j.1467-839X.2006.00197.x; Mackay J, 2013, LANCET, V381, P1581, DOI 10.1016/S0140-6736(13)60854-5; McGhee SM, 2006, TOB CONTROL, V15, P125, DOI 10.1136/tc.2005.013292; Milligan S., 2006, FAMILY WELLBEING IND; Robles TF, 2003, PHYSIOL BEHAV, V79, P409, DOI 10.1016/S0031-9384(03)00160-4; Rowland C, 2012, BMJ SUPPORT PALLIAT, V2, P312, DOI 10.1136/bmjspcare-2011-000186; SHERIDAN MJ, 1995, CHILD ABUSE NEGLECT, V19, P519, DOI 10.1016/0145-2134(95)00012-W; Sung HY, 2006, TOB CONTROL, V15, pI5, DOI 10.1136/tc.2005.015412; Tsang IK, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130299; Tsoh JY, 2011, ADDICT BEHAV, V36, P294, DOI 10.1016/j.addbeh.2010.11.009; Wang MP, 2014, ADDICTION, V109, P1165, DOI 10.1111/add.12531; Wang MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073049; Wollny I., 2010, FAMILY WELLBEING CAN; Zubrick S, 2000, INDICATORS SOCIAL FA	28	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161761	10.1371/journal.pone.0161761	http://dx.doi.org/10.1371/journal.pone.0161761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU5NN	27560663	gold, Green Published, Green Submitted			2022-12-26	WOS:000382258600092
J	Zelenko, Z; Gallagher, EJ; Tobin-Hess, A; Belardi, V; Rostoker, R; Blank, J; Dina, Y; LeRoith, D				Zelenko, Z.; Gallagher, E. J.; Tobin-Hess, A.; Belardi, V.; Rostoker, R.; Blank, J.; Dina, Y.; LeRoith, D.			Silencing vimentin expression decreases pulmonary metastases in a pre-diabetic mouse model of mammary tumor progression	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TYPE-2 DIABETES-MELLITUS; MICE LACKING VIMENTIN; BREAST-CANCER; IGF-I; INSULIN-RESISTANCE; CELL MIGRATION; INCREASED RISK; HYPERINSULINEMIA; INVASION	Increased breast cancer risk and mortality has been associated with obesity and type 2 diabetes (T2D). Hyperinsulinemia, a key factor in obesity, pre-diabetes and T2D, has been associated with decreased breast cancer survival. In this study, a mouse model of pre-diabetes (MKR mouse) was used to investigate the mechanisms through which endogenous hyperinsulinemia promotes mammary tumor metastases. The MKR mice developed larger primary tumors and greater number of pulmonary metastases compared with wild-type (WT) mice after injection with c-Myc/Vegf overexpressing MVT-1 cells. Analysis of the primary tumors showed significant increase in vimentin protein expression in the MKR mice compared with WT. We hypothesized that vimentin was an important mediator in the effect of hyperinsulinemia on breast cancer metastasis. Lentiviral short hairpin RNA knockdown of vimentin led to a significant decrease in invasion of the MVT-1 cells and abrogated the increase in cell invasion in response to insulin. In the pre-diabetic MKR mouse, vimentin knockdown led to a decrease in pulmonary metastases. In vitro, we found that insulin increased pAKT, prevented caspase 3 activation, and increased vimentin. Inhibiting the phosphatidylinositol 3 kinase/AKT pathway, using NVP-BKM120, increased active caspase 3 and decreased vimentin levels. This study is the first to show that vimentin has an important role in tumor metastasis in vivo in the setting of pre-diabetes and endogenous hyperinsulinemia. Vimentin targeting may be an important therapeutic strategy to reduce metastases in patients with obesity, pre-diabetes or T2D.	[Zelenko, Z.; Gallagher, E. J.; Tobin-Hess, A.; Belardi, V.; Blank, J.; Dina, Y.; LeRoith, D.] Icahn Sch Med Mt Sinai, Div Endocrinol Diabet & Bone Dis, One Gustave L Levy Pl,Box 1055, New York, NY 10029 USA; [Rostoker, R.; LeRoith, D.] CRIR, Haifa, Israel; [Rostoker, R.; LeRoith, D.] Technion, Fac Med, Diabet & Metab Clin Res Ctr Excellence, Haifa, Israel	Icahn School of Medicine at Mount Sinai; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	LeRoith, D (corresponding author), Icahn Sch Med Mt Sinai, Div Endocrinol Diabet & Bone Dis, One Gustave L Levy Pl,Box 1055, New York, NY 10029 USA.	Derek.LeRoith@mssm.edu			NCI grant [2R01CA128799-06A1]; American Diabetes grant [1-13-BS-108]; NIH/NCI [1K08CA190770]; NCI Supplement [R01CA171558-02S1]; NATIONAL CANCER INSTITUTE [K08CA190770, R01CA128799, R01CA171558] Funding Source: NIH RePORTER	NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Diabetes grant; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Supplement; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NCI grant (grant 2R01CA128799-06A1) to DLR. American Diabetes grant 1-13-BS-108 to DLR. NIH/NCI 1K08CA190770 to EJG. NCI Supplement R01CA171558-02S1 to YD. Scuola di Specializzazione in Endocrinologia e Malattie del Metabolismo, University of Pisa to VB.	ADAMI HO, 1991, CANCER CAUSE CONTROL, V2, P307, DOI 10.1007/BF00051670; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Borowsky AD, 2005, CLIN EXP METASTAS, V22, P47, DOI 10.1007/s10585-005-2908-5; Cannata D, 2010, ENDOCRINOLOGY, V151, P5751, DOI 10.1210/en.2010-0792; Chari ST, 2005, GASTROENTEROLOGY, V129, P504, DOI 10.1053/j.gastro.2005.05.007; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; Eckes B, 1998, J CELL SCI, V111, P1897; Eckes B, 2000, J CELL SCI, V113, P2455; Ferguson RD, 2013, ENDOCR-RELAT CANCER, V20, P391, DOI 10.1530/ERC-12-0333; Ferguson RD, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3089; Fernandez AM, 2001, GENE DEV, V15, P1926, DOI 10.1101/gad.908001; Fierz Y, 2010, DIABETES, V59, P686, DOI 10.2337/db09-1291; FRANKE WW, 1982, DIFFERENTIATION, V23, P43, DOI 10.1111/j.1432-0436.1982.tb01266.x; Gilles C, 1999, J CELL SCI, V112, P4615; Goodwin PJ, 2002, J CLIN ONCOL, V20, P42, DOI 10.1200/JCO.20.1.42; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hines IN, 2011, AM J PATHOL, V179, P2855, DOI 10.1016/j.ajpath.2011.08.014; Lawlor DA, 2004, CANCER CAUSE CONTROL, V15, P267, DOI 10.1023/B:CACO.0000024225.14618.a8; LeRoith D, 2006, INT J BIOCHEM CELL B, V38, P904, DOI 10.1016/j.biocel.2005.01.019; Lipscombe LL, 2008, BREAST CANCER RES TR, V109, P389, DOI 10.1007/s10549-007-9654-0; Los M, 2002, MOL BIOL CELL, V13, P978, DOI 10.1091/mbc.01-05-0272; Marshall J, 2011, METHODS MOL BIOL, V769, P97, DOI 10.1007/978-1-61779-207-6_8; McInroy L, 2007, BIOCHEM BIOPH RES CO, V360, P109, DOI 10.1016/j.bbrc.2007.06.036; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Moore CB, 2010, METHODS MOL BIOL, V629, P139, DOI 10.1007/978-1-60761-657-3_10; Novosyadlyy R, 2010, CANCER RES, V70, P741, DOI 10.1158/0008-5472.CAN-09-2141; Onitilo AA, 2012, CANCER CAUSE CONTROL, V23, P967, DOI 10.1007/s10552-012-9972-3; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pei XF, 2004, IN VITRO CELL DEV-AN, V40, P14; Redaniel MTM, 2012, CANCER CAUSE CONTROL, V23, P1785, DOI 10.1007/s10552-012-0057-0; Rostoker R, 2015, ENDOCR-RELAT CANCER, V22, P145, DOI 10.1530/ERC-14-0490; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Shen XC, 2015, J BIOL CHEM, V290, P11578, DOI 10.1074/jbc.M114.620237; Svegliati-Baroni G, 2011, GUT, V60, P108, DOI 10.1136/gut.2010.219741; Tezcan O, 2014, BIOMED PHARMACOTHER, V68, P357, DOI 10.1016/j.biopha.2014.01.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Wei JC, 2008, ANTICANCER RES, V28, P327; Yang Y, 2012, CANCER, V119, P1512; Yu Y, 2014, BRIT J CANCER, V110, P724, DOI 10.1038/bjc.2013.768; Zanders MMJ, 2013, MATURITAS, V74, P37, DOI 10.1016/j.maturitas.2012.10.007; Zhang PH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-567; Zhu QS, 2011, ONCOGENE, V30, P457, DOI 10.1038/onc.2010.421	45	26	26	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 9	2017	36	10					1394	1403		10.1038/onc.2016.305	http://dx.doi.org/10.1038/onc.2016.305			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EN2TG	27568979	Green Accepted			2022-12-26	WOS:000395862500008
J	Torres, MA; Hoffarth, E; Eugenio, L; Savtchouk, J; Chen, X; Morris, JS; Facchini, PJ; Ng, KKS				Torres, Miguel A.; Hoffarth, Elesha; Eugenio, Luiz; Savtchouk, Julia; Chen, Xue; Morris, Jeremy S.; Facchini, Peter J.; Ng, Kenneth K. -S.			Structural and Functional Studies of Pavine N-Methyltransferase from Thalictrum flavum Reveal Novel Insights into Substrate Recognition and Catalytic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; enzyme mechanism; protein structure; secondary metabolism; x-ray crystallography; Benzylisoquinoline alkaloid biosynthesis	ALKALOID BIOSYNTHESIS; CRYSTAL-STRUCTURES; MOLECULAR-CLONING; BINDING-PROTEINS; METABOLISM	Benzylisoquinoline alkaloids (BIAs) are produced in a wide variety of plants and include many common analgesic, antitussive, and anticancer compounds. Several members of a distinct family of S-adenosylmethionine (SAM)-dependent N-methyltransferases (NMTs) play critical roles in BIA biosynthesis, but the molecular basis of substrate recognition and catalysis is not known for NMTs involved in BIA metabolism. To address this issue, the crystal structure of pavine NMT from Thalictrum flavum was solved using selenomethionine-substituted protein (d(min) = 2.8 ). Additional structures were determined for the native protein (d(min) = 2.0 ) as well as binary complexes with SAM (d(min) = 2.3 ) or the reaction product S-adenosylhomocysteine (d(min) = 1.6 ). The structure of a complex with S-adenosylhomocysteine and two molecules of tetrahydropapaverine (THP; one as the S conformer and a second in the R configuration) (d(min) = 1.8 ) revealed key features of substrate recognition. Pavine NMT converted racemic THP to laudanosine, but the enzyme showed a preference for (+/-)-pavine and (S)-reticuline as substrates. These structures suggest the involvement of highly conserved residues at the active site. Mutagenesis of three residues near the methyl group of SAM and the nitrogen atom of the alkaloid acceptor decreased enzyme activity without disrupting the structure of the protein. The binding site for THP provides a framework for understanding substrate specificity among numerous NMTs involved in the biosynthesis of BIAs and other specialized metabolites. This information will facilitate metabolic engineering efforts aimed at producing medicinally important compounds in heterologous systems, such as yeast.	[Torres, Miguel A.; Hoffarth, Elesha; Eugenio, Luiz; Savtchouk, Julia; Chen, Xue; Morris, Jeremy S.; Facchini, Peter J.; Ng, Kenneth K. -S.] Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Torres, Miguel A.; Hoffarth, Elesha; Eugenio, Luiz; Savtchouk, Julia; Ng, Kenneth K. -S.] Univ Calgary, Alberta Glyc Ctr, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary	Ng, KKS (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.; Ng, KKS (corresponding author), Univ Calgary, Alberta Glyc Ctr, Calgary, AB T2N 1N4, Canada.	ngk@ucalgary.ca		Ng, Kenneth K.S./0000-0001-7280-8445; Torres, Megan/0000-0001-6126-709X	Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; Department of Energy Office of Biological and Environmental Research and by the National Institutes of Health, NIGMS [P41GM103393]; National Center for Research Resources [P41RR001209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; Department of Energy Office of Biological and Environmental Research and by the National Institutes of Health, NIGMS; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Some of the X-ray diffraction data were measured at beamline 08ID-1 of the Canadian Light Source (CLS), which is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan. Some of the diffraction data were also measured at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by the National Institutes of Health, NIGMS (including P41GM103393) and the National Center for Research Resources (P41RR001209). We thank Dr. Jillian Hagel for assistance with the chiral analysis of THP.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Choi KB, 2002, J BIOL CHEM, V277, P830, DOI 10.1074/jbc.M106405200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Desgagne-Penix I, 2012, PLANT MOL BIOL, V79, P295, DOI 10.1007/s11103-012-9913-2; Drinkwater N, 2009, BIOCHEM J, V422, P463, DOI 10.1042/BJ20090702; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Facchini PJ, 2003, PHYTOCHEMISTRY, V64, P177, DOI 10.1016/S0031-9422(03)00292-9; Farrow SC, 2015, NAT CHEM BIOL, V11, P728, DOI [10.1038/NCHEMBIO.1879, 10.1038/nchembio.1879]; Farrow SC, 2012, PHYTOCHEMISTRY, V77, P79, DOI 10.1016/j.phytochem.2012.02.014; Fossati E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4283; Gana R, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-6; Garg A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09064; Hagel JM, 2013, PLANT CELL PHYSIOL, V54, P647, DOI 10.1093/pcp/pct020; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang CYF, 2002, J BIOL CHEM, V277, P34367, DOI 10.1074/jbc.M202468200; Jain A, 2008, ACTA CRYSTALLOGR F, V64, P1066, DOI 10.1107/S1744309108033046; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Komoto J, 2004, BIOCHEMISTRY-US, V43, P14385, DOI 10.1021/bi0486785; Kozbial PZ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-19; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee SG, 2012, J BIOL CHEM, V287, P1426, DOI 10.1074/jbc.M111.315267; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Liscombe DK, 2009, PLANT J, V60, P729, DOI 10.1111/j.1365-313X.2009.03980.x; Morris JS, 2016, J BIOL CHEM, V291, P23416, DOI 10.1074/jbc.M116.750893; Ropivia J, 2010, MOLECULES, V15, P6476, DOI 10.3390/molecules15096476; Saen-oon S, 2014, J BIOL CHEM, V289, P33815, DOI 10.1074/jbc.M114.611319; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Takata Y, 2003, BIOCHEMISTRY-US, V42, P8394, DOI 10.1021/bi034245a; Thodey K, 2014, NAT CHEM BIOL, V10, P837, DOI [10.1038/NCHEMBIO.1613, 10.1038/nchembio.1613]; Wu Q, 2013, ARCH BIOCHEM BIOPHYS, V539, P1, DOI 10.1016/j.abb.2013.08.019; Zhang JY, 2016, J AM CHEM SOC, V138, P9158, DOI 10.1021/jacs.6b03462; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730	33	20	21	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23403	23415		10.1074/jbc.M116.747261	http://dx.doi.org/10.1074/jbc.M116.747261			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27573242	hybrid, Green Published			2022-12-26	WOS:000387884400004
J	Martin, GM; Rex, EA; Devaraneni, P; Denton, JS; Boodhansingh, KE; DeLeon, DD; Stanley, CA; Shyng, SL				Martin, Gregory M.; Rex, Emily A.; Devaraneni, Prasanna; Denton, Jerod S.; Boodhansingh, Kara E.; DeLeon, Diva D.; Stanley, Charles A.; Shyng, Show-Ling			Pharmacological Correction of Trafficking Defects in ATP-sensitive Potassium Channels Caused by Sulfonylurea Receptor 1 Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; ATP-binding cassette transporter subfamily C member 8 (ABCC8); chaperone; gating; hypoglycemia; insulin secretion; intracellular trafficking; potassium channel; protein misfolding; protein processing	PANCREATIC BETA-CELLS; CONGENITAL HYPERINSULINISM; INSULIN-SECRETION; FAMILIAL HYPERINSULINISM; K+ CHANNELS; INFANCY; DIAGNOSIS; DISEASES; ABCC8; RESCUE	ATP-sensitive potassium (K-ATP) channels play a key role in mediating glucose-stimulated insulin secretion by coupling metabolic signals to -cell membrane potential. Loss of K-ATP channel function due to mutations in ABCC8 or KCNJ11, genes encoding the sulfonylurea receptor 1 (SUR1) or the inwardly rectifying potassium channel Kir6.2, respectively, results in congenital hyperinsulinism. Many SUR1 mutations prevent trafficking of channel proteins from the endoplasmic reticulum to the cell surface. Channel inhibitors, including sulfonylureas and carbamazepine, have been shown to correct channel trafficking defects. In the present study, we identified 13 novel SUR1 mutations that cause channel trafficking defects, the majority of which are amenable to pharmacological rescue by glibenclamide and carbamazepine. By contrast, none of the mutant channels were rescued by K-ATP channel openers. Cross-linking experiments showed that K-ATP channel inhibitors promoted interactions between the N terminus of Kir6.2 and SUR1, whereas channel openers did not, suggesting the inhibitors enhance intersubunit interactions to overcome channel biogenesis and trafficking defects. Functional studies of rescued mutant channels indicate that most mutants rescued to the cell surface exhibited WT-like sensitivity to ATP, MgADP, and diazoxide. In intact cells, recovery of channel function upon trafficking rescue by reversible sulfonylureas or carbamazepine was facilitated by the K-ATP channel opener diazoxide. Our study expands the list of K-ATP channel trafficking mutations whose function can be recovered by pharmacological ligands and provides further insight into the structural mechanism by which channel inhibitors correct channel biogenesis and trafficking defects.	[Martin, Gregory M.; Rex, Emily A.; Devaraneni, Prasanna; Shyng, Show-Ling] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Denton, Jerod S.] Vanderbilt Univ, Dept Anesthesiol, Nashville, TN 37232 USA; [Boodhansingh, Kara E.; DeLeon, Diva D.; Stanley, Charles A.] Childrens Hosp Philadelphia, Div Endocrinol Diabet, Philadelphia, PA 19104 USA	Oregon Health & Science University; Vanderbilt University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Shyng, SL (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	shyngs@ohsu.edu	De Leon, Diva D./V-8626-2019	De Leon, Diva D./0000-0003-1225-8087	National Institutes of Health [R01DK066485, F31DK105800, R01DK098517, R37DK056268]; Goldsmith Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066485, F31DK105800, R01DK098517, R37DK056268, R01DK057699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Goldsmith Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01DK066485 (to S.-L. S.), F31DK105800 (to G. M. M.), R01DK098517 (to D. D. D. L.), and R37DK056268 (to C. A. S.) and a grant from the Goldsmith Foundation (to D. D. D. L. and C. A. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Aguilar-Bryan L, 2001, RECENT PROG HORM RES, V56, P47, DOI 10.1210/rp.56.1.47; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Ashcroft FM, 1998, TRENDS NEUROSCI, V21, P288, DOI 10.1016/S0166-2236(98)01225-9; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Cartier EA, 2001, P NATL ACAD SCI USA, V98, P2882, DOI 10.1073/pnas.051499698; Chan KW, 2003, EMBO J, V22, P3833, DOI 10.1093/emboj/cdg376; Chen PC, 2013, J BIOL CHEM, V288, P20942, DOI 10.1074/jbc.M113.470948; Conti LR, 2001, J BIOL CHEM, V276, P41270, DOI 10.1074/jbc.M106555200; Convertino M, 2016, ACS CHEM BIOL, V11, P1471, DOI 10.1021/acschembio.6b00195; Cosgrove KE, 2004, EUR J PHARMACOL, V486, P133, DOI 10.1016/j.ejphar.2003.12.017; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; De Vroede M, 2004, PEDIATRICS, V114, pE520, DOI 10.1542/peds.2003-1180-L; Devaraneni PK, 2015, J BIOL CHEM, V290, P7980, DOI 10.1074/jbc.M114.634576; Fernandez-Marmiesse A, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9401; Flanagan SE, 2009, HUM MUTAT, V30, P170, DOI 10.1002/humu.20838; Fukuda Y, 2011, J BIOL CHEM, V286, P8481, DOI 10.1074/jbc.M110.174516; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Greer RM, 2007, PEDIATR DEVEL PATHOL, V10, P25, DOI 10.2350/06-04-0083.1; Hardy OT, 2007, J PEDIATR-US, V150, P140, DOI 10.1016/j.jpeds.2006.08.028; Leidenheimer NJ, 2014, PHARMACOL RES, V83, P10, DOI 10.1016/j.phrs.2014.01.005; MacMullen CM, 2011, DIABETES, V60, P1797, DOI 10.2337/db10-1631; Martin GM, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00386; Nestorowicz A, 1996, HUM MOL GENET, V5, P1813, DOI 10.1093/hmg/5.11.1813; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nielsen FE, 2006, J MED CHEM, V49, P4127, DOI 10.1021/jm060042j; Otonkoski T, 2006, DIABETES, V55, P13, DOI 10.2337/diabetes.55.01.06.db05-1128; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Pratt EB, 2009, J BIOL CHEM, V284, P7951, DOI 10.1074/jbc.M807012200; Raab-Graham KF, 1999, J BIOL CHEM, V274, P29122, DOI 10.1074/jbc.274.41.29122; Raphemot R, 2014, MOL PHARMACOL, V85, P858, DOI 10.1124/mol.114.091884; Sampson HM, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-11; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; Snider KE, 2013, J CLIN ENDOCR METAB, V98, pE355, DOI 10.1210/jc.2012-2169; Stanley CA, 2016, J CLIN ENDOCR METAB, V101, P815, DOI 10.1210/jc.2015-3651; Suchi M, 2006, MODERN PATHOL, V19, P122, DOI 10.1038/modpathol.3800497; Taschenberger G, 2002, J BIOL CHEM, V277, P17139, DOI 10.1074/jbc.M200363200; Tornovsky S, 2004, J CLIN ENDOCR METAB, V89, P6224, DOI 10.1210/jc.2004-1233; Verheul JC, 2011, NED TIJDSCHR GENEES, V155, pA3343; Welch WJ, 2004, SEMIN CELL DEV BIOL, V15, P31, DOI 10.1016/j.semcdb.2003.12.011; Yan FF, 2007, DIABETES, V56, P2339, DOI 10.2337/db07-0150; Yan FF, 2006, J BIOL CHEM, V281, P33403, DOI 10.1074/jbc.M605195200; Yan FF, 2004, J BIOL CHEM, V279, P11096, DOI 10.1074/jbc.M312810200; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhou Q, 2014, CHANNELS, V8, P376, DOI 10.4161/chan.29117	47	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21971	21983		10.1074/jbc.M116.749366	http://dx.doi.org/10.1074/jbc.M116.749366			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27573238	Green Published, hybrid			2022-12-26	WOS:000386332600013
J	Woodall, BP; Woodall, MC; Luongo, TS; Grisanti, LA; Tilley, DG; Elrod, JW; Koch, WJ				Woodall, Benjamin P.; Woodall, Meryl C.; Luongo, Timothy S.; Grisanti, Laurel A.; Tilley, Douglas G.; Elrod, John W.; Koch, Walter J.			Skeletal Muscle-specific G Protein-coupled Receptor Kinase 2 Ablation Alters Isolated Skeletal Muscle Mechanics and Enhances Clenbuterol-stimulated Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adrenergic receptor; Akt PKB; G protein-coupled receptor (GPCR); mouse; muscle hypertrophy; muscle physiology	MYOCARDIAL CONTRACTILE FUNCTION; CARDIAC-FUNCTION; INSULIN-RESISTANCE; HEART; EXPRESSION; THERAPY; INHIBITION; NORMALIZES; FAILURE; GROWTH	GRK2, a G protein-coupled receptor kinase, plays a critical role in cardiac physiology. Adrenergic receptors are the primary target for GRK2 activity in the heart; phosphorylation by GRK2 leads to desensitization of these receptors. As such, levels of GRK2 activity in the heart directly correlate with cardiac contractile function. Furthermore, increased expression of GRK2 after cardiac insult exacerbates injury and speeds progression to heart failure. Despite the importance of this kinase in both the physiology and pathophysiology of the heart, relatively little is known about the role of GRK2 in skeletal muscle function and disease. In this study we generated a novel skeletal muscle-specific GRK2 knock-out (KO) mouse (MLC-Cre:GRK2(fl/fl)) to gain a better understanding of the role of GRK2 in skeletal muscle physiology. In isolated muscle mechanics testing, GRK2 ablation caused a significant decrease in the specific force of contraction of the fast-twitch extensor digitorum longus muscle yet had no effect on the slow-twitch soleus muscle. Despite these effects in isolated muscle, exercise capacity was not altered in MLC-Cre:GRK2(fl/fl) mice compared with wild-type controls. Skeletal muscle hypertrophy stimulated by clenbuterol, a (2)-adrenergic receptor ((2)AR) agonist, was significantly enhanced in MLC-Cre:GRK2(fl/fl) mice; mechanistically, this seems to be due to increased clenbuterol-stimulated pro-hypertrophic Akt signaling in the GRK2 KO skeletal muscle. In summary, our study provides the first insights into the role of GRK2 in skeletal muscle physiology and points to a role for GRK2 as a modulator of contractile properties in skeletal muscle as well as (2)AR-induced hypertrophy.	[Woodall, Benjamin P.; Woodall, Meryl C.; Luongo, Timothy S.; Grisanti, Laurel A.; Tilley, Douglas G.; Elrod, John W.; Koch, Walter J.] Temple Univ, Lewis Katz Sch Med, Ctr Translat Med, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Koch, WJ (corresponding author), Temple Univ, Dept Pharmacol, Ctr Translat Med, 3500 N Broad St,941 MERB, Philadelphia, PA 19140 USA.	walter.koch@temple.edu	Luongo, Timothy/AAY-1073-2020	Tilley, Douglas/0000-0002-9681-3377; Elrod, John/0000-0003-3925-2224; Luongo, Timothy/0000-0001-7621-7992	National Institutes of Health [P01 HL091799, R37 HL061690, R01 HL085503, P01 HL075443, P01 HL108806]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL061690, P01HL091799, R01HL123966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA037830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institutes of Health Grant P01 HL091799. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; The W. W. Smith Chair in Cardiovascular Medicine at the Lewis Katz School of Medicine at Temple University. Supported by National Institutes of Health Grants R37 HL061690, R01 HL085503, P01 HL075443 (Project 2), and P01 HL108806 (Project 3). To whom correspondence should be addressed: Dept. of Pharmacology, Center for Translational Medicine, Temple University, 3500 N. Broad St., 941 MERB, Philadelphia, PA 19140-4106. Tel.: 215-707-9820; Fax: 215-707-9890; E-mail: walter.koch@temple.edu.	Akhter SA, 1999, CIRCULATION, V100, P648, DOI 10.1161/01.CIR.100.6.648; Barton ER, 2005, MUSCLE NERVE, V32, P751, DOI 10.1002/mus.20425; BENSON DW, 1991, J SURG RES, V50, P1; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Brinks H, 2010, CIRC RES, V107, P1140, DOI 10.1161/CIRCRESAHA.110.221010; Cairns SP, 2015, J PHYSIOL-LONDON, V593, P4713, DOI 10.1113/JP270909; Chen M, 2013, CIRC RES, V112, P1121, DOI 10.1161/CIRCRESAHA.112.300754; Ciccarelli M, 2011, CIRCULATION, V123, P1953, DOI 10.1161/CIRCULATIONAHA.110.988642; Garcia-Guerra L, 2010, DIABETES, V59, P2407, DOI 10.2337/db10-0771; Harding VB, 2001, P NATL ACAD SCI USA, V98, P5809, DOI 10.1073/pnas.091102398; Hinkle RT, 2002, MUSCLE NERVE, V25, P729, DOI 10.1002/mus.10092; Iaccarino G, 1998, CIRCULATION, V98, P1783, DOI 10.1161/01.CIR.98.17.1783; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kline WO, 2007, J APPL PHYSIOL, V102, P740, DOI 10.1152/japplphysiol.00873.2006; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; Lynch GS, 2008, PHYSIOL REV, V88, P729, DOI 10.1152/physrev.00028.2007; MALTIN CA, 1986, BIOSCIENCE REP, V6, P293, DOI 10.1007/BF01115158; Matkovich SJ, 2006, CIRC RES, V99, P996, DOI 10.1161/01.RES.0000247932.71270.2c; Parsons SA, 2004, J BIOL CHEM, V279, P26192, DOI 10.1074/jbc.M313800200; Petrofski JA, 2003, J MOL CELL CARDIOL, V35, P1167, DOI 10.1016/S0022-2828(03)00243-8; Raake PW, 2012, CIRCULATION, V125, P2108, DOI 10.1161/CIRCULATIONAHA.111.044255; Raake PWJ, 2013, EUR HEART J, V34, P1437, DOI 10.1093/eurheartj/ehr447; Rengo G, 2009, CIRCULATION, V119, P89, DOI 10.1161/CIRCULATIONAHA.108.803999; Rockman HA, 1998, J BIOL CHEM, V273, P18180, DOI 10.1074/jbc.273.29.18180; Rockman HA, 1998, P NATL ACAD SCI USA, V95, P7000, DOI 10.1073/pnas.95.12.7000; Sato PY, 2015, J MOL CELL CARDIOL, V89, P360, DOI 10.1016/j.yjmcc.2015.10.002; Sato PY, 2015, PHYSIOL REV, V95, P377, DOI 10.1152/physrev.00015.2014; Schumacher SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0154; Selsby JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030063; Shah AS, 2001, CIRCULATION, V103, P1311; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; Woo AYH, 2012, ACTA PHARMACOL SIN, V33, P335, DOI 10.1038/aps.2011.201; Woodall MC, 2014, CIRC RES, V114, P1661, DOI 10.1161/CIRCRESAHA.114.300513; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008; ZEMAN RJ, 1988, AM J PHYSIOL, V254, pE726, DOI 10.1152/ajpendo.1988.254.6.E726	35	5	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21913	21924		10.1074/jbc.M116.721282	http://dx.doi.org/10.1074/jbc.M116.721282			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27566547	hybrid, Green Published			2022-12-26	WOS:000386332600008
J	Ishangulyyeva, G; Najar, A; Curtis, JM; Erbilgin, N				Ishangulyyeva, Guncha; Najar, Ahmed; Curtis, Jonathan M.; Erbilgin, Nadir			Fatty Acid Composition of Novel Host Jack Pine Do Not Prevent Host Acceptance and Colonization by the Invasive Mountain Pine Beetle and Its Symbiotic Fungus	PLOS ONE			English	Article							INSECT HERBIVORE; DENDROCTONUS-PONDEROSAE; POPULATION-DYNAMICS; ERUPTIVE HERBIVORE; RANGE EXPANSION; LINOLENIC ACID; BOREAL FOREST; SCOTS PINE; BIOSYNTHESIS; PLANTS	Fatty acids are major components of plant lipids and can affect growth and development of insect herbivores. Despite a large literature examining the roles of fatty acids in conifers, relatively few studies have tested the effects of fatty acids on insect herbivores and their microbial symbionts. Particularly, whether fatty acids can affect the suitability of conifers for insect herbivores has never been studied before. Thus, we evaluated if composition of fatty acids impede or facilitate colonization of jack pine (Pinus banksiana) by the invasive mountain pine beetle (Dendroctonus ponderosae) and its symbiotic fungus (Grosmannia clavigera). This is the first study to examine the effects of tree fatty acids on any bark beetle species and its symbiotic fungus. In a novel bioassay, we found that plant tissues (hosts and non-host) amended with synthetic fatty acids at concentrations representative of jack pine were compatible with beetle larvae. Likewise, G. clavigera grew in media amended with lipid fractions or synthetic fatty acids at concentrations present in jack pine. In contrast, fatty acids and lipid composition of a non-host were not suitable for the beetle larvae or the fungus. Apparently, concentrations of individual, rather than total, fatty acids determined the suitability of jack pine. Furthermore, sampling of host and non-host tree species across Canada demonstrated that the composition of jack pine fatty acids was similar to the different populations of beetle's historical hosts. These results demonstrate that fatty acids composition compatible with insect herbivores and their microbial symbionts can be important factor defining host suitability to invasive insects.	[Ishangulyyeva, Guncha; Najar, Ahmed; Erbilgin, Nadir] Univ Alberta, Dept Renewable Resources, 4-42 Earth Sci Bldg, Edmonton, AB T6G 2E3, Canada; [Curtis, Jonathan M.] Univ Alberta, Dept Agr Food & Nutr Sci, 3-60D South Acad Bldg, Edmonton, AB T6G 2P5, Canada	University of Alberta; University of Alberta	Erbilgin, N (corresponding author), Univ Alberta, Dept Renewable Resources, 4-42 Earth Sci Bldg, Edmonton, AB T6G 2E3, Canada.	erbilgin@ualberta.ca	Erbilgin, Nadir/F-3675-2014	Erbilgin, Nadir/0000-0001-9912-8095	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by NSERC-Discovery to NE.	Ammunet T, 2011, ECOGRAPHY, V34, P848, DOI 10.1111/j.1600-0587.2011.06685.x; ANDREWS TL, 1972, PESTIC BIOCHEM PHYS, V2, P257, DOI 10.1016/0048-3575(72)90028-4; Angelcheva L, 2014, NEW PHYTOL, V204, P545, DOI 10.1111/nph.12950; Avis TJ, 2001, APPL ENVIRON MICROB, V67, P956, DOI 10.1128/AEM.67.2.956-960.2001; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Becerra JX, 1997, SCIENCE, V276, P253, DOI 10.1126/science.276.5310.253; BERENBAUM MR, 1995, P NATL ACAD SCI USA, V92, P2, DOI 10.1073/pnas.92.1.2; Bleiker KP, 2007, ENVIRON ENTOMOL, V36, P1384, DOI 10.1603/0046-225X(2007)36[1384:DBOFAT]2.0.CO;2; BRACKEN GK, 1982, CAN ENTOMOL, V114, P567, DOI 10.4039/Ent114567-7; Cale JA, 2015, CAN J FOREST RES, V45, P1873, DOI 10.1139/cjfr-2015-0277; Cullingham CI, 2011, MOL ECOL, V20, P2157, DOI 10.1111/j.1365-294X.2011.05086.x; Curtis JM, 2008, J AM OIL CHEM SOC, V85, P297, DOI 10.1007/s11746-008-1194-1; De Moraes CM, 2004, P NATL ACAD SCI USA, V101, P8993, DOI 10.1073/pnas.0403248101; Dworkin I, 2009, GENETICS, V181, P721, DOI 10.1534/genetics.108.093419; Erbilgin N, 2014, NEW PHYTOL, V201, P940, DOI 10.1111/nph.12573; Feeny P., 1991, P315; FISCHER C, 1991, TREES-STRUCT FUNCT, V5, P187, DOI 10.1007/BF00227524; Futuyma DJ, 2001, ENCY BIODIVERSITY, V1, P753; GAO Y, 1994, MATER ORGANISMEN, V28, P105; Goodsman DW, 2012, ENVIRON ENTOMOL, V41, P478, DOI 10.1603/EN11205; Grant GG, 2000, ENVIRON ENTOMOL, V29, P164, DOI 10.1603/0046-225X(2000)029[0164:OROSBL]2.0.CO;2; Hansen AK, 2014, MOL ECOL, V23, P1473, DOI 10.1111/mec.12421; Harwood JL, 2005, BIOL SCI SER, P27; Joern A, 2012, ECOLOGY, V93, P1002, DOI 10.1890/11-1142.1; KYBURZ S, 1991, EUR J FOREST PATHOL, V21, P49; Mansson PE, 2006, ENTOMOL EXP APPL, V121, P191, DOI [10.1111/j.1570-8703.2006.00481.x, 10.1111/j.1570-7458.2006.00481.x]; Murphy SM, 2006, ECOL MONOGR, V76, P399, DOI 10.1890/0012-9615(2006)076[0399:CFOANO]2.0.CO;2; Myrholm CL, 2016, CAN ENTOMOL, V148, P68, DOI 10.4039/tce.2015.28; Novak M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120119; Otte T, 2015, J CHEM ECOL, V41, P32, DOI 10.1007/s10886-014-0535-9; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; REID RW, 1970, CAN ENTOMOL, V102, P617, DOI 10.4039/Ent102617-5; Roeder KA, 2014, FUNCT ECOL, V28, P1135, DOI 10.1111/1365-2435.12262; RULE GS, 1989, ARCH INSECT BIOCHEM, V12, P89, DOI 10.1002/arch.940120203; SAFRANYIK L, 1983, Journal of the Entomological Society of British Columbia, V80, P10; Safranyik L, 2010, CAN ENTOMOL, V142, P415, DOI 10.4039/n08-CPA01; Santana O, 2012, CHEM BIODIVERS, V9, P567, DOI 10.1002/cbdv.201100083; Schoonhoven L. M., 2005, Insect-plant biology; Scriber JM, 2010, INSECT SCI, V17, P471, DOI 10.1111/j.1744-7917.2010.01357.x; Shepherd T, 1999, PHYTOCHEMISTRY, V52, P1239, DOI 10.1016/S0031-9422(99)00413-6; Six Diana L., 2012, Insects, V3, P339, DOI 10.3390/insects3010339; Slansky F. Jr, 1985, P87; Song MM, 2014, J CHEM ECOL, V40, P181, DOI 10.1007/s10886-014-0381-9; STANLEYSAMUELSON DW, 1988, ARCH INSECT BIOCHEM, V9, P1, DOI 10.1002/arch.940090102; VANDERWEL D, 1992, J CHEM ECOL, V18, P1389, DOI 10.1007/BF00994364; Wallin KF, 2004, ECOL MONOGR, V74, P101, DOI 10.1890/02-4004; Walters D, 2004, MYCOPATHOLOGIA, V157, P87, DOI 10.1023/B:MYCO.0000012222.68156.2c; Wang YM, 2006, J LIPID RES, V47, P530, DOI 10.1194/jlr.M500346-JLR200; Weber H, 2002, TRENDS PLANT SCI, V7, P217, DOI 10.1016/S1360-1385(02)02250-1; Wolff RL, 1997, TREES-STRUCT FUNCT, V12, P113; Wolff RL, 2001, LIPIDS, V36, P439, DOI 10.1007/s11745-001-0741-5; Wood S. L., 1982, The bark and ambrosia beetles of North and Central America (Coleoptera : Scolytidae), a taxonomic monograph.	52	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162046	10.1371/journal.pone.0162046	http://dx.doi.org/10.1371/journal.pone.0162046			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583820	Green Submitted, Green Published, gold			2022-12-26	WOS:000382855600092
J	Li, XH; Zhang, YZ; Wei, ZW; Guan, ZB; Cai, YJ; Liao, XR				Li, Xunhang; Zhang, Yanzhou; Wei, Zhiwen; Guan, Zhengbing; Cai, Yujie; Liao, Xiangru			Antifungal Activity of Isolated Bacillus amyloliquefaciens SYBC H47 for the Biocontrol of Peach Gummosis	PLOS ONE			English	Article							SUBTILIS SUBSP SUBTILIS; TOF MS ANALYSIS; BOTRYOSPHAERIA-DOTHIDEA; ANTIMICROBIAL ACTIVITY; CYCLIC LIPOPEPTIDES; BIOLOGICAL-CONTROL; FENGYCIN; STRAINS; IDENTIFICATION; ITURIN	The gummosis disease is caused by Botryosphaeria dothidea (Moug. ex. Fr) Ces. et de Not., and it is one of the most important diseases of stone fruits worldwide. The use of biocontrol as an alternative approach to synthetic chemical fungicides has aroused general concern about how to control plant diseases that are caused by phytopathogens. The aim of this study is to isolate Bacillus strains from raw honeys with the capacity to inhibit B. dothidea and to explore the mechanisms by which they could be used in the biocontrol of peach gummosis. Bacillus amyloliquefaciens SYBC H47 was isolated and identified on the basis of its physiological and biochemical characteristics and its 16S rRNA and gyrB gene sequences. The cell suspension and the cell-free supernatant of its culture showed significant antifungal activity against Aspergillus niger, Mucor racemosus, Fusarium oxysporum, Penicillium citrinum, and Candida albicans by agar-diffusion assays. The primary antifungal substances were bacillomycin L, fengycin, and surfactin, which were analyzed by HPLC LC/ESI-MS/MS. Bacillomycin L showed the best inhibitory effect against conidial germination of B. dothidea, followed by fengycin and surfactin. Surfactin had limited effects on mycelial growth, contrary to those of bacillomycin L and fengycin. However, a mixture of the three lipopeptides had a synergistic effect that disrupted the structure of the conidia and mycelia. In order to reduce the production cost, the use of waste frying peanut oil and soy oil as the sole carbon source increased the lipopeptide yield levels by approximately 17% (2.42 g/L) and 110% (4.35 g/L), respectively. In a field trial, the decreases in the infected gummosis rate (IGR) and the disease severity index (DSI) through cell suspension treatments were 20% and 57.5% (in 2014), respectively, and 40% and 57.5% (in 2015), respectively, in comparison with the control. In conclusion, B. amyloliquefaciens SYBC H47 could inhibit the germination of conidia and the growth of mycelia from B. dothidea; therefore, this strain behaves as a potential biocontrol agent against the gummosis disease.	[Li, Xunhang; Zhang, Yanzhou; Wei, Zhiwen; Guan, Zhengbing; Cai, Yujie; Liao, Xiangru] Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Sch Biotechnol, 1800 Lihu Ave, Wuxi 214122, Peoples R China; [Li, Xunhang] Jiangxi Agr Univ, Biosci & Engn Coll, Nanchang 330045, Peoples R China	Jiangnan University; Jiangxi Agricultural University	Liao, XR (corresponding author), Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Sch Biotechnol, 1800 Lihu Ave, Wuxi 214122, Peoples R China.	liaoxiangru@163.com		li, xunhang/0000-0003-4603-8322	Development of Science-technology of agriculture supporting project of Wuxi [CLE01N1310]; Collaborative Innovation Involving Production, Teaching and Research funds of Jiangsu Province [BY2014023-28]; Young Science Fund of Jiangxi Province [20122BAB214027]	Development of Science-technology of agriculture supporting project of Wuxi; Collaborative Innovation Involving Production, Teaching and Research funds of Jiangsu Province; Young Science Fund of Jiangxi Province	This work was funded by the Development of Science-technology of agriculture supporting project of Wuxi (CLE01N1310); Collaborative Innovation Involving Production, Teaching and Research funds of Jiangsu Province (BY2014023-28); and Young Science Fund of Jiangxi Province (20122BAB214027).	Akpa E, 2001, APPL BIOCHEM BIOTECH, V91-3, P551, DOI 10.1385/ABAB:91-93:1-9:551; Aktuganov G, 2014, J CHROMATOGR B, V973, P9, DOI 10.1016/j.jchromb.2014.09.042; Ali Khanzada M, 2005, PAK J BOT, V37, P1023; Alvarez F, 2012, J APPL MICROBIOL, V112, P159, DOI 10.1111/j.1365-2672.2011.05182.x; Aranda FJ, 2005, BBA-BIOMEMBRANES, V1713, P51, DOI 10.1016/j.bbamem.2005.05.003; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Banat IM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00697; Beckman TG, 2003, HORTSCIENCE, V38, P1141, DOI 10.21273/HORTSCI.38.6.1141; Bednarski W, 2004, BIORESOURCE TECHNOL, V95, P15, DOI 10.1016/j.biortech.2004.01.009; Borriss R, 2011, INT J SYST EVOL MICR, V61, P1786, DOI 10.1099/ijs.0.023267-0; Brown JH, 1939, AM J PUBLIC HEALTH N, V29, P404, DOI 10.2105/AJPH.29.4.404; Carrillo C, 2003, BBA-BIOMEMBRANES, V1611, P91, DOI 10.1016/S0005-2736(03)00029-4; Choi SM, 2011, ARCH PHARM RES, V34, P289, DOI 10.1007/s12272-011-0215-z; Chowdhury SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068818; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Damm U, 2007, MYCOLOGIA, V99, P664, DOI 10.3852/mycologia.99.5.664; Deleu M, 2005, J COLLOID INTERF SCI, V283, P358, DOI 10.1016/j.jcis.2004.09.036; Duan YB, 2014, J PEST SCI, V87, P221, DOI 10.1007/s10340-013-0526-6; Dunne C, 1997, MICROBIOL-UK, V143, P3921, DOI 10.1099/00221287-143-12-3921; Fox SL, 2000, BIORESOURCE TECHNOL, V75, P235, DOI 10.1016/S0960-8524(00)00059-6; Frankowski J, 2001, ARCH MICROBIOL, V176, P421, DOI 10.1007/s002030100347; FRIDLENDER M, 1993, SOIL BIOL BIOCHEM, V25, P1211, DOI 10.1016/0038-0717(93)90217-Y; Ghribi D, 2011, AFR J MICROBIOL RES, V5, P4927, DOI 10.5897/AJMR11.1125; Gong AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116871; Guo QG, 2014, MICROBIOL RES, V169, P533, DOI 10.1016/j.micres.2013.12.001; Haba E, 2000, J APPL MICROBIOL, V88, P379, DOI 10.1046/j.1365-2672.2000.00961.x; HOURDOU ML, 1989, LIPIDS, V24, P940, DOI 10.1007/BF02544538; Hutsebaut D, 2006, SYST APPL MICROBIOL, V29, P650, DOI 10.1016/j.syapm.2006.02.001; Idris EE, 2004, Z PFLANZENK PFLANZEN, V111, P583; Islam Md. Rezuanul, 2012, Mycobiology, V40, P59, DOI 10.5941/MYCO.2012.40.1.059; Kumar P, 2012, MICROBIOL RES, V167, P493, DOI 10.1016/j.micres.2012.05.002; Lee HJ, 2008, INT J FOOD MICROBIOL, V126, P240, DOI 10.1016/j.ijfoodmicro.2008.04.030; Ma ZH, 2001, PLANT DIS, V85, P183, DOI 10.1094/PDIS.2001.85.2.183; Madhaiyan M, 2010, INT J SYST EVOL MICR, V60, P2490, DOI 10.1099/ijs.0.015487-0; MAGETDANA R, 1994, TOXICOLOGY, V87, P151, DOI 10.1016/0300-483X(94)90159-7; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Meena KR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/473050; MICHAILIDES TJ, 1991, PHYTOPATHOLOGY, V81, P566, DOI 10.1094/Phyto-81-566; Minaxi, 2012, APPL SOIL ECOL, V59, P124, DOI 10.1016/j.apsoil.2011.08.001; Monaci L, 2016, RAPID COMMUN MASS SP, V30, P45, DOI 10.1002/rcm.7408; Ongena M, 2005, APPL MICROBIOL BIOT, V69, P29, DOI 10.1007/s00253-005-1940-3; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Perneel M, 2007, J APPL MICROBIOL, V103, P1007, DOI 10.1111/j.1365-2672.2007.03345.x; Pluhacek T, 2016, MASS SPECTROM REV, V35, P35, DOI 10.1002/mas.21461; Pradhan AK, 2013, APPL BIOCHEM BIOTECH, V171, P1362, DOI 10.1007/s12010-013-0428-3; Price NPJ, 2007, FEMS MICROBIOL LETT, V271, P83, DOI 10.1111/j.1574-6968.2007.00702.x; PUSEY PL, 1993, PLANT DIS, V77, P170, DOI 10.1094/PD-77-0170; Rajkumar M, 2010, TRENDS BIOTECHNOL, V28, P142, DOI 10.1016/j.tibtech.2009.12.002; Ramesh A, 2013, J VIROL MICROBIOL, V2013, DOI 10.5171/2013.446006; Romero D, 2007, J APPL MICROBIOL, V103, P969, DOI 10.1111/j.1365-2672.2007.03323.x; Romero D, 2007, MOL PLANT MICROBE IN, V20, P430, DOI 10.1094/MPMI-20-4-0430; Shoda M, 2000, J BIOSCI BIOENG, V89, P515, DOI 10.1016/S1389-1723(00)80049-3; Torres MJ, 2016, MICROBIOL RES, V182, P31, DOI 10.1016/j.micres.2015.09.005; Torres MJ, 2015, WORLD J MICROB BIOT, V31, P929, DOI 10.1007/s11274-015-1847-9; Trummler K, 2003, EUR J LIPID SCI TECH, V105, P563, DOI 10.1002/ejlt.200300816; Vance-Harrop MH, 2003, BRAZ J MICROBIOL, V34, P120, DOI 10.1590/S1517-83822003000200006; VanGinkel M, 1996, PLANT DIS, V80, P863, DOI 10.1094/PD-80-0863; Volpon L, 1999, EUR J BIOCHEM, V264, P200, DOI 10.1046/j.1432-1327.1999.00605.x; Waewthongrak W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109386; Wang LT, 2008, INT J SYST EVOL MICR, V58, P671, DOI 10.1099/ijs.0.65191-0; Williams BH, 2002, J MASS SPECTROM, V37, P259, DOI 10.1002/jms.279; YAMAMOTO S, 1995, APPL ENVIRON MICROB, V61, P1104, DOI 10.1128/AEM.61.3.1104-1109.1995; Yang H, 2015, ANAL BIOANAL CHEM, V407, P2529, DOI 10.1007/s00216-015-8486-8; Zhang B, 2013, BBA-BIOMEMBRANES, V1828, P2230, DOI 10.1016/j.bbamem.2013.05.033; Zhao PC, 2014, J BASIC MICROB, V54, P448, DOI 10.1002/jobm.201200414; Zhao YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092486; Zhu Z, 2013, J ENVIRON MANAGE, V127, P96, DOI 10.1016/j.jenvman.2013.04.017	67	26	33	11	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162125	10.1371/journal.pone.0162125	http://dx.doi.org/10.1371/journal.pone.0162125			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583463	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600108
J	Shishavan, MH; Bidadkosh, A; Yazdani, S; Lambooy, S; van den Born, J; Buikema, H; Henning, RH; Deelman, LE				Shishavan, Mahdi Hamidi; Bidadkosh, Arash; Yazdani, Saleh; Lambooy, Sebastiaan; van den Born, Jacob; Buikema, Hendrik; Henning, Robert H.; Deelman, Leo E.			Differential Effects of Long Term FTY720 Treatment on Endothelial versus Smooth Muscle Cell Signaling to S1P in Rat Mesenteric Arteries	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTORS; SPHINGOSINE-1-PHOSPHATE RECEPTOR-2; COX-2 EXPRESSION; INHIBITION; HEART; VASOCONSTRICTION; CONSTRICTION; VASCULATURE; RESISTANCE; MODULATOR	The sphingosine-1-phosphate (S1P) analog FTY720 exerts pleiotropic effects on the cardiovascular system and causes down-regulation of S1P receptors. Myogenic constriction is an important mechanism regulating resistance vessel function and is known to be modulated by S1P. Here we investigated myogenic constriction and vascular function of mesenteric arteries of rats chronically treated with FTY720. Wistar rats received FTY720 1mg/kg/daily for six weeks. At termination, blood pressure was recorded and small mesenteric arteries collected for vascular studies in a perfusion set up. Myogenic constriction to increased intraluminal pressure was low, but a sub-threshold dose of S1P profoundly augmented myogenic constriction in arteries of both controls and animals chronically treated with FTY720. Interestingly, endothelial denudation blocked the response to S1P in arteries of FTY720-treated animals, but not in control rats. In acute experiments, presence of FTY720 significantly augmented the contractile response to S1P, an effect that was partially abolished after the inhibition of cyclooxygenase (COX-)-derived prostaglandins. FTY720 down regulated S1P1 but not S1P2 in renal resistance arteries and in cultured human endothelial cells. This study therefore demonstrates the endothelium is able to compensate for the complete loss of responsiveness of the smooth muscle layer to S1P after long term FTY720 treatment through a mechanism that most likely involves enhanced production of contractile prostaglandins by the endothelium.	[Shishavan, Mahdi Hamidi; Bidadkosh, Arash; Lambooy, Sebastiaan; Buikema, Hendrik; Henning, Robert H.; Deelman, Leo E.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Dept Med, Groningen, Netherlands; [Yazdani, Saleh; van den Born, Jacob] Univ Groningen, Univ Med Ctr Groningen, Div Nephrol, Dept Med, Groningen, Netherlands	University of Groningen; University of Groningen	Shishavan, MH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Dept Med, Groningen, Netherlands.	m.hamidi.shishavan@umcg.nl	Henning, Robert H/AAY-5222-2020; Deelman, Leo/A-9140-2018	Deelman, Leo/0000-0003-1798-8353; Henning, Robert/0000-0002-5135-4621	University Medical Center Groningen	University Medical Center Groningen	The author(s) received funding from University Medical Center Groningen for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2008, J MOL HISTOL, V39, P527, DOI 10.1007/s10735-008-9193-y; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2002, CURR OPIN IMMUNOL, V14, P569, DOI 10.1016/S0952-7915(02)00374-6; Danieli-Betto D, 2010, AM J PHYSIOL-CELL PH, V298, pC550, DOI 10.1152/ajpcell.00072.2009; Delaey C, 2002, EXP EYE RES, V75, P243, DOI 10.1006/exer.2002.2028; Fryer RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052985; Gonzalez-Cabrera Pedro J, 2014, F1000Prime Rep, V6, P109, DOI 10.12703/P6-109; Guan ZR, 2014, J AM SOC NEPHROL, V25, P1774, DOI 10.1681/ASN.2013060656; Ham A, 2014, KIDNEY INT, V85, P807, DOI 10.1038/ki.2013.345; Hoefer J, 2010, CIRC RES, V107, P923, DOI 10.1161/CIRCRESAHA.110.226464; Hsieh HL, 2006, J CELL PHYSIOL, V207, P757, DOI 10.1002/jcp.20621; Huang KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043874; Hui S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138142; Jung B, 2012, DEV CELL, V23, P600, DOI 10.1016/j.devcel.2012.07.015; Kataoka H, 2005, CELL MOL IMMUNOL, V2, P439; Krump-Konvalinkova V, 2005, ARTERIOSCL THROM VAS, V25, P546, DOI 10.1161/01.ATV.0000154360.36106.d9; Lee JF, 2009, AM J PHYSIOL-HEART C, V296, pH33, DOI 10.1152/ajpheart.00097.2008; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Means CK, 2009, CARDIOVASC RES, V82, P193, DOI 10.1093/cvr/cvp086; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Murakami A, 2010, MOL PHARMACOL, V77, P704, DOI 10.1124/mol.109.061481; Ohmori T, 2003, CARDIOVASC RES, V58, P170, DOI 10.1016/S0008-6363(03)00260-8; Peter BF, 2008, CIRC RES, V103, P315, DOI 10.1161/CIRCRESAHA.108.173575; Salomone S, 2008, BRIT J PHARMACOL, V153, P140, DOI 10.1038/sj.bjp.0707581; Samarska IV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097196; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Skoura A, 2007, J CLIN INVEST, V117, P2506, DOI 10.1172/JCI31123; Sobel K, 2013, J BIOL CHEM, V288, P14839, DOI 10.1074/jbc.M112.426726; Spijkers LJA, 2012, BRIT J PHARMACOL, V166, P1411, DOI 10.1111/j.1476-5381.2012.01865.x; Spijkers LJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021817; Vavrinec P, 2011, J RENIN-ANGIO-ALDO S, V12, P184, DOI 10.1177/1470320310391328; Volzke A, 2014, BBA-MOL CELL BIOL L, V1841, P11, DOI 10.1016/j.bbalip.2013.09.009; Wang F, 2010, J CLIN INVEST, V120, P3979, DOI 10.1172/JCI42315; Zimmer J, 2016, PEDIATR SURG INT, V32, P147, DOI 10.1007/s00383-015-3825-6	34	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162029	10.1371/journal.pone.0162029	http://dx.doi.org/10.1371/journal.pone.0162029			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583547	gold, Green Published, Green Submitted			2022-12-26	WOS:000382855600089
J	Ushiki, T; Huntington, ND; Glaser, SP; Kiu, H; Georgiou, A; Zhang, JG; Metcalf, D; Nicola, NA; Roberts, AW; Alexander, WS				Ushiki, Takashi; Huntington, Nicholas D.; Glaser, Stefan P.; Kiu, Hiu; Georgiou, Angela; Zhang, Jian-Guo; Metcalf, Donald; Nicola, Nicos A.; Roberts, Andrew W.; Alexander, Warren S.			Rapid Inflammation in Mice Lacking Both SOCS1 and SOCS3 in Hematopoietic Cells	PLOS ONE			English	Article							CYTOKINE SIGNALING SOCS; IN-VITRO; T-CELLS; SUPPRESSOR; INHIBITION; LETHALITY; PATHWAYS; PROTEINS; ABSENCE; VIVO	The Suppressors of Cytokine Signalling (SOCS) proteins are negative regulators of cytokine signalling required to prevent excess cellular responses. SOCS1 and SOCS3 are essential to prevent inflammatory disease, SOCS1 by attenuating responses to IFN gamma and gamma-common (gamma c) cytokines, and SOCS3 via regulation of G-CSF and IL-6 signalling. SOCS1 and SOCS3 show significant sequence homology and are the only SOCS proteins to possess a KIR domain. The possibility of overlapping or redundant functions was investigated in inflammatory disease via generation of mice lacking both SOCS1 and SOCS3 in hematopoietic cells. Loss of SOCS3 significantly accelerated the pathology and inflammatory disease characteristic of SOCS1 deficiency. We propose a model in which SOCS1 and SOCS3 operate independently to control specific cytokine responses and together modulate the proliferation and activation of lymphoid and myeloid cells to prevent rapid inflammatory disease.	[Ushiki, Takashi; Glaser, Stefan P.; Kiu, Hiu; Georgiou, Angela; Zhang, Jian-Guo; Metcalf, Donald; Nicola, Nicos A.; Roberts, Andrew W.; Alexander, Warren S.] Walter & Eliza Hall Inst Med Res, Canc & Haematol Div, Parkville, Vic, Australia; [Huntington, Nicholas D.] Walter & Eliza Hall Inst Med Res, Mol Immunol Div, Parkville, Vic, Australia; [Ushiki, Takashi] Niigata Univ, Div Transfus & Regenerat Med, Med & Dent Hosp, Niigata, Japan; [Huntington, Nicholas D.; Glaser, Stefan P.; Zhang, Jian-Guo; Metcalf, Donald; Nicola, Nicos A.; Roberts, Andrew W.; Alexander, Warren S.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia	Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; Niigata University; University of Melbourne	Alexander, WS (corresponding author), Walter & Eliza Hall Inst Med Res, Canc & Haematol Div, Parkville, Vic, Australia.; Alexander, WS (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.	alexandw@wehi.edu.au	Roberts, Andrew W./C-6736-2012; Huntington, NICHOLAS/AAV-4704-2020	Roberts, Andrew W./0000-0002-7341-5720; Huntington, NICHOLAS/0000-0002-5267-7211	Australian National Health and Medical Research Council (NHMRC) [361646, 1016647, 1058344, 0461276, 1078737, 637309, 1079560]; Victorian State Government Operational Infrastructure Support Grant; Australia Cancer Research Fund	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support Grant; Australia Cancer Research Fund	This work was supported by a Program Grant (1016647), Fellowships (WSA:1058344, NDH:0461276, NAN:1078737, AWR:637309, 1079560) and an Independent Research Institutes Infrastructure Support Scheme Grant (361646) from the Australian National Health and Medical Research Council (NHMRC, https://www.nhmrc.gov.au), a Victorian State Government Operational Infrastructure Support Grant and the Australia Cancer Research Fund (https://acrf.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed CMI, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00183; Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Anastassiadis K, 2010, METHOD ENZYMOL, V477, P109, DOI 10.1016/S0076-6879(10)77007-5; Brysha M, 2001, J BIOL CHEM, V276, P22086, DOI 10.1074/jbc.M102737200; Carow B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00058; CHERVENICK PA, 1968, AM J PHYSIOL, V215, P353, DOI 10.1152/ajplegacy.1968.215.2.353; Cornish AL, 2003, J BIOL CHEM, V278, P22755, DOI 10.1074/jbc.M303021200; Cornish AL, 2003, J IMMUNOL, V170, P878, DOI 10.4049/jimmunol.170.2.878; Croker BA, 2004, IMMUNITY, V20, P153, DOI 10.1016/S1074-7613(04)00022-6; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Croker BA, 2012, IMMUNOL CELL BIOL, V90, P124, DOI 10.1038/icb.2011.29; Croom HA, 2008, MOL IMMUNOL, V45, P2888, DOI 10.1016/j.molimm.2008.01.024; Davey GM, 2005, J EXP MED, V202, P1099, DOI 10.1084/jem.20050003; Kershaw NJ, 2013, BIOCHEM SOC T, V41, P1042, DOI 10.1042/BST20130077; Kershaw NJ, 2013, NAT STRUCT MOL BIOL, V20, P469, DOI 10.1038/nsmb.2519; Kiu H, 2007, GROWTH FACTORS, V25, P319, DOI 10.1080/08977190701830151; Kiu H, 2009, GROWTH FACTORS, V27, P384, DOI 10.3109/08977190903210954; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Metcalf D, 2002, P NATL ACAD SCI USA, V99, P943, DOI 10.1073/pnas.022628499; Roberts AW, 2001, P NATL ACAD SCI USA, V98, P9324, DOI 10.1073/pnas.161271798; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Takahashi R, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/943149; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; Ushiki T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011114; Wormald S, 2006, J BIOL CHEM, V281, P11135, DOI 10.1074/jbc.M509595200	27	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162111	10.1371/journal.pone.0162111	http://dx.doi.org/10.1371/journal.pone.0162111			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583437	Green Published, gold			2022-12-26	WOS:000382855600106
J	Wermuth, PJ; Li, ZD; Mendoza, FA; Jimenez, SA				Wermuth, Peter J.; Li, Zhaodong; Mendoza, Fabian A.; Jimenez, Sergio A.			Stimulation of Transforming Growth Factor-beta 1-Induced Endothelial-To-Mesenchymal Transition and Tissue Fibrosis by Endothelin-1 (ET-1): A Novel Profibrotic Effect of ET-1	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; FACTOR-BETA; SYSTEMIC-SCLEROSIS; TGF-BETA; CARDIAC FIBROSIS; FIBROTIC DISEASES; FACTOR EXPRESSION; LUNG FIBROBLASTS; KIDNEY FIBROSIS; IN-VITRO	TGF-beta-induced endothelial-to-mesenchymal transition (EndoMT) is a newly recognized source of profibrotic activated myofibroblasts and has been suggested to play a role in the pathogenesis of various fibrotic processes. Endothelin-1 (ET-1) has been implicated in the development of tissue fibrosis but its participation in TGF-beta-induced EndoMT has not been studied. Here we evaluated the role of ET-1 on TGF-beta 1-induced EndoMT in immunopurified CD31(+)/CD102(+) murine lung microvascular endothelial cells. The expression levels of alpha-smooth muscle actin (alpha-SMA), of relevant profibrotic genes, and of various transcription factors involved in the EndoMT process were assessed employing quantitative RT-PCR, immunofluorescence histology and Western blot analysis. TGF-beta 1 caused potent induction of EndoMT whereas ET-1 alone had a minimal effect. However, ET-1 potentiated TGF-beta 1-induced EndoMT and TGF-beta 1-stimulated expression of mesenchymal cell specific and profibrotic genes and proteins. ET-1 also induced expression of the TGF-beta receptor 1 and 2 genes, suggesting a plausible autocrine mechanism to potentiate TGF-beta-mediated EndoMT and fibrosis. Stimulation of TGF-beta 1-induced skin and lung fibrosis by ET-1 was confirmed in vivo in an animal model of TGF-beta 1-induced tissue fibrosis. These results suggest a novel role for ET-1 in the establishment and progression of tissue fibrosis.	[Wermuth, Peter J.; Li, Zhaodong; Jimenez, Sergio A.] Thomas Jefferson Univ, Jefferson Inst Mol Med, Philadelphia, PA 19107 USA; [Mendoza, Fabian A.] Thomas Jefferson Univ, Div Rheumatol, Dept Med, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Jimenez, SA (corresponding author), Thomas Jefferson Univ, Jefferson Inst Mol Med, Philadelphia, PA 19107 USA.	Sergio.jimenez@jefferson.edu		Wermuth, Peter/0000-0002-0242-7265; Jimenez, Sergio/0000-0001-5213-1203	National Institutes of Health [AR19616]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by AR19616 National Institutes of Health www.nih.gov SAJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham David, 2005, Current Vascular Pharmacology, V3, P369; Arciniegas E, 2005, ENDOTHELIUM-J ENDOTH, V12, P193, DOI 10.1080/10623320500227283; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Chester Adrian H, 2014, Glob Cardiol Sci Pract, V2014, P62, DOI 10.5339/gcsp.2014.29; Cipriani P, 2015, J RHEUMATOL, V42, P1808, DOI 10.3899/jrheum.150088; Cutolo M, 2015, J RHEUMATOL, V42, P456, DOI 10.3899/jrheum.141070; Darby IA, 2016, CELL MOL LIFE SCI, V73, P1145, DOI 10.1007/s00018-015-2110-0; Good RB, 2015, AM J PATHOL, V185, P1850, DOI 10.1016/j.ajpath.2015.03.019; Goumans MJ, 2008, TRENDS CARDIOVAS MED, V18, P293, DOI 10.1016/j.tcm.2009.01.001; Herzog EL, 2010, EXP HEMATOL, V38, P548, DOI 10.1016/j.exphem.2010.03.004; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Jain R, 2007, AM J RESP CELL MOL, V37, P38, DOI 10.1165/rcmb.2006-0353OC; Jimenez SA, 2016, MATRIX BIOL, V51, P26, DOI 10.1016/j.matbio.2016.01.012; Jing J, 2015, EUR CYTOKINE NETW, V26, P10, DOI 10.1684/ecn.2015.0360; Kawanabe Y, 2011, CELL MOL LIFE SCI, V68, P195, DOI 10.1007/s00018-010-0518-0; Kramann R, 2013, J PATHOL, V231, P273, DOI 10.1002/path.4253; Lagares D, 2010, ARTHRITIS RHEUM-US, V62, P878, DOI 10.1002/art.27307; Lambers C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073399; Leask A, 2015, CIRC RES, V116, P1269, DOI 10.1161/CIRCRESAHA.116.305381; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lee K, 2012, INT REV CEL MOL BIO, V294, P171, DOI 10.1016/B978-0-12-394305-7.00004-5; Li JH, 2010, NEPHROLOGY, V15, P507, DOI 10.1111/j.1440-1797.2010.01319.x; Li MR, 2016, EXP BIOL MED, V241, P1, DOI 10.1177/1535370215597194; Li ZD, 2013, AM J PATHOL, V182, P325, DOI 10.1016/j.ajpath.2012.10.022; Li ZD, 2011, ARTHRITIS RHEUM-US, V63, P2473, DOI 10.1002/art.30317; Makino K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097972; Manne J, 2013, BIOCHEM RES INT, V2013, DOI 10.1155/2013/436053; Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1; MASAKI T, 1989, J CARDIOVASC PHARM, V13, pS1, DOI 10.1097/00005344-198900135-00002; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Medici D, 2001, BIOCHEM J, V437, P515; Mendoza FA, 2016, ARTHRITIS RHEUMATOL, V68, P210, DOI 10.1002/art.39421; Papadopulos F, 2007, ULTRASTRUCT PATHOL, V31, P401, DOI 10.1080/01913120701719189; Piera-Velazquez S, 2016, J CLIN MED, V5, DOI 10.3390/jcm5040045; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Postlethwaite AE, 2004, CURR OPIN RHEUMATOL, V16, P733, DOI 10.1097/01.bor.0000139310.77347.9c; Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144; Ranchoux B, 2015, CIRCULATION, V131, P1006, DOI 10.1161/CIRCULATIONAHA.114.008750; Recchia AG, 2009, J MOL CELL CARDIOL, V46, P352, DOI 10.1016/j.yjmcc.2008.11.017; Rieder F, 2011, AM J PATHOL, V179, P2660, DOI 10.1016/j.ajpath.2011.07.042; ROBERTS AB, 1990, PHILOS T R SOC B, V327, P145, DOI 10.1098/rstb.1990.0050; Rodriguez-Pascual F, 2014, LIFE SCI, V118, P156, DOI 10.1016/j.lfs.2013.12.024; Shao DM, 2011, PHARMACOL RES, V63, P504, DOI 10.1016/j.phrs.2011.03.003; Shephard P, 2004, THROMB HAEMOSTASIS, V92, P262, DOI 10.1160/TH03-11-0669; Simonson MS, 2011, J BIOL CHEM, V286, P11003, DOI 10.1074/jbc.M110.190793; SPORN MB, 1986, SCIENCE, V233, P532, DOI 10.1126/science.3487831; Strieter RM, 2009, J LEUKOCYTE BIOL, V86, P1111, DOI 10.1189/jlb.0309132; Swigris JJ, 2010, BIODRUGS, V24, P49, DOI 10.2165/11319550-000000000-00000; ten Dijke P, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002722; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; van Meeteren LA, 2012, CELL TISSUE RES, V347, P177, DOI 10.1007/s00441-011-1222-6; VARGA J, 1987, BIOCHEM J, V247, P597, DOI 10.1042/bj2470597; Varga John, 2009, Front Biosci (Schol Ed), V1, P226, DOI 10.2741/s22; Weng CM, 2014, BIOCHEM PHARMACOL, V88, P402, DOI 10.1016/j.bcp.2014.01.030; Widyantoro B, 2010, CIRCULATION, V121, P2407, DOI 10.1161/CIRCULATIONAHA.110.938217; Xu SW, 2007, MATRIX BIOL, V26, P625, DOI 10.1016/j.matbio.2007.06.003; Xu SW, 2004, MOL BIOL CELL, V15, P2707, DOI 10.1091/mbc.E03-12-0902; Xu SW, 2004, J BIOL CHEM, V279, P23098, DOI 10.1074/jbc.M311430200; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513	63	57	58	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161988	10.1371/journal.pone.0161988	http://dx.doi.org/10.1371/journal.pone.0161988			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583804	Green Published, gold, Green Submitted			2022-12-26	WOS:000382855600081
J	Zhu, H; Wang, NJ; Han, B; Li, Q; Chen, Y; Zhu, CF; Chen, YC; Xia, FZ; Cang, Z; Lu, M; Chen, C; Lin, DP; Lu, YL				Zhu, Hui; Wang, Ningjian; Han, Bing; Li, Qin; Chen, Yi; Zhu, Chunfang; Chen, Yingchao; Xia, Fangzhen; Cang, Zhen; Lu, Meng; Chen, Chi; Lin, Dongping; Lu, Yingli			Low Sex Hormone-Binding Globulin Levels Associate with Prediabetes in Chinese Men Independent of Total Testosterone	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; RISK-FACTORS; METABOLIC SYNDROME; OBESE MEN; WOMEN; PREVALENCE; INSULIN; GLUCOSE; HYPOGONADISM; PREDICTOR	Objective The association ns between prediabetes and androgens have been rarely reported, especially in Chinese men. We aimed to investigate whether androgens were associated with the prevalence of prediabetes diagnosed with new American Diabetes Association criteria in Chinese men and then to assess which androgen value was the most relevant factor. Methods A total of 2654 men (52.6 +/- 13.4 years old) were selected. Serum total testosterone (TT), sex hormone-binding globulin (SHBG) and free testosterone (FT) were measured. Covariance analysis of different androgen values were performed in age subgroups. Multinomial logistic regression was used for the association of TT, SHBG and FT with prediabetes and diabetes, as well as prediabetes in age subgroups. Results According to ADA new criteria, normoglycemia, prediabetes, and diabetes were diagnosed in 1405, 907 and 342 men, respectively. In covariance analysis, SHBG of prediabetes were found lower than that of normoglycemia but higher than that of diabetes (P <0.05). In multi-nomial logistic regression, serum TT and SHBG were inversely associated with prediabetes and diabetes. While, after full adjustment for age, residence area, economic status, waist circumference, metabolic factors, other two androgen values and HOMA-IR, only the associations of SHBG with prevalence of prediabetes and diabetes persisted statistically significant, especially in the elderly with prediabetes (all P for trend <0.05). Conclusions Serum androgen was inversely associated with prediabetes and diabetes in Chinese men. Low serum SHBG was the most relevant factor for prediabetes and diabetes. Whether it is an independent predictor for incident prediabetes in Chinese men needs further explorations.	[Zhu, Hui; Wang, Ningjian; Han, Bing; Li, Qin; Chen, Yi; Zhu, Chunfang; Chen, Yingchao; Xia, Fangzhen; Cang, Zhen; Lu, Meng; Chen, Chi; Lin, Dongping; Lu, Yingli] Shanghai Jiao Tong Univ, Sch Med, Inst & Dept Endocrinol & Metab, Shanghai Peoples Hosp 9, Shanghai 200011, Peoples R China	Shanghai Jiao Tong University	Lu, YL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst & Dept Endocrinol & Metab, Shanghai Peoples Hosp 9, Shanghai 200011, Peoples R China.	luyingli2008@126.com						Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Botella-Carretero JI, 2013, J ENDOCRINOL INVEST, V36, P227, DOI 10.3275/8469; Brambilla DJ, 2007, CLIN ENDOCRINOL, V67, P853, DOI 10.1111/j.1365-2265.2007.02976.x; Brand JS, 2011, CLIN ENDOCRINOL, V74, P572, DOI 10.1111/j.1365-2265.2010.03951.x; Cavalot F, 2006, J CLIN ENDOCR METAB, V91, P813, DOI 10.1210/jc.2005-1005; Corona G, 2011, INT J ANDROL, V34, P528, DOI 10.1111/j.1365-2605.2010.01117.x; Ding EL, 2007, DIABETOLOGIA, V50, P2076, DOI 10.1007/s00125-007-0785-y; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Ding EL, 2009, NEW ENGL J MED, V361, P1152, DOI 10.1056/NEJMoa0804381; Farias JM, 2014, J CLIN ENDOCR METAB, V99, P4698, DOI 10.1210/jc.2014-2585; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Grossmann M, 2008, J CLIN ENDOCR METAB, V93, P1834, DOI 10.1210/jc.2007-2177; Grossmann M, 2011, J CLIN ENDOCR METAB, V96, P2341, DOI 10.1210/jc.2011-0118; Haider A, 2014, OBES RES CLIN PRACT, V8, pE339, DOI 10.1016/j.orcp.2013.10.005; Ho CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074173; Kalyani RR, 2009, J CLIN ENDOCR METAB, V94, P4127, DOI 10.1210/jc.2009-0910; Kapoor D, 2007, DIABETES CARE, V30, P911, DOI 10.2337/dc06-1426; Laaksonen DE, 2004, DIABETES CARE, V27, P1036, DOI 10.2337/diacare.27.5.1036; Lakshman KM, 2010, J GERONTOL A-BIOL, V65, P503, DOI 10.1093/gerona/glq002; Le TN, 2012, TRENDS ENDOCRIN MET, V23, P32, DOI 10.1016/j.tem.2011.09.005; NIELSEN J, 1969, J CLIN ENDOCR METAB, V29, P1062, DOI 10.1210/jcem-29-8-1062; Oh JY, 2002, DIABETES CARE, V25, P55, DOI 10.2337/diacare.25.1.55; Peter A, 2010, DIABETES, V59, P3167, DOI 10.2337/db10-0179; Rabijewski M, 2014, AGING MALE, V17, P141, DOI 10.3109/13685538.2014.936000; Reynolds K, 2007, OBESITY, V15, P10, DOI 10.1038/oby.2007.527; Salminen M, 2015, GERIATR GERONTOL INT, V15, P559, DOI 10.1111/ggi.12312; Saukkonen T, 2011, DIABETES CARE, V34, P2314, DOI 10.2337/dc11-0183; Selva DM, 2007, J CLIN INVEST, V117, P3979, DOI 10.1172/JCI32249; Simo R, 2012, DIABETES, V61, P372, DOI 10.2337/db11-0727; Stefan N, 2013, NAT REV ENDOCRINOL, V9, P144, DOI 10.1038/nrendo.2012.258; Stefan N, 2009, NEW ENGL J MED, V361, P2675, DOI 10.1056/NEJMc0910143; Stellato RK, 2000, DIABETES CARE, V23, P490, DOI 10.2337/diacare.23.4.490; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Tanabe M, 2014, ENDOCR J; Vikan T, 2010, EUR J ENDOCRINOL, V162, P747, DOI 10.1530/EJE-09-0943; Wang C, 2011, DIABETES CARE, V34, P1669, DOI 10.2337/dc10-2339; Wang N, 2015, ACTA DIABETOL, V12, P12; Xu L, 2014, AM J HUM BIOL, V26, P99, DOI 10.1002/ajhb.22482; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Zarotsky V, 2014, ANDROLOGY-US, V2, P819, DOI 10.1111/andr.274	40	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162004	10.1371/journal.pone.0162004	http://dx.doi.org/10.1371/journal.pone.0162004			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583401	Green Published, gold, Green Submitted			2022-12-26	WOS:000382855600085
J	Hajian, B; Scocchera, E; Keshipeddy, S; G-Dayanandan, N; Shoen, C; Krucinska, J; Reeve, S; Cynamon, M; Anderson, AC; Wright, DL				Hajian, Behnoush; Scocchera, Eric; Keshipeddy, Santosh; G-Dayanandan, Narendran; Shoen, Carolyn; Krucinska, Jolanta; Reeve, Stephanie; Cynamon, Michael; Anderson, Amy C.; Wright, Dennis L.			Propargyl-Linked Antifolates Are Potent Inhibitors of Drug-Sensitive and Drug-Resistant Mycobacterium tuberculosis	PLOS ONE			English	Article							DIHYDROFOLATE-REDUCTASE; CRYSTAL-STRUCTURES; CANDIDA-ALBICANS; REVEAL; LOPINAVIR/RITONAVIR; PERMEABILITY; MECHANISMS; FEATURES; DESIGN; TOOL	Mycobacterium tuberculosis continues to cause widespread, life-threatening disease. In the last decade, this threat has grown dramatically as multi-and extensively-drug resistant (MDR and XDR) bacteria have spread globally and the number of agents that effectively treat these infections is significantly reduced. We have been developing the propargyl-linked antifolates (PLAs) as potent inhibitors of the essential enzyme dihydrofolate reductase (DHFR) from bacteria and recently found that charged PLAs with partial zwitterionic character showed improved mycobacterial cell permeability. Building on a hypothesis that these PLAs may penetrate the outer membrane of M. tuberculosis and inhibit the essential cytoplasmic DHFR, we screened a group of PLAs for antitubercular activity. In this work, we identified several PLAs as potent inhibitors of the growth of M. tuberculosis with several of the compounds exhibiting minimum inhibition concentrations equal to or less than 1 mu g/mL. Furthermore, two of the compounds were very potent inhibitors of MDR and XDR strains. A high resolution crystal structure of one PLA bound to DHFR from M. tuberculosis reveals the interactions of the ligands with the target enzyme.	[Hajian, Behnoush; Scocchera, Eric; Keshipeddy, Santosh; G-Dayanandan, Narendran; Krucinska, Jolanta; Reeve, Stephanie; Anderson, Amy C.; Wright, Dennis L.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA; [Shoen, Carolyn; Cynamon, Michael] Vet Affairs Med Ctr, Syracuse, NY USA	University of Connecticut; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Anderson, AC; Wright, DL (corresponding author), Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA.	amy.anderson@uconn.edu; dennis.wright@uconn.edu	Reeve, Stephanie/P-9563-2018; Reeve, Stephanie/AAX-8449-2020	Reeve, Stephanie/0000-0003-2064-405X; Reeve, Stephanie/0000-0003-2064-405X; Wright, Dennis/0000-0003-4634-3351	National Institutes of Health [AI104841, AI111957]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI111957, R01AI104841] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI104841 and AI111957 to ACA and DLW, https://projectreporter.nih.gov/project_info_description.cfm?aid=8960331&icde=29395386&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC, https://projectreporter.nih.gov/project_info_description.cfm?aid=8997401&icde=29395386&ddparam=& ddvalue=&ddsub=& cr=csb=default&cs=ASC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Balasubramanian V, 2014, ANTIMICROB AGENTS CH, V58, P495, DOI 10.1128/AAC.01903-13; Cipriani P, 2014, EXPERT REV CLIN IMMU, V10, P1519, DOI 10.1586/1744666X.2014.962996; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frey KM, 2012, ANTIMICROB AGENTS CH, V56, P3556, DOI 10.1128/AAC.06263-11; Frey KM, 2010, J STRUCT BIOL, V170, P93, DOI 10.1016/j.jsb.2009.12.011; Frey KM, 2009, J MOL BIOL, V387, P1298, DOI 10.1016/j.jmb.2009.02.045; G-Dayanandan N, 2014, J MED CHEM, V57, P2643, DOI 10.1021/jm401916j; Galagan JE, 2014, NAT REV GENET, V15, P307, DOI 10.1038/nrg3664; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gillespie SH, 2002, ANTIMICROB AGENTS CH, V46, P267, DOI 10.1128/AAC.46.2.267-274.2002; Hagner Nicole, 2010, Cancer Manag Res, V2, P293, DOI 10.2147/CMR.S10043; Hong W, 2015, SCI REPORTS, V5, P1; Keshipeddy S, 2015, J AM CHEM SOC, V137, P8983, DOI 10.1021/jacs.5b01442; Khachi H, 2009, J ANTIMICROB CHEMOTH, V64, P871, DOI 10.1093/jac/dkp263; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Kumar A, 2015, ACS INFECT DIS, V1, P604, DOI 10.1021/acsinfecdis.5b00063; Kumar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039961; L'homme RFA, 2009, AIDS, V23, P863, DOI 10.1097/QAD.0b013e328329148e; Lamb KM, 2014, ANTIMICROB AGENTS CH, V58, P7484, DOI 10.1128/AAC.03555-14; Lamb KM, 2013, BIOCHEMISTRY-US, V52, P7318, DOI 10.1021/bi400852h; Lee SH, 2013, MOLECULES, V18, P13870, DOI 10.3390/molecules181113870; Lele AC, 2015, ACS MED CHEM LETT, V6, P1140, DOI 10.1021/acsmedchemlett.5b00367; Li RB, 2000, J MOL BIOL, V295, P307, DOI 10.1006/jmbi.1999.3328; Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007; Lombardo M, 2015, ACS INF DIS; Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Merget B, 2013, BIOINFORMATICS, V29, P62, DOI 10.1093/bioinformatics/bts641; Nixon MR, 2014, CHEM BIOL, V21, P819, DOI 10.1016/j.chembiol.2014.04.009; Paulsen JL, 2013, BIOORG MED CHEM LETT, V23, P1279, DOI 10.1016/j.bmcl.2013.01.008; Paulsen JL, 2011, CHEM BIOL DRUG DES, V78, P505, DOI 10.1111/j.1747-0285.2011.01169.x; Ruslami R, 2010, ANTIMICROB AGENTS CH, V54, P1068, DOI 10.1128/AAC.00447-09; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scocchera E, 2016, ACS MED CHEM LETT, V7, P692, DOI 10.1021/acsmedchemlett.6b00120; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; Viswanathan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029434; Zhou WD, 2013, MEDCHEMCOMM, V4, P908, DOI 10.1039/c3md00104k	41	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161740	10.1371/journal.pone.0161740	http://dx.doi.org/10.1371/journal.pone.0161740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580226	gold, Green Published, Green Submitted			2022-12-26	WOS:000382877400039
J	Bzdega, K; Janlak, A; Kslazczyk, T; Lewandowska, A; Gancarek, M; Sliwinska, E; Tokarska-Guzik, B				Bzdega, Katarzyna; Janlak, Agnieszka; Kslazczyk, Tomasz; Lewandowska, Agata; Gancarek, Malgorzata; Sliwinska, Elwira; Tokarska-Guzik, Barbara			A Survey of Genetic Variation and Genome Evolution within the Invasive Fallopia Complex	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; POLYMORPHISM AFLP MARKERS; SEX-CHROMOSOME SYSTEM; HOUTT. RONSE DECR.; POLYGONACEAE COMPLEX; SPP. POLYGONACEAE; MULTIPLE SOURCES; BRASSICA-NAPUS; CENTRAL-EUROPE; DNA-SEQUENCES	The knotweed taxa Fallopia japonica, F. sachalinensis and their interspecific hybrid F. x bohemica are some of the most aggressive invaders in Europe and North America and they are serious threats to native biodiversity. At the same time, they constitute a unique model system for the creation of hybrids and studies of the initiation of evolutionary processes. In the presented study, we focused on (i) examining genetic diversity in selected populations of three Fallopia taxa in the invaded (Poland) and native ranges (Japan), (ii) establishing genome size and ploidy levels and (iii) identifying ribosomal DNA (rDNA)-bearing chromosomes in all of the taxa from the invaded range. We found that the genetic diversity within particular taxa was generally low regardless of their geographical origin. A higher level of clonality was observed for the Polish populations compared to the Japanese populations. Our study suggests that the co-occurrence of F. sachalinensis together with the other two taxa in the same stand may be the source of the higher genetic variation within the F. x bohemica hybrid. Some shift towards the contribution of F. japonica alleles was also observed for selected F. x bohemica individuals, which indicates the possibility of producing more advanced generations of F. x bohemica hybrids. All of the F. sachalinensis individuals were hexaploid (2n = 6x = 66; 2C = 6.01 pg), while those of F. japonica were mostly octoploid (2n = 8x = 88; 2C = 8.87 pg) and all of the F. x bohemica plants except one were hexaploid (2n = 6x = 66; 2C = 6.46 pg). Within the chromosome complement of F. japonica, F. sachalinensis and F. x bohemica, the physical mapping of the rDNA loci provided markers for 16, 13 and 10 chromosomes, respectively. In F. x bohemica, a loss of some of rDNA loci was observed, which indicates the occurrence of genome changes in the hybrid.	[Bzdega, Katarzyna; Lewandowska, Agata; Gancarek, Malgorzata; Tokarska-Guzik, Barbara] Univ Silesia, Dept Bot & Nat Protect, Katowice, Poland; [Janlak, Agnieszka] Univ Silesia, Dept Genet, Katowice, Poland; [Kslazczyk, Tomasz] Polish Acad Sci, Inst Plant Genet, Dept Environm Stress Biol, Poznan, Poland; [Sliwinska, Elwira] UTP Univ Sci & Technol, Dept Plant Genet Physiol & Biotechnol, Bydgoszcz, Poland	University of Silesia in Katowice; University of Silesia in Katowice; Polish Academy of Sciences; Institute of Plant Genetics of the Polish Academy of Sciences; Bydgoszcz University of Science & Technology	Bzdega, K (corresponding author), Univ Silesia, Dept Bot & Nat Protect, Katowice, Poland.	katarzyna.bzdega@us.edu.pl	Tokarska-Guzik, Barbara/L-8891-2019; Sliwinska, Elwira K/J-3920-2019	Sliwinska, Elwira K/0000-0001-6597-5309; Tokarska-Guzik, Barbara/0000-0002-4058-1220; Bzdega, Katarzyna/0000-0002-4603-2847; Janiak, Agnieszka/0000-0003-0225-7216	Ministry of Science and Higher Education, Poland [N N305 384738]	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland)	This work was supported by N N305 384738 of 2010-2014, Ministry of Science and Higher Education, Poland, http://www.nauka.gov.pl/en/.	Amsellem L, 2000, MOL ECOL, V9, P443, DOI 10.1046/j.1365-294x.2000.00876.x; [Anonymous], 2005, PHYLIP PHYLOGENY INF; Bailey J, 2013, HEREDITY, V110, P105, DOI 10.1038/hdy.2012.98; Bailey J, 2003, PLANT INVASIONS: ECOLOGICAL THREATS AND MANAGEMENT SOLUTIONS, P183; Bailey J. P., 2000, Watsonia, V23, P93; Bailey JP, 2007, ECOL RES, V22, P920, DOI 10.1007/s11284-007-0419-3; Bailey JP, 2009, BIOL INVASIONS, V11, P1189, DOI 10.1007/s10530-008-9381-4; BAILEY JP, 1992, PLANT SYST EVOL, V180, P29, DOI 10.1007/BF00940396; Barney JN, 2006, CAN J PLANT SCI, V86, P887, DOI 10.4141/P05-170; BEERLING DJ, 1994, J ECOL, V82, P959, DOI 10.2307/2261459; Blocka-Wandas M, 2007, SEX PLANT REPROD, V20, P171, DOI 10.1007/s00497-007-0053-9; Buhk C, 2015, PERSPECT PLANT ECOL, V17, P274, DOI 10.1016/j.ppees.2015.05.001; Bzdega K, 2012, FLORA, V207, P636, DOI 10.1016/j.flora.2012.05.002; CHILD L, 2000, JAPANESE KNOTWEED MA; Choi JH, 2000, BIOINFORMATICS, V16, P1056, DOI 10.1093/bioinformatics/16.11.1056; Chrtek J., 1983, CASOPIS NARODNIHO MU, V152, P120; Datson PM, 2006, CHROMOSOME RES, V14, P845, DOI 10.1007/s10577-006-1092-z; Dlugosch KM, 2008, MOL ECOL, V17, P4583, DOI 10.1111/j.1365-294X.2008.03932.x; Dlugosch KM, 2008, ECOL LETT, V11, P701, DOI 10.1111/j.1461-0248.2008.01181.x; Doyle J. J., 1987, PHYTOCHEM B, P11; Du ZY, 2009, AQUAT BOT, V91, P47, DOI 10.1016/j.aquabot.2009.02.006; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; EXCOFFIER L, 1992, GENETICS, V131, P479; Fukui S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116111; Gammon MA, 2007, AM J BOT, V94, P948, DOI 10.3732/ajb.94.6.948; Garcia S, 2009, CHROMOSOMA, V118, P85, DOI 10.1007/s00412-008-0179-z; Gaskin JF, 2014, BIOL INVASIONS, V16, P2127, DOI 10.1007/s10530-014-0652-y; Genton BJ, 2005, MOL ECOL, V14, P4275, DOI 10.1111/j.1365-294X.2005.02750.x; GERLACH WL, 1980, NUCLEIC ACIDS RES, V8, P4851, DOI 10.1093/nar/8.21.4851; Gibbs Russell G. E., 1987, BOT SURV S AFRICA 1, V2, P1; Grabowska-Joachimiak A, 2015, CHROMOSOME RES, V23, P187, DOI 10.1007/s10577-014-9446-4; Grimsby JL, 2007, AM J BOT, V94, P957, DOI 10.3732/ajb.94.6.957; Hasterok R, 2006, ANN BOT-LONDON, V97, P205, DOI 10.1093/aob/mcj031; Henry P, 2009, MOL ECOL, V18, P2819, DOI 10.1111/j.1365-294X.2009.04237.x; Hollingsworth ML, 1998, MOL ECOL, V7, P1681, DOI 10.1046/j.1365-294x.1998.00498.x; Jager EJ, 1995, SCHR R VEGETAT KDE, V27, P395; Komuro S, 2013, GENOME, V56, P131, DOI 10.1139/gen-2013-0003; Krebs C, 2010, PLANT BIOLOGY, V12, P215, DOI 10.1111/j.1438-8677.2009.00219.x; Ksiazczyk T, 2015, PROTOPLASMA, V252, P985, DOI 10.1007/s00709-014-0734-9; Ksiazczyk T, 2011, CHROMOSOMA, V120, P557, DOI 10.1007/s00412-011-0331-z; Lembicz M, 2011, FLORA, V206, P792, DOI 10.1016/j.flora.2011.04.006; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Malinska H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-291; Mandak B, 2005, PLANT SYST EVOL, V253, P219, DOI 10.1007/s00606-005-0316-6; Mandak B, 2003, ANN BOT-LONDON, V92, P265, DOI 10.1093/aob/mcg141; Matesanz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093217; Mishima M, 2002, CHROMOSOMA, V110, P550, DOI 10.1007/s00412-001-0175-z; Novak SJ, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P201; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Owen S. J., 1996, ECOLOGICAL WEEDS CON; Parepa M, 2014, EVOL APPL, V7, P413, DOI 10.1111/eva.12139; Pedrosa-Harand A, 2006, THEOR APPL GENET, V112, P924, DOI 10.1007/s00122-005-0196-8; PIELOU E C, 1969, P286; PYSEK P, 1993, J BIOGEOGR, V20, P413, DOI 10.2307/2845589; Pysek P, 2013, INVAD NAT SPRING SER, V7, P209, DOI 10.1007/978-94-007-7750-7_11; Richards CL, 2008, AM J BOT, V95, P931, DOI 10.3732/ajb.2007364; Richards CL, 2012, ECOL LETT, V15, P1016, DOI 10.1111/j.1461-0248.2012.01824.x; Richards Moorehead & Laing Ltd, 1990, JAP KNOTW REYN JAP W; Rosenthal DM, 2008, MOL ECOL, V17, P4657, DOI 10.1111/j.1365-294X.2008.03844.x; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Saldana A, 2009, GAYANA BOT, V66, P283; Schluter PM, 2006, MOL ECOL NOTES, V6, P569, DOI 10.1111/j.1471-8286.2006.01225.x; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; Stout JC, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plu087; Suda J, 2010, PRESLIA, V82, P97; SUKOPP H, 1995, PLANT INVASIONS, P151; Taylor DR, 2007, EVOLUTION, V61, P334, DOI 10.1111/j.1558-5646.2007.00037.x; Tiebre MS, 2007, AM J BOT, V94, P1900, DOI 10.3732/ajb.94.11.1900; Tiebre MS, 2007, ANN BOT-LONDON, V99, P193, DOI 10.1093/aob/mcl242; Tokarska-Guzik B., 2012, ROSLINY OBCEGO POCHO, P1; Tokarska-Guzik B., 2005, ESTABLISHMENT SPREAD; UNFRIED I, 1990, NUCLEIC ACIDS RES, V18, P4011, DOI 10.1093/nar/18.13.4011; Urgenson LS, 2009, BIOL CONSERV, V142, P1536, DOI 10.1016/j.biocon.2009.02.023; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Vila M., 2000, BIOL INVASIONS, V2, P207, DOI 10.1023/ A:1010003603310; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wan T, 2012, PLANT SYST EVOL, V298, P1195, DOI 10.1007/s00606-012-0621-9; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; Xiong ZY, 2011, P NATL ACAD SCI USA, V108, P7908, DOI 10.1073/pnas.1014138108; Zhang YY, 2010, MOL ECOL, V19, P1774, DOI 10.1111/j.1365-294X.2010.04609.x	81	11	12	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161854	10.1371/journal.pone.0161854	http://dx.doi.org/10.1371/journal.pone.0161854			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575805	Green Submitted, Green Published, gold			2022-12-26	WOS:000382877200043
J	Delorme, C; Roze, E; Grabli, D; Mayer, JM; Degos, B; Vidailhet, M; Worbe, Y				Delorme, Cecile; Roze, Emmanuel; Grabli, David; Mayer, Jean-Michel; Degos, Bertrand; Vidailhet, Marie; Worbe, Yulia			Explicit Agency in Patients with Cervical Dystonia: Altered Recognition of Temporal Discrepancies between Motor Actions and Their Feedback	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; FOCAL DYSTONIA; METACOGNITION; ABNORMALITIES; INTEGRATION; MOVEMENT; ILLUSION; SPACE; DISCRIMINATION; REPRESENTATION	Background Abnormalities in the cognitive processing of movement have been demonstrated in patients with dystonia. The sense of agency, which is the experience of initiating and controlling one's own actions, has never before been studied in these patients. Objectives We investigated whether the sense of agency is altered in patients with cervical dystonia. Methods We used an explicit metacognitive agency task in which participants had to catch targets with a cursor by moving a computer's mouse. The task included several conditions in which the control over the cursor could be disrupted by adding a spatial or a temporal discrepancy between the mouse and the cursor's movements. Participants had to acknowledge these discrepancies and reflect them in metacognitive judgements of agency. Results Twenty cervical dystonia patients and 20 matched controls were included in the study. Despite performing equally well as the matched controls, cervical dystonia patients did not fully recognize alterations of agency when a temporal lag was added between their movement and the visual feedback. Moreover, they relied predominantly on their perceived performance to provide judgements of agency and less on their objective degree of controls. There was no correlation between agency scores and clinical severity of dystonia measured by the Toronto Western Spasmodic Torticollis Rating Scale. Conclusion We demonstrated an abnormal processing of agency in cervical dystonia patients, even for motor actions not affected by dystonia. The exact contribution of abnormal agency to dystonia pathophysiology remains to be clarified.	[Delorme, Cecile; Roze, Emmanuel; Grabli, David; Vidailhet, Marie; Worbe, Yulia] Univ Paris 06, CNRS UMR 7225, Sorbonne Univ, ICM,UMR S 975, Paris, France; [Delorme, Cecile; Roze, Emmanuel; Grabli, David; Mayer, Jean-Michel; Degos, Bertrand; Vidailhet, Marie; Worbe, Yulia] Grp Hosp Pitie Salpetriere, AP HP, Dept Neurol, 47-83 Blvd Hop, Paris, France; [Worbe, Yulia] Grp Hosp Pitie Salpetriere, French Reference Ctr Gilles de la Tourette Syndro, 47-83 Blvd Hop, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Worbe, Y (corresponding author), Univ Paris 06, CNRS UMR 7225, Sorbonne Univ, ICM,UMR S 975, Paris, France.; Worbe, Y (corresponding author), Grp Hosp Pitie Salpetriere, AP HP, Dept Neurol, 47-83 Blvd Hop, Paris, France.; Worbe, Y (corresponding author), Grp Hosp Pitie Salpetriere, French Reference Ctr Gilles de la Tourette Syndro, 47-83 Blvd Hop, Paris, France.	yworbe@gmail.com	Worbe, Yulia/GYV-3751-2022	Worbe, Yulia/0000-0001-5903-9370				Albanese A, 2013, MOVEMENT DISORD, V28, P863, DOI 10.1002/mds.25475; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Avanzino L, 2015, NEUROPSYCHOLOGIA, V79, P288, DOI 10.1016/j.neuropsychologia.2015.07.008; Avanzino L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116607; Consky E, 1990, NEUROLOGY, V40; Delorme C, 2016, CORTEX, V77, P132, DOI 10.1016/j.cortex.2016.02.003; Fabbrini G, 2010, MOVEMENT DISORD, V25, P459, DOI 10.1002/mds.22983; Farrer C, 2008, CEREB CORTEX, V18, P254, DOI 10.1093/cercor/bhm050; Filip P, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/908741; Fiorio M, 2007, NEUROPSYCHOLOGIA, V45, P2346, DOI 10.1016/j.neuropsychologia.2007.02.005; Fiorio M, 2011, BRAIN, V134, P1428, DOI 10.1093/brain/awr026; Frima N, 2008, MOVEMENT DISORD, V23, P373, DOI 10.1002/mds.21838; Frith CD, 2000, BRAIN RES REV, V31, P357, DOI 10.1016/S0165-0173(99)00052-1; Kanovsky P, 2002, MOVEMENT DISORD, V17, P1143, DOI 10.1002/mds.10284; Kimmich O, 2014, MOVEMENT DISORD, V29, P804, DOI 10.1002/mds.25822; LeDoux MS, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000069; Martino D, 2015, MOVEMENT DISORD, V30, P1005, DOI 10.1002/mds.26225; Maurer C, 2016, NEUROLOGY, V86; Metcalfe J, 2007, J EXP PSYCHOL GEN, V136, P184, DOI 10.1037/0096-3445.136.2.184; Metcalfe J, 2012, PHILOS T R SOC B, V367, P1391, DOI 10.1098/rstb.2012.0006; Metcalfe J, 2010, COGNITION, V116, P267, DOI 10.1016/j.cognition.2010.05.009; Miele DB, 2011, J COGNITIVE NEUROSCI, V23, P3620, DOI 10.1162/jocn_a_00052; Molloy FM, 2003, BRAIN, V126, P2175, DOI 10.1093/brain/awg219; Moore JW, 2012, CONSCIOUS COGN, V21, P59, DOI 10.1016/j.concog.2011.08.010; Muller SV, 2005, MOVEMENT DISORD, V20, P58, DOI 10.1002/mds.20293; Opavsky R, 2011, J NEUROL SCI, V306, P71, DOI 10.1016/j.jns.2011.03.040; Prudente CN, 2014, NEUROSCIENCE, V260, P23, DOI 10.1016/j.neuroscience.2013.11.062; Quartarone A, 2013, MOVEMENT DISORD, V28, P958, DOI 10.1002/mds.25532; Ritterband-Rosenbaum A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00471; Scontrini A, 2009, J NEUROL NEUROSUR PS, V80, P1315, DOI 10.1136/jnnp.2009.178236; Sirigu A, 1999, BRAIN, V122, P1867, DOI 10.1093/brain/122.10.1867; Spati J, 2015, J PSYCHIATR NEUROSCI, V40, P394, DOI 10.1503/jpn.140225; Synofzik M, 2008, CONSCIOUS COGN, V17, P219, DOI 10.1016/j.concog.2007.03.010; Synofzik M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00127; Walsh R, 2007, J NEUROL NEUROSUR PS, V78, P980, DOI 10.1136/jnnp.2006.105585; Wegner DM, 1999, AM PSYCHOL, V54, P480, DOI 10.1037/0003-066X.54.7.480; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Xing J, 2000, J COGNITIVE NEUROSCI, V12, P601, DOI 10.1162/089892900562363; Zalla T, 2015, CONSCIOUS COGN, V31, P126, DOI 10.1016/j.concog.2014.11.001	40	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0162191	10.1371/journal.pone.0162191	http://dx.doi.org/10.1371/journal.pone.0162191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EE	27575487	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877200060
J	Edmunds, DR; Kauffman, MJ; Schumaker, BA; Lindzey, FG; Cook, WE; Kreeger, TJ; Grogan, RG; Cornish, TE				Edmunds, David R.; Kauffman, Matthew J.; Schumaker, Brant A.; Lindzey, Frederick G.; Cook, Walter E.; Kreeger, Terry J.; Grogan, Ronald G.; Cornish, Todd E.			Chronic Wasting Disease Drives Population Decline of White-Tailed Deer	PLOS ONE			English	Article							RANGING MULE DEER; SPONGIFORM ENCEPHALOPATHY; HARVEST VULNERABILITY; AFRICAN BUFFALO; PREVALENCE; ELK; WISCONSIN; SURVIVAL; IMMUNOHISTOCHEMISTRY; EPIDEMIOLOGY	Chronic wasting disease (CWD) is an invariably fatal transmissible spongiform encephalopathy of white-tailed deer, mule deer, elk, and moose. Despite a 100% fatality rate, areas of high prevalence, and increasingly expanding geographic endemic areas, little is known about the population-level effects of CWD in deer. To investigate these effects, we tested the null hypothesis that high prevalence CWD did not negatively impact white-tailed deer population sustainability. The specific objectives of the study were to monitor CWD-positive and CWD-negative white-tailed deer in a high-prevalence CWD area longitudinally via radio-telemetry and global positioning system (GPS) collars. For the two populations, we determined the following: a) demographic and disease indices, b) annual survival, and c) finite rate of population growth (lambda). The CWD prevalence was higher in females (42%) than males (28.8%) and hunter harvest and clinical CWD were the most frequent causes of mortality, with CWD-positive deer over-represented in harvest and total mortalities. Survival was significantly lower for CWD-positive deer and separately by sex; CWD-positive deer were 4.5 times more likely to die annually than CWD-negative deer while bucks were 1.7 times more likely to die than does. Population lambda was 0.896 (0.859-0.980), which indicated a 10.4% annual decline. We show that a chronic disease that becomes endemic in wildlife populations has the potential to be population-limiting and the strong population-level effects of CWD suggest affected populations are not sustainable at high disease prevalence under current harvest levels.	[Edmunds, David R.; Schumaker, Brant A.; Grogan, Ronald G.; Cornish, Todd E.] Univ Wyoming, Dept Vet Sci, Laramie, WY 82071 USA; [Kauffman, Matthew J.; Lindzey, Frederick G.] Univ Wyoming, US Geol Survey, Dept Zool & Physiol, Wyoming Cooperat Fish & Wildlife Res Unit, Laramie, WY 82071 USA; [Cook, Walter E.] Univ Wyoming, Coll Agr & Nat Resources, Laramie, WY 82071 USA; [Kreeger, Terry J.] Wyoming Game & Fish Dept, Wheatland, WY USA; [Edmunds, David R.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Cook, Walter E.] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77845 USA	University of Wyoming; United States Department of the Interior; United States Geological Survey; University of Wyoming; University of Wyoming; Colorado State University; Texas A&M University System; Texas A&M University College Station	Edmunds, DR (corresponding author), Univ Wyoming, Dept Vet Sci, Laramie, WY 82071 USA.; Edmunds, DR (corresponding author), Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA.	Dave.Edmunds@rams.colostate.edu		Edmunds, David/0000-0002-5212-8271	Morris Animal Foundation [D07ZO-159, D07ZO-425]; United States Geological Survey [000679]; Wyoming Game and Fish Department [000679]; International Association of Fish and Wildlife Agencies [000679]; Wyoming Wildlife/Livestock Disease Research Partnership [5-35466]; National Cattleman's Beef Association; Whitetails Unlimited	Morris Animal Foundation; United States Geological Survey(United States Geological Survey); Wyoming Game and Fish Department; International Association of Fish and Wildlife Agencies; Wyoming Wildlife/Livestock Disease Research Partnership; National Cattleman's Beef Association; Whitetails Unlimited	This work was primarily supported by the Morris Animal Foundation (www.morrisanimalfoundation.org) through grant numbers: Established Investigator = D07ZO-159 (TEC, DRE, MJK, FGL, WEC, and TJK), and Fellowship Training Grant = D07ZO-425 (funded DRE's graduate research stipend). The United States Geological Survey (www.usgs.gov), Wyoming Game and Fish Department (https://wgfd.wyo.gov), and International Association of Fish and Wildlife Agencies (www.fishwildlife.org) each jointly funded parts of this work through grant number 000679 over multiple years (TEC, TJK, and DRE). The Wyoming Wildlife/Livestock Disease Research Partnership (http://wyagric.state.wy.us/divisions/ts/sections-a-programs/wildlifelivestock-disease-research) partially funded this work through project number 5-35466 (TEC, FGL, DRE, and TJK). Whitetails Unlimited (www.whitetailsunlimited.com) also provided some support (no grant number; TEC, FGL, DRE, and TJK), and National Cattleman's Beef Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2007, INTRO CATEGORICAL DA; [Anonymous], 2007, HDB WILDLIFE CHEM IM; [Anonymous], 2010, INTR SURV AN SAS; Baeten LA, 2007, J WILDLIFE DIS, V43, P309, DOI 10.7589/0090-3558-43.2.309; Bishop CJ, 2009, WILDLIFE MONOGR, P1, DOI 10.2193/2008-107; Blanchong JA, 2012, J WILDLIFE DIS, V48, P361, DOI 10.7589/0090-3558-48.2.361; Burnham K.P., 2010, MODEL SELECTION MULT; Caswell, 2000, MATRIX POPULATION MO; CLOVER MELVIN R., 1956, CALIFORNIA FISH AND GAME, V42, P199; Conner MM, 2000, J WILDLIFE DIS, V36, P691, DOI 10.7589/0090-3558-36.4.691; COX DR, 1972, J R STAT SOC B, V34, P187; COX DR, 1983, J R STAT SOC B, V45, P391; Cross PC, 2009, J APPL ECOL, V46, P467, DOI 10.1111/j.1365-2664.2008.01589.x; CURETON EE, 1957, AM STAT, V11, P21, DOI 10.2307/2681591; Dulberger J, 2010, J WILDLIFE DIS, V46, P1086, DOI 10.7589/0090-3558-46.4.1086; Duquette JF, 2012, WILDLIFE SOC B, V36, P115, DOI 10.1002/wsb.115; Dusek G. L., 1989, WILDLIFE MONOGR, V104, P3; Edmunds D. R., 2008, THESIS; Edmunds DR, 2013, THESIS; Farnsworth ML, 2005, ECOL APPL, V15, P119, DOI 10.1890/04-0194; Fisher RA, 1934, P R SOC LOND A-CONTA, V144, P0285, DOI 10.1098/rspa.1934.0050; Grear DA, 2006, J WILDLIFE MANAGE, V70, P546, DOI 10.2193/0022-541X(2006)70[546:DPAHVO]2.0.CO;2; Huang F, 2000, J WILDLIFE MANAGE, V64, P492, DOI 10.2307/3803246; Jolles AE, 2005, ECOLOGY, V86, P2358, DOI 10.1890/05-0038; Joly DO, 2006, J WILDLIFE DIS, V42, P578, DOI 10.7589/0090-3558-42.3.578; Kreeger TJ, 2002, HDB WILDLIFE CHEM IN; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; Miller MW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004019; Miller MW, 2005, J WILDLIFE DIS, V41, P275, DOI 10.7589/0090-3558-41.2.275; Miller MW, 2000, J WILDLIFE DIS, V36, P676, DOI 10.7589/0090-3558-36.4.676; Miller MW, 2002, VET REC, V151, P610, DOI 10.1136/vr.151.20.610; Monello RJ, 2014, J WILDLIFE MANAGE, V78, P214, DOI 10.1002/jwmg.665; Morris W. F., 2002, QUANTITATIVE CONSERV; O'Rourke KI, 2000, J CLIN MICROBIOL, V38, P3254, DOI 10.1128/JCM.38.9.3254-3259.2000; Perez-Heydrich C, 2012, OIKOS, V121, P377, DOI 10.1111/j.1600-0706.2011.19735.x; POLLOCK KH, 1989, J WILDLIFE MANAGE, V53, P7, DOI 10.2307/3801296; POLLOCK KH, 1989, BIOMETRICS, V45, P99, DOI 10.2307/2532037; R Core Team, 2016, LANGUAGE ENV STAT CO; Rosenberry CS, 1999, WILDLIFE SOC B, V27, P858; Sargeant GA, 2011, J WILDLIFE MANAGE, V75, P171, DOI 10.1002/jwmg.27; Schuler Karin Kipper, 2006, THESIS; Smith T, 2003, 28 ANN SAS US GROUP; Stubben C, 2008, POPBIO CONSTRUCTION, V1; Wasserberg G, 2009, J APPL ECOL, V46, P457, DOI 10.1111/j.1365-2664.2008.01576.x; Webb SL, 2008, J WILDLIFE MANAGE, V72, P310, DOI 10.2193/2007-101; Williams AL, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00013.1; WILLIAMS ES, 1982, J WILDLIFE DIS, V18, P465, DOI 10.7589/0090-3558-18.4.465; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89; Wolfe LL, 2002, J WILDLIFE MANAGE, V66, P564, DOI 10.2307/3803124	51	96	97	6	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161127	10.1371/journal.pone.0161127	http://dx.doi.org/10.1371/journal.pone.0161127			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575545	Green Submitted, Green Published, gold			2022-12-26	WOS:000382877200017
J	Lal, MM; Southgate, PC; Jerry, DR; Bosserelle, C; Zenger, KR				Lal, Monal M.; Southgate, Paul C.; Jerry, Dean R.; Bosserelle, Cyprien; Zenger, Kyall R.			A Parallel Population Genomic and Hydrodynamic Approach to Fishery Management of Highly-Dispersive Marine Invertebrates: The Case of the Fijian Black-Lip Pearl Oyster Pinctada margaritifera	PLOS ONE			English	Article							SIZE N-E; GENETIC DIVERSITY; MULTILOCUS HETEROZYGOSITY; RE-IMPLEMENTATION; FRENCH-POLYNESIA; LOCAL SELECTION; GROWTH; WILD; CONNECTIVITY; LARVAL	Fishery management and conservation of marine species increasingly relies on genetic data to delineate biologically relevant stock boundaries. Unfortunately for high gene flow species which may display low, but statistically significant population structure, there is no clear consensus on the level of differentiation required to resolve distinct stocks. The use of fine-scale neutral and adaptive variation, considered together with environmental data can offer additional insights to this problem. Genome-wide genetic data (4,123 SNPs), together with an independent hydrodynamic particle dispersal model were used to inform farm and fishery management in the Fijian black-lip pearl oyster Pinctada margaritifera, where comprehensive fishery management is lacking, and the sustainability of exploitation uncertain. Weak fine-scale patterns of population structure were detected, indicative of broad-scale panmixia among wild oysters, while a hatchery-sourced farmed population exhibited a higher degree of genetic divergence (F-st = 0.0850-0.102). This hatchery-produced population had also experienced a bottleneck (N-eLD = 5.1; 95% C.I. = [5.1-5.3]); compared to infinite NeLD estimates for all wild oysters. Simulation of larval transport pathways confirmed the existence of broad-scale mixture by surface ocean currents, correlating well with fine-scale patterns of population structuring. Fst outlier tests failed to detect large numbers of loci supportive of selection, with 2-5 directional outlier SNPs identified (average F-st = 0.116). The lack of biologically significant population genetic structure, absence of evidence for local adaptation and larval dispersal simulation, all indicate the existence of a single genetic stock of P. margaritifera in the Fiji Islands. This approach using independent genomic and oceanographic tools has allowed fundamental insights into stock structure in this species,	[Lal, Monal M.; Southgate, Paul C.; Jerry, Dean R.; Zenger, Kyall R.] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld, Australia; [Lal, Monal M.; Southgate, Paul C.; Jerry, Dean R.; Zenger, Kyall R.] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia; [Southgate, Paul C.] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Australian Ctr Pacific Isl Res, Maroochydore, Qld, Australia; [Bosserelle, Cyprien] Secretariat Pacific Community, Geosci Div, Suva, Fiji	James Cook University; James Cook University; University of the Sunshine Coast	Lal, MM (corresponding author), James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld, Australia.; Lal, MM (corresponding author), James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia.	monal.lal@my.jcu.edu.au	Jerry, Dean R/B-3053-2012; Zenger, Kyall R/ABD-2101-2020	Zenger, Kyall R/0000-0001-6817-8786; Jerry, Dean/0000-0003-3735-1798; Lal, Monal/0000-0002-8545-2887	Australian Centre for International Agricultural Research (ACIAR) Project [FIS/2009/057]	Australian Centre for International Agricultural Research (ACIAR) Project(Australian Ctr Intl Agr Res)	This study was conducted within the Australian Centre for International Agricultural Research (ACIAR) Project FIS/2009/057: "Pearl Industry Development in the Western Pacific" led by PCS at the University of the Sunshine Coast. The funding source (ACIAR) had no role in the study design, data collection and analysis, interpretation of the data, decision to publish, or preparation of the manuscript. For further information please visit: http://aciar.gov.au/project/fis/2009/057.	Adamkewicz SL, 1996, AM MALACOL BULL, V13, P97; ALAGARSWAMI K, 1989, AQUACULTURE, V76, P43, DOI 10.1016/0044-8486(89)90250-0; Alho JS, 2010, MOL ECOL RESOUR, V10, P720, DOI 10.1111/j.1755-0998.2010.02830.x; Andre C, 2011, HEREDITY, V106, P270, DOI 10.1038/hdy.2010.71; Andrews KR, 2014, MOL ECOL, V23, P1661, DOI 10.1111/mec.12686; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Arnaud-Haond S, 2003, AQUACULTURE, V219, P181, DOI 10.1016/S0044-8486(02)00568-9; Arnaud-Haond S, 2008, MAR BIOL, V155, P147, DOI 10.1007/s00227-008-1013-0; Ball Roderick D, 2013, Methods Mol Biol, V1019, P37, DOI 10.1007/978-1-62703-447-0_3; Beer AC, 2000, J SHELLFISH RES, V19, P821; Belkhir K., 2004, GENETIX 4 05 LOGICIE; Berry O, 2012, MOL ECOL, V21, P2145, DOI 10.1111/j.1365-294X.2012.05520.x; Cannuel R, 2009, BIOL BULL-US, V217, P173, DOI 10.1086/BBLv217n2p173; CARVALHO GR, 1994, REV FISH BIOL FISHER, V4, P326, DOI 10.1007/BF00042908; Catchen J, 2013, MOL ECOL, V22, P2864, DOI 10.1111/mec.12330; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chassignet EP, 2007, J MARINE SYST, V65, P60, DOI 10.1016/j.jmarsys.2005.09.016; Cummings JA, 2005, Q J ROY METEOR SOC, V131, P3583, DOI 10.1256/qj.05.105; Dao HT, 2015, PLOS ONE, P10; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Doroudi Mehdi S., 2003, Molluscan Research, V23, P101, DOI 10.1071/MR02015; Doroudi MS, 2002, AQUACULTURE, V209, P117, DOI 10.1016/S0044-8486(01)00736-0; DURAND P, 1993, AQUACULTURE, V110, P27, DOI 10.1016/0044-8486(93)90431-W; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Foll M., 2012, ECOLOGY, V20, P1450; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Friedman K, 2002, FIJI ISLANDS COUNTRY; Friedman KJ, 1999, J SHELLFISH RES, V18, P159; Friedman KJ, 2000, AQUACULTURE, V187, P299, DOI 10.1016/S0044-8486(00)00311-2; Funk WC, 2012, TRENDS ECOL EVOL, V27, P489, DOI 10.1016/j.tree.2012.05.012; Gaggiotti OE, 2009, EVOLUTION, V63, P2939, DOI 10.1111/j.1558-5646.2009.00779.x; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; GE, 2007, ILL AUTOSEQ G 50 DOC, P1; Gogarten SM, 2012, BIOINFORMATICS, V28, P3329, DOI 10.1093/bioinformatics/bts610; Gosling EM, 2015, MARINE BIVALVE MOLLU, P270; Halliwell GR, 2004, OCEAN MODEL, V7, P285, DOI 10.1016/j.ocemod.2003.10.002; Hare MP, 2000, MAR BIOL, V137, P953, DOI 10.1007/s002270000402; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; Hauser L, 2011, MOL ECOL RESOUR, V11, P150, DOI 10.1111/j.1755-0998.2010.02961.x; Hayes Ben, 2013, Methods Mol Biol, V1019, P149, DOI 10.1007/978-1-62703-447-0_6; Huang Huateng, 2014, SYSTEMATIC BIOL; Jerry DR, 2012, AQUACULTURE, V338, P66, DOI 10.1016/j.aquaculture.2012.02.001; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2011, BIOINFORMATICS; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Knutsen H, 2011, MOL ECOL, V20, P768, DOI 10.1111/j.1365-294X.2010.04979.x; Kovach RP, 2012, P ROY SOC B-BIOL SCI, V279, P3870, DOI 10.1098/rspb.2012.1158; Kvingedal R, 2008, AQUACULTURE, V279, P23, DOI 10.1016/j.aquaculture.2008.04.022; Kvingedal R, 2010, AQUACULTURE, V304, P1, DOI 10.1016/j.aquaculture.2010.02.035; Lal MM, 2016, MAR GENOM, V25, P57, DOI 10.1016/j.margen.2015.10.010; Lemer S, 2014, MAR BIOL, V161, P2035, DOI 10.1007/s00227-014-2484-9; Lemer S, 2012, MOL ECOL, V21, P2949, DOI 10.1111/j.1365-294X.2012.05588.x; Lemer S, 2011, J HERED, V102, P243, DOI 10.1093/jhered/esq123; Liggins L, 2013, GEOGR COMPASS, V7, P173, DOI 10.1111/gec3.12031; Limborg MT, 2012, MOL ECOL, V21, P3686, DOI 10.1111/j.1365-294X.2012.05639.x; Lind CE, 2010, AQUAC RES, V41, P1229, DOI 10.1111/j.1365-2109.2009.02410.x; Lind CE, 2009, AQUACULTURE, V286, P12, DOI 10.1016/j.aquaculture.2008.09.009; Markey KL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147628; Miller AD, 2013, ECOL EVOL, V3, P1248, DOI 10.1002/ece3.535; Nayfa MG, 2016, MARINE GENOMICS; Neo ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058819; Neuditschko M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048375; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Palumbi SR, 2003, ECOL APPL, V13, pS146; Passfield K, 1995, REPORT PEAR IN PRESS, P1; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Penaloza C, 2014, 10 WORLD C GEN APPL, P1; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Pit JH, 2003, AQUACULT INT, V11, P545, DOI 10.1023/B:AQUI.0000013310.17400.97; Pouvreau S, 2000, AQUACULTURE, V184, P133, DOI 10.1016/S0044-8486(99)00319-1; Pouvreau S, 2001, AQUAT LIVING RESOUR, V14, P155, DOI 10.1016/S0990-7440(01)01120-2; Pujolar JM, 2014, MOL ECOL, V23, P2514, DOI 10.1111/mec.12753; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Puritz JB, 2014, DEMYSTIFYING RAD FAD; Reiss H, 2009, FISH FISH, V10, P361, DOI 10.1111/j.1467-2979.2008.00324.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Saucedo PE, 2008, PEARL OYSTER, P131, DOI 10.1016/B978-0-444-52976-3.00005-X; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Slate J, 2004, HEREDITY, V93, P255, DOI 10.1038/sj.hdy.6800485; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Southgate PC, 2008, PEARL OYSTER, P303, DOI 10.1016/B978-0-444-52976-3.00009-7; Southgate PC, 2008, PEARL OYSTER, P231, DOI 10.1016/B978-0-444-52976-3.00007-3; SPC, 2007, SPC AQ ACT PLAN 2007; SPC, 2003, PROF HIGH INT AQ COM; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Steinig EJ, 2016, MOL ECOLOGY RESOURCE, P1; Team RC, 2016, R LANG ENV STAT COMP; Thomas Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095050; Tsafrir D, 2005, BIOINFORMATICS, V21, P2301, DOI 10.1093/bioinformatics/bti329; Viikmae B, 2013, OCEAN DYNAM, V63, P589, DOI 10.1007/s10236-013-0615-3; Vilisoni MTJ, 2012, THESIS; Wada KT, 2008, PEARL OYSTER, P37, DOI 10.1016/B978-0-444-52976-3.00002-4; Wada KT, 2008, PEARL OYSTER, P437, DOI 10.1016/B978-0-444-52976-3.00012-7; Waples RS, 2008, FISH FISH, V9, P423, DOI 10.1111/j.1467-2979.2008.00303.x; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Ward RD, 2000, HYDROBIOLOGIA, V420, P191, DOI 10.1023/A:1003928327503; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; White C, 2010, OCEAN CURRENT HELP E; White TA, 2010, MOL ECOL, V19, P216, DOI 10.1111/j.1365-294X.2009.04446.x; Wood S, 2014, GLOBAL ECOL BIOGEOGR, V23, P1, DOI 10.1111/geb.12101; Zarraonaindia I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042201; Zenger KR, 2007, ANIM GENET, V38, P7, DOI 10.1111/j.1365-2052.2006.01543.x; Zenger KR, 2007, 17 ASS ADV AN BREED, P123	109	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161390	10.1371/journal.pone.0161390	http://dx.doi.org/10.1371/journal.pone.0161390			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27559735	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000382258600037
J	Tischler, AD; Leistikow, RL; Ramakrishnan, P; Voskuil, MI; McKinney, JD				Tischler, Anna D.; Leistikow, Rachel L.; Ramakrishnan, Pavithra; Voskuil, Martin I.; McKinney, John D.			Mycobacterium tuberculosis Phosphate Uptake System Component PstA2 Is Not Required for Gene Regulation or Virulence	PLOS ONE			English	Article							BINDING; DEFICIENT; SMEGMATIS; SURVIVAL; RECEPTOR	The Mycobacterium tuberculosis genome encodes two complete high-affinity Pst phosphate-specific transporters. We previously demonstrated that a membrane-spanning component of one Pst system, PstA1, was essential both for M. tuberculosis virulence and for regulation of gene expression in response to external phosphate availability. To determine if the alternative Pst system is similarly required for virulence or gene regulation, we constructed a deletion of pstA2. Transcriptome analysis revealed that PstA2 is not required for regulation of gene expression in phosphate-replete growth conditions. PstA2 was also dispensable for replication and virulence of M. tuberculosis in a mouse aerosol infection model. However, a Delta pstA1 Delta pstA2 double mutant was attenuated in mice lacking the cytokine interferon-gamma, suggesting that M. tuberculosis requires high-affinity phosphate transport to survive phosphate limitation encountered in the host. Surprisingly, Delta pstA2 bacteria were more resistant to acid stress in vitro. This phenotype is intrinsic to the alternative Pst transporter since a Delta pstS1 mutant exhibited similar acid resistance. Our data indicate that the two M. tuberculosis Pst transporters have distinct physiological functions, with the PstA1 transporter being specifically involved in phosphate sensing and gene regulation while the PstA2 transporter influences survival in acidic conditions.	[Tischler, Anna D.; Ramakrishnan, Pavithra] Univ Minnesota, Dept Microbiol & Immunol, Minneapolis, MN 55455 USA; [Tischler, Anna D.; McKinney, John D.] Swiss Fed Inst Technol EPFL, Sch Life Sci, Lausanne, Switzerland; [Leistikow, Rachel L.; Voskuil, Martin I.] Univ Colorado Denver, Sch Med, Dept Immunol & Microbiol, Aurora, CO USA	University of Minnesota System; University of Minnesota Twin Cities; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Tischler, AD (corresponding author), Univ Minnesota, Dept Microbiol & Immunol, Minneapolis, MN 55455 USA.; Tischler, AD (corresponding author), Swiss Fed Inst Technol EPFL, Sch Life Sci, Lausanne, Switzerland.	tischler@umn.edu		Tischler, Anna/0000-0001-8404-0250	Cancer Research Institute; University of Minnesota; National Institutes of Health (NIH) [T32 AI052066]; NIH [R01 AI061505]; Swiss National Science Foundation [310030_156945]	Cancer Research Institute; University of Minnesota(University of Minnesota System); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by an Irvington Post-doctoral Fellowship of the Cancer Research Institute (A.D.T.), start-up funding from the University of Minnesota (A.D.T.), National Institutes of Health (NIH) training grant T32 AI052066 (R.L.L.), NIH grant R01 AI061505 (M.I.V.) and Swiss National Science Foundation grant 310030_156945 (J.D.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braibant M, 2000, FEMS MICROBIOL REV, V24, P449, DOI 10.1111/j.1574-6976.2000.tb00550.x; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Esparza M, 2015, SCAND J IMMUNOL, V81, P46, DOI 10.1111/sji.12249; Ferraris DM, 2014, PROTEINS, V82, P2268, DOI 10.1002/prot.24548; Furtwangler K, 2010, MOL MICROBIOL, V76, P378, DOI 10.1111/j.1365-2958.2010.07101.x; Gebhard S, 2006, MICROBIOL-SGM, V152, P3453, DOI 10.1099/mic.0.29201-0; Hsieh YJ, 2010, CURR OPIN MICROBIOL, V13, P198, DOI 10.1016/j.mib.2010.01.014; Kirksey MA, 2011, INFECT IMMUN, V79, P2829, DOI 10.1128/IAI.00097-11; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Mudrak B, 2012, INFECT IMMUN, V80, P1794, DOI 10.1128/IAI.06277-11; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pavelka MS, 1999, J BACTERIOL, V181, P4780, DOI 10.1128/JB.181.16.4780-4789.1999; Peirs P, 2005, INFECT IMMUN, V73, P1898, DOI 10.1128/IAI.73.3.1898-1902.2005; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rifat D, 2009, J INFECT DIS, V200, P1126, DOI 10.1086/605700; SENANAYAKE SD, 1995, MOL BIOTECHNOL, V4, P13, DOI 10.1007/BF02907467; Tischler AD, 2013, INFECT IMMUN, V81, P317, DOI 10.1128/IAI.01136-12; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; Vanzembergh F, 2010, TUBERCULOSIS, V90, P338, DOI 10.1016/j.tube.2010.09.004; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Vyas NK, 2003, STRUCTURE, V11, P765, DOI 10.1016/S0969-2126(03)00109-6; WANG ZM, 1994, J BIOL CHEM, V269, P25091; Wanner BL, 1996, ESCHERICHIA COLI SAL, P1357, DOI DOI 10.1007/978-3-642-75969-7_16; Zhang YJJ, 2013, CELL, V155, P1296, DOI 10.1016/j.cell.2013.10.045	27	6	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161467	10.1371/journal.pone.0161467	http://dx.doi.org/10.1371/journal.pone.0161467			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27557082	Green Submitted, gold, Green Published			2022-12-26	WOS:000382258100044
J	Boskovic, J; Martinez-Gago, J; Mendez-Pertuz, M; Buscato, A; Martinez-Torrecuadrada, JL; Blasco, MA				Boskovic, Jasminka; Martinez-Gago, Jaime; Mendez-Pertuz, Marinela; Buscato, Alberto; Luis Martinez-Torrecuadrada, Jorge; Blasco, Maria A.			Molecular Architecture of Full-length TRF1 Favors Its Interaction with DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA binding protein; electron microscopy (EM); protein structure; shelterin; telomere; telomeric repeat-binding factor 1 (TERF1); protein structure; electron microscopy (EM); telomere; telomeric repeat binding factor1 (TRF1)	TELOMERIC PROTEINS TRF1; COMPLEX; SHELTERIN; RAP1; TANKYRASE; GENE; TIN2; EXPRESSION; PROTECTION; REGULATOR	Telomeres are specific DNA-protein structures found at both ends of eukaryotic chromosomes that protect the genome from degradation and from being recognized as double-stranded breaks. In vertebrates, telomeres are composed of tandem repeats of the TTAGGG sequence that are bound by a six-subunit complex called shelterin. Molecular mechanisms of telomere functions remain unknown in large part due to lack of structural data on shelterins, shelterin complex, and its interaction with the telomeric DNA repeats. TRF1 is one of the best studied shelterin components; however, the molecular architecture of the full-length protein remains unknown. We have used single-particle electron microscopy to elucidate the structure of TRF1 and its interaction with telomeric DNA sequence. Our results demonstrate that full-length TRF1 presents a molecular architecture that assists its interaction with telometic DNA and at the same time makes TRFH domains accessible to other TRF1 binding partners. Furthermore, our studies suggest hypothetical models on how other proteins as TIN2 and tankyrase contribute to regulate TRF1 function.	[Boskovic, Jasminka; Buscato, Alberto] Spanish Natl Canc Res Ctr CNIO, Electron Microscopy Unit, Struct Biol & Biocomp Programme, Madrid 28029, Spain; [Martinez-Gago, Jaime; Luis Martinez-Torrecuadrada, Jorge] Spanish Natl Canc Res Ctr CNIO, Crystallog & Prot Engn Unit, Struct Biol & Biocomp Programme, Madrid 28029, Spain; [Mendez-Pertuz, Marinela; Blasco, Maria A.] Spanish Natl Canc Res Ctr CNIO, Mol Oncol Programme, Telomeres & Telomerase Grp, Madrid 28029, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Boskovic, J (corresponding author), Spanish Natl Canc Res Ctr CNIO, Electron Microscopy Unit, Struct Biol & Biocomp Programme, Madrid 28029, Spain.; Blasco, MA (corresponding author), Spanish Natl Canc Res Ctr CNIO, Mol Oncol Programme, Telomeres & Telomerase Grp, Madrid 28029, Spain.	jboskovic@cnio.es; mblasco@cnio.es	Martinez-Torrecuadrada, Jorge L./AAG-1090-2019; Blasco, Maria A./M-1694-2014; boskovic, jasminka/L-5117-2018	Blasco, Maria A./0000-0002-4211-233X; boskovic, jasminka/0000-0001-6135-0686; Martinez-Torrecuadrada, Jorge Luis/0000-0002-8240-6623	Spanish Ministry of Economy and Competitiveness [SAF2013-45111RETOS]; Fundacion Botin	Spanish Ministry of Economy and Competitiveness(Spanish Government); Fundacion Botin	The M. A. B laboratory is supported by the Spanish Ministry of Economy and Competitiveness Project SAF2013-45111RETOS and the Fundacion Botin. We thank Oscar Llorca and Santiago Ramon for valuable comments and Maria Moreno for critical reading of the manuscript.	Bainbridge MN, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju384; Calvete O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9383; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Court R, 2005, EMBO REP, V6, P39, DOI 10.1038/sj.embor.7400314; De Boeck G, 2009, J PATHOL, V217, P327, DOI 10.1002/path.2500; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Diotti R, 2011, NUCLEUS-PHILA, V2, P119, DOI 10.4161/nucl.2.2.15135; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; Garcia-Beccaria M, 2015, EMBO MOL MED, V7, P930, DOI 10.15252/emmm.201404497; Gaullier G, 2016, NUCLEIC ACIDS RES, V44, P1962, DOI 10.1093/nar/gkv1531; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Hsiao SJ, 2008, BIOCHIMIE, V90, P83, DOI 10.1016/j.biochi.2007.07.012; Karlseder J, 2003, MOL CELL BIOL, V23, P6533, DOI 10.1128/MCB.23.18.6533-6541.2003; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kim SH, 2003, EMBO REP, V4, P685, DOI 10.1038/sj.embor.embor872; Li B, 2016, ACTA CRYSTALLOGR F, V72, P320, DOI 10.1107/S2053230X16004131; Martinez P, 2013, CELL REP, V3, P2059, DOI 10.1016/j.celrep.2013.05.030; Martinez P, 2010, AGING CELL, V9, P653, DOI 10.1111/j.1474-9726.2010.00596.x; Martinez P, 2010, NAT CELL BIOL, V12, P768, DOI 10.1038/ncb2081; Martinez-Torrecuadrada JL, 2005, J BIOTECHNOL, V115, P23, DOI 10.1016/j.jbiotec.2004.07.011; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramsay AJ, 2013, NAT GENET, V45, P526, DOI 10.1038/ng.2584; Savage SA, 2008, AM J HUM GENET, V82, P501, DOI 10.1016/j.ajhg.2007.10.004; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Schneider RP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2946; Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Takai KK, 2011, MOL CELL, V44, P647, DOI 10.1016/j.molcel.2011.08.043; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Walker JR, 2012, MECH AGEING DEV, V133, P421, DOI 10.1016/j.mad.2012.05.002; Walne AJ, 2008, BLOOD, V112, P3594, DOI 10.1182/blood-2008-05-153445; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Yokoyama N, 2000, BBA-GENE STRUCT EXPR, V1493, P119, DOI 10.1016/S0167-4781(00)00170-6; ZHONG Z, 1992, MOL CELL BIOL, V12, P4834, DOI 10.1128/MCB.12.11.4834	38	4	4	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21829	21835		10.1074/jbc.M116.744896	http://dx.doi.org/10.1074/jbc.M116.744896			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27563064	Green Published, hybrid			2022-12-26	WOS:000385999200045
J	Garcia-Martin, E; Garcia-Campayo, J; Puebla-Guedea, M; Ascaso, FJ; Roca, M; Gutierrez-Ruiz, F; Vilades, E; Polo, V; Larrosa, JM; Pablo, LE; Satue, M				Garcia-Martin, Elena; Garcia-Campayo, Javier; Puebla-Guedea, Marta; Ascaso, Francisco J.; Roca, Miguel; Gutierrez-Ruiz, Fernando; Vilades, Elisa; Polo, Vicente; Larrosa, Jose M.; Pablo, Luis E.; Satue, Maria			Fibromyalgia Is Correlated with Retinal Nerve Fiber Layer Thinning	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; LINEAR DISCRIMINANT FUNCTION; SPANISH VERSION; HEALTH-STATUS; DISEASE; THICKNESS; REPRODUCIBILITY; QUESTIONNAIRE; DISABILITY; PERFUSION	Objective To investigate whether fibromyalgia induces axonal damage in the optic nerve that can be detected using optical coherence tomography (OCT), as the retinal nerve fiber layer (RNFL) is atrophied in patients with fibromyalgia compared with controls. Methods Fibromyalgia patients (n = 116) and age-matched healthy controls (n = 144) were included in this observational and prospective cohort study. All subjects underwent visual acuity measurement and structural analysis of the RNFL using two OCT devices (Cirrus and Spectralis). Fibromyalgia patients were evaluated according to Giesecke's fibromyalgia subgroups, the Fibromyalgia Impact Questionnaire (FIQ), and the European Quality of Life-5 Dimensions (EQ5D) scale. We compared the differences between fibromyalgia patients and controls, and analyzed the correlations between OCT measurements, disease duration, fibromyalgia subgroups, severity, and quality of life. The impact on quality of life in fibromyalgia subgroups and in patients with different disease severity was also analyzed. Results A significant decrease in the RNFL was detected in fibromyalgia patients compared with controls using the two OCT devices: Cirrus OCT ganglion cell layer analysis registered a significant decrease in the minimum thickness of the inner plexiform layer (74.99 +/- 16.63 vs 79.36 +/- 3.38 mu m, respectively; p = 0.023), nasal inferior, temporal inferior and temporal superior sectors (p = 0.040; 0.011 and 0.046 respectively). The Glaucoma application of the Spectralis OCT revealed thinning in the nasal, temporal inferior and temporal superior sectors (p = 0.009, 0.006, and 0.002 respectively) of fibromyalgia patients and the Axonal application in all sectors, except the nasal superior and temporal sectors. The odds ratio (OR) to estimate the size effect of FM in RNFL thickness was 1.39. RNFL atrophy was detected in patients with FIQ scores <60 (patients in early disease stages) compared with controls in the temporal inferior sector (78.74 +/- 17.75 vs 81.65 +/- 3.61; p = 0.020) and the temporal superior sector (78.20 +/- 14.50 vs 80.74 +/- 3.88; p = 0.039) with Cirrus OCT; in the temporal inferior sector (145.85 +/- 24.32 vs 150.18 +/- 19.71; p = 0.012) and temporal superior sector (131.54 +/- 20.53 vs 138.13 +/- 16.67; p = 0.002) with the Glaucoma application of the Spectralis OCT; and in all sectors, except the average, nasal superior, and temporal sectors, and parameters with the Axonal application of the Spectralis OCT. Temporal inferior RNFL thickness was significantly reduced in patients with severe fibromyalgia (FIQ >= 60) compared with patients with mild fibromyalgia (FIQ<60; 145.85 +/- 24.32 vs 138.99 +/- 18.09 mu m, respectively; 145.43 +/- 13.21 vs 139.85 +/- 13.09 mu m, p = 0.032 with the Glaucoma application and p = 0.021 with the Axonal application). The subgroup with biologic fibromyalgia exhibited significant thinning in the temporal inferior and superior sectors (115.17 +/- 20.82 mu m and 117.05 +/- 24.19 mu m, respectively) compared with the depressive (130.83 +/- 22.97 mu m and 127.71 +/- 26.10 mu m, respectively) and atypical (128.60 +/- 26.54 mu m and 125.55 +/- 23.65 mu m, respectively) subgroups (p = 0.005 and 0.001 respectively). Conclusions Fibromyalgia causes subclinical axonal damage in the RNFL that can be detected using innocuous and non-invasive OCT, even in the early disease stages. The impact on the RNFL in the temporal sectors is greater in patients with biologic fibromyalgia, suggesting the presence of neurodegenerative processes in this subgroup of patients with fibromyalgia.	[Garcia-Martin, Elena; Gutierrez-Ruiz, Fernando; Vilades, Elisa; Polo, Vicente; Larrosa, Jose M.; Pablo, Luis E.; Satue, Maria] Miguel Servet Univ Hosp, Dept Ophthalmol, Zaragoza, Spain; [Garcia-Martin, Elena; Garcia-Campayo, Javier; Puebla-Guedea, Marta; Ascaso, Francisco J.; Gutierrez-Ruiz, Fernando; Vilades, Elisa; Polo, Vicente; Larrosa, Jose M.; Pablo, Luis E.; Satue, Maria] IIS Aragon, Aragones Inst Hlth Res, Zaragoza, Spain; [Garcia-Campayo, Javier; Puebla-Guedea, Marta] Miguel Servet Univ Hosp, Dept Psychiat, Red Invest Atenc Primaria REDIAPP, Zaragoza, Spain; [Ascaso, Francisco J.] Lozano Blesa Univ Hosp, Dept Ophthalmol, Zaragoza, Spain; [Roca, Miguel] Univ Balearic Isl, Inst Univ Invest Ciencies Salut IUNICS, Palma De Mallorca, Spain	Miguel Servet University Hospital; Miguel Servet University Hospital; Lozano Blesa University Clinical Hospital; Universitat de les Illes Balears	Garcia-Martin, E (corresponding author), Miguel Servet Univ Hosp, Dept Ophthalmol, Zaragoza, Spain.; Garcia-Martin, E (corresponding author), IIS Aragon, Aragones Inst Hlth Res, Zaragoza, Spain.	egmvivax@yahoo.com	PUYUELO, FCO. JAVIER ASCASO/I-8426-2019; Roca, Miquel/T-9897-2017	Roca, Miquel/0000-0001-7301-8373; Polo Llorens, Vicente/0000-0002-1402-3129; Garcia-Campayo, Javier/0000-0002-3797-4218; GARCIA-MARTIN, ELENA/0000-0001-6258-2489; Satue, Maria/0000-0002-1609-5994; Perez-Olivan, Susana/0000-0003-3513-4714; Larrosa, Jose Manuel/0000-0003-4403-4854; Larrosa Poves, Jose Manuel/0000-0002-6745-7668; Pablo, Luis/0000-0003-2389-8282				Aaker GD, 2010, CLIN OPHTHALMOL, V4, P1427, DOI 10.2147/OPTH.S15136; Almarcegui C, 2010, NEUROPHYSIOL CLIN, V40, P129, DOI 10.1016/j.neucli.2009.12.001; Badia X, 1999, MED CLIN-BARCELONA, V112, P79; Bennett RM, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-27; Clauw DJ, 2011, MAYO CLIN PROC, V86, P907, DOI 10.4065/mcp.2011.0206; Foerster BR, 2011, AM J NEURORADIOL, V32, P1873, DOI 10.3174/ajnr.A2614; Garcia-Campayo J, 2009, CURR OPIN PSYCHIATR, V22, P224, DOI 10.1097/YCO.0b013e3283252d43; Garcia-Martin E, 2014, OPHTHALMOLOGY, V121, P573, DOI 10.1016/j.ophtha.2013.09.035; Garcia-Martin E, 2013, NEUROLOGY, V81, P76, DOI 10.1212/WNL.0b013e318299ccd9; Garcia-Martin E, 2012, OPHTHALMOLOGY, V119, P2161, DOI 10.1016/j.ophtha.2012.05.003; Garcia-Martin E, 2012, OPHTHALMOLOGY, V119, P1705, DOI 10.1016/j.ophtha.2012.01.046; Garcia-Martin E, 2011, BRIT J OPHTHALMOL, V95, P1577, DOI 10.1136/bjo.2010.199232; Giesecke T, 2003, ARTHRITIS RHEUM, V48, P2916, DOI 10.1002/art.11272; Goldenberg DL, 2009, AM J MED, V122, P14; Gracely RH, 2002, ARTHRITIS RHEUM-US, V46, P1333, DOI 10.1002/art.10225; Grazioli E, 2008, J NEUROL SCI, V268, P12, DOI 10.1016/j.jns.2007.10.020; Gupta Preeya K, 2011, Open Neurol J, V5, P1, DOI 10.2174/1874205X01105010001; Jensen KB, 2013, ARTHRITIS RHEUM-US, V65, P3293, DOI 10.1002/art.38170; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; Larrosa JM, 2014, INVEST OPHTH VIS SCI, V55, P3043, DOI 10.1167/iovs.13-13629; Mountz JM, 1998, AM J MED SCI, V315, P385, DOI 10.1097/00000441-199806000-00007; Noval S, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/472790; Polo V, 2014, EYE, V28, P680, DOI 10.1038/eye.2014.51; Pulicken M, 2007, NEUROLOGY, V69, P2085, DOI 10.1212/01.wnl.0000294876.49861.dc; Ratchford JN, 2009, NEUROLOGY, V73, P302, DOI 10.1212/WNL.0b013e3181af78b8; Rivera J, 2004, CLIN EXP RHEUMATOL, V22, P554; Saidha S, 2013, JAMA NEUROL, V70, P34, DOI 10.1001/jamaneurol.2013.573; Satue M, 2014, BRIT J OPHTHALMOL, V98, P350, DOI 10.1136/bjophthalmol-2013-304152; Schuman JS, 1996, OPHTHALMOLOGY, V103, P1889, DOI 10.1016/S0161-6420(96)30410-7; Shokouhi M, 2016, CLIN J PAIN, V32, P495, DOI 10.1097/AJP.0000000000000295; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wu ZQ, 2009, J GLAUCOMA, V18, P213, DOI 10.1097/IJG.0b013e31817eee20	32	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161574	10.1371/journal.pone.0161574	http://dx.doi.org/10.1371/journal.pone.0161574			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584145	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600042
J	Ramalhosa, F; Soares-Cunha, C; Seixal, RM; Sousa, N; Carvalho, F				Ramalhosa, Fatima; Soares-Cunha, Carina; Seixal, Rui Miguel; Sousa, Nuno; Carvalho, Franky			The Impact of Prenatal Exposure to Dexamethasone on Gastrointestinal Function in Rats	PLOS ONE			English	Article							NEONATAL MATERNAL SEPARATION; ENTERIC NERVOUS-SYSTEM; IRRITABLE-BOWEL-SYNDROME; EPIDERMAL-GROWTH-FACTOR; INTERSTITIAL-CELLS; ANTENATAL CORTICOSTEROIDS; GASTRIC-MOTILITY; POSTNATAL-DEVELOPMENT; TRYPTOPHAN-HYDROXYLASE; INTESTINAL MOTILITY	Antenatal treatment with synthetic glucocorticoids is commonly used in pregnant women at risk of preterm delivery to accelerate tissue maturation. Exposure to glucocorticoids during development has been hypothesized to underlie different functional gastrointestinal (GI) and motility disorders. Herein, we investigated the impact of in utero exposure to synthetic glucocorticoids (iuGC) on GI function of adult rats. Wistar male rats, born from pregnant dams treated with dexamethasone (DEX), were studied at different ages. Length, histologic analysis, proliferation and apoptosis assays, GI transit, permeability and serotonin (5-HT) content of GI tract were measured. iuGC treatment decreased small intestine size and decreased gut transit. However, iuGC had no impact on intestinal permeability. iuGC differentially impacts the structure and function of the GI tract, which leads to long-lasting alterations in the small intestine that may predispose subjects prone to disorders of the GI tract.	[Ramalhosa, Fatima; Soares-Cunha, Carina; Seixal, Rui Miguel; Sousa, Nuno; Carvalho, Franky] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst, Braga, Portugal; [Ramalhosa, Fatima; Soares-Cunha, Carina; Seixal, Rui Miguel; Sousa, Nuno; Carvalho, Franky] Life & Hlth Sci Res Inst Biomaterials, Biodegradables & Biometr Associate Lab, Braga, Portugal; [Carvalho, Franky] Hosp Braga, Dept Gen Surg, Braga, Portugal; [Sousa, Nuno] Univ Minho, Life & Hlth Sci Res Inst ICVS, Campus Gualtar, P-4710057 Braga, Portugal	Universidade do Minho; Hospital de Braga; Universidade do Minho	Ramalhosa, F (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst, Braga, Portugal.; Ramalhosa, F (corresponding author), Life & Hlth Sci Res Inst Biomaterials, Biodegradables & Biometr Associate Lab, Braga, Portugal.	fatimaramalhosa@ecsaude.uminho.pt	Ramalhosa, FÃtima/L-3648-2019; Sousa, Nuno JC/N-9137-2017; Soares-Cunha, Carina/T-5091-2018	Sousa, Nuno JC/0000-0002-8755-5126; Seixal, Rui/0000-0002-6932-9432; Soares-Cunha, Carina/0000-0001-9470-644X; Ramalhosa, Fatima/0000-0003-4986-4320; Carvalho, Ana/0000-0002-5901-0399	Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/52058/2012, SFRH/BD/51992/2012]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	We acknowledge the Portuguese Foundation for Science and Technology (FCT) for providing a fellowship to Fatima Ramalhosa (SFRH/BD/52058/2012) and Carina Soares-Cunha (SFRH/BD/51992/2012).	Anderson RB, 2000, LANDES BIOSCIENCE; AZMITIA EC, 1993, J NEUROSCI, V13, P5041, DOI 10.1523/JNEUROSCI.13-12-05041.1993; Babygirija R, 2010, AM J PHYSIOL-REG I, V298, pR157, DOI 10.1152/ajpregu.00328.2009; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Barreau F, 2007, PEDIATR RES, V62, P240, DOI 10.1203/PDR.0b013e3180db2949; Bergmann KR, 2013, AM J PATHOL, V182, P1595, DOI 10.1016/j.ajpath.2013.01.013; BERSETH CL, 1987, AM J PHYSIOL, V253, pG662, DOI 10.1152/ajpgi.1987.253.5.G662; Biology C, 1998, SITU, P36; Jimenez MB, 2009, REV ESP ENFERM DIG, V101, P553, DOI 10.4321/s1130-01082009000800006; BLAKE HH, 1983, AM J PHYSIOL, V244, pR537, DOI 10.1152/ajpregu.1983.244.4.R537; Bradford K, 2012, CLIN GASTROENTEROL H, V10, P385, DOI 10.1016/j.cgh.2011.12.018; BRANCHEK TA, 1989, J COMP NEUROL, V285, P262, DOI 10.1002/cne.902850208; BRANCHEK TA, 1987, J COMP NEUROL, V258, P597, DOI 10.1002/cne.902580409; Brownfoot FC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006764.pub3; Bulbul M, 2012, AM J PHYSIOL-GASTR L, V302, pG702, DOI 10.1152/ajpgi.00447.2011; Burns AJ, 2009, SEMIN PEDIATR SURG, V18, P196, DOI 10.1053/j.sempedsurg.2009.07.001; Carai MAM, 2004, EUR J PHARMACOL, V494, P221, DOI 10.1016/j.ejphar.2004.05.005; Chang L, 2009, NEUROGASTROENT MOTIL, V21, P149, DOI 10.1111/j.1365-2982.2008.01171.x; Chen M, 2011, WORLD J GASTROENTERO, V17, P2933, DOI 10.3748/wjg.v17.i24.2933; Chmielewski V, 2000, IMMUNOL CELL BIOL, V78, P238, DOI 10.1046/j.1440-1711.2000.00905.x; Cho Won Kyoung, 2016, Korean J Pediatr, V59, P1, DOI 10.3345/kjp.2016.59.1.1; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Clarke G, 2009, TRENDS MOL MED, V15, P478, DOI 10.1016/j.molmed.2009.08.001; Coates MD, 2006, NEUROGASTROENT MOTIL, V18, P464, DOI 10.1111/j.1365-2982.2006.00792.x; Collins J, 2014, NEUROGASTROENT MOTIL, V26, P98, DOI 10.1111/nmo.12236; Costalos C, 2003, EARLY HUM DEV, V74, P83, DOI 10.1016/S0378-3782(03)00087-2; Coutinho SV, 2002, AM J PHYSIOL-GASTR L, V282, pG307, DOI 10.1152/ajpgi.00240.2001; CROWLEY P, 1990, BRIT J OBSTET GYNAEC, V97, P11, DOI 10.1111/j.1471-0528.1990.tb01711.x; Crowther CA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-104; Der-Silaphet T, 1998, GASTROENTEROLOGY, V114, P724, DOI 10.1016/S0016-5085(98)70586-4; Di Mauro A, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-15; DIORIO D, 1993, J NEUROSCI, V13, P3839; Enomoto H, 2009, NEUROGASTROENT MOTIL, V21, P684, DOI 10.1111/j.1365-2982.2009.01325.x; Falcone RA, 2000, J PEDIATR SURG, V35, P365, DOI 10.1016/S0022-3468(00)90042-3; FaussonePellegrini MS, 1996, ACTA ANAT, V155, P113; Fidalgo S, 2013, BIOGERONTOLOGY, V14, P21, DOI 10.1007/s10522-012-9406-3; Finlay BL, 1998, BRAIN BEHAV EVOLUT, V52, P232, DOI 10.1159/000006566; French NP, 2004, AM J OBSTET GYNECOL, V190, P588, DOI 10.1016/j.ajog.2003.12.016; Gareau MG, 2008, CURR MOL MED, V8, P274, DOI 10.2174/156652408784533760; Gartner H, 2003, J CELL PHYSIOL, V194, P80, DOI 10.1002/jcp.10189; Gianino S, 2003, DEVELOPMENT, V130, P2187, DOI 10.1242/dev.00433; Gordon PV, 2001, PEDIATR DEVEL PATHOL, V4, P532, DOI 10.1007/s10024001-0096-0; Guan YF, 2003, BRAIN RES, V984, P33, DOI 10.1016/S0006-8993(03)03016-6; Gwynne RM, 2007, AM J PHYSIOL-GASTR L, V292, pG1162, DOI 10.1152/ajpgi.00441.2006; Han J, 2010, HISTOCHEM CELL BIOL, V133, P163, DOI 10.1007/s00418-009-0655-4; Hao MM, 2010, NEUROGASTROENT MOTIL, V22, pe127, DOI 10.1111/j.1365-2982.2009.01462.x; Hassan AHS, 1996, EXP NEUROL, V140, P43, DOI 10.1006/exnr.1996.0113; Haynes LE, 2001, NEUROSCIENCE, V104, P57, DOI 10.1016/S0306-4522(01)00070-7; He X, 2012, CELLS TISSUES ORGANS, V196, P175, DOI 10.1159/000332381; HENNING SJ, 1981, AM J PHYSIOL, V241, pG199, DOI 10.1152/ajpgi.1981.241.3.G199; HENNING SJ, 1978, AM J PHYSIOL, V235, pE451, DOI 10.1152/ajpendo.1978.235.5.E451; Hiroi R, 2016, NEUROSCIENCE, V320, P43, DOI 10.1016/j.neuroscience.2016.01.055; Hirvikoski T, 2007, J CLIN ENDOCR METAB, V92, P542, DOI 10.1210/jc.2006-1340; Huot RL, 2001, PSYCHOPHARMACOLOGY, V158, P366, DOI 10.1007/s002130100701; HURLEYGIUS KM, 1986, BRAIN RES, V365, P241, DOI 10.1016/0006-8993(86)91635-5; KEDINGER M, 1990, DIFFERENTIATION, V43, P87, DOI 10.1111/j.1432-0436.1990.tb00434.x; Keightley MC, 1998, ENDOCRINOLOGY, V139, P2479, DOI 10.1210/en.139.5.2479; Klooker TK, 2009, AM J GASTROENTEROL, V104, P2250, DOI 10.1038/ajg.2009.282; LEES GJ, 1993, J NEUROL SCI, V114, P119, DOI 10.1016/0022-510X(93)90285-7; Liu DR, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-30; Liu MT, 2009, J NEUROSCI, V29, P9683, DOI 10.1523/JNEUROSCI.1145-09.2009; Lundgren O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016295; Luo JC, 2003, J PHARMACOL EXP THER, V307, P692, DOI 10.1124/jpet.103.055202; MAJUMDAR APN, 1985, SCAND J GASTROENTERO, V20, P65, DOI 10.3109/00365528509089634; Marciniak B, 2011, CURR PHARM BIOTECHNO, V12, P750, DOI 10.2174/138920111795470868; MARTIN GR, 1984, AM J PHYSIOL, V246, pG695, DOI 10.1152/ajpgi.1984.246.6.G695; Matini P, 1997, CELL TISSUE RES, V288, P11, DOI 10.1007/s004410050788; Mesquita AR, 2009, SEMIN FETAL NEONAT M, V14, P130, DOI 10.1016/j.siny.2008.11.002; MIETTINEN PJ, 1993, PEDIATR RES, V33, P481, DOI 10.1203/00006450-199305000-00012; Mihatsch WA, 2005, BIOL NEONATE, V87, P160, DOI 10.1159/000082367; Miracle X, 2008, J PERINAT MED, V36, P191, DOI 10.1515/JPM.2008.032; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Moussaoui N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088382; Nagano M, 2012, NEUROPHARMACOLOGY, V63, P292, DOI 10.1016/j.neuropharm.2012.03.027; Nahata M, 2014, NEUROGASTROENT MOTIL, V26, P821, DOI 10.1111/nmo.12336; Nanthakumar NN, 2013, GLYCOBIOLOGY, V23, P1131, DOI 10.1093/glycob/cwt050; NANTHAKUMAR NN, 1993, AM J PHYSIOL, V264, pG306, DOI 10.1152/ajpgi.1993.264.2.G306; Nasyrova DI, 2009, J EVOL BIOCHEM PHYS+, V45, P78, DOI 10.1134/S0022093009010074; Neal CR, 2004, AM J PHYSIOL-REG I, V287, pR375, DOI 10.1152/ajpregu.00012.2004; Nijenhuis CM, 2012, BRIT J CLIN PHARMACO, V73, P16, DOI 10.1111/j.1365-2125.2011.04075.x; Noorlander CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085671; O'Mahony SM, 2011, PSYCHOPHARMACOLOGY, V214, P71, DOI 10.1007/s00213-010-2010-9; Oines E, 2012, PHYSIOL BEHAV, V105, P1058, DOI 10.1016/j.physbeh.2011.11.024; Oliveira M, 2006, BIOL PSYCHIAT, V59, P844, DOI 10.1016/j.biopsych.2005.08.020; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Orazizadeh M, 2010, ANDROLOGIA, V42, P247, DOI 10.1111/j.1439-0272.2009.00985.x; Pacha J, 2003, PEDIATR RES, V53, P808, DOI 10.1203/01.PDR.0000058923.08017.6F; Panteleev S, 2000, AUTON NEUROSCI-BASIC, V86, P78, DOI 10.1016/S1566-0702(00)00249-6; PRESSLEY L, 1975, ENDOCRINOLOGY, V97, P588, DOI 10.1210/endo-97-3-588; Ren TH, 2007, AM J PHYSIOL-GASTR L, V292, pG849, DOI 10.1152/ajpgi.00400.2006; Rich-Edwards JW, 2005, BMJ-BRIT MED J, V330, P1115, DOI 10.1136/bmj.38434.629630.E0; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Roberts RR, 2010, J PHYSIOL-LONDON, V588, P1153, DOI 10.1113/jphysiol.2009.185421; Rodrigues AJ, 2012, MOL PSYCHIATR, V17, P1295, DOI 10.1038/mp.2011.126; Roque S, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00004; Sanders KM, 2006, ANNU REV PHYSIOL, V68, P307, DOI 10.1146/annurev.physiol.68.040504.094718; Schaeffer C, 2000, GUT, V47, P192, DOI 10.1136/gut.47.2.192; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Severi C, 2014, EUR J HISTOCHEM, V58, P307, DOI 10.4081/ejh.2014.2457; Sheppard KE, 1999, AM J PHYSIOL-GASTR L, V277, pG541, DOI 10.1152/ajpgi.1999.277.3.G541; Sikander A, 2009, CLIN CHIM ACTA, V403, P47, DOI 10.1016/j.cca.2009.01.028; Smith JT, 2000, ENDOCRINOLOGY, V141, P2422, DOI 10.1210/en.141.7.2422; Sze CI, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/628094; SZE PY, 1980, DEV NEUROSCI-BASEL, V3, P217, DOI 10.1159/000112394; Thacker M, 2011, NEUROGASTROENT MOTIL, V23, pE500, DOI 10.1111/j.1365-2982.2011.01696.x; TRAUTMAN PD, 1995, PSYCHONEUROENDOCRINO, V20, P439, DOI 10.1016/0306-4530(94)00070-0; VANEEKELEN JAM, 1992, PROG HISTOCHEM CYTOC, V26, P250, DOI 10.1016/S0079-6336(11)80102-6; Velisek L, 2006, NEUROPSYCHOPHARMACOL, V31, P2140, DOI 10.1038/sj.npp.1301016; Wallace AS, 2009, NEUROGASTROENT MOTIL, V21, P768, DOI 10.1111/j.1365-2982.2009.01309.x; Ward SM, 2004, NEUROGASTROENT MOTIL, V16, P112, DOI 10.1111/j.1743-3150.2004.00485.x; Welberg LAM, 2001, NEUROSCIENCE, V104, P71, DOI 10.1016/S0306-4522(01)00065-3; WEST MJ, 1990, PROG BRAIN RES, V83, P13; Wester T, 1999, GUT, V44, P65, DOI 10.1136/gut.44.1.65; Wigger A, 1999, PHYSIOL BEHAV, V66, P293, DOI 10.1016/S0031-9384(98)00300-X; Young HM, 1996, DEV BIOL, V180, P97, DOI 10.1006/dbio.1996.0287	116	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161750	10.1371/journal.pone.0161750	http://dx.doi.org/10.1371/journal.pone.0161750			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584049	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600053
J	Boyan, BD; Hyzy, SL; Pan, QF; Scott, KM; Coutts, RD; Healey, R; Schwartz, Z				Boyan, Barbara D.; Hyzy, Sharon L.; Pan, Qingfen; Scott, Kayla M.; Coutts, Richard D.; Healey, Robert; Schwartz, Zvi			24R,25-Dihydroxyvitamin D3 Protects against Articular Cartilage Damage following Anterior Cruciate Ligament Transection in Male Rats	PLOS ONE			English	Article							GROWTH-PLATE CHONDROCYTES; VITAMIN-D METABOLITES; FACTOR-BETA; KNEE OSTEOARTHRITIS; SUBCHONDRAL BONE; 1,25-DIHYDROXYVITAMIN D-3; MATRIX-METALLOPROTEINASE; MENISCECTOMIZED MODELS; FUNCTIONAL LIMITATIONS; CELL MATURATION	Osteoarthritis (OA) in humans is associated with low circulating 25-hydroxyvitamin D3 [25(OH)D-3]. In vitamin D replete rats, radiolabeled 24R,25-dihydroxyvitamin D3 [24R,25(OH)(2)D-3] accumulates in articular cartilage following injection of [H-3]-25(OH)D-3. Previously, we showed that 24R,25(OH)(2)D-3 blocks chondrocyte apoptosis via phospholipase D and p53, suggesting a role for 24R,25(OH)(2)D-3 in maintaining cartilage health. We examined the ability of 24R,25(OH)(2)D-3 to prevent degenerative changes in articular cartilage in an OA-like environment and the potential mechanisms involved. In vitro, rat articular chondrocytes were treated with IL-1 beta with and without 24R,25(OH)(2)D-3 or 1 alpha,25(OH)(2)D-3. 24R,25(OH)(2)D-3 but not 1 alpha,25(OH)(2)D-3 blocked the effects of IL-1 beta in a dose-dependent manner, and its effect was partially mediated through the TGF-beta 1 signaling pathway. In vivo, unilateral anterior cruciate ligament transections were performed in immunocompetent rats followed by intra-articular injections of 24R,25(OH)(2)D-3 or vehicle (t = 0, 7, 14, 21 days). Tissues were harvested on day 28. Joints treated with vehicle had changes typical of OA whereas joints treated with 24R,25(OH)(2)D-3 had less articular cartilage damage and levels of inflammatory mediators. These results indicate that 24R,25(OH)(2)D-3 protects against OA, and suggest that it may be a therapeutic approach for preventing trauma-induced osteoarthritis.	[Boyan, Barbara D.; Hyzy, Sharon L.; Scott, Kayla M.; Schwartz, Zvi] Virginia Commonwealth Univ, Sch Engn, Dept Biomed Engn, Richmond, VA 23284 USA; [Boyan, Barbara D.] Georgia Tech, Wallace H Coulter Dept Biomed Engn, Atlanta, GA USA; [Boyan, Barbara D.] Emory Univ, Georgia Inst Technol, Coll Engn, Atlanta, GA 30322 USA; [Pan, Qingfen] Georgia Inst Technol, Sch Mech Engn, Coll Engn, Atlanta, GA 30332 USA; [Coutts, Richard D.; Healey, Robert] Univ Calif San Diego, Dept Orthoped Surg, San Diego, CA 92103 USA; [Schwartz, Zvi] Univ Texas Hlth Sci Ctr San Antonio, Dept Periodont, San Antonio, TX 78229 USA	Virginia Commonwealth University; University System of Georgia; Georgia Institute of Technology; Emory University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University of California System; University of California San Diego; University of Texas System; University of Texas Health San Antonio	Boyan, BD (corresponding author), Virginia Commonwealth Univ, Sch Engn, Dept Biomed Engn, Richmond, VA 23284 USA.; Boyan, BD (corresponding author), Georgia Tech, Wallace H Coulter Dept Biomed Engn, Atlanta, GA USA.; Boyan, BD (corresponding author), Emory Univ, Georgia Inst Technol, Coll Engn, Atlanta, GA 30322 USA.	bboyan@vcu.edu			Society for Women's Health Research; Price Gilbert Jr. Foundation	Society for Women's Health Research; Price Gilbert Jr. Foundation	This research was supported by grants from the Society for Women's Health Research [http://www.womenshealthresearch.org/] and the Price Gilbert Jr. Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleton CTG, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2120; Batiste DL, 2004, OSTEOARTHR CARTILAGE, V12, P986, DOI 10.1016/j.joca.2004.08.010; Bauge C, 2007, ARTHRITIS RHEUM, V56, P3020, DOI 10.1002/art.22840; Boyan BD, 2010, J STEROID BIOCHEM, V121, P212, DOI 10.1016/j.jsbmb.2010.03.057; Boyan BD, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-3; BOYAN BD, 1988, ENDOCRINOLOGY, V122, P2851, DOI 10.1210/endo-122-6-2851; Boyan BD, 2004, VITAMIN D; Caron JP, 1996, ARTHRITIS RHEUM, V39, P1535, DOI 10.1002/art.1780390914; CHANDRASEKHAR S, 1988, BIOCHEM BIOPH RES CO, V157, P1352, DOI 10.1016/S0006-291X(88)81024-6; Chen DF, 2013, INT J BIOL SCI, V9, P649, DOI 10.7150/ijbs.6726; Chen JX, 2010, J BIOL CHEM, V285, P37041, DOI 10.1074/jbc.M110.157115; Chen WJ, 1999, MICROBES INFECT, V1, P1367, DOI 10.1016/S1286-4579(99)00249-X; Coleman RM, 2013, TISSUE ENG PT A, V19, P475, DOI [10.1089/ten.tea.2012.0125, 10.1089/ten.TEA.2012.0125]; Denison TA, 2009, J CELL BIOCHEM, V107, P155, DOI 10.1002/jcb.22111; Dillon CF, 2006, J RHEUMATOL, V33, P2271; Elisseeff J, 2001, J ORTHOP RES, V19, P1098, DOI 10.1016/S0736-0266(01)00054-7; Elsaid KA, 2008, ARTHRITIS RHEUM-US, V58, P1707, DOI 10.1002/art.23495; FAIRNEY A, 1987, ANN RHEUM DIS, V46, P370, DOI 10.1136/ard.46.5.370; Felson DT, 2007, ARTHRITIS RHEUM-US, V56, P129, DOI 10.1002/art.22292; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Fuerst M, 2009, ARTHRITIS RHEUM, V60, P2694, DOI 10.1002/art.24774; Galois L, 2004, OSTEOARTHR CARTILAGE, V12, P779, DOI 10.1016/j.joca.2004.06.008; Gerwin N, 2010, OSTEOARTHR CARTILAGE, V18, pS24, DOI 10.1016/j.joca.2010.05.030; Goldring MB, 2011, CURR OPIN RHEUMATOL, V23, P471, DOI 10.1097/BOR.0b013e328349c2b1; Goldring SR, 2009, MED CLIN N AM, V93, P25, DOI 10.1016/j.mcna.2008.09.006; Griffin TM, 2005, EXERC SPORT SCI REV, V33, P195, DOI 10.1097/00003677-200510000-00008; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; Hayami T, 2006, BONE, V38, P234, DOI 10.1016/j.bone.2005.08.007; Hayami T, 2004, ARTHRITIS RHEUM-US, V50, P1193, DOI 10.1002/art.20124; Hurst-Kennedy J, 2010, J STEROID BIOCHEM, V122, P264, DOI 10.1016/j.jsbmb.2010.05.010; IWASAKI M, 1993, ENDOCRINOLOGY, V132, P1603, DOI 10.1210/en.132.4.1603; Jackson AR, 2009, CURR RHEUMATOL REV, V5, P40, DOI 10.2174/157339709787315320; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kanwar JR, 2015, DRUG DES DEV THER, V9, P2927, DOI 10.2147/DDDT.S77369; Kawamura K, 2005, EXP HEMATOL, V33, P865, DOI 10.1016/j.exphem.2005.05.010; KNUTSON JC, 1974, BIOCHEMISTRY-US, V13, P1543, DOI 10.1021/bi00704a034; Kobayashi M, 2005, ARTHRITIS RHEUM-US, V52, P128, DOI 10.1002/art.20776; Koshy PJT, 2002, ARTHRITIS RHEUM, V46, P961, DOI 10.1002/art.10212; Lee JE, 2004, BIOMATERIALS, V25, P4163, DOI 10.1016/j.biomaterials.2003.10.057; Lee YJ, 2011, RHEUMATOL INT, V31, P1571, DOI 10.1007/s00296-010-1520-4; Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396; Lohmander LS, 2004, ARTHRITIS RHEUM-US, V50, P3145, DOI 10.1002/art.20589; McNary SM, 2014, TISSUE ENG PT A, V20, P921, DOI [10.1089/ten.tea.2013.0043, 10.1089/ten.TEA.2013.0043]; MISKO TP, 1993, ANAL BIOCHEM, V214, P11, DOI 10.1006/abio.1993.1449; Moody HR, 2012, J ANAT, V221, P47, DOI 10.1111/j.1469-7580.2012.01513.x; Nelson F, 2006, OSTEOARTHR CARTILAGE, V14, P114, DOI 10.1016/j.joca.2005.08.005; Neu CP, 2010, ARTHRITIS RHEUM-US, V62, P2680, DOI 10.1002/art.27577; Olivares-Navarrete R, 2013, SPINE J, V13, P1563, DOI 10.1016/j.spinee.2013.03.047; Pan QF, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0080-z; Pedrozo HA, 1999, J CELL BIOCHEM, V72, P151, DOI 10.1002/(SICI)1097-4644(19990101)72:1<151::AID-JCB16>3.3.CO;2-5; Pedrozo HA, 1999, CALCIFIED TISSUE INT, V64, P50, DOI 10.1007/s002239900578; Pedrozo HA, 1998, J CELL PHYSIOL, V177, P343, DOI 10.1002/(SICI)1097-4652(199811)177:2<343::AID-JCP16>3.0.CO;2-A; Pickarski M, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-197; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Relic B, 2001, J IMMUNOL, V166, P2775, DOI 10.4049/jimmunol.166.4.2775; Schwartz Z, 2001, CALCIFIED TISSUE INT, V69, P365, DOI 10.1007/s00223-001-1009-y; SCHWARTZ Z, 1989, J BONE MINER RES, V4, P199; SCHWARTZ Z, 1992, ENDOCRINOLOGY, V130, P2495, DOI 10.1210/en.130.5.2495; Schwartz Z, 2001, STEROIDS, V66, P683, DOI 10.1016/S0039-128X(01)00100-3; Seo EG, 1996, ENDOCRINE, V5, P147, DOI 10.1007/BF02738700; Setton LA, 1999, OSTEOARTHR CARTILAGE, V7, P2, DOI 10.1053/joca.1998.0170; Silver FH, 2001, CRIT REV BIOMED ENG, V29, P373, DOI 10.1615/CritRevBiomedEng.v29.i4.10; Smith GN, 1999, ARTHRITIS RHEUM, V42, P545, DOI 10.1002/1529-0131(199904)42:3<545::AID-ANR20>3.0.CO;2-4; Smith MD, 1997, J RHEUMATOL, V24, P365; Sylvia VL, 2001, BBA-MOL CELL RES, V1499, P209, DOI 10.1016/S0167-4889(00)00120-8; TANAKA Y, 1974, SCIENCE, V183, P1198, DOI 10.1126/science.183.4130.1198; Tetlow LC, 1999, ARTHRITIS RES, V1, P63, DOI 10.1186/ar12; Valderrabano Victor, 2010, J Aging Res, V2011, P374653, DOI 10.4061/2011/374653; Wachsmuth L, 2004, J RHEUMATOL, V31, P315; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Zhang FF, 2014, J NUTR, V144, P2002, DOI 10.3945/jn.114.193227; Zhong M, 2011, CALCIFIED TISSUE INT, V88, P96, DOI 10.1007/s00223-010-9433-5	73	19	20	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161782	10.1371/journal.pone.0161782	http://dx.doi.org/10.1371/journal.pone.0161782			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575371	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877200037
J	Cheng, F; Twardowski, L; Reifenberg, K; Winter, K; Canisius, A; Pross, E; Fan, JL; Schmitt, E; Shultz, LD; Lackner, KJ; Torzewski, M				Cheng, Fei; Twardowski, Laura; Reifenberg, Kurt; Winter, Kerstin; Canisius, Antje; Pross, Eva; Fan, Jianglin; Schmitt, Edgar; Shultz, Leonard D.; Lackner, Karl J.; Torzewski, Michael			Combined B, T and NK Cell Deficiency Accelerates Atherosclerosis in BALB/c Mice	PLOS ONE			English	Article							RECEPTOR-NULL MICE; APOLIPOPROTEIN-E; LYMPHOCYTE DEFICIENCY; IMMUNE-RESPONSES; KNOCKOUT MICE; HYPERCHOLESTEROLEMIA; EXPRESSION; LESIONS; MOUSE; DIET	This study focused on the unique properties of both the Ldlr knockout defect (closely mimicking the human situation) and the BALB/c (C) inbred mouse strain (Th-2 slanted immune response). We generated two immunodeficient strains with severe combined B- and T-cell immunodeficiency with or without a complete lack of natural killer cells to revisit the role of adaptive immune responses on atherogenesis. C-Ldlr(-/-) Rag1(-/-) mice, which show severe combined B- and T-cell immunodeficiency and C-Ldlr(-/-) Rag1(-/-) Il2rg(-/-) mice, which combine the T- and B-cell defect with a complete lack of natural killer cells and inactivation of multiple cytokine signalling pathways were fed an atherogenic Western type diet (WTD). Both B6Ldlr(-/-) and C-Ldlr(-/-) immunocompetent mice were used as controls. Body weights and serum cholesterol levels of both immunodeficient strains were significantly increased compared to C-Ldlr(-/-) controls, except for cholesterol levels of C-Ldlr(-/-) Rag1(-/-) double mutants after 12 weeks on the WTD. Quantification of the aortic sinus plaque area revealed that both strains of immunodeficient mice developed significantly more atherosclerosis compared to C-Ldlr(-/-) controls after 24 weeks on the WTD. Increased atherosclerotic lesion development in C-Ldlr(-/-) Rag1(-/-) Il2rg(-/-) triple mutants was associated with significantly increased numbers of macrophages and significantly decreased numbers of smooth muscle cells compared to both C-Ldlr(-/-) wild type and C-Ldlr(-/-) Rag1(-/-) double mutants pointing to a plaque destabilizing effect of NK cell loss. Collectively, the present study reveals a previously unappreciated complexity with regard to the impact of lymphocytes on lipoprotein metabolism and the role of lymphocyte subsets in plaque composition.	[Cheng, Fei; Winter, Kerstin; Pross, Eva] Dr Margarete Fischer Inst Clin Pharmacol, Stuttgart, Germany; [Cheng, Fei; Winter, Kerstin; Pross, Eva] Stuttgart & Univ Tubingen, Tubingen, Germany; [Twardowski, Laura; Torzewski, Michael] Robert Bosch Krankenhaus, Dept Lab Med, Stuttgart, Germany; [Reifenberg, Kurt] German Canc Res Ctr, Ctr Preclin Res, Heidelberg, Germany; [Canisius, Antje; Lackner, Karl J.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Clin Chem & Lab Med, Mainz, Germany; [Fan, Jianglin] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Pathol, Yamanashi, Japan; [Schmitt, Edgar] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Immunol, Mainz, Germany; [Shultz, Leonard D.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA	University of Stuttgart; Bosch; Robert Bosch Krankenhaus; Helmholtz Association; German Cancer Research Center (DKFZ); Johannes Gutenberg University of Mainz; University of Yamanashi; Johannes Gutenberg University of Mainz; Jackson Laboratory	Torzewski, M (corresponding author), Robert Bosch Krankenhaus, Dept Lab Med, Stuttgart, Germany.	michael.torzewski@rbk.de		Fan, Jianglin/0000-0002-1737-6130	Robert Bosch Foundation, Germany	Robert Bosch Foundation, Germany	This work was supported by the Robert Bosch Foundation, Germany. MT received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2014, CIRC RES, V114, P1640, DOI 10.1161/CIRCRESAHA.114.302761; Aslanian AM, 2005, ARTERIOSCL THROM VAS, V25, P628, DOI 10.1161/01.ATV.0000153046.59370.13; Caligiuri G, 2002, J CLIN INVEST, V109, P745, DOI 10.1172/JCI200207272; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Chen AS, 2014, J IMMUNOL, V193, P35, DOI 10.4049/jimmunol.1302469; Dansky HM, 1997, P NATL ACAD SCI USA, V94, P4642, DOI 10.1073/pnas.94.9.4642; Daugherty A, 1997, J CLIN INVEST, V100, P1575, DOI 10.1172/JCI119681; DESANCTIS JB, 1995, IMMUNOLOGY, V86, P399; Fan JL, 2001, J BIOL CHEM, V276, P40071, DOI 10.1074/jbc.M105456200; FYFE AI, 1994, J CLIN INVEST, V94, P2516, DOI 10.1172/JCI117622; Getz GS, 2011, THROMB HAEMOSTASIS, V106, P814, DOI 10.1160/TH11-05-0336; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; JUOMPAN L, 1994, BBA-MOL CELL RES, V1224, P1, DOI 10.1016/0167-4889(94)90106-6; Klingenberg R, 2013, J CLIN INVEST, V123, P1323, DOI 10.1172/JCI63891; Koike T, 2009, ARTERIOSCL THROM VAS, V29, P2047, DOI 10.1161/ATVBAHA.109.190264; Lai DZ, 2011, J EXP MED, V208, P1093, DOI 10.1084/jem.20101527; Lehr HA, 1997, J HISTOCHEM CYTOCHEM, V45, P1559, DOI 10.1177/002215549704501112; Libby P, 2013, IMMUNITY, V38, P1092, DOI 10.1016/j.immuni.2013.06.009; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Maczek C, 1996, J LIPID RES, V37, P1363; Major AS, 2002, ARTERIOSCL THROM VAS, V22, P1892, DOI 10.1161/01.ATV.0000039169.47943.EE; Martin-Murphy BV, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0080949, 10.1371/journal.pone.0103352, 10.1371/journal.pone.0109166]; Miyagi T, 2010, J GASTROENTEROL, V45, P1247, DOI 10.1007/s00535-010-0272-y; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nakai Y, 2004, BLOOD, V104, P2051, DOI 10.1182/blood-2003-10-3485; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Roselaar SE, 1998, J LIPID RES, V39, P1740; Schulte S, 2008, AM J PATHOL, V172, P1500, DOI 10.2353/ajpath.2008.070776; Schulz U, 2010, SCAND J IMMUNOL, V72, P319, DOI 10.1111/j.1365-3083.2010.02435.x; Selathurai A, 2014, CARDIOVASC RES, V102, P128, DOI 10.1093/cvr/cvu016; Song L, 2001, J CLIN INVEST, V108, P251, DOI 10.1172/JCI11380; Spencer MW, 2004, AM J NEPHROL, V24, P20, DOI 10.1159/000075362; Torzewski M, 2007, ARTERIOSCL THROM VAS, V27, P850, DOI 10.1161/01.ATV.0000258809.47285.07; VanderLaan PA, 2007, AM J PATHOL, V170, P1100, DOI 10.2353/ajpath.2007.060188; Whitman SC, 2004, ARTERIOSCL THROM VAS, V24, P1049, DOI 10.1161/01.ATV.0000124923.95545.2c; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhou XH, 1998, J CLIN INVEST, V101, P1717, DOI 10.1172/JCI1216	39	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0157311	10.1371/journal.pone.0157311	http://dx.doi.org/10.1371/journal.pone.0157311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564380	Green Published, gold, Green Submitted			2022-12-26	WOS:000382496300001
J	Press, MO; Lanctot, A; Queitsch, C				Press, Maximilian O.; Lanctot, Amy; Queitsch, Christine			PIF4 and ELF3 Act Independently in Arabidopsis thaliana Thermoresponsive Flowering	PLOS ONE			English	Article							EC NIGHTTIME REPRESSOR; CLOCK TRANSCRIPTIONAL CIRCUITRY; AMBIENT-TEMPERATURE; CIRCADIAN CLOCK; NATURAL VARIATION; TIME; GROWTH; LIGHT; INDUCTION; AUXIN	Plants have evolved elaborate mechanisms controlling developmental responses to environmental stimuli. A particularly important stimulus is temperature. Previous work has identified the interplay of PIF4 and ELF3 as a central circuit underlying thermal responses in Arabidopsis thaliana. However, thermal responses vary widely among strains, possibly offering mechanistic insights into the wiring of this circuit. ELF3 contains a polyglutamine (polyQ) tract that is crucial for ELF3 function and varies in length across strains. Here, we use transgenic analysis to test the hypothesis that natural polyQ variation in ELF3 is associated with the observed natural variation in thermomorphogenesis. We found little evidence that the polyQ tract plays a specific role in thermal responses beyond modulating general ELF3 function. Instead, we made the serendipitous discovery that ELF3 plays a crucial, PIF4-independent role in thermoresponsive flowering under conditions more likely to reflect field conditions. We present evidence that ELF3 acts through the photoperiodic pathway, pointing to a previously unknown symmetry between low and high ambient temperature responses. Moreover, in analyzing two strain backgrounds with different thermal responses, we demonstrate that responses may be shifted rather than fundamentally rewired across strains. Our findings tie together disparate observations into a coherent framework in which multiple pathways converge in accelerating flowering in response to temperature, with some such pathways modulated by photoperiod.	[Press, Maximilian O.; Queitsch, Christine] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Lanctot, Amy] Univ Washington, Dept Biol, Mol & Cellular Biol Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Queitsch, C (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	queitsch@uw.edu		Press, Maximilian/0000-0001-9233-2157	National Institutes of Health grant NIH New Innovator Award [DP2OD008371]; NSF [MCB-1516701]; NIH New Innovator Award [DP2OD008371]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008371] Funding Source: NIH RePORTER	National Institutes of Health grant NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant NIH New Innovator Award DP2OD008371 and NSF MCB-1516701 to CQ (https://commonfund.nih.gov/newinnovator/index). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Philip Wigge and Jaehoon Jung for ideas, helpful conversations, sharing unpublished data, and comments on this manuscript. We thank Evan Eichler for use of the LightCycler instrument. We thank members of the Queitsch lab for helpful discussions. This work was supported by NIH New Innovator Award DP2OD008371 and NSF MCB-1516701 to CQ.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; [Anonymous], 2021, LANG ENV STAT COMP; Bai MY, 2012, NAT CELL BIOL, V14, P810, DOI 10.1038/ncb2546; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Box MS, 2015, CURR BIOL, V25, P194, DOI 10.1016/j.cub.2014.10.076; Covington MF, 2001, PLANT CELL, V13, P1305, DOI 10.1105/tpc.13.6.1305; Duek PD, 2005, TRENDS PLANT SCI, V10, P51, DOI 10.1016/j.tplants.2004.12.005; Edwards K.D., 2015, BIORXIV, P30577, DOI [10.1101/030577, DOI 10.1101/030577]; Edwards KD, 2006, PLANT CELL, V18, P639, DOI 10.1105/tpc.105.038315; Edwards KD, 2005, GENETICS, V170, P387, DOI 10.1534/genetics.104.035238; Fernandez V, 2016, PLANT J, V86, P426, DOI 10.1111/tpj.13183; Filo J, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.4161/15592324.2014.992707; Galvao VC, 2015, PLANT J, V84, P949, DOI 10.1111/tpj.13051; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Gould PD, 2006, PLANT CELL, V18, P1177, DOI 10.1105/tpc.105.039990; Huq E, 2002, EMBO J, V21, P2441, DOI 10.1093/emboj/21.10.2441; Ibanez C, 2015, COLD SPRING HARBOR L, DOI [10.1101/0172851111/j.1365-313X.2009.03983.x, DOI 10.1101/0172851111/J.1365-313X.2009.03983.X]; Jang K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12071; Johansson H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5848; Kim WY, 2005, PLANT PHYSIOL, V139, P1557, DOI 10.1104/pp.105.067173; Kleinboelting N, 2012, NUCLEIC ACIDS RES, V40, pD1211, DOI 10.1093/nar/gkr1047; Koini MA, 2009, CURR BIOL, V19, P408, DOI 10.1016/j.cub.2009.01.046; Kumar SV, 2012, NATURE, V484, P242, DOI 10.1038/nature10928; Lee HJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6473; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Leivar P, 2011, TRENDS PLANT SCI, V16, P19, DOI 10.1016/j.tplants.2010.08.003; Liu JZ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00267; Lorenzo CD, 2016, PHOTOCHEM PHOTOBIOL, V92, P3, DOI 10.1111/php.12535; Lorrain S, 2008, PLANT J, V53, P312, DOI 10.1111/j.1365-313X.2007.03341.x; Luo Q, 2014, PLANT CELL, V26, P2441, DOI 10.1105/tpc.113.121657; McWatters HG, 2000, NATURE, V408, P716, DOI 10.1038/35047079; Mizuno T, 2015, PLANT CELL PHYSIOL, V56, P1738, DOI 10.1093/pcp/pcv094; Mizuno T, 2014, PLANT CELL PHYSIOL, V55, P2139, DOI 10.1093/pcp/pcu144; Mizuno T, 2014, PLANT CELL PHYSIOL, V55, P958, DOI 10.1093/pcp/pcu030; Nieto C, 2015, CURR BIOL, V25, P187, DOI 10.1016/j.cub.2014.10.070; Nomoto Y, 2012, PLANT CELL PHYSIOL, V53, P1950, DOI 10.1093/pcp/pcs137; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Nusinow DA, 2011, NATURE, V475, P398, DOI 10.1038/nature10182; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Proveniers MCG, 2013, TRENDS PLANT SCI, V18, P59, DOI 10.1016/j.tplants.2012.09.002; Quint M, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2015.190, 10.1038/NPLANTS.2015.190]; Raschke A, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0566-6; Sawa M, 2011, P NATL ACAD SCI USA, V108, P11698, DOI 10.1073/pnas.1106771108; Sawyer LA, 1997, SCIENCE, V278, P2117, DOI 10.1126/science.278.5346.2117; Seaton DD, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145766; Song YH, 2013, TRENDS PLANT SCI, V18, P575, DOI 10.1016/j.tplants.2013.05.003; Stavang JA, 2009, PLANT J, V60, P589, DOI 10.1111/j.1365-313X.2009.03983.x; Strasser B, 2009, PLANT J, V58, P629, DOI 10.1111/j.1365-313X.2009.03811.x; Sun JQ, 2013, PLANT CELL, V25, P2102, DOI 10.1105/tpc.113.112417; Thines B, 2010, P NATL ACAD SCI USA, V107, P3257, DOI 10.1073/pnas.0911006107; Thines BC, 2014, J EXP BOT, V65, P1141, DOI 10.1093/jxb/ert487; Undurraga SF, 2012, P NATL ACAD SCI USA, V109, P19363, DOI 10.1073/pnas.1211021109; Uversky VN, 2009, PROTEIN J, V28, P305, DOI 10.1007/s10930-009-9201-4; van Zanten M, 2009, PLANT PHYSIOL, V151, P1446, DOI 10.1104/pp.109.144386; Wigge PA, 2013, CURR OPIN PLANT BIOL, V16, P661, DOI 10.1016/j.pbi.2013.08.004; Zagotta MT, 1996, PLANT J, V10, P691, DOI 10.1046/j.1365-313X.1996.10040691.x	58	11	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161791	10.1371/journal.pone.0161791	http://dx.doi.org/10.1371/journal.pone.0161791			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564448	Green Published, Green Submitted, gold			2022-12-26	WOS:000382496300019
J	Yeboah-Manu, D; Asare, P; Asante-Poku, A; Otchere, ID; Osei-Wusu, S; Danso, E; Forson, A; Koram, KA; Gagneux, S				Yeboah-Manu, Dorothy; Asare, P.; Asante-Poku, A.; Otchere, I. D.; Osei-Wusu, S.; Danso, E.; Forson, A.; Koram, K. A.; Gagneux, Sebastien			Spatio-Temporal Distribution of Mycobacterium tuberculosis Complex Strains in Ghana	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; AFRICANUM; MEMBER; BOVIS; VIRULENCE; CAMEROON; NOV	Background There is a perception that genomic differences in the species/lineages of the nine species making the Mycobacterium tuberculosis complex (MTBC) may affect the efficacy of distinct control tools in certain geographical areas. We therefore analyzed the prevalence and spatial distribution of MTBC species and lineages among isolates from pulmonary TB cases over an 8-year period, 2007-2014. Methodology Mycobacterial species isolated by culture from consecutively recruited pulmonary tuberculosis patients presenting at selected district/sub-district health facilities were confirmed as MTBC by IS6110 and rpo beta PCR and further assigned lineages and sub lineages by spoligo-typing and large sequence polymorphism PCR (RDs 4, 9, 12, 702, 711) assays. Patient characteristics, residency, and risks were obtained with a structured questionnaire. We used SaTScan and ArcMap analyses to identify significantly clustered MTBC lineages within selected districts and spatial display, respectively. Results Among 2,551 isolates, 2,019 (79.1%), 516 (20.2%) and 16 (0.6%) were identified as M. tuberculosis sensu stricto (MTBss), M. africanum (Maf), 15 M. bovis and 1 M. caprae, respectively. The proportions of MTBss and Maf were fairly constant within the study period. Maf spoligotypes were dominated by Spoligotype International Type (SIT) 331 (25.42%), SIT 326 (15.25%) and SIT 181 (14.12%). We found M. bovis to be significantly higher in Northern Ghana (1.9% of 212) than Southern Ghana (0.5% of 2339) (p = 0.020). Using the purely spatial and space-time analysis, seven significant MTBC lineage clusters (p < 0.05) were identified. Notable among the clusters were Ghana and Cameroon sub-lineages found to be associated with north and south, respectively. Conclusion This study demonstrated that overall, 79.1% of TB in Ghana is caused by MTBss and 20% by M. africanum. Unlike some West African Countries, we did not observe a decline of Maf prevalence in Ghana.	[Yeboah-Manu, Dorothy; Asare, P.; Asante-Poku, A.; Otchere, I. D.; Osei-Wusu, S.; Danso, E.; Koram, K. A.] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Accra, Ghana; [Forson, A.] Korle Bu Teaching Hosp, Dept Chest Dis, Korle Bu, Accra, Ghana; [Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; [Gagneux, Sebastien] Univ Basel, Basel, Switzerland	University of Ghana; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Yeboah-Manu, D (corresponding author), Univ Ghana, Noguchi Mem Inst Med Res, Legon, Accra, Ghana.	dyeboah-manu@noguchi.ug.edu.gh	Gagneux, Sebastien/ABE-7909-2020; Asante-Poku, Adwoa/AAF-5216-2020; Otchere, Isaac Darko/ABV-4511-2022; Yeboah-Manu, Dorothy/A-1933-2016	Otchere, Isaac Darko/0000-0001-8982-9488; Osei-Wusu, Stephen/0000-0003-2840-3568; Gagneux, Sebastien/0000-0001-7783-9048; Yeboah-Manu, Dorothy/0000-0002-1663-6287; Asante-Poku, Adwoa/0000-0001-8929-193X	Wellcome Trust [097134/Z/11/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust fellowship grant 097134/Z/11/Z to DYM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo Kk, 2007, Ghana Med J, V41, P52; [Anonymous], 2012, GHANA STAT SERVICE N; [Anonymous], 2014, GHANA STAT SERVICE D; [Anonymous], 2013, GHANA STAT SERVICE G; [Anonymous], 2013, GHANA STAT SERVICE N; Aranaz A, 1999, INT J SYST BACTERIOL, V49, P1263, DOI 10.1099/00207713-49-3-1263; Asante-Poku A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003370; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cousins DV, 2003, INT J SYST EVOL MICR, V53, P1305, DOI 10.1099/ijs.0.02401-0; Dangisso MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126369; de Jong BC, 2006, J INFECT DIS, V193, P1279, DOI 10.1086/502977; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744; de Jong BC, 2010, FEMS IMMUNOL MED MIC, V58, P102, DOI 10.1111/j.1574-695X.2009.00628.x; Diop S, 1976, Bull Soc Med Afr Noire Lang Fr, V21, P50; Dosso M, 1999, INT J TUBERC LUNG D, V3, P805; ESRI, 2010, ARCMAP 10 0; Frota CC, 2004, MICROBIOL-SGM, V150, P1519, DOI 10.1099/mic.0.26660-0; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Goyal M, 1999, J INFECTION, V38, P171, DOI 10.1016/S0163-4453(99)90246-3; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; HUET M, 1971, Revue de Tuberculose et de Pneumologie, V35, P413; Jakko van I, 2012, EMERG INFECT DIS, V18, P653, DOI [10.3201/eid1804.110888, DOI 10.3201/EID1804.110888]; Kallenius G, 1999, J CLIN MICROBIOL, V37, P3872; Kammerer JS, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-15; Koro FK, 2013, J CLIN MICROBIOL, V51, P299, DOI 10.1128/JCM.01196-12; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff MA., 2015, SATSCANTM USER GUIDE; Laniado-Laborin R, 2014, INFECT GENET EVOL, V27, P1, DOI 10.1016/j.meegid.2014.06.020; Meyer CG, 2008, TUBERCULOSIS, V88, P482, DOI 10.1016/j.tube.2008.05.004; Michel AL, 2010, VET MICROBIOL, V140, P371, DOI 10.1016/j.vetmic.2009.08.029; Nana Yakam A, 2014, INT J TUBERC LUNG D, V18, P292, DOI [10.5588/ijtld.13.0573, DOI 10.5588/IJTLD.13.0573]; Niobe-Eyangoh SN, 2003, J CLIN MICROBIOL, V41, P2547, DOI 10.1128/JCM.41.6.2547-2553.2003; Rebuma F, 2013, EMERG INFECT DIS, V19, P460, DOI [10.3201/eid1903.120256, DOI 10.3201/EID1903.120256]; Shryock H.S., 1980, METHODS MAT DEMOGRAP; UNICEF, 2014, GEN 2030 AFR CHILD D; WELLS AQ, 1937, LANCET, P1221; WHO, 2014, GLOB TUB REP 2014; Yeboah-Manu D, 2004, J CLIN MICROBIOL, V42, P5875, DOI 10.1128/JCM.42.12.5875-5876.2004; Yeboah-Manu D, 2001, J CLIN MICROBIOL, V39, P4166, DOI 10.1128/JCM.39.11.4166-4168.2001; Yeboah-Manu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021906; Zhao F, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]	46	28	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2016	11	8							e0161892	10.1371/journal.pone.0161892	http://dx.doi.org/10.1371/journal.pone.0161892			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU8WL	27564240	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000382496300032
J	Brunner, C; Brunner-Herglotz, B; Ziegler, A; Frech, C; Amann, G; Ladenstein, R; Ambros, IM; Ambros, PF				Brunner, Clemens; Brunner-Herglotz, Bettina; Ziegler, Andrea; Frech, Christian; Amann, Gabriele; Ladenstein, Ruth; Ambros, Inge M.; Ambros, Peter F.			Tumor Touch Imprints as Source for Whole Genome Analysis of Neuroblastoma Tumors	PLOS ONE			English	Article							P53 MUTATIONS; CYTOLOGY; RISK; DIAGNOSIS; ALK; DNA; QUANTIFICATION; CELLULARITY; SAMPLES; BREAST	Introduction Tumor touch imprints (TTIs) are routinely used for the molecular diagnosis of neuroblastomas by interphase fluorescence in-situ hybridization (I-FISH). However, in order to facilitate a comprehensive, up-to-date molecular diagnosis of neuroblastomas and to identify new markers to refine risk and therapy stratification methods, whole genome approaches are needed. We examined the applicability of an ultra-high density SNP array platform that identifies copy number changes of varying sizes down to a few exons for the detection of genomic changes in tumor DNA extracted from TTIs. Material and Methods DNAs were extracted from TTIs of 46 neuroblastoma and 4 other pediatric tumors. The DNAs were analyzed on the Cytoscan HD SNP array platform to evaluate numerical and structural genomic aberrations. The quality of the data obtained from TTIs was compared to that from randomly chosen fresh or fresh frozen solid tumors (n = 212) and I-FISH validation was performed. Results SNP array profiles were obtained from 48 (out of 50) TTI DNAs of which 47 showed genomic aberrations. The high marker density allowed for single gene analysis, e.g. loss of nine exons in the ATRX gene and the visualization of chromothripsis. Data quality was comparable to fresh or fresh frozen tumor SNP profiles. SNP array results were confirmed by I-FISH. Conclusion TTIs are an excellent source for SNP array processing with the advantage of simple handling, distribution and storage of tumor tissue on glass slides. The minimal amount of tumor tissue needed to analyze whole genomes makes TTIs an economic surrogate source in the molecular diagnostic work up of tumor samples.	[Brunner, Clemens; Brunner-Herglotz, Bettina; Ziegler, Andrea; Frech, Christian; Ambros, Inge M.; Ambros, Peter F.] St Anna Kinderkrebsforsch, CCRI, Dept Tumor Biol, Vienna, Austria; [Amann, Gabriele] Med Univ Vienna, Inst Clin Pathol, Vienna, Austria; [Ladenstein, Ruth] St Anna Kinderkrebsforsch, CCRI, S2IRP, Vienna, Austria; [Ladenstein, Ruth; Ambros, Peter F.] Med Univ Vienna, Dept Pediat, Vienna, Austria	Saint Anna Children's Hospital; Medical University of Vienna; Saint Anna Children's Hospital; Medical University of Vienna	Ambros, PF (corresponding author), St Anna Kinderkrebsforsch, CCRI, Dept Tumor Biol, Vienna, Austria.; Ambros, PF (corresponding author), Med Univ Vienna, Dept Pediat, Vienna, Austria.	peter.ambros@ccri.at	Ambros, Peter/AAA-1266-2021	Ambros, Peter/0000-0002-5507-7211	Austrian National Bank [13422]; European Union [HEALTH-F2-2011-261474]; Austrian Science Fund [I 2799-B28]; St. Anna Kinderkrebsforschung	Austrian National Bank; European Union(European Commission); Austrian Science Fund(Austrian Science Fund (FWF)); St. Anna Kinderkrebsforschung	This study was supported by: Austrian National Bank (Grant#13422; https://www.oenb.at/), European Union's Seventh Framework Program (HEALTH-F2-2011-261474; https://ec.europa.eu/research/fp7/index_en.cfm), Austrian Science Fund (Grant# I 2799-B28; https://www.fwf.ac.at/), and St. Anna Kinderkrebsforschung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi MR, 2015, MOL ONCOL, V9, P545, DOI 10.1016/j.molonc.2014.10.010; Affymetrix Inc, 2014, AFF CHROM AN SUIT CH; Ambros IM, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00202; Ambros PF, 2009, BRIT J CANCER, V100, P1471, DOI 10.1038/sj.bjc.6605014; Berbegall AP, 2015, ONCOGENE; Bogen D, 2016, INT J CANC; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Cheung NKV, 2012, JAMA-J AM MED ASSOC, V307, P1062, DOI 10.1001/jama.2012.228; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Dogan S, 2013, CANCER CYTOPATHOL, V121, P354, DOI 10.1002/cncy.21292; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Gleeson FC, 2014, CANCER CYTOPATHOL, V122, P822, DOI 10.1002/cncy.21464; Instituto de Investigacion Sanitaria La Fe, 2012, EUR LOW INT RISK NEU; Kehl S, 2014, ANTICANCER RES, V34, P153; Killian JK, 2010, J MOL DIAGN, V12, P739, DOI 10.2353/jmoldx.2010.090238; KOVACH JS, 1991, JNCI-J NATL CANCER I, V83, P1004, DOI 10.1093/jnci/83.14.1004; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Mangia A, 2008, ARCH PATHOL LAB MED, V132, P974, DOI 10.1043/1543-2165(2008)132[974:TICITT]2.0.CO;2; MCMANUS AP, 1995, J PATHOL, V176, P137, DOI 10.1002/path.1711760206; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Narath R, 2004, CYTOM PART B-CLIN CY, V57B, P15, DOI 10.1002/cyto.b.10058; Peifer M, 2015, NATURE, V526, P700, DOI 10.1038/nature14980; R Core Team, 2021, R LANGUAGE ENV STAT; Ribeiro CNM, 2004, BRAZ J MED BIOL RES, V37, P635, DOI 10.1590/S0100-879X2004000500002; Ricevuto E, 1996, AM J PATHOL, V148, P405; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Schleiermacher G, 2011, BRIT J CANCER, V105, P1940, DOI 10.1038/bjc.2011.472; Scucchi LF, 1997, ACTA CYTOL, V41, P1489	31	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161369	10.1371/journal.pone.0161369	http://dx.doi.org/10.1371/journal.pone.0161369			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560999	Green Submitted, gold, Green Published			2022-12-26	WOS:000382258600036
J	Malo, CS; Renner, DN; Kelcher, AMH; Jin, F; Hansen, MJ; Pavelko, KD; Johnson, AJ				Malo, Courtney S.; Renner, Danielle N.; Kelcher, April M. Huseby; Jin, Fang; Hansen, Michael J.; Pavelko, Kevin D.; Johnson, Aaron J.			The Effect of Vector Silencing during Picornavirus Vaccination against Experimental Melanoma and Glioma	PLOS ONE			English	Article							T-CELL IMMUNITY; VIRUS; SYSTEM	Virus vector-based vaccination against tumor-specific antigens remains a promising therapeutic approach to overcome the immune suppressive tumor microenvironment. However, the extent that the desired CD8 T cell response against the targeted tumor antigen is impacted by the CD8 T cell response against the virus vector is unclear. To address this question, we used picornavirus vaccination with Theiler's murine encephalomyelitis virus (TMEV) as our vector against tumor-expressed ovalbumin (OVA(257-264)) antigen in both the B16-OVA murine melanoma and GL261-quad cassette murine glioma models. Prior to vaccination, we employed vector silencing to inhibit the CD8 T cell response against the immunodominant TMEV antigen, VP2(121-130). We then monitored the resulting effect on the CD8 T cell response against the targeted tumor-specific antigen, ovalbumin. We demonstrate that employing vector silencing in the context of B16-OVA melanoma does not reduce tumor burden or improve survival, while TMEV-OVA vaccination without vector silencing controls tumor burden. Meanwhile, employing vector silencing during picornavirus vaccination against the GL261-quad cassette glioma resulted in a lower frequency of tumor antigen-specific CD8 T cells. The results of this study are relevant to antigen-specific immunotherapy, in that the virus vector-specific CD8 T cell response is not competing with tumor antigen-specific CD8 T cells. Furthermore, vector silencing may have the adverse consequence of reducing the tumor antigen-specific CD8 T cell response, as demonstrated by our findings in the GL261-quad cassette model.	[Malo, Courtney S.; Kelcher, April M. Huseby; Jin, Fang; Hansen, Michael J.; Pavelko, Kevin D.; Johnson, Aaron J.] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; [Malo, Courtney S.; Renner, Danielle N.; Kelcher, April M. Huseby] Mayo Clin, Mayo Grad Sch, Rochester, MN USA; [Renner, Danielle N.] Mayo Clin, Neurobiol Dis Grad Program, Rochester, MN USA; [Johnson, Aaron J.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Johnson, AJ (corresponding author), Mayo Clin, Dept Immunol, Rochester, MN 55905 USA.; Johnson, AJ (corresponding author), Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.	Johnson.Aaron2@mayo.edu	Pavelko, Kevin D/K-7072-2019	Pavelko, Kevin D/0000-0001-7555-1315; Huseby Kelcher, April/0000-0002-9665-2921	National Cancer Institute [R21 CA186976-1]; Mayo Foundation for Medical Education and Research; NATIONAL CANCER INSTITUTE [R21CA186976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007425] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mayo Foundation for Medical Education and Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors received funding for this work through the National Cancer Institute (R21 CA186976-1) and the Mayo Foundation for Medical Education and Research.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Bell MP, 2014, VIRAL IMMUNOL, V27, P361, DOI 10.1089/vim.2014.0045; Bell MP, 2016, MOL CANC THER, V28; Bridle BW, 2010, MOL THER, V18, P1430, DOI 10.1038/mt.2010.98; Brown MC, 2014, CANCER-AM CANCER SOC, V120, P3277, DOI 10.1002/cncr.28862; Burchill MA, 2015, EUR J IMMUNOL, V45, P3140, DOI 10.1002/eji.201545749; Donson AM, 2012, ONCOIMMUNOLOGY, V1, P1648, DOI 10.4161/onci.21747; Harrington LE, 2002, J VIROL, V76, P3329, DOI 10.1128/JVI.76.7.3329-3337.2002; Johnson AJ, 2001, FASEB J, V15, P2760, DOI 10.1096/fj.01-0373fje; Johnson HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111401; Johnson HL, 2014, J NEUROVIROL, V20, P107, DOI 10.1007/s13365-013-0187-5; Johnson HL, 2012, J IMMUNOL, V189, P1937, DOI 10.4049/jimmunol.1200658; Kenney LL, 2015, J VIROL, V89, P10786, DOI 10.1128/JVI.01432-15; McDole JR, 2010, AM J PATHOL, V177, P1823, DOI 10.2353/ajpath.2010.100231; Merrill MK, 2004, NEURO-ONCOLOGY, V6, P208, DOI 10.1215/S1152851703000577; Neagu MR, 2015, CURR TREAT OPTION ON, V16, DOI 10.1007/s11864-015-0371-3; Ochiai H, 2006, CLIN CANCER RES, V12, P1349, DOI 10.1158/1078-0432.CCR-05-1595; Oh T, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-107; Padfield E, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00005; Pavelko KD, 2013, MOL THER, V21, P1087, DOI 10.1038/mt.2013.52; Pavelko KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020217; Ramshaw IA, 2000, IMMUNOL TODAY, V21, P163, DOI 10.1016/S0167-5699(00)01612-1; Reed BK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137984; Renner DN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125565; Renner DN, 2015, NEUROTHERAPEUTICS; Suidan GL, 2010, J IMMUNOL, V184, P1031, DOI 10.4049/jimmunol.0902773; Thorne A H, 2016, NEUROONCOL, V10; Vigil A, 2008, MOL THER, V16, P1883, DOI 10.1038/mt.2008.181; Wongthida P, 2011, HUM GENE THER, V22, P1343, DOI 10.1089/hum.2010.216; Xu XY, 2012, CONTEMPORARY INNOVATION AND DEVELOPMENT IN STATISTICAL SCIENCE, P28; Zavala F, 2001, VIROLOGY, V280, P155, DOI 10.1006/viro.2000.0792	31	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0162064	10.1371/journal.pone.0162064	http://dx.doi.org/10.1371/journal.pone.0162064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560502	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258600131
J	Williams, A; Hunter, MC; Kammerer, M; Kane, DA; Jordan, NR; Mortensen, DA; Smith, RG; Snapp, S; Davis, AS				Williams, Alwyn; Hunter, Mitchell C.; Kammerer, Melanie; Kane, Daniel A.; Jordan, Nicholas R.; Mortensen, David A.; Smith, Richard G.; Snapp, Sieglinde; Davis, Adam S.			Soil Water Holding Capacity Mitigates Downside Risk and Volatility in US Rainfed Maize: Time to Invest in Soil Organic Matter?	PLOS ONE			English	Article							CLIMATE-CHANGE; AGRICULTURE; CARBON; PRODUCTIVITY; VARIABILITY; ADAPTATION; STABILITY; INCREASE; IMPACTS	Yield stability is fundamental to global food security in the face of climate change, and better strategies are needed for buffering crop yields against increased weather variability. Regional-scale analyses of yield stability can support robust inferences about buffering strategies for widely-grown staple crops, but have not been accomplished. We present a novel analytical approach, synthesizing 2000-2014 data on weather and soil factors to quantify their impact on county-level maize yield stability in four US states that vary widely in these factors (Illinois, Michigan, Minnesota and Pennsylvania). Yield stability is quantified as both 'downside risk' (minimum yield potential, MYP) and 'volatility' (temporal yield variability). We show that excessive heat and drought decreased mean yields and yield stability, while higher precipitation increased stability. Soil water holding capacity strongly affected yield volatility in all four states, either directly (Minnesota and Pennsylvania) or indirectly, via its effects on MYP (Illinois and Michigan). We infer that factors contributing to soil water holding capacity can help buffer maize yields against variable weather. Given that soil water holding capacity responds (within limits) to agronomic management, our analysis highlights broadly relevant management strategies for buffering crop yields against climate variability, and informs region-specific strategies.	[Williams, Alwyn; Jordan, Nicholas R.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA; [Hunter, Mitchell C.; Kammerer, Melanie; Mortensen, David A.] Penn State Univ, Dept Plant Sci, University Pk, PA 16802 USA; [Kane, Daniel A.; Snapp, Sieglinde] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Smith, Richard G.] Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA; [Davis, Adam S.] USDA ARS, Global Change & Photosynth Res Unit, Urbana, IL 61801 USA	University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Michigan State University; University System Of New Hampshire; University of New Hampshire; United States Department of Agriculture (USDA)	Davis, AS (corresponding author), USDA ARS, Global Change & Photosynth Res Unit, Urbana, IL 61801 USA.	asdavis1@illinois.edu	Williams, Alwyn/P-8851-2017; mahsum, masot/ABC-4546-2020; Snapp, Sieglinde/AAU-8121-2020; Snapp, Sieg/GWQ-5774-2022; Kammerer, Melanie/K-8123-2019	Williams, Alwyn/0000-0003-4386-8478; Snapp, Sieglinde/0000-0002-9738-0649; Kammerer, Melanie/0000-0002-0678-9087; Davis, Adam/0000-0002-7196-1197; Smith, Richard G./0000-0002-3571-5888; Hunter, Mitchell/0000-0002-4562-7806	Agriculture and Food Research Initiative of the United States Department of Agriculture, National Institute for Food and Agriculture [2011-67003-30343]	Agriculture and Food Research Initiative of the United States Department of Agriculture, National Institute for Food and Agriculture	This work was supported by Agriculture and Food Research Initiative of the United States Department of Agriculture, National Institute for Food and Agriculture (grant number 2011-67003-30343; https://nifa.usda.gov/program/agriculture-and-food-research-initiative-afri). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; Bodner G, 2015, AGRON SUSTAIN DEV, V35, P401, DOI 10.1007/s13593-015-0283-4; Bommarco R, 2013, TRENDS ECOL EVOL, V28, P230, DOI 10.1016/j.tree.2012.10.012; Cook BI, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400082; Doring TF, 2015, FIELD CROP RES, V183, P294, DOI 10.1016/j.fcr.2015.08.005; Elliott J, 2014, P NATL ACAD SCI USA, V111, P3239, DOI 10.1073/pnas.1222474110; FINLAY KW, 1963, AUST J AGR RES, V14, P742, DOI 10.1071/AR9630742; Franzluebbers AJ, 2002, SOIL TILL RES, V66, P197, DOI 10.1016/S0167-1987(02)00027-2; Giller KE, 2009, FIELD CROP RES, V114, P23, DOI 10.1016/j.fcr.2009.06.017; Gleick PH, 2003, ANNU REV ENV RESOUR, V28, P275, DOI 10.1146/annurev.energy.28.040202.122849; Gornall J, 2010, PHILOS T R SOC B, V365, P2973, DOI 10.1098/rstb.2010.0158; Hatcher L., 1994, STEP BY STEP APPROAC; Hildebrand P.E, 1996, ADAPTABILITY ANAL ME; Iglesias A, 2012, CLIMATIC CHANGE, V112, P143, DOI 10.1007/s10584-011-0344-x; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R., 2015, SUSTAINABLE INTENSIF; Lobell DB, 2014, SCIENCE, V344, P516, DOI 10.1126/science.1251423; Lobell DB, 2013, NAT CLIM CHANGE, V3, P497, DOI [10.1038/nclimate1832, 10.1038/NCLIMATE1832]; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; McDaniel MD, 2014, ECOL APPL, V24, P560, DOI 10.1890/13-0616.1; Ngwira AR, 2013, RENEW AGR FOOD SYST, V28, P350, DOI 10.1017/S1742170512000257; Pan GX, 2009, AGR ECOSYST ENVIRON, V129, P344, DOI 10.1016/j.agee.2008.10.008; Powlson DS, 2014, NAT CLIM CHANGE, V4, P678, DOI 10.1038/NCLIMATE2292; RCore Team, 2020, R LANG ENV STAT COMP; Rosenzweig C, 2014, P NATL ACAD SCI USA, V111, P3268, DOI 10.1073/pnas.1222463110; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Smith RG, 2007, AGRON J, V99, P1629, DOI 10.2134/agronj2007.0096; Stewart CE, 2007, BIOGEOCHEMISTRY, V86, P19, DOI 10.1007/s10533-007-9140-0; Trenberth KE, 2014, NAT CLIM CHANGE, V4, P17, DOI 10.1038/NCLIMATE2067; Urban D, 2012, CLIMATIC CHANGE, V112, P525, DOI 10.1007/s10584-012-0428-2; USDA National Agricultural Statistics Service, 2016, QUICK STATS DAT; USDA National Agricultural Statistics Service, 2014, 2014 CULT LAYER; USDA Natural Resources Conservation Service, 2016, WEB SOIL SURV; Zibilske LM, 2007, SOIL SCI SOC AM J, V71, P793, DOI 10.2136/sssaj2006.0217	34	69	69	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0160974	10.1371/journal.pone.0160974	http://dx.doi.org/10.1371/journal.pone.0160974			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560666	gold, Green Submitted, Green Published			2022-12-26	WOS:000382258600022
J	Patykowski, J; Dell, M; Gibson, M				Patykowski, John; Dell, Matthew; Gibson, Maria			Germination Ecology and Seed Dispersal of a Critically Endangered Plant: A Case Study of Pomaderris vacciniifolia (Round-Leaf Pomaderris)	PLOS ONE			English	Article							POPULATION VIABILITY ANALYSIS; MYRMECOCHOROUS PLANTS; HABITAT FRAGMENTATION; POSTFIRE GERMINATION; MEDITERRANEAN BASIN; HEAT-SHOCK; FIRE; SMOKE; SOIL; CONSERVATION	Change in ecosystem disturbance regimes from human land-use poses a worldwide problem for management of rare species. Two important types of disturbance influencing the persistence of species in Australian ecosystems are habitat fragmentation and fire. In this study, seed dispersal and the germination ecology of Pomaderris vacciniifolia-a critically endangered, rare endemic Australian shrub-were examined to identify likely influences of fire and fragmentation on the decline of populations. The response of seed germination to simulated effects of wildfire and canopy openings was investigated, as was the unaided dispersal capability of seeds from parent plants. A significant increase in germination rate was observed following 100 degrees C heat treatment to seeds, while smoke and light exposure had little influence. Seed imbibition was strongly influenced by heat treatment. The findings indicate a likely positive post-fire germination response, with implications for recruitment success determined by moisture availability following fire. Unaided seed dispersal was limited, which partly explains the apparent decline of populations. Understanding disturbance requirements for threatened species, and subsequent management of landscapes for disturbance, will aid conservation of rare species throughout the world.	[Patykowski, John; Gibson, Maria] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Geelong, Vic, Australia; [Dell, Matthew] Ecol Australia, Fairfield, Vic, Australia	Deakin University	Patykowski, J (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Geelong, Vic, Australia.	jwpat@deakin.edu.au			Deakin University; Field Naturalists Club of Victoria	Deakin University; Field Naturalists Club of Victoria	The authors received funding from Deakin University and the Field Naturalists Club of Victoria for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AULD TD, 1991, AUST J ECOL, V16, P53, DOI 10.1111/j.1442-9993.1991.tb01481.x; AULD TD, 1986, AUST J ECOL, V11, P373, DOI 10.1111/j.1442-9993.1986.tb01407.x; Barton K., 2015, MUMIN MULTIMODEL INF; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; BERG RY, 1975, AUST J BOT, V23, P475, DOI 10.1071/BT9750475; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; BRADSTOCK RA, 1995, J APPL ECOL, V32, P76, DOI 10.2307/2404417; Brown S, 2009, BIOL CONSERV, V142, P432, DOI 10.1016/j.biocon.2008.11.005; Bureau of Meteorology, 2013, CLIM DAT ONL; Chiwocha SDS, 2009, PLANT SCI, V177, P252, DOI 10.1016/j.plantsci.2009.06.007; Crosti R, 2006, FOREST ECOL MANAG, V221, P306, DOI 10.1016/j.foreco.2005.10.005; DEPI, 2016, BIOD INT MAP MELB VI; DIXON KW, 1995, OECOLOGIA, V101, P185, DOI 10.1007/BF00317282; Ford HA, 2001, BIOL CONSERV, V97, P71, DOI 10.1016/S0006-3207(00)00101-4; Gaston K.J., 1994, RARITY, P1; Gomez C, 1998, J BIOGEOGR, V25, P573, DOI 10.1046/j.1365-2699.1998.2530573.x; Hyvarinen E, 2006, CONSERV BIOL, V20, P1711, DOI 10.1111/j.1523-1739.2006.00511.x; Kani I, 2011, TURK J BOT, V35, P411, DOI [10.3906/bot-1012-90, DOI 10.3906/BOT-1012-90]; KEELEY JE, 1991, BOT REV, V57, P81, DOI 10.1007/BF02858766; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; Kleijn D, 2008, J APPL ECOL, V45, P680, DOI 10.1111/j.1365-2664.2007.01444.x; Krawchuk MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005102; Lang NL, 2007, CAN J BOT, V85, P557, DOI 10.1139/B07-051; Leal LC, 2014, OECOLOGIA, V174, P173, DOI 10.1007/s00442-013-2740-6; Moreira B, 2010, ANN BOT-LONDON, V105, P627, DOI 10.1093/aob/mcq017; Morrison DA, 2000, AUSTRAL ECOL, V25, P292, DOI 10.1111/j.1442-9993.2000.tb00031.x; Nield AP, 2009, AUST J BOT, V57, P451, DOI 10.1071/BT09043; Olisa B. S., 2010, Research Journal of Seed Science, V3, P150, DOI 10.3923/rjss.2010.150.159; Orozco-Segovia A, 2007, ANN BOT-LONDON, V99, P581, DOI 10.1093/aob/mcm001; Patykowski J, 2014, VICTORIAN NAT, V131, P44; Paula S, 2008, J ECOL, V96, P543, DOI 10.1111/j.1365-2745.2008.01359.x; Pearson RG, 2005, BIOL CONSERV, V123, P389, DOI 10.1016/j.biocon.2004.12.006; Pinheiro J, 2015, NLME LINEAR NONLINEA; R. Core Team, 2015, R A LANGUAGE AND ENV; Royal Botanic Gardens Victoria, 2015, VICFLORA FLOR VICT M; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Seo M, 2009, PLANT MOL BIOL, V69, P463, DOI 10.1007/s11103-008-9429-y; Soons MB, 2005, J ECOL, V93, P1214, DOI 10.1111/j.1365-2745.2005.01064.x; Syphard AD, 2009, CONSERV BIOL, V23, P758, DOI 10.1111/j.1523-1739.2009.01223.x; TerHeerdt GNJ, 1996, FUNCT ECOL, V10, P144, DOI 10.2307/2390273; Thomas PB, 2007, AUSTRAL ECOL, V32, P605, DOI 10.1111/j.1442-9993.2007.01730.x; Thomas PB, 2003, AUSTRAL ECOL, V28, P674, DOI 10.1046/j.1442-9993.2003.1330.doc.x; Trakhtenbrot A, 2005, DIVERS DISTRIB, V11, P173, DOI 10.1111/j.1366-9516.2005.00156.x; Turner SR, 2005, SEED SCI RES, V15, P51, DOI 10.1079/SSR2004197; Van Calster H, 2008, J ECOL, V96, P927, DOI 10.1111/j.1365-2745.2008.01412.x; Walsh NG, 1999, FLORA VICTORIA, P85; WILLSON MF, 1993, VEGETATIO, V108, P261; Yates CJ, 2002, BIOL CONSERV, V108, P13, DOI 10.1016/S0006-3207(02)00084-8; Yates CJ, 2010, PLANT ECOL, V211, P305, DOI 10.1007/s11258-010-9791-0; ZAMMIT C, 1987, ECOLOGY, V68, P1984, DOI 10.2307/1939889	53	3	3	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0161665	10.1371/journal.pone.0161665	http://dx.doi.org/10.1371/journal.pone.0161665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27557152	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258100063
J	Harjes, U; Bridges, E; Gharpure, KM; Roxanis, I; Sheldon, H; Miranda, F; Mangala, LS; Pradeep, S; Lopez-Berestein, G; Ahmed, A; Fielding, B; Sood, AK; Harris, AL				Harjes, U.; Bridges, E.; Gharpure, K. M.; Roxanis, I.; Sheldon, H.; Miranda, F.; Mangala, L. S.; Pradeep, S.; Lopez-Berestein, G.; Ahmed, A.; Fielding, B.; Sood, A. K.; Harris, A. L.			Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4	ONCOGENE			English	Article							ACID-BINDING PROTEIN; OXYGEN SPECIES PRODUCTION; OVARIAN-CANCER; FATTY-ACIDS; CELLS; GROWTH; PHOSPHORYLATION; ANGIOGENESIS; METABOLISM; ACTIVATION	Fatty acid binding protein 4 (FABP4) is a fatty acid chaperone, which is induced during adipocyte differentiation. Previously we have shown that FABP4 in endothelial cells is induced by the NOTCH1 signalling pathway, the latter of which is involved in mechanisms of resistance to antiangiogenic tumour therapy. Here, we investigated the role of FABP4 in endothelial fatty acid metabolism and tumour angiogenesis. We analysed the effect of transient FABP4 knockdown in human umbilical vein endothelial cells on fatty acid metabolism, viability and angiogenesis. Through therapeutic delivery of siRNA targeting mouse FABP4, we investigated the effect of endothelial FABP4 knockdown on tumour growth and blood vessel formation. In vitro, siRNA-mediated FABP4 knockdown in endothelial cells led to a marked increase of endothelial fatty acid oxidation, an increase of reactive oxygen species and decreased angiogenesis. In vivo, we found that increased NOTCH1 signalling in tumour xenografts led to increased expression of endothelial FABP4 that decreased when NOTCH1 and VEGFA inhibitors were used in combination. Angiogenesis, growth and metastasis in ovarian tumour xenografts were markedly inhibited by therapeutic siRNA delivery targeting mouse endothelial FABP4. Therapeutic targeting of endothelial FABP4 by siRNA in vivo has antiangiogenic and antitumour effects with minimal toxicity and should be investigated further.	[Harjes, U.; Bridges, E.; Sheldon, H.; Harris, A. L.] Univ Oxford, Dept Oncol, WIMM, Hypoxia & Growth Factor Grp, Oxford OX1 2JD, England; [Gharpure, K. M.; Mangala, L. S.; Pradeep, S.; Sood, A. K.] Univ Texas Austin, Dept Gynecol Oncol, Austin, TX 78712 USA; [Roxanis, I.] Oxford Univ Hosp, Dept Cellular Pathol, Oxford, England; [Roxanis, I.] John Radcliffe Hosp, NIHR Biomed Res Ctr Oxford, Oxford, England; [Miranda, F.; Ahmed, A.] Univ Oxford, Nuffield Dept Obstet & Gynaecol, WIMM, Ovarian Canc Cell Lab, Oxford OX1 2JD, England; [Mangala, L. S.; Lopez-Berestein, G.; Sood, A. K.] Univ Texas Austin, MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Dept Gynecol Oncol, Austin, TX 78712 USA; [Lopez-Berestein, G.; Sood, A. K.] Univ Texas Austin, Dept Canc Biol, Austin, TX 78712 USA; [Fielding, B.] Univ Surrey, Dept Nutr Sci, Guildford GU2 5XH, Surrey, England; [Harjes, U.] Univ Leuven, Dept Oncol, Lab Angiogenesis & Vasc Metab, B-3000 Leuven, Belgium; [Harjes, U.] VIB, Vesalius Res Ctr, Lab Angiogenesis & Vasc Metab, B-3000 Leuven, Belgium	University of Oxford; University of Texas System; University of Texas Austin; University of Oxford; University of Oxford; University of Texas System; University of Texas Austin; UTMD Anderson Cancer Center; University of Texas System; University of Texas Austin; University of Surrey; KU Leuven; Flanders Institute for Biotechnology (VIB)	Harris, AL (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, Osler Rd Headington, Oxford OX3 9DS, England.	aharris.lab@imm.ox.ac.uk	Harris, Adrian L/ABA-3343-2020; Sood, Anoop Kumar/A-7344-2013	Harris, Adrian L/0000-0003-1376-8409; Sood, Anoop Kumar/0000-0001-5702-4108; Sheldon, Helen/0000-0002-0945-5496; Harjes, Ulrike/0000-0003-0376-1262; Gharpure, Kshipra/0000-0003-4954-5696	Cancer Research UK; Breast Cancer Research Foundation; NIH [CA109298, P50 CA083639, P50 CA098258, UH2 TR000943]; RGK Foundation; Glider Foundation; Betty Anne Asche Murray Distinguished Professorship; Altman Goldstein Discovery Fellowship; Medical research Council; Ovarian Cancer Action; Oxford Biomedical Research Centre, the National Institute of Health Research; National Health Service Biomedical Research Centre; NATIONAL CANCER INSTITUTE [R01CA109298, P50CA083639, P50CA098258, P30CA016672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000943] Funding Source: NIH RePORTER; Cancer Research UK [11359, 16466, 18974] Funding Source: researchfish; Medical Research Council [G0902418, G0300648] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish; MRC [G0902418] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Breast Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RGK Foundation; Glider Foundation; Betty Anne Asche Murray Distinguished Professorship; Altman Goldstein Discovery Fellowship; Medical research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ovarian Cancer Action(Ovarian Cancer Action); Oxford Biomedical Research Centre, the National Institute of Health Research; National Health Service Biomedical Research Centre; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Portions of this work were supported by Cancer Research UK, Breast Cancer Research Foundation and National Health Service Biomedical Research Centre, the NIH (CA109298, P50 CA083639, P50 CA098258, UH2 TR000943), the RGK Foundation, the Glider Foundation and the Betty Anne Asche Murray Distinguished Professorship. KMG is supported by Altman Goldstein Discovery Fellowship. AA and FM are funded by the Medical research Council, Ovarian Cancer Action and the Oxford Biomedical Research Centre, the National Institute of Health Research.	Bao Zhengzheng, 2013, Genes Cancer, V4, P297, DOI 10.1177/1947601913499155; Bensaad K, 2014, CELL REP, V9, P349, DOI 10.1016/j.celrep.2014.08.056; Brandes RP, 2014, FREE RADICAL BIO MED, V76, P208, DOI 10.1016/j.freeradbiomed.2014.07.046; Cataltepe O, 2012, NEUROPATH APPL NEURO, V38, P400, DOI 10.1111/j.1365-2990.2011.01237.x; Coe NR, 1999, J LIPID RES, V40, P967; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882; Garin-Shkolnik T, 2014, DIABETES, V63, P900, DOI 10.2337/db13-0436; Harjes U, 2016, CRIT REV ONCOL HEMAT, V97, P15, DOI 10.1016/j.critrevonc.2015.10.011; Harjes U, 2014, J BIOL CHEM, V289, P23168, DOI 10.1074/jbc.M114.576512; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Hu W, 2011, CANCER RES, V71, P6030, DOI 10.1158/0008-5472.CAN-10-2719; Huang J, 2016, MOL CANCER THER, V15, P1344, DOI 10.1158/1535-7163.MCT-15-0144; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Levi L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9794; Li JL, 2011, CANCER RES, V71, P6073, DOI 10.1158/0008-5472.CAN-11-1704; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Lu CH, 2007, CANCER RES, V67, P1757, DOI 10.1158/0008-5472.CAN-06-3700; Mashek DG, 2006, CURR OPIN LIPIDOL, V17, P274, DOI 10.1097/01.mol.0000226119.20307.2b; Masiero M, 2013, CANCER CELL, V24, P229, DOI 10.1016/j.ccr.2013.06.004; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Olsauskas-Kuprys R, 2013, ONCOTARGETS THER, V6, P943, DOI 10.2147/OTT.S33766; Oza AM, 2015, LANCET ONCOL, V16, P928, DOI 10.1016/S1470-2045(15)00086-8; Pike LS, 2011, BBA-BIOENERGETICS, V1807, P726, DOI 10.1016/j.bbabio.2010.10.022; Rosca MG, 2012, DIABETES, V61, P2074, DOI 10.2337/db11-1437; Schoors S, 2015, NATURE, V520, P192, DOI 10.1038/nature14362; Schultheis B, 2014, J CLIN ONCOL, V32, P4141, DOI 10.1200/JCO.2013.55.0376; Smith AJ, 2007, J BIOL CHEM, V282, P32424, DOI 10.1074/jbc.M703730200; Smith NR, 2013, CLIN CANCER RES, V19, P6943, DOI 10.1158/1078-0432.CCR-13-1637; Wang HC, 2014, CLIN CHIM ACTA, V436, P243, DOI 10.1016/j.cca.2014.06.005; Wu JR, 2010, J BIOPHARM STAT, V20, P954, DOI 10.1080/10543401003618983	32	44	47	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 16	2017	36	7					912	921		10.1038/onc.2016.256	http://dx.doi.org/10.1038/onc.2016.256			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8JG	27568980	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000394169100004
J	Wigington, CP; Morris, KJ; Newman, LE; Corbett, AH				Wigington, Callie P.; Morris, Kevin J.; Newman, Laura E.; Corbett, Anita H.			The Polyadenosine RNA-binding Protein, Zinc Finger Cys(3)His Protein 14 (ZC3H14), Regulates the Pre-mRNA Processing of a Key ATP Synthase Subunit mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP synthase; post-transcriptional regulation; RNA; RNA-binding protein; RNA processing; RNA splicing; MSUT2; Nab2; ZC3H14	POLY(A) TAIL LENGTH; NUCLEAR POLY(A)-BINDING PROTEIN; BROWN ADIPOSE-TISSUE; GENE-EXPRESSION; CYTOCHROME-C; MITOCHONDRIAL MORPHOLOGY; SACCHAROMYCES-CEREVISIAE; SPECIFICITY FACTOR; CELL VIABILITY; APOPTOSIS	Polyadenosine RNA-binding proteins (Pabs) regulate multiple steps in gene expression. This protein family includes the well studied Pabs, PABPN1 and PABPC1, as well as the newly characterized Pab, zinc finger CCCH-type containing protein 14 (ZC3H14). Mutations in ZC3H14 are linked to a form of intellectual disability. To probe the function of ZC3H14, we performed a transcriptome-wide analysis of cells depleted of either ZC3H14 or the control Pab, PABPN1. Depletion of PABPN1 affected approximate to 17% of expressed transcripts, whereas ZC3H14 affected only approximate to 1% of expressed transcripts. To assess the function of ZC3H14 in modulating target mRNAs, we selected the gene encoding the ATP synthase F-0 subunit C (ATP5G1) transcript. Knockdown of ZC3H14 significantly reduced ATP5G1 steady-state mRNA levels. Consistent with results suggesting that ATP5G1 turnover increases upon depletion of ZC3H14, double knockdown of ZC3H14 and the nonsense-mediated decay factor, UPF1, rescues ATP5G1 transcript levels. Furthermore, fractionation reveals an increase in the amount of ATP5G1 pre-mRNA that reaches the cytoplasm when ZC3H14 is depleted and that ZC3H14 binds to ATP5G1 pre-mRNA in the nucleus. These data support a role for ZC3H14 in ensuring proper nuclear processing and retention of ATP5G1 pre-mRNA. Consistent with the observation that ATP5G1 is a rate-limiting component for ATP synthase activity, knockdown of ZC3H14 decreases cellular ATP levels and causes mitochondrial fragmentation. These data suggest that ZC3H14 modulates pre-mRNA processing of select mRNA transcripts and plays a critical role in regulating cellular energy levels, observations that have broad implications for proper neuronal function.	[Wigington, Callie P.; Morris, Kevin J.; Newman, Laura E.; Corbett, Anita H.] Emory Univ, Dept Biochem, Atlanta, GA 30322 USA; [Wigington, Callie P.; Morris, Kevin J.; Newman, Laura E.; Corbett, Anita H.] Emory Univ, Grad Program Biochem Cell & Dev Biol, Atlanta, GA 30322 USA	Emory University; Emory University	Corbett, AH (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	acorbe2@emory.edu	Corbett, Anita/AAH-6106-2021	Corbett, Anita/0000-0002-0461-6895; Newman, Laura/0000-0001-5559-713X	National Institutes of Health [P30NS055077]; NATIONAL CANCER INSTITUTE [F31CA168321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367, R01GM058728, R01GM090158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the members of the Corbett and Kahn laboratories for helpful discussions and contributions to this work. The HEK293-T17 and HeLa cells were a generous gift from the Kahn laboratory at Emory University. The MB-231 and D556 cells were a generous gift from the Vertino and Read laboratories, respectively, at the Winship Cancer Institute. The Emory Neuroscience Microscopy Core facilities was a recipient of National Institutes of Health Grant P30NS055077.	Abouantoun TJ, 2009, MOL CANCER THER, V8, P1137, DOI 10.1158/1535-7163.MCT-08-0889; Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; ANDERSON JT, 1993, MOL CELL BIOL, V13, P2730, DOI 10.1128/MCB.13.5.2730; Andersson U, 1997, BIOCHEM J, V323, P379, DOI 10.1042/bj3230379; Apponi LH, 2007, MOL CELL BIOL, V27, P6569, DOI 10.1128/MCB.00881-07; Apponi LH, 2010, HUM MOL GENET, V19, P1058, DOI 10.1093/hmg/ddp569; Aschrafi A, 2012, CELL MOL LIFE SCI, V69, P4017, DOI 10.1007/s00018-012-1064-8; BAER BW, 1983, J CELL BIOL, V96, P717, DOI 10.1083/jcb.96.3.717; Banerjee A, 2013, FEBS J, V280, P4230, DOI 10.1111/febs.12294; Beaulieu YB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003078; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; Blackinton JG, 2014, SEMIN CELL DEV BIOL, V34, P44, DOI 10.1016/j.semcdb.2014.05.014; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chan YA, 2014, TRENDS GENET, V30, P245, DOI 10.1016/j.tig.2014.03.005; CHANCE B, 1963, J BIOL CHEM, V238, P418; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; De Grassi A, 2006, GENE, V371, P224, DOI 10.1016/j.gene.2005.11.022; Duborjal H, 2002, GENOME RES, V12, P1901, DOI 10.1101/gr.194102; DYER MR, 1989, BIOCHEM J, V260, P249, DOI 10.1042/bj2600249; DYER MR, 1993, BIOCHEM J, V293, P51, DOI 10.1042/bj2930051; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Fasken MB, 2005, NAT STRUCT MOL BIOL, V12, P482, DOI 10.1038/nsmb945; Fasken MB, 2008, J BIOL CHEM, V283, P27130, DOI 10.1074/jbc.M803649200; GAY NJ, 1985, EMBO J, V4, P3519, DOI 10.1002/j.1460-2075.1985.tb04111.x; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Green DM, 2002, J BIOL CHEM, V277, P7752, DOI 10.1074/jbc.M110053200; Guppy M, 2002, BIOCHEM J, V364, P309, DOI 10.1042/bj3640309; Guthrie CR, 2011, HUM MOL GENET, V20, P1989, DOI 10.1093/hmg/ddr079; Hector RE, 2002, EMBO J, V21, P1800, DOI 10.1093/emboj/21.7.1800; HOUSTEK J, 1995, J BIOL CHEM, V270, P7689, DOI 10.1074/jbc.270.13.7689; HURWITZ J, 1962, P NATL ACAD SCI USA, V48, P1222, DOI 10.1073/pnas.48.7.1222; Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; KAPUT J, 1989, J CELL BIOL, V109, P101, DOI 10.1083/jcb.109.1.101; Karam R, 2013, BBA-GENE REGUL MECH, V1829, P624, DOI 10.1016/j.bbagrm.2013.03.002; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kelly SM, 2007, P NATL ACAD SCI USA, V104, P12306, DOI 10.1073/pnas.0701244104; Kelly SM, 2014, RNA, V20, P681, DOI 10.1261/rna.043984.113; Kelly SM, 2012, RNA BIOL, V9, P555, DOI 10.4161/rna.20187; Kerwitz Y, 2003, EMBO J, V22, P3705, DOI 10.1093/emboj/cdg347; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V289, pC881, DOI 10.1152/ajpcell.00104.2005; Kramarova TV, 2008, FASEB J, V22, P55, DOI 10.1096/fj.07-8581com; Kuhn U, 2009, J BIOL CHEM, V284, P22803, DOI 10.1074/jbc.M109.018226; Kuhlmann SI, 2014, NUCLEIC ACIDS RES, V42, P672, DOI 10.1093/nar/gkt876; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Kuhn U, 2003, J BIOL CHEM, V278, P16916, DOI 10.1074/jbc.M209886200; Kuhn U, 1996, J MOL BIOL, V256, P20, DOI 10.1006/jmbi.1996.0065; Kurosaki T, 2014, GENE DEV, V28, P1900, DOI 10.1101/gad.245506.114; Kwong JQ, 2007, J CELL BIOL, V179, P1163, DOI 10.1083/jcb.200704059; Lenzken SC, 2014, WIRES RNA, V5, P565, DOI 10.1002/wrna.1231; Leung SW, 2009, GENE, V439, P71, DOI 10.1016/j.gene.2009.02.022; Liu-Yesucevitz L, 2011, J NEUROSCI, V31, P16086, DOI 10.1523/JNEUROSCI.4105-11.2011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Nagaoka K, 2006, BBA-GENE STRUCT EXPR, V1759, P132, DOI 10.1016/j.bbaexp.2006.04.004; Natera-Naranjo O, 2012, MOL CELL NEUROSCI, V49, P263, DOI 10.1016/j.mcn.2011.12.006; Pak C, 2011, P NATL ACAD SCI USA, V108, P12390, DOI 10.1073/pnas.1107103108; Phillips T., 2008, NAT ED, V1, P199; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Pullmann R, 2007, MOL CELL BIOL, V27, P6265, DOI 10.1128/MCB.00500-07; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Romano M, 2013, J BIOMOL SCREEN, V18, P967, DOI 10.1177/1087057113497256; Roth KM, 2005, MOL CELL BIOL, V25, P1577, DOI 10.1128/MCB.25.5.1577-1585.2005; SACHS AB, 1987, MOL CELL BIOL, V7, P3268, DOI 10.1128/MCB.7.9.3268; Sangawa H, 1997, J BIOL CHEM, V272, P6034, DOI 10.1074/jbc.272.9.6034; Sauvanet C, 2010, SEMIN CELL DEV BIOL, V21, P558, DOI 10.1016/j.semcdb.2009.12.006; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Silver I, 1998, ADV EXP MED BIOL, V454, P7; SINGH B, 1990, BIOCHEM BIOPH RES CO, V169, P391, DOI 10.1016/0006-291X(90)90344-M; Soucek S., 2016, MOL BIOL CELL, DOI [10.1128/MCB.00402-16, DOI 10.1128/MCB.00402-16]; Soucek S, 2012, BBA-GENE REGUL MECH, V1819, P546, DOI 10.1016/j.bbagrm.2012.03.006; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; St-Sauveur VG, 2013, MOL CELL BIOL, V33, P4718, DOI 10.1128/MCB.00887-13; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tuck AC, 2013, CELL, V154, P996, DOI 10.1016/j.cell.2013.07.047; Viphakone N, 2008, NUCLEIC ACIDS RES, V36, P2418, DOI 10.1093/nar/gkn080; Vives-Bauza C, 2010, MOL BIOL CELL, V21, P131, DOI 10.1091/mbc.E09-06-0483; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Wigington CP, 2014, WIRES RNA, V5, P601, DOI 10.1002/wrna.1233; Wilson AC, 2011, INT J CLIN EXP PATHO, V4, P147; WILSON SM, 1994, J CELL BIOL, V127, P1173, DOI 10.1083/jcb.127.5.1173; Wu XY, 2012, GENE, V500, P10, DOI 10.1016/j.gene.2012.03.021; Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493; YAN WL, 1994, GENOMICS, V24, P375, DOI 10.1006/geno.1994.1631; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yang NC, 2002, ANAL BIOCHEM, V306, P323, DOI 10.1006/abio.2002.5698; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	93	11	12	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22442	22459		10.1074/jbc.M116.754069	http://dx.doi.org/10.1074/jbc.M116.754069			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27563065	Green Published, hybrid			2022-12-26	WOS:000386760600008
J	Yoshida, A; Tomita, T; Atomi, H; Kuzuyama, T; Nishiyama, M				Yoshida, Ayako; Tomita, Takeo; Atomi, Haruyuki; Kuzuyama, Tomohisa; Nishiyama, Makoto			Lysine Biosynthesis of Thermococcus kodakarensis with the Capacity to Function as an Ornithine Biosynthetic System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid; archaea; biosynthesis; crystal structure; evolution; protein complex; carrier protein	COMPLETE GENOME SEQUENCE; THERMUS-THERMOPHILUS; ESCHERICHIA-COLI; ARGININE-BIOSYNTHESIS; CARRIER PROTEIN; EVOLUTION; PATHWAYS; ACID; BACTERIUM; SYNTHASE	We recently discovered a biosynthetic system using a novel amino group carrier protein called LysW for lysine biosynthesis via -aminoadipate (AAA), and revealed that this system is also utilized in the biosynthesis of arginine by Sulfolobus. In the present study, we focused on the biosynthesis of lysine and ornithine in the hyperthermophilic archaeon Thermococcus kodakarensis, and showed that their biosynthesis is accomplished by a single set of metabolic enzymes. We also determined the crystal structure of the LysX family protein from T. kodakarensis, which catalyzes the conjugation of LysW with either AAA or glutamate, in a complex with LysW--AAA. This crystal structure is the first example to show how LysX recognizes AAA as a substrate and provides a structural basis for the bifunctionality of the LysX family protein from T. kodakarensis. Based on comparisons with other LysX family proteins, we propose a mechanism for substrate recognition and its relationship with molecular evolution among LysX family proteins, which have different substrate specificities.	[Yoshida, Ayako; Tomita, Takeo; Kuzuyama, Tomohisa; Nishiyama, Makoto] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Atomi, Haruyuki] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Atomi, Haruyuki] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, 7 Gobancho, Tokyo 1020076, Japan	University of Tokyo; Kyoto University; Japan Science & Technology Agency (JST)	Nishiyama, M (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	umanis@mail.ecc.u-tokyo.ac.jp		Atomi, Haruyuki/0000-0001-9687-6426; Kuzuyama, Tomohisa/0000-0002-7221-5858; Yoshida, Ayako/0000-0002-3668-9001	Japan Society for the Promotion of Science KAKENHI [24228001]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grant 24228001 (to M.N.). The authors declare that they have no conflicts of interest with the contents of this article.	Alifano P, 1996, MICROBIOL REV, V60, P44, DOI 10.1128/MMBR.60.1.44-69.1996; Baetens M, 1998, MICROBIOL-SGM, V144, P479, DOI 10.1099/00221287-144-2-479; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Copley RR, 2000, J MOL BIOL, V303, P627, DOI 10.1006/jmbi.2000.4152; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fondi M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S3; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hara T, 1996, BIOCHEMISTRY-US, V35, P11967, DOI 10.1021/bi9605245; Horie A, 2009, NAT CHEM BIOL, V5, P673, DOI 10.1038/nchembio.198; Irvin SD, 1998, J MOL EVOL, V46, P401, DOI 10.1007/PL00006319; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Jung JH, 2014, J BIOTECHNOL, V174, P14, DOI 10.1016/j.jbiotec.2014.01.022; Kobashi N, 1999, J BACTERIOL, V181, P1713, DOI 10.1128/JB.181.6.1713-1718.1999; Lazcano A, 1996, CELL, V85, P793, DOI 10.1016/S0092-8674(00)81263-5; LEISINGER T, 1975, J BIOL CHEM, V250, P1690; MARTIN PR, 1992, J BACTERIOL, V174, P2694, DOI 10.1128/jb.174.8.2694-2701.1992; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishida H, 1999, GENOME RES, V9, P1175, DOI 10.1101/gr.9.12.1175; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouchi T, 2013, NAT CHEM BIOL, V9, P277, DOI [10.1038/NCHEMBIO.1200, 10.1038/nchembio.1200]; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Tawfik DS, 2010, NAT CHEM BIOL, V6, P692, DOI 10.1038/nchembio.441; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UMBARGER HE, 1978, ANNU REV BIOCHEM, V47, P533, DOI 10.1146/annurev.bi.47.070178.002533; Velasco AM, 2002, J MOL EVOL, V55, P445, DOI 10.1007/s00239-002-2340-2; VOGEL HJ, 1964, AM NAT, V98, P435, DOI 10.1086/282338; Xu Y, 2007, MICROBIOL MOL BIOL R, V71, P36, DOI 10.1128/MMBR.00032-06; YASUKAWA T, 1995, J BIOL CHEM, V270, P25328, DOI 10.1074/jbc.270.43.25328; Yoshida A, 2015, J BIOL CHEM, V290, P435, DOI 10.1074/jbc.M114.595983	34	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21630	21643		10.1074/jbc.M116.743021	http://dx.doi.org/10.1074/jbc.M116.743021			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27566549	Green Published, hybrid			2022-12-26	WOS:000385999200029
J	Enooku, K; Uranbileg, B; Ikeda, H; Kurano, M; Sato, M; Kudo, H; Maki, H; Koike, K; Hasegawa, K; Kokudo, N; Yatomi, Y				Enooku, Kenichiro; Uranbileg, Baasanjav; Ikeda, Hitoshi; Kurano, Makoto; Sato, Masaya; Kudo, Hiroki; Maki, Harufumi; Koike, Kazuhiko; Hasegawa, Kiyoshi; Kokudo, Norihiro; Yatomi, Yutaka			Higher LPA2 and LPA6 mRNA Levels in Hepatocellular Carcinoma Are Associated with Poorer Differentiation, Microvascular Invasion and Earlier Recurrence with Higher Serum Autotaxin Levels	PLOS ONE			English	Article							PLASMA LYSOPHOSPHATIDIC ACID; PROTEIN-COUPLED RECEPTOR; LYSOPHOSPHOLIPASE-D; INTRAHEPATIC METASTASIS; PHOSPHOLIPASE A(1); STELLATE CELLS; RHO; MOTILITY; TUMORIGENICITY; IDENTIFICATION	Hepatocellular carcinoma (HCC) commonly develops in patients with liver fibrosis; in these patients, the blood levels of lysophosphatidic acid (LPA) and its generating enzyme autotaxin (ATX) increase with the liver fibrosis stage. We aimed to examine the potential relevance of ATX and LPA in HCC. Fifty-eight HCC patients who underwent surgical treatment were consecutively enrolled in the study. Among the LPA receptors in HCC, higher LPA2 mRNA levels correlated with poorer differentiation, and higher LPA6 mRNA levels correlated with microvascular invasion, which suggested a higher malignant potential of HCC with increased LPA2 and LPA6 expression. In patients with primary HCC, neither LPA2 nor LPA6 mRNA levels were associated with recurrence. However, when serum ATX levels were combined for analysis as a surrogate for plasma LPA levels, the cumulative intrahepatic recurrence rate was higher in patients in whom both serum ATX levels and LPA2 or LPA6 mRNA levels were higher than the median. However, the mRNA level of phosphatidic acid-selective phospholipase A1., another LPA-generating enzyme, in HCC patients was not associated with pathological findings or recurrence, even in combination with the expression of LPA receptors. Higher LPA2 mRNA levels were associated with poorer differentiation, and higher LPA6 levels were associated with microvascular invasion in HCC; both became a risk factor for recurrence after surgical treatment when combined with increased serum ATX levels. ATX and LPA receptors merit consideration as therapeutic targets of HCC.	[Enooku, Kenichiro; Koike, Kazuhiko] Univ Tokyo, Dept Gastroenterol, Tokyo, Japan; [Uranbileg, Baasanjav; Ikeda, Hitoshi; Kurano, Makoto; Sato, Masaya; Yatomi, Yutaka] Univ Tokyo, Dept Clin Lab Med, Tokyo, Japan; [Kudo, Hiroki; Maki, Harufumi; Hasegawa, Kiyoshi; Kokudo, Norihiro] Univ Tokyo, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Ikeda, H (corresponding author), Univ Tokyo, Dept Clin Lab Med, Tokyo, Japan.	ikeda-1im@h.u-tokyo.ac.jp		Maki, Harufumi/0000-0002-9032-1371; Yatomi, Yutaka/0000-0003-1719-4297	JSPS KAKENHI [15H05906]; CREST from JST/AMED	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST from JST/AMED	This work was supported by JSPS KAKENHI Grant Number 15H05906 (Y.Y.) and CREST from JST/AMED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; Baker DL, 2002, JAMA-J AM MED ASSOC, V287, P3081, DOI 10.1001/jama.287.23.3081; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Genda T, 1999, HEPATOLOGY, V30, P1027, DOI 10.1002/hep.510300420; Higgs HN, 1998, J BIOL CHEM, V273, P5468, DOI 10.1074/jbc.273.10.5468; Ikeda H, 1998, BIOCHEM BIOPH RES CO, V248, P436, DOI 10.1006/bbrc.1998.8983; Ikeda H, 2003, AM J PHYSIOL-GASTR L, V285, pG880, DOI 10.1152/ajpgi.00039.2003; Ishii S, 2015, BIOCHEM BIOPH RES CO, V461, P59, DOI 10.1016/j.bbrc.2015.03.169; Kazantseva A, 2006, SCIENCE, V314, P982, DOI 10.1126/science.1133276; Kondo M, 2014, CLIN CHIM ACTA, V433, P128, DOI 10.1016/j.cca.2014.03.006; Lin SB, 2010, AM J PHYSIOL-GASTR L, V299, pG1128, DOI 10.1152/ajpgi.00321.2010; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Machiela MJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11843; Mazzocca A, 2015, CANCER RES, V75, P532, DOI 10.1158/0008-5472.CAN-14-1607; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Moolenaar WH, 2002, J CELL BIOL, V158, P197, DOI 10.1083/jcb.200206094; Nakagawa H, 2011, CLIN CHIM ACTA, V412, P1201, DOI 10.1016/j.cca.2011.03.014; Nakamura K, 2008, CLIN CHIM ACTA, V388, P51, DOI 10.1016/j.cca.2007.10.005; Nakamura K, 2007, CLIN BIOCHEM, V40, P274, DOI 10.1016/j.clinbiochem.2006.10.009; Park SY, 2011, ONCOGENE, V30, P1351, DOI 10.1038/onc.2010.517; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Shimomura Y, 2008, NAT GENET, V40, P335, DOI 10.1038/ng.100; Sokolov E, 2013, J SURG RES, V180, P104, DOI 10.1016/j.jss.2012.10.054; Sonoda H, 2002, J BIOL CHEM, V277, P34254, DOI 10.1074/jbc.M201659200; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Takamura M, 2001, HEPATOLOGY, V33, P577, DOI 10.1053/jhep.2001.22652; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Watanabe N, 2007, LIFE SCI, V81, P1009, DOI 10.1016/j.lfs.2007.08.013; Watanabe N, 2007, J CLIN GASTROENTEROL, V41, P616, DOI 10.1097/01.mcg.0000225642.90898.0e; Yamamoto K, 2010, J GASTROENTEROL, V45, P1272, DOI 10.1007/s00535-010-0278-5; Yamashita H, 2006, J SURG ONCOL, V93, P30, DOI 10.1002/jso.20397; Yanase M, 2000, BIOCHEM BIOPH RES CO, V277, P72, DOI 10.1006/bbrc.2000.3634; Yanase M, 2003, BIOCHEM BIOPH RES CO, V305, P223, DOI 10.1016/S0006-291X(03)00726-5; Yu SX, 2008, JNCI-J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378	37	28	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161825	10.1371/journal.pone.0161825	http://dx.doi.org/10.1371/journal.pone.0161825			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583415	Green Submitted, Green Published, gold			2022-12-26	WOS:000382855600065
J	Hatta, T; Giambini, H; Zhao, CF; Sperling, JW; Steinmann, SP; Itoi, E; An, KN				Hatta, Taku; Giambini, Hugo; Zhao, Chunfeng; Sperling, John W.; Steinmann, Scott P.; Itoi, Eiji; An, Kai-Nan			Biomechanical Effect of Margin Convergence Techniques: Quantitative Assessment of Supraspinatus Muscle Stiffness	PLOS ONE			English	Article							ROTATOR CUFF TEARS; SHEAR-WAVE ELASTOGRAPHY; TENSION OVERLOAD; REPAIR INTEGRITY; NATURAL-HISTORY; STRAIN; FEASIBILITY; DOMINANCE; FAILURE; HAND	Although the margin convergence (MC) technique has been recognized as an option for rotator cuff repair, little is known about the biomechanical effect on repaired rotator cuff muscle, especially after supplemented footprint repair. The purpose of this study was to assess the passive stiffness changes of the supraspinatus (SSP) muscle after MC techniques using shear wave elastography (SWE). A 30 x 40-mm U-shaped rotator cuff tear was created in 8 cadaveric shoulders. Each specimen was repaired with 6 types of MC technique (1-, 2-, 3-suture MC with/without footprint repair, in a random order) at 30 degrees glenohumeral abduction. Passive stiffness of four anatomical regions in the SSP muscle was measured based on an established SWE method. Data were obtained from the SSP muscle at 0 degrees abduction under 8 different conditions: intact (before making a tear), torn, and postoperative conditions with 6 techniques. MC techniques using 1-, or 2-suture combined with footprint repair showed significantly higher stiffness values than the intact condition. Passive stiffness of the SSP muscle was highest after a 1-suture MC with footprint repair for all regions when compared among all repair procedures. There was no significant difference between the intact condition and a 3-suture MC with footprint repair. MC techniques with single stitch and subsequent footprint repair may have adverse effects on muscle properties and tensile loading on repair, increasing the risk of retear of repairs. Adding more MC stitches could reverse these adverse effects.	[Hatta, Taku; Giambini, Hugo; Zhao, Chunfeng; An, Kai-Nan] Mayo Clin, Biomech Lab, Div Orthoped Res, Rochester, MN 55905 USA; [Giambini, Hugo; Sperling, John W.; Steinmann, Scott P.] Mayo Clin, Dept Orthoped Surg, Rochester, MN USA; [Itoi, Eiji] Tohoku Univ, Dept Orthopaed Surg, Sch Med, Sendai, Miyagi, Japan	Mayo Clinic; Mayo Clinic; Tohoku University	An, KN (corresponding author), Mayo Clin, Biomech Lab, Div Orthoped Res, Rochester, MN 55905 USA.	an.kainan@mayo.edu	Hatta, Taku/AEI-5559-2022		National Institute of Arthritis And Musculoskeletal And Skin Diseases of the National Institutes of Health [R21 AR065550]; National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program [T32-AR56950]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR065550, T32AR056950] Funding Source: NIH RePORTER	National Institute of Arthritis And Musculoskeletal And Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis And Musculoskeletal And Skin Diseases of the National Institutes of Health under Award Number R21 AR065550. We would also like to acknowledge the National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program T32-AR56950. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andarawis-Puri N, 2009, J BIOMECH, V42, P158, DOI 10.1016/j.jbiomech.2008.10.020; Brandenburg JE, 2015, J ULTRAS MED, V34, P663, DOI 10.7863/ultra.34.4.663; Burkhart SS, 1997, ARTHROSCOPY, V13, P720, DOI 10.1016/S0749-8063(97)90006-2; Burkhart SS, 1997, ARTHROSCOPY, V13, P172, DOI 10.1016/S0749-8063(97)90151-1; Burkhart SS, 2000, ARTHROSCOPY, V16, P82, DOI 10.1016/S0749-8063(00)90133-6; Burkhart SS, 2004, ANN BIOMED ENG, V32, P166, DOI 10.1023/B:ABME.0000007801.44277.df; Burkhart SS, 1996, ARTHROSCOPY, V12, P335, DOI 10.1016/S0749-8063(96)90070-5; Burkhart SS, 2001, CLIN ORTHOP RELAT R, P107; Dierckman BD, 2012, ARTHROSCOPY, V28, P52, DOI 10.1016/j.arthro.2011.07.014; Eby SF, 2013, J BIOMECH, V46, P2381, DOI 10.1016/j.jbiomech.2013.07.033; Ferraioli G, 2014, J ULTRAS MED, V33, P197, DOI 10.7863/ultra.33.2.197; Galatz LM, 2004, J BONE JOINT SURG AM, V86A, P219, DOI 10.2106/00004623-200402000-00002; HARRYMAN DT, 1991, J BONE JOINT SURG AM, V73A, P982, DOI 10.2106/00004623-199173070-00004; Hatta T, 2015, J BIOMECH, DOI [10.1016/j.jbiomech.2015.09.038, DOI 10.1002/CA.20896]; Iannotti, 1994, J Am Acad Orthop Surg, V2, P87; Itoigawa Y, 2015, CLIN ANAT, V28, P213, DOI 10.1002/ca.22498; Kim KC, 2013, J BONE JOINT SURG AM, V95A, P536, DOI 10.2106/JBJS.L.00397; Kim S, 2010, CLIN ANAT, V23, P48, DOI 10.1002/ca.20896; Koo TK, 2014, CLIN BIOMECH, V29, P33, DOI 10.1016/j.clinbiomech.2013.11.009; Lovric V, 2013, KNEE SURG SPORT TR A, V21, P466, DOI 10.1007/s00167-012-1972-z; Mall NA, 2010, J BONE JOINT SURG AM, V92A, P2623, DOI 10.2106/JBJS.I.00506; Maman E, 2009, J BONE JOINT SURG AM, V91A, P1898, DOI 10.2106/JBJS.G.01335; Mazzocca AD, 2011, ARTHROSCOPY, V27, P330, DOI 10.1016/j.arthro.2010.09.003; Mazzocca AD, 2010, ARTHROSCOPY, V26, P592, DOI 10.1016/j.arthro.2010.02.009; MILGROM C, 1995, J BONE JOINT SURG BR, V77B, P296, DOI 10.1302/0301-620X.77B2.7706351; Minagawa H, 2013, J ORTHOP, V10, P8, DOI 10.1016/j.jor.2013.01.008; Murray TF, 2002, J SHOULDER ELB SURG, V11, P19, DOI 10.1067/mse.2002.120142; Park HY, 2014, ULTRASOUND MED BIOL, V40, P1058, DOI 10.1016/j.ultrasmedbio.2013.12.021; Park MC, 2007, J SHOULDER ELB SURG, V16, P461, DOI 10.1016/j.jse.2006.09.010; Safran O, 2011, AM J SPORT MED, V39, P710, DOI 10.1177/0363546510393944; Sano H, 2013, AM J SPORT MED, V41, P2262, DOI 10.1177/0363546513497565; Schwartz C, 2014, J SHOULDER ELB SURG, V23, P873, DOI 10.1016/j.jse.2013.08.020; Shindle Michael K, 2011, HSS J, V7, P208; Taniguchi K, 2015, SCAND J MED SCI SPOR, V25, P32, DOI 10.1111/sms.12146; Wolf EM, 2005, ARTHROSCOPY, V21, P881, DOI 10.1016/j.arthro.2005.03.014; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Yamaguchi K, 2001, J SHOULDER ELB SURG, V10, P199, DOI 10.1067/mse.2001.113086	37	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162110	10.1371/journal.pone.0162110	http://dx.doi.org/10.1371/journal.pone.0162110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583402	Green Published, gold, Green Submitted			2022-12-26	WOS:000382855600105
J	Zhou, SM; Xu, RH; He, FS; Zhou, JX; Wang, Y; Zhou, JL; Wang, MB; Zhou, WH				Zhou, Shaoming; Xu, Ruihuan; He, Fusheng; Zhou, Jiaxiu; Wang, Yan; Zhou, Jianli; Wang, Mingbang; Zhou, Wenhao			Diversity of Gut Microbiota Metabolic Pathways in 10 Pairs of Chinese Infant Twins	PLOS ONE			English	Article							FATTY-ACIDS; LIFE; DYNAMICS; DISEASE; SHAPES; GENES	Early colonization of gut microbiota in human gut is a complex process. It remains unclear when gut microbiota colonization occurs and how it proceeds. In order to study gut microbiota composition in human early life, the present study recruited 10 healthy pairs of twins, including five monozygotic (MZ) and five dizygotic (DZ) twin pairs, whose age ranged from 0 to 6 years old. 20 fecal samples from these twins were processed by shotgun metagenomic sequencing, and their averaged data outputs were generated as 2G per sample. We used MEGAN5 to perform taxonomic and functional annotation of the metagenomic data, and systematically analyzed those 20 samples, including Jaccard index similarity, principle component, clustering, and correlation analyses. Our findings indicated that within our study group: 1) MZ-twins share more microbes than DZ twins or non-twin pairs, 2) gut microbiota distribution is relatively stable at metabolic pathways level, 3) age represents the strongest factor that can account for variation in gut microbiota, and 4) a clear metabolic pathway shift can be observed, which speculatively occurs around the age of 1 year old. This research will serve as a base for future studies of gut microbiota-related disease research.	[Zhou, Shaoming; Zhou, Jianli] Shenzhen Childrens Hosp, Div Gastroenterol, Shenzhen, Guangdong, Peoples R China; [Xu, Ruihuan] Longgang Cent Hosp, Clin Lab, Shenzhen, Guangdong, Peoples R China; [He, Fusheng; Wang, Mingbang] Shenzhen Following Precis Med Res Inst, Shenzhen, Guangdong, Peoples R China; [Zhou, Jiaxiu] Shenzhen Childrens Hosp, Div Psychol, Shenzhen, Guangdong, Peoples R China; [Wang, Yan; Wang, Mingbang] Shenzhen Imuno Biotech Co Ltd, Shenzhen, Peoples R China; [Wang, Mingbang; Zhou, Wenhao] Fudan Univ, Childrens Hosp, Div Neonatol, Shanghai, Peoples R China; [Wang, Mingbang; Zhou, Wenhao] Fudan Univ, Childrens Hosp, Key Lab Birth Defects, Shanghai, Peoples R China; [Zhou, Wenhao] Fudan Univ, Childrens Hosp, Key Lab Neonatal Dis, Minist Hlth, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Zhou, SM (corresponding author), Shenzhen Childrens Hosp, Div Gastroenterol, Shenzhen, Guangdong, Peoples R China.; Wang, MB (corresponding author), Shenzhen Following Precis Med Res Inst, Shenzhen, Guangdong, Peoples R China.; Wang, MB (corresponding author), Shenzhen Imuno Biotech Co Ltd, Shenzhen, Peoples R China.; Wang, MB; Zhou, WH (corresponding author), Fudan Univ, Childrens Hosp, Div Neonatol, Shanghai, Peoples R China.; Wang, MB; Zhou, WH (corresponding author), Fudan Univ, Childrens Hosp, Key Lab Birth Defects, Shanghai, Peoples R China.; Zhou, WH (corresponding author), Fudan Univ, Childrens Hosp, Key Lab Neonatal Dis, Minist Hlth, Shanghai, Peoples R China.	zhousm15d@aliyun.com; Mingbang.wang.bgi@qq.com; zwhchfu@126.com	Wang, Mingbang/F-4457-2018; wenhao, zhou/AAA-1505-2020	Wang, Mingbang/0000-0002-5989-5377; Zhou, Wenhao/0000-0001-8956-7238	Shenzhen Science Technology Research & Development Fund from Shenzhen Science Technology and Innovation Commission [JCYJ20140416141331514, JCYJ20140411150159429, JCYJ20140415151845360, JCYJ20130401114111453]; Longgang District Science Fundamental Research fund from Longgang District Science Technology and Innovation Commission of Shenzhen [201406063001021]; Shanghai Municipal Commission of Health and Family Planning [2013ZYJB0015]; Science and Technology Commission of Shanghai Municipal [14411950402]; Shenzhen Imuno Biotech Co., Ltd [20150308]	Shenzhen Science Technology Research & Development Fund from Shenzhen Science Technology and Innovation Commission; Longgang District Science Fundamental Research fund from Longgang District Science Technology and Innovation Commission of Shenzhen; Shanghai Municipal Commission of Health and Family Planning; Science and Technology Commission of Shanghai Municipal(Science & Technology Commission of Shanghai Municipality (STCSM)); Shenzhen Imuno Biotech Co., Ltd	This project was support by Shenzhen Science Technology Research & Development Fund (No. JCYJ20140416141331514, JCYJ20140411150159429, JCYJ20140415151845360, and JCYJ20130401114111453) from Shenzhen Science Technology and Innovation Commission, Longgang District Science Fundamental Research fund (No. 201406063001021) from Longgang District Science Technology and Innovation Commission of Shenzhen, Shanghai Municipal Commission of Health and Family Planning (No. 2013ZYJB0015), Science and Technology Commission of Shanghai Municipal (No. 14411950402) and by Shenzhen Imuno Biotech Co., Ltd (No. 20150308). The funder listed provided support, only Shenzhen Imuno Biotech Co., Ltd provide in the form of salaries for authors MW and YW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Ardeshir A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008791; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Azad MB, 2013, CAN MED ASSOC J, V185, P385, DOI 10.1503/cmaj.121189; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.04.004, 10.1016/j.chom.2015.05.012]; Cahenzli J, 2013, CELL HOST MICROBE, V14, P559, DOI 10.1016/j.chom.2013.10.004; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; FernandezBanares F, 1997, CLIN NUTR, V16, P177, DOI 10.1016/S0261-5614(97)80003-9; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Jensen LJ, 2008, NUCLEIC ACIDS RES, V36, pD250, DOI 10.1093/nar/gkm796; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Suchodolski JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127378; Tims S, 2013, ISME J, V7, P707, DOI 10.1038/ismej.2012.146; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang AH, 2013, MOL BIOSYST, V9, P2259, DOI 10.1039/c3mb70171a	28	24	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161627	10.1371/journal.pone.0161627	http://dx.doi.org/10.1371/journal.pone.0161627			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583441	Green Published, gold, Green Submitted			2022-12-26	WOS:000382855600046
J	AL Nahdi, A; de Leaniz, CG; King, AJ				AL Nahdi, Abdullah; de Leaniz, Carlos Garcia; King, Andrew J.			Spatio-Temporal Variation in Length-Weight Relationships and Condition of the Ribbonfish Trichiurus lepturus (Linnaeus, 1758): Implications for Fisheries Management	PLOS ONE			English	Article							ARABIAN SEA; REPRODUCTIVE-BIOLOGY; PATTERNS; BIOMASS; GROWTH; BIAS	Knowledge of length-weight relationships for commercially exploited fish is an important tool for assessing and managing of fish stocks. However, analyses of length-weight relationship fisheries data typically do not consider the inherent differences in length-weight relationships for fish caught from different habitats, seasons, or years, and this can affect the utility of these data for developing condition indices or calculating fisheries biomass. Here, we investigated length-weight relationships for ribbonfish Trichiurus lepturus in the waters of the Arabian Sea off Oman collected during three periods (2001-02, 2007-08, and 2014-15) and showed that a multivariate modelling approach that considers the areas and seasons in which ribbonfish were caught improved estimation of length-weight relationships. We used the outputs of these models to explore spatio-temporal variations in condition indices and relative weights among ribbonfish, revealing fish of 85-125 cm were in the best overall condition. We also found that condition differed according to where and when fish were caught, with condition lowest during spring and pre-south-west monsoon periods and highest during and after the south-west monsoons. We interpret these differences to be a consequence of variability in temperature and food availability. Based on our findings, we suggest fishing during seasons that have the lowest impact on fish condition and which are commercially most viable; such fishery management would enhance fisheries conservation and economic revenue in the region.	[AL Nahdi, Abdullah; de Leaniz, Carlos Garcia; King, Andrew J.] Swansea Univ, Coll Sci, Dept Biosci, Singleton Pk, Swansea, W Glam, Wales; [AL Nahdi, Abdullah] Minist Agr & Fisheries Wealth, Directorate Fisheries Res, Marine Sci & Fisheries Ctr, Muscat, Oman	Swansea University	AL Nahdi, A (corresponding author), Swansea Univ, Coll Sci, Dept Biosci, Singleton Pk, Swansea, W Glam, Wales.; AL Nahdi, A (corresponding author), Minist Agr & Fisheries Wealth, Directorate Fisheries Res, Marine Sci & Fisheries Ctr, Muscat, Oman.	750302@swansea.ac.uk	Al Nahdi, Abdullah/M-6688-2015	Al Nahdi, Abdullah/0000-0001-6205-3405	Swansea University, UK; Ministry of Agriculture and Fisheries Wealth, Oman; Ministry of Agriculture and Fisheries Wealth (Sultanate of Oman)	Swansea University, UK; Ministry of Agriculture and Fisheries Wealth, Oman; Ministry of Agriculture and Fisheries Wealth (Sultanate of Oman)	This research was supported by Swansea University, UK (http://www.swansea.ac.uk/) and funded by the Ministry of Agriculture and Fisheries Wealth, Oman (http://maf.gov.om/pages/index.aspx?lang=AR&DId=0&I=0&CId=0&CMSId=40) and for postgraduate assistantship by Agriculture and Fisheries Development Fund (http://www.afdf.gov.om/index.php/home?lang=english) to AN. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the scientific staff and crew of R/V Independent 1 which were part of the "Fish Resources Survey of the Arabian Sea Coast of Oman" project for providing data. Thanks also to the biologists in the Marine Science and Fisheries Centre for their assistance in sample collection and technical support in the laboratory. The Ministry of Agriculture and Fisheries Wealth (Sultanate of Oman) provided resources and support to enable this study. All data used in this manuscript are presented as a supplementary file. We thank Heather M. Patterson and an anonymous reviewer for their constructive comments on the previous versions of the manuscript.	Al-Nahdi A, 2009, INDIAN J FISH, V56, P73; Anderson RO, 1996, FISHERIES TECHNIQUES, P447; [Anonymous], 2015, FISHERIES STAT BOOK, P250; Ashjian CJ, 2002, DEEP-SEA RES PT II, V49, P2377, DOI 10.1016/S0967-0645(02)00041-3; Bailey T, 1995, INTERACTIVE SPATIAL; Blackwell Brian G., 2000, Reviews in Fisheries Science, V8, P1, DOI 10.1080/10641260091129161; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Carron, 1999, ARABIAN MARGINAL SEA; Cheng CH, 2001, FISHERIES SCI, V67, P3, DOI 10.1046/j.1444-2906.2001.00192.x; Claereboudt MR, 2005, FISH RES, V73, P273, DOI 10.1016/j.fishres.2005.02.009; Earth N, 2013, 1 10M CULTURAL VECTO; Froese R, 2006, J APPL ICHTHYOL, V22, P241, DOI 10.1111/j.1439-0426.2006.00805.x; Fulton T. W., 1902, RATE GROWTH SEA FISH; Ghosh S, 2014, INDIAN J GEO-MAR SCI, V43, P755; Godad SP, 2011, MAR MICROPALEONTOL, V78, P25, DOI 10.1016/j.marmicro.2010.09.006; HAYES DB, 1995, CAN J FISH AQUAT SCI, V52, P84, DOI 10.1139/f95-008; HILBORN R, 1992; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; Kang HJ, 2015, OCEAN SCI J, V50, P237, DOI 10.1007/s12601-015-0021-5; Kwok KY, 1999, MAR ECOL PROG SER, V176, P39, DOI 10.3354/meps176039; Lai HL, 2004, FISH RES, V70, P377, DOI 10.1016/j.fishres.2004.08.014; LECREN ED, 1951, J ANIM ECOL, V20, P201, DOI 10.2307/1540; Lewin WC, 2006, REV FISH SCI, V14, P305, DOI 10.1080/10641260600886455; LIAO HS, 1995, T AM FISH SOC, V124, P387, DOI 10.1577/1548-8659(1995)124<0387:RWWRAA>2.3.CO;2; McIlwain J, 2006, J APPL ICHTHYOL, V22, P167, DOI 10.1111/j.1439-0426.2006.00723.x; MURPHY B R, 1990, North American Journal of Fisheries Management, V10, P85, DOI 10.1577/1548-8675(1990)010<0085:EOTRWW>2.3.CO;2; Naqvi S.W.A., 2010, ARABIAN SEA HIGH NUT; Neumann RM, 2012, FISHERIES TECHNIQUES, THIRD EDITION, P637; Ogle D.H., 2014, FSA FISHERIES STOCK; Ogle DH, 2009, N AM J FISH MANAGE, V29, P850, DOI 10.1577/M08-176.1; Pardoe H, 2008, MAR ECOL PROG SER, V362, P261, DOI 10.3354/meps07409; Piontkovski S, 2015, INT J ENVIRON STUD, P1; Planque B, 2010, J MARINE SYST, V79, P403, DOI 10.1016/j.jmarsys.2008.12.018; Pope KL, 2001, ASSESSMENT FISH COND; Randall JE., 1995, COASTAL FISHES OMAN, DOI DOI 10.2307/1447687; REIST JD, 1985, CAN J ZOOL, V63, P1429, DOI 10.1139/z85-213; SPRUGEL DG, 1983, ECOLOGY, V64, P209, DOI 10.2307/1937343; Team RC, 2014, R LANG ENV STAT COMP; van Overzee HMJ, 2015, REV FISH BIOL FISHER, V25, P65, DOI 10.1007/s11160-014-9370-x; Zhou SJ, 2010, P NATL ACAD SCI USA, V107, P9485, DOI 10.1073/pnas.0912771107	40	18	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161989	10.1371/journal.pone.0161989	http://dx.doi.org/10.1371/journal.pone.0161989			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579485	Green Submitted, Green Published, gold			2022-12-26	WOS:000382877400050
J	Andonian, P; Viallon, M; Le Goff, C; de Bourguignon, C; Tourel, C; Morel, J; Giardini, G; Gergele, L; Millet, GP; Croisille, P				Andonian, Pierre; Viallon, Magalie; Le Goff, Caroline; de Bourguignon, Charles; Tourel, Charline; Morel, Jerome; Giardini, Guido; Gergele, Laurent; Millet, Gregoire P.; Croisille, Pierre			Shear-Wave Elastography Assessments of Quadriceps Stiffness Changes prior to, during and after Prolonged Exercise: A Longitudinal Study during an Extreme Mountain Ultra-Marathon	PLOS ONE			English	Article							INDUCED MUSCLE DAMAGE; ECCENTRIC EXERCISE; MECHANICAL-PROPERTIES; SKELETAL-MUSCLE; SOFT-TISSUE; FORCE; RESPONSES; ULTRAMARATHON; BIOMECHANICS; RELIABILITY	In sports medicine, there is increasing interest in quantifying the elastic properties of skeletal muscle, especially during extreme muscular stimulation, to improve our understanding of the impact of alterations in skeletal muscle stiffness on resulting pain or injuries, as well as the mechanisms underlying the relationships between these parameters. Our main objective was to determine whether real-time shear-wave elastography (SWE) can monitor changes in quadriceps muscle elasticity during an extreme mountain ultra-marathon, a powerful mechanical stress model. Our study involved 50 volunteers participating in an extreme mountain marathon (distance: 330 km, elevation: + 24,000 m). Quantitative SWE velocity and shear modulus measurements were performed in most superficial quadriceps muscle heads at the following 4 time points: before the race, halfway through the race, upon finishing the race and after recovery (+ 48 h). Blood biomarker levels were also measured. A significant decrease in the quadriceps shear modulus was observed upon finishing the race (3.31 +/- 0.61 kPa) (p < 0.001) compared to baseline (3.56 +/- 0.63 kPa), followed by a partial recovery + 48 h after the race (3.45 +/- 0.6 kPa) (p = 0.002) across all muscle heads, as well as for each of the following three muscle heads: the rectus femoris (p = 0.003), the vastus medialis (p = 0.033) and the vastus lateralis (p = 0.001). Our study is the first to assess changes in muscle stiffness during prolonged extreme physical endurance exercises based on shear modulus measurements using non-invasive SWE. We concluded that decreases in stiffness, which may have resulted from quadriceps overuse in the setting of supra-physiological stress caused by the extreme distance and unique elevation of the race, may have been responsible for the development of inflammation and muscle swelling. SWE may hence represent a promising tool for monitoring physiologic or pathological variations in muscle stiffness and may be useful for diagnosing and monitoring muscle changes.	[Andonian, Pierre; Viallon, Magalie; de Bourguignon, Charles; Croisille, Pierre] Univ Jean Monnet, CHU St Etienne, Dept Radiol, St Etienne, France; [Viallon, Magalie; Croisille, Pierre] Univ Lyon, UJM St Etienne, CREATIS, INSERM U1206,CNRS UMR 5520,INSA, F-42023 St Etienne, France; [Le Goff, Caroline] Univ Liege, CHU Sart Tilman, Dept Clin Chem, EuSpLM, Liege, Belgium; [Tourel, Charline; Morel, Jerome; Gergele, Laurent] CHU St Etienne, Dept Intens Care, St Etienne, France; [Giardini, Guido] Valle DAosta Reg Hosp, Mt Med Ctr, Dept Neurol & Neurophysiol, Aosta, Italy; [Millet, Gregoire P.] Univ Lausanne ISSUL, Inst Sport Sci, Lausanne, Switzerland	CHU de St Etienne; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); University of Liege; CHU de St Etienne; Azienda USL della Valle d'Aosta	Croisille, P (corresponding author), Univ Jean Monnet, CHU St Etienne, Dept Radiol, St Etienne, France.; Croisille, P (corresponding author), Univ Lyon, UJM St Etienne, CREATIS, INSERM U1206,CNRS UMR 5520,INSA, F-42023 St Etienne, France.	pierre.croisille@creatis.insa-lyon.fr	Millet, Gregoire P/F-4104-2012; Croisille, Pierre/H-4928-2014; Le Goff, Caroline/AAE-8177-2021; Viallon, Magalie/H-4471-2014	Millet, Gregoire P/0000-0001-8081-4423; Croisille, Pierre/0000-0003-4019-3460; Viallon, Magalie/0000-0001-9118-0438	Universite de Lyon, within the program "Investissements d'Avenir" [ANR-11-LABX-0063, ANR-11-IDEX-0007]	Universite de Lyon, within the program "Investissements d'Avenir"(French National Research Agency (ANR))	The authors are especially grateful to Supersonic Imagine, who contributed to this study by providing two of their ultrasound diagnostic systems equipped with the most advanced SWE module during the Tor des Geants. The authors also thank Sysmex for their support in providing a pocH-100i (TM) automated hematology analyzer (Sysmex, Villepinte, France). This work was performed within the framework of the LABEX PRIMES (ANR-11-LABX-0063) of Universite de Lyon, within the program "Investissements d'Avenir" (ANR-11-IDEX-0007) operated by the French National Research Agency (ANR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi R, 2014, SCAND J MED SCI SPOR, V24, P950, DOI 10.1111/sms.12111; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Avela J, 1999, J APPL PHYSIOL, V86, P1292, DOI 10.1152/jappl.1999.86.4.1292; Balnave CD, 1996, J PHYSIOL-LONDON, V492, P705, DOI 10.1113/jphysiol.1996.sp021339; Bell RAV, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0086-6; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Blazevich AJ, 2006, SPORTS MED, V36, P1003, DOI 10.2165/00007256-200636120-00002; Botanlioglu H, 2013, SKELETAL RADIOL, V42, P659, DOI 10.1007/s00256-012-1520-4; Bouillard K, 2014, J NEUROPHYSIOL, V111, P768, DOI 10.1152/jn.00595.2013; Brandenburg JE, 2014, ARCH PHYS MED REHAB, V95, P2207, DOI 10.1016/j.apmr.2014.07.007; Catheline S, 2004, J ACOUST SOC AM, V116, P3734, DOI 10.1121/1.1815075; Chen SG, 2009, IEEE T ULTRASON FERR, V56, P55, DOI 10.1109/TUFFC.2009.1005; Clarkson PM, 2002, AM J PHYS MED REHAB, V81, pS52, DOI [10.1097/00002060-200211001-00007, 10.1097/01.PHM.0000029772.45258.43]; CLARKSON PM, 1992, MED SCI SPORT EXER, V24, P512; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cowan S. M., 2000, PHYS THER SPORT, V1, P129, DOI DOI 10.1054/PTSP.2000.0036; Crommert ME, 2015, SCAND J MED SCI SPOR, V25, pE490, DOI 10.1111/sms.12341; DAVIES CTM, 1986, J APPL PHYSIOL, V61, P611, DOI 10.1152/jappl.1986.61.2.611; de Lange P, 2007, FASEB J, V21, P3431, DOI 10.1096/fj.07-8527rev; DIETZ V, 1981, BRAIN, V104, P431, DOI 10.1093/brain/104.3.431; Dubois G, 2015, ULTRASOUND MED BIOL, V41, P2284, DOI 10.1016/j.ultrasmedbio.2015.04.020; Eby SF, 2015, CLIN BIOMECH, V30, P22, DOI 10.1016/j.clinbiomech.2014.11.011; Feasson L, 2006, Ann Readapt Med Phys, V49, P289, DOI 10.1016/j.annrmp.2006.04.015; FRIDEN J, 1981, EXPERIENTIA, V37, P506, DOI 10.1007/BF01986165; Friden J, 2001, ACTA PHYSIOL SCAND, V171, P321, DOI 10.1046/j.1365-201x.2001.00834.x; Fulford J, 2015, SCAND J MED SCI SPOR, V25, pE28, DOI 10.1111/sms.12234; Gennisson JL, 2007, J ACOUST SOC AM, V122, P3211, DOI 10.1121/1.2793605; Gennisson JL, 2010, ULTRASOUND MED BIOL, V36, P789, DOI 10.1016/j.ultrasmedbio.2010.02.013; Giovanelli N, 2016, INT J SPORT PHYSIOL, V11, P522, DOI 10.1123/ijspp.2014-0602; Green MA, 2012, NMR BIOMED, V25, P852, DOI 10.1002/nbm.1801; Guilhem G, 2016, ACTA PHYSIOL, V217, P152, DOI 10.1111/apha.12654; Guilhem G, 2013, MED SCI SPORT EXER, V45, P326, DOI 10.1249/MSS.0b013e31826e7066; Heroux ME, 2013, ACTA PHYSIOL, V208, P294, DOI 10.1111/apha.12133; HIKIDA RS, 1983, J NEUROL SCI, V59, P185, DOI 10.1016/0022-510X(83)90037-0; Hill JC, 2014, PHYSICIAN SPORTSMED, V42, P45, DOI 10.3810/psm.2014.09.2075; Hjorth M, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12473; HOWELL JN, 1993, J PHYSIOL-LONDON, V464, P183, DOI 10.1113/jphysiol.1993.sp019629; Hug F, 2015, EXERC SPORT SCI REV, V43, P125, DOI 10.1249/JES.0000000000000049; Jamart C, 2012, EUR J APPL PHYSIOL, V112, P3173, DOI 10.1007/s00421-011-2287-3; Kim Jooyoung, 2015, J Exerc Nutrition Biochem, V19, P123, DOI 10.5717/jenb.2015.15061910; Kjaer M, 2006, J ANAT, V208, P445, DOI 10.1111/j.1469-7580.2006.00549.x; Knechtle B, 2008, J SPORT SCI MED, V7, P357; Koo TK, 2014, CLIN BIOMECH, V29, P33, DOI 10.1016/j.clinbiomech.2013.11.009; Kot BCW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044348; Kreider R B, 1991, Int J Sport Nutr, V1, P3; Lacourpaille L, 2014, ACTA PHYSIOL, V211, P135, DOI 10.1111/apha.12272; Lacourpaille L, 2015, MUSCLE NERVE, V51, P284, DOI 10.1002/mus.24445; Lacourpaille L, 2012, PHYSIOL MEAS, V33, pN19, DOI 10.1088/0967-3334/33/3/N19; Lakens D, 2015, CALCULATING REPORTIN, P1, DOI [10.3389/fpsyg.2013.00863/abstract, DOI 10.3389/FPSYG.2013.00863/ABSTRACT]; Lee SSM, 2015, CLIN BIOMECH, V30, P269, DOI 10.1016/j.clinbiomech.2015.01.004; LEHMANN JF, 1989, ARCH PHYS MED REHAB, V70, P6; Leonard CT, 2003, ARCH PHYS MED REHAB, V84, P928, DOI 10.1016/S0003-9993(03)00006-6; Lieber RL, 2004, MUSCLE NERVE, V29, P615, DOI 10.1002/mus.20059; MANFREDI TG, 1991, MED SCI SPORT EXER, V23, P1028; Garcia-Manso JM, 2011, J SPORT SCI, V29, P619, DOI 10.1080/02640414.2010.548822; Maufrais C, 2016, AM J PHYSIOL-HEART C, V310, pH1340, DOI 10.1152/ajpheart.00037.2016; MCCARTHY DA, 1988, SPORTS MED, V6, P333, DOI 10.2165/00007256-198806060-00002; MCGRAW KO, 1992, PSYCHOL BULL, V111, P361, DOI 10.1037/0033-2909.111.2.361; Millet GP, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-77; Millet GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017059; Mueller SM, 2015, EUR J APPL PHYSIOL, V115, P795, DOI 10.1007/s00421-014-3051-2; Neumayr G, 2003, INT J SPORTS MED, V24, P131, DOI 10.1055/s-2003-38205; NEWHAM DJ, 1987, J APPL PHYSIOL, V63, P1381, DOI 10.1152/jappl.1987.63.4.1381; Newton MJ, 2008, J STRENGTH COND RES, V22, P597, DOI 10.1519/JSC.0b013e3181660003; Nieman DC, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0003-z; Overgaard K, 2002, J APPL PHYSIOL, V92, P1891, DOI 10.1152/japplphysiol.00669.2001; Palmeri ML, 2008, ULTRASOUND MED BIOL, V34, P546, DOI 10.1016/j.ultrasmedbio.2007.10.009; Proske U, 2001, J PHYSIOL-LONDON, V537, P333, DOI 10.1111/j.1469-7793.2001.00333.x; RADIN EL, 1986, ACTA MED SCAND, P143; Regueme SC, 2005, EUR J APPL PHYSIOL, V93, P398, DOI 10.1007/s00421-004-1221-3; Roth SM, 1999, J APPL PHYSIOL, V86, P1833, DOI 10.1152/jappl.1999.86.6.1833; Rousson V, 2002, STAT MED, V21, P3431, DOI 10.1002/sim.1253; Sahlin K, 2010, J APPL PHYSIOL, V108, P780, DOI 10.1152/japplphysiol.00966.2009; Saugy J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065596; Semmler A, 2013, J NEUROL, V260, P151, DOI 10.1007/s00415-012-6605-4; Skenderi KP, 2006, MED SCI SPORT EXER, V38, P1054, DOI 10.1249/01.mss.0000222831.35897.5f; Sloniger MA, 1997, J APPL PHYSIOL, V83, P2073, DOI 10.1152/jappl.1997.83.6.2073; Stupka N, 2000, J APPL PHYSIOL, V89, P2325, DOI 10.1152/jappl.2000.89.6.2325; Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002; Vitiello D, 2015, EXTREME PHYSIOL MED, V4, DOI 10.1186/s13728-015-0037-6; Voloshina AS, 2015, J EXP BIOL, V218, P711, DOI 10.1242/jeb.106518; Warren GL, 2008, HUMAN ANIMAL EXPT MU; Weismann C, 2011, BREAST CARE, V6, P98, DOI 10.1159/000327504; Whitehead NP, 2001, J PHYSIOL-LONDON, V533, P593, DOI 10.1111/j.1469-7793.2001.0593a.x; YAMAKOSHI Y, 1990, IEEE T ULTRASON FERR, V37, P45, DOI 10.1109/58.46969; Yanagisawa O, 2011, CLIN RADIOL, V66, P815, DOI 10.1016/j.crad.2011.03.012	86	65	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161855	10.1371/journal.pone.0161855	http://dx.doi.org/10.1371/journal.pone.0161855			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579699	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877400044
J	Liu, WS; Zhao, Y; You, JL; Qi, DH; Zhou, Y; Chen, JK; Song, ZP				Liu, Wensheng; Zhao, Yao; You, Jianling; Qi, Danhui; Zhou, Yin; Chen, Jiakuan; Song, Zhiping			Morphological and Genetic Variation along a North-to-South Transect in Stipa purpurea, a Dominant Grass on the Qinghai-Tibetan Plateau: Implications for Response to Climate Change	PLOS ONE			English	Article							LOCAL ADAPTATION; ALPINE PLANT; ALTITUDINAL GRADIENT; FLOW; GROWTH; REPRODUCTION; EVOLUTIONARY; PLASTICITY; ALLOMETRY; DIVERSITY	Estimating the potential of species to cope with rapid environmental climatic modifications is of vital importance for determining their future viability and conservation. The variation between existing populations along a climatic gradient may predict how a species will respond to future climate change. Stipa purpurea is a dominant grass species in the alpine steppe and meadow of the Qinghai-Tibetan Plateau (QTP). Ecological niche modelling was applied to S. purpurea, and its distribution was found to be most strongly correlated with the annual precipitation and the mean temperature of the warmest quarter. We established a north-to-south transect over 2000 km long on the QTP reflecting the gradients of temperature and precipitation, and then we estimated the morphological by sampling fruited tussocks and genetic divergence by using 11 microsatellite markers between 20 populations along the transect. Reproductive traits (the number of seeds and reproductive shoots), the reproductive-vegetative growth ratio and the length of roots in the S. purpurea populations varied significantly with climate variables. S. purpurea has high genetic diversity (He = 0.585), a large effective population size (Ne > 1,000), and a considerable level of gene flow between populations. The S. purpurea populations have a mosaic genetic structure: some distant populations (over 1000 km apart) clustered genetically, whereas closer populations (< 100 km apart) had diverged significantly, suggesting local adaptation. Asymmetrical long-distance inter-population gene flow occurs along the sampling transect and might be mediated by seed dispersal via migratory herbivores, such as the chiru (Pantholops hodgsonii). These findings suggest that population performance variation and gene flow both facilitate the response of S. purpurea to climate change.	[Liu, Wensheng; Zhao, Yao; You, Jianling; Zhou, Yin; Chen, Jiakuan; Song, Zhiping] Fudan Univ, Inst Biodivers Sci, Key Lab Biodivers Sci & Ecol Engn, Minist Educ, Shanghai, Peoples R China; [Liu, Wensheng; Qi, Danhui] Southwest Forestry Univ, Coll Environm Sci & Engn, Kunming, Peoples R China; [Liu, Wensheng] Cent South Univ Forestry & Technol, Coll Life Sci & Technol, Changsha, Hunan, Peoples R China	Fudan University; Southwest Forestry University - China; Central South University of Forestry & Technology	Song, ZP (corresponding author), Fudan Univ, Inst Biodivers Sci, Key Lab Biodivers Sci & Ecol Engn, Minist Educ, Shanghai, Peoples R China.	songzp@fudan.edu.cn	liu, wen/HGE-3071-2022	you, jianling/0000-0002-0683-7915	Ministry of Science and Technology [2014CB954103]; Applied Fundamental Research Foundation of Yunnan Province [2014GA003]; National Natural Science Foundation of China [31160048]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Applied Fundamental Research Foundation of Yunnan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the Ministry of Science and Technology (Grant No. 2014CB954103), the Applied Fundamental Research Foundation of Yunnan Province (2014GA003), and the National Natural Science Foundation of China (Grant No. 31160048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful to X.Y. Pan, H. Guo and W. Zhou for assistance with data analyses, and Y. G. Wang, W.J. Zhang and J. Yang for their comments on the paper. This research was funded by the Ministry of Science and Technology (Grant No. 2014CB954103), the Applied Fundamental Research Foundation of Yunnan Province (2014GA003), and the National Natural Science Foundation of China (Grant No. 31160048).	Alsos IG, 2007, SCIENCE, V316, P1606, DOI 10.1126/science.1139178; Beerli P., 2008, MIGRATE VERSION 3 0; Blanquart F, 2013, ECOL LETT, V16, P1195, DOI 10.1111/ele.12150; Blass C, 2010, J ARID ENVIRON, V74, P991, DOI 10.1016/j.jaridenv.2009.12.002; Byars SG, 2007, EVOLUTION, V61, P2925, DOI 10.1111/j.1558-5646.2007.00248.x; Byars SG, 2009, ANN BOT-LONDON, V103, P885, DOI 10.1093/aob/mcp018; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Durka W, 2013, PLANT SYST EVOL, V299, P259, DOI 10.1007/s00606-012-0719-0; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falster DS, 2006, USERS GUIDE TO SMATR; Faubet P, 2007, MOL ECOL, V16, P1149, DOI 10.1111/j.1365-294X.2007.03218.x; Franks SJ, 2014, EVOL APPL, V7, P123, DOI 10.1111/eva.12112; Garcia-Fernandez A, 2012, ANN BOT-LONDON, V110, P1221, DOI 10.1093/aob/mcs195; Gonzalo-Turpin H, 2009, J ECOL, V97, P742, DOI 10.1111/j.1365-2745.2009.01509.x; Guo H, 2012, J ECOL, V100, P452, DOI 10.1111/j.1365-2745.2011.01884.x; Hadfield JD, 2016, ECOL LETT, V19, P780, DOI 10.1111/ele.12614; Hamasha HR, 2013, PLANT BIOLOGY, V15, P882, DOI 10.1111/j.1438-8677.2012.00689.x; HENDRIX SD, 1991, NEW PHYTOL, V119, P299, DOI 10.1111/j.1469-8137.1991.tb01034.x; Johansson F, 2013, MOL ECOL, V22, P5608, DOI 10.1111/mec.12497; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; KLINKHAMER PGL, 1992, FUNCT ECOL, V6, P308, DOI 10.2307/2389522; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; Lind MI, 2011, J EVOLUTION BIOL, V24, P2696, DOI 10.1111/j.1420-9101.2011.02393.x; Liu WS, 2009, ANN APPL BIOL, V154, P57, DOI 10.1111/j.1744-7348.2008.00274.x; Liu WS, 2011, AM J BOT, V98, pE150, DOI 10.3732/ajb.1000444; Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI [10.1002/1097-0088(20001130)20:14<1729::AID-JOC556>3.0.CO;2-Y, 10.1002/1097-0088(20001130)20:14&lt;1729::AID-JOC556&gt;3.0.CO;2-Y]; Luo WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071749; Manel S, 2012, MOL ECOL, V21, P3729, DOI 10.1111/j.1365-294X.2012.05656.x; Matter P, 2013, ANN BOT-LONDON, V111, P611, DOI 10.1093/aob/mct021; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peakall R, 2001, GENAIEX GENETIC ANAL; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Ronnenberg K, 2011, BASIC APPL ECOL, V12, P141, DOI 10.1016/j.baae.2010.12.002; Sexton JP, 2014, EVOLUTION, V68, P1, DOI 10.1111/evo.12258; Sexton JP, 2011, P NATL ACAD SCI USA, V108, P11704, DOI 10.1073/pnas.1100404108; Shen DF, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S1-S11; Stoeckel S, 2006, MOL ECOL, V15, P2109, DOI 10.1111/j.1365-294X.2006.02926.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vasseur F, 2012, ECOL LETT, V15, P1149, DOI 10.1111/j.1461-0248.2012.01839.x; Wang ZT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097907, 10.1371/journal.pone.0114792, 10.1371/journal.pone.0103645, 10.1371/journal.pone.0089948, 10.1371/journal.pone.0087381, 10.1371/journal.pone.0091755, 10.1371/journal.pone.0109571, 10.1371/journal.pone.0104657]; Weiner J, 2009, J ECOL, V97, P1220, DOI 10.1111/j.1365-2745.2009.01559.x; Weppler T, 2006, J ECOL, V94, P869, DOI 10.1111/j.1365-2745.2006.01134.x; Wilson GA, 2003, GENETICS, V163, P1177; Wrange AL, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-156; Yue PP, 2011, RUSS J ECOL+, V42, P50, DOI 10.1134/S1067413611010140; Zhang FF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060712; [张镱锂 Zhang Yili], 2002, [地理研究, Geographical Research], V21, P1	50	16	17	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161972	10.1371/journal.pone.0161972	http://dx.doi.org/10.1371/journal.pone.0161972			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580056	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877400049
J	McNeill, JB; Avens, L; Hall, AG; Goshe, LR; Harms, CA; Owens, DW				McNeill, Joanne Braun; Avens, Larisa; Hall, April Goodman; Goshe, Lisa R.; Harms, Craig A.; Owens, David W.			Female-Bias in a Long-Term Study of a Species with Temperature-Dependent Sex Determination: Monitoring Sex Ratios for Climate Change Research	PLOS ONE			English	Article							TURTLES; IMPACTS	Alterations have occurred and continue to manifest in the Earth's biota as a result of climate change. Animals exhibiting temperature dependent sex determination (TSD), including sea turtles, are perhaps most vulnerable to a warming of the Earth as highly skewed sex ratios can result, potentially leading to population extinction resulting from decreased male recruitment. Recent studies have begun to quantify climate change impacts to sea turtle populations, especially in terms of predicting effects on hatchling sex ratios. However, given the inherent difficulty in studying sex ratios at this life stage, a more accurate assessment of changes in population sex ratios might be derived by evaluating the juvenile portion of foraging aggregations. We investigated the long-term trend in sex ratio of a juvenile logger-head (Caretta caretta) sea turtle population inhabiting Pamlico and Core Sounds, North Carolina, USA. We used plasma testosterone reference ranges measured using radioimmunoassay (RIA) to assign sex for 959 turtles and confirmed sex assignment of a subset (N = 58) of the sampled turtles through laparoscopic examination of their gonads. Our results demonstrate that for this particular population of loggerheads, sex ratios (3Females: 1Male) had not significantly changed over a 10 year period (1998-2007), nor showed any significant difference among 5-cm straight carapace length (SCL) size classes. Ultimately, these findings provide a basis for comparison with future sex ratios, and highlight the importance of establishing similar long-term studies monitoring secondary, rather than primary, sex ratios, so that needed mitigation measures to climate change impacts can be implemented.	[McNeill, Joanne Braun; Avens, Larisa; Hall, April Goodman; Goshe, Lisa R.] NOAA, Southeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Beaufort, NC 28516 USA; [Harms, Craig A.] North Carolina State Univ, Ctr Marine Sci & Technol, Coll Vet Med, Morehead City, NC USA; [Owens, David W.] Univ Charleston South Carolina, Coll Charleston, Charleston, SC USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of North Carolina; North Carolina State University; College of Charleston	McNeill, JB (corresponding author), NOAA, Southeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Beaufort, NC 28516 USA.	joanne.b.mcneill@noaa.gov	Braun McNeill, Joanne/M-5653-2016	Braun McNeill, Joanne/0000-0002-3209-1547				Avens L, 2015, MAR BIOL, V162, P1749, DOI 10.1007/s00227-015-2705-x; Bass AL, 2004, CONSERV GENET, V5, P783, DOI 10.1007/s10592-004-1979-1; Braun-McNeill J, 2007, HERPETOLOGICA, V63, P275, DOI 10.1655/0018-0831(2007)63[275:SROTRR]2.0.CO;2; Broderick AC, 2001, PHYSIOL BIOCHEM ZOOL, V74, P161, DOI 10.1086/319661; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Delgado C, 2010, MAR BIOL, V157, P979, DOI 10.1007/s00227-009-1378-8; Epperly Sheryan P., 2007, Endangered Species Research, V3, P283, DOI 10.3354/esr00054; Freedberg S, 2001, EVOLUTION, V55, P1049, DOI 10.1554/0014-3820(2001)055[1049:CIAAMF]2.0.CO;2; Fuentes MMPB, 2013, ECOL MODEL, V251, P150, DOI 10.1016/j.ecolmodel.2012.12.020; Fuentes MMPB, 2010, J EXP MAR BIOL ECOL, V383, P56, DOI 10.1016/j.jembe.2009.11.003; GUTHRIE JF, 1973, MAR FISH REV, V35, P27; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Hamann M., 2007, CLIMATE CHANGE GREAT, P466; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Hawkes LA, 2007, GLOBAL CHANGE BIOL, V13, P923, DOI 10.1111/j.1365-2486.2007.01320.x; Hawkes LA, 2013, AQUAT BIOL, V18, P9, DOI 10.3354/ab00475; Hays Graeme C., 2014, Frontiers in Marine Science, V1, P00043; Higgins E, 1928, EXAMINATION SUMMER F, P29; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Hulin V, 2009, OECOLOGIA, V160, P493, DOI 10.1007/s00442-009-1313-1; JANZEN FJ, 1991, Q REV BIOL, V66, P149, DOI 10.1086/417143; Janzen FJ, 1994, P NATL ACAD SCI USA, V91, P7847; Kallimanis AS, 2010, OIKOS, V119, P197, DOI 10.1111/j.1600-0706.2009.17674.x; Laloe JO, 2016, J EXP MAR BIOL ECOL, V474, P92, DOI 10.1016/j.jembe.2015.09.015; Laloe JO, 2014, NAT CLIM CHANGE, V4, P513, DOI 10.1038/NCLIMATE2236; Levitus S, 2001, SCIENCE, V292, P267, DOI 10.1126/science.1058154; Lutcavage Molly E., 1997, P387; Maffucci F, 2013, MAR BIOL, V160, P1097, DOI 10.1007/s00227-012-2160-x; Mitchell NJ, 2010, SEX DEV, V4, P129, DOI 10.1159/000282494; Mitchell NJ, 2010, GLOBAL CHANGE BIOL, V16, P60, DOI 10.1111/j.1365-2486.2009.01964.x; MROSOVSKY N, 1994, J EXP ZOOL, V270, P16, DOI 10.1002/jez.1402700104; MROSOVSKY N, 1984, SCIENCE, V225, P739, DOI 10.1126/science.225.4663.739; Mrosovsky N., 2009, Endangered Species Research, V8, P147, DOI 10.3354/esr00200; Owens D.W., 1978, Florida Marine Research Publications, P12; Owens David W., 1997, P315; OWENS DW, 1980, HERPETOLOGICA, V36, P17; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Patino-Martinez J, 2012, GLOBAL CHANGE BIOL, V18, P401, DOI 10.1111/j.1365-2486.2011.02532.x; Saba VS, 2012, NATURE CLIMATE CHANG; Tomillo PS, 2014, BIOL CONSERV, V176, P71, DOI 10.1016/j.biocon.2014.05.011; Scott R, 2012, FUNCT ECOL, V26, P227, DOI 10.1111/j.1365-2435.2011.01915.x; Shoop C. Robert, 1998, Chelonian Conservation and Biology, V3, P93; STANDORA EA, 1985, COPEIA, P711, DOI 10.2307/1444765; Tucker JK, 2008, CHELONIAN CONSERV BI, V7, P60, DOI 10.2744/CCB-0670.1; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weishampel JF, 2004, GLOBAL CHANGE BIOL, V10, P1424, DOI 10.1111/j.1529-8817.2003.00817.x; WIBBELS T, 1991, CAN J ZOOL, V69, P2973, DOI 10.1139/z91-419; Wibbels T, 2003, CRC MAR BIOL SER, P103; Wibbels Thane, 2000, Chelonian Conservation and Biology, V3, P756; Wibbels TR, 1987, SEXING TECHNIQUES SE; Witt MJ, 2010, J EXP BIOL, V213, P901, DOI 10.1242/jeb.038133; Wyneken J, 2001, NMFSSEFSC470 NOAA, DOI DOI 10.1007/SPRINGERREFERENCE_; Wyneken J, 2006, 26 ANN S SEA TURTL B; Wyneken J, 2007, HERPETOLOGICA, V63, P19, DOI 10.1655/0018-0831(2007)63[19:DSIPLS]2.0.CO;2; Wyneken J, 2015, J EXP ZOOL PART B, V324, P295, DOI 10.1002/jez.b.22620; YNTEMA CL, 1980, HERPETOLOGICA, V36, P33; Zar J.H., 2010, BIOSTAT ANAL	58	14	14	0	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0160911	10.1371/journal.pone.0160911	http://dx.doi.org/10.1371/journal.pone.0160911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579608	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877400011
J	Yokoe, M; Takayama-Watanabe, E; Saito, Y; Kutsuzawa, M; Fujita, K; Ochi, H; Nakauchi, Y; Watanabe, A				Yokoe, Misato; Takayama-Watanabe, Eriko; Saito, Yoko; Kutsuzawa, Megumi; Fujita, Kosuke; Ochi, Haruki; Nakauchi, Yuni; Watanabe, Akihiko			A Novel Cysteine Knot Protein for Enhancing Sperm Motility That Might Facilitate the Evolution of Internal Fertilization in Amphibians	PLOS ONE			English	Article							CYNOPS-PYRRHOGASTER; INITIATING SUBSTANCE; NEWT; SPERMATOZOA; CHEMOATTRACTANT; MECHANISMS; PEPTIDE; OVIDUCT; EGGS	Internal fertilization ensures successful reproduction of tetrapod vertebrates on land, although how this mode of reproduction evolved is unknown. Here, we identified a novel gene encoding sperm motility-initiating substance (SMIS), a key protein for the internal fertilization of the urodele Cynops pyrrhogaster by Edman degradation of an isolated protein and subsequent reverse transcription polymerase chain reaction. The SMIS gene encoded a 150 amino-acid sequence including the cysteine knot (CK) motif. No gene with substantial similarity to the SMIS was in the data bank of any model organisms. An active site of the SMIS was in the C-terminal region of the 2nd loop of CK motif. A synthetic peptide including the active site sequence bound to the midpiece and initiated/enhanced the circular motion of C. pyrrhogaster sperm, which allows penetration of the egg jelly specialized for the internal fertilization of this species. The synthetic peptide bound to whole sperm of Rhacophorus arboreus and enhanced the rotary motion, which is adapted to propel the sperm through egg coat matrix specialized for arboreal reproduction, while it bound to the tip of head and tail of Bufo japonicus sperm, and enhanced the vibratory motion, which is suited to sperm penetration through the egg jelly specialized for the reproduction of that species in freshwater. The polyclonal antibody against the active site of the SMIS specifically bound to egg coat matrix of R. arboreus. These findings suggest that diversification of amphibian reproductive modes accompanies the specialization of egg coat and the adaptation of sperm motility to penetrate the specialized egg coat, and SMIS acts as the sperm motility enhancer of anurans and urodeles that might facilitate to adaptively optimize sperm motility for allowing the establishment of internal fertilization.	[Yokoe, Misato; Saito, Yoko; Kutsuzawa, Megumi; Fujita, Kosuke; Nakauchi, Yuni; Watanabe, Akihiko] Yamagata Univ, Fac Sci, Dept Biol, Yamagata, Japan; [Takayama-Watanabe, Eriko] Yamagata Univ, Inst Arts & Sci, Yamagata, Japan; [Ochi, Haruki] Yamagata Univ, Sch Med, Yamagata, Japan	Yamagata University; Yamagata University; Yamagata University	Watanabe, A (corresponding author), Yamagata Univ, Fac Sci, Dept Biol, Yamagata, Japan.	watan@sci.kj.yamagata-u.ac.jp	Ochi, Haruki/AAR-7235-2020	Ochi, Haruki/0000-0002-0088-581X; Takayama-Watanabe, Eriko/0000-0001-5950-6207; Watanabe, Akihiko/0000-0002-0382-5433; Nakauchi, Yuni/0000-0003-1152-6123	JSPS KAKENHI [JP24570246, JP16K07459, 15K07165]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI No. JP24570246 AW, JSPS KAKENHI No. JP16K07459 AW, and JSPS KAKENHI No. 15K07165 ET-W.	[Anonymous], 2020, BIOL AMPHIBIANS, V28, P32; ASHIZAWA K, 1987, J REPROD FERTIL, V81, P495, DOI 10.1530/jrf.0.0810495; Axelsson MAB, 1998, J BIOL CHEM, V273, P18864, DOI 10.1074/jbc.273.30.18864; Boschert V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081710; CLAPPER DL, 1982, GAMETE RES, V6, P315, DOI 10.1002/mrd.1120060404; Greven H, 1998, J EXP ZOOL, V282, P507; Mizuno J, 1999, ZYGOTE, V7, P329, DOI 10.1017/S0967199499000738; MORISAWA M, 1980, SCIENCE, V210, P1145, DOI 10.1126/science.7444445; MORISAWA M, 1994, ZOOL SCI, V11, P647; Muto K, 2011, J MORPHOL, V272, P1422, DOI 10.1002/jmor.10994; Muto K, 2009, CELL MOTIL CYTOSKEL, V66, P281, DOI 10.1002/cm.20358; Neubaum DM, 1999, CURR TOP DEV BIOL, V41, P67; ODA S, 1995, DEV GROWTH DIFFER, V37, P257; Ohta M, 2010, ZOOL SCI, V27, P875, DOI 10.2108/zsj.27.875; Olson JH, 2001, P NATL ACAD SCI USA, V98, P11205, DOI 10.1073/pnas.211316798; OSANAI M, 1989, INVERTEBR REPROD DEV, V15, P97, DOI 10.1080/07924259.1989.9672029; Perez-Vilar J, 1998, J BIOL CHEM, V273, P14442, DOI 10.1074/jbc.273.23.14442; PILLAI MC, 1993, J EXP ZOOL, V265, P336, DOI 10.1002/jez.1402650316; Scheltinga David M., 2003, P119; Sive H.L., 2000, EARLY DEV XENOPUS LA, P249; Strunker T, 2011, NATURE, V471, P382, DOI 10.1038/nature09769; Takahashi T, 2013, DEV GROWTH DIFFER, V55, P657, DOI 10.1111/dgd.12073; Takayama-Watanabe E, 2012, ZYGOTE, V20, P417, DOI 10.1017/S0967199412000226; Ukita M, 1999, ZOOL SCI, V16, P793, DOI 10.2108/zsj.16.793; van der Horst G, 1995, ADV SPERMATOZOAL PHY, P333; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; Wake MH, 1998, J EXP ZOOL, V282, P477; WARD GE, 1985, J CELL BIOL, V101, P2324, DOI 10.1083/jcb.101.6.2324; Watanabe A., 2003, REPROD BIOL PHYLOGEN, p423 ; Watanabe T, 2010, INT J DEV BIOL, V54, P591, DOI 10.1387/ijdb.092894tw; YANAGIMACHI R, 1994, PHYSL REPROD, V0002, P00189; Yoshida M, 2002, P NATL ACAD SCI USA, V99, P14831, DOI 10.1073/pnas.242470599	32	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0160445	10.1371/journal.pone.0160445	http://dx.doi.org/10.1371/journal.pone.0160445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579691	gold, Green Published, Green Submitted			2022-12-26	WOS:000382877400004
J	Abedi-Astaneh, F; Hajjaran, H; Yaghoobi-Ershadi, MR; Hanafi-Bojd, AA; Mohebali, M; Shirzadi, MR; Rassi, Y; Akhavan, AA; Mahmoudi, B				Abedi-Astaneh, Fatemeh; Hajjaran, Homa; Yaghoobi-Ershadi, Mohammad Reza; Hanafi-Bojd, Ahmad Ali; Mohebali, Mehdi; Shirzadi, Mohammad Reza; Rassi, Yavar; Akhavan, Amir Ahmad; Mahmoudi, Bagher			Risk Mapping and Situational Analysis of Cutaneous Leishmaniasis in an Endemic Area of Central Iran: A GIS-Based Survey	PLOS ONE			English	Article							GEOGRAPHICAL INFORMATION-SYSTEMS; PHLEBOTOMINE SAND FLIES; VISCERAL LEISHMANIASIS; DIPTERA PSYCHODIDAE; NICHE MODEL; VECTORS; DISEASE; FOCUS; TRANSMISSION; DIAGNOSIS	Introduction Cutaneous leishmaniasis (CL) is among the top 10 infectious disease priorities in the world, and the leading cause of morbidity in Iran. The present study was conducted to assess the risk of CL, and to determine some epidemiological features of the disease in endemic areas of Qom Province in Central Iran during 2009 to 2013. Methods Data regarding human cases of the disease were obtained from the Qom Province Health Center, prepared and stored in a spatial database created in ArcGIS10.3. A total of 9 out of 212 Leishmania spp. positive slides taken in 2013 from patients residing in Qom city were examined using molecular methods and the species of Leishmania was identified by PCR-RFLP. Those 9 patients had no history of travel outside the city. Spatial analysis and clustering methods were applied to find major hot spots and susceptible areas for the establishment of novel foci of the disease. Transmission patterns were examined for spatial autocorrelation using the Moran's / statistical application, and for the clustering of high or low values using the Getis-Ord Gi* statistics. Results During the period of study, a total of 1767 CL cases were passively reported in the area, out of which were 65% males and 35% females. The highest and lowest numbers of cases were reported in 2010 and 2013, respectively. Importantly, 979 cases were reported from urban areas, while the remainder came from rural areas. Leishmania major was detected as the causative agent of CL in the city of Qom. Remarkably, most patients recorded in Qom city were associated with a history of travel to the endemic areas of CL within the province, or to other endemic areas of the disease in Iran. Spatial distribution of CL cases revealed northeastern and southwestern quarters of the city were the major hot spots of the disease (P<0.05). Hot spot and CL transmission risk analysis across the province indicated that more than 40 villages were located in high and very high risk areas of CL transmission. Conclusions Due to the existence of hot spots (P<0.05) of CL in successive years in some quarters of Qom city, along with detection of L. major from the patients without a history of travel, there may be potential of local transmission of the disease within the city. Therefore, it is necessary to conduct a comprehensive study concerning the hot spots of CL in Qom city for curtailing the incidence of the disease in the city. The methodology and the results of this study is essential in serving as a yardstick for subsequent similar studies that will be carried out in other endemic areas of CL in Iran and providing an adequate tool for the establishment of a national database of cutaneous leishmaniasis.	[Abedi-Astaneh, Fatemeh; Mahmoudi, Bagher] Qom Univ Med Sci, Deputy Hlth, Dept Communicable Dis, Qom, Iran; [Abedi-Astaneh, Fatemeh; Yaghoobi-Ershadi, Mohammad Reza; Hanafi-Bojd, Ahmad Ali; Rassi, Yavar; Akhavan, Amir Ahmad] Univ Tehran Med Sci, Sch Publ Hlth, Dept Med Entomol & Vector Control, Tehran, Iran; [Hajjaran, Homa; Mohebali, Mehdi] Univ Tehran Med Sci, Sch Publ Hlth, Dept Med Parasitol & Mycol, Tehran, Iran; [Shirzadi, Mohammad Reza] Minist Hlth & Med Educ, CDC, Zoonot Dept, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Ministry of Health & Medical Education (MOHME)	Yaghoobi-Ershadi, MR; Hanafi-Bojd, AA (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Med Entomol & Vector Control, Tehran, Iran.	yaghoobi.reza@gmail.com; aahanafibojd@tums.ac.ir	mohebali, mehdi/ABF-3606-2021	shirzadi, mohammad reza/0000-0002-7993-8362	Tehran University of Medical Sciences [25191]	Tehran University of Medical Sciences(Tehran University of Medical Sciences)	This study was financially supported by Deputy of Research, Tehran University of Medical Sciences, Project No. 25191.; The authors are grateful to the Deputy Director and staff of Qom University of Medical Sciences, for their immense contributions and kindness in the field studies. This study was financially supported by Deputy of Research, Tehran University of Medical Sciences, Project No. 25191.	Abedi-Astaneh F, 2015, ACTA TROP, V149, P246, DOI 10.1016/j.actatropica.2015.05.030; Ali-Akbarpour Mohsen, 2012, J Cutan Aesthet Surg, V5, P30, DOI 10.4103/0974-2077.94338; Alvar J, 2006, ADV PARASIT, V61, P223, DOI 10.1016/S0065-308X(05)61006-8; Bhunia GS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-64; Boots B.N., 1998, POINT PATTERN ANAL N; Desjeux P, 2001, T ROY SOC TROP MED H, V95, P239, DOI 10.1016/S0035-9203(01)90223-8; Farzin-Nia B, 2007, IRAN J ARTHROPOD-BOR, V1, P48; Farzinnia B., 2005, STUDY HUMAN INFECT V; Farzinnia B., 2008, STUDY HUMAN INFECT V; Farzinnia B., 2003, IRAN J PUBL HEAL, V32, P35; Hajjaran H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/789326; Hanafi-Bojd AA, 2015, ZOONOSES PUBLIC HLTH, V62, P644, DOI 10.1111/zph.12202; Hanafi-Bojd AA, 2015, J MED ENTOMOL, V52, P557, DOI 10.1093/jme/tjv058; Hazratian T, 2011, ASIAN PAC J TROP MED, V4, P604, DOI 10.1016/S1995-7645(11)60156-9; Karimi A, 2014, ACTA TROP, V132, P131, DOI 10.1016/j.actatropica.2014.01.004; Kazemi-Rad E, 2008, IRAN J PUBLIC HEALTH, V37, P54; Kelly JM, 1993, METHOD MOL BIOL; Malone JB, 2012, GEOSPATIAL HEALTH, V6, pS1; Mitchell A., 2005, ESRI GUIDE GIS ANAL; Mollalo A, 2015, ZOONOSES PUBLIC HLTH, V62, P18, DOI 10.1111/zph.12109; Nadim A, 2009, LEISHMANIA PARASITE; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; Ready PD, 2013, ANNU REV ENTOMOL, V58, P227, DOI 10.1146/annurev-ento-120811-153557; Saghafipour A., 2012, J ILAM U MED SCI, V21, P64; Saghafipour A., 2010, J QOM U MED SCI, V5, P30; Saghafipour A., 2014, IRANIAN J INFECT DIS, V19, P43; Salahi-Moghaddam A, 2010, GEOSPATIAL HEALTH, V5, P71, DOI 10.4081/gh.2010.188; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; Seid A, 2014, GEOSPATIAL HEALTH, V8, P377, DOI 10.4081/gh.2014.27; Shirzadi MR, 2015, E MEDITERR HEALTH J, V21, P736, DOI 10.26719/2015.21.10.736; Tsegaw T, 2013, GEOSPATIAL HEALTH, V7, P299, DOI 10.4081/gh.2013.88; World Health Organisation, 2010, WHO TECHN REP SER, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/TRS/WH0_; Yaghoobi-Ershadi MR, 2012, J ARTHROPOD-BORNE DI, V6, P1; Yaghoobi-Ershadi MR, 2001, ACTA TROP, V79, P115, DOI 10.1016/S0001-706X(01)00085-7; YaghoobiErshadi MR, 1996, T ROY SOC TROP MED H, V90, P503, DOI 10.1016/S0035-9203(96)90295-3	35	33	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161317	10.1371/journal.pone.0161317	http://dx.doi.org/10.1371/journal.pone.0161317			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27574805	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877200022
J	Bart, RR; Tague, CL; Moritz, MA				Bart, Ryan R.; Tague, Christina L.; Moritz, Max A.			Effect of Tree-to-Shrub Type Conversion in Lower Montane Forests of the Sierra Nevada (USA) on Streamflow	PLOS ONE			English	Article							MIXED-CONIFER FOREST; CLIMATE-CHANGE; BARK BEETLES; WATER-USE; CALIFORNIA; VEGETATION; FIRE; MORTALITY; DYNAMICS; DROUGHT	Higher global temperatures and increased levels of disturbance are contributing to greater tree mortality in many forest ecosystems. These same drivers can also limit forest regeneration, leading to vegetation type conversion. For the Sierra Nevada of California, little is known about how type conversion may affect streamflow, a critical source of water supply for urban, agriculture and environmental purposes. In this paper, we examined the effects of tree-to-shrub type conversion, in combination with climate change, on streamflow in two lower montane forest watersheds in the Sierra Nevada. A spatially distributed ecohydrologic model was used to simulate changes in streamflow, evaporation, and transpiration following type conversion, with an explicit focus on the role of vegetation size and aspect. Model results indicated that streamflow may show negligible change or small decreases following type conversion when the difference between tree and shrub leaf areas is small, partly due to the higher stomatal conductivity and the deep rooting depth of shrubs. In contrast, streamflow may increase when post-conversion shrubs have a small leaf area relative to trees. Model estimates also suggested that vegetation change could have a greater impact on streamflow magnitude than the direct hydrologic impacts of increased temperatures. Temperature increases, however, may have a greater impact on streamflow timing. Tree-to- shrub type conversion increased streamflow only marginally during dry years (annual precipitation < 800 mm), with most streamflow change observed during wetter years. These modeling results underscore the importance of accounting for changes in vegetation communities to accurately characterize future hydrologic regimes for the Sierra Nevada.	[Bart, Ryan R.] Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA; [Tague, Christina L.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Moritz, Max A.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Berkeley	Bart, RR (corresponding author), Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA.	ryanrbart@eri.ucsb.edu		Tague, Christina (Naomi)/0000-0003-1463-308X; Bart, Ryan/0000-0002-7235-8007	California Energy Commission [500-10-045]; National Science Foundation through the Southern Sierra Critical Zone Observatory [EAR-0725097]	California Energy Commission; National Science Foundation through the Southern Sierra Critical Zone Observatory(National Science Foundation (NSF))	This research was funded by the California Energy Commission (500-10-045) and the National Science Foundation through the Southern Sierra Critical Zone Observatory (EAR-0725097). This work is a contribution of the Western Mountain Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HD, 2012, ECOHYDROLOGY, V5, P145, DOI 10.1002/eco.233; Allen CD, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00203.1; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; [Anonymous], 2000, EARTH INTERACT, DOI DOI 10.1175/1087-3562(2000)004%3C0003:PASAOT%3E2.0.CO;2; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Bart R, 2010, J HYDROL, V388, P370, DOI 10.1016/j.jhydrol.2010.05.016; Batllori E, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/3/034018; Bentz BJ, 2010, BIOSCIENCE, V60, P602, DOI 10.1525/bio.2010.60.8.6; Bohlman GN, 2016, FOREST ECOL MANAG, V374, P195, DOI 10.1016/j.foreco.2016.05.008; Canadell J, 1996, Oecologia, V108, P583, DOI 10.1007/BF00329030; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; CDWR, 2013, REPORT NO BULLETIN; Christensen L, 2008, HYDROL PROCESS, V22, P3576, DOI 10.1002/hyp.6961; Collins BM, 2013, LANDSCAPE ECOL, V28, P1801, DOI 10.1007/s10980-013-9923-8; Cristea NC, 2014, HYDROL PROCESS, V28, P3896, DOI 10.1002/hyp.9909; D'Antonio C, 2016, CEC5002016018; Das T, 2011, CLIMATIC CHANGE, V109, P71, DOI 10.1007/s10584-011-0298-z; DELUCIA EH, 1991, ECOLOGY, V72, P51, DOI 10.2307/1938901; Dennison PE, 2014, GEOPHYS RES LETT, V41, P2928, DOI 10.1002/2014GL059576; Diffenbaugh NS, 2015, P NATL ACAD SCI USA, V112, P3931, DOI 10.1073/pnas.1422385112; Fites-Kaufman JA, 2007, TERRESTRIAL VEGETATION OF CALIFORNIA, 3RD EDITION, P456; Garfin G, 2013, ASSESSMENT OF CLIMAT; Godsey SE, 2014, HYDROL PROCESS, V28, P5048, DOI 10.1002/hyp.9943; Goforth BR, 2008, FOREST ECOL MANAG, V256, P36, DOI 10.1016/j.foreco.2008.03.032; Goulden ML, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002027; Goulden ML, 2014, P NATL ACAD SCI USA, V111, P14071, DOI 10.1073/pnas.1319316111; Griffin D, 2014, GEOPHYS RES LETT, V41, P9017, DOI 10.1002/2014GL062433; Holbrook WS, 2014, EARTH SURF PROC LAND, V39, P366, DOI 10.1002/esp.3502; Hunsaker CT, 2012, J AM WATER RESOUR AS, V48, P667, DOI 10.1111/j.1752-1688.2012.00641.x; Huxman TE, 2005, ECOLOGY, V86, P308, DOI 10.1890/03-0583; JARVIS PG, 1976, PHILOS T ROY SOC B, V273, P593, DOI 10.1098/rstb.1976.0035; Jiang XY, 2013, J CLIMATE, V26, P3671, DOI 10.1175/JCLI-D-12-00430.1; Lauvaux CA, 2016, FOREST ECOL MANAG, V363, P74, DOI 10.1016/j.foreco.2015.12.016; Lenihan JM, 2008, CLIMATIC CHANGE, V87, pS215, DOI 10.1007/s10584-007-9362-0; Madani K, 2010, CLIMATIC CHANGE, V102, P521, DOI 10.1007/s10584-009-9750-8; McIntyre PJ, 2015, P NATL ACAD SCI USA, V112, P1458, DOI 10.1073/pnas.1410186112; Millar CI, 2012, CAN J FOREST RES, V42, P749, DOI [10.1139/X2012-031, 10.1139/x2012-031]; Monteith J L, 1965, Symp Soc Exp Biol, V19, P205; Moore J, 2015, FOREST HLTH PROTECTI; Moritz MA, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00345.1; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; Null SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009932; Odion DC, 2010, J ECOL, V98, P96, DOI 10.1111/j.1365-2745.2009.01597.x; Potter C., 2014, NAT RESOUR, V05, P597, DOI [10.4236/nr.2014.511052, DOI 10.4236/NR.2014.511052]; Rauscher SA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034424; Rheinheimer DE, 2014, J WATER RES PLAN MAN, V140, P714, DOI 10.1061/(ASCE)WR.1943-5452.0000373; Richardson JJ, 2009, AGR FOREST METEOROL, V149, P1152, DOI 10.1016/j.agrformet.2009.02.007; Royce EB, 2001, AM J BOT, V88, P911, DOI 10.2307/2657044; Schwartz MW, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00003.1; Son K, 2015, THESIS; Stevens JT, 2015, GLOBAL CHANGE BIOL, V21, P2379, DOI 10.1111/gcb.12824; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; Tague C, 2009, ECOHYDROLOGY, V2, P541, DOI 10.1002/eco.88; Tague CL, 2004, EARTH INTERACT, V8; Tague CL, 2013, HYDROL EARTH SYST SC, V17, P341, DOI 10.5194/hess-17-341-2013; Tague C, 2013, J GEOPHYS RES-BIOGEO, V118, P875, DOI 10.1002/jgrg.20073; Taylor AH, 1998, FOREST ECOL MANAG, V111, P285, DOI 10.1016/S0378-1127(98)00342-9; Thorne JH, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00300.1; Thorne James H., 2008, Madrono, V55, P223, DOI 10.3120/0024-9637-55.3.223; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Williams AP, 2013, NAT CLIM CHANGE, V3, P292, DOI [10.1038/nclimate1693, 10.1038/NCLIMATE1693]; Xu M, 2001, TREE PHYSIOL, V21, P309, DOI 10.1093/treephys/21.5.309; Young CA, 2009, J AM WATER RESOUR AS, V45, P1409, DOI 10.1111/j.1752-1688.2009.00375.x	63	39	39	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161805	10.1371/journal.pone.0161805	http://dx.doi.org/10.1371/journal.pone.0161805			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575592	Green Published, gold			2022-12-26	WOS:000382877200040
J	Lin, CF; Chen, CL; Chien, SY; Tseng, PC; Wang, YC; Tsai, TT				Lin, Chiou-Feng; Chen, Chia-Ling; Chien, Shun-Yi; Tseng, Po-Chun; Wang, Yu-Chih; Tsai, Tsung-Ting			Oxidative Stress Facilitates IFN-gamma- Induced Mimic Extracellular Trap Cell Death in A549 Lung Epithelial Cancer Cells	PLOS ONE			English	Article							REGULATORY FACTOR-I; INTERFERON-GAMMA; GROWTH-INHIBITION; INNATE IMMUNITY; NADPH OXIDASE; AUTOPHAGY; PAD4; TRANSCRIPTION; ACTIVATION; MECHANISMS	We previously demonstrated that IFN-gamma induces an autophagy-regulated mimic extracellular trap cell death (ETosis) in A549 human lung cancer cells. Regarding reactive oxygen species (ROS) are involved in ETosis, this study investigated the role of oxidative stress. After IFN-gamma stimulation, a necrosis-like cell death mimic ETosis occurred accompanied by the inhibition of cell growth, aberrant nuclear staining, and nucleosome release. ROS were generated in a time-dependent manner with an increase in NADPH oxidase component protein expression. STAT1-mediated IFN regulatory factor-1 activation was essential for upregulating ROS production. By genetically silencing p47phox, IFN-gamma-induced ROS and mimic ETosis were significantly attenuated. This mechanistic study indicated that ROS may mediate DNA damage followed by histone H3 citrullination. Furthermore, ROS promoted IFN-gamma induced mimic ETosis in cooperation with autophagy. These findings further demonstrate that ROS regulates IFN-gamma-induced mimic ETosis in lung epithelial malignancy.	[Lin, Chiou-Feng; Chien, Shun-Yi; Tseng, Po-Chun; Wang, Yu-Chih; Tsai, Tsung-Ting] Taipei Med Univ, Dept Microbiol & Immunol, Sch Med, Coll Med, Taipei 110, Taiwan; [Lin, Chiou-Feng] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei 110, Taiwan; [Chen, Chia-Ling] Taipei Med Univ, Translat Res Ctr, Taipei 110, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University	Lin, CF (corresponding author), Taipei Med Univ, Dept Microbiol & Immunol, Sch Med, Coll Med, Taipei 110, Taiwan.; Lin, CF (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei 110, Taiwan.	cflin2014@tmu.edu.tw			National Health Research Institutes, Taiwan [NHRI-EX102-9917NC]; Ministry of Science and Technology, Taiwan [MOST100-2320-B-006-009-MY3]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grant NHRI-EX102-9917NC from the National Health Research Institutes, Taiwan and grant MOST100-2320-B-006-009-MY3 from the Ministry of Science and Technology, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; CASSATELLA MA, 1990, J BIOL CHEM, V265, P20241; Decker T, 2002, J CLIN INVEST, V109, P1271, DOI 10.1172/JCI200215770; Eklund EA, 1999, J IMMUNOL, V163, P6095; Etulain J, 2015, BLOOD, V126, P242, DOI 10.1182/blood-2015-01-624023; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Guachalla LM, 2010, CELL CYCLE, V9, P4058, DOI 10.4161/cc.9.20.13577; Guimaraes-Costa Anderson B, 2012, J Parasitol Res, V2012, P929743, DOI 10.1155/2012/929743; GUPTA JW, 1992, CANCER RES, V52, P2530; Harvat BL, 1997, ONCOGENE, V14, P2111, DOI 10.1038/sj.onc.1201055; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kivinen K, 2005, EXP CELL RES, V311, P62, DOI 10.1016/j.yexcr.2005.08.006; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kominsky S, 1998, ONCOGENE, V17, P2973, DOI 10.1038/sj.onc.1202217; Kumatori A, 2002, J BIOL CHEM, V277, P9103, DOI 10.1074/jbc.M109803200; Li PY, 2012, CANCER LETT, V314, P213, DOI 10.1016/j.canlet.2011.09.031; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Lin CF, 2016, J INTERF CYTOK RES, V36, P100, DOI 10.1089/jir.2015.0011; Luth S, 2011, CANCER RES, V71, P3763, DOI 10.1158/0008-5472.CAN-10-3232; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Rohrbach AS, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00360; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Schmitt MJ, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-41; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Street SEA, 2002, J EXP MED, V196, P129, DOI 10.1084/jem.20020063; Sur Chowdhury Chanchal, 2014, Arthritis Res Ther, V16, pR122, DOI 10.1186/ar4579; Thapa RJ, 2011, MOL CELL BIOL, V31, P2934, DOI 10.1128/MCB.05445-11; Tu SP, 2011, CANCER RES, V71, P4247, DOI 10.1158/0008-5472.CAN-10-4009; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Wartha F, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.121pe25; Watanabe Y, 2003, J CELL BIOCHEM, V89, P244, DOI 10.1002/jcb.10501; Xu XL, 1998, CANCER RES, V58, P2832; Yang D, 2007, EXP EYE RES, V85, P462, DOI 10.1016/j.exer.2007.06.013	36	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0162157	10.1371/journal.pone.0162157	http://dx.doi.org/10.1371/journal.pone.0162157			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575372	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877200059
J	Liu, MF; Zhang, CY; Cai, H; Liu, FF; Liu, Y; Li, JJ; Pan, YQ; Guo, CH; He, ZH; Ke, Y				Liu, Mengfei; Zhang, Chanyuan; Cai, Hong; Liu, Fangfang; Liu, Ying; Li, Jingjing; Pan, Yaqi; Guo, Chuanhai; He, Zhonghu; Ke, Yang			The Willingness to Change Risky Health Behaviors among Chinese Rural Residents: What We Learned from a Population-Based Esophageal Cancer Cohort Study	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; SQUAMOUS-CELL CARCINOMA; ALCOHOL; SMOKING; MEN	Background The effectiveness of health interventions can be impaired by low socio-economic status and poor living conditions of the target population. However, the specifics of this problem in rural China are still unclear, and appropriate strategies should be explored. Methods In 2013, we conducted a questionnaire-based investigation among 410 participants from a population-based esophageal cancer cohort study in rural Anyang, China. Information regarding their demographic characteristics, levels of exposure to four health-risk behaviors, including smoking, alcohol consumption, risky dietary behaviors and poor hygiene, as well as willingness to change these behaviors, and data on potential predictors of willingness to change behaviors were collected. Results In this study, 33.3%(23/69), 25.0%(13/52), 60.7%(68/112) and 62.2%(237/381) of respondents reported that they were willing to change smoking, alcohol consumption, risky dietary behaviors and poor hygiene, respectively. Older people had higher exposure levels and less willingness to change these four health-risk behaviors. The levels of these four health-risk behaviors were negatively associated with willingness to change, while faith in people and behavioral change in surrounding people increased willingness to change risky behaviors. Conclusions In behavior-intervention-based health-promotion programs in rural China, the elderly and highly exposed populations should be the most difficult part and community-or household-based intervention would be more efficient.	[Liu, Mengfei; Zhang, Chanyuan; Cai, Hong; Liu, Fangfang; Liu, Ying; Li, Jingjing; Pan, Yaqi; Guo, Chuanhai; He, Zhonghu; Ke, Yang] Peking Univ, Canc Hosp & Inst, Genet Lab, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China	Peking University	He, ZH; Ke, Y (corresponding author), Peking Univ, Canc Hosp & Inst, Genet Lab, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China.	zhonghuhe@foxmail.com; keyang@bjmu.edu.cn		He, Zhonghu/0000-0002-4444-7950	Charity Project of National Ministry of Health [201202014]; "973" Project of National Ministry of Science and Technology Grant [2012CB910803]; "863" Key Projects of National Ministry of Science and Technology Grant [2012AA02A209, 2012AA022502]; Beijing Municipal Science and Technology Commission [Z141100002114046]; Natural Science Foundation of China [81473033]	Charity Project of National Ministry of Health; "973" Project of National Ministry of Science and Technology Grant; "863" Key Projects of National Ministry of Science and Technology Grant; Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Charity Project of National Ministry of Health [grant number 201202014]; "973" Project of National Ministry of Science and Technology Grant [grant number 2012CB910803]; "863" Key Projects of National Ministry of Science and Technology Grant [grant numbers 2012AA02A209, 2012AA022502]; and Beijing Municipal Science and Technology Commission [grant number Z141100002114046] to Y. Ke. Natural Science Foundation of China [grant number 81473033] to Z. He. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto M, 2004, ALCOHOL ALCOHOLISM, V39, P532, DOI 10.1093/alcalc/agh090; Blankenship KM, 2000, AIDS, V14, pS11, DOI 10.1097/00002030-200006001-00003; Chai J, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1253-6; Christiansen BA, 2015, NICOTINE TOB RES, V17, P1002, DOI 10.1093/ntr/ntu345; Deborah L. EG., 2004, SMOKING RELATED BEHA; Fan YH, 2008, NUTR CANCER, V60, P354, DOI 10.1080/01635580701883011; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Guo FC, 2012, CANCER EPIDEM BIOMAR, V21, P780, DOI 10.1158/1055-9965.EPI-11-1206; He ZH, 2014, CARCINOGENESIS, V35, P816, DOI 10.1093/carcin/bgt483; He ZH, 2013, EMERG INFECT DIS, V19, P992, DOI 10.3201/eid1906.111597; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Khan N, 2010, CANCER LETT, V293, P133, DOI 10.1016/j.canlet.2009.12.013; Li J Y, 1982, Natl Cancer Inst Monogr, V62, P113; Li K, 2002, INT J CANCER, V102, P271, DOI [10.1002/ijc.10706, 10.1002/jhc.10706]; Li Q, 2011, NEW ENGL J MED, V364, P2469, DOI 10.1056/NEJMc1102459; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018776; Liu FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031602; Liu MF, 2015, SCI REP-UK, V5, DOI 10.1038/srep10986; Liu MF, 2014, CANCER EPIDEM BIOMAR, V23, P2857, DOI 10.1158/1055-9965.EPI-14-0365; Lyu Jun, 2014, Zhonghua Liu Xing Bing Xue Za Zhi, V35, P875; McCahon D, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1502-8; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037//0022-006X.51.3.390; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; Stringhini S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000419; Wang JB, 2010, CANCER CAUSE CONTROL, V21, P959, DOI 10.1007/s10552-010-9523-8; Wu M, 2009, INT J CANCER, V124, P1907, DOI 10.1002/ijc.24142; YANG CS, 1980, CANCER RES, V40, P2633; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	28	4	4	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161999	10.1371/journal.pone.0161999	http://dx.doi.org/10.1371/journal.pone.0161999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575990	gold, Green Published, Green Submitted			2022-12-26	WOS:000382877200054
J	Khan, ZN; Ahmed, S; Ali, M				Khan, Z. N.; Ahmed, S.; Ali, M.			Effect of Thermal Budget on the Electrical Characterization of Atomic Layer Deposited HfSiO/TiN Gate Stack MOSCAP Structure	PLOS ONE			English	Article							CAPACITANCE; FREQUENCY	Metal Oxide Semiconductor (MOS) capacitors (MOSCAP) have been instrumental in making CMOS nano-electronics realized for back-to-back technology nodes. High-k gate stacks including the desirable metal gate processing and its integration into CMOS technology remain an active research area projecting the solution to address the requirements of technology roadmaps. Screening, selection and deposition of high-k gate dielectrics, post-deposition thermal processing, choice of metal gate structure and its post-metal deposition annealing are important parameters to optimize the process and possibly address the energy efficiency of CMOS electronics at nano scales. Atomic layer deposition technique is used throughout this work because of its known deposition kinetics resulting in excellent electrical properties and conformal structure of the device. The dynamics of annealing greatly influence the electrical properties of the gate stack and consequently the reliability of the process as well as manufacturable device. Again, the choice of the annealing technique (migration of thermal flux into the layer), time-temperature cycle and sequence are key parameters influencing the device's output characteristics. This work presents a careful selection of annealing process parameters to provide sufficient thermal budget to Si MOSCAP with atomic layer deposited HfSiO high-k gate dielectric and TiN gate metal. The post-process annealing temperatures in the range of 600 degrees C-1000 degrees C with rapid dwell time provide a better trade-off between the desirable performance of Capacitance-Voltage hysteresis and the leakage current. The defect dynamics is thought to be responsible for the evolution of electrical characteristics in this Si MOSCAP structure specifically designed to tune the trade-off at low frequency for device application.	[Khan, Z. N.; Ahmed, S.; Ali, M.] Int Islamic Univ, AEL, Islamabad, Pakistan; [Khan, Z. N.] Comsats Inst Informat Technol, Islamabad, Pakistan	International Islamic University, Pakistan; COMSATS University Islamabad (CUI)	Khan, ZN (corresponding author), Int Islamic Univ, AEL, Islamabad, Pakistan.; Khan, ZN (corresponding author), Comsats Inst Informat Technol, Islamabad, Pakistan.	zeeshan.najam@comsats.edu.pk	SHUJA, AHMED/N-2608-2015; ali, muhammad/GYR-3505-2022; Ali, Muhammad/GXH-4405-2022	SHUJA, AHMED/0000-0002-4829-6520; Ali, Muhammad/0000-0002-1444-7888				Aydogan S, 2012, MICROELECTRON RELIAB, V52, P1362, DOI 10.1016/j.microrel.2012.02.016; BULUCEA CD, 1970, ELECTRON LETT, V6, P479, DOI 10.1049/el:19700336; Chen Z, 2007, APPL PHYS LETT, V91; Chen ZhiTan, 2007, South China Fruits, P1; Cristea M., 2014, EMERG TRENDS ELECT E, V1, P29, DOI [10.2139/ssrn.3433675, DOI 10.2139/SSRN.3433675]; GAGNON G, 1994, J APPL PHYS, V75, P1565, DOI 10.1063/1.356392; Han Kai, 2013, J SEMICONDUCTORS, V34; Khojier K., 2013, J THEOR APPL PHYS, V7, P1; Solovan MM, 2013, SEMICONDUCTORS+, V47, P1174, DOI 10.1134/S1063782613090248; Solovan MN, 2013, PHYS SOLID STATE+, V55, P2234, DOI 10.1134/S1063783413110255; Tataroglu A, 2008, MICROELECTRON ENG, V85, P2256, DOI 10.1016/j.mee.2008.07.001; Wang Y., 2010, THESIS; Xueli M, 2014, J SEMICONDUCTORS, V35; Zhao Chun, 2012, ISRN NANOTECHNOLOGY, V2012	14	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161736	10.1371/journal.pone.0161736	http://dx.doi.org/10.1371/journal.pone.0161736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571412	Green Published, gold, Green Submitted			2022-12-26	WOS:000382876700031
J	Muyldermans, G; Ducoffre, G; Leroy, M; Dupont, Y; Quolin, S				Muyldermans, Gaetan; Ducoffre, Genevieve; Leroy, Mathias; Dupont, Yves; Quolin, Sophie		Participating Sentinel Labs	Surveillance of Infectious Diseases by the Sentinel Laboratory Network in Belgium: 30 Years of Continuous Improvement	PLOS ONE			English	Article							EPIDEMIOLOGIC SURVEILLANCE	In 1983 the sentinel laboratory network was established because of the need to describe the epidemiological evolution of infectious diseases. During the study period of 30 years (1983-2013), microbiology laboratories reported on weekly basis the laboratory diagnosed cases for a selection of infectious diseases. This resulted in a large longitudinal laboratory based database allowing to provide trends over time and distribution by person and place. During this period, adaptations to data collection were made due to changes in diagnostic methods and public health priorities, introduction and application of digital revolution, and multiple reorganizations of the laboratories. Since the surveillance network is dynamic, it necessitates a continuous evaluation to ensure that, over time, it continues to be representative of the general epidemiological trends in the country. Secondly the aim is to examine the robustness and stability of this surveillance system. Here we demonstrated that the flexibility of the data collection methodology by the sentinel laboratory network is unique and that adaptations do not affect the capacity of the system to follow trends. Therefore, the surveillance by this network is representative of the current epidemiological situation in Belgium. To our knowledge, no such surveillance network with such a long-term follow-up and demonstrated stability for multiple infectious diseases in the general population was earlier described. Furthermore, expected trends due to the implementation of vaccination or other events were accurately detected. The collected data obtained from this network allows interesting comparisons with other national and international information sources.	[Muyldermans, Gaetan; Ducoffre, Genevieve; Leroy, Mathias; Dupont, Yves; Quolin, Sophie; Participating Sentinel Labs] WIV ISP, OD Publ Hlth & Surveillance, Unit Epidemiol Infect Dis, Brussels, Belgium		Muyldermans, G (corresponding author), WIV ISP, OD Publ Hlth & Surveillance, Unit Epidemiol Infect Dis, Brussels, Belgium.	gaetan.muyldermans@wiv-isp.be	Muyldermans, Gaetan/AAE-7235-2020	Melin, Pierrette/0000-0002-2159-5774; /0000-0003-0284-5210	Flemish region; Walloon-Brussels federation; Flemish Community; Brussels Capital; French-speaking Community	Flemish region; Walloon-Brussels federation; Flemish Community; Brussels Capital; French-speaking Community	The sentinel laboratory network was funded by the Flemish region and the Walloon-Brussels federation.; The Flemish Community, Brussels Capital and the French-speaking Community for their financial support.	Berger N, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0145-9; Bernard A, 2002, INT J TOXICOL, V21, P333, DOI 10.1080/10915810290096540; Dufour B, 2000, VET RES, V31, P169, DOI 10.1051/vetres:2000116; European Centre for Disease Prevention and Control (ECDC), 2014, ANN EP REP SEX TRANS; European Centre for Disease Prevention and Control (ECDC), 2013, ANN EP REP REP 2011; Hanquet G, 2011, VACCINE, V29, P4698, DOI 10.1016/j.vaccine.2011.04.098; Institute of Public Health (Belgium), SURV SEX TRANSM INF; Institute of Public Health (Belgium), ANN REP NAT REF CTR; Muyldermans G, 2013, ARCH PUBLIC HEALTH, V71, DOI 10.1186/0778-7367-71-8; STROOBANT A, 1986, INT J EPIDEMIOL, V15, P386, DOI 10.1093/ije/15.3.386; Vandenbergh H., 2004, BROCH SEM DIAGN SURV; Vellinga A, 2002, EMERG INFECT DIS, V8, P19, DOI 10.3201/eid0801.010129; Voldstedlund M., 2014, EURO SURVEILL, V19; WALCKIERS D, 1991, GENITOURIN MED, V67, P374; WALCKIERS D, 1991, EPIDEMIOL INFECT, V106, P297, DOI 10.1017/S0950268800048445	15	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0160429	10.1371/journal.pone.0160429	http://dx.doi.org/10.1371/journal.pone.0160429			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571203	Green Published, Green Submitted, gold			2022-12-26	WOS:000382876700004
J	Schob, S; Meyer, J; Gawlitza, M; Frydrychowicz, C; Muller, W; Preuss, M; Bure, L; Quaschling, U; Hoffmann, KT; Surov, A				Schob, Stefan; Meyer, Jonas; Gawlitza, Matthias; Frydrychowicz, Clara; Mueller, Wolf; Preuss, Matthias; Bure, Lionel; Quaeschling, Ulf; Hoffmann, Karl-Titus; Surov, Alexey			Diffusion-Weighted MRI Reflects Proliferative Activity in Primary CNS Lymphoma	PLOS ONE			English	Article							NERVOUS-SYSTEM LYMPHOMA; COEFFICIENT VALUES; PERFUSION; BODY	Purpose To investigate if apparent diffusion coefficient (ADC) values within primary central nervous system lymphoma correlate with cellularity and proliferative activity in corresponding histological samples. Materials and Methods Echo-planar diffusion-weighted magnetic resonance images obtained from 21 patients with primary central nervous system lymphoma were reviewed retrospectively. Regions of interest were drawn on ADC maps corresponding to the contrast enhancing parts of the tumors. Biopsies from all 21 patients were histologically analyzed. Nuclei count, total nuclei area and average nuclei area were measured. The proliferation index was estimated as Ki-67 positive nuclei divided by total number of nuclei. Correlations of ADC values and histopathologic parameters were determined statistically. Results Ki-67 staining revealed a statistically significant correlation with ADCmin (r = -0.454, p = 0.038), ADCmean (r = -0.546, p = 0.010) and ADCmax (r = -0.515, p = 0.017). Furthermore, ADCmean correlated in a statistically significant manner with total nucleic area (r = -0.500, p = 0.021). Conclusion Low ADCmin, ADCmean and ADCmax values reflect a high proliferative activity of primary cental nervous system lymphoma. Low ADCmean values-in concordance with several previously published studies-indicate an increased cellularity within the tumor.	[Schob, Stefan; Gawlitza, Matthias; Quaeschling, Ulf; Hoffmann, Karl-Titus] Univ Hosp Leipzig, Dept Neuroradiol, Leipzig, Germany; [Frydrychowicz, Clara; Mueller, Wolf] Univ Hosp Leipzig, Dept Neuropathol, Leipzig, Germany; [Surov, Alexey] Univ Hosp Leipzig, Dept Diagnost & Intervent Radiol, Leipzig, Germany; [Meyer, Jonas] Univ Halle Wittenberg, Dept Radiol, Halle, Germany; [Preuss, Matthias] Univ Hosp Leipzig, Dept Neurosurg, Leipzig, Germany; [Bure, Lionel] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Dept Radiol, Montreal, PQ, Canada	Leipzig University; Leipzig University; Leipzig University; Martin Luther University Halle Wittenberg; Leipzig University; McGill University	Schob, S (corresponding author), Univ Hosp Leipzig, Dept Neuroradiol, Leipzig, Germany.	Stefan.Schob@medizin.uni-leipzig.de		Krause, Matthias/0000-0002-7026-2837; Hoffmann, Karl-Titus/0000-0001-7693-887X; schob, stefan/0000-0003-2846-5443				[Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Barajas RF, 2010, AM J NEURORADIOL, V31, P60, DOI 10.3174/ajnr.A1750; Batchelor T, 2006, J CLIN ONCOL, V24, P1281, DOI 10.1200/JCO.2005.04.8819; Chen LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099865; Chen LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079008; Chen YB, 2012, MAGN RESON IMAGING, V30, P165, DOI 10.1016/j.mri.2011.09.019; Cotton F, 2006, J NEURORADIOLOGY, V33, P220, DOI 10.1016/S0150-9861(06)77267-4; Demir S, 2015, DIAGN INTERV RADIOL, V21, P184, DOI 10.5152/dir.2014.14187; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Guo AC, 2002, RADIOLOGY, V224, P177, DOI 10.1148/radiol.2241010637; GuzmLn-De-Villoria JA, 2015, ADDED VALUE ADV CONV, P1, DOI [10.1186/s40644-014-0035-8, DOI 10.1186/S40644-014-0035-8]; Haldorsen IS, 2011, AM J NEURORADIOL, V32, P984, DOI 10.3174/ajnr.A2171; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He X, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-153; Ho KC, 2009, EUR J NUCL MED MOL I, V36, P200, DOI 10.1007/s00259-008-0936-5; Jeon TY, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150163; Kickingereder P, 2014, RADIOLOGY, V272, P843, DOI 10.1148/radiol.14132740; Kivrak AS, 2013, DIAGN INTERV RADIOL, V19, P433, DOI 10.5152/dir.2013.13034; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Mabray MC, 2016, AM J NEURORADIOL, V37, P74, DOI 10.3174/ajnr.A4450; Olson JE, 2002, CANCER, V95, P1504, DOI 10.1002/cncr.10851; Priola AM, 2016, J MAGN RESON IMAGING, V44, P758, DOI 10.1002/jmri.25203; Priola AM, 2016, CRIT REV ONCOL HEMAT, V98, P335, DOI 10.1016/j.critrevonc.2015.11.012; Sasaki M, 2008, RADIOLOGY, V249, P624, DOI 10.1148/radiol.2492071681; Schluter C, 1993, J CELL, P1; Schob S, 2017, MOL IMAGING BIOL, V19, P138, DOI 10.1007/s11307-016-0978-1; Surawicz T S, 1999, Neuro Oncol, V1, P14, DOI 10.1093/neuonc/1.1.14; Surov A, 2015, ANTICANCER RES, V35, P6841; Wu XC, 2013, EUR J RADIOL, V82, pE158, DOI 10.1016/j.ejrad.2012.11.021; Zacharia TT, 2008, J NEUROIMAGING, V18, P411, DOI 10.1111/j.1552-6569.2007.00231.x	30	46	48	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161386	10.1371/journal.pone.0161386	http://dx.doi.org/10.1371/journal.pone.0161386			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571268	Green Published, gold, Green Submitted			2022-12-26	WOS:000382876700017
J	Vladescu, A; Titorencu, I; Dekhtyar, Y; Jinga, V; Pruna, V; Balaceanu, M; Dinu, M; Pana, I; Vendina, V; Braic, M				Vladescu, Alina; Titorencu, Irina; Dekhtyar, Yuri; Jinga, Victor; Pruna, Vasile; Balaceanu, Mihai; Dinu, Mihaela; Pana, Iulian; Vendina, Viktorija; Braic, Mariana			In Vitro Biocompatibility of Si Alloyed Multi-Principal Element Carbide Coatings	PLOS ONE			English	Article							HIGH-ENTROPY ALLOYS; OXIDE NET CHARGE; C THIN-FILMS; MECHANICAL-PROPERTIES; SUBSTRATE-TEMPERATURE; SURFACE-ROUGHNESS; BONE-FORMATION; TITANIUM; ADHESION; MICROSTRUCTURE	In the current study, we have examined the possibility to improve the biocompatibility of the (TiZrNbTaHf)C through replacement of either Ti or Ta by Si. The coatings were deposited on Si and 316L stainless steel substrates by magnetron sputtering in an Ar+CH4 mixed atmosphere and were examined for elemental composition, chemical bonds, surface topography, surface electrical charge and biocompatible characteristics. The net surface charge was evaluated at nano and macroscopic scale by measuring the electrical potential and work function, respectively. The biocompatible tests comprised determination of cell viability and cell attachment to the coated surface. The deposited coatings had C/(metal+Si) ratios close to unity, while a mixture of metallic carbide, free-carbon and oxidized species formed on the film surface. The coatings' surfaces were smooth and no influence of surface roughness on electrical charge or biocompatibility was found. The biocompatible characteristics correlated well with the electrical potential/work function, suggesting a significant role of surface charge in improving biocompatibility, particularly cell attachment to coating's surface. Replacement of either Ti or Ta by Si in the (TiZrNbTaHf) C coating led to an enhanced surface electrical charge, as well as to superior biocompatible properties, with best results for the (TiZrNbSiHf) C coating.	[Vladescu, Alina; Balaceanu, Mihai; Dinu, Mihaela; Pana, Iulian; Braic, Mariana] Natl Inst Optoelelect, Magurele, Romania; [Titorencu, Irina; Jinga, Victor; Pruna, Vasile] Romanian Acad, Inst Cellular Biol & Pathol Nicolae Simionescu, Bucharest, Romania; [Dekhtyar, Yuri; Vendina, Viktorija] Riga Tech Univ, 1 Kalkustr, Rga, Latvia; [Pana, Iulian] Univ Bucharest, Fac Phys, Magurele, Romania	Romanian Academy of Sciences; Nicolae Simionescu Institute of Cellular Biology & Pathology; Riga Technical University; University of Bucharest	Braic, M (corresponding author), Natl Inst Optoelelect, Magurele, Romania.	mariana.braic@inoe.ro	Pana, Iulian/L-3947-2019; Titorencu, Irina/Y-4766-2019; Vasile, Pruna/AAQ-8923-2021; Dinu, Mihaela/AAY-5129-2021; Braic, Mariana/AAY-7041-2020; Vladescu, Alina/B-5605-2011	Pana, Iulian/0000-0003-1368-6219; Titorencu, Irina/0000-0001-9312-5811; Vladescu, Alina/0000-0001-5770-4541; BRAIC, Mariana/0000-0002-2543-5866; Dinu, Mihaela/0000-0002-3149-6972; Lazdina, Dagnija/0000-0001-8280-3912	grant of the Romanian National Authority for Scientific Research, CNCS-UEFISCDI [PN-II-ID-PCE-2011-3-1016]; project INOVA-OPTIMA SMIS [49164];  [658/2014]	grant of the Romanian National Authority for Scientific Research, CNCS-UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); project INOVA-OPTIMA SMIS; 	This work was funded by a grant of the Romanian National Authority for Scientific Research, CNCS-UEFISCDI, project number PN-II-ID-PCE-2011-3-1016. Part of the analysis were carried out by using the equipment acquired by the infrastructure project INOVA-OPTIMA SMIS code 49164, contract no. 658/2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by a grant of the Romanian National Authority for Scientific Research, CNCS-UEFISCDI, project number PN-II-ID-PCE-2011-3-1016. EDS analysis was carried out by using the equipment acquired by the infrastructure project INOVA-OPTIMA SMIS code 49164, contract no. 658/2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank dr. C. Logofatu from the National Institute for Materials Physics (Magurele, Romania) for XPS measurements.	Agarwal B. K., 1991, SECONDARY SPECTRA SA, P155, DOI [10.1007/978-3-540-38668-1_4, DOI 10.1007/978-3-540-38668-1_4]; [Anonymous], 1993, SURF PHYS CHEM MECH; Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2; Balla VK, 2010, JOM, P61; Bauer S, 2013, PROG MATER SCI, V58, P261, DOI 10.1016/j.pmatsci.2012.09.001; Bondar O. V., 2013, 2013 23rd International Crimean Conference "Microwave & Telecommunication Technology" (CriMiCo), P802; Braic L, 2010, OPTOELECTRON ADV MAT, V4, P2013; Braic M, 2005, SURF COAT TECH, V200, P1014, DOI 10.1016/j.surfcoat.2005.02.140; Braic M, 2013, APPL SURF SCI, V284, P671, DOI 10.1016/j.apsusc.2013.07.152; Braic M, 2011, THIN SOLID FILMS, V519, P4092, DOI 10.1016/j.tsf.2011.01.375; Braic M, 2011, THIN SOLID FILMS, V519, P4064, DOI 10.1016/j.tsf.2011.01.193; Braic V, 2014, SURF COAT TECH, V258, P996, DOI 10.1016/j.surfcoat.2014.07.044; Braic V, 2012, SURF COAT TECH, V211, P117, DOI 10.1016/j.surfcoat.2011.09.033; Braic V, 2012, J MECH BEHAV BIOMED, V10, P197, DOI 10.1016/j.jmbbm.2012.02.020; Brama M, 2007, BIOMATERIALS, V28, P595, DOI 10.1016/j.biomaterials.2006.08.018; Bystrov VS, 2012, J APPL PHYS, V111, DOI 10.1063/1.4721373; Chang SY, 2011, THIN SOLID FILMS, V519, P4865, DOI 10.1016/j.tsf.2011.01.043; Chang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095590; Chu CL, 2011, MAT SCI ENG C-MATER, V31, P423, DOI 10.1016/j.msec.2010.10.023; Cotrut CM, 2013, THIN SOLID FILMS, V538, P48, DOI 10.1016/j.tsf.2012.12.100; Crist B.V., 2004, HDB MONOCHROMATIC XP, V1st; Curtis A, 2001, PHYS MED BIOL, V46, pR47, DOI 10.1088/0031-9155/46/4/201; Dekhtyar Y, 2008, NATO SCIENCE PEACE S, P169, DOI 10.1007/978-1-4020-8903-9_10; Dekhtyar Y, 2009, IFMBE PROC, V25, P245, DOI 10.1007/978-3-642-03900-3_70; Eklund P, 2007, SURF COAT TECH, V201, P6465, DOI 10.1016/j.surfcoat.2006.12.016; Fall J, 2001, PHYS REV B, V65; Feng XG, 2013, NUCL INSTRUM METH B, V301, P29, DOI 10.1016/j.nimb.2013.03.001; Goldstein J, 2003, SCANNING ELECT MICRO, V3rd, P391, DOI [10.1007/978-1-4615-0215-9, DOI 10.1007/978-1-4615-0215-9]; Gongadze E, 2011, INT J NANOMED, V6, P1801, DOI [10.2147/IJN.S21755, 10.2147/IJN.S16982]; Guo CY, 2012, INT J BIOMATER, V2012, DOI 10.1155/2012/381535; HAMAMOTO N, 1995, ARCH ORAL BIOL, V40, P97, DOI 10.1016/0003-9969(94)00153-3; Holzwarth U., 2012, TOTAL HIP ARTHROPLAS, DOI DOI 10.2788/31286; Jansson U, 2013, THIN SOLID FILMS, V536, P1, DOI 10.1016/j.tsf.2013.02.019; Kabaso D, 2011, COMPUT METHOD BIOMEC, V14, P469, DOI 10.1080/10255842.2010.534986; Khang G, 2015, BIOSURF BIOTRIBOL, V1, P202, DOI DOI 10.1016/J.BSBT2015.08.004; Khlusov IA, 2013, NOVEL CONCEPTS NICHE, P99; KRUKOWSKI M, 1990, J ORAL MAXIL SURG, V48, P468, DOI 10.1016/0278-2391(90)90233-R; Krzanowski JE, 2006, SURF COAT TECH, V201, P2942, DOI 10.1016/j.surfcoat.2006.06.005; Liang SC, 2011, APPL SURF SCI, V258, P399, DOI 10.1016/j.apsusc.2011.09.006; Liang SC, 2011, APPL SURF SCI, V257, P7709, DOI 10.1016/j.apsusc.2011.04.014; Lopes C, 2007, SURF COAT TECH, V201, P7180, DOI 10.1016/j.surfcoat.2007.01.025; Lotfi M, 2013, ADV BIOMATERIALS SCI, P1, DOI DOI 10.5772/56420; MacDonald DE, 2011, COLLOID SURFACE B, V82, P173, DOI 10.1016/j.colsurfb.2010.08.031; MAROUDAS NG, 1975, J THEOR BIOL, V49, P417, DOI 10.1016/0022-5193(75)90182-4; MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314; Nedoma J, 2011, TOTAL REPLACEMENT HU, P34; Negrila CC, 2008, J CRYST GROWTH, V310, P1576, DOI 10.1016/j.jcrysgro.2007.11.001; NONNENMACHER M, 1991, APPL PHYS LETT, V58, P2921, DOI 10.1063/1.105227; Novaes Jr Arthur Belém, 2010, Braz. Dent. J., V21, P471, DOI 10.1590/S0103-64402010000600001; Ohgaki M, 2001, J BIOMED MATER RES, V57, P366, DOI 10.1002/1097-4636(20011205)57:3<366::AID-JBM1179>3.0.CO;2-X; Orf ND, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3089677; Pattanayak DK, 2009, J MATER SCI-MATER M, V20, P2401, DOI 10.1007/s10856-009-3815-0; Pegueroles M, 2010, ACTA BIOMATER, V6, P291, DOI 10.1016/j.actbio.2009.07.030; PERIDES G, 1987, J BIOL CHEM, V262, P13742; Pogrebnjak AD, 2014, MATER CHEM PHYS, V147, P1079, DOI 10.1016/j.matchemphys.2014.06.062; Probst J, 2001, SURF COAT TECH, V148, P226, DOI 10.1016/S0257-8972(01)01357-3; Ramazanoglu M, 2011, IMPLANT DENTISTRY - A RAPIDLY EVOLVING PRACTICE, P57; Rapuano BE, 2011, COLLOID SURFACE B, V82, P95, DOI 10.1016/j.colsurfb.2010.08.023; Richards RG, 1996, INJURY, V27, P38; Serro AP, 2009, SURF COAT TECH, V203, P3701, DOI 10.1016/j.surfcoat.2009.06.010; Shtansky DV, 2010, SURF COAT TECH, V205, P728, DOI 10.1016/j.surfcoat.2010.07.063; SKRIVER HL, 1992, PHYS REV B, V46, P7157, DOI 10.1103/PhysRevB.46.7157; Smeets Ralf, 2009, Head Face Med, V5, P13, DOI 10.1186/1746-160X-5-13; Smith IO, 2004, J BIOMED MATER RES A, V70A, P436, DOI 10.1002/jbm.a.30098; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; Tsai MH, 2014, MATER RES LETT, V2, P107, DOI 10.1080/21663831.2014.912690; Veprek S, 1997, SURF COAT TECH, V97, P15, DOI 10.1016/S0257-8972(97)00279-X; Victoria G, 2009, INDIAN J ORTHOP, V43, P117, DOI 10.4103/0019-5413.50844; Vladescu A, 2008, J NANOSCI NANOTECHNO, V8, P717, DOI 10.1166/jnn.2008.D218; Yeh JW, 2006, ANN CHIM-SCI MAT, V31, P633, DOI 10.3166/acsm.31.633-648; Yeh JW, 2007, MATER SCI FORUM, V560, P1, DOI 10.4028/www.scientific.net/MSF.560.1; Yeh JW, 2004, ADV ENG MATER, V6, P299, DOI 10.1002/adem.200300567; Zoita CN, 2010, SURF COAT TECH, V204, P2002, DOI 10.1016/j.surfcoat.2009.08.050	73	30	31	9	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161151	10.1371/journal.pone.0161151	http://dx.doi.org/10.1371/journal.pone.0161151			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571361	Green Published, gold, Green Submitted			2022-12-26	WOS:000382876700012
J	Desai, S; Srambikkal, N; Yadav, HD; Shetake, N; Balla, MMS; Kumar, A; Ray, P; Ghosh, A; Pandey, BN				Desai, Sejal; Srambikkal, Nishad; Yadav, Hansa D.; Shetake, Neena; Balla, Murali M. S.; Kumar, Amit; Ray, Pritha; Ghosh, Anu; Pandey, B. N.			Molecular Understanding of Growth Inhibitory Effect from Irradiated to Bystander Tumor Cells in Mouse Fibrosarcoma Tumor Model	PLOS ONE			English	Article							RADIATION-INDUCED BYSTANDER; MICROBEAM IRRADIATION; IN-VIVO; IONIZING-RADIATION; HUMAN FIBROBLASTS; EPITHELIAL-CELLS; GAMMA-RADIATION; CANCER-CELLS; SURVIVAL; RELEVANCE	Even though bystander effects pertaining to radiation risk assessment has been extensively studied, the molecular players of radiation induced bystander effect (RIBE) in the context of cancer radiotherapy are poorly known. In this regard, the present study is aimed to investigate the effect of irradiated tumor cells on the bystander counterparts in mouse fibrosarcoma (WEHI 164 cells) tumor model. Mice co-implanted with WEHI 164 cells.-irradiated with a lethal dose of 15 Gy and unirradiated (bystander) WEHI 164 cells showed inhibited tumor growth, which was measured in terms of tumor volume and Luc(+)WEHI 164 cells based bioluminescence in vivo imaging. Histopathological analysis and other assays revealed decreased mitotic index, increased apoptosis and senescence in these tumor tissues. In addition, poor angiogenesis was observed in these tumor tissues, which was further confirmed by fluorescence imaging of tumor vascularisation and CD31 expression by immuno-histochemistry. Interestingly, the growth inhibitory bystander effect was exerted more prominently by soluble factors obtained from the irradiated tumor cells than the cellular fraction. Cytokine profiling of the supernatants obtained from the irradiated tumor cells showed increased levels of VEGF, Rantes, PDGF, GMCSF and IL-2 and decreased levels of IL-6 and SCF. Comparative proteomic analysis of the supernatants from the irradiated tumor cells showed differential expression of total 24 protein spots (21 up-and 3 down-regulated) when compared with the supernatant from the unirradiated control cells. The proteins which showed substantially higher level in the supernatant from the irradiated cells included diphosphate kinase B, heat shock cognate, annexin A1, angiopoietin-2, actin (cytoplasmic 1/2) and stress induced phosphoprotein 1. However, the levels of proteins like annexin A2, protein S100 A4 and cofilin was found to be lower in this supernatant. In conclusion, our results provided deeper insight about the damaging RIBE in an in vivo tumor model, which may have significant implication in improvement of cancer radiotherapy.	[Desai, Sejal; Srambikkal, Nishad; Yadav, Hansa D.; Shetake, Neena; Balla, Murali M. S.; Kumar, Amit; Ghosh, Anu; Pandey, B. N.] Bhabha Atom Res Ctr, Radiat Biol & Hlth Sci Div, Bombay, Maharashtra, India; [Ray, Pritha] Tata Mem Hosp, Adv Ctr Training Res & Educ Canc, Navi Mumbai, Maharashtra, India; [Desai, Sejal; Kumar, Amit; Ray, Pritha; Ghosh, Anu; Pandey, B. N.] Homi Bhabha Natl Inst, Bombay, Maharashtra, India	Bhabha Atomic Research Center (BARC); Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Homi Bhabha National Institute	Pandey, BN (corresponding author), Bhabha Atom Res Ctr, Radiat Biol & Hlth Sci Div, Bombay, Maharashtra, India.; Pandey, BN (corresponding author), Homi Bhabha Natl Inst, Bombay, Maharashtra, India.	badrinarain@yahoo.co.in	Patwardhan, Sejal/HGL-8441-2022; Ghosh, Anu/ABF-4180-2020	Patwardhan, Sejal/0000-0003-2797-4158; Shetake, Neena/0000-0002-6865-417X; Kumar, Professor Amit/0000-0002-5913-4308; S, NISHAD/0000-0001-6428-1233; Ghosh, Anu/0000-0003-4528-8602	Department of Atomic Energy (DAE) Graduate Fellowship Scheme	Department of Atomic Energy (DAE) Graduate Fellowship Scheme	Sejal Desai would like to acknowledge Department of Atomic Energy (DAE) Graduate Fellowship Scheme for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato R, 2007, J MOL MED, V85, P707, DOI 10.1007/s00109-007-0205-2; Lizarbe MA, 2013, INT J MOL SCI, V14, P2652, DOI 10.3390/ijms14022652; Astorgues-Xerri L, 2014, CANCER TREAT REV, V40, P307, DOI 10.1016/j.ctrv.2013.07.007; Asur R, 2015, CANCER LETT, V356, P52, DOI 10.1016/j.canlet.2013.10.032; Autsavapromporn N, 2015, INT J RADIAT BIOL, V91, P62, DOI 10.3109/09553002.2014.950715; Azzam EI, 2004, HUM EXP TOXICOL, V23, P61, DOI 10.1191/0960327104ht418oa; Banumathy G, 2010, CELLULAR SENESCENCE AND TUMOR SUPPRESSION, P109, DOI 10.1007/978-1-4419-1075-2_5; Belyakov OV, 2005, P NATL ACAD SCI USA, V102, P14203, DOI 10.1073/pnas.0505020102; Buonanno M, 2015, RADIAT RES, V184, P219, DOI 10.1667/RR14057.1; Butterworth KT, 2013, CLIN ONCOL-UK, V25, P586, DOI 10.1016/j.clon.2013.06.005; Chang CY, 2015, INT J MOL SCI, V16, P4095, DOI 10.3390/ijms16024095; Desai S, 2014, MUTAT RES-FUND MOL M, V763, P39, DOI 10.1016/j.mrfmmm.2014.03.004; Desai S, 2013, CYTOKINE, V61, P54, DOI 10.1016/j.cyto.2012.08.022; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Fernandez-Palomo C, 2015, PHYS MEDICA, V31, P584, DOI 10.1016/j.ejmp.2015.03.004; Fischer C, 2005, J BIOL CHEM, V280, P37266, DOI 10.1074/jbc.M411580200; Furlong H, 2015, DOSE RESPON IN PRESS, V13; Gaikwad SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055971; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hajjar Katherine A, 2015, Trans Am Clin Climatol Assoc, V126, P144; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Kumar C, 2016, INT J RADIAT BIOL, V92, P173, DOI 10.3109/09553002.2016.1144944; Liao EC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.220; Liu B, 2011, CHINESE SCI BULL, V56, P3122, DOI 10.1007/s11434-011-4679-5; Luce A, 2009, CARCINOGENESIS, V30, P432, DOI 10.1093/carcin/bgp008; Lyng FM, 2002, RADIAT RES, V157, P365, DOI 10.1667/0033-7587(2002)157[0365:IOAICE]2.0.CO;2; Mothersill C, 1997, INT J RADIAT BIOL, V71, P421, DOI 10.1080/095530097144030; Nishad S, 2016, MUTAT RES-GEN TOX EN, V797, P9, DOI 10.1016/j.mrgentox.2016.01.001; O'Dowd C, 2006, RADIAT RES, V166, P611, DOI 10.1667/RR0606.1; Oppenheim Joost, 1996, Cytokine and Growth Factor Reviews, V7, P279, DOI 10.1016/S1359-6101(96)00025-1; Pandey BN, 2005, INDIAN J RAD RES, V2, P13; Perretti M, 2004, J LEUKOCYTE BIOL, V76, P25, DOI 10.1189/jlb.1103552; Perretti M, 2003, NEWS PHYSIOL SCI, V18, P60, DOI 10.1152/nips.01424.2002; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Rzeszowska-Wolny J, 2009, EUR J PHARMACOL, V625, P156, DOI 10.1016/j.ejphar.2009.07.028; Sanchez-Ruderisch H, 2011, CELL DEATH DIFFER, V18, P806, DOI 10.1038/cdd.2010.148; Shareef MM, 2007, CANCER RES, V67, P11811, DOI 10.1158/0008-5472.CAN-07-0722; Sherbet GV, 1998, ANTICANCER RES, V18, P2415; Shetake NG, 2015, INT J HYPERTHER, V31, P909, DOI 10.3109/02656736.2015.1075072; Sugimoto MA, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/8239258; Xue LY, 2002, P NATL ACAD SCI USA, V99, P13765, DOI 10.1073/pnas.182209699; Yan W, 2000, MOL CELL ENDOCRINOL, V165, P115, DOI 10.1016/S0303-7207(00)00257-4; Yang HY, 2007, RADIAT RES, V168, P292, DOI 10.1667/RR0864.1	44	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161662	10.1371/journal.pone.0161662	http://dx.doi.org/10.1371/journal.pone.0161662			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27561007	gold, Green Published, Green Submitted			2022-12-26	WOS:000382258600076
J	Harrison, T; Ruiz, J; Sloan, DB; Ben-Hur, A; Boucher, C				Harrison, Thomas; Ruiz, Jaime; Sloan, Daniel B.; Ben-Hur, Asa; Boucher, Christina			aPPRove: An HMM-Based Method for Accurate Prediction of RNA-Pentatricopeptide Repeat Protein Binding Events	PLOS ONE			English	Article							PPR MOTIF; GENES	Pentatricopeptide repeat containing proteins (PPRs) bind to RNA transcripts originating from mitochondria and plastids. There are two classes of PPR proteins. The P class contains tandem P-type motif sequences, and the PLS class contains alternating P, L and S type sequences. In this paper, we describe a novel tool that predicts PPR-RNA interaction; specifically, our method, which we call aPPRove, determines where and how a PLS-class PPR protein will bind to RNA when given a PPR and one or more RNA transcripts by using a combinatorial binding code for site specificity proposed by Barkan et al. Our results demonstrate that aPPRove successfully locates how and where a PPR protein belonging to the PLS class can bind to RNA. For each binding event it outputs the binding site, the aminoacid-nucleotide interaction, and its statistical significance. Furthermore, we show that our method can be used to predict binding events for PLS-class proteins using a known edit site and the statistical significance of aligning the PPR protein to that site. In particular, we use our method to make a conjecture regarding an interaction between CLB19 and the second intronic region of ycf3. The aPPRove web server can be found at www.cs.colostate.edu/similar to approve.	[Harrison, Thomas; Ben-Hur, Asa] Colorado State Univ, Dept Comp Sci, Ft Collins, CO 80523 USA; [Ruiz, Jaime; Boucher, Christina] Univ Florida, Dept Comp & Informat Sci & Engn, Gainesville, FL 32611 USA; [Sloan, Daniel B.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	Colorado State University; State University System of Florida; University of Florida; Colorado State University	Harrison, T (corresponding author), Colorado State Univ, Dept Comp Sci, Ft Collins, CO 80523 USA.	thomas.harrison@cs.colostate.edu						Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Arenas A, 2014, MITOCHONDRION, V19, P126, DOI 10.1016/j.mito.2014.08.006; BAIROCH A, 1992, NUCLEIC ACIDS RES, V20, P2013, DOI 10.1093/nar/20.suppl.2013; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Bellucci M, 2011, NAT METHODS, V8, P444, DOI 10.1038/nmeth.1611; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson DA, 2003, NUCLEIC ACIDS RES, V31, P23, DOI 10.1093/nar/gkg057; Durbin R., 1998, BIOL SEQUENCE ANAL P; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fujii S, 2011, P NATL ACAD SCI USA, V108, P1723, DOI 10.1073/pnas.1007667108; Fujimori S, 2012, BIOINFORMATION, V8, P729, DOI 10.6026/97320630008729; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Glisovic T, 2008, FEBS LETT, V6, pe255; Hogan D, 2008, PLOS BIOL, V582, P1997; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Lewis BA, 2011, NUCLEIC ACIDS RES, V39, pD277, DOI 10.1093/nar/gkq1108; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Muppirala UK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-489; Okuda K, 2014, PLANT J, V80, P870, DOI 10.1111/tpj.12687; Pancaldi V, 2011, NUCLEIC ACIDS RES, V39, P5826, DOI 10.1093/nar/gkr160; Prikryl J, 2011, P NATL ACAD SCI USA, V108, P415, DOI 10.1073/pnas.1012076108; Ruwe H, 2013, FEBS LETT, V587, P1429, DOI 10.1016/j.febslet.2013.03.022; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Takenaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065343; Tome JM, 2014, NAT METHODS, V11, P683, DOI [10.1038/NMETH.2970, 10.1038/nmeth.2970]; Wang Y, 2013, MOL BIOSYST, V9, P133, DOI 10.1039/c2mb25292a; Wang ZH, 2006, PLANT CELL, V18, P676, DOI 10.1105/tpc.105.038240; Wu T, 2006, NUCLEIC ACIDS RES, V34, pD150, DOI 10.1093/nar/gkj025; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; Yap A, 2015, PLANT J, V81, P661, DOI 10.1111/tpj.12756	31	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0160645	10.1371/journal.pone.0160645	http://dx.doi.org/10.1371/journal.pone.0160645			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560805	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258600013
J	Kong, N; Wu, YG; Meng, Q; Wang, ZZ; Zuo, YW; Pan, X; Tong, W; Zheng, H; Li, GX; Yang, S; Yu, H; Zhou, EM; Shan, TL; Tong, GZ				Kong, Ning; Wu, Yongguang; Meng, Qiong; Wang, Zhongze; Zuo, Yewen; Pan, Xi; Tong, Wu; Zheng, Hao; Li, Guoxin; Yang, Shen; Yu, Hai; Zhou, En-min; Shan, Tongling; Tong, Guangzhi			Suppression of Virulent Porcine Epidemic Diarrhea Virus Proliferation by the PI3K/Akt/GSK-3 alpha/beta Pathway	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; SIGNALING PATHWAY; PI3K/AKT PATHWAY; UNITED-STATES; PROTEIN; REPLICATION; ACTIVATION; INFECTION; CELLS; ENTRY	Porcine epidemic diarrhea virus (PEDV) has recently caused high mortality in suckling piglets with subsequent large economic losses to the swine industry. Many intracellular signaling pathways, including the phosphatidylinositol 3-kinase (PI3K)/Akt pathway, are activated by viral infection. The PI3K/Akt pathway is an important cellular pathway that has been shown to be required for virus replication. In the present study, we found that the PEDV JS-2013 strain activated Akt in Vero cells at early (5-15 min) and late stages (8-10 h) of infection. Inhibiting PI3K, an upstream activator of Akt, enhanced PEDV replication. Inhibiting GSK-3 alpha/beta, one of the downstream effectors of PI3K/Akt pathway and regulated by Akt during PEDV infected Vero cells, also enhanced PEDV replication. Collectively, our data suggest that PI3K/Akt/GSK-3 alpha/beta signaling pathway is activated by PEDV and functions in inhibiting PEDV replication.	[Kong, Ning; Wu, Yongguang; Meng, Qiong; Wang, Zhongze; Zuo, Yewen; Pan, Xi; Tong, Wu; Zheng, Hao; Li, Guoxin; Yang, Shen; Yu, Hai; Shan, Tongling; Tong, Guangzhi] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Dept Swine Infect Dis, Shanghai, Peoples R China; [Kong, Ning; Tong, Wu; Zheng, Hao; Li, Guoxin; Yu, Hai; Shan, Tongling; Tong, Guangzhi] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China; [Kong, Ning; Zhou, En-min] Northwest A&F Univ, Dept Vet Prevent Med, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China; [Meng, Qiong] Xinyang Normal Univ, Dept Zool, Coll Life Sci, Xinyang 464000, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Northwest A&F University - China; Xinyang Normal University	Shan, TL; Tong, GZ (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Dept Swine Infect Dis, Shanghai, Peoples R China.; Shan, TL; Tong, GZ (corresponding author), Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China.	shantongling@shvri.ac.cn; gztong@shvri.ac.cn	Shan, Tongling/AFG-8328-2022; yang, shen/GWC-0424-2022	Shan, Tongling/0000-0002-5329-6349; 	National Natural Science Foundation of China [31201915]; Shanghai Science and Technology Program for Agriculture [2013-5-5, 2013-3-6]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Program for Agriculture	This work was supported by the National Natural Science Foundation of China (grant no. 31201915) and the Shanghai Science and Technology Program for Agriculture (grant nos. 2013-5-5 and 2013-3-6).	Ajmone-Cat M.A., 2015, BRAIN BEHAV IMMUN; Alwine JC, 2008, CURR TOP MICROBIOL, V325, P263; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; Bridgen A, 1998, ADV EXP MED BIOL, V440, P781; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chen JF, 2012, J VIROL, V86, P3408, DOI 10.1128/JVI.07150-11; Chen Q, 2014, J CLIN MICROBIOL, V52, P234, DOI 10.1128/JCM.02820-13; Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0; Diehl N, 2013, VIRUSES-BASEL, V5, P3192, DOI 10.3390/v5123192; Dunn EF, 2012, PROG MOL BIOL TRANSL, V106, P223, DOI 10.1016/B978-0-12-396456-4.00002-X; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fang XJ, 2002, MOL CELL BIOL, V22, P2099, DOI 10.1128/MCB.22.7.2099-2110.2002; Hassan B, 2013, SURG ONCOL CLIN N AM, V22, P641, DOI 10.1016/j.soc.2013.06.008; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Hirata N, 2014, BIOCHEM BIOPH RES CO, V450, P891, DOI 10.1016/j.bbrc.2014.06.077; Izmailyan R, 2012, J VIROL, V86, P6677, DOI 10.1128/JVI.06860-11; Khan KA, 2015, MOL CELL BIOL, V35, P3029, DOI 10.1128/MCB.00344-15; Kim H, 2015, J VIROL; Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9; Li WT, 2012, EMERG INFECT DIS, V18, P1350, DOI 10.3201/eid1808.120002; Li WH, 2006, J VIROL, V80, P4211, DOI 10.1128/JVI.80.9.4211-4219.2006; Liu XQ, 2015, VIROLOGY, V479, P568, DOI 10.1016/j.virol.2015.02.040; Martelli R, 2008, VET REC, V162, P307, DOI 10.1136/vr.162.10.307; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Mizutani T, 2005, BBA-MOL BASIS DIS, V1741, P4, DOI 10.1016/j.bbadis.2005.04.004; Mole B, 2013, NATURE, V499, P388, DOI 10.1038/499388a; Nagy B, 1996, ACTA VET HUNG, V44, P9; Neilson J, 2001, CURR OPIN IMMUNOL, V13, P346, DOI 10.1016/S0952-7915(00)00225-9; Pan Xi, 2015, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V34, P51, DOI 10.1089/mab.2014.0062; Park SJ, 2011, ARCH VIROL, V156, P577, DOI 10.1007/s00705-010-0892-9; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Peyrollier K, 2000, BIOCHEM J, V350, P361, DOI 10.1042/0264-6021:3500361; Puranaveja S, 2009, EMERG INFECT DIS, V15, P1112, DOI 10.3201/eid1507.081256; Rahaus M, 2007, CELL SIGNAL, V19, P312, DOI 10.1016/j.cellsig.2006.07.003; SAITO Y, 1994, BIOCHEM J, V303, P27, DOI 10.1042/bj3030027; Shin YK, 2007, J GEN VIROL, V88, P13, DOI 10.1099/vir.0.82419-0; Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Su MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004196; Sun L, 2012, J BIOL CHEM, V287, P22882, DOI 10.1074/jbc.M111.306373; Sun RQ, 2012, EMERG INFECT DIS, V18, P161, DOI 10.3201/eid1801.111259; Surviladze Z, 2013, J VIROL, V87, P2508, DOI 10.1128/JVI.02319-12; Wang HZ, 2011, CYTOKINE, V53, P130, DOI 10.1016/j.cyto.2010.10.009; Wang Y, 2015, DNA CELL BIOL; WOOD EN, 1977, VET REC, V100, P243, DOI 10.1136/vr.100.12.243; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Wu CH, 2009, J BIOL CHEM, V284, P5229, DOI 10.1074/jbc.M805747200; Xue M, 2014, NUCLEIC ACIDS RES, V42, P9862, DOI 10.1093/nar/gku583; Zhang XZ, 2015, INFECT GENET EVOL, V34, P415, DOI 10.1016/j.meegid.2015.06.008; Zhu LQ, 2013, ARCH VIROL, V158, P1227, DOI 10.1007/s00705-013-1620-z	51	20	20	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161508	10.1371/journal.pone.0161508	http://dx.doi.org/10.1371/journal.pone.0161508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560518	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258600051
J	Li, YY; Kulvicius, T; Tetzlaff, C				Li, Yinyun; Kulvicius, Tomas; Tetzlaff, Christian			Induction and Consolidation of Calcium-Based Homo- and Heterosynaptic Potentiation and Depression	PLOS ONE			English	Article							LONG-TERM POTENTIATION; TIMING-DEPENDENT PLASTICITY; SYNAPTIC PLASTICITY; DENDRITIC SPINES; NEURON MODEL; RELEASE; CA2+; LTD; SPIKES; MEMORY	The adaptive mechanisms of homo-and heterosynaptic plasticity play an important role in learning and memory. In order to maintain plasticity-induced changes for longer time scales (up to several days), they have to be consolidated by transferring them from a short-lasting early-phase to a long-lasting late-phase state. The underlying processes of this synaptic consolidation are already well-known for homosynaptic plasticity, however, it is not clear whether the same processes also enable the induction and consolidation of heterosynaptic plasticity. In this study, by extending a generic calcium-based plasticity model with the processes of synaptic consolidation, we show in simulations that indeed heterosynaptic plasticity can be induced and, furthermore, consolidated by the same underlying processes as for homosynaptic plasticity. Furthermore, we show that by local diffusion processes the heterosynaptic effect can be restricted to a few synapses neighboring the homosynaptically changed ones. Taken together, this generic model reproduces many experimental results of synaptic tagging and consolidation, provides several predictions for heterosynaptic induction and consolidation, and yields insights into the complex interactions between homo-and heterosynaptic plasticity over a broad variety of time (minutes to days) and spatial scales (several micrometers).	[Li, Yinyun; Kulvicius, Tomas] Univ Gottingen, Inst Phys Biophys 3, D-37077 Gottingen, Germany; [Li, Yinyun; Tetzlaff, Christian] Univ Gottingen, Bernstein Ctr Computat Neurosci, D-37077 Gottingen, Germany; [Kulvicius, Tomas] Univ Southern Denmark, Maersk Mc Kinney Moller Inst, DK-5230 Odense, Denmark; [Tetzlaff, Christian] Max Planck Inst Dynam & Self Org, D-37077 Gottingen, Germany; [Tetzlaff, Christian] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Li, Yinyun] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China	University of Gottingen; University of Gottingen; University of Southern Denmark; Max Planck Society; Weizmann Institute of Science; Beijing Normal University	Li, YY (corresponding author), Univ Gottingen, Inst Phys Biophys 3, D-37077 Gottingen, Germany.; Li, YY (corresponding author), Univ Gottingen, Bernstein Ctr Computat Neurosci, D-37077 Gottingen, Germany.; Li, YY (corresponding author), Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China.	yinyun.li@phys.uni-goettingen.de		Li, Yinyun/0000-0002-8286-160X	European Community [600578]; Federal Ministry of Education and Research (BMBF) Germany; Max-Planck-Gesellschaft [01GQ1005B]; University of Southern Denmark	European Community(European Commission); Federal Ministry of Education and Research (BMBF) Germany(Federal Ministry of Education & Research (BMBF)); Max-Planck-Gesellschaft(Max Planck Society); University of Southern Denmark	The research leading to these results has received funding from the European Community's Seventh Framework Programme FP7/2007-2013 (Programme and Theme: ICT-2011.2.1, Cognitive Systems and Robotics) under grant agreement no. 600578 as well as from the Federal Ministry of Education and Research (BMBF) Germany to the Goettingen Bernstein Center for Computational Neuroscience Project D1; Max-Planck-Gesellschaft, grant no. 01GQ1005B; and was partially supported by the University of Southern Denmark through its grant to the Centre for BioRobotics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Prof. Florentin Worgotter for fruitful discussions and critics on the manuscript. The research leading to these results has received funding from the European Community's Seventh Framework Programme FP7/2007-2013 (Programme and Theme: ICT-2011.2.1, Cognitive Systems and Robotics) under grant agreement no. 600578 as well as from the Federal Ministry of Education and Research (BMBF) Germany to the Gottingen Bernstein Center for Computational Neuroscience Project D1 and grant no. 01GQ1005B and was partially supported by the University of Southern Denmark through its grant to the Centre for BioRobotics.	Abraham WC, 2003, PHILOS T R SOC B, V358, P735, DOI 10.1098/rstb.2002.1222; Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Barrett AB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000259; Bathellier B, 2012, NEURON, V76, P435, DOI 10.1016/j.neuron.2012.07.008; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Biess A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002182; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BONHOEFFER T, 1989, P NATL ACAD SCI USA, V86, P8113, DOI 10.1073/pnas.86.20.8113; Butz M, 2009, BRAIN RES REV, V60, P287, DOI 10.1016/j.brainresrev.2008.12.023; Chen JY, 2013, J NEUROSCI, V33, P15915, DOI 10.1523/JNEUROSCI.5088-12.2013; Chen JD, 2013, GLIA, V61, P178, DOI 10.1002/glia.22425; Chistiakova M, 2014, NEUROSCIENTIST, V20, P483, DOI 10.1177/1073858414529829; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Clopath C, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000248; De Roo M, 2008, PLOS BIOL, V6, P1850, DOI 10.1371/journal.pbio.0060219; Deneve S, 2016, NAT NEUROSCI, V19, P375, DOI 10.1038/nn.4243; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Doiron B, 2016, NAT NEUROSCI, V19, P383, DOI 10.1038/nn.4242; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Effenberger F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004420; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Fauth M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004031; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Fu M, 2012, NATURE, V483, P92, DOI 10.1038/nature10844; Gjorgjieva J, 2011, P NATL ACAD SCI USA, V108, P19383, DOI 10.1073/pnas.1105933108; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Graupner M, 2012, P NATL ACAD SCI USA, V109, P3991, DOI 10.1073/pnas.1109359109; Han EB, 2013, J NEUROSCI, V33, P1314, DOI 10.1523/JNEUROSCI.3219-12.2013; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Higley MJ, 2008, NEURON, V59, P902, DOI 10.1016/j.neuron.2008.08.020; Huang Y Y, 1994, Learn Mem, V1, P74; Ismailov I, 2004, J NEUROSCI, V24, P9847, DOI 10.1523/JNEUROSCI.0738-04.2004; Jia HB, 2014, P NATL ACAD SCI USA, V111, P9277, DOI 10.1073/pnas.1408525111; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Kampa BM, 2006, J PHYSIOL-LONDON, V574, P283, DOI 10.1113/jphysiol.2006.111062; Kastellakis G, 2015, PROG NEUROBIOL, V126, P19, DOI 10.1016/j.pneurobio.2014.12.002; Kobayashi R, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.009.2009; Koch Christof, 1999, P1; Larkum ME, 2008, CURR OPIN NEUROBIOL, V18, P321, DOI 10.1016/j.conb.2008.08.013; Lee KFH, 2016, NEURON, V89, P784, DOI 10.1016/j.neuron.2016.01.012; Legenstein R, 2011, J NEUROSCI, V31, P10787, DOI 10.1523/JNEUROSCI.5684-10.2011; Lisman J, 2005, NAT NEUROSCI, V8, P839, DOI 10.1038/nn0705-839; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Lovatt D, 2012, P NATL ACAD SCI USA, V109, P6265, DOI 10.1073/pnas.1120997109; LYNCH GS, 1977, NATURE, V266, P737, DOI 10.1038/266737a0; Magee JC, 2005, CURR OPIN NEUROBIOL, V15, P334, DOI 10.1016/j.conb.2005.05.013; Makino H, 2011, NEURON, V72, P1001, DOI 10.1016/j.neuron.2011.09.036; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALSBURG CV, 1973, KYBERNETIK, V14, P85, DOI 10.1007/BF00288907; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; Miner D, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004759; Mizuno T, 2001, EUR J NEUROSCI, V14, P701, DOI 10.1046/j.0953-816x.2001.01679.x; Murthy VN, 2000, P NATL ACAD SCI USA, V97, P901, DOI 10.1073/pnas.97.2.901; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; Neveu D, 1996, J NEUROPHYSIOL, V75, P2157, DOI 10.1152/jn.1996.75.5.2157; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Oh WC, 2015, CELL REP, V10, P162, DOI 10.1016/j.celrep.2014.12.016; OJA E, 1982, J MATH BIOL, V15, P267, DOI 10.1007/BF00275687; Papper M, 2011, LEARN MEMORY, V18, P58, DOI 10.1101/lm.2024811; Pfister JP, 2006, J NEUROSCI, V26, P9673, DOI 10.1523/JNEUROSCI.1425-06.2006; Poort J, 2015, NEURON, V86, P1478, DOI 10.1016/j.neuron.2015.05.037; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; Reymann KG, 2007, NEUROPHARMACOLOGY, V52, P24, DOI 10.1016/j.neuropharm.2006.07.026; ROCHESTER N, 1956, IRE T INFORM THEOR, V2, P80, DOI 10.1109/TIT.1956.1056810; Rogerson T, 2014, NAT REV NEUROSCI, V15, P157, DOI 10.1038/nrn3667; Rose CR, 2001, NEURON, V31, P519, DOI 10.1016/S0896-6273(01)00402-0; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Sajikumar S, 2007, J NEUROSCI, V27, P5068, DOI 10.1523/JNEUROSCI.4940-06.2007; Sajikumar S, 2014, P NATL ACAD SCI USA, V111, P12217, DOI 10.1073/pnas.1403643111; SCHILLER J, 1995, J PHYSIOL-LONDON, V487, P583, DOI 10.1113/jphysiol.1995.sp020902; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; SEJNOWSKI IJ, 1977, J THEOR BIOL, V69, P385, DOI 10.1016/0022-5193(77)90146-1; SEJNOWSKI TJ, 1977, J MATH BIOL, V4, P303, DOI 10.1007/BF00275079; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Tetzlaff C, 2015, SCI REP-UK, V5, DOI 10.1038/srep12866; Tetzlaff C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003307; Tetzlaff C, 2012, BIOL CYBERN, V106, P715, DOI 10.1007/s00422-012-0529-z; Tetzlaff C, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00047; Tetzlaff C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001013; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Volgushev M, 2000, EUR J NEUROSCI, V12, P4255, DOI 10.1046/j.0953-816X.2000.01322.x; Yamauchi S, 2011, FRONT COMPUT NEUROSC, V5, DOI [10.3389/fncom.2011.00042, 10.3389/fncom.2011.00029]; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yeung LC, 2004, P NATL ACAD SCI USA, V101, P14943, DOI 10.1073/pnas.0405555101; Yger P, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00138; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Ziegler L, 2015, J NEUROSCI, V35, P1319, DOI 10.1523/JNEUROSCI.3989-14.2015	97	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161679	10.1371/journal.pone.0161679	http://dx.doi.org/10.1371/journal.pone.0161679			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560350	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258600079
J	Ripich, T; Chacon-Martinez, CA; Fischer, L; Pernis, A; Kiessling, N; Garbe, AI; Jessberger, R				Ripich, Tatsiana; Chacon-Martinez, Carlos Andres; Fischer, Luise; Pernis, Alessandra; Kiessling, Nadine; Garbe, Annette I.; Jessberger, Rolf			SWEF Proteins Distinctly Control Maintenance and Differentiation of Hematopoietic Stem Cells	PLOS ONE			English	Article							BONE-MARROW; T-CELLS; SWAP-70; ACTIN; SYSTEM	SWAP-70 and DEF6, two proteins that feature similar domain and motif arrangements, are mainly known for their functions in differentiated hematopoietic cells. Both proteins interact with and regulate RhoGTPases and F-actin dynamics, yet their role in hematopoietic stem and precursor cells (HSPCs) remained unexplored. Here, the role of the SWEF proteins SWAP-70 and DEF6 in HSPCs was examined. Both SWEF proteins are expressed in HSCs. HSCs and different precursor populations were analyzed in mice deficient for SWAP-70, DEF6, SWAP-70 and DEF6 (double knockout, DKO), and wild-type controls. HSPCs isolated from these strains were used for competitive adoptive transfer into irradiated wild-type mice. Reconstitution of the myeloid and lymphoid lineages in the recipient mice was determined. The numbers of HSPCs in the bone marrow of Swap-70(-/-) and Swap-70(-/-) Def6(-/-) mice were >3-fold increased. When transplanted into lethally irradiated wild-type recipients, the reconstitution potential of Swap-70(-/-) HSPCs was intrinsically impaired in competing with wild-type HSPCs for contribution to hematopoiesis. Def6(-/-) HSPCs show wild type-like reconstitution potential under the same transplantation conditions. DKO HSPCs reconstituted to only 25% of wild-type levels, indicating a partial rescue by DEF6 deficiency in the Swap-70(-/-) background. Our study reveals the two SWEF proteins as important contributors to HSPC biology. Despite their similarity these two proteins regulate HSC/progenitor homeostasis, self-renewal, lineage contributions and repopulation in a distinct and mostly antagonistic manner.	[Ripich, Tatsiana; Chacon-Martinez, Carlos Andres; Kiessling, Nadine; Garbe, Annette I.; Jessberger, Rolf] Tech Univ Dresden, Inst Physiol Chem, D-01307 Dresden, Germany; [Fischer, Luise; Garbe, Annette I.] Tech Univ Dresden, Osteoimmunol, CRTD, D-01307 Dresden, Germany; [Pernis, Alessandra] Hosp Special Surg, Autoimmun & Inflammat Program, New York, NY 10021 USA; [Chacon-Martinez, Carlos Andres] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Max Planck Society	Jessberger, R (corresponding author), Tech Univ Dresden, Inst Physiol Chem, D-01307 Dresden, Germany.	rolf.jessberger@tu-dresden.de	Garbe, Annette I/A-4824-2014; Chacón-Martínez, Carlos Andrés/L-1782-2019		DFG (Deutsche Forschungsgemeninschaft) [SFB655, GA1576/1-1/2 (SPP1468 IMMUNOBONE)]; DFG-Center for Regenerative Therapies Dresden, Cluster of Excellence [FZT 111]	DFG (Deutsche Forschungsgemeninschaft); DFG-Center for Regenerative Therapies Dresden, Cluster of Excellence(German Research Foundation (DFG))	This work was supported by a grant to RJ through the DFG (Deutsche Forschungsgemeninschaft) SFB655, and by DFG GA1576/1-1/2 (SPP1468 IMMUNOBONE) to RJ and AIG, and by the FZT 111 (DFG-Center for Regenerative Therapies Dresden, Cluster of Excellence) to AIG.	Becart S, 2007, J CLIN INVEST, V117, P2164, DOI 10.1172/JCI31640; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Biswas PS, 2012, J EXP MED, V209, P581, DOI 10.1084/jem.20111195; Borggrefe T, 1998, J BIOL CHEM, V273, P17025, DOI 10.1074/jbc.273.27.17025; Chacon-Martinez CA, 2013, J BIOL CHEM, V288, P28687, DOI 10.1074/jbc.M113.461277; Chen QZ, 2009, J LEUKOCYTE BIOL, V85, P539, DOI 10.1189/jlb.0308219; Chopin M, 2010, EUR J IMMUNOL, V40, P3544, DOI 10.1002/eji.201040556; Feau S, 2013, J IMMUNOL, V190, P174, DOI 10.4049/jimmunol.1201685; Garbe AI, 2012, J BONE MINER RES, V27, P2085, DOI 10.1002/jbmr.1670; Gupta S, 2003, HUM IMMUNOL, V64, P389, DOI 10.1016/S0198-8859(03)00024-7; Hotfilder M, 1999, BRIT J HAEMATOL, V106, P335, DOI 10.1046/j.1365-2141.1999.01551.x; Ihara S, 2006, J CELL SCI, V119, P500, DOI 10.1242/jcs.02767; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; Ocana-Morgner C, 2009, BLOOD, V113, P1474, DOI 10.1182/blood-2008-04-152587; Pearce G, 2006, NAT IMMUNOL, V7, P827, DOI 10.1038/ni1365; Pearce G, 2011, BLOOD, V117, P1574, DOI 10.1182/blood-2010-07-295659; Quemeneur L, 2008, BLOOD, V111, P2714, DOI 10.1182/blood-2007-07-102822; Ripich T, 2011, HAEMATOL-HEMATOL J, V96, P1743, DOI 10.3324/haematol.2011.050468; Shinohara M, 2002, NATURE, V416, P759, DOI 10.1038/416759a; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Tanaka Y, 2003, IMMUNITY, V18, P403, DOI 10.1016/S1074-7613(03)00054-2; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; Wakamatsu I, 2006, MOL CELL BIOCHEM, V293, P137, DOI 10.1007/s11010-006-9236-1; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159	24	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161060	10.1371/journal.pone.0161060	http://dx.doi.org/10.1371/journal.pone.0161060			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27561029	Green Published, Green Submitted, gold			2022-12-26	WOS:000382258600026
J	Sanchez, MI; Paredes, I; Lebouvier, M; Green, AJ				Sanchez, Marta I.; Paredes, Irene; Lebouvier, Marion; Green, Andy J.			Functional Role of Native and Invasive Filter-Feeders, and the Effect of Parasites: Learning from Hypersaline Ecosystems	PLOS ONE			English	Article							AMERICAN BRINE SHRIMP; GREAT-SALT-LAKE; ARTEMIA-FRANCISCANA; SALINITY GRADIENT; FOOD-WEB; POPULATION-DYNAMICS; AVIAN CESTODES; FEEDING RATES; PARTHENOGENETICA; SURVIVAL	Filter-feeding organisms are often keystone species with a major influence on the dynamics of aquatic ecosystems. Studies of filtering rates in such taxa are therefore vital in order to understand ecosystem functioning and the impact of natural and anthropogenic stressors such as parasites, climate warming and invasive species. Brine shrimps Artemia spp. are the dominant grazers in hypersaline systems and are a good example of such keystone taxa. Hypersaline ecosystems are relatively simplified environments compared with much more complex freshwater and marine ecosystems, making them suitable model systems to address these questions. The aim of this study was to compare feeding rates at different salinities and temperatures between clonal A. parthenogenetica (native to Eurasia and Africa) and the invasive American brine shrimp A. franciscana, which is excluding native Artemia from many localities. We considered how differences observed in laboratory experiments upscale at the ecosystem level across both spatial and temporal scales (as indicated by chlorophyll-a concentration and turbidity). In laboratory experiments, feeding rates increased at higher temperatures and salinities in both Artemia species and sexes, whilst A. franciscana consistently fed at higher rates. A field study of temporal dynamics revealed significantly higher concentrations of chlorophyll-a in sites occupied by A. parthenogenetica, supporting our experimental findings. Artemia parthenogenetica density and biomass were negatively correlated with chlorophyll-a concentration at the spatial scale. We also tested the effect of cestode parasites, which are highly prevalent in native Artemia but much rarer in the invasive species. The cestodes Flamingolepis liguloides and Anomotaenia tringae decreased feeding rates in native Artemia, whilst Confluaria podicipina had no significant effect. Total parasite prevalence was positively correlated with turbidity. Overall, parasites are likely to reduce feeding rates in the field, and their negative impact on host fecundity is likely to exacerbate the difference between grazing rates of native and alien Artemia populations at the ecosystem level. The results of this study provide evidence for the first time that the replacement of native Artemia by A. franciscana may havemajor consequences for the functioning of hypersaline ecosystems. The strong effect of parasites on feeding rate underlines the importance of taking parasites into account in order to improve our understanding of the functioning of aquatic ecosystems.	[Sanchez, Marta I.; Paredes, Irene; Lebouvier, Marion; Green, Andy J.] CSIC, EBD, Dept Wetland Ecol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Sanchez, MI (corresponding author), CSIC, EBD, Dept Wetland Ecol, Seville, Spain.	marta.sanchez@ebd.csic.es	Sánchez, Marta I/E-9723-2010; Green, Andy J/A-5189-2008	Sánchez, Marta I/0000-0002-8349-5410; Green, Andy J/0000-0002-1268-4951	Ramon y Cajal postdoctoral contract from the Spanish Ministry of Science and Innovation; Spanish Ministry of Science and Innovation [CGL2010-16028, CGL2013-47674-P]	Ramon y Cajal postdoctoral contract from the Spanish Ministry of Science and Innovation; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	MIS was supported by a Ramon y Cajal postdoctoral contract from the Spanish Ministry of Science and Innovation. This research was supported by projects CGL2010-16028 and CGL2013-47674-P funded by the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAT F, 1991, HYDROBIOLOGIA, V212, P39, DOI 10.1007/BF00025985; Amat F, 2005, BIOL INVASIONS, V7, P37, DOI 10.1007/s10530-004-9634-9; Amat Francisco, 2007, Limnetica, V26, P387; APHA A, 1985, STANDARD METHODS EXA; Bastviken DTE, 1998, FRESHWATER BIOL, V39, P375, DOI 10.1046/j.1365-2427.1998.00283.x; Benlloch S, 2002, ENVIRON MICROBIOL, V4, P349, DOI 10.1046/j.1462-2920.2002.00306.x; Blanco S, 2004, INT REV HYDROBIOL, V89, P250, DOI 10.1002/iroh.200310684; Browne RA, 2000, J EXP MAR BIOL ECOL, V244, P29, DOI 10.1016/S0022-0981(99)00125-2; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; Casamayor EO, 2002, ENVIRON MICROBIOL, V4, P338, DOI 10.1046/j.1462-2920.2002.00297.x; Coop RL, 1996, INT J PARASITOL, V26, P951, DOI 10.1016/S0020-7519(96)80070-1; Crompton DWT, 1970, ECOLOGICAL APPROACH; Dahesht L.E., 2013, Brazilian Journal of Aquatic Science and Technology, V17, P1; Dick JTA, 2014, BIOL INVASIONS, V16, P735, DOI 10.1007/s10530-013-0550-8; Estrada M, 2004, FEMS MICROBIOL ECOL, V49, P281, DOI 10.1016/j.femsec.2004.04.002; Evjemo JO, 1992, THESIS, P98; Exton MS, 1997, APPETITE, V29, P369, DOI 10.1006/appe.1997.0116; Georgiev BB, 2007, PARASITOL RES, V101, P1647, DOI 10.1007/s00436-007-0708-3; Georgiev BB, 2005, ACTA PARASITOL, V50, P105; Georgiev BB, 2014, ACTA PARASITOL, V59, P380, DOI 10.2478/s11686-014-0255-x; Gliwicz ZM, 2010, HYDROBIOLOGIA, V653, P103, DOI 10.1007/s10750-010-0347-z; Hernandez AD, 2008, INT J PARASITOL, V38, P683, DOI 10.1016/j.ijpara.2007.09.008; Holmes J.C., 1990, P34; Hudson PJ, 2006, TRENDS ECOL EVOL, V21, P381, DOI 10.1016/j.tree.2006.04.007; Joint I, 2002, FEMS MICROBIOL ECOL, V39, P245, DOI 10.1111/j.1574-6941.2002.tb00927.x; JURGENS K, 1994, MAR ECOL PROG SER, V112, P169, DOI 10.3354/meps112169; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kimbro DL, 2009, OECOLOGIA, V160, P563, DOI 10.1007/s00442-009-1322-0; Lefevre T, 2009, TRENDS ECOL EVOL, V24, P41, DOI 10.1016/j.tree.2008.08.007; Lenz P.H., 1987, P5; Makridis P, 1999, J PLANKTON RES, V21, P2191, DOI 10.1093/plankt/21.11.2191; Migliore L, 1993, INT J SALT LAKE RES, V2, P141; Mohebbi Fereidun, 2010, International Journal of Aquatic Science, V1, P19; Munoz J, 2008, MOL ECOL, V17, P3160, DOI 10.1111/j.1365-294X.2008.03818.x; Pedros-Alio C, 2000, FEMS MICROBIOL ECOL, V32, P143, DOI 10.1016/S0168-6496(00)00025-8; Persson J, 2007, OIKOS, V116, P1152, DOI 10.1111/j.2007.0030-1299.15639.x; POULIN R, 1994, PARASITOLOGY, V109, pS109, DOI 10.1017/S0031182000085127; PROVASOLI L, 1959, BIOL BULL, V117, P347, DOI 10.2307/1538914; Redon S, 2015, FOLIA PARASIT, V62; Redon S, 2015, AQUAT INVASIONS, V10, P415, DOI 10.3391/ai.2015.10.4.05; Redon S, 2015, PEERJ, V3, DOI 10.7717/peerj.1073; REEVE MR, 1963, J EXP BIOL, V40, P207; Rehage JS, 2005, ECOL FRESHW FISH, V14, P352, DOI 10.1111/j.1600-0633.2005.00109.x; Sanchez MI, 2007, BEHAV PROCESS, V74, P293, DOI 10.1016/j.beproc.2006.11.002; Sanchez MI, 2006, PARASITOL RES, V100, P111, DOI 10.1007/s00436-006-0248-2; Sanchez MI, 2012, BIOL INVASIONS, V14, P1819, DOI 10.1007/s10530-012-0192-2; Sanchez MI, 2006, ARCH HYDROBIOL, V166, P199, DOI 10.1127/0003-9136/2006/0166-0199; Sanchez MI, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005459; Sanchez MI, 2016, PEERJ, V4, DOI 10.7717/peerj.1703; Sanchez MI, 2013, PARASITOL RES, V112, P1913, DOI 10.1007/s00436-013-3347-x; Sanchez MI, 2013, INT J PARASITOL, V43, P73, DOI 10.1016/j.ijpara.2012.11.003; Sanchez MI, 2009, J PARASITOL, V95, P20, DOI 10.1645/GE-1550.1; Sanchez MI, 2009, ETHOLOGY, V115, P196, DOI 10.1111/j.1439-0310.2008.01601.x; Savage Alan, 1998, International Journal of Salt Lake Research, V7, P1; Shirdhankar M.M., 2003, Asian Fisheries Science, V16, P69; SICK LV, 1976, MAR BIOL, V35, P69, DOI 10.1007/BF00386675; SIMS GK, 1995, COMMUN SOIL SCI PLAN, V26, P303, DOI 10.1080/00103629509369298; Stein RA, 1995, CAN J FISH AQUAT SCI, V52, P2518, DOI 10.1139/f95-842; Strickland JDH, 1968, B FISH RES BD CAN, V16; Thomas F, 2010, OIKOS, V119, P1217, DOI 10.1111/j.1600-0706.2009.18077.x; TRIANTAPHYLLIDIS GV, 1995, HYDROBIOLOGIA, V302, P215, DOI 10.1007/BF00032111; Vanhaecke P, 1984, J EXP MAR BIOL ECOL, V98, P167; Varo I, 2015, AQUAT TOXICOL, V161, P208, DOI 10.1016/j.aquatox.2015.02.008; Varo N, 2011, HYDROBIOLOGIA, V664, P163, DOI 10.1007/s10750-010-0596-x; Vasileva GP, 2009, ACTA PARASITOL, V54, P143, DOI 10.2478/s11686-009-0025-3; Wurtsbaugh WA, 2001, HYDROBIOLOGIA, V466, P119, DOI 10.1023/A:1014502510903; WURTSBAUGH WA, 1990, CAN J FISH AQUAT SCI, V47, P100, DOI 10.1139/f90-010; WURTSBAUGH WA, 1992, OECOLOGIA, V89, P168, DOI 10.1007/BF00317215	68	21	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161478	10.1371/journal.pone.0161478	http://dx.doi.org/10.1371/journal.pone.0161478			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560978	gold, Green Published, Green Submitted			2022-12-26	WOS:000382258600045
J	Toro, JF; Salgado, DM; Vega, R; Rodriguez, JA; Rodriguez, LS; Angel, J; Franco, MA; Greenberg, HB; Naravez, CF				Toro, Jessica F.; Salgado, Doris M.; Vega, Rocio; Rodriguez, Jairo A.; Rodriguez, Luz-Stella; Angel, Juana; Franco, Manuel A.; Greenberg, Harry B.; Naravez, Carlos F.			Total and Envelope Protein-Specific Antibody-Secreting Cell Response in Pediatric Dengue Is Highly Modulated by Age and Subsequent Infections	PLOS ONE			English	Article							MEMORY B-CELLS; VIRUS-INFECTION; IGM; GLYCOPROTEIN; EXPRESSION; RECEPTORS; PHENOTYPE; CYTOKINES; SUBSETS; HUMANS	The response of antibody-secreting cells (ASC) induced by dengue has only recently started to be characterized. We propose that young age and previous infections could be simple factors that affect this response. Here, we evaluated the primary and secondary responses of circulating ASC in infants (6-12 months old) and children (1-14 years old) infected with dengue showing different degrees of clinical severity. The ASC response was delayed and of lower magnitude in infants, compared with older children. In primary infection (PI), the total and envelope (E) protein-specific IgM ASC were dominant in infants but not in children, and a negative correlation was found between age and the number of IgM ASC (rho = -0.59, P = 0.03). However, infants with plasma dengue-specific IgG detectable in the acute phase developed an intense ASC response largely dominated by IgG and comparable to that of children with secondary infection (SI). IgM and IgG produced by ASC circulating in PI or SI were highly cross-reactive among the four serotypes. Dengue infection caused the disturbance of B cell subsets, particularly a decrease in the relative frequency of naive B cells. Higher frequencies of total and E protein-specific IgM ASC in the infants and IgG in the children were associated with clinically severe forms of infection. Therefore, the ASC response induced by dengue is highly influenced by the age at which infection occurs and previous immune status, and its magnitude is a relevant element in the clinical outcome. These results are important in the search for correlates of protection and for determining the ideal age for vaccinating against dengue.	[Toro, Jessica F.; Salgado, Doris M.; Vega, Rocio; Rodriguez, Jairo A.; Naravez, Carlos F.] Univ Surcolombiana, Fac Salud, Programa Med, Neiva, Colombia; [Toro, Jessica F.; Salgado, Doris M.; Vega, Rocio; Rodriguez, Jairo A.] Hosp Univ Neiva, Dept Pediat, Neiva, Colombia; [Rodriguez, Luz-Stella; Angel, Juana; Franco, Manuel A.] Pontificia Univ Javeriana, Inst Genet Humana, Bogota, Colombia; [Greenberg, Harry B.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Greenberg, Harry B.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Pontificia Universidad Javeriana; Stanford University; Stanford University	Naravez, CF (corresponding author), Univ Surcolombiana, Fac Salud, Programa Med, Neiva, Colombia.	cfnarvaez@usco.edu.co	CORTES, Manuel Antonio FRANCO/M-7517-2014; Angel, Juana/O-2908-2014	CORTES, Manuel Antonio FRANCO/0000-0002-0265-0563; Angel, Juana/0000-0001-6623-5337; Narvaez, Carlos/0000-0003-0129-5210; greenberg, harry/0000-0002-2128-9080; Salgado, Doris Martha/0000-0002-1663-1996; Rodriguez C., Luz-Stella/0000-0003-4990-5807; Rodriguez, Jairo Antonio/0000-0002-1409-7304	COLCIENCIAS, Colombia [112451929053]	COLCIENCIAS, Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was funded by COLCIENCIAS, Colombia, grant 112451929053 to CFN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlowitz DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128269; Arias J, 2014, VIROLOGY, V452, P42, DOI 10.1016/j.virol.2013.12.027; Balakrishnan T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029430; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Castaneda DM, 2016, VIROLOGY, V497, P136, DOI 10.1016/j.virol.2016.07.014; Dalrymple NA, 2012, J VIROL, V86, P6408, DOI 10.1128/JVI.00213-12; Hernandez SID, 2013, J CLIN VIROL, V58, P258, DOI 10.1016/j.jcv.2013.06.016; Dowling DJ, 2014, TRENDS IMMUNOL, V35, P299, DOI 10.1016/j.it.2014.04.007; Duddy M, 2007, J IMMUNOL, V178, P6092, DOI 10.4049/jimmunol.178.10.6092; Garcia-Bates TM, 2013, J IMMUNOL, V190, P80, DOI 10.4049/jimmunol.1103350; Gonzalez AM, 2003, VIROLOGY, V305, P93, DOI 10.1006/viro.2002.1708; Goriely S, 2004, J EXP MED, V199, P1011, DOI 10.1084/jem.20031272; Guzman MG, 2000, AM J EPIDEMIOL, V152, P793, DOI 10.1093/aje/152.9.793; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170; Halstead SB, 2012, PAEDIATR INT CHILD H, V32, P5, DOI 10.1179/2046904712Z.00000000045; Hong S, 2013, J IMMUNOL, V191, P127, DOI 10.4049/jimmunol.1203540; Hunsperger EA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003171; INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418; Hernandez SID, 2013, J CLIN VIROL, V58, P751, DOI 10.1016/j.jcv.2013.09.026; Kaur K, 2007, BLOOD, V110, P2948, DOI 10.1182/blood-2007-01-069245; Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lee FEH, 2010, J INFECT DIS, V202, P1659, DOI 10.1086/657158; Narvaez CF, 2010, J VIROL, V84, P4543, DOI 10.1128/JVI.02550-09; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; Sanz I, 2008, SEMIN IMMUNOL, V20, P67, DOI 10.1016/j.smim.2007.12.006; Siegrist CA, 2009, NAT REV IMMUNOL, V9, P185, DOI 10.1038/nri2508; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Valdes K, 2000, CLIN DIAGN LAB IMMUN, V7, P856, DOI 10.1128/CDLI.7.5.856-857.2000; Valero N, 2014, VIRAL IMMUNOL, V27, P151, DOI 10.1089/vim.2013.0123; Valero N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073221; Dang VD, 2014, CURR OPIN IMMUNOL, V28, P77, DOI 10.1016/j.coi.2014.02.009; Watanaveeradej V, 2003, AM J TROP MED HYG, V69, P123, DOI 10.4269/ajtmh.2003.69.123; Wei CW, 2011, CYTOM PART A, V79A, P894, DOI 10.1002/cyto.a.21112; Willems F, 2009, EUR J IMMUNOL, V39, P26, DOI 10.1002/eji.200838391; World Health Organization, 2009, DENGUE GUIDELINES DI; Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11; Xu MH, 2012, J IMMUNOL, V189, P5877, DOI 10.4049/jimmunol.1201688; Zompi S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001568	41	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161795	10.1371/journal.pone.0161795	http://dx.doi.org/10.1371/journal.pone.0161795			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560782	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258600102
J	Yang, CH; Yang, PC; Li, J; Yang, F; Zhang, AB				Yang, Cong-Hui; Yang, Peng-Cheng; Li, Jing; Yang, Fan; Zhang, Ai-Bing			Transcriptome Characterization of Dendrolimus punctatus and Expression Profiles at Different Developmental Stages	PLOS ONE			English	Article							BOMBYX-MORI; PINE MOTH; GENE; PROTEIN; RNA; IDENTIFICATION; EMBRYOS; LASIOCAMPIDAE; LEPIDOPTERA; AUTOPHAGY	The pine moth Dendrolimus punctatus (Walker) is a common insect pest that confers serious damage to conifer forests in south of China. Extensive physiology and ecology studies on D. punctatus have been carried out, but the lack of genetic information has limited our understanding of the molecular mechanisms behind its development and resistance. Using RNA-seq approach, we characterized the transcriptome of this pine moth and investigated its developmental expression profiles during egg, larval, pupal, and adult stages. A total of 107.6 million raw reads were generated that were assembled into 70,664 unigenes. More than 30% unigenes were annotated by searching for homology in protein databases. To better understand the process of metamorphosis, we pairwise compared four developmental phases and obtained 17,624 differential expression genes. Functional enrichment analysis of differentially expressed genes showed positive correlation with specific physiological activities of each stage, and these results were confirmed by qRT-PCR experiments. This study provides a valuable genomic resource of D. punctatus covering all its developmental stages, and will promote future studies on biological processes at the molecular level.	[Yang, Cong-Hui; Li, Jing; Yang, Fan; Zhang, Ai-Bing] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Yang, Peng-Cheng] Chinese Acad Sci, Beijing Inst Life Sci, Beijing, Peoples R China	Capital Normal University; Chinese Academy of Sciences	Zhang, AB (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	zhangab2008@mail.cnu.edu.cn	; Yang, Pengcheng/N-1037-2014	zhang, ai bing/0000-0002-6580-5462; Yang, Pengcheng/0000-0001-5496-8357; ZHANG, Ai-bing/0000-0003-3450-5421	National Science Fund for Distinguished Young Scholars of China [31425023]; Natural Science Foundation of China [31272340]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13081]; Science and Technology Foundation Project [2012FY110803]	National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Science and Technology Foundation Project	This work was supported by The National Science Fund for Distinguished Young Scholars of China (to Zhang, Grant No. 31425023), the Natural Science Foundation of China (to Zhang, Grant No. 31272340), the Program for Changjiang Scholars and Innovative Research Team in University (IRT13081), and a Science and Technology Foundation Project (2012FY110803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio G, 2006, STUD HEALTH TECHNOL, V120, P194; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brody T, 1999, TRENDS GENET, V15, P333, DOI 10.1016/S0168-9525(99)01775-8; Chai CL, 2010, SCI SERICULTURE, V36, P25; Chen C, 1990, SPECIES GEOGRAPHIC D; Chen SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015633; Chung KT, 2000, EUR J BIOCHEM, V267, P677, DOI 10.1046/j.1432-1327.2000.01034.x; Dai QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032544; Delon I, 2004, TRENDS GENET, V20, P305, DOI 10.1016/j.tig.2004.05.003; Enserink JM, 2010, OVERVIEW CDK1 CONTRO; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Futahashi R, 2008, INSECT BIOCHEM MOLEC, V38, P1138, DOI 10.1016/j.ibmb.2008.05.007; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hou T.Q, 1987, INTRO PINE CATERPILL; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; JIANG Z, 1986, BIOCHIM BIOPHYS ACTA, V882, P427; JONES MEE, 1995, DEV BIOL, V169, P436, DOI 10.1006/dbio.1995.1159; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kong XB, 2001, CHINESE SCI BULL, V46, P2077; Li SW, 2012, CNAPHALOCROSIS MEDIN, V7, DOI [10.1371/journal.pone.0047401, DOI 10.1371/JOURNAL.PONE.0047401]; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATSUURA S, 1976, Cell Structure and Function, V1, P223; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moussian B, 2005, J MORPHOL, V264, P117, DOI 10.1002/jmor.10324; Moussian B, 2010, INSECT BIOCHEM MOLEC, V40, P363, DOI 10.1016/j.ibmb.2010.03.003; NEWMARK PA, 1994, DEVELOPMENT, V120, P1303; Nie Hong-Yi, 2010, Acta Entomologica Sinica, V53, P369; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Qin J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1566-5; Raz E, 2000, GENOME BIOL, V1, P1, DOI [10.1186/gb-2000-1-3-reviews1017, DOI 10.1186/GB-2000-1-3-REVIEWS1017]; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Romanelli D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/902315; ROTH S, 1993, DEVELOPMENT, V117, P1385; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Sanson B, 2001, EMBO REP, V2, P1083, DOI 10.1093/embo-reports/kve255; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Sotillos S, 2005, DEV DYNAM, V232, P738, DOI 10.1002/dvdy.20270; TASHIRO Y, 1976, Cell Structure and Function, V1, P205; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Telfer WH, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.5001; Tettamanti G, 2008, CURR PHARM DESIGN, V14, P116, DOI 10.2174/138161208783378716; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TSAI P. H., 1958, ACTA ENT SINICA, V8, P327; TSAI Pang-hua, 1961, Acta Entomologica Sinica, V10, P355; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Weers PMM, 2003, INSECT BIOCHEM MOLEC, V33, P1249, DOI 10.1016/j.ibmb.2003.06.013; Wen Xiaoshui, 1993, Acta Agriculturae Universitatis Jiangxiensis, V15, P461; Wong YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033323; Yoon C, 1997, DEVELOPMENT, V124, P3157; Zhang AB, 2003, APPL ENTOMOL ZOOL, V38, P177, DOI 10.1303/aez.2003.177; Zhang AB, 2003, J BEIJING FORESTRY U, V26, P54; Zhang AB, 2003, ACTA ENTOMOL SINICA, V47, P236; Zhang AB, 2004, CHINESE BULL ENTOMOL, V2, P146, DOI DOI 10.3969/j.issn.0452-8255.2004.02.011; Zhang Qi-Lin, 2013, Acta Entomologica Sinica, V56, P1489; Zhang SF, 2014, INSECT SCI, V21, P597, DOI 10.1111/1744-7917.12074; Zhao GL, 2008, GENE EXPR PATTERNS, V8, P254, DOI 10.1016/j.gep.2007.12.006; Zhu QiangLong, 2014, Journal of Northeast Agricultural University (English Edition), V21, P84	62	14	15	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0161667	10.1371/journal.pone.0161667	http://dx.doi.org/10.1371/journal.pone.0161667			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NN	27560151	gold, Green Published, Green Submitted			2022-12-26	WOS:000382258600078
J	Nguyen, TT; Quan, XL; Xu, SH; Das, R; Cha, SK; Kong, ID; Shong, M; Wollheim, CB; Park, KS				Tuyet Thi Nguyen; Quan, Xianglan; Xu, Shanhua; Das, Ranjan; Cha, Seung-Kuy; Kong, In Deok; Shong, Minho; Wollheim, Claes B.; Park, Kyu-Sang			Intracellular alkalinization by phosphate uptake via type III sodium-phosphate cotransporter participates in high-phosphate-induced mitochondrial oxidative stress and defective insulin secretion	FASEB JOURNAL			English	Article						inorganic phosphate; pancreatic beta cells; mitochondrial permeability transition; endoplasmic reticulum stress; superoxide	PERMEABILITY TRANSITION PORE; INORGANIC-PHOSPHATE; BETA-CELLS; KLOTHO; CALCIFICATION; STIMULATION; METABOLISM; FLUORESCENCE; HOMEOSTASIS; GENERATION	Elevated plasma levels of inorganic phosphate (Pi) are harmful, causing, among other complications, vascular calcification and defective insulin secretion. The underlying molecular mechanisms of these complications remain poorly understood. We demonstrated the role of Pi transport across the plasmalemma on Pi toxicity in INS-1E rat clonal beta cells and rat pancreatic islet cells. Type III sodium-phosphate cotransporters (NaP(i)s) are the predominant P-i transporters expressed in insulin-secreting cells. Transcript and protein levels of sodium-dependent phosphate transporter 1 and 2 (PiT-1and -2), isotypes of type III NaPi, were up-regulated by high-Pi incubation. In patch-clamp experiments, extracellular P-i elicited a Na+-dependent, inwardly rectifying current, which was markedly reduced under acidic extracellular conditions. Cellular uptake of P-i elicited cytosolic alkalinization; intriguingly, this pH change facilitated P-i transport into the mitochondrial matrix. Increased mitochondrial P-i uptake accelerated superoxide generation, mitochondrial permeability transition (mPT), and endoplasmic reticulum stress-mediated translational attenuation, leading to reduced insulin content and impaired glucose-stimulated insulin secretion. Silencing of PiT-1/2 prevented Pi-induced superoxide generation and mPT, and restored insulin secretion. We propose that P-i transport across the plasma membrane and consequent cytosolic alkalinization could be a therapeutic target for protection from P-i toxicity in insulin-secreting cells, as well as in other cell types.-Nguyen, T. T., Quan, X., Xu, S., Das, R., Cha, S.-K., Kong, I. D., Shong, M., Wollheim, C. B., Park, K.-S. Intracellular alkalinization by phosphate uptake via type III sodium-phosphate cotransporter participates in high-phosphate-induced mitochondrial oxidative stress and defective insulin secretion.	[Tuyet Thi Nguyen; Quan, Xianglan; Xu, Shanhua; Das, Ranjan; Cha, Seung-Kuy; Kong, In Deok; Park, Kyu-Sang] Yonsei Univ, Wonju Coll Med, Dept Physiol, Wonju, South Korea; [Tuyet Thi Nguyen] Yonsei Univ, Wonju Coll Med, Mitohormesis Translat Res Ctr, Wonju, South Korea; [Tuyet Thi Nguyen] Tan Tao Univ, Dept Physiol, Coll Med, Long An, Vietnam; [Shong, Minho] Chungnam Natl Univ, Sch Med, Res Ctr Endocrine & Metab Dis, Daejeon, South Korea; [Wollheim, Claes B.] Univ Geneva, Dept Cell Physiol & Metab, Geneva, Switzerland	Yonsei University; Yonsei University; Chungnam National University; University of Geneva	Park, KS (corresponding author), Yonsei Univ, Dept Physiol, Mitohormesis Translat Res Ctr, Wonju Coll Med, Ilsan Ro 20, Wonju 26426, Gangwon Do, South Korea.	qsang@yonsei.ac.kr	/H-7803-2012; Das, Ranjan/AFQ-6329-2022; DAS, RANJAN/ABE-4002-2021	Das, Ranjan/0000-0002-7951-4121; Park, Kyu-Sang/0000-0003-0322-9807; shong, minho/0000-0002-0247-7115; Wollheim, Claes/0000-0002-4570-9879	Korean National Research Foundation (NRF) - Ministry of Science, Information and Communications Technology, and Future Planning [NRF-2014M3A9D8034464]	Korean National Research Foundation (NRF) - Ministry of Science, Information and Communications Technology, and Future Planning	This work was supported in part by a grant from the Korean National Research Foundation (NRF) funded by the Ministry of Science, Information and Communications Technology, and Future Planning (NRF-2014M3A9D8034464) (to M.S.).	Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Back SH, 2012, EXP DIABETES RES, DOI 10.1155/2012/618396; Bose S, 2003, J BIOL CHEM, V278, P39155, DOI 10.1074/jbc.M306409200; BUKOWIECKI L, 1979, BIOCHIM BIOPHYS ACTA, V583, P370, DOI 10.1016/0304-4165(79)90461-6; Crouthamel MH, 2013, ARTERIOSCL THROM VAS, V33, P2625, DOI 10.1161/ATVBAHA.113.302249; Di Marco GS, 2013, KIDNEY INT, V83, P213, DOI 10.1038/ki.2012.300; FADDA GZ, 1991, J CLIN INVEST, V87, P255, DOI 10.1172/JCI114979; Forster IC, 2013, MOL ASPECTS MED, V34, P386, DOI 10.1016/j.mam.2012.07.007; Forster IC, 2012, CURR TOP MEMBR, V70, P313, DOI 10.1016/B978-0-12-394316-3.00010-7; Gautier CA, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-22; Gonzalez-Parra E, 2012, CARDIOVASC PATHOL, V21, P372, DOI 10.1016/j.carpath.2012.02.008; Halestrap AP, 2015, FASEB J, V78, P129; HAROOTUNIAN AT, 1989, J BIOL CHEM, V264, P19458; Hu MC, 2013, SEMIN NEPHROL, V33, P118, DOI 10.1016/j.semnephrol.2012.12.013; Jain N, 2013, J NEPHROL, V26, P856, DOI 10.5301/jn.5000242; JANJIC D, 1992, DIABETOLOGIA, V35, P482, DOI 10.1007/BF02342448; Koshkin V, 2004, J BIOL CHEM, V279, P41368, DOI 10.1074/jbc.M406914200; Kuro-o M, 2013, KIDNEY INT SUPPL, V3, P420, DOI 10.1038/kisup.2013.88; Kuro-o M, 2013, NAT REV NEPHROL, V9, P650, DOI 10.1038/nrneph.2013.111; Leibrock CB, 2015, J AM SOC NEPHROL, V26, P2423, DOI 10.1681/ASN.2014030230; Li XW, 2006, CIRC RES, V98, P905, DOI 10.1161/01.RES.0000216409.20863.e7; Lorenzo C, 2014, DIABETOLOGIA, V57, P1366, DOI 10.1007/s00125-014-3241-9; Massry SG, 2001, AM J KIDNEY DIS, V38, pS58, DOI 10.1053/ajkd.2001.27404; Miyamoto KI, 2011, J PHARM SCI-US, V100, P3719, DOI 10.1002/jps.22614; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Penido MGMG, 2012, PEDIATR NEPHROL, V27, P2039, DOI 10.1007/s00467-012-2175-z; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; PIERCE M, 1978, ENDOCRINOLOGY, V103, P971, DOI 10.1210/endo-103-3-971; Quan XL, 2015, J BIOL CHEM, V290, P4086, DOI 10.1074/jbc.M114.632547; Quan X, 2013, MOL CELL ENDOCRINOL, V381, P198, DOI 10.1016/j.mce.2013.08.003; Razzaque MS, 2011, CLIN SCI, V120, P91, DOI 10.1042/CS20100377; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Sekiguchi S, 2011, AM J PHYSIOL-RENAL, V300, pF848, DOI 10.1152/ajprenal.00334.2010; Selivanov VA, 2008, J BIOL CHEM, V283, P29292, DOI 10.1074/jbc.M801019200; Takeda E, 2004, BIOFACTORS, V21, P345, DOI 10.1002/biof.552210167; Takeda E, 2004, J CELL MOL MED, V8, P191, DOI 10.1111/j.1582-4934.2004.tb00274.x; Nguyen TT, 2015, AM J PHYSIOL-ENDOC M, V308, pE933, DOI 10.1152/ajpendo.00009.2015; Utsugi T, 2000, METABOLISM, V49, P1118, DOI 10.1053/meta.2000.8606; Werner A, 1998, J EXP BIOL, V201, P3135; Wiederkehr A, 2009, EMBO J, V28, P417, DOI 10.1038/emboj.2008.302; Zorov DB, 2009, CARDIOVASC RES, V83, P213, DOI 10.1093/cvr/cvp151	42	12	13	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					3979	3988		10.1096/fj.201600455RR	http://dx.doi.org/10.1096/fj.201600455RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27565711	Green Published			2022-12-26	WOS:000388201500006
J	Gupta, S; Tang, C; Tran, M; Kadouri, DE				Gupta, Shilpi; Tang, Chi; Tran, Michael; Kadouri, Daniel E.			Effect of Predatory Bacteria on Human Cell Lines	PLOS ONE			English	Article							BDELLOVIBRIO-BACTERIOVORUS; MICAVIBRIO-AERUGINOSAVORUS; ACTIVATED MACROPHAGES; ANIMAL-MODELS; EXPRESSION; RECEPTORS; MONOCYTES; RESPONSES; CYTOKINE; BIOFILMS	Predatory bacteria are Gram-negative bacteria that prey on other Gram-negative bacteria and have been considered as potential therapeutic agents against multi-drug resistant pathogens. In vivo animal models have demonstrated that predatory bacteria are non-toxic and non-immunogenic in rodents. In order to consider the use of predatory bacteria as live antibiotics, it is important to investigate their effect on human cells. The aim of this study was to determine the effect of Bdellovibrio bacteriovorus strains 109J and HD100, and Micavibrio aeruginosavorus strain ARL-13 on cell viability and inflammatory responses of five human cell lines, representative of clinically relevant tissues. We found that the predators were not cytotoxic to any of the human cell lines tested. Microscopic imaging showed no signs of cell detachment, as compared to predator-free cells. In comparison to an E. coli control, exposure to higher concentrations of the predators did not trigger a significant elevation of pro-inflammatory cytokines in four of the five human cell lines tested. Our work underlines the non-pathogenic attributes of predatory bacteria on human cells and highlights their potential use as live antibiotics against human pathogens.	[Gupta, Shilpi; Tran, Michael; Kadouri, Daniel E.] Rutgers Sch Dent Med, Dept Oral Biol, Newark, NJ 07103 USA; [Tang, Chi] Rutgers New Jersey Med Sch, Dept Med, Newark, NJ USA; [Tang, Chi] Rutgers New Jersey Med Sch, Ctr Emerging Pathogens, Newark, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Kadouri, DE (corresponding author), Rutgers Sch Dent Med, Dept Oral Biol, Newark, NJ 07103 USA.	kadourde@sdm.rutgers.edu			Department of the ARMY USAMRAA grant [W81XWH-12-2-0067]; U.S. Army Research Office; Defense Advanced Research Projects Agency [W911NF-15-2-0036]	Department of the ARMY USAMRAA grant; U.S. Army Research Office; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	The research was sponsored by the Department of the ARMY USAMRAA grant #W81XWH-12-2-0067 and by the U.S. Army Research Office and the Defense Advanced Research Projects Agency and accomplished under Cooperative Agreement Number W911NF-15-2-0036 to DEK. The authors would like to thank Robert Shanks and Nancy Connell for reviewing the work and for their constructive comments. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the Army Research Office, DARPA, or the U.S. Government.	ABRAM D, 1974, J BACTERIOL, V118, P663, DOI 10.1128/JB.118.2.663-680.1974; Allen HK, 2014, ANN NY ACAD SCI, V1323, P91, DOI 10.1111/nyas.12468; Atterbury RJ, 2011, APPL ENVIRON MICROB, V77, P5794, DOI 10.1128/AEM.00426-11; Beutler B, 2003, J LEUKOCYTE BIOL, V74, P479, DOI 10.1189/jlb.0203082; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Curfs JHAJ, 1997, CLIN MICROBIOL REV, V10, P742, DOI 10.1128/CMR.10.4.742; Dashiff A, 2011, J APPL MICROBIOL, V110, P431, DOI 10.1111/j.1365-2672.2010.04900.x; Dashiff Aliza, 2009, Open Microbiol J, V3, P87, DOI 10.2174/1874285800903000087; Davidov Y, 2006, ENVIRON MICROBIOL, V8, P2179, DOI 10.1111/j.1462-2920.2006.01101.x; de Waal Malefyt R., 1991, J EXP MED, V174, P1209, DOI DOI 10.1084/JEM.174.5.1209; Dori-Bachash M, 2008, APPL ENVIRON MICROB, V74, P7152, DOI 10.1128/AEM.01736-08; DOYLE MP, 1991, INT J FOOD MICROBIOL, V12, P289, DOI 10.1016/0168-1605(91)90143-D; Dwidar M, 2012, BMB REP, V45, P71, DOI 10.5483/BMBRep.2012.45.2.71; El Fiky A, 2013, HUM IMMUNOL, V74, P1524, DOI 10.1016/j.humimm.2013.08.267; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Kadouri D, 2005, APPL ENVIRON MICROB, V71, P4044, DOI 10.1128/AEM.71.7.4044-4051.2005; Kadouri D, 2007, APPL ENVIRON MICROB, V73, P605, DOI 10.1128/AEM.01893-06; Kadouri DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063397; LAMBINA V A, 1983, Mikrobiologiya, V52, P777; LENZ RW, 1978, ARCH MICROBIOL, V119, P245, DOI 10.1007/BF00405402; MacGowan A, 2001, CLIN INFECT DIS, V33, pS214, DOI 10.1086/321850; Mak IWY, 2014, AM J TRANSL RES, V6, P114; Maruyama M, 2007, BIOL PHARM BULL, V30, P2091, DOI 10.1248/bpb.30.2091; Mizoguchi K, 2003, APPL ENVIRON MICROB, V69, P170, DOI 10.1128/AEM.69.1.170-176.2003; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Mukherjee S, 2016, APPL ENVIRON MICROB, V82, P1653, DOI 10.1128/AEM.03611-15; Rendulic S, 2004, SCIENCE, V303, P689, DOI 10.1126/science.1093027; Saltikov CW, 2003, P NATL ACAD SCI USA, V100, P10983, DOI 10.1073/pnas.1834303100; Schwudke D, 2003, J BIOL CHEM, V278, P27502, DOI 10.1074/jbc.M303012200; Segura M, 2002, CLIN EXP IMMUNOL, V127, P243, DOI 10.1046/j.1365-2249.2002.01768.x; Shanks RMQ, 2014, FUTURE MICROBIOL, V9, P429, DOI [10.2217/FMB.14.19, 10.2217/fmb.14.19]; Shanks RMQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066723; Shatzkes K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12899; Shi YF, 2006, CELL RES, V16, P126, DOI 10.1038/sj.cr.7310017; SHILO M, 1965, J GEN MICROBIOL, V40, P317, DOI 10.1099/00221287-40-3-317; STOLP H, 1963, ANTON VAN LEE J M S, V29, P217, DOI 10.1007/BF02046064; Stolp H., 1962, J PHYTOPATHOL, V45, P364, DOI [10.1111/j.1439-0434.1962.tb02050.x, DOI 10.1111/J.1439-0434.1962.TB02050.X]; Takashiba S, 1999, INFECT IMMUN, V67, P5573, DOI 10.1128/IAI.67.11.5573-5578.1999; Theuretzbacher U, 2012, INT J ANTIMICROB AG, V39, P295, DOI 10.1016/j.ijantimicag.2011.12.006; VERKLOVA Z S, 1973, Gigiena i Sanitariya, V38, P10; Wall RJ, 2008, THERIOGENOLOGY, V69, P2, DOI 10.1016/j.theriogenology.2007.09.030; Wang Z, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-453; WESTERGAARD JM, 1977, APPL ENVIRON MICROB, V34, P506, DOI 10.1128/AEM.34.5.506-511.1977; WESTON SA, 1990, J IMMUNOL METHODS, V133, P87, DOI 10.1016/0022-1759(90)90322-M	44	37	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161242	10.1371/journal.pone.0161242	http://dx.doi.org/10.1371/journal.pone.0161242			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579919	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877400021
J	Hunley, K; Gwin, K; Liberman, B				Hunley, Keith; Gwin, Kiela; Liberman, Brendan			A Reassessment of the Impact of European Contact on the Structure of Native American Genetic Diversity	PLOS ONE			English	Article							SOUTH-AMERICA; POPULATION-STRUCTURE; CENTRAL ANDES; PATTERNS; HISTORY; FLOW; SETTLEMENT; PACKAGE; MEXICO; MTDNA	Our current understanding of pre-Columbian history in the Americas rests in part on several trends identified in recent genetic studies. The goal of this study is to reexamine these trends in light of the impact of post-Columbian admixture and the methods used to study admixture. The previously-published data consist of 645 autosomal microsatellite genotypes from 1046 individuals in 63 populations. We used STRUCTURE to estimate ancestry proportions and tested the sensitivity of these estimates to the choice of the number of clusters, K. We used partial correlation analyses to examine the relationship between gene diversity and geographic distance from Beringia, controlling for non-Native American ancestry (from Africa, Europe and East Asia), and taking into account alternative paths of migration. Principal component analysis and multidimensional scaling were used to investigate the relationships between Andean and non-Andean populations and to explore gene-language correspondence. We found that 1) European and East Asian ancestry estimates decline as K increases, especially in Native Canadian populations, 2) a north-south decline in gene diversity is driven by low diversity in Amazonian and Paraguayan populations, not serial founder effects from Beringia, 3) controlling for non-Native American ancestry, populations in the Andes and Mesoamerica have higher gene diversity than populations in other regions, and 4) patterns of genetic and linguistic diversity are poorly correlated. We conclude that patterns of diversity previously attributed to pre-Columbian processes may in part reflect post-Columbian admixture and the choice of K in STRUCTURE analyses. Accounting for admixture, the pattern of diversity is inconsistent with a north-south founder effect process, though the genetic similarities between Mesoamerican and Andean populations are consistent with rapid dispersal along the western coast of the Americas. Further, even setting aside the disruptive effects of European contact, gene-language congruence is unlikely to have ever existed at the geographic scale analyzed here.	[Hunley, Keith; Gwin, Kiela; Liberman, Brendan] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA	University of New Mexico	Hunley, K (corresponding author), Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA.	khunley@unm.edu		Hunley, Keith/0000-0003-0987-8277	National Science Foundation BCS (the Cultural and Biological Significance of Ethnic Substructure in New Mexican Hispanics) [0962825]	National Science Foundation BCS (the Cultural and Biological Significance of Ethnic Substructure in New Mexican Hispanics)	This work was funded by National Science Foundation BCS #0962825 (the Cultural and Biological Significance of Ethnic Substructure in New Mexican Hispanics).	Alves I, 2016, MOL BIOL EVOL, V33, P946, DOI 10.1093/molbev/msv332; Bodner M, 2012, GENOME RES, V22, P811, DOI 10.1101/gr.131722.111; Bolnick DA, 2004, AM J HUM GENET, V75, P519; Bright W., 1988, AM REFERENCE BOOKS A, V19; Cabana GS, 2014, HUM BIOL, V86, P147; Campbell Lyle, 1997, AM INDIAN LANGUAGES; Chafe W., 1987, CURR ANTHROPOL, V28, P652; Crawford MH, 2001, THE ORIGINS OF NATIV; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fagundes NJR, 2002, AM J PHYS ANTHROPOL, V117, P68, DOI 10.1002/ajpa.10015; Foster M., 1982, LANG SOC, V7, P7; Fuselli S, 2003, MOL BIOL EVOL, V20, P1682, DOI 10.1093/molbev/msg188; Goddard I, 1994, METHOD THEORY INVEST; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; GOLLA V, 1988, AM ANTHROPOL, V90, P434, DOI 10.1525/aa.1988.90.2.02a00320; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; Hill JH, 2001, AM ANTHROPOL, V103, P913, DOI 10.1525/aa.2001.103.4.913; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Hunley K, 2005, P NATL ACAD SCI USA, V102, P1312, DOI 10.1073/pnas.0409301102; Hunley KL, 2007, AM J PHYS ANTHROPOL, V132, P622, DOI 10.1002/ajpa.20542; Hunley K, 2011, AM J PHYS ANTHROPOL, V146, P530, DOI 10.1002/ajpa.21506; Jari Oksanen, 2013, VEGAN COMMUNITY ECOL; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kim S, 2015, COMMUNICATIONS STAT, V22, P665, DOI DOI 10.5351/CSAM.2015.22.6.665; KRAUSS M, 1992, LANGUAGE, V68, P4, DOI 10.1353/lan.1992.0075; Krauss M, 1981, SUBARCTIC HANDBOOK O, V6; Lewis CM, 2008, MOL BIOL EVOL, V25, P478, DOI 10.1093/molbev/msm225; Lewis P. M., 2016, ETHNOLOGUE LANGUAGES, V19th; Luiselli D, 2000, AM J PHYS ANTHROPOL, V113, P5, DOI 10.1002/1096-8644(200009)113:1<5::AID-AJPA2>3.0.CO;2-U; MCMAHON AMS, 1995, T PHILOL SOC, V93, P125, DOI 10.1111/j.1467-968X.1995.tb00438.x; Moreno-Estrada A, 2014, SCIENCE, V344, P1280, DOI 10.1126/science.1251688; Nei M., 1987, MOL EVOLUTIONARY GEN; Neuwirth E, 2011, RCOLORBREWER COLORBR; Nichols J, 1996, LANGUAGE, V72, P336, DOI 10.2307/416653; Nychka D., 2016, FIELDS TOOLS SPATIAL; Pemberton TJ, 2013, G3-GENES GENOM GENET, V3, P891, DOI 10.1534/g3.113.005728; Pritchard JK, 2000, GENETICS, V155, P945; Ray N, 2010, MOL BIOL EVOL, V27, P337, DOI 10.1093/molbev/msp238; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; RIBEIRO Darcy, 1962, POLITICA INDIGENISTA; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Skoglund P, 2015, NATURE, V525, P104, DOI 10.1038/nature14895; Tarazona-Santos E, 2001, AM J HUM GENET, V68, P1485, DOI 10.1086/320601; Verdu P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004530; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Yang NN, 2010, ANN HUM GENET, V74, P525, DOI 10.1111/j.1469-1809.2010.00608.x; Zegura SL, 2004, MOL BIOL EVOL, V21, P164, DOI 10.1093/molbev/msh009	49	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161018	10.1371/journal.pone.0161018	http://dx.doi.org/10.1371/journal.pone.0161018			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EG	27579784	Green Submitted, Green Published, gold			2022-12-26	WOS:000382877400013
J	Gao, HT; Xu, R; Cao, WX; Zhou, X; Yan, YHM; Lu, LG; Xu, Q; Shen, Y				Gao, Hai-Tao; Xu, Run; Cao, Wei-Xin; Zhou, Xu; Yan, Ye-Hui-Mei; Lu, Lingeng; Xu, Qian; Shen, Yang			Food Emulsifier Glycerin Monostearate Increases Internal Exposure Levels of Six Priority Controlled Phthalate Esters and Exacerbates Their Male Reproductive Toxicities in Rats	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; P-GLYCOPROTEIN; DI-(2-ETHYLHEXYL) PHTHALATE; DI(2-ETHYLHEXYL) PHTHALATE; DIETARY EXPOSURE; HUMAN-MILK; PVC TOYS; METABOLITES; CHINA; CHROMATOGRAPHY	Human beings are inevitably exposed to ubiquitous phthalate esters (PAEs). Processed, packaged foods are popular nowadays, in which emulsifiers are frequently added as food additives. It is unclear how emulsifiers affect the bioavailability of ingested PAEs contaminants and their toxicities. The purposes of our study were to explore whether food emulsifier Glycerin Monostearate (GMS) could increase the internal exposure levels of six priority controlled PAEs and affect their reproductive toxicities when male rats are exposed to PAEs mixture (MIXPs). The male rats were exposed to MIXPs by gavage for thirty days in combination with or without given GMS. Phthalate monoesters (MPAEs), primary metabolites of PAEs, in rat urine were used as biomarkers to predict the internal exposure levels of the six PAEs, and their concentrations were determined using UPLC-MS. The reproductive toxicity was evaluated using serum testosterone levels test and histopathology of testes. Results showed that compared to PAEs exposure alone, the internal exposure levels of PAEs increased by 30%-49% in the presence of GMS. PAEs exposure led to the reduction of testosterone level by 23.4%-42.1% in the presence and absence of GMS, respectively, compared to the baseline. Testosterone levels in MIXPs+GMS and DEHP+GMS group were decreased by 9.1% and 13.6%, respectively, compared with MIXPs and DEHP group. Histopathology showed that injuries of testis (deciduous spermatids) were observed, and GMS exacerbated the injuries. The results indicated food emulsifiers chronically taken up might increase safety risks of food PAEs contaminants.	[Gao, Hai-Tao; Xu, Run; Cao, Wei-Xin; Zhou, Xu; Yan, Ye-Hui-Mei; Xu, Qian] Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing 210009, Jiangsu, Peoples R China; [Xu, Qian] Southeast Univ, Suzhou Key Lab Environm & Biosafety, Suzhou 215123, Peoples R China; [Lu, Lingeng; Xu, Qian] Yale Univ, Sch Publ Hlth, Sch Med, Dept Chron Dis Epidemiol, 60 Coll St, New Haven, CT 06520 USA; [Shen, Yang] Southeast Univ, Sch Med, Zhong Da Hosp, Dept Obstet & Gynecol, Nanjing 210009, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China; Yale University; Southeast University - China	Xu, Q (corresponding author), Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing 210009, Jiangsu, Peoples R China.; Xu, Q (corresponding author), Southeast Univ, Suzhou Key Lab Environm & Biosafety, Suzhou 215123, Peoples R China.; Xu, Q (corresponding author), Yale Univ, Sch Publ Hlth, Sch Med, Dept Chron Dis Epidemiol, 60 Coll St, New Haven, CT 06520 USA.; Shen, Y (corresponding author), Southeast Univ, Sch Med, Zhong Da Hosp, Dept Obstet & Gynecol, Nanjing 210009, Jiangsu, Peoples R China.	q_xu68@163.com; shenyang0924@sina.cn		Gao, Haitao/0000-0003-3986-7261	Socail Development Research Program of Jiangsu Province Science and Technology Department [BE2015646]; Maternal and Child Healthcare Project of Jiangsu Province Health Department [F201407]; Youth Fund Project of Jiangsu Province Health Department [Q201305]; Science and Technology Project of Nanjing City [201201054]; Student Research Training Program [1510286111]	Socail Development Research Program of Jiangsu Province Science and Technology Department; Maternal and Child Healthcare Project of Jiangsu Province Health Department; Youth Fund Project of Jiangsu Province Health Department; Science and Technology Project of Nanjing City; Student Research Training Program	This work received financial support from Socail Development Research Program of Jiangsu Province Science and Technology Department (http://xmsb.jschina.com.cn/indexActionlto_index.action) Project No.: BE2015646, to QX, Maternal and Child Healthcare Project of Jiangsu Province Health Department (http://www.jswst.gov.cn/jsswshjhsywyh/index.html) Project No.:F201407, to YS, Youth Fund Project of Jiangsu Province Health Department (http://www.jswst.gov.cn/jsswshjhsywyh/index.html) Project No.:Q201305, to QX, Science and Technology Project of Nanjing City (http://www.njkj.gov.cn/) Project No.:201201054, to QX, and Student Research Training Program (http://srtp.seu.edu.cn/) 1510286111, to XZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235; Alvi MM, 2014, AAPS PHARMSCITECH, V15, P339, DOI 10.1208/s12249-013-0065-8; Amberg-Muller JP, 2010, J VERBRAUCH LEBENSM, V5, P429, DOI 10.1007/s00003-010-0620-0; Anderson WAC, 2001, FOOD ADDIT CONTAM A, V18, P1068, DOI 10.1080/02652030110050113; Barlow NJ, 2003, TOXICOL SCI, V73, P431, DOI 10.1093/toxsci/kfg087; Barta CA, 2008, MOL PHARMACEUT, V5, P863, DOI 10.1021/mp800050q; Bhatia H, 2015, J APPL TOXICOL, V35, P806, DOI 10.1002/jat.3076; Biedermann-Brem S, 2008, CHROMATOGRAPHIA, V68, P227, DOI 10.1365/s10337-008-0672-9; Bouma K, 2002, FOOD ADDIT CONTAM, V19, P602, DOI 10.1080/02652030210125137; Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI 10.1016/j.jchromb.2004.02.006; Chang-Liao WL, 2013, MOLECULES, V18, P11452, DOI 10.3390/molecules180911452; Chen L, 2012, SCI TOTAL ENVIRON, V427, P60, DOI 10.1016/j.scitotenv.2012.03.090; Chen ML, 2008, ENVIRON INT, V34, P79, DOI 10.1016/j.envint.2007.07.004; Chen XP, 2014, INT J ENV RES PUB HE, V11, P3156, DOI 10.3390/ijerph110303156; Cheng Z, 2013, ENVIRON INT, V57-58, P75, DOI 10.1016/j.envint.2013.04.005; Csaki KF, 2011, MED HYPOTHESES, V76, P676, DOI 10.1016/j.mehy.2011.01.030; David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.2307/3435032; Erkekoglu P, 2011, DRUG CHEM TOXICOL, V34, P379, DOI 10.3109/01480545.2010.547499; Farajzadeh MA, 2012, J SEP SCI, V35, P742, DOI 10.1002/jssc.201100853; Fujimaki Kayumi, 2006, Nihon Eiseigaku Zasshi, V61, P340; [高海涛 Gao Haitao], 2015, [食品工业科技, Science & Technology of Food Industry], V36, P280; Guo Y, 2011, ENVIRON INT, V37, P893, DOI 10.1016/j.envint.2011.03.005; Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804; Helal MAM, 2014, REPROD BIOL, V14, P182, DOI 10.1016/j.repbio.2014.04.002; Hennessy M, 2007, PHARMACOL RES, V55, P1, DOI 10.1016/j.phrs.2006.10.007; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077; Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P77, DOI 10.1078/1438-4639-00272; Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205; Lerner A, 2015, AUTOIMMUN REV, V14, P479, DOI 10.1016/j.autrev.2015.01.009; Lu Y, 2014, TOXICOL SCI, V139, P317, DOI 10.1093/toxsci/kfu055; Lugea A, 2000, GUT, V46, P515, DOI 10.1136/gut.46.4.515; Moffit JS, 2007, TOXICOL PATHOL, V35, P719, DOI 10.1080/01926230701481931; Mortensen GK, 2005, ANAL BIOANAL CHEM, V382, P1084, DOI 10.1007/s00216-005-3218-0; National Health and Family Planning Commission (NHFPC), 2014, GB27602014 NHFPC; POLLACK GM, 1985, TOXICOL APPL PHARM, V79, P246, DOI 10.1016/0041-008X(85)90346-1; Roberts CL, 2013, J CROHNS COLITIS, V7, P338, DOI 10.1016/j.crohns.2013.01.004; Russo MV, 2014, ANAL METHODS-UK, V6, P7030, DOI [10.1039/c4ay00926f, 10.1039/C4AY00926F]; Rusyn I, 2006, CRIT REV TOXICOL, V36, P459, DOI 10.1080/10408440600779065; Schecter A, 2013, ENVIRON HEALTH PERSP, V121, P473, DOI 10.1289/ehp.1206367; Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018; Strac IV, 2013, J APPL TOXICOL, V33, P214, DOI 10.1002/jat.1741; Tellez-Rojo MM, 2013, SCI TOTAL ENVIRON, V461, P386, DOI 10.1016/j.scitotenv.2013.05.021; US EPA, 2007, PHTH SUMM 2007; Wang B, 2015, ENVIRON SCI TECHNOL, V49, P1120, DOI 10.1021/es504455a; Wang YX, 2016, ENVIRON RES, V150, P557, DOI 10.1016/j.envres.2015.11.023; Wang YX, 2016, ENVIRON POLLUT, V211, P173, DOI 10.1016/j.envpol.2015.12.052; Wu T, 2008, CHROMATOGRAPHIA, V68, P803, DOI 10.1365/s10337-008-0788-y; Xia DN, 2014, J PHARM SCI-US, V103, P697, DOI 10.1002/jps.23830; Ye T, 2014, AQUAT TOXICOL, V146, P115, DOI 10.1016/j.aquatox.2013.10.025; Yoshimura M, 2006, BUNSEKI KAGAKU, V55, P661, DOI 10.2116/bunsekikagaku.55.661; [于云江 Yu Yunjiang], 2014, [环境化学, Environmental Chemistry], V33, P194; Zhang HJ, 2003, ARCH PHARM RES, V26, P768, DOI 10.1007/BF02976689; Zhu SJ, 2009, EUR J PHARM SCI, V37, P573, DOI 10.1016/j.ejps.2009.05.001	54	15	17	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161253	10.1371/journal.pone.0161253	http://dx.doi.org/10.1371/journal.pone.0161253			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575856	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877200021
J	Kim, MH; Cho, JS; Kim, Y; Lee, CH; Lee, MK; Shin, DH				Kim, Mi-Hyun; Cho, Jeong Su; Kim, Yeongdae; Lee, Chang Hun; Lee, Min Ki; Shin, Dong Hoon			Discriminating between Terminal- and Non-Terminal Respiratory Unit-Type Lung Adenocarcinoma Based on MicroRNA Profiles	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; GROWTH-FACTOR-RECEPTOR; TUMORIGENIC PROPERTIES; POOR-PROGNOSIS; A549 CELLS; CANCER; EXPRESSION; TUMOR; GLYCOLYSIS; CARCINOMA	Lung adenocarcinomas can be classified into terminal respiratory unit (TRU) and non-TRU types. We previously reported that non-TRU-type adenocarcinoma has unique clinical and morphological features as compared to the TRU type. Here we investigated whether micro (mi)RNA expression profiles can be used to distinguish between these two subtypes of lung adenocarcinoma. The expression of 1205 human and 144 human viral miRNAs was analyzed in TRU-and non-TRU-type lung adenocarcinoma samples (n = 4 each) by microarray. Results were validated by quantitative real-time (qRT-)PCR and in situ hybridization. A comparison of miRNA profiles revealed 29 miRNAs that were differentially expressed between TRU- and non-TRU adenocarcinoma types. Specifically, hsa-miR-494 and ebv-miR-BART19 were up regulated by > 5-fold, whereas hsa-miR-551b was down regulated by > 5-fold in the non-TRU relative to the TRU type. The miRNA signature was confirmed by qRT-PCR analysis using an independent set of paired adenocarcinoma (non-TRU-type, n = 21 and TRU-type, n = 12) and normal tissue samples. Non-TRU samples showed increased expression of miR-494 (p = 0.033) and ebv-miR-BART19 (p = 0.001) as compared to TRU-type samples. Both miRNAs were weakly expressed in the TRU type but strongly expressed in the non-TRU type. Neither subtype showed miR-551b expression. TRU- and non-TRU-type adenocarcinomas have distinct miRNA expression profiles, suggesting that tumorigenesis in lung adenocarcinoma occur via different pathways.	[Kim, Mi-Hyun; Lee, Min Ki] Pusan Natl Univ, Sch Med, Dept Internal Med, Busan, South Korea; [Cho, Jeong Su; Kim, Yeongdae] Pusan Natl Univ, Sch Med, Dept Thorac Surg, Busan, South Korea; [Lee, Chang Hun; Shin, Dong Hoon] Pusan Natl Univ, Sch Med, Dept Pathol, Yangsan, South Korea; [Kim, Mi-Hyun; Shin, Dong Hoon] Pusan Natl Univ, Med Res Inst, Busan, South Korea	Pusan National University; Pusan National University; Pusan National University; Pusan National University Hospital; Pusan National University	Lee, MK (corresponding author), Pusan Natl Univ, Sch Med, Dept Internal Med, Busan, South Korea.; Shin, DH (corresponding author), Pusan Natl Univ, Sch Med, Dept Pathol, Yangsan, South Korea.; Shin, DH (corresponding author), Pusan Natl Univ, Med Res Inst, Busan, South Korea.	leemk@pusan.ac.kr; donghshin@chol.com			Basic Science Research Program of the National Research Foundation of Korea - Ministry of Education, Science and Technology [2011-0012351, 2014R1A1A2058077]	Basic Science Research Program of the National Research Foundation of Korea - Ministry of Education, Science and Technology	This research was supported by the Basic Science Research Program of the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2011-0012351 and 2014R1A1A2058077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2022, CANC FACTS FIGURES 2; Ationu A, 1999, BLOOD, V94, P3193, DOI 10.1182/blood.V94.9.3193.421k26_3193_3198; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Crawford M, 2009, BIOCHEM BIOPH RES CO, V388, P483, DOI 10.1016/j.bbrc.2009.07.143; Duan HH, 2010, TOXICOL IN VITRO, V24, P928, DOI 10.1016/j.tiv.2009.11.013; Kim WK, 2011, CLIN CANCER RES, V17, P7584, DOI 10.1158/1078-0432.CCR-11-0166; Kim YK, 2015, HISTOPATHOLOGY, V67, P520, DOI 10.1111/his.12693; Koshiol J, 2011, BRIT J CANCER, V105, P320, DOI 10.1038/bjc.2011.221; Liu LX, 2012, FEBS J, V279, P3800, DOI 10.1111/j.1742-4658.2012.08741.x; Liu Y, 2012, J IMMUNOL, V188, P5500, DOI 10.4049/jimmunol.1103505; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Marquitz AR, 2012, P NATL ACAD SCI USA, V109, P9593, DOI 10.1073/pnas.1202910109; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Pandya D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136058; Park WY, 2012, MODERN PATHOL, V25, P1265, DOI 10.1038/modpathol.2012.76; Romano G, 2012, P NATL ACAD SCI USA, V109, P16570, DOI 10.1073/pnas.1207917109; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sumiyoshi S, 2014, LUNG CANCER, V84, P281, DOI 10.1016/j.lungcan.2014.03.013; Tominaga E, 2013, EXP CELL RES, V319, P77, DOI 10.1016/j.yexcr.2012.10.015; Travis WD, 1999, WHO INT CLASSIFICATI, P156; Wang XH, 2010, CIRCULATION, V122, P1308, DOI 10.1161/CIRCULATIONAHA.110.964684; Xiao L, 2014, ONCOGENE, V33, P4568, DOI 10.1038/onc.2014.32; Yatabe Y, 2005, AM J SURG PATHOL, V29, P633, DOI 10.1097/01.pas.0000157935.28066.35; Yatabe Y, 2002, AM J SURG PATHOL, V26, P767, DOI 10.1097/00000478-200206000-00010; Yatabe Y, 2007, PATHOL INT, V57, P233, DOI 10.1111/j.1440-1827.2007.02098.x; Yu QQ, 2014, BIOMED PHARMACOTHER, V68, P155, DOI 10.1016/j.biopha.2014.01.005	26	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0160996	10.1371/journal.pone.0160996	http://dx.doi.org/10.1371/journal.pone.0160996			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575252	gold, Green Published, Green Submitted			2022-12-26	WOS:000382877200014
J	Cnossen, MC; Polinder, S; Lingsma, HF; Maas, AIR; Menon, D; Steyerberg, EW				Cnossen, Maryse C.; Polinder, Suzanne; Lingsma, Hester F.; Maas, Andrew I. R.; Menon, David; Steyerberg, Ewout W.		CENTER-Tbi Invest Participants	Variation in Structure and Process of Care in Traumatic Brain Injury: Provider Profiles of European Neurotrauma Centers Participating in the CENTER-TBI Study	PLOS ONE			English	Article							QUESTIONNAIRE; MANAGEMENT; QUALITY; LENGTH	Introduction The strength of evidence underpinning care and treatment recommendations in traumatic brain injury (TBI) is low. Comparative effectiveness research (CER) has been proposed as a framework to provide evidence for optimal care for TBI patients. The first step in CER is to map the existing variation. The aim of current study is to quantify variation in general structural and process characteristics among centers participating in the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study. Methods We designed a set of 11 provider profiling questionnaires with 321 questions about various aspects of TBI care, chosen based on literature and expert opinion. After pilot testing, questionnaires were disseminated to 71 centers from 20 countries participating in the CENTER-TBI study. Reliability of questionnaires was estimated by calculating a concordance rate among 5% duplicate questions. Results All 71 centers completed the questionnaires. Median concordance rate among duplicate questions was 0.85. The majority of centers were academic hospitals (n = 65, 92%), designated as a level I trauma center (n = 48, 68%) and situated in an urban location (n = 70, 99%). The availability of facilities for neuro-trauma care varied across centers; e.g. 40 (57%) had a dedicated neuro-intensive care unit (ICU), 36 (51%) had an in-hospital rehabilitation unit and the organization of the ICU was closed in 64% (n = 45) of the centers. In addition, we found wide variation in processes of care, such as the ICU admission policy and intracranial pressure monitoring policy among centers. Conclusion Even among high-volume, specialized neurotrauma centers there is substantial variation in structures and processes of TBI care. This variation provides an opportunity to study effectiveness of specific aspects of TBI care and to identify best practices with CER approaches.	[Cnossen, Maryse C.; Polinder, Suzanne; Lingsma, Hester F.; Steyerberg, Ewout W.] Erasmus MC, Ctr Med Decis Sci, Dept Publ Hlth, Rotterdam, Netherlands; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium; [Menon, David] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England	Erasmus University Rotterdam; Erasmus MC; University of Antwerp; University of Antwerp; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Lingsma, HF (corresponding author), Erasmus MC, Ctr Med Decis Sci, Dept Publ Hlth, Rotterdam, Netherlands.	h.lingsma@erasmusmc.nl	Santos, Edgar/AAV-2506-2021; Gomez, Pedro A./E-2411-2014; Sahakian, Barbara/AAW-1198-2020; Viani, Rafael/V-1196-2018; Gomez, Pedro/N-5051-2019; Vande Vyvere, Thijs/AAB-5180-2022; Badenes, Rafael/K-6628-2019; Castaño-Leon, Ana M/ABF-6322-2020; Laureys, Steven/AAN-2097-2021; Oresic, Matej/K-7673-2016; Rossi, Sandra/AHH-8015-2022; Cooper, D. James/G-7961-2013; Ercole, Ari/B-6288-2009; Sahuquillo, Juan/B-3577-2008; Lagares, Alfonso/B-2969-2011; Stocchetti, Nino/O-7444-2017; Majdan, Marek/K-5017-2012; van der Jagt, Mathieu/G-1905-2017	Santos, Edgar/0000-0002-8976-5549; Gomez, Pedro A./0000-0002-4185-5238; Sahakian, Barbara/0000-0001-7352-1745; Gomez, Pedro/0000-0002-4185-5238; Vande Vyvere, Thijs/0000-0003-4032-5443; Badenes, Rafael/0000-0001-7017-0150; Castaño-Leon, Ana M/0000-0002-7918-5049; Laureys, Steven/0000-0002-3096-3807; Oresic, Matej/0000-0002-2856-9165; Rossi, Sandra/0000-0002-9963-8121; Cooper, D. James/0000-0002-5872-9051; Ercole, Ari/0000-0001-8350-8093; Sahuquillo, Juan/0000-0003-0713-5875; Lagares, Alfonso/0000-0003-3996-0554; Andelic, Nada/0000-0002-3719-4406; van der Naalt, Joukje/0000-0001-9873-2418; Stocchetti, Nino/0000-0003-3250-6834; Cameron, Peter/0000-0002-1443-557X; Te Ao, Braden/0000-0002-1050-200X; Williams, Guy/0000-0001-5223-6654; Sanchez-Porras, Renan/0000-0002-9084-8114; CAUSIN, Francesco/0000-0001-6491-7027; Feigin, Valery L./0000-0002-6372-1740; Esser, Patrick/0000-0002-3227-0115; Smielewski, Peter/0000-0001-5096-3938; Pomposo Gaztelu, Inigo/0000-0002-3095-2649; Stamatakis, Emmanuel Andreas/0000-0001-6955-9601; Kondziella, Daniel/0000-0001-5562-9808; Lanyon, Linda/0000-0002-0885-1825; Majdan, Marek/0000-0001-8037-742X; Wade, Derick/0000-0002-1188-8442; Parizel, Paul M./0000-0002-0221-2854; Morganti-Kossmann, Cristina/0000-0002-0807-2063; MARTIN, Didier Herman/0000-0001-7325-4958; Wang, Kevin/0000-0002-9343-6473; Volovici, Victor/0000-0002-5798-5360; Newcombe, Virginia/0000-0001-6044-9035; Ledig, Christian/0000-0003-4862-3138; Ortolano, Fabrizio/0000-0003-1996-948X; persona, paolo/0000-0003-1584-5148; Della Corte, Francesco/0000-0003-1736-2318; Bragge, Peter/0000-0003-0745-5131; van der Jagt, Mathieu/0000-0003-2566-8325; Synnot, Anneliese/0000-0002-4008-4208	European Commission 7th Framework program [602150]; National Institute for Health Research [NF-SI-0512-10090] Funding Source: researchfish	European Commission 7th Framework program; National Institute for Health Research(National Institute for Health Research (NIHR))	Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Commission 7th Framework program (602150). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AD HOC COMM HLTH, 1996, TDRGEN961 WHO AD HOC; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Checkley W, 2014, CRIT CARE MED, V42, P344, DOI 10.1097/CCM.0b013e3182a275d7; Cnossen MC, 2015, J NEUROTRAUMA; Enblad P, 2004, INTENS CARE MED, V30, P1058, DOI 10.1007/s00134-004-2206-8; European Brain Injury Consortium, EBIC CTR SURV; European Comission, 2007, REM RES PUBL PRIV SE; Galesic M, 2009, PUBLIC OPIN QUART, V73, P349, DOI 10.1093/poq/nfp031; I. o. Medicine, 2009, IN NAT PRIOR COMP EF; Kalantar JS, 1999, J CLIN EPIDEMIOL, V52, P1117, DOI 10.1016/S0895-4356(99)00051-7; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7	15	40	41	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161367	10.1371/journal.pone.0161367	http://dx.doi.org/10.1371/journal.pone.0161367			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571205	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000382876700016
J	Kanonidis, EI; Roy, MM; Deighton, RF; Le Bihan, T				Kanonidis, Evangelos I.; Roy, Marcia M.; Deighton, Ruth F.; Le Bihan, Thierry			Protein Co-Expression Analysis as a Strategy to Complement a Standard Quantitative Proteomics Approach: Case of a Glioblastoma Multiforme Study	PLOS ONE			English	Article							MASS-SPECTROMETRY; PYRUVATE-KINASE; INTERACTION NETWORKS; ENDOPLASMIC-RETICULUM; GEL-ELECTROPHORESIS; CANCER CELLS; EXPRESSION; CARCINOMA; PROLIFERATION; MITOCHONDRIA	Although correlation network studies from co-expression analysis are increasingly popular, they are rarely applied to proteomics datasets. Protein co-expression analysis provides a complementary view of underlying trends, which can be overlooked by conventional data analysis. The core of the present study is based on Weighted Gene Co-expression Network Analysis applied to a glioblastoma multiforme proteomic dataset. Using this method, we have identified three main modules which are associated with three different membrane associated groups; mitochondrial, endoplasmic reticulum, and a vesicle fraction. The three networks based on protein co-expression were assessed against a publicly available database (STRING) and show a statistically significant overlap. Each of the three main modules were de-clustered into smaller networks using different strategies based on the identification of highly connected networks, hierarchical clustering and enrichment of Gene Ontology functional terms. Most of the highly connected proteins found in the endoplasmic reticulum module were associated with redox activity while a core of the unfolded protein response was identified in addition to proteins involved in oxidative stress pathways. The proteins composing the electron transfer chain were found differently affected with proteins from mitochondrial Complex I being more down-regulated than proteins from Complex III. Finally, the two pyruvate kinases isoforms show major differences in their co-expressed protein networks suggesting roles in different cellular locations.	[Kanonidis, Evangelos I.; Le Bihan, Thierry] Univ Edinburgh, SynthSys, Waddington Bldg, Edinburgh EH9 3BF, Midlothian, Scotland; [Kanonidis, Evangelos I.; Le Bihan, Thierry] Univ Edinburgh, Sch Biol Sci, Waddington Bldg, Edinburgh EH9 3BF, Midlothian, Scotland; [Roy, Marcia M.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh EH16 4SB, Midlothian, Scotland; [Deighton, Ruth F.] Univ Edinburgh, Edinburgh Med Sch, Biomed Sci, Edinburgh EH8 9AG, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh	Le Bihan, T (corresponding author), Univ Edinburgh, SynthSys, Waddington Bldg, Edinburgh EH9 3BF, Midlothian, Scotland.; Le Bihan, T (corresponding author), Univ Edinburgh, Sch Biol Sci, Waddington Bldg, Edinburgh EH9 3BF, Midlothian, Scotland.	thierry.lebihan@ed.ac.uk	Le Bihan, Thierry/AAN-2534-2020	Roy, Marcia/0000-0002-4088-3958; Le Bihan, Thierry/0000-0003-0498-8063	European Union's Seventh Framework Programme for research, technological development and demonstration [602470]	European Union's Seventh Framework Programme for research, technological development and demonstration	This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602470.	Alldridge L, 2008, J PROTEOME RES, V7, P1458, DOI 10.1021/pr7007829; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Bluemlein K, 2011, ONCOTARGET, V2, P393; Brohee S, 2012, METHODS MOL BIOL, V804, P327, DOI 10.1007/978-1-61779-361-5_18; Chae YC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3139; Chen YR, 2006, J PROTEOME RES, V5, P2727, DOI 10.1021/pr060212g; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; Deighton RF, 2014, J NEURO-ONCOL, V118, P247, DOI 10.1007/s11060-014-1430-5; Denervaud N, 2013, P NATL ACAD SCI USA, V110, P15842, DOI 10.1073/pnas.1308265110; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Friedman DB, 2004, PROTEOMICS, V4, P793, DOI 10.1002/pmic.200300635; Garbis SD, 2008, J PROTEOME RES, V7, P3146, DOI 10.1021/pr800060r; Gibbs David L, 2013, J Clin Bioinforma, V3, P11, DOI 10.1186/2043-9113-3-11; Gu Y, 2007, J PROTEOME RES, V6, P4256, DOI 10.1021/pr070319j; Han DF, 2015, ONCOTARGET, V6, P26119, DOI 10.18632/oncotarget.4444; He Y, 2012, NUCLEIC ACIDS RES, V40, pD964, DOI 10.1093/nar/gkr936; Herrmann AG, 2013, J CEREBR BLOOD F MET, V33, P673, DOI 10.1038/jcbfm.2012.204; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Ishida A, 2009, NEUROCHEM RES, V34, P807, DOI 10.1007/s11064-008-9833-3; James R, 2012, J CEREBR BLOOD F MET, V32, P164, DOI 10.1038/jcbfm.2011.120; Kaimal V, 2010, NUCLEIC ACIDS RES, V38, pW96, DOI 10.1093/nar/gkq418; Krause K, 2007, ENDOCRINOLOGY, V148, P1754, DOI 10.1210/en.2006-0752; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Levin Y, 2011, PROTEOMICS, V11, P2565, DOI 10.1002/pmic.201100033; Mudunuri U, 2009, BIOINFORMATICS, V25, P555, DOI 10.1093/bioinformatics/btn654; Nishimura Y, 2013, BRIT J CANCER, V108, P1324, DOI 10.1038/bjc.2013.65; Onda T, 2006, BRIT J CANCER, V94, P698, DOI 10.1038/sj.bjc.6602986; Pancaldi V, 2010, MOL BIOSYST, V6, P543, DOI 10.1039/b913876p; Patwardhan AJ, 2006, PROTEOMICS, V6, P2903, DOI 10.1002/pmic.200500582; Pradeep C., 2013, J COMPUT SCI SYST BI, V6, P215; Raturi A, 2013, BBA-MOL CELL RES, V1833, P213, DOI 10.1016/j.bbamcr.2012.04.013; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Song MS, 2001, CANCER RES, V61, P8322; Storey JD, 2005, PLOS BIOL, V3, P1380, DOI 10.1371/journal.pbio.0030267; Sun YL, 2008, J PROTEOME RES, V7, P3847, DOI 10.1021/pr800153s; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tufo G, 2014, CELL DEATH DIFFER, V21, P685, DOI 10.1038/cdd.2013.193; Wang L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003414; Wang ZY, 2013, AUTOPHAGY, V9, P925, DOI 10.4161/auto.24229; Wegener KM, 2010, MOL CELL PROTEOMICS, V9, DOI 10.1074/mcp.M110.000109	45	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161828	10.1371/journal.pone.0161828	http://dx.doi.org/10.1371/journal.pone.0161828			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571357	Green Submitted, Green Published, gold			2022-12-26	WOS:000382876700036
J	Wang, Y; Kim, MH; Tabaei, SR; Park, JH; Na, K; Chung, S; Zhdanov, VP; Cho, NJ				Wang, Yan; Kim, Myung Hee; Tabaei, Seyed R.; Park, Jae Hyeok; Na, Kyuhwan; Chung, Seok; Zhdanov, Vladimir P.; Cho, Nam-Joon			Spheroid Formation of Hepatocarcinoma Cells in Microwells: Experiments and Monte Carlo Simulations	PLOS ONE			English	Article							ROTATING-WALL VESSEL; STEM-CELL; LIVER-TISSUE; PROLIFERATION; DIFFERENTIATION; GROWTH; GENERATION; MODEL; KI-67; EXPRESSION	The formation of spherical aggregates during the growth of cell population has long been observed under various conditions. We observed the formation of such aggregates during proliferation of Huh-7.5 cells, a human hepatocarcinoma cell line, in a microfabricated low-adhesion microwell system (SpheroFilm; formed of mass-producible silicone elastomer) on the length scales up to 500 mu m. The cell proliferation was also tracked with immunofluorescence staining of F-actin and cell proliferation marker Ki-67. Meanwhile, our complementary 3D Monte Carlo simulations, taking cell diffusion and division, cell-cell and cell-scaffold adhesion, and gravity into account, illustrate the role of these factors in the formation of spheroids. Taken together, our experimental and simulation results provide an integrative view of the process of spheroid formation for Huh-7.5 cells.	[Wang, Yan; Kim, Myung Hee; Tabaei, Seyed R.; Park, Jae Hyeok; Cho, Nam-Joon] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore, Singapore; [Wang, Yan; Kim, Myung Hee; Tabaei, Seyed R.; Park, Jae Hyeok; Cho, Nam-Joon] Nanyang Technol Univ, Ctr Biomimet Sensor Sci, Singapore, Singapore; [Na, Kyuhwan; Chung, Seok] Korea Univ, Sch Mech Engn, Seoul, South Korea; [Zhdanov, Vladimir P.] Russian Acad Sci, Boreskov Inst Catalysis, Novosibirsk, Russia; [Cho, Nam-Joon] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Korea University; Boreskov Institute of Catalysis, Siberian Branch, Russian Academy of Sciences; Russian Academy of Sciences; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Cho, NJ (corresponding author), Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore, Singapore.; Cho, NJ (corresponding author), Nanyang Technol Univ, Ctr Biomimet Sensor Sci, Singapore, Singapore.; Cho, NJ (corresponding author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore, Singapore.	njcho@ntu.edu.sg	Cho, Nam-Joon/J-7816-2012; Cho, Nam-Joon/A-3475-2019	Cho, Nam-Joon/0000-0002-8692-8955; Tabaei, Seyed/0000-0002-2857-786X	National Research Foundation Singapore [NRF-NRFF2011-01, NRF-CRP10-2012-07]; National Research Foundation of Singapore	National Research Foundation Singapore(National Research Foundation, Singapore); National Research Foundation of Singapore(National Research Foundation, Singapore)	This work was funded by National Research Foundation Singapore (www.nrf.gov.sg), NRF-NRFF2011-01 and NRF-CRP10-2012-07, awarded to NJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Research Foundation of Singapore.	Argyrakis P, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066108; Barrio RA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003026; BECKER JL, 1993, J CELL BIOCHEM, V51, P283, DOI 10.1002/jcb.240510307; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Brown LA, 2003, IN VITRO CELL DEV-AN, V39, P13; Chang TT, 2009, TISSUE ENG PT A, V15, P559, DOI 10.1089/ten.tea.2007.0434; de Rooij DG, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108639; Deisboeck TS, 2011, ANNU REV BIOMED ENG, V13, P127, DOI 10.1146/annurev-bioeng-071910-124729; Ehsan SM, 2013, TISSUE ENG PT A, V19, P1433, DOI [10.1089/ten.tea.2012.0587, 10.1089/ten.TEA.2012.0587]; GERDES J, 1984, J IMMUNOL, V133, P1710; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; GOODWIN TJ, 1992, IN VITRO CELL DEV-AN, V28A, P47; HALL PA, 1990, CELL TISSUE KINET, V23, P505, DOI 10.1111/j.1365-2184.1990.tb01343.x; Jeong D, 2012, BIOMECH MODEL MECHAN, V11, P677, DOI 10.1007/s10237-011-0342-y; Kaita KDE, 1997, LIVER, V17, P13; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Kim C, 2011, LAB CHIP, V11, P246, DOI [10.1039/c0lc00036a, 10.1039/c01c00036a]; Kim MH, 2016, MACROMOL BIOSCI, V16, P314, DOI 10.1002/mabi.201500338; Kim MH, 2016, INTEGR BIOL-UK, V8, P156, DOI 10.1039/c5ib00269a; Lee BH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118123; Lee J, 2008, TISSUE ENG PART B-RE, V14, P61, DOI 10.1089/teb.2007.0150; Lee J, 2009, BIOMATERIALS, V30, P4687, DOI 10.1016/j.biomaterials.2009.05.024; Makhaniok A, 2013, BIOSYSTEMS, V114, P227, DOI 10.1016/j.biosystems.2013.10.001; O'Brien CM, 2015, TISSUE ENG PART B-RE, V21, P103, DOI [10.1089/ten.teb.2014.0168, 10.1089/ten.TEB.2014.0168]; Ovadia J, 2014, J SCI COMPUT, V58, P149, DOI 10.1007/s10915-013-9728-6; Robu A, 2012, BIOSYSTEMS, V109, P430, DOI 10.1016/j.biosystems.2012.06.002; SASAKI K, 1987, J CELL PHYSIOL, V133, P579, DOI 10.1002/jcp.1041330321; Scianna M, 2013, J THEOR BIOL, V333, P174, DOI 10.1016/j.jtbi.2013.04.037; Sun Y, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/1/015008; Swat MH, 2012, METHOD CELL BIOL, V110, P325, DOI 10.1016/B978-0-12-388403-9.00013-8; Timmins NE, 2005, CELL TISSUE RES, V320, P207, DOI 10.1007/s00441-004-1064-6; Urdy S, 2012, BIOL REV, V87, P786, DOI 10.1111/j.1469-185X.2012.00221.x; Varner VD, 2014, ANNU REV CHEM BIOMOL, V5, P507, DOI 10.1146/annurev-chembioeng-060713-040016; Wong SF, 2011, BIOMATERIALS, V32, P8087, DOI 10.1016/j.biomaterials.2011.07.028; Wu JC, 2013, CURR OPIN CHEM ENG, V2, P17, DOI 10.1016/j.coche.2013.01.001; Zhdanov VP, 2008, PHYSICA A, V387, P6126, DOI 10.1016/j.physa.2008.07.010; Zhdanov VP, 2004, PHYS CHEM CHEM PHYS, V6, P4347, DOI 10.1039/b407371c; Zhdanov VP, 2004, PHYS CHEM CHEM PHYS, V6, P138, DOI 10.1039/b311073g	38	17	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2016	11	8							e0161915	10.1371/journal.pone.0161915	http://dx.doi.org/10.1371/journal.pone.0161915			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4DZ	27571565	Green Published, gold, Green Submitted			2022-12-26	WOS:000382876700044
J	Fisher, CT; Fernandez-Diaz, JC; Cohen, AS; Cruz, ON; Gonzales, AM; Leisz, SJ; Pezzutti, F; Shrestha, R; Carter, W				Fisher, Christopher T.; Fernandez-Diaz, Juan Carlos; Cohen, Anna S.; Cruz, Oscar Neil; Gonzales, Alicia M.; Leisz, Stephen J.; Pezzutti, Florencia; Shrestha, Ramesh; Carter, William			Identifying Ancient Settlement Patterns through LiDAR in the Mosquitia Region of Honduras	PLOS ONE			English	Article							LANDSCAPE ARCHAEOLOGY; STATE FORMATION; AIRBORNE LIDAR; MAYA; AGRICULTURE; COLLAPSE; URBANISM; ANTHROPOCENE; MESOPOTAMIA; POPULATION	The Mosquitia ecosystem of Honduras occupies the fulcrum between the American continents and as such constitutes a critical region for understanding past patterns of socio-political development and interaction. Heavy vegetation, rugged topography, and remoteness have limited scientific investigation. This paper presents prehistoric patterns of settlement and landuse for a critical valley within the Mosquitia derived from airborne LiDAR scanning and field investigation. We show that (i) though today the valley is a wilderness it was densely inhabited in the past; (ii) that this population was organized into a three-tiered system composed of 19 settlements dominated by a city; and, (iii) that this occupation was embedded within a human engineered landscape. We also add to a growing body of literature that demonstrates the utility of LiDAR as means for rapid cultural assessments in undocumented regions for analysis and conservation. Our ultimate hope is for our work to promote protections to safeguard the unique and critically endangered Mosquitia ecosystem and other similar areas in need of preservation.	[Fisher, Christopher T.; Leisz, Stephen J.; Pezzutti, Florencia] Colorado State Univ, Dept Anthropol, Ft Collins, CO 80523 USA; [Fernandez-Diaz, Juan Carlos; Shrestha, Ramesh; Carter, William] Univ Houston, Natl Ctr Airborne Laser Mapping, Houston, TX USA; [Cohen, Anna S.] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; [Cruz, Oscar Neil] Inst Hondureno Antropol & Hist, Tegucigalpa, Honduras	Colorado State University; University of Houston System; University of Houston; University of Washington; University of Washington Seattle	Fisher, CT (corresponding author), Colorado State Univ, Dept Anthropol, Ft Collins, CO 80523 USA.	Ctfisher@colostate.edu	Leisz, Stephen/GQY-8145-2022; Fernandez-Diaz, Juan Carlos/ABA-4796-2021; Carter, William Robert/GSJ-1964-2022	Fernandez-Diaz, Juan Carlos/0000-0003-3703-7555; Leisz, Stephen/0000-0002-0726-8996; Fisher, Christopher/0000-0003-3358-5415; Cohen, Anna S./0000-0001-5655-8626	National Geographic Society; TAFFS TV; Honduran Special Forces; Directorate For Geosciences [1339015] Funding Source: National Science Foundation	National Geographic Society(National Geographic Society); TAFFS TV; Honduran Special Forces; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the Instituto Hondureno de Antropologia e Historia and the Honduran government for permits and assistance. We would also like to thank Steve Elkins, Bill Benenson, and others from the UTL Foundation. We also thank the National Geographic Society, TAFFS TV, and the Honduran Special Forces for their support.	ALMENDARES J, 1993, LANCET, V342, P1400, DOI 10.1016/0140-6736(93)92758-L; Anoveros JMG, 1988, MESOAMERICA, V9, P47; Asner GP, 2010, P NATL ACAD SCI USA, V107, P16738, DOI 10.1073/pnas.1004875107; Axelsson P., 2000, INT ARCH PHOTOGRAMM, VXXXIII, P33; Bailey T, 1995, INTERACTIVE SPATIAL; Baker DJ, 2016, GLOBAL CHANGE BIOL, V22, P2392, DOI 10.1111/gcb.13273; Balkansky AK, 2006, J ARCHAEOL RES, V14, P53, DOI 10.1007/s10814-005-9001-0; Banning E.B., 2002, ARCHAEOLOGICAL SURVE; Barthel S, 2013, ECOL ECON, V86, P224, DOI 10.1016/j.ecolecon.2012.06.018; Begley C, 2001, 15 S INV ARQ GUAT 20, P36; Begley Christopher T., 1999, ELITE POWER STRATEGI; Bevan A, 2006, CONFRONTING SCALE IN ARCHAEOLOGY, P217; Bevan A, 2013, J ARCHAEOL SCI, V40, P2415, DOI 10.1016/j.jas.2012.12.025; Bill Cassandra R., 2014, MAYA THEIR CENTRAL A, P83; Billman BR, 1999, SETTLEMENT PATTERN S; Blanton RE., 2013, HOUSES HOUSEHOLDS CO; Bonta M, 2003, 7 NAMES BELLBIRD CON; Bush MB, 2015, J BIOGEOGR, V42, P2277, DOI 10.1111/jbi.12638; CARTER WE, 2015, GEODETIC IMAGING AIR, P1, DOI DOI 10.1007/1345_; Carter WE, 2016, AM SCI, V104, P28; Chase AF, 2014, REMOTE SENS-BASEL, V6, P8671, DOI 10.3390/rs6098671; Chase AF, 2012, P NATL ACAD SCI USA, V109, P12916, DOI 10.1073/pnas.1205198109; Chase AF, 2011, J ARCHAEOL SCI, V38, P387, DOI 10.1016/j.jas.2010.09.018; Chase Arlen F, 1998, CULTURE AGR, V20, P60, DOI DOI 10.1525/CAG.1998.20.2-3.60; Chase Arlen F., 2014, ARCHAEOLOGICAL PAPER, V24, P11, DOI DOI 10.1111/APAA.12026; Cherry J. F., 2003, THEORY PRACTICE MEDI, V1, P137; Clement CR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2459; Collar A, 2015, J ARCHAEOL METHOD TH, V22, P1, DOI 10.1007/s10816-014-9235-6; Covey RA, 2013, J ANTHROPOL ARCHAEOL, V32, P538, DOI 10.1016/j.jaa.2013.09.001; Crema ER, 2010, J ARCHAEOL SCI, V37, P1118, DOI 10.1016/j.jas.2009.12.012; Cruz-Castillo ON, 2009, PATRON ASENTAMIENTO, pXXV; Cruz-Castillo ON, 2010, INTRO ARQUEOLOGIA HO, pXXVI; Cruz-Castillo ON, 2009, INFORME VISITA INSPE; Cucina A., 2014, ARCHAEOLOGY BIOARCHA; Cuddy Thomas W., 2007, POLITICAL IDENTITY A; CUELLAR A. M., 2009, QUIJOS CHIEFDOMS SOC; Davidson W.V., 1991, COLUMBIAN CONSEQUENC, P205; Denevan WM, 2011, GEOGR REV, V101, P576, DOI 10.1111/j.1931-0846.2011.00118.x; Donkin RA, AGR TERRACING ABORIG; Douglas PMJ, 2015, P NATL ACAD SCI USA, V112, P5607, DOI 10.1073/pnas.1419133112; Drennan RD, 2006, P NATL ACAD SCI USA, V103, P3960, DOI 10.1073/pnas.0510862103; Drennan RD, 2004, J ARCHAEOL SCI, V31, P533, DOI 10.1016/j.jas.2003.10.002; Drennan RD, 1989, PREHISPANIC CHIEFDOM; Ebdon David, 1991, STAT GEOGRAPHY PRACT; Ebert J., 1992, DISTRIBUTIONAL ARCHA; Epstein JF, 1957, LATE CERAMIC HORIZON; Estrada A, 2006, DEV PRIMATOL, P1, DOI 10.1007/0-387-25872-8_1; Evans D, 2015, ANTIQUITY, V89, P1402, DOI 10.15184/aqy.2015.157; FALCONER SE, 1995, AM ANTIQUITY, V60, P37, DOI 10.2307/282075; Fall PL, 2012, J ARCHAEOL SCI, V39, P2335, DOI 10.1016/j.jas.2012.02.010; Feinman GM, 1998, GROUND PLANS ARCHAIC, P15; Fernandez-Diaz JC, 2014, REMOTE SENS-BASEL, V6, P9951, DOI 10.3390/rs6109951; Fernandez-Diaz JC, 2014, INT GEOSCI REMOTE SE, P902, DOI 10.1109/IGARSS.2014.6946571; Fish SK., 1990, ARCHAEOLOGY REGIONS; Fisher C.T., 2012, EOS T AM GEOPHYS UN, V93, P413, DOI [10.1029/2012EO420002, DOI 10.1029/2012E0420002]; Fisher C, 2014, J ANTHROPOL ARCHAEOL, V36, P196, DOI 10.1016/j.jaa.2014.10.001; Fisher CT, 2011, PHOTOGRAMM ENG REM S, V77, P962; Fisher CT, 2005, AM ANTHROPOL, V107, P62, DOI 10.1525/aa.2005.107.1.062; Fisher CT., 2010, INTERIM REPORT LEGAD; Fisher CT, 2011, INTERIM REPORT LEGAD; Fisher CT, 2009, ARCHAEOLOGY ENV CHAN; Fisher CT., 2012, INTERIM REPORT LEGAD; Folan W.J., 1983, J FIELD ARCHAEOL, V10, P453, DOI DOI 10.2307/529468; Fotheringham AS, 2008, SAGE HDB SPATIAL ANA; Fulminante F, 2014, URBANISATION ROME LA; Glass John, 1966, HDB MIDDLE AM INDIAN, V4, P157; Glennie CL, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/8/086801; Gonthier DJ, 2013, TROP CONSERV SCI, V6, P584, DOI 10.1177/194008291300600409; Gonzalez Fernandez V, 2013, TYPOLOGICAL TYRANNY, P133; Haddad DE, 2012, GEOSPHERE, V8, P771, DOI 10.1130/GES00701.1; Hanson P, 2008, HONDURAS TROPICAL FO; Harrower MJ, 2014, AFR ARCHAEOL REV, V31, P513, DOI 10.1007/s10437-014-9165-4; Head MJ, 2015, QUATERN INT, V383, P4, DOI 10.1016/j.quaint.2015.06.039; Healy, 1984, RECENT DEV ISTHMIAN, P227; Healy P., 1993, NE HONDURAS POTTERY, P294; Healy Paul F., 1984, ARCHAEOLOGY LOWER CE, P113; Healy Paul H., 1978, J FIELD ARCHAEOL, V5, P15; Heckenberger MJ, 2008, SCIENCE, V321, P1214, DOI 10.1126/science.1159769; Herlihy P, 1997, CONSERVATION CULTURA, P99; Hirth K, 1988, SE CLASSIC MAYA ZONE, P297; Hodder I., 1979, SPATIAL ANAL ARCHAEO; Hoopes JW, 2005, J ARCHAEOL RES, V13, P1, DOI 10.1007/s10814-005-0809-4; HORTON RE, 1945, GEOL SOC AM BULL, V56, P275, DOI 10.1130/0016-7606(1945)56[275:edosat]2.0.co;2; Houseal B, 1985, CULT SURVIV, V9; Hritz C, 2014, J ARCHAEOL RES, V22, P229, DOI 10.1007/s10814-013-9072-2; Ieisz SR, 2013, MAPPING ARCHAEOLOGIC; Isendahl C, 2013, CITIES, V31, P132, DOI 10.1016/j.cities.2012.07.012; Isendahl C, 2012, ANTIQUITY, V86, P1112, DOI 10.1017/S0003598X00048286; JOHNSON GA, 1980, ECON GEOGR, V56, P234, DOI 10.2307/142715; JOHNSON GA, 1977, ANNU REV ANTHROPOL, V6, P479, DOI 10.1146/annurev.an.06.100177.002403; Johnson GA, 1972, MAN SETTLEMENT URBAN, P769; Joyce AA, 2009, ANCIENT MESOAM, V20, P189, DOI 10.1017/S0956536109990125; Joyce Rosemary A., 1991, CERRO PALENQUE POWER; Kantner J, 2008, J ARCHAEOL RES, V16, P37, DOI 10.1007/s10814-007-9017-8; Kennett DJ, 2012, SCIENCE, V338, P788, DOI 10.1126/science.1226299; Kowalewski SA, 2008, J ARCHAEOL RES, V16, P225, DOI 10.1007/s10814-008-9020-8; La Bastille A, 1978, WILDLAND CONSERVATIO; Lange Frederick W., 1984, ARCHAEOLOGY LOWER CE; Laparidou S, 2015, HOLOCENE, V25, P1537, DOI 10.1177/0959683615594472; Lara Pinto Gloria, 1991, RESERVA BIOSFERA RIO, P16; Lawrence D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152563; Leisz S. J., 2013, MAPPING ARCHAEOLOGIC, V5, P199, DOI 10.1007/978-1-4614-6074-9_16; LINARES OF, 1979, ANNU REV ANTHROPOL, V8, P21, DOI 10.1146/annurev.an.08.100179.000321; Luke C, 2012, ARCHEOL PAP AM ANTHR, P114, DOI 10.1111/j.1551-8248.2012.01040.x; Marcus Joyce, 2008, ANCIENT CITY NEW PER; Marcus Joyce, 1996, ZAPOTEC CIVILIZATION; Markofsky S, 2014, J ARCHAEOL METHOD TH, V21, P697, DOI 10.1007/s10816-013-9172-9; Masini N, 2013, LECT NOTES COMPUT SC, V7972, P663, DOI 10.1007/978-3-642-39643-4_48; Masson MA, 2012, P NATL ACAD SCI USA, V109, P18237, DOI 10.1073/pnas.1213638109; Mckey D, 2010, P NATL ACAD SCI USA, V107, P7823, DOI 10.1073/pnas.0908925107; Meigs A, 2013, LITHOSPHERE-US, V5, P226, DOI 10.1130/RF.L004.1; Menze BH, 2012, P NATL ACAD SCI USA, V109, pE778, DOI 10.1073/pnas.1115472109; Naesset E, 2002, REMOTE SENS ENVIRON, V80, P88, DOI 10.1016/S0034-4257(01)00290-5; Negre Perez J, 2015, MATH ARCHAEOLOGY, P369; Niemel KS, 2015, J WORLD ANTHR, V2; Orton C, ARCH E CALCOLATORI, V15, P299; PARSONS JR, 1972, ANNU REV ANTHROPOL, V1, P127, DOI 10.1146/annurev.an.01.100172.001015; Parsons M.H., 1990, MAGUEY UTILIZATION H; Pearson CE., 1980, J ANTHROPOL RES, V36, P453, DOI [10.1086/jar.36.4.3629614, DOI 10.1086/JAR.36.4.3629614]; Peterson CE, 2010, P NATL ACAD SCI USA, V107, P5756, DOI 10.1073/pnas.1000949107; PINDER D, 1979, AM ANTIQUITY, V44, P430, DOI 10.2307/279543; Piperno DR, 2015, HOLOCENE, V25, P1588, DOI 10.1177/0959683615588374; Plog F., 1971, DISTRIBUTION PREHIST, P7; Pownall T, 1779, ARCHAEOLOGIA, V5; Project CICAR, 2011, SETTL PATT CHIF REG; Prufer KM, 2015, J ARCHAEOL SCI, V57, P1, DOI 10.1016/j.jas.2015.02.013; RIPLEY BD, 1979, J ROY STAT SOC B MET, V41, P368; Rodriguez VP, 2013, J ARCHAEOL RES, V21, P75, DOI 10.1007/s10814-012-9060-y; Rogers XII C., 1782, ARCHAEOLOGIA, V6, P107, DOI [10.1017/S0261340900020129, DOI 10.1017/S0261340900020129]; Roosevelt AC, 2013, ANTHROPOCENE, V4, P69, DOI 10.1016/j.ancene.2014.05.001; Rosenswig RM, 2015, ARCHAEOL ANTHROP SCI, V7, P487, DOI 10.1007/s12520-014-0210-7; Rosenswig RM, 2013, J ARCHAEOL SCI, V40, P1493, DOI 10.1016/j.jas.2012.10.034; Rossignol J., 2013, SPACE TIME ARCHAEOLO; Ruddiman WF, 2015, SCIENCE, V348, P38, DOI 10.1126/science.aaa7297; Ruddiman WF, 2013, ANNU REV EARTH PL SC, V41, P45, DOI 10.1146/annurev-earth-050212-123944; Savage SH, 1997, J ARCHAEOL SCI, V24, P233, DOI 10.1006/jasc.1996.0106; Savage SH, RANKSIZE SIMULATION; Scarborough VL, 2012, P NATL ACAD SCI USA, V109, P12408, DOI 10.1073/pnas.1202881109; Schortman EM, 2014, LAT AM ANTIQ, V25, P344, DOI 10.7183/1045-6635.25.3.344; Smith BD, 2014, MISSISSIPPIAN SETTLE; Smith ME, 2007, J PLAN HIST, V6, P3, DOI 10.1177/1538513206293713; Smith Monica L., 2003, SOCIAL CONSTRUCTION; Spinden HJ, 1928, GEOGR REV, V18, P641, DOI 10.2307/207952; Spinden Herbert J., 1924, P 21 INT C AM, P529; Stahl P.W., 1995, ARCHAEOLOGY LOWLAND; Stone Doris, 1941, ARCHAEOLOGY N COAST; STRAHLER AN, 1952, GEOL SOC AM BULL, V63, P1117, DOI 10.1130/0016-7606(1952)63[1117:HAAOET]2.0.CO;2; Strong WD., 1948, ARCHEOLOGY HONDURAS, P71; Strong WD., 1934, EXPLORATIONS FIELD W; Taladoire Eric, 2001, SPORT LIFE DEATH MES, P97; TARBOTON DG, 1991, HYDROL PROCESS, V5, P81, DOI 10.1002/hyp.3360050107; Thompson VD, 2011, ARCHAEOL PROSPECT, V18, P195, DOI 10.1002/arp.400; Thurston TL, 2001, LANDSCAPES CONFLICT; Trigger B., DETERMINANTS URBAN G; Trigger B.G., 1968, SETTLEMENT ARCHAEOLO, P53; Trigger BG., 1967, AM ANTIQUITY, V32, P149, DOI [DOI 10.2307/277900, 10.2307/277900]; Turner BL, 2012, P NATL ACAD SCI USA, V109, P13908, DOI 10.1073/pnas.1210106109; Urunuela Gabriela, 2009, ART URBANISM MESOAME, P135; VOORRIPS A, 1987, AM ANTIQUITY, V52, P500, DOI 10.2307/281596; Walker JH, 2012, J ARCHAEOL RES, V20, P309, DOI 10.1007/s10814-012-9057-6; Wantzen KM, 2008, AQUAT ECOL-SAN DIEGO, P199, DOI 10.1016/B978-012088449-0.50009-1; Waters CN, 2016, SCIENCE, V351, P137, DOI 10.1126/science.aad2622; Wernke SA, 2011, CHUNGARA, V43, P203, DOI 10.4067/S0717-73562011000200004; West R., 1966, MIDDLE AM ITS LANDS; Wilkinson TJ, 2003, ARCHAEOLOGICAL LANDS; WRIGHT HT, 1975, AM ANTHROPOL, V77, P267, DOI 10.1525/aa.1975.77.2.02a00020; Yakam-Simen F., 1999, IEEE 1999 International Geoscience and Remote Sensing Symposium. IGARSS'99 (Cat. No.99CH36293), P2578, DOI 10.1109/IGARSS.1999.771582; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	168	34	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0159890	10.1371/journal.pone.0159890	http://dx.doi.org/10.1371/journal.pone.0159890			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DU5NN	27560962	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258600005
J	Munsters, NM; van den Boomen, C; Hooge, ITC; Kemner, C				Munsters, Nicolette M.; van den Boomen, Carlijn; Hooge, Ignace T. C.; Kemner, Chantal			The Role of Global and Local Visual Information during Gaze-Cued Orienting of Attention	PLOS ONE			English	Article							SPATIAL-FREQUENCY; FACE PERCEPTION; FEARFUL FACES; TIME; LUMINANCE; DIRECTION; CORTEX; SHIFTS	Gaze direction is an important social communication tool. Global and local visual information are known to play specific roles in processing socially relevant information from a face. The current study investigated whether global visual information has a primary role during gaze-cued orienting of attention and, as such, may influence quality of interaction. Adults performed a gaze-cueing task in which a centrally presented face cued (valid or invalid) the location of a peripheral target through a gaze shift. We measured brain activity (electroencephalography) towards the cue and target and behavioral responses (manual and saccadic reaction times) towards the target. The faces contained global (i.e. lower spatial frequencies), local (i.e. higher spatial frequencies), or a selection of both global and local (i.e. mid-band spatial frequencies) visual information. We found a gaze cue-validity effect (i.e. valid versus invalid), but no interaction effects with spatial frequency content. Furthermore, behavioral responses towards the target were in all cue conditions slower when lower spatial frequencies were not present in the gaze cue. These results suggest that whereas gaze-cued orienting of attention can be driven by both global and local visual information, global visual information determines the speed of behavioral responses towards other entities appearing in the surrounding of gaze cue stimuli.	[Munsters, Nicolette M.; van den Boomen, Carlijn; Hooge, Ignace T. C.; Kemner, Chantal] Univ Utrecht, Helmholtz Inst, Dept Expt Psychol, Utrecht, Netherlands; [Munsters, Nicolette M.; van den Boomen, Carlijn; Kemner, Chantal] Univ Utrecht, Dept Dev Psychol, Utrecht, Netherlands; [Munsters, Nicolette M.; Kemner, Chantal] Univ Med Ctr, Dept Child & Adolescent Psychiat, Brain Ctr Rudolf Magnus, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University Medical Center	Munsters, NM (corresponding author), Univ Utrecht, Helmholtz Inst, Dept Expt Psychol, Utrecht, Netherlands.; Munsters, NM (corresponding author), Univ Utrecht, Dept Dev Psychol, Utrecht, Netherlands.; Munsters, NM (corresponding author), Univ Med Ctr, Dept Child & Adolescent Psychiat, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.	n.m.munsters@gmail.com			the Netherlands Organization for Scientific Research (NWO) VICI Grant [45307004]	the Netherlands Organization for Scientific Research (NWO) VICI Grant(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research (NWO; www.nwo.nl/en) VICI Grant (45307004) to C.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando S, 2002, PERCEPTION, V31, P657, DOI 10.1068/p3332; Bex PJ, 2002, J OPT SOC AM A, V19, P1096, DOI 10.1364/JOSAA.19.001096; CARY MS, 1978, SOC PSYCHOL, V41, P269, DOI DOI 10.2307/3033565; De Jong MC, 2008, J AM ACAD CHILD PSY, V47, P443, DOI 10.1097/CHI.0b013e31816429a6; Doherty MJ, 2015, COGNITION, V137, P72, DOI 10.1016/j.cognition.2015.01.001; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Friesen CK, 2004, J EXP PSYCHOL HUMAN, V30, P319, DOI 10.1037/0096-1523.30.2.319; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Goffaux V, 2006, J EXP PSYCHOL HUMAN, V32, P1023, DOI 10.1037/0096-1523.32.4.1023; Graham R, 2009, MODULATION REFLEXIVE, V18, P331; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hietanen JK, 2008, BRAIN RES, V1215, P123, DOI 10.1016/j.brainres.2008.03.091; Holmes A, 2010, SOC NEUROSCI-UK, V5, P285, DOI 10.1080/17470910903422819; Holmqvist K., 2011, EYE TRACKING COMPREH; Hooge Ignace, 2013, Front Psychol, V4, P996, DOI 10.3389/fpsyg.2013.00996; Hori E, 2005, PHYSIOL BEHAV, V84, P397, DOI 10.1016/j.physbeh.2005.01.002; Jahfari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076467; Lassalle A, 2015, SOC NEUROSCI-UK, V10, P70, DOI 10.1080/17470919.2014.958616; Leonard HC, 2010, J EXP CHILD PSYCHOL, V106, P193, DOI 10.1016/j.jecp.2010.03.005; Morrison DJ, 2001, PSYCHON B REV, V8, P454, DOI 10.3758/BF03196180; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Pfeiffer UJ, 2013, NEUROSCI BIOBEHAV R, V37, P2516, DOI 10.1016/j.neubiorev.2013.07.017; Pourtois G, 2005, HUM BRAIN MAPP, V26, P65, DOI 10.1002/hbm.20130; Praamstra P, 2005, J NEUROPHYSIOL, V94, P764, DOI 10.1152/jn.01052.2004; Ruiz-Soler M, 2006, PSYCHOL RES-PSYCH FO, V70, P273, DOI 10.1007/s00426-005-0215-z; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Schuller AM, 2004, CLIN NEUROPHYSIOL, V115, P1161, DOI 10.1016/j.clinph.2003.12.022; Schuller AM, 2001, NEUROREPORT, V12, P2381, DOI 10.1097/00001756-200108080-00019; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Shepherd SV, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00005; Simpson GV, 2006, NEUROREPORT, V17, P1595, DOI 10.1097/01.wnr.0000236858.78339.52; Skottun BC, 2007, J CLIN EXP NEUROPSYC, V29, P860, DOI 10.1080/13803390601147637; TOOTELL RBH, 1988, J NEUROSCI, V8, P1610; van den Boomen C, 2012, Front Psychiatry, V3, P16, DOI 10.3389/fpsyt.2012.00016; VASSILEV A, 1976, VISION RES, V16, P89, DOI 10.1016/0042-6989(76)90081-X; Vlamings PHJM, 2009, J VISION, V9, DOI 10.1167/9.5.12; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Winston JS, 2003, CURR BIOL, V13, P1824, DOI 10.1016/j.cub.2003.09.038	39	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2016	11	8							e0160405	10.1371/journal.pone.0160405	http://dx.doi.org/10.1371/journal.pone.0160405			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU5NN	27560368	gold, Green Published, Green Submitted			2022-12-26	WOS:000382258600010
J	Park, SM; Li, TC; Wu, SW; Li, WQ; Qureshi, AA; Cho, EY				Park, Sang Min; Li, Tricia; Wu, Shaowei; Li, Wen-Qing; Qureshi, Abrar A.; Cho, Eunyoung			Vitamin D Intake and Risk of Skin Cancer in US Women and Men	PLOS ONE			English	Article							BASAL-CELL CARCINOMA; PLASMA 25-HYDROXYVITAMIN D; PROSPECTIVE COHORT; DAIRY-PRODUCTS; OVARIAN-CANCER; SUN EXPOSURE; FOOD-INTAKE; D LEVEL; NONMELANOMA; MELANOMA	Previous studies suggested a protective effect of vitamin D against skin cancer development. However, epidemiologic studies on orally taken vitamin D and risk of skin cancer (basal cell carcinoma [BCC], squamous cell carcinoma [SCC], and melanoma) are few. We prospectively evaluated whether total, dietary and supplemental vitamin D intake were associated with skin cancer risk based on 63,760 women in the Nurses' Health Study (1984-2010) and 41,530 men in the Health Professionals Follow-up Study (1986-2010). Dietary information on vitamin D intake was assessed every 2 to 4 years during the follow-up and cumulative averaged intake was used. We used Cox proportional hazard models to compute the hazard ratios (HR) and 95% confidence intervals (CI). Pooled HR of cohort-specific results were calculated using a random-effects model. During the follow-up, we documented 20,840 BCC, 2,329 SCC and 1,320 melanoma cases. Vitamin D consumption was not associated with the risk of SCC or melanoma but was modestly positively associated with BCC; the pooled HRs of BCC for extreme quintiles of vitamin D intake were 1.10 (95% CI = 1.05-1.15; P-trend = 0.05) for total vitamin D and 1.13 (95% CI = 1.07 to 1.20; P-trend < 0.01) for dietary vitamin D. Stratified analysis according to sun exposure related factors showed similar results. In conclusion, vitamin D intake was positively associated with risk of BCC, while null associations were found with SCC and melanoma. Our data do not support a beneficial role of orally taken vitamin D on skin cancer carcinogenesis.	[Park, Sang Min; Qureshi, Abrar A.; Cho, Eunyoung] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Park, Sang Min; Qureshi, Abrar A.; Cho, Eunyoung] Harvard Med Sch, Boston, MA 02115 USA; [Park, Sang Min] Seoul Natl Univ, Coll Med, Dept Family Med, Seoul, South Korea; [Park, Sang Min] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Li, Tricia; Wu, Shaowei; Li, Wen-Qing; Qureshi, Abrar A.; Cho, Eunyoung] Brown Univ, Dept Dermatol, Warren Alpert Med Sch, Providence, RI 02912 USA; [Li, Wen-Qing; Qureshi, Abrar A.; Cho, Eunyoung] Brown Univ, Dept Epidemiol, Sch Publ Hlth, Providence, RI 02912 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Seoul National University (SNU); Seoul National University (SNU); Brown University; Brown University	Cho, EY (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.; Cho, EY (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Cho, EY (corresponding author), Brown Univ, Dept Dermatol, Warren Alpert Med Sch, Providence, RI 02912 USA.; Cho, EY (corresponding author), Brown Univ, Dept Epidemiol, Sch Publ Hlth, Providence, RI 02912 USA.	eunyoung_cho@brown.edu	Cho, Eunyoung/AAV-4469-2020; Park, Sang Min/V-9194-2019	Cho, Eunyoung/0000-0001-6594-2582; Li, Wen-Qing/0000-0002-8336-5552	National Institutes of Health [CA186107, CA176726, CA137365]; National Research Foundation of Korea Grant - the Korean Government [2013R1A1A1A05004957]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea Grant - the Korean Government	This work was supported by the National Institutes of Health (CA186107, CA176726, and CA137365), and National Research Foundation of Korea Grant funded by the Korean Government (grant no. 2013R1A1A1A05004957). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2009, INT J CANCER, V124, P250, DOI 10.1002/ijc.23904; Armstrong BK, 1996, CANCER SURV, V26, P133; Asgari MM, 2010, J INVEST DERMATOL, V130, P1438, DOI 10.1038/jid.2009.402; Asgari MM, 2009, J INVEST DERMATOL, V129, P1675, DOI 10.1038/jid.2008.451; Bikle DD, 2008, J INVEST DERMATOL, V128, P2357, DOI 10.1038/jid.2008.249; Bikle Daniel D, 2012, Photochem Photobiol Sci, V11, P1808, DOI 10.1039/c2pp25251a; Bikle DD, 2010, J BONE MINER METAB, V28, P117, DOI 10.1007/s00774-009-0153-8; Burns EM, 2015, PHOTOCHEM PHOTOBIOL, V91, P201, DOI 10.1111/php.12382; Caini S, 2014, EUR J CANCER, V50, P2649, DOI 10.1016/j.ejca.2014.06.024; Cho E, 2005, J CLIN ONCOL, V23, P2669, DOI 10.1200/JCO.2005.11.108; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Cottingham KL, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-149; deCastro BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108098; Dixon KM, 2011, CANCER PREV RES, V4, P1485, DOI 10.1158/1940-6207.CAPR-11-0165; Duarte-Salles T, 2014, INT J CANCER, V135, P1662, DOI 10.1002/ijc.28812; Eide MJ, 2011, ARCH DERMATOL, V147, P1379, DOI 10.1001/archdermatol.2011.231; Faber MT, 2012, ACTA ONCOL, V51, P454, DOI 10.3109/0284186X.2011.636754; Fartasch M, 2012, DTSCH ARZTEBL INT, V109, P715, DOI 10.3238/arztebl.2012.0715; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Fung TT, 2003, INT J CANCER, V103, P110, DOI 10.1002/ijc.10798; Fung TT, 2002, CANCER CAUSE CONTROL, V13, P221, DOI 10.1023/A:1015036317596; Grant WB, 2010, J PHOTOCH PHOTOBIO B, V101, P130, DOI 10.1016/j.jphotobiol.2010.04.008; Holick MF, 2006, MAYO CLIN PROC, V81, P353, DOI 10.4065/81.3.353; Hollis BW, 1996, CALCIFIED TISSUE INT, V58, P4, DOI 10.1007/s002239900002; Hughes MC, 2006, INT J CANCER, V119, P1953, DOI 10.1002/ijc.22061; Hunt KM, 2014, CANCER LETT, V354, P211, DOI 10.1016/j.canlet.2014.08.016; Hunter D J, 1992, Ann Epidemiol, V2, P231, DOI 10.1016/1047-2797(92)90055-U; Hunter David J., 1990, Annals of Epidemiology, V1, P13; Joh HK, 2013, JNCI-J NATL CANCER I, V105, P726, DOI 10.1093/jnci/djt082; Leonardi G, 2012, ENVIRON HEALTH PERSP, V120, P721, DOI 10.1289/ehp.1103534; Liang GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035211; Pi JB, 2005, INT J CANCER, V116, P20, DOI 10.1002/ijc.20990; Pothiawala S, 2012, CANCER CAUSE CONTROL, V23, P717, DOI 10.1007/s10552-012-9941-x; Reddy KK, 2013, J INVEST DERMATOL, V133, P589, DOI 10.1038/jid.2012.427; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Seifert M, 2004, J STEROID BIOCHEM, V89-90, P375, DOI 10.1016/j.jsbmb.2004.03.002; Song FJ, 2012, INT J EPIDEMIOL, V41, P1694, DOI 10.1093/ije/dys146; Surdu S, 2013, INT J CANCER, V133, P2182, DOI 10.1002/ijc.28216; Tang JY, 2011, J CLIN ONCOL, V29, P3078, DOI 10.1200/JCO.2011.34.5967; Tang JY, 2011, CANCER PREV RES, V4, P744, DOI 10.1158/1940-6207.CAPR-10-0285; Torniainen S, 2007, CANCER EPIDEM BIOMAR, V16, P956, DOI 10.1158/1055-9965.EPI-06-0985; van Dam RM, 2000, AM J CLIN NUTR, V71, P135; van der Pols JC, 2013, J INVEST DERMATOL, V133, P637, DOI 10.1038/jid.2012.346; Weinstein SJ, 2015, INT J CANCER, V136, pE654, DOI 10.1002/ijc.29157; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Wu SW, 2013, AM J EPIDEMIOL, V178, P890, DOI 10.1093/aje/kwt073	47	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2016	11	8							e0160308	10.1371/journal.pone.0160308	http://dx.doi.org/10.1371/journal.pone.0160308			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU5NI	27557122	Green Published, gold, Green Submitted			2022-12-26	WOS:000382258100010
J	Wang, HZ; Liu, J; Xu, XP; Huang, QM; Chen, SS; Yang, PQ; Chen, SJ; Song, YQ				Wang, Hongzhi; Liu, Jin; Xu, Xiaoping; Huang, Qingming; Chen, Shanshan; Yang, Peiqiang; Chen, Shaojiang; Song, Yiqiao			Fully-Automated High-Throughput NMR System for Screening of Haploid Kernels of Maize (Corn) by Measurement of Oil Content	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; LOW-FIELD NMR; DOUBLED HAPLOIDS; INDUCTION; INDUCERS; SEEDS; IDENTIFICATION; QUALITY; PROTON	One of the modern crop breeding techniques uses doubled haploid plants that contain an identical pair of chromosomes in order to accelerate the breeding process. Rapid haploid identification method is critical for large-scale selections of double haploids. The conventional methods based on the color of the endosperm and embryo seeds are slow, manual and prone to error. On the other hand, there exists a significant difference between diploid and haploid seeds generated by high oil inducer, which makes it possible to use oil content to identify the haploid. This paper describes a fully-automated high-throughput NMR screening system for maize haploid kernel identification. The system is comprised of a sampler unit to select a single kernel to feed for measurement of NMR and weight, and a kernel sorter to distribute the kernel according to the measurement result. Tests of the system show a consistent accuracy of 94% with an average screening time of 4 seconds per kernel. Field test result is described and the directions for future improvement are discussed.	[Wang, Hongzhi; Xu, Xiaoping; Huang, Qingming; Chen, Shanshan] Shanghai Univ Med & Hlth Sci, Shanghai, Peoples R China; [Wang, Hongzhi; Yang, Peiqiang] East China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai, Peoples R China; [Liu, Jin; Chen, Shaojiang] China Agr Univ, Natl Maize Improvement Ctr, Beijing, Peoples R China; [Song, Yiqiao] Schlumberger Doll Res Ctr, Cambridge, MA 02139 USA; [Song, Yiqiao] Mass Gen Hosp, Charlestown, MA 02114 USA	Shanghai University of Medicine & Health Sciences; East China Normal University; China Agricultural University; Schlumberger	Wang, HZ (corresponding author), Shanghai Univ Med & Hlth Sci, Shanghai, Peoples R China.; Wang, HZ (corresponding author), East China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai, Peoples R China.; Chen, SJ (corresponding author), China Agr Univ, Natl Maize Improvement Ctr, Beijing, Peoples R China.; Song, YQ (corresponding author), Schlumberger Doll Res Ctr, Cambridge, MA 02139 USA.; Song, YQ (corresponding author), Mass Gen Hosp, Charlestown, MA 02114 USA.	wanghzhi2000@sina.com; chen368@126.com; ysong@nmr.mgh.harvard.edu		Song, Yiqiao/0000-0002-3416-4279; Chiu, Chih-Yu/0000-0002-6842-1253	13th Five-year National High-tech program: Maize Heterosis utilization technology and hybrid breeding, and Modern Maize Industry Technology System from China government [CARS-02-09]	13th Five-year National High-tech program: Maize Heterosis utilization technology and hybrid breeding, and Modern Maize Industry Technology System from China government	This work was supported by The 13th Five-year National High-tech program: Maize Heterosis utilization technology and hybrid breeding, and Modern Maize Industry Technology System (CARS-02-09) from China government. The funder provided support in the form of salaries for authors [HZW, JL, XPX, QMH and SSC], but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Blumich B, 2000, NMR IMAGING MAT; Chalyk ST, 2001, RUSS J GENET+, V37, P1382, DOI 10.1023/A:1013291711912; CHEN RS, 1994, J MAGN RESON SER A, V110, P77, DOI 10.1006/jmra.1994.1184; Chen ShaoJiang, 2003, Acta Agronomica Sinica, V29, P587; Colnago LA, 2007, ANAL CHEM, V79, P1271, DOI 10.1021/ac062091+; CONWAY TF, 1963, J AM OIL CHEM SOC, V40, P265, DOI 10.1007/BF02633686; Dang NC, 2012, EUPHYTICA, V183, P153, DOI 10.1007/s10681-011-0423-0; Dong X, 2014, MOL BREEDING, V34, P1147, DOI 10.1007/s11032-014-0106-3; Gambhir P. N., 1992, Trends in Food Science & Technology, V3, P191, DOI 10.1016/0924-2244(92)90188-3; Gao SQ, 2009, J MAGN RESON, V197, P208, DOI 10.1016/j.jmr.2008.12.022; Geiger HH, 2009, MAYDICA, V54, P485; Greener J, 2000, J AM CERAM SOC, V83, P623; Hills BP, 2006, ANNU REP NMR SPECTRO, V58, P177, DOI 10.1016/S0066-4103(05)58004-9; Kotyk JJ, 2005, J AM OIL CHEM SOC, V82, P855, DOI 10.1007/s11746-005-1155-5; Leslie HR, 1994, B MAGN RESON, V14, P86; Liu J., 2012, T CHINESE SOC AGR EN, V28, P233; Liu Z., 2000, ACTA AGRONOMICA SINI, V26, P570; Luetkmeyer L, 2007, MACROMOL SYMP, V258, P108, DOI 10.1002/masy.200751212; Marcone MF, 2013, FOOD RES INT, V51, P729, DOI 10.1016/j.foodres.2012.12.046; Melchinger AE, 2014, CROP SCI, V54, P1497, DOI 10.2135/cropsci2013.12.0851; Melchinger AE, 2013, SCI REP-UK, V3, DOI 10.1038/srep02129; Mitchell J, 2014, PROG NUCL MAG RES SP, V76, P1, DOI 10.1016/j.pnmrs.2013.09.001; Nordon A, 2001, ANALYST, V126, P260, DOI 10.1039/b009293m; Prestes RA, 2007, ANAL CHIM ACTA, V596, P325, DOI 10.1016/j.aca.2007.06.022; Prigge V, 2012, GENETICS, V190, P781, DOI 10.1534/genetics.111.133066; Prigge V, 2011, CROP SCI, V51, P1498, DOI 10.2135/cropsci2010.10.0568; Rober FK, 2005, MAYDICA, V50, P275; Samii-Saket G, 2011, J AM OIL CHEM SOC, V88, P1795, DOI 10.1007/s11746-011-1849-1; Song YQ, 2013, J MAGN RESON, V229, P12, DOI 10.1016/j.jmr.2012.11.010; Thygesen LG, 2001, LEBENSM-WISS TECHNOL, V34, P469, DOI 10.1006/fstl.2001.0788; Todt H, 2006, FOOD CHEM, V96, P436, DOI 10.1016/j.foodchem.2005.04.032	31	41	42	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2016	11	7							e0159444	10.1371/journal.pone.0159444	http://dx.doi.org/10.1371/journal.pone.0159444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ID	27583451	Green Submitted, gold, Green Published			2022-12-26	WOS:000381515200021
J	Wang, HC; Chou, CY; Chiou, CR; Tian, GL; Chiu, CY				Wang, Hsueh-Ching; Chou, Chiao-Ying; Chiou, Chyi-Rong; Tian, Guanglong; Chiu, Chih-Yu			Humic Acid Composition and Characteristics of Soil Organic Matter in Relation to the Elevation Gradient of Moso Bamboo Plantations	PLOS ONE			English	Article							CARBON POOLS; FOREST; DECOMPOSITION; MINERALIZATION; CHRONOSEQUENCE; SEQUESTRATION; RECALCITRANT; DYNAMICS; NITROGEN; LABILE	Studying the influence of climatic and/or site-specific factors on soil organic matter (SOM) along an elevation gradient is important for understanding the response of SOM to global warming. We evaluated the composition of SOM and structure of humic acids along an altitudinal gradient from 600 to 1400 m in moso bamboo (Phyllostachys edulis) plantations in central Taiwan using NMR spectroscopy and photometric analysis. Total organic C and total nitrogen (N) content increased with increasing elevation. Aromaticity decreased and Delta logK (the logarithm of the absorbance ratio of humic acids at 400 and 600 nm) increased with increasing elevation, which suggests that SOM humification decreased with increasing elevation. High temperature at low elevations seemed to enhance the decomposition (less accumulation of total organic C and N) and humification (high aromaticity and low Delta logK). The alkyl-C/O-alkyl-C (A/O-A) ratio of humic acids increased with increasing elevation, which suggests that SOM humification increased with increasing elevation; this finding was contrary to the trend observed for Delta logK and aromaticity. Such a discrepancy might be due to the relatively greater remaining of SOM derived from high alkyl-C broadleaf litter of previous forest at high elevations. The ratio of recalcitrant C to total organic C was low at low elevations, possibly because of enhanced decomposition of recalcitrant SOM from the previous broadleaf forest during long-term intensive cultivation and high temperature. Overall, the change in SOM pools and in the rate of humification with elevation was primarily affected by changes in climatic conditions along the elevation gradient in these bamboo plantations. However, when the composition of SOM, as assessed by NMR spectroscopy and photometric analysis was considered, site-specific factors such as residual SOM from previous forest and intensive cultivation history could also have an important effect on the humic acid composition and humification of SOM.	[Wang, Hsueh-Ching; Chiu, Chih-Yu] Acad Sinica, Biodivers Res Ctr, Taipei 11529, Taiwan; [Chou, Chiao-Ying] Natl Taiwan Univ, Biodivers Res Ctr, Taipei 10617, Taiwan; [Chiou, Chyi-Rong] Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei 10617, Taiwan; [Tian, Guanglong] Lue Hing R&D Lab, Metropolitan Water Reclamat Dist Greater Chicago, Environm Monitoring & Res Div, Monitoring & Res Dept, 6001 W Pershing Rd, Cicero, IL 60804 USA	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University	Chiu, CY (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 11529, Taiwan.	bochiu@sinica.edu.tw		Song, Yiqiao/0000-0002-3416-4279; Chiu, Chih-Yu/0000-0002-6842-1253	Academia Sinica; Ministry and Technology, Taiwan [MOST 104-2621-B-001-005]	Academia Sinica(Academia Sinica - Taiwan); Ministry and Technology, Taiwan	This study was sponsored by Academia Sinica and the Ministry and Technology, Taiwan (MOST 104-2621-B-001-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldock JA, 1997, AUST J SOIL RES, V35, P1061, DOI 10.1071/S97004; Belay-Tedla A, 2009, SOIL BIOL BIOCHEM, V41, P110, DOI 10.1016/j.soilbio.2008.10.003; BEYER L, 1995, BIOL FERT SOILS, V19, P197, DOI 10.1007/BF00336159; Chang EH, 2016, APPL SOIL ECOL, V98, P213, DOI 10.1016/j.apsoil.2015.10.018; Chen T.H., 2014, Q J CHIN FOR, V47, P181; Chinese-American Joint Commission on Rural Reconstruction, 1956, LAND US FOR RES MAPS; Chung TL, 2012, J FOREST RES-JPN, V17, P458, DOI 10.1007/s10310-011-0319-9; Ciais P, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P465; Djukic I, 2010, J PLANT NUTR SOIL SC, V173, P30, DOI 10.1002/jpln.200900027; FAO, 2005, PROGR SUST FOR MAN C, P107; Fu J., 2001, BAMBOO, V22, P5; Garten CT, 2006, GEODERMA, V136, P342, DOI 10.1016/j.geoderma.2006.03.049; Garten CT, 1999, BIOGEOCHEMISTRY, V45, P115, DOI 10.1007/BF01106778; Garten CT, 2004, SOIL BIOL BIOCHEM, V36, P1491, DOI 10.1016/j.soilbio.2004.04.019; Gerzabek M, 1996, HUMIFICATION, P116; Gutierrez-Giron A, 2015, GEODERMA, V237, P1, DOI 10.1016/j.geoderma.2014.08.005; HATCHER PG, 1981, SOIL SCI SOC AM J, V45, P1089, DOI 10.2136/sssaj1981.03615995004500060016x; Huang CY, 2014, J SOIL SEDIMENT, V14, P1061, DOI 10.1007/s11368-014-0870-z; Jien SH, 2011, J FOREST RES-JPN, V16, P275, DOI 10.1007/s10310-010-0231-8; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Kogel-Knabner I, 1997, GEODERMA, V80, P243, DOI 10.1016/S0016-7061(97)00055-4; Kumada K., 1987, Chemistry of soil organic matter., p241pp; Lal R, 2004, GEODERMA, V123, P1, DOI 10.1016/j.geoderma.2004.01.032; Li YF, 2013, FOREST ECOL MANAG, V303, P121, DOI 10.1016/j.foreco.2013.04.021; Lin H.L., 2000, CHRONICLES FORESTRY; Lin YT, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv033; Liu J, 2011, FOREST ECOL MANAG, V262, P1131, DOI 10.1016/j.foreco.2011.06.015; Lobovikov M., 2007, WORLD BAMBOO RESOURC, VVolume 18; McLauchlan KK, 2004, SOIL SCI SOC AM J, V68, P1616, DOI 10.2136/sssaj2004.1616; National Land Surveying and Mapping Center, 2012, 2 TIM LAND US INV PL; Ostertag R, 2008, ECOSYSTEMS, V11, P701, DOI 10.1007/s10021-008-9152-1; Raich JW, 2006, ECOLOGY, V87, P76, DOI 10.1890/05-0023; Rodeghiero M, 2005, GLOBAL CHANGE BIOL, V11, P1024, DOI 10.1111/j.1365-2486.2005.00963.x; Rossi CQ, 2016, AGR ECOSYST ENVIRON, V216, P34, DOI 10.1016/j.agee.2015.09.022; Rovira P, 2002, GEODERMA, V107, P109, DOI 10.1016/S0016-7061(01)00143-4; Schindlbacher A, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001191; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Schoening I, 2005, BIOGEOCHEMISTRY, V73, P475, DOI 10.1007/s10533-004-0897-0; Shih TF, 1996, TAIWAN FORT MAPS REV; Stockmann U, 2013, AGR ECOSYST ENVIRON, V164, P80, DOI 10.1016/j.agee.2012.10.001; Wang JT, 2015, MICROB ECOL, V69, P135, DOI 10.1007/s00248-014-0465-7; Wei DW, 2008, MEASURE TAIWAN 1984; Zech W, 1997, GEODERMA, V79, P117, DOI 10.1016/S0016-7061(97)00040-2	43	41	42	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162193	10.1371/journal.pone.0162193	http://dx.doi.org/10.1371/journal.pone.0162193			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583451	Green Published, gold, Green Submitted			2022-12-26	WOS:000382855600117
J	Zhou, Y; Shah, SZA; Yang, LF; Zhang, ZQ; Zhou, XM; Zhao, DM				Zhou, Yang; Shah, Syed Zahid Ali; Yang, Lifeng; Zhang, Zhongqiu; Zhou, Xiangmei; Zhao, Deming			Virulent Mycobacterium bovis Beijing Strain Activates the NLRP7 Inflammasome in THP-1 Macrophages	PLOS ONE			English	Article							AIM2 INFLAMMASOME; TUBERCULOSIS INFECTION; LISTERIA-MONOCYTOGENES; IL-1-BETA PRODUCTION; PROTEIN; SECRETION; HUMANS; RECOGNITION; LIPOPROTEIN; PYROPTOSIS	Mycobacterium bovis is the causative agent of tuberculosis in a wide range of mammals, including humans. Macrophages are the first line of host defense. They secrete proinflammatory cytokines, such as interleukin-1 beta (IL-1 beta), in response to mycobacterial infection, but the underlying mechanisms by which human macrophages are activated and release IL-1 beta following M. bovis infection are poorly understood. Here we show that the 'nucleotide binding and oligomerization of domain-like receptor (NLR) family pyrin domain containing 7 protein' (NLRP7) inflammasome is involved in IL-1 beta secretion and caspase-1 activation induced by M. bovis infection in THP-1 macrophages. NLRP7 inflammasome activation promotes the induction of pyroptosis as well as the expression of tumor necrosis factor alpha (TNF-alpha), Chemokine (C-C motif) ligand 3 (CCL3) and IL-1 beta mRNAs. Thus, the NLRP7 inflammasome contributes to IL-1 beta secretion and induction of pyroptosis in response to M. bovis infection in THP-1 macrophages.	[Zhou, Yang; Shah, Syed Zahid Ali; Yang, Lifeng; Zhou, Xiangmei; Zhao, Deming] China Agr Univ, Coll Vet Med, Natl Anim Transmissible Spongiform Encephalopathy, Key Lab Anim Epidemiol & Zoonosis,Minist Agr, Beijing 100193, Peoples R China; [Zhou, Yang; Shah, Syed Zahid Ali; Yang, Lifeng; Zhou, Xiangmei; Zhao, Deming] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Zhang, Zhongqiu] Minist Agr Peoples Republ China, Vet Bur, Beijing 100125, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University; Ministry of Agriculture & Rural Affairs	Zhou, XM; Zhao, DM (corresponding author), China Agr Univ, Coll Vet Med, Natl Anim Transmissible Spongiform Encephalopathy, Key Lab Anim Epidemiol & Zoonosis,Minist Agr, Beijing 100193, Peoples R China.; Zhou, XM; Zhao, DM (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.	zhouxm@cau.edu.cn; zhaodm@cau.edu.cn	Shah, Syed Zahid Ali/GQQ-7452-2022; Buchowski, Maciej S./A-2683-2008	Buchowski, Maciej S./0000-0002-0566-1743; Shah, Syed Zahid Ali/0000-0003-4705-229X; Shah, Syed Zahid Ali/0000-0002-9638-5800	MoSTRCUK international cooperation project [2013DFG32500]; National Natural Science Foundation of China [31572487]; Funding of State Key Lab of Agrobiotechnology [2012SKLAB06-14]; CAU Foreign Experts Major Projects [2012z018]; Foreign Experts Recruitment Program [GDW20151100036]; NATIONAL CANCER INSTITUTE [R01CA092447] Funding Source: NIH RePORTER	MoSTRCUK international cooperation project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funding of State Key Lab of Agrobiotechnology; CAU Foreign Experts Major Projects; Foreign Experts Recruitment Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by MoSTRCUK international cooperation project (Project No. 2013DFG32500) http://www.istcp.org.cn, National Natural Science Foundation of China (Project No. 31572487) https://isisn.nsfc.gov.cn, Funding of State Key Lab of Agrobiotechnology (Project No. 2012SKLAB06-14) http://cbs.cau.edu.cn, 2015 CAU Foreign Experts Major Projects (Project No: 2012z018) http://cau.edu.cn, and High-end Foreign Experts Recruitment Program (Project No: GDW20151100036) http://cepms.safea.gov.cn.	Alfonso-Loeches S, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00216; Algood HMS, 2003, CYTOKINE GROWTH F R, V14, P467, DOI 10.1016/S1359-6101(03)00054-6; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Baker MG, 2006, EPIDEMIOL INFECT, V134, P1068, DOI 10.1017/S0950268806005930; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bigi F, 1997, MICROBIOL-SGM, V143, P3599, DOI 10.1099/00221287-143-11-3599; Bigi F, 2000, MICROBIOL-UK, V146, P1011, DOI 10.1099/00221287-146-4-1011; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036292; Dorhoi A, 2012, EUR J IMMUNOL, V42, P374, DOI 10.1002/eji.201141548; Fend R, 2005, J CLIN MICROBIOL, V43, P1745, DOI 10.1128/JCM.43.4.1745-1751.2005; Haneklaus M, 2012, J IMMUNOL, V189, P3795, DOI 10.4049/jimmunol.1200312; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Lee HM, 2013, GLIA, V61, P441, DOI 10.1002/glia.22448; Loria JRD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066818; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; Muller B, 2013, EMERG INFECT DIS, V19, P899, DOI 10.3201/eid1906.120543; Murdoch S, 2006, NAT GENET, V38, P300, DOI 10.1038/ng1740; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Saiga H, 2012, INT IMMUNOL, V24, P637, DOI 10.1093/intimm/dxs062; Sauer JD, 2011, P NATL ACAD SCI USA, V108, P12419, DOI 10.1073/pnas.1019041108; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Saunders BM, 2005, J IMMUNOL, V174, P4852, DOI 10.4049/jimmunol.174.8.4852; Schroder K, 2012, IMMUNOBIOLOGY, V217, P1325, DOI 10.1016/j.imbio.2012.07.020; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Segueni N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126058; Shah S, 2013, J IMMUNOL, V191, P3514, DOI 10.4049/jimmunol.1301331; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878; Wiker HG, 1998, INFECT IMMUN, V66, P1445, DOI 10.1128/IAI.66.4.1445-1452.1998; Yang Y, 2013, J INFECT DIS, V208, P1849, DOI 10.1093/infdis/jit347; Zhou Y, 2015, ANTON LEEUW INT J G, V108, P163, DOI 10.1007/s10482-015-0475-6	41	28	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152853	10.1371/journal.pone.0152853	http://dx.doi.org/10.1371/journal.pone.0152853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27583358	gold, Green Published, Green Submitted			2022-12-26	WOS:000373592100039
J	Weston, C; Winfield, I; Harris, M; Hodgson, R; Shah, A; Dowell, SJ; Mobarec, JC; Woodlock, DA; Reynolds, CA; Poyner, DR; Watkins, HA; Ladds, G				Weston, Cathryn; Winfield, Ian; Harris, Matthew; Hodgson, Rose; Shah, Archna; Dowell, Simon J.; Mobarec, Juan Carlos; Woodlock, David A.; Reynolds, Christopher A.; Poyner, David R.; Watkins, Harriet A.; Ladds, Graham			Receptor Activity-modifying Protein-directed G Protein Signaling Specificity for the Calcitonin Gene-related Peptide Family of Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); molecular dynamics; molecular modeling; signal transduction; yeast; adrenomedullin; adrenomedullin 2; CGRP; RAMP; signal bias	COUPLED RECEPTORS; CGRP RECEPTOR; ADRENOMEDULLIN; PHARMACOLOGY; DYNAMICS; ACTIVATION; INTERMEDIN; PATHWAYS; AMYLIN; CELLS	The calcitonin gene-related peptide (CGRP) family of G protein-coupled receptors (GPCRs) is formed through the association of the calcitonin receptor-like receptor (CLR) and one of three receptor activity-modifying proteins (RAMPs). Binding of one of the three peptide ligands, CGRP, adrenomedullin (AM), and intermedin/adrenomedullin 2 (AM2), is well known to result in a G(s)-mediated increase in cAMP. Here we used modified yeast strains that couple receptor activation to cell growth, via chimeric yeast/G subunits, and HEK-293 cells to characterize the effect of different RAMP and ligand combinations on this pathway. We not only demonstrate functional couplings to both G(s) and G(q) but also identify a G(i) component to CLR signaling in both yeast and HEK-293 cells, which is absent in HEK-293S cells. We show that the CGRP family of receptors displays both ligand- and RAMP-dependent signaling bias among the G(s), G(i), and G(q/11) pathways. The results are discussed in the context of RAMP interactions probed through molecular modeling and molecular dynamics simulations of the RAMP-GPCR-G protein complexes. This study further highlights the importance of RAMPs to CLR pharmacology and to bias in general, as well as identifying the importance of choosing an appropriate model system for the study of GPCR pharmacology.	[Weston, Cathryn; Winfield, Ian; Hodgson, Rose; Shah, Archna] Univ Warwick, Warwick Med Sch, Div Biomed Cell Biol, Coventry CV4 7AL, W Midlands, England; [Winfield, Ian; Harris, Matthew; Ladds, Graham] Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England; [Dowell, Simon J.] GlaxoSmithkline, Dept Platform Technol & Sci, Stevenage SG1 2NY, Herts, England; [Mobarec, Juan Carlos; Woodlock, David A.; Reynolds, Christopher A.] Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England; [Poyner, David R.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Watkins, Harriet A.] Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand; [Watkins, Harriet A.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1010, New Zealand	University of Warwick; University of Cambridge; GlaxoSmithKline; University of Essex; Aston University; University of Auckland; University of Auckland	Ladds, G (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	grl30@cam.ac.uk	Harris, Matt/AAV-1471-2021; Reynolds, Christopher/G-1036-2010	Harris, Matt/0000-0002-7918-5735; Dowell, Simon/0000-0001-6499-7573; Reynolds, Christopher/0000-0001-9267-5141; Mobarec, Juan Carlos/0000-0001-9482-4294; Ladds, Graham/0000-0001-7320-9612; Poyner, David R/0000-0003-1590-112X	National Heart Foundation of New Zealand; School of Biological Sciences, University of Auckland [BB/M00015X/1, BB/M000176/1, BB/M006883/1]; BBSRC; BBSRC Doctoral Training Partnership Grant [BB/JO14540/1]; MRC Doctoral Training Partnership [MR/J003964/1]; Warwick Impact Fund; Warwick Research Development Fund [RD13301]; Warwick Undergraduate Research Scholarship Scheme; Biotechnology and Biological Sciences Research Council [BB/M00015X/1, BB/M007529/1, BB/M000176/1, BB/M00015X/2, BB/M006883/1, 1643678] Funding Source: researchfish; Medical Research Council [1361423] Funding Source: researchfish; BBSRC [1643678, BB/M00015X/1, BB/M00015X/2, BB/M007529/1, BB/M006883/1, BB/M000176/1] Funding Source: UKRI	National Heart Foundation of New Zealand; School of Biological Sciences, University of Auckland(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Doctoral Training Partnership Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC Doctoral Training Partnership(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Warwick Impact Fund; Warwick Research Development Fund; Warwick Undergraduate Research Scholarship Scheme; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the National Heart Foundation of New Zealand (to H. A. W.), the School of Biological Sciences, University of Auckland seed fund (to H. A. W.), Grants BB/M00015X/1 (to G. L.), BB/M000176/1 (to D. R. P.), and BB/M006883/1 (to C. A. R.) from the BBSRC, BBSRC Doctoral Training Partnership Grant BB/JO14540/1 (to M. H.), MRC Doctoral Training Partnership MR/J003964/1 (to I. W.), the Warwick Impact Fund (to C. W. and G. L.), Grant RD13301 from the Warwick Research Development Fund (to C. W. and G. L.), and the Warwick Undergraduate Research Scholarship Scheme (to A. S. and R. H). The authors declare they have no conflicts of interest with the contents of this article.	Aiyar N, 1999, MOL CELL BIOCHEM, V197, P179, DOI 10.1023/A:1006962221332; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Booe JM, 2015, MOL CELL, V58, P1040, DOI 10.1016/j.molcel.2015.04.018; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Brown AJ, 2000, YEAST, V16, P11, DOI 10.1002/(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO;2-K; Case D. A., 2016, AMBER 2016; Christopoulos G, 1999, MOL PHARMACOL, V56, P235, DOI 10.1124/mol.56.1.235; Dickson CJ, 2014, J CHEM THEORY COMPUT, V10, P865, DOI 10.1021/ct4010307; Disa J, 2000, NEUROPEPTIDES, V34, P229, DOI 10.1054/npep.2000.0810; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dowell SJ, 2002, RECEPTOR CHANNEL, V8, P343, DOI 10.1080/10606820214647; Edvinsson L, 2013, CURR PROTEIN PEPT SC, V14, P386, DOI 10.2174/13892037113149990055; Figueroa KW, 2009, J PHARMACOL EXP THER, V328, P331, DOI 10.1124/jpet.108.145219; Fritz-Six KL, 2008, J CLIN INVEST, V118, P40, DOI 10.1172/JCI33302; Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14; Gingell JJ, 2010, PEPTIDES, V31, P1400, DOI 10.1016/j.peptides.2010.03.027; Harikumar KG, 2009, BIOCHEMISTRY-US, V48, P11773, DOI 10.1021/bi901326k; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; Hay DL, 2016, BIOCHEM SOC T, V44, P568, DOI 10.1042/BST20150237; Hay DL, 2003, REGUL PEPTIDES, V112, P139, DOI 10.1016/S0167-0115(03)00032-6; Hoang HN, 2015, J MED CHEM, V58, P4080, DOI 10.1021/acs.jmedchem.5b00166; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Holmes D, 2013, CURR PROTEIN PEPT SC, V14, P294, DOI 10.2174/13892037113149990049; Hong YG, 2012, BRIT J PHARMACOL, V166, P110, DOI 10.1111/j.1476-5381.2011.01530.x; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Ichikawa-Shindo Y, 2008, J CLIN INVEST, V118, P29, DOI 10.1172/JCI33022; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kataoka Y, 2010, J CARDIOVASC PHARM, V56, P413, DOI 10.1097/FJC.0b013e3181f15b45; Kato J, 2015, EUR J PHARMACOL, V764, P140, DOI 10.1016/j.ejphar.2015.06.061; KIM DH, 1991, PFLUG ARCH EUR J PHY, V418, P338, DOI 10.1007/BF00550871; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Kuwasako K, 2010, BIOCHEM BIOPH RES CO, V392, P380, DOI 10.1016/j.bbrc.2010.01.030; Ladds G, 2005, TRENDS BIOTECHNOL, V23, P367, DOI 10.1016/j.tibtech.2005.05.007; Ladds G, 2003, MOL MICROBIOL, V47, P781, DOI 10.1046/j.1365-2958.2003.03336.x; Ladds G, 2009, EUR J PHARMACOL, V610, P23, DOI 10.1016/j.ejphar.2009.03.042; Li Y, 2016, PHYS CHEM CHEM PHYS, V18, P12642, DOI 10.1039/c6cp00798h; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Main MJ, 1998, FEBS LETT, V441, P6, DOI 10.1016/S0014-5793(98)01507-5; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Miret JJ, 2002, J BIOL CHEM, V277, P6881, DOI 10.1074/jbc.M107384200; Perez-Castells J, 2012, BIOPOLYMERS, V97, P45, DOI 10.1002/bip.21700; Permpoonputtana K, 2016, LIFE SCI, V144, P19, DOI 10.1016/j.lfs.2015.11.015; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; Qi T, 2013, BRIT J PHARMACOL, V168, P644, DOI 10.1111/j.1476-5381.2012.02197.x; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Roh J, 2004, J BIOL CHEM, V279, P7264, DOI 10.1074/jbc.M305332200; Russell FA, 2014, PHYSIOL REV, V94, P1099, DOI 10.1152/physrev.00034.2013; SHIMEKAKE Y, 1995, J BIOL CHEM, V270, P4412, DOI 10.1074/jbc.270.9.4412; Singh R, 2015, J PHYS CHEM B, V119, P2806, DOI 10.1021/jp509814n; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Smillie SJ, 2011, NEUROPEPTIDES, V45, P93, DOI 10.1016/j.npep.2010.12.002; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Takei Y, 2004, FEBS LETT, V556, P53, DOI 10.1016/S0014-5793(03)01368-1; Walker CS, 2010, TRENDS PHARMACOL SCI, V31, P476, DOI 10.1016/j.tips.2010.06.006; Walker R. C., 2014, 248 NAT M AM CHEM SO; Watkins HA, 2014, BRIT J PHARMACOL, V171, P772, DOI 10.1111/bph.12508; Watkins HA, 2016, J BIOL CHEM, V291, P11657, DOI 10.1074/jbc.M115.688218; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Weston C, 2014, BRIT J PHARMACOL, V171, P3651, DOI 10.1111/bph.12716; Weston C, 2015, J BIOL CHEM, V290, P23009, DOI 10.1074/jbc.M114.624601; WILEY JW, 1992, J PHYSIOL-LONDON, V455, P367, DOI 10.1113/jphysiol.1992.sp019306; Woolley MJ, 2013, CURR PROTEIN PEPT SC, V14, P358, DOI 10.2174/13892037113149990053; Wootten D, 2013, BRIT J PHARMACOL, V168, P822, DOI 10.1111/j.1476-5381.2012.02202.x; Wootten D, 2016, CELL, V165, P1632, DOI 10.1016/j.cell.2016.05.023; Wootten D, 2016, MOL PHARMACOL, V89, P335, DOI 10.1124/mol.115.101246; Wunder F, 2008, MOL PHARMACOL, V73, P1235, DOI 10.1124/mol.107.042283; Yang DH, 2016, J BIOL CHEM, V291, P12991, DOI 10.1074/jbc.M116.721977; Yang LL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8859	72	55	55	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21925	21944		10.1074/jbc.M116.751362	http://dx.doi.org/10.1074/jbc.M116.751362			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27913664	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000386332600009
J	Zhou, YE; Buchowski, MS; Liu, JG; Schlundt, DG; Ukoli, FAM; Blot, WJ; Hargreaves, MK				Zhou, Yuan E.; Buchowski, Maciej S.; Liu, Jianguo; Schlundt, David G.; Ukoli, Flora A. M.; Blot, William J.; Hargreaves, Margaret K.			Plasma Lycopene Is Associated with Pizza and Pasta Consumption in Middle-Aged and Older African American and White Adults in the Southeastern USA in a Cross-Sectional Study	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; 3RD NATIONAL-HEALTH; ALPHA-TOCOPHEROL; DIETARY PATTERNS; UNITED-STATES; RACIAL-DIFFERENCES; NUTRIENT INTAKE; ENERGY-INTAKE; CANCER-RISK; NHANES-III	Background The role of dietary lycopene in chronic disease prevention is not well known. Methods This study examined intake of lycopene and other antioxidants from lycopene-rich foods (e.g., pizza and pasta) simultaneously with plasma levels of lycopene and other antioxidants in a representative cross-sectional sample (187 Blacks, 182 Whites, 40-79 years old) from the Southern Community Cohort Study (SCCS). The SCCS is an ongoing study conducted in populations at high risk for chronic diseases living in Southeastern United States. Dietary intake was assessed using a validated food frequency questionnaire (FFQ), and plasma levels of lycopene and other antioxidants were measured at baseline (2002-2005). The participants were classified into tertiles according to consumption of pizza and pasta food groups. Results Lycopene dietary intake and plasma lycopene concentrations were significantly higher in the highest (tertile 3) compared to tertiles 1 and 2 (both P < 0.01). Total energy intake ranged from 1964.3 +/- 117.1 kcal/day (tertile 1) to 3277.7 +/- 115.8 kcal/day (tertile 3) (P<0.0001). After adjusting for age and energy intake, total dietary fat, saturated fatty acids, trans-fatty acids, and sodium intakes were significantly higher in tertile 3 than tertiles 2 and 1 (all P < 0.01). Vitamin C intake was significantly lower in tertile 3 than tertiles 1 and 2 (P = 0.003). Except for gamma-tocopherol being higher in tertile 3 than tertiles 1 and 2 (P = 0.015), the plasma concentrations of antioxidants were lower in tertile 3 than tertiles 1 and 2 ( beta-carotene, alpha-carotene, lutein and zeaxanthin, all P<0.05). Conclusions In the SCCS population, pizza and pasta were the main sources of dietary lycopene and their intake was associated with plasma lycopene concentration. Diets with frequent pizza and pasta consumption were high in energy, saturated fatty acids, trans-fatty acids, sodium and low in other antioxidants. Future studies of lycopene as a protective dietary factor against chronic disease should consider the overall nutritional quality of lycopene-containing foods.	[Zhou, Yuan E.; Liu, Jianguo; Hargreaves, Margaret K.] Meharry Med Coll, Dept Internal Med, Nashville, TN 37208 USA; [Buchowski, Maciej S.; Blot, William J.] Vanderbilt Univ, Dept Med, Nashville, TN 37212 USA; [Schlundt, David G.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Ukoli, Flora A. M.] Meharry Med Coll, Dept Surg, Nashville, TN 37208 USA	Meharry Medical College; Vanderbilt University; Vanderbilt University; Meharry Medical College	Zhou, YE (corresponding author), Meharry Med Coll, Dept Internal Med, Nashville, TN 37208 USA.	yzhou@mmc.edu	Shah, Syed Zahid Ali/GQQ-7452-2022; Buchowski, Maciej S./A-2683-2008	Buchowski, Maciej S./0000-0002-0566-1743; Shah, Syed Zahid Ali/0000-0003-4705-229X; Shah, Syed Zahid Ali/0000-0002-9638-5800	NCI grant from the National Cancer Institute [R01 CA092447]; CTSA grant from the National Center for Advancing Translational Sciences [202815-502001-20]; CNPC grant from the National Cancer Institute [3 U54 CA1 S3708-03]; NIDDK grant from the National Institute of Diabetes and Digestive and Kidney Diseases [1 P30 DK092986]; Vanderbilt-Ingram Cancer Center (US) [P30CA068485]; NATIONAL CANCER INSTITUTE [R01CA092447] Funding Source: NIH RePORTER	NCI grant from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CTSA grant from the National Center for Advancing Translational Sciences; CNPC grant from the National Cancer Institute; NIDDK grant from the National Institute of Diabetes and Digestive and Kidney Diseases; Vanderbilt-Ingram Cancer Center (US); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NCI grant R01 CA092447 from the National Cancer Institute, CTSA grant 202815-502001-20 from the National Center for Advancing Translational Sciences, CNPC grant 3 U54 CA1 S3708-03 from the National Cancer Institute, NIDDK grant 1 P30 DK092986 from the National Institute of Diabetes and Digestive and Kidney Diseases, and Vanderbilt-Ingram Cancer Center (US) P30CA068485. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron KJ, 2011, AM J CLIN NUTR, V94, P1071, DOI 10.3945/ajcn.111.013094; Block G, 2004, J FOOD COMPOS ANAL, V17, P439, DOI 10.1016/j.jfca.2004.02.007; Bovell-Benjamin A, 2010, J HEALTH CARE POOR U, V21, P57, DOI 10.1353/hpu.0.0361; Buchowski MS, 2003, CELL MOL BIOL, V49, P1295; Clinton SK, 1996, CANCER EPIDEM BIOMAR, V5, P823; COATES RJ, 1991, AM J EPIDEMIOL, V134, P658, DOI 10.1093/oxfordjournals.aje.a116138; Cook A, 2000, J EPIDEMIOL COMMUN H, V54, P611, DOI 10.1136/jech.54.8.611; CRAFT NE, 1988, CLIN CHEM, V34, P44; Cullen MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032930; DI MASCIO P, 1989, ARCH BIOCHEM BIOPHYS, V274, P532, DOI 10.1016/0003-9861(89)90467-0; Dulloo AG, 2012, OBES REV, V13, P1, DOI 10.1111/j.1467-789X.2012.01032.x; Epplein M, 2009, CANCER EPIDEM BIOMAR, V18, P1962, DOI 10.1158/1055-9965.EPI-09-0003; Estadella D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/137579; FRANKE AA, 1993, J CHROMATOGR-BIOMED, V614, P43, DOI 10.1016/0378-4347(93)80222-P; Garcia AL, 2008, BRIT J NUTR, V99, P1293, DOI 10.1017/S0007114507868486; Gerster H, 1997, J AM COLL NUTR, V16, P109; Grainger EM, 2015, BRIT J NUTR, V114, P596, DOI 10.1017/S0007114515002202; Gross M, 2003, AM J CLIN NUTR, V77, P458, DOI 10.1093/ajcn/77.2.458; GROSS MD, 1995, CLIN CHEM, V41, P943; Gutierrez OM, 2014, AM J KIDNEY DIS, V64, P204, DOI 10.1053/j.ajkd.2014.02.013; Hajjar I, 2003, J NUTR, V133, P211, DOI 10.1093/jn/133.1.211; Hall WD, 1997, AM J MED SCI, V313, P195, DOI 10.1097/00000441-199704000-00002; Hargreaves MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084972; HORNE DW, 1988, CLIN CHEM, V34, P2357; Institute of Medicine, 2004, DIET REF INT WAT POT; Institute of Medicine Food and Nutrition Board, 2002, DIET REF INT EN CARB; Johansson L, 1998, AM J CLIN NUTR, V68, P266, DOI 10.1093/ajcn/68.2.266; Judd SE, 2013, STROKE, V44, P3305, DOI 10.1161/STROKEAHA.113.002636; Kachan D, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140023; Kiage JN, 2014, AM J CLIN NUTR, V99, P1071, DOI 10.3945/ajcn.113.075713; Locher JL, 2004, ALABAMA HERITAGE, V74, P6; Mackinnon ES, 2011, J NUTR HEALTH AGING, V15, P133, DOI 10.1007/s12603-011-0026-4; Mayne ST, 2003, J NUTR, V133, p933S, DOI 10.1093/jn/133.3.933S; Mayne ST, 1999, J NUTR, V129, P849, DOI 10.1093/jn/129.4.849; MENEELY GR, 1976, AM J CARDIOL, V38, P768, DOI 10.1016/0002-9149(76)90356-8; Obisesan TO, 2000, STROKE, V31, P19, DOI 10.1161/01.STR.31.1.19; Paeratakul S, 2003, J AM DIET ASSOC, V103, P1332, DOI 10.1016/S0002-8223(03)01086-1; Rao AV, 2007, PHARMACOL RES, V55, P207, DOI 10.1016/j.phrs.2007.01.012; Rao AV, 2006, ADV FOOD NUTR RES, V51, P99, DOI 10.1016/S1043-4526(06)51002-2; Re R, 2003, EUR J CLIN NUTR, V57, P1545, DOI 10.1038/sj.ejcn.1601723; Riccioni G, 2008, EUR REV MED PHARMACO, V12, P183; Schwab U, 2014, FOOD NUTR RES, V58, DOI 10.3402/fnr.v58.25145; Shah M, 2010, J NUTR EDUC BEHAV, V42, P99, DOI 10.1016/j.jneb.2009.02.001; Shi J, 2000, CRIT REV FOOD SCI, V40, P1, DOI 10.1080/10408690091189275; Siega-Riz A M, 2001, J Am Med Womens Assoc (1972), V56, P44; Signorello LB, 2010, J HEALTH CARE POOR U, V21, P26, DOI 10.1353/hpu.0.0245; Signorello LB, 2010, AM J EPIDEMIOL, V171, P488, DOI 10.1093/aje/kwp402; Signorello LB, 2009, AM J EPIDEMIOL, V170, P104, DOI 10.1093/aje/kwp098; Soory Mena, 2012, Infectious Disorders - Drug Targets, V12, P388; Stimpson JP, 2007, J AM DIET ASSOC, V107, P1895, DOI 10.1016/j.jada.2007.08.016; Stimpson JP, 2007, J AM DIET ASSOC, V107, P1218, DOI 10.1016/j.jada.2007.04.008; Talegawkar SA, 2007, J NUTR, V137, P2297, DOI 10.1093/jn/137.10.2297; Testa R, 2014, CURR OPIN CLIN NUTR, V17, P338, DOI 10.1097/MCO.0000000000000066; TONUCCI LH, 1995, J AGR FOOD CHEM, V43, P579, DOI 10.1021/jf00051a005; United States Department of Agriculture (USDA) National Agricultural Library, 2016, USDA NUTR DAT LISTS; Voeks JH, 2008, STROKE, V39, P1675, DOI 10.1161/STROKEAHA.107.507053; Wei MY, 2012, J ONCOL, V2012, DOI 10.1155/2012/271063; Whelton PK, 2014, CURR OPIN LIPIDOL, V25, P75, DOI 10.1097/MOL.0000000000000033; Williams CD, 2009, CANCER EPIDEM BIOMAR, V18, P1552, DOI 10.1158/1055-9965.EPI-08-1146	59	28	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161918	10.1371/journal.pone.0161918	http://dx.doi.org/10.1371/journal.pone.0161918			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583358	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600074
